WB:WBGene00000001	aap-1
Exhibits protein kinase binding activity. Is involved in dauer larval development; determination of adult lifespan; and insulin receptor signaling pathway. Localizes to phosphatidylinositol 3-kinase complex. Is expressed in intestine and neurons. Human ortholog(s) of this gene are implicated in SHORT syndrome and agammaglobulinemia. Is an ortholog of human PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3).

WB:WBGene00000002	aat-1
Contributes to L-amino acid transmembrane transporter activity. Is involved in amino acid transmembrane transport. Localizes to amino acid transport complex. Is expressed in tail. Human ortholog(s) of this gene are implicated in cystinuria and lysinuric protein intolerance. Is an ortholog of human SLC7A8 (solute carrier family 7 member 8).

WB:WBGene00000003	aat-2
Is predicted to have L-amino acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria and lysinuric protein intolerance. Is an ortholog of human SLC7A7 (solute carrier family 7 member 7).

WB:WBGene00000004	aat-3
Contributes to L-amino acid transmembrane transporter activity. Is involved in amino acid transmembrane transport. Localizes to amino acid transport complex. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68. Is an ortholog of human SLC7A5 (solute carrier family 7 member 5) and SLC7A8 (solute carrier family 7 member 8).

WB:WBGene00000005	aat-4
Is predicted to have L-amino acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68. Is an ortholog of human SLC7A5 (solute carrier family 7 member 5) and SLC7A8 (solute carrier family 7 member 8).

WB:WBGene00000006	aat-5
Is predicted to have L-amino acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68.

WB:WBGene00000007	aat-6
Exhibits PDZ domain binding activity. Localizes to apical plasma membrane. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68.

WB:WBGene00000008	aat-7
Is predicted to have L-amino acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68.

WB:WBGene00000009	aat-8
Is predicted to have L-amino acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68.

WB:WBGene00000010	aat-9
Is predicted to have L-amino acid transmembrane transporter activity. Localizes to cell surface. Is expressed in body wall musculature and neurons. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68. Is an ortholog of several human genes including SLC7A11 (solute carrier family 7 member 11); SLC7A5 (solute carrier family 7 member 5); and SLC7A8 (solute carrier family 7 member 8).

WB:WBGene00000011	abc-1
Is involved in embryo development; mitotic cell cycle; and vulval development.

WB:WBGene00000012	abf-1
Is expressed in body wall musculature; intestine; neurons; and pharynx. Is predicted to encode a protein with the following domains: Nematode antimicrobial peptide; Antibacterial factor-related peptide; and Antibacterial factor-related peptide superfamily.

WB:WBGene00000013	abf-2
Is involved in defense response to Gram-negative bacterium and defense response to Gram-positive bacterium. Is expressed in excretory cell; marginal cell; and pharyngeal neurons.

WB:WBGene00000014	abf-3
Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in intestine and rectal gland cell.

WB:WBGene00000015	abf-4
Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Cadmium Chloride; resveratrol; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00000016	abf-5
Is enriched in FLP based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00000017	abf-6
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; multi-walled carbon nanotube; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00000018	abl-1
Is predicted to have non-membrane spanning protein tyrosine kinase activity. Is involved in several processes, including defense response to other organism; negative regulation of DNA damage response, signal transduction by p53 class mediator; and negative regulation of engulfment of apoptotic cell. Is expressed in Q cell; germ cell; neurons; pharynx; and ventral nerve cord. Is an ortholog of human ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) and ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase).

WB:WBGene00000019	abt-1
Is predicted to have ATPase-coupled transmembrane transporter activity and lipid transporter activity. Is involved in RNA interference. Human ortholog(s) of this gene are implicated in several diseases, including Tangier disease; autosomal recessive congenital ichthyosis (multiple); and retinal degeneration (multiple).

WB:WBGene00000020	abt-2
Is predicted to have ATPase-coupled transmembrane transporter activity and lipid transporter activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 9; autosomal recessive congenital ichthyosis (multiple); and retinal degeneration (multiple). Is an ortholog of human ABCA4 (ATP binding cassette subfamily A member 4).

WB:WBGene00000021	abt-3
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on RNA-seq; tiling array; and microarray studies. Is affected by four chemicals including Tunicamycin; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00000022	abt-4
Is predicted to have ATPase-coupled transmembrane transporter activity and lipid transporter activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis (multiple); pulmonary alveolar proteinosis; and retinal degeneration (multiple). Is an ortholog of human ABCA3 (ATP binding cassette subfamily A member 3).

WB:WBGene00000023	abt-5
Is predicted to have ATPase-coupled transmembrane transporter activity and lipid transporter activity. Is expressed in head. Human ortholog(s) of this gene are implicated in several diseases, including Tangier disease; autosomal recessive congenital ichthyosis (multiple); and retinal degeneration (multiple). Is an ortholog of human ABCA3 (ATP binding cassette subfamily A member 3).

WB:WBGene00000024	abu-1
Is involved in endoplasmic reticulum unfolded protein response. Localizes to integral component of endoplasmic reticulum membrane. Is expressed in pharynx.

WB:WBGene00000025	abu-2
Is involved in endoplasmic reticulum unfolded protein response.

WB:WBGene00000026	abu-3
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies. Is affected by resveratrol; Chlorpyrifos; and Sirolimus based on microarray studies.

WB:WBGene00000027	abu-4
Is involved in endoplasmic reticulum unfolded protein response.

WB:WBGene00000028	abu-5
Is involved in endoplasmic reticulum unfolded protein response. Is expressed in pharyngeal muscle cell.

WB:WBGene00000029	abu-6
Is involved in pharynx development. Is expressed in pharyngeal muscle cell.

WB:WBGene00000030	abu-7
Is involved in pharynx development.

WB:WBGene00000031	abu-8
Is involved in pharynx development.

WB:WBGene00000032	abu-9
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; eat-2; and xbp-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Ethanol; multi-walled carbon nanotube; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00000033	abu-10
Is involved in endoplasmic reticulum unfolded protein response.

WB:WBGene00000034	abu-11
Is involved in endoplasmic reticulum unfolded protein response.

WB:WBGene00000035	ace-1
Exhibits acetylcholinesterase activity and identical protein binding activity. Is involved in acetylcholine catabolic process and regulation of locomotion. Localizes to extracellular space. Is expressed in CEP; M cell; OLL; body wall musculature; and non-striated muscle. Is an ortholog of human ACHE (acetylcholinesterase (Cartwright blood group)) and BCHE (butyrylcholinesterase).

WB:WBGene00000036	ace-2
Exhibits acetylcholinesterase activity and protein homodimerization activity. Is involved in acetylcholine catabolic process; cholinergic synaptic transmission; and regulation of locomotion. Is expressed in several structures, including command interneuron; neurons; pm5; somatic nervous system; and tail hypodermis. Is an ortholog of human BCHE (butyrylcholinesterase).

WB:WBGene00000037	ace-3
Exhibits acetylcholinesterase activity and protein homodimerization activity. Is involved in several processes, including acetylcholine catabolic process; hatching; and regulation of backward locomotion. Is expressed in body wall musculature; neurons; pharyngeal muscle cell; and vulva. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human BCHE (butyrylcholinesterase).

WB:WBGene00000038	ace-4
Is predicted to have cholinesterase activity. Is expressed in body wall musculature; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human BCHE (butyrylcholinesterase).

WB:WBGene00000039	acn-1
Is predicted to have exopeptidase activity. Is involved in ecdysis, collagen and cuticulin-based cuticle; nematode male tail tip morphogenesis; and plasma membrane fusion. Is expressed in excretory gland cell; hypodermis; vulva; and in male. Is an ortholog of human ACE2 (angiotensin I converting enzyme 2).

WB:WBGene00000040	aco-1
Exhibits aconitate hydratase activity. Is involved in tricarboxylic acid metabolic process. Localizes to cytosol. Is expressed in seam cell. Is an ortholog of human ACO1 (aconitase 1).

WB:WBGene00000041	aco-2
Is predicted to have 4 iron, 4 sulfur cluster binding activity and aconitate hydratase activity. Localizes to mitochondrion. Is expressed widely. Human ortholog(s) of this gene are implicated in infantile cerebellar-retinal degeneration and optic atrophy 9. Is an ortholog of human ACO2 (aconitase 2).

WB:WBGene00000042	acr-2
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in several processes, including calcium ion import across plasma membrane; neuromuscular synaptic transmission; and regulation of muscle contraction. Localizes to neuron projection. Is expressed in cholinergic neurons; somatic nervous system; and vulval muscle. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00000043	acr-3
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in calcium ion import across plasma membrane. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy 3; congenital myasthenic syndrome (multiple); and multiple pterygium syndrome. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00000044	acr-5
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is involved in cellular response to nicotine. Is expressed in nerve ring; neurons; and tail.

WB:WBGene00000045	acr-6
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy 3; congenital myasthenic syndrome (multiple); and multiple pterygium syndrome. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00000046	acr-7
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is expressed in pharyngeal muscle cell. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000047	acr-8
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is expressed in body wall musculature; enteric muscle; nerve ring; neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy 3; congenital myasthenic syndrome (multiple); and multiple pterygium syndrome. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00000048	acr-9
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000049	acr-10
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000050	acr-11
Is predicted to have acetylcholine receptor activity. Is involved in chemical synaptic transmission. Human ortholog(s) of this gene are implicated in chromosome 15q13.3 microdeletion syndrome. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000051	acr-12
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in calcium ion import across plasma membrane and regulation of muscle contraction. Localizes to synapse. Is expressed in neurons. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy 3; congenital myasthenic syndrome (multiple); and multiple pterygium syndrome. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00000053	acr-14
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is expressed in intestine; muscle cell; and neurons. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000054	acr-15
Is predicted to have acetylcholine receptor activity. Is involved in cellular response to nicotine and chemical synaptic transmission. Is expressed in body wall musculature and neurons. Is used to study nicotine dependence. Human ortholog(s) of this gene are implicated in chromosome 15q13.3 microdeletion syndrome. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000055	acr-16
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in ion transmembrane transport. Localizes to cell projection. Is expressed in body wall musculature; linker cell; muscle cell; and neurons. Is used to study nicotine dependence. Human ortholog(s) of this gene are implicated in chromosome 15q13.3 microdeletion syndrome. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000056	acr-17
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00000057	acr-18
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is expressed in neurons and ray.

WB:WBGene00000058	acr-19
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Human ortholog(s) of this gene are implicated in chromosome 15q13.3 microdeletion syndrome. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00000059	acr-20
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00000060	acr-21
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is expressed in cholinergic neurons and ventral cord neurons. Is an ortholog of human CHRNA9 (cholinergic receptor nicotinic alpha 9 subunit).

WB:WBGene00000061	lgc-11
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00000062	acr-23
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is expressed in body wall musculature; interneuron; and touch receptor neurons. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00000063	act-1
Is predicted to be a structural constituent of cytoskeleton. Is involved in several processes, including cortical actin cytoskeleton organization; mitotic cytokinesis; and muscle organ development. Is expressed in body wall musculature and gonad. Human ortholog(s) of this gene are implicated in Baraitser-Winter syndrome and autosomal dominant nonsyndromic deafness 20. Is an ortholog of human ACTB (actin beta).

WB:WBGene00000064	act-2
Is predicted to have ATP binding activity. Is involved in several processes, including cortical actin cytoskeleton organization; cytoskeleton-dependent cytokinesis; and locomotion. Localizes to actin filament and cell cortex. Is expressed in body wall musculature; gonad; hypodermis; and neurons. Human ortholog(s) of this gene are implicated in Baraitser-Winter syndrome and autosomal dominant nonsyndromic deafness 20. Is an ortholog of human ACTB (actin beta).

WB:WBGene00000065	act-3
Is predicted to have ATP binding activity. Is involved in cortical actin cytoskeleton organization; embryo development; and mitotic cytokinesis. Localizes to striated muscle thin filament. Is expressed in gonad and head. Human ortholog(s) of this gene are implicated in Baraitser-Winter syndrome and autosomal dominant nonsyndromic deafness 20.

WB:WBGene00000066	act-4
Is predicted to be a structural constituent of cytoskeleton. Localizes to striated muscle thin filament. Is expressed in body wall musculature; gonad; spermatheca; and vulval muscle. Human ortholog(s) of this gene are implicated in Baraitser-Winter syndrome and autosomal dominant nonsyndromic deafness 20. Is an ortholog of human ACTB (actin beta).

WB:WBGene00000067	act-5
Is predicted to have ATP binding activity. Is involved in several processes, including larval feeding behavior; microvillus assembly; and positive regulation of eating behavior. Localizes to microvillar actin bundle and terminal web. Is expressed in excretory cell; gonad; intestine; pharyngeal-intestinal valve; and rectal gland cell.

WB:WBGene00000068	acy-1
Is predicted to have adenylate cyclase activity. Is involved in several processes, including cell death; memory; and regulation of defecation. Is expressed in body wall musculature; ganglia; neurons; ventral nerve cord; and vulval muscle. Is an ortholog of human ADCY9 (adenylate cyclase 9).

WB:WBGene00000069	acy-2
Is predicted to have adenylate cyclase activity. Is involved in adenylate cyclase-modulating G protein-coupled receptor signaling pathway and nematode larval development. Is expressed in CANL; CANR; head ganglion; and ventral cord neurons. Is an ortholog of human ADCY2 (adenylate cyclase 2) and ADCY4 (adenylate cyclase 4).

WB:WBGene00000070	acy-3
Is predicted to have calcium- and calmodulin-responsive adenylate cyclase activity. Is involved in negative regulation of protein kinase C signaling and regulation of establishment of cell polarity.

WB:WBGene00000071	acy-4
Is predicted to have adenylate cyclase activity. Is involved in positive regulation of oocyte maturation. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 44. Is an ortholog of human ADCY6 (adenylate cyclase 6).

WB:WBGene00000072	add-1
Is predicted to have actin filament binding activity; spectrin binding activity; and structural molecule activity. Is involved in memory; receptor localization to synapse; and regulation of actin cytoskeleton reorganization. Localizes to postsynaptic density. Is expressed in GLR; coelomocyte; and neurons. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of human ADD1 (adducin 1); ADD2 (adducin 2); and ADD3 (adducin 3).

WB:WBGene00000073	add-2
Is predicted to have actin filament binding activity; spectrin binding activity; and structural molecule activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of human ADD1 (adducin 1).

WB:WBGene00000074	adm-2
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 18; cone-rod dystrophy 9; and early infantile epileptic encephalopathy 61. Is an ortholog of several human genes including ADAM12 (ADAM metallopeptidase domain 12); ADAM28 (ADAM metallopeptidase domain 28); and ADAM9 (ADAM metallopeptidase domain 9).

WB:WBGene00000075	adm-4
Is predicted to have metalloendopeptidase activity. Is involved in Notch signaling pathway and cell fate specification. Is expressed in spermatheca and tail. Is an ortholog of human ADAM17 (ADAM metallopeptidase domain 17).

WB:WBGene00000076	adn-1
No description available

WB:WBGene00000077	adn-2
No description available

WB:WBGene00000078	adp-1
Is involved in negative adaptation of signaling pathway.

WB:WBGene00000079	adr-1
Exhibits mRNA binding activity. Is involved in several processes, including adenosine to inosine editing; determination of adult lifespan; and regulation of vulval development. Localizes to cytosolic ribosome and nucleus. Is expressed in nervous system and vulva. Is an ortholog of human ADAD1 (adenosine deaminase domain containing 1).

WB:WBGene00000080	adr-2
Exhibits double-stranded RNA adenosine deaminase activity. Is involved in adenosine to inosine editing; determination of adult lifespan; and positive regulation of chemotaxis. Localizes to cytoplasm and nucleus. Is expressed in germ line. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome and dyschromatosis symmetrica hereditaria. Is an ortholog of human ADAR (adenosine deaminase RNA specific) and ADARB1 (adenosine deaminase RNA specific B1).

WB:WBGene00000081	ads-1
Is predicted to have FAD binding activity and alkylglycerone-phosphate synthase activity. Human ortholog(s) of this gene are implicated in rhizomelic chondrodysplasia punctata type 3. Is an ortholog of human AGPS (alkylglycerone phosphate synthase).

WB:WBGene00000082	adt-1
Is predicted to have metal ion binding activity and metalloendopeptidase activity. Is expressed in several structures, including amphid neurons; body wall musculature; pharyngeal muscle cell; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is an ortholog of human ADAMTS6 (ADAM metallopeptidase with thrombospondin type 1 motif 6).

WB:WBGene00000083	adt-2
Is predicted to have metal ion binding activity and metalloendopeptidase activity. Is involved in several processes, including collagen fibril organization; determination of adult lifespan; and regulation of cell size. Is expressed in socket cell and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is an ortholog of human ADAMTS17 (ADAM metallopeptidase with thrombospondin type 1 motif 17); ADAMTS19 (ADAM metallopeptidase with thrombospondin type 1 motif 19); and ADAMTS6 (ADAM metallopeptidase with thrombospondin type 1 motif 6).

WB:WBGene00000084	aex-1
Is involved in several processes, including lipid transport involved in lipid storage; oviposition; and positive regulation of transport. Is expressed in amphid neurons; body wall musculature; and intestine.

WB:WBGene00000085	aex-2
Is predicted to have neuropeptide receptor activity. Is involved in lipid transport involved in lipid storage; neuropeptide signaling pathway; and positive regulation of transport. Is expressed in alimentary muscle; head mesodermal cell; and somatic nervous system.

WB:WBGene00000086	aex-3
Is predicted to have Rab guanyl-nucleotide exchange factor activity. Is involved in several processes, including nervous system development; oviposition; and positive regulation of transport. Localizes to cell. Is expressed in neurons. Is used to study alcohol use disorder. Is an ortholog of human MADD (MAP kinase activating death domain).

WB:WBGene00000088	aex-5
Exhibits serine-type endopeptidase activity. Is involved in several processes, including neuropeptide processing; positive regulation of synaptic growth at neuromuscular junction; and positive regulation of transport. Localizes to extracellular space. Human ortholog(s) of this gene are implicated in proprotein convertase 1/3 deficiency. Is an ortholog of human PCSK1 (proprotein convertase subtilisin/kexin type 1).

WB:WBGene00000089	aex-6
Is predicted to have GTPase activity. Is involved in exocytosis; positive regulation of cellular protein catabolic process; and positive regulation of defecation. Localizes to synaptic vesicle. Is expressed in ALML; ALMR; BDUL; BDUR; and neurons. Human ortholog(s) of this gene are implicated in Griscelli syndrome type 2. Is an ortholog of human RAB27A (RAB27A, member RAS oncogene family).

WB:WBGene00000090	age-1
Is predicted to have 1-phosphatidylinositol-3-kinase activity and 1-phosphatidylinositol-4-phosphate 3-kinase activity. Is involved in several processes, including dauer entry; insulin receptor signaling pathway involved in determination of adult lifespan; and regulation of synaptic growth at neuromuscular junction. Localizes to cytoplasm; non-motile cilium; and phosphatidylinositol 3-kinase complex. Is expressed in amphid neurons; hypodermis; and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in several diseases, including CLOVES syndrome; epidermal nevus; and gastrointestinal system cancer (multiple). Is an ortholog of human PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) and PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta).

WB:WBGene00000091	age-2
No description available

WB:WBGene00000092	ags-3
Exhibits G-protein alpha-subunit binding activity and GTPase activator activity. Is involved in regulation of feeding behavior. Localizes to membrane. Is expressed in several structures, including hermaphrodite gonad; intestine; muscle cell; neurons; and tail. Is an ortholog of human GPSM1 (G protein signaling modulator 1) and GPSM2 (G protein signaling modulator 2).

WB:WBGene00000093	agt-1
Exhibits damaged DNA binding activity and transferase activity, transferring alkyl or aryl (other than methyl) groups. Is involved in DNA dealkylation involved in DNA repair. Is an ortholog of human MGMT (O-6-methylguanine-DNA methyltransferase).

WB:WBGene00000094	agt-2
Is predicted to have transferase activity.

WB:WBGene00000095	aha-1
Exhibits DNA binding activity; DNA-binding transcription factor activity; and RNA polymerase II transcription factor binding activity. Contributes to sequence-specific DNA binding activity. Is involved in several processes, including positive regulation of transcription by RNA polymerase II; social behavior; and transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in hypodermis; intestine; neurons; and pharynx. Is an ortholog of human ARNT (aryl hydrocarbon receptor nuclear translocator) and ARNT2 (aryl hydrocarbon receptor nuclear translocator 2).

WB:WBGene00000096	ahr-1
Exhibits DNA binding activity and RNA polymerase II transcription factor binding activity. Is involved in negative regulation of locomotion and response to xenobiotic stimulus. Is expressed in ALML; ALMR; RMEL; RMER; and neurons. Is an ortholog of human AHR (aryl hydrocarbon receptor).

WB:WBGene00000097	aip-1
Is predicted to have zinc ion binding activity. Is involved in cellular response to misfolded protein and response to arsenic-containing substance. Localizes to cytoplasm and nucleus. Is expressed in body wall musculature; excretory cell; pharynx; and somatic gonad. Is an ortholog of human ZFAND2B (zinc finger AN1-type containing 2B).

WB:WBGene00000098	air-1
Exhibits protein kinase activity. Is involved in mitotic spindle assembly; positive regulation of protein localization to centrosome; and protein phosphorylation. Localizes to condensed nuclear chromosome and cytoskeleton. Is expressed in anterior distal tip cell; germ line; and posterior distal tip cell. Human ortholog(s) of this gene are implicated in spermatogenic failure 5. Is an ortholog of human AURKC (aurora kinase C).

WB:WBGene00000099	air-2
Exhibits ATPase binding activity; kinesin binding activity; and protein serine/threonine kinase activity. Is involved in several processes, including cellular protein modification process; cytoskeleton organization; and regulation of actomyosin contractile ring contraction. Localizes to condensed nuclear chromosome and spindle midzone. Is expressed in oocyte and sperm. Human ortholog(s) of this gene are implicated in spermatogenic failure 5. Is an ortholog of human AURKB (aurora kinase B) and AURKC (aurora kinase C).

WB:WBGene00000100	ajm-1
Is predicted to have cytoskeletal protein binding activity. Is involved in cell-cell junction organization and embryo development. Localizes to several cellular components, including adherens junction; apicolateral plasma membrane; and dendrite terminus. Is expressed in several structures, including arcade cell and epithelial cell. Is an ortholog of human AJM1 (apical junction component 1 homolog).

WB:WBGene00000101	aka-1
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 15. Is an ortholog of human ZFYVE16 (zinc finger FYVE-type containing 16) and ZFYVE9 (zinc finger FYVE-type containing 9).

WB:WBGene00000102	akt-1
Exhibits calmodulin binding activity; phosphatidylinositol-3,4,5-trisphosphate binding activity; and protein serine/threonine kinase activity. Is involved in several processes, including cellular protein modification process; insulin receptor signaling pathway; and intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator. Localizes to several cellular components, including cytoplasmic side of plasma membrane; dendrite; and neuronal cell body. Is expressed in several structures, including excretory canal; neurons; pharynx; rectal gland cell; and vulva. Is used to study cancer. Human ortholog(s) of this gene are implicated in several diseases, including Proteus syndrome; autoimmune lymphoproliferative syndrome type 3; and type 2 diabetes mellitus. Is an ortholog of human AKT1 (AKT serine/threonine kinase 1); AKT2 (AKT serine/threonine kinase 2); and AKT3 (AKT serine/threonine kinase 3).

WB:WBGene00000103	akt-2
Exhibits phosphatidylinositol-3,4,5-trisphosphate binding activity and protein serine/threonine kinase activity. Is involved in several processes, including cellular protein modification process; determination of adult lifespan; and insulin receptor signaling pathway. Is expressed in several structures, including excretory canal; neurons; pharynx; rectum; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Proteus syndrome; autoimmune lymphoproliferative syndrome type 3; and type 2 diabetes mellitus. Is an ortholog of human AKT2 (AKT serine/threonine kinase 2) and AKT3 (AKT serine/threonine kinase 3).

WB:WBGene00000104	ale-1
No description available

WB:WBGene00000105	alg-1
Exhibits RNA binding activity and nuclease activity. Is involved in several processes, including gene silencing by RNA; hermaphrodite genitalia development; and vulval development. Localizes to P-body and RISC complex. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; gonad; somatic cell; and tail. Is an ortholog of human AGO2 (argonaute RISC catalytic component 2).

WB:WBGene00000106	alg-2
Exhibits RNA binding activity and nuclease activity. Is involved in embryo development; gene silencing by RNA; and nematode larval development. Localizes to RISC complex and cytoplasm. Is expressed in several structures, including gonad; hypodermis; neurons; somatic cell; and ventral nerve cord. Is an ortholog of human AGO2 (argonaute RISC catalytic component 2).

WB:WBGene00000107	alh-1
Is predicted to have aldehyde dehydrogenase (NAD+) activity. Is used to study obesity. Is an ortholog of human ALDH2 (aldehyde dehydrogenase 2 family member).

WB:WBGene00000108	alh-2
Is predicted to have aldehyde dehydrogenase (NAD+) activity. Is an ortholog of human ALDH1B1 (aldehyde dehydrogenase 1 family member B1) and ALDH2 (aldehyde dehydrogenase 2 family member).

WB:WBGene00000109	alh-3
Is predicted to have aldehyde dehydrogenase (NAD+) activity and formyltetrahydrofolate dehydrogenase activity. Is an ortholog of human ALDH1L1 (aldehyde dehydrogenase 1 family member L1) and ALDH1L2 (aldehyde dehydrogenase 1 family member L2).

WB:WBGene00000110	alh-4
Is predicted to have 3-chloroallyl aldehyde dehydrogenase activity. Human ortholog(s) of this gene are implicated in Sjogren-Larsson syndrome. Is an ortholog of human ALDH3A1 (aldehyde dehydrogenase 3 family member A1) and ALDH3B1 (aldehyde dehydrogenase 3 family member B1).

WB:WBGene00000111	alh-5
Is predicted to have 3-chloroallyl aldehyde dehydrogenase activity. Human ortholog(s) of this gene are implicated in Sjogren-Larsson syndrome. Is an ortholog of human ALDH3A1 (aldehyde dehydrogenase 3 family member A1).

WB:WBGene00000112	alh-6
Is predicted to have 1-pyrroline-5-carboxylate dehydrogenase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in hyperprolinemia type 2. Is an ortholog of human ALDH4A1 (aldehyde dehydrogenase 4 family member A1).

WB:WBGene00000113	alh-7
Is predicted to have succinate-semialdehyde dehydrogenase (NAD+) activity. Human ortholog(s) of this gene are implicated in succinic semialdehyde dehydrogenase deficiency. Is an ortholog of human ALDH5A1 (aldehyde dehydrogenase 5 family member A1).

WB:WBGene00000114	alh-8
Is predicted to have fatty-acyl-CoA binding activity; malonate-semialdehyde dehydrogenase (acetylating) activity; and methylmalonate-semialdehyde dehydrogenase (acylating) activity. Localizes to mitochondrion. Is an ortholog of human ALDH6A1 (aldehyde dehydrogenase 6 family member A1).

WB:WBGene00000115	alh-9
Is predicted to have aldehyde dehydrogenase (NAD+) activity. Is expressed in ABa and seam cell. Is an ortholog of human ALDH7A1 (aldehyde dehydrogenase 7 family member A1).

WB:WBGene00000116	alh-10
Is predicted to have oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of human ALDH8A1 (aldehyde dehydrogenase 8 family member A1).

WB:WBGene00000117	alh-11
Is predicted to have 4-trimethylammoniobutyraldehyde dehydrogenase activity and aminobutyraldehyde dehydrogenase activity. Is an ortholog of human ALDH9A1 (aldehyde dehydrogenase 9 family member A1).

WB:WBGene00000118	alh-12
Is predicted to have 4-trimethylammoniobutyraldehyde dehydrogenase activity and aminobutyraldehyde dehydrogenase activity. Is an ortholog of human ALDH9A1 (aldehyde dehydrogenase 9 family member A1).

WB:WBGene00000119	ali-1
No description available

WB:WBGene00000120	aly-1
Is predicted to have nucleic acid binding activity. Is an ortholog of human ALYREF (Aly/REF export factor).

WB:WBGene00000121	aly-2
Is predicted to have nucleic acid binding activity. Is an ortholog of human ALYREF (Aly/REF export factor).

WB:WBGene00000122	aly-3
Is predicted to have nucleic acid binding activity. Is an ortholog of human ALYREF (Aly/REF export factor).

WB:WBGene00000123	ama-1
Contributes to RNA polymerase II activity. Is involved in several processes, including mRNA transcription by RNA polymerase II; positive regulation of gastrulation; and positive regulation of transcription, DNA-templated. Localizes to nucleus and transcriptionally active chromatin. Is an ortholog of human POLR2A (RNA polymerase II subunit A).

WB:WBGene00000124	ama-2
No description available

WB:WBGene00000125	amo-1
No description available

WB:WBGene00000126	amo-2
No description available

WB:WBGene00000127	amo-4
No description available

WB:WBGene00000128	amo-5
No description available

WB:WBGene00000129	amo-6
No description available

WB:WBGene00000130	amo-7
No description available

WB:WBGene00000131	amo-8
No description available

WB:WBGene00000132	amo-9
No description available

WB:WBGene00000133	amt-1
Is predicted to have ammonium transmembrane transporter activity.

WB:WBGene00000134	amt-2
Is predicted to have ammonium transmembrane transporter activity. Is involved in aging.

WB:WBGene00000135	amt-3
Is predicted to have ammonium transmembrane transporter activity. Is expressed in head and tail.

WB:WBGene00000136	amt-4
Is predicted to have ammonium transmembrane transporter activity.

WB:WBGene00000137	amx-1
Exhibits histone demethylase activity (H3-dimethyl-K4 specific). Is involved in histone H3-K4 demethylation. Is expressed in chemosensory neurons. Is an ortholog of human KDM1B (lysine demethylase 1B).

WB:WBGene00000138	amx-2
Is predicted to have several functions, including flavin adenine dinucleotide binding activity; histone demethylase activity (H3-dimethyl-K4 specific); and transcription factor binding activity. Is expressed in several structures, including HSN; anus; pharyngeal muscle cell; rectal epithelium; and vulva. Human ortholog(s) of this gene are implicated in Brunner Syndrome. Is an ortholog of human IL4I1 (interleukin 4 induced 1); MAOA (monoamine oxidase A); and MAOB (monoamine oxidase B).

WB:WBGene00000139	amx-3
Is predicted to have polyamine oxidase activity. Human ortholog(s) of this gene are implicated in Brunner Syndrome. Is an ortholog of human SMOX (spermine oxidase).

WB:WBGene00000140	anc-1
Is predicted to have actin binding activity. Is involved in cytoskeleton organization; nucleus organization; and pronuclear migration. Localizes to nuclear envelope and perinuclear region of cytoplasm. Is expressed in several structures, including body wall musculature; intestinal cell; and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including epidermolysis bullosa (multiple); intrinsic cardiomyopathy (multiple); and myopathy (multiple). Is an ortholog of human SYNE2 (spectrin repeat containing nuclear envelope protein 2).

WB:WBGene00000141	anx-1
No description available

WB:WBGene00000142	aos-1
Contributes to SUMO activating enzyme activity. Is involved in protein sumoylation. Is an ortholog of human SAE1 (SUMO1 activating enzyme subunit 1).

WB:WBGene00000143	apc-2
Is predicted to have ubiquitin protein ligase binding activity. Is an ortholog of human ANAPC2 (anaphase promoting complex subunit 2).

WB:WBGene00000144	apc-10
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Anaphase-promoting complex, subunit 10 (APC10); APC10/DOC domain; Galactose-binding-like domain superfamily; and Anaphase-promoting complex subunit APC10/Doc1. Is an ortholog of human ANAPC10 (anaphase promoting complex subunit 10).

WB:WBGene00000145	apc-11
Exhibits ubiquitin-protein transferase activity. Is involved in anaphase-promoting complex-dependent catabolic process; embryo development; and meiotic chromosome segregation. Is expressed in germ line. Is an ortholog of human ANAPC11 (anaphase promoting complex subunit 11).

WB:WBGene00000146	ape-1
Exhibits p53 binding activity. Is involved in negative regulation of apoptotic process. Is expressed in several structures, including neurons and ventral nerve cord. Is an ortholog of human PPP1R13B (protein phosphatase 1 regulatory subunit 13B) and TP53BP2 (tumor protein p53 binding protein 2).

WB:WBGene00000147	aph-1
Is predicted to have endopeptidase activity. Is involved in several processes, including oocyte development; pharynx development; and protein localization to cell surface. Is an ortholog of human APH1A (aph-1 homolog A, gamma-secretase subunit) and APH1B (aph-1 homolog B, gamma-secretase subunit).

WB:WBGene00000148	aph-2
Is involved in several processes, including Notch signaling pathway; oviposition; and pharynx development. Localizes to plasma membrane. Is expressed in oocyte. Human ortholog(s) of this gene are implicated in hidradenitis suppurativa. Is an ortholog of human NCSTN (nicastrin).

WB:WBGene00000149	apl-1
Is predicted to have heparin binding activity and transition metal ion binding activity. Is involved in body morphogenesis; ecdysis, collagen and cuticulin-based cuticle; and nematode larval development. Localizes to cytoplasmic vesicle; neuron projection; and neuronal cell body. Is expressed in several structures, including epithelial cell; excretory cell; hermaphrodite gonad; neurons; and pharyngeal-intestinal valve. Is used to study Alzheimer's disease. Human ortholog(s) of this gene are implicated in APP-related cerebral amyloid angiopathy and Alzheimer's disease 1. Is an ortholog of human APLP1 (amyloid beta precursor like protein 1) and APLP2 (amyloid beta precursor like protein 2).

WB:WBGene00000150	apm-1
Is involved in apical protein localization. Is expressed in head; nerve ring; tail; and vulva. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 50. Is an ortholog of human AP1M2 (adaptor related protein complex 1 subunit mu 2).

WB:WBGene00000151	apn-1
Exhibits 3'-tyrosyl-DNA phosphodiesterase activity; DNA-(apurinic or apyrimidinic site) endonuclease activity; and double-stranded DNA 3'-5' exodeoxyribonuclease activity. Is involved in base-excision repair. Is expressed in hermaphrodite gonad and male gonad.

WB:WBGene00000152	apo-2
No description available

WB:WBGene00000153	apo-3
No description available

WB:WBGene00000154	apo-4
No description available

WB:WBGene00000155	app-1
Exhibits metalloaminopeptidase activity; protein homodimerization activity; and zinc ion binding activity. Is involved in proteolysis. Localizes to cytoplasm. Is expressed in intestine. Is an ortholog of human XPNPEP1 (X-prolyl aminopeptidase 1).

WB:WBGene00000156	apr-1
Exhibits beta-catenin binding activity and protein N-terminus binding activity. Is involved in several processes, including embryonic morphogenesis; engulfment of apoptotic cell; and regulation of Wnt signaling pathway. Localizes to adherens junction; cell cortex; and nucleus. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and excretory cell. Human ortholog(s) of this gene are implicated in familial adenomatous polyposis 1; gastrointestinal system cancer (multiple); and hereditary desmoid disease. Is an ortholog of human APC (APC regulator of WNT signaling pathway) and APC2 (APC regulator of WNT signaling pathway 2).

WB:WBGene00000157	aps-2
Is predicted to have clathrin binding activity. Is involved in several processes, including body morphogenesis; clathrin-dependent endocytosis; and nematode larval development. Is expressed in neurons. Human ortholog(s) of this gene are implicated in familial hypocalciuric hypercalcemia 3. Is an ortholog of human AP2S1 (adaptor related protein complex 2 subunit sigma 1).

WB:WBGene00000158	apg-1
Is predicted to have clathrin binding activity. Is involved in apical protein localization and protein secretion. Is an ortholog of human AP1G1 (adaptor related protein complex 1 subunit gamma 1) and AP1G2 (adaptor related protein complex 1 subunit gamma 2).

WB:WBGene00000159	aps-1
Is involved in apical protein localization. Human ortholog(s) of this gene are implicated in MEDNIK syndrome; psoriasis 15; and syndromic X-linked intellectual disability 5. Is an ortholog of human AP1S1 (adaptor related protein complex 1 subunit sigma 1) and AP1S2 (adaptor related protein complex 1 subunit sigma 2).

WB:WBGene00000160	apb-1
Is predicted to have clathrin binding activity. Is involved in embryo development and receptor-mediated endocytosis. Is an ortholog of human AP1B1 (adaptor related protein complex 1 subunit beta 1).

WB:WBGene00000161	apa-2
Exhibits GTPase activating protein binding activity and protein C-terminus binding activity. Is involved in clathrin-dependent endocytosis; embryo development; and protein localization. Localizes to clathrin-coated endocytic vesicle and presynaptic periactive zone. Is expressed in several structures, including anterior gonad arm; germ line; intestine; nervous system; and vulva. Is an ortholog of human AP2A1 (adaptor related protein complex 2 subunit alpha 1) and AP2A2 (adaptor related protein complex 2 subunit alpha 2).

WB:WBGene00000162	apd-3
Is enriched in AVK; OLL; PVD; RIS; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; D-glucose; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; AP-3 complex subunit delta-1; Adaptin N terminal region; Clathrin/coatomer adaptor, adaptin-like, N-terminal; Armadillo-like helical; Armadillo-type fold; and Adaptor protein complex AP-3, delta subunit. Is an ortholog of human AP3D1 (adaptor related protein complex 3 subunit delta 1).

WB:WBGene00000163	apb-3
Is involved in embryo development and lysosome organization. Is expressed in motor neurons. Human ortholog(s) of this gene are implicated in Hermansky-Pudlak syndrome 2 and early infantile epileptic encephalopathy 48. Is an ortholog of human AP3B1 (adaptor related protein complex 3 subunit beta 1) and AP3B2 (adaptor related protein complex 3 subunit beta 2).

WB:WBGene00000164	apm-3
Is involved in lipid storage and lysosome organization. Is expressed in muscle cell; pharynx; spermatheca; and vulva. Is an ortholog of human AP3M1 (adaptor related protein complex 3 subunit mu 1).

WB:WBGene00000165	aps-3
Is enriched in body wall muscle cell; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; D-glucose; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Clathrin adaptor complex small chain; Longin-like domain superfamily; Adaptor protein complex, sigma subunit; and AP complex, mu/sigma subunit. Is an ortholog of human AP3S1 (adaptor related protein complex 3 subunit sigma 1) and AP3S2 (adaptor related protein complex 3 subunit sigma 2).

WB:WBGene00000166	apt-9
Exhibits protein N-terminus binding activity. Is involved in protein secretion. Is an ortholog of human GGA1 (golgi associated, gamma adaptin ear containing, ARF binding protein 1).

WB:WBGene00000168	apx-1
Is predicted to have Notch binding activity. Is involved in several processes, including embryonic pattern specification; lateral inhibition; and regulation of vulval development. Is expressed in several structures, including P6.paa; P6.pap; P6.ppa; non-striated muscle; and vulva. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is an ortholog of human DLL3 (delta like canonical Notch ligand 3).

WB:WBGene00000169	aqp-1
Exhibits channel activity. Is involved in defense response to Gram-negative bacterium; glycerol transport; and innate immune response. Localizes to basolateral plasma membrane. Is expressed in intestine and pharynx. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP9 (aquaporin 9).

WB:WBGene00000170	aqp-2
Exhibits water channel activity. Is involved in water transport. Is expressed in excretory cell; hypodermis; and muscle cell. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP9 (aquaporin 9).

WB:WBGene00000171	aqp-3
Exhibits water channel activity. Is involved in glycerol transport and water transport. Is expressed in excretory cell; intestine; and vas deferens. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP9 (aquaporin 9).

WB:WBGene00000172	aqp-4
Exhibits water channel activity. Is involved in water transport. Localizes to apical plasma membrane. Is expressed in intestine. Is an ortholog of human AQP8 (aquaporin 8).

WB:WBGene00000173	aqp-5
Is predicted to have water channel activity. Localizes to cell surface. Is expressed in IL1 neuron. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP8 (aquaporin 8).

WB:WBGene00000174	aqp-6
Exhibits water channel activity. Is involved in water transport. Localizes to neuronal cell body and non-motile cilium. Is expressed in IL1 neuron. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP8 (aquaporin 8).

WB:WBGene00000175	aqp-7
Exhibits water channel activity. Is involved in glycerol transport and water transport. Is expressed in muscle cell. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP9 (aquaporin 9).

WB:WBGene00000176	aqp-8
Is predicted to have channel activity. Localizes to cell surface. Is expressed in several structures, including excretory system; germ line; intestinal cell; non-striated muscle; and ray. Human ortholog(s) of this gene are implicated in Bothnian type palmoplantar keratoderma; cataract 15 multiple types; and nephrogenic diabetes insipidus. Is an ortholog of human AQP9 (aquaporin 9).

WB:WBGene00000177	aqp-9
Is predicted to have channel activity. Is an ortholog of human AQP11 (aquaporin 11).

WB:WBGene00000178	aqp-10
Is predicted to have channel activity. Is involved in innate immune response. Is an ortholog of human AQP11 (aquaporin 11); AQP12A (aquaporin 12A); and AQP12B (aquaporin 12B).

WB:WBGene00000179	aqp-11
Is predicted to have channel activity. Is an ortholog of human AQP11 (aquaporin 11); AQP12A (aquaporin 12A); and AQP12B (aquaporin 12B).

WB:WBGene00000180	arc-1
Is predicted to have GTP binding activity. Is an ortholog of human TRIM23 (tripartite motif containing 23).

WB:WBGene00000181	ard-1
Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability type 10. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B10 (hydroxysteroid 17-beta dehydrogenase 10).

WB:WBGene00000182	arf-1.2
Is predicted to have GTP binding activity. Is involved in several processes, including mitochondrion organization; oocyte development; and regulation of receptor-mediated endocytosis. Localizes to endoplasmic reticulum. Is expressed in pharyngeal muscle cell; uterus; and ventral nerve cord. Is an ortholog of human ARF1 (ADP ribosylation factor 1) and ARF3 (ADP ribosylation factor 3).

WB:WBGene00000183	arf-3
Is predicted to have GTP binding activity. Is involved in embryo development and germ cell development. Is expressed in several structures, including body wall musculature; intestine; pharyngeal muscle cell; ventral nerve cord; and vulva. Is an ortholog of human ARF5 (ADP ribosylation factor 5).

WB:WBGene00000184	arf-6
Is predicted to have GTP binding activity. Is involved in negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; positive regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; and positive regulation of endosome to plasma membrane protein transport. Localizes to basolateral plasma membrane; cytoplasmic side of apical plasma membrane; and recycling endosome membrane. Is expressed in several structures, including excretory cell; intestine; pharyngeal muscle cell; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in Joubert syndrome 8. Is an ortholog of human ARF6 (ADP ribosylation factor 6).

WB:WBGene00000185	arg-1
Is expressed in several structures, including head mesodermal cell; male distal tip cell; non-striated muscle; somatic gonad precursor; and tail. Is predicted to encode a protein with the following domains: Delta serrate ligand; EGF-like domain; and Delta/Serrate/lag-2 (DSL) protein.

WB:WBGene00000186	ark-1
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is involved in embryo development; negative regulation of epidermal growth factor receptor signaling pathway; and negative regulation of vulval development.

WB:WBGene00000187	arl-1
Is predicted to have GTP binding activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is expressed in hyp10; hyp11; hyp8; hyp9; and ventral nerve cord. Is an ortholog of human ARL1 (ADP ribosylation factor like GTPase 1).

WB:WBGene00000188	arl-3
Is predicted to have GTP binding activity. Is expressed in head neurons and tail neurons. Human ortholog(s) of this gene are implicated in Joubert syndrome 8. Is an ortholog of human ARL3 (ADP ribosylation factor like GTPase 3).

WB:WBGene00000189	arl-5
Is predicted to have GTP binding activity. Is involved in microtubule cytoskeleton organization. Human ortholog(s) of this gene are implicated in Joubert syndrome 8 and chylomicron retention disease. Is an ortholog of human ARL5A (ADP ribosylation factor like GTPase 5A) and ARL5B (ADP ribosylation factor like GTPase 5B).

WB:WBGene00000190	arf-1.1
Is predicted to have GTP binding activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in Joubert syndrome 8 and chylomicron retention disease. Is an ortholog of human ARF1 (ADP ribosylation factor 1) and ARF3 (ADP ribosylation factor 3).

WB:WBGene00000191	arl-7
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Sodium Chloride; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00000192	arl-8
Is predicted to have GTP binding activity. Is involved in axo-dendritic transport; endosome to lysosome transport; and regulation of anterograde synaptic vesicle transport. Localizes to lysosome and presynaptic active zone. Colocalizes with synaptic vesicle. Is expressed in coelomocyte and muscle cell. Is an ortholog of human ARL8A (ADP ribosylation factor like GTPase 8A).

WB:WBGene00000193	arl-6
Exhibits GTPase activity. Is involved in intracellular transport. Localizes to axoneme; cytosol; and dendrite. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 3 and retinitis pigmentosa 55. Is an ortholog of human ARL6 (ADP ribosylation factor like GTPase 6).

WB:WBGene00000195	arr-1
Is predicted to have G protein-coupled receptor binding activity. Is involved in multicellular organismal process and positive regulation of growth rate. Is expressed in HSN; amphid neurons; somatic nervous system; and tail. Human ortholog(s) of this gene are implicated in Oguchi disease-1 and retinitis pigmentosa 47. Is an ortholog of human ARRB1 (arrestin beta 1) and ARRB2 (arrestin beta 2).

WB:WBGene00000196	aars-1
Is predicted to have anion binding activity and catalytic activity, acting on a tRNA. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 8. Is an ortholog of human AARS2 (alanyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00000197	aars-2
Is predicted to have anion binding activity and catalytic activity, acting on a tRNA. Is expressed widely. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2N and early infantile epileptic encephalopathy 29. Is an ortholog of human AARS1 (alanyl-tRNA synthetase 1).

WB:WBGene00000198	art-1
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability and catecholaminergic polymorphic ventricular tachycardia 3. Is an ortholog of human TECR (trans-2,3-enoyl-CoA reductase).

WB:WBGene00000199	arx-1
Is predicted to contribute to actin filament binding activity. Is involved in Arp2/3 complex-mediated actin nucleation; embryonic morphogenesis; and epithelial cell migration. Localizes to cell leading edge and cytoplasm. Is expressed in hypodermis. Is an ortholog of human ACTR3 (actin related protein 3).

WB:WBGene00000200	arx-2
Is predicted to contribute to actin filament binding activity. Is involved in Arp2/3 complex-mediated actin nucleation; embryonic morphogenesis; and epithelial cell migration. Is expressed in Q cell; anchor cell; apoptotic cell; and seam cell. Is an ortholog of human ACTR2 (actin related protein 2).

WB:WBGene00000201	arx-3
Is predicted to have actin filament binding activity. Is an ortholog of human ARPC1A (actin related protein 2/3 complex subunit 1A) and ARPC1B (actin related protein 2/3 complex subunit 1B).

WB:WBGene00000202	exos-4.2
Is enriched in ASER; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Zidovudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: 3' exoribonuclease family, domain 1; Exoribonuclease, phosphorolytic domain 1; Ribosomal protein S5 domain 2-type fold; PNPase/RNase PH domain superfamily; and Exoribonuclease, PH domain 2 superfamily. Is an ortholog of human EXOSC6 (exosome component 6).

WB:WBGene00000203	arx-5
Is predicted to contribute to actin filament binding activity. Is involved in epithelial cell migration and morphogenesis of embryonic epithelium. Localizes to striated muscle dense body. Is an ortholog of human ARPC3 (actin related protein 2/3 complex subunit 3).

WB:WBGene00000204	arx-6
Is predicted to have actin binding activity. Is involved in epithelial cell migration and morphogenesis of embryonic epithelium. Is an ortholog of human ARPC4 (actin related protein 2/3 complex subunit 4) and ARPC4-TTLL3 (ARPC4-TTLL3 readthrough).

WB:WBGene00000205	arx-7
Is predicted to have actin filament binding activity. Is involved in Arp2/3 complex-mediated actin nucleation; epithelial cell migration; and morphogenesis of embryonic epithelium. Localizes to cytoplasm. Is expressed in anchor cell; hypodermis; and linker cell. Is an ortholog of human ARPC5 (actin related protein 2/3 complex subunit 5) and ARPC5L (actin related protein 2/3 complex subunit 5 like).

WB:WBGene00000206	asb-1
Is predicted to have proton transmembrane transporter activity. Localizes to mitochondrion and non-motile cilium. Is expressed in germ line. Is an ortholog of human ATP5PB (ATP synthase peripheral stalk-membrane subunit b).

WB:WBGene00000207	asb-2
Is predicted to have proton transmembrane transporter activity. Is expressed in several structures, including gonad. Is an ortholog of human ATP5PB (ATP synthase peripheral stalk-membrane subunit b).

WB:WBGene00000208	trip-4
Is predicted to have transcription coactivator activity. Is involved in dauer larval development. Is an ortholog of human TRIP4 (thyroid hormone receptor interactor 4).

WB:WBGene00000209	asg-1
Is predicted to have proton transmembrane transporter activity. Is an ortholog of human ATP5MG (ATP synthase membrane subunit g).

WB:WBGene00000210	asg-2
Is predicted to have proton transmembrane transporter activity. Localizes to mitochondrion and non-motile cilium. Is an ortholog of human ATP5MG (ATP synthase membrane subunit g).

WB:WBGene00000211	asm-1
Exhibits sphingomyelin phosphodiesterase activity. Is involved in ceramide biosynthetic process and sphingomyelin catabolic process. Localizes to extracellular region and lysosome. Human ortholog(s) of this gene are implicated in Niemann-Pick disease type A and Niemann-Pick disease type B. Is an ortholog of human SMPD1 (sphingomyelin phosphodiesterase 1).

WB:WBGene00000212	asm-2
Exhibits sphingomyelin phosphodiesterase activity. Is involved in ceramide biosynthetic process and sphingomyelin catabolic process. Localizes to extracellular region. Human ortholog(s) of this gene are implicated in Niemann-Pick disease type A and Niemann-Pick disease type B. Is an ortholog of human SMPD1 (sphingomyelin phosphodiesterase 1).

WB:WBGene00000213	asm-3
Is predicted to have acid sphingomyelin phosphodiesterase activity. Is involved in lipid droplet disassembly. Human ortholog(s) of this gene are implicated in Niemann-Pick disease type A and Niemann-Pick disease type B. Is an ortholog of human SMPD1 (sphingomyelin phosphodiesterase 1).

WB:WBGene00000214	asp-1
Is predicted to have aspartic-type endopeptidase activity. Localizes to cytoplasm and external side of apical plasma membrane. Is expressed in intestinal cell and intestine. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of human CTSE (cathepsin E); PGA5 (pepsinogen A5); and PGC (progastricsin).

WB:WBGene00000215	asp-2
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy.

WB:WBGene00000216	asp-3
Is predicted to have aspartic-type endopeptidase activity. Is involved in necrotic cell death. Localizes to lysosome. Is expressed in intestine and uterus. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of human NAPSA (napsin A aspartic peptidase).

WB:WBGene00000217	asp-4
Is predicted to have aspartic-type endopeptidase activity. Is involved in necrotic cell death and proteolysis. Localizes to lysosome. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 10. Is an ortholog of human CTSD (cathepsin D).

WB:WBGene00000218	asp-5
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00000219	asp-6
Is predicted to have aspartic-type endopeptidase activity. Localizes to extracellular space. Is expressed in hypodermal cell; intestine; muscle cell; pharynx; and pseudocoelom. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy.

WB:WBGene00000220	atf-2
Exhibits RNA polymerase II regulatory region DNA binding activity. Is involved in negative regulation of transcription by RNA polymerase II. Is expressed in digestive tract; egg-laying apparatus; excretory system; neurons; and ventral nerve cord. Is an ortholog of human NFIL3 (nuclear factor, interleukin 3 regulated).

WB:WBGene00000221	atf-4
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is an ortholog of human ATF4 (activating transcription factor 4) and ATF5 (activating transcription factor 5).

WB:WBGene00000222	atf-6
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in ATF6-mediated unfolded protein response; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; and response to tunicamycin. Is expressed in several structures, including intestine; muscle cell; pharyngeal gland cell; rectum; and vulva. Human ortholog(s) of this gene are implicated in achromatopsia 7 and osteogenesis imperfecta type 16. Is an ortholog of human ATF6 (activating transcription factor 6) and ATF6B (activating transcription factor 6 beta).

WB:WBGene00000223	atf-7
Exhibits mitogen-activated protein kinase binding activity. Is involved in defense response to Gram-negative bacterium; regulation of innate immune response; and regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in body wall musculature; hypodermis; intestine; neurons; and rectal epithelial cell. Is an ortholog of human ATF2 (activating transcription factor 2) and CREB5 (cAMP responsive element binding protein 5).

WB:WBGene00000224	atgp-1
Is predicted to have catalytic activity. Localizes to plasma membrane. Human ortholog(s) of this gene are implicated in cystinuria. Is an ortholog of human SLC3A1 (solute carrier family 3 member 1) and SLC3A2 (solute carrier family 3 member 2).

WB:WBGene00000225	atgp-2
Contributes to L-amino acid transmembrane transporter activity. Is involved in amino acid transmembrane transport. Localizes to amino acid transport complex. Human ortholog(s) of this gene are implicated in cystinuria. Is an ortholog of human SLC3A1 (solute carrier family 3 member 1).

WB:WBGene00000226	atl-1
Is predicted to have 1-phosphatidylinositol-3-kinase activity and protein serine/threonine kinase activity. Is involved in DNA damage checkpoint; embryo development; and meiotic chromosome segregation. Localizes to nucleus. Is expressed in gonad. Human ortholog(s) of this gene are implicated in Seckel syndrome 1; ataxia telangiectasia; and breast cancer. Is an ortholog of human ATR (ATR serine/threonine kinase).

WB:WBGene00000227	atm-1
Is predicted to have protein serine/threonine kinase activity. Is involved in response to ionizing radiation. Localizes to chromatin. Is used to study ataxia telangiectasia. Human ortholog(s) of this gene are implicated in ataxia telangiectasia and breast cancer. Is an ortholog of human ATM (ATM serine/threonine kinase).

WB:WBGene00000228	atn-1
Is predicted to have actin binding activity. Localizes to dense body; striated muscle dense body; and striated muscle thin filament. Is expressed in tail. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1AA; focal segmental glomerulosclerosis 1; and platelet-type bleeding disorder 15. Is an ortholog of human ACTN2 (actinin alpha 2).

WB:WBGene00000229	atp-2
Exhibits protein domain specific binding activity. Is predicted to contribute to ATPase activity and proton-transporting ATP synthase activity, rotational mechanism. Is involved in several processes, including determination of adult lifespan; inductive cell migration; and pharyngeal pumping. Localizes to mitochondrion and non-motile cilium. Is expressed in HOB; head; ray neuron type B; and tail. Is an ortholog of human ATP5F1B (ATP synthase F1 subunit beta).

WB:WBGene00000230	atp-3
Is predicted to have proton-transporting ATP synthase activity, rotational mechanism. Is involved in determination of adult lifespan and mitochondrial ATP synthesis coupled proton transport. Is an ortholog of human ATP5PO (ATP synthase peripheral stalk subunit OSCP).

WB:WBGene00000231	atx-2
Exhibits protein C-terminus binding activity. Is involved in several processes, including gamete generation; positive regulation of cell cycle; and regulation of microtubule cytoskeleton organization. Localizes to cytoplasm. Is expressed in body wall musculature; dorsal nerve cord; germ line; gonad; and ventral nerve cord. Human ortholog(s) of this gene are implicated in late onset Parkinson's disease and spinocerebellar ataxia type 2. Is an ortholog of human ATXN2L (ataxin 2 like).

WB:WBGene00000232	avr-14
Exhibits drug binding activity and extracellularly glutamate-gated chloride channel activity. Is involved in several processes, including locomotion involved in locomotory behavior; regulation of pharyngeal pumping; and response to drug. Localizes to membrane. Is expressed in neurons and somatic nervous system. Human ortholog(s) of this gene are implicated in hyperekplexia 2. Is an ortholog of human GLRA3 (glycine receptor alpha 3) and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00000233	avr-15
Is predicted to have chloride channel activity. Is involved in action potential; locomotion involved in locomotory behavior; and regulation of pharyngeal pumping. Is expressed in motor neurons; pharynx; preanal ganglion neurons; somatic nervous system; and in male. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRB (glycine receptor beta).

WB:WBGene00000234	bac-1
No description available

WB:WBGene00000235	baf-1
Is predicted to have double-stranded DNA binding activity and identical protein binding activity. Is involved in several processes, including chromosome organization; chromosome segregation; and response to X-ray. Localizes to condensed chromosome, centromeric region; cytoplasm; and nucleus. Is used to study muscular dystrophy. Is an ortholog of human BANF1 (BAF nuclear assembly factor 1).

WB:WBGene00000236	bag-1
Is predicted to have chaperone binding activity. Is an ortholog of human BAG1 (BAG cochaperone 1).

WB:WBGene00000237	bam-2
Localizes to integral component of plasma membrane. Is expressed in head neurons; somatic gonad; tail neurons; ventral cord neurons; and vulF.

WB:WBGene00000238	bar-1
Exhibits RNA polymerase II-specific DNA-binding transcription factor binding activity and transcription coactivator activity. Is involved in several processes, including left/right axis specification; mitochondrial unfolded protein response; and oviposition. Localizes to several cellular components, including adherens junction; cytosol; and nucleus. Is expressed in several structures, including gonad; intestine; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including arrhythmogenic right ventricular dysplasia 12; autosomal dominant non-syndromic intellectual disability 19; and endocrine gland cancer (multiple). Is an ortholog of human CTNNB1 (catenin beta 1) and JUP (junction plakoglobin).

WB:WBGene00000239	bas-1
Is predicted to have L-dopa decarboxylase activity. Is involved in several processes, including oviposition; phenol-containing compound biosynthetic process; and turning behavior involved in mating. Is expressed in dopaminergic neurons and serotonergic neurons. Is used to study cocaine abuse and nicotine dependence. Human ortholog(s) of this gene are implicated in aromatic L-amino acid decarboxylase deficiency. Is an ortholog of human DDC (dopa decarboxylase).

WB:WBGene00000240	pah-1
Exhibits phenylalanine 4-monooxygenase activity and tryptophan 5-monooxygenase activity. Is involved in several processes, including cellular amino acid metabolic process; determination of adult lifespan; and melanin biosynthetic process. Is expressed in hypodermis; seam cell; and tail. Is used to study phenylketonuria. Human ortholog(s) of this gene are implicated in phenylketonuria. Is an ortholog of human PAH (phenylalanine hydroxylase).

WB:WBGene00000241	bbs-1
Is predicted to have patched binding activity and smoothened binding activity. Is involved in intraciliary retrograde transport; non-motile cilium assembly; and protein localization to cilium. Localizes to axoneme; ciliary basal body; and neuron projection. Is expressed in ciliated neurons and sensory neurons. Is used to study Bardet-Biedl syndrome and alcohol use disorder. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 1. Is an ortholog of human BBS1 (Bardet-Biedl syndrome 1).

WB:WBGene00000242	bbs-2
Is involved in non-motile cilium assembly. Localizes to ciliary basal body and neuron projection. Is expressed in ciliated neurons and sensory neurons. Is used to study Bardet-Biedl syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 2 and retinitis pigmentosa 74. Is an ortholog of human BBS2 (Bardet-Biedl syndrome 2).

WB:WBGene00000244	bbs-8
Is involved in several processes, including cilium organization; positive regulation of cellular protein localization; and protein localization to microvillus membrane. Localizes to several cellular components, including ciliary basal body; ciliary base; and dendrite terminus. Is expressed in ciliated neurons; head; and sensory neurons. Is used to study Bardet-Biedl syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 8 and retinitis pigmentosa 51. Is an ortholog of human TTC8 (tetratricopeptide repeat domain 8).

WB:WBGene00000245	bca-1
Is predicted to have carbonate dehydratase activity and zinc ion binding activity. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00000246	bcc-1
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in diffuse cystic renal dysplasia. Is an ortholog of human BICC1 (BicC family RNA binding protein 1).

WB:WBGene00000247	bec-1
Is involved in several processes, including autophagy; gamete generation; and nematode male tail tip morphogenesis. Localizes to cytoplasmic vesicle and nucleus. Is expressed in several structures, including gonad; intestine; nervous system; pharynx; and vulva. Is an ortholog of human BECN1 (beclin 1).

WB:WBGene00000248	ben-1
Is predicted to have GTP binding activity and structural molecule activity. Is involved in chemosensory behavior and oviposition. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); congenital fibrosis of the extraocular muscles; and hypomyelinating leukodystrophy 6. Is an ortholog of human TUBB3 (tubulin beta 3 class III) and TUBB6 (tubulin beta 6 class V).

WB:WBGene00000249	bir-1
Is predicted to have metal ion binding activity. Is involved in several processes, including chromosome organization; inductive cell migration; and oviposition. Localizes to condensed chromosome and spindle midzone. Is expressed in egg-laying apparatus; hypodermis; pharynx; rectal muscle; and somatic nervous system. Is an ortholog of human BIRC5 (baculoviral IAP repeat containing 5).

WB:WBGene00000250	bir-2
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in X-linked lymphoproliferative syndrome 1; X-linked lymphoproliferative syndrome 2; and familial cold autoinflammatory syndrome 4. Is an ortholog of human BIRC2 (baculoviral IAP repeat containing 2); BIRC3 (baculoviral IAP repeat containing 3); and XIAP (X-linked inhibitor of apoptosis).

WB:WBGene00000251	bli-1
Is predicted to have extracellular matrix structural constituent. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Localizes to medial layer of collagen and cuticulin-based cuticle extracellular matrix. Is expressed in hyp7 syncytium and seam cell.

WB:WBGene00000252	bli-2
Is predicted to be a structural constituent of collagen and cuticulin-based cuticle. Is involved in collagen and cuticulin-based cuticle development.

WB:WBGene00000253	bli-3
Exhibits NAD(P)H oxidase (H(2)O(2)-forming activity; heme binding activity; and peroxidase activity. Is involved in several processes, including cuticle development involved in collagen and cuticulin-based cuticle molting cycle; defense response to other organism; and post-embryonic body morphogenesis. Localizes to plasma membrane. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in X-linked chronic granulomatous disease. Is an ortholog of human DUOX1 (dual oxidase 1) and DUOX2 (dual oxidase 2).

WB:WBGene00000254	bli-4
Is predicted to have serine-type endopeptidase activity. Is involved in several processes, including cellular response to salt; collagen and cuticulin-based cuticle development; and positive regulation of synaptic growth at neuromuscular junction. Localizes to nucleus. Is expressed in head; hypodermis; ventral cord neurons; and vulva. Human ortholog(s) of this gene are implicated in proprotein convertase 1/3 deficiency. Is an ortholog of human PCSK5 (proprotein convertase subtilisin/kexin type 5).

WB:WBGene00000255	bli-5
Exhibits serine-type endopeptidase activity. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle; protein catabolic process; and vulval development. Is expressed in excretory cell; excretory duct; and vulva. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00000256	bli-6
Is predicted to be a structural constituent of cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle.

WB:WBGene00000257	bmk-1
Is predicted to have ATP-dependent microtubule motor activity, plus-end-directed and microtubule binding activity. Is involved in negative regulation of mitotic spindle elongation. Localizes to spindle midzone and spindle pole. Human ortholog(s) of this gene are implicated in microcephaly with or without chorioretinopathy, lymphedema, or mental retardation. Is an ortholog of human KIF11 (kinesin family member 11).

WB:WBGene00000259	bpl-1
Is predicted to have biotin-[acetyl-CoA-carboxylase] ligase activity. Is expressed in Psub1. Human ortholog(s) of this gene are implicated in holocarboxylase synthetase deficiency. Is an ortholog of human HLCS (holocarboxylase synthetase).

WB:WBGene00000260	bpr-1
No description available

WB:WBGene00000261	bpr-2
No description available

WB:WBGene00000262	bra-1
Exhibits signaling receptor binding activity. Is involved in determination of adult lifespan and negative regulation of transforming growth factor beta receptor signaling pathway. Localizes to axon and dendrite. Is expressed in neurons. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 30. Is an ortholog of human ZMYND11 (zinc finger MYND-type containing 11).

WB:WBGene00000263	F23H11.5
Is expressed in hypodermis; intestine; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: Deltamethrin resistance and Deltamethrin resistance protein prag01.

WB:WBGene00000264	brc-1
Exhibits ubiquitin protein ligase activity. Is involved in several processes, including DNA metabolic process; cellular response to ionizing radiation; and nuclear division. Localizes to BRCA1-BARD1 complex. Human ortholog(s) of this gene are implicated in breast cancer. Is an ortholog of human BRCA1 (BRCA1 DNA repair associated).

WB:WBGene00000265	brd-1
Exhibits ubiquitin protein ligase activity. Is involved in DNA repair and protein ubiquitination. Localizes to BRCA1-BARD1 complex. Is an ortholog of human BARD1 (BRCA1 associated RING domain 1).

WB:WBGene00000266	bre-1
Exhibits GDP-mannose 4,6-dehydratase activity. Is involved in GDP-L-fucose biosynthetic process; GDP-mannose metabolic process; and response to toxic substance. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human GMDS (GDP-mannose 4,6-dehydratase).

WB:WBGene00000267	bre-2
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00000268	bre-3
Exhibits beta-1,4-mannosyltransferase activity. Is involved in response to toxic substance. Localizes to cytoplasm. Is expressed in head neurons.

WB:WBGene00000269	bre-4
Exhibits beta-1,4-N-acetylgalactosaminyltransferase activity. Is involved in positive regulation of Notch signaling pathway; protein glycosylation; and response to toxic substance. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IId. Is an ortholog of human B4GALT2 (beta-1,4-galactosyltransferase 2) and B4GALT3 (beta-1,4-galactosyltransferase 3).

WB:WBGene00000270	bre-5
Exhibits acetylgalactosaminyltransferase activity. Is involved in several processes, including carbohydrate biosynthetic process; positive regulation of Notch signaling pathway; and regulation of mesodermal cell fate specification. Is an ortholog of human B3GALNT1 (beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)) and B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5).

WB:WBGene00000271	brf-1
Is predicted to have RNA polymerase III type 3 promoter sequence-specific DNA binding activity and transcription factor binding activity. Is an ortholog of human BRF1 (BRF1 RNA polymerase III transcription initiation factor subunit).

WB:WBGene00000272	bro-1
Is predicted to contribute to sequence-specific DNA binding activity. Is involved in nematode male tail tip morphogenesis and stem cell population maintenance. Localizes to nucleus. Is expressed in hypodermis; muscle cell; pharyngeal neurons; ray precursor cell; and uterine seam cell. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human CBFB (core-binding factor subunit beta).

WB:WBGene00000273	brp-1
Is enriched in PLM and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Cry5B; Aspirin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00000274	btf-1
Is predicted to have DNA binding activity and DNA-dependent ATPase activity. Is an ortholog of human BTAF1 (B-TFIID TATA-box binding protein associated factor 1).

WB:WBGene00000275	bub-1
Exhibits kinetochore binding activity. Is involved in several processes, including cytoskeleton organization; meiotic nuclear division; and positive regulation of nematode male tail tip morphogenesis. Localizes to kinetochore. Colocalizes with chromosome. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in colorectal cancer and mosaic variegated aneuploidy syndrome 1. Is an ortholog of human BUB1 (BUB1 mitotic checkpoint serine/threonine kinase).

WB:WBGene00000276	byn-1
Is predicted to have snoRNA binding activity. Is an ortholog of human BYSL (bystin like).

WB:WBGene00000277	cab-1
Is involved in chemical synaptic transmission; positive regulation of anterior/posterior axon guidance; and ventral cord development. Is an ortholog of human NPDC1 (neural proliferation, differentiation and control 1).

WB:WBGene00000278	cad-1
Is involved in positive regulation of necrotic cell death.

WB:WBGene00000279	cah-1
Is predicted to have carbonate dehydratase activity and zinc ion binding activity. Is expressed in ciliated neurons; head ganglion; sensory neurons; and tail neurons. Human ortholog(s) of this gene are implicated in isolated hyperchlorhidrosis. Is an ortholog of human CA10 (carbonic anhydrase 10) and CA11 (carbonic anhydrase 11).

WB:WBGene00000280	cah-2
Is predicted to have carbonate dehydratase activity and zinc ion binding activity. Is expressed in intestine; muscle cell; neurons; pharynx; and vulva. Human ortholog(s) of this gene are implicated in isolated hyperchlorhidrosis. Is an ortholog of human CA10 (carbonic anhydrase 10).

WB:WBGene00000281	cah-3
Is predicted to have carbonate dehydratase activity and zinc ion binding activity. Is expressed in pharynx; somatic cell; and vulva. Human ortholog(s) of this gene are implicated in autosomal recessive osteopetrosis 3 and isolated hyperchlorhidrosis. Is an ortholog of human CA5B (carbonic anhydrase 5B).

WB:WBGene00000282	cah-4
Exhibits carbonate dehydratase activity. Is involved in small molecule metabolic process. Is expressed in several structures, including body wall musculature; enteric muscle; excretory cell; rectal muscle; and somatic nervous system. Human ortholog(s) of this gene are implicated in isolated hyperchlorhidrosis and retinitis pigmentosa 17. Is an ortholog of human CA3 (carbonic anhydrase 3).

WB:WBGene00000283	cah-5
Is predicted to have carbonate dehydratase activity and zinc ion binding activity. Is expressed in several structures, including body wall musculature; head neurons; intestine; pharynx; and vulva. Human ortholog(s) of this gene are implicated in autosomal recessive osteopetrosis 3; cerebellar ataxia, mental retardation and dysequlibrium syndrome; and isolated hyperchlorhidrosis. Is an ortholog of several human genes including CA1 (carbonic anhydrase 1); CA5A (carbonic anhydrase 5A); and CA5B (carbonic anhydrase 5B).

WB:WBGene00000284	cah-6
Is predicted to have carbonate dehydratase activity and zinc ion binding activity. Is expressed in head neurons; nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in isolated hyperchlorhidrosis. Is an ortholog of human CA8 (carbonic anhydrase 8).

WB:WBGene00000285	cal-1
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00000286	cal-2
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00000287	cal-3
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00000288	cal-4
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00000289	cam-1
Exhibits Wnt-protein binding activity; frizzled binding activity; and transmembrane receptor protein tyrosine kinase activity. Is involved in generation of neurons; neuroblast migration; and peptidyl-tyrosine phosphorylation. Localizes to several cellular components, including dendrite; neuromuscular junction; and neuronal cell body membrane. Is expressed in several structures, including QL.aa; body wall musculature; nervous system; pharynx; and seam cell. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive nonsyndromic deafness (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human ROR1 (receptor tyrosine kinase like orphan receptor 1) and ROR2 (receptor tyrosine kinase like orphan receptor 2).

WB:WBGene00000290	cam-2
No description available

WB:WBGene00000291	can-1
No description available

WB:WBGene00000292	cap-1
Is predicted to have actin filament binding activity. Localizes to dynactin complex. Is an ortholog of human CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1) and CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2).

WB:WBGene00000293	cap-2
Exhibits actin filament binding activity. Is involved in actin cytoskeleton organization and embryonic axis specification. Localizes to cytoplasm and dynactin complex. Is expressed in tail. Is an ortholog of human CAPZB (capping actin protein of muscle Z-line subunit beta).

WB:WBGene00000294	cas-1
Is predicted to have actin binding activity and adenylate cyclase binding activity. Is expressed in body wall musculature; intestine; neurons; pharynx; and spermatheca. Is an ortholog of human CAP1 (cyclase associated actin cytoskeleton regulatory protein 1) and CAP2 (cyclase associated actin cytoskeleton regulatory protein 2).

WB:WBGene00000295	cat-1
Exhibits dopamine:sodium symporter activity and serotonin:sodium symporter activity. Is involved in dopamine metabolic process; feeding behavior; and monoamine transport. Localizes to synaptic vesicle. Is expressed in gonad; nervous system; and in male. Is used to study amphetamine abuse and cocaine abuse. Is an ortholog of human SLC18A1 (solute carrier family 18 member A1).

WB:WBGene00000296	cat-2
Exhibits tyrosine 3-monooxygenase activity. Is involved in several processes, including cellular response to amphetamine; dopamine biosynthetic process from tyrosine; and male mating behavior. Localizes to axon. Is expressed in dopaminergic neurons and male-specific anatomical entity. Is used to study amphetamine abuse; cocaine abuse; and nicotine dependence. Is an ortholog of human TH (tyrosine hydroxylase).

WB:WBGene00000297	cat-3
No description available

WB:WBGene00000298	cat-4
Exhibits GTP cyclohydrolase I activity. Is involved in dopamine biosynthetic process from tyrosine; melanin biosynthetic process; and tetrahydrobiopterin biosynthetic process. Is expressed in several structures, including body wall musculature; dopaminergic neurons; hyp7 syncytium; intestinal cell; and serotonergic neurons. Human ortholog(s) of this gene are implicated in dystonia 5. Is an ortholog of human GCH1 (GTP cyclohydrolase 1).

WB:WBGene00000299	cat-5
No description available

WB:WBGene00000300	cat-6
Is involved in non-motile cilium assembly.

WB:WBGene00000301	cav-1
Is predicted to have molecular adaptor activity. Is involved in Ras protein signal transduction; meiotic cell cycle; and regulation of oviposition. Localizes to several cellular components, including cytoplasmic side of plasma membrane; cytoplasmic vesicle; and perinuclear region of cytoplasm. Is expressed in embryonic cell; germ cell; nervous system; pharynx; and tail. Human ortholog(s) of this gene are implicated in several diseases, including congenital generalized lipodystrophy type 3; intrinsic cardiomyopathy (multiple); and muscle tissue disease (multiple). Is an ortholog of human CAV1 (caveolin 1) and CAV3 (caveolin 3).

WB:WBGene00000302	cav-2
Exhibits lipid transporter activity. Is involved in parturition and regulation of oviposition. Localizes to apical plasma membrane. Is an ortholog of human CAV2 (caveolin 2).

WB:WBGene00000308	C04A11.t1
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00000310	C05C9.t1
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00000311	C05C9.t2
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00000366	cbp-1
Exhibits RNA polymerase II-specific DNA-binding transcription factor binding activity; histone acetyltransferase activity; and lysine N-acetyltransferase activity, acting on acetyl phosphate as donor. Is involved in several processes, including histone acetylation; regulation of neuron projection development; and spermatogenesis. Localizes to cytoplasm and nucleus. Is expressed in alimentary system; distal tip cell; head; and tail. Human ortholog(s) of this gene are implicated in Rubinstein-Taybi syndrome. Is an ortholog of human CREBBP (CREB binding protein).

WB:WBGene00000367	cca-1
Is predicted to have low voltage-gated calcium channel activity and voltage-gated sodium channel activity. Is involved in membrane depolarization; positive regulation of action potential; and regulation of pharyngeal pumping. Is expressed in several structures, including alimentary muscle; distal tip cell; pharyngeal neurons; serotonergic neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including epilepsy (multiple); heart conduction disease (multiple); and neuropathy (multiple). Is an ortholog of human CACNA1I (calcium voltage-gated channel subunit alpha1 I).

WB:WBGene00000368	ccb-1
Is predicted to have high voltage-gated calcium channel activity. Is involved in positive regulation of locomotion; regulation of calcium ion transport; and striated muscle contraction involved in embryonic body morphogenesis. Localizes to presynaptic active zone. Is expressed in muscle cell. Human ortholog(s) of this gene are implicated in Brugada syndrome 4; episodic ataxia type 5; and idiopathic generalized epilepsy 9. Is an ortholog of human CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1) and CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2).

WB:WBGene00000369	ccf-1
Is predicted to have poly(A)-specific ribonuclease activity. Is involved in nuclear-transcribed mRNA poly(A) tail shortening and oogenesis. Localizes to CCR4-NOT complex; P granule; and P-body. Is expressed in germ line. Is an ortholog of human CNOT7 (CCR4-NOT transcription complex subunit 7) and CNOT8 (CCR4-NOT transcription complex subunit 8).

WB:WBGene00000370	ccg-1
Is enriched in PLM; coelomocyte; germ line; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including aldicarb; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00000371	cox-5B
Is predicted to have cytochrome-c oxidase activity. Is involved in determination of adult lifespan; lipid storage; and mitochondrial ATP synthesis coupled proton transport. Is an ortholog of human COX5B (cytochrome c oxidase subunit 5B).

WB:WBGene00000372	cyp-13A7
Is predicted to have monooxygenase activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in essential hypertension and platelet-type bleeding disorder 14. Is an ortholog of human CYP3A4 (cytochrome P450 family 3 subfamily A member 4) and TBXAS1 (thromboxane A synthase 1).

WB:WBGene00000373	cyp-14A5
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is involved in response to gamma radiation. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00000374	cyp-31A1
Is enriched in neurons and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Lithium Chloride; lithium carbonate; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00000375	cyp-44A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in several diseases, including cerebrotendinous xanthomatosis; congenital adrenal hyperplasia; and congenital adrenal insufficiency. Is an ortholog of human CYP24A1 (cytochrome P450 family 24 subfamily A member 1) and CYP27B1 (cytochrome P450 family 27 subfamily B member 1).

WB:WBGene00000376	ccr-4
Is predicted to have poly(A)-specific ribonuclease activity. Is involved in nuclear-transcribed mRNA poly(A) tail shortening. Localizes to CCR4-NOT complex and cytoplasm. Is expressed in body wall musculature; germ line; neurons; somatic cell; and in male. Is an ortholog of human CNOT6 (CCR4-NOT transcription complex subunit 6) and CNOT6L (CCR4-NOT transcription complex subunit 6 like).

WB:WBGene00000377	cct-1
Is predicted to have ATP binding activity and unfolded protein binding activity. Localizes to chaperonin-containing T-complex and nucleus. Is expressed in nerve ring and in male. Is an ortholog of human TCP1 (t-complex 1).

WB:WBGene00000378	cct-2
Is predicted to have ATP binding activity and unfolded protein binding activity. Is expressed in head; pharyngeal muscle cell; tail; and touch receptor neurons. Is an ortholog of human CCT2 (chaperonin containing TCP1 subunit 2).

WB:WBGene00000379	cct-4
Is predicted to have unfolded protein binding activity. Is involved in post-embryonic body morphogenesis. Is expressed in head; tail; and touch receptor neurons. Is an ortholog of human CCT4 (chaperonin containing TCP1 subunit 4).

WB:WBGene00000380	cct-5
Is predicted to have unfolded protein binding activity. Localizes to chaperonin-containing T-complex. Is an ortholog of human CCT5 (chaperonin containing TCP1 subunit 5).

WB:WBGene00000381	cct-6
Is predicted to have ATP binding activity and unfolded protein binding activity. Is an ortholog of human CCT6A (chaperonin containing TCP1 subunit 6A) and CCT6B (chaperonin containing TCP1 subunit 6B).

WB:WBGene00000382	cdc-6
Is predicted to have DNA replication origin binding activity. Localizes to condensed nuclear chromosome; cytoplasm; and nucleolus. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in Meier-Gorlin syndrome 5. Is an ortholog of human CDC6 (cell division cycle 6).

WB:WBGene00000383	cdc-14
Exhibits phosphoprotein phosphatase activity. Is involved in several processes, including cytoskeleton-dependent cytokinesis; mitotic spindle midzone assembly; and negative regulation of cell cycle. Localizes to cytoskeleton; midbody; and nucleolus. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 32. Is an ortholog of human CDC14A (cell division cycle 14A) and CDC14B (cell division cycle 14B).

WB:WBGene00000384	cdc-16
No description available

WB:WBGene00000386	cdc-25.1
Is predicted to have protein tyrosine phosphatase activity. Is involved in meiotic spindle organization and positive regulation of mitotic cell cycle. Localizes to nucleus. Is expressed in several structures, including Z2; Z3; germ line; oocyte; and sperm. Is an ortholog of human CDC25A (cell division cycle 25A); CDC25B (cell division cycle 25B); and CDC25C (cell division cycle 25C).

WB:WBGene00000387	cdc-25.2
Is predicted to have protein tyrosine phosphatase activity. Is expressed in several structures, including body wall musculature; diagonal muscle; hypodermis; oocyte; and ventral nerve cord. Is an ortholog of human CDC25A (cell division cycle 25A); CDC25B (cell division cycle 25B); and CDC25C (cell division cycle 25C).

WB:WBGene00000388	cdc-25.3
Is predicted to have protein tyrosine phosphatase activity. Localizes to nucleus. Is an ortholog of human CDC25A (cell division cycle 25A) and CDC25B (cell division cycle 25B).

WB:WBGene00000389	cdc-25.4
Is predicted to have protein tyrosine phosphatase activity. Is expressed in ganglia; germ cell; male-specific anatomical entity; pharyngeal cell; and ventral nerve cord. Is an ortholog of human CDC25A (cell division cycle 25A) and CDC25B (cell division cycle 25B).

WB:WBGene00000390	cdc-42
Exhibits GTP binding activity and GTPase activity. Is involved in several processes, including establishment of mitotic spindle orientation; positive regulation of clathrin-dependent endocytosis; and positive regulation of nematode male tail tip morphogenesis. Localizes to several cellular components, including centrosome; cytosol; and recycling endosome. Is expressed in several structures, including hermaphrodite gonad; hyp7; hypodermal cell; nerve ring; and vulva. Is an ortholog of human CDC42 (cell division cycle 42).

WB:WBGene00000391	cdd-1
Exhibits RNA binding activity and deoxycytidine deaminase activity. Is involved in RNA modification; deoxycytidine catabolic process; and uridine biosynthetic process. Is expressed in intestine; pharynx; and tail. Is an ortholog of human CDA (cytidine deaminase).

WB:WBGene00000392	cdd-2
Exhibits RNA binding activity; cytidine deaminase activity; and deoxycytidine deaminase activity. Is involved in RNA modification; embryo development; and pyrimidine nucleoside metabolic process. Is expressed in intestine. Is an ortholog of human CDA (cytidine deaminase).

WB:WBGene00000393	cdf-1
Exhibits protein kinase binding activity. Is involved in cellular response to zinc ion; positive regulation of Ras protein signal transduction; and positive regulation of vulval development. Localizes to basolateral plasma membrane. Is expressed in several structures, including rectal valve cell; vulval cell; vulval cell; vulval cell; and vulval muscle. Human ortholog(s) of this gene are implicated in hypermanganesemia with dystonia 1 and type 2 diabetes mellitus. Is an ortholog of human SLC30A1 (solute carrier family 30 member 1) and SLC30A10 (solute carrier family 30 member 10).

WB:WBGene00000395	cdh-3
Is predicted to have structural molecule activity. Is involved in basement membrane disassembly and nematode male tail tip morphogenesis. Localizes to basement membrane; cytoplasm; and plasma membrane. Is expressed in several structures, including HSN; VC neuron; anchor cell; epithelial cell; and excretory cell. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Van Maldergem syndrome 1; and reproductive organ cancer (multiple). Is an ortholog of human PCDH11X (protocadherin 11 X-linked) and PCDH11Y (protocadherin 11 Y-linked).

WB:WBGene00000396	cdh-4
Is predicted to have calcium ion binding activity. Is expressed in VD neuron; non-striated muscle; rectal gland cell; spermatheca; and ventral cord neurons. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple). Is an ortholog of human FAT3 (FAT atypical cadherin 3).

WB:WBGene00000397	cdh-5
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple). Is an ortholog of human PCDH15 (protocadherin related 15).

WB:WBGene00000399	cdh-7
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple).

WB:WBGene00000401	cdh-9
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple). Is an ortholog of several human genes including PCDH1 (protocadherin 1); PCDH20 (protocadherin 20); and PCDH7 (protocadherin 7).

WB:WBGene00000402	cdh-10
Is predicted to have calcium ion binding activity. Is expressed in K cell; K' cell; mc1; mc2; and seam cell. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple).

WB:WBGene00000403	casy-1
Exhibits insulin receptor binding activity. Is involved in cellular protein localization and olfactory learning. Localizes to several cellular components, including Golgi apparatus; extracellular space; and neuronal cell body membrane. Is expressed in neurons. Is an ortholog of human CLSTN1 (calsyntenin 1) and CLSTN2 (calsyntenin 2).

WB:WBGene00000405	cdk-1
Exhibits cyclin-dependent protein serine/threonine kinase activity and protein kinase binding activity. Is involved in several processes, including cell division; oocyte maturation; and positive regulation of cellular protein metabolic process. Localizes to cytoplasm and nucleus. Is expressed in embryonic cell and germ cell. Is an ortholog of human CDK1 (cyclin dependent kinase 1).

WB:WBGene00000406	cdk-4
Exhibits protein serine/threonine kinase activity. Is involved in several processes, including cellular protein modification process; gonad development; and positive regulation of cell cycle process. Is expressed in gonad; intestine; neurons; and vulva. Is used to study cancer. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 12. Is an ortholog of human CDK4 (cyclin dependent kinase 4) and CDK6 (cyclin dependent kinase 6).

WB:WBGene00000407	cdk-5
Exhibits protein kinase activity. Is involved in several processes, including regulation of dense core granule transport; regulation of neuron remodeling; and regulation of synapse organization. Localizes to axon and synapse. Is an ortholog of human CDK5 (cyclin dependent kinase 5).

WB:WBGene00000408	cdk-7
Is predicted to have RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin-dependent protein serine/threonine kinase activity. Is involved in mRNA transcription and mitotic cell cycle, embryonic. Is an ortholog of human CDK7 (cyclin dependent kinase 7).

WB:WBGene00000409	cdk-8
Is predicted to have RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin-dependent protein serine/threonine kinase activity. Is expressed in anchor cell and neurons. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 12. Is an ortholog of human CDK19 (cyclin dependent kinase 19) and CDK8 (cyclin dependent kinase 8).

WB:WBGene00000410	cdk-9
Is predicted to have several functions, including cyclin binding activity; kinase activity; and transcription factor binding activity. Is involved in several processes, including germ cell development; nematode larval development; and regulation of protein modification process. Localizes to chromosome. Is expressed in several structures, including germ line. Is an ortholog of human CDK9 (cyclin dependent kinase 9).

WB:WBGene00000411	cdl-1
Exhibits mRNA 3'-UTR binding activity. Is involved in apoptotic process; embryo development; and mitotic chromosome condensation. Is expressed widely. Is an ortholog of human SLBP (stem-loop binding protein).

WB:WBGene00000412	cdr-1
Is involved in stress response to cadmium ion. Localizes to lysosome. Is expressed in intestinal cell and intestine. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00000413	cdt-1
Is predicted to have DNA binding activity and DNA polymerase binding activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Localizes to chromatin; cytoplasm; and nucleus. Is expressed in anchor cell; germ line; and vulD. Human ortholog(s) of this gene are implicated in Meier-Gorlin syndrome 4. Is an ortholog of human CDT1 (chromatin licensing and DNA replication factor 1).

WB:WBGene00000414	cec-1
Is predicted to have DNA binding activity. Is expressed in several structures, including germ line; oocyte; and somatic cell. Is an ortholog of human CBX4 (chromobox 4); CBX6 (chromobox 6); and CBX8 (chromobox 8).

WB:WBGene00000415	ced-1
Exhibits scavenger receptor activity. Is involved in several processes, including cytoskeleton organization; left/right axis specification; and phagocytosis. Localizes to several cellular components, including phagocytic cup; phagocytic vesicle membrane; and pseudopodium membrane. Is expressed in body wall musculature; engulfing cell; hyp7 syncytium; and muscle cell. Human ortholog(s) of this gene are implicated in early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome. Is an ortholog of human MEGF10 (multiple EGF like domains 10).

WB:WBGene00000416	ced-2
Is predicted to have SH3/SH2 adaptor activity. Is involved in several processes, including engulfment of apoptotic cell; positive regulation of distal tip cell migration; and positive regulation of engulfment of apoptotic cell. Is an ortholog of human CRK (CRK proto-oncogene, adaptor protein) and CRKL (CRK like proto-oncogene, adaptor protein).

WB:WBGene00000417	ced-3
Exhibits cysteine-type endopeptidase activator activity involved in apoptotic process; cysteine-type endopeptidase activity involved in execution phase of apoptosis; and identical protein binding activity. Is involved in several processes, including positive regulation of apoptotic process; positive regulation of proteolysis; and protein maturation. Localizes to several cellular components, including caspase complex; mitochondrion; and neuronal cell body. Is expressed in several structures, including ABaraapapaa; NSM; apoptotic cell; germ line; and oocyte. Human ortholog(s) of this gene are implicated in several diseases, including autoimmune lymphoproliferative syndrome (multiple); gastrointestinal system cancer (multiple); and non-Hodgkin lymphoma. Is an ortholog of human CASP2 (caspase 2).

WB:WBGene00000418	ced-4
Exhibits several functions, including ATP binding activity; BH domain binding activity; and enzyme regulator activity. Is involved in several processes, including muscle cell cellular homeostasis; positive regulation of proteolysis; and regulation of apoptotic process. Localizes to several cellular components, including caspase complex; cytosol; and mitochondrion. Is expressed in several structures, including germ line.

WB:WBGene00000419	ced-5
Exhibits SH3 domain binding activity and enzyme binding activity. Is predicted to contribute to guanyl-nucleotide exchange factor activity. Is involved in several processes, including engulfment of apoptotic cell; left/right axis specification; and positive regulation of distal tip cell migration. Localizes to guanyl-nucleotide exchange factor complex and presynapse. Is expressed in body wall muscle cell; hermaphrodite somatic gonadal cell; and intestinal cell. Is an ortholog of human DOCK1 (dedicator of cytokinesis 1).

WB:WBGene00000420	ced-6
Exhibits clathrin adaptor activity and scavenger receptor binding activity. Is involved in several processes, including engulfment of apoptotic cell; left/right axis specification; and positive regulation of distal tip cell migration. Localizes to cytoplasmic side of plasma membrane and phagocytic vesicle. Is an ortholog of human GULP1 (GULP PTB domain containing engulfment adaptor 1).

WB:WBGene00000421	ced-7
Is predicted to have ATP binding activity; ATPase-coupled transmembrane transporter activity; and lipid transporter activity. Is involved in several processes, including engulfment of apoptotic cell; left/right axis specification; and phospholipid efflux. Localizes to plasma membrane. Is expressed in Z2; Z3; germ line; neuronal sheath cell; and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis (multiple); pulmonary alveolar proteinosis; and retinal degeneration (multiple). Is an ortholog of human ABCA3 (ATP binding cassette subfamily A member 3).

WB:WBGene00000422	ced-8
Is involved in several processes, including apoptotic process involved in development; engulfment of apoptotic cell; and phosphatidylserine exposure on apoptotic cell surface. Localizes to plasma membrane. Is an ortholog of human XKR4 (XK related 4); XKR6 (XK related 6); and XKR7 (XK related 7).

WB:WBGene00000423	ced-9
Exhibits GTPase activator activity and protein sequestering activity. Is involved in several processes, including positive regulation of brood size; positive regulation of cellular component organization; and positive regulation of oviposition. Localizes to several cellular components, including mitochondrial outer membrane; neuronal cell body; and perinuclear region of cytoplasm. Is expressed in several structures, including gonad. Human ortholog(s) of this gene are implicated in follicular lymphoma. Is an ortholog of human BCL2L2 (BCL2 like 2).

WB:WBGene00000424	ced-10
Exhibits GTP binding activity and GTPase activity. Is involved in several processes, including cytoskeleton organization; embryonic morphogenesis; and generation of neurons. Localizes to several cellular components, including cytoplasmic side of plasma membrane; cytoplasmic vesicle; and neuronal cell body. Is expressed in several structures, including CAN; GABAergic neurons; distal tip cell; intestine; and somatic nervous system. Is used to study epilepsy. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 48. Is an ortholog of human RAC1 (Rac family small GTPase 1) and RAC2 (Rac family small GTPase 2).

WB:WBGene00000425	ced-11
Is involved in apoptotic process. Is expressed in apoptotic cell; head; hypodermis; and tail. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and progressive familial heart block type IB.

WB:WBGene00000426	ced-12
Exhibits Rho GTPase binding activity; phosphatidylinositol phosphate binding activity; and proline-rich region binding activity. Is predicted to contribute to guanyl-nucleotide exchange factor activity. Is involved in several processes, including cytoskeleton organization; engulfment of apoptotic cell; and left/right axis specification. Localizes to cytoplasm; guanyl-nucleotide exchange factor complex; and plasma membrane. Is expressed in intestinal cell and tail. Is an ortholog of human ELMO1 (engulfment and cell motility 1).

WB:WBGene00000427	ced-13
Exhibits BH domain binding activity. Is involved in intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator and positive regulation of apoptotic process.

WB:WBGene00000428	ceh-1
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in double outlet right ventricle and spastic ataxia 8. Is an ortholog of human NKX1-1 (NK1 homeobox 1).

WB:WBGene00000429	ceh-2
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in neurons; pharynx; somatic nervous system; and vulva. Is an ortholog of human EMX1 (empty spiracles homeobox 1).

WB:WBGene00000430	ceh-5
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity. Is expressed in dorsal nerve cord; head muscle; intestine; tail neurons; and ventral nerve cord. Is an ortholog of human VAX1 (ventral anterior homeobox 1) and VAX2 (ventral anterior homeobox 2).

WB:WBGene00000431	ceh-6
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in excretion; transdifferentiation; and water homeostasis. Localizes to cytosol and nucleus. Is expressed in body wall musculature; head neurons; hyp7 syncytium; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in auditory system disease (multiple) and hypopituitarism. Is an ortholog of human POU3F2 (POU class 3 homeobox 2); POU3F3 (POU class 3 homeobox 3); and POU3F4 (POU class 3 homeobox 4).

WB:WBGene00000432	ceh-7
Is predicted to have DNA binding activity. Is expressed in head neurons and in male.

WB:WBGene00000433	ceh-8
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in Z1 and Z4. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human RAX (retina and anterior neural fold homeobox).

WB:WBGene00000434	ceh-9
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in dorsal nerve cord; head muscle; head neurons; intestine; and ventral nerve cord. Human ortholog(s) of this gene are implicated in double outlet right ventricle and spastic ataxia 8.

WB:WBGene00000435	ceh-10
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in generation of neurons; oviposition; and regulation of cell migration. Localizes to nucleus. Is expressed in ABalapppaa; CAN; head neurons; seam cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human VSX1 (visual system homeobox 1) and VSX2 (visual system homeobox 2).

WB:WBGene00000436	ceh-12
Is predicted to have DNA binding activity. Is expressed in VB neuron; ventral nerve cord; and vulval muscle. Human ortholog(s) of this gene are implicated in Currarino syndrome. Is an ortholog of human MNX1 (motor neuron and pancreas homeobox 1).

WB:WBGene00000437	ceh-13
Is predicted to have DNA-binding transcription factor activity. Is involved in cell-cell adhesion and embryo development. Localizes to cytoplasm and nucleus. Is expressed in several structures, including egg-laying apparatus; hypodermis; sensory neurons; somatic nervous system; and in male. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple). Is an ortholog of human HOXB1 (homeobox B1).

WB:WBGene00000438	ceh-14
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in neuron development; positive regulation of transcription by RNA polymerase II; and thermosensory behavior. Localizes to nucleus. Is expressed in several structures, including hypodermal cell; neurons; somatic nervous system; spermatheca; and tail. Human ortholog(s) of this gene are implicated in several diseases, including congenital ptosis; myopathy (multiple); and nail-patella syndrome. Is an ortholog of human LHX3 (LIM homeobox 3) and LHX4 (LIM homeobox 4).

WB:WBGene00000439	ceh-16
Exhibits sequence-specific DNA binding activity. Is involved in several processes, including embryonic body morphogenesis; epidermal cell fate specification; and regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including ABarpa; ABplaa; hyp5; retrovesicular ganglion neurons; and seam cell. Is an ortholog of human EN1 (engrailed homeobox 1) and EN2 (engrailed homeobox 2).

WB:WBGene00000440	ceh-17
Exhibits DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in axon guidance; positive regulation of transcription by RNA polymerase II; and regulation of axon extension. Localizes to nucleus. Is expressed in DA8; head muscle; head neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in congenital central hypoventilation syndrome and congenital fibrosis of the extraocular muscles. Is an ortholog of human PHOX2A (paired like homeobox 2A).

WB:WBGene00000441	ceh-18
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in epidermis development; gamete generation; and negative regulation of oocyte maturation. Localizes to nucleus. Is expressed in body wall musculature; gonad; neurons; non-striated muscle; and somatic nervous system. Is an ortholog of human POU2F3 (POU class 2 homeobox 3).

WB:WBGene00000442	ceh-19
Is predicted to have DNA binding activity. Is expressed in neurons.

WB:WBGene00000443	ceh-20
Exhibits RNA polymerase II transcription coactivator binding activity and cis-regulatory region sequence-specific DNA binding activity. Contributes to RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including mesodermal cell fate specification; positive regulation of mesodermal cell fate specification; and regulation of asymmetric cell division. Localizes to RNA polymerase II transcription factor complex. Is expressed in several structures, including P11.aaap; neurons; seam cell; somatic nervous system; and vulval cell. Is an ortholog of human PBX2 (PBX homeobox 2).

WB:WBGene00000444	ceh-21
Is predicted to have DNA binding activity. Is expressed widely.

WB:WBGene00000445	ceh-22
Exhibits sequence-specific DNA binding activity. Is involved in cell fate specification; pharyngeal muscle development; and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including G1; gonad; neurons; pharyngeal cell; and ventral nerve cord. Human ortholog(s) of this gene are implicated in double outlet right ventricle. Is an ortholog of human NKX2-2 (NK2 homeobox 2).

WB:WBGene00000446	ceh-23
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in determination of adult lifespan and positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation. Localizes to nucleus. Is expressed in intestine; nervous system; and tail. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta type 4; orofacial cleft 15; and split hand-foot malformation 1 with sensorineural hearing loss.

WB:WBGene00000447	ceh-24
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in head muscle; intestine; neurons; non-striated muscle; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including choreatic disease; double outlet right ventricle; and spastic ataxia 8. Is an ortholog of human NKX2-1 (NK2 homeobox 1) and NKX2-4 (NK2 homeobox 4).

WB:WBGene00000448	pros-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in excretory cell; labial sensillum; neuronal sheath cell; and neurons. Is an ortholog of human PROX1 (prospero homeobox 1) and PROX2 (prospero homeobox 2).

WB:WBGene00000449	ceh-27
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in intestine and nerve ring. Human ortholog(s) of this gene are implicated in several diseases, including congenital heart disease (multiple); congenital nongoitrous hypothyroidism 5; and spastic ataxia 8.

WB:WBGene00000450	ceh-28
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in positive regulation of transcription by RNA polymerase II and regulation of synapse organization. Is expressed in several structures, including ABalaappa; ABalaappaa; ABalaappap; ABalapapa; and M4 neuron. Human ortholog(s) of this gene are implicated in double outlet right ventricle and spastic ataxia 8. Is an ortholog of human NKX2-6 (NK2 homeobox 6).

WB:WBGene00000451	ceh-30
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in negative regulation of apoptotic process; nervous system development; and sex differentiation. Localizes to nucleus. Is expressed in embryonic cell and neurons. Is an ortholog of human BARHL1 (BarH like homeobox 1) and BARHL2 (BarH like homeobox 2).

WB:WBGene00000452	ceh-31
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head neurons and pharynx. Is an ortholog of human BARHL1 (BarH like homeobox 1) and BARHL2 (BarH like homeobox 2).

WB:WBGene00000453	ceh-32
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and transcription regulatory region sequence-specific DNA binding activity. Is involved in post-embryonic animal morphogenesis. Localizes to nucleus. Is expressed in anterior hypodermis; gonadal sheath cell; head ganglion; intestine; and nerve ring. Human ortholog(s) of this gene are implicated in branchiootorenal syndrome 2; holoprosencephaly 2; and microphthalmia (multiple). Is an ortholog of human SIX3 (SIX homeobox 3) and SIX6 (SIX homeobox 6).

WB:WBGene00000454	ceh-33
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and transcription regulatory region sequence-specific DNA binding activity. Is expressed in head and head muscle. Human ortholog(s) of this gene are implicated in several diseases, including autosomal dominant nonsyndromic deafness 23; branchiootorenal syndrome (multiple); and microphthalmia (multiple). Is an ortholog of human SIX1 (SIX homeobox 1) and SIX2 (SIX homeobox 2).

WB:WBGene00000455	ceh-34
Exhibits sequence-specific DNA binding activity. Is involved in mesodermal cell fate specification; positive regulation of apoptotic process involved in development; and regulation of transcription, DNA-templated. Localizes to nucleus. Is expressed in body wall musculature; corpus; head; male sex myoblast; and pharyngeal neurons. Human ortholog(s) of this gene are implicated in branchiootorenal syndrome 2. Is an ortholog of human SIX2 (SIX homeobox 2) and SIX5 (SIX homeobox 5).

WB:WBGene00000457	ceh-36
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in neuron fate specification; positive regulation of transcription by RNA polymerase II; and sensory perception of chemical stimulus. Localizes to nucleus. Is expressed in ABaraappa; ABaraappaa; amphid neurons; and head neurons. Human ortholog(s) of this gene are implicated in several diseases, including Leri-Weill dyschondrosteosis; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human OTX1 (orthodenticle homeobox 1) and OTX2 (orthodenticle homeobox 2).

WB:WBGene00000458	ceh-37
Exhibits DNA binding activity, bending and double-stranded telomeric DNA binding activity. Is involved in neuron fate specification; olfactory behavior; and regulation of transcription by RNA polymerase II. Localizes to nuclear chromosome, telomeric region. Is expressed in dorsal nerve cord; excretory cell; head; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Waardenburg's syndrome (multiple); diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human OTX2 (orthodenticle homeobox 2).

WB:WBGene00000459	ceh-38
Is predicted to have DNA binding activity. Is expressed in several structures, including body wall musculature; excretory cell; intestine; neurons; and somatic nervous system.

WB:WBGene00000460	ceh-39
Is predicted to have DNA binding activity. Is involved in negative regulation of transcription by RNA polymerase II and primary sex determination. Localizes to condensed nuclear chromosome and germ cell nucleus. Is expressed in body wall musculature; germ line; gonad; neurons; and ventral nerve cord.

WB:WBGene00000461	ceh-40
Is predicted to have DNA binding activity and DNA-binding transcription factor activity. Is expressed in dopaminergic neurons. Human ortholog(s) of this gene are implicated in ceft palate, cardiac defects, and intellectual disabillity and holoprosencephaly 4. Is an ortholog of human PBX2 (PBX homeobox 2).

WB:WBGene00000462	ceh-41
Is predicted to have DNA binding activity. Is expressed in body wall musculature; dorsal nerve cord; head muscle; head neurons; and ventral nerve cord.

WB:WBGene00000463	ceh-43
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in embryo development. Is expressed in several structures, including CAN; anterior hypodermis; ganglia; neuronal sheath cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta type 4; orofacial cleft 15; and split hand-foot malformation 1 with sensorineural hearing loss. Is an ortholog of human DLX1 (distal-less homeobox 1) and DLX6 (distal-less homeobox 6).

WB:WBGene00000464	ceh-44
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in dorsal nerve cord; head muscle; and ventral nerve cord. Is an ortholog of human CUX2 (cut like homeobox 2).

WB:WBGene00000465	cpg-1
Exhibits chitin binding activity. Is involved in several processes, including eggshell formation; mitotic cytokinesis; and regulation of cytokinesis. Localizes to external encapsulating structure. Is expressed in eggshell; germ line; and oocyte.

WB:WBGene00000466	cel-1
Exhibits polynucleotide 5'-phosphatase activity. Is involved in polynucleotide 5' dephosphorylation and positive regulation of gene expression. Is expressed in tail. Is an ortholog of human RNGTT (RNA guanylyltransferase and 5'-phosphatase).

WB:WBGene00000467	cep-1
Exhibits several functions, including DNA-binding transcription factor activity; protein homodimerization activity; and zinc ion binding activity. Is involved in several processes, including determination of adult lifespan; intracellular signal transduction; and response to hypoxia. Localizes to nucleolus and nucleoplasm. Is expressed in Z2; Z3; germ line; pharyngeal cell; and pharynx. Is used to study cancer.

WB:WBGene00000468	ces-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in negative regulation of programmed cell death and negative regulation of transcription by RNA polymerase II. Is an ortholog of human SCRT1 (scratch family transcriptional repressor 1) and SCRT2 (scratch family transcriptional repressor 2).

WB:WBGene00000469	ces-2
Exhibits RNA polymerase II regulatory region DNA binding activity and sequence-specific double-stranded DNA binding activity. Is involved in apoptotic process and positive regulation of programmed cell death. Is expressed in excretory duct cell. Is used to study acute lymphoblastic leukemia. Is an ortholog of human DBP (D-box binding PAR bZIP transcription factor) and TEF (TEF transcription factor, PAR bZIP family member).

WB:WBGene00000470	ces-3
No description available

WB:WBGene00000471	ces-4
No description available

WB:WBGene00000472	cey-1
Is predicted to have nucleic acid binding activity. Localizes to endoplasmic reticulum. Is expressed in germ cell; germ line; pharynx; and somatic cell. Is an ortholog of human YBX3 (Y-box binding protein 3).

WB:WBGene00000473	cey-2
Is predicted to have nucleic acid binding activity. Localizes to ribonucleoprotein complex. Is expressed in germ cell; germ line; pharynx; and somatic cell. Is an ortholog of human YBX1 (Y-box binding protein 1).

WB:WBGene00000474	cey-3
Exhibits ribonucleoprotein complex binding activity. Localizes to ribonucleoprotein complex. Is expressed in germ cell; head muscle; intestine; somatic cell; and somatic nervous system. Is an ortholog of human YBX1 (Y-box binding protein 1).

WB:WBGene00000475	cey-4
Exhibits ribonucleoprotein complex binding activity. Localizes to ribonucleoprotein complex. Is expressed in germ cell; germ line; and somatic cell. Is an ortholog of human YBX1 (Y-box binding protein 1) and YBX2 (Y-box binding protein 2).

WB:WBGene00000476	cfi-1
Exhibits sequence-specific DNA binding activity. Is involved in cell fate commitment; neuron differentiation; and regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in head muscle; neurons; and pharyngeal muscle cell. Is an ortholog of human ARID3A (AT-rich interaction domain 3A) and ARID3C (AT-rich interaction domain 3C).

WB:WBGene00000477	cft-1
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in excretory canal. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC1 (ATP binding cassette subfamily C member 1).

WB:WBGene00000478	cfz-2
Is predicted to have Wnt-activated receptor activity and Wnt-protein binding activity. Is involved in generation of neurons and neuroblast migration. Is expressed in intestine; nervous system; and pharynx. Human ortholog(s) of this gene are implicated in omodysplasia. Is an ortholog of human FZD5 (frizzled class receptor 5).

WB:WBGene00000479	cgh-1
Is predicted to have RNA helicase activity and mRNA binding activity. Is involved in several processes, including cytoplasmic mRNA processing body assembly; determination of adult lifespan; and negative regulation of translation. Localizes to cytoplasmic ribonucleoprotein granule and messenger ribonucleoprotein complex. Is expressed in several structures, including PVD; Z2; Z3; germ line; and gonad. Is an ortholog of human DDX6 (DEAD-box helicase 6).

WB:WBGene00000480	cgp-1
Is predicted to have translation elongation factor activity. Is an ortholog of human GTPBP1 (GTP binding protein 1).

WB:WBGene00000481	cha-1
Exhibits choline O-acetyltransferase activity. Is involved in acetylcholine biosynthetic process. Localizes to several cellular components, including cytosol; excitatory synapse; and neuronal cell body. Is expressed in IL2 neuron. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 6. Is an ortholog of human CHAT (choline O-acetyltransferase).

WB:WBGene00000482	chd-3
Is predicted to have DNA helicase activity. Is involved in cell fate determination; negative regulation of Ras protein signal transduction; and negative regulation of vulval development. Is expressed in several structures, including distal tip cell; pharynx; ventral nerve cord; vulva; and vulval precursor cell. Human ortholog(s) of this gene are implicated in immunodeficiency-centromeric instability-facial anomalies syndrome 4. Is an ortholog of human CHD3 (chromodomain helicase DNA binding protein 3) and CHD4 (chromodomain helicase DNA binding protein 4).

WB:WBGene00000483	che-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including response to lithium ion; response to magnesium ion; and response to methionine. Is expressed in ASEL and ASER. Is an ortholog of human ZNF500 (zinc finger protein 500).

WB:WBGene00000484	che-2
Is involved in several processes, including chemotaxis to cAMP; negative regulation of transforming growth factor beta receptor signaling pathway; and positive regulation of locomotion involved in locomotory behavior. Localizes to ciliary basal body and non-motile cilium. Is expressed in neurons. Human ortholog(s) of this gene are implicated in asphyxiating thoracic dystrophy 2. Is an ortholog of human IFT80 (intraflagellar transport 80).

WB:WBGene00000485	che-3
Is predicted to have ATP-dependent microtubule motor activity, minus-end-directed; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Is involved in several processes, including dauer entry; non-motile cilium assembly; and positive regulation of dauer larval development. Localizes to non-motile cilium. Is expressed in I4 neuron; PDEL; PDER; and nerve ring. Human ortholog(s) of this gene are implicated in asphyxiating thoracic dystrophy 3. Is an ortholog of human DYNC2H1 (dynein cytoplasmic 2 heavy chain 1).

WB:WBGene00000486	che-5
No description available

WB:WBGene00000487	che-6
Is predicted to have cGMP binding activity; intracellular cAMP-activated cation channel activity; and intracellular cGMP-activated cation channel activity. Localizes to neuronal cell body. Is expressed in ASEL; ASER; AWCL; and AWCR. Human ortholog(s) of this gene are implicated in several diseases, including achromatopsia 3; heart conduction disease (multiple); and retinal degeneration (multiple). Is an ortholog of human CNGA1 (cyclic nucleotide gated channel subunit alpha 1); CNGA2 (cyclic nucleotide gated channel subunit alpha 2); and CNGA4 (cyclic nucleotide gated channel subunit alpha 4).

WB:WBGene00000488	che-7
Is predicted to have gap junction channel activity. Is expressed in body ganglion; head neurons; and tail neurons.

WB:WBGene00000490	che-11
Is involved in several processes, including dauer entry; determination of adult lifespan; and positive regulation of intracellular protein transport. Localizes to non-motile cilium. Is expressed in head and neurons. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 9 with or without polydactyly. Is an ortholog of human IFT140 (intraflagellar transport 140).

WB:WBGene00000491	che-12
Is involved in several processes, including cilium assembly; hyperosmotic response; and sensory perception. Localizes to cilium; dendrite; and neuronal cell body. Is expressed in amphid neurons and phasmid neurons. Is an ortholog of human TOGARAM1 (TOG array regulator of axonemal microtubules 1).

WB:WBGene00000492	che-13
Is involved in chemosensory behavior and cilium organization. Localizes to ciliary transition zone; cytoskeleton; and intraciliary transport particle B. Is expressed in neurons. Is an ortholog of human IFT57 (intraflagellar transport 57).

WB:WBGene00000493	che-14
Localizes to apical plasma membrane. Is expressed in epithelial cell; excretory system; hypodermis; rectum; and vulva. Is an ortholog of human DISP1 (dispatched RND transporter family member 1) and DISP2 (dispatched RND transporter family member 2).

WB:WBGene00000494	che-15
No description available

WB:WBGene00000495	che-16
No description available

WB:WBGene00000496	chs-1
Is predicted to have chitin synthase activity. Is involved in cell wall chitin biosynthetic process; eggshell formation; and positive regulation of protein localization to cell cortex. Localizes to cell cortex and plasma membrane. Is expressed in Psub1.

WB:WBGene00000497	chs-2
Is predicted to have chitin synthase activity. Is involved in chitin biosynthetic process and positive regulation of nematode larval development. Is expressed in pharynx. Is an ortholog of human HAS1 (hyaluronan synthase 1); HAS2 (hyaluronan synthase 2); and HAS3 (hyaluronan synthase 3).

WB:WBGene00000498	chk-1
Is predicted to have protein serine/threonine kinase activity. Is involved in embryo development and mitotic DNA replication checkpoint. Is expressed in germ line. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 54; glycogen storage disease IXc; and hypertrophic cardiomyopathy 1. Is an ortholog of human CHEK1 (checkpoint kinase 1).

WB:WBGene00000499	chk-2
Is predicted to have protein serine/threonine kinase activity. Is involved in positive regulation of histone H3-K9 methylation. Human ortholog(s) of this gene are implicated in several diseases, including Li-Fraumeni syndrome 2; osteosarcoma; and prostate cancer. Is an ortholog of human CHEK2 (checkpoint kinase 2).

WB:WBGene00000500	chn-1
Exhibits several functions, including Hsp70 protein binding activity; chaperone binding activity; and ubiquitin protein ligase binding activity. Is involved in several processes, including oviposition; protein ubiquitination; and sarcomere organization. Localizes to cytoplasm. Is expressed in several structures, including copulatory spicule; germ line; hermaphrodite distal tip cell; intestine; and pharynx. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 16. Is an ortholog of human STUB1 (STIP1 homology and U-box containing protein 1).

WB:WBGene00000501	cho-1
Exhibits choline transmembrane transporter activity. Is involved in choline transport. Localizes to axon; neuronal cell body; and synaptic vesicle. Is expressed in nerve ring and neurons. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 20; distal hereditary motor neuronopathy type 7A; and renal glycosuria. Is an ortholog of human SLC5A7 (solute carrier family 5 member 7).

WB:WBGene00000502	chp-1
Is predicted to have zinc ion binding activity. Is an ortholog of human CHORDC1 (cysteine and histidine rich domain containing 1) and ITGB1BP2 (integrin subunit beta 1 binding protein 2).

WB:WBGene00000503	cht-1
Is predicted to have chitin binding activity and chitinase activity. Is involved in response to fungus. Is expressed in gonad. Human ortholog(s) of this gene are implicated in schizophrenia. Is an ortholog of human CHI3L1 (chitinase 3 like 1) and CHIT1 (chitinase 1).

WB:WBGene00000504	cib-1
Is involved in cell fate specification and embryo development.

WB:WBGene00000505	cib-3
No description available

WB:WBGene00000506	cic-1
Is predicted to have cyclin-dependent protein serine/threonine kinase regulator activity. Is expressed in neurons. Is an ortholog of human CCNC (cyclin C).

WB:WBGene00000507	cit-1.1
Is predicted to have cyclin-dependent protein serine/threonine kinase activator activity. Is expressed widely. Is an ortholog of human CCNT1 (cyclin T1).

WB:WBGene00000508	cit-1.2
Is predicted to have cyclin-dependent protein serine/threonine kinase activator activity. Is involved in embryo development and regulation of phosphorylation of RNA polymerase II C-terminal domain. Localizes to nucleus. Is expressed in several structures, including head. Is an ortholog of human CCNT1 (cyclin T1).

WB:WBGene00000509	cka-1
Exhibits choline kinase activity. Is involved in CDP-choline pathway. Localizes to cell cortex. Human ortholog(s) of this gene are implicated in megaconial type congenital muscular dystrophy. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

WB:WBGene00000510	cka-2
Exhibits choline kinase activity. Is involved in CDP-choline pathway. Human ortholog(s) of this gene are implicated in megaconial type congenital muscular dystrophy. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

WB:WBGene00000511	ckb-1
Is predicted to have ATP binding activity and choline kinase activity. Human ortholog(s) of this gene are implicated in megaconial type congenital muscular dystrophy. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

WB:WBGene00000512	ckb-2
Exhibits choline kinase activity. Is involved in CDP-choline pathway and IRE1-mediated unfolded protein response. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in megaconial type congenital muscular dystrophy. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

WB:WBGene00000513	ckb-3
Is predicted to have ATP binding activity and choline kinase activity. Is expressed in Z1; Z4; pm6; and somatic gonad. Human ortholog(s) of this gene are implicated in megaconial type congenital muscular dystrophy. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

WB:WBGene00000514	ckb-4
Exhibits choline kinase activity. Is involved in CDP-choline pathway. Human ortholog(s) of this gene are implicated in megaconial type congenital muscular dystrophy. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

WB:WBGene00000515	ckc-1
Is predicted to have kinase activity. Is an ortholog of human ETNK1 (ethanolamine kinase 1).

WB:WBGene00000516	cki-1
Is predicted to have cyclin-dependent protein serine/threonine kinase inhibitor activity. Is involved in several processes, including negative regulation of epidermal cell differentiation; negative regulation of mitotic cell cycle; and regulation of DNA endoreduplication. Localizes to nucleus. Is expressed in several structures, including excretory duct; hermaphrodite somatic gonadal cell; hypodermal cell; pharynx; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in Beckwith-Wiedemann syndrome; IMAGe syndrome; and multiple endocrine neoplasia type 4.

WB:WBGene00000517	cki-2
Is predicted to have cyclin-dependent protein serine/threonine kinase inhibitor activity. Is involved in several processes, including cell cycle arrest; gonad development; and regulation of cell cycle process. Is expressed in several structures, including germ line; hyp7; hyp7; hyp7; and hyp7. Human ortholog(s) of this gene are implicated in Beckwith-Wiedemann syndrome; IMAGe syndrome; and multiple endocrine neoplasia type 4. Is an ortholog of human CDKN1B (cyclin dependent kinase inhibitor 1B).

WB:WBGene00000518	ckk-1
Exhibits calmodulin binding activity and calmodulin-dependent protein kinase activity. Is involved in several processes, including positive regulation of CREB transcription factor activity; positive regulation of protein kinase activity; and transcription, DNA-templated. Localizes to cytoplasm and nucleus. Is expressed in head neurons; tail neurons; and vulval muscle. Is an ortholog of human CAMKK1 (calcium/calmodulin dependent protein kinase kinase 1).

WB:WBGene00000519	cku-70
Is predicted to contribute to double-stranded DNA binding activity. Is involved in DNA repair. Is an ortholog of human XRCC6 (X-ray repair cross complementing 6).

WB:WBGene00000520	cku-80
Is predicted to contribute to double-stranded DNA binding activity. Is involved in DNA repair. Is an ortholog of human XRCC5 (X-ray repair cross complementing 5).

WB:WBGene00000521	cky-1
Contributes to sequence-specific DNA binding activity. Is involved in positive regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in pharyngeal cell. Is an ortholog of human NPAS4 (neuronal PAS domain protein 4).

WB:WBGene00000522	clc-1
Is involved in defense response to Gram-positive bacterium; epithelial cell-cell adhesion; and innate immune response. Localizes to cell-cell junction. Is expressed in pharynx.

WB:WBGene00000523	clc-2
Is involved in epithelial cell-cell adhesion. Localizes to plasma membrane. Is expressed in hypodermis and seam cell.

WB:WBGene00000524	clc-3
Localizes to plasma membrane.

WB:WBGene00000525	clc-4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Zidovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00000526	clc-5
Is enriched in Z1.p; Z4.a; hypodermis; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Clc-like and Clc protein-like.

WB:WBGene00000527	cle-1
Is involved in several processes, including cholinergic synaptic transmission; generation of neurons; and inductive cell migration. Localizes to basement membrane and cell junction. Is expressed in several structures, including basal lamina; head mesodermal cell; neurons; smooth muscle; and somatic nervous system. Is an ortholog of human COL15A1 (collagen type XV alpha 1 chain) and COL18A1 (collagen type XVIII alpha 1 chain).

WB:WBGene00000528	clh-1
Is predicted to have voltage-gated chloride channel activity. Is expressed in several structures, including amphid sheath cell; anterior hypodermis; intestine; spermatheca; and vulD. Human ortholog(s) of this gene are implicated in Bartter disease (multiple); idiopathic generalized epilepsy 11; and primary hyperaldosteronism. Is an ortholog of human CLCN2 (chloride voltage-gated channel 2).

WB:WBGene00000529	clh-2
Is predicted to have voltage-gated chloride channel activity. Is expressed in several structures, including ganglia; intestine; pharyngeal-intestinal valve; somatic nervous system; and vulval muscle. Human ortholog(s) of this gene are implicated in Bartter disease (multiple); idiopathic generalized epilepsy 11; and primary hyperaldosteronism. Is an ortholog of human CLCN2 (chloride voltage-gated channel 2).

WB:WBGene00000530	clh-3
Is predicted to have voltage-gated chloride channel activity. Localizes to plasma membrane. Is expressed in egg-laying apparatus; epithelial cell; excretory cell; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including Bartter disease (multiple); idiopathic generalized epilepsy 11; and myotonia congenita. Is an ortholog of human CLCN2 (chloride voltage-gated channel 2).

WB:WBGene00000531	clh-4
Is predicted to have voltage-gated chloride channel activity. Is expressed in excretory cell. Human ortholog(s) of this gene are implicated in Bartter disease (multiple); idiopathic generalized epilepsy 11; and primary hyperaldosteronism. Is an ortholog of human CLCN2 (chloride voltage-gated channel 2).

WB:WBGene00000532	clh-5
Is predicted to have chloride ion binding activity; solute:proton antiporter activity; and voltage-gated chloride channel activity. Is expressed in several structures, including head and tail. Human ortholog(s) of this gene are implicated in X-linked recessive hypophosphatemic rickets; non-syndromic X-linked intellectual disability; and renal tubular transport disease (multiple). Is an ortholog of human CLCN3 (chloride voltage-gated channel 3) and CLCN4 (chloride voltage-gated channel 4).

WB:WBGene00000533	clh-6
Is predicted to have chloride transmembrane transporter activity. Is involved in lysosomal protein catabolic process. Is expressed in several structures, including body wall musculature; head; intestine; non-striated muscle; and tail. Human ortholog(s) of this gene are implicated in autosomal dominant osteopetrosis 2 and autosomal recessive osteopetrosis 4. Is an ortholog of human CLCN7 (chloride voltage-gated channel 7).

WB:WBGene00000534	cpi-2
Exhibits cysteine-type endopeptidase inhibitor activity. Is involved in positive regulation of vitellogenesis; regulation of oocyte development; and regulation of protein processing. Localizes to extracellular space and yolk granule. Is expressed in hypodermis; pharyngeal gland cell; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in CST3-related cerebral amyloid angiopathy and age related macular degeneration 11. Is an ortholog of human CST3 (cystatin C).

WB:WBGene00000535	cpi-1
Exhibits cysteine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in CST3-related cerebral amyloid angiopathy and age related macular degeneration 11. Is an ortholog of several human genes including CST2 (cystatin SA); CST3 (cystatin C); and CST4 (cystatin S).

WB:WBGene00000536	clk-1
Exhibits transcription regulatory region DNA binding activity. Is involved in several processes, including positive regulation of growth rate; regulation of protein modification process; and regulation of transcription by RNA polymerase II. Localizes to mitochondrion and nucleus. Is expressed widely. Human ortholog(s) of this gene are implicated in primary coenzyme Q10 deficiency 8. Is an ortholog of human COQ7 (coenzyme Q7, hydroxylase).

WB:WBGene00000537	clk-2
Is predicted to have Hsp90 protein binding activity and telomeric DNA binding activity. Is involved in several processes, including DNA damage checkpoint; determination of adult lifespan; and response to X-ray. Localizes to cytoplasm. Is expressed in several structures, including distal tip cell; head ganglion; and preanal ganglion neurons. Is an ortholog of human TELO2 (telomere maintenance 2).

WB:WBGene00000538	clk-3
Is involved in determination of adult lifespan and regulation of growth.

WB:WBGene00000539	cln-3.1
Is involved in determination of adult lifespan and regulation of oviposition. Localizes to cytoplasm. Is expressed in cuticle; diagonal muscle; hypodermis; intestine; and pharynx. Is used to study neuronal ceroid lipofuscinosis. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 3. Is an ortholog of human CLN3 (CLN3 lysosomal/endosomal transmembrane protein, battenin).

WB:WBGene00000540	cln-3.2
Is involved in determination of adult lifespan and regulation of oviposition. Is used to study neuronal ceroid lipofuscinosis. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 3. Is an ortholog of human CLN3 (CLN3 lysosomal/endosomal transmembrane protein, battenin).

WB:WBGene00000541	cln-3.3
Is involved in determination of adult lifespan and regulation of oviposition. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 3. Is an ortholog of human CLN3 (CLN3 lysosomal/endosomal transmembrane protein, battenin).

WB:WBGene00000542	clp-1
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is involved in several processes, including mitochondrion organization; muscle cell cellular homeostasis; and positive regulation of sarcomere organization. Localizes to M band. Is expressed in GABAergic neurons; hypodermis; intestine; pharyngeal muscle cell; and vulva. Is used to study Duchenne muscular dystrophy and hereditary spastic paraplegia. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy. Is an ortholog of several human genes including CAPN1 (calpain 1); CAPN2 (calpain 2); and CAPN8 (calpain 8).

WB:WBGene00000543	clp-2
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is expressed in head; hypodermis; intestinal cell; muscle cell; and tail. Is an ortholog of human CAPN7 (calpain 7).

WB:WBGene00000544	clp-3
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy. Is an ortholog of human CAPN1 (calpain 1) and CAPN2 (calpain 2).

WB:WBGene00000545	clp-4
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is expressed in GABAergic neurons; body wall musculature; dorsal nerve cord; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy. Is an ortholog of human CAPN11 (calpain 11); CAPN2 (calpain 2); and CAPN9 (calpain 9).

WB:WBGene00000546	clp-6
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy. Is an ortholog of human CAPN1 (calpain 1) and CAPN2 (calpain 2).

WB:WBGene00000547	clp-7
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is expressed in several structures, including excretory cell; hypodermis; neurons; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy. Is an ortholog of human CAPN1 (calpain 1) and CAPN2 (calpain 2).

WB:WBGene00000548	clr-1
Exhibits transmembrane receptor protein tyrosine phosphatase activity. Is involved in several processes, including negative regulation of fibroblast growth factor receptor signaling pathway; netrin-activated signaling pathway; and positive regulation of synapse assembly. Localizes to plasma membrane and postsynapse. Is expressed in several structures, including AVA; body wall musculature; muscle cell; preanal ganglion; and somatic gonad. Human ortholog(s) of this gene are implicated in severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, Nk cell-positive. Is an ortholog of human PTPRA (protein tyrosine phosphatase receptor type A); PTPRC (protein tyrosine phosphatase receptor type C); and PTPRE (protein tyrosine phosphatase receptor type E).

WB:WBGene00000549	cls-2
Is predicted to have microtubule binding activity. Is involved in several processes, including cytoplasmic streaming; cytoskeleton organization; and nuclear division. Localizes to several cellular components, including cytoskeleton; kinetochore; and nucleus. Is expressed in embryonic cell. Is an ortholog of human CLASP1 (cytoplasmic linker associated protein 1) and CLASP2 (cytoplasmic linker associated protein 2).

WB:WBGene00000550	clu-1
Is predicted to have mRNA binding activity. Is an ortholog of human CLUH (clustered mitochondria homolog).

WB:WBGene00000551	clx-1
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; procyanidin; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00000552	cmd-1
Is predicted to have calcium ion binding activity and enzyme regulator activity. Is involved in several processes, including apoptotic cell clearance; embryo development; and establishment of meiotic spindle orientation. Localizes to cell periphery; cytoskeleton; and nuclear membrane. Human ortholog(s) of this gene are implicated in catecholaminergic polymorphic ventricular tachycardia 4 and long QT syndrome 14. Is an ortholog of human CALM1 (calmodulin 1) and CALM3 (calmodulin 3).

WB:WBGene00000553	cmk-1
Exhibits calmodulin binding activity and calmodulin-dependent protein kinase activity. Is involved in several processes, including generation of neurons; regulation of transcription, DNA-templated; and thermosensory behavior. Localizes to cytoplasm and nucleus. Is expressed in neurons and vulval muscle. Is an ortholog of human CAMK1 (calcium/calmodulin dependent protein kinase I).

WB:WBGene00000554	cnb-1
Exhibits calcium ion binding activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is expressed in several structures, including germ line; gonad; muscle cell; neurons; and somatic nervous system. Is an ortholog of human PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha).

WB:WBGene00000555	cnc-1
Is involved in defense response to fungus and innate immune response.

WB:WBGene00000556	cnc-2
Is involved in defense response to Gram-negative bacterium; defense response to fungus; and innate immune response. Is expressed in hypodermis.

WB:WBGene00000557	cnc-3
Is enriched in PLM; germline precursor cell; hypodermis; intestine; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercury hydroxide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00000558	cnc-4
Is involved in defense response to fungus and innate immune response. Is expressed in hypodermis; intestine; and seam cell.

WB:WBGene00000559	cnc-5
Is involved in defense response to fungus and innate immune response.

WB:WBGene00000560	cnc-6
Is involved in defense response to fungus and innate immune response. Is expressed in intestine.

WB:WBGene00000561	cnd-1
Is predicted to have DNA-binding transcription factor activity. Is involved in axonal fasciculation. Localizes to nucleus. Is expressed in several structures, including ABalpapaa; ABalppapa; ABplaapaa; ABplppaap; and neuroblasts. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 6; persistent hyperplastic primary vitreous; and type 2 diabetes mellitus. Is an ortholog of human NEUROD1 (neuronal differentiation 1); NEUROD4 (neuronal differentiation 4); and NEUROD6 (neuronal differentiation 6).

WB:WBGene00000562	cng-1
Is predicted to have cGMP binding activity; intracellular cAMP-activated cation channel activity; and intracellular cGMP-activated cation channel activity. Is involved in several processes, including negative regulation of cGMP-mediated signaling; sensory perception of chemical stimulus; and sensory processing. Localizes to neuronal cell body. Is expressed in amphid neurons and head neurons. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 24; eye disease (multiple); and heart conduction disease (multiple). Is an ortholog of human CNGA1 (cyclic nucleotide gated channel subunit alpha 1); CNGA2 (cyclic nucleotide gated channel subunit alpha 2); and CNGA3 (cyclic nucleotide gated channel subunit alpha 3).

WB:WBGene00000563	cng-3
Is predicted to have cGMP binding activity; intracellular cAMP-activated cation channel activity; and intracellular cGMP-activated cation channel activity. Is involved in multicellular organismal reproductive process; positive regulation of growth rate; and response to heat. Localizes to non-motile cilium. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 24; eye disease (multiple); and heart conduction disease (multiple). Is an ortholog of human CNGA1 (cyclic nucleotide gated channel subunit alpha 1); CNGA2 (cyclic nucleotide gated channel subunit alpha 2); and CNGA3 (cyclic nucleotide gated channel subunit alpha 3).

WB:WBGene00000564	cnk-1
Is enriched in AVK; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in syndromic X-linked mental retardation Hough type. Is predicted to encode a protein with the following domains: Phosphorylation site; Connector enhancer of kinase suppressor of ras; PH domain; PDZ domain; SAM domain (Sterile alpha motif); PDZ domain; Sterile alpha motif domain; Pleckstrin homology domain; PH-like domain superfamily; Sterile alpha motif/pointed domain superfamily; CRIC domain; and PDZ superfamily. Is an ortholog of human CNKSR2 (connector enhancer of kinase suppressor of Ras 2) and CNKSR3 (CNKSR family member 3).

WB:WBGene00000565	cnt-1
Exhibits Rab GTPase binding activity and phosphatidylinositol phosphate binding activity. Is involved in apoptotic process; negative regulation of phosphate metabolic process; and positive regulation of endosome to plasma membrane protein transport. Localizes to basolateral plasma membrane; cytoplasmic side of apical plasma membrane; and endosome. Is used to study cancer. Is an ortholog of human ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) and ACAP3 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 3).

WB:WBGene00000566	cnt-2
Is predicted to have several functions, including GTP binding activity; GTPase activator activity; and GTPase activity. Is involved in several processes, including activation of GTPase activity; asymmetric neuroblast division; and cell fate determination involved in pattern specification. Is expressed in tail. Is an ortholog of human AGAP3 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 3).

WB:WBGene00000567	cnx-1
Exhibits calcium ion binding activity. Is involved in IRE1-mediated unfolded protein response and response to heat. Localizes to perinuclear region of cytoplasm. Is expressed in copulatory spicule; excretory cell; nervous system; seam cell; and spermatheca. Is an ortholog of human CANX (calnexin).

WB:WBGene00000568	cod-1
No description available

WB:WBGene00000569	cod-2
No description available

WB:WBGene00000570	cod-3
No description available

WB:WBGene00000571	cod-4
No description available

WB:WBGene00000572	cod-5
No description available

WB:WBGene00000573	cod-6
No description available

WB:WBGene00000574	cod-7
No description available

WB:WBGene00000575	cod-8
No description available

WB:WBGene00000576	cod-9
No description available

WB:WBGene00000577	cod-10
No description available

WB:WBGene00000578	cod-11
No description available

WB:WBGene00000579	cod-12
No description available

WB:WBGene00000580	cod-13
No description available

WB:WBGene00000581	cod-14
No description available

WB:WBGene00000582	cod-15
No description available

WB:WBGene00000583	cof-2
Is enriched in coelomocyte and neurons based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in juvenile glaucoma. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies); Olfactomedin-like domain; Olfactomedin-like domain; and Collagen triple helix repeat. Is an ortholog of human GLDN (gliomedin).

WB:WBGene00000584	cog-1
Exhibits repressing transcription factor binding activity. Is involved in several processes, including neuron development involved in amphid sensory organ development; oviposition; and regulation of gene expression. Is expressed in several structures, including egg-laying apparatus; head neurons; male-specific anatomical entity; phasmid sensillum; and spermathecal-uterine junction. Human ortholog(s) of this gene are implicated in double outlet right ventricle and spastic ataxia 8. Is an ortholog of human NKX6-2 (NK6 homeobox 2).

WB:WBGene00000585	cogc-2
Is involved in gonad morphogenesis and regulation of cell migration. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIq. Is an ortholog of human COG2 (component of oligomeric golgi complex 2).

WB:WBGene00000591	coh-1
Is predicted to have chromatin binding activity. Is expressed in several structures, including anterior distal tip cell; anterior gonad arm; germ line; and posterior distal tip cell. Is an ortholog of human RAD21L1 (RAD21 cohesin complex component like 1).

WB:WBGene00000592	coh-3
Is involved in meiotic sister chromatid cohesion.

WB:WBGene00000593	col-2
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000594	col-3
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000595	col-5
No description available

WB:WBGene00000596	col-7
Is predicted to be a structural constituent of cuticle. Is expressed in seam cell.

WB:WBGene00000597	col-8
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000598	col-9
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000599	col-10
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000600	col-11
No description available

WB:WBGene00000601	col-12
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000602	col-13
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000603	col-14
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000604	col-15
No description available

WB:WBGene00000605	col-16
No description available

WB:WBGene00000606	col-17
Is enriched in DA neuron; VA neuron; germline precursor cell; and hypodermis based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-eight chemicals including hydrogen sulfide; Nitric Oxide; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00000607	col-18
No description available

WB:WBGene00000608	col-19
Is a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Localizes to alae of collagen and cuticulin-based cuticle extracellular matrix and annuli extracellular matrix. Is expressed in cuticle; hyp7 syncytium; syncytium; vulva; and in male.

WB:WBGene00000609	col-20
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000610	col-33
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000611	col-34
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000612	col-35
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000613	col-36
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000614	col-37
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000615	col-38
Is predicted to be a structural constituent of cuticle. Is expressed in hyp7 syncytium and seam cell.

WB:WBGene00000616	col-39
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000617	col-40
Is predicted to be a structural constituent of cuticle. Is expressed in hypodermis.

WB:WBGene00000618	col-41
Is predicted to be a structural constituent of cuticle. Is expressed in hypodermis and vulval precursor cell.

WB:WBGene00000620	col-43
Is predicted to be a structural constituent of cuticle. Is expressed in hypodermis.

WB:WBGene00000621	col-44
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000622	col-45
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000623	col-46
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000624	col-47
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and aak-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in Barrett's esophagus. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000625	col-48
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000626	col-49
Is predicted to be a structural constituent of cuticle. Is expressed in hyp7 syncytium and seam cell.

WB:WBGene00000627	col-50
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000628	col-51
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000629	col-52
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride; Colistin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000630	col-53
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including age-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000631	col-54
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000632	col-55
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol; fluoranthene; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00000633	col-56
Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000634	col-58
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000636	col-60
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000637	col-61
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000638	col-62
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000639	col-63
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000640	col-64
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000641	col-65
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000642	col-66
Is affected by several genes including daf-2; prg-1; and dpy-9 based on RNA-seq and microarray studies. Is affected by five chemicals including Hydrolyzable Tannins; Colistin; and dafa#1 based on microarray studies.

WB:WBGene00000644	col-68
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000645	col-69
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000646	H17B01.2
Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twenty-two chemicals including Mercuric Chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00000647	col-71
Is predicted to have extracellular matrix structural constituent. Is expressed in hyp7 syncytium and seam cell.

WB:WBGene00000648	col-72
Is enriched in AVK; GABAergic neurons; and amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Alovudine; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000649	col-73
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000650	col-74
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000651	col-75
Is predicted to be a structural constituent of collagen and cuticulin-based cuticle.

WB:WBGene00000652	col-76
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000653	col-77
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000654	col-78
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000655	col-79
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000656	col-80
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000657	col-81
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000658	col-83
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000659	col-84
Is predicted to have extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 5. Is an ortholog of human COLQ (collagen like tail subunit of asymmetric acetylcholinesterase).

WB:WBGene00000660	col-85
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000661	col-86
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000662	col-87
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000663	col-88
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000664	col-89
Is predicted to be a structural constituent of cuticle. Is involved in IRE1-mediated unfolded protein response. Is expressed in head; neurons; and tail. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000665	col-90
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000666	col-91
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000667	col-92
Is predicted to be a structural constituent of cuticle. Is expressed in hypodermis.

WB:WBGene00000668	col-93
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000669	col-94
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000670	col-95
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000671	col-96
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000672	col-97
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000673	col-98
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000674	col-99
Is predicted to have extracellular matrix structural constituent. Is involved in axon guidance. Localizes to several cellular components, including extracellular space; neuromuscular junction; and spanning component of plasma membrane. Is expressed in anal depressor muscle; body wall musculature; hypodermis; neurons; and retrovesicular ganglion. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 19. Is an ortholog of human COL13A1 (collagen type XIII alpha 1 chain).

WB:WBGene00000675	col-101
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000676	col-102
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000677	col-103
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000678	col-104
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000679	col-105
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000680	col-106
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000681	col-107
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000682	col-108
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000683	col-109
Is predicted to be a structural constituent of cuticle. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00000684	col-110
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000685	col-111
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000687	col-113
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000688	col-114
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000689	col-115
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000690	col-116
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000691	col-117
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000692	col-118
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000693	col-119
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000694	col-120
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000695	col-121
Is predicted to have extracellular matrix structural constituent. Is expressed in hyp7 syncytium.

WB:WBGene00000696	col-122
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000697	col-123
Is predicted to have extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 5. Is an ortholog of human COLQ (collagen like tail subunit of asymmetric acetylcholinesterase).

WB:WBGene00000698	col-124
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000699	col-125
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000700	col-126
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000701	col-127
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000702	col-128
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000703	col-129
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000704	col-130
Is predicted to be a structural constituent of cuticle. Is expressed in intestine and vulva.

WB:WBGene00000705	col-131
Is enriched in ALM; GABAergic neurons; and PLM based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000706	col-132
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000707	col-133
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000708	col-135
Is predicted to have extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 19; epidermolysis bullosa dystrophica (multiple); and nonsyndromic congenital nail disorder 8.

WB:WBGene00000709	col-136
Is affected by several genes including rrf-3; sir-2.1; and prg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00000710	col-137
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000711	col-138
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000712	col-139
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000713	col-140
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000714	col-141
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000715	col-142
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000716	col-143
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000717	col-144
Is predicted to be a structural constituent of cuticle. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000718	col-145
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000719	col-146
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000720	col-147
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000721	col-148
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000722	col-149
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000723	col-150
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000724	col-151
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000725	col-152
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000726	col-153
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000727	col-154
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000728	col-155
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000729	col-156
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000730	col-157
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000731	col-158
Is predicted to be a structural constituent of collagen and cuticulin-based cuticle.

WB:WBGene00000732	col-159
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000733	col-160
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000734	col-161
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000735	col-162
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000736	col-163
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00000737	col-164
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000738	col-165
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000739	col-166
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000740	col-167
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000741	col-168
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000742	col-169
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000743	col-170
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000744	col-171
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000745	col-172
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000746	col-173
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000747	col-174
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000748	col-175
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000749	col-176
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000750	col-177
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including D-glucose; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000751	col-178
Is predicted to have extracellular matrix structural constituent. Is expressed widely.

WB:WBGene00000752	col-179
Is predicted to have extracellular matrix structural constituent. Is involved in defense response to Gram-negative bacterium and innate immune response.

WB:WBGene00000753	col-180
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000754	col-181
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000755	col-182
Is enriched in PLM; hypodermis; and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00000756	col-183
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000757	col-184
Is predicted to be a structural constituent of cuticle. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00000758	col-185
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000759	col-186
Is predicted to be a structural constituent of cuticle.

WB:WBGene00000760	col-187
Is enriched in AVK and seam cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus based on RNA-seq studies. Human ortholog(s) of this gene are implicated in Barrett's esophagus. Is predicted to encode a protein with the following domains: Collagen triple helix repeat (20 copies) and Collagen triple helix repeat.

WB:WBGene00000761	coq-1
Is predicted to have transferase activity, transferring alkyl or aryl (other than methyl) groups. Is involved in ubiquinone biosynthetic process. Human ortholog(s) of this gene are implicated in primary coenzyme Q10 deficiency 2. Is an ortholog of human PDSS1 (decaprenyl diphosphate synthase subunit 1).

WB:WBGene00000762	coq-2
Is predicted to have 4-hydroxybenzoate decaprenyltransferase activity. Is involved in ubiquinone biosynthetic process. Human ortholog(s) of this gene are implicated in primary coenzyme Q10 deficiency 1. Is an ortholog of human COQ2 (coenzyme Q2, polyprenyltransferase).

WB:WBGene00000763	coq-3
Is predicted to have methyltransferase activity. Is involved in nematode larval development and ubiquinone biosynthetic process. Is an ortholog of human COQ3 (coenzyme Q3, methyltransferase).

WB:WBGene00000764	coq-4
Is involved in ubiquinone biosynthetic process. Human ortholog(s) of this gene are implicated in primary coenzyme Q10 deficiency 7. Is an ortholog of human COQ4 (coenzyme Q4).

WB:WBGene00000765	coq-5
Is predicted to have methyltransferase activity. Is involved in ubiquinone biosynthetic process. Is an ortholog of human COQ5 (coenzyme Q5, methyltransferase).

WB:WBGene00000766	coq-6
Is predicted to have oxidoreductase activity. Is involved in ubiquinone biosynthetic process. Human ortholog(s) of this gene are implicated in primary coenzyme Q10 deficiency 6. Is an ortholog of human COQ6 (coenzyme Q6, monooxygenase).

WB:WBGene00000767	coq-8
Is predicted to have kinase activity. Is involved in ubiquinone biosynthetic process. Is expressed in coelomocyte; hypodermis; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9 and primary coenzyme Q10 deficiency 4. Is an ortholog of human COQ8A (coenzyme Q8A) and COQ8B (coenzyme Q8B).

WB:WBGene00000768	cor-1
Is predicted to have actin filament binding activity. Is expressed in several structures, including QL.a; QL.pa; QR.a; QR.pa; and oxygen sensory neurons. Human ortholog(s) of this gene are implicated in coronin-1A deficiency. Is an ortholog of several human genes including CORO1A (coronin 1A); CORO1B (coronin 1B); and CORO1C (coronin 1C).

WB:WBGene00000769	cow-1
No description available

WB:WBGene00000770	cpb-1
Is predicted to have mRNA 3'-UTR binding activity; ribosome binding activity; and translation regulator activity, nucleic acid binding. Is involved in meiotic cell cycle and spermatogenesis. Localizes to cytoplasm. Is expressed in germ line. Is an ortholog of human CPEB2 (cytoplasmic polyadenylation element binding protein 2).

WB:WBGene00000771	cpb-2
Is predicted to have mRNA 3'-UTR binding activity; ribosome binding activity; and translation regulator activity, nucleic acid binding. Is an ortholog of human CPEB2 (cytoplasmic polyadenylation element binding protein 2).

WB:WBGene00000772	cpb-3
Is predicted to have mRNA 3'-UTR binding activity; ribosome binding activity; and translation regulator activity, nucleic acid binding. Is expressed in PVDL; PVDR; and germ line. Is an ortholog of human CPEB1 (cytoplasmic polyadenylation element binding protein 1).

WB:WBGene00000773	cpf-1
Is enriched in Psub3; germ line; and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cleavage stimulation factor subunit 1, dimerisation domain; WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; Cleavage stimulation factor subunit 1, dimerisation domain; WD40-repeat-containing domain superfamily; and CSTF1, dimerization domain superfamily. Is an ortholog of human CSTF1 (cleavage stimulation factor subunit 1).

WB:WBGene00000774	cpf-2
Is predicted to have mRNA binding activity. Localizes to nuclear speck. Is an ortholog of human CSTF2 (cleavage stimulation factor subunit 2) and CSTF2T (cleavage stimulation factor subunit 2 tau variant).

WB:WBGene00000775	cpin-1
Is predicted to have hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds. Is an ortholog of human GDA (guanine deaminase).

WB:WBGene00000776	cpl-1
Is predicted to have cysteine-type endopeptidase activity. Is involved in several processes, including lipid droplet disassembly; positive regulation of vitellogenesis; and regulation of apoptosis involved in tissue homeostasis. Localizes to several cellular components, including extracellular space; lysosome; and yolk granule. Is expressed in several structures, including cuticle; eggshell; hermaphrodite gonad; pharynx; and vulva. Is an ortholog of human CTSL (cathepsin L) and CTSV (cathepsin V).

WB:WBGene00000777	cpn-1
Is enriched in NSM; Psub1; germ line; germline precursor cell; and intestine based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on proteomic; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Calponin family repeat; Calponin repeat; Calponin homology domain; Smooth muscle protein/calponin; and CH domain superfamily. Is an ortholog of human TAGLN (transgelin); TAGLN2 (transgelin 2); and TAGLN3 (transgelin 3).

WB:WBGene00000778	cpn-2
Is enriched in PLM and hypodermis based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Calponin family repeat; Calponin repeat; Calponin homology domain; Smooth muscle protein/calponin; and CH domain superfamily. Is an ortholog of human TAGLN (transgelin); TAGLN2 (transgelin 2); and TAGLN3 (transgelin 3).

WB:WBGene00000779	cpn-3
Localizes to myofibril. Is expressed in anal region; body wall musculature; egg-laying apparatus; enteric muscle; and head neurons. Is an ortholog of several human genes including CNN3 (calponin 3); TAGLN (transgelin); and TAGLN3 (transgelin 3).

WB:WBGene00000780	cpn-4
Is enriched in intestine; muscle cell; neurons; pharynx; and retrovesicular ganglion based on microarray; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including aldicarb; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Calponin homology domain; Smooth muscle protein/calponin; and CH domain superfamily.

WB:WBGene00000781	cpr-1
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00000782	cpr-2
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00000783	cpr-3
Is predicted to have cysteine-type endopeptidase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis. Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00000784	cpr-4
Exhibits cysteine-type endopeptidase activity. Is involved in cellular response to UV; cellular response to gamma radiation; and proteolysis involved in cellular protein catabolic process. Localizes to extracellular region. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00000785	cpr-5
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00000786	cpr-6
Is predicted to have cysteine-type endopeptidase activity. Localizes to lysosome. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00000787	cps-6
Exhibits nuclease activity; protein homodimerization activity; and sequence-specific DNA binding activity. Is involved in RNA catabolic process and apoptotic DNA fragmentation. Localizes to mitochondrion. Is an ortholog of human ENDOG (endonuclease G).

WB:WBGene00000788	cpz-1
Is predicted to have cysteine-type endopeptidase activity. Is involved in several processes, including ecdysis, collagen and cuticulin-based cuticle; gonad morphogenesis; and post-embryonic body morphogenesis. Localizes to collagen and cuticulin-based cuticle extracellular matrix; extracellular space; and yolk granule. Is expressed in several structures, including anterior hypodermis; cuticle; intestine; pharynx; and vulva. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human CTSZ (cathepsin Z).

WB:WBGene00000789	cpz-2
Is predicted to have cysteine-type endopeptidase activity. Is an ortholog of human CTSZ (cathepsin Z).

WB:WBGene00000792	crb-1
Is predicted to have calcium ion binding activity. Localizes to apical part of cell and cytoplasm. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 8; pigmented paravenous chorioretinal atrophy; and retinitis pigmentosa 12. Is an ortholog of human CRB1 (crumbs cell polarity complex component 1).

WB:WBGene00000793	crh-1
Exhibits transcription coactivator binding activity. Is involved in several processes, including determination of adult lifespan; positive regulation of transcription by RNA polymerase II; and thermosensory behavior. Is expressed in several structures, including germ line; gonad; head ganglion; intestine; and neurons. Human ortholog(s) of this gene are implicated in achromatopsia 7 and osteogenesis imperfecta type 16. Is an ortholog of human ATF1 (activating transcription factor 1); CREB1 (cAMP responsive element binding protein 1); and CREM (cAMP responsive element modulator).

WB:WBGene00000794	crn-1
Exhibits flap endonuclease activity. Is involved in apoptotic DNA fragmentation. Localizes to nucleus. Is an ortholog of human FEN1 (flap structure-specific endonuclease 1).

WB:WBGene00000795	crn-2
Exhibits deoxyribonuclease activity. Is involved in apoptotic DNA fragmentation and apoptotic cell clearance. Is expressed in head and tail. Is an ortholog of human TATDN1 (TatD DNase domain containing 1).

WB:WBGene00000796	crn-3
Is predicted to have 3'-5'-exoribonuclease activity and single-stranded RNA binding activity. Is involved in apoptotic DNA fragmentation; apoptotic cell clearance; and embryo development. Is an ortholog of human EXOSC10 (exosome component 10).

WB:WBGene00000797	crn-4
Exhibits nuclease activity and single-stranded DNA binding activity. Is involved in DNA catabolic process, exonucleolytic; RNA catabolic process; and apoptotic DNA fragmentation. Is an ortholog of human ERI1 (exoribonuclease 1).

WB:WBGene00000798	crn-5
Exhibits double-stranded DNA binding activity and enzyme binding activity. Is involved in RNA processing; apoptotic DNA fragmentation; and positive regulation of deoxyribonuclease activity. Localizes to exosome (RNase complex). Is an ortholog of human EXOSC5 (exosome component 5).

WB:WBGene00000799	crn-6
Exhibits deoxyribonuclease II activity. Is involved in apoptotic DNA fragmentation. Is an ortholog of human DNASE2B (deoxyribonuclease 2 beta).

WB:WBGene00000800	cars-1
Is predicted to have ATP binding activity and cysteine-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 27. Is an ortholog of human CARS1 (cysteinyl-tRNA synthetase 1).

WB:WBGene00000801	cars-2
Is enriched in OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and isp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00000802	crt-1
Exhibits calcium ion binding activity. Is involved in several processes, including IRE1-mediated unfolded protein response; hemidesmosome assembly; and negative regulation of oxidative stress-induced neuron death. Localizes to cytoplasm. Is expressed in several structures, including coelomocyte; excretory system; intestine; pharynx; and sperm. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in essential thrombocythemia and myelofibrosis. Is an ortholog of human CALR (calreticulin).

WB:WBGene00000803	csb-1
Is predicted to have DNA binding activity and DNA-dependent ATPase activity. Is involved in UV protection and transcription-coupled nucleotide-excision repair. Is expressed in several structures, including copulatory spicule; egg-laying apparatus; neurons; oocyte; and postcloacal sensillum. Human ortholog(s) of this gene are implicated in several diseases, including CHARGE syndrome; Cockayne syndrome; and Coffin-Siris syndrome 4. Is an ortholog of human ERCC6 (ERCC excision repair 6, chromatin remodeling factor).

WB:WBGene00000804	csc-1
Is involved in mitotic cleavage furrow ingression and nuclear division. Localizes to condensed nuclear chromosome; meiotic spindle midzone; and mitotic spindle midzone. Is expressed in oocyte.

WB:WBGene00000805	csg-1
No description available

WB:WBGene00000806	csg-2
No description available

WB:WBGene00000807	csg-3
No description available

WB:WBGene00000808	csg-4
No description available

WB:WBGene00000809	csg-6
No description available

WB:WBGene00000810	csg-7
No description available

WB:WBGene00000811	csg-8
No description available

WB:WBGene00000812	csk-1
Exhibits protein tyrosine kinase activity. Is involved in several processes, including larval feeding behavior; muscle fiber development; and pharyngeal pumping. Localizes to cell-cell junction and plasma membrane. Is expressed in several structures, including anus; head neurons; hermaphrodite somatic gonadal cell; pharyngeal muscle cell; and vulval cell. Is an ortholog of human CSK (C-terminal Src kinase).

WB:WBGene00000813	csn-1
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; daf-12; and npr-1 based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: 26S proteasome subunit RPN7; PCI domain; Proteasome component (PCI) domain; 26S proteasome regulatory subunit Rpn7/COP9 signalosome complex subunit 1; COP9 signalosome complex subunit 1; and Winged helix DNA-binding domain superfamily. Is an ortholog of human GPS1 (G protein pathway suppressor 1).

WB:WBGene00000814	csn-2
Is predicted to have transcription corepressor activity. Is expressed in head. Is an ortholog of human COPS2 (COP9 signalosome subunit 2).

WB:WBGene00000815	csn-3
Is involved in establishment of mitotic spindle localization; mitotic cytokinesis; and ubiquitin-dependent protein catabolic process. Localizes to COP9 signalosome. Is an ortholog of human COPS3 (COP9 signalosome subunit 3).

WB:WBGene00000816	csn-4
Is predicted to contribute to NEDD8-specific protease activity. Is an ortholog of human COPS4 (COP9 signalosome subunit 4).

WB:WBGene00000817	csn-5
Exhibits DEAD/H-box RNA helicase binding activity and protein C-terminus binding activity. Is involved in gonad development; oogenesis; and protein deneddylation. Localizes to A band and nucleus. Is expressed in tail. Is an ortholog of human COPS5 (COP9 signalosome subunit 5).

WB:WBGene00000818	csn-6
Is enriched in GABAergic neurons; NSM; and germ line based on RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Maintenance of mitochondrial structure and function; JAB1/Mov34/MPN/PAD-1 ubiquitin protease; JAB1/MPN/MOV34 metalloenzyme domain; and Rpn11/EIF3F, C-terminal. Is an ortholog of human COPS6 (COP9 signalosome subunit 6).

WB:WBGene00000819	csp-1
Exhibits cysteine-type endopeptidase activity. Is involved in several processes, including negative regulation of cellular response to manganese ion; positive regulation of apoptotic process; and protein maturation. Localizes to germ cell nucleus. Is expressed in germ line. Is an ortholog of several human genes including CASP2 (caspase 2); CASP3 (caspase 3); and CASP6 (caspase 6).

WB:WBGene00000820	csp-2
Exhibits caspase binding activity; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; and zymogen binding activity. Is involved in positive regulation of brood size; positive regulation of fertilization; and regulation of apoptotic process. Localizes to protease inhibitor complex. Is expressed in germ line. Human ortholog(s) of this gene are implicated in several diseases, including autoimmune lymphoproliferative syndrome (multiple); gastrointestinal system cancer (multiple); and non-Hodgkin lymphoma. Is an ortholog of human CASP6 (caspase 6).

WB:WBGene00000821	csp-3
Exhibits caspase binding activity; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; and zymogen binding activity. Is involved in several processes, including positive regulation of locomotion involved in locomotory behavior; positive regulation of oviposition; and regulation of apoptotic process. Localizes to cytoplasm. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in several diseases, including autoimmune lymphoproliferative syndrome (multiple); gastrointestinal system cancer (multiple); and non-Hodgkin lymphoma.

WB:WBGene00000822	csq-1
Exhibits calcium ion binding activity. Is involved in calcium ion homeostasis. Localizes to several cellular components, including apical plasma membrane; nucleus; and sarcolemma. Is expressed in body wall musculature; isthmus; terminal bulb; and vulval muscle. Human ortholog(s) of this gene are implicated in catecholaminergic polymorphic ventricular tachycardia 1 and catecholaminergic polymorphic ventricular tachycardia 2. Is an ortholog of human CASQ1 (calsequestrin 1).

WB:WBGene00000824	cta-1
No description available

WB:WBGene00000825	cta-2
No description available

WB:WBGene00000826	cta-3
No description available

WB:WBGene00000827	cta-4
No description available

WB:WBGene00000828	cta-5
No description available

WB:WBGene00000829	ctb-1
Is predicted to have electron transfer activity and metal ion binding activity. Human ortholog(s) of this gene are implicated in Leber hereditary optic neuropathy and MELAS syndrome.

WB:WBGene00000830	ctl-1
Exhibits catalase activity. Human ortholog(s) of this gene are implicated in acatalasia. Is an ortholog of human CAT (catalase).

WB:WBGene00000831	ctl-2
Exhibits catalase activity. Is involved in determination of adult lifespan and peroxisome organization. Localizes to peroxisome. Human ortholog(s) of this gene are implicated in acatalasia. Is an ortholog of human CAT (catalase).

WB:WBGene00000832	ctn-1
Is predicted to have actin filament binding activity and cadherin binding activity. Is involved in regulation of locomotion. Localizes to plasma membrane and striated muscle dense body. Is expressed in body wall musculature; non-striated muscle; and somatic nervous system. Is used to study Duchenne muscular dystrophy. Is an ortholog of human CTNNAL1 (catenin alpha like 1).

WB:WBGene00000833	cts-1
Is predicted to have citrate (Si)-synthase activity. Localizes to mitochondrion. Is expressed in anal depressor muscle and ventral cord neurons. Is an ortholog of human CS (citrate synthase).

WB:WBGene00000834	cua-1
Exhibits copper ion transmembrane transporter activity. Is involved in copper ion transport. Localizes to vacuolar membrane. Is expressed in neurons; pharynx; and pm6. Is used to study Menkes disease. Human ortholog(s) of this gene are implicated in several diseases, including Menkes disease; Wilson disease; and neurodegenerative disease (multiple). Is an ortholog of human ATP7A (ATPase copper transporting alpha) and ATP7B (ATPase copper transporting beta).

WB:WBGene00000835	cuc-1
Exhibits copper chaperone activity. Is involved in copper ion transport. Localizes to cytosol. Is expressed in hyp5; hyp6; and hyp7 syncytium. Is an ortholog of human ATOX1 (antioxidant 1 copper chaperone).

WB:WBGene00000836	cul-1
Is predicted to have ubiquitin protein ligase binding activity. Is involved in several processes, including negative regulation of DNA damage response, signal transduction by p53 class mediator; negative regulation of cell cycle; and regulation of apoptotic process. Is expressed in intestine; muscle cell; and neurons. Is an ortholog of human CUL1 (cullin 1).

WB:WBGene00000837	cul-2
Is predicted to have ubiquitin protein ligase binding activity. Is involved in several processes, including male sex determination; meiotic chromosome segregation; and proteasome-mediated ubiquitin-dependent protein catabolic process. Localizes to Cul2-RING ubiquitin ligase complex; cytoplasm; and nucleus. Is expressed in several structures, including P1; P12; P2; germ line; and nerve ring. Is an ortholog of human CUL2 (cullin 2).

WB:WBGene00000838	cul-3
Exhibits POZ domain binding activity. Is involved in protein catabolic process; protein polyubiquitination; and striated muscle myosin thick filament assembly. Localizes to Cul3-RING ubiquitin ligase complex. Is expressed in head; linker cell; and tail. Is an ortholog of human CUL3 (cullin 3).

WB:WBGene00000839	cul-4
Is predicted to have ubiquitin protein ligase binding activity. Is involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Is expressed in embryonic cell; germ line; gonad; intestine; and oocyte. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Cabezas type. Is an ortholog of human CUL4B (cullin 4B).

WB:WBGene00000840	cul-5
Is predicted to have ubiquitin protein ligase binding activity. Is expressed in several structures, including head; intestine; nervous system; tail; and vulval muscle. Is an ortholog of human CUL5 (cullin 5).

WB:WBGene00000841	cul-6
Is predicted to have ubiquitin protein ligase binding activity. Is involved in defense response to virus. Is expressed in intestine and pharynx. Is an ortholog of human CUL1 (cullin 1).

WB:WBGene00000842	cup-1
Is involved in endocytosis.

WB:WBGene00000843	cup-2
Is predicted to have misfolded protein binding activity and ubiquitin-specific protease binding activity. Is involved in endocytosis and response to misfolded protein. Localizes to early endosome and perinuclear endoplasmic reticulum. Is expressed widely. Is an ortholog of human DERL1 (derlin 1).

WB:WBGene00000844	cup-3
Is involved in endocytosis.

WB:WBGene00000845	cup-4
Is predicted to have ion channel activity. Is involved in several processes, including determination of adult lifespan; positive regulation of oviposition; and response to paraquat. Localizes to cytoplasmic vesicle membrane.

WB:WBGene00000846	cup-5
Is predicted to have NAADP-sensitive calcium-release channel activity and phosphatidylinositol-3,5-bisphosphate binding activity. Is involved in several processes, including determination of adult lifespan; lipid transport involved in lipid storage; and negative regulation of endocytosis. Localizes to endolysosome and lysosomal membrane. Is expressed in coelomocyte; head; intestinal cell; and neurons. Is used to study glycoproteinosis. Human ortholog(s) of this gene are implicated in mucolipidosis type IV. Is an ortholog of human MCOLN1 (mucolipin 1) and MCOLN3 (mucolipin 3).

WB:WBGene00000848	cup-8
Is involved in endocytosis.

WB:WBGene00000849	cup-9
Is involved in endocytosis.

WB:WBGene00000850	cup-11
Is involved in endocytosis.

WB:WBGene00000851	cut-1
Is predicted to be a structural constituent of cuticle. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is expressed in seam cell.

WB:WBGene00000853	cut-6
Localizes to alae of collagen and cuticulin-based cuticle extracellular matrix. Is expressed in hypodermal cell. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple).

WB:WBGene00000854	cux-7
Is enriched in OLL; body wall muscle cell; germ line; and interneuron based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including D-glucose; Zidovudine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human AKAP17A (A-kinase anchoring protein 17A).

WB:WBGene00000857	cwn-1
Exhibits receptor tyrosine kinase binding activity. Is involved in several processes, including generation of neurons; neuroblast migration; and regulation of vulval development. Is expressed in several structures, including CAN; hypodermal cell; intestine; muscle cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Mullerian aplasia and hyperandrogenism; Schopf-Schulz-Passarge syndrome; and bone development disease (multiple). Is an ortholog of human WNT4 (Wnt family member 4).

WB:WBGene00000858	cwn-2
Is predicted to have frizzled binding activity and receptor ligand activity. Is involved in several processes, including axis specification; generation of neurons; and neuroblast migration. Is expressed in several structures, including RME; pharynx; rectal gland cell; vulval cell; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including Mullerian aplasia and hyperandrogenism; Schopf-Schulz-Passarge syndrome; and bone development disease (multiple). Is an ortholog of human WNT5A (Wnt family member 5A) and WNT5B (Wnt family member 5B).

WB:WBGene00000859	cwp-1
Is enriched in ciliated neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00000860	cwp-2
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and rrf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00000861	cwp-3
Is enriched in neurons and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; alg-1; and mex-3 based on tiling array and RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00000862	cwp-4
Is enriched in head mesodermal cell; neurons; and ray based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; daf-12; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Sodium Chloride and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00000863	cya-1
Is predicted to contribute to protein kinase activity. Is involved in meiotic cell cycle. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNA1 (cyclin A1).

WB:WBGene00000864	cya-2
Is predicted to contribute to protein kinase activity. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNP (cyclin P).

WB:WBGene00000865	cyb-1
Exhibits cyclin-dependent protein serine/threonine kinase regulator activity and ubiquitin protein ligase binding activity. Is predicted to contribute to protein kinase activity. Is involved in mitotic cell cycle; oocyte maturation; and positive regulation of protein phosphorylation. Localizes to cytoplasm and nucleus. Is expressed in male gonad and oocyte. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNB2 (cyclin B2).

WB:WBGene00000866	cyb-2.1
Is predicted to contribute to protein kinase activity. Is involved in anterior/posterior axis specification, embryo and oocyte maturation. Is expressed in germ line. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNB1 (cyclin B1) and CCNB2 (cyclin B2).

WB:WBGene00000867	cyb-2.2
Is predicted to contribute to protein kinase activity. Is involved in anterior/posterior axis specification, embryo; meiotic cell cycle; and oocyte maturation. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNB2 (cyclin B2).

WB:WBGene00000868	cyb-3
Exhibits cyclin-dependent protein serine/threonine kinase regulator activity. Is predicted to contribute to protein kinase activity. Is involved in several processes, including chromosome organization; positive regulation of mitotic metaphase/anaphase transition; and pronuclear migration. Localizes to cytoplasm and nucleus. Is expressed in several structures, including EMS; Psub1; Psub2; germ line; and male gonad. Is an ortholog of human CCNB3 (cyclin B3).

WB:WBGene00000869	cyc-1
Is predicted to have electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity. Is involved in determination of adult lifespan and mitochondrial ATP synthesis coupled proton transport. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 6. Is an ortholog of human CYC1 (cytochrome c1).

WB:WBGene00000870	cyd-1
Is predicted to contribute to protein kinase activity. Is involved in several processes, including gonad development; positive regulation of asymmetric protein localization involved in cell fate determination; and regulation of cell cycle process. Is expressed in gonad; hypodermis; intestine; neurons; and vulva. Human ortholog(s) of this gene are implicated in multiple myeloma; primary ciliary dyskinesia 29; and von Hippel-Lindau disease. Is an ortholog of human CCND1 (cyclin D1); CCND2 (cyclin D2); and CCND3 (cyclin D3).

WB:WBGene00000871	cye-1
Exhibits cyclin-dependent protein serine/threonine kinase regulator activity. Is predicted to contribute to protein kinase activity. Is involved in several processes, including DNA endoreduplication; regulation of cellular protein localization; and regulation of mitotic cell cycle. Localizes to chromatin and nucleus. Is expressed in several structures, including germ line; gonad; and male sex myoblast. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNE1 (cyclin E1) and CCNE2 (cyclin E2).

WB:WBGene00000872	cyk-1
Is predicted to have Rho GTPase binding activity and actin binding activity. Is involved in pronuclear migration. Localizes to cleavage furrow and cytoplasmic side of plasma membrane. Colocalizes with actomyosin contractile ring. Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in autosomal dominant auditory neuropathy 1; autosomal dominant nonsyndromic deafness 1; and premature ovarian failure. Is an ortholog of human DIAPH3 (diaphanous related formin 3).

WB:WBGene00000873	cyk-2
Is involved in embryo development and mitotic cleavage furrow formation.

WB:WBGene00000874	cyk-3
Exhibits thiol-dependent ubiquitin-specific protease activity. Is involved in several processes, including cellular water homeostasis; mitotic cleavage furrow formation; and positive regulation of actin cytoskeleton reorganization. Localizes to cytoplasm and microtubule organizing center. Is expressed in coelomocyte; excretory cell; head neurons; hypodermis; and pharynx. Is an ortholog of human USP32 (ubiquitin specific peptidase 32).

WB:WBGene00000875	cyk-4
Exhibits GTPase activator activity. Is involved in cytoskeleton-dependent cytokinesis; mitotic spindle midzone assembly; and positive regulation of GTPase activity. Localizes to centralspindlin complex; mitotic spindle midzone; and plasma membrane. Is expressed in germ cell; gonad; and tail. Is an ortholog of human RACGAP1 (Rac GTPase activating protein 1).

WB:WBGene00000876	cyl-1
Is predicted to have cyclin-dependent protein serine/threonine kinase regulator activity. Is an ortholog of human CCNL2 (cyclin L2).

WB:WBGene00000877	cyn-1
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Localizes to mitochondrion. Is an ortholog of human PPIA (peptidylprolyl isomerase A).

WB:WBGene00000878	cyn-2
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Is an ortholog of human PPIA (peptidylprolyl isomerase A) and PPIAL4C (peptidylprolyl isomerase A like 4C).

WB:WBGene00000879	cyn-3
Exhibits peptidyl-prolyl cis-trans isomerase activity. Is involved in protein peptidyl-prolyl isomerization. Localizes to cell. Is expressed in excretory system. Is an ortholog of human PPIA (peptidylprolyl isomerase A).

WB:WBGene00000880	cyn-4
Is predicted to have peptidyl-prolyl cis-trans isomerase activity and ubiquitin-ubiquitin ligase activity. Is involved in feminization of hermaphroditic germ-line. Is expressed in body wall musculature; germ line; intestine; pharynx; and uterus. Is an ortholog of human PPIL2 (peptidylprolyl isomerase like 2).

WB:WBGene00000881	cyn-5
Exhibits peptidyl-prolyl cis-trans isomerase activity. Is involved in protein peptidyl-prolyl isomerization. Localizes to cytoplasm. Is expressed in intestine. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 9. Is an ortholog of human PPIB (peptidylprolyl isomerase B).

WB:WBGene00000882	cyn-6
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 9. Is an ortholog of human PPIB (peptidylprolyl isomerase B).

WB:WBGene00000883	cyn-7
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Is an ortholog of human PPIA (peptidylprolyl isomerase A).

WB:WBGene00000884	cyn-8
Exhibits peptidyl-prolyl cis-trans isomerase activity. Localizes to nucleus. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 9. Is an ortholog of human PPIG (peptidylprolyl isomerase G).

WB:WBGene00000885	cyn-9
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 9. Is an ortholog of human PPIG (peptidylprolyl isomerase G).

WB:WBGene00000886	cyn-10
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human PPIL3 (peptidylprolyl isomerase like 3).

WB:WBGene00000887	cyn-11
Is predicted to have several functions, including cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Is an ortholog of human PPIH (peptidylprolyl isomerase H).

WB:WBGene00000888	cyn-12
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human PPIL1 (peptidylprolyl isomerase like 1).

WB:WBGene00000889	cyn-13
Exhibits nuclease activity. Is involved in apoptotic DNA fragmentation. Is an ortholog of human PPIE (peptidylprolyl isomerase E).

WB:WBGene00000890	sig-7
Exhibits RNA polymerase II complex binding activity. Is involved in several processes, including positive regulation of macromolecule metabolic process; positive regulation of oocyte development; and positive regulation of vulval development. Localizes to nucleoplasm and transcriptionally active chromatin. Is expressed in several structures, including intestine. Is an ortholog of human PPIL4 (peptidylprolyl isomerase like 4).

WB:WBGene00000891	cyn-15
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human PPWD1 (peptidylprolyl isomerase domain and WD repeat containing 1).

WB:WBGene00000892	cyn-16
Exhibits peptidyl-prolyl cis-trans isomerase activity. Is expressed in intestine and ventral cord neurons. Is an ortholog of human CWC27 (CWC27 spliceosome associated cyclophilin).

WB:WBGene00000893	cyn-17
Is enriched in germ line and pharynx based on microarray and proteomic studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00000894	dab-1
Exhibits clathrin heavy chain binding activity and protein domain specific binding activity. Is involved in several processes, including ecdysis, collagen and cuticulin-based cuticle; oviposition; and positive regulation of growth rate. Localizes to Golgi-associated vesicle; cell cortex; and extrinsic component of cytoplasmic side of plasma membrane. Colocalizes with clathrin-coated vesicle. Is expressed in several structures, including amphid sheath cell; anchor cell; oocyte; vulval cell; and vulval cell. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 37 and type 2 diabetes mellitus. Is an ortholog of human DAB1 (DAB adaptor protein 1) and DAB2 (DAB adaptor protein 2).

WB:WBGene00000895	dac-1
Is expressed in amphid neurons; cuticular ala; and tail. Is predicted to encode a protein with the following domains: SKI/SNO/DAC family; SKI/SNO/DAC domain; Putative DNA-binding domain superfamily; and Ski-like, DNA-binding domain superfamily. Is an ortholog of human DACH2 (dachshund family transcription factor 2).

WB:WBGene00000896	dad-1
Is predicted to contribute to oligosaccharyl transferase activity. Is involved in negative regulation of apoptotic process. Is an ortholog of human DAD1 (defender against cell death 1).

WB:WBGene00000897	daf-1
Is predicted to have SMAD binding activity and transforming growth factor beta receptor activity, type I. Is involved in several processes, including dauer entry; larval feeding behavior; and response to bacterium. Is expressed in several structures, including distal tip cell; head ganglion; inner labial sensillum; neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Loeys-Dietz syndrome (multiple); fibrodysplasia ossificans progressiva; and hereditary hemorrhagic telangiectasia. Is an ortholog of human ACVR1C (activin A receptor type 1C).

WB:WBGene00000898	daf-2
Exhibits PTB domain binding activity; SH2 domain binding activity; and protein kinase binding activity. Is involved in several processes, including dauer exit; regulation of cellular catabolic process; and regulation of gene expression. Localizes to several cellular components, including cytoplasmic vesicle; neuronal cell body; and spanning component of plasma membrane. Is expressed in amphid neurons; gonad; hypodermis; and nerve ring. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in several diseases, including endocrine gland cancer (multiple); hematologic cancer (multiple); and synostosis (multiple). Is an ortholog of human IGF1R (insulin like growth factor 1 receptor); INSR (insulin receptor); and INSRR (insulin receptor related receptor).

WB:WBGene00000899	daf-3
Exhibits cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including determination of adult lifespan; positive regulation of dauer larval development; and regulation of pharyngeal pumping. Localizes to condensed chromosome; cytoplasm; and nucleus. Is expressed in several structures, including P1; P2; hermaphrodite distal tip cell; hypodermal cell; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Loeys-Dietz syndrome 3; aortic valve disease 2; and juvenile polyposis syndrome. Is an ortholog of human SMAD4 (SMAD family member 4).

WB:WBGene00000900	daf-4
Exhibits BMP binding activity. Is involved in several processes, including dauer entry; defense response to other organism; and regulation of transcription by RNA polymerase II. Localizes to plasma membrane. Is expressed in several structures, including ganglia; intestine; pharynx; somatic nervous system; and tail hypodermis. Is used to study Marfan syndrome. Human ortholog(s) of this gene are implicated in several diseases, including Loeys-Dietz syndrome 2; fibrodysplasia ossificans progressiva; and hereditary hemorrhagic telangiectasia. Is an ortholog of human ACVR2B (activin A receptor type 2B).

WB:WBGene00000901	daf-5
Is predicted to have SMAD binding activity and transcription corepressor activity. Is involved in several processes, including determination of adult lifespan; positive regulation of dauer larval development; and transforming growth factor beta receptor signaling pathway. Localizes to cytoplasm and nucleus. Is expressed in several structures, including XXX cell; ganglia; hermaphrodite distal tip cell; intestine; and muscle cell.

WB:WBGene00000902	daf-6
Is involved in several processes, including negative regulation of transcription by RNA polymerase II; positive regulation of dauer larval development; and regulation of insulin receptor signaling pathway. Localizes to cytoplasmic vesicle and plasma membrane. Is expressed in several structures, including cuticle; excretory system; interfacial epithelial cell; neurons; and vulval cell. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00000903	daf-7
Is predicted to have cytokine activity and transforming growth factor beta receptor binding activity. Is involved in several processes, including cellular response to cGMP; regulation of gene expression; and response to bacterium. Localizes to extracellular space. Is expressed in coelomocyte; head neurons; pharynx; and in male. Human ortholog(s) of this gene are implicated in several diseases, including Loeys-Dietz syndrome (multiple); bone disease (multiple); and microphthalmia (multiple). Is an ortholog of human GDF11 (growth differentiation factor 11) and MSTN (myostatin).

WB:WBGene00000904	daf-8
Exhibits RNA polymerase II transcription factor binding activity. Is involved in several processes, including dauer entry; oviposition; and regulation of transcription by RNA polymerase II. Localizes to cytosol and nucleus. Is expressed in excretory cell; hermaphrodite distal tip cell; intestine; neurons; and ventral nerve cord. Is an ortholog of human SMAD2 (SMAD family member 2) and SMAD3 (SMAD family member 3).

WB:WBGene00000905	daf-9
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in cell-cell signaling; dauer larval development; and regulation of cell migration. Localizes to neuronal cell body and perinuclear region of cytoplasm. Is expressed in several structures, including anterior ganglion; excretory cell; head neurons; spermatheca; and vulval muscle. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2S1 (cytochrome P450 family 2 subfamily S member 1).

WB:WBGene00000906	daf-10
Is involved in several processes, including non-motile cilium assembly; positive regulation of dauer larval development; and receptor localization to non-motile cilium. Localizes to ciliary basal body. Human ortholog(s) of this gene are implicated in Sensenbrenner syndrome. Is an ortholog of human IFT122 (intraflagellar transport 122).

WB:WBGene00000907	daf-11
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including cellular response to cGMP; chemotaxis to cAMP; and positive regulation of transforming growth factor beta receptor signaling pathway. Localizes to dendrite; neuronal cell body; and non-motile cilium.

WB:WBGene00000908	daf-12
Exhibits nuclear receptor activity; sequence-specific DNA binding activity; and steroid hormone binding activity. Is involved in several processes, including chemotaxis to cAMP; positive regulation of dauer larval development; and response to biotin. Localizes to nucleus. Is expressed in several structures, including gonad; neurons; pharyngeal muscle cell; somatic gonad precursor; and vulva. Is an ortholog of human NR1I2 (nuclear receptor subfamily 1 group I member 2) and VDR (vitamin D receptor).

WB:WBGene00000909	daf-13
No description available

WB:WBGene00000910	daf-14
Is involved in several processes, including determination of adult lifespan; negative regulation of dauer larval development; and oviposition. Is expressed in several structures, including anal sphincter muscle; excretory duct cell; intestine; nerve ring; and phasmid sheath cell. Human ortholog(s) of this gene are implicated in aortic valve disease 2.

WB:WBGene00000911	daf-15
Is predicted to have protein kinase activator activity and protein-macromolecule adaptor activity. Is involved in dauer larval development; determination of adult lifespan; and regulation of autophagosome assembly. Localizes to TORC1 complex. Is expressed in several structures, including body wall musculature; excretory cell; hermaphrodite distal tip cell; intestine; and pharyngeal muscle cell. Is an ortholog of human RPTOR (regulatory associated protein of MTOR complex 1).

WB:WBGene00000912	daf-16
Exhibits several functions, including 14-3-3 protein binding activity; DNA-binding transcription factor activity; and enzyme binding activity. Is involved in several processes, including defense response to other organism; regulation of dauer larval development; and regulation of transcription, DNA-templated. Localizes to cytosol and nucleus. Is expressed in several structures, including gonad; hypodermis; neurons; somatic cell; and ventral nerve cord. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in several diseases, including alveolar rhabdomyosarcoma; anterior segment dysgenesis 2; and lens disease (multiple). Is an ortholog of human FOXO1 (forkhead box O1); FOXO3 (forkhead box O3); and FOXO4 (forkhead box O4).

WB:WBGene00000913	daf-18
Exhibits protein tyrosine phosphatase activity. Is involved in several processes, including determination of adult lifespan; positive regulation of dauer larval development; and protein import into nucleus. Localizes to several cellular components, including cytoplasmic side of plasma membrane; dendrite; and neuronal cell body. Is expressed in several structures, including Z2; egg-laying apparatus; germ line; oocyte; and somatic nervous system. Is used to study cancer. Human ortholog(s) of this gene are implicated in Bannayan-Riley-Ruvalcaba syndrome; macrocephaly-autism syndrome; and prostate cancer. Is an ortholog of human PTEN (phosphatase and tensin homolog).

WB:WBGene00000914	daf-19
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in positive regulation of transcription by RNA polymerase II and regulation of non-motile cilium assembly. Localizes to nucleus. Is expressed in several structures, including body wall musculature; excretory cell; intestine; neurons; and somatic nervous system. Is an ortholog of human RFX1 (regulatory factor X1); RFX2 (regulatory factor X2); and RFX3 (regulatory factor X3).

WB:WBGene00000915	hsp-90
Exhibits several functions, including ATPase activity; glucocorticoid receptor binding activity; and protein phosphatase 5 binding activity. Is involved in several processes, including chemotaxis to cAMP; positive regulation of phosphoprotein phosphatase activity; and response to biotin. Localizes to perinuclear region of cytoplasm and protein-containing complex. Is expressed in several structures, including excretory system; germ line; intestine; nerve ring; and pharynx. Is an ortholog of human HSP90AA1 (heat shock protein 90 alpha family class A member 1) and HSP90AB1 (heat shock protein 90 alpha family class B member 1).

WB:WBGene00000917	daf-25
Is predicted to have metal ion binding activity. Is involved in several processes, including dauer exit; positive regulation of cGMP-mediated signaling; and protein localization to cell periphery. Localizes to non-motile cilium. Is expressed in intestine and sensory neurons. Is an ortholog of human ANKMY2 (ankyrin repeat and MYND domain containing 2).

WB:WBGene00000918	daf-26
No description available

WB:WBGene00000919	daf-27
No description available

WB:WBGene00000920	daf-28
Is predicted to have insulin receptor binding activity. Is involved in several processes, including insulin receptor signaling pathway; negative regulation of dauer entry; and protein import into nucleus. Localizes to extracellular space and synapse. Is expressed in several structures, including distal tip cell; egg-laying apparatus; neurons; pharynx; and ventral nerve cord.

WB:WBGene00000921	daf-29
No description available

WB:WBGene00000922	daf-30
No description available

WB:WBGene00000923	daf-31
Is predicted to have peptide-glutamate-N-acetyltransferase activity and peptide-serine-N-acetyltransferase activity. Is involved in several processes, including dauer exit; determination of adult lifespan; and positive regulation of DNA-binding transcription factor activity. Is expressed in hypodermal cell and neurons. Human ortholog(s) of this gene are implicated in Ogden syndrome. Is an ortholog of human NAA10 (N-alpha-acetyltransferase 10, NatA catalytic subunit) and NAA11 (N-alpha-acetyltransferase 11, NatA catalytic subunit).

WB:WBGene00000924	daf-32
No description available

WB:WBGene00000925	daf-33
No description available

WB:WBGene00000926	daf-34
No description available

WB:WBGene00000927	daf-35
No description available

WB:WBGene00000928	dao-2
Is enriched in PLM; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00000929	dao-3
Is predicted to have methenyltetrahydrofolate cyclohydrolase activity and methylenetetrahydrofolate dehydrogenase (NADP+) activity. Human ortholog(s) of this gene are implicated in neural tube defect. Is an ortholog of human MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase).

WB:WBGene00000930	dao-4
Is expressed in hyp7 syncytium and seam cell.

WB:WBGene00000931	dao-5
Exhibits RNA polymerase I core binding activity and rDNA binding activity. Is involved in several processes, including insulin receptor signaling pathway; nucleolar large rRNA transcription by RNA polymerase I; and regulation of chromatin silencing at rDNA. Localizes to nucleolus and nucleoplasm. Is expressed in germline precursor cell; gonadal sheath cell; hypodermis; and somatic cell. Is an ortholog of human NOLC1 (nucleolar and coiled-body phosphoprotein 1).

WB:WBGene00000932	dao-6
Is enriched in GABAergic neurons; excretory cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Cadmium Chloride; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00000933	dap-3
Is predicted to be a structural constituent of ribosome. Is an ortholog of human DAP3 (death associated protein 3).

WB:WBGene00000934	dat-1
Exhibits amine transmembrane transporter activity; chloride channel activity; and dopamine:sodium symporter activity. Is involved in several processes, including cellular response to amphetamine; dopamine uptake involved in synaptic transmission; and negative regulation of cellular response to manganese ion. Localizes to neuron projection membrane; neuronal cell body membrane; and presynaptic membrane. Is expressed in dopaminergic neurons. Human ortholog(s) of this gene are implicated in Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of human SLC6A2 (solute carrier family 6 member 2).

WB:WBGene00000935	daz-1
Is predicted to have mRNA 3'-UTR binding activity and translation activator activity. Localizes to cytoplasm. Is expressed in germ line; gonad; and in male. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2. Is an ortholog of human BOLL (boule homolog, RNA binding protein).

WB:WBGene00000936	dbl-1
Is predicted to have BMP receptor binding activity; cytokine activity; and protein serine/threonine kinase activator activity. Is involved in several processes, including defense response to other organism; nematode male tail tip morphogenesis; and positive regulation of macromolecule biosynthetic process. Is expressed in body wall musculature; nervous system; pm2 precursor; and in male. Is used to study Marfan syndrome. Human ortholog(s) of this gene are implicated in several diseases, including Klippel-Feil syndrome 1; Leber congenital amaurosis 17; and bone development disease (multiple). Is an ortholog of human BMP10 (bone morphogenetic protein 10).

WB:WBGene00000937	dbr-1
Is predicted to have RNA lariat debranching enzyme activity. Is an ortholog of human DBR1 (debranching RNA lariats 1).

WB:WBGene00000938	dcp-66
Is expressed in neurons and tail. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 18. Is predicted to encode a protein with the following domains: Phosphorylation site and Transcriptional repressor p66. Is an ortholog of human GATAD2B (GATA zinc finger domain containing 2B).

WB:WBGene00000939	dcr-1
Exhibits deoxyribonuclease I activity and ribonuclease III activity. Is involved in several processes, including nucleic acid metabolic process; olfactory learning; and positive regulation of primary miRNA processing. Localizes to cytosol and nucleus. Is expressed in germ line; intestine; neurons; and somatic cell. Human ortholog(s) of this gene are implicated in multinodular goiter and pleuropulmonary blastoma. Is an ortholog of human DICER1 (dicer 1, ribonuclease III).

WB:WBGene00000940	dcs-1
Exhibits RNA 7-methylguanosine cap binding activity; hydrolase activity, acting on acid anhydrides; and sulfate adenylyltransferase (ADP) activity. Is involved in several processes, including mRNA catabolic process; response to heat; and sulfur compound metabolic process. Localizes to cytoplasm and nucleus. Is an ortholog of human DCPS (decapping enzyme, scavenger).

WB:WBGene00000941	ddp-1
Is predicted to have metal ion binding activity. Is involved in mitochondrion organization. Is used to study deafness-dystonia-optic neuronopathy syndrome. Human ortholog(s) of this gene are implicated in deafness-dystonia-optic neuronopathy syndrome. Is an ortholog of human TIMM8A (translocase of inner mitochondrial membrane 8A).

WB:WBGene00000942	deb-1
Is a structural constituent of cytoskeleton. Is involved in cytoskeletal anchoring at plasma membrane and positive regulation of ovulation. Localizes to several cellular components, including cytoskeleton; dense body; and striated muscle dense body. Is expressed in gonad. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1W and hypertrophic cardiomyopathy 15. Is an ortholog of human VCL (vinculin).

WB:WBGene00000943	dec-1
No description available

WB:WBGene00000944	dec-2
No description available

WB:WBGene00000945	dec-7
No description available

WB:WBGene00000946	dec-9
No description available

WB:WBGene00000947	dec-10
No description available

WB:WBGene00000948	dec-11
No description available

WB:WBGene00000949	dec-12
No description available

WB:WBGene00000950	deg-1
Is predicted to have sodium channel activity. Is involved in response to acidic pH and response to amino acid. Is expressed in AVG; IL1 neuron; anal depressor muscle; body wall musculature; and command interneuron. Is used to study hypokalemic periodic paralysis and neurodegenerative disease. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1B (sodium channel epithelial 1 subunit beta) and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00000951	deg-3
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is involved in positive regulation of locomotion involved in locomotory behavior and regulation of programmed cell death. Is expressed in ALA; AVG; PVC; and mechanosensory neurons. Is used to study neurodegenerative disease.

WB:WBGene00000952	del-1
Is predicted to have sodium channel activity. Is expressed in cholinergic neurons and in male. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1A (sodium channel epithelial 1 subunit alpha); SCNN1B (sodium channel epithelial 1 subunit beta); and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00000953	del-2
Is expressed in ASEL; ASER; and neurons.

WB:WBGene00000954	des-1
No description available

WB:WBGene00000955	des-2
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Localizes to integral component of plasma membrane. Is expressed in AIYL; AIYR; ALA; IL2 neuron; and pm1. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00000956	des-3
No description available

WB:WBGene00000957	des-4
No description available

WB:WBGene00000958	dgk-1
Exhibits Rho GTPase binding activity and diacylglycerol kinase activity. Is involved in several processes, including cellular response to dopamine; regulation of defecation; and regulation of oviposition. Localizes to several cellular components, including cell body; cytosol; and perinuclear region of cytoplasm. Is expressed in excretory canal; neurons; and ventral cord neurons. Is an ortholog of human DGKQ (diacylglycerol kinase theta).

WB:WBGene00000959	dgk-2
Is predicted to have diacylglycerol kinase activity. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 7. Is an ortholog of human DGKE (diacylglycerol kinase epsilon).

WB:WBGene00000960	dgk-3
Is predicted to have diacylglycerol kinase activity. Is involved in olfactory behavior; regulation of long-term neuronal synaptic plasticity; and thermotaxis. Is expressed in amphid neurons; head; and pharyngeal lumen. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 7. Is an ortholog of human DGKB (diacylglycerol kinase beta).

WB:WBGene00000961	dgn-1
Is predicted to have laminin binding activity. Is involved in several processes, including axon extension involved in axon guidance; gonad morphogenesis; and inductive cell migration. Localizes to basal plasma membrane. Is expressed in several structures, including ALM; PVP; e2; gonad; and lumbar ganglion. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2P and congenital muscular dystrophy-dystroglycanopathy type A9. Is an ortholog of human DAG1 (dystroglycan 1).

WB:WBGene00000962	dhc-1
Is predicted to have ATP-dependent microtubule motor activity, minus-end-directed; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Is involved in several processes, including cytoskeleton-dependent intracellular transport; establishment of meiotic spindle orientation; and generation of neurons. Localizes to several cellular components, including kinetochore; nuclear envelope; and spindle pole. Is expressed in germ cell; head; somatic cell; and tail. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2O; autosomal dominant non-syndromic intellectual disability 13; and spinal muscular atrophy with lower extremity predominance 1. Is an ortholog of human DYNC1H1 (dynein cytoplasmic 1 heavy chain 1).

WB:WBGene00000963	dhp-1
Exhibits hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides. Is involved in pyrimidine nucleobase catabolic process. Localizes to nucleus. Is expressed in hyp7 syncytium. Human ortholog(s) of this gene are implicated in dihydropyrimidinase deficiency. Is an ortholog of human DPYS (dihydropyrimidinase) and DPYSL3 (dihydropyrimidinase like 3).

WB:WBGene00000964	dhp-2
Exhibits hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides. Is involved in pyrimidine nucleobase catabolic process. Localizes to cytoplasm. Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in dihydropyrimidinase deficiency. Is an ortholog of human DPYS (dihydropyrimidinase).

WB:WBGene00000965	dhs-1
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Zidovudine; Atrazine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRSX (dehydrogenase/reductase X-linked).

WB:WBGene00000966	dhs-2
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) and SDR9C7 (short chain dehydrogenase/reductase family 9C member 7).

WB:WBGene00000967	dhs-3
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Is involved in multicellular organismal response to stress. Localizes to lipid droplet. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human SDR16C5 (short chain dehydrogenase/reductase family 16C member 5).

WB:WBGene00000968	dhs-4
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human RDH10 (retinol dehydrogenase 10).

WB:WBGene00000969	dhs-5
Is predicted to have oxidoreductase activity. Is expressed in enteric muscle; hypodermis; and vulval muscle, type 1. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12) and HSD17B3 (hydroxysteroid 17-beta dehydrogenase 3).

WB:WBGene00000970	dhs-6
Is enriched in germ line and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by stavudine and Zidovudine based on RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: SCP-2 sterol transfer family; short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; SCP2 sterol-binding domain; NAD(P)-binding domain superfamily; and SCP2 sterol-binding domain superfamily. Is an ortholog of human HSDL2 (hydroxysteroid dehydrogenase like 2).

WB:WBGene00000971	dhs-7
Is enriched in intestine and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; D-glucose; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 12; early infantile epileptic encephalopathy 28; and esophageal cancer. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human WWOX (WW domain containing oxidoreductase).

WB:WBGene00000972	dhs-8
Is enriched in PLM and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including hydrogen sulfide; tryptophan; and methylmercury hydroxide based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 12; early infantile epileptic encephalopathy 28; and esophageal cancer. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human WWOX (WW domain containing oxidoreductase).

WB:WBGene00000973	dhs-9
Is expressed in head. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRS1 (dehydrogenase/reductase 1).

WB:WBGene00000974	dhs-11
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; let-7; and gld-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B8 (hydroxysteroid 17-beta dehydrogenase 8).

WB:WBGene00000975	dhs-12
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including Rifampin; Sirolimus; and Cholestanol based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR1 (carbonyl reductase 1) and CBR3 (carbonyl reductase 3).

WB:WBGene00000976	dhs-13
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRS2 (dehydrogenase/reductase 2) and DHRS4 (dehydrogenase/reductase 4).

WB:WBGene00000977	dhs-14
Is enriched in head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Rotenone; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00000978	dhs-15
Is enriched in RID and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00000979	dhs-16
Exhibits steroid dehydrogenase activity. Is involved in oxidation-reduction process. Is expressed in head neurons; hypodermis; tail neurons; and terminal bulb. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) and SDR9C7 (short chain dehydrogenase/reductase family 9C member 7).

WB:WBGene00000980	dhs-17
Is enriched in several structures, including germ line; head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily.

WB:WBGene00000981	dhs-18
Is enriched in ASER; Psub1; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; lactoferrin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSDL2 (hydroxysteroid dehydrogenase like 2).

WB:WBGene00000982	dhs-19
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human SDR16C5 (short chain dehydrogenase/reductase family 16C member 5).

WB:WBGene00000983	dhs-20
Is enriched in Psub1; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) and SDR9C7 (short chain dehydrogenase/reductase family 9C member 7).

WB:WBGene00000984	dhs-21
Exhibits L-xylulose reductase (NADP+) activity and carbonyl reductase (NADPH) activity. Is involved in xylulose catabolic process. Localizes to plasma membrane. Is expressed in hermaphrodite gonad; hypodermis; and intestine. Human ortholog(s) of this gene are implicated in pentosuria. Is an ortholog of human DCXR (dicarbonyl and L-xylulose reductase).

WB:WBGene00000985	dhs-22
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and germ line based on proteomic and RNA-seq studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on microarray; proteomic; and RNA-seq studies. Is affected by four chemicals including Rotenone; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human RDH13 (retinol dehydrogenase 13).

WB:WBGene00000986	dhs-23
Is expressed in head. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00000987	dhs-24
Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily.

WB:WBGene00000988	dhs-25
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor and quinone binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B8 (hydroxysteroid 17-beta dehydrogenase 8).

WB:WBGene00000989	dhs-26
Is enriched in intestine and neuronal sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRS1 (dehydrogenase/reductase 1).

WB:WBGene00000990	dhs-27
Is predicted to have oxidoreductase activity. Is an ortholog of human HSDL1 (hydroxysteroid dehydrogenase like 1).

WB:WBGene00000991	dhs-28
Is involved in several processes, including ascaroside biosynthetic process; dauer entry; and pheromone biosynthetic process. Localizes to peroxisome. Is expressed in hypodermis. Is used to study obesity. Human ortholog(s) of this gene are implicated in D-bifunctional protein deficiency and Perrault syndrome. Is an ortholog of human HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4).

WB:WBGene00000992	dhs-29
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13.

WB:WBGene00000993	dhs-30
Is enriched in coelomocyte; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; antimycin; and resveratrol based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRS7B (dehydrogenase/reductase 7B).

WB:WBGene00000994	ints-6
Is expressed in several structures, including neurons. Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily. Is an ortholog of human INTS6 (integrator complex subunit 6) and INTS6L (integrator complex subunit 6 like).

WB:WBGene00000995	die-1
Is involved in neuron development involved in amphid sensory organ development and positive regulation of gene expression. Is expressed in several structures, including amphid neurons; intestine; pharynx; somatic nervous system; and tail.

WB:WBGene00000996	dif-1
Is predicted to have transmembrane transporter activity. Is involved in mitochondrial transport. Localizes to mitochondrial envelope. Is expressed in intestine. Human ortholog(s) of this gene are implicated in carnitine-acylcarnitine translocase deficiency. Is an ortholog of human SLC25A20 (solute carrier family 25 member 20).

WB:WBGene00000997	dif-2
No description available

WB:WBGene00000998	dig-1
Is predicted to have calcium ion binding activity and catalytic activity. Is expressed in several structures, including GLR; body wall musculature; head mesodermal cell; male sex myoblast; and non-striated muscle. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and nonsyndromic deafness (multiple).

WB:WBGene00000999	dig-2
No description available

WB:WBGene00001000	dim-1
Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1KK and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Immunoglobulin I-set domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin-like fold; Immunoglobulin-like domain superfamily; and Basigin-like. Is an ortholog of human MYPN (myopalladin).

WB:WBGene00001001	dis-3
Is predicted to have 3'-5'-exoribonuclease activity and endonuclease activity. Is an ortholog of human DIS3 (DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease).

WB:WBGene00001002	div-1
Is predicted to have DNA binding activity. Is expressed in gonad; vulva; and vulval precursor cell. Is an ortholog of human POLA2 (DNA polymerase alpha 2, accessory subunit).

WB:WBGene00001003	div-2
No description available

WB:WBGene00001005	dlc-1
Is predicted to have dynein intermediate chain binding activity and dynein light intermediate chain binding activity. Is expressed in several structures, including germ cell; germ line; intestine; rectal valve cell; and ventral nerve cord. Is an ortholog of human DYNLL2 (dynein light chain LC8-type 2).

WB:WBGene00001006	dlg-1
Is predicted to have guanylate kinase activity. Is involved in embryo development and zonula adherens assembly. Localizes to adherens junction and apical junction complex. Is expressed in epithelial cell; intestine; and pharyngeal epithelial cell. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human DLG1 (discs large MAGUK scaffold protein 1).

WB:WBGene00001007	dli-1
Is predicted to have dynein heavy chain binding activity. Is involved in regulation of dendrite morphogenesis and retrograde axonal transport. Localizes to microtubule plus-end and neuron projection. Is expressed in ciliated neurons; hypodermis; and pharynx. Is an ortholog of human DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1) and DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2).

WB:WBGene00001008	dlk-1
Exhibits protein C-terminus binding activity and ubiquitin protein ligase binding activity. Is involved in several processes, including generation of neurons; p38MAPK cascade; and positive regulation of MAP kinase activity. Localizes to neuronal cell body and synapse. Is expressed in PLML and PLMR. Is an ortholog of human MAP3K12 (mitogen-activated protein kinase kinase kinase 12).

WB:WBGene00001009	dmo-1
No description available

WB:WBGene00001010	dmo-2
No description available

WB:WBGene00001011	dmo-3
No description available

WB:WBGene00001012	dmo-5
No description available

WB:WBGene00001013	dmo-6
No description available

WB:WBGene00001014	dmo-7
No description available

WB:WBGene00001015	dmo-8
No description available

WB:WBGene00001016	dna-2
Exhibits 5'-3' DNA helicase activity; single-stranded DNA endodeoxyribonuclease activity; and single-stranded DNA helicase activity. Is involved in DNA metabolic process. Localizes to nucleus. Is expressed in gonad; oocyte; spermatheca; and uterus. Human ortholog(s) of this gene are implicated in Seckel syndrome 8; autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions  6; and neurodegenerative disease (multiple). Is an ortholog of human DNA2 (DNA replication helicase/nuclease 2).

WB:WBGene00001017	dnc-1
Is predicted to have dynein intermediate chain binding activity and microtubule binding activity. Is involved in several processes, including chromosome segregation; establishment of mitotic spindle orientation; and single fertilization. Localizes to several cellular components, including cytoskeleton; kinetochore; and midbody. Is expressed in AB; P0; and Psub1. Human ortholog(s) of this gene are implicated in Perry syndrome; amyotrophic lateral sclerosis type 1; and distal hereditary motor neuronopathy type 7B. Is an ortholog of human DCTN1 (dynactin subunit 1).

WB:WBGene00001018	dnc-2
Is predicted to have motor activity. Is involved in chromosome segregation; establishment of mitotic spindle orientation; and single fertilization. Localizes to cytoplasm; cytoskeleton; and kinetochore. Is expressed in body wall musculature; neurons; seam cell; somatic nervous system; and tail. Is an ortholog of human DCTN2 (dynactin subunit 2).

WB:WBGene00001019	dnj-1
Is predicted to have Hsp70 protein binding activity. Is involved in cellular protein-containing complex assembly. Localizes to endoplasmic reticulum membrane. Is expressed in head neurons; tail neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1. Is an ortholog of human DNAJB12 (DnaJ heat shock protein family (Hsp40) member B12) and DNAJB14 (DnaJ heat shock protein family (Hsp40) member B14).

WB:WBGene00001020	dnj-2
Is enriched in ALM; PLM; germ line; neurons; and seam cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by six chemicals including Atrazine; Cry5B; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC25-GNG10 (DNAJC25-GNG10 readthrough).

WB:WBGene00001021	dnj-3
Is enriched in several structures, including arcade cell; germ line; muscle cell; neurons; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC4 (DnaJ heat shock protein family (Hsp40) member C4).

WB:WBGene00001022	dnj-4
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1; distal spinal muscular atrophy type 5; and primary ciliary dyskinesia 34. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC4 (DnaJ heat shock protein family (Hsp40) member C4).

WB:WBGene00001023	dnj-5
Is enriched in RIS; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Cleavage inducing molecular chaperone; DnaJ domain; DnaJ domain; Cleavage inducing molecular chaperone, Jiv; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC14 (DnaJ heat shock protein family (Hsp40) member C14).

WB:WBGene00001025	dnj-7
Is predicted to have misfolded protein binding activity and protein kinase inhibitor activity. Is involved in PERK-mediated unfolded protein response. Is expressed in head. Is an ortholog of human DNAJC3 (DnaJ heat shock protein family (Hsp40) member C3).

WB:WBGene00001026	dnj-8
Is enriched in body wall muscle cell; germ line; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin domain; Thioredoxin-like superfamily; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC16 (DnaJ heat shock protein family (Hsp40) member C16).

WB:WBGene00001027	dnj-9
Is enriched in germ line based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including bisphenol S; stavudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DnaJ domain; Domain of unknown function (DUF3395); DnaJ domain; DnaJ-like protein C11, C-terminal; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC11 (DnaJ heat shock protein family (Hsp40) member C11).

WB:WBGene00001028	dnj-10
Is predicted to have unfolded protein binding activity. Is involved in embryo development and nematode larval development. Is expressed in head and tail. Is an ortholog of human DNAJA3 (DnaJ heat shock protein family (Hsp40) member A3).

WB:WBGene00001029	dnj-11
Is predicted to have DNA binding activity. Localizes to cytosol. Is expressed in several structures, including head; muscle cell; neurons; and tail. Is an ortholog of human DNAJC2 (DnaJ heat shock protein family (Hsp40) member C2).

WB:WBGene00001030	dnj-12
Is predicted to have heat shock protein binding activity; metal ion binding activity; and unfolded protein binding activity. Is an ortholog of human DNAJA1 (DnaJ heat shock protein family (Hsp40) member A1).

WB:WBGene00001031	dnj-13
Is predicted to have chaperone binding activity and unfolded protein binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1. Is an ortholog of human DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1).

WB:WBGene00001032	dnj-14
Is involved in determination of adult lifespan; locomotion; and neurotransmitter secretion. Is used to study neuronal ceroid lipofuscinosis. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 4B. Is an ortholog of human DNAJC5 (DnaJ heat shock protein family (Hsp40) member C5).

WB:WBGene00001033	dnj-15
Is predicted to have ATPase activator activity and chaperone binding activity. Is an ortholog of human HSCB (HscB mitochondrial iron-sulfur cluster cochaperone).

WB:WBGene00001034	dnj-16
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1 and distal spinal muscular atrophy type 5. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; and Chaperone J-domain superfamily.

WB:WBGene00001035	dnj-17
Is predicted to have nucleic acid binding activity and zinc ion binding activity. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in Shwachman-Diamond syndrome. Is an ortholog of human DNAJC21 (DnaJ heat shock protein family (Hsp40) member C21).

WB:WBGene00001036	dnj-18
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; and Chaperone J-domain superfamily.

WB:WBGene00001037	dnj-19
Is predicted to have heat shock protein binding activity; metal ion binding activity; and unfolded protein binding activity. Is involved in response to topologically incorrect protein. Is an ortholog of human DNAJA2 (DnaJ heat shock protein family (Hsp40) member A2).

WB:WBGene00001038	dnj-20
Is predicted to have unfolded protein binding activity. Is an ortholog of human DNAJB11 (DnaJ heat shock protein family (Hsp40) member B11).

WB:WBGene00001039	dnj-21
Is predicted to have ATPase activator activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in 3-methylglutaconic aciduria type 5. Is an ortholog of human DNAJC19 (DnaJ heat shock protein family (Hsp40) member C19).

WB:WBGene00001040	dnj-22
Is enriched in AFD; AVA; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1; distal spinal muscular atrophy type 5; and primary ciliary dyskinesia 34. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; Nucleotide-binding alpha-beta plait domain superfamily; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC17 (DnaJ heat shock protein family (Hsp40) member C17).

WB:WBGene00001041	dnj-23
Is predicted to have heat shock protein binding activity. Is an ortholog of human DNAJC9 (DnaJ heat shock protein family (Hsp40) member C9).

WB:WBGene00001042	dnj-24
Localizes to nucleus. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1 and distal spinal muscular atrophy type 5. Is an ortholog of human DNAJB6 (DnaJ heat shock protein family (Hsp40) member B6).

WB:WBGene00001043	dnj-25
Is predicted to have clathrin binding activity. Is involved in receptor-mediated endocytosis. Human ortholog(s) of this gene are implicated in Parkinson's disease 19A. Is an ortholog of human DNAJC6 (DnaJ heat shock protein family (Hsp40) member C6).

WB:WBGene00001044	dnj-26
Is predicted to have Hsp70 protein binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 1. Is an ortholog of human DNAJB12 (DnaJ heat shock protein family (Hsp40) member B12) and DNAJB14 (DnaJ heat shock protein family (Hsp40) member B14).

WB:WBGene00001045	dnj-27
Is predicted to have disulfide oxidoreductase activity. Is involved in IRE1-mediated unfolded protein response. Localizes to endoplasmic reticulum lumen. Is expressed in several structures, including body wall musculature; gonadal sheath cell; intestine; rectum; and vulva. Is an ortholog of human DNAJC10 (DnaJ heat shock protein family (Hsp40) member C10).

WB:WBGene00001046	dnj-28
Is predicted to have chaperone binding activity and misfolded protein binding activity. Is involved in PERK-mediated unfolded protein response. Is expressed in head and tail. Is an ortholog of human DNAJC3 (DnaJ heat shock protein family (Hsp40) member C3).

WB:WBGene00001047	dnj-29
Is enriched in AVK and germ line based on proteomic and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and isp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by multi-walled carbon nanotube; Atrazine; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; DnaJ domain; Sec63 Brl domain; DnaJ domain; Sec63 domain; Immunoglobulin E-set; Translocation protein Sec63; C2 domain superfamily; and Chaperone J-domain superfamily. Is an ortholog of human SEC63 (SEC63 homolog, protein translocation regulator).

WB:WBGene00001048	dnj-30
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: DnaJ homolog subfamily C member 8. Is an ortholog of human DNAJC8 (DnaJ heat shock protein family (Hsp40) member C8).

WB:WBGene00001049	dog-1
Is predicted to have DNA helicase activity. Is involved in DNA metabolic process; regulation of DNA-dependent DNA replication; and reproduction. Is expressed in head and tail. Is used to study Fanconi anemia. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group J and breast cancer. Is an ortholog of human BRIP1 (BRCA1 interacting protein C-terminal helicase 1).

WB:WBGene00001050	dom-3
Is predicted to have several functions, including RNA binding activity; metal ion binding activity; and nuclease activity. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00001051	cks-1
Exhibits protein kinase binding activity. Is involved in regulation of mitotic cell cycle, embryonic. Is an ortholog of human CKS1B (CDC28 protein kinase regulatory subunit 1B).

WB:WBGene00001052	dop-1
Exhibits dopamine neurotransmitter receptor activity, coupled via Gs; epinephrine binding activity; and norepinephrine binding activity. Is involved in several processes, including adenylate cyclase-activating dopamine receptor signaling pathway; habituation; and mechanosensory behavior. Is expressed in several structures, including accessory cell; excretory gland cell; head muscle; mechanosensory neurons; and neurons. Is an ortholog of human DRD1 (dopamine receptor D1) and DRD5 (dopamine receptor D5).

WB:WBGene00001053	dop-2
Exhibits dopamine neurotransmitter receptor activity, coupled via Gi/Go. Is involved in several processes, including cellular response to nicotine; cellular response to organonitrogen compound; and male mating behavior. Is expressed in body ganglion; head neurons; male-specific anatomical entity; and tail neurons. Is used to study Parkinson's disease and nicotine dependence. Human ortholog(s) of this gene are implicated in attention deficit hyperactivity disorder; essential tremor 1; and schizophrenia. Is an ortholog of human DRD2 (dopamine receptor D2) and DRD3 (dopamine receptor D3).

WB:WBGene00001054	dpf-1
Is predicted to have aminopeptidase activity and serine-type peptidase activity. Is an ortholog of human DPP4 (dipeptidyl peptidase 4).

WB:WBGene00001055	dpf-2
Is predicted to have aminopeptidase activity and serine-type peptidase activity. Is expressed in head. Is an ortholog of human FAP (fibroblast activation protein alpha).

WB:WBGene00001056	dpf-3
Is predicted to have serine-type peptidase activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 33. Is an ortholog of human DPP9 (dipeptidyl peptidase 9).

WB:WBGene00001057	dpf-4
Is predicted to have serine-type peptidase activity. Localizes to nucleus. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 33.

WB:WBGene00001058	dpf-5
Is predicted to have serine-type endopeptidase activity. Is an ortholog of human APEH (acylaminoacyl-peptide hydrolase).

WB:WBGene00001059	dpf-6
Is predicted to have aminopeptidase activity and serine-type peptidase activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 33.

WB:WBGene00001060	dpf-7
Is predicted to have serine-type endopeptidase activity. Is an ortholog of human APEH (acylaminoacyl-peptide hydrolase).

WB:WBGene00001061	dpl-1
Exhibits protein C-terminus binding activity and transcription factor binding activity. Is involved in several processes, including negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter; negative regulation of Ras protein signal transduction; and negative regulation of vulval development. Localizes to nucleus. Is expressed in germ line; gonad; and hyp7 syncytium. Is an ortholog of human TFDP1 (transcription factor Dp-1) and TFDP2 (transcription factor Dp-2).

WB:WBGene00001062	dpr-1
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00001063	dpy-1
Is involved in body morphogenesis and regulation of growth.

WB:WBGene00001064	dpy-2
Is predicted to be a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle; post-embryonic body morphogenesis; and regulation of growth. Is expressed in head neurons and pharynx.

WB:WBGene00001065	dpy-3
Is predicted to be a structural constituent of cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle.

WB:WBGene00001066	dpy-4
Is predicted to have extracellular matrix structural constituent. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle.

WB:WBGene00001067	dpy-5
Is a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle; post-embryonic body morphogenesis; and regulation of growth. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Barrett's esophagus.

WB:WBGene00001068	dpy-6
Exhibits calmodulin binding activity.

WB:WBGene00001069	dpy-7
Is a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle and post-embryonic body morphogenesis. Localizes to annular furrow extracellular matrix. Is expressed in several structures, including P1; P12; P2; cuticle; and hypodermis.

WB:WBGene00001070	dpy-8
Is predicted to have extracellular matrix structural constituent. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle.

WB:WBGene00001071	dpy-9
Is predicted to be a structural constituent of cuticle.

WB:WBGene00001072	dpy-10
Is predicted to be a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle; locomotion; and post-embryonic body morphogenesis.

WB:WBGene00001073	dpy-11
Exhibits protein disulfide oxidoreductase activity. Is involved in several processes, including cellular protein modification process; cuticle development involved in collagen and cuticulin-based cuticle molting cycle; and post-embryonic body morphogenesis. Localizes to cytoplasm. Is expressed in several structures, including R1_hyp; R2_hyp; R3_hyp; R4_hyp; and R5_hyp. Is an ortholog of human TMX1 (thioredoxin related transmembrane protein 1).

WB:WBGene00001074	dpy-13
Is predicted to be a structural constituent of cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Localizes to collagen and cuticulin-based cuticle extracellular matrix.

WB:WBGene00001075	dpy-14
Is predicted to have extracellular matrix structural constituent. Is expressed in anterior ganglion; hyp7 syncytium; and lateral ganglion left neurons.

WB:WBGene00001076	dpy-17
Is predicted to be a structural constituent of cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Is used to study Marfan syndrome.

WB:WBGene00001077	dpy-18
Exhibits procollagen-proline 4-dioxygenase activity. Is involved in several processes, including cuticle development involved in collagen and cuticulin-based cuticle molting cycle; embryonic body morphogenesis; and peptidyl-proline hydroxylation. Localizes to cell and endoplasmic reticulum. Is expressed in hypodermis; muscle cell; neurons; and pharynx. Is an ortholog of human P4HA2 (prolyl 4-hydroxylase subunit alpha 2).

WB:WBGene00001078	dpy-19
Exhibits mannosyltransferase activity. Is involved in protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan. Localizes to perinuclear region of cytoplasm. Is expressed in several structures, including P1; P2; QL; QR; and seam cell. Human ortholog(s) of this gene are implicated in spermatogenic failure 9. Is an ortholog of human DPY19L1 (dpy-19 like C-mannosyltransferase 1).

WB:WBGene00001079	dpy-20
Exhibits sequence-specific double-stranded DNA binding activity.

WB:WBGene00001080	dpy-21
Is predicted to have dioxygenase activity and metal ion binding activity. Localizes to X chromosome. Is an ortholog of human RSBN1 (round spermatid basic protein 1) and RSBN1L (round spermatid basic protein 1 like).

WB:WBGene00001081	dpy-22
Is predicted to have transcription coactivator activity. Is involved in negative regulation of epidermal growth factor receptor signaling pathway and negative regulation of vulval development. Localizes to nucleus. Is expressed in several structures, including hypodermal cell; intestine; pharynx; and vulva. Human ortholog(s) of this gene are implicated in FG syndrome and Ohdo syndrome. Is an ortholog of human MED12L (mediator complex subunit 12L).

WB:WBGene00001082	dpy-23
Is involved in several processes, including positive regulation of Wnt protein secretion; positive regulation of necrotic cell death; and protein localization to non-motile cilium. Localizes to periciliary membrane compartment and synaptic vesicle. Is expressed in anal depressor muscle; germ line; neurons; rectal epithelial cell; and spermatheca. Is an ortholog of human AP2M1 (adaptor related protein complex 2 subunit mu 1).

WB:WBGene00001084	dpy-25
No description available

WB:WBGene00001085	dpy-26
Is involved in dosage compensation by hypoactivation of X chromosome; meiotic sister chromatid segregation; and mitotic sister chromatid segregation. Localizes to condensed nuclear chromosome and dosage compensation complex. Is expressed widely.

WB:WBGene00001086	dpy-27
Exhibits sequence-specific DNA binding activity. Is involved in dosage compensation by hypoactivation of X chromosome. Localizes to X chromosome; dosage compensation complex; and nuclear chromosome. Is an ortholog of human SMC4 (structural maintenance of chromosomes 4).

WB:WBGene00001087	dpy-28
Is predicted to have chromatin binding activity and histone binding activity. Is involved in meiotic sister chromatid segregation; mitotic sister chromatid segregation; and negative regulation of reciprocal meiotic recombination. Localizes to X chromosome and nucleus. Is an ortholog of human NCAPD2 (non-SMC condensin I complex subunit D2).

WB:WBGene00001088	dpy-30
Is involved in several processes, including dosage compensation by hypoactivation of X chromosome; nematode male tail tip morphogenesis; and transdifferentiation. Localizes to nucleus. Is an ortholog of human DPY30 (dpy-30 histone methyltransferase complex regulatory subunit).

WB:WBGene00001089	dre-1
Is predicted to have ubiquitin-protein transferase activity. Is involved in several processes, including gonad development; mesodermal cell migration; and nematode larval development. Localizes to cytoplasm and nucleus. Is expressed in several structures, including gonad; hypodermis; non-striated muscle; vulva; and vulval cell. Is an ortholog of human FBXO11 (F-box protein 11).

WB:WBGene00001090	drh-1
Is predicted to have ATP binding activity; DNA binding activity; and helicase activity. Is involved in RNA interference. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome. Is an ortholog of human DDX58 (DExD/H-box helicase 58); DHX58 (DExH-box helicase 58); and IFIH1 (interferon induced with helicase C domain 1).

WB:WBGene00001091	drh-2
Is enriched in OLL; PVD; intestine; muscle cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; levamisole; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00001092	dro-1
Is predicted to have TBP-class protein binding activity; core promoter binding activity; and transcription corepressor activity. Is an ortholog of human DR1 (down-regulator of transcription 1).

WB:WBGene00001093	drp-1
Is predicted to have GTP binding activity; GTPase activity; and microtubule binding activity. Is involved in apoptotic mitochondrial changes; embryo development; and mitochondrial fission. Localizes to mitochondrion. Is expressed in several structures, including germ line; non-striated muscle; preanal ganglion; rectal muscle; and somatic nervous system. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in several diseases, including centronuclear myopathy 1; early infantile epileptic encephalopathy 31; and neuropathy (multiple). Is an ortholog of human DNM1L (dynamin 1 like).

WB:WBGene00001094	dars-1
Is predicted to have RNA binding activity and aspartate-tRNA ligase activity. Is an ortholog of human DARS1 (aspartyl-tRNA synthetase 1).

WB:WBGene00001095	dars-2
Is predicted to have ATP binding activity; aminoacyl-tRNA ligase activity; and nucleic acid binding activity. Is an ortholog of human DARS2 (aspartyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00001096	dsc-1
Is predicted to have DNA binding activity. Is involved in positive regulation of defecation rhythm and regulation of transcription, DNA-templated. Localizes to cell projection; cytoplasm; and nucleus. Is expressed in amphid neurons; enteric muscle; and mechanosensory neurons. Human ortholog(s) of this gene are implicated in keratoconus.

WB:WBGene00001097	dsc-2
No description available

WB:WBGene00001098	dsc-3
No description available

WB:WBGene00001099	dsc-4
Is predicted to have lipid transfer activity and phospholipid transporter activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in intestine. Human ortholog(s) of this gene are implicated in abdominal obesity-metabolic syndrome 1 and abetalipoproteinemia. Is an ortholog of human MTTP (microsomal triglyceride transfer protein).

WB:WBGene00001100	dsc-5
No description available

WB:WBGene00001101	dsh-1
Exhibits receptor tyrosine kinase binding activity. Is involved in Wnt signaling pathway, regulating spindle positioning. Is expressed in egg-laying apparatus; neurons; somatic gonad; and tail. Human ortholog(s) of this gene are implicated in autosomal dominant Robinow syndrome 1 and autosomal dominant Robinow syndrome 3. Is an ortholog of human DVL2 (dishevelled segment polarity protein 2) and DVL3 (dishevelled segment polarity protein 3).

WB:WBGene00001102	dsh-2
Is predicted to have frizzled binding activity. Is involved in several processes, including Wnt signaling pathway, regulating spindle positioning; embryonic morphogenesis; and left/right axis specification. Localizes to cell cortex. Is expressed in Z1; Z4; anterior distal tip cell; and posterior distal tip cell. Human ortholog(s) of this gene are implicated in autosomal dominant Robinow syndrome 1; autosomal dominant Robinow syndrome 2; and autosomal dominant Robinow syndrome 3. Is an ortholog of human DVL1 (dishevelled segment polarity protein 1); DVL2 (dishevelled segment polarity protein 2); and DVL3 (dishevelled segment polarity protein 3).

WB:WBGene00001103	dsl-1
Exhibits Notch binding activity. Is expressed in several structures, including P6.paa; P6.pap; P6.ppa; P6.ppp; and vulval cell.

WB:WBGene00001104	dsl-2
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Delta serrate ligand; Delta/Serrate/lag-2 (DSL) protein; and Protein Lag2.

WB:WBGene00001105	dsl-3
Is enriched in Z1; Z4; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Lithium Chloride; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Delta serrate ligand; Delta/Serrate/lag-2 (DSL) protein; and Protein Lag2.

WB:WBGene00001106	dsl-4
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including pgl-1; isp-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in Alagille syndrome and tetralogy of Fallot. Is predicted to encode a protein with the following domains: Delta serrate ligand; EGF-like domain; EGF-like domain; Delta/Serrate/lag-2 (DSL) protein; and EGF-like domain, extracellular.

WB:WBGene00001107	dsl-5
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Delta serrate ligand; Delta/Serrate/lag-2 (DSL) protein; and Protein Lag2.

WB:WBGene00001108	dsl-6
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Delta serrate ligand; EGF-like domain; EGF-like domain; Delta/Serrate/lag-2 (DSL) protein; and Protein Lag2.

WB:WBGene00001109	dsl-7
Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by six chemicals including methylmercuric chloride; D-glucose; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Delta serrate ligand; Delta/Serrate/lag-2 (DSL) protein; and Protein Lag2.

WB:WBGene00001110	duo-1
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability. Is an ortholog of human USP29 (ubiquitin specific peptidase 29).

WB:WBGene00001111	duo-2
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including mex-1; smg-2; and spn-4 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00001112	duo-3
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Y-linked spermatogenic failure 2; and non-syndromic X-linked intellectual disability. Is an ortholog of human USP29 (ubiquitin specific peptidase 29).

WB:WBGene00001113	dur-1
Is enriched in BAG; body wall muscle cell; body wall musculature; germ line; and muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00001114	dur-91
No description available

WB:WBGene00001115	dyb-1
Exhibits acetylcholine transmembrane transporter activity and cytoskeletal protein binding activity. Is involved in several processes, including muscle cell cellular homeostasis; positive regulation of cholinergic synaptic transmission; and sarcomere organization. Localizes to dystrobrevin complex. Is expressed in body wall musculature; non-striated muscle; somatic nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in left ventricular noncompaction. Is an ortholog of human DTNA (dystrobrevin alpha) and DTNB (dystrobrevin beta).

WB:WBGene00001116	dyc-1
Is a structural constituent of muscle. Is involved in several processes, including muscle cell cellular homeostasis; regulation of oviposition; and sarcomere organization. Localizes to axon; dystrophin-associated glycoprotein complex; and striated muscle dense body. Is expressed in SDQL; SDQR; body wall musculature; head neurons; and vulval muscle. Is used to study Duchenne muscular dystrophy. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 37 and type 2 diabetes mellitus. Is an ortholog of human NOS1AP (nitric oxide synthase 1 adaptor protein).

WB:WBGene00001117	dyf-1
Is predicted to have intraciliary transport particle B binding activity. Is involved in intraciliary transport; protein localization to plasma membrane; and protein polyglutamylation. Localizes to axonemal microtubule and ciliary basal body. Is expressed in amphid neurons; inner labial neurons; outer labial neurons; and phasmid neurons. Is an ortholog of human TTC30B (tetratricopeptide repeat domain 30B).

WB:WBGene00001118	dyf-2
Is involved in chemotaxis; cilium organization; and olfactory behavior. Localizes to intraciliary transport particle B and non-motile cilium. Is expressed in neurons and oxygen sensory neurons. Human ortholog(s) of this gene are implicated in asphyxiating thoracic dystrophy 5; craniometaphyseal dysplasia; and nephronophthisis 13. Is an ortholog of human WDR19 (WD repeat domain 19).

WB:WBGene00001119	dyf-3
Is involved in several processes, including chemosensory behavior; cilium assembly; and response to alkaline pH. Localizes to axon; dendrite; and neuronal cell body. Is expressed in neurons. Is an ortholog of human CLUAP1 (clusterin associated protein 1).

WB:WBGene00001120	dyf-4
No description available

WB:WBGene00001121	dyf-5
Is predicted to have ATP binding activity and MAP kinase activity. Is involved in cilium organization and regulation of non-motile cilium assembly. Localizes to several cellular components, including dendrite; neuronal cell body; and non-motile cilium. Is expressed in lateral ganglion and neurons. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome; juvenile myoclonic epilepsy 10; and retinitis pigmentosa 62. Is an ortholog of human MAK (male germ cell associated kinase).

WB:WBGene00001122	dyf-6
Is involved in intraciliary transport and non-motile cilium assembly. Localizes to dendrite and neuronal cell body. Is expressed in ciliated neurons and hypodermis. Is an ortholog of human IFT46 (intraflagellar transport 46).

WB:WBGene00001123	dyf-7
Exhibits protein self-association. Is involved in amphid sensory organ dendrite retrograde extension. Localizes to dendrite membrane.

WB:WBGene00001125	dyf-9
No description available

WB:WBGene00001126	dyf-10
No description available

WB:WBGene00001127	dyf-11
Is predicted to have microtubule binding activity. Is involved in several processes, including cilium organization; dauer entry; and protein-containing complex assembly. Localizes to axoneme; ciliary basal body; and intraciliary transport particle B. Is expressed in ciliated neurons and sensory neurons. Is an ortholog of human TRAF3IP1 (TRAF3 interacting protein 1).

WB:WBGene00001128	dyf-12
No description available

WB:WBGene00001129	dyf-13
Is predicted to have intraciliary transport particle B binding activity. Is expressed in neurons. Is an ortholog of human TTC26 (tetratricopeptide repeat domain 26).

WB:WBGene00001130	dyn-1
Exhibits GTPase activity. Is involved in several processes, including phagosome maturation involved in apoptotic cell clearance; positive regulation of necrotic cell death; and receptor-mediated endocytosis. Localizes to several cellular components, including periciliary membrane compartment; pseudopodium; and spindle microtubule. Is expressed in several structures, including neurons; non-striated muscle; pharyngeal-intestinal valve; rectal valve cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease dominant intermediate B; centronuclear myopathy 1; and early infantile epileptic encephalopathy 31. Is an ortholog of human DNM1 (dynamin 1); DNM2 (dynamin 2); and DNM3 (dynamin 3).

WB:WBGene00001131	dys-1
Is predicted to have actin binding activity and zinc ion binding activity. Is involved in several processes, including forward locomotion; muscle cell cellular homeostasis; and sarcomere organization. Localizes to dystrobrevin complex and striated muscle dense body. Is expressed in body wall musculature; head muscle; pharyngeal muscle cell; and vulval muscle. Is used to study Duchenne muscular dystrophy. Is an ortholog of human DMD (dystrophin).

WB:WBGene00001132	alp-1
Is predicted to have actin binding activity and muscle alpha-actinin binding activity. Is involved in determination of adult lifespan and pharyngeal pumping. Localizes to several cellular components, including actin filament bundle; basal part of cell; and striated muscle dense body. Is expressed in body wall musculature; hypodermis; marginal cell; and pharyngeal muscle cell. Is used to study cardiomyopathy and myopathy. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1C and myofibrillar myopathy 4. Is an ortholog of human LDB3 (LIM domain binding 3).

WB:WBGene00001133	eat-2
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in several processes, including larval feeding behavior; regulation of eating behavior; and regulation of gene expression. Localizes to acetylcholine-gated channel complex and neuromuscular junction. Is expressed in pm4 and pm5. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00001134	eat-3
Is predicted to have GTPase activity and microtubule binding activity. Is involved in several processes, including mitochondrial fusion; nematode larval development; and response to superoxide. Localizes to mitochondrion. Is expressed in intestinal cell; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Behr syndrome; dominant optic atrophy plus syndrome; and mitochondrial DNA depletion syndrome 14. Is an ortholog of human OPA1 (OPA1 mitochondrial dynamin like GTPase).

WB:WBGene00001135	eat-4
Is predicted to have L-glutamate transmembrane transporter activity and glutamate:sodium symporter activity. Is involved in several processes, including negative regulation of turning behavior involved in mating; positive regulation of backward locomotion; and positive regulation of male mating behavior. Is expressed in intestine; neurons; and pharynx. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 25. Is an ortholog of human SLC17A6 (solute carrier family 17 member 6); SLC17A7 (solute carrier family 17 member 7); and SLC17A8 (solute carrier family 17 member 8).

WB:WBGene00001136	eat-5
Is predicted to have gap junction hemi-channel activity. Is expressed in K' cell and pharynx.

WB:WBGene00001137	eat-6
Exhibits sodium:potassium-exchanging ATPase activity. Is involved in several processes, including action potential; establishment or maintenance of transmembrane electrochemical gradient; and monovalent inorganic cation transport. Localizes to membrane. Is expressed in several structures, including coelomocyte; intestine; neurons; pharynx; and vulval muscle. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2DD; alternating hemiplegia of childhood; and dystonia 12. Is an ortholog of human ATP1A3 (ATPase Na+/K+ transporting subunit alpha 3).

WB:WBGene00001139	eat-8
No description available

WB:WBGene00001140	eat-9
No description available

WB:WBGene00001141	eat-10
Is involved in regulation of growth.

WB:WBGene00001142	eat-13
No description available

WB:WBGene00001143	eat-14
No description available

WB:WBGene00001144	eat-15
No description available

WB:WBGene00001145	eat-16
Exhibits GTPase activator activity. Is involved in several processes, including dopamine receptor signaling pathway; phospholipase C-inhibiting G protein-coupled receptor signaling pathway; and regulation of oviposition. Localizes to cytoplasm; neuron projection; and plasma membrane. Is expressed in HSNL; HSNR; neurons; pharyngeal muscle cell; and vulval muscle. Human ortholog(s) of this gene are implicated in bradyopsia; essential hypertension; and gastrointestinal system cancer (multiple). Is an ortholog of human RGS11 (regulator of G protein signaling 11) and RGS9 (regulator of G protein signaling 9).

WB:WBGene00001147	eat-18
Is involved in chemical synaptic transmission and regulation of pharyngeal pumping.

WB:WBGene00001148	eat-20
Is predicted to have calcium ion binding activity. Localizes to axon and cell surface. Is expressed in several structures, including anterior ganglion (post); labial sensillum; pharynx; ray neurons; and somatic nervous system.

WB:WBGene00001149	bcat-1
Is predicted to have branched-chain-amino-acid transaminase activity. Is involved in embryo development and nematode larval development. Localizes to mitochondrion. Is an ortholog of human BCAT1 (branched chain amino acid transaminase 1) and BCAT2 (branched chain amino acid transaminase 2).

WB:WBGene00001150	ech-1.1
Is predicted to have enoyl-CoA hydratase activity and long-chain-3-hydroxyacyl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in mitochondrial trifunctional protein deficiency. Is an ortholog of human HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha).

WB:WBGene00001151	ech-2
Is predicted to have catalytic activity. Is an ortholog of human ECHDC3 (enoyl-CoA hydratase domain containing 3).

WB:WBGene00001152	ech-3
Is predicted to have catalytic activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2.

WB:WBGene00001153	ech-4
Is predicted to have catalytic activity and fatty-acyl-CoA binding activity. Is involved in fatty acid beta-oxidation and lipid storage. Is expressed in hypodermis. Is an ortholog of human ECI2 (enoyl-CoA delta isomerase 2).

WB:WBGene00001154	ech-5
Is predicted to have enoyl-CoA hydratase activity. Human ortholog(s) of this gene are implicated in 3-methylglutaconic aciduria type 1 and Y-linked spermatogenic failure 2. Is an ortholog of human AUH (AU RNA binding methylglutaconyl-CoA hydratase) and ECHDC2 (enoyl-CoA hydratase domain containing 2).

WB:WBGene00001155	ech-6
Is predicted to have enoyl-CoA hydratase activity. Localizes to mitochondrion. Is an ortholog of human ECHS1 (enoyl-CoA hydratase, short chain 1).

WB:WBGene00001156	ech-7
Is predicted to have enoyl-CoA hydratase activity. Is an ortholog of human ECHS1 (enoyl-CoA hydratase, short chain 1).

WB:WBGene00001157	ech-8
Is predicted to have 3-hydroxyacyl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in Fanconi syndrome. Is an ortholog of human EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase).

WB:WBGene00001158	ech-9
Is predicted to have 3-hydroxyacyl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in Fanconi syndrome. Is an ortholog of human EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase).

WB:WBGene00001159	eff-1
Exhibits identical protein binding activity. Is involved in several processes, including male anatomical structure morphogenesis; oviposition; and pharyngeal muscle development. Localizes to several cellular components, including cell-cell contact zone; extracellular region; and integral component of plasma membrane. Is expressed in several structures, including hyp7; hyp7; hypodermis; tail spike; and vulval cell.

WB:WBGene00001160	efk-1
Exhibits elongation factor-2 kinase activity. Is involved in protein phosphorylation. Is an ortholog of human EEF2K (eukaryotic elongation factor 2 kinase).

WB:WBGene00001161	efl-1
Exhibits protein C-terminus binding activity; protein N-terminus binding activity; and transcription factor binding activity. Is involved in several processes, including embryonic digestive tract morphogenesis; negative regulation of Ras protein signal transduction; and negative regulation of vulval development. Is expressed in gonad. Is an ortholog of human E2F5 (E2F transcription factor 5).

WB:WBGene00001162	efl-2
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific; sequence-specific DNA binding activity; and transcription factor binding activity. Is expressed in dorsal nerve cord; head muscle; intestine; spermatheca; and ventral nerve cord. Is an ortholog of human E2F1 (E2F transcription factor 1).

WB:WBGene00001163	efn-2
Is predicted to have ephrin receptor binding activity. Is expressed in several structures, including excretory gland cell; head neurons; motor neurons; pharyngeal muscle cell; and retrovesicular ganglion neurons. Human ortholog(s) of this gene are implicated in craniofrontonasal syndrome. Is an ortholog of human EFNB3 (ephrin B3).

WB:WBGene00001164	efn-3
Is predicted to have ephrin receptor binding activity. Human ortholog(s) of this gene are implicated in craniofrontonasal syndrome. Is an ortholog of human EFNB1 (ephrin B1); EFNB2 (ephrin B2); and EFNB3 (ephrin B3).

WB:WBGene00001165	efn-4
Is predicted to have ephrin receptor binding activity. Is involved in several processes, including embryonic morphogenesis; nematode male tail tip morphogenesis; and regulation of axon guidance. Localizes to axon and neuronal cell body. Is expressed in several structures, including CAN; epithelial cell; ganglia; intestinal cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in craniofrontonasal syndrome. Is an ortholog of human EFNA1 (ephrin A1).

WB:WBGene00001166	eftu-2
Is predicted to have GTPase activity and U5 snRNA binding activity. Human ortholog(s) of this gene are implicated in mandibulofacial dysostosis, Guion-Almeida type. Is an ortholog of human EFTUD2 (elongation factor Tu GTP binding domain containing 2).

WB:WBGene00001167	eef-2
Is predicted to have GTPase activity; ribosome binding activity; and translation elongation factor activity. Is involved in defense response to Gram-negative bacterium and negative regulation of gene expression. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 26. Is an ortholog of human EEF2 (eukaryotic translation elongation factor 2).

WB:WBGene00001168	eef-1A.1
Is predicted to have GTP binding activity; GTPase activity; and translation elongation factor activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 38 and early infantile epileptic encephalopathy 33. Is an ortholog of human EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) and EEF1A2 (eukaryotic translation elongation factor 1 alpha 2).

WB:WBGene00001169	eef-1A.2
Exhibits GTPase activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 38 and early infantile epileptic encephalopathy 33. Is an ortholog of human EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) and EEF1A2 (eukaryotic translation elongation factor 1 alpha 2).

WB:WBGene00001170	egl-1
Is involved in several processes, including actin filament depolymerization; oviposition; and positive regulation of cellular component organization. Localizes to cytosol; mitochondrion; and presynapse. Is expressed in several structures, including ABalappaapp; ABaraapapaad; ABaraapppaad; HSN; and proctodeal cell.

WB:WBGene00001171	egl-2
Exhibits protein kinase binding activity. Is involved in chemosensory behavior; muscle contraction; and oviposition. Localizes to microvillus membrane. Is expressed in intestinal cell; lumbar neurons; neurons; and vulval muscle. Is an ortholog of human KCNH5 (potassium voltage-gated channel subfamily H member 5).

WB:WBGene00001172	egl-3
Exhibits FBXO family protein binding activity and serine-type endopeptidase activity. Is involved in several processes, including larval feeding behavior; modulation of chemical synaptic transmission; and protein maturation. Localizes to axon. Is expressed in head; mechanosensory neurons; pharynx; and tail. Is used to study alcohol use disorder. Is an ortholog of human PCSK2 (proprotein convertase subtilisin/kexin type 2).

WB:WBGene00001173	egl-4
Exhibits cGMP-dependent protein kinase activity. Is involved in several processes, including chemotropism; larval feeding behavior; and regulation of signal transduction. Localizes to cytosol and nucleus. Is expressed in several structures, including marginal cell; nerve ring; neurons; spermatheca; and vulval muscle. Is used to study ciliopathy. Human ortholog(s) of this gene are implicated in thoracic aortic aneurysm. Is an ortholog of human PRKG1 (protein kinase cGMP-dependent 1).

WB:WBGene00001174	egl-5
Exhibits transcription factor binding activity. Is involved in several processes, including anterior/posterior pattern specification; nematode male tail tip morphogenesis; and regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including neurons; non-striated muscle; ray precursor cell; rectal epithelial cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple). Is an ortholog of several human genes including HOXA7 (homeobox A7); HOXB7 (homeobox B7); and HOXD8 (homeobox D8).

WB:WBGene00001175	egl-6
Is predicted to have G protein-coupled peptide receptor activity. Is involved in negative regulation of oviposition. Is expressed in GLR; nerve ring; and neurons.

WB:WBGene00001176	egl-7
No description available

WB:WBGene00001177	egl-8
Is predicted to have phosphatidylinositol phospholipase C activity. Is involved in several processes, including positive regulation of acetylcholine secretion, neurotransmission; positive regulation of axon regeneration; and thermotaxis. Localizes to plasma membrane. Is expressed in intestine; nervous system; non-striated muscle; and vas deferens. Is used to study nicotine dependence. Is an ortholog of human PLCB4 (phospholipase C beta 4).

WB:WBGene00001178	egl-9
Exhibits peptidyl-proline 4-dioxygenase activity. Is involved in peptidyl-proline hydroxylation to 4-hydroxy-L-proline; regulation of protein localization; and response to hypoxia. Localizes to dendrite and nucleus. Is expressed in ventral nerve cord and vulval precursor cell. Human ortholog(s) of this gene are implicated in familial erythrocytosis 3. Is an ortholog of human EGLN1 (egl-9 family hypoxia inducible factor 1).

WB:WBGene00001179	egl-10
Is involved in several processes, including dopamine receptor signaling pathway; regulation of oviposition; and rhythmic behavior. Localizes to cytoplasm and neuron projection. Is expressed in body wall musculature and neurons. Human ortholog(s) of this gene are implicated in bradyopsia; colorectal cancer; and hepatocellular carcinoma. Is an ortholog of human RGS6 (regulator of G protein signaling 6) and RGS7 (regulator of G protein signaling 7).

WB:WBGene00001180	egl-11
No description available

WB:WBGene00001181	egl-12
No description available

WB:WBGene00001182	egl-13
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in several processes, including cell fate specification; generation of neurons; and vulval development. Localizes to nucleus. Is expressed in several structures, including developing hermaphrodite gonad; egg-laying apparatus; intestinal cell; neurons; and uterine pi cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; PCWH syndrome; and Waardenburg's syndrome (multiple). Is an ortholog of human SOX5 (SRY-box transcription factor 5) and SOX6 (SRY-box transcription factor 6).

WB:WBGene00001183	egl-14
No description available

WB:WBGene00001184	egl-15
Exhibits protein kinase activity. Is involved in several processes, including fibroblast growth factor receptor signaling pathway; muscle cell cellular homeostasis; and oviposition. Is expressed in head neurons; hypodermis; intestine; male sex myoblast; and vulval muscle. Is used to study bone disease. Human ortholog(s) of this gene are implicated in several diseases, including bone development disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human FGFR1 (fibroblast growth factor receptor 1); FGFR3 (fibroblast growth factor receptor 3); and FGFR4 (fibroblast growth factor receptor 4).

WB:WBGene00001185	egl-17
Is predicted to have fibroblast growth factor receptor binding activity. Is involved in regulation of cell migration and regulation of oviposition. Localizes to extracellular space. Is expressed in several structures, including M4 neuron; dorsal uterine cell; hyp5; male-specific anatomical entity; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including LADD syndrome; bone disease (multiple); and hypogonadotropic hypogonadism (multiple). Is an ortholog of human FGF17 (fibroblast growth factor 17); FGF18 (fibroblast growth factor 18); and FGF8 (fibroblast growth factor 8).

WB:WBGene00001186	egl-18
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including cell fate specification; nematode larval development; and positive regulation of nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in several structures, including ABprpppppaa; body wall muscle cell from MS lineage; nervous system; seam cell; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; congenital heart disease (multiple); and hematologic cancer (multiple).

WB:WBGene00001187	egl-19
Exhibits voltage-gated calcium channel activity. Is involved in several processes, including determination of left/right asymmetry in nervous system; positive regulation of striated muscle contraction; and regulation of pharyngeal pumping. Localizes to plasma membrane. Is expressed in several structures, including alimentary muscle; body wall musculature; neurons; preanal ganglion; and tail. Is used to study Duchenne muscular dystrophy. Human ortholog(s) of this gene are implicated in several diseases, including epilepsy (multiple); heart conduction disease (multiple); and neuropathy (multiple). Is an ortholog of human CACNA1C (calcium voltage-gated channel subunit alpha1 C) and CACNA1S (calcium voltage-gated channel subunit alpha1 S).

WB:WBGene00001188	egl-20
Exhibits receptor tyrosine kinase binding activity. Is involved in several processes, including generation of neurons; left/right axis specification; and mitochondrial unfolded protein response. Localizes to cell and extracellular space. Is expressed in several structures, including body wall muscle cell from C lineage; intestinal muscle; neuroblasts; rectal epithelial cell; and somatic nervous system. Is an ortholog of human WNT16 (Wnt family member 16).

WB:WBGene00001189	egl-21
Exhibits carboxypeptidase activity. Is involved in several processes, including acetylcholine secretion, neurotransmission; cellular response to carbon dioxide; and positive regulation of secretion. Localizes to axon; cytoplasmic vesicle; and neuronal cell body. Is expressed in nerve ring; neurons; and preanal ganglion. Human ortholog(s) of this gene are implicated in carboxypeptidase N deficiency. Is an ortholog of human CPN1 (carboxypeptidase N subunit 1).

WB:WBGene00001190	egl-23
Is predicted to have potassium ion leak channel activity.

WB:WBGene00001191	egl-24
No description available

WB:WBGene00001193	egl-26
Is involved in several processes, including cell morphogenesis; oviposition; and vulval development. Localizes to apical plasma membrane. Is expressed in several structures, including buccal cavity; excretory canal; hermaphrodite gonad; rectum; and vulval cell.

WB:WBGene00001194	egl-27
Exhibits RNA polymerase II transcription factor binding activity; chromatin binding activity; and enzyme binding activity. Is involved in several processes, including cell adhesion; hemidesmosome assembly; and nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in several structures, including Y cell; intestinal cell; neurons; pharynx; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in dentatorubral-pallidoluysian atrophy. Is an ortholog of human RERE (arginine-glutamic acid dipeptide repeats).

WB:WBGene00001195	egl-28
No description available

WB:WBGene00001196	egl-30
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is involved in several processes, including cellular response to dopamine; positive regulation of protein import into nucleus; and regulation of secretion. Localizes to several cellular components, including axon; extrinsic component of cytoplasmic side of plasma membrane; and neuronal cell body. Is expressed in several structures, including vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including Sturge-Weber syndrome; autosomal dominant hypocalcemia 2; and familial hypocalciuric hypercalcemia 2. Is an ortholog of human GNA11 (G protein subunit alpha 11) and GNAQ (G protein subunit alpha q).

WB:WBGene00001197	egl-31
No description available

WB:WBGene00001198	egl-32
Is involved in several processes, including oviposition; regulation of oviposition; and transforming growth factor beta receptor signaling pathway.

WB:WBGene00001199	egl-33
No description available

WB:WBGene00001200	egl-34
No description available

WB:WBGene00001201	egl-35
No description available

WB:WBGene00001202	egl-36
Exhibits voltage-gated ion channel activity. Is involved in ion transmembrane transport. Is expressed in head muscle; hermaphrodite distal tip cell; neurons; non-striated muscle; and spermatheca. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNC1 (potassium voltage-gated channel subfamily C member 1); KCNC2 (potassium voltage-gated channel subfamily C member 2); and KCNC4 (potassium voltage-gated channel subfamily C member 4).

WB:WBGene00001203	egl-37
No description available

WB:WBGene00001204	egl-38
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; uterus development; and vulval development. Localizes to nucleus. Is expressed in body wall musculature; egg-laying apparatus; head neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human PAX5 (paired box 5).

WB:WBGene00001205	egl-40
Is involved in negative regulation of dauer larval development.

WB:WBGene00001206	egl-42
No description available

WB:WBGene00001207	egl-43
Is predicted to have DNA-binding transcription factor activity. Is involved in regulation of cell migration and regulation of neuron differentiation. Localizes to nucleus. Is expressed in several structures, including MSaaap; MSpaap; gonad; neurons; and somatic gonad precursor. Is an ortholog of human MECOM (MDS1 and EVI1 complex locus).

WB:WBGene00001208	egl-44
Exhibits RNA polymerase II transcription coactivator binding activity and RNA polymerase II transcription factor binding activity. Is involved in generation of neurons; positive regulation of exit from mitosis; and positive regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in several structures, including anterior hypodermis; body wall musculature; ganglia; neurons; and pharynx. Human ortholog(s) of this gene are implicated in Sveinsson chorioretinal atrophy. Is an ortholog of several human genes including TEAD2 (TEA domain transcription factor 2); TEAD3 (TEA domain transcription factor 3); and TEAD4 (TEA domain transcription factor 4).

WB:WBGene00001209	egl-45
Is predicted to contribute to translation initiation factor activity. Is involved in embryo development and oviposition. Is expressed in neurons. Is an ortholog of human EIF3A (eukaryotic translation initiation factor 3 subunit A).

WB:WBGene00001210	egl-46
Exhibits RNA polymerase II transcription factor binding activity. Is involved in cell fate commitment; generation of neurons; and positive regulation of exit from mitosis. Localizes to nucleus. Is expressed in several structures, including QL.aa; QL.pp; QR.aa; QR.pp; and neurons. Is an ortholog of human INSM1 (INSM transcriptional repressor 1) and INSM2 (INSM transcriptional repressor 2).

WB:WBGene00001211	egl-47
Is predicted to have G protein-coupled receptor activity. Is involved in G protein-coupled receptor signaling pathway and oviposition. Is expressed in HSNL; HSNR; PVQL; PVQR; and vulva.

WB:WBGene00001212	egl-49
No description available

WB:WBGene00001213	egl-50
No description available

WB:WBGene00001214	ego-1
Is predicted to have RNA-directed 5'-3' RNA polymerase activity. Is involved in RNA interference; gamete generation; and nuclear pore distribution. Localizes to P granule; condensed nuclear chromosome; and metaphase plate. Is expressed in germ line.

WB:WBGene00001215	ego-2
Is involved in positive regulation of Notch signaling pathway and protein localization to basolateral plasma membrane. Localizes to cytoplasm and nucleus. Is expressed widely. Is an ortholog of human PTPN23 (protein tyrosine phosphatase non-receptor type 23).

WB:WBGene00001216	ego-3
No description available

WB:WBGene00001217	ego-4
No description available

WB:WBGene00001218	ego-5
No description available

WB:WBGene00001220	eha-1
No description available

WB:WBGene00001221	ehn-1
No description available

WB:WBGene00001222	ehn-2
No description available

WB:WBGene00001223	ehn-3
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity. Is involved in gonad development and positive regulation of gene expression. Localizes to nucleus. Is expressed in Z1; Z4; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in nephronophthisis 14.

WB:WBGene00001224	ehs-1
Is involved in chemical synaptic transmission and synaptic vesicle endocytosis. Localizes to axon; plasma membrane; and synapse. Is expressed in dorsal nerve cord; nerve ring; and ventral nerve cord. Is an ortholog of human EPS15L1 (epidermal growth factor receptor pathway substrate 15 like 1).

WB:WBGene00001225	eif-3.B
Is predicted to contribute to translation initiation factor activity. Is an ortholog of human EIF3B (eukaryotic translation initiation factor 3 subunit B).

WB:WBGene00001226	eif-3.C
Is predicted to contribute to translation initiation factor activity. Is an ortholog of human EIF3CL (eukaryotic translation initiation factor 3 subunit C like).

WB:WBGene00001227	eif-3.D
Is predicted to have translation initiation factor activity. Is expressed in pharynx. Is an ortholog of human EIF3D (eukaryotic translation initiation factor 3 subunit D).

WB:WBGene00001228	eif-3.E
Is predicted to have translation initiation factor activity. Is expressed in head and tail. Is an ortholog of human EIF3E (eukaryotic translation initiation factor 3 subunit E).

WB:WBGene00001229	eif-3.F
Is predicted to contribute to translation initiation factor activity. Is involved in negative regulation of transcription by RNA polymerase II and translation. Is an ortholog of human EIF3F (eukaryotic translation initiation factor 3 subunit F).

WB:WBGene00001230	eif-3.G
Is predicted to have translation initiation factor activity. Is expressed in germ line. Is an ortholog of human EIF3G (eukaryotic translation initiation factor 3 subunit G).

WB:WBGene00001231	eif-3.H
Is predicted to contribute to translation initiation factor activity. Is an ortholog of human EIF3H (eukaryotic translation initiation factor 3 subunit H).

WB:WBGene00001232	eif-3.I
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF3I (eukaryotic translation initiation factor 3 subunit I).

WB:WBGene00001233	eif-3.K
Is predicted to contribute to translation initiation factor activity. Is involved in positive regulation of apoptotic process. Localizes to cytoplasm. Is expressed in several structures, including embryonic cell and germ line. Is an ortholog of human EIF3K (eukaryotic translation initiation factor 3 subunit K).

WB:WBGene00001234	eif-6
Is predicted to have ribosomal large subunit binding activity. Is involved in gene silencing by miRNA. Is an ortholog of human EIF6 (eukaryotic translation initiation factor 6).

WB:WBGene00001235	elb-1
Exhibits protein domain specific binding activity. Localizes to Cul2-RING ubiquitin ligase complex. Is an ortholog of human ELOB (elongin B).

WB:WBGene00001236	elc-1
Exhibits protein domain specific binding activity and protein-macromolecule adaptor activity. Is involved in anterior/posterior axis specification, embryo; positive regulation of metaphase/anaphase transition of meiotic cell cycle; and sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation. Localizes to Cul2-RING ubiquitin ligase complex. Is expressed in hypodermis; pharynx; and vulval muscle. Is an ortholog of human ELOC (elongin C).

WB:WBGene00001237	elc-2
Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Skp1 family, tetramerisation domain; S-phase kinase-associated protein 1-like; SKP1/BTB/POZ domain superfamily; SKP1 component, POZ domain; and Elongin-C. Is an ortholog of human ELOC (elongin C).

WB:WBGene00001238	eld-1
No description available

WB:WBGene00001239	elo-1
Is predicted to have fatty acid elongase activity. Is involved in unsaturated fatty acid biosynthetic process. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001240	elo-2
Is predicted to have fatty acid elongase activity. Is involved in several processes, including determination of adult lifespan; growth; and lipid metabolic process. Is expressed in intestine; pharyngeal muscle cell; tail; uterus; and ventral nerve cord. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001241	elo-3
Is predicted to have fatty acid elongase activity. Is expressed in tail. Is an ortholog of human ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001242	elo-4
Is predicted to have fatty acid elongase activity. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001243	elo-5
Is predicted to have fatty acid elongase activity. Is expressed in amphid neurons and intestine. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001244	elo-6
Is predicted to have fatty acid elongase activity. Is expressed in amphid neurons; intestine; nerve ring; and vulva. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001245	elo-7
Is predicted to have fatty acid elongase activity. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001246	elo-8
Is predicted to have fatty acid elongase activity.

WB:WBGene00001247	elo-9
Is predicted to have fatty acid elongase activity. Is an ortholog of human ELOVL3 (ELOVL fatty acid elongase 3) and ELOVL6 (ELOVL fatty acid elongase 6).

WB:WBGene00001248	elp-1
Is predicted to have microtubule binding activity. Localizes to dendrite; neuromuscular junction; and neuronal cell body. Is expressed in several structures, including hypodermal cell; intestine; mechanosensory neurons; spermatheca; and vulval muscle. Is used to study Duchenne muscular dystrophy. Human ortholog(s) of this gene are implicated in spermatogenic failure 20 and subcortical band heterotopia. Is an ortholog of human EML2 (EMAP like 2).

WB:WBGene00001249	elt-1
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity. Is involved in several processes, including epidermal cell fate specification; regulation of transcription by RNA polymerase II; and spermatid development. Localizes to nucleus. Is expressed in several structures, including hyp7; hyp7; hyp7; seam cell; and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; congenital heart disease (multiple); and hematologic cancer (multiple). Is an ortholog of human GATA1 (GATA binding protein 1).

WB:WBGene00001250	elt-2
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including defense response to other organism; endoderm development; and nematode larval development. Localizes to nucleus. Is expressed in several structures, including AWC; Ealaa; Ealp; Earaa; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; congenital heart disease (multiple); and hypoparathyroidism-deafness-renal disease syndrome. Is an ortholog of human GATA4 (GATA binding protein 4) and GATA5 (GATA binding protein 5).

WB:WBGene00001251	elt-3
Exhibits RNA polymerase II regulatory region DNA binding activity. Is involved in determination of adult lifespan and positive regulation of transcription from RNA polymerase II promoter in response to increased salt. Localizes to nucleus. Is expressed in several structures, including Caaaaa; Caaaap; hermaphrodite distal tip cell; hypodermal cell; and rectum. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; congenital heart disease (multiple); and hypoparathyroidism-deafness-renal disease syndrome.

WB:WBGene00001252	elt-4
Exhibits double-stranded DNA binding activity. Localizes to nucleus. Is expressed in intestine; marginal cell; pm6; and pm7. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; congenital heart disease (multiple); and hypoparathyroidism-deafness-renal disease syndrome. Is an ortholog of human GATA4 (GATA binding protein 4) and GATA5 (GATA binding protein 5).

WB:WBGene00001253	elt-6
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in several structures, including ABplaapppa; ABplaapppp; ABprpppppaa; P9/10L; and body wall muscle cell from MS lineage. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; hypoparathyroidism-deafness-renal disease syndrome; and trichorhinophalangeal syndrome type I.

WB:WBGene00001256	emb-2
No description available

WB:WBGene00001257	emb-3
No description available

WB:WBGene00001258	emb-4
Is predicted to have mRNA binding activity. Localizes to nucleus. Is expressed in embryonic cell. Is an ortholog of human AQR (aquarius intron-binding spliceosomal factor).

WB:WBGene00001259	emb-5
Is predicted to have histone binding activity and nucleosome binding activity. Is expressed in tail. Is an ortholog of human SUPT6H (SPT6 homolog, histone chaperone and transcription elongation factor).

WB:WBGene00001261	emb-7
No description available

WB:WBGene00001262	emb-8
Is predicted to have coenzyme binding activity and oxidoreductase activity. Is involved in eggshell formation and lipid biosynthetic process. Is expressed in intestine; neurons; and pharynx. Human ortholog(s) of this gene are implicated in Antley-Bixler syndrome. Is an ortholog of human POR (cytochrome p450 oxidoreductase).

WB:WBGene00001263	emb-9
Is predicted to have extracellular matrix structural constituent. Is involved in several processes, including extracellular matrix organization; nematode larval development; and positive regulation of axon regeneration. Localizes to basement membrane. Is expressed in several structures, including coelomocyte; egg-laying apparatus; gonad; nerve ring; and rectal muscle. Human ortholog(s) of this gene are implicated in X-linked deafness 6; autosomal recessive Alport syndrome; and benign familial hematuria. Is an ortholog of human COL4A5 (collagen type IV alpha 5 chain).

WB:WBGene00001265	emb-11
No description available

WB:WBGene00001266	emb-12
No description available

WB:WBGene00001267	emb-13
Is involved in embryonic morphogenesis.

WB:WBGene00001269	emb-15
No description available

WB:WBGene00001271	emb-17
No description available

WB:WBGene00001272	emb-18
No description available

WB:WBGene00001273	emb-19
No description available

WB:WBGene00001274	emb-20
No description available

WB:WBGene00001275	emb-21
No description available

WB:WBGene00001276	emb-22
No description available

WB:WBGene00001277	emb-23
No description available

WB:WBGene00001278	emb-24
No description available

WB:WBGene00001279	emb-25
No description available

WB:WBGene00001280	emb-26
No description available

WB:WBGene00001281	emb-27
Is predicted to have ubiquitin protein ligase activity. Is involved in asymmetric cell division; eggshell formation; and polarity specification of anterior/posterior axis. Localizes to synapse. Is expressed in GABAergic neurons. Is an ortholog of human CDC16 (cell division cycle 16).

WB:WBGene00001282	emb-28
No description available

WB:WBGene00001284	emb-30
Is involved in several processes, including anterior/posterior axis specification; asymmetric cell division; and metaphase/anaphase transition of meiosis I. Is an ortholog of human ANAPC4 (anaphase promoting complex subunit 4).

WB:WBGene00001285	emb-31
No description available

WB:WBGene00001286	emb-32
No description available

WB:WBGene00001287	emb-34
No description available

WB:WBGene00001288	emb-35
No description available

WB:WBGene00001289	emb-40
No description available

WB:WBGene00001290	emb-46
No description available

WB:WBGene00001291	emb-47
No description available

WB:WBGene00001292	emb-48
No description available

WB:WBGene00001293	emb-49
No description available

WB:WBGene00001294	emb-50
No description available

WB:WBGene00001295	emb-52
No description available

WB:WBGene00001296	emb-53
No description available

WB:WBGene00001297	emb-57
No description available

WB:WBGene00001298	emb-60
No description available

WB:WBGene00001299	emb-61
No description available

WB:WBGene00001300	emb-62
No description available

WB:WBGene00001301	emb-67
No description available

WB:WBGene00001302	emb-85
No description available

WB:WBGene00001303	sec-61.G
Is predicted to have P-P-bond-hydrolysis-driven protein transmembrane transporter activity. Is involved in oocyte growth and ovulation. Localizes to cell. Is expressed in germ line. Is an ortholog of human SEC61G (SEC61 translocon subunit gamma).

WB:WBGene00001304	emo-2
No description available

WB:WBGene00001305	emo-3
No description available

WB:WBGene00001306	emo-4
No description available

WB:WBGene00001307	emo-5
No description available

WB:WBGene00001308	emo-6
No description available

WB:WBGene00001309	emr-1
Exhibits lamin binding activity. Is involved in chromosome segregation; mitotic cytokinesis; and response to X-ray. Localizes to integral component of nuclear inner membrane. Is used to study Emery-Dreifuss muscular dystrophy. Is an ortholog of human LEMD1 (LEM domain containing 1).

WB:WBGene00001310	end-1
Exhibits DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in endodermal cell fate specification and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in E; E lineage cell; Ea; and Ep. Human ortholog(s) of this gene are implicated in several diseases, including Down syndrome; congenital heart disease (multiple); and hypoparathyroidism-deafness-renal disease syndrome.

WB:WBGene00001311	end-3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in endodermal cell fate specification and mesodermal cell fate specification. Localizes to nucleus. Is expressed in E; E lineage cell; Ea; Ep; and intestine.

WB:WBGene00001312	eno-2
No description available

WB:WBGene00001313	eno-3
No description available

WB:WBGene00001314	eno-4
No description available

WB:WBGene00001315	eno-6
No description available

WB:WBGene00001316	eno-7
No description available

WB:WBGene00001317	eno-8
No description available

WB:WBGene00001318	eno-9
No description available

WB:WBGene00001319	eno-11
No description available

WB:WBGene00001320	ent-1
Is predicted to have nucleoside transmembrane transporter activity. Localizes to plasma membrane. Is expressed in intestine; isthmus; metacorpus; procorpus; and terminal bulb. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00001322	enu-1
No description available

WB:WBGene00001323	enu-2
No description available

WB:WBGene00001324	eor-1
Is predicted to have DNA binding activity and DNA-binding transcription factor activity. Is involved in several processes, including determination of adult lifespan; nematode male tail tip morphogenesis; and positive regulation of proteasomal ubiquitin-dependent protein catabolic process. Localizes to nucleus. Is expressed in several structures, including dorsal nerve cord; gonad; and pharynx. Human ortholog(s) of this gene are implicated in brittle cornea syndrome. Is an ortholog of human ZBTB17 (zinc finger and BTB domain containing 17) and ZNF358 (zinc finger protein 358).

WB:WBGene00001325	eor-2
Is involved in several processes, including Ras protein signal transduction; nematode male tail tip morphogenesis; and neuron migration. Localizes to nucleus. Is expressed in several structures, including hyp12; hyp7; neurons; ventral nerve cord; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; PCWH syndrome; and Waardenburg's syndrome (multiple).

WB:WBGene00001326	eos-1
Is involved in osmosensory signaling pathway.

WB:WBGene00001327	eos-2
Exhibits osmosensor activity. Is involved in osmosensory signaling pathway.

WB:WBGene00001328	epi-1
Is predicted to have extracellular matrix structural constituent. Is involved in several processes, including basement membrane organization; generation of neurons; and positive regulation of endopeptidase activity. Localizes to basement membrane. Is expressed in several structures, including anal depressor muscle; basal lamina; body wall musculature; egg-laying apparatus; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Pierson syndrome; amelogenesis imperfecta type 1A; and junctional epidermolysis bullosa (multiple). Is an ortholog of human LAMA5 (laminin subunit alpha 5).

WB:WBGene00001329	epn-1
Localizes to early phagosome; phagocytic cup; and pseudopodium. Is expressed in anterior gonad arm; coelomocyte; head; intestine; and vulva. Is an ortholog of human EPN1 (epsin 1) and EPN2 (epsin 2).

WB:WBGene00001330	eps-8
Exhibits actin filament binding activity. Is predicted to contribute to Rac guanyl-nucleotide exchange factor activity. Is involved in several processes, including barbed-end actin filament capping; cytoskeleton organization; and epidermis morphogenesis. Localizes to apical part of cell; brush border; and hemidesmosome. Is expressed in several structures, including hyp7; hyp7; hyp7; hyp7; and hyp7. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 102 and autosomal recessive nonsyndromic deafness 106. Is an ortholog of human EPS8L2 (EPS8 like 2).

WB:WBGene00001331	erd-2.1
Is predicted to have ER retention sequence binding activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in head and tail. Is an ortholog of human KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1) and KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2).

WB:WBGene00001332	eri-1
Exhibits 3'-5'-exoribonuclease activity. Is involved in several processes, including RNA metabolic process; meiotic chromosome segregation; and regulation of gene expression. Localizes to cytoplasm. Is expressed in neurons and spermatheca. Is an ortholog of human ERI1 (exoribonuclease 1).

WB:WBGene00001333	erm-1
Exhibits cytoskeletal adaptor activity and structural molecule activity. Is involved in several processes, including actin filament organization; nematode larval development; and protein localization to basolateral plasma membrane. Localizes to several cellular components, including actin filament; apical cortex; and apical plasma membrane. Is expressed in PVDL; PVDR; uterine toroidal epithelial cell; and vulval precursor cell. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 11; autosomal recessive nonsyndromic deafness 24; and hereditary elliptocytosis. Is an ortholog of human EZR (ezrin); MSN (moesin); and RDX (radixin).

WB:WBGene00001334	ero-1
Is predicted to have protein disulfide isomerase activity and protein disulfide oxidoreductase activity. Is involved in IRE1-mediated unfolded protein response and protein folding in endoplasmic reticulum. Is an ortholog of human ERO1A (endoplasmic reticulum oxidoreductase 1 alpha) and ERO1B (endoplasmic reticulum oxidoreductase 1 beta).

WB:WBGene00001335	F35A5.8
Is enriched in several structures, including germ line; head mesodermal cell; neurons; retrovesicular ganglion; and somatic nervous system based on Chronogram; tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; cadmium; and fluoranthene based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive chronic granulomatous disease cytochrome b-positive type III. Is predicted to encode a protein with the following domains: BAR domain; SH3 domain; BAR domain; AH/BAR domain superfamily; and SH3-like domain superfamily. Is an ortholog of human SH3GLB1 (SH3 domain containing GRB2 like, endophilin B1) and SH3GLB2 (SH3 domain containing GRB2 like, endophilin B2).

WB:WBGene00001336	qars-1
Is predicted to have glutamine-tRNA ligase activity. Is an ortholog of human QARS1 (glutaminyl-tRNA synthetase 1).

WB:WBGene00001337	ears-1
Is predicted to have proline-tRNA ligase activity. Is an ortholog of human EPRS1 (glutamyl-prolyl-tRNA synthetase 1).

WB:WBGene00001338	ears-2
Is predicted to have glutamate-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 12. Is an ortholog of human EARS2 (glutamyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00001340	etr-1
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Localizes to nucleus. Is expressed in body wall musculature; cloacal sphincter muscle; copulatory spicule; non-striated muscle; and somatic gonad. Is an ortholog of human CELF1 (CUGBP Elav-like family member 1) and CELF2 (CUGBP Elav-like family member 2).

WB:WBGene00001341	evl-1
No description available

WB:WBGene00001342	evl-2
No description available

WB:WBGene00001343	evl-3
No description available

WB:WBGene00001344	evl-4
No description available

WB:WBGene00001345	fos-1
Exhibits several functions, including enzyme binding activity; identical protein binding activity; and transcription factor binding activity. Is involved in several processes, including basement membrane disassembly; negative regulation of stress response to copper ion; and regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in several structures, including gonad; neurons; uterine pi cell; ventral uterine precursor; and vulval cell. Is an ortholog of human FOS (Fos proto-oncogene, AP-1 transcription factor subunit); FOSL1 (FOS like 1, AP-1 transcription factor subunit); and FOSL2 (FOS like 2, AP-1 transcription factor subunit).

WB:WBGene00001346	evl-6
No description available

WB:WBGene00001347	evl-7
No description available

WB:WBGene00001348	evl-8
No description available

WB:WBGene00001349	evl-9
No description available

WB:WBGene00001350	evl-12
No description available

WB:WBGene00001351	evl-13
No description available

WB:WBGene00001352	evl-14
Is involved in meiotic sister chromatid cohesion and mitotic sister chromatid cohesion. Is an ortholog of human PDS5B (PDS5 cohesin associated factor B).

WB:WBGene00001353	evl-15
No description available

WB:WBGene00001354	evl-16
No description available

WB:WBGene00001355	evl-17
No description available

WB:WBGene00001357	evl-19
No description available

WB:WBGene00001358	evl-20
Is predicted to have GTP binding activity. Is involved in several processes, including cortical microtubule organization; female genitalia development; and mitotic cytokinesis. Localizes to cytoplasm; cytoskeleton; and plasma membrane. Is expressed in several structures, including P3.p hermaphrodite; hermaphrodite gonad; hyp12; proctodeum; and vulval cell. Is an ortholog of human ARL2 (ADP ribosylation factor like GTPase 2).

WB:WBGene00001359	evl-21
No description available

WB:WBGene00001360	evl-23
No description available

WB:WBGene00001361	evl-24
No description available

WB:WBGene00001362	exc-1
Is predicted to have GTP binding activity. Is involved in epithelial cell development and regulation of tube size. Is expressed in amphid sheath cell and excretory canal. Is an ortholog of human IRGC (immunity related GTPase cinema).

WB:WBGene00001363	exc-2
Is involved in epithelial cell development and regulation of tube size. Is expressed in excretory canal; pharyngeal segment; pharyngeal-intestinal valve; rectal valve cell; and uterine seam cell.

WB:WBGene00001364	exc-3
Is involved in epithelial cell development and regulation of tube size.

WB:WBGene00001365	exc-4
Is predicted to have chloride channel activity. Is involved in epithelial cell development and regulation of tube size. Localizes to several cellular components, including apical junction complex; apical plasma membrane; and lysosome. Is expressed in several structures, including amphid sheath cell; excretory system; pharyngeal muscle cell; rectum; and vulva. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human CLIC2 (chloride intracellular channel 2).

WB:WBGene00001366	exc-5
Is predicted to have guanyl-nucleotide exchange factor activity. Is involved in several processes, including cell morphogenesis; epithelial cell development; and positive regulation of actin filament binding activity. Localizes to several cellular components, including actin cytoskeleton; apical cortex; and cell body. Is expressed in excretory cell; hermaphrodite gonad; neurons; pharyngeal muscle cell; and rectal epithelium. Is used to study Aarskog syndrome and Charcot-Marie-Tooth disease type 4H. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4H. Is an ortholog of human FGD2 (FYVE, RhoGEF and PH domain containing 2); FGD3 (FYVE, RhoGEF and PH domain containing 3); and FGD4 (FYVE, RhoGEF and PH domain containing 4).

WB:WBGene00001368	exc-7
Exhibits single-stranded RNA binding activity. Is involved in several processes, including epithelial cell development; regulation of alternative mRNA splicing, via spliceosome; and regulation of neuron differentiation. Localizes to nuclear speck. Is expressed in several structures, including excretory cell; neurons; somatic nervous system; tail; and vulva. Is an ortholog of human ELAVL4 (ELAV like RNA binding protein 4).

WB:WBGene00001369	exc-8
Is involved in epithelial cell development and regulation of tube size.

WB:WBGene00001371	exl-1
Is predicted to have chloride channel activity. Localizes to several cellular components, including bounding membrane of organelle; endoplasmic reticulum; and striated muscle dense body. Is expressed in coelomocyte; intestine; muscle cell; and neurons. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human CLIC2 (chloride intracellular channel 2).

WB:WBGene00001372	exo-3
Exhibits DNA-(apurinic or apyrimidinic site) endonuclease activity and phosphoric diester hydrolase activity. Is involved in base-excision repair; embryo development; and nematode larval development. Is expressed in hermaphrodite gonad and male gonad. Is an ortholog of human APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1).

WB:WBGene00001373	exp-1
Exhibits GABA receptor activity and excitatory extracellular ligand-gated ion channel activity. Is involved in several processes, including lipid transport involved in lipid storage; monovalent inorganic cation transport; and positive regulation of intestinal lipid absorption. Localizes to neuromuscular junction. Is expressed in Y cell; enteric muscle; and neurons.

WB:WBGene00001374	exp-2
Exhibits inward rectifier potassium channel activity. Is involved in potassium ion transmembrane transport. Is expressed in intestinal cell; muscle cell; nerve ring; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNF1 (potassium voltage-gated channel modifier subfamily F member 1).

WB:WBGene00001375	exp-3
No description available

WB:WBGene00001376	exp-4
No description available

WB:WBGene00001377	eya-1
Is predicted to have protein tyrosine phosphatase activity and transcription coactivator activity. Is involved in several processes, including oviposition; positive regulation of cellular response to heat; and regulation of apoptotic process. Localizes to nucleus. Is expressed in several structures, including body wall musculature; intestine; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including autosomal dominant nonsyndromic deafness 10; branchiootic syndrome; and branchiootorenal syndrome 1. Is an ortholog of human EYA1 (EYA transcriptional coactivator and phosphatase 1); EYA2 (EYA transcriptional coactivator and phosphatase 2); and EYA4 (EYA transcriptional coactivator and phosphatase 4).

WB:WBGene00001378	fab-1
No description available

WB:WBGene00001379	fab-2
No description available

WB:WBGene00001380	fab-3
No description available

WB:WBGene00001381	fab-4
No description available

WB:WBGene00001382	faf-1
No description available

WB:WBGene00001383	fam-1
No description available

WB:WBGene00001384	fam-2
No description available

WB:WBGene00001385	far-1
Is predicted to have lipid binding activity. Is expressed in male.

WB:WBGene00001386	far-2
Is predicted to have fatty acid binding activity and retinol binding activity. Is expressed in body wall musculature; vulval muscle; and in male.

WB:WBGene00001387	far-3
Is predicted to have lipid binding activity. Is expressed in vulva and in male.

WB:WBGene00001388	far-4
Is predicted to have lipid binding activity.

WB:WBGene00001389	far-5
Is predicted to have lipid binding activity. Is expressed in male.

WB:WBGene00001390	far-6
Is predicted to have lipid binding activity. Is expressed in male.

WB:WBGene00001391	far-7
Exhibits oleic acid binding activity. Localizes to cytoplasm. Is expressed in excretory canal; excretory cell; hypodermis; and in male.

WB:WBGene00001392	far-8
Is predicted to have lipid binding activity.

WB:WBGene00001393	fat-1
Exhibits omega-3 fatty acid desaturase activity. Is involved in positive regulation of locomotion and unsaturated fatty acid biosynthetic process. Is expressed in intestine; nerve ring; and touch receptor neurons. Is used to study alcohol use disorder.

WB:WBGene00001394	fat-2
Exhibits delta12-fatty acid dehydrogenase activity and stearoyl-CoA 9-desaturase activity. Is involved in several processes, including collagen and cuticulin-based cuticle development; fatty acid biosynthetic process; and innate immune response.

WB:WBGene00001395	fat-3
Exhibits stearoyl-CoA 9-desaturase activity. Is involved in several processes, including oviposition; pharyngeal pumping; and signal release. Is expressed in body wall musculature; head neurons; intestine; pharynx; and tail neurons. Is used to study alcohol use disorder. Is an ortholog of human FADS1 (fatty acid desaturase 1) and FADS2 (fatty acid desaturase 2).

WB:WBGene00001396	fat-4
Exhibits stearoyl-CoA 9-desaturase activity. Is involved in unsaturated fatty acid biosynthetic process. Is expressed in nerve ring and touch receptor neurons. Is used to study alcohol use disorder. Is an ortholog of human FADS2 (fatty acid desaturase 2) and FADS3 (fatty acid desaturase 3).

WB:WBGene00001397	fat-5
Is predicted to have iron ion binding activity and stearoyl-CoA 9-desaturase activity. Is involved in long-chain fatty acid biosynthetic process and multicellular organism development. Is expressed in intestine and tail. Is an ortholog of human SCD5 (stearoyl-CoA desaturase 5).

WB:WBGene00001398	fat-6
Exhibits stearoyl-CoA 9-desaturase activity. Is involved in innate immune response; long-chain fatty acid biosynthetic process; and multicellular organism development. Is expressed in hypodermis. Is an ortholog of human SCD5 (stearoyl-CoA desaturase 5).

WB:WBGene00001399	fat-7
Exhibits stearoyl-CoA 9-desaturase activity. Is involved in fatty acid biosynthetic process and multicellular organism development. Is an ortholog of human SCD5 (stearoyl-CoA desaturase 5).

WB:WBGene00001400	fax-1
Exhibits DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is involved in several processes, including neuron fate specification; regulation of backward locomotion; and regulation of forward locomotion. Localizes to nucleus. Is expressed in several structures, including CEP; hermaphrodite distal tip cell; interneuron; pharyngeal motor neurons; and rect_D. Human ortholog(s) of this gene are implicated in enhanced S-cone syndrome and retinitis pigmentosa 37. Is an ortholog of human NR2E3 (nuclear receptor subfamily 2 group E member 3).

WB:WBGene00001401	fbf-1
Exhibits mRNA 3'-UTR binding activity. Is involved in germline cell cycle switching, mitotic to meiotic cell cycle; olfactory learning; and regulation of gene expression. Localizes to germ cell nucleus and perinuclear region of cytoplasm. Is expressed in germ line.

WB:WBGene00001402	fbf-2
Exhibits mRNA 3'-UTR binding activity. Is involved in negative regulation of translation. Localizes to P granule.

WB:WBGene00001403	fbl-1
Exhibits extracellular matrix structural constituent. Is involved in extracellular matrix organization; positive regulation of locomotion; and protein localization. Localizes to basement membrane. Is expressed in ALM; GLR; basal lamina; hyp7 syncytium; and nerve ring. Human ortholog(s) of this gene are implicated in Doyne honeycomb retinal dystrophy and synpolydactyly. Is an ortholog of human FBLN1 (fibulin 1).

WB:WBGene00001404	fbp-1
Is predicted to have fructose 1,6-bisphosphate 1-phosphatase activity. Human ortholog(s) of this gene are implicated in fructose-1,6-bisphosphatase deficiency. Is an ortholog of human FBP1 (fructose-bisphosphatase 1) and FBP2 (fructose-bisphosphatase 2).

WB:WBGene00001405	fce-1
Exhibits metalloendopeptidase activity. Is involved in CAAX-box protein processing. Localizes to membrane. Is expressed in head. Human ortholog(s) of this gene are implicated in lethal restrictive dermopathy. Is an ortholog of human ZMPSTE24 (zinc metallopeptidase STE24).

WB:WBGene00001406	fce-2
Exhibits cysteine-type endopeptidase activity. Is involved in CAAX-box protein processing. Localizes to membrane. Is an ortholog of human RCE1 (Ras converting CAAX endopeptidase 1).

WB:WBGene00001407	feb-1
No description available

WB:WBGene00001408	fed-1
No description available

WB:WBGene00001409	fed-2
No description available

WB:WBGene00001410	feh-1
Exhibits amyloid-beta binding activity. Is involved in embryo development; feeding behavior; and nematode larval development. Colocalizes with actin filament. Is expressed in nerve ring; pharynx; tail neurons; and ventral cord neurons. Is an ortholog of human APBB2 (amyloid beta precursor protein binding family B member 2) and APBB3 (amyloid beta precursor protein binding family B member 3).

WB:WBGene00001411	fem-1
Exhibits protein phosphatase binding activity. Is involved in several processes, including male sex determination; masculinization of hermaphroditic germ-line; and transcription factor catabolic process. Localizes to Cul2-RING ubiquitin ligase complex. Is expressed in several structures, including germ line. Is an ortholog of human FEM1A (fem-1 homolog A) and FEM1C (fem-1 homolog C).

WB:WBGene00001412	fem-2
Exhibits calmodulin-dependent protein phosphatase activity. Is involved in several processes, including masculinization of hermaphroditic germ-line; nematode male tail tip morphogenesis; and peptidyl-threonine dephosphorylation. Localizes to protein-containing complex. Human ortholog(s) of this gene are implicated in maple syrup urine disease. Is an ortholog of human PPM1F (protein phosphatase, Mg2+/Mn2+ dependent 1F).

WB:WBGene00001413	fem-3
Exhibits protein phosphatase binding activity. Is involved in several processes, including male somatic sex determination; masculinization of hermaphroditic germ-line; and positive regulation of macromolecule metabolic process. Localizes to cytoplasm and protein-containing complex. Is expressed in germ line; spermatid; and in male.

WB:WBGene00001414	fer-1
Is predicted to have calcium-dependent phospholipid binding activity. Is involved in several processes, including amoeboid sperm motility; plasma membrane organization; and pseudopodium organization. Localizes to several cellular components, including integral component of organelle membrane; neuronal cell body membrane; and pseudopodium membrane. Is expressed in spermatid; spermatocyte; and in male. Human ortholog(s) of this gene are implicated in Miyoshi muscular dystrophy 1; autosomal recessive limb-girdle muscular dystrophy type 2B; and distal muscular dystrophy with anterior tibial onset. Is an ortholog of human DYSF (dysferlin).

WB:WBGene00001415	fer-2
No description available

WB:WBGene00001417	fer-4
No description available

WB:WBGene00001418	fer-6
No description available

WB:WBGene00001419	fer-7
No description available

WB:WBGene00001420	fer-14
No description available

WB:WBGene00001422	fez-1
No description available

WB:WBGene00001423	fib-1
Is predicted to have RNA binding activity; histone-glutamine methyltransferase activity; and rRNA methyltransferase activity. Is involved in nucleologenesis and positive regulation of translation. Localizes to nucleolus and nucleoplasm. Is an ortholog of human FBL (fibrillarin).

WB:WBGene00001424	fis-1
Localizes to mitochondrial outer membrane. Is an ortholog of human FIS1 (fission, mitochondrial 1).

WB:WBGene00001425	fis-2
Is involved in apoptotic process. Localizes to mitochondrion. Is an ortholog of human FIS1 (fission, mitochondrial 1).

WB:WBGene00001426	fkb-1
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human FKBP2 (FKBP prolyl isomerase 2).

WB:WBGene00001427	fkb-2
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human FKBP1A (FKBP prolyl isomerase 1A) and FKBP1B (FKBP prolyl isomerase 1B).

WB:WBGene00001428	fkb-3
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Bruck syndrome; endogenous depression; and osteogenesis imperfecta type 11. Is an ortholog of human FKBP9 (FKBP prolyl isomerase 9).

WB:WBGene00001429	fkb-4
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Human ortholog(s) of this gene are implicated in Bruck syndrome; endogenous depression; and osteogenesis imperfecta type 11. Is an ortholog of human FKBP10 (FKBP prolyl isomerase 10).

WB:WBGene00001430	fkb-5
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Bruck syndrome; endogenous depression; and osteogenesis imperfecta type 11. Is an ortholog of human FKBP9 (FKBP prolyl isomerase 9).

WB:WBGene00001431	fkb-6
Exhibits Hsp90 protein binding activity and peptidyl-prolyl cis-trans isomerase activity. Is involved in protein peptidyl-prolyl isomerization. Is expressed in dorsal nerve cord; intestine; and ventral nerve cord. Human ortholog(s) of this gene are implicated in Bruck syndrome; endogenous depression; and osteogenesis imperfecta type 11. Is an ortholog of human FKBP4 (FKBP prolyl isomerase 4).

WB:WBGene00001432	fkb-7
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Human ortholog(s) of this gene are implicated in Bruck syndrome; endogenous depression; and osteogenesis imperfecta type 11. Is an ortholog of human FKBP7 (FKBP prolyl isomerase 7).

WB:WBGene00001433	fkb-8
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human FKBP1A (FKBP prolyl isomerase 1A); FKBP1B (FKBP prolyl isomerase 1B); and FKBP1C (FKBP prolyl isomerase 1C).

WB:WBGene00001434	fkh-2
Exhibits DNA-binding transcription factor activity. Is involved in several processes, including nematode larval development; neuron differentiation; and non-motile cilium assembly. Localizes to nucleus. Is expressed in several structures, including AWB; Daaa; body wall muscle cell from D lineage; head muscle; and somatic nervous system. Human ortholog(s) of this gene are implicated in Rett syndrome; anterior segment dysgenesis 2; and lens disease (multiple). Is an ortholog of human FOXG1 (forkhead box G1).

WB:WBGene00001435	fkh-3
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00001436	fkh-4
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Localizes to nucleus.

WB:WBGene00001437	fkh-5
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head neurons.

WB:WBGene00001438	fkh-6
Exhibits sequence-specific DNA binding activity. Is involved in male germ-line sex determination and male gonad development. Is expressed in gonadal sheath cell; male gonad; somatic gonad precursor; spermatheca; and in male. Human ortholog(s) of this gene are implicated in several diseases, including Bamforth-Lazarus syndrome; anterior segment dysgenesis 2; and lens disease (multiple). Is an ortholog of human FOXE3 (forkhead box E3).

WB:WBGene00001439	fkh-7
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is expressed in several structures, including intestine; neurons; pharynx; reproductive system; and ventral nerve cord. Human ortholog(s) of this gene are implicated in intellectual disability-severe speech delay-mild dysmorphism syndrome and speech-language disorder-1. Is an ortholog of human FOXP1 (forkhead box P1); FOXP2 (forkhead box P2); and FOXP4 (forkhead box P4).

WB:WBGene00001440	fkh-8
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in ASEL; ASER; head neurons; neurons; and tail neurons. Human ortholog(s) of this gene are implicated in anterior segment dysgenesis 2; lens disease (multiple); and persistent fetal circulation syndrome. Is an ortholog of human FOXR1 (forkhead box R1).

WB:WBGene00001441	fkh-9
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in axon regeneration; determination of adult lifespan; and learning or memory. Localizes to nucleus. Is expressed in several structures, including intestine; neurons; pharyngeal-intestinal valve; rectal valve cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Bamforth-Lazarus syndrome; eye disease (multiple); and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome. Is an ortholog of human FOXL1 (forkhead box L1).

WB:WBGene00001442	fkh-10
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in gonad and pharyngeal neurons. Human ortholog(s) of this gene are implicated in anterior segment dysgenesis 2; lens disease (multiple); and persistent fetal circulation syndrome. Is an ortholog of human FOXJ1 (forkhead box J1).

WB:WBGene00001443	fli-1
Is predicted to have actin filament binding activity. Localizes to nucleus. Is expressed in body wall musculature; germ line; hermaphrodite gonad; and non-striated muscle. Is an ortholog of human FLII (FLII actin remodeling protein).

WB:WBGene00001444	flp-1
Exhibits neuropeptide receptor binding activity. Is involved in several processes, including hyperosmotic response; mechanosensory behavior; and regulation of oviposition. Is expressed in RIG; nerve ring; and neurons.

WB:WBGene00001445	flp-2
Is expressed in MC neuron; interneuron; and nerve ring.

WB:WBGene00001446	flp-3
Is involved in negative regulation of action potential; neuropeptide signaling pathway; and regulation of pharyngeal pumping. Is expressed in head; neurons; and somatic nervous system.

WB:WBGene00001447	flp-4
Is expressed in nerve ring; pharyngeal neurons; and sensory neurons. Is predicted to encode a protein with the following domains: FMRFamide related peptide family and FMRFamide-related peptide-like.

WB:WBGene00001448	flp-5
Is expressed in head; neurons; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: FMRFamide related peptide family and FMRFamide-related peptide-like.

WB:WBGene00001449	flp-6
Is expressed in I1 neuron; ciliated neurons; head; and somatic nervous system. Is predicted to encode a protein with the following domains: FMRFamide related peptide family and FMRFamide-related peptide-like.

WB:WBGene00001450	flp-7
Exhibits neuropeptide receptor binding activity. Is involved in negative regulation of locomotion; neuropeptide signaling pathway; and second-messenger-mediated signaling. Localizes to extracellular space. Is expressed in ganglia; head neurons; and nerve ring.

WB:WBGene00001451	flp-8
Is involved in negative regulation of turning behavior involved in mating. Is expressed in PVM; head; and tail.

WB:WBGene00001452	flp-9
Exhibits neuropeptide receptor binding activity. Is involved in action potential; locomotory behavior; and neuropeptide signaling pathway. Is expressed in nerve ring.

WB:WBGene00001453	flp-10
Is involved in negative regulation of oviposition; negative regulation of turning behavior involved in mating; and thigmotaxis. Is expressed in nerve ring and neurons.

WB:WBGene00001454	flp-11
Exhibits neuropeptide receptor binding activity. Is involved in neuropeptide signaling pathway and sleep. Is expressed in nerve ring; neurons; and uv1.

WB:WBGene00001455	flp-12
Is involved in negative regulation of turning behavior involved in mating. Is expressed in BAG; motor neurons; nerve ring; and nerve ring neurons.

WB:WBGene00001456	flp-13
Exhibits neuropeptide receptor binding activity. Is involved in neuropeptide signaling pathway. Is expressed in nerve ring; neurons; and spicule protractor muscle.

WB:WBGene00001457	flp-14
Is expressed in ganglia and nerve ring. Is predicted to encode a protein with the following domains: FMRFamide related peptide family and FMRFamide-related peptide-like.

WB:WBGene00001458	flp-15
Is expressed in I2 neuron; PHA; accessory cell; and nerve ring.

WB:WBGene00001459	flp-16
Is involved in cellular response to carbon dioxide; negative regulation of pharyngeal pumping; and negative regulation of striated muscle contraction. Is expressed in nerve ring.

WB:WBGene00001460	flp-17
Is involved in negative regulation of oviposition. Localizes to neuron projection and neuronal cell body. Is expressed in BAG; nerve ring; and neurons.

WB:WBGene00001461	flp-18
Is predicted to have neuropeptide Y receptor binding activity. Is involved in neuropeptide signaling pathway and regulation of muscle contraction. Is expressed in head; neurons; tail; and in male.

WB:WBGene00001462	flp-19
Is expressed in HSN; head neurons; nerve ring; and tail.

WB:WBGene00001463	flp-20
Is involved in negative regulation of turning behavior involved in mating. Is expressed in nerve ring and neurons.

WB:WBGene00001464	flp-21
Exhibits neuropeptide Y receptor binding activity. Is involved in G protein-coupled receptor signaling pathway involved in social behavior; feeding behavior; and neuropeptide signaling pathway. Is expressed in several structures, including P9; head neurons; pharyngeal neurons; spicule neurons; and tail neurons.

WB:WBGene00001465	flr-1
Is predicted to have sodium channel activity. Is involved in defecation and ultradian rhythm. Localizes to nuclear membrane and plasma membrane. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human ASIC1 (acid sensing ion channel subunit 1) and ASIC4 (acid sensing ion channel subunit family member 4).

WB:WBGene00001466	flr-2
Is predicted to have hormone receptor binding activity. Localizes to extracellular space. Is expressed in interneuron and pharyngeal neurons. Is an ortholog of human GPHA2 (glycoprotein hormone subunit alpha 2).

WB:WBGene00001467	flr-3
No description available

WB:WBGene00001468	flr-4
Is predicted to have protein serine/threonine kinase activity. Is involved in defecation. Localizes to plasma membrane. Is expressed in AUAL; AUAR; intestine; isthmus; and neurons. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis and lung cancer.

WB:WBGene00001469	flr-5
No description available

WB:WBGene00001470	baz-2
Is predicted to have DNA binding activity and metal ion binding activity. Is expressed in several structures, including AB lineage cell; P9/10L; hermaphrodite distal tip cell; neurons; and vulva. Is an ortholog of human BAZ2A (bromodomain adjacent to zinc finger domain 2A) and BAZ2B (bromodomain adjacent to zinc finger domain 2B).

WB:WBGene00001471	flu-1
No description available

WB:WBGene00001473	flu-3
No description available

WB:WBGene00001474	flu-4
No description available

WB:WBGene00001475	fmi-1
Is predicted to have G protein-coupled receptor activity and calcium ion binding activity. Is involved in anterior/posterior axon guidance and interneuron axon guidance. Localizes to axon. Is expressed in nervous system and somatic nervous system. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 45. Is an ortholog of human CELSR2 (cadherin EGF LAG seven-pass G-type receptor 2).

WB:WBGene00001476	fmo-1
Is predicted to have monooxygenase activity. Is expressed in excretory gland cell and head. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO4 (flavin containing dimethylaniline monoxygenase 4).

WB:WBGene00001477	fmo-2
Is predicted to have monooxygenase activity. Localizes to cytoplasm. Is expressed in excretory gland cell; intestinal cell; intestine; and neurons. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO5 (flavin containing dimethylaniline monoxygenase 5).

WB:WBGene00001478	fmo-3
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO5 (flavin containing dimethylaniline monoxygenase 5).

WB:WBGene00001479	fmo-4
Is predicted to have monooxygenase activity. Is expressed in excretory duct cell; excretory socket cell; hypodermal cell; intestine; and ventral nerve cord. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO4 (flavin containing dimethylaniline monoxygenase 4) and FMO5 (flavin containing dimethylaniline monoxygenase 5).

WB:WBGene00001480	fmo-5
Is predicted to have monooxygenase activity. Is expressed in excretory gland cell; intestine; and ventral nerve cord. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO5 (flavin containing dimethylaniline monoxygenase 5).

WB:WBGene00001481	fog-1
Exhibits mRNA 3'-UTR binding activity. Is involved in cell fate specification; germ-line sex determination; and spermatogenesis. Localizes to cytoplasm and nuclear periphery. Is expressed in germ line.

WB:WBGene00001482	fog-2
Is involved in several processes, including hermaphrodite germ-line sex determination; positive regulation of cell differentiation; and positive regulation of stem cell proliferation. Localizes to cytoplasm. Is expressed in germ line.

WB:WBGene00001483	fog-3
Is predicted to have transcription corepressor activity. Is involved in several processes, including masculinization of hermaphroditic germ-line; positive regulation of oocyte development; and spermatogenesis. Localizes to cytoplasm and nuclear periphery. Is expressed in germ line. Is an ortholog of human TOB1 (transducer of ERBB2, 1).

WB:WBGene00001484	fox-1
Exhibits poly(A) binding activity; poly(G) binding activity; and poly(U) RNA binding activity. Is involved in several processes, including dosage compensation by hypoactivation of X chromosome; mating behavior; and primary sex determination. Localizes to nucleus. Is expressed in body wall musculature; intestine; pharynx; and vulval muscle. Is an ortholog of human RBFOX1 (RNA binding fox-1 homolog 1).

WB:WBGene00001485	fre-1
Is predicted to have coenzyme binding activity and oxidoreductase activity. Localizes to nucleus. Is expressed in neurons and pharyngeal muscle cell. Is an ortholog of human NDOR1 (NADPH dependent diflavin oxidoreductase 1).

WB:WBGene00001486	frh-1
Is predicted to have 2 iron, 2 sulfur cluster binding activity; ferroxidase activity; and iron ion binding activity. Is involved in determination of adult lifespan; response to hydrogen peroxide; and response to superoxide. Localizes to mitochondrion. Is expressed in amphid neurons; body wall musculature; pharyngeal muscle cell; and spermatheca. Is used to study Friedreich ataxia. Human ortholog(s) of this gene are implicated in Friedreich ataxia 1. Is an ortholog of human FXN (frataxin).

WB:WBGene00001487	frk-1
Exhibits beta-catenin binding activity and protein kinase activity. Is involved in several processes, including embryonic body morphogenesis; protein autophosphorylation; and regulation of epidermal cell differentiation. Localizes to several cellular components, including cell-cell junction; nucleus; and plasma membrane. Is expressed in several structures, including germ line; hermaphrodite gonad; hypodermis; intestine; and sperm. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00001488	frm-1
Is predicted to have actin binding activity and structural molecule activity. Localizes to plasma membrane. Is expressed in several structures, including intestine and pharynx. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 11 and hereditary elliptocytosis. Is an ortholog of human EPB41L1 (erythrocyte membrane protein band 4.1 like 1).

WB:WBGene00001489	frm-2
Is predicted to have cytoskeletal protein binding activity. Is expressed in intestinal cell; pharyngeal epithelial cell; and sensory neurons. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 11 and hereditary elliptocytosis. Is an ortholog of human EPB41L4B (erythrocyte membrane protein band 4.1 like 4B) and EPB41L5 (erythrocyte membrane protein band 4.1 like 5).

WB:WBGene00001490	frm-3
Exhibits GABA receptor binding activity. Is involved in gamma-aminobutyric acid receptor clustering. Is expressed in dorsal nerve cord. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4H. Is an ortholog of human FARP1 (FERM, ARH/RhoGEF and pleckstrin domain protein 1) and FARP2 (FERM, ARH/RhoGEF and pleckstrin domain protein 2).

WB:WBGene00001491	frm-4
Is expressed in PVDL; PVDR; head; and tail. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 11 and hereditary elliptocytosis. Is predicted to encode a protein with the following domains: FERM C-terminal PH-like domain; FERM N-terminal domain; FERM central domain; PH-like domain superfamily; FERM/acyl-CoA-binding protein superfamily; FERM, N-terminal; FERM, C-terminal PH-like domain; FERM central domain; Band 4.1 domain; Ubiquitin-like domain superfamily; and FERM superfamily, second domain. Is an ortholog of human FRMD3 (FERM domain containing 3) and FRMD5 (FERM domain containing 5).

WB:WBGene00001492	frm-5.1
Is enriched in OLL; PVD; coelomocyte; head mesodermal cell; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hydrocephalus. Human FRMPD2 exhibits 1-phosphatidylinositol binding activity. Is predicted to encode a protein with the following domains: FERM N-terminal domain; FERM central domain; PDZ domain; FERM C-terminal PH-like domain; PDZ domain; KIND domain; PH-like domain superfamily; FERM/acyl-CoA-binding protein superfamily; FERM, N-terminal; FERM, C-terminal PH-like domain; FERM central domain; Band 4.1 domain; Ubiquitin-like domain superfamily; FERM superfamily, second domain; and PDZ superfamily. Is an ortholog of human FRMPD2 (FERM and PDZ domain containing 2).

WB:WBGene00001493	frm-7
Is enriched in several structures, including AFD; body wall musculature; germ line; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FERM central domain; FERM C-terminal PH-like domain; PH-like domain superfamily; FERM, C-terminal PH-like domain; FERM central domain; Band 4.1 domain; Ubiquitin-like domain superfamily; and FERM superfamily, second domain. Is an ortholog of human FRMD1 (FERM domain containing 1).

WB:WBGene00001494	frm-8
Is expressed in PVDL and PVDR. Is predicted to encode a protein with the following domains: FERM N-terminal domain; FERM central domain; WW domain; PDZ domain; WW domain; PDZ domain; FERM/acyl-CoA-binding protein superfamily; FERM, N-terminal; FERM central domain; Band 4.1 domain; Ubiquitin-like domain superfamily; FERM superfamily, second domain; and PDZ superfamily. Is an ortholog of human FRMPD1 (FERM and PDZ domain containing 1) and FRMPD4 (FERM and PDZ domain containing 4).

WB:WBGene00001495	F31B12.3
Is enriched in head mesodermal cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Human ortholog(s) of this gene are implicated in open-angle glaucoma.

WB:WBGene00001496	frm-10
Is enriched in AFD; AVK; cephalic sheath cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; sir-2.1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FERM/acyl-CoA-binding protein superfamily and FERM superfamily, second domain. Is an ortholog of human FRMD8 (FERM domain containing 8).

WB:WBGene00001497	fars-1
Is predicted to have phenylalanine-tRNA ligase activity. Is involved in negative regulation of transcription by RNA polymerase II and translation. Is an ortholog of human FARSA (phenylalanyl-tRNA synthetase subunit alpha).

WB:WBGene00001498	fars-3
Is predicted to have several functions, including ATP binding activity; magnesium ion binding activity; and phenylalanine-tRNA ligase activity. Is an ortholog of human FARSB (phenylalanyl-tRNA synthetase subunit beta).

WB:WBGene00001499	fsn-1
Exhibits protease binding activity. Is involved in several processes, including negative regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of neuromuscular synaptic transmission; and regulation of nervous system development. Localizes to neuromuscular junction; neuron projection; and presynapse. Is an ortholog of human FBXO45 (F-box protein 45).

WB:WBGene00001500	ftn-1
Exhibits identical protein binding activity. Is involved in cellular iron ion homeostasis. Is expressed in intestine and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in hemochromatosis type 5; hyperferritinemia-cataract syndrome; and neurodegeneration with brain iron accumulation 3. Is an ortholog of human FTMT (ferritin mitochondrial).

WB:WBGene00001501	ftn-2
Exhibits identical protein binding activity. Is involved in defense response to Gram-positive bacterium. Is expressed in body wall musculature and hypodermis. Human ortholog(s) of this gene are implicated in hemochromatosis type 5; hyperferritinemia-cataract syndrome; and neurodegeneration with brain iron accumulation 3. Is an ortholog of human FTMT (ferritin mitochondrial).

WB:WBGene00001502	ftt-2
Exhibits transcription factor binding activity. Is involved in cytoplasmic sequestering of protein; dauer larval development; and negative regulation of protein import into nucleus. Localizes to cytoplasm and nucleus. Is expressed in several structures, including C; E; Psub3; gonad; and intestine. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 56. Is an ortholog of human YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) and YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta).

WB:WBGene00001503	fum-1
Is predicted to have fumarate hydratase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in fumarase deficiency. Is an ortholog of human FH (fumarate hydratase).

WB:WBGene00001505	fut-1
Exhibits 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity and glycoprotein 3-alpha-L-fucosyltransferase activity. Is involved in carbohydrate biosynthetic process and fucosylation. Is expressed in chemosensory neurons; pharyngeal-intestinal valve; rectal valve cell; and retrovesicular ganglion. Is an ortholog of human FUT3 (fucosyltransferase 3 (Lewis blood group)); FUT5 (fucosyltransferase 5); and FUT9 (fucosyltransferase 9).

WB:WBGene00001506	fut-2
Exhibits galactoside 2-alpha-L-fucosyltransferase activity. Is involved in macromolecule glycosylation. Is expressed in intestinal cell.

WB:WBGene00001507	fut-4
Is predicted to have fucosyltransferase activity. Is an ortholog of human FUT7 (fucosyltransferase 7).

WB:WBGene00001508	fut-8
Exhibits galactoside 6-L-fucosyltransferase activity and glycoprotein 6-alpha-L-fucosyltransferase activity. Is involved in fucosylation and protein N-linked glycosylation. Is an ortholog of human FUT8 (fucosyltransferase 8).

WB:WBGene00001509	fzo-1
Is predicted to have GTPase activity. Is involved in mitochondrial fusion. Is expressed in tail. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2A2A; Charcot-Marie-Tooth disease type 2A2B; and Charcot-Marie-Tooth disease type 6. Is an ortholog of human MFN1 (mitofusin 1) and MFN2 (mitofusin 2).

WB:WBGene00001510	fzr-1
Is predicted to have anaphase-promoting complex binding activity and ubiquitin-protein transferase activator activity. Is involved in cell cycle G1/S phase transition and regulation of cell division. Localizes to cytoplasm and nucleus. Is expressed in intestinal cell; seam cell; ventral cord blast cell; and vulval precursor cell. Is an ortholog of human FZR1 (fizzy and cell division cycle 20 related 1).

WB:WBGene00001511	fzy-1
Is predicted to have anaphase-promoting complex binding activity and ubiquitin-protein transferase activator activity. Is involved in several processes, including metaphase/anaphase transition of meiosis I; polar body extrusion after meiotic divisions; and polarity specification of anterior/posterior axis. Localizes to condensed chromosome and cytoplasm. Is an ortholog of human CDC20 (cell division cycle 20).

WB:WBGene00001512	gab-1
Exhibits GABA-A receptor activity and extracellular ligand-gated ion channel activity. Is involved in ion transport. Is expressed in neurons. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 43; early infantile epileptic encephalopathy 45; and infantile or early childhood epileptic encephalopathy 2. Is an ortholog of human GABRB1 (gamma-aminobutyric acid type A receptor subunit beta1); GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2); and GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3).

WB:WBGene00001513	gad-1
Is involved in cell migration involved in gastrulation; establishment of mitotic spindle orientation; and regulation of mitotic cell cycle. Is expressed in germ line. Is an ortholog of human WDR70 (WD repeat domain 70).

WB:WBGene00001514	xnd-1
Is expressed in several structures, including P4; Z2; Z3; germ line; and pharynx. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00001515	gap-1
Is predicted to have GTPase activator activity. Is involved in chemosensory behavior; learning or memory; and negative regulation of Ras protein signal transduction. Is an ortholog of human RASA2 (RAS p21 protein activator 2) and RASA3 (RAS p21 protein activator 3).

WB:WBGene00001516	gap-2
Is predicted to have GTPase activator activity. Is involved in learning or memory and negative regulation of Ras protein signal transduction. Is expressed in several structures, including head muscle; head neurons; non-striated muscle; tail; and vulva. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 5. Is an ortholog of human RASAL2 (RAS protein activator like 2).

WB:WBGene00001517	gar-1
Exhibits G protein-coupled acetylcholine receptor activity. Is involved in cholinergic synaptic transmission. Localizes to postsynaptic membrane. Is expressed in PVM and head neurons. Human ortholog(s) of this gene are implicated in essential tremor 1; prune belly syndrome; and schizophrenia.

WB:WBGene00001518	gar-2
Exhibits G protein-coupled acetylcholine receptor activity. Is involved in G protein-coupled receptor signaling pathway; negative regulation of cholinergic synaptic transmission; and response to drug. Localizes to axon. Is expressed in neurons. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome.

WB:WBGene00001519	gar-3
Exhibits G protein-coupled acetylcholine receptor activity. Is involved in several processes, including G protein-coupled acetylcholine receptor signaling pathway; positive regulation of acetylcholine secretion, neurotransmission; and positive regulation of protein localization to synapse. Localizes to integral component of plasma membrane. Is expressed in body wall musculature; linker cell; neurons; non-striated muscle; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome. Is an ortholog of human CHRM1 (cholinergic receptor muscarinic 1); CHRM3 (cholinergic receptor muscarinic 3); and CHRM5 (cholinergic receptor muscarinic 5).

WB:WBGene00001520	gas-1
Is predicted to have several functions, including 4 iron, 4 sulfur cluster binding activity; NAD binding activity; and NADH dehydrogenase (ubiquinone) activity. Is involved in mitochondrial electron transport, NADH to ubiquinone and response to drug. Localizes to intracellular membrane-bounded organelle. Is expressed in anterior gonad arm; body wall musculature; nervous system; non-striated muscle; and tail. Is used to study alcohol use disorder. Is an ortholog of human NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2).

WB:WBGene00001521	gas-2
No description available

WB:WBGene00001522	gbh-1
Is predicted to have gamma-butyrobetaine dioxygenase activity and iron ion binding activity. Is an ortholog of human BBOX1 (gamma-butyrobetaine hydroxylase 1).

WB:WBGene00001523	gbh-2
Is predicted to have iron ion binding activity and trimethyllysine dioxygenase activity. Is an ortholog of human TMLHE (trimethyllysine hydroxylase, epsilon).

WB:WBGene00001526	gck-1
Exhibits mitogen-activated protein kinase binding activity and protein serine/threonine kinase activity. Is involved in several processes, including negative regulation of MAP kinase activity; positive regulation of endocytic recycling; and regulation of Golgi organization. Localizes to cytoplasm and cytoplasmic side of apical plasma membrane. Human ortholog(s) of this gene are implicated in lung cancer. Is an ortholog of human STK24 (serine/threonine kinase 24); STK25 (serine/threonine kinase 25); and STK26 (serine/threonine kinase 26).

WB:WBGene00001527	gcs-1
Is predicted to have glutamate-cysteine ligase activity. Is involved in several processes, including glutathione biosynthetic process; response to arsenic-containing substance; and response to superoxide. Is expressed in ASIL; ASIR; intestine; and pharynx. Human ortholog(s) of this gene are implicated in glutamate-cysteine ligase deficiency. Is an ortholog of human GCLC (glutamate-cysteine ligase catalytic subunit).

WB:WBGene00001528	gcy-1
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including chemosensory behavior; response to lithium ion; and response to potassium ion. Is expressed in PVT; head neurons; and intestine. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001529	gcy-2
Is expressed in PVT and lateral ganglion. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001530	gcy-3
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in ASER; ASIL; ASIR; and PVT. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001531	gcy-4
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including chemosensory behavior; chemotaxis; and response to salt. Is expressed in ASER.

WB:WBGene00001532	gcy-5
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including chemosensory behavior; chemotaxis; and response to salt. Localizes to cilium. Is expressed in ASER; amphid neurons; head neurons; and nervous system.

WB:WBGene00001533	gcy-6
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including chemosensory behavior; positive regulation of calcium-mediated signaling; and response to magnesium ion. Is expressed in ASEL.

WB:WBGene00001534	gcy-7
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in chemosensory behavior; chemotaxis; and response to magnesium ion. Localizes to cilium. Is expressed in ASEL.

WB:WBGene00001535	gcy-8
Exhibits guanylate cyclase activity. Is involved in several processes, including microvillus organization; thermosensory behavior; and thermotaxis. Localizes to microvillus membrane and neuron projection terminus. Is expressed in AFDL and AFDR.

WB:WBGene00001536	gcy-9
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including cellular response to acidic pH; detection of carbon dioxide; and positive regulation of neuronal action potential. Localizes to neuronal cell body and non-motile cilium. Is expressed in BAGL and BAGR.

WB:WBGene00001537	gcy-11
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in pharyngeal muscle cell.

WB:WBGene00001538	gcy-12
Exhibits guanylate cyclase activity. Is involved in negative regulation of dauer larval development; regulation of growth; and regulation of locomotion involved in locomotory behavior. Localizes to dendrite; non-motile cilium; and perikaryon. Is expressed in excretory gland cell; ganglia; head muscle; and head neurons. Human ortholog(s) of this gene are implicated in congenital diarrhea 6. Is an ortholog of human GUCY2C (guanylate cyclase 2C).

WB:WBGene00001539	gcy-13
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in RIML; RIMR; and nervous system.

WB:WBGene00001540	gcy-14
Exhibits identical protein binding activity. Is involved in several processes, including chemosensory behavior; response to alkaline pH; and response to lithium ion. Is expressed in ASEL; AWCL; AWCR; and PVT. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001541	gcy-15
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in ASGL and ASGR.

WB:WBGene00001542	gcy-17
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in PHAL; PHAR; and head.

WB:WBGene00001543	gcy-18
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in detection of temperature stimulus; thermosensory behavior; and thermotaxis. Localizes to microvillus membrane and neuron projection terminus. Is expressed in intestine and nervous system.

WB:WBGene00001544	gcy-19
Is predicted to have ATP binding activity; guanylate cyclase activity; and protein kinase activity. Is expressed in inner labial neurons and nervous system.

WB:WBGene00001545	gcy-20
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in ASEL; AWCL; AWCR; excretory canal; and excretory gland cell. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001546	gcy-21
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in ADLL; ADLR; ASGL; and ASGR.

WB:WBGene00001547	gcy-22
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in several processes, including response to lithium ion; response to magnesium ion; and response to methionine. Is expressed in ASER. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001548	gcy-23
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in detection of temperature stimulus; thermosensory behavior; and thermotaxis. Localizes to neuron projection terminus. Is expressed in AFDL and AFDR.

WB:WBGene00001549	gcy-25
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in AQR; PQR; URXL; and URXR.

WB:WBGene00001550	gcy-27
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is involved in chemosensory behavior and sensory perception of bitter taste. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00001551	gcy-31
Exhibits oxygen sensor activity. Is involved in response to oxygen levels. Is expressed in BAGL; BAGR; and head.

WB:WBGene00001552	gcy-32
Is predicted to have several functions, including GTP binding activity; guanylate cyclase activity; and heme binding activity. Is expressed in AQR; PQR; URXL; and URXR. Is an ortholog of human GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1).

WB:WBGene00001553	gcy-33
Exhibits carbon monoxide sensor activity; nitric oxide binding activity; and oxygen sensor activity. Is involved in chemosensory behavior; response to oxygen levels; and sensory perception of bitter taste. Is expressed in oxygen sensory neurons.

WB:WBGene00001554	gcy-34
Is predicted to have several functions, including GTP binding activity; guanylate cyclase activity; and heme binding activity. Is involved in chemosensory behavior and sensory perception of bitter taste. Is an ortholog of human GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1).

WB:WBGene00001555	gcy-35
Exhibits carbon monoxide binding activity; nitric oxide binding activity; and oxygen sensor activity. Is involved in several processes, including aerotaxis; cGMP-mediated signaling; and response to hyperoxia. Localizes to dendrite and neuronal cell body. Is expressed in body wall musculature and pharyngeal muscle cell. Is an ortholog of human GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1).

WB:WBGene00001556	gcy-36
Exhibits oxygen sensor activity. Is involved in feeding behavior and response to oxygen levels. Localizes to dendrite and neuronal cell body. Is an ortholog of human GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1).

WB:WBGene00001557	gcy-37
Is predicted to have several functions, including GTP binding activity; guanylate cyclase activity; and heme binding activity. Is an ortholog of human GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1).

WB:WBGene00001558	gdi-1
Is predicted to have Rab GDP-dissociation inhibitor activity and Rab GTPase binding activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human GDI1 (GDP dissociation inhibitor 1) and GDI2 (GDP dissociation inhibitor 2).

WB:WBGene00001559	gei-1
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in colorectal cancer. Is an ortholog of human DLC1 (DLC1 Rho GTPase activating protein) and STARD13 (StAR related lipid transfer domain containing 13).

WB:WBGene00001560	gei-3
Is predicted to have DNA binding activity. Is expressed in head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 45.

WB:WBGene00001561	gei-4
Is involved in negative regulation of Ras protein signal transduction and negative regulation of vulval development.

WB:WBGene00001562	lin-66
Is involved in negative regulation of gene expression and regulation of development, heterochronic. Localizes to cytoplasm. Is expressed in body wall musculature; hypodermis; intestine; neurons; and vulval muscle.

WB:WBGene00001563	gei-6
Is enriched in OLL; PLM; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-16; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq; proteomic; and microarray studies.

WB:WBGene00001564	icl-1
Is predicted to have isocitrate lyase activity and malate synthase activity. Is involved in determination of adult lifespan. Localizes to mitochondrion. Is expressed in hypodermal cell and pharynx.

WB:WBGene00001565	gei-8
Is predicted to have several functions, including DNA binding activity; histone deacetylase binding activity; and transcription corepressor activity. Is expressed in several structures, including anal depressor muscle; egg-laying apparatus; germ line; somatic nervous system; and tail ganglion. Is an ortholog of human NCOR1 (nuclear receptor corepressor 1).

WB:WBGene00001566	acdh-13
Is predicted to have fatty-acyl-CoA binding activity and very-long-chain-acyl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6 and peroxisomal acyl-CoA oxidase deficiency.

WB:WBGene00001568	snpc-4
Is predicted to have DNA binding activity. Is involved in protein folding. Is expressed in germ cell; head neurons; intestine; and somatic gonad. Is an ortholog of human SNAPC4 (small nuclear RNA activating complex polypeptide 4).

WB:WBGene00001569	meg-3
Is involved in embryo development; gamete generation; and organelle localization. Localizes to P granule and cell. Is expressed in several structures, including germ cell and oocyte.

WB:WBGene00001570	gei-13
Is predicted to have metal ion binding activity.

WB:WBGene00001571	gei-14
Is enriched in GABAergic neurons; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including D-glucose; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00001572	gei-15
Localizes to cell junction and striated muscle dense body.

WB:WBGene00001574	gei-17
Exhibits RNA polymerase II transcription factor binding activity and SUMO ligase activity. Is involved in several processes, including meiotic metaphase I plate congression; protein autosumoylation; and regulation of response to DNA damage stimulus. Localizes to metaphase plate and nuclear chromatin. Is expressed in motor neurons. Is an ortholog of several human genes including PIAS1 (protein inhibitor of activated STAT 1); PIAS2 (protein inhibitor of activated STAT 2); and PIAS3 (protein inhibitor of activated STAT 3).

WB:WBGene00001575	gei-18
Is expressed in anterior hypodermis and pharynx. Is predicted to encode a protein with the following domains: Lamina-associated polypeptide 1C and LAP1C-like, C-terminal domain superfamily.

WB:WBGene00001576	gem-3
No description available

WB:WBGene00001577	gem-4
Is predicted to have calcium-dependent phospholipid binding activity. Is expressed in several structures, including Z2; Z3; head mesodermal cell; hermaphrodite gonad; and somatic gonad precursor. Is an ortholog of human CPNE8 (copine 8).

WB:WBGene00001578	ges-1
Exhibits carboxylic ester hydrolase activity. Is involved in cellular catabolic process. Localizes to peroxisome. Is expressed in pharynx. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00001579	gex-2
Is predicted to have RNA 7-methylguanosine cap binding activity. Is involved in several processes, including embryonic body morphogenesis; positive regulation of clathrin-dependent endocytosis; and positive regulation of oviposition. Localizes to SCAR complex and cell junction. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 65. Is an ortholog of human CYFIP1 (cytoplasmic FMR1 interacting protein 1) and CYFIP2 (cytoplasmic FMR1 interacting protein 2).

WB:WBGene00001580	gex-3
Is predicted to contribute to Rac GTPase binding activity. Is involved in several processes, including embryonic morphogenesis; oviposition; and positive regulation of clathrin-dependent endocytosis. Localizes to SCAR complex and cell junction. Is expressed in intestinal cell. Is an ortholog of human NCKAP1 (NCK associated protein 1).

WB:WBGene00001581	gfi-1
Is involved in chromatin remodeling. Localizes to membrane raft. Is expressed in I1L; I1R; RIH; and intestine.

WB:WBGene00001582	gfi-2
Is enriched in ASER; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and aak-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including D-glucose; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human PPP1R16A (protein phosphatase 1 regulatory subunit 16A) and PPP1R16B (protein phosphatase 1 regulatory subunit 16B).

WB:WBGene00001583	gfi-3
Is predicted to have ubiquitin protein ligase activity. Is expressed in germ line and sperm. Is an ortholog of human ANAPC5 (anaphase promoting complex subunit 5).

WB:WBGene00001584	nrde-4
Is involved in RNA interference.

WB:WBGene00001585	gfl-1
Is predicted to have chromatin binding activity. Is involved in RNA interference. Is an ortholog of human YEATS4 (YEATS domain containing 4).

WB:WBGene00001586	ggr-1
Is predicted to contribute to chloride channel activity. Is expressed in AIB; nerve ring neurons; and ventral cord neurons. Is an ortholog of several human genes including GLRA1 (glycine receptor alpha 1); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00001587	ggr-2
Is predicted to contribute to chloride channel activity. Is expressed in nerve ring and neurons. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00001588	ggr-3
Is predicted to have chloride channel activity.

WB:WBGene00001589	gip-1
Is predicted to contribute to microtubule minus-end binding activity.

WB:WBGene00001590	C45G3.3
Is enriched in AFD; OLL; PVD; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: Lipoyltransferase/lipoate-protein ligase. Is an ortholog of human LIPT1 (lipoyltransferase 1).

WB:WBGene00001591	glc-1
Exhibits extracellularly glutamate-gated chloride channel activity; glutamate binding activity; and identical protein binding activity. Is involved in chloride transmembrane transport; locomotion involved in locomotory behavior; and protein complex oligomerization. Localizes to integral component of plasma membrane. Is expressed in body wall musculature; head neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00001592	glc-2
Exhibits extracellularly glutamate-gated chloride channel activity. Is involved in chloride transmembrane transport. Localizes to integral component of plasma membrane. Is expressed in pm4. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of several human genes including GLRA1 (glycine receptor alpha 1); GLRA2 (glycine receptor alpha 2); and GLRA3 (glycine receptor alpha 3).

WB:WBGene00001593	glc-3
Is predicted to have chloride channel activity. Is involved in locomotion involved in locomotory behavior; sensory perception of chemical stimulus; and sensory processing. Is expressed in AIYL; AIYR; and tail neurons. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of human GLRA1 (glycine receptor alpha 1).

WB:WBGene00001594	glc-4
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00001595	gld-1
Exhibits mRNA 3'-UTR binding activity; mRNA 5'-UTR binding activity; and single-stranded RNA binding activity. Is involved in several processes, including negative regulation of macromolecule metabolic process; oocyte fate determination; and positive regulation of female gonad development. Localizes to P granule and cytosol. Is expressed in germ line; head neurons; tail neurons; ventral nerve cord; and in male. Is an ortholog of human QKI (QKI, KH domain containing RNA binding).

WB:WBGene00001596	gld-2
Exhibits polynucleotide adenylyltransferase activity. Is involved in several processes, including RNA polyadenylation; nucleus organization; and positive regulation of meiosis I. Localizes to P granule and RNA-directed RNA polymerase complex. Is expressed in germ line and oocyte. Is an ortholog of human TENT2 (terminal nucleotidyltransferase 2).

WB:WBGene00001597	gld-3
Exhibits protein domain specific binding activity. Contributes to polynucleotide adenylyltransferase activity. Is involved in several processes, including gamete generation; masculinization of hermaphroditic germ-line; and vulval development. Localizes to P granule and RNA-directed RNA polymerase complex. Is expressed in germ line and in male.

WB:WBGene00001598	glh-1
Exhibits RNA helicase activity; enzyme binding activity; and protein self-association. Is involved in germ cell development and post-embryonic development. Localizes to P granule. Is expressed in germ line and gonad. Is an ortholog of human DDX4 (DEAD-box helicase 4).

WB:WBGene00001599	glh-2
Exhibits JUN kinase binding activity; RNA helicase activity; and protein self-association. Is involved in germ cell development and post-embryonic development. Localizes to P granule. Is expressed in germ line and gonad. Is an ortholog of human DDX4 (DEAD-box helicase 4).

WB:WBGene00001600	glh-3
Exhibits DEAD/H-box RNA helicase binding activity; JUN kinase binding activity; and protein self-association. Localizes to P granule. Is expressed in gonad. Is an ortholog of human DDX4 (DEAD-box helicase 4).

WB:WBGene00001601	glh-4
Exhibits JUN kinase binding activity. Is involved in gamete generation and regulation of cell population proliferation. Localizes to P granule.

WB:WBGene00001602	gln-1
Is predicted to have glutamate-ammonia ligase activity. Is an ortholog of human GLUL (glutamate-ammonia ligase).

WB:WBGene00001603	gln-2
Is predicted to have ATP binding activity and glutamate-ammonia ligase activity. Is expressed in germ line. Is an ortholog of human GLUL (glutamate-ammonia ligase).

WB:WBGene00001604	gln-3
Is predicted to have ATP binding activity and glutamate-ammonia ligase activity. Is an ortholog of human GLUL (glutamate-ammonia ligase).

WB:WBGene00001605	gln-4
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00001606	gln-5
Is predicted to have glutamate-ammonia ligase activity. Is an ortholog of human GLUL (glutamate-ammonia ligase).

WB:WBGene00001607	gln-6
Is predicted to have glutamate-ammonia ligase activity. Is expressed in anterior gonad arm and germ line. Is an ortholog of human GLUL (glutamate-ammonia ligase).

WB:WBGene00001608	R07B1.8
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00001609	glp-1
Exhibits RNA polymerase II transcription factor binding activity and transcription coactivator activity. Is involved in several processes, including maintenance of dauer; pharyngeal muscle development; and positive regulation of cell population proliferation. Localizes to several cellular components, including RNA polymerase II transcription factor complex; lateral plasma membrane; and spanning component of plasma membrane. Is expressed in several structures, including anus; germ line; neurons; somatic nervous system; and vulval precursor cell. Is used to study cancer. Human ortholog(s) of this gene are implicated in several diseases, including Adams-Oliver syndrome; Alagille syndrome; and CADASIL 1. Is an ortholog of human NOTCH1 (notch receptor 1); NOTCH2 (notch receptor 2); and NOTCH3 (notch receptor 3).

WB:WBGene00001612	glr-1
Exhibits enzyme binding activity and ionotropic glutamate receptor activity. Is involved in several processes, including forward locomotion; learning or memory; and positive regulation of backward locomotion. Localizes to several cellular components, including ionotropic glutamate receptor complex; neuron projection membrane; and perinuclear endoplasmic reticulum. Is expressed in ganglia; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy (multiple) and intellectual disability (multiple). Is an ortholog of several human genes including GRIA2 (glutamate ionotropic receptor AMPA type subunit 2); GRIA3 (glutamate ionotropic receptor AMPA type subunit 3); and GRIA4 (glutamate ionotropic receptor AMPA type subunit 4).

WB:WBGene00001613	glr-2
Is predicted to have ligand-gated ion channel activity and signaling receptor activity. Is expressed in DVA; M1 neuron; linker cell; nerve ring; and neurons. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 18; electroclinical syndrome (multiple); and intellectual disability (multiple). Is an ortholog of human GRIA1 (glutamate ionotropic receptor AMPA type subunit 1); GRIA2 (glutamate ionotropic receptor AMPA type subunit 2); and GRIA3 (glutamate ionotropic receptor AMPA type subunit 3).

WB:WBGene00001614	glr-3
Is predicted to have glutamate receptor activity and transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential. Is involved in detection of cold stimulus involved in thermoception and detection of temperature stimulus involved in sensory perception of pain. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy (multiple) and non-syndromic intellectual disability (multiple). Is an ortholog of human GRIK1 (glutamate ionotropic receptor kainate type subunit 1).

WB:WBGene00001615	glr-4
Is predicted to have glutamate receptor activity and transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential. Is expressed in DA9; SABVL; SABVR; and VB neuron. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 18; electroclinical syndrome (multiple); and intellectual disability (multiple). Is an ortholog of human GRIK1 (glutamate ionotropic receptor kainate type subunit 1).

WB:WBGene00001616	glr-5
Is predicted to have glutamate receptor activity and transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential. Is expressed in VC neuron and nerve ring neurons. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 18; electroclinical syndrome (multiple); and intellectual disability (multiple). Is an ortholog of human GRIK1 (glutamate ionotropic receptor kainate type subunit 1) and GRIK3 (glutamate ionotropic receptor kainate type subunit 3).

WB:WBGene00001617	glr-6
Is predicted to have glutamate receptor activity and transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential.

WB:WBGene00001618	glr-7
Is predicted to have transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 18; electroclinical syndrome (multiple); and intellectual disability (multiple).

WB:WBGene00001619	glr-8
Is predicted to have ligand-gated ion channel activity and signaling receptor activity. Is expressed in M3L; M3R; M4 neuron; and M5 neuron. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 18; electroclinical syndrome (multiple); and intellectual disability (multiple).

WB:WBGene00001620	glt-1
Exhibits L-glutamate transmembrane transporter activity. Localizes to cell projection. Is expressed in body wall musculature; cephalic sheath cell; hypodermis; and muscle cell. Human ortholog(s) of this gene are implicated in dicarboxylic aminoaciduria; early infantile epileptic encephalopathy 41; and schizophrenia 18. Is an ortholog of human SLC1A2 (solute carrier family 1 member 2).

WB:WBGene00001621	glt-3
Is predicted to have symporter activity. Is expressed in excretory cell and pharynx. Is used to study neurodegenerative disease. Human ortholog(s) of this gene are implicated in several diseases, including dicarboxylic aminoaciduria; early infantile epileptic encephalopathy 41; and episodic ataxia type 6. Is an ortholog of human SLC1A2 (solute carrier family 1 member 2).

WB:WBGene00001622	glt-4
Is predicted to have metal ion binding activity and symporter activity. Is expressed in head neurons and metacorpus. Human ortholog(s) of this gene are implicated in several diseases, including dicarboxylic aminoaciduria; early infantile epileptic encephalopathy 41; and episodic ataxia type 6. Is an ortholog of several human genes including SLC1A1 (solute carrier family 1 member 1); SLC1A4 (solute carrier family 1 member 4); and SLC1A5 (solute carrier family 1 member 5).

WB:WBGene00001623	glt-5
Is predicted to have symporter activity. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in several diseases, including dicarboxylic aminoaciduria; early infantile epileptic encephalopathy 41; and episodic ataxia type 6. Is an ortholog of human SLC1A2 (solute carrier family 1 member 2).

WB:WBGene00001624	glt-6
Is predicted to have symporter activity. Is expressed in marginal cell. Human ortholog(s) of this gene are implicated in several diseases, including dicarboxylic aminoaciduria; early infantile epileptic encephalopathy 41; and episodic ataxia type 6. Is an ortholog of human SLC1A2 (solute carrier family 1 member 2).

WB:WBGene00001625	glt-7
Is predicted to have symporter activity. Is expressed in excretory canal. Human ortholog(s) of this gene are implicated in several diseases, including dicarboxylic aminoaciduria; early infantile epileptic encephalopathy 41; and episodic ataxia type 6. Is an ortholog of human SLC1A2 (solute carrier family 1 member 2).

WB:WBGene00001626	gly-1
Is expressed in pharyngeal neurons and seam cell. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of human GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)) and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00001627	gly-2
Exhibits calmodulin binding activity and transferase activity, transferring hexosyl groups. Is involved in protein N-linked glycosylation. Localizes to nucleus. Is expressed in hermaphrodite gonad; neurons; pharyngeal-intestinal valve; pm8; and somatic nervous system. Is an ortholog of human MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase).

WB:WBGene00001628	gly-3
Exhibits polypeptide N-acetylgalactosaminyltransferase activity. Is involved in protein O-linked glycosylation via threonine. Is expressed in hypodermis; intestine; rectal gland cell; and reproductive system. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis. Is an ortholog of human GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13).

WB:WBGene00001629	gly-4
Exhibits polypeptide N-acetylgalactosaminyltransferase activity. Is involved in protein O-linked glycosylation via threonine. Is an ortholog of human GALNT2 (polypeptide N-acetylgalactosaminyltransferase 2).

WB:WBGene00001630	gly-5
Exhibits polypeptide N-acetylgalactosaminyltransferase activity. Is involved in protein O-linked glycosylation via threonine. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis. Is an ortholog of human GALNT12 (polypeptide N-acetylgalactosaminyltransferase 12) and POC1B-GALNT4 (POC1B-GALNT4 readthrough).

WB:WBGene00001631	gly-6
Is predicted to have carbohydrate binding activity; metal ion binding activity; and transferase activity, transferring glycosyl groups. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis. Is an ortholog of human GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13).

WB:WBGene00001632	gly-7
Is predicted to have carbohydrate binding activity; metal ion binding activity; and transferase activity, transferring glycosyl groups. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis. Is an ortholog of human GALNT7 (polypeptide N-acetylgalactosaminyltransferase 7).

WB:WBGene00001633	gly-8
Is predicted to have Notch binding activity. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis. Is an ortholog of human GALNT11 (polypeptide N-acetylgalactosaminyltransferase 11) and GALNTL5 (polypeptide N-acetylgalactosaminyltransferase like 5).

WB:WBGene00001635	gly-10
Is predicted to have carbohydrate binding activity; metal ion binding activity; and polypeptide N-acetylgalactosaminyltransferase activity. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis. Is an ortholog of human GALNT10 (polypeptide N-acetylgalactosaminyltransferase 10) and GALNTL6 (polypeptide N-acetylgalactosaminyltransferase like 6).

WB:WBGene00001636	gly-11
Is predicted to have carbohydrate binding activity; metal ion binding activity; and polypeptide N-acetylgalactosaminyltransferase activity. Is expressed in excretory cell; hypodermis; and pharyngeal cell. Is an ortholog of human GALNT11 (polypeptide N-acetylgalactosaminyltransferase 11).

WB:WBGene00001637	gly-12
Exhibits alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity. Is involved in protein N-linked glycosylation. Localizes to perinuclear region of cytoplasm. Is expressed in body wall musculature; ganglia; hypodermis; and intestine.

WB:WBGene00001638	gly-13
Is predicted to have alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity. Localizes to perinuclear region of cytoplasm. Is expressed in several structures, including ganglia; intestine; muscle cell; ventral nerve cord; and vulva. Is an ortholog of human MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase).

WB:WBGene00001639	gly-14
Exhibits alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity. Is involved in protein N-linked glycosylation. Localizes to perinuclear region of cytoplasm. Is an ortholog of human MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase).

WB:WBGene00001640	gly-15
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of human GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)) and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00001641	gly-16
Is expressed in seam cell. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)); and GCNT4 (glucosaminyl (N-acetyl) transferase 4).

WB:WBGene00001642	gly-17
Is affected by several genes including sir-2.1; nhr-25; and ifg-1 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of human GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)) and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00001643	gly-18
Is expressed in several structures, including ALA; GLR; enteric muscle; hermaphrodite distal tip cell; and vulval muscle, type 1. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of human GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)); GCNT4 (glucosaminyl (N-acetyl) transferase 4); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00001644	gly-19
Is expressed in anal sphincter muscle and intestine. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of human GCNT4 (glucosaminyl (N-acetyl) transferase 4).

WB:WBGene00001645	gly-20
Is predicted to have alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity. Is involved in protein N-linked glycosylation. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIa. Is an ortholog of human MGAT2 (alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase).

WB:WBGene00001646	gna-1
Is predicted to have glucosamine 6-phosphate N-acetyltransferase activity and monosaccharide binding activity. Is an ortholog of human GNPNAT1 (glucosamine-phosphate N-acetyltransferase 1).

WB:WBGene00001647	gna-2
Is predicted to have glucosamine 6-phosphate N-acetyltransferase activity and monosaccharide binding activity. Is involved in chitin biosynthetic process and eggshell formation. Is an ortholog of human GNPNAT1 (glucosamine-phosphate N-acetyltransferase 1).

WB:WBGene00001648	goa-1
Exhibits several functions, including G protein-coupled acetylcholine receptor activity; GTP binding activity; and GTPase activity. Is involved in several processes, including detection of cold stimulus involved in thermoception; negative regulation of axon regeneration; and negative regulation of cholinergic synaptic transmission. Localizes to cell cortex. Is expressed in several structures, including neurons; non-striated muscle; pharynx; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 17. Is an ortholog of human GNAO1 (G protein subunit alpha o1).

WB:WBGene00001649	gob-1
Exhibits trehalose-phosphatase activity. Is involved in carbohydrate derivative catabolic process; dephosphorylation; and trehalose biosynthetic process. Localizes to cytoplasm. Is expressed in several structures, including body wall musculature; head neurons; intestine; pharynx; and tail.

WB:WBGene00001650	gon-1
Exhibits metallopeptidase activity. Is involved in several processes, including animal organ development; endoplasmic reticulum to Golgi vesicle-mediated transport; and negative regulation of presynapse assembly. Is expressed in amphid neurons; excretory cell; gonad; motor neurons; and muscle cell. Is used to study type 2 diabetes mellitus. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is an ortholog of human ADAMTS20 (ADAM metallopeptidase with thrombospondin type 1 motif 20) and ADAMTS9 (ADAM metallopeptidase with thrombospondin type 1 motif 9).

WB:WBGene00001651	gon-2
Is predicted to have cation transmembrane transporter activity. Is involved in defecation; gonad development; and mitotic cell cycle. Is expressed in gonad and intestine. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is an ortholog of human TRPM1 (transient receptor potential cation channel subfamily M member 1); TRPM3 (transient receptor potential cation channel subfamily M member 3); and TRPM7 (transient receptor potential cation channel subfamily M member 7).

WB:WBGene00001652	gon-3
No description available

WB:WBGene00001653	gon-4
Is predicted to have transcription coregulator activity. Is involved in gonad development and positive regulation of cell division. Localizes to germ cell nucleus. Is expressed in germ line and gonad. Is an ortholog of human GON4L (gon-4 like) and YY1AP1 (YY1 associated protein 1).

WB:WBGene00001654	gon-5
No description available

WB:WBGene00001655	gon-6
No description available

WB:WBGene00001656	gon-7
No description available

WB:WBGene00001657	gon-8
No description available

WB:WBGene00001658	gon-9
No description available

WB:WBGene00001659	gon-11
No description available

WB:WBGene00001660	gop-1
Is predicted to have Rab GTPase binding activity. Is expressed in coelomocyte; intestinal cell; non-striated muscle; and somatic nervous system. Is an ortholog of human CLEC16A (C-type lectin domain containing 16A).

WB:WBGene00001661	gop-2
Is predicted to have GTPase activity. Is an ortholog of human GPN1 (GPN-loop GTPase 1).

WB:WBGene00001662	gop-3
Is enriched in AFD; germ line; germline precursor cell; and intestine based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Surface antigen; Bacterial surface antigen (D15); and Surface antigen D15-like. Is an ortholog of human SAMM50 (SAMM50 sorting and assembly machinery component).

WB:WBGene00001663	gpa-1
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is expressed in SPD; chemosensory neurons; head; and postcloacal sensillum. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001664	gpa-2
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is involved in G protein-coupled receptor signaling pathway involved in defense response to Gram-negative bacterium; olfactory learning; and positive regulation of gene expression. Localizes to axon; neuronal cell body; and non-motile cilium. Is expressed in anal sphincter muscle; ganglia; and pharyngeal cell. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001665	gpa-3
Exhibits olfactory receptor binding activity. Is involved in several processes, including G protein-coupled receptor signaling pathway involved in defense response to Gram-negative bacterium; cellular response to cGMP; and regulation of gene expression. Localizes to axon; neuronal cell body; and non-motile cilium. Is expressed in AWAL; AWAR; AWCL; and AWCR. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001666	gpa-4
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Localizes to non-motile cilium. Is expressed in ASIL and ASIR. Human ortholog(s) of this gene are implicated in achromatopsia 4; congenital stationary night blindness 1G; and congenital stationary night blindness autosomal dominant 3. Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001667	gpa-5
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Localizes to axon; neuronal cell body; and synapse. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAL (G protein subunit alpha L).

WB:WBGene00001668	gpa-6
Is predicted to have D5 dopamine receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Localizes to axon and neuronal cell body. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001669	gpa-7
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Localizes to cytosol and nucleus. Is expressed in head; muscle cell; neurons; tail; and in male. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAO1 (G protein subunit alpha o1) and GNAZ (G protein subunit alpha z).

WB:WBGene00001670	gpa-8
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is expressed in AQR; PQR; URXL; URXR; and head. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001671	gpa-9
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is expressed in ASJ; lumbar neurons; pharyngeal muscle cell; and spermatheca. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of several human genes including GNAT1 (G protein subunit alpha transducin 1); GNAT2 (G protein subunit alpha transducin 2); and GNAT3 (G protein subunit alpha transducin 3).

WB:WBGene00001672	gpa-10
Is predicted to have D5 dopamine receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is involved in short-term memory. Is expressed in neurons and spermatheca. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNA12 (G protein subunit alpha 12); GNA13 (G protein subunit alpha 13); and GNAZ (G protein subunit alpha z).

WB:WBGene00001673	gpa-11
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is involved in determination of adult lifespan and serotonin receptor signaling pathway. Is expressed in ADLL; ADLR; ASHL; and ASHR. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAZ (G protein subunit alpha z).

WB:WBGene00001674	gpa-12
Is predicted to have D5 dopamine receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is involved in defense response to fungus and positive regulation of gene expression. Localizes to cytoplasm and nucleus. Is expressed in several structures, including excretory cell; intestine; nerve ring; neurons; and pharynx. Human ortholog(s) of this gene are implicated in achromatopsia 4; congenital stationary night blindness 1G; and congenital stationary night blindness autosomal dominant 3. Is an ortholog of human GNA12 (G protein subunit alpha 12) and GNA13 (G protein subunit alpha 13).

WB:WBGene00001675	gpa-13
Exhibits G-protein alpha-subunit binding activity. Localizes to axon; neuronal cell body; and non-motile cilium. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of several human genes including GNAT1 (G protein subunit alpha transducin 1); GNAT2 (G protein subunit alpha transducin 2); and GNAT3 (G protein subunit alpha transducin 3).

WB:WBGene00001676	gpa-14
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is expressed in neurons and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNA15 (G protein subunit alpha 15).

WB:WBGene00001677	gpa-15
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Localizes to non-motile cilium. Is expressed in chemosensory neurons and hermaphrodite somatic gonadal cell. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of several human genes including GNAT1 (G protein subunit alpha transducin 1); GNAT2 (G protein subunit alpha transducin 2); and GNAT3 (G protein subunit alpha transducin 3).

WB:WBGene00001678	gpa-16
Is predicted to have several functions, including G-protein beta/gamma-subunit complex binding activity; GTPase activity; and purine ribonucleoside binding activity. Is involved in embryonic axis specification and establishment of mitotic spindle orientation. Localizes to cell cortex. Is expressed in several structures, including Psub4; Z2; Z3; neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in achromatopsia 4; congenital stationary night blindness 1G; and congenital stationary night blindness autosomal dominant 3. Is an ortholog of human GNAI1 (G protein subunit alpha i1).

WB:WBGene00001679	gpb-1
Is involved in several processes, including establishment of mitotic spindle orientation; negative regulation of locomotion; and regulation of oviposition. Is expressed in several structures, including body wall musculature; germ line; intestine; pharynx; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease dominant intermediate F; autosomal dominant non-syndromic intellectual disability 42; and congenital stationary night blindness 1H. Is an ortholog of human GNB1 (G protein subunit beta 1); GNB2 (G protein subunit beta 2); and GNB4 (G protein subunit beta 4).

WB:WBGene00001680	gpb-2
Is involved in several processes, including G protein-coupled acetylcholine receptor signaling pathway; dopamine receptor signaling pathway; and regulation of oviposition. Localizes to neuronal cell body. Is expressed in body wall musculature; neurons; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human GNB5 (G protein subunit beta 5).

WB:WBGene00001681	gpc-1
Is predicted to have G-protein beta-subunit binding activity. Is involved in sensory perception of taste. Is expressed in PHB and amphid neurons. Is an ortholog of human GNG7 (G protein subunit gamma 7).

WB:WBGene00001682	gpc-2
Is predicted to have GTPase activity. Is expressed in muscle cell and neurons. Is an ortholog of human GNG13 (G protein subunit gamma 13).

WB:WBGene00001683	gpd-1
Is predicted to have glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity. Is expressed in germ line. Is an ortholog of human GAPDH (glyceraldehyde-3-phosphate dehydrogenase).

WB:WBGene00001684	gpd-2
Is predicted to have glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity. Is expressed in several structures, including AB; Psub1; and head. Is an ortholog of human GAPDH (glyceraldehyde-3-phosphate dehydrogenase).

WB:WBGene00001685	gpd-3
Is predicted to have glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity. Is expressed in several structures, including gonad. Is an ortholog of human GAPDH (glyceraldehyde-3-phosphate dehydrogenase).

WB:WBGene00001686	gpd-4
Is predicted to have glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity. Is expressed in germ line. Is an ortholog of human GAPDH (glyceraldehyde-3-phosphate dehydrogenase).

WB:WBGene00001687	gpn-1
Is involved in several processes, including epidermis morphogenesis; nematode larval development; and neuron migration. Is expressed in neuroblasts and ventral cord neurons. Human ortholog(s) of this gene are implicated in Simpson-Golabi-Behmel syndrome type 1; nephroblastoma; and omodysplasia. Is an ortholog of human GPC1 (glypican 1) and GPC6 (glypican 6).

WB:WBGene00001688	gpr-1
Exhibits G-protein alpha-subunit binding activity and GDP-dissociation inhibitor activity. Localizes to aster and cell cortex. Is expressed in P lineage cell.

WB:WBGene00001689	gpr-2
Exhibits GDP-dissociation inhibitor activity. Localizes to aster and cell cortex. Is expressed in P lineage cell.

WB:WBGene00001690	grd-1
Is enriched in ASER; hypodermis; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain; Hint module; Hedgehog protein, Hint domain; Hint domain C-terminal; Hint domain N-terminal; Ground-like domain; and Hint domain superfamily. Is an ortholog of human IHH (Indian hedgehog signaling molecule).

WB:WBGene00001691	grd-2
Is predicted to have cholesterol binding activity; endopeptidase activity; and signaling receptor binding activity. Is expressed in excretory duct and excretory pore. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is an ortholog of human DHH (desert hedgehog signaling molecule).

WB:WBGene00001692	grd-3
Is predicted to have signaling receptor binding activity. Is involved in defense response to Gram-negative bacterium. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00001693	grd-4
Is enriched in dopaminergic neurons and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including cholesterol; lathosterol; and methylmercuric chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001694	grd-5
Is predicted to have signaling receptor binding activity. Is involved in embryo development. Is expressed in anterior arcade cell; pharyngeal neurons; rectal epithelium; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00001695	grd-6
Is expressed in excretory duct and excretory pore. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001696	grd-7
Is predicted to have signaling receptor binding activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00001697	grd-8
Is expressed in OLLL and OLLR. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001698	grd-9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride; resveratrol; and single-walled carbon nanotube based on microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001699	grd-10
Is enriched in several structures, including PLM; germ line; non-striated muscle; somatic nervous system; and tail neurons based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001700	grd-11
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercury hydroxide; Zidovudine; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Hint module; Ground-like domain; Hedgehog protein, Hint domain; Hint domain C-terminal; Hint domain N-terminal; Ground-like domain; and Hint domain superfamily. Is an ortholog of human DHH (desert hedgehog signaling molecule); IHH (Indian hedgehog signaling molecule); and SHH (sonic hedgehog signaling molecule).

WB:WBGene00001701	grd-12
Is expressed in head; tail; and vulC. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001702	grd-13
Is expressed in intestine; isthmus; metacorpus; procorpus; and rectal epithelium. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00001703	grd-14
Is expressed in rectal epithelium. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00001704	grd-15
Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Mianserin; Zidovudine; and Psoralens based on RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001705	grd-16
Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00001706	grd-17
Is affected by several genes including clk-1; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; D-glucose; and metformin based on RNA-seq studies.

WB:WBGene00001707	grh-1
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in Van der Woude syndrome and autosomal dominant nonsyndromic deafness 28. Is an ortholog of human GRHL1 (grainyhead like transcription factor 1).

WB:WBGene00001708	grk-1
Is predicted to have ATP binding activity and G protein-coupled receptor kinase activity. Human ortholog(s) of this gene are implicated in Oguchi disease-2. Is an ortholog of human GRK4 (G protein-coupled receptor kinase 4); GRK5 (G protein-coupled receptor kinase 5); and GRK6 (G protein-coupled receptor kinase 6).

WB:WBGene00001709	grk-2
Is predicted to have ATP binding activity and G protein-coupled receptor kinase activity. Is involved in several processes, including positive regulation of growth rate; positive regulation of oviposition; and serotonin catabolic process. Is expressed in neurons and vulval muscle. Human ortholog(s) of this gene are implicated in Oguchi disease-2. Is an ortholog of human GRK2 (G protein-coupled receptor kinase 2) and GRK3 (G protein-coupled receptor kinase 3).

WB:WBGene00001710	grl-1
Is expressed in lumbar ganglion and tail. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001711	grl-2
Is expressed in head. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001712	grl-3
Is enriched in PLM; Z1; Z4; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and let-7 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001713	grl-4
Is expressed in anterior arcade cell; head; hypodermis; and vulval cell. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001714	grl-5
Is expressed in hypodermis and rectal epithelium. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001715	grl-6
Is expressed in PVT. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001716	grl-7
Is enriched in OLL; PLM; PVD; and germline precursor cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-five chemicals including Nitric Oxide; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001717	grl-8
Is expressed in rectal epithelium. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001718	grl-9
Is expressed in terminal bulb. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001719	grl-10
Is expressed in tail; vulA; vulB1; and vulB2. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001720	grl-11
Is expressed in pm6. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001721	grl-12
Is expressed in AMsoL and AMsoR. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001722	grl-13
Is enriched in AVA and dopaminergic neurons based on tiling array studies. Is affected by several genes including clk-1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001723	grl-14
Is expressed in anterior arcade cell. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001724	grl-15
Is expressed in vulB1; vulB2; vulC; vulD; and vulE. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001725	grl-16
Is enriched in several structures, including ASER; DA neuron; germ line; germline precursor cell; and intestine based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001726	grl-17
Is expressed in head and terminal bulb. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001727	grl-18
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001728	grl-19
Is expressed in excretory duct and excretory pore. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001729	grl-20
Is enriched in AVK and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including cholesterol; lathosterol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001730	grl-21
Is enriched in germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; quantitative PCR; tiling array; and RNA-seq studies. Is affected by twenty chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001731	grl-22
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001732	grl-23
Is enriched in AVK and FLP based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00001733	grl-24
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including sir-2.1; alg-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercury hydroxide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001734	grl-25
Is expressed in intestine; nervous system; and reproductive system. Is predicted to encode a protein with the following domain: .

WB:WBGene00001735	grl-26
Is expressed in anterior arcade cell and posterior arcade cell. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001736	grl-27
Is expressed in anterior arcade cell; head; posterior arcade cell; and seam cell. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001737	grl-28
Is expressed in AMshL and AMshR. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001738	grl-29
Is expressed in rectal epithelium. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001739	grl-30
Is affected by several genes including daf-12; eri-1; and lin-15B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00001740	gro-1
Is predicted to have tRNA dimethylallyltransferase activity. Is involved in determination of adult lifespan and regulation of growth. Localizes to mitochondrion and nucleus. Is expressed widely. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 35. Is an ortholog of human TRIT1 (tRNA isopentenyltransferase 1).

WB:WBGene00001741	gro-2
No description available

WB:WBGene00001742	gro-3
No description available

WB:WBGene00001743	grp-1
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Localizes to midbody and nucleus. Is expressed in somatic cell. Is an ortholog of human CYTH1 (cytohesin 1); CYTH3 (cytohesin 3); and CYTH4 (cytohesin 4).

WB:WBGene00001744	gars-1
Is predicted to have glycine-tRNA ligase activity and protein dimerization activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2D and distal hereditary motor neuronopathy type 5A. Is an ortholog of human GARS1 (glycyl-tRNA synthetase 1).

WB:WBGene00001745	gsa-1
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Is involved in several processes, including negative regulation of protein kinase C signaling; positive regulation of oocyte maturation; and regulation of defecation. Is expressed in several structures, including excretory cell; intestine; neurons; non-striated muscle; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAL (G protein subunit alpha L).

WB:WBGene00001746	gsk-3
Exhibits protein serine/threonine kinase activity. Is involved in several processes, including Wnt signaling pathway, regulating spindle positioning; engulfment of apoptotic cell; and left/right axis specification. Is an ortholog of human GSK3B (glycogen synthase kinase 3 beta).

WB:WBGene00001747	gsp-1
Is predicted to have protein serine/threonine phosphatase activity. Is involved in negative regulation of protein phosphorylation and positive regulation of gene expression. Is an ortholog of human PPP1CB (protein phosphatase 1 catalytic subunit beta).

WB:WBGene00001748	gsp-2
Exhibits protein serine/threonine phosphatase activity. Is involved in peptidyl-serine dephosphorylation. Localizes to chromosome; cytoplasm; and nuclear membrane. Is expressed in body wall musculature; gonad; intestine; and nervous system. Is an ortholog of human PPP1CA (protein phosphatase 1 catalytic subunit alpha).

WB:WBGene00001749	gst-1
Exhibits glutathione transferase activity. Is involved in several processes, including defense response to other organism; negative regulation of cellular response to manganese ion; and regulation of neuron death. Is expressed in DA neuron. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00001750	gst-2
Is predicted to have glutathione transferase activity. Is expressed in head. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001751	gst-3
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001752	gst-4
Exhibits glutathione transferase activity. Is involved in glutathione metabolic process. Localizes to contractile fiber. Is expressed in body wall musculature; hypodermis; muscle cell; and pharynx. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001753	gst-5
Is predicted to have glutathione transferase activity. Is involved in innate immune response. Is expressed in intestine and nerve ring. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001754	gst-6
Is predicted to have glutathione transferase activity. Is involved in innate immune response. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001755	gst-7
Is predicted to have glutathione transferase activity. Is involved in innate immune response. Is expressed in germ line; head; and hypodermis. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001756	gst-8
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001757	gst-9
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001758	gst-10
Exhibits glutathione transferase activity. Is involved in several processes, including determination of adult lifespan; heat acclimation; and response to UV-C. Is expressed in head and tail. Is used to study obesity. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00001759	gst-11
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001760	gst-12
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001761	gst-13
Is predicted to have glutathione transferase activity. Is involved in innate immune response. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001762	gst-14
Is predicted to have glutathione transferase activity. Is expressed in intestine and pharynx. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001763	gst-15
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001764	gst-16
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001765	gst-17
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001766	gst-18
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001767	gst-19
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001768	gst-20
Is predicted to have glutathione transferase activity. Is involved in determination of adult lifespan. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001769	gst-21
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001770	gst-22
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001771	gst-23
Is predicted to have glutathione transferase activity. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00001772	gst-24
Is predicted to have glutathione transferase activity. Is involved in innate immune response. Is expressed in head and tail. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001773	gst-25
Is predicted to have glutathione transferase activity. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00001774	gst-26
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001775	gst-27
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001776	gst-28
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001777	gst-29
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001778	gst-30
Is predicted to have glutathione transferase activity. Is expressed in head; tail; and vulva. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001779	gst-31
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001780	gst-32
Is predicted to have glutathione transferase activity. Is involved in response to reactive oxygen species. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001781	gst-33
Is predicted to have glutathione transferase activity. Is expressed in tail. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001782	gst-34
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001783	gst-35
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001784	gst-36
Is predicted to have glutathione peroxidase activity and glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001785	gst-37
Is predicted to have glutathione transferase activity. Is expressed in gonad; head; and tail. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001786	gst-38
Is predicted to have glutathione transferase activity. Is involved in PERK-mediated unfolded protein response and innate immune response. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001787	gst-39
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001788	gst-40
Is predicted to have glutathione transferase activity. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

WB:WBGene00001789	gst-41
Is predicted to have glutathione transferase activity. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00001790	gst-42
Exhibits identical protein binding activity. Is expressed in intestine. Is an ortholog of human GSTZ1 (glutathione S-transferase zeta 1).

WB:WBGene00001791	gst-43
Is predicted to have glutathione transferase activity and maleylacetoacetate isomerase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTZ1 (glutathione S-transferase zeta 1).

WB:WBGene00001792	gst-44
Is predicted to have glutathione dehydrogenase (ascorbate) activity. Is involved in response to reactive oxygen species. Is expressed in excretory cell. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTO1 (glutathione S-transferase omega 1) and GSTO2 (glutathione S-transferase omega 2).

WB:WBGene00001793	gsy-1
Is predicted to have glycogen (starch) synthase activity. Is an ortholog of human GYS1 (glycogen synthase 1) and GYS2 (glycogen synthase 2).

WB:WBGene00001794	gta-1
Is predicted to have 4-aminobutyrate transaminase activity and pyridoxal phosphate binding activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in GABA aminotransferase deficiency. Is an ortholog of human ABAT (4-aminobutyrate aminotransferase).

WB:WBGene00001795	gtl-1
Is involved in defecation. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is an ortholog of human TRPM7 (transient receptor potential cation channel subfamily M member 7).

WB:WBGene00001796	gtl-2
Is predicted to have ion channel activity. Localizes to basal plasma membrane. Is expressed in excretory canal; excretory cell; hypodermis; pharyngeal muscle cell; and pharynx. Is used to study MASA syndrome. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is an ortholog of human TRPM7 (transient receptor potential cation channel subfamily M member 7).

WB:WBGene00001798	gum-2
No description available

WB:WBGene00001799	gum-3
No description available

WB:WBGene00001800	gum-4
No description available

WB:WBGene00001801	gum-5
No description available

WB:WBGene00001802	gum-6
No description available

WB:WBGene00001803	lite-1
Exhibits blue light photoreceptor activity. Is involved in several processes, including negative phototaxis; phototransduction; and response to UV-A. Localizes to neuron projection; neuronal cell body; and plasma membrane. Is expressed in ganglia; hyp3; and pharyngeal neurons.

WB:WBGene00001804	gur-3
Localizes to nucleus. Is expressed in AVDL; AVDR; I2L; I2R; and I4 neuron.

WB:WBGene00001805	gur-4
Is enriched in body wall muscle cell; hypodermis; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00001806	gur-5
Is enriched in amphid sheath cell and cephalic sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00001807	gus-1
No description available

WB:WBGene00001808	gut-2
Is predicted to have RNA binding activity. Is an ortholog of human LSM2 (LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated).

WB:WBGene00001809	gut-4
No description available

WB:WBGene00001810	hab-1
No description available

WB:WBGene00001811	haf-1
Exhibits peptide transmembrane transporter activity. Is involved in mitochondrial unfolded protein response and protein import into mitochondrial matrix. Localizes to integral component of mitochondrial inner membrane. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB10 (ATP binding cassette subfamily B member 10).

WB:WBGene00001812	haf-2
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in RNA interference. Is expressed in intestine and muscle cell. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB9 (ATP binding cassette subfamily B member 9).

WB:WBGene00001813	haf-3
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in intestine and spermatheca. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB10 (ATP binding cassette subfamily B member 10).

WB:WBGene00001814	haf-4
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in growth; lipid metabolic process; and lysosomal transport. Localizes to lysosomal membrane. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB9 (ATP binding cassette subfamily B member 9).

WB:WBGene00001815	hmt-1
Exhibits cadmium ion transmembrane transporter activity. Is involved in cadmium ion transmembrane transport; detoxification of cadmium ion; and detoxification of copper ion. Localizes to integral component of membrane and vacuolar membrane. Is expressed in coelomocyte; head neurons; intestinal cell; and tail neurons. Human ortholog(s) of this gene are implicated in dyschromatosis universalis hereditaria. Is an ortholog of human ABCB6 (ATP binding cassette subfamily B member 6 (Langereis blood group)).

WB:WBGene00001816	haf-6
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in RNA interference. Localizes to perinuclear endoplasmic reticulum. Is expressed in germ line; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB8 (ATP binding cassette subfamily B member 8).

WB:WBGene00001817	haf-7
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human TAP2 (transporter 2, ATP binding cassette subfamily B member).

WB:WBGene00001818	haf-8
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human TAP2 (transporter 2, ATP binding cassette subfamily B member).

WB:WBGene00001819	haf-9
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in RNA interference; growth; and lysosomal transport. Localizes to lysosomal membrane. Is an ortholog of human ABCB9 (ATP binding cassette subfamily B member 9).

WB:WBGene00001820	ham-1
Exhibits DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; generation of neurons; and protein localization to actomyosin contractile ring. Localizes to cell cortex and nucleus. Is expressed in neuroblasts. Human ortholog(s) of this gene are implicated in pre-eclampsia. Is an ortholog of human STOX1 (storkhead box 1) and STOX2 (storkhead box 2).

WB:WBGene00001821	ham-2
Is predicted to have DNA-binding transcription factor activity. Is involved in cell fate determination; cell migration; and regulation of neuron differentiation. Localizes to nucleus.

WB:WBGene00001823	hap-1
Is predicted to have nucleoside-triphosphate diphosphatase activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 35. Is an ortholog of human ITPA (inosine triphosphatase).

WB:WBGene00001824	hbl-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including negative regulation of transcription by RNA polymerase II; nematode larval development; and oviposition. Localizes to nucleus. Is expressed in several structures, including body wall musculature; germ line; hypodermis; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in gingival fibromatosis 5. Is an ortholog of human ZNF131 (zinc finger protein 131); ZNF518A (zinc finger protein 518A); and ZNF518B (zinc finger protein 518B).

WB:WBGene00001825	hcd-1
No description available

WB:WBGene00001826	hcd-2
No description available

WB:WBGene00001827	hcf-1
Exhibits transcription factor binding activity. Is predicted to contribute to histone acetyltransferase activity. Is involved in several processes, including dauer exit; determination of adult lifespan; and negative regulation of transcription by transcription factor localization. Localizes to nucleus. Is expressed widely. Is an ortholog of human HCFC2 (host cell factor C2).

WB:WBGene00001828	hch-1
Is predicted to have metalloendopeptidase activity. Is involved in hatching and neuron migration. Is expressed in hypodermis and seam cell.

WB:WBGene00001829	hcp-1
Is predicted to have cytoskeletal protein binding activity. Is involved in several processes, including chromosome organization; cytoskeleton organization; and nuclear division. Localizes to condensed chromosome kinetochore; nucleus; and spindle. Is expressed in AB and Psub1.

WB:WBGene00001830	hcp-2
Is involved in cytoskeleton organization; nuclear division; and protein localization. Localizes to kinetochore.

WB:WBGene00001831	hcp-3
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in several processes, including mitotic nuclear division; negative regulation of mitotic centrosome separation; and protein localization to chromosome. Localizes to condensed chromosome, centromeric region; kinetochore; and nucleus. Colocalizes with chromosome. Is expressed in embryonic cell; hyp3; hyp4; hyp7 syncytium; and seam cell.

WB:WBGene00001832	hcp-4
Is involved in several processes, including kinetochore assembly; mitotic nuclear division; and negative regulation of mitotic centrosome separation. Localizes to chromosome; cytoplasm; and nucleoplasm. Colocalizes with chromosome.

WB:WBGene00001833	hcp-6
Is predicted to have chromatin binding activity and histone binding activity. Is involved in attachment of mitotic spindle microtubules to kinetochore; embryo development; and mitotic chromosome condensation. Localizes to condensed chromosome, centromeric region; condensin complex; and nucleoplasm. Is an ortholog of human NCAPD3 (non-SMC condensin II complex subunit D3).

WB:WBGene00001834	hda-1
Exhibits RNA polymerase II repressing transcription factor binding activity and histone deacetylase activity. Contributes to transcription corepressor activity. Is involved in several processes, including negative regulation of signal transduction; negative regulation of stress response to copper ion; and regulation of transcription by RNA polymerase II. Localizes to NuRD complex; cytoplasm; and germ cell nucleus. Is expressed in anchor cell; germ line; nervous system; tail; and vulva. Is an ortholog of human HDAC1 (histone deacetylase 1) and HDAC2 (histone deacetylase 2).

WB:WBGene00001835	hda-2
Is predicted to have histone deacetylase activity and transcription corepressor activity. Is involved in DNA protection and nematode male tail tip morphogenesis. Is an ortholog of human HDAC3 (histone deacetylase 3).

WB:WBGene00001836	hda-3
Is predicted to have histone deacetylase activity and transcription corepressor activity. Is involved in DNA protection. Localizes to nucleus. Is expressed in several structures, including ASHL and ASHR. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 5. Is an ortholog of human HDAC1 (histone deacetylase 1) and HDAC2 (histone deacetylase 2).

WB:WBGene00001837	hda-4
Exhibits transcription factor binding activity. Is involved in negative regulation of transcription by RNA polymerase II and regulation of neuron differentiation. Localizes to nucleus. Is expressed in body wall musculature; motor neurons; odorsensory neurons; seam cell; and somatic nervous system. Is an ortholog of human HDAC4 (histone deacetylase 4) and HDAC5 (histone deacetylase 5).

WB:WBGene00001838	hda-10
Is predicted to have histone deacetylase activity. Is an ortholog of human HDAC10 (histone deacetylase 10).

WB:WBGene00001839	hdl-1
Is predicted to have aromatic-L-amino-acid decarboxylase activity and pyridoxal phosphate binding activity. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome and spastic quadriplegia. Is an ortholog of human HDC (histidine decarboxylase).

WB:WBGene00001840	hel-1
Exhibits transcription factor binding activity. Is involved in determination of adult lifespan and positive regulation of gene expression. Localizes to nucleus and transcription factor complex. Is expressed in hypodermis; intestine; and neurons. Is an ortholog of human DDX39A (DExD-box helicase 39A).

WB:WBGene00001841	hen-1
Is predicted to have transmembrane receptor protein tyrosine kinase activator activity. Is involved in several processes, including associative learning; dauer larval development; and sensory processing. Localizes to axon and neuronal cell body. Is expressed in neurons; pharyngeal muscle cell; and vulva.

WB:WBGene00001842	her-1
Exhibits signaling receptor binding activity. Is involved in male sex determination. Localizes to extracellular region.

WB:WBGene00001843	hgo-1
Is predicted to have homogentisate 1,2-dioxygenase activity. Localizes to striated muscle dense body. Is expressed in body wall musculature and vulval muscle. Human ortholog(s) of this gene are implicated in alkaptonuria. Is an ortholog of human HGD (homogentisate 1,2-dioxygenase).

WB:WBGene00001844	hid-1
Is involved in several processes, including cellular response to carbon dioxide; defecation; and negative regulation of pharyngeal pumping. Localizes to several cellular components, including Golgi apparatus; cytosol; and neuron projection. Is expressed in intestine; nervous system; and uv1. Is an ortholog of human HID1 (HID1 domain containing).

WB:WBGene00001845	hid-2
Is involved in dauer larval development and response to heat.

WB:WBGene00001846	hid-3
No description available

WB:WBGene00001847	hid-4
Is involved in dauer larval development and response to heat.

WB:WBGene00001848	hid-5
No description available

WB:WBGene00001849	hid-6
No description available

WB:WBGene00001850	hid-7
No description available

WB:WBGene00001851	hif-1
Exhibits DNA-binding transcription factor activity and RNA polymerase II transcription factor binding activity. Is involved in several processes, including cellular response to caloric restriction; determination of adult lifespan; and heat acclimation. Localizes to nucleus. Is expressed widely. Is used to study cancer. Human ortholog(s) of this gene are implicated in familial erythrocytosis 4 and obesity. Is an ortholog of human EPAS1 (endothelial PAS domain protein 1) and HIF1A (hypoxia inducible factor 1 subunit alpha).

WB:WBGene00001852	hil-1
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Is involved in several processes, including body morphogenesis; oviposition; and pharynx development. Localizes to intermediate filament cytoskeleton and nucleolus. Is expressed in several structures, including body wall musculature; excretory system; head neurons; marginal cell; and vulval muscle. Is an ortholog of human H1-0 (H1.0 linker histone).

WB:WBGene00001853	hil-2
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Is an ortholog of human H1-0 (H1.0 linker histone).

WB:WBGene00001854	hil-3
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Is expressed widely. Is an ortholog of human H1-0 (H1.0 linker histone).

WB:WBGene00001855	hil-4
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Is expressed widely. Is an ortholog of several human genes including H1-2 (H1.2 linker histone, cluster member); H1-4 (H1.4 linker histone, cluster member); and H1-5 (H1.5 linker histone, cluster member).

WB:WBGene00001856	hil-5
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Is expressed widely. Is an ortholog of several human genes including H1-1 (H1.1 linker histone, cluster member); H1-3 (H1.3 linker histone, cluster member); and H1-6 (H1.6 linker histone, cluster member).

WB:WBGene00001857	hil-6
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Is expressed widely. Is an ortholog of human H1-0 (H1.0 linker histone).

WB:WBGene00001858	hil-7
Is predicted to have DNA binding activity. Is expressed widely.

WB:WBGene00001859	hil-8
Is predicted to have DNA binding activity.

WB:WBGene00001860	him-1
Exhibits DNA binding activity. Is involved in several processes, including chromosome segregation; response to UV; and response to X-ray. Localizes to cohesin complex and nuclear chromatin. Is expressed in linker cell. Is an ortholog of human SMC1A (structural maintenance of chromosomes 1A) and SMC1B (structural maintenance of chromosomes 1B).

WB:WBGene00001861	him-2
No description available

WB:WBGene00001862	him-3
Exhibits DNA binding activity. Is involved in regulation of centriole-centriole cohesion and synaptonemal complex assembly. Localizes to lateral element. Is expressed in oocyte and spermatocyte. Is an ortholog of human HORMAD2 (HORMA domain containing 2).

WB:WBGene00001863	him-4
Exhibits extracellular matrix structural constituent. Is involved in basement membrane disassembly. Localizes to basement membrane. Is expressed in body wall musculature; germ cell; and gonad. Human ortholog(s) of this gene are implicated in age related macular degeneration 1; dilated cardiomyopathy 1KK; and myopathy (multiple). Is an ortholog of human HMCN1 (hemicentin 1).

WB:WBGene00001864	him-5
Is involved in meiotic DNA double-strand break formation involved in reciprocal meiotic recombination and meiotic chromosome segregation. Localizes to condensed chromosome. Is expressed in gonad.

WB:WBGene00001865	him-6
Exhibits 3'-5' DNA helicase activity and enzyme binding activity. Is involved in several processes, including DNA metabolic process; determination of adult lifespan; and mitotic cell cycle. Is used to study Bloom syndrome. Human ortholog(s) of this gene are implicated in Bloom syndrome. Is an ortholog of human BLM (BLM RecQ like helicase).

WB:WBGene00001866	him-7
No description available

WB:WBGene00001867	him-8
Is involved in meiotic chromosome segregation. Localizes to X chromosome; condensed nuclear chromosome; and nuclear envelope.

WB:WBGene00001869	him-10
Is predicted to have structural molecule activity. Is involved in several processes, including attachment of spindle microtubules to kinetochore; chromosome organization; and mitotic spindle organization. Localizes to Ndc80 complex. Is an ortholog of human NUF2 (NUF2 component of NDC80 kinetochore complex).

WB:WBGene00001870	him-11
No description available

WB:WBGene00001871	him-13
No description available

WB:WBGene00001872	him-14
Is predicted to have DNA-dependent ATPase activity. Is involved in chiasma assembly; embryo development; and resolution of meiotic recombination intermediates. Localizes to nucleus. Is expressed in embryonic cell and gonad. Is an ortholog of human MSH4 (mutS homolog 4).

WB:WBGene00001874	him-17
Is involved in germline cell cycle switching, mitotic to meiotic cell cycle and resolution of meiotic recombination intermediates. Localizes to nuclear chromatin. Is expressed in germ line; head; and tail.

WB:WBGene00001875	his-1
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4-16 (H4 histone 16) and H4C2 (H4 clustered histone 2).

WB:WBGene00001876	his-2
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H3C7 (H3 clustered histone 7).

WB:WBGene00001877	his-3
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001878	his-4
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001879	his-5
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001880	his-6
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C12 (H3 clustered histone 12); H3C4 (H3 clustered histone 4); and H3C6 (H3 clustered histone 6).

WB:WBGene00001881	his-7
Is predicted to have DNA binding activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001882	his-8
Is predicted to have DNA binding activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001883	his-9
Is predicted to have DNA binding activity and protein heterodimerization activity. Is expressed in several structures, including MI neuron and e3D. Is an ortholog of several human genes including H3C10 (H3 clustered histone 10); H3C4 (H3 clustered histone 4); and H3C8 (H3 clustered histone 8).

WB:WBGene00001884	his-10
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001885	his-11
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in innate immune response. Localizes to chromatin. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001886	his-12
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001887	his-13
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C11 (H3 clustered histone 11); H3C12 (H3 clustered histone 12); and H3C8 (H3 clustered histone 8).

WB:WBGene00001888	his-14
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001889	his-15
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in innate immune response. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001890	his-16
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001891	his-17
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C1 (H3 clustered histone 1); H3C10 (H3 clustered histone 10); and H3C11 (H3 clustered histone 11).

WB:WBGene00001892	his-18
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001893	his-19
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001894	his-20
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001895	his-21
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001896	his-22
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001898	his-24
Is predicted to have double-stranded DNA binding activity and nucleosomal DNA binding activity. Localizes to cytoplasm and nuclear chromosome, telomeric region. Is expressed in several structures, including germ line and gonad. Is an ortholog of human H1-0 (H1.0 linker histone).

WB:WBGene00001899	his-25
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C1 (H3 clustered histone 1); H3C2 (H3 clustered histone 2); and H3C6 (H3 clustered histone 6).

WB:WBGene00001900	his-26
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in positive regulation of transcription by RNA polymerase II. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001901	his-27
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C10 (H3 clustered histone 10); H3C3 (H3 clustered histone 3); and H3C7 (H3 clustered histone 7).

WB:WBGene00001902	his-28
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001903	his-29
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001904	his-30
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001905	his-31
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001906	his-32
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C1 (H3 clustered histone 1); H3C12 (H3 clustered histone 12); and H3C7 (H3 clustered histone 7).

WB:WBGene00001907	his-33
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001908	his-34
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in innate immune response. Is an ortholog of several human genes including H2BC13 (H2B clustered histone 13); H2BC18 (H2B clustered histone 18); and H2BC21 (H2B clustered histone 21).

WB:WBGene00001909	his-35
Is predicted to have DNA binding activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001910	C50F4.6
Is enriched in body wall musculature; germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Mianserin; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00001911	his-37
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001912	his-38
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in positive regulation of transcription by RNA polymerase II. Is an ortholog of human H4C15 (H4 clustered histone 15).

WB:WBGene00001913	his-39
Is predicted to have DNA binding activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001914	his-40
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H3C1 (H3 clustered histone 1).

WB:WBGene00001915	his-41
Is predicted to have DNA binding activity. Is an ortholog of human H2BC13 (H2B clustered histone 13).

WB:WBGene00001916	his-42
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C1 (H3 clustered histone 1); H3C12 (H3 clustered histone 12); and H3C4 (H3 clustered histone 4).

WB:WBGene00001917	his-43
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in innate immune response. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001918	his-44
Is predicted to have DNA binding activity. Is involved in innate immune response. Localizes to chromatin. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001919	his-45
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C10 (H3 clustered histone 10); H3C11 (H3 clustered histone 11); and H3C12 (H3 clustered histone 12).

WB:WBGene00001920	his-46
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001921	his-47
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001922	his-48
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in innate immune response. Is expressed in gonad. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001923	his-49
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C1 (H3 clustered histone 1); H3C12 (H3 clustered histone 12); and H3C8 (H3 clustered histone 8).

WB:WBGene00001924	his-50
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001925	his-51
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001926	his-52
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001927	his-53
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001928	his-54
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001929	his-55
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C2 (H3 clustered histone 2); H3C6 (H3 clustered histone 6); and H3C8 (H3 clustered histone 8).

WB:WBGene00001930	his-56
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001931	his-57
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001932	his-58
Is predicted to have DNA binding activity and protein heterodimerization activity. Is expressed in sperm and spermatid. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001933	his-59
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C11 (H3 clustered histone 11); H3C12 (H3 clustered histone 12); and H3C2 (H3 clustered histone 2).

WB:WBGene00001934	his-60
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001935	his-61
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001936	his-62
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2BC1 (H2B clustered histone 1).

WB:WBGene00001937	his-63
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of several human genes including H3C10 (H3 clustered histone 10); H3C11 (H3 clustered histone 11); and H3C6 (H3 clustered histone 6).

WB:WBGene00001938	his-64
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in positive regulation of transcription by RNA polymerase II. Is expressed in head and tail. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001939	his-65
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001940	his-66
Is predicted to have DNA binding activity. Is an ortholog of several human genes including H2BC11 (H2B clustered histone 11); H2BC5 (H2B clustered histone 5); and H2BC9 (H2B clustered histone 9).

WB:WBGene00001941	his-67
Is predicted to have DNA binding activity. Is involved in positive regulation of transcription by RNA polymerase II. Is an ortholog of human H4C2 (H4 clustered histone 2).

WB:WBGene00001942	his-68
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H2AX (H2A.X variant histone).

WB:WBGene00001943	his-69
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H3-3B (H3.3 histone B) and H3-5 (H3.5 histone).

WB:WBGene00001944	his-70
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H3-5 (H3.5 histone).

WB:WBGene00001945	his-71
Is predicted to have DNA binding activity and protein heterodimerization activity. Is expressed widely. Is an ortholog of human H3-3B (H3.3 histone B).

WB:WBGene00001946	his-72
Is predicted to have DNA binding activity and protein heterodimerization activity. Localizes to nucleosome and nucleus. Is expressed widely. Is an ortholog of human H3-3B (H3.3 histone B).

WB:WBGene00001947	his-73
Is predicted to have DNA binding activity and protein heterodimerization activity.

WB:WBGene00001948	hlh-1
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II regulatory region sequence-specific DNA binding activity; and protein homodimerization activity. Is involved in several processes, including positive regulation of mesodermal cell fate specification; positive regulation of transcription by RNA polymerase II; and transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including C lineage cell; D lineage cell; I4 neuron; MSaaaapa; and body wall muscle cell. Is an ortholog of several human genes including MYF5 (myogenic factor 5); MYF6 (myogenic factor 6); and MYOD1 (myogenic differentiation 1).

WB:WBGene00001949	hlh-2
Exhibits several functions, including DNA-binding transcription factor activity, RNA polymerase II-specific; bHLH transcription factor binding activity; and protein dimerization activity. Contributes to RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including generation of neurons; gonad morphogenesis; and nematode male tail tip morphogenesis. Localizes to RNA polymerase II transcription factor complex and cytoplasm. Is expressed in several structures, including distal tip cell; lateral ganglion; non-striated muscle; ray precursor cell; and terminal bulb. Human ortholog(s) of this gene are implicated in Fuchs' endothelial dystrophy; Pitt-Hopkins syndrome; and craniosynostosis. Is an ortholog of human TCF12 (transcription factor 12); TCF3 (transcription factor 3); and TCF4 (transcription factor 4).

WB:WBGene00001950	hlh-3
Exhibits protein heterodimerization activity and sequence-specific DNA binding activity. Contributes to RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including generation of neurons; regulation of oviposition; and transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in several structures, including AB lineage cell; ABplapppapp; ABplpapaaa; nerve ring; and neurons. Human ortholog(s) of this gene are implicated in congenital central hypoventilation syndrome. Is an ortholog of human ASCL1 (achaete-scute family bHLH transcription factor 1).

WB:WBGene00001951	hlh-4
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and bHLH transcription factor binding activity. Is predicted to contribute to DNA-binding transcription factor activity. Is involved in positive regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in ABalppppaav; ABpraaapaav; ADLL; and ADLR. Human ortholog(s) of this gene are implicated in congenital central hypoventilation syndrome. Is an ortholog of human ASCL3 (achaete-scute family bHLH transcription factor 3).

WB:WBGene00001952	hlh-6
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific. Is predicted to contribute to DNA-binding transcription factor activity. Is involved in several processes, including pharyngeal gland morphogenesis; pharynx development; and positive regulation of pharynx morphogenesis. Localizes to cell projection and nucleus. Human ortholog(s) of this gene are implicated in congenital central hypoventilation syndrome. Is an ortholog of human ASCL3 (achaete-scute family bHLH transcription factor 3).

WB:WBGene00001953	hlh-8
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in mesodermal cell fate specification; positive regulation of transcription by RNA polymerase II; and vulval cell fate specification. Is expressed in several structures, including M.dla; M.dra; M.vla; body wall muscle cell from M lineage; and enteric muscle. Human ortholog(s) of this gene are implicated in several diseases, including Barber-Say syndrome; Sweeney-Cox syndrome; and synostosis (multiple). Is an ortholog of human TWIST1 (twist family bHLH transcription factor 1) and TWIST2 (twist family bHLH transcription factor 2).

WB:WBGene00001954	hlh-10
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in ADLL; ADLR; ASEL; ASER; and neurons. Is an ortholog of human MSC (musculin) and TCF21 (transcription factor 21).

WB:WBGene00001955	hlh-11
Is predicted to have DNA-binding transcription factor activity. Is expressed in excretory cell; male-specific anatomical entity; non-striated muscle; pharynx; and somatic nervous system. Is an ortholog of human TFAP4 (transcription factor AP-4).

WB:WBGene00001956	hlh-12
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in anterior distal tip cell; distal tip cell; linker cell; and posterior distal tip cell. Human ortholog(s) of this gene are implicated in Barber-Say syndrome; ablepharon macrostomia syndrome; and premature ovarian failure.

WB:WBGene00001957	hlh-13
Exhibits transcription factor binding activity. Is involved in dauer exit; insulin receptor signaling pathway; and response to oxidative stress. Is expressed in neurons. Human ortholog(s) of this gene are implicated in Barber-Say syndrome and ablepharon macrostomia syndrome. Is an ortholog of human PTF1A (pancreas associated transcription factor 1a).

WB:WBGene00001958	hlh-14
Is predicted to contribute to DNA-binding transcription factor activity. Is involved in several processes, including generation of neurons; oviposition; and positive regulation of growth rate. Localizes to nucleus. Is expressed in several structures, including ABplapppaap; ABplapppapa; ABprapppaap; ABprapppapa; and neurons. Human ortholog(s) of this gene are implicated in congenital central hypoventilation syndrome. Is an ortholog of human ASCL1 (achaete-scute family bHLH transcription factor 1) and ASCL2 (achaete-scute family bHLH transcription factor 2).

WB:WBGene00001959	hlh-15
Exhibits RNA polymerase II transcription factor binding activity. Is an ortholog of human NHLH1 (nescient helix-loop-helix 1) and NHLH2 (nescient helix-loop-helix 2).

WB:WBGene00001960	hlh-16
Is predicted to have protein dimerization activity. Is expressed in ABplpapaaa; ABplpapaap; ABprpapaaa; ABprpapaap; and ventral ganglion. Human ortholog(s) of this gene are implicated in congenital malabsorptive diarrhea 4; diabetes mellitus (multiple); and persistent hyperplastic primary vitreous. Is an ortholog of human OLIG1 (oligodendrocyte transcription factor 1).

WB:WBGene00001961	hlh-17
Is predicted to have protein dimerization activity. Is involved in positive regulation of dopaminergic synaptic transmission and positive regulation of transcription by RNA polymerase II. Is expressed in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and ventral cord neurons. Human ortholog(s) of this gene are implicated in congenital malabsorptive diarrhea 4 and persistent hyperplastic primary vitreous. Is an ortholog of human BHLHE23 (basic helix-loop-helix family member e23).

WB:WBGene00001962	hlh-19
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00001963	btb-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and mut-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00001964	hlh-25
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including MSpa; anal depressor muscle; body wall musculature; intestinal cell; and neurons.

WB:WBGene00001965	hlh-26
Is predicted to have DNA binding activity and protein dimerization activity. Is expressed in ABpla; ABplp; ABpra; and ABprp.

WB:WBGene00001966	hlh-27
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including ABpla; ABplp; ABprp; MSaa; and MSpa.

WB:WBGene00001967	hlh-28
Is predicted to have protein dimerization activity. Is expressed in several structures, including E; Ea; Ep; MSa; and MSp.

WB:WBGene00001968	hlh-29
Is predicted to have protein dimerization activity. Is expressed in several structures, including amphid sheath cell; coelomocyte; ganglia; non-striated muscle; and rectal gland cell.

WB:WBGene00001969	hlp-1
No description available

WB:WBGene00001970	hlp-2
No description available

WB:WBGene00001971	hmg-1.1
Is predicted to have DNA binding activity, bending and transcription factor binding activity. Is expressed in head neurons; pharynx; tail neurons; ventral nerve cord; and vulva.

WB:WBGene00001972	hmg-1.2
Exhibits transcription regulatory region DNA binding activity. Is involved in several processes, including gonad development; positive regulation of transcription by RNA polymerase II; and vulval development. Localizes to nucleus. Is expressed in several structures, including tail. Is an ortholog of human HMGB3 (high mobility group box 3).

WB:WBGene00001973	hmg-3
Is predicted to have histone binding activity and nucleosome binding activity. Is involved in pharynx development and regulation of embryonic development. Localizes to nucleus. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 15. Is an ortholog of human SSRP1 (structure specific recognition protein 1).

WB:WBGene00001974	hmg-4
Is predicted to have histone binding activity and nucleosome binding activity. Is involved in pharynx development and regulation of embryonic development. Localizes to nucleus. Is expressed in several structures, including coelomocyte; head muscle; neurons; somatic cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 15. Is an ortholog of human SSRP1 (structure specific recognition protein 1).

WB:WBGene00001975	hmg-5
Exhibits identical protein binding activity and telomeric DNA binding activity. Is involved in mitochondrial DNA metabolic process. Localizes to mitochondrial nucleoid and nuclear chromosome, telomeric region. Is expressed in dorsal nerve cord; head muscle; head neurons; oocyte; and ventral nerve cord. Is an ortholog of human TFAM (transcription factor A, mitochondrial).

WB:WBGene00001976	hmg-11
Is predicted to have DNA binding activity. Is expressed in head.

WB:WBGene00001977	hmg-12
Is predicted to have DNA-(apurinic or apyrimidinic site) endonuclease activity.

WB:WBGene00001978	hmp-1
Exhibits actin filament binding activity and beta-catenin binding activity. Is involved in several processes, including cortical actin cytoskeleton organization; embryonic morphogenesis; and regulation of actin cytoskeleton organization. Localizes to adherens junction; apical junction complex; and catenin complex. Is expressed in several structures, including distal tip cell; germ cell; intestinal cell; neuroblasts; and pharyngeal cell. Human ortholog(s) of this gene are implicated in patterned macular dystrophy 2. Is an ortholog of human CTNNA2 (catenin alpha 2).

WB:WBGene00001979	hmp-2
Exhibits several functions, including alpha-catenin binding activity; cadherin binding activity; and transcription coactivator activity. Is involved in several processes, including cytoskeleton organization; embryonic morphogenesis; and left/right axis specification. Localizes to adherens junction; catenin complex; and nucleus. Is expressed in distal tip cell and germ cell. Human ortholog(s) of this gene are implicated in several diseases, including arrhythmogenic right ventricular dysplasia 12; autosomal dominant non-syndromic intellectual disability 19; and endocrine gland cancer (multiple). Is an ortholog of human JUP (junction plakoglobin).

WB:WBGene00001980	hmr-1
Exhibits beta-catenin binding activity and delta-catenin binding activity. Is involved in cytoskeleton organization; embryo development; and gastrulation. Localizes to adherens junction; catenin complex; and spanning component of plasma membrane. Is expressed in several structures, including germline precursor cell; hypodermis; motor neurons; nerve ring; and neuroblasts. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 45.

WB:WBGene00001981	hnd-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including Daa; Dap; Dpa; Dpp; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in several diseases, including Barber-Say syndrome; Sweeney-Cox syndrome; and synostosis (multiple).

WB:WBGene00001982	hnl-1
No description available

WB:WBGene00001983	hoe-1
Is predicted to have endonuclease activity and metal ion binding activity. Is involved in several processes, including germ cell development; nematode larval development; and positive regulation of vulval development. Is expressed in germ line. Is used to study prostate cancer. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 17. Is an ortholog of human ELAC2 (elaC ribonuclease Z 2).

WB:WBGene00001984	hog-1
Is expressed in rectal epithelium. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domains: Hint module; Hedgehog protein, Hint domain; Hint domain C-terminal; Hint domain N-terminal; and Hint domain superfamily. Is an ortholog of human DHH (desert hedgehog signaling molecule).

WB:WBGene00001985	hop-1
Is predicted to have endopeptidase activity. Is involved in several processes, including oviposition; positive regulation of Notch signaling pathway; and regulation of vulval development. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease (multiple); Pick's disease; and dilated cardiomyopathy (multiple). Is an ortholog of human PSEN2 (presenilin 2).

WB:WBGene00001986	hot-1
Is enriched in AFD; RID; head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including skn-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00001987	hot-2
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and seam cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; eat-2; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00001988	hot-3
Is enriched in AVK; intestine; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by Tunicamycin; Zidovudine; and Colistin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00001989	hot-4
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00001990	hot-5
Is enriched in coelomocyte; head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00001991	hot-6
Is enriched in body wall musculature; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including aldicarb; stavudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00001992	hot-7
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; lin-35; and smg-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including nicotinic acid; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00001993	hpd-1
Is predicted to have 4-hydroxyphenylpyruvate dioxygenase activity. Human ortholog(s) of this gene are implicated in hawkinsinuria and tyrosinemia type III. Is an ortholog of human HPD (4-hydroxyphenylpyruvate dioxygenase).

WB:WBGene00001994	hpk-1
Is predicted to have protein serine/threonine kinase activity and protein tyrosine kinase activity. Is involved in several processes, including autophagosome assembly; determination of adult lifespan; and response to heat. Localizes to nucleus. Is expressed in several structures, including gonad and neurons. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 7. Is an ortholog of human HIPK1 (homeodomain interacting protein kinase 1) and HIPK2 (homeodomain interacting protein kinase 2).

WB:WBGene00001995	hpl-1
Exhibits enzyme binding activity. Is involved in several processes, including negative regulation of Ras protein signal transduction; negative regulation of vulval development; and positive regulation of growth rate. Localizes to nuclear heterochromatin. Is expressed in several structures, including neurons. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis. Is an ortholog of human CBX3 (chromobox 3).

WB:WBGene00001996	hpl-2
Exhibits chromatin binding activity. Is involved in several processes, including negative regulation of vulval development; olfactory learning; and positive regulation of growth rate. Localizes to condensed chromosome and nuclear periphery. Is expressed in several structures, including AWCL and AWCR. Is an ortholog of human CBX3 (chromobox 3).

WB:WBGene00001997	hpr-9
Is predicted to have 3'-5' exonuclease activity. Is an ortholog of human RAD9A (RAD9 checkpoint clamp component A) and RAD9B (RAD9 checkpoint clamp component B).

WB:WBGene00001998	hpr-17
Is predicted to have chromatin binding activity. Is an ortholog of human RAD17 (RAD17 checkpoint clamp loader component).

WB:WBGene00001999	hrpa-1
Is predicted to have RNA binding activity. Is involved in hemidesmosome assembly. Localizes to chromosome, telomeric region. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 20; inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 2; and inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 3. Is an ortholog of human HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1) and HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1).

WB:WBGene00002000	hrpr-1
Is predicted to have mRNA binding activity. Localizes to nucleus. Is expressed widely. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human HNRNPR (heterogeneous nuclear ribonucleoprotein R) and SYNCRIP (synaptotagmin binding cytoplasmic RNA interacting protein).

WB:WBGene00002001	hars-1
Is predicted to have histidine-tRNA ligase activity and identical protein binding activity. Is involved in several processes, including negative regulation of transcription by RNA polymerase II; nematode larval development; and translation. Is used to study Perrault syndrome and sensory peripheral neuropathy. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease, axonal type 2W; Perrault syndrome; and Usher syndrome type 3B. Is an ortholog of human HARS1 (histidyl-tRNA synthetase 1).

WB:WBGene00002002	hsb-1
Is predicted to have transcription corepressor activity. Is an ortholog of human HSBP1 (heat shock factor binding protein 1).

WB:WBGene00002003	hse-5
Is predicted to have heparosan-N-sulfate-glucuronate 5-epimerase activity. Is involved in heparan sulfate proteoglycan biosynthetic process, enzymatic modification; regulation of cell migration; and regulation of growth. Is expressed in hypodermis. Is an ortholog of human GLCE (glucuronic acid epimerase).

WB:WBGene00002004	hsf-1
Exhibits calmodulin binding activity; promoter-specific chromatin binding activity; and sequence-specific double-stranded DNA binding activity. Is involved in several processes, including dauer larval development; defense response to other organism; and determination of adult lifespan. Localizes to nuclear stress granule. Is expressed in several structures, including body wall musculature; hypodermis; intestine; neurons; and somatic cell. Human ortholog(s) of this gene are implicated in cataract 5 multiple types. Is an ortholog of human HSF1 (heat shock transcription factor 1) and HSF2 (heat shock transcription factor 2).

WB:WBGene00002005	hsp-1
Exhibits ATPase activity. Is involved in determination of adult lifespan; response to heat; and retrograde transport, endosome to Golgi. Localizes to cytosol and nucleus. Is expressed in germ line and intestine. Is an ortholog of human HSPA1B (heat shock protein family A (Hsp70) member 1B) and HSPA8 (heat shock protein family A (Hsp70) member 8).

WB:WBGene00002006	hsp-2
Is enriched in germ line based on proteomic studies. Is affected by several genes including daf-16; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00002007	hsp-3
Is predicted to have several functions, including ATP binding activity; ATPase activity; and unfolded protein binding activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in several structures, including germ line; hypodermis; intestinal muscle; pharyngeal-intestinal valve; and tail. Is an ortholog of human HSPA5 (heat shock protein family A (Hsp70) member 5).

WB:WBGene00002008	hsp-4
Exhibits RNA polymerase II transcription factor binding activity. Is involved in endoplasmic reticulum unfolded protein response. Localizes to rough endoplasmic reticulum. Is expressed in PVDL; PVDR; intestinal muscle; and spermatheca. Is an ortholog of human HSPA5 (heat shock protein family A (Hsp70) member 5).

WB:WBGene00002009	hsp-5
No description available

WB:WBGene00002010	hsp-6
Is predicted to have several functions, including ATP binding activity; ATPase activity; and unfolded protein binding activity. Is involved in mitochondrial unfolded protein response. Localizes to mitochondrion. Is expressed in muscle cell. Human ortholog(s) of this gene are implicated in autosomal dominant sideroblastic anemia 4. Is an ortholog of human HSPA9 (heat shock protein family A (Hsp70) member 9).

WB:WBGene00002011	hsp-12.2
Exhibits heat shock protein binding activity. Localizes to cytoplasm. Human ortholog(s) of this gene are implicated in several diseases, including cataract (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of several human genes including CRYAA (crystallin alpha A); CRYAA2 (crystallin alpha A2); and HSPB2 (heat shock protein family B (small) member 2).

WB:WBGene00002012	hsp-12.3
Exhibits heat shock protein binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAB (crystallin alpha B) and HSPB6 (heat shock protein family B (small) member 6).

WB:WBGene00002013	hsp-12.6
Exhibits identical protein binding activity. Colocalizes with cytoplasm. Is expressed in hypodermis; intestine; muscle cell; and spermatid. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAB (crystallin alpha B) and HSPB6 (heat shock protein family B (small) member 6).

WB:WBGene00002015	hsp-16.1
Is predicted to have unfolded protein binding activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in several structures, including coelomocyte; enteric muscle; intestine; pharynx; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple).

WB:WBGene00002016	hsp-16.2
Is predicted to have unfolded protein binding activity. Is involved in response to heat. Localizes to cytoplasm. Is expressed in several structures, including coelomocyte; enteric muscle; gonad; somatic nervous system; and spermatid. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAB (crystallin alpha B).

WB:WBGene00002017	hsp-16.11
Is predicted to have unfolded protein binding activity. Is involved in endoplasmic reticulum unfolded protein response and response to heat. Localizes to Golgi medial cisterna. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple).

WB:WBGene00002018	hsp-16.41
Is predicted to have unfolded protein binding activity. Is involved in defense response to Gram-negative bacterium and response to heat. Is expressed in several structures, including alimentary muscle; coelomocyte; intestine; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of several human genes including CRYAA (crystallin alpha A); HSPB1 (heat shock protein family B (small) member 1); and HSPB2 (heat shock protein family B (small) member 2).

WB:WBGene00002019	hsp-16.48
Is predicted to have unfolded protein binding activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in several structures, including coelomocyte; enteric muscle; intestine; pharynx; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAA (crystallin alpha A); HSPB1 (heat shock protein family B (small) member 1); and HSPB2 (heat shock protein family B (small) member 2).

WB:WBGene00002020	hsp-16.49
Is predicted to have unfolded protein binding activity. Is involved in determination of adult lifespan; endoplasmic reticulum unfolded protein response; and response to heat. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple).

WB:WBGene00002021	hsp-17
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAB (crystallin alpha B) and HSPB1 (heat shock protein family B (small) member 1).

WB:WBGene00002023	hsp-25
Localizes to M band and striated muscle dense body. Is expressed in body wall musculature; gonad; pharynx; and spermatheca. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2 (multiple); cataract 9 multiple types; and distal hereditary motor neuronopathy type 2 (multiple). Is an ortholog of human HSPB1 (heat shock protein family B (small) member 1).

WB:WBGene00002024	hsp-43
Is expressed in several structures, including copulatory spicule; hermaphrodite gonad; pharyngeal-intestinal valve; rectal valve cell; and vulva. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2 (multiple); cataract 9 multiple types; and distal hereditary motor neuronopathy type 2 (multiple). Is predicted to encode a protein with the following domains: Hsp20/alpha crystallin family; Alpha crystallin/Small heat shock protein, animal type; Alpha crystallin/Hsp20 domain; and HSP20-like chaperone. Is an ortholog of human HSPB1 (heat shock protein family B (small) member 1) and HSPB2 (heat shock protein family B (small) member 2).

WB:WBGene00002025	hsp-60
Exhibits transcription factor binding activity. Is involved in several processes, including mitochondrial unfolded protein response; mitochondrion organization; and nematode larval development. Localizes to mitochondrion. Is expressed in hypodermis; intestine; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 13 and hypomyelinating leukodystrophy 4. Is an ortholog of human HSPD1 (heat shock protein family D (Hsp60) member 1).

WB:WBGene00002026	hsp-70
Is predicted to have several functions, including ATP binding activity; ATPase activity; and unfolded protein binding activity. Is involved in determination of adult lifespan and response to heat. Localizes to chaperonin-containing T-complex. Is an ortholog of human HSPA6 (heat shock protein family A (Hsp70) member 6).

WB:WBGene00002027	hsr-9
Is predicted to have histone binding activity. Is expressed in germ cell. Is an ortholog of human TP53BP1 (tumor protein p53 binding protein 1).

WB:WBGene00002028	hst-1
Is predicted to have [heparan sulfate]-glucosamine N-sulfotransferase activity; deacetylase activity; and heparan sulfate N-acetylglucosaminyltransferase activity. Is an ortholog of human NDST1 (N-deacetylase and N-sulfotransferase 1); NDST2 (N-deacetylase and N-sulfotransferase 2); and NDST4 (N-deacetylase and N-sulfotransferase 4).

WB:WBGene00002029	hst-2
Exhibits heparan sulfate 2-O-sulfotransferase activity. Is involved in several processes, including heparan sulfate proteoglycan biosynthetic process, enzymatic modification; regulation of axon guidance; and regulation of cell migration. Is expressed in several structures, including P6.paa; P6.pap; P6.ppa; hermaphrodite distal tip cell; and somatic nervous system. Is an ortholog of human HS2ST1 (heparan sulfate 2-O-sulfotransferase 1).

WB:WBGene00002030	hst-3.1
Is predicted to have [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity. Is involved in heparan sulfate proteoglycan biosynthetic process. Is expressed in several structures, including coelomocyte; distal tip cell; neurons; non-striated muscle; and rectal epithelial cell. Is an ortholog of human HS3ST5 (heparan sulfate-glucosamine 3-sulfotransferase 5).

WB:WBGene00002031	hst-6
Is predicted to have heparan sulfate 6-O-sulfotransferase activity. Is involved in heparan sulfate proteoglycan biosynthetic process, enzymatic modification and regulation of growth. Is expressed in AIBL; AIBR; RIML; RIMR; and neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 15 with or without anosmia. Is an ortholog of human HS6ST1 (heparan sulfate 6-O-sulfotransferase 1) and HS6ST3 (heparan sulfate 6-O-sulfotransferase 3).

WB:WBGene00002032	htp-1
Is involved in regulation of centriole-centriole cohesion. Localizes to lateral element. Is an ortholog of human HORMAD1 (HORMA domain containing 1) and HORMAD2 (HORMA domain containing 2).

WB:WBGene00002033	htp-2
Is involved in regulation of centriole-centriole cohesion. Localizes to lateral element. Is an ortholog of human HORMAD1 (HORMA domain containing 1) and HORMAD2 (HORMA domain containing 2).

WB:WBGene00002034	htp-3
Is involved in meiotic DNA double-strand break formation and synapsis. Localizes to lateral element and nuclear chromatin. Is expressed in Z2; Z3; embryonic cell; germ line; and neurons.

WB:WBGene00002035	hum-1
Is predicted to have actin filament binding activity; actin-dependent ATPase activity; and microfilament motor activity. Human ortholog(s) of this gene are implicated in focal segmental glomerulosclerosis 6. Is an ortholog of human MYO1E (myosin IE).

WB:WBGene00002036	hum-2
Is predicted to have actin filament binding activity; actin-dependent ATPase activity; and microfilament motor activity. Is expressed in DB1. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYO5A (myosin VA); MYO5B (myosin VB); and MYO5C (myosin VC).

WB:WBGene00002037	hum-4
Exhibits calmodulin binding activity. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYO15A (myosin XVA).

WB:WBGene00002038	hum-5
Is predicted to have actin filament binding activity; actin-dependent ATPase activity; and microfilament motor activity. Is expressed in head and tail. Is an ortholog of human MYO1D (myosin ID) and MYO1G (myosin IG).

WB:WBGene00002039	hum-6
Exhibits transcription factor binding activity. Human ortholog(s) of this gene are implicated in Usher syndrome type 1; autosomal dominant nonsyndromic deafness 11; and autosomal recessive nonsyndromic deafness 2. Is an ortholog of human MYO7A (myosin VIIA).

WB:WBGene00002040	hum-7
Exhibits calmodulin binding activity and plus-end directed microfilament motor activity. Is involved in actin-myosin filament sliding. Is expressed in accessory cell; pharynx; pm6; pm7; and terminal bulb. Human ortholog(s) of this gene are implicated in several diseases, including Carney complex; distal arthrogryposis (multiple); and inclusion body myositis. Is an ortholog of human MYO9B (myosin IXB).

WB:WBGene00002041	hum-8
Is predicted to have actin filament binding activity; actin-dependent ATPase activity; and microfilament motor activity. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYO6 (myosin VI).

WB:WBGene00002042	hus-1
Is involved in several processes, including DNA metabolic process; chromosome segregation; and intrinsic apoptotic signaling pathway in response to DNA damage. Localizes to germ cell nucleus and nuclear chromatin. Is expressed in germ line. Is an ortholog of human HUS1 (HUS1 checkpoint clamp component).

WB:WBGene00002043	hyl-1
Is predicted to have sphingosine N-acyltransferase activity. Is involved in regulation of locomotion. Localizes to axon. Is expressed in motor neurons. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 9. Is an ortholog of human CERS2 (ceramide synthase 2); CERS5 (ceramide synthase 5); and CERS6 (ceramide synthase 6).

WB:WBGene00002044	hyl-2
Is predicted to have N-acyltransferase activity. Is expressed in head; hypodermis; intestine; tail; and terminal bulb. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 9. Is an ortholog of human CERS2 (ceramide synthase 2); CERS5 (ceramide synthase 5); and CERS6 (ceramide synthase 6).

WB:WBGene00002045	icd-1
Is involved in embryo development and negative regulation of apoptotic process. Localizes to mitochondrion. Is expressed in several structures, including germ line; intestine; pharynx; preanal ganglion; and somatic nervous system. Is an ortholog of human BTF3 (basic transcription factor 3).

WB:WBGene00002046	icln-1
Is enriched in germ line; intestine; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; D-glucose; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Regulator of volume decrease after cellular swelling; ICln; PH-like domain superfamily; and ICln/Lot5. Is an ortholog of human CLNS1A (chloride nucleotide-sensitive channel 1A).

WB:WBGene00002047	icp-1
Exhibits protein serine/threonine kinase activator activity. Is involved in several processes, including female meiotic nuclear division; mitotic nuclear division; and positive regulation of protein serine/threonine kinase activity. Localizes to kinetochore and nucleus. Is an ortholog of human INCENP (inner centromere protein).

WB:WBGene00002048	ida-1
Is predicted to have transmembrane receptor protein tyrosine phosphatase activity. Is involved in positive regulation of anterior/posterior axon guidance; positive regulation of neurotransmitter secretion; and ventral cord development. Localizes to dense core granule and synapse. Is expressed in several structures, including buccal cavity; neurons; preanal ganglion; somatic nervous system; and uv1. Is used to study Parkinson's disease and diabetes mellitus. Is an ortholog of human PTPRN (protein tyrosine phosphatase receptor type N) and PTPRN2 (protein tyrosine phosphatase receptor type N2).

WB:WBGene00002049	idf-1
Is involved in body morphogenesis and syncytium formation by plasma membrane fusion.

WB:WBGene00002050	ifa-1
Localizes to intermediate filament. Is expressed in several structures, including egg-laying apparatus; excretory cell; neurons; pharyngeal-intestinal valve; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is an ortholog of human LMNA (lamin A/C) and LMNB2 (lamin B2).

WB:WBGene00002051	ifa-3
Is expressed in hypodermis and ventral cord neurons. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Intermediate filament protein; Lamin Tail Domain; Lamin tail domain; Intermediate filament, ifa/ifb; Lamin tail domain superfamily; Intermediate filament, rod domain; and Intermediate filament, rod domain, coil 1B. Is an ortholog of human LMNA (lamin A/C); LMNB1 (lamin B1); and LMNB2 (lamin B2).

WB:WBGene00002052	ifa-4
Is expressed in several structures, including egg-laying apparatus; excretory canal; pharyngeal-intestinal valve; rectum; and spermathecal-uterine valve cell. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is predicted to encode a protein with the following domains: Lamin Tail Domain; Intermediate filament protein; Lamin tail domain; Intermediate filament, ifa/ifb; Lamin tail domain superfamily; Intermediate filament, rod domain; and Intermediate filament, rod domain, coil 1B. Is an ortholog of human LMNB2 (lamin B2).

WB:WBGene00002053	ifb-1
Localizes to apical plasma membrane. Is expressed in several structures, including egg-laying apparatus; excretory system; pharyngeal-intestinal valve; pharynx; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is an ortholog of human LMNA (lamin A/C) and LMNB2 (lamin B2).

WB:WBGene00002054	ifb-2
Localizes to apical cortex and terminal web. Is expressed in intestine. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is an ortholog of human LMNB2 (lamin B2).

WB:WBGene00002055	ifc-1
Is expressed in hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Intermediate filament protein; Intermediate filament, rod domain; and Intermediate filament, rod domain, coil 1B. Is an ortholog of human KRT1 (keratin 1); KRT71 (keratin 71); and KRT76 (keratin 76).

WB:WBGene00002056	ifc-2
Localizes to cytoplasm and desmosome. Is expressed in hypodermis; intestinal cell; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is an ortholog of several human genes including KRT71 (keratin 71); KRT73 (keratin 73); and KRT77 (keratin 77).

WB:WBGene00002057	ifd-1
Is expressed in intestine. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Lamin Tail Domain; Intermediate filament protein; Lamin tail domain; Lamin tail domain superfamily; Intermediate filament, rod domain; and Intermediate filament, rod domain, coil 1B. Is an ortholog of human LMNA (lamin A/C) and LMNB1 (lamin B1).

WB:WBGene00002058	ifd-2
Is enriched in ASER; head mesodermal cell; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including methylmercuric chloride; D-glucopyranose; and Zidovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Intermediate filament protein; Intermediate filament, rod domain; and Intermediate filament, rod domain, coil 1B. Is an ortholog of human KRT85 (keratin 85); LMNA (lamin A/C); and LMNB1 (lamin B1).

WB:WBGene00002059	ife-1
Exhibits RNA 7-methylguanosine cap binding activity and RNA trimethylguanosine cap binding activity. Is involved in embryo development; oocyte maturation; and spermatid development. Localizes to P granule. Is expressed in germ line and gonad. Is an ortholog of human EIF4E (eukaryotic translation initiation factor 4E) and EIF4E1B (eukaryotic translation initiation factor 4E family member 1B).

WB:WBGene00002060	ife-2
Exhibits RNA 7-methylguanosine cap binding activity and RNA trimethylguanosine cap binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of response to oxidative stress; and positive regulation of translation. Localizes to cytoplasmic stress granule. Is expressed in several structures, including excretory canal; germ line; pharynx; spermatheca; and vulva. Is an ortholog of human EIF4E (eukaryotic translation initiation factor 4E) and EIF4E1B (eukaryotic translation initiation factor 4E family member 1B).

WB:WBGene00002061	ife-3
Exhibits RNA 7-methylguanosine cap binding activity. Is involved in embryo development. Is expressed in germ line. Is an ortholog of human EIF4E (eukaryotic translation initiation factor 4E) and EIF4E1B (eukaryotic translation initiation factor 4E family member 1B).

WB:WBGene00002062	ife-4
Exhibits RNA 7-methylguanosine cap binding activity. Is expressed in several structures, including HSN; pharyngeal cell; somatic cell; somatic gonad precursor; and somatic nervous system. Is an ortholog of human EIF4E2 (eukaryotic translation initiation factor 4E family member 2).

WB:WBGene00002063	ife-5
Exhibits RNA 7-methylguanosine cap binding activity and RNA trimethylguanosine cap binding activity. Is involved in embryo development. Is expressed in germ line. Is an ortholog of human EIF4E (eukaryotic translation initiation factor 4E) and EIF4E1B (eukaryotic translation initiation factor 4E family member 1B).

WB:WBGene00002064	iff-1
Is predicted to have translation elongation factor activity. Is involved in gamete generation and protein localization. Is expressed in germ line and gonad. Is an ortholog of human EIF5A (eukaryotic translation initiation factor 5A) and EIF5A2 (eukaryotic translation initiation factor 5A2).

WB:WBGene00002065	iff-2
Is predicted to have translation elongation factor activity. Is involved in several processes, including gonad morphogenesis; nematode larval development; and nematode male tail tip morphogenesis. Is expressed in excretory cell; hypodermis; pharynx; rectal muscle; and spermatheca. Is an ortholog of human EIF5A (eukaryotic translation initiation factor 5A) and EIF5A2 (eukaryotic translation initiation factor 5A2).

WB:WBGene00002066	ifg-1
Is predicted to have mRNA binding activity and translation initiation factor activity. Localizes to cytosol and eukaryotic translation initiation factor 4F complex. Is expressed in several structures, including gonad. Is an ortholog of human EIF4G3 (eukaryotic translation initiation factor 4 gamma 3).

WB:WBGene00002067	ifp-1
Is expressed in head; head neurons; intestine; pharynx; and ventral nerve cord. Is predicted to encode a protein with the following domains: Phosphorylation site; Intermediate filament protein; Lamin tail domain superfamily; Intermediate filament, rod domain; and Intermediate filament, rod domain, coil 1B.

WB:WBGene00002068	ify-1
Exhibits protease binding activity and ubiquitin protein ligase binding activity. Is involved in several processes, including cortical granule exocytosis; nuclear division; and protein stabilization. Localizes to condensed chromosome; cytoplasm; and spindle microtubule. Is expressed in germ cell.

WB:WBGene00002069	ikb-1
Is involved in defense response to Gram-negative bacterium. Localizes to cytoplasm. Is an ortholog of human BCL3 (BCL3 transcription coactivator).

WB:WBGene00002070	ile-1
Is predicted to have mannose binding activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human LMAN1 (lectin, mannose binding 1).

WB:WBGene00002071	ile-2
Is predicted to have mannose binding activity. Is an ortholog of human LMAN2 (lectin, mannose binding 2).

WB:WBGene00002072	ima-1
Exhibits nuclear import signal receptor activity. Is involved in protein import into nucleus. Localizes to cytoplasm; nuclear pore; and nucleoplasm. Is expressed in germ line.

WB:WBGene00002073	ima-2
Exhibits nuclear import signal receptor activity. Is involved in several processes, including mitotic nuclear envelope reassembly; protein import into nucleus; and regulation of chromosome segregation. Localizes to cytoplasm and nuclear envelope. Is expressed in Z2; Z3; and germ line. Is an ortholog of human KPNA2 (karyopherin subunit alpha 2) and KPNA7 (karyopherin subunit alpha 7).

WB:WBGene00002074	ima-3
Exhibits nuclear import signal receptor activity. Is involved in several processes, including nematode larval development; nuclear pore organization; and protein import into nucleus. Localizes to cytoplasm and nuclear pore. Is expressed in germ line; gonad; hypodermis; muscle cell; and neurons. Is an ortholog of human KPNA3 (karyopherin subunit alpha 3) and KPNA4 (karyopherin subunit alpha 4).

WB:WBGene00002075	imb-1
Is predicted to have nuclear import signal receptor activity and nuclear localization sequence binding activity. Is involved in embryo development and reproduction. Is an ortholog of human KPNB1 (karyopherin subunit beta 1).

WB:WBGene00002076	imb-2
Is predicted to have nuclear import signal receptor activity and nuclear localization sequence binding activity. Is an ortholog of human TNPO1 (transportin 1) and TNPO2 (transportin 2).

WB:WBGene00002077	imb-3
Is predicted to have nuclear import signal receptor activity and nuclear localization sequence binding activity. Is an ortholog of human IPO5 (importin 5) and RANBP6 (RAN binding protein 6).

WB:WBGene00002078	xpo-1
Is predicted to have nuclear export signal receptor activity. Is an ortholog of human XPO1 (exportin 1).

WB:WBGene00002079	xpo-2
Is predicted to have nuclear export signal receptor activity. Is an ortholog of human CSE1L (chromosome segregation 1 like).

WB:WBGene00002080	xpo-3
Is predicted to have Ran GTPase binding activity and tRNA binding activity. Is an ortholog of human XPOT (exportin for tRNA).

WB:WBGene00002081	ina-1
Exhibits transmembrane signaling receptor activity. Is involved in several processes, including cell-cell adhesion mediated by integrin; generation of neurons; and nematode male tail tip morphogenesis. Localizes to integrin complex and phagocytic cup. Is expressed in several structures, including distal tip cell; hermaphrodite gonad; male-specific anatomical entity; pharynx; and vulE. Is used to study epilepsy. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy due to integrin alpha-7 deficiency; inherited blood coagulation disease (multiple); and junctional epidermolysis bullosa with pyloric atresia. Is an ortholog of human ITGA3 (integrin subunit alpha 3); ITGA6 (integrin subunit alpha 6); and ITGA7 (integrin subunit alpha 7).

WB:WBGene00002082	inb-1
No description available

WB:WBGene00002083	inf-1
Is predicted to have RNA helicase activity and translation initiation factor activity. Is expressed in germ line; intestine; and neurons. Is an ortholog of human EIF4A1 (eukaryotic translation initiation factor 4A1).

WB:WBGene00002084	ins-1
Is predicted to have hormone activity. Is involved in several processes, including learning or memory; negative regulation of insulin receptor signaling pathway; and regulation of dauer entry. Localizes to several cellular components, including cytoplasmic vesicle; neuron projection; and neuronal cell body. Is expressed in several structures, including distal tip cell; egg-laying apparatus; head muscle; neurons; and somatic nervous system.

WB:WBGene00002085	ins-2
Is predicted to have hormone activity. Is involved in negative regulation of dauer entry. Is expressed in amphid sensillum; ciliated neurons; head muscle; intestine; and nerve ring.

WB:WBGene00002086	ins-3
Is predicted to have hormone activity. Is involved in dauer larval development and negative regulation of dauer entry. Is expressed in several structures, including coelomocyte; egg-laying apparatus; gonad; head muscle; and nervous system.

WB:WBGene00002087	ins-4
Is predicted to have hormone activity. Is involved in dauer larval development; negative regulation of dauer entry; and regulation of synaptic growth at neuromuscular junction. Is expressed in several structures, including gonad; head muscle; neurons; somatic nervous system; and vulva.

WB:WBGene00002088	ins-5
Is predicted to have hormone activity. Is involved in dauer larval development. Is expressed in several structures, including coelomocyte; head muscle; neurons; somatic nervous system; and vulva.

WB:WBGene00002089	ins-6
Exhibits insulin receptor binding activity. Is involved in several processes, including insulin receptor signaling pathway; negative regulation of dauer entry; and olfactory learning. Is expressed in several structures, including ciliated neurons; coelomocyte; head muscle; somatic nervous system; and tail.

WB:WBGene00002090	ins-7
Is predicted to have hormone activity. Is involved in olfactory learning. Is expressed in several structures, including distal tip cell; egg-laying apparatus; head muscle; neurons; and somatic nervous system.

WB:WBGene00002091	ins-8
Is predicted to have hormone activity. Is expressed in several structures, including egg-laying apparatus; gonad; head muscle; neurons; and somatic nervous system.

WB:WBGene00002092	ins-9
Is predicted to have hormone activity. Is expressed in coelomocyte; intestine; nerve ring; and neurons.

WB:WBGene00002093	ins-10
Is expressed in several structures, including coelomocyte; head muscle; neurons; ventral nerve cord; and vulva.

WB:WBGene00002094	ins-11
Is involved in innate immune response. Is expressed in several structures, including coelomocyte; distal tip cell; head muscle; neurons; and somatic nervous system.

WB:WBGene00002095	ins-12
Is expressed in head neurons; motor neurons; nerve ring neurons; rectum; and sensory neurons. Is predicted to encode a protein with the following domain: Insulin-like superfamily.

WB:WBGene00002096	ins-13
Is predicted to have hormone activity. Is expressed in intestine; neurons; and rectum.

WB:WBGene00002097	ins-14
Is expressed in head neurons; motor neurons; nerve ring neurons; and sensory neurons. Is predicted to encode a protein with the following domain: Insulin-like superfamily.

WB:WBGene00002098	ins-15
Is predicted to have hormone activity. Is expressed in several structures, including egg-laying apparatus; gonad; head muscle; neurons; and ventral nerve cord.

WB:WBGene00002099	ins-16
Is expressed in distal tip cell; intestine; neurons; and pharynx. Is predicted to encode a protein with the following domain: Insulin-like superfamily.

WB:WBGene00002100	ins-17
Is involved in dauer larval development. Is expressed in several structures, including egg-laying apparatus; gonad; head muscle; neurons; and somatic nervous system.

WB:WBGene00002101	ins-18
Is involved in maintenance of dauer; negative regulation of insulin receptor signaling pathway; and regulation of dauer entry. Is expressed in several structures, including coelomocyte; gonad; head muscle; nerve ring; and neurons.

WB:WBGene00002102	ins-19
Is predicted to have hormone activity.

WB:WBGene00002103	ins-20
Is predicted to have hormone activity. Is expressed in head neurons and sensory neurons.

WB:WBGene00002104	ins-21
Is expressed in intestine; nerve ring; neurons; spermatheca; and vulval muscle.

WB:WBGene00002105	ins-22
Is expressed in nervous system; pharynx; rectum; and vulval muscle.

WB:WBGene00002106	ins-23
Is predicted to have hormone activity. Is expressed in gonad; neurons; non-striated muscle; pharynx; and somatic nervous system.

WB:WBGene00002107	ins-24
Is predicted to have hormone activity.

WB:WBGene00002108	ins-25
Is predicted to have hormone activity. Is expressed in motor neurons; nerve ring neurons; and tail neurons.

WB:WBGene00002109	ins-26
Is predicted to have hormone activity. Is expressed in several structures, including coelomocyte; head muscle; intestine; neurons; and ventral nerve cord.

WB:WBGene00002110	ins-27
Is predicted to have hormone activity. Is expressed in body wall musculature; distal tip cell; hypodermis; and non-striated muscle.

WB:WBGene00002111	ins-28
Is predicted to have hormone activity. Is expressed in coelomocyte; intestine; neurons; and vulva.

WB:WBGene00002112	ins-29
Is predicted to have hormone activity. Is expressed in coelomocyte; head neurons; pharynx; and sensory neurons.

WB:WBGene00002113	ins-30
Is predicted to have hormone activity. Is expressed in head muscle; intestine; neurons; and ventral nerve cord.

WB:WBGene00002114	ins-31
Is predicted to have hormone activity. Is expressed in coelomocyte; male gonad; and seminal vesicle.

WB:WBGene00002115	ins-32
Is predicted to have hormone activity. Is expressed in intestine and nervous system.

WB:WBGene00002116	ins-33
Is predicted to have hormone activity. Is expressed in head muscle; head neurons; and tail.

WB:WBGene00002117	ins-34
Is expressed in several structures, including coelomocyte; head muscle; intestine; uterus; and ventral nerve cord.

WB:WBGene00002118	ins-35
Is expressed in neurons; rectum; and ventral nerve cord.

WB:WBGene00002119	ins-36
Is expressed in several structures, including coelomocyte; head muscle; intestine; neurons; and ventral nerve cord.

WB:WBGene00002120	ins-37
Is predicted to have hormone activity. Is expressed in intestine.

WB:WBGene00002121	ins-38
Is expressed in coelomocyte; neurons; and ventral nerve cord.

WB:WBGene00002123	inx-1
Is predicted to have gap junction channel activity. Localizes to gap junction. Is expressed in neurons and pm1.

WB:WBGene00002124	inx-2
Is predicted to have gap junction hemi-channel activity. Is expressed in AVK; intestine; pharyngeal-intestinal valve; and pharynx.

WB:WBGene00002125	inx-3
Is predicted to have gap junction hemi-channel activity. Is involved in embryonic morphogenesis. Localizes to cytoplasm and gap junction. Is expressed in several structures, including arcade cell; cephalic sheath cell; neurons; pharyngeal cell; and rectum.

WB:WBGene00002127	inx-5
Is predicted to have gap junction hemi-channel activity. Is expressed in hermaphrodite gonad; interfacial epithelial cell; interneuron; and intestine.

WB:WBGene00002128	inx-6
Is predicted to have gap junction hemi-channel activity. Is expressed in head neurons; pharyngeal cell; and rectal valve cell.

WB:WBGene00002129	inx-7
Is predicted to have gap junction hemi-channel activity. Is expressed in g1AR; g1P; neurons; pharyngeal cell; and rectal gland cell.

WB:WBGene00002130	inx-8
Is predicted to have gap junction hemi-channel activity. Localizes to gap junction. Is expressed in several structures, including egg-laying apparatus; ganglia; gonad; pharyngeal muscle cell; and spermatocyte.

WB:WBGene00002131	inx-9
Is predicted to have gap junction channel activity. Localizes to gap junction. Is expressed in several structures, including gonad; interfacial epithelial cell; nerve ring neurons; pharyngeal cell; and spermatocyte.

WB:WBGene00002132	inx-10
Is predicted to have gap junction hemi-channel activity. Localizes to gap junction. Is expressed in several structures, including DD neuron; hermaphrodite gonad; interneuron; pharyngeal cell; and rectal epithelium.

WB:WBGene00002133	inx-11
Is predicted to have gap junction hemi-channel activity. Localizes to gap junction. Is expressed in several structures, including egg-laying apparatus; epithelial cell; pharynx; spermatocyte; and tail neurons.

WB:WBGene00002134	inx-12
Is predicted to have gap junction hemi-channel activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is expressed in several structures, including head ganglion; interfacial epithelial cell; neurons; posterior lateral ganglion; and tail hypodermis.

WB:WBGene00002135	inx-13
Is predicted to have gap junction channel activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is expressed in several structures, including CAN; amphid sheath cell; ganglia; pharyngeal motor neurons; and tail hypodermis.

WB:WBGene00002136	inx-14
Is predicted to have gap junction hemi-channel activity. Is involved in negative regulation of oocyte maturation. Localizes to gap junction. Is expressed in several structures, including GABAergic neurons; germ cell; germ line; non-striated muscle; and somatic gonad precursor.

WB:WBGene00002137	inx-15
Is predicted to have gap junction channel activity. Is expressed in intestine.

WB:WBGene00002138	inx-16
Is predicted to have gap junction hemi-channel activity. Is involved in calcium-mediated signaling; regulation of defecation rhythm; and regulation of neuromuscular synaptic transmission. Localizes to gap junction. Is expressed in intestine.

WB:WBGene00002139	inx-17
Is predicted to have gap junction hemi-channel activity. Is expressed in nerve ring neurons and rectal valve cell.

WB:WBGene00002140	inx-18
Is predicted to have gap junction channel activity. Localizes to gap junction. Is expressed in g1AL; g1AR; g1P; head neurons; and interneuron.

WB:WBGene00002141	inx-19
Exhibits calcium channel inhibitor activity; gap junction hemi-channel activity; and protein kinase inhibitor activity. Is involved in several processes, including determination of left/right asymmetry in nervous system; inactivation of MAPKKK activity; and intercellular transport. Localizes to gap junction and neuronal cell body membrane. Is expressed in several structures, including K' cell; head neurons; hermaphrodite distal tip cell; intestine; and lumbar neurons.

WB:WBGene00002142	inx-20
Is predicted to have gap junction channel activity. Is expressed in pharyngeal cell and rectal valve cell.

WB:WBGene00002143	inx-21
Is predicted to have gap junction channel activity. Localizes to gap junction. Is expressed in several structures, including Z2; Z3; germ cell; intestine; and somatic gonad precursor.

WB:WBGene00002144	inx-22
Is predicted to have gap junction channel activity. Is involved in negative regulation of oocyte maturation. Localizes to gap junction. Is expressed in several structures, including GLR; germ cell; germ line; gonad; and somatic gonad precursor.

WB:WBGene00002145	ipp-2
No description available

WB:WBGene00002146	ipp-5
Is predicted to have inositol-polyphosphate 5-phosphatase activity. Is involved in several processes, including hermaphrodite genitalia morphogenesis; inositol phosphate-mediated signaling; and ovulation. Is expressed in spermatheca. Is an ortholog of human INPP5A (inositol polyphosphate-5-phosphatase A).

WB:WBGene00002147	ire-1
Exhibits endoribonuclease activity. Is involved in several processes, including endoplasmic reticulum unfolded protein response; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; and positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress. Localizes to neuronal cell body. Is expressed widely. Is an ortholog of human ERN1 (endoplasmic reticulum to nucleus signaling 1).

WB:WBGene00002148	gon-14
Exhibits signaling receptor binding activity. Is involved in several processes, including defecation; gonad morphogenesis; and negative regulation of vulval development. Localizes to nucleus. Is expressed in several structures, including amphid socket cell; anal sphincter muscle; gonad; pharyngeal segment; and somatic gonad precursor.

WB:WBGene00002149	irk-1
Exhibits inward rectifier potassium channel activity. Is involved in regulation of G protein-coupled receptor signaling pathway and regulation of oviposition. Localizes to neuron projection and neuronal cell body. Is expressed in egg-laying apparatus and neurons. Human ortholog(s) of this gene are implicated in several diseases, including diabetes mellitus (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of several human genes including KCNJ14 (potassium inwardly rectifying channel subfamily J member 14); KCNJ18 (potassium inwardly rectifying channel subfamily J member 18); and KCNJ4 (potassium inwardly rectifying channel subfamily J member 4).

WB:WBGene00002150	irk-2
Is predicted to have inward rectifier potassium channel activity. Human ortholog(s) of this gene are implicated in several diseases, including diabetes mellitus (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNJ5 (potassium inwardly rectifying channel subfamily J member 5).

WB:WBGene00002151	irk-3
Is predicted to have inward rectifier potassium channel activity. Is involved in short-term memory. Human ortholog(s) of this gene are implicated in several diseases, including diabetes mellitus (multiple); heart conduction disease (multiple); and long QT syndrome (multiple).

WB:WBGene00002152	iars-1
Is predicted to have isoleucine-tRNA ligase activity. Is expressed in body wall musculature; hypodermis; and ventral nerve cord. Is an ortholog of human IARS1 (isoleucyl-tRNA synthetase 1).

WB:WBGene00002153	iars-2
Is predicted to have isoleucine-tRNA ligase activity. Is an ortholog of human IARS2 (isoleucyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00002162	isp-1
Is predicted to contribute to ubiquinol-cytochrome-c reductase activity. Is involved in several processes, including mitochondrial electron transport, ubiquinol to cytochrome c; regulation of gene expression; and regulation of protein phosphorylation. Is expressed in head and tail. Is an ortholog of human UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1).

WB:WBGene00002163	ist-1
Is predicted to have insulin receptor binding activity; phosphatidylinositol 3-kinase binding activity; and transmembrane receptor protein tyrosine kinase adaptor activity. Is involved in dauer larval development; insulin receptor signaling pathway; and short-term memory.

WB:WBGene00002169	isw-1
Is predicted to have ATPase activity; DNA binding activity; and transcription factor binding activity. Is involved in positive regulation of transcription by RNA polymerase II and positive regulation of vulval development. Localizes to nuclear chromatin. Is expressed in several structures, including head. Is an ortholog of human SMARCA1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1).

WB:WBGene00002173	itr-1
Exhibits myosin binding activity. Is involved in several processes, including hermaphrodite genitalia morphogenesis; mating; and positive regulation of pharyngeal pumping. Localizes to endoplasmic reticulum and membrane. Is expressed in several structures, including egg-laying apparatus; ganglia; gonad; non-striated muscle; and tail hypodermis. Human ortholog(s) of this gene are implicated in Gillespie syndrome; autosomal dominant cerebellar ataxia (multiple); and myopathy (multiple). Is an ortholog of human ITPR1 (inositol 1,4,5-trisphosphate receptor type 1).

WB:WBGene00002174	itx-1
Localizes to adherens junction and basolateral plasma membrane. Is expressed in anterior ganglion; intestine; spermatheca; and vulval muscle.

WB:WBGene00002175	jac-1
Exhibits cadherin binding activity. Is involved in embryonic body morphogenesis; regulation of actin cytoskeleton organization; and regulation of protein localization. Localizes to adherens junction and catenin complex. Is expressed in head. Human ortholog(s) of this gene are implicated in arrhythmogenic right ventricular dysplasia 9 and blepharocheilodontic syndrome 2. Is an ortholog of human ARVCF (ARVCF delta catenin family member).

WB:WBGene00002176	jip-1
Is enriched in head mesodermal cell; neurons; pharynx; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; allantoin; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 37 and type 2 diabetes mellitus. Is predicted to encode a protein with the following domains: Variant SH3 domain; Phosphotyrosine interaction domain (PTB/PID); SH3 domain; PTB/PI domain; PH-like domain superfamily; and SH3-like domain superfamily. Is an ortholog of human MAPK8IP1 (mitogen-activated protein kinase 8 interacting protein 1).

WB:WBGene00002177	jkk-1
Exhibits JUN kinase kinase activity. Is involved in activation of JUN kinase activity; hyperosmotic response; and locomotion. Localizes to axon; cytoplasm; and neuronal cell body. Is expressed in neurons. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 6 with or without polydactyly. Is an ortholog of human MAP2K7 (mitogen-activated protein kinase kinase 7).

WB:WBGene00002178	jnk-1
Exhibits JUN kinase activity and transcription factor binding activity. Is involved in several processes, including JUN phosphorylation; negative regulation of cellular response to manganese ion; and vesicle transport along actin filament. Localizes to several cellular components, including axon; neuronal cell body; and nucleus. Is expressed in AIYL; AIYR; and neurons. Is an ortholog of human MAPK10 (mitogen-activated protein kinase 10) and MAPK8 (mitogen-activated protein kinase 8).

WB:WBGene00002179	jph-1
Is predicted to have structural molecule activity. Is involved in locomotion and positive regulation of engulfment of apoptotic cell. Is expressed in body wall musculature; muscle cell; and nerve ring. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2K; Huntington's disease-like 2; and hypertrophic cardiomyopathy 17. Is an ortholog of human JPH1 (junctophilin 1) and JPH3 (junctophilin 3).

WB:WBGene00002180	jtr-1
Is enriched in Psub1; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human JTB exhibits protein kinase binding activity. Is predicted to encode a protein with the following domains: Jumping translocation breakpoint protein (JTB) and Jumping translocation breakpoint. Is an ortholog of human JTB (jumping translocation breakpoint).

WB:WBGene00002181	kal-1
Exhibits heparan sulfate proteoglycan binding activity; heparin binding activity; and syndecan binding activity. Is involved in several processes, including epidermis morphogenesis; generation of neurons; and nematode male tail tip morphogenesis. Localizes to cell surface. Is expressed in several structures, including egg-laying apparatus; excretory cell; nerve ring; neuroblasts; and neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 1 with or without anosmia. Is an ortholog of human ANOS1 (anosmin 1).

WB:WBGene00002182	kap-1
Contributes to microtubule motor activity. Is involved in intraciliary anterograde transport; negative regulation of non-motile cilium assembly; and positive regulation of non-motile cilium assembly. Localizes to axonemal heterotrimeric kinesin-II complex; ciliary transition zone; and non-motile cilium. Is expressed in ciliated neurons. Is an ortholog of human KIFAP3 (kinesin associated protein 3).

WB:WBGene00002183	kat-1
Is predicted to have acetyl-CoA C-acetyltransferase activity. Localizes to mitochondrion. Is expressed in body wall musculature. Is used to study obesity. Human ortholog(s) of this gene are implicated in beta-ketothiolase deficiency. Is an ortholog of human ACAT1 (acetyl-CoA acetyltransferase 1).

WB:WBGene00002184	kel-1
Is expressed in g1. Is predicted to encode a protein with the following domains: Kelch motif; Kelch repeat type 1; and Kelch-type beta propeller. Is an ortholog of human KLHL2 (kelch like family member 2) and KLHL3 (kelch like family member 3).

WB:WBGene00002185	kel-3
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Kelch motif; BTB And C-terminal Kelch; BTB/POZ domain; BTB/POZ domain; Kelch repeat type 1; SKP1/BTB/POZ domain superfamily; BTB/Kelch-associated; Kelch-type beta propeller; and BTB-kelch protein. Is an ortholog of human KLHL18 (kelch like family member 18).

WB:WBGene00002186	kel-10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; methylmercury hydroxide; and nicotinic acid based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in spermatogenic failure 11. Is predicted to encode a protein with the following domains: BTB And C-terminal Kelch; Kelch motif; BTB/POZ domain; BTB/POZ domain; Kelch repeat type 1; SKP1/BTB/POZ domain superfamily; BTB/Kelch-associated; Kelch-type beta propeller; and BTB-kelch protein. Is an ortholog of human KLHL10 (kelch like family member 10).

WB:WBGene00002187	kgb-1
Exhibits several functions, including DEAD/H-box RNA helicase binding activity; JUN kinase activity; and RNA polymerase II repressing transcription factor binding activity. Is involved in several processes, including gamete generation; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding activity; and positive regulation of macromolecule metabolic process. Localizes to cytoplasm. Is expressed in several structures, including excretory cell; germ line; gonad; nerve ring; and tail ganglion. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10. Is an ortholog of human MAPK10 (mitogen-activated protein kinase 10).

WB:WBGene00002188	kgb-2
Is predicted to have JUN kinase activity. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10. Is an ortholog of human MAPK10 (mitogen-activated protein kinase 10).

WB:WBGene00002189	kin-1
Exhibits cAMP-dependent protein kinase activity. Is involved in positive regulation of oocyte maturation and protein phosphorylation. Is expressed in several structures, including excretory cell; gonad; head muscle; intestine; and ventral cord neurons. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 19 and primary pigmented nodular adrenocortical disease. Is an ortholog of human PRKACA (protein kinase cAMP-activated catalytic subunit alpha) and PRKACB (protein kinase cAMP-activated catalytic subunit beta).

WB:WBGene00002190	kin-2
Is predicted to have 3',5'-cyclic-GMP phosphodiesterase activity and cAMP-dependent protein kinase regulator activity. Is involved in several processes, including medium-term memory; negative regulation of oocyte maturation; and negative regulation of protein kinase C signaling. Localizes to cAMP-dependent protein kinase complex; cytosol; and membrane. Is expressed in body wall musculature; hypodermis; and intestine. Human ortholog(s) of this gene are implicated in Carney complex; acrodysostosis; and primary pigmented nodular adrenocortical disease. Is an ortholog of human PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta).

WB:WBGene00002191	kin-3
Exhibits protein serine/threonine kinase activity. Is involved in peptidyl-serine phosphorylation; response to hermaphrodite contact; and vulval location. Localizes to several cellular components, including neuronal cell body; non-motile cilium; and protein kinase CK2 complex. Is an ortholog of human CSNK2A1 (casein kinase 2 alpha 1).

WB:WBGene00002192	kin-4
Is predicted to have protein serine/threonine kinase activity. Is expressed in head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations. Is an ortholog of human MAST1 (microtubule associated serine/threonine kinase 1) and MAST4 (microtubule associated serine/threonine kinase family member 4).

WB:WBGene00002193	kin-5
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00002194	kin-6
Is affected by several genes including daf-12; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and Sodium Chloride based on microarray and RNA-seq studies. Human FER exhibits epidermal growth factor receptor binding activity; lipid binding activity; and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00002195	kin-9
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00002196	kin-10
Is predicted to have protein kinase regulator activity. Is involved in response to hermaphrodite contact and vulval location. Localizes to several cellular components, including neuronal cell body; non-motile cilium; and protein kinase CK2 complex. Is expressed in germ cell; gonad; intestine; pharynx; and vulva. Is an ortholog of human CSNK2B (casein kinase 2 beta).

WB:WBGene00002197	kin-12
No description available

WB:WBGene00002198	kin-14
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is expressed in head neurons; marginal cell; pharyngeal muscle cell; pharyngeal-intestinal valve; and tail neurons. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00002199	kin-15
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is expressed in hyp6 and hyp7 syncytium. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including KIT (KIT proto-oncogene, receptor tyrosine kinase); PDGFRA (platelet derived growth factor receptor alpha); and PDGFRB (platelet derived growth factor receptor beta).

WB:WBGene00002200	kin-16
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is expressed in hyp6 and hyp7 syncytium. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including CSF1R (colony stimulating factor 1 receptor); KIT (KIT proto-oncogene, receptor tyrosine kinase); and PDGFRA (platelet derived growth factor receptor alpha).

WB:WBGene00002201	kin-18
Is predicted to have MAP kinase kinase kinase activity. Is involved in several processes, including negative regulation of MAP kinase activity; regulation of meiosis I; and regulation of pharyngeal pumping. Localizes to cell cortex. Is expressed in several structures, including alimentary muscle; excretory cell; intestine; nerve ring; and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in lung cancer. Is an ortholog of human TAOK2 (TAO kinase 2) and TAOK3 (TAO kinase 3).

WB:WBGene00002202	kin-19
Is predicted to have protein serine/threonine kinase activity. Is involved in Wnt signaling pathway, regulating spindle positioning and positive regulation of proteasomal ubiquitin-dependent protein catabolic process. Localizes to centrosome; cytoplasm; and nucleus. Is expressed in several structures, including BDU; marginal cell; seam cell; tail; and vulva. Is an ortholog of human CSNK1A1 (casein kinase 1 alpha 1).

WB:WBGene00002203	kin-20
Is predicted to have protein serine/threonine kinase activity. Is expressed in HSNL; HSNR; and seam cell. Human ortholog(s) of this gene are implicated in advanced sleep phase syndrome 2. Is an ortholog of human CSNK1D (casein kinase 1 delta).

WB:WBGene00002204	kin-21
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00002205	kin-23
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including KIT (KIT proto-oncogene, receptor tyrosine kinase); PDGFRA (platelet derived growth factor receptor alpha); and PDGFRB (platelet derived growth factor receptor beta).

WB:WBGene00002206	kin-24
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00002207	sid-3
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is involved in RNA interference. Localizes to cytoplasm. Is expressed in several structures, including excretory canal; intestine; phasmid neurons; rectal gland cell; and somatic cell. Is an ortholog of human TNK2 (tyrosine kinase non receptor 2).

WB:WBGene00002208	kin-26
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00002209	kin-27
No description available

WB:WBGene00002210	kin-29
Exhibits histone deacetylase inhibitor activity and protein serine/threonine kinase activity. Is involved in several processes, including dauer entry; positive regulation of growth rate; and transforming growth factor beta receptor signaling pathway. Localizes to cytoplasm and nucleus. Is expressed in several structures, including intestine; lateral ganglion; neurons; non-striated muscle; and ventral nerve cord. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 30. Is an ortholog of human SIK2 (salt inducible kinase 2).

WB:WBGene00002211	kin-30
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including KIT (KIT proto-oncogene, receptor tyrosine kinase); PDGFRA (platelet derived growth factor receptor alpha); and PDGFRB (platelet derived growth factor receptor beta).

WB:WBGene00002212	kin-31
Is expressed in body wall musculature.

WB:WBGene00002213	kin-32
Is predicted to have ATP binding activity and protein tyrosine kinase activity. Is expressed in body wall musculature; head mesodermal cell; head neurons; and uterine muscle. Is an ortholog of human PTK2 (protein tyrosine kinase 2) and PTK2B (protein tyrosine kinase 2 beta).

WB:WBGene00002214	klc-1
Is predicted to have microtubule motor activity. Is involved in establishment of meiotic spindle localization and polar body extrusion after meiotic divisions. Human ortholog(s) of this gene are implicated in SPOAN syndrome. Is an ortholog of human KLC1 (kinesin light chain 1).

WB:WBGene00002215	klc-2
Exhibits kinesin binding activity. Is involved in several processes, including axon extension; establishment of meiotic spindle localization; and polar body extrusion after meiotic divisions. Localizes to cytoplasm; kinesin I complex; and nuclear envelope. Is expressed in body ganglion; muscle cell; pharynx; and somatic nervous system. Human ortholog(s) of this gene are implicated in SPOAN syndrome. Is an ortholog of human KLC1 (kinesin light chain 1).

WB:WBGene00002216	klp-3
Is predicted to have ATPase activity; microtubule binding activity; and microtubule motor activity. Is involved in chromosome separation. Is expressed in marginal cell. Is an ortholog of human KIFC3 (kinesin family member C3).

WB:WBGene00002217	klp-4
Is predicted to have ATPase activity; microtubule binding activity; and microtubule motor activity. Localizes to axon; cytoplasmic microtubule; and neuronal cell body. Is expressed in dorsal nerve cord and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2A1; acrocallosal syndrome; and complex cortical dysplasia with other brain malformations 3. Is an ortholog of human KIF13A (kinesin family member 13A).

WB:WBGene00002218	klp-6
Is predicted to have ATPase activity; microtubule binding activity; and microtubule motor activity. Localizes to several cellular components, including dendrite; neuronal cell body; and non-motile cilium. Is expressed in ciliated neurons and head. Is used to study autosomal dominant polycystic kidney disease. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2A1; acrocallosal syndrome; and complex cortical dysplasia with other brain malformations 3.

WB:WBGene00002219	klp-7
Exhibits kinetochore binding activity. Is involved in several processes, including cytoskeleton organization; maintenance of centrosome location; and regulation of mitotic cell cycle. Localizes to centrosome; condensed chromosome kinetochore; and meiotic spindle pole. Colocalizes with chromosome. Is expressed in neurons. Human ortholog(s) of this gene are implicated in complex cortical dysplasia with other brain malformations 3. Is an ortholog of human KIF2A (kinesin family member 2A); KIF2B (kinesin family member 2B); and KIF2C (kinesin family member 2C).

WB:WBGene00002220	gcc-1
Is expressed in head. Is predicted to encode a protein with the following domains: Phosphorylation site; GRIP domain; and GRIP domain. Is an ortholog of human GCC1 (GRIP and coiled-coil domain containing 1).

WB:WBGene00002221	klp-10
Is enriched in germ line; head mesodermal cell; and intestine based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is an ortholog of human KIF15 (kinesin family member 15).

WB:WBGene00002222	klp-11
Exhibits microtubule motor activity. Is involved in microtubule-based movement. Localizes to axonemal heterotrimeric kinesin-II complex. Is expressed in amphid neurons; dorsal nerve cord; inner labial neurons; phasmid neurons; and ventral nerve cord. Is an ortholog of human KIF3B (kinesin family member 3B) and KIF3C (kinesin family member 3C).

WB:WBGene00002223	klp-12
Is predicted to have ATPase activity; microtubule binding activity; and microtubule motor activity. Is expressed in head. Human ortholog(s) of this gene are implicated in several diseases, including acrocallosal syndrome; complex cortical dysplasia with other brain malformations 3; and neuropathy (multiple). Is an ortholog of human KIF21A (kinesin family member 21A) and KIF21B (kinesin family member 21B).

WB:WBGene00002224	klp-13
Is predicted to have ATP-dependent microtubule motor activity, plus-end-directed and microtubule binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2A1; acrocallosal syndrome; and complex cortical dysplasia with other brain malformations 3. Is an ortholog of human KIF19 (kinesin family member 19).

WB:WBGene00002225	klp-15
Exhibits ATP-dependent microtubule motor activity, minus-end-directed. Is involved in chromosome segregation and microtubule-based movement. Is expressed in germ line and hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); hereditary sensory and autonomic neuropathy type 2 (multiple); and hereditary spastic paraplegia (multiple). Is an ortholog of human KIFC1 (kinesin family member C1).

WB:WBGene00002226	klp-16
Is predicted to have ATP-dependent microtubule motor activity and microtubule binding activity. Is involved in chromosome segregation. Localizes to neuronal cell body. Is expressed in several structures, including ABa; EMS; Psub2; germ line; and head. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); hereditary sensory and autonomic neuropathy type 2 (multiple); and hereditary spastic paraplegia (multiple). Is an ortholog of human KIFC1 (kinesin family member C1).

WB:WBGene00002227	klp-17
Is predicted to have ATP binding activity; microtubule binding activity; and microtubule motor activity. Is involved in chromosome segregation. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); hereditary sensory and autonomic neuropathy type 2 (multiple); and hereditary spastic paraplegia (multiple).

WB:WBGene00002228	klp-18
Is predicted to have ATPase activity; microtubule binding activity; and microtubule motor activity. Is involved in spindle assembly involved in meiosis. Localizes to cell cortex; microtubule; and spindle pole. Is expressed in Z2; Z3; and germ line. Is an ortholog of human KIF15 (kinesin family member 15).

WB:WBGene00002229	klp-19
Is predicted to have ATPase activity; microtubule binding activity; and microtubule motor activity. Is involved in meiotic chromosome condensation and meiotic spindle midzone assembly. Localizes to condensed nuclear chromosome; nucleoplasm; and spindle. Is expressed in germ line. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2A1; acrocallosal syndrome; and complex cortical dysplasia with other brain malformations (multiple). Is an ortholog of human KIF4A (kinesin family member 4A).

WB:WBGene00002230	klp-20
Exhibits microtubule motor activity. Is involved in microtubule-based movement. Localizes to axonemal heterotrimeric kinesin-II complex. Is expressed in ciliated neurons and head. Is an ortholog of human KIF3A (kinesin family member 3A).

WB:WBGene00002231	knl-1
Exhibits microtubule binding activity. Is involved in several processes, including cytoskeleton organization; meiotic chromosome segregation; and protein localization to kinetochore involved in kinetochore assembly. Localizes to chromatin and condensed chromosome outer kinetochore.

WB:WBGene00002232	kpc-1
Exhibits serine-type endopeptidase activity and signaling receptor binding activity. Is involved in several processes, including generation of neurons; negative regulation of dauer entry; and protein maturation. Localizes to neuronal cell body. Is expressed in several structures, including PVD; epithelial cell; nervous system; pharyngeal-intestinal valve; and pharynx. Is an ortholog of human FURIN (furin, paired basic amino acid cleaving enzyme).

WB:WBGene00002233	kqt-1
Exhibits potassium channel activity. Is involved in G protein-coupled acetylcholine receptor signaling pathway; intracellular signal transduction; and potassium ion transport. Is expressed in head neurons; pharyngeal muscle cell; and touch receptor neurons. Is used to study long QT syndrome and obsolete infantile epileptic encephalopathy. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNQ4 (potassium voltage-gated channel subfamily Q member 4).

WB:WBGene00002234	kqt-2
Is predicted to have calmodulin binding activity and delayed rectifier potassium channel activity. Is involved in defecation. Is expressed in amphid neurons; intestine; sensory neurons; tail; and in male. Human ortholog(s) of this gene are implicated in several diseases, including Beckwith-Wiedemann syndrome; heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNQ1 (potassium voltage-gated channel subfamily Q member 1).

WB:WBGene00002235	kqt-3
Exhibits potassium channel activity. Is involved in G protein-coupled acetylcholine receptor signaling pathway and potassium ion transport. Is expressed in head neurons; intestine; and sensory neurons. Is used to study Jervell-Lange Nielsen syndrome. Human ortholog(s) of this gene are implicated in several diseases, including Beckwith-Wiedemann syndrome; heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNQ1 (potassium voltage-gated channel subfamily Q member 1).

WB:WBGene00002238	kars-1
Is predicted to have lysine-tRNA ligase activity and tRNA binding activity. Is involved in several processes, including determination of adult lifespan; positive regulation of nematode larval development; and regulation of brood size. Is expressed in tail. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease recessive intermediate B and autosomal recessive nonsyndromic deafness 89. Is an ortholog of human KARS1 (lysyl-tRNA synthetase 1).

WB:WBGene00002239	ksr-1
Exhibits mitogen-activated protein kinase kinase binding activity and protein kinase activity. Is involved in several processes, including defense response to Gram-positive bacterium; myoblast migration; and positive regulation of vulval development. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human KSR1 (kinase suppressor of ras 1).

WB:WBGene00002240	ksr-2
Exhibits protein kinase activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of vulval development; and vulval development. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human KSR1 (kinase suppressor of ras 1) and KSR2 (kinase suppressor of ras 2).

WB:WBGene00002241	kup-1
Is enriched in intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00002242	kvs-1
Exhibits voltage-gated potassium channel activity. Is involved in several processes, including forward locomotion; hyperosmotic response; and mechanosensory behavior. Localizes to voltage-gated potassium channel complex. Is expressed in PDA; amphid neurons; anal depressor muscle; sperm; and ventral cord neurons. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNF1 (potassium voltage-gated channel modifier subfamily F member 1).

WB:WBGene00002243	lad-2
Exhibits semaphorin receptor activity. Is involved in anterior/posterior axon guidance; dorsal/ventral axon guidance; and regulation of axon guidance. Localizes to integral component of plasma membrane. Is expressed in cholinergic neurons. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and familial adult myoclonic epilepsy 5. Is an ortholog of human CHL1 (cell adhesion molecule L1 like) and L1CAM (L1 cell adhesion molecule).

WB:WBGene00002244	laf-1
Exhibits RNA strand annealing activity; RNA-dependent ATPase activity; and identical protein binding activity. Is involved in several processes, including masculinization of hermaphroditic germ-line; positive regulation of embryonic development; and positive regulation of fertilization. Localizes to P granule. Is expressed in germ line. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2. Is an ortholog of human DDX3X (DEAD-box helicase 3 X-linked) and DDX3Y (DEAD-box helicase 3 Y-linked).

WB:WBGene00002245	lag-1
Exhibits Notch binding activity; double-stranded DNA binding activity; and sequence-specific DNA binding activity. Is involved in several processes, including dauer exit; oviposition; and positive regulation of vulval development. Localizes to RNA polymerase II transcription factor complex. Is expressed in Z1.ppp; Z4.aaa; and ventral uterine precursor. Human ortholog(s) of this gene are implicated in Adams-Oliver syndrome. Is an ortholog of human RBPJ (recombination signal binding protein for immunoglobulin kappa J region).

WB:WBGene00002246	lag-2
Exhibits Notch binding activity. Is involved in several processes, including maintenance of dauer; positive regulation of stem cell proliferation; and regulation of vulval development. Localizes to cell projection membrane; integral component of plasma membrane; and neuronal cell body membrane. Is expressed in several structures, including distal tip cell; germ line; hypodermal cell; neurons; and vulval cell.

WB:WBGene00002247	lam-1
Is involved in pharynx development and positive regulation of locomotion. Localizes to basement membrane. Is expressed in intestine. Human ortholog(s) of this gene are implicated in several diseases, including Pierson syndrome; amelogenesis imperfecta type 1A; and junctional epidermolysis bullosa (multiple). Is an ortholog of human LAMB1 (laminin subunit beta 1) and LAMB2 (laminin subunit beta 2).

WB:WBGene00002248	lam-3
Localizes to basement membrane. Is expressed in several structures, including excretory canal; pharyngeal-intestinal valve; pharynx; somatic nervous system; and spermatheca. Human ortholog(s) of this gene are implicated in several diseases, including Pierson syndrome; amelogenesis imperfecta type 1A; and junctional epidermolysis bullosa (multiple). Is an ortholog of human LAMA2 (laminin subunit alpha 2).

WB:WBGene00002249	lap-1
Exhibits identical protein binding activity. Is involved in regulation of growth rate and regulation of oviposition. Is expressed in buccal cavity; intestine; and pharynx. Is an ortholog of human NPEPL1 (aminopeptidase like 1).

WB:WBGene00002250	lap-2
Is predicted to have aminopeptidase activity; manganese ion binding activity; and metalloexopeptidase activity.

WB:WBGene00002251	lat-1
Exhibits endopeptidase activity and protein homodimerization activity. Is involved in several processes, including anterior/posterior pattern specification; embryo development; and self proteolysis. Localizes to integral component of plasma membrane. Is expressed in several structures, including ABarppaapa; AIY; Caaaaa; Caaaap; and pharynx. Human ortholog(s) of this gene are implicated in bone disease (multiple); primary failure of tooth eruption; and type 2 diabetes mellitus. Is an ortholog of human ADGRL3 (adhesion G protein-coupled receptor L3).

WB:WBGene00002252	lat-2
Exhibits endopeptidase activity. Is involved in self proteolysis. Is expressed in excretory cell and pharynx. Human ortholog(s) of this gene are implicated in bone development disease (multiple); primary failure of tooth eruption; and type 2 diabetes mellitus. Is an ortholog of human ADGRL1 (adhesion G protein-coupled receptor L1) and ADGRL2 (adhesion G protein-coupled receptor L2).

WB:WBGene00002253	lbp-1
Is predicted to have lipid binding activity.

WB:WBGene00002254	lbp-2
Is predicted to have lipid binding activity.

WB:WBGene00002255	lbp-3
Is predicted to have lipid binding activity.

WB:WBGene00002256	lbp-4
Is predicted to have lipid binding activity.

WB:WBGene00002257	lbp-5
Exhibits fatty acid binding activity. Localizes to nucleus and perinuclear region of cytoplasm. Is expressed in hypodermis and tail. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1G. Is an ortholog of human FABP7 (fatty acid binding protein 7).

WB:WBGene00002258	lbp-6
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1G. Is an ortholog of human FABP7 (fatty acid binding protein 7).

WB:WBGene00002259	lbp-7
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1G. Is an ortholog of several human genes including FABP5 (fatty acid binding protein 5); FABP9 (fatty acid binding protein 9); and PMP2 (peripheral myelin protein 2).

WB:WBGene00002260	lbp-8
Exhibits long-chain fatty acid transporter activity and oleic acid binding activity. Is involved in long-chain fatty acid transport. Localizes to lysosome and nucleus. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1G. Is an ortholog of several human genes including FABP5 (fatty acid binding protein 5); FABP9 (fatty acid binding protein 9); and PMP2 (peripheral myelin protein 2).

WB:WBGene00002261	ldb-1
Exhibits DNA-binding transcription factor activity and LIM domain binding activity. Is involved in several processes, including mechanosensory behavior; synapse assembly; and vulval development. Is expressed in several structures, including AIY; body wall musculature; gonad; neurons; and vulval muscle. Is an ortholog of human LDB1 (LIM domain binding 1) and LDB2 (LIM domain binding 2).

WB:WBGene00002262	ldh-1
Is predicted to have L-lactate dehydrogenase activity. Is expressed in tail. Is an ortholog of human LDHA (lactate dehydrogenase A).

WB:WBGene00002263	lea-1
Is predicted to have lipid binding activity. Is involved in hyperosmotic response; response to desiccation; and response to heat. Is expressed in several structures, including body wall musculature; gonad; head neurons; and tail neurons. Is an ortholog of human PLIN4 (perilipin 4).

WB:WBGene00002264	lec-1
Exhibits galactoside binding activity. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is an ortholog of several human genes including LGALS9 (galectin 9); LGALS9B (galectin 9B); and LGALS9C (galectin 9C).

WB:WBGene00002265	lec-2
Is predicted to have carbohydrate binding activity. Localizes to membrane raft and plasma membrane. Is an ortholog of human LGALS9 (galectin 9).

WB:WBGene00002266	lec-3
Is predicted to have carbohydrate binding activity. Localizes to plasma membrane. Is an ortholog of human LGALS9 (galectin 9) and LGALS9C (galectin 9C).

WB:WBGene00002267	lec-4
Exhibits galactoside binding activity. Localizes to membrane raft. Is an ortholog of human LGALS9 (galectin 9); LGALS9B (galectin 9B); and LGALS9C (galectin 9C).

WB:WBGene00002268	lec-5
Is predicted to have carbohydrate binding activity. Localizes to membrane raft. Is an ortholog of human LGALS9 (galectin 9); LGALS9B (galectin 9B); and LGALS9C (galectin 9C).

WB:WBGene00002269	lec-6
Is predicted to have galactoside binding activity. Localizes to cytoplasm. Is expressed in intestine and pharynx. Is an ortholog of human LGALS1 (galectin 1) and LGALS7B (galectin 7B).

WB:WBGene00002270	lec-7
Is predicted to have galactoside binding activity. Is an ortholog of human LGALS3 (galectin 3).

WB:WBGene00002271	lec-8
Exhibits glycolipid binding activity. Is involved in response to toxic substance. Localizes to cytoplasmic vesicle. Is expressed in intestine; pharyngeal-intestinal valve; tail; virL; and virR. Is an ortholog of human LGALS3 (galectin 3).

WB:WBGene00002272	lec-9
Exhibits glycolipid binding activity. Localizes to cytoplasm. Is an ortholog of human LGALS3 (galectin 3).

WB:WBGene00002273	lec-10
Exhibits glycolipid binding activity. Localizes to apical part of cell and cytoplasm. Is expressed in intestine.

WB:WBGene00002274	lec-11
Is predicted to have galactoside binding activity. Is involved in innate immune response. Localizes to cytoplasm.

WB:WBGene00002275	lem-2
Exhibits chromatin DNA binding activity and lamin binding activity. Is involved in chromosome segregation; mitotic cytokinesis; and response to X-ray. Localizes to nuclear envelope. Is used to study Emery-Dreifuss muscular dystrophy. Human ortholog(s) of this gene are implicated in Buschke-Ollendorff syndrome and cataract 46 juvenile-onset. Is an ortholog of human LEMD2 (LEM domain nuclear envelope protein 2).

WB:WBGene00002276	lem-3
Exhibits endodeoxyribonuclease activity. Is involved in several processes, including DNA metabolic process; cellular response to hydroxyurea; and response to UV-C. Localizes to several cellular components, including condensed chromosome; midbody; and mitotic spindle midzone. Is expressed in embryonic cell. Is an ortholog of human ANKLE1 (ankyrin repeat and LEM domain containing 1).

WB:WBGene00002278	lep-2
Is predicted to have RNA binding activity; metal ion binding activity; and transferase activity. Is expressed in developing hermaphrodite gonad; hypodermis; neurons; and pharynx. Human ortholog(s) of this gene are implicated in Prader-Willi syndrome. Is an ortholog of human MKRN1 (makorin ring finger protein 1) and MKRN2 (makorin ring finger protein 2).

WB:WBGene00002279	let-1
Is involved in embryo development and nematode larval development.

WB:WBGene00002280	let-2
Exhibits extracellular matrix structural constituent conferring tensile strength. Is involved in several processes, including embryo development; gonad morphogenesis; and regulation of distal tip cell migration. Localizes to collagen type IV trimer. Is expressed in several structures, including coelomocyte; egg-laying apparatus; rectal muscle; spermatheca; and tail. Is an ortholog of human COL4A5 (collagen type IV alpha 5 chain) and COL4A6 (collagen type IV alpha 6 chain).

WB:WBGene00002281	let-3
Is involved in nematode larval development.

WB:WBGene00002282	let-4
Is involved in several processes, including epithelial cell development; nematode larval development; and positive regulation of membrane permeability. Localizes to apical part of cell. Is expressed in excretory system; hypodermis; rectal epithelial cell; and vulva.

WB:WBGene00002283	let-5
Is involved in nematode larval development.

WB:WBGene00002284	let-6
Is involved in nematode larval development.

WB:WBGene00002285	let-7
Exhibits mRNA 3'-UTR binding activity. Is involved in several processes, including negative regulation of Ras protein signal transduction; negative regulation of gene expression; and regulation of development, heterochronic. Localizes to RISC complex. Is expressed in several structures, including gonad; hypodermis; somatic nervous system; touch receptor neurons; and vulval precursor cell. Is used to study cancer.

WB:WBGene00002286	let-9
No description available

WB:WBGene00002287	let-10
No description available

WB:WBGene00002288	let-11
No description available

WB:WBGene00002289	let-12
No description available

WB:WBGene00002290	let-13
No description available

WB:WBGene00002291	let-14
No description available

WB:WBGene00002292	let-15
No description available

WB:WBGene00002293	let-16
No description available

WB:WBGene00002294	let-18
No description available

WB:WBGene00002295	let-19
Is predicted to have transcription coregulator activity. Is expressed in several structures, including TL.a; TL.p; TR.a; TR.p; and seam cell. Human ortholog(s) of this gene are implicated in dextro-looped transposition of the great arteries 1. Is an ortholog of human MED13 (mediator complex subunit 13) and MED13L (mediator complex subunit 13L).

WB:WBGene00002296	let-20
No description available

WB:WBGene00002297	ect-2
Exhibits guanyl-nucleotide exchange factor activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; mitotic cytokinesis; and positive regulation of GTPase activity. Localizes to cell cortex. Is expressed in several structures, including germ line; hermaphrodite gonad; hyp7; neuroblasts; and somatic gonad precursor. Is an ortholog of human ECT2 (epithelial cell transforming 2).

WB:WBGene00002298	let-22
No description available

WB:WBGene00002299	let-23
Is predicted to have epidermal growth factor-activated receptor activity. Is involved in several processes, including determination of adult lifespan; ovulation; and positive regulation of vulval development. Localizes to several cellular components, including apical plasma membrane; basolateral plasma membrane; and lateral plasma membrane. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; apoptotic cell; epithelial cell; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including brain disease (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human ERBB4 (erb-b2 receptor tyrosine kinase 4).

WB:WBGene00002300	let-24
No description available

WB:WBGene00002301	let-25
No description available

WB:WBGene00002302	let-26
No description available

WB:WBGene00002303	let-27
No description available

WB:WBGene00002304	let-28
No description available

WB:WBGene00002305	let-30
No description available

WB:WBGene00002306	let-31
No description available

WB:WBGene00002307	let-32
No description available

WB:WBGene00002308	let-33
No description available

WB:WBGene00002309	let-34
No description available

WB:WBGene00002310	let-35
No description available

WB:WBGene00002311	let-36
No description available

WB:WBGene00002312	let-37
No description available

WB:WBGene00002313	let-38
No description available

WB:WBGene00002314	let-39
No description available

WB:WBGene00002315	let-40
No description available

WB:WBGene00002316	let-41
No description available

WB:WBGene00002318	let-43
No description available

WB:WBGene00002319	let-44
No description available

WB:WBGene00002320	let-45
No description available

WB:WBGene00002321	let-46
No description available

WB:WBGene00002322	let-47
No description available

WB:WBGene00002323	let-48
No description available

WB:WBGene00002324	let-49
Is predicted to have transcription coregulator activity. Is involved in embryo development and reproduction. Is an ortholog of human MED7 (mediator complex subunit 7).

WB:WBGene00002325	let-50
No description available

WB:WBGene00002326	let-51
No description available

WB:WBGene00002327	let-52
No description available

WB:WBGene00002328	let-53
No description available

WB:WBGene00002329	let-54
No description available

WB:WBGene00002330	let-55
No description available

WB:WBGene00002331	let-56
No description available

WB:WBGene00002332	let-57
No description available

WB:WBGene00002333	let-58
No description available

WB:WBGene00002334	let-59
No description available

WB:WBGene00002335	let-60
Exhibits GTP binding activity and enzyme binding activity. Is involved in several processes, including learning or memory; positive regulation of receptor localization to synapse; and positive regulation of vulval development. Localizes to cell cortex. Is expressed in several structures, including germ line; gonad; head neurons; pharyngeal muscle cell; and vulval cell. Is used to study cancer. Human ortholog(s) of this gene are implicated in several diseases, including Costello syndrome; endocrine gland cancer (multiple); and gastrointestinal system cancer (multiple). Is an ortholog of human HRAS (HRas proto-oncogene, GTPase).

WB:WBGene00002336	let-61
No description available

WB:WBGene00002337	let-63
No description available

WB:WBGene00002338	let-64
No description available

WB:WBGene00002340	let-66
No description available

WB:WBGene00002341	let-67
No description available

WB:WBGene00002342	let-68
No description available

WB:WBGene00002343	let-69
No description available

WB:WBGene00002344	let-70
Exhibits ubiquitin protein ligase binding activity and ubiquitin-protein transferase activity. Is involved in protein ubiquitination and ubiquitin-dependent protein catabolic process. Is expressed in several structures, including P1; P2; linker cell; ventral ganglion; and ventral nerve cord. Is an ortholog of human UBE2D1 (ubiquitin conjugating enzyme E2 D1); UBE2D2 (ubiquitin conjugating enzyme E2 D2); and UBE2D3 (ubiquitin conjugating enzyme E2 D3).

WB:WBGene00002345	let-71
No description available

WB:WBGene00002346	let-72
No description available

WB:WBGene00002347	let-73
No description available

WB:WBGene00002348	myo-1
Is a structural constituent of muscle. Is involved in muscle contraction and pharyngeal pumping. Localizes to striated muscle myosin thick filament. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of several human genes including MYH13 (myosin heavy chain 13); MYH3 (myosin heavy chain 3); and MYH7 (myosin heavy chain 7).

WB:WBGene00002349	let-78
No description available

WB:WBGene00002350	let-79
No description available

WB:WBGene00002351	let-80
No description available

WB:WBGene00002352	let-81
No description available

WB:WBGene00002353	let-82
No description available

WB:WBGene00002354	let-83
No description available

WB:WBGene00002355	let-84
No description available

WB:WBGene00002356	let-85
No description available

WB:WBGene00002357	let-86
No description available

WB:WBGene00002358	let-87
No description available

WB:WBGene00002359	let-88
No description available

WB:WBGene00002360	let-89
No description available

WB:WBGene00002361	let-90
No description available

WB:WBGene00002362	let-91
No description available

WB:WBGene00002363	let-92
Exhibits DEAD/H-box RNA helicase binding activity. Is involved in cytoskeleton organization and nuclear envelope organization. Localizes to several cellular components, including axonal growth cone; centrosome; and protein phosphatase type 2A complex. Is an ortholog of human PPP2CA (protein phosphatase 2 catalytic subunit alpha) and PPP2CB (protein phosphatase 2 catalytic subunit beta).

WB:WBGene00002364	let-93
No description available

WB:WBGene00002365	let-96
No description available

WB:WBGene00002366	let-97
No description available

WB:WBGene00002367	let-98
No description available

WB:WBGene00002368	let-99
Is involved in establishment of mitotic spindle orientation. Localizes to cell cortex. Is expressed in embryonic cell.

WB:WBGene00002369	let-100
No description available

WB:WBGene00002371	let-102
No description available

WB:WBGene00002374	let-105
No description available

WB:WBGene00002375	let-106
No description available

WB:WBGene00002376	let-107
No description available

WB:WBGene00002378	let-109
No description available

WB:WBGene00002379	let-110
No description available

WB:WBGene00002380	let-111
No description available

WB:WBGene00002381	let-112
No description available

WB:WBGene00002382	let-113
No description available

WB:WBGene00002383	let-114
No description available

WB:WBGene00002384	let-115
No description available

WB:WBGene00002385	let-116
No description available

WB:WBGene00002386	let-117
No description available

WB:WBGene00002387	let-118
No description available

WB:WBGene00002388	let-119
No description available

WB:WBGene00002389	let-120
No description available

WB:WBGene00002390	let-121
No description available

WB:WBGene00002391	let-122
No description available

WB:WBGene00002392	let-123
No description available

WB:WBGene00002393	lpr-1
Is involved in nematode larval development and tube development. Is expressed in several structures, including P1; P12; P2; excretory system; and hypodermal cell.

WB:WBGene00002394	let-125
No description available

WB:WBGene00002395	let-126
No description available

WB:WBGene00002396	let-127
No description available

WB:WBGene00002397	let-128
No description available

WB:WBGene00002399	let-130
No description available

WB:WBGene00002400	let-131
No description available

WB:WBGene00002401	let-132
No description available

WB:WBGene00002402	let-133
No description available

WB:WBGene00002403	let-134
No description available

WB:WBGene00002404	let-135
No description available

WB:WBGene00002405	let-136
No description available

WB:WBGene00002406	let-137
No description available

WB:WBGene00002407	let-138
No description available

WB:WBGene00002408	let-139
No description available

WB:WBGene00002409	let-140
No description available

WB:WBGene00002410	let-141
No description available

WB:WBGene00002411	let-142
No description available

WB:WBGene00002412	let-143
No description available

WB:WBGene00002413	let-144
No description available

WB:WBGene00002414	let-145
No description available

WB:WBGene00002415	let-146
No description available

WB:WBGene00002417	let-148
No description available

WB:WBGene00002418	let-149
No description available

WB:WBGene00002419	let-150
No description available

WB:WBGene00002420	let-151
No description available

WB:WBGene00002422	let-153
No description available

WB:WBGene00002423	let-154
No description available

WB:WBGene00002424	let-155
No description available

WB:WBGene00002425	let-156
No description available

WB:WBGene00002426	let-157
No description available

WB:WBGene00002427	let-158
No description available

WB:WBGene00002428	let-159
No description available

WB:WBGene00002429	let-160
No description available

WB:WBGene00002430	let-161
No description available

WB:WBGene00002431	let-162
No description available

WB:WBGene00002432	let-163
No description available

WB:WBGene00002433	let-164
No description available

WB:WBGene00002434	let-170
No description available

WB:WBGene00002435	let-171
No description available

WB:WBGene00002436	let-172
No description available

WB:WBGene00002437	let-173
No description available

WB:WBGene00002438	let-174
No description available

WB:WBGene00002439	let-175
No description available

WB:WBGene00002440	let-176
No description available

WB:WBGene00002441	let-178
No description available

WB:WBGene00002442	let-179
No description available

WB:WBGene00002443	let-180
No description available

WB:WBGene00002444	let-181
No description available

WB:WBGene00002445	let-182
No description available

WB:WBGene00002446	let-183
No description available

WB:WBGene00002447	let-184
No description available

WB:WBGene00002448	let-185
No description available

WB:WBGene00002449	let-186
No description available

WB:WBGene00002450	let-187
No description available

WB:WBGene00002451	let-188
No description available

WB:WBGene00002452	let-189
No description available

WB:WBGene00002453	let-190
No description available

WB:WBGene00002454	let-191
No description available

WB:WBGene00002455	let-192
No description available

WB:WBGene00002456	let-193
No description available

WB:WBGene00002457	let-201
No description available

WB:WBGene00002458	let-202
No description available

WB:WBGene00002459	let-203
No description available

WB:WBGene00002460	let-204
No description available

WB:WBGene00002461	let-205
No description available

WB:WBGene00002462	let-206
No description available

WB:WBGene00002463	let-207
No description available

WB:WBGene00002464	let-208
No description available

WB:WBGene00002465	let-236
No description available

WB:WBGene00002466	let-237
Is involved in embryo development.

WB:WBGene00002467	let-238
No description available

WB:WBGene00002468	let-239
No description available

WB:WBGene00002469	let-240
No description available

WB:WBGene00002470	let-241
No description available

WB:WBGene00002471	let-242
No description available

WB:WBGene00002472	let-243
No description available

WB:WBGene00002473	let-244
No description available

WB:WBGene00002474	let-245
No description available

WB:WBGene00002475	let-246
No description available

WB:WBGene00002476	let-247
No description available

WB:WBGene00002477	let-248
No description available

WB:WBGene00002478	let-249
No description available

WB:WBGene00002479	let-250
No description available

WB:WBGene00002480	let-251
No description available

WB:WBGene00002481	let-252
No description available

WB:WBGene00002482	let-253
No description available

WB:WBGene00002483	let-254
No description available

WB:WBGene00002484	let-255
No description available

WB:WBGene00002485	let-256
No description available

WB:WBGene00002486	let-257
No description available

WB:WBGene00002487	let-258
No description available

WB:WBGene00002488	let-259
No description available

WB:WBGene00002489	let-260
No description available

WB:WBGene00002490	let-261
No description available

WB:WBGene00002491	let-262
No description available

WB:WBGene00002492	let-263
No description available

WB:WBGene00002493	let-264
No description available

WB:WBGene00002494	let-265
No description available

WB:WBGene00002495	let-266
No description available

WB:WBGene00002496	let-267
No description available

WB:WBGene00002497	let-268
Exhibits UDP-glucose:glycoprotein glucosyltransferase activity. Is involved in collagen biosynthetic process and protein glycosylation. Is expressed in GLR and body wall musculature. Human ortholog(s) of this gene are implicated in Bruck syndrome. Is an ortholog of human PLOD1 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) and PLOD3 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 3).

WB:WBGene00002498	let-269
No description available

WB:WBGene00002499	let-270
No description available

WB:WBGene00002500	let-271
No description available

WB:WBGene00002501	let-272
No description available

WB:WBGene00002502	let-273
No description available

WB:WBGene00002503	let-274
No description available

WB:WBGene00002504	let-275
No description available

WB:WBGene00002505	let-276
No description available

WB:WBGene00002506	let-277
No description available

WB:WBGene00002507	let-278
No description available

WB:WBGene00002508	let-279
No description available

WB:WBGene00002509	let-280
No description available

WB:WBGene00002510	let-281
No description available

WB:WBGene00002511	let-282
No description available

WB:WBGene00002512	let-284
No description available

WB:WBGene00002513	let-285
No description available

WB:WBGene00002514	let-286
No description available

WB:WBGene00002515	let-287
No description available

WB:WBGene00002516	let-288
No description available

WB:WBGene00002517	let-289
No description available

WB:WBGene00002518	let-290
No description available

WB:WBGene00002519	let-291
No description available

WB:WBGene00002520	let-292
No description available

WB:WBGene00002521	let-293
No description available

WB:WBGene00002522	let-294
No description available

WB:WBGene00002523	let-295
No description available

WB:WBGene00002524	let-296
No description available

WB:WBGene00002525	let-297
No description available

WB:WBGene00002526	let-298
No description available

WB:WBGene00002527	let-301
No description available

WB:WBGene00002528	let-302
No description available

WB:WBGene00002529	let-303
No description available

WB:WBGene00002530	let-304
No description available

WB:WBGene00002531	let-305
No description available

WB:WBGene00002532	let-306
No description available

WB:WBGene00002533	let-307
No description available

WB:WBGene00002534	let-308
No description available

WB:WBGene00002535	let-309
No description available

WB:WBGene00002536	let-311
No description available

WB:WBGene00002537	let-312
No description available

WB:WBGene00002538	let-313
No description available

WB:WBGene00002539	let-314
No description available

WB:WBGene00002540	let-315
No description available

WB:WBGene00002541	let-316
No description available

WB:WBGene00002542	let-317
No description available

WB:WBGene00002543	let-318
No description available

WB:WBGene00002544	let-319
No description available

WB:WBGene00002545	let-320
No description available

WB:WBGene00002546	let-321
No description available

WB:WBGene00002547	let-322
No description available

WB:WBGene00002548	let-323
No description available

WB:WBGene00002549	let-324
No description available

WB:WBGene00002550	let-325
No description available

WB:WBGene00002551	let-326
No description available

WB:WBGene00002552	let-327
No description available

WB:WBGene00002553	let-329
No description available

WB:WBGene00002554	let-330
No description available

WB:WBGene00002555	let-331
No description available

WB:WBGene00002556	let-332
No description available

WB:WBGene00002557	let-334
No description available

WB:WBGene00002558	let-335
No description available

WB:WBGene00002559	let-336
No description available

WB:WBGene00002560	let-337
No description available

WB:WBGene00002561	let-338
No description available

WB:WBGene00002562	let-339
No description available

WB:WBGene00002563	let-340
No description available

WB:WBGene00002564	let-342
No description available

WB:WBGene00002565	let-343
No description available

WB:WBGene00002566	let-344
No description available

WB:WBGene00002567	let-345
No description available

WB:WBGene00002568	let-346
No description available

WB:WBGene00002569	let-347
No description available

WB:WBGene00002570	let-348
No description available

WB:WBGene00002571	let-349
No description available

WB:WBGene00002572	let-350
Is involved in reproduction.

WB:WBGene00002573	let-351
No description available

WB:WBGene00002574	let-352
No description available

WB:WBGene00002575	let-353
No description available

WB:WBGene00002577	let-356
No description available

WB:WBGene00002578	let-357
No description available

WB:WBGene00002579	let-359
No description available

WB:WBGene00002580	let-360
No description available

WB:WBGene00002581	let-361
No description available

WB:WBGene00002583	let-363
Is predicted to have protein serine/threonine kinase activity. Is involved in several processes, including box C/D snoRNP assembly; regulation of gene expression; and response to sodium arsenite. Localizes to TORC1 complex; TORC2 complex; and cytoplasm. Is expressed in several structures, including intestine; muscle cell; neurons; pharynx; and vulva. Is an ortholog of human MTOR (mechanistic target of rapamycin kinase).

WB:WBGene00002587	let-367
No description available

WB:WBGene00002589	let-369
No description available

WB:WBGene00002591	let-371
No description available

WB:WBGene00002592	let-372
No description available

WB:WBGene00002593	let-373
No description available

WB:WBGene00002594	let-374
No description available

WB:WBGene00002595	let-375
No description available

WB:WBGene00002596	let-376
No description available

WB:WBGene00002601	let-381
Exhibits sequence-specific DNA binding activity. Is involved in mesodermal cell fate specification; nematode larval development; and positive regulation of mesodermal cell fate specification. Localizes to nucleus. Is expressed in M.dlp; M.drp; body wall muscle cell from M lineage; and coelomocyte. Human ortholog(s) of this gene are implicated in several diseases, including Bamforth-Lazarus syndrome; anterior segment dysgenesis 2; and lens disease (multiple). Is an ortholog of human FOXF1 (forkhead box F1).

WB:WBGene00002607	let-387
No description available

WB:WBGene00002608	let-388
No description available

WB:WBGene00002610	let-390
No description available

WB:WBGene00002612	let-392
No description available

WB:WBGene00002613	let-393
No description available

WB:WBGene00002614	let-394
No description available

WB:WBGene00002615	let-395
No description available

WB:WBGene00002618	let-398
No description available

WB:WBGene00002619	let-399
No description available

WB:WBGene00002621	let-401
No description available

WB:WBGene00002622	let-402
No description available

WB:WBGene00002623	let-403
No description available

WB:WBGene00002624	let-404
No description available

WB:WBGene00002625	let-405
No description available

WB:WBGene00002626	let-406
No description available

WB:WBGene00002627	let-407
No description available

WB:WBGene00002628	let-408
No description available

WB:WBGene00002629	let-409
No description available

WB:WBGene00002630	let-410
No description available

WB:WBGene00002631	let-411
No description available

WB:WBGene00002632	let-413
Is involved in several processes, including embryonic digestive tract morphogenesis; maintenance of epithelial cell apical/basal polarity; and protein transport. Localizes to basolateral plasma membrane. Is expressed in epithelial cell; nerve ring; rectum; and spermatheca. Is an ortholog of human SCRIB (scribble planar cell polarity protein).

WB:WBGene00002633	let-414
No description available

WB:WBGene00002634	let-415
No description available

WB:WBGene00002635	let-416
No description available

WB:WBGene00002636	let-417
No description available

WB:WBGene00002637	let-418
Exhibits transcription factor binding activity. Contributes to RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in embryonic digestive tract morphogenesis; negative regulation of transcription by RNA polymerase II; and negative regulation of vulval development. Localizes to RNA polymerase II transcription repressor complex. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P8.p hermaphrodite; gonad; and somatic nervous system. Human ortholog(s) of this gene are implicated in immunodeficiency-centromeric instability-facial anomalies syndrome 4. Is an ortholog of human CHD3 (chromodomain helicase DNA binding protein 3) and CHD4 (chromodomain helicase DNA binding protein 4).

WB:WBGene00002638	let-419
No description available

WB:WBGene00002639	let-420
No description available

WB:WBGene00002640	let-421
No description available

WB:WBGene00002641	let-422
No description available

WB:WBGene00002642	let-423
No description available

WB:WBGene00002643	let-424
No description available

WB:WBGene00002644	let-426
No description available

WB:WBGene00002645	let-427
No description available

WB:WBGene00002646	let-428
No description available

WB:WBGene00002647	let-429
No description available

WB:WBGene00002648	let-430
No description available

WB:WBGene00002649	let-431
No description available

WB:WBGene00002650	let-433
No description available

WB:WBGene00002651	let-434
No description available

WB:WBGene00002652	let-436
No description available

WB:WBGene00002653	let-437
No description available

WB:WBGene00002654	let-438
No description available

WB:WBGene00002655	let-439
No description available

WB:WBGene00002656	let-440
No description available

WB:WBGene00002657	let-441
No description available

WB:WBGene00002658	let-442
No description available

WB:WBGene00002659	let-443
No description available

WB:WBGene00002660	let-444
No description available

WB:WBGene00002661	let-445
No description available

WB:WBGene00002662	let-447
No description available

WB:WBGene00002663	let-448
No description available

WB:WBGene00002664	let-449
No description available

WB:WBGene00002665	let-450
No description available

WB:WBGene00002666	let-452
No description available

WB:WBGene00002667	let-453
No description available

WB:WBGene00002668	let-454
No description available

WB:WBGene00002669	let-455
No description available

WB:WBGene00002670	let-456
No description available

WB:WBGene00002671	let-458
No description available

WB:WBGene00002672	let-459
No description available

WB:WBGene00002673	let-460
No description available

WB:WBGene00002675	let-463
No description available

WB:WBGene00002676	let-464
No description available

WB:WBGene00002677	let-466
No description available

WB:WBGene00002678	let-467
No description available

WB:WBGene00002679	let-468
No description available

WB:WBGene00002680	let-469
No description available

WB:WBGene00002681	let-470
No description available

WB:WBGene00002682	let-471
No description available

WB:WBGene00002683	let-472
No description available

WB:WBGene00002684	let-473
No description available

WB:WBGene00002685	let-474
No description available

WB:WBGene00002686	let-475
No description available

WB:WBGene00002687	let-476
No description available

WB:WBGene00002688	let-478
No description available

WB:WBGene00002689	let-479
No description available

WB:WBGene00002690	let-480
No description available

WB:WBGene00002691	let-481
No description available

WB:WBGene00002692	let-500
No description available

WB:WBGene00002693	let-501
No description available

WB:WBGene00002694	let-502
Is predicted to have GTP-Rho binding activity and Rho-dependent protein serine/threonine kinase activity. Is involved in several processes, including embryonic body morphogenesis; pharyngeal gland morphogenesis; and pharynx development. Localizes to adherens junction; contractile fiber; and nucleus. Is expressed in several structures, including P3.p hermaphrodite; Z2; Z3; gonad; and hypodermis. Is an ortholog of human ROCK1 (Rho associated coiled-coil containing protein kinase 1) and ROCK2 (Rho associated coiled-coil containing protein kinase 2).

WB:WBGene00002696	let-504
Is predicted to have chromatin binding activity. Is an ortholog of human NKAP (NFKB activating protein).

WB:WBGene00002697	let-505
No description available

WB:WBGene00002698	let-506
No description available

WB:WBGene00002699	let-507
No description available

WB:WBGene00002700	let-508
No description available

WB:WBGene00002702	let-510
No description available

WB:WBGene00002703	let-511
No description available

WB:WBGene00002704	let-513
No description available

WB:WBGene00002705	let-514
No description available

WB:WBGene00002706	let-515
No description available

WB:WBGene00002707	let-516
No description available

WB:WBGene00002709	let-518
No description available

WB:WBGene00002711	let-520
No description available

WB:WBGene00002712	let-521
No description available

WB:WBGene00002714	let-523
No description available

WB:WBGene00002715	let-524
No description available

WB:WBGene00002716	let-525
No description available

WB:WBGene00002717	let-526
Is predicted to contribute to nucleosome binding activity. Is involved in nematode larval development and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including excretory cell; gonad; pharynx; tail precursor cell; and vulva. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in Coffin-Siris syndrome 1 and Coffin-Siris syndrome 2. Is an ortholog of human ARID1A (AT-rich interaction domain 1A) and ARID1B (AT-rich interaction domain 1B).

WB:WBGene00002719	let-528
No description available

WB:WBGene00002721	let-530
No description available

WB:WBGene00002723	let-532
No description available

WB:WBGene00002724	let-533
No description available

WB:WBGene00002726	let-535
No description available

WB:WBGene00002727	let-536
No description available

WB:WBGene00002728	let-538
No description available

WB:WBGene00002729	let-539
No description available

WB:WBGene00002730	let-540
No description available

WB:WBGene00002731	let-541
No description available

WB:WBGene00002732	let-542
No description available

WB:WBGene00002733	let-543
No description available

WB:WBGene00002734	let-544
No description available

WB:WBGene00002735	let-545
No description available

WB:WBGene00002736	let-546
No description available

WB:WBGene00002737	let-547
No description available

WB:WBGene00002738	let-548
No description available

WB:WBGene00002739	let-549
No description available

WB:WBGene00002740	let-550
No description available

WB:WBGene00002741	let-551
No description available

WB:WBGene00002742	let-552
No description available

WB:WBGene00002743	let-554
No description available

WB:WBGene00002744	let-555
No description available

WB:WBGene00002745	let-556
No description available

WB:WBGene00002746	let-557
No description available

WB:WBGene00002747	let-558
No description available

WB:WBGene00002748	let-559
No description available

WB:WBGene00002749	let-560
No description available

WB:WBGene00002750	let-571
No description available

WB:WBGene00002751	let-572
No description available

WB:WBGene00002752	let-573
No description available

WB:WBGene00002753	let-574
No description available

WB:WBGene00002756	let-577
No description available

WB:WBGene00002757	let-578
No description available

WB:WBGene00002758	let-579
No description available

WB:WBGene00002759	let-580
No description available

WB:WBGene00002761	let-582
No description available

WB:WBGene00002762	let-583
No description available

WB:WBGene00002763	let-584
No description available

WB:WBGene00002765	let-586
No description available

WB:WBGene00002766	let-587
No description available

WB:WBGene00002767	let-588
No description available

WB:WBGene00002768	let-589
No description available

WB:WBGene00002769	let-590
No description available

WB:WBGene00002770	let-592
No description available

WB:WBGene00002771	let-593
No description available

WB:WBGene00002776	let-598
No description available

WB:WBGene00002778	let-600
No description available

WB:WBGene00002783	let-607
Is predicted to have DNA-binding transcription factor activity. Is involved in several processes, including protein folding; regulation of establishment of cell polarity; and regulation of signal transduction. Is expressed in several structures, including coelomocyte; excretory cell; gonad; pseudocoelom; and somatic cell. Human ortholog(s) of this gene are implicated in achromatopsia 7 and osteogenesis imperfecta type 16. Is an ortholog of human CREB3 (cAMP responsive element binding protein 3); CREB3L3 (cAMP responsive element binding protein 3 like 3); and CREB3L4 (cAMP responsive element binding protein 3 like 4).

WB:WBGene00002785	let-609
No description available

WB:WBGene00002786	let-610
No description available

WB:WBGene00002789	let-613
No description available

WB:WBGene00002790	let-614
No description available

WB:WBGene00002791	let-615
No description available

WB:WBGene00002792	let-618
No description available

WB:WBGene00002793	let-619
No description available

WB:WBGene00002794	let-620
No description available

WB:WBGene00002795	let-621
No description available

WB:WBGene00002796	let-622
No description available

WB:WBGene00002797	let-623
No description available

WB:WBGene00002798	let-624
No description available

WB:WBGene00002799	let-625
No description available

WB:WBGene00002800	let-626
No description available

WB:WBGene00002801	let-627
No description available

WB:WBGene00002802	let-628
No description available

WB:WBGene00002803	let-629
No description available

WB:WBGene00002804	let-630
Is predicted to have rRNA binding activity and ribosomal small subunit binding activity. Is an ortholog of human PTCD3 (pentatricopeptide repeat domain 3).

WB:WBGene00002806	let-632
No description available

WB:WBGene00002807	let-633
No description available

WB:WBGene00002808	let-634
No description available

WB:WBGene00002809	let-635
No description available

WB:WBGene00002810	let-636
No description available

WB:WBGene00002811	let-637
No description available

WB:WBGene00002812	let-638
No description available

WB:WBGene00002813	let-639
No description available

WB:WBGene00002814	let-640
No description available

WB:WBGene00002815	let-641
No description available

WB:WBGene00002816	let-642
No description available

WB:WBGene00002817	let-643
No description available

WB:WBGene00002818	let-644
No description available

WB:WBGene00002819	let-645
No description available

WB:WBGene00002821	let-647
No description available

WB:WBGene00002822	let-648
No description available

WB:WBGene00002823	let-649
No description available

WB:WBGene00002824	let-650
No description available

WB:WBGene00002825	let-651
No description available

WB:WBGene00002826	let-652
No description available

WB:WBGene00002827	let-653
Is a structural constituent of cuticle. Is involved in several processes, including embryonic ectodermal digestive tract morphogenesis; negative regulation of tube lumen cavitation; and positive regulation of vulval development. Localizes to apical plasma membrane; extracellular space; and supramolecular fiber. Is expressed in excretory duct cell; excretory socket cell; rectal epithelial cell; and vulval cell.

WB:WBGene00002828	let-655
No description available

WB:WBGene00002829	let-656
No description available

WB:WBGene00002830	let-657
No description available

WB:WBGene00002831	let-658
No description available

WB:WBGene00002832	let-659
No description available

WB:WBGene00002833	let-660
No description available

WB:WBGene00002834	let-661
No description available

WB:WBGene00002835	let-662
No description available

WB:WBGene00002836	let-664
No description available

WB:WBGene00002837	let-700
No description available

WB:WBGene00002838	let-702
No description available

WB:WBGene00002839	let-704
No description available

WB:WBGene00002840	let-705
No description available

WB:WBGene00002841	let-706
No description available

WB:WBGene00002842	let-707
No description available

WB:WBGene00002843	let-709
No description available

WB:WBGene00002844	let-710
No description available

WB:WBGene00002845	let-711
Is predicted to have molecular adaptor activity. Is involved in several processes, including cytoskeleton organization; negative regulation of gene expression; and nematode larval development. Localizes to CCR4-NOT complex and cytoplasm. Is expressed in germ line; gonad; and in male. Is an ortholog of human CNOT1 (CCR4-NOT transcription complex subunit 1).

WB:WBGene00002846	let-712
No description available

WB:WBGene00002847	let-713
No description available

WB:WBGene00002848	let-714
No description available

WB:WBGene00002849	let-715
No description available

WB:WBGene00002850	let-716
Is predicted to have RNA binding activity. Is an ortholog of human PDCD11 (programmed cell death 11).

WB:WBGene00002851	let-717
No description available

WB:WBGene00002852	let-718
No description available

WB:WBGene00002853	let-719
No description available

WB:WBGene00002854	let-720
No description available

WB:WBGene00002855	let-721
Is predicted to have 4 iron, 4 sulfur cluster binding activity; oxidoreductase activity; and ubiquinone binding activity. Localizes to mitochondrion. Is expressed in gonad; hypodermis; spermatheca; tail; and vas deferens. Human ortholog(s) of this gene are implicated in multiple acyl-CoA dehydrogenase deficiency. Is an ortholog of human ETFDH (electron transfer flavoprotein dehydrogenase).

WB:WBGene00002856	let-722
No description available

WB:WBGene00002857	let-723
No description available

WB:WBGene00002858	let-724
No description available

WB:WBGene00002859	let-725
No description available

WB:WBGene00002860	let-727
No description available

WB:WBGene00002861	let-728
No description available

WB:WBGene00002862	let-729
No description available

WB:WBGene00002863	let-730
No description available

WB:WBGene00002864	let-732
No description available

WB:WBGene00002865	let-733
No description available

WB:WBGene00002866	let-734
No description available

WB:WBGene00002867	let-736
No description available

WB:WBGene00002868	let-737
No description available

WB:WBGene00002869	let-738
No description available

WB:WBGene00002870	let-739
No description available

WB:WBGene00002871	let-741
No description available

WB:WBGene00002872	let-743
No description available

WB:WBGene00002873	let-746
No description available

WB:WBGene00002874	let-747
No description available

WB:WBGene00002875	let-748
No description available

WB:WBGene00002876	let-750
No description available

WB:WBGene00002877	let-752
No description available

WB:WBGene00002878	let-753
No description available

WB:WBGene00002879	let-754
Is predicted to have ATP binding activity and adenylate kinase activity. Is involved in negative regulation of protein kinase C signaling and regulation of establishment of cell polarity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in reticular dysgenesis. Is an ortholog of human AK2 (adenylate kinase 2).

WB:WBGene00002880	let-755
No description available

WB:WBGene00002881	let-756
Exhibits growth factor activity; protein kinase binding activity; and transcription factor binding activity. Is involved in fibroblast growth factor receptor signaling pathway; nematode larval development; and regulation of cell projection organization. Localizes to cytoplasm; extracellular space; and nucleus. Is expressed in several structures, including CAN; OLL; cephalic sensillum; muscle cell; and pharyngeal cell. Human ortholog(s) of this gene are implicated in several diseases, including LADD syndrome; bone disease (multiple); and hypogonadotropic hypogonadism (multiple). Is an ortholog of human FGF16 (fibroblast growth factor 16) and FGF20 (fibroblast growth factor 20).

WB:WBGene00002882	let-758
No description available

WB:WBGene00002883	let-759
No description available

WB:WBGene00002884	let-760
No description available

WB:WBGene00002885	let-761
No description available

WB:WBGene00002886	let-762
No description available

WB:WBGene00002887	let-763
No description available

WB:WBGene00002888	let-764
No description available

WB:WBGene00002889	let-765
Is predicted to have chromatin DNA binding activity and histone binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of Ras protein signal transduction; and vulval cell fate specification. Localizes to nucleus. Is expressed in several structures, including hyp7; hyp7; hyp7; hyp7; and hyp7. Is an ortholog of human SBNO1 (strawberry notch homolog 1).

WB:WBGene00002890	let-766
No description available

WB:WBGene00002891	let-767
Exhibits long-chain-fatty-acyl-CoA reductase activity and testosterone dehydrogenase [NAD(P)] activity. Is involved in several processes, including cellular hormone metabolic process; female genitalia development; and long-chain fatty acid biosynthetic process. Localizes to apical cortex and endoplasmic reticulum. Is expressed in hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12).

WB:WBGene00002892	let-768
No description available

WB:WBGene00002893	let-769
No description available

WB:WBGene00002894	let-771
No description available

WB:WBGene00002895	let-774
No description available

WB:WBGene00002896	let-775
No description available

WB:WBGene00002897	let-776
No description available

WB:WBGene00002898	let-777
No description available

WB:WBGene00002899	let-778
No description available

WB:WBGene00002900	let-780
No description available

WB:WBGene00002901	let-782
No description available

WB:WBGene00002902	let-783
No description available

WB:WBGene00002903	let-784
No description available

WB:WBGene00002904	let-786
No description available

WB:WBGene00002905	let-789
No description available

WB:WBGene00002906	let-791
No description available

WB:WBGene00002907	let-792
No description available

WB:WBGene00002908	let-793
No description available

WB:WBGene00002909	let-794
No description available

WB:WBGene00002910	let-795
No description available

WB:WBGene00002911	let-796
No description available

WB:WBGene00002912	let-797
No description available

WB:WBGene00002913	let-798
No description available

WB:WBGene00002914	let-799
No description available

WB:WBGene00002915	let-805
Is predicted to have cytokine binding activity and cytokine receptor activity. Is involved in hemidesmosome assembly. Localizes to hemidesmosome. Is expressed in hypodermal cell; hypodermis; pharynx; touch receptor neurons; and uterine seam cell. Is an ortholog of human FN1 (fibronectin 1).

WB:WBGene00002916	let-809
No description available

WB:WBGene00002917	let-810
No description available

WB:WBGene00002918	let-811
No description available

WB:WBGene00002919	let-812
No description available

WB:WBGene00002920	let-813
No description available

WB:WBGene00002921	let-814
No description available

WB:WBGene00002922	let-815
No description available

WB:WBGene00002923	let-816
No description available

WB:WBGene00002924	let-817
No description available

WB:WBGene00002925	let-818
No description available

WB:WBGene00002926	let-819
No description available

WB:WBGene00002927	let-820
No description available

WB:WBGene00002928	let-821
No description available

WB:WBGene00002929	let-822
No description available

WB:WBGene00002930	let-823
No description available

WB:WBGene00002931	let-824
No description available

WB:WBGene00002932	let-825
No description available

WB:WBGene00002933	let-826
No description available

WB:WBGene00002934	let-827
No description available

WB:WBGene00002935	let-828
No description available

WB:WBGene00002936	let-829
No description available

WB:WBGene00002937	let-830
No description available

WB:WBGene00002938	let-831
No description available

WB:WBGene00002939	let-832
No description available

WB:WBGene00002940	let-834
No description available

WB:WBGene00002941	let-835
No description available

WB:WBGene00002942	let-836
No description available

WB:WBGene00002943	let-837
No description available

WB:WBGene00002944	let-838
No description available

WB:WBGene00002945	let-839
No description available

WB:WBGene00002946	let-840
No description available

WB:WBGene00002947	let-841
No description available

WB:WBGene00002948	let-842
No description available

WB:WBGene00002949	let-843
No description available

WB:WBGene00002950	let-844
No description available

WB:WBGene00002951	let-852
No description available

WB:WBGene00002952	let-853
No description available

WB:WBGene00002953	let-854
No description available

WB:WBGene00002954	let-855
No description available

WB:WBGene00002955	let-856
No description available

WB:WBGene00002956	let-857
No description available

WB:WBGene00002957	let-858
Is predicted to have RNA binding activity. Is involved in gastrulation and germ-line stem cell division. Localizes to germ cell nucleus; nuclear chromatin; and nucleoplasm. Is expressed in somatic cell. Is an ortholog of human CWC22 (CWC22 spliceosome associated protein homolog).

WB:WBGene00002958	let-908
No description available

WB:WBGene00002959	let-972
No description available

WB:WBGene00002960	let-974
No description available

WB:WBGene00002961	let-975
No description available

WB:WBGene00002962	let-976
No description available

WB:WBGene00002963	let-977
No description available

WB:WBGene00002964	let-978
No description available

WB:WBGene00002965	let-979
No description available

WB:WBGene00002966	let-980
No description available

WB:WBGene00002967	let-981
No description available

WB:WBGene00002968	let-982
No description available

WB:WBGene00002969	let-983
No description available

WB:WBGene00002970	let-984
No description available

WB:WBGene00002971	let-985
No description available

WB:WBGene00002972	let-986
No description available

WB:WBGene00002973	let-987
No description available

WB:WBGene00002974	lev-1
Exhibits acetylcholine receptor activity and acetylcholine-gated cation-selective channel activity. Is involved in inorganic cation transmembrane transport; regulation of locomotion; and regulation of oviposition. Localizes to neuron projection; neuronal cell body; and postsynaptic membrane. Is expressed in body wall musculature; dorsal nerve cord; nerve ring; ventral cord neurons; and ventral nerve cord. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00002975	lev-8
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is expressed in several structures, including DD neuron; anal depressor muscle; ganglia; head neurons; and uterine-vulval cell. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome (multiple) and multiple pterygium syndrome. Is an ortholog of human CHRNA1 (cholinergic receptor nicotinic alpha 1 subunit); CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00002976	lev-9
Is predicted to have peptidase inhibitor activity. Localizes to extracellular space. Is expressed in body wall musculature; cholinergic neurons; dorsal nerve cord; nerve ring; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including complement deficiency (multiple); degeneration of macula and posterior pole (multiple); and familial hemophagocytic lymphohistiocytosis 2. Is an ortholog of human C4BPA (complement component 4 binding protein alpha) and CSMD3 (CUB and Sushi multiple domains 3).

WB:WBGene00002977	lev-10
Localizes to membrane; synapse; and varicosity.

WB:WBGene00002978	lev-11
Exhibits actin filament binding activity. Is involved in several processes, including actin filament organization; regulation of actin polymerization or depolymerization; and spicule insertion. Localizes to striated muscle thin filament. Is expressed in several structures, including body wall musculature; germ line; intestine; non-striated muscle; and pharynx. Human ortholog(s) of this gene are implicated in intrinsic cardiomyopathy (multiple) and muscle tissue disease (multiple). Is an ortholog of human TPM1 (tropomyosin 1) and TPM3 (tropomyosin 3).

WB:WBGene00002979	lfe-2
Is predicted to have ATP binding activity and inositol-1,4,5-trisphosphate 3-kinase activity. Is involved in hermaphrodite genitalia morphogenesis. Is expressed in spermatheca. Human ortholog(s) of this gene are implicated in Kawasaki disease. Is an ortholog of human ITPKA (inositol-trisphosphate 3-kinase A).

WB:WBGene00002980	lgg-1
Is predicted to have GABA receptor binding activity; microtubule binding activity; and ubiquitin protein ligase binding activity. Is involved in several processes, including autophagy; positive regulation of autophagosome assembly; and positive regulation of necrotic cell death. Localizes to bounding membrane of organelle; neuron projection; and neuronal cell body. Is expressed in several structures, including egg-laying apparatus; germ cell; hypodermis; intestine; and nervous system. Is an ortholog of human GABARAPL1 (GABA type A receptor associated protein like 1).

WB:WBGene00002981	lgg-2
Is predicted to have microtubule binding activity and ubiquitin protein ligase binding activity. Is involved in defense response to Gram-positive bacterium and positive regulation of autophagosome maturation. Localizes to autophagosome membrane. Is expressed in hypodermis; muscle cell; pharynx; spermatheca; and vulva. Is an ortholog of human MAP1LC3A (microtubule associated protein 1 light chain 3 alpha).

WB:WBGene00002982	lgg-3
Is involved in determination of adult lifespan. Localizes to autophagosome membrane. Is an ortholog of human ATG12 (autophagy related 12).

WB:WBGene00002983	lgx-1
Is predicted to have hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds. Is expressed in somatic cell.

WB:WBGene00002984	lgx-2
No description available

WB:WBGene00002985	lig-1
Is predicted to have DNA ligase (ATP) activity. Is an ortholog of human LIG1 (DNA ligase 1).

WB:WBGene00002986	lig-4
Is predicted to have ATP binding activity; DNA binding activity; and DNA ligase (ATP) activity. Is involved in DNA repair. Is expressed in head neurons; tail neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in DNA ligase IV deficiency and multiple myeloma. Is an ortholog of human LIG4 (DNA ligase 4).

WB:WBGene00002987	lim-4
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in cell fate specification and regulation of transcription, DNA-templated. Localizes to nucleus. Is expressed in several structures, including ABalpppppa; ABpraaappa; head muscle; head neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including congenital ptosis; myopathy (multiple); and nail-patella syndrome. Is an ortholog of human LHX6 (LIM homeobox 6) and LHX8 (LIM homeobox 8).

WB:WBGene00002988	lim-6
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including gamma-aminobutyric acid biosynthetic process; neuron differentiation; and uterus morphogenesis. Localizes to nucleus. Is expressed in several structures, including amphid neurons; excretory system; hermaphrodite gonad; nerve ring neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including congenital ptosis; myopathy (multiple); and nail-patella syndrome. Is an ortholog of human LMX1B (LIM homeobox transcription factor 1 beta).

WB:WBGene00002989	lim-7
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in several processes, including gonad morphogenesis; head morphogenesis; and pharynx development. Localizes to nucleus. Is expressed in several structures, including body wall musculature; gonadal sheath cell; intestine; rectum; and somatic nervous system. Is an ortholog of human ISL2 (ISL LIM homeobox 2).

WB:WBGene00002990	lin-1
Exhibits sequence-specific DNA binding activity. Contributes to RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including negative regulation of transcription by RNA polymerase II; oviposition; and vulval development. Localizes to RNA polymerase II transcription repressor complex. Is expressed in vulval precursor cell. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human ELK1 (ETS transcription factor ELK1).

WB:WBGene00002991	lin-2
Exhibits insulin-like growth factor receptor binding activity. Is involved in several processes, including oviposition; positive regulation of vulval development; and protein localization to membrane. Localizes to cell junction. Is expressed in CAN; HSN; body wall musculature; and nerve ring. Is used to study autism spectrum disorder. Human ortholog(s) of this gene are implicated in FG syndrome; congenital nonspherocytic hemolytic anemia; and syndromic X-linked intellectual disability Najm type. Is an ortholog of human CASK (calcium/calmodulin dependent serine protein kinase).

WB:WBGene00002992	lin-3
Is predicted to have epidermal growth factor receptor binding activity. Is involved in several processes, including oviposition; positive regulation of ovulation; and positive regulation of vulval development. Localizes to plasma membrane. Is expressed in several structures, including excretory canal; germ line; hermaphrodite gonad; rectal epithelial cell; and vulF.

WB:WBGene00002993	lin-4
Exhibits mRNA 3'-UTR binding activity. Is involved in several processes, including negative regulation of gene expression; oviposition; and regulation of nematode larval development. Localizes to polysome. Is expressed in several structures, including P5.p hermaphrodite; P7.p hermaphrodite; gonad; neurons; and ventral nerve cord.

WB:WBGene00002994	lin-5
Exhibits dynein complex binding activity. Is involved in several processes, including cytoskeleton organization; gonad development; and locomotion. Localizes to cell cortex; condensed chromosome; and cytoskeleton.

WB:WBGene00002996	lin-7
Exhibits protein C-terminus binding activity; protein-macromolecule adaptor activity; and signaling receptor binding activity. Is involved in several processes, including oviposition; positive regulation of vulval development; and protein localization to basolateral plasma membrane. Localizes to cell-cell junction. Is an ortholog of human LIN7C (lin-7 homolog C, crumbs cell polarity complex component).

WB:WBGene00002997	lin-8
Is involved in negative regulation of vulval development. Localizes to nucleus. Is expressed in germ line; head neurons; and oocyte.

WB:WBGene00002998	lin-9
Is predicted to have DNA binding activity. Is involved in several processes, including male sex differentiation; negative regulation of vulval development; and regulation of neurogenesis. Localizes to DRM complex. Is an ortholog of human LIN9 (lin-9 DREAM MuvB core complex component).

WB:WBGene00002999	lin-10
Exhibits Rab GTPase binding activity. Is involved in several processes, including neuron-neuron synaptic transmission; positive regulation of backward locomotion; and positive regulation of vulval development. Localizes to several cellular components, including Golgi trans cisterna; neuronal cell body; and trans-Golgi network transport vesicle. Is expressed in ganglia; somatic nervous system; and vulva. Is an ortholog of human APBA1 (amyloid beta precursor protein binding family A member 1); APBA2 (amyloid beta precursor protein binding family A member 2); and APBA3 (amyloid beta precursor protein binding family A member 3).

WB:WBGene00003000	lin-11
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including axonal fasciculation; oviposition; and positive regulation of vulval development. Is expressed in several structures, including head muscle; neurons; somatic nervous system; uterus; and vulva. Is an ortholog of human LHX1 (LIM homeobox 1) and LHX5 (LIM homeobox 5).

WB:WBGene00003001	lin-12
Exhibits RNA polymerase II transcription factor binding activity. Is involved in several processes, including nematode larval development; oviposition; and positive regulation of mesodermal cell fate specification. Localizes to RNA polymerase II transcription factor complex and apical plasma membrane. Is expressed in several structures, including body wall muscle cell from M lineage; gonadal sheath cell; somatic nervous system; vulval cell; and vulval precursor cell. Is an ortholog of human NOTCH4 (notch receptor 4).

WB:WBGene00003002	lin-13
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in negative regulation of vulval development and reproduction. Localizes to nucleus. Is expressed in several structures, including body wall musculature; hermaphrodite distal tip cell; hypodermal cell; intestine; and neurons. Human ortholog(s) of this gene are implicated in nephronophthisis 14.

WB:WBGene00003003	lin-14
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity and single-stranded DNA binding activity. Is involved in several processes, including negative regulation of transcription by RNA polymerase II; regulation of cell fate specification; and regulation of nematode larval development, heterochronic. Localizes to condensed nuclear chromosome. Is expressed in several structures, including QL; QR; neurons; oocyte; and somatic nervous system.

WB:WBGene00003004	lin-15
No description available

WB:WBGene00003005	lin-16
No description available

WB:WBGene00003006	lin-17
Exhibits receptor tyrosine kinase binding activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; axis specification; and generation of neurons. Localizes to neuron projection membrane. Is expressed in several structures, including P3.p male; P4.p male; PQR; epithelial cell; and male-specific anatomical entity. Human ortholog(s) of this gene are implicated in exudative vitreoretinopathy 1. Is an ortholog of human FZD4 (frizzled class receptor 4).

WB:WBGene00003007	lin-18
Is predicted to have ATP binding activity and protein kinase activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; axis specification; and positive regulation of neurogenesis. Localizes to cytoplasm; nucleus; and plasma membrane. Is expressed in body wall musculature; neurons; and vulva. Is an ortholog of human RYK (receptor like tyrosine kinase).

WB:WBGene00003008	lin-22
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including anterior/posterior pattern specification; epidermal cell fate specification; and nematode male tail tip morphogenesis. Is expressed in seam cell. Is an ortholog of human HES1 (hes family bHLH transcription factor 1).

WB:WBGene00003009	lin-23
Exhibits beta-catenin binding activity and phosphatase binding activity. Is involved in several processes, including negative regulation of centrosome duplication; regulation of protein stability; and ubiquitin-dependent protein catabolic process. Localizes to cytoplasmic SCF ubiquitin ligase complex; cytosol; and nucleus. Is expressed in several structures, including body wall musculature; enteric muscle; germ line; hypodermal cell; and neurons. Is an ortholog of human FBXW11 (F-box and WD repeat domain containing 11).

WB:WBGene00003010	lin-24
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; gld-1; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including Zidovudine; Cry5B; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00003011	lin-25
Is involved in several processes, including defense response to Gram-positive bacterium; oviposition; and vulval development. Localizes to cytoplasm and nucleus. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P8.p hermaphrodite; hermaphrodite distal tip cell; and vulval cell.

WB:WBGene00003012	lin-26
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including ectoderm development; establishment or maintenance of epithelial cell apical/basal polarity; and vulval development. Localizes to nucleus. Is expressed in several structures, including Z2; epithelial cell; germ line; gonad; and somatic gonad precursor.

WB:WBGene00003013	lin-27
No description available

WB:WBGene00003014	lin-28
Exhibits RNA binding activity and enzyme binding activity. Is involved in several processes, including regulation of cell fate specification; regulation of development, heterochronic; and regulation of gene expression. Localizes to cytoplasm and nucleus. Is expressed in germ line; hypodermis; muscle cell; nervous system; and neurons. Is an ortholog of human LIN28A (lin-28 homolog A) and LIN28B (lin-28 homolog B).

WB:WBGene00003015	lin-29
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in regulation of development, heterochronic; regulation of nematode larval development; and regulation of programmed cell death. Localizes to nucleus. Is expressed in several structures, including R2_hyp; gonad; hypodermis; neurons; and proctodeal cell. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is an ortholog of human ZNF362 (zinc finger protein 362).

WB:WBGene00003016	lin-30
No description available

WB:WBGene00003017	lin-31
Exhibits sequence-specific DNA binding activity. Is involved in vulval development. Localizes to nucleus. Is expressed in several structures, including P11.p; P9.p; gonad; nerve ring; and vulval precursor cell. Is an ortholog of human FOXB2 (forkhead box B2).

WB:WBGene00003018	lin-32
Exhibits protein heterodimerization activity; protein homodimerization activity; and sequence-specific DNA binding activity. Is involved in several processes, including embryo development; nematode male tail tip morphogenesis; and neuron development. Localizes to nucleus. Is expressed in several structures, including QL.a; QR.a; distal tip cell; oxygen sensory neurons; and ray precursor cell. Human ortholog(s) of this gene are implicated in congenital malabsorptive diarrhea 4 and persistent hyperplastic primary vitreous. Is an ortholog of human ATOH1 (atonal bHLH transcription factor 1).

WB:WBGene00003019	lin-33
Is enriched in GABAergic neurons; NSM; excretory cell; hypodermis; and sensory neurons based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including procyanidin; Sirolimus; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00003020	lin-35
Exhibits protein C-terminus binding activity. Is involved in several processes, including negative regulation of cell cycle; negative regulation of vulval development; and positive regulation of brood size. Localizes to nucleus. Is expressed in several structures, including head and tail. Human ortholog(s) of this gene are implicated in several diseases, including lung small cell carcinoma; osteosarcoma; and retinoblastoma. Is an ortholog of human RBL1 (RB transcriptional corepressor like 1) and RBL2 (RB transcriptional corepressor like 2).

WB:WBGene00003021	lin-36
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in embryonic digestive tract morphogenesis. Is expressed in several structures, including hyp7; hyp7; hyp7; neurons; and vulval cell.

WB:WBGene00003022	lin-37
Is involved in embryonic digestive tract morphogenesis. Localizes to nucleus. Is expressed widely.

WB:WBGene00003024	lin-39
Exhibits cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including positive regulation of mesodermal cell fate specification; positive regulation of transcription, DNA-templated; and positive regulation of vulval development. Localizes to nucleus. Is expressed in several structures, including hypodermis; male-specific anatomical entity; neurons; somatic nervous system; and ventral cord blast cell. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple). Is an ortholog of human HOXA5 (homeobox A5).

WB:WBGene00003025	lin-40
Is predicted to have RNA polymerase II repressing transcription factor binding activity; histone deacetylase binding activity; and transcription coregulator activity. Is expressed in distal tip cell and somatic cell. Is an ortholog of human MTA2 (metastasis associated 1 family member 2) and MTA3 (metastasis associated 1 family member 3).

WB:WBGene00003026	lin-41
Exhibits mRNA binding activity and translation repressor activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of brood size; and regulation of gene expression. Localizes to cytoplasm and messenger ribonucleoprotein complex. Is expressed in germ cell; hypodermal cell; intestine; nervous system; and pharynx. Human ortholog(s) of this gene are implicated in familial Mediterranean fever. Is an ortholog of human TRIM71 (tripartite motif containing 71).

WB:WBGene00003028	lin-43
No description available

WB:WBGene00003029	lin-44
Is predicted to have frizzled binding activity and receptor ligand activity. Is involved in several processes, including generation of neurons; nematode male tail tip morphogenesis; and neuroblast migration. Is expressed in several structures, including P6.pa; P6.pp; anchor cell; rectal epithelial cell; and tail. Human ortholog(s) of this gene are implicated in several diseases, including Mullerian aplasia and hyperandrogenism; Schopf-Schulz-Passarge syndrome; and bone development disease (multiple). Is an ortholog of human WNT10A (Wnt family member 10A) and WNT10B (Wnt family member 10B).

WB:WBGene00003030	lin-45
Exhibits Ras GTPase binding activity. Is involved in several processes, including defense response to Gram-positive bacterium; intracellular signal transduction; and vulval development. Is expressed in head neurons and vulval precursor cell. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human ARAF (A-Raf proto-oncogene, serine/threonine kinase).

WB:WBGene00003031	lin-46
Is predicted to have molecular adaptor activity; molybdopterin adenylyltransferase activity; and molybdopterin molybdotransferase activity. Is involved in regulation of development, heterochronic. Localizes to cytoplasm and nucleus. Is expressed in hypodermis and seam cell. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and molybdenum cofactor deficiency type C. Is an ortholog of human GPHN (gephyrin).

WB:WBGene00003032	lin-47
No description available

WB:WBGene00003033	lin-48
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; DNA-binding transcription repressor activity, RNA polymerase II-specific; and sequence-specific DNA binding activity. Is involved in hindgut morphogenesis and nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in ciliated neurons; interfacial epithelial cell; intestine; labial sensillum; and tail. Human ortholog(s) of this gene are implicated in posterior polymorphous corneal dystrophy 1. Is an ortholog of human OVOL1 (ovo like transcriptional repressor 1).

WB:WBGene00003034	lin-49
Is predicted to have metal ion binding activity. Is an ortholog of human BRPF3 (bromodomain and PHD finger containing 3).

WB:WBGene00003035	lin-52
Is involved in embryo development; negative regulation of signal transduction; and regulation of neurogenesis. Is expressed in AS neuron; VA neuron; anal depressor muscle; chemosensory neurons; and excretory cell. Is an ortholog of human LIN52 (lin-52 DREAM MuvB core complex component).

WB:WBGene00003036	lin-53
Exhibits histone deacetylase binding activity. Is involved in several processes, including embryonic digestive tract morphogenesis; hermaphrodite genitalia development; and nematode male tail tip morphogenesis. Localizes to DRM complex. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P7.p hermaphrodite; and P8.p hermaphrodite. Is an ortholog of human RBBP4 (RB binding protein 4, chromatin remodeling factor) and RBBP7 (RB binding protein 7, chromatin remodeling factor).

WB:WBGene00003037	lin-54
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to DRM complex; autosome; and condensed nuclear chromosome. Is expressed in several structures, including pharynx and vulva. Is an ortholog of human LIN54 (lin-54 DREAM MuvB core complex component) and TESMIN (testis expressed metallothionein like protein).

WB:WBGene00003038	lin-56
Is involved in several processes, including protein localization to nucleus; protein stabilization; and vulval development. Localizes to nucleus. Is expressed in somatic cell.

WB:WBGene00003039	mir-48
Is involved in miRNA mediated inhibition of translation and positive regulation of development, heterochronic. Is expressed in P5.p hermaphrodite; P7.p hermaphrodite; RID; and seam cell. Is used to study Parkinson's disease.

WB:WBGene00003040	lin-59
Is predicted to have histone methyltransferase activity (H3-K36 specific). Is involved in several processes, including ectodermal cell fate specification; nematode male tail tip morphogenesis; and oviposition. Is expressed in hypodermis and muscle cell. Is used to study leukemia. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 1; and autosomal dominant non-syndromic intellectual disability (multiple). Is an ortholog of human ASH1L (ASH1 like histone lysine methyltransferase).

WB:WBGene00003041	lin-61
Is involved in vulval development. Localizes to chromatin and nucleus. Is expressed widely. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 11. Is an ortholog of human SFMBT2 (Scm like with four mbt domains 2).

WB:WBGene00003042	lin-62
No description available

WB:WBGene00003043	lip-1
Is predicted to have MAP kinase tyrosine/serine/threonine phosphatase activity. Is involved in several processes, including negative regulation of intracellular signal transduction; positive regulation of vulval development; and vulval cell fate specification. Localizes to plasma membrane. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and germ line. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 19 with or without anosmia and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP6 (dual specificity phosphatase 6) and DUSP7 (dual specificity phosphatase 7).

WB:WBGene00003044	lir-1
Is expressed in several structures, including head; intestinal cell; muscle cell; pharynx; and tail.

WB:WBGene00003045	lir-2
Is enriched in intestine; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; stavudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00003046	lir-3
Is predicted to have DNA binding activity and metal ion binding activity. Is expressed in muscle cell; neurons; spermatheca; and vulva.

WB:WBGene00003047	lis-1
Is predicted to have dynein complex binding activity and microtubule plus-end binding activity. Is involved in several processes, including chiasma assembly; cytoskeleton organization; and engulfment of apoptotic cell. Localizes to several cellular components, including cytoskeleton; kinetochore; and perinuclear region of cytoplasm. Is expressed in several structures, including hermaphrodite gonad; hypodermis; neurons; preanal ganglion; and somatic nervous system. Human ortholog(s) of this gene are implicated in lissencephaly. Is an ortholog of human PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1).

WB:WBGene00003048	lit-1
Exhibits beta-catenin binding activity; protein N-terminus binding activity; and protein serine/threonine kinase activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; cell fate specification; and cellular protein modification process. Localizes to cell cortex; nucleus; and serine/threonine protein kinase complex. Is expressed in several structures, including hermaphrodite gonad; pharynx; tail hypodermis; and vulva. Is an ortholog of human NLK (nemo like kinase).

WB:WBGene00003049	liv-2
No description available

WB:WBGene00003050	liv-4
No description available

WB:WBGene00003051	liv-5
No description available

WB:WBGene00003052	lmn-1
Exhibits histone binding activity; identical protein binding activity; and structural molecule activity. Is involved in several processes, including determination of adult lifespan; nuclear migration along microtubule; and nuclear pore distribution. Localizes to nuclear envelope and nuclear periphery. Is expressed in several structures, including ventral cord blast cell. Is used to study Emery-Dreifuss muscular dystrophy; congenital muscular dystrophy; and progeria. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is an ortholog of human LMNA (lamin A/C).

WB:WBGene00003053	lmp-1
Localizes to cytoplasmic vesicle and lysosomal membrane. Is expressed in coelomocyte; germ line; and pharynx.

WB:WBGene00003054	lmr-1
No description available

WB:WBGene00003055	lon-1
Is involved in several processes, including negative regulation of DNA endoreduplication; positive regulation of growth rate; and transforming growth factor beta receptor signaling pathway involved in regulation of growth. Localizes to adherens junction and integral component of plasma membrane. Is expressed in head; hypodermis; intestinal cell; intestine; and tail. Is an ortholog of human PI15 (peptidase inhibitor 15).

WB:WBGene00003056	lon-2
Exhibits growth factor binding activity. Is involved in several processes, including negative regulation of transforming growth factor beta receptor signaling pathway; regulation of mesodermal cell fate specification; and transforming growth factor beta receptor signaling pathway involved in regulation of growth. Localizes to cell surface. Is expressed in hypodermis and intestine.

WB:WBGene00003057	lon-3
Is predicted to be a structural constituent of collagen and cuticulin-based cuticle. Is involved in body morphogenesis and regulation of growth. Localizes to annuli extracellular matrix. Is expressed in several structures, including cuticle; hyp7; hyp7; hyp7; and hypodermal cell.

WB:WBGene00003058	lov-1
Exhibits protein domain specific binding activity. Is involved in response to hermaphrodite contact and vulval location. Localizes to neuronal cell body and non-motile cilium. Is expressed in CEM and in male. Is used to study autosomal dominant polycystic kidney disease. Human ortholog(s) of this gene are implicated in polycystic kidney disease 1. Is an ortholog of human PKDREJ (polycystin family receptor for egg jelly).

WB:WBGene00003059	lpd-2
Is expressed in nervous system. Is predicted to encode a protein with the following domains: Sas10/Utp3/C1D family and Sas10/Utp3/C1D. Is an ortholog of human NGDN (neuroguidin).

WB:WBGene00003060	lpd-3
Is expressed in intestine. Human ortholog(s) of this gene are implicated in Alkuraya-Kucinskas syndrome. Is predicted to encode a protein with the following domains: Fragile site-associated protein C-terminus; Fragile site-associated protein, C-terminal; and Protein KIAA1109. Is an ortholog of human KIAA1109 (KIAA1109).

WB:WBGene00003061	lpd-5
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is involved in lipid storage. Human ortholog(s) of this gene are implicated in mitochondrial complex I deficiency. Is an ortholog of human NDUFS4 (NADH:ubiquinone oxidoreductase subunit S4).

WB:WBGene00003062	lpd-6
Is predicted to have rRNA binding activity. Is involved in lipid storage. Is an ortholog of human PPAN-P2RY11 (PPAN-P2RY11 readthrough).

WB:WBGene00003063	lpd-7
Is predicted to have ribonucleoprotein complex binding activity. Is involved in lipid storage. Is an ortholog of human PES1 (pescadillo ribosomal biogenesis factor 1).

WB:WBGene00003064	lpd-8
Is predicted to have 4 iron, 4 sulfur cluster binding activity and iron ion binding activity. Is involved in lipid storage. Human ortholog(s) of this gene are implicated in multiple mitochondrial dysfunctions syndrome 1. Is an ortholog of human NFU1 (NFU1 iron-sulfur cluster scaffold).

WB:WBGene00003065	lpd-9
Is involved in lipid storage.

WB:WBGene00003066	lpl-1
Is predicted to have lipoyl(octanoyl) transferase activity and octanoyl transferase activity (acting on glycine-cleavage complex H protein). Is an ortholog of human LIPT2 (lipoyl(octanoyl) transferase 2).

WB:WBGene00003067	lrg-1
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including nicotinic acid; Alovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00003068	lrk-1
Is predicted to have metal ion binding activity; protein serine/threonine kinase activity; and purine ribonucleoside triphosphate binding activity. Is involved in several processes, including axon extension involved in axon guidance; negative regulation of neuron death; and synaptic vesicle transport. Localizes to Golgi apparatus and neuronal cell body. Is expressed in hermaphrodite distal tip cell; neurons; pharynx; and vulva. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human LRRK1 (leucine rich repeat kinase 1).

WB:WBGene00003069	lrn-1
Is involved in conditioned taste aversion.

WB:WBGene00003070	lrn-2
Is involved in conditioned taste aversion.

WB:WBGene00003071	lrp-1
Exhibits sterol transporter activity. Is involved in several processes, including ecdysis, collagen and cuticulin-based cuticle; nematode larval development; and sterol transport. Localizes to apical plasma membrane and endocytic vesicle. Colocalizes with Golgi-associated vesicle. Is expressed in head; hyp6; and hyp7 syncytium. Human ortholog(s) of this gene are implicated in Donnai-Barrow syndrome and familial hypercholesterolemia. Is an ortholog of human LRP2 (LDL receptor related protein 2).

WB:WBGene00003072	lrp-2
Is involved in regulation of cell migration. Colocalizes with Golgi-associated vesicle. Is expressed in tail. Human ortholog(s) of this gene are implicated in several diseases, including Donnai-Barrow syndrome; bone disease (multiple); and congenital myasthenic syndrome 17. Is an ortholog of human LRP1 (LDL receptor related protein 1).

WB:WBGene00003073	lars-1
Is predicted to have leucine-tRNA ligase activity. Is involved in negative regulation of transcription by RNA polymerase II; positive regulation of protein phosphorylation; and translation. Is an ortholog of human LARS1 (leucyl-tRNA synthetase 1).

WB:WBGene00003074	lars-2
Is predicted to have leucine-tRNA ligase activity. Is expressed in body wall musculature; intestine; and neurons. Human ortholog(s) of this gene are implicated in Perrault syndrome. Is an ortholog of human LARS2 (leucyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00003075	lrx-1
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including multi-walled carbon nanotube; D-glucose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in methylmalonic acidemia due to transcobalamin receptor defect. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; and LDL receptor-like superfamily.

WB:WBGene00003076	lsm-1
Is predicted to have RNA cap binding activity. Localizes to P-body and cytoplasmic stress granule. Is expressed in germ line and somatic cell. Is an ortholog of human LSM1 (LSM1 homolog, mRNA degradation associated).

WB:WBGene00003077	lsm-3
Is predicted to have RNA binding activity. Localizes to P-body. Is an ortholog of human LSM3 (LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated).

WB:WBGene00003078	lsm-4
Is predicted to have U6 snRNA binding activity. Localizes to cytoplasm and nucleus. Is expressed in germ line and somatic cell.

WB:WBGene00003079	lsm-5
Is predicted to have RNA binding activity. Is an ortholog of human LSM5 (LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated).

WB:WBGene00003080	lsm-6
Is predicted to have RNA binding activity. Is expressed in body wall musculature; hermaphrodite somatic gonadal cell; and muscle cell. Is an ortholog of human LSM6 (LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated).

WB:WBGene00003081	lsm-7
Is enriched in body wall muscle cell; germ line; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; clk-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: LSM domain; LSM domain, eukaryotic/archaea-type; and LSM domain superfamily. Is an ortholog of human LSM7 (LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated).

WB:WBGene00003082	lsm-8
Is predicted to have RNA binding activity. Is an ortholog of human LSM8 (LSM8 homolog, U6 small nuclear RNA associated).

WB:WBGene00003083	lst-1
Exhibits G-protein alpha-subunit binding activity. Is expressed in several structures, including accessory cell; amphid neurons; germ line; gonad; and oocyte.

WB:WBGene00003084	lst-2
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Is an ortholog of human ZFYVE28 (zinc finger FYVE-type containing 28).

WB:WBGene00003085	ccar-1
Is involved in hemidesmosome assembly. Is expressed widely. Is an ortholog of human CCAR1 (cell division cycle and apoptosis regulator 1).

WB:WBGene00003086	lst-4
Exhibits enzyme binding activity; phosphatidylinositol phosphate binding activity; and protein self-association. Is involved in execution phase of apoptosis and phagosome-lysosome fusion involved in apoptotic cell clearance. Localizes to early phagosome. Is expressed in embryonic cell; gonad; and gonadal sheath cell. Is an ortholog of human SNX18 (sorting nexin 18) and SNX33 (sorting nexin 33).

WB:WBGene00003087	lsy-2
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity. Is expressed in several structures, including ASE; head muscle; head neurons; intestine; and somatic nervous system. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is an ortholog of human ZNF148 (zinc finger protein 148).

WB:WBGene00003088	lsy-6
Exhibits mRNA 3'-UTR binding activity. Is involved in determination of left/right asymmetry in nervous system and gene silencing by miRNA. Is expressed in ASEL; head neurons; and tail neurons.

WB:WBGene00003089	ltd-1
Is predicted to have metal ion binding activity. Localizes to cell-cell junction and cytoplasm. Is expressed in epithelial cell and isthmus. Human ortholog(s) of this gene are implicated in myofibrillar myopathy 7. Is an ortholog of human KY (kyphoscoliosis peptidase).

WB:WBGene00003090	lys-1
Is involved in defense response to Gram-negative bacterium; defense response to Gram-positive bacterium; and innate immune response. Localizes to apical part of cell and cytoplasmic vesicle. Is expressed in ciliated neurons; head neurons; and intestine.

WB:WBGene00003091	lys-2
Is predicted to have lysozyme activity. Is involved in defense response to Gram-negative bacterium; defense response to Gram-positive bacterium; and innate immune response.

WB:WBGene00003092	lys-3
Is involved in stress response to copper ion.

WB:WBGene00003093	lys-4
Is predicted to have lysozyme activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00003094	lys-5
Is predicted to have lysozyme activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00003095	lys-6
Is predicted to have lysozyme activity.

WB:WBGene00003096	lys-7
Is involved in defense response to other organism. Is expressed in head neurons; intestine; and rectal gland cell.

WB:WBGene00003097	lys-8
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AR; g1P; neurons; and pharyngeal gland cell.

WB:WBGene00003098	lys-9
Is enriched in NSM based on tiling array studies. Is affected by several genes including lin-4; lin-14; and dpy-27 based on RNA-seq and microarray studies. Is affected by five chemicals including tryptophan; Mercuric Chloride; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: Glycoside hydrolase superfamily.

WB:WBGene00003099	lys-10
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Glycoside hydrolase superfamily.

WB:WBGene00003100	mab-3
Exhibits RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in nematode male tail tip morphogenesis; positive regulation of nematode male tail tip morphogenesis; and regulation of transcription by RNA polymerase II. Is expressed in ADF; SMD; and in male.

WB:WBGene00003101	mab-4
No description available

WB:WBGene00003102	mab-5
Contributes to RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; neuroblast migration; and regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in several structures, including body wall musculature; male-specific anatomical entity; neurons; somatic nervous system; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple). Is an ortholog of human HOXA6 (homeobox A6) and HOXB6 (homeobox B6).

WB:WBGene00003103	mab-6
No description available

WB:WBGene00003104	mab-7
Is expressed in PQR; hypodermis; and vulva. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF1794); EGF-like domain; Calycin; and Domain of unknown function DUF1794. Is an ortholog of human THAP4 (THAP domain containing 4).

WB:WBGene00003105	mab-8
No description available

WB:WBGene00003106	mab-9
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including cell fate specification; nematode male tail tip morphogenesis; and post-embryonic hindgut morphogenesis. Localizes to nucleus. Is expressed in several structures, including B.a; B.p; neurons; proctodeum; and rectal epithelial cell. Human ortholog(s) of this gene are implicated in several diseases, including X-linked cleft palate with or without ankyloglossia; adrenocorticotropic hormone deficiency; and dysostosis (multiple). Is an ortholog of human TBX20 (T-box transcription factor 20).

WB:WBGene00003107	mab-10
Is predicted to have transcription coregulator activity. Is involved in regulation of vulval development. Is expressed in several structures, including gonad; hypodermis; pharynx; somatic nervous system; and vulval cell. Is an ortholog of human NAB1 (NGFI-A binding protein 1) and NAB2 (NGFI-A binding protein 2).

WB:WBGene00003108	mab-12
No description available

WB:WBGene00003109	mab-17
No description available

WB:WBGene00003110	mab-19
No description available

WB:WBGene00003111	mab-20
Exhibits semaphorin receptor binding activity. Is involved in several processes, including embryonic morphogenesis; generation of neurons; and male anatomical structure morphogenesis. Localizes to cell surface. Is expressed in several structures, including linker cell; ray neurons; ray precursor cell; somatic nervous system; and vulval cell. Human ortholog(s) of this gene are implicated in CHARGE syndrome; hypogonadotropic hypogonadism (multiple); and retinal degeneration (multiple). Is an ortholog of human SEMA4D (semaphorin 4D).

WB:WBGene00003112	mab-21
Is involved in cell fate commitment and embryo development. Is expressed in several structures, including PVC; VA2; hyp7 syncytium; ray 6; and sensory neurons. Is an ortholog of human MAB21L1 (mab-21 like 1) and MAB21L2 (mab-21 like 2).

WB:WBGene00003114	mab-23
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is involved in several processes, including neuron fate determination; regulation of male mating behavior; and regulation of nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in several structures, including U cell; hermaphrodite gonad; neurons; tail hypodermis; and ventral nerve cord.

WB:WBGene00003115	mab-24
No description available

WB:WBGene00003116	mab-25
No description available

WB:WBGene00003117	mab-27
No description available

WB:WBGene00003119	mac-1
Is predicted to have ATPase activity and preribosome binding activity. Is involved in lipid storage; negative regulation of apoptotic process; and positive regulation of nematode larval development. Is an ortholog of human NVL (nuclear VCP like).

WB:WBGene00003121	mad-2
No description available

WB:WBGene00003122	mad-3
No description available

WB:WBGene00003123	mag-1
Is enriched in germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mago nashi protein; Mago nashi protein; and Mago nashi superfamily. Is an ortholog of human MAGOH (mago homolog, exon junction complex subunit) and MAGOHB (mago homolog B, exon junction complex subunit).

WB:WBGene00003124	mai-1
Exhibits ATPase inhibitor activity. Is involved in negative regulation of ATPase activity. Localizes to cytoplasm. Is expressed in coelomocyte; cuticle; hypodermis; rectum; and vulva. Is an ortholog of human ATP5IF1 (ATP synthase inhibitory factor subunit 1).

WB:WBGene00003128	mal-4
No description available

WB:WBGene00003129	map-1
Is predicted to have metal ion binding activity and metalloaminopeptidase activity. Is an ortholog of human METAP1 (methionyl aminopeptidase 1).

WB:WBGene00003130	map-2
Exhibits exopeptidase activity. Is involved in gamete generation and proteolysis. Is an ortholog of human METAP2 (methionyl aminopeptidase 2).

WB:WBGene00003131	mar-1
No description available

WB:WBGene00003132	mat-1
Is predicted to have ubiquitin protein ligase activity. Is involved in asymmetric cell division; cortical granule exocytosis; and polarity specification of anterior/posterior axis. Is an ortholog of human CDC27 (cell division cycle 27).

WB:WBGene00003133	mat-2
Is involved in several processes, including establishment of meiotic spindle localization; metaphase/anaphase transition of cell cycle; and polarity specification of anterior/posterior axis. Localizes to anaphase-promoting complex. Is an ortholog of human ANAPC1 (anaphase promoting complex subunit 1).

WB:WBGene00003134	mat-3
Is predicted to have ubiquitin protein ligase activity. Is involved in asymmetric cell division; polarity specification of anterior/posterior axis; and positive regulation of metaphase/anaphase transition of meiosis I. Is an ortholog of human CDC23 (cell division cycle 23).

WB:WBGene00003135	mau-1
No description available

WB:WBGene00003136	mau-2
Is predicted to have double-stranded DNA binding activity. Is involved in anterior/posterior axon guidance; dorsal/ventral axon guidance; and oviposition. Localizes to axon and cytoplasm. Is expressed in nervous system; oocyte; and vulval muscle. Is an ortholog of human MAU2 (MAU2 sister chromatid cohesion factor).

WB:WBGene00003137	mau-3
No description available

WB:WBGene00003138	mau-4
No description available

WB:WBGene00003139	mau-5
No description available

WB:WBGene00003140	mau-6
No description available

WB:WBGene00003141	mau-7
No description available

WB:WBGene00003142	mau-8
Is expressed in body wall musculature; germ line; hypodermis; intestine; and pharynx. Is predicted to encode a protein with the following domains: Phosducin; Phosducin, thioredoxin-like domain; and Thioredoxin-like superfamily. Is an ortholog of human PDCL (phosducin like).

WB:WBGene00003143	max-1
Is involved in motor neuron axon guidance. Is expressed in neurons. Is an ortholog of human PLEKHH2 (pleckstrin homology, MyTH4 and FERM domain containing H2).

WB:WBGene00003144	max-2
Exhibits Rac GTPase binding activity and mitogen-activated protein kinase kinase kinase binding activity. Is involved in several processes, including activation of JUN kinase activity; inductive cell migration; and motor neuron axon guidance. Is expressed in neurons; pharynx; and ventral nerve cord. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis and lung cancer. Is an ortholog of human PAK1 (p21 (RAC1) activated kinase 1) and PAK3 (p21 (RAC1) activated kinase 3).

WB:WBGene00003145	max-4
No description available

WB:WBGene00003146	max-5
No description available

WB:WBGene00003147	max-6
No description available

WB:WBGene00003148	mbf-1
Is predicted to have DNA binding activity. Is expressed in tail. Is an ortholog of human EDF1 (endothelial differentiation related factor 1).

WB:WBGene00003149	mbk-1
Is predicted to have protein serine/threonine kinase activity and transcription coactivator activity. Is expressed in several structures, including anterior gonad arm. Is used to study Down syndrome. Human ortholog(s) of this gene are implicated in abdominal obesity-metabolic syndrome 3 and autosomal dominant non-syndromic intellectual disability 7. Is an ortholog of human DYRK1A (dual specificity tyrosine phosphorylation regulated kinase 1A) and DYRK1B (dual specificity tyrosine phosphorylation regulated kinase 1B).

WB:WBGene00003150	mbk-2
Exhibits protein serine/threonine kinase activity and protein tyrosine kinase activity. Is involved in several processes, including P granule disassembly; asymmetric protein localization involved in cell fate determination; and cellular protein modification process. Localizes to several cellular components, including P granule; condensed chromosome; and cytoskeleton. Is expressed in several structures, including body wall musculature; embryonic cell; gonad; oocyte; and pharynx. Is used to study Down syndrome. Is an ortholog of human DYRK3 (dual specificity tyrosine phosphorylation regulated kinase 3).

WB:WBGene00003151	mca-1
Exhibits calcium transmembrane transporter activity, phosphorylative mechanism and calmodulin binding activity. Is involved in calcium ion transport and cellular calcium ion homeostasis. Localizes to membrane. Is expressed in excretory canal. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; Kufor-Rakeb syndrome; and alternating hemiplegia of childhood. Is an ortholog of human ATP2B3 (ATPase plasma membrane Ca2+ transporting 3).

WB:WBGene00003153	mca-3
Is predicted to have calcium transmembrane transporter activity, phosphorylative mechanism. Is involved in several processes, including negative regulation of cytosolic calcium ion concentration; positive regulation of endocytosis; and positive regulation of growth rate. Localizes to plasma membrane. Is expressed in body wall musculature; coelomocyte; intestine; nervous system; and touch receptor neurons. Human ortholog(s) of this gene are implicated in Kufor-Rakeb syndrome and autosomal recessive nonsyndromic deafness 12. Is an ortholog of several human genes including ATP2B1 (ATPase plasma membrane Ca2+ transporting 1); ATP2B3 (ATPase plasma membrane Ca2+ transporting 3); and ATP2B4 (ATPase plasma membrane Ca2+ transporting 4).

WB:WBGene00003154	mcm-2
Is predicted to contribute to 3'-5' DNA helicase activity. Localizes to condensed chromosome and pronucleus. Is expressed in excretory cell; intestine; and uterus. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 70. Is an ortholog of human MCM2 (minichromosome maintenance complex component 2).

WB:WBGene00003155	mcm-3
Is predicted to have DNA replication origin binding activity and single-stranded DNA binding activity. Localizes to condensed chromosome and pronucleus. Is an ortholog of human MCM3 (minichromosome maintenance complex component 3).

WB:WBGene00003156	mcm-4
Is predicted to have DNA replication origin binding activity and single-stranded DNA binding activity. Is involved in gonad development; locomotion; and nervous system development. Localizes to nucleus. Is expressed in several structures, including P lineage cell; Q lineage cell; Z2; somatic gonad precursor; and sperm. Is an ortholog of human MCM4 (minichromosome maintenance complex component 4).

WB:WBGene00003157	mcm-5
Is predicted to contribute to 3'-5' DNA helicase activity. Human ortholog(s) of this gene are implicated in Meier-Gorlin syndrome 8. Is an ortholog of human MCM5 (minichromosome maintenance complex component 5).

WB:WBGene00003158	mcm-6
Is predicted to contribute to single-stranded 3'-5' DNA helicase activity. Human ortholog(s) of this gene are implicated in lactose intolerance. Is an ortholog of human MCM6 (minichromosome maintenance complex component 6).

WB:WBGene00003159	mcm-7
Is predicted to contribute to single-stranded 3'-5' DNA helicase activity. Is involved in MCM complex assembly; embryo development; and mitotic sister chromatid segregation. Is expressed in head; intestine; and tail. Is an ortholog of human MCM7 (minichromosome maintenance complex component 7).

WB:WBGene00003160	mdf-1
Exhibits protein kinase binding activity. Is involved in embryo development; mitotic spindle assembly; and regulation of mitotic sister chromatid separation. Localizes to kinetochore; nuclear membrane; and nuclear periphery. Is expressed in Z1; Z2; Z3; Z4; and intestine. Human ortholog(s) of this gene are implicated in prostate cancer. Is an ortholog of human MAD1L1 (mitotic arrest deficient 1 like 1).

WB:WBGene00003161	mdf-2
Is involved in embryo development; mitotic spindle assembly checkpoint; and response to anoxia. Localizes to cytoskeleton and nucleus. Is expressed in germ line. Is an ortholog of human MAD2L1 (mitotic arrest deficient 2 like 1).

WB:WBGene00003162	mdh-2
Is predicted to have L-malate dehydrogenase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 51. Is an ortholog of human MDH2 (malate dehydrogenase 2).

WB:WBGene00003163	mdl-1
Exhibits protein heterodimerization activity. Contributes to sequence-specific DNA binding activity. Is involved in determination of adult lifespan and regulation of cell differentiation. Localizes to nucleus and transcription factor complex. Is expressed in body wall musculature; neurons; pharynx; and somatic nervous system. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in prostate cancer. Is an ortholog of human MXD3 (MAX dimerization protein 3) and MXI1 (MAX interactor 1, dimerization protein).

WB:WBGene00003164	mdt-6
Is predicted to have transcription coregulator activity. Is an ortholog of human MED6 (mediator complex subunit 6).

WB:WBGene00003165	mec-1
Is predicted to have serine-type endopeptidase inhibitor activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch; extracellular structure organization; and mechanosensory behavior. Is expressed in PVT; cholinergic neurons; intestinal muscle; and touch receptor neurons. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human TFPI2 (tissue factor pathway inhibitor 2).

WB:WBGene00003166	mec-2
Exhibits cholesterol binding activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Localizes to neuron projection membrane. Is expressed in touch receptor neurons. Is used to study nephrotic syndrome. Is an ortholog of human STOM (stomatin).

WB:WBGene00003167	mec-3
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II regulatory region sequence-specific DNA binding activity; and transcription factor binding activity. Is involved in several processes, including mechanosensory behavior; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding activity; and positive regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in touch receptor neurons; ventral nerve cord; and vulva. Is an ortholog of human LHX1 (LIM homeobox 1) and LHX5 (LIM homeobox 5).

WB:WBGene00003168	mec-4
Exhibits ligand-gated sodium channel activity. Is involved in several processes, including detection of mechanical stimulus involved in sensory perception of touch; negative regulation of turning behavior involved in mating; and positive regulation of response to external stimulus. Localizes to axon; integral component of plasma membrane; and neuron projection membrane. Is expressed in touch receptor neurons. Is used to study hypokalemic periodic paralysis; ischemia; and neurodegenerative disease. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1B (sodium channel epithelial 1 subunit beta) and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00003169	mec-5
Is predicted to have extracellular matrix structural constituent. Is involved in detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Localizes to extracellular matrix. Is expressed in head; hypodermis; muscle cell; tail; and touch receptor neurons.

WB:WBGene00003170	mec-6
Is predicted to have arylesterase activity and sodium channel activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Is expressed in several structures, including enteric muscle; excretory cell; mechanosensory neurons; nerve ring; and neurons. Is an ortholog of human PON1 (paraoxonase 1); PON2 (paraoxonase 2); and PON3 (paraoxonase 3).

WB:WBGene00003171	mec-7
Is predicted to have GTP binding activity. Is involved in several processes, including detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Localizes to neuron projection and neuronal cell body. Is expressed in BDU and mechanosensory neurons. Human ortholog(s) of this gene are implicated in complex cortical dysplasia with other brain malformations 1 and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBB6 (tubulin beta 6 class V).

WB:WBGene00003172	mec-8
Is predicted to have mRNA binding activity. Is involved in several processes, including hemidesmosome assembly; mechanosensory behavior; and nematode larval development. Localizes to nucleus. Is expressed in several structures, including anterior hypodermis; head muscle; hyp7 syncytium; neurons; and vulva. Is an ortholog of human RBPMS (RNA binding protein, mRNA processing factor) and RBPMS2 (RNA binding protein, mRNA processing factor 2).

WB:WBGene00003173	mec-9
Is predicted to have calcium ion binding activity and serine-type endopeptidase inhibitor activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Is expressed in PVDL; PVDR; head neurons; touch receptor neurons; and ventral cord neurons. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human SPINT2 (serine peptidase inhibitor, Kunitz type 2).

WB:WBGene00003174	mec-10
Exhibits ligand-gated sodium channel activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Localizes to cell body membrane. Is expressed in neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1A (sodium channel epithelial 1 subunit alpha); SCNN1B (sodium channel epithelial 1 subunit beta); and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00003175	mec-12
Is predicted to have GTP binding activity. Is involved in several processes, including detection of mechanical stimulus involved in sensory perception of touch; positive regulation of response to external stimulus; and thigmotaxis. Localizes to axon; microtubule; and neuronal cell body. Is expressed in nerve ring and neurons. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 22 and lissencephaly. Is an ortholog of human TUBA1A (tubulin alpha 1a).

WB:WBGene00003176	mec-14
Is predicted to have oxidoreductase activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch; mechanosensory behavior; and positive regulation of response to external stimulus. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2. Is an ortholog of human KCNAB1 (potassium voltage-gated channel subfamily A member regulatory beta subunit 1).

WB:WBGene00003177	mec-15
Is involved in several processes, including detection of mechanical stimulus involved in sensory perception of touch; positive regulation of GABAergic synaptic transmission; and positive regulation of nervous system process. Localizes to perikaryon. Is expressed in neurons and spermatheca. Is an ortholog of human FBXW9 (F-box and WD repeat domain containing 9).

WB:WBGene00003178	mec-17
Exhibits tubulin N-acetyltransferase activity. Is involved in mechanoreceptor differentiation; protein acetylation; and thigmotaxis. Is expressed in touch receptor neurons. Is used to study neurodegenerative disease. Is an ortholog of human ATAT1 (alpha tubulin acetyltransferase 1).

WB:WBGene00003179	mec-18
Is predicted to have CoA-ligase activity. Is involved in detection of mechanical stimulus involved in sensory perception of touch and mechanosensory behavior. Localizes to cell. Is expressed in PLML; PLMR; and touch receptor neurons.

WB:WBGene00003180	med-1
Exhibits sequence-specific DNA binding activity. Is involved in endodermal cell fate specification and pharynx development. Localizes to nucleus. Is expressed in several structures, including MSaaaap; MSaapap; MSappp; MSppapa; and MSppapp.

WB:WBGene00003181	med-2
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is involved in endodermal cell fate specification and pharynx development. Is expressed in E; EMS; MS; and gonad.

WB:WBGene00003182	mef-2
Exhibits sequence-specific DNA binding activity. Is involved in negative regulation of transcription by RNA polymerase II; positive regulation of transcription by RNA polymerase II; and regulation of acetylcholine secretion, neurotransmission. Localizes to nucleus. Is expressed in several structures, including hypodermis. Is used to study autism spectrum disorder and intellectual disability. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 20 and coronary artery disease. Is an ortholog of human MEF2D (myocyte enhancer factor 2D).

WB:WBGene00003183	mei-1
Exhibits several functions, including ATP binding activity; MATH domain binding activity; and microtubule-severing ATPase activity. Is involved in several processes, including cytoskeleton organization; female meiotic nuclear division; and negative regulation of meiotic spindle elongation. Localizes to katanin complex; nucleus; and spindle pole. Colocalizes with chromatin. Is expressed in ciliated neurons; germ line; and head neurons. Is an ortholog of human KATNA1 (katanin catalytic subunit A1).

WB:WBGene00003184	mei-2
Contributes to microtubule-severing ATPase activity. Is involved in embryo development; meiotic spindle organization; and microtubule depolymerization. Localizes to cytoplasm; cytoskeleton; and nucleus.

WB:WBGene00003185	mek-1
Exhibits JUN kinase kinase activity and SH2 domain binding activity. Is involved in several processes, including gamete generation; positive regulation of axon extension involved in regeneration; and stress-activated MAPK cascade. Is expressed in several structures, including ganglia; hermaphrodite gonad; intestine; nerve ring; and pharynx. Is an ortholog of human MAP2K7 (mitogen-activated protein kinase kinase 7).

WB:WBGene00003186	mek-2
Exhibits MAP kinase kinase activity and scaffold protein binding activity. Is involved in defense response to Gram-positive bacterium; intracellular signal transduction; and vulval development. Human ortholog(s) of this gene are implicated in Noonan syndrome 1; cardiofaciocutaneous syndrome 3; and cardiofaciocutaneous syndrome 4. Is an ortholog of human MAP2K1 (mitogen-activated protein kinase kinase 1) and MAP2K2 (mitogen-activated protein kinase kinase 2).

WB:WBGene00003187	mel-1
Is involved in embryo development.

WB:WBGene00003189	mel-3
Is involved in embryo development.

WB:WBGene00003190	mel-4
Is involved in embryo development.

WB:WBGene00003191	mel-5
Is involved in embryo development.

WB:WBGene00003192	mel-7
Is involved in embryo development.

WB:WBGene00003193	mel-8
Is involved in embryo development.

WB:WBGene00003194	mel-9
Is involved in embryo development.

WB:WBGene00003195	mel-10
Is involved in embryo development.

WB:WBGene00003196	mel-11
Is predicted to have enzyme inhibitor activity and phosphatase regulator activity. Is involved in embryo development and embryonic body morphogenesis. Localizes to adherens junction and cytoplasm. Is expressed in Z2; Z3; hyp7 syncytium; intestine; and pharynx. Is an ortholog of human PPP1R12B (protein phosphatase 1 regulatory subunit 12B).

WB:WBGene00003197	mel-12
Is involved in embryo development.

WB:WBGene00003198	mel-13
Is involved in embryo development.

WB:WBGene00003199	mel-14
Is involved in embryo development.

WB:WBGene00003201	mel-16
Is involved in embryo development.

WB:WBGene00003202	mel-17
Is involved in embryo development.

WB:WBGene00003203	mel-18
Is involved in embryo development.

WB:WBGene00003204	mel-20
Is involved in embryo development.

WB:WBGene00003205	mel-22
Is involved in embryo development.

WB:WBGene00003206	mel-23
No description available

WB:WBGene00003207	mel-24
No description available

WB:WBGene00003208	mel-25
No description available

WB:WBGene00003209	mel-26
Exhibits several functions, including cullin family protein binding activity; identical protein binding activity; and protein-macromolecule adaptor activity. Is involved in several processes, including cytoskeleton organization; positive regulation of TORC1 signaling; and regulation of mitotic spindle elongation. Localizes to several cellular components, including cleavage furrow; condensed chromosome; and sarcomere. Is expressed in germ line and muscle cell.

WB:WBGene00003210	mel-28
Exhibits molecular adaptor activity. Is involved in mitotic sister chromatid segregation and nuclear pore complex assembly. Localizes to condensed chromosome kinetochore; nuclear pore; and nucleoplasm.

WB:WBGene00003211	mel-29
No description available

WB:WBGene00003212	mel-30
No description available

WB:WBGene00003213	mel-31
No description available

WB:WBGene00003214	mel-32
Is predicted to have several functions, including cation binding activity; glycine hydroxymethyltransferase activity; and nucleic acid binding activity. Is involved in embryo development. Localizes to mitochondrion. Is an ortholog of human SHMT1 (serine hydroxymethyltransferase 1).

WB:WBGene00003215	mel-33
No description available

WB:WBGene00003216	memi-1
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00003217	mel-44
No description available

WB:WBGene00003218	mep-1
Exhibits several functions, including enzyme binding activity; identical protein binding activity; and transcription factor binding activity. Is involved in several processes, including hermaphrodite genitalia development; oocyte development; and vulval development. Localizes to nucleus. Is expressed in anchor cell; embryonic cell; excretory cell; germ line; and somatic nervous system.

WB:WBGene00003219	mes-1
Is predicted to have protein serine/threonine kinase activity and protein tyrosine kinase activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; establishment of mitotic spindle localization; and left/right axis specification. Localizes to plasma membrane. Is expressed in E; Psub2; Psub3; and Psub4. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; lung cancer; and non-syndromic X-linked intellectual disability.

WB:WBGene00003220	mes-2
Exhibits histone methyltransferase activity. Is involved in germ-line stem cell division; histone H3-K27 trimethylation; and regulation of gene expression, epigenetic. Localizes to PcG protein complex and nucleosome. Is expressed in Z2; Z3; germ line; hypodermis; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Sotos syndrome; Weaver syndrome; and autosomal dominant non-syndromic intellectual disability (multiple). Is an ortholog of human EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit).

WB:WBGene00003221	mes-3
Is involved in histone H3-K27 methylation. Localizes to PcG protein complex and nucleosome. Is expressed in several structures, including Caa; Psub4; Z2; Z3; and germ line.

WB:WBGene00003222	mes-4
Exhibits histone methyltransferase activity (H3-K36 specific). Is involved in germ-line sex determination; histone H3-K36 methylation; and regulation of gene expression. Localizes to X chromosome; autosome; and nuclear chromosome. Is expressed in Z2; Z3; and germ line. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 1; and autosomal dominant non-syndromic intellectual disability (multiple). Is an ortholog of human NSD2 (nuclear receptor binding SET domain protein 2) and NSD3 (nuclear receptor binding SET domain protein 3).

WB:WBGene00003223	mes-5
No description available

WB:WBGene00003224	mes-6
Is predicted to contribute to histone methyltransferase activity (H3-K27 specific) and nucleosome binding activity. Is involved in histone H3-K27 methylation. Localizes to PcG protein complex and nucleosome. Is expressed in Z2; Z3; germ line; intestinal cell; and oocyte. Is an ortholog of human EED (embryonic ectoderm development).

WB:WBGene00003225	mev-1
Is predicted to have heme binding activity. Is involved in several processes, including defense response to other organism; mitochondrial electron transport, succinate to ubiquinone; and regulation of response to oxidative stress. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in Carney-Stratakis syndrome; gastrointestinal stromal tumor; and paraganglioma. Is an ortholog of human SDHC (succinate dehydrogenase complex subunit C).

WB:WBGene00003226	mev-2
No description available

WB:WBGene00003227	mev-3
No description available

WB:WBGene00003228	mex-1
Is predicted to have mRNA 3'-UTR binding activity. Is involved in several processes, including embryonic pattern specification; establishment of cell polarity; and formation of primary germ layer. Localizes to P granule. Is expressed in germ line. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00003229	mex-3
Exhibits single-stranded RNA binding activity. Is involved in several processes, including negative regulation of muscle cell differentiation; organelle inheritance; and regulation of gene expression. Localizes to P granule. Is expressed in distal tip cell and embryonic cell. Is an ortholog of human MEX3A (mex-3 RNA binding family member A) and MEX3B (mex-3 RNA binding family member B).

WB:WBGene00003230	mex-5
Exhibits RNA binding activity; protein domain specific binding activity; and protein kinase binding activity. Is involved in regulation of protein localization. Localizes to P granule and centrosome. Is expressed in germ line; head muscle; head neurons; intestine; and somatic nervous system. Is an ortholog of human ZFP36L1 (ZFP36 ring finger protein like 1).

WB:WBGene00003231	mex-6
Exhibits mRNA 3'-UTR binding activity; protein domain specific binding activity; and protein kinase binding activity. Is involved in regulation of protein localization. Localizes to P granule. Is expressed in AB; ABa; ABp; and germ line.

WB:WBGene00003232	mgl-1
Is predicted to have group II metabotropic glutamate receptor activity. Is involved in positive regulation of lipid storage. Is expressed in nerve ring; neurons; and pharyngeal nervous system. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1B. Is an ortholog of human GRM2 (glutamate metabotropic receptor 2) and GRM3 (glutamate metabotropic receptor 3).

WB:WBGene00003233	mgl-2
Is predicted to have G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; glutamate receptor activity; and neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration. Is expressed in several structures, including glutamatergic neurons; head neurons; pharyngeal nervous system; somatic nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 13 and spinocerebellar ataxia 44. Is an ortholog of human GRM1 (glutamate metabotropic receptor 1) and GRM5 (glutamate metabotropic receptor 5).

WB:WBGene00003234	mif-1
Is enriched in intestine; muscle cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in juvenile rheumatoid arthritis. Is predicted to encode a protein with the following domains: Macrophage migration inhibitory factor (MIF); Macrophage migration inhibitory factor; and Tautomerase/MIF superfamily. Is an ortholog of human MIF (macrophage migration inhibitory factor).

WB:WBGene00003235	mif-2
Is expressed in body wall musculature; hypodermis; and vulval muscle. Is predicted to encode a protein with the following domains: Macrophage migration inhibitory factor (MIF); Macrophage migration inhibitory factor; and Tautomerase/MIF superfamily. Is an ortholog of human DDT (D-dopachrome tautomerase) and DDTL (D-dopachrome tautomerase like).

WB:WBGene00003236	mif-3
Is involved in regulation of lipid storage and regulation of peptide transport. Localizes to nucleus. Is expressed in body wall musculature; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human DDTL (D-dopachrome tautomerase like).

WB:WBGene00003237	mif-4
Is enriched in OLL; PVD; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Lithium Chloride; Cry5B; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Macrophage migration inhibitory factor (MIF); Macrophage migration inhibitory factor; and Tautomerase/MIF superfamily.

WB:WBGene00003238	mig-1
Is predicted to have Wnt-activated receptor activity and Wnt-protein binding activity. Is involved in generation of neurons; mitochondrial unfolded protein response; and neuroblast migration. Is expressed in anal depressor muscle; head muscle; and neurons. Human ortholog(s) of this gene are implicated in nonsyndromic congenital nail disorder 10 and omodysplasia.

WB:WBGene00003239	mig-2
Exhibits GTPase activity and protein kinase binding activity. Is involved in several processes, including cytoskeleton organization; engulfment of apoptotic cell; and generation of neurons. Localizes to cytoplasm; cytoplasmic side of plasma membrane; and neuron projection. Is expressed in several structures, including CAN; HSN; hermaphrodite distal tip cell; touch receptor neurons; and vulval cell. Is used to study epilepsy. Is an ortholog of human RHOG (ras homolog family member G).

WB:WBGene00003240	mig-4
No description available

WB:WBGene00003241	mig-5
Is predicted to have frizzled binding activity. Is involved in several processes, including cell fate specification; inductive cell migration; and non-canonical Wnt signaling pathway. Localizes to cell cortex. Is expressed in several structures, including hermaphrodite distal tip cell; linker cell; nerve ring; posterior lateral left ganglion; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in autosomal dominant Robinow syndrome 1; autosomal dominant Robinow syndrome 2; and autosomal dominant Robinow syndrome 3. Is an ortholog of human DVL1 (dishevelled segment polarity protein 1); DVL2 (dishevelled segment polarity protein 2); and DVL3 (dishevelled segment polarity protein 3).

WB:WBGene00003242	mig-6
Is predicted to have peptidase activity and serine-type endopeptidase inhibitor activity. Is involved in several processes, including cell morphogenesis; embryo development; and nematode larval development. Localizes to basement membrane. Is expressed in several structures, including CAN; GLR; basal lamina; enteric muscle; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is an ortholog of human PAPLN (papilin, proteoglycan like sulfated glycoprotein).

WB:WBGene00003243	mig-10
Exhibits SH3 domain binding activity. Is involved in several processes, including lamellipodium assembly; nervous system development; and oviposition. Localizes to several cellular components, including filamentous actin; growth cone membrane; and neuronal cell body membrane. Is expressed in hermaphrodite gonad; neurons; and tail. Is an ortholog of human RAPH1 (Ras association (RalGDS/AF-6) and pleckstrin homology domains 1).

WB:WBGene00003244	mig-12
No description available

WB:WBGene00003245	mig-13
Is involved in positive regulation of cell migration. Localizes to axon; neuronal cell body; and plasma membrane. Is expressed in several structures, including QR.a; QR.p; QR.pa; body ganglion; and somatic neurons. Human ortholog(s) of this gene are implicated in methylmalonic acidemia due to transcobalamin receptor defect.

WB:WBGene00003246	mig-14
Is predicted to have Wnt-protein binding activity. Is involved in several processes, including Wnt signaling pathway; embryonic morphogenesis; and left/right axis specification. Localizes to basolateral plasma membrane and cytoplasmic vesicle. Is expressed in several structures, including CAN; anal region; intestinal muscle; tail hypodermis; and ventral nerve cord. Is an ortholog of human WLS (Wnt ligand secretion mediator).

WB:WBGene00003247	mig-15
Is predicted to have protein serine/threonine kinase activity. Is involved in several processes, including body morphogenesis; dorsal/ventral axon guidance; and regulation of GABAergic synaptic transmission. Is expressed in several structures, including QL; QR; body wall musculature; pharynx; and somatic nervous system. Is used to study epilepsy. Is an ortholog of human MINK1 (misshapen like kinase 1) and TNIK (TRAF2 and NCK interacting kinase).

WB:WBGene00003248	mig-17
Exhibits metallopeptidase activity. Is involved in several processes, including gonad morphogenesis; protein maturation; and regulation of distal tip cell migration. Localizes to basement membrane and extracellular space. Is expressed in body wall musculature; gonad; hypodermis; intestine; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil.

WB:WBGene00003249	mig-18
Is expressed in body wall musculature; gonad; and pharyngeal muscle cell. Is predicted to encode a protein with the following domain: Abnormal cell migration protein 18-like.

WB:WBGene00003250	mig-19
No description available

WB:WBGene00003251	mig-20
No description available

WB:WBGene00003252	mig-21
Is predicted to have signaling receptor activity. Is involved in several processes, including nervous system development; neuroblast migration; and regulation of canonical Wnt signaling pathway. Is expressed in QL; QR; and body wall musculature.

WB:WBGene00003253	mig-22
Exhibits enzyme binding activity. Is expressed in anterior distal tip cell; oocyte; posterior distal tip cell; and vulva. Is an ortholog of human CHPF (chondroitin polymerizing factor) and CHPF2 (chondroitin polymerizing factor 2).

WB:WBGene00003254	mig-23
Exhibits adenosine-diphosphatase activity; guanosine-diphosphatase activity; and uridine-diphosphatase activity. Is involved in several processes, including gonad morphogenesis; nucleobase-containing compound catabolic process; and positive regulation of protein glycosylation. Localizes to cytoplasm. Is expressed in head and tail. Is an ortholog of human ENTPD4 (ectonucleoside triphosphate diphosphohydrolase 4) and ENTPD7 (ectonucleoside triphosphate diphosphohydrolase 7).

WB:WBGene00003256	mig-25
No description available

WB:WBGene00003257	mig-26
No description available

WB:WBGene00003258	cogc-1
Is involved in several processes, including hermaphrodite genitalia morphogenesis; regulation of cell migration; and vulval development. Is expressed in germ line. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIg. Is an ortholog of human COG1 (component of oligomeric golgi complex 1).

WB:WBGene00003259	mio-1
No description available

WB:WBGene00003260	mir-1
Is expressed in body wall musculature; muscle cell; and pharyngeal muscle cell. Is used to study Parkinson's disease.

WB:WBGene00003261	mir-2
Is predicted to have mRNA binding activity involved in posttranscriptional gene silencing. Is expressed in neurons.

WB:WBGene00003262	mir-34
Is involved in several processes, including determination of adult lifespan; negative regulation of autophagy; and response to heat. Is expressed in excretory canal; hypodermis; neurons; somatic nervous system; and vulval precursor cell.

WB:WBGene00003263	mir-35
Is predicted to have mRNA binding activity. Is expressed in germ line.

WB:WBGene00003264	mir-36
Is predicted to have mRNA binding activity. Is expressed in germ line.

WB:WBGene00003265	mir-37
Is predicted to have mRNA binding activity. Is expressed in germ line.

WB:WBGene00003266	mir-38
Is expressed in germ line.

WB:WBGene00003267	mir-39
Is expressed in germ line.

WB:WBGene00003268	mir-40
Is expressed in germ line.

WB:WBGene00003269	mir-41
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by four chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and nicotine based on RNA-seq studies.

WB:WBGene00003270	mir-42
Is expressed in seam cell.

WB:WBGene00003271	mir-43
Is expressed in germ line and seam cell.

WB:WBGene00003272	mir-44
Is expressed in seam cell.

WB:WBGene00003273	mir-45
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00003274	mir-46
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00003275	mir-47
Is affected by several genes including hsf-1; eat-2; and alg-1 based on RNA-seq studies. Is affected by nicotine; multi-walled carbon nanotube; and Microcystin-LR based on quantitative PCR; RNA-seq; and microarray studies.

WB:WBGene00003277	mir-49
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00003278	mir-50
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is used to study Parkinson's disease.

WB:WBGene00003279	mir-51
Is expressed in arcade cell and tail hypodermis.

WB:WBGene00003280	mir-52
Is expressed in several structures, including arcade cell; coelomocyte; gonad; hypodermis; and vulva.

WB:WBGene00003281	mir-53
Is expressed in arcade cell; distal tip cell; hypodermis; muscle cell; and neurons.

WB:WBGene00003282	mir-54
Is expressed in several structures, including excretory system; hypodermis; neurons; and seam cell.

WB:WBGene00003283	mir-55
Is expressed in several structures, including excretory system; hypodermis; neurons; and seam cell.

WB:WBGene00003284	mir-56
Is expressed in several structures, including excretory system; hypodermis; neurons; and seam cell.

WB:WBGene00003285	mir-57
Is expressed in several structures, including P11; P12; body wall musculature; hypodermis; and tail spike.

WB:WBGene00003286	mir-58.1
Is expressed in several structures, including excretory cell; hypodermis; intestine; pharynx; and spermatheca.

WB:WBGene00003287	mir-59
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00003288	mir-60
Is affected by several genes including daf-12; eat-2; and glp-4 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00003289	mir-61
Is involved in gene silencing by miRNA and regulation of vulval development. Is expressed in several structures, including P5.p hermaphrodite; P5.pa; P5.pp; P7.p hermaphrodite; and P7.pa.

WB:WBGene00003290	mir-62
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00003291	mir-63
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00003292	mir-64
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is used to study Parkinson's disease.

WB:WBGene00003293	mir-65
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies. Is used to study Parkinson's disease.

WB:WBGene00003294	mir-66
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00003295	mir-67
Is expressed in body wall musculature; intestinal muscle; and vulval muscle.

WB:WBGene00003296	Y51H4A.27
No description available

WB:WBGene00003297	Y41D4B.25
Is affected by daf-12 based on tiling array studies.

WB:WBGene00003298	mir-70
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies. Is affected by methylmercury hydroxide based on RNA-seq studies.

WB:WBGene00003299	mir-71
Exhibits mRNA 3'-UTR binding activity. Is involved in several processes, including determination of adult lifespan; determination of left/right asymmetry in nervous system; and regulation of gene expression. Is expressed in several structures, including AWC; excretory cell; hypodermis; somatic gonad; and vulval precursor cell.

WB:WBGene00003300	mir-72
Is affected by several genes including daf-12; eat-2; and glp-4 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00003301	mir-73
Is affected by several genes including daf-12; eat-2; and glp-4 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00003302	mir-74
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by Microcystin-LR and sanguinarine based on microarray and RNA-seq studies.

WB:WBGene00003303	mir-75
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by methylmercury hydroxide based on RNA-seq studies.

WB:WBGene00003304	mir-76
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00003305	mir-77
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is used to study Parkinson's disease.

WB:WBGene00003306	mir-78
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by Microcystin-LR based on microarray studies.

WB:WBGene00003307	mir-79
Is expressed in hypodermis.

WB:WBGene00003308	mir-80
Is involved in regulation of gene expression. Is expressed in excretory cell; hypodermis; pharynx; somatic nervous system; and tail neurons. Is used to study Parkinson's disease.

WB:WBGene00003309	mir-81
Is affected by several genes including eat-2; alg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00003310	mir-82
Is expressed in amphid neurons; excretory gland cell; and tail neurons.

WB:WBGene00003311	mir-83
Is expressed in body wall musculature; neurons; and pharynx. Is used to study Parkinson's disease.

WB:WBGene00003312	mir-84
Is predicted to have translation repressor activity. Is involved in several processes, including miRNA mediated inhibition of translation; negative regulation of Ras protein signal transduction; and positive regulation of development, heterochronic. Is expressed in several structures, including gonad; somatic gonad precursor; touch receptor neurons; vulval cell; and vulval precursor cell. Is used to study Parkinson's disease.

WB:WBGene00003313	mir-85
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00003314	mir-86
Is expressed in dorsal nerve cord; nerve ring; tail neurons; and ventral nerve cord.

WB:WBGene00003315	mir-87
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00003316	C32E12.6
No description available

WB:WBGene00003317	C32C4.4
No description available

WB:WBGene00003318	mir-90
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by nicotine and sanguinarine based on quantitative PCR and RNA-seq studies.

WB:WBGene00003319	mir-124
Is expressed in nervous system and tail. Is used to study Werner syndrome.

WB:WBGene00003321	mir-228
Is expressed in germ line; neuronal sheath cell; and seam cell.

WB:WBGene00003322	mir-229
Is affected by several genes including eat-2; alg-1; and alg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00003323	mir-230
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by nicotine and sanguinarine based on quantitative PCR and RNA-seq studies. Is used to study Parkinson's disease.

WB:WBGene00003324	mir-231
Is expressed in muscle cell.

WB:WBGene00003325	mir-232
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00003326	mir-233
Is expressed in intestine.

WB:WBGene00003327	mir-234
Is expressed in neurons.

WB:WBGene00003328	mir-235
Is expressed in AMsoL; AMsoR; and hypodermis.

WB:WBGene00003329	mir-236
Is expressed in pharynx.

WB:WBGene00003330	mir-237
Is expressed in gonad; seam cell; somatic gonad precursor; and vulval precursor cell.

WB:WBGene00003331	mir-238
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies. Is used to study Parkinson's disease.

WB:WBGene00003332	mir-239.1
Is affected by several genes including daf-12; eat-2; and glp-4 based on tiling array and RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00003333	mir-239.2
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by graphene oxide; sodium arsenite; and paraquat based on RNA-seq studies.

WB:WBGene00003334	mir-240
Is expressed in intestinal cell.

WB:WBGene00003335	mir-241
Is involved in miRNA mediated inhibition of translation and positive regulation of development, heterochronic. Is expressed in body wall musculature; excretory canal; hermaphrodite distal tip cell; and touch receptor neurons. Is used to study Parkinson's disease.

WB:WBGene00003336	mir-242
Is affected by several genes including daf-12; alg-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by nicotine based on quantitative PCR and RNA-seq studies.

WB:WBGene00003337	mir-243
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by nicotine; multi-walled carbon nanotube; and sanguinarine based on quantitative PCR and RNA-seq studies.

WB:WBGene00003338	mir-244
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies. Is affected by graphene oxide and nicotine based on RNA-seq studies.

WB:WBGene00003339	mir-245
Is expressed in neurons.

WB:WBGene00003340	mir-246
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00003341	mir-247
Is expressed in neurons and seam cell.

WB:WBGene00003342	mir-248
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies.

WB:WBGene00003343	mir-249
Is expressed in head neurons and seam cell.

WB:WBGene00003344	mir-250
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies.

WB:WBGene00003345	mir-251
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00003346	mir-252
Is affected by several genes including eat-2; alg-1; and alg-2 based on RNA-seq studies. Is affected by Microcystin-LR based on microarray studies.

WB:WBGene00003347	mir-253
Is affected by several genes including eat-2; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00003348	mir-254
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine and sanguinarine based on RNA-seq studies.

WB:WBGene00003349	mir-255
Is affected by several genes including eat-2; alg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine and multi-walled carbon nanotube based on quantitative PCR and RNA-seq studies.

WB:WBGene00003350	mir-256
No description available

WB:WBGene00003351	mir-257
Is affected by several genes including alg-1; alg-2; and meg-3 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00003352	mir-258.1
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00003353	mir-259
Is affected by several genes including daf-12; eat-2; and alg-1 based on tiling array and RNA-seq studies. Is affected by nicotine; multi-walled carbon nanotube; and graphene oxide based on quantitative PCR and RNA-seq studies.

WB:WBGene00003354	mir-260
Is affected by several genes including glp-4; alg-1; and dpy-21 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; nicotine; and sodium arsenite based on RNA-seq studies.

WB:WBGene00003355	mir-261
No description available

WB:WBGene00003356	mir-262
Is affected by several genes including glp-4; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00003357	mir-264
No description available

WB:WBGene00003358	mir-265
No description available

WB:WBGene00003359	mir-266
No description available

WB:WBGene00003360	mir-267
No description available

WB:WBGene00003361	mir-268
Is affected by daf-12 based on tiling array studies.

WB:WBGene00003362	mir-269
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00003363	mir-270
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00003364	mir-271
No description available

WB:WBGene00003365	mir-272
No description available

WB:WBGene00003366	mir-273
Exhibits translation repressor activity, mRNA regulatory element binding. Is involved in asymmetric protein localization involved in cell fate determination; gene silencing by miRNA; and neuroblast fate determination. Is expressed in ASEL and ASER.

WB:WBGene00003367	mix-1
Is predicted to have ATP binding activity. Is involved in several processes, including dosage compensation by hypoactivation of X chromosome; mitotic chromosome condensation; and positive regulation of nematode male tail tip morphogenesis. Localizes to chromosome, centromeric region; condensed chromosome; and dosage compensation complex. Is expressed in AB. Is an ortholog of human SMC2 (structural maintenance of chromosomes 2).

WB:WBGene00003368	mkk-4
Exhibits mitogen-activated protein kinase kinase kinase binding activity. Is involved in several processes, including activation of MAPK activity; p38MAPK cascade; and regulation of nervous system development. Localizes to cytoplasm. Is expressed in head; neurons; and pharynx. Is an ortholog of human MAP2K4 (mitogen-activated protein kinase kinase 4).

WB:WBGene00003369	mlc-1
Is predicted to have calcium ion binding activity. Is involved in several processes, including muscle organ development; nematode larval development; and regulation of muscle contraction. Localizes to muscle myosin complex. Is expressed in anal depressor muscle; body wall musculature; pharyngeal muscle cell; pharynx; and vulval muscle. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 10. Is an ortholog of human MYL5 (myosin light chain 5).

WB:WBGene00003370	mlc-2
Is predicted to have calcium ion binding activity. Is involved in several processes, including nematode larval development; regulation of muscle contraction; and regulation of pharyngeal pumping. Is expressed in body wall musculature; pharyngeal muscle cell; pharynx; and vulval muscle. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 10. Is an ortholog of human MYL5 (myosin light chain 5).

WB:WBGene00003371	mlc-3
Localizes to striated muscle myosin thick filament. Is expressed in head neurons; nervous system; tail neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 8. Is an ortholog of several human genes including MYL1 (myosin light chain 1); MYL6 (myosin light chain 6); and MYL6B (myosin light chain 6B).

WB:WBGene00003372	mlc-4
Is predicted to have calcium ion binding activity. Is involved in several processes, including cytoskeleton-dependent cytokinesis; embryonic body morphogenesis; and nematode larval development. Localizes to cytoplasm and filamentous actin. Is an ortholog of human MYL9 (myosin light chain 9).

WB:WBGene00003373	mlh-1
Is predicted to have ATPase activity. Human ortholog(s) of this gene are implicated in Muir-Torre syndrome and hereditary nonpolyposis colorectal cancer type 2. Is an ortholog of human MLH1 (mutL homolog 1).

WB:WBGene00003374	mlk-1
Exhibits protein kinase C binding activity; receptor tyrosine kinase binding activity; and scaffold protein binding activity. Is involved in several processes, including activation of MAPK activity; generation of neurons; and p38MAPK cascade. Is expressed in body wall musculature; hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human MAP3K10 (mitogen-activated protein kinase kinase kinase 10) and MAP3K9 (mitogen-activated protein kinase kinase kinase 9).

WB:WBGene00003375	mlp-1
Is predicted to have metal ion binding activity. Localizes to striated muscle dense body. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1M and hypertrophic cardiomyopathy 12. Is an ortholog of human CSRP1 (cysteine and glycine rich protein 1).

WB:WBGene00003376	mls-1
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in muscle cell fate specification and post-embryonic development. Localizes to nucleus. Is expressed in anal depressor muscle and egg-laying apparatus. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in several diseases, including CAKUT2; DiGeorge syndrome; and congenital heart disease (multiple). Is an ortholog of human TBX1 (T-box transcription factor 1).

WB:WBGene00003377	mls-2
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including establishment of mitotic spindle orientation; neuron differentiation involved in amphid sensory organ development; and regulation of mesodermal cell fate specification. Localizes to nucleus. Is expressed in several structures, including M.dla; M.dra; body wall musculature; head neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in oculoauricular syndrome. Is an ortholog of human HMX1 (H6 family homeobox 1).

WB:WBGene00003378	mml-1
Is predicted to have DNA-binding transcription factor activity. Is involved in determination of adult lifespan and negative regulation of transcription by RNA polymerase II. Localizes to mitochondrion and nucleus. Is expressed in excretory cell; hypodermis; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in Williams-Beuren syndrome. Is an ortholog of human MLXIP (MLX interacting protein) and MLXIPL (MLX interacting protein like).

WB:WBGene00003379	mnm-1
No description available

WB:WBGene00003380	mnm-2
Is predicted to have metal ion binding activity. Is involved in positive regulation of axon guidance. Localizes to nucleus. Is expressed in several structures, including intestine; neurons; rectum; spermathecal-uterine junction; and vulva.

WB:WBGene00003381	mnm-3
No description available

WB:WBGene00003382	mnm-4
No description available

WB:WBGene00003384	moc-1
Is predicted to have molybdopterin adenylyltransferase activity and molybdopterin molybdotransferase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and molybdenum cofactor deficiency type C. Is an ortholog of human GPHN (gephyrin).

WB:WBGene00003385	moc-2
Is enriched in hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; lin-35; and fog-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and molybdenum cofactor deficiency type C. Is predicted to encode a protein with the following domains: Probable molybdopterin binding domain; MoaB/Mog domain; and MoaB/Mog-like domain superfamily. Is an ortholog of human GPHN (gephyrin).

WB:WBGene00003386	mod-1
Exhibits G protein-coupled serotonin receptor activity; chloride channel activity; and extracellular ligand-gated ion channel activity. Is involved in behavioral response to starvation; chloride transport; and positive regulation of fatty acid beta-oxidation by serotonin receptor signaling pathway. Localizes to neuronal cell body. Is expressed in body wall musculature and neurons. Is used to study cocaine abuse.

WB:WBGene00003387	mod-5
Exhibits serotonin:sodium symporter activity. Is involved in serotonin uptake. Is expressed in several structures, including nerve ring. Is used to study cocaine abuse. Human ortholog(s) of this gene are implicated in several diseases, including Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of human SLC6A4 (solute carrier family 6 member 4).

WB:WBGene00003388	moe-3
Is predicted to have mRNA 3'-UTR binding activity. Is expressed in coelomocyte; gonad; intestine; neurons; and ventral nerve cord. Is an ortholog of human ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00003389	mog-1
Is predicted to have RNA binding activity. Is involved in feminization of hermaphroditic germ-line. Is expressed widely. Is an ortholog of human DHX38 (DEAH-box helicase 38).

WB:WBGene00003390	mog-2
Exhibits U2 snRNA binding activity. Is involved in feminization of hermaphroditic germ-line; germline cell cycle switching, mitotic to meiotic cell cycle; and mRNA 3'-splice site recognition. Localizes to U2 snRNP and nucleoplasm. Is an ortholog of human SNRPA1 (small nuclear ribonucleoprotein polypeptide A').

WB:WBGene00003391	mog-3
Is involved in feminization of hermaphroditic germ-line and meiotic cell cycle. Localizes to nucleus. Is expressed in germ line. Is an ortholog of human CWC25 (CWC25 spliceosome associated protein homolog).

WB:WBGene00003392	mog-4
Is predicted to have RNA binding activity. Is involved in several processes, including embryonic body morphogenesis; feminization of hermaphroditic germ-line; and germ cell development. Is an ortholog of human DHX16 (DEAH-box helicase 16).

WB:WBGene00003393	mog-5
Is predicted to have RNA binding activity. Is involved in several processes, including embryonic body morphogenesis; feminization of hermaphroditic germ-line; and germ cell development.

WB:WBGene00003394	mom-1
Is predicted to have Wnt-protein binding activity and palmitoleoyltransferase activity. Is involved in several processes, including Wnt signaling pathway, regulating spindle positioning; asymmetric protein localization involved in cell fate determination; and embryonic morphogenesis. Human ortholog(s) of this gene are implicated in focal dermal hypoplasia. Is an ortholog of human PORCN (porcupine O-acyltransferase).

WB:WBGene00003395	mom-2
Exhibits receptor tyrosine kinase binding activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; embryonic morphogenesis; and generation of neurons. Is expressed in several structures, including HSN; Z2; Z3; anchor cell; and epithelial cell. Human ortholog(s) of this gene are implicated in several diseases, including Mullerian aplasia and hyperandrogenism; Schopf-Schulz-Passarge syndrome; and bone development disease (multiple).

WB:WBGene00003396	mom-4
Exhibits MAP kinase kinase kinase activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; cell fate specification; and cellular protein modification process. Localizes to striated muscle dense body. Is expressed in BAGL and BAGR. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human MAP3K7 (mitogen-activated protein kinase kinase kinase 7).

WB:WBGene00003397	mom-5
Is predicted to have Wnt-activated receptor activity. Is involved in several processes, including Wnt signaling pathway, regulating spindle positioning; embryonic morphogenesis; and generation of neurons. Is expressed in several structures, including QL.a; QR.a; QR.pa; anus; and nervous system. Human ortholog(s) of this gene are implicated in nonsyndromic congenital nail disorder 10 and omodysplasia. Is an ortholog of human FZD1 (frizzled class receptor 1) and FZD7 (frizzled class receptor 7).

WB:WBGene00003398	mor-1
No description available

WB:WBGene00003399	mor-2
No description available

WB:WBGene00003400	dapk-1
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1CC and hypertrophic cardiomyopathy 20. Is an ortholog of human DAPK1 (death associated protein kinase 1).

WB:WBGene00003401	mpk-1
Exhibits MAP kinase activity. Is involved in several processes, including cellular protein modification process; oocyte maturation; and positive regulation of macromolecule metabolic process. Localizes to cytoplasm and nucleus. Is expressed in F cell; U cell; germ line; gonad; and oocyte. Is an ortholog of human MAPK1 (mitogen-activated protein kinase 1).

WB:WBGene00003402	mpk-2
Is predicted to have ATP binding activity and MAP kinase activity. Is an ortholog of human MAPK7 (mitogen-activated protein kinase 7).

WB:WBGene00003403	mps-1
Exhibits potassium channel regulator activity and protein serine/threonine kinase activity. Is involved in several processes, including cellular protein modification process; hyperosmotic response; and mechanosensory behavior. Localizes to neuron projection membrane; neuronal cell body membrane; and voltage-gated potassium channel complex. Is expressed in amphid neurons; touch receptor neurons; and vulva.

WB:WBGene00003404	mpz-1
Exhibits GTPase activating protein binding activity. Localizes to axon. Is expressed in body wall musculature; nerve ring; neurons; and vulval muscle. Is an ortholog of human MPDZ (multiple PDZ domain crumbs cell polarity complex component) and PATJ (PATJ crumbs cell polarity complex component).

WB:WBGene00003405	mre-11
Is predicted to have 3'-5'-exodeoxyribonuclease activity and single-stranded DNA endodeoxyribonuclease activity. Localizes to nucleus. Is an ortholog of human MRE11 (MRE11 homolog, double strand break repair nuclease).

WB:WBGene00003406	mrg-1
Is involved in embryo development; germ cell development; and regulation of transcription by RNA polymerase II. Localizes to autosome. Is expressed in several structures, including Caa; Cpa; Ea; Psub4; and oocyte. Is an ortholog of human MORF4L1 (mortality factor 4 like 1) and MORF4L2 (mortality factor 4 like 2).

WB:WBGene00003407	mrp-1
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in RNA interference; dauer larval development; and stress response to metal ion. Localizes to integral component of plasma membrane. Is expressed in several structures, including intestine; pharyngeal-intestinal valve; pharynx; rectal valve cell; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; arterial calcification of infancy; and diabetes mellitus (multiple). Is an ortholog of human ABCC1 (ATP binding cassette subfamily C member 1) and ABCC3 (ATP binding cassette subfamily C member 3).

WB:WBGene00003408	mrp-2
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC3 (ATP binding cassette subfamily C member 3).

WB:WBGene00003409	mrp-3
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC2 (ATP binding cassette subfamily C member 2).

WB:WBGene00003410	mrp-4
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in lipid transport involved in lipid storage and lysosome organization. Localizes to endocytic vesicle and gut granule. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC2 (ATP binding cassette subfamily C member 2).

WB:WBGene00003411	mrp-5
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in several structures, including body wall musculature; hypodermis; intestine; muscle cell; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC5 (ATP binding cassette subfamily C member 5).

WB:WBGene00003412	mrp-6
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC4 (ATP binding cassette subfamily C member 4).

WB:WBGene00003413	mrp-7
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in response to methylmercury. Is expressed in DA neuron. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and cystic fibrosis. Is an ortholog of human ABCC2 (ATP binding cassette subfamily C member 2).

WB:WBGene00003414	mrp-8
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including Dubin-Johnson syndrome; bronchiectasis 1; and diabetes mellitus (multiple). Is an ortholog of human ABCC2 (ATP binding cassette subfamily C member 2).

WB:WBGene00003415	mars-1
Is predicted to have ATP binding activity; methionine-tRNA ligase activity; and tRNA binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2U. Is an ortholog of human MARS1 (methionyl-tRNA synthetase 1).

WB:WBGene00003416	mars-2
No description available

WB:WBGene00003417	mrt-2
Is predicted to have 3'-5' exonuclease activity and damaged DNA binding activity. Is involved in DNA damage checkpoint; DNA metabolic process; and intrinsic apoptotic signaling pathway in response to DNA damage. Is an ortholog of human RAD1 (RAD1 checkpoint DNA exonuclease).

WB:WBGene00003418	msh-2
Is predicted to contribute to DNA binding activity and MutLalpha complex binding activity. Is involved in DNA metabolic process; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; and reproduction. Human ortholog(s) of this gene are implicated in Lynch syndrome 1 and Muir-Torre syndrome. Is an ortholog of human MSH2 (mutS homolog 2).

WB:WBGene00003419	msh-3
No description available

WB:WBGene00003420	msh-4
Is enriched in Z1.p; Z4.a; germline precursor cell; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00003421	msh-5
Is predicted to have DNA-dependent ATPase activity. Is involved in chiasma assembly. Localizes to nucleus. Is an ortholog of human MSH5 (mutS homolog 5).

WB:WBGene00003422	msh-6
Is predicted to contribute to MutLalpha complex binding activity; oxidized purine DNA binding activity; and single thymine insertion binding activity. Is involved in maintenance of DNA repeat elements and mismatch repair. Is used to study Lynch syndrome. Human ortholog(s) of this gene are implicated in endometrial cancer and hereditary nonpolyposis colorectal cancer type 5. Is an ortholog of human MSH6 (mutS homolog 6).

WB:WBGene00003423	msi-1
Exhibits mRNA binding activity. Is involved in nervous system process. Localizes to cytoplasm. Is expressed in SMDVL; head neurons; and intestine. Is an ortholog of human MSI2 (musashi RNA binding protein 2).

WB:WBGene00003424	msp-3
Is expressed in gonad; oocyte; and spermatocyte. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003425	msp-10
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003426	msp-19
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003427	msp-24
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003428	msp-29
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003429	msp-31
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003430	msp-32
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003431	msp-33
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003432	msp-36
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003433	msp-37
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003434	msp-38
Is involved in oocyte maturation and positive regulation of smooth muscle contraction. Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003435	msp-40
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003436	msp-41
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003437	msp-42
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003438	msp-45
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003439	msp-46
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003440	msp-47
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003441	msp-48
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003442	msp-49
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003443	msp-50
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003444	msp-51
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003445	msp-52
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003446	msp-53
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003447	msp-54
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003448	msp-55
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003449	msp-56
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003450	msp-57
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003451	msp-58
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003452	msp-59
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003453	msp-60
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003454	msp-61
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003455	msp-62
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003456	msp-63
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003457	msp-64
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003458	msp-65
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003459	msp-70
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003460	msp-71
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003461	msp-72
Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003462	msp-74
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003463	msp-76
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003464	msp-77
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003465	msp-78
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003466	msp-79
Is involved in oocyte maturation; positive regulation of MAPK cascade; and positive regulation of smooth muscle contraction. Is expressed in gonad; oocyte; and sperm.

WB:WBGene00003467	msp-81
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003468	msp-113
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003469	msp-142
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003470	msp-152
Is expressed in gonad; oocyte; and sperm. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00003471	mtd-1
Is expressed in touch receptor neurons.

WB:WBGene00003472	mtk-1
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human MAP3K4 (mitogen-activated protein kinase kinase kinase 4).

WB:WBGene00003473	mtl-1
Is predicted to have cadmium ion binding activity; copper ion binding activity; and zinc ion binding activity. Is involved in several processes, including response to cadmium ion; response to lead ion; and response to mercury ion. Is expressed in intestine; pharynx; and terminal bulb.

WB:WBGene00003474	mtl-2
Is predicted to have metal ion binding activity. Is involved in response to cadmium ion and response to heat. Is expressed in intestinal cell and intestine.

WB:WBGene00003475	mtm-1
Exhibits phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; phosphatidylinositol-3-phosphatase activity; and phosphatidylinositol-4,5-bisphosphate binding activity. Is involved in negative regulation of engulfment of apoptotic cell and phospholipid dephosphorylation. Localizes to apical cortex; cytosol; and plasma membrane. Is expressed in several structures, including coelomocyte; hermaphrodite somatic gonadal cell; neurons; pharynx; and vulva. Is used to study centronuclear myopathy. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4B1; Charcot-Marie-Tooth disease type 4B2; and centronuclear myopathy X-linked. Is an ortholog of human MTMR1 (myotubularin related protein 1) and MTMR2 (myotubularin related protein 2).

WB:WBGene00003476	mtm-3
Exhibits phosphatase activity. Is involved in several processes, including inositol phosphate dephosphorylation; positive regulation of autophagosome maturation; and regulation of endocytosis. Localizes to cytoplasm. Is expressed in body wall musculature and head neurons. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4B2 and centronuclear myopathy X-linked. Is an ortholog of human MTMR3 (myotubularin related protein 3).

WB:WBGene00003477	mtm-5
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4B2; Charcot-Marie-Tooth disease type 4B3; and centronuclear myopathy X-linked. Is an ortholog of human SBF2 (SET binding factor 2).

WB:WBGene00003478	mtm-6
Exhibits phosphatase binding activity. Is involved in several processes, including nematode larval development; phosphatidylinositol metabolic process; and pinocytosis. Localizes to apical plasma membrane and cytosol. Is expressed in several structures, including anal depressor muscle; coelomocyte; intestinal cell; preanal ganglion; and tail. Is used to study centronuclear myopathy. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4B2 and centronuclear myopathy X-linked. Is an ortholog of human MTMR6 (myotubularin related protein 6).

WB:WBGene00003479	mtm-9
Exhibits phosphatase binding activity. Is involved in pinocytosis and regulation of cell migration. Localizes to cytosol and plasma membrane. Is expressed in several structures, including CAN; PDE; coelomocyte; epithelial cell; and vulva. Is used to study centronuclear myopathy. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4B2 and centronuclear myopathy X-linked. Is an ortholog of human MTMR9 (myotubularin related protein 9).

WB:WBGene00003480	klf-3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in fatty acid homeostasis. Is expressed in germ line and vulva. Is used to study obesity. Human ortholog(s) of this gene are implicated in several diseases, including chromosome 15q13.3 microdeletion syndrome; maturity-onset diabetes of the young type 7; and prostate cancer. Is an ortholog of human KLF2 (Kruppel like factor 2).

WB:WBGene00003481	mua-2
No description available

WB:WBGene00003482	mua-3
Is predicted to have collagen binding activity and intermediate filament binding activity. Is involved in cell-matrix adhesion. Localizes to hemidesmosome and intermediate filament. Is expressed in several structures, including amphid neurons; enteric muscle; excretory system; phasmid sensillum; and rectum. Is used to study Marfan syndrome. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple).

WB:WBGene00003483	mua-4
No description available

WB:WBGene00003484	mua-5
No description available

WB:WBGene00003485	mua-6
Is involved in cell-cell adhesion. Localizes to hemidesmosome. Is expressed in hypodermis; touch receptor neurons; uterus; and ventral cord neurons. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is an ortholog of human LMNB2 (lamin B2).

WB:WBGene00003486	mua-7
No description available

WB:WBGene00003487	mua-8
No description available

WB:WBGene00003488	mua-9
No description available

WB:WBGene00003489	mua-10
No description available

WB:WBGene00003490	mud-1
No description available

WB:WBGene00003491	mum-1
No description available

WB:WBGene00003492	mum-2
No description available

WB:WBGene00003493	mum-3
No description available

WB:WBGene00003494	mup-1
No description available

WB:WBGene00003495	mup-2
Is predicted to contribute to calcium-dependent ATPase activity and tropomyosin binding activity. Is involved in several processes, including axonal fasciculation; larval somatic muscle development; and sarcomere organization. Human ortholog(s) of this gene are implicated in intrinsic cardiomyopathy (multiple) and muscle tissue disease (multiple). Is an ortholog of human TNNT1 (troponin T1, slow skeletal type) and TNNT3 (troponin T3, fast skeletal type).

WB:WBGene00003496	mup-3
No description available

WB:WBGene00003497	mup-4
Is predicted to have calcium ion binding activity. Localizes to hemidesmosome and hemidesmosome associated protein complex. Is expressed in body wall musculature; hypodermis; pharynx; seam cell; and touch receptor neurons. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is an ortholog of human MATN2 (matrilin 2) and MATN4 (matrilin 4).

WB:WBGene00003498	mut-1
No description available

WB:WBGene00003499	mut-2
Is predicted to have nucleotidyltransferase activity. Is involved in embryo development; meiotic chromosome segregation; and negative regulation of macromolecule metabolic process. Localizes to perinuclear region of cytoplasm. Is expressed in germ line. Human ortholog(s) of this gene are implicated in spastic ataxia 4.

WB:WBGene00003500	mut-3
No description available

WB:WBGene00003501	mut-4
No description available

WB:WBGene00003502	mut-5
No description available

WB:WBGene00003503	mut-6
No description available

WB:WBGene00003504	mut-7
Is predicted to have 3'-5'-exoribonuclease activity involved in mature miRNA 3'-end processing. Is involved in RNA interference; negative regulation of transposition, DNA-mediated; and olfactory learning. Localizes to cytosol; nucleus; and perinuclear region of cytoplasm. Is expressed in AWCL; AWCR; and somatic cell. Is an ortholog of human EXD3 (exonuclease 3'-5' domain containing 3).

WB:WBGene00003506	mut-9
No description available

WB:WBGene00003507	mut-14
Is predicted to have RNA binding activity and RNA helicase activity. Is involved in RNA interference. Localizes to perinuclear region of cytoplasm. Is expressed in germ cell and germ line.

WB:WBGene00003508	mut-16
Is involved in production of siRNA involved in RNA interference. Localizes to nucleus and perinuclear region of cytoplasm. Is expressed in several structures, including germ cell; germ line; and somatic cell.

WB:WBGene00003509	mxl-1
Exhibits protein domain specific binding activity and protein heterodimerization activity. Contributes to sequence-specific DNA binding activity. Is involved in determination of adult lifespan. Localizes to nucleus and transcription factor complex. Is expressed in tail neurons. Human ortholog(s) of this gene are implicated in pheochromocytoma. Is an ortholog of human MAX (MYC associated factor X).

WB:WBGene00003510	mxl-2
Is predicted to have DNA-binding transcription factor activity. Is involved in determination of adult lifespan and negative regulation of gene expression. Localizes to cytoplasm and nucleus. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in Williams-Beuren syndrome. Is an ortholog of human MLX (MAX dimerization protein MLX).

WB:WBGene00003511	mxl-3
Exhibits DNA-binding transcription factor activity and RNA polymerase II regulatory region DNA binding activity. Is involved in regulation of fatty acid biosynthetic process and transcription by RNA polymerase II. Localizes to cytoplasm and nucleus. Is expressed in AWCL; AWCR; neurons; and pharynx. Is used to study diabetes mellitus. Human ortholog(s) of this gene are implicated in pheochromocytoma. Is an ortholog of human MAX (MYC associated factor X).

WB:WBGene00003514	myo-2
Is predicted to have microfilament motor activity. Is expressed in neurons and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH6 (myosin heavy chain 6) and MYH7 (myosin heavy chain 7).

WB:WBGene00003515	myo-3
Exhibits motor activity. Is involved in locomotory behavior and positive regulation of ovulation. Localizes to A band and striated muscle myosin thick filament. Is expressed in body wall musculature; enteric muscle; gonad; vulval muscle; and in male. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH6 (myosin heavy chain 6) and MYH7 (myosin heavy chain 7).

WB:WBGene00003516	nab-1
Is predicted to have actin filament binding activity. Is involved in synapse assembly. Localizes to cytoskeleton; presynaptic active zone; and presynaptic periactive zone. Is expressed in several structures, including egg-laying apparatus; excretory canal; hermaphrodite distal tip cell; neurons; and somatic nervous system. Is an ortholog of human PPP1R9A (protein phosphatase 1 regulatory subunit 9A) and PPP1R9B (protein phosphatase 1 regulatory subunit 9B).

WB:WBGene00003517	nac-1
Exhibits low-affinity sodium:dicarboxylate symporter activity and succinate transmembrane transporter activity. Is involved in succinate transport. Is expressed in alimentary system. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 25. Is an ortholog of human SLC13A2 (solute carrier family 13 member 2); SLC13A3 (solute carrier family 13 member 3); and SLC13A5 (solute carrier family 13 member 5).

WB:WBGene00003518	nac-2
Exhibits citrate transmembrane transporter activity and succinate transmembrane transporter activity. Is involved in several processes, including carboxylic acid transport; determination of adult lifespan; and lipid metabolic process. Is expressed in rect_D; rect_VL; and rect_VR. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 25. Is an ortholog of human SLC13A2 (solute carrier family 13 member 2); SLC13A3 (solute carrier family 13 member 3); and SLC13A5 (solute carrier family 13 member 5).

WB:WBGene00003519	nac-3
Exhibits high-affinity sodium:dicarboxylate symporter activity and succinate transmembrane transporter activity. Is involved in determination of adult lifespan and succinate transport. Is expressed in alimentary system. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 25. Is an ortholog of human SLC13A2 (solute carrier family 13 member 2); SLC13A3 (solute carrier family 13 member 3); and SLC13A5 (solute carrier family 13 member 5).

WB:WBGene00003520	nas-1
Is predicted to have metalloendopeptidase activity. Is expressed in arcade cell; marginal cell; and pharyngeal muscle cell. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003521	nas-2
Is predicted to have metalloendopeptidase activity. Is expressed in head; intestine; and rectal gland cell.

WB:WBGene00003522	nas-3
Is predicted to have metalloendopeptidase activity. Is expressed in PDE; hypodermal cell; intestine; and pharyngeal muscle cell.

WB:WBGene00003523	nas-4
Is predicted to have metalloendopeptidase activity. Is expressed in intestine; marginal cell; and pharynx. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003524	nas-5
Is predicted to have metalloendopeptidase activity. Is involved in pharyngeal pumping and pharynx development. Is expressed in marginal cell; pharyngeal gland cell; rectal gland cell; and uterine seam cell.

WB:WBGene00003525	nas-6
Is predicted to have metalloendopeptidase activity. Is involved in pharyngeal pumping and pharynx development. Is expressed in body wall musculature; hyp7 syncytium; intestine; mc2; and pharyngeal muscle cell. Is an ortholog of human MEP1A (meprin A subunit alpha) and MEP1B (meprin A subunit beta).

WB:WBGene00003526	nas-7
Is predicted to have metalloendopeptidase activity. Is involved in pharyngeal pumping and pharynx development. Is expressed in several structures, including arcade cell; hypodermis; pharyngeal cell; spermatheca; and vulva. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003527	nas-8
Is predicted to have metalloendopeptidase activity. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003528	nas-9
Is predicted to have metalloendopeptidase activity. Is expressed in hyp7 syncytium; spermatheca; and uterus.

WB:WBGene00003529	nas-10
Is predicted to have metalloendopeptidase activity and zinc ion binding activity.

WB:WBGene00003530	nas-11
Is predicted to have metalloendopeptidase activity. Is expressed in hyp7 syncytium; intestine; and neuronal sheath cell.

WB:WBGene00003531	nas-12
Is predicted to have metalloendopeptidase activity. Is expressed in g1AL; g1AR; g1P; g2L; and g2R. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003532	nas-13
Is predicted to have metalloendopeptidase activity. Is expressed in IL2L; IL2R; and amphid neurons. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003533	nas-14
Is predicted to have metalloendopeptidase activity. Is expressed in marginal cell and pharyngeal muscle cell. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003534	nas-15
Is predicted to have metalloendopeptidase activity. Is expressed in marginal cell; pm3; pm4; pm5; and pm6. Is an ortholog of human ASTL (astacin like metalloendopeptidase).

WB:WBGene00003535	nas-16
Is predicted to have metalloendopeptidase activity. Is expressed in intestine.

WB:WBGene00003536	nas-17
Is predicted to have metalloendopeptidase activity.

WB:WBGene00003537	nas-18
Is predicted to have metalloendopeptidase activity.

WB:WBGene00003538	nas-19
Is predicted to have metalloendopeptidase activity. Is expressed in marginal cell; pharyngeal muscle cell; rectal gland cell; and spermatheca.

WB:WBGene00003539	nas-20
Is predicted to have metalloendopeptidase activity.

WB:WBGene00003540	nas-21
Is predicted to have metalloendopeptidase activity. Is expressed in gonad; hyp7 syncytium; intestine; and uterine seam cell.

WB:WBGene00003541	nas-22
Is predicted to have metalloendopeptidase activity.

WB:WBGene00003542	nas-23
Is predicted to have metalloendopeptidase activity. Is expressed in hyp7 syncytium; intestine; pharyngeal muscle cell; and rectum.

WB:WBGene00003543	nas-24
Is predicted to have metalloendopeptidase activity.

WB:WBGene00003544	nas-25
Is predicted to have metalloendopeptidase activity. Is expressed in arcade cell; marginal cell; and rectal gland cell.

WB:WBGene00003545	nas-27
Is predicted to have metalloendopeptidase activity. Is expressed in hyp7 syncytium; intestine; and rectal epithelium.

WB:WBGene00003546	nas-28
Is predicted to have metalloendopeptidase activity. Is expressed in coelomocyte; intestine; and pharyngeal muscle cell.

WB:WBGene00003547	nas-29
Is predicted to have metalloendopeptidase activity.

WB:WBGene00003548	nas-30
Is predicted to have metalloendopeptidase activity. Is expressed in rectal epithelium.

WB:WBGene00003549	nas-31
Is predicted to have metalloendopeptidase activity. Is expressed in AMshL; AMshR; PHshL; PHshR; and head.

WB:WBGene00003550	nas-32
Is predicted to have metalloendopeptidase activity. Is expressed in head mesodermal cell; head neurons; and non-striated muscle.

WB:WBGene00003551	nas-33
Is predicted to have metalloendopeptidase activity. Is expressed in hyp12; intestine; and tail hypodermis.

WB:WBGene00003552	nas-36
Is predicted to have metalloendopeptidase activity. Is involved in molting cycle. Is expressed in hypodermal cell and vulva.

WB:WBGene00003553	nas-37
Exhibits metalloendopeptidase activity. Is involved in collagen and cuticulin-based cuticle development and ecdysis, collagen and cuticulin-based cuticle. Localizes to extracellular region. Is expressed in cuticle; epithelial cell; intestine; and rectal gland cell.

WB:WBGene00003554	nas-38
Is predicted to have metalloendopeptidase activity. Is involved in PERK-mediated unfolded protein response.

WB:WBGene00003555	nas-39
Is predicted to have metallopeptidase activity. Is expressed in neurons and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in atrial heart septal defect 6 and osteogenesis imperfecta type 13. Is an ortholog of human BMP1 (bone morphogenetic protein 1); TLL1 (tolloid like 1); and TLL2 (tolloid like 2).

WB:WBGene00003556	nas-40
Is enriched in male based on RNA-seq studies. Is affected by rrf-3 based on RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00003558	nca-2
Is predicted to have cation channel activity. Is involved in positive regulation of GABAergic synaptic transmission; positive regulation of cholinergic synaptic transmission; and positive regulation of locomotion. Is expressed in several structures, including intestine; pharyngeal neurons; and somatic nervous system. Is an ortholog of human NALCN (sodium leak channel, non-selective).

WB:WBGene00003559	ncl-1
Exhibits translation repressor activity. Is involved in several processes, including negative regulation of ribosome biogenesis; negative regulation of transcription, DNA-templated; and nucleologenesis. Localizes to cytoplasm. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human TRIM2 (tripartite motif containing 2) and TRIM3 (tripartite motif containing 3).

WB:WBGene00003560	ncl-2
No description available

WB:WBGene00003561	ncr-1
Is involved in several processes, including cholesterol homeostasis; positive regulation of growth rate; and regulation of oviposition. Is expressed in several structures, including excretory cell; head neurons; hypodermis; lumbar neurons; and pharynx. Is used to study Niemann-Pick disease. Is an ortholog of human NPC1 (NPC intracellular cholesterol transporter 1) and NPC1L1 (NPC1 like intracellular cholesterol transporter 1).

WB:WBGene00003562	ncr-2
Is involved in cholesterol homeostasis; cholesterol transport; and nematode larval development. Is expressed in XXXL; XXXR; gonadal sheath cell; spermatheca; and ventral nerve cord. Is used to study Niemann-Pick disease. Human ortholog(s) of this gene are implicated in Niemann-Pick disease type C1. Is an ortholog of human NPC1 (NPC intracellular cholesterol transporter 1).

WB:WBGene00003563	ncs-1
Is predicted to have calcium ion binding activity. Is involved in chemosensory behavior; chemotaxis; and response to alkaline pH. Localizes to neuronal cell body. Is expressed in head neurons; pm1; and tail neurons. Is an ortholog of human NCS1 (neuronal calcium sensor 1).

WB:WBGene00003564	ncs-2
Is predicted to have calcium ion binding activity. Is expressed in GABAergic neurons; cholinergic neurons; and nervous system. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14 and retinitis pigmentosa 48. Is an ortholog of human RCVRN (recoverin).

WB:WBGene00003565	ncs-3
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14 and retinitis pigmentosa 48.

WB:WBGene00003566	ncx-1
Is predicted to have calcium:sodium antiporter activity. Is expressed in AIYL and AIYR. Human ortholog(s) of this gene are implicated in Fraser syndrome (multiple); Usher syndrome type 2C; and familial febrile seizures 4. Is an ortholog of human SLC8A3 (solute carrier family 8 member A3).

WB:WBGene00003567	ncx-2
Is predicted to have calcium:sodium antiporter activity. Is expressed in non-striated muscle and pharynx. Is an ortholog of human SLC8A1 (solute carrier family 8 member A1); SLC8A2 (solute carrier family 8 member A2); and SLC8A3 (solute carrier family 8 member A3).

WB:WBGene00003568	ncx-3
Is predicted to have calcium:sodium antiporter activity. Is expressed in dorsal nerve cord; head neurons; phasmid neurons; and ventral nerve cord. Is an ortholog of human SLC8A2 (solute carrier family 8 member A2).

WB:WBGene00003569	ncx-4
Is predicted to have calcium channel activity and calcium, potassium:sodium antiporter activity. Is expressed in amphid neurons; labial sensillum; somatic nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1D. Is an ortholog of human SLC24A2 (solute carrier family 24 member 2).

WB:WBGene00003570	ncx-5
Is predicted to have calcium channel activity and calcium, potassium:sodium antiporter activity. Is expressed in oxygen sensory neurons. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1D. Is an ortholog of human SLC24A2 (solute carrier family 24 member 2).

WB:WBGene00003571	ncx-6
Is predicted to have antiporter activity. Is expressed in ADLL and ADLR. Is an ortholog of human SLC8B1 (solute carrier family 8 member B1).

WB:WBGene00003572	ncx-7
Is predicted to have antiporter activity. Is expressed in ADLL; ADLR; amphid neurons; and tail neurons. Is an ortholog of human SLC8B1 (solute carrier family 8 member B1).

WB:WBGene00003573	ncx-8
Is expressed in intestine and pharynx. Is predicted to encode a protein with the following domains: Sodium/calcium exchanger protein and Sodium/calcium exchanger membrane region. Is an ortholog of human SLC8B1 (solute carrier family 8 member B1).

WB:WBGene00003574	ncx-9
Exhibits calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential. Is involved in calcium export from the mitochondrion and regulation of dorsal/ventral axon guidance. Localizes to mitochondrion. Is expressed in head neurons; neurons; and seam cell. Is an ortholog of human SLC8B1 (solute carrier family 8 member B1).

WB:WBGene00003575	ncx-10
Is expressed in pharyngeal muscle cell and terminal bulb. Is predicted to encode a protein with the following domains: Sodium/calcium exchanger protein and Sodium/calcium exchanger membrane region. Is an ortholog of human SLC8B1 (solute carrier family 8 member B1).

WB:WBGene00003576	ndc-80
Exhibits protein domain specific binding activity. Is involved in several processes, including chromosome organization; positive regulation of chromosome organization; and positive regulation of protein localization to kinetochore. Localizes to Ndc80 complex. Is an ortholog of human NDC80 (NDC80 kinetochore complex component).

WB:WBGene00003577	ndg-4
Is expressed in hyp3; hyp5; and intestine. Is predicted to encode a protein with the following domain: Nose resistant-to-fluoxetine protein, N-terminal.

WB:WBGene00003578	ndx-1
Is predicted to have hydrolase activity and metal ion binding activity. Localizes to sarcoplasmic reticulum. Is expressed in spermatheca and vulval muscle. Is an ortholog of human NUDT18 (nudix hydrolase 18).

WB:WBGene00003579	ndx-2
Is predicted to have ADP-ribose diphosphatase activity. Is an ortholog of human NUDT5 (nudix hydrolase 5).

WB:WBGene00003580	ndx-3
Is predicted to have hydrolase activity and metal ion binding activity. Is an ortholog of human NUDT8 (nudix hydrolase 8).

WB:WBGene00003581	ndx-4
Exhibits 5-phosphoribosyl 1-pyrophosphate pyrophosphatase activity and bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity. Is involved in nucleotide metabolic process. Is an ortholog of human NUDT2 (nudix hydrolase 2).

WB:WBGene00003582	dcap-2
Exhibits m7G(5')pppN diphosphatase activity. Is involved in several processes, including deadenylation-dependent decapping of nuclear-transcribed mRNA; determination of adult lifespan; and nematode larval development. Localizes to P granule and P-body. Is an ortholog of human DCP2 (decapping mRNA 2).

WB:WBGene00003583	ndx-6
Is predicted to have adenosine-diphosphatase activity. Is an ortholog of human NUDT9 (nudix hydrolase 9).

WB:WBGene00003584	ndx-7
Is predicted to have hydrolase activity and metal ion binding activity. Is an ortholog of human NUDT19 (nudix hydrolase 19).

WB:WBGene00003585	ndx-8
Exhibits acetyl-CoA hydrolase activity; hydroxymethylglutaryl-CoA hydrolase activity; and succinyl-CoA hydrolase activity. Is involved in coenzyme A catabolic process. Is an ortholog of human NUDT7 (nudix hydrolase 7).

WB:WBGene00003586	ndx-9
Is predicted to have NADH pyrophosphatase activity. Is an ortholog of human NUDT13 (nudix hydrolase 13).

WB:WBGene00003587	ned-8
Is predicted to have protein tag and ubiquitin protein ligase binding activity. Is involved in negative regulation of DNA damage response, signal transduction by p53 class mediator; negative regulation of gene expression; and regulation of apoptotic process. Localizes to cytoplasm and nucleus. Is an ortholog of human NEDD8 (NEDD8 ubiquitin like modifier).

WB:WBGene00003588	nex-1
Exhibits heparin binding activity and phospholipid binding activity. Is involved in engulfment of apoptotic cell. Localizes to intracellular membrane-bounded organelle and plasma membrane. Is expressed in hypodermis; pharynx; spermathecal-uterine junction; uterine toroidal epithelial cell; and vulva. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 23. Is an ortholog of human ANXA13 (annexin A13).

WB:WBGene00003589	nex-2
Exhibits anion binding activity. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 23. Is an ortholog of human ANXA11 (annexin A11) and ANXA7 (annexin A7).

WB:WBGene00003590	nex-3
Exhibits anion binding activity. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 23.

WB:WBGene00003591	nex-4
Is predicted to have calcium ion binding activity; heparin binding activity; and phospholipid binding activity. Is an ortholog of several human genes including ANXA10 (annexin A10); ANXA7 (annexin A7); and ANXA8L1 (annexin A8 like 1).

WB:WBGene00003592	nfi-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including determination of adult lifespan; regulation of oviposition; and regulation of pharyngeal pumping. Is expressed in several structures, including body wall musculature; egg-laying apparatus; intestine; neurons; and pharynx. Human ortholog(s) of this gene are implicated in Marshall-Smith syndrome; NFIA-related disorder; and Sotos syndrome. Is an ortholog of human NFIA (nuclear factor I A); NFIB (nuclear factor I B); and NFIC (nuclear factor I C).

WB:WBGene00003593	nfm-1
Is predicted to have actin binding activity. Is expressed in excretory gland cell; intestinal cell; pharyngeal muscle cell; and rectal gland cell. Human ortholog(s) of this gene are implicated in neurilemmomatosis and neurofibromatosis 2. Is an ortholog of human NF2 (neurofibromin 2).

WB:WBGene00003594	nft-1
Exhibits bis(5'-adenosyl)-triphosphatase activity. Is involved in nucleobase-containing compound metabolic process. Is expressed in tail. Is an ortholog of human NIT1 (nitrilase 1).

WB:WBGene00003595	ngn-1
Is predicted to have protein dimerization activity. Is expressed in ABaraappaa. Human ortholog(s) of this gene are implicated in congenital malabsorptive diarrhea 4; diabetes mellitus (multiple); and persistent hyperplastic primary vitreous. Is an ortholog of human NEUROG1 (neurogenin 1) and NEUROG3 (neurogenin 3).

WB:WBGene00003596	ngp-1
Is predicted to have GTP binding activity. Is an ortholog of human GNL2 (G protein nucleolar 2).

WB:WBGene00003597	nhl-1
Exhibits ubiquitin-protein transferase activity. Is involved in protein ubiquitination. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Charcot-Marie-Tooth disease type 2R; and Opitz-GBBB syndrome. Is an ortholog of human TRIM2 (tripartite motif containing 2) and TRIM3 (tripartite motif containing 3).

WB:WBGene00003598	nhl-2
Exhibits DEAD/H-box RNA helicase binding activity. Is involved in positive regulation of development, heterochronic; protein localization to cell cortex; and regulation of establishment of cell polarity. Localizes to P granule and P-body. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human TRIM45 (tripartite motif containing 45).

WB:WBGene00003599	nhl-3
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human PML (PML nuclear body scaffold).

WB:WBGene00003600	nhr-1
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00003601	nhr-2
Is predicted to have several functions, including DNA-binding transcription factor activity; nuclear receptor transcription coactivator activity; and transcription factor binding activity. Localizes to nucleus. Is expressed in several structures, including Cpaaaa; Cpaaap; Cpaapa; Cpaapp; and germ line. Human ortholog(s) of this gene are implicated in congenital nongoitrous hypothyroidism 6.

WB:WBGene00003602	nhr-3
Is predicted to have chromatin binding activity; nuclear receptor activity; and transcription regulatory region sequence-specific DNA binding activity. Is expressed in head neurons; hypodermis; muscle cell; and ventral nerve cord.

WB:WBGene00003603	nhr-4
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Is expressed in intestine; neurons; pharynx; and tail.

WB:WBGene00003604	nhr-5
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003605	nhr-6
Exhibits DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is involved in positive regulation of transcription by RNA polymerase II; regulation of ovulation; and spermathecum morphogenesis. Localizes to nucleus. Is expressed in chemosensory neurons and spermatheca. Human ortholog(s) of this gene are implicated in extraskeletal myxoid chondrosarcoma and late onset Parkinson's disease. Is an ortholog of human NR4A1 (nuclear receptor subfamily 4 group A member 1) and NR4A2 (nuclear receptor subfamily 4 group A member 2).

WB:WBGene00003606	nhr-7
Is predicted to have several functions, including DNA-binding transcription factor activity; nuclear receptor transcription coactivator activity; and transcription factor binding activity.

WB:WBGene00003607	nhr-8
Is predicted to have several functions, including nuclear receptor activity; nuclear receptor transcription coactivator activity; and transcription factor binding activity. Is involved in cholesterol homeostasis. Localizes to nucleus. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8. Is an ortholog of human NR1I2 (nuclear receptor subfamily 1 group I member 2); NR1I3 (nuclear receptor subfamily 1 group I member 3); and VDR (vitamin D receptor).

WB:WBGene00003608	nhr-9
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003609	nhr-10
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00003610	nhr-11
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003611	nhr-12
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003612	nhr-13
Is predicted to have DNA-binding transcription factor activity. Is expressed in intestine.

WB:WBGene00003613	nhr-14
Exhibits steroid hormone binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003614	nhr-15
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head muscle and pharynx.

WB:WBGene00003615	nhr-16
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003616	nhr-17
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human RXRA (retinoid X receptor alpha) and RXRG (retinoid X receptor gamma).

WB:WBGene00003617	nhr-18
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in anal depressor muscle; intestinal muscle; and vulval muscle.

WB:WBGene00003618	nhr-19
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity.

WB:WBGene00003619	nhr-20
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head and tail.

WB:WBGene00003620	nhr-21
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003621	nhr-22
Is predicted to have DNA-binding transcription factor activity. Localizes to cytosol and nucleus. Is expressed in coelomocyte; hypodermis; intestine; neurons; and non-striated muscle.

WB:WBGene00003622	nhr-23
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in molting cycle and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in gonad; head neurons; and oocyte. Human ortholog(s) of this gene are implicated in idiopathic generalized epilepsy 15. Is an ortholog of human RORB (RAR related orphan receptor B) and RORC (RAR related orphan receptor C).

WB:WBGene00003623	nhr-25
Exhibits armadillo repeat domain binding activity. Is involved in molting cycle; positive regulation of nematode male tail tip morphogenesis; and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including excretory system; gonad; hypodermal cell; tail; and vulval precursor cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8. Is an ortholog of human NR5A1 (nuclear receptor subfamily 5 group A member 1) and NR5A2 (nuclear receptor subfamily 5 group A member 2).

WB:WBGene00003624	nhr-28
Is predicted to have DNA-binding transcription factor activity. Is expressed in hypodermis; intestine; and pharynx.

WB:WBGene00003625	nhr-31
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Is involved in embryo development; post-embryonic animal morphogenesis; and response to osmotic stress. Is expressed in excretory cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003626	nhr-32
Is predicted to have DNA-binding transcription factor activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003627	nhr-34
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003628	nhr-35
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003629	nhr-38
Is predicted to have chromatin binding activity; nuclear receptor activity; and transcription regulatory region sequence-specific DNA binding activity. Is expressed in AFDL and AFDR.

WB:WBGene00003630	nhr-40
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including P1; P2; egg-laying apparatus; rectal gland cell; and somatic nervous system.

WB:WBGene00003632	nhr-42
Is predicted to have DNA-binding transcription factor activity. Is expressed in hypodermis; intestine; and pharynx.

WB:WBGene00003633	nhr-43
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in dorsal nerve cord; excretory cell; head neurons; hypodermis; and intestine.

WB:WBGene00003634	nhr-44
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head muscle; intestine; neurons; and pharynx.

WB:WBGene00003635	nhr-45
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003636	nhr-46
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Is expressed in several structures, including hypodermis; intestine; muscle cell; neurons; and spermatheca.

WB:WBGene00003637	nhr-47
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head neurons; spermatheca; tail neurons; and ventral nerve cord.

WB:WBGene00003638	nhr-48
Is predicted to have several functions, including DNA-binding transcription factor activity; nuclear receptor transcription coactivator activity; and transcription factor binding activity. Is expressed in several structures, including anterior gonad arm; pharyngeal gland cell; and spermatheca. Human ortholog(s) of this gene are implicated in osteoporosis and rickets. Is an ortholog of human NR1I2 (nuclear receptor subfamily 1 group I member 2) and VDR (vitamin D receptor).

WB:WBGene00003639	nhr-49
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in determination of adult lifespan; positive regulation of transcription from RNA polymerase II promoter in response to stress; and regulation of fatty acid metabolic process. Localizes to cytoplasm and nucleus. Is expressed in hypodermis; intestinal cell; muscle cell; and neurons. Is used to study alcohol use disorder and obesity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003640	nhr-50
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in ganglia; neurons; and tail.

WB:WBGene00003641	nhr-51
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons; intestine; and tail neurons.

WB:WBGene00003642	nhr-52
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons.

WB:WBGene00003643	nhr-53
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003644	nhr-54
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons; intestine; pharynx; and tail neurons.

WB:WBGene00003645	nhr-55
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003646	nhr-56
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in dorsal nerve cord; head neurons; intestine; tail neurons; and ventral nerve cord.

WB:WBGene00003647	nhr-57
Is predicted to have DNA-binding transcription factor activity. Is involved in response to hypoxia. Is expressed in several structures, including cephalic sheath cell; ciliated neurons; excretory system; intestine; and vulva.

WB:WBGene00003648	nhr-58
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in excretory cell; excretory duct; excretory gland cell; and vulva.

WB:WBGene00003649	nhr-59
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003650	nhr-60
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nuclear envelope. Is expressed in several structures, including VC neuron; pharyngeal gland cell; ray; seam cell; and uv1. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003651	nhr-61
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003652	nhr-62
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Is expressed in several structures, including excretory cell; intestine; neurons; spermatheca; and ventral nerve cord.

WB:WBGene00003653	nhr-63
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in metacorpus; procorpus; terminal bulb; and vulva.

WB:WBGene00003654	nhr-64
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in hypodermis; intestine; neurons; and pharynx. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003655	nhr-65
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in several structures, including excretory cell; intestine; muscle cell; pharynx; and tail spike.

WB:WBGene00003656	nhr-66
Is predicted to have DNA-binding transcription factor activity. Is expressed in several structures, including ganglia; head neurons; hypodermis; spermatheca; and terminal bulb.

WB:WBGene00003657	nhr-67
Exhibits DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including gonad morphogenesis; positive regulation of cell cycle arrest; and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including excretory cell; head ganglion; neurons; rectal valve cell; and vulval cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human NR2E1 (nuclear receptor subfamily 2 group E member 1).

WB:WBGene00003658	nhr-68
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head muscle and head neurons.

WB:WBGene00003659	nhr-69
Exhibits SMAD binding activity and steroid hormone binding activity. Is involved in negative regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including ASI; hypodermis; intestine; tail neurons; and uterine toroidal epithelial cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003660	nhr-70
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003661	nhr-71
Is predicted to have DNA-binding transcription factor activity. Is expressed in intestine; pharyngeal neurons; seam cell; and vulva.

WB:WBGene00003662	nhr-72
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00003663	nhr-73
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00003664	nhr-74
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003665	nhr-75
Is expressed in seam cell.

WB:WBGene00003667	nhr-77
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00003668	nhr-78
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003669	nhr-79
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including Ealaa; Ealp; Earaa; amphid neurons; and intestine.

WB:WBGene00003670	nhr-80
Is predicted to have DNA-binding transcription factor activity. Is involved in determination of adult lifespan; positive regulation of fatty acid metabolic process; and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in head; intestine; muscle cell; somatic nervous system; and tail neurons.

WB:WBGene00003671	nhr-81
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00003672	nhr-82
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00003673	nhr-83
Is expressed in ganglia and neurons.

WB:WBGene00003674	nhr-84
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in ganglia; intestine; and pharynx.

WB:WBGene00003675	nhr-85
Is predicted to have several functions, including DNA-binding transcription factor activity; nuclear receptor transcription coactivator activity; and transcription factor binding activity. Is expressed in excretory duct cell; hypodermis; rectal epithelium; and vulva. Human ortholog(s) of this gene are implicated in familial partial lipodystrophy type 3; obesity; and type 2 diabetes mellitus. Is an ortholog of human NR1D2 (nuclear receptor subfamily 1 group D member 2).

WB:WBGene00003676	nhr-86
Is predicted to have DNA-binding transcription factor activity. Localizes to nucleus. Is expressed in hypodermis and pharynx.

WB:WBGene00003677	nhr-87
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003678	nhr-88
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003679	nhr-89
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003680	nhr-90
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in amphid neurons; intestine; and phasmid neurons.

WB:WBGene00003681	nhr-91
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in anterior ganglion; excretory cell; seam cell; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human NR6A1 (nuclear receptor subfamily 6 group A member 1).

WB:WBGene00003682	nhr-92
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003683	nhr-93
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003684	nhr-94
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003685	nhr-95
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003686	nhr-96
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003687	nhr-97
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003688	nhr-98
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in pharynx.

WB:WBGene00003689	nhr-99
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003690	nhr-100
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003691	nhr-101
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00003692	nhr-102
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003693	nhr-103
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003694	nhr-104
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003695	nhr-105
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity.

WB:WBGene00003696	nhr-106
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003697	nhr-107
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003698	nhr-108
Is predicted to have DNA-binding transcription factor activity. Is expressed in head neurons; intestine; neurons; pharyngeal gland cell; and tail neurons.

WB:WBGene00003699	nhr-109
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003700	nhr-110
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003701	nhr-111
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in PVD; head neurons; intestine; pharynx; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in enhanced S-cone syndrome and retinitis pigmentosa 37. Is an ortholog of human NR2E3 (nuclear receptor subfamily 2 group E member 3).

WB:WBGene00003702	nhr-112
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in head and tail.

WB:WBGene00003703	nhr-113
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003704	nhr-114
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in germ line; hypodermis; and intestine.

WB:WBGene00003705	nhr-115
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is involved in innate immune response.

WB:WBGene00003706	nhr-116
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003707	nhr-117
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in terminal bulb.

WB:WBGene00003708	nhr-118
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00003709	nhr-119
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00003710	nhr-120
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003711	nhr-121
Exhibits steroid hormone binding activity.

WB:WBGene00003712	nhr-122
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003713	nhr-123
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in dorsal nerve cord; head neurons; intestine; pharynx; and ventral nerve cord.

WB:WBGene00003714	nhr-124
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003715	nhr-125
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003716	nhr-126
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003717	nhr-127
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00003718	nhr-128
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003719	nhr-129
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003720	nhr-130
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003721	nhr-131
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in intestine and pharynx.

WB:WBGene00003722	nhr-132
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in excretory cell and vulva.

WB:WBGene00003723	nhr-133
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in several structures, including coelomocyte; excretory cell; neurons; rectal gland cell; and ventral nerve cord.

WB:WBGene00003724	nhr-134
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003725	nhr-135
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00003726	nhr-136
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in response to starvation. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00003727	nhr-137
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00003728	nhr-138
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00003729	nhx-1
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed in AIYL; AIYR; hypodermis; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in Christianson syndrome; autosomal recessive spinocerebellar ataxia 19; and congenital secretory sodium diarrhea 8. Is an ortholog of human SLC9A1 (solute carrier family 9 member A1).

WB:WBGene00003730	nhx-2
Exhibits sodium:proton antiporter activity. Is involved in several processes, including determination of adult lifespan; positive regulation of fatty acid transport; and positive regulation of growth rate. Localizes to apical plasma membrane. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Christianson syndrome; autosomal recessive spinocerebellar ataxia 19; and congenital secretory sodium diarrhea 8. Is an ortholog of human SLC9A2 (solute carrier family 9 member A2) and SLC9A5 (solute carrier family 9 member A5).

WB:WBGene00003731	nhx-3
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed in epithelial cell; hypodermis; and spermathecal-uterine junction. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 19 and congenital secretory sodium diarrhea 8. Is an ortholog of human SLC9A3 (solute carrier family 9 member A3) and SLC9A5 (solute carrier family 9 member A5).

WB:WBGene00003732	nhx-4
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed widely. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 19 and congenital secretory sodium diarrhea 8.

WB:WBGene00003733	nhx-5
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed in several structures, including HSN; excretory cell; ganglia; ventral nerve cord; and vulC. Human ortholog(s) of this gene are implicated in Christianson syndrome; autosomal recessive spinocerebellar ataxia 19; and congenital secretory sodium diarrhea 8. Is an ortholog of human SLC9A6 (solute carrier family 9 member A6) and SLC9A9 (solute carrier family 9 member A9).

WB:WBGene00003734	nhx-6
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Christianson syndrome; autosomal recessive spinocerebellar ataxia 19; and congenital secretory sodium diarrhea 8. Is an ortholog of human SLC9A1 (solute carrier family 9 member A1) and SLC9A2 (solute carrier family 9 member A2).

WB:WBGene00003735	nhx-8
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed in several structures, including hypodermis; pharyngeal muscle cell; pharyngeal-intestinal valve; rectal valve cell; and vulva. Is an ortholog of human SLC9A8 (solute carrier family 9 member A8).

WB:WBGene00003736	nhx-9
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is expressed in excretory cell; intestine; and phasmid sensillum. Human ortholog(s) of this gene are implicated in Christianson syndrome; autosomal recessive spinocerebellar ataxia 19; and congenital secretory sodium diarrhea 8. Is an ortholog of human SLC9A2 (solute carrier family 9 member A2) and SLC9A5 (solute carrier family 9 member A5).

WB:WBGene00003738	nid-1
Exhibits extracellular matrix structural constituent. Is involved in several processes, including cholinergic synaptic transmission; nervous system development; and protein localization to synapse. Localizes to basal part of cell and basement membrane. Is expressed in several structures, including enteric muscle; gonad; labial sensillum; neurons; and vulval cell. Human ortholog(s) of this gene are implicated in Donnai-Barrow syndrome and familial hypercholesterolemia. Is an ortholog of human NID1 (nidogen 1) and NID2 (nidogen 2).

WB:WBGene00003739	nlp-1
Is involved in cellular response to carbon dioxide; negative regulation of pharyngeal pumping; and thigmotaxis. Is expressed in intestine; lateral ganglion; and neurons.

WB:WBGene00003740	nlp-2
Is involved in embryo development and positive regulation of error-prone translesion synthesis. Is expressed in head neurons and intestine.

WB:WBGene00003741	nlp-3
Is expressed in alimentary muscle; intestine; neurons; oocyte; and vulva.

WB:WBGene00003742	nlp-4
Is enriched in several structures, including cephalic sheath cell; coelomocyte; germ line; sensory neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Heme; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00003743	nlp-5
Is expressed in nervous system and spermatheca.

WB:WBGene00003744	nlp-6
Is expressed in intestine and neurons.

WB:WBGene00003745	nlp-7
Is involved in several processes, including determination of adult lifespan; positive regulation of oviposition; and response to paraquat. Is expressed in egg-laying apparatus and nervous system.

WB:WBGene00003746	nlp-8
Is expressed in intestine; neurons; and pharynx.

WB:WBGene00003747	nlp-9
Is expressed in intestine; neurons; spermatheca; and vulval muscle.

WB:WBGene00003748	nlp-10
Is expressed in lateral ganglion; neurons; and in male.

WB:WBGene00003749	nlp-11
Is expressed in neurons.

WB:WBGene00003750	nlp-12
Exhibits cholecystokinin receptor binding activity. Is involved in foraging behavior and neuropeptide signaling pathway. Localizes to neuron projection and neuronal cell body. Is expressed in DVA; coelomocyte; and tail neurons.

WB:WBGene00003751	nlp-13
Is expressed in several structures, including intestine; pharyngeal neurons; spermatheca; tail; and vulva. Is predicted to encode a protein with the following domain: .

WB:WBGene00003752	nlp-14
Is predicted to have neuropeptide hormone activity. Is involved in cellular response to carbon dioxide and negative regulation of pharyngeal pumping. Is expressed in neurons and in male.

WB:WBGene00003753	nlp-15
Is predicted to have neuropeptide hormone activity. Is expressed in body wall musculature; intestine; neurons; pharynx; and vulva.

WB:WBGene00003754	nlp-16
Is expressed in head neurons; intestine; and lateral ganglion.

WB:WBGene00003755	nlp-17
Is enriched in hypodermis; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00003756	nlp-18
Is expressed in intestine; neurons; rectal gland cell; and spermatheca.

WB:WBGene00003757	nlp-19
Is expressed in head neurons; pharyngeal neurons; spermatheca; and ventral nerve cord.

WB:WBGene00003758	nlp-20
Is expressed in head neurons; intestine; pharyngeal neurons; spermatheca; and tail neurons.

WB:WBGene00003759	nlp-21
Is expressed in body wall musculature; dorsal nerve cord; intestine; and neurons.

WB:WBGene00003760	nlp-22
Is involved in embryo development and positive regulation of error-prone translesion synthesis. Is expressed in RIAL; RIAR; head; and ventral nerve cord.

WB:WBGene00003761	nlp-23
Is expressed in hypodermis and tail.

WB:WBGene00003762	nlp-24
Is expressed in ASIL; ASIR; hypodermis; pharyngeal neurons; and spermatheca.

WB:WBGene00003763	nlp-25
Is expressed in embryonic cell.

WB:WBGene00003764	nlp-26
Is expressed in hypodermis.

WB:WBGene00003765	nlp-27
Is involved in defense response to Gram-negative bacterium. Is expressed in ASI; head neurons; hypodermis; intestine; and spermatheca.

WB:WBGene00003766	nlp-28
Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00003767	nlp-29
Is predicted to have neuropeptide receptor binding activity. Is expressed in hyp7 syncytium; hypodermis; and intestine.

WB:WBGene00003768	nlp-30
Is expressed in hypodermis. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00003769	nlp-31
Exhibits double-stranded DNA binding activity. Is involved in defense response to Gram-negative bacterium; defense response to fungus; and killing of cells of other organism. Is expressed in hypodermis.

WB:WBGene00003770	nlp-32
Is expressed in head.

WB:WBGene00003771	nlp-33
Is involved in defense response to fungus and innate immune response.

WB:WBGene00003772	nlr-1
Is predicted to have calcium ion binding activity. Is expressed in RIS; g1AR; g1P; pharyngeal gland cell; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in cortical dysplasia-focal epilepsy syndrome. Is an ortholog of human CNTNAP2 (contactin associated protein 2) and CNTNAP5 (contactin associated protein family member 5).

WB:WBGene00003773	nlt-1
Is predicted to have lipid binding activity. Is an ortholog of human SCP2D1 (SCP2 sterol binding domain containing 1).

WB:WBGene00003774	nmr-1
Is predicted to contribute to NMDA glutamate receptor activity. Is involved in locomotory behavior and regulation of forward locomotion. Localizes to integral component of plasma membrane; neuron projection; and synapse. Is expressed in gonadal sheath cell and oocyte. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 8. Is an ortholog of human GRIN1 (glutamate ionotropic receptor NMDA type subunit 1).

WB:WBGene00003775	nmr-2
Is predicted to have NMDA glutamate receptor activity and transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 6; autosomal recessive spinocerebellar ataxia 18; and electroclinical syndrome (multiple). Is an ortholog of human GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C).

WB:WBGene00003776	nmy-1
Is predicted to have ATP binding activity; actin filament binding activity; and motor activity. Is involved in several processes, including locomotion; nematode larval development; and regulation of embryonic cell shape. Localizes to adherens junction and contractile fiber. Is expressed in head; hypodermis; and tail. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH10 (myosin heavy chain 10) and MYH9 (myosin heavy chain 9).

WB:WBGene00003777	nmy-2
Exhibits calmodulin binding activity and protein kinase binding activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; polarity specification of anterior/posterior axis; and positive regulation of nematode male tail tip morphogenesis. Localizes to cell cortex; cleavage furrow; and contractile ring. Colocalizes with spindle. Is expressed in several structures, including distal tip cell; germ line; hypodermal cell; neuroblasts; and rectal gland cell. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH10 (myosin heavy chain 10) and MYH14 (myosin heavy chain 14).

WB:WBGene00003778	nnt-1
Is predicted to have NAD binding activity; NAD(P)+ transhydrogenase activity; and NADP binding activity. Localizes to mitochondrion. Is expressed in ganglia; intestine; pharyngeal-intestinal valve; and somatic nervous system. Is an ortholog of human NNT (nicotinamide nucleotide transhydrogenase).

WB:WBGene00003779	nob-1
Exhibits sequence-specific DNA binding activity. Is involved in several processes, including embryonic body morphogenesis; nematode male tail tip morphogenesis; and positive regulation of nematode male tail tip morphogenesis. Is expressed in head muscle; intestine; linker cell; somatic nervous system; and tail. Is an ortholog of human HOXD12 (homeobox D12).

WB:WBGene00003780	nob-3
No description available

WB:WBGene00003783	nos-1
Is predicted to have RNA binding activity and zinc ion binding activity. Is involved in medium-term memory and short-term memory. Is expressed in Z2 and Z3. Human ortholog(s) of this gene are implicated in spermatogenic failure 12. Is an ortholog of human MRM3 (mitochondrial rRNA methyltransferase 3) and Nanos3.

WB:WBGene00003784	nos-2
Is predicted to have zinc ion binding activity. Is involved in oogenesis and regulation of cell cycle. Localizes to cytoplasm. Is expressed in P0; P4; Z2; and Z3. Human ortholog(s) of this gene are implicated in spermatogenic failure 12.

WB:WBGene00003785	nos-3
Is predicted to have RNA binding activity. Is involved in positive regulation of meiotic nuclear division. Localizes to cytoplasm. Is expressed in several structures, including Psub3; Psub4; Z2; Z3; and germ line.

WB:WBGene00003786	npa-1
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on proteomic; microarray; and RNA-seq studies. Is affected by seventeen chemicals including Astaxanthin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nematode polyprotein allergen ABA-1; Polyprotein allergen, nematode; and DVA-1 superfamily.

WB:WBGene00003787	npp-1
Exhibits calmodulin binding activity. Is involved in several processes, including establishment of mitotic spindle orientation; nuclear pore organization; and positive regulation of mitotic cell cycle, embryonic. Localizes to nuclear envelope. Is expressed in several structures, including hypodermis. Is an ortholog of human NUP54 (nucleoporin 54).

WB:WBGene00003788	npp-2
Is predicted to be a structural constituent of nuclear pore. Is involved in embryo development; nucleus organization; and protein localization to organelle. Localizes to nuclear pore. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 17. Is an ortholog of human NUP85 (nucleoporin 85).

WB:WBGene00003789	npp-3
Is predicted to be a structural constituent of nuclear pore. Is involved in several processes, including establishment of mitotic spindle orientation; positive regulation of nematode male tail tip morphogenesis; and regulation of mitotic cell cycle. Is expressed in embryonic cell. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 13. Is an ortholog of human NUP205 (nucleoporin 205).

WB:WBGene00003790	npp-4
Is predicted to have phospholipid binding activity. Is involved in several processes, including determination of adult lifespan; establishment of mitotic spindle orientation; and nucleus organization. Human ortholog(s) of this gene are implicated in striatonigral degeneration.

WB:WBGene00003791	npp-5
Is predicted to be a structural constituent of nuclear pore. Is involved in several processes, including kinetochore assembly; regulation of cellular response to hypoxia; and regulation of nucleus size. Localizes to nuclear membrane and nuclear pore. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 11 and ovarian dysgenesis 6. Is an ortholog of human NUP107 (nucleoporin 107).

WB:WBGene00003792	npp-6
Is predicted to be a structural constituent of nuclear pore. Is involved in several processes, including nucleus organization; positive regulation of nematode male tail tip morphogenesis; and protein localization to organelle. Localizes to nuclear membrane and nuclear pore. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 19. Is an ortholog of human NUP160 (nucleoporin 160).

WB:WBGene00003793	npp-7
Is predicted to have nuclear localization sequence binding activity. Is involved in several processes, including determination of adult lifespan; nucleus organization; and regulation of exit from mitosis. Localizes to nuclear membrane and nuclear pore. Is an ortholog of human NUP153 (nucleoporin 153).

WB:WBGene00003794	npp-8
Is predicted to be a structural constituent of nuclear pore. Is involved in embryo development; nucleus organization; and regulation of exit from mitosis. Localizes to nuclear pore. Human ortholog(s) of this gene are implicated in familial atrial fibrillation. Is an ortholog of human NUP155 (nucleoporin 155).

WB:WBGene00003795	npp-9
Is predicted to contribute to GTPase activator activity. Is involved in embryo development and nucleus organization. Localizes to nuclear pore. Is an ortholog of several human genes including RANBP2 (RAN binding protein 2); RGPD3 (RANBP2 like and GRIP domain containing 3); and RGPD6 (RANBP2 like and GRIP domain containing 6).

WB:WBGene00003796	npp-10
Exhibits RNA binding activity. Is involved in several processes, including mitotic chromosome centromere condensation; nuclear pore distribution; and protein localization to organelle. Localizes to P granule; kinetochore; and nuclear pore. Is an ortholog of human NUP98 (nucleoporin 98 and 96 precursor).

WB:WBGene00003797	npp-11
Is predicted to have phospholipid binding activity. Is involved in embryo development; establishment of mitotic spindle orientation; and nucleus organization. Localizes to nuclear envelope. Is expressed in head. Human ortholog(s) of this gene are implicated in striatonigral degeneration. Is an ortholog of human NUP62 (nucleoporin 62).

WB:WBGene00003798	npp-12
Localizes to nuclear pore. Is an ortholog of human NUP210 (nucleoporin 210).

WB:WBGene00003799	npp-13
Is predicted to be a structural constituent of nuclear pore. Is involved in several processes, including establishment of mitotic spindle orientation; mitotic chromosome centromere condensation; and regulation of mitotic cell cycle. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 12. Is an ortholog of human NUP93 (nucleoporin 93).

WB:WBGene00003800	npp-14
Exhibits caspase binding activity. Is involved in inhibition of cysteine-type endopeptidase activity involved in apoptotic process and negative regulation of execution phase of apoptosis. Human ortholog(s) of this gene are implicated in acute lymphoblastic leukemia and acute myeloid leukemia. Is an ortholog of human NUP214 (nucleoporin 214).

WB:WBGene00003801	npp-15
Is predicted to be a structural constituent of nuclear pore. Localizes to kinetochore; nuclear membrane; and nuclear pore. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 18. Is an ortholog of human NUP133 (nucleoporin 133).

WB:WBGene00003802	npp-16
Is enriched in GABAergic neurons; NSM; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and PH-like domain superfamily. Is an ortholog of human NUP50 (nucleoporin 50).

WB:WBGene00003803	rae-1
Is predicted to have RNA binding activity and ubiquitin binding activity. Is an ortholog of human RAE1 (ribonucleic acid export 1).

WB:WBGene00003804	npp-18
Is predicted to have structural molecule activity. Is an ortholog of human SEH1L (SEH1 like nucleoporin).

WB:WBGene00003805	npp-19
Is predicted to have phospholipid binding activity and single-stranded DNA binding activity. Is involved in embryo development; nucleus organization; and regulation of exit from mitosis. Localizes to nuclear pore. Is an ortholog of human NUP35 (nucleoporin 35).

WB:WBGene00003806	npp-20
Is predicted to have structural molecule activity. Is involved in several processes, including mitotic chromosome centromere condensation; positive regulation of division septum assembly; and protein import into nucleus. Localizes to nuclear pore. Is an ortholog of human SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component).

WB:WBGene00003807	npr-1
Exhibits neuropeptide receptor activity. Is involved in several processes, including G protein-coupled receptor signaling pathway; behavioral response to ethanol; and thermotaxis. Localizes to several cellular components, including axon; dendrite; and neuronal cell body. Is expressed in excretory system; neurons; pharyngeal muscle cell; and preanal ganglion. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human NPY1R (neuropeptide Y receptor Y1).

WB:WBGene00003808	npr-2
Is predicted to have neuropeptide Y receptor activity. Is expressed in head neurons and interneuron. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus.

WB:WBGene00003809	nrf-1
No description available

WB:WBGene00003810	nrf-3
No description available

WB:WBGene00003811	nrf-4
No description available

WB:WBGene00003812	nrf-5
Exhibits phosphatidylserine binding activity. Is involved in lipid transport and positive regulation of engulfment of apoptotic cell. Localizes to extracellular region. Is expressed in apoptotic cell; body wall musculature; intestine; and pharyngeal cell. Human ortholog(s) of this gene are implicated in hyperalphalipoproteinemia 1.

WB:WBGene00003813	nrf-6
Is predicted to have lipid binding activity and transferase activity, transferring acyl groups other than amino-acyl groups. Is expressed in hyp3; hyp5; and intestine.

WB:WBGene00003814	nrf-8
No description available

WB:WBGene00003815	nars-1
Is predicted to have ATP binding activity; asparagine-tRNA ligase activity; and nucleic acid binding activity. Is involved in negative regulation of transcription by RNA polymerase II and translation. Is an ortholog of human NARS1 (asparaginyl-tRNA synthetase 1).

WB:WBGene00003816	asns-1
Is predicted to have asparagine synthase (glutamine-hydrolyzing) activity. Is an ortholog of human ASNS (asparagine synthetase (glutamine-hydrolyzing)).

WB:WBGene00003818	nsf-1
Is predicted to have ATPase activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in neurons; pharynx; uterus; and vulva. Is an ortholog of human NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase).

WB:WBGene00003821	nst-1
Is predicted to have GTP binding activity. Is involved in germ cell development; nematode larval development; and regulation of growth. Localizes to nucleolus and nucleoplasm. Is expressed widely. Is an ortholog of human GNL3L (G protein nucleolar 3 like).

WB:WBGene00003822	nsy-1
Exhibits MAP kinase kinase kinase activity; mitogen-activated protein kinase kinase binding activity; and protein kinase activator activity. Is involved in several processes, including defense response to other organism; oviposition; and positive regulation of MAP kinase activity. Localizes to several cellular components, including axon cytoplasm; cell; and postsynaptic density. Is expressed in head; rectal gland cell; and tail. Is used to study amphetamine abuse. Is an ortholog of human MAP3K15 (mitogen-activated protein kinase kinase kinase 15) and MAP3K5 (mitogen-activated protein kinase kinase kinase 5).

WB:WBGene00003825	ntl-2
Is enriched in C; germ line; neurons; and ventral nerve cord based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including resveratrol; Atrazine; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: NOT2 / NOT3 / NOT5 family; NOT2/NOT3/NOT5, C-terminal; CCR4-NOT complex subunit 2/3/5, N-terminal domain superfamily; and Not2/Not3/Not5. Is an ortholog of human CNOT2 (CCR4-NOT transcription complex subunit 2).

WB:WBGene00003826	ntl-3
Is enriched in germ line; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NOT2 / NOT3 / NOT5 family; NOT2/NOT3/NOT5, C-terminal; CCR4-NOT complex subunit 2/3/5, N-terminal domain superfamily; and Not2/Not3/Not5. Is an ortholog of human CNOT3 (CCR4-NOT transcription complex subunit 3).

WB:WBGene00003827	ntl-4
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human CNOT4 (CCR4-NOT transcription complex subunit 4).

WB:WBGene00003828	nuc-1
Exhibits deoxyribonuclease II activity. Is involved in apoptotic DNA fragmentation. Localizes to lysosome. Is an ortholog of human DNASE2 (deoxyribonuclease 2, lysosomal).

WB:WBGene00003829	nud-1
Exhibits identical protein binding activity and unfolded protein binding activity. Is involved in several processes, including GABAergic synaptic transmission; pronuclear migration; and vulval development. Is expressed in gonad; hypodermis; intestine; and neurons. Is an ortholog of human NUDC (nuclear distribution C, dynein complex regulator).

WB:WBGene00003830	num-1
Exhibits enzyme binding activity and protein domain specific binding activity. Is involved in endocytic recycling; phospholipid transport; and protein targeting to membrane. Localizes to basolateral plasma membrane; cytoplasm; and integral component of plasma membrane. Is expressed in several structures, including alimentary muscle; hermaphrodite gonad; nerve ring; pseudocoelom; and rectal valve cell. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 37 and type 2 diabetes mellitus. Is an ortholog of human NUMB (NUMB endocytic adaptor protein) and NUMBL (NUMB like endocytic adaptor protein).

WB:WBGene00003831	nuo-1
Is predicted to have several functions, including 4 iron, 4 sulfur cluster binding activity; NADH dehydrogenase (ubiquinone) activity; and coenzyme binding activity. Is involved in several processes, including dauer exit; inductive cell migration; and mitochondrial electron transport, NADH to ubiquinone. Localizes to mitochondrion. Is used to study mitochondrial complex I deficiency. Is an ortholog of human NDUFV1 (NADH:ubiquinone oxidoreductase core subunit V1).

WB:WBGene00003832	nup-1
No description available

WB:WBGene00003833	nup-2
No description available

WB:WBGene00003834	nxf-1
Is predicted to have RNA binding activity. Localizes to nuclear pore; nucleolus; and nucleoplasm. Is an ortholog of human NXF1 (nuclear RNA export factor 1).

WB:WBGene00003835	nxf-2
Is predicted to have RNA binding activity. Is an ortholog of human NXF1 (nuclear RNA export factor 1).

WB:WBGene00003836	nxt-1
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nuclear transport factor 2 (NTF2) domain; Nuclear transport factor 2; and NTF2-like domain superfamily. Is an ortholog of human NXT1 (nuclear transport factor 2 like export factor 1) and NXT2 (nuclear transport factor 2 like export factor 2).

WB:WBGene00003837	oat-1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00003838	ocr-1
Is predicted to have calcium channel activity. Is expressed in ADLL; ADLR; AWAL; and AWAR. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease axonal type 2C; motor neuron disease (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human TRPV5 (transient receptor potential cation channel subfamily V member 5) and TRPV6 (transient receptor potential cation channel subfamily V member 6).

WB:WBGene00003839	ocr-2
Is predicted to have calcium channel activity. Localizes to non-motile cilium and plasma membrane. Is expressed in AWA; sensory neurons; and uterus. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease axonal type 2C; motor neuron disease (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human TRPV5 (transient receptor potential cation channel subfamily V member 5) and TRPV6 (transient receptor potential cation channel subfamily V member 6).

WB:WBGene00003840	ocr-3
Is predicted to have calcium channel activity. Is expressed in rectal gland cell and socket cell. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease axonal type 2C; motor neuron disease (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human TRPV5 (transient receptor potential cation channel subfamily V member 5) and TRPV6 (transient receptor potential cation channel subfamily V member 6).

WB:WBGene00003841	ocr-4
Is predicted to have calcium channel activity. Is expressed in OLQDL; OLQDR; OLQVL; OLQVR; and uv1. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease axonal type 2C; motor neuron disease (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human TRPV5 (transient receptor potential cation channel subfamily V member 5).

WB:WBGene00003842	oct-1
Exhibits organic cation transmembrane transporter activity. Is involved in determination of adult lifespan and organic cation transport. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A4 (solute carrier family 22 member 4) and SLC22A5 (solute carrier family 22 member 5).

WB:WBGene00003843	oct-2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A4 (solute carrier family 22 member 4) and SLC22A5 (solute carrier family 22 member 5).

WB:WBGene00003844	odc-1
Is predicted to have ornithine decarboxylase activity. Is expressed in intestine and male gonad. Is an ortholog of human ODC1 (ornithine decarboxylase 1).

WB:WBGene00003845	odd-1
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in intestine. Is an ortholog of human OSR1 (odd-skipped related transcription factor 1) and OSR2 (odd-skipped related transciption factor 2).

WB:WBGene00003846	odd-2
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in intestine. Is an ortholog of human OSR1 (odd-skipped related transcription factor 1) and OSR2 (odd-skipped related transciption factor 2).

WB:WBGene00003847	blmp-1
Exhibits cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including dauer entry; negative regulation of distal tip cell migration; and regulation of transcription by RNA polymerase II. Localizes to cytoplasm and nucleus. Is expressed in several structures, including distal tip cell; dorsal nerve cord; enteric muscle; neurons; and tail hypodermis. Is an ortholog of human PRDM1 (PR/SET domain 1).

WB:WBGene00003848	odr-1
Is predicted to have ATP binding activity; guanylate cyclase activity; and protein kinase activity. Is expressed in I1 neuron and odorsensory neurons. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 1; choroidal sclerosis; and cone-rod dystrophy 6. Is an ortholog of human GUCY2D (guanylate cyclase 2D, retinal) and GUCY2F (guanylate cyclase 2F, retinal).

WB:WBGene00003849	odr-2
Is involved in olfactory behavior and response to odorant. Localizes to axon; extrinsic component of plasma membrane; and neuronal cell body. Is expressed in dorsal nerve cord; head neurons; nerve ring; tail neurons; and ventral nerve cord.

WB:WBGene00003850	odr-3
Exhibits olfactory receptor binding activity. Is involved in several processes, including hyperosmotic response; olfactory behavior; and response to odorant. Localizes to neuronal cell body and non-motile cilium. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple). Is an ortholog of human GNAI1 (G protein subunit alpha i1); GNAO1 (G protein subunit alpha o1); and GNAZ (G protein subunit alpha z).

WB:WBGene00003851	odr-4
Is involved in olfactory behavior; receptor localization to non-motile cilium; and response to odorant. Localizes to intracellular membrane-bounded organelle and protein-containing complex. Is expressed in chemosensory neurons and neurons. Is an ortholog of human ODR4 (odr-4 GPCR localization factor homolog).

WB:WBGene00003852	odr-5
No description available

WB:WBGene00003853	odr-6
No description available

WB:WBGene00003854	odr-7
Exhibits DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in negative adaptation of signaling pathway; positive chemotaxis; and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in AWAL and AWAR.

WB:WBGene00003856	odr-10
Exhibits G protein-coupled olfactory receptor activity and G-protein alpha-subunit binding activity. Is involved in several processes, including detection of chemical stimulus involved in sensory perception; olfactory behavior; and positive chemotaxis. Localizes to several cellular components, including neuronal cell body; non-motile cilium; and periciliary membrane compartment. Is expressed in AWAL; AWAR; and in male.

WB:WBGene00003857	ogr-1
No description available

WB:WBGene00003858	ogt-1
Exhibits protein N-acetylglucosaminyltransferase activity; protein O-GlcNAc transferase activity; and protein serine/threonine phosphatase activity. Is involved in several processes, including cellular protein modification process; glycogen metabolic process; and lipid storage. Localizes to nucleus and perinuclear region of cytoplasm. Is expressed in several structures, including hypodermal cell; intestine; and neurons. Is used to study type 2 diabetes mellitus. Human ortholog(s) of this gene are implicated in X-linked mental retardation 106. Is an ortholog of human OGT (O-linked N-acetylglucosamine (GlcNAc) transferase).

WB:WBGene00003859	oig-1
Is expressed in neurons and retrovesicular ganglion neurons. Is predicted to encode a protein with the following domains: Immunoglobulin I-set domain; Immunoglobulin subtype 2; Immunoglobulin I-set; Immunoglobulin-like fold; and Immunoglobulin-like domain superfamily.

WB:WBGene00003860	oig-2
Localizes to sarcoplasmic reticulum. Is expressed in several structures, including midbody; neurons; pharynx; tail; and ventral nerve cord.

WB:WBGene00003861	oig-3
Is expressed in PVT; gonad; gonadal sheath cell; and pharynx. Is predicted to encode a protein with the following domains: Phosphorylation site; Immunoglobulin I-set domain; Immunoglobulin I-set; Immunoglobulin-like fold; and Immunoglobulin-like domain superfamily.

WB:WBGene00003862	old-1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is expressed in hypodermis; male gonad; neurons; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including dysostosis (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including CSF1R (colony stimulating factor 1 receptor); KIT (KIT proto-oncogene, receptor tyrosine kinase); and PDGFRA (platelet derived growth factor receptor alpha).

WB:WBGene00003863	old-2
Is predicted to have transmembrane receptor protein tyrosine kinase activator activity and transmembrane receptor protein tyrosine kinase activity. Is involved in determination of adult lifespan. Human ortholog(s) of this gene are implicated in several diseases, including dysostosis (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including KIT (KIT proto-oncogene, receptor tyrosine kinase); PDGFRA (platelet derived growth factor receptor alpha); and PDGFRB (platelet derived growth factor receptor beta).

WB:WBGene00003864	oma-1
Exhibits mRNA 3'-UTR AU-rich region binding activity and translation repressor activity, mRNA regulatory element binding. Is involved in several processes, including digestive tract development; negative regulation of cell differentiation; and oocyte development. Localizes to P granule; centrosome; and messenger ribonucleoprotein complex. Is expressed in several structures, including head muscle; neurons; oocyte; somatic nervous system; and vulva. Is an ortholog of human ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00003865	oma-2
Exhibits translation repressor activity, mRNA regulatory element binding. Is involved in several processes, including oocyte development; regulation of cellular protein metabolic process; and regulation of meiotic cell cycle process involved in oocyte maturation. Localizes to P granule and centrosome. Is expressed in several structures, including germ line; head muscle; intestine; oocyte; and somatic nervous system. Is an ortholog of human ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00003866	ooc-1
Is involved in embryo development.

WB:WBGene00003867	ooc-2
No description available

WB:WBGene00003868	ooc-3
Is predicted to have chloride channel activity. Is involved in embryo development; establishment of mitotic spindle orientation; and protein localization. Localizes to endoplasmic reticulum. Is expressed in P0.

WB:WBGene00003869	ooc-4
No description available

WB:WBGene00003870	ooc-5
Is predicted to have ATPase activity. Is involved in cellular response to misfolded protein. Localizes to several cellular components, including cytoskeleton; endoplasmic reticulum; and perinuclear region of cytoplasm. Is expressed in several structures, including CAN; intestine; pharyngeal-intestinal valve; pharynx; and rectal gland cell. Human ortholog(s) of this gene are implicated in torsion dystonia 1. Is an ortholog of human TOR1A (torsin family 1 member A) and TOR1B (torsin family 1 member B).

WB:WBGene00003876	pept-2
Is predicted to have dipeptide transmembrane transporter activity and peptide:proton symporter activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in anal depressor muscle; anal sphincter muscle; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human SLC15A1 (solute carrier family 15 member 1).

WB:WBGene00003877	pept-1
Exhibits dipeptide transmembrane transporter activity. Is involved in several processes, including ion homeostasis; positive regulation of growth rate; and regulation of signal transduction. Localizes to apical plasma membrane. Is expressed in intestine. Is an ortholog of human SLC15A1 (solute carrier family 15 member 1).

WB:WBGene00003878	pept-3
Exhibits dipeptide transmembrane transporter activity and proton channel activity. Is involved in dipeptide transport and proton transmembrane transport. Is expressed in AVAL; AVAR; pharynx; and touch receptor neurons. Is an ortholog of human SLC15A1 (solute carrier family 15 member 1) and SLC15A2 (solute carrier family 15 member 2).

WB:WBGene00003879	ora-1
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00003880	ora-2
No description available

WB:WBGene00003881	ora-4
No description available

WB:WBGene00003882	orc-2
Is predicted to have DNA replication origin binding activity. Localizes to nuclear chromosome. Is an ortholog of human ORC2 (origin recognition complex subunit 2).

WB:WBGene00003883	osm-1
Is involved in dauer entry and non-motile cilium assembly. Localizes to ciliary transition zone; intraciliary transport particle B; and non-motile cilium. Is expressed in amphid neurons; ciliated neurons; phasmid neurons; and sensory neurons. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 71 and short-rib thoracic dysplasia 10 with or without polydactyly. Is an ortholog of human IFT172 (intraflagellar transport 172).

WB:WBGene00003884	osm-3
Exhibits ATP-dependent microtubule motor activity, plus-end-directed. Is involved in several processes, including cilium organization; dauer entry; and regulation of non-motile cilium assembly. Localizes to several cellular components, including cytoskeleton; neuronal cell body; and perinuclear region of cytoplasm. Colocalizes with microtubule. Is expressed in ciliated neurons. Is an ortholog of human KIF17 (kinesin family member 17).

WB:WBGene00003885	osm-5
Is predicted to have kinesin binding activity. Is involved in several processes, including dauer entry; locomotory exploration behavior; and non-motile cilium assembly. Localizes to several cellular components, including ciliary basal body; intraciliary transport particle B; and non-motile cilium. Is expressed in amphid sensillum and neurons. Is used to study autosomal dominant polycystic kidney disease. Is an ortholog of human IFT88 (intraflagellar transport 88).

WB:WBGene00003886	osm-6
Is involved in several processes, including cellular response to salt; non-motile cilium assembly; and sensory perception of mechanical stimulus. Localizes to several cellular components, including ciliary basal body; ciliary transition zone; and neuronal cell body. Is expressed in neurons. Is an ortholog of human IFT52 (intraflagellar transport 52).

WB:WBGene00003887	osm-7
Is predicted to have Notch binding activity. Is involved in response to osmotic stress. Is expressed in hypodermis.

WB:WBGene00003888	osm-8
Is involved in response to osmotic stress. Localizes to extracellular space. Is expressed in hyp7 syncytium.

WB:WBGene00003889	osm-9
Exhibits calcium channel activity. Is involved in several processes, including negative adaptation of signaling pathway; olfactory learning; and sensory perception of smell. Localizes to neuronal cell body; non-motile cilium; and perinuclear region of cytoplasm. Is expressed in rectal gland cell; sensory neurons; and uterine toroidal epithelial cell. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2C; motor neuron disease (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human TRPV5 (transient receptor potential cation channel subfamily V member 5).

WB:WBGene00003890	osm-10
Exhibits osmosensor activity. Is involved in osmosensory signaling pathway. Localizes to axon; cytoplasm; and neuronal cell body.

WB:WBGene00003891	osm-11
Exhibits Notch binding activity. Is involved in several processes, including positive regulation of Notch signaling pathway; response to osmotic stress; and vulval development. Localizes to apical part of cell and extracellular space. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and hermaphrodite gonad.

WB:WBGene00003892	osm-12
Is involved in chemotaxis; cilium organization; and protein localization to microvillus membrane. Localizes to ciliary basal body; neuron projection; and non-motile cilium. Is expressed in ciliated neurons and sensory neurons. Is used to study Bardet-Biedl syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 7. Is an ortholog of human BBS7 (Bardet-Biedl syndrome 7).

WB:WBGene00003893	ost-1
Exhibits calcium ion binding activity. Localizes to basement membrane and extracellular space. Is expressed in body wall musculature; gonad; head; pharynx; and vulval muscle. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 17. Is an ortholog of human SPARC (secreted protein acidic and cysteine rich).

WB:WBGene00003898	oxi-1
Is predicted to have ubiquitin conjugating enzyme activity. Human ortholog(s) of this gene are implicated in Kaufman oculocerebrofacial syndrome. Is an ortholog of human UBE3B (ubiquitin protein ligase E3B).

WB:WBGene00003899	oxy-2
No description available

WB:WBGene00003900	oxy-3
No description available

WB:WBGene00003901	paa-1
Exhibits DEAD/H-box RNA helicase binding activity. Is predicted to contribute to protein serine/threonine phosphatase activity. Is involved in embryo development. Localizes to several cellular components, including cytoskeleton; nuclear envelope; and protein phosphatase type 2A complex. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 36 and lung cancer. Is an ortholog of human PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha) and PPP2R1B (protein phosphatase 2 scaffold subunit Abeta).

WB:WBGene00003902	pab-1
Exhibits mRNA binding activity and protein C-terminus binding activity. Is involved in several processes, including gamete generation; positive regulation of vulval development; and regulation of mitotic cell cycle. Localizes to P granule; P-body; and polysome. Is expressed in intestine. Is an ortholog of human PABPC1 (poly(A) binding protein cytoplasmic 1).

WB:WBGene00003903	pab-2
Is predicted to have mRNA 3'-UTR binding activity; poly(A) binding activity; and poly(U) RNA binding activity. Localizes to polysome. Is an ortholog of human PABPC1 (poly(A) binding protein cytoplasmic 1).

WB:WBGene00003904	pabp-2
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in oculopharyngeal muscular dystrophy. Is an ortholog of human PABPN1 (poly(A) binding protein nuclear 1).

WB:WBGene00003905	pad-1
Is expressed in head and tail. Is used to study Down syndrome. Is predicted to encode a protein with the following domains: Dopey, N-terminal; Dopey, N-terminal; Armadillo-type fold; and Protein dopey. Is an ortholog of human DOP1A (DOP1 leucine zipper like protein A).

WB:WBGene00003906	paf-1
Exhibits 1-alkyl-2-acetylglycerophosphocholine esterase activity. Is involved in lipid catabolic process. Human ortholog(s) of this gene are implicated in asthma. Is an ortholog of human PAFAH2 (platelet activating factor acetylhydrolase 2) and PLA2G7 (phospholipase A2 group VII).

WB:WBGene00003907	paf-2
Exhibits 1-alkyl-2-acetylglycerophosphocholine esterase activity. Is involved in lipid catabolic process and morphogenesis of embryonic epithelium. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in asthma. Is an ortholog of human PAFAH2 (platelet activating factor acetylhydrolase 2) and PLA2G7 (phospholipase A2 group VII).

WB:WBGene00003908	pag-1
No description available

WB:WBGene00003909	pag-3
Exhibits transcription corepressor activity. Is involved in several processes, including generation of neurons; negative regulation of secretion by cell; and regulation of backward locomotion. Localizes to nucleus. Is expressed in several structures, including P1.aap; P11.aaap; P12.aaap; neurons; and retrovesicular ganglion. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 22 with or without anosmia; hypogonadotropic hypogonadism 7 with or without anosmia; and platelet-type bleeding disorder 17. Is an ortholog of human GFI1B (growth factor independent 1B transcriptional repressor).

WB:WBGene00003910	pag-6
No description available

WB:WBGene00003911	pak-1
Exhibits GTP binding activity and protein kinase activity. Is involved in several processes, including hemidesmosome assembly; inductive cell migration; and motor neuron axon guidance. Localizes to several cellular components, including cytosol; hemidesmosome; and neuronal cell body. Colocalizes with intermediate filament. Is expressed in several structures, including P5.p hermaphrodite; P7.p hermaphrodite; gonad; hypodermis; and neurons. Human ortholog(s) of this gene are implicated in lung cancer and non-syndromic X-linked intellectual disability. Is an ortholog of human PAK1 (p21 (RAC1) activated kinase 1) and PAK3 (p21 (RAC1) activated kinase 3).

WB:WBGene00003912	pal-1
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including ectodermal cell fate commitment; muscle cell fate commitment; and positive regulation of transcription by RNA polymerase II. Localizes to condensed nuclear chromosome. Is expressed in several structures, including ABprpppppaa; enteric muscle; oocyte; rectal epithelial cell; and tail spike. Is an ortholog of human CDX1 (caudal type homeobox 1).

WB:WBGene00003913	pal-2
No description available

WB:WBGene00003914	pam-1
Exhibits metalloaminopeptidase activity. Is involved in several processes, including exit from meiosis; first cell cycle pseudocleavage; and regulation of oocyte maturation. Localizes to condensed chromosome; cytoplasm; and mitotic spindle pole. Is expressed in amphid process; intestine; male-specific anatomical entity; nerve ring; and tail neurons. Is an ortholog of human NPEPPS (aminopeptidase puromycin sensitive).

WB:WBGene00003915	pan-1
Exhibits DEAD/H-box RNA helicase binding activity. Is involved in germ cell development and molting cycle. Localizes to P granule and plasma membrane. Is expressed in several structures, including germ line; gonad; head muscle; nerve ring; and somatic cell. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1F and familial temporal lobe epilepsy 1. Is an ortholog of human LRRTM4 (leucine rich repeat transmembrane neuronal 4).

WB:WBGene00003916	par-1
Exhibits myosin II tail binding activity; protein serine/threonine kinase activity; and ubiquitin protein ligase binding activity. Is involved in several processes, including asymmetric neuroblast division; asymmetric protein localization involved in cell fate determination; and vulval development. Localizes to P granule and cell cortex. Is expressed in germ line and vulva. Is an ortholog of human MARK2 (microtubule affinity regulating kinase 2) and MARK3 (microtubule affinity regulating kinase 3).

WB:WBGene00003917	par-2
Exhibits microtubule binding activity; phosphatidylinositol phosphate binding activity; and protein kinase binding activity. Is involved in asymmetric cell division; asymmetric protein localization involved in cell fate determination; and establishment of mitotic spindle orientation. Localizes to P granule; posterior cell cortex; and protein-containing complex. Is expressed in germ line.

WB:WBGene00003918	par-3
Is predicted to have phosphatidylinositol binding activity. Is involved in several processes, including cell adhesion; establishment of mitotic spindle orientation; and polarity specification of anterior/posterior axis. Localizes to several cellular components, including P granule; anterior cell cortex; and apical cortex. Is expressed in several structures, including AB; Psub1; excretory cell; hermaphrodite gonad; and vulval cell. Is an ortholog of human PARD3 (par-3 family cell polarity regulator) and PARD3B (par-3 family cell polarity regulator beta).

WB:WBGene00003919	par-4
Exhibits calmodulin binding activity and protein serine/threonine kinase activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; determination of adult lifespan; and positive regulation of dauer larval development. Localizes to cell cortex. Is expressed widely. Human ortholog(s) of this gene are implicated in Peutz-Jeghers syndrome; pancreatic carcinoma; and testicular germ cell cancer. Is an ortholog of human STK11 (serine/threonine kinase 11).

WB:WBGene00003920	par-5
Is involved in several processes, including asymmetric protein localization involved in cell fate determination; first cell cycle pseudocleavage; and polarity specification of anterior/posterior axis. Localizes to cell cortex and nucleus. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 56. Is an ortholog of human YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) and YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta).

WB:WBGene00003921	par-6
Exhibits Rho GTPase binding activity and protein kinase C binding activity. Is involved in several processes, including cell adhesion; establishment of mitotic spindle localization; and polarity specification of anterior/posterior axis. Localizes to P granule; cell cortex; and integral component of membrane. Is expressed in several structures, including ABa; EMS; Psub2; Psub3; and excretory cell. Is an ortholog of human PARD6A (par-6 family cell polarity regulator alpha); PARD6B (par-6 family cell polarity regulator beta); and PARD6G (par-6 family cell polarity regulator gamma).

WB:WBGene00003922	pas-1
Is predicted to have endopeptidase activity. Is an ortholog of human PSMA6 (proteasome 20S subunit alpha 6).

WB:WBGene00003923	pas-2
Exhibits identical protein binding activity. Is an ortholog of human PSMA2 (proteasome 20S subunit alpha 2).

WB:WBGene00003924	pas-3
Is predicted to have endopeptidase activity. Is an ortholog of human PSMA4 (proteasome 20S subunit alpha 4).

WB:WBGene00003925	pas-4
Is predicted to have endopeptidase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in JMP syndrome. Is an ortholog of human PSMA7 (proteasome 20S subunit alpha 7) and PSMA8 (proteasome 20S subunit alpha 8).

WB:WBGene00003926	pas-5
Is predicted to have endopeptidase activity. Is expressed in body wall musculature; germ line; gonad; hypodermis; and vulva. Is an ortholog of human PSMA5 (proteasome 20S subunit alpha 5).

WB:WBGene00003927	pas-6
Is predicted to have endopeptidase activity. Is an ortholog of human PSMA1 (proteasome 20S subunit alpha 1).

WB:WBGene00003928	pas-7
Exhibits identical protein binding activity. Localizes to cytoplasm and nucleus. Is an ortholog of human PSMA3 (proteasome 20S subunit alpha 3).

WB:WBGene00003929	pat-2
Exhibits transmembrane signaling receptor activity. Is involved in several processes, including mitochondrion organization; muscle cell cellular homeostasis; and positive regulation of cellular component organization. Localizes to M band; cell surface; and striated muscle dense body. Is expressed in body wall musculature; distal tip cell; hypodermis; and touch receptor neurons. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy due to integrin alpha-7 deficiency; inherited blood coagulation disease (multiple); and junctional epidermolysis bullosa with pyloric atresia. Is an ortholog of human ITGA5 (integrin subunit alpha 5) and ITGA8 (integrin subunit alpha 8).

WB:WBGene00003930	pat-3
Is predicted to have integrin binding activity. Is involved in several processes, including mitochondrion organization; muscle cell cellular homeostasis; and positive regulation of cellular component organization. Localizes to several cellular components, including contractile fiber; focal adhesion; and lateral plasma membrane. Is expressed in several structures, including GABAergic neurons; egg-laying apparatus; enteric muscle; gonad; and vulval precursor cell. Human ortholog(s) of this gene are implicated in leukocyte adhesion deficiency 1. Is an ortholog of human ITGB1 (integrin subunit beta 1).

WB:WBGene00003931	pat-4
Exhibits integrin binding activity and protein-macromolecule adaptor activity. Is involved in several processes, including hermaphrodite genitalia morphogenesis; mitochondrion organization; and positive regulation of supramolecular fiber organization. Localizes to several cellular components, including adherens junction; basal plasma membrane; and contractile fiber. Is expressed in body wall musculature; gonad; non-striated muscle; pharynx; and touch receptor neurons. Is an ortholog of human ILK (integrin linked kinase).

WB:WBGene00003932	pat-6
Is predicted to have actin binding activity. Is involved in several processes, including mitochondrion organization; muscle cell cellular homeostasis; and positive regulation of sarcomere organization. Localizes to M band; basal plasma membrane; and striated muscle dense body. Is expressed in body wall musculature; gonad; non-striated muscle; and touch receptor neurons. Is an ortholog of human PARVA (parvin alpha) and PARVB (parvin beta).

WB:WBGene00003933	pat-9
Is involved in regulation of striated muscle cell differentiation. Localizes to nucleus. Colocalizes with nuclear chromatin. Is expressed in body wall musculature and gonad. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 58.

WB:WBGene00003934	pat-10
Exhibits troponin I binding activity. Is involved in embryo development; muscle contraction; and skeletal muscle thin filament assembly. Localizes to contractile fiber. Is expressed in body wall musculature; gonadal sheath cell; rectal muscle; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00003935	pat-11
No description available

WB:WBGene00003936	pat-12
Is involved in embryonic morphogenesis and hemidesmosome assembly. Localizes to hemidesmosome. Is expressed in head neurons; mechanosensory neurons; rectum; seam cell; and spermatheca.

WB:WBGene00003937	pax-1
Is predicted to have DNA binding activity. Is expressed in epithelial cell and pharyngeal cell. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human PAX9 (paired box 9).

WB:WBGene00003938	pax-2
Is predicted to have DNA binding activity. Is expressed in vulD. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human PAX2 (paired box 2) and PAX8 (paired box 8).

WB:WBGene00003939	pax-3
Is predicted to have DNA binding activity. Is involved in hemidesmosome assembly. Is expressed in several structures, including AB lineage cell; E lineage cell; P9/10L; hypodermal cell; and tail. Human ortholog(s) of this gene are implicated in several diseases, including Waardenburg's syndrome (multiple); diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human PAX3 (paired box 3).

WB:WBGene00003940	pbm-1
No description available

WB:WBGene00003941	pbo-1
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in Usher syndrome type 1J and autosomal recessive nonsyndromic deafness 48. Is an ortholog of human CHP1 (calcineurin like EF-hand protein 1) and CHP2 (calcineurin like EF-hand protein 2).

WB:WBGene00003942	pbo-3
No description available

WB:WBGene00003943	pbo-4
Is predicted to have potassium:proton antiporter activity and sodium:proton antiporter activity. Is involved in several processes, including defecation; lipid transport involved in lipid storage; and positive regulation of intestinal lipid absorption. Localizes to basolateral plasma membrane. Is expressed in intestine. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 19 and congenital secretory sodium diarrhea 8.

WB:WBGene00003946	pbo-7
No description available

WB:WBGene00003947	pbs-1
Is predicted to have endopeptidase activity. Human ortholog(s) of this gene are implicated in JMP syndrome. Is an ortholog of human PSMB6 (proteasome 20S subunit beta 6).

WB:WBGene00003948	pbs-2
Is predicted to have endopeptidase activity. Human ortholog(s) of this gene are implicated in JMP syndrome. Is an ortholog of human PSMB7 (proteasome 20S subunit beta 7).

WB:WBGene00003949	pbs-3
Is predicted to have endopeptidase activity. Is an ortholog of human PSMB3 (proteasome 20S subunit beta 3).

WB:WBGene00003950	pbs-4
Is predicted to have endopeptidase activity. Is an ortholog of human PSMB2 (proteasome 20S subunit beta 2).

WB:WBGene00003951	pbs-5
Is predicted to have endopeptidase activity. Human ortholog(s) of this gene are implicated in JMP syndrome. Is an ortholog of human PSMB5 (proteasome 20S subunit beta 5) and PSMB8 (proteasome 20S subunit beta 8).

WB:WBGene00003952	pbs-6
Is predicted to have endopeptidase activity. Is expressed in pharynx. Is an ortholog of human PSMB1 (proteasome 20S subunit beta 1).

WB:WBGene00003953	pbs-7
Is predicted to have endopeptidase activity. Is an ortholog of human PSMB4 (proteasome 20S subunit beta 4).

WB:WBGene00003954	pcm-1
Exhibits protein-L-isoaspartate (D-aspartate) O-methyltransferase activity. Is involved in several processes, including cellular protein modification process; multicellular organismal response to stress; and regulation of autophagy. Localizes to axon; cytosol; and neuronal cell body. Is expressed in several structures, including alimentary muscle; dorso-rectal ganglion; gonad; somatic nervous system; and vulval muscle. Is an ortholog of human PCMT1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase).

WB:WBGene00003955	pcn-1
Exhibits DNA polymerase binding activity. Is an ortholog of human PCNA (proliferating cell nuclear antigen).

WB:WBGene00003956	pcp-1
Is predicted to have dipeptidyl-peptidase activity. Is an ortholog of human PRCP (prolylcarboxypeptidase).

WB:WBGene00003957	pcp-2
Is predicted to have dipeptidyl-peptidase activity. Localizes to membrane raft. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00003958	pcp-3
Is predicted to have dipeptidyl-peptidase activity. Localizes to membrane raft. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00003959	pcp-4
Is predicted to have dipeptidyl-peptidase activity. Localizes to membrane raft. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00003960	pcs-1
Exhibits glutathione gamma-glutamylcysteinyltransferase activity. Is involved in detoxification of mercury ion; phytochelatin biosynthetic process; and stress response to metal ion. Is expressed in several structures, including coelomocyte; non-striated muscle; pharyngeal-intestinal valve; pharynx; and rectal valve cell.

WB:WBGene00003961	pct-1
Is predicted to have protein serine/threonine kinase activity. Localizes to axon and dendrite. Is an ortholog of human CDK16 (cyclin dependent kinase 16).

WB:WBGene00003962	pdi-1
Exhibits protein disulfide isomerase activity and protein-glutamine gamma-glutamyltransferase activity. Is involved in protein deglutathionylation. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Cole-Carpenter syndrome. Is an ortholog of human P4HB (prolyl 4-hydroxylase subunit beta).

WB:WBGene00003963	pdi-2
Exhibits protein disulfide isomerase activity and protein-glutamine gamma-glutamyltransferase activity. Contributes to peptidyl-proline 4-dioxygenase activity. Is involved in cellular protein modification process; extracellular matrix assembly; and oxidation-reduction process. Localizes to procollagen-proline 4-dioxygenase complex. Is expressed in several structures, including germ line and hypodermis. Human ortholog(s) of this gene are implicated in Cole-Carpenter syndrome. Is an ortholog of human P4HB (prolyl 4-hydroxylase subunit beta).

WB:WBGene00003964	pdi-3
Exhibits protein disulfide isomerase activity and protein-glutamine gamma-glutamyltransferase activity. Is involved in several processes, including cellular protein modification process; male anatomical structure morphogenesis; and oviposition. Is expressed in hypodermis; intestine; and seam cell. Is an ortholog of human PDIA3 (protein disulfide isomerase family A member 3).

WB:WBGene00003965	pdk-1
Exhibits protein kinase activity. Is involved in several processes, including dauer larval development; learning or memory; and regulation of synaptic growth at neuromuscular junction. Localizes to axon; neuronal cell body; and nucleus. Is expressed in several structures, including gonad; intestine; neurons; pharynx; and ventral nerve cord. Is an ortholog of human PDPK1 (3-phosphoinositide dependent protein kinase 1).

WB:WBGene00003966	pdl-1
Is predicted to have 3',5'-cyclic-nucleotide phosphodiesterase activity. Is expressed in oxygen sensory neurons. Human ortholog(s) of this gene are implicated in Joubert syndrome 22. Is an ortholog of human PDE6D (phosphodiesterase 6D).

WB:WBGene00003967	pdr-1
Exhibits ubiquitin conjugating enzyme binding activity. Contributes to ubiquitin-protein transferase activity. Is involved in several processes, including cellular protein metabolic process; determination of adult lifespan; and negative regulation of engulfment of apoptotic cell. Localizes to mitochondrial outer membrane; neuronal cell body; and ubiquitin ligase complex. Is expressed in muscle cell and neurons. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in Parkinson's disease 2; lung cancer; and ovarian cancer. Is an ortholog of human PRKN (parkin RBR E3 ubiquitin protein ligase).

WB:WBGene00003968	peb-1
Exhibits RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including hindgut morphogenesis; positive regulation of growth rate; and vulval development. Localizes to nucleus. Is expressed in several structures, including germ line; hypodermis; pharyngeal cell; pharyngeal-intestinal valve; and rectal epithelial cell.

WB:WBGene00003969	pef-1
Is predicted to have protein serine/threonine phosphatase activity. Localizes to neuronal cell body. Is expressed in hypodermis; intestinal cell; muscle cell; and neurons. Is an ortholog of human PPEF1 (protein phosphatase with EF-hand domain 1).

WB:WBGene00003970	pek-1
Exhibits eukaryotic translation initiation factor 2alpha kinase activity. Is involved in several processes, including PERK-mediated unfolded protein response; peptidyl-serine phosphorylation; and regulation of necrotic cell death. Is expressed in intestine; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in Wolcott-Rallison syndrome. Is an ortholog of human EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3).

WB:WBGene00003971	pel-1
No description available

WB:WBGene00003972	pel-2
No description available

WB:WBGene00003973	pel-3
No description available

WB:WBGene00003974	pel-4
No description available

WB:WBGene00003975	pen-2
Is involved in several processes, including Notch signaling pathway; germ cell development; and pharynx development. Localizes to membrane. Is expressed in intestine; muscle cell; neurons; and vulva. Human ortholog(s) of this gene are implicated in hidradenitis suppurativa. Is an ortholog of human PSENEN (presenilin enhancer, gamma-secretase subunit).

WB:WBGene00003976	pes-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in embryo development and nematode larval development. Is expressed in several structures, including ABplaaaap; ABplaaapa; body wall muscle cell from D lineage; neurons; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in blepharophimosis, ptosis, and epicanthus inversus syndrome and premature ovarian failure.

WB:WBGene00003977	pes-2.1
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00003978	pes-4
Is predicted to have RNA binding activity. Is expressed in rectal epithelium. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human PCBP2 (poly(rC) binding protein 2); PCBP3 (poly(rC) binding protein 3); and PCBP4 (poly(rC) binding protein 4).

WB:WBGene00003979	pes-5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Aspirin; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00003980	pes-7
Is expressed in ganglia and tail. Is predicted to encode a protein with the following domains: RasGAP C-terminus; GTPase-activator protein for Ras-like GTPase; Calponin homology (CH) domain; RasGAP protein, C-terminal; Calponin homology domain; Ras GTPase-activating domain; Rho GTPase activation protein; and CH domain superfamily. Is an ortholog of human IQGAP1 (IQ motif containing GTPase activating protein 1) and IQGAP3 (IQ motif containing GTPase activating protein 3).

WB:WBGene00003981	pes-8
Is expressed in hermaphrodite gonad and rectum.

WB:WBGene00003982	pes-9
Is predicted to have dipeptidase activity and metal ion binding activity. Is an ortholog of human CNDP2 (carnosine dipeptidase 2).

WB:WBGene00003983	pes-10
Localizes to cytoplasm and nucleus.

WB:WBGene00003984	pes-11
No description available

WB:WBGene00003985	pes-12
No description available

WB:WBGene00003986	mct-4
Is predicted to have monocarboxylic acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A14 (solute carrier family 16 member 14).

WB:WBGene00003987	pes-23
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14) and SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00003988	pex-3
No description available

WB:WBGene00003989	pfn-1
Is predicted to have actin monomer binding activity. Is expressed in gonadal sheath cell; nerve ring; neurons; spermatheca; and vulva.

WB:WBGene00003990	pfn-2
Is predicted to have actin monomer binding activity. Is involved in muscle thin filament assembly. Is expressed in pharynx and spermatheca.

WB:WBGene00003991	pfn-3
Is predicted to have actin monomer binding activity. Is involved in muscle thin filament assembly. Localizes to striated muscle dense body. Is expressed in body wall musculature. Is an ortholog of human PFN4 (profilin family member 4).

WB:WBGene00003992	pgl-1
Exhibits endoribonuclease activity; identical protein binding activity; and protein self-association. Is involved in P granule organization; RNA phosphodiester bond hydrolysis, endonucleolytic; and germ-line stem cell division. Localizes to P granule. Is expressed in germ line.

WB:WBGene00003993	pgl-2
Localizes to P granule. Is expressed in germ line.

WB:WBGene00003994	pgl-3
Exhibits endoribonuclease activity and identical protein binding activity. Is involved in RNA phosphodiester bond hydrolysis, endonucleolytic. Localizes to P granule. Is expressed in Psub1 and germ line.

WB:WBGene00003995	pgp-1
Is predicted to have ATPase-coupled transmembrane transporter activity and efflux transmembrane transporter activity. Is involved in defense response to other organism; response to metal ion; and response to nematicide. Localizes to apical plasma membrane. Is expressed in intestinal cell; intestine; and pharynx. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1).

WB:WBGene00003996	pgp-2
Is predicted to have ATP binding activity; ATPase activity; and ATPase-coupled transmembrane transporter activity. Is involved in lipid storage and organelle organization. Localizes to gut granule membrane. Is expressed in AWAL and AWAR. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00003997	pgp-3
Is predicted to have ATPase-coupled transmembrane transporter activity and efflux transmembrane transporter activity. Is involved in defense response to Gram-negative bacterium; innate immune response; and stress response to cadmium ion. Localizes to apical plasma membrane. Is expressed in excretory canal; excretory cell; intestinal cell; intestine; and pharynx. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1).

WB:WBGene00003998	pgp-4
Is predicted to have ATPase-coupled transmembrane transporter activity and efflux transmembrane transporter activity. Is involved in RNA interference and stress response to cadmium ion. Is expressed in excretory canal. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1).

WB:WBGene00003999	pgp-5
Is predicted to have ATPase-coupled transmembrane transporter activity and efflux transmembrane transporter activity. Is involved in several processes, including defense response to bacterium; response to nematicide; and stress response to metal ion. Is expressed in intestine. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1).

WB:WBGene00004000	pgp-6
Is predicted to have ATPase-coupled transmembrane transporter activity and efflux transmembrane transporter activity. Is involved in response to nematicide. Is expressed in amphid neurons and head. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004001	pgp-7
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in stress response to cadmium ion. Is expressed in tail. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004002	pgp-8
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004003	pgp-9
Is predicted to have ATPase-coupled transmembrane transporter activity and efflux transmembrane transporter activity. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004004	pgp-10
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple).

WB:WBGene00004005	pgp-11
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in RNA interference. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004006	pgp-12
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in response to nematicide. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004007	pgp-13
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in amphid neurons and intestine. Human ortholog(s) of this gene are implicated in MHC class I deficiency; inflammatory bowel disease 13; and intrahepatic cholestasis (multiple). Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1); ABCB11 (ATP binding cassette subfamily B member 11); and ABCB5 (ATP binding cassette subfamily B member 5).

WB:WBGene00004008	pgp-14
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in response to nematicide. Human ortholog(s) of this gene are implicated in MHC class I deficiency; bile duct disease (multiple); and inflammatory bowel disease 13. Is an ortholog of human ABCB1 (ATP binding cassette subfamily B member 1) and ABCB11 (ATP binding cassette subfamily B member 11).

WB:WBGene00004009	pgp-15
Is expressed in head neurons and tail neurons.

WB:WBGene00004010	pha-1
Is predicted to have alpha-(1->3)-fucosyltransferase activity. Is involved in embryonic digestive tract morphogenesis; nematode larval development; and reproduction. Localizes to cytoplasm. Is expressed in body wall muscle cell and pharynx.

WB:WBGene00004011	pha-2
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including muscle cell fate specification; pharyngeal gland morphogenesis; and pharyngeal muscle development. Localizes to nucleus. Is expressed in head neurons; intestine; pharynx; and rectal gland cell. Is an ortholog of human HHEX (hematopoietically expressed homeobox).

WB:WBGene00004012	pha-3
Is involved in regulation of growth.

WB:WBGene00004013	pha-4
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Is involved in several processes, including pharynx development; positive regulation of cellular metabolic process; and response to sodium arsenite. Localizes to nucleus. Is expressed in several structures, including enteric muscle; gonad; neurons; pharynx; and rectum. Is an ortholog of human FOXA1 (forkhead box A1) and FOXA2 (forkhead box A2).

WB:WBGene00004014	phb-1
Is involved in several processes, including defecation; gamete generation; and mitochondrion morphogenesis. Localizes to mitochondrial prohibitin complex. Is expressed in several structures, including body wall musculature; excretory canal; hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in breast cancer. Is an ortholog of human PHB (prohibitin).

WB:WBGene00004015	phb-2
Is involved in several processes, including defecation; gamete generation; and mitochondrion morphogenesis. Localizes to mitochondrial prohibitin complex. Is expressed in body wall musculature; excretory canal; hypodermis; intestine; and neurons. Is an ortholog of human PHB2 (prohibitin 2).

WB:WBGene00004016	phf-5
Localizes to cytoplasm and nucleus. Is expressed in body wall musculature; intestine; pharyngeal muscle cell; pharynx; and rectal muscle. Is an ortholog of human PHF5A (PHD finger protein 5A).

WB:WBGene00004017	phg-1
Is involved in multicellular organism development and negative regulation of cell cycle G1/S phase transition. Localizes to anchored component of plasma membrane. Is expressed in muscle cell and pharynx. Is an ortholog of human GAS1 (growth arrest specific 1).

WB:WBGene00004018	phm-2
Is expressed in several structures, including body wall musculature; intestine; pharynx; somatic nervous system; and vulva.

WB:WBGene00004019	phm-3
No description available

WB:WBGene00004020	pho-1
Is predicted to have acid phosphatase activity. Localizes to membrane raft. Is expressed in intestine.

WB:WBGene00004021	pho-2
No description available

WB:WBGene00004022	pho-3
No description available

WB:WBGene00004023	pho-4
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Histidine phosphatase superfamily.

WB:WBGene00004024	php-3
Is predicted to have DNA binding activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is expressed in several structures, including coelomocyte; head neurons; intestine; somatic nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple). Is an ortholog of human HOXA10 (homeobox A10).

WB:WBGene00004025	phy-2
Exhibits peptidyl-proline 4-dioxygenase activity. Is predicted to contribute to procollagen-proline 4-dioxygenase activity. Is involved in macromolecule modification and oxidation-reduction process. Localizes to endoplasmic reticulum. Is expressed in excretory cell; hypodermis; and spermatheca. Is an ortholog of human P4HA1 (prolyl 4-hydroxylase subunit alpha 1) and P4HA2 (prolyl 4-hydroxylase subunit alpha 2).

WB:WBGene00004026	phy-3
Is predicted to contribute to procollagen-proline 4-dioxygenase activity. Is expressed in spermatheca.

WB:WBGene00004027	pie-1
Is predicted to have mRNA 3'-UTR binding activity. Is involved in several processes, including embryonic pattern specification; formation of primary germ layer; and negative regulation of macromolecule metabolic process. Localizes to several cellular components, including P granule; centrosome; and cytosol. Is expressed in germ line; head muscle; and nerve ring.

WB:WBGene00004028	pif-1
Is predicted to have 5'-3' DNA helicase activity; ATP binding activity; and DNA binding activity. Is an ortholog of human PIF1 (PIF1 5'-to-3' DNA helicase).

WB:WBGene00004029	pik-1
Is predicted to have protein serine/threonine kinase activity. Is expressed in RMGL; RMGR; and nervous system. Is an ortholog of human IRAK1 (interleukin 1 receptor associated kinase 1).

WB:WBGene00004030	pin-2
Is predicted to have metal ion binding activity. Localizes to cytoplasm; nucleus; and varicosity. Is expressed in PVT. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2W. Is an ortholog of human LIMS1 (LIM zinc finger domain containing 1) and LIMS2 (LIM zinc finger domain containing 2).

WB:WBGene00004031	pis-1
Localizes to MLL3/4 complex. Is an ortholog of human PAXIP1 (PAX interacting protein 1).

WB:WBGene00004032	pkc-1
Exhibits protein kinase C activity. Is involved in several processes, including insulin-like growth factor receptor signaling pathway; regulated exocytosis; and sensory perception of touch. Localizes to cell. Is expressed in ganglia; linker cell; and neurons. Human ortholog(s) of this gene are implicated in cerebral infarction. Is an ortholog of human PRKCE (protein kinase C epsilon).

WB:WBGene00004033	pkc-2
Exhibits calcium-dependent protein kinase C activity. Is involved in peptidyl-serine phosphorylation. Localizes to several cellular components, including cytosol; neuron projection; and neuronal cell body. Is expressed in body wall musculature; intestine; neurons; somatic nervous system; and tail ganglion. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 14. Is an ortholog of human PRKCA (protein kinase C alpha).

WB:WBGene00004034	pkc-3
Exhibits protein domain specific binding activity and protein serine/threonine kinase activity. Is involved in several processes, including defense response to fungus; gonad development; and peptidyl-serine phosphorylation. Localizes to apical plasma membrane; cortical actin cytoskeleton; and cytosol. Is expressed in several structures, including anterior hypodermis; enteric muscle; pharyngeal-intestinal valve; tail hypodermis; and vulva. Is an ortholog of human PRKCI (protein kinase C iota) and PRKCZ (protein kinase C zeta).

WB:WBGene00004035	pkd-2
Exhibits calcium channel activity. Is involved in calcium ion transport; response to hermaphrodite contact; and vulval location. Localizes to several cellular components, including ciliary membrane; endoplasmic reticulum; and sensory dendrite. Is expressed in CEM; nerve ring; neurons; and ray. Is used to study autosomal dominant polycystic kidney disease. Human ortholog(s) of this gene are implicated in polycystic kidney disease 1. Is an ortholog of human PKD2 (polycystin 2, transient receptor potential cation channel) and PKD2L1 (polycystin 2 like 1, transient receptor potential cation channel).

WB:WBGene00004036	plc-1
Exhibits GTPase inhibitor activity; Ras GTPase binding activity; and phosphatidylinositol phospholipase C activity. Is involved in several processes, including 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process; defense response to Gram-positive bacterium; and positive regulation of protein import into nucleus. Is expressed in excretory system; intestine; neurons; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 3. Is an ortholog of human PLCE1 (phospholipase C epsilon 1).

WB:WBGene00004037	plc-2
Is predicted to have phosphatidylinositol phospholipase C activity. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 12; familial cold autoinflammatory syndrome 3; and nonsyndromic congenital nail disorder 3. Is an ortholog of human PLCB1 (phospholipase C beta 1) and PLCB3 (phospholipase C beta 3).

WB:WBGene00004038	plc-3
Is predicted to have phosphatidylinositol phospholipase C activity. Is involved in sleep. Is expressed in ALA; gonad; intestine; and non-striated muscle. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 12; familial cold autoinflammatory syndrome 3; and nonsyndromic congenital nail disorder 3. Is an ortholog of human PLCG1 (phospholipase C gamma 1).

WB:WBGene00004039	plc-4
Is predicted to have phosphatidylinositol phospholipase C activity. Is expressed in vas deferens. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 12; familial cold autoinflammatory syndrome 3; and nonsyndromic congenital nail disorder 3. Is an ortholog of human PLCD3 (phospholipase C delta 3).

WB:WBGene00004040	pld-1
Is predicted to have N-acylphosphatidylethanolamine-specific phospholipase D activity; phosphatidylinositol binding activity; and phospholipase D activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in developmental cardiac valvular defect. Is an ortholog of human PLD2 (phospholipase D2).

WB:WBGene00004041	plg-1
Is expressed in vas deferens and in male.

WB:WBGene00004042	plk-1
Exhibits protein kinase activity. Is involved in several processes, including cytoskeleton organization; meiotic nuclear division; and positive regulation of nematode male tail tip morphogenesis. Localizes to several cellular components, including condensed chromosome; cytoskeleton; and nucleus. Is expressed in AB and embryonic cell. Is an ortholog of human PLK1 (polo like kinase 1).

WB:WBGene00004043	plk-2
Is predicted to have protein serine/threonine kinase activity. Is involved in regulation of meiosis I. Localizes to cytoplasm. Is expressed in germ line. Is an ortholog of human PLK1 (polo like kinase 1).

WB:WBGene00004044	plk-3
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human PLK1 (polo like kinase 1).

WB:WBGene00004045	pll-1
Is predicted to have GABA receptor binding activity; inositol 1,4,5 trisphosphate binding activity; and phosphatidylinositol phospholipase C activity. Is expressed in AIYL and AIYR. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 12; familial cold autoinflammatory syndrome 3; and nonsyndromic congenital nail disorder 3. Is an ortholog of human PLCL2 (phospholipase C like 2).

WB:WBGene00004046	plp-1
Exhibits double-stranded telomeric DNA binding activity. Is involved in germ cell development and regulation of locomotion. Localizes to P granule and nucleus. Is expressed in several structures, including Caa; Cpa; Ea; Psub4; and oocyte. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 31. Is an ortholog of human PURB (purine rich element binding protein B).

WB:WBGene00004047	plx-1
Exhibits semaphorin receptor activity. Is involved in epidermis development; male anatomical structure morphogenesis; and regulation of cellular component movement. Localizes to integral component of membrane and ruffle. Colocalizes with actin filament. Is expressed in several structures, including DA9; epithelial cell; non-striated muscle; somatic nervous system; and tail. Is an ortholog of human PLXNA2 (plexin A2); PLXNA3 (plexin A3); and PLXNA4 (plexin A4).

WB:WBGene00004048	plx-2
Exhibits semaphorin receptor activity. Is involved in several processes, including generation of neurons; nematode larval development; and nematode male tail tip morphogenesis. Localizes to cell leading edge and cell surface. Is expressed in several structures, including P3/4L; P9/10L; P9/10R; neuroblasts; and ray structural cell. Is an ortholog of human PLXNC1 (plexin C1) and PLXND1 (plexin D1).

WB:WBGene00004049	parp-1
Exhibits NAD+ ADP-ribosyltransferase activity. Is involved in determination of adult lifespan and protein poly-ADP-ribosylation. Is used to study type 2 diabetes mellitus. Is an ortholog of human PARP1 (poly(ADP-ribose) polymerase 1).

WB:WBGene00004050	parp-2
Exhibits NAD+ ADP-ribosyltransferase activity. Is involved in protein poly-ADP-ribosylation. Is an ortholog of human PARP2 (poly(ADP-ribose) polymerase 2).

WB:WBGene00004051	parg-1
Exhibits poly(ADP-ribose) glycohydrolase activity. Is involved in nucleotide-sugar metabolic process and response to gamma radiation. Localizes to neuron projection and nucleus. Is expressed in tail neurons and ventral cord neurons. Is an ortholog of human BPHL (biphenyl hydrolase like).

WB:WBGene00004052	parg-2
Exhibits poly(ADP-ribose) glycohydrolase activity. Is involved in nucleotide-sugar metabolic process and response to gamma radiation. Localizes to cytoplasm. Is expressed in head neurons and tail neurons. Is an ortholog of human BPHL (biphenyl hydrolase like).

WB:WBGene00004053	tank-1
Is predicted to have NAD+ ADP-ribosyltransferase activity and protein ADP-ribosylase activity. Is involved in intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of programmed cell death; and response to gamma radiation. Localizes to nucleus.

WB:WBGene00004054	AC8.1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by Alovudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00004055	pmk-1
Exhibits MAP kinase activity; molecular function regulator; and transcription factor binding activity. Is involved in several processes, including behavioral response to nicotine; cellular protein modification process; and defense response to other organism. Localizes to cytosol and nucleus. Is expressed in several structures, including head neurons; intestine; and vulval precursor cell. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10. Is an ortholog of human MAPK11 (mitogen-activated protein kinase 11) and MAPK14 (mitogen-activated protein kinase 14).

WB:WBGene00004056	pmk-2
Exhibits MAP kinase activity. Is involved in intracellular signal transduction and response to osmotic stress. Localizes to cytoplasm. Is expressed in ganglia; gonad; intestine; and nerve ring. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10. Is an ortholog of human MAPK12 (mitogen-activated protein kinase 12).

WB:WBGene00004057	pmk-3
Exhibits protein kinase binding activity; protein phosphatase binding activity; and protein serine/threonine kinase activity. Is involved in several processes, including behavioral response to nicotine; generation of neurons; and p38MAPK cascade. Localizes to cytoplasm and nucleus. Is expressed in several structures, including amphid neurons; gonad; and intestine. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00004058	pmp-1
Is predicted to have several functions, including ATP binding activity; ATPase activity; and protein homodimerization activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 5. Is an ortholog of human ABCD3 (ATP binding cassette subfamily D member 3).

WB:WBGene00004059	pmp-2
Is predicted to have several functions, including ATP binding activity; ATPase activity; and protein homodimerization activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 5. Is an ortholog of human ABCD3 (ATP binding cassette subfamily D member 3).

WB:WBGene00004060	pmp-3
Is predicted to have ATP binding activity; ATPase activity; and ATPase-coupled transmembrane transporter activity. Is an ortholog of human ABCD4 (ATP binding cassette subfamily D member 4).

WB:WBGene00004061	pmp-4
Is predicted to have ATP binding activity; ATPase activity; and ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in adrenoleukodystrophy. Is an ortholog of human ABCD1 (ATP binding cassette subfamily D member 1) and ABCD2 (ATP binding cassette subfamily D member 2).

WB:WBGene00004062	pmp-5
Is predicted to have ATP binding activity; ATPase activity; and ATPase-coupled transmembrane transporter activity. Is an ortholog of human ABCD4 (ATP binding cassette subfamily D member 4).

WB:WBGene00004063	pmr-1
Exhibits calcium transmembrane transporter activity, phosphorylative mechanism and manganese transmembrane transporter activity, phosphorylative mechanism. Is involved in several processes, including metal ion transport; response to calcium ion; and response to manganese ion. Localizes to Golgi apparatus and membrane. Is expressed in male gonad; seam cell; and spermatheca. Human ortholog(s) of this gene are implicated in Hailey-Hailey disease. Is an ortholog of human ATP2C1 (ATPase secretory pathway Ca2+ transporting 1).

WB:WBGene00004064	pms-2
Is predicted to have ATPase activity. Human ortholog(s) of this gene are implicated in hereditary nonpolyposis colorectal cancer type 4. Is an ortholog of human PMS2 (PMS1 homolog 2, mismatch repair system component).

WB:WBGene00004066	pna-2
No description available

WB:WBGene00004068	pnk-1
Is predicted to have pantothenate kinase activity. Human ortholog(s) of this gene are implicated in pantothenate kinase-associated neurodegeneration. Is an ortholog of human PANK2 (pantothenate kinase 2); PANK3 (pantothenate kinase 3); and PANK4 (pantothenate kinase 4 (inactive)).

WB:WBGene00004070	pnm-2
No description available

WB:WBGene00004071	pnm-3
No description available

WB:WBGene00004072	pnm-4
No description available

WB:WBGene00004073	pnm-5
No description available

WB:WBGene00004074	pnm-6
No description available

WB:WBGene00004075	pod-1
Exhibits actin filament binding activity. Localizes to cell cortex of cell tip and cleavage furrow. Is an ortholog of human CORO7-PAM16 (CORO7-PAM16 readthrough).

WB:WBGene00004076	pod-2
Is predicted to have acetyl-CoA carboxylase activity. Is involved in several processes, including establishment or maintenance of epithelial cell apical/basal polarity; polarity specification of anterior/posterior axis; and water homeostasis. Is an ortholog of human ACACA (acetyl-CoA carboxylase alpha).

WB:WBGene00004077	pop-1
Exhibits several functions, including RNA polymerase II transcription factor binding activity; beta-catenin binding activity; and enzyme binding activity. Is involved in several processes, including mesodermal cell fate commitment; mitochondrial unfolded protein response; and regulation of transcription, DNA-templated. Localizes to cytoplasm and nucleus. Is expressed in several structures, including ABplpapaaa; ABprpapaaa; oocyte; somatic nervous system; and vulva. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human LEF1 (lymphoid enhancer binding factor 1).

WB:WBGene00004078	pos-1
Exhibits mRNA 3'-UTR binding activity; poly(U) RNA binding activity; and transcription corepressor activity. Is involved in several processes, including cell fate specification; embryonic pattern specification; and negative regulation of transcription by RNA polymerase II. Localizes to P granule. Is expressed in several structures, including Psub4; germ line; neurons; oocyte; and rectal gland cell. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00004083	pph-1
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00004084	pph-2
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00004085	pph-4.1
Is predicted to have protein serine/threonine phosphatase activity. Is involved in chiasma assembly; embryo development; and regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination. Localizes to centrosome and cytoplasm. Is an ortholog of human PPP4C (protein phosphatase 4 catalytic subunit).

WB:WBGene00004086	pph-4.2
Is predicted to have metal ion binding activity and phosphoprotein phosphatase activity. Is an ortholog of human PPP4C (protein phosphatase 4 catalytic subunit).

WB:WBGene00004087	ppk-1
Exhibits 1-phosphatidylinositol-4-phosphate 5-kinase activity and calmodulin binding activity. Is involved in protein localization; regulation of mitotic spindle elongation; and regulation of protein localization. Localizes to plasma membrane. Is expressed in egg-laying apparatus; gonad; seam cell; and ventral nerve cord. Is an ortholog of human PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha).

WB:WBGene00004088	ppk-2
Is predicted to have ATP binding activity and phosphatidylinositol phosphate kinase activity. Is an ortholog of human PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha).

WB:WBGene00004089	ppk-3
Is predicted to have 1-phosphatidylinositol-3-phosphate 5-kinase activity and phosphatidylinositol-3-phosphate binding activity. Localizes to axon; cytoplasm; and neuronal cell body. Is expressed in hypodermis; non-striated muscle; somatic nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in Fleck corneal dystrophy. Is an ortholog of human PIKFYVE (phosphoinositide kinase, FYVE-type zinc finger containing).

WB:WBGene00004090	eif-2Bgamma
Is predicted to have guanyl-nucleotide exchange factor activity and translation initiation factor activity. Localizes to cytoplasm. Human ortholog(s) of this gene are implicated in leukoencephalopathy with vanishing white matter. Is an ortholog of human EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma).

WB:WBGene00004091	pps-1
Exhibits adenylylsulfate kinase activity and sulfate adenylyltransferase (ATP) activity. Is involved in 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process. Localizes to nucleus. Is expressed in epithelial cell and pharyngeal gland cell. Human ortholog(s) of this gene are implicated in spondyloepimetaphyseal dysplasia, Pakistani type. Is an ortholog of human PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) and PAPSS2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2).

WB:WBGene00004092	ppt-1
Exhibits palmitoyl-(protein) hydrolase activity. Is involved in several processes, including cellular protein catabolic process; mitochondrion organization; and oviposition. Is used to study neuronal ceroid lipofuscinosis. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 1. Is an ortholog of human PPT1 (palmitoyl-protein thioesterase 1).

WB:WBGene00004093	ppw-1
Is predicted to have nucleic acid binding activity.

WB:WBGene00004094	ppw-2
Is predicted to have nucleic acid binding activity.

WB:WBGene00004095	pqe-1
Is predicted to have exonuclease activity. Is involved in negative regulation of gene expression. Localizes to nucleus. Is expressed in ventral cord neurons. Is an ortholog of human REXO1 (RNA exonuclease 1 homolog).

WB:WBGene00004096	pqm-1
Is involved in defense response to Gram-negative bacterium; determination of adult lifespan; and innate immune response. Localizes to cytoplasm and nucleus. Is expressed in head muscle; head neurons; and pseudocoelom.

WB:WBGene00004098	pqn-2
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including aldicarb; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004099	abu-15
Is involved in endoplasmic reticulum unfolded protein response and pharynx development. Is expressed in pharyngeal muscle cell.

WB:WBGene00004100	pqn-8
Is involved in pharyngeal gland morphogenesis. Is expressed in g1.

WB:WBGene00004101	hgrs-1
Exhibits ubiquitin binding activity. Is involved in protein localization to non-motile cilium. Localizes to ESCRT-0 complex; early endosome; and endosome membrane. Is expressed in several structures, including coelomocyte; excretory canal; hermaphrodite gonad; intestine; and vulva. Is an ortholog of human HGS (hepatocyte growth factor-regulated tyrosine kinase substrate).

WB:WBGene00004102	pqn-10
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including aldicarb; Rotenone; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00004103	pqn-11
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00004104	pqn-13
Is enriched in DA neuron; GABAergic neurons; head mesodermal cell; pharynx; and seam cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including 1-methylnicotinamide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine rich repeat and Cysteine rich repeat, tripleX.

WB:WBGene00004105	szy-20
Is predicted to have RNA binding activity. Is involved in several processes, including negative regulation of protein localization to centrosome; positive regulation of mitotic cell cycle, embryonic; and regulation of cell cycle process. Localizes to centrosome; cytoplasm; and nucleolus.

WB:WBGene00004106	pqn-15
Is predicted to have DNA binding activity; DNA-dependent ATPase activity; and transcription factor binding activity. Human ortholog(s) of this gene are implicated in several diseases, including CHARGE syndrome; Coffin-Siris syndrome 4; and Schimke immuno-osseous dysplasia.

WB:WBGene00004107	pqn-16
Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004108	pqn-18
Is enriched in head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00004109	stam-1
Exhibits protein C-terminus binding activity and ubiquitin binding activity. Is involved in several processes, including endosome to lysosome transport; ephrin receptor signaling pathway; and response to hermaphrodite contact. Localizes to ESCRT-0 complex; cilium; and early endosome. Is expressed in CEM; male gonad; neurons; and pharyngeal-intestinal valve. Is an ortholog of human STAM (signal transducing adaptor molecule) and STAM2 (signal transducing adaptor molecule 2).

WB:WBGene00004110	pqn-20
Is enriched in AVK; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by six chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004111	pqn-21
Localizes to nucleus. Is expressed in several structures, including body wall musculature; intestine; spermatheca; tail; and ventral nerve cord.

WB:WBGene00004112	pqn-22
Is enriched in body wall muscle cell; germ line; and muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including methylmercuric chloride; Alovudine; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 1B. Is predicted to encode a protein with the following domain: Zasp-like motif. Is an ortholog of human LIMD2 (LIM domain containing 2).

WB:WBGene00004113	pqn-24
Localizes to mitochondrion. Is expressed in head muscle.

WB:WBGene00004114	pqn-25
Is expressed in intestine and pharyngeal gland cell. Is predicted to encode a protein with the following domains: EB module; Lustrin, cysteine-rich repeated domain; EB domain; Cysteine-rich repeat; and Lustrin, cysteine-rich repeated.

WB:WBGene00004115	pqn-26
Is enriched in GABAergic neurons; head mesodermal cell; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including D-glucose; sesamin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Thioredoxin-like superfamily.

WB:WBGene00004116	pqn-27
Is enriched in AVK; NSM; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; age-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including nicotine; Zidovudine; and Diazinon based on proteomic; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: MIF4G-like domain superfamily and Armadillo-type fold.

WB:WBGene00004117	sin-3
Contributes to histone deacetylase activity. Is involved in several processes, including cell fate specification; nematode male tail mating organ morphogenesis; and vulval development. Is expressed in CEP; inner labial neurons; ray structural cell; socket cell; and ventral nerve cord. Human ortholog(s) of this gene are implicated in chromosome 15q24 deletion syndrome. Is an ortholog of human SIN3A (SIN3 transcription regulator family member A) and SIN3B (SIN3 transcription regulator family member B).

WB:WBGene00004118	pqn-29
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Cadmium Chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004119	pqn-31
Is enriched in head mesodermal cell and pharynx based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00004120	pqn-32
Is enriched in intestine and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including hydrogen sulfide; Nitric Oxide; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00004121	ptrn-1
Exhibits microtubule minus-end binding activity. Is involved in cytoplasmic microtubule organization and nematode larval development. Colocalizes with microtubule. Is expressed in hypodermis; intestine; nervous system; and pharynx. Is an ortholog of human CAMSAP1 (calmodulin regulated spectrin associated protein 1) and CAMSAP3 (calmodulin regulated spectrin associated protein family member 3).

WB:WBGene00004122	pqn-35
Is expressed in pharyngeal muscle cell.

WB:WBGene00004123	pqn-36
Is enriched in DA neuron; GABAergic neurons; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including skn-1; rrf-3; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; metformin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00004124	pqn-37
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-7 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00004125	mdt-30
Is enriched in AVA; OLL; PVD; and germ line based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00004126	pqn-39
Is enriched in neurons and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by Rifampin; allantoin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00004127	abu-12
Is predicted to have histone methyltransferase activity (H3-K79 specific).

WB:WBGene00004128	pqn-41
Is expressed in several structures, including linker cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00004129	pqn-42
Is enriched in GABAergic neurons; body wall muscle cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00004130	ketn-1
Exhibits actin filament binding activity. Localizes to I band. Is expressed in anal depressor muscle; body wall musculature; male gonad; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in centronuclear myopathy 5; myofibrillar myopathy 3; and spheroid body myopathy. Is an ortholog of human MYOT (myotilin).

WB:WBGene00004131	pqn-44
Is predicted to have RNA adenylyltransferase activity. Is an ortholog of human TENT5A (terminal nucleotidyltransferase 5A); TENT5B (terminal nucleotidyltransferase 5B); and TENT5C (terminal nucleotidyltransferase 5C).

WB:WBGene00004132	ifet-1
Is predicted to have mRNA binding activity. Is involved in negative regulation of translation. Localizes to P granule and messenger ribonucleoprotein complex. Is an ortholog of human EIF4ENIF1 (eukaryotic translation initiation factor 4E nuclear import factor 1).

WB:WBGene00004133	abu-13
Is enriched in OLL; PLM; PVD; hypodermis; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004134	myrf-1
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is involved in ecdysis, collagen and cuticulin-based cuticle and nematode larval development. Localizes to basal part of cell and endoplasmic reticulum. Is expressed in several structures, including ciliated neurons; excretory duct; gonad; pharyngeal cell; and somatic nervous system. Is an ortholog of human MYRF (myelin regulatory factor).

WB:WBGene00004135	pqn-48
Is enriched in body wall muscle cell; body wall musculature; germ line; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00004136	pqn-51
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transcription factor IIA, alpha/beta subunit; Transcription factor IIA, alpha/beta subunit; and Transcription factor IIA, beta-barrel. Is an ortholog of human GTF2A1 (general transcription factor IIA subunit 1).

WB:WBGene00004138	pqn-53
Localizes to nucleus.

WB:WBGene00004139	pqn-54
Is enriched in DA neuron; pharynx; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004140	ebax-1
Exhibits Hsp90 protein binding activity; misfolded protein binding activity; and signaling receptor binding activity. Is involved in several processes, including positive regulation of oviposition; regulation of axon guidance; and regulation of male mating behavior. Localizes to several cellular components, including Cul2-RING ubiquitin ligase complex; cytosol; and neuronal cell body. Is expressed in excretory cell; nervous system; and vulval muscle. Is an ortholog of human ZSWIM8 (zinc finger SWIM-type containing 8).

WB:WBGene00004141	pqn-57
Is involved in endoplasmic reticulum unfolded protein response. Is expressed in pharyngeal muscle cell and rectum.

WB:WBGene00004143	pqn-59
Is expressed widely. Is predicted to encode a protein with the following domains: Phosphorylation site and UBA-like superfamily. Is an ortholog of human UBAP2 (ubiquitin associated protein 2).

WB:WBGene00004144	pqn-60
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including methylmercuric chloride; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00004145	pqn-62
Is enriched in body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: SAP domain superfamily.

WB:WBGene00004146	pqn-63
Is enriched in DA neuron and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including cholesterol; lathosterol; and hydrogen sulfide based on microarray and RNA-seq studies.

WB:WBGene00004147	larp-5
Is predicted to have RNA binding activity. Is expressed in PVDL; PVDR; and neurons. Is an ortholog of human LARP4B (La ribonucleoprotein 4B).

WB:WBGene00004148	pqn-65
Is expressed in gonad. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00004149	trpl-5
Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is predicted to encode a protein with the following domain: .

WB:WBGene00004150	pqn-67
Is expressed in tail. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00004151	pqn-68
Is predicted to have D-tyrosyl-tRNA(Tyr) deacylase activity. Is an ortholog of human DTD1 (D-aminoacyl-tRNA deacylase 1).

WB:WBGene00004152	pqn-70
Is enriched in germ line; head mesodermal cell; and neurons based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including gld-1; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00004153	pqn-71
Is enriched in arcade cell; intestine; pharyngeal-intestinal valve cell; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including aldicarb; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004154	pqn-72
Is enriched in AFD; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00004155	pqn-73
Is expressed in arcade cell.

WB:WBGene00004156	pqn-74
Is predicted to have chitin binding activity. Is involved in endoplasmic reticulum unfolded protein response.

WB:WBGene00004157	pqn-75
Is expressed in pharyngeal gland cell and pharynx.

WB:WBGene00004158	pqn-76
Is affected by several genes including daf-2; sir-2.1; and adr-1 based on RNA-seq and microarray studies. Is affected by Neurotoxins; Cry5B; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1096) and Protein of unknown function DUF1096.

WB:WBGene00004159	pqn-78
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including aldicarb; Neurotoxins; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1096) and Protein of unknown function DUF1096.

WB:WBGene00004160	pqn-79
Is affected by several genes including daf-2; clk-1; and pmk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including aldicarb; Neurotoxins; and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1096) and Protein of unknown function DUF1096.

WB:WBGene00004161	pqn-80
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including sir-2.1; lin-39; and dcr-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: HPC2 and ubinuclein domain and Hpc2-related domain.

WB:WBGene00004163	pqn-82
Is expressed in intestine.

WB:WBGene00004164	pqn-83
Is enriched in excretory cell; germ line; and hypodermis based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00004165	pqn-84
Is predicted to have galactoside binding activity.

WB:WBGene00004166	pqn-85
Is predicted to have chromatin binding activity. Is involved in embryo development and mitotic sister chromatid segregation. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 1. Is an ortholog of human NIPBL (NIPBL cohesin loading factor).

WB:WBGene00004167	pqn-87
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity.

WB:WBGene00004168	pqn-88
Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00004169	pqn-89
Is enriched in RIS; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00004170	pqn-90
Is affected by several genes including clk-1; lin-15B; and aak-2 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including aldicarb; sodium arsenite; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004171	pqn-91
Is affected by several genes including sir-2.1; lin-15B; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Heme; sodium arsenite; and Neurotoxins based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004172	pqn-92
Is expressed in head neurons and pharynx.

WB:WBGene00004173	pqn-94
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00004174	abu-14
Is involved in pharynx development. Is expressed in buccal cavity; cuticle; grinder; marginal cell; and pharyngeal muscle cell.

WB:WBGene00004175	pqn-96
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00004176	pqn-97
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; clk-1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including tryptophan; methylmercuric chloride; and Mercuric Chloride based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00004177	pqn-98
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; bisphenol A; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00004178	prg-1
Exhibits 21U-RNA binding activity. Is involved in 21U-RNA metabolic process; gamete generation; and positive regulation of mitotic nuclear division. Localizes to P granule. Is expressed in germ line. Is an ortholog of human PIWIL1 (piwi like RNA-mediated gene silencing 1).

WB:WBGene00004179	prg-2
Is expressed in germ line. Is an ortholog of human PIWIL1 (piwi like RNA-mediated gene silencing 1).

WB:WBGene00004180	pri-1
Is predicted to have DNA primase activity and single-stranded DNA binding activity. Is an ortholog of human PRIM1 (DNA primase subunit 1).

WB:WBGene00004181	pri-2
Is predicted to have 4 iron, 4 sulfur cluster binding activity; DNA binding activity; and metal ion binding activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is an ortholog of human PRIM2 (DNA primase subunit 2).

WB:WBGene00004182	prk-1
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human PIM3 (Pim-3 proto-oncogene, serine/threonine kinase).

WB:WBGene00004183	prk-2
Is predicted to have protein serine/threonine kinase activity. Is involved in regulation of synapse assembly. Is an ortholog of human PIM2 (Pim-2 proto-oncogene, serine/threonine kinase) and PIM3 (Pim-3 proto-oncogene, serine/threonine kinase).

WB:WBGene00004184	T19D2.2
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human PTP4A2 (protein tyrosine phosphatase 4A2).

WB:WBGene00004185	pro-1
Is involved in germ cell development; gonad development; and rRNA processing. Is expressed widely. Is an ortholog of human WDR18 (WD repeat domain 18).

WB:WBGene00004186	prpf-4
Is predicted to have protein kinase activity. Is an ortholog of human PRPF4B (pre-mRNA processing factor 4B).

WB:WBGene00004187	prp-8
Is predicted to have RNA binding activity. Is expressed in germ line. Is used to study retinitis pigmentosa. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 13. Is an ortholog of human PRPF8 (pre-mRNA processing factor 8).

WB:WBGene00004188	prp-21
Is predicted to have RNA binding activity. Is an ortholog of human SF3A1 (splicing factor 3a subunit 1).

WB:WBGene00004189	pars-1
Is predicted to have proline-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 21. Is an ortholog of human EPRS1 (glutamyl-prolyl-tRNA synthetase 1).

WB:WBGene00004190	pars-2
Is predicted to have proline-tRNA ligase activity. Is an ortholog of human PARS2 (prolyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00004191	prx-1
Is predicted to have ATPase activity. Human ortholog(s) of this gene are implicated in Heimler syndrome 1 and peroxisome biogenesis disorder 1A. Is an ortholog of human PEX1 (peroxisomal biogenesis factor 1).

WB:WBGene00004192	prx-2
Is enriched in ASER and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including biotin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 5A. Is predicted to encode a protein with the following domains: Pex2 / Pex12 amino terminal region; Zinc finger, RING-type; Pex, N-terminal; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human PEX2 (peroxisomal biogenesis factor 2).

WB:WBGene00004193	prx-3
Is predicted to have protein-macromolecule adaptor activity. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 10A. Is an ortholog of human PEX3 (peroxisomal biogenesis factor 3).

WB:WBGene00004194	prx-5
Exhibits peroxisome targeting sequence binding activity. Is involved in nematode larval development and protein import into peroxisome matrix. Is expressed in neurons. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 2A; peroxisome biogenesis disorder 2B; and rhizomelic chondrodysplasia punctata type 5. Is an ortholog of human PEX5 (peroxisomal biogenesis factor 5).

WB:WBGene00004195	prx-6
Is predicted to have ATPase activity. Is involved in nematode larval development. Human ortholog(s) of this gene are implicated in Heimler syndrome 2 and peroxisome biogenesis disorder 4A. Is an ortholog of human PEX6 (peroxisomal biogenesis factor 6).

WB:WBGene00004196	prx-11
Is involved in defense response to Gram-negative bacterium and innate immune response. Is an ortholog of human PEX11G (peroxisomal biogenesis factor 11 gamma).

WB:WBGene00004197	prx-12
Is predicted to have ubiquitin-protein transferase activity. Is involved in nematode larval development and peroxisome organization. Human ortholog(s) of this gene are implicated in Refsum disease; infantile Refsum disease; and peroxisome biogenesis disorder 3A. Is an ortholog of human PEX12 (peroxisomal biogenesis factor 12).

WB:WBGene00004198	prx-13
Is involved in nematode larval development. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 11A. Is an ortholog of human PEX13 (peroxisomal biogenesis factor 13).

WB:WBGene00004199	prx-14
Is predicted to have signaling receptor binding activity. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 13A. Is an ortholog of human PEX14 (peroxisomal biogenesis factor 14).

WB:WBGene00004200	prx-16
No description available

WB:WBGene00004201	prx-19
Is involved in nematode larval development. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 12A. Is an ortholog of human PEX19 (peroxisomal biogenesis factor 19).

WB:WBGene00004202	pry-1
Exhibits armadillo repeat domain binding activity; protein C-terminus binding activity; and ubiquitin ligase-substrate adaptor activity. Is involved in several processes, including negative regulation of canonical Wnt signaling pathway; negative regulation of vulval development; and proteasome-mediated ubiquitin-dependent protein catabolic process. Localizes to several cellular components, including beta-catenin destruction complex; cell cortex; and nucleus. Is expressed in several structures, including QL.a; neurons; seam cell; ventral cord blast cell; and vulval precursor cell. Is an ortholog of human AXIN1 (axin 1) and AXIN2 (axin 2).

WB:WBGene00004203	swsn-1
Exhibits identical protein binding activity. Is involved in several processes, including gonad development; negative regulation of vulval development; and positive regulation of growth rate. Is expressed in several structures, including vulval cell. Is used to study alcohol use disorder. Is an ortholog of human SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1) and SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2).

WB:WBGene00004204	swsn-4
Is predicted to have DNA binding activity; DNA-dependent ATPase activity; and transcription factor binding activity. Is expressed in several structures, including head; hyp7 syncytium; tail; ventral cord neurons; and vulval cell. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in Coffin-Siris syndrome 4. Is an ortholog of human SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) and SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4).

WB:WBGene00004205	psr-1
Exhibits identical protein binding activity and phosphatidylserine binding activity. Is involved in engulfment of apoptotic cell. Localizes to spanning component of plasma membrane. Is expressed in engulfing cell. Is an ortholog of human JMJD6 (jumonji domain containing 6, arginine demethylase and lysine hydroxylase).

WB:WBGene00004206	pst-1
Exhibits 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity. Is involved in 3'-phosphoadenosine 5'-phosphosulfate transport. Localizes to integral component of Golgi membrane. Is expressed in AMshL; AMshR; pharyngeal gland cell; and seam cell. Is an ortholog of human SLC35B2 (solute carrier family 35 member B2).

WB:WBGene00004207	ptb-1
Is predicted to have mRNA binding activity. Is expressed in several structures, including amphid neurons; head; muscle cell; somatic gonad; and tail. Is an ortholog of human PTBP1 (polypyrimidine tract binding protein 1); PTBP2 (polypyrimidine tract binding protein 2); and PTBP3 (polypyrimidine tract binding protein 3).

WB:WBGene00004208	ptc-1
Is predicted to have hedgehog family protein binding activity; hedgehog receptor activity; and smoothened binding activity. Is involved in molting cycle. Localizes to integral component of plasma membrane. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in holoprosencephaly 7; medulloblastoma; and nevoid basal cell carcinoma syndrome. Is an ortholog of human PTCH1 (patched 1) and PTCH2 (patched 2).

WB:WBGene00004209	ptc-2
Is enriched in coelomocyte; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by paraquat and Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in holoprosencephaly 7; medulloblastoma; and nevoid basal cell carcinoma syndrome. Is an ortholog of human PTCH1 (patched 1) and PTCH2 (patched 2).

WB:WBGene00004210	ptc-3
Is predicted to have hedgehog family protein binding activity; hedgehog receptor activity; and smoothened binding activity. Is involved in molting cycle. Localizes to apical plasma membrane and cytoplasmic vesicle. Is expressed in several structures, including CEP; cloaca; egg-laying apparatus; excretory duct; and preanal ganglion. Human ortholog(s) of this gene are implicated in holoprosencephaly 7; medulloblastoma; and nevoid basal cell carcinoma syndrome. Is an ortholog of human PTCH1 (patched 1) and PTCH2 (patched 2).

WB:WBGene00004211	ptd-2
Is enriched in several structures, including Z1.p; Z4.a; cephalic sheath cell; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including hydrogen sulfide; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Patched family and Protein patched/dispatched. Is an ortholog of human DISP1 (dispatched RND transporter family member 1).

WB:WBGene00004212	ptl-1
Exhibits kinesin binding activity and microtubule binding activity. Is involved in microtubule polymerization and positive regulation of nematode male tail tip morphogenesis. Localizes to axon. Is expressed in intestinal muscle; neurons; and tail. Human ortholog(s) of this gene are implicated in frontotemporal dementia; neurodegenerative disease (multiple); and progressive supranuclear palsy. Is an ortholog of human MAPT (microtubule associated protein tau).

WB:WBGene00004213	ptp-1
Is predicted to have protein tyrosine phosphatase activity. Localizes to sarcoplasmic reticulum. Is expressed in muscle cell; nerve ring; neurons; pharyngeal nervous system; and ventral nerve cord. Is an ortholog of human PTPN4 (protein tyrosine phosphatase non-receptor type 4).

WB:WBGene00004214	ptp-2
Is predicted to have protein tyrosine phosphatase activity. Is involved in several processes, including nematode larval development; positive regulation of signal transduction; and positive regulation of vulval development. Localizes to cytoplasmic vesicle. Is expressed in body wall musculature; head ganglion; pharynx; spermatheca; and tail. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome 1; Noonan syndrome 1; and juvenile myelomonocytic leukemia. Is an ortholog of human PTPN11 (protein tyrosine phosphatase non-receptor type 11) and PTPN6 (protein tyrosine phosphatase non-receptor type 6).

WB:WBGene00004215	ptp-3
Is predicted to have transmembrane receptor protein tyrosine phosphatase activity. Is involved in several processes, including embryonic morphogenesis; nervous system development; and neuroblast migration. Localizes to adherens junction and synapse. Is expressed in embryonic cell; hypodermis; and nervous system. Is an ortholog of human PTPRD (protein tyrosine phosphatase receptor type D) and PTPRF (protein tyrosine phosphatase receptor type F).

WB:WBGene00004216	ptr-1
Is involved in molting cycle and nematode male tail tip morphogenesis. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004217	ptr-2
Is predicted to have transmembrane transporter activity. Is involved in mitotic cytokinesis; molting cycle; and nematode male tail tip morphogenesis. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004218	ptr-3
Is involved in molting cycle. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004219	ptr-4
Is involved in endocytosis; molting cycle; and nematode male tail tip morphogenesis. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004220	ptr-5
Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004221	ptr-6
Is involved in molting cycle. Is expressed in anterior hypodermis. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004222	ptr-8
Is involved in molting cycle. Is expressed in hypodermis and rectum. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004223	ptr-9
Is involved in molting cycle. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004224	ptr-10
Is involved in molting cycle. Is expressed in accessory cell. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004225	ptr-11
Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004226	ptr-12
Is involved in molting cycle. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004227	ptr-13
Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004228	ptr-14
Is predicted to have transmembrane transporter activity. Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004229	ptr-15
Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004230	ptr-16
Is enriched in Z1; Z4; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Patched family and Protein patched/dispatched. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004231	ptr-17
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Patched family and Protein patched/dispatched. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004232	ptr-18
Is involved in endocytosis; molting cycle; and nematode male tail tip morphogenesis. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004233	ptr-19
Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004234	ptr-20
Is involved in molting cycle and nematode male tail tip morphogenesis. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004235	ptr-21
Is involved in molting cycle. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004236	ptr-22
Is involved in molting cycle. Is an ortholog of human PTCHD3 (patched domain containing 3).

WB:WBGene00004237	ptr-23
Is involved in endocytosis; molting cycle; and nematode male tail tip morphogenesis. Is expressed in hypodermis. Is an ortholog of human PTCHD1 (patched domain containing 1); PTCHD3 (patched domain containing 3); and PTCHD4 (patched domain containing 4).

WB:WBGene00004238	ptr-24
Is involved in molting cycle.

WB:WBGene00004239	puf-3
Exhibits mRNA 3'-UTR binding activity. Is expressed in germ line.

WB:WBGene00004240	puf-4
Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Sodium Chloride and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00004241	puf-5
Is predicted to have mRNA 3'-UTR binding activity. Is involved in positive regulation of embryonic development. Localizes to P granule. Is expressed in germ line and oocyte.

WB:WBGene00004242	puf-6
Is predicted to have mRNA 3'-UTR binding activity. Is involved in germ cell development and negative regulation of cell population proliferation.

WB:WBGene00004243	puf-7
Is predicted to have mRNA 3'-UTR binding activity. Is involved in germ cell development.

WB:WBGene00004244	puf-8
Exhibits mRNA 3'-UTR binding activity. Is involved in male meiotic nuclear division; negative regulation of MAPK cascade; and spermatogenesis. Localizes to P granule and nuclear periphery. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; germ line; sperm; and vulva. Is an ortholog of human PUM1 (pumilio RNA binding family member 1) and PUM2 (pumilio RNA binding family member 2).

WB:WBGene00004245	puf-9
Is predicted to have mRNA 3'-UTR binding activity. Is expressed in several structures, including HSN; gonad; ventral nerve cord; vulval muscle; and vulval precursor cell. Is an ortholog of human PUM1 (pumilio RNA binding family member 1) and PUM2 (pumilio RNA binding family member 2).

WB:WBGene00004246	puf-10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Alovudine; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00004247	pun-1
No description available

WB:WBGene00004248	pus-1
Is predicted to have pseudouridine synthase activity. Human ortholog(s) of this gene are implicated in myopathy, lactic acidosis, and sideroblastic anemia 1. Is an ortholog of human PUS1 (pseudouridine synthase 1).

WB:WBGene00004249	pvf-1
Is predicted to have growth factor receptor binding activity. Is involved in negative regulation of netrin-activated signaling pathway and nematode male tail tip morphogenesis. Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in basal ganglia calcification and dermatofibrosarcoma protuberans. Is an ortholog of human PDGFA (platelet derived growth factor subunit A).

WB:WBGene00004250	pvl-4
No description available

WB:WBGene00004251	pvl-5
No description available

WB:WBGene00004252	pvl-6
No description available

WB:WBGene00004253	pvp-1
No description available

WB:WBGene00004254	pxf-1
Exhibits Rap guanyl-nucleotide exchange factor activity. Is involved in collagen and cuticulin-based cuticle development; epidermis development; and molting cycle. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is expressed in several structures, including cholinergic neurons; hermaphrodite somatic gonadal cell; hyp4; nerve ring neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 4; Noonan syndrome 9; and familial adult myoclonic epilepsy 7. Is an ortholog of human RAPGEF2 (Rap guanine nucleotide exchange factor 2).

WB:WBGene00004255	epac-1
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 4; familial adult myoclonic epilepsy 7; and platelet-type bleeding disorder 18. Is an ortholog of human RAPGEF3 (Rap guanine nucleotide exchange factor 3).

WB:WBGene00004256	pxn-1
Is predicted to have peroxidase activity. Is involved in muscle attachment and positive regulation of axon guidance. Localizes to basement membrane. Is expressed in several structures, including egg-laying apparatus; excretory cell; intestine; somatic nervous system; and spermathecal-uterine valve cell. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7. Is an ortholog of human PXDN (peroxidasin).

WB:WBGene00004257	pxn-2
Is predicted to have peroxidase activity. Is involved in several processes, including embryonic body morphogenesis; generation of neurons; and muscle attachment. Localizes to basement membrane. Is expressed in PVQL; PVQR; hypodermis; and vulval muscle. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7. Is an ortholog of human PXDN (peroxidasin).

WB:WBGene00004258	pyc-1
Is predicted to have pyruvate carboxylase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in pyruvate carboxylase deficiency disease. Is an ortholog of human PC (pyruvate carboxylase).

WB:WBGene00004259	pyr-1
Is predicted to contribute to carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity. Is involved in several processes, including pharyngeal gland morphogenesis; pharynx development; and pyrimidine nucleobase biosynthetic process. Is expressed in intestine. Is used to study carbamoyl phosphate synthetase I deficiency disease and orotic aciduria. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 50. Is an ortholog of human CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase).

WB:WBGene00004261	qid-6
No description available

WB:WBGene00004264	qua-1
Is involved in molting cycle and nematode larval development. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is expressed in several structures, including P1; P12; P2; excretory system; and hypodermal cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is an ortholog of human DHH (desert hedgehog signaling molecule); IHH (Indian hedgehog signaling molecule); and SHH (sonic hedgehog signaling molecule).

WB:WBGene00004265	qui-1
Is involved in response to alkaloid and sensory perception of bitter taste. Localizes to several cellular components, including dendrite; neuronal cell body; and nucleus. Is expressed in ganglia and nerve ring. Is an ortholog of human NWD1 (NACHT and WD repeat domain containing 1).

WB:WBGene00004266	rab-1
Is predicted to have GTPase activity. Is expressed in tail. Is an ortholog of human RAB1A (RAB1A, member RAS oncogene family).

WB:WBGene00004267	rab-3
Is predicted to have GTPase activity. Is involved in several processes, including nervous system development; regulation of GABAergic synaptic transmission; and regulation of pharyngeal pumping. Localizes to neuron projection and synaptic vesicle. Is expressed in neurons. Is used to study alcohol use disorder and epilepsy. Is an ortholog of human RAB3A (RAB3A, member RAS oncogene family) and RAB3C (RAB3C, member RAS oncogene family).

WB:WBGene00004268	rab-5
Exhibits GTPase activating protein binding activity and GTPase activity. Is involved in several processes, including apical protein localization; phagosome maturation involved in apoptotic cell clearance; and receptor-mediated endocytosis. Localizes to cell cortex; cytoplasmic vesicle; and periciliary membrane compartment. Is expressed in several structures, including ventral cord neurons. Is an ortholog of human RAB5A (RAB5A, member RAS oncogene family) and RAB5B (RAB5B, member RAS oncogene family).

WB:WBGene00004269	rab-6.1
Is predicted to have GTPase activity. Is involved in cortical granule exocytosis. Localizes to Golgi cisterna and cortical granule. Is expressed in several structures, including RIG; command interneuron; gonad; intestine; and vulva. Is an ortholog of human RAB6A (RAB6A, member RAS oncogene family) and RAB6C (RAB6C, member RAS oncogene family).

WB:WBGene00004270	rab-6.2
Exhibits GTP binding activity. Is involved in several processes, including early endosome to Golgi transport; protein stabilization; and regulation of AMPA receptor activity. Localizes to Golgi trans cisterna. Colocalizes with Golgi apparatus. Is expressed in several structures, including coelomocyte; command interneuron; gonad; pharynx; and vulva. Is an ortholog of human RAB6A (RAB6A, member RAS oncogene family) and RAB6B (RAB6B, member RAS oncogene family).

WB:WBGene00004271	rab-7
Exhibits GTPase activity. Is involved in several processes, including oocyte growth; phagolysosome assembly involved in apoptotic cell clearance; and positive regulation of early endosome to late endosome transport. Localizes to late endosome membrane; lysosome; and phagocytic vesicle membrane. Is expressed in several structures, including oocyte. Is used to study obesity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2B. Is an ortholog of human RAB7A (RAB7A, member RAS oncogene family).

WB:WBGene00004272	rab-8
Exhibits GTPase activating protein binding activity and ankyrin repeat binding activity. Is involved in several processes, including embryonic genitalia morphogenesis; negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; and protein secretion. Localizes to apical cortex; apical plasma membrane; and cytoplasmic vesicle. Is expressed in body wall musculature. Is an ortholog of human RAB8B (RAB8B, member RAS oncogene family).

WB:WBGene00004273	rab-10
Exhibits GTPase activating protein binding activity and ankyrin repeat binding activity. Is involved in several processes, including endocytic recycling; negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process; and receptor recycling. Localizes to several cellular components, including Golgi medial cisterna; cytoplasmic vesicle; and neuronal cell body. Is expressed in several structures, including PVD; coelomocyte; hermaphrodite gonad; hypodermis; and somatic nervous system. Is an ortholog of human RAB10 (RAB10, member RAS oncogene family).

WB:WBGene00004274	rab-11.1
Is predicted to have GTPase activity. Is involved in several processes, including cortical granule exocytosis; eggshell formation; and positive regulation of cytokinesis. Localizes to cortical granule and recycling endosome. Is expressed in gonad. Is an ortholog of human RAB11A (RAB11A, member RAS oncogene family) and RAB11B (RAB11B, member RAS oncogene family).

WB:WBGene00004275	rab-11.2
Is predicted to have GTPase activity. Is an ortholog of human RAB11A (RAB11A, member RAS oncogene family).

WB:WBGene00004276	rab-14
Is predicted to have GTPase activity. Is involved in phagolysosome assembly involved in apoptotic cell clearance and phagosome acidification involved in apoptotic cell clearance. Localizes to early endosome; phagocytic vesicle; and trans-Golgi network. Is expressed in gonadal sheath cell; hypodermis; intestine; and pharyngeal muscle cell. Is an ortholog of human RAB14 (RAB14, member RAS oncogene family).

WB:WBGene00004277	rab-18
Is predicted to have GTPase activity. Human ortholog(s) of this gene are implicated in Warburg micro syndrome 3. Is an ortholog of human RAB18 (RAB18, member RAS oncogene family).

WB:WBGene00004278	rab-19
Is predicted to have GTPase activity. Is expressed in anal depressor muscle and excretory cell. Is an ortholog of human RAB43 (RAB43, member RAS oncogene family).

WB:WBGene00004279	rab-21
Is predicted to have GTPase activity. Is an ortholog of human RAB21 (RAB21, member RAS oncogene family).

WB:WBGene00004281	rab-28
Is predicted to have GTPase activity. Is involved in several processes, including axoneme assembly; locomotory exploration behavior; and regulation of cilium assembly. Localizes to several cellular components, including axoneme; ciliary base; and periciliary membrane compartment. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 18. Is an ortholog of human RAB28 (RAB28, member RAS oncogene family).

WB:WBGene00004282	rab-30
Is predicted to have GTPase activity. Is an ortholog of human RAB30 (RAB30, member RAS oncogene family).

WB:WBGene00004283	rab-33
Is predicted to have GTPase activity. Human ortholog(s) of this gene are implicated in Smith-McCort dysplasia. Is an ortholog of human RAB33B (RAB33B, member RAS oncogene family).

WB:WBGene00004284	rab-35
Exhibits GTPase activating protein binding activity and ankyrin repeat binding activity. Is involved in endocytic recycling. Localizes to early endosome; plasma membrane; and recycling endosome membrane. Is expressed in several structures, including oocyte. Is an ortholog of human RAB35 (RAB35, member RAS oncogene family).

WB:WBGene00004285	rab-37
Is predicted to have GTPase activity. Is expressed in head neurons and tail neurons. Is an ortholog of human RAB26 (RAB26, member RAS oncogene family).

WB:WBGene00004286	rab-39
Is predicted to have GTPase activity. Is expressed in head mesodermal cell; head neurons; hypodermis; rectal gland cell; and tail neurons. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human RAB39A (RAB39A, member RAS oncogene family) and RAB39B (RAB39B, member RAS oncogene family).

WB:WBGene00004287	rac-2
Exhibits GTP binding activity and GTPase activity. Is involved in actin filament organization; axon guidance; and neuron migration. Localizes to axon and plasma membrane. Is expressed in nerve ring and neurons. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 48. Is an ortholog of human RAC1 (Rac family small GTPase 1).

WB:WBGene00004291	rad-4
Is involved in several processes, including embryo development; meiotic chromosome segregation; and response to UV.

WB:WBGene00004293	rad-7
Is involved in reproduction and response to UV.

WB:WBGene00004295	rad-9
Is involved in embryo development; reproduction; and response to UV.

WB:WBGene00004296	rad-50
Is predicted to contribute to 3'-5' exonuclease activity; DNA helicase activity; and single-stranded DNA endodeoxyribonuclease activity. Is an ortholog of human RAD50 (RAD50 double strand break repair protein).

WB:WBGene00004297	rad-51
Exhibits several functions, including DEAD/H-box RNA helicase binding activity; identical protein binding activity; and recombinase activity. Is involved in several processes, including intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; meiotic chromosome condensation; and negative regulation of apoptotic process. Localizes to condensed nuclear chromosome; germ cell nucleus; and site of double-strand break. Is expressed in gonad. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group R and breast cancer. Is an ortholog of human RAD51 (RAD51 recombinase).

WB:WBGene00004298	rad-54.L
Is predicted to have DNA translocase activity. Localizes to nucleus. Human ortholog(s) of this gene are implicated in breast cancer and non-Hodgkin lymphoma. Is an ortholog of human RAD54L (RAD54 like).

WB:WBGene00004299	ram-1
No description available

WB:WBGene00004300	ram-2
Is predicted to be a structural constituent of cuticle. Is involved in nematode male tail tip morphogenesis and sensory organ development.

WB:WBGene00004301	ram-5
Is involved in nematode male tail tip morphogenesis. Localizes to integral component of plasma membrane. Is expressed in ray structural cell.

WB:WBGene00004302	ran-1
Is predicted to have GTPase activity. Is involved in embryo development and oogenesis. Is an ortholog of human RAN (RAN, member RAS oncogene family).

WB:WBGene00004303	ran-2
Is predicted to have GTPase activator activity. Is involved in embryo development. Is expressed in intestinal cell. Is an ortholog of human RANGAP1 (Ran GTPase activating protein 1).

WB:WBGene00004304	ran-3
Is predicted to have Ran guanyl-nucleotide exchange factor activity and chromatin binding activity. Is involved in embryo development and positive regulation of nematode male tail tip morphogenesis. Is an ortholog of human RCC1 (regulator of chromosome condensation 1).

WB:WBGene00004305	ran-4
Is enriched in several structures, including body wall musculature; germ line; germline precursor cell; intestine; and muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nuclear transport factor 2 (NTF2) domain; Nuclear transport factor 2; and NTF2-like domain superfamily. Is an ortholog of human NUTF2 (nuclear transport factor 2).

WB:WBGene00004306	ran-5
Is predicted to contribute to GTPase activator activity. Is an ortholog of human RANBP3 (RAN binding protein 3) and RANBP3L (RAN binding protein 3 like).

WB:WBGene00004307	rap-1
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is involved in collagen and cuticulin-based cuticle development and epidermis development. Is expressed in several structures, including germ line; gonad; and neurons. Is an ortholog of human RAP1A (RAP1A, member of RAS oncogene family) and RAP1B (RAP1B, member of RAS oncogene family).

WB:WBGene00004308	rap-2
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is involved in collagen and cuticulin-based cuticle development and epidermis development. Is expressed in DA8; DA9; and motor neurons. Is an ortholog of human RAP2A (RAP2A, member of RAS oncogene family).

WB:WBGene00004309	rap-3
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4.

WB:WBGene00004310	ras-1
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is involved in parturition and vulval development. Is used to study cancer. Is an ortholog of human RRAS (RAS related).

WB:WBGene00004311	ras-2
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is an ortholog of human MRAS (muscle RAS oncogene homolog).

WB:WBGene00004312	rba-1
Is involved in cell fate specification; nematode male tail tip morphogenesis; and regulation of neurogenesis. Is an ortholog of human RBBP7 (RB binding protein 7, chromatin remodeling factor).

WB:WBGene00004313	rbc-1
Is expressed in several structures, including cuticle; neurons; ventral nerve cord; vulva; and vulval muscle, type 1. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 71. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; RAVE protein 1 C terminal; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; RAVE complex protein Rav1 C-terminal; and WD40-repeat-containing domain superfamily. Is an ortholog of human DMXL1 (Dmx like 1) and DMXL2 (Dmx like 2).

WB:WBGene00004314	rbc-2
Is enriched in AVK; OLL; PLM; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in amelogenesis imperfecta hypomaturation type 2A3. Is predicted to encode a protein with the following domains: Phosphorylation site; WD domain, G-beta repeat; WD40 repeat; Quinoprotein alcohol dehydrogenase-like superfamily; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR7 (WD repeat domain 7).

WB:WBGene00004315	rbd-1
Is predicted to have RNA binding activity. Is involved in several processes, including collagen and cuticulin-based cuticle development; positive regulation of growth rate; and vulval development. Localizes to nucleolus. Is an ortholog of human RBM19 (RNA binding motif protein 19).

WB:WBGene00004316	rbf-1
Is predicted to have Rab GTPase binding activity and metal ion binding activity. Is involved in dense core granule exocytosis and positive regulation of locomotion. Localizes to synaptic vesicle. Is expressed in dorsal nerve cord; nerve ring; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11. Is an ortholog of human DOC2A (double C2 domain alpha).

WB:WBGene00004317	rbg-1
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is involved in amyloid fibril formation; autophagy; and positive regulation of autophagosome assembly. Human ortholog(s) of this gene are implicated in Warburg micro syndrome 1. Is an ortholog of human RAB3GAP1 (RAB3 GTPase activating protein catalytic subunit 1).

WB:WBGene00004318	rbg-2
Is predicted to have enzyme regulator activity. Human ortholog(s) of this gene are implicated in Martsolf syndrome and Warburg micro syndrome 2. Is an ortholog of human RAB3GAP2 (RAB3 GTPase activating non-catalytic protein subunit 2).

WB:WBGene00004319	rbr-2
Exhibits histone demethylase activity (H3-dimethyl-K4 specific) and histone demethylase activity (H3-trimethyl-K4 specific). Is involved in determination of adult lifespan; histone H3-K4 demethylation; and regulation of vulval development. Localizes to nucleus. Is expressed in several structures, including anchor cell and vulval precursor cell. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and syndromic X-linked intellectual disability Claes-Jensen type. Is an ortholog of human KDM5B (lysine demethylase 5B) and KDM5C (lysine demethylase 5C).

WB:WBGene00004320	rbx-1
Is predicted to have NEDD8 transferase activity; cullin family protein binding activity; and ubiquitin protein ligase activity. Is involved in several processes, including negative regulation of response to DNA damage stimulus; positive regulation of metaphase/anaphase transition of meiotic cell cycle; and sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation. Localizes to Cul2-RING ubiquitin ligase complex. Is expressed in germ line; gonad; linker cell; and oocyte. Is an ortholog of human RBX1 (ring-box 1).

WB:WBGene00004321	rcan-1
Exhibits protein phosphatase 2B binding activity and protein serine/threonine phosphatase inhibitor activity. Is involved in several processes, including male mating behavior; positive regulation of nematode male tail tip morphogenesis; and thermosensory behavior. Is expressed in several structures, including non-striated muscle; pharyngeal cell; somatic nervous system; tail; and vulva. Is used to study Down syndrome. Is an ortholog of human RCAN1 (regulator of calcineurin 1); RCAN2 (regulator of calcineurin 2); and RCAN3 (RCAN family member 3).

WB:WBGene00004322	rcq-5
Is predicted to have 3'-5' DNA helicase activity and four-way junction helicase activity. Localizes to nucleus. Is expressed in several structures, including germ line; intestinal cell; and oocyte. Is an ortholog of human RECQL5 (RecQ like helicase 5).

WB:WBGene00004323	rde-1
Exhibits DEAD/H-box RNA helicase binding activity; endoribonuclease activity, producing 5'-phosphomonoesters; and siRNA binding activity. Is involved in chromatin silencing by small RNA and conversion of ds siRNA to ss siRNA involved in RNA interference. Localizes to RISC complex.

WB:WBGene00004324	rde-2
Is involved in RNA interference; meiotic chromosome segregation; and negative regulation of transposition, DNA-mediated. Localizes to cytosol and perinuclear region of cytoplasm. Is expressed in germ line.

WB:WBGene00004326	rde-4
Exhibits double-stranded RNA binding activity; protein homodimerization activity; and single-stranded RNA binding activity. Is involved in production of siRNA involved in RNA interference. Localizes to ribonucleoprotein complex.

WB:WBGene00004328	rdy-2
Is expressed in excretory canal; hyp7 syncytium; and neuronal sheath cell.

WB:WBGene00004330	rdy-4
No description available

WB:WBGene00004331	rdy-5
No description available

WB:WBGene00004332	rec-1
Is involved in meiotic DNA double-strand break formation involved in reciprocal meiotic recombination.

WB:WBGene00004333	rec-8
Is predicted to have chromatin binding activity and damaged DNA binding activity. Is involved in double-strand break repair; meiotic chromosome segregation; and regulation of centriole-centriole cohesion. Localizes to cytoskeleton; nuclear chromosome; and nucleoplasm. Is expressed in Z2; Z3; embryonic cell; and gonad.

WB:WBGene00004334	ref-1
Is predicted to have protein dimerization activity. Is involved in several processes, including epidermal cell fate specification; negative regulation of transcription by RNA polymerase II; and nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in several structures, including E lineage cell; embryonic cell; intestine; mc3V; and pharyngeal cell.

WB:WBGene00004335	ref-2
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity and RNA polymerase II transcription factor binding activity. Is involved in DNA-templated transcription, initiation; nematode larval development; and neuron fate specification. Localizes to cytoplasm and nucleus. Is expressed in several structures, including IL1 neuron; P3.p male; neuroblasts; rectal epithelial cell; and ventral nerve cord. Is an ortholog of several human genes including ZIC1 (Zic family member 1); ZIC3 (Zic family member 3); and ZIC4 (Zic family member 4).

WB:WBGene00004336	ret-1
Localizes to endomembrane system. Is expressed in several structures, including gonad and nervous system. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 12. Is an ortholog of human RTN3 (reticulon 3).

WB:WBGene00004337	rfc-1
Is predicted to have DNA binding activity. Is an ortholog of human RFC1 (replication factor C subunit 1).

WB:WBGene00004338	rfc-2
Is predicted to contribute to DNA clamp loader activity. Is an ortholog of human RFC2 (replication factor C subunit 2).

WB:WBGene00004339	rfc-3
Is predicted to contribute to DNA clamp loader activity. Is an ortholog of human RFC3 (replication factor C subunit 3).

WB:WBGene00004340	rfc-4
Is predicted to contribute to DNA clamp loader activity. Is involved in DNA replication. Is an ortholog of human RFC4 (replication factor C subunit 4).

WB:WBGene00004341	rfl-1
Is predicted to have NEDD8 activating enzyme activity. Is involved in negative regulation of DNA damage response, signal transduction by p53 class mediator and protein neddylation. Localizes to cytoplasm and nucleus. Is expressed in head; tail; and vulval cell. Is an ortholog of human UBA3 (ubiquitin like modifier activating enzyme 3).

WB:WBGene00004342	rfs-1
Exhibits ATPase binding activity. Is predicted to contribute to four-way junction DNA binding activity. Is involved in DNA recombinase assembly and resolution of meiotic recombination intermediates. Localizes to DNA recombinase mediator complex. Is an ortholog of human RAD51D (RAD51 paralog D).

WB:WBGene00004343	rgr-1
Is predicted to have transcription coregulator activity. Is expressed in germ line. Is an ortholog of human MED14 (mediator complex subunit 14).

WB:WBGene00004344	rgs-1
Exhibits GTPase activator activity. Is involved in chemosensory behavior and sensory perception of bitter taste. Is expressed in head; neurons; and tail. Human ortholog(s) of this gene are implicated in bradyopsia; essential hypertension; and gastrointestinal system cancer (multiple). Is an ortholog of human RGS17 (regulator of G protein signaling 17).

WB:WBGene00004345	rgs-2
Exhibits GTPase activator activity. Is expressed in head neurons; pharyngeal muscle cell; tail neurons; uterine muscle; and ventral cord neurons. Human ortholog(s) of this gene are implicated in bradyopsia; essential hypertension; and gastrointestinal system cancer (multiple). Is an ortholog of human RGS17 (regulator of G protein signaling 17).

WB:WBGene00004346	rgs-3
Is involved in chemosensory behavior and sensory perception of bitter taste. Is expressed in amphid neurons and phasmid neurons.

WB:WBGene00004347	rgs-4
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in bradyopsia; essential hypertension; and gastrointestinal system cancer (multiple). Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; and RGS domain superfamily.

WB:WBGene00004348	rgs-5
Is enriched in several structures, including AVK; cephalic sheath cell; germ line; intestine; and pharynx based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Alovudine; Zidovudine; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; and RGS domain superfamily. Is an ortholog of human AKAP10 (A-kinase anchoring protein 10).

WB:WBGene00004349	rgs-6
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in bradyopsia; essential hypertension; and gastrointestinal system cancer (multiple). Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; and RGS domain superfamily. Is an ortholog of human RGS14 (regulator of G protein signaling 14).

WB:WBGene00004350	rgs-7
Exhibits GTPase activator activity. Localizes to cell cortex. Human ortholog(s) of this gene are implicated in bradyopsia; essential hypertension; and gastrointestinal system cancer (multiple). Is an ortholog of human RGS16 (regulator of G protein signaling 16); RGS18 (regulator of G protein signaling 18); and RGS2 (regulator of G protein signaling 2).

WB:WBGene00004351	rgs-8.1
Is expressed in PVT and intestine. Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; RGS, subdomain 1/3; and RGS domain superfamily.

WB:WBGene00004352	rgs-9
Is enriched in NSM and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; bisphenol A; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; RGS, subdomain 1/3; and RGS domain superfamily.

WB:WBGene00004353	rgs-10
Is involved in embryo development and reproduction. Is an ortholog of human RGS16 (regulator of G protein signaling 16); RGS18 (regulator of G protein signaling 18); and RGS8 (regulator of G protein signaling 8).

WB:WBGene00004354	rgs-11
Is enriched in Z1.p; Z4.a; germ line; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; Rotenone; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; RGS, subdomain 1/3; and RGS domain superfamily. Is an ortholog of human RGS16 (regulator of G protein signaling 16); RGS18 (regulator of G protein signaling 18); and RGS8 (regulator of G protein signaling 8).

WB:WBGene00004355	rha-1
Is predicted to have 3'-5' DNA helicase activity; double-stranded DNA binding activity; and double-stranded RNA binding activity. Is involved in germ cell development and negative regulation of gene expression, epigenetic. Is expressed in germ line and oocyte. Is an ortholog of human DHX9 (DExH-box helicase 9).

WB:WBGene00004356	rhi-1
Is predicted to have Rac GTPase binding activity and Rho GDP-dissociation inhibitor activity. Localizes to cytosol and membrane. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 8. Is an ortholog of human ARHGDIA (Rho GDP dissociation inhibitor alpha) and ARHGDIB (Rho GDP dissociation inhibitor beta).

WB:WBGene00004357	rho-1
Exhibits several functions, including GTP binding activity; GTPase activating protein binding activity; and GTPase activity. Is involved in several processes, including cytoskeleton organization; positive regulation of acetylcholine secretion, neurotransmission; and positive regulation of locomotion. Localizes to cell cortex and cleavage furrow. Is expressed widely. Is an ortholog of human RHOA (ras homolog family member A).

WB:WBGene00004358	rhr-1
Is predicted to have ammonium transmembrane transporter activity. Is expressed in head. Human ortholog(s) of this gene are implicated in Rh deficiency syndrome and overhydrated hereditary stomatocytosis. Is an ortholog of human RHAG (Rh associated glycoprotein) and RHBG (Rh family B glycoprotein).

WB:WBGene00004359	rhr-2
Is predicted to have ammonium transmembrane transporter activity. Is expressed in several structures, including body wall musculature; head neurons; spermatheca; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in Rh deficiency syndrome and overhydrated hereditary stomatocytosis. Is an ortholog of human RHAG (Rh associated glycoprotein) and RHBG (Rh family B glycoprotein).

WB:WBGene00004360	rib-1
Exhibits enzyme binding activity. Contributes to acetylglucosaminyltransferase activity and glucuronosyltransferase activity. Is involved in heparan sulfate proteoglycan biosynthetic process and pharynx development. Localizes to protein-containing complex. Is expressed in several structures, including alimentary muscle; hypodermal cell; nervous system; pharynx; and reproductive system. Is used to study hereditary multiple exostoses. Human ortholog(s) of this gene are implicated in chondrosarcoma and hereditary multiple exostoses. Is an ortholog of human EXT1 (exostosin glycosyltransferase 1).

WB:WBGene00004361	rib-2
Exhibits enzyme binding activity and heparan sulfate N-acetylglucosaminyltransferase activity. Contributes to glucuronosyltransferase activity. Is involved in embryonic morphogenesis; heparan sulfate proteoglycan biosynthetic process; and pharynx development. Localizes to protein-containing complex. Is used to study hereditary multiple exostoses. Is an ortholog of human EXTL3 (exostosin like glycosyltransferase 3).

WB:WBGene00004362	ric-1
Is involved in cholinergic synaptic transmission.

WB:WBGene00004363	ric-3
Is predicted to have acetylcholine receptor binding activity. Is involved in several processes, including cholinergic synaptic transmission; positive regulation of cholinergic synaptic transmission; and protein localization to cell surface. Localizes to intracellular membrane-bounded organelle; neuron projection; and neuronal cell body. Is expressed in body wall musculature; neurons; and pharyngeal muscle cell. Is an ortholog of human RIC3 (RIC3 acetylcholine receptor chaperone).

WB:WBGene00004364	ric-4
Is predicted to have SNAP receptor activity and syntaxin binding activity. Is involved in cholinergic synaptic transmission. Localizes to plasma membrane and synapse. Is expressed in head; mechanosensory neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 18. Is an ortholog of human SNAP23 (synaptosome associated protein 23) and SNAP25 (synaptosome associated protein 25).

WB:WBGene00004365	ric-6
No description available

WB:WBGene00004367	ric-8
Exhibits GTPase activator activity and guanyl-nucleotide exchange factor activity. Is involved in several processes, including negative regulation of protein kinase C signaling; protein localization to cell cortex; and regulation of feeding behavior. Localizes to aster; cell cortex; and kinetochore microtubule. Is expressed in germ line and neurons. Is an ortholog of human RIC8A (RIC8 guanine nucleotide exchange factor A) and RIC8B (RIC8 guanine nucleotide exchange factor B).

WB:WBGene00004368	ric-19
Exhibits Rab GTPase binding activity. Is involved in dense core granule maturation; regulation of locomotion involved in locomotory behavior; and regulation of neurotransmitter secretion. Localizes to Golgi apparatus. Is expressed in several structures, including excretory system; ganglia; head; pharyngeal neurons; and ventral nerve cord. Is an ortholog of human ICA1L (islet cell autoantigen 1 like).

WB:WBGene00004369	rig-1
Is expressed in PVC; head ganglion; hypodermis; and pharyngeal cell. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domain: .

WB:WBGene00004370	rig-3
Is predicted to have cell-cell adhesion mediator activity. Localizes to axon and synapse. Is expressed in several structures, including AVA; amphid sheath cell; coelomocyte; pharyngeal neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and nonsyndromic deafness (multiple).

WB:WBGene00004371	rig-4
Is expressed in several structures, including DA neuron; excretory cell; somatic neurons; spermathecal-uterine junction; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: Fibronectin type III domain; Immunoglobulin I-set domain; Immunoglobulin domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Fibronectin type III; Immunoglobulin I-set; Immunoglobulin-like fold; Fibronectin type III superfamily; and Immunoglobulin-like domain superfamily. Is an ortholog of human SDK2 (sidekick cell adhesion molecule 2).

WB:WBGene00004372	rig-5
Is expressed in several structures, including g1AL; g1AR; g1P; head ganglion; and pharyngeal neurons. Human ortholog(s) of this gene are implicated in ovarian cancer. Is predicted to encode a protein with the following domains: Immunoglobulin domain; Immunoglobulin I-set domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin-like fold; and Immunoglobulin-like domain superfamily. Is an ortholog of human LSAMP (limbic system associated membrane protein).

WB:WBGene00004373	rme-1
Exhibits ATPase activity and protein domain specific binding activity. Is involved in several processes, including endocytic recycling; lipid tube assembly involved in organelle fission; and positive regulation of necrotic cell death. Localizes to recycling endosome membrane. Is expressed in coelomocyte; germ line; gonad; intestine; and pharynx. Is an ortholog of human EHD1 (EH domain containing 1).

WB:WBGene00004374	rme-2
Exhibits low-density lipoprotein particle receptor activity. Is involved in embryo development; oocyte development; and ovulation. Localizes to endosome membrane and integral component of plasma membrane. Is expressed in germ cell; germ line; and gonad. Human ortholog(s) of this gene are implicated in renal hypomagnesemia 4.

WB:WBGene00004375	rme-4
Is predicted to have Rab guanyl-nucleotide exchange factor activity and phosphatidylinositol phosphate binding activity. Is involved in endocytic recycling. Localizes to clathrin-coated pit. Is expressed in several structures, including engulfing cell and linker cell. Is an ortholog of human DENND1A (DENN domain containing 1A) and DENND1B (DENN domain containing 1B).

WB:WBGene00004377	rme-6
Exhibits Rab GTPase binding activity. Is involved in several processes, including molting cycle; positive regulation of GTPase activity; and regulation of clathrin-dependent endocytosis. Localizes to clathrin-coated endocytic vesicle; early endosome; and plasma membrane. Is expressed in several structures, including anterior gonad arm; coelomocyte; intestine; oocyte; and pharynx. Is an ortholog of human GAPVD1 (GTPase activating protein and VPS9 domains 1).

WB:WBGene00004378	rme-8
Exhibits identical protein binding activity. Is involved in several processes, including mechanosensory behavior; positive regulation of nematode male tail tip morphogenesis; and protein localization to postsynaptic membrane. Localizes to endosome. Is expressed in coelomocyte; hypodermal cell; muscle cell; oocyte; and uterus. Is an ortholog of human DNAJC13 (DnaJ heat shock protein family (Hsp40) member C13).

WB:WBGene00004380	rnf-1
Is predicted to have metal ion binding activity.

WB:WBGene00004381	rnf-5
Exhibits ubiquitin protein ligase activity. Is involved in several processes, including inductive cell migration; striated muscle cell development; and ubiquitin-dependent protein catabolic process. Localizes to cell junction; nucleus; and striated muscle dense body. Is an ortholog of human RNF185 (ring finger protein 185).

WB:WBGene00004382	rnh-1.0
Exhibits RNA-DNA hybrid ribonuclease activity. Is involved in RNA phosphodiester bond hydrolysis, endonucleolytic. Human ortholog(s) of this gene are implicated in autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 2. Is an ortholog of human RNASEH1 (ribonuclease H1).

WB:WBGene00004383	rnh-2
Is predicted to have RNA-DNA hybrid ribonuclease activity. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome. Is an ortholog of human RNASEH2A (ribonuclease H2 subunit A).

WB:WBGene00004384	rnp-1
Is predicted to have mRNA binding activity. Is involved in oocyte fate commitment; positive regulation of oocyte development; and spermatogenesis. Is an ortholog of human RBM4 (RNA binding motif protein 4) and RBM4B (RNA binding motif protein 4B).

WB:WBGene00004385	rnp-2
Is predicted to have U1 snRNA binding activity. Is an ortholog of human SNRPA (small nuclear ribonucleoprotein polypeptide A).

WB:WBGene00004386	rnp-3
Is predicted to have U1 snRNA binding activity. Is an ortholog of human SNRPA (small nuclear ribonucleoprotein polypeptide A).

WB:WBGene00004387	rnp-4
Is predicted to have mRNA binding activity. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in thrombocytopenia-absent radius syndrome. Is an ortholog of human RBM8A (RNA binding motif protein 8A).

WB:WBGene00004388	rnp-5
Is predicted to have RNA binding activity. Is an ortholog of human RNPS1 (RNA binding protein with serine rich domain 1).

WB:WBGene00004389	rnp-6
Is predicted to have RNA binding activity. Is an ortholog of human PUF60 (poly(U) binding splicing factor 60).

WB:WBGene00004390	rnp-7
Is predicted to have U1 snRNA binding activity and mRNA binding activity. Is an ortholog of human SNRNP70 (small nuclear ribonucleoprotein U1 subunit 70).

WB:WBGene00004391	rnr-1
Is predicted to have ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor. Is expressed in head; somatic gonad precursor; and tail. Is an ortholog of human RRM1 (ribonucleotide reductase catalytic subunit M1).

WB:WBGene00004392	rnr-2
Is predicted to have ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor. Is involved in embryo development. Is expressed in gonad. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5; mitochondrial DNA depletion syndrome 8a; and mitochondrial DNA depletion syndrome 8b. Is an ortholog of human RRM2 (ribonucleotide reductase regulatory subunit M2).

WB:WBGene00004393	rnt-1
Exhibits SMAD binding activity. Is involved in embryo development; nematode male tail tip morphogenesis; and regulation of growth. Localizes to nucleus. Is expressed in body wall musculature; intestine; neurons; ray precursor cell; and seam cell. Human ortholog(s) of this gene are implicated in cleidocranial dysplasia and metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome. Is an ortholog of human RUNX2 (RUNX family transcription factor 2).

WB:WBGene00004394	rol-1
Is predicted to be a structural constituent of cuticle.

WB:WBGene00004395	rol-3
Is predicted to have ATP binding activity and protein kinase activity. Is involved in embryo development and locomotion. Localizes to cell leading edge and cell periphery. Is expressed in head; seam cell; and vulval precursor cell. Is an ortholog of human ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase).

WB:WBGene00004397	rol-6
Is a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is expressed in hypodermis.

WB:WBGene00004398	rol-8
Is predicted to be a structural constituent of cuticle.

WB:WBGene00004399	rol-9
No description available

WB:WBGene00004400	rom-1
Is predicted to have serine-type endopeptidase activity. Is involved in positive regulation of vulval development. Is expressed in several structures, including head and tail. Human ortholog(s) of this gene are implicated in palmoplantar keratoderma-esophageal carcinoma syndrome. Is an ortholog of human RHBDL1 (rhomboid like 1) and RHBDL3 (rhomboid like 3).

WB:WBGene00004401	rom-2
Is predicted to have serine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in palmoplantar keratoderma-esophageal carcinoma syndrome. Is an ortholog of human RHBDL1 (rhomboid like 1); RHBDL2 (rhomboid like 2); and RHBDL3 (rhomboid like 3).

WB:WBGene00004402	rom-3
Is predicted to have serine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in palmoplantar keratoderma-esophageal carcinoma syndrome. Is an ortholog of human RHBDF1 (rhomboid 5 homolog 1).

WB:WBGene00004403	rom-4
Is predicted to have serine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in palmoplantar keratoderma-esophageal carcinoma syndrome. Is an ortholog of human RHBDF1 (rhomboid 5 homolog 1).

WB:WBGene00004404	rom-5
Is predicted to have serine-type endopeptidase activity. Is an ortholog of human PARL (presenilin associated rhomboid like).

WB:WBGene00004405	rop-1
Is predicted to have RNA binding activity. Is expressed in several structures, including intestine and neurons. Is an ortholog of human RO60 (Ro60, Y RNA binding protein).

WB:WBGene00004406	rot-1
No description available

WB:WBGene00004407	rot-3
No description available

WB:WBGene00004408	rla-0
Is predicted to have large ribosomal subunit rRNA binding activity. Is expressed in tail. Is an ortholog of human RPLP0 (ribosomal protein lateral stalk subunit P0).

WB:WBGene00004409	rla-1
Is predicted to have protein kinase activator activity and ribonucleoprotein complex binding activity. Is an ortholog of human RPLP1 (ribosomal protein lateral stalk subunit P1).

WB:WBGene00004410	rla-2
Is expressed in body wall musculature and intestine. Is predicted to encode a protein with the following domains: Phosphorylation site; 60s Acidic ribosomal protein; and Ribosomal protein P1/P2, N-terminal domain. Is an ortholog of human RPLP2 (ribosomal protein lateral stalk subunit P2).

WB:WBGene00004411	rpc-1
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Human ortholog(s) of this gene are implicated in hypomyelinating leukodystrophy 7 with or without oligodontia and-or hypogonadotropic hypogonadism. Is an ortholog of human POLR3A (RNA polymerase III subunit A).

WB:WBGene00004412	rpl-1
Is predicted to have RNA binding activity. Is an ortholog of human RPL10A (ribosomal protein L10a).

WB:WBGene00004413	rpl-2
Is predicted to have RNA binding activity. Is an ortholog of human RPL8 (ribosomal protein L8).

WB:WBGene00004414	rpl-3
Is predicted to have RNA binding activity. Is an ortholog of human RPL3 (ribosomal protein L3).

WB:WBGene00004415	rpl-4
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Is an ortholog of human RPL4 (ribosomal protein L4).

WB:WBGene00004416	rpl-5
Is predicted to have 5S rRNA binding activity. Is expressed in hyp7 syncytium; intestine; and pharyngeal cell. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPL5 (ribosomal protein L5).

WB:WBGene00004417	rpl-6
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Is an ortholog of human RPL6 (ribosomal protein L6).

WB:WBGene00004418	rpl-7
Is predicted to have RNA binding activity. Is an ortholog of human RPL7 (ribosomal protein L7).

WB:WBGene00004419	rpl-7A
Exhibits calmodulin binding activity. Is an ortholog of human RPL7A (ribosomal protein L7a).

WB:WBGene00004420	rpl-9
Is predicted to be a structural constituent of ribosome. Is involved in determination of adult lifespan. Is expressed in intestine and tail. Is an ortholog of human RPL9 (ribosomal protein L9).

WB:WBGene00004421	rpl-10
Is predicted to be a structural constituent of ribosome. Is expressed in head; pharyngeal muscle cell; and tail. Human ortholog(s) of this gene are implicated in syndromic X-linked mental retardation 35. Is an ortholog of human RPL10 (ribosomal protein L10).

WB:WBGene00004422	rpl-11.1
Is predicted to have RNA binding activity. Is expressed in germ line. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPL11 (ribosomal protein L11).

WB:WBGene00004423	rpl-11.2
Is predicted to have RNA binding activity. Is expressed in embryonic cell; head; posterior gonad arm; and tail. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPL11 (ribosomal protein L11).

WB:WBGene00004424	rpl-12
Is predicted to have large ribosomal subunit rRNA binding activity. Is involved in regulation of alternative mRNA splicing, via spliceosome. Is expressed in intestine. Is an ortholog of human RPL12 (ribosomal protein L12).

WB:WBGene00004425	rpl-13
Is predicted to have RNA binding activity. Is an ortholog of human RPL13 (ribosomal protein L13).

WB:WBGene00004426	rpl-14
Is predicted to have RNA binding activity. Is an ortholog of human RPL14 (ribosomal protein L14).

WB:WBGene00004427	rpl-15
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPL15 (ribosomal protein L15).

WB:WBGene00004428	rpl-16
Is predicted to have mRNA binding activity. Is an ortholog of human RPL13A (ribosomal protein L13a).

WB:WBGene00004429	rpl-17
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL17-C18orf32 (RPL17-C18orf32 readthrough).

WB:WBGene00004430	rpl-18
Is predicted to have RNA binding activity. Is an ortholog of human RPL18 (ribosomal protein L18).

WB:WBGene00004431	rpl-19
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Is an ortholog of human RPL19 (ribosomal protein L19).

WB:WBGene00004432	rpl-20
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL18A (ribosomal protein L18a).

WB:WBGene00004433	rpl-21
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in hypotrichosis 12. Is an ortholog of human RPL21 (ribosomal protein L21).

WB:WBGene00004434	rpl-22
Is predicted to have RNA binding activity. Is an ortholog of human RPL22 (ribosomal protein L22).

WB:WBGene00004435	rpl-23
Is predicted to have large ribosomal subunit rRNA binding activity. Is an ortholog of human RPL23 (ribosomal protein L23).

WB:WBGene00004436	rpl-24.1
Is predicted to have RNA binding activity. Is an ortholog of human RPL24 (ribosomal protein L24).

WB:WBGene00004437	rpl-24.2
Is predicted to have RNA binding activity. Is an ortholog of human RSL24D1 (ribosomal L24 domain containing 1).

WB:WBGene00004438	rpl-25.1
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL23A (ribosomal protein L23a).

WB:WBGene00004439	rpl-25.2
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL23A (ribosomal protein L23a).

WB:WBGene00004440	rpl-26
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPL26 (ribosomal protein L26) and RPL26L1 (ribosomal protein L26 like 1).

WB:WBGene00004441	rpl-27
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL27 (ribosomal protein L27).

WB:WBGene00004442	rpl-28
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL28 (ribosomal protein L28).

WB:WBGene00004443	rpl-29
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL29 (ribosomal protein L29).

WB:WBGene00004444	rpl-30
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Is an ortholog of human RPL30 (ribosomal protein L30).

WB:WBGene00004445	rpl-31
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL31 (ribosomal protein L31).

WB:WBGene00004446	rpl-32
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL32 (ribosomal protein L32).

WB:WBGene00004447	rpl-33
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPL35A (ribosomal protein L35a).

WB:WBGene00004448	rpl-34
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL34 (ribosomal protein L34).

WB:WBGene00004449	rpl-35
Is predicted to have mRNA binding activity. Is an ortholog of human RPL35 (ribosomal protein L35).

WB:WBGene00004450	rpl-36
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL36 (ribosomal protein L36).

WB:WBGene00004451	rpl-37
Is predicted to have RNA binding activity. Is an ortholog of human RPL37 (ribosomal protein L37).

WB:WBGene00004452	rpl-38
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL38 (ribosomal protein L38).

WB:WBGene00004453	rpl-39
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL39 (ribosomal protein L39).

WB:WBGene00004454	rpl-36.A
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL36A (ribosomal protein L36a) and RPL36AL (ribosomal protein L36a like).

WB:WBGene00004455	rpl-42
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including rrf-3; pgl-1; and aak-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00004456	rpl-43
Is predicted to have metal ion binding activity. Is an ortholog of human RPL37A (ribosomal protein L37a).

WB:WBGene00004457	rpm-1
Exhibits mitogen-activated protein kinase kinase kinase binding activity; protein phosphatase binding activity; and ubiquitin protein ligase activity. Is involved in several processes, including dorsal/ventral axon guidance; negative regulation of intracellular signal transduction; and regulation of nervous system development. Localizes to axon; neuromuscular junction; and presynaptic periactive zone. Is expressed in several structures, including coelomocyte; hermaphrodite distal tip cell; nerve ring; pharynx; and touch receptor neurons. Is an ortholog of human MYCBP2 (MYC binding protein 2).

WB:WBGene00004458	rpn-1
Is predicted to have enzyme regulator activity. Is involved in nematode larval development and reproduction. Is an ortholog of human PSMD2 (proteasome 26S subunit, non-ATPase 2).

WB:WBGene00004459	rpn-2
Exhibits protein kinase C binding activity. Localizes to several cellular components, including cell cortex; mitotic spindle; and nuclear membrane. Is expressed in intestine. Is an ortholog of human PSMD1 (proteasome 26S subunit, non-ATPase 1).

WB:WBGene00004460	rpn-3
Is predicted to have enzyme regulator activity. Is expressed in head; intestine; and tail. Is an ortholog of human PSMD3 (proteasome 26S subunit, non-ATPase 3).

WB:WBGene00004461	rpn-5
Is enriched in germ line; germline precursor cell; muscle cell; and somatic gonad precursor based on proteomic; Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PCI domain; 26S proteasome regulatory subunit RPN5 C-terminal domain; Proteasome component (PCI) domain; 26S Proteasome non-ATPase regulatory subunit 12; Winged helix-like DNA-binding domain superfamily; Winged helix DNA-binding domain superfamily; 26S Proteasome non-ATPase regulatory subunit 12/COP9 signalosome complex subunit 4; and 26S proteasome regulatory subunit RPN5, C-terminal domain. Is an ortholog of human PSMD12 (proteasome 26S subunit, non-ATPase 12).

WB:WBGene00004462	rpn-6.1
Is predicted to have structural molecule activity. Is involved in determination of adult lifespan; proteasome assembly; and ubiquitin-dependent protein catabolic process. Localizes to nucleus. Is expressed in pharynx. Is an ortholog of human PSMD11 (proteasome 26S subunit, non-ATPase 11).

WB:WBGene00004463	rpn-7
Is predicted to have enzyme regulator activity. Is expressed in tail. Is an ortholog of human PSMD6 (proteasome 26S subunit, non-ATPase 6).

WB:WBGene00004464	rpn-8
Is enriched in germ line and muscle cell based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including Linolenic Acids; Zidovudine; and Progesterone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: JAB1/Mov34/MPN/PAD-1 ubiquitin protease; Maintenance of mitochondrial structure and function; JAB1/MPN/MOV34 metalloenzyme domain; and Rpn11/EIF3F, C-terminal. Is an ortholog of human PSMD7 (proteasome 26S subunit, non-ATPase 7).

WB:WBGene00004465	rpn-9
Is predicted to have structural molecule activity. Is an ortholog of human PSMD13 (proteasome 26S subunit, non-ATPase 13).

WB:WBGene00004466	rpn-10
Is predicted to have polyubiquitin modification-dependent protein binding activity. Is involved in spermatogenesis and ubiquitin-dependent protein catabolic process. Localizes to cytoplasm and nucleus. Is expressed in several structures, including excretory cell; gonad; intestine; pharynx; and vulva. Is an ortholog of human PSMD4 (proteasome 26S subunit, non-ATPase 4).

WB:WBGene00004467	rpn-11
Is predicted to have metallopeptidase activity; proteasome binding activity; and thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human PSMD14 (proteasome 26S subunit, non-ATPase 14).

WB:WBGene00004468	rpn-12
Is enriched in germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including Zidovudine; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CSN8/PSMD8/EIF3K family; 26S proteasome non-ATPase regulatory subunit Rpn12; and CSN8/PSMD8/EIF3K. Is an ortholog of human PSMD8 (proteasome 26S subunit, non-ATPase 8).

WB:WBGene00004469	rps-0
Is predicted to be a structural constituent of ribosome. Is expressed in tail. Is an ortholog of human RPSA (ribosomal protein SA).

WB:WBGene00004470	rps-1
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS3A (ribosomal protein S3A).

WB:WBGene00004471	rps-2
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS2 (ribosomal protein S2).

WB:WBGene00004472	rps-3
Is predicted to have DNA-(apurinic or apyrimidinic site) endonuclease activity and damaged DNA binding activity. Is an ortholog of human RPS3 (ribosomal protein S3).

WB:WBGene00004473	rps-4
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2. Is an ortholog of human RPS4X (ribosomal protein S4 X-linked).

WB:WBGene00004474	rps-5
Is predicted to have mRNA binding activity and rRNA binding activity. Is an ortholog of human RPS5 (ribosomal protein S5).

WB:WBGene00004475	rps-6
Is predicted to be a structural constituent of ribosome. Is involved in determination of adult lifespan. Is an ortholog of human RPS6 (ribosomal protein S6).

WB:WBGene00004476	rps-7
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS7 (ribosomal protein S7).

WB:WBGene00004477	rps-8
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS8 (ribosomal protein S8).

WB:WBGene00004478	rps-9
Is predicted to have rRNA binding activity. Is an ortholog of human RPS9 (ribosomal protein S9).

WB:WBGene00004479	rps-10
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS10 (ribosomal protein S10).

WB:WBGene00004480	rps-11
Is predicted to be a structural constituent of ribosome. Is involved in determination of adult lifespan. Is an ortholog of human RPS11 (ribosomal protein S11).

WB:WBGene00004481	rps-12
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS12 (ribosomal protein S12).

WB:WBGene00004482	rps-13
Is predicted to have small ribosomal subunit rRNA binding activity. Is an ortholog of human RPS13 (ribosomal protein S13).

WB:WBGene00004483	rps-14
Is predicted to have mRNA 5'-UTR binding activity and small ribosomal subunit rRNA binding activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in chromosome 5q deletion syndrome. Is an ortholog of human RPS14 (ribosomal protein S14).

WB:WBGene00004484	rps-15
Is predicted to be a structural constituent of ribosome. Is involved in determination of adult lifespan. Is an ortholog of human RPS15 (ribosomal protein S15).

WB:WBGene00004485	rps-16
Is predicted to have RNA binding activity. Is an ortholog of human RPS16 (ribosomal protein S16).

WB:WBGene00004486	rps-17
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS17 (ribosomal protein S17).

WB:WBGene00004487	rps-18
Is predicted to have RNA binding activity. Is an ortholog of human RPS18 (ribosomal protein S18).

WB:WBGene00004488	rps-19
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS19 (ribosomal protein S19).

WB:WBGene00004489	rps-20
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS20 (ribosomal protein S20).

WB:WBGene00004490	rps-21
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS21 (ribosomal protein S21).

WB:WBGene00004491	rps-22
Is predicted to be a structural constituent of ribosome. Is involved in determination of adult lifespan. Is an ortholog of human RPS15A (ribosomal protein S15a).

WB:WBGene00004492	rps-23
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS23 (ribosomal protein S23).

WB:WBGene00004493	rps-24
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS24 (ribosomal protein S24).

WB:WBGene00004494	rps-25
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS25 (ribosomal protein S25).

WB:WBGene00004495	rps-26
Is predicted to have mRNA binding activity. Is involved in determination of adult lifespan. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS26 (ribosomal protein S26).

WB:WBGene00004496	rps-27
Is predicted to have RNA binding activity. Is an ortholog of human RPS27 (ribosomal protein S27).

WB:WBGene00004497	rps-28
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPS28 (ribosomal protein S28).

WB:WBGene00004498	rps-29
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia. Is an ortholog of human RPS29 (ribosomal protein S29).

WB:WBGene00004499	rps-30
Is predicted to be a structural constituent of ribosome. Is an ortholog of human FAU (FAU ubiquitin like and ribosomal protein S30 fusion).

WB:WBGene00004501	rpt-1
Is predicted to have ATPase activity and TBP-class protein binding activity. Is an ortholog of human PSMC2 (proteasome 26S subunit, ATPase 2).

WB:WBGene00004502	rpt-2
Exhibits ubiquitin protein ligase binding activity. Is involved in negative regulation of gene expression. Is expressed in head. Is an ortholog of human PSMC1 (proteasome 26S subunit, ATPase 1).

WB:WBGene00004503	rpt-3
Is predicted to have ATP binding activity and proteasome-activating ATPase activity. Is an ortholog of human PSMC4 (proteasome 26S subunit, ATPase 4).

WB:WBGene00004504	rpt-4
Exhibits identical protein binding activity. Is involved in proteasome-mediated ubiquitin-dependent protein catabolic process and regulation of protein stability. Is an ortholog of human PSMC6 (proteasome 26S subunit, ATPase 6).

WB:WBGene00004505	rpt-5
Is predicted to have ATP binding activity and hydrolase activity. Is expressed in head and tail. Is an ortholog of human PSMC3 (proteasome 26S subunit, ATPase 3).

WB:WBGene00004506	rpt-6
Is predicted to have TBP-class protein binding activity. Is an ortholog of human PSMC5 (proteasome 26S subunit, ATPase 5).

WB:WBGene00004507	rpy-1
Is predicted to have acetylcholine receptor binding activity; metal ion binding activity; and protein membrane adaptor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 11 and fetal akinesia deformation sequence syndrome 1. Is an ortholog of human RAPSN (receptor associated protein of the synapse).

WB:WBGene00004508	rrf-1
Exhibits DEAD/H-box RNA helicase binding activity and RNA-directed 5'-3' RNA polymerase activity. Is involved in hermaphrodite genitalia morphogenesis and production of siRNA involved in RNA interference. Localizes to mutator focus; nucleus; and polysome.

WB:WBGene00004509	rrf-2
Is predicted to have RNA-directed 5'-3' RNA polymerase activity. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00004510	rrf-3
Is predicted to have RNA-directed 5'-3' RNA polymerase activity. Is involved in chromatin silencing by small RNA and spermatogenesis. Is expressed in head and tail.

WB:WBGene00004511	rrn-1
No description available

WB:WBGene00004512	rrn-1.1
Is affected by several genes including daf-16; aak-2; and pptr-1 based on RNA-seq and microarray studies. Is affected by Ethanol and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00004513	rrn-1.2
Is affected by several genes including daf-16; daf-12; and aak-2 based on RNA-seq studies. Is affected by Ethanol and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00004514	rrn-1.3
No description available

WB:WBGene00004515	rrn-1.4
No description available

WB:WBGene00004516	rrn-1.5
No description available

WB:WBGene00004517	rrn-1.6
No description available

WB:WBGene00004518	rrn-1.7
No description available

WB:WBGene00004519	rrn-1.8
No description available

WB:WBGene00004520	rrn-1.9
No description available

WB:WBGene00004521	rrn-1.10
No description available

WB:WBGene00004522	rrn-1.11
No description available

WB:WBGene00004523	rrn-1.12
No description available

WB:WBGene00004524	rrn-1.13
No description available

WB:WBGene00004525	rrn-1.14
No description available

WB:WBGene00004526	rrn-1.15
No description available

WB:WBGene00004527	rrn-1.16
No description available

WB:WBGene00004528	rrn-1.17
No description available

WB:WBGene00004529	rrn-1.18
No description available

WB:WBGene00004530	rrn-1.19
No description available

WB:WBGene00004531	rrn-1.20
No description available

WB:WBGene00004532	rrn-1.21
No description available

WB:WBGene00004533	rrn-1.22
No description available

WB:WBGene00004534	rrn-1.23
No description available

WB:WBGene00004535	rrn-1.24
No description available

WB:WBGene00004536	rrn-1.25
No description available

WB:WBGene00004537	rrn-1.26
No description available

WB:WBGene00004538	rrn-1.27
No description available

WB:WBGene00004539	rrn-1.28
No description available

WB:WBGene00004540	rrn-1.29
No description available

WB:WBGene00004541	rrn-1.30
No description available

WB:WBGene00004542	rrn-1.31
No description available

WB:WBGene00004543	rrn-1.32
No description available

WB:WBGene00004544	rrn-1.33
No description available

WB:WBGene00004545	rrn-1.34
No description available

WB:WBGene00004546	rrn-1.35
No description available

WB:WBGene00004547	rrn-1.36
No description available

WB:WBGene00004548	rrn-1.37
No description available

WB:WBGene00004549	rrn-1.38
No description available

WB:WBGene00004550	rrn-1.39
No description available

WB:WBGene00004551	rrn-1.40
No description available

WB:WBGene00004552	rrn-1.41
No description available

WB:WBGene00004553	rrn-1.42
No description available

WB:WBGene00004554	rrn-1.43
No description available

WB:WBGene00004555	rrn-1.44
No description available

WB:WBGene00004556	rrn-1.45
No description available

WB:WBGene00004557	rrn-1.46
No description available

WB:WBGene00004558	rrn-1.47
No description available

WB:WBGene00004559	rrn-1.48
No description available

WB:WBGene00004560	rrn-1.49
No description available

WB:WBGene00004561	rrn-1.50
No description available

WB:WBGene00004562	rrn-1.51
No description available

WB:WBGene00004563	rrn-1.52
No description available

WB:WBGene00004564	rrn-1.53
No description available

WB:WBGene00004565	rrn-1.54
No description available

WB:WBGene00004566	rrn-1.55
No description available

WB:WBGene00004567	rrn-2.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and npr-1 based on RNA-seq studies. Is affected by seven chemicals including Ethanol; Nitric Oxide; and 1-methylnicotinamide based on RNA-seq studies.

WB:WBGene00004568	rrn-2.2
No description available

WB:WBGene00004569	rrn-2.3
No description available

WB:WBGene00004570	rrn-2.4
No description available

WB:WBGene00004571	rrn-2.5
No description available

WB:WBGene00004572	rrn-2.6
No description available

WB:WBGene00004573	rrn-2.7
No description available

WB:WBGene00004574	rrn-2.8
No description available

WB:WBGene00004575	rrn-2.9
No description available

WB:WBGene00004576	rrn-2.10
No description available

WB:WBGene00004577	rrn-2.11
No description available

WB:WBGene00004578	rrn-2.12
No description available

WB:WBGene00004579	rrn-2.13
No description available

WB:WBGene00004580	rrn-2.14
No description available

WB:WBGene00004581	rrn-2.15
No description available

WB:WBGene00004582	rrn-2.16
No description available

WB:WBGene00004583	rrn-2.17
No description available

WB:WBGene00004584	rrn-2.18
No description available

WB:WBGene00004585	rrn-2.19
No description available

WB:WBGene00004586	rrn-2.20
No description available

WB:WBGene00004587	rrn-2.21
No description available

WB:WBGene00004588	rrn-2.22
No description available

WB:WBGene00004589	rrn-2.23
No description available

WB:WBGene00004590	rrn-2.24
No description available

WB:WBGene00004591	rrn-2.25
No description available

WB:WBGene00004592	rrn-2.26
No description available

WB:WBGene00004593	rrn-2.27
No description available

WB:WBGene00004594	rrn-2.28
No description available

WB:WBGene00004595	rrn-2.29
No description available

WB:WBGene00004596	rrn-2.30
No description available

WB:WBGene00004597	rrn-2.31
No description available

WB:WBGene00004598	rrn-2.32
No description available

WB:WBGene00004599	rrn-2.33
No description available

WB:WBGene00004600	rrn-2.34
No description available

WB:WBGene00004601	rrn-2.35
No description available

WB:WBGene00004602	rrn-2.36
No description available

WB:WBGene00004603	rrn-2.37
No description available

WB:WBGene00004604	rrn-2.38
No description available

WB:WBGene00004605	rrn-2.39
No description available

WB:WBGene00004606	rrn-2.40
No description available

WB:WBGene00004607	rrn-2.41
No description available

WB:WBGene00004608	rrn-2.42
No description available

WB:WBGene00004609	rrn-2.43
No description available

WB:WBGene00004610	rrn-2.44
No description available

WB:WBGene00004611	rrn-2.45
No description available

WB:WBGene00004612	rrn-2.46
No description available

WB:WBGene00004613	rrn-2.47
No description available

WB:WBGene00004614	rrn-2.48
No description available

WB:WBGene00004615	rrn-2.49
No description available

WB:WBGene00004616	rrn-2.50
No description available

WB:WBGene00004617	rrn-2.51
No description available

WB:WBGene00004618	rrn-2.52
No description available

WB:WBGene00004619	rrn-2.53
No description available

WB:WBGene00004620	rrn-2.54
No description available

WB:WBGene00004621	rrn-2.55
No description available

WB:WBGene00004622	rrn-3.1
Is affected by several genes including daf-16; npr-1; and lin-28 based on RNA-seq studies. Is affected by four chemicals including Rotenone; multi-walled carbon nanotube; and sesamin based on RNA-seq and microarray studies.

WB:WBGene00004623	rrn-3.2
No description available

WB:WBGene00004624	rrn-3.3
No description available

WB:WBGene00004625	rrn-3.4
No description available

WB:WBGene00004626	rrn-3.5
No description available

WB:WBGene00004627	rrn-3.6
No description available

WB:WBGene00004628	rrn-3.7
No description available

WB:WBGene00004629	rrn-3.8
No description available

WB:WBGene00004630	rrn-3.9
No description available

WB:WBGene00004631	rrn-3.10
No description available

WB:WBGene00004632	rrn-3.11
No description available

WB:WBGene00004633	rrn-3.12
No description available

WB:WBGene00004634	rrn-3.13
No description available

WB:WBGene00004635	rrn-3.14
No description available

WB:WBGene00004636	rrn-3.15
No description available

WB:WBGene00004637	rrn-3.16
No description available

WB:WBGene00004638	rrn-3.17
No description available

WB:WBGene00004639	rrn-3.18
No description available

WB:WBGene00004640	rrn-3.19
No description available

WB:WBGene00004641	rrn-3.20
No description available

WB:WBGene00004642	rrn-3.21
No description available

WB:WBGene00004643	rrn-3.22
No description available

WB:WBGene00004644	rrn-3.23
No description available

WB:WBGene00004645	rrn-3.24
No description available

WB:WBGene00004646	rrn-3.25
No description available

WB:WBGene00004647	rrn-3.26
No description available

WB:WBGene00004648	rrn-3.27
No description available

WB:WBGene00004649	rrn-3.28
No description available

WB:WBGene00004650	rrn-3.29
No description available

WB:WBGene00004651	rrn-3.30
No description available

WB:WBGene00004652	rrn-3.31
No description available

WB:WBGene00004653	rrn-3.32
No description available

WB:WBGene00004654	rrn-3.33
No description available

WB:WBGene00004655	rrn-3.34
No description available

WB:WBGene00004656	rrn-3.35
No description available

WB:WBGene00004657	rrn-3.36
No description available

WB:WBGene00004658	rrn-3.37
No description available

WB:WBGene00004659	rrn-3.38
No description available

WB:WBGene00004660	rrn-3.39
No description available

WB:WBGene00004661	rrn-3.40
No description available

WB:WBGene00004662	rrn-3.41
No description available

WB:WBGene00004663	rrn-3.42
No description available

WB:WBGene00004664	rrn-3.43
No description available

WB:WBGene00004665	rrn-3.44
No description available

WB:WBGene00004666	rrn-3.45
No description available

WB:WBGene00004667	rrn-3.46
No description available

WB:WBGene00004668	rrn-3.47
No description available

WB:WBGene00004669	rrn-3.48
No description available

WB:WBGene00004670	rrn-3.49
No description available

WB:WBGene00004671	rrn-3.50
No description available

WB:WBGene00004672	rrn-3.51
No description available

WB:WBGene00004673	rrn-3.52
No description available

WB:WBGene00004674	rrn-3.53
No description available

WB:WBGene00004675	rrn-3.54
No description available

WB:WBGene00004676	rrn-3.55
No description available

WB:WBGene00004677	rrn-3.56
Is affected by several genes including daf-16; eat-2; and npr-1 based on RNA-seq studies. Is affected by seven chemicals including Rotenone; multi-walled carbon nanotube; and allantoin based on RNA-seq studies.

WB:WBGene00004678	rrs-1
No description available

WB:WBGene00004679	rars-1
Is predicted to have arginine-tRNA ligase activity. Is involved in determination of adult lifespan; regulation of gene expression; and translation. Human ortholog(s) of this gene are implicated in hypomyelinating leukodystrophy 9. Is an ortholog of human RARS1 (arginyl-tRNA synthetase 1).

WB:WBGene00004680	rars-2
Is predicted to have arginine-tRNA ligase activity. Is expressed in body wall musculature and pharynx. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 6. Is an ortholog of human RARS2 (arginyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00004681	rsd-2
Localizes to several cellular components, including cytosol; endoplasmic reticulum; and nucleolus. Is expressed in germ cell.

WB:WBGene00004682	rsd-3
Is expressed in several structures, including body wall musculature; coelomocyte; excretory canal; intestine; and pharynx. Is predicted to encode a protein with the following domains: Phosphorylation site; ENTH domain; ENTH/VHS; ENTH  domain; and Clathrin interactor 1. Is an ortholog of human CLINT1 (clathrin interactor 1).

WB:WBGene00004683	rsd-4
No description available

WB:WBGene00004684	rsd-6
Localizes to cytoplasm.

WB:WBGene00004685	rsn-1
No description available

WB:WBGene00004686	rsn-2
No description available

WB:WBGene00004687	rsn-3
No description available

WB:WBGene00004688	rsn-4
No description available

WB:WBGene00004689	rsn-5
No description available

WB:WBGene00004690	rsn-6
No description available

WB:WBGene00004691	rsn-7
No description available

WB:WBGene00004692	rsn-8
No description available

WB:WBGene00004693	rsn-9
No description available

WB:WBGene00004694	rsn-10
No description available

WB:WBGene00004695	rsn-11
No description available

WB:WBGene00004696	rsn-12
No description available

WB:WBGene00004697	rsn-13
No description available

WB:WBGene00004698	rsp-1
Is predicted to have RNA binding activity. Is involved in multicellular organism development; regulation of growth rate; and spermatogenesis. Localizes to nucleus. Is expressed in several structures, including intestine and pharyngeal neurons. Is an ortholog of human SRSF6 (serine and arginine rich splicing factor 6).

WB:WBGene00004699	rsp-2
Is predicted to have mRNA binding activity. Is involved in several processes, including nematode larval development; regulation of growth rate; and spermatogenesis. Localizes to nucleus. Is expressed widely. Is an ortholog of human SRSF6 (serine and arginine rich splicing factor 6).

WB:WBGene00004700	rsp-3
Is predicted to have RNA binding activity. Is involved in embryo development. Is expressed in PVDL; PVDR; and gonad. Is an ortholog of human SRSF1 (serine and arginine rich splicing factor 1).

WB:WBGene00004701	rsp-4
Is predicted to have RNA binding activity. Localizes to nucleus. Is expressed widely. Is an ortholog of human SRSF2 (serine and arginine rich splicing factor 2).

WB:WBGene00004702	rsp-5
Is predicted to have mRNA binding activity. Localizes to nucleus. Is expressed widely.

WB:WBGene00004703	rsp-6
Is predicted to have RNA binding activity. Is involved in gonad development and regulation of DNA-templated transcription, termination. Localizes to nucleus. Is expressed in several structures, including PVDL and PVDR. Is an ortholog of human SRSF7 (serine and arginine rich splicing factor 7).

WB:WBGene00004704	rsp-7
Is predicted to have RNA binding activity. Is an ortholog of human SREK1 (splicing regulatory glutamic acid and lysine rich protein 1).

WB:WBGene00004705	rsp-8
Is predicted to have RNA binding activity. Is expressed in head and tail. Is an ortholog of human TRA2A (transformer 2 alpha homolog) and TRA2B (transformer 2 beta homolog).

WB:WBGene00004706	rsr-1
Is expressed in hypodermis. Is predicted to encode a protein with the following domains: Phosphorylation site; PWI domain; PWI domain; and PWI domain superfamily. Is an ortholog of human SRRM1 (serine and arginine repetitive matrix 1).

WB:WBGene00004708	rte-1
No description available

WB:WBGene00004709	rtm-1
No description available

WB:WBGene00004710	rtm-2
No description available

WB:WBGene00004711	rtm-3
No description available

WB:WBGene00004712	rtm-4
No description available

WB:WBGene00004713	rtr-1
No description available

WB:WBGene00004714	rtu-1
No description available

WB:WBGene00004715	rtw-3
No description available

WB:WBGene00004716	rtw-5
No description available

WB:WBGene00004717	rtw-6
No description available

WB:WBGene00004718	rtw-7
No description available

WB:WBGene00004719	sad-1
Exhibits tau-protein kinase activity. Is involved in several processes, including nervous system development; peptidyl-serine phosphorylation; and synaptic vesicle transport. Localizes to axon and dendrite. Is expressed in nervous system. Is an ortholog of human BRSK1 (BR serine/threonine kinase 1) and BRSK2 (BR serine/threonine kinase 2).

WB:WBGene00004721	san-1
Is involved in mitotic spindle assembly checkpoint and response to anoxia. Localizes to kinetochore and nucleoplasm. Is an ortholog of human BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B).

WB:WBGene00004723	sap-49
Is predicted to have RNA binding activity. Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in Nager acrofacial dysostosis. Is an ortholog of human SF3B4 (splicing factor 3b subunit 4).

WB:WBGene00004725	sas-2
No description available

WB:WBGene00004726	sas-4
Is involved in centriole replication and maintenance of protein location. Localizes to centriole. Is expressed in gonad; intestinal cell; and sperm.

WB:WBGene00004727	sax-1
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Is involved in several processes, including cell projection assembly; negative regulation of cell growth; and regulation of cell shape. Localizes to several cellular components, including axon; dendrite; and nucleus. Is expressed in hypodermis; muscle cell; nerve ring; and seam cell. Is an ortholog of human STK38 (serine/threonine kinase 38) and STK38L (serine/threonine kinase 38 like).

WB:WBGene00004728	sax-2
Is involved in neuron projection development. Is expressed in head neurons; tail neurons; and ventral nerve cord. Is an ortholog of human FRY (FRY microtubule binding protein) and FRYL (FRY like transcription coactivator).

WB:WBGene00004729	sax-3
Exhibits axon guidance receptor activity. Is involved in generation of neurons. Localizes to integral component of plasma membrane. Is expressed in several structures, including RME; body wall musculature; neuroblasts; posterior lateral ganglion; and ventral cord neurons. Human ortholog(s) of this gene are implicated in vesicoureteral reflux. Is an ortholog of human ROBO1 (roundabout guidance receptor 1) and ROBO2 (roundabout guidance receptor 2).

WB:WBGene00004730	sax-5
No description available

WB:WBGene00004731	sax-6
No description available

WB:WBGene00004732	sax-7
Exhibits ankyrin binding activity. Is involved in several processes, including establishment of mitotic spindle orientation; gastrulation; and generation of neurons. Localizes to several cellular components, including lateral plasma membrane; neuron projection membrane; and neuronal cell body membrane. Is expressed in several structures, including gonad; neurons; pharynx; somatic nervous system; and vulval cell. Is used to study MASA syndrome. Is an ortholog of human NRCAM (neuronal cell adhesion molecule).

WB:WBGene00004734	sax-9
No description available

WB:WBGene00004735	sbp-1
Exhibits DNA-binding transcription factor activity. Is involved in several processes, including determination of adult lifespan; positive regulation of lipid storage; and response to anoxia. Localizes to nucleus. Is expressed in amphid neurons and intestine. Is used to study alcohol use disorder. Is an ortholog of human SREBF2 (sterol regulatory element binding transcription factor 2).

WB:WBGene00004736	sca-1
Exhibits calcium transmembrane transporter activity, phosphorylative mechanism and chromatin DNA binding activity. Is involved in several processes, including IRE1-mediated unfolded protein response; calcium ion import; and determination of adult lifespan. Localizes to several cellular components, including cytoplasmic vesicle; nuclear envelope; and sarcoplasmic reticulum. Is expressed in several structures, including egg-laying apparatus; excretory system; intestine; non-striated muscle; and spermatheca. Human ortholog(s) of this gene are implicated in acrokeratosis verruciformis and keratosis follicularis. Is an ortholog of human ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3).

WB:WBGene00004737	scc-1
Is predicted to have chromatin binding activity and damaged DNA binding activity. Is involved in meiotic cell cycle. Localizes to cohesin complex and nucleus. Is expressed in several structures, including SDQ; germ line; seam cell; touch receptor neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 4. Is an ortholog of human RAD21L1 (RAD21 cohesin complex component like 1).

WB:WBGene00004738	scc-3
Is predicted to have DNA binding activity and chromatin binding activity. Is involved in meiotic sister chromatid cohesion and mitotic sister chromatid segregation. Localizes to chromatin and cohesin complex. Is expressed in gonad. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 47 and premature ovarian failure. Is an ortholog of human STAG1 (stromal antigen 1) and STAG3 (stromal antigen 3).

WB:WBGene00004739	scd-1
Is enriched in head mesodermal cell and neurons based on Chronogram; microarray; RNA-seq; and tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including 1-methylnicotinamide; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00004740	scd-2
Is predicted to have ATP binding activity and transmembrane receptor protein tyrosine kinase activity. Is involved in dauer larval development; sensory perception of chemical stimulus; and sensory processing. Is expressed in AIAL; AIAR; NSML; and NSMR. Human ortholog(s) of this gene are implicated in several diseases, including endocrine gland cancer (multiple); hematologic cancer (multiple); and synostosis (multiple). Is an ortholog of human ALK (ALK receptor tyrosine kinase) and LTK (leukocyte receptor tyrosine kinase).

WB:WBGene00004741	scd-3
No description available

WB:WBGene00004742	scl-1
Is involved in determination of adult lifespan; response to UV; and response to heat. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00004743	scm-1
Localizes to cytoplasmic vesicle. Is expressed in amphid neurons; coelomocyte; and spermatheca. Is an ortholog of human SCAMP3 (secretory carrier membrane protein 3).

WB:WBGene00004744	scp-1
Is predicted to have sterol binding activity. Is an ortholog of human SCAP (SREBF chaperone).

WB:WBGene00004745	sdc-1
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in positive regulation of histone H3-K4 methylation; regulation of gene expression; and sex determination. Localizes to nuclear chromosome.

WB:WBGene00004746	sdc-2
Is involved in dosage compensation by hypoactivation of X chromosome and negative regulation of transcription by RNA polymerase II. Localizes to nuclear chromosome.

WB:WBGene00004747	sdc-3
Exhibits sequence-specific DNA binding activity. Is involved in mitotic sister chromatid segregation; regulation of gene expression; and sex determination. Localizes to X chromosome and nucleus. Is expressed in germ line and oocyte. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5.

WB:WBGene00004748	sdf-9
Is predicted to have protein tyrosine phosphatase activity. Is involved in dauer larval development. Localizes to plasma membrane. Is expressed in XXXL; XXXR; and head.

WB:WBGene00004749	sdn-1
Is involved in embryo development; epidermis morphogenesis; and nematode larval development. Localizes to cell surface. Is expressed in several structures, including neuroblasts; neurons; pharynx; somatic nervous system; and vulva. Human ortholog(s) of this gene are implicated in obesity. Is an ortholog of human SDC1 (syndecan 1).

WB:WBGene00004750	sea-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in dosage compensation by hypoactivation of X chromosome; positive regulation of transcription by RNA polymerase II; and sex determination. Localizes to nucleus. Is expressed in several structures, including coelomocyte; head muscle; intestine; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including X-linked cleft palate with or without ankyloglossia; adrenocorticotropic hormone deficiency; and dysostosis (multiple). Is an ortholog of human MGA (MAX dimerization protein MGA).

WB:WBGene00004751	sea-2
Exhibits double-stranded RNA binding activity and single-stranded RNA binding activity. Is involved in several processes, including determination of adult lifespan; regulation of gene expression; and response to heat. Localizes to cytoplasm and nucleus. Is expressed in intestinal cell; nerve ring neurons; neurons; pharyngeal muscle cell; and seam cell.

WB:WBGene00004752	sec-5
Is expressed in anchor cell; embryonic cell; and excretory canal. Is predicted to encode a protein with the following domains: IPT/TIG domain; Exocyst complex component Sec5; IPT domain; Immunoglobulin-like fold; Immunoglobulin E-set; Exocyst complex component EXOC2/Sec5; and Exocyst complex component EXOC2/Sec5, N-terminal domain. Is an ortholog of human EXOC2 (exocyst complex component 2).

WB:WBGene00004753	sec-8
Is expressed in embryonic cell; excretory canal; and hypodermis. Is predicted to encode a protein with the following domains: Sec8 exocyst complex component specific domain; Sec8 exocyst complex component specific domain; and Exocyst complex component Sec8/EXOC4. Is an ortholog of human EXOC4 (exocyst complex component 4).

WB:WBGene00004754	sec-23
Is predicted to have GTPase activator activity. Localizes to endoplasmic reticulum exit site. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in congenital dyserythropoietic anemia type II and craniolenticulosutural dysplasia. Is an ortholog of human SEC23A (Sec23 homolog A, COPII coat complex component) and SEC23B (SEC23 homolog B, COPII coat complex component).

WB:WBGene00004755	sec-24.1
Is predicted to have zinc ion binding activity. Is expressed widely. Human ortholog(s) of this gene are implicated in Cole-Carpenter syndrome. Is an ortholog of human SEC24D (SEC24 homolog D, COPII coat complex component).

WB:WBGene00004756	sec-24.2
Is predicted to have zinc ion binding activity. Is expressed in DA neuron. Is an ortholog of human SEC24B (SEC24 homolog B, COPII coat complex component).

WB:WBGene00004758	sek-1
Exhibits MAP kinase kinase activity; mitogen-activated protein kinase kinase kinase binding activity; and protein serine/threonine kinase activator activity. Is involved in several processes, including defense response to other organism; p38MAPK cascade; and positive regulation of oviposition. Is expressed in excretory canal; linker cell; neurons; rectal epithelium; and uterine-vulval cell. Is used to study Parkinson's disease. Is an ortholog of human MAP2K6 (mitogen-activated protein kinase kinase 6).

WB:WBGene00004759	sel-1
Is predicted to contribute to ubiquitin-protein transferase activity. Is involved in negative regulation of Notch signaling pathway. Localizes to cytoplasmic vesicle. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P7.p hermaphrodite; and P8.p hermaphrodite. Is an ortholog of human SEL1L (SEL1L adaptor subunit of ERAD E3 ubiquitin ligase) and SEL1L2 (SEL1L2 adaptor subunit of ERAD E3 ligase).

WB:WBGene00004760	sel-2
Is involved in several processes, including apical protein localization; negative regulation of Notch signaling pathway; and regulation of vulval development. Localizes to perinuclear region of cytoplasm. Is expressed in several structures, including ganglia; pharyngeal-intestinal valve; rectum; somatic nervous system; and vulva. Is used to study autism spectrum disorder. Human ortholog(s) of this gene are implicated in common variable immunodeficiency. Is an ortholog of human NBEA (neurobeachin).

WB:WBGene00004761	sel-4
No description available

WB:WBGene00004762	sel-5
Is predicted to have AP-2 adaptor complex binding activity and protein serine/threonine kinase activity. Is used to study Parkinson's disease. Is an ortholog of human AAK1 (AP2 associated kinase 1).

WB:WBGene00004764	sel-7
Exhibits identical protein binding activity and sequence-specific DNA binding activity. Is involved in several processes, including lateral inhibition; positive regulation of Notch signaling pathway; and regulation of mesodermal cell fate specification. Localizes to nucleus. Is expressed in body wall musculature; pharyngeal muscle cell; and seam cell.

WB:WBGene00004765	sel-8
Exhibits transcription coactivator activity. Is involved in Notch signaling pathway; positive regulation of stem cell proliferation; and positive regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and neurons.

WB:WBGene00004766	sel-9
Is involved in endoplasmic reticulum to Golgi vesicle-mediated transport; regulation of Notch signaling pathway; and regulation of transport. Is an ortholog of human TMED2 (transmembrane p24 trafficking protein 2).

WB:WBGene00004767	sel-10
Exhibits protein homodimerization activity and protein kinase binding activity. Is involved in several processes, including negative regulation of Notch signaling pathway; negative regulation of centrosome duplication; and regulation of vulval development. Localizes to axon and cytoplasm. Is expressed in body wall musculature; gonad; intestine; neurons; and pharynx. Is an ortholog of human FBXW7 (F-box and WD repeat domain containing 7).

WB:WBGene00004768	sel-11
Is predicted to have ubiquitin protein ligase activity. Is involved in growth; regulation of Notch signaling pathway; and regulation of gene expression. Is an ortholog of human SYVN1 (synoviolin 1).

WB:WBGene00004769	sel-12
Is predicted to have endopeptidase activity. Is involved in several processes, including apical protein localization; oviposition; and regulation of signal transduction. Localizes to perinuclear region of cytoplasm. Is used to study Alzheimer's disease. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease (multiple); Pick's disease; and dilated cardiomyopathy (multiple). Is an ortholog of human PSEN2 (presenilin 2).

WB:WBGene00004770	sem-1
No description available

WB:WBGene00004771	sem-2
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in several processes, including cell fate specification; positive regulation of oviposition; and positive regulation of vulval development. Localizes to nucleus. Is expressed in several structures, including E lineage cell; M.v nucleus; RMH; body wall muscle cell from M lineage; and neuroblasts. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; PCWH syndrome; and Waardenburg's syndrome (multiple). Is an ortholog of human SOX4 (SRY-box transcription factor 4) and SOX7 (SRY-box transcription factor 7).

WB:WBGene00004772	sem-3
No description available

WB:WBGene00004773	sem-4
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including mesodermal cell differentiation; neuroblast differentiation; and transdifferentiation. Localizes to nucleus. Is expressed in several structures, including HSN; M lineage cell; rectal epithelial cell; rectum; and tail hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Duane-radial ray syndrome; IVIC syndrome; and Townes-Brocks syndrome. Is an ortholog of human SALL1 (spalt like transcription factor 1) and SALL3 (spalt like transcription factor 3).

WB:WBGene00004774	sem-5
Exhibits epidermal growth factor receptor binding activity. Is involved in several processes, including male genitalia development; nematode larval development; and regulation of vulval development. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P7.p hermaphrodite; and P8.p hermaphrodite. Is an ortholog of human GRB2 (growth factor receptor bound protein 2).

WB:WBGene00004775	sep-1
Is predicted to have cysteine-type endopeptidase activity. Is involved in several processes, including cortical granule exocytosis; nuclear division; and polarity specification of anterior/posterior axis. Localizes to several cellular components, including cortical granule; cytoskeleton; and nucleus. Is an ortholog of human ESPL1 (extra spindle pole bodies like 1, separase).

WB:WBGene00004776	ser-1
Exhibits G protein-coupled serotonin receptor activity and serotonin binding activity. Is involved in several processes, including male mating behavior; oviposition; and serotonin receptor signaling pathway. Localizes to plasma membrane. Is expressed in several structures, including egg-laying apparatus; intestine; neurons; pharyngeal muscle cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in alcohol dependence; endogenous depression; and schizophrenia. Is an ortholog of human HTR2B (5-hydroxytryptamine receptor 2B).

WB:WBGene00004777	ser-2
Exhibits tyramine receptor activity. Is involved in octopamine or tyramine signaling pathway. Localizes to integral component of plasma membrane. Is expressed in body wall musculature; excretory gland cell; neurons; non-striated muscle; and uterine toroidal epithelial cell.

WB:WBGene00004778	ser-3
Exhibits octopamine receptor activity. Is involved in octopamine or tyramine signaling pathway. Is expressed in several structures, including ASH; SIA; head muscle; hermaphrodite gonad; and lumbar ganglion.

WB:WBGene00004779	ser-4
Exhibits G protein-coupled serotonin receptor activity. Is involved in serotonin receptor signaling pathway. Is expressed in neurons; vulval cell; and vulval muscle, type 2. Human ortholog(s) of this gene are implicated in vesicoureteral reflux. Is an ortholog of human HTR1A (5-hydroxytryptamine receptor 1A).

WB:WBGene00004780	ser-7
Is predicted to have G protein-coupled serotonin receptor activity. Localizes to membrane. Is expressed in marginal cell; pharyngeal neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in asthma; familial adult myoclonic epilepsy 2; and obesity. Is an ortholog of human HTR7 (5-hydroxytryptamine receptor 7).

WB:WBGene00004781	set-1
Is predicted to have histone-lysine N-methyltransferase activity. Is involved in embryo development. Localizes to nucleus. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P7.p hermaphrodite; and P8.p hermaphrodite. Is an ortholog of human KMT5A (lysine methyltransferase 5A).

WB:WBGene00004782	set-2
Exhibits histone methyltransferase activity (H3-K4 specific). Is involved in determination of adult lifespan; histone H3-K4 methylation; and transdifferentiation. Localizes to nucleus. Is expressed in several structures, including body ganglion; germ line; intestine; and pharynx. Human ortholog(s) of this gene are implicated in Sotos syndrome; acute myeloid leukemia; and autosomal dominant non-syndromic intellectual disability 29. Is an ortholog of human SETD1A (SET domain containing 1A, histone lysine methyltransferase) and SETD1B (SET domain containing 1B, histone lysine methyltransferase).

WB:WBGene00004783	seu-1
Is involved in dorsal/ventral axon guidance. Localizes to nucleus. Is expressed in several structures, including hermaphrodite distal tip cell; intestine; pharynx; spermatheca; and ventral nerve cord.

WB:WBGene00004784	seu-2
Is involved in dorsal/ventral axon guidance.

WB:WBGene00004785	seu-3
Is involved in dorsal/ventral axon guidance.

WB:WBGene00004786	sex-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in dosage compensation by hypoactivation of X chromosome; negative regulation of transcription by RNA polymerase II; and primary sex determination. Localizes to nucleus. Is expressed in anterior distal tip cell; intestine; oocyte; and posterior distal tip cell. Human ortholog(s) of this gene are implicated in several diseases, including acute promyelocytic leukemia; familial partial lipodystrophy type 3; and obesity. Is an ortholog of human RARA (retinoic acid receptor alpha).

WB:WBGene00004787	sft-1
Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4K and Leigh disease. Is predicted to encode a protein with the following domains: SURF1 family and Surfeit locus 1/Shy1. Is an ortholog of human SURF1 (SURF1 cytochrome c oxidase assembly factor).

WB:WBGene00004788	sft-4
Is involved in several processes, including negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of vulval development; and positive regulation of cellular protein catabolic process. Localizes to perinuclear region of cytoplasm. Is expressed in several structures, including head; hermaphrodite gonad; pharyngeal muscle cell; tail; and vulval precursor cell. Is an ortholog of human SURF4 (surfeit 4).

WB:WBGene00004789	sgk-1
Exhibits phosphatidylinositol-3,4,5-trisphosphate binding activity and protein serine/threonine kinase activity. Is involved in several processes, including mesendoderm development; peptidyl-serine phosphorylation; and regulation of protein localization to basolateral plasma membrane. Localizes to cytoplasm and nucleus. Is expressed in intestine; neurons; and tail neurons. Is an ortholog of human SGK1 (serum/glucocorticoid regulated kinase 1) and SGK2 (serum/glucocorticoid regulated kinase 2).

WB:WBGene00004790	sgn-1
Is enriched in body wall muscle cell and muscle cell based on tiling array; proteomic; and microarray studies. Is affected by several genes including rrf-3; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2C; autosomal recessive limb-girdle muscular dystrophy type 2F; and dilated cardiomyopathy 1L. Is predicted to encode a protein with the following domains: Sarcoglycan complex subunit protein; Sarcoglycan complex subunit protein; and Sarcoglycan gamma/delta/zeta. Is an ortholog of human SGCD (sarcoglycan delta); SGCG (sarcoglycan gamma); and SGCZ (sarcoglycan zeta).

WB:WBGene00004791	sgs-2
No description available

WB:WBGene00004792	shv-1
No description available

WB:WBGene00004793	shw-3
Exhibits voltage-gated potassium channel activity. Is involved in potassium ion transport. Localizes to axolemma; dendrite membrane; and neuronal cell body membrane. Is expressed in PLML; PLMR; head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNC1 (potassium voltage-gated channel subfamily C member 1); KCNC2 (potassium voltage-gated channel subfamily C member 2); and KCNC4 (potassium voltage-gated channel subfamily C member 4).

WB:WBGene00004794	sia-1
No description available

WB:WBGene00004795	sid-1
Exhibits RNA transmembrane transporter activity and double-stranded RNA binding activity. Is involved in RNA interference and dsRNA transport. Localizes to integral component of plasma membrane. Is expressed in several structures, including pharynx. Is an ortholog of human SIDT1 (SID1 transmembrane family member 1) and SIDT2 (SID1 transmembrane family member 2).

WB:WBGene00004796	sid-2
Is involved in RNA interference and RNA transport. Localizes to apical plasma membrane and cytoplasm. Is expressed in excretory duct and intestine.

WB:WBGene00004798	sip-1
Is predicted to have unfolded protein binding activity. Is involved in several processes, including determination of adult lifespan; embryo development; and response to heat. Localizes to cytosol. Is expressed in body wall musculature and gonad. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2 (multiple); cataract 9 multiple types; and distal hereditary motor neuronopathy type 2 (multiple). Is an ortholog of several human genes including CRYAA (crystallin alpha A); HSPB2 (heat shock protein family B (small) member 2); and HSPB8 (heat shock protein family B (small) member 8).

WB:WBGene00004799	sir-2
No description available

WB:WBGene00004800	sir-2.1
Exhibits deacetylase activity. Is involved in several processes, including chromosome organization; determination of adult lifespan; and intrinsic apoptotic signaling pathway in response to DNA damage. Localizes to nuclear chromosome, telomeric region and perinuclear region of cytoplasm. Is expressed in several structures, including intestinal cell; neurons; retrovesicular ganglion; tail; and ventral nerve cord. Is used to study alcohol use disorder. Is an ortholog of human SIRT1 (sirtuin 1).

WB:WBGene00004801	sir-2.2
Is predicted to have several functions, including NAD+ binding activity; NAD-dependent protein deacetylase activity; and zinc ion binding activity. Is involved in innate immune response. Localizes to mitochondrion. Is an ortholog of human SIRT4 (sirtuin 4).

WB:WBGene00004802	sir-2.3
Is predicted to have several functions, including NAD+ binding activity; NAD-dependent protein deacetylase activity; and zinc ion binding activity. Localizes to mitochondrion. Is expressed in body wall musculature; head; pharynx; and somatic gonad. Is an ortholog of human SIRT4 (sirtuin 4).

WB:WBGene00004803	sir-2.4
Exhibits transcription factor binding activity. Is involved in P granule assembly and response to heat. Localizes to P granule; cytoplasmic stress granule; and nuclear pore. Is expressed in head neurons; spermathecal-uterine valve cell; and tail neurons. Is an ortholog of human SIRT6 (sirtuin 6).

WB:WBGene00004804	skn-1
Exhibits Hsp70 protein binding activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including endoplasmic reticulum unfolded protein response; positive regulation of cellular response to manganese ion; and positive regulation of transcription from RNA polymerase II promoter in response to heat stress. Localizes to endoplasmic reticulum; mitochondrion; and nucleus. Is expressed in several structures, including germ line; head ganglion; intestine; neurons; and pharynx. Is an ortholog of human NFE2L1 (nuclear factor, erythroid 2 like 1); NFE2L2 (nuclear factor, erythroid 2 like 2); and NFE2L3 (nuclear factor, erythroid 2 like 3).

WB:WBGene00004805	skn-4
No description available

WB:WBGene00004806	skp-1
Is involved in several processes, including oviposition; uterus development; and vulval development. Is expressed in egg-laying apparatus; hypodermis; pharynx; rectal muscle; and somatic nervous system. Is an ortholog of human SNW1 (SNW domain containing 1).

WB:WBGene00004807	skr-1
Is predicted to contribute to ubiquitin protein ligase activity. Is involved in several processes, including negative regulation of centrosome duplication; negative regulation of response to DNA damage stimulus; and regulation of protein stability. Is expressed in several structures, including pharynx and spermatheca. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004808	skr-2
Is predicted to contribute to ubiquitin protein ligase activity. Is involved in several processes, including establishment of mitotic spindle orientation; negative regulation of centrosome duplication; and regulation of protein stability. Localizes to SCF ubiquitin ligase complex. Is expressed in intestine. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004809	skr-3
Is predicted to contribute to ubiquitin protein ligase activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in intestine and pharynx. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004810	skr-4
Is predicted to contribute to ubiquitin protein ligase activity. Is expressed in intestine. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004811	skr-5
Is predicted to contribute to ubiquitin protein ligase activity. Is involved in determination of adult lifespan. Is expressed in hypodermis; intestinal cell; and vulval muscle. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004812	skr-6
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004813	skr-7
Is predicted to contribute to ubiquitin protein ligase activity. Is involved in negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004814	skr-8
Is predicted to contribute to ubiquitin protein ligase activity. Is expressed in intestine. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004815	skr-9
Is predicted to contribute to ubiquitin protein ligase activity. Is expressed in intestine. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004816	skr-10
Is predicted to contribute to ubiquitin protein ligase activity. Is involved in several processes, including larval development; mitotic cell cycle; and post-embryonic body morphogenesis. Localizes to SCF ubiquitin ligase complex. Is expressed in intestine. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004817	skr-11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Lithium Chloride; stavudine; and Atrazine based on microarray and RNA-seq studies.

WB:WBGene00004818	skr-12
Is predicted to contribute to ubiquitin protein ligase activity. Is expressed in ASIL; ASIR; intestine; and pharynx. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004819	skr-13
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004820	skr-14
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004821	skr-15
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004822	skr-16
Is predicted to have ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004823	skr-17
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004824	F56B3.4
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RPAP1-like, N-terminal; RNA polymerase II-associated protein 1, N-terminal; and RNA polymerase II-associated protein RPAP1/Rba50. Is an ortholog of human RPAP1 (RNA polymerase II associated protein 1).

WB:WBGene00004825	skr-19
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004826	skr-20
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004827	skr-21
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00004828	sle-1
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00004829	sli-1
Is predicted to have SH3 domain binding activity; receptor tyrosine kinase binding activity; and ubiquitin protein ligase activity. Is involved in negative regulation of vulval development. Is expressed in several structures, including anal depressor muscle; body wall musculature; distal tip cell; head; and intestine. Human ortholog(s) of this gene are implicated in juvenile myelomonocytic leukemia. Is an ortholog of human CBLB (Cbl proto-oncogene B) and CBLC (Cbl proto-oncogene C).

WB:WBGene00004830	slo-1
Exhibits calcium-activated potassium channel activity and voltage-gated potassium channel activity. Is involved in several processes, including behavioral response to ethanol; pharyngeal pumping; and sarcomere organization. Localizes to M band; striated muscle dense body; and synapse. Is expressed in several structures, including AWC; body wall musculature; non-striated muscle; pharyngeal neurons; and somatic nervous system. Is used to study Duchenne muscular dystrophy and alcohol use disorder. Is an ortholog of human KCNMA1 (potassium calcium-activated channel subfamily M alpha 1).

WB:WBGene00004831	slo-2
Exhibits calcium-activated potassium channel activity and outward rectifier potassium channel activity. Is involved in positive regulation of neurotransmitter secretion and potassium ion transport. Localizes to axon. Is expressed in amphid neurons; body wall musculature; motor neurons; nerve ring; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy 5; early infantile epileptic encephalopathy 14; and early infantile epileptic encephalopathy 57. Is an ortholog of human KCNT1 (potassium sodium-activated channel subfamily T member 1) and KCNT2 (potassium sodium-activated channel subfamily T member 2).

WB:WBGene00004832	sls-1
No description available

WB:WBGene00004833	sls-2.1
Is affected by several genes including daf-12; cep-1; and unc-75 based on tiling array and RNA-seq studies.

WB:WBGene00004834	sls-2.2
Is enriched in NSM based on RNA-seq studies. Is affected by daf-12 based on tiling array studies.

WB:WBGene00004835	sls-2.3
Is affected by daf-12; hpl-2; and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00004836	sls-2.4
Is enriched in NSM based on RNA-seq studies. Is affected by daf-12; cep-1; and ints-4 based on tiling array and RNA-seq studies.

WB:WBGene00004837	sls-2.5
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00004838	sls-2.6
No description available

WB:WBGene00004839	sls-2.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00004840	sls-2.8
Is affected by several genes including daf-2; cep-1; and alg-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and D-glucose based on RNA-seq studies.

WB:WBGene00004841	sls-2.9
Is affected by hpl-2; ints-1; and ints-4 based on tiling array and RNA-seq studies.

WB:WBGene00004842	sls-2.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00004843	sls-2.11
Is affected by hpl-2 and adr-1 based on tiling array and RNA-seq studies.

WB:WBGene00004844	sls-2.12
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00004845	sls-2.13
No description available

WB:WBGene00004846	sls-2.14
Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00004847	sls-2.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00004848	sls-2.16
Is affected by clk-1; daf-2; and ints-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00004849	sls-2.17
Is enriched in germ line based on RNA-seq studies. Is affected by clk-1 based on microarray studies.

WB:WBGene00004850	sls-2.18
Is affected by clk-1 based on microarray studies.

WB:WBGene00004851	sls-2.19
Is affected by adr-1 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00004854	slt-1
Exhibits signaling receptor binding activity. Is involved in generation of neurons. Is expressed in anal sphincter muscle; anterior hypodermis; body wall musculature; nerve ring neurons; and socket cell. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome; high myopia-sensorineural deafness syndrome; and trichotillomania. Is an ortholog of human SLIT2 (slit guidance ligand 2) and SLIT3 (slit guidance ligand 3).

WB:WBGene00004855	sma-1
Is predicted to have actin binding activity and phospholipid binding activity. Is involved in several processes, including pharyngeal gland morphogenesis; pharynx development; and positive regulation of cell size. Localizes to apical plasma membrane; cytoplasm; and nucleus. Is expressed in several structures, including excretory cell; hermaphrodite gonad; intestine; neurons; and pharynx. Is an ortholog of human SPTBN5 (spectrin beta, non-erythrocytic 5).

WB:WBGene00004856	sma-2
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; pharynx development; and positive regulation of nematode male tail tip morphogenesis. Is expressed in head. Human ortholog(s) of this gene are implicated in Loeys-Dietz syndrome 3 and primary pulmonary hypertension. Is an ortholog of human SMAD9 (SMAD family member 9).

WB:WBGene00004857	sma-3
Exhibits transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity. Is involved in several processes, including defense response to other organism; nematode male tail tip morphogenesis; and positive regulation of nematode male tail tip morphogenesis. Localizes to cytoplasm and nucleus. Is expressed in several structures, including hypodermis; intestine; pharynx; somatic gonad; and tail. Human ortholog(s) of this gene are implicated in aortic valve disease 2. Is an ortholog of human SMAD1 (SMAD family member 1).

WB:WBGene00004858	sma-4
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in several processes, including determination of adult lifespan; nematode male tail tip morphogenesis; and positive regulation of cell size. Is expressed in head neurons and pseudocoelom. Is an ortholog of human SMAD4 (SMAD family member 4).

WB:WBGene00004859	sma-5
Is predicted to have ATP binding activity and MAP kinase activity. Is involved in several processes, including determination of adult lifespan; parturition; and positive regulation of cell size. Is expressed in excretory cell; hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00004860	sma-6
Exhibits BMP binding activity. Is involved in several processes, including defense response to other organism; nematode male tail tip morphogenesis; and positive regulation of macromolecule metabolic process. Is expressed in ASI; hypodermis; intestinal cell; pharynx; and tail. Human ortholog(s) of this gene are implicated in several diseases, including Loeys-Dietz syndrome (multiple); brachydactyly (multiple); and fibrodysplasia ossificans progressiva. Is an ortholog of human BMPR1A (bone morphogenetic protein receptor type 1A) and BMPR1B (bone morphogenetic protein receptor type 1B).

WB:WBGene00004861	sma-8
No description available

WB:WBGene00004862	sma-9
Exhibits transcription coactivator activity and transcription corepressor activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of mesodermal cell fate specification; and transforming growth factor beta receptor signaling pathway. Localizes to nucleus. Is expressed in several structures, including excretory cell; intestine; spermatheca; ventral cord neurons; and vulva. Is used to study Alzheimer's disease. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 43. Is an ortholog of human HIVEP1 (HIVEP zinc finger 1).

WB:WBGene00004864	sma-12
Is involved in regulation of growth and transforming growth factor beta receptor signaling pathway.

WB:WBGene00004865	sma-13
Is involved in regulation of growth and transforming growth factor beta receptor signaling pathway.

WB:WBGene00004866	sma-14
Is involved in nematode male tail tip morphogenesis; regulation of growth; and transforming growth factor beta receptor signaling pathway.

WB:WBGene00004867	sma-15
No description available

WB:WBGene00004868	sma-16
Is involved in nematode male tail tip morphogenesis and regulation of growth.

WB:WBGene00004869	sma-17
Is involved in regulation of growth.

WB:WBGene00004870	sma-18
Is involved in regulation of growth.

WB:WBGene00004871	sma-19
Is involved in regulation of growth and transforming growth factor beta receptor signaling pathway.

WB:WBGene00004872	sma-20
Is involved in dauer larval development; nematode male tail tip morphogenesis; and regulation of growth.

WB:WBGene00004873	smc-3
Is predicted to have ATP binding activity. Localizes to cohesin complex and nuclear chromatin. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 3. Is an ortholog of human SMC3 (structural maintenance of chromosomes 3).

WB:WBGene00004874	smc-4
Is predicted to have ATP binding activity. Is involved in mitotic sister chromatid segregation and positive regulation of nematode male tail tip morphogenesis. Localizes to chromosome, centromeric region and condensed chromosome. Is expressed in head; linker cell; and tail. Is an ortholog of human SMC4 (structural maintenance of chromosomes 4).

WB:WBGene00004875	smd-1
Exhibits adenosylmethionine decarboxylase activity. Is involved in spermidine biosynthetic process and spermine biosynthetic process. Is expressed in intestine and neurons. Is an ortholog of human AMD1 (adenosylmethionine decarboxylase 1).

WB:WBGene00004876	smf-1
Is predicted to have cadmium ion transmembrane transporter activity; iron ion transmembrane transporter activity; and manganese ion transmembrane transporter activity. Is involved in several processes, including negative regulation of cellular response to manganese ion; response to manganese ion; and transition metal ion homeostasis. Localizes to apical plasma membrane. Is expressed in several structures, including excretory cell; hermaphrodite gonad; intestine; nerve ring; and neurons. Human ortholog(s) of this gene are implicated in hypochromic microcytic anemia. Is an ortholog of human SLC11A1 (solute carrier family 11 member 1).

WB:WBGene00004877	smf-2
Is predicted to have cadmium ion transmembrane transporter activity; iron ion transmembrane transporter activity; and manganese ion transmembrane transporter activity. Is involved in iron ion homeostasis; manganese ion homeostasis; and response to manganese ion. Localizes to apical plasma membrane. Is expressed in dopaminergic neurons; gonadal sheath cell; marginal cell; and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in hypochromic microcytic anemia. Is an ortholog of human SLC11A1 (solute carrier family 11 member 1) and SLC11A2 (solute carrier family 11 member 2).

WB:WBGene00004878	smf-3
Is predicted to have cadmium ion transmembrane transporter activity; iron ion transmembrane transporter activity; and manganese ion transmembrane transporter activity. Is involved in response to manganese ion; response to oxidative stress; and transition metal ion homeostasis. Localizes to apical plasma membrane and organelle membrane. Is expressed in several structures, including excretory cell; hypodermal cell; intestinal cell; neurons; and vulva. Human ortholog(s) of this gene are implicated in hypochromic microcytic anemia. Is an ortholog of human SLC11A1 (solute carrier family 11 member 1) and SLC11A2 (solute carrier family 11 member 2).

WB:WBGene00004879	smg-1
Is predicted to have protein serine/threonine kinase activity. Is involved in genitalia development and nucleobase-containing compound catabolic process. Is an ortholog of human SMG1 (SMG1 nonsense mediated mRNA decay associated PI3K related kinase).

WB:WBGene00004880	smg-2
Exhibits protein phosphatase 2A binding activity. Is involved in several processes, including RNA interference; embryonic genitalia morphogenesis; and nucleobase-containing compound catabolic process. Localizes to cytoplasm and nucleus. Is expressed in intestinal cell and muscle cell. Is an ortholog of human UPF1 (UPF1 RNA helicase and ATPase).

WB:WBGene00004881	smg-3
Exhibits enzyme binding activity. Is involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Is an ortholog of human UPF2 (UPF2 regulator of nonsense mediated mRNA decay).

WB:WBGene00004882	smg-4
Is predicted to have mRNA binding activity. Is involved in hermaphrodite genitalia development; male genitalia development; and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Localizes to nucleus and perinuclear region of cytoplasm. Is expressed in intestinal cell; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability 14. Is an ortholog of human UPF3A (UPF3A regulator of nonsense mediated mRNA decay) and UPF3B (UPF3B regulator of nonsense mediated mRNA decay).

WB:WBGene00004883	smg-5
Exhibits DEAD/H-box RNA helicase binding activity and protein phosphatase 2A binding activity. Is involved in embryonic genitalia morphogenesis; ncRNA metabolic process; and negative regulation of gene expression. Localizes to cytoplasm and nucleus.

WB:WBGene00004884	smg-6
Is predicted to have telomerase RNA binding activity and telomeric DNA binding activity. Is involved in RNA interference; embryonic genitalia morphogenesis; and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Is an ortholog of human SMG6 (SMG6 nonsense mediated mRNA decay factor).

WB:WBGene00004885	smg-7
Is predicted to have telomerase RNA binding activity and telomeric DNA binding activity. Is involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Localizes to cytoplasm and nucleus. Is an ortholog of human SMG7 (SMG7 nonsense mediated mRNA decay factor).

WB:WBGene00004886	smi-1
Is involved in embryo development. Localizes to cytoplasm. Is expressed in body wall musculature; intestine; and ventral cord neurons. Is used to study spinal muscular atrophy. Is an ortholog of human GEMIN2 (gem nuclear organelle associated protein 2).

WB:WBGene00004887	smn-1
Exhibits protein self-association. Is involved in several processes, including determination of adult lifespan; pharyngeal pumping; and vulval development. Localizes to nucleus. Is expressed in several structures, including body wall musculature; excretory cell; hypodermis; intestine; and vulval muscle. Is used to study spinal muscular atrophy. Human ortholog(s) of this gene are implicated in survival motor neuron spinal muscular atrophy (multiple). Is an ortholog of human SMN2 (survival of motor neuron 2, centromeric).

WB:WBGene00004888	smo-1
Exhibits identical protein binding activity. Is involved in several processes, including chromosome organization; multicellular organismal locomotion; and muscle cell cellular homeostasis. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P8.p hermaphrodite; hermaphrodite somatic gonadal cell; and ventral nerve cord. Human ortholog(s) of this gene are implicated in orofacial cleft 10. Is an ortholog of human SUMO1 (small ubiquitin like modifier 1).

WB:WBGene00004889	smp-1
Exhibits semaphorin receptor binding activity. Is involved in nematode male tail mating organ morphogenesis. Is expressed in several structures, including hermaphrodite distal tip cell; non-striated muscle; ray; somatic nervous system; and vulval cell. Human ortholog(s) of this gene are implicated in CHARGE syndrome; hypogonadotropic hypogonadism (multiple); and retinal degeneration (multiple). Is an ortholog of human SEMA6A (semaphorin 6A).

WB:WBGene00004890	smp-2
Is predicted to have chemorepellent activity and semaphorin receptor binding activity. Is involved in nematode male tail mating organ morphogenesis. Is expressed in several structures, including hook; inner labial neurons; pharyngeal cell; ray; and vulval cell. Human ortholog(s) of this gene are implicated in CHARGE syndrome; hypogonadotropic hypogonadism (multiple); and retinal degeneration (multiple). Is an ortholog of several human genes including SEMA6A (semaphorin 6A); SEMA6C (semaphorin 6C); and SEMA7A (semaphorin 7A (John Milton Hagen blood group)).

WB:WBGene00004891	smr-1
Is enriched in AFD; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and sir-2.1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by six chemicals including Mianserin; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human SMNDC1 (survival motor neuron domain containing 1).

WB:WBGene00004892	sms-1
Is predicted to have ceramide cholinephosphotransferase activity and sphingomyelin synthase activity. Is expressed in head muscle; pharyngeal cell; rectal muscle; spermatheca; and vulval muscle. Is an ortholog of human SGMS2 (sphingomyelin synthase 2).

WB:WBGene00004893	sms-2
Is predicted to have ceramide cholinephosphotransferase activity and sphingomyelin synthase activity. Is an ortholog of human SGMS1 (sphingomyelin synthase 1) and SGMS2 (sphingomyelin synthase 2).

WB:WBGene00004894	sms-3
Is predicted to have ceramide cholinephosphotransferase activity and sphingomyelin synthase activity. Is an ortholog of human SGMS1 (sphingomyelin synthase 1) and SGMS2 (sphingomyelin synthase 2).

WB:WBGene00004895	smu-1
Exhibits protein homodimerization activity. Is involved in several processes, including mechanosensory behavior; nematode larval development; and regulation of alternative mRNA splicing, via spliceosome. Localizes to nucleus. Is expressed in several structures, including germ line. Is an ortholog of human SMU1 (SMU1 DNA replication regulator and spliceosomal factor).

WB:WBGene00004896	smu-2
Is involved in several processes, including mechanosensory behavior; nematode larval development; and regulation of alternative mRNA splicing, via spliceosome. Localizes to nucleolus. Is expressed widely. Is an ortholog of human IK (IK cytokine).

WB:WBGene00004897	snb-1
Is predicted to have SNAP receptor activity and syntaxin binding activity. Is involved in several processes, including chemical synaptic transmission; defecation; and regulation of hindgut contraction. Localizes to several cellular components, including axon; cytoplasmic vesicle; and presynaptic active zone. Is expressed in AIY; somatic nervous system; and tail. Human ortholog(s) of this gene are implicated in spastic ataxia 1. Is an ortholog of human VAMP2 (vesicle associated membrane protein 2).

WB:WBGene00004898	snb-2
Is predicted to have SNAP receptor activity and syntaxin binding activity. Human ortholog(s) of this gene are implicated in spastic ataxia 1. Is an ortholog of human VAMP1 (vesicle associated membrane protein 1).

WB:WBGene00004899	snb-5
Is predicted to have SNAP receptor activity and syntaxin binding activity. Human ortholog(s) of this gene are implicated in spastic ataxia 1.

WB:WBGene00004900	snf-1
Is predicted to have neurotransmitter:sodium symporter activity. Human ortholog(s) of this gene are implicated in Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome.

WB:WBGene00004901	snf-2
Is predicted to have gamma-aminobutyric acid:sodium symporter activity and neurotransmitter binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of several human genes including SLC6A11 (solute carrier family 6 member 11); SLC6A12 (solute carrier family 6 member 12); and SLC6A6 (solute carrier family 6 member 6).

WB:WBGene00004902	snf-3
Exhibits amino-acid betaine transmembrane transporter activity. Is involved in amino-acid betaine transport. Is expressed in excretory canal; neurons; tail hypodermis; and vulval cell. Human ortholog(s) of this gene are implicated in Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of human SLC6A11 (solute carrier family 6 member 11); SLC6A12 (solute carrier family 6 member 12); and SLC6A13 (solute carrier family 6 member 13).

WB:WBGene00004903	snf-4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00004904	snf-5
Is predicted to have gamma-aminobutyric acid:sodium symporter activity and neurotransmitter binding activity. Is expressed in amphid neurons; intestinal cell; pharyngeal neurons; and rectal gland cell. Human ortholog(s) of this gene are implicated in several diseases, including Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of several human genes including SLC6A12 (solute carrier family 6 member 12); SLC6A13 (solute carrier family 6 member 13); and SLC6A8 (solute carrier family 6 member 8).

WB:WBGene00004905	snf-6
Exhibits PDZ domain binding activity and acetylcholine transmembrane transporter activity. Is involved in acetylcholine transport; choline transport; and positive regulation of locomotion. Is expressed in body wall musculature; enteric muscle; neurons; and vulval muscle. Is used to study Duchenne muscular dystrophy. Human ortholog(s) of this gene are implicated in hyperekplexia 3. Is an ortholog of human SLC6A14 (solute carrier family 6 member 14).

WB:WBGene00004906	snf-7
Is predicted to have gamma-aminobutyric acid:sodium symporter activity and neurotransmitter binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of several human genes including SLC6A11 (solute carrier family 6 member 11); SLC6A12 (solute carrier family 6 member 12); and SLC6A6 (solute carrier family 6 member 6).

WB:WBGene00004907	snf-8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Tunicamycin; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00004908	snf-9
Is predicted to have gamma-aminobutyric acid:sodium symporter activity and neurotransmitter binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of several human genes including SLC6A11 (solute carrier family 6 member 11); SLC6A12 (solute carrier family 6 member 12); and SLC6A13 (solute carrier family 6 member 13).

WB:WBGene00004909	snf-10
Is predicted to have serotonin binding activity and serotonin:sodium symporter activity. Is involved in positive regulation of amoeboid sperm motility. Localizes to cell body membrane. Is expressed in germ line; secondary spermatocyte; sperm; spermatid; and spermatocyte. Human ortholog(s) of this gene are implicated in Hartnup disease.

WB:WBGene00004910	snf-11
Exhibits gamma-aminobutyric acid:sodium symporter activity. Is involved in gamma-aminobutyric acid transport. Localizes to neuron projection and neuronal cell body. Is expressed in several structures, including GLR; enteric muscle; head mesodermal cell; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome. Is an ortholog of human SLC6A1 (solute carrier family 6 member 1).

WB:WBGene00004911	snf-12
Exhibits transcription factor binding activity. Is involved in positive regulation of antifungal peptide production. Localizes to apical part of cell and endocytic vesicle. Is expressed in excretory cell; hypodermis; socket cell; and vulva.

WB:WBGene00004912	sng-1
Localizes to synaptic vesicle. Is expressed in ganglia; neurons; and somatic nervous system. Is an ortholog of human SYNGR1 (synaptogyrin 1) and SYNGR3 (synaptogyrin 3).

WB:WBGene00004913	snn-1
Is predicted to have ATP binding activity. Is involved in neuromuscular synaptic transmission. Localizes to presynaptic periactive zone. Human ortholog(s) of this gene are implicated in schizophrenia. Is an ortholog of human SYN3 (synapsin III).

WB:WBGene00004914	snr-1
Is predicted to have RNA binding activity. Localizes to P granule. Is expressed in germ line; gonad; head; and tail. Is an ortholog of human SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide).

WB:WBGene00004915	snr-2
Is predicted to have RNA binding activity. Is expressed in gonad. Human ortholog(s) of this gene are implicated in Prader-Willi syndrome; autistic disorder; and cerebrocostomandibular syndrome. Is an ortholog of human SNRPB (small nuclear ribonucleoprotein polypeptides B and B1).

WB:WBGene00004916	snr-3
Is predicted to have RNA binding activity. Localizes to P granule. Is expressed in gonad. Is an ortholog of human SNRPD1 (small nuclear ribonucleoprotein D1 polypeptide).

WB:WBGene00004917	snr-4
Is expressed in gonad. Is predicted to encode a protein with the following domains: LSM domain; LSM domain, eukaryotic/archaea-type; LSM domain superfamily; and Small nuclear ribonucleoprotein Sm D2. Is an ortholog of human SNRPD2 (small nuclear ribonucleoprotein D2 polypeptide).

WB:WBGene00004918	snr-5
Is predicted to have RNA binding activity. Is expressed in several structures, including enteric muscle; excretory cell; hypodermis; nervous system; and reproductive system. Is an ortholog of human SNRPF (small nuclear ribonucleoprotein polypeptide F).

WB:WBGene00004919	snr-6
Is predicted to have RNA binding activity. Localizes to P granule. Is expressed in gonad. Human ortholog(s) of this gene are implicated in hypotrichosis 11. Is an ortholog of human SNRPE (small nuclear ribonucleoprotein polypeptide E).

WB:WBGene00004920	snr-7
Is predicted to have RNA binding activity. Localizes to P granule. Is expressed in gonad. Is an ortholog of human SNRPG (small nuclear ribonucleoprotein polypeptide G).

WB:WBGene00004921	snt-1
Is predicted to have several functions, including calcium ion binding activity; phospholipid binding activity; and syntaxin binding activity. Is involved in several processes, including defecation; positive regulation of necrotic cell death; and regulation of pharyngeal pumping. Localizes to synaptic vesicle. Is expressed in gonad; neurons; pharyngeal nerve process; and somatic nervous system. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11 and congenital myasthenic syndrome 7. Is an ortholog of human SYT1 (synaptotagmin 1) and SYT2 (synaptotagmin 2).

WB:WBGene00004922	snt-2
Is predicted to have several functions, including calcium ion binding activity; phospholipid binding activity; and syntaxin binding activity. Localizes to dense core granule. Is expressed in head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11. Is an ortholog of several human genes including SYT1 (synaptotagmin 1); SYT5 (synaptotagmin 5); and SYT8 (synaptotagmin 8).

WB:WBGene00004923	snt-3
Is predicted to have several functions, including calcium ion binding activity; phospholipid binding activity; and syntaxin binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11. Is an ortholog of human SYT1 (synaptotagmin 1) and SYT2 (synaptotagmin 2).

WB:WBGene00004924	snt-4
Is predicted to have several functions, including SNARE binding activity; calcium ion binding activity; and phospholipid binding activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11. Is an ortholog of human SYT4 (synaptotagmin 4).

WB:WBGene00004925	snt-5
Is predicted to have several functions, including calcium ion binding activity; phospholipid binding activity; and syntaxin binding activity. Is an ortholog of several human genes including SYT10 (synaptotagmin 10); SYT3 (synaptotagmin 3); and SYT6 (synaptotagmin 6).

WB:WBGene00004926	snt-6
Is predicted to have several functions, including SNARE binding activity; calcium ion binding activity; and phospholipid binding activity. Is an ortholog of human SYT7 (synaptotagmin 7).

WB:WBGene00004927	snx-1
Exhibits phosphatidylinositol-3,4,5-trisphosphate binding activity and protein self-association. Is involved in several processes, including mechanosensory behavior; phagosome-lysosome fusion involved in apoptotic cell clearance; and protein localization to postsynaptic membrane. Localizes to early endosome and early phagosome. Is expressed in body wall musculature; gonadal sheath cell; head; hypodermis; and tail. Is an ortholog of human SNX1 (sorting nexin 1) and SNX2 (sorting nexin 2).

WB:WBGene00004928	soc-1
Is involved in dauer larval development. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 26. Is an ortholog of human GAB2 (GRB2 associated binding protein 2).

WB:WBGene00004929	soc-2
Exhibits Ras GTPase binding activity. Is involved in several processes, including fibroblast growth factor receptor signaling pathway; positive regulation of Ras protein signal transduction; and vulval development. Is expressed in tail. Human ortholog(s) of this gene are implicated in agammaglobulinemia 5. Is an ortholog of human SHOC2 (SHOC2 leucine rich repeat scaffold protein).

WB:WBGene00004930	sod-1
Exhibits copper ion binding activity; protein homodimerization activity; and superoxide dismutase activity. Is involved in several processes, including regulation of brood size; regulation of vulval development; and removal of superoxide radicals. Localizes to cytosol and mitochondrion. Is expressed in several structures, including intestinal cell; somatic gonad; and somatic nervous system. Is an ortholog of human SOD1 (superoxide dismutase 1).

WB:WBGene00004931	sod-2
Exhibits protein homodimerization activity and superoxide dismutase activity. Is involved in removal of superoxide radicals. Localizes to mitochondrial respirasome. Is expressed in head and tail. Is an ortholog of human SOD2 (superoxide dismutase 2).

WB:WBGene00004932	sod-3
Exhibits protein homodimerization activity and superoxide dismutase activity. Is involved in removal of superoxide radicals. Localizes to mitochondrial respirasome. Is expressed in several structures, including head; intestine; pharynx; tail; and vulva. Is an ortholog of human SOD2 (superoxide dismutase 2).

WB:WBGene00004933	sod-4
Exhibits superoxide dismutase activity. Is involved in superoxide metabolic process. Localizes to extracellular space and membrane. Is expressed in somatic gonad. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 1. Is an ortholog of human SOD3 (superoxide dismutase 3).

WB:WBGene00004935	sog-2
Is involved in embryo development and germ cell development.

WB:WBGene00004936	sog-3
Is involved in embryo development and germ cell development.

WB:WBGene00004937	sog-4
Is involved in embryo development and germ cell development.

WB:WBGene00004938	sog-5
Is involved in embryo development and germ cell development.

WB:WBGene00004939	sog-6
Is involved in embryo development and germ cell development.

WB:WBGene00004940	sog-7
No description available

WB:WBGene00004941	sog-8
No description available

WB:WBGene00004942	sog-9
No description available

WB:WBGene00004943	sog-10
Is involved in embryo development; germ cell development; and masculinization of hermaphroditic germ-line.

WB:WBGene00004944	sol-1
Exhibits channel regulator activity. Is involved in several processes, including hyperosmotic response; positive regulation of glutamatergic synaptic transmission; and thigmotaxis. Localizes to ionotropic glutamate receptor complex; neuron projection membrane; and synapse.

WB:WBGene00004945	sop-2
Exhibits RNA binding activity; protein homodimerization activity; and ubiquitin protein ligase binding activity. Is involved in several processes, including negative regulation of cytoplasmic mRNA processing body assembly; neuron differentiation; and regulation of gene expression. Localizes to nuclear speck. Is expressed widely.

WB:WBGene00004946	sop-3
Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and neurons. Is predicted to encode a protein with the following domain: .

WB:WBGene00004947	sos-1
Exhibits calmodulin binding activity. Is involved in several processes, including embryo development; female gamete generation; and positive regulation of vulval development. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 4; familial adult myoclonic epilepsy 7; and platelet-type bleeding disorder 18. Is an ortholog of human SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1).

WB:WBGene00004949	sox-2
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in neuron fate specification. Is expressed in several structures, including head neurons; hypodermis; inner labial neurons; neuroblasts; and rectal epithelial cell. Human ortholog(s) of this gene are implicated in syndromic microphthalmia. Is an ortholog of human SOX14 (SRY-box transcription factor 14).

WB:WBGene00004950	sox-3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Is expressed in head neurons and rectal epithelial cell. Human ortholog(s) of this gene are implicated in syndromic microphthalmia. Is an ortholog of human SOX14 (SRY-box transcription factor 14) and SOX21 (SRY-box transcription factor 21).

WB:WBGene00004951	spc-1
Is predicted to have calcium ion binding activity. Is involved in several processes, including embryonic body morphogenesis; nematode larval development; and regulation of growth. Is expressed in several structures, including body wall musculature; hermaphrodite gonad; hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Carvajal syndrome; epidermolysis bullosa (multiple); and muscular dystrophy (multiple). Is an ortholog of human SPTAN1 (spectrin alpha, non-erythrocytic 1).

WB:WBGene00004952	spd-1
Is predicted to have microtubule binding activity. Is involved in several processes, including ciliary body morphogenesis; gonad development; and mitotic spindle midzone assembly. Localizes to microtubule; mitotic spindle midzone; and nucleus. Is an ortholog of human PRC1 (protein regulator of cytokinesis 1).

WB:WBGene00004953	spd-2
Exhibits protein kinase binding activity. Is involved in several processes, including centriole replication; embryo development; and vulval development. Localizes to centriole; cytoplasm; and pericentriolar material. Is expressed in intestinal cell.

WB:WBGene00004954	spd-3
Is involved in embryo development; microtubule cytoskeleton organization; and vulval development. Localizes to mitochondrion.

WB:WBGene00004955	spd-5
Exhibits identical protein binding activity. Is involved in centrosome cycle; positive regulation of mitotic cell cycle, embryonic; and protein localization to organelle. Localizes to centrosome and cytoplasm.

WB:WBGene00004956	spe-1
No description available

WB:WBGene00004957	spe-3
Is involved in oogenesis and spermatid development.

WB:WBGene00004958	spe-4
Is predicted to have endopeptidase activity. Is involved in several processes, including membrane organization; protein localization; and spermatid development. Localizes to intracellular membrane-bounded organelle. Is expressed in male.

WB:WBGene00004959	spe-5
Is predicted to have ATP binding activity. Is involved in positive regulation of programmed cell death. Is expressed in sperm and spermatocyte. Is an ortholog of human ATP6V1B1 (ATPase H+ transporting V1 subunit B1).

WB:WBGene00004960	spe-6
Is predicted to have protein serine/threonine kinase activity. Is involved in male meiosis chromosome separation; regulation of cellular protein localization; and spermatid differentiation. Is expressed in sperm.

WB:WBGene00004961	spe-7
Is involved in spermatogenesis.

WB:WBGene00004962	spe-8
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is involved in spermatid development. Localizes to plasma membrane. Is expressed in sperm and spermatocyte. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00004963	spe-9
Is predicted to have signaling receptor binding activity. Is involved in single fertilization. Localizes to several cellular components, including cell surface; cytoplasm; and pseudopodium. Is expressed in sperm and spermatid. Human ortholog(s) of this gene are implicated in Alagille syndrome and tetralogy of Fallot. Is an ortholog of human DLL1 (delta like canonical Notch ligand 1) and DLL4 (delta like canonical Notch ligand 4).

WB:WBGene00004964	spe-10
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is involved in several processes, including amoeboid sperm motility; positive regulation of cell size; and pseudopodium organization. Localizes to membrane-bounded organelle. Is expressed in spermatid. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability and syndromic X-linked intellectual disability Raymond type. Is an ortholog of human ZDHHC2 (zinc finger DHHC-type palmitoyltransferase 2) and ZDHHC20 (zinc finger DHHC-type palmitoyltransferase 20).

WB:WBGene00004965	spe-11
Is involved in eggshell formation and prevention of polyspermy. Localizes to nucleus.

WB:WBGene00004966	spe-12
Is involved in spermatid development. Localizes to plasma membrane. Is expressed in spermatid and in male.

WB:WBGene00004967	spe-13
Is involved in single fertilization.

WB:WBGene00004968	spe-14
No description available

WB:WBGene00004969	spe-15
Is predicted to have actin filament binding activity; actin-dependent ATPase activity; and microfilament motor activity. Is involved in organelle localization and spermatid development. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 22 and autosomal recessive nonsyndromic deafness 37. Is an ortholog of human MYO6 (myosin VI).

WB:WBGene00004970	spe-16
No description available

WB:WBGene00004971	spe-17
Is involved in spermatid development.

WB:WBGene00004972	spe-26
Is predicted to have actin binding activity. Is expressed in spermatocyte and in male.

WB:WBGene00004973	spe-27
Is involved in spermatid development. Is expressed in sperm; spermatocyte; and in male.

WB:WBGene00004974	spe-29
Is involved in spermatid development.

WB:WBGene00004975	spe-39
Is involved in spermatid development; vacuolar protein processing; and vacuolar transport. Localizes to cytoplasm. Is expressed in male-specific anatomical entity and in male. Human ortholog(s) of this gene are implicated in arthrogryposis, renal dysfunction, and cholestasis 2. Is an ortholog of human VIPAS39 (VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog).

WB:WBGene00004976	spe-41
Exhibits store-operated calcium channel activity. Is involved in calcium ion transport; cellular calcium ion homeostasis; and single fertilization. Localizes to cytoplasmic vesicle; integral component of plasma membrane; and pseudopodium membrane. Is expressed in sperm and spermatid. Human ortholog(s) of this gene are implicated in focal segmental glomerulosclerosis 2.

WB:WBGene00004977	spf-1
No description available

WB:WBGene00004978	spg-7
Is predicted to have metalloendopeptidase activity. Is involved in several processes, including mitochondrial protein processing; positive regulation of nematode male tail tip morphogenesis; and regulation of gene expression. Is expressed in germ line. Human ortholog(s) of this gene are implicated in spastic ataxia 5 and spinocerebellar ataxia type 28. Is an ortholog of human AFG3L2 (AFG3 like matrix AAA peptidase subunit 2).

WB:WBGene00004979	sph-1
Is predicted to have syntaxin-1 binding activity. Localizes to cytoplasmic vesicle. Is expressed in anal sphincter muscle and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human SYP (synaptophysin) and SYPL1 (synaptophysin like 1).

WB:WBGene00004980	spk-1
Exhibits protein serine/threonine kinase activity. Is involved in embryo development and protein phosphorylation. Is expressed in several structures, including gonad and tail. Is an ortholog of human SRPK2 (SRSF protein kinase 2).

WB:WBGene00004981	spl-1
Is predicted to have sphinganine-1-phosphate aldolase activity. Is expressed in head and intestine. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 14. Is an ortholog of human SGPL1 (sphingosine-1-phosphate lyase 1).

WB:WBGene00004984	spn-4
Is predicted to have mRNA binding activity. Localizes to P granule. Is expressed in several structures, including Psub4; Z2; Z3; germ line; and oocyte.

WB:WBGene00004985	spo-11
Is predicted to have DNA binding activity and endodeoxyribonuclease activity, producing 3'-phosphomonoesters. Is involved in meiotic DNA double-strand break processing. Is an ortholog of human SPO11 (SPO11 initiator of meiotic double stranded breaks).

WB:WBGene00004986	spp-1
Exhibits channel activity. Is involved in defense response to other organism; pathogenesis; and pore formation in membrane of other organism. Localizes to pore complex.

WB:WBGene00004987	spp-2
Is involved in defense response to Gram-positive bacterium.

WB:WBGene00004988	spp-3
Exhibits identical protein binding activity. Is involved in defense response to Gram-negative bacterium and defense response to Gram-positive bacterium. Localizes to protein-containing complex. Is expressed in SDQR.

WB:WBGene00004989	spp-4
Is enriched in hypodermis; intestine; male-specific anatomical entity; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Heme; methylmercuric chloride; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like.

WB:WBGene00004990	spp-5
Exhibits channel activity. Is involved in defense response to Gram-negative bacterium and defense response to Gram-positive bacterium.

WB:WBGene00004991	spp-6
Is enriched in ALM; PLM; body wall muscle cell; and intestine based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including skn-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like.

WB:WBGene00004992	spp-7
Is expressed in head neurons; intestine; and pm7. Human ortholog(s) of this gene are implicated in pulmonary alveolar proteinosis and sphingolipidosis (multiple). Is predicted to encode a protein with the following domains: Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like.

WB:WBGene00004993	spp-8
Is enriched in OLL; PVD; and intestine based on SAGE; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; Mianserin; and D-glucose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in pulmonary alveolar proteinosis and sphingolipidosis (multiple). Is predicted to encode a protein with the following domains: Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like. Is an ortholog of human PSAP (prosaposin).

WB:WBGene00004994	spp-9
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like.

WB:WBGene00004995	spp-10
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and antimycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in pulmonary alveolar proteinosis. Is predicted to encode a protein with the following domains: Saposin-like type B, region 1; Saposin-like type B, region 2; Saposin-like type B, region 1; Saposin B type, region 2; Saposin B type domain; Saposin; and Saposin-like. Is an ortholog of human PSAP (prosaposin) and PSAPL1 (prosaposin like 1).

WB:WBGene00004996	spp-11
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including glycine; Chlorpyrifos; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00004997	spp-12
Exhibits channel activity. Is involved in defense response to Gram-positive bacterium; pathogenesis; and pore formation in membrane of other organism. Localizes to pore complex. Is expressed in I6 neuron; NSML; and NSMR.

WB:WBGene00004998	spp-13
Is enriched in hypodermis and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercury hydroxide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like.

WB:WBGene00004999	spp-14
Is expressed in male. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00005000	spp-15
Is enriched in body wall muscle cell; coelomocyte; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Saposin-like type B, region 2; Saposin B type, region 2; Saposin B type domain; and Saposin-like.

WB:WBGene00005001	spp-16
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00005002	spp-17
Is enriched in DA neuron; VA neuron; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00005003	spp-18
Is involved in innate immune response.

WB:WBGene00005004	spp-19
Is predicted to have transmembrane receptor protein serine/threonine kinase activity.

WB:WBGene00005005	spp-20
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including diallyl trisulfide; Tunicamycin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Saposin-like type B, region 1; Saposin-like type B, region 1; Saposin B type domain; and Saposin-like.

WB:WBGene00005006	spr-1
Is predicted to have several functions, including DNA-binding transcription factor activity; transcription corepressor activity; and transcription factor binding activity. Is an ortholog of human RCOR3 (REST corepressor 3).

WB:WBGene00005007	spr-2
Is involved in regulation of oviposition. Localizes to nucleus. Is expressed widely. Is an ortholog of human SET (SET nuclear proto-oncogene).

WB:WBGene00005008	spr-3
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00005009	spr-4
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in response to oxidative stress. Is expressed in neurons. Is used to study Alzheimer's disease.

WB:WBGene00005010	spr-5
Exhibits histone demethylase activity (H3-dimethyl-K4 specific). Is involved in histone H3-K4 demethylation and regulation of gene expression, epigenetic. Localizes to cytoplasm and nucleus. Is expressed in germ line. Human ortholog(s) of this gene are implicated in Brunner Syndrome and variegate porphyria. Is an ortholog of human KDM1A (lysine demethylase 1A).

WB:WBGene00005011	F26F4.8
Is enriched in several structures, including Z4.a; cephalic sheath cell; coelomocyte; germ line; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00005012	F26F4.2
Is enriched in germ line; intestine; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00005013	jmjd-1.1
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Siderius type. Is an ortholog of human KDM7A (lysine demethylase 7A).

WB:WBGene00005014	spt-4
Is predicted to have RNA polymerase II complex binding activity and single-stranded RNA binding activity. Is an ortholog of human SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit).

WB:WBGene00005015	spt-5
Is predicted to have mRNA binding activity. Localizes to chromosome. Is expressed in several structures, including head and tail. Is an ortholog of human SUPT5H (SPT5 homolog, DSIF elongation factor subunit).

WB:WBGene00005016	sqt-1
Is a structural constituent of collagen and cuticulin-based cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle.

WB:WBGene00005017	sqt-2
Is predicted to be a structural constituent of cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle.

WB:WBGene00005018	sqt-3
Is predicted to be a structural constituent of cuticle. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Localizes to collagen and cuticulin-based cuticle extracellular matrix. Is expressed in hypodermis.

WB:WBGene00005019	sqv-1
Is predicted to have NAD+ binding activity and UDP-glucuronate decarboxylase activity. Is involved in several processes, including oviposition; pharynx development; and vulval development. Localizes to cytoplasm. Is expressed in coelomocyte; oocyte; uterus; and vulva. Is an ortholog of human UXS1 (UDP-glucuronate decarboxylase 1).

WB:WBGene00005020	sqv-2
Exhibits galactosylxylosylprotein 3-beta-galactosyltransferase activity. Is involved in several processes, including glycosaminoglycan biosynthetic process; oviposition; and vulval development. Localizes to Golgi apparatus. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Ehlers-Danlos syndrome progeroid type. Is an ortholog of human B3GALT6 (beta-1,3-galactosyltransferase 6).

WB:WBGene00005021	sqv-3
Exhibits galactosyltransferase activity. Is involved in several processes, including oviposition; positive regulation of axon regeneration; and proteoglycan biosynthetic process. Localizes to membrane. Is an ortholog of human B4GALT7 (beta-1,4-galactosyltransferase 7).

WB:WBGene00005022	sqv-4
Exhibits UDP-glucose 6-dehydrogenase activity and identical protein binding activity. Is involved in several processes, including glycosaminoglycan biosynthetic process; oviposition; and vulval development. Localizes to cytoplasm. Is expressed in several structures, including germ line; hermaphrodite gonad; hypodermis; oocyte; and vulva. Is an ortholog of human UGDH (UDP-glucose 6-dehydrogenase).

WB:WBGene00005023	sqv-5
Exhibits enzyme binding activity. Is involved in several processes, including oviposition; positive regulation of vulval development; and vulval development. Localizes to cytoplasm. Is expressed in oocyte; uterus; and vulva. Human ortholog(s) of this gene are implicated in temtamy preaxial brachydactyly syndrome. Is an ortholog of human CHSY1 (chondroitin sulfate synthase 1) and CHSY3 (chondroitin sulfate synthase 3).

WB:WBGene00005024	sqv-6
Exhibits protein xylosyltransferase activity. Is involved in several processes, including UDP-D-xylose metabolic process; glycosaminoglycan biosynthetic process; and oviposition. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is an ortholog of human XYLT1 (xylosyltransferase 1) and XYLT2 (xylosyltransferase 2).

WB:WBGene00005025	sqv-7
Exhibits UDP-N-acetylgalactosamine transmembrane transporter activity; UDP-galactose transmembrane transporter activity; and UDP-glucuronic acid transmembrane transporter activity. Is involved in several processes, including oviposition; proteoglycan biosynthetic process; and pyrimidine nucleotide-sugar transmembrane transport. Localizes to cytoplasm. Is expressed in hermaphrodite distal tip cell; oocyte; seam cell; and vulval cell. Human ortholog(s) of this gene are implicated in schneckenbecken dysplasia. Is an ortholog of human SLC35D1 (solute carrier family 35 member D1) and SLC35D2 (solute carrier family 35 member D2).

WB:WBGene00005026	sqv-8
Exhibits glucuronosyltransferase activity. Is involved in several processes, including chondroitin sulfate biosynthetic process; oviposition; and pharynx development. Localizes to membrane. Human ortholog(s) of this gene are implicated in Larsen-like syndrome B3GAT3 type. Is an ortholog of human B3GAT3 (beta-1,3-glucuronyltransferase 3).

WB:WBGene00005027	sra-1
Is predicted to have olfactory receptor activity.

WB:WBGene00005028	sra-2
Is predicted to have olfactory receptor activity. Is expressed in body wall musculature; head; and head neurons.

WB:WBGene00005029	sra-3
Is predicted to have olfactory receptor activity.

WB:WBGene00005030	sra-4
Is predicted to have olfactory receptor activity. Is expressed in pharynx.

WB:WBGene00005031	sra-5
Is affected by eri-1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005032	sra-6
Is predicted to have olfactory receptor activity. Localizes to cilium. Is expressed in head and tail.

WB:WBGene00005033	sra-7
Is predicted to have olfactory receptor activity. Is expressed in head and tail.

WB:WBGene00005034	sra-8
Is predicted to have olfactory receptor activity.

WB:WBGene00005035	sra-9
Is predicted to have olfactory receptor activity.

WB:WBGene00005036	sra-10
Is predicted to have olfactory receptor activity. Is expressed in dorsal ganglion; muscle cell; and neurons.

WB:WBGene00005037	sra-11
Is predicted to have olfactory receptor activity. Is involved in detection of chemical stimulus involved in sensory perception and olfactory learning. Is expressed in VC neuron; interneuron; pharyngeal neurons; and ventral ganglion.

WB:WBGene00005038	sra-12
Is predicted to have olfactory receptor activity.

WB:WBGene00005039	sra-13
Exhibits olfactory receptor activity. Is involved in several processes, including detection of chemical stimulus involved in sensory perception of smell; negative regulation of response to food; and negative regulation of vulval development. Is expressed in amphid neurons; body wall musculature; head; hypodermis; and muscle cell.

WB:WBGene00005040	sra-14
Is predicted to have olfactory receptor activity. Is expressed in RID; chemosensory neurons; and ray.

WB:WBGene00005041	sra-15
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00005042	sra-16
Is affected by sir-2.1 based on microarray studies. Is affected by Microcystin-LR based on microarray studies.

WB:WBGene00005043	sra-17
Is predicted to have G protein-coupled receptor activity. Is expressed in ASIL; ASIR; AWAL; AWAR; and neurons.

WB:WBGene00005044	sra-18
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005045	sra-19
Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray studies. Is affected by resveratrol; adsorbable organic bromine compound; and Sirolimus based on microarray studies.

WB:WBGene00005046	sra-20
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005047	sra-21
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005048	sra-22
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005049	sra-23
Is predicted to have G protein-coupled receptor activity. Is expressed in PQR; head; and neurons.

WB:WBGene00005050	sra-24
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005051	sra-25
Is predicted to have G protein-coupled receptor activity. Is expressed in head neurons and tail.

WB:WBGene00005052	sra-26
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005053	sra-27
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005054	sra-28
Is predicted to have G protein-coupled receptor activity. Is expressed in ASIL; ASIR; PQR; and neurons.

WB:WBGene00005055	sra-29
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005056	sra-30
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005057	sra-31
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005058	sra-32
Is predicted to have olfactory receptor activity.

WB:WBGene00005059	sra-33
Is predicted to have olfactory receptor activity.

WB:WBGene00005060	sra-34
Is predicted to have olfactory receptor activity.

WB:WBGene00005061	sra-35
Is predicted to have olfactory receptor activity. Is expressed in HSN and head neurons.

WB:WBGene00005062	sra-36
Is predicted to have olfactory receptor activity. Is expressed in ASIL; ASIR; DA8; DA9; and VA11.

WB:WBGene00005063	sra-37
Is enriched in body wall musculature and head mesodermal cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by seven chemicals including aldicarb; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00005064	sra-38
Is predicted to have transmembrane signaling receptor activity. Is expressed in head.

WB:WBGene00005065	sra-39
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00005066	srb-1
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005067	srb-2
Is affected by several genes including clk-1; ain-1; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00005068	srb-3
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005069	srb-4
Is affected by hmg-4 based on RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00005070	srb-5
Is predicted to have G protein-coupled receptor activity. Is expressed in ASKL and ASKR.

WB:WBGene00005071	srb-6
Is predicted to have transmembrane signaling receptor activity. Is involved in defense response to Gram-positive bacterium and detection of chemical stimulus. Localizes to cilium. Is expressed in head; phasmid neurons; and tail.

WB:WBGene00005072	srb-7
Is expressed in head.

WB:WBGene00005073	srb-8
Is affected by several genes including daf-12; lin-4; and lin-14 based on tiling array and microarray studies. Is affected by five chemicals including resveratrol; Atrazine; and Chlorpyrifos based on microarray studies.

WB:WBGene00005074	srb-9
Is enriched in hypodermis based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00005075	srb-10
Is affected by sir-2.1 and ain-1 based on microarray studies. Is affected by four chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00005076	srb-11
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005077	src-1
Exhibits netrin receptor binding activity and non-membrane spanning protein tyrosine kinase activity. Is involved in several processes, including axis specification; commissural neuron axon guidance; and embryonic morphogenesis. Localizes to contractile fiber and phagocytic cup. Is expressed in several structures, including anchor cell; anus; distal tip cell; head neurons; and vulval cell. Human ortholog(s) of this gene are implicated in colorectal cancer and maturity-onset diabetes of the young type 11. Is an ortholog of human FYN (FYN proto-oncogene, Src family tyrosine kinase) and SRC (SRC proto-oncogene, non-receptor tyrosine kinase).

WB:WBGene00005078	src-2
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is involved in pharynx development. Is expressed in anus; pharyngeal muscle cell; and vulva. Is an ortholog of human FRK (fyn related Src family tyrosine kinase).

WB:WBGene00005079	srd-1
Is expressed in AWAL and AWAR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005080	srd-2
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including clk-1; mir-34; and spe-44 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005081	srd-3
Is enriched in FLP; NSM; RID; and head mesodermal cell based on microarray; RNA-seq; and tiling array studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Tunicamycin; antimycin; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005082	srd-4
Is expressed in BAGL; BAGR; DA9; motor neurons; and tail neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005083	srd-5
Is expressed in ASIL; ASIR; and AWC-OFF. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005084	srd-6
No description available

WB:WBGene00005085	srd-7
Is affected by several genes including clk-1; eat-2; and bar-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005086	srd-8
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and dpy-21 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005087	srd-9
Is affected by several genes including clk-1; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005088	srd-10
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005089	srd-11
Is expressed in AWBL; AWBR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005090	srd-12
Is affected by drh-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005091	srd-13
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005092	srd-14
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; Rotenone; and Zidovudine based on RNA-seq studies.

WB:WBGene00005093	srd-15
Is expressed in amphid neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005094	srd-16
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005095	srd-17
Is expressed in AWCL and AWCR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005096	srd-18
Is enriched in AFD; NSM; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by clk-1 and mir-243 based on microarray studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005097	srd-19
Is affected by clk-1 and eat-2 based on microarray and RNA-seq studies. Is affected by resveratrol; tetrabromobisphenol A; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005098	srd-20
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Psoralens; allantoin; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005099	srd-21
Is affected by cyc-1 and drh-3 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005100	srd-22
Is affected by clk-1; daf-2; and eat-2 based on microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00005101	srd-23
Localizes to neuronal cell body and non-motile cilium. Is expressed in ASKL; ASKR; AWBL; and AWBR.

WB:WBGene00005102	srd-24
Is affected by clk-1 based on microarray studies.

WB:WBGene00005103	srd-25
Is affected by clk-1; ain-1; and ain-2 based on microarray studies. Is affected by Atrazine and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005104	srd-26
Is affected by clk-1; mir-34; and nhl-2 based on microarray and RNA-seq studies. Is affected by tryptophan and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005105	srd-27
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus; Ag nanoparticles; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005106	srd-28
Is involved in short-term memory.

WB:WBGene00005107	srd-29
Is affected by hpl-2; mir-34; and sir-2.1 based on tiling array and microarray studies. Is affected by Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005108	srd-30
Is affected by several genes including clk-1; eat-2; and dpy-21 based on microarray and RNA-seq studies. Is affected by allantoin and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005109	srd-31
Is affected by rsr-2 based on tiling array studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005110	srd-32
Is expressed in several structures, including distal tip cell; enteric muscle; head mesodermal cell; neurons; and pharyngeal-intestinal valve. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005111	srd-33
Is expressed in ASEL; ASER; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005112	srd-34
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including aldicarb; fluoranthene; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005113	srd-35
Is enriched in PLM; germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005114	srd-36
Is expressed in ASKL and ASKR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005115	srd-37
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00005116	srd-38
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005117	srd-39
Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005118	srd-40
Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005119	srd-41
Is enriched in body wall musculature based on microarray studies. Is affected by rsr-2; clk-1; and ain-2 based on tiling array and microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005120	srd-42
Is affected by several genes including hpl-2; drh-3; and rrf-2 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005121	srd-43
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by mir-34 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005122	srd-44
Is affected by rsr-2; drh-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005123	srd-45
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005124	srd-46
Is enriched in germ line based on RNA-seq studies. Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005125	srd-47
Is affected by cyc-1 and rsr-2 based on microarray and tiling array studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005126	srd-48
Is affected by several genes including sir-2.1; prg-1; and mut-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005127	srd-49
Is enriched in neurons based on microarray studies. Is affected by thoc-5; nhr-86; and ain-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005128	srd-50
Is affected by hpl-2 and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005129	srd-51
Is enriched in RID and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol; Cry5B; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005130	srd-52
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00005131	srd-53
Is affected by several genes including rrf-3; sek-1; and aak-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005132	srd-54
Is affected by several genes including his-72; his-71; and his-74 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005133	srd-55
Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005134	srd-56
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including sir-2.1; drh-3; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by dibromoacetic acid and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005135	srd-58
Is affected by eat-2 and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005136	srd-59
Is enriched in NSM based on tiling array studies. Is affected by cyc-1; emr-1; and clk-1 based on microarray and RNA-seq studies. Is affected by resveratrol; cadmium; and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005137	srd-60
Is enriched in DD neuron; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including pgl-1; hsp-6; and daf-19 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005138	srd-61
Is affected by several genes including daf-16; pgl-1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005139	srd-62
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00005140	srd-63
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including sodium arsenite; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005141	srd-64
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucopyranose; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005142	srd-65
Is enriched in AVE and germ line based on tiling array and RNA-seq studies. Is affected by several genes including dpy-21; ain-1; and cyc-1 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and dafa#1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005143	srd-66
Is affected by several genes including pgl-1; mex-3; and glh-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005144	srd-67
Is enriched in NSM based on tiling array studies. Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005145	srd-68
Is enriched in NSM based on tiling array studies. Is affected by mir-34 based on microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005146	srd-69
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; drh-3; and adr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by dafa#1 and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005147	srd-70
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005148	srd-71
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00005149	sre-1
Is expressed in neurons. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00005150	sre-2
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00005151	srf-1
No description available

WB:WBGene00005152	srf-2
No description available

WB:WBGene00005153	srf-3
Exhibits UDP-N-acetylglucosamine transmembrane transporter activity and UDP-galactose transmembrane transporter activity. Is involved in UDP-N-acetylglucosamine transmembrane transport and UDP-galactose transmembrane transport. Localizes to integral component of Golgi membrane and perinuclear region of cytoplasm. Is expressed in pharyngeal gland cell; seam cell; spermatheca; and vas deferens. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIm. Is an ortholog of human SLC35A2 (solute carrier family 35 member A2).

WB:WBGene00005154	srf-4
No description available

WB:WBGene00005155	srf-5
No description available

WB:WBGene00005156	srf-6
No description available

WB:WBGene00005157	srf-8
No description available

WB:WBGene00005158	srf-9
No description available

WB:WBGene00005159	srg-1
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005160	srg-2
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005161	srg-3
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005162	srg-4
Is predicted to have transmembrane signaling receptor activity. Is expressed in ASIL; ASIR; ASKL; ASKR; and PVT.

WB:WBGene00005163	srg-5
Is predicted to have transmembrane signaling receptor activity. Is expressed in ciliated neurons and ray.

WB:WBGene00005164	srg-6
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005165	srg-7
Is predicted to have transmembrane signaling receptor activity. Is expressed in head.

WB:WBGene00005166	srg-8
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005167	srg-9
Is predicted to have transmembrane signaling receptor activity. Is expressed in head; neurons; and tail.

WB:WBGene00005168	srg-10
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005169	srg-11
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005170	srg-13
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005171	srg-14
Is predicted to have transmembrane signaling receptor activity. Is expressed in head neurons; tail; and in male.

WB:WBGene00005172	srg-15
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005173	srg-16
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005174	srg-17
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005175	srg-18
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by clk-1; sir-2.1; and rrf-3 based on microarray studies.

WB:WBGene00005176	srg-19
Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00005177	srg-20
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005178	srg-21
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005179	srg-22
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005180	srg-23
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005181	srg-24
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005182	srg-25
Is predicted to have transmembrane signaling receptor activity. Is expressed in ciliated neurons.

WB:WBGene00005183	srg-26
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005184	srg-27
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005185	srg-28
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005186	srg-29
Is predicted to have transmembrane signaling receptor activity. Is expressed in ASIL; ASIR; head muscle; neurons; and pharynx.

WB:WBGene00005187	srg-30
Is predicted to have transmembrane signaling receptor activity. Is expressed in ASEL; ASER; and neurons.

WB:WBGene00005188	srg-31
Is predicted to have transmembrane signaling receptor activity. Is expressed in amphid neurons; anal depressor muscle; and lumbar neurons.

WB:WBGene00005189	srg-32
Is predicted to have transmembrane signaling receptor activity. Is expressed in interneuron.

WB:WBGene00005190	srg-33
Is predicted to have transmembrane signaling receptor activity. Is expressed in ASIL and ASIR.

WB:WBGene00005191	srg-34
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005192	srg-35
Is affected by eat-2 and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00005193	srg-36
Is predicted to have transmembrane signaling receptor activity. Is involved in dauer larval development. Localizes to non-motile cilium. Is expressed in ASIL; ASIR; and neurons.

WB:WBGene00005194	srg-37
Is predicted to have transmembrane signaling receptor activity. Is involved in dauer larval development. Is expressed in ASIL and ASIR.

WB:WBGene00005195	srg-38
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005196	srg-39
Is predicted to have transmembrane signaling receptor activity. Is expressed in ASIL; ASIR; PVT; intestine; and pharynx.

WB:WBGene00005197	srg-40
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005198	srg-41
Is predicted to have transmembrane signaling receptor activity. Is expressed in nervous system and tail neurons.

WB:WBGene00005199	srg-42
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005200	srg-43
No description available

WB:WBGene00005201	srg-44
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005202	srg-45
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005203	srg-46
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005204	srg-47
Is predicted to have transmembrane signaling receptor activity. Localizes to cilium. Is expressed in ASIL and ASIR.

WB:WBGene00005205	srg-48
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005206	srg-49
Is affected by wdr-23; daf-16; and smn-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00005207	srg-50
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005208	srg-51
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005210	srg-53
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005211	srg-54
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005212	srg-55
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005213	srg-56
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005214	srg-57
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005215	srg-58
Is predicted to have transmembrane signaling receptor activity. Is expressed in AIML; AIMR; ASIL; and ASIR.

WB:WBGene00005216	srg-59
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005217	srg-60
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005218	srg-61
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005219	srg-62
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005220	srg-63
Is affected by dafa#1 based on microarray studies.

WB:WBGene00005221	srg-64
Is predicted to have transmembrane signaling receptor activity. Is expressed in head neurons.

WB:WBGene00005222	srg-65
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005223	srg-66
Is predicted to have transmembrane signaling receptor activity. Is expressed in ASIL and ASIR.

WB:WBGene00005224	srg-67
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005225	srg-68
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005226	srg-69
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005227	srh-1
Is affected by several genes including pgl-1; aak-2; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by glycine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005228	srh-2
Is expressed in several structures, including Eala; Ealp; Eara; Earp; and intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005229	srh-3
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005230	srh-4
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005231	srh-5
Is expressed in ADLL; ADLR; ASHL; and ASHR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005232	srh-6
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00005233	srh-7
Is expressed in head neurons; intestine; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005234	srh-8
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including skn-1; eat-2; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005235	srh-9
Is enriched in germ line based on RNA-seq studies. Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00005236	srh-10
Is expressed in ASHL; ASHR; ASJL; and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005237	srh-11
Is expressed in several structures, including PQR; PVT; head muscle; lateral ganglion; and ray. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005238	srh-12
No description available

WB:WBGene00005239	srh-13
No description available

WB:WBGene00005240	srh-15
Is expressed in ASHL; ASHR; PHAL; and PHAR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005241	srh-16
Is affected by several genes including let-60; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including tryptophan; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005242	srh-17
Is affected by several genes including mab-5; csr-1; and hpl-2 based on RNA-seq and microarray studies. Is affected by glycine and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005243	srh-18
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005244	srh-19
Is affected by several genes including pgl-1; csr-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005245	srh-20
Is enriched in neurons based on microarray studies. Is affected by several genes including lin-4; lin-14; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including resveratrol; Acrylamide; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005246	srh-21
Is affected by several genes including elt-2; dpy-21; and unc-70 based on RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; resveratrol; and Microcystin-LR based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005247	srh-22
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including lin-4; lin-14; and clk-1 based on tiling array and microarray studies. Is affected by four chemicals including Tunicamycin; resveratrol; and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005248	srh-23
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies. Is affected by resveratrol; Atrazine; and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005249	srh-25
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005250	srh-27
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; aak-2; and mex-1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005251	srh-28
Is expressed in ASHL; ASHR; ASJL; and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005252	srh-29
Is affected by resveratrol based on microarray studies.

WB:WBGene00005253	srh-30
Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; cadmium; and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005254	srh-31
Is enriched in NSM based on tiling array studies. Is affected by several genes including pgl-1; bar-1; and alg-1 based on RNA-seq and microarray studies. Is affected by dafa#1 and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005255	srh-32
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including let-60; hpl-2; and ain-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol; Acrylamide; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005256	srh-33
Is affected by several genes including mex-3; let-418; and mir-34 based on RNA-seq and microarray studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005257	srh-34
Is affected by several genes including clk-1; mex-3; and ain-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; tryptophan; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005258	srh-35
Is enriched in intestine based on microarray studies. Is affected by several genes including clk-1; hpl-2; and mut-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005259	srh-36
Is affected by several genes including eri-1; mir-34; and rpn-10 based on RNA-seq and microarray studies. Is affected by fluoranthene; allantoin; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005260	srh-37
Is affected by lin-35 and mir-34 based on microarray studies. Is affected by resveratrol; cadmium; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005261	srh-38
Is affected by several genes including eat-2; sir-2.1; and mex-1 based on microarray and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005262	srh-39
Is enriched in intestine based on RNA-seq studies. Is affected by rsr-2 and spc-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005263	srh-40
Is affected by several genes including daf-12; sir-2.1; and cyc-1 based on microarray and tiling array studies. Is affected by Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005264	srh-41
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005265	srh-42
Is affected by mir-34 and drh-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005266	srh-43
No description available

WB:WBGene00005267	srh-44
Is affected by several genes including clk-1; fbf-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005268	srh-45
Is affected by several genes including daf-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005269	srh-46
Is enriched in GABAergic neurons; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; Sodium Chloride; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005270	srh-47
Is affected by rsr-2 and daf-12 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005271	srh-48
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and tert-Butylhydroperoxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005272	srh-49
Is affected by several genes including clk-1; sir-2.1; and drh-3 based on microarray and RNA-seq studies. Is affected by six chemicals including resveratrol; cadmium; and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005273	srh-50
Is affected by ain-1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005274	srh-51
Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005275	srh-52
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005276	srh-53
No description available

WB:WBGene00005277	srh-54
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00005278	srh-55
Is affected by several genes including daf-12; eat-2; and spn-4 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005279	srh-56
Is affected by several genes including eat-2; pmk-1; and tdp-1 based on tiling array and microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005280	srh-57
Is enriched in neurons based on microarray studies. Is affected by rsr-2 based on tiling array studies. Is affected by Tunicamycin and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005281	srh-59
Is affected by several genes including sir-2.1; spn-4; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005282	srh-60
Is affected by several genes including clk-1; pmk-1; and drh-3 based on microarray and RNA-seq studies. Is affected by Atrazine; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005283	srh-61
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Sirolimus and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005284	srh-62
Is expressed in OLL and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005285	srh-63
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005286	srh-65
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00005287	srh-66
Is affected by tatn-1 and clk-1 based on RNA-seq and microarray studies.

WB:WBGene00005288	srh-67
Is affected by dpy-21; ain-1; and ain-2 based on RNA-seq and microarray studies. Is affected by resveratrol; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005289	srh-68
Is expressed in ADLL; ADLR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005290	srh-69
Is enriched in DA neuron; VA neuron; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by four chemicals including aldicarb; Tunicamycin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005291	srh-70
Is enriched in intestine; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005292	srh-71
Is expressed in chemosensory neurons; pharynx; and ray. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005293	srh-72
Is affected by several genes including clk-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005294	srh-73
Is affected by rsr-2; lin-14; and lin-4 based on tiling array and microarray studies. Is affected by resveratrol; cadmium; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005295	srh-74
Is expressed in AWA and chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005296	srh-75
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including sir-2.1; hpl-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and Microcystin-LR based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005297	srh-76
Is expressed in head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005298	srh-77
Is affected by mex-3 and sir-2.1 based on RNA-seq and microarray studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00005299	srh-78
Is affected by several genes including let-60; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005300	srh-79
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005301	srh-80
Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005302	srh-81
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol; Colistin; and nitroguanidine based on microarray studies.

WB:WBGene00005303	srh-82
Is affected by rsr-2; spn-4; and tdp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by tetrabromobisphenol A and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005304	srh-83
Is affected by rsr-2 and hmg-3 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005305	srh-84
Is affected by sir-2.1 and let-60 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00005306	srh-85
Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005307	srh-86
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies.

WB:WBGene00005308	srh-87
Is affected by several genes including clk-1; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including resveratrol; Atrazine; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005309	srh-88
Is affected by several genes including eat-2; rrf-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including dibromoacetic acid; tetrabromobisphenol A; and Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005310	srh-89
Is affected by rsr-2; drh-3; and eat-2 based on tiling array and RNA-seq studies. Is affected by Atrazine; dafa#1; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005311	srh-90
Is affected by clk-1; daf-2; and eat-2 based on microarray studies. Is affected by dibromoacetic acid and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005312	srh-91
No description available

WB:WBGene00005313	srh-92
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005314	srh-93
Is affected by clk-1 based on microarray studies.

WB:WBGene00005315	srh-95
Is enriched in germ line based on RNA-seq studies. Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005316	srh-97
Is affected by several genes including pgl-1; rrf-1; and glh-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005317	srh-98
Is enriched in muscle cell based on microarray studies. Is affected by several genes including clk-1; elt-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; cadmium; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005318	srh-99
Is affected by several genes including eat-2; alg-1; and mex-1 based on RNA-seq studies. Is affected by nine chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005319	srh-100
Is expressed in ASIL; ASIR; ASJL; ASJR; and ventral ganglion. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005320	srh-101
Is affected by clk-1 and sir-2.1 based on microarray studies.

WB:WBGene00005321	srh-102
Is affected by hpl-2; rsr-2; and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005322	srh-103
Is affected by tdp-1 based on microarray studies.

WB:WBGene00005323	srh-104
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005324	T27A1.1
Is enriched in several structures, including PLM; Z4.a; carbon dioxide sensory neurons; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including aak-2; mex-3; and prg-1 based on RNA-seq and tiling array studies. Is affected by four chemicals including cadmium; Chlorpyrifos; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005325	srh-106
No description available

WB:WBGene00005326	srh-107
Is affected by chd-3; let-418; and eat-2 based on RNA-seq and microarray studies. Is affected by dibromoacetic acid based on microarray studies.

WB:WBGene00005327	srh-108
Is enriched in neurons based on microarray studies. Is affected by Sirolimus and allantoin based on microarray studies.

WB:WBGene00005328	srh-109
Is affected by rsr-2 and eat-2 based on tiling array and RNA-seq studies. Is affected by four chemicals including tetrabromobisphenol A; Microcystin-LR; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005329	srh-110
Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00005330	srh-111
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; Psoralens; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005331	srh-112
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005332	srh-113
Is affected by several genes including sir-2.1; ain-1; and adr-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005333	srh-114
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00005334	srh-115
Is affected by several genes including eat-2; sir-2.1; and ain-2 based on microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005335	srh-116
Is affected by several genes including clk-1; eat-2; and eri-1 based on microarray; tiling array; and RNA-seq studies. Is affected by aldicarb and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005336	srh-117
Is affected by several genes including clk-1; sir-2.1; and mut-2 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00005337	srh-118
Is affected by several genes including clk-1; dpy-21; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005338	srh-119
Is affected by several genes including let-60; pgl-1; and eri-1 based on microarray; tiling array; and RNA-seq studies. Is affected by hydrogen sulfide and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005339	srh-120
Is affected by rsr-2; klf-1; and mut-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005340	srh-122
Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005341	srh-123
Is enriched in muscle cell based on microarray studies. Is affected by several genes including sir-2.1; alg-1; and ain-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005342	srh-125
Is affected by several genes including eat-2; mex-3; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005343	srh-126
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00005344	srh-127
Is expressed in pharyngeal neurons and sensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005345	srh-128
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; dpy-21; and drh-3 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005346	srh-129
Is enriched in RID and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including Sodium Chloride; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005347	srh-130
Is expressed in head neurons; sensory neurons; and vulval cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005348	srh-131
Is affected by cyc-1; daf-2; and eat-2 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005349	srh-132
Is expressed in ADLL; ADLR; and head mesodermal cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005350	srh-133
Is affected by several genes including pgl-1; glh-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005351	srh-134
Is affected by several genes including clk-1; eri-1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005352	srh-135
Is affected by rsr-2; hmg-3; and adr-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005353	srh-136
Is affected by several genes including eat-2; prg-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005354	srh-137
Is affected by rsr-2 and mut-2 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005355	srh-138
Is enriched in NSM based on tiling array studies. Is affected by several genes including jmjd-3.1; jmjd-1.2; and rsr-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005356	srh-139
Is expressed in ADLL; ADLR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005357	srh-140
Is affected by age-1; mir-34; and sir-2.1 based on microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005358	srh-141
Is affected by several genes including sir-2.1; sin-3; and rsr-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005359	srh-142
Is expressed in chemosensory neurons and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005360	srh-144
Is affected by clk-1; adr-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00005361	srh-145
Is affected by rsr-2; drh-3; and daf-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005362	srh-146
Is affected by several genes including clk-1; alg-1; and dpy-21 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005363	srh-147
Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005364	srh-148
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005365	srh-149
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005366	srh-150
Is enriched in neurons based on microarray studies. Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005367	srh-151
Is affected by resveratrol based on microarray studies.

WB:WBGene00005368	srh-152
No description available

WB:WBGene00005369	srh-153
Is affected by sir-2.1 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00005370	srh-154
Is enriched in muscle cell and neurons based on microarray studies. Is affected by several genes including sir-2.1; ain-1; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005371	srh-155
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005372	srh-156
Is affected by sir-2.1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005373	srh-157
Is affected by cyc-1; clk-1; and rrf-1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005374	srh-158
Is affected by daf-16 and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00005375	srh-159
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005376	srh-160
Is affected by several genes including daf-2; let-60; and sir-2.1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005377	srh-161
No description available

WB:WBGene00005378	srh-162
Is affected by clk-1 based on microarray studies.

WB:WBGene00005379	srh-163
Is affected by several genes including skn-1; clk-1; and alg-1 based on microarray and RNA-seq studies. Is affected by Rifampin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00005380	srh-164
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00005381	srh-165
Is affected by several genes including eat-2; mut-2; and mir-34 based on tiling array and microarray studies. Is affected by allantoin and Sirolimus based on microarray studies.

WB:WBGene00005382	srh-166
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including alg-1; hpl-2; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005383	srh-167
Is affected by mir-34 and sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005384	srh-168
Is affected by sir-2.1 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00005385	srh-169
Is affected by mir-34 and eat-2 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005386	srh-170
Is affected by several genes including clk-1; eat-2; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005387	srh-171
Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005388	srh-172
Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005389	srh-173
Is enriched in muscle cell based on microarray studies. Is affected by rsr-2 and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including tryptophan; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005390	srh-174
Is affected by rsr-2; clk-1; and ifg-1 based on tiling array and microarray studies. Is affected by Atrazine and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005391	srh-175
Is enriched in muscle cell and neurons based on microarray studies. Is affected by sir-2.1 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00005392	srh-177
Is enriched in DA neuron; I5 neuron; SAB; VA neuron; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-16; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005393	srh-178
Is affected by dpy-21 and rrf-3 based on RNA-seq and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005394	srh-179
Is affected by several genes including age-1; let-60; and daf-12 based on microarray and RNA-seq studies. Is affected by resveratrol and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005395	srh-180
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005396	srh-181
Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005397	srh-182
Is expressed in neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005398	srh-183
Is affected by several genes including drh-3; cyc-1; and ifg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005399	srh-184
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including age-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005400	srh-185
Is affected by several genes including sir-2.1; pgl-1; and nhr-25 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005401	srh-186
Is affected by several genes including clk-1; eat-2; and lin-15B based on microarray and tiling array studies. Is affected by Atrazine and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005402	srh-187
Is enriched in AFD based on RNA-seq studies. Is affected by daf-12; rsr-2; and rrf-1 based on tiling array and microarray studies. Is affected by resveratrol; Acrylamide; and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005403	srh-189
Is affected by several genes including daf-16; daf-12; and lin-4 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00005404	srh-190
Is affected by daf-12; clk-1; and ain-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Serpentine type 7TM GPCR chemoreceptor Srh; and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005405	srh-192
Is affected by several genes including daf-2; clk-1; and mex-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005406	srh-193
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005407	srh-194
Is affected by ain-1 based on microarray studies. Is affected by Diazinon and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005408	srh-195
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005409	srh-198
Is affected by eat-2 and adr-2 based on RNA-seq studies. Is affected by Psoralens and allantoin based on RNA-seq studies.

WB:WBGene00005410	srh-199
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005411	srh-200
Is affected by several genes including daf-2; alg-1; and mex-1 based on microarray and RNA-seq studies. Is affected by four chemicals including fluoranthene; dafa#1; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005412	srh-201
Is expressed in amphid neurons; pharynx; and tail neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005413	srh-202
Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005414	srh-203
Is affected by clk-1 and eat-2 based on microarray studies. Is affected by dafa#1 and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Serpentine type 7TM GPCR chemoreceptor Srh; and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005415	srh-204
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005416	srh-206
Is affected by several genes including pgl-1; aak-2; and alg-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and dafa#1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005417	srh-207
Is affected by several genes including clk-1; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005418	srh-208
Is affected by several genes including mex-1; hpl-2; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005419	srh-209
Is affected by mir-34; sir-2.1; and let-60 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005420	srh-210
Is expressed in several structures, including ASH; head mesodermal cell; pharyngeal-intestinal valve; retrovesicular ganglion; and vulva.

WB:WBGene00005421	srh-211
Is expressed in PHA and amphid neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005422	srh-212
Is enriched in GABAergic neurons; excretory cell; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005423	srh-213
Is enriched in FLP and NSM based on microarray and tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005424	srh-214
Is affected by several genes including sir-2.1; unc-70; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by tetrabromobisphenol A; Microcystin-LR; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005425	srh-215
Is enriched in NSM and muscle cell based on tiling array and microarray studies. Is affected by several genes including clk-1; dpy-21; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by fluoranthene and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005426	srh-216
Is affected by several genes including clk-1; elt-2; and drh-3 based on microarray and RNA-seq studies. Is affected by copper sulfate and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005427	srh-217
Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005428	srh-218
Is expressed in chemosensory neurons and head. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005429	srh-219
Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005430	srh-220
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005431	srh-221
Is affected by dpy-21 based on RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00005432	srh-222
Is affected by rsr-2 and mut-2 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005433	srh-223
Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005434	srh-224
Is affected by sir-2.1 based on microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00005435	srh-227
Is affected by rsr-2 and pptr-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005436	srh-228
Is affected by csr-1; mir-34; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005437	srh-229
Is affected by several genes including clk-1; eat-2; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Alovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005438	srh-230
Is affected by several genes including daf-12; dpy-21; and hpl-2 based on RNA-seq studies.

WB:WBGene00005439	srh-231
Is affected by rsr-2 and prg-1 based on tiling array studies. Is affected by tetrabromobisphenol A and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005440	srh-233
Is affected by several genes including eat-2; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005441	srh-234
Is predicted to have G protein-coupled receptor activity. Localizes to cilium. Is expressed in ADLL and ADLR.

WB:WBGene00005442	srh-235
Is affected by mir-34 and tdp-1 based on microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005443	srh-236
Is affected by rsr-2 based on tiling array studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005444	srh-237
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including diallyl trisulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005445	srh-238
Is affected by adr-1; sir-2.1; and tdp-1 based on RNA-seq and microarray studies. Is affected by dafa#1 and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005446	srh-239
Is affected by several genes including clk-1; sir-2.1; and nhr-25 based on microarray; tiling array; and RNA-seq studies. Is affected by Colistin and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005447	srh-240
Is affected by several genes including elt-2; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005448	srh-241
Is expressed in ASIL; ASIR; ASKL; ASKR; and intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005449	srh-243
Is affected by cyc-1 based on microarray studies. Is affected by Atrazine and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005450	srh-244
Is affected by several genes including daf-12; clk-1; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including resveratrol; cadmium; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005451	srh-245
Is affected by several genes including rrf-3; eri-1; and mut-2 based on microarray and RNA-seq studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005452	srh-246
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005453	srh-247
Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005454	srh-248
Is affected by several genes including sir-2.1; set-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005455	srh-249
Is affected by clk-1 based on microarray studies.

WB:WBGene00005456	srh-250
Is affected by several genes including clk-1; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005457	srh-251
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by Testosterone and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005458	srh-252
Is affected by several genes including eat-2; mir-34; and adr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005459	srh-253
Is affected by sir-2.1 based on microarray studies. Is affected by Chlorpyrifos and nitroguanidine based on microarray studies.

WB:WBGene00005460	srh-254
Is affected by sir-2.1 and let-60 based on microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005461	srh-255
Is affected by several genes including clk-1; hpl-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by 2 and 4-dinitroanisole based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005462	srh-256
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00005463	srh-257
Is affected by sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005464	srh-258
Is affected by clk-1; sir-2.1; and acs-3 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005465	srh-259
No description available

WB:WBGene00005466	srh-260
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00005467	srh-261
Is affected by several genes including clk-1; eat-2; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by allantoin based on microarray studies.

WB:WBGene00005468	srh-262
Is affected by several genes including clk-1; sir-2.1; and let-418 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005469	srh-263
Is affected by daf-2 based on microarray studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00005470	srh-264
Is affected by several genes including clk-1; unc-75; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005471	srh-265
Is affected by clk-1; sir-2.1; and ahr-1 based on microarray studies. Is affected by four chemicals including Acrylamide; Atrazine; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005472	srh-266
Is expressed in ADLL; ADLR; and seam cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005473	srh-267
No description available

WB:WBGene00005474	srh-268
Is affected by several genes including sir-2.1; ins-11; and pmt-2 based on RNA-seq and microarray studies. Is affected by Cry5B; Sirolimus; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005475	srh-269
Is expressed in chemosensory neurons; coelomocyte; and pharyngeal cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005476	srh-270
Is expressed in amphid sensillum; chemosensory neurons; head ganglion; ray; and vulva. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005477	srh-271
Is enriched in neurons based on microarray studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005478	srh-272
Is affected by several genes including dpy-21; unc-70; and drh-3 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005479	srh-274
Is affected by several genes including sir-2.1; mex-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005480	srh-275
Is affected by several genes including let-60; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including resveratrol; fluoranthene; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005481	srh-276
Is enriched in ALM and PLM based on microarray studies. Is affected by drh-3 and let-60 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005482	srh-277
Is expressed in AINL; AINR; PVQL; PVQR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005483	srh-278
Is enriched in NSM based on tiling array studies. Is affected by several genes including lin-4; lin-14; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005484	srh-279
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005485	srh-280
Is affected by sir-2.1 and let-60 based on microarray studies.

WB:WBGene00005486	srh-281
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005487	srh-282
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005488	srh-283
Is affected by several genes including mir-34; ubc-9; and his-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin; antimycin; and adsorbable organic bromine compound based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005489	srh-284
Is affected by cyc-1; hpl-2; and mir-34 based on microarray and tiling array studies. Is affected by nanoparticle based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005490	srh-286
Is affected by several genes including pgl-1; glh-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Serpentine type 7TM GPCR chemoreceptor Srh; and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005491	srh-287
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005492	srh-288
Is enriched in NSM based on tiling array studies. Is affected by hpl-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005493	srh-289
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005494	srh-290
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005495	srh-291
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005496	srh-292
Is affected by hpl-2; rsr-2; and mir-34 based on tiling array and microarray studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005497	srh-293
Is affected by eat-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005498	srh-294
Is affected by eat-2 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00005499	srh-295
Is enriched in muscle cell based on microarray studies. Is affected by mir-34; sir-2.1; and eri-1 based on microarray studies. Is affected by dibromoacetic acid; tetrabromobisphenol A; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005500	srh-296
Is enriched in NSM and amphid sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and copper sulfate based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005501	srh-297
Is affected by mir-35 and gei-8 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005502	srh-298
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including age-1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by cadmium and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005503	srh-299
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005504	srh-300
Is enriched in AVE and AVK based on tiling array and RNA-seq studies. Is affected by csr-1; clk-1; and let-60 based on RNA-seq and microarray studies. Is affected by four chemicals including Atrazine; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005505	srh-301
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is affected by Atrazine and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005506	srh-302
Is affected by cyc-1 based on microarray studies.

WB:WBGene00005507	srh-303
Is affected by several genes including mex-3; mex-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005508	srh-304
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005509	srh-305
Is affected by clk-1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005510	srh-306
No description available

WB:WBGene00005511	srh-307
Is enriched in muscle cell based on microarray studies. Is affected by several genes including eat-2; pgl-1; and eri-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00005512	srh-105
Is affected by several genes including daf-16; rrf-3; and sir-2.1 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005513	sri-1
Is expressed in OLL and interneuron. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005514	sri-2
Is enriched in neurons based on microarray studies. Is affected by several genes including sir-2.1; ain-1; and ain-2 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005515	sri-3
No description available

WB:WBGene00005516	sri-4
Is affected by several genes including clk-1; pmk-1; and tatn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005517	sri-5
Is expressed in chemosensory neurons; egg-laying apparatus; pharynx; and ventral nerve cord. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005518	sri-6
Is affected by mir-34 and eat-2 based on microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005519	sri-7
Is affected by several genes including eat-2; pgl-1; and eri-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005520	sri-8
Is enriched in germ line based on RNA-seq studies. Is affected by tatn-1 and hpl-2 based on RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00005521	sri-9
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005522	sri-10
Is enriched in germ line based on RNA-seq studies. Is affected by rsr-2; drh-3; and spn-4 based on tiling array and RNA-seq studies. Is affected by tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005523	sri-11
Is enriched in body wall musculature and muscle cell based on microarray studies. Is affected by several genes including daf-16; elt-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including tryptophan; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005524	sri-12
Is expressed in ganglia. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005525	sri-13
Is affected by rsr-2 and daf-2 based on tiling array and microarray studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005526	sri-14
Is involved in detection of chemical stimulus involved in sensory perception. Is expressed in ASHL; ASHR; AWCL; and AWCR.

WB:WBGene00005527	sri-15
Is affected by ifg-1; sir-2.1; and let-60 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005528	sri-16
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Zidovudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005529	sri-17
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on RNA-seq studies. Is affected by Rifampin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005530	sri-18
Is expressed in BDU; I1 neuron; and chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005531	sri-19
Is expressed in body wall musculature; head neurons; and vulval muscle. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005532	sri-20
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including eat-2; ain-1; and spn-4 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005533	sri-21
Is expressed in RMD and chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005534	sri-22
Is affected by ham-3 and daf-2 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00005535	sri-23
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00005536	sri-24
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005537	sri-25
Is affected by several genes including prg-1; unc-75; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005538	sri-26
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005539	sri-27
Is expressed in intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005540	sri-28
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005541	sri-29
Is affected by several genes including daf-2; daf-12; and dpy-21 based on tiling array and RNA-seq studies. Is affected by tryptophan; resveratrol; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005542	sri-30
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-12; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; resveratrol; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005543	sri-31
Is affected by several genes including let-60; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005544	sri-32
Is affected by thoc-5 and ain-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005545	sri-33
Is affected by several genes including clk-1; rrf-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005546	sri-34
Is affected by several genes including rrf-1; alg-1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005547	sri-35
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00005548	sri-36
Is expressed in PVT; head ganglion; pharyngeal-intestinal valve; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005549	sri-37
Is affected by several genes including daf-2; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005550	sri-38
Is affected by several genes including eat-2; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005551	sri-39
Is expressed in neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005552	sri-40
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Lithium Chloride; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005553	sri-41
Is enriched in neurons based on microarray studies. Is affected by mut-2 and eat-2 based on microarray studies.

WB:WBGene00005554	sri-42
Is affected by hpl-2 and mir-34 based on tiling array and microarray studies. Is affected by aldicarb; Diazinon; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005555	sri-43
Is affected by several genes including age-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; metformin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005556	sri-44
Is affected by adr-1 and eat-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00005557	sri-45
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005558	sri-46
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including rrf-1; mut-2; and smg-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005559	sri-47
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; drh-3; and adr-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005560	sri-48
Is affected by several genes including sir-2.1; drh-3; and rrf-2 based on RNA-seq and microarray studies. Is affected by resveratrol; Colistin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005561	sri-49
Is affected by ifg-1; adr-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00005562	sri-50
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005563	sri-51
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005564	sri-52
Is affected by cyc-1 and eat-2 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00005565	sri-53
Is affected by hpl-2 and sir-2.1 based on tiling array and microarray studies. Is affected by resveratrol; Chlorpyrifos; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005566	sri-54
Is enriched in NSM and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and eri-1 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005567	sri-55
Is affected by several genes including isp-1; cyc-1; and rpn-10 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00005568	sri-56
Is affected by clk-1 and sir-2.1 based on microarray studies.

WB:WBGene00005569	sri-57
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including indole; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005570	sri-58
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00005571	sri-59
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00005572	sri-60
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005573	sri-61
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005574	sri-62
Is expressed in ADLL; ADLR; and intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005575	sri-63
Is affected by several genes including daf-16; ain-1; and drh-3 based on RNA-seq and microarray studies. Is affected by cadmium and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005576	sri-64
Is affected by hmg-3 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00005577	sri-65
Is affected by several genes including lin-4; lin-14; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by aldicarb; tetrabromobisphenol A; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005578	sri-66
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005579	sri-67
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005580	sri-68
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00005581	sri-69
Is affected by several genes including lin-35; lin-15B; and drh-3 based on microarray and RNA-seq studies. Is affected by resveratrol and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005582	sri-70
Is enriched in neurons based on microarray studies. Is affected by several genes including hsf-1; clk-1; and elt-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005583	sri-71
Is affected by several genes including pgl-1; rrf-1; and glh-1 based on microarray and RNA-seq studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005584	sri-72
Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005585	sri-73
Is affected by dpy-21; lin-14; and lin-4 based on RNA-seq and microarray studies. Is affected by Chlorpyrifos; Diazinon; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005586	sri-74
Is affected by several genes including lin-4; lin-14; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and sodium arsenite based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005587	sri-75
Is affected by alg-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00005588	sri-76
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Progesterone and Sirolimus based on microarray studies.

WB:WBGene00005589	sri-77
Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005590	sri-78
Is affected by several genes including eat-2; mex-1; and dpy-21 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00005591	srj-1
Is affected by daf-12; rsr-2; and dpy-21 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005592	srj-4
Is expressed in coelomocyte; neurons; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005593	srj-5
Is expressed in ASIL; ASIR; PVT; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005594	srj-6
Is enriched in NSM based on tiling array studies. Is affected by several genes including lin-4; lin-14; and mex-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005595	srj-7
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005596	srj-8
Is enriched in NSM based on tiling array studies. Is affected by several genes including mut-2; mir-34; and adr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005597	srj-9
Is enriched in NSM based on tiling array studies. Is affected by several genes including let-60; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005598	srj-10
Is enriched in intestine and ray based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005599	srj-11
Is affected by several genes including lin-4; lin-14; and clk-1 based on RNA-seq and microarray studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005600	srj-12
Is affected by clk-1 based on microarray studies.

WB:WBGene00005601	srj-13
Is expressed in intestine; neurons; pharynx; ventral ganglion; and vulval muscle. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005602	srj-14
Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including tryptophan; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005603	srj-15
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005604	srj-16
Is enriched in GABAergic neurons based on tiling array studies. Is affected by rsr-2; clk-1; and tdp-1 based on tiling array and microarray studies. Is affected by four chemicals including dibromoacetic acid; tetrabromobisphenol A; and Microcystin-LR based on microarray studies.

WB:WBGene00005605	srj-17
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by estrogen and resveratrol based on microarray studies.

WB:WBGene00005606	srj-18
Is affected by rsr-2; thoc-5; and mex-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005607	srj-19
Is affected by several genes including unc-75; hpl-2; and his-72 based on tiling array and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005608	srj-20
Is expressed in ASIL; ASIR; PVT; neurons; and seam cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005609	srj-21
Is expressed in CP neuron and odorsensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005610	srj-22
Is expressed in CP neuron and odorsensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005611	srj-23
Is expressed in ASIL; ASIR; and intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005612	srj-24
Is expressed in ASIL; ASIR; BAGL; and BAGR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005613	srj-25
Is expressed in ASIL; ASIR; and ventral ganglion. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005614	srj-26
Is affected by several genes including rrf-3; dpy-21; and drh-3 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Triclosan based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005615	srj-27
Is expressed in PVT; head neurons; and ray. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005616	srj-29
Is affected by several genes including npr-1; hpl-2; and kri-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; stavudine; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005617	srj-32
Is affected by several genes including daf-16; daf-12; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005618	srj-33
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by fluoranthene; Chlorpyrifos; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005619	srj-34
Is affected by clk-1 and eat-2 based on microarray and RNA-seq studies. Is affected by metformin; Sirolimus; and tetrabromobisphenol A based on RNA-seq and microarray studies.

WB:WBGene00005620	srj-35
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00005621	srj-37
Is enriched in muscle cell based on microarray studies. Is affected by several genes including sir-2.1; ain-1; and ain-2 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005622	srj-38
Is expressed in neurons; pharynx; somatic nervous system; and in male. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005623	srj-39
Is affected by several genes including clk-1; sir-2.1; and rrf-1 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005624	srj-40
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005625	srj-42
Is affected by several genes including clk-1; eat-2; and cyc-1 based on microarray and tiling array studies. Is affected by dafa#1 and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005626	srj-44
Is expressed in head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005627	srj-45
Is expressed in AVM; amphid neurons; head neurons; and seam cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005628	srj-49
Is affected by prg-1; eat-2; and mex-3 based on tiling array and RNA-seq studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005629	srj-50
Is affected by several genes including daf-2; sir-2.1; and hpl-2 based on microarray and tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005630	srj-51
Is affected by adr-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00005631	srj-52
Is affected by clk-1 and eat-2 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005632	srj-53
Is affected by cyc-1; clk-1; and mex-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005633	srj-54
Is expressed in AIML; AIMR; and in male. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005634	srj-55
Is affected by several genes including mex-1; hpl-2; and ints-5 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005635	srj-57
Is affected by several genes including clk-1; sir-2.1; and smn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srj and 7TM GPCR, serpentine receptor class j (Srj).

WB:WBGene00005636	srl-1
No description available

WB:WBGene00005637	srl-2
No description available

WB:WBGene00005638	srm-1
Is expressed in ganglia and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00005639	srm-2
Is expressed in neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00005640	srn-1
Is expressed in amphid neurons and head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00005641	sro-1
Is predicted to have G protein-coupled photoreceptor activity. Is expressed in SIADL; SIADR; SIAVL; and SIAVR. Human ortholog(s) of this gene are implicated in eye disease (multiple).

WB:WBGene00005642	srp-1
Is predicted to have serine-type endopeptidase inhibitor activity. Localizes to endoplasmic reticulum. Human ortholog(s) of this gene are implicated in several diseases, including alpha 1-antitrypsin deficiency; alpha-2-plasmin inhibitor deficiency; and osteogenesis imperfecta (multiple). Is an ortholog of human SERPINI1 (serpin family I member 1).

WB:WBGene00005643	srp-2
Exhibits cysteine-type endopeptidase inhibitor activity and serine-type endopeptidase inhibitor activity. Is involved in negative regulation of cysteine-type endopeptidase activity. Is expressed in several structures, including anal sphincter muscle; cuticle; epithelial cell; intestine; and phasmid neurons. Is used to study familial encephalopathy with neuroserpin inclusion bodies. Human ortholog(s) of this gene are implicated in several diseases, including alpha 1-antitrypsin deficiency; alpha-2-plasmin inhibitor deficiency; and osteogenesis imperfecta (multiple). Is an ortholog of human SERPINI1 (serpin family I member 1).

WB:WBGene00005644	srp-3
Is predicted to have serine-type endopeptidase inhibitor activity. Is expressed in body wall musculature; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including alpha 1-antitrypsin deficiency; alpha-2-plasmin inhibitor deficiency; and osteogenesis imperfecta (multiple). Is an ortholog of human SERPINI1 (serpin family I member 1).

WB:WBGene00005646	srp-5
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by Hydrolyzable Tannins; Humic Substances; and Sirolimus based on microarray studies.

WB:WBGene00005647	srp-6
Is predicted to have serine-type endopeptidase inhibitor activity. Is expressed in hermaphrodite gonad; intestine; pharyngeal-intestinal valve; socket cell; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including alpha 1-antitrypsin deficiency; alpha-2-plasmin inhibitor deficiency; and osteogenesis imperfecta (multiple). Is an ortholog of human SERPINB10 (serpin family B member 10) and SERPINB11 (serpin family B member 11).

WB:WBGene00005648	srp-7
Is predicted to have serine-type endopeptidase inhibitor activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in several diseases, including alpha 1-antitrypsin deficiency; alpha-2-plasmin inhibitor deficiency; and osteogenesis imperfecta (multiple). Is an ortholog of human SERPINB11 (serpin family B member 11).

WB:WBGene00005649	srp-8
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including alpha 1-antitrypsin deficiency; alpha-2-plasmin inhibitor deficiency; and osteogenesis imperfecta (multiple). Is an ortholog of human SERPINI1 (serpin family I member 1).

WB:WBGene00005650	srp-9
Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including aldicarb; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00005651	srp-10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including aldicarb; methylmercuric chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00005652	srr-1
Is expressed in neuronal sheath cell; pharynx; and ray. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005653	srr-2
Is expressed in isthmus and terminal bulb. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005654	srr-3
Is expressed in several structures, including RMD; anal depressor muscle; head mesodermal cell; pharyngeal-intestinal valve; and phasmid neurons. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005655	srr-4
Is involved in determination of adult lifespan. Is expressed in head neurons; hypodermis; pharynx; phasmid neurons; and vulva.

WB:WBGene00005656	srr-5
Is enriched in AFD based on RNA-seq studies. Is affected by lin-15B; elt-2; and rrf-1 based on microarray and RNA-seq studies. Is affected by tryptophan and cadmium based on microarray studies.

WB:WBGene00005657	srr-6
Is expressed in retrovesicular ganglion. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005658	srr-7
Is expressed in PVT and lateral ganglion. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005659	srr-8
Is expressed in ASIL; ASIR; PVT; excretory cell; and head neurons. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005660	srr-9
Is expressed in ASIL; ASIR; and neurons. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005661	srr-10
Is expressed in ganglia; head neurons; and rectal gland cell. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF267 and Protein of unknown function DUF267, Caenorhabditis species.

WB:WBGene00005662	sars-2
Is predicted to have serine-tRNA ligase activity and tRNA binding activity. Is an ortholog of human SARS2 (seryl-tRNA synthetase 2, mitochondrial).

WB:WBGene00005663	sars-1
Is predicted to have serine-tRNA ligase activity and tRNA binding activity. Is involved in negative regulation of transcription by RNA polymerase II and translation. Is an ortholog of human SARS1 (seryl-tRNA synthetase 1).

WB:WBGene00005664	sru-1
Is expressed in ciliated neurons and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005665	sru-2
Is expressed in PHAL; PHAR; PHBL; and PHBR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005666	sru-3
Is enriched in neurons based on microarray studies. Is affected by several genes including sir-2.1; prg-1; and ain-1 based on tiling array and microarray studies. Is affected by Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005667	sru-4
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005668	sru-5
Is affected by dpy-21 and hpl-2 based on RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00005669	sru-6
Is enriched in NSM based on tiling array studies. Is affected by sir-2.1 based on microarray studies. Is affected by Diazinon; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005670	sru-7
Is enriched in AVK and RID based on RNA-seq studies. Is affected by several genes including elt-2; dpy-21; and hpl-2 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005671	sru-8
Is expressed in neurons and ventral ganglion. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005672	sru-9
Is affected by several genes including clk-1; bar-1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005673	sru-10
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00005674	sru-11
Is enriched in muscle cell based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005675	sru-12
Is expressed in OLL and chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005676	sru-13
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; alg-1; and prg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005677	sru-14
No description available

WB:WBGene00005678	sru-15
Is affected by several genes including lin-15B; dpy-21; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005679	sru-16
Is affected by clk-1; cyc-1; and mir-34 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005680	sru-17
Is expressed in neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005681	sru-18
Is affected by several genes including daf-16; drh-3; and mir-34 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005682	sru-19
Is affected by clk-1; mex-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol; cadmium; and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005683	sru-20
Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005684	sru-21
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005685	sru-22
Is affected by several genes including daf-2; glp-1; and let-60 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including tryptophan; Sodium Chloride; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005686	sru-23
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005687	sru-24
Is affected by several genes including eat-2; ain-1; and mir-34 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005688	sru-25
Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005689	sru-26
Is affected by several genes including clk-1; drh-3; and tatn-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005690	sru-27
Is expressed in neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005691	sru-28
Is enriched in neurons and retrovesicular ganglion based on microarray studies. Is affected by mir-34; rrf-1; and tbx-2 based on microarray studies. Is affected by Chlorpyrifos; Diazinon; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005692	sru-29
Is enriched in muscle cell based on microarray studies. Is affected by several genes including eat-2; lin-15B; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005693	sru-30
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005694	sru-31
Is affected by several genes including clk-1; sir-2.1; and mut-2 based on microarray and RNA-seq studies. Is affected by Atrazine and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005695	sru-32
Is affected by dpy-21 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00005696	sru-33
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00005697	sru-34
Is enriched in AVK based on RNA-seq studies. Is affected by clk-1 based on microarray studies.

WB:WBGene00005698	sru-35
Is affected by several genes including daf-12; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including sesamin; Atrazine; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005699	sru-36
Is affected by several genes including daf-16; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005700	sru-37
Is enriched in germ line based on RNA-seq studies. Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by resveratrol and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005701	sru-38
Localizes to several cellular components, including dendrite; neuronal cell body; and non-motile cilium. Is expressed in ASHL; ASHR; AWBL; and AWBR.

WB:WBGene00005702	sru-39
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; resveratrol; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005703	sru-40
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including Ethanol; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005704	sru-41
Is affected by cyc-1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005705	sru-42
Is affected by several genes including sir-2.1; drh-3; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005706	sru-43
Is affected by eat-2 and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00005707	sru-44
Is affected by several genes including let-418; cyc-1; and mir-34 based on microarray and RNA-seq studies. Is affected by tryptophan and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005708	sru-45
Is affected by rsr-2; rpn-10; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including tryptophan; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005709	sru-46
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by allantoin and nitroguanidine based on microarray studies.

WB:WBGene00005710	sru-47
Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005711	sru-48
Is expressed in PVT; amphid neurons; and intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00005712	srv-1
Is expressed in CAN; amphid neurons; and excretory duct. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005713	srv-2
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005714	srv-3
Is predicted to have transmembrane signaling receptor activity. Is expressed in ADLL and ADLR.

WB:WBGene00005715	srv-4
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005716	srv-5
Is predicted to have transmembrane signaling receptor activity. Is expressed in amphid neurons and sensory neurons.

WB:WBGene00005717	srv-6
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00005718	srv-7
Is enriched in DA neuron; VA neuron; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; lin-35; and cep-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005719	srv-8
Is expressed in ASKL; ASKR; PHCL; PHCR; and sensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005720	srv-9
Is affected by several genes including clk-1; sir-2.1; and spn-4 based on proteomic; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005721	srv-10
Is affected by drh-3 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005722	srv-11
Is expressed in ASHL and ASHR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005723	srv-12
Is expressed in ADLL; ADLR; ASJL; and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005724	srv-13
Is affected by several genes including mex-3; mex-1; and spn-4 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005725	srv-14
Is affected by several genes including aak-2; dpy-21; and drh-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005726	srv-15
Is affected by several genes including daf-2; eat-2; and csr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005727	srv-16
Is affected by several genes including age-1; isp-1; and unc-75 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005728	srv-17
Is expressed in ASIL; ASIR; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005729	srv-18
Is affected by several genes including clk-1; eat-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00005730	srv-19
Is affected by several genes including sir-2.1; eri-1; and prg-1 based on microarray and tiling array studies. Is affected by dibromoacetic acid and tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005731	srv-20
Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005732	srv-21
Is expressed in ASHL; ASHR; ASJL; ASJR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005733	srv-22
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005734	srv-23
Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005735	srv-24
Is affected by several genes including pgl-1; aak-2; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005736	srv-25
Is affected by several genes including clk-1; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005737	srv-26
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005738	srv-27
Is expressed in nerve ring neurons and sensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005739	srv-28
Is affected by several genes including dpy-21; lin-22; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005740	srv-29
Is affected by several genes including daf-16; lin-4; and lin-14 based on tiling array; RNA-seq; and microarray studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005741	srv-30
Is enriched in neurons based on tiling array studies. Is affected by clk-1 and adr-1 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005742	srv-31
Is affected by several genes including clk-1; spn-4; and drh-3 based on microarray and RNA-seq studies. Is affected by Alovudine and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005743	srv-32
Is expressed in PVQ and carbon dioxide sensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005744	ops-1
Is expressed in ADLL; ADLR; ASGL; and ASGR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005745	srv-34
Is expressed in ASKL; ASKR; AWAL; AWAR; and retrovesicular ganglion. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00005746	srv-35
Is affected by cyc-1 and rrf-1 based on microarray studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00005747	srv-36
Is enriched in OLL; PVD; cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on microarray and RNA-seq studies. Is affected by resveratrol; adsorbable organic bromine compound; and allantoin based on microarray studies.

WB:WBGene00005748	srw-1
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005749	srw-2
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005750	srw-3
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005751	srw-4
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005752	srw-5
No description available

WB:WBGene00005753	srw-6
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005754	srw-7
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005755	srw-8
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005756	srw-9
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005757	srw-10
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005758	srw-11
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005759	srw-12
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005760	srw-13
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005761	srw-14
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005762	srw-15
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005763	srw-16
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005764	srw-17
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005765	srw-18
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00005766	srw-19
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005767	srw-20
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005768	srw-21
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005769	srw-22
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005770	srw-23
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005771	srw-24
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005772	srw-25
Is affected by cox-5B; his-3; and hmg-3 based on RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00005773	srw-26
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005774	srw-27
Is affected by ain-1 and let-60 based on microarray studies.

WB:WBGene00005775	srw-28
No description available

WB:WBGene00005776	srw-29
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in neuronal sheath cell.

WB:WBGene00005777	srw-30
Is affected by several genes including cyd-1; cdk-4; and rsr-2 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00005778	srw-31
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005779	srw-32
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005780	srw-33
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005781	srw-34
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005782	srw-35
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005783	srw-36
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005784	srw-37
Is enriched in muscle cell and neurons based on microarray studies. Is affected by rsr-2 based on tiling array studies. Is affected by dibromoacetic acid; Microcystin-LR; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005785	srw-38
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005786	srw-39
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005787	srw-40
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005788	srw-41
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005789	srw-42
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005790	srw-43
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005791	srw-44
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005792	srw-45
Is affected by clk-1 based on microarray studies.

WB:WBGene00005793	srw-46
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005794	srw-47
Is affected by several genes including sir-2.1; mdt-15; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by dibromoacetic acid based on microarray studies.

WB:WBGene00005795	srw-48
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005796	srw-49
No description available

WB:WBGene00005797	srw-50
Is affected by resveratrol based on microarray studies.

WB:WBGene00005798	srw-51
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005799	srw-52
Is affected by dafa#1 and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005800	srw-53
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005801	srw-54
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005802	srw-55
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005803	srw-56
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005804	srw-57
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005805	srw-58
Is affected by several genes including sir-2.1; prg-1; and ain-1 based on tiling array and microarray studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00005806	srw-59
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005807	srw-60
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005808	srw-61
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005809	srw-62
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005810	srw-63
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005811	srw-64
Is affected by several genes including eat-2; nhr-25; and dpy-21 based on microarray and RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00005812	srw-65
Is affected by daf-16; hpl-2; and rsr-2 based on tiling array studies.

WB:WBGene00005813	srw-66
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005814	srw-67
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005815	srw-68
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005816	srw-69
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005817	srw-70
Is affected by several genes including daf-16; sir-2.1; and mdt-15 based on microarray and tiling array studies. Is affected by resveratrol; tetrabromobisphenol A; and dafa#1 based on microarray studies.

WB:WBGene00005818	srw-71
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005819	srw-72
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005820	srw-73
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005821	srw-74
No description available

WB:WBGene00005822	srw-75
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00005823	srw-76
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005824	srw-77
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005825	srw-78
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including pgl-1; dpy-21; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00005826	srw-79
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005827	srw-80
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00005828	srw-81
No description available

WB:WBGene00005829	srw-82
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005830	srw-83
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005831	srw-84
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005832	srw-85
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in neurons.

WB:WBGene00005833	srw-86
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Ethanol; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00005834	srw-87
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005835	srw-88
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005836	srw-89
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005837	srw-90
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005838	srw-91
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005839	srw-92
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00005840	srw-93
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005841	srw-94
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005842	srw-95
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005843	srw-96
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including tryptophan; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00005844	srw-97
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005845	srw-98
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005846	srw-99
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005847	srw-100
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005848	srw-101
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005849	srw-102
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005850	srw-103
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in amphid neurons; head neurons; and nervous system.

WB:WBGene00005851	srw-104
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol and dafa#1 based on microarray studies.

WB:WBGene00005852	srw-105
Is affected by cyc-1 and sir-2.1 based on microarray studies.

WB:WBGene00005853	srw-106
Is affected by several genes including clk-1; sir-2.1; and isp-1 based on microarray studies. Is affected by Ethanol; resveratrol; and Sirolimus based on microarray studies.

WB:WBGene00005854	srw-107
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005855	srw-108
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in ASKL; ASKR; and anterior hypodermis.

WB:WBGene00005856	srw-109
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005857	srw-110
No description available

WB:WBGene00005858	srw-111
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005859	srw-112
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005860	srw-113
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005861	srw-114
Is affected by several genes including lin-4; lin-14; and sir-2.1 based on microarray studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies.

WB:WBGene00005862	srw-115
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005863	srw-116
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00005864	srw-117
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005865	srw-118
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005866	srw-119
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in ASGL and ASGR.

WB:WBGene00005867	srw-120
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005868	srw-121
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005869	srw-122
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005870	srw-123
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005871	srw-124
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005872	srw-125
Is affected by allantoin based on microarray studies.

WB:WBGene00005873	srw-126
Is affected by daf-2; eat-2; and sir-2.1 based on microarray studies.

WB:WBGene00005874	srw-127
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005875	srw-128
No description available

WB:WBGene00005876	srw-129
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005877	srw-130
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005878	srw-131
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies.

WB:WBGene00005879	srw-132
Is affected by several genes including let-60; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00005880	srw-133
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005881	srw-134
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005882	srw-135
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005883	srw-136
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005884	srw-137
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005885	srw-138
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in ADLL and ADLR.

WB:WBGene00005886	srw-139
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in neurons.

WB:WBGene00005887	srw-140
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005888	srw-141
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005889	srw-142
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005890	srw-143
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005891	srw-144
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00005892	srx-1
Is expressed in head mesodermal cell; neurons; and non-striated muscle. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005893	srx-2
Is enriched in RIS based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and hsp-6 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005894	srx-3
Is expressed in motor neurons and nerve ring neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005895	srx-4
Is expressed in amphid neurons; rectal epithelial cell; and vulval cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005896	srx-5
Is affected by age-1; eat-2; and spn-4 based on microarray and RNA-seq studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00005897	srx-6
Is enriched in NSM based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and rrf-1 based on tiling array and microarray studies. Is affected by four chemicals including Chlorpyrifos; Diazinon; and tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005898	srx-7
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005899	srx-8
Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on microarray and RNA-seq studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005900	srx-9
Is affected by age-1; drh-3; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005901	srx-10
Is expressed in ASIL; ASIR; PVT; intestine; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005902	srx-11
Is enriched in RID based on RNA-seq studies. Is affected by cyc-1; hpl-2; and wdr-5.1 based on microarray and RNA-seq studies. Is affected by stavudine and Colistin based on RNA-seq and microarray studies.

WB:WBGene00005903	srx-12
Is expressed in ADFL; ADFR; and amphid sheath cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005904	srx-13
Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005905	srx-14
Is expressed in chemosensory neurons and head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005906	srx-15
Is affected by clk-1 and ints-4 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00005907	srx-16
Is affected by several genes including rrf-3; sir-2.1; and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005908	srx-17
Is expressed in ASIL; ASIR; PVT; and ventral ganglion. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005909	srx-18
Is affected by cyc-1 and clk-1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005910	srx-19
Is affected by several genes including clk-1; sir-2.1; and alg-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005911	srx-20
Is affected by rsr-2 based on tiling array studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005912	srx-21
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005913	srx-22
Is expressed in ASIL; ASIR; I2 neuron; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005914	srx-23
Is affected by age-1 and mir-34 based on microarray studies. Is affected by Chlorpyrifos; Diazinon; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005915	srx-24
Is affected by mir-34; drh-3; and ain-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005916	srx-25
Is affected by mdt-15 and nhr-25 based on microarray studies.

WB:WBGene00005917	srx-26
Is affected by rsr-2 and eat-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005918	srx-27
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by allantoin and Sirolimus based on microarray studies.

WB:WBGene00005919	srx-28
Is affected by rsr-2 and prg-1 based on tiling array studies. Is affected by Diazinon and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005920	srx-29
Is affected by drh-3 and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005921	srx-30
Is affected by cyc-1; clk-1; and eat-2 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00005922	srx-31
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by Chlorpyrifos; Diazinon; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005923	srx-32
Is enriched in NSM based on tiling array studies. Is affected by ain-1 and eat-2 based on microarray studies. Is affected by resveratrol and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005924	srx-33
Is affected by several genes including eat-2; hpl-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005925	srx-34
Is affected by several genes including eat-2; sir-2.1; and dpy-21 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005926	srx-35
Is affected by several genes including eat-2; mex-1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00005927	srx-36
Is affected by rsr-2; hpl-2; and let-60 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005928	srx-37
No description available

WB:WBGene00005929	srx-38
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including elt-2; dpy-21; and drh-3 based on microarray and RNA-seq studies. Is affected by resveratrol; Chlorpyrifos; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005930	srx-39
Is affected by rsr-2; prg-1; and sir-2.1 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005931	fbxa-199
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005932	srx-41
Is expressed in dorsal nerve cord; head muscle; head neurons; and tail neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005933	srx-42
Is affected by hpl-2 and alg-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005934	srx-43
Exhibits pheromone receptor activity. Is involved in calcium-mediated signaling; cellular response to pheromone; and locomotory exploration behavior. Localizes to non-motile cilium and perikaryon. Is expressed in ASIL and ASIR.

WB:WBGene00005935	srx-44
Is expressed in ADLL; ADLR; ASJL; and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005936	srx-45
Is predicted to have G protein-coupled receptor activity. Is expressed in linker cell.

WB:WBGene00005937	srx-46
Is affected by several genes including eat-2; sir-2.1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005938	srx-47
Is expressed in intestine; odorsensory neurons; and tail. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005939	srx-48
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005940	srx-49
Is affected by rsr-2 and spt-16 based on tiling array and RNA-seq studies. Is affected by Mercuric Chloride and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005941	srx-50
Is affected by several genes including daf-2; clk-1; and lin-22 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005942	srx-51
Is affected by several genes including clk-1; hpl-2; and drh-3 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005943	srx-52
Is affected by clk-1 and sir-2.1 based on microarray studies.

WB:WBGene00005944	srx-53
Is affected by several genes including hpl-2; cyc-1; and mir-34 based on microarray and tiling array studies. Is affected by five chemicals including resveratrol; dibromoacetic acid; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005945	srx-54
Is affected by several genes including daf-2; let-60; and ain-1 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005946	srx-55
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00005947	srx-56
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and alg-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005948	srx-57
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00005949	srx-58
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005950	srx-59
Is enriched in FLP and NSM based on microarray and tiling array studies. Is affected by several genes including eat-2; hpl-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by aldicarb; paraquat; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005951	srx-60
Is affected by mir-34 and sir-2.1 based on microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005952	srx-61
Is affected by cyc-1 and adr-1 based on microarray and RNA-seq studies.

WB:WBGene00005953	srx-62
Is affected by several genes including eat-2; mut-2; and mir-34 based on microarray and RNA-seq studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005954	srx-63
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and mir-34 based on tiling array and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005955	srx-64
Is enriched in neurons based on microarray studies. Is affected by clk-1; mir-34; and drh-3 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005956	srx-65
Is enriched in NSM based on tiling array studies. Is affected by rsr-2; lin-14; and lin-4 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005957	srx-66
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005958	srx-67
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; drh-3; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Chlorpyrifos; Diazinon; and tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005959	srx-68
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005960	srx-69
Is affected by rrf-1 based on microarray studies. Is affected by single-walled carbon nanotube based on microarray studies.

WB:WBGene00005961	srx-70
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00005962	srx-71
Is affected by clk-1 based on microarray studies. Is affected by resveratrol and allantoin based on microarray studies.

WB:WBGene00005963	srx-72
Is affected by clk-1 and adr-1 based on microarray and RNA-seq studies.

WB:WBGene00005964	srx-73
Is affected by several genes including sir-2.1; dpy-21; and mdt-15 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005965	srx-74
Is affected by several genes including clk-1; dpy-21; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005966	srx-75
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including sir-2.1; cyc-1; and ain-2 based on microarray and RNA-seq studies.

WB:WBGene00005967	srx-76
Is expressed in neurons and in male. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005968	srx-77
Is affected by several genes including let-60; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; adsorbable organic bromine compound; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005969	srx-78
Is affected by clk-1; mex-3; and spn-4 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005970	srx-79
Is affected by tatn-1; mir-34; and rrf-1 based on RNA-seq and microarray studies. Is affected by resveratrol; Diazinon; and copper sulfate based on microarray studies.

WB:WBGene00005971	srx-80
Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005972	srx-81
No description available

WB:WBGene00005973	srx-82
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005974	srx-83
No description available

WB:WBGene00005975	srx-84
Is affected by several genes including daf-2; clk-1; and hpl-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005976	srx-85
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005977	srx-86
Is affected by several genes including clk-1; elt-2; and dpy-21 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005978	srx-87
Is affected by hpl-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005979	srx-88
Is affected by several genes including sir-2.1; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005980	srx-89
Is affected by several genes including pgl-1; alg-1; and glh-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00005981	srx-90
Is affected by several genes including age-1; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including aldicarb; Rifampin; and dibromoacetic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005982	srx-91
Is affected by several genes including lin-4; lin-14; and eat-2 based on microarray and RNA-seq studies.

WB:WBGene00005983	srx-92
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; prg-1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005984	srx-93
Is affected by rsr-2 based on tiling array studies. Is affected by tryptophan and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005985	srx-94
Is affected by sir-2.1 based on microarray studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00005986	srx-95
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005987	srx-96
Is affected by several genes including sir-2.1; mex-3; and ain-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005988	srx-97
Is enriched in neurons based on microarray studies. Is affected by several genes including lin-4; lin-14; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005989	srx-98
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; eat-2; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including tryptophan; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005990	srx-99
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00005991	srx-100
No description available

WB:WBGene00005992	srx-101
Is affected by several genes including daf-12; sir-2.1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005993	srx-102
Is affected by sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005994	srx-103
Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00005995	srx-104
Is enriched in FLP based on microarray studies. Is affected by rsr-2; dpy-21; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005996	srx-105
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00005997	srx-106
Is affected by cyc-1 based on microarray studies.

WB:WBGene00005998	srx-107
Is enriched in FLP based on microarray studies. Is affected by clk-1; dpy-21; and tdp-1 based on microarray and RNA-seq studies. Is affected by resveratrol and dafa#1 based on microarray studies.

WB:WBGene00005999	srx-108
Is affected by several genes including let-60; sir-2.1; and eri-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006000	srx-109
Is affected by clk-1 and eri-1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00006001	srx-110
Is expressed in PHBL and PHBR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006002	srx-111
Is affected by several genes including clk-1; sir-2.1; and mex-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; sesamin; and Cadmium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006003	srx-112
Is affected by several genes including let-60; clk-1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006004	srx-113
Is expressed in DVA; FLPL; FLPR; PLML; and PLMR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006005	srx-114
Is affected by several genes including daf-12; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Serpentine type 7TM GPCR chemoreceptor Srx; and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006006	srx-115
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006007	srx-116
Is affected by rsr-2; mir-34; and daf-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006008	srx-117
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by paraquat; resveratrol; and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006009	srx-118
Is affected by several genes including daf-2; clk-1; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube and Cadmium Chloride based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006010	srx-119
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006011	srx-120
Is affected by ain-2 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006012	srx-121
Is affected by hpl-2 based on tiling array studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006013	srx-122
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006014	srx-123
Is enriched in FLP based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and cyc-1 based on microarray and RNA-seq studies.

WB:WBGene00006015	srx-124
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00006016	srx-125
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006017	srx-126
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by dafa#1 and allantoin based on microarray studies.

WB:WBGene00006018	srx-127
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00006019	srx-128
Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006020	srx-129
Is affected by several genes including eat-2; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006021	srx-130
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006022	srx-131
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006023	srx-132
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00006024	srx-133
Is affected by several genes including clk-1; sir-2.1; and mir-34 based on tiling array and microarray studies. Is affected by Acrylamide and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006025	srx-134
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including sir-2.1; prg-1; and nhr-25 based on tiling array; RNA-seq; and microarray studies. Is affected by Mercuric Chloride and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006026	srx-135
Is affected by several genes including sir-2.1; ifg-1; and spc-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006027	srx-136
Is affected by several genes including daf-2; dpy-21; and ubc-9 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006028	srx-137
Is affected by several genes including clk-1; sir-2.1; and prg-1 based on tiling array and microarray studies. Is affected by Progesterone; cadmium; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00006029	srx-138
Is affected by cyc-1 and sir-2.1 based on microarray studies.

WB:WBGene00006038	ssp-9
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00006039	ssp-10
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on RNA-seq; microarray; and proteomic studies. Is affected by twenty-three chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00006040	ssp-11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00006044	ssp-16
Is expressed in male gonad. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00006047	ssp-19
Exhibits protein homodimerization activity. Is expressed in spermatheca.

WB:WBGene00006048	ssp-31
Is enriched in AFD; amphid sheath cell; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00006049	ssp-32
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; antimycin; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00006050	ssq-1
Is enriched in amphid sheath cell; germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00006051	ssq-2
Is enriched in amphid sheath cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00006052	ssq-3
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-eight chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00006053	ssq-4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00006054	ssr-1
No description available

WB:WBGene00006055	ssr-2
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4. Is an ortholog of human RASD1 (ras related dexamethasone induced 1).

WB:WBGene00006056	sss-1
Is enriched in amphid sheath cell; germ line; intestine; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00006057	sss-2
Is enriched in germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirty chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00006058	sst-20
Is enriched in AVA; arcade cell; germ line; pharyngeal-intestinal valve cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00006059	stc-1
Is predicted to have several functions, including ATP binding activity; ATPase activity; and unfolded protein binding activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human HSPA13 (heat shock protein family A (Hsp70) member 13).

WB:WBGene00006060	sth-1
Localizes to plasma membrane. Is expressed in germ line and spermatheca.

WB:WBGene00006061	stl-1
Localizes to mitochondrion. Is expressed in head neurons and pharynx. Is an ortholog of human STOML2 (stomatin like 2).

WB:WBGene00006062	stn-1
Exhibits acetylcholine transmembrane transporter activity and calcium channel regulator activity. Is involved in several processes, including acetylcholine transport; muscle cell cellular homeostasis; and sarcomere organization. Localizes to dystrophin-associated glycoprotein complex. Is expressed in body wall musculature; neurons; and vulval muscle. Is used to study Duchenne muscular dystrophy. Human ortholog(s) of this gene are implicated in long QT syndrome 12. Is an ortholog of human SNTB1 (syntrophin beta 1) and SNTB2 (syntrophin beta 2).

WB:WBGene00006063	sto-1
Is enriched in several structures, including Z4.a; dopaminergic neurons; germ line; intestine; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Rotenone; and bisphenol S based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; Stomatin-1; Band 7/SPFH domain superfamily; and Band-7 stomatin-like. Is an ortholog of human STOM (stomatin) and STOML3 (stomatin like 3).

WB:WBGene00006064	sto-2
Is enriched in head mesodermal cell and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; Band 7/SPFH domain superfamily; and Band-7 stomatin-like. Is an ortholog of human STOM (stomatin).

WB:WBGene00006065	sto-3
Is expressed in RIB; ray neuron type B; and tail. Is predicted to encode a protein with the following domains: SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; Band 7/SPFH domain superfamily; and Band-7 stomatin-like. Is an ortholog of human STOM (stomatin) and STOML3 (stomatin like 3).

WB:WBGene00006066	sto-4
Is expressed in neurons. Is predicted to encode a protein with the following domains: SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; Band 7/SPFH domain superfamily; and Band-7 stomatin-like. Is an ortholog of human STOM (stomatin).

WB:WBGene00006067	sto-5
Is expressed in FLPL and FLPR. Is predicted to encode a protein with the following domains: SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; Band 7/SPFH domain superfamily; and Band-7 stomatin-like.

WB:WBGene00006068	sto-6
Is enriched in coelomocyte; muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; Band 7/SPFH domain superfamily; and Band-7 stomatin-like. Is an ortholog of human STOM (stomatin).

WB:WBGene00006069	str-1
Is predicted to have G protein-coupled olfactory receptor activity. Localizes to non-motile cilium.

WB:WBGene00006070	str-2
Is predicted to have G protein-coupled olfactory receptor activity. Localizes to non-motile cilium. Is expressed in ASIL; ASIR; AWC-ON; AWCL; and AWCR.

WB:WBGene00006071	str-3
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in ASIL and ASIR.

WB:WBGene00006072	str-4
Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006073	str-5
Is affected by csr-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006074	str-6
Is affected by hpl-2; mex-3; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006075	str-7
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including hydrogen sulfide; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006076	str-8
Is affected by several genes including eri-1; hpl-2; and mut-2 based on tiling array; RNA-seq; and microarray studies. Is affected by cadmium; allantoin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006077	str-9
Is enriched in intestine based on microarray studies. Is affected by several genes including clk-1; elt-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006078	str-10
Is affected by sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006079	str-11
No description available

WB:WBGene00006080	str-12
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and alg-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006081	str-13
Is enriched in NSM based on tiling array studies. Is affected by hpl-2 and sir-2.1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006082	str-14
Is affected by cyc-1 and drh-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006083	str-15
Is affected by several genes including eat-2; sir-2.1; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006084	str-16
Is enriched in AVE and NSM based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006085	str-18
Is affected by several genes including ain-1; drh-3; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006086	str-19
Is affected by several genes including daf-2; age-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol; adsorbable organic bromine compound; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006087	str-20
Is affected by several genes including sir-2.1; hpl-2; and spn-4 based on tiling array; microarray; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006088	str-21
No description available

WB:WBGene00006089	str-22
Is affected by clk-1 and eat-2 based on microarray studies.

WB:WBGene00006090	str-23
Is affected by several genes including eat-2; mir-34; and zip-2 based on tiling array; microarray; and RNA-seq studies. Is affected by aldicarb; Mercuric Chloride; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006091	str-24
Is affected by 2 and 4-dinitroanisole based on microarray studies.

WB:WBGene00006092	str-25
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006093	str-27
Is affected by rsr-2; mir-34; and daf-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006094	str-28
Is enriched in intestine based on microarray studies. Is affected by ain-1 and ain-2 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006095	str-29
No description available

WB:WBGene00006096	str-30
Is enriched in AVK based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies. Is affected by Atrazine and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006097	str-31
Is expressed in PVT; hypodermis; rectal epithelial cell; and vulva. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006098	str-32
Is affected by several genes including clk-1; sir-2.1; and alg-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006099	str-33
Is expressed in ALML; ALMR; PLML; PLMR; and head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006100	str-34
No description available

WB:WBGene00006101	str-35
Is affected by clk-1 and sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006102	str-37
Is affected by several genes including daf-2; ain-1; and let-418 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006103	str-38
Is affected by several genes including unc-70; drh-3; and cyc-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; resveratrol; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006104	str-39
Is enriched in NSM based on tiling array studies. Is affected by several genes including isp-1; prg-1; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006105	str-40
Is enriched in AVE based on tiling array studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006106	str-41
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; hsp-6; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including aldicarb; resveratrol; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006107	str-42
No description available

WB:WBGene00006108	str-43
Is affected by hpl-2; sir-2.1; and eri-1 based on tiling array and microarray studies. Is affected by aldicarb and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006109	str-44
Localizes to non-motile cilium. Is expressed in AWAL; AWAR; AWBL; AWBR; and in male.

WB:WBGene00006110	str-45
Is affected by rsr-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006111	str-46
Is affected by hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006112	str-47
Is affected by dpy-21; drh-3; and hpl-2 based on RNA-seq studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006113	str-48
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and csr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine; fluoranthene; and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006114	str-49
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00006115	str-50
No description available

WB:WBGene00006116	str-51
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00006117	str-52
Is expressed in chemosensory neurons; head; pharynx; tail hypodermis; and tail neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006118	str-53
Is affected by let-60 based on microarray studies.

WB:WBGene00006119	str-54
No description available

WB:WBGene00006120	str-55
Is affected by several genes including let-60; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including aldicarb; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006121	str-56
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by Testosterone and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006122	str-57
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including clk-1; eat-2; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006123	str-58
Is affected by lin-14 and lin-4 based on microarray studies.

WB:WBGene00006124	str-60
Is affected by several genes including sir-2.1; hpl-2; and mut-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006125	str-61
Is affected by several genes including eat-2; sir-2.1; and ain-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006126	str-63
Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006127	str-64
Is enriched in ray based on microarray studies. Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by resveratrol; Atrazine; and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006128	str-66
Is affected by several genes including clk-1; eat-2; and mir-34 based on tiling array and microarray studies. Is affected by estrogen and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006129	str-67
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Chlorpyrifos and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006130	str-68
Is affected by several genes including eat-2; pgl-1; and csr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006131	str-69
Is affected by rsr-2 based on tiling array studies. Is affected by cadmium and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006132	str-70
Is affected by resveratrol based on microarray studies.

WB:WBGene00006133	str-71
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006134	str-73
Is affected by several genes including eat-2; mex-1; and spn-4 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006135	str-74
Is expressed in amphid neurons and head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006136	str-76
Is affected by pgrn-1 based on RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Serpentine type 7TM GPCR chemoreceptor Str; and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006137	str-77
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006138	str-78
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006139	str-79
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006140	str-81
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006141	str-82
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006142	str-83
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006143	str-84
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in PVQ; chemosensory neurons; and retrovesicular ganglion.

WB:WBGene00006144	str-85
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in head neurons and pharynx.

WB:WBGene00006145	str-86
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006146	str-87
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006147	str-88
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006148	str-89
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006149	str-90
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in neurons.

WB:WBGene00006150	str-92
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006151	str-93
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006152	str-94
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006153	str-96
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006154	str-97
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in ASIL; ASIR; and M1 neuron.

WB:WBGene00006155	str-99
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006156	str-101
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006157	str-102
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in anal depressor muscle and head neurons.

WB:WBGene00006158	str-103
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006159	str-106
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006160	str-108
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006161	str-109
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006162	str-111
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006163	str-112
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006164	str-113
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006165	str-114
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in chemosensory neurons; head muscle; and vulval muscle.

WB:WBGene00006166	str-115
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006167	str-116
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in AWAL; AWAR; and in male.

WB:WBGene00006168	str-117
No description available

WB:WBGene00006169	str-118
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006170	str-119
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006171	str-120
Is affected by several genes including clk-1; pgl-1; and dpy-21 based on microarray and RNA-seq studies. Is affected by dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006172	str-121
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in head neurons and pharynx.

WB:WBGene00006173	str-122
Is affected by several genes including sir-2.1; pgl-1; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fluoranthene and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00006174	str-123
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in ASIL; ASIR; neurons; pharyngeal neurons; and pharynx.

WB:WBGene00006175	str-124
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006176	str-125
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in head neurons and interneuron.

WB:WBGene00006177	str-128
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies.

WB:WBGene00006178	str-129
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in head neurons.

WB:WBGene00006179	str-130
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in AWC-OFF and neurons.

WB:WBGene00006180	str-131
Is predicted to have G protein-coupled olfactory receptor activity. Is involved in short-term memory.

WB:WBGene00006181	str-133
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00006182	str-134
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006183	str-135
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006184	str-136
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006185	str-137
Is affected by let-60 based on microarray studies.

WB:WBGene00006186	str-139
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006187	str-138
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006188	str-140
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006189	str-141
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006190	str-143
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in PVT; excretory system; head neurons; intestine; and pharynx.

WB:WBGene00006191	str-144
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006192	str-145
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006193	str-146
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006194	str-147
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00006195	str-148
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in excretory duct cell; excretory pore; and seam cell.

WB:WBGene00006196	str-149
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006197	str-150
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006198	str-151
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006199	str-153
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006200	str-154
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006201	str-155
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006202	str-156
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006203	str-158
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006204	str-159
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006205	str-160
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006206	str-161
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006207	str-162
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006208	str-163
Is predicted to have G protein-coupled olfactory receptor activity. Localizes to non-motile cilium. Is expressed in AWBL and AWBR.

WB:WBGene00006209	str-164
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in AWAL; AWAR; and in male.

WB:WBGene00006210	str-165
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006211	str-166
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006212	str-168
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006213	str-169
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006214	str-170
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006215	str-171
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006216	str-172
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006217	str-173
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006218	str-174
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006219	str-175
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006220	str-176
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00006221	str-177
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006222	str-178
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in ADLL; ADLR; and PVT.

WB:WBGene00006223	str-179
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by metformin and Psoralens based on RNA-seq studies.

WB:WBGene00006224	str-180
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006225	str-181
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006226	str-182
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006227	str-183
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00006228	str-185
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006229	str-187
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006230	str-188
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006231	str-190
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006232	str-193
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006233	str-196
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006234	str-198
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006235	str-199
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in AWCL; AWCR; and nervous system.

WB:WBGene00006236	str-200
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006237	str-204
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006238	str-205
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006239	str-206
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006240	str-207
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006241	str-208
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006242	str-209
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006243	str-210
No description available

WB:WBGene00006244	str-211
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006245	str-212
No description available

WB:WBGene00006246	str-213
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00006247	str-214
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006248	str-216
Is affected by smg-2; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00006249	str-217
Is predicted to have G protein-coupled olfactory receptor activity. Is involved in response to insecticide. Is expressed in ADLL and ADLR.

WB:WBGene00006250	str-219
Is affected by resveratrol based on microarray studies.

WB:WBGene00006251	str-220
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in AWBL and AWBR.

WB:WBGene00006252	str-221
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006253	str-222
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006254	str-223
Is affected by hpl-2; sftb-1; and eri-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00006255	str-224
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and allantoin based on microarray studies.

WB:WBGene00006256	str-225
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006257	str-226
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006258	str-227
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006259	str-228
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006260	str-229
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006261	str-230
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006262	str-231
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in ASIL and ASIR.

WB:WBGene00006263	str-232
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006264	str-233
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in BAGL; BAGR; head; head neurons; and rectal epithelial cell.

WB:WBGene00006265	str-236
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in several structures, including ASI; PVT; intestine; pharynx; and ventral ganglion.

WB:WBGene00006266	str-238
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006267	str-239
No description available

WB:WBGene00006268	str-240
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006269	str-242
No description available

WB:WBGene00006270	str-243
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006271	str-244
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006272	str-245
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006273	str-246
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006274	str-247
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in several structures, including ASI; PVT; head; intestine; and vulval muscle.

WB:WBGene00006275	str-248
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006276	str-249
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in PVT and head neurons.

WB:WBGene00006277	str-250
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in several structures, including ASI; pharynx; rectal epithelium; somatic nervous system; and tail hypodermis.

WB:WBGene00006278	str-252
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006279	str-253
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in head neurons.

WB:WBGene00006280	str-254
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006281	str-255
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006282	str-256
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006283	str-257
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006284	str-258
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00006285	str-259
Is affected by smg-2 based on RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00006286	str-260
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in AWAL; AWAR; and in male.

WB:WBGene00006287	str-261
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in ASKL; ASKR; AWAL; and AWAR.

WB:WBGene00006288	str-262
Is predicted to have G protein-coupled olfactory receptor activity. Is expressed in head neurons and vulval muscle.

WB:WBGene00006289	str-263
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00006290	stu-2
No description available

WB:WBGene00006291	stu-3
No description available

WB:WBGene00006292	stu-6
No description available

WB:WBGene00006293	stu-8
Is involved in embryo development; mitotic cell cycle; and vulval development.

WB:WBGene00006294	stu-9
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00006295	stu-10
Is involved in embryo development and establishment of mitotic spindle orientation.

WB:WBGene00006296	stu-11
Is involved in embryo development and establishment of mitotic spindle orientation.

WB:WBGene00006297	stu-12
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00006298	stu-13
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00006299	stu-14
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00006300	stu-15
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00006301	stu-16
Is involved in embryo development; mitotic cell cycle; and vulval development.

WB:WBGene00006302	stu-17
Is involved in embryo development; mitotic cell cycle; and vulval development.

WB:WBGene00006304	stu-19
Is involved in embryo development and mitotic cell cycle.

WB:WBGene00006305	sud-1
No description available

WB:WBGene00006306	sue-1
Is predicted to have several functions, including calcium ion binding activity; phospholipid binding activity; and syntaxin binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11.

WB:WBGene00006307	suf-1
Is predicted to have mRNA binding activity. Is an ortholog of human CSTF3 (cleavage stimulation factor subunit 3).

WB:WBGene00006308	sul-1
Exhibits heparan sulfate 6-O-sulfotransferase activity. Is involved in heparan sulfate proteoglycan biosynthetic process, enzymatic modification. Human ortholog(s) of this gene are implicated in X-linked chondrodysplasia punctata 1. Is an ortholog of human SULF2 (sulfatase 2).

WB:WBGene00006309	sul-2
Is predicted to have sulfuric ester hydrolase activity. Human ortholog(s) of this gene are implicated in X-linked chondrodysplasia punctata 1; X-linked ichthyosis; and metachromatic leukodystrophy. Is an ortholog of human ARSL (arylsulfatase L).

WB:WBGene00006310	sul-3
Is predicted to have sulfuric ester hydrolase activity. Human ortholog(s) of this gene are implicated in X-linked chondrodysplasia punctata 1 and mucopolysaccharidosis VI. Is an ortholog of human ARSI (arylsulfatase family member I) and ARSJ (arylsulfatase family member J).

WB:WBGene00006311	sun-1
Is predicted to have protein membrane adaptor activity. Is involved in several processes, including centrosome localization; embryo development; and regulation of centrosome duplication. Localizes to nuclear envelope. Is expressed in several structures, including Caa; Psub4; Z2; Z3; and germ line. Human ortholog(s) of this gene are implicated in spermatogenic failure 16. Is an ortholog of human SPAG4 (sperm associated antigen 4); SUN3 (Sad1 and UNC84 domain containing 3); and SUN5 (Sad1 and UNC84 domain containing 5).

WB:WBGene00006313	sup-2
No description available

WB:WBGene00006314	sup-5
Is expressed in several structures, including body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva.

WB:WBGene00006315	sup-6
Is affected by several genes including rrf-3; daf-12; and pgl-1 based on tiling array and RNA-seq studies. Is affected by Tunicamycin and sodium arsenite based on RNA-seq studies.

WB:WBGene00006316	sup-7
Is expressed in several structures, including body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva.

WB:WBGene00006318	sup-9
Is predicted to have potassium ion leak channel activity. Is involved in regulation of muscle contraction. Localizes to integral component of plasma membrane; muscle cell projection membrane; and striated muscle dense body. Is expressed in body wall musculature; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in Birk-Barel syndrome and primary pulmonary hypertension. Is an ortholog of human KCNK3 (potassium two pore domain channel subfamily K member 3) and KCNK9 (potassium two pore domain channel subfamily K member 9).

WB:WBGene00006319	sup-10
Exhibits potassium channel regulator activity. Is involved in regulation of muscle contraction and regulation of potassium ion transport. Localizes to integral component of plasma membrane and striated muscle dense body. Is expressed in anal depressor muscle; body wall musculature; head neurons; intestinal muscle; and vulval muscle.

WB:WBGene00006320	sup-11
No description available

WB:WBGene00006321	sup-12
Exhibits pre-mRNA intronic binding activity and single-stranded RNA binding activity. Is involved in several processes, including alternative mRNA splicing, via spliceosome; regulation of actin cytoskeleton organization; and regulation of alternative mRNA splicing, via spliceosome. Localizes to nuclear speck and ribonucleoprotein complex. Is an ortholog of human RBM24 (RNA binding motif protein 24) and RBM38 (RNA binding motif protein 38).

WB:WBGene00006322	sup-13
No description available

WB:WBGene00006323	sup-16
No description available

WB:WBGene00006324	sup-17
Is predicted to have metalloendopeptidase activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of transforming growth factor beta receptor signaling pathway; and vulval development. Localizes to cytoplasmic vesicle membrane and plasma membrane. Is expressed in M lineage cell; hypodermis; intestinal cell; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 18; cone-rod dystrophy 9; and early infantile epileptic encephalopathy 61. Is an ortholog of human ADAM10 (ADAM metallopeptidase domain 10).

WB:WBGene00006326	sup-19
No description available

WB:WBGene00006327	sup-21
Is expressed in body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva.

WB:WBGene00006328	sup-22
No description available

WB:WBGene00006329	sup-23
No description available

WB:WBGene00006330	sup-24
Is expressed in several structures, including body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva.

WB:WBGene00006331	sup-26
Exhibits mRNA 3'-UTR binding activity. Is involved in negative regulation of translation. Localizes to cytoplasm. Is expressed in several structures, including gonad. Is an ortholog of human RBMS1 (RNA binding motif single stranded interacting protein 1); RBMS2 (RNA binding motif single stranded interacting protein 2); and RBMS3 (RNA binding motif single stranded interacting protein 3).

WB:WBGene00006332	sup-27
No description available

WB:WBGene00006333	sup-28
Is expressed in body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva.

WB:WBGene00006334	sup-29
Is expressed in body wall musculature; intestine; uterus; and vulva.

WB:WBGene00006335	sup-30
No description available

WB:WBGene00006336	sup-31
No description available

WB:WBGene00006337	sup-32
No description available

WB:WBGene00006338	sup-33
Is expressed in several structures, including body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva.

WB:WBGene00006339	sup-34
Is expressed in body wall musculature; egg-laying apparatus; hypodermis; intestine; and neurons.

WB:WBGene00006342	sup-37
Is involved in embryonic digestive tract morphogenesis. Localizes to nucleus. Is expressed in neurons; pharynx; and spermatheca.

WB:WBGene00006344	sup-39
Is affected by daf-12; rsr-2; and sftb-1 based on tiling array and RNA-seq studies.

WB:WBGene00006345	sup-40
No description available

WB:WBGene00006346	sup-41
No description available

WB:WBGene00006347	sup-42
No description available

WB:WBGene00006348	sup-43
No description available

WB:WBGene00006349	sur-2
Is involved in defense response to Gram-positive bacterium; regulation of protein catabolic process; and regulation of transcription by RNA polymerase II. Localizes to mediator complex. Is expressed in several structures, including hyp7; hyp7; hyp7; hyp7; and vulval cell. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is an ortholog of human MED23 (mediator complex subunit 23).

WB:WBGene00006350	sur-4
No description available

WB:WBGene00006351	sur-5
Is predicted to have ATP binding activity and acetoacetate-CoA ligase activity. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; gonad; hypodermal cell; and somatic cell. Is an ortholog of human AACS (acetoacetyl-CoA synthetase).

WB:WBGene00006352	sur-6
Is predicted to have protein phosphatase regulator activity. Is involved in embryo development; nematode larval development; and positive regulation of vulval development. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 12. Is an ortholog of human PPP2R2A (protein phosphatase 2 regulatory subunit Balpha); PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta); and PPP2R2D (protein phosphatase 2 regulatory subunit Bdelta).

WB:WBGene00006353	sur-7
Is involved in several processes, including cellular response to zinc ion; muscle cell cellular homeostasis; and positive regulation of Ras protein signal transduction. Localizes to endoplasmic reticulum membrane. Is expressed in several structures, including hypodermis; muscle cell; pharynx; tail; and vulva.

WB:WBGene00006354	sus-1
No description available

WB:WBGene00006355	suv-2
No description available

WB:WBGene00006356	suv-3
No description available

WB:WBGene00006357	suv-4
No description available

WB:WBGene00006358	suv-5
No description available

WB:WBGene00006359	swp-1
Is predicted to have RNA binding activity. Is an ortholog of human SFSWAP (splicing factor SWAP).

WB:WBGene00006360	syc-1
No description available

WB:WBGene00006361	syc-2
No description available

WB:WBGene00006362	syc-3
No description available

WB:WBGene00006363	syd-1
Exhibits GTPase activator activity; Rho GTPase binding activity; and Roundabout binding activity. Is involved in several processes, including activation of GTPase activity; axo-dendritic transport; and locomotion. Localizes to presynaptic membrane. Is expressed in nerve ring and neurons. Is an ortholog of human SYDE1 (synapse defective Rho GTPase homolog 1) and SYDE2 (synapse defective Rho GTPase homolog 2).

WB:WBGene00006364	syd-2
Exhibits kinesin binding activity; protein homodimerization activity; and receptor signaling complex adaptor activity. Is involved in several processes, including oviposition; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed; and positive regulation of anterograde synaptic vesicle transport. Localizes to axon; cytoplasm; and presynaptic active zone dense projection. Is expressed in dorsal nerve cord; lateral nerve cord; muscle cell; neurons; and ventral nerve cord. Is an ortholog of human PPFIA1 (PTPRF interacting protein alpha 1); PPFIA2 (PTPRF interacting protein alpha 2); and PPFIA3 (PTPRF interacting protein alpha 3).

WB:WBGene00006365	syg-1
Exhibits cell adhesion molecule binding activity. Is involved in actin filament bundle assembly; cell-cell signaling; and nervous system development. Localizes to axon and synapse. Is expressed in egg-laying apparatus; head muscle; hypodermis; and neurons. Is used to study nephrotic syndrome. Is an ortholog of human KIRREL1 (kirre like nephrin family adhesion molecule 1); KIRREL2 (kirre like nephrin family adhesion molecule 2); and KIRREL3 (kirre like nephrin family adhesion molecule 3).

WB:WBGene00006366	sym-1
Localizes to extracellular space. Human ortholog(s) of this gene are implicated in cornea plana. Is an ortholog of several human genes including FMOD (fibromodulin); KERA (keratocan); and PRELP (proline and arginine rich end leucine rich repeat protein).

WB:WBGene00006367	sym-2
Is predicted to have RNA binding activity. Is involved in embryo development; embryonic body morphogenesis; and multicellular organismal movement. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 109 and schizophrenia 19. Is an ortholog of human ESRP1 (epithelial splicing regulatory protein 1).

WB:WBGene00006368	sym-3
Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Lithium Chloride; Zidovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: N-terminal C2 in EEIG1 and EHBP1 proteins; NT-type C2 domain; and Protein FAM102-like. Is an ortholog of human FAM102A (family with sequence similarity 102 member A) and FAM102B (family with sequence similarity 102 member B).

WB:WBGene00006369	sym-4
Is predicted to have Rab GTPase binding activity. Is an ortholog of human WDR44 (WD repeat domain 44).

WB:WBGene00006371	syx-3
Is predicted to have SNAP receptor activity and SNARE binding activity. Is involved in positive regulation of defecation and regulation of muscle contraction. Localizes to plasma membrane. Human ortholog(s) of this gene are implicated in familial hemophagocytic lymphohistiocytosis 4. Is an ortholog of human STX11 (syntaxin 11) and STX19 (syntaxin 19).

WB:WBGene00006372	syx-2
Is predicted to have SNAP receptor activity and SNARE binding activity. Is involved in short-term memory. Is expressed in head neurons and ventral cord neurons. Human ortholog(s) of this gene are implicated in familial hemophagocytic lymphohistiocytosis 4. Is an ortholog of human STX11 (syntaxin 11) and STX19 (syntaxin 19).

WB:WBGene00006373	syx-5
Is predicted to have SNAP receptor activity and SNARE binding activity. Is an ortholog of human STX5 (syntaxin 5).

WB:WBGene00006374	syx-4
Is predicted to have SNAP receptor activity and SNARE binding activity. Is involved in cortical granule exocytosis; positive regulation of cytokinesis; and regulation of exocytosis. Localizes to several cellular components, including cleavage furrow; cortical granule; and perinuclear region of cytoplasm. Is expressed in gonad and seam cell. Human ortholog(s) of this gene are implicated in familial hemophagocytic lymphohistiocytosis 4. Is an ortholog of human STX4 (syntaxin 4).

WB:WBGene00006375	syp-1
Exhibits protein homodimerization activity. Is involved in positive regulation of reciprocal meiotic recombination; regulation of chromosome segregation; and synaptonemal complex assembly. Localizes to central element. Is expressed in germ line.

WB:WBGene00006376	syp-2
Is involved in positive regulation of reciprocal meiotic recombination and synaptonemal complex assembly. Localizes to central element.

WB:WBGene00006377	syp-3
Is involved in chiasma assembly; embryo development; and synaptonemal complex assembly. Localizes to central element and lateral element.

WB:WBGene00006378	syr-1
No description available

WB:WBGene00006379	sys-1
Exhibits scaffold protein binding activity; transcription coactivator activity; and transcription factor binding activity. Is involved in several processes, including gonad development; polarity specification of proximal/distal axis; and regulation of transcription, DNA-templated. Localizes to centrosome; cytoplasm; and nucleus. Colocalizes with pericentriolar material. Is expressed in several structures, including ABplpapaap; ABprpapaap; Z1.aa; posterior distal tip cell; and tail hypodermis.

WB:WBGene00006380	tab-1
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in head neurons and intestine. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta type 4; orofacial cleft 15; and split hand-foot malformation 1 with sensorineural hearing loss. Is an ortholog of human BSX (brain specific homeobox).

WB:WBGene00006381	tac-1
Exhibits protein domain specific binding activity. Is involved in several processes, including cytoskeleton organization; pronuclear migration; and regulation of microtubule polymerization or depolymerization. Localizes to cytoplasm; cytoskeleton; and kinetochore.

WB:WBGene00006382	taf-1
Is predicted to contribute to transcription regulatory region DNA binding activity. Is involved in embryo development and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Human ortholog(s) of this gene are implicated in X-linked dystonia-parkinsonism. Is an ortholog of human TAF1 (TATA-box binding protein associated factor 1) and TAF1L (TATA-box binding protein associated factor 1 like).

WB:WBGene00006383	taf-2
Is predicted to have chromatin binding activity and transcription regulatory region DNA binding activity. Is involved in embryo development and positive regulation of transcription by RNA polymerase II. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is an ortholog of human TAF2 (TATA-box binding protein associated factor 2).

WB:WBGene00006384	taf-3
Is predicted to have metal ion binding activity and protein heterodimerization activity. Is an ortholog of human TAF3 (TATA-box binding protein associated factor 3).

WB:WBGene00006385	taf-4
Is predicted to have DNA binding activity and transcription factor binding activity. Is involved in embryo development; positive regulation of transcription by RNA polymerase II; and regulation of mitotic cell cycle, embryonic. Localizes to cytoplasm and nucleus. Human ortholog(s) of this gene are implicated in spermatogenic failure 13. Is an ortholog of human TAF4 (TATA-box binding protein associated factor 4) and TAF4B (TATA-box binding protein associated factor 4b).

WB:WBGene00006386	taf-5
Localizes to nucleus. Is an ortholog of human TAF5 (TATA-box binding protein associated factor 5).

WB:WBGene00006387	taf-6.1
Is predicted to have RNA polymerase II general transcription initiation factor activity and protein heterodimerization activity. Is an ortholog of human TAF6 (TATA-box binding protein associated factor 6).

WB:WBGene00006388	taf-7.1
Is predicted to have several functions, including histone acetyltransferase binding activity; histone acetyltransferase regulator activity; and transcription factor binding activity. Is an ortholog of human TAF7 (TATA-box binding protein associated factor 7).

WB:WBGene00006389	taf-7.2
Is predicted to have several functions, including histone acetyltransferase binding activity; transcription coactivator activity; and transcription factor binding activity. Is an ortholog of human TAF7 (TATA-box binding protein associated factor 7).

WB:WBGene00006390	taf-8
Is predicted to have protein heterodimerization activity. Is an ortholog of human TAF8 (TATA-box binding protein associated factor 8).

WB:WBGene00006391	taf-9
Is predicted to have transcription factor binding activity and transcription regulatory region DNA binding activity. Is involved in embryo development; positive regulation of transcription by RNA polymerase II; and regulation of mitotic cell cycle, embryonic. Localizes to nucleus. Is an ortholog of human TAF9 (TATA-box binding protein associated factor 9) and TAF9B (TATA-box binding protein associated factor 9b).

WB:WBGene00006392	taf-10
Is predicted to have translation initiation factor activity. Is involved in embryo development; positive regulation of transcription by RNA polymerase II; and regulation of mitotic cell cycle, embryonic. Localizes to nucleus. Is an ortholog of human TAF10 (TATA-box binding protein associated factor 10).

WB:WBGene00006393	taf-11.1
Is predicted to have transcription coactivator activity and transcription factor binding activity. Is an ortholog of human TAF11 (TATA-box binding protein associated factor 11).

WB:WBGene00006394	taf-11.2
Is predicted to have transcription coactivator activity and transcription factor binding activity. Is an ortholog of human TAF11 (TATA-box binding protein associated factor 11).

WB:WBGene00006395	taf-11.3
Is predicted to have transcription coactivator activity and transcription factor binding activity. Is an ortholog of human TAF11 (TATA-box binding protein associated factor 11).

WB:WBGene00006396	taf-12
Is predicted to have DNA binding activity and TBP-class protein binding activity. Localizes to nucleus. Is an ortholog of human TAF12 (TATA-box binding protein associated factor 12).

WB:WBGene00006397	taf-13
Is predicted to have DNA binding activity and transcription coregulator activity. Is an ortholog of human TAF13 (TATA-box binding protein associated factor 13).

WB:WBGene00006399	tag-4
Is affected by several genes including sir-2.1; hpl-2; and spn-4 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00006402	fut-3
Exhibits 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity. Is involved in fucosylation. Is an ortholog of human FUT5 (fucosyltransferase 5); FUT6 (fucosyltransferase 6); and FUT7 (fucosyltransferase 7).

WB:WBGene00006404	tag-10
Localizes to membrane raft. Is expressed in amphid neurons.

WB:WBGene00006405	itsn-1
Is involved in positive regulation of synaptic vesicle endocytosis. Localizes to endocytic vesicle and presynaptic periactive zone. Is expressed in neurons; somatic nervous system; tail; and vulva. Is an ortholog of human ITSN2 (intersectin 2).

WB:WBGene00006406	srgp-1
Exhibits GTPase activator activity; Rac GTPase binding activity; and protein self-association. Is involved in several processes, including negative regulation of phagocytosis, engulfment; positive regulation of GTPase activity; and regulation of cell-cell adhesion. Localizes to adherens junction and cell cortex. Is expressed in hypodermis; nerve ring; somatic cell; and spermatheca. Human ortholog(s) of this gene are implicated in thyroid gland follicular carcinoma. Is an ortholog of human ARHGAP4 (Rho GTPase activating protein 4) and SRGAP3 (SLIT-ROBO Rho GTPase activating protein 3).

WB:WBGene00006407	lim-9
Exhibits protein domain specific binding activity. Localizes to M band. Is expressed in several structures, including body wall musculature; excretory canal; non-striated muscle; spermatheca; and vulva. Is an ortholog of human FHL2 (four and a half LIM domains 2).

WB:WBGene00006408	tag-18
Is enriched in body wall muscle cell; germ line; intestine; and muscle cell based on proteomic; Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00006409	hdl-2
Is predicted to have carboxy-lyase activity and pyridoxal phosphate binding activity. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome. Is an ortholog of human HDC (histidine decarboxylase).

WB:WBGene00006410	nck-1
Is predicted to have kinase activity. Localizes to cytoplasm and nucleus. Is expressed in several structures, including egg-laying apparatus; gonad; hypodermis; neuroblasts; and neurons. Is an ortholog of human NCK2 (NCK adaptor protein 2).

WB:WBGene00006411	octr-1
Exhibits octopamine receptor activity. Is involved in negative regulation of innate immune response; octopamine signaling pathway; and regulation of IRE1-mediated unfolded protein response. Is expressed in head neurons; sensory neurons; tail; uterine toroidal epithelial cell; and in male. Human ortholog(s) of this gene are implicated in asthma; familial adult myoclonic epilepsy 2; and obesity. Is an ortholog of human ADRA2A (adrenoceptor alpha 2A).

WB:WBGene00006412	nlg-1
Is predicted to have neurexin family protein binding activity and signaling receptor activity. Is involved in gamma-aminobutyric acid receptor clustering and negative regulation of neurotransmitter secretion. Localizes to axon; dendrite; and synapse. Is expressed in several structures, including body wall musculature; diagonal muscle; neurons; tail; and ventral nerve cord. Is used to study autism spectrum disorder. Is an ortholog of human NLGN1 (neuroligin 1) and NLGN4X (neuroligin 4 X-linked).

WB:WBGene00006414	raga-1
Is predicted to have GTPase activity. Is involved in several processes, including determination of adult lifespan; positive regulation of TOR signaling; and regulation of growth. Is an ortholog of human RRAGA (Ras related GTP binding A) and RRAGB (Ras related GTP binding B).

WB:WBGene00006415	tag-30
Is expressed in body wall musculature; intestinal muscle; and rectal muscle. Is predicted to encode a protein with the following domains: PHR domain; BTB And C-terminal Kelch; BTB/POZ domain; BTB/POZ domain; SKP1/BTB/POZ domain superfamily; BTB/Kelch-associated; PHR; and PHR domain superfamily. Is an ortholog of human BTBD1 (BTB domain containing 1) and BTBD2 (BTB domain containing 2).

WB:WBGene00006416	sams-5
Is predicted to have methionine adenosyltransferase activity. Is expressed in MI neuron. Is an ortholog of human MAT1A (methionine adenosyltransferase 1A) and MAT2A (methionine adenosyltransferase 2A).

WB:WBGene00006418	spl-2
Is predicted to have sphinganine-1-phosphate aldolase activity. Is involved in defense response to Gram-positive bacterium. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 14. Is an ortholog of human SGPL1 (sphingosine-1-phosphate lyase 1).

WB:WBGene00006419	oac-39
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00006423	asd-2
Exhibits pre-mRNA intronic binding activity and single-stranded RNA binding activity. Is involved in regulation of alternative mRNA splicing, via spliceosome. Localizes to P granule; nucleus; and ribonucleoprotein complex. Is expressed in body wall musculature; hypodermis; and pharyngeal muscle cell. Is an ortholog of human QKI (QKI, KH domain containing RNA binding).

WB:WBGene00006424	ctbp-1
Is predicted to have several functions, including DNA binding activity; NAD binding activity; and metal ion binding activity. Localizes to nucleus. Is expressed in hypodermis and nervous system. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in Wolf-Hirschhorn syndrome and primary hyperoxaluria type 2. Is an ortholog of human CTBP2 (C-terminal binding protein 2).

WB:WBGene00006428	tkr-3
Is predicted to have neuropeptide Y receptor activity. Is expressed in tail.

WB:WBGene00006429	arrd-3
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00006430	tag-51
Is enriched in body wall musculature; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including glp-1; skn-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Humic Substances; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00006431	tag-52
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in anchor cell; gonad; spermatheca; and uterine toroidal epithelial cell. Is an ortholog of human ARHGEF39 (Rho guanine nucleotide exchange factor 39).

WB:WBGene00006432	atrn-1
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Peroxides and Rotenone based on proteomic and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Pierson syndrome; amelogenesis imperfecta type 1A; and junctional epidermolysis bullosa (multiple). Is predicted to encode a protein with the following domains: Laminin EGF domain; Kelch motif; Kelch motif; Plexin repeat; CUB domain; EGF-like domain; CUB domain; Laminin EGF domain; Plexin repeat; Kelch repeat type 1; Galactose oxidase/kelch, beta-propeller; Kelch-type beta propeller; PSI domain; and Spermadhesin, CUB domain superfamily. Is an ortholog of human ATRN (attractin).

WB:WBGene00006433	sdhb-1
Is predicted to have iron-sulfur cluster binding activity and ubiquinone binding activity. Localizes to mitochondrion. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in Carney-Stratakis syndrome; gastrointestinal stromal tumor; and paraganglioma. Is an ortholog of human SDHB (succinate dehydrogenase complex iron sulfur subunit B).

WB:WBGene00006434	prdx-2
Exhibits thioredoxin peroxidase activity. Is involved in several processes, including determination of adult lifespan; heat acclimation; and hydrogen peroxide catabolic process. Localizes to cytoplasm. Is expressed in body wall musculature; corpus; gonad; head; and tail. Human ortholog(s) of this gene are implicated in methylmalonic aciduria and homocystinuria type cblC. Is an ortholog of human PRDX1 (peroxiredoxin 1) and PRDX2 (peroxiredoxin 2).

WB:WBGene00006435	stdh-4
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12).

WB:WBGene00006436	ttn-1
Exhibits actin filament binding activity and myosin binding activity. Localizes to A band and I band. Is expressed in muscle cell.

WB:WBGene00006437	mrck-1
Is predicted to have protein serine/threonine kinase activity. Is involved in several processes, including embryonic body morphogenesis; positive regulation of endocytic recycling; and regulation of Golgi organization. Localizes to cytoplasm. Is expressed in Ea and Ep. Human ortholog(s) of this gene are implicated in myotonic dystrophy type 1. Is an ortholog of human CDC42BPA (CDC42 binding protein kinase alpha) and CDC42BPB (CDC42 binding protein kinase beta).

WB:WBGene00006438	nrfl-1
Exhibits protein membrane adaptor activity. Localizes to apical plasma membrane. Is expressed in excretory canal; pharyngeal muscle cell; and tail. Human ortholog(s) of this gene are implicated in hypophosphatemic nephrolithiasis/osteoporosis 2. Is an ortholog of human SLC9A3R1 (SLC9A3 regulator 1).

WB:WBGene00006439	ant-1.1
Is predicted to have ATP:ADP antiporter activity. Is involved in determination of adult lifespan; mitochondrion organization; and positive regulation of apoptotic process. Localizes to mitochondrion. Is expressed in several structures, including body wall musculature; hermaphrodite somatic gonadal cell; intestine; pharynx; and vulva. Is used to study mitochondrial metabolism disease. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2; mitochondrial DNA depletion syndrome 12a; and mitochondrial DNA depletion syndrome 12b. Is an ortholog of human SLC25A5 (solute carrier family 25 member 5).

WB:WBGene00006440	tag-63
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; head mesodermal cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00006441	cpna-4
Is predicted to have calcium-dependent phospholipid binding activity.

WB:WBGene00006442	tag-65
Is predicted to have nucleic acid binding activity. Is an ortholog of human CHERP (calcium homeostasis endoplasmic reticulum protein).

WB:WBGene00006443	pak-2
Is predicted to have protein serine/threonine kinase activity. Is involved in nematode larval development. Human ortholog(s) of this gene are implicated in lung cancer. Is an ortholog of human PAK4 (p21 (RAC1) activated kinase 4) and PAK5 (p21 (RAC1) activated kinase 5).

WB:WBGene00006444	shn-1
Is predicted to have GKAP/Homer scaffold activity and ionotropic glutamate receptor binding activity. Is involved in defecation and rhythmic behavior. Is expressed in several structures, including amphid neurons; pharyngeal-intestinal valve; somatic nervous system; sperm; and vulva. Is used to study autism spectrum disorder. Human ortholog(s) of this gene are implicated in Phelan-McDermid syndrome and schizophrenia 15. Is an ortholog of human SHANK1 (SH3 and multiple ankyrin repeat domains 1).

WB:WBGene00006445	tag-68
Is predicted to have DNA binding activity. Is expressed in head neurons; intestine; and ventral nerve cord. Human ortholog(s) of this gene are implicated in aortic valve disease 2. Is an ortholog of human SMAD6 (SMAD family member 6) and SMAD7 (SMAD family member 7).

WB:WBGene00006446	atx-3
Exhibits thiol-dependent ubiquitin-specific protease activity. Is involved in chemical synaptic transmission. Localizes to cytoplasm and nucleus. Is expressed in coelomocyte; head; somatic nervous system; and tail neurons. Human ortholog(s) of this gene are implicated in Machado-Joseph disease. Is an ortholog of human ATXN3 (ataxin 3).

WB:WBGene00006447	tag-72
Is predicted to have RNA binding activity and mRNA (guanine-N7-)-methyltransferase activity. Is an ortholog of human RNMT (RNA guanine-7 methyltransferase).

WB:WBGene00006448	glod-4
Is involved in determination of adult lifespan and methylglyoxal metabolic process. Is expressed widely. Is an ortholog of human GLOD4 (glyoxalase domain containing 4).

WB:WBGene00006449	alg-4
Is predicted to have nucleic acid binding activity. Is involved in spermatogenesis.

WB:WBGene00006450	tag-77
Is predicted to have phosphatidylinositol phosphate binding activity. Is expressed in hermaphrodite gonad and somatic gonad precursor. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4H. Is an ortholog of human FGD5 (FYVE, RhoGEF and PH domain containing 5).

WB:WBGene00006452	heh-1
Is predicted to have sterol binding activity. Is an ortholog of human NPC2 (NPC intracellular cholesterol transporter 2).

WB:WBGene00006454	aex-4
Is predicted to have SNAP receptor activity and syntaxin binding activity. Is involved in positive regulation of defecation and positive regulation of protein secretion. Colocalizes with plasma membrane.

WB:WBGene00006459	tag-89
Is predicted to have G protein-coupled serotonin receptor activity.

WB:WBGene00006460	ppm-1.A
Is predicted to have magnesium-dependent protein serine/threonine phosphatase activity. Is an ortholog of human PPM1A (protein phosphatase, Mg2+/Mn2+ dependent 1A).

WB:WBGene00006461	tag-96
Is predicted to have galactokinase activity. Is an ortholog of human GALK2 (galactokinase 2).

WB:WBGene00006462	svh-5
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in intestine and neurons. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human EHF (ETS homologous factor) and ELF5 (E74 like ETS transcription factor 5).

WB:WBGene00006463	nduf-2.2
Is predicted to have NAD binding activity; oxidoreductase activity, acting on NAD(P)H; and quinone binding activity. Is an ortholog of human NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2).

WB:WBGene00006464	bath-47
Is expressed in head. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00006465	fntb-1
Is predicted to contribute to protein farnesyltransferase activity. Is expressed in body wall musculature; neurons; pharyngeal muscle cell; rectal epithelial cell; and vulval cell. Is an ortholog of human CHURC1-FNTB (CHURC1-FNTB readthrough).

WB:WBGene00006466	tag-115
Is enriched in AVK; cephalic sheath cell; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SAC3/GANP family and SAC3/GANP/THP3. Is an ortholog of human SAC3D1 (SAC3 domain containing 1).

WB:WBGene00006467	magu-2
Is enriched in several structures, including arcade cell; head mesodermal cell; intestine; neurons; and pharyngeal-intestinal valve cell based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including stavudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Guanylate kinase; Variant SH3 domain; PDZ domain; SH3 domain; PDZ domain; Guanylate kinase/L-type calcium channel beta subunit; P-loop containing nucleoside triphosphate hydrolase; MAGUK p55 subfamily member 5; SH3-like domain superfamily; and PDZ superfamily. Is an ortholog of human MPP5 (membrane palmitoylated protein 5).

WB:WBGene00006468	rhgf-1
Is predicted to have Rho guanyl-nucleotide exchange factor activity and metal ion binding activity. Is expressed in nervous system and spermatheca. Human ortholog(s) of this gene are implicated in neurodevelopmental disorder with midbrain and hindbrain malformations. Is an ortholog of human ARHGEF11 (Rho guanine nucleotide exchange factor 11).

WB:WBGene00006470	tag-120
Is expressed in excretory system; neurons; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: Inhibitor of apoptosis-promoting Bax1; Bax inhibitor 1-related; and MFS transporter superfamily. Is an ortholog of human FAIM2 (Fas apoptotic inhibitory molecule 2) and TMBIM1 (transmembrane BAX inhibitor motif containing 1).

WB:WBGene00006471	nhr-233
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00006472	tag-123
Is expressed in several structures, including anterior gonad arm; head; pharyngeal muscle cell; rectal epithelium; and vulva. Is predicted to encode a protein with the following domains: Endomembrane protein 70 and Nonaspanin (TM9SF). Is an ortholog of human TM9SF2 (transmembrane 9 superfamily member 2).

WB:WBGene00006473	tag-124
Is predicted to have pseudouridine synthase activity. Is an ortholog of human PUS3 (pseudouridine synthase 3).

WB:WBGene00006474	wdr-5.1
Exhibits RNA polymerase II transcription factor binding activity. Is involved in determination of adult lifespan; histone H3-K4 methylation; and transdifferentiation. Localizes to MLL3/4 complex and cytoplasm. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; hermaphrodite gonad; neurons; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 20; nephronophthisis 20; and primary autosomal recessive microcephaly 2 with or without cortical malformations. Is an ortholog of human WDR5 (WD repeat domain 5).

WB:WBGene00006475	tyra-3
Is predicted to have G protein-coupled serotonin receptor activity and octopamine receptor activity. Is expressed in SDQ; gonad; head neurons; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome.

WB:WBGene00006476	rhgf-2
Exhibits Rho guanyl-nucleotide exchange factor activity. Is involved in several processes, including Rho protein signal transduction; activation of GTPase activity; and cell morphogenesis. Localizes to axon and cell body. Is expressed in several structures, including pharyngeal cell; seam cell; somatic nervous system; tail; and touch receptor neurons. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease recessive intermediate C and distal spinal muscular atrophy type 4. Is an ortholog of human PLEKHG5 (pleckstrin homology and RhoGEF domain containing G5).

WB:WBGene00006477	chup-1
Exhibits cholesterol binding activity. Is involved in cholesterol import. Localizes to several cellular components, including Golgi apparatus; endosome; and lysosome. Is expressed in several structures, including anal depressor muscle; hypodermis; intestine; pharynx; and reproductive system. Is an ortholog of human SIDT1 (SID1 transmembrane family member 1) and SIDT2 (SID1 transmembrane family member 2).

WB:WBGene00006478	tag-131
Is enriched in PLM; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including sir-2.1; alg-1; and fbf-1 based on RNA-seq; microarray; and proteomic studies. Is affected by four chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Cytochrome b5-like Heme/Steroid binding domain; Cytochrome b5-like heme/steroid binding domain; and Cytochrome b5-like heme/steroid binding domain superfamily. Is an ortholog of human CYB5D2 (cytochrome b5 domain containing 2).

WB:WBGene00006479	tmbi-4
Is enriched in dopaminergic neurons; excretory cell; hypodermis; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Inhibitor of apoptosis-promoting Bax1; and Bax inhibitor 1-related. Is an ortholog of human TMBIM4 (transmembrane BAX inhibitor motif containing 4).

WB:WBGene00006481	plrg-1
Is expressed in head and tail. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; and WD40-repeat-containing domain superfamily. Is an ortholog of human PLRG1 (pleiotropic regulator 1).

WB:WBGene00006483	dgk-4
Is predicted to have diacylglycerol kinase activity. Is expressed in gonad; head; and tail. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 7. Is an ortholog of human DGKH (diacylglycerol kinase eta).

WB:WBGene00006484	tag-138
Is predicted to have actin filament binding activity; clathrin binding activity; and phosphatidylinositol bisphosphate binding activity. Is an ortholog of human HIP1 (huntingtin interacting protein 1) and HIP1R (huntingtin interacting protein 1 related).

WB:WBGene00006486	zipt-16
Is predicted to have zinc ion transmembrane transporter activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in several diseases, including acrodermatitis enteropathica; congenital disorder of glycosylation type IIn; and hypermanganesemia with dystonia 2. Is an ortholog of human SLC39A14 (solute carrier family 39 member 14) and SLC39A8 (solute carrier family 39 member 8).

WB:WBGene00006487	zipt-17
Is predicted to have zinc ion transmembrane transporter activity. Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in acrodermatitis enteropathica. Is an ortholog of human SLC39A12 (solute carrier family 39 member 12) and SLC39A4 (solute carrier family 39 member 4).

WB:WBGene00006488	F56D6.6
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including clk-1; eat-2; and csr-1 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies.

WB:WBGene00006489	zhit-3
Is predicted to have metal ion binding activity. Localizes to nucleus. Is an ortholog of human ZNHIT6 (zinc finger HIT-type containing 6).

WB:WBGene00006490	kdin-1
Is predicted to have PDZ domain binding activity and protein kinase regulator activity. Is expressed in excretory cell. Is an ortholog of human KIDINS220 (kinase D interacting substrate 220).

WB:WBGene00006491	acl-3
Is predicted to have O-acyltransferase activity. Human ortholog(s) of this gene are implicated in Barth syndrome. Is an ortholog of human TAZ (tafazzin).

WB:WBGene00006492	let-391
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006493	ivns-1
Is enriched in AFD; body wall musculature; intestine; pharynx; and somatic gonad precursor based on Chronogram and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; Tunicamycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; Kelch motif; BTB/POZ domain; Kelch repeat type 1; Galactose oxidase/kelch, beta-propeller; SKP1/BTB/POZ domain superfamily; BTB/Kelch-associated; and Kelch-type beta propeller. Is an ortholog of human IVNS1ABP (influenza virus NS1A binding protein).

WB:WBGene00006494	zipt-7.2
Is predicted to have zinc ion transmembrane transporter activity. Is expressed in somatic cell. Is an ortholog of human SLC39A7 (solute carrier family 39 member 7).

WB:WBGene00006495	cpna-1
Exhibits phosphatase binding activity and protein-macromolecule adaptor activity. Is involved in positive regulation of sarcomere organization. Localizes to M band and striated muscle dense body. Is expressed in body wall musculature.

WB:WBGene00006496	cgef-1
Is predicted to have guanyl-nucleotide exchange factor activity. Is involved in positive regulation of GTPase activity and protein localization. Localizes to cell cortex and nucleoplasm. Is expressed in hermaphrodite gonad; neurons; somatic gonad precursor; and vulva. Is an ortholog of human MCF2 (MCF.2 cell line derived transforming sequence) and MCF2L (MCF.2 cell line derived transforming sequence like).

WB:WBGene00006497	tag-151
Is predicted to have GTP binding activity; GTPase activity; and U3 snoRNA binding activity. Is an ortholog of human TSR1 (TSR1 ribosome maturation factor).

WB:WBGene00006498	ten-1
Is involved in several processes, including axon development; gonad development; and post-embryonic animal morphogenesis. Localizes to nucleus and plasma membrane. Is expressed in several structures, including body muscle cell; gonad; hypodermis; interfacial epithelial cell; and neurons. Human ortholog(s) of this gene are implicated in essential tremor 5. Is an ortholog of several human genes including TENM2 (teneurin transmembrane protein 2); TENM3 (teneurin transmembrane protein 3); and TENM4 (teneurin transmembrane protein 4).

WB:WBGene00006499	tag-153
Is enriched in germ line; germline precursor cell; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and gld-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; NOT2 / NOT3 / NOT5 family; NOT2/NOT3/NOT5, C-terminal; CCR4-NOT complex subunit 2/3/5, N-terminal domain superfamily; and Not2/Not3/Not5.

WB:WBGene00006503	snx-3
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Localizes to endosome. Is expressed in several structures, including pharynx and rectal epithelial cell. Is an ortholog of human SNX12 (sorting nexin 12) and SNX3 (sorting nexin 3).

WB:WBGene00006504	kcc-1
Exhibits potassium:chloride symporter activity. Is involved in chloride transport and potassium ion transport. Is expressed in several structures, including hermaphrodite distal tip cell; pharyngeal muscle cell; tail neurons; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in epilepsy (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SLC12A4 (solute carrier family 12 member 4); SLC12A5 (solute carrier family 12 member 5); and SLC12A7 (solute carrier family 12 member 7).

WB:WBGene00006505	lagr-1
Is predicted to have sphingosine N-acyltransferase activity. Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in dextro-looped transposition of the great arteries 3; progressive myoclonus epilepsy 8; and right atrial isomerism. Is an ortholog of human CERS1 (ceramide synthase 1).

WB:WBGene00006508	tns-1
Is predicted to have protein tyrosine phosphatase activity. Is involved in positive regulation of axon regeneration. Localizes to axon. Is expressed in DD neuron; VD neuron; head; and intestinal muscle. Is an ortholog of human TNS2 (tensin 2) and TNS3 (tensin 3).

WB:WBGene00006509	tag-164
Is enriched in AFD; PLM; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including nicotinic acid; methylmercuric chloride; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: PapD-like superfamily.

WB:WBGene00006510	mtrr-1
Is predicted to have coenzyme binding activity and oxidoreductase activity. Human ortholog(s) of this gene are implicated in neural tube defect. Is an ortholog of human MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase).

WB:WBGene00006512	abcf-1
Is predicted to have ATP binding activity. Is an ortholog of human ABCF1 (ATP binding cassette subfamily F member 1).

WB:WBGene00006513	rimb-1
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Variant SH3 domain; Variant SH3 domain; SH3 domain; Fibronectin type III; Immunoglobulin-like fold; SH3-like domain superfamily; Fibronectin type III superfamily; and RIMS-binding protein 1/2/3. Is an ortholog of human RIMBP2 (RIMS binding protein 2).

WB:WBGene00006514	tdp-1
Exhibits single-stranded RNA binding activity. Is involved in several processes, including determination of adult lifespan; hyperosmotic response; and response to oxidative stress. Localizes to nucleus. Is expressed in several structures, including body wall musculature; intestine; muscle cell; neurons; and pharynx. Is used to study amyotrophic lateral sclerosis. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 10. Is an ortholog of human TARDBP (TAR DNA binding protein).

WB:WBGene00006515	txdc-9
Is involved in microtubule cytoskeleton organization. Localizes to cytoplasm and nucleus. Is expressed in nervous system; pharynx; and vulva. Is an ortholog of human TXNDC9 (thioredoxin domain containing 9).

WB:WBGene00006516	vps-16
Is predicted to have actin binding activity. Is involved in digestive tract development and embryo development. Is an ortholog of human VPS16 (VPS16 core subunit of CORVET and HOPS complexes).

WB:WBGene00006517	madd-3
Is predicted to have ATP binding activity; protein serine/threonine kinase activity; and protein tyrosine kinase activity. Is expressed in anal depressor muscle; anal sphincter muscle; body wall musculature; and vulval muscle. Is an ortholog of human CLK2 (CDC like kinase 2).

WB:WBGene00006518	bckd-1B
Is predicted to have alpha-ketoacid dehydrogenase activity. Is involved in positive regulation of fatty acid biosynthetic process and positive regulation of nematode larval development. Human ortholog(s) of this gene are implicated in maple syrup urine disease. Is an ortholog of human BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta).

WB:WBGene00006519	cox-6A
Is predicted to contribute to cytochrome-c oxidase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease recessive intermediate D. Is an ortholog of human COX6A1 (cytochrome c oxidase subunit 6A1) and COX6A2 (cytochrome c oxidase subunit 6A2).

WB:WBGene00006520	tag-175
Is expressed in head; neurons; spermatheca; and vulva. Is predicted to encode a protein with the following domains: SNARE associated Golgi protein and SNARE associated Golgi protein. Is an ortholog of human TMEM41B (transmembrane protein 41B).

WB:WBGene00006522	abcx-1
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is expressed in hyp11; hyp8; and hyp9. Human ortholog(s) of this gene are implicated in sitosterolemia. Is an ortholog of human ABCG5 (ATP binding cassette subfamily G member 5).

WB:WBGene00006523	tam-1
Is predicted to have metal ion binding activity. Is involved in several processes, including chromosome segregation; negative regulation of vulval development; and positive regulation of gene expression, epigenetic. Localizes to germ cell nucleus. Is expressed in several structures, including germ line.

WB:WBGene00006524	tap-1
Exhibits mitogen-activated protein kinase kinase kinase binding activity and protein kinase activator activity. Is involved in endodermal cell fate specification; negative regulation of Ras protein signal transduction; and positive regulation of protein kinase activity. Is expressed in cholinergic neurons; coelomocyte; and somatic neurons. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1).

WB:WBGene00006525	tax-2
Contributes to intracellular cGMP-activated cation channel activity. Is involved in several processes, including G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; generation of neurons; and negative regulation of cGMP-mediated signaling. Localizes to cation channel complex. Is expressed in amphid neurons and oxygen sensory neurons. Human ortholog(s) of this gene are implicated in several diseases, including achromatopsia 3; heart conduction disease (multiple); and retinal degeneration (multiple). Is an ortholog of human CNGB1 (cyclic nucleotide gated channel subunit beta 1) and CNGB3 (cyclic nucleotide gated channel subunit beta 3).

WB:WBGene00006526	tax-4
Exhibits intracellular cAMP-activated cation channel activity and intracellular cGMP-activated cation channel activity. Is involved in several processes, including G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; generation of neurons; and negative regulation of cGMP-mediated signaling. Localizes to several cellular components, including cation channel complex; ciliary inversin compartment; and non-motile cilium. Human ortholog(s) of this gene are implicated in several diseases, including early infantile epileptic encephalopathy 24; eye disease (multiple); and heart conduction disease (multiple). Is an ortholog of human CNGA1 (cyclic nucleotide gated channel subunit alpha 1); CNGA2 (cyclic nucleotide gated channel subunit alpha 2); and CNGA3 (cyclic nucleotide gated channel subunit alpha 3).

WB:WBGene00006527	tax-6
Exhibits calcium ion binding activity and calmodulin-dependent protein phosphatase activity. Is involved in several processes, including male mating behavior; peptidyl-serine dephosphorylation; and positive regulation of growth rate. Localizes to several cellular components, including dendrite; neuronal cell body; and non-motile cilium. Is expressed in several structures, including germ line; head neurons; muscle cell; tail neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in infantile or early childhood epileptic encephalopathy 1. Is an ortholog of human PPP3CB (protein phosphatase 3 catalytic subunit beta) and PPP3CC (protein phosphatase 3 catalytic subunit gamma).

WB:WBGene00006528	tba-1
Is predicted to have GTP binding activity. Is involved in embryo development; establishment of mitotic spindle orientation; and regulation of cytokinesis. Localizes to several cellular components, including cytoskeleton; dendrite; and neuronal cell body. Is expressed in several structures, including ganglia; germ line; intestine; neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 22; brain disease (multiple); and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBA8 (tubulin alpha 8).

WB:WBGene00006529	tba-2
Is predicted to have GTP binding activity. Is involved in several processes, including centrosome localization; establishment of mitotic spindle orientation; and regulation of cytokinesis. Is expressed in several structures, including body wall musculature; intestine; neurons; pharynx; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis type 22; brain disease (multiple); and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBA1A (tubulin alpha 1a).

WB:WBGene00006530	tba-4
Is predicted to have GTP binding activity. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 22; brain disease (multiple); and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBA8 (tubulin alpha 8).

WB:WBGene00006531	tba-5
Is predicted to have GTP binding activity. Localizes to axonemal microtubule. Is expressed in amphid neurons and phasmid neurons. Human ortholog(s) of this gene are implicated in complex cortical dysplasia with other brain malformations 1 and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBAL3 (tubulin alpha like 3).

WB:WBGene00006532	tba-6
Is predicted to have GTP binding activity. Is expressed in HSN; ciliated neurons; intestine; and vulva. Human ortholog(s) of this gene are implicated in complex cortical dysplasia with other brain malformations 1 and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBAL3 (tubulin alpha like 3).

WB:WBGene00006533	tba-7
Is predicted to have GTP binding activity. Is expressed in touch receptor neurons. Human ortholog(s) of this gene are implicated in autosomal dominant macrothrombocytopenia TUBB1-related; brain disease (multiple); and congenital fibrosis of the extraocular muscles.

WB:WBGene00006534	tba-8
Is predicted to have GTP binding activity. Is expressed in germ line; posterior lateral ganglion; retrovesicular ganglion; seam cell; and ventral cord neurons. Human ortholog(s) of this gene are implicated in several diseases, including autosomal dominant macrothrombocytopenia TUBB1-related; complex cortical dysplasia with other brain malformations (multiple); and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBAL3 (tubulin alpha like 3).

WB:WBGene00006535	tba-9
Is predicted to have GTP binding activity. Is expressed in RIG; accessory cell; ciliated neurons; ventral cord neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in complex cortical dysplasia with other brain malformations 1 and congenital fibrosis of the extraocular muscles.

WB:WBGene00006536	tbb-1
Is predicted to have GTP binding activity. Localizes to spindle microtubule. Is expressed in body wall musculature; intestine; neurons; pharynx; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); congenital fibrosis of the extraocular muscles; and hypomyelinating leukodystrophy 6. Is an ortholog of human TUBB (tubulin beta class I); TUBB3 (tubulin beta 3 class III); and TUBB6 (tubulin beta 6 class V).

WB:WBGene00006537	tbb-2
Is predicted to have GTP binding activity. Is involved in meiotic spindle organization. Localizes to spindle microtubule. Is expressed in several structures, including germ line; gonad; oocyte; tail; and touch receptor neurons. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); congenital fibrosis of the extraocular muscles; and hypomyelinating leukodystrophy 6. Is an ortholog of human TUBB (tubulin beta class I); TUBB3 (tubulin beta 3 class III); and TUBB6 (tubulin beta 6 class V).

WB:WBGene00006538	tbb-4
Is predicted to have GTP binding activity. Localizes to axonemal microtubule. Is expressed in HSN; accessory cell; ciliated neurons; and vulval muscle. Is an ortholog of human TUBB4B (tubulin beta 4B class IVb).

WB:WBGene00006539	tbb-6
Is predicted to have GTP binding activity. Is involved in PERK-mediated unfolded protein response. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in autosomal dominant macrothrombocytopenia TUBB1-related; complex cortical dysplasia with other brain malformations (multiple); and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBB1 (tubulin beta 1 class VI).

WB:WBGene00006540	tbg-1
Is predicted to have GTP binding activity. Is involved in several processes, including cytoskeleton organization; maintenance of centrosome location; and regulation of mitotic cell cycle. Localizes to centrosome and cytoplasm. Is expressed in gonad. Human ortholog(s) of this gene are implicated in complex cortical dysplasia with other brain malformations 1; complex cortical dysplasia with other brain malformations 4; and congenital fibrosis of the extraocular muscles. Is an ortholog of human TUBG1 (tubulin gamma 1) and TUBG2 (tubulin gamma 2).

WB:WBGene00006541	tbh-1
Exhibits tyramine-beta hydroxylase activity. Is involved in octopamine biosynthetic process. Localizes to synapse. Is expressed in RICL; RICR; and gonad. Human ortholog(s) of this gene are implicated in dopamine beta-hydroxylase deficiency. Is an ortholog of human DBH (dopamine beta-hydroxylase).

WB:WBGene00006542	tbp-1
Exhibits AT DNA binding activity; DNA-binding transcription factor activity; and transcription factor binding activity. Is involved in positive regulation of transcription, DNA-templated. Localizes to nucleus. Is expressed in gonad. Human ortholog(s) of this gene are implicated in late onset Parkinson's disease and spinocerebellar ataxia type 17. Is an ortholog of human TBP (TATA-box binding protein) and TBPL2 (TATA-box binding protein like 2).

WB:WBGene00006543	tbx-2
Exhibits enzyme binding activity. Is involved in several processes, including muscle cell fate specification; olfactory behavior; and pharyngeal muscle development. Localizes to cytoplasm and nucleus. Is expressed in amphid neurons; body wall musculature; head neurons; and pharynx. Is an ortholog of human TBX2 (T-box transcription factor 2) and TBX3 (T-box transcription factor 3).

WB:WBGene00006544	tbx-7
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006545	tbx-8
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in embryonic body morphogenesis. Localizes to nucleus. Is expressed in several structures, including Eal; Ear; Epl; Epr; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including adrenocorticotropic hormone deficiency; asthma, nasal polyps, and aspirin intolerance; and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006546	tbx-9
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in embryonic body morphogenesis. Localizes to nucleus. Is expressed in several structures, including ABarpa; Eal; Ear; Epl; and Epr. Human ortholog(s) of this gene are implicated in adrenocorticotropic hormone deficiency; atrial heart septal defect 4; and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006547	tbx-11
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in several diseases, including DiGeorge syndrome; congenital heart disease (multiple); and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006549	tbx-30
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00006550	tbx-31
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006551	tbx-32
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006552	tbx-33
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006553	tbx-34
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006554	tbx-35
Exhibits sequence-specific DNA binding activity. Is involved in cell fate specification; pharyngeal muscle development; and positive regulation of transcription by RNA polymerase II. Is expressed in several structures, including MSaa; MSpa; MSpp; head neurons; and intestine. Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006555	tbx-36
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006556	tbx-37
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in pharynx development. Localizes to nucleus. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in several diseases, including adrenocorticotropic hormone deficiency; asthma, nasal polyps, and aspirin intolerance; and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006557	tbx-38
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in pharynx development. Localizes to nucleus. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in several diseases, including adrenocorticotropic hormone deficiency; asthma, nasal polyps, and aspirin intolerance; and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006558	tbx-39
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head muscle; head neurons; intestine; tail neurons; and ventral nerve cord. Is an ortholog of human EOMES (eomesodermin); TBR1 (T-box brain transcription factor 1); and TBX21 (T-box transcription factor 21).

WB:WBGene00006559	tbx-40
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in phasmid neurons. Human ortholog(s) of this gene are implicated in several diseases, including X-linked cleft palate with or without ankyloglossia; adrenocorticotropic hormone deficiency; and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00006560	tbx-41
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00006561	tcl-2
Is involved in asymmetric cell division. Localizes to cytoplasm and nucleus. Is expressed in several structures, including TL.p; TR.p; inner labial neurons; seam cell; and tail neurons.

WB:WBGene00006562	tdc-1
Exhibits tyrosine decarboxylase activity. Is involved in octopamine biosynthetic process. Localizes to axon and neuronal cell body. Is expressed in hermaphrodite gonad and lateral ganglion. Is an ortholog of human DDC (dopa decarboxylase).

WB:WBGene00006563	teg-1
Is involved in positive regulation of stem cell differentiation. Localizes to cytoplasm and nucleoplasm. Is expressed in seam cell; uterus; and vulva. Is an ortholog of human CD2BP2 (CD2 cytoplasmic tail binding protein 2).

WB:WBGene00006565	tfg-1
Is predicted to have identical protein binding activity. Is involved in several processes, including endoplasmic reticulum to Golgi vesicle-mediated transport; maintenance of protein localization in organelle; and regulation of cell size. Localizes to endoplasmic reticulum exit site. Colocalizes with mitochondrion. Is expressed in germ line; hypodermis; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2 and hereditary spastic paraplegia 57. Is an ortholog of human TFG (trafficking from ER to golgi regulator).

WB:WBGene00006566	tgt-1
Is predicted to have metal ion binding activity and queuine tRNA-ribosyltransferase activity. Is an ortholog of human QTRT1 (queuine tRNA-ribosyltransferase catalytic subunit 1).

WB:WBGene00006567	tgt-2
Is predicted to have metal ion binding activity and queuine tRNA-ribosyltransferase activity. Is an ortholog of human QTRT2 (queuine tRNA-ribosyltransferase accessory subunit 2).

WB:WBGene00006568	thk-1
Is predicted to have thymidine kinase activity. Is an ortholog of human TK1 (thymidine kinase 1).

WB:WBGene00006569	tig-1
No description available

WB:WBGene00006570	tig-2
Is predicted to have cytokine activity. Is expressed in cholinergic neurons; pharyngeal muscle cell; and touch receptor neurons. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 17; bone disease (multiple); and microphthalmia (multiple). Is an ortholog of human BMP8A (bone morphogenetic protein 8a) and BMP8B (bone morphogenetic protein 8b).

WB:WBGene00006571	tim-1
Is predicted to have DNA binding activity. Is involved in chromosome organization; embryo development; and regulation of sister chromatid cohesion. Localizes to nucleus. Is an ortholog of human TIMELESS (timeless circadian regulator).

WB:WBGene00006572	tin-9.1
Is predicted to have metal ion binding activity. Is involved in protein insertion into mitochondrial inner membrane; regulation of growth; and reproduction. Is an ortholog of human TIMM9 (translocase of inner mitochondrial membrane 9).

WB:WBGene00006573	tin-10
Is predicted to have metal ion binding activity. Is involved in protein insertion into mitochondrial inner membrane; regulation of growth; and reproduction. Is an ortholog of human TIMM10 (translocase of inner mitochondrial membrane 10).

WB:WBGene00006574	tin-13
Is predicted to have metal ion binding activity. Is an ortholog of human TIMM13 (translocase of inner mitochondrial membrane 13).

WB:WBGene00006575	tir-1
Exhibits several functions, including enzyme binding activity; identical protein binding activity; and protein serine/threonine kinase activator activity. Is involved in several processes, including NAD catabolic process; activation of MAPK activity; and defense response to other organism. Localizes to axon cytoplasm. Is expressed in head. Is used to study amyotrophic lateral sclerosis. Is an ortholog of human SARM1 (sterile alpha and TIR motif containing 1).

WB:WBGene00006576	tkr-1
Is predicted to have tachykinin receptor activity. Is expressed in ADEsoL; ADEsoR; PDEsoL; and PDEsoR. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 11 with or without anosmia. Is an ortholog of human TACR1 (tachykinin receptor 1) and TACR3 (tachykinin receptor 3).

WB:WBGene00006577	tlf-1
Is predicted to have DNA binding activity; DNA-binding transcription factor activity; and transcription factor binding activity. Is involved in embryo development; positive regulation of protein phosphorylation; and regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including germ line. Is an ortholog of human TBPL1 (TATA-box binding protein like 1).

WB:WBGene00006578	tli-1
Is predicted to have ubiquitin binding activity and ubiquitin conjugating enzyme binding activity. Is expressed in head and tail. Is an ortholog of human TOLLIP (toll interacting protein).

WB:WBGene00006579	tlk-1
Exhibits protein serine/threonine kinase activity. Is involved in positive regulation of protein kinase activity; protein autophosphorylation; and regulation of transcription by RNA polymerase II. Localizes to nuclear chromatin. Is expressed in germ line; head; posterior lateral ganglion; somatic cell; and somatic gonad. Is an ortholog of human TLK2 (tousled like kinase 2).

WB:WBGene00006580	tlp-1
Is predicted to have repressing transcription factor binding activity. Is involved in positive regulation of transcription by RNA polymerase II. Is expressed in several structures, including body wall musculature; rectal valve cell; somatic nervous system; tail precursor cell; and tail spike. Is an ortholog of human ZNF503 (zinc finger protein 503) and ZNF703 (zinc finger protein 703).

WB:WBGene00006582	tmd-2
Is predicted to have tropomyosin binding activity. Localizes to myofibril. Human ortholog(s) of this gene are implicated in nemaline myopathy 10. Is an ortholog of human LMOD2 (leiomodin 2) and LMOD3 (leiomodin 3).

WB:WBGene00006583	tnc-2
Exhibits troponin I binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93. Is an ortholog of human CALML6 (calmodulin like 6) and EFCAB9 (EF-hand calcium binding domain 9).

WB:WBGene00006584	tni-1
Exhibits troponin C binding activity. Is involved in backward locomotion. Localizes to muscle thin filament tropomyosin. Is expressed in several structures, including body wall musculature; gonad; non-striated muscle; rectal muscle; and in male. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 2B1 and intrinsic cardiomyopathy (multiple). Is an ortholog of human TNNI1 (troponin I1, slow skeletal type); TNNI2 (troponin I2, fast skeletal type); and TNNI3 (troponin I3, cardiac type).

WB:WBGene00006585	tni-3
Exhibits troponin C binding activity. Is involved in muscle contraction; oviposition; and post-embryonic body morphogenesis. Localizes to sarcomere. Is expressed in body wall musculature; non-striated muscle; rectal muscle; and in male. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 2B1 and intrinsic cardiomyopathy (multiple). Is an ortholog of human TNNI1 (troponin I1, slow skeletal type).

WB:WBGene00006586	tni-4
Exhibits troponin C binding activity. Is involved in embryo development and pharyngeal pumping. Localizes to sarcomere. Is expressed in pharyngeal muscle cell and pharynx. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 2B1 and intrinsic cardiomyopathy (multiple). Is an ortholog of human TNNI1 (troponin I1, slow skeletal type) and TNNI2 (troponin I2, fast skeletal type).

WB:WBGene00006587	tnt-2
Is predicted to contribute to calcium-dependent ATPase activity and tropomyosin binding activity. Human ortholog(s) of this gene are implicated in intrinsic cardiomyopathy (multiple) and muscle tissue disease (multiple). Is an ortholog of human TNNT1 (troponin T1, slow skeletal type).

WB:WBGene00006588	tnt-3
Is predicted to contribute to calcium-dependent ATPase activity and tropomyosin binding activity. Human ortholog(s) of this gene are implicated in intrinsic cardiomyopathy (multiple) and muscle tissue disease (multiple). Is an ortholog of human TNNT1 (troponin T1, slow skeletal type); TNNT2 (troponin T2, cardiac type); and TNNT3 (troponin T3, fast skeletal type).

WB:WBGene00006589	tnt-4
Is predicted to contribute to calcium-dependent ATPase activity and tropomyosin binding activity. Is involved in several processes, including nematode larval development; pharyngeal gland morphogenesis; and pharynx development. Human ortholog(s) of this gene are implicated in intrinsic cardiomyopathy (multiple) and muscle tissue disease (multiple). Is an ortholog of human TNNT1 (troponin T1, slow skeletal type); TNNT2 (troponin T2, cardiac type); and TNNT3 (troponin T3, fast skeletal type).

WB:WBGene00006590	toc-1
Is predicted to have cation transmembrane transporter activity. Is an ortholog of human SLC30A6 (solute carrier family 30 member 6).

WB:WBGene00006591	toh-1
Is predicted to have metalloendopeptidase activity. Is expressed in arcade cell; egg-laying apparatus; hyp7 syncytium; intestine; and neuronal sheath cell.

WB:WBGene00006592	dpy-31
Is predicted to have metalloendopeptidase activity. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle. Is expressed in several structures, including amphid sheath cell; excretory duct; hypodermis; socket cell; and vulva.

WB:WBGene00006593	tol-1
Is predicted to have signaling receptor activity. Is involved in defense response to Gram-negative bacterium and embryo development. Is expressed in neurons. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1F and familial temporal lobe epilepsy 1. Is an ortholog of human CPN2 (carboxypeptidase N subunit 2).

WB:WBGene00006594	tom-1
Is predicted to have several functions, including GTPase activator activity; Rab GTPase binding activity; and syntaxin binding activity. Is involved in cellular response to salt; regulation of synaptic vesicle exocytosis; and synaptic vesicle priming. Localizes to several cellular components, including GABA-ergic synapse; cholinergic synapse; and extrinsic component of neuronal dense core vesicle membrane. Is expressed in head neurons; tail neurons; and ventral cord neurons. Is an ortholog of human STXBP5 (syntaxin binding protein 5) and STXBP5L (syntaxin binding protein 5 like).

WB:WBGene00006595	top-1
Exhibits DNA topoisomerase type I (single strand cut, ATP-independent) activity. Localizes to nucleolus and spindle pole centrosome. Is expressed in several structures, including IL socket cell; excretory cell; gonad; neurons; and oocyte. Is an ortholog of human TOP1 (DNA topoisomerase I) and TOP1MT (DNA topoisomerase I mitochondrial).

WB:WBGene00006596	top-3
Exhibits DNA topoisomerase type I (single strand cut, ATP-independent) activity. Is involved in DNA topological change. Human ortholog(s) of this gene are implicated in autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 5. Is an ortholog of human TOP3A (DNA topoisomerase III alpha).

WB:WBGene00006597	tor-1
Is predicted to have ATPase activity. Is expressed in anal depressor muscle; head mesodermal cell; head neurons; and intestinal muscle. Human ortholog(s) of this gene are implicated in torsion dystonia 1. Is an ortholog of human TOR1A (torsin family 1 member A) and TOR1B (torsin family 1 member B).

WB:WBGene00006598	tor-2
Is predicted to have ATPase activity. Is involved in cellular response to misfolded protein; negative regulation of gene expression; and regulation of neuron apoptotic process. Localizes to endoplasmic reticulum. Is expressed in neurons. Human ortholog(s) of this gene are implicated in torsion dystonia 1. Is an ortholog of human TOR1A (torsin family 1 member A) and TOR1B (torsin family 1 member B).

WB:WBGene00006599	tpa-1
Exhibits mitogen-activated protein kinase kinase kinase binding activity and protein serine/threonine kinase activity. Is involved in several processes, including defense response to other organism; positive regulation of macromolecule metabolic process; and positive regulation of response to external stimulus. Is expressed in tail. Human ortholog(s) of this gene are implicated in autoimmune lymphoproliferative syndrome type 3. Is an ortholog of human PRKCD (protein kinase C delta) and PRKCQ (protein kinase C theta).

WB:WBGene00006600	tph-1
Is predicted to have tryptophan 5-monooxygenase activity. Is involved in several processes, including determination of adult lifespan; positive regulation of transforming growth factor beta receptor signaling pathway; and serotonin biosynthetic process from tryptophan. Localizes to cytosol and neuron projection. Is expressed in pharynx and somatic nervous system. Is used to study alcohol use disorder and cocaine abuse. Human ortholog(s) of this gene are implicated in endogenous depression. Is an ortholog of human TPH1 (tryptophan hydroxylase 1).

WB:WBGene00006601	tpi-1
Is predicted to have triose-phosphate isomerase activity. Is involved in cell redox homeostasis and determination of adult lifespan. Localizes to myofibril. Human ortholog(s) of this gene are implicated in triosephosphate isomerase deficiency. Is an ortholog of human TPI1 (triosephosphate isomerase 1).

WB:WBGene00006602	tps-1
Is predicted to have alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity. Is expressed in intestine.

WB:WBGene00006603	tps-2
Is predicted to have alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity.

WB:WBGene00006604	tra-1
Exhibits RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity; and protein C-terminus binding activity. Is involved in several processes, including female somatic sex determination; negative regulation of transcription by RNA polymerase II; and positive regulation of neuron apoptotic process. Localizes to cytoplasm and nucleus. Is expressed in germ line; gonad; intestine; somatic cell; and somatic gonad precursor. Human ortholog(s) of this gene are implicated in several diseases, including Culler-Jones syndrome; Greig cephalopolysyndactyly syndrome; and Pallister-Hall syndrome. Is an ortholog of human GLI2 (GLI family zinc finger 2).

WB:WBGene00006605	tra-2
Exhibits transmembrane signaling receptor activity. Is involved in several processes, including hermaphrodite germ-line sex determination; oocyte fate determination; and oocyte morphogenesis. Localizes to nucleus; perinuclear region of cytoplasm; and spanning component of plasma membrane. Is expressed in germ line.

WB:WBGene00006606	tra-3
Exhibits cysteine-type endopeptidase activity. Is involved in female germ-line sex determination; feminization of hermaphrodite soma; and proteolysis. Is expressed in several structures, including excretory cell; hypodermis; intestine; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in neovascular inflammatory vitreoretinopathy and type 2 diabetes mellitus. Is an ortholog of human CAPN5 (calpain 5).

WB:WBGene00006607	tre-1
Is predicted to have alpha,alpha-trehalase activity. Is an ortholog of human TREH (trehalase).

WB:WBGene00006608	tre-2
Is predicted to have alpha,alpha-trehalase activity. Is an ortholog of human TREH (trehalase).

WB:WBGene00006609	tre-3
Is predicted to have alpha,alpha-trehalase activity. Localizes to membrane raft. Is expressed in head and tail. Is an ortholog of human TREH (trehalase).

WB:WBGene00006610	tre-4
Is predicted to have alpha,alpha-trehalase activity. Is expressed in neurons and tail. Is an ortholog of human TREH (trehalase).

WB:WBGene00006611	tre-5
Is predicted to have alpha,alpha-trehalase activity. Is expressed in head. Is an ortholog of human TREH (trehalase).

WB:WBGene00006612	trf-1
Is predicted to have ubiquitin-protein transferase activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in CEMDL; CEMDR; CEMVL; CEMVR; and tail. Is an ortholog of human TRAF4 (TNF receptor associated factor 4).

WB:WBGene00006613	trm-1
Is predicted to have tRNA (guanine-N2-)-methyltransferase activity. Is an ortholog of human TRMT1 (tRNA methyltransferase 1).

WB:WBGene00006614	trp-1
Is predicted to have inositol 1,4,5 trisphosphate binding activity and store-operated calcium channel activity. Is expressed in neurons and non-striated muscle. Is used to study nicotine dependence. Is an ortholog of human TRPC3 (transient receptor potential cation channel subfamily C member 3).

WB:WBGene00006615	trp-2
Is predicted to have inositol 1,4,5 trisphosphate binding activity and store-operated calcium channel activity. Is expressed in ASER; SMDDL; SMDDR; SMDVL; and SMDVR. Is used to study nicotine dependence. Is an ortholog of human TRPC4 (transient receptor potential cation channel subfamily C member 4) and TRPC5 (transient receptor potential cation channel subfamily C member 5).

WB:WBGene00006616	trp-4
Is predicted to have calcium channel activity. Is expressed in DVA; DVC; and dopaminergic neurons.

WB:WBGene00006617	tars-1
Is predicted to have threonine-tRNA ligase activity. Is involved in determination of adult lifespan. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 21. Is an ortholog of human TARS1 (threonyl-tRNA synthetase 1) and TARS3 (threonyl-tRNA synthetase 3).

WB:WBGene00006618	trt-1
Is predicted to have telomerase RNA binding activity; telomerase RNA reverse transcriptase activity; and telomeric DNA binding activity. Is involved in telomere maintenance via telomerase. Human ortholog(s) of this gene are implicated in several diseases, including acute myeloid leukemia; dyskeratosis congenita (multiple); and idiopathic pulmonary fibrosis. Is an ortholog of human TERT (telomerase reverse transcriptase).

WB:WBGene00006619	try-1
Is predicted to have serine-type endopeptidase activity. Is expressed in germ line. Is an ortholog of human PRSS33 (serine protease 33).

WB:WBGene00006620	svh-1
Is predicted to have serine-type endopeptidase activity. Is involved in several processes, including positive regulation of gonad development; positive regulation of pharyngeal pumping; and protein destabilization. Is expressed in ADLL and ADLR. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 1; autosomal recessive nonsyndromic deafness 39; and inherited blood coagulation disease (multiple). Is an ortholog of human TMPRSS15 (transmembrane serine protease 15).

WB:WBGene00006621	try-3
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00006622	try-4
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00006623	try-5
Is predicted to have serine-type endopeptidase activity. Is involved in spermatid development. Localizes to extracellular space and secretory vesicle. Is expressed in several structures, including head; male gonad; male gonadal cell; tail; and uterus.

WB:WBGene00006624	try-6
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00006625	try-7
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00006626	tsn-1
Is predicted to have RNA binding activity and nuclease activity. Is involved in gene silencing by miRNA. Localizes to RISC complex; cytosol; and nucleus. Is expressed in head and tail. Is an ortholog of human SND1 (staphylococcal nuclease and tudor domain containing 1).

WB:WBGene00006627	tsp-1
Is involved in innate immune response. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability.

WB:WBGene00006628	tsp-2
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including methylmercury hydroxide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family and Tetraspanin/Peripherin.

WB:WBGene00006629	tsp-3
Is enriched in NSM based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; and Tetraspanin/Peripherin.

WB:WBGene00006630	tsp-4
Is enriched in DA neuron; OLL; PVD; and VA neuron based on tiling array studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Cadmium Chloride; and resveratrol based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human CD9 (CD9 molecule) and TSPAN2 (tetraspanin 2).

WB:WBGene00006631	tsp-5
Is affected by several genes including daf-2; clk-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and resveratrol based on microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human CD9 (CD9 molecule).

WB:WBGene00006632	tsp-6
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human CD9 (CD9 molecule).

WB:WBGene00006633	tsp-7
Is expressed in DA neuron; head neurons; tail neurons; touch receptor neurons; and ventral cord neurons. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human CD63 (CD63 molecule).

WB:WBGene00006634	tsp-8
Is enriched in several structures, including germ line; head mesodermal cell; muscle cell; neurons; and somatic nervous system based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on proteomic; RNA-seq; and microarray studies. Is affected by twelve chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human CD9 (CD9 molecule).

WB:WBGene00006635	tsp-9
Is enriched in intestine; pharynx; and somatic gonad precursor based on microarray; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by Cry5B and paraquat based on microarray studies. Human ortholog(s) of this gene are implicated in common variable immunodeficiency. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human CD81 (CD81 molecule).

WB:WBGene00006636	tsp-10
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; Rotenone; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin.

WB:WBGene00006637	tsp-11
Is enriched in body wall muscle cell; body wall musculature; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; and Tetraspanin/Peripherin. Is an ortholog of several human genes including CD53 (CD53 molecule); TSPAN4 (tetraspanin 4); and TSPAN9 (tetraspanin 9).

WB:WBGene00006638	tsp-12
Exhibits protease binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of oviposition; and regulation of embryonic development. Localizes to cytoplasmic vesicle membrane and plasma membrane. Is expressed in several structures, including M lineage cell; germ line; intestine; pharynx; and vulval precursor cell. Is used to study cancer. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is an ortholog of human TSPAN5 (tetraspanin 5).

WB:WBGene00006639	tsp-13
Is enriched in NSM; Z1.p; Z4.a; intestine; and male distal tip cell based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including skn-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin.

WB:WBGene00006640	tsp-14
Exhibits protease binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; positive regulation of oviposition; and regulation of embryonic development. Is used to study cancer. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is an ortholog of human TSPAN10 (tetraspanin 10).

WB:WBGene00006641	tsp-15
Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle and skin epidermis development. Is expressed in body wall musculature; hyp7 syncytium; pharynx; seam cell; and vulva. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability.

WB:WBGene00006642	tsp-16
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin.

WB:WBGene00006643	tsp-17
Exhibits D2 dopamine receptor binding activity. Is involved in cellular response to paraquat; negative regulation of oxidative stress-induced neuron death; and regulation of dopamine uptake involved in synaptic transmission. Localizes to several cellular components, including axon; dendrite; and perinuclear region of cytoplasm. Is expressed in several structures, including NSM; body wall musculature; dopaminergic neurons; hermaphrodite gonad; and vulva. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability.

WB:WBGene00006644	tsp-18
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Cry5B; and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domain: Tetraspanin, EC2 domain superfamily.

WB:WBGene00006645	tsp-19
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family and Tetraspanin/Peripherin.

WB:WBGene00006646	tsp-20
Is enriched in DA neuron; VA neuron; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin. Is an ortholog of human TSPAN11 (tetraspanin 11).

WB:WBGene00006647	tsr-1
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including antimycin; paraquat; and resveratrol based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 2. Is predicted to encode a protein with the following domains: Exportin 1-like protein; Armadillo-like helical; Exportin-1/Importin-beta-like; and Armadillo-type fold. Is an ortholog of human TNPO3 (transportin 3).

WB:WBGene00006648	ttb-1
Is predicted to have RNA polymerase II complex recruiting activity; RNA polymerase II core promoter sequence-specific DNA binding activity; and TBP-class protein binding activity. Is an ortholog of human GTF2B (general transcription factor IIB).

WB:WBGene00006649	tth-1
Is predicted to have actin monomer binding activity. Is expressed in distal tip cell; nerve ring; oocyte; spermatheca; and terminal bulb. Is an ortholog of human TMSB4X (thymosin beta 4 X-linked).

WB:WBGene00006650	tts-1
Is enriched in muscle cell and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies.

WB:WBGene00006651	tts-2
Is enriched in DA neuron; head mesodermal cell; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00006652	ttx-1
Exhibits DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including regulation of plasma membrane bounded cell projection assembly; thermosensory behavior; and transcription by RNA polymerase II. Localizes to nucleus. Is expressed in AFDL; AFDR; and marginal cell. Human ortholog(s) of this gene are implicated in several diseases, including Leri-Weill dyschondrosteosis; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human OTX1 (orthodenticle homeobox 1).

WB:WBGene00006653	ttx-2
No description available

WB:WBGene00006654	ttx-3
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including generation of neurons; thermosensory behavior; and thermotaxis. Is expressed in head muscle; head neurons; and pharyngeal neurons. Human ortholog(s) of this gene are implicated in congenital ptosis; hypopituitarism; and myopathy (multiple). Is an ortholog of human LHX9 (LIM homeobox 9).

WB:WBGene00006655	tub-1
Is involved in receptor localization to non-motile cilium. Is expressed in neurons. Is used to study obesity. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 15 and retinitis pigmentosa 14. Is an ortholog of human TUB (TUB bipartite transcription factor); TULP1 (TUB like protein 1); and TULP3 (TUB like protein 3).

WB:WBGene00006656	twk-1
Is predicted to have potassium ion leak channel activity. Is expressed in distal tip cell; gonadal sheath cell; and hypodermis.

WB:WBGene00006657	twk-2
Is predicted to have potassium ion leak channel activity. Is expressed in neurons. Is an ortholog of human KCNK18 (potassium two pore domain channel subfamily K member 18).

WB:WBGene00006658	twk-3
Is predicted to have potassium ion leak channel activity. Is expressed in RIGL; RIGR; neurons; and pharynx.

WB:WBGene00006659	twk-4
Is predicted to have potassium ion leak channel activity. Is expressed in sensory neurons.

WB:WBGene00006660	twk-5
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006661	twk-6
Is predicted to have potassium ion leak channel activity. Is expressed in hypodermis and tail.

WB:WBGene00006662	twk-7
Is predicted to have potassium ion leak channel activity. Is expressed in neurons and ventral nerve cord.

WB:WBGene00006663	twk-8
Is predicted to have potassium ion leak channel activity. Is expressed in body wall musculature.

WB:WBGene00006664	twk-9
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006665	twk-10
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006666	twk-11
Is predicted to have potassium ion leak channel activity. Is an ortholog of human KCNK18 (potassium two pore domain channel subfamily K member 18).

WB:WBGene00006667	twk-12
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006668	twk-13
Is predicted to have potassium ion leak channel activity. Is expressed in cholinergic neurons and ventral cord neurons.

WB:WBGene00006669	twk-14
Is predicted to have potassium ion leak channel activity. Is an ortholog of human KCNK12 (potassium two pore domain channel subfamily K member 12) and KCNK13 (potassium two pore domain channel subfamily K member 13).

WB:WBGene00006670	twk-16
Is predicted to have potassium ion leak channel activity. Is expressed in DVA and interneuron.

WB:WBGene00006671	twk-17
Is predicted to have potassium ion leak channel activity. Is expressed in neurons.

WB:WBGene00006672	twk-18
Exhibits outward rectifier potassium channel activity. Is involved in locomotion; muscle contraction; and potassium ion transport. Is expressed in body wall musculature.

WB:WBGene00006673	twk-20
Is predicted to have potassium ion leak channel activity. Is expressed in muscle cell and neurons. Human ortholog(s) of this gene are implicated in Birk-Barel syndrome and primary pulmonary hypertension. Is an ortholog of human KCNK15 (potassium two pore domain channel subfamily K member 15); KCNK3 (potassium two pore domain channel subfamily K member 3); and KCNK9 (potassium two pore domain channel subfamily K member 9).

WB:WBGene00006674	twk-21
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006675	twk-22
Is predicted to have potassium ion leak channel activity. Is expressed in pharynx.

WB:WBGene00006676	twk-23
Is predicted to have potassium ion leak channel activity. Is expressed in intestine; muscle cell; and neurons.

WB:WBGene00006677	twk-24
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006678	twk-25
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006679	twk-26
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006680	twk-28
Is predicted to have potassium ion leak channel activity. Is expressed in body wall musculature. Is an ortholog of human KCNK18 (potassium two pore domain channel subfamily K member 18).

WB:WBGene00006681	twk-29
Is predicted to have potassium ion leak channel activity. Is expressed in interneuron.

WB:WBGene00006682	twk-30
Is predicted to have potassium ion leak channel activity. Is expressed in DD neuron; motor neurons; neurons; and ventral cord neurons.

WB:WBGene00006683	twk-31
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006684	twk-32
Is predicted to have potassium ion leak channel activity. Is expressed in interneuron.

WB:WBGene00006685	twk-33
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006686	twk-34
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006687	twk-35
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006688	twk-36
Is predicted to have potassium ion leak channel activity. Is expressed in excretory cell.

WB:WBGene00006689	twk-37
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006690	twk-39
Is predicted to have potassium ion leak channel activity. Is an ortholog of human KCNK18 (potassium two pore domain channel subfamily K member 18).

WB:WBGene00006691	twk-40
Is predicted to have potassium ion leak channel activity. Is expressed in cholinergic neurons and ventral cord neurons.

WB:WBGene00006692	twk-42
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006693	twk-43
Is predicted to have potassium ion leak channel activity. Is expressed in cholinergic neurons and ventral cord neurons.

WB:WBGene00006694	twk-44
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006695	twk-45
Is predicted to have potassium ion leak channel activity.

WB:WBGene00006696	twk-46
Is predicted to have potassium ion leak channel activity. Is expressed in NSML; NSMR; PDEL; and PDER. Is an ortholog of human KCNK1 (potassium two pore domain channel subfamily K member 1) and KCNK6 (potassium two pore domain channel subfamily K member 6).

WB:WBGene00006697	uaf-1
Exhibits pre-mRNA 3'-splice site binding activity. Is involved in several processes, including embryonic body morphogenesis; mRNA 3'-splice site recognition; and nematode larval development. Localizes to nucleoplasm. Is an ortholog of human U2AF2 (U2 small nuclear RNA auxiliary factor 2).

WB:WBGene00006698	uaf-2
Exhibits pre-mRNA 3'-splice site binding activity. Is an ortholog of human U2AF1L5 (U2 small nuclear RNA auxiliary factor 1 like 5).

WB:WBGene00006699	uba-1
Is predicted to have ubiquitin activating enzyme activity. Is involved in several processes, including gamete generation; nematode male tail tip morphogenesis; and regulation of phosphorylation of RNA polymerase II C-terminal domain. Localizes to nucleus. Is expressed in anterior hypodermis; germ line; midbody; neurons; and pharynx. Is an ortholog of human UBA1 (ubiquitin like modifier activating enzyme 1).

WB:WBGene00006700	uba-2
Exhibits SUMO activating enzyme activity. Is involved in several processes, including anterior/posterior pattern specification; nematode larval development; and protein sumoylation. Is an ortholog of human UBA2 (ubiquitin like modifier activating enzyme 2).

WB:WBGene00006701	ubc-1
Exhibits ubiquitin conjugating enzyme activity and ubiquitin protein ligase binding activity. Is predicted to contribute to single-stranded DNA binding activity. Is involved in DNA repair and protein ubiquitination. Localizes to ubiquitin conjugating enzyme complex. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Nascimento type. Is an ortholog of human UBE2A (ubiquitin conjugating enzyme E2 A) and UBE2B (ubiquitin conjugating enzyme E2 B).

WB:WBGene00006702	ubc-3
Is predicted to have ATP binding activity and transferase activity. Is an ortholog of human CDC34 (cell division cycle 34, ubiqiutin conjugating enzyme) and UBE2R2 (ubiquitin conjugating enzyme E2 R2).

WB:WBGene00006703	ubc-6
Is predicted to have ubiquitin conjugating enzyme activity. Is expressed in germ line and oocyte. Is an ortholog of human UBE2J1 (ubiquitin conjugating enzyme E2 J1).

WB:WBGene00006704	ubc-7
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human UBE2G1 (ubiquitin conjugating enzyme E2 G1).

WB:WBGene00006705	ubc-8
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human UBE2H (ubiquitin conjugating enzyme E2 H).

WB:WBGene00006706	ubc-9
Exhibits RNA polymerase II transcription factor binding activity; SAM domain binding activity; and SUMO conjugating enzyme activity. Is involved in several processes, including negative regulation of transcription by RNA polymerase II; pharyngeal muscle development; and protein sumoylation. Is expressed in body wall musculature; coelomocyte; pharynx; tail; and in male. Is an ortholog of human UBE2I (ubiquitin conjugating enzyme E2 I).

WB:WBGene00006707	ubc-12
Exhibits NEDD8 transferase activity. Is involved in negative regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of nematode male tail tip morphogenesis; and protein neddylation. Is expressed in hyp10. Is an ortholog of human UBE2F (ubiquitin conjugating enzyme E2 F (putative)).

WB:WBGene00006708	ubc-13
Contributes to ubiquitin-protein transferase activity. Is involved in protein ubiquitination and regulation of protein localization to cell surface. Localizes to ubiquitin conjugating enzyme complex. Is expressed in several structures, including intestinal cell. Is an ortholog of human UBE2N (ubiquitin conjugating enzyme E2 N).

WB:WBGene00006709	ubc-14
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human UBE2G2 (ubiquitin conjugating enzyme E2 G2).

WB:WBGene00006710	ubc-15
Exhibits ubiquitin protein ligase binding activity. Is an ortholog of human UBE2J2 (ubiquitin conjugating enzyme E2 J2).

WB:WBGene00006711	ubc-16
Is predicted to have ubiquitin conjugating enzyme activity. Is involved in protein ubiquitination. Is expressed in germ line and oocyte. Is an ortholog of human UBE2W (ubiquitin conjugating enzyme E2 W).

WB:WBGene00006712	ubc-17
Is predicted to have cysteine-type endopeptidase inhibitor activity and ubiquitin conjugating enzyme activity. Is an ortholog of human BIRC6 (baculoviral IAP repeat containing 6).

WB:WBGene00006713	ubc-18
Exhibits ubiquitin conjugating enzyme activity and ubiquitin protein ligase binding activity. Is involved in several processes, including cellular protein metabolic process; embryonic digestive tract morphogenesis; and positive regulation of ubiquitin-protein transferase activity. Is an ortholog of human UBE2L3 (ubiquitin conjugating enzyme E2 L3).

WB:WBGene00006714	ubc-19
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human AKTIP (AKT interacting protein).

WB:WBGene00006715	ubc-20
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human UBE2K (ubiquitin conjugating enzyme E2 K).

WB:WBGene00006716	ubc-21
Is predicted to have ubiquitin conjugating enzyme activity. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group T. Is an ortholog of human UBE2K (ubiquitin conjugating enzyme E2 K).

WB:WBGene00006717	ubc-22
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human UBE2K (ubiquitin conjugating enzyme E2 K).

WB:WBGene00006718	ubc-23
Is expressed in intestinal cell. Is predicted to encode a protein with the following domains: UBA-like domain; UAS; and Thioredoxin-like superfamily. Is an ortholog of human FAF1 (Fas associated factor 1).

WB:WBGene00006719	ubc-24
Is predicted to have ubiquitin conjugating enzyme activity and ubiquitin protein ligase binding activity.

WB:WBGene00006720	ubc-25
Is predicted to have ubiquitin conjugating enzyme activity. Is involved in locomotion. Localizes to cytosol; neuronal cell body; and nucleus. Is expressed in body wall musculature; embryonic cell; non-striated muscle; and somatic nervous system. Is an ortholog of human UBE2Q1 (ubiquitin conjugating enzyme E2 Q1) and UBE2Q2 (ubiquitin conjugating enzyme E2 Q2).

WB:WBGene00006721	ubh-1
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human UCHL1 (ubiquitin C-terminal hydrolase L1) and UCHL3 (ubiquitin C-terminal hydrolase L3).

WB:WBGene00006722	ubh-2
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human UCHL3 (ubiquitin C-terminal hydrolase L3).

WB:WBGene00006723	ubh-3
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human UCHL1 (ubiquitin C-terminal hydrolase L1) and UCHL3 (ubiquitin C-terminal hydrolase L3).

WB:WBGene00006724	ubh-4
Exhibits thiol-dependent ubiquitin-specific protease activity. Is involved in negative regulation of proteasomal ubiquitin-dependent protein catabolic process and protein deubiquitination. Is expressed in intestine; muscle cell; and neurons. Is an ortholog of human UCHL5 (ubiquitin C-terminal hydrolase L5).

WB:WBGene00006725	ubl-1
Is predicted to have protein tag and ubiquitin protein ligase binding activity. Is an ortholog of human RPS27A (ribosomal protein S27a).

WB:WBGene00006726	ubl-5
Is predicted to have protein tag. Is involved in mitochondrial unfolded protein response and positive regulation of gene expression. Localizes to cytosol and nuclear transcription factor complex. Is expressed in intestine; pharynx; and terminal bulb. Is an ortholog of human UBL5 (ubiquitin like 5).

WB:WBGene00006727	ubq-1
Is predicted to have protein tag and ubiquitin protein ligase binding activity. Is expressed in body wall musculature. Is an ortholog of human UBC (ubiquitin C).

WB:WBGene00006728	ubq-2
Is predicted to have protein tag and ubiquitin protein ligase binding activity. Is involved in polarity specification of anterior/posterior axis. Is expressed in several structures, including hermaphrodite gonad; intestine; pharyngeal-intestinal valve; pharynx; and somatic nervous system. Is an ortholog of human UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1).

WB:WBGene00006729	ucp-4
Is involved in response to cold. Is expressed in head muscle; head neurons; hypodermis; pharyngeal muscle cell; and pharynx. Is an ortholog of human SLC25A27 (solute carrier family 25 member 27).

WB:WBGene00006730	uev-1
Exhibits ubiquitin conjugating enzyme binding activity. Is involved in regulation of locomotion involved in locomotory behavior and regulation of protein localization to cell surface. Localizes to cytosol; neuron projection; and nucleus. Is expressed in several structures, including anus; distal tip cell; germ line; neurons; and ventral nerve cord. Is an ortholog of human UBE2V2 (ubiquitin conjugating enzyme E2 V2).

WB:WBGene00006731	uev-2
Is predicted to have ubiquitin conjugating enzyme activity.

WB:WBGene00006732	uev-3
Is predicted to have ubiquitin conjugating enzyme activity. Is expressed in several structures, including ventral cord neurons.

WB:WBGene00006733	ufd-1
Is predicted to have polyubiquitin modification-dependent protein binding activity. Is involved in ER-associated misfolded protein catabolic process; embryo development; and positive regulation of protein localization to nucleus. Localizes to VCP-NPL4-UFD1 AAA ATPase complex and nucleus. Is used to study velocardiofacial syndrome. Is an ortholog of human UFD1 (ubiquitin recognition factor in ER associated degradation 1).

WB:WBGene00006734	ufd-2
Exhibits chaperone binding activity; ubiquitin protein ligase binding activity; and ubiquitin-ubiquitin ligase activity. Is involved in determination of adult lifespan; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; and protein ubiquitination. Localizes to cytoplasm and nucleus. Is expressed in body wall musculature; hypodermis; neurons; and pharyngeal muscle cell. Is an ortholog of human UBE4B (ubiquitination factor E4B).

WB:WBGene00006735	ula-1
Is predicted to have NEDD8 activating enzyme activity. Is involved in negative regulation of DNA damage response, signal transduction by p53 class mediator. Is an ortholog of human NAE1 (NEDD8 activating enzyme E1 subunit 1).

WB:WBGene00006736	ulp-1
Is predicted to have cysteine-type peptidase activity. Is involved in several processes, including embryo development; positive regulation of error-prone translesion synthesis; and protein desumoylation. Is an ortholog of human SENP1 (SUMO specific peptidase 1) and SENP2 (SUMO specific peptidase 2).

WB:WBGene00006737	ulp-2
Is predicted to have SUMO-specific isopeptidase activity. Is involved in adherens junction maintenance; protein desumoylation; and regulation of cell-cell adhesion involved in gastrulation. Localizes to cytosol and nucleus. Is expressed in hypodermis and neuroblasts. Is an ortholog of human SENP7 (SUMO specific peptidase 7).

WB:WBGene00006738	ulp-3
Is predicted to have cysteine-type peptidase activity. Is an ortholog of human SENP8 (SUMO peptidase family member, NEDD8 specific).

WB:WBGene00006739	ulp-4
Is predicted to have cysteine-type peptidase activity. Is involved in protein desumoylation. Localizes to mitochondrial matrix. Is expressed in HSNL; HSNR; body wall musculature; hypodermis; and pharynx. Is an ortholog of human SENP7 (SUMO specific peptidase 7).

WB:WBGene00006740	ulp-5
Is predicted to have cysteine-type peptidase activity.

WB:WBGene00006741	unc-1
Is involved in positive regulation of cell communication by electrical coupling and response to drug. Localizes to axon and gap junction. Is expressed in several structures, including enteric muscle; ganglia; head neurons; somatic nervous system; and vulval muscle. Is an ortholog of human STOM (stomatin) and STOML3 (stomatin like 3).

WB:WBGene00006742	unc-2
Is predicted to have voltage-gated calcium channel activity. Is involved in several processes, including determination of left/right asymmetry in nervous system; negative regulation of transforming growth factor beta receptor signaling pathway; and response to heat. Localizes to presynaptic active zone membrane. Is expressed in several structures, including body wall musculature; excretory canal; nerve ring; neurons; and pharyngeal muscle cell. Is used to study migraine. Human ortholog(s) of this gene are implicated in brain disease (multiple); hereditary ataxia (multiple); and spermatogenic failure 7. Is an ortholog of human CACNA1A (calcium voltage-gated channel subunit alpha1 A).

WB:WBGene00006743	unc-3
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity; histone acetyltransferase binding activity; and identical protein binding activity. Is involved in several processes, including dauer larval development; positive regulation of transcription by RNA polymerase II; and regulation of neuron projection development. Localizes to nucleus. Colocalizes with nuclear chromatin. Is expressed in ABalappaap; ABalappaapp; and neurons. Is an ortholog of human EBF3 (EBF transcription factor 3).

WB:WBGene00006744	unc-4
Exhibits DNA-binding transcription factor activity. Is involved in several processes, including nervous system development; regulation of synapse structure or activity; and synaptic vesicle transport. Localizes to axon and nucleus. Is expressed in neurons and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Waardenburg's syndrome (multiple); diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human UNCX (UNC homeobox).

WB:WBGene00006745	unc-5
Exhibits netrin receptor activity and protein tyrosine kinase binding activity. Is involved in several processes, including establishment or maintenance of actin cytoskeleton polarity; generation of neurons; and nematode male tail tip morphogenesis. Localizes to axonal growth cone. Is expressed in several structures, including distal tip cell; excretory canal; head neurons; motor neurons; and somatic nervous system. Is an ortholog of human UNC5A (unc-5 netrin receptor A); UNC5B (unc-5 netrin receptor B); and UNC5C (unc-5 netrin receptor C).

WB:WBGene00006746	unc-6
Is predicted to have signaling receptor binding activity. Is involved in several processes, including establishment or maintenance of actin cytoskeleton polarity; generation of neurons; and nematode male tail tip morphogenesis. Localizes to axon; basement membrane; and cytoplasm. Is expressed in several structures, including P1; VA12; accessory cell; interneuron; and somatic neurons. Is an ortholog of human NTN1 (netrin 1).

WB:WBGene00006747	unc-7
Exhibits gap junction channel activity. Is involved in several processes, including oviposition; regulation of neuronal signal transduction; and spicule insertion. Localizes to gap junction and neuron projection membrane. Is expressed in several structures, including OL socket cell; g1AR; muscle cell; neurons; and pharyngeal gland cell.

WB:WBGene00006748	unc-8
Is predicted to have cation channel activity. Is involved in locomotion. Localizes to neuronal cell body. Is expressed in neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1A (sodium channel epithelial 1 subunit alpha); SCNN1B (sodium channel epithelial 1 subunit beta); and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00006749	unc-9
Exhibits gap junction channel activity. Is involved in ion transmembrane transport. Localizes to gap junction. Is expressed in several structures, including anchor cell; muscle cell; neurons; phasmid sheath cell; and somatic nervous system.

WB:WBGene00006750	unc-10
Exhibits Rab GTPase binding activity and protein C-terminus binding activity. Is involved in several processes, including chemical synaptic transmission; defecation; and positive regulation of cholinergic synaptic transmission. Localizes to axon and presynaptic active zone. Is expressed in dorsal nerve cord; nerve ring; and ventral nerve cord. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 7. Is an ortholog of human RIMS1 (regulating synaptic membrane exocytosis 1).

WB:WBGene00006751	unc-11
Is predicted to have SNARE binding activity; clathrin heavy chain binding activity; and phosphatidylinositol binding activity. Is involved in several processes, including endocytosis; positive regulation of necrotic cell death; and protein localization to postsynaptic membrane. Localizes to clathrin-coated pit and presynaptic membrane. Is expressed in coelomocyte; intestine; somatic nervous system; and uv1. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human PICALM (phosphatidylinositol binding clathrin assembly protein) and SNAP91 (synaptosome associated protein 91).

WB:WBGene00006752	unc-13
Is predicted to have calmodulin binding activity and syntaxin-1 binding activity. Is involved in several processes, including positive regulation of oocyte development; regulation of oviposition; and regulation of pharyngeal pumping. Localizes to presynaptic active zone. Is expressed in head neurons; neurons; tail neurons; and ventral nerve cord. Is an ortholog of human UNC13A (unc-13 homolog A) and UNC13B (unc-13 homolog B).

WB:WBGene00006753	unc-14
Exhibits protein kinase binding activity and scaffold protein binding activity. Is involved in regulation of protein localization and synaptic vesicle localization. Localizes to neuron projection. Is expressed in several structures, including hypodermis; intestine; motor neurons; muscle cell; and uterus.

WB:WBGene00006754	unc-15
Exhibits SH3 domain binding activity; cytoskeletal protein binding activity; and protein kinase binding activity. Is involved in several processes, including positive regulation of ovulation; positive regulation of sarcomere organization; and skeletal muscle myosin thick filament assembly. Localizes to A band and myosin filament. Is expressed in alimentary muscle; body wall musculature; gonad; vulval muscle; and in male. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple).

WB:WBGene00006755	unc-16
Exhibits MAP-kinase scaffold activity; kinesin binding activity; and receptor signaling complex adaptor activity. Is involved in several processes, including oviposition; regulation of JNK cascade; and vesicle-mediated transport. Localizes to axon; cell body; and cytoplasm. Is expressed in body wall musculature; hypodermis; intestine; and nervous system. Is an ortholog of human MAPK8IP3 (mitogen-activated protein kinase 8 interacting protein 3) and SPAG9 (sperm associated antigen 9).

WB:WBGene00006756	unc-17
Exhibits acetylcholine transmembrane transporter activity. Is involved in several processes, including cholinergic synaptic transmission; nematode larval development; and regulation of pharyngeal pumping. Localizes to several cellular components, including excitatory synapse; neuron projection; and synaptic vesicle. Is expressed in neurons; pm2; somatic nervous system; and in male. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 21. Is an ortholog of human SLC18A3 (solute carrier family 18 member A3).

WB:WBGene00006757	unc-18
Exhibits syntaxin binding activity. Is involved in cholinergic synaptic transmission; positive regulation of neurotransmitter secretion; and synaptic vesicle docking. Localizes to axon. Is expressed in head neurons and ventral cord neurons. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 4 and familial hemophagocytic lymphohistiocytosis 5. Is an ortholog of human STXBP1 (syntaxin binding protein 1).

WB:WBGene00006758	unc-20
No description available

WB:WBGene00006759	unc-22
Exhibits protein kinase binding activity and protein serine/threonine kinase activity. Is involved in several processes, including behavioral response to nicotine; cellular protein modification process; and positive regulation of sarcomere organization. Localizes to A band. Is expressed in body wall musculature; pharyngeal muscle cell; and vulval muscle. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1KK and myopathy (multiple). Is an ortholog of human TTN (titin).

WB:WBGene00006760	unc-23
Exhibits heat shock protein binding activity. Is involved in muscle attachment. Localizes to M band; nucleolus; and striated muscle dense body. Is expressed in several structures, including anal depressor muscle; excretory canal; pharynx; touch receptor neurons; and vulva. Is an ortholog of human BAG2 (BAG cochaperone 2).

WB:WBGene00006761	unc-24
Is enriched in body wall muscle cell; head mesodermal cell; and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including age-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SCP-2 sterol transfer family; SPFH domain / Band 7 family; Band 7 domain; Stomatin/HflK/HflC family; SCP2 sterol-binding domain; Band 7/SPFH domain superfamily; SCP2 sterol-binding domain superfamily; and Band-7 stomatin-like. Is an ortholog of human STOML1 (stomatin like 1).

WB:WBGene00006762	unc-25
Is predicted to have glutamate decarboxylase activity and pyridoxal phosphate binding activity. Is involved in GABAergic synaptic transmission. Localizes to several cellular components, including inhibitory synapse; perikaryon; and synaptic vesicle. Is expressed in EF neuron and neurons. Is used to study alcohol use disorder and epilepsy. Human ortholog(s) of this gene are implicated in spastic quadriplegia. Is an ortholog of human GAD1 (glutamate decarboxylase 1) and GAD2 (glutamate decarboxylase 2).

WB:WBGene00006763	unc-26
Is predicted to have phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity and phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity. Is involved in several processes, including Golgi vesicle uncoating; cytoskeleton organization; and synaptic vesicle endocytosis. Localizes to synapse. Is expressed in tail and ventral cord neurons. Is used to study Down syndrome. Human ortholog(s) of this gene are implicated in several diseases, including Parkinson's disease 20; X-linked recessive disease (multiple); and congenital muscular dystrophy with cataracts and intellectual disability. Is an ortholog of human SYNJ1 (synaptojanin 1).

WB:WBGene00006764	unc-27
Exhibits troponin C binding activity. Is involved in locomotion and sarcomere organization. Localizes to sarcomere. Is expressed in body wall musculature; non-striated muscle; and rectal muscle. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 2B1 and intrinsic cardiomyopathy (multiple). Is an ortholog of human TNNI1 (troponin I1, slow skeletal type) and TNNI2 (troponin I2, fast skeletal type).

WB:WBGene00006765	unc-29
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in several processes, including neuromuscular synaptic transmission; positive regulation of acetylcholine secretion, neurotransmission; and positive regulation of locomotion involved in locomotory behavior. Localizes to neuron projection; neuronal cell body; and postsynaptic membrane. Is expressed in body wall musculature; head neurons; non-striated muscle; and somatic nervous system. Is an ortholog of several human genes including CHRNB2 (cholinergic receptor nicotinic beta 2 subunit); CHRNB3 (cholinergic receptor nicotinic beta 3 subunit); and CHRNB4 (cholinergic receptor nicotinic beta 4 subunit).

WB:WBGene00006766	unc-30
Exhibits sequence-specific DNA binding activity. Is involved in neuron differentiation; positive regulation of transcription by RNA polymerase II; and regulation of locomotion. Localizes to nucleus. Is expressed in intestine and neurons. Human ortholog(s) of this gene are implicated in clubfoot and eye disease (multiple). Is an ortholog of human PITX1 (paired like homeodomain 1) and PITX2 (paired like homeodomain 2).

WB:WBGene00006767	unc-31
Is predicted to have calcium ion binding activity and phosphatidylinositol-4,5-bisphosphate binding activity. Is involved in several processes, including cellular response to carbon dioxide; nervous system development; and secretion by cell. Localizes to several cellular components, including axon; dense core granule; and neuronal cell body. Is expressed in egg-laying apparatus; neurons; and spermatheca. Is an ortholog of human CADPS (calcium dependent secretion activator).

WB:WBGene00006768	unc-32
Is predicted to have ATPase binding activity and proton-transporting ATPase activity, rotational mechanism. Is involved in several processes, including cholinergic synaptic transmission; defense response to Gram-positive bacterium; and nematode larval development. Localizes to vacuolar proton-transporting V-type ATPase complex. Is expressed in several structures, including alimentary muscle; hermaphrodite gonad; neurons; somatic nervous system; and vulva. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IIA; autosomal recessive osteopetrosis 1; and renal tubular acidosis. Is an ortholog of human ATP6V0A1 (ATPase H+ transporting V0 subunit a1).

WB:WBGene00006769	unc-33
Exhibits filamin binding activity; protein heterodimerization activity; and protein homodimerization activity. Is involved in several processes, including axon guidance; cytoskeleton organization; and negative regulation of microtubule polymerization. Localizes to neuron projection. Is expressed in amphid socket cell; neuroblasts; neurons; pharyngeal cell; and somatic nervous system.

WB:WBGene00006770	unc-34
Exhibits signaling receptor binding activity. Is involved in axon development; gonad morphogenesis; and positive regulation of locomotion. Localizes to several cellular components, including cell junction; cell leading edge; and filopodium tip. Is expressed in epithelial cell. Is used to study tauopathy. Is an ortholog of human EVL (Enah/Vasp-like).

WB:WBGene00006771	tln-1
Is predicted to have actin filament binding activity. Is involved in negative regulation of epidermal growth factor receptor signaling pathway; regulation of vulval development; and vulval cell fate specification. Localizes to basement membrane; contractile fiber; and lateral plasma membrane. Is expressed in several structures, including Psub4; Z2; Z3; distal tip cell; and vulval cell. Is an ortholog of human TLN2 (talin 2).

WB:WBGene00006772	unc-36
Exhibits calcium channel regulator activity and voltage-gated calcium channel activity. Is involved in several processes, including oviposition; pharyngeal pumping; and serotonin receptor signaling pathway. Localizes to endoplasmic reticulum membrane and voltage-gated calcium channel complex. Is expressed in head muscle; neurons; non-striated muscle; and ventral nerve cord. Human ortholog(s) of this gene are implicated in cone dystrophy. Is an ortholog of human CACNA2D3 (calcium voltage-gated channel auxiliary subunit alpha2delta 3) and CACNA2D4 (calcium voltage-gated channel auxiliary subunit alpha2delta 4).

WB:WBGene00006773	unc-37
Exhibits transcription factor binding activity. Is involved in several processes, including chemical synaptic transmission; regulation of axonogenesis; and regulation of synapse structure or activity. Localizes to nucleus. Is expressed in several structures, including germ line; head; and tail. Is an ortholog of human TLE3 (TLE family member 3, transcriptional corepressor) and TLE4 (TLE family member 4, transcriptional corepressor).

WB:WBGene00006774	unc-38
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in several processes, including calcium ion import across plasma membrane; neuromuscular synaptic transmission; and positive regulation of locomotion involved in locomotory behavior. Localizes to neuron projection and postsynaptic membrane. Is expressed in several structures, including body wall musculature; copulatory spicule; enteric muscle; oblique male muscle; and somatic nervous system. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy (multiple); congenital myasthenic syndrome (multiple); and multiple pterygium syndrome. Is an ortholog of human CHRNA3 (cholinergic receptor nicotinic alpha 3 subunit) and CHRNA6 (cholinergic receptor nicotinic alpha 6 subunit).

WB:WBGene00006775	unc-39
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and transcription regulatory region sequence-specific DNA binding activity. Is involved in several processes, including generation of neurons; mesodermal cell migration; and oviposition. Localizes to nucleus. Is expressed in several structures, including RID; amphid neurons; body wall musculature; coelomocyte; and neuroblasts. Is used to study branchiootorenal syndrome and myotonic dystrophy type 1. Human ortholog(s) of this gene are implicated in branchiootorenal syndrome 2. Is an ortholog of human SIX4 (SIX homeobox 4) and SIX5 (SIX homeobox 5).

WB:WBGene00006776	unc-40
Exhibits netrin receptor activity and protein domain specific binding activity. Is involved in several processes, including cell surface receptor signaling pathway; generation of neurons; and nematode male tail tip morphogenesis. Localizes to several cellular components, including axonal growth cone; cell projection membrane; and integral component of plasma membrane. Is expressed in several structures, including QL.aa; hermaphrodite distal tip cell; motor neurons; neuroblasts; and touch receptor neurons. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; gastrointestinal system cancer (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human DCC (DCC netrin 1 receptor) and NEO1 (neogenin 1).

WB:WBGene00006777	unc-41
Is involved in positive regulation of locomotion. Localizes to synapse. Is expressed in DD neuron; VD neuron; and cholinergic neurons. Is an ortholog of human STON2 (stonin 2).

WB:WBGene00006778	unc-42
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in neuron fate specification and positive regulation of transcription by RNA polymerase II. Is expressed in hypodermis; nerve ring; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human PROP1 (PROP paired-like homeobox 1).

WB:WBGene00006779	unc-43
Exhibits identical protein binding activity; ion channel binding activity; and kinase activity. Is involved in cellular protein modification process; medium-term memory; and positive regulation of gene expression. Localizes to axon cytoplasm. Is expressed in several structures, including AWC; copulatory spicule; gonadal sheath cell; oocyte; and somatic nervous system. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 53 and autosomal dominant mental retardation 54. Is an ortholog of human CAMK2B (calcium/calmodulin dependent protein kinase II beta) and CAMK2D (calcium/calmodulin dependent protein kinase II delta).

WB:WBGene00006780	unc-44
Exhibits cell adhesion molecule binding activity. Is involved in several processes, including cytoskeleton organization; generation of neurons; and negative regulation of microtubule polymerization. Localizes to lateral plasma membrane. Is expressed in hermaphrodite gonad; hypodermis; intestinal cell; and vulval cell. Human ortholog(s) of this gene are implicated in ankyrin-B-related cardiac arrhythmia; autosomal recessive non-syndromic intellectual disability; and hereditary spherocytosis type 1. Is an ortholog of human ANK2 (ankyrin 2) and ANK3 (ankyrin 3).

WB:WBGene00006781	unc-45
Exhibits identical protein binding activity and ubiquitin protein ligase binding activity. Is involved in several processes, including locomotion; oviposition; and sarcomere organization. Localizes to cell cortex and cleavage furrow. Is expressed in body wall musculature and non-striated muscle. Human ortholog(s) of this gene are implicated in cataract 43 and spermatogenic failure 6. Is an ortholog of human UNC45B (unc-45 myosin chaperone B).

WB:WBGene00006782	unc-46
Localizes to cytoplasmic vesicle and neuromuscular junction. Is expressed in GLR and neurons.

WB:WBGene00006783	unc-47
Is predicted to have gamma-aminobutyric acid:proton symporter activity. Localizes to synaptic vesicle. Is expressed in neurons. Is used to study alcohol use disorder. Is an ortholog of human SLC32A1 (solute carrier family 32 member 1).

WB:WBGene00006784	unc-49
Is predicted to have GABA-A receptor activity and extracellular ligand-gated ion channel activity. Is involved in gamma-aminobutyric acid signaling pathway; locomotory behavior; and regulation of backward locomotion. Localizes to neuromuscular junction and postsynaptic membrane. Colocalizes with postsynapse. Is expressed in anal sphincter muscle; body wall musculature; dorsal nerve cord; nerve ring; and ventral nerve cord.

WB:WBGene00006785	unc-50
Is involved in receptor localization to synapse and regulation of muscle contraction. Localizes to integral component of Golgi membrane. Is expressed in several structures, including alimentary muscle; gonad; intestine; neurons; and vulval muscle. Is an ortholog of human UNC50 (unc-50 inner nuclear membrane RNA binding protein).

WB:WBGene00006786	unc-51
Exhibits protein kinase activity. Is involved in several processes, including autophagy; generation of neurons; and nematode male tail tip morphogenesis. Localizes to axon and neuronal cell body. Is expressed in body wall musculature; motor neurons; and pharyngeal muscle cell. Is an ortholog of human ULK2 (unc-51 like autophagy activating kinase 2).

WB:WBGene00006787	unc-52
Exhibits extracellular matrix structural constituent. Is involved in several processes, including animal organ morphogenesis; hemidesmosome assembly; and mitochondrion organization. Localizes to basement membrane and striated muscle dense body. Is expressed in alimentary muscle; body wall musculature; gonad; and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in several diseases, including Carpenter syndrome; Pierson syndrome; and junctional epidermolysis bullosa (multiple). Is an ortholog of human HSPG2 (heparan sulfate proteoglycan 2).

WB:WBGene00006788	unc-53
Is predicted to have actin filament binding activity. Is involved in several processes, including backward locomotion; determination of muscle attachment site; and positive regulation of cellular component movement. Localizes to cytoplasm. Is expressed in several structures, including excretory cell; hermaphrodite distal tip cell; neurons; non-striated muscle; and socket cell. Is an ortholog of human NAV1 (neuron navigator 1).

WB:WBGene00006789	unc-54
Exhibits actin filament binding activity and microfilament motor activity. Is involved in several processes, including muscle contraction; oviposition; and skeletal muscle myosin thick filament assembly. Localizes to A band; muscle myosin complex; and striated muscle myosin thick filament. Is expressed in anal depressor muscle; body wall musculature; head; vulval muscle; and in male. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH1 (myosin heavy chain 1); MYH6 (myosin heavy chain 6); and MYH7 (myosin heavy chain 7).

WB:WBGene00006790	unc-55
Is predicted to have several functions, including DNA-binding transcription factor activity; nuclear receptor transcription coactivator activity; and transcription factor binding activity. Is expressed in motor neurons; somatic nervous system; and spicule muscle. Is an ortholog of human NR2F1 (nuclear receptor subfamily 2 group F member 1).

WB:WBGene00006791	unc-57
Is involved in clathrin-dependent endocytosis and positive regulation of necrotic cell death. Localizes to neuromuscular junction. Is expressed in head; intestine; neurons; and spermatheca. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human SH3GL3 (SH3 domain containing GRB2 like 3, endophilin A3).

WB:WBGene00006792	unc-58
Exhibits outward rectifier potassium channel activity. Is involved in several processes, including muscle contraction; parturition; and regulation of muscle contraction. Is expressed in interneuron and motor neurons.

WB:WBGene00006793	unc-59
Is predicted to have GTPase activity and molecular adaptor activity. Is involved in locomotion; oviposition; and post-embryonic development. Localizes to cleavage furrow and midbody. Is expressed in several structures, including distal tip cell; germ line; sex myoblast; sperm; and vulval muscle. Is an ortholog of human SEPTIN7 (septin 7).

WB:WBGene00006794	unc-60
Exhibits actin filament binding activity. Is involved in several processes, including actin filament severing; cytoskeleton organization; and positive regulation of actin filament polymerization. Localizes to ribonucleoprotein complex and striated muscle thin filament. Is expressed in several structures, including germ line; hermaphrodite gonad; nerve ring; oocyte; and vulva. Human ortholog(s) of this gene are implicated in nemaline myopathy 7. Is an ortholog of human CFL1 (cofilin 1); CFL2 (cofilin 2); and DSTN (destrin, actin depolymerizing factor).

WB:WBGene00006795	unc-61
Is predicted to have GTPase activity and molecular adaptor activity. Localizes to cleavage furrow and midbody. Is expressed in anterior distal tip cell; nerve ring; posterior distal tip cell; and ventral cord neurons. Is an ortholog of human SEPTIN11 (septin 11); SEPTIN6 (septin 6); and SEPTIN8 (septin 8).

WB:WBGene00006796	unc-62
Is predicted to have DNA binding activity. Is involved in mesodermal cell fate specification; muscle cell differentiation; and positive regulation of translation. Localizes to nucleus. Is expressed in several structures, including body wall musculature; neurons; reproductive system; ventral nerve cord; and vulval precursor cell. Is used to study leukemia and restless legs syndrome. Human ortholog(s) of this gene are implicated in ceft palate, cardiac defects, and intellectual disabillity. Is an ortholog of human MEIS1 (Meis homeobox 1).

WB:WBGene00006797	unc-63
Exhibits acetylcholine-gated cation-selective channel activity. Is involved in several processes, including calcium ion import across plasma membrane; positive regulation of locomotion involved in locomotory behavior; and regulation of oviposition. Localizes to neuromuscular junction and postsynaptic membrane. Is expressed in ganglia; head muscle; motor neurons; non-striated muscle; and ventral nerve cord. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in autosomal dominant nocturnal frontal lobe epilepsy (multiple); congenital myasthenic syndrome (multiple); and multiple pterygium syndrome. Is an ortholog of human CHRNA2 (cholinergic receptor nicotinic alpha 2 subunit); CHRNA3 (cholinergic receptor nicotinic alpha 3 subunit); and CHRNA6 (cholinergic receptor nicotinic alpha 6 subunit).

WB:WBGene00006798	unc-64
Exhibits chaperone binding activity. Is involved in several processes, including chemical synaptic transmission; insulin receptor signaling pathway; and nervous system development. Localizes to several cellular components, including basolateral plasma membrane; dendrite; and neuronal cell body. Is expressed in several structures, including excretory gland cell; hermaphrodite gonad; intestine; pharyngeal neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in generalized epilepsy with febrile seizures plus 9. Is an ortholog of human STX1A (syntaxin 1A) and STX1B (syntaxin 1B).

WB:WBGene00006799	unc-65
Is involved in cholinergic synaptic transmission.

WB:WBGene00006801	unc-68
Is predicted to have calcium ion binding activity; calcium-induced calcium release activity; and ryanodine-sensitive calcium-release channel activity. Is involved in locomotion; positive regulation of programmed cell death; and protein localization to organelle. Localizes to I band and sarcoplasmic reticulum. Is expressed in body wall musculature; intestine; neurons; and non-striated muscle. Human ortholog(s) of this gene are implicated in arrhythmogenic right ventricular dysplasia 2; catecholaminergic polymorphic ventricular tachycardia 1; and myopathy (multiple). Is an ortholog of human RYR1 (ryanodine receptor 1).

WB:WBGene00006802	unc-69
Is involved in regulation of axon extension and regulation of synapse organization. Localizes to axon; neuronal cell body; and perinuclear region of cytoplasm. Is expressed in CAN; HSN; ganglia; somatic nervous system; and touch receptor neurons. Is an ortholog of human SCOC (short coiled-coil protein).

WB:WBGene00006803	unc-70
Is predicted to have actin binding activity and phospholipid binding activity. Is involved in several processes, including dendrite development; embryonic body morphogenesis; and muscle cell cellular homeostasis. Localizes to cell junction; contractile fiber; and lateral plasma membrane. Is expressed in spermatheca and spermathecal-uterine valve cell. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 14; hereditary spherocytosis type 2; and spinocerebellar ataxia type 5. Is an ortholog of human SPTB (spectrin beta, erythrocytic).

WB:WBGene00006804	unc-71
Is predicted to have metallopeptidase activity. Localizes to membrane. Is expressed in several structures, including buccal cavity; excretory system; nerve ring; neuronal sheath cell; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 18; cone-rod dystrophy 9; and early infantile epileptic encephalopathy 61. Is an ortholog of several human genes including ADAM11 (ADAM metallopeptidase domain 11); ADAM23 (ADAM metallopeptidase domain 23); and ADAM9 (ADAM metallopeptidase domain 9).

WB:WBGene00006805	unc-73
Exhibits Rac guanyl-nucleotide exchange factor activity. Is involved in several processes, including engulfment of apoptotic cell; generation of neurons; and modulation of chemical synaptic transmission. Localizes to axon; cytoplasm; and muscle cell projection. Is expressed in several structures, including egg-laying apparatus; hermaphrodite gonad; lumbar ganglion; neurons; and tail hypodermis. Is used to study epilepsy. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 44. Is an ortholog of human KALRN (kalirin RhoGEF kinase).

WB:WBGene00006806	unc-74
Is involved in regulation of oviposition.

WB:WBGene00006807	unc-75
Exhibits single-stranded RNA binding activity. Is involved in several processes, including cholinergic synaptic transmission; positive regulation of synaptic transmission; and regulation of alternative mRNA splicing, via spliceosome. Localizes to nuclear speck. Is expressed in neurons and pharyngeal gland cell. Is an ortholog of human CELF5 (CUGBP Elav-like family member 5).

WB:WBGene00006808	unc-76
Exhibits syntaxin binding activity. Is involved in axonal fasciculation; regulation of axon extension; and regulation of synapse organization. Localizes to axon; neuronal cell body; and perinuclear region of cytoplasm. Is expressed in neurons and somatic nervous system. Is an ortholog of human FEZ1 (fasciculation and elongation protein zeta 1) and FEZ2 (fasciculation and elongation protein zeta 2).

WB:WBGene00006809	unc-77
Exhibits cation channel activity. Is involved in positive regulation of GABAergic synaptic transmission; positive regulation of cholinergic synaptic transmission; and positive regulation of locomotion. Localizes to axon. Is expressed in cholinergic neurons; nerve ring; pharyngeal neurons; and tail ganglion. Human ortholog(s) of this gene are implicated in several diseases, including epilepsy (multiple); heart conduction disease (multiple); and neuropathy (multiple). Is an ortholog of human NALCN (sodium leak channel, non-selective).

WB:WBGene00006810	unc-78
Exhibits actin filament binding activity. Is involved in several processes, including cytoskeleton organization; locomotion; and regulation of actin polymerization or depolymerization. Localizes to actomyosin, actin portion; myofibril; and sarcoplasm. Is expressed in body wall musculature; pharynx; spermatheca; uterus; and vulva. Is an ortholog of human WDR1 (WD repeat domain 1).

WB:WBGene00006811	unc-79
Is involved in several processes, including response to anesthetic; response to ethanol; and response to toluene. Localizes to axon. Is expressed in head neurons; nerve ring; tail neurons; and ventral cord neurons. Is used to study alcohol use disorder. Is an ortholog of human UNC79 (unc-79 homolog, NALCN channel complex subunit).

WB:WBGene00006812	unc-80
Exhibits cation channel activity. Is involved in cation homeostasis; positive regulation of locomotion; and response to anesthetic. Localizes to axon and cation channel complex. Is expressed in cholinergic neurons; excretory canal; hermaphrodite distal tip cell; non-striated muscle; and somatic nervous system. Is an ortholog of human UNC80 (unc-80 homolog, NALCN channel complex subunit).

WB:WBGene00006814	unc-82
Is a structural constituent of muscle. Is involved in striated muscle myosin thick filament assembly and striated muscle paramyosin thick filament assembly. Localizes to M band. Is expressed in body wall musculature. Is an ortholog of human NUAK1 (NUAK family kinase 1) and NUAK2 (NUAK family kinase 2).

WB:WBGene00006815	unc-83
Exhibits dynein light chain binding activity. Is involved in several processes, including oviposition; protein localization to nuclear envelope; and vulval development. Localizes to nuclear outer membrane. Is expressed in several structures, including P1; P12; P2; P3; and P9.

WB:WBGene00006816	unc-84
Exhibits lamin binding activity. Is involved in several processes, including nuclear migration along microtubule; oviposition; and vulval development. Localizes to integral component of membrane and nuclear inner membrane. Colocalizes with lamin filament. Is expressed in several structures, including oocyte. Human ortholog(s) of this gene are implicated in spermatogenic failure 16. Is an ortholog of human SUN2 (Sad1 and UNC84 domain containing 2).

WB:WBGene00006817	unc-85
Is predicted to have histone binding activity. Is involved in oviposition and post-embryonic development. Localizes to nucleus. Is expressed in several structures, including germ line. Is an ortholog of human ASF1A (anti-silencing function 1A histone chaperone) and ASF1B (anti-silencing function 1B histone chaperone).

WB:WBGene00006818	unc-86
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II regulatory region sequence-specific DNA binding activity; and transcription factor binding activity. Is involved in mechanosensory behavior; neuron development; and positive regulation of transcription from RNA polymerase II promoter involved in neuron fate specification. Localizes to RNA polymerase II transcription factor complex. Is expressed in neurons. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 15 and hypopituitarism. Is an ortholog of human POU4F2 (POU class 4 homeobox 2).

WB:WBGene00006819	unc-87
Exhibits actin filament binding activity and myosin binding activity. Is involved in cytoskeleton organization; negative regulation of muscle filament sliding; and negative regulation of plus-end directed microfilament motor activity. Localizes to I band and cytoskeleton. Is expressed in several structures, including non-striated muscle; pharynx; spermatheca; ventral ganglion; and vulva.

WB:WBGene00006820	unc-89
Exhibits MATH domain binding activity; Rho guanyl-nucleotide exchange factor activity; and phosphatase binding activity. Is involved in several processes, including cytoskeleton organization; pharyngeal gland morphogenesis; and regulation of striated muscle contraction. Localizes to M band. Is expressed in alimentary muscle; gonad; tail; and vulval muscle. Human ortholog(s) of this gene are implicated in centronuclear myopathy 5; myofibrillar myopathy 3; and spheroid body myopathy. Is an ortholog of human SPEG (striated muscle enriched protein kinase).

WB:WBGene00006821	unc-90
No description available

WB:WBGene00006822	unc-93
Exhibits potassium channel regulator activity. Is involved in regulation of muscle contraction and regulation of potassium ion transport. Localizes to plasma membrane and striated muscle dense body. Is expressed in SIA; body wall musculature; and non-striated muscle. Is an ortholog of human UNC93A (unc-93 homolog A).

WB:WBGene00006823	unc-94
Is predicted to have tropomyosin binding activity. Is involved in several processes, including cytoskeleton organization; nematode larval development; and pointed-end actin filament capping. Localizes to striated muscle thin filament and terminal web. Is expressed in intestine; pharyngeal muscle cell; seam cell; spermatheca; and uterine muscle. Human ortholog(s) of this gene are implicated in nemaline myopathy 10. Is an ortholog of several human genes including TMOD2 (tropomodulin 2); TMOD3 (tropomodulin 3); and TMOD4 (tropomodulin 4).

WB:WBGene00006824	unc-95
Exhibits protein domain specific binding activity. Localizes to M band; nucleus; and striated muscle dense body. Human ortholog(s) of this gene are implicated in several diseases, including congenital ptosis; myopathy (multiple); and nail-patella syndrome.

WB:WBGene00006825	unc-96
Exhibits myosin binding activity. Is involved in locomotion; regulation of cytoskeleton organization; and striated muscle myosin thick filament assembly. Localizes to M band and striated muscle myosin thick filament. Is expressed in anal depressor muscle; body wall musculature; and pharyngeal muscle cell.

WB:WBGene00006826	unc-97
Exhibits myosin binding activity. Is involved in several processes, including mitochondrion organization; muscle cell cellular homeostasis; and positive regulation of sarcomere organization. Localizes to several cellular components, including basal plasma membrane; contractile fiber; and nucleoplasm. Is expressed in body wall musculature and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2W. Is an ortholog of human LIMS1 (LIM zinc finger domain containing 1).

WB:WBGene00006827	unc-98
Exhibits myosin binding activity. Is involved in several processes, including locomotory behavior; myofibril assembly; and post-embryonic body morphogenesis. Localizes to M band and nucleus. Is expressed in anal depressor muscle; body wall musculature; head muscle; and vulval muscle.

WB:WBGene00006828	unc-100
No description available

WB:WBGene00006829	unc-101
Is involved in several processes, including apical protein localization; cilium assembly; and receptor localization to non-motile cilium. Is expressed in several structures, including germ line; head; and tail. Is an ortholog of human AP1M1 (adaptor related protein complex 1 subunit mu 1).

WB:WBGene00006830	unc-103
Is predicted to have voltage-gated potassium channel activity. Is involved in mating behavior and regulation of muscle contraction. Is expressed in body wall musculature; neurons; non-striated muscle; and in male. Is used to study long QT syndrome. Human ortholog(s) of this gene are implicated in several diseases, including achromatopsia 3; heart conduction disease (multiple); and retinal degeneration (multiple). Is an ortholog of human KCNH2 (potassium voltage-gated channel subfamily H member 2) and KCNH7 (potassium voltage-gated channel subfamily H member 7).

WB:WBGene00006831	unc-104
Exhibits ATP-dependent microtubule motor activity, plus-end-directed; cytoskeletal protein binding activity; and phosphatidylinositol phosphate binding activity. Is involved in several processes, including chemical synaptic transmission; regulation of intracellular transport; and regulation of nervous system development. Localizes to several cellular components, including axon; dendrite; and neuronal cell body. Is expressed in neurons and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2A1; acrocallosal syndrome; and hereditary sensory and autonomic neuropathy type 2 (multiple). Is an ortholog of human KIF1B (kinesin family member 1B).

WB:WBGene00006832	unc-105
Exhibits ion channel activity. Is involved in calcium ion transport; magnesium ion transport; and muscle organ development. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1A (sodium channel epithelial 1 subunit alpha); SCNN1B (sodium channel epithelial 1 subunit beta); and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00006833	unc-108
Exhibits GTPase activity. Is involved in several processes, including dense core granule maturation; phagosome maturation involved in apoptotic cell clearance; and regulation of locomotion involved in locomotory behavior. Localizes to several cellular components, including Golgi apparatus; cytoplasmic vesicle; and lysosome. Is expressed in coelomocyte; gonadal sheath cell; and nervous system. Is an ortholog of human RAB2A (RAB2A, member RAS oncogene family).

WB:WBGene00006835	unc-111
No description available

WB:WBGene00006836	unc-112
Exhibits integrin binding activity; protein self-association; and protein-macromolecule adaptor activity. Is involved in several processes, including hermaphrodite genitalia morphogenesis; mitochondrion organization; and positive regulation of supramolecular fiber organization. Localizes to cell-substrate junction; contractile fiber; and plasma membrane. Is expressed in body wall musculature; non-striated muscle; and spermatheca. Human ortholog(s) of this gene are implicated in Kindler syndrome and leukocyte adhesion deficiency 3. Is an ortholog of human FERMT1 (fermitin family member 1) and FERMT2 (fermitin family member 2).

WB:WBGene00006837	unc-113
No description available

WB:WBGene00006838	unc-114
No description available

WB:WBGene00006839	unc-115
Exhibits actin filament binding activity. Is involved in neuron projection morphogenesis; regulation of filopodium assembly; and regulation of lamellipodium assembly. Localizes to basal plasma membrane and cytoplasm. Is expressed in several structures, including PDE; excretory cell; pharynx; somatic nervous system; and vulva. Is an ortholog of human ABLIM1 (actin binding LIM protein 1).

WB:WBGene00006840	unc-116
Exhibits ATP-dependent microtubule motor activity, plus-end-directed. Is involved in several processes, including cytoskeleton organization; cytoskeleton-dependent intracellular transport; and polar body extrusion after meiotic divisions. Localizes to several cellular components, including kinesin I complex; neuron projection; and nuclear envelope. Is expressed in several structures, including AVA; body ganglion; muscle cell; tail; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); hereditary sensory and autonomic neuropathy type 2 (multiple); and non-syndromic intellectual disability (multiple). Is an ortholog of human KIF5A (kinesin family member 5A) and KIF5C (kinesin family member 5C).

WB:WBGene00006841	unc-117
No description available

WB:WBGene00006842	unc-118
No description available

WB:WBGene00006843	unc-119
Is predicted to have lipid binding activity. Is involved in several processes, including negative regulation of axon extension; regulation of oviposition; and regulation of pharyngeal pumping. Localizes to axon. Is expressed in body wall musculature; ganglia; neurons; somatic nervous system; and in male. Is an ortholog of human UNC119 (unc-119 lipid binding chaperone) and UNC119B (unc-119 lipid binding chaperone B).

WB:WBGene00006844	unc-120
Is predicted to have DNA binding activity and protein dimerization activity. Localizes to nucleus. Is expressed in non-striated muscle and pharyngeal cell. Is an ortholog of human SRF (serum response factor).

WB:WBGene00006845	unc-122
Is involved in negative regulation of cholinergic synaptic transmission. Localizes to postsynaptic membrane. Is expressed in body wall musculature and coelomocyte. Human ortholog(s) of this gene are implicated in juvenile glaucoma. Is an ortholog of human GLDN (gliomedin).

WB:WBGene00006846	unc-123
No description available

WB:WBGene00006848	unc-125
No description available

WB:WBGene00006849	unc-126
No description available

WB:WBGene00006850	unc-127
No description available

WB:WBGene00006851	unc-128
No description available

WB:WBGene00006852	unc-129
Exhibits signaling receptor binding activity. Is involved in several processes, including axon guidance; backward locomotion; and inductive cell migration. Is expressed in several structures, including CAN; PDE socket cell; body wall musculature; cholinergic neurons; and terminal bulb. Is an ortholog of human BMP3 (bone morphogenetic protein 3) and GDF10 (growth differentiation factor 10).

WB:WBGene00006853	unc-130
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity and transcription corepressor activity. Is involved in several processes, including axon extension involved in axon guidance; negative regulation of transcription by RNA polymerase II; and nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in several structures, including HO neuron; hypodermis; ray; tail; and ventral body wall muscle. Human ortholog(s) of this gene are implicated in anterior segment dysgenesis 2; lens disease (multiple); and persistent fetal circulation syndrome. Is an ortholog of human FOXD4 (forkhead box D4).

WB:WBGene00006854	unc-131
No description available

WB:WBGene00006856	usp-14
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity. Is an ortholog of human USP14 (ubiquitin specific peptidase 14).

WB:WBGene00006857	uts-1
No description available

WB:WBGene00006858	uts-2
No description available

WB:WBGene00006859	uts-3
No description available

WB:WBGene00006860	uts-4
No description available

WB:WBGene00006861	cal-5
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00006862	pnk-4
Is predicted to have pantothenate kinase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in pantothenate kinase-associated neurodegeneration. Is an ortholog of human PANK4 (pantothenate kinase 4 (inactive)).

WB:WBGene00006863	gyg-1
Is predicted to have glycogenin glucosyltransferase activity. Localizes to striated muscle dense body. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in glycogen storage disease XV. Is an ortholog of human GYG1 (glycogenin 1).

WB:WBGene00006864	npr-16
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is expressed in anal depressor muscle; neurons; ventral nerve cord; and vulval muscle, type 1. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 8 with or without anosmia.

WB:WBGene00006865	slcf-2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in arterial tortuosity syndrome. Is an ortholog of human SLC2A5 (solute carrier family 2 member 5).

WB:WBGene00006866	uxt-1
No description available

WB:WBGene00006867	uxt-2
No description available

WB:WBGene00006868	vab-1
Exhibits ephrin receptor activity and protein domain specific binding activity. Is involved in several processes, including embryonic morphogenesis; generation of neurons; and oocyte maturation. Localizes to axon and plasma membrane. Is expressed in several structures, including hypodermal cell; neuroblasts; neurons; oocyte; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including brain disease (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human EPHA1 (EPH receptor A1) and EPHB2 (EPH receptor B2).

WB:WBGene00006869	vab-2
Exhibits ephrin receptor binding activity. Is involved in ephrin receptor signaling pathway and epidermis morphogenesis. Localizes to anchored component of external side of plasma membrane and axon. Is expressed in several structures, including anterior ganglion; neuroblasts; neurons; somatic nervous system; and ventral ganglion (post). Human ortholog(s) of this gene are implicated in craniofrontonasal syndrome. Is an ortholog of human EFNB1 (ephrin B1) and EFNB2 (ephrin B2).

WB:WBGene00006870	vab-3
Is predicted to have DNA-binding transcription factor activity. Is involved in several processes, including anterior/posterior pattern specification; nematode male tail tip morphogenesis; and positive regulation of transcription by RNA polymerase II. Localizes to cytoplasm and nucleus. Is expressed in several structures, including anterior ganglion (post); distal tip cell; head muscle; neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including diabetes mellitus (multiple); eye disease (multiple); and premature ovarian failure. Is an ortholog of human PAX6 (paired box 6).

WB:WBGene00006871	vab-5
No description available

WB:WBGene00006872	vab-6
No description available

WB:WBGene00006873	vab-7
Is predicted to have DNA binding activity. Localizes to nucleus. Is expressed in muscle cell; neurons; somatic nervous system; and tail hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human EVX1 (even-skipped homeobox 1) and EVX2 (even-skipped homeobox 2).

WB:WBGene00006874	vab-8
Is predicted to have ATP-dependent microtubule motor activity, plus-end-directed and microtubule binding activity. Is involved in several processes, including generation of neurons; mesodermal cell migration; and oviposition. Colocalizes with striated muscle thin filament. Is expressed in body wall musculature and neurons. Is an ortholog of human KIF26A (kinesin family member 26A) and KIF26B (kinesin family member 26B).

WB:WBGene00006875	vab-9
Is involved in cell-cell adhesion; defense response to Gram-negative bacterium; and innate immune response. Localizes to cell junction. Is expressed in epithelial cell; hypodermis; and nerve ring. Is an ortholog of human TMEM47 (transmembrane protein 47).

WB:WBGene00006876	vab-10
Is predicted to have actin filament binding activity and structural molecule activity. Is involved in epidermis morphogenesis. Localizes to apical plasma membrane; basal plasma membrane; and hemidesmosome. Colocalizes with intermediate filament. Is expressed in several structures, including body wall musculature; gonad; intestinal lumen; nerve ring; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Carvajal syndrome; epidermolysis bullosa (multiple); and muscular dystrophy (multiple). Is an ortholog of human DST (dystonin).

WB:WBGene00006877	vab-11
No description available

WB:WBGene00006878	vab-12
No description available

WB:WBGene00006880	vab-14
No description available

WB:WBGene00006881	vab-15
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in embryonic morphogenesis; locomotory behavior; and parturition. Localizes to nucleus. Is expressed in several structures, including P1; P12; P2; neuroblasts; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including orofacial cleft 5; parietal foramina; and tooth agenesis. Is an ortholog of human MSX2 (msh homeobox 2).

WB:WBGene00006882	vab-19
Is involved in several processes, including actin cytoskeleton organization; cell-cell junction maintenance; and embryo development. Localizes to cell-cell junction and hemidesmosome. Colocalizes with intermediate filament and neuron projection. Is expressed in hypodermis; marginal cell; uterus; and vulD. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 16 and spastic quadriplegia. Is an ortholog of human KANK1 (KN motif and ankyrin repeat domains 1).

WB:WBGene00006883	vab-22
No description available

WB:WBGene00006884	vac-1
No description available

WB:WBGene00006885	vac-2
No description available

WB:WBGene00006886	vap-1
Is expressed in amphid sheath cell. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2) and CRISP3 (cysteine rich secretory protein 3).

WB:WBGene00006887	vav-1
Is predicted to have guanyl-nucleotide exchange factor activity and metal ion binding activity. Is involved in several processes, including negative regulation of Notch signaling pathway; positive regulation of nematode male tail tip morphogenesis; and regulation of vulval development. Is expressed in several structures, including gonad; intestinal cell; neurons; pharyngeal cell; and tail hypodermis. Is an ortholog of human VAV1 (vav guanine nucleotide exchange factor 1); VAV2 (vav guanine nucleotide exchange factor 2); and VAV3 (vav guanine nucleotide exchange factor 3).

WB:WBGene00006888	vbh-1
Is predicted to have RNA binding activity and RNA helicase activity. Is involved in several processes, including masculinization of hermaphroditic germ-line; positive regulation of embryonic development; and positive regulation of fertilization. Localizes to P granule and cytoplasmic stress granule. Is expressed in several structures, including Z2; Z3; germ cell; somatic cell; and in male. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2. Is an ortholog of human DDX3X (DEAD-box helicase 3 X-linked) and DDX3Y (DEAD-box helicase 3 Y-linked).

WB:WBGene00006889	pfd-3
Is predicted to have tubulin binding activity. Localizes to cytoplasm. Is expressed in body wall musculature; head muscle; oocyte; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human VBP1 (VHL binding protein 1).

WB:WBGene00006890	vem-1
Is involved in innate immune response. Localizes to axon. Is expressed in AVG; head neurons; and somatic nervous system. Is an ortholog of human PGRMC1 (progesterone receptor membrane component 1).

WB:WBGene00006891	ven-1
No description available

WB:WBGene00006892	ven-2
No description available

WB:WBGene00006893	spon-1
Is predicted to have serine-type endopeptidase inhibitor activity. Is involved in axon development; cell adhesion mediated by integrin; and muscle attachment. Localizes to M band; basement membrane; and striated muscle dense body. Is expressed in basal lamina; coelomocyte; excretory canal; and pharynx. Is an ortholog of human SPON1 (spondin 1).

WB:WBGene00006894	ver-1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is involved in nematode male tail tip morphogenesis. Is expressed in intestinal muscle; intestine; and neuronal sheath cell. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human FLT1 (fms related receptor tyrosine kinase 1).

WB:WBGene00006895	ver-2
Is expressed in ADLL and ADLR.

WB:WBGene00006896	ver-3
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is involved in nematode male tail tip morphogenesis. Is expressed in ALA; anal sphincter muscle; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human FLT1 (fms related receptor tyrosine kinase 1).

WB:WBGene00006897	ver-4
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is involved in nematode male tail tip morphogenesis. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human FLT1 (fms related receptor tyrosine kinase 1); FLT4 (fms related receptor tyrosine kinase 4); and KDR (kinase insert domain receptor).

WB:WBGene00006901	vet-5
No description available

WB:WBGene00006902	vet-6
Is involved in gastrulation. Localizes to cytoplasm.

WB:WBGene00006903	vet-7
No description available

WB:WBGene00006904	vet-8
No description available

WB:WBGene00006905	vet-9
No description available

WB:WBGene00006906	vet-10
No description available

WB:WBGene00006907	vet-11
No description available

WB:WBGene00006908	vex-1
No description available

WB:WBGene00006910	vha-1
Is predicted to have proton-transporting ATPase activity, rotational mechanism. Is involved in several processes, including lysosomal lumen acidification; ovulation; and regulation of syncytium formation by plasma membrane fusion. Localizes to membrane raft. Is expressed in excretory cell and rectum. Is an ortholog of human ATP6V0C (ATPase H+ transporting V0 subunit c).

WB:WBGene00006911	vha-2
Is predicted to have proton transmembrane transporter activity. Is expressed in excretory cell and rectum. Is an ortholog of human ATP6V0C (ATPase H+ transporting V0 subunit c).

WB:WBGene00006912	vha-3
Is predicted to have proton transmembrane transporter activity. Is expressed in excretory cell; hypodermis; and intestinal cell. Is an ortholog of human ATP6V0C (ATPase H+ transporting V0 subunit c).

WB:WBGene00006913	vha-4
Is predicted to have proton-transporting ATPase activity, rotational mechanism. Is involved in embryo development. Is expressed in excretory cell and rectum. Is an ortholog of human ATP6V0B (ATPase H+ transporting V0 subunit b).

WB:WBGene00006914	vha-5
Is predicted to have ATPase binding activity and proton-transporting ATPase activity, rotational mechanism. Is involved in several processes, including collagen and cuticulin-based cuticle development; exosomal secretion; and multicellular organismal water homeostasis. Localizes to several cellular components, including cell body membrane; cytoplasmic vesicle; and vacuolar proton-transporting V-type ATPase complex. Is expressed in several structures, including excretory cell; hypodermis; neuronal sheath cell; pharynx; and vulva. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IIA; autosomal recessive osteopetrosis 1; and renal tubular acidosis. Is an ortholog of several human genes including ATP6V0A1 (ATPase H+ transporting V0 subunit a1); ATP6V0A2 (ATPase H+ transporting V0 subunit a2); and TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3).

WB:WBGene00006915	vha-6
Is predicted to have ATPase binding activity and proton-transporting ATPase activity, rotational mechanism. Is involved in nematode larval development. Localizes to apical plasma membrane and vacuolar proton-transporting V-type ATPase complex. Is expressed in Psub2; excretory cell; hypodermis; pharyngeal-intestinal valve; and uterus. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IIA; autosomal recessive osteopetrosis 1; and renal tubular acidosis. Is an ortholog of several human genes including ATP6V0A1 (ATPase H+ transporting V0 subunit a1); ATP6V0A4 (ATPase H+ transporting V0 subunit a4); and TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3).

WB:WBGene00006916	vha-7
Is predicted to have ATPase binding activity and proton-transporting ATPase activity, rotational mechanism. Is expressed in hypodermis; spermatheca; and uterus. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IIA; autosomal recessive osteopetrosis 1; and renal tubular acidosis. Is an ortholog of human ATP6V0A1 (ATPase H+ transporting V0 subunit a1) and ATP6V0A4 (ATPase H+ transporting V0 subunit a4).

WB:WBGene00006917	vha-8
Is predicted to have proton-exporting ATPase activity, phosphorylative mechanism. Localizes to apical plasma membrane and cytoplasm. Is expressed in head; hypodermis; and intestine. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IIC. Is an ortholog of human ATP6V1E1 (ATPase H+ transporting V1 subunit E1) and ATP6V1E2 (ATPase H+ transporting V1 subunit E2).

WB:WBGene00006918	vha-9
Is predicted to have ATPase-coupled ion transmembrane transporter activity. Is involved in lysosomal lumen acidification. Is an ortholog of human ATP6V1F (ATPase H+ transporting V1 subunit F).

WB:WBGene00006919	vha-10
Is predicted to have proton-exporting ATPase activity, phosphorylative mechanism. Is involved in positive regulation of programmed cell death and programmed cell death. Is an ortholog of human ATP6V1G2 (ATPase H+ transporting V1 subunit G2).

WB:WBGene00006920	vha-11
Is predicted to have proton-exporting ATPase activity, phosphorylative mechanism and proton-transporting ATPase activity, rotational mechanism. Is involved in embryo development and ovulation. Is expressed in excretory cell; hypodermis; and intestinal cell. Is an ortholog of human ATP6V1C1 (ATPase H+ transporting V1 subunit C1) and ATP6V1C2 (ATPase H+ transporting V1 subunit C2).

WB:WBGene00006921	vha-12
Is predicted to have ATP binding activity and hydrolase activity. Is involved in several processes, including cell death; regulation of intracellular pH; and regulation of syncytium formation by plasma membrane fusion. Is expressed in excretory pore; hypodermal cell; muscle cell; neurons; and somatic cell. Is an ortholog of human ATP6V1B1 (ATPase H+ transporting V1 subunit B1) and ATP6V1B2 (ATPase H+ transporting V1 subunit B2).

WB:WBGene00006922	vhl-1
Is involved in response to hypoxia. Localizes to Cul2-RING ubiquitin ligase complex. Is expressed widely. Is used to study von Hippel-Lindau disease. Is an ortholog of human VHL (von Hippel-Lindau tumor suppressor) and VHLL (VHL like).

WB:WBGene00006923	vhp-1
Exhibits JUN kinase phosphatase activity; MAP kinase tyrosine/serine/threonine phosphatase activity; and mitogen-activated protein kinase binding activity. Is involved in several processes, including regulation of MAPK cascade; regulation of defense response to bacterium; and regulation of protein localization to nucleus. Is an ortholog of human DUSP16 (dual specificity phosphatase 16) and DUSP8 (dual specificity phosphatase 8).

WB:WBGene00006924	vig-1
Is predicted to have RNA binding activity. Localizes to RISC complex. Is expressed in neurons. Is an ortholog of human SERBP1 (SERPINE1 mRNA binding protein 1).

WB:WBGene00006925	vit-1
Is predicted to have lipid transporter activity.

WB:WBGene00006926	vit-2
Is predicted to have lipid transporter activity. Localizes to cytoplasmic vesicle; vesicle lumen; and yolk granule. Is expressed in embryonic cell; gonad; intestine; oocyte; and pseudocoelom.

WB:WBGene00006927	vit-3
Is predicted to have lipid transporter activity. Is expressed in intestine.

WB:WBGene00006928	vit-4
Is predicted to have lipid transporter activity.

WB:WBGene00006929	vit-5
Is predicted to have lipid transporter activity.

WB:WBGene00006930	vit-6
Is predicted to have lipid transporter activity. Is involved in negative regulation of protein oxidation; negative regulation of reactive oxygen species biosynthetic process; and positive regulation of cholesterol import.

WB:WBGene00006931	vps-26
Localizes to cytosol. Is an ortholog of human VPS26A (VPS26, retromer complex component A) and VPS26B (VPS26, retromer complex component B).

WB:WBGene00006932	vps-34
Exhibits 1-phosphatidylinositol-3-kinase activity. Is involved in several processes, including ecdysis, collagen and cuticulin-based cuticle; positive regulation of engulfment of apoptotic cell; and positive regulation of triglyceride lipase activity. Localizes to cytoplasm; nuclear outer membrane; and nucleolus. Is an ortholog of human PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3).

WB:WBGene00006933	vps-35
Is involved in protein localization to postsynaptic membrane and regulation of presynapse assembly. Localizes to cytosol; dendrite; and neuronal cell body. Is expressed in several structures, including body wall musculature; ciliated neurons; coelomocyte; intestine; and pharynx. Human ortholog(s) of this gene are implicated in Parkinson's disease 17. Is an ortholog of human VPS35 (VPS35 retromer complex component).

WB:WBGene00006934	vps-54
Exhibits syntaxin binding activity. Localizes to GARP complex. Is expressed in body wall musculature. Is an ortholog of human VPS54 (VPS54 subunit of GARP complex).

WB:WBGene00006935	vars-1
Is predicted to have valine-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 20.

WB:WBGene00006936	glp-4
Is predicted to have valine-tRNA ligase activity. Is involved in determination of adult lifespan. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 20. Is an ortholog of human VARS1 (valyl-tRNA synthetase 1).

WB:WBGene00006937	wah-1
Exhibits enzyme binding activity. Is involved in apoptotic DNA fragmentation; positive regulation of phosphatidylserine exposure on apoptotic cell surface; and positive regulation of phospholipid scramblase activity. Localizes to cytosol; mitochondrion; and nucleus. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease X-linked recessive 4; X-linked deafness 5; and combined oxidative phosphorylation deficiency 6. Is an ortholog of human AIFM1 (apoptosis inducing factor mitochondria associated 1).

WB:WBGene00006938	wee-1.1
Is predicted to have protein serine/threonine kinase activity. Is expressed in Ea and Ep. Is an ortholog of human PKMYT1 (protein kinase, membrane associated tyrosine/threonine 1).

WB:WBGene00006939	wee-1.2
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00006940	wee-1.3
Exhibits cyclin-dependent protein serine/threonine kinase inhibitor activity. Is involved in several processes, including negative regulation of meiotic cell cycle process involved in oocyte maturation; negative regulation of ovulation; and oocyte maturation. Localizes to several cellular components, including condensed chromosome; nuclear envelope; and perinuclear endoplasmic reticulum. Is expressed in several structures, including germ line; intestine; oocyte; somatic cell; and spermatheca. Is an ortholog of human PKMYT1 (protein kinase, membrane associated tyrosine/threonine 1).

WB:WBGene00006941	wnk-1
Is predicted to have chloride channel inhibitor activity; potassium channel inhibitor activity; and protein serine/threonine kinase activity. Is involved in multicellular organismal water homeostasis; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription from RNA polymerase II promoter in response to increased salt. Is expressed in body wall musculature; excretory cell; and spermatheca. Is used to study pseudohypoaldosteronism. Human ortholog(s) of this gene are implicated in hereditary sensory and autonomic neuropathy type 2A. Is an ortholog of human WNK4 (WNK lysine deficient protein kinase 4).

WB:WBGene00006942	wrk-1
Is predicted to have axon guidance receptor activity. Is expressed in several structures, including SMDVL; body ganglion; head neurons; hermaphrodite distal tip cell; and interfacial epithelial cell. Human ortholog(s) of this gene are implicated in ovarian cancer.

WB:WBGene00006943	wrm-1
Exhibits several functions, including nuclear hormone receptor binding activity; protein serine/threonine kinase activator activity; and transcription coactivator activity. Contributes to protein kinase activity. Is involved in several processes, including axis specification; digestive tract development; and regulation of gastrulation. Localizes to cell cortex; nucleus; and serine/threonine protein kinase complex. Is expressed in several structures, including E; Psub2; gonadal primordium; linker cell; and seam cell. Is an ortholog of human CTNNB1 (catenin beta 1) and JUP (junction plakoglobin).

WB:WBGene00006944	wrn-1
Exhibits 3'-5' DNA helicase activity. Is involved in DNA metabolic process; determination of adult lifespan; and response to ionizing radiation. Localizes to nucleoplasm and site of double-strand break. Is expressed in germ line. Is used to study Werner syndrome. Human ortholog(s) of this gene are implicated in Werner syndrome. Is an ortholog of human WRN (WRN RecQ like helicase).

WB:WBGene00006945	wars-1
Is predicted to have tryptophan-tRNA ligase activity. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 9. Is an ortholog of human WARS1 (tryptophanyl-tRNA synthetase 1).

WB:WBGene00006946	prx-10
Is predicted to have tryptophan-tRNA ligase activity. Is used to study obesity. Is an ortholog of human WARS2 (tryptophanyl tRNA synthetase 2, mitochondrial).

WB:WBGene00006947	wrt-1
Is predicted to have peptidase activity. Is expressed in hyp10; hyp6; hyp7 syncytium; hyp8; and hyp9. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00006948	wrt-2
Is expressed in hypodermal cell and hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domain: .

WB:WBGene00006949	wrt-3
Is expressed in several structures, including g1AR; g1P; hermaphrodite distal tip cell; muscle cell; and pharyngeal gland cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domain: Warthog protein 3.

WB:WBGene00006950	wrt-4
Is predicted to have peptidase activity. Is expressed in hyp10; hyp6; hyp7 syncytium; hyp8; and hyp9. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; holoprosencephaly 3; and solitary median maxillary central incisor. Is an ortholog of human DHH (desert hedgehog signaling molecule).

WB:WBGene00006951	wrt-5
Is predicted to have signaling receptor binding activity. Is expressed in several structures, including excretory system; hermaphrodite gonad; pharyngeal-intestinal valve; phasmid socket cell; and rectal valve cell. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3.

WB:WBGene00006952	wrt-6
Is predicted to have peptidase activity. Is expressed in anterior ganglion (ant); hypodermis; and neuronal sheath cell. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; holoprosencephaly 3; and solitary median maxillary central incisor. Is an ortholog of human DHH (desert hedgehog signaling molecule).

WB:WBGene00006953	wrt-7
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Diazinon; and single-walled carbon nanotube based on microarray studies. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; holoprosencephaly 3; and solitary median maxillary central incisor. Is predicted to encode a protein with the following domains: Hint module; Hedgehog protein, Hint domain; Hint domain C-terminal; Hint domain N-terminal; and Hint domain superfamily. Is an ortholog of human DHH (desert hedgehog signaling molecule).

WB:WBGene00006954	wrt-8
Is predicted to have peptidase activity. Is expressed in hyp10; hyp6; hyp7 syncytium; hyp8; and hyp9. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; holoprosencephaly 3; and solitary median maxillary central incisor. Is an ortholog of human DHH (desert hedgehog signaling molecule).

WB:WBGene00006955	wrt-9
Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; bone development disease (multiple); and holoprosencephaly 3. Is predicted to encode a protein with the following domain: Warthog protein 3.

WB:WBGene00006956	wrt-10
Is expressed in hypodermis; interfacial epithelial cell; and intestine.

WB:WBGene00006957	wsp-1
Exhibits Rac GTPase binding activity and cytoskeletal regulatory protein binding activity. Is involved in several processes, including embryonic morphogenesis; positive regulation of clathrin-dependent endocytosis; and positive regulation of oviposition. Localizes to cell cortex; cell leading edge; and presynaptic periactive zone. Colocalizes with cortical actin cytoskeleton. Is expressed in several structures, including Q cell; anchor cell; apoptotic cell; uterine epithelial cell; and vulval cell. Is an ortholog of human WASL (WASP like actin nucleation promoting factor).

WB:WBGene00006958	wve-1
Is predicted to have actin binding activity. Is involved in several processes, including generation of neurons; positive regulation of clathrin-dependent endocytosis; and positive regulation of oviposition. Is expressed in Q cell and anchor cell. Is an ortholog of human WASF1 (WASP family member 1) and WASF3 (WASP family member 3).

WB:WBGene00006959	xbp-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in IRE1-mediated unfolded protein response; age-dependent general metabolic decline; and negative regulation of developmental process. Is expressed widely. Is an ortholog of human XBP1 (X-box binding protein 1).

WB:WBGene00006960	xbx-1
Is predicted to contribute to ATP-dependent microtubule motor activity, minus-end-directed. Is involved in intraciliary retrograde transport and non-motile cilium assembly. Localizes to several cellular components, including ciliary base; ciliary transition zone; and cytoskeleton. Is expressed in neurons. Is an ortholog of human DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1).

WB:WBGene00006961	xnp-1
Is predicted to have ATP binding activity; DNA binding activity; and DNA helicase activity. Is involved in several processes, including embryo development; hermaphrodite genitalia development; and vulval development. Is expressed in germ line; hermaphrodite gonad; and vulval precursor cell. Is used to study intellectual disability. Human ortholog(s) of this gene are implicated in alpha thalassemia-X-linked intellectual disability syndrome. Is an ortholog of human ATRX (ATRX chromatin remodeler).

WB:WBGene00006962	xol-1
Is involved in dosage compensation by hypoactivation of X chromosome and male sex determination.

WB:WBGene00006963	xpa-1
Is predicted to have damaged DNA binding activity. Is involved in several processes, including DNA metabolic process; determination of adult lifespan; and response to UV-C. Localizes to nucleus. Human ortholog(s) of this gene are implicated in xeroderma pigmentosum group A. Is an ortholog of human XPA (XPA, DNA damage recognition and repair factor).

WB:WBGene00006964	xrn-2
Exhibits 5'-3' exoribonuclease activity. Is involved in several processes, including miRNA catabolic process; negative regulation of gene silencing by miRNA; and regulation of vulval development. Localizes to nucleus. Is expressed in M5 neuron; PVT; intestine; and pharyngeal epithelial cell. Is an ortholog of human XRN2 (5'-3' exoribonuclease 2).

WB:WBGene00006965	xtr-1
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00006966	xtr-2
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00006967	yrn-1
Localizes to ribonucleoprotein complex.

WB:WBGene00006968	yars-2
Is predicted to have tyrosine-tRNA ligase activity. Human ortholog(s) of this gene are implicated in myopathy, lactic acidosis, and sideroblastic anemia 2. Is an ortholog of human YARS2 (tyrosyl-tRNA synthetase 2).

WB:WBGene00006970	zag-1
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in axon guidance and positive regulation of axon extension. Localizes to nucleus. Is expressed in body wall musculature; enteric muscle; neurons; pharynx; and somatic nervous system. Human ortholog(s) of this gene are implicated in Fuchs' endothelial dystrophy; Mowat-Wilson syndrome; and posterior polymorphous corneal dystrophy 3. Is an ortholog of human ZEB1 (zinc finger E-box binding homeobox 1) and ZEB2 (zinc finger E-box binding homeobox 2).

WB:WBGene00006971	zak-1
Is predicted to have ATP binding activity and MAP kinase kinase kinase activity. Human ortholog(s) of this gene are implicated in centronuclear myopathy 6 with fiber-type disproportion. Is an ortholog of human MAP3K20 (mitogen-activated protein kinase kinase kinase 20).

WB:WBGene00006972	zen-2
No description available

WB:WBGene00006973	zen-3
No description available

WB:WBGene00006974	zen-4
Exhibits several functions, including ATP-dependent microtubule motor activity, plus-end-directed; identical protein binding activity; and microtubule binding activity. Is involved in several processes, including nuclear division; pronuclear migration; and regulation of actomyosin contractile ring contraction. Localizes to cleavage furrow; cytoskeleton; and midbody. Is expressed in germ cell and gonad. Is an ortholog of human KIF23 (kinesin family member 23).

WB:WBGene00006975	zfp-1
Exhibits chromatin binding activity and methylated histone binding activity. Is involved in RNA interference. Localizes to condensed chromosome and nucleus. Is expressed in several structures, including germ line; intestine; oocyte; pharynx; and seam cell. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human MLLT10 (MLLT10 histone lysine methyltransferase DOT1L cofactor).

WB:WBGene00006976	zhp-3
Is predicted to have SUMO transferase activity. Is involved in embryo development; meiotic chromosome segregation; and synaptonemal complex disassembly. Localizes to synaptonemal complex. Is an ortholog of human RNF212B (ring finger protein 212B).

WB:WBGene00006977	zif-1
Is involved in embryo development and ubiquitin-dependent protein catabolic process.

WB:WBGene00006978	zig-1
Is predicted to have cell-cell adhesion mediator activity. Is expressed in ASEL; ASER; PVT; body wall musculature; and neurons. Is an ortholog of human BSG (basigin (Ok blood group)).

WB:WBGene00006979	zig-2
Is expressed in ASIL; ASIR; PVT; and head neurons. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and gastrointestinal system cancer (multiple). Is predicted to encode a protein with the following domains: Immunoglobulin I-set domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin-like fold; Immunoglobulin-like domain superfamily; and Basigin-like.

WB:WBGene00006980	zig-3
Is predicted to have cell-cell adhesion mediator activity. Is expressed in ASI; body wall musculature; nerve ring neurons; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and gastrointestinal system cancer (multiple).

WB:WBGene00006981	zig-4
Is involved in neuron development. Is expressed in neurons and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and gastrointestinal system cancer (multiple).

WB:WBGene00006982	zig-5
Is involved in pattern specification process. Is expressed in ganglia.

WB:WBGene00006983	zig-6
Is involved in homeostatic process. Is expressed in body wall musculature; enteric muscle; head neurons; and vulval muscle.

WB:WBGene00006984	zig-7
Is predicted to have cell-cell adhesion mediator activity. Is expressed in body wall musculature.

WB:WBGene00006985	zig-8
Is expressed in PVT; head; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: Immunoglobulin I-set domain; Immunoglobulin V-set domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin V-set domain; Immunoglobulin-like fold; Immunoglobulin-like domain superfamily; and Zwei Ig domain protein zig-8.

WB:WBGene00006986	zip-1
Is predicted to have DNA binding activity.

WB:WBGene00006987	zmp-1
Exhibits metallopeptidase activity. Is involved in basement membrane disassembly. Localizes to cell surface. Is expressed in several structures, including gonad; vulval cell; vulval cell; vulval cell; and vulval cell. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type. Is an ortholog of human MMP17 (matrix metallopeptidase 17).

WB:WBGene00006988	zyg-1
Exhibits identical protein binding activity and protein serine/threonine kinase activity. Is involved in several processes, including cytoskeleton organization; positive regulation of cell cycle; and regulation of cellular protein localization. Localizes to centriole and centrosome. Human ortholog(s) of this gene are implicated in glycogen storage disease IXc and hypertrophic cardiomyopathy 1.

WB:WBGene00006990	zyg-3
No description available

WB:WBGene00006991	zyg-5
No description available

WB:WBGene00006992	zyg-7
No description available

WB:WBGene00006993	zyg-8
Exhibits microtubule binding activity. Is involved in establishment of mitotic spindle localization and negative regulation of microtubule depolymerization. Localizes to centrosome and cytoplasm. Colocalizes with spindle microtubule and spindle pole. Is expressed in germ line; gonad; hypodermis; neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 1 and lissencephaly. Is an ortholog of human DCLK1 (doublecortin like kinase 1).

WB:WBGene00006994	zyg-9
Is predicted to have microtubule binding activity and microtubule plus end polymerase. Is involved in embryo development; meiotic spindle organization; and spindle elongation. Localizes to cytoplasm; cytoskeleton; and kinetochore. Is an ortholog of human CKAP5 (cytoskeleton associated protein 5).

WB:WBGene00006995	zyg-10
No description available

WB:WBGene00006996	zyg-11
Exhibits cyclin binding activity. Is involved in several processes, including anaphase-promoting complex-dependent catabolic process; positive regulation of metaphase/anaphase transition of meiotic cell cycle; and sister chromosome movement towards spindle pole involved in meiotic sister chromatid segregation. Localizes to Cul2-RING ubiquitin ligase complex. Is an ortholog of human ZYG11B (zyg-11 family member B, cell cycle regulator).

WB:WBGene00006997	zyg-12
Exhibits dynein light intermediate chain binding activity and protein self-association. Is involved in several processes, including centrosome localization; chromosome segregation; and pronuclear migration. Localizes to centrosome and nuclear envelope. Is expressed in gonad and oocyte. Human ortholog(s) of this gene are implicated in hydrocephalus and spinocerebellar ataxia type 40. Is an ortholog of human HOOK1 (hook microtubule tethering protein 1).

WB:WBGene00006998	zyg-13
No description available

WB:WBGene00006999	zyx-1
Exhibits DEAD/H-box RNA helicase binding activity. Is involved in maintenance of synapse structure and reproduction. Localizes to M band; nucleus; and striated muscle dense body. Is expressed in muscle cell and neurons. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human LPP (LIM domain containing preferred translocation partner in lipoma).

WB:WBGene00007000	tufm-1
Is predicted to have translation elongation factor activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 4. Is an ortholog of human TUFM (Tu translation elongation factor, mitochondrial).

WB:WBGene00007001	tufm-2
Is predicted to have translation elongation factor activity. Is an ortholog of human TUFM (Tu translation elongation factor, mitochondrial).

WB:WBGene00007002	pre-1
Is involved in determination of adult lifespan; multicellular organism reproduction; and multicellular organismal response to stress.

WB:WBGene00007003	pre-7
Is involved in determination of adult lifespan; multicellular organism reproduction; and multicellular organismal response to stress.

WB:WBGene00007004	pre-33
Is involved in determination of adult lifespan; multicellular organism reproduction; and multicellular organismal response to stress.

WB:WBGene00007005	ssc-3
No description available

WB:WBGene00007006	npr-3
Is predicted to have G protein-coupled photoreceptor activity. Is expressed in ventral cord neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus.

WB:WBGene00007007	mak-2
Exhibits mitogen-activated protein kinase binding activity. Is involved in behavioral response to nicotine; positive regulation of 3'-UTR-mediated mRNA stabilization; and regulation of nervous system development. Localizes to cytoplasm; nucleus; and synapse. Is expressed in body wall musculature; intestine; and pharynx. Human ortholog(s) of this gene are implicated in lissencephaly and patterned macular dystrophy 3. Is an ortholog of human MAPKAPK2 (MAPK activated protein kinase 2) and MAPKAPK3 (MAPK activated protein kinase 3).

WB:WBGene00007008	rfp-1
Exhibits ubiquitin conjugating enzyme binding activity. Is involved in glycolipid metabolic process. Localizes to nucleus. Is expressed in germ line; intestinal cell; nerve ring; oocyte; and pharynx. Is an ortholog of human RNF20 (ring finger protein 20) and RNF40 (ring finger protein 40).

WB:WBGene00007009	wwp-1
Exhibits ubiquitin conjugating enzyme activity. Is involved in determination of adult lifespan; protein ubiquitination; and regulation of protein catabolic process. Localizes to cytoplasm. Is expressed in GABAergic neurons; cholinergic neurons; coelomocyte; somatic neurons; and vulval muscle. Is an ortholog of human ITCH (itchy E3 ubiquitin protein ligase); WWP1 (WW domain containing E3 ubiquitin protein ligase 1); and WWP2 (WW domain containing E3 ubiquitin protein ligase 2).

WB:WBGene00007010	alx-1
Exhibits Notch binding activity and protein C-terminus binding activity. Is involved in several processes, including endocytic recycling; endosome organization; and regulation of protein catabolic process. Localizes to basolateral plasma membrane; multivesicular body; and recycling endosome. Is expressed in several structures, including vulva. Is an ortholog of human PDCD6IP (programmed cell death 6 interacting protein).

WB:WBGene00007011	mdt-1.2
Is enriched in PLM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007012	mdt-4
Is predicted to have transcription coregulator activity. Is an ortholog of human MED4 (mediator complex subunit 4).

WB:WBGene00007013	mdt-8
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity and transcription coregulator activity. Is an ortholog of human MED8 (mediator complex subunit 8).

WB:WBGene00007014	mdt-10
Is predicted to have transcription coregulator activity. Is an ortholog of human MED10 (mediator complex subunit 10).

WB:WBGene00007015	mdt-11
Is predicted to have transcription coregulator activity. Is an ortholog of human MED11 (mediator complex subunit 11).

WB:WBGene00007016	mdt-15
Exhibits nuclear hormone receptor binding activity and transcription coactivator activity. Is involved in several processes, including determination of adult lifespan; nematode larval development; and sequestering of triglyceride. Is expressed in head. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability 34.

WB:WBGene00007017	mdt-17
Is predicted to have transcription coregulator activity. Human ortholog(s) of this gene are implicated in infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly. Is an ortholog of human MED17 (mediator complex subunit 17).

WB:WBGene00007018	mdt-18
Is predicted to have transcription coregulator activity. Is an ortholog of human MED18 (mediator complex subunit 18).

WB:WBGene00007019	mdt-19
Is predicted to have transcription factor binding activity. Is an ortholog of human MED19 (mediator complex subunit 19).

WB:WBGene00007020	mdt-20
Is predicted to have transcription coactivator activity. Is an ortholog of human MED20 (mediator complex subunit 20).

WB:WBGene00007021	immp-1
Is predicted to have serine-type peptidase activity. Is an ortholog of human IMMP1L (inner mitochondrial membrane peptidase subunit 1).

WB:WBGene00007022	mdt-22
Is predicted to have transcription coregulator activity. Is an ortholog of human MED22 (mediator complex subunit 22).

WB:WBGene00007023	mdt-27
Is enriched in body wall muscle cell; coelomocyte; germ line; head mesodermal cell; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mediator complex subunit 27 and Mediator complex, subunit Med27.

WB:WBGene00007024	plin-1
Is involved in embryo development. Is expressed in germ line; hypodermal cell; and intestinal cell.

WB:WBGene00007025	mdt-29
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in lateral inhibition; positive regulation of Notch signaling pathway; and regulation of cell fate specification. Is expressed in body wall musculature.

WB:WBGene00007026	mdt-31
Is predicted to have transcription coregulator activity. Is an ortholog of human MED31 (mediator complex subunit 31).

WB:WBGene00007027	ssl-1
Is predicted to have ATPase activity and histone binding activity. Is involved in negative regulation of cell fate specification. Human ortholog(s) of this gene are implicated in Floating-Harbor syndrome. Is an ortholog of human SRCAP (Snf2 related CREBBP activator protein).

WB:WBGene00007028	trr-1
Is predicted to have transcription coregulator activity. Is involved in negative regulation of vulval development; positive regulation of growth rate; and reproduction. Localizes to condensed chromosome and nucleus. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and germ line. Human ortholog(s) of this gene are implicated in ataxia telangiectasia and breast cancer. Is an ortholog of human TRRAP (transformation/transcription domain associated protein).

WB:WBGene00007029	mys-1
Is predicted to have H4 histone acetyltransferase activity and histone binding activity. Is involved in several processes, including negative regulation of cell fate specification; negative regulation of transcription, DNA-templated; and protein localization to chromatin. Is an ortholog of human KAT5 (lysine acetyltransferase 5).

WB:WBGene00007030	epc-1
Is predicted to contribute to histone acetyltransferase activity. Is expressed in tail. Is an ortholog of human EPC1 (enhancer of polycomb homolog 1).

WB:WBGene00007031	erf-1
Is involved in nematode male tail tip morphogenesis.

WB:WBGene00007032	erf-2
Is involved in nematode male tail tip morphogenesis.

WB:WBGene00007033	erf-3
No description available

WB:WBGene00007034	erf-4
No description available

WB:WBGene00007035	erf-5
No description available

WB:WBGene00007036	sod-5
Is predicted to have copper ion binding activity and superoxide dismutase activity. Is expressed in amphid neurons. Is an ortholog of human SOD1 (superoxide dismutase 1).

WB:WBGene00007038	gon-16
No description available

WB:WBGene00007039	gon-15
No description available

WB:WBGene00007041	tag-180
Is predicted to have voltage-gated calcium channel activity. Is expressed in head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in cone dystrophy. Is an ortholog of human CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2).

WB:WBGene00007042	pbrm-1
Is predicted to have chromatin binding activity. Is expressed in head; somatic cell; tail; and tail precursor cell. Is used to study alcohol use disorder. Is an ortholog of human PBRM1 (polybromo 1).

WB:WBGene00007043	algn-10
Is predicted to have dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity and dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity. Human ortholog(s) of this gene are implicated in long QT syndrome 2. Is an ortholog of human ALG10B (ALG10 alpha-1,2-glucosyltransferase B).

WB:WBGene00007044	cpna-5
Is predicted to have calcium-dependent phospholipid binding activity. Is expressed in neurons.

WB:WBGene00007045	pgap-2
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by nine chemicals including Zidovudine; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family; Frag1/DRAM/Sfk1; and Post-GPI attachment to proteins factor 2. Is an ortholog of human PGAP2 (post-GPI attachment to proteins 2).

WB:WBGene00007047	wts-1
Exhibits RNA polymerase II transcription coactivator binding activity and protein kinase activity. Is involved in several processes, including apical protein localization; digestive tract development; and negative regulation of protein import into nucleus. Localizes to apical plasma membrane and cytoplasm. Is expressed in several structures, including excretory canal; hypodermis; intestine; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations. Is an ortholog of human LATS1 (large tumor suppressor kinase 1).

WB:WBGene00007048	nfx-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is an ortholog of human NFX1 (nuclear transcription factor, X-box binding 1).

WB:WBGene00007049	tag-191
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007050	utp-20
Is enriched in germ line; hypodermis; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Down-regulated in metastasis; Down-regulated-in-metastasis protein; and Armadillo-type fold. Is an ortholog of human UTP20 (UTP20 small subunit processome component).

WB:WBGene00007053	chd-7
Is predicted to have ATP binding activity and helicase activity. Human ortholog(s) of this gene are implicated in CHARGE syndrome; hypogonadotropic hypogonadism 5 with or without anosmia; and immunodeficiency-centromeric instability-facial anomalies syndrome 4. Is an ortholog of human CHD6 (chromodomain helicase DNA binding protein 6).

WB:WBGene00007054	scpl-1
Exhibits several functions, including LIM domain binding activity; phosphatase activity; and protein-macromolecule adaptor activity. Is involved in dephosphorylation and regulation of oviposition. Localizes to I band and M band. Is expressed in body wall musculature; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human CTDSP1 (CTD small phosphatase 1) and CTDSPL (CTD small phosphatase like).

WB:WBGene00007055	tag-196
Is predicted to have cysteine-type endopeptidase activity. Is expressed in intestine and tail. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human CTSF (cathepsin F).

WB:WBGene00007056	crn-7
Is predicted to have deoxyribonuclease II activity. Is an ortholog of human DNASE2 (deoxyribonuclease 2, lysosomal).

WB:WBGene00007057	ant-1.2
Is predicted to have ATP:ADP antiporter activity. Localizes to mitochondrion. Is expressed in body wall musculature; head neurons; intestine; pharynx; and seam cell. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2; mitochondrial DNA depletion syndrome 12a; and mitochondrial DNA depletion syndrome 12b. Is an ortholog of human SLC25A4 (solute carrier family 25 member 4) and SLC25A6 (solute carrier family 25 member 6).

WB:WBGene00007058	dmd-6
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in several structures, including neurons; pharynx; rectum; tail; and vulva.

WB:WBGene00007059	vps-52
Exhibits Rab GTPase binding activity and syntaxin binding activity. Is involved in negative regulation of dense core granule transport; positive regulation of dense core granule transport; and positive regulation of locomotion involved in locomotory behavior. Localizes to Golgi apparatus; perikaryon; and perinuclear region of cytoplasm. Is expressed in distal tip cell; neurons; somatic cell; and somatic gonad. Is an ortholog of human VPS52 (VPS52 subunit of GARP complex).

WB:WBGene00007060	wht-6
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in gallbladder disease and sitosterolemia. Is an ortholog of human ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)).

WB:WBGene00007062	ebp-3
Is predicted to have microtubule plus-end binding activity. Is an ortholog of human MAPRE1 (microtubule associated protein RP/EB family member 1); MAPRE2 (microtubule associated protein RP/EB family member 2); and MAPRE3 (microtubule associated protein RP/EB family member 3).

WB:WBGene00007063	2L52.1
Is enriched in OLL; PVD; and body wall muscle cell based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00007064	rga-9
Is predicted to have GTPase activator activity. Is an ortholog of human ARHGAP20 (Rho GTPase activating protein 20).

WB:WBGene00007065	pot-3
Is predicted to have single-stranded telomeric DNA binding activity.

WB:WBGene00007066	3R5.2
Is affected by several genes including daf-16; clk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00007067	4R79.2
Is predicted to have GTPase activity. Is an ortholog of human RAB44 (RAB44, member RAS oncogene family).

WB:WBGene00007068	cTel55X.1
Is enriched in OLL; PVD; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by six chemicals including 1-methylnicotinamide; Rotenone; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FAR-17a/AIG1-like protein and FAR-17a/AIG1-like protein. Is an ortholog of human AIG1 (androgen induced 1).

WB:WBGene00007070	ugt-49
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT2A3 (UDP glucuronosyltransferase family 2 member A3); UGT2B10 (UDP glucuronosyltransferase family 2 member B10); and UGT2B11 (UDP glucuronosyltransferase family 2 member B11).

WB:WBGene00007071	AC3.5
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity.

WB:WBGene00007072	ugt-1
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A4 (UDP glucuronosyltransferase family 1 member A4); UGT1A8 (UDP glucuronosyltransferase family 1 member A8); and UGT1A9 (UDP glucuronosyltransferase family 1 member A9).

WB:WBGene00007073	ugt-2
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00007074	AC8.2
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride and Diazinon based on microarray studies.

WB:WBGene00007075	AC8.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00007076	AC8.4
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including metformin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007077	AC8.5
Is affected by several genes including daf-16; dpy-21; and cyc-1 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Atrazine; and cadmium based on RNA-seq and microarray studies.

WB:WBGene00007078	AC8.6
Is affected by several genes including daf-16; let-60; and sir-2.1 based on microarray and RNA-seq studies.

WB:WBGene00007079	AC8.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007080	sfxn-1.1
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN1 (sideroflexin 1) and SFXN3 (sideroflexin 3).

WB:WBGene00007081	AH6.3
Is enriched in germ line; ray; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00007082	acs-10
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ACSBG1 (acyl-CoA synthetase bubblegum family member 1) and ACSBG2 (acyl-CoA synthetase bubblegum family member 2).

WB:WBGene00007083	AH10.2
Is enriched in DA neuron; GABAergic neurons; I5 neuron; SAB; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007085	AH10.4
Is enriched in head mesodermal cell and pharynx based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; fluoranthene; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007087	B0001.2
Is enriched in Psub1; body wall muscle cell; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00007088	B0001.3
Is enriched in body wall muscle cell; germ line; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including sir-2.1; fbf-1; and sma-4 based on RNA-seq and microarray studies. Is affected by eleven chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007089	B0001.4
Is predicted to have kinase activity. Is an ortholog of human UCK1 (uridine-cytidine kinase 1) and UCK2 (uridine-cytidine kinase 2).

WB:WBGene00007090	B0001.5
Is enriched in germ line; germline precursor cell; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including sir-2.1; lin-35; and pgl-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007091	eri-12
Localizes to cytoplasm.

WB:WBGene00007092	B0001.7
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and elt-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00007093	B0001.8
Is enriched in germ line; germline precursor cell; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including dpy-10; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007094	B0019.2
Is predicted to have DNA binding activity.

WB:WBGene00007096	B0024.3
Is enriched in body wall muscle cell; head mesodermal cell; intestine; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A11. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00007097	B0024.4
Localizes to membrane raft.

WB:WBGene00007099	trx-2
Is predicted to have protein disulfide oxidoreductase activity. Localizes to mitochondrion. Is expressed in AIY; ASEL; body wall musculature; and vulval muscle. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 29. Is an ortholog of human TXN2 (thioredoxin 2).

WB:WBGene00007100	asps-1
Is expressed in head; hypodermis; intestine; pharynx; and tail. Human ortholog(s) of this gene are implicated in alveolar soft part sarcoma. Is predicted to encode a protein with the following domains: TUG ubiquitin-like domain; TUG ubiquitin-like domain; and Ubiquitin-like domain superfamily. Is an ortholog of human ASPSCR1 (ASPSCR1 tether for SLC2A4, UBX domain containing).

WB:WBGene00007101	B0024.11
Is predicted to have pseudouridine synthase activity. Is an ortholog of human PUS7 (pseudouridine synthase 7).

WB:WBGene00007102	B0024.13
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Human ortholog(s) of this gene are implicated in Kahrizi syndrome and congenital disorder of glycosylation Iq. Is an ortholog of human SRD5A3 (steroid 5 alpha-reductase 3).

WB:WBGene00007103	crm-1
Is predicted to have insulin-like growth factor binding activity and serine-type endopeptidase inhibitor activity. Is expressed in PVR; cholinergic neurons; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including idiopathic pulmonary fibrosis; nonsyndromic deafness (multiple); and von Willebrand's disease (multiple). Is an ortholog of human CRIM1 (cysteine rich transmembrane BMP regulator 1).

WB:WBGene00007104	B0024.15
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity. Is an ortholog of human B3GALT1 (beta-1,3-galactosyltransferase 1).

WB:WBGene00007105	znf-207
Is predicted to have microtubule binding activity. Is expressed in muscle cell; nerve ring; nervous system; tail; and ventral nerve cord. Is an ortholog of human ZNF207 (zinc finger protein 207).

WB:WBGene00007106	B0035.3
Is enriched in germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Sirolimus based on RNA-seq and microarray studies. Human MACROD2 exhibits deacetylase activity and hydrolase activity, acting on glycosyl bonds. Is predicted to encode a protein with the following domains: Macro domain; Macro domain; and Macro domain-like. Is an ortholog of human MACROD1 (mono-ADP ribosylhydrolase 1) and MACROD2 (mono-ADP ribosylhydrolase 2).

WB:WBGene00007107	pfd-4
Is predicted to have unfolded protein binding activity. Is an ortholog of human PFDN4 (prefoldin subunit 4).

WB:WBGene00007108	gspd-1
Is predicted to have glucose-6-phosphate dehydrogenase activity. Human ortholog(s) of this gene are implicated in congenital nonspherocytic hemolytic anemia. Is an ortholog of human G6PD (glucose-6-phosphate dehydrogenase).

WB:WBGene00007109	edg-1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00007110	leo-1
Is predicted to have RNA polymerase II C-terminal domain phosphoserine binding activity. Is an ortholog of human LEO1 (LEO1 homolog, Paf1/RNA polymerase II complex component).

WB:WBGene00007111	sart-3
Exhibits U4 snRNA binding activity. Localizes to nucleoplasm. Is an ortholog of human SART3 (spliceosome associated factor 3, U4/U6 recycling protein).

WB:WBGene00007112	B0035.13
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including aldicarb; tryptophan; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00007113	B0035.15
Localizes to mitochondrion. Is an ortholog of human NDUFAF4 (NADH:ubiquinone oxidoreductase complex assembly factor 4).

WB:WBGene00007114	mttu-1
Is predicted to have ATP binding activity; sulfurtransferase activity; and tRNA binding activity. Human ortholog(s) of this gene are implicated in aminoglycoside-induced deafness. Is an ortholog of human TRMU (tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase).

WB:WBGene00007115	B0198.2
Is enriched in FLP; GABAergic neurons; RIS; dopaminergic neurons; and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007116	B0198.3
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; lung cancer; and non-syndromic X-linked intellectual disability.

WB:WBGene00007117	spe-42
Is involved in single fertilization. Is expressed in sperm. Is an ortholog of human DCST2 (DC-STAMP domain containing 2).

WB:WBGene00007118	npp-22
Is predicted to be a structural constituent of nuclear pore. Localizes to nuclear pore. Is an ortholog of human NDC1 (NDC1 transmembrane nucleoporin).

WB:WBGene00007119	calf-1
Is involved in several processes, including determination of left/right asymmetry in nervous system; protein exit from endoplasmic reticulum; and protein localization to synapse. Localizes to endoplasmic reticulum membrane. Is expressed in AWCL and AWCR.

WB:WBGene00007120	B0250.3
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and sma-4 based on RNA-seq studies.

WB:WBGene00007121	B0250.4
Is enriched in body wall musculature; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007122	B0250.5
Is predicted to have 3-hydroxyisobutyrate dehydrogenase activity. Is an ortholog of human HIBADH (3-hydroxyisobutyrate dehydrogenase).

WB:WBGene00007123	srbc-79
Is affected by rsr-2; mir-34; and sir-2.1 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00007124	B0250.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including bisphenol A; bisphenol S; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007125	B0250.8
Is enriched in AFD; ASER; PLM; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; mex-1; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Atrazine; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00007126	dhcr-7
Is predicted to have 7-dehydrocholesterol reductase activity and sterol delta7 reductase activity. Human ortholog(s) of this gene are implicated in Greenberg dysplasia; Pelger-Huet anomaly; and Smith-Lemli-Opitz syndrome. Is an ortholog of human DHCR7 (7-dehydrocholesterol reductase).

WB:WBGene00007127	srbc-78
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00007128	memb-1
Is predicted to have SNAP receptor activity and SNARE binding activity. Is expressed widely. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 6. Is an ortholog of human GOSR2 (golgi SNAP receptor complex member 2).

WB:WBGene00007129	B0272.3
Is predicted to have 3-hydroxyacyl-CoA dehydrogenase activity and NAD+ binding activity. Is expressed widely. Human ortholog(s) of this gene are implicated in familial hyperinsulinemic hypoglycemia 4. Is an ortholog of human HADH (hydroxyacyl-CoA dehydrogenase).

WB:WBGene00007130	B0272.4
Is predicted to have isomerase activity. Is expressed widely. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2. Is an ortholog of human CDYL2 (chromodomain Y like 2) and ECI2 (enoyl-CoA delta isomerase 2).

WB:WBGene00007131	pals-26
Is enriched in several structures, including Z4.a; dopaminergic neurons; excretory cell; head mesodermal cell; and male distal tip cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007132	pals-27
Is enriched in several structures, including coelomocyte; excretory cell; head mesodermal cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007133	B0284.3
Is predicted to have nucleic acid binding activity.

WB:WBGene00007134	pals-28
Is enriched in cephalic sheath cell and dopaminergic neurons based on tiling array studies. Is affected by several genes including skn-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; nanoparticle; and metformin based on microarray and RNA-seq studies.

WB:WBGene00007135	cdk-12
Is predicted to have several functions, including cyclin binding activity; kinase activity; and transcription factor binding activity. Is involved in nematode larval development; phosphorylation of RNA polymerase II C-terminal domain; and regulation of histone H3-K36 trimethylation. Localizes to chromosome. Is expressed in several structures, including germ line and head. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 12. Is an ortholog of human CDK12 (cyclin dependent kinase 12).

WB:WBGene00007136	B0285.3
Is expressed in head.

WB:WBGene00007137	lcmt-1
Is predicted to have protein C-terminal leucine carboxyl O-methyltransferase activity. Is an ortholog of human LCMT1 (leucine carboxyl methyltransferase 1).

WB:WBGene00007138	B0285.6
Is predicted to have citrate transmembrane transporter activity and succinate transmembrane transporter activity. Is expressed in excretory cell. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 25. Is an ortholog of human SLC13A2 (solute carrier family 13 member 2); SLC13A3 (solute carrier family 13 member 3); and SLC13A5 (solute carrier family 13 member 5).

WB:WBGene00007139	mnp-1
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is expressed in Z1; Z4; body wall musculature; neuroblasts; and neurons.

WB:WBGene00007140	cyp-29A4
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00007141	pitr-4
Is predicted to have sodium:inorganic phosphate symporter activity. Human ortholog(s) of this gene are implicated in basal ganglia calcification. Is an ortholog of human SLC20A1 (solute carrier family 20 member 1) and SLC20A2 (solute carrier family 20 member 2).

WB:WBGene00007142	ttr-18
Is enriched in PLM; cephalic sheath cell; coelomocyte; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; D-glucose; and nicotine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00007143	B0334.3
Is predicted to have carbon-carbon lyase activity and thiamine pyrophosphate binding activity. Is an ortholog of human HACL1 (2-hydroxyacyl-CoA lyase 1).

WB:WBGene00007144	B0334.4
Is predicted to have phosphatidic acid transfer activity. Is expressed in tail. Is an ortholog of human PRELID1 (PRELI domain containing 1).

WB:WBGene00007145	B0334.5
Is predicted to have inorganic cation transmembrane transporter activity. Is an ortholog of human NDUFAF6 (NADH:ubiquinone oxidoreductase complex assembly factor 6).

WB:WBGene00007146	B0334.6
Is predicted to have G protein-coupled receptor activity. Is an ortholog of human GPR139 (G protein-coupled receptor 139).

WB:WBGene00007147	B0334.9
Is affected by several genes including pgl-1; sma-4; and glh-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00007148	B0334.10
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00007149	B0334.13
Is enriched in AFD; ASER; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007150	acly-2
Is predicted to have ATP citrate synthase activity. Is an ortholog of human ACLY (ATP citrate lyase).

WB:WBGene00007151	B0365.2
Is affected by several genes including sir-2.1; smg-2; and smn-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00007152	clec-225
Is predicted to have carbohydrate binding activity.

WB:WBGene00007153	clec-41
Is predicted to have carbohydrate binding activity. Is involved in positive regulation of chemotaxis.

WB:WBGene00007154	dhc-3
Is predicted to have ATP-dependent microtubule motor activity, minus-end-directed; dynein intermediate chain binding activity; and dynein light intermediate chain binding activity. Is expressed in HSN; OLQ; and lumbar right ganglion neurons. Human ortholog(s) of this gene are implicated in primary ciliary dyskinesia 7.

WB:WBGene00007155	B0379.1
Is enriched in body wall muscle cell; body wall musculature; germ line; head mesodermal cell; and muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007156	B0379.2
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007158	B0379.6
Is affected by several genes including daf-16; hpl-2; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00007159	B0379.7
Is enriched in arcade cell; germ line; muscle cell; pharyngeal-intestinal valve cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on proteomic; microarray; and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00007160	B0391.1
Is enriched in muscle cell based on microarray studies. Is affected by clk-1; daf-2; and eat-2 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00007161	B0391.3
Is affected by several genes including daf-2; csr-1; and drh-3 based on RNA-seq and microarray studies.

WB:WBGene00007162	fbxa-153
Is enriched in germ line; neurons; retrovesicular ganglion; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007163	fbxa-154
Is enriched in neurons and retrovesicular ganglion based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007164	fbxa-139
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and unc-70 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00007165	B0391.10
Is enriched in several structures, including AVA; body wall muscle cell; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00007166	fbxa-152
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; F-box domain; F-box domain; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007167	rbg-3
Exhibits GTPase activator activity. Localizes to cytoplasm. Is expressed in amphid neurons and phasmid neurons. Is used to study obesity. Is an ortholog of human TBC1D5 (TBC1 domain family member 5).

WB:WBGene00007168	B0393.3
Is predicted to contribute to ubiquitin-protein transferase activity.

WB:WBGene00007169	B0393.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and dpy-10 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; D-glucose; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: piRNA pathway germ-plasm component and Maelstrom domain.

WB:WBGene00007170	B0393.5
Is predicted to have calcium ion binding activity and extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in Weill-Marchesani syndrome and primary congenital glaucoma.

WB:WBGene00007171	B0393.6
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, RING-type and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00007172	B0393.7
Is enriched in coelomocyte; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; sma-2; and lem-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; and LDL receptor-like superfamily.

WB:WBGene00007173	B0393.8
Is enriched in germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007174	mboa-1
Is predicted to have O-acyltransferase activity. Is expressed in head and tail. Is an ortholog of human SOAT1 (sterol O-acyltransferase 1).

WB:WBGene00007175	B0395.3
Is predicted to have carnitine O-acetyltransferase activity. Is an ortholog of human CRAT (carnitine O-acetyltransferase).

WB:WBGene00007176	kcnl-1
Is predicted to have calmodulin binding activity and small conductance calcium-activated potassium channel activity. Human ortholog(s) of this gene are implicated in dehydrated hereditary stomatocytosis 2. Is an ortholog of several human genes including KCNN2 (potassium calcium-activated channel subfamily N member 2); KCNN3 (potassium calcium-activated channel subfamily N member 3); and KCNN4 (potassium calcium-activated channel subfamily N member 4).

WB:WBGene00007177	oac-1
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00007178	B0457.2
Is enriched in hypodermis and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007179	B0457.4
Is enriched in germ line; male-specific anatomical entity; somatic gonad precursor; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and cadmium based on RNA-seq and microarray studies.

WB:WBGene00007180	B0457.6
Is enriched in several structures, including excretory cell; germline precursor cell; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Rotenone; bisphenol A; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007181	B0462.1
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00007182	fbxb-119
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Mercuric Chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00007183	B0462.4
Is affected by several genes including skn-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including tryptophan; Mercuric Chloride; and sodium arsenite based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007184	ctr-9
Is predicted to have RNA polymerase II complex binding activity. Is an ortholog of human CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex component).

WB:WBGene00007185	nlp-36
Is expressed in head and tail. Is predicted to encode a protein with the following domain: Neuropeptide-like peptide 36.

WB:WBGene00007186	B0464.6
Is enriched in AVA; germ line; neurons; and somatic gonad precursor based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Cytochrome B561, N terminal; and Cytochrome B561-related. Is an ortholog of human TMEM209 (transmembrane protein 209).

WB:WBGene00007187	tag-342
Exhibits calmodulin binding activity.

WB:WBGene00007188	B0464.9
Is predicted to have protein C-terminal methylesterase activity and protein phosphatase 2A binding activity. Is an ortholog of human PPME1 (protein phosphatase methylesterase 1).

WB:WBGene00007189	pigm-1
Is predicted to have mannosyltransferase activity. Is an ortholog of human PIGM (phosphatidylinositol glycan anchor biosynthesis class M).

WB:WBGene00007190	rmd-3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily. Is an ortholog of human RMDN2 (regulator of microtubule dynamics 2) and RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00007191	lgc-20
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00007192	B0491.5
Is enriched in OLL; PVD; and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on proteomic; tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007193	B0491.6
Is enriched in OLL; PVD; germ line; germline precursor cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and mab-5 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including stavudine; resveratrol; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00007194	B0491.7
Is predicted to have diphthine synthase activity. Is an ortholog of human DPH5 (diphthamide biosynthesis 5).

WB:WBGene00007195	thoc-7
Is enriched in germ line; germline precursor cell; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; resveratrol; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tho complex subunit 7 and THO complex subunit 7/Mft1. Is an ortholog of human THOC7 (THO complex 7).

WB:WBGene00007196	B0513.4
Is enriched in dopaminergic neurons; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including hydrogen sulfide; Alovudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00007197	prdh-1
Is predicted to have FAD binding activity and proline dehydrogenase activity. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in hyperprolinemia type 1 and schizophrenia 4. Is an ortholog of human PRODH (proline dehydrogenase 1).

WB:WBGene00007198	B0513.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007199	B0513.7
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00007200	vamp-8
Is predicted to have SNAP receptor activity and SNARE binding activity. Is an ortholog of human VAMP8 (vesicle associated membrane protein 8).

WB:WBGene00007201	exos-4.1
Is predicted to have RNA binding activity. Is an ortholog of human EXOSC4 (exosome component 4).

WB:WBGene00007202	B0564.2
Is predicted to have dioxygenase activity. Is an ortholog of human ALKBH6 (alkB homolog 6).

WB:WBGene00007203	best-1
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00007204	best-2
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00007205	B0564.5
No description available

WB:WBGene00007206	B0564.6
Is enriched in head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; clk-1; and dpy-7 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat, cysteine-containing subtype and Leucine-rich repeat domain superfamily.

WB:WBGene00007207	B0564.7
Is enriched in body wall muscle cell; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease. Is an ortholog of human TBRG4 (transforming growth factor beta regulator 4).

WB:WBGene00007208	B0564.9
Is predicted to contribute to ubiquitin-protein transferase activity.

WB:WBGene00007209	BE10.1
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007210	agmo-1
Is predicted to have glyceryl-ether monooxygenase activity. Is expressed in hyp7 syncytium and seam cell. Is an ortholog of human AGMO (alkylglycerol monooxygenase).

WB:WBGene00007211	BE10.3
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00007212	BE10.4
Is enriched in cephalic sheath cell; germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007213	C01A2.1
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007214	C01A2.2
Is enriched in germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007215	oxa-1
Is predicted to have membrane insertase activity. Localizes to mitochondrion. Is expressed in body wall musculature and pharyngeal muscle cell. Is an ortholog of human OXA1L (OXA1L mitochondrial inner membrane protein).

WB:WBGene00007216	C01A2.4
Is enriched in AFD; NSM; PLM; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 17 and chromosome 3-linked frontotemporal dementia. Human CHMP2B exhibits protein domain specific binding activity. Is predicted to encode a protein with the following domains: Snf7 and Snf7 family. Is an ortholog of human CHMP2B (charged multivesicular body protein 2B).

WB:WBGene00007217	tads-1
Is enriched in AFD; dopaminergic neurons; germ line; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and sma-4 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Zidovudine; Tunicamycin; and antimycin based on RNA-seq and microarray studies. Human RTF2 exhibits DNA binding activity. Is predicted to encode a protein with the following domains: Rtf2 RING-finger; Replication termination factor 2; and Replication termination factor 2, RING-finger. Is an ortholog of human RTF2 (replication termination factor 2).

WB:WBGene00007218	C01A2.6
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Sodium Chloride; allantoin; and Psoralens based on RNA-seq studies.

WB:WBGene00007219	nlp-38
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007220	C01B9.1
Is enriched in OLL; PVD; body wall musculature; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00007221	cpna-3
Is predicted to have calcium-dependent phospholipid binding activity.

WB:WBGene00007222	C01F6.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Alovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Glycogen recognition site of AMP-activated protein kinase; Immunoglobulin-like fold; Immunoglobulin E-set; and AMP-activated protein kinase, glycogen-binding domain.

WB:WBGene00007223	C01F6.9
Is enriched in AFD; germ line; and intestine based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including hsf-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; bisphenol S; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human ZNF706 (zinc finger protein 706).

WB:WBGene00007224	C01G6.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00007225	C01G6.3
Is enriched in several structures, including Z4.a; cephalic sheath cell; germ line; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty chemicals including Heme; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00007226	C01G6.4
Is expressed in body wall musculature; intestine; neurons; and non-striated muscle. Human RNF11 exhibits ubiquitin protein ligase activity. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human RNF11 (ring finger protein 11).

WB:WBGene00007227	C01G6.5
Is enriched in germ line; head mesodermal cell; and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-12; gld-1; and aak-2 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by fourteen chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; FHA domain; Forkhead-associated (FHA) domain; SMAD/FHA domain superfamily; Zinc finger, RING/FYVE/PHD-type; and Transcription factor 19. Is an ortholog of human TCF19 (transcription factor 19).

WB:WBGene00007228	acs-7
Is predicted to have catalytic activity. Is expressed in intestinal cell.

WB:WBGene00007229	C01G6.9
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00007230	C01G10.1
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function; BRCA1 C Terminus (BRCT) domain; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00007231	C01G10.4
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00007232	C01G10.5
Is enriched in OLL; PVD; and neurons based on tiling array studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including tryptophan; Tunicamycin; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00007233	C01G10.6
Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Sodium Chloride; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007234	C01G10.7
Is predicted to have magnesium ion binding activity. Is expressed in head. Is an ortholog of human CLYBL (citramalyl-CoA lyase).

WB:WBGene00007235	ahsa-1
Is predicted to have ATPase activator activity; Hsp90 protein binding activity; and chaperone binding activity. Is an ortholog of human AHSA1 (activator of HSP90 ATPase activity 1).

WB:WBGene00007236	C01G10.9
Is predicted to have S-methyl-5-thioribose-1-phosphate isomerase activity. Is an ortholog of human MRI1 (methylthioribose-1-phosphate isomerase 1).

WB:WBGene00007237	C01G10.10
Is predicted to have N(6)-L-threonylcarbamoyladenine synthase activity; metal ion binding activity; and metalloendopeptidase activity. Is an ortholog of human OSGEPL1 (O-sialoglycoprotein endopeptidase like 1).

WB:WBGene00007238	C01G10.13
Is affected by Atrazine based on microarray studies.

WB:WBGene00007239	C01G10.14
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; D-glucose; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00007240	C01G10.15
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by Sodium Chloride and antimycin based on RNA-seq studies.

WB:WBGene00007241	txt-12
Is enriched in AFD; PLM; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00007242	madf-5
Is enriched in dopaminergic neurons; hypodermis; mechanosensory neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00007243	nspb-7
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Cry5B; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00007244	C01G12.3
Is enriched in amphid sheath cell; germ line; pharyngeal muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00007245	C01G12.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; mex-3; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Mianserin; and Zidovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00007246	nspb-10
Is affected by several genes including daf-2; rrf-3; and let-7 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Neurotoxins; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00007247	C01G12.7
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Sodium Chloride; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007248	catp-4
Is predicted to have sodium:potassium-exchanging ATPase activity. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; Kufor-Rakeb syndrome; and alternating hemiplegia of childhood. Is an ortholog of human ATP4A (ATPase H+/K+ transporting subunit alpha).

WB:WBGene00007249	C01G12.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007250	nspb-8
Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including hydrogen sulfide; D-glucose; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00007251	nspb-9
Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00007252	mlt-2
Is involved in ecdysis, collagen and cuticulin-based cuticle.

WB:WBGene00007253	C01H6.3
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2HC domain-containing protein.

WB:WBGene00007254	C01H6.4
Is predicted to have N,N-dimethylaniline monooxygenase activity; NADP binding activity; and flavin adenine dinucleotide binding activity. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO2 (flavin containing dimethylaniline monoxygenase 2) and FMO5 (flavin containing dimethylaniline monoxygenase 5).

WB:WBGene00007255	cnnm-4
Is predicted to have transmembrane transporter activity. Is involved in determination of adult lifespan and positive regulation of gonad development. Human ortholog(s) of this gene are implicated in Jalili syndrome and renal hypomagnesemia 6.

WB:WBGene00007256	swsn-9
Is expressed in muscle cell; pharynx; and somatic gonad. Is used to study alcohol use disorder. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function (DUF3512); Bromodomain; Bromodomain; Protein of unknown function DUF3512; and Bromodomain-like superfamily. Is an ortholog of human BRD7 (bromodomain containing 7) and BRD9 (bromodomain containing 9).

WB:WBGene00007257	C01H6.8
Is enriched in hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007258	hasp-1
Exhibits G-protein alpha-subunit binding activity. Is expressed in PHB; PVT; head neurons; intestine; and seam cell. Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00007259	C02B4.3
Is affected by daf-12; eri-1; and eat-2 based on tiling array and microarray studies. Is affected by Atrazine; fluoranthene; and paraquat based on microarray studies.

WB:WBGene00007260	olrn-1
Is involved in olfactory learning. Is expressed in head neurons; pharyngeal cell; and rectal gland cell.

WB:WBGene00007261	lron-3
Is enriched in body wall musculature; head mesodermal cell; hypodermis; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome; high myopia-sensorineural deafness syndrome; and trichotillomania. Is predicted to encode a protein with the following domains: Leucine Rich Repeat; Cysteine-rich flanking region, C-terminal; Leucine-rich repeat; and Leucine-rich repeat domain superfamily. Is an ortholog of human TPBG (trophoblast glycoprotein).

WB:WBGene00007262	jud-4
Is expressed in hypodermis and vulval muscle. Is predicted to encode a protein with the following domain: .

WB:WBGene00007264	C02F4.4
Is enriched in ASER; PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007265	C02F4.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and lin-39 based on RNA-seq and microarray studies.

WB:WBGene00007266	C03A3.1
Is enriched in head mesodermal cell; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00007267	C03A3.2
Is enriched in several structures, including coelomocyte; germline precursor cell; head mesodermal cell; mechanosensory neurons; and somatic nervous system based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transmembrane amino acid transporter protein and Amino acid transporter, transmembrane domain. Is an ortholog of human TMEM104 (transmembrane protein 104).

WB:WBGene00007268	C03A3.3
Is expressed in touch receptor neurons. Is predicted to encode a protein with the following domains: Metallo-beta-lactamase superfamily; Metallo-beta-lactamase; and Ribonuclease Z/Hydroxyacylglutathione hydrolase-like. Is an ortholog of human MBLAC2 (metallo-beta-lactamase domain containing 2).

WB:WBGene00007269	C03C10.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007270	rei-1
Is predicted to have protein kinase inhibitor activity. Is an ortholog of human SH3BP5L (SH3 binding domain protein 5 like).

WB:WBGene00007271	C03C10.5
Is enriched in intestine and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00007273	C03C10.7
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including Mianserin; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007274	C03C11.1
Is enriched in DD neuron; germ line; intestine; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nineteen chemicals including nicotinic acid; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; DUF236 repeat; and DUF236 repeat.

WB:WBGene00007275	C03D6.1
Is predicted to have nucleic acid binding activity. Is expressed in tail.

WB:WBGene00007277	asfl-1
Is predicted to have histone binding activity. Is involved in DNA replication; gamete generation; and regulation of brood size. Is an ortholog of human ASF1A (anti-silencing function 1A histone chaperone) and ASF1B (anti-silencing function 1B histone chaperone).

WB:WBGene00007278	lab-1
Exhibits protein phosphatase 1 binding activity. Is involved in meiotic sister chromatid cohesion and regulation of protein localization to nucleus. Localizes to condensed chromosome and nucleus.

WB:WBGene00007279	C03E10.1
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00007280	C03E10.2
No description available

WB:WBGene00007281	C03E10.3
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00007282	clec-223
Is predicted to have carbohydrate binding activity. Is expressed in spermatheca.

WB:WBGene00007283	clec-222
Is predicted to have carbohydrate binding activity.

WB:WBGene00007284	C03H12.1
Is enriched in cephalic sheath cell; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by Diazinon and Chlorpyrifos based on microarray studies. Human ortholog(s) of this gene are implicated in Cole-Carpenter syndrome. Is predicted to encode a protein with the following domain: Glypican. Is an ortholog of human TXNDC11 (thioredoxin domain containing 11).

WB:WBGene00007285	C04A11.1
Is enriched in coelomocyte; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007286	C04A11.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including methylmercury hydroxide; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007287	gck-4
Is predicted to have protein serine/threonine kinase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in lung cancer. Is an ortholog of human SLK (STE20 like kinase) and STK10 (serine/threonine kinase 10).

WB:WBGene00007288	C04A11.5
Is enriched in PLM; excretory cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including D-glucose; stavudine; and Sodium Chloride based on RNA-seq studies.

WB:WBGene00007289	C04B4.1
Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007290	C04B4.2
Is expressed in head. Is predicted to encode a protein with the following domain: .

WB:WBGene00007291	lips-2
Is predicted to have lipase activity.

WB:WBGene00007292	C04B4.4
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007293	C04B4.5
Is affected by cyc-1 and rsr-2 based on microarray and tiling array studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00007294	C04B4.6
Is affected by rsr-2 based on tiling array studies. Is affected by Atrazine and dibromoacetic acid based on microarray studies. Human ortholog(s) of this gene are implicated in type 1 diabetes mellitus 5. Is predicted to encode a protein with the following domain: Ubiquitin-like domain superfamily.

WB:WBGene00007295	C04C11.1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and cep-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; CAP domain; and CAP superfamily.

WB:WBGene00007296	arrd-25
Is enriched in germ line; head mesodermal cell; muscle cell; and neurons based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by seven chemicals including 1-methylnicotinamide; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set.

WB:WBGene00007297	C04F12.1
Is predicted to have nucleic acid binding activity. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00007298	C04F12.2
No description available

WB:WBGene00007299	C04F12.5
Is enriched in several structures, including germ line; germline precursor cell; intestine; neurons; and ventral nerve cord based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and let-60 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007300	C04F12.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including age-1; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride; Chlorpyrifos; and Colistin based on microarray studies.

WB:WBGene00007301	C04F12.7
Is enriched in germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00007302	C04F12.8
Is predicted to have protein tyrosine/serine/threonine phosphatase activity. Localizes to striated muscle myosin thick filament. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 19 with or without anosmia and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP14 (dual specificity phosphatase 14).

WB:WBGene00007303	rnh-1.3
Is predicted to have RNA-DNA hybrid ribonuclease activity. Is an ortholog of human RNASEH1 (ribonuclease H1).

WB:WBGene00007304	ttr-39
Is enriched in DD neuron; GABAergic neurons; OLL; PVD; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00007305	ttbk-5
Is predicted to have protein serine/threonine kinase activity. Is expressed in ASIL; ASIR; amphid neurons; and neurons.

WB:WBGene00007306	C04G2.5
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Heme; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00007307	spch-1
Is involved in male meiotic nuclear division. Localizes to nuclear chromatin. Is expressed in sperm.

WB:WBGene00007308	C04G2.9
Is enriched in amphid sheath cell; germ line; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by thirty-three chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00007309	C04G2.10
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00007310	irld-21
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00007311	C04H4.1
Is enriched in GABAergic neurons; NSM; OLL; PVD; and neurons based on tiling array studies. Is affected by rsr-2; csr-1; and mir-34 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00007312	C04H5.1
Is predicted to have protein heterodimerization activity. Is an ortholog of human TRMT112 (tRNA methyltransferase subunit 11-2).

WB:WBGene00007313	clec-147
Is predicted to have carbohydrate binding activity.

WB:WBGene00007314	gcy-29
Is predicted to have guanylate cyclase activity and peptide receptor activity. Is expressed in AVK and amphid neurons.

WB:WBGene00007315	C04H5.7
Is enriched in AVE; Z1.p; Z4.a; germ line; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Lithium Chloride; Heme; and diallyl trisulfide based on microarray and RNA-seq studies.

WB:WBGene00007316	nlp-41
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00007317	C05A9.2
Is enriched in cephalic sheath cell; dopaminergic neurons; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007319	C05B5.1
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by stavudine; dafa#1; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007320	C05B5.2
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including hydrogen sulfide; Ethanol; and nicotinic acid based on microarray and RNA-seq studies.

WB:WBGene00007321	C05B5.4
Is enriched in AVE based on tiling array studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C05B5.4-like.

WB:WBGene00007322	C05B5.5
Is enriched in Z1.p; Z4.a; germ line; intestine; and male distal tip cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including stavudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007323	fbxa-155
Is enriched in coelomocyte; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including tryptophan; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007324	C05B5.8
Is enriched in several structures, including GABAergic neurons; amphid sheath cell; excretory cell; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00007325	C05C9.1
Is predicted to have lipid binding activity. Is an ortholog of several human genes including BPI (bactericidal permeability increasing protein); BPIFC (BPI fold containing family C); and PLTP (phospholipid transfer protein).

WB:WBGene00007326	C05C9.2
Is enriched in AFD; ASER; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007327	C05C9.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including D-glucose; Alovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00007328	pho-10
Is predicted to have acid phosphatase activity. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal) and ACP3 (acid phosphatase 3).

WB:WBGene00007329	C05C10.2
Is predicted to have RNA binding activity and transcription termination site sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2S and distal spinal muscular atrophy 1.

WB:WBGene00007330	C05C10.3
Is predicted to have 3-oxoacid CoA-transferase activity. Localizes to mitochondrion. Is an ortholog of human OXCT1 (3-oxoacid CoA-transferase 1).

WB:WBGene00007331	pho-11
Is predicted to have acid phosphatase activity.

WB:WBGene00007332	C05C10.5
Is expressed in germ line.

WB:WBGene00007333	ufd-3
Is predicted to have ubiquitin binding activity. Localizes to cytoplasm. Is an ortholog of human PLAA (phospholipase A2 activating protein).

WB:WBGene00007334	C05C10.7
Is enriched in germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including manganese chloride; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00007335	C05C12.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007336	C05C12.4
Is enriched in AFD; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007337	C05C12.5
Is enriched in AFD; ASER; germ line; neurons; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twenty-two chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00007338	C05C12.6
Is enriched in head mesodermal cell; muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00007339	C05D12.1
Is enriched in GABAergic neurons; excretory cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: Eukaryotic cytochrome b561; DOMON domain; and Cytochrome b561/ferric reductase transmembrane. Is an ortholog of human FRRS1 (ferric chelate reductase 1).

WB:WBGene00007340	C05D12.2
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in inclusion-cell disease and pseudo-Hurler polydystrophy. Is predicted to encode a protein with the following domain: .

WB:WBGene00007341	C05D12.4
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00007342	C05D12.5
Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00007343	C05E7.1
Is enriched in GABAergic neurons; germline precursor cell; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including 1-methylnicotinamide; D-glucose; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: GM2-AP, lipid-recognition domain superfamily.

WB:WBGene00007344	C05E7.2
Is enriched in DA neuron and hypodermis based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by twenty-three chemicals including Heme; aldicarb; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: GM2-AP, lipid-recognition domain superfamily.

WB:WBGene00007345	C05E7.3
Is enriched in arcade cell; neurons; pharyngeal-intestinal valve cell; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007346	frpr-2
Is enriched in AFD and AVK based on RNA-seq studies. Is affected by several genes including mex-3; mex-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube; antimycin; and glycine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srsx and Serpentine type 7TM GPCR chemoreceptor Srsx.

WB:WBGene00007347	C05G5.1
Is predicted to have cofactor transmembrane transporter activity. Localizes to plasma membrane. Is expressed in head neurons; nerve ring; tail neurons; and ventral nerve cord. Is an ortholog of human SLC49A3 (solute carrier family 49 member 3).

WB:WBGene00007348	C05G5.2
Is enriched in ASER and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Zidovudine; resveratrol; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00007349	C05G5.3
Is enriched in AVA; coelomocyte; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Matrix-remodeling-associated protein 7. Is an ortholog of human MXRA7 (matrix remodeling associated 7).

WB:WBGene00007350	sucl-1
Is predicted to have nucleoside diphosphate kinase activity and succinate-CoA ligase (ADP-forming) activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 9. Is an ortholog of human SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha).

WB:WBGene00007351	C05G5.5
Is predicted to have metalloendopeptidase activity. Is an ortholog of human TRABD2B (TraB domain containing 2B).

WB:WBGene00007352	cdc-48.1
Exhibits ATPase activity and identical protein binding activity. Is involved in several processes, including ER-associated misfolded protein catabolic process; determination of adult lifespan; and positive regulation of mitotic cell cycle, embryonic. Localizes to VCP-NPL4-UFD1 AAA ATPase complex; nucleoplasm; and perinuclear region of cytoplasm. Is expressed in several structures, including body wall musculature; germ line; and gonad. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2Y; amyotrophic lateral sclerosis type 14; and inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1. Is an ortholog of human VCP (valosin containing protein).

WB:WBGene00007353	txt-13
Is enriched in ASER; PLM; head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00007354	C06A1.3
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00007355	rpb-6
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is involved in developmental process and reproduction. Is an ortholog of human POLR2F (RNA polymerase II, I and III subunit F).

WB:WBGene00007356	C06A1.6
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Neurotoxins; Testosterone; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007357	C06A12.3
Is enriched in coelomocyte; head mesodermal cell; male-specific anatomical entity; muscle cell; and neurons based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF727); GSKIP domain; GSKIP domain superfamily; and GSK3B-interacting protein. Is an ortholog of human GSKIP (GSK3B interacting protein).

WB:WBGene00007358	lact-6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including let-60; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9 and primary coenzyme Q10 deficiency 4. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00007359	C06A12.8
Is enriched in male based on RNA-seq studies. Is affected by nhr-114; rsr-2; and daf-2 based on microarray and tiling array studies.

WB:WBGene00007360	C06B3.1
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00007361	oac-3
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00007362	cyp-35C1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in response to xenobiotic stimulus. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00007363	stdh-1
Is predicted to have oxidoreductase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12).

WB:WBGene00007364	stdh-3
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12).

WB:WBGene00007365	C06B3.6
Is enriched in PLM; coelomocyte; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including diallyl trisulfide; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00007366	C06B3.7
Is enriched in intestine; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including Heme; Nitric Oxide; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00007367	nhr-150
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00007368	C06B8.2
Is enriched in OLL; PVD; body wall musculature; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00007369	C06B8.3
Is enriched in NSM based on tiling array studies. Is affected by clk-1 and drh-3 based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily.

WB:WBGene00007370	str-264
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00007371	C06B8.5
No description available

WB:WBGene00007372	C06B8.7
Is predicted to have scavenger receptor activity.

WB:WBGene00007373	C06B8.11
Is enriched in NSM based on tiling array studies.

WB:WBGene00007374	C06C3.3
Is enriched in dopaminergic neurons; intestine; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 66 and nephronophthisis 19. Is predicted to encode a protein with the following domains: Doublecortin; Doublecortin domain; and Doublecortin domain superfamily.

WB:WBGene00007375	C06C3.4
Is expressed in hypodermis.

WB:WBGene00007376	C06C3.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including age-1; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007377	C06C3.7
Is enriched in body wall muscle cell and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00007378	lido-17
Is predicted to have ATP-dependent peptidase activity and serine-type endopeptidase activity.

WB:WBGene00007379	C06C6.1
Is enriched in NSM and neurons based on tiling array studies. Is affected by several genes including daf-2; mex-1; and mir-34 based on microarray and RNA-seq studies. Is affected by resveratrol; tetrabromobisphenol A; and Sirolimus based on microarray studies.

WB:WBGene00007380	C06C6.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by four chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00007381	C06C6.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00007382	C06C6.8
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including manganese chloride; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00007383	C06C6.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00007384	swt-3
Is predicted to have sugar transmembrane transporter activity. Is expressed in Z1; Z4; and spermatheca. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).

WB:WBGene00007385	atp-5
Is predicted to have proton transmembrane transporter activity. Is an ortholog of human ATP5PD (ATP synthase peripheral stalk subunit d).

WB:WBGene00007386	C06H2.2
Is predicted to have lipid binding activity. Is an ortholog of human STARD7 (StAR related lipid transfer domain containing 7).

WB:WBGene00007387	jmjd-5
Is predicted to have histone demethylase activity (H3-K36 specific). Is an ortholog of human KDM8 (lysine demethylase 8).

WB:WBGene00007388	folt-1
Is predicted to have folic acid binding activity and vitamin transmembrane transporter activity. Is expressed in head; head muscle; and tail. Human ortholog(s) of this gene are implicated in biotin-responsive basal ganglia disease and thiamine-responsive megaloblastic anemia syndrome. Is an ortholog of human SLC19A2 (solute carrier family 19 member 2) and SLC19A3 (solute carrier family 19 member 3).

WB:WBGene00007389	glb-3
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00007390	lmtr-3
Is enriched in carbon dioxide sensory neurons; dopaminergic neurons; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and let-7 based on RNA-seq; tiling array; microarray; and proteomic studies. Is affected by five chemicals including Rotenone; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitogen-activated protein kinase kinase 1 interacting and Ragulator complex protein LAMTOR3. Is an ortholog of human LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3).

WB:WBGene00007391	C06H2.7
Is enriched in excretory cell; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and tert-Butylhydroperoxide based on RNA-seq studies.

WB:WBGene00007392	fbxa-156
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; D-glucopyranose; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007393	fbxa-157
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; levamisole; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007394	C06H5.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease.

WB:WBGene00007395	dcar-1
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is involved in defense response to fungus and response to wounding. Localizes to apical plasma membrane and non-motile cilium. Is expressed in PVQ; amphid neurons; hyp7 syncytium; and uterus.

WB:WBGene00007396	rnp-9
Is predicted to have RNA binding activity. Is involved in several processes, including determination of adult lifespan; hyperosmotic response; and response to heat. Localizes to nucleus. Is expressed in head neurons; spermatheca; tail neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human TIA1 (TIA1 cytotoxic granule associated RNA binding protein) and TIAL1 (TIA1 cytotoxic granule associated RNA binding protein like 1).

WB:WBGene00007397	C07A4.2
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including indole; 4-bromodiphenyl ether; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00007398	C07A4.3
Is enriched in CEPshDL; CEPshDR; CEPshVL; and CEPshVR based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR2 (GLI pathogenesis related 2).

WB:WBGene00007399	clec-162
Is predicted to have carbohydrate binding activity.

WB:WBGene00007400	bud-31
Is enriched in NSM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: G10 protein and G10 protein. Is an ortholog of human BUD31 (BUD31 homolog).

WB:WBGene00007401	C07A9.5
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including bone development disease (multiple); intrinsic cardiomyopathy (multiple); and myopathy (multiple).

WB:WBGene00007402	ugt-60
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of human UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00007403	set-3
Is predicted to have methyltransferase activity. Is expressed in AB; Psub1; hypodermis; and intestine. Human ortholog(s) of this gene are implicated in spermatogenic failure 14. Is an ortholog of human SMYD4 (SET and MYND domain containing 4).

WB:WBGene00007404	best-5
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00007405	C07A9.9
Is enriched in hypodermis and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 4-bromodiphenyl ether; Zidovudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00007406	C07A9.10
Is affected by several genes including clk-1; sir-2.1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Tunicamycin; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007407	C07B5.2
Is enriched in hypodermis and intestine based on tiling array and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007408	C07B5.3
Is enriched in AFD; ASER; dopaminergic neurons; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including nicotinic acid; Mercuric Chloride; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007409	C07B5.4
Is predicted to have GTP-Rho binding activity. Is an ortholog of human RTKN (rhotekin) and RTKN2 (rhotekin 2).

WB:WBGene00007410	C07B5.6
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007411	C07C7.1
Is enriched in AFD; ASER; AVK; PLM; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; aak-2; and mex-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00007412	stip-1
Is predicted to have nucleic acid binding activity. Is an ortholog of human TFIP11 (tuftelin interacting protein 11).

WB:WBGene00007413	pro-2
Is predicted to have histone binding activity; repressing transcription factor binding activity; and transcription corepressor activity. Is an ortholog of human NOC2L (NOC2 like nucleolar associated transcriptional repressor).

WB:WBGene00007414	C07E3.3
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including diallyl trisulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007415	C07E3.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00007416	ceh-57
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord; intestine; and ventral nerve cord.

WB:WBGene00007417	ceh-58
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord; head neurons; nerve ring; tail neurons; and ventral nerve cord.

WB:WBGene00007418	C07E3.8
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00007419	C07E3.9
Is predicted to have calcium ion binding activity and carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in familial benign fleck retina. Is an ortholog of human PLA2G1B (phospholipase A2 group IB).

WB:WBGene00007420	C07E3.10
Is enriched in hypodermis and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by nineteen chemicals including Heme; methylmercury hydroxide; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00007421	C07H4.1
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Cry5B; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007422	ugt-17
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00007423	C08B6.2
Is affected by several genes including skn-1; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including tryptophan; 1-methylnicotinamide; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00007424	C08B6.3
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00007425	C08B6.4
Is predicted to have chitinase activity. Is expressed in amphid neurons and hypodermis.

WB:WBGene00007426	C08B6.5
Is affected by several genes including lin-4; lin-14; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T25E4.2-like.

WB:WBGene00007427	C08B6.6
Is affected by several genes including daf-2; eat-2; and spn-4 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including methylmercuric chloride; Tunicamycin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00007428	wdr-20
Is involved in positive regulation of locomotion involved in locomotory behavior; positive regulation of macromolecule metabolic process; and positive regulation of protein localization to cell surface. Is expressed in head neurons; tail neurons; and ventral nerve cord. Is an ortholog of human WDR20 (WD repeat domain 20).

WB:WBGene00007429	C08B6.8
Is predicted to have 3'-5'-exoribonuclease activity. Is an ortholog of human REXO2 (RNA exonuclease 2).

WB:WBGene00007430	C08B6.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Cry5B; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007431	C08B6.11
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007432	srxa-18
Is affected by rsr-2 and spn-4 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00007433	swsn-7
Is predicted to have DNA binding activity. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in Coffin-Siris syndrome 6. Is an ortholog of human ARID2 (AT-rich interaction domain 2).

WB:WBGene00007434	arp-6
Is predicted to have nucleosome binding activity. Is an ortholog of human ACTR6 (actin related protein 6).

WB:WBGene00007435	algn-6
Is predicted to have dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ic. Is an ortholog of human ALG6 (ALG6 alpha-1,3-glucosyltransferase).

WB:WBGene00007436	C08B11.9
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Human C1orf50 exhibits identical protein binding activity. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2452) and Protein of unknown function DUF2452. Is an ortholog of human C1orf50 (chromosome 1 open reading frame 50).

WB:WBGene00007437	C08E8.1
Is enriched in ALM; PLM; germ line; and pharyngeal muscle cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including clk-1; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein.

WB:WBGene00007438	C08E8.2
Is predicted to have strictosidine synthase activity. Is an ortholog of human APMAP (adipocyte plasma membrane associated protein).

WB:WBGene00007439	C08E8.3
Is enriched in hypodermis and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including multi-walled carbon nanotube; bisphenol A; and procyanidin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007440	C08E8.4
Is involved in innate immune response.

WB:WBGene00007441	C08E8.5
Is enriched in AFD; ASER; PLM; and intestine based on RNA-seq studies. Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by Mercuric Chloride and Tunicamycin based on microarray studies.

WB:WBGene00007442	C08E8.6
Is enriched in ASER based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00007443	pfd-1
Is predicted to have unfolded protein binding activity. Is involved in gonad development. Localizes to cytoplasm. Is expressed in head muscle; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human PFDN1 (prefoldin subunit 1).

WB:WBGene00007444	C08F8.2
Is predicted to have DNA binding activity; DNA helicase activity; and RNA helicase activity. Is an ortholog of human SUPV3L1 (Suv3 like RNA helicase).

WB:WBGene00007445	C08F8.3
Is enriched in germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00007446	mboa-4
Is predicted to have transferase activity. Is an ortholog of human MBOAT1 (membrane bound O-acyltransferase domain containing 1) and MBOAT2 (membrane bound O-acyltransferase domain containing 2).

WB:WBGene00007447	fbxb-9
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007448	C08F8.6
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007449	C08F8.9
Is enriched in ASER; PLM; germ line; intestine; and male-specific anatomical entity based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; npr-1; and fog-2 based on RNA-seq and microarray studies. Is affected by four chemicals including D-glucose; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00007450	C08F11.1
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and aak-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007451	C08F11.2
Is affected by rsr-2 based on tiling array studies. Is affected by resveratrol and cadmium based on microarray studies.

WB:WBGene00007452	C08F11.3
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Mercuric Chloride; Tunicamycin; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00007453	fbxa-98
Is enriched in AVA; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; levamisole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00007454	C08F11.7
Is enriched in AVA; coelomocyte; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00007455	ugt-22
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A5 (UDP glucuronosyltransferase family 1 member A5); UGT1A6 (UDP glucuronosyltransferase family 1 member A6); and UGT2B17 (UDP glucuronosyltransferase family 2 member B17).

WB:WBGene00007456	srz-29
Is affected by rsr-2 and prg-1 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00007457	C08F11.10
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00007458	ule-4
Is enriched in several structures, including dopaminergic neurons; germ line; intestine; neuronal sheath cell; and pharyngeal muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including Heme; Ethanol; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1505) and Protein of unknown function DUF1505.

WB:WBGene00007459	C08F11.12
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twenty-one chemicals including hydrogen sulfide; Nitric Oxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1505) and Protein of unknown function DUF1505.

WB:WBGene00007460	C08F11.13
Is enriched in OLL; PVD; head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; 1-methylnicotinamide; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00007461	C08F11.14
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00007462	ctsa-3.2
Is predicted to have serine-type carboxypeptidase activity. Human ortholog(s) of this gene are implicated in galactosialidosis. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00007463	vgln-1
Is predicted to have RNA binding activity. Is an ortholog of human HDLBP (high density lipoprotein binding protein).

WB:WBGene00007464	algn-8
Is predicted to have dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ih. Is an ortholog of human ALG8 (ALG8 alpha-1,3-glucosyltransferase).

WB:WBGene00007465	chil-1
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007466	chil-2
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007467	chil-3
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007468	C08H9.8
Is affected by clk-1 and daf-2 based on microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00007469	chil-4
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007470	chil-5
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007471	chil-6
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007472	chil-7
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007473	chil-8
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00007474	C08H9.15
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00007475	B0285.t1
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00007476	C09E9.1
Is expressed in tail. Is predicted to encode a protein with the following domains: Tumour suppressor candidate 2 and Tumour suppressor candidate 2. Is an ortholog of human TUSC2 (tumor suppressor 2, mitochondrial calcium regulator).

WB:WBGene00007478	C09F9.1
Is enriched in NSM; germ line; muscle cell; and in male based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007479	C09F9.2
Is enriched in OLL; PVD; and hypodermis based on microarray; tiling array; and proteomic studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by nineteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EGF-like domain; DOMON domain; Trypsin Inhibitor like cysteine rich domain; SEA domain; SEA domain; EGF-like domain; Trypsin Inhibitor-like, cysteine rich domain; DOMON domain; EGF-like domain, extracellular; Serine protease inhibitor-like superfamily; and SEA domain superfamily.

WB:WBGene00007480	glna-1
Is predicted to have glutaminase activity. Is expressed in several structures, including mc2; mc3DL; mc3DR; mc3V; and neurons. Is an ortholog of human GLS (glutaminase) and GLS2 (glutaminase 2).

WB:WBGene00007481	C09F9.4
Is affected by several genes including daf-16; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007482	C09F12.2
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; let-60; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Nucleotide-diphospho-sugar transferases.

WB:WBGene00007483	C09F12.3
Is enriched in GABAergic neurons and excretory cell based on tiling array studies. Is affected by several genes including clk-1; elt-2; and mir-34 based on microarray and RNA-seq studies. Is affected by 1-methylnicotinamide based on RNA-seq studies. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00007484	C09G1.2
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007485	C09G1.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00007486	C09G1.4
Is predicted to have Rho GTPase binding activity and protein kinase C binding activity.

WB:WBGene00007487	C09G1.5
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including fog-2; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq studies.

WB:WBGene00007488	dph-2
Is predicted to have transferase activity. Is an ortholog of human DPH2 (diphthamide biosynthesis 2).

WB:WBGene00007489	C09G5.7
Is enriched in germ line; germline precursor cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007490	mks-5
Is involved in several processes, including non-motile cilium assembly; protein localization to cilium; and protein to membrane docking. Localizes to ciliary basal body and ciliary transition zone. Is expressed in chemosensory neurons and ciliated neurons. Is used to study ciliopathy. Human ortholog(s) of this gene are implicated in several diseases, including COACH syndrome; Joubert syndrome 7; and retinal disease (multiple). Is an ortholog of human RPGRIP1L (RPGRIP1 like).

WB:WBGene00007492	C09G9.1
Is enriched in OLL; PVD; germ line; germline precursor cell; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007493	npp-23
Localizes to kinetochore and nuclear pore. Is an ortholog of human NUP43 (nucleoporin 43).

WB:WBGene00007494	C09G9.3
Is enriched in NSM and PLM based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: C6 domain.

WB:WBGene00007495	C09G9.5
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00007496	npax-4
Is predicted to have DNA binding activity. Is expressed in body wall musculature and pseudocoelom.

WB:WBGene00007497	C09G9.8
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007499	C09H10.5
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007500	nasp-1
Is predicted to have histone binding activity. Is expressed in metacorpus; pharynx; and terminal bulb. Is an ortholog of human NASP (nuclear autoantigenic sperm protein).

WB:WBGene00007501	apc-17
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Anaphase-promoting complex subunit 1.

WB:WBGene00007502	glb-4
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00007503	C09H10.9
Is enriched in AVK; germ line; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007504	nbs-1
Is enriched in germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FHA domain; Forkhead-associated (FHA) domain; and SMAD/FHA domain superfamily.

WB:WBGene00007505	pezo-1
Is predicted to have cation channel activity and mechanosensitive ion channel activity. Human ortholog(s) of this gene are implicated in dehydrated hereditary stomatocytosis 1; distal arthrogryposis type 3; and distal arthrogryposis type 5. Is an ortholog of human PIEZO1 (piezo type mechanosensitive ion channel component 1) and PIEZO2 (piezo type mechanosensitive ion channel component 2).

WB:WBGene00007506	fbxc-58
Is involved in innate immune response. Is expressed in body wall musculature; neuronal sheath cell; pharyngeal-intestinal valve; and vulval muscle.

WB:WBGene00007507	C10C5.3
Is predicted to have aminoacylase activity. Is an ortholog of human ACY1 (aminoacylase 1).

WB:WBGene00007508	C10C5.4
Is predicted to have aminoacylase activity. Is an ortholog of human ACY1 (aminoacylase 1).

WB:WBGene00007509	C10C5.5
Is predicted to have aminoacylase activity. Is an ortholog of human ACY1 (aminoacylase 1).

WB:WBGene00007511	C10C5.7
Is enriched in OLL; PVD; dopaminergic neurons; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; prg-1; and sma-2 based on RNA-seq and microarray studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00007512	C10C6.3
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PH domain and PHLA2/3, PH domain.

WB:WBGene00007513	wht-2
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in head. Is an ortholog of human ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)).

WB:WBGene00007514	catp-8
Is predicted to have ATP binding activity; ATPase activity; and metal ion binding activity. Is an ortholog of human ATP13A1 (ATPase 13A1).

WB:WBGene00007515	C10C6.7
Is expressed in RIS; pharyngeal neurons; and sensory neurons.

WB:WBGene00007516	gpx-5
Is predicted to have glutathione peroxidase activity. Is involved in response to reactive oxygen species. Is expressed in head. Is an ortholog of human GPX5 (glutathione peroxidase 5) and GPX6 (glutathione peroxidase 6).

WB:WBGene00007517	gpx-3
Is predicted to have glutathione peroxidase activity. Is an ortholog of human GPX3 (glutathione peroxidase 3).

WB:WBGene00007518	del-8
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00007520	C11E4.6
Is enriched in head mesodermal cell; male-specific anatomical entity; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphotyrosine interaction domain (PTB/PID); SAM domain (Sterile alpha motif); Ankyrin repeats (3 copies); Sterile alpha motif domain; Ankyrin repeat; PTB/PI domain; PH-like domain superfamily; Sterile alpha motif/pointed domain superfamily; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human ANKS1A (ankyrin repeat and sterile alpha motif domain containing 1A) and ANKS1B (ankyrin repeat and sterile alpha motif domain containing 1B).

WB:WBGene00007521	C11E4.7
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00007522	C11E4.8
Is enriched in AVK; dopaminergic neurons; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007523	C11G6.2
Is predicted to have ATP binding activity and DNA helicase activity.

WB:WBGene00007525	C11G10.1
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007528	C11H1.2
Is predicted to have voltage-gated anion channel activity. Is an ortholog of human GPR89B (G protein-coupled receptor 89B).

WB:WBGene00007529	C11H1.3
Is predicted to have ubiquitin protein ligase activity. Is involved in negative regulation of vulval development and protein localization to basolateral plasma membrane. Localizes to cytoplasmic vesicle. Is expressed in vulval precursor cell. Is an ortholog of human MGRN1 (mahogunin ring finger 1) and RNF157 (ring finger protein 157).

WB:WBGene00007530	C11H1.5
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thrombospondin type-1 (TSP1) repeat and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00007531	C11H1.7
Is predicted to have signaling receptor binding activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 60. Is an ortholog of human CNPY3 (canopy FGF signaling regulator 3) and CNPY4 (canopy FGF signaling regulator 4).

WB:WBGene00007533	cbl-1
Is predicted to have carbon-sulfur lyase activity and pyridoxal phosphate binding activity.

WB:WBGene00007534	fubl-1
Is predicted to have RNA binding activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human FUBP1 (far upstream element binding protein 1) and FUBP3 (far upstream element binding protein 3).

WB:WBGene00007535	ttr-19
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including sir-2.1; rrf-1; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fluoranthene and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00007536	daf-36
Is predicted to have 2 iron, 2 sulfur cluster binding activity; metal ion binding activity; and oxidoreductase activity. Localizes to cytoplasm. Is expressed in head mesodermal cell; intestine; neurons; and seam cell.

WB:WBGene00007537	fipr-8
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Ethanol; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00007538	C12D8.9
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Cry5B; and paraquat based on microarray studies.

WB:WBGene00007539	B0334.12
Is affected by hda-6 and ptl-1 based on RNA-seq studies.

WB:WBGene00007540	C12D8.13
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies.

WB:WBGene00007541	fipr-4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by six chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00007542	C12D8.15
Is enriched in AFD and neurons based on tiling array and RNA-seq studies. Is affected by several genes including mir-34; adr-2; and rsr-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00007543	fipr-7
Is enriched in CEM; HOB; IL2 neuron; germ line; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including methylmercury hydroxide; manganese chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00007544	fipr-6
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by D-glucose and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00007545	C13B4.1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including age-1; sir-2.1; and pmk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: Eukaryotic cytochrome b561; DOMON domain; DOMON domain; and Cytochrome b561/ferric reductase transmembrane. Is an ortholog of human FRRS1 (ferric chelate reductase 1).

WB:WBGene00007546	nhr-153
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in response to starvation and short-term memory. Is expressed in intestine; neurons; pharynx; and rectum. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00007547	nhr-154
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in response to starvation. Is expressed in alimentary muscle; head neurons; intestine; pharynx; and rectal valve cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00007548	C13C4.4
Is predicted to have inorganic diphosphatase activity and protein histidine phosphatase activity. Is an ortholog of human LHPP (phospholysine phosphohistidine inorganic pyrophosphate phosphatase).

WB:WBGene00007549	spin-1
Is predicted to have transmembrane transporter activity. Is expressed in tail. Is an ortholog of human SPNS1 (sphingolipid transporter 1 (putative)); SPNS2 (sphingolipid transporter 2); and SPNS3 (sphingolipid transporter 3 (putative)).

WB:WBGene00007550	C13C4.6
Is predicted to have cofactor transmembrane transporter activity. Is an ortholog of human SLC49A3 (solute carrier family 49 member 3).

WB:WBGene00007551	C13C4.7
Is enriched in body wall muscle cell and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and sma-4 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: PLAT/LH2 domain; PLAT/LH2 domain; and PLAT/LH2 domain superfamily.

WB:WBGene00007552	C13C12.2
Is enriched in NSM; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00007553	C13G3.1
Is enriched in germ line; hypodermis; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including aldicarb; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00007554	pptr-2
Is predicted to have protein phosphatase activator activity. Is involved in P granule assembly. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 35. Is an ortholog of human PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma).

WB:WBGene00007555	dohh-1
Is predicted to have cofactor binding activity; deoxyhypusine monooxygenase activity; and iron ion binding activity. Is expressed in head. Is an ortholog of human DOHH (deoxyhypusine hydroxylase).

WB:WBGene00007556	algn-9
Is predicted to have mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Il. Is an ortholog of human ALG9 (ALG9 alpha-1,2-mannosyltransferase).

WB:WBGene00007557	C14A4.6
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007558	C14A4.7
Is enriched in Z1; Z4; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007559	C14A4.8
Is enriched in PLM; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; D-glucose; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00007560	C14A4.9
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-three chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007561	ccm-3
Exhibits protein kinase binding activity. Is involved in several processes, including positive regulation of GTPase activity; positive regulation of endocytic recycling; and regulation of Golgi organization. Localizes to cytoplasm; cytoplasmic side of apical plasma membrane; and growing cell tip. Is expressed in several structures, including excretory canal; germ line; intestinal cell; oocyte; and pharynx. Human ortholog(s) of this gene are implicated in cerebral cavernous malformation 3. Is an ortholog of human PDCD10 (programmed cell death 10).

WB:WBGene00007562	C14A4.12
Is expressed in excretory canal; pharyngeal-intestinal valve; virL; and virR.

WB:WBGene00007563	C14A4.13
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007564	mrps-22
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 5 and ovarian dysgenesis 7. Is an ortholog of human MRPS22 (mitochondrial ribosomal protein S22).

WB:WBGene00007565	clec-48
Is predicted to have signaling receptor activity. Is an ortholog of human MRC1 (mannose receptor C-type 1); MRC2 (mannose receptor C type 2); and PLA2R1 (phospholipase A2 receptor 1).

WB:WBGene00007567	C14A6.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including lin-35; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00007568	C14A6.4
No description available

WB:WBGene00007569	C14A6.5
Is enriched in DA neuron; NSM; and VA neuron based on tiling array studies. Is affected by several genes including daf-2; age-1; and aak-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and glycine based on microarray and RNA-seq studies.

WB:WBGene00007570	C14A6.6
Is enriched in body wall muscle cell; germ line; germline precursor cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00007571	C14A6.7
Is enriched in DA neuron; VA neuron; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and ain-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and Colistin based on RNA-seq and microarray studies.

WB:WBGene00007572	C14A6.8
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and resveratrol based on microarray and RNA-seq studies.

WB:WBGene00007573	C14B1.2
Is enriched in several structures, including BAG; germ line; germline precursor cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007574	C14B1.3
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human FBXO6 (F-box protein 6).

WB:WBGene00007576	dph-1
Is predicted to have transferase activity. Is an ortholog of human DPH1 (diphthamide biosynthesis 1).

WB:WBGene00007577	nrde-1
Is involved in RNA interference. Localizes to nucleus.

WB:WBGene00007578	C14B1.7
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00007579	C14B1.8
Is enriched in cephalic sheath cell; coelomocyte; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including aak-2; isp-1; and cgh-1 based on microarray and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: SIKE family and SIKE family. Is an ortholog of human FGFR1OP2 (FGFR1 oncogene partner 2) and SIKE1 (suppressor of IKBKE 1).

WB:WBGene00007580	C14B1.9
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chondroitin proteoglycan 4 and Chondroitin proteoglycan 4.

WB:WBGene00007581	alkb-8
Is predicted to have tRNA (uracil) methyltransferase activity. Localizes to cytoplasm. Is expressed in several structures, including body wall musculature; egg-laying apparatus; intestinal cell; pharyngeal muscle cell; and somatic gonad. Is an ortholog of human ALKBH8 (alkB homolog 8, tRNA methyltransferase).

WB:WBGene00007583	C14B4.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including glp-1; let-60; and hsf-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007584	C14C10.1
Is predicted to have inorganic phosphate transmembrane transporter activity. Is an ortholog of human SLC25A3 (solute carrier family 25 member 3).

WB:WBGene00007585	C14C10.2
Is enriched in AFD; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and isp-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq studies.

WB:WBGene00007586	ril-2
Is enriched in several structures, including coelomocyte; excretory cell; germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Cry5B; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Batten's disease protein Cln3.

WB:WBGene00007587	mma-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by ten chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetratricopeptide-like helical domain superfamily and Leucine-rich PPR motif-containing protein.

WB:WBGene00007588	C14C10.5
Is predicted to have lysine-acetylated histone binding activity; peptidase activator activity; and proteasome binding activity. Is an ortholog of human PSME4 (proteasome activator subunit 4).

WB:WBGene00007589	erg-28
Is expressed in body wall musculature and intestine.

WB:WBGene00007590	ttr-43
Is enriched in amphid sheath cell; cephalic sheath cell; dopaminergic neurons; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sek-1; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; metformin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00007591	zipt-13
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A13 (solute carrier family 39 member 13).

WB:WBGene00007592	C14H10.2
Is enriched in head mesodermal cell; hypodermis; muscle cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including lin-4; lin-14; and sir-2.1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: JAKMIP CC3 domain and Janus kinase and microtubule-interacting protein, C-terminal domain. Is an ortholog of human JAKMIP3 (Janus kinase and microtubule interacting protein 3).

WB:WBGene00007593	C14H10.3
Is predicted to have sphinganine-1-phosphate aldolase activity. Is an ortholog of human PDXDC1 (pyridoxal dependent decarboxylase domain containing 1).

WB:WBGene00007594	lgc-23
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00007595	C15A7.2
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Rhodopsin-like GPCR transmembrane domain and Intimal thickness related receptor, IRP. Is an ortholog of human TMEM145 (transmembrane protein 145).

WB:WBGene00007597	C15A11.2
Is enriched in GABAergic neurons; body wall muscle cell; germ line; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007598	C15A11.4
Is enriched in germline precursor cell; hypodermis; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq; tiling array; and microarray studies. Is affected by sixteen chemicals including 1-methylnicotinamide; manganese chloride; and sodium arsenite based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sulfite exporter TauE/SafE and Transmembrane protein TauE-like.

WB:WBGene00007599	C15A11.7
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including Nitric Oxide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sulfite exporter TauE/SafE and Transmembrane protein TauE-like.

WB:WBGene00007600	C15C6.1
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00007601	C15C6.2
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-six chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007602	C15C6.3
Is enriched in AVK; NSM; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Atrazine; fluoranthene; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007603	popl-4
Is predicted to contribute to ribonuclease MRP activity and ribonuclease P activity. Is an ortholog of human POP4 (POP4 homolog, ribonuclease P/MRP subunit).

WB:WBGene00007604	xbx-9
Is expressed in neurons.

WB:WBGene00007605	hrg-7
Is predicted to have aspartic-type endopeptidase activity. Is expressed in amphid neurons and phasmid neurons. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy and neuronal ceroid lipofuscinosis 10. Is an ortholog of human REN (renin).

WB:WBGene00007606	C15C8.4
Is predicted to have heparin binding activity; low-density lipoprotein particle receptor binding activity; and receptor antagonist activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in myopia. Is an ortholog of human LRPAP1 (LDL receptor related protein associated protein 1).

WB:WBGene00007607	C15C8.5
Is enriched in neurons and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including tryptophan; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007608	C15C8.6
Is affected by several genes including elt-2; sir-2.1; and ain-2 based on microarray and RNA-seq studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00007609	C15C8.7
Is enriched in body wall muscle cell; germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; multi-walled carbon nanotube; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00007610	C15H7.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00007611	C15H7.4
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PH domain and PHLA2/3, PH domain.

WB:WBGene00007613	C15H11.1
Is enriched in amphid sheath cell; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00007614	gnrr-2
Is predicted to have G protein-coupled peptide receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus.

WB:WBGene00007615	set-31
Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis. Is predicted to encode a protein with the following domains: Chromo/chromo shadow domain; SET domain; and Chromo-like domain superfamily.

WB:WBGene00007616	rpoa-12
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR1H (RNA polymerase I subunit H).

WB:WBGene00007617	rrbs-1
Is enriched in germ line; intestine; and somatic gonad precursor based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including glp-1; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including D-glucose; bisphenol S; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosome biogenesis regulatory protein (RRS1) and Ribosomal biogenesis regulatory protein. Is an ortholog of human RRS1 (ribosome biogenesis regulator 1 homolog).

WB:WBGene00007618	C15H11.10
Is enriched in NSM and hypodermis based on tiling array studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride; paraquat; and Sirolimus based on microarray studies.

WB:WBGene00007619	C15H11.11
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Mianserin; multi-walled carbon nanotube; and Rifampin based on RNA-seq studies.

WB:WBGene00007620	ocrl-1
Is predicted to have phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity. Human ortholog(s) of this gene are implicated in Dent disease and oculocerebrorenal syndrome. Is an ortholog of human INPP5B (inositol polyphosphate-5-phosphatase B).

WB:WBGene00007621	C16C2.4
Is enriched in ASER; AVA; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BSD domain; BSD domain; and BSD domain superfamily. Is an ortholog of human SYAP1 (synapse associated protein 1).

WB:WBGene00007622	C16C10.1
Is expressed in tail. Is predicted to encode a protein with the following domains: Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; and Mitochondrial carrier domain superfamily. Is an ortholog of human SLC25A40 (solute carrier family 25 member 40).

WB:WBGene00007623	C16C10.2
Is enriched in several structures, including PLM; body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and lin-35 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Utp11 protein and Small-subunit processome, Utp11. Is an ortholog of human UTP11 (UTP11 small subunit processome component).

WB:WBGene00007624	hrde-1
Is predicted to have nucleic acid binding activity. Is involved in RNA interference and germ cell development. Localizes to RNAi effector complex and nucleus. Is expressed in germ cell and germ line.

WB:WBGene00007625	C16C10.4
Is enriched in body wall muscle cell; germ line; intestine; mechanosensory neurons; and somatic gonad precursor based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Sin3 associated polypeptide p18 (SAP18); Sin3 associated polypeptide p18; and Sin3 associated polypeptide p18 superfamily. Is an ortholog of human SAP18 (Sin3A associated protein 18).

WB:WBGene00007626	rnf-121
Exhibits ubiquitin protein ligase activity. Is involved in PERK-mediated unfolded protein response; inductive cell migration; and ubiquitin-dependent ERAD pathway. Localizes to Golgi membrane and sarcoplasmic reticulum membrane. Is expressed in body wall musculature; gonad; hypodermis; and vulva. Is an ortholog of human RNF121 (ring finger protein 121) and RNF175 (ring finger protein 175).

WB:WBGene00007627	ccdc-55
Is predicted to have mRNA binding activity. Is involved in inductive cell migration and nematode larval development. Localizes to cytoplasm and nucleus. Is expressed in gonad; hypodermis; muscle cell; and vulva. Is an ortholog of human NSRP1 (nuclear speckle splicing regulatory protein 1).

WB:WBGene00007628	C16C10.8
Is predicted to have DNA binding activity. Is an ortholog of human LYAR (Ly1 antibody reactive).

WB:WBGene00007629	C16C10.9
Is enriched in several structures, including Z1.p; Z4.a; coelomocyte; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007630	har-1
Is involved in determination of adult lifespan and mitochondrion organization. Localizes to mitochondrion and striated muscle dense body. Is expressed in intestine and ventral nerve cord. Human ortholog(s) of this gene are implicated in FTDALS2 and Parkinson's disease 22. Is an ortholog of human CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing 10).

WB:WBGene00007631	wht-3
Is predicted to have ATPase-coupled transmembrane transporter activity. Human ortholog(s) of this gene are implicated in gallbladder disease and sitosterolemia. Is an ortholog of human ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)).

WB:WBGene00007632	C16C10.13
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Mianserin; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007633	C16D2.1
Is enriched in several structures, including body wall musculature; coelomocyte; germ line; intestine; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: SKP1-like, dimerisation domain superfamily.

WB:WBGene00007635	npr-4
Is predicted to have neuropeptide Y receptor activity. Is involved in regulation of muscle contraction. Is expressed in several structures, including PQR; coelomocyte; interneuron; nerve ring; and rectal gland cell. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus.

WB:WBGene00007637	dhhc-7
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human ZDHHC21 (zinc finger DHHC-type palmitoyltransferase 21).

WB:WBGene00007638	C17D12.3
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in NGLY1-deficiency. Is predicted to encode a protein with the following domains: Peptide N glycanase, PAW domain; Galactose-binding-like domain superfamily; and PAW domain superfamily.

WB:WBGene00007639	C17D12.5
Is enriched in several structures, including I5 neuron; amphid sheath cell; cholinergic neurons; germ line; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Ubiquitin-conjugating enzyme/RWD-like.

WB:WBGene00007640	pcmd-1
Is expressed in germ line.

WB:WBGene00007641	C17E4.1
Is enriched in Z1; Z4; amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including eat-2; dpy-7; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007642	C17E4.2
Is expressed in head; intestine; and vulval muscle.

WB:WBGene00007643	marc-3
Is predicted to have ubiquitin-protein transferase activity. Is expressed in accessory cell and pharyngeal muscle cell. Is an ortholog of human MARCHF3 (membrane associated ring-CH-type finger 3).

WB:WBGene00007644	C17E4.4
Is enriched in arcade cell; germ line; germline precursor cell; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including Rotenone; Rifampin; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00007645	C17E4.6
Is enriched in germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: YL1 nuclear protein C-terminal domain; YL1 nuclear protein; Vps72/YL1 family; and Vps72/YL1, C-terminal. Is an ortholog of human VPS72 (vacuolar protein sorting 72 homolog).

WB:WBGene00007646	nkb-1
Is predicted to contribute to sodium:potassium-exchanging ATPase activity. Is expressed in head neurons; pharyngeal muscle cell; tail neurons; ventral cord neurons; and vulval muscle, type 1. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of human ATP1B1 (ATPase Na+/K+ transporting subunit beta 1); ATP1B2 (ATPase Na+/K+ transporting subunit beta 2); and ATP1B3 (ATPase Na+/K+ transporting subunit beta 3).

WB:WBGene00007647	C17E4.10
Is enriched in germ line; hypodermis; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; dpy-10; and gld-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including D-glucose; levamisole; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007648	folr-1
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007649	C17G1.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; metformin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007650	ugt-23
Is predicted to have UDP-glycosyltransferase activity. Is involved in gastrulation. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00007651	nra-3
Is predicted to have metal ion binding activity.

WB:WBGene00007652	C17G1.5
Is enriched in GABAergic neurons; excretory cell; germ line; intestine; and somatic gonad precursor based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; lin-35; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007653	cysl-1
Exhibits cysteine synthase activity and enzyme binding activity. Is involved in cysteine biosynthetic process from serine and response to hypoxia. Localizes to striated muscle dense body. Is expressed in body wall musculature; hypodermis; and nervous system. Is an ortholog of human CBSL (cystathionine beta-synthase like).

WB:WBGene00007654	C17H1.1
Is affected by several genes including skn-1; eat-2; and hpl-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007655	C17H1.2
Is enriched in cephalic sheath cell; dopaminergic neurons; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00007656	pals-2
Is expressed in hypodermis and neurons.

WB:WBGene00007657	pals-3
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00007658	pals-4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007659	pals-5
Is involved in innate immune response.

WB:WBGene00007660	pals-6
Is enriched in OLL; PVD; dopaminergic neurons; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Nitric Oxide; Tunicamycin; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007661	pals-7
Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00007662	pals-8
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including skn-1; clk-1; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Mercuric Chloride; Zidovudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007664	seb-3
Is predicted to have G protein-coupled receptor activity. Is involved in behavioral response to ethanol; locomotory behavior; and response to heat. Localizes to axon and neuronal cell body. Is expressed in body wall musculature; nervous system; ray 1; and rectal gland cell. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in bone development disease (multiple) and primary failure of tooth eruption. Is an ortholog of human CRHR2 (corticotropin releasing hormone receptor 2).

WB:WBGene00007666	C18B12.4
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human RNF13 (ring finger protein 13).

WB:WBGene00007667	fbxa-97
Is enriched in body wall muscle cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007668	C18B12.6
Is expressed in anal depressor muscle; anal sphincter muscle; anterior distal tip cell; posterior distal tip cell; and tail neurons. Is predicted to encode a protein with the following domains: Endoplasmic reticulum vesicle transporter; Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC); Endoplasmic reticulum vesicle transporter, C-terminal; and Endoplasmic reticulum vesicle transporter, N-terminal. Is an ortholog of human ERGIC2 (ERGIC and golgi 2).

WB:WBGene00007669	C18D1.2
Is predicted to have transmembrane transporter activity.

WB:WBGene00007670	stg-1
Exhibits channel regulator activity. Is involved in positive regulation of glutamatergic synaptic transmission. Is expressed in neurons. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 10. Is an ortholog of human CACNG8 (calcium voltage-gated channel auxiliary subunit gamma 8).

WB:WBGene00007672	fbxa-136
Is affected by several genes including daf-16; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mercuric Chloride; Tunicamycin; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ubiquitin interacting motif; and F-box A protein FB155/FB224.

WB:WBGene00007673	C18D4.3
Is affected by smn-1 and daf-12 based on RNA-seq studies. Is affected by aldicarb and resveratrol based on microarray studies.

WB:WBGene00007674	C18D4.4
Is enriched in cephalic sheath cell; excretory cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily.

WB:WBGene00007675	C18D4.6
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00007676	srz-57
Is affected by let-60; daf-2; and daf-16 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00007677	C18D4.8
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00007678	srz-90
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00007679	C18D11.1
Is enriched in PLM; germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including 1-methylnicotinamide; Rotenone; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007680	maa-1
Exhibits fatty-acyl-CoA binding activity. Is involved in endocytic recycling; endosome organization; and multicellular organism reproduction. Localizes to several cellular components, including basal part of cell; endosome; and integral component of Golgi membrane. Is expressed in hypodermis. Is an ortholog of human ACBD4 (acyl-CoA binding domain containing 4) and ACBD5 (acyl-CoA binding domain containing 5).

WB:WBGene00007681	C18D11.3
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-12; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4602) and Protein of unknown function DUF4602.

WB:WBGene00007682	C18D11.6
Is enriched in several structures, including cephalic sheath cell; coelomocyte; excretory cell; germline precursor cell; and ventral nerve cord based on tiling array studies. Is affected by several genes including skn-1; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; indole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007683	C18E9.2
Is enriched in coelomocyte; germ line; hypodermis; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; let-60; and lin-4 based on RNA-seq and microarray studies. Is affected by six chemicals including D-glucose; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Translocation protein Sec62; and Translocation protein Sec62. Is an ortholog of human SEC62 (SEC62 homolog, preprotein translocation factor).

WB:WBGene00007684	C18E9.4
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; dopaminergic neurons; germ line; and intestine based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; let-7; and gld-1 based on RNA-seq; microarray; and proteomic studies. Is affected by six chemicals including biotin; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: NADH-ubiquinone oxidoreductase B12 subunit family and NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3. Is an ortholog of human NDUFB3 (NADH:ubiquinone oxidoreductase subunit B3).

WB:WBGene00007685	C18E9.5
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by six chemicals including Rotenone; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007686	tomm-40
Is predicted to have protein transmembrane transporter activity. Is involved in protein import into mitochondrial matrix. Localizes to mitochondrial membrane. Is expressed in gonadal sheath cell; intestine; pharyngeal muscle cell; and tail hypodermis. Is an ortholog of human TOMM40 (translocase of outer mitochondrial membrane 40).

WB:WBGene00007687	C18E9.7
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 56; congenital afibrinogenemia; and familial hypobetalipoproteinemia 2. Is predicted to encode a protein with the following domains: Fibronectin type III domain; Fibronectin type III; Immunoglobulin-like fold; and Fibronectin type III superfamily.

WB:WBGene00007688	C18E9.8
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00007689	C18E9.9
Is involved in innate immune response.

WB:WBGene00007690	sftd-3
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; isp-1; and fbf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Got1/Sft2-like family; Vesicle transport protein, Got1/SFT2-like; and Vesicle transport protein SFT2. Is an ortholog of human SFT2D3 (SFT2 domain containing 3).

WB:WBGene00007691	cest-8
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8.

WB:WBGene00007692	cest-9.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold.

WB:WBGene00007693	cest-7
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8.

WB:WBGene00007694	C23H4.6
Is expressed in tail. Is predicted to encode a protein with the following domains: Structural maintenance of chromosomes protein 6 and P-loop containing nucleoside triphosphate hydrolase. Is an ortholog of human SMC6 (structural maintenance of chromosomes 6).

WB:WBGene00007695	cest-9.2
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8.

WB:WBGene00007696	tram-1
Localizes to dendrite terminus; periciliary membrane compartment; and rough endoplasmic reticulum. Is an ortholog of human TRAM1 (translocation associated membrane protein 1).

WB:WBGene00007697	C24F3.2
Is predicted to have protein tyrosine/serine/threonine phosphatase activity. Human ortholog(s) of this gene are implicated in Lafora disease; hypogonadotropic hypogonadism 19 with or without anosmia; and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP12 (dual specificity phosphatase 12).

WB:WBGene00007698	qns-1
Exhibits NAD+ synthase activity. Is involved in NAD biosynthetic process and determination of adult lifespan. Is an ortholog of human NADSYN1 (NAD synthetase 1).

WB:WBGene00007699	C24H11.1
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00007700	C24H11.2
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00007701	srd-74
Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; nicotine; and Sirolimus based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00007702	C24H11.5
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; lin-35; and fog-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gem-associated protein 7 (Gemin7) and SMN complex, gem-associated protein 7. Is an ortholog of human GEMIN7 (gem nuclear organelle associated protein 7).

WB:WBGene00007703	gbf-1
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Is involved in several processes, including endoplasmic reticulum organization; endosomal transport; and mitochondrion organization. Localizes to Golgi cis cisterna and endoplasmic reticulum exit site. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1).

WB:WBGene00007704	mdt-21
Is predicted to have transcription coregulator activity. Is an ortholog of human MED21 (mediator complex subunit 21).

WB:WBGene00007705	C25A1.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: N-terminal domain of NEFA-interacting nuclear protein NIP30; FAM192A/Fyv6, N-terminal; and PSME3-interacting protein. Is an ortholog of human PSME3IP1 (proteasome activator subunit 3 interacting protein 1).

WB:WBGene00007707	fath-1
Is predicted to have fatty acid alpha-hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 35. Is an ortholog of human FA2H (fatty acid 2-hydroxylase).

WB:WBGene00007708	nola-3
Is predicted to have box H/ACA snoRNA binding activity and telomerase RNA binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive dyskeratosis congenita 1. Is an ortholog of human NOP10 (NOP10 ribonucleoprotein).

WB:WBGene00007709	clec-87
Is predicted to have carbohydrate binding activity. Is an ortholog of human KLRF2 (killer cell lectin like receptor F2).

WB:WBGene00007710	rsa-1
Exhibits protein phosphatase 2A binding activity. Is involved in embryo development; mitotic spindle assembly; and protein localization to organelle. Localizes to centrosome. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14; retinitis pigmentosa 48; and torsion dystonia 2. Is an ortholog of human PPP2R3C (protein phosphatase 2 regulatory subunit B''gamma).

WB:WBGene00007711	lid-1
Is predicted to have carboxylic ester hydrolase activity. Localizes to lipid droplet. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia and neutral lipid storage disease. Is an ortholog of human ABHD4 (abhydrolase domain containing 4, N-acyl phospholipase B) and ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase).

WB:WBGene00007712	mrpl-34
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL43 (mitochondrial ribosomal protein L43).

WB:WBGene00007713	C25A1.15
Is enriched in seam cell based on RNA-seq studies. Is affected by daf-12; drh-3; and mut-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine and cadmium based on microarray studies.

WB:WBGene00007714	C25D7.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00007715	C25D7.2
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007716	fbxa-82
Is enriched in intestine and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including multi-walled carbon nanotube; levamisole; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00007717	C25D7.5
Is involved in innate immune response.

WB:WBGene00007718	otub-1
Exhibits thiol-dependent ubiquitin-specific protease activity. Is involved in protein K48-linked deubiquitination. Localizes to plasma membrane. Is expressed in distal tip cell; neuronal sheath cell; neurons; pharynx; and ventral nerve cord. Is an ortholog of human OTUB1 (OTU deubiquitinase, ubiquitin aldehyde binding 1) and OTUB2 (OTU deubiquitinase, ubiquitin aldehyde binding 2).

WB:WBGene00007719	C25D7.9
Is affected by several genes including eat-2; spn-4; and mir-34 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00007720	C25D7.10
Is enriched in several structures, including germ line; intestine; muscle cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007721	C25D7.12
Is enriched in germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007722	C25D7.15
Is enriched in germ line; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by Rotenone; Rifampin; and Sirolimus based on RNA-seq studies.

WB:WBGene00007723	C25F9.2
Is predicted to have DNA binding activity; DNA-directed DNA polymerase activity; and nucleotide binding activity.

WB:WBGene00007724	C25F9.4
Is predicted to have ATP binding activity.

WB:WBGene00007725	C25F9.5
Is predicted to have ATP binding activity.

WB:WBGene00007726	C25F9.6
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rifampin; D-glucose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00007727	C25F9.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00007728	C25F9.9
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on microarray and RNA-seq studies. Is affected by five chemicals including tryptophan; Rifampin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007729	clec-185
Is predicted to have carbohydrate binding activity.

WB:WBGene00007730	C25G4.2
Is predicted to have hydrolase activity. Is an ortholog of human OVCA2 (OVCA2 serine hydrolase domain containing).

WB:WBGene00007731	C25G4.3
Is enriched in AFD; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Rotenone; Humic Substances; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosome-binding factor A; Ribosome-binding factor A; K homology domain-like, alpha/beta; Ribosome-binding factor A domain superfamily; and Putative ribosome-binding factor A, mitochondrial. Is an ortholog of human RBFA (ribosome binding factor A).

WB:WBGene00007732	spe-44
Exhibits DNA-binding transcription activator activity, RNA polymerase II-specific. Is involved in regulation of transcription from RNA polymerase II promoter involved in spermatogenesis. Localizes to autosome. Is expressed in germ line; sperm; and in male. Is an ortholog of human GMEB1 (glucocorticoid modulatory element binding protein 1) and GMEB2 (glucocorticoid modulatory element binding protein 2).

WB:WBGene00007733	smz-1
Is involved in male meiosis chromosome segregation. Localizes to nuclear chromatin. Is expressed in male gonad and sperm.

WB:WBGene00007734	C25G4.7
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00007735	C25G4.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including eat-2; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00007736	igdb-2
Is expressed in amphid sheath cell; amphid socket cell; and hypodermis. Is predicted to encode a protein with the following domains: DB module; Domain of unknown function DB; and Immunoglobulin-like domain superfamily.

WB:WBGene00007739	C26C6.4
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00007740	C26C6.6
Is predicted to have metal ion binding activity.

WB:WBGene00007741	glb-8
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in familial erythrocytosis 6; hemolytic anemia (multiple); and sickle cell anemia.

WB:WBGene00007742	C26C6.8
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-12; sek-1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SH3 domain; Variant SH3 domain; SH3 domain; and SH3-like domain superfamily.

WB:WBGene00007743	C26C6.9
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including Mianserin; Zidovudine; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: emp24/gp25L/p24 family/GOLD; GOLD domain; and TMP21-related.

WB:WBGene00007744	C26D10.3
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in myofibrillar myopathy 8. Is an ortholog of human PYROXD1 (pyridine nucleotide-disulphide oxidoreductase domain 1).

WB:WBGene00007745	C26D10.4
Is predicted to have fucokinase activity. Is an ortholog of human FCSK (fucose kinase).

WB:WBGene00007746	C26D10.6
Is enriched in intestine; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007747	C26E1.1
Is enriched in male based on RNA-seq studies. Is affected by rsr-2 based on tiling array studies.

WB:WBGene00007748	C26E1.2
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; D-glucose; and levamisole based on microarray and RNA-seq studies.

WB:WBGene00007749	ceh-79
Is predicted to have DNA binding activity. Is expressed in several structures, including body wall musculature; gonad; intestine; neurons; and somatic nervous system.

WB:WBGene00007750	syg-2
Exhibits cell adhesion molecule binding activity and protein homodimerization activity. Is involved in cell-cell signaling; nervous system development; and protein localization to synapse. Is expressed in several structures, including P6.paa; P6.pap; P6.ppa; egg-laying apparatus; and neurons. Is used to study nephrotic syndrome. Is an ortholog of human NPHS1 (NPHS1 adhesion molecule, nephrin).

WB:WBGene00007751	C26G2.2
Is enriched in BAG and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00007752	wdfy-3
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in primary autosomal dominant microcephaly 18. Is an ortholog of human WDFY3 (WD repeat and FYVE domain containing 3).

WB:WBGene00007753	C27A7.1
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial calcification of infancy; autosomal recessive hypophosphatemic rickets; and obesity. Is an ortholog of human ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1); ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2); and ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3).

WB:WBGene00007754	C27A7.2
Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Ethanol; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00007755	C27A7.3
Is predicted to have hydrolase activity and metal ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial calcification of infancy; autosomal recessive hypophosphatemic rickets; and obesity. Is an ortholog of human ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) and ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3).

WB:WBGene00007756	C27A7.5
Is predicted to have asparaginase activity. Is an ortholog of human ASPG (asparaginase).

WB:WBGene00007757	C27A7.6
Is predicted to have cofactor transmembrane transporter activity. Is an ortholog of human SLC49A3 (solute carrier family 49 member 3).

WB:WBGene00007758	C27A7.8
Is enriched in BAG; amphid sheath cell; excretory cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00007759	C27A7.9
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including clk-1; hpl-2; and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00007760	C27B7.2
Is enriched in body wall muscle cell; germ line; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterized conserved protein (DUF2358) and Protein of unknown function DUF2358. Is an ortholog of human C6orf136 (chromosome 6 open reading frame 136).

WB:WBGene00007761	rad-26
Is predicted to have ATP binding activity. Is an ortholog of human RAD54L2 (RAD54 like 2).

WB:WBGene00007762	C27B7.5
Is predicted to have nucleic acid binding activity and zinc ion binding activity.

WB:WBGene00007763	C27B7.6
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00007764	C27B7.7
Is enriched in PLM; body wall musculature; intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including Mercuric Chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and familial adult myoclonic epilepsy 5. Is predicted to encode a protein with the following domains: Fibronectin type III domain; Fibronectin type III; Immunoglobulin-like fold; Fibronectin type III superfamily; and Immunoglobulin-like domain superfamily. Is an ortholog of human DSCAM (DS cell adhesion molecule) and DSCAML1 (DS cell adhesion molecule like 1).

WB:WBGene00007765	C27B7.9
Is enriched in cephalic sheath cell; dopaminergic neurons; excretory cell; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00007766	C27C7.1
Is enriched in several structures, including I5 neuron; cholinergic neurons; germ line; germline precursor cell; and head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007767	C27C7.2
Is affected by ubc-9 and sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00007768	C27C7.5
Is predicted to have galactoside binding activity. Is an ortholog of human LGALS12 (galectin 12).

WB:WBGene00007769	C27C7.7
Is affected by several genes including daf-2; eat-2; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Pes-10; Pes-10; and Armadillo-type fold.

WB:WBGene00007770	nhr-259
Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8. Is predicted to encode a protein with the following domains: Nuclear hormone receptor, ligand-binding domain and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00007771	C27C12.1
Is enriched in AFD; ASER; germ line; head mesodermal cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-like helical.

WB:WBGene00007772	egrh-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in negative regulation of MAP kinase activity; negative regulation of oocyte maturation; and negative regulation of ovulation. Localizes to nucleus and perinuclear region of cytoplasm. Is expressed in body wall musculature; hermaphrodite somatic gonadal cell; nervous system; pharynx; and sperm. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); Denys-Drash syndrome; and Frasier syndrome. Is an ortholog of human EGR1 (early growth response 1).

WB:WBGene00007773	C27C12.3
Is expressed in germ line.

WB:WBGene00007774	C27C12.4
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by paraquat and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00007775	acd-3
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human ASIC5 (acid sensing ion channel subunit family member 5).

WB:WBGene00007776	dmd-4
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in neurons. Is an ortholog of human DMRT3 (doublesex and mab-3 related transcription factor 3).

WB:WBGene00007777	C27D8.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007778	C27D8.2
Is enriched in AVA; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB And C-terminal Kelch and BTB/Kelch-associated.

WB:WBGene00007779	C27D8.3
Is enriched in AVA; OLL; PVD; intestine; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007780	C27D8.4
Is predicted to have catalytic activity. Is expressed in intestine and pharynx.

WB:WBGene00007781	C27H2.1
No description available

WB:WBGene00007784	ruvb-1
Is predicted to have DNA helicase activity. Is involved in several processes, including TOR signaling; box C/D snoRNP assembly; and positive regulation of translation. Localizes to cytoplasm and nucleus. Is expressed in gonad and pharyngeal cell. Is an ortholog of human RUVBL1 (RuvB like AAA ATPase 1).

WB:WBGene00007785	tofu-1
Is enriched in AVA; AVK; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; Mianserin; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00007786	rmd-2
Is enriched in germ line and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including let-7; gld-1; and clk-1 based on proteomic; microarray; and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; Cry5B; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; and Tetratricopeptide repeat. Is an ortholog of human RMDN2 (regulator of microtubule dynamics 2) and RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00007787	C27H6.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; microarray; and proteomic studies. Is affected by six chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Uncharacterised protein family (UPF0160); and Metal-dependent protein hydrolase. Is an ortholog of human MYG1 (MYG1 exonuclease).

WB:WBGene00007788	C28A5.1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00007789	C28A5.2
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00007791	C28A5.6
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00007792	C28D4.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on proteomic; microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00007793	C28D4.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00007794	C28D4.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248) and Domain of unknown function DUF1248.

WB:WBGene00007795	C28D4.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00007796	C28D4.10
Is enriched in GABAergic neurons; body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including hpl-2; mir-34; and wrn-1 based on RNA-seq and microarray studies. Is affected by four chemicals including methylmercuric chloride; Mianserin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Ubiquitin-like domain superfamily.

WB:WBGene00007797	C29A12.1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00007798	C29A12.2
Is affected by several genes including daf-2; hsf-1; and sek-1 based on RNA-seq and microarray studies. Is affected by Zidovudine and Sodium Chloride based on RNA-seq studies.

WB:WBGene00007799	nrx-1
Is involved in negative regulation of receptor clustering. Localizes to presynaptic active zone. Is expressed in GABAergic neurons; cholinergic neurons; nervous system; and ventral cord neurons. Is used to study autism spectrum disorder. Human ortholog(s) of this gene are implicated in Pitt-Hopkins-like syndrome 2. Is an ortholog of human NRXN1 (neurexin 1).

WB:WBGene00007800	C29A12.6
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and let-7 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00007801	trpa-1
Is predicted to have ion channel activity. Localizes to neuronal cell body and non-motile cilium. Is expressed in several structures, including excretory system; pharyngeal muscle cell; sensory neurons; ventral nerve cord; and vulva. Human ortholog(s) of this gene are implicated in familial episodic pain syndrome 1. Is an ortholog of human TRPA1 (transient receptor potential cation channel subfamily A member 1).

WB:WBGene00007802	cutl-27
Is enriched in PLM and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; skn-1; and let-60 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain; Zona pellucida domain; and PAN/Apple domain.

WB:WBGene00007803	C29E6.6
No description available

WB:WBGene00007804	C29F3.3
Is enriched in excretory cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007805	clec-231
Is predicted to have carbohydrate binding activity.

WB:WBGene00007806	clec-230
Is predicted to have carbohydrate binding activity.

WB:WBGene00007807	C29F3.7
Is involved in innate immune response. Localizes to membrane raft.

WB:WBGene00007808	best-7
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00007809	C29F4.3
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007810	C29F7.1
Is enriched in ASER; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including tryptophan; indole; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00007811	C29F7.2
Is expressed in pharynx. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00007812	C29F7.3
Exhibits UMP kinase activity. Is involved in UDP biosynthetic process. Is expressed in pharynx. Is an ortholog of human CMPK1 (cytidine/uridine monophosphate kinase 1).

WB:WBGene00007813	jmjd-3.3
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; chromatin DNA binding activity; and histone demethylase activity (H3-K27 specific). Human ortholog(s) of this gene are implicated in Kabuki syndrome. Is an ortholog of human KDM6A (lysine demethylase 6A); KDM6B (lysine demethylase 6B); and UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked).

WB:WBGene00007816	C30F2.2
Is enriched in AFD; ASER; PLM; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00007817	C30F2.3
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00007818	C30F2.4
Is enriched in ASER; NSM; dopaminergic neurons; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; isp-1; and hsp-6 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007819	C30F2.5
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including 4-bromodiphenyl ether; metformin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007820	clec-199
Is predicted to have carbohydrate binding activity. Is expressed in head neurons and in male.

WB:WBGene00007821	clec-201
Is affected by several genes including smg-2; ahr-1; and rsr-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00007822	clec-202
Is predicted to have carbohydrate binding activity.

WB:WBGene00007823	C30H6.5
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eighteen chemicals including tryptophan; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00007824	dlat-2
Is predicted to have transferase activity, transferring acyl groups. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human PDHX (pyruvate dehydrogenase complex component X).

WB:WBGene00007825	C30H6.8
Is enriched in NSM; germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Rotenone; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily.

WB:WBGene00007826	C30H6.9
Is enriched in AFD; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00007827	trh-1
Is expressed in M4 neuron and M5 neuron.

WB:WBGene00007829	oac-5
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00007830	C31A11.2
No description available

WB:WBGene00007831	srbc-83
Is affected by several genes including let-60; clk-1; and sir-2.1 based on microarray studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00007832	srbc-82
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including eat-2; dpy-21; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00007833	oac-6
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00007834	srxa-7
Is expressed in PVT and chemosensory neurons. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00007835	oac-7
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00007836	C31C9.2
Is predicted to have phosphoglycerate dehydrogenase activity. Human ortholog(s) of this gene are implicated in Neu-Laxova syndrome 1 and PHGDH deficiency. Is an ortholog of human PHGDH (phosphoglycerate dehydrogenase).

WB:WBGene00007837	fbxa-167
Is enriched in body wall muscle cell; head mesodermal cell; hypodermis; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00007838	fbxa-168
Is enriched in PLM; Z1; and Z4 based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00007839	C31C9.5
No description available

WB:WBGene00007840	C31C9.6
Is predicted to have actin filament binding activity. Human ortholog(s) of this gene are implicated in Wiskott-Aldrich syndrome and thrombocytopenia.

WB:WBGene00007841	C31C9.7
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00007842	C31E10.1
Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00007843	C31E10.2
No description available

WB:WBGene00007844	irld-24
Is affected by several genes including rrf-3; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007846	C31E10.5
Is enriched in GABAergic neurons; body wall muscle cell; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including stavudine; Zidovudine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain-containing protein (DUF2037); CCDC93, coiled-coil domain; and Coiled-coil domain-containing protein 93. Is an ortholog of human CCDC93 (coiled-coil domain containing 93).

WB:WBGene00007847	C31E10.6
Is enriched in GABAergic neurons; body wall muscle cell; coelomocyte; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain-containing protein (DUF2037); CCDC93, coiled-coil domain; and Coiled-coil domain-containing protein 93. Is an ortholog of human CCDC93 (coiled-coil domain containing 93).

WB:WBGene00007848	cytb-5.1
Is predicted to have heme binding activity and metal ion binding activity. Localizes to perinuclear region of cytoplasm. Is an ortholog of human CYB5B (cytochrome b5 type B).

WB:WBGene00007849	tbc-19
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBC1D2 (TBC1 domain family member 2).

WB:WBGene00007850	C31G12.1
Is enriched in germ line and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00007851	clec-245
Is predicted to have carbohydrate binding activity.

WB:WBGene00007852	C31G12.3
Is affected by lin-15B and rsr-2 based on microarray and tiling array studies. Is affected by Atrazine and dafa#1 based on microarray studies.

WB:WBGene00007853	C31G12.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; Psoralens; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007854	C31H5.1
Is enriched in amphid sheath cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by Cadmium Chloride and adsorbable organic bromine compound based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia and neutral lipid storage disease. Is predicted to encode a protein with the following domains: Alpha/beta hydrolase of unknown function (DUF1057); Protein of unknown function DUF1057; and Alpha/Beta hydrolase fold.

WB:WBGene00007855	C31H5.4
Is enriched in hypodermis; intestine; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; Rotenone; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00007856	C31H5.5
Is enriched in intestine; muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007857	C31H5.6
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT1 (acyl-CoA thioesterase 1).

WB:WBGene00007858	C31H5.7
Is enriched in several structures, including Z4.a; dopaminergic neurons; intestine; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007859	mrps-31
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS31 (mitochondrial ribosomal protein S31).

WB:WBGene00007860	rilp-1
Is predicted to have dynein light intermediate chain binding activity and small GTPase binding activity. Is an ortholog of human RILPL1 (Rab interacting lysosomal protein like 1).

WB:WBGene00007861	C32A9.1
Is enriched in amphid sheath cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Tunicamycin; metformin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00007862	kvs-2
Is predicted to have voltage-gated potassium channel activity. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNF1 (potassium voltage-gated channel modifier subfamily F member 1).

WB:WBGene00007863	C32C4.3
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including D-glucose; Alovudine; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00007864	irg-6
Is involved in response to gamma radiation.

WB:WBGene00007865	srz-15
Is affected by several genes including npr-1; eri-1; and drh-3 based on RNA-seq and microarray studies. Is affected by Tunicamycin; resveratrol; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00007866	C32H11.3
Is enriched in CEPshDL; CEPshDR; CEPshVL; and CEPshVR based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including tryptophan; 1-methylnicotinamide; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00007867	C32H11.4
Is involved in innate immune response.

WB:WBGene00007868	C32H11.5
Is enriched in ALM; GABAergic neurons; PLM; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; nicotinic acid; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00007869	C32H11.6
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; D-glucose; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00007870	C32H11.7
Is enriched in AFD; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00007871	C32H11.8
Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and Diazinon based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00007872	C32H11.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00007873	dod-21
Is enriched in FLP and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; quantitative PCR; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Heme; methylmercury hydroxide; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00007874	C32H11.11
Is affected by several genes including daf-2; eat-2; and bar-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00007875	dod-24
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00007876	dct-19
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00007877	nfki-1
Is predicted to have transcription factor binding activity. Is expressed in RMGL; RMGR; and nervous system. Is an ortholog of human NFKBIZ (NFKB inhibitor zeta).

WB:WBGene00007878	C33A11.2
Is expressed in several structures, including CAN; gonad; head; pharyngeal cell; and tail. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family and Frag1/DRAM/Sfk1. Is an ortholog of human DRAM1 (DNA damage regulated autophagy modulator 1) and DRAM2 (DNA damage regulated autophagy modulator 2).

WB:WBGene00007880	C33A12.1
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is an ortholog of human NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5).

WB:WBGene00007881	nlp-35
Is enriched in ASER; GABAergic neurons; RIS; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007882	C33A12.3
Is expressed widely. Is predicted to encode a protein with the following domain: . Is an ortholog of human C4orf33 (chromosome 4 open reading frame 33).

WB:WBGene00007883	C33A12.4
Is expressed in AVJ and ciliated neurons.

WB:WBGene00007884	C33A12.5
No description available

WB:WBGene00007885	ugt-21
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00007886	ethe-1
Is predicted to have hydrolase activity, acting on ester bonds and sulfur dioxygenase activity. Human ortholog(s) of this gene are implicated in ethylmalonic encephalopathy. Is an ortholog of human ETHE1 (ETHE1 persulfide dioxygenase).

WB:WBGene00007887	gadr-2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-type fold and Leucine-rich repeat domain superfamily.

WB:WBGene00007888	ttr-9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00007889	C33A12.16
Is affected by clk-1; lin-14; and lin-4 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00007890	C33A12.19
Is enriched in dopaminergic neurons; germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00007891	C33B4.2
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007892	C33B4.4
Is enriched in several structures, including carbon dioxide sensory neurons; germ line; muscle cell; somatic gonad precursor; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00007893	C33B4.5
Is affected by several genes including drh-3; wrn-1; and emb-4 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00007894	C33D3.3
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; D-glucose; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00007895	C33D3.4
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including let-60; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by antimycin and dafa#1 based on RNA-seq and microarray studies.

WB:WBGene00007896	C33D3.5
Is enriched in ASER; body wall musculature; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and mex-3 based on microarray and RNA-seq studies. Is affected by tryptophan and Mercuric Chloride based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00007897	clec-182
Is predicted to have carbohydrate binding activity.

WB:WBGene00007898	C33D9.3
Is enriched in intestine; muscle cell; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00007899	C33D9.5
Is enriched in body wall muscle cell; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007900	C33D9.6
Is expressed in hypodermis; muscle cell; and ventral cord neurons.

WB:WBGene00007901	C33D9.8
Is enriched in AFD; AVA; body wall muscle cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; D-glucose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00007902	C33D9.9
Is enriched in coelomocyte and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00007903	lgc-21
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00007904	C33G3.4
Is predicted to have beta-mannosidase activity. Human ortholog(s) of this gene are implicated in beta-mannosidosis. Is an ortholog of human MANBA (mannosidase beta).

WB:WBGene00007905	C33G3.5
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00007906	C33G3.6
Is enriched in cephalic sheath cell; coelomocyte; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by D-glucose and paraquat based on RNA-seq and microarray studies.

WB:WBGene00007907	C34B4.2
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity.

WB:WBGene00007908	C34B4.3
Is enriched in AFD; ASER; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srv and 7TM GPCR, serpentine receptor class v (Srv).

WB:WBGene00007909	C34B4.4
Is enriched in AFD and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; elt-2; and mex-3 based on tiling array and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007910	C34B4.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mes-2 based on microarray; RNA-seq; and tiling array studies. Is affected by multi-walled carbon nanotube and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00007911	C34B7.1
Is enriched in arcade cell; dopaminergic neurons; pharyngeal-intestinal valve cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00007912	figo-1
Is predicted to have phosphoric ester hydrolase activity. Is expressed in GABAergic neurons; body wall musculature; head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4J; Yunis-Varon syndrome; and amyotrophic lateral sclerosis type 11. Is an ortholog of human FIG4 (FIG4 phosphoinositide 5-phosphatase).

WB:WBGene00007913	cyp-36A1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is expressed in body wall musculature; intestine; neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00007914	mys-4
Is predicted to have histone acetyltransferase activity and histone binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 32 and blepharophimosis-intellectual disability syndrome, SBBYS type. Is an ortholog of human KAT6B (lysine acetyltransferase 6B) and KAT7 (lysine acetyltransferase 7).

WB:WBGene00007916	C34C6.3
Is enriched in PLM; RIS; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including aldicarb; Ethanol; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00007917	C34C6.4
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on CH-OH group of donors. Is expressed in gonad. Is an ortholog of human CHDH (choline dehydrogenase).

WB:WBGene00007918	sphk-1
Is predicted to have D-erythro-sphingosine kinase activity and acetyltransferase activity. Is involved in mitochondrial unfolded protein response; positive regulation of acetylcholine secretion, neurotransmission; and regulation of locomotion. Localizes to several cellular components, including mitochondrion; neuronal cell body; and presynaptic periactive zone. Is expressed in several structures, including body wall musculature; excretory canal; intestine; linker cell; and neurons. Is an ortholog of human SPHK1 (sphingosine kinase 1) and SPHK2 (sphingosine kinase 2).

WB:WBGene00007919	cup-16
Is involved in endocytosis and lysosomal protein catabolic process.

WB:WBGene00007920	C34C12.1
Is affected by several genes including daf-16; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1280) and Protein of unknown function DUF1280.

WB:WBGene00007921	C34C12.2
Is enriched in body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by twelve chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007922	pph-6
Is predicted to have metal ion binding activity and phosphoprotein phosphatase activity. Is involved in cortical actin cytoskeleton organization; establishment of mitotic spindle localization; and first cell cycle pseudocleavage. Localizes to astral microtubule and cell cortex. Is an ortholog of human PPP6C (protein phosphatase 6 catalytic subunit).

WB:WBGene00007923	C34C12.4
Is expressed in several structures, including gland cell; intestine; marginal cell; non-striated muscle; and spermatheca. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2615) and Uncharacterised protein family, CD034/YQF4. Is an ortholog of human SMIM14 (small integral membrane protein 14).

WB:WBGene00007924	rsu-1
Is involved in innate immune response. Is expressed in body wall musculature; distal tip cell; pharyngeal muscle cell; ventral cord neurons; and vulval muscle. Is an ortholog of human RSU1 (Ras suppressor protein 1).

WB:WBGene00007925	C34C12.6
Is enriched in OLL; PVD; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L2 (SEC14 like lipid binding 2); SEC14L3 (SEC14 like lipid binding 3); and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00007926	C34C12.7
Is enriched in AFD; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00007927	C34C12.8
Is predicted to have adenyl-nucleotide exchange factor activity and unfolded protein binding activity. Localizes to mitochondrion. Is an ortholog of human GRPEL1 (GrpE like 1, mitochondrial).

WB:WBGene00007928	C34C12.9
Is enriched in body wall muscle cell and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; elt-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00007929	dmd-10
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in body wall musculature; head neurons; intestine; and vulval muscle. Is an ortholog of human DMRTB1 (DMRT like family B with proline rich C-terminal 1).

WB:WBGene00007930	dmd-11
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in AVG; head neurons; and in male.

WB:WBGene00007931	C34D1.4
Is enriched in OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; levamisole; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00007932	zip-5
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head muscle; head neurons; tail neurons; and ventral nerve cord.

WB:WBGene00007933	C34E7.3
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00007934	C34E7.4
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including D-glucose; bisphenol S; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: GM2-AP, lipid-recognition domain superfamily.

WB:WBGene00007935	C34E11.2
Is enriched in GABAergic neurons and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MH2 domain; SMAD domain, Dwarfin-type; SMAD/FHA domain superfamily; and SMAD-like domain superfamily.

WB:WBGene00007937	C34E11.4
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00007938	C34F6.1
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00007939	C34F6.5
Is enriched in NSM; intestine; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including resveratrol; Atrazine; and Cry5B based on microarray studies.

WB:WBGene00007941	C34F6.7
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human TMEM129 (transmembrane protein 129, E3 ubiquitin ligase).

WB:WBGene00007942	idh-2
Is predicted to have isocitrate dehydrogenase (NADP+) activity. Human ortholog(s) of this gene are implicated in D-2-hydroxyglutaric aciduria 2. Is an ortholog of human IDH2 (isocitrate dehydrogenase (NADP(+)) 2).

WB:WBGene00007943	C34F6.9
Is enriched in germ line; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and aak-2 based on microarray; RNA-seq; and tiling array studies. Is affected by stavudine; paraquat; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Y-linked spermatogenic failure 2; and non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Phosphorylation site; Ubiquitin carboxyl-terminal hydrolase; PAN2 domain; and Papain-like cysteine peptidase superfamily.

WB:WBGene00007944	C34F6.10
Is expressed in RIH and body wall musculature. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 1B. Is predicted to encode a protein with the following domains: Fibronectin type III domain; Fibronectin type III; Immunoglobulin-like fold; and Fibronectin type III superfamily. Is an ortholog of human FNDC3B (fibronectin type III domain containing 3B).

WB:WBGene00007945	C34F6.11
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including paraquat; Progesterone; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00007946	ugt-33
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00007947	C35A5.3
Is predicted to have transmembrane transporter activity.

WB:WBGene00007948	C35A5.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including tryptophan; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00007949	C35A5.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00007950	C35A5.6
Is enriched in hypodermis; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: AKAP7 2'5' RNA ligase-like domain and Protein kinase A anchor protein, nuclear localisation signal domain.

WB:WBGene00007951	dmsr-8
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00007952	C35A5.8
Is predicted to have nuclear export signal receptor activity. Is expressed widely. Is an ortholog of human XPO7 (exportin 7).

WB:WBGene00007953	hda-11
Is predicted to have protein deacetylase activity. Is an ortholog of human HDAC11 (histone deacetylase 11).

WB:WBGene00007954	gcp-2.2
Is predicted to have carboxypeptidase activity. Human ortholog(s) of this gene are implicated in hemochromatosis type 3. Is an ortholog of human FOLH1 (folate hydrolase 1) and NAALAD2 (N-acetylated alpha-linked acidic dipeptidase 2).

WB:WBGene00007955	selt-1.1
Is predicted to have thioredoxin-disulfide reductase activity. Is expressed in several structures, including amphid neurons; body wall musculature; interfacial epithelial cell; pharyngeal cell; and vulval cell. Is an ortholog of human SELENOT (selenoprotein T).

WB:WBGene00007956	trpp-9
Is enriched in coelomocyte; germ line; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in non-syndromic intellectual disability. Is predicted to encode a protein with the following domains: Phosphorylation site; Transport protein Trs120 or TRAPPC9, TRAPP II complex subunit; and TRAPP II complex, Trs120. Is an ortholog of human TRAPPC9 (trafficking protein particle complex 9).

WB:WBGene00007957	C35C5.8
Is enriched in dopaminergic neurons; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including Rotenone; Tunicamycin; and Ethanol based on RNA-seq and microarray studies.

WB:WBGene00007958	C35C5.9
Is enriched in cephalic sheath cell; dopaminergic neurons; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including aldicarb; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00007959	C35C5.10
Is enriched in intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TMEM164 family and Transmembrane protein 164. Is an ortholog of human TMEM164 (transmembrane protein 164).

WB:WBGene00007960	C35D6.3
Is affected by several genes including daf-2; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by stavudine and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: PAZ domain superfamily.

WB:WBGene00007961	C35D6.4
Is predicted to have mRNA 3'-UTR binding activity. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00007962	C35D6.5
Is affected by several genes including daf-2; alg-1; and hsp-6 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00007963	cyp-25A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 14. Is an ortholog of human TBXAS1 (thromboxane A synthase 1).

WB:WBGene00007964	cyp-25A2
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 14. Is an ortholog of human TBXAS1 (thromboxane A synthase 1).

WB:WBGene00007965	C36A4.4
Is predicted to have uridylyltransferase activity. Is an ortholog of human UAP1 (UDP-N-acetylglucosamine pyrophosphorylase 1) and UAP1L1 (UDP-N-acetylglucosamine pyrophosphorylase 1 like 1).

WB:WBGene00007966	maph-1.3
Is predicted to have actin binding activity and microtubule binding activity. Is an ortholog of human MAP1S (microtubule associated protein 1S).

WB:WBGene00007967	cyp-25A4
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 14. Is an ortholog of human TBXAS1 (thromboxane A synthase 1).

WB:WBGene00007968	C36A4.7
No description available

WB:WBGene00007969	acs-19
Is predicted to have AMP binding activity; ATP binding activity; and acetate-CoA ligase activity. Is involved in positive regulation of proteasomal ubiquitin-dependent protein catabolic process and regulation of response to oxidative stress. Is expressed in hypodermis; intestine; and neurons. Is an ortholog of human ACSS2 (acyl-CoA synthetase short chain family member 2).

WB:WBGene00007970	C36A4.10
Is enriched in AVK; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by hydrogen sulfide and Sirolimus based on microarray studies.

WB:WBGene00007971	rpb-3
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2C (RNA polymerase II subunit C).

WB:WBGene00007972	prp-4
Is predicted to have U4 snRNA binding activity and U6 snRNA binding activity. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 70. Is an ortholog of human PRPF4 (pre-mRNA processing factor 4).

WB:WBGene00007973	C36B1.6
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007974	dhfr-1
Is predicted to have NADP binding activity and dihydrofolate reductase activity. Human ortholog(s) of this gene are implicated in megaloblastic anemia. Is an ortholog of human DHFR2 (dihydrofolate reductase 2).

WB:WBGene00007975	gls-1
Localizes to P granule and polysome. Is expressed in germ line.

WB:WBGene00007976	C36B1.9
Is predicted to have metal ion binding activity.

WB:WBGene00007977	gska-3
Is predicted to have MAP kinase activity. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00007978	C36B1.11
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00007979	imp-1
Is predicted to have aspartic endopeptidase activity, intramembrane cleaving. Is expressed in neurons. Is an ortholog of human SPPL2A (signal peptide peptidase like 2A).

WB:WBGene00007980	C36E8.1
Is predicted to have RNA polymerase I core binding activity and RNA polymerase I general transcription initiation factor activity. Is an ortholog of human RRN3 (RRN3 homolog, RNA polymerase I transcription factor).

WB:WBGene00007981	glb-11
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in neurons; pharynx; and somatic nervous system.

WB:WBGene00007982	pxd-1
Is expressed in head and tail. Is predicted to encode a protein with the following domain: Plexin domain-containing protein. Is an ortholog of human PLXDC1 (plexin domain containing 1) and PLXDC2 (plexin domain containing 2).

WB:WBGene00007983	C36E8.4
Is enriched in GABAergic neurons and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Variant SH3 domain; FCH domain; SH3 domain; AH/BAR domain superfamily; and SH3-like domain superfamily. Is an ortholog of human NOSTRIN (nitric oxide synthase trafficking).

WB:WBGene00007984	irx-1
Is predicted to have DNA binding activity. Localizes to nucleus. Is expressed in several structures, including DD neuron; head muscle; head neurons; intestine; and somatic nervous system. Is an ortholog of human IRX5 (iroquois homeobox 5).

WB:WBGene00007985	swah-1
Is expressed in intestine. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00007986	C36F7.5
Is enriched in NSM; amphid sheath cell; germ line; neurons; and in male based on proteomic; RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including manganese chloride; D-glucose; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00007987	C36H8.1
Is enriched in several structures, including AVG; RIM; amphid sheath cell; command interneuron; and germ line based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00007988	best-8
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1) and BEST2 (bestrophin 2).

WB:WBGene00007989	fipr-22
Is enriched in GABAergic neurons; excretory cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and indole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007990	fipr-23
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eighteen chemicals including Rotenone; multi-walled carbon nanotube; and indole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007991	C37A5.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007992	fipr-24
Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00007993	idhb-1
Is predicted to have isocitrate dehydrogenase (NAD+) activity. Is expressed in head. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 46. Is an ortholog of human IDH3B (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta).

WB:WBGene00007994	C37E2.2
Is enriched in head mesodermal cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; dpy-7; and sek-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; manganese chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FAR-17a/AIG1-like protein and FAR-17a/AIG1-like protein. Is an ortholog of human AIG1 (androgen induced 1).

WB:WBGene00007995	C37E2.3
Is affected by several genes including clk-1; eat-2; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: FAR-17a/AIG1-like protein and FAR-17a/AIG1-like protein. Is an ortholog of human AIG1 (androgen induced 1).

WB:WBGene00007996	C38C6.3
Is enriched in PLM; body wall musculature; germline precursor cell; and hypodermis based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by seventeen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00007997	sre-13
Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00007998	C38C6.5
Is enriched in PLM and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00007999	tag-297
Is expressed in head neurons and hypodermis.

WB:WBGene00008000	slc-17.2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC17A5 (solute carrier family 17 member 5).

WB:WBGene00008001	C38C10.3
Is enriched in amphid sheath cell; germ line; hypodermis; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF508) and Protein of unknown function DUF508.

WB:WBGene00008002	nlp-48
Is enriched in muscle cell and neurons based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including indole; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008003	enu-3.2
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008005	C38D4.4
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008006	tag-325
Is predicted to have GTPase activator activity. Is an ortholog of human ARHGAP27 (Rho GTPase activating protein 27) and ARHGAP9 (Rho GTPase activating protein 9).

WB:WBGene00008007	C38D4.7
Is enriched in germ line; head mesodermal cell; and in male based on RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Rotenone; Mianserin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008008	metl-5
Is predicted to have methyltransferase activity. Is an ortholog of human METTL5 (methyltransferase like 5).

WB:WBGene00008009	fbxa-171
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00008010	C38D9.2
Is expressed in intestinal cell.

WB:WBGene00008011	C38D9.3
No description available

WB:WBGene00008012	fbxa-133
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by Ethanol; Atrazine; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00008013	C38D9.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by paraquat and Sirolimus based on microarray studies.

WB:WBGene00008014	fbxa-172
Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Alovudine; stavudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00008015	fbxa-174
Is enriched in DA neuron; VA neuron; body wall muscle cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00008016	C38D9.8
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008017	fbxa-176
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; antimycin; and paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00008018	tbc-8
Exhibits Rab GTPase binding activity. Is involved in dense core granule maturation. Localizes to Golgi apparatus; cytosol; and early endosome. Is expressed in neurons. Is an ortholog of human SGSM2 (small G protein signaling modulator 2).

WB:WBGene00008019	C38H2.2
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Is expressed in several structures, including tail. Is an ortholog of human C1GALT1 (core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1).

WB:WBGene00008020	C38H2.3
Is enriched in BAG; PLM; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008021	C39B10.1
Is enriched in RIS; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; npr-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008022	lgc-41
Is predicted to contribute to chloride channel activity. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00008023	C39B10.3
Is enriched in several structures, including Z4.a; intestine; male distal tip cell; muscle cell; and somatic gonad precursor based on SAGE; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including tryptophan; metformin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00008024	C39B10.4
Is enriched in NSM; Z1; Z4; coelomocyte; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; smg-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008025	C39B10.5
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including eat-2; dpy-21; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008026	scl-4
Is affected by several genes including daf-16; daf-2; and ung-1 based on microarray and tiling array studies.

WB:WBGene00008027	scl-5
Is expressed in pharyngeal gland cell. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00008028	scl-6
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00008029	scl-7
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00008030	scl-8
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2) and CRISP3 (cysteine rich secretory protein 3).

WB:WBGene00008031	C39E9.7
Is predicted to have transmembrane transporter activity.

WB:WBGene00008032	C39E9.8
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including 1-methylnicotinamide; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008033	spin-2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SPNS1 (sphingolipid transporter 1 (putative)).

WB:WBGene00008034	prcc-1
Is enriched in AFD; body wall muscle cell; germ line; germline precursor cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sir-2.1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including D-glucose; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in papillary renal cell carcinoma. Is predicted to encode a protein with the following domains: Mitotic checkpoint regulator, MAD2B-interacting and Proline-rich protein PRCC. Is an ortholog of human PRCC (proline rich mitotic checkpoint control factor).

WB:WBGene00008035	C39E9.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 54. Is predicted to encode a protein with the following domains: SAP domain; SAP domain; and SAP domain superfamily.

WB:WBGene00008036	C40C9.3
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008037	C40C9.4
Is affected by several genes including clk-1; sir-2.1; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; fluoranthene; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00008038	C40H1.2
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including tryptophan; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00008039	C40H1.3
Is enriched in neurons based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Joubert syndrome 25. Is predicted to encode a protein with the following domain: . Is an ortholog of human CEP104 (centrosomal protein 104).

WB:WBGene00008040	ttr-5
Is enriched in germ line; head mesodermal cell; male-specific anatomical entity; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00008041	ufc-1
Exhibits ubiquitin conjugating enzyme binding activity. Localizes to striated muscle dense body. Is expressed in intestine and neurons. Is an ortholog of human UFC1 (ubiquitin-fold modifier conjugating enzyme 1).

WB:WBGene00008042	C40H1.7
Is enriched in OLL; PVD; intestine; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Rotenone; bisphenol A; and indole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00008043	C40H1.8
Is enriched in dopaminergic neurons and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by twenty-three chemicals including Ethanol; tryptophan; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00008044	C40H1.9
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; stavudine; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00008045	C40H5.2
Is predicted to have calcium ion binding activity.

WB:WBGene00008047	lact-7
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including D-glucose; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Beta-lactamase; Bacterial tandem repeat domain 1; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00008048	hpo-41
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008050	chst-1
Exhibits chondroitin 4-sulfotransferase activity. Is involved in chondroitin sulfate biosynthetic process and positive regulation of response to oxidative stress.

WB:WBGene00008051	lron-4
Is enriched in AFD and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily.

WB:WBGene00008052	ctns-1
Is predicted to have L-cystine transmembrane transporter activity. Is involved in L-cystine transport; lysosome organization; and phagocytosis. Localizes to lysosomal membrane. Is used to study cystinosis. Human ortholog(s) of this gene are implicated in cystinosis. Is an ortholog of human CTNS (cystinosin, lysosomal cystine transporter).

WB:WBGene00008053	cdc-48.2
Exhibits ATPase activity and identical protein binding activity. Is involved in several processes, including ER-associated misfolded protein catabolic process; negative regulation of protein localization to centrosome; and protein localization to nucleus. Localizes to VCP-NPL4-UFD1 AAA ATPase complex and nucleus. Is expressed in body wall musculature and germ line. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2Y; amyotrophic lateral sclerosis type 14; and inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1. Is an ortholog of human VCP (valosin containing protein).

WB:WBGene00008054	C41C4.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by hpl-2 and rsr-2 based on tiling array studies.

WB:WBGene00008055	cyp-34A3
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and smg-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00008056	nhr-164
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008057	irld-25
Is affected by several genes including sir-2.1; mut-2; and mir-34 based on microarray and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00008058	C41G6.12
Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00008059	C41G6.13
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; nanoparticle; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008060	C41G6.16
Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array and microarray studies.

WB:WBGene00008061	mina-1
Exhibits RNA binding activity. Is involved in negative regulation of apoptotic process; negative regulation of gene expression; and regulation of gene silencing. Is expressed in oocyte.

WB:WBGene00008062	set-32
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; head mesodermal cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and elt-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 1; and autosomal dominant non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domains: SET domain and SET domain.

WB:WBGene00008063	C41G7.6
Is expressed in nervous system. Is predicted to encode a protein with the following domain: .

WB:WBGene00008064	C41G7.7
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00008065	npr-18
Is predicted to have G protein-coupled receptor activity. Is expressed in ASER.

WB:WBGene00008066	fbxb-65
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00008067	C43D7.4
Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008068	sdz-6
Is involved in gastrulation.

WB:WBGene00008069	C43D7.7
Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Psoralens based on RNA-seq studies.

WB:WBGene00008070	C43D7.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including bisphenol S; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008071	fbxb-64
Is affected by several genes including daf-2; eat-2; and drh-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00008072	C43F9.4
Is affected by several genes including daf-16; daf-12; and lin-4 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including aldicarb; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00008073	C43F9.5
Is affected by several genes including let-60; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including tryptophan; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00008074	nkb-2
Is predicted to contribute to sodium:potassium-exchanging ATPase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of human ATP1B1 (ATPase Na+/K+ transporting subunit beta 1).

WB:WBGene00008075	C43F9.7
Is enriched in ASER and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; isp-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Colistin; adsorbable organic bromine compound; and nitroguanidine based on microarray studies.

WB:WBGene00008076	lgc-43
Is predicted to contribute to chloride channel activity.

WB:WBGene00008077	oac-8
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00008078	vps-50
Is involved in positive regulation of dense core granule transport and positive regulation of locomotion involved in locomotory behavior. Is an ortholog of human VPS50 (VPS50 subunit of EARP/GARPII complex).

WB:WBGene00008079	C44B9.2
Is enriched in germ line; germline precursor cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008080	C44B9.3
Is enriched in AB; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C05B5.4-like.

WB:WBGene00008081	athp-1
Is predicted to have transcription coregulator activity. Is an ortholog of human PHF12 (PHD finger protein 12).

WB:WBGene00008082	com-1
Is predicted to have DNA binding activity and single-stranded DNA endodeoxyribonuclease activity. Human ortholog(s) of this gene are implicated in Seckel syndrome 2. Is an ortholog of human RBBP8 (RB binding protein 8, endonuclease).

WB:WBGene00008083	cyp-29A1
Is enriched in AVK based on RNA-seq studies. Is affected by cyc-1; clk-1; and hpl-2 based on microarray and RNA-seq studies.

WB:WBGene00008084	C44C10.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00008085	smcl-1
Is predicted to have ATP binding activity; chromatin binding activity; and protein heterodimerization activity. Is expressed in germ line.

WB:WBGene00008086	C44C10.5
Is enriched in Z1.p; Z4.a; germ line; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008087	C44C10.6
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00008088	C44C10.7
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00008089	C44C10.9
Is enriched in GABAergic neurons and germline precursor cell based on microarray and tiling array studies. Is affected by several genes including daf-2; daf-12; and let-7 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by eleven chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008090	C44C10.10
Is enriched in NSM based on tiling array studies. Is affected by several genes including let-60; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: AAA domain; P-loop containing nucleoside triphosphate hydrolase; and Rad50/SbcC-type AAA domain.

WB:WBGene00008091	C44F1.1
Is enriched in dopaminergic neurons; intestine; pharyngeal muscle cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008092	gmeb-3
Is predicted to have DNA binding activity and transcription coactivator activity. Is an ortholog of human GMEB1 (glucocorticoid modulatory element binding protein 1).

WB:WBGene00008093	lron-1
Is expressed in pharynx. Is predicted to encode a protein with the following domains: BspA type Leucine rich repeat region (6 copies); Leucine rich repeat; Cysteine-rich flanking region, C-terminal; Leucine-rich repeat; Leucine-rich repeat, typical subtype; BspA type Leucine rich repeat region; and Leucine-rich repeat domain superfamily. Is an ortholog of human LRRC15 (leucine rich repeat containing 15).

WB:WBGene00008094	C44H4.4
Is expressed in head. Is predicted to encode a protein with the following domains: N-terminal region of Chorein or VPS13; UHRF1-binding protein 1-like; and Vacuolar protein sorting-associated protein 13, N-terminal domain. Is an ortholog of human UHRF1BP1 (UHRF1 binding protein 1) and UHRF1BP1L (UHRF1 binding protein 1 like).

WB:WBGene00008095	C44H4.6
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 12. Is an ortholog of human GSK3B (glycogen synthase kinase 3 beta).

WB:WBGene00008096	C44H4.8
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; dpy-7; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00008097	ugt-15
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT2A3 (UDP glucuronosyltransferase family 2 member A3) and UGT2B15 (UDP glucuronosyltransferase family 2 member B15).

WB:WBGene00008098	C44H9.2
Is affected by drh-3 and eat-2 based on RNA-seq and microarray studies. Is affected by resveratrol; Atrazine; and allantoin based on microarray studies.

WB:WBGene00008099	C44H9.4
Is predicted to have RNA binding activity and transcription termination site sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in Seckel syndrome 8; autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions  6; and neurodegenerative disease (multiple).

WB:WBGene00008100	C44H9.5
Is enriched in OLL; PVD; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Sirolimus; Rifampin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008101	C44H9.6
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008102	C44H9.7
Is enriched in intestine and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008104	B0395.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00008105	C45B11.2
Is enriched in AFD; amphid sheath cell; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008106	C45B11.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by hydrogen sulfide and Tunicamycin based on microarray studies.

WB:WBGene00008107	aspm-1
Exhibits calmodulin binding activity and protein domain specific binding activity. Is involved in establishment of meiotic spindle orientation; meiotic spindle organization; and regulation of protein localization. Localizes to spindle midzone and spindle pole. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 5. Is an ortholog of human ASPM (assembly factor for spindle microtubules).

WB:WBGene00008110	C46C2.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of several human genes including SLC22A1 (solute carrier family 22 member 1); SLC22A15 (solute carrier family 22 member 15); and SLC22A17 (solute carrier family 22 member 17).

WB:WBGene00008111	C46C2.3
Is enriched in AFD; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00008112	C46C2.4
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including let-60; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00008113	C46C2.5
Is enriched in germ line and hypodermis based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00008114	C46C2.6
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008117	gsr-1
Exhibits glutathione-disulfide reductase activity. Is involved in ecdysis, collagen and cuticulin-based cuticle; oxidation-reduction process; and response to superoxide. Localizes to cytosol. Is expressed in several structures, including Epr; Epra; coelomocyte; excretory canal; and hermaphrodite gonad. Is an ortholog of human GSR (glutathione-disulfide reductase).

WB:WBGene00008118	madf-8
Is enriched in Psub1; Psub3; germ line; germline precursor cell; and hypodermis based on RNA-seq studies. Is affected by several genes including dpy-10; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00008119	C46F11.4
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX42 (DEAD-box helicase 42).

WB:WBGene00008120	C46F11.5
Is expressed in body wall musculature.

WB:WBGene00008121	C46F11.6
Is enriched in germ line; head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin-2 like Rad60 SUMO-like; Membrane-anchored ubiquitin-fold protein; Ubiquitin-like domain superfamily; UBL3-like, ubiquitin domain; and UBL3-like. Is an ortholog of human UBL3 (ubiquitin like 3).

WB:WBGene00008122	C47A4.1
Is affected by several genes including daf-16; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human DNAJC25-GNG10 (DNAJC25-GNG10 readthrough).

WB:WBGene00008123	ent-4
Is predicted to have nucleoside transmembrane transporter activity. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00008124	C47A4.3
Is predicted to have protein serine/threonine phosphatase activity. Is an ortholog of human PPP1CA (protein phosphatase 1 catalytic subunit alpha).

WB:WBGene00008125	C47A4.5
Is enriched in amphid sheath cell; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including aldicarb; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008126	sre-21
Is expressed in ADLL; ADLR; and hypodermis. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00008127	ddo-1
Exhibits D-aspartate oxidase activity; D-glutamate oxidase activity; and cofactor binding activity. Is involved in oxidation-reduction process. Is expressed in hypodermis and intestinal cell. Is an ortholog of human DDO (D-aspartate oxidase).

WB:WBGene00008128	srab-12
Is expressed in head and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00008129	C47A10.12
Is enriched in AVE based on tiling array studies. Is affected by several genes including npr-1; dpy-21; and unc-70 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; 2; and 4-dinitroanisole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00008130	fbxa-140
Is enriched in NSM; germ line; and seam cell based on RNA-seq studies. Is affected by several genes including daf-12; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00008131	C47B2.2
Is predicted to have kinase activity. Localizes to striated muscle dense body. Is an ortholog of human UPRT (uracil phosphoribosyltransferase homolog).

WB:WBGene00008132	gale-1
Exhibits UDP-N-acetylglucosamine 4-epimerase activity and UDP-glucose 4-epimerase activity. Is involved in several processes, including gonad morphogenesis; negative regulation of endoplasmic reticulum unfolded protein response; and positive regulation of vulval development. Is expressed in head. Is used to study galactosemia. Human ortholog(s) of this gene are implicated in galactose epimerase deficiency. Is an ortholog of human GALE (UDP-galactose-4-epimerase).

WB:WBGene00008133	efsc-1
Is predicted to have translation elongation factor activity. Is involved in selenocysteine incorporation. Is an ortholog of human EEFSEC (eukaryotic elongation factor, selenocysteine-tRNA specific).

WB:WBGene00008134	C47B2.9
Is predicted to have RNA binding activity. Is an ortholog of human MTRES1 (mitochondrial transcription rescue factor 1).

WB:WBGene00008135	B0491.t1
No description available

WB:WBGene00008136	C47D12.2
Localizes to endoplasmic reticulum. Human ortholog(s) of this gene are implicated in Smith-McCort dysplasia. Is an ortholog of human DYM (dymeclin).

WB:WBGene00008137	sfxn-1.4
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN1 (sideroflexin 1) and SFXN3 (sideroflexin 3).

WB:WBGene00008138	C47D12.4
Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00008139	C47D12.5
Is enriched in several structures, including coelomocyte; germ line; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Mercuric Chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008140	xpf-1
Exhibits enzyme binding activity. Is involved in several processes, including negative regulation of nematode larval development; positive regulation of embryonic development; and resolution of meiotic recombination intermediates. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group Q; XFE progeroid syndrome; and xeroderma pigmentosum group F. Is an ortholog of human ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit).

WB:WBGene00008141	C47E8.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008142	C47E8.3
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; eat-2; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00008143	C47E8.4
Is enriched in germ line; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: XAP5, circadian clock regulator and XAP5 protein. Is an ortholog of human FAM50A (family with sequence similarity 50 member A).

WB:WBGene00008144	gasr-8
Is predicted to have Rab GTPase binding activity. Localizes to ciliary basal body. Is expressed in amphid neurons; ciliated neurons; head neurons; sensory neurons; and tail neurons. Is an ortholog of human GAS8 (growth arrest specific 8).

WB:WBGene00008145	set-5
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545); SET domain; and SPK domain. Is an ortholog of human KMT2E (lysine methyltransferase 2E (inactive)) and SETD5 (SET domain containing 5).

WB:WBGene00008146	C47E8.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00008147	C47E12.2
Is predicted to have ATP:ADP antiporter activity. Is an ortholog of human SLC25A4 (solute carrier family 25 member 4); SLC25A5 (solute carrier family 25 member 5); and SLC25A6 (solute carrier family 25 member 6).

WB:WBGene00008148	C47E12.3
Is predicted to have calcium ion binding activity and mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human EDEM1 (ER degradation enhancing alpha-mannosidase like protein 1).

WB:WBGene00008149	pyp-1
Is predicted to have inorganic diphosphatase activity. Is involved in innate immune response. Localizes to neuron projection and vacuole. Is expressed in coelomocyte and neurons. Is an ortholog of human PPA1 (inorganic pyrophosphatase 1) and PPA2 (inorganic pyrophosphatase 2).

WB:WBGene00008150	mam-2
Is enriched in several structures, including ASER; Z4.a; germline precursor cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MAM domain and Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00008151	rrp-1
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; stavudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleolar protein,Nop52 and Nucleolar, Nop52. Is an ortholog of human RRP1 (ribosomal RNA processing 1).

WB:WBGene00008152	C47E12.9
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; bisphenol A; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008153	C47E12.10
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; manganese chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00008154	C47E12.11
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00008155	C47E12.12
Is enriched in body wall muscle cell; germ line; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including manganese chloride; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008156	C47E12.13
Is affected by several genes including daf-2; rrf-3; and alg-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00008157	C47F8.1
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00008158	nhr-165
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in hyp7 syncytium and seam cell.

WB:WBGene00008159	C47F8.3
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00008160	glct-4
Is predicted to have galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity. Human ortholog(s) of this gene are implicated in Larsen-like syndrome B3GAT3 type. Is an ortholog of human B3GAT2 (beta-1,3-glucuronyltransferase 2).

WB:WBGene00008161	C47F8.5
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00008162	C47F8.6
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity. Is an ortholog of human B3GALT4 (beta-1,3-galactosyltransferase 4).

WB:WBGene00008163	C47F8.7
Is enriched in intestine and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00008164	C47G2.3
Is predicted to have mitochondrion targeting sequence binding activity and protein transmembrane transporter activity. Is an ortholog of human TIMM22 (translocase of inner mitochondrial membrane 22).

WB:WBGene00008165	C47G2.4
Is enriched in AVK; cephalic sheath cell; germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LMBR1-like membrane protein and LMBR1-like membrane protein. Is an ortholog of human LMBRD2 (LMBR1 domain containing 2).

WB:WBGene00008166	saps-1
Exhibits protein phosphatase binding activity. Is involved in cortical actin cytoskeleton organization; establishment of mitotic spindle localization; and first cell cycle pseudocleavage. Localizes to astral microtubule and cell cortex. Is an ortholog of human PPP6R1 (protein phosphatase 6 regulatory subunit 1); PPP6R2 (protein phosphatase 6 regulatory subunit 2); and PPP6R3 (protein phosphatase 6 regulatory subunit 3).

WB:WBGene00008167	acox-1.5
Is predicted to have acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Is involved in pheromone biosynthetic process. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6 and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACOX1 (acyl-CoA oxidase 1).

WB:WBGene00008168	C48B4.3
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008169	C48B4.6
Is enriched in Psub1; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5373) and Protein of unknown function DUF5373.

WB:WBGene00008170	C48B4.7
Is enriched in AFD; body wall musculature; germ line; germline precursor cell; and head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5373) and Protein of unknown function DUF5373.

WB:WBGene00008171	C48B4.8
Is enriched in several structures, including body wall musculature; germ line; germline precursor cell; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00008172	C48B4.9
Is enriched in AFD; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5373) and Protein of unknown function DUF5373.

WB:WBGene00008173	C48B4.10
Is enriched in Z1; Z4; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5373) and Protein of unknown function DUF5373.

WB:WBGene00008174	C48B4.11
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00008175	C48B4.12
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008176	C48B4.13
Is enriched in AFD; Z1; Z4; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008177	C48D1.1
Is enriched in AFD; OLL; PVD; intestine; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-type fold and Leucine-rich repeat domain superfamily.

WB:WBGene00008178	C48D1.5
Is enriched in germ line and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00008179	B0491.t2
No description available

WB:WBGene00008180	C48D5.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00008183	rin-1
Exhibits GTPase binding activity. Is involved in dorsal/ventral axon guidance and neuron migration. Localizes to cell periphery; cytoplasm; and filopodium. Is expressed in body wall musculature; gonad; head neurons; and hypodermis. Is an ortholog of human RIN2 (Ras and Rab interactor 2).

WB:WBGene00008184	C49A1.1
Is affected by several genes including eat-2; sir-2.1; and lin-35 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008185	best-10
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00008186	best-11
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00008187	C49A1.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00008188	clec-115
Is affected by eat-2 and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; C-type lectin-like/link domain superfamily; and C-type lectin fold.

WB:WBGene00008189	C49A1.8
No description available

WB:WBGene00008190	clec-114
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by rsr-2; csr-1; and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00008191	C49A1.10
Is expressed in body wall musculature.

WB:WBGene00008192	C49C3.2
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008193	C49C3.3
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00008194	C49C3.4
Is predicted to have Notch binding activity. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 8; pigmented paravenous chorioretinal atrophy; and retinitis pigmentosa 12.

WB:WBGene00008195	ceh-88
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and transcription regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including coelomocyte; excretory cell; hyp12; tail hypodermis; and ventral nerve cord.

WB:WBGene00008196	C49C3.6
Is enriched in AFD; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00008197	C49C3.7
Is enriched in body wall muscle cell; germ line; germline precursor cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008198	C49C3.8
Is enriched in several structures, including body wall muscle cell; excretory cell; germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Alovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008199	C49C3.9
Is involved in defense response to Gram-negative bacterium and innate immune response.

WB:WBGene00008200	C49C3.10
Is predicted to have ATP binding activity and protein kinase activity.

WB:WBGene00008201	C49C3.11
Is predicted to have carbohydrate binding activity.

WB:WBGene00008202	clec-197
Is predicted to have carbohydrate binding activity. Is expressed in male gonad.

WB:WBGene00008203	clec-198
Is predicted to have carbohydrate binding activity.

WB:WBGene00008204	C49C3.15
Is enriched in OLL; PVD; Z1; Z4; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and sma-4 based on microarray and RNA-seq studies. Is affected by Humic Substances and Sirolimus based on microarray studies.

WB:WBGene00008205	sams-1
Is predicted to have methionine adenosyltransferase activity. Is involved in negative regulation of lipid storage. Is expressed in body wall musculature; dorsal nerve cord; and ventral nerve cord. Is an ortholog of human MAT1A (methionine adenosyltransferase 1A) and MAT2A (methionine adenosyltransferase 2A).

WB:WBGene00008206	set-6
Is expressed in embryonic cell; gonad; muscle cell; and sperm. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 1; and autosomal dominant non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domains: SET domain and SET domain.

WB:WBGene00008207	C49F5.3
Is enriched in AFD; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00008208	nhr-167
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008209	C49F5.5
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity.

WB:WBGene00008210	C49F5.6
Is enriched in several structures, including NSM; Z4.a; germ line; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including D-glucose; bisphenol A; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008211	C49F5.7
Is enriched in NSM; germ line; hypodermis; and intestine based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twenty-one chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00008212	C49F5.8
Is enriched in coelomocyte and intestine based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; dpy-21; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00008213	C49F8.1
Is enriched in ciliated neurons; pharynx; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by aldicarb and paraquat based on microarray and RNA-seq studies.

WB:WBGene00008214	gem-1
Is predicted to have monocarboxylic acid transmembrane transporter activity. Localizes to plasma membrane. Is expressed in several structures, including hermaphrodite distal tip cell; neurons; pharynx; somatic gonad precursor; and vulval muscle. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A14 (solute carrier family 16 member 14) and SLC16A9 (solute carrier family 16 member 9).

WB:WBGene00008215	C49F8.3
Is enriched in PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00008216	mec-19
Is expressed in mechanosensory neurons.

WB:WBGene00008217	C50B6.1
Is enriched in muscle cell based on microarray studies. Is affected by several genes including cye-1; cdk-2; and mir-34 based on tiling array and microarray studies. Is affected by dibromoacetic acid and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00008218	nasp-2
Is predicted to have histone binding activity. Is expressed in germ line. Is an ortholog of human NASP (nuclear autoantigenic sperm protein).

WB:WBGene00008219	C50B6.3
Is enriched in AB; AVA; body wall muscle cell; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including manganese chloride; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00008220	C50B6.7
Is predicted to have alpha-amylase activity; alpha-amylase activity (releasing maltohexaose); and cation binding activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in cystinuria. Is an ortholog of human AMY2A (amylase alpha 2A) and AMY2B (amylase alpha 2B).

WB:WBGene00008221	nhr-168
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00008222	C50B6.9
Is enriched in PLM; germ line; hypodermis; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and pmk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including hydrogen sulfide; Mianserin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Alpha/Beta hydrolase fold. Is an ortholog of human ABHD10 (abhydrolase domain containing 10, depalmitoylase).

WB:WBGene00008223	lgc-48
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in hyperekplexia 1. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00008224	slrp-1
Is predicted to have RNA binding activity. Is an ortholog of human SLIRP (SRA stem-loop interacting RNA binding protein).

WB:WBGene00008225	nuaf-1
Is predicted to have unfolded protein binding activity. Is involved in mitochondrial respiratory chain complex I assembly. Is an ortholog of human NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1).

WB:WBGene00008226	C50B8.4
Is enriched in several structures, including AVA; dopaminergic neurons; head mesodermal cell; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; npr-1; and dpy-7 based on microarray and RNA-seq studies. Is affected by eleven chemicals including levamisole; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00008227	C50B8.5
Is enriched in ASER; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008228	C50B8.6
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008229	C50F4.1
Is enriched in head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including 1-methylnicotinamide; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ecdysteroid kinase; Ecdysteroid kinase-like; Protein kinase-like domain superfamily; and CHK kinase-like.

WB:WBGene00008230	pfk-1.2
Is predicted to have several functions, including 6-phosphofructokinase activity; adenyl ribonucleotide binding activity; and fructose-6-phosphate binding activity. Human ortholog(s) of this gene are implicated in glycogen storage disease VII. Is an ortholog of human PFKL (phosphofructokinase, liver type); PFKM (phosphofructokinase, muscle); and PFKP (phosphofructokinase, platelet).

WB:WBGene00008231	tag-329
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple).

WB:WBGene00008232	C50F4.4
Is expressed in head neurons; tail neurons; touch receptor neurons; and ventral nerve cord.

WB:WBGene00008233	C50F4.8
Is involved in defense response to Gram-positive bacterium.

WB:WBGene00008234	C50F4.9
Is involved in innate immune response.

WB:WBGene00008235	C50F4.10
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00008236	C50F4.12
Is predicted to have double-stranded DNA binding activity. Is an ortholog of human MTERF3 (mitochondrial transcription termination factor 3).

WB:WBGene00008237	nstp-10
Is predicted to have GDP-fucose transmembrane transporter activity and antiporter activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIc. Is an ortholog of human SLC35C1 (solute carrier family 35 member C1).

WB:WBGene00008238	C50F4.16
Is predicted to have UDP-sugar diphosphatase activity. Is an ortholog of human NUDT14 (nudix hydrolase 14).

WB:WBGene00008239	fshr-1
Is predicted to have G protein-coupled peptide receptor activity. Is involved in defense response to other organism; response to oxidative stress; and stress response to cadmium ion. Is expressed in intestine; neurons; pharynx; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including congenital nongoitrous hypothyroidism 1; familial male-limited precocious puberty; and ovarian dysgenesis 1. Is an ortholog of human LHCGR (luteinizing hormone/choriogonadotropin receptor).

WB:WBGene00008240	C50H2.4
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008241	C50H2.5
Is enriched in FLP based on microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008242	ceh-75
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord and head neurons.

WB:WBGene00008243	C50H2.7
Is predicted to have histone kinase activity (H3-T3 specific).

WB:WBGene00008244	fipr-11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including aldicarb; D-glucose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00008245	fipr-10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Ethanol; D-glucose; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00008246	C50H2.13
Is enriched in germ line and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008247	srsx-26
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00008248	srsx-27
Is predicted to have G protein-coupled receptor activity. Is expressed in ASIL and ASIR.

WB:WBGene00008249	srsx-28
Is predicted to have G protein-coupled receptor activity. Is expressed in chemosensory neurons and cholinergic neurons.

WB:WBGene00008250	srsx-29
Is predicted to have G protein-coupled receptor activity. Is expressed in ADFL; ADFR; PHAL; and PHAR.

WB:WBGene00008251	srsx-30
Is predicted to have G protein-coupled receptor activity. Is expressed in GABAergic neurons; I4 neuron; and head.

WB:WBGene00008252	C51E3.6
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC23A1 (solute carrier family 23 member 1) and SLC23A2 (solute carrier family 23 member 2).

WB:WBGene00008253	C51E3.8
Is affected by several genes including clk-1; lin-39; and adr-1 based on RNA-seq; tiling array; and microarray studies. Is affected by estrogen and Acrylamide based on microarray studies.

WB:WBGene00008254	C51E3.9
Is enriched in AVE; body wall muscle cell; body wall musculature; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00008255	C51E3.10
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including tryptophan; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008256	glb-12
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in hermaphrodite gonad; neurons; and vulva.

WB:WBGene00008257	C52A11.3
Is enriched in AVE based on tiling array studies. Is affected by several genes including daf-16; cyc-1; and mir-34 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain; and PDZ superfamily.

WB:WBGene00008258	mans-2
Is predicted to have mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Is an ortholog of human MAN1A2 (mannosidase alpha class 1A member 2) and MAN1C1 (mannosidase alpha class 1C member 1).

WB:WBGene00008259	C52E4.7
Is enriched in AVK; NSM; germ line; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Histidine phosphatase superfamily. Is an ortholog of human UBASH3B (ubiquitin associated and SH3 domain containing B).

WB:WBGene00008260	C52G5.2
Is enriched in PLM; Z1; Z4; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including aldicarb; D-glucopyranose; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF1794); Calycin; and Domain of unknown function DUF1794. Is an ortholog of human THAP4 (THAP domain containing 4).

WB:WBGene00008261	C52G5.3
Is enriched in neurons based on tiling array studies. Is affected by drh-3; spc-1; and unc-70 based on RNA-seq studies. Is affected by tryptophan and Cry5B based on microarray studies.

WB:WBGene00008262	ril-1
Is enriched in germline precursor cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including Rotenone; resveratrol; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00008263	C53A5.2
Is enriched in ASER; OLL; PVD; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human TRMT5 (tRNA methyltransferase 5).

WB:WBGene00008265	kcnl-4
Is predicted to have calmodulin binding activity and small conductance calcium-activated potassium channel activity. Human ortholog(s) of this gene are implicated in dehydrated hereditary stomatocytosis 2. Is an ortholog of human KCNN1 (potassium calcium-activated channel subfamily N member 1) and KCNN4 (potassium calcium-activated channel subfamily N member 4).

WB:WBGene00008266	C53A5.6
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq studies. Is predicted to encode a protein with the following domains: Kelch motif; Zinc finger, RING-type; Kelch repeat type 1; Zinc finger, RING/FYVE/PHD-type; and Kelch-type beta propeller.

WB:WBGene00008267	C53A5.9
Is enriched in body wall muscle cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; rrf-3; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Mercuric Chloride; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Kelch motif; Kelch repeat type 1; and Kelch-type beta propeller.

WB:WBGene00008268	srt-32
Is affected by several genes including lin-15B; drh-3; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00008269	C53A5.11
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including skn-1; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Kelch motif; Kelch repeat type 1; Galactose oxidase/kelch, beta-propeller; and Kelch-type beta propeller.

WB:WBGene00008270	C53A5.13
Is enriched in I5 neuron; cholinergic neurons; germline precursor cell; hypodermis; and retrovesicular ganglion based on tiling array; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Fibronectin type III domain; Fibronectin type III; Immunoglobulin-like fold; and Fibronectin type III superfamily.

WB:WBGene00008271	suex-2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00008272	C53B4.2
Is enriched in AFD; AVK; coelomocyte; and in male based on tiling array and RNA-seq studies. Is affected by several genes including age-1; let-7; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF851) and Protein of unknown function DUF851.

WB:WBGene00008273	C53B4.3
Is predicted to have transmembrane transporter activity. Localizes to nucleus. Human ortholog(s) of this gene are implicated in breast cancer; embryonal rhabdomyosarcoma; and lung cancer. Is an ortholog of human SLC22A18 (solute carrier family 22 member 18).

WB:WBGene00008274	pdzd-8
Is predicted to have lipid binding activity and metal ion binding activity. Is an ortholog of human PDZD8 (PDZ domain containing 8).

WB:WBGene00008275	nstp-1
Is predicted to have UDP-N-acetylglucosamine transmembrane transporter activity and UDP-xylose transmembrane transporter activity. Is an ortholog of human SLC35B4 (solute carrier family 35 member B4).

WB:WBGene00008277	mltn-12
Is enriched in hypodermis and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00008278	npr-10
Is predicted to have neuropeptide Y receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human PRLHR (prolactin releasing hormone receptor).

WB:WBGene00008279	C53C7.3
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00008280	acc-2
Is predicted to have chloride channel activity. Is expressed in PHA; glutamatergic neurons; and interneuron.

WB:WBGene00008281	C53D6.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin domain; Thioredoxin-like superfamily; and Thioredoxin domain-containing protein 15. Is an ortholog of human TXNDC15 (thioredoxin domain containing 15).

WB:WBGene00008282	C53D6.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by tryptophan; multi-walled carbon nanotube; and glycine based on microarray and RNA-seq studies.

WB:WBGene00008283	C53D6.6
Is predicted to have protein dimerization activity. Is an ortholog of human ZBED1 (zinc finger BED-type containing 1).

WB:WBGene00008284	C53D6.7
Is predicted to have carbohydrate binding activity. Is an ortholog of several human genes including LGALS9 (galectin 9); LGALS9B (galectin 9B); and LGALS9C (galectin 9C).

WB:WBGene00008285	C53D6.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including pgl-1; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008286	C54C6.4
Is affected by clk-1; dpy-21; and ain-1 based on microarray and RNA-seq studies. Is affected by cadmium and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00008287	C54C6.5
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sma-2; dpy-21; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008288	C54C6.6
Is enriched in dopaminergic neurons; germ line; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; aak-2; and sma-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; Mianserin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF667); CFA20 domain; and Cilia- and flagella-associated protein 20/C3orf67. Is an ortholog of human CFAP20 (cilia and flagella associated protein 20).

WB:WBGene00008289	nhr-169
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008290	bgnt-1.8
Is predicted to have transferase activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00008291	C54C8.3
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity. Is an ortholog of human B3GALT4 (beta-1,3-galactosyltransferase 4).

WB:WBGene00008292	C54C8.4
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; manganese chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273 and Protein of unknown function DUF273.

WB:WBGene00008293	glct-5
Is predicted to have galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity. Human ortholog(s) of this gene are implicated in Larsen-like syndrome B3GAT3 type. Is an ortholog of human B3GAT2 (beta-1,3-glucuronyltransferase 2).

WB:WBGene00008294	clec-11
Is predicted to have carbohydrate binding activity.

WB:WBGene00008295	nlp-39
Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including tryptophan; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00008296	cdr-2
Is involved in regulation of protein deneddylation and stress response to cadmium ion. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00008297	cdr-3
Is involved in stress response to cadmium ion. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00008298	C54D10.3
Is enriched in OLL and PVD based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; Rotenone; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00008299	C54D10.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; D-glucose; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tetraspanin family; Tetraspanin, EC2 domain superfamily; and Tetraspanin/Peripherin.

WB:WBGene00008300	C54D10.5
Is expressed in anal depressor muscle; head muscle; lateral ganglion; retrovesicular ganglion neurons; and ventral ganglion. Is predicted to encode a protein with the following domain: .

WB:WBGene00008301	pals-39
Is enriched in DA neuron; VA neuron; dopaminergic neurons; and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Tunicamycin; D-glucose; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00008302	pals-38
Is enriched in body wall muscle cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008303	C54D10.9
Is enriched in AFD; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00008304	C54D10.10
Is predicted to have serine-type endopeptidase inhibitor activity. Is an ortholog of human TFPI2 (tissue factor pathway inhibitor 2).

WB:WBGene00008306	C54E10.1
Is enriched in AFD; ASER; and AVK based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Alovudine and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00008307	ncs-5
Is predicted to have calcium ion binding activity. Is expressed in body wall musculature and head neurons. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14 and retinitis pigmentosa 48. Is an ortholog of several human genes including KCNIP1 (potassium voltage-gated channel interacting protein 1); KCNIP2 (potassium voltage-gated channel interacting protein 2); and KCNIP4 (potassium voltage-gated channel interacting protein 4).

WB:WBGene00008308	C54E10.3
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including clk-1; fbf-1; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008309	nhr-170
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008310	C54E10.6
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; lin-35; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008311	rskn-2
Is predicted to have ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Is an ortholog of human RPS6KA4 (ribosomal protein S6 kinase A4) and RPS6KA5 (ribosomal protein S6 kinase A5).

WB:WBGene00008312	C54G4.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008313	C54G4.3
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00008314	C54G4.4
Is enriched in GABAergic neurons and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including complement deficiency (multiple); degeneration of macula and posterior pole (multiple); and familial hemophagocytic lymphohistiocytosis 2. Is predicted to encode a protein with the following domains: Lectin C-type domain; Sushi repeat (SCR repeat); Sushi/SCR/CCP domain; C-type lectin-like; Galactose-binding-like domain superfamily; C-type lectin-like/link domain superfamily; C-type lectin fold; and Sushi/SCR/CCP superfamily. Is an ortholog of human SELL (selectin L).

WB:WBGene00008315	C54G4.5
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008316	dod-18
Is predicted to have nucleoside-triphosphate diphosphatase activity. Is an ortholog of human ASMTL (acetylserotonin O-methyltransferase like).

WB:WBGene00008317	C54G4.7
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Abhydrolase domain containing 18; Abhydrolase domain containing 18; and Alpha/Beta hydrolase fold. Is an ortholog of human ABHD18 (abhydrolase domain containing 18).

WB:WBGene00008318	C54G4.9
Is enriched in several structures, including AVK; body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; allantoin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008319	C54G10.1
Is affected by several genes including daf-2; rrf-3; and lin-4 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin; Sodium Chloride; and adsorbable organic bromine compound based on microarray and RNA-seq studies.

WB:WBGene00008320	slc-25A29
Is predicted to have acyl carnitine transmembrane transporter activity. Is an ortholog of human SLC25A29 (solute carrier family 25 member 29).

WB:WBGene00008321	C55A1.1
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00008322	C55A1.4
Is affected by several genes including daf-16; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including aldicarb; Rifampin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00008323	C55A1.6
Is enriched in GABAergic neurons; coelomocyte; excretory cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00008324	C55A1.7
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00008325	C55A1.9
Is affected by clk-1; eat-2; and mut-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008326	C55A1.11
Is enriched in AVA and germ line based on tiling array and RNA-seq studies. Is affected by rsr-2 and ain-1 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00008327	srz-44
Is affected by rsr-2; drh-3; and smn-1 based on tiling array and RNA-seq studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00008328	srz-43
Is affected by clk-1 based on microarray studies.

WB:WBGene00008330	C55A6.1
Is predicted to have poly-ADP-D-ribose binding activity and ubiquitin-protein transferase activity. Is an ortholog of human RNF146 (ring finger protein 146).

WB:WBGene00008331	ttll-5
Is predicted to have ATP binding activity and ligase activity. Is involved in response to hermaphrodite contact. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 19. Is an ortholog of human TTLL5 (tubulin tyrosine ligase like 5).

WB:WBGene00008332	C55A6.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR3 (carbonyl reductase 3).

WB:WBGene00008333	C55A6.4
Is enriched in hypodermis; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including Tunicamycin; bisphenol A; and juglone based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR3 (carbonyl reductase 3).

WB:WBGene00008334	sdz-8
Is enriched in body wall muscle cell and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirty-six chemicals including tryptophan; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR3 (carbonyl reductase 3).

WB:WBGene00008335	C55A6.6
Is enriched in PLM; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twenty chemicals including tryptophan; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR3 (carbonyl reductase 3).

WB:WBGene00008336	C55A6.7
Is involved in defense response to Gram-negative bacterium and innate immune response. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is an ortholog of human CBR3 (carbonyl reductase 3).

WB:WBGene00008337	C55A6.8
Is affected by rsr-2; daf-2; and sir-2.1 based on tiling array and microarray studies.

WB:WBGene00008338	pafo-1
Is predicted to have RNA polymerase II complex binding activity and chromatin binding activity. Is an ortholog of human PAF1 (PAF1 homolog, Paf1/RNA polymerase II complex component).

WB:WBGene00008339	C55A6.10
Localizes to striated muscle dense body. Is an ortholog of human C12orf4 (chromosome 12 open reading frame 4).

WB:WBGene00008340	C55A6.11
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008341	ttr-44
Is enriched in ASER; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; bisphenol A; and Neurotoxins based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00008342	frpr-5
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00008343	C56A3.4
Is enriched in AFD; cephalic sheath cell; germ line; germline precursor cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including dpy-10; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C3HC4 type (RING finger) and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human RNF26 (ring finger protein 26).

WB:WBGene00008344	C56A3.5
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00008345	C56A3.6
Is predicted to have calcium ion binding activity. Is an ortholog of human MICU3 (mitochondrial calcium uptake family member 3).

WB:WBGene00008346	C56A3.8
Is predicted to have 1-phosphatidylinositol 4-kinase activity. Is an ortholog of human PI4K2A (phosphatidylinositol 4-kinase type 2 alpha) and PI4K2B (phosphatidylinositol 4-kinase type 2 beta).

WB:WBGene00008348	C56G7.3
Is predicted to have GTPase activator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 88. Is an ortholog of human ELMOD3 (ELMO domain containing 3).

WB:WBGene00008349	CE7X_3.1
Is affected by several genes including pgl-1; nhr-49; and alg-1 based on RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and tert-Butylhydroperoxide based on RNA-seq studies.

WB:WBGene00008350	CE7X_3.2
Is enriched in DA neuron; VA neuron; and intestine based on tiling array studies. Is affected by several genes including daf-16; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00008351	cTel7X.1
Is affected by tatn-1; smg-2; and eat-2 based on RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00008352	fbxa-6
Is enriched in OLL; PVD; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including levamisole; stavudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00008353	D1025.1
Is enriched in NSM; OLL; PVD; body wall muscle cell; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by single-walled carbon nanotube and paraquat based on microarray studies.

WB:WBGene00008354	gcsh-1
Is enriched in PLM; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Rotenone; Tunicamycin; and indole based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in glycine encephalopathy. Is predicted to encode a protein with the following domains: Glycine cleavage H-protein; Glycine cleavage system H-protein; Single hybrid motif; Glycine cleavage system H-protein, subgroup; and Glycine cleavage system H-protein/Simiate. Is an ortholog of human GCSH (glycine cleavage system protein H).

WB:WBGene00008355	fbxa-141
Is enriched in AVA; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00008356	nspc-20
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Mianserin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008357	nspc-16
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Ethanol; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008358	nspc-18
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; Mianserin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008359	nspc-17
Is enriched in NSM and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Mianserin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008360	nspc-19
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Ethanol; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008361	ints-7
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Rotenone; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-like helical; Armadillo-type fold; and Integrator complex subunit 7. Is an ortholog of human INTS7 (integrator complex subunit 7).

WB:WBGene00008362	cfim-2
Is predicted to have nucleic acid binding activity. Is an ortholog of human CPSF6 (cleavage and polyadenylation specific factor 6) and CPSF7 (cleavage and polyadenylation specific factor 7).

WB:WBGene00008363	D1046.2
Is enriched in AFD; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including manganese chloride; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00008364	slc-25A26
Is predicted to have S-adenosyl-L-methionine transmembrane transporter activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 28. Is an ortholog of human SLC25A26 (solute carrier family 25 member 26).

WB:WBGene00008365	D1046.4
Is predicted to have transmembrane transporter activity.

WB:WBGene00008366	tpra-1
Is expressed in head neurons and tail. Is predicted to encode a protein with the following domains: Predicted membrane protein and Transmembrane protein TPRA1/CAND2/CAND8. Is an ortholog of human TPRA1 (transmembrane protein adipocyte associated 1).

WB:WBGene00008367	D1053.2
Is predicted to have histone methyltransferase activity (H3-K79 specific).

WB:WBGene00008368	D1053.3
Is enriched in ASER; NSM; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008369	D1053.4
Is predicted to have transmembrane receptor protein serine/threonine kinase activity.

WB:WBGene00008370	D1054.1
Is predicted to have triglyceride lipase activity. Is an ortholog of human PNPLA4 (patatin like phospholipase domain containing 4).

WB:WBGene00008371	D1054.3
Is enriched in body wall muscle cell; germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: SGS domain and SGS domain. Is an ortholog of human SUGT1 (SGT1 homolog, MIS12 kinetochore complex assembly cochaperone).

WB:WBGene00008372	D1054.5
Is enriched in OLL; PVD; dopaminergic neurons; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00008373	D1054.6
Is affected by clk-1; smg-2; and hmg-3 based on microarray and RNA-seq studies.

WB:WBGene00008374	clec-220
Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00008375	D1054.8
Is enriched in OLL; PVD; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rifampin; juglone; and Alovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00008376	D1054.9
Is enriched in GABAergic neurons and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00008377	D1054.10
Is enriched in several structures, including AVK; cephalic sheath cell; dopaminergic neurons; germ line; and intestine based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by sixteen chemicals including Heme; Ethanol; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008378	ule-3
Is enriched in cephalic sheath cell; dopaminergic neurons; germ line; and hypodermis based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by fifteen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008379	secs-1
Exhibits identical protein binding activity. Is expressed in head neurons and ventral nerve cord. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 2D. Is an ortholog of human SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase).

WB:WBGene00008380	prp-38
Is enriched in AVE; germ line; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PRP38 family and Pre-mRNA-splicing factor 38. Is an ortholog of human PRPF38A (pre-mRNA processing factor 38A).

WB:WBGene00008381	D1081.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride; manganese chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; Peptidase S1, PA clan; and Peptidase S1, PA clan, chymotrypsin-like fold.

WB:WBGene00008382	D1081.4
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity.

WB:WBGene00008383	D1081.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00008384	D1081.6
Is enriched in body wall musculature; cephalic sheath cell; germ line; germline precursor cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008385	D1081.7
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008386	cdc-5L
Is predicted to have DNA binding activity. Is an ortholog of human CDC5L (cell division cycle 5 like).

WB:WBGene00008387	zhp-2
Is predicted to have SUMO transferase activity. Is an ortholog of human RNF212B (ring finger protein 212B).

WB:WBGene00008388	D1086.1
Is enriched in ALM; PLM; and muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including hydrogen sulfide; tryptophan; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00008389	D1086.2
Is enriched in dopaminergic neurons; germ line; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including tryptophan; Sodium Chloride; and tert-Butylhydroperoxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00008390	D1086.3
Is enriched in several structures, including Z1.p; Z4.a; cephalic sheath cell; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirty-two chemicals including Heme; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00008392	D1086.5
Is enriched in dopaminergic neurons; head mesodermal cell; mechanosensory neurons; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00008393	D1086.6
Is enriched in cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00008394	D1086.7
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00008395	D1086.8
Is enriched in body wall muscle cell; dopaminergic neurons; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00008396	D1086.9
Is enriched in cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; multi-walled carbon nanotube; and Ag nanoparticles based on RNA-seq and microarray studies.

WB:WBGene00008397	D2005.1
Is predicted to have double-stranded RNA adenosine deaminase activity; double-stranded RNA binding activity; and tRNA-specific adenosine deaminase activity. Is an ortholog of human ADAD2 (adenosine deaminase domain containing 2).

WB:WBGene00008398	D2005.3
Is predicted to have DNA binding activity. Is an ortholog of human PDCD5 (programmed cell death 5).

WB:WBGene00008399	D2005.4
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and elt-2 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008400	drh-3
Exhibits RNA binding activity; RNA polymerase binding activity; and RNA-dependent ATPase activity. Is involved in P granule assembly and production of siRNA involved in RNA interference. Localizes to P granule; condensed nuclear chromosome; and metaphase plate. Is expressed widely. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome. Is an ortholog of human DHX58 (DExH-box helicase 58).

WB:WBGene00008401	D2005.6
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Membrane-associating domain; and Marvel domain.

WB:WBGene00008402	wdfy-2
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Is involved in endocytosis. Is an ortholog of human WDFY2 (WD repeat and FYVE domain containing 2).

WB:WBGene00008403	csa-1
Is predicted to contribute to ubiquitin-protein transferase activity. Is used to study Cockayne syndrome. Human ortholog(s) of this gene are implicated in Cockayne syndrome and UV-sensitive syndrome. Is an ortholog of human ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit).

WB:WBGene00008404	wbp-2
Is predicted to have chromatin DNA binding activity and transcription coactivator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 107. Is an ortholog of human WBP2 (WW domain binding protein 2).

WB:WBGene00008405	ttll-12
Is predicted to have ATP binding activity. Is involved in oviposition. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human TTLL12 (tubulin tyrosine ligase like 12).

WB:WBGene00008407	D2023.3
Is enriched in intestine; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Sodium Chloride; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C2 domain; C2 domain; and C2 domain superfamily.

WB:WBGene00008408	D2023.4
Is predicted to have N-acetyltransferase activity. Is an ortholog of human SAT2 (spermidine/spermine N1-acetyltransferase family member 2).

WB:WBGene00008409	mpst-1
Is predicted to have thiosulfate sulfurtransferase activity. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00008410	D2023.6
Is enriched in AFD; Psub1; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ABC1 family; UbiB domain; and Protein kinase-like domain superfamily. Is an ortholog of human ADCK1 (aarF domain containing kinase 1).

WB:WBGene00008411	mans-1
Is predicted to have mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Is an ortholog of human MAN1A1 (mannosidase alpha class 1A member 1).

WB:WBGene00008412	D2030.2
Is predicted to have ATP binding activity and ATP-dependent peptidase activity. Is an ortholog of human CLPX (caseinolytic mitochondrial matrix peptidase chaperone subunit X).

WB:WBGene00008413	D2030.3
Localizes to nucleus.

WB:WBGene00008414	D2030.4
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is an ortholog of human NDUFB7 (NADH:ubiquinone oxidoreductase subunit B7).

WB:WBGene00008415	mce-1
Is predicted to have methylmalonyl-CoA epimerase activity. Localizes to mitochondrion. Is expressed in body wall musculature; hypodermis; intestine; and pharynx. Is used to study methylmalonic acidemia. Is an ortholog of human MCEE (methylmalonyl-CoA epimerase).

WB:WBGene00008417	D2030.7
Is expressed in head neurons. Is predicted to encode a protein with the following domain: .

WB:WBGene00008418	D2030.8
Is enriched in germ line; germline precursor cell; hypodermis; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GDSL/SGNH-like Acyl-Esterase family found in Pmr5 and Cas1p and PC-Esterase. Is an ortholog of human PCED1A (PC-esterase domain containing 1A).

WB:WBGene00008419	wdr-23
Exhibits transcription factor binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of cellular response to manganese ion; and proteasome-mediated ubiquitin-dependent protein catabolic process. Localizes to several cellular components, including mitochondrial outer membrane; striated muscle dense body; and synaptic vesicle. Is expressed in ASIL; ASIR; head; muscle cell; and tail. Is an ortholog of human DCAF11 (DDB1 and CUL4 associated factor 11).

WB:WBGene00008420	D2030.11
Is enriched in body wall muscle cell; germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00008421	D2030.12
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00008422	D2045.2
Is predicted to have molecular adaptor activity. Is an ortholog of human ECPAS (Ecm29 proteasome adaptor and scaffold).

WB:WBGene00008423	D2045.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00008424	D2045.7
Is predicted to have ATP binding activity and protein kinase activity. Is an ortholog of human STK16 (serine/threonine kinase 16).

WB:WBGene00008425	D2045.8
Is enriched in several structures, including GABAergic neurons; Z4.a; intestine; male distal tip cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; procyanidin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10).

WB:WBGene00008426	D2045.9
Is predicted to have procollagen galactosyltransferase activity. Is an ortholog of human COLGALT1 (collagen beta(1-O)galactosyltransferase 1) and COLGALT2 (collagen beta(1-O)galactosyltransferase 2).

WB:WBGene00008427	atg-10
Is involved in autophagy. Is an ortholog of human ATG10 (autophagy related 10).

WB:WBGene00008428	eif-2Bepsilon
Is predicted to have guanyl-nucleotide exchange factor activity; translation initiation factor activity; and translation initiation factor binding activity. Human ortholog(s) of this gene are implicated in leukoencephalopathy with vanishing white matter. Is an ortholog of human EIF2B5 (eukaryotic translation initiation factor 2B subunit epsilon).

WB:WBGene00008429	etc-1
Exhibits ubiquitin protein ligase activity. Is involved in positive regulation of metaphase/anaphase transition of meiotic cell cycle; regulation of metaphase/anaphase transition of meiosis II; and ubiquitin-dependent protein catabolic process. Is an ortholog of human UBE3C (ubiquitin protein ligase E3C).

WB:WBGene00008430	hgap-2
Is predicted to have GTPase activator activity. Is involved in determination of adult lifespan. Is expressed in pharyngeal muscle cell. Is an ortholog of human RALGAPB (Ral GTPase activating protein non-catalytic subunit beta).

WB:WBGene00008431	piga-1
Is predicted to have phosphatidylinositol N-acetylglucosaminyltransferase activity. Human ortholog(s) of this gene are implicated in multiple congenital anomalies-hypotonia-seizures syndrome 2 and paroxysmal nocturnal hemoglobinuria. Is an ortholog of human PIGA (phosphatidylinositol glycan anchor biosynthesis class A).

WB:WBGene00008432	D2085.7
Is predicted to have Atg8 ligase activity. Is an ortholog of human ATG10 (autophagy related 10).

WB:WBGene00008433	marc-2
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human MARCHF1 (membrane associated ring-CH-type finger 1) and MARCHF2 (membrane associated ring-CH-type finger 2).

WB:WBGene00008434	D2089.3
Is enriched in germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including skn-1; clk-1; and lin-35 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is an ortholog of human CDPF1 (cysteine rich DPF motif domain containing 1).

WB:WBGene00008435	glna-2
Is predicted to have glutaminase activity. Is expressed in head neurons. Is an ortholog of human GLS (glutaminase) and GLS2 (glutaminase 2).

WB:WBGene00008436	DH11.2
Is enriched in several structures, including PLM; RIS; carbon dioxide sensory neurons; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including 1-methylnicotinamide; Rotenone; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00008438	DH11.5
Is predicted to have several functions, including calcium ion binding activity; phospholipid binding activity; and syntaxin binding activity.

WB:WBGene00008439	mfb-1
Is expressed in several structures, including head; hypodermal cell; tail; touch receptor neurons; and ventral nerve cord. Is predicted to encode a protein with the following domains: F-box-like domain superfamily and F-box only protein 25/32. Is an ortholog of human FBXO25 (F-box protein 25) and FBXO32 (F-box protein 32).

WB:WBGene00008440	DY3.8
Is enriched in cephalic sheath cell; germ line; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq studies.

WB:WBGene00008441	usp-50
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity. Is an ortholog of human USP8 (ubiquitin specific peptidase 8).

WB:WBGene00008442	E01B7.2
Is predicted to have transcription coregulator activity.

WB:WBGene00008443	pde-3
Is predicted to have 3',5'-cyclic-AMP phosphodiesterase activity. Is involved in several processes, including determination of adult lifespan; negative regulation of cGMP-mediated signaling; and response to alkaline pH. Human ortholog(s) of this gene are implicated in several diseases, including hypertension and brachydactyly syndrome; primary pigmented nodular adrenocortical disease; and retinal disease (multiple). Is an ortholog of human PDE3A (phosphodiesterase 3A).

WB:WBGene00008444	tbc-14
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBC1D15 (TBC1 domain family member 15) and TBC1D17 (TBC1 domain family member 17).

WB:WBGene00008446	E01G4.3
Is enriched in several structures, including DD neuron; body wall musculature; head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008447	E01G4.5
Is enriched in germ line; intestine; male-specific anatomical entity; muscle cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; allantoin; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00008448	E01G4.6
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; and RNA-seq studies. Is affected by twenty chemicals including Heme; hydrogen sulfide; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00008449	E01G6.1
Is predicted to have chitin binding activity and serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00008450	E01G6.2
Is enriched in body wall musculature; neurons; retrovesicular ganglion; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008451	cest-3
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8.

WB:WBGene00008452	mrps-5
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS5 (mitochondrial ribosomal protein S5).

WB:WBGene00008453	E02A10.3
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00008454	E02A10.4
Is enriched in AFD; ASER; dopaminergic neurons; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00008455	E02H1.1
Is predicted to have rRNA (adenine-N6,N6-)-dimethyltransferase activity. Is an ortholog of human DIMT1 (DIMT1 rRNA methyltransferase and ribosome maturation factor).

WB:WBGene00008456	eral-1
Is predicted to have rRNA binding activity and ribosomal small subunit binding activity. Human ortholog(s) of this gene are implicated in Perrault syndrome 6. Is an ortholog of human ERAL1 (Era like 12S mitochondrial rRNA chaperone 1).

WB:WBGene00008457	E02H1.5
Is enriched in PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including glp-1; let-60; and dpy-10 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; antimycin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RNA transcription, translation and transport factor protein and RNA transcription, translation and transport factor protein. Is an ortholog of human RTRAF (RNA transcription, translation and transport factor).

WB:WBGene00008458	E02H1.6
Is predicted to have ATP binding activity and adenylate kinase activity. Is an ortholog of human TAF9 (TATA-box binding protein associated factor 9).

WB:WBGene00008459	mrpl-53
Is enriched in dopaminergic neurons; germ line; hypodermis; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Thioredoxin-like superfamily. Is an ortholog of human MRPL53 (mitochondrial ribosomal protein L53).

WB:WBGene00008460	E02H4.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including skn-1; eat-2; and pgl-1 based on tiling array and RNA-seq studies. Is affected by eight chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008462	E02H4.4
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; stavudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Spermadhesin, CUB domain superfamily.

WB:WBGene00008463	E02H4.5
Is enriched in BAG; dopaminergic neurons; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; dpy-21; and ubc-9 based on tiling array; RNA-seq; and microarray studies. Is affected by Tunicamycin and resveratrol based on microarray studies.

WB:WBGene00008464	E02H4.6
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00008465	E03A3.5
Is enriched in GABAergic neurons based on tiling array studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00008468	E03G2.1
Is affected by several genes including eat-2; sir-2.1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Mercuric Chloride and dibromoacetic acid based on microarray studies.

WB:WBGene00008469	E03H4.1
No description available

WB:WBGene00008470	E03H4.2
Is enriched in NSM based on tiling array studies. Is affected by cyc-1 and lin-15B based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00008471	E03H4.3
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00008472	E03H4.4
Is affected by several genes including eat-2; bar-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Ethanol; multi-walled carbon nanotube; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00008473	E03H4.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00008474	nhr-174
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008475	oac-13
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00008476	E03H4.8
Is predicted to have structural molecule activity. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 19. Is an ortholog of human COPB2 (COPI coat complex subunit beta 2).

WB:WBGene00008477	clec-17
Is predicted to have carbohydrate binding activity.

WB:WBGene00008478	E03H4.11
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00008479	glct-2
Is predicted to have galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity. Is an ortholog of human B3GAT1 (beta-1,3-glucuronyltransferase 1) and B3GAT2 (beta-1,3-glucuronyltransferase 2).

WB:WBGene00008480	eif-2A
Is predicted to have ribosome binding activity; tRNA binding activity; and translation initiation factor activity. Is involved in positive regulation of gene expression. Is an ortholog of human EIF2A (eukaryotic translation initiation factor 2A).

WB:WBGene00008481	E04D5.2
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00008482	cut-4
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eighteen chemicals including aldicarb; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00008483	E04D5.4
Is enriched in AFD; OLL; PVD; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by nineteen chemicals including 1-methylnicotinamide; Tunicamycin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00008484	E04D5.5
Is enriched in head mesodermal cell and neurons based on RNA-seq and microarray studies. Is affected by several genes including skn-1; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008485	ugt-43
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A10 (UDP glucuronosyltransferase family 1 member A10); UGT1A8 (UDP glucuronosyltransferase family 1 member A8); and UGT2B15 (UDP glucuronosyltransferase family 2 member B15).

WB:WBGene00008486	ugt-44
Is predicted to have UDP-glycosyltransferase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A5 (UDP glucuronosyltransferase family 1 member A5); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2A3 (UDP glucuronosyltransferase family 2 member A3).

WB:WBGene00008487	F01D4.3
Is enriched in AVK; FLP; germ line; and in male based on microarray and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; methylmercuric chloride; and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00008488	F01D4.5
Is predicted to have metal ion binding activity. Is expressed in hypodermis; male gonad; nervous system; and vulva.

WB:WBGene00008489	srb-17
Is predicted to have transmembrane signaling receptor activity. Is expressed in chemosensory neurons; head muscle; intestine; seam cell; and vulva.

WB:WBGene00008490	F01D4.8
Is predicted to have cysteine synthase activity and pyridoxal phosphate binding activity.

WB:WBGene00008491	bgnt-1.1
Is predicted to have transferase activity. Is expressed in phasmid sheath cell. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A13. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00008492	F01D5.1
Is involved in innate immune response.

WB:WBGene00008493	F01D5.2
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including Rotenone; Tunicamycin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00008494	F01D5.3
Is involved in innate immune response.

WB:WBGene00008495	F01D5.5
Is involved in innate immune response.

WB:WBGene00008496	F01D5.6
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Modulator of levamisole receptor-1 and Modulator of levamisole receptor-1.

WB:WBGene00008497	F01D5.7
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in PHARC syndrome. Is an ortholog of human ABHD17B (abhydrolase domain containing 17B, depalmitoylase) and ABHD17C (abhydrolase domain containing 17C, depalmitoylase).

WB:WBGene00008498	F01D5.8
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in PHARC syndrome. Is an ortholog of human ABHD17B (abhydrolase domain containing 17B, depalmitoylase) and ABHD17C (abhydrolase domain containing 17C, depalmitoylase).

WB:WBGene00008499	cyp-37A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5.

WB:WBGene00008500	F01D5.10
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00008501	fbxa-177
Is affected by rsr-2 based on tiling array studies. Is affected by Progesterone based on microarray studies.

WB:WBGene00008502	skih-2
Is predicted to have RNA helicase activity. Human ortholog(s) of this gene are implicated in trichohepatoenteric syndrome 2. Is an ortholog of human SKIV2L (Ski2 like RNA helicase).

WB:WBGene00008503	F01G4.4
Is enriched in several structures, including DD neuron; germ line; germline precursor cell; male distal tip cell; and seam cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including aldicarb; manganese chloride; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00008504	pigq-1
Is predicted to contribute to phosphatidylinositol N-acetylglucosaminyltransferase activity. Localizes to endoplasmic reticulum. Is an ortholog of human PIGQ (phosphatidylinositol glycan anchor biosynthesis class Q).

WB:WBGene00008505	F01G4.6
Is predicted to have inorganic phosphate transmembrane transporter activity. Is an ortholog of human SLC25A3 (solute carrier family 25 member 3).

WB:WBGene00008506	tkt-1
Is predicted to have catalytic activity. Is an ortholog of human TKT (transketolase) and TKTL2 (transketolase like 2).

WB:WBGene00008507	F01G10.4
Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including indole; Rifampin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00008508	F01G10.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00008509	F01G10.6
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including 1-methylnicotinamide; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008510	lipl-7
Is predicted to have hydrolase activity, acting on ester bonds. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of several human genes including LIPF (lipase F, gastric type); LIPK (lipase family member K); and LIPN (lipase family member N).

WB:WBGene00008511	F01G10.9
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including Heme; methylmercury hydroxide; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008512	F01G10.10
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in hyperalphalipoproteinemia 1. Is an ortholog of human BPI (bactericidal permeability increasing protein) and LBP (lipopolysaccharide binding protein).

WB:WBGene00008513	F02A9.1
Is enriched in intestine; muscle cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including nanoparticle; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008514	mrpl-44
Is predicted to have ribonuclease III activity. Is expressed in metacorpus; pm4; pm7; and terminal bulb. Human ortholog(s) of this gene are implicated in 3-Methylcrotonyl-CoA carboxylase 2 deficiency and combined oxidative phosphorylation deficiency 16. Is an ortholog of human MCCC2 (methylcrotonoyl-CoA carboxylase 2).

WB:WBGene00008515	F02C12.1
Is predicted to have zinc ion binding activity.

WB:WBGene00008516	F02C12.2
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Mercuric Chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Phosphorylation site; Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00008517	F02C12.3
Is enriched in OLL; PVD; germ line; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00008518	irld-2
Is affected by several genes including sir-2.1; pgl-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00008519	cyp-13B1
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A43 (cytochrome P450 family 3 subfamily A member 43); and CYP3A5 (cytochrome P450 family 3 subfamily A member 5).

WB:WBGene00008520	F02D8.1
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and alg-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008521	F02D8.4
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of human CPA3 (carboxypeptidase A3) and CPB1 (carboxypeptidase B1).

WB:WBGene00008522	nlp-59
Is enriched in head mesodermal cell; neurons; and somatic nervous system based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008523	F02D10.2
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies.

WB:WBGene00008524	F02D10.3
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including let-60; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008526	F02D10.6
Is enriched in dopaminergic neurons; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercury hydroxide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00008527	set-8
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Kleefstra syndrome 2; Sotos syndrome; and autosomal dominant non-syndromic intellectual disability (multiple).

WB:WBGene00008528	F02E9.1
Is predicted to have unfolded protein binding activity. Localizes to endoplasmic reticulum.

WB:WBGene00008529	F02E9.3
Is enriched in AVK; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00008530	F02E9.5
Is enriched in AFD; ASER; PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; sir-2.1; and fbf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF776. Is an ortholog of human OSER1 (oxidative stress responsive serine rich 1).

WB:WBGene00008531	F02E9.7
Is predicted to have acid phosphatase activity; ferric iron binding activity; and ferrous iron binding activity. Is an ortholog of human ACP5 (acid phosphatase 5, tartrate resistant).

WB:WBGene00008532	dpt-1
Is predicted to have dipeptidyl-peptidase activity. Is an ortholog of human DPP3 (dipeptidyl peptidase 3).

WB:WBGene00008533	F02E9.10
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by nine chemicals including nicotine; Zidovudine; and Psoralens based on proteomic; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR61 (WD repeat domain 61).

WB:WBGene00008534	F02H6.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008535	F02H6.2
Is enriched in AB; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008536	F02H6.3
Is enriched in NSM; cephalic sheath cell; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008537	F02H6.4
Is enriched in cephalic sheath cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Mianserin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00008538	sqrd-1
Is predicted to have FAD binding activity and sulfide:quinone oxidoreductase activity. Is an ortholog of human SQOR (sulfide quinone oxidoreductase).

WB:WBGene00008539	F02H6.6
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; hpl-2; and drh-3 based on RNA-seq and microarray studies. Is affected by Alovudine and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008540	F02H6.7
Is affected by hpl-2; csr-1; and rsd-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008541	F07A5.2
Is enriched in AVK; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirty-one chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008542	scav-6
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercuric chloride; Mianserin; and D-glucopyranose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 10 and progressive myoclonus epilepsy 4. Is predicted to encode a protein with the following domains: CD36 family and CD36 family. Is an ortholog of human SCARB1 (scavenger receptor class B member 1) and SCARB2 (scavenger receptor class B member 2).

WB:WBGene00008543	F07A5.4
Is enriched in coelomocyte; intestine; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in juvenile glaucoma. Is predicted to encode a protein with the following domains: Olfactomedin-like domain and Olfactomedin-like domain. Is an ortholog of human MYOC (myocilin) and OLFM1 (olfactomedin 1).

WB:WBGene00008545	F07A11.1
Is enriched in BAG based on tiling array studies. Is affected by several genes including daf-16; pgl-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including allantoin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008546	gfat-1
Is predicted to have glutamine-fructose-6-phosphate transaminase (isomerizing) activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in tail. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 12 and congenital myasthenic syndrome 4C. Is an ortholog of human GFPT1 (glutamine--fructose-6-phosphate transaminase 1) and GFPT2 (glutamine-fructose-6-phosphate transaminase 2).

WB:WBGene00008547	F07A11.4
Is predicted to have metal ion binding activity and thiol-dependent ubiquitinyl hydrolase activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability. Is an ortholog of human USP19 (ubiquitin specific peptidase 19).

WB:WBGene00008548	F07A11.5
Is predicted to have ATP binding activity; metal ion binding activity; and ribokinase activity. Is an ortholog of human RBKS (ribokinase).

WB:WBGene00008549	din-1
Is predicted to have RNA binding activity. Localizes to nucleus. Is expressed in several structures, including body wall musculature; hermaphrodite distal tip cell; intestine; pharynx; and vulval precursor cell. Is an ortholog of human SPEN (spen family transcriptional repressor).

WB:WBGene00008550	F07B10.4
Is affected by several genes including clk-1; elt-2; and drh-3 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and nitroguanidine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00008551	lgc-36
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Human ortholog(s) of this gene are implicated in alcohol dependence; early infantile epileptic encephalopathy 19; and idiopathic generalized epilepsy 13. Is an ortholog of several human genes including GABRA2 (gamma-aminobutyric acid type A receptor subunit alpha2); GABRA6 (gamma-aminobutyric acid type A receptor subunit alpha6); and GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3).

WB:WBGene00008552	srsx-31
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00008553	F07C6.2
Is enriched in AFD; AVK; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; Rotenone; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008554	F07C6.3
Is enriched in AFD; amphid sheath cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; bisphenol A; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008555	F07C6.4
Is enriched in OLL; PVD; body wall musculature; germ line; and germline precursor cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and fog-2 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FERM C-terminal PH-like domain; Domain of unknown function (DUF3338); FERM, C-terminal PH-like domain; and Domain of unknown function DUF3338. Is an ortholog of human FRMD4A (FERM domain containing 4A) and FRMD4B (FERM domain containing 4B).

WB:WBGene00008556	F07D3.3
Is predicted to have nucleic acid binding activity.

WB:WBGene00008557	F07H5.6
Is enriched in GABAergic neurons; coelomocyte; head mesodermal cell; hypodermis; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00008558	F07H5.7
Is enriched in cephalic sheath cell; head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008559	F07H5.8
Is enriched in DA neuron; GABAergic neurons; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; Rotenone; and sodium arsenite based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine rich repeat and Cysteine rich repeat, tripleX.

WB:WBGene00008560	pho-13
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily.

WB:WBGene00008561	F07H5.10
Is enriched in Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and gld-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RAI1 like PD-(D/E)XK nuclease; RAI1-like; and RAI1-like family. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00008563	F07H5.13
Is enriched in AVK; NSM; body wall muscle cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00008564	acox-1.1
Is predicted to have acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Is involved in ascaroside biosynthetic process. Localizes to peroxisomal matrix. Is expressed in hypodermis; intestinal cell; and intestine. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACOX1 (acyl-CoA oxidase 1).

WB:WBGene00008565	acox-1.2
Is predicted to have acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Is involved in ascaroside biosynthetic process. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACOX1 (acyl-CoA oxidase 1).

WB:WBGene00008566	acox-1.3
Is predicted to have acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Is involved in ascaroside biosynthetic process. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACOX1 (acyl-CoA oxidase 1).

WB:WBGene00008567	acox-1.4
Is predicted to have acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACOX1 (acyl-CoA oxidase 1).

WB:WBGene00008568	F08A8.5
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00008569	fbxa-101
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00008570	kcnl-2
Is predicted to have calmodulin binding activity and small conductance calcium-activated potassium channel activity. Is involved in positive regulation of oviposition. Localizes to neuron projection. Is expressed in nervous system; seam cell; and vulval muscle. Human ortholog(s) of this gene are implicated in dehydrated hereditary stomatocytosis 2. Is an ortholog of human KCNN1 (potassium calcium-activated channel subfamily N member 1).

WB:WBGene00008571	prmn-1
Is enriched in several structures, including germ line; neurons; pharynx; retrovesicular ganglion; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Stargardt disease; cone-rod dystrophy 12; and retinitis pigmentosa 41. Is predicted to encode a protein with the following domains: Prominin and Prominin. Is an ortholog of human PROM1 (prominin 1) and PROM2 (prominin 2).

WB:WBGene00008572	F08B12.4
Localizes to nucleus. Is expressed in body wall musculature; metacorpus; and tail.

WB:WBGene00008574	srbc-61
Is affected by several genes including eat-2; sir-2.1; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00008575	scl-24
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Mercuric Chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00008576	F08G2.4
Is enriched in intestine and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Alovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00008577	F08G2.5
Is involved in innate immune response.

WB:WBGene00008578	F08G2.7
Is affected by several genes including daf-2; daf-12; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Zidovudine and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008579	F08G2.8
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00008580	dsb-1
Localizes to condensed chromosome. Is expressed in gonad.

WB:WBGene00008581	acl-13
Is predicted to have transferase activity, transferring acyl groups. Is an ortholog of human LPGAT1 (lysophosphatidylglycerol acyltransferase 1).

WB:WBGene00008582	F08G5.3
Is enriched in head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by metformin; Sirolimus; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00008583	ugt-65
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A3 (UDP glucuronosyltransferase family 1 member A3); UGT1A5 (UDP glucuronosyltransferase family 1 member A5); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00008584	irg-4
Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in head neurons and intestine.

WB:WBGene00008585	F08G12.1
Is predicted to have GTP binding activity and GTPase activity. Is expressed in head muscle; hermaphrodite distal tip cell; neurons; and pharyngeal muscle cell. Is an ortholog of human RABL6 (RAB, member RAS oncogene family like 6).

WB:WBGene00008586	snrp-40.1
Is enriched in ASER; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; and WD40-repeat-containing domain superfamily. Is an ortholog of human SNRNP40 (small nuclear ribonucleoprotein U5 subunit 40).

WB:WBGene00008587	F08G12.3
Is enriched in ASER; coelomocyte; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00008588	F08G12.5
Is predicted to have metal ion binding activity.

WB:WBGene00008589	nlp-57
Is expressed in intestine and nervous system.

WB:WBGene00008590	F08H9.2
Is enriched in amphid sheath cell and germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008591	F08H9.3
Is predicted to have metal ion binding activity. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAB (crystallin alpha B) and HSPB6 (heat shock protein family B (small) member 6).

WB:WBGene00008592	F08H9.4
Is predicted to have metal ion binding activity. Is involved in response to topologically incorrect protein. Is expressed in excretory canal; head neurons; and ventral cord neurons. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease type 2 (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human CRYAB (crystallin alpha B) and HSPB6 (heat shock protein family B (small) member 6).

WB:WBGene00008593	clec-227
Is predicted to have carbohydrate binding activity.

WB:WBGene00008594	clec-57
Is predicted to have carbohydrate binding activity.

WB:WBGene00008595	clec-56
Is predicted to have carbohydrate binding activity.

WB:WBGene00008596	clec-54
Is predicted to have carbohydrate binding activity.

WB:WBGene00008597	clec-55
Is predicted to have carbohydrate binding activity.

WB:WBGene00008598	spin-3
Is predicted to have transmembrane transporter activity. Is expressed in amphid neurons; intestine; and retrovesicular ganglion neurons. Is an ortholog of human SPNS1 (sphingolipid transporter 1 (putative)); SPNS2 (sphingolipid transporter 2); and SPNS3 (sphingolipid transporter 3 (putative)).

WB:WBGene00008599	F09A5.2
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00008600	F09A5.3
Is enriched in intestine and neurons based on RNA-seq studies. Is affected by several genes including let-60; daf-12; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00008601	mob-2
Is enriched in intestine and neurons based on proteomic and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; Atrazine; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mob1/phocein family; MOB kinase activator family; and MOB kinase activator superfamily. Is an ortholog of human MOB2 (MOB kinase activator 2).

WB:WBGene00008602	oac-14
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00008603	F09B9.4
Is expressed in body wall musculature. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008604	F09B9.5
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR2 (GLI pathogenesis related 2).

WB:WBGene00008605	mlt-9
Is expressed in hypodermis. Is predicted to encode a protein with the following domain: Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00008606	dhhc-1
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human ZDHHC24 (zinc finger DHHC-type containing 24).

WB:WBGene00008607	F09B12.3
Is predicted to have phospholipase activity. Is an ortholog of human PLBD2 (phospholipase B domain containing 2).

WB:WBGene00008609	F09B12.5
Is affected by several genes including sek-1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Donnai-Barrow syndrome; bone disease (multiple); and cerebellar ataxia, mental retardation and dysequlibrium syndrome. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; and LDL receptor-like superfamily. Is an ortholog of human LRP3 (LDL receptor related protein 3).

WB:WBGene00008610	F09C3.2
Is predicted to have phosphoglycolate phosphatase activity. Is expressed in hypodermis; intestine; and motor neurons. Is an ortholog of human NANP (N-acetylneuraminic acid phosphatase).

WB:WBGene00008611	fbxb-68
Is affected by several genes including daf-2; eat-2; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00008612	fbxa-103
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00008613	fbxb-69
Is enriched in CEM; HOB; IL2 neuron; neurons; and ray neuron type B based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00008614	F09C3.6
No description available

WB:WBGene00008615	F09C6.1
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Actin-crosslinking.

WB:WBGene00008616	fbxa-44
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and tert-Butylhydroperoxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00008617	F09C6.3
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and lin-35 based on RNA-seq; tiling array; and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; sodium arsenite; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008618	fbxa-45
Is affected by several genes including clk-1; cyc-1; and ahr-1 based on microarray and tiling array studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00008619	nhr-262
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity.

WB:WBGene00008620	F09C6.10
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Sodium Chloride; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008621	F09C8.1
Is predicted to have phospholipase activity. Is expressed in intestine. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00008622	F09C8.2
Is enriched in AFD; ASER; AVK; OLL; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including aldicarb; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Coiled-coil domain-containing protein R3HC1/R3HCL. Is an ortholog of human R3HCC1L (R3H domain and coiled-coil containing 1 like).

WB:WBGene00008623	spe-43
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and hsp-6 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; fluoranthene; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: DX module and Domain of unknown function DX.

WB:WBGene00008624	crld-1
Is predicted to have calcium ion binding activity and protein disulfide isomerase activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in several structures, including body wall musculature; gonad; hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is an ortholog of human CRELD1 (cysteine rich with EGF like domains 1).

WB:WBGene00008625	scl-14
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and elt-2 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including aldicarb; methylmercuric chloride; and Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00008626	nlp-79
Is enriched in OLL; PVD; dopaminergic neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including skn-1; pgl-1; and sma-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00008627	hpx-2
Is predicted to have peroxidase activity. Is involved in defense response to Gram-positive bacterium. Is expressed in gland cell and hypodermis. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7.

WB:WBGene00008628	ttr-21
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00008629	cpt-5
Is predicted to have carnitine O-palmitoyltransferase activity.

WB:WBGene00008630	nhr-175
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity.

WB:WBGene00008631	F10A3.1
Is enriched in AVA; body wall muscle cell; and intestine based on tiling array and microarray studies. Is affected by several genes including hsf-1; eat-2; and npr-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00008632	fbxa-88
Is affected by several genes including daf-2; glp-1; and age-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Heme; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00008633	fbxa-18
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00008634	F10A3.4
Is expressed in intestine and tail neurons. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00008635	F10A3.7
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by copper sulfate based on microarray studies.

WB:WBGene00008636	F10A3.11
Is enriched in ALM; FLP; PLM; germ line; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; resveratrol; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00008637	F10A3.12
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00008638	F10A3.16
Is affected by csr-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00008639	F10B5.2
Is enriched in germ line; germline precursor cell; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; let-60; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including bisphenol S; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: AAR2 protein; A1 cistron-splicing factor, AAR2; AAR2, C-terminal domain superfamily; and AAR2, N-terminal domain superfamily. Is an ortholog of human AAR2 (AAR2 splicing factor).

WB:WBGene00008640	F10B5.3
Is enriched in AVA; AVE; dopaminergic neurons; pharynx; and ventral nerve cord based on microarray and tiling array studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by fourteen chemicals including nicotinic acid; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; SKP1/BTB/POZ domain superfamily; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00008641	pch-2
Is predicted to have ATP binding activity. Localizes to condensed chromosome kinetochore. Is an ortholog of human TRIP13 (thyroid hormone receptor interactor 13).

WB:WBGene00008642	ints-11
Is enriched in germ line; germline precursor cell; head mesodermal cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and clk-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by fourteen chemicals including bisphenol S; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Beta-Casp domain; Zn-dependent metallo-hydrolase RNA specificity domain; Metallo-beta-lactamase superfamily domain; Metallo-beta-lactamase; Zn-dependent metallo-hydrolase, RNA specificity domain; Beta-Casp domain; and Ribonuclease Z/Hydroxyacylglutathione hydrolase-like. Is an ortholog of human INTS11 (integrator complex subunit 11).

WB:WBGene00008643	tmem-138
Localizes to ciliary transition zone. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in Joubert syndrome 16. Is an ortholog of human TMEM138 (transmembrane protein 138).

WB:WBGene00008644	F10C2.3
Is predicted to have catalytic activity.

WB:WBGene00008645	F10C2.4
Is predicted to have 3'-5'-exodeoxyribonuclease activity and DNA-directed DNA polymerase activity. Is an ortholog of human POLD1 (DNA polymerase delta 1, catalytic subunit).

WB:WBGene00008646	F10C2.5
Is predicted to have calcium ion binding activity and mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Is an ortholog of human EDEM2 (ER degradation enhancing alpha-mannosidase like protein 2).

WB:WBGene00008647	F10C2.7
Is predicted to have transmembrane transporter activity. Is expressed in intestine.

WB:WBGene00008648	F10D11.2
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008649	F10D11.3
Is enriched in germ line; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; D-glucose; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00008650	F10D11.4
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008651	F10D11.5
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including nicotinic acid; manganese chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PDZ superfamily and Uncharacterized protein T15H9.4-like.

WB:WBGene00008652	F10D11.6
Is predicted to have lipid binding activity. Is an ortholog of human LBP (lipopolysaccharide binding protein).

WB:WBGene00008654	pfas-1
Is predicted to have phosphoribosylformylglycinamidine synthase activity. Is expressed in intestinal cell. Is an ortholog of human PFAS (phosphoribosylformylglycinamidine synthase).

WB:WBGene00008655	lips-3
Is predicted to have lipase activity.

WB:WBGene00008656	lron-5
Is expressed in nerve ring; tail; and ventral nerve cord. Is predicted to encode a protein with the following domains: Leucine rich repeat; Cysteine-rich flanking region, C-terminal; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily.

WB:WBGene00008657	clec-154
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00008658	clec-152
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008659	clec-151
Is predicted to have carbohydrate binding activity.

WB:WBGene00008660	clec-153
Is predicted to have carbohydrate binding activity.

WB:WBGene00008661	F10G8.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00008662	F10G8.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00008663	eak-6
Is predicted to have protein tyrosine phosphatase activity. Is involved in dauer larval development. Localizes to plasma membrane. Is expressed in XXXL and XXXR.

WB:WBGene00008664	nubp-1
Is predicted to have iron-sulfur cluster binding activity. Is involved in regulation of non-motile cilium assembly. Is expressed in amphid neurons; inner labial neurons; outer labial neurons; and phasmid neurons. Is an ortholog of human NUBP1 (nucleotide binding protein 1).

WB:WBGene00008665	ercc-1
Exhibits enzyme binding activity and identical protein binding activity. Is involved in UV-damage excision repair and base-excision repair. Is an ortholog of human ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit).

WB:WBGene00008666	F10G8.8
Is enriched in OLL; PLM; PVD; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 28. Is predicted to encode a protein with the following domains: PH domain; Pleckstrin homology domain; and PH-like domain superfamily. Is an ortholog of human MPRIP (myosin phosphatase Rho interacting protein).

WB:WBGene00008667	F10G8.9
Is predicted to have 3-oxoacyl-[acyl-carrier-protein] synthase activity. Is an ortholog of human OXSM (3-oxoacyl-ACP synthase, mitochondrial).

WB:WBGene00008669	acs-14
Is predicted to have catalytic activity. Is an ortholog of human ACSBG1 (acyl-CoA synthetase bubblegum family member 1).

WB:WBGene00008670	eif-2Bdelta
Is predicted to have translation initiation factor activity. Is involved in several processes, including determination of adult lifespan; lipid storage; and translation. Human ortholog(s) of this gene are implicated in leukoencephalopathy with vanishing white matter. Is an ortholog of human EIF2B4 (eukaryotic translation initiation factor 2B subunit delta).

WB:WBGene00008671	F11A5.3
Is predicted to have GTPase activity. Is an ortholog of human RAB2B (RAB2B, member RAS oncogene family).

WB:WBGene00008672	F11A5.4
Is predicted to have GTPase activity. Is an ortholog of human RAB2B (RAB2B, member RAS oncogene family).

WB:WBGene00008673	F11A5.5
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00008675	irld-26
Is affected by several genes including lin-4; lin-14; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00008676	oac-15
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00008677	F11A5.9
Is predicted to have transmembrane transporter activity.

WB:WBGene00008678	stdh-2
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12).

WB:WBGene00008679	F11A5.13
Is enriched in GABAergic neurons; excretory cell; hypodermis; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008680	F11A5.15
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008681	scrm-4
Is predicted to have phospholipid scramblase activity. Is an ortholog of human PLSCR3 (phospholipid scramblase 3).

WB:WBGene00008682	lex-1
Is predicted to have ATPase activity; chromatin binding activity; and histone binding activity. Is involved in regulation of heterochromatin assembly. Is an ortholog of human ATAD2 (ATPase family AAA domain containing 2) and ATAD2B (ATPase family AAA domain containing 2B).

WB:WBGene00008683	repo-1
Is predicted to have nucleic acid binding activity and zinc ion binding activity. Is expressed in head. Is an ortholog of human SF3A2 (splicing factor 3a subunit 2).

WB:WBGene00008684	mig-32
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in several processes, including negative regulation of vulval development; nematode male tail tip morphogenesis; and regulation of axon extension involved in axon guidance. Localizes to nucleolus. Is expressed in several structures, including germ line. Is an ortholog of human PCGF3 (polycomb group ring finger 3).

WB:WBGene00008685	mon-2
Is enriched in PLM; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including hsf-1; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domains: Dimerisation and cyclophilin-binding domain of Mon2; Guanine nucleotide exchange factor in Golgi transport N-terminal; C-terminal region of Mon2 protein; Armadillo-type fold; Protein Mon2-like; Mon2, dimerisation and cyclophilin-binding domain; Guanine nucleotide exchange factor, N-terminal; and Mon2, C-terminal. Is an ortholog of human MON2 (MON2 homolog, regulator of endosome-to-Golgi trafficking).

WB:WBGene00008686	F11A10.5
Is enriched in AVK; germ line; germline precursor cell; and neurons based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; npr-1; and sek-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ST7 protein; ST7; and Tetratricopeptide-like helical domain superfamily. Is an ortholog of human ST7 (suppression of tumorigenicity 7).

WB:WBGene00008687	F11A10.6
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and lin-35 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; fluoranthene; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: TMEM115/Pdh1/Rbl19. Is an ortholog of human TMEM115 (transmembrane protein 115).

WB:WBGene00008688	rbm-34
Is predicted to have RNA binding activity. Is an ortholog of human RBM34 (RNA binding motif protein 34).

WB:WBGene00008690	F11C1.1
Is predicted to have protein disulfide oxidoreductase activity. Is an ortholog of human CHCHD4 (coiled-coil-helix-coiled-coil-helix domain containing 4).

WB:WBGene00008691	mff-1
Is enriched in germ line; hypodermis; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008692	scav-4
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by sixteen chemicals including multi-walled carbon nanotube; D-glucose; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 10 and progressive myoclonus epilepsy 4. Is predicted to encode a protein with the following domains: CD36 family and CD36 family. Is an ortholog of human SCARB1 (scavenger receptor class B member 1) and SCARB2 (scavenger receptor class B member 2).

WB:WBGene00008693	F11C1.4
Is enriched in DA neuron; VA neuron; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipid-droplet associated hydrolase; Lipid droplet-associated hydrolase; and Alpha/Beta hydrolase fold. Is an ortholog of human LDAH (lipid droplet associated hydrolase).

WB:WBGene00008694	vwa-8
Is predicted to have ATP binding activity and ATPase activity. Is an ortholog of human VWA8 (von Willebrand factor A domain containing 8).

WB:WBGene00008695	F11C3.1
Is predicted to have helicase activity.

WB:WBGene00008696	clec-255
Is predicted to have carbohydrate binding activity.

WB:WBGene00008697	F11D11.2
No description available

WB:WBGene00008698	F11D11.3
Is involved in innate immune response.

WB:WBGene00008699	F11D11.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on RNA-seq; proteomic; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008700	clec-254
Is predicted to have carbohydrate binding activity.

WB:WBGene00008701	F11D11.6
Is affected by several genes including clk-1; aak-2; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00008702	clec-252
Is affected by several genes including clk-1; eat-2; and isp-1 based on microarray and tiling array studies. Is predicted to encode a protein with the following domains: Phosphorylation site; PAN-like domain; PAN-3 domain; C-type lectin-like/link domain superfamily; and C-type lectin fold.

WB:WBGene00008703	clec-251
Is affected by several genes including sir-2.1; aak-2; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00008704	F11D11.9
No description available

WB:WBGene00008706	gba-3
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in Gaucher's disease (multiple); Lewy body dementia; and late onset Parkinson's disease. Is an ortholog of human GBA (glucosylceramidase beta).

WB:WBGene00008707	F11E6.3
Is enriched in NSM; cephalic sheath cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including diallyl trisulfide; nicotinic acid; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008708	F11E6.4
Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008709	F11E6.6
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family and Frag1/DRAM/Sfk1. Is an ortholog of human TMEM150B (transmembrane protein 150B).

WB:WBGene00008710	F11E6.7
Is enriched in several structures, including PLM; germ line; head mesodermal cell; male distal tip cell; and pharyngeal muscle cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human RIF1 (replication timing regulatory factor 1).

WB:WBGene00008711	F11E6.8
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human MET (MET proto-oncogene, receptor tyrosine kinase).

WB:WBGene00008712	F11E6.9
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Tunicamycin; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008713	F11E6.10
Is enriched in AFD; ASER; BAG; amphid sheath cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; allantoin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00008714	F11F1.1
Is predicted to have several functions, including ATP binding activity; ATPase activity; and unfolded protein binding activity.

WB:WBGene00008716	F11F1.4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including metformin; Sirolimus; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00008717	F11F1.5
Is enriched in DA neuron; VA neuron; cephalic sheath cell; dopaminergic neurons; and germ line based on tiling array and RNA-seq studies. Is affected by rsr-2; clk-1; and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00008719	ttr-52
Exhibits several functions, including phosphatidylserine binding activity; protein homodimerization activity; and protein-macromolecule adaptor activity. Is involved in aminophospholipid transport; apoptotic process involved in development; and recognition of apoptotic cell. Localizes to cell surface and extracellular vesicle.

WB:WBGene00008720	F12F6.1
Is enriched in OLL; PVD; germ line; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including glp-1; daf-12; and dpy-10 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by eight chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008722	F12F6.7
Is predicted to have DNA binding activity and DNA-directed DNA polymerase activity. Is an ortholog of human POLD2 (DNA polymerase delta 2, accessory subunit).

WB:WBGene00008723	F12F6.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00008724	F13A7.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00008725	F13A7.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Papain-like cysteine peptidase superfamily.

WB:WBGene00008726	F13A7.11
Is involved in innate immune response.

WB:WBGene00008727	F13A7.12
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00008728	sre-36
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00008729	F13B12.1
Localizes to nucleus. Is expressed in anal depressor muscle; head neurons; pharyngeal-intestinal valve; and tail. Is an ortholog of human IWS1 (interacts with SUPT6H, CTD assembly factor 1).

WB:WBGene00008730	F13B12.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00008731	F13B12.3
Is enriched in FLP and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucopyranose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is predicted to encode a protein with the following domain: .

WB:WBGene00008732	F13B12.4
Is predicted to have cysteine synthase activity and pyridoxal phosphate binding activity.

WB:WBGene00008733	F13B12.6
Is predicted to have signaling adaptor activity. Is an ortholog of human SH2D4A (SH2 domain containing 4A) and SH2D4B (SH2 domain containing 4B).

WB:WBGene00008734	F13B12.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Tunicamycin; paraquat; and allantoin based on microarray studies.

WB:WBGene00008735	F13D2.1
Is predicted to have endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 1; age related macular degeneration 9; and complement deficiency (multiple).

WB:WBGene00008736	gnrr-6
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00008737	gnrr-7
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00008739	F13D12.3
Is expressed in head and rectal epithelium.

WB:WBGene00008740	F13D12.5
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008741	ctsa-1.2
Is predicted to have serine-type carboxypeptidase activity. Is expressed in intestine. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00008742	F13D12.8
Is enriched in several structures, including excretory cell; germline precursor cell; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008743	F13D12.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mycolic acid cyclopropane synthetase; Mycolic acid cyclopropane synthase; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00008744	F13D12.10
Is enriched in body wall musculature; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00008745	F13E6.1
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Phosphorylation site; Tumour protein D52 family; and Tumour protein D52. Is an ortholog of human TPD52 (tumor protein D52); TPD52L1 (TPD52 like 1); and TPD52L2 (TPD52 like 2).

WB:WBGene00008746	F13E6.2
Is predicted to have ATP binding activity and nucleobase-containing compound kinase activity. Is an ortholog of human AK5 (adenylate kinase 5).

WB:WBGene00008747	phf-31
Is predicted to have metal ion binding activity.

WB:WBGene00008748	yap-1
Exhibits RNA polymerase II transcription factor binding activity and protein kinase binding activity. Is involved in establishment of cell polarity and positive regulation of transcription by RNA polymerase II. Localizes to RNA polymerase II transcription factor complex; axoneme; and ciliary base. Is expressed in several structures, including excretory system; hermaphrodite gonad; pharyngeal muscle cell; tail hypodermis; and vulva. Human ortholog(s) of this gene are implicated in uveal coloboma-cleft lip and palate-intellectual disability. Is an ortholog of human WWTR1 (WW domain containing transcription regulator 1) and YAP1 (Yes1 associated transcriptional regulator).

WB:WBGene00008749	plpp-1.3
Is predicted to have lipid phosphatase activity and phosphatidate phosphatase activity.

WB:WBGene00008750	F13E9.1
Is predicted to have protein kinase binding activity. Is an ortholog of human NISCH (nischarin).

WB:WBGene00008751	fipr-14
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including rrf-3; sir-2.1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00008752	fipr-15
Is involved in response to hypoxia.

WB:WBGene00008753	F13E9.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by four chemicals including procyanidin; Sodium Chloride; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00008754	F13E9.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00008755	sdz-13
Is affected by several genes including daf-2; eat-2; and mex-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00008756	F13E9.7
No description available

WB:WBGene00008757	F13E9.8
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and procyanidin based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00008758	F13E9.9
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00008759	F13E9.10
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and hpl-2 based on tiling array and RNA-seq studies. Is affected by eight chemicals including tryptophan; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00008760	F13E9.11
Is enriched in DA neuron; OLL; PLM; PVD; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CECR6/TMEM121 family; Cat eye syndrome critical region protein 6; and CECR6/TMEM121 family. Is an ortholog of human TMEM121B (transmembrane protein 121B).

WB:WBGene00008761	F13E9.12
Is enriched in neurons based on tiling array studies. Is affected by several genes including clk-1; elt-2; and bar-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and allantoin based on RNA-seq studies.

WB:WBGene00008762	ztf-2
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity. Is expressed in pharyngeal neurons; pharynx; rectum; and vulva. Human ortholog(s) of this gene are implicated in gingival fibromatosis 5 and pleomorphic adenoma.

WB:WBGene00008763	F13G3.3
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00008764	dylt-1
Is expressed in ADFL and ADFR. Is predicted to encode a protein with the following domains: Tctex-1 family; Dynein light chain Tctex-1 like; and Tctex-1-like superfamily. Is an ortholog of human DYNLT1 (dynein light chain Tctex-type 1) and DYNLT3 (dynein light chain Tctex-type 3).

WB:WBGene00008765	ttx-7
Is predicted to have inositol monophosphate 1-phosphatase activity and metal ion binding activity. Is involved in chemotaxis; protein localization to synapse; and thermotaxis. Localizes to cytoplasm. Is expressed in several structures, including coelomocyte; gonad; intestine; neurons; and ventral nerve cord. Is an ortholog of human IMPA2 (inositol monophosphatase 2).

WB:WBGene00008766	F13G3.6
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glycosyl transferase family 2; Glycosyltransferase 2-like; and Nucleotide-diphospho-sugar transferases. Is an ortholog of human B3GNTL1 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1).

WB:WBGene00008767	F13G3.7
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; lin-28; and cgh-1 based on microarray and RNA-seq studies. Is affected by stavudine and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; and Mitochondrial carrier domain superfamily. Is an ortholog of human SLC25A44 (solute carrier family 25 member 44).

WB:WBGene00008768	F13G3.10
Is enriched in germ line; intestine; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by eleven chemicals including Rotenone; Cry5B; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human HYPK (huntingtin interacting protein K).

WB:WBGene00008769	mrpl-13
Is predicted to have mRNA binding activity. Is an ortholog of human MRPL13 (mitochondrial ribosomal protein L13).

WB:WBGene00008770	F13G3.12
Is enriched in GABAergic neurons and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including aak-2; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008772	irld-4
Is enriched in muscle cell and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00008773	F13H10.1
Is enriched in GABAergic neurons; NSM; and PLM based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and lin-4 based on microarray and RNA-seq studies. Is affected by four chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008774	F13H10.3
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC38A9 (solute carrier family 38 member 9).

WB:WBGene00008775	mogs-1
Is predicted to have mannosyl-oligosaccharide glucosidase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIb. Is an ortholog of human MOGS (mannosyl-oligosaccharide glucosidase).

WB:WBGene00008776	F13H10.5
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial calcification of infancy; autosomal recessive hypophosphatemic rickets; and obesity. Is an ortholog of human ENPP6 (ectonucleotide pyrophosphatase/phosphodiesterase 6).

WB:WBGene00008777	F13H10.6
Is enriched in AFD; ASER; NSM; muscle cell; and somatic gonad precursor based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Cry5B; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008778	nhr-264
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008779	F14B4.1
Is predicted to have Wnt-activated receptor activity and Wnt-protein binding activity. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia and renal hypomagnesemia 4.

WB:WBGene00008780	hxk-1
Is predicted to have fructokinase activity; glucokinase activity; and mannokinase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4G; diabetes mellitus (multiple); and familial hyperinsulinemic hypoglycemia 3. Is an ortholog of human GCK (glucokinase).

WB:WBGene00008781	rpoa-2
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Localizes to nucleolus. Is expressed in several structures, including intestine. Is an ortholog of human POLR1B (RNA polymerase I subunit B).

WB:WBGene00008782	sdz-14
Is enriched in dopaminergic neurons; hypodermis; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Mercuric Chloride; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00008783	F14B6.2
Localizes to plasma membrane.

WB:WBGene00008784	F14B6.3
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00008785	F14B6.4
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00008786	oac-16
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00008787	F14B6.6
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00008788	F14D7.1
Is enriched in FLP; germ line; intestine; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00008789	F14D7.2
Is expressed in germ line.

WB:WBGene00008790	F14D7.3
Is affected by drh-3; adr-1; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00008791	F14D7.4
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008792	F14D7.5
Is enriched in amphid sheath cell and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00008793	F14D7.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00008794	F14D7.7
Is enriched in amphid sheath cell and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00008795	F14D7.8
Is enriched in BAG; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; resveratrol; and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00008796	F14D7.9
Is enriched in seam cell based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and alg-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00008797	F14D7.10
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00008798	F14D7.11
Is enriched in CEM; HOB; IL2 neuron; neurons; and ray neuron type B based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; alg-1; and hpl-2 based on microarray and RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00008799	F14E5.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00008800	F14E5.2
Is predicted to have fibroblast growth factor binding activity. Is an ortholog of human GLG1 (golgi glycoprotein 1).

WB:WBGene00008801	acp-3
Is enriched in AVK; amphid sheath cell; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal); ACP3 (acid phosphatase 3); and ACP4 (acid phosphatase 4).

WB:WBGene00008802	acp-2
Is expressed in ALML; ALMR; PLML; PLMR; and spermatheca. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal); ACP3 (acid phosphatase 3); and ACP4 (acid phosphatase 4).

WB:WBGene00008803	lips-10
Is predicted to have lipase activity.

WB:WBGene00008804	acp-4
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-16; hsp-6; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb and tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily.

WB:WBGene00008805	git-1
Is predicted to have GTPase activator activity; kinase activity; and metal ion binding activity. Is involved in gonad morphogenesis and inductive cell migration. Localizes to hemidesmosome and presynaptic active zone. Is an ortholog of human GIT1 (GIT ArfGAP 1) and GIT2 (GIT ArfGAP 2).

WB:WBGene00008806	mboa-7
Exhibits O-acyltransferase activity. Is involved in several processes, including nematode larval development; oviposition; and phosphatidylinositol biosynthetic process. Localizes to intracellular membrane-bounded organelle. Is expressed in several structures, including hermaphrodite distal tip cell; intestine; pharyngeal muscle cell; spermatheca; and vulva. Is an ortholog of human MBOAT7 (membrane bound O-acyltransferase domain containing 7).

WB:WBGene00008807	F14F3.4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008808	ntr-2
Is predicted to have G protein-coupled receptor activity. Is expressed in RMEV; ganglia; intestine; and oblique male muscle. Human ortholog(s) of this gene are implicated in nephrogenic diabetes insipidus. Is an ortholog of several human genes including AVPR1B (arginine vasopressin receptor 1B); AVPR2 (arginine vasopressin receptor 2); and OXTR (oxytocin receptor).

WB:WBGene00008809	cyp-13A11
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A43 (cytochrome P450 family 3 subfamily A member 43); CYP3A5 (cytochrome P450 family 3 subfamily A member 5); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00008810	cyp-13A12
Is predicted to have monooxygenase activity. Is expressed in marginal cell. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A5 (cytochrome P450 family 3 subfamily A member 5); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00008811	F14F7.4
Is enriched in DD neuron; germ line; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00008812	F14F7.5
Is enriched in FLP and in male based on microarray and RNA-seq studies. Is affected by several genes including let-60; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00008813	srz-2
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol and dibromoacetic acid based on microarray studies.

WB:WBGene00008814	srz-1
Is expressed in chemosensory neurons and intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00008815	srz-103
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00008816	F14F8.8
Is enriched in body wall muscle cell; germ line; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; Tunicamycin; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00008817	F14F8.9
Is affected by several genes including clk-1; sir-2.1; and prg-1 based on tiling array and microarray studies. Is affected by Diazinon; Sirolimus; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Smr domain and Smr domain superfamily.

WB:WBGene00008818	srz-101
Is affected by clk-1 and drh-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00008819	shw-1
Is predicted to have delayed rectifier potassium channel activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal dominant mental retardation 46; autosomal dominant nonsyndromic deafness 2A; and electroclinical syndrome (multiple). Is an ortholog of human KCNC1 (potassium voltage-gated channel subfamily C member 1) and KCNC2 (potassium voltage-gated channel subfamily C member 2).

WB:WBGene00008820	nlp-55
Is enriched in head mesodermal cell and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008821	best-12
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of several human genes including BEST2 (bestrophin 2); BEST3 (bestrophin 3); and BEST4 (bestrophin 4).

WB:WBGene00008822	F14H3.3
Is enriched in BAG; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; D-glucose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00008823	F14H3.4
Is enriched in AB; germ line; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00008824	F14H3.5
Is enriched in cephalic sheath cell; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Lithium Chloride; Rotenone; and 4-bromodiphenyl ether based on microarray and RNA-seq studies.

WB:WBGene00008825	F14H3.6
Is enriched in several structures, including Psub2; germ line; hypodermis; neuronal sheath cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008826	fbxa-100
Is enriched in germ line; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including elt-2; npr-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride; resveratrol; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00008827	F14H3.8
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00008828	F14H3.9
Is affected by hpl-2 and rsr-2 based on tiling array studies. Is affected by cadmium based on microarray studies.

WB:WBGene00008829	cyp-35D1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00008830	nhr-176
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00008831	F14H3.12
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Rotenone; levamisole; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Kinase associated domain 1; Kinase associated domain 1 (KA1); and KA1 domain/Ssp2, C-terminal.

WB:WBGene00008832	obr-2
Is predicted to have sterol binding activity and sterol transporter activity. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 67. Is an ortholog of human OSBPL2 (oxysterol binding protein like 2).

WB:WBGene00008833	F14H8.2
Is enriched in NSM based on RNA-seq and tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including 1-methylnicotinamide; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008834	F14H8.4
Is enriched in NSM based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00008835	F14H8.5
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008836	F15A2.7
No description available

WB:WBGene00008837	sre-38
Is enriched in muscle cell based on microarray studies. Is affected by hpl-2 based on RNA-seq studies. Is affected by aldicarb and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00008838	F15A4.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00008839	sre-37
Is affected by several genes including clk-1; eat-2; and unc-70 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00008840	F15A4.5
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and prg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00008841	F15A4.6
Is expressed in pharyngeal gland cell. Is predicted to encode a protein with the following domains: ShK domain-like; CC domain; ShKT domain; and CC domain.

WB:WBGene00008842	chil-28
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008843	arrd-9
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; metformin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00008844	F15A4.10
Is enriched in NSM; germ line; pharyngeal muscle cell; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and clk-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including hydrogen sulfide; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00008847	fbxb-102
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; multi-walled carbon nanotube; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00008848	inft-2
Is expressed in excretory cell. Human ortholog(s) of this gene are implicated in autosomal dominant auditory neuropathy 1 and autosomal dominant nonsyndromic deafness 1. Is predicted to encode a protein with the following domains: Phosphorylation site; Formin Homology 2 Domain; Formin, FH2 domain; and Formin, FH2 domain superfamily.

WB:WBGene00008849	try-10
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00008850	F15B9.6
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including Heme; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008851	F15B9.8
Is enriched in several structures, including AFD; NSM; germline precursor cell; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00008852	ubql-1
Is predicted to have polyubiquitin modification-dependent protein binding activity. Is involved in protein export from nucleus; regulation of nucleobase-containing compound metabolic process; and ubiquitin-dependent ERAD pathway. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 15. Is an ortholog of human UBQLN1 (ubiquilin 1).

WB:WBGene00008853	clec-101
Is predicted to have carbohydrate binding activity.

WB:WBGene00008854	F15D3.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpin (serine protease inhibitor); Serpin family; Serpin domain; Serpin superfamily; Serpin superfamily, domain 1; and Serpin superfamily, domain 2.

WB:WBGene00008855	F15D3.5
Is enriched in intestine based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00008856	F15D3.6
Is predicted to have phosphatidic acid transfer activity. Is an ortholog of human PRELID3A (PRELI domain containing 3A) and PRELID3B (PRELI domain containing 3B).

WB:WBGene00008857	timm-23
Is predicted to have mitochondrion targeting sequence binding activity and protein transmembrane transporter activity. Is involved in protein import into mitochondrial matrix. Is an ortholog of human TIMM23 (translocase of inner mitochondrial membrane 23).

WB:WBGene00008858	pals-1
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including tryptophan; Tunicamycin; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00008859	F15D4.2
Is enriched in germ line; germline precursor cell; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caspase activity and apoptosis inhibitor 1 and Caspase activity and apoptosis inhibitor 1. Is an ortholog of human CAAP1 (caspase activity and apoptosis inhibitor 1).

WB:WBGene00008860	romo-1
Is enriched in Psub1; germ line; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Reactive mitochondrial oxygen species modulator 1 and Romo1/Mgr2. Is an ortholog of human ROMO1 (reactive oxygen species modulator 1).

WB:WBGene00008861	F15D4.4
Is predicted to have cysteine-type peptidase activity. Is expressed in pharyngeal gland cell.

WB:WBGene00008862	F15D4.5
Is expressed in g1AL; g1AR; g2L; and g2R.

WB:WBGene00008863	F15D4.6
Is enriched in several structures, including DA neuron; coelomocyte; germ line; germline precursor cell; and interneuron based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008864	F15D4.7
No description available

WB:WBGene00008865	F15G9.1
Localizes to striated muscle dense body and striated muscle thin filament. Is expressed in hypodermis and muscle cell.

WB:WBGene00008866	F15G9.2
Is enriched in intestine based on microarray studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; resveratrol; and Atrazine based on microarray studies.

WB:WBGene00008868	F15G9.5
Is enriched in head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008869	F15G9.6
Is enriched in PLM and germ line based on RNA-seq studies. Is affected by several genes including aak-2; hpl-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008870	F15H9.1
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00008871	tag-314
Is predicted to have metal ion binding activity and ubiquitin-protein transferase activity.

WB:WBGene00008872	F15H10.5
Is affected by several genes including mir-34; smn-1; and emb-4 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride; Mercuric Chloride; and nanoparticle based on microarray studies.

WB:WBGene00008873	F15H10.6
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including skn-1; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00008874	F15H10.7
Is predicted to have catalytic activity.

WB:WBGene00008875	F15H10.8
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including methylmercury hydroxide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008876	F16A11.1
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human RSPRY1 (ring finger and SPRY domain containing 1).

WB:WBGene00008877	rtcb-1
Exhibits RNA ligase (ATP) activity. Is involved in several processes, including IRE1-mediated unfolded protein response; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate; and vulval development. Localizes to cytoplasm and nucleus. Is an ortholog of human RTCB (RNA 2',3'-cyclic phosphate and 5'-OH ligase).

WB:WBGene00008878	ppfr-1
Exhibits protein domain specific binding activity. Is predicted to contribute to protein serine/threonine phosphatase activity. Is involved in several processes, including establishment of mitotic spindle orientation; polar body extrusion after meiotic divisions; and regulation of spindle elongation. Localizes to cytoplasm. Is expressed in several structures, including intestine; neurons; pharynx; ventral nerve cord; and vulval muscle. Is an ortholog of human PPP4R1 (protein phosphatase 4 regulatory subunit 1).

WB:WBGene00008879	F16B12.1
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including let-60; daf-12; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB domain; CUB domain; and Spermadhesin, CUB domain superfamily.

WB:WBGene00008880	F16B12.4
Is enriched in several structures, including AFD; Z4.a; coelomocyte; intestine; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008881	F16B12.5
Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008882	F16B12.6
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-12; dpy-10; and eat-2 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by six chemicals including Cry5B; Diazinon; and Quercetin based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008883	F16B12.7
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00008884	nhr-281
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00008885	F16C3.1
Is predicted to have G protein-coupled receptor activity and neuropeptide binding activity. Is expressed in AIYL and AIYR.

WB:WBGene00008886	F16C3.2
Is enriched in ASER and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and indole based on RNA-seq and microarray studies.

WB:WBGene00008887	tbcd-1
Is predicted to have GTPase activator activity and beta-tubulin binding activity. Is involved in microtubule cytoskeleton organization. Is an ortholog of human TBCD (tubulin folding cofactor D).

WB:WBGene00008888	F16D3.5
No description available

WB:WBGene00008889	F16D3.6
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1182) and Protein of unknown function DUF1182.

WB:WBGene00008890	ser-5
Is predicted to have alpha1-adrenergic receptor activity. Is involved in positive regulation of oviposition. Is expressed in body wall musculature; egg-laying apparatus; and lateral ganglion. Human ortholog(s) of this gene are implicated in asthma; familial adult myoclonic epilepsy 2; and obesity. Is an ortholog of human ADRA1A (adrenoceptor alpha 1A); ADRA1B (adrenoceptor alpha 1B); and ADRA1D (adrenoceptor alpha 1D).

WB:WBGene00008891	clec-42
Is predicted to have carbohydrate binding activity. Is expressed in neurons.

WB:WBGene00008892	clec-246
Is predicted to have carbohydrate binding activity.

WB:WBGene00008893	F16H6.3
Is affected by several genes including sir-2.1; eri-1; and mdt-15 based on microarray studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00008894	F16H6.4
Is enriched in ASER; PLM; and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I) and PGPEP1L (pyroglutamyl-peptidase I like).

WB:WBGene00008897	F16H6.7
Is enriched in ASER and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; and Peptidase C15, pyroglutamyl peptidase I-like. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I) and PGPEP1L (pyroglutamyl-peptidase I like).

WB:WBGene00008898	F16H6.8
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008899	F16H6.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008900	F16H6.10
Is involved in innate immune response.

WB:WBGene00008901	nhr-27
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 45. Is an ortholog of human CIC (capicua transcriptional repressor).

WB:WBGene00008902	phf-32
Is predicted to have metal ion binding activity and transcription corepressor activity.

WB:WBGene00008903	F17A2.4
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00008904	F17A2.13
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008905	F17B5.1
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including Ethanol; Tunicamycin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL1 (nucleoredoxin like 1).

WB:WBGene00008906	oac-17
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00008907	clec-109
Is predicted to have carbohydrate binding activity.

WB:WBGene00008908	F17B5.4
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00008909	clec-110
Is predicted to have carbohydrate binding activity.

WB:WBGene00008910	F17C8.3
Is enriched in body wall muscle cell; germ line; and muscle cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00008911	F17C8.6
Is predicted to have cation channel activity.

WB:WBGene00008912	F17C8.7
Is enriched in germ line; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Heme; D-glucose; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00008914	F17C11.2
Is expressed in AIYL and AIYR.

WB:WBGene00008915	F17C11.4
Is enriched in AFD; ASER; OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including D-glucose; tert-Butylhydroperoxide; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008916	clec-221
Is predicted to have carbohydrate binding activity.

WB:WBGene00008917	F17C11.6
Is enriched in intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Mercuric Chloride; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00008918	pigt-1
Is predicted to contribute to GPI-anchor transamidase activity. Human ortholog(s) of this gene are implicated in multiple congenital anomalies-hypotonia-seizures syndrome 3 and paroxysmal nocturnal hemoglobinuria. Is an ortholog of human PIGT (phosphatidylinositol glycan anchor biosynthesis class T).

WB:WBGene00008919	vps-36
Is predicted to have ubiquitin binding activity. Is expressed in pharyngeal muscle cell. Is an ortholog of human VPS36 (vacuolar protein sorting 36 homolog).

WB:WBGene00008920	eef-1G
Is predicted to have translation elongation factor activity. Is an ortholog of human EEF1G (eukaryotic translation elongation factor 1 gamma).

WB:WBGene00008921	ctf-4
Is predicted to have chromatin binding activity. Is an ortholog of human WDHD1 (WD repeat and HMG-box DNA binding protein 1).

WB:WBGene00008922	F17C11.11
Is enriched in AFD; NSM; body wall musculature; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Tunicamycin; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00008923	F17C11.12
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14) and SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00008924	F17E5.2
Is predicted to have ATP transmembrane transporter activity. Is an ortholog of human SLC25A23 (solute carrier family 25 member 23) and SLC25A25 (solute carrier family 25 member 25).

WB:WBGene00008925	F17H10.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome. Is predicted to encode a protein with the following domain: Alpha/Beta hydrolase fold. Is an ortholog of human SERAC1 (serine active site containing 1).

WB:WBGene00008926	F17H10.2
Is enriched in dopaminergic neurons; germline precursor cell; and hypodermis based on tiling array studies. Is affected by several genes including rrf-3; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008927	snx-17
Is predicted to have phosphatidylinositol binding activity. Is an ortholog of human SNX31 (sorting nexin 31).

WB:WBGene00008928	F17H10.4
Is enriched in body wall muscle cell based on tiling array studies. Is affected by clk-1; rsr-2; and daf-2 based on microarray and tiling array studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00008929	F18A11.2
Is enriched in head mesodermal cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Ethanol; Mianserin; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00008930	F18A11.3
Is enriched in ASER; AVE; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; sir-2.1; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including hydrogen sulfide; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterised protein family UPF0729. Is an ortholog of human C18orf32 (chromosome 18 open reading frame 32).

WB:WBGene00008932	F18A11.5
Is enriched in several structures, including NSM; germ line; head mesodermal cell; mechanosensory neurons; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00008933	F18A11.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00008934	F18C12.3
Is enriched in coelomocyte; germ line; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and let-60 based on microarray; proteomic; and RNA-seq studies. Is affected by D-glucose and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; BUD22; Bud22 domain; and Bud22/Serum response factor-binding protein 1. Is an ortholog of human SRFBP1 (serum response factor binding protein 1).

WB:WBGene00008935	F18C12.4
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008936	papl-1
Is predicted to have acid phosphatase activity and metal ion binding activity. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00008937	srt-43
Is enriched in NSM based on tiling array studies. Is affected by several genes including rrf-3; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00008939	F18H3.1
Is expressed in head neurons; pharyngeal neurons; and sensory neurons. Is predicted to encode a protein with the following domains: SPRY domain; SPRY domain; Concanavalin A-like lectin/glucanase domain superfamily; SPRY domain-containing protein 7; and B30.2/SPRY domain superfamily. Is an ortholog of human SPRYD7 (SPRY domain containing 7).

WB:WBGene00008940	F18H3.4
Is involved in IRE1-mediated unfolded protein response and innate immune response.

WB:WBGene00008941	srz-33
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00008942	srz-34
Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies.

WB:WBGene00008943	srz-36
Is affected by several genes including lin-15B; hpl-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by Rifampin; dibromoacetic acid; and nitroguanidine based on RNA-seq and microarray studies.

WB:WBGene00008944	F19B2.5
Is predicted to have ATP binding activity.

WB:WBGene00008945	F19B2.6
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and dcr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including 1-methylnicotinamide; stavudine; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00008946	F19B2.7
Is predicted to have ATP binding activity; ATP-dependent peptidase activity; and serine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in CODAS syndrome.

WB:WBGene00008947	srz-16
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00008948	F19B6.1
Is predicted to have kinase activity. Is involved in embryo development. Is an ortholog of human UCKL1 (uridine-cytidine kinase 1 like 1).

WB:WBGene00008949	F19B6.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Psoralens; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00008950	wht-5
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in positive regulation of nematode male tail tip morphogenesis. Is an ortholog of human ABCG1 (ATP binding cassette subfamily G member 1).

WB:WBGene00008951	F19C6.2
Is enriched in amphid sheath cell; germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Cry5B; Diazinon; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SGT1 protein and Ecd family. Is an ortholog of human ECD (ecdysoneless cell cycle regulator).

WB:WBGene00008952	F19C6.3
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is an ortholog of human NELL1 (neural EGFL like 1).

WB:WBGene00008953	F19C6.4
Is enriched in several structures, including GABAergic neurons; cephalic sheath cell; coelomocyte; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including D-glucose; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00008954	F19C6.5
Is enriched in intestine and pharyngeal muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; 4-bromodiphenyl ether; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cation efflux transmembrane domain superfamily.

WB:WBGene00008955	F19D8.2
Is enriched in Z1.p; Z4.a; male distal tip cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00008956	nekl-3
Is predicted to have ATP binding activity; metal ion binding activity; and protein serine/threonine kinase activity. Is involved in gonad development; growth; and molting cycle. Localizes to apical plasma membrane. Is expressed in hyp7 syncytium; hypodermal cell; neurons; and vulva. Is an ortholog of human NEK7 (NIMA related kinase 7).

WB:WBGene00008957	glb-13
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head; somatic nervous system; and tail neurons. Is an ortholog of human NGB (neuroglobin).

WB:WBGene00008958	F19H6.3
Is affected by several genes including daf-2; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercuric chloride; Psoralens; and glycine based on microarray and RNA-seq studies. Is an ortholog of human RIF1 (replication timing regulatory factor 1).

WB:WBGene00008959	F19H6.4
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Is an ortholog of human SRD5A1 (steroid 5 alpha-reductase 1).

WB:WBGene00008960	F19H6.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00008961	F19H6.6
Is enriched in AFD; ASER; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Zidovudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008963	F19H8.2
Is enriched in OLL; PLM; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including tryptophan; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00008964	mltn-9
Is enriched in OLL; PVD; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; Rotenone; and juglone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00008965	mltn-10
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including D-glucose; Zidovudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00008966	F20B10.2
Is affected by several genes including daf-16; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00008967	F20B10.3
Is enriched in DA neuron; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00008968	elli-1
Is involved in P granule assembly and embryo development. Localizes to cytoplasm.

WB:WBGene00008969	cdc-50.B
Is involved in innate immune response. Is an ortholog of human TMEM30A (transmembrane protein 30A) and TMEM30B (transmembrane protein 30B).

WB:WBGene00008970	F20C5.5
Is enriched in Z1; Z4; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00008971	F20C5.6
Is enriched in coelomocyte; intestine; neurons; somatic gonad precursor; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including 1-methylnicotinamide; Rotenone; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00008972	F20C5.7
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00008973	F20D1.1
Is expressed in several structures, including anterior gonad arm. Is predicted to encode a protein with the following domains: Uncharacterized conserved protein CG6151-P and TVP18/Calcium channel flower. Is an ortholog of human CACFD1 (calcium channel flower domain containing 1).

WB:WBGene00008974	tbc-1
Is expressed in anterior gonad arm. Is predicted to encode a protein with the following domains: Rab-GTPase-TBC domain; Rab-GTPase-TBC domain; Rhodanese-like domain; Rab-GTPase-TBC domain superfamily; Rhodanese-like domain superfamily; and TBC1 domain family member 23. Is an ortholog of human TBC1D23 (TBC1 domain family member 23).

WB:WBGene00008975	F20D1.3
Is expressed in anterior gonad arm. Is predicted to encode a protein with the following domain: Kelch-type beta propeller.

WB:WBGene00008976	plp-2
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II regulatory region sequence-specific DNA binding activity; and purine-rich negative regulatory element binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 31. Is an ortholog of human PURA (purine rich element binding protein A); PURB (purine rich element binding protein B); and PURG (purine rich element binding protein G).

WB:WBGene00008977	iglr-1
Is expressed in head neurons and ventral nerve cord. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1F and familial temporal lobe epilepsy 1. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily.

WB:WBGene00008978	cutl-3
Is enriched in Psub1 based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00008979	slc-25A18.1
Is predicted to have L-aspartate transmembrane transporter activity and L-glutamate transmembrane transporter activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 3. Is an ortholog of human SLC25A22 (solute carrier family 25 member 22).

WB:WBGene00008980	emre-1
Is involved in mitochondrial calcium ion homeostasis and mitochondrial calcium ion transmembrane transport. Localizes to mitochondrion. Is an ortholog of human SMDT1 (single-pass membrane protein with aspartate rich tail 1).

WB:WBGene00008981	srz-48
Is enriched in NSM based on tiling array studies. Is affected by eat-2 based on microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00008982	srsx-2
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00008983	F20E11.5
Is enriched in NSM based on tiling array studies. Is affected by cyc-1; rsr-2; and drh-3 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00008984	F20E11.7
Is affected by several genes including daf-12; eri-1; and rrf-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00008985	F20G2.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Heme; tryptophan; and Rotenone based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR1 (carbonyl reductase 1) and CBR3 (carbonyl reductase 3).

WB:WBGene00008986	F20G2.2
Is enriched in ASER; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and D-glucopyranose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR1 (carbonyl reductase 1) and CBR3 (carbonyl reductase 3).

WB:WBGene00008987	F20G2.3
Is enriched in several structures, including ASER; germ line; germline precursor cell; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: GOLD domain superfamily and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00008988	F20G2.5
Is involved in defense response to Gram-negative bacterium and innate immune response.

WB:WBGene00008989	F20G2.6
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including pgl-1; alg-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Tunicamycin and Triclosan based on microarray studies.

WB:WBGene00008990	smgl-1
Is involved in nuclear-transcribed mRNA catabolic process. Is an ortholog of human NBAS (NBAS subunit of NRZ tethering complex).

WB:WBGene00008991	F20G4.2
Is enriched in several structures, including Z1.p; Z4.a; germ line; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including gld-1; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00008992	F21A3.2
Is enriched in AVG; RIM; carbon dioxide sensory neurons; command interneuron; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by four chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00008993	F21A3.3
Is enriched in AFD; Z1; Z4; hypodermis; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like; Domain of unknown function (DUF1794); ShKT domain; Calycin; and Domain of unknown function DUF1794. Is an ortholog of human THAP4 (THAP domain containing 4).

WB:WBGene00008994	F21A3.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00008995	prde-1
Is predicted to have protein serine/threonine kinase activity. Is involved in piRNA biosynthetic process. Localizes to autosome. Is expressed in PLML; PLMR; and germ cell.

WB:WBGene00008996	glb-14
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in VC neuron; head neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in hemolytic anemia (multiple); primary polycythemia (multiple); and sickle cell anemia. Is an ortholog of human CYGB (cytoglobin).

WB:WBGene00008997	lgc-31
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00008998	ncs-4
Is predicted to have calcium ion binding activity. Is expressed in body wall musculature; diagonal muscle; head neurons; tail neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14 and retinitis pigmentosa 48. Is an ortholog of human KCNIP2 (potassium voltage-gated channel interacting protein 2) and KCNIP3 (potassium voltage-gated channel interacting protein 3).

WB:WBGene00008999	myrf-2
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is an ortholog of human MYRF (myelin regulatory factor).

WB:WBGene00009000	arrd-28
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: Arrestin C-terminal-like domain.

WB:WBGene00009001	tyr-3
Is predicted to have copper ion binding activity and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen. Is expressed in head mesodermal cell. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type III. Is an ortholog of human TYR (tyrosinase) and TYRP1 (tyrosinase related protein 1).

WB:WBGene00009002	hint-1
Is enriched in body wall muscle cell; germ line; intestine; and mechanosensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Gamstorp-Wohlfart syndrome. Is predicted to encode a protein with the following domains: HIT domain; Histidine triad (HIT) protein; and HIT-like superfamily. Is an ortholog of human HINT1 (histidine triad nucleotide binding protein 1).

WB:WBGene00009004	pfd-6
Is predicted to have chaperone binding activity. Localizes to cytoplasm. Is expressed in body wall musculature; hypodermal cell; intestinal cell; and non-striated muscle. Is an ortholog of human PFDN6 (prefoldin subunit 6).

WB:WBGene00009005	F21C3.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; antimycin; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00009006	F21D5.1
Is predicted to have phosphoacetylglucosamine mutase activity. Is an ortholog of human PGM3 (phosphoglucomutase 3).

WB:WBGene00009007	otub-3
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human OTUD6A (OTU deubiquitinase 6A) and OTUD6B (OTU deubiquitinase 6B).

WB:WBGene00009008	F21D5.3
Is predicted to have ferroxidase activity.

WB:WBGene00009009	F21D5.4
Is predicted to have DNA binding activity.

WB:WBGene00009010	F21D5.5
Exhibits double-stranded DNA binding activity. Human ortholog(s) of this gene are implicated in microcephaly, seizures, and developmental delay. Is an ortholog of human PNKP (polynucleotide kinase 3'-phosphatase).

WB:WBGene00009011	F21D5.6
Is predicted to have RNA-DNA hybrid ribonuclease activity. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome. Is an ortholog of human RNASEH2B (ribonuclease H2 subunit B).

WB:WBGene00009012	F21D5.7
Is predicted to contribute to GTPase activity. Human ortholog(s) of this gene are implicated in Shwachman-Diamond syndrome. Is an ortholog of human SRP54 (signal recognition particle 54).

WB:WBGene00009013	mrps-33
Is enriched in body wall muscle cell; germ line; hypodermis; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including hydrogen sulfide; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Mitochondrial ribosomal subunit S27 and Ribosomal protein S27/S33, mitochondrial. Is an ortholog of human MRPS33 (mitochondrial ribosomal protein S33).

WB:WBGene00009014	F21D5.9
Is expressed in epithelial cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00009015	F21D9.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00009016	F21D9.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00009017	F21D9.3
Is enriched in body wall muscle cell and coelomocyte based on tiling array studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on tiling array and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00009018	F21D9.4
Is enriched in ALM; PLM; body wall muscle cell; and muscle cell based on tiling array and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Acetyltransferase (GNAT) domain; Acyl-CoA N-acyltransferase; and YitH, acetyltransferase (GNAT) domain.

WB:WBGene00009019	F21D9.5
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00009020	F21D9.6
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009021	F21D9.8
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009023	F21G4.1
Is predicted to have sodium-independent organic anion transmembrane transporter activity. Is expressed in socket cell. Is an ortholog of human SLCO2A1 (solute carrier organic anion transporter family member 2A1).

WB:WBGene00009024	F21G4.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; glycine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009025	phf-34
Is predicted to have metal ion binding activity.

WB:WBGene00009026	F21G4.5
Is enriched in Z1; Z4; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; let-60; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009027	F21G4.6
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including sek-1; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; stavudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Huntington's disease. Is predicted to encode a protein with the following domain: Huntingtin family. Is an ortholog of human HTT (huntingtin).

WB:WBGene00009028	F21H7.2
Is enriched in coelomocyte; germ line; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00009029	F21H7.3
Is expressed in body wall musculature. Is predicted to encode a protein with the following domain: .

WB:WBGene00009030	clec-233
Is predicted to have carbohydrate binding activity.

WB:WBGene00009031	F21H7.5
Is enriched in amphid sheath cell; germ line; hypodermis; muscle cell; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and let-7 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twenty-two chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00009032	bgnt-1.3
Is predicted to have transferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00009033	F21H7.12
Is enriched in dopaminergic neurons; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; stavudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009034	F22B3.3
No description available

WB:WBGene00009035	gfat-2
Is predicted to have glutamine-fructose-6-phosphate transaminase (isomerizing) activity. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 12 and congenital myasthenic syndrome 4C. Is an ortholog of human GFPT1 (glutamine--fructose-6-phosphate transaminase 1) and GFPT2 (glutamine-fructose-6-phosphate transaminase 2).

WB:WBGene00009036	F22B3.5
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009037	F22B3.6
No description available

WB:WBGene00009038	F22B3.7
Is affected by several genes including rrf-3; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; D-glucose; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00009039	F22B3.8
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00009041	cut-3
Is enriched in DA neuron; VA neuron; germline precursor cell; hypodermis; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-three chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00009042	F22B5.4
Is enriched in neurons; ventral nerve cord; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Heme; aldicarb; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00009043	F22B5.5
Is enriched in FLP; germ line; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248) and Domain of unknown function DUF1248.

WB:WBGene00009044	F22B5.6
Is enriched in FLP based on microarray studies. Is affected by several genes including eat-2; dcr-1; and aak-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009045	F22B5.10
Is predicted to have calcium channel activity. Is involved in calcium ion transmembrane transport and endoplasmic reticulum calcium ion homeostasis. Localizes to striated muscle dense body. Is an ortholog of human TMCO1 (transmembrane and coiled-coil domains 1).

WB:WBGene00009046	F22B8.3
Is affected by several genes including let-60; cyc-1; and ifg-1 based on microarray and tiling array studies. Is affected by Microcystin-LR and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00009047	F22B8.4
Is affected by several genes including daf-16; daf-12; and pmk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009048	cth-1
Is predicted to have cystathionine gamma-lyase activity and pyridoxal phosphate binding activity. Human ortholog(s) of this gene are implicated in cystathioninuria. Is an ortholog of human CTH (cystathionine gamma-lyase).

WB:WBGene00009049	F22B8.7
Is predicted to have catalytic activity; molybdenum ion binding activity; and pyridoxal phosphate binding activity. Is involved in regulation of protein deneddylation. Localizes to cytoplasm and nucleus. Is an ortholog of human MTARC1 (mitochondrial amidoxime reducing component 1) and MTARC2 (mitochondrial amidoxime reducing component 2).

WB:WBGene00009050	F22D6.2
Is predicted to have DNA binding activity and zinc ion binding activity. Localizes to nucleus. Is an ortholog of human ZFAND5 (zinc finger AN1-type containing 5) and ZFAND6 (zinc finger AN1-type containing 6).

WB:WBGene00009051	nduf-6
Is involved in mitochondrial electron transport, NADH to ubiquinone and response to drug. Localizes to mitochondrion. Is an ortholog of human NDUFS6 (NADH:ubiquinone oxidoreductase subunit S6).

WB:WBGene00009052	ekl-1
Is involved in P granule assembly and production of small RNA involved in gene silencing by RNA. Localizes to condensed nuclear chromosome; cytoplasm; and metaphase plate.

WB:WBGene00009054	F22D6.9
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00009055	F22D6.14
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including fog-2; aak-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by stavudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00009056	F22D6.15
Is enriched in AFD; PLM; and amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; aak-2; and alg-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Immunoglobulin-like fold.

WB:WBGene00009057	cept-1
Is predicted to have diacylglycerol cholinephosphotransferase activity and ethanolaminephosphotransferase activity. Is an ortholog of human CEPT1 (choline/ethanolamine phosphotransferase 1).

WB:WBGene00009058	F22E12.1
Is predicted to have serine-type endopeptidase inhibitor activity. Is an ortholog of human TFPI (tissue factor pathway inhibitor).

WB:WBGene00009059	chw-1
Is predicted to have GTP binding activity; GTPase activity; and protein kinase binding activity. Is involved in establishment or maintenance of cell polarity and vulval development. Is expressed in several structures, including hyp7; hyp7; hyp7; hyp7; and hyp7. Is an ortholog of human RHOU (ras homolog family member U) and RHOV (ras homolog family member V).

WB:WBGene00009060	F22E12.3
Is enriched in intestine and pharynx based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009061	pals-14
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Nitric Oxide; Ethanol; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009062	F22G12.2
No description available

WB:WBGene00009063	F22G12.3
Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00009064	F22G12.4
Is predicted to have 1-phosphatidylinositol binding activity. Is an ortholog of human ANKFY1 (ankyrin repeat and FYVE domain containing 1).

WB:WBGene00009065	F22G12.5
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in spermatheca and uterine toroidal epithelial cell. Is an ortholog of human DOCK10 (dedicator of cytokinesis 10); DOCK11 (dedicator of cytokinesis 11); and DOCK9 (dedicator of cytokinesis 9).

WB:WBGene00009067	F23A7.1
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00009068	F23A7.3
Is enriched in coelomocyte; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00009069	F23A7.4
Is enriched in germline precursor cell; intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Ethanol; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009070	F23A7.5
Is enriched in head mesodermal cell and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00009071	F23A7.6
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00009072	F23A7.7
No description available

WB:WBGene00009073	delm-1
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human ASIC2 (acid sensing ion channel subunit 2).

WB:WBGene00009075	F23B2.7
Is expressed in gonad.

WB:WBGene00009076	F23B2.8
Is enriched in AVK based on RNA-seq studies. Is affected by rsr-2 based on tiling array studies.

WB:WBGene00009077	F23B2.10
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain and Zinc finger, RING-type.

WB:WBGene00009078	rpb-12
Is predicted to have DNA binding activity; DNA-directed 5'-3' RNA polymerase activity; and zinc ion binding activity. Is an ortholog of human POLR2K (RNA polymerase II, I and III subunit K).

WB:WBGene00009079	F23B12.1
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00009081	F23B12.4
Is enriched in PLM; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Lithium Chloride; hydrogen sulfide; and methylmercury hydroxide based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: Reeler domain and Reeler domain.

WB:WBGene00009082	dlat-1
Is predicted to have dihydrolipoyllysine-residue acetyltransferase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human DLAT (dihydrolipoamide S-acetyltransferase).

WB:WBGene00009084	F23B12.7
Is enriched in body wall muscle cell; germ line; intestine; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by six chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CBF/Mak21 family; CCAAT-binding factor; Armadillo-type fold; and CEBPZ/Mak21-like. Is an ortholog of human CEBPZ (CCAAT enhancer binding protein zeta).

WB:WBGene00009085	F23D12.1
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009086	F23D12.2
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009087	F23D12.3
Is enriched in AFD; ASER; PLM; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and sma-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5354) and Protein of unknown function DUF5354.

WB:WBGene00009088	F23D12.4
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Alovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009089	jmjd-3.2
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; chromatin DNA binding activity; and histone demethylase activity (H3-K27 specific). Human ortholog(s) of this gene are implicated in Kabuki syndrome. Is an ortholog of human KDM6A (lysine demethylase 6A); KDM6B (lysine demethylase 6B); and UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked).

WB:WBGene00009090	fipr-3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; manganese chloride; and D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00009091	F23D12.7
Is enriched in OLL; PVD; body wall muscle cell; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009092	tomm-20
Is predicted to have mitochondrion targeting sequence binding activity. Is an ortholog of human TOMM20 (translocase of outer mitochondrial membrane 20).

WB:WBGene00009093	F23H12.3
Is enriched in BAG; NSM; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009094	F23H12.5
Is predicted to have chemorepellent activity and semaphorin receptor binding activity. Human ortholog(s) of this gene are implicated in CHARGE syndrome; hypogonadotropic hypogonadism (multiple); and retinal degeneration (multiple).

WB:WBGene00009095	F23H12.7
Is enriched in AVE; neurons; and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including isp-1; mex-3; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00009096	fipr-1
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including nicotinic acid; Rotenone; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00009097	fipr-2
Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; nicotinic acid; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00009098	ehbp-1
Exhibits Rab GTPase binding activity. Is involved in endocytic recycling; protein secretion; and receptor recycling. Localizes to early endosome membrane and recycling endosome membrane. Is expressed in several structures, including body wall musculature; hermaphrodite gonad; intestine; nerve ring; and pharynx. Human ortholog(s) of this gene are implicated in prostate cancer. Is an ortholog of human EHBP1 (EH domain binding protein 1).

WB:WBGene00009099	F25B3.2
Is affected by several genes including daf-16; daf-12; and lin-4 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00009100	rgef-1
Exhibits Rap guanyl-nucleotide exchange factor activity. Is involved in chemotaxis and positive regulation of Ras protein signal transduction. Localizes to cytoplasm and intracellular membrane-bounded organelle. Is expressed in nervous system and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 4; familial adult myoclonic epilepsy 7; and platelet-type bleeding disorder 18. Is an ortholog of human RASGRP3 (RAS guanyl releasing protein 3).

WB:WBGene00009101	F25B3.4
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00009102	F25B3.5
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; 4-bromodiphenyl ether; and levamisole based on microarray and RNA-seq studies.

WB:WBGene00009103	rtfo-1
Is predicted to have RNA polymerase II C-terminal domain phosphoserine binding activity. Localizes to nucleus. Is an ortholog of human RTF1 (RTF1 homolog, Paf1/RNA polymerase II complex component).

WB:WBGene00009104	F25C8.1
Is affected by several genes including rrf-3; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Tunicamycin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00009106	acs-12
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability.

WB:WBGene00009107	txt-10
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol; Atrazine; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domain: MFS transporter superfamily.

WB:WBGene00009108	F25D1.3
Is predicted to have cytokine activity. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis. Is an ortholog of human IL17C (interleukin 17C).

WB:WBGene00009109	degt-1
Is predicted to have sodium channel activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00009110	F25D1.5
Is predicted to have nucleotide binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00009112	tag-353
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human HERPUD1 (homocysteine inducible ER protein with ubiquitin like domain 1) and HERPUD2 (HERPUD family member 2).

WB:WBGene00009113	maph-1.2
Is predicted to have microtubule binding activity. Is an ortholog of human MAP1S (microtubule associated protein 1S).

WB:WBGene00009114	F25D7.5
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Alagille syndrome and tetralogy of Fallot. Is predicted to encode a protein with the following domains: Mitochondrial glycoprotein and C-type lectin fold.

WB:WBGene00009115	F25F2.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00009116	snx-27
Is predicted to have phosphatidylinositol binding activity. Is an ortholog of human SNX27 (sorting nexin 27).

WB:WBGene00009117	F25H2.3
Is affected by several genes including daf-12; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ankyrin repeat-containing domain superfamily.

WB:WBGene00009118	F25H2.4
Localizes to striated muscle dense body. Is an ortholog of human EMC8 (ER membrane protein complex subunit 8) and EMC9 (ER membrane protein complex subunit 9).

WB:WBGene00009119	ndk-1
Exhibits identical protein binding activity. Is involved in several processes, including positive regulation of MAPK cascade; positive regulation of vulval development; and regulation of engulfment of apoptotic cell. Is expressed in head. Human ortholog(s) of this gene are implicated in primary ciliary dyskinesia 6. Is an ortholog of human NME1 (NME/NM23 nucleoside diphosphate kinase 1).

WB:WBGene00009120	F25H2.6
Is predicted to have ceramide 1-phosphate binding activity; ceramide 1-phosphate transfer activity; and phosphatidylinositol-4-phosphate binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 34. Is an ortholog of human CERT1 (ceramide transporter 1).

WB:WBGene00009121	F25H2.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273 and Protein of unknown function DUF273.

WB:WBGene00009122	tct-1
Is predicted to have calcium ion binding activity. Localizes to endoplasmic reticulum. Is an ortholog of human TPT1 (tumor protein, translationally-controlled 1).

WB:WBGene00009123	F25H2.12
Localizes to striated muscle dense body. Is an ortholog of human RRNAD1 (ribosomal RNA adenine dimethylase domain containing 1).

WB:WBGene00009124	rtel-1
Is predicted to have ATP binding activity; DNA helicase activity; and DNA polymerase binding activity. Is involved in regulation of double-strand break repair via homologous recombination. Human ortholog(s) of this gene are implicated in autosomal recessive dyskeratosis congenita 5. Is an ortholog of human RTEL1 (regulator of telomere elongation helicase 1).

WB:WBGene00009125	F25H5.2
Is enriched in amphid sheath cell; germ line; head mesodermal cell; interneuron; and in male based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00009126	pyk-1
Is predicted to have pyruvate kinase activity. Human ortholog(s) of this gene are implicated in pyruvate kinase deficiency of red cells. Is an ortholog of human PKLR (pyruvate kinase L/R) and PKM (pyruvate kinase M1/2).

WB:WBGene00009127	clsp-1
Is predicted to have anaphase-promoting complex binding activity. Localizes to nucleus. Is an ortholog of human CLSPN (claspin).

WB:WBGene00009128	mrpl-54
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL54 (mitochondrial ribosomal protein L54).

WB:WBGene00009129	F25H5.7
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00009130	F25H5.8
Is enriched in GABAergic neurons; amphid sheath cell; excretory cell; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00009131	F25H8.1
Is predicted to have tRNA (guanine-N1-)-methyltransferase activity and tRNA binding activity. Is an ortholog of human TRMT10A (tRNA methyltransferase 10A).

WB:WBGene00009132	F25H8.2
Is predicted to have RNA binding activity. Localizes to nucleus. Is an ortholog of human NAF1 (nuclear assembly factor 1 ribonucleoprotein).

WB:WBGene00009133	bed-3
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in molting cycle; regulation of cell division; and vulval cell fate specification. Is expressed in M lineage cell; hypodermal cell; and vulval cell.

WB:WBGene00009134	lurp-2
Is affected by several genes including sir-2.1; hpl-2; and ain-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ly-6 antigen/uPA receptor-like.

WB:WBGene00009135	F25H9.2
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Zidovudine; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00009136	lurp-3
Is predicted to have kinase activity.

WB:WBGene00009137	bath-39
Is enriched in AVK; NSM; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; Mianserin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00009138	F25H9.6
Is predicted to have catalytic activity. Is an ortholog of human PPCDC (phosphopantothenoylcysteine decarboxylase).

WB:WBGene00009139	F25H9.7
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Complex1_LYR-like and Succinate dehydrogenase assembly factor 3, mitochondrial. Is an ortholog of human SDHAF3 (succinate dehydrogenase complex assembly factor 3).

WB:WBGene00009140	F26A3.1
Is enriched in several structures, including body wall musculature; coelomocyte; excretory cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipid-droplet associated hydrolase; Lipid droplet-associated hydrolase; and Alpha/Beta hydrolase fold. Is an ortholog of human LDAH (lipid droplet associated hydrolase).

WB:WBGene00009141	ncbp-2
Is predicted to have RNA cap binding activity. Localizes to nuclear envelope and nuclear periphery. Is expressed in germ cell. Is an ortholog of human NCBP2 (nuclear cap binding protein subunit 2).

WB:WBGene00009142	F26A3.4
Is predicted to have protein tyrosine/serine/threonine phosphatase activity. Localizes to striated muscle dense body. Is expressed in neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 19 with or without anosmia and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP14 (dual specificity phosphatase 14).

WB:WBGene00009143	F26A3.5
Is expressed in intestine.

WB:WBGene00009144	del-3
Is predicted to have sodium channel activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00009145	F26A3.7
Is expressed in spermatheca. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF3752) and Protein of unknown function DUF3752. Is an ortholog of human GPALPP1 (GPALPP motifs containing 1).

WB:WBGene00009146	F26C11.1
Is predicted to have acid phosphatase activity. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal) and ACP3 (acid phosphatase 3).

WB:WBGene00009147	F26C11.3
Is expressed in coelomocyte and intestine. Is predicted to encode a protein with the following domains: Sushi/SCR/CCP domain; Sushi/SCR/CCP superfamily; and Uncharacterized protein F26C11.3-like.

WB:WBGene00009148	F26D2.3
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00009149	F26D2.10
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ankyrin repeat; Domain of unknown function; BRCA1 C Terminus (BRCT) domain; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00009150	clec-234
Is predicted to have carbohydrate binding activity.

WB:WBGene00009151	F26D2.13
Is enriched in NSM based on tiling array studies. Is affected by several genes including let-60; clk-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Zidovudine; and cadmium based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009152	F26D2.14
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Tunicamycin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009153	F26D2.15
Is enriched in coelomocyte and germ line based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00009154	F26D2.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including sodium arsenite; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009155	lhfp-4
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including aldicarb; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 67. Is predicted to encode a protein with the following domains: Lipoma HMGIC fusion partner-like protein and Lipoma HMGIC fusion partner-like protein. Is an ortholog of human LHFPL4 (LHFPL tetraspan subfamily member 4).

WB:WBGene00009156	clec-196
Is predicted to have carbohydrate binding activity. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis. Is an ortholog of human KLRF2 (killer cell lectin like receptor F2).

WB:WBGene00009157	F26E4.2
Is enriched in excretory cell; germline precursor cell; hypodermis; and neurons based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including age-1; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; levamisole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009158	F26E4.3
Is predicted to have cysteine-type peptidase activity and extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human TINAGL1 (tubulointerstitial nephritis antigen like 1).

WB:WBGene00009159	F26E4.4
Is predicted to have DNA binding activity.

WB:WBGene00009160	F26E4.5
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00009161	cox-7C
Is predicted to have cytochrome-c oxidase activity. Is an ortholog of human COX7C (cytochrome c oxidase subunit 7C).

WB:WBGene00009162	F26E4.7
Is predicted to have cell adhesion molecule binding activity. Human ortholog(s) of this gene are implicated in corneal dystrophy (multiple). Is an ortholog of human POSTN (periostin).

WB:WBGene00009163	drsh-1
Exhibits ribonuclease III activity. Is involved in primary miRNA processing and sexual reproduction. Is an ortholog of human DROSHA (drosha ribonuclease III).

WB:WBGene00009164	hrdl-1
Is predicted to have ubiquitin protein ligase activity. Is involved in growth and regulation of neuron death. Is an ortholog of human AMFR (autocrine motility factor receptor).

WB:WBGene00009165	gpx-1
Exhibits phospholipid-hydroperoxide glutathione peroxidase activity. Is involved in oxidation-reduction process and regulation of peptide transport. Is an ortholog of human GPX4 (glutathione peroxidase 4).

WB:WBGene00009166	F26F2.1
Is involved in innate immune response.

WB:WBGene00009167	F26F2.2
Is affected by several genes including lin-35; lin-15B; and spn-4 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009168	F26F2.3
Is affected by several genes including skn-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including nanoparticle; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009169	F26F2.4
Is enriched in intestine and neurons based on tiling array studies. Is affected by several genes including skn-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009170	F26F2.5
Is enriched in ventral nerve cord based on tiling array studies. Is affected by several genes including skn-1; rrf-3; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Mercuric Chloride; and sesamin based on microarray and RNA-seq studies.

WB:WBGene00009171	clec-263
Is predicted to have carbohydrate binding activity.

WB:WBGene00009172	F26F2.7
Is enriched in NSM; germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Eukaryotic membrane protein family and Tapt1 family. Is an ortholog of human TAPT1 (transmembrane anterior posterior transformation 1).

WB:WBGene00009173	prom-1
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mianserin; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box only protein 47.

WB:WBGene00009174	F26H9.2
Is enriched in body wall musculature; germ line; neurons; somatic nervous system; and vulval muscle based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; RPEL repeat; and RPEL repeat. Is an ortholog of human PHACTR2 (phosphatase and actin regulator 2) and PHACTR4 (phosphatase and actin regulator 4).

WB:WBGene00009175	F26H9.3
No description available

WB:WBGene00009176	nmat-2
Is predicted to have nicotinamide-nucleotide adenylyltransferase activity and nicotinate-nucleotide adenylyltransferase activity. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 9. Is an ortholog of human NMNAT1 (nicotinamide nucleotide adenylyltransferase 1).

WB:WBGene00009177	F26H9.5
Is predicted to have O-phospho-L-serine:2-oxoglutarate aminotransferase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in Neu-Laxova syndrome 2 and PSAT deficiency. Is an ortholog of human PSAT1 (phosphoserine aminotransferase 1).

WB:WBGene00009178	uggt-2
Is predicted to have UDP-glucose:glycoprotein glucosyltransferase activity and unfolded protein binding activity. Is involved in IRE1-mediated unfolded protein response; regulation of embryonic development; and regulation of nematode larval development. Is an ortholog of human UGGT1 (UDP-glucose glycoprotein glucosyltransferase 1) and UGGT2 (UDP-glucose glycoprotein glucosyltransferase 2).

WB:WBGene00009179	kbp-3
Localizes to Ndc80 complex and condensed chromosome kinetochore.

WB:WBGene00009180	nurf-1
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity and methylated histone binding activity. Is involved in positive regulation of transcription by RNA polymerase II. Is expressed in several structures, including head; pharyngeal-intestinal valve; pharynx; tail; and vulva. Is an ortholog of human BPTF (bromodomain PHD finger transcription factor).

WB:WBGene00009182	F26H11.4
Is enriched in AVK; germ line; head mesodermal cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; Ethanol; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009183	F27C8.2
Is enriched in GABAergic neurons; body wall muscle cell; excretory cell; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; D-glucose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Acyl-CoA N-acyltransferase.

WB:WBGene00009184	F27C8.3
Is affected by several genes including clk-1; aak-2; and hsp-6 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00009185	F27C8.5
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00009186	trcs-1
Is predicted to have hydrolase activity. Is expressed in germ line. Is an ortholog of human AADACL3 (arylacetamide deacetylase like 3) and AADACL4 (arylacetamide deacetylase like 4).

WB:WBGene00009187	F27D4.1
Is predicted to have electron transfer activity and flavin adenine dinucleotide binding activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in multiple acyl-CoA dehydrogenase deficiency. Is an ortholog of human ETFA (electron transfer flavoprotein subunit alpha).

WB:WBGene00009188	lsy-22
Exhibits repressing transcription factor binding activity. Is expressed in several structures, including body wall musculature and pharyngeal muscle cell.

WB:WBGene00009189	F27D4.4
Is predicted to have metal ion binding activity. Is expressed in hypodermis and intestine. Is an ortholog of human ZC3H15 (zinc finger CCCH-type containing 15).

WB:WBGene00009190	F27D4.6
Is expressed in pharyngeal neurons. Is predicted to encode a protein with the following domain: .

WB:WBGene00009191	F27D4.7
Is enriched in AFD; BAG; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by Rotenone and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Got1/Sft2-like family; Vesicle transport protein, Got1/SFT2-like; and Vesicle transport protein SFT2. Is an ortholog of human SFT2D1 (SFT2 domain containing 1) and SFT2D2 (SFT2 domain containing 2).

WB:WBGene00009192	asah-2
Is predicted to have N-acylsphingosine amidohydrolase activity. Human ortholog(s) of this gene are implicated in Farber lipogranulomatosis and spinal muscular atrophy with progressive myoclonic epilepsy. Is an ortholog of human ASAH1 (N-acylsphingosine amidohydrolase 1).

WB:WBGene00009193	F27E5.3
Is enriched in NSM; arcade cell; germ line; pharyngeal-intestinal valve cell; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00009194	F27E5.5
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00009195	hpo-33
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and nhl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including tryptophan; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00009196	F28B1.2
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009197	F28B1.3
Is enriched in pharynx and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009200	F28C1.1
Is enriched in germ line; head mesodermal cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including age-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; bisphenol S; and Linolenic Acids based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Alternative splicing regulator; Suppressor of white apricot, N-terminal domain; and Suppressor of white apricot. Is an ortholog of human CLASRP (CLK4 associating serine/arginine rich protein).

WB:WBGene00009201	F28C1.3
Is enriched in body wall musculature; coelomocyte; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine Rich repeat; Leucine-rich repeat; and Leucine-rich repeat domain superfamily. Is an ortholog of human PPP1R37 (protein phosphatase 1 regulatory subunit 37).

WB:WBGene00009202	aptf-4
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II regulatory region sequence-specific DNA binding activity; and transcription coactivator activity. Is expressed in head neurons and ventral nerve cord. Human ortholog(s) of this gene are implicated in Char syndrome and branchiooculofacial syndrome. Is an ortholog of human TFAP2D (transcription factor AP-2 delta).

WB:WBGene00009203	aptf-3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II regulatory region sequence-specific DNA binding activity; and transcription coactivator activity. Is expressed in head neurons and intestine. Human ortholog(s) of this gene are implicated in Char syndrome and branchiooculofacial syndrome. Is an ortholog of several human genes including TFAP2A (transcription factor AP-2 alpha); TFAP2C (transcription factor AP-2 gamma); and TFAP2D (transcription factor AP-2 delta).

WB:WBGene00009204	pigg-1
Is predicted to have CP2 mannose-ethanolamine phosphotransferase activity. Is an ortholog of human PIGG (phosphatidylinositol glycan anchor biosynthesis class G).

WB:WBGene00009205	F28C6.5
Is enriched in germline precursor cell; hypodermis; muscle cell; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by six chemicals including Heme; glycine; and estrogen based on microarray and RNA-seq studies.

WB:WBGene00009206	B0513.t1
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00009207	F28C6.8
Is predicted to have phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity. Is an ortholog of human PTPMT1 (protein tyrosine phosphatase mitochondrial 1).

WB:WBGene00009208	F28C6.9
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; elt-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009209	F28C6.10
Is enriched in muscle cell; neurons; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mianserin; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00009210	F28C12.6
Is affected by rsr-2 based on tiling array studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00009211	wdr-46
Localizes to nucleolus. Is expressed in body wall musculature; germ line; head; hypodermis; and intestine. Is an ortholog of human WDR46 (WD repeat domain 46).

WB:WBGene00009212	atz-1
Is enriched in germ line; intestine; and pharyngeal muscle cell based on microarray; Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00009213	thn-1
Is involved in defense response to Gram-negative bacterium and innate immune response.

WB:WBGene00009214	thn-3
Is enriched in GABAergic neurons and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including fluoranthene; Quercetin; and copper sulfate based on microarray studies.

WB:WBGene00009215	thn-2
Is involved in defense response to Gram-negative bacterium and defense response to Gram-positive bacterium.

WB:WBGene00009216	F28D1.6
Is enriched in intestine and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009217	spe-45
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including aldicarb; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Immunoglobulin-like domain superfamily.

WB:WBGene00009218	acs-20
Is predicted to have long-chain fatty acid transporter activity and long-chain fatty acid-CoA ligase activity. Localizes to intracellular membrane-bounded organelle. Is expressed in anal depressor muscle; anal sphincter muscle; head; hyp7 syncytium; and seam cell. Is an ortholog of human SLC27A1 (solute carrier family 27 member 1).

WB:WBGene00009219	dpm-3
Is predicted to contribute to dolichyl-phosphate beta-D-mannosyltransferase activity. Is an ortholog of human DPM3 (dolichyl-phosphate mannosyltransferase subunit 3, regulatory).

WB:WBGene00009220	F28D9.4
Is enriched in OLL; PVD; germ line; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray; proteomic; and RNA-seq studies. Is affected by bisphenol S; Sirolimus; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Transmembrane protein 242.

WB:WBGene00009221	acs-2
Is predicted to have catalytic activity. Is involved in fatty acid metabolic process. Localizes to mitochondrion. Is expressed in body wall musculature; hypodermis; intestine; neurons; and pharynx. Is an ortholog of human ACSF2 (acyl-CoA synthetase family member 2).

WB:WBGene00009222	fbxa-95
Is enriched in cholinergic neurons; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00009223	mdt-28
Is expressed in several structures, including gonad; hypodermis; and intestine.

WB:WBGene00009224	F28F8.7
Is predicted to have DNA-binding transcription factor activity; transcription factor binding activity; and transcription regulatory region DNA binding activity.

WB:WBGene00009225	fbxa-94
Is enriched in several structures, including I5 neuron; cholinergic neurons; germline precursor cell; head mesodermal cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray and RNA-seq studies. Is affected by resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00009226	cyp-37B1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is involved in defense response to Gram-positive bacterium. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00009227	F28G4.2
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including aldicarb; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00009228	F28G4.3
Is affected by several genes including sir-2.1; pmk-1; and dpy-21 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647); Protein of unknown function DUF1647; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00009229	F28G4.4
Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00009230	oac-18
Is enriched in NSM and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and alg-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009231	ceh-89
Is predicted to have DNA binding activity. Is an ortholog of human HOPX (HOP homeobox).

WB:WBGene00009232	nkat-1
Is predicted to have kynurenine-oxoglutarate transaminase activity. Is expressed in RID; RIML; RIMR; RMDVL; and RMDVR. Is an ortholog of human KYAT3 (kynurenine aminotransferase 3).

WB:WBGene00009233	F28H6.4
Is predicted to have DNA binding activity.

WB:WBGene00009234	F28H6.6
Is enriched in ASER; OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including aldicarb; Zidovudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00009235	F28H6.7
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by allantoin and Sirolimus based on microarray studies.

WB:WBGene00009236	F28H7.2
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00009237	F28H7.3
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on SAGE; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on proteomic; microarray; and RNA-seq studies. Is affected by thirty chemicals including Heme; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00009238	selt-1.2
Is predicted to have thioredoxin-disulfide reductase activity. Is expressed in AWBL and AWBR. Is an ortholog of human SELENOT (selenoprotein T).

WB:WBGene00009239	irld-6
Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00009240	F28H7.7
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00009241	F28H7.8
Is enriched in PLM; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; CRAL/TRIO, N-terminal domain superfamily; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00009242	sre-6
Is enriched in body wall musculature; phasmid neurons; somatic nervous system; and vulval muscle based on Chronogram studies. Is affected by several genes including clk-1; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Tunicamycin; single-walled carbon nanotube; and Selenium based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00009243	F29C6.1
Is enriched in PLM; germ line; germline precursor cell; hypodermis; and pharyngeal muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009245	rict-1
Is predicted to have enzyme activator activity. Is involved in mesendoderm development. Localizes to TORC2 complex. Is expressed in several structures, including head neurons; intestine; pharynx; spermatheca; and ventral nerve cord. Is an ortholog of human RICTOR (RPTOR independent companion of MTOR complex 2).

WB:WBGene00009246	gfm-1
Is predicted to have GTPase activity and translation elongation factor activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 1. Is an ortholog of human GFM1 (G elongation factor mitochondrial 1).

WB:WBGene00009247	bath-45
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including aldicarb; hydrogen sulfide; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00009248	F29C12.6
Is affected by several genes including eat-2; sir-2.1; and hsp-6 based on microarray and RNA-seq studies. Is affected by five chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009249	F29C12.7
Is affected by daf-16; fbf-1; and nuo-6 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00009250	F29D10.1
Is enriched in germ line; muscle cell; neurons; somatic gonad precursor; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009251	F29D10.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009252	F29D10.3
Is affected by several genes including sir-2.1; alg-1; and mex-3 based on proteomic; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; resveratrol; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00009254	capg-1
Is involved in embryo development; meiotic sister chromatid segregation; and mitotic sister chromatid segregation. Localizes to dosage compensation complex.

WB:WBGene00009255	ugt-34
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A8 (UDP glucuronosyltransferase family 1 member A8); UGT2A3 (UDP glucuronosyltransferase family 2 member A3); and UGT2B15 (UDP glucuronosyltransferase family 2 member B15).

WB:WBGene00009256	tut-2
Is predicted to have sulfurtransferase activity. Is an ortholog of human CTU2 (cytosolic thiouridylase subunit 2).

WB:WBGene00009257	F29G6.1
Is enriched in ASER; PLM; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; D-glucose; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Netherton syndrome. Is predicted to encode a protein with the following domains: Kazal-type serine protease inhibitor domain; Kazal-type serine protease inhibitor domain; Kazal domain; and Kazal domain superfamily.

WB:WBGene00009258	ccdc-149
Localizes to ciliary base. Is expressed in neurons. Is an ortholog of human CCDC149 (coiled-coil domain containing 149).

WB:WBGene00009259	hpo-34
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by fourteen chemicals including Cry5B; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009260	calm-1
Is predicted to have calcium ion binding activity. Is expressed in cholinergic neurons and ventral nerve cord. Human ortholog(s) of this gene are implicated in Usher syndrome type 1J and autosomal recessive nonsyndromic deafness 48. Is an ortholog of human CIB2 (calcium and integrin binding family member 2) and CIB3 (calcium and integrin binding family member 3).

WB:WBGene00009261	F30A10.2
Is enriched in germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq; tiling array; and microarray studies. Is affected by sixteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009262	F30A10.3
Is predicted to have kinase activity. Human ortholog(s) of this gene are implicated in Kawasaki disease. Is an ortholog of human IP6K3 (inositol hexakisphosphate kinase 3).

WB:WBGene00009263	F30A10.4
Is enriched in germ line and neurons based on tiling array and RNA-seq studies. Is affected by several genes including let-60; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00009264	sac-1
Is predicted to have phosphatidylinositol-4-phosphate phosphatase activity. Is expressed in intestine; pharyngeal neurons; pharynx; spermatheca; and tail. Is an ortholog of human SACM1L (SAC1 like phosphatidylinositide phosphatase).

WB:WBGene00009265	F30A10.7
No description available

WB:WBGene00009266	F30A10.9
Is enriched in body wall muscle cell; germ line; intestine; mechanosensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Fcf1; PIN domain; rRNA-processing protein Fcf1/Utp23; and PIN-like domain superfamily. Is an ortholog of human FCF1 (FCF1 rRNA-processing protein).

WB:WBGene00009267	usp-48
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Is expressed widely. Is an ortholog of human USP48 (ubiquitin specific peptidase 48).

WB:WBGene00009268	F30A10.11
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009269	F30A10.12
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009270	F30F8.1
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009271	glna-3
Is predicted to have glutaminase activity. Is expressed in AWBL; AWBR; and head neurons. Is an ortholog of human GLS (glutaminase) and GLS2 (glutaminase 2).

WB:WBGene00009272	gras-1
Is expressed in oocyte. Is predicted to encode a protein with the following domains: Phosphorylation site; PDZ domain; PDZ domain; PDZ superfamily; and PDZ domain 6. Is an ortholog of human TAMALIN (trafficking regulator and scaffold protein tamalin).

WB:WBGene00009273	F30F8.4
No description available

WB:WBGene00009274	F30F8.5
Is enriched in ALM; FLP; PLM; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including age-1; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Mianserin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009276	F30F8.9
Is enriched in several structures, including NSM; PLM; carbon dioxide sensory neurons; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including Cry5B; Hydrolyzable Tannins; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: LETM1-like protein and LETM1-like. Is an ortholog of human LETMD1 (LETM1 domain containing 1).

WB:WBGene00009277	F30F8.10
Is predicted to have histone acetyltransferase activity and peptide alpha-N-acetyltransferase activity. Is an ortholog of human NAA60 (N-alpha-acetyltransferase 60, NatF catalytic subunit).

WB:WBGene00009278	npr-33
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in essential hypertension.

WB:WBGene00009279	F31B9.2
Is affected by several genes including rrf-3; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by antimycin and glycine based on RNA-seq studies.

WB:WBGene00009280	F31B9.3
Is enriched in several structures, including cephalic sheath cell; cholinergic neurons; germ line; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009281	F31B9.4
Is affected by several genes including daf-2; rrf-3; and bar-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin; antimycin; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00009283	F31B12.4
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00009284	F31C3.2
Is enriched in body wall muscle cell; germ line; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Alovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cid1 family poly A polymerase; PAP/25A-associated; and Nucleotidyltransferase superfamily. Is an ortholog of human TENT2 (terminal nucleotidyltransferase 2).

WB:WBGene00009285	F31C3.3
Is enriched in body wall musculature; germ line; somatic nervous system; and vulval muscle based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Alovudine; and Deoxyglucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RNA pol II promoter Fmp27 protein domain; Domain of unknown function (DUF2405); Golgi-body localisation protein domain; FMP27, domain of unknown function DUF2405; FMP27, GFWDK domain; and FMP27,  C-terminal. Is an ortholog of human KIAA0100 (KIAA0100).

WB:WBGene00009286	zipt-1
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A1 (solute carrier family 39 member 1).

WB:WBGene00009287	psf-2
Is predicted to contribute to 3'-5' DNA helicase activity. Is an ortholog of human GINS2 (GINS complex subunit 2).

WB:WBGene00009288	F31C3.6
Is enriched in AFD; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009289	exos-7
Is predicted to have AU-rich element binding activity. Is expressed in motor neurons. Is an ortholog of human EXOSC7 (exosome component 7).

WB:WBGene00009290	F31D4.2
Is predicted to have phosphatase activity. Is expressed widely. Is an ortholog of human ARMT1 (acidic residue methyltransferase 1).

WB:WBGene00009291	clec-264
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00009292	F31D4.5
Is enriched in NSM and intestine based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PH domain; Pleckstrin homology domain; and PH-like domain superfamily. Is an ortholog of human PLEKHD1 (pleckstrin homology and coiled-coil domain containing D1).

WB:WBGene00009293	F31D4.8
Is enriched in ASER; OLL; PVD; body wall musculature; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009294	F31D4.9
Is enriched in NSM; OLL; PVD; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; D-glucose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: NADH-ubiquinone oxidoreductase MWFE subunit and NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex subunit 1.

WB:WBGene00009295	fbxa-180
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00009296	F31E9.3
Is enriched in coelomocyte; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00009297	sdz-16
Is enriched in hypodermis and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009298	srz-58
Is enriched in AFD and neurons based on tiling array and RNA-seq studies. Is affected by several genes including hpl-2; his-24; and hpl-1 based on RNA-seq and microarray studies. Is affected by cadmium; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00009299	F31E9.6
Is enriched in body wall muscle cell; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00009300	F31F6.1
Is enriched in NSM; germ line; germline precursor cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00009301	F31F6.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including hydrogen sulfide; Rotenone; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00009302	F31F6.3
Is enriched in AVE and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; bisphenol A; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00009303	lips-8
Is predicted to have lipase activity.

WB:WBGene00009304	eva-1
Is predicted to have carbohydrate binding activity. Localizes to M band; cell junction; and striated muscle dense body. Is expressed in body wall musculature; hypodermis; pharyngeal muscle cell; and ventral nerve cord. Human ortholog(s) of this gene are implicated in bone development disease (multiple); primary failure of tooth eruption; and type 2 diabetes mellitus. Is an ortholog of human EVA1C (eva-1 homolog C).

WB:WBGene00009305	metl-17
Is predicted to be a structural constituent of ribosome. Is an ortholog of human METTL17 (methyltransferase like 17).

WB:WBGene00009306	maph-1.1
Is predicted to have actin binding activity and microtubule binding activity. Localizes to microtubule cytoskeleton. Is expressed in body wall musculature; egg-laying apparatus; hypodermis; intestinal cell; and neurons. Is an ortholog of human MAP1S (microtubule associated protein 1S).

WB:WBGene00009307	F32A11.1
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on RNA-seq; proteomic; and microarray studies. Is affected by stavudine and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SNase-like, OB-fold superfamily and Protein C3orf33-like. Is an ortholog of human C3orf33 (chromosome 3 open reading frame 33).

WB:WBGene00009308	F32A11.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00009309	F32A11.4
Is affected by several genes including daf-16; clk-1; and alg-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00009310	F32A11.5
Is expressed in neurons.

WB:WBGene00009311	mltn-1
Is enriched in Z1; Z4; hypodermis; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercury hydroxide; Rotenone; and manganese chloride based on RNA-seq studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00009312	F32B4.1
Is enriched in ASER and neurons based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by resveratrol and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647); Protein of unknown function DUF1647; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00009313	F32B4.2
Is predicted to have mitochondrion targeting sequence binding activity. Is an ortholog of human TOMM20 (translocase of outer mitochondrial membrane 20) and TOMM20L (translocase of outer mitochondrial membrane 20 like).

WB:WBGene00009314	F32B4.4
Is predicted to have sequence-specific DNA binding activity. Is an ortholog of human SAFB (scaffold attachment factor B); SAFB2 (scaffold attachment factor B2); and SLTM (SAFB like transcription modulator).

WB:WBGene00009315	F32B4.5
Is enriched in AFD; RIS; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including aak-2; mex-3; and mex-1 based on RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 3 and scalp-ear-nipple syndrome. Is predicted to encode a protein with the following domain: . Is an ortholog of human KCTD16 (potassium channel tetramerization domain containing 16) and KCTD8 (potassium channel tetramerization domain containing 8).

WB:WBGene00009316	abhd-11.1
Is predicted to have hydrolase activity. Is an ortholog of human ABHD11 (abhydrolase domain containing 11).

WB:WBGene00009318	F32B4.8
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; manganese chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00009319	mccc-1
Is predicted to have ATP binding activity and ligase activity. Human ortholog(s) of this gene are implicated in 3-Methylcrotonyl-CoA carboxylase 1 deficiency. Is an ortholog of human MCCC1 (methylcrotonoyl-CoA carboxylase 1).

WB:WBGene00009320	prp-18
Is enriched in body wall muscle cell; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; bisphenol A; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: pre-mRNA processing factor 4 (PRP4) like; Prp18 domain; Prp18; Pre-mRNA processing factor 4 (PRP4)-like; PRP4-like superfamily; and Pre-mRNA-splicing factor 18. Is an ortholog of human PRPF18 (pre-mRNA processing factor 18).

WB:WBGene00009321	F32B6.4
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including Heme; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009322	tbc-3
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Localizes to Golgi apparatus. Is expressed in hermaphrodite distal tip cell; neurons; pharynx; rect_D; and seam cell. Is an ortholog of human TBC1D22B (TBC1 domain family member 22B).

WB:WBGene00009323	best-13
Is predicted to have chloride channel activity. Is expressed in vulB1; vulB2; vulC; vulD; and vulE. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00009324	ttbk-3
Is predicted to have protein serine/threonine kinase activity. Is expressed in neurons.

WB:WBGene00009325	F32D8.15
Is predicted to have calcium channel regulator activity. Is expressed in head neurons; motor neurons; and tail neurons. Is an ortholog of human INAFM2 (InaF motif containing 2).

WB:WBGene00009326	F32D8.1
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Is an ortholog of human DCLK3 (doublecortin like kinase 3).

WB:WBGene00009327	F32D8.2
Is affected by several genes including daf-16; daf-12; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF229.

WB:WBGene00009328	F32D8.3
Is enriched in Z1; Z4; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by twelve chemicals including aldicarb; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00009329	F32D8.4
Is enriched in AVK; body wall muscle cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rotenone; resveratrol; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PIH1 N-terminal domain and PIH1, N-terminal. Is an ortholog of human PIH1D1 (PIH1 domain containing 1).

WB:WBGene00009330	F32D8.5
Is enriched in several structures, including body wall musculature; excretory cell; germ line; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by thirteen chemicals including stavudine; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in mitochondrial complex V (ATP synthase) deficiency nuclear type 2. Is predicted to encode a protein with the following domains: Phosphorylation site; Assembly, mitochondrial proton-transport ATP synth complex; and TMEM70 family. Is an ortholog of human TMEM70 (transmembrane protein 70).

WB:WBGene00009331	F32D8.7
Is predicted to have serine-type endopeptidase inhibitor activity. Is involved in PERK-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00009332	F32D8.8
Is enriched in Z1; Z4; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00009333	zzz-1
Is enriched in AVK; body wall muscle cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009334	F32D8.12
Is predicted to have D-lactate dehydrogenase (cytochrome) activity; D-lactate dehydrogenase activity; and flavin adenine dinucleotide binding activity. Is an ortholog of human LDHD (lactate dehydrogenase D).

WB:WBGene00009335	F32D8.13
Is predicted to have phosphomevalonate kinase activity. Human ortholog(s) of this gene are implicated in porokeratosis. Is an ortholog of human PMVK (phosphomevalonate kinase).

WB:WBGene00009336	F32D8.14
Is enriched in germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sir-2.1; and lin-39 based on RNA-seq; tiling array; and microarray studies. Is affected by Rotenone; Sirolimus; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Yip1 domain and Yip1 domain. Is an ortholog of human YIPF5 (Yip1 domain family member 5).

WB:WBGene00009337	uig-1
Exhibits protein domain specific binding activity. Is involved in regulation of engulfment of apoptotic cell. Localizes to striated muscle dense body. Is expressed in OLL; non-striated muscle; tail; and vulva. Is an ortholog of human PLEKHG1 (pleckstrin homology and RhoGEF domain containing G1).

WB:WBGene00009338	F32G8.2
Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF229.

WB:WBGene00009339	F32G8.3
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00009340	best-14
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00009341	thoc-3
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Zidovudine; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and TREX component Tex1/THOC3. Is an ortholog of human THOC3 (THO complex 3).

WB:WBGene00009342	fasn-1
Is predicted to have several functions, including fatty acid synthase activity; oxidoreductase activity; and phosphopantetheine binding activity. Is expressed in hypodermal cell; intestine; neurons; and spermatheca. Is an ortholog of human FASN (fatty acid synthase).

WB:WBGene00009343	F32H2.6
Is predicted to have catalytic activity.

WB:WBGene00009344	F32H2.7
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009345	F32H2.8
Is affected by several genes including daf-16; daf-12; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273 and Protein of unknown function DUF273.

WB:WBGene00009346	F32H2.10
Is enriched in AFD; NSM; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Armadillo-type fold.

WB:WBGene00009347	F32H5.1
Is predicted to have cysteine-type peptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00009349	F32H5.3
Is enriched in AFD; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Heme; hydrogen sulfide; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00009350	F32H5.4
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14) and SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00009352	F33A8.4
Is predicted to have rRNA (adenine-N6-)-methyltransferase activity. Is an ortholog of human ZCCHC4 (zinc finger CCHC-type containing 4).

WB:WBGene00009353	sdhd-1
Is predicted to have heme binding activity and ubiquinone binding activity. Human ortholog(s) of this gene are implicated in Carney-Stratakis syndrome; mitochondrial complex II deficiency; and paraganglioma. Is an ortholog of human SDHD (succinate dehydrogenase complex subunit D).

WB:WBGene00009354	ilkp-1
Is predicted to have magnesium-dependent protein serine/threonine phosphatase activity. Is an ortholog of human ILKAP (ILK associated serine/threonine phosphatase).

WB:WBGene00009355	F33A8.7
Is enriched in DA neuron; hypodermis; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00009356	F33A8.10
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00009357	F33C8.2
Is enriched in neurons based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00009358	F33C8.4
Is enriched in head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; daf-12; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009359	clec-102
Is predicted to have carbohydrate binding activity.

WB:WBGene00009360	F33E2.4
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00009361	F33E2.5
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009362	F33E2.6
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009363	F33E2.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00009364	wbp-11
Is enriched in FLP and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WW domain binding protein 11 and WW domain binding protein 11. Is an ortholog of human WBP11 (WW domain binding protein 11).

WB:WBGene00009365	F33H1.4
Is expressed in gonad.

WB:WBGene00009366	F33H2.2
Is enriched in body wall muscle cell; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and npr-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FAM91 N-terminus; FAM91 C-terminus; FAM91, N-terminal domain; FAM91, C-terminal domain; and FAM91. Is an ortholog of human FAM91A1 (family with sequence similarity 91 member A1).

WB:WBGene00009367	F33H2.3
Is predicted to have histone binding activity. Is an ortholog of human ANP32A (acidic nuclear phosphoprotein 32 family member A); ANP32B (acidic nuclear phosphoprotein 32 family member B); and ANP32E (acidic nuclear phosphoprotein 32 family member E).

WB:WBGene00009368	pole-1
Is predicted to have DNA binding activity; DNA-directed DNA polymerase activity; and single-stranded DNA 3'-5' exodeoxyribonuclease activity. Is an ortholog of human POLE (DNA polymerase epsilon, catalytic subunit).

WB:WBGene00009369	F33H2.6
Is enriched in body wall muscle cell; germ line; intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by four chemicals including stavudine; Cry5B; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily. Is an ortholog of human RMDN1 (regulator of microtubule dynamics 1).

WB:WBGene00009370	set-10
Is predicted to have histone-lysine N-methyltransferase activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in spermatogenic failure 14. Is an ortholog of human SMYD1 (SET and MYND domain containing 1); SMYD2 (SET and MYND domain containing 2); and SMYD3 (SET and MYND domain containing 3).

WB:WBGene00009371	F33H2.8
Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; methylmercury hydroxide; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00009372	evl-18
Is predicted to have DNA replication origin binding activity; chromatin binding activity; and single-stranded DNA binding activity. Localizes to nucleus. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in Meier-Gorlin syndrome 7. Is an ortholog of human CDC45 (cell division cycle 45).

WB:WBGene00009373	F34D10.3
Is enriched in germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and cye-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; cadmium; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00009374	F34D10.4
Is enriched in germ line; germline precursor cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009375	F34D10.6
Is enriched in intestine and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (many copies); Ankyrin repeats (3 copies); Dpy-30 motif; Ankyrin repeat; Dpy-30 motif; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00009377	F34D10.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00009378	F34H10.1
Is enriched in AVK based on RNA-seq studies. Is affected by drh-3 and eat-2 based on RNA-seq and microarray studies. Is an ortholog of human RPS27A (ribosomal protein S27a).

WB:WBGene00009380	F34H10.3
Is enriched in AFD; ASER; OLL; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Cry5B; levamisole; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009381	F34H10.4
Is expressed in head.

WB:WBGene00009382	F34H10.5
Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009383	F35B12.3
Is enriched in FLP; OLL; and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Rotenone; bisphenol A; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00009384	piit-1
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human TFPI2 (tissue factor pathway inhibitor 2).

WB:WBGene00009385	sas-5
Is involved in centriole replication. Localizes to centriole and cytoplasm.

WB:WBGene00009386	tag-290
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human TFPI (tissue factor pathway inhibitor).

WB:WBGene00009387	glb-15
Is predicted to have heme binding activity and oxygen binding activity.

WB:WBGene00009388	F35B12.9
Is enriched in amphid sheath cell; cephalic sheath cell; and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009389	F35B12.10
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: DAN domain; DAN; Cystine knot, C-terminal; and Cystine-knot cytokine. Is an ortholog of human GREM1 (gremlin 1, DAN family BMP antagonist).

WB:WBGene00009390	F35C5.1
Is enriched in AVA; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; manganese chloride; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009391	F35C5.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Trimeric LpxA-like superfamily and Serine/arginine repetitive matrix protein 5.

WB:WBGene00009392	F35C5.4
Is affected by clk-1; spt-16; and daf-2 based on microarray and RNA-seq studies. Is affected by resveratrol and tetrabromobisphenol A based on microarray studies.

WB:WBGene00009393	clec-62
Is involved in innate immune response.

WB:WBGene00009394	clec-63
Is predicted to have carbohydrate binding activity. Is expressed in germ line and intestine.

WB:WBGene00009395	clec-64
Is predicted to have carbohydrate binding activity. Is expressed in head neurons and in male.

WB:WBGene00009396	clec-65
Is predicted to have carbohydrate binding activity. Is expressed in intestine.

WB:WBGene00009397	clec-66
Is predicted to have carbohydrate binding activity. Is involved in innate immune response. Is expressed in intestine.

WB:WBGene00009398	nspb-11
Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00009399	ddn-2
Is expressed in amphid neurons; inner labial neurons; and intestine. Is predicted to encode a protein with the following domain: .

WB:WBGene00009400	F35C5.12
Is enriched in Z1; Z4; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Knottin, scorpion toxin-like and Knottin, scorpion toxin-like superfamily.

WB:WBGene00009401	F35C11.2
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00009402	F35C11.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00009403	F35C11.4
Is enriched in GABAergic neurons; excretory cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and dpy-10 based on RNA-seq and microarray studies. Is affected by eleven chemicals including aldicarb; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Transmembrane protein 246. Is an ortholog of human PGAP4 (post-GPI attachment to proteins GalNAc transferase 4).

WB:WBGene00009404	F35C11.5
Is predicted to have phospholipase A2 activity.

WB:WBGene00009405	F35C11.6
Is enriched in AFD; PLM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009406	F35C11.7
Is enriched in OLL; PVD; and amphid sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including aak-2; sma-2; and sma-4 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Cry5B; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00009408	F35C12.3
Is enriched in coelomocyte; hypodermis; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and let-60 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00009409	F35E2.1
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1182) and Protein of unknown function DUF1182.

WB:WBGene00009410	F35E2.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00009411	F35E2.3
Is enriched in FLP; germ line; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride; Chlorpyrifos; and Sirolimus based on microarray studies.

WB:WBGene00009412	F35E2.5
Is enriched in germ line; muscle cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00009413	oac-19
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00009414	F35E2.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including let-60; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009415	F35E2.8
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009416	F35E2.9
Is enriched in AVK; GABAergic neurons; NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00009417	F35E8.1
Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Ethanol; methylmercuric chloride; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009418	F35E8.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Mercuric Chloride; antimycin; and adsorbable organic bromine compound based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009419	F35E8.4
Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies.

WB:WBGene00009420	F35E8.6
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by resveratrol and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009421	F35E8.7
Is affected by several genes including daf-2; daf-12; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009422	F35E8.9
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Acrylamide; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009423	F35E8.10
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009424	F35E8.13
Is enriched in DA neuron; VA neuron; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including Rifampin; Mianserin; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009425	scl-16
Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009426	F35E12.2
Is affected by several genes including daf-2; eat-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009427	fbxa-181
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; mpk-1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; methylmercury hydroxide; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00009428	F35E12.4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Rotenone; and indole based on RNA-seq and microarray studies.

WB:WBGene00009429	irg-5
Is involved in defense response to Gram-positive bacterium.

WB:WBGene00009430	F35E12.6
Is involved in innate immune response.

WB:WBGene00009431	dct-17
Is involved in defense response to Gram-negative bacterium and innate immune response. Localizes to membrane raft.

WB:WBGene00009432	cld-9
Is involved in innate immune response.

WB:WBGene00009433	F35E12.9
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Tunicamycin; D-glucopyranose; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009434	F35E12.10
Localizes to membrane raft.

WB:WBGene00009435	F35G2.1
Is predicted to have flavin-linked sulfhydryl oxidase activity and protein disulfide isomerase activity. Is an ortholog of human QSOX1 (quiescin sulfhydryl oxidase 1) and QSOX2 (quiescin sulfhydryl oxidase 2).

WB:WBGene00009436	marb-1
Is predicted to have catalytic activity. Is an ortholog of human ISOC2 (isochorismatase domain containing 2).

WB:WBGene00009437	F35G2.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including tryptophan; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00009438	F35G2.5
Is enriched in hypodermis and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00009439	mlcd-1
Is predicted to have malonyl-CoA decarboxylase activity. Is an ortholog of human MLYCD (malonyl-CoA decarboxylase).

WB:WBGene00009440	idhg-1
Is predicted to have isocitrate dehydrogenase (NAD+) activity. Is an ortholog of human IDH3G (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma).

WB:WBGene00009441	wdr-48
Is predicted to have ubiquitin binding activity. Is involved in positive regulation of locomotion involved in locomotory behavior; positive regulation of macromolecule metabolic process; and positive regulation of protein localization to cell surface. Is expressed in head neurons and tail. Is an ortholog of human WDR48 (WD repeat domain 48).

WB:WBGene00009442	F35G12.5
Is enriched in NSM; germ line; and germline precursor cell based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00009443	F35G12.7
Is predicted to have copper ion binding activity. Is an ortholog of human CUTA (cutA divalent cation tolerance homolog).

WB:WBGene00009444	erh-2
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Enhancer of rudimentary; Enhancer of rudimentary; and Enhancer of rudimentary superfamily. Is an ortholog of human ERH (ERH mRNA splicing and mitosis factor).

WB:WBGene00009445	F35G12.12
Is enriched in germ line based on RNA-seq and microarray studies. Is affected by several genes including glp-1; daf-12; and dpy-10 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteasome non-ATPase 26S subunit and 26S proteasome non-ATPase regulatory subunit 5. Is an ortholog of human PSMD5 (proteasome 26S subunit, non-ATPase 5).

WB:WBGene00009446	F35H8.1
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including D-glucose; resveratrol; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00009447	F35H8.2
Is enriched in dopaminergic neurons; germline precursor cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14.

WB:WBGene00009448	zfp-2
Is predicted to have DNA binding activity and metal ion binding activity. Is expressed in body wall musculature; hermaphrodite gonad; pharynx; seam cell; and vulva. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is an ortholog of human PRDM6 (PR/SET domain 6); ZBTB16 (zinc finger and BTB domain containing 16); and ZBTB45 (zinc finger and BTB domain containing 45).

WB:WBGene00009449	F35H8.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009450	ugt-58
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT8 (UDP glycosyltransferase 8).

WB:WBGene00009451	cids-2
Is predicted to have RNA polymerase II complex binding activity. Is involved in mRNA 3'-end processing. Is an ortholog of human RPRD2 (regulation of nuclear pre-mRNA domain containing 2).

WB:WBGene00009452	F36A2.2
Is predicted to have tRNA dihydrouridine synthase activity. Is an ortholog of human DUS1L (dihydrouridine synthase 1 like).

WB:WBGene00009453	F36A2.3
Is predicted to have oxidoreductase activity.

WB:WBGene00009454	F36A2.7
Is expressed in several structures, including pharynx and spermatheca.

WB:WBGene00009455	phip-1
Is predicted to have protein histidine phosphatase activity. Is expressed in pharyngeal motor neurons and ventral cord neurons. Is an ortholog of human PHPT1 (phosphohistidine phosphatase 1).

WB:WBGene00009456	F36A2.9
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00009457	F36A2.10
Is enriched in amphid sheath cell; germ line; hypodermis; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009458	F36A2.11
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00009459	F36A2.12
Is enriched in germ line; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009460	ubr-5
Is predicted to have ubiquitin binding activity; ubiquitin-protein transferase activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in Angelman syndrome; Prader-Willi syndrome; and autosomal recessive non-syndromic intellectual disability. Is an ortholog of human UBR5 (ubiquitin protein ligase E3 component n-recognin 5).

WB:WBGene00009461	madf-2
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00009462	sre-22
Is expressed in URBL; URBR; and body wall musculature. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00009463	F36D1.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00009464	F36D1.5
Is enriched in DA neuron; VA neuron; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00009465	F36D1.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; and Peptidase S1, PA clan.

WB:WBGene00009466	F36D1.7
Is enriched in GABAergic neurons; excretory cell; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00009467	F36D1.8
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00009468	F36D1.9
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including rrf-3; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00009469	F36D3.1
Is expressed in gonad.

WB:WBGene00009470	F36D3.4
Is expressed in spermatheca. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00009471	F36D3.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BRCA1 C Terminus (BRCT) domain; Ankyrin repeat; Domain of unknown function; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00009472	F36D3.7
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by Rifampin and Psoralens based on RNA-seq studies.

WB:WBGene00009473	F36D3.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00009474	clec-235
Is affected by lin-15B; drh-3; and eat-2 based on microarray and RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009475	F36F2.1
Is predicted to have actin binding activity. Localizes to endoplasmic reticulum. Is an ortholog of human ABRA (actin binding Rho activating protein).

WB:WBGene00009476	F36F2.2
Is enriched in Psub1; body wall muscle cell; dopaminergic neurons; head mesodermal cell; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Tunicamycin; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00009477	rbpl-1
Is predicted to have nucleic acid binding activity; ubiquitin protein ligase activity; and zinc ion binding activity. Is expressed in intestine; neurons; spermatheca; and vulva. Is an ortholog of human RBBP6 (RB binding protein 6, ubiquitin ligase).

WB:WBGene00009478	syx-7
Is predicted to have SNAP receptor activity and SNARE binding activity. Is an ortholog of human STX12 (syntaxin 12) and STX7 (syntaxin 7).

WB:WBGene00009479	fcp-1
Exhibits RNA polymerase II CTD heptapeptide repeat phosphatase activity. Is involved in dephosphorylation of RNA polymerase II C-terminal domain. Is an ortholog of human CTDP1 (CTD phosphatase subunit 1).

WB:WBGene00009480	F36F2.7
Is enriched in GABAergic neurons; excretory cell; and intestine based on tiling array studies. Is affected by several genes including eat-2; mex-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00009481	F36F2.8
Is enriched in AFD and BAG based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: EB module and EB domain.

WB:WBGene00009482	F36G3.1
Is enriched in FLP and hypodermis based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including levamisole; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009483	F36G3.2
Is enriched in head mesodermal cell; intestine; mechanosensory neurons; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Acyl-CoA N-acyltransferase.

WB:WBGene00009484	F36G3.3
Is enriched in intestine; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1C. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human LITAF (lipopolysaccharide induced TNF factor).

WB:WBGene00009485	F36G9.3
Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00009486	F36G9.7
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009487	clec-232
Is predicted to have carbohydrate binding activity.

WB:WBGene00009488	oac-20
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00009489	F36G9.13
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00009490	fbxa-99
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including age-1; let-60; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Heme; tryptophan; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00009491	F36G9.15
Is enriched in AVE and NSM based on tiling array studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Tunicamycin; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00009492	F36H1.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00009493	hrg-4
Exhibits heme binding activity and heme transporter activity. Is involved in heme transport. Localizes to plasma membrane. Is an ortholog of human SLC48A1 (solute carrier family 48 member 1).

WB:WBGene00009494	hrg-5
Is predicted to have heme binding activity and heme transporter activity. Is an ortholog of human SLC48A1 (solute carrier family 48 member 1).

WB:WBGene00009495	hrg-6
Is predicted to have heme binding activity and heme transporter activity. Is an ortholog of human SLC48A1 (solute carrier family 48 member 1).

WB:WBGene00009496	F36H1.11
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00009497	F36H1.12
Is affected by several genes including eat-2; hpl-2; and kri-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00009498	tat-5
Is predicted to have ATPase-coupled intramembrane lipid transporter activity. Is involved in embryo development and reproduction. Localizes to cytoplasmic vesicle and plasma membrane. Is expressed widely. Human ortholog(s) of this gene are implicated in benign recurrent intrahepatic cholestasis 1; intrahepatic cholestasis of pregnancy 1; and progressive familial intrahepatic cholestasis 1. Is an ortholog of human ATP9A (ATPase phospholipid transporting 9A (putative)).

WB:WBGene00009499	ent-6
Is predicted to have nucleoside transmembrane transporter activity. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00009500	F36H2.3
Is enriched in amphid sheath cell; dopaminergic neurons; and intestine based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; D-glucose; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including complement deficiency (multiple); degeneration of macula and posterior pole (multiple); and familial hemophagocytic lymphohistiocytosis 2. Human CR1 exhibits complement receptor activity and opsonin binding activity. Is predicted to encode a protein with the following domains: Sushi repeat (SCR repeat); Sushi/SCR/CCP domain; and Sushi/SCR/CCP superfamily. Is an ortholog of human CR1 (complement C3b/C4b receptor 1 (Knops blood group)).

WB:WBGene00009501	F37A8.1
Is enriched in germ line; muscle cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00009502	F37A8.2
Is enriched in AVK; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009503	F37A8.5
Is predicted to have metal ion binding activity. Is an ortholog of several human genes including YPEL1 (yippee like 1); YPEL2 (yippee like 2); and YPEL3 (yippee like 3).

WB:WBGene00009504	F37B12.1
Is enriched in AFD; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including bisphenol A; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009505	F37B12.3
Is predicted to have transferase activity, transferring alkyl or aryl (other than methyl) groups. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 55 and congenital disorder of glycosylation Iaa. Is an ortholog of human NUS1 (NUS1 dehydrodolichyl diphosphate synthase subunit).

WB:WBGene00009507	mus-101
Is involved in several processes, including DNA-dependent DNA replication; embryo development; and germ cell proliferation. Is an ortholog of human TOPBP1 (DNA topoisomerase II binding protein 1).

WB:WBGene00009508	row-1
Is enriched in dopaminergic neurons; germ line; and head mesodermal cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by D-glucose; Zidovudine; and paraquat based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including White-Sutton syndrome; hereditary sensory and autonomic neuropathy type 8; and hypogonadotropic hypogonadism (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human POGZ (pogo transposable element derived with ZNF domain) and ZNF280B (zinc finger protein 280B).

WB:WBGene00009509	F37D6.3
Is predicted to have RNA binding activity.

WB:WBGene00009510	F37D6.4
Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including D-glucose; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00009511	F37H8.2
Is enriched in ASER; AVA; GABAergic neurons; OLL; and PVD based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00009512	bigr-1
Is predicted to have hydrolase activity. Is expressed in intestine and ventral nerve cord.

WB:WBGene00009513	sfxn-1.2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN1 (sideroflexin 1) and SFXN3 (sideroflexin 3).

WB:WBGene00009514	F37H8.5
Localizes to cytoplasm. Is expressed in ventral nerve cord. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00009515	clec-170
Is predicted to have carbohydrate binding activity.

WB:WBGene00009516	F38A1.2
No description available

WB:WBGene00009517	clec-167
Is predicted to have carbohydrate binding activity.

WB:WBGene00009518	clec-166
Is predicted to have carbohydrate binding activity. Is expressed in rectum.

WB:WBGene00009519	F38A1.6
Is enriched in NSM and intestine based on tiling array studies. Is affected by several genes including sir-2.1; smg-2; and mir-34 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009520	clec-168
Is predicted to have carbohydrate binding activity.

WB:WBGene00009521	F38A1.8
Is predicted to have GTPase activity and signal recognition particle binding activity. Is an ortholog of human SRPRA (SRP receptor subunit alpha).

WB:WBGene00009522	F38A1.9
Is enriched in OLL; PVD; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; indole; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009523	clec-165
Is predicted to have carbohydrate binding activity.

WB:WBGene00009524	F38A1.11
Is affected by several genes including clk-1; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Cadmium Chloride; resveratrol; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00009525	F38A1.13
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; clk-1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009526	clec-169
Is predicted to have carbohydrate binding activity.

WB:WBGene00009527	C02B4.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00009528	F38A6.4
Is enriched in AFD; PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00009529	F38B2.2
Is enriched in dopaminergic neurons; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including D-glucose; Zidovudine; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein F10E9.3-like.

WB:WBGene00009530	F38B2.3
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-12; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB domain; CUB domain; and Spermadhesin, CUB domain superfamily.

WB:WBGene00009531	F38B2.4
Is predicted to have ATP binding activity and adenylate kinase activity. Human ortholog(s) of this gene are implicated in hemolytic anemia. Is an ortholog of human AK1 (adenylate kinase 1).

WB:WBGene00009532	ccch-1
Is predicted to have mRNA 3'-UTR binding activity. Localizes to sarcoplasmic reticulum. Is expressed in GABAergic neurons; cholinergic neurons; head neurons; and intestine. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L1 (ZFP36 ring finger protein like 1).

WB:WBGene00009533	F38B7.2
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00009534	F38B7.3
Is enriched in NSM; dopaminergic neurons; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Cry5B and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PH domain; Pleckstrin homology domain; PH-like domain superfamily; and Pleckstrin homology domain-containing family B member 1/2.

WB:WBGene00009535	F38C2.1
Is enriched in NSM based on tiling array studies. Is affected by dop-1; mir-34; and drh-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including indole; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: NTF2-like domain superfamily.

WB:WBGene00009536	F38C2.4
Is affected by dpy-21; mir-34; and mut-2 based on RNA-seq and microarray studies. Is affected by tetrabromobisphenol A and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; Methyltransferase-like protein 24; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00009537	ccch-2
Is predicted to have mRNA 3'-UTR binding activity. Is expressed in dorsal nerve cord; head muscle; head neurons; intestine; and ventral nerve cord. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00009538	clec-191
Is predicted to have carbohydrate binding activity.

WB:WBGene00009539	F38C2.7
Is predicted to have mRNA 3'-UTR binding activity. Is expressed widely. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00009540	hlh-31
Is predicted to have protein dimerization activity. Human ortholog(s) of this gene are implicated in congenital malabsorptive diarrhea 4 and persistent hyperplastic primary vitreous. Is an ortholog of human BHLHE22 (basic helix-loop-helix family member e22) and BHLHE23 (basic helix-loop-helix family member e23).

WB:WBGene00009541	cutl-17
Is enriched in DA neuron; GABAergic neurons; and VA neuron based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; manganese chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain; Zona pellucida domain; and PAN/Apple domain.

WB:WBGene00009542	copb-2
Is predicted to have structural molecule activity. Is involved in embryo development; intracellular protein transport; and oocyte development. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 19. Is an ortholog of human COPB2 (COPI coat complex subunit beta 2).

WB:WBGene00009543	F38E11.6
Is predicted to have ATP binding activity and nucleobase-containing compound kinase activity.

WB:WBGene00009544	F38E11.9
Is enriched in AFD; Z1; Z4; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009546	fbxb-3
Is enriched in Z1; Z4; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00009547	F38H4.3
Is enriched in GABAergic neurons; NSM; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009548	F38H4.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00009549	F38H4.5
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Amidinotransferase. Is an ortholog of human DDAH1 (dimethylarginine dimethylaminohydrolase 1).

WB:WBGene00009550	F38H4.6
Is enriched in AFD and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00009551	mob-1
Is enriched in AFD; ASER; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including glp-1; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; D-glucose; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Mob1/phocein family; MOB kinase activator family; and MOB kinase activator superfamily. Is an ortholog of human MOB1B (MOB kinase activator 1B).

WB:WBGene00009552	piki-1
Is predicted to have 1-phosphatidylinositol-3-kinase activity and 1-phosphatidylinositol-4-phosphate 3-kinase activity. Is involved in several processes, including phagosome maturation involved in apoptotic cell clearance; phosphatidylinositol-3-phosphate biosynthetic process; and positive regulation of phagocytosis, engulfment. Localizes to early phagosome and pseudopodium. Is an ortholog of human PIK3C2B (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta).

WB:WBGene00009553	hinf-1
Is enriched in AVK; germ line; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Alovudine; stavudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human HINFP (histone H4 transcription factor).

WB:WBGene00009554	F39B2.3
Is predicted to have NADPH binding activity; NADPH:quinone reductase activity; and mRNA 3'-UTR binding activity. Is an ortholog of human CRYZ (crystallin zeta).

WB:WBGene00009555	C02B4.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00009556	F39B2.5
Is predicted to have 1-phosphatidylinositol-3-kinase regulator activity. Is an ortholog of human SOCS7 (suppressor of cytokine signaling 7).

WB:WBGene00009557	mtcu-1
Is predicted to have GTP binding activity and GTPase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 23. Is an ortholog of human GTPBP3 (GTP binding protein 3, mitochondrial).

WB:WBGene00009558	F39B2.8
Is predicted to have G protein-coupled receptor activity. Is expressed in head neurons; motor neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1E. Is an ortholog of human GPR158 (G protein-coupled receptor 158).

WB:WBGene00009559	mtx-1
Is enriched in AFD; Psub1; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Outer mitochondrial membrane transport complex protein; Glutathione S-transferase, C-terminal domain; Mitochondrial outer membrane transport complex protein, metaxin; Mitochondrial outer membrane transport complex Sam37/metaxin, N-terminal domain; Metaxin, glutathione S-transferase domain; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human MTX1 (metaxin 1) and MTX3 (metaxin 3).

WB:WBGene00009560	psa-3
Exhibits RNA polymerase II transcription coactivator binding activity. Is involved in regulation of asymmetric cell division. Localizes to nucleus. Is expressed in several structures, including TL.aa; TL.pa; TR.aa; TR.pa; and hypodermal cell.

WB:WBGene00009561	F39D8.3
Is enriched in germline precursor cell; hypodermis; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including 1-methylnicotinamide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00009562	flp-22
Exhibits neuropeptide receptor binding activity. Is involved in neuropeptide signaling pathway. Is expressed in head neurons; interneuron; somatic neurons; and uv1.

WB:WBGene00009563	F39H2.3
Is enriched in body wall muscle cell; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 74 and multiple mitochondrial dysfunctions syndrome 3. Is predicted to encode a protein with the following domains: Aminomethyltransferase folate-binding domain; Aminomethyltransferase, folate-binding domain; YgfZ/GcvT conserved site; GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1; and Aminomethyltransferase-like. Is an ortholog of human IBA57 (iron-sulfur cluster assembly factor IBA57).

WB:WBGene00009565	F39H11.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including resveratrol; Humic Substances; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Bucentaur or craniofacial development and BCNT-C domain. Is an ortholog of human CFDP1 (craniofacial development protein 1).

WB:WBGene00009566	srsx-1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00009567	srbc-25
Is enriched in DA neuron; VA neuron; and hypodermis based on tiling array studies. Is affected by several genes including eat-2; drh-3; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00009568	srbc-26
Is enriched in NSM based on tiling array studies. Is affected by hpl-2; mir-34; and ifo-1 based on tiling array and microarray studies. Is affected by resveratrol and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00009569	srz-66
Is expressed in ADLL; ADLR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00009570	srz-65
No description available

WB:WBGene00009571	F40D4.12
Is enriched in intestine based on tiling array studies. Is affected by several genes including clk-1; elt-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00009572	F40D4.13
Is enriched in head mesodermal cell; neurons; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including allantoin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009573	F40E10.5
Is enriched in mechanosensory neurons and pharynx based on microarray; tiling array; and proteomic studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009574	F40E10.6
Is expressed in several structures, including egg-laying apparatus; nervous system; pharyngeal-intestinal valve; rectal valve cell; and tail hypodermis. Is predicted to encode a protein with the following domains: Organic solute transporter Ostalpha and Organic solute transporter subunit alpha/Transmembrane protein 184. Is an ortholog of human TMEM184A (transmembrane protein 184A) and TMEM184B (transmembrane protein 184B).

WB:WBGene00009575	F40F8.1
Exhibits UMP kinase activity. Is involved in UDP biosynthetic process. Is expressed in head and neurons. Is an ortholog of human CMPK1 (cytidine/uridine monophosphate kinase 1).

WB:WBGene00009576	F40F8.3
Is enriched in several structures, including AFD; arcade cell; germ line; intestine; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Mercuric Chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Transmembrane protein 42. Is an ortholog of human TMEM42 (transmembrane protein 42).

WB:WBGene00009577	F40F8.4
Is enriched in AFD; amphid sheath cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009578	F40F8.5
Is enriched in PLM; body wall muscle cell; head mesodermal cell; intestine; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including methylmercury hydroxide; Rotenone; and D-glucopyranose based on RNA-seq studies.

WB:WBGene00009579	arrd-6
Is expressed in amphid process; head ganglion; nerve ring; tail neurons; and ventral nerve cord. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human TXNIP (thioredoxin interacting protein).

WB:WBGene00009580	xbx-6
Is expressed in neurons; pharyngeal muscle cell; tail; and ventral nerve cord. Is predicted to encode a protein with the following domains: Inhibitor of apoptosis-promoting Bax1 and Bax inhibitor 1-related. Is an ortholog of human FAIM2 (Fas apoptotic inhibitory molecule 2) and TMBIM1 (transmembrane BAX inhibitor motif containing 1).

WB:WBGene00009581	F40F9.3
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-two chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PDZ superfamily and Uncharacterized protein T15H9.4-like.

WB:WBGene00009582	slcr-46.3
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC46A1 (solute carrier family 46 member 1); SLC46A2 (solute carrier family 46 member 2); and SLC46A3 (solute carrier family 46 member 3).

WB:WBGene00009583	aagr-3
Exhibits alpha-1,4-glucosidase activity. Is involved in glycogen catabolic process. Human ortholog(s) of this gene are implicated in congenital sucrase-isomaltase deficiency; glycogen storage disease II; and polycystic kidney disease 3. Is an ortholog of human GANAB (glucosidase II alpha subunit).

WB:WBGene00009584	drap-1
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity and transcription coregulator activity. Is an ortholog of human DRAP1 (DR1 associated protein 1).

WB:WBGene00009585	cal-7
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93. Is an ortholog of human EFCAB2 (EF-hand calcium binding domain 2).

WB:WBGene00009586	F40F9.10
Is predicted to have tRNA methyltransferase activity. Is an ortholog of human TRMT12 (tRNA methyltransferase 12 homolog).

WB:WBGene00009587	mig-38
Is predicted to have copper ion binding activity; primary amine oxidase activity; and quinone binding activity. Is expressed in gonad; head; neurons; somatic gonad precursor; and tail. Is an ortholog of human BICRAL (BRD4 interacting chromatin remodeling complex associated protein like).

WB:WBGene00009588	F40F11.3
Is enriched in AFD; AVK; RID; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: COMPASS (Complex proteins associated with Set1p) component shg1.

WB:WBGene00009589	F40F11.4
Is predicted to have calcium ion binding activity.

WB:WBGene00009590	ttr-4
Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009591	F40F12.2
No description available

WB:WBGene00009592	F40F12.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including nicotinic acid; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00009593	mam-7
Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MAM domain and Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00009594	cyld-1
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is expressed in several structures, including arcade cell; pharyngeal cell; pharyngeal-intestinal valve; rectal gland cell; and spermatheca. Human ortholog(s) of this gene are implicated in Brooke-Spiegler syndrome. Is an ortholog of human CYLD (CYLD lysine 63 deubiquitinase).

WB:WBGene00009595	cbp-3
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity. Is involved in PERK-mediated unfolded protein response.

WB:WBGene00009596	sre-8
Is affected by several genes including elt-2; sir-2.1; and drh-3 based on microarray and RNA-seq studies. Is affected by Atrazine; Chlorpyrifos; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00009597	F40G12.2
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009598	F40G12.3
Is affected by several genes including alg-1; mex-1; and drh-3 based on RNA-seq and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00009599	F40G12.4
Is enriched in amphid sheath cell and germ line based on RNA-seq studies. Is affected by several genes including rrf-3; pgl-1; and eri-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00009600	F40G12.5
Is enriched in GABAergic neurons; amphid sheath cell; and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rifampin; indole; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00009601	F40G12.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00009602	F40G12.7
Is affected by several genes including daf-2; clk-1; and mex-1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Alovudine; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00009603	srt-33
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00009604	F40G12.9
Is affected by several genes including daf-2; eat-2; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00009605	F40G12.10
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00009606	F40G12.11
Is expressed in germ line.

WB:WBGene00009607	oac-26
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00009608	nhr-265
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00009609	oac-27
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00009610	oac-28
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00009611	F41D3.6
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00009612	F41D3.7
Is affected by Tunicamycin; resveratrol; and Sirolimus based on microarray studies.

WB:WBGene00009613	F41D3.8
Is affected by cyc-1; daf-16; and sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00009614	F41D3.9
Is affected by several genes including daf-12; clk-1; and sma-2 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00009615	oac-25
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00009616	F41D3.11
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and nanoparticle based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273; Protein of unknown function DUF273; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00009617	slc-9B.1
Is predicted to have solute:proton antiporter activity. Is expressed in excretory canal; excretory cell; and pharynx. Is an ortholog of human SLC9B1 (solute carrier family 9 member B1) and SLC9B2 (solute carrier family 9 member B2).

WB:WBGene00009618	F41E7.2
Is predicted to have solute:proton antiporter activity. Is an ortholog of human SLC9B1 (solute carrier family 9 member B1) and SLC9B2 (solute carrier family 9 member B2).

WB:WBGene00009619	npr-6
Is predicted to have neuropeptide Y receptor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human PRLHR (prolactin releasing hormone receptor).

WB:WBGene00009620	fip-5
Is enriched in PLM and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Rotenone; bisphenol A; and juglone based on RNA-seq and microarray studies.

WB:WBGene00009621	fipr-21
Is enriched in germline precursor cell and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00009622	F41E7.6
Is predicted to have carnitine O-octanoyltransferase activity. Is expressed in anal depressor muscle; anal sphincter muscle; intestinal muscle; neurons; and pharyngeal-intestinal valve. Is an ortholog of human CROT (carnitine O-octanoyltransferase).

WB:WBGene00009623	F41E7.7
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including D-glucose; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009624	cnc-8
Is enriched in hypodermis and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Rotenone; D-glucose; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00009625	F41E7.9
Is enriched in AFD; ASER; PLM; and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00009626	F42A8.1
Is expressed in head; intestine; and vulva. Is predicted to encode a protein with the following domain: Abnormal cell migration protein 18-like.

WB:WBGene00009627	cup-15
Is involved in lysosome organization. Human ortholog(s) of this gene are implicated in autosomal recessive osteopetrosis 5. Is an ortholog of human OSTM1 (osteoclastogenesis associated transmembrane protein 1).

WB:WBGene00009628	tatn-1
Is predicted to have L-tyrosine:2-oxoglutarate aminotransferase activity and pyridoxal phosphate binding activity. Is involved in dauer entry. Human ortholog(s) of this gene are implicated in tyrosinemia type II. Is an ortholog of human TAT (tyrosine aminotransferase).

WB:WBGene00009629	sprr-2
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in SDQ and neurons.

WB:WBGene00009630	F42E8.1
Is enriched in neurons based on tiling array studies. Is affected by several genes including pgl-1; aak-2; and fbf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009631	F42E8.2
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Acrylamide based on microarray and RNA-seq studies.

WB:WBGene00009632	ttyh-1
Is predicted to have intracellular calcium activated chloride channel activity and volume-sensitive chloride channel activity. Is an ortholog of human TTYH1 (tweety family member 1) and TTYH3 (tweety family member 3).

WB:WBGene00009633	F42E11.3
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including clk-1; sir-2.1; and dpy-21 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009634	nspc-9
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009635	F42F12.3
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Is involved in innate immune response. Is an ortholog of human SRD5A1 (steroid 5 alpha-reductase 1).

WB:WBGene00009636	F42F12.4
Is predicted to have acireductone dioxygenase [iron(II)-requiring] activity. Is an ortholog of human ADI1 (acireductone dioxygenase 1).

WB:WBGene00009637	nspc-13
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009638	nspc-14
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009639	nspc-15
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Mianserin; Deoxyglucose; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009640	nspc-10
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including hydrogen sulfide; D-glucose; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009641	F42G4.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including nicotinic acid; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009642	F42G4.5
Is enriched in AFD; OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00009643	F42G4.6
Is enriched in germ line; intestine; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Mianserin; D-glucose; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009644	F42G4.7
Is affected by several genes including daf-16; skn-1; and mex-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00009645	F42G10.1
Is predicted to have metallopeptidase activity.

WB:WBGene00009646	F42H11.1
Is enriched in ALM; PLM; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; age-1; and lin-4 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; antimycin; and Colistin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00009647	phlp-2
Is predicted to have metal ion binding activity and phosphoprotein phosphatase activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in agammaglobulinemia 5. Is an ortholog of human PHLPP1 (PH domain and leucine rich repeat protein phosphatase 1) and PHLPP2 (PH domain and leucine rich repeat protein phosphatase 2).

WB:WBGene00009648	zhit-2
Is predicted to have metal ion binding activity. Is an ortholog of human ZNHIT2 (zinc finger HIT-type containing 2).

WB:WBGene00009649	F43C1.5
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUE domain; Ubiquitin system component CUE; UBA-like superfamily; and CUE domain-containing protein 1. Is an ortholog of human CUEDC1 (CUE domain containing 1).

WB:WBGene00009650	ccnk-1
Is predicted to have cyclin-dependent protein serine/threonine kinase activator activity. Is involved in nematode larval development and phosphorylation of RNA polymerase II C-terminal domain. Localizes to nucleus. Is an ortholog of human CCNK (cyclin K).

WB:WBGene00009651	F43D2.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009652	F43D2.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009653	F43D9.1
Localizes to centrosome. Is expressed in head neurons; interneuron; and muscle cell.

WB:WBGene00009654	sly-1
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domains: Sec1 family; Sec1-like protein; Sec1-like, domain 2; Sec1-like superfamily; Sec1-like, domain 3a; and Sec1-like, domain 1. Is an ortholog of human SCFD1 (sec1 family domain containing 1).

WB:WBGene00009656	F43G6.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009657	F43G6.4
Is enriched in germ line; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 5. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009658	pap-3
Is predicted to have polynucleotide adenylyltransferase activity. Is an ortholog of human PAPOLA (poly(A) polymerase alpha); PAPOLB (poly(A) polymerase beta); and PAPOLG (poly(A) polymerase gamma).

WB:WBGene00009659	F43G6.7
Is enriched in NSM; germ line; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00009660	F43G6.8
Is enriched in AFD; PLM; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Cry5B; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00009661	patr-1
Is predicted to have RNA binding activity. Is involved in determination of adult lifespan. Localizes to P-body. Is an ortholog of human PATL1 (PAT1 homolog 1, processing body mRNA decay factor) and PATL2 (PAT1 homolog 2).

WB:WBGene00009662	F43G6.10
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009663	hda-5
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 5. Is an ortholog of human HDAC10 (histone deacetylase 10).

WB:WBGene00009664	idha-1
Is predicted to have isocitrate dehydrogenase (NAD+) activity. Is involved in protein folding. Localizes to mitochondrion. Is expressed in head and tail. Is an ortholog of human IDH3A (isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha).

WB:WBGene00009665	lmd-1
Is enriched in coelomocyte; germ line; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; gld-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Atrazine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LysM domain; LysM domain; and LysM domain superfamily. Is an ortholog of human LYSMD3 (LysM domain containing 3) and LYSMD4 (LysM domain containing 4).

WB:WBGene00009666	slc-25A42
Is predicted to have ATP transmembrane transporter activity. Is expressed in head. Is an ortholog of human SLC25A42 (solute carrier family 25 member 42).

WB:WBGene00009667	F43G9.4
Is enriched in body wall muscle cell; coelomocyte; germ line; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00009668	cfim-1
Exhibits identical protein binding activity. Is an ortholog of human NUDT21 (nudix hydrolase 21).

WB:WBGene00009669	F43G9.7
No description available

WB:WBGene00009670	F43G9.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; D-glucose; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00009671	mfap-1
Is involved in regulation of alternative mRNA splicing, via spliceosome. Localizes to nucleus. Is expressed in body wall musculature; intestine; pharynx; and vulval muscle. Is an ortholog of human MFAP1 (microfibril associated protein 1).

WB:WBGene00009672	F43G9.12
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is an ortholog of human GCFC2 (GC-rich sequence DNA-binding factor 2) and PAXBP1 (PAX3 and PAX7 binding protein 1).

WB:WBGene00009673	F43G9.13
Is enriched in several structures, including excretory cell; germ line; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Putative transmembrane protein 170 and Transmembrane protein 170. Is an ortholog of human TMEM170A (transmembrane protein 170A) and TMEM170B (transmembrane protein 170B).

WB:WBGene00009674	nucb-1
Is predicted to have calcium ion binding activity. Is expressed in body wall musculature; intestinal cell; neurons; and non-striated muscle. Is an ortholog of human NUCB1 (nucleobindin 1) and NUCB2 (nucleobindin 2).

WB:WBGene00009675	F44A6.3
Is enriched in several structures, including ASER; Z4.a; head mesodermal cell; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009676	F44A6.4
Is enriched in PLM; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009677	F44A6.5
Is enriched in ASER; PLM; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; Tunicamycin; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00009678	magu-4
Is expressed in hypodermis; neurons; pharynx; spermatheca; and vulval cell. Is predicted to encode a protein with the following domains: PDZ domain; P-loop containing nucleoside triphosphate hydrolase; SH3-like domain superfamily; and PDZ superfamily. Is an ortholog of human DLG5 (discs large MAGUK scaffold protein 5).

WB:WBGene00009679	F44D12.2
Is enriched in excretory cell; germ line; hypodermis; intestine; and neurons based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009680	msd-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00009681	gipc-2
Is enriched in NSM; amphid sheath cell; germ line; male-specific anatomical entity; and in male based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by thirty-two chemicals including Ethanol; tryptophan; and methylmercury hydroxide based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 15. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain-containing protein GIPC1/2/3; and PDZ superfamily. Is an ortholog of human GIPC1 (GIPC PDZ domain containing family member 1); GIPC2 (GIPC PDZ domain containing family member 2); and GIPC3 (GIPC PDZ domain containing family member 3).

WB:WBGene00009682	msd-2
Localizes to cell body and pseudopodium.

WB:WBGene00009683	F44D12.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009684	msd-3
Localizes to cell body and pseudopodium.

WB:WBGene00009685	F44D12.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including methylmercury hydroxide; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009686	ent-7
Is predicted to have nucleoside transmembrane transporter activity. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00009687	F44D12.10
Is affected by drh-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: RING-type zinc-finger; Zinc finger, RING/FYVE/PHD-type; and RING-type zinc-finger, LisH dimerisation motif.

WB:WBGene00009688	F44E5.1
Is enriched in germ line; muscle cell; neurons; and retrovesicular ganglion based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and aak-2 based on RNA-seq and proteomic studies. Is affected by five chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00009689	F44E5.2
Is affected by several genes including daf-2; pgl-1; and csr-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00009690	F44E5.3
Is enriched in AVK and NSM based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and pgl-1 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00009691	F44E5.4
Is enriched in GABAergic neurons; cephalic sheath cell; intestine; and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty-nine chemicals including Heme; Cyclosporine; and dimedone based on microarray; proteomic; and RNA-seq studies. Is predicted to encode a protein with the following domains: Hsp70 protein; Heat shock protein 70 family; Heat shock protein 70kD, peptide-binding domain superfamily; Heat shock protein 70kD, C-terminal domain superfamily; and ATPase, nucleotide binding domain.

WB:WBGene00009692	F44E5.5
Is predicted to have several functions, including ATP binding activity; ATPase activity; and unfolded protein binding activity. Is an ortholog of human HSPA6 (heat shock protein family A (Hsp70) member 6).

WB:WBGene00009693	F44F1.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride and paraquat based on microarray studies.

WB:WBGene00009695	clp-8
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy. Is an ortholog of human CAPN15 (calpain 15).

WB:WBGene00009696	F44F1.4
Is enriched in excretory cell; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein sepa-1.

WB:WBGene00009697	F44F1.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009698	F44F1.6
Localizes to cytoplasm.

WB:WBGene00009700	lurp-1
Is enriched in ALM; NSM; PLM; head mesodermal cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; bisphenol S; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Ly-6 antigen/uPA receptor-like.

WB:WBGene00009701	egg-3
Exhibits protein kinase binding activity. Is involved in cortical actin cytoskeleton organization; female gamete generation; and positive regulation of protein localization to cell cortex. Localizes to cell cortex.

WB:WBGene00009702	F44F4.3
Is enriched in germ line; germline precursor cell; interneuron; seam cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and lin-4 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; indole; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00009703	F44F4.8
No description available

WB:WBGene00009704	F44F4.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including antimycin; paraquat; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00009705	F44F4.10
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009706	argk-1
Is predicted to have creatine kinase activity. Is expressed in IL socket cell and OL socket cell. Is an ortholog of human CKMT2 (creatine kinase, mitochondrial 2).

WB:WBGene00009707	srxa-16
Is affected by several genes including drh-3; cyc-1; and mir-34 based on microarray; tiling array; and RNA-seq studies. Is affected by paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx; 7TM GPCR, serpentine receptor class xa (Srxa); and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00009708	F44G3.7
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpin family; Serpin superfamily; Serpin superfamily, domain 1; and Serpin superfamily, domain 2.

WB:WBGene00009709	fbxa-144
Is enriched in ALM; AVA; and PLM based on tiling array and microarray studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Zidovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00009710	F44G3.10
Is involved in innate immune response.

WB:WBGene00009711	F44G4.1
Is enriched in AVA; body wall muscle cell; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by nine chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Brix domain and Brix domain. Is an ortholog of human RPF1 (ribosome production factor 1 homolog).

WB:WBGene00009712	F44G4.2
Localizes to mitochondrion. Is an ortholog of human NDUFB2 (NADH:ubiquinone oxidoreductase subunit B2).

WB:WBGene00009713	F44G4.3
Is enriched in arcade cell; body wall muscle cell; germ line; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009714	F44G4.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009715	F44G4.6
Is enriched in body wall muscle cell; head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including aak-2; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; multi-walled carbon nanotube; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00009716	F44G4.7
Is enriched in ASER and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by Rotenone and Colistin based on RNA-seq and microarray studies.

WB:WBGene00009717	dep-1
Exhibits phosphatase activity. Is involved in positive regulation of vulval development; protein dephosphorylation; and vulval cell fate specification. Is expressed in several structures, including P5.paa; P5.pap; P5.ppa; vulval cell; and vulval cell. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 6. Is an ortholog of human PTPRB (protein tyrosine phosphatase receptor type B).

WB:WBGene00009720	F45B8.3
Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including 1-methylnicotinamide; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009721	F45D3.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including diallyl trisulfide; hydrogen sulfide; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Pes-10 and Pes-10.

WB:WBGene00009722	F45D3.2
Is expressed in body wall musculature. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009723	F45D3.3
Is enriched in PLM; germline precursor cell; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; Rotenone; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00009724	F45D3.4
Is enriched in several structures, including AFD; body wall musculature; germline precursor cell; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00009725	F45E6.1
Is affected by several genes including daf-2; daf-12; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009726	tbc-13
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBC1D13 (TBC1 domain family member 13).

WB:WBGene00009727	lips-1
Is predicted to have lipase activity.

WB:WBGene00009728	sdz-19
Is enriched in AVK; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Mercuric Chloride; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein lin-15B-like.

WB:WBGene00009729	F45E10.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A4 (solute carrier family 22 member 4) and SLC22A5 (solute carrier family 22 member 5).

WB:WBGene00009730	myo-6
Is predicted to have ATP binding activity; actin filament binding activity; and motor activity. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH6 (myosin heavy chain 6); MYH7 (myosin heavy chain 7); and MYH7B (myosin heavy chain 7B).

WB:WBGene00009731	exo-1
Is predicted to have 5'-3' exodeoxyribonuclease activity and 5'-flap endonuclease activity. Is an ortholog of human EXO1 (exonuclease 1).

WB:WBGene00009732	cope-1
Is predicted to have structural molecule activity. Localizes to mitochondrion. Is an ortholog of human COPE (COPI coat complex subunit epsilon).

WB:WBGene00009733	F45G2.7
Is enriched in germ line; germline precursor cell; interneuron; motor neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Mianserin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00009734	F45G2.8
Is enriched in AVK; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Pam16; Mitochondrial import inner membrane translocase subunit Tim16; and Chaperone J-domain superfamily. Is an ortholog of human PAM16 (presequence translocase associated motor 16).

WB:WBGene00009735	F45G2.9
Is predicted to have rRNA (uridine-2'-O-)-methyltransferase activity. Is an ortholog of human MRM2 (mitochondrial rRNA methyltransferase 2).

WB:WBGene00009736	F45G2.10
Is enriched in body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Iron-sulfur cluster assembly protein; MIP18 family-like; Fe-S cluster assembly domain superfamily; and MIP18 family. Is an ortholog of human CIAO2B (cytosolic iron-sulfur assembly component 2B).

WB:WBGene00009738	hecw-1
Is predicted to have ubiquitin protein ligase activity. Is involved in regulation of defense response to bacterium. Is expressed in SMDVL and head neurons. Is an ortholog of human HECW1 (HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1) and HECW2 (HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2).

WB:WBGene00009739	F45H10.2
Is predicted to contribute to ubiquinol-cytochrome-c reductase activity. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 4. Is an ortholog of human UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII).

WB:WBGene00009740	F45H10.3
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is an ortholog of human NDUFA7 (NADH:ubiquinone oxidoreductase subunit A7).

WB:WBGene00009741	drr-1
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Mianserin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009742	F45H10.5
Is enriched in body wall muscle cell; dopaminergic neurons; head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; glh-1; and atfs-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00009743	sptf-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in ASJ; epithelial cell; intestinal cell; and pharyngeal cell. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 12.

WB:WBGene00009744	hpo-35
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by six chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009745	cox-19
Is enriched in NSM; germ line; intestine; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CHCH domain and CHCH. Is an ortholog of human COX19 (cytochrome c oxidase assembly factor COX19).

WB:WBGene00009746	F46A8.3
Is predicted to have galactoside binding activity. Is an ortholog of human LGALSL (galectin like).

WB:WBGene00009747	F46A8.4
Is predicted to have galactoside binding activity. Is an ortholog of human LGALSL (galectin like).

WB:WBGene00009748	F46A8.5
Is predicted to have galactoside binding activity. Is an ortholog of human LGALS12 (galectin 12).

WB:WBGene00009749	F46A8.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00009750	F46A8.7
Is enriched in AFD; ASER; and neurons based on RNA-seq and microarray studies. Is affected by several genes including skn-1; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Tunicamycin; Cadmium Chloride; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00009751	F46A8.8
Is predicted to have galactoside binding activity. Is an ortholog of human LGALSL (galectin like).

WB:WBGene00009752	F46A8.9
Is affected by several genes including daf-2; dpy-10; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including methylmercuric chloride; Cisplatin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00009753	scrm-6
Is predicted to have phospholipid scramblase activity. Is an ortholog of several human genes including PLSCR1 (phospholipid scramblase 1); PLSCR3 (phospholipid scramblase 3); and PLSCR4 (phospholipid scramblase 4).

WB:WBGene00009754	F46A9.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including nicotinic acid; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00009755	F46A9.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00009756	F46B3.1
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; pmk-1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00009757	F46B3.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including age-1; let-60; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009758	ttr-11
Is expressed in DVA; HSNL; HSNR; excretory gland cell; and hyp10. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00009759	ttr-12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family and Transthyretin-like.

WB:WBGene00009760	F46B3.7
Is enriched in AVK and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including lin-4; lin-14; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including tryptophan; Tunicamycin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00009761	F46B3.8
Is affected by several genes including sir-2.1; hpl-2; and mir-34 based on tiling array and microarray studies. Is affected by fluoranthene; tetrabromobisphenol A; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00009762	F46B3.9
Is affected by several genes including daf-16; daf-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: Follistatin-like, N-terminal.

WB:WBGene00009763	srz-18
Is affected by several genes including daf-2; eri-1; and rrf-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00009764	srz-17
Is affected by clk-1; daf-2; and sir-2.1 based on microarray studies.

WB:WBGene00009765	F46B3.14
Is affected by several genes including clk-1; csr-1; and ain-1 based on RNA-seq and microarray studies. Is affected by Diazinon and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: Follistatin-like, N-terminal.

WB:WBGene00009766	F46B3.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus and allantoin based on microarray studies.

WB:WBGene00009767	F46B3.16
Is affected by several genes including clk-1; eat-2; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol; fluoranthene; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box associated domain, type 2; and F-box protein she-1-like.

WB:WBGene00009768	F46B6.2
Is enriched in AVE; RID; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and Zidovudine based on RNA-seq studies.

WB:WBGene00009769	F46B6.4
Is predicted to have GTP binding activity and metal ion binding activity. Is an ortholog of human GTPBP6 (GTP binding protein 6 (putative)).

WB:WBGene00009770	F46B6.5
Is enriched in germ line; germline precursor cell; hypodermis; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Zidovudine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LisH and LIS1 homology motif.

WB:WBGene00009771	F46B6.6
Is predicted to have GTP binding activity and GTPase activity. Is an ortholog of human MTIF2 (mitochondrial translational initiation factor 2).

WB:WBGene00009772	ztf-7
Is enriched in coelomocyte; germ line; and neurons based on proteomic; Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; let-7; and gld-1 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by seven chemicals including Rotenone; Cry5B; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; C2H2 type zinc-finger (2 copies); Zinc finger C2H2-type; Zinc finger C2H2 superfamily; Zinc finger protein 277; and ZN622/Rei1/Reh1, zinc finger C2H2-type. Is an ortholog of human ZNF277 (zinc finger protein 277).

WB:WBGene00009773	lipl-2
Is predicted to have hydrolase activity, acting on ester bonds. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of several human genes including LIPF (lipase F, gastric type); LIPK (lipase family member K); and LIPN (lipase family member N).

WB:WBGene00009774	F46B6.9
Is enriched in BAG; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009775	F46B6.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by hydrogen sulfide and methylmercuric chloride based on microarray studies.

WB:WBGene00009776	F46B6.12
Is predicted to have zinc ion binding activity. Is an ortholog of human CZIB (CXXC motif containing zinc binding protein).

WB:WBGene00009777	F46C3.2
Is enriched in body wall musculature and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00009778	F46C5.1
Is enriched in DA neuron; VA neuron; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5380) and Uncharacterised protein family F46C5.1.

WB:WBGene00009779	F46C5.2
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; pmk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009780	F46C5.4
Is enriched in germ line; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009781	F46C5.6
Is predicted to have protein phosphatase regulator activity. Is an ortholog of human PPP4R4 (protein phosphatase 4 regulatory subunit 4).

WB:WBGene00009782	F46C5.7
Is enriched in neurons; seam cell; ventral nerve cord; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine and paraquat based on microarray studies.

WB:WBGene00009783	rer-1
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human RER1 (retention in endoplasmic reticulum sorting receptor 1).

WB:WBGene00009784	F46C5.9
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human TBL2 (transducin beta like 2).

WB:WBGene00009785	F46C5.10
Is enriched in AFD; PLM; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5380) and Uncharacterised protein family F46C5.1.

WB:WBGene00009786	F46F2.1
Is affected by several genes including pgl-1; glh-1; and smg-2 based on tiling array and RNA-seq studies. Is affected by nine chemicals including aldicarb; stavudine; and metformin based on microarray and RNA-seq studies.

WB:WBGene00009787	F46F2.3
Is expressed in hypodermis.

WB:WBGene00009788	F46F2.4
Is affected by several genes including lin-4; lin-14; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009789	F46F2.5
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00009790	lgc-44
Is predicted to contribute to chloride channel activity.

WB:WBGene00009791	F46F3.3
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009793	pkn-1
Is predicted to have protein serine/threonine kinase activity. Localizes to M band and striated muscle dense body. Is expressed in neurons and pharyngeal muscle cell. Is an ortholog of human PKN3 (protein kinase N3).

WB:WBGene00009796	F46G10.1
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 3 and scalp-ear-nipple syndrome. Is predicted to encode a protein with the following domains: Phosphorylation site; BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD18 (potassium channel tetramerization domain containing 18) and KCTD6 (potassium channel tetramerization domain containing 6).

WB:WBGene00009797	F46G10.2
Is enriched in AFD; body wall musculature; male-specific anatomical entity; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009798	F46G10.4
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rifampin; allantoin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00009799	lgc-47
Is predicted to have chloride channel activity.

WB:WBGene00009800	rrc-1
Exhibits GTPase activator activity. Is involved in positive regulation of GTPase activity. Is expressed in GLRL; GLRR; coelomocyte; excretory cell; and uterine seam cell. Human ortholog(s) of this gene are implicated in Adams-Oliver syndrome. Is an ortholog of human ARHGAP33 (Rho GTPase activating protein 33).

WB:WBGene00009801	ipla-2
Is predicted to have actin filament binding activity. Is involved in intestinal lipid catabolic process and response to starvation. Localizes to cytoplasm. Human ortholog(s) of this gene are implicated in Parkinson's disease 14; autosomal recessive nonsyndromic deafness 36; and neurodegeneration with brain iron accumulation (multiple). Is an ortholog of human PLA2G6 (phospholipase A2 group VI).

WB:WBGene00009802	F47B8.1
Is enriched in muscle cell based on microarray studies. Is affected by several genes including age-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00009803	F47B8.2
Is enriched in hypodermis; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00009804	F47B8.3
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity. Is expressed in several structures, including GABAergic neurons; head muscle; head neurons; intestinal cell; and pharyngeal cell.

WB:WBGene00009805	F47B8.4
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity. Is involved in innate immune response.

WB:WBGene00009806	F47B8.5
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercury hydroxide; 1-methylnicotinamide; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00009807	pepm-1
Is expressed in vulC; vulD; vulE; and vulF. Is predicted to encode a protein with the following domains: Peptidase M1 N-terminal domain and Aminopeptidase N-like , N-terminal.

WB:WBGene00009808	srm-4
Is expressed in ciliated neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00009809	F47B8.8
Is expressed in vulva. Is predicted to encode a protein with the following domains: Peptidase M1 N-terminal domain and Aminopeptidase N-like , N-terminal.

WB:WBGene00009810	srm-6
Is expressed in amphid neurons; intestine; and retrovesicular ganglion. Is predicted to encode a protein with the following domain: .

WB:WBGene00009811	F47B8.10
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in glycogen storage disease I. Is an ortholog of human SLC37A4 (solute carrier family 37 member 4).

WB:WBGene00009812	suca-1
Is predicted to have succinate-CoA ligase (ADP-forming) activity. Localizes to mitochondrion. Is expressed in anterior gonad arm. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 5. Is an ortholog of human SUCLA2 (succinate-CoA ligase ADP-forming subunit beta).

WB:WBGene00009813	haly-1
Is predicted to have histidine ammonia-lyase activity. Is involved in histidine catabolic process; stress response to zinc ion; and zinc ion homeostasis. Human ortholog(s) of this gene are implicated in histidinemia. Is an ortholog of human HAL (histidine ammonia-lyase).

WB:WBGene00009814	F47B10.3
Is expressed in head neurons and tail neurons.

WB:WBGene00009815	F47B10.4
Is affected by several genes including eat-2; aak-2; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009816	F47B10.5
Is enriched in cephalic sheath cell; dopaminergic neurons; hypodermis; and mechanosensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Mianserin; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00009817	F47B10.6
Is enriched in NSM and coelomocyte based on tiling array studies. Is affected by several genes including clk-1; hpl-2; and rpn-10 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; resveratrol; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00009818	acbp-3
Is predicted to have fatty-acyl-CoA binding activity and lipid binding activity. Is involved in lipid storage. Is expressed in body wall musculature and pharynx. Is an ortholog of human ACBD4 (acyl-CoA binding domain containing 4) and ACBD5 (acyl-CoA binding domain containing 5).

WB:WBGene00009819	F47B10.8
Is enriched in muscle cell; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including tryptophan; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009820	F47B10.9
Is enriched in Z1.p; Z4.a; male distal tip cell; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; levamisole; and tert-Butylhydroperoxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00009821	F47C8.1
No description available

WB:WBGene00009822	clec-113
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; mex-3; and csr-1 based on tiling array and RNA-seq studies. Is affected by four chemicals including Psoralens; Sirolimus; and Ethanol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00009823	gadr-6
Is enriched in body wall musculature; intestine; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including D-glucopyranose; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-like helical; Armadillo-type fold; and Leucine-rich repeat domain superfamily.

WB:WBGene00009824	gpdh-1
Is predicted to have glycerol-3-phosphate dehydrogenase (quinone) activity and glycerol-3-phosphate dehydrogenase [NAD+] activity. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in Brugada syndrome 2. Is an ortholog of human GPD1 (glycerol-3-phosphate dehydrogenase 1) and GPD1L (glycerol-3-phosphate dehydrogenase 1 like).

WB:WBGene00009825	F47G4.4
Contributes to microtubule-severing ATPase activity. Is involved in microtubule depolymerization. Localizes to katanin complex. Is an ortholog of human KATNB1 (katanin regulatory subunit B1).

WB:WBGene00009826	F47G4.5
Contributes to microtubule-severing ATPase activity. Is involved in microtubule depolymerization. Localizes to katanin complex. Is expressed in amphid neurons; inner labial neurons; outer labial neurons; and phasmid neurons.

WB:WBGene00009827	hmg-6
Is predicted to have DNA binding activity. Is expressed in amphid neurons; head neurons; phasmid neurons; and tail neurons. Is an ortholog of human TOX4 (TOX high mobility group box family member 4).

WB:WBGene00009828	F47G4.8
Is affected by several genes including rrf-3; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb; cadmium; and allantoin based on microarray studies.

WB:WBGene00009829	tmed-10
Is enriched in germ line; hypodermis; sensory neurons; somatic nervous system; and tail neurons based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including let-60; daf-12; and let-7 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by five chemicals including Rotenone; stavudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: emp24/gp25L/p24 family/GOLD; GOLD domain; and TMP21-related. Is an ortholog of human TMED10 (transmembrane p24 trafficking protein 10).

WB:WBGene00009830	cutl-18
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Heme; methylmercuric chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain; Zona pellucida domain; and PAN/Apple domain.

WB:WBGene00009831	F47G9.4
Is predicted to have Hsp70 protein binding activity and zinc ion binding activity. Is an ortholog of human RNF207 (ring finger protein 207).

WB:WBGene00009832	F47G9.5
No description available

WB:WBGene00009833	F47G9.6
Is predicted to have galactoside binding activity.

WB:WBGene00009834	lsy-27
Is expressed in ASE; embryonic cell; head; somatic nervous system; and tail neurons. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00009835	F47H4.2
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Tunicamycin; 4-bromodiphenyl ether; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00009836	fbxa-185
Is enriched in intestine and neurons based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; elt-2; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00009837	fbxa-186
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00009838	fbxa-187
Is enriched in OLL; PVD; and neurons based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by four chemicals including paraquat; resveratrol; and copper sulfate based on RNA-seq and microarray studies.

WB:WBGene00009839	fbxa-188
Is enriched in PLM; Z1; Z4; body wall muscle cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; F-box domain; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00009840	fbxa-189
Is enriched in several structures, including Z4.a; intestine; male distal tip cell; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; bisphenol A; and sesamin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00009841	fbxa-134
Is affected by several genes including eat-2; sir-2.1; and lin-22 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00009842	igeg-2
Is enriched in GABAergic neurons; excretory cell; head mesodermal cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Mercuric Chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold and Immunoglobulin-like domain superfamily.

WB:WBGene00009843	F48C5.2
Is enriched in hypodermis; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including stavudine; Tunicamycin; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain; Apple domain; and PAN/Apple domain.

WB:WBGene00009844	cwp-5
Is involved in neuronal signal transduction and response to hermaphrodite contact. Localizes to cell body; dendrite; and non-motile cilium. Is expressed in CEM; HOB; and ray neuron type B.

WB:WBGene00009846	F48F5.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00009848	F48F5.6
Is enriched in ASER and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and cep-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009849	F48F7.3
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00009850	F48F7.5
Is enriched in germline precursor cell; head mesodermal cell; hypodermis; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by ten chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009851	F48F7.6
Is enriched in body wall muscle cell; excretory cell; head mesodermal cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00009852	arrd-24
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; pmk-1; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including tryptophan; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00009853	arrd-27
Is affected by several genes including clk-1; aak-2; and mex-3 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00009854	clec-31
Is predicted to have carbohydrate binding activity.

WB:WBGene00009855	clec-22
Is predicted to have carbohydrate binding activity.

WB:WBGene00009856	clec-24
Is predicted to have carbohydrate binding activity.

WB:WBGene00009857	clec-28
Is predicted to have carbohydrate binding activity.

WB:WBGene00009858	thn-4
Is affected by daf-2; nhr-25; and daf-16 based on microarray studies. Is affected by Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Thaumatin family; Thaumatin family; and Osmotin/thaumatin-like superfamily.

WB:WBGene00009859	clec-33
Is predicted to have carbohydrate binding activity.

WB:WBGene00009860	clec-32
Is predicted to have carbohydrate binding activity.

WB:WBGene00009861	fbxb-8
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00009862	fbxb-67
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and npr-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00009863	F49B2.3
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including aldicarb; methylmercuric chloride; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00009864	F49B2.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00009865	F49B2.6
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is an ortholog of human ERAP1 (endoplasmic reticulum aminopeptidase 1); ERAP2 (endoplasmic reticulum aminopeptidase 2); and LNPEP (leucyl and cystinyl aminopeptidase).

WB:WBGene00009866	F49C5.3
Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by hydrogen sulfide based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009867	F49C5.4
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human NIM1K (NIM1 serine/threonine protein kinase).

WB:WBGene00009868	F49C5.5
Is affected by several genes including eat-2; sir-2.1; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including fluoranthene; Diazinon; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00009869	F49C5.7
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and mut-2 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin and Sirolimus based on microarray studies.

WB:WBGene00009870	F49C5.8
No description available

WB:WBGene00009871	F49C12.1
Is affected by several genes including clk-1; alg-1; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Ethanol; fluoranthene; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00009872	F49C12.2
Is enriched in AVK and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; npr-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Ethanol; tryptophan; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00009873	F49C12.3
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Ethanol; tryptophan; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00009874	F49C12.4
Is affected by several genes including clk-1; npr-1; and sek-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Ethanol; tryptophan; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00009875	F49C12.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00009876	F49C12.6
Is predicted to have carbohydrate transmembrane transporter activity. Is expressed in excretory cell. Is an ortholog of human TMEM144 (transmembrane protein 144).

WB:WBGene00009877	F49C12.7
Is enriched in several structures, including ASER; coelomocyte; germ line; head mesodermal cell; and intestine based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00009878	F49C12.9
Is predicted to have polyubiquitin modification-dependent protein binding activity.

WB:WBGene00009879	F49C12.10
Is predicted to have methyltransferase activity.

WB:WBGene00009880	F49C12.11
Is expressed in coelomocyte; hypodermis; and neurons. Is predicted to encode a protein with the following domains: Phosphorylation site; Translation machinery associated TMA7; and Translation machinery associated TMA7. Is an ortholog of human TMA7 (translation machinery associated 7 homolog).

WB:WBGene00009881	F49C12.12
Is predicted to have endoribonuclease activity. Is an ortholog of human RNASEK (ribonuclease K).

WB:WBGene00009882	vha-17
Is predicted to have hydrolase activity and proton transmembrane transporter activity. Is involved in embryo development; embryonic body morphogenesis; and regulation of syncytium formation by plasma membrane fusion. Localizes to apical junction complex and apical plasma membrane. Is expressed in excretory cell; hypodermal cell; and intestine. Is an ortholog of human ATP6V0E1 (ATPase H+ transporting V0 subunit e1) and ATP6V0E2 (ATPase H+ transporting V0 subunit e2).

WB:WBGene00009883	F49C12.14
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; paraquat; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009884	F49C12.15
Is enriched in germ line; intestine; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty-two chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009885	moc-5
Is predicted to have several functions, including 4 iron, 4 sulfur cluster binding activity; GTP 3',8'-cyclase activity; and GTP binding activity. Human ortholog(s) of this gene are implicated in molybdenum cofactor deficiency type A. Is an ortholog of human MOCS1 (molybdenum cofactor synthesis 1).

WB:WBGene00009886	F49E2.2
Is enriched in several structures, including Z4.a; intestine; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including glp-1; skn-1; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; SH3 domain; SH3 domain; and SH3-like domain superfamily.

WB:WBGene00009887	glb-17
Is predicted to have heme binding activity and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in hemolytic anemia (multiple); primary polycythemia (multiple); and sickle cell anemia.

WB:WBGene00009888	F49E2.5
Is enriched in Psub1; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including diallyl trisulfide; Tunicamycin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF612 and Protein of unknown function DUF612.

WB:WBGene00009889	F49E11.2
Is enriched in AVK; NSM; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; manganese chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Putative G-protein coupled receptor, Chromadorea.

WB:WBGene00009890	scl-9
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00009891	scl-10
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by Tunicamycin; Microcystin-LR; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00009892	scl-11
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including cholesterol; lathosterol; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2) and GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00009893	F49E11.7
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00009894	F49E11.8
Is enriched in NSM based on tiling array studies. Is affected by rsr-2; hpl-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00009895	scl-2
Is expressed in intestinal cell. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00009896	scl-3
Is expressed in g1AL; g1AR; g1P; g2L; and g2R. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00009897	skpo-1
Exhibits peroxidase activity. Is involved in defense response to Gram-positive bacterium; determination of adult lifespan; and negative regulation of gene expression. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7. Is an ortholog of human LPO (lactoperoxidase).

WB:WBGene00009898	dod-23
Is enriched in germ line; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twenty-two chemicals including aldicarb; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00009899	efl-3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific; sequence-specific DNA binding activity; and transcription factor binding activity. Is expressed in VA neuron; VB neuron; head neurons; and ventral nerve cord. Is an ortholog of human E2F7 (E2F transcription factor 7).

WB:WBGene00009900	F49E12.7
Is enriched in amphid sheath cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and ain-1 based on RNA-seq and microarray studies. Is affected by fluoranthene and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009901	F49E12.8
Is enriched in dopaminergic neurons and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009902	drd-1
Is predicted to have C-4 methylsterol oxidase activity. Is an ortholog of human FAXDC2 (fatty acid hydroxylase domain containing 2).

WB:WBGene00009903	F49E12.10
Is predicted to have C-4 methylsterol oxidase activity. Is an ortholog of human FAXDC2 (fatty acid hydroxylase domain containing 2).

WB:WBGene00009904	F49E12.12
Is enriched in AFD; ASER; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Ethanol; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Post-GPI attachment to proteins factor 2.

WB:WBGene00009905	clec-240
Is predicted to have carbohydrate binding activity.

WB:WBGene00009906	clec-241
Is predicted to have carbohydrate binding activity.

WB:WBGene00009907	F49H6.3
Is affected by several genes including clk-1; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Heme; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00009908	F49H6.5
Is predicted to have 4 iron, 4 sulfur cluster binding activity; catalytic activity; and metal ion binding activity. Human ortholog(s) of this gene are implicated in molybdenum cofactor deficiency type A. Is an ortholog of human MOCS1 (molybdenum cofactor synthesis 1).

WB:WBGene00009909	F49H6.8
Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00009910	srz-92
Is affected by let-60 based on microarray studies. Is affected by dafa#1 and Sirolimus based on microarray studies.

WB:WBGene00009911	srz-93
No description available

WB:WBGene00009912	srz-94
Is expressed in muscle cell. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00009913	F49H6.12
Is affected by mir-34 and eat-2 based on microarray studies. Is affected by Mercuric Chloride and Sirolimus based on microarray studies.

WB:WBGene00009914	F49H6.13
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Heme; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00009915	F52A8.1
Is enriched in several structures, including NSM; body wall musculature; germ line; intestine; and somatic gonad precursor based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including gld-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00009916	F52A8.3
Is enriched in AVK; DA neuron; VA neuron; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00009917	glb-18
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Localizes to endoplasmic reticulum. Is expressed in ventral nerve cord.

WB:WBGene00009918	gcsh-2
Is enriched in NSM; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in glycine encephalopathy. Is predicted to encode a protein with the following domains: Glycine cleavage H-protein; Glycine cleavage system H-protein; Single hybrid motif; Glycine cleavage system H-protein, subgroup; and Glycine cleavage system H-protein/Simiate. Is an ortholog of human GCSH (glycine cleavage system protein H).

WB:WBGene00009919	kbrl-1
Is predicted to have GTP binding activity and GTPase activity. Is expressed in head. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4. Is an ortholog of human NKIRAS1 (NFKB inhibitor interacting Ras like 1).

WB:WBGene00009920	abts-1
Exhibits anion:anion antiporter activity and chloride transmembrane transporter activity. Is involved in cholinergic synaptic transmission; regulation of GABAergic synaptic transmission; and response to arsenic-containing substance. Is expressed in HSN; accessory cell; body wall musculature; head; and pharynx. Is an ortholog of human SLC4A10 (solute carrier family 4 member 10).

WB:WBGene00009921	F52B5.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00009922	F52B5.3
Is predicted to have RNA binding activity. Is an ortholog of human YTHDC2 (YTH domain containing 2).

WB:WBGene00009923	F52B5.7
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2 superfamily.

WB:WBGene00009924	cfp-1
Is involved in transdifferentiation. Is an ortholog of human CXXC1 (CXXC finger protein 1).

WB:WBGene00009925	F52B11.2
Is predicted to have phosphomannomutase activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ia. Is an ortholog of human PMM2 (phosphomannomutase 2).

WB:WBGene00009926	noah-2
Is involved in molting cycle.

WB:WBGene00009927	F52B11.5
Is enriched in several structures, including PLM; head mesodermal cell; intestine; muscle cell; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009929	abts-2
Is predicted to have inorganic anion exchanger activity. Localizes to basolateral plasma membrane. Is expressed in dorsal-rectal ganglion neurons; gonadal sheath cell; and tail neurons. Human ortholog(s) of this gene are implicated in Fuchs' endothelial dystrophy; congenital hereditary endothelial dystrophy of cornea; and corneal dystrophy-perceptive deafness syndrome. Is an ortholog of human SLC4A11 (solute carrier family 4 member 11).

WB:WBGene00009930	F52D10.2
Is expressed in head and tail. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 37 and type 2 diabetes mellitus. Is predicted to encode a protein with the following domains: Phosphotyrosine interaction domain (PTB/PID); PTB/PI domain; and PH-like domain superfamily. Is an ortholog of human FAM43B (family with sequence similarity 43 member B).

WB:WBGene00009931	F52D10.4
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009933	F52E10.2
Is affected by rsr-2; ifg-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00009935	F52E10.4
Is enriched in coelomocyte and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009936	C02D4.t1
Is affected by hmg-3 and adr-1 based on RNA-seq studies.

WB:WBGene00009937	lsl-1
Is enriched in AVK; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; gld-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in eye disease (multiple) and transient neonatal diabetes mellitus. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human ZFP57 (ZFP57 zinc finger protein).

WB:WBGene00009938	F52F12.5
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00009939	ztf-11
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including generation of neurons; nematode larval development; and positive regulation of transdifferentiation. Localizes to nucleus. Is expressed in g1 and head neurons. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 39. Is an ortholog of human MYT1L (myelin transcription factor 1 like).

WB:WBGene00009940	strl-1
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia. Is an ortholog of human STAR (steroidogenic acute regulatory protein).

WB:WBGene00009941	F52F12.8
Is enriched in amphid sheath cell and germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00009942	F52F12.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00009943	F52G2.3
Is enriched in OLL; PVD; body wall muscle cell; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; RSD-2 N-terminal domain; and RSD-2, N-terminal.

WB:WBGene00009944	mtcu-2
Is predicted to have flavin adenine dinucleotide binding activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 10. Is an ortholog of human MTO1 (mitochondrial tRNA translation optimization 1).

WB:WBGene00009945	bath-38
Is expressed in several structures, including hypodermis and pharynx. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00009946	ogr-2
Is expressed in gonad. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00009947	ttc-36
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including juglone; 4-bromodiphenyl ether; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TPR repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and Tetratricopeptide repeat protein 36. Is an ortholog of human TTC36 (tetratricopeptide repeat domain 36).

WB:WBGene00009948	F52H3.6
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00009949	F53A2.1
Is enriched in AVK; dopaminergic neurons; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009950	sdz-20
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009951	F53A2.3
Is enriched in RIM; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009952	acaa-2
Is predicted to have acetyl-CoA C-acetyltransferase activity. Is an ortholog of human ACAA2 (acetyl-CoA acyltransferase 2).

WB:WBGene00009953	F53A2.9
Is enriched in several structures, including body wall muscle cell; coelomocyte; excretory cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00009954	F53B2.1
Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00009955	eak-4
Is involved in dauer larval development. Localizes to plasma membrane. Is expressed in XXXL and XXXR.

WB:WBGene00009956	F53B2.5
Is predicted to have nuclear localization sequence binding activity.

WB:WBGene00009957	F53B2.8
Is enriched in head mesodermal cell; intestine; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirty chemicals including Ethanol; Nitric Oxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00009958	madd-4
Exhibits signaling receptor binding activity. Is involved in dorsal/ventral axon guidance and synapse organization. Localizes to extracellular space. Is expressed in blast cell; neurons; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is an ortholog of human ADAMTSL1 (ADAMTS like 1); ADAMTSL3 (ADAMTS like 3); and THSD4 (thrombospondin type 1 domain containing 4).

WB:WBGene00009959	F53B6.4
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-two chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00009960	F53B6.5
Is affected by several genes including let-60; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Creatinase/aminopeptidase-like; Winged helix-like DNA-binding domain superfamily; and Winged helix DNA-binding domain superfamily. Is an ortholog of human METAP2 (methionyl aminopeptidase 2).

WB:WBGene00009961	cutl-7
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including lin-4; lin-14; and eat-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00009962	F53B6.7
Is enriched in OLL; PVD; germ line; and in male based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 1); Histidine phosphatase superfamily, clade-1; and Histidine phosphatase superfamily. Is an ortholog of human UBASH3A (ubiquitin associated and SH3 domain containing A) and UBASH3B (ubiquitin associated and SH3 domain containing B).

WB:WBGene00009963	fipr-26
Is enriched in cephalic sheath cell; dopaminergic neurons; excretory cell; hypodermis; and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-six chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00009964	fip-6
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Nitric Oxide; methylmercury hydroxide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00009965	frpr-9
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00009966	isy-1
Is involved in regulation of primary miRNA processing. Localizes to nucleus. Is expressed in several structures, including hypodermis and neurons. Is an ortholog of human ISY1-RAB43 (ISY1-RAB43 readthrough).

WB:WBGene00009967	F53B7.4
Is enriched in AVA; AVE; neurons; and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including sir-2.1; dpy-21; and drh-3 based on RNA-seq and microarray studies. Is affected by copper sulfate based on microarray studies.

WB:WBGene00009968	fig-1
Is expressed in amphid sheath cell and phasmid sheath cell. Is predicted to encode a protein with the following domains: C6 domain; Thrombospondin type-1 (TSP1) repeat; C6 domain; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00009969	F53B7.7
Is enriched in several structures, including excretory cell; intestine; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and dpy-7 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009971	F53C11.1
Localizes to membrane raft.

WB:WBGene00009972	oac-33
Is enriched in muscle cell based on microarray studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00009973	F53C11.3
Is predicted to have oxidoreductase activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is an ortholog of human DECR1 (2,4-dienoyl-CoA reductase 1).

WB:WBGene00009974	F53C11.4
Is enriched in AVK; NSM; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including bisphenol S; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00009975	F53C11.5
Is enriched in OLL; PVD; dopaminergic neurons; germ line; and intestine based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009976	swan-2
Is involved in response to heat and response to osmotic stress. Is expressed in head. Is an ortholog of human DCAF7 (DDB1 and CUL4 associated factor 7).

WB:WBGene00009977	swan-1
Exhibits LIM domain binding activity and Rac GTPase binding activity. Is involved in several processes, including negative regulation of phagocytosis, engulfment; regulation of GTPase activity; and regulation of axon extension. Localizes to cytoplasm. Is expressed in several structures, including neuroblasts and neurons. Is an ortholog of human DCAF7 (DDB1 and CUL4 associated factor 7).

WB:WBGene00009978	F53E4.1
Is predicted to have chromatin binding activity. Is expressed in tail. Is an ortholog of human KLHDC3 (kelch domain containing 3).

WB:WBGene00009979	cutl-1
Is enriched in intestine based on microarray studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00009980	F53F1.2
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2. Is an ortholog of human AKR1B1 (aldo-keto reductase family 1 member B) and AKR1D1 (aldo-keto reductase family 1 member D1).

WB:WBGene00009981	F53F1.3
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00009982	F53F1.4
Is enriched in AFD; ASER; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-five chemicals including aldicarb; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00009983	cut-2
Is predicted to be a structural constituent of cuticle.

WB:WBGene00009984	F53F1.6
Is enriched in body wall muscle cell; coelomocyte; germline precursor cell; and intestine based on tiling array; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00009985	F53F4.1
Is enriched in GABAergic neurons; amphid sheath cell; excretory cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by Colistin based on microarray studies.

WB:WBGene00009986	F53F4.2
Is affected by several genes including rrf-3; elt-2; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009987	tbcb-1
Is enriched in FLP; PLM; germ line; and neurons based on microarray and RNA-seq studies. Is affected by several genes including let-7; gld-1; and clk-1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CAP-Gly domain; Ubiquitin-like domain; Ubiquitin-like domain; CAP Gly-rich domain; Ubiquitin-like domain superfamily; and CAP Gly-rich domain superfamily. Is an ortholog of human TBCB (tubulin folding cofactor B).

WB:WBGene00009988	F53F4.4
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00009990	F53F4.7
Is affected by several genes including daf-16; let-60; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; Alovudine; and single-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00009991	F53F4.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00009992	F53F4.10
Is predicted to contribute to NADH dehydrogenase activity. Is an ortholog of human NDUFV2 (NADH:ubiquinone oxidoreductase core subunit V2).

WB:WBGene00009993	F53F4.11
Is predicted to have RNA binding activity. Is an ortholog of human RSL1D1 (ribosomal L1 domain containing 1).

WB:WBGene00009994	F53F4.12
Is enriched in AVK; body wall muscle cell; germ line; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by four chemicals including Zidovudine; Humic Substances; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00009995	F53F4.13
Is expressed in amphid sheath cell and phasmid sheath cell. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00009996	sde-2
Is enriched in AVA; body wall muscle cell; germ line; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; fbf-1; and hlh-30 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; levamisole; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Silencing defective 2 N-terminal ubiquitin domain; Telomere stability C-terminal; and Sde2, N-terminal ubiquitin domain. Is an ortholog of human SDE2 (SDE2 telomere maintenance homolog).

WB:WBGene00009997	F53F4.15
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00009998	klf-2
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in intestine. Human ortholog(s) of this gene are implicated in several diseases, including chromosome 15q13.3 microdeletion syndrome; maturity-onset diabetes of the young type 7; and prostate cancer. Is an ortholog of human KLF5 (Kruppel like factor 5).

WB:WBGene00009999	srsx-35
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00010000	F53F8.3
Is enriched in BAG; germ line; germline precursor cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00010001	F53F8.4
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; DB module; and Domain of unknown function DB.

WB:WBGene00010002	F53F8.5
Is enriched in NSM; germ line; and seam cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; SAM domain (Sterile alpha motif); Sterile alpha motif domain; Sterile alpha motif/pointed domain superfamily; and Uncharacterized protein C19orf47-like. Is an ortholog of human C19orf47 (chromosome 19 open reading frame 47).

WB:WBGene00010003	F53F8.6
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; eat-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00010004	F53H2.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Sirolimus; multi-walled carbon nanotube; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00010005	cnc-7
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including 1-methylnicotinamide; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00010006	F53H2.3
Is expressed in gonad and intestine.

WB:WBGene00010007	F53H4.2
Is enriched in GABAergic neurons and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including aldicarb; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00010008	F53H4.3
Is enriched in Z1; Z4; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010009	F53H4.4
Is enriched in muscle cell and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq; tiling array; and microarray studies. Is affected by nine chemicals including Cry5B; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010010	gmeb-2
Is predicted to have DNA binding activity and transcription coactivator activity. Is an ortholog of human GMEB1 (glucocorticoid modulatory element binding protein 1) and GMEB2 (glucocorticoid modulatory element binding protein 2).

WB:WBGene00010011	F53H4.6
Is predicted to have DNA-dependent ATPase activity. Human ortholog(s) of this gene are implicated in several diseases, including CHARGE syndrome; Cockayne syndrome; and Coffin-Siris syndrome 4. Is an ortholog of human ERCC6 (ERCC excision repair 6, chromatin remodeling factor).

WB:WBGene00010012	saeg-1
Is predicted to have DNA-binding transcription factor activity; transcription factor binding activity; and transcription regulatory region DNA binding activity. Localizes to nucleus. Is an ortholog of human TRERF1 (transcriptional regulating factor 1).

WB:WBGene00010013	F54B3.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 18. Is predicted to encode a protein with the following domains: Phosphorylation site and Protein SZT2. Is an ortholog of human SZT2 (SZT2 subunit of KICSTOR complex).

WB:WBGene00010014	F54B3.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mianserin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010015	atad-3
Is predicted to have zinc ion binding activity. Is involved in mitochondrion organization. Localizes to mitochondrion. Is an ortholog of human ATAD3A (ATPase family AAA domain containing 3A).

WB:WBGene00010016	F54B8.1
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including clk-1; pmk-1; and aak-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Cadmium Chloride; Atrazine; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00010017	nhr-282
Is enriched in Z1; Z4; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and pmk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Atrazine; fluoranthene; and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00010018	fbxa-69
Is enriched in several structures, including Z4.a; dopaminergic neurons; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; manganese chloride; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00010019	F54B8.4
Is predicted to have death domain binding activity. Is involved in innate immune response. Is an ortholog of human DAP (death associated protein).

WB:WBGene00010020	srbc-48
Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010021	srbc-49
Is enriched in neurons based on microarray studies. Is affected by rsr-2 and eat-2 based on tiling array and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010022	srbc-50
Is enriched in intestine based on microarray studies. Is affected by several genes including hpl-2; ain-1; and cyc-1 based on microarray and tiling array studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010023	srbc-51
Is affected by several genes including clk-1; eat-2; and spn-4 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010024	srbc-52
Is expressed in PVT.

WB:WBGene00010025	srbc-54
Is affected by rsr-2 and eat-2 based on tiling array and microarray studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010026	srbc-56
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010027	F54B11.4
Is enriched in RID based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00010028	F54B11.5
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human RNF141 (ring finger protein 141).

WB:WBGene00010030	F54B11.7
Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010031	F54B11.8
Is enriched in Z1.p; Z4.a; male distal tip cell; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010032	F54B11.9
Is enriched in ALM; GABAergic neurons; PLM; body wall muscle cell; and muscle cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including skn-1; daf-12; and dpy-7 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including 1-methylnicotinamide; D-glucose; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00010033	F54B11.10
Is enriched in ASER; NSM; PLM; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; pmk-1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00010034	F54B11.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by sixteen chemicals including bisphenol A; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010035	F54C8.1
Is predicted to have 3-hydroxyacyl-CoA dehydrogenase activity and NAD+ binding activity. Human ortholog(s) of this gene are implicated in familial hyperinsulinemic hypoglycemia 4. Is an ortholog of human HADH (hydroxyacyl-CoA dehydrogenase).

WB:WBGene00010036	cpar-1
Is predicted to have DNA binding activity and protein heterodimerization activity. Is involved in mitotic sister chromatid segregation. Localizes to condensed chromosome and nucleus. Colocalizes with chromosome.

WB:WBGene00010037	F54C8.4
Is predicted to have mRNA guanylyltransferase activity. Is expressed in AB and pharynx. Is an ortholog of human DUSP11 (dual specificity phosphatase 11).

WB:WBGene00010038	rheb-1
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is expressed in head neurons; hypodermis; tail neurons; and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4. Is an ortholog of human RHEB (Ras homolog, mTORC1 binding).

WB:WBGene00010039	F54C8.6
Is enriched in DA neuron; VA neuron; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; Cry5B; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010040	F54C8.7
Is predicted to have phospholipid binding activity. Is involved in IRE1-mediated unfolded protein response. Localizes to mitochondrion. Is an ortholog of human ARFIP1 (ADP ribosylation factor interacting protein 1) and ARFIP2 (ADP ribosylation factor interacting protein 2).

WB:WBGene00010041	F54C9.3
Is enriched in head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010042	bcs-1
Is predicted to have ATP binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bjornstad syndrome; GRACILE syndrome; and mitochondrial complex III deficiency nuclear type 1. Is an ortholog of human BCS1L (BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone).

WB:WBGene00010043	F54C9.7
Is involved in negative regulation of fatty acid transport; regulation of lipid storage; and regulation of peptide transport. Is expressed in excretory cell; hypodermis; intestinal cell; and pharyngeal muscle cell.

WB:WBGene00010044	F54C9.9
Is enriched in coelomocyte; germ line; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; sek-1; and pgl-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including D-glucose; Linolenic Acids; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; KRI1-like family; KRI1-like family C-terminal; KRR1 interacting protein 1; and Kri1-like, C-terminal. Is an ortholog of human KRI1 (KRI1 homolog).

WB:WBGene00010045	F54C9.11
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in hypodermis; vulA; vulB1; vulB2; and vulval muscle. Is an ortholog of human RAB3IP (RAB3A interacting protein).

WB:WBGene00010046	F54D1.1
Is predicted to have RNA binding activity. Is an ortholog of human QKI (QKI, KH domain containing RNA binding).

WB:WBGene00010047	F54D1.6
Is predicted to have microtubule-severing ATPase activity.

WB:WBGene00010048	F54D5.2
Is enriched in several structures, including Psub3; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010049	F54D5.3
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5352) and Protein of unknown function DUF5352.

WB:WBGene00010050	F54D5.4
Is involved in innate immune response.

WB:WBGene00010051	F54D5.5
Is enriched in germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Cry5B; and glycine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010052	F54D5.7
Is predicted to have flavin adenine dinucleotide binding activity; glutaryl-CoA dehydrogenase activity; and glutaryl-CoA hydrolase activity. Human ortholog(s) of this gene are implicated in glutaric acidemia I. Is an ortholog of human GCDH (glutaryl-CoA dehydrogenase).

WB:WBGene00010053	F54D5.9
Is enriched in AVK; germ line; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box only protein 47. Is an ortholog of human FBXO47 (F-box protein 47).

WB:WBGene00010054	gtf-2E2
Exhibits RNA polymerase II complex binding activity. Is involved in transcription initiation from RNA polymerase II promoter. Localizes to transcription factor TFIIE complex. Is an ortholog of human GTF2E2 (general transcription factor IIE subunit 2).

WB:WBGene00010055	F54D5.12
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity. Human ortholog(s) of this gene are implicated in D-2-hydroxyglutaric aciduria 1. Is an ortholog of human D2HGDH (D-2-hydroxyglutarate dehydrogenase).

WB:WBGene00010056	smc-6
Is predicted to have ATP binding activity. Localizes to condensed nuclear chromosome and nucleoplasm. Is an ortholog of human SMC6 (structural maintenance of chromosomes 6).

WB:WBGene00010057	F54D5.15
Is enriched in GABAergic neurons based on microarray studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including stavudine; Zidovudine; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010058	F54E4.2
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00010059	F54E4.3
Is enriched in body wall musculature; head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including aldicarb; nanoparticle; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00010060	F54E4.4
Is expressed in AIYL and AIYR. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type III. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00010061	F54E12.2
Is predicted to have ATP binding activity. Is an ortholog of human TTF2 (transcription termination factor 2).

WB:WBGene00010062	lipl-1
Is predicted to have hydrolase activity, acting on ester bonds. Is involved in lipid catabolic process. Localizes to lysosome. Is expressed in intestine. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of several human genes including LIPF (lipase F, gastric type); LIPK (lipase family member K); and LIPN (lipase family member N).

WB:WBGene00010063	dhrs-4
Exhibits carbonyl reductase (NADPH) activity. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is an ortholog of human DHRS2 (dehydrogenase/reductase 2); DHRS4 (dehydrogenase/reductase 4); and DHRS4L2 (dehydrogenase/reductase 4 like 2).

WB:WBGene00010064	F54F7.2
Is enriched in AVK; coelomocyte; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00010065	F54F7.3
Is enriched in AVG; RIM; amphid sheath cell; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including Ethanol; Rotenone; and sodium arsenite based on RNA-seq and microarray studies.

WB:WBGene00010066	F54F7.6
Is enriched in germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010067	dot-1.2
Is predicted to have histone methyltransferase activity (H3-K79 specific). Is an ortholog of human DOT1L (DOT1 like histone lysine methyltransferase).

WB:WBGene00010068	F54F7.8
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including tryptophan; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00010069	F54F11.1
Is expressed in pharyngeal gland cell. Is predicted to encode a protein with the following domain: SGNH hydrolase superfamily.

WB:WBGene00010070	nep-17
Is predicted to have metalloendopeptidase activity. Localizes to membrane raft. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension. Is an ortholog of human KEL (Kell metallo-endopeptidase (Kell blood group)).

WB:WBGene00010071	sre-45
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00010072	F54F12.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010073	F54F12.2
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sek-1; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010074	irld-34
Is enriched in ASER; muscle cell; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including alg-1; daf-19; and dpy-21 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; resveratrol; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00010075	F55A11.1
Is predicted to have calcium ion binding activity. Is an ortholog of human MCFD2 (multiple coagulation factor deficiency 2, ER cargo receptor complex subunit).

WB:WBGene00010077	F55A11.4
Is predicted to have ATP transmembrane transporter activity and calcium ion binding activity. Is an ortholog of human SLC25A25 (solute carrier family 25 member 25).

WB:WBGene00010079	F55A11.6
Is predicted to have glutathione transferase activity.

WB:WBGene00010080	F55A11.7
Is enriched in GABAergic neurons; germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010081	F55A11.8
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010082	F55A11.11
Is enriched in head mesodermal cell and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 1); Histidine phosphatase superfamily, clade-1; and Histidine phosphatase superfamily. Is an ortholog of human UBASH3B (ubiquitin associated and SH3 domain containing B).

WB:WBGene00010083	xdh-1
Is predicted to have flavin adenine dinucleotide binding activity and xanthine dehydrogenase activity. Human ortholog(s) of this gene are implicated in xanthinuria. Is an ortholog of human XDH (xanthine dehydrogenase).

WB:WBGene00010084	F55B11.2
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00010085	F55B11.3
Is enriched in dopaminergic neurons and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq; microarray; and proteomic studies.

WB:WBGene00010086	F55B11.4
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; D-glucopyranose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010087	F55B11.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including aldicarb; Ethanol; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00010088	F55B12.2
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00010089	hpo-31
Is predicted to have RNA binding activity and nucleotidyltransferase activity. Human ortholog(s) of this gene are implicated in sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay. Is an ortholog of human TRNT1 (tRNA nucleotidyl transferase 1).

WB:WBGene00010091	ssp-35
Is enriched in coelomocyte; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-five chemicals including Ethanol; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00010092	F55C5.2
Is enriched in coelomocyte; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010093	capg-2
Is involved in mitotic sister chromatid segregation. Is an ortholog of human NCAPG2 (non-SMC condensin II complex subunit G2).

WB:WBGene00010094	tsfm-1
Is predicted to have translation elongation factor activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 3. Is an ortholog of human TSFM (Ts translation elongation factor, mitochondrial).

WB:WBGene00010095	F55C5.6
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00010096	rskd-1
Is predicted to have ATP binding activity; phosphatidylinositol binding activity; and protein kinase activity. Is expressed in GABAergic neurons; rectal muscle; retrovesicular ganglion; and somatic nervous system. Is an ortholog of human RPS6KC1 (ribosomal protein S6 kinase C1).

WB:WBGene00010097	srpa-68
Is predicted to have signal recognition particle binding activity. Is an ortholog of human SRP68 (signal recognition particle 68).

WB:WBGene00010098	F55C5.10
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00010099	fbxb-117
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Mercuric Chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00010100	F55C9.3
Is enriched in DA neuron; NSM; VA neuron; and intestine based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: PAZ domain superfamily.

WB:WBGene00010101	fbxb-57
Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00010102	F55C9.5
Is enriched in hypodermis; intestine; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00010103	F55C9.6
Is affected by several genes including eat-2; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010104	fbxb-60
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00010105	fbxb-62
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00010106	fbxb-61
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; indole; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00010107	F55C9.11
Is affected by spn-4 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00010108	F55C10.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00010109	F55C10.5
Is predicted to have protein serine/threonine phosphatase inhibitor activity. Is an ortholog of human PPP1R14B (protein phosphatase 1 regulatory inhibitor subunit 14B).

WB:WBGene00010110	F55D12.1
Is enriched in AFD; ASER; PLM; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010111	F55D12.2
Is enriched in PLM; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including aldicarb; D-glucose; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 44. Is predicted to encode a protein with the following domain: . Is an ortholog of human SESTD1 (SEC14 and spectrin domain containing 1).

WB:WBGene00010112	nhr-191
Is affected by several genes including sir-2.1; cyc-1; and adr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00010113	F55D12.5
Is enriched in germ line; germline precursor cell; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00010114	F55D12.6
Is enriched in amphid sheath cell; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00010115	aakb-1
Is predicted to contribute to AMP-activated protein kinase activity. Is expressed in body wall musculature; neurons; non-striated muscle; rectal valve cell; and tail hypodermis. Is an ortholog of human PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) and PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2).

WB:WBGene00010116	cest-13
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00010117	nkb-3
Is predicted to contribute to sodium:potassium-exchanging ATPase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of human ATP1B1 (ATPase Na+/K+ transporting subunit beta 1); ATP1B2 (ATPase Na+/K+ transporting subunit beta 2); and ATP1B3 (ATPase Na+/K+ transporting subunit beta 3).

WB:WBGene00010118	F55F3.4
Is affected by several genes including daf-16; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; manganese chloride; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00010119	F55G7.1
Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00010120	dot-1.4
Is predicted to have histone methyltransferase activity (H3-K79 specific). Is an ortholog of human DOT1L (DOT1 like histone lysine methyltransferase).

WB:WBGene00010121	F55G7.3
Is affected by csr-1 and alg-1 based on RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00010122	F55G11.1
Is enriched in hypodermis; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by estrogen and Sirolimus based on microarray studies.

WB:WBGene00010123	F55G11.2
Is involved in innate immune response.

WB:WBGene00010124	F55G11.4
Is involved in defense response to Gram-negative bacterium. Is expressed in intestine.

WB:WBGene00010125	dod-22
Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in head neurons and rectal gland cell.

WB:WBGene00010126	F55G11.6
Is affected by several genes including skn-1; daf-12; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Mercuric Chloride; Tunicamycin; and sodium arsenite based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010127	F55G11.7
Is involved in innate immune response. Is expressed in amphid neurons; head neurons; intestine; phasmid neurons; and rectal gland cell.

WB:WBGene00010128	F55G11.8
Is involved in innate immune response.

WB:WBGene00010129	F55G11.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including sir-2.1; dpy-21; and mut-2 based on tiling array; RNA-seq; and microarray studies. Is affected by estrogen; Atrazine; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00010130	vha-14
Is predicted to contribute to proton-exporting ATPase activity, phosphorylative mechanism. Is an ortholog of human ATP6V1D (ATPase H+ transporting V1 subunit D).

WB:WBGene00010131	F55H2.5
Is predicted to have oxidoreductase activity. Is an ortholog of human CYB561 (cytochrome b561).

WB:WBGene00010132	F55H2.7
Is enriched in C; germ line; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00010133	F55H12.2
Is enriched in PLM; carbon dioxide sensory neurons; coelomocyte; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including diallyl trisulfide; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies.

WB:WBGene00010134	F55H12.3
Is predicted to have Notch binding activity. Human ortholog(s) of this gene are implicated in Alagille syndrome and tetralogy of Fallot.

WB:WBGene00010135	F55H12.4
Is expressed in anus; hypodermis; pharynx; and vulva. Is predicted to encode a protein with the following domain: .

WB:WBGene00010136	F55H12.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010137	ztf-26
Is predicted to have DNA binding activity. Is expressed in head muscle; head neurons; hypodermis; nerve ring neurons; and ventral nerve cord.

WB:WBGene00010138	anoh-1
Is predicted to have protein dimerization activity. Is expressed in intestine; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including Scott syndrome; autosomal recessive spinocerebellar ataxia 10; and muscular dystrophy (multiple). Is an ortholog of human ANO4 (anoctamin 4); ANO5 (anoctamin 5); and ANO6 (anoctamin 6).

WB:WBGene00010139	F56A8.3
Is expressed in intestine; neurons; pharynx; and rectal gland cell. Is predicted to encode a protein with the following domain: . Is an ortholog of human LRRC59 (leucine rich repeat containing 59).

WB:WBGene00010140	F56A8.4
Is enriched in AFD; body wall musculature; germ line; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including manganese chloride; stavudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010141	F56A8.5
Is enriched in AFD; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00010142	F56A8.8
Is enriched in AVK and FLP based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Mercuric Chloride; allantoin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010143	F56A12.2
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010144	F56C4.1
Is enriched in DA neuron; VA neuron; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; dpy-21; and let-418 based on RNA-seq studies. Is affected by six chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010145	F56C4.2
Is affected by eat-2 and spn-4 based on RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and Sirolimus based on microarray studies.

WB:WBGene00010146	glb-19
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons and tail neurons.

WB:WBGene00010147	F56D5.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00010148	F56D5.3
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00010149	F56D5.5
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00010150	F56D5.6
Is enriched in coelomocyte; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00010151	F56D5.7
No description available

WB:WBGene00010152	F56D5.9
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); BRCT domain; Ankyrin repeat; Ankyrin repeat-containing domain; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00010153	srxa-2
Is enriched in NSM based on tiling array studies. Is affected by several genes including alg-1; prg-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Acrylamide and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00010155	F56F3.4
Is predicted to have zinc ion binding activity. Is an ortholog of human ZFAND3 (zinc finger AN1-type containing 3).

WB:WBGene00010157	oac-34
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00010158	pes-2.2
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00010159	wbp-4
Is predicted to have RNA binding activity. Is an ortholog of human WBP4 (WW domain binding protein 4).

WB:WBGene00010160	png-1
Exhibits peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity; protein disulfide oxidoreductase activity; and protein-disulfide reductase activity. Is involved in cell redox homeostasis; cellular protein metabolic process; and negative regulation of collateral sprouting. Localizes to cytoplasm. Is expressed in body wall musculature; gonad; neurons; pharynx; and vulva. Human ortholog(s) of this gene are implicated in NGLY1-deficiency. Is an ortholog of human NGLY1 (N-glycanase 1).

WB:WBGene00010161	F56G4.6
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sek-1; and hsp-6 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010162	F56H6.1
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00010163	F56H6.2
Is enriched in AVK and muscle cell based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00010164	F56H6.3
Is enriched in body wall muscle cell based on tiling array studies. Is affected by rsr-2; ints-8; and daf-16 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; allantoin; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00010165	F56H6.4
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00010166	gmd-2
Exhibits GDP-mannose 4,6-dehydratase activity. Is involved in GDP-L-fucose biosynthetic process and GDP-mannose metabolic process. Is an ortholog of human GMDS (GDP-mannose 4,6-dehydratase).

WB:WBGene00010167	bgnt-1.6
Is predicted to have transferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00010168	F56H6.7
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00010169	clec-18
Is predicted to have carbohydrate binding activity.

WB:WBGene00010170	F56H6.9
Is affected by several genes including let-60; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00010171	oac-35
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00010172	oac-36
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00010173	F56H6.13
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00010174	F56H9.2
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; head mesodermal cell; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Mianserin; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010175	F56H11.2
Is enriched in several structures, including excretory cell; germline precursor cell; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010176	F56H11.6
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine and cadmium based on microarray studies.

WB:WBGene00010177	F57A8.1
Is expressed widely. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010178	yif-1
Is expressed in linker cell. Is used to study Parkinson's disease. Is predicted to encode a protein with the following domains: YIF1 and Yif1 family. Is an ortholog of human YIF1A (Yip1 interacting factor homolog A, membrane trafficking protein) and YIF1B (Yip1 interacting factor homolog B, membrane trafficking protein).

WB:WBGene00010179	F57A8.4
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00010180	nhr-192
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010181	F57A8.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including manganese chloride; D-glucose; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DX module and Domain of unknown function DX.

WB:WBGene00010182	F57A8.7
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00010183	fipr-13
Is enriched in body wall muscle cell; dopaminergic neurons; germ line; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010184	F57A10.2
Is expressed in germ line. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00010185	F57A10.4
Is enriched in AFD; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00010186	nhr-283
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010187	F57B1.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including tryptophan; nicotinic acid; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00010188	F57B1.5
Is enriched in head mesodermal cell; hypodermis; intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010189	F57B1.6
Is enriched in GABAergic neurons; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00010191	dmsr-1
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in AIY; RID; and tail neurons.

WB:WBGene00010192	F57B7.2
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; lin-35; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including bisphenol A; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00010193	btb-20
Is enriched in NSM; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and elt-2 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including manganese chloride; bisphenol S; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00010194	btb-19
Is enriched in NSM; Psub1; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including manganese chloride; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00010195	pot-2
Exhibits G-rich strand telomeric DNA binding activity. Is involved in negative regulation of telomere maintenance via telomere lengthening and telomere maintenance. Localizes to nuclear chromosome, telomeric region.

WB:WBGene00010196	F57C2.4
Is enriched in cephalic sheath cell; dopaminergic neurons; excretory cell; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Heme; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies.

WB:WBGene00010197	F57C2.5
Is predicted to have strictosidine synthase activity. Localizes to sarcoplasmic reticulum. Is an ortholog of human APMAP (adipocyte plasma membrane associated protein).

WB:WBGene00010198	spat-1
Is predicted to have protein kinase binding activity. Localizes to cytoplasm; kinetochore; and nucleus. Is expressed in EMS and P2. Is an ortholog of human BORA (BORA aurora kinase A activator).

WB:WBGene00010199	bet-2
Is enriched in OLL; PVD; and germ line based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Cry5B; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Bromodomain; Bromodomain; and Bromodomain-like superfamily. Is an ortholog of human BRD2 (bromodomain containing 2) and BRDT (bromodomain testis associated).

WB:WBGene00010200	F57C7.4
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; clk-1; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: REJ domain and PKD/REJ-like domain.

WB:WBGene00010202	F57E7.1
Is enriched in amphid sheath cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; multi-walled carbon nanotube; and paraquat based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00010203	F57E7.2
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; mir-34; and jmjd-1.2 based on tiling array; RNA-seq; and microarray studies. Is affected by Mercuric Chloride and resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010204	F57F5.1
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00010205	F57F5.3
Is enriched in PLM and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010206	F57G4.1
Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; nanoparticle; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00010207	F57G4.2
No description available

WB:WBGene00010208	F57G4.3
No description available

WB:WBGene00010209	fbxa-191
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and metformin based on microarray and RNA-seq studies.

WB:WBGene00010210	F57G4.5
No description available

WB:WBGene00010211	F57G4.6
No description available

WB:WBGene00010212	fbxa-192
Is enriched in I5 neuron; cholinergic neurons; germ line; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including manganese chloride; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00010213	F57G4.9
No description available

WB:WBGene00010214	slc-9B.2
Is predicted to have solute:proton antiporter activity. Is an ortholog of human SLC9B1 (solute carrier family 9 member B1) and SLC9B2 (solute carrier family 9 member B2).

WB:WBGene00010215	nhr-193
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010216	F57G8.7
Is enriched in several structures, including cephalic sheath cell; coelomocyte; dopaminergic neurons; mechanosensory neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Heme; Tunicamycin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010217	sre-31
Is affected by several genes including daf-2; mex-1; and unc-70 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00010218	sre-30
Is affected by several genes including clk-1; mex-1; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00010219	F57G9.3
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010220	sre-29
Is affected by rsr-2; ifg-1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by dibromoacetic acid and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00010221	F57G12.1
Is enriched in body wall musculature; coelomocyte; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010222	F57G12.2
Is enriched in OLL; PLM; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010223	F58A3.3
Is affected by several genes including skn-1; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010224	F58A3.4
Is enriched in coelomocyte; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00010225	ttr-31
Is enriched in cephalic sheath cell; coelomocyte; hypodermis; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00010226	F58A4.1
Is enriched in amphid sheath cell; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010227	F58A4.2
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including manganese chloride; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010228	clec-161
Is predicted to have signaling receptor activity. Is expressed in germ line and vas deferens.

WB:WBGene00010229	F58A4.6
Is enriched in germ line; germline precursor cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4807) and Protein of unknown function DUF4807.

WB:WBGene00010230	rpac-19
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Human ortholog(s) of this gene are implicated in Treacher Collins syndrome. Is an ortholog of human POLR1D (RNA polymerase I and III subunit D).

WB:WBGene00010231	F58B3.4
Is predicted to have RNA binding activity. Is an ortholog of human ESF1 (ESF1 nucleolar pre-rRNA processing protein homolog).

WB:WBGene00010232	F58B3.6
Is enriched in AFD; dopaminergic neurons; germ line; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including lin-4; lin-14; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interferon-related protein conserved region; Interferon-related developmental regulator (IFRD); Interferon-related developmental regulator, C-terminal; Interferon-related developmental regulator, N-terminal; Armadillo-type fold; and Interferon-related developmental regulator. Is an ortholog of human IFRD1 (interferon related developmental regulator 1) and IFRD2 (interferon related developmental regulator 2).

WB:WBGene00010233	rbm-17
Is predicted to have RNA binding activity. Is an ortholog of human RBM17 (RNA binding motif protein 17).

WB:WBGene00010234	ttr-50
Is enriched in cephalic sheath cell; germ line; head mesodermal cell; intestine; and pharyngeal muscle cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00010235	F58B4.2
Is enriched in BAG; PLM; excretory cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and adsorbable organic bromine compound based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cytochrome b5-like Heme/Steroid binding domain; Cytochrome b5-like heme/steroid binding domain; and Cytochrome b5-like heme/steroid binding domain superfamily.

WB:WBGene00010236	F58B4.3
Is expressed in ASEL; ASER; and neurons. Is predicted to encode a protein with the following domain: .

WB:WBGene00010237	scvp-1
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Secreted clade V proteins and Secreted clade V protein.

WB:WBGene00010238	F58B4.5
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-one chemicals including tryptophan; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00010239	F58B4.6
Is enriched in ASER; head mesodermal cell; intestine; and neurons based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010240	gadr-1
Is expressed widely.

WB:WBGene00010241	F58D2.2
Is enriched in GABAergic neurons; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010242	F58D5.2
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; manganese chloride; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00010243	F58D5.3
Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010244	F58D5.5
Is enriched in NSM; OLL; PVD; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010245	F58D5.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Tunicamycin; manganese chloride; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00010246	F58D5.7
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00010247	F58D5.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including methylmercuric chloride; Cry5B; and paraquat based on microarray studies.

WB:WBGene00010248	F58D5.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; antimycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00010249	F58D12.1
No description available

WB:WBGene00010250	F58D12.3
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II.

WB:WBGene00010251	sta-2
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in several processes, including defense response to fungus; positive regulation of antifungal peptide production; and response to wounding. Localizes to several cellular components, including endocytic vesicle; hemidesmosome; and hemidesmosome associated protein complex. Is expressed in hypodermis; interfacial epithelial cell; intestine; and vulva. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis and hyper IgE recurrent infection syndrome 1. Is an ortholog of human STAT5A (signal transducer and activator of transcription 5A); STAT5B (signal transducer and activator of transcription 5B); and STAT6 (signal transducer and activator of transcription 6).

WB:WBGene00010253	F58E6.4
Is enriched in intestine and neurons based on tiling array studies. Is affected by several genes including daf-2; daf-12; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by Heme; tryptophan; and Mercuric Chloride based on microarray studies.

WB:WBGene00010254	F58E6.5
Is predicted to have FFAT motif binding activity.

WB:WBGene00010255	F58E6.6
Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010256	hrg-3
Exhibits heme binding activity and heme transporter activity. Is involved in defense response to Gram-negative bacterium and heme transport. Localizes to extracellular space. Is expressed in intestinal cell.

WB:WBGene00010257	F58E6.8
Is enriched in AVK and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Heme; tryptophan; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010258	F58E6.11
Is expressed in pharynx.

WB:WBGene00010259	ric-7
Is involved in several processes, including positive regulation of protein localization to presynapse; positive regulation of synapse pruning; and secretion by cell. Localizes to mitochondrion and synapse. Is expressed in GABAergic neurons; cholinergic neurons; and head muscle.

WB:WBGene00010260	ddx-17
Is predicted to have RNA binding activity and RNA helicase activity. Is involved in pre-miRNA processing. Is expressed in PVDL; PVDR; and neurons. Is an ortholog of human DDX17 (DEAD-box helicase 17).

WB:WBGene00010261	srh-308
Is affected by several genes including daf-12; sir-2.1; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00010262	droe-4
Is enriched in ASER; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Neurotoxins; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5354) and Protein of unknown function DUF5354.

WB:WBGene00010263	wago-4
Is predicted to have RNA binding activity. Is involved in chromatin silencing by small RNA and regulation of gene silencing by RNA. Is expressed in EMS; Psub1; Z2; Z3; and oocyte.

WB:WBGene00010264	F58G1.2
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity. Is expressed in dorsal nerve cord; head muscle; and ventral nerve cord.

WB:WBGene00010265	F58G1.3
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00010266	dct-18
Is enriched in head mesodermal cell and pharyngeal muscle cell based on SAGE; tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; Rotenone; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00010267	lips-9
Is predicted to have lipase activity.

WB:WBGene00010268	arrd-10
Is enriched in germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC5 (arrestin domain containing 5).

WB:WBGene00010269	F58G1.7
Is enriched in ASER; body wall muscle cell; pharynx; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010270	F58G1.8
Is predicted to have GTPase activity and translation elongation factor activity.

WB:WBGene00010271	F58G1.9
Is enriched in body wall muscle cell; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00010272	amph-1
Is predicted to have phospholipid binding activity. Is involved in lipid tube assembly involved in organelle fission; nucleus localization; and nucleus organization. Localizes to nuclear envelope; perinuclear region of cytoplasm; and recycling endosome. Is expressed in several structures, including coelomocyte; gonadal sheath cell; hypodermis; intestinal cell; and pharynx. Human ortholog(s) of this gene are implicated in centronuclear myopathy 2. Is an ortholog of human BIN1 (bridging integrator 1).

WB:WBGene00010273	srm-3
Is expressed in excretory cell; intestine; neurons; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00010274	F58G6.3
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00010275	acc-1
Is predicted to have chloride channel activity. Is expressed in ganglia and neurons.

WB:WBGene00010276	C03A3.t1
No description available

WB:WBGene00010277	F58G6.7
Is predicted to have copper ion transmembrane transporter activity.

WB:WBGene00010278	F58G6.8
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00010279	letm-1
Is expressed widely. Human ortholog(s) of this gene are implicated in Wolf-Hirschhorn syndrome. Is predicted to encode a protein with the following domains: LETM1-like protein and LETM1-like. Is an ortholog of human LETM1 (leucine zipper and EF-hand containing transmembrane protein 1).

WB:WBGene00010280	rde-12
Exhibits enzyme binding activity. Is involved in production of siRNA involved in RNA interference and response to exogenous dsRNA. Localizes to P granule; RNAi effector complex; and perinuclear region of cytoplasm. Is expressed in germ line and somatic cell.

WB:WBGene00010281	F58G11.3
Is enriched in GABAergic neurons; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010282	F58G11.4
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00010283	ccz-1
Is involved in lipid droplet disassembly and phagolysosome assembly involved in apoptotic cell clearance. Localizes to phagocytic vesicle. Is used to study Hermansky-Pudlak syndrome. Is an ortholog of human CCZ1 (CCZ1 homolog, vacuolar protein trafficking and biogenesis associated).

WB:WBGene00010284	aman-2
Is predicted to have alpha-mannosidase activity. Localizes to Golgi apparatus. Is expressed in head; pharynx; and ventral nerve cord. Is an ortholog of human MAN2A1 (mannosidase alpha class 2A member 1).

WB:WBGene00010285	F58H1.2
Is expressed in hypodermis.

WB:WBGene00010286	F58H1.3
Is predicted to have acireductone synthase activity. Is an ortholog of human ENOPH1 (enolase-phosphatase 1).

WB:WBGene00010288	F58H1.5
Is enriched in several structures, including NSM; head mesodermal cell; intestine; mechanosensory neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010289	F58H1.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including nicotinic acid; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010290	F58H1.7
Is expressed in glutamatergic neurons. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; and LDL receptor-like superfamily.

WB:WBGene00010291	F58H10.1
Is enriched in AVK; OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010292	F59A1.6
Is enriched in body wall muscle cell; hypodermis; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; pmk-1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Zidovudine; allantoin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010293	fbxa-108
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00010294	fbxa-129
Is enriched in DA neuron; VA neuron; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010295	fbxa-193
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq studies.

WB:WBGene00010296	dgat-2
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Localizes to lipid droplet. Is an ortholog of human MOGAT1 (monoacylglycerol O-acyltransferase 1).

WB:WBGene00010297	F59A1.11
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00010298	F59A1.12
Is enriched in neurons based on microarray studies. Is affected by hpl-2 based on RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010299	F59A1.13
Is predicted to have transmembrane transporter activity.

WB:WBGene00010300	F59A1.15
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: MFS transporter superfamily.

WB:WBGene00010301	F59A1.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; hpl-2; and nhl-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00010303	cri-3
Is predicted to have mRNA binding activity; mitochondrial ribosome binding activity; and translation activator activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 33. Is an ortholog of human C1QBP (complement C1q binding protein).

WB:WBGene00010304	clpf-1
Exhibits ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity. Is involved in nucleotide phosphorylation. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 10. Is an ortholog of human CLP1 (cleavage factor polyribonucleotide kinase subunit 1).

WB:WBGene00010305	F59A2.5
Is enriched in germ line; hypodermis; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Transcription factor Pcc1 and CTAG/Pcc1 family.

WB:WBGene00010306	golg-4
Is enriched in coelomocyte and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray; RNA-seq; and proteomic studies. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 2 and Cornelia de Lange syndrome 3. Is predicted to encode a protein with the following domains: GRIP domain and GRIP domain. Is an ortholog of human GOLGA4 (golgin A4).

WB:WBGene00010307	skat-1
Is predicted to have amino acid transmembrane transporter activity. Is expressed in head neurons; intestine; tail neurons; ventral cord neurons; and vulval muscle. Is an ortholog of several human genes including SLC36A1 (solute carrier family 36 member 1); SLC36A2 (solute carrier family 36 member 2); and SLC36A3 (solute carrier family 36 member 3).

WB:WBGene00010308	F59B2.3
Is predicted to have N-acetylglucosamine-6-phosphate deacetylase activity. Is an ortholog of human AMDHD2 (amidohydrolase domain containing 2).

WB:WBGene00010309	rpn-6.2
Is predicted to have structural molecule activity. Is an ortholog of human PSMD11 (proteasome 26S subunit, non-ATPase 11).

WB:WBGene00010310	F59B2.8
Is enriched in AVA; AVK; Z1; Z4; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00010311	F59B2.9
Is enriched in Z1; Z4; germ line; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00010313	F59B2.11
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010314	F59B2.12
Is expressed in coelomocyte; g1; head; and vas deferens.

WB:WBGene00010315	F59B2.13
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in CANL; CANR; DVB; PVT; and body wall musculature.

WB:WBGene00010316	F59B8.1
Is enriched in neurons; retrovesicular ganglion; ventral nerve cord; and in male based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including aldicarb; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010317	idh-1
Is predicted to have isocitrate dehydrogenase (NADP+) activity. Is expressed in tail. Is an ortholog of human IDH1 (isocitrate dehydrogenase (NADP(+)) 1).

WB:WBGene00010318	F59B10.2
Is enriched in AFD; ASER; BAG; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010319	F59B10.3
Is enriched in ASER; GABAergic neurons; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00010320	F59B10.4
Is enriched in excretory cell; germline precursor cell; male-specific anatomical entity; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Rifampin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010321	F59B10.5
Is enriched in NSM; coelomocyte; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Heme; D-glucose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010322	F59B10.6
Is enriched in NSM; coelomocyte; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010323	dhhc-12
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is expressed in head neurons and tail neurons. Is an ortholog of several human genes including ZDHHC21 (zinc finger DHHC-type palmitoyltransferase 21); ZDHHC22 (zinc finger DHHC-type palmitoyltransferase 22); and ZDHHC23 (zinc finger DHHC-type palmitoyltransferase 23).

WB:WBGene00010324	F59C6.3
Is enriched in body wall muscle cell; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010325	exos-3
Is predicted to have RNA binding activity. Localizes to cytoplasm and nucleus. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 1B. Is an ortholog of human EXOSC3 (exosome component 3).

WB:WBGene00010326	F59C6.5
Is enriched in OLL; PVD; germ line; and hypodermis based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; let-60; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NADH-ubiquinone oxidoreductase subunit 10; NADH-ubiquinone oxidoreductase, subunit 10; and NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10. Is an ortholog of human NDUFB10 (NADH:ubiquinone oxidoreductase subunit B10).

WB:WBGene00010327	F59C6.8
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00010328	F59C6.11
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Rotenone; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00010329	pcdr-1
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is expressed in cholinergic neurons; ciliated neurons; rectal epithelium; ventral cord neurons; and vulval muscle. Is an ortholog of human GPR21 (G protein-coupled receptor 21).

WB:WBGene00010330	F59D12.2
Is enriched in OLL; PVD; intestine; and pharyngeal muscle cell based on tiling array; proteomic; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010331	F59D12.3
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00010332	F59D12.5
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq; microarray; and tiling array studies. Is affected by seven chemicals including hydrogen sulfide; cadmium; and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00010333	copz-1
Is involved in embryo development; intracellular protein transport; and oocyte development. Is an ortholog of human COPZ1 (COPI coat complex subunit zeta 1).

WB:WBGene00010334	del-5
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human ASIC5 (acid sensing ion channel subunit family member 5).

WB:WBGene00010335	F59F3.6
Is enriched in neurons and in male based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 3 and scalp-ear-nipple syndrome. Is predicted to encode a protein with the following domains: BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00010336	acox-1.6
Is predicted to have acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6 and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACOX1 (acyl-CoA oxidase 1).

WB:WBGene00010337	serp-1.1
Is enriched in several structures, including ASER; head mesodermal cell; mechanosensory neurons; non-striated muscle; and somatic nervous system based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ribosome associated membrane protein RAMP4 and Stress-associated endoplasmic reticulum protein. Is an ortholog of human SERP1 (stress associated endoplasmic reticulum protein 1) and SERP2 (stress associated endoplasmic reticulum protein family member 2).

WB:WBGene00010338	F59F4.3
Is enriched in excretory cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including age-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including aldicarb; multi-walled carbon nanotube; and cadmium based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010339	acl-1
Is predicted to have 1-acylglycerol-3-phosphate O-acyltransferase activity. Is expressed in gonad. Human ortholog(s) of this gene are implicated in congenital generalized lipodystrophy type 1. Is an ortholog of human AGPAT1 (1-acylglycerol-3-phosphate O-acyltransferase 1).

WB:WBGene00010340	slcf-1
Is predicted to have monocarboxylic acid transmembrane transporter activity. Localizes to basolateral plasma membrane. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A3 (solute carrier family 16 member 3).

WB:WBGene00010341	glo-3
Is involved in gastrulation. Localizes to gut granule membrane. Is expressed in intestine.

WB:WBGene00010342	F59F5.3
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including brain disease (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00010343	F59F5.4
Is predicted to be a structural constituent of cuticle.

WB:WBGene00010344	F59F5.5
Is enriched in muscle cell and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010345	F59F5.7
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Electron transfer DM13 and DM13 domain.

WB:WBGene00010348	H01G02.1
Is enriched in GABAergic neurons; dopaminergic neurons; excretory cell; intestine; and pharyngeal muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00010349	dyf-18
Is predicted to have cyclin-dependent protein serine/threonine kinase activity. Is expressed in amphid neurons; head; inner labial neurons; outer labial neurons; and phasmid neurons. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 2 and primary autosomal recessive microcephaly 12. Is an ortholog of human CDK20 (cyclin dependent kinase 20); CDKL2 (cyclin dependent kinase like 2); and CDKL3 (cyclin dependent kinase like 3).

WB:WBGene00010350	H01G02.3
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010351	cbd-1
Is predicted to have chitin binding activity. Is involved in eggshell formation; positive regulation of protein localization to cell cortex; and positive regulation of protein localization to plasma membrane. Localizes to cell periphery. Is expressed in germ line and oocyte.

WB:WBGene00010352	fbxb-76
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00010353	memi-3
Is enriched in germ line; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010354	cyp-31A2
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is involved in several processes, including asymmetric cell division; embryonic morphogenesis; and female gamete generation. Is used to study Bietti crystalline corneoretinal dystrophy. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00010355	clec-229
Is predicted to have carbohydrate binding activity.

WB:WBGene00010356	famk-1
Exhibits manganese ion binding activity and protein serine/threonine kinase activity. Is involved in protein phosphorylation. Human ortholog(s) of this gene are implicated in amelogenesis imperfecta type 1G. Is an ortholog of human FAM20C (FAM20C golgi associated secretory pathway kinase).

WB:WBGene00010357	H03A11.2
Is predicted to have microtubule binding activity. Is expressed in ASEL; ASER; and neurons. Is an ortholog of human SAXO1 (stabilizer of axonemal microtubules 1) and SAXO2 (stabilizer of axonemal microtubules 2).

WB:WBGene00010358	H03G16.1
Is enriched in FLP and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by rsr-2 and eat-2 based on tiling array and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00010359	mam-6
Is affected by several genes including mex-3; fbf-1; and mex-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Sodium Chloride; copper sulfate; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00010360	fbxa-96
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00010361	H03G16.5
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including skn-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00010362	enu-3.1
Is involved in axon extension involved in axon guidance. Localizes to neuronal cell body. Is expressed in head; nervous system; and seam cell.

WB:WBGene00010363	H04D03.2
Is predicted to have chromatin binding activity and methylated histone binding activity.

WB:WBGene00010364	H04D03.3
Is predicted to have molecular adaptor activity. Is an ortholog of human ECPAS (Ecm29 proteasome adaptor and scaffold).

WB:WBGene00010365	H04D03.4
Is enriched in AFD and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; bisphenol A; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00010366	H05L14.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010367	H05L14.2
Is expressed in gonad. Is predicted to encode a protein with the following domain: .

WB:WBGene00010368	H06A10.1
Is involved in nematode larval development.

WB:WBGene00010369	chd-1
Is predicted to have ATP binding activity and helicase activity. Human ortholog(s) of this gene are implicated in immunodeficiency-centromeric instability-facial anomalies syndrome 4. Is an ortholog of human CHD1 (chromodomain helicase DNA binding protein 1).

WB:WBGene00010370	ctg-1
Is enriched in GABAergic neurons; germ line; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; GOLD domain superfamily; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L2 (SEC14 like lipid binding 2) and SEC14L3 (SEC14 like lipid binding 3).

WB:WBGene00010371	H06O01.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00010372	H08J19.1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; hpl-2; and spc-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube; adsorbable organic bromine compound; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010373	H08M01.1
Is enriched in germ line; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00010374	rga-5
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RhoGAP domain; Rho GTPase-activating protein domain; and Rho GTPase activation protein. Is an ortholog of human ARHGAP35 (Rho GTPase activating protein 35) and ARHGAP5 (Rho GTPase activating protein 5).

WB:WBGene00010375	H09F14.1
Is predicted to have G protein-coupled receptor activity and neuropeptide binding activity.

WB:WBGene00010376	C05E7.t1
No description available

WB:WBGene00010377	nspa-1
Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010378	H12D21.2
Is enriched in arcade cell; germ line; neurons; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010379	H12D21.3
Is affected by several genes including hsf-1; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010380	mpst-2
Is predicted to have thiosulfate sulfurtransferase activity. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00010381	H12D21.5
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010382	H12D21.6
Is affected by several genes including clk-1; elt-2; and egl-9 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; procyanidin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010383	mpst-3
Is predicted to have thiosulfate sulfurtransferase activity. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00010384	H12D21.8
No description available

WB:WBGene00010385	H12D21.9
Is enriched in body wall musculature and muscle cell based on microarray studies. Is affected by several genes including ced-3; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including paraquat; Atrazine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010386	H12D21.10
Is predicted to have transferase activity, transferring glycosyl groups. Human ortholog(s) of this gene are implicated in Adams-Oliver syndrome. Is an ortholog of human EOGT (EGF domain specific O-linked N-acetylglucosamine transferase).

WB:WBGene00010387	H12D21.11
Is enriched in intestine and neurons based on tiling array and microarray studies. Is affected by several genes including elt-2; drh-3; and mir-34 based on microarray and RNA-seq studies.

WB:WBGene00010388	srz-42
Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010389	srz-31
Is enriched in NSM based on tiling array studies. Is affected by drh-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010390	srz-30
Is affected by clk-1 and ifg-1 based on microarray studies.

WB:WBGene00010391	oac-37
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00010392	oac-38
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00010393	H12I19.6
No description available

WB:WBGene00010394	srz-59
Is affected by hpl-2; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010395	H12I19.8
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00010396	H13N06.2
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00010397	suox-1
Is predicted to have heme binding activity; molybdopterin cofactor binding activity; and sulfite oxidase activity. Human ortholog(s) of this gene are implicated in isolated sulfite oxidase deficiency. Is an ortholog of human SUOX (sulfite oxidase).

WB:WBGene00010399	clec-13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by Tunicamycin and Ethanol based on microarray studies. Is predicted to encode a protein with the following domains: CUB domain; Lectin C-type domain; CUB domain; C-type lectin-like; C-type lectin-like/link domain superfamily; C-type lectin fold; and Spermadhesin, CUB domain superfamily.

WB:WBGene00010400	clec-14
Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Ethanol based on microarray studies.

WB:WBGene00010401	H16D19.3
Is expressed in seam cell. Is predicted to encode a protein with the following domains: Zinc-finger of C2H2 type and Zinc finger C2H2-type.

WB:WBGene00010402	H16D19.4
Is enriched in GABAergic neurons; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00010403	otpl-8
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1) and OTOP2 (otopetrin 2).

WB:WBGene00010404	H19J13.2
Is affected by rsr-2; daf-2; and eat-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5354) and Protein of unknown function DUF5354.

WB:WBGene00010405	erfa-3
Is predicted to have GTPase activity and translation release factor activity. Is an ortholog of human GSPT1 (G1 to S phase transition 1).

WB:WBGene00010406	math-33
Exhibits RNA polymerase II-specific DNA-binding transcription factor binding activity and thiol-dependent ubiquitin-specific protease activity. Is involved in several processes, including hemidesmosome assembly; maintenance of centrosome location; and positive regulation of DNA-binding transcription factor activity. Localizes to cytoplasm and nucleus. Is expressed in several structures, including germ line. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability. Is an ortholog of human USP7 (ubiquitin specific peptidase 7).

WB:WBGene00010407	scb-1
Localizes to nucleus. Is expressed in somatic cell.

WB:WBGene00010408	mboa-2
Is predicted to have diacylglycerol O-acyltransferase activity. Human ortholog(s) of this gene are implicated in congenital diarrhea 7 with exudative enteropathy. Is an ortholog of human DGAT1 (diacylglycerol O-acyltransferase 1).

WB:WBGene00010409	H21P03.2
Is enriched in AVK; NSM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including manganese chloride; Mianserin; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nse4 C-terminal; Non-structural maintenance of chromosome element 4, C-terminal; and Nse4/EID family. Is an ortholog of human EID3 (EP300 interacting inhibitor of differentiation 3) and NSMCE4A (NSE4 homolog A, SMC5-SMC6 complex component).

WB:WBGene00010410	nhr-267
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010411	H25K10.1
Is predicted to have acid phosphatase activity and metal ion binding activity. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00010412	H25K10.2
Is enriched in body wall muscle cell based on tiling array studies. Is affected by daf-2; pmt-2; and sir-2.1 based on microarray studies.

WB:WBGene00010413	H25K10.4
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including skn-1; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including 4-bromodiphenyl ether; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00010414	hpa-1
Is affected by several genes including eat-2; rrf-1; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00010415	irld-39
Is affected by several genes including let-60; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00010416	hxk-2
Is predicted to have fructokinase activity; glucokinase activity; and mannokinase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4G; diabetes mellitus (multiple); and familial hyperinsulinemic hypoglycemia 3. Is an ortholog of several human genes including HK1 (hexokinase 1); HK3 (hexokinase 3); and HKDC1 (hexokinase domain containing 1).

WB:WBGene00010417	clpr-3
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy.

WB:WBGene00010418	H27A22.1
Is predicted to have glutaminyl-peptide cyclotransferase activity and zinc ion binding activity. Is expressed in head and tail. Is an ortholog of human QPCT (glutaminyl-peptide cyclotransferase) and QPCTL (glutaminyl-peptide cyclotransferase like).

WB:WBGene00010419	atp-1
Exhibits enterobactin binding activity. Is predicted to contribute to ATPase activity. Is involved in iron import into cell. Localizes to mitochondrion. Is expressed in tail. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 22 and mitochondrial complex V (ATP synthase) deficiency nuclear type 4. Is an ortholog of human ATP5F1A (ATP synthase F1 subunit alpha).

WB:WBGene00010420	mcrs-1
Is predicted to contribute to histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); and histone acetyltransferase activity (H4-K8 specific). Is an ortholog of human MCRS1 (microspherule protein 1).

WB:WBGene00010421	slc-36.4
Is predicted to have L-amino acid transmembrane transporter activity. Is an ortholog of human SLC36A2 (solute carrier family 36 member 2); SLC36A3 (solute carrier family 36 member 3); and SLC36A4 (solute carrier family 36 member 4).

WB:WBGene00010422	H32K16.2
Is enriched in body wall muscle cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010423	zmp-5
Is predicted to have metalloendopeptidase activity. Is expressed in dorsal uterine cell. Is an ortholog of several human genes including MMP14 (matrix metallopeptidase 14); MMP16 (matrix metallopeptidase 16); and MMP8 (matrix metallopeptidase 8).

WB:WBGene00010424	lep-5
Is expressed in several structures, including nervous system; pharynx; seam cell; somatic gonad; and vulva.

WB:WBGene00010425	lpin-1
Is predicted to have phosphatidate phosphatase activity and transcription coactivator activity. Is involved in several processes, including lipid storage; nematode larval development; and nuclear envelope organization. Localizes to endoplasmic reticulum; nuclear envelope; and nucleoplasm. Is expressed in head neurons and hypodermis. Is used to study obesity. Human ortholog(s) of this gene are implicated in myoglobinuria. Is an ortholog of human LPIN1 (lipin 1) and LPIN3 (lipin 3).

WB:WBGene00010426	H37A05.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including stavudine; Zidovudine; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00010427	hpo-11
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human NRBP2 (nuclear receptor binding protein 2).

WB:WBGene00010428	dcn-1
Is predicted to have cullin family protein binding activity; ubiquitin conjugating enzyme binding activity; and ubiquitin-like protein binding activity. Is involved in cytoskeleton organization; protein catabolic process; and protein neddylation. Localizes to cytoplasm and nucleus. Is an ortholog of human DCUN1D2 (defective in cullin neddylation 1 domain containing 2).

WB:WBGene00010430	C05E7.t2
No description available

WB:WBGene00010431	C05E7.t3
No description available

WB:WBGene00010432	H39E23.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; npr-1; and mex-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00010433	H40L08.1
Is enriched in cephalic sheath cell; intestine; and neurons based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by four chemicals including resveratrol; fluoranthene; and Quercetin based on microarray studies. Is predicted to encode a protein with the following domains: UBA-like domain; UBA-like superfamily; and Ubiquitin-like domain superfamily. Is an ortholog of human FAF2 (Fas associated factor family member 2).

WB:WBGene00010434	H40L08.3
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010435	JC8.2
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including D-glucose; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human PWP1 (PWP1 homolog, endonuclein).

WB:WBGene00010436	JC8.4
Is predicted to have tRNA-specific adenosine-34 deaminase activity. Is an ortholog of human ADAT2 (adenosine deaminase tRNA specific 2).

WB:WBGene00010437	cox-11
Is predicted to have copper ion binding activity. Is an ortholog of human COX11 (cytochrome c oxidase copper chaperone COX11).

WB:WBGene00010439	JC8.7
Is predicted to have histone binding activity; poly-ADP-D-ribose binding activity; and zinc ion binding activity. Is an ortholog of human HPF1 (histone PARylation factor 1).

WB:WBGene00010440	ttr-51
Is expressed in spermatheca. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00010442	bus-12
Is predicted to have antiporter activity. Is expressed in intestine and seam cell. Is an ortholog of human SLC35D3 (solute carrier family 35 member D3).

WB:WBGene00010444	magi-1
Exhibits beta-catenin binding activity and glutamate receptor binding activity. Is involved in habituation; long-term memory; and regulation of protein localization. Localizes to adherens junction and synapse. Is expressed in several structures, including anus; egg-laying apparatus; intestine; neurons; and pharynx. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 15. Is an ortholog of human MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2) and MAGI3 (membrane associated guanylate kinase, WW and PDZ domain containing 3).

WB:WBGene00010446	K01A6.4
Is enriched in amphid sheath cell and neurons based on microarray and RNA-seq studies. Is affected by several genes including rrf-3; elt-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by nine chemicals including aldicarb; Mercuric Chloride; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00010447	K01A6.5
Is enriched in GABAergic neurons and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00010448	K01A6.6
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00010449	K01A11.1
Is enriched in germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010450	metl-18
Is predicted to have methyltransferase activity. Is an ortholog of human METTL18 (methyltransferase like 18).

WB:WBGene00010451	K01A11.3
Is affected by several genes including skn-1; clk-1; and eat-2 based on RNA-seq studies. Is affected by four chemicals including Rotenone; multi-walled carbon nanotube; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00010452	K01A11.5
No description available

WB:WBGene00010453	fozi-1
Is involved in mesodermal cell fate specification and positive regulation of mesodermal cell fate specification. Localizes to nucleus. Is expressed in several structures, including M.dla; amphid neurons; body wall muscle cell from M lineage; coelomocyte; and somatic nervous system.

WB:WBGene00010454	K01B6.3
Is enriched in AFD; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by seventeen chemicals including Rotenone; multi-walled carbon nanotube; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010455	K01B6.4
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00010456	K01C8.1
Is predicted to have L-serine ammonia-lyase activity and L-threonine ammonia-lyase activity.

WB:WBGene00010457	K01C8.2
Is enriched in AVE; pharynx; and seam cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pmk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is predicted to encode a protein with the following domains: Lustrin, cysteine-rich repeated domain; Cysteine-rich repeat; and Lustrin, cysteine-rich repeated.

WB:WBGene00010458	mrpl-10
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL10 (mitochondrial ribosomal protein L10).

WB:WBGene00010459	slc-25A32
Is predicted to have FAD transmembrane transporter activity and folic acid transmembrane transporter activity. Is an ortholog of human SLC25A32 (solute carrier family 25 member 32).

WB:WBGene00010460	clec-142
Is predicted to have carbohydrate binding activity.

WB:WBGene00010461	K01D12.1
Is enriched in coelomocyte; hypodermis; and intestine based on tiling array studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00010462	K01D12.2
No description available

WB:WBGene00010463	K01D12.3
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00010464	K01D12.5
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00010465	miga-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitoguardin and Mitoguardin. Is an ortholog of human MIGA1 (mitoguardin 1) and MIGA2 (mitoguardin 2).

WB:WBGene00010466	K01D12.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010467	K01D12.8
Is enriched in AFD; dopaminergic neurons; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; D-glucose; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010468	K01D12.9
Is enriched in AFD; ASER; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Heme; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010469	K01D12.10
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; single-walled carbon nanotube; and Ag nanoparticles based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010470	cdr-4
Is involved in stress response to cadmium ion. Localizes to lysosome. Is expressed in pm5; pm6; and pm7. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00010471	cdr-6
Is enriched in NSM; OLL; PLM; PVD; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; Rotenone; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase, C-terminal domain; Glutathione S-transferase N-terminal domain; Thioredoxin-like fold; Metaxin, glutathione S-transferase domain; Thioredoxin-like superfamily; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00010472	cdr-7
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Mianserin; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase N-terminal domain; Glutathione S-transferase, C-terminal domain; Thioredoxin-like fold; Metaxin, glutathione S-transferase domain; Thioredoxin-like superfamily; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00010473	hrg-2
Exhibits heme binding activity. Is expressed in hypodermis. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00010474	K01D12.15
Is enriched in arcade cell; germ line; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010475	K01F9.2
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; Tunicamycin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies.

WB:WBGene00010476	rnf-113
Exhibits ubiquitin-protein transferase activity. Is involved in protein ubiquitination. Localizes to nucleus. Is expressed in head neurons; tail neurons; and ventral nerve cord. Is an ortholog of human RNF113A (ring finger protein 113A) and RNF113B (ring finger protein 113B).

WB:WBGene00010477	enu-3.6
Is enriched in several structures, including RIM; germ line; interneuron; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010478	K01G5.5
Is predicted to have pseudouridine synthase activity. Human ortholog(s) of this gene are implicated in X-linked dyskeratosis congenita. Is an ortholog of human DKC1 (dyskerin pseudouridine synthase 1).

WB:WBGene00010479	K01G5.8
Localizes to nucleolus. Is an ortholog of human FAM32A (family with sequence similarity 32 member A).

WB:WBGene00010480	tasp-1
Is predicted to have threonine-type endopeptidase activity. Is an ortholog of human TASP1 (taspase 1).

WB:WBGene00010481	K01G5.10
Is predicted to have hydrolase activity. Is an ortholog of human HDHD3 (haloacid dehalogenase like hydrolase domain containing 3).

WB:WBGene00010483	K01G12.3
Is enriched in AB; germ line; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Mianserin; D-glucose; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010484	dph-3
Is predicted to have metal ion binding activity. Localizes to nucleus. Is an ortholog of human DPH3 (diphthamide biosynthesis 3).

WB:WBGene00010485	ant-1.3
Is predicted to have ATP:ADP antiporter activity. Is expressed in VA11 and intestine. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2; mitochondrial DNA depletion syndrome 12a; and mitochondrial DNA depletion syndrome 12b. Is an ortholog of human SLC25A4 (solute carrier family 25 member 4) and SLC25A5 (solute carrier family 25 member 5).

WB:WBGene00010486	K01H12.4
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00010487	K02A11.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Diazinon; paraquat; and Sirolimus based on microarray studies.

WB:WBGene00010488	endu-1
Is predicted to have RNA binding activity and endoribonuclease activity. Is an ortholog of human ENDOU (endonuclease, poly(U) specific).

WB:WBGene00010489	K02B7.1
No description available

WB:WBGene00010490	K02B7.2
No description available

WB:WBGene00010491	K02B7.3
Is enriched in GABAergic neurons; body wall muscle cell; excretory cell; germ line; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010492	meg-1
Is involved in P granule disassembly and germ cell proliferation. Localizes to P granule. Is expressed in Psub2; Psub3; Psub4; and germ line.

WB:WBGene00010493	meg-2
Is involved in P granule disassembly. Localizes to P granule. Is expressed in germ line.

WB:WBGene00010494	K02B9.3
Is affected by rsr-2; alg-1; and eat-2 based on tiling array and RNA-seq studies. Is affected by cadmium and allantoin based on microarray studies.

WB:WBGene00010495	K02B12.2
Is enriched in GABAergic neurons; germ line; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; bisphenol A; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00010496	sec-12
Is predicted to have GTPase activator activity and Sar guanyl-nucleotide exchange factor activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human PREB (prolactin regulatory element binding).

WB:WBGene00010497	axl-1
Exhibits protein kinase binding activity. Is involved in axon guidance and negative regulation of Wnt signaling pathway.

WB:WBGene00010498	tnsl-1
Is enriched in several structures, including Z4.a; body wall muscle cell; germ line; germline precursor cell; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; hsf-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including aldicarb; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ankyrin repeats (many copies); Ankyrin repeats (3 copies); Ankyrin repeat; Tetratricopeptide-like helical domain superfamily; Ankyrin repeat-containing domain; Leucine-rich repeat domain superfamily; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human TONSL (tonsoku like, DNA repair protein).

WB:WBGene00010499	K02B12.6
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including rrf-3; let-7; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including tryptophan; Mianserin; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00010500	K02B12.7
Is predicted to have GTPase activator activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human ARFGAP1 (ADP ribosylation factor GTPase activating protein 1).

WB:WBGene00010501	K02C4.2
Is enriched in OLL; PVD; dopaminergic neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010502	K02C4.3
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability. Is an ortholog of human USP28 (ubiquitin specific peptidase 28).

WB:WBGene00010503	K02C4.5
Is enriched in OLL; PVD; hypodermis; intestine; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010504	K02D3.1
Is enriched in AVK and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein F10E9.3-like.

WB:WBGene00010505	K02D3.2
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia. Is an ortholog of human STARD4 (StAR related lipid transfer domain containing 4).

WB:WBGene00010506	K02E2.1
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Microcystin-LR based on microarray studies.

WB:WBGene00010507	K02E2.6
Is enriched in hypodermis; intestine; muscle cell; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including rrf-3; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: gag-polyprotein putative aspartyl protease and Aspartic peptidase domain superfamily.

WB:WBGene00010508	K02E2.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF713.

WB:WBGene00010509	K02E2.8
Is enriched in germline precursor cell; hypodermis; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including tryptophan; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00010510	ent-3
Is predicted to have nucleoside transmembrane transporter activity. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00010511	sre-7
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00010512	K02E11.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; multi-walled carbon nanotube; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010513	K02E11.4
Is expressed in amphid sheath cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00010514	K02E11.5
Is enriched in AFD; amphid sheath cell; arcade cell; pharyngeal-intestinal valve cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; bisphenol A; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010515	K02E11.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including Rotenone; multi-walled carbon nanotube; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010516	K02E11.7
Is enriched in PLM; amphid sheath cell; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010517	K02E11.8
Is affected by clk-1 and daf-16 based on microarray and RNA-seq studies.

WB:WBGene00010518	K02E11.9
Is enriched in amphid sheath cell; arcade cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00010519	K03A11.1
Is enriched in BAG and hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; D-glucose; and nanoparticle based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: E2F-DP heterodimerization region.

WB:WBGene00010520	cpx-2
Is predicted to have syntaxin binding activity. Is expressed in head neurons and tail neurons. Human ortholog(s) of this gene are implicated in Wolf-Hirschhorn syndrome and early infantile epileptic encephalopathy 63. Is an ortholog of human CPLX1 (complexin 1) and CPLX2 (complexin 2).

WB:WBGene00010521	K03A11.4
Is predicted to have catalytic activity.

WB:WBGene00010522	K03A11.5
Is enriched in head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including bisphenol S; stavudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00010523	K03B8.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by cadmium and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010524	K03B8.6
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type.

WB:WBGene00010525	K03B8.8
Is expressed in Z1 and Z4.

WB:WBGene00010526	K03B8.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; Mercuric Chloride; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00010527	srz-74
Is affected by several genes including prg-1; drh-3; and rsr-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including tryptophan; resveratrol; and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010528	K03D3.2
Is enriched in several structures, including cephalic sheath cell; coelomocyte; dopaminergic neurons; mechanosensory neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; Mianserin; and nanoparticle based on RNA-seq and microarray studies.

WB:WBGene00010529	srz-21
Is affected by several genes including let-60; clk-1; and eat-2 based on microarray studies. Is affected by Chlorpyrifos and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00010530	srz-61
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010531	K03D3.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including age-1; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00010532	K03D3.6
No description available

WB:WBGene00010533	K03D3.8
No description available

WB:WBGene00010534	fbxa-102
Is affected by several genes including hpl-2; drh-3; and sin-3 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00010535	K03D7.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; allantoin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010536	K03D7.9
Is affected by hpl-2 and rsr-2 based on tiling array studies.

WB:WBGene00010537	mys-2
Is predicted to have histone acetyltransferase activity (H4-K16 specific) and histone binding activity. Is expressed in germ line. Is an ortholog of human KAT8 (lysine acetyltransferase 8).

WB:WBGene00010538	ttr-3
Is expressed in seam cell and ventral cord blast cell. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00010539	ttr-2
Is enriched in germ line; hypodermis; intestine; and muscle cell based on proteomic; Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00010540	K03H1.5
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nidogen-like; Sushi repeat (SCR repeat); AMOP domain; von Willebrand factor type D domain; Sushi/SCR/CCP domain; von Willebrand factor, type D domain; IPT domain; NIDO domain; AMOP domain; Immunoglobulin-like fold; Immunoglobulin E-set; and Sushi/SCR/CCP superfamily. Is an ortholog of human SUSD2 (sushi domain containing 2).

WB:WBGene00010541	ttr-1
Is enriched in NSM; coelomocyte; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00010542	K03H1.7
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cell division cycle-associated protein 3.

WB:WBGene00010543	K03H1.8
Is affected by several genes including daf-2; eat-2; and hsp-6 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Tunicamycin; and Sirolimus based on microarray studies.

WB:WBGene00010544	K03H1.9
Is enriched in NSM; germ line; and muscle cell based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00010545	cbp-2
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in Rubinstein-Taybi syndrome. Is an ortholog of human CREBBP (CREB binding protein).

WB:WBGene00010546	K03H1.11
Is enriched in NSM; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00010547	K03H1.12
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00010550	K04B12.2
Is enriched in ASER; OLL; PVD; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00010551	smg-8
Is involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Localizes to striated muscle dense body. Is an ortholog of human SMG8 (SMG8 nonsense mediated mRNA decay factor).

WB:WBGene00010552	K04C1.2
Is enriched in OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Zidovudine; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Sterile alpha motif/pointed domain superfamily.

WB:WBGene00010553	K04C1.3
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity.

WB:WBGene00010554	mlc-6
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 8. Is an ortholog of several human genes including MYL1 (myosin light chain 1); MYL3 (myosin light chain 3); and MYL4 (myosin light chain 4).

WB:WBGene00010555	K04C1.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010556	rack-1
Is predicted to have protein kinase C binding activity and ribosome binding activity. Is involved in several processes, including cytoskeleton-dependent cytokinesis; defense response to fungus; and motor neuron axon guidance. Localizes to several cellular components, including centrosome; growth cone; and nuclear envelope. Is expressed in anterior distal tip cell; neurons; and posterior distal tip cell. Is an ortholog of human RACK1 (receptor for activated C kinase 1).

WB:WBGene00010557	mspn-1
Is predicted to have ATP binding activity. Is an ortholog of human ATAD1 (ATPase family AAA domain containing 1).

WB:WBGene00010558	ptp-4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010559	K04D7.6
Is enriched in neurons based on tiling array studies. Is affected by several genes including mex-3; mex-1; and dpy-21 based on tiling array and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010560	eif-2beta
Is predicted to have mRNA binding activity; translation initiation factor activity; and translation initiation factor binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of transcription by RNA polymerase II; and translation. Is an ortholog of human EIF2S2 (eukaryotic translation initiation factor 2 subunit beta).

WB:WBGene00010562	cdc-48.3
Exhibits ATPase activity; protein kinase binding activity; and protein kinase inhibitor activity. Is involved in negative regulation of protein kinase activity. Localizes to cytoplasm. Is an ortholog of human SPATA5 (spermatogenesis associated 5).

WB:WBGene00010563	K04G2.4
Is enriched in germ line; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00010564	ath-1
Is predicted to have carboxylic ester hydrolase activity and palmitoyl-(protein) hydrolase activity. Is an ortholog of human LYPLA1 (lysophospholipase 1) and LYPLA2 (lysophospholipase 2).

WB:WBGene00010565	vacl-14
Is enriched in OLL; PVD; coelomocyte; germ line; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vacuolar 14 Fab1-binding region; Vacuolar protein 14 C-terminal Fig4p binding; Armadillo-like helical; Armadillo-type fold; Vacuolar protein 14 C-terminal Fig4-binding domain; Vacuole morphology and inheritance protein 14; and Vacuole morphology and inheritance protein 14, Fab1-binding region. Is an ortholog of human VAC14 (VAC14 component of PIKFYVE complex).

WB:WBGene00010566	K04G2.7
Is predicted to have DNA binding activity.

WB:WBGene00010567	K04G2.9
Localizes to plasma membrane. Is an ortholog of human CMTM8 (CKLF like MARVEL transmembrane domain containing 8) and PLLP (plasmolipin).

WB:WBGene00010568	K04G2.10
Is enriched in BAG; germ line; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00010569	scbp-2
Is predicted to have mRNA 3'-UTR binding activity; ribonucleoprotein complex binding activity; and selenocysteine insertion sequence binding activity.

WB:WBGene00010570	K04G11.1
Is enriched in muscle cell based on microarray studies. Is affected by daf-12; rsr-2; and daf-2 based on tiling array and microarray studies.

WB:WBGene00010571	K04G11.3
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; pgl-1; and dpy-21 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Zidovudine; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RSD-2 N-terminal domain and RSD-2, N-terminal.

WB:WBGene00010572	wdr-5.2
Is enriched in ASER and dopaminergic neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including aldicarb; stavudine; and metformin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Joubert syndrome 3; cone-rod dystrophy 20; and nephronophthisis 20. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; WD40-repeat-containing domain superfamily; and WD40-repeat-containing protein Swd3/WDR5. Is an ortholog of human WDR5 (WD repeat domain 5).

WB:WBGene00010573	K04H4.2
Is predicted to have chitin binding activity.

WB:WBGene00010574	K04H4.5
Is enriched in GABAergic neurons; germ line; muscle cell; somatic gonad precursor; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and lin-4 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00010575	flp-25
Is expressed in ASEL; ASER; and neurons. Is predicted to encode a protein with the following domains: FMRFamide related peptide family and FMRFamide-related peptide-like.

WB:WBGene00010576	clec-116
Is predicted to have carbohydrate binding activity.

WB:WBGene00010577	K04H8.2
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; C-type lectin-like; PAN-3 domain; and C-type lectin fold.

WB:WBGene00010578	K04H8.3
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00010579	K05C4.2
Is enriched in Psub1; germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; microarray; and proteomic studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Jagunal, ER re-organisation during oogenesis and Protein jagunal. Is an ortholog of human JAGN1 (jagunal homolog 1).

WB:WBGene00010580	K05C4.3
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00010581	K05C4.4
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including stavudine; antimycin; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00010582	K05C4.5
Is enriched in NSM; body wall muscle cell; and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including bisphenol S; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Quinoprotein alcohol dehydrogenase-like superfamily; and WD40/YVTN repeat-like-containing domain superfamily. Is an ortholog of human UTP4 (UTP4 small subunit processome component).

WB:WBGene00010583	K05C4.7
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including let-7; dpy-10; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-like helical; Armadillo-type fold; and Uncharacterised conserved protein UCP013899, metal binding. Is an ortholog of human ARMC1 (armadillo repeat containing 1).

WB:WBGene00010584	K05C4.8
Is enriched in coelomocyte; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010585	K05C4.9
Is enriched in neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00010586	K05C4.10
Is enriched in AVK; NSM; Z1.p; Z4.a; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00010587	sol-2
Exhibits channel regulator activity. Is involved in several processes, including hyperosmotic response; positive regulation of glutamatergic synaptic transmission; and thigmotaxis. Localizes to ionotropic glutamate receptor complex and neuron projection membrane. Is expressed in command interneuron; head neurons; and tail neurons.

WB:WBGene00010588	srz-14
Is enriched in muscle cell based on microarray studies. Is affected by several genes including rrf-3; sir-2.1; and mut-2 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010589	cyp-33D1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00010590	srz-13
Is enriched in muscle cell based on microarray studies. Is affected by several genes including rrf-3; sir-2.1; and aak-2 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010591	K05D4.9
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00010592	K06A4.2
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; head mesodermal cell; hypodermis; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; dpy-7; and pgl-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Tunicamycin; multi-walled carbon nanotube; and sesamin based on microarray and RNA-seq studies.

WB:WBGene00010593	gsnl-1
Exhibits actin filament binding activity; actin monomer binding activity; and phosphatidylinositol-4,5-bisphosphate binding activity. Is involved in several processes, including actin filament depolymerization; barbed-end actin filament capping; and positive regulation of synapse pruning. Localizes to actin cytoskeleton and striated muscle dense body. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Finnish type amyloidosis. Is an ortholog of human GSN (gelsolin) and SCIN (scinderin).

WB:WBGene00010594	swt-5
Is predicted to have sugar transmembrane transporter activity. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).

WB:WBGene00010595	haao-1
Is predicted to have 3-hydroxyanthranilate 3,4-dioxygenase activity. Is an ortholog of human HAAO (3-hydroxyanthranilate 3,4-dioxygenase).

WB:WBGene00010596	K06A4.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010597	K06A4.7
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00010598	K06B4.3
Is affected by several genes including clk-1; sir-2.1; and mir-34 based on tiling array and microarray studies.

WB:WBGene00010599	K06B4.4
Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00010600	nhr-196
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons.

WB:WBGene00010601	nhr-268
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010602	nhr-197
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010603	nhr-198
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00010604	nhr-199
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00010605	K06G5.1
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including Mianserin; D-glucopyranose; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010606	cyp-13B2
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A5 (cytochrome P450 family 3 subfamily A member 5); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00010607	K06G5.3
Is affected by several genes including clk-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00010608	K07A1.1
Is enriched in AFD; FLP; germ line; germline precursor cell; and head mesodermal cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq studies.

WB:WBGene00010609	dut-1
Is predicted to have dUTP diphosphatase activity and magnesium ion binding activity. Is expressed in intestine. Is an ortholog of human DUT (deoxyuridine triphosphatase).

WB:WBGene00010610	K07A1.3
Is predicted to have ATP binding activity and peptidase activity. Is an ortholog of human C19orf54 (chromosome 19 open reading frame 54).

WB:WBGene00010611	K07A1.4
Is enriched in germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010612	K07A1.5
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00010613	K07A1.6
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00010614	cri-1
Is expressed in amphid neurons; intestine; marginal cell; and rectal gland cell. Is predicted to encode a protein with the following domains: Headcase protein; Headcase protein; and Headcase, middle domain. Is an ortholog of human HECA (hdc homolog, cell cycle regulator).

WB:WBGene00010615	ate-1
Is predicted to have arginyltransferase activity. Is an ortholog of human ATE1 (arginyltransferase 1).

WB:WBGene00010616	K07A1.10
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Growth arrest and DNA-damage-inducible proteins-interacting protein 1; Growth arrest/ DNA-damage-inducible protein-interacting protein 1; and Growth arrest and DNA damage-inducible proteins-interacting protein 1 domain superfamily. Is an ortholog of human GADD45GIP1 (GADD45G interacting protein 1).

WB:WBGene00010617	K07A1.13
Is enriched in several structures, including RIM; germ line; interneuron; male distal tip cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00010618	K07A1.14
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by methylmercuric chloride and Colistin based on microarray studies.

WB:WBGene00010619	K07A1.15
Is enriched in NSM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; gld-1; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including hydrogen sulfide; Mianserin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: LSM domain; LSM domain, eukaryotic/archaea-type; and LSM domain superfamily. Is an ortholog of human LSM10 (LSM10, U7 small nuclear RNA associated).

WB:WBGene00010620	K07A12.1
Is predicted to have DNA-binding transcription factor activity. Is an ortholog of human TCF25 (transcription factor 25).

WB:WBGene00010621	egg-6
Is expressed in excretory system; neurons; pharynx; rectal epithelial cell; and vulva. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily.

WB:WBGene00010622	K07A12.4
Is predicted to have GTPase activity. Is an ortholog of human HBS1L (HBS1 like translational GTPase).

WB:WBGene00010623	K07A12.5
Is enriched in AVA; germ line; intestine; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00010624	mrps-15
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS15 (mitochondrial ribosomal protein S15).

WB:WBGene00010625	K07C5.2
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00010626	K07C5.3
Is predicted to have DNA ligase (ATP) activity. Is an ortholog of human LIG3 (DNA ligase 3).

WB:WBGene00010627	nol-56
Is predicted to have snoRNA binding activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 36. Is an ortholog of human NOP56 (NOP56 ribonucleoprotein).

WB:WBGene00010628	ceeh-2
Exhibits epoxide hydrolase activity. Is involved in cellular lipid metabolic process. Is an ortholog of human EPHX3 (epoxide hydrolase 3) and EPHX4 (epoxide hydrolase 4).

WB:WBGene00010629	sluh-7
Is predicted to have pre-mRNA 3'-splice site binding activity; second spliceosomal transesterification activity; and zinc ion binding activity. Is an ortholog of human SLU7 (SLU7 homolog, splicing factor).

WB:WBGene00010630	ttll-15
Is predicted to have ATP binding activity and ligase activity. Is involved in oviposition.

WB:WBGene00010631	cash-1
Is involved in several processes, including positive regulation of GTPase activity; positive regulation of endocytic recycling; and regulation of Golgi organization. Is an ortholog of human STRN (striatin) and STRN3 (striatin 3).

WB:WBGene00010632	K07C5.9
Is expressed in intestine and nervous system.

WB:WBGene00010633	nspd-2
Is enriched in amphid sheath cell; germline precursor cell; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00010634	K07F5.6
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010635	K07F5.7
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by Tunicamycin and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00010636	K07F5.8
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010637	K07F5.12
Is predicted to have carbohydrate transmembrane transporter activity. Is an ortholog of human TMEM144 (transmembrane protein 144).

WB:WBGene00010638	K07F5.14
Is enriched in body wall muscle cell; germ line; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by six chemicals including manganese chloride; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human NOL8 (nucleolar protein 8).

WB:WBGene00010639	K07F5.15
Is enriched in NSM; germ line; muscle cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2462) and Uncharacterised protein family UPF0390. Is an ortholog of human TMEM167B (transmembrane protein 167B).

WB:WBGene00010640	K07F5.16
Is expressed in head neurons; hypodermis; intestine; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: DnaJ domain; DnaJ domain; J domain-containing protein 1-like; and Chaperone J-domain superfamily. Is an ortholog of human DNAJC12 (DnaJ heat shock protein family (Hsp40) member C12).

WB:WBGene00010641	crml-1
Exhibits GTPase activating protein binding activity. Is involved in generation of neurons; negative regulation of Rac protein signal transduction; and regulation of cell migration. Localizes to plasma membrane. Is expressed in several structures, including distal tip cell; epithelial cell; excretory canal; neurons; and vulva. Is an ortholog of human CARMIL2 (capping protein regulator and myosin 1 linker 2) and CARMIL3 (capping protein regulator and myosin 1 linker 3).

WB:WBGene00010642	mks-6
Is involved in non-motile cilium assembly and protein localization to ciliary transition zone. Localizes to ciliary transition zone and dendrite terminus. Is expressed in ciliated neurons; head; and tail. Is used to study ciliopathy. Human ortholog(s) of this gene are implicated in COACH syndrome; Joubert syndrome 9; and Meckel syndrome 6. Is an ortholog of human CC2D2A (coiled-coil and C2 domain containing 2A).

WB:WBGene00010643	K07G5.4
Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010644	K07G5.5
Is predicted to have cadmium ion transmembrane transporter activity; ferrous iron transmembrane transporter activity; and zinc efflux active transmembrane transporter activity. Human ortholog(s) of this gene are implicated in hypermanganesemia with dystonia 1 and type 2 diabetes mellitus.

WB:WBGene00010645	fecl-1
Is predicted to have ferrochelatase activity. Is an ortholog of human FECH (ferrochelatase).

WB:WBGene00010646	K08C7.1
Is predicted to have transmembrane transporter activity.

WB:WBGene00010647	K08C7.4
Is expressed in amphid neurons. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010648	K08C7.6
Localizes to sarcoplasmic reticulum.

WB:WBGene00010649	K08C7.7
Is enriched in PLM; body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010650	K08C9.1
Is enriched in I5 neuron; cholinergic neurons; germ line; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Ethanol; tryptophan; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00010651	K08C9.2
Is expressed in spermatheca.

WB:WBGene00010652	K08C9.5
Is enriched in CEM; FLP; HOB; IL2 neuron; and ray neuron type B based on microarray and RNA-seq studies. Is affected by several genes including age-1; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including aldicarb; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00010653	K08C9.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00010654	K08C9.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domain: S27a-like superfamily.

WB:WBGene00010655	K08D8.1
Is enriched in intestine and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00010656	K08D8.2
Is enriched in intestine based on tiling array and microarray studies. Is affected by several genes including clk-1; eat-2; and hpl-2 based on microarray and RNA-seq studies. Is affected by tryptophan; Cadmium Chloride; and adsorbable organic bromine compound based on microarray and RNA-seq studies.

WB:WBGene00010657	K08D8.3
Is enriched in ASER and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010658	K08D8.4
Is involved in innate immune response.

WB:WBGene00010659	K08D8.5
Is involved in response to gamma radiation. Is expressed in head neurons; intestine; and rectal gland cell.

WB:WBGene00010660	K08D8.6
Localizes to membrane raft.

WB:WBGene00010661	tyr-2
Exhibits dopachrome isomerase activity. Is involved in cellular metabolic process. Is expressed in hypodermis and uterine muscle. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type IA and oculocutaneous albinism type IB. Is an ortholog of human DCT (dopachrome tautomerase) and TYR (tyrosinase).

WB:WBGene00010662	K08E3.2
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00010663	toca-2
Is involved in several processes, including negative regulation of protein localization to adherens junction; positive regulation of clathrin-dependent endocytosis; and positive regulation of oviposition. Localizes to several cellular components, including cell-cell junction; intracellular vesicle; and plasma membrane. Is expressed in spermatheca and uterus. Is an ortholog of human FNBP1 (formin binding protein 1); FNBP1L (formin binding protein 1 like); and TRIP10 (thyroid hormone receptor interactor 10).

WB:WBGene00010664	dbn-1
Is predicted to have actin filament binding activity. Is an ortholog of human DBNL (drebrin like).

WB:WBGene00010665	K08E3.5
Is predicted to have UTP:glucose-1-phosphate uridylyltransferase activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human UGP2 (UDP-glucose pyrophosphorylase 2).

WB:WBGene00010666	K08E4.2
Is predicted to have ceramide 1-phosphate binding activity and ceramide 1-phosphate transfer activity. Is an ortholog of human CPTP (ceramide-1-phosphate transfer protein).

WB:WBGene00010667	K08E4.3
Is enriched in GABAergic neurons; excretory cell; germ line; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010669	bath-37
Is enriched in NSM and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; pgl-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010670	tmed-1
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human TMED1 (transmembrane p24 trafficking protein 1) and TMED5 (transmembrane p24 trafficking protein 5).

WB:WBGene00010671	eak-7
Localizes to plasma membrane. Is expressed in body wall musculature; hypodermis; pharynx; and vulva. Is an ortholog of human MEAK7 (MTOR associated protein, eak-7 homolog).

WB:WBGene00010672	K08E7.4
Is enriched in amphid sheath cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00010673	K08E7.5
Is enriched in OLL; PVD; germline precursor cell; and hypodermis based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-two chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00010674	K08E7.6
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010675	K08E7.8
Is enriched in body wall muscle cell; intestine; muscle cell; and somatic gonad precursor based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; and Leucine-rich repeat domain superfamily. Is an ortholog of human LRRC20 (leucine rich repeat containing 20).

WB:WBGene00010676	ctf-18
Is predicted to have ATP binding activity. Is an ortholog of human CHTF18 (chromosome transmission fidelity factor 18).

WB:WBGene00010677	gtbp-1
Is predicted to have mRNA binding activity. Localizes to cytoplasmic stress granule. Is an ortholog of human G3BP1 (G3BP stress granule assembly factor 1).

WB:WBGene00010678	K08F4.3
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; male distal tip cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and clk-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Translocon-associated protein beta (TRAPB) and Translocon-associated protein subunit beta. Is an ortholog of human SSR2 (signal sequence receptor subunit 2).

WB:WBGene00010679	K08F4.5
Is enriched in GABAergic neurons; NSM; amphid sheath cell; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00010680	K08F4.12
Is enriched in GABAergic neurons; dopaminergic neurons; excretory cell; intestine; and neurons based on tiling array studies. Is affected by tdp-1; mir-34; and adr-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00010681	mak-1
Exhibits protein kinase activity and protein kinase binding activity. Is involved in adult locomotory behavior; behavioral response to nicotine; and protein autophosphorylation. Localizes to A band. Is expressed in body wall muscle cell and tail. Human ortholog(s) of this gene are implicated in lissencephaly. Is an ortholog of human MAPKAPK2 (MAPK activated protein kinase 2) and MAPKAPK3 (MAPK activated protein kinase 3).

WB:WBGene00010682	K08F8.5
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00010683	K08F8.7
Is enriched in ciliated neurons; dopaminergic neurons; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00010684	K08F9.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A5 (solute carrier family 2 member 5).

WB:WBGene00010685	aipl-1
Is predicted to have actin filament binding activity. Is involved in actin filament organization and regulation of protein localization. Is expressed in body wall musculature; head neurons; intestine; and spermatheca. Is an ortholog of human WDR1 (WD repeat domain 1).

WB:WBGene00010686	K08F9.3
Is enriched in cephalic sheath cell; germ line; intestine; and touch receptor neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; Sodium Chloride; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Glycoside hydrolase superfamily.

WB:WBGene00010687	K08F9.4
Is enriched in germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including D-glucose; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010688	srz-12
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00010689	K08H2.2
Is affected by several genes including eat-2; dcr-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Mercuric Chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010690	K08H2.3
Is enriched in NSM; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on RNA-seq; tiling array; and microarray studies. Is affected by seventeen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010691	K08H2.4
Is enriched in several structures, including FLP; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010692	K08H2.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010693	K08H2.7
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-12; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00010694	bgnt-1.5
Is predicted to have transferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00010697	uda-1
Exhibits guanosine-diphosphatase activity and uridine-diphosphatase activity. Is involved in GDP metabolic process and UDP metabolic process. Localizes to cytoplasmic vesicle membrane. Is an ortholog of human ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)) and ENTPD6 (ectonucleoside triphosphate diphosphohydrolase 6).

WB:WBGene00010698	K08H10.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00010699	trpp-6
Is enriched in AFD; germ line; germline precursor cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Rotenone; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transport protein particle (TRAPP) component; Transport protein particle (TRAPP) component; NO signalling/Golgi transport ligand-binding domain superfamily; and TRAPP complex, Trs33 subunit. Is an ortholog of human TRAPPC6B (trafficking protein particle complex 6B).

WB:WBGene00010700	nipi-3
Is predicted to have mitogen-activated protein kinase kinase binding activity. Is involved in defense response to fungus and positive regulation of gene expression. Is expressed in CAN; hypodermis; motor neurons; pharynx; and touch receptor neurons. Human ortholog(s) of this gene are implicated in lissencephaly.

WB:WBGene00010701	ent-2
Is predicted to have nucleoside transmembrane transporter activity. Localizes to plasma membrane. Is expressed in intestine; isthmus; metacorpus; procorpus; and terminal bulb. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00010702	usp-33
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Y-linked spermatogenic failure 2; and non-syndromic X-linked intellectual disability. Is an ortholog of human USP20 (ubiquitin specific peptidase 20) and USP44 (ubiquitin specific peptidase 44).

WB:WBGene00010703	K09A9.6
Is predicted to have peptide-aspartate beta-dioxygenase activity. Is an ortholog of human ASPH (aspartate beta-hydroxylase).

WB:WBGene00010704	K09A11.1
Is predicted to have DNA binding activity and protein dimerization activity. Is an ortholog of human ZBED1 (zinc finger BED-type containing 1).

WB:WBGene00010705	cyp-14A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is an ortholog of human CYP2D6 (cytochrome P450 family 2 subfamily D member 6) and CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00010706	cyp-14A2
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is expressed in intestine. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00010707	cyp-14A3
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00010708	phf-33
Is predicted to have metal ion binding activity.

WB:WBGene00010709	nol-9
Is predicted to have polynucleotide 5'-hydroxyl-kinase activity. Is an ortholog of human NOL9 (nucleolar protein 9).

WB:WBGene00010711	K09B11.4
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and atfs-1 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Alovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00010712	K09B11.5
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00010713	uso-1
Is enriched in germ line; head mesodermal cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and lin-35 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; D-glucose; and nicotine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Uso1 / p115 like vesicle tethering protein, head region; Armadillo tether-repeat of vescicular transport factor; Uso1 / p115 like vesicle tethering protein, C terminal region; Vesicle tethering protein Uso1/P115-like , head domain; Uso1/p115-like vesicle tethering protein, C-terminal; Armadillo-like helical; Armadillo-type fold; and Vesicle tethering protein p115, armadillo tether-repeat. Is an ortholog of human USO1 (USO1 vesicle transport factor).

WB:WBGene00010714	mam-3
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00010715	K09C8.2
Is expressed in seminal vesicle and vas deferens.

WB:WBGene00010716	lge-1
Is predicted to have glucuronosyltransferase activity and xylosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human LARGE1 (LARGE xylosyl- and glucuronyltransferase 1) and LARGE2 (LARGE xylosyl- and glucuronyltransferase 2).

WB:WBGene00010717	K09C8.7
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010718	K09C8.8
Is enriched in AVE and excretory cell based on tiling array studies. Is affected by several genes including daf-16; daf-12; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00010719	K09E4.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010720	algn-3
Is predicted to have dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Id. Is an ortholog of human ALG3 (ALG3 alpha-1,3- mannosyltransferase).

WB:WBGene00010721	K09E4.3
Is predicted to have methyltransferase activity. Is an ortholog of human NDUFAF5 (NADH:ubiquinone oxidoreductase complex assembly factor 5).

WB:WBGene00010722	K09E4.4
Is enriched in neurons; retrovesicular ganglion; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2V and mucopolysaccharidosis type IIIB. Is predicted to encode a protein with the following domains: Alpha-N-acetylglucosaminidase (NAGLU) tim-barrel domain; Alpha-N-acetylglucosaminidase (NAGLU) C-terminal domain; Alpha-N-acetylglucosaminidase; Glycoside hydrolase superfamily; Alpha-N-acetylglucosaminidase, C-terminal; and Alpha-N-acetylglucosaminidase, tim-barrel domain. Is an ortholog of human NAGLU (N-acetyl-alpha-glucosaminidase).

WB:WBGene00010723	cpg-7
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including D-glucose; Cadmium Chloride; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00010724	K09E9.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00010725	erv-46
Is expressed in alimentary muscle and vulval muscle, type 1. Is predicted to encode a protein with the following domains: Endoplasmic reticulum vesicle transporter; Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC); Endoplasmic reticulum vesicle transporter, C-terminal; and Endoplasmic reticulum vesicle transporter, N-terminal. Is an ortholog of human ERGIC3 (ERGIC and golgi 3).

WB:WBGene00010726	K09E9.3
Is enriched in germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Lithium Chloride; Alovudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00010727	K09G1.1
Is enriched in PLM; cephalic sheath cell; hypodermis; and muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human CMTM4 (CKLF like MARVEL transmembrane domain containing 4) and CMTM6 (CKLF like MARVEL transmembrane domain containing 6).

WB:WBGene00010728	K09G1.2
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00010730	ensa-1
Is predicted to have protein phosphatase inhibitor activity. Is an ortholog of human ARPP19 (cAMP regulated phosphoprotein 19) and ENSA (endosulfine alpha).

WB:WBGene00010731	K10C3.4
Is expressed in hermaphrodite distal tip cell; hypodermis; neurons; pharyngeal cell; and vulva. Human ortholog(s) of this gene are implicated in nanophthalmos. Is predicted to encode a protein with the following domain: Transmembrane protein 98. Is an ortholog of human TMEM98 (transmembrane protein 98).

WB:WBGene00010732	K10C3.5
Is predicted to have GTPase activity and ribosome binding activity. Is an ortholog of human EFL1 (elongation factor like GTPase 1).

WB:WBGene00010733	C06B8.t1
No description available

WB:WBGene00010734	parn-1
Exhibits 3'-5'-exoribonuclease activity. Is involved in RNA metabolic process and reproduction. Localizes to P granule. Human ortholog(s) of this gene are implicated in autosomal recessive dyskeratosis congenita 6. Is an ortholog of human PARN (poly(A)-specific ribonuclease) and PNLDC1 (PARN like, ribonuclease domain containing 1).

WB:WBGene00010735	frpr-15
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00010736	istr-1
Is enriched in germ line; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Atrazine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Regulator of Vps4 activity in the MVB pathway; Vacuolar protein sorting-associated protein Ist1; and Vacuolar protein sorting-associated protein IST1-like. Is an ortholog of human IST1 (IST1 factor associated with ESCRT-III).

WB:WBGene00010737	K10C8.4
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and alg-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00010738	K10D3.4
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00010740	K10D3.6
Is enriched in several structures, including GABAergic neurons; Z4.a; excretory cell; male distal tip cell; and mechanosensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00010741	lgc-49
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in hyperekplexia 1 and hyperekplexia 2. Is an ortholog of several human genes including GLRA3 (glycine receptor alpha 3); GLRA4 (glycine receptor alpha 4 (pseudogene)); and GLRB (glycine receptor beta).

WB:WBGene00010742	K10D6.2
Is expressed in hypodermis; inner labial neurons; and sensory neurons. Is predicted to encode a protein with the following domains: Clc-like and Clc protein-like.

WB:WBGene00010743	K10D6.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010744	K10D6.4
Is enriched in ASER; dopaminergic neurons; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including levamisole; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00010745	dod-17
Is involved in innate immune response.

WB:WBGene00010746	K10D11.2
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010747	K10D11.3
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain; CUB-like domain; and Spermadhesin, CUB domain superfamily.

WB:WBGene00010748	K10D11.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including let-60; eat-2; and ahr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010749	K10D11.5
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including D-glucopyranose; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; CUB-like domain; and CUB-like domain.

WB:WBGene00010750	K10D11.6
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Tunicamycin; D-glucose; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00010752	K10G4.3
Is enriched in OLL; PVD; head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including bisphenol A; 4-bromodiphenyl ether; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00010753	K10G4.4
Is affected by several genes including clk-1; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00010754	K10G4.5
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00010755	vglu-2
Is predicted to have L-glutamate transmembrane transporter activity. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 25. Is an ortholog of human SLC17A6 (solute carrier family 17 member 6); SLC17A7 (solute carrier family 17 member 7); and SLC17A8 (solute carrier family 17 member 8).

WB:WBGene00010756	K10G9.2
Is enriched in body wall musculature; head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including Rotenone; stavudine; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010757	pad-2
Is predicted to have peptide-O-fucosyltransferase activity. Is expressed in body wall musculature; hermaphrodite gonad; hypodermis; and somatic nervous system. Is used to study Down syndrome. Is an ortholog of human POFUT2 (protein O-fucosyltransferase 2).

WB:WBGene00010758	vnut-1
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC17A9 (solute carrier family 17 member 9).

WB:WBGene00010759	cysl-2
Exhibits L-3-cyanoalanine synthase activity and cysteine synthase activity. Is involved in cysteine biosynthetic process from serine. Is used to study Down syndrome. Is an ortholog of human CBSL (cystathionine beta-synthase like).

WB:WBGene00010760	K10H10.4
Is enriched in ASER; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010761	K10H10.5
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010762	K10H10.6
Is enriched in ASER and RID based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including aldicarb; methylmercuric chloride; and Mercuric Chloride based on microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 12; early infantile epileptic encephalopathy 28; and esophageal cancer. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human WWOX (WW domain containing oxidoreductase).

WB:WBGene00010763	K10H10.7
Is predicted to have protein phosphatase 1 binding activity and protein serine/threonine phosphatase inhibitor activity. Is an ortholog of human PPP1R11 (protein phosphatase 1 regulatory inhibitor subunit 11).

WB:WBGene00010764	K10H10.9
Is enriched in NSM based on tiling array studies. Is affected by lin-15B and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00010765	K10H10.10
Is predicted to have protein phosphatase 1 binding activity and protein serine/threonine phosphatase inhibitor activity.

WB:WBGene00010766	mrps-27
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial 28S ribosomal protein S27; 28S ribosomal protein S27, mitochondrial; and MRPS27/PTCD2. Is an ortholog of human MRPS27 (mitochondrial ribosomal protein S27).

WB:WBGene00010767	blos-9
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including glp-1; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; BLOC-1-related complex sub-unit 8; and BLOC-1-related complex subunit 8. Is an ortholog of human BORCS8 (BLOC-1 related complex subunit 8).

WB:WBGene00010768	K11D2.1
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by hydrogen sulfide; sodium arsenite; and Diazinon based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Regulator of chromosome condensation (RCC1) repeat; Regulator of chromosome condensation, RCC1; and Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II. Is an ortholog of human RCCD1 (RCC1 domain containing 1).

WB:WBGene00010769	asah-1
Is predicted to have N-acylsphingosine amidohydrolase activity. Human ortholog(s) of this gene are implicated in Farber lipogranulomatosis and spinal muscular atrophy with progressive myoclonic epilepsy. Is an ortholog of human ASAH1 (N-acylsphingosine amidohydrolase 1).

WB:WBGene00010770	K11D2.4
Is enriched in several structures, including AVE; NSM; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and lin-28 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; manganese chloride; and Psoralens based on RNA-seq studies. Human ortholog(s) of this gene are implicated in transient neonatal diabetes mellitus. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human ZNF398 (zinc finger protein 398).

WB:WBGene00010771	K11D2.5
Is predicted to have double-stranded DNA binding activity. Is an ortholog of human MTERF4 (mitochondrial transcription termination factor 4).

WB:WBGene00010772	K11D9.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease.

WB:WBGene00010773	K11E4.1
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00010774	K11E4.2
Is enriched in dopaminergic neurons and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; elt-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PH-like domain superfamily and SH2 domain superfamily.

WB:WBGene00010775	poml-1
Is predicted to have arylesterase activity. Is expressed in neurons. Is an ortholog of human PON1 (paraoxonase 1); PON2 (paraoxonase 2); and PON3 (paraoxonase 3).

WB:WBGene00010776	pix-1
Is predicted to have guanyl-nucleotide exchange factor activity and kinase activity. Is involved in gonad morphogenesis; inductive cell migration; and neuron migration. Localizes to several cellular components, including adherens junction; cytoplasm; and hemidesmosome. Is expressed in hermaphrodite gonad; hypodermis; and somatic gonad precursor. Is an ortholog of human ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6) and ARHGEF7 (Rho guanine nucleotide exchange factor 7).

WB:WBGene00010777	C06B8.t2
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00010778	gpdh-2
Is predicted to have glycerol-3-phosphate dehydrogenase (quinone) activity and glycerol-3-phosphate dehydrogenase [NAD+] activity. Is involved in intracellular accumulation of glycerol. Is expressed in excretory cell and hypodermis. Human ortholog(s) of this gene are implicated in Brugada syndrome 2. Is an ortholog of human GPD1 (glycerol-3-phosphate dehydrogenase 1) and GPD1L (glycerol-3-phosphate dehydrogenase 1 like).

WB:WBGene00010779	K11H3.2
Is enriched in amphid sheath cell; germ line; muscle cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010780	K11H3.3
Is enriched in several structures, including AFD; cephalic sheath cell; coelomocyte; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by six chemicals including biotin; Rifampin; and allantoin based on microarray and RNA-seq studies. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in combined D-2- and L-2-hydroxyglutaric aciduria. Is predicted to encode a protein with the following domains: Phosphorylation site; Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; and Mitochondrial carrier domain superfamily. Is an ortholog of human SLC25A1 (solute carrier family 25 member 1).

WB:WBGene00010781	K11H3.4
Is enriched in Psub1; germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies.

WB:WBGene00010782	K11H3.5
Is enriched in BAG; OLL; PVD; dopaminergic neurons; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00010783	mrpl-36
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL36 (mitochondrial ribosomal protein L36).

WB:WBGene00010784	twk-48
Is predicted to have potassium ion leak channel activity. Is an ortholog of human KCNK18 (potassium two pore domain channel subfamily K member 18).

WB:WBGene00010785	top-2
Is predicted to have several functions, including ATP binding activity; DNA binding activity; and DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity. Is involved in mitotic sister chromatid separation. Is an ortholog of human TOP2A (DNA topoisomerase II alpha).

WB:WBGene00010786	K12D12.4
Is enriched in germ line; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00010787	K12D12.5
Is predicted to have RNA-DNA hybrid ribonuclease activity.

WB:WBGene00010788	sulp-4
Exhibits chloride transmembrane transporter activity; oxalate transmembrane transporter activity; and sulfate transmembrane transporter activity. Localizes to apical plasma membrane. Is expressed in excretory cell. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human SLC26A5 (solute carrier family 26 member 5) and SLC26A6 (solute carrier family 26 member 6).

WB:WBGene00010789	sulp-5
Is predicted to have transmembrane transporter activity. Localizes to apical plasma membrane. Is expressed in excretory canal and seam cell. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human SLC26A5 (solute carrier family 26 member 5) and SLC26A6 (solute carrier family 26 member 6).

WB:WBGene00010790	sodh-1
Is predicted to have alcohol dehydrogenase (NAD+) activity. Is involved in defense response to Gram-positive bacterium. Is expressed in hypodermis; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in alcohol dependence and late onset Parkinson's disease.

WB:WBGene00010791	sodh-2
Is predicted to have alcohol dehydrogenase (NAD+) activity. Human ortholog(s) of this gene are implicated in alcohol dependence and late onset Parkinson's disease.

WB:WBGene00010792	K12G11.6
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00010793	LLC1.2
Is enriched in head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-two chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010794	dld-1
Is predicted to have dihydrolipoyl dehydrogenase activity and flavin adenine dinucleotide binding activity. Human ortholog(s) of this gene are implicated in maple syrup urine disease. Is an ortholog of human DLD (dihydrolipoamide dehydrogenase).

WB:WBGene00010795	M01A8.1
Is enriched in body wall musculature; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including aldicarb; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010796	clip-1
Exhibits microtubule binding activity. Is involved in nucleus localization and nucleus organization. Localizes to nuclear envelope. Is expressed in pharynx. Is an ortholog of human CLIP2 (CAP-Gly domain containing linker protein 2).

WB:WBGene00010797	srbc-75
Is affected by several genes including sir-2.1; drh-3; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010798	srbc-76
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; pmk-1; and mut-2 based on tiling array and microarray studies. Is affected by resveratrol and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00010799	chil-12
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00010800	srsx-37
Is predicted to have G protein-coupled receptor activity. Is expressed in ADLL; ADLR; and AWC-OFF.

WB:WBGene00010801	M01B2.8
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00010802	srsx-39
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00010803	M01B2.10
Is enriched in neurons and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phytanoyl-CoA hydroxylase-interacting protein-like. Is an ortholog of human PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like).

WB:WBGene00010804	M01E5.1
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00010805	M01E5.2
Is predicted to have GTP binding activity; GTPase activity; and magnesium ion binding activity. Is an ortholog of human MTG2 (mitochondrial ribosome associated GTPase 2).

WB:WBGene00010806	M01E5.3
Is enriched in AFD; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Zidovudine; fluoranthene; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterised protein family UPF0561.

WB:WBGene00010807	M01E5.4
Localizes to cytoplasm. Is an ortholog of human C2orf68 (chromosome 2 open reading frame 68).

WB:WBGene00010808	sepa-1
Exhibits protein self-association and protein-macromolecule adaptor activity. Is involved in autophagy. Localizes to cytoplasm. Is expressed in head; intestine; and tail.

WB:WBGene00010809	M01F1.3
Is predicted to have lipoate synthase activity. Is an ortholog of human LIAS (lipoic acid synthetase).

WB:WBGene00010810	M01F1.4
Is enriched in AVE; FLP; coelomocyte; germ line; and germline precursor cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including Tunicamycin; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Transmembrane protein TqsA-like. Is an ortholog of human TMEM245 (transmembrane protein 245).

WB:WBGene00010811	hmit-1.3
Is predicted to have myo-inositol:proton symporter activity. Localizes to apical plasma membrane. Is expressed in amphid sheath cell; head; and phasmid sheath cell. Human ortholog(s) of this gene are implicated in arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A13 (solute carrier family 2 member 13).

WB:WBGene00010812	mrpl-35
Is enriched in germ line; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and let-7 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by six chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ribosomal protein L35, mitochondrial. Is an ortholog of human MRPL35 (mitochondrial ribosomal protein L35).

WB:WBGene00010813	pitp-1
Is predicted to have phospholipid binding activity and phospholipid transporter activity. Localizes to ciliary transition zone and synapse. Is expressed in ASEL; ASER; AWCL; and AWCR. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 5. Is an ortholog of human PITPNM2 (phosphatidylinositol transfer protein membrane associated 2).

WB:WBGene00010814	M01F1.8
Is enriched in germ line; germline precursor cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010815	M01F1.9
Is predicted to have Rab guanyl-nucleotide exchange factor activity. Is an ortholog of human RGP1 (RGP1 homolog, RAB6A GEF complex partner 1).

WB:WBGene00010817	M01G12.2
Is predicted to have serine-type endopeptidase inhibitor activity.

WB:WBGene00010818	srt-21
Is affected by several genes including eat-2; fbf-1; and ain-1 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00010819	M01G12.5
Is affected by slr-2 based on microarray studies. Is affected by four chemicals including Mercuric Chloride; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpin (serine protease inhibitor); Serpin family; Serpin domain; and Serpin superfamily.

WB:WBGene00010820	M01G12.6
Is affected by several genes including daf-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00010821	M01G12.7
Is enriched in DA neuron; VA neuron; and coelomocyte based on tiling array studies. Is affected by several genes including skn-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; allantoin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: RAI1-like family.

WB:WBGene00010822	M01G12.9
Is enriched in coelomocyte; head mesodermal cell; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including methylmercuric chloride; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Spt5 C-terminal nonapeptide repeat binding Spt4 and RAI1-like family.

WB:WBGene00010823	M01G12.10
Is affected by rsr-2 and rrf-3 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00010824	M01G12.11
Is affected by cyc-1; clk-1; and nhr-25 based on microarray studies.

WB:WBGene00010825	M01G12.14
Is enriched in several structures, including coelomocyte; germ line; male distal tip cell; neurons; and retrovesicular ganglion based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Cadmium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: RAI1-like family. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00010827	txt-19
Is expressed in AIYL and AIYR.

WB:WBGene00010828	M02B1.3
Localizes to plasma membrane. Is an ortholog of human TLCD1 (TLC domain containing 1) and TLCD2 (TLC domain containing 2).

WB:WBGene00010829	M02B1.4
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Cry5B; and Diazinon based on microarray studies.

WB:WBGene00010830	M02G9.1
Is enriched in GABAergic neurons and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010831	M02G9.2
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by sixteen chemicals including methylmercury hydroxide; methylmercuric chloride; and sodium arsenite based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1096) and Protein of unknown function DUF1096.

WB:WBGene00010832	M02G9.3
Is enriched in ASER and DA neuron based on RNA-seq and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including indole; Sodium Chloride; and Colistin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010833	M03B6.1
Is enriched in coelomocyte; muscle cell; neurons; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Tunicamycin; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00010834	mct-3
Is predicted to have monocarboxylic acid transmembrane transporter activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A4 (solute carrier family 16 member 4).

WB:WBGene00010835	M03B6.3
Is enriched in hypodermis and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; methylmercuric chloride; and D-glucose based on RNA-seq; microarray; and proteomic studies.

WB:WBGene00010836	M03B6.4
Is enriched in germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010837	M03B6.5
Is enriched in body wall muscle cell and coelomocyte based on tiling array studies. Is affected by several genes including egl-5; prg-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00010838	M03C11.1
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations and myotonic dystrophy type 1. Is an ortholog of human STK32A (serine/threonine kinase 32A) and STK32B (serine/threonine kinase 32B).

WB:WBGene00010839	chl-1
Is predicted to have DNA helicase activity. Is involved in positive regulation of cell population proliferation. Human ortholog(s) of this gene are implicated in Warsaw breakage syndrome. Is an ortholog of human DDX11 (DEAD/H-box helicase 11).

WB:WBGene00010840	M03C11.3
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including lin-28; isp-1; and alg-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including Rotenone; Zidovudine; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00010842	ymel-1
Is predicted to have ATP binding activity; metal ion binding activity; and metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in optic atrophy 11. Is an ortholog of human YME1L1 (YME1 like 1 ATPase).

WB:WBGene00010843	M03C11.6
Is enriched in several structures, including Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010844	prp-3
Is enriched in AVA; germ line; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 18. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1115); pre-mRNA processing factor 3 (PRP3); Domain of unknown function DUF1115; Pre-mRNA-splicing factor 3; and U4/U6 small nuclear ribonucleoprotein Prp3. Is an ortholog of human PRPF3 (pre-mRNA processing factor 3).

WB:WBGene00010845	M03C11.8
Is predicted to have DNA binding activity; DNA-dependent ATPase activity; and chromatin binding activity. Human ortholog(s) of this gene are implicated in adermatoglyphia. Is an ortholog of human SMARCAD1 (SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1).

WB:WBGene00010846	M04B2.2
Is predicted to have tRNA (guanine) methyltransferase activity. Is an ortholog of human THUMPD3 (THUMP domain containing 3).

WB:WBGene00010847	M04B2.4
Is predicted to have aminomethyltransferase activity. Is an ortholog of human FOXRED1 (FAD dependent oxidoreductase domain containing 1).

WB:WBGene00010848	M04B2.6
Is enriched in body wall muscle cell; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00010849	M04B2.7
Is enriched in germ line; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; bisphenol A; and Psoralens based on RNA-seq studies.

WB:WBGene00010850	M04C3.1
Is predicted to have ATP binding activity.

WB:WBGene00010851	M04C3.2
Is predicted to have ATP binding activity. Is involved in innate immune response.

WB:WBGene00010853	M04C7.2
No description available

WB:WBGene00010854	M04C7.3
Is enriched in AVA; RID; arcade cell; pharyngeal-intestinal valve cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00010855	M04C7.4
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00010856	M04C9.1
Is enriched in GABAergic neurons; PLM; body wall muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I).

WB:WBGene00010857	M04C9.2
Is affected by several genes including daf-12; clk-1; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Sodium Chloride; and Ag nanoparticles based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I).

WB:WBGene00010858	M04C9.3
Is enriched in OLL; PVD; excretory cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I).

WB:WBGene00010859	M04C9.4
Is enriched in ASER and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including tryptophan; Rotenone; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010862	M04D8.4
Is enriched in muscle cell based on microarray studies. Is affected by cyc-1 and rsr-2 based on microarray and tiling array studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00010863	M04D8.5
Is enriched in Z1; Z4; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; Atrazine; and cadmium based on microarray studies.

WB:WBGene00010864	xbx-3
Is expressed in neurons.

WB:WBGene00010865	M04D8.7
Is enriched in AFD; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00010866	M04D8.8
Is affected by rsr-2 based on tiling array studies. Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00010867	tag-260
Is enriched in body wall musculature; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 39. Is predicted to encode a protein with the following domain: . Is an ortholog of human IRF2BPL (interferon regulatory factor 2 binding protein like).

WB:WBGene00010868	somi-1
Localizes to nucleus. Colocalizes with nuclear chromosome. Is expressed in several structures, including gonad; hypodermal cell; intestine; neurons; and vulval precursor cell.

WB:WBGene00010869	M05B5.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010870	let-522
Is expressed in pharynx.

WB:WBGene00010871	M05B5.3
Is enriched in several structures, including excretory cell; germ line; head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00010872	M05B5.4
Is predicted to have O-acyltransferase activity. Human ortholog(s) of this gene are implicated in Norum disease. Is an ortholog of human PLA2G15 (phospholipase A2 group XV).

WB:WBGene00010873	trpa-2
Is expressed in ASEL; ASER; and neurons. Is predicted to encode a protein with the following domain: .

WB:WBGene00010874	M05D6.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010875	M05D6.2
Is enriched in AVK; body wall muscle cell; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including let-7; gld-1; and eat-2 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including D-glucose; Zidovudine; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: T-complex protein 11 and T-complex 11. Is an ortholog of human TCP11 (t-complex 11) and TCP11L1 (t-complex 11 like 1).

WB:WBGene00010876	M05D6.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00010877	lact-4
Is enriched in coelomocyte; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; Mianserin; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9 and primary coenzyme Q10 deficiency 4. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00010878	M05D6.5
Localizes to endoplasmic reticulum.

WB:WBGene00010879	taap-1
Is enriched in several structures, including body wall musculature; coelomocyte; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and let-60 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including hydrogen sulfide; Rotenone; and juglone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1075) and Protein of unknown function DUF1075. Is an ortholog of human FAM162A (family with sequence similarity 162 member A) and FAM162B (family with sequence similarity 162 member B).

WB:WBGene00010880	M05D6.8
Is enriched in neurons and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00010881	M05D6.9
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00010882	atg-7
Is predicted to have Atg12 activating enzyme activity and Atg8 activating enzyme activity. Is involved in several processes, including autophagy; determination of adult lifespan; and positive regulation of autophagosome assembly. Is an ortholog of human ATG7 (autophagy related 7).

WB:WBGene00010883	M7.7
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010884	M7.8
Is predicted to have N-acetyltransferase activity.

WB:WBGene00010885	M7.9
Is enriched in body wall musculature; germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00010886	M7.10
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00010887	M7.12
Is predicted to have N-acetyltransferase activity.

WB:WBGene00010888	dlc-2
Is predicted to have dynein intermediate chain binding activity and dynein light intermediate chain binding activity. Is expressed in head muscle; intestine; neurons; and pharyngeal muscle cell.

WB:WBGene00010889	M18.3
Is predicted to have asparagine synthase (glutamine-hydrolyzing) activity. Localizes to cytoplasm. Is an ortholog of human ASNSD1 (asparagine synthetase domain containing 1).

WB:WBGene00010890	ddb-1
Is predicted to have damaged DNA binding activity. Is involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Is expressed in several structures, including hyp7; hyp7; hyp7; hyp7; and rectum. Is an ortholog of human DDB1 (damage specific DNA binding protein 1).

WB:WBGene00010891	M18.6
Is enriched in PLM; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is predicted to encode a protein with the following domain: Lon, substrate-binding domain. Is an ortholog of human CRBN (cereblon).

WB:WBGene00010892	dhhc-6
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Raymond type. Is an ortholog of human ZDHHC6 (zinc finger DHHC-type palmitoyltransferase 6).

WB:WBGene00010893	cutl-9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00010894	M28.2
Is affected by several genes including daf-2; eat-2; and csr-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00010895	M28.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010896	M28.5
Is predicted to have RNA binding activity. Is an ortholog of human SNU13 (small nuclear ribonucleoprotein 13).

WB:WBGene00010897	lact-3
Is enriched in OLL; PVD; and intestine based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including aldicarb; Cry5B; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9 and primary coenzyme Q10 deficiency 4. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00010898	nphp-1
Is involved in several processes, including determination of adult lifespan; male mating behavior; and non-motile cilium assembly. Localizes to several cellular components, including ciliary basal body; ciliary base; and ciliary transition zone. Is expressed in ciliated neurons; cloacal ganglion; postcloacal sensillum; and sensory neurons. Is used to study nephronophthisis. Human ortholog(s) of this gene are implicated in Joubert syndrome 4; Senior-Loken syndrome; and nephronophthisis 1. Is an ortholog of human NPHP1 (nephrocystin 1).

WB:WBGene00010899	M28.8
Is enriched in dopaminergic neurons and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Heme; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010900	M28.9
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including hydrogen sulfide; Ethanol; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Prominin and Prominin.

WB:WBGene00010901	M28.10
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including manganese chloride; nicotine; and stavudine based on RNA-seq; proteomic; and microarray studies.

WB:WBGene00010902	M79.2
Is predicted to have transferase activity, transferring acyl groups. Localizes to striated muscle dense body.

WB:WBGene00010904	ugt-62
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A6 (UDP glucuronosyltransferase family 1 member A6); UGT1A8 (UDP glucuronosyltransferase family 1 member A8); and UGT1A9 (UDP glucuronosyltransferase family 1 member A9).

WB:WBGene00010905	mrps-34
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 32. Is an ortholog of human MRPS34 (mitochondrial ribosomal protein S34).

WB:WBGene00010906	M88.3
Is enriched in ciliated neurons; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010907	M88.4
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; resveratrol; and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: PTB/PI domain and PH-like domain superfamily.

WB:WBGene00010908	imph-1
Is predicted to have RNA binding activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human IGF2BP2 (insulin like growth factor 2 mRNA binding protein 2) and IGF2BP3 (insulin like growth factor 2 mRNA binding protein 3).

WB:WBGene00010909	cisd-3.1
Is predicted to have 2 iron, 2 sulfur cluster binding activity. Human ortholog(s) of this gene are implicated in Wolfram syndrome 2. Is an ortholog of human CISD3 (CDGSH iron sulfur domain 3).

WB:WBGene00010910	M106.2
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and npr-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by Rotenone; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00010911	M106.3
Is predicted to have oxidoreductase activity. Is expressed in head and tail. Is an ortholog of human PTGR2 (prostaglandin reductase 2).

WB:WBGene00010912	gmps-1
Is predicted to have GMP synthase activity. Is an ortholog of human GMPS (guanine monophosphate synthase).

WB:WBGene00010913	M110.3
Is predicted to have zinc ion binding activity. Is an ortholog of human MARCHF5 (membrane associated ring-CH-type finger 5).

WB:WBGene00010914	M110.6
No description available

WB:WBGene00010915	M110.7
Is predicted to have lysophospholipase activity. Human ortholog(s) of this gene are implicated in several diseases, including Boucher-Neuhauser syndrome; Laurence-Moon syndrome; and Oliver-McFarlane syndrome. Is an ortholog of human PNPLA7 (patatin like phospholipase domain containing 7).

WB:WBGene00010916	M110.8
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including mex-3; mex-1; and spn-4 based on microarray and RNA-seq studies. Is affected by Cisplatin based on RNA-seq studies.

WB:WBGene00010917	M110.9
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by glycine and Colistin based on RNA-seq and microarray studies.

WB:WBGene00010918	M117.1
Is predicted to have transmembrane transporter activity.

WB:WBGene00010919	M117.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 56. Is predicted to encode a protein with the following domains: 14-3-3 protein; 14-3-3 protein; 14-3-3 domain; and 14-3-3 domain superfamily.

WB:WBGene00010920	M117.4
Is enriched in germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010921	fbxb-4
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00010922	M142.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by Rotenone; stavudine; and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Anticodon-binding domain; Anticodon-binding domain; and Protein Lsm12-like. Is an ortholog of human LSM12 (LSM12 homolog).

WB:WBGene00010923	rle-1
Exhibits ubiquitin-protein transferase activity. Is involved in determination of adult lifespan; response to heat; and ubiquitin-dependent protein catabolic process. Is an ortholog of human RC3H1 (ring finger and CCCH-type domains 1) and RC3H2 (ring finger and CCCH-type domains 2).

WB:WBGene00010924	M153.1
Is predicted to have pyrroline-5-carboxylate reductase activity. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IIB; autosomal recessive cutis laxa type IIIB; and hypomyelinating leukodystrophy 10. Is an ortholog of human PYCR1 (pyrroline-5-carboxylate reductase 1).

WB:WBGene00010925	mfsd-11
Is enriched in PLM; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00010926	M153.3
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00010927	clec-259
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including lin-15B; mex-3; and spn-4 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00010928	clec-258
Is predicted to have carbohydrate binding activity.

WB:WBGene00010929	srt-45
Is expressed in AWC-OFF and head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00010930	srt-46
Is enriched in muscle cell based on microarray studies. Is affected by cyc-1 and eat-2 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00010931	M162.5
Is predicted to have transmembrane transporter activity.

WB:WBGene00010932	M162.6
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including let-60; eat-2; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including tryptophan; allantoin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00010933	M162.7
Is enriched in germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Zidovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00010934	fbxa-118
Is enriched in head mesodermal cell and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00010935	M163.1
Is enriched in coelomocyte; muscle cell; sensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00010936	ztf-14
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in neonatal diabetes mellitus with congenital hypothyroidism.

WB:WBGene00010937	M163.5
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by tryptophan; resveratrol; and fluoranthene based on microarray studies.

WB:WBGene00010938	M163.6
Is enriched in NSM based on tiling array studies. Is affected by eat-2; daf-2; and mex-1 based on RNA-seq and microarray studies. Is affected by Microcystin-LR based on microarray studies.

WB:WBGene00010939	M163.7
Is affected by rsr-2; daf-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00010940	M163.8
Is enriched in intestine based on microarray studies. Is affected by several genes including rrf-3; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00010941	gss-1
Is predicted to have glutathione binding activity and glutathione synthase activity. Is expressed in head. Is an ortholog of human GSS (glutathione synthetase).

WB:WBGene00010942	chch-3
Is enriched in germ line; hypodermis; intestine; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Testosterone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human CHCHD3 (coiled-coil-helix-coiled-coil-helix domain containing 3).

WB:WBGene00010943	M176.4
Is predicted to have alkenylglycerophosphocholine hydrolase activity and alkenylglycerophosphoethanolamine hydrolase activity. Localizes to endoplasmic reticulum. Is an ortholog of human TMEM86A (transmembrane protein 86A) and TMEM86B (transmembrane protein 86B).

WB:WBGene00010944	M176.5
Is expressed in neurons and pharynx.

WB:WBGene00010945	chil-13
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00010946	M176.10
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on RNA-seq and microarray studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010947	M176.11
Is enriched in NSM; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including glp-1; daf-12; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including Rotenone; Mianserin; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00010948	M195.2
Is enriched in DA neuron and pharynx based on microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010949	M195.4
Is affected by several genes including sir-2.1; ubc-9; and jmjd-3.1 based on microarray and RNA-seq studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00010950	srt-44
Is affected by several genes including nhr-25; drh-3; and pptr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00010951	M199.2
Is affected by several genes including dpy-10; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including D-glucose; Zidovudine; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00010952	clec-188
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by drh-3 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00010953	clec-190
Is predicted to have carbohydrate binding activity.

WB:WBGene00010954	clec-189
Is predicted to have carbohydrate binding activity.

WB:WBGene00010955	M199.7
Is affected by several genes including daf-16; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00010956	M199.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by clk-1; daf-2; and eat-2 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010957	nduo-6
Is predicted to have NADH dehydrogenase (ubiquinone) activity.

WB:WBGene00010958	ndfl-4
Is predicted to have NADH dehydrogenase (ubiquinone) activity.

WB:WBGene00010959	nduo-1
Is predicted to contribute to NADH dehydrogenase activity. Human ortholog(s) of this gene are implicated in Leber hereditary optic neuropathy and MELAS syndrome.

WB:WBGene00010960	atp-6
Is predicted to have proton transmembrane transporter activity.

WB:WBGene00010961	nduo-2
Is predicted to have NADH dehydrogenase (ubiquinone) activity.

WB:WBGene00010962	ctc-3
Is predicted to have electron transfer activity and oxidoreduction-driven active transmembrane transporter activity. Human ortholog(s) of this gene are implicated in Leber hereditary optic neuropathy and MELAS syndrome.

WB:WBGene00010963	nduo-4
Is predicted to contribute to NADH dehydrogenase activity. Human ortholog(s) of this gene are implicated in Leber hereditary optic neuropathy.

WB:WBGene00010964	ctc-1
Is predicted to contribute to cytochrome-c oxidase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in MELAS syndrome.

WB:WBGene00010965	ctc-2
Is predicted to contribute to cytochrome-c oxidase activity. Human ortholog(s) of this gene are implicated in MELAS syndrome.

WB:WBGene00010966	nduo-3
Is predicted to have NADH dehydrogenase (ubiquinone) activity.

WB:WBGene00010967	nduo-5
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Human ortholog(s) of this gene are implicated in Leber hereditary optic neuropathy and MELAS syndrome.

WB:WBGene00010968	R01E6.2
Is enriched in ALM; OLL; PLM; and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; manganese chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Pepsin inhibitor-3-like repeated domain; Pepsin inhibitor-3-like repeated domain; and Pepsin inhibitor-3 domain superfamily.

WB:WBGene00010969	R01E6.5
Is expressed in spicule neurons and vulva.

WB:WBGene00010970	glb-20
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in body wall musculature; enteric muscle; head neurons; and somatic nervous system.

WB:WBGene00010971	R01E6.7
Is enriched in neurons and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and let-60 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00010972	R01H10.4
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T19C3.2-like.

WB:WBGene00010973	rip-1
Localizes to DNA recombinase mediator complex.

WB:WBGene00010974	bbs-5
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Localizes to ciliary base; cytoskeleton; and non-motile cilium. Is expressed in head; neurons; outer labial neurons; and tail. Is used to study Bardet-Biedl syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 5. Is an ortholog of human BBS5 (Bardet-Biedl syndrome 5).

WB:WBGene00010975	R01H10.7
Is predicted to have phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity. Is an ortholog of human INPP4A (inositol polyphosphate-4-phosphatase type I A) and INPP4B (inositol polyphosphate-4-phosphatase type II B).

WB:WBGene00010976	R02D5.1
Is enriched in OLL; PLM; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including 1-methylnicotinamide; Cry5B; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00010977	R02D5.3
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Rotenone; D-glucopyranose; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Modulator of levamisole receptor-1 and Modulator of levamisole receptor-1.

WB:WBGene00010978	R02D5.4
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by ins-11; drh-3; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00010979	R02D5.6
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00010980	R02D5.7
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00010981	blos-8
Is enriched in germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BLOC-1-related complex sub-unit 7 and BLOC-1-related complex subunit 7. Is an ortholog of human BORCS7 (BLOC-1 related complex subunit 7).

WB:WBGene00010982	flp-32
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00010983	mocs-1
Is predicted to have Mo-molybdopterin cofactor sulfurase activity. Is expressed in amphid sheath cell; head; and socket cell. Is used to study autism spectrum disorder. Human ortholog(s) of this gene are implicated in xanthinuria. Is an ortholog of human MOCOS (molybdenum cofactor sulfurase).

WB:WBGene00010984	nkat-3
Is predicted to have kynurenine-oxoglutarate transaminase activity. Is expressed in gonad; pharyngeal muscle cell; and tail. Is an ortholog of human KYAT3 (kynurenine aminotransferase 3).

WB:WBGene00010985	R03A10.5
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including manganese chloride; 4-bromodiphenyl ether; and levamisole based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00010986	sprr-1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00010987	R03C1.1
Is enriched in DA neuron; GABAergic neurons; and pharynx based on microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including aldicarb; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies.

WB:WBGene00010988	metr-1
Is predicted to have methionine synthase activity. Human ortholog(s) of this gene are implicated in neural tube defect. Is an ortholog of human MTR (5-methyltetrahydrofolate-homocysteine methyltransferase).

WB:WBGene00010989	R03D7.2
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Tunicamycin; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2S and distal spinal muscular atrophy 1. Is predicted to encode a protein with the following domains: AAA domain; P-loop containing nucleoside triphosphate hydrolase; and DNA2/NAM7 helicase-like, AAA domain.

WB:WBGene00010990	tceb-3
Is involved in transcription elongation from RNA polymerase II promoter. Localizes to transcription elongation factor complex. Is an ortholog of human ELOA (elongin A).

WB:WBGene00010991	R03D7.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00010992	R03D7.8
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00010993	vha-20
Is predicted to have signaling receptor activity. Is involved in nematode larval development. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Hedera type. Is an ortholog of human ATP6AP2 (ATPase H+ transporting accessory protein 2).

WB:WBGene00010994	lgc-25
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00010995	ceh-90
Is predicted to have DNA binding activity. Is expressed in head muscle; intestine; neurons; and somatic nervous system.

WB:WBGene00010996	R03G8.1
Is predicted to have catalytic activity.

WB:WBGene00010997	R03G8.2
No description available

WB:WBGene00010998	R03G8.3
Is predicted to have catalytic activity.

WB:WBGene00010999	R03G8.4
Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including methylmercury hydroxide; resveratrol; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00011000	R03G8.6
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is an ortholog of human ERAP1 (endoplasmic reticulum aminopeptidase 1); ERAP2 (endoplasmic reticulum aminopeptidase 2); and LNPEP (leucyl and cystinyl aminopeptidase).

WB:WBGene00011001	R04B5.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00011002	nhr-205
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00011003	R04B5.5
Is predicted to have metal ion binding activity and oxidoreductase activity. Is expressed in body wall musculature and intestine. Is an ortholog of human SORD (sorbitol dehydrogenase).

WB:WBGene00011004	R04B5.6
Is predicted to have metal ion binding activity and oxidoreductase activity. Is expressed in head neurons and pharyngeal cell. Is an ortholog of human SORD (sorbitol dehydrogenase).

WB:WBGene00011005	R04B5.7
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including let-60; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00011006	ugt-47
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT2B17 (UDP glucuronosyltransferase family 2 member B17); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00011007	R04B5.10
Is affected by cdk-4 and cyd-1 based on microarray studies. Is affected by Progesterone and dafa#1 based on microarray studies.

WB:WBGene00011008	R04B5.11
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00011009	cyp-14A4
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is expressed in intestine. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00011010	R04D3.2
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011011	R04D3.3
Is enriched in germ line; germline precursor cell; hypodermis; neurons; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including methylmercury hydroxide; Rotenone; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011012	R04D3.4
Is enriched in germ line; germline precursor cell; hypodermis; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00011013	srxa-8
Is affected by clk-1 and drh-3 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00011014	hpo-30
Localizes to dendrite. Is expressed in body wall musculature; neurons; and ventral nerve cord.

WB:WBGene00011015	R04F11.2
Is predicted to have proton transmembrane transporter activity. Is an ortholog of human ATP5ME (ATP synthase membrane subunit e).

WB:WBGene00011016	R04F11.3
Is predicted to contribute to DNA-directed DNA polymerase activity.

WB:WBGene00011017	R04F11.5
Localizes to endoplasmic reticulum. Is an ortholog of human TIMM29 (translocase of inner mitochondrial membrane 29).

WB:WBGene00011018	R05A10.1
Is enriched in cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including nicotinic acid; Sodium Chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011019	R05A10.2
Is enriched in PLM; amphid sheath cell; hypodermis; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011020	R05A10.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00011021	R05A10.4
Is enriched in PLM; amphid sheath cell; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Ethanol; nanoparticle; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1505) and Protein of unknown function DUF1505.

WB:WBGene00011022	R05A10.5
Is affected by several genes including daf-2; rrf-3; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00011023	R05A10.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00011024	R05A10.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including rrf-3; daf-12; and sir-2.1 based on microarray and RNA-seq studies. Is affected by methylmercury hydroxide and glycine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00011025	R05A10.8
Is affected by several genes including bar-1; aak-2; and lin-22 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; and Methyltransferase-like protein 24.

WB:WBGene00011026	R05D7.1
Is enriched in body wall muscle cell; cephalic sheath cell; dopaminergic neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011027	R05D7.2
Is enriched in germ line; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00011028	R05D7.3
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sek-1; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; allantoin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised conserved protein (DUF2371) and Protein of unknown function DUF2371, TMEM200. Is an ortholog of human TMEM200A (transmembrane protein 200A).

WB:WBGene00011029	abhd-11.2
Is predicted to have hydrolase activity. Is an ortholog of human ABHD11 (abhydrolase domain containing 11).

WB:WBGene00011030	R05D7.5
Is enriched in GABAergic neurons; excretory cell; germ line; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including lin-35; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by Rotenone and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00011032	ddx-52
Is predicted to have RNA binding activity and RNA helicase activity. Is involved in protein folding. Is an ortholog of human DDX52 (DExD-box helicase 52).

WB:WBGene00011033	tmem-208
Is enriched in body wall musculature; germ line; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SRP-independent targeting protein 2/TMEM208 and SRP-independent targeting protein 2/TMEM208. Is an ortholog of human TMEM208 (transmembrane protein 208).

WB:WBGene00011034	paxt-1
Localizes to nucleolus and nucleoplasm. Is an ortholog of human CDKN2AIPNL (CDKN2A interacting protein N-terminal like) and NKRF (NFKB repressing factor).

WB:WBGene00011035	snrp-27
Is enriched in NSM; germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: U4/U6.U5 small nuclear ribonucleoproteins and U4/U6.U5 small nuclear ribonucleoprotein 27kDa protein. Is an ortholog of human SNRNP27 (small nuclear ribonucleoprotein U4/U6.U5 subunit 27).

WB:WBGene00011036	edc-3
Is predicted to have mRNA binding activity. Is expressed in hypodermal cell; intestinal cell; neurons; and pharyngeal muscle cell. Is an ortholog of human EDC3 (enhancer of mRNA decapping 3).

WB:WBGene00011037	R05D11.9
Is predicted to have sphingomyelin phosphodiesterase D activity. Is an ortholog of human SMPD4 (sphingomyelin phosphodiesterase 4).

WB:WBGene00011038	R05H5.3
Is expressed in germ line. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00011039	R05H5.4
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00011040	arv-1
Is enriched in germ line; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 38. Is predicted to encode a protein with the following domains: Arv1-like family and Arv1 protein. Is an ortholog of human ARV1 (ARV1 homolog, fatty acid homeostasis modulator).

WB:WBGene00011041	R05H5.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by dafa#1 and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011042	R05H10.1
Is predicted to have N-acetyltransferase activity.

WB:WBGene00011043	rbm-28
Is predicted to have RNA binding activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human RBM28 (RNA binding motif protein 28).

WB:WBGene00011044	R05H10.3
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00011045	gpx-2
Is predicted to have peroxidase activity. Is an ortholog of human GPX4 (glutathione peroxidase 4).

WB:WBGene00011046	R05H10.7
Is predicted to have N-acetyltransferase activity.

WB:WBGene00011047	tebp-1
Is enriched in ASER; AVK; NSM; and germ line based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sek-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011048	R06A4.3
No description available

WB:WBGene00011049	sdz-26
Is expressed in E; Ea; and Ep. Is predicted to encode a protein with the following domains: Pes-10 and Pes-10.

WB:WBGene00011050	agl-1
Is predicted to have 4-alpha-glucanotransferase activity and amylo-alpha-1,6-glucosidase activity. Human ortholog(s) of this gene are implicated in glycogen storage disease III. Is an ortholog of human AGL (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase).

WB:WBGene00011051	pfs-2
Localizes to nuclear speck. Is an ortholog of human WDR33 (WD repeat domain 33).

WB:WBGene00011052	arrd-11
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00011053	arrd-12
Is enriched in amphid sheath cell; body wall muscle cell; intestine; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and hsp-6 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin, C-terminal; and Immunoglobulin E-set.

WB:WBGene00011054	arrd-13
Is enriched in several structures, including RIS; body wall muscle cell; coelomocyte; germ line; and germline precursor cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on RNA-seq; microarray; and tiling array studies. Is affected by ten chemicals including Alovudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00011055	arrd-14
Is enriched in arcade cell; hypodermis; pharyngeal-intestinal valve cell; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00011056	R06B9.5
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and npr-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011058	fdps-1
Is predicted to have dimethylallyltranstransferase activity and geranyltranstransferase activity. Is expressed in germ line. Is an ortholog of human FDPS (farnesyl diphosphate synthase).

WB:WBGene00011059	R06C1.4
Is predicted to have mRNA binding activity.

WB:WBGene00011060	R06C1.6
Is enriched in muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011061	wago-1
Exhibits DEAD/H-box RNA helicase binding activity. Localizes to P granule. Is expressed in germ line.

WB:WBGene00011062	R06C7.2
Is predicted to have SUMO transferase activity.

WB:WBGene00011063	cpg-3
Is expressed in germ line. Is predicted to encode a protein with the following domain: Chondroitin proteoglycan 3.

WB:WBGene00011064	adsl-1
Is predicted to have (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity and N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity. Human ortholog(s) of this gene are implicated in adenylosuccinase lyase deficiency. Is an ortholog of human ADSL (adenylosuccinate lyase).

WB:WBGene00011065	R06C7.6
Is predicted to have protein-N-terminal glutamine amidohydrolase activity. Is an ortholog of human NTAQ1 (N-terminal glutamine amidase 1).

WB:WBGene00011066	ztf-15
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 21 and immunodeficiency-centromeric instability-facial anomalies syndrome 2.

WB:WBGene00011067	vps-11
Is predicted to have protein-macromolecule adaptor activity. Is expressed in gonad. Human ortholog(s) of this gene are implicated in hypomyelinating leukodystrophy 12. Is an ortholog of human VPS11 (VPS11 core subunit of CORVET and HOPS complexes).

WB:WBGene00011068	set-14
Is predicted to have histone-lysine N-methyltransferase activity. Is expressed in hypodermis; intestine; and neurons. Human ortholog(s) of this gene are implicated in spermatogenic failure 14. Is an ortholog of human SMYD2 (SET and MYND domain containing 2).

WB:WBGene00011069	ceh-62
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord; neurons; tail neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple). Is an ortholog of human HOXC9 (homeobox C9) and HOXD10 (homeobox D10).

WB:WBGene00011070	msrp-7
Is enriched in FLP and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including aldicarb; Rotenone; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00011071	R06F6.8
Is predicted to have Rab guanyl-nucleotide exchange factor activity. Is an ortholog of human RIC1 (RIC1 homolog, RAB6A GEF complex partner 1).

WB:WBGene00011072	tag-209
Is enriched in amphid sheath cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including D-glucose; bisphenol A; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00011073	R07A4.2
Is enriched in head mesodermal cell; intestine; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00011074	R07A4.3
Is enriched in hypodermis; intestine; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011075	R07A4.4
Is enriched in GABAergic neurons; amphid sheath cell; and excretory cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00011076	scav-5
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 10 and progressive myoclonus epilepsy 4. Is predicted to encode a protein with the following domains: CD36 family and CD36 family. Is an ortholog of human SCARB1 (scavenger receptor class B member 1) and SCARB2 (scavenger receptor class B member 2).

WB:WBGene00011077	R07B1.5
Is enriched in body wall muscle cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including methylmercury hydroxide; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00011078	R07B1.6
Is enriched in NSM; OLL; and PVD based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including tryptophan; methylmercury hydroxide; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00011079	R07B1.7
Is enriched in OLL; PVD; and coelomocyte based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00011081	R07B1.9
Is expressed in pharynx.

WB:WBGene00011082	R07B1.11
Is enriched in AVE; dopaminergic neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including glp-1; elt-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by Rotenone; D-glucose; and Sodium Chloride based on RNA-seq studies.

WB:WBGene00011083	glo-1
Is predicted to have GTPase activity. Is involved in lipid storage and lysosome organization. Localizes to gut granule membrane. Is expressed in intestine. Is an ortholog of human RAB32 (RAB32, member RAS oncogene family) and RAB38 (RAB38, member RAS oncogene family).

WB:WBGene00011084	srsx-21
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00011087	R07B7.2
Is enriched in AVG; RIM; command interneuron; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00011088	kmo-2
Is predicted to have NAD(P)H oxidase (H(2)O(2)-forming activity; flavin adenine dinucleotide binding activity; and kynurenine 3-monooxygenase activity. Is an ortholog of human KMO (kynurenine 3-monooxygenase).

WB:WBGene00011089	kmo-1
Is predicted to have NAD(P)H oxidase (H(2)O(2)-forming activity; flavin adenine dinucleotide binding activity; and kynurenine 3-monooxygenase activity. Is an ortholog of human KMO (kynurenine 3-monooxygenase).

WB:WBGene00011090	R07B7.6
Is enriched in FLP and intestine based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)); and GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type).

WB:WBGene00011092	R07B7.8
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00011093	R07B7.9
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00011094	R07B7.10
Is predicted to have acyl carnitine transmembrane transporter activity. Is an ortholog of human SLC25A47 (solute carrier family 25 member 47).

WB:WBGene00011095	gana-1
Is predicted to have alpha-galactosidase activity. Is involved in glycoside catabolic process. Localizes to cytoplasm. Is expressed in coelomocyte. Is used to study Fabry disease. Human ortholog(s) of this gene are implicated in Fabry disease. Is an ortholog of human GLA (galactosidase alpha) and NAGA (alpha-N-acetylgalactosaminidase).

WB:WBGene00011096	R07B7.12
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00011097	nhr-206
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in response to starvation. Is expressed in several structures, including anal sphincter muscle; hyp12; rectal gland cell; tail hypodermis; and vulva. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00011098	nhr-207
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in response to starvation. Is expressed in several structures, including anal sphincter muscle; gonad; pharyngeal neurons; pharyngeal-intestinal valve; and rectal valve cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00011099	nhr-208
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in response to starvation. Is expressed in several structures, including anal sphincter muscle; hyp12; pharynx; rectum; and tail hypodermis. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00011100	nhr-209
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00011101	R07D5.2
Is enriched in DA neuron; RIS; VA neuron; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; bisphenol A; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011102	R07E3.1
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis.

WB:WBGene00011103	R07E3.2
Is enriched in intestine; neurons; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011104	cut-5
Is expressed in seam cell. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00011105	R07E3.4
Is predicted to have ATP:ADP antiporter activity. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2; mitochondrial DNA depletion syndrome 12a; and mitochondrial DNA depletion syndrome 12b. Is an ortholog of several human genes including SLC25A31 (solute carrier family 25 member 31); SLC25A5 (solute carrier family 25 member 5); and SLC25A6 (solute carrier family 25 member 6).

WB:WBGene00011106	acl-5
Is predicted to have transferase activity, transferring acyl groups. Localizes to endoplasmic reticulum. Is expressed in head. Is an ortholog of human GPAT3 (glycerol-3-phosphate acyltransferase 3) and GPAT4 (glycerol-3-phosphate acyltransferase 4).

WB:WBGene00011107	R07E3.6
Is enriched in AFD; OLL; PLM; PVD; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011108	R07E3.7
Is enriched in several structures, including cephalic sheath cell; excretory cell; head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00011109	gpch-1
Is predicted to have RNA binding activity. Is an ortholog of human GPATCH1 (G-patch domain containing 1).

WB:WBGene00011110	prdx-3
Is predicted to have thioredoxin peroxidase activity. Is an ortholog of human PRDX3 (peroxiredoxin 3).

WB:WBGene00011111	snfc-5
Is predicted to have transcription coactivator activity. Human ortholog(s) of this gene are implicated in Coffin-Siris syndrome 3; atypical teratoid rhabdoid tumor; and neurilemmomatosis. Is an ortholog of human SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1).

WB:WBGene00011112	R07E5.4
Is enriched in ASER; Z1; Z4; germline precursor cell; and intestine based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; sodium arsenite; and indole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00011113	R07E5.5
Is enriched in AVA; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including sodium arsenite; multi-walled carbon nanotube; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2 superfamily.

WB:WBGene00011114	R07E5.6
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including nicotinic acid; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011115	R07E5.7
Is involved in IRE1-mediated unfolded protein response. Localizes to plasma membrane. Is expressed in neurons. Human ortholog(s) of this gene are implicated in X-linked myopathy with excessive autophagy.

WB:WBGene00011116	pdcd-2
Is predicted to have metal ion binding activity. Is an ortholog of human PDCD2 (programmed cell death 2).

WB:WBGene00011117	R07E5.11
Is enriched in several structures, including excretory cell; germ line; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00011119	mpc-1
Is predicted to have pyruvate transmembrane transporter activity. Human ortholog(s) of this gene are implicated in mitochondrial pyruvate carrier deficiency. Is an ortholog of human MPC1 (mitochondrial pyruvate carrier 1).

WB:WBGene00011120	R07E5.15
Is enriched in germ line; somatic gonad precursor; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00011121	R07E5.17
Is enriched in ASER; BAG; PLM; dopaminergic neurons; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00011122	cpt-2
Is predicted to have carnitine O-palmitoyltransferase activity. Human ortholog(s) of this gene are implicated in carnitine palmitoyltransferase II deficiency. Is an ortholog of human CPT2 (carnitine palmitoyltransferase 2).

WB:WBGene00011123	nuaf-3
Is involved in mitochondrial respiratory chain complex I assembly. Localizes to mitochondrion. Is an ortholog of human NDUFAF3 (NADH:ubiquinone oxidoreductase complex assembly factor 3).

WB:WBGene00011124	sdz-27
Is involved in gastrulation.

WB:WBGene00011125	R07H5.5
No description available

WB:WBGene00011126	R07H5.6
No description available

WB:WBGene00011127	fbxb-79
Is affected by several genes including eat-2; rrf-1; and mex-3 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00011128	adk-1
Is predicted to have adenosine kinase activity. Human ortholog(s) of this gene are implicated in hypermethioninemia due to adenosine kinase deficiency. Is an ortholog of human ADK (adenosine kinase).

WB:WBGene00011129	R07H5.9
Is enriched in PLM; germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011130	zip-6
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00011131	R07H5.11
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-16; lin-35; and pgl-1 based on microarray and RNA-seq studies. Is affected by stavudine; Rifampin; and allantoin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in spastic ataxia 4. Is predicted to encode a protein with the following domain: .

WB:WBGene00011132	R08A2.1
Is enriched in NSM; arcade cell; germ line; and pharyngeal-intestinal valve cell based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00011133	R08A2.2
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00011134	ssp-33
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00011135	fbxa-147
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including bar-1; aak-2; and hsp-6 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00011136	R08A2.5
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; Zidovudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00011137	R08A2.7
Is enriched in AFD; ASER; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; alg-1; and sma-2 based on tiling array; RNA-seq; and microarray studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011139	R08B4.3
Is predicted to have metal ion binding activity.

WB:WBGene00011140	R08B4.4
Is affected by several genes including elt-2; dpy-21; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by tryptophan; multi-walled carbon nanotube; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00011141	nlp-66
Is enriched in BAG; OLL; PVD; neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and npr-1 based on tiling array and RNA-seq studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00011142	R08D7.1
Is enriched in AVA and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; age-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Pre-mRNA-splicing factor of RES complex; and Bud13. Is an ortholog of human BUD13 (BUD13 homolog).

WB:WBGene00011143	rpap-2
Is predicted to have RNA polymerase II CTD heptapeptide repeat phosphatase activity. Is an ortholog of human RPAP2 (RNA polymerase II associated protein 2).

WB:WBGene00011144	R08D7.4
Is enriched in body wall muscle cell; germ line; intestine; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by D-glucose; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Complex 1 protein (LYR family); Complex 1 LYR protein; and LYR motif-containing protein 1. Is an ortholog of human EEF2KMT (eukaryotic elongation factor 2 lysine methyltransferase).

WB:WBGene00011145	R08D7.5
Is predicted to have calcium ion binding activity and enzyme regulator activity.

WB:WBGene00011146	pde-2
Is predicted to have 3',5'-cyclic-nucleotide phosphodiesterase activity and protein homodimerization activity. Is involved in several processes, including negative regulation of cyclic nucleotide-gated ion channel activity; positive regulation of oviposition; and regulation of cGMP-mediated signaling. Is expressed in AFDL and AFDR. Is an ortholog of human PDE2A (phosphodiesterase 2A).

WB:WBGene00011147	R08D7.7
Is predicted to have xylulokinase activity. Is an ortholog of human XYLB (xylulokinase).

WB:WBGene00011149	R08H2.8
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; resveratrol; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00011150	nhr-269
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00011151	R08H2.10
Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine; cadmium; and fluoranthene based on microarray studies.

WB:WBGene00011152	R09A8.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011153	R09A8.2
Is enriched in AB and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including D-glucose; bisphenol A; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011154	R09A8.5
Is expressed in alimentary muscle; body wall musculature; rectal valve cell; and tail hypodermis.

WB:WBGene00011155	rbm-3.1
Is predicted to have mRNA binding activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human RBM3 (RNA binding motif protein 3).

WB:WBGene00011156	rbm-3.2
Is predicted to have mRNA binding activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human RBM3 (RNA binding motif protein 3).

WB:WBGene00011157	chil-15
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011158	chil-16
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011159	chil-17
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011160	R09D1.4
Is affected by several genes including alg-1; dpy-21; and cox-5B based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011161	chil-18
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011162	chil-19
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011163	chil-20
Is enriched in NSM based on tiling array studies. Is affected by several genes including age-1; let-60; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Tunicamycin; paraquat; and resveratrol based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011164	chil-21
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011165	R09D1.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011166	chil-22
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011167	chil-23
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011168	R09D1.12
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including CSF1R (colony stimulating factor 1 receptor); KIT (KIT proto-oncogene, receptor tyrosine kinase); and PDGFRA (platelet derived growth factor receptor alpha).

WB:WBGene00011169	R09D1.13
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including dysostosis (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00011170	R09D1.14
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including clk-1; eat-2; and ain-2 based on tiling array and microarray studies. Human ortholog(s) of this gene are implicated in schizophrenia. Is predicted to encode a protein with the following domains: Glycosyl hydrolases family 18; Glycoside hydrolase family 18, catalytic domain; and Glycoside hydrolase superfamily.

WB:WBGene00011171	R09E10.1
Is enriched in AVK; germ line; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00011172	R09E10.2
Is enriched in AVK; amphid sheath cell; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including manganese chloride; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011173	acs-18
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ACSL1 (acyl-CoA synthetase long chain family member 1).

WB:WBGene00011174	acs-23
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including multi-walled carbon nanotube; Diazinon; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00011175	R09E10.5
Is predicted to have microtubule-severing ATPase activity.

WB:WBGene00011176	R09E10.6
Is enriched in AVK; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-eight chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011177	R09E10.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; pmk-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011178	R09E10.9
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including pmk-1; isp-1; and hsp-6 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including methylmercuric chloride; multi-walled carbon nanotube; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00011179	R09H10.1
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00011180	R09H10.2
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00011181	R09H10.3
Exhibits identical protein binding activity. Human ortholog(s) of this gene are implicated in carpal tunnel syndrome; dystransthyretinemic hyperthyroxinemia; and transthyretin amyloidosis. Is an ortholog of human TTR (transthyretin).

WB:WBGene00011182	R09H10.5
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EGF-like domain and MD domain.

WB:WBGene00011183	R09H10.6
Is predicted to have calcium ion binding activity.

WB:WBGene00011184	R09H10.7
Is enriched in GABAergic neurons; coelomocyte; excretory cell; intestine; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00011185	R10D12.1
Is predicted to have transmembrane transporter activity.

WB:WBGene00011186	clec-226
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00011187	R10D12.6
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including clk-1; pmk-1; and hpl-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Mercuric Chloride; Tunicamycin; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00011188	R10D12.7
Is affected by several genes including eri-1; aak-2; and dpy-21 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00011189	R10D12.8
Is enriched in NSM; germ line; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including D-glucose; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00011190	swt-6
Is enriched in dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-eight chemicals including Heme; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Sugar efflux transporter for intercellular exchange and SWEET sugar transporter.

WB:WBGene00011191	R10D12.10
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00011192	srh-24
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray studies. Is affected by seven chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00011193	algn-13
Is predicted to have transferase activity, transferring hexosyl groups. Is an ortholog of human ALG13 (ALG13 UDP-N-acetylglucosaminyltransferase subunit).

WB:WBGene00011194	R10D12.13
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-60; and dpy-10 based on microarray and RNA-seq studies. Is affected by nine chemicals including Atrazine; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain containing protein (DUF2052); Ccdc97-like; and Domain of unknown function DUF2052. Is an ortholog of human CCDC97 (coiled-coil domain containing 97).

WB:WBGene00011195	sao-1
Exhibits WD40-repeat domain binding activity. Is involved in negative regulation of Notch signaling pathway and regulation of protein deneddylation. Localizes to cell cortex and cleavage furrow.

WB:WBGene00011196	R10D12.15
Is predicted to have chitinase activity.

WB:WBGene00011197	srw-145
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in accessory cell; phasmid neurons; and sensory neurons.

WB:WBGene00011198	R10E4.1
Is enriched in excretory cell; germ line; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00011200	R10E4.3
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercuric chloride; metformin; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00011201	nth-1
Exhibits 5-formyluracil DNA N-glycosylase activity and 5-hydroxymethyluracil DNA N-glycosylase activity. Is involved in cellular response to hydrogen peroxide and depyrimidination. Human ortholog(s) of this gene are implicated in familial adenomatous polyposis 3. Is an ortholog of human NTHL1 (nth like DNA glycosylase 1).

WB:WBGene00011202	R10E4.6
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including skn-1; dpy-10; and gld-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including methylmercuric chloride; resveratrol; and cadmium based on microarray studies.

WB:WBGene00011203	R10E4.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00011204	R10E4.8
No description available

WB:WBGene00011205	R10E4.9
Is predicted to have 3-hydroxyacyl-CoA dehydratase activity. Localizes to plasma membrane. Is an ortholog of human HACD3 (3-hydroxyacyl-CoA dehydratase 3).

WB:WBGene00011206	R10E4.11
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Zinc finger C2H2-type.

WB:WBGene00011207	R10E8.1
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00011208	R10E8.2
Is affected by several genes including npr-1; drh-3; and rsr-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00011209	R10E8.3
Is enriched in OLL; PVD; and intestine based on microarray and tiling array studies. Is affected by several genes including clk-1; elt-2; and bar-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00011210	R10E8.4
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011211	R10E8.5
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00011212	R10E8.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; Zidovudine; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00011213	R10E8.8
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and elt-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box-like domain superfamily.

WB:WBGene00011214	R10E9.2
Is enriched in several structures, including GABAergic neurons; RIM; germ line; interneuron; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-three chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00011215	R10E9.3
Is enriched in Z1; Z4; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011216	usp-46
Exhibits ionotropic glutamate receptor binding activity and thiol-dependent ubiquitin-specific protease activity. Is involved in several processes, including positive regulation of locomotion involved in locomotory behavior; protein deubiquitination involved in ubiquitin-dependent protein catabolic process; and regulation of AMPA receptor activity. Localizes to endosome and neuronal cell body. Is expressed in body wall musculature; intestine; nervous system; pharynx; and vulval muscle. Is an ortholog of human USP12 (ubiquitin specific peptidase 12) and USP46 (ubiquitin specific peptidase 46).

WB:WBGene00011217	R10E11.5
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011218	R10E11.6
Is enriched in AVK; NSM; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EF-hand domain pair and Synergin gamma. Is an ortholog of human SYNRG (synergin gamma).

WB:WBGene00011219	srxa-10
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including sir-2.1; pgl-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00011220	R10E11.9
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including dpy-7; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Sodium Chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00011221	R10E12.2
Is enriched in coelomocyte; germ line; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Rifampin; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C05B5.4-like.

WB:WBGene00011222	R10H10.3
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Mercuric Chloride; D-glucose; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; CUB domain; CUB domain; von Willebrand factor, type A; Uncharacterised conserved protein UCP027682, CUB, vWA; Spermadhesin, CUB domain superfamily; and von Willebrand factor A-like domain superfamily.

WB:WBGene00011223	R10H10.4
Is expressed in AIYL and AIYR. Is predicted to encode a protein with the following domain: Neuropeptide-like peptide 36.

WB:WBGene00011224	R10H10.6
Is predicted to have riboflavin kinase activity. Is an ortholog of human RFK (riboflavin kinase).

WB:WBGene00011225	R10H10.7
Is enriched in NSM; Psub1; and germ line based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-type fold. Is an ortholog of human TTI1 (TELO2 interacting protein 1).

WB:WBGene00011226	slc-25A21
Is predicted to have ATP transmembrane transporter activity. Is an ortholog of human SLC25A21 (solute carrier family 25 member 21).

WB:WBGene00011227	nlp-67
Is enriched in several structures, including RIS; body wall musculature; head mesodermal cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including 1-methylnicotinamide; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00011228	R11.3
Is enriched in Z1; Z4; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on RNA-seq and microarray studies. Is affected by tryptophan and allantoin based on microarray studies.

WB:WBGene00011229	R11.4
Is enriched in BAG and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Mianserin; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00011230	nud-2
Is predicted to have microtubule binding activity. Is involved in GABAergic synaptic transmission; nuclear migration; and synaptic vesicle transport. Localizes to nuclear envelope. Is expressed in several structures, including hypodermal cell; non-striated muscle; pharyngeal-intestinal valve; rectal valve cell; and tail hypodermis. Human ortholog(s) of this gene are implicated in lissencephaly. Is an ortholog of human NDEL1 (nudE neurodevelopment protein 1 like 1).

WB:WBGene00011231	R11A5.3
Is expressed in Z1 and Z4.

WB:WBGene00011232	pck-2
Is predicted to have manganese ion binding activity and phosphoenolpyruvate carboxykinase (GTP) activity. Is expressed in several structures, including muscle cell. Is an ortholog of human PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial).

WB:WBGene00011234	R11A5.6
Is affected by several genes including daf-12; sir-2.1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Tunicamycin; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00011235	suro-1
Is predicted to have metallocarboxypeptidase activity. Localizes to collagen and cuticulin-based cuticle extracellular matrix and cytoplasm. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of several human genes including CPA1 (carboxypeptidase A1); CPA4 (carboxypeptidase A4); and CPA5 (carboxypeptidase A5).

WB:WBGene00011236	R11A8.1
Is enriched in coelomocyte; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00011237	gkow-1
Is predicted to have nucleic acid binding activity. Is an ortholog of human GPKOW (G-patch domain and KOW motifs).

WB:WBGene00011238	ugt-59
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A5 (UDP glucuronosyltransferase family 1 member A5); UGT2B28 (UDP glucuronosyltransferase family 2 member B28); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00011239	pges-2
Is expressed in hypodermis; intestinal cell; lumbar ganglion; muscle cell; and retrovesicular ganglion. Is predicted to encode a protein with the following domains: Glutathione S-transferase, N-terminal domain; Glutathione S-transferase, N-terminal; Thioredoxin-like superfamily; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human PTGES2 (prostaglandin E synthase 2).

WB:WBGene00011240	mask-1
Is predicted to have RNA binding activity. Is expressed in head. Is an ortholog of human ANKHD1-EIF4EBP3 (ANKHD1-EIF4EBP3 readthrough) and ANKRD17 (ankyrin repeat domain 17).

WB:WBGene00011241	mpz-5
Is enriched in OLL; PVD; body wall muscle cell; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T15H9.4-like.

WB:WBGene00011242	R11D1.1
Is enriched in AVK; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucose; levamisole; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human DCAF5 (DDB1 and CUL4 associated factor 5).

WB:WBGene00011243	R11D1.2
Is affected by several genes including let-60; pgl-1; and bar-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00011244	R11D1.3
Is expressed in amphid sheath cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00011245	R11D1.4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; sir-2.1; and mir-34 based on tiling array and microarray studies. Is affected by dafa#1 and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011246	R11D1.7
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including dpy-21; ain-1; and ain-2 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00011247	mrpl-49
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL49 (mitochondrial ribosomal protein L49).

WB:WBGene00011248	R11D1.10
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Is an ortholog of human ZFYVE19 (zinc finger FYVE-type containing 19).

WB:WBGene00011249	R11G10.2
Is predicted to have selenium binding activity. Is an ortholog of human SELENBP1 (selenium binding protein 1).

WB:WBGene00011250	R11H6.2
Is enriched in germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serine incorporator (Serinc) and Serine incorporator/TMS membrane protein. Is an ortholog of human SERINC1 (serine incorporator 1) and SERINC3 (serine incorporator 3).

WB:WBGene00011251	glb-22
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00011252	R11H6.4
Is enriched in several structures, including Z4.a; germ line; male distal tip cell; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00011253	R11H6.5
Is expressed in pharyngeal neurons. Is predicted to encode a protein with the following domains: DZF domain; DZF domain; and Nucleotidyltransferase superfamily. Is an ortholog of human ILF2 (interleukin enhancer binding factor 2).

WB:WBGene00011254	R12G8.1
Is predicted to have ATP binding activity; metal ion binding activity; and protein serine/threonine kinase activity.

WB:WBGene00011255	R12H7.4
Is affected by several genes including eat-2; dpy-7; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011257	npax-3
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord; head neurons; intestine; and tail neurons.

WB:WBGene00011258	best-15
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00011259	miz-1
Is predicted to have RNA polymerase II transcription factor binding activity; SUMO ligase activity; and transcription coregulator activity. Is expressed in several structures, including anal depressor muscle; egg-laying apparatus; nervous system; pharyngeal-intestinal valve; and pharynx. Is an ortholog of human ZMIZ2 (zinc finger MIZ-type containing 2).

WB:WBGene00011260	cnnm-5
Is predicted to have transmembrane transporter activity. Is involved in determination of adult lifespan and positive regulation of gonad development. Human ortholog(s) of this gene are implicated in Jalili syndrome and renal hypomagnesemia 6. Is an ortholog of several human genes including CNNM1 (cyclin and CBS domain divalent metal cation transport mediator 1); CNNM3 (cyclin and CBS domain divalent metal cation transport mediator 3); and CNNM4 (cyclin and CBS domain divalent metal cation transport mediator 4).

WB:WBGene00011261	nphp-4
Is involved in several processes, including larval foraging behavior; male mating behavior; and plasma membrane bounded cell projection organization. Localizes to ciliary basal body; ciliary transition zone; and non-motile cilium. Is expressed in ganglia and neurons. Is used to study Meckel syndrome and nephronophthisis. Human ortholog(s) of this gene are implicated in Senior-Loken syndrome and nephronophthisis 4. Is an ortholog of human NPHP4 (nephrocystin 4).

WB:WBGene00011262	pho-8
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Heme; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal) and ACP3 (acid phosphatase 3).

WB:WBGene00011263	R13H4.5
Is expressed in several structures, including anal depressor muscle; excretory cell; intestine; rectal muscle; and vulva. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00011264	R13H4.6
Is predicted to have ATP binding activity; ATP-dependent peptidase activity; and serine-type endopeptidase activity.

WB:WBGene00011265	R13H4.7
Is enriched in RIS; dopaminergic neurons; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and hsp-6 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011266	R13H4.8
Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; methylmercuric chloride; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011267	fbxb-85
Is enriched in AVA and NSM based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Mercuric Chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00011268	pde-12
Is predicted to have 3'-5'-exoribonuclease activity. Is an ortholog of human PDE12 (phosphodiesterase 12).

WB:WBGene00011269	R17.3
Is expressed in intestine and rectal gland cell. Is predicted to encode a protein with the following domains: Somatomedin B domain; Thrombospondin type-1 (TSP1) repeat; Somatomedin B domain; Somatomedin B-like domain superfamily; Thrombospondin type-1 (TSP1) repeat superfamily; and Somatomedin-B and thrombospondin type-1 domain-containing protein. Is an ortholog of human SBSPON (somatomedin B and thrombospondin type 1 domain containing).

WB:WBGene00011270	R31.2
Localizes to striated muscle myosin thick filament. Is an ortholog of human ANKRD40 (ankyrin repeat domain 40).

WB:WBGene00011271	flad-1
Is predicted to have FMN adenylyltransferase activity. Is an ortholog of human FLAD1 (flavin adenine dinucleotide synthetase 1).

WB:WBGene00011272	dtmk-1
Is predicted to have nucleoside diphosphate kinase activity; thymidylate kinase activity; and uridylate kinase activity. Is an ortholog of human DTYMK (deoxythymidylate kinase).

WB:WBGene00011273	R53.4
Is enriched in several structures, including intestine; pharynx; somatic nervous system; tail neurons; and vulval muscle based on Chronogram and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial F1F0-ATP synthase, subunit f and Mitochondrial F1-F0 ATP synthase subunit F, predicted. Is an ortholog of human ATP5MF (ATP synthase membrane subunit f).

WB:WBGene00011274	R53.5
Is predicted to have antioxidant activity. Is expressed in hypodermis; muscle cell; and ventral nerve cord. Is an ortholog of human PRXL2A (peroxiredoxin like 2A).

WB:WBGene00011275	psf-1
Is enriched in cephalic sheath cell; germ line; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and lin-4 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GINS complex protein; GINS complex, subunit Psf1; GINS subunit, domain A; and GINS, helical bundle-like domain superfamily. Is an ortholog of human GINS1 (GINS complex subunit 1).

WB:WBGene00011276	aakg-5
Is predicted to have kinase activity. Is expressed in several structures, including epithelial cell; excretory cell; hermaphrodite gonad; neurons; and vulva.

WB:WBGene00011277	R53.8
Is enriched in PLM; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; let-60; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00011278	R74.2
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011279	asd-1
Exhibits single-stranded RNA binding activity. Is expressed in body wall musculature; intestine; nervous system; and vulval muscle. Is an ortholog of human RBFOX1 (RNA binding fox-1 homolog 1); RBFOX2 (RNA binding fox-1 homolog 2); and RBFOX3 (RNA binding fox-1 homolog 3).

WB:WBGene00011280	pelo-1
Is predicted to have ribosome binding activity. Is an ortholog of human PELO (pelota mRNA surveillance and ribosome rescue factor).

WB:WBGene00011281	R74.7
Is predicted to have tRNA methyltransferase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human FTSJ1 (FtsJ RNA 2'-O-methyltransferase 1).

WB:WBGene00011282	R74.8
Is enriched in germ line; germline precursor cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including glp-1; gld-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Six-bladed beta-propeller, TolB-like.

WB:WBGene00011283	ttbk-7
Is predicted to have protein serine/threonine kinase activity. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 11. Is an ortholog of human TTBK2 (tau tubulin kinase 2).

WB:WBGene00011284	ttr-27
Is enriched in OLL; PVD; and intestine based on tiling array and microarray studies. Is affected by several genes including skn-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including bisphenol A; levamisole; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011285	ttr-28
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; Mercuric Chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011286	ttr-29
Is enriched in ALM and PLM based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty chemicals including 1-methylnicotinamide; Rotenone; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011287	glb-24
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00011288	R102.1
Is enriched in head mesodermal cell; muscle cell; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and prg-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00011289	R102.2
Is expressed in neurons. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00011290	R102.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including eat-2; npr-1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011291	R102.4
Is predicted to have L-allo-threonine aldolase activity.

WB:WBGene00011292	allo-1
Exhibits protein homodimerization activity. Is involved in autophagosome assembly and regulation of autophagy. Localizes to cytoplasm.

WB:WBGene00011293	R102.6
Is enriched in dopaminergic neurons; germline precursor cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including levamisole; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011294	R102.7
Is enriched in NSM; cephalic sheath cell; dopaminergic neurons; germ line; and hypodermis based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin and Psoralens based on RNA-seq studies.

WB:WBGene00011295	R102.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; D-glucose; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011296	glb-21
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; pharynx; ventral cord neurons; and ventral nerve cord. Human ortholog(s) of this gene are implicated in hemolytic anemia (multiple); primary polycythemia (multiple); and sickle cell anemia.

WB:WBGene00011297	R102.10
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011298	R107.2
Is predicted to have ATP-dependent NAD(P)H-hydrate dehydratase activity. Is an ortholog of human NAXD (NAD(P)HX dehydratase).

WB:WBGene00011299	ikke-1
Is predicted to have protein serine/threonine kinase activity. Is involved in protein phosphorylation and regulation of autophagy. Localizes to cytoplasm. Is expressed in intestinal muscle. Human ortholog(s) of this gene are implicated in FTDALS4. Is an ortholog of human IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon) and TBK1 (TANK binding kinase 1).

WB:WBGene00011300	R107.5
Is enriched in germ line; hypodermis; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; daf-12; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00011302	R166.2
Is enriched in germ line; germline precursor cell; neurons; and somatic gonad precursor based on Chronogram and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by stavudine and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cleft lip and palate transmembrane protein 1 (CLPTM1) and Cleft lip and palate transmembrane 1. Is an ortholog of human CLPTM1 (CLPTM1 regulator of GABA type A receptor forward trafficking).

WB:WBGene00011303	R166.3
Is enriched in body wall musculature; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including gld-1; sir-2.1; and fbf-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Cry5B; and Linolenic Acids based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: AMMECR1; AMMECR1 domain; AMMECR1; AMMECR1, N-terminal; and AMMECR1 domain superfamily. Is an ortholog of human AMMECR1 (AMMECR nuclear protein 1) and AMMECR1L (AMMECR1 like).

WB:WBGene00011304	mnk-1
Is predicted to have calcium-dependent protein serine/threonine kinase activity and calmodulin binding activity. Is involved in behavioral response to nicotine; determination of adult lifespan; and regulation of protein deneddylation. Localizes to nucleus. Is expressed in body wall musculature; intestine; pharyngeal muscle cell; pharynx; and vulval muscle. Is an ortholog of human MKNK1 (MAPK interacting serine/threonine kinase 1).

WB:WBGene00011305	R186.1
Is enriched in body wall muscle cell; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Heme; TPEN; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transport and Golgi organisation 2 and Transport and Golgi organisation protein 2. Is an ortholog of human TANGO2 (transport and golgi organization 2 homolog).

WB:WBGene00011306	R186.3
Is predicted to have GTP binding activity. Is an ortholog of human SRPRB (SRP receptor subunit beta).

WB:WBGene00011307	mpst-7
Is predicted to have thiosulfate sulfurtransferase activity. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00011308	pnn-1
Is enriched in AVA; germ line; and neurons based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: pinin/SDK/memA/ protein conserved region; Pinin/SDK/MemA protein; and Pinin. Is an ortholog of human PNN (pinin, desmosome associated protein).

WB:WBGene00011309	R186.8
Is enriched in ASER; germ line; intestine; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and let-7 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by stavudine; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Ribosomal protein L33 superfamily.

WB:WBGene00011310	T01B4.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and elt-2 based on RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011311	T01B7.5
Is enriched in OLL; PVD; germ line; and somatic gonad precursor based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including D-glucose; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sas10 C-terminal domain and Sas10 C-terminal domain. Is an ortholog of human UTP3 (UTP3 small subunit processome component).

WB:WBGene00011312	trcs-2
Is enriched in OLL; PVD; germ line; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including bisphenol S; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011313	T01B7.8
Is enriched in DA neuron; intestine; mechanosensory neurons; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011314	T01B7.9
Is enriched in head mesodermal cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011315	mbr-1
Is predicted to have DNA binding activity. Is expressed in gonad; intestine; nerve ring neurons; sensory neurons; and vulva. Is an ortholog of human LCORL (ligand dependent nuclear receptor corepressor like).

WB:WBGene00011317	T01C1.4
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; alg-1; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and nanoparticle based on RNA-seq and microarray studies.

WB:WBGene00011318	cdt-2
Is involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Localizes to nucleus. Is expressed in vulval cell and vulval precursor cell. Is an ortholog of human DTL (denticleless E3 ubiquitin protein ligase homolog).

WB:WBGene00011319	T01C3.2
Is predicted to have transcription coactivator activity. Localizes to nucleus.

WB:WBGene00011320	T01C3.3
Is expressed in germ line and oocyte. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00011321	fil-1
Exhibits lipase activity. Is involved in lipid catabolic process.

WB:WBGene00011322	irld-14
Is enriched in AVG; RIM; amphid sheath cell; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011323	mut-15
Localizes to perinuclear region of cytoplasm. Is expressed in germ line.

WB:WBGene00011324	hrde-2
Is enriched in NSM; germ line; germline precursor cell; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011325	T01C3.11
Is enriched in Z1; Z4; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00011326	T01D3.1
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal dominant nonsyndromic deafness 56; congenital afibrinogenemia; and familial hypobetalipoproteinemia 2.

WB:WBGene00011327	hlh-34
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in AVJL and AVJR. Human ortholog(s) of this gene are implicated in familial erythrocytosis 4 and obesity. Is an ortholog of human NPAS1 (neuronal PAS domain protein 1).

WB:WBGene00011328	T01D3.3
Is predicted to have metal ion binding activity and peptidase inhibitor activity.

WB:WBGene00011329	zipt-9
Is predicted to have metal ion transmembrane transporter activity. Is expressed in seam cell. Is an ortholog of human SLC39A9 (solute carrier family 39 member 9).

WB:WBGene00011330	T01D3.6
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in idiopathic pulmonary fibrosis; megalocornea; and nonsyndromic deafness (multiple). Is an ortholog of human FCGBP (Fc fragment of IgG binding protein).

WB:WBGene00011331	T01E8.1
Is predicted to contribute to ubiquitin-protein transferase activity. Is an ortholog of human LRRC29 (leucine rich repeat containing 29).

WB:WBGene00011333	nrde-2
Is involved in RNA interference and chromatin silencing by small RNA. Localizes to nucleus. Is an ortholog of human NRDE2 (NRDE-2, necessary for RNA interference, domain containing).

WB:WBGene00011334	mrps-14
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS14 (mitochondrial ribosomal protein S14).

WB:WBGene00011335	T01E8.8
Is enriched in NSM; dopaminergic neurons; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011336	ubxn-5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: UBX domain; UBX domain; and Ubiquitin-like domain superfamily.

WB:WBGene00011337	T01G1.2
Is expressed in head. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011338	sec-31
Is predicted to have structural molecule activity. Is an ortholog of human SEC31A (SEC31 homolog A, COPII coat complex component) and SEC31B (SEC31 homolog B, COPII coat complex component).

WB:WBGene00011339	T01G5.1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including dysostosis (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00011340	ugt-30
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00011341	T01G5.6
Is affected by several genes including clk-1; eat-2; and hpl-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin; allantoin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00011342	T01G5.7
Is enriched in cephalic sheath cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; Neurotoxins; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00011344	T01G9.2
Localizes to striated muscle dense body. Is an ortholog of human C16orf70 (chromosome 16 open reading frame 70).

WB:WBGene00011345	dma-1
Exhibits protease binding activity. Is involved in generation of neurons. Localizes to dendrite membrane. Is expressed in head neurons; mechanosensory neurons; somatic nervous system; and vulva. Human ortholog(s) of this gene are implicated in cornea plana.

WB:WBGene00011346	C06B8.t3
Is affected by daf-2 based on microarray studies.

WB:WBGene00011348	T01H3.2
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Is an ortholog of human TECPR1 (tectonin beta-propeller repeat containing 1).

WB:WBGene00011349	T01H3.3
Is predicted to have transmembrane transporter activity. Is expressed in body wall musculature; nerve ring; pharynx; spermatheca; and vulval muscle.

WB:WBGene00011350	perm-1
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Is an ortholog of human HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1); HSD3B2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2); and HSD3B7 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7).

WB:WBGene00011351	T01H3.5
Is enriched in AVK; excretory cell; intestine; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and isp-1 based on RNA-seq studies. Is affected by Tunicamycin; Cry5B; and Chlorpyrifos based on microarray studies.

WB:WBGene00011352	rskn-1
Is predicted to have ribosomal protein S6 kinase activity. Human ortholog(s) of this gene are implicated in Coffin-Lowry syndrome and non-syndromic X-linked intellectual disability. Is an ortholog of human RPS6KA1 (ribosomal protein S6 kinase A1).

WB:WBGene00011353	T01H8.2
Is predicted to have several functions, including L-serine ammonia-lyase activity; amino-acid racemase activity; and anion binding activity. Is an ortholog of human SRR (serine racemase).

WB:WBGene00011354	lgc-13
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00011355	lgc-14
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00011356	lgc-15
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00011357	T01H10.4
Is affected by wdr-5.1; swsn-2.2; and hmg-3 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; resveratrol; and dafa#1 based on microarray studies.

WB:WBGene00011358	lgc-16
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00011359	lgc-17
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00011360	lgc-18
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00011361	lyst-1
Is expressed in neurons and pharyngeal cell. Human ortholog(s) of this gene are implicated in Chediak-Higashi syndrome; common variable immunodeficiency; and gray platelet syndrome. Is predicted to encode a protein with the following domains: Beige/BEACH domain; BEACH domain; and BEACH domain superfamily. Is an ortholog of human LYST (lysosomal trafficking regulator).

WB:WBGene00011362	cest-1.1
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase) and CES2 (carboxylesterase 2).

WB:WBGene00011363	ocam-1
Is predicted to have DNA binding activity.

WB:WBGene00011364	cest-1.2
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase) and CES2 (carboxylesterase 2).

WB:WBGene00011365	T02C1.1
Is predicted to have metal ion binding activity. Is an ortholog of human LONRF2 (LON peptidase N-terminal domain and ring finger 2) and LONRF3 (LON peptidase N-terminal domain and ring finger 3).

WB:WBGene00011366	T02C1.2
Is enriched in cephalic sheath cell; excretory cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in RIDDLE syndrome. Is predicted to encode a protein with the following domains: Zinc finger, C3HC4 type (RING finger); Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human RNF169 (ring finger protein 169).

WB:WBGene00011367	snpc-3.4
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: snRNA-activating protein of 50kDa MW C terminal and snRNA-activating protein complex, subunit 3. Is an ortholog of human SNAPC3 (small nuclear RNA activating complex polypeptide 3).

WB:WBGene00011368	tftc-5
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tau95 Triple barrel domain; RNA polymerase III transcription factor (TF)IIIC subunit HTH domain; Transcription factor IIIC subunit 5, HTH domain; Transcription factor IIIC subunit  Tfc1/Sfc1; Transcription factor IIIC subunit Tfc1/Sfc1, triple barrel domain; and TFIIIC, subcomplex tauA subunit Sfc1, triple barrel domain superfamily. Is an ortholog of human GTF3C5 (general transcription factor IIIC subunit 5).

WB:WBGene00011369	T02C12.4
Is enriched in germline precursor cell and in male based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Sodium Chloride; and metformin based on microarray and RNA-seq studies.

WB:WBGene00011370	T02D1.1
No description available

WB:WBGene00011371	T02D1.4
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011372	npr-26
Is predicted to have G protein-coupled receptor activity and peptide binding activity.

WB:WBGene00011373	T02D1.7
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and nhl-2 based on tiling array and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011374	T02D1.8
Is enriched in carbon dioxide sensory neurons; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00011375	T02E1.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Regulator protein PHA-1 and Regulator protein, PHA-1.

WB:WBGene00011376	gla-3
Is predicted to have mRNA 3'-UTR binding activity. Localizes to cell cortex. Is expressed in germ line; muscle cell; and somatic cell.

WB:WBGene00011378	T02E1.6
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Zidovudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011379	T02E1.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: SURF4 family and Surfeit locus 4. Is an ortholog of human SURF4 (surfeit 4).

WB:WBGene00011380	T02E1.8
Is enriched in several structures, including RIS; Z4.a; ciliated neurons; head mesodermal cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00011381	npr-25
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00011382	dop-5
Is predicted to have G protein-coupled serotonin receptor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome.

WB:WBGene00011383	T02E9.5
Is enriched in Psub1; cephalic sheath cell; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00011386	T02G6.3
Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011387	T02G6.4
Is affected by several genes including daf-2; rrf-3; and mex-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Pao retrotransposon peptidase and Retrotransposon, Pao.

WB:WBGene00011388	T02G6.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00011389	T02G6.6
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including indole; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011390	T02G6.7
Is affected by several genes including clk-1; hpl-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and copper sulfate based on microarray studies. Is an ortholog of human LGALS12 (galectin 12).

WB:WBGene00011391	mrps-12
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS12 (mitochondrial ribosomal protein S12).

WB:WBGene00011392	sbt-1
Exhibits peptidase activator activity and peptidase inhibitor activity. Is involved in negative regulation of peptidase activity; positive regulation of hydrolase activity; and regulation of muscle contraction. Is expressed in neurons and pharynx. Is an ortholog of human SCG5 (secretogranin V).

WB:WBGene00011393	T03D8.6
Is predicted to have glutathione hydrolase activity and peptidyltransferase activity. Human ortholog(s) of this gene are implicated in gamma-glutamyl transpeptidase deficiency. Is an ortholog of human GGT1 (gamma-glutamyltransferase 1).

WB:WBGene00011394	T03D8.7
Is enriched in AVE; FLP; OLL; PVD; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011395	T03E6.2
Is affected by several genes including daf-16; clk-1; and mir-34 based on microarray and tiling array studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00011396	nhr-271
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in amphid neurons and rectal gland cell.

WB:WBGene00011397	T03E6.8
Is enriched in Z1; Z4; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Tunicamycin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00011398	qdpr-1
Is predicted to have 6,7-dihydropteridine reductase activity; NADH binding activity; and NADPH binding activity. Is expressed in several structures, including CEP; gonad; hypodermis; serotonergic neurons; and tail. Is an ortholog of human QDPR (quinoid dihydropteridine reductase).

WB:WBGene00011399	T03F6.3
Is predicted to have glucosamine-6-phosphate deaminase activity and identical protein binding activity. Is expressed in tail. Is an ortholog of human GNPDA1 (glucosamine-6-phosphate deaminase 1) and GNPDA2 (glucosamine-6-phosphate deaminase 2).

WB:WBGene00011400	T03F6.4
Is enriched in OLL; PVD; and dopaminergic neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box-like domain superfamily.

WB:WBGene00011401	T03F6.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia (multiple); and retinitis pigmentosa 77. Is predicted to encode a protein with the following domains: TB2/DP1, HVA22 family and TB2/DP1/HVA22-related protein. Is an ortholog of human REEP5 (receptor accessory protein 5) and REEP6 (receptor accessory protein 6).

WB:WBGene00011402	T03F7.5
Is enriched in neurons based on tiling array studies. Is affected by several genes including sir-2.1; eri-1; and daf-19 based on microarray studies. Is affected by multi-walled carbon nanotube and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00011403	T03F7.6
Is affected by several genes including sir-2.1; csr-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including resveratrol; Atrazine; and fluoranthene based on microarray studies.

WB:WBGene00011404	T03F7.7
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; dpy-10; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Heme; Rotenone; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; GOLD domain superfamily; and CRAL-TRIO lipid binding domain superfamily.

WB:WBGene00011405	clec-155
Is enriched in OLL; PVD; muscle cell; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including aldicarb; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00011407	ppat-1
Is predicted to have amidophosphoribosyltransferase activity; iron-sulfur cluster binding activity; and metal ion binding activity. Is expressed in intestine. Is an ortholog of human PPAT (phosphoribosyl pyrophosphate amidotransferase).

WB:WBGene00011408	nifk-1
Is predicted to have RNA binding activity. Is an ortholog of human NIFK (nucleolar protein interacting with the FHA domain of MKI67).

WB:WBGene00011409	T04A8.7
Is predicted to have 1,4-alpha-glucan branching enzyme activity. Human ortholog(s) of this gene are implicated in glycogen storage disease IV. Is an ortholog of human GBE1 (1,4-alpha-glucan branching enzyme 1).

WB:WBGene00011410	T04A8.8
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including let-7; dpy-10; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin-2 like Rad60 SUMO-like; Rad60/SUMO-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00011411	sel-13
Is predicted to have nucleic acid binding activity and zinc ion binding activity. Is an ortholog of human ZNF830 (zinc finger protein 830).

WB:WBGene00011412	mrpl-16
Is predicted to have rRNA binding activity. Is an ortholog of human MRPL16 (mitochondrial ribosomal protein L16).

WB:WBGene00011414	T04A8.13
Is enriched in AVA; DA neuron; VA neuron; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Ethanol; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011415	him-18
Exhibits enzyme binding activity and identical protein binding activity. Contributes to 3'-flap endonuclease activity; 5'-flap endonuclease activity; and crossover junction endodeoxyribonuclease activity. Is involved in DNA metabolic process; embryo development; and mitotic sister chromatid segregation. Localizes to Slx1-Slx4 complex. Is expressed in germ line. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group P. Is an ortholog of human SLX4 (SLX4 structure-specific endonuclease subunit).

WB:WBGene00011416	T04A11.1
Is predicted to have catalytic activity. Is an ortholog of human PBLD (phenazine biosynthesis like protein domain containing).

WB:WBGene00011417	T04A11.2
Is predicted to have catalytic activity. Is an ortholog of human PBLD (phenazine biosynthesis like protein domain containing).

WB:WBGene00011418	igdb-1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucopyranose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Immunoglobulin domain; Fibronectin type III domain; DB module; Domain of unknown function DB; Immunoglobulin subtype 2; Immunoglobulin subtype; Fibronectin type III; Cysteine-rich repeat; Immunoglobulin; Immunoglobulin-like fold; Fibronectin type III superfamily; and Immunoglobulin-like domain superfamily.

WB:WBGene00011419	T04A11.4
Is predicted to have catalytic activity. Is an ortholog of human PBLD (phenazine biosynthesis like protein domain containing).

WB:WBGene00011420	T04A11.5
Is predicted to have catalytic activity. Is an ortholog of human PBLD (phenazine biosynthesis like protein domain containing).

WB:WBGene00011421	T04B2.1
Is affected by several genes including sir-2.1; alg-1; and cyc-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011422	T04B2.3
Is enriched in several structures, including mechanosensory neurons; muscle cell; pharynx; somatic nervous system; and tail neurons based on Chronogram; microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including let-60; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including methylmercury hydroxide; Rotenone; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011423	ipla-7
Is predicted to have hydrolase activity. Is expressed in intestine; pharyngeal-intestinal valve; pharynx; virL; and virR. Human ortholog(s) of this gene are implicated in Parkinson's disease 14; neurodegeneration with brain iron accumulation 2a; and neurodegeneration with brain iron accumulation 2b.

WB:WBGene00011424	dhs-31
Is expressed in hypodermis; vulB1; vulB2; vulD; and vulva. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR1 (carbonyl reductase 1) and CBR3 (carbonyl reductase 3).

WB:WBGene00011425	T04B2.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011426	T04C10.3
Is affected by several genes including daf-12; mex-1; and dpy-21 based on tiling array and RNA-seq studies.

WB:WBGene00011427	T04C12.1
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011428	nlp-80
Is enriched in neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including aldicarb; nicotinic acid; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00011429	T04C12.7
Is enriched in coelomocyte; dopaminergic neurons; hypodermis; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Tunicamycin; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011430	T04C12.8
Is enriched in AFD; ASER; PLM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011431	T04D3.1
Localizes to cytoplasm.

WB:WBGene00011432	sdz-30
Localizes to cytoplasm.

WB:WBGene00011433	pde-1
Exhibits 3',5'-cyclic-AMP phosphodiesterase activity; 3',5'-cyclic-GMP phosphodiesterase activity; and calmodulin binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of intracellular signal transduction; and response to alkaline pH. Is expressed in AFDL; AFDR; and head. Is an ortholog of human PDE1A (phosphodiesterase 1A).

WB:WBGene00011434	T04D3.5
Is expressed in germ line.

WB:WBGene00011435	T04D3.8
Is enriched in cholinergic neurons; germ line; pharyngeal cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00011436	T04F3.1
Is predicted to have catalytic activity and pyridoxal phosphate binding activity. Is an ortholog of human ACCS (1-aminocyclopropane-1-carboxylate synthase homolog (inactive)).

WB:WBGene00011437	smoc-1
Is predicted to have calcium ion binding activity. Is expressed in hypodermis; pharyngeal-intestinal valve cell; and pharynx. Human ortholog(s) of this gene are implicated in dentin dysplasia and microphthalmia with limb anomalies. Is an ortholog of human SMOC1 (SPARC related modular calcium binding 1) and SMOC2 (SPARC related modular calcium binding 2).

WB:WBGene00011438	T04F3.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00011439	T04F3.4
Is predicted to have calcium ion binding activity. Is an ortholog of human MCFD2 (multiple coagulation factor deficiency 2, ER cargo receptor complex subunit).

WB:WBGene00011440	sfxn-1.5
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN1 (sideroflexin 1) and SFXN3 (sideroflexin 3).

WB:WBGene00011441	T04F8.2
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Alovudine and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Rhodopsin-like GPCR transmembrane domain and Intimal thickness related receptor, IRP. Is an ortholog of human GPR180 (G protein-coupled receptor 180).

WB:WBGene00011442	T04F8.3
Is enriched in neurons and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by Mianserin; Atrazine; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ubiquitin-like domain superfamily.

WB:WBGene00011443	cutl-11
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00011444	T04F8.6
Is enriched in body wall musculature; intestine; muscle cell; neurons; and retrovesicular ganglion based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-12; and fog-2 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; Diazinon; and Humic Substances based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Seckel syndrome 7. Is predicted to encode a protein with the following domain: EF-hand domain pair. Is an ortholog of human NINL (ninein like).

WB:WBGene00011445	T04F8.7
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Tunicamycin; Cry5B; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: SH3-like domain superfamily.

WB:WBGene00011446	T04F8.8
Is enriched in GABAergic neurons and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011447	T04F8.9
Is enriched in CEM; HOB; IL2 neuron; neurons; and ray neuron type B based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00011448	tag-348
Is expressed in body wall musculature and vulval muscle.

WB:WBGene00011449	T04H1.2
Exhibits identical protein binding activity. Is expressed in gonad. Is an ortholog of human GTPBP2 (GTP binding protein 2).

WB:WBGene00011450	ttr-22
Is enriched in OLL and PVD based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; D-glucose; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011451	T04H1.5
Is predicted to have nucleic acid binding activity. Is an ortholog of human GPATCH11 (G-patch domain containing 11).

WB:WBGene00011452	ugt-55
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2A3 (UDP glucuronosyltransferase family 2 member A3); UGT2B11 (UDP glucuronosyltransferase family 2 member B11); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00011453	ugt-56
Is predicted to have UDP-glycosyltransferase activity. Is expressed in ASEL; ASER; ASHL; ASHR; and nervous system. Is an ortholog of several human genes including UGT2A3 (UDP glucuronosyltransferase family 2 member A3); UGT2B11 (UDP glucuronosyltransferase family 2 member B11); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00011454	lron-14
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in several diseases, including congenital nongoitrous hypothyroidism 1; ovarian dysgenesis 1; and ovarian hyperstimulation syndrome. Is an ortholog of human CHADL (chondroadherin like).

WB:WBGene00011455	T05A1.4
No description available

WB:WBGene00011456	T05A1.5
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A9 (solute carrier family 22 member 9).

WB:WBGene00011458	irld-47
Is affected by several genes including daf-2; sir-2.1; and hpl-2 based on tiling array and microarray studies. Is affected by copper sulfate based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00011459	T05A6.5
Is affected by several genes including let-60; clk-1; and sir-2.1 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00011460	ttr-14
Is enriched in amphid sheath cell; germ line; hypodermis; and intestine based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011462	vap-2
Is enriched in hypodermis and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2) and CRISP3 (cysteine rich secretory protein 3).

WB:WBGene00011463	T05A10.6
Is enriched in neurons based on microarray and RNA-seq studies. Is affected by several genes including skn-1; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; D-glucose; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: CAP superfamily.

WB:WBGene00011464	T05B9.1
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011465	T05B9.2
Is enriched in ALM; AVK; FLP; PLM; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; lin-35; and lin-28 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00011466	T05C12.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00011467	decr-1.3
Is predicted to have 2,4-dienoyl-CoA reductase (NADPH) activity. Is an ortholog of human DECR1 (2,4-dienoyl-CoA reductase 1).

WB:WBGene00011468	T05C12.4
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including methylmercury hydroxide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011469	dylt-3
Is expressed in ciliated neurons and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: Tctex-1 family; Dynein light chain Tctex-1 like; and Tctex-1-like superfamily.

WB:WBGene00011470	C08E8.t3
No description available

WB:WBGene00011471	T05C12.8
Is enriched in ASER; BAG; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; eat-2; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domain: Ankyrin repeat-containing domain superfamily.

WB:WBGene00011472	T05C12.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; antimycin; and Atrazine based on microarray and RNA-seq studies.

WB:WBGene00011473	T05C12.11
Is enriched in OLL; PVD; intestine; neurons; and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00011474	aldo-1
Exhibits fructose-bisphosphate aldolase activity and identical protein binding activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is expressed in gonad; intestinal muscle; and spermathecal-uterine valve cell. Human ortholog(s) of this gene are implicated in hereditary fructose intolerance syndrome. Is an ortholog of human ALDOA (aldolase, fructose-bisphosphate A) and ALDOC (aldolase, fructose-bisphosphate C).

WB:WBGene00011475	T05D4.2
Is enriched in AVK; BAG; NSM; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00011476	exc-12
Is enriched in GABAergic neurons; amphid sheath cell; excretory cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011478	T05D4.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00011479	T05E11.2
Is enriched in GABAergic neurons; body wall muscle cell; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; metformin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Clc-like and Clc protein-like.

WB:WBGene00011480	enpl-1
Is predicted to have unfolded protein binding activity. Is expressed in head and pharynx. Is an ortholog of human HSP90B1 (heat shock protein 90 beta family member 1).

WB:WBGene00011481	imp-2
Exhibits aspartic endopeptidase activity, intramembrane cleaving. Is involved in several processes, including ecdysis, collagen and cuticulin-based cuticle; positive regulation of embryonic development; and regulation of nematode larval development. Is an ortholog of human HM13 (histocompatibility minor 13).

WB:WBGene00011482	pigk-1
Is predicted to have GPI-anchor transamidase activity. Is an ortholog of human PIGK (phosphatidylinositol glycan anchor biosynthesis class K).

WB:WBGene00011483	T05E11.7
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00011484	T05E11.8
Is enriched in DD neuron; amphid sheath cell; hypodermis; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00011485	srbc-14
Is affected by several genes including eat-2; let-418; and chd-3 based on tiling array and RNA-seq studies. Is affected by resveratrol and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00011486	T05E12.3
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including hydrogen sulfide; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00011487	T05E12.6
Is enriched in DA neuron; I5 neuron; SAB; intestine; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Heme; diallyl trisulfide; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00011488	nra-2
Is involved in protein-containing complex assembly and regulation of protein targeting to membrane. Localizes to endoplasmic reticulum. Is expressed in body wall musculature; egg-laying apparatus; excretory canal; neurons; and pharyngeal muscle cell. Is an ortholog of human NCLN (nicalin).

WB:WBGene00011489	T05F1.2
Is expressed in germ line. Is predicted to encode a protein with the following domain: .

WB:WBGene00011490	T05F1.4
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011491	T05F1.5
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-one chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00011492	T05F1.7
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including alg-1; wdr-23; and nhl-2 based on RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011493	T05F1.8
Is predicted to have inorganic phosphate transmembrane transporter activity. Is an ortholog of human SLC25A3 (solute carrier family 25 member 3).

WB:WBGene00011494	T05F1.9
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011495	T05F1.11
Is enriched in OLL; PVD; and intestine based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL1 (nucleoredoxin like 1).

WB:WBGene00011496	T05F1.12
No description available

WB:WBGene00011497	T05F1.13
Is enriched in body wall muscle cell and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; F-box associated domain, type 2; Leucine-rich repeat domain superfamily; and F-box-like domain superfamily.

WB:WBGene00011498	T05G5.1
Is enriched in PLM; body wall muscle cell; germ line; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; proteomic; RNA-seq; and tiling array studies. Is affected by five chemicals including levamisole; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011499	T05G5.4
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including sir-2.1; alg-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00011500	T05G5.5
Is predicted to have dephospho-CoA kinase activity. Localizes to mitochondrion. Is an ortholog of human DCAKD (dephospho-CoA kinase domain containing).

WB:WBGene00011501	rmd-1
Localizes to mitotic spindle pole and spindle microtubule. Is expressed in germ line. Is an ortholog of human RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00011502	vps-53
Is involved in positive regulation of locomotion involved in locomotory behavior; regulation of brood size; and regulation of dense core granule transport. Localizes to GARP complex; perikaryon; and perinuclear region of cytoplasm. Is expressed in body wall musculature; intestine; and pharynx. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 2E. Is an ortholog of human VPS53 (VPS53 subunit of GARP complex).

WB:WBGene00011503	gcc-2
Is enriched in coelomocyte; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GRIP domain; Rab binding domain; GRIP domain; and GCC2, Rab binding domain. Is an ortholog of human GCC2 (GRIP and coiled-coil domain containing 2).

WB:WBGene00011505	pzf-1
Is involved in meiotic chromosome segregation and positive regulation of meiotic cell cycle. Is expressed in gonad.

WB:WBGene00011506	srbc-77
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00011507	T05H10.1
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Is involved in anterior/posterior axis specification, embryo. Localizes to cytoplasm. Is expressed in germ line. Is an ortholog of human USP47 (ubiquitin specific peptidase 47).

WB:WBGene00011508	T05H10.3
Is enriched in dopaminergic neurons; germline precursor cell; and intestine based on Chronogram and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty-six chemicals including cholesterol; lathosterol; and aldicarb based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011509	T05H10.4
Is enriched in several structures, including AFD; Z4.a; germ line; head mesodermal cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including methylmercury hydroxide; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011510	pdha-1
Is predicted to have pyruvate dehydrogenase (acetyl-transferring) activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) and PDHA2 (pyruvate dehydrogenase E1 subunit alpha 2).

WB:WBGene00011511	gpcp-2
Is predicted to have glycerophosphocholine phosphodiesterase activity. Is an ortholog of human GPCPD1 (glycerophosphocholine phosphodiesterase 1).

WB:WBGene00011512	T05H10.8
Is enriched in DA neuron; VA neuron; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; AhpC/TSA antioxidant enzyme; and Peroxiredoxin-like 2A/B/C.

WB:WBGene00011513	fbxa-197
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00011514	fbxa-198
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011515	oac-42
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00011516	T06C12.9
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00011517	cgt-1
Is predicted to have ceramide glucosyltransferase activity. Is involved in glucosylceramide biosynthetic process; nematode larval development; and regulation of protein localization to basolateral plasma membrane. Is expressed in several structures, including excretory system; pharyngeal muscle cell; pharyngeal-intestinal valve; rectal gland cell; and rectal valve cell. Is an ortholog of human UGCG (UDP-glucose ceramide glucosyltransferase).

WB:WBGene00011518	T06C12.11
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00011519	T06C12.12
Is predicted to have ceramide glucosyltransferase activity.

WB:WBGene00011520	nhr-213
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in several structures, including excretory system; intestine; pharynx; somatic nervous system; and vulva.

WB:WBGene00011521	T06C12.14
Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including resveratrol; Acrylamide; and 2 based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00011522	srap-1
Is expressed in cuticle; nervous system; seam cell; syncytium; and vulva. Is predicted to encode a protein with the following domains: Repeat of unknown function (DUF1174); PAN/Apple domain; and Repeat of unknown function DUF1174.

WB:WBGene00011523	T06D8.2
Is enriched in neurons and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sek-1; and alg-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Joubert syndrome 25. Is predicted to encode a protein with the following domains: UvrB/uvrC motif; UVR domain; and Armadillo-like helical. Is an ortholog of human CEP104 (centrosomal protein 104).

WB:WBGene00011524	plpr-1
Is predicted to have lipid phosphatase activity and phosphatidate phosphatase activity. Is an ortholog of human PLPPR1 (phospholipid phosphatase related 1) and PLPPR5 (phospholipid phosphatase related 5).

WB:WBGene00011525	T06D8.4
No description available

WB:WBGene00011526	cox-15
Is predicted to have oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor. Human ortholog(s) of this gene are implicated in Leigh disease and fatal infantile cardioencephalomyopathy due to cytochrome c oxidase deficiency 2. Is an ortholog of human COX15 (cytochrome c oxidase assembly homolog COX15).

WB:WBGene00011527	cchl-1
Is predicted to have holocytochrome-c synthase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in syndromic microphthalmia. Is an ortholog of human HCCS (holocytochrome c synthase).

WB:WBGene00011528	fndc-1
Is involved in mitophagy. Is an ortholog of human FUNDC1 (FUN14 domain containing 1) and FUNDC2 (FUN14 domain containing 2).

WB:WBGene00011529	T06D8.9
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human SARAF (store-operated calcium entry associated regulatory factor).

WB:WBGene00011530	T06D8.10
Is predicted to have peroxidase activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7.

WB:WBGene00011531	rsbp-1
Localizes to cell body and neuron projection. Is expressed in body wall musculature; muscle cell; nervous system; pharynx; and vulva.

WB:WBGene00011532	chaf-1
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including D-glucose; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chromatin assembly factor 1 subunit A and Chromatin assembly factor 1 subunit A. Is an ortholog of human CHAF1A (chromatin assembly factor 1 subunit A).

WB:WBGene00011533	T06E4.5
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including nicotinic acid; antimycin; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011534	T06E4.7
Is enriched in AFD; germ line; intestine; and pharynx based on microarray; proteomic; and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00011535	T06E4.8
Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00011536	T06E4.9
Is enriched in germ line; intestine; and pharynx based on microarray; proteomic; and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercury hydroxide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011537	T06E4.10
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011538	T06E6.1
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including bisphenol S; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and WDR74/Nsa1. Is an ortholog of human WDR74 (WD repeat domain 74).

WB:WBGene00011539	fbxa-135
Is enriched in DA neuron; VA neuron; intestine; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00011540	T06E6.10
Is enriched in OLL; PLM; PVD; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00011541	srbc-63
Is affected by several genes including sir-2.1; ain-1; and ain-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00011542	fbxa-104
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and mex-1 based on RNA-seq and microarray studies. Is affected by Sirolimus and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00011543	acl-2
Is predicted to have 1-acylglycerol-3-phosphate O-acyltransferase activity. Human ortholog(s) of this gene are implicated in congenital generalized lipodystrophy type 1. Is an ortholog of human AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2).

WB:WBGene00011544	T06E8.2
Is affected by several genes including daf-12; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus and nitroguanidine based on microarray studies.

WB:WBGene00011545	T06G6.3
Is enriched in BAG; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00011546	T06G6.4
Is enriched in several structures, including AFD; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00011547	T06G6.5
Is expressed in coelomocyte; head muscle; head neurons; intestine; and tail neurons.

WB:WBGene00011548	T06G6.6
Is enriched in OLL; PVD; hypodermis; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011549	T06G6.8
Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00011550	T06G6.11
Is affected by several genes including daf-16; clk-1; and nhr-25 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011551	T06G6.12
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Zidovudine; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00011554	T07A5.1
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Tunicamycin; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1X and muscular dystrophy (multiple). Is predicted to encode a protein with the following domains: LicD family; LicD family; and Fukutin-related. Is an ortholog of human FKTN (fukutin).

WB:WBGene00011556	vglu-3
Is predicted to have L-glutamate transmembrane transporter activity. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 25. Is an ortholog of human SLC17A6 (solute carrier family 17 member 6); SLC17A7 (solute carrier family 17 member 7); and SLC17A8 (solute carrier family 17 member 8).

WB:WBGene00011557	T07A5.4
Is affected by several genes including eat-2; alg-1; and his-72 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00011558	ostf-4
Is predicted to have transferase activity. Is an ortholog of human OST4 (oligosaccharyltransferase complex subunit 4, non-catalytic).

WB:WBGene00011559	umps-1
Exhibits orotate phosphoribosyltransferase activity and orotidine-5'-phosphate decarboxylase activity. Is involved in several processes, including embryonic digestive tract morphogenesis; positive regulation of brood size; and pyrimidine-containing compound biosynthetic process. Localizes to cytoplasm. Is expressed in head; intestine; neurons; and tail. Is used to study orotic aciduria. Human ortholog(s) of this gene are implicated in orotic aciduria. Is an ortholog of human UMPS (uridine monophosphate synthetase).

WB:WBGene00011560	T07C4.3
Is enriched in germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including bisphenol S; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011561	ttr-15
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011562	sas-7
Is enriched in germ line; head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including gld-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by antimycin and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011563	jmjd-4
Is enriched in germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies. Is affected by Zidovudine based on RNA-seq studies. Human JMJD4 exhibits oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors. Is predicted to encode a protein with the following domains: JmjC domain, hydroxylase and JmjC domain. Is an ortholog of human JMJD4 (jumonji domain containing 4).

WB:WBGene00011564	ugt-50
Is predicted to have UDP-glycosyltransferase activity. Is expressed in PVQ; intestine; and lateral ganglion. Is an ortholog of human UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00011565	nhr-272
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00011566	nhr-214
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons.

WB:WBGene00011567	nhr-215
Is enriched in AFD; ASER; PLM; and neurons based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00011568	nhr-26
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00011569	T07C12.2
No description available

WB:WBGene00011570	sre-28
Is expressed in head. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00011571	ttr-46
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011572	mam-5
Is affected by several genes including age-1; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MAM domain, meprin/A5/mu; MAM domain; and Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00011573	anmt-3
Is predicted to have N-methyltransferase activity. Is expressed in body wall musculature and pharyngeal muscle cell. Is an ortholog of human INMT (indolethylamine N-methyltransferase); NNMT (nicotinamide N-methyltransferase); and PNMT (phenylethanolamine N-methyltransferase).

WB:WBGene00011574	T07C12.10
Is enriched in muscle cell and neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium; tetrabromobisphenol A; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011575	madf-4
Is enriched in AFD; dopaminergic neurons; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00011576	rmh-2
Is predicted to have nucleotide binding activity. Is an ortholog of human RMI1 (RecQ mediated genome instability 1).

WB:WBGene00011577	fipr-12
Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00011578	npr-20
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 44.

WB:WBGene00011579	T07D4.2
Is predicted to have hydrolase activity. Is an ortholog of human MPPED1 (metallophosphoesterase domain containing 1) and MPPED2 (metallophosphoesterase domain containing 2).

WB:WBGene00011580	ddx-19
Is predicted to have RNA binding activity and RNA helicase activity. Is involved in germ cell development. Localizes to P granule. Is expressed in tail. Is an ortholog of human DDX19A (DEAD-box helicase 19A) and DDX19B (DEAD-box helicase 19B).

WB:WBGene00011581	T07D10.1
Is enriched in arcade cell; neurons; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by seven chemicals including tryptophan; Tunicamycin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011582	ntr-1
Is predicted to have G protein-coupled receptor activity. Is expressed in intestine and neurons. Human ortholog(s) of this gene are implicated in nephrogenic diabetes insipidus. Is an ortholog of human AVPR1B (arginine vasopressin receptor 1B) and AVPR2 (arginine vasopressin receptor 2).

WB:WBGene00011583	T07D10.3
Is expressed in seam cell. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00011584	clec-15
Is predicted to have carbohydrate binding activity.

WB:WBGene00011585	clec-16
Is affected by several genes including daf-16; rrf-1; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including cadmium; Colistin; and 2 based on microarray studies.

WB:WBGene00011586	flp-33
Is enriched in NSM; dopaminergic neurons; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011587	anp-1
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is an ortholog of human ERAP1 (endoplasmic reticulum aminopeptidase 1) and ERAP2 (endoplasmic reticulum aminopeptidase 2).

WB:WBGene00011589	T07F10.3
Is predicted to have RNA binding activity. Is an ortholog of human TRNAU1AP (tRNA selenocysteine 1 associated protein 1).

WB:WBGene00011590	bus-19
Is enriched in AFD; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including aldicarb; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: SNARE associated Golgi protein and SNARE associated Golgi protein. Is an ortholog of human TMEM41A (transmembrane protein 41A).

WB:WBGene00011591	T07F10.5
Is predicted to contribute to protein kinase activity.

WB:WBGene00011592	T07F10.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including sir-2.1; dcr-1; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011593	T07G12.2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC23A1 (solute carrier family 23 member 1) and SLC23A2 (solute carrier family 23 member 2).

WB:WBGene00011594	T07G12.3
Is predicted to have catalytic activity.

WB:WBGene00011595	T07G12.4
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC23A1 (solute carrier family 23 member 1) and SLC23A2 (solute carrier family 23 member 2).

WB:WBGene00011596	T07G12.5
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC23A1 (solute carrier family 23 member 1) and SLC23A2 (solute carrier family 23 member 2).

WB:WBGene00011597	zim-1
Localizes to condensed nuclear chromosome.

WB:WBGene00011598	T07G12.7
No description available

WB:WBGene00011599	T07G12.8
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011600	zim-2
Localizes to condensed nuclear chromosome.

WB:WBGene00011601	zim-3
Localizes to condensed nuclear chromosome.

WB:WBGene00011604	T08A11.1
Is predicted to contribute to GTPase activator activity. Is an ortholog of human DEPDC5 (DEP domain containing 5, GATOR1 subcomplex subunit).

WB:WBGene00011605	sftb-1
Is predicted to have mRNA binding activity. Is involved in negative regulation of gene expression. Human ortholog(s) of this gene are implicated in myelodysplastic syndrome. Is an ortholog of human SF3B1 (splicing factor 3b subunit 1).

WB:WBGene00011606	tmed-12
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: emp24/gp25L/p24 family/GOLD; GOLD domain; and TMP21-related. Is an ortholog of human TMED4 (transmembrane p24 trafficking protein 4) and TMED9 (transmembrane p24 trafficking protein 9).

WB:WBGene00011607	T08D2.2
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Alovudine based on RNA-seq studies.

WB:WBGene00011608	T08D2.3
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by Rifampin; Sirolimus; and allantoin based on RNA-seq studies.

WB:WBGene00011609	T08D2.4
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00011610	T08D2.5
Is enriched in germline precursor cell; hypodermis; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; D-glucose; and tert-Butylhydroperoxide based on microarray and RNA-seq studies.

WB:WBGene00011611	T08D2.6
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; age-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Alovudine and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011612	T08D2.7
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including Li-Fraumeni syndrome 2; osteosarcoma; and prostate cancer. Is an ortholog of human CHEK2 (checkpoint kinase 2).

WB:WBGene00011613	T08D2.8
Is predicted to have microtubule binding activity and microtubule plus end polymerase. Is an ortholog of human CKAP5 (cytoskeleton associated protein 5).

WB:WBGene00011614	nfya-1
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in several structures, including excretory cell; gonad; head neurons; oocyte; and somatic nervous system. Is an ortholog of human NFYA (nuclear transcription factor Y subunit alpha).

WB:WBGene00011615	lsd-1
Is predicted to have several functions, including flavin adenine dinucleotide binding activity; histone demethylase activity (H3-dimethyl-K4 specific); and transcription factor binding activity. Human ortholog(s) of this gene are implicated in Brunner Syndrome and variegate porphyria. Is an ortholog of human KDM1A (lysine demethylase 1A).

WB:WBGene00011616	T08D10.3
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; D-glucose; and Zidovudine based on RNA-seq studies.

WB:WBGene00011617	T08G3.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00011618	T08G3.6
Is affected by several genes including rrf-3; hpl-2; and mut-2 based on tiling array and microarray studies. Is affected by Diazinon and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011619	T08G3.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00011620	T08G3.11
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by hpl-2; rsr-2; and eri-1 based on tiling array and microarray studies. Is affected by Atrazine and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011621	T08G3.13
Is affected by several genes including hpl-2; drh-3; and ubc-9 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00011622	T08G5.1
Is enriched in intestine and male-specific anatomical entity based on microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00011623	T08G5.2
Is affected by several genes including lin-4; lin-14; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00011624	T08G5.3
Is enriched in PLM; Z1; Z4; muscle cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00011625	vps-39
Is enriched in germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vacuolar sorting protein 39 domain 2; Vacuolar sorting protein 39 domain 1; CNH domain; Citron homology (CNH) domain; WD40/YVTN repeat-like-containing domain superfamily; Vacuolar sorting protein 39/Transforming growth factor beta receptor-associated domain 1; Vacuolar sorting protein 39/Transforming growth factor beta receptor-associated domain 2; Vam6/VPS39/TRAP1 family; and WD40-repeat-containing domain superfamily. Is an ortholog of human VPS39 (VPS39 subunit of HOPS complex).

WB:WBGene00011626	T08G5.7
Is enriched in ASER based on RNA-seq studies. Is affected by cyc-1; mir-34; and mex-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00011627	T08G5.8
Is affected by several genes including eat-2; sir-2.1; and pptr-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00011628	T08G5.9
Is affected by several genes including sir-2.1; nuo-6; and pptr-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00011629	T08G11.1
Is expressed in vulval muscle. Human ortholog(s) of this gene are implicated in Parkinson's disease 23 and choreaacanthocytosis. Is predicted to encode a protein with the following domains: Phosphorylation site; Vacuolar-sorting-associated 13 protein C-terminal; Vacuolar sorting-associated protein 13, N-terminal; SHR-binding domain of vacuolar-sorting associated protein 13; N-terminal region of Chorein or VPS13; Repeating coiled region of VPS13; Vacuolar protein sorting-associated protein 13, SHR-binding domain; Vacuolar protein sorting-associated protein 13; Vacuolar protein sorting-associated protein 13, N-terminal domain; VPS13, repeated coiled region; Vacuolar protein sorting-associated protein 13, C-terminal; and Vacuolar protein sorting-associated protein 13, second N-terminal domain. Is an ortholog of human VPS13A (vacuolar protein sorting 13 homolog A).

WB:WBGene00011630	T08G11.3
Is predicted to have microtubule binding activity. Is an ortholog of human SAXO1 (stabilizer of axonemal microtubules 1) and SAXO2 (stabilizer of axonemal microtubules 2).

WB:WBGene00011631	T08G11.4
Is predicted to have RNA trimethylguanosine synthase activity. Is an ortholog of human TGS1 (trimethylguanosine synthase 1).

WB:WBGene00011633	T09A5.4
Is affected by several genes including lin-35; pgl-1; and rrf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Atrazine based on microarray and RNA-seq studies.

WB:WBGene00011634	T09A5.5
Localizes to mitochondrion.

WB:WBGene00011635	mdmh-35
Is enriched in body wall muscle cell; germ line; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised protein family (UPF0203) and Mitochondrial distribution/morphology family 35/apoptosis. Is an ortholog of human TRIAP1 (TP53 regulated inhibitor of apoptosis 1).

WB:WBGene00011636	cec-3
Is predicted to have DNA binding activity. Is involved in negative regulation of gene expression. Localizes to nucleus.

WB:WBGene00011637	sds-22
Is predicted to have protein kinase binding activity. Is an ortholog of human PPP1R7 (protein phosphatase 1 regulatory subunit 7).

WB:WBGene00011638	ostb-1
Is predicted to contribute to dolichyl-diphosphooligosaccharide-protein glycotransferase activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ir. Is an ortholog of human DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit).

WB:WBGene00011639	ztf-17
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in body wall musculature; gonad; intestine; pharynx; and ventral nerve cord. Is an ortholog of human ZFP42 (ZFP42 zinc finger protein).

WB:WBGene00011640	T09A5.14
Is enriched in AFD; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and mex-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00011641	T09A5.15
Is enriched in AFD; ASER; germ line; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00011642	T09B9.1
Is predicted to have hydrolase activity. Is an ortholog of human AADACL3 (arylacetamide deacetylase like 3) and AADACL4 (arylacetamide deacetylase like 4).

WB:WBGene00011643	slc-17.9
Is predicted to have transmembrane transporter activity.

WB:WBGene00011644	T09B9.3
Is predicted to have phosphoric diester hydrolase activity. Is an ortholog of human GDE1 (glycerophosphodiester phosphodiesterase 1).

WB:WBGene00011645	T09B9.4
Is enriched in several structures, including carbon dioxide sensory neurons; cephalic sheath cell; germ line; germline precursor cell; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including resveratrol; Hydrolyzable Tannins; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Uncharacterized conserved protein H4 (DUF2046); and Protein of unknown function DUF2046. Is an ortholog of human CCDC6 (coiled-coil domain containing 6).

WB:WBGene00011646	T09B9.5
Is affected by several genes including let-60; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011647	noca-1
Is involved in cytoplasmic microtubule organization; germ cell development; and nematode larval development. Colocalizes with microtubule. Is expressed in hyp7 syncytium and intestinal cell.

WB:WBGene00011648	cni-1
Exhibits signaling receptor binding activity. Is involved in several processes, including negative regulation of anterograde synaptic vesicle transport; negative regulation of receptor localization to synapse; and regulation of glutamate receptor signaling pathway. Localizes to several cellular components, including Golgi apparatus; neuronal cell body; and perinuclear endoplasmic reticulum. Is expressed in AVAL; AVAR; and nervous system. Is an ortholog of human CNIH1 (cornichon family AMPA receptor auxiliary protein 1).

WB:WBGene00011649	T09E8.4
Is enriched in neurons based on tiling array studies. Is affected by several genes including clk-1; eat-2; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00011650	glct-1
Is predicted to have galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity. Is an ortholog of human B3GAT1 (beta-1,3-glucuronyltransferase 1) and B3GAT2 (beta-1,3-glucuronyltransferase 2).

WB:WBGene00011651	nhr-217
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00011652	T09E11.3
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00011653	oac-43
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00011654	oac-44
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00011655	T09E11.6
Is affected by hpl-2 and clk-1 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00011656	oac-45
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00011657	T09E11.8
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00011658	T09E11.9
Is affected by several genes including clk-1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by cadmium based on microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00011659	T09E11.10
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00011660	T09E11.11
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00011661	ztf-27
Is enriched in AFD; ASER; and intestine based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00011662	T09F3.2
Is predicted to have pyrimidine nucleotide transmembrane transporter activity. Is expressed in head and tail. Is an ortholog of human SLC25A36 (solute carrier family 25 member 36).

WB:WBGene00011663	T09F3.4
Is predicted to have RNA-DNA hybrid ribonuclease activity.

WB:WBGene00011664	T09F3.5
Is predicted to have RNA-DNA hybrid ribonuclease activity.

WB:WBGene00011665	T09F5.1
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity. Is an ortholog of human B3GALT4 (beta-1,3-galactosyltransferase 4).

WB:WBGene00011666	T09F5.2
Is affected by several genes including daf-12; sir-2.1; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; allantoin; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00011667	T09F5.7
No description available

WB:WBGene00011668	clec-47
Is predicted to have carbohydrate binding activity. Is involved in response to gamma radiation.

WB:WBGene00011669	T09F5.10
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and lin-4 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Ethanol; tryptophan; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248) and Domain of unknown function DUF1248.

WB:WBGene00011670	fbxa-84
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00011671	cyp-13A4
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A5 (cytochrome P450 family 3 subfamily A member 5); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00011672	cyp-13A5
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A43 (cytochrome P450 family 3 subfamily A member 43); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00011673	cyp-13A6
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension and platelet-type bleeding disorder 14. Is an ortholog of human CYP3A4 (cytochrome P450 family 3 subfamily A member 4) and TBXAS1 (thromboxane A synthase 1).

WB:WBGene00011674	cyp-13A8
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of human CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00011675	cyp-13A3
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A43 (cytochrome P450 family 3 subfamily A member 43); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00011676	cyp-13A2
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension and platelet-type bleeding disorder 14. Is an ortholog of human CYP3A4 (cytochrome P450 family 3 subfamily A member 4) and TBXAS1 (thromboxane A synthase 1).

WB:WBGene00011677	cyp-13A1
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension and platelet-type bleeding disorder 14. Is an ortholog of human CYP3A4 (cytochrome P450 family 3 subfamily A member 4) and TBXAS1 (thromboxane A synthase 1).

WB:WBGene00011678	T10B9.9
Is enriched in neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and metformin based on RNA-seq and microarray studies.

WB:WBGene00011679	ucr-2.2
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 5. Is an ortholog of human UQCRC2 (ubiquinol-cytochrome c reductase core protein 2).

WB:WBGene00011680	T10B10.3
Is expressed in anterior gonad arm. Is predicted to encode a protein with the following domains: Pleckstrin homology domain; PH-like domain superfamily; and RUN domain superfamily.

WB:WBGene00011681	T10B10.4
Is predicted to have glycine N-acyltransferase activity. Localizes to endoplasmic reticulum. Is an ortholog of human GLYATL3 (glycine-N-acyltransferase like 3).

WB:WBGene00011682	snt-7
Is predicted to have several functions, including SNARE binding activity; calcium ion binding activity; and phospholipid binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11.

WB:WBGene00011683	phat-6
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AL; g1AR; g1P; g2L; and g2R.

WB:WBGene00011684	T10B10.8
Is enriched in OLL; PVD; head mesodermal cell; intestine; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; tryptophan; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Nucleotide-diphospho-sugar transferases.

WB:WBGene00011685	T10B10.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011686	T10C6.2
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00011687	cwc-15
Is predicted to have RNA binding activity. Localizes to nucleus. Is expressed in hypodermis; neurons; spermatheca; and vulva. Is an ortholog of human CWC15 (CWC15 spliceosome associated protein homolog).

WB:WBGene00011688	T10C6.6
Is predicted to have transmembrane transporter activity. Localizes to plasma membrane. Is an ortholog of human SLC37A3 (solute carrier family 37 member 3).

WB:WBGene00011689	T10C6.7
Is enriched in Z1; Z4; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011690	T10C6.9
Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011691	T10C6.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011692	T10G3.1
Is enriched in OLL; PVD; body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Cry5B; levamisole; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011693	T10G3.2
Is enriched in RIS and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00011694	T10G3.3
Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Tunicamycin; D-glucopyranose; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Abnormal cell migration protein 18-like.

WB:WBGene00011695	T10G3.4
Is affected by several genes including daf-2; eat-2; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Mercuric Chloride; indole; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00011696	eea-1
Exhibits phosphatidylinositol-3-phosphate binding activity. Is involved in endocytosis. Localizes to early endosome and endocytic vesicle. Is expressed in hypodermis and intestine. Is an ortholog of human EEA1 (early endosome antigen 1).

WB:WBGene00011697	T10H4.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; unc-70; and spc-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phytanoyl-CoA hydroxylase-interacting protein-like. Is an ortholog of human PHYHIP (phytanoyl-CoA 2-hydroxylase interacting protein) and PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like).

WB:WBGene00011698	cyp-34A1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00011699	cyp-34A2
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00011701	srab-17
Is affected by rsr-2 based on tiling array studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00011702	srab-18
Is affected by several genes including sir-2.1; lin-35; and spn-4 based on microarray and RNA-seq studies. Is affected by resveratrol; Microcystin-LR; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00011703	srab-19
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011704	sdz-31
Is involved in gastrulation. Is expressed in several structures, including E; Ea; Ep; MSaa; and MSpa.

WB:WBGene00011705	clp-9
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is expressed in tail. Is an ortholog of human CAPN15 (calpain 15).

WB:WBGene00011706	T11B7.1
Is enriched in AVK and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011707	T11B7.2
Is enriched in intestine; muscle cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including aldicarb; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00011708	T11B7.5
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011709	T11F9.1
Is enriched in AVK; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by metformin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00011710	T11F9.7
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; pmk-1; and eri-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011712	T11F9.10
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011713	T11F9.12
Is enriched in neurons; pharynx; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including manganese chloride; levamisole; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Bacterial protein of unknown function (HtrL_YibB) and HtrL protein.

WB:WBGene00011714	T11F9.13
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00011715	T11F9.14
Is affected by several genes including clk-1; hpl-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including aldicarb; Tunicamycin; and resveratrol based on microarray studies.

WB:WBGene00011716	T11F9.19
Is affected by several genes including clk-1; pgl-1; and prg-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00011717	T11G6.2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC37A3 (solute carrier family 37 member 3).

WB:WBGene00011718	T11G6.3
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC37A3 (solute carrier family 37 member 3).

WB:WBGene00011719	T11G6.4
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC37A3 (solute carrier family 37 member 3).

WB:WBGene00011720	T11G6.5
Is enriched in germ line; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human TASOR (transcription activation suppressor).

WB:WBGene00011721	T11G6.7
Is enriched in NSM; head mesodermal cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and rrf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and Colistin based on microarray and RNA-seq studies.

WB:WBGene00011722	rbm-22
Is predicted to have U6 snRNA binding activity and pre-mRNA binding activity. Localizes to nucleus. Is an ortholog of human RBM22 (RNA binding motif protein 22).

WB:WBGene00011723	T12A7.2
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome. Is predicted to encode a protein with the following domain: EGF-like domain.

WB:WBGene00011724	scl-18
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and bar-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin; Zidovudine; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2) and CRISP3 (cysteine rich secretory protein 3).

WB:WBGene00011725	lips-5
Is predicted to have lipase activity.

WB:WBGene00011726	lpr-2
Is predicted to have retinoid binding activity and retinol transmembrane transporter activity.

WB:WBGene00011727	T12A7.6
Is enriched in body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Cry5B; levamisole; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00011728	T12A7.7
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including clk-1; rrf-1; and mex-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011729	set-16
Exhibits histone methyltransferase activity (H3-K4 specific). Is involved in histone H3-K4 methylation and regulation of vulval development. Localizes to MLL3/4 complex. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P5.p hermaphrodite; P8.p hermaphrodite; and linker cell. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 2; and Sotos syndrome. Is an ortholog of human KMT2C (lysine methyltransferase 2C).

WB:WBGene00011730	drr-2
Is predicted to have RNA binding activity. Localizes to polysome. Is expressed in several structures, including coelomocyte; excretory canal; neurons; ventral nerve cord; and vulva. Is an ortholog of human EIF4H (eukaryotic translation initiation factor 4H).

WB:WBGene00011731	acbp-5
Is predicted to have fatty-acyl-CoA binding activity. Is expressed in intestine and pharynx. Is an ortholog of human ACBD6 (acyl-CoA binding domain containing 6).

WB:WBGene00011732	arrd-17
Exhibits protein phosphatase 2B binding activity. Is expressed in nervous system. Is an ortholog of several human genes including ARRDC1 (arrestin domain containing 1); ARRDC4 (arrestin domain containing 4); and TXNIP (thioredoxin interacting protein).

WB:WBGene00011733	T12D8.5
Is enriched in body wall musculature; head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-one chemicals including hydrogen sulfide; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00011734	mlc-5
Is predicted to have calcium ion binding activity. Is involved in mitotic cytokinesis. Localizes to actin cytoskeleton. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 8. Is an ortholog of human MYL1 (myosin light chain 1); MYL6 (myosin light chain 6); and MYL6B (myosin light chain 6B).

WB:WBGene00011735	hip-1
Is predicted to have heat shock protein binding activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is expressed in head and tail. Is an ortholog of human ST13 (ST13 Hsp70 interacting protein).

WB:WBGene00011736	T12D8.9
Is expressed in alimentary muscle; body wall musculature; and vulval muscle.

WB:WBGene00011737	sqst-1
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and protein kinase C binding activity. Localizes to cytoplasm. Is expressed in several structures, including head; hypodermal cell; muscle cell; tail; and vulva. Human ortholog(s) of this gene are implicated in FTDALS3 and Paget's disease of bone. Is an ortholog of human SQSTM1 (sequestosome 1).

WB:WBGene00011738	T12G3.2
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011739	T12G3.4
Is predicted to have strictosidine synthase activity. Is an ortholog of human APMAP (adipocyte plasma membrane associated protein).

WB:WBGene00011740	mrpl-51
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL51 (mitochondrial ribosomal protein L51).

WB:WBGene00011741	T12G3.6
Is expressed widely.

WB:WBGene00011742	tgn-38
Is enriched in AFD; OLL; PVD; germ line; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Keratinocyte-associated transmembrane protein 2. Is an ortholog of human C5orf15 (chromosome 5 open reading frame 15).

WB:WBGene00011743	T13F2.2
Is predicted to have transcription coactivator activity. Is an ortholog of human SUB1 (SUB1 regulator of transcription).

WB:WBGene00011744	T13F2.4
Is enriched in ASER; PLM; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including methylmercury hydroxide; manganese chloride; and antimycin based on RNA-seq studies.

WB:WBGene00011745	sre-4
Is expressed in neurons. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00011746	T13F2.6
Is enriched in several structures, including Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including manganese chloride; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011747	sna-2
Is enriched in AVA; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011748	T13F2.9
Is enriched in several structures, including cholinergic neurons; coelomocyte; intestine; ventral nerve cord; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00011749	ssp-36
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; D-glucose; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00011750	nhr-218
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00011751	T13F3.4
Is affected by rsr-2; prg-1; and clk-1 based on tiling array and microarray studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00011752	fbxa-2
Is enriched in several structures, including GABAergic neurons; excretory cell; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; Alovudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00011753	T13F3.6
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty-seven chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00011754	T13F3.7
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and mex-3 based on RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00011755	T13H5.1
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human PTPRK (protein tyrosine phosphatase receptor type K).

WB:WBGene00011756	ctg-2
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; 4-bromodiphenyl ether; and Alovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; GOLD domain superfamily; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00011757	cht-2
Is predicted to have chitin binding activity and hydrolase activity, acting on glycosyl bonds. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011758	T13H5.4
Is predicted to have RNA binding activity. Is an ortholog of human SF3A3 (splicing factor 3a subunit 3).

WB:WBGene00011759	mrps-18B
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS18B (mitochondrial ribosomal protein S18B).

WB:WBGene00011760	T13H5.6
Is enriched in body wall musculature; hypodermis; and neurons based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Na,K-Atpase Interacting protein and Na,K-Atpase Interacting protein. Is an ortholog of human NKAIN4 (sodium/potassium transporting ATPase interacting 4).

WB:WBGene00011761	T13H5.8
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including Zidovudine; antimycin; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cleft lip and palate transmembrane protein 1 (CLPTM1); Cleft lip and palate transmembrane 1; and Cleft lip and palate transmembrane protein 1-like protein. Is an ortholog of human CLPTM1L (CLPTM1 like).

WB:WBGene00011762	T13H10.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00011763	T14B1.1
Is expressed in hypodermis; muscle cell; neurons; and ventral nerve cord.

WB:WBGene00011765	frpr-17
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00011766	T14C1.2
No description available

WB:WBGene00011767	agxt-1
Is predicted to have alanine-glyoxylate transaminase activity and serine-pyruvate transaminase activity. Human ortholog(s) of this gene are implicated in primary hyperoxaluria type 1. Is an ortholog of human AGXT (alanine--glyoxylate and serine--pyruvate aminotransferase).

WB:WBGene00011768	oac-46
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00011770	T14G8.2
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Mianserin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011771	T14G8.3
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human HYOU1 (hypoxia up-regulated 1).

WB:WBGene00011772	T14G8.4
Is enriched in AFD; PLM; and neurons based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercury hydroxide; methylmercuric chloride; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00011773	ttr-53
Is enriched in germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including gld-1; hsf-1; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Rotenone; metformin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011774	ttr-54
Is enriched in several structures, including AVA; germ line; head mesodermal cell; mechanosensory neurons; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including let-60; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011775	copg-1
Is predicted to have structural molecule activity. Is an ortholog of human COPG1 (COPI coat complex subunit gamma 1).

WB:WBGene00011776	pigs-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Zidovudine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphatidylinositol-glycan biosynthesis class S protein and Phosphatidylinositol-glycan biosynthesis class S protein. Is an ortholog of human PIGS (phosphatidylinositol glycan anchor biosynthesis class S).

WB:WBGene00011777	T14G10.8
Is enriched in AVK; germ line; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00011778	T15D6.1
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00011779	bgnt-1.7
Is predicted to have transferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00011780	T15D6.5
Is predicted to have acetylgalactosaminyltransferase activity and acetylglucosaminyltransferase activity.

WB:WBGene00011781	glct-3
Is predicted to have galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity. Human ortholog(s) of this gene are implicated in Larsen-like syndrome B3GAT3 type. Is an ortholog of human B3GAT2 (beta-1,3-glucuronyltransferase 2).

WB:WBGene00011782	T15D6.8
Is affected by several genes including bar-1; sin-3; and ets-4 based on microarray; tiling array; and RNA-seq studies. Is affected by sodium arsenite and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00011783	T15D6.9
Is enriched in intestine based on microarray studies. Is affected by rsr-2; clk-1; and daf-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00011784	T15D6.10
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00011785	T15D6.11
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by stavudine; Zidovudine; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00011786	T15D6.12
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00011788	hal-3
Is enriched in germ line; germline precursor cell; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00011789	T15H9.4
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T15H9.4-like.

WB:WBGene00011790	T15H9.5
Is enriched in several structures, including amphid sheath cell; body wall muscle cell; coelomocyte; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00011791	pap-2
Is predicted to have polynucleotide adenylyltransferase activity. Is an ortholog of human PAPOLA (poly(A) polymerase alpha); PAPOLB (poly(A) polymerase beta); and PAPOLG (poly(A) polymerase gamma).

WB:WBGene00011792	T16A9.1
No description available

WB:WBGene00011793	T16A9.3
Is enriched in AFD; PLM; body wall muscle cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and lin-35 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00011794	nep-21
Is predicted to have metal ion binding activity and metalloendopeptidase activity. Is expressed in accessory cell; anterior ganglion; lumbar ganglion; and ventral nerve cord. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00011795	T16A9.5
Is enriched in cholinergic neurons; pharyngeal neurons; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-four chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interactor of ZYG-11 and Protein of unknown function DUF856, Caenorhabditis species.

WB:WBGene00011796	T16G1.2
Is enriched in germline precursor cell; hypodermis; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011797	T16G1.3
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00011798	T16G1.4
Is enriched in coelomocyte; dopaminergic neurons; germ line; intestine; and sensory neurons based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; and RNA-seq studies. Is affected by twenty-three chemicals including tryptophan; Tunicamycin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00011799	T16G1.5
Is enriched in germ line and intestine based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including tryptophan; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00011800	T16G1.6
Is expressed in head neurons and intestine. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00011801	T16G1.7
Is enriched in several structures, including amphid sheath cell; dopaminergic neurons; germ line; head mesodermal cell; and mechanosensory neurons based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-six chemicals including Heme; 1-methylnicotinamide; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00011802	T16G1.9
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by four chemicals including Chlorpyrifos; Diazinon; and Humic Substances based on microarray studies. Human ortholog(s) of this gene are implicated in breast cancer. Is predicted to encode a protein with the following domains: Phosphorylation site; Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; Beta-hexosaminidase-like, domain 2; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00011803	T16G12.1
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is involved in embryo development; regulation of meiotic cell cycle process involved in oocyte maturation; and regulation of oviposition.

WB:WBGene00011804	T16G12.3
Is enriched in germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00011805	T16G12.4
Is enriched in body wall muscle cell; coelomocyte; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and ced-3 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00011806	ekl-6
Is enriched in germ line; muscle cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Required for nuclear transport of RNA pol II C-terminus 1; Required for nuclear transport of RNA pol II C-terminus 2; Armadillo-like helical; Armadillo-type fold; RNA polymerase II assembly factor Rtp1, C-terminal domain 2; RNA polymerase II assembly factor Rtp1, C-terminal; and TANGO6/Rtp1. Is an ortholog of human TANGO6 (transport and golgi organization 6 homolog).

WB:WBGene00011807	T16G12.6
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Exportin 1-like protein; Armadillo-like helical; Exportin-1/Importin-beta-like; and Armadillo-type fold. Is an ortholog of human IPO13 (importin 13).

WB:WBGene00011808	T16G12.7
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00011809	T16G12.8
Is enriched in AFD; germ line; intestine; pharyngeal muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including age-1; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00011810	T16G12.9
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and male-specific anatomical entity based on RNA-seq studies. Is affected by several genes including fog-2; pgl-1; and aak-2 based on RNA-seq; microarray; and proteomic studies. Is affected by Alovudine based on RNA-seq studies.

WB:WBGene00011811	T16H12.1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011812	T16H12.2
Is enriched in several structures, including AFD; germ line; germline precursor cell; head mesodermal cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; ced-3; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011813	T16H12.3
Is enriched in body wall muscle cell; germ line; germline precursor cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011814	gtf-2H2C
Is predicted to have zinc ion binding activity. Is an ortholog of human GTF2H2C (GTF2H2 family member C).

WB:WBGene00011815	spop-1
Is predicted to have ubiquitin protein ligase binding activity. Is an ortholog of human SPOPL (speckle type BTB/POZ protein like).

WB:WBGene00011816	srt-55
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by sir-2.1; daf-2; and daf-16 based on microarray studies. Is affected by Atrazine and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00011817	T16H12.9
Is enriched in GABAergic neurons; amphid sheath cell; dopaminergic neurons; excretory cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by Rotenone; antimycin; and Cadmium Chloride based on RNA-seq studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00011818	srt-57
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by tetrabromobisphenol A based on microarray studies.

WB:WBGene00011819	hal-2
Localizes to nucleoplasm. Is expressed in germ cell.

WB:WBGene00011820	T18D3.1
Is enriched in AFD; coelomocyte; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including D-glucose; nanoparticle; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and WD repeat-containing protein 89.

WB:WBGene00011821	cdf-2
Is predicted to have zinc ion transmembrane transporter activity. Is involved in cellular response to zinc ion and zinc ion transmembrane transport. Localizes to gut granule membrane. Is expressed in intestine. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human SLC30A8 (solute carrier family 30 member 8).

WB:WBGene00011822	T18D3.5
Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00011823	T18D3.6
Is enriched in dopaminergic neurons; hypodermis; intestine; sensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011824	tsct-1
Is predicted to have DNA-binding transcription factor activity. Is expressed in body wall musculature; nerve ring; and pharyngeal muscle cell. Is an ortholog of human TSC22D3 (TSC22 domain family member 3).

WB:WBGene00011826	T18D3.9
Is enriched in ASER; excretory cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on tiling array and RNA-seq studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 6. Is predicted to encode a protein with the following domains: Mpv17 / PMP22 family and Mpv17/PMP22. Is an ortholog of human MPV17 (mitochondrial inner membrane protein MPV17).

WB:WBGene00011827	T19A6.1
Is enriched in germ line; head mesodermal cell; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq; microarray; and tiling array studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PQ loop repeat and PQ-loop repeat. Is an ortholog of human SLC66A2 (solute carrier family 66 member 2).

WB:WBGene00011828	nepr-1
Is involved in regulation of nuclear division. Is an ortholog of human CNEP1R1 (CTD nuclear envelope phosphatase 1 regulatory subunit 1).

WB:WBGene00011829	T19A6.4
Is predicted to have carbohydrate transmembrane transporter activity. Is an ortholog of human TMEM144 (transmembrane protein 144).

WB:WBGene00011830	cyp-29A2
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00011831	T19B10.2
Is expressed in hypodermis.

WB:WBGene00011832	bgal-1
Is predicted to have beta-galactosidase activity. Human ortholog(s) of this gene are implicated in GM1 gangliosidosis (multiple) and mucopolysaccharidosis type IVB. Is an ortholog of human GLB1 (galactosidase beta 1) and GLB1L (galactosidase beta 1 like).

WB:WBGene00011833	T19B10.5
Is enriched in Z1.p; Z4.a; hypodermis; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; Rotenone; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 3 and Charcot-Marie-Tooth disease type 4F. Is predicted to encode a protein with the following domains: Phosphorylation site; PDZ domain; PDZ domain; and PDZ superfamily. Is an ortholog of human PRX (periaxin).

WB:WBGene00011834	dvc-1
Is predicted to have polyubiquitin modification-dependent protein binding activity. Is involved in cellular response to DNA damage stimulus. Localizes to nucleus. Is expressed widely. Human ortholog(s) of this gene are implicated in Ruijs-Aalfs syndrome. Is an ortholog of human SPRTN (SprT-like N-terminal domain).

WB:WBGene00011835	pgap-1
Is predicted to have phosphatidylinositol deacylase activity. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is an ortholog of human PGAP1 (post-GPI attachment to proteins inositol deacylase 1).

WB:WBGene00011836	mam-4
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; manganese chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00011837	srsx-33
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00011838	T19C4.1
Is enriched in hypodermis and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011839	T19C4.5
Is predicted to have heme binding activity and oxygen carrier activity. Is expressed in AIYL and AIYR.

WB:WBGene00011840	srbc-62
Is affected by several genes including age-1; clk-1; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00011841	scl-25
Is enriched in GABAergic neurons; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray and RNA-seq studies. Is affected by eight chemicals including Mercuric Chloride; Tunicamycin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00011842	T19C9.6
Is affected by rsr-2; smn-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine and Sirolimus based on microarray studies.

WB:WBGene00011843	T19C9.7
No description available

WB:WBGene00011844	T19C9.8
Is enriched in cholinergic neurons; coelomocyte; head mesodermal cell; intestine; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twenty-two chemicals including Heme; tryptophan; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011846	chil-25
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00011847	chil-26
Is predicted to have chitin binding activity.

WB:WBGene00011848	chil-27
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glycosyl hydrolases family 18; Glycoside hydrolase family 18, catalytic domain; and Glycoside hydrolase superfamily.

WB:WBGene00011849	T19H5.4
Is enriched in AFD and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00011850	T20B3.1
Is predicted to have carnitine O-octanoyltransferase activity. Is an ortholog of human CROT (carnitine O-octanoyltransferase).

WB:WBGene00011851	clec-23
Is affected by several genes including daf-16; clk-1; and smg-2 based on microarray and RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00011852	clec-26
Is predicted to have carbohydrate binding activity.

WB:WBGene00011853	clec-40
Is predicted to have carbohydrate binding activity.

WB:WBGene00011854	T20B3.14
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; lin-39; and sod-2 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011855	clec-183
Is predicted to have carbohydrate binding activity.

WB:WBGene00011856	T20D3.2
Is enriched in germ line; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011857	coa-4
Is enriched in ASER; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00011858	T20D3.5
Is enriched in OLL; PVD; germ line; intestine; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including glp-1; clk-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; and Mitochondrial carrier domain superfamily. Is an ortholog of human SLC25A51 (solute carrier family 25 member 51) and SLC25A52 (solute carrier family 25 member 52).

WB:WBGene00011859	T20D3.6
Localizes to cytoplasm. Is an ortholog of human HIGD2A (HIG1 hypoxia inducible domain family member 2A).

WB:WBGene00011860	pigc-1
Is predicted to have phosphatidylinositol N-acetylglucosaminyltransferase activity. Localizes to nucleus. Is an ortholog of human PIGC (phosphatidylinositol glycan anchor biosynthesis class C).

WB:WBGene00011864	T20F10.2
Is enriched in OLL; PVD; germ line; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; daf-12; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by stavudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00011865	T20F10.4
No description available

WB:WBGene00011867	chc-1
Is predicted to have clathrin light chain binding activity. Is involved in several processes, including apical protein localization; determination of adult lifespan; and positive regulation of clathrin-dependent endocytosis. Localizes to several cellular components, including apical plasma membrane; clathrin-coated endocytic vesicle; and mitotic spindle. Is expressed in coelomocyte; germ line; hypodermal cell; and pharyngeal cell. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 56. Is an ortholog of human CLTC (clathrin heavy chain) and CLTCL1 (clathrin heavy chain like 1).

WB:WBGene00011868	best-18
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00011869	dod-6
Is involved in pharyngeal gland morphogenesis.

WB:WBGene00011870	T20G5.8
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00011871	T20G5.9
Is predicted to have RNA binding activity. Is an ortholog of human PYM1 (PYM homolog 1, exon junction complex associated factor).

WB:WBGene00011872	blos-1
Is involved in endosomal transport. Is expressed in excretory cell; intestine; and nervous system. Is an ortholog of human BLOC1S1 (biogenesis of lysosomal organelles complex 1 subunit 1).

WB:WBGene00011873	T20G5.12
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00011874	T20G5.13
Is enriched in intestine and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine; cadmium; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00011875	cox-14
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Cytochrome oxidase c assembly and Cytochrome c oxidase assembly protein COX14.

WB:WBGene00011876	srz-6
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00011877	T21B4.3
Is enriched in NSM based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; Colistin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00011878	ador-1
Is predicted to have neuropeptide Y receptor activity. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome. Is an ortholog of human ADORA2B (adenosine A2b receptor).

WB:WBGene00011879	pho-7
Is enriched in GABAergic neurons; body wall musculature; excretory cell; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; bisphenol A; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal).

WB:WBGene00011880	T21B6.3
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; bisphenol A; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 7 with or without anosmia. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; PAN/Apple domain; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00011882	nstp-9
Is predicted to have GDP-fucose transmembrane transporter activity and antiporter activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIc. Is an ortholog of human SLC35C1 (solute carrier family 35 member C1).

WB:WBGene00011883	mrpl-50
Is enriched in AB; dopaminergic neurons; germ line; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rifampin; allantoin; and Ethanol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosomal subunit 39S and Ribosomal protein L50, mitochondria. Is an ortholog of human MRPL50 (mitochondrial ribosomal protein L50).

WB:WBGene00011884	enol-1
Is predicted to have magnesium ion binding activity and phosphopyruvate hydratase activity. Is expressed in head. Is an ortholog of human ENO1 (enolase 1); ENO2 (enolase 2); and ENO3 (enolase 3).

WB:WBGene00011885	T21B10.3
Is enriched in germ line; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and daf-12 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00011886	T21B10.4
Is enriched in AB; AVK; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00011887	set-17
Is predicted to have DNA-binding transcription factor activity; RNA polymerase II regulatory region sequence-specific DNA binding activity; and chromatin DNA binding activity. Is expressed in several structures, including body wall musculature; excretory cell; intestine; primary spermatocyte; and vulval muscle. Is an ortholog of human PRDM7 (PR/SET domain 7).

WB:WBGene00011888	cutl-15
Is enriched in body wall musculature; hypodermis; intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00011890	mics-1
Is enriched in body wall muscle cell; germ line; hypodermis; and neurons based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Zidovudine; Hydrolyzable Tannins; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain; and PDZ superfamily. Is an ortholog of human SYNJ2BP (synaptojanin 2 binding protein).

WB:WBGene00011891	del-6
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00011892	erh-1
Exhibits identical protein binding activity. Is an ortholog of human ERH (ERH mRNA splicing and mitosis factor).

WB:WBGene00011893	T21C9.6
Is predicted to have ATP binding activity and kinase activity.

WB:WBGene00011894	ttr-23
Is enriched in ASER; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twenty-three chemicals including Heme; hydrogen sulfide; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00011895	T21C9.9
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including 1-methylnicotinamide; nicotinic acid; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00011896	T21C9.11
Is enriched in coelomocyte and neurons based on tiling array and microarray studies. Is affected by several genes including daf-12; eat-2; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00011897	scpl-4
Is predicted to have phosphoprotein phosphatase activity. Human ortholog(s) of this gene are implicated in 3-methylglutaconic aciduria type 9. Is an ortholog of human TIMM50 (translocase of inner mitochondrial membrane 50).

WB:WBGene00011898	T21C9.13
Is expressed in germ line.

WB:WBGene00011899	nlp-68
Is enriched in male-specific anatomical entity; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00011900	T21C12.4
Is enriched in NSM; body wall muscle cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00011902	T21E8.4
Is enriched in Z1; Z4; coelomocyte; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; hpl-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00011903	T21E8.5
Is predicted to have DNA binding activity and transposase activity.

WB:WBGene00011904	hlb-1
Is involved in several processes, including neuromuscular junction development; positive regulation of locomotion; and regulation of pharyngeal pumping. Is an ortholog of human PPFIBP1 (PPFIA binding protein 1) and PPFIBP2 (PPFIA binding protein 2).

WB:WBGene00011906	hsp-12.1
Localizes to striated muscle dense body. Human ortholog(s) of this gene are implicated in several diseases, including cataract (multiple); distal hereditary motor neuronopathy type 2 (multiple); and myofibrillar myopathy (multiple). Is an ortholog of human HSPB2 (heat shock protein family B (small) member 2) and HSPB6 (heat shock protein family B (small) member 6).

WB:WBGene00011908	pash-1
Is predicted to contribute to ribonuclease III activity. Is involved in several processes, including primary miRNA processing; regulation of epidermal cell differentiation; and regulation of vulval development. Is expressed in head; hypodermis; intestine; marginal cell; and pharyngeal muscle cell. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in velocardiofacial syndrome. Is an ortholog of human DGCR8 (DGCR8 microprocessor complex subunit).

WB:WBGene00011909	T22A3.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Kringle domain; Kringle; Kringle-like fold; and Kringle superfamily.

WB:WBGene00011910	alg-3
Is predicted to have nucleic acid binding activity. Is involved in spermatogenesis. Localizes to P granule. Is expressed in germ line. Is an ortholog of human AGO1 (argonaute RISC component 1); AGO3 (argonaute RISC catalytic component 3); and AGO4 (argonaute RISC component 4).

WB:WBGene00011911	T22B3.3
Is enriched in NSM; somatic gonad precursor; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00011912	T22C1.1
Is predicted to have ubiquitin protein ligase activity and zinc ion binding activity. Is an ortholog of human UBR7 (ubiquitin protein ligase E3 component n-recognin 7).

WB:WBGene00011913	glb-26
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Localizes to membrane and nuclear lamina. Is expressed in anal depressor muscle; head mesodermal cell; intestinal muscle; and in male.

WB:WBGene00011914	pigu-1
Is predicted to contribute to GPI-anchor transamidase activity. Is an ortholog of human PIGU (phosphatidylinositol glycan anchor biosynthesis class U).

WB:WBGene00011915	ctf-8
Is enriched in several structures, including AFD; cephalic sheath cell; germ line; head mesodermal cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and lin-35 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Rifampin; allantoin; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ctf8 and Chromosome transmission fidelity protein 8. Is an ortholog of human CHTF8 (chromosome transmission fidelity factor 8).

WB:WBGene00011916	T22C1.5
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00011917	T22C1.6
Is predicted to have syntaxin binding activity. Localizes to endoplasmic reticulum. Is expressed in head and tail. Is an ortholog of human TXLNA (taxilin alpha).

WB:WBGene00011918	T22C1.8
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00011919	T22C1.9
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00011920	T22C1.11
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including levamisole; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00011921	T22C1.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and drh-3 based on tiling array and RNA-seq studies. Is affected by allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00011922	T22C8.1
Is affected by several genes including sir-2.1; prg-1; and unc-70 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by multi-walled carbon nanotube and Acrylamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00011923	chhy-1
Exhibits hexosaminidase activity. Is involved in chondroitin sulfate catabolic process. Is expressed in PLML; PLMR; head; intestinal cell; and vulva. Human ortholog(s) of this gene are implicated in mucopolysaccharidosis IX. Is an ortholog of several human genes including HYAL2 (hyaluronidase 2); HYAL3 (hyaluronidase 3); and HYAL4 (hyaluronidase 4).

WB:WBGene00011924	T22C8.3
Is enriched in intestine; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00011925	T22C8.4
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including skn-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2 superfamily.

WB:WBGene00011926	sptf-2
Is expressed in head neurons and intestine. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human SP5 (Sp5 transcription factor).

WB:WBGene00011927	T22C8.6
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011928	cutl-12
Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011929	T22G5.1
Is predicted to have phosphoric diester hydrolase activity. Is an ortholog of human GDE1 (glycerophosphodiester phosphodiesterase 1).

WB:WBGene00011930	T22G5.3
Is enriched in FLP; body wall muscle cell; intestine; neurons; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00011931	srsx-19
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00011932	sptl-3
Is predicted to have pyridoxal phosphate binding activity and serine C-palmitoyltransferase activity. Human ortholog(s) of this gene are implicated in erythropoietic protoporphyria; hereditary sensory and autonomic neuropathy type 1C; and sideroblastic anemia 1. Is an ortholog of human SPTLC2 (serine palmitoyltransferase long chain base subunit 2) and SPTLC3 (serine palmitoyltransferase long chain base subunit 3).

WB:WBGene00011933	oac-47
Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including cadmium; fluoranthene; and Chlorpyrifos based on microarray studies.

WB:WBGene00011934	T22H2.4
Is enriched in body wall muscle cell; body wall musculature; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rifampin; Sirolimus; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of Unknown Function (DUF326) and Protein of unknown function DUF326.

WB:WBGene00011935	scrm-1
Exhibits phospholipid scramblase activity. Is involved in phosphatidylserine exposure on apoptotic cell surface. Localizes to integral component of plasma membrane. Is expressed in several structures, including germ line. Is an ortholog of human PLSCR1 (phospholipid scramblase 1).

WB:WBGene00011936	pgrn-1
Is expressed in coelomocyte; neurons; and pseudocoelom. Is used to study frontotemporal dementia. Human ortholog(s) of this gene are implicated in Grn-related frontotemporal lobar degeneration with Tdp43 inclusions and neuronal ceroid lipofuscinosis 11. Is predicted to encode a protein with the following domains: Granulin; Granulin; Granulin superfamily; and Granulin family. Is an ortholog of human GRN (granulin precursor).

WB:WBGene00011937	ilc-17.1
Is predicted to have cytokine activity. Is involved in positive regulation of locomotion and response to oxygen levels. Localizes to extracellular region.

WB:WBGene00011938	alh-13
Is predicted to have glutamate-5-semialdehyde dehydrogenase activity. Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in cutis laxa (multiple) and hereditary spastic paraplegia (multiple). Is an ortholog of human ALDH18A1 (aldehyde dehydrogenase 18 family member A1).

WB:WBGene00011939	prmt-9
Is predicted to have methyltransferase activity. Is an ortholog of human PRMT9 (protein arginine methyltransferase 9).

WB:WBGene00011940	T23B5.3
Is enriched in NSM; OLL; PVD; germ line; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including hydrogen sulfide; Zidovudine; and paraquat based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011941	T23B5.4
Is predicted to have translation release factor activity. Is an ortholog of human C12orf65 (chromosome 12 open reading frame 65).

WB:WBGene00011942	T23D5.3
Is enriched in muscle cell based on microarray studies. Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by four chemicals including resveratrol; Chlorpyrifos; and Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00011943	T23D5.8
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00011944	T23D8.3
Is enriched in body wall muscle cell; dopaminergic neurons; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; aak-2; and hlh-30 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Low temperature viability protein and Low temperature viability protein Ltv1. Is an ortholog of human LTV1 (LTV1 ribosome biogenesis factor).

WB:WBGene00011945	alg-5
Is predicted to have nucleic acid binding activity.

WB:WBGene00011947	T23F1.3
Is enriched in NSM based on tiling array studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00011948	rocf-1
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00011949	T23F6.1
Is enriched in DA neuron and germ line based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including D-glucose; Neurotoxins; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00011950	T23F6.2
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercury hydroxide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00011951	T23F6.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00011952	T23F6.5
Is enriched in hypodermis; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercury hydroxide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00011953	ppm-2
Exhibits ubiquitin protein ligase binding activity. Is involved in negative regulation of axon extension and positive regulation of synapse assembly. Localizes to presynaptic active zone. Is expressed in mechanosensory neurons; motor neurons; muscle cell; nerve ring neurons; and pharynx. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human PPM1A (protein phosphatase, Mg2+/Mn2+ dependent 1A).

WB:WBGene00011954	T23F11.2
Is enriched in several structures, including AVK; DD neuron; arcade cell; germ line; and pharyngeal-intestinal valve cell based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00011955	cdka-1
Is predicted to have cyclin-dependent protein serine/threonine kinase activator activity. Is involved in several processes, including GABAergic synaptic transmission; regulation of dense core granule transport; and synaptic vesicle transport. Is an ortholog of human CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1).

WB:WBGene00011956	T23F11.4
Is enriched in FLP; RIS; germ line; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by hydrogen sulfide; paraquat; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011957	T23F11.6
Is enriched in ASER and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00011958	T23G4.2
Is predicted to have ATP-dependent peptidase activity and serine-type endopeptidase activity.

WB:WBGene00011959	nyn-1
Is involved in production of siRNA involved in RNA interference.

WB:WBGene00011960	oac-48
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00011961	T23G4.5
Is enriched in body wall muscle cell; coelomocyte; germline precursor cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including let-60; rrf-3; and cyc-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00011962	T23G5.2
Is enriched in RIS; coelomocyte; germ line; head mesodermal cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; PRELI-like family; and PRELI/MSF1 domain. Is an ortholog of human SEC14L1 (SEC14 like lipid binding 1).

WB:WBGene00011963	T23G5.3
Is enriched in AFD; ASER; PLM; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Mianserin; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 3 and scalp-ear-nipple syndrome. Is predicted to encode a protein with the following domains: BTB/POZ domain; P21-Rho-binding domain; CRIB domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; SKP1/BTB/POZ domain superfamily; and CRIB domain superfamily. Is an ortholog of several human genes including KCNRG (potassium channel regulator); KCTD18 (potassium channel tetramerization domain containing 18); and KCTD19 (potassium channel tetramerization domain containing 19).

WB:WBGene00011964	saeg-2
Is predicted to have DNA binding activity and nucleosome binding activity. Localizes to nucleus. Is an ortholog of human DNTTIP1 (deoxynucleotidyltransferase terminal interacting protein 1).

WB:WBGene00011965	T23G7.2
Is predicted to have hydrolase activity. Is an ortholog of human TMPPE (transmembrane protein with metallophosphoesterase domain).

WB:WBGene00011966	T23G7.3
Is predicted to have nucleic acid binding activity. Is an ortholog of human PINX1 (PIN2 (TERF1) interacting telomerase inhibitor 1).

WB:WBGene00011967	pir-1
Is predicted to have mRNA guanylyltransferase activity. Is an ortholog of human DUSP11 (dual specificity phosphatase 11).

WB:WBGene00011968	T23G11.1
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-six chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00011969	T23G11.4
Is enriched in cephalic sheath cell; germ line; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Hepatocellular carcinoma-associated antigen 59 and Telomere length and silencing protein 1. Is an ortholog of human C9orf78 (chromosome 9 open reading frame 78).

WB:WBGene00011970	rlbp-1
Is predicted to have GTPase activator activity and Ral GTPase binding activity. Is an ortholog of human RALBP1 (ralA binding protein 1).

WB:WBGene00011971	lron-9
Is expressed in head neurons; muscle cell; seam cell; and ventral cord neurons. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1F and familial temporal lobe epilepsy 1. Is predicted to encode a protein with the following domain: .

WB:WBGene00011972	T23G11.7
Is predicted to have SNARE binding activity. Is an ortholog of human UVRAG (UV radiation resistance associated).

WB:WBGene00011973	T23G11.10
Is affected by several genes including eat-2; hsp-6; and mex-1 based on tiling array and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00011974	xbx-5
Is expressed in gonad and neurons.

WB:WBGene00011975	T24B1.1
Is predicted to have protein homodimerization activity. Is an ortholog of human GOLGA5 (golgin A5).

WB:WBGene00011976	chmp-7
Is enriched in germ line; seam cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-60 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by Zidovudine; antimycin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Snf7; and Snf7 family. Is an ortholog of human CHMP7 (charged multivesicular body protein 7).

WB:WBGene00011977	T24B8.3
Is enriched in muscle cell and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; bisphenol A; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00011978	T24B8.4
Is predicted to have actin binding activity.

WB:WBGene00011979	sysm-1
Is involved in innate immune response. Is expressed in intestine.

WB:WBGene00011980	T24B8.7
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability. Is an ortholog of human USP24 (ubiquitin specific peptidase 24) and USP9X (ubiquitin specific peptidase 9 X-linked).

WB:WBGene00011981	enri-2
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011982	T24C2.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011983	fbxa-81
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00011984	T24C2.5
Is enriched in dopaminergic neurons; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucopyranose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00011985	T24D1.2
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00011986	T24D1.3
Is enriched in several structures, including AFD; NSM; cephalic sheath cell; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00011988	har-2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00011989	T24D5.1
Is affected by several genes including daf-2; clk-1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00011990	T24D5.2
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011991	T24D5.3
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and male-specific anatomical entity based on RNA-seq studies. Is affected by several genes including sir-2.1; mex-1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00011992	T24D5.4
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations.

WB:WBGene00011993	T24D5.5
Is affected by several genes including daf-2; sir-2.1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011994	samp-1
Is predicted to have actin filament binding activity and lamin binding activity. Is involved in embryo development and nuclear migration along microtubule. Localizes to nuclear envelope. Is an ortholog of human TMEM201 (transmembrane protein 201).

WB:WBGene00011995	rsf-1
Is predicted to have metal ion binding activity. Is expressed in pharynx and vulva. Is an ortholog of human RASSF1 (Ras association domain family member 1) and RASSF5 (Ras association domain family member 5).

WB:WBGene00011996	T24F1.4
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; aak-2; and alg-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Lithium Chloride; D-glucose; and nanoparticle based on microarray and RNA-seq studies.

WB:WBGene00011997	nlp-51
Is enriched in neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00011999	T24F1.7
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00012000	T24H10.1
Is predicted to have DNA binding activity and zinc ion binding activity. Is an ortholog of human TCEA1 (transcription elongation factor A1) and TCEA2 (transcription elongation factor A2).

WB:WBGene00012002	T24H10.4
Is enriched in excretory cell; germ line; germline precursor cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Eukaryotic protein of unknown function (DUF829); Protein of unknown function DUF829, TMEM53; and Alpha/Beta hydrolase fold. Is an ortholog of human TMEM53 (transmembrane protein 53).

WB:WBGene00012003	T24H10.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including tryptophan; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00012004	dyrb-1
Is predicted to have dynein intermediate chain binding activity. Localizes to several cellular components, including chromosome; cytoskeleton; and perinuclear region of cytoplasm. Is expressed in ciliated neurons and intestine. Is an ortholog of human DYNLRB1 (dynein light chain roadblock-type 1) and DYNLRB2 (dynein light chain roadblock-type 2).

WB:WBGene00012005	jun-1
Exhibits sequence-specific DNA binding activity and transcription factor binding activity. Is involved in several processes, including determination of adult lifespan; positive regulation of RNA splicing; and response to starvation. Localizes to nucleus. Is expressed in several structures, including excretory cell; hermaphrodite gonad; nervous system; pharyngeal-intestinal valve; and pharynx. Is an ortholog of human JUN (Jun proto-oncogene, AP-1 transcription factor subunit); JUNB (JunB proto-oncogene, AP-1 transcription factor subunit); and JUND (JunD proto-oncogene, AP-1 transcription factor subunit).

WB:WBGene00012007	T25B9.1
Is predicted to have glycine C-acetyltransferase activity and pyridoxal phosphate binding activity. Is an ortholog of human GCAT (glycine C-acetyltransferase).

WB:WBGene00012008	T25B9.2
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00012009	T25B9.3
Is enriched in DA neuron; GABAergic neurons; VA neuron; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pmk-1; lin-35; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; Sirolimus; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00012010	T25B9.4
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00012011	T25B9.5
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00012012	T25B9.6
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00012013	ugt-54
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A6 (UDP glucuronosyltransferase family 1 member A6); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2A3 (UDP glucuronosyltransferase family 2 member A3).

WB:WBGene00012014	T25B9.8
Is enriched in AFD; AVA; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012015	T25B9.9
Is predicted to have NADP binding activity and phosphogluconate dehydrogenase (decarboxylating) activity. Is involved in defense response to Gram-negative bacterium and negative regulation of gene expression. Is an ortholog of human PGD (phosphogluconate dehydrogenase).

WB:WBGene00012016	inpp-1
Is predicted to have phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity. Localizes to cytoplasm. Human ortholog(s) of this gene are implicated in Joubert syndrome 1. Is an ortholog of human INPP5E (inositol polyphosphate-5-phosphatase E).

WB:WBGene00012017	shpk-1
Is predicted to have sedoheptulokinase activity. Is an ortholog of human SHPK (sedoheptulokinase).

WB:WBGene00012018	T25C12.3
Is enriched in germ line; head mesodermal cell; intestine; and pharyngeal muscle cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domains: Lectin C-type domain; von Willebrand factor type A domain; EGF-like domain; C-type lectin-like; von Willebrand factor, type A; MD domain; C-type lectin-like/link domain superfamily; C-type lectin fold; and von Willebrand factor A-like domain superfamily.

WB:WBGene00012019	dkf-2
Exhibits protein homodimerization activity and protein serine/threonine kinase activity. Is involved in several processes, including defense response to other organism; determination of adult lifespan; and protein import into nucleus. Localizes to cytoplasmic side of plasma membrane; cytosol; and serine/threonine protein kinase complex. Is expressed in AVF; NSM; head neurons; lumbar neurons; and spermathecal-uterine junction. Is an ortholog of human PRKD3 (protein kinase D3).

WB:WBGene00012020	gyg-2
Is predicted to have glycogenin glucosyltransferase activity. Is expressed in germ line. Human ortholog(s) of this gene are implicated in glycogen storage disease XV. Is an ortholog of human GYG1 (glycogenin 1).

WB:WBGene00012021	T25E12.6
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Mianserin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00012022	clec-39
Is predicted to have carbohydrate binding activity.

WB:WBGene00012023	clec-34
Is predicted to have carbohydrate binding activity.

WB:WBGene00012024	clec-29
Is predicted to have carbohydrate binding activity.

WB:WBGene00012025	clec-38
Is predicted to have carbohydrate binding activity. Is involved in several processes, including generation of neurons; presynapse assembly; and synaptic vesicle localization. Is expressed in PLML; PLMR; head neurons; intestine; and ventral cord neurons.

WB:WBGene00012026	srz-100
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; sodium arsenite; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00012027	fbxa-127
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on RNA-seq; tiling array; and microarray studies. Is affected by sixteen chemicals including methylmercury hydroxide; D-glucopyranose; and sodium arsenite based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00012028	srz-99
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00012029	T25G3.1
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; age-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4604); Domain of unknown function DUF4604; and Uncharacterized protein KIAA1143-like. Is an ortholog of human KIAA1143 (KIAA1143).

WB:WBGene00012030	T25G3.3
Is predicted to have ribosomal large subunit binding activity. Is an ortholog of human NMD3 (NMD3 ribosome export adaptor).

WB:WBGene00012031	gpdh-3
Is predicted to have calcium ion binding activity and sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human GPD2 (glycerol-3-phosphate dehydrogenase 2).

WB:WBGene00012032	T26C5.2
Is enriched in OLL; PVD; hypodermis; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00012033	T26C5.3
Is predicted to have solute:proton symporter activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 42. Is an ortholog of human SLC33A1 (solute carrier family 33 member 1).

WB:WBGene00012034	T26C5.4
Is enriched in dopaminergic neurons; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012035	T26C5.5
Is enriched in RIS; head mesodermal cell; and neurons based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012036	clec-103
Is predicted to have carbohydrate binding activity.

WB:WBGene00012037	T26E3.4
Is expressed in several structures, including intestine; neurons; pseudocoelom; and tail hypodermis. Is predicted to encode a protein with the following domains: RWD domain; RWD domain; Ubiquitin-conjugating enzyme/RWD-like; and GIR2-like. Is an ortholog of human RWDD1 (RWD domain containing 1).

WB:WBGene00012038	T26E3.5
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012039	T26E3.6
Is involved in regulation of protein deneddylation. Localizes to cytoplasm and nucleus.

WB:WBGene00012040	T26E3.7
Is predicted to have ATP binding activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 22 and mitochondrial complex V (ATP synthase) deficiency nuclear type 4.

WB:WBGene00012041	T26E3.8
Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012042	T26E3.10
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; alg-1; and mex-1 based on tiling array and RNA-seq studies. Is affected by Triclosan based on microarray studies.

WB:WBGene00012043	irld-52
Is affected by several genes including sir-2.1; adr-1; and rsr-2 based on tiling array; RNA-seq; and microarray studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00012044	T26E4.2
Is affected by several genes including sir-2.1; lin-15B; and cyc-1 based on microarray and tiling array studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012045	T26E4.3
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00012046	T26E4.4
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity. Is expressed in hyp7 syncytium.

WB:WBGene00012047	T26E4.5
Is affected by several genes including sir-2.1; ain-1; and smg-2 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00012048	srxa-17
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00012049	T26E4.7
Is affected by let-60 based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273; Protein of unknown function DUF273; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00012050	nhr-223
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00012051	T26E4.9
Is affected by several genes including sir-2.1; mex-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00012052	T26E4.10
Is affected by several genes including eat-2; sir-2.1; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including methylmercuric chloride; Atrazine; and fluoranthene based on microarray studies.

WB:WBGene00012053	srbc-74
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol and Diazinon based on microarray studies.

WB:WBGene00012054	srsx-38
Is predicted to have G protein-coupled receptor activity. Is expressed in PVT and neurons.

WB:WBGene00012055	srsx-36
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00012056	nhr-285
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00012057	T26F2.1
Is predicted to have chitinase activity.

WB:WBGene00012058	T26F2.2
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00012059	T26G10.1
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX47 (DEAD-box helicase 47).

WB:WBGene00012060	T26G10.3
Is predicted to be a structural constituent of ribosome.

WB:WBGene00012061	T26G10.4
Is affected by cyc-1 and sir-2.1 based on microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00012062	T26G10.5
Is enriched in BAG; dopaminergic neurons; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including aldicarb; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00012063	fbxb-1
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Mianserin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00012064	fbxb-115
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00012065	fbxb-2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Mianserin; allantoin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00012066	fbxb-116
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00012067	sqst-3
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and protein kinase C binding activity. Human ortholog(s) of this gene are implicated in FTDALS3 and Paget's disease of bone.

WB:WBGene00012068	oac-49
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00012069	T26H5.4
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Tunicamycin; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012070	T26H5.8
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity. Is an ortholog of human FUT1 (fucosyltransferase 1 (H blood group)) and FUT2 (fucosyltransferase 2).

WB:WBGene00012071	T26H8.1
No description available

WB:WBGene00012072	T26H8.4
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00012073	cpd-2
Is predicted to have metallocarboxypeptidase activity. Is involved in regulation of muscle contraction. Human ortholog(s) of this gene are implicated in carboxypeptidase N deficiency. Is an ortholog of human CPM (carboxypeptidase M) and CPN1 (carboxypeptidase N subunit 1).

WB:WBGene00012074	T27A8.2
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is expressed in head muscle; head neurons; pharyngeal neurons; somatic nervous system; and tail.

WB:WBGene00012075	T27A8.3
Is predicted to have aminopeptidase activity. Is an ortholog of human METAP2 (methionyl aminopeptidase 2).

WB:WBGene00012077	T27A8.5
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including sir-2.1; hpl-2; and set-2 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including cadmium; Diazinon; and dibromoacetic acid based on microarray studies.

WB:WBGene00012078	srz-50
Is affected by clk-1 based on microarray studies. Is affected by Progesterone and Sirolimus based on microarray studies.

WB:WBGene00012079	T27C5.6
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00012080	clec-244
Is enriched in NSM based on tiling array studies. Is affected by clk-1 and ints-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00012081	T27C5.8
Is enriched in arcade cell; intestine; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00012082	T27C5.9
No description available

WB:WBGene00012083	T27C5.10
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00012084	npr-15
Is predicted to have G protein-coupled receptor activity. Is expressed in amphid neurons; head neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in essential hypertension.

WB:WBGene00012085	T27D12.1
Is predicted to have transmembrane transporter activity.

WB:WBGene00012086	clec-144
Is predicted to have carbohydrate binding activity.

WB:WBGene00012087	T27E7.1
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-five chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00012088	T27E7.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00012089	T27E7.4
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00012090	T27E7.5
Is affected by several genes including eat-2; sir-2.1; and mut-2 based on tiling array and microarray studies. Is affected by tryptophan and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012091	pals-29
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including skn-1; elt-2; and lin-35 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Mercuric Chloride; and nanoparticle based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012092	T27E7.7
No description available

WB:WBGene00012093	T27E7.9
Is affected by several genes including sir-2.1; bar-1; and drh-3 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00012094	T27E9.2
Is predicted to have ubiquinol-cytochrome-c reductase activity. Is an ortholog of human UQCRH (ubiquinol-cytochrome c reductase hinge protein).

WB:WBGene00012095	pssy-2
Is enriched in germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Lenz-Majewski hyperostotic dwarfism. Is predicted to encode a protein with the following domains: Phosphatidyl serine synthase and Phosphatidyl serine synthase. Is an ortholog of human PTDSS1 (phosphatidylserine synthase 1).

WB:WBGene00012096	T27E9.6
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00012097	abcf-2
Is predicted to have ATP binding activity. Is expressed in head. Is an ortholog of human ABCF2 (ATP binding cassette subfamily F member 2).

WB:WBGene00012098	fbxb-86
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Alovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00012099	acc-4
Is predicted to have chloride channel activity. Is expressed in neurons.

WB:WBGene00012100	sipa-1
Is predicted to have GTPase activator activity. Human ortholog(s) of this gene are implicated in cataract 45. Is an ortholog of human SIPA1 (signal-induced proliferation-associated 1); SIPA1L1 (signal induced proliferation associated 1 like 1); and SIPA1L2 (signal induced proliferation associated 1 like 2).

WB:WBGene00012101	zip-10
Exhibits core promoter binding activity. Is involved in regulation of gene expression. Localizes to nucleus. Is expressed in neurons.

WB:WBGene00012102	T27F6.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and antimycin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00012103	clec-12
Is predicted to have carbohydrate binding activity.

WB:WBGene00012104	sygl-1
Is expressed in germ cell; germ line; and gonad.

WB:WBGene00012105	T27F6.6
Is predicted to have sphingomyelin phosphodiesterase activity. Is an ortholog of human SMPD2 (sphingomyelin phosphodiesterase 2).

WB:WBGene00012106	T27F6.7
Is enriched in several structures, including excretory cell; germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; gld-1; and npr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00012107	T27F6.8
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00012108	T28A8.2
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00012109	T28A8.3
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; dpy-10; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00012110	T28A8.4
Is enriched in body wall musculature; germ line; germline precursor cell; and hypodermis based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00012111	T28A8.5
Is enriched in OLL; PVD; germ line; and germline precursor cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00012112	T28A8.6
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including manganese chloride; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00012113	T28B8.1
Is expressed in head muscle; neurons; pharyngeal muscle cell; and vulval muscle.

WB:WBGene00012114	T28B8.3
Is predicted to have lysine-acetylated histone binding activity; peptidase activator activity; and proteasome binding activity. Is an ortholog of human PSME4 (proteasome activator subunit 4).

WB:WBGene00012115	T28B8.4
Is predicted to have lysine-acetylated histone binding activity; peptidase activator activity; and proteasome binding activity. Is an ortholog of human PSME4 (proteasome activator subunit 4).

WB:WBGene00012116	del-4
Is predicted to have sodium channel activity. Is expressed in ganglia and neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00012117	T28B11.1
Is enriched in coelomocyte; germ line; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and gld-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including Cry5B; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; F-box-like; F-box domain; and F-box-like domain superfamily.

WB:WBGene00012118	grsp-2
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012119	T28C6.3
Is enriched in ventral nerve cord based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00012120	T28C6.5
Is enriched in ventral nerve cord and in male based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012121	T28C6.7
Is expressed in tail. Is predicted to encode a protein with the following domain: .

WB:WBGene00012122	T28C6.8
Is enriched in hypodermis; intestine; muscle cell; sensory neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterized conserved protein (DUF2367) and Brain protein I3.

WB:WBGene00012123	T28D6.3
Is enriched in hypodermis and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00012124	T28D6.4
Is enriched in AFD; ASER; PLM; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; eat-2; and mab-5 based on microarray and RNA-seq studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (many copies); Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; P-loop containing nucleoside triphosphate hydrolase; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human ANKRD50 (ankyrin repeat domain 50).

WB:WBGene00012125	T28D6.5
Is enriched in AVK; NSM; head mesodermal cell; and neurons based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012126	T28D6.6
Is predicted to have GTP binding activity. Is an ortholog of human DRG1 (developmentally regulated GTP binding protein 1).

WB:WBGene00012127	T28D6.7
Is predicted to have lipid binding activity. Is an ortholog of human CD226 (CD226 molecule).

WB:WBGene00012128	nra-1
Is predicted to have calcium-dependent phospholipid binding activity. Is involved in receptor localization to synapse. Localizes to plasma membrane. Is expressed in body wall musculature; head neurons; tail neurons; and ventral cord neurons. Is an ortholog of human CPNE5 (copine 5).

WB:WBGene00012130	slc-17.4
Is predicted to have transmembrane transporter activity.

WB:WBGene00012131	T28F3.5
Is predicted to have ATP binding activity and acetyl-CoA carboxylase activity. Is an ortholog of human ACACA (acetyl-CoA carboxylase alpha) and ACACB (acetyl-CoA carboxylase beta).

WB:WBGene00012132	ifta-2
Is predicted to have GTPase activity. Is involved in several processes, including dauer larval development; determination of adult lifespan; and insulin-like growth factor receptor signaling pathway. Localizes to axoneme and ciliary base. Is expressed in amphid neurons and phasmid neurons. Human ortholog(s) of this gene are implicated in Joubert syndrome 8. Is an ortholog of human IFT22 (intraflagellar transport 22).

WB:WBGene00012133	T28F3.7
Is affected by wdr-23; dpy-21; and eat-2 based on RNA-seq studies.

WB:WBGene00012134	T28F3.8
Is enriched in DA neuron; I5 neuron; SAB; head mesodermal cell; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including bisphenol S; stavudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 8; pigmented paravenous chorioretinal atrophy; and retinitis pigmentosa 12. Is predicted to encode a protein with the following domain: .

WB:WBGene00012135	T28F3.9
Is enriched in coelomocyte and neurons based on tiling array studies. Is affected by several genes including daf-16; alg-1; and rde-4 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Sirolimus; and Atrazine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00012136	T28F4.1
Is enriched in AFD; ASER; PLM; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00012137	asic-2
Is predicted to have sodium channel activity. Is expressed in ciliated neurons and sensory neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00012138	T28F4.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00012139	T28F4.4
Is enriched in coelomocyte; germ line; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including D-glucose; bisphenol S; and levamisole based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in ACTH-independent macronodular adrenal hyperplasia 2. Is predicted to encode a protein with the following domains: Armadillo-like helical and Armadillo-type fold.

WB:WBGene00012140	T28F4.5
Is predicted to have death domain binding activity. Is an ortholog of human DAP (death associated protein) and DAPL1 (death associated protein like 1).

WB:WBGene00012142	T28H10.1
Is predicted to have holo-[acyl-carrier-protein] synthase activity. Is an ortholog of human AASDHPPT (aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase).

WB:WBGene00012143	T28H10.2
Is enriched in hypodermis; intestine; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; D-glucose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like; Domain of unknown function (DUF1794); ShKT domain; Calycin; and Domain of unknown function DUF1794. Is an ortholog of human THAP4 (THAP domain containing 4).

WB:WBGene00012144	T28H10.3
Is predicted to have cysteine-type endopeptidase activity. Is involved in PERK-mediated unfolded protein response. Is an ortholog of human LGMN (legumain).

WB:WBGene00012145	nlp-46
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by nhr-114; adr-1; and unc-70 based on microarray and RNA-seq studies.

WB:WBGene00012146	VB0393L.2
Is enriched in intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00012147	VC27A7L.1
Is expressed in neurons.

WB:WBGene00012148	inos-1
Is predicted to have inositol-3-phosphate synthase activity. Is expressed in germ line. Is an ortholog of human ISYNA1 (inositol-3-phosphate synthase 1).

WB:WBGene00012149	VF13D12L.3
Is predicted to have oxidoreductase activity.

WB:WBGene00012150	syx-17
Is predicted to have SNAP receptor activity and SNARE binding activity. Is an ortholog of human STX17 (syntaxin 17).

WB:WBGene00012151	VH15N14R.1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012152	cnc-10
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and dpy-7 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; bisphenol S; and Alovudine based on RNA-seq studies.

WB:WBGene00012155	VW02B12L.2
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00012156	ebp-2
Is predicted to have microtubule plus-end binding activity. Localizes to several cellular components, including cytoskeleton; kinetochore; and non-motile cilium. Is expressed in several structures, including hypodermis; nervous system; and ventral nerve cord. Is an ortholog of human MAPRE1 (microtubule associated protein RP/EB family member 1); MAPRE2 (microtubule associated protein RP/EB family member 2); and MAPRE3 (microtubule associated protein RP/EB family member 3).

WB:WBGene00012157	adbp-1
Is involved in positive regulation of protein localization to nucleus. Localizes to nucleus. Is expressed in hyp7 syncytium; intestine; neurons; pharynx; and seam cell.

WB:WBGene00012158	ucr-2.1
Is predicted to have metalloendopeptidase activity. Is expressed in gonad. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 5. Is an ortholog of human UQCRC2 (ubiquinol-cytochrome c reductase core protein 2).

WB:WBGene00012159	VY10G11R.1
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00012162	sek-6
Is predicted to have JUN kinase kinase activity and protein serine/threonine kinase activity. Is an ortholog of human MAP2K4 (mitogen-activated protein kinase kinase 4).

WB:WBGene00012163	VZK822L.2
Is enriched in OLL; PVD; dopaminergic neurons; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012164	W01A8.2
Is enriched in several structures, including germ line; germline precursor cell; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; resveratrol; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised ACR, YggU family COG1872; Protein of unknown function DUF167; and YggU-like superfamily. Is an ortholog of human C15orf40 (chromosome 15 open reading frame 40).

WB:WBGene00012165	cutl-6
Is enriched in PLM; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00012166	nuo-6
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is expressed in body wall musculature; germ line; gonad; and hypodermis. Is an ortholog of human NDUFB4 (NADH:ubiquinone oxidoreductase subunit B4).

WB:WBGene00012167	tofu-5
Is expressed in germ cell.

WB:WBGene00012168	W01A8.6
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of several human genes including CPA4 (carboxypeptidase A4); CPB2 (carboxypeptidase B2); and CPO (carboxypeptidase O).

WB:WBGene00012169	ttbk-4
Is predicted to have protein serine/threonine kinase activity. Is expressed in ASIL; ASIR; amphid neurons; and neurons.

WB:WBGene00012170	W01B6.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00012171	W01B6.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: PapD-like superfamily.

WB:WBGene00012172	W01B6.5
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00012173	W01B6.6
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00012174	W01B6.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including tryptophan; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012175	W01C9.1
Is enriched in Z1.p; Z4.a; male distal tip cell; pharynx; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00012176	W01C9.2
Is enriched in Z1.p; Z4.a; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012177	decr-1.2
Is predicted to have 2,4-dienoyl-CoA reductase (NADPH) activity. Is an ortholog of human DECR1 (2,4-dienoyl-CoA reductase 1).

WB:WBGene00012178	glb-27
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00012179	W01D2.1
Is predicted to have RNA binding activity. Is an ortholog of human RPL37 (ribosomal protein L37).

WB:WBGene00012180	W01D2.3
Is enriched in AVK; muscle cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia 31; and hereditary spastic paraplegia 72.

WB:WBGene00012181	srt-11
Is affected by several genes including eat-2; ain-1; and drh-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00012182	osta-3
Is expressed in ciliated neurons. Is predicted to encode a protein with the following domains: Organic solute transporter Ostalpha and Organic solute transporter subunit alpha/Transmembrane protein 184. Is an ortholog of human SLC51A (solute carrier family 51 subunit alpha).

WB:WBGene00012183	W01D2.6
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00012184	mnr-1
Is involved in generation of neurons. Localizes to extracellular space and plasma membrane. Is expressed in ALA; pharynx; and tail neurons. Is an ortholog of human FAM151B (family with sequence similarity 151 member B).

WB:WBGene00012185	W01F3.2
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type.

WB:WBGene00012186	mlt-11
Is predicted to have serine-type endopeptidase inhibitor activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00012187	rpb-11
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2J (RNA polymerase II subunit J).

WB:WBGene00012188	W01G7.4
Is enriched in NSM and germ line based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on proteomic; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transcription factor Iwr1; Transcription factor Iwr1 domain; and Probable RNA polymerase II nuclear localization protein SLC7A6OS.

WB:WBGene00012189	W02A2.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and glycine based on microarray and RNA-seq studies.

WB:WBGene00012190	W02A2.5
Is affected by several genes including lin-15B; csr-1; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by Cry5B and Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 18; electroclinical syndrome (multiple); and intellectual disability (multiple). Is predicted to encode a protein with the following domain: Uncharacterized protein T25E4.2-like.

WB:WBGene00012191	W02A2.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00012192	W02A11.1
Is predicted to have tRNA (adenine-N1-)-methyltransferase activity. Is an ortholog of human TRMT61A (tRNA methyltransferase 61A).

WB:WBGene00012193	vps-25
Is predicted to have protein homodimerization activity and structural molecule activity. Is expressed in body wall musculature; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human VPS25 (vacuolar protein sorting 25 homolog).

WB:WBGene00012194	toe-4
Is expressed in head. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human RNF111 (ring finger protein 111).

WB:WBGene00012195	bath-34
Is enriched in AVK; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and lin-28 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00012196	bath-35
Is enriched in DA neuron; I5 neuron; SAB; germline precursor cell; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00012197	W02B8.1
Is enriched in AVK; body wall muscle cell; body wall musculature; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012198	W02B8.2
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human CIT (citron rho-interacting serine/threonine kinase).

WB:WBGene00012199	mltn-3
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00012200	mltn-4
Is enriched in NSM based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00012201	W02B12.1
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00012202	cest-15
Is enriched in excretory cell; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Lithium Chloride; Cry5B; and Humic Substances based on microarray studies.

WB:WBGene00012203	rga-1
Exhibits GTPase regulator activity. Is involved in positive regulation of GTPase activity. Is an ortholog of human ARHGAP1 (Rho GTPase activating protein 1).

WB:WBGene00012204	mfn-1
Is predicted to have iron ion transmembrane transporter activity. Is an ortholog of human SLC25A28 (solute carrier family 25 member 28) and SLC25A37 (solute carrier family 25 member 37).

WB:WBGene00012205	metl-1
Is predicted to have tRNA (guanine-N7-)-methyltransferase activity. Is an ortholog of human METTL1 (methyltransferase like 1).

WB:WBGene00012206	W02B12.11
Is predicted to have transferase activity, transferring glycosyl groups. Is expressed in several structures, including body wall musculature; hermaphrodite gonad; hypodermis; intestine; and vulva. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IId. Is an ortholog of human B4GALT5 (beta-1,4-galactosyltransferase 5).

WB:WBGene00012207	W02B12.12
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00012208	W02D9.2
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; gld-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Yip1 domain and Yip1 domain. Is an ortholog of human YIPF6 (Yip1 domain family member 6).

WB:WBGene00012209	hmg-20
Is predicted to have DNA binding activity. Is expressed in body wall musculature; head neurons; seam cell; ventral nerve cord; and vulval muscle. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 15. Is an ortholog of human HMG20A (high mobility group 20A) and HMG20B (high mobility group 20B).

WB:WBGene00012210	W02D9.4
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; bisphenol S; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012211	ssp-37
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00012212	W02D9.6
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Rotenone; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00012213	W02D9.7
Is enriched in RIM; interneuron; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including hydrogen sulfide; Ethanol; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00012214	W02D9.8
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00012215	W02D9.9
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012216	W02D9.10
Is enriched in head mesodermal cell; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Lithium Chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012217	W02H3.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00012218	W02H3.2
Is enriched in RID based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies.

WB:WBGene00012219	W03C9.1
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00012220	W03C9.2
Localizes to striated muscle dense body.

WB:WBGene00012221	W03C9.5
Is enriched in several structures, including germ line; hypodermis; intestine; mechanosensory neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012222	W03C9.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00012223	W03C9.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00012224	W03G11.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LEM3 (ligand-effect modulator 3) family / CDC50 family and CDC50/LEM3 family. Is an ortholog of human TMEM30A (transmembrane protein 30A) and TMEM30B (transmembrane protein 30B).

WB:WBGene00012225	W03G11.3
Is predicted to have alpha-L-fucosidase activity. Human ortholog(s) of this gene are implicated in fucosidosis. Is an ortholog of human FUCA2 (alpha-L-fucosidase 2).

WB:WBGene00012226	W03G11.4
Is enriched in body wall musculature; head mesodermal cell; hypodermis; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; bisphenol S; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012227	W03H9.1
Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1280); Protein of unknown function DUF1280; and Zinc finger, FYVE/PHD-type.

WB:WBGene00012228	W03H9.2
Is enriched in AVA; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012230	cacn-1
Is predicted to have RNA binding activity. Is involved in several processes, including gonad development; positive regulation of cell migration; and regulation of Wnt signaling pathway. Localizes to cytoplasm and spliceosomal complex. Is expressed in several structures, including germ line; hermaphrodite gonad; hypodermal cell; intestine; and vulva. Is an ortholog of human CACTIN (cactin, spliceosome C complex subunit).

WB:WBGene00012231	W04A4.2
Is enriched in cephalic sheath cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012232	W04A4.3
Is affected by several genes including eat-2; sir-2.1; and mut-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT.

WB:WBGene00012233	clpr-1
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy.

WB:WBGene00012234	ints-4
Is enriched in body wall muscle cell; germ line; germline precursor cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HEAT repeats; Armadillo-like helical; and Armadillo-type fold. Is an ortholog of human INTS4 (integrator complex subunit 4).

WB:WBGene00012235	W04A4.6
Is enriched in intestine and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-12; sir-2.1; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00012236	W04A8.1
Is predicted to have RNA polymerase II CTD heptapeptide repeat phosphatase activity. Is an ortholog of human MCPH1 (microcephalin 1).

WB:WBGene00012237	W04A8.2
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including ced-3; pgl-1; and dcr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00012238	W04A8.3
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012239	W04A8.4
Is predicted to have 3'-5' exonuclease activity and nucleic acid binding activity. Localizes to endoplasmic reticulum.

WB:WBGene00012240	W04A8.5
Is enriched in AVE; NSM; germ line; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012241	W04A8.6
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012242	srt-39
Is affected by smg-2; drh-3; and daf-2 based on RNA-seq and microarray studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00012243	W04D2.4
Is enriched in germ line; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; gld-1; and sir-2.1 based on RNA-seq; microarray; and proteomic studies. Is affected by eight chemicals including Linolenic Acids; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012244	mrps-11
Is predicted to have mRNA 5'-UTR binding activity and small ribosomal subunit rRNA binding activity. Is an ortholog of human MRPS11 (mitochondrial ribosomal protein S11).

WB:WBGene00012245	rbm-25
Is predicted to have mRNA binding activity. Is an ortholog of human RBM25 (RNA binding motif protein 25).

WB:WBGene00012246	fbxa-131
Is affected by drh-3 and mdt-15 based on RNA-seq and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00012247	W04E12.2
Is enriched in germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercury hydroxide; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00012248	W04E12.3
Is enriched in body wall muscle cell; coelomocyte; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including mex-1; hpl-2; and spn-4 based on tiling array and RNA-seq studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00012249	W04E12.4
Is enriched in body wall muscle cell; cholinergic neurons; germline precursor cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including copper sulfate; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00012250	W04E12.5
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012251	clec-49
Is predicted to have monosaccharide binding activity and signaling receptor activity. Is an ortholog of human MRC1 (mannose receptor C-type 1); MRC2 (mannose receptor C type 2); and PLA2R1 (phospholipase A2 receptor 1).

WB:WBGene00012252	W04E12.7
Is enriched in GABAergic neurons; PLM; and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I) and PGPEP1L (pyroglutamyl-peptidase I like).

WB:WBGene00012253	clec-50
Is predicted to have signaling receptor activity. Is expressed in intestine. Is an ortholog of human MRC1 (mannose receptor C-type 1); MRC2 (mannose receptor C type 2); and PLA2R1 (phospholipase A2 receptor 1).

WB:WBGene00012254	W04E12.9
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: MFS transporter superfamily.

WB:WBGene00012255	lpr-6
Is expressed in amphid neurons. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00012256	lpr-5
Is expressed in several structures, including seam cell. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00012257	lpr-4
Is expressed in body wall musculature and muscle cell. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00012258	W04G3.5
Is predicted to have ribose phosphate diphosphokinase activity. Is an ortholog of human PRPSAP1 (phosphoribosyl pyrophosphate synthetase associated protein 1) and PRPSAP2 (phosphoribosyl pyrophosphate synthetase associated protein 2).

WB:WBGene00012259	sulp-7
Is predicted to have transmembrane transporter activity. Is expressed in body wall musculature; hypodermis; intestine; pharyngeal muscle cell; and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of several human genes including SLC26A1 (solute carrier family 26 member 1); SLC26A2 (solute carrier family 26 member 2); and SLC26A4 (solute carrier family 26 member 4).

WB:WBGene00012260	W04G3.7
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by tryptophan and glycine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012261	lpr-3
Is expressed in excretory duct; excretory pore; and vulva. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00012263	W04G5.1
No description available

WB:WBGene00012264	W04G5.3
Is enriched in intestine based on microarray studies. Is affected by several genes including hpl-2; his-24; and ain-1 based on RNA-seq and microarray studies.

WB:WBGene00012265	W04G5.4
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00012266	W04G5.5
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00012267	W04G5.7
Is enriched in body wall muscle cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; glh-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00012268	W04G5.8
Is enriched in Z1; Z4; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Sodium Chloride; allantoin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00012269	W04G5.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Human ortholog(s) of this gene are implicated in NGLY1-deficiency. Is predicted to encode a protein with the following domains: PNGase C-terminal domain, mannose-binding module PAW; Peptide N glycanase, PAW domain; Galactose-binding-like domain superfamily; and PAW domain superfamily.

WB:WBGene00012270	W04G5.10
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including dysostosis (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including KIT (KIT proto-oncogene, receptor tyrosine kinase); PDGFRA (platelet derived growth factor receptor alpha); and PDGFRB (platelet derived growth factor receptor beta).

WB:WBGene00012271	W05B2.2
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00012272	dhc-4
Is enriched in BAG; hypodermis; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including manganese chloride; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Dynein heavy chain, N-terminal region 2; Dynein heavy chain, domain-2; P-loop containing nucleoside triphosphate hydrolase; and Dynein heavy chain, domain 2, N-terminal.

WB:WBGene00012274	W05B5.1
Is enriched in NSM; head mesodermal cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012275	npr-14
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in AIYL and AIYR.

WB:WBGene00012276	his-74
Is predicted to have DNA binding activity and protein heterodimerization activity. Is an ortholog of human H3-3B (H3.3 histone B) and H3-5 (H3.5 histone).

WB:WBGene00012277	ccch-3
Is predicted to have metal ion binding activity. Is expressed in dorsal nerve cord; head muscle; head neurons; intestine; and ventral nerve cord.

WB:WBGene00012278	W05B10.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012279	W05B10.4
Is predicted to have Ras GTPase binding activity. Is expressed in several structures, including pharynx; vulval cell; vulval cell; vulval cell; and vulval cell.

WB:WBGene00012280	W05E10.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00012281	W05E10.2
Is enriched in neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including age-1; prg-1; and unc-70 based on microarray; tiling array; and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00012282	W05E10.5
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by nine chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012283	W05H5.1
Is affected by mir-34 and mex-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00012284	W05H5.2
Is affected by several genes including sir-2.1; hpl-2; and drh-3 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00012285	pitr-6
Is predicted to have sodium:inorganic phosphate symporter activity. Human ortholog(s) of this gene are implicated in basal ganglia calcification. Is an ortholog of human SLC20A1 (solute carrier family 20 member 1) and SLC20A2 (solute carrier family 20 member 2).

WB:WBGene00012286	sre-35
Is affected by several genes including daf-2; pgl-1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012287	sre-33
Is enriched in muscle cell based on microarray studies. Is affected by eat-2 and sir-2.1 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012288	sre-32
Is affected by several genes including eat-2; mex-3; and mex-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012289	W05H12.1
Is expressed in dorsal nerve cord; head neurons; tail neurons; and ventral nerve cord.

WB:WBGene00012290	W05H12.2
Is enriched in body wall muscle cell; head mesodermal cell; intestine; neurons; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by Psoralens based on RNA-seq studies.

WB:WBGene00012291	W06A7.2
Localizes to plasma membrane.

WB:WBGene00012292	C11E4.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00012293	W06A7.4
Is predicted to have carbohydrate transmembrane transporter activity. Is an ortholog of human TMEM144 (transmembrane protein 144).

WB:WBGene00012294	nspa-8
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Ethanol; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00012295	nmat-1
Is predicted to have nicotinamide-nucleotide adenylyltransferase activity and nicotinate-nucleotide adenylyltransferase activity. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 9. Is an ortholog of human NMNAT1 (nicotinamide nucleotide adenylyltransferase 1).

WB:WBGene00012296	spe-46
Is expressed in sperm.

WB:WBGene00012297	W06D4.3
Is enriched in several structures, including Z1.p; Z4.a; excretory cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BAR domain; BAR domain; and AH/BAR domain superfamily.

WB:WBGene00012298	prmt-7
Is predicted to have protein-arginine omega-N monomethyltransferase activity. Is an ortholog of human PRMT7 (protein arginine methyltransferase 7).

WB:WBGene00012299	W06D11.1
Is enriched in several structures, including BAG; Z4.a; germ line; germline precursor cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including bisphenol A; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012300	W06D11.2
Is enriched in BAG based on tiling array studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00012301	W06D11.3
Is enriched in carbon dioxide sensory neurons; cholinergic neurons; germ line; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including bisphenol A; tert-Butylhydroperoxide; and metformin based on RNA-seq and microarray studies.

WB:WBGene00012302	dot-1.3
Is predicted to have histone methyltransferase activity (H3-K79 specific). Is an ortholog of human DOT1L (DOT1 like histone lysine methyltransferase).

WB:WBGene00012303	W06D11.5
Is affected by several genes including daf-2; sir-2.1; and drh-3 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; dibromoacetic acid; and 2 based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012304	cutl-4
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including eat-2; dpy-7; and eri-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including 1-methylnicotinamide; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00012305	W06D12.6
Is affected by let-60 based on microarray studies.

WB:WBGene00012306	W06F12.2
Is enriched in Psub1; cholinergic neurons; head mesodermal cell; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012307	W06F12.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00012308	oac-53
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00012309	W06G6.2
Is affected by cyc-1 and clk-1 based on microarray studies.

WB:WBGene00012310	mltn-11
Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00012311	W06G6.9
Is affected by several genes including let-60; pmk-1; and alg-1 based on microarray and RNA-seq studies. Is affected by Colistin; adsorbable organic bromine compound; and nitroguanidine based on microarray studies.

WB:WBGene00012312	W06G6.10
Is enriched in body wall muscle cell; coelomocyte; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pmk-1; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; Mianserin; and procyanidin based on RNA-seq and microarray studies.

WB:WBGene00012313	W06G6.11
Is affected by several genes including clk-1; bar-1; and alg-1 based on microarray and RNA-seq studies.

WB:WBGene00012314	W06G6.12
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hda-1; and daf-10 based on microarray studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00012315	immt-2
Is involved in cristae formation; mitochondrion morphogenesis; and response to reactive oxygen species. Localizes to mitochondrial proton-transporting ATP synthase complex. Is an ortholog of human IMMT (inner membrane mitochondrial protein).

WB:WBGene00012316	ctps-1
Is predicted to have CTP synthase activity and identical protein binding activity. Is an ortholog of human CTPS1 (CTP synthase 1) and CTPS2 (CTP synthase 2).

WB:WBGene00012317	ztf-6
Is expressed in several structures, including head muscle; hyp7; hypodermis; postdeirid sensillum; and tail. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is predicted to encode a protein with the following domains: Phosphorylation site; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00012318	srxa-1
Is expressed in ADFL; ADFR; AWBL; and AWBR. Is predicted to encode a protein with the following domains: Phosphorylation site; Caenorhabditis serpentine receptor-like protein, class xa; and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00012319	ipla-3
Is predicted to have actin filament binding activity. Human ortholog(s) of this gene are implicated in Parkinson's disease 14; neurodegeneration with brain iron accumulation 2a; and neurodegeneration with brain iron accumulation 2b. Is an ortholog of human PLA2G6 (phospholipase A2 group VI).

WB:WBGene00012320	srxa-3
Is affected by dpy-21 and acs-3 based on RNA-seq and microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00012321	srxa-6
Is expressed in ASIL; ASIR; PHBL; and PHBR. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00012322	W07A12.4
Is enriched in PLM; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including levamisole; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including cold-induced sweating syndrome 3; giant axonal neuropathy 1; and nemaline myopathy (multiple). Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB And C-terminal Kelch; BTB/POZ domain; SKP1/BTB/POZ domain superfamily; and BTB/Kelch-associated. Is an ortholog of human BTBD17 (BTB domain containing 17).

WB:WBGene00012323	oac-54
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00012324	rhy-1
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Is involved in negative regulation of cellular response to hypoxia and response to hypoxia. Localizes to perinuclear region of cytoplasm. Is expressed in body wall musculature; hypodermis; neurons; socket cell; and vulva.

WB:WBGene00012325	W07A12.8
Is enriched in AVA; intestine; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: CoA-transferase family III domain superfamily.

WB:WBGene00012326	W07E11.1
Is predicted to have glutamate synthase (NADH) activity.

WB:WBGene00012328	W07G1.1
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and mex-3 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 66 and nephronophthisis 19. Is predicted to encode a protein with the following domains: Doublecortin; Doublecortin domain; and Doublecortin domain superfamily. Is an ortholog of human DCDC2B (doublecortin domain containing 2B).

WB:WBGene00012329	sre-44
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Phosphorylation site; C. elegans Sre G protein-coupled chemoreceptor; and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012330	zip-3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is an ortholog of human ATF5 (activating transcription factor 5).

WB:WBGene00012332	rpi-1
Localizes to axonemal microtubule; ciliary base; and ciliary transition zone. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 66 and nephronophthisis 19. Is an ortholog of human DCDC2B (doublecortin domain containing 2B).

WB:WBGene00012333	sre-43
Is expressed in AWB and chemosensory neurons. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012334	W07G1.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012335	W07G4.1
Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012336	W07G4.2
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00012337	scyl-1
Is predicted to have kinase activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 21. Is an ortholog of human SCYL1 (SCY1 like pseudokinase 1).

WB:WBGene00012339	W07G4.5
Is enriched in AFD; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012340	dct-15
Is predicted to have glucose transmembrane transporter activity.

WB:WBGene00012341	catp-6
Is predicted to have ATP binding activity; ATPase activity; and metal ion binding activity. Is involved in protein folding. Localizes to cytoplasmic vesicle and plasma membrane. Is expressed in several structures, including egg-laying apparatus; gonad; oocyte; pharynx; and somatic gonad precursor. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in Kufor-Rakeb syndrome. Is an ortholog of human ATP13A3 (ATPase 13A3).

WB:WBGene00012342	mtr-4
Is predicted to have RNA helicase activity. Is expressed in PVDL and PVDR. Is an ortholog of human MTREX (Mtr4 exosome RNA helicase).

WB:WBGene00012343	casc-3
Is predicted to have RNA binding activity. Is expressed widely. Is an ortholog of human CASC3 (CASC3 exon junction complex subunit).

WB:WBGene00012344	ola-1
Is predicted to have ATPase activity. Localizes to endoplasmic reticulum. Is an ortholog of human OLA1 (Obg like ATPase 1).

WB:WBGene00012345	W08E3.4
Is predicted to have FFAT motif binding activity.

WB:WBGene00012346	W08G11.1
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercury hydroxide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00012347	W08G11.3
Is enriched in AVK; RID; and germ line based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; resveratrol; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00012348	pptr-1
Exhibits protein kinase binding activity and protein phosphatase activator activity. Contributes to protein serine/threonine phosphatase activity. Is involved in several processes, including P granule assembly; determination of adult lifespan; and negative regulation of insulin receptor signaling pathway. Localizes to cytosol. Is expressed in head; spermatheca; tail; and vulva. Is an ortholog of human PPP2R5B (protein phosphatase 2 regulatory subunit B'beta).

WB:WBGene00012349	W08G11.5
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00012350	C11G10.t1
No description available

WB:WBGene00012351	W09C5.1
Localizes to nucleolus. Is expressed in ventral nerve cord. Is an ortholog of human NSA2 (NSA2 ribosome biogenesis factor).

WB:WBGene00012352	dkf-1
Exhibits protein serine/threonine kinase activity. Is involved in several processes, including defense response to Gram-positive bacterium; determination of adult lifespan; and positive regulation of protein import into nucleus. Localizes to several cellular components, including axon; dendrite; and neuronal cell body. Is expressed in neurons. Is an ortholog of human PRKD3 (protein kinase D3).

WB:WBGene00012353	W09C5.7
Is predicted to have phosphatidylinositol-4-phosphate phosphatase activity. Human ortholog(s) of this gene are implicated in X-linked recessive disease (multiple) and congenital muscular dystrophy with cataracts and intellectual disability. Is an ortholog of human INPP5F (inositol polyphosphate-5-phosphatase F).

WB:WBGene00012354	cox-4
Is predicted to have cytochrome-c oxidase activity. Is involved in mitochondrial electron transport, cytochrome c to oxygen. Is an ortholog of human COX4I1 (cytochrome c oxidase subunit 4I1) and COX4I2 (cytochrome c oxidase subunit 4I2).

WB:WBGene00012355	W09C5.9
Is enriched in AVE; intestine; and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including daf-16; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00012356	W09D6.1
Is predicted to have catalytic activity. Is an ortholog of human AASDH (aminoadipate-semialdehyde dehydrogenase).

WB:WBGene00012357	W09D6.4
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Lithium Chloride; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00012358	W09D6.5
Is enriched in head mesodermal cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012359	W09D10.1
Is predicted to have GTPase activator activity. Is an ortholog of human SMAP1 (small ArfGAP 1) and SMAP2 (small ArfGAP2).

WB:WBGene00012360	tat-3
Is predicted to have ATPase-coupled intramembrane lipid transporter activity. Is involved in sterol metabolic process. Is expressed in several structures, including XXX cell; anchor cell; distal tip cell; pharynx; and vulva. Human ortholog(s) of this gene are implicated in benign recurrent intrahepatic cholestasis 1; intrahepatic cholestasis of pregnancy 1; and progressive familial intrahepatic cholestasis 1. Is an ortholog of human ATP10A (ATPase phospholipid transporting 10A (putative)); ATP10B (ATPase phospholipid transporting 10B (putative)); and ATP10D (ATPase phospholipid transporting 10D (putative)).

WB:WBGene00012361	mrpl-12
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL12 (mitochondrial ribosomal protein L12).

WB:WBGene00012362	W09D10.4
Is predicted to have metal ion binding activity and phosphoprotein phosphatase activity. Is an ortholog of human PPTC7 (protein phosphatase targeting COQ7).

WB:WBGene00012363	W09D10.5
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00012364	zmp-4
Is predicted to have metalloendopeptidase activity. Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type. Is an ortholog of human HPX (hemopexin).

WB:WBGene00012365	W09G3.1
Is enriched in germ line; head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including fbf-1; sma-2; and gld-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Kelch motif; Kelch repeat type 1; and Kelch-type beta propeller.

WB:WBGene00012366	maea-1
Is enriched in ASER; body muscle cell; germ line; and somatic nervous system based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; fog-2; and eri-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Cry5B; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CTLH/CRA C-terminal to LisH motif domain; LIS1 homology motif; CTLH, C-terminal LisH motif; CRA domain; CTLH/CRA C-terminal to LisH motif domain; and Protein Fyv10/Macrophage erythroblast attacher. Is an ortholog of human MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase).

WB:WBGene00012368	fbxa-93
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; smg-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00012369	W09G3.6
Is enriched in germ line; head mesodermal cell; intestine; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Hermansky-Pudlak syndrome 5 and hereditary spastic paraplegia 49. Is predicted to encode a protein with the following domain: . Is an ortholog of human HPS5 (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2).

WB:WBGene00012370	W09G3.7
Is expressed in amphid neurons; hypodermis; and intestine. Is predicted to encode a protein with the following domain: . Is an ortholog of human RCC1L (RCC1 like).

WB:WBGene00012371	W09G3.8
Is enriched in AFD; ASER; germ line; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Yos1-like and Yos1-like. Is an ortholog of human IER3IP1 (immediate early response 3 interacting protein 1).

WB:WBGene00012372	W09H1.1
Is predicted to have protein tyrosine/serine/threonine phosphatase activity.

WB:WBGene00012373	W09H1.3
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein C3orf33-like. Is an ortholog of human C3orf33 (chromosome 3 open reading frame 33).

WB:WBGene00012374	W09H1.4
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012375	mecr-1
Is predicted to have trans-2-enoyl-CoA reductase (NADPH) activity. Is expressed in tail. Is an ortholog of human MECR (mitochondrial trans-2-enoyl-CoA reductase).

WB:WBGene00012376	nduf-7
Is predicted to contribute to NADH dehydrogenase activity. Is expressed in intestine. Is an ortholog of human NDUFS7 (NADH:ubiquinone oxidoreductase core subunit S7).

WB:WBGene00012377	C12C8.t1
No description available

WB:WBGene00012378	W10G6.1
Is enriched in DA neuron; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012379	Y1A5A.1
Is predicted to have metal ion binding activity.

WB:WBGene00012381	Y2H9A.4
Is enriched in coelomocyte; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00012382	ttr-16
Is enriched in PLM; body wall musculature; head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; D-glucose; and nicotine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00012383	ttr-17
Is enriched in OLL; PVD; body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-one chemicals including diallyl trisulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00012384	Y5F2A.3
Is enriched in body wall muscle cell based on tiling array studies. Is affected by cyc-1; rsr-2; and ain-1 based on microarray and tiling array studies. Is affected by Atrazine and Chlorpyrifos based on microarray studies.

WB:WBGene00012385	Y5F2A.4
Is expressed in nerve ring and tail neurons. Human ortholog(s) of this gene are implicated in gingival fibromatosis 5; pleomorphic adenoma; and posterior polymorphous corneal dystrophy 1. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00012386	agef-1
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Is expressed in coelomocyte; intestine; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability and periventricular nodular heterotopia. Is an ortholog of human ARFGEF1 (ADP ribosylation factor guanine nucleotide exchange factor 1) and ARFGEF2 (ADP ribosylation factor guanine nucleotide exchange factor 2).

WB:WBGene00012387	Y6B3B.1
Is expressed in coelomocyte and hypodermis.

WB:WBGene00012388	Y6B3B.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00012389	Y6B3B.4
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: S phase cyclin A-associated protein in the endoplasmic reticulum and S phase cyclin A-associated protein in the endoplasmic reticulum, N-terminal. Is an ortholog of human SCAPER (S-phase cyclin A associated protein in the ER).

WB:WBGene00012390	gpap-1
Is predicted to have 3'-nucleotidase activity. Is an ortholog of human BPNT2 (3'(2'), 5'-bisphosphate nucleotidase 2).

WB:WBGene00012391	Y6B3B.7
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012392	Y6B3B.8
No description available

WB:WBGene00012393	Y6B3B.9
Is predicted to have endonuclease activity. Human ortholog(s) of this gene are implicated in Wilson-Turner syndrome. Is an ortholog of human LAS1L (LAS1 like ribosome biogenesis factor).

WB:WBGene00012394	hsd-1
Exhibits 3-beta-hydroxy-delta5-steroid dehydrogenase activity. Is involved in nematode larval development and sterol biosynthetic process. Is expressed in XXXL and XXXR. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1. Is an ortholog of human SDR42E2 (short chain dehydrogenase/reductase family 42E, member 2).

WB:WBGene00012395	Y6D1A.1
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012396	Y6D1A.2
Is enriched in PLM; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00012397	Y6E2A.1
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00012398	Y6E2A.4
Is enriched in several structures, including coelomocyte; head mesodermal cell; male distal tip cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Tunicamycin; levamisole; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00012399	Y6E2A.5
Is enriched in several structures, including head mesodermal cell; male distal tip cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00012400	Y6E2A.7
Is enriched in body wall muscle cell; dopaminergic neurons; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF713.

WB:WBGene00012401	irld-57
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00012402	sfxn-1.3
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN1 (sideroflexin 1) and SFXN3 (sideroflexin 3).

WB:WBGene00012403	srz-45
Is expressed in chemosensory neurons.

WB:WBGene00012404	Y6G8.2
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; D-glucopyranose; and tert-Butylhydroperoxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00012405	ztf-25
Is expressed in embryonic cell; head muscle; intestine; and somatic nervous system. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00012406	srz-91
Is affected by rsr-2; clk-1; and daf-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00012407	Y7A5A.1
Is predicted to have delta24(24-1) sterol reductase activity.

WB:WBGene00012408	Y7A5A.2
Is enriched in hypodermis; intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Mianserin; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012409	Y7A5A.3
Is enriched in neurons; retrovesicular ganglion; and in male based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including aldicarb; methylmercuric chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00012411	Y7A5A.5
Is enriched in DA neuron; coelomocyte; interneuron; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including fluoranthene; paraquat; and tetrabromobisphenol A based on microarray studies.

WB:WBGene00012412	Y7A5A.6
Is enriched in AFD and hypodermis based on RNA-seq studies. Is affected by several genes including skn-1; elt-2; and mex-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00012413	Y7A5A.7
Is enriched in muscle cell and neurons based on microarray studies. Is affected by rsr-2 and lin-22 based on tiling array and RNA-seq studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00012414	Y7A5A.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00012415	Y7A5A.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin and Psoralens based on RNA-seq studies.

WB:WBGene00012416	Y7A9A.1
Is predicted to have glutathione hydrolase activity and peptidyltransferase activity. Human ortholog(s) of this gene are implicated in gamma-glutamyl transpeptidase deficiency. Is an ortholog of human GGT1 (gamma-glutamyltransferase 1).

WB:WBGene00012418	Y7A9C.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including aldicarb; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00012419	srz-73
Is affected by several genes including let-60; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00012420	Y7A9D.1
Is enriched in germ line; head mesodermal cell; hypodermis; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00012421	Y9C2UA.1
Localizes to plasma membrane.

WB:WBGene00012423	Y10G11A.1
Is predicted to have 5'-nucleotidase activity. Human ortholog(s) of this gene are implicated in hemolytic anemia. Is an ortholog of human NT5C3A (5'-nucleotidase, cytosolic IIIA) and NT5C3B (5'-nucleotidase, cytosolic IIIB).

WB:WBGene00012424	dlc-3
Is predicted to have dynein intermediate chain binding activity and dynein light intermediate chain binding activity. Is expressed in body wall musculature; distal tip cell; and vulval muscle.

WB:WBGene00012425	dlc-4
Is predicted to have dynein intermediate chain binding activity and dynein light intermediate chain binding activity.

WB:WBGene00012426	Y11D7A.1
Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies.

WB:WBGene00012428	Y11D7A.3
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00012429	Y11D7A.5
Is enriched in OLL; PLM; PVD; germline precursor cell; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq; tiling array; and microarray studies. Is affected by nineteen chemicals including Heme; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00012430	Y11D7A.6
No description available

WB:WBGene00012431	Y11D7A.7
Is enriched in several structures, including AFD; germ line; germline precursor cell; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by eighteen chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00012432	Y11D7A.8
Is expressed in amphid neurons. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00012433	Y11D7A.9
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-one chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family; Frag1/DRAM/Sfk1; and Post-GPI attachment to proteins factor 2. Is an ortholog of human PGAP2 (post-GPI attachment to proteins 2).

WB:WBGene00012434	Y11D7A.10
Is enriched in germ line; intestine; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including hydrogen sulfide; D-glucose; and Chlorpyrifos based on microarray and RNA-seq studies.

WB:WBGene00012435	flh-1
Exhibits DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is involved in negative regulation of transcription, DNA-templated and nematode larval development.

WB:WBGene00012436	flh-3
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity. Is involved in negative regulation of transcription, DNA-templated.

WB:WBGene00012437	nmy-3
Is predicted to have ATP binding activity; actin filament binding activity; and motor activity.

WB:WBGene00012439	Y12A6A.1
Localizes to membrane raft.

WB:WBGene00012440	nlp-53
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012441	glb-28
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00012442	Y15E3A.3
Is affected by several genes including daf-2; skn-1; and aak-2 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00012443	Y15E3A.4
Is predicted to have transmembrane transporter activity. Localizes to plasma membrane.

WB:WBGene00012444	Y15E3A.5
Is enriched in body wall musculature; intestine; muscle cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; 4-bromodiphenyl ether; and Cadmium Chloride based on RNA-seq and microarray studies.

WB:WBGene00012445	Y16B4A.2
Is predicted to have serine-type carboxypeptidase activity. Localizes to membrane raft. Human ortholog(s) of this gene are implicated in galactosialidosis.

WB:WBGene00012446	nhr-230
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00012448	cyp-33D3
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00012449	nhr-231
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons; intestine; pharynx; and rectal gland cell.

WB:WBGene00012450	Y17D7B.2
Is enriched in AVA and AVE based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00012451	Y17D7B.3
Is enriched in AFD and FLP based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including copper sulfate; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00012452	Y17D7B.4
Is enriched in head mesodermal cell; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012453	Y17D7B.5
Is enriched in intestine; muscle cell; and neurons based on microarray studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Alovudine; Chlorpyrifos; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00012454	clec-256
Is predicted to have carbohydrate binding activity.

WB:WBGene00012455	Y17D7C.1
Is enriched in BAG; DA neuron; and VA neuron based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00012456	Y17D7C.2
Is enriched in intestine and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00012457	acbp-6
Is predicted to have fatty-acyl-CoA binding activity.

WB:WBGene00012458	ash-2
Is predicted to contribute to histone methyltransferase activity (H3-K4 specific). Is involved in determination of adult lifespan; histone H3-K4 methylation; and transdifferentiation. Localizes to MLL3/4 complex. Is expressed in germ line. Is an ortholog of human ASH2L (ASH2 like, histone lysine methyltransferase complex subunit).

WB:WBGene00012459	Y17G7B.3
Is predicted to have hydroxyacylglutathione hydrolase activity. Is an ortholog of human HAGH (hydroxyacylglutathione hydrolase).

WB:WBGene00012460	dhps-1
Is predicted to have deoxyhypusine synthase activity. Is an ortholog of human DHPS (deoxyhypusine synthase).

WB:WBGene00012461	glb-29
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00012462	Y17G7B.8
Is involved in innate immune response.

WB:WBGene00012463	nadk-2
Is predicted to have NAD+ kinase activity. Is an ortholog of human NADK2 (NAD kinase 2, mitochondrial).

WB:WBGene00012464	arrd-7
Is enriched in cephalic sheath cell; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Cry5B; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00012465	Y17G7B.12
Is predicted to have exonuclease activity. Is an ortholog of human REXO4 (REX4 homolog, 3'-5' exonuclease).

WB:WBGene00012466	ippk-1
Is predicted to have inositol pentakisphosphate 2-kinase activity. Is an ortholog of human IPPK (inositol-pentakisphosphate 2-kinase).

WB:WBGene00012467	arrd-8
Is affected by several genes including clk-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including tryptophan; Tunicamycin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00012468	Y17G7B.17
Is predicted to have DNA binding activity. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human MLF2 (myeloid leukemia factor 2).

WB:WBGene00012469	Y17G7B.18
Is predicted to have O-methyltransferase activity; RNA methyltransferase activity; and snRNA binding activity. Is an ortholog of human MEPCE (methylphosphate capping enzyme).

WB:WBGene00012470	Y17G7B.19
Is enriched in muscle cell and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012471	Y17G7B.20
Is enriched in body wall muscle cell; coelomocyte; germ line; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Aspirin; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00012472	Y17G7B.21
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00012473	Y17G7B.22
Is enriched in AVA; AVK; head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00012474	attf-6
Is expressed in head muscle; head neurons; intestine; pharynx; and ventral nerve cord. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012475	Y18D10A.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00012476	Y18D10A.3
Is predicted to have NADHX epimerase activity and NADPHX epimerase activity. Is an ortholog of human NAXE (NAD(P)HX epimerase).

WB:WBGene00012477	Y18D10A.4
Is affected by several genes including eat-2; mex-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00012478	mxt-1
Is predicted to have eukaryotic initiation factor 4E binding activity and translation initiation factor activity.

WB:WBGene00012479	Y18D10A.9
Is enriched in ASER and germ line based on RNA-seq studies. Is affected by several genes including daf-2; lin-35; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by paraquat; Sirolimus; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; Probable cytosolic iron-sulfur protein assembly protein, CIAO1/Cia1; and WD40-repeat-containing domain superfamily. Is an ortholog of human CIAO1 (cytosolic iron-sulfur assembly component 1).

WB:WBGene00012480	clec-104
Is predicted to have carbohydrate binding activity.

WB:WBGene00012481	Y18D10A.11
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012482	clec-106
Is predicted to have carbohydrate binding activity.

WB:WBGene00012483	coa-5
Is enriched in AFD; ASER; intestine; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in fatal infantile cardioencephalomyopathy due to cytochrome c oxidase deficiency 3. Is predicted to encode a protein with the following domains: Cytochrome c oxidase assembly protein PET191 and Cytochrome c oxidase assembly protein PET191. Is an ortholog of human COA5 (cytochrome c oxidase assembly factor 5).

WB:WBGene00012484	car-1
Localizes to cytoplasmic ribonucleoprotein granule; cytoskeleton; and messenger ribonucleoprotein complex. Colocalizes with endoplasmic reticulum. Is expressed in germ line and gonad. Is an ortholog of human LSM14A (LSM14A mRNA processing body assembly factor) and LSM14B (LSM family member 14B).

WB:WBGene00012485	fbxa-121
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Atrazine; cadmium; and Chlorpyrifos based on microarray studies.

WB:WBGene00012486	Y18D10A.21
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including aldicarb; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012487	Y18D10A.23
Is predicted to have amino acid transmembrane transporter activity. Is expressed in excretory canal; excretory cell; and ut2. Is an ortholog of human SLC38A11 (solute carrier family 38 member 11); SLC38A7 (solute carrier family 38 member 7); and SLC38A8 (solute carrier family 38 member 8).

WB:WBGene00012488	clec-105
Is predicted to have carbohydrate binding activity.

WB:WBGene00012489	Y19D2B.1
Is predicted to have GTP binding activity. Human ortholog(s) of this gene are implicated in brain disease (multiple) and congenital fibrosis of the extraocular muscles.

WB:WBGene00012490	Y19D2B.2
Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00012491	Y20C6A.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; levamisole; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00012492	fbxb-7
Is enriched in several structures, including PLM; Z1.p; Z4.a; germ line; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00012493	Y20C6A.3
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00012494	nhr-232
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00012496	Y24F12A.1
Is predicted to have hydrolase activity, acting on ester bonds. Is an ortholog of human TATDN2 (TatD DNase domain containing 2).

WB:WBGene00012497	ragc-1
Is predicted to have GTPase activity. Is involved in determination of adult lifespan and regulation of autophagosome assembly. Is an ortholog of human RRAGC (Ras related GTP binding C) and RRAGD (Ras related GTP binding D).

WB:WBGene00012498	Y24F12A.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012499	Y24F12A.4
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00012500	hpo-2
Is enriched in RID; body wall musculature; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin-like/link domain superfamily.

WB:WBGene00012501	Y26D4A.3
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00012502	clec-107
Is predicted to have carbohydrate binding activity.

WB:WBGene00012503	Y26D4A.5
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including clk-1; lin-15B; and hpl-2 based on microarray and tiling array studies.

WB:WBGene00012504	clec-108
Is predicted to have carbohydrate binding activity.

WB:WBGene00012505	pals-13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and mir-34 based on microarray studies. Is affected by six chemicals including allantoin; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012506	Y26D4A.9
No description available

WB:WBGene00012507	Y26D4A.10
No description available

WB:WBGene00012508	Y26D4A.11
No description available

WB:WBGene00012509	Y26D4A.12
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00012511	Y26D4A.14
No description available

WB:WBGene00012512	ekl-5
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including glp-1; daf-12; and dpy-10 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00012513	Y26E6A.2
Is enriched in GABAergic neurons and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-60; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by Zidovudine and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012514	Y26E6A.3
Is enriched in GABAergic neurons; amphid sheath cell; excretory cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF938); Protein of unknown function DUF938; and S-adenosyl-L-methionine-dependent methyltransferase. Is an ortholog of human METTL26 (methyltransferase like 26).

WB:WBGene00012515	Y26G10.1
Is affected by several genes including age-1; clk-1; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012516	sqst-4
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and protein kinase C binding activity. Human ortholog(s) of this gene are implicated in FTDALS3 and Paget's disease of bone. Is an ortholog of human SQSTM1 (sequestosome 1).

WB:WBGene00012517	srbc-73
Is affected by cyc-1 based on microarray studies. Is affected by Chlorpyrifos and Sirolimus based on microarray studies.

WB:WBGene00012518	comt-2
Is predicted to have S-adenosylmethionine-dependent methyltransferase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 63; panic disorder; and schizophrenia. Is an ortholog of human COMTD1 (catechol-O-methyltransferase domain containing 1).

WB:WBGene00012519	Y32B12A.4
Is affected by several genes including daf-2; sir-2.1; and nuo-6 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride; Tunicamycin; and dibromoacetic acid based on microarray studies.

WB:WBGene00012520	Y32B12A.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by rsr-2 based on tiling array studies. Is affected by four chemicals including nanoparticle; cadmium; and Microcystin-LR based on microarray studies.

WB:WBGene00012521	Y32B12B.1
Is enriched in DA neuron; VA neuron; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Zidovudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012522	Y32B12B.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and clk-1 based on RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including Tunicamycin; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00012523	srbc-65
Is affected by several genes including let-60; sir-2.1; and lin-35 based on tiling array and microarray studies. Is affected by Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00012524	Y32B12B.4
Is enriched in NSM; germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein lin-15B-like.

WB:WBGene00012525	Y32B12C.1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Tunicamycin; Sodium Chloride; and tert-Butylhydroperoxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Smr domain; and Smr domain superfamily.

WB:WBGene00012526	Y32B12C.3
Is affected by several genes including eat-2; hpl-2; and smg-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00012527	set-22
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SET domain and SET domain.

WB:WBGene00012528	pap-1
Is predicted to have polynucleotide adenylyltransferase activity. Is an ortholog of human PAPOLB (poly(A) polymerase beta).

WB:WBGene00012529	Y32F6A.4
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC38A8 (solute carrier family 38 member 8).

WB:WBGene00012530	Y32F6A.5
Is predicted to have serine-type carboxypeptidase activity. Is an ortholog of human SCPEP1 (serine carboxypeptidase 1).

WB:WBGene00012531	Y32F6B.1
Is predicted to have sodium-independent organic anion transmembrane transporter activity. Is an ortholog of human SLCO3A1 (solute carrier organic anion transporter family member 3A1).

WB:WBGene00012532	crp-1
Is predicted to have GTP binding activity; GTPase activity; and protein kinase binding activity. Localizes to recycling endosome and trans-Golgi network. Is expressed in several structures, including excretory cell; pharyngeal-intestinal valve; rectal epithelium; socket cell; and vulva.

WB:WBGene00012533	fbxa-209
Is enriched in ASER; OLL; PLM; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; antimycin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00012534	Y37A1A.1
No description available

WB:WBGene00012535	Y37A1A.2
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Heme; 1-methylnicotinamide; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00012536	Y37A1A.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A5 (solute carrier family 2 member 5).

WB:WBGene00012537	Y37A1B.4
Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00012538	Y37A1B.5
Is predicted to have selenium binding activity. Is an ortholog of human SELENBP1 (selenium binding protein 1).

WB:WBGene00012540	Y37A1B.7
Is enriched in germline precursor cell; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00012541	irld-55
Is affected by several genes including sir-2.1; spn-4; and drh-3 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012542	irld-56
Is affected by several genes including clk-1; sir-2.1; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00012543	nkcc-1
Is predicted to have sodium:potassium:chloride symporter activity. Is expressed in body wall musculature; intestine; neurons; oocyte; and vulval muscle. Human ortholog(s) of this gene are implicated in epilepsy (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SLC12A2 (solute carrier family 12 member 2) and SLC12A3 (solute carrier family 12 member 3).

WB:WBGene00012544	Y37D8A.2
Is predicted to have phospholipase activity. Is an ortholog of human PLBD2 (phospholipase B domain containing 2).

WB:WBGene00012545	Y37D8A.3
Is enriched in NSM; OLL; PVD; hypodermis; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Mianserin; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Abnormal cell migration protein 18-like.

WB:WBGene00012546	Y37D8A.4
Is enriched in germ line; germline precursor cell; intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Heme; Rotenone; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: SH2 domain; SH2 domain; and SH2 domain superfamily.

WB:WBGene00012547	Y37D8A.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including nicotinic acid; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interactor of ZYG-11 and Protein of unknown function DUF856, Caenorhabditis species.

WB:WBGene00012548	Y37D8A.6
Is enriched in intestine; muscle cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1C. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human LITAF (lipopolysaccharide induced TNF factor).

WB:WBGene00012549	Y37D8A.8
Is enriched in DA neuron; I5 neuron; SAB; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein.

WB:WBGene00012550	spcs-2
Is predicted to have peptidase activity. Is involved in IRE1-mediated unfolded protein response. Localizes to sarcoplasmic reticulum. Is used to study Parkinson's disease. Is an ortholog of human SPCS2 (signal peptidase complex subunit 2).

WB:WBGene00012551	cec-7
Is enriched in germ line; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including aldicarb; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; RNA binding activity-knot of a chromodomain; Chromo/chromo shadow domain; MRG; Chromo-like domain superfamily; and RNA binding activity-knot of a chromodomain. Is an ortholog of human MORF4L1 (mortality factor 4 like 1) and MORF4L2 (mortality factor 4 like 2).

WB:WBGene00012552	enu-3.5
Is enriched in OLL; RIM; germ line; and interneuron based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012553	cox-5A
Is predicted to have cytochrome-c oxidase activity. Is involved in mitochondrial electron transport, cytochrome c to oxygen. Is an ortholog of human COX5A (cytochrome c oxidase subunit 5A).

WB:WBGene00012554	Y37D8A.16
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00012555	npp-25
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised protein family (UPF0121) and TMEM33/Pom33 family. Is an ortholog of human TMEM33 (transmembrane protein 33).

WB:WBGene00012556	mrps-10
Is enriched in germ line and muscle cell based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ribosomal protein S10p/S20e; Ribosomal protein S10 domain; Ribosomal protein S10 domain superfamily; and 28S ribosomal protein S10, mitochondrial. Is an ortholog of human MRPS10 (mitochondrial ribosomal protein S10).

WB:WBGene00012557	Y37D8A.19
Is enriched in AVK and germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by thirteen chemicals including Heme; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012558	rbm-7
Is predicted to have single-stranded RNA binding activity. Is an ortholog of human RBM7 (RNA binding motif protein 7).

WB:WBGene00012559	epg-3
Is involved in macroautophagy and negative regulation of autophagosome assembly. Localizes to cytoplasm. Is expressed in body wall musculature and pharyngeal muscle cell. Is an ortholog of human VMP1 (vacuole membrane protein 1).

WB:WBGene00012560	Y37D8A.25
Is enriched in AFD; germ line; and intestine based on RNA-seq studies. Is affected by several genes including pgl-1; alg-1; and gld-2 based on tiling array; RNA-seq; and microarray studies. Is affected by hydrogen sulfide; Zidovudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PH domain; Pleckstrin homology domain; and PH-like domain superfamily. Is an ortholog of human PHETA1 (PH domain containing endocytic trafficking adaptor 1) and PHETA2 (PH domain containing endocytic trafficking adaptor 2).

WB:WBGene00012561	Y37D8A.26
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein.

WB:WBGene00012562	Y37H2A.1
Is predicted to have hydrolase activity, acting on ester bonds. Is an ortholog of human TATDN2 (TatD DNase domain containing 2).

WB:WBGene00012563	Y37H2A.3
No description available

WB:WBGene00012564	fbxa-107
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Mianserin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00012565	fbxa-210
Is enriched in DA neuron; VA neuron; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including manganese chloride; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00012566	fbxa-211
Is enriched in FLP; germ line; germline precursor cell; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00012567	Y37H2A.7
Is enriched in germline precursor cell based on RNA-seq studies. Is affected by several genes including elt-2; hsp-6; and gld-2 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00012568	fbxa-212
Is enriched in germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including manganese chloride; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012569	fbxc-46
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012570	Y37H2A.10
Is enriched in DA neuron; I5 neuron; SAB; VA neuron; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00012571	Y37H2A.11
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including eat-2; lin-35; and bar-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including aldicarb; hydrogen sulfide; and methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012572	Y37H2B.1
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00012573	Y37H2C.1
Is enriched in GABAergic neurons; OLL; PVD; and dopaminergic neurons based on microarray and tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is an ortholog of human SIDT1 (SID1 transmembrane family member 1).

WB:WBGene00012574	fbxa-213
Is affected by rsr-2; clk-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by dibromoacetic acid; tetrabromobisphenol A; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00012575	Y37H2C.4
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00012576	Y37H9A.1
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and hsf-1 based on RNA-seq and microarray studies. Is affected by Humic Substances and Sirolimus based on microarray studies.

WB:WBGene00012577	Y37H9A.2
Is affected by several genes including daf-2; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012578	Y37H9A.3
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is an ortholog of human CC2D1A (coiled-coil and C2 domain containing 1A).

WB:WBGene00012579	Y38E10A.1
Is affected by cyc-1 and rsr-2 based on microarray and tiling array studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00012580	Y38E10A.2
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by drh-3 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00012581	Y38E10A.3
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including diallyl trisulfide; Tunicamycin; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00012582	clec-8
Is predicted to have carbohydrate binding activity.

WB:WBGene00012583	clec-4
Is predicted to have carbohydrate binding activity.

WB:WBGene00012584	ceh-100
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity. Is expressed widely. Is an ortholog of human NOTO (notochord homeobox).

WB:WBGene00012585	lips-15
Is predicted to have lipase activity.

WB:WBGene00012586	Y38E10A.8
Is predicted to have eukaryotic translation initiation factor 2alpha kinase activity. Human ortholog(s) of this gene are implicated in Wolcott-Rallison syndrome. Is an ortholog of human EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) and EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3).

WB:WBGene00012587	Y38E10A.9
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and egl-9 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012588	lips-16
Is enriched in excretory cell and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00012589	nspe-4
Is enriched in germline precursor cell and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012590	nspe-3
Is enriched in body wall muscle cell; germline precursor cell; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012591	nspe-1
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirty-one chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012592	Y38E10A.14
Is enriched in PLM; germ line; hypodermis; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-two chemicals including hydrogen sulfide; Rifampin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012593	nspe-7
Is enriched in AFD; PLM; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including hydrogen sulfide; tryptophan; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012594	nspe-5
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; sir-2.1; and dpy-7 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012595	Y38E10A.17
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-six chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012596	nhr-234
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in congenital nongoitrous hypothyroidism 6.

WB:WBGene00012597	nhr-235
Is expressed in neurons. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00012600	Y38E10A.22
Is predicted to have adenyl-nucleotide exchange factor activity.

WB:WBGene00012602	Y38E10A.24
Is enriched in neurons and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including aldicarb; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00012603	nspe-6
Is enriched in arcade cell; pharyngeal-intestinal valve cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Tunicamycin; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012604	nspe-2
Is enriched in arcade cell; germline precursor cell; hypodermis; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00012605	Y38F1A.1
Is enriched in ALM; PLM; germ line; muscle cell; and in male based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including nicotinic acid; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00012606	Y38F1A.2
Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in autosomal dominant sensory ataxia 1. Is an ortholog of human RNF170 (ring finger protein 170).

WB:WBGene00012607	Y38F1A.4
Is affected by several genes including daf-2; let-60; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Sodium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00012608	hphd-1
Is predicted to have alcohol dehydrogenase (NAD+) activity and hydroxyacid-oxoacid transhydrogenase activity. Is an ortholog of human ADHFE1 (alcohol dehydrogenase iron containing 1).

WB:WBGene00012609	Y38F1A.7
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including tryptophan; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00012610	Y38F1A.8
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 4-bromodiphenyl ether; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family; Frag1/DRAM/Sfk1; and Post-GPI attachment to proteins factor 2.

WB:WBGene00012612	Y38H6A.1
Is affected by rsr-2; sir-2.1; and eat-2 based on tiling array and microarray studies. Is affected by procyanidin; Hydrolyzable Tannins; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012614	Y38H6A.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Sirolimus; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00012615	dct-16
Is enriched in cholinergic neurons; head mesodermal cell; intestine; pharyngeal cell; and retrovesicular ganglion based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Cyclosporine; dimedone; and Rotenone based on proteomic; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00012616	dct-14
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cilia BBSome complex subunit 10 and Cilia BBSome complex subunit 10. Is an ortholog of human BBIP1 (BBSome interacting protein 1).

WB:WBGene00012617	Y38H6C.4
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-16; let-60; and eat-2 based on tiling array and microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00012618	dct-10
Is enriched in AVK; DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Alovudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012619	Y38H6C.6
No description available

WB:WBGene00012620	Y38H6C.7
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including eat-2; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00012621	Y38H6C.8
Is predicted to have carbohydrate binding activity. Is an ortholog of human REG1A (regenerating family member 1 alpha) and REG3G (regenerating family member 3 gamma).

WB:WBGene00012622	Y38H6C.9
Is enriched in AVK; GABAergic neurons; NSM; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00012623	fbxa-149
Is enriched in NSM and RID based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00012624	fbxa-150
Is involved in innate immune response.

WB:WBGene00012625	Y38H6C.13
Is affected by several genes including eat-2; sir-2.1; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box protein she-1-like.

WB:WBGene00012626	famh-161
Localizes to axoneme; ciliary base; and ciliary transition zone. Is expressed in ciliated neurons. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 28. Is an ortholog of human FAM161B (FAM161 centrosomal protein B).

WB:WBGene00012627	Y38H6C.15
Is enriched in Z1.p; Z4.a; body wall muscle cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00012628	Y38H6C.16
Is predicted to have cholestenol delta-isomerase activity.

WB:WBGene00012629	slc-36.3
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC36A2 (solute carrier family 36 member 2); SLC36A3 (solute carrier family 36 member 3); and SLC36A4 (solute carrier family 36 member 4).

WB:WBGene00012630	Y38H6C.18
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is affected by Rifampin; Sirolimus; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012631	vmo-1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; npr-1; and sek-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Ethanol; Rotenone; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00012632	Y38H6C.20
Is predicted to have protein kinase activity. Is an ortholog of human STYK1 (serine/threonine/tyrosine kinase 1).

WB:WBGene00012633	Y38H6C.21
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; tryptophan; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00012634	Y38H6C.23
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including 1-methylnicotinamide; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00012635	Y38H8A.1
Is enriched in hypodermis and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012636	Y38H8A.2
Is predicted to have metal ion binding activity.

WB:WBGene00012637	Y38H8A.3
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 11. Is an ortholog of human TTBK1 (tau tubulin kinase 1) and TTBK2 (tau tubulin kinase 2).

WB:WBGene00012638	Y38H8A.4
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human TSSK1B (testis specific serine kinase 1B) and TSSK6 (testis specific serine kinase 6).

WB:WBGene00012639	fezf-1
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; rrf-3; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Rifampin; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 22 with or without anosmia and hypogonadotropic hypogonadism 7 with or without anosmia. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human FEZF1 (FEZ family zinc finger 1) and FEZF2 (FEZ family zinc finger 2).

WB:WBGene00012640	Y38H8A.7
Is enriched in germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00012641	epg-6
Exhibits phosphatidylinositol phosphate binding activity. Is involved in autophagosome assembly. Localizes to cytoplasm. Is expressed widely. Human ortholog(s) of this gene are implicated in neurodegeneration with brain iron accumulation 5. Is an ortholog of human WDR45 (WD repeat domain 45).

WB:WBGene00012642	Y39A1A.2
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00012643	Y39A1A.3
Is enriched in AFD; NSM; germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sjogren's syndrome/scleroderma autoantigen 1 (Autoantigen p27) and Sjoegren syndrome/scleroderma autoantigen 1. Is an ortholog of human ZNRD2 (zinc ribbon domain containing 2).

WB:WBGene00012644	rabx-5
Is predicted to have DNA binding activity and zinc ion binding activity. Is involved in endosomal vesicle fusion; molting cycle; and positive regulation of GTPase activity. Localizes to early endosome. Is an ortholog of human RABGEF1 (RAB guanine nucleotide exchange factor 1).

WB:WBGene00012645	mrpl-22
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL22 (mitochondrial ribosomal protein L22).

WB:WBGene00012646	lron-10
Is enriched in several structures, including RIS; dopaminergic neurons; germ line; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including gld-1; sir-2.1; and aak-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012647	swt-4
Is predicted to have sugar transmembrane transporter activity. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).

WB:WBGene00012648	Y39A1A.9
Is enriched in head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Meiosis-specific coiled-coil domain-containing protein MEIOC and Meiosis-specific coiled-coil domain-containing protein MEIOC. Is an ortholog of human MEIOC (meiosis specific with coiled-coil domain).

WB:WBGene00012649	Y39A1A.10
Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube and cadmium based on RNA-seq and microarray studies.

WB:WBGene00012650	orc-1
Is predicted to have DNA replication origin binding activity. Human ortholog(s) of this gene are implicated in Meier-Gorlin syndrome 1. Is an ortholog of human ORC1 (origin recognition complex subunit 1).

WB:WBGene00012651	orc-4
Is predicted to have DNA replication origin binding activity.

WB:WBGene00012652	Y39A1A.14
Is predicted to have rRNA (pseudouridine) methyltransferase activity and rRNA binding activity. Human ortholog(s) of this gene are implicated in Bowen-Conradi syndrome. Is an ortholog of human EMG1 (EMG1 N1-specific pseudouridine methyltransferase).

WB:WBGene00012653	C12C8.t2
No description available

WB:WBGene00012654	Y39A1A.16
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00012655	Y39A1A.17
Is affected by several genes including eat-2; sir-2.1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00012656	Y39A1A.18
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00012657	Y39A1A.20
Is enriched in germ line; head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-60; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00012658	Y39A1A.21
Exhibits protein-lysine N-methyltransferase activity. Is involved in peptidyl-lysine trimethylation; positive regulation of proton-transporting ATP synthase activity, rotational mechanism; and regulation of mitochondrial ATP synthesis coupled proton transport. Is an ortholog of human ATPSCKMT (ATP synthase c subunit lysine N-methyltransferase).

WB:WBGene00012659	Y39A1A.22
Is predicted to have inositol hexakisphosphate binding activity and phosphate ion transmembrane transporter activity. Is an ortholog of human XPR1 (xenotropic and polytropic retrovirus receptor 1).

WB:WBGene00012660	Y39A1A.24
Is enriched in body wall musculature; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including age-1; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012661	clec-163
Is predicted to have carbohydrate binding activity.

WB:WBGene00012662	Y39A1C.1
Localizes to striated muscle dense body. Is expressed in nerve ring. Is an ortholog of human TMIE (transmembrane inner ear).

WB:WBGene00012663	hex-3
Exhibits hexosaminidase activity. Is involved in carbohydrate metabolic process. Is expressed in intestine. Is an ortholog of human HEXD (hexosaminidase D).

WB:WBGene00012664	Y39B6A.1
Is enriched in head mesodermal cell; intestine; mechanosensory neurons; and muscle cell based on SAGE; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-seven chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Srp40/Nopp140.

WB:WBGene00012665	pph-5
Exhibits Hsp90 protein binding activity and phosphoprotein phosphatase activity. Is involved in negative regulation of exocytosis and protein localization to organelle. Localizes to cytoplasm; mitotic spindle; and protein-containing complex. Is expressed widely. Is an ortholog of human PPP5C (protein phosphatase 5 catalytic subunit).

WB:WBGene00012666	Y39B6A.3
Is predicted to have 2 iron, 2 sulfur cluster binding activity. Human ortholog(s) of this gene are implicated in multiple mitochondrial dysfunctions syndrome 5. Is an ortholog of human ISCA1 (iron-sulfur cluster assembly 1).

WB:WBGene00012668	Y39B6A.5
Is enriched in ASER; body wall muscle cell; coelomocyte; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq; microarray; and tiling array studies. Is affected by fourteen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00012669	Y39B6A.7
Is predicted to have triglyceride lipase activity.

WB:WBGene00012670	Y39B6A.8
Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00012671	Y39B6A.9
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including let-60; rrf-3; and let-7 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; D-glucose; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012672	Y39B6A.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including hydrogen sulfide; manganese chloride; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00012673	dyf-17
Localizes to ciliary transition zone. Is expressed in nervous system.

WB:WBGene00012674	bed-1
Is predicted to have DNA binding activity.

WB:WBGene00012675	Y39B6A.13
Is enriched in AFD; body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00012676	pro-3
Is enriched in body wall muscle cell and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by Rotenone; D-glucose; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NUC130/3NT domain; SDA1; SDA1 domain; Uncharacterised domain NUC130/133, N-terminal; Armadillo-type fold; and Sda1. Is an ortholog of human SDAD1 (SDA1 domain containing 1).

WB:WBGene00012678	zhp-4
Is predicted to have SUMO transferase activity. Is an ortholog of human RNF212 (ring finger protein 212) and RNF212B (ring finger protein 212B).

WB:WBGene00012679	Y39B6A.18
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00012680	Y39B6A.21
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Rotenone; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00012681	asp-15
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00012682	asp-16
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00012683	asp-17
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00012684	Y39B6A.25
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tudor domain; Tudor domain; SNase-like, OB-fold superfamily; and RING finger protein 17.

WB:WBGene00012686	Y39B6A.27
Is enriched in GABAergic neurons and excretory cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Ethanol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00012688	Y39B6A.29
Is enriched in GABAergic neurons; excretory cell; and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00012689	Y39B6A.30
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00012690	Y39B6A.31
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; manganese chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00012692	Y39B6A.33
Is predicted to have 5S rRNA binding activity. Is involved in positive regulation of cellular respiration. Localizes to nucleolus. Is an ortholog of human NOP53 (NOP53 ribosome biogenesis factor).

WB:WBGene00012693	Y39B6A.34
Is enriched in ASER; PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease. Is predicted to encode a protein with the following domains: Apoptogenic protein 1 and Cytochrome c oxidase assembly factor 8. Is an ortholog of human COA8 (cytochrome c oxidase assembly factor 8).

WB:WBGene00012694	gtf-2F2
Is predicted to have ATP binding activity; DNA binding activity; and DNA helicase activity. Is an ortholog of human GTF2F2 (general transcription factor IIF subunit 2).

WB:WBGene00012695	Y39B6A.37
Is enriched in several structures, including AFD; body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and lin-39 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012696	reps-1
Is expressed in excretory secretory system; intestine; muscle cell; somatic nervous system; and vulva. Is predicted to encode a protein with the following domains: Phosphorylation site; Cytoskeletal-regulatory complex EF hand; EH domain; and EF-hand domain pair. Is an ortholog of human REPS1 (RALBP1 associated Eps domain containing 1) and REPS2 (RALBP1 associated Eps domain containing 2).

WB:WBGene00012697	mrps-35
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS35 (mitochondrial ribosomal protein S35).

WB:WBGene00012698	sws-1
Is predicted to have zinc ion binding activity. Is an ortholog of human ZSWIM7 (zinc finger SWIM-type containing 7).

WB:WBGene00012699	Y39B6A.41
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00012700	Y39B6A.42
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00012701	Y39B6A.43
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; lin-35; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including D-glucose; stavudine; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00012702	ztf-20
Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Zidovudine; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00012703	nhr-145
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00012704	mlt-3
Is involved in ecdysis, collagen and cuticulin-based cuticle. Is an ortholog of human ANKS3 (ankyrin repeat and sterile alpha motif domain containing 3).

WB:WBGene00012705	sre-18
Is affected by several genes including daf-16; daf-12; and mex-3 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012706	sre-17
Is affected by vhl-1 based on microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00012707	sre-16
Is expressed in head. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012708	sre-19
Is affected by rsr-2 and adr-1 based on tiling array and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012709	sre-15
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including aldicarb; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012710	Y39C12A.9
Is enriched in muscle cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Chaperone J-domain superfamily.

WB:WBGene00012711	Y39E4A.1
Is enriched in DD neuron; GABAergic neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00012712	ttm-1
Is predicted to have zinc ion transmembrane transporter activity. Is involved in response to cadmium ion and response to nematicide. Is expressed in head neurons; hypodermis; seam cell; and vulva. Is an ortholog of human SLC30A8 (solute carrier family 30 member 8).

WB:WBGene00012713	bckd-1A
Is predicted to have alpha-ketoacid dehydrogenase activity. Human ortholog(s) of this gene are implicated in maple syrup urine disease. Is an ortholog of human BCKDHA (branched chain keto acid dehydrogenase E1 subunit alpha).

WB:WBGene00012714	abce-1
Is predicted to have ATP binding activity; iron ion binding activity; and ribosomal small subunit binding activity. Is expressed in several structures, including muscle cell; neurons; and vulva. Is an ortholog of human ABCE1 (ATP binding cassette subfamily E member 1).

WB:WBGene00012715	snpc-1.2
Is predicted to have sequence-specific DNA binding activity. Is an ortholog of human SNAPC1 (small nuclear RNA activating complex polypeptide 1).

WB:WBGene00012716	Y39E4B.5
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00012717	Y39E4B.6
Is predicted to have cyclin-dependent protein serine/threonine kinase inhibitor activity and snRNA binding activity.

WB:WBGene00012718	dhhc-8
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human ZDHHC5 (zinc finger DHHC-type palmitoyltransferase 5) and ZDHHC8 (zinc finger DHHC-type palmitoyltransferase 8).

WB:WBGene00012719	Y39E4B.10
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; isp-1; and sma-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00012720	Y39E4B.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012721	Y39E4B.13
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Diazinon; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00012722	Y39G8B.1
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis and congenital bile acid synthesis defect 2. Is an ortholog of human AKR1B1 (aldo-keto reductase family 1 member B).

WB:WBGene00012723	Y39G8B.2
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2. Is an ortholog of human AKR1A1 (aldo-keto reductase family 1 member A1).

WB:WBGene00012724	sre-48
Is affected by several genes including daf-16; eat-2; and eri-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012725	sre-47
Is expressed in head. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00012726	Y39G8B.5
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in FTDALS4. Is an ortholog of human IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon) and TBK1 (TANK binding kinase 1).

WB:WBGene00012727	Y39G8B.7
Is enriched in OLL; PVD; intestine; and male-specific anatomical entity based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Heme; Tunicamycin; and TPEN based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00012728	Y39G8B.9
Is enriched in head mesodermal cell; intestine; pharyngeal muscle cell; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; tiling array; and microarray studies. Is affected by thirteen chemicals including 1-methylnicotinamide; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00012729	Y39G8B.10
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00012730	xrn-1
Is predicted to have 5'-3' exonuclease activity and RNA binding activity. Is involved in determination of adult lifespan and negative regulation of cytoplasmic mRNA processing body assembly. Is expressed in hypodermis and rectum. Is an ortholog of human XRN1 (5'-3' exoribonuclease 1).

WB:WBGene00012731	Y39G8C.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00012732	Y40B1A.1
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: WW domain; WW domain; WW domain superfamily; and WW domain-containing adapter protein with coiled-coil.

WB:WBGene00012734	Y40B1A.3
Is enriched in OLL; PVD; arcade cell; and pharyngeal-intestinal valve cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rotenone and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012735	sptf-3
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and chromatin binding activity. Is involved in several processes, including generation of neurons; nematode larval development; and positive regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in several structures, including MSpaa; g1AR; hypodermal cell; pharyngeal cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including chromosome 15q13.3 microdeletion syndrome; maturity-onset diabetes of the young type 7; and prostate cancer. Is an ortholog of human SP6 (Sp6 transcription factor).

WB:WBGene00012738	eif-3.J
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF3J (eukaryotic translation initiation factor 3 subunit J).

WB:WBGene00012739	Y40B1B.7
Localizes to nucleolus. Is expressed in ventral nerve cord. Is an ortholog of human CCDC86 (coiled-coil domain containing 86).

WB:WBGene00012740	slc-25A46
Is enriched in NSM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 6. Is predicted to encode a protein with the following domains: Phosphorylation site; Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; Mitochondrial carrier domain superfamily; and Solute carrier family 25 member 46. Is an ortholog of human SLC25A46 (solute carrier family 25 member 46).

WB:WBGene00012741	Y40H4A.2
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00012742	Y40H7A.2
Is affected by several genes including pmk-1; daf-19; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by dibromoacetic acid; Colistin; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; and Methyltransferase-like protein 24.

WB:WBGene00012743	Y40H7A.3
Is affected by several genes including daf-16; daf-12; and aak-2 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; and Methyltransferase-like protein 24.

WB:WBGene00012744	Y40H7A.4
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; Methyltransferase-like protein 24; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00012745	Y40H7A.7
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00012746	Y40H7A.9
Is enriched in DA neuron; NSM; VA neuron; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00012747	Y40H7A.10
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSF (cathepsin F).

WB:WBGene00012748	Y40H7A.11
Is enriched in AVE and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1C. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human CDIP1 (cell death inducing p53 target 1).

WB:WBGene00012749	Y41C4A.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012750	faah-6
Is predicted to have amidase activity and fatty acid amide hydrolase activity. Is an ortholog of human FAAH (fatty acid amide hydrolase).

WB:WBGene00012752	C12C8.t3
No description available

WB:WBGene00012753	Y41C4A.6
Is enriched in neurons and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00012754	Y41C4A.7
Is enriched in AVK; NSM; somatic gonad precursor; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PapD-like superfamily and Immunoglobulin-like fold.

WB:WBGene00012755	Y41C4A.8
Is involved in innate immune response. Is an ortholog of human TP53I13 (tumor protein p53 inducible protein 13).

WB:WBGene00012756	Y41C4A.9
Is predicted to have U3 snoRNA binding activity and rRNA binding activity. Is an ortholog of human UTP25 (UTP25 small subunit processor component).

WB:WBGene00012757	Y41C4A.11
Is involved in IRE1-mediated unfolded protein response. Is expressed in pharynx.

WB:WBGene00012758	Y41C4A.12
Is enriched in excretory cell; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00012759	sup-1
Localizes to neuron projection; neuronal cell body membrane; and synapse. Is expressed in body wall musculature; neurons; and ventral nerve cord.

WB:WBGene00012760	Y41C4A.17
Is enriched in AVK; RIS; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012761	Y41C4A.18
Is enriched in cephalic sheath cell based on tiling array studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00012762	Y41E3.1
Is predicted to have catalytic activity.

WB:WBGene00012763	atln-2
Is predicted to have GTP binding activity and GTPase activity. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in hereditary sensory neuropathy type 1D; hereditary sensory neuropathy type 1F; and hereditary spastic paraplegia 3A. Is an ortholog of human ATL2 (atlastin GTPase 2).

WB:WBGene00012764	Y41E3.6
Is enriched in GABAergic neurons; head mesodermal cell; and sensory neurons based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and nhr-25 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00012765	Y41E3.7
Is predicted to have fatty-acyl-CoA binding activity. Is an ortholog of human ACBD3 (acyl-CoA binding domain containing 3).

WB:WBGene00012766	Y41E3.8
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human SELENOK (selenoprotein K).

WB:WBGene00012767	fcd-2
Is predicted to have DNA polymerase binding activity. Is involved in nucleotide-excision repair and regulation of DNA-dependent DNA replication. Localizes to nucleus. Is expressed in germ line. Is used to study Fanconi anemia. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group D2. Is an ortholog of human FANCD2 (FA complementation group D2).

WB:WBGene00012768	eef-1B.2
Is predicted to have guanyl-nucleotide exchange factor activity. Is an ortholog of human EEF1B2 (eukaryotic translation elongation factor 1 beta 2) and FDXACB1 (ferredoxin-fold anticodon binding domain containing 1).

WB:WBGene00012769	hrpu-1
Is enriched in AVE; OLL; PLM; PVD; and germ line based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; Rotenone; and Cry5B based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 54. Is predicted to encode a protein with the following domains: SPRY domain; AAA domain; SPRY domain; Concanavalin A-like lectin/glucanase domain superfamily; P-loop containing nucleoside triphosphate hydrolase; and B30.2/SPRY domain superfamily. Is an ortholog of human HNRNPU (heterogeneous nuclear ribonucleoprotein U) and HNRNPUL1 (heterogeneous nuclear ribonucleoprotein U like 1).

WB:WBGene00012770	srt-47
Is expressed in AWC-OFF and head neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00012771	Y41E3.13
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012772	srt-49
Is affected by several genes including eat-2; aak-2; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00012773	srt-48
Is affected by several genes including eat-2; mir-34; and meg-3 based on microarray and RNA-seq studies. Is affected by tryptophan and Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00012775	srt-50
Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00012776	Y42A5A.1
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is an ortholog of human ERAP1 (endoplasmic reticulum aminopeptidase 1) and ERAP2 (endoplasmic reticulum aminopeptidase 2).

WB:WBGene00012777	lact-8
Is enriched in AFD; ASER; hypodermis; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including levamisole; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00012778	Y42A5A.3
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; levamisole; and procyanidin based on microarray and RNA-seq studies.

WB:WBGene00012779	cdkl-1
Is predicted to have cyclin-dependent protein serine/threonine kinase activity. Is involved in non-motile cilium assembly and regulation of cilium assembly. Localizes to ciliary transition zone. Is expressed in amphid neurons and phasmid neurons. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 12. Is an ortholog of human CDKL1 (cyclin dependent kinase like 1).

WB:WBGene00012780	Y42A5A.5
Is enriched in cephalic sheath cell; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including alg-1; dpy-21; and hpl-2 based on RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Complex 1 protein (LYR family) and Complex 1 LYR protein. Is an ortholog of human ETFRF1 (electron transfer flavoprotein regulatory factor 1).

WB:WBGene00012781	nspd-7
Is enriched in intestine and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00012782	Y43C5A.2
Is enriched in OLL; PVD; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Fibrinogen beta and gamma chains, C-terminal globular domain; Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain; and Fibrinogen-like, C-terminal.

WB:WBGene00012783	Y43C5A.3
Exhibits double-stranded DNA binding activity. Is involved in defense response to Gram-negative bacterium and killing of cells of other organism. Is expressed in hyp7 syncytium and ventral cord blast cell.

WB:WBGene00012784	Y43C5A.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Mianserin; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00012785	Y43C5B.2
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00012786	Y43C5B.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; and Mitochondrial carrier domain superfamily. Is an ortholog of human SLC25A44 (solute carrier family 25 member 44).

WB:WBGene00012787	Y43D4A.1
Is predicted to have neurotransmitter:sodium symporter activity. Human ortholog(s) of this gene are implicated in several diseases, including Hartnup disease; creatine transporter deficiency; and postural orthostatic tachycardia syndrome.

WB:WBGene00012788	Y43D4A.2
Is predicted to have UDP-glycosyltransferase activity.

WB:WBGene00012789	Y43D4A.3
Is predicted to have cofactor transmembrane transporter activity.

WB:WBGene00012790	Y43D4A.4
Is predicted to have cofactor transmembrane transporter activity. Is an ortholog of human SLC49A3 (solute carrier family 49 member 3).

WB:WBGene00012791	Y43D4A.5
Is enriched in AVK; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Heme; hydrogen sulfide; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00012792	Y43D4A.6
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 54; glycogen storage disease IXc; and hypertrophic cardiomyopathy 1. Is an ortholog of human CHEK1 (checkpoint kinase 1).

WB:WBGene00012793	Y43D4A.7
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00012794	Y43E12A.2
Localizes to mitochondrion. Is an ortholog of human ZCCHC24 (zinc finger CCHC-type containing 24).

WB:WBGene00012795	Y43E12A.3
Is enriched in germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by eleven chemicals including bisphenol S; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00012796	Y43F4A.1
Is predicted to have peptidase activity. Is an ortholog of human LMLN (leishmanolysin like peptidase).

WB:WBGene00012797	Y43F4A.2
No description available

WB:WBGene00012798	Y43F4A.3
Is expressed in head neurons and intestinal cell.

WB:WBGene00012799	Y43F4A.4
Is predicted to have 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity and alpha-ketoacid dehydrogenase activity.

WB:WBGene00012801	Y43F4B.2
No description available

WB:WBGene00012802	set-25
Is predicted to have metal ion binding activity and methyltransferase activity. Localizes to nuclear heterochromatin. Is expressed in hypodermis; intestine; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 2; and autosomal dominant non-syndromic intellectual disability (multiple).

WB:WBGene00012803	Y43F4B.5
Is predicted to have intramolecular transferase activity, phosphotransferases and metal ion binding activity. Localizes to nucleus. Is an ortholog of human PGM2 (phosphoglucomutase 2).

WB:WBGene00012804	slc-36.1
Is predicted to have amino acid transmembrane transporter activity. Is expressed in head and hypodermis. Is an ortholog of human SLC36A4 (solute carrier family 36 member 4).

WB:WBGene00012806	Y43F4B.9
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq; tiling array; and microarray studies. Is affected by five chemicals including hydrogen sulfide; Zidovudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human DPH7 (diphthamide biosynthesis 7).

WB:WBGene00012807	Y43F4B.10
Is enriched in body wall muscle cell; dopaminergic neurons; germ line; hypodermis; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Human CDK2AP1 exhibits DNA polymerase binding activity. Is predicted to encode a protein with the following domains: Cyclin-dependent kinase 2-associated protein and Cyclin-dependent kinase 2-associated protein 1/2. Is an ortholog of human CDK2AP1 (cyclin dependent kinase 2 associated protein 1) and CDK2AP2 (cyclin dependent kinase 2 associated protein 2).

WB:WBGene00012808	Y43F8A.1
Is enriched in GABAergic neurons; OLL; PVD; dopaminergic neurons; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; daf-19; and dpy-21 based on RNA-seq and microarray studies. Is affected by six chemicals including Mercuric Chloride; multi-walled carbon nanotube; and Cadmium Chloride based on microarray and RNA-seq studies.

WB:WBGene00012809	Y43F8A.2
Is enriched in germ line; neurons; retrovesicular ganglion; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00012810	nceh-1
Is predicted to have hydrolase activity. Is an ortholog of human AADAC (arylacetamide deacetylase); AADACL2 (arylacetamide deacetylase like 2); and NCEH1 (neutral cholesterol ester hydrolase 1).

WB:WBGene00012811	slcr-46.2
Is enriched in several structures, including NSM; amphid sheath cell; body wall musculature; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hereditary folate malabsorption. Is predicted to encode a protein with the following domain: MFS transporter superfamily. Is an ortholog of human SLC46A1 (solute carrier family 46 member 1) and SLC46A3 (solute carrier family 46 member 3).

WB:WBGene00012812	Y43F8B.1
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on proteomic; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012813	Y43F8B.2
Is involved in innate immune response. Localizes to striated muscle dense body. Is expressed in several structures, including nerve ring; tail hypodermis; and ventral nerve cord. Is an ortholog of human GSKIP (GSK3B interacting protein).

WB:WBGene00012814	Y43F8B.3
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human SPINT2 (serine peptidase inhibitor, Kunitz type 2).

WB:WBGene00012815	phy-4
Contributes to peptidyl-proline 4-dioxygenase activity. Is involved in peptidyl-proline hydroxylation to 4-hydroxy-L-proline. Localizes to procollagen-proline 4-dioxygenase complex. Is expressed in excretory duct; pharyngeal gland cell; and pharyngeal-intestinal valve.

WB:WBGene00012816	scl-21
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human CRISP1 (cysteine rich secretory protein 1); CRISP2 (cysteine rich secretory protein 2); and CRISP3 (cysteine rich secretory protein 3).

WB:WBGene00012817	Y43F8B.6
Is affected by hpl-2 based on tiling array studies. Is affected by adsorbable organic bromine compound and Sirolimus based on microarray studies.

WB:WBGene00012818	Y43F8B.7
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00012819	Y43F8B.9
Is enriched in hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; Rotenone; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00012820	Y43F8B.10
Is enriched in neurons and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and lin-39 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00012821	Y43F8B.11
Is enriched in body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and hsp-6 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00012822	Y43F8B.12
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; bisphenol S; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012823	Y43F8B.13
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012824	Y43F8B.14
Is predicted to have ATP binding activity.

WB:WBGene00012825	Y43F8C.3
Is enriched in intestine; male-specific anatomical entity; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; Tunicamycin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00012826	dyf-19
Is involved in non-motile cilium assembly. Localizes to ciliary basal body. Is expressed in ciliated neurons. Is an ortholog of human FBF1 (Fas binding factor 1).

WB:WBGene00012827	Y43F8C.5
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012828	Y43F8C.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including hsf-1; pmk-1; and sek-1 based on RNA-seq and microarray studies. Is affected by Rotenone and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Chromatin complexes subunit BAP18. Is an ortholog of human C17orf49 (chromosome 17 open reading frame 49).

WB:WBGene00012829	Y43F8C.7
Is enriched in excretory cell; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by cadmium and allantoin based on microarray studies. Is predicted to encode a protein with the following domain: ER membrane protein complex subunit 10. Is an ortholog of human EMC10 (ER membrane protein complex subunit 10).

WB:WBGene00012830	mrps-28
Is enriched in ASER; germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by Rifampin; allantoin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial ribosomal protein MRP-S35 and Ribosomal protein S28, mitochondrial. Is an ortholog of human MRPS28 (mitochondrial ribosomal protein S28).

WB:WBGene00012831	Y43F8C.9
Is enriched in arcade cell; pharyngeal-intestinal valve cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00012832	dmd-3
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is involved in several processes, including nematode male tail tip morphogenesis; neuron differentiation; and regulation of gene expression. Localizes to neuronal cell body. Is expressed in several structures, including PHC; epithelial cell; gonad; ray neuron type A; and tail hypodermis. Is an ortholog of human DMRT2 (doublesex and mab-3 related transcription factor 2).

WB:WBGene00012833	Y43F8C.11
Is enriched in AFD; ASER; dopaminergic neurons; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sid-5 family and Systemic RNA interference defective protein 5.

WB:WBGene00012834	Y43F8C.13
Is predicted to have metal ion binding activity.

WB:WBGene00012835	ani-3
Is predicted to have GTP-Rho binding activity. Human ortholog(s) of this gene are implicated in focal segmental glomerulosclerosis 8. Is an ortholog of human ANLN (anillin actin binding protein).

WB:WBGene00012836	Y43F8C.15
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by cyc-1; hpl-2; and rsr-2 based on microarray and tiling array studies.

WB:WBGene00012837	Y43F8C.16
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00012838	Y43F8C.17
Is affected by several genes including clk-1; smg-2; and unc-70 based on microarray and RNA-seq studies. Is affected by nine chemicals including aldicarb; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00012839	Y43F8C.18
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including clk-1; aak-2; and hpl-2 based on microarray and RNA-seq studies. Is affected by six chemicals including bisphenol A; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00012840	grsp-1
Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; bisphenol A; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012841	Y43F11A.1
Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012844	Y43F11A.4
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012845	set-24
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 23. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545); SET domain; and SPK domain.

WB:WBGene00012846	srxa-14
Is expressed in ADLL; ADLR; AIML; and AIMR. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00012847	srxa-15
Is affected by several genes including daf-2; sir-2.1; and hsp-6 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and glycine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00012848	Y44A6B.3
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; D-glucose; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012849	ttr-13
Is affected by several genes including sir-2.1; eri-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00012850	Y44A6C.1
Is enriched in head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; levamisole; and tert-Butylhydroperoxide based on microarray and RNA-seq studies.

WB:WBGene00012851	Y44A6C.2
Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012852	Y44A6D.1
Is enriched in AVK and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00012853	Y44A6D.2
Is enriched in head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and elt-2 based on proteomic; microarray; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; sesamin; and nanoparticle based on RNA-seq and microarray studies.

WB:WBGene00012854	Y44A6D.3
Is expressed in body wall musculature. Is predicted to encode a protein with the following domain: Winged helix-like DNA-binding domain superfamily.

WB:WBGene00012855	Y44A6D.5
Is predicted to have branched-chain-amino-acid transaminase activity. Is an ortholog of human BCAT1 (branched chain amino acid transaminase 1) and BCAT2 (branched chain amino acid transaminase 2).

WB:WBGene00012856	Y44A6D.6
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including pgl-1; csr-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00012857	pbo-5
Exhibits extracellular ligand-gated ion channel activity. Is involved in several processes, including defecation; lipid transport involved in lipid storage; and positive regulation of intestinal lipid absorption. Is expressed in RIFL; RIFR; RIS; and body wall musculature.

WB:WBGene00012858	Y44F5A.1
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; WD repeat protein 55; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR55 (WD repeat domain 55).

WB:WBGene00012859	Y45F3A.1
Is enriched in DA neuron; germ line; interneuron; retrovesicular ganglion; and in male based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including manganese chloride; Mianserin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00012860	acdh-11
Is predicted to have nucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Is expressed in head. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6 and peroxisomal acyl-CoA oxidase deficiency.

WB:WBGene00012861	Y45F3A.4
Is enriched in head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and lin-35 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00012862	Y45F3A.5
Is affected by several genes including clk-1; aak-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by dafa#1 and allantoin based on microarray studies.

WB:WBGene00012863	Y45F3A.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00012864	Y45F3A.9
Is predicted to have RNA binding activity and RNA methyltransferase activity. Is an ortholog of human MRM1 (mitochondrial rRNA methyltransferase 1).

WB:WBGene00012866	afmd-2
Is predicted to have arylformamidase activity. Is an ortholog of human AFMID (arylformamidase).

WB:WBGene00012867	seld-1
Is predicted to have selenide, water dikinase activity. Is an ortholog of human SEPHS1 (selenophosphate synthetase 1) and SEPHS2 (selenophosphate synthetase 2).

WB:WBGene00012868	tbc-9
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of several human genes including TBC1D8 (TBC1 domain family member 8); TBC1D8B (TBC1 domain family member 8B); and TBC1D9 (TBC1 domain family member 9).

WB:WBGene00012869	Y45F10A.7
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity.

WB:WBGene00012870	Y45F10B.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride; paraquat; and Colistin based on microarray studies.

WB:WBGene00012871	Y45F10B.3
Is enriched in amphid sheath cell; arcade cell; pharyngeal-intestinal valve cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including manganese chloride; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012872	Y45F10B.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00012873	Y45F10B.9
Is affected by several genes including daf-2; pgl-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00012874	Y45F10B.12
Is affected by several genes including clk-1; sir-2.1; and pmk-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00012875	Y45F10B.13
Is enriched in AFD; body wall muscle cell; germ line; head mesodermal cell; and muscle cell based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including 1-methylnicotinamide; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012876	Y45F10B.15
Is affected by several genes including pgl-1; aak-2; and glh-1 based on tiling array and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00012877	Y45F10C.1
Is enriched in AFD and in male based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00012878	Y45F10C.2
Is expressed in uterine epithelial cell. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1505) and Protein of unknown function DUF1505.

WB:WBGene00012879	fbxa-215
Is enriched in several structures, including AFD; germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00012880	Y45F10C.4
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by twenty chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1505) and Protein of unknown function DUF1505.

WB:WBGene00012881	Y45F10C.5
No description available

WB:WBGene00012882	Y45F10D.1
No description available

WB:WBGene00012883	Y45F10D.2
Is affected by several genes including skn-1; rrf-3; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00012885	iscu-1
Is predicted to have 2 iron, 2 sulfur cluster binding activity; 4 iron, 4 sulfur cluster binding activity; and ferrous iron binding activity. Is an ortholog of human ISCU (iron-sulfur cluster assembly enzyme).

WB:WBGene00012886	Y45F10D.6
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including tryptophan; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012887	Y45F10D.7
Is enriched in germ line; seam cell; and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including bisphenol S; bisphenol A; and Atrazine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in open-angle glaucoma. Is predicted to encode a protein with the following domains: Anaphase-promoting complex subunit 4 WD40 domain; Utp21 specific WD40 associated putative domain; WD40 repeat; Small-subunit processome, Utp21; Anaphase-promoting complex subunit 4, WD40 domain; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR36 (WD repeat domain 36).

WB:WBGene00012888	sas-6
Exhibits identical protein binding activity and protein domain specific binding activity. Is involved in centriole replication; protein localization; and regulation of cell cycle. Localizes to centriole and cytoplasm.

WB:WBGene00012889	icap-1
Is enriched in dopaminergic neurons; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including sir-2.1; lin-35; and prg-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: PH-like domain superfamily. Is an ortholog of human ITGB1BP1 (integrin subunit beta 1 binding protein 1).

WB:WBGene00012890	lact-9
Is enriched in intestine; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on proteomic; microarray; and RNA-seq studies. Is affected by four chemicals including antimycin; Atrazine; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like. Is an ortholog of human LACTB (lactamase beta).

WB:WBGene00012891	sorb-1
Is involved in maintenance of mitochondrion location and sarcomere organization. Localizes to dense body; focal adhesion; and plasma membrane. Is expressed in body wall musculature; non-striated muscle; and uterus. Human ortholog(s) of this gene are implicated in autosomal recessive chronic granulomatous disease cytochrome b-positive type III. Is an ortholog of human SORBS2 (sorbin and SH3 domain containing 2) and SORBS3 (sorbin and SH3 domain containing 3).

WB:WBGene00012892	Y45F10D.14
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012893	Y45F10D.15
Is enriched in neurons based on tiling array studies. Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray and RNA-seq studies.

WB:WBGene00012894	tbc-17
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human USP6NL (USP6 N-terminal like).

WB:WBGene00012895	cox-10
Is predicted to have farnesyltranstransferase activity. Human ortholog(s) of this gene are implicated in Leigh disease and cytochrome-c oxidase deficiency disease. Is an ortholog of human COX10 (cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10).

WB:WBGene00012896	snrp-200
Is predicted to have RNA binding activity and RNA helicase activity. Is expressed in excretory cell; gonad; head ganglion; intestine; and pharynx. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 33. Is an ortholog of human SNRNP200 (small nuclear ribonucleoprotein U5 subunit 200).

WB:WBGene00012897	pisy-1
Is predicted to have CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity. Is an ortholog of human CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase).

WB:WBGene00012898	Y46G5A.6
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012899	Y46G5A.7
Is enriched in several structures, including germ line; head mesodermal cell; male distal tip cell; pharynx; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; bisphenol S; and Linolenic Acids based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00012900	Y46G5A.8
Is enriched in several structures, including Z4.a; germ line; head mesodermal cell; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; methylmercury hydroxide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00012901	cnp-2
Is expressed in intestine. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012903	vps-2
Localizes to cytoplasm. Is expressed in tail. Is an ortholog of human CHMP2A (charged multivesicular body protein 2A).

WB:WBGene00012904	tiar-2
Is predicted to have mRNA binding activity. Is involved in several processes, including determination of adult lifespan; hyperosmotic response; and nematode larval development. Localizes to cytoplasmic stress granule and nucleus. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human TIA1 (TIA1 cytotoxic granule associated RNA binding protein) and TIAL1 (TIA1 cytotoxic granule associated RNA binding protein like 1).

WB:WBGene00012905	Y46G5A.14
Is enriched in I5 neuron; cholinergic neurons; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; antimycin; and cadmium based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012906	Y46G5A.15
Is enriched in NSM; head mesodermal cell; muscle cell; and neurons based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Cry5B; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00012907	cpt-1
Is predicted to have carnitine O-palmitoyltransferase activity. Human ortholog(s) of this gene are implicated in carnitine palmitoyltransferase I deficiency and hereditary spastic paraplegia 73. Is an ortholog of human CPT1A (carnitine palmitoyltransferase 1A) and CPT1B (carnitine palmitoyltransferase 1B).

WB:WBGene00012908	Y46G5A.18
Is predicted to have nucleic acid binding activity. Is an ortholog of human R3HDM4 (R3H domain containing 4).

WB:WBGene00012909	spds-1
Is predicted to have spermidine synthase activity. Is an ortholog of human SRM (spermidine synthase).

WB:WBGene00012910	Y46G5A.20
Is enriched in intestine; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00012911	acl-7
Is predicted to have glycerone-phosphate O-acyltransferase activity. Human ortholog(s) of this gene are implicated in rhizomelic chondrodysplasia punctata type 2. Is an ortholog of human GNPAT (glyceronephosphate O-acyltransferase).

WB:WBGene00012912	Y46G5A.22
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00012913	Y46G5A.23
Is affected by isp-1; eat-2; and nhl-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00012914	bcmo-1
Is predicted to have beta-carotene 15,15'-monooxygenase activity; carotenoid dioxygenase activity; and retinal isomerase activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 2; carotenemia; and retinitis pigmentosa 20. Is an ortholog of human BCO1 (beta-carotene oxygenase 1).

WB:WBGene00012915	lgc-35
Is predicted to have chloride channel activity. Is expressed in head mesodermal cell; neurons; non-striated muscle; and in male.

WB:WBGene00012916	Y46G5A.28
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Pes-10 and Pes-10.

WB:WBGene00012917	Y46G5A.29
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis.

WB:WBGene00012918	Y46G5A.32
No description available

WB:WBGene00012919	Y46G5A.34
Is enriched in several structures, including I5 neuron; cholinergic neurons; intestine; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012920	alkb-7
Is enriched in NSM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: 2OG-Fe(II) oxygenase superfamily; Alpha-ketoglutarate-dependent dioxygenase AlkB-like; Alpha-ketoglutarate-dependent dioxygenase alkB homologue 7; and Alpha-ketoglutarate-dependent dioxygenase AlkB-like superfamily. Is an ortholog of human ALKBH7 (alkB homolog 7).

WB:WBGene00012921	Y46G5A.36
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; manganese chloride; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012922	Y47D3A.1
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00012923	fbxa-128
Is expressed in pharyngeal-intestinal valve. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00012924	Y47D3A.5
Is enriched in I5 neuron; cholinergic neurons; head mesodermal cell; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00012925	wht-8
Is predicted to have ATPase-coupled transmembrane transporter activity. Is an ortholog of human ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)).

WB:WBGene00012926	Y47D3A.13
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00012927	Y47D3A.14
Is predicted to have tRNA-specific adenosine-34 deaminase activity. Is expressed in pharyngeal gland cell and pm7. Is an ortholog of human ADAT3 (adenosine deaminase tRNA specific 3).

WB:WBGene00012928	aakb-2
Is predicted to contribute to AMP-activated protein kinase activity. Is an ortholog of human PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2).

WB:WBGene00012929	rsks-1
Is predicted to have ribosomal protein S6 kinase activity. Is involved in several processes, including determination of adult lifespan; nematode larval development; and positive regulation of autophagosome assembly. Is expressed in several structures, including Eala; Ealaa; Ealp; Earaa; and Earp. Is an ortholog of human RPS6KB2 (ribosomal protein S6 kinase B2).

WB:WBGene00012930	obr-1
Is predicted to have sterol binding activity and sterol transporter activity. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 67. Is an ortholog of human OSBP (oxysterol binding protein) and OSBP2 (oxysterol binding protein 2).

WB:WBGene00012931	Y47D3A.20
Is enriched in germ line; head mesodermal cell; neurons; pharynx; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; aak-2; and sma-4 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00012932	Y47D3A.21
Is predicted to have mRNA binding activity. Is an ortholog of human DENR (density regulated re-initiation and release factor).

WB:WBGene00012933	mib-1
Is predicted to have ubiquitin-protein transferase activity. Is expressed in vulva. Is an ortholog of human MIB1 (mindbomb E3 ubiquitin protein ligase 1) and MIB2 (mindbomb E3 ubiquitin protein ligase 2).

WB:WBGene00012934	gly-9
Is predicted to have carbohydrate binding activity; metal ion binding activity; and transferase activity, transferring glycosyl groups. Human ortholog(s) of this gene are implicated in hyperphosphatemic familial tumoral calcinosis.

WB:WBGene00012935	mcm-10
Is predicted to have DNA replication origin binding activity and single-stranded DNA binding activity. Is an ortholog of human MCM10 (minichromosome maintenance 10 replication initiation factor).

WB:WBGene00012936	pola-1
Is predicted to have several functions, including DNA binding activity; DNA-directed DNA polymerase activity; and nucleotide binding activity. Is an ortholog of human POLA1 (DNA polymerase alpha 1, catalytic subunit).

WB:WBGene00012937	Y47D3A.31
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; tryptophan; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00012938	Y47D3A.32
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and bar-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00012939	subs-4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00012940	Y47D3B.3
Is affected by several genes including clk-1; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Alovudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Abnormal cell migration protein 18-like.

WB:WBGene00012941	Y47D3B.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00012942	Y47D3B.6
Is enriched in DA neuron and pharyngeal muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EB module and EB domain.

WB:WBGene00012943	bed-2
Is predicted to have DNA binding activity.

WB:WBGene00012945	Y47H9A.1
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00012946	Y47H9B.2
Is enriched in NSM; body wall muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00012947	Y47H9C.1
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-eight chemicals including Heme; hydrogen sulfide; and Nitric Oxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00012948	dhhc-2
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Raymond type. Is an ortholog of human ZDHHC9 (zinc finger DHHC-type palmitoyltransferase 9).

WB:WBGene00012949	Y47H9C.3
No description available

WB:WBGene00012950	eif-2Bbeta
Is predicted to contribute to guanyl-nucleotide exchange factor activity. Human ortholog(s) of this gene are implicated in leukoencephalopathy with vanishing white matter. Is an ortholog of human EIF2B2 (eukaryotic translation initiation factor 2B subunit beta).

WB:WBGene00012951	Y47H9C.8
Is enriched in arcade cell; germ line; germline precursor cell; mechanosensory neurons; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Protein canopy homolog.

WB:WBGene00012952	Y47H9C.9
Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1280) and Protein of unknown function DUF1280.

WB:WBGene00012953	fbxa-216
Is enriched in OLL; PLM; PVD; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00012954	fbxa-217
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00012955	Y47H9C.12
Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase and Mos1 transposase, HTH domain.

WB:WBGene00012956	Y47H9C.14
Is affected by several genes including daf-12; eat-2; and smg-2 based on tiling array and RNA-seq studies. Is affected by ten chemicals including Rotenone; multi-walled carbon nanotube; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00012958	Y47H10A.2
Is enriched in Z1; Z4; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00012959	Y47H10A.3
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Tunicamycin; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: RAI1-like family. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00012960	Y47H10A.4
Is enriched in head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; hsf-1; and lin-39 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Zidovudine; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: RAI1-like family. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00012961	Y47H10A.5
Is expressed in intestine. Is predicted to encode a protein with the following domain: RAI1-like family.

WB:WBGene00012962	dmsr-5
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00012964	Y48A6B.3
Is predicted to have box H/ACA snoRNA binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive dyskeratosis congenita 1 and autosomal recessive dyskeratosis congenita 2. Is an ortholog of human NHP2 (NHP2 ribonucleoprotein).

WB:WBGene00012965	fipr-17
Is expressed in vas deferens. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00012966	exos-1
Localizes to cytoplasm and nucleus. Is expressed in head. Is an ortholog of human EXOSC1 (exosome component 1).

WB:WBGene00012967	kvs-4
Is predicted to have voltage-gated potassium channel activity. Is expressed in preanal ganglion neurons and touch receptor neurons. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNF1 (potassium voltage-gated channel modifier subfamily F member 1).

WB:WBGene00012968	Y48A6B.7
Is predicted to have guanosine deaminase activity.

WB:WBGene00012969	Y48A6B.8
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00012970	Y48A6B.9
Is predicted to have trans-2-enoyl-CoA reductase (NADPH) activity. Human ortholog(s) of this gene are implicated in alcohol dependence and late onset Parkinson's disease. Is an ortholog of human MECR (mitochondrial trans-2-enoyl-CoA reductase).

WB:WBGene00012972	rsa-2
Exhibits beta-catenin binding activity and protein-macromolecule adaptor activity. Is involved in embryonic digestive tract development; mitotic spindle organization; and protein localization to organelle. Localizes to centrosome.

WB:WBGene00012973	spat-2
Is predicted to have actin filament binding activity.

WB:WBGene00012974	Y48A6C.1
Is enriched in Z1.p; Z4.a; male distal tip cell; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq studies.

WB:WBGene00012975	Y48A6C.2
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00012976	sup-35
Localizes to cytoplasm and nucleus. Is expressed in head muscle; intestine; pharyngeal cell; and pharynx. Is an ortholog of human RMDN2 (regulator of microtubule dynamics 2) and RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00012977	Y48A6C.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Rix1 complex component involved in 60S ribosome maturation; Armadillo-like helical; Armadillo-type fold; Pre-rRNA-processing protein Ipi1, N-terminal; and Testis-expressed protein 10/pre-rRNA-processing protein Ipi1. Is an ortholog of human TEX10 (testis expressed 10).

WB:WBGene00012978	Y48B6A.1
Is predicted to have ribonucleoprotein complex binding activity. Is an ortholog of human BOP1 (BOP1 ribosomal biogenesis factor).

WB:WBGene00012979	Y48B6A.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00012980	efhd-1
Is predicted to have calcium ion binding activity. Is an ortholog of human EFHD1 (EF-hand domain family member D1) and EFHD2 (EF-hand domain family member D2).

WB:WBGene00012981	Y48B6A.10
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00012982	jmjd-2
Exhibits histone demethylase activity (H3-K36 specific) and histone demethylase activity (H3-K9 specific). Is involved in histone H3-K36 demethylation and histone H3-K9 demethylation. Is expressed in pharynx. Is an ortholog of human KDM4C (lysine demethylase 4C).

WB:WBGene00012983	men-1
Is predicted to have malate dehydrogenase (decarboxylating) (NADP+) activity. Is an ortholog of human ME1 (malic enzyme 1) and ME3 (malic enzyme 3).

WB:WBGene00012984	Y48B6A.13
Is predicted to have diphosphomevalonate decarboxylase activity. Is an ortholog of human MVD (mevalonate diphosphate decarboxylase).

WB:WBGene00012985	Y48C3A.1
Is expressed in head and tail.

WB:WBGene00012986	Y48C3A.2
No description available

WB:WBGene00012987	Y48C3A.3
Is enriched in OLL; PVD; dopaminergic neurons; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase, C-terminal domain; Glutathione S-transferase N-terminal domain; Thioredoxin-like fold; Metaxin, glutathione S-transferase domain; Thioredoxin-like superfamily; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00012988	ztf-22
Is expressed in dorsal nerve cord; head muscle; head neurons; intestine; and ventral nerve cord. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00012989	Y48C3A.5
Is enriched in head mesodermal cell; intestine; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; Zidovudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00012990	sam-10
Is involved in negative regulation of gene expression; nervous system development; and regulation of protein localization to synapse. Localizes to nucleus. Is expressed in ganglia; touch receptor neurons; and vulva. Is an ortholog of human SSBP2 (single stranded DNA binding protein 2) and SSBP3 (single stranded DNA binding protein 3).

WB:WBGene00012992	mrpl-20
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL20 (mitochondrial ribosomal protein L20).

WB:WBGene00012993	dmsr-3
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00012994	Y48C3A.12
Is predicted to have DNA-binding transcription factor activity. Is an ortholog of human TSC22D4 (TSC22 domain family member 4).

WB:WBGene00012995	Y48C3A.14
Is predicted to have DNA topoisomerase activity. Is expressed in head. Is an ortholog of human TOP3B (DNA topoisomerase III beta).

WB:WBGene00012996	pinn-4
Is predicted to have DNA binding activity and peptidyl-prolyl cis-trans isomerase activity. Localizes to plasma membrane. Is expressed in head; intestinal cell; and tail. Is an ortholog of human PIN4 (peptidylprolyl cis/trans isomerase, NIMA-interacting 4).

WB:WBGene00012997	Y48C3A.18
Is predicted to have nucleotidyltransferase activity and tRNA binding activity. Is an ortholog of human YRDC (yrdC N6-threonylcarbamoyltransferase domain containing).

WB:WBGene00012998	Y48C3A.20
Is predicted to have pseudouridine synthase activity. Is an ortholog of human PUS10 (pseudouridine synthase 10).

WB:WBGene00012999	rpoa-1
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Human ortholog(s) of this gene are implicated in acrofacial dysostosis Cincinnati type. Is an ortholog of human POLR1A (RNA polymerase I subunit A).

WB:WBGene00013000	ddl-2
Is predicted to have alpha-tubulin binding activity. Is involved in cytoplasmic sequestering of protein; determination of adult lifespan; and regulation of transcription regulatory region DNA binding activity. Is expressed in neurons. Is an ortholog of human WASHC1 (WASH complex subunit 1).

WB:WBGene00013001	noa-1
Is predicted to have GTP binding activity. Is an ortholog of human NOA1 (nitric oxide associated 1).

WB:WBGene00013002	Y48E1B.3
Is predicted to contribute to protein farnesyltransferase activity. Is an ortholog of human PGGT1B (protein geranylgeranyltransferase type I subunit beta).

WB:WBGene00013004	mrpl-37
Is enriched in body wall muscle cell; germ line; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-35; and lin-28 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Rifampin; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human MRPL37 (mitochondrial ribosomal protein L37).

WB:WBGene00013006	lin-38
Is involved in negative regulation of vulval development.

WB:WBGene00013007	Y48E1B.8
Is enriched in AVK; body wall musculature; coelomocyte; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-eight chemicals including Heme; Ethanol; and tryptophan based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00013008	clec-146
Is predicted to have carbohydrate binding activity. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis.

WB:WBGene00013009	fbxc-23
Is enriched in AVE; body wall muscle cell; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00013010	C12C8.t4
No description available

WB:WBGene00013011	snx-14
Is predicted to have phosphatidylinositol binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 20. Is an ortholog of human SNX14 (sorting nexin 14).

WB:WBGene00013013	clec-145
Is predicted to have carbohydrate binding activity.

WB:WBGene00013014	Y48E1C.1
Is predicted to have calmodulin-lysine N-methyltransferase activity. Is an ortholog of human CAMKMT (calmodulin-lysine N-methyltransferase).

WB:WBGene00013015	Y48E1C.2
Is predicted to have carnosine N-methyltransferase activity. Is an ortholog of human CARNMT1 (carnosine N-methyltransferase 1).

WB:WBGene00013017	Y48E1C.4
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00013018	Y48G10A.1
Is predicted to have S-formylglutathione hydrolase activity. Is an ortholog of human ESD (esterase D).

WB:WBGene00013019	Y48G10A.2
Is enriched in body wall muscle cell; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013020	Y48G10A.3
Localizes to striated muscle dense body. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4D. Is an ortholog of human NDRG1 (N-myc downstream regulated 1); NDRG2 (NDRG family member 2); and NDRG3 (NDRG family member 3).

WB:WBGene00013021	ints-8
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on RNA-seq; microarray; and proteomic studies. Is affected by five chemicals including Rotenone; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Integrator complex subunit 8. Is an ortholog of human INTS8 (integrator complex subunit 8).

WB:WBGene00013022	Y48G10A.5
No description available

WB:WBGene00013023	Y48G10A.6
Is enriched in OLL; PVD; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00013024	cept-2
Is predicted to have diacylglycerol cholinephosphotransferase activity and ethanolaminephosphotransferase activity. Is an ortholog of human CEPT1 (choline/ethanolamine phosphotransferase 1).

WB:WBGene00013025	vha-13
Is predicted to have proton-transporting ATPase activity, rotational mechanism. Is involved in lysosomal lumen acidification. Is expressed in head. Human ortholog(s) of this gene are implicated in autosomal recessive cutis laxa type IID. Is an ortholog of human ATP6V1A (ATPase H+ transporting V1 subunit A).

WB:WBGene00013026	Y49A3A.3
Is predicted to have tRNA methyltransferase activity. Is an ortholog of human TRMT13 (tRNA methyltransferase 13 homolog).

WB:WBGene00013027	Y49A3A.4
Is enriched in AFD; DA neuron; VA neuron; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including bisphenol S; Sodium Chloride; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00013028	efhc-1
Is predicted to have alpha-tubulin binding activity. Is expressed in ciliated neurons and ray. Human ortholog(s) of this gene are implicated in juvenile absence epilepsy 1 and juvenile myoclonic epilepsy. Is an ortholog of human EFHC1 (EF-hand domain containing 1).

WB:WBGene00013029	glrx-5
Is predicted to have 2 iron, 2 sulfur cluster binding activity; metal ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in autosomal recessive pyridoxine-refractory sideroblastic anemia 3. Is an ortholog of human GLRX5 (glutaredoxin 5).

WB:WBGene00013030	Y49E10.4
Is predicted to have protein disulfide isomerase activity. Is an ortholog of human PDIA6 (protein disulfide isomerase family A member 6).

WB:WBGene00013031	Y49E10.7
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucopyranose; multi-walled carbon nanotube; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00013032	wht-9
Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq; microarray; and tiling array studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00013033	Y49E10.10
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013034	tat-1
Exhibits ATPase-coupled intramembrane lipid transporter activity. Is involved in several processes, including lysosome organization; phospholipid translocation; and regulation of phagocytosis, engulfment. Localizes to several cellular components, including Golgi apparatus; apical plasma membrane; and basolateral plasma membrane. Colocalizes with endosome. Is expressed in several structures, including intestine. Human ortholog(s) of this gene are implicated in cerebellar ataxia, mental retardation and dysequlibrium syndrome and intrahepatic cholestasis (multiple). Is an ortholog of human ATP8A1 (ATPase phospholipid transporting 8A1) and ATP8A2 (ATPase phospholipid transporting 8A2).

WB:WBGene00013035	Y49E10.16
Is enriched in head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on SAGE; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including stavudine; Rifampin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00013036	fbxa-218
Is enriched in body wall musculature and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00013037	Y49E10.18
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00013038	ani-1
Exhibits GTP-Rho binding activity and microtubule binding activity. Is involved in several processes, including cytoskeleton organization; first cell cycle pseudocleavage; and nematode male tail tip morphogenesis. Localizes to several cellular components, including cleavage furrow; growth cone; and midbody. Colocalizes with microtubule. Is expressed in several structures, including QL.a; QL.pa; germ line; neuroblasts; and neurons. Human ortholog(s) of this gene are implicated in focal segmental glomerulosclerosis 8. Is an ortholog of human ANLN (anillin actin binding protein).

WB:WBGene00013039	scav-3
Is expressed in gonadal sheath cell; hypodermis; tail; and vulva. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 10 and progressive myoclonus epilepsy 4. Is predicted to encode a protein with the following domains: CD36 family and CD36 family. Is an ortholog of human SCARB1 (scavenger receptor class B member 1).

WB:WBGene00013040	Y49E10.21
Is enriched in OLL; PVD; and intestine based on microarray and tiling array studies. Is affected by several genes including sma-2; sma-4; and mir-34 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00013041	pstk-1
Is predicted to have kinase activity and tRNA binding activity. Is an ortholog of human PSTK (phosphoseryl-tRNA kinase).

WB:WBGene00013042	cccp-1
Exhibits Rab GTPase binding activity. Is involved in dense core granule maturation and regulation of locomotion involved in locomotory behavior. Localizes to axon; neuronal cell body; and perinuclear region of cytoplasm. Is expressed in intestine and spermatheca. Is an ortholog of human CCDC186 (coiled-coil domain containing 186).

WB:WBGene00013043	arrd-16
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC4 (arrestin domain containing 4).

WB:WBGene00013044	Y49E10.25
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00013045	Y49E10.27
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity.

WB:WBGene00013046	Y50E8A.1
Is enriched in hypodermis and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00013047	Y50E8A.2
Is enriched in amphid sheath cell; intestine; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; D-glucose; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00013048	Y50E8A.5
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00013049	Y50E8A.6
Is predicted to have sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human GPD2 (glycerol-3-phosphate dehydrogenase 2).

WB:WBGene00013050	lipl-8
Is predicted to have hydrolase activity, acting on ester bonds. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of human LIPN (lipase family member N).

WB:WBGene00013051	Y50E8A.8
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by daf-16; dpy-7; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013052	scrm-7
Is predicted to have phospholipid scramblase activity. Is an ortholog of several human genes including PLSCR1 (phospholipid scramblase 1); PLSCR3 (phospholipid scramblase 3); and PLSCR5 (phospholipid scramblase family member 5).

WB:WBGene00013053	Y50E8A.10
Is enriched in AVA and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00013054	Y50E8A.11
Is affected by several genes including skn-1; eat-2; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including tryptophan; Rifampin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013055	Y50E8A.12
Is predicted to have nucleic acid binding activity.

WB:WBGene00013056	Y50E8A.14
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00013058	clec-247
Is predicted to have carbohydrate binding activity.

WB:WBGene00013059	Y51A2A.3
Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00013060	Y51A2A.4
Is enriched in dopaminergic neurons and neurons based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fluoranthene and Triclosan based on microarray studies.

WB:WBGene00013061	Y51A2A.5
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013062	Y51A2A.6
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domain: C-type lectin fold.

WB:WBGene00013063	clec-249
Is predicted to have carbohydrate binding activity.

WB:WBGene00013064	clec-248
Is affected by rsr-2; lin-14; and lin-4 based on tiling array and microarray studies.

WB:WBGene00013066	Y51A2B.2
Is affected by prg-1 based on tiling array studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00013067	nhr-288
Is affected by hpl-2 and prg-1 based on tiling array studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00013068	Y51A2B.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00013069	Y51A2B.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: CAP superfamily.

WB:WBGene00013070	Y51A2B.6
Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Domain of unknown function WSN.

WB:WBGene00013071	Y51A2B.8
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including clk-1; aak-2; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Mercuric Chloride based on microarray studies.

WB:WBGene00013072	Y51A2D.1
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSC (cathepsin C); CTSK (cathepsin K); and CTSS (cathepsin S).

WB:WBGene00013073	hmit-1.1
Is predicted to have myo-inositol:proton symporter activity. Localizes to apical plasma membrane. Is expressed in intestinal cell. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A13 (solute carrier family 2 member 13).

WB:WBGene00013074	hmit-1.2
Is predicted to have myo-inositol:proton symporter activity. Localizes to apical plasma membrane and basal plasma membrane. Is expressed in amphid sheath cell; excretory canal; and phasmid sheath cell. Human ortholog(s) of this gene are implicated in arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A13 (solute carrier family 2 member 13).

WB:WBGene00013075	ints-5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and isp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including Zidovudine; Hydrolyzable Tannins; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Integrator complex subunit 5 N-terminus; Integrator complex subunit 5 C-terminus; Integrator complex subunit 5, C-terminal; Integrator complex subunit 5, N-terminal; and Integrator complex subunit 5. Is an ortholog of human INTS5 (integrator complex subunit 5).

WB:WBGene00013076	Y51A2D.8
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of several human genes including CTSC (cathepsin C); CTSS (cathepsin S); and CTSW (cathepsin W).

WB:WBGene00013077	ttr-24
Is enriched in PLM; dopaminergic neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; D-glucopyranose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00013078	ttr-25
Is enriched in body wall muscle cell; dopaminergic neurons; intestine; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00013079	ttr-26
Is enriched in body wall musculature; dopaminergic neurons; head mesodermal cell; male-specific anatomical entity; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-six chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00013080	Y51A2D.13
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 46. Is an ortholog of human PLD3 (phospholipase D family member 3); PLD4 (phospholipase D family member 4); and PLD5 (phospholipase D family member 5).

WB:WBGene00013081	txt-14
Is enriched in head mesodermal cell; intestine; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by seventeen chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00013082	grdn-1
Is predicted to have dynein light intermediate chain binding activity and microtubule binding activity. Is involved in several processes, including plasma membrane bounded cell projection organization; positive regulation of cell projection organization; and positive regulation of protein localization to cilium. Localizes to centriole and ciliary basal body. Is expressed in sensory neurons. Human ortholog(s) of this gene are implicated in hydrocephalus and spinocerebellar ataxia type 40. Is an ortholog of human CCDC88C (coiled-coil domain containing 88C).

WB:WBGene00013083	Y51A2D.18
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14) and SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00013085	mpz-6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PDZ superfamily and Uncharacterized protein T15H9.4-like.

WB:WBGene00013086	arrd-2
Is enriched in germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on proteomic; microarray; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00013087	Y51B9A.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013088	Y51B9A.6
Is predicted to have transmembrane transporter activity.

WB:WBGene00013089	Y51B9A.7
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Chlorpyrifos based on microarray and RNA-seq studies.

WB:WBGene00013090	Y51B9A.8
Is affected by several genes including daf-16; daf-2; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including nanoparticle; Cisplatin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like; CC domain; ShKT domain; and CC domain.

WB:WBGene00013091	Y51B9A.9
Is predicted to have ATP binding activity and protein kinase activity.

WB:WBGene00013093	cup-14
Is involved in lysosome organization. Human ortholog(s) of this gene are implicated in autosomal recessive osteopetrosis 6 and autosomal recessive spinocerebellar ataxia 15. Is an ortholog of human PLEKHM1 (pleckstrin homology and RUN domain containing M1).

WB:WBGene00013094	Y51H1A.3
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is an ortholog of human NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8).

WB:WBGene00013095	ing-3
Is predicted to contribute to histone acetyltransferase activity. Is expressed in several structures, including hypodermis; intestine; pharynx; spermatheca; and vulva. Is used to study cancer. Human ortholog(s) of this gene are implicated in head and neck squamous cell carcinoma. Is an ortholog of human ING3 (inhibitor of growth family member 3).

WB:WBGene00013096	mcd-1
Is predicted to have metal ion binding activity. Is involved in nematode larval development; positive regulation of growth rate; and programmed cell death.

WB:WBGene00013098	Y51H4A.1
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013100	zip-7
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00013101	Y51H4A.5
Is enriched in PLM and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Heme; tryptophan; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00013102	Y51H4A.6
Is affected by rsr-2; daf-2; and pmt-2 based on tiling array and microarray studies. Is affected by paraquat based on microarray studies.

WB:WBGene00013103	Y51H4A.7
Is predicted to have urocanate hydratase activity. Is an ortholog of human UROC1 (urocanate hydratase 1).

WB:WBGene00013104	Y51H4A.8
Is enriched in arcade cell; head mesodermal cell; pharyngeal muscle cell; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013105	fip-7
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; hpl-2; and nhl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013106	set-26
Exhibits histone methyltransferase activity (H3-K9 specific). Is involved in histone H3-K9 trimethylation. Is expressed in several structures, including germ cell; hypodermis; intestine; muscle cell; and somatic cell. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 23. Is an ortholog of human KMT2E (lysine methyltransferase 2E (inactive)) and SETD5 (SET domain containing 5).

WB:WBGene00013107	Y51H4A.13
Is enriched in body wall muscle cell; cephalic sheath cell; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zc3h12a-like Ribonuclease NYN domain and Ribonuclease Zc3h12a-like, NYN domain. Is an ortholog of human KHNYN (KH and NYN domain containing) and N4BP1 (NEDD4 binding protein 1).

WB:WBGene00013108	Y51H4A.14
No description available

WB:WBGene00013109	Y51H4A.15
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and aak-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Pre-rRNA-processing protein TSR2; and Pre-rRNA-processing protein TSR2. Is an ortholog of human TSR2 (TSR2 ribosome maturation factor).

WB:WBGene00013111	sta-1
Exhibits sequence-specific DNA binding activity. Is involved in dauer larval development and positive regulation of transcription by RNA polymerase II. Localizes to cytoplasm and nucleus. Is expressed in coelomocyte; head; somatic nervous system; and tail ganglion. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis and hyper IgE recurrent infection syndrome 1. Is an ortholog of human STAT5A (signal transducer and activator of transcription 5A) and STAT5B (signal transducer and activator of transcription 5B).

WB:WBGene00013112	Y51H4A.18
Is affected by several genes including daf-16; pmk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Atrazine and cadmium based on microarray studies.

WB:WBGene00013113	Y51H4A.19
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies. Is affected by cadmium based on microarray studies.

WB:WBGene00013114	Y51H4A.20
Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00013116	Y51H4A.22
Is affected by several genes including daf-2; age-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and metformin based on microarray and RNA-seq studies.

WB:WBGene00013117	Y51H4A.23
Is affected by wdr-23 based on RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00013118	Y51H4A.24
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rifampin; allantoin; and Cry5B based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 8; pigmented paravenous chorioretinal atrophy; and retinitis pigmentosa 12. Is predicted to encode a protein with the following domain: .

WB:WBGene00013119	Y51H4A.25
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; D-glucopyranose; and Cry5B based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00013120	fipr-28
Is enriched in male based on RNA-seq studies. Is affected by several genes including age-1; rrf-3; and sma-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013121	spe-38
Is involved in sperm entry. Localizes to cell cortex. Is expressed in sperm and spermatid.

WB:WBGene00013122	impt-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Zidovudine; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: RWD domain; RWD domain; Ubiquitin-conjugating enzyme/RWD-like; and Impact family. Is an ortholog of human IMPACT (impact RWD domain protein).

WB:WBGene00013123	Y52B11A.3
Is predicted to have cytochrome-b5 reductase activity, acting on NAD(P)H and heme binding activity. Is an ortholog of human CYB5R4 (cytochrome b5 reductase 4).

WB:WBGene00013124	Y52B11A.4
Is predicted to have GTP binding activity and calcium channel regulator activity. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; autoimmune lymphoproliferative syndrome type 4; and epidermal nevus. Is an ortholog of several human genes including GEM (GTP binding protein overexpressed in skeletal muscle); REM1 (RRAD and GEM like GTPase 1); and RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator).

WB:WBGene00013125	clec-92
Is predicted to have carbohydrate binding activity.

WB:WBGene00013126	mltn-2
Is affected by several genes including clk-1; eat-2; and mex-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Alovudine; Sodium Chloride; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00013127	Y52B11A.8
Is predicted to have phospholipase A2 activity.

WB:WBGene00013128	dxbp-1
Is predicted to have double-stranded DNA binding activity. Localizes to nucleolus. Is expressed in several structures, including somatic cell. Is an ortholog of human KIN (Kin17 DNA and RNA binding protein).

WB:WBGene00013129	Y52B11A.10
Is predicted to have RNA binding activity. Is an ortholog of human NOM1 (nucleolar protein with MIF4G domain 1).

WB:WBGene00013130	Y52B11B.1
Is enriched in AFD; AVK; DA neuron; and hypodermis based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Ethanol; methylmercury hydroxide; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00013131	pigl-1
Is predicted to have N-acetylglucosaminylphosphatidylinositol deacetylase activity. Is an ortholog of human PIGL (phosphatidylinositol glycan anchor biosynthesis class L).

WB:WBGene00013132	strd-1
Exhibits protein kinase binding activity and protein serine/threonine kinase activator activity. Is involved in several processes, including asymmetric neuroblast division; maintenance of dauer; and positive regulation of peptidyl-threonine phosphorylation. Localizes to several cellular components, including cell body; cell cortex; and nucleus. Is expressed in excretory canal; nervous system; and pharynx. Human ortholog(s) of this gene are implicated in lung cancer. Is an ortholog of human STRADA (STE20 related adaptor alpha).

WB:WBGene00013134	hsf-2
Is expressed in head neurons.

WB:WBGene00013135	rga-2
Is predicted to have GTPase activator activity. Is expressed in rectum; socket cell; uterus; and vulva. Is an ortholog of human ARHGAP20 (Rho GTPase activating protein 20).

WB:WBGene00013136	tmem-189
Is predicted to have plasmanylethanolamine desaturase activity. Is an ortholog of human PEDS1-UBE2V1 (PEDS1-UBE2V1 readthrough).

WB:WBGene00013137	Y53C10A.6
Is enriched in AB; body wall muscle cell; germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013138	Y53C10A.10
Is enriched in amphid sheath cell; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00013139	Y53C12A.3
Is enriched in NSM; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Yip1 domain; Yip1 domain; and YIP1 family member 3. Is an ortholog of human YIPF3 (Yip1 domain family member 3).

WB:WBGene00013140	mop-25.2
Is predicted to contribute to protein serine/threonine kinase activity. Is involved in asymmetric neuroblast division. Is an ortholog of human CAB39 (calcium binding protein 39) and CAB39L (calcium binding protein 39 like).

WB:WBGene00013141	Y53C12A.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Aspirin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00013142	Y53C12A.7
Is enriched in hypodermis; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including tryptophan; methylmercuric chloride; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HEAT repeat; HEAT repeat; Armadillo-like helical; and Armadillo-type fold.

WB:WBGene00013143	Y53C12B.1
Is predicted to have snoRNA binding activity. Is expressed in tail. Is an ortholog of human TBL3 (transducin beta like 3).

WB:WBGene00013144	pno-1
Is predicted to have RNA binding activity. Is an ortholog of human PNO1 (partner of NOB1 homolog).

WB:WBGene00013145	cutl-2
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00013146	Y53C12B.7
Is enriched in AVK; coelomocyte; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and Cadmium Chloride based on RNA-seq studies.

WB:WBGene00013147	eyg-1
Is predicted to have DNA binding activity. Is expressed in head and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Leri-Weill dyschondrosteosis; diabetes mellitus (multiple); and eye disease (multiple).

WB:WBGene00013148	Y53F4A.2
Is enriched in neurons; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on RNA-seq; proteomic; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00013149	Y53F4B.1
Is predicted to have ATP binding activity and protein serine/threonine kinase activity.

WB:WBGene00013150	pole-4
Is predicted to have protein heterodimerization activity. Is an ortholog of human POLE4 (DNA polymerase epsilon 4, accessory subunit).

WB:WBGene00013151	nsun-5
Is predicted to have RNA binding activity and methyltransferase activity. Is an ortholog of human NSUN5 (NOP2/Sun RNA methyltransferase 5).

WB:WBGene00013152	Y53F4B.5
Is enriched in germline precursor cell based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013153	Y53F4B.6
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by copper sulfate and Sirolimus based on microarray studies.

WB:WBGene00013154	Y53F4B.7
Is enriched in pharynx based on microarray studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Sodium Chloride; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013155	Y53F4B.8
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mercuric Chloride; Rotenone; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00013156	Y53F4B.9
Is predicted to have DNA binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2Y; amyotrophic lateral sclerosis type 14; and inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1. Is an ortholog of human ATAD5 (ATPase family AAA domain containing 5).

WB:WBGene00013157	Y53F4B.10
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013158	Y53F4B.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00013159	Y53F4B.12
Is enriched in neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Rifampin; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68. Is predicted to encode a protein with the following domains: Amino acid permease and Amino acid permease/ SLC12A domain. Is an ortholog of human SLC7A14 (solute carrier family 7 member 14).

WB:WBGene00013160	Y53F4B.13
Is predicted to have mRNA (nucleoside-2'-O-)-methyltransferase activity. Is an ortholog of human CMTR1 (cap methyltransferase 1).

WB:WBGene00013161	Y53F4B.14
Is predicted to have unfolded protein binding activity. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease. Is an ortholog of human PET100 (PET100 cytochrome c oxidase chaperone).

WB:WBGene00013162	Y53F4B.16
Is affected by several genes including clk-1; sir-2.1; and mex-1 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; dafa#1; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00013163	Y53F4B.17
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; clk-1; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013164	Y53F4B.18
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by Rotenone; Sirolimus; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Amidase; Amidase signature domain; and Amidase signature (AS) superfamily. Is an ortholog of human FAAH2 (fatty acid amide hydrolase 2).

WB:WBGene00013165	Y53F4B.19
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00013166	Y53F4B.20
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity.

WB:WBGene00013167	Y53F4B.21
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is predicted to encode a protein with the following domains: WASH complex subunit 7, C-terminal; WASH complex subunit 7; WASH complex subunit 7; WASH complex subunit 7, central domain; and WASH complex subunit 7, C-terminal. Is an ortholog of human WASHC4 (WASH complex subunit 4).

WB:WBGene00013168	arp-1
Is predicted to contribute to cytoskeletal protein-membrane adaptor activity. Localizes to dynactin complex. Is an ortholog of human ACTR1A (actin related protein 1A).

WB:WBGene00013169	Y53F4B.23
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and 4-bromodiphenyl ether based on RNA-seq and microarray studies.

WB:WBGene00013170	Y53F4B.24
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; manganese chloride; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013171	Y53F4B.25
Is enriched in germline precursor cell; hypodermis; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00013172	Y53F4B.26
Is affected by several genes including pgl-1; lin-15B; and glh-1 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00013173	Y53F4B.27
Is enriched in body wall musculature; germline precursor cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including hydrogen sulfide; Ethanol; and Nitric Oxide based on microarray and RNA-seq studies.

WB:WBGene00013174	Y53F4B.34
No description available

WB:WBGene00013175	Y53F4B.36
Is enriched in neurons; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including D-glucose; antimycin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013176	Y53F4B.39
Is predicted to have endoribonuclease activity and single-stranded RNA binding activity. Is an ortholog of human LACTB2 (lactamase beta 2).

WB:WBGene00013177	rsy-1
Localizes to nucleus and presynaptic active zone. Is expressed in HSNL and neurons. Is an ortholog of human PNISR (PNN interacting serine and arginine rich protein).

WB:WBGene00013178	Y53H1A.2
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: zinc-finger C2H2-type; Zinc finger C2H2-type; Zinc finger C2H2 superfamily; and Zinc-finger C2H2-type 11.

WB:WBGene00013179	clec-100
Is predicted to have carbohydrate binding activity.

WB:WBGene00013180	cutl-10
Is expressed in posterior gonad arm. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00013181	Y53H1B.2
Is enriched in PLM; body wall muscle cell; body wall musculature; male-specific anatomical entity; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including aldicarb; diallyl trisulfide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00013182	Y53H1B.4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including pgl-1; alg-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin; Alovudine; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00013184	clpr-4
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including autosomal recessive limb-girdle muscular dystrophy type 2A; hereditary spastic paraplegia 76; and neovascular inflammatory vitreoretinopathy.

WB:WBGene00013186	Y53H1C.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00013187	npr-34
Is predicted to have neuropeptide Y receptor activity.

WB:WBGene00013188	smg-9
Is involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Is an ortholog of human SMG9 (SMG9 nonsense mediated mRNA decay factor).

WB:WBGene00013189	Y54E2A.4
Is predicted to have 3'-5' DNA helicase activity and RNA binding activity. Is an ortholog of human ASCC3 (activating signal cointegrator 1 complex subunit 3).

WB:WBGene00013190	Y54E2A.5
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00013192	Y54E2A.7
Is enriched in head mesodermal cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; nicotinic acid; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013193	Y54E2A.8
Is predicted to have protein heterodimerization activity.

WB:WBGene00013194	Y54E2A.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00013195	Y54E2A.10
Is enriched in neurons; pharynx; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by allantoin; Sirolimus; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Modulator of levamisole receptor-1 and Modulator of levamisole receptor-1.

WB:WBGene00013196	tbc-20
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Human ortholog(s) of this gene are implicated in Warburg micro syndrome 4. Is an ortholog of human TBC1D20 (TBC1 domain family member 20).

WB:WBGene00013197	ttm-5
Is predicted to have sphingolipid delta-4 desaturase activity. Is an ortholog of human DEGS1 (delta 4-desaturase, sphingolipid 1) and DEGS2 (delta 4-desaturase, sphingolipid 2).

WB:WBGene00013198	Y54E5A.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013200	Y54E5A.5
Localizes to sarcoplasmic reticulum. Is an ortholog of human PBDC1 (polysaccharide biosynthesis domain containing 1).

WB:WBGene00013201	dus-2
Is predicted to have flavin adenine dinucleotide binding activity and tRNA dihydrouridine synthase activity. Is an ortholog of human DUS2 (dihydrouridine synthase 2).

WB:WBGene00013202	Y54E5A.7
Is expressed in germ line and oocyte. Is predicted to encode a protein with the following domain: CTLH, C-terminal LisH motif. Is an ortholog of human RANBP10 (RAN binding protein 10) and RANBP9 (RAN binding protein 9).

WB:WBGene00013203	Y54E5A.8
Is enriched in hypodermis; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and pmk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including aldicarb; Mianserin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00013204	Y54E5B.2
Is predicted to have snoRNA binding activity. Is an ortholog of human WDR6 (WD repeat domain 6).

WB:WBGene00013207	zipt-2.3
Is predicted to have zinc ion transmembrane transporter activity. Localizes to gut granule. Is expressed in intestinal cell. Is an ortholog of human SLC39A1 (solute carrier family 39 member 1).

WB:WBGene00013208	Y54G9A.5
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; gld-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013209	bub-3
Is predicted to have ubiquitin binding activity. Is involved in embryo development; meiotic spindle assembly checkpoint; and mitotic spindle assembly checkpoint. Localizes to nucleoplasm. Is an ortholog of human BUB3 (BUB3 mitotic checkpoint protein).

WB:WBGene00013210	Y54G9A.7
Is enriched in germ line; germline precursor cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including age-1; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013211	Y54G9A.9
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; pmk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013212	Y54G11A.1
Is enriched in AVK; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00013213	Y54G11A.2
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including Hydrolyzable Tannins; Humic Substances; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; NFACT protein RNA binding domain; NFACT, RNA-binding domain; and Jlp2/Ccd25. Is an ortholog of human CCDC25 (coiled-coil domain containing 25).

WB:WBGene00013214	Y54G11A.3
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX43 (DEAD-box helicase 43).

WB:WBGene00013215	Y54G11A.4
Is enriched in NSM; intestine; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetratricopeptide-like helical domain superfamily and Tetratricopeptide repeat protein 38. Is an ortholog of human TTC38 (tetratricopeptide repeat domain 38).

WB:WBGene00013216	Y54G11A.7
Is enriched in several structures, including body wall musculature; coelomocyte; muscle cell; neurons; and somatic nervous system based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Heme; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tetratricopeptide-like helical domain superfamily and Tetratricopeptide repeat protein 38. Is an ortholog of human TTC38 (tetratricopeptide repeat domain 38).

WB:WBGene00013217	ddl-3
Is enriched in AVE; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by Rotenone; stavudine; and Cry5B based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 2. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and Tetratricopeptide repeat protein 19. Is an ortholog of human TTC19 (tetratricopeptide repeat domain 19).

WB:WBGene00013218	Y54G11A.9
Is predicted to have 2 iron, 2 sulfur cluster binding activity; 4 iron, 4 sulfur cluster binding activity; and iron ion binding activity. Human ortholog(s) of this gene are implicated in multiple mitochondrial dysfunctions syndrome 4. Is an ortholog of human ISCA2 (iron-sulfur cluster assembly 2).

WB:WBGene00013219	Y54G11A.11
Is predicted to have RNA polymerase II complex binding activity. Localizes to nucleolus. Is an ortholog of human ELOF1 (elongation factor 1 homolog).

WB:WBGene00013220	ctl-3
Is predicted to have catalase activity and heme binding activity. Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in acatalasia. Is an ortholog of human CAT (catalase).

WB:WBGene00013221	Y54G11A.14
Is enriched in AVG; RIM; command interneuron; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Alovudine; and metformin based on RNA-seq studies.

WB:WBGene00013222	dmsr-6
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00013223	efa-6
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Is involved in several processes, including mitotic nuclear envelope disassembly; negative regulation of axon extension involved in regeneration; and regulation of microtubule cytoskeleton organization. Localizes to cell cortex; microtubule minus-end; and plasma membrane. Is expressed in U.la; U.lp; and linker cell. Is an ortholog of human PSD (pleckstrin and Sec7 domain containing).

WB:WBGene00013224	Y55D9A.2
Is predicted to have nucleic acid binding activity. Is an ortholog of human AGGF1 (angiogenic factor with G-patch and FHA domains 1).

WB:WBGene00013225	Y56A3A.2
Is predicted to have metalloendopeptidase activity. Is an ortholog of human MBTPS2 (membrane bound transcription factor peptidase, site 2).

WB:WBGene00013226	faah-5
Is predicted to have amidase activity and fatty acid amide hydrolase activity. Is an ortholog of human FAAH (fatty acid amide hydrolase).

WB:WBGene00013227	Y56A3A.6
Is expressed in germ line. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013228	Y56A3A.7
Is expressed in excretory system; gonad; hypodermis; intestine; and pharynx. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013229	Y56A3A.9
No description available

WB:WBGene00013230	fbxb-22
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00013231	tsen-2
Is predicted to have tRNA-intron endonuclease activity. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 2B. Is an ortholog of human TSEN2 (tRNA splicing endonuclease subunit 2).

WB:WBGene00013232	faah-4
Is predicted to have amidase activity and fatty acid amide hydrolase activity. Is an ortholog of human FAAH (fatty acid amide hydrolase).

WB:WBGene00013233	sdz-33
Is expressed in several structures, including Caa; Cap; Cpa; Ea; and Psub4. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00013234	fbxb-24
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00013235	Y56A3A.16
Is predicted to have phosphatidylinositol phosphate binding activity. Is an ortholog of human RUBCN (rubicon autophagy regulator) and RUBCNL (rubicon like autophagy enhancer).

WB:WBGene00013236	Y56A3A.18
Is predicted to have ribosomal large subunit binding activity. Is expressed in head. Is an ortholog of human ZNF593 (zinc finger protein 593).

WB:WBGene00013237	Y56A3A.19
Is predicted to have acyl binding activity and acyl carrier activity. Is an ortholog of human NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1).

WB:WBGene00013238	trap-4
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Iy. Is predicted to encode a protein with the following domains: Translocon-associated protein, delta subunit precursor (TRAP-delta) and Translocon-associated. Is an ortholog of human SSR4 (signal sequence receptor subunit 4).

WB:WBGene00013239	Y56A3A.22
Is enriched in AVK; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and clk-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF1279); and Domain of unknown function DUF1279. Is an ortholog of human FAM210A (family with sequence similarity 210 member A).

WB:WBGene00013240	Y56A3A.28
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; pgl-1; and sma-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00013241	ung-1
Exhibits uracil DNA N-glycosylase activity. Is involved in base-excision repair. Localizes to nucleus. Human ortholog(s) of this gene are implicated in immunodeficiency with hyper IgM type 5. Is an ortholog of human UNG (uracil DNA glycosylase).

WB:WBGene00013242	Y56A3A.30
Is enriched in several structures, including ASER; Z1.p; Z4.a; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including aldicarb; antimycin; and Cadmium Chloride based on microarray and RNA-seq studies.

WB:WBGene00013243	Y56A3A.31
Is enriched in ASER; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and npr-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including Rotenone; stavudine; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4507) and Protein of unknown function DUF4507. Is an ortholog of human C7orf26 (chromosome 7 open reading frame 26).

WB:WBGene00013244	Y56A3A.33
Is predicted to have exonuclease activity.

WB:WBGene00013246	Y57A10A.1
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including manganese chloride; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00013247	Y57A10A.2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00013248	Y57A10A.3
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including glp-1; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00013249	Y57A10A.4
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including ced-3; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00013250	Y57A10A.5
Is enriched in AVA; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including ced-3; dpy-10; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00013251	Y57A10A.6
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00013252	Y57A10A.7
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and elt-2 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by ten chemicals including manganese chloride; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00013253	Y57A10A.8
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including dpy-10; npr-1; and fog-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00013254	tag-276
Is enriched in C; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00013255	tric-1B.1
Is predicted to have potassium channel activity. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 14. Is an ortholog of human TMEM38A (transmembrane protein 38A) and TMEM38B (transmembrane protein 38B).

WB:WBGene00013256	Y57A10A.13
Is predicted to have 3'-5' exonuclease activity. Is an ortholog of human EXD3 (exonuclease 3'-5' domain containing 3).

WB:WBGene00013257	Y57A10A.14
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013258	polg-1
Is predicted to have 3'-5' exonuclease activity and DNA-directed DNA polymerase activity. Is involved in several processes, including determination of adult lifespan; mitochondrial DNA replication; and mitochondrion organization. Human ortholog(s) of this gene are implicated in chronic progressive external ophthalmoplegia (multiple); mitochondrial DNA depletion syndrome (multiple); and sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. Is an ortholog of human POLG (DNA polymerase gamma, catalytic subunit).

WB:WBGene00013259	trpp-5
Localizes to plasma membrane. Is an ortholog of human TRAPPC5 (trafficking protein particle complex 5).

WB:WBGene00013260	rsr-2
Localizes to nuclear chromatin and nuclear speck. Is expressed in germ line and somatic cell. Is an ortholog of human SRRM2 (serine/arginine repetitive matrix 2).

WB:WBGene00013261	sinh-1
Is predicted to have phosphatidylinositol-4,5-bisphosphate binding activity. Is involved in mesendoderm development. Is an ortholog of human MAPKAP1 (MAPK associated protein 1).

WB:WBGene00013263	txdc-12.1
Is enriched in PLM; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on proteomic; RNA-seq; and microarray studies. Is affected by twenty-one chemicals including methylmercury hydroxide; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like and Thioredoxin-like superfamily. Is an ortholog of human TXNDC12 (thioredoxin domain containing 12).

WB:WBGene00013264	Y57A10A.24
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is predicted to encode a protein with the following domains: Lustrin, cysteine-rich repeated domain; Cysteine-rich repeat; and Lustrin, cysteine-rich repeated.

WB:WBGene00013265	parn-2
Is predicted to have 3'-5'-exoribonuclease activity and snRNA binding activity. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 7. Is an ortholog of human TOE1 (target of EGR1, exonuclease).

WB:WBGene00013266	Y57A10A.26
Is enriched in hypodermis and somatic gonad precursor based on tiling array; proteomic; and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including Lithium Chloride; 1-methylnicotinamide; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase, C-terminal domain; Glutathione S-transferase N-terminal domain; Thioredoxin-like fold; Metaxin, glutathione S-transferase domain; Thioredoxin-like superfamily; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00013267	Y57A10A.27
Is enriched in germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by Humic Substances based on microarray studies.

WB:WBGene00013268	tric-1B.2
Is predicted to have potassium channel activity. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 14. Is an ortholog of human TMEM38A (transmembrane protein 38A) and TMEM38B (transmembrane protein 38B).

WB:WBGene00013269	Y57A10A.29
Is enriched in germ line; intestine; muscle cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in paraganglioma. Is predicted to encode a protein with the following domains: Flavinator of succinate dehydrogenase; Flavinator of succinate dehydrogenase; and Flavinator of succinate dehydrogenase superfamily. Is an ortholog of human SDHAF2 (succinate dehydrogenase complex assembly factor 2).

WB:WBGene00013270	Y57A10A.31
Is predicted to have ubiquitin binding activity and ubiquitin-protein transferase activity. Human ortholog(s) of this gene are implicated in Gordon Holmes syndrome.

WB:WBGene00013272	aqp-12
Is predicted to have channel activity.

WB:WBGene00013273	marc-5
Is predicted to have MHC protein binding activity and ubiquitin protein ligase activity. Is an ortholog of human MARCHF1 (membrane associated ring-CH-type finger 1).

WB:WBGene00013275	btb-14
Is enriched in PLM; body wall muscle cell; body wall musculature; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucopyranose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00013276	sre-42
Is affected by several genes including let-60; spn-4; and cyc-1 based on microarray and RNA-seq studies. Is affected by tetrabromobisphenol A and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00013277	sre-41
Is affected by several genes including daf-2; mut-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by cadmium; paraquat; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00013278	Y57A10B.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Pes-10 and Pes-10.

WB:WBGene00013279	Y57A10B.7
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013280	Y57A10C.1
Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013281	sre-27
Is expressed in neurons. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00013282	sre-26
Is affected by several genes including daf-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol; fluoranthene; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00013283	sre-25
Is affected by clk-1 based on microarray studies. Is affected by Sirolimus and allantoin based on microarray studies.

WB:WBGene00013284	daf-22
Exhibits propanoyl-CoA C-acyltransferase activity. Is involved in several processes, including ascaroside biosynthetic process; dauer larval development; and pheromone biosynthetic process. Localizes to peroxisome. Is expressed in body wall musculature; hypodermis; intestine; and neurons. Is used to study obesity. Is an ortholog of human SCP2 (sterol carrier protein 2).

WB:WBGene00013285	dct-12
Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; proteomic; and RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013286	Y57A10C.8
Is enriched in FLP based on microarray studies. Is affected by several genes including his-72; his-71; and his-74 based on RNA-seq studies. Is affected by four chemicals including dafa#1; Sirolimus; and 2 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013287	Y57A10C.9
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Atrazine; Diazinon; and allantoin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013288	Y57A10C.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube; dibromoacetic acid; and tetrabromobisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013289	tag-273
Is predicted to have actin filament binding activity. Is an ortholog of human LIMA1 (LIM domain and actin binding 1).

WB:WBGene00013290	Y57G11A.2
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-seven chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00013292	Y57G11A.4
Is enriched in germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain. Is an ortholog of human FRRS1L (ferric chelate reductase 1 like).

WB:WBGene00013293	Y57G11A.5
Is predicted to have RNA binding activity. Is an ortholog of human SRSF7 (serine and arginine rich splicing factor 7).

WB:WBGene00013294	pals-30
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013295	Y57G11B.2
Is enriched in ASER; coelomocyte; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including Cadmium Chloride; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013296	Y57G11B.3
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Mercuric Chloride; manganese chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00013297	Y57G11B.5
Is enriched in cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-one chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00013298	Y57G11B.6
Is enriched in BAG; dopaminergic neurons; and neurons based on tiling array studies. Is affected by several genes including mex-3; mex-1; and prg-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00013299	irld-18
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00013300	lgc-7
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00013301	Y57G11C.3
Is predicted to have 6-phosphogluconolactonase activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human PGLS (6-phosphogluconolactonase).

WB:WBGene00013302	vti-1
Is predicted to have SNAP receptor activity and SNARE binding activity. Is an ortholog of human VTI1A (vesicle transport through interaction with t-SNAREs 1A).

WB:WBGene00013303	Y57G11C.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Serpin superfamily.

WB:WBGene00013304	ptp-5.2
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00013305	Y57G11C.7
Is affected by several genes including daf-12; lin-15B; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00013306	Y57G11C.8
Is enriched in germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; manganese chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cyclin-like superfamily.

WB:WBGene00013307	Y57G11C.9
Is predicted to have RNA binding activity. Is an ortholog of human PPHLN1 (periphilin 1).

WB:WBGene00013308	nuo-3
Is enriched in germ line; hypodermis; intestine; neurons; and retrovesicular ganglion based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by biotin; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6. Is an ortholog of human NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6).

WB:WBGene00013310	Y57G11C.14
Is enriched in germ line; somatic gonad precursor; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00013311	sec-61.A
Is predicted to have protein transmembrane transporter activity; ribosome binding activity; and signal sequence binding activity. Is an ortholog of human SEC61A1 (SEC61 translocon subunit alpha 1) and SEC61A2 (SEC61 translocon subunit alpha 2).

WB:WBGene00013312	hhat-2
Is predicted to have palmitoyltransferase activity. Is an ortholog of human HHAT (hedgehog acyltransferase).

WB:WBGene00013313	Y57G11C.18
Is enriched in AVK; OLL; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by Sodium Chloride; Rifampin; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00013314	Y57G11C.19
No description available

WB:WBGene00013315	Y57G11C.20
Is expressed in intestine.

WB:WBGene00013316	Y57G11C.21
Is affected by several genes including daf-2; alg-1; and drh-3 based on RNA-seq and microarray studies. Is affected by hydrogen sulfide based on microarray studies.

WB:WBGene00013317	Y57G11C.22
Exhibits protein kinase C binding activity. Is an ortholog of human PICK1 (protein interacting with PRKCA 1).

WB:WBGene00013318	Y57G11C.23
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00013319	ccch-5
Is predicted to have mRNA 3'-UTR binding activity. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00013320	srt-51
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00013321	Y57G11C.31
Is enriched in OLL; PLM; PVD; and amphid sheath cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00013322	talp-3
Is enriched in neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00013323	Y57G11C.33
Is predicted to contribute to protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human GOLGA7 (golgin A7) and GOLGA7B (golgin A7 family member B).

WB:WBGene00013324	mrps-7
Is predicted to have mRNA binding activity and rRNA binding activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 34. Is an ortholog of human MRPS7 (mitochondrial ribosomal protein S7).

WB:WBGene00013325	Y57G11C.36
Is predicted to have mRNA binding activity.

WB:WBGene00013326	anoh-2
Is expressed in somatic nervous system; spermatheca; and touch receptor neurons. Is predicted to encode a protein with the following domains: Calcium-activated chloride channel and Anoctamin. Is an ortholog of human ANO8 (anoctamin 8).

WB:WBGene00013327	Y57G11C.38
Is enriched in amphid sheath cell and muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including D-glucose; bisphenol A; and metformin based on RNA-seq studies.

WB:WBGene00013328	Y57G11C.39
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00013329	Y57G11C.40
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013330	Y57G11C.41
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin and Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013331	Y57G11C.42
Is enriched in AVG; RIM; command interneuron; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00013332	Y57G11C.43
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sek-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Chromatin associated protein KTI12; Protein KTI12/L-seryl-tRNA(Sec) kinase; and P-loop containing nucleoside triphosphate hydrolase. Is an ortholog of human KTI12 (KTI12 chromatin associated homolog).

WB:WBGene00013333	Y57G11C.44
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00013334	nlp-56
Is enriched in hypodermis; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00013335	Y57G11C.46
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00013336	pnc-2
Exhibits nicotinamidase activity. Is involved in nicotinamide metabolic process.

WB:WBGene00013337	Y57G11C.48
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; npr-1; and pgl-1 based on RNA-seq and tiling array studies. Is affected by six chemicals including methylmercuric chloride; Rifampin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00013338	lgc-8
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00013339	phf-14
Is predicted to have metal ion binding activity. Is an ortholog of human PHF14 (PHD finger protein 14).

WB:WBGene00013340	tcc-1
Exhibits kinesin binding activity. Is involved in spindle localization. Localizes to endoplasmic reticulum membrane.

WB:WBGene00013341	Y59A8A.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00013343	prp-6
Is enriched in germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and sma-2 based on RNA-seq and microarray studies. Is affected by Rotenone and Zidovudine based on RNA-seq studies. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 60. Is predicted to encode a protein with the following domains: PRP1 splicing factor, N-terminal; HAT (Half-A-TPR) repeat; PRP1 splicing factor, N-terminal; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and Pre-mRNA-processing factor 6/Prp1/STA1. Is an ortholog of human PRPF6 (pre-mRNA processing factor 6).

WB:WBGene00013344	ebp-1
Is predicted to have microtubule plus-end binding activity. Localizes to cell cortex and cytoskeleton. Is an ortholog of human MAPRE1 (microtubule associated protein RP/EB family member 1) and MAPRE3 (microtubule associated protein RP/EB family member 3).

WB:WBGene00013345	Y59A8B.8
Is predicted to have soluble NSF attachment protein activity and syntaxin binding activity. Is an ortholog of human NAPG (NSF attachment protein gamma).

WB:WBGene00013347	nova-1
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human NOVA1 (NOVA alternative splicing regulator 1).

WB:WBGene00013348	fbxa-106
Is enriched in several structures, including DA neuron; germ line; germline precursor cell; head mesodermal cell; and interneuron based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; elt-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; manganese chloride; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013349	Y59A8B.12
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and npr-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00013350	slr-2
Is expressed in intestine. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00013351	Y59A8B.19
Is affected by several genes including daf-2; clk-1; and vhl-1 based on microarray and tiling array studies. Is affected by Quercetin and single-walled carbon nanotube based on microarray studies.

WB:WBGene00013352	lon-8
Is involved in nematode male tail tip morphogenesis and regulation of growth. Is expressed in hyp4; hyp7 syncytium; and intestine.

WB:WBGene00013353	Y59A8B.21
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7.

WB:WBGene00013354	snx-6
Exhibits protein self-association. Is involved in execution phase of apoptosis and phagosome-lysosome fusion involved in apoptotic cell clearance. Localizes to early phagosome. Is an ortholog of human SNX32 (sorting nexin 32) and SNX6 (sorting nexin 6).

WB:WBGene00013355	gck-3
Exhibits protein kinase binding activity and protein serine/threonine kinase activity. Is involved in several processes, including cellular protein modification process; multicellular organismal water homeostasis; and positive regulation of transcription from RNA polymerase II promoter in response to increased salt. Localizes to cytoplasm. Is expressed in body wall musculature; excretory system; hypodermis; oocyte; and spermatheca. Is an ortholog of human STK39 (serine/threonine kinase 39).

WB:WBGene00013356	Y59A8B.24
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-12; cyc-1; and mir-34 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00013357	clec-260
Is predicted to have carbohydrate binding activity.

WB:WBGene00013358	abhd-3.1
Is predicted to have acylglycerol lipase activity and short-chain carboxylesterase activity. Is an ortholog of human ABHD1 (abhydrolase domain containing 1) and ABHD3 (abhydrolase domain containing 3, phospholipase).

WB:WBGene00013359	Y60A3A.8
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013360	tmed-4
Is enriched in OLL; PVD; hypodermis; and intestine based on Chronogram and tiling array studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domains: emp24/gp25L/p24 family/GOLD; GOLD domain; and TMP21-related. Is an ortholog of human TMED9 (transmembrane p24 trafficking protein 9).

WB:WBGene00013361	fars-2
Is predicted to have phenylalanine-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 14 and hereditary spastic paraplegia 77. Is an ortholog of human FARS2 (phenylalanyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00013362	algn-7
Is predicted to have UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ij and congenital myasthenic syndrome 13. Is an ortholog of human DPAGT1 (dolichyl-phosphate N-acetylglucosaminephosphotransferase 1).

WB:WBGene00013363	nhr-240
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by clk-1 and smg-2 based on microarray and RNA-seq studies. Is affected by dibromoacetic acid; tetrabromobisphenol A; and dafa#1 based on microarray studies.

WB:WBGene00013364	Y60A3A.16
Is predicted to have protein serine/threonine kinase activity and tau-protein kinase activity.

WB:WBGene00013365	Y60A3A.19
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sek-1; fog-2; and alg-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human YIPF4 (Yip1 domain family member 4).

WB:WBGene00013366	Y60A3A.21
Is enriched in dopaminergic neurons; hypodermis; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00013367	Y60A3A.23
Is enriched in hypodermis and neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Tunicamycin; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00013368	Y60A9.1
Is enriched in neurons based on tiling array studies. Is affected by several genes including rrf-3; his-72; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by stavudine; resveratrol; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00013369	Y60A9.2
Is affected by several genes including daf-2; eat-2; and mut-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013370	Y60A9.3
Is predicted to have mRNA 3'-UTR binding activity. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00013371	Y60A9A.1
Is affected by clk-1; drh-3; and adr-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00013372	Y61B8B.2
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00013373	popl-7
Is predicted to contribute to ribonuclease P activity. Is an ortholog of human POP7 (POP7 homolog, ribonuclease P/MRP subunit).

WB:WBGene00013374	Y62E10A.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00013375	srsx-25
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00013376	Y62E10A.6
Is predicted to have NADPH-adrenodoxin reductase activity. Is an ortholog of human FDXR (ferredoxin reductase).

WB:WBGene00013378	emc-3
Is enriched in excretory cell; germ line; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Integral membrane protein EMC3/TMCO1-like; Integral membrane protein EMC3/TMCO1-like; and ER membrane protein complex subunit 3. Is an ortholog of human EMC3 (ER membrane protein complex subunit 3).

WB:WBGene00013379	Y62E10A.13
Is predicted to have magnesium ion binding activity and phosphoserine phosphatase activity. Is expressed in head. Human ortholog(s) of this gene are implicated in PSPH deficiency. Is an ortholog of human PSPH (phosphoserine phosphatase).

WB:WBGene00013380	memi-2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013381	cyp-31A5
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00013382	gcl-1
Exhibits identical protein binding activity. Is an ortholog of human GMCL1 (germ cell-less 1, spermatogenesis associated).

WB:WBGene00013383	aptf-2
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to cytoplasm and nucleus. Is expressed in AB lineage cell and C lineage cell. Human ortholog(s) of this gene are implicated in Char syndrome and branchiooculofacial syndrome. Is an ortholog of human TFAP2D (transcription factor AP-2 delta).

WB:WBGene00013385	Y62E10A.19
Is enriched in several structures, including PLM; dopaminergic neurons; germline precursor cell; pharyngeal muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; Rotenone; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00013386	C12C8.t5
No description available

WB:WBGene00013387	Y62F5A.9
Is expressed in pharyngeal gland cell.

WB:WBGene00013388	Y62F5A.10
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00013389	Y62H9A.1
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including clk-1; dpy-21; and drh-3 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00013390	Y62H9A.2
Is affected by prg-1 and pmt-2 based on tiling array and microarray studies.

WB:WBGene00013391	Y62H9A.3
Is enriched in RIM and interneuron based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013392	Y62H9A.4
Is enriched in germ line and seam cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; and RNA-seq studies. Is affected by seventeen chemicals including Lithium Chloride; Heme; and diallyl trisulfide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013393	Y62H9A.5
Is expressed in spermatheca. Is predicted to encode a protein with the following domain: .

WB:WBGene00013394	ule-5
Is enriched in AVK; cephalic sheath cell; dopaminergic neurons; and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Heme; Ethanol; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013395	Y62H9A.7
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and ubc-9 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00013396	Y62H9A.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including let-60; eat-2; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013397	Y62H9A.9
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013398	Y62H9A.10
Is affected by several genes including elt-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srsx and Serpentine type 7TM GPCR chemoreceptor Srsx.

WB:WBGene00013399	Y62H9A.11
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and aak-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00013400	Y62H9A.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; let-60; and pmk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Mercuric Chloride; Cry5B; and glycine based on microarray and RNA-seq studies.

WB:WBGene00013401	Y62H9A.13
Is enriched in head mesodermal cell; neurons; and in male based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00013402	Y62H9A.14
Is affected by several genes including let-60; clk-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domain: Aspartate decarboxylase-like domain superfamily.

WB:WBGene00013403	fbxb-100
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00013404	fbxb-101
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and sesamin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00013405	tdpt-1
Exhibits identical protein binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 23. Is an ortholog of human TDP2 (tyrosyl-DNA phosphodiesterase 2).

WB:WBGene00013406	Y63D3A.7
Is enriched in AFD; ASER; PLM; and germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including biotin; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Mitochondrial ribosomal protein L51 / S25 / CI-B8 domain; Ribosomal protein/NADH dehydrogenase domain; NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 2; and Thioredoxin-like superfamily. Is an ortholog of human NDUFA2 (NADH:ubiquinone oxidoreductase subunit A2).

WB:WBGene00013407	fld-1
Is involved in several processes, including membrane assembly; phospholipid homeostasis; and plasma membrane organization. Localizes to plasma membrane. Is expressed widely. Is an ortholog of human TLCD2 (TLC domain containing 2).

WB:WBGene00013408	fbxb-93
Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00013409	fbxb-56
Is enriched in AVA; DA neuron; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00013410	fbxb-94
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Mercuric Chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00013411	Y64G10A.1
Is affected by several genes including rrf-3; mut-2; and drh-3 based on microarray and RNA-seq studies. Is affected by four chemicals including dafa#1; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00013412	Y64G10A.2
Is enriched in AVA; AVE; and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; prg-1; and drh-3 based on tiling array and RNA-seq studies. Is affected by four chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00013413	Y64G10A.3
No description available

WB:WBGene00013414	Y64G10A.5
No description available

WB:WBGene00013415	ilcr-1
Is predicted to have interleukin-17 receptor activity. Is involved in positive regulation of locomotion and response to oxygen levels. Localizes to plasma membrane and receptor complex. Is expressed in RMGL and RMGR. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis. Is an ortholog of human IL17RA (interleukin 17 receptor A); IL17RB (interleukin 17 receptor B); and IL17RC (interleukin 17 receptor C).

WB:WBGene00013416	Y64G10A.7
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome. Is an ortholog of human MEGF6 (multiple EGF like domains 6).

WB:WBGene00013417	srab-24
Is expressed in AVEL; AVER; AWBL; AWBR; and neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00013418	Y65A5A.1
Is enriched in body wall musculature; hypodermis; intestine; and pharyngeal muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00013419	Y65A5A.2
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Aspirin based on RNA-seq and microarray studies.

WB:WBGene00013421	fbxa-220
Is enriched in muscle cell based on microarray studies. Is affected by several genes including clk-1; pgl-1; and mex-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00013422	popl-5
Is predicted to contribute to ribonuclease P activity. Is an ortholog of human POP5 (POP5 homolog, ribonuclease P/MRP subunit).

WB:WBGene00013424	Y66A7A.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including manganese chloride; Sodium Chloride; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00013425	ceh-91
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord; head muscle; and ventral nerve cord.

WB:WBGene00013426	Y66A7A.7
Is enriched in ASER; PLM; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013427	Y66D12A.1
Is affected by several genes including eat-2; pgl-1; and sma-2 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00013428	Y66D12A.2
No description available

WB:WBGene00013429	Y66D12A.3
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013431	ceh-92
Is predicted to have DNA binding activity.

WB:WBGene00013432	Y66D12A.6
Is enriched in ASER; PLM; germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00013433	Y66D12A.7
Is predicted to have ATP binding activity and glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity. Is expressed in tail. Is an ortholog of human GATC (glutamyl-tRNA amidotransferase subunit C).

WB:WBGene00013434	Y66D12A.8
Is enriched in body wall muscle cell; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; npr-1; and aak-2 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: UPF0428 family. Is an ortholog of human CXorf56 (chromosome X open reading frame 56).

WB:WBGene00013435	Y66D12A.9
Is predicted to have endopeptidase activator activity. Is an ortholog of human PSME3 (proteasome activator subunit 3).

WB:WBGene00013436	Y66D12A.10
Is enriched in body wall muscle cell; coelomocyte; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Mianserin; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phospholipase D-like domain at C-terminus of MIT; MIT, C-terminal phospholipase D-like domain; MIT domain superfamily; and MIT, C-terminal domain superfamily. Is an ortholog of human MITD1 (microtubule interacting and trafficking domain containing 1).

WB:WBGene00013437	Y66D12A.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00013438	ztf-29
Is enriched in ASER and body wall musculature based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Cry5B; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00013439	Y66D12A.13
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14) and SLC22A15 (solute carrier family 22 member 15).

WB:WBGene00013440	nrps-1
Is predicted to have phosphopantetheine binding activity. Is expressed in CANL and CANR. Is an ortholog of human AASDH (aminoadipate-semialdehyde dehydrogenase).

WB:WBGene00013441	xpb-1
Is predicted to contribute to RNA polymerase II CTD heptapeptide repeat kinase activity. Human ortholog(s) of this gene are implicated in xeroderma pigmentosum group B. Is an ortholog of human ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit).

WB:WBGene00013442	Y66D12A.16
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on RNA-seq and tiling array studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013443	such-1
Is predicted to have ubiquitin protein ligase activity. Is expressed in germ line; head neurons; sperm; and vulval precursor cell. Is an ortholog of human ANAPC5 (anaphase promoting complex subunit 5).

WB:WBGene00013445	Y66D12A.19
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; npr-1; and sek-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq studies.

WB:WBGene00013446	Y66D12A.21
Is enriched in germ line; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and npr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TM2 domain and TM2 domain. Is an ortholog of human TM2D1 (TM2 domain containing 1).

WB:WBGene00013447	nars-2
Is predicted to have ATP binding activity and aminoacyl-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 24. Is an ortholog of human NARS2 (asparaginyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00013448	Y66D12A.24
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Lithium Chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CD20-like family and CD20-like family.

WB:WBGene00013449	Y67A6A.1
Is enriched in hypodermis and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013450	oac-56
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00013451	Y67A10A.2
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by aldicarb; methylmercuric chloride; and Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013452	Y67A10A.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00013453	fbxa-83
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013454	fbxa-126
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; mex-1; and spn-4 based on RNA-seq and microarray studies. Is affected by aldicarb; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013455	ssu-2
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human SSUH2 (ssu-2 homolog).

WB:WBGene00013456	Y67A10A.7
Is enriched in head mesodermal cell; intestine; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in X-linked deafness 7. Is predicted to encode a protein with the following domains: Armadillo-like; Armadillo repeat-containing domain; Armadillo-like helical; and Armadillo-type fold. Is an ortholog of human ARMC10 (armadillo repeat containing 10).

WB:WBGene00013457	paqr-3
Is predicted to have signaling receptor activity. Is expressed in excretory duct cell; gonadal sheath cell; rectal gland cell; and vulva. Is an ortholog of human PAQR3 (progestin and adipoQ receptor family member 3).

WB:WBGene00013458	Y67A10A.9
Is enriched in hypodermis and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-7 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Clc-like; and Clc protein-like.

WB:WBGene00013459	Y67A10A.10
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; aak-2; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; D-glucose; and bisphenol A based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00013460	cpsf-3
Is predicted to have 5'-3' exonuclease activity; RNA binding activity; and endoribonuclease activity. Is expressed in tail. Is an ortholog of human CPSF3 (cleavage and polyadenylation specific factor 3).

WB:WBGene00013461	Y67H2A.2
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including mab-5; sek-1; and pgl-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human KLHDC10 (kelch domain containing 10).

WB:WBGene00013462	micu-1
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in myopathy with extrapyramidal signs. Is an ortholog of human MICU1 (mitochondrial calcium uptake 1).

WB:WBGene00013463	kdp-1
Localizes to cytoplasm and nuclear envelope.

WB:WBGene00013464	Y67H2A.7
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 31. Is an ortholog of human MIPEP (mitochondrial intermediate peptidase).

WB:WBGene00013465	Y67H2A.10
Is enriched in body wall musculature; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; npr-1; and aak-2 based on RNA-seq; microarray; and proteomic studies. Is affected by four chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00013466	srz-47
Is affected by several genes including clk-1; cyc-1; and rsr-2 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00013467	Y68A4A.5
Is affected by cyc-1; rpn-10; and adr-1 based on microarray and RNA-seq studies. Is affected by dafa#1 and Sirolimus based on microarray studies.

WB:WBGene00013468	srz-96
Is enriched in muscle cell based on microarray studies. Is affected by blmp-1; sir-2.1; and tdp-1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00013469	Y68A4A.10
Is affected by dpy-21; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00013470	clec-243
Is predicted to have carbohydrate binding activity.

WB:WBGene00013471	clec-242
Is predicted to have carbohydrate binding activity.

WB:WBGene00013472	Y68A4B.3
Is enriched in coelomocyte and ventral nerve cord based on tiling array studies. Is affected by several genes including clk-1; daf-19; and ubc-9 based on tiling array and microarray studies. Is affected by four chemicals including Tunicamycin; resveratrol; and Quercetin based on microarray studies.

WB:WBGene00013473	Y69E1A.1
Is enriched in body wall muscle cell; cholinergic neurons; coelomocyte; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interactor of ZYG-11 and Protein of unknown function DUF856, Caenorhabditis species.

WB:WBGene00013474	Y69E1A.2
Is enriched in NSM and male-specific anatomical entity based on tiling array and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirty-one chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00013475	Y69E1A.3
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00013476	Y69E1A.4
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00013477	Y69E1A.5
Is enriched in GABAergic neurons; OLL; PVD; body wall muscle cell; and muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twelve chemicals including manganese chloride; D-glucose; and nicotine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Phosphatidylethanolamine-binding protein; Phosphatidylethanolamine-binding protein; Phosphatidylethanolamine-binding protein, eukaryotic; and PEBP-like superfamily. Is an ortholog of human PEBP4 (phosphatidylethanolamine binding protein 4).

WB:WBGene00013478	Y69E1A.8
Is enriched in ALM; FLP; PLM; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00013479	Y69H2.1
Is enriched in ASER; amphid sheath cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including sir-2.1; aak-2; and aak-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF1182.

WB:WBGene00013480	egas-3
Is predicted to have calcium ion binding activity and sodium channel activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis.

WB:WBGene00013481	Y69H2.3
Is enriched in several structures, including amphid sheath cell; excretory cell; germ line; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; Mianserin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; Follistatin-like, N-terminal; and Serine protease inhibitor-like superfamily.

WB:WBGene00013482	Y69H2.7
Is enriched in arcade cell; germ line; intestine; neurons; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by Zidovudine; paraquat; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00013483	nhr-241
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00013484	Y69H2.9
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; bisphenol S; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00013485	Y69H2.10
Is enriched in amphid sheath cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including hydrogen sulfide; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00013486	egas-1
Is predicted to have calcium ion binding activity and sodium channel activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis.

WB:WBGene00013487	egas-2
Is predicted to have calcium ion binding activity and sodium channel activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis.

WB:WBGene00013489	col-42
Is predicted to be a structural constituent of cuticle.

WB:WBGene00013490	Y70C5A.2
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by lin-15B and wdr-5.1 based on microarray studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00013491	Y70C5B.1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by lin-15B based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00013492	Y70C5C.1
Is predicted to have catalytic activity and metal ion binding activity. Is an ortholog of human IDE (insulin degrading enzyme).

WB:WBGene00013493	clec-9
Is predicted to have carbohydrate binding activity.

WB:WBGene00013494	irld-58
Is affected by cyc-1 and sir-2.1 based on microarray studies.

WB:WBGene00013495	clec-236
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00013496	Y70D2A.1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00013497	hex-5
Exhibits hexosaminidase activity. Is involved in carbohydrate metabolic process. Is expressed in head muscle; tail; and vulva. Is an ortholog of human HEXD (hexosaminidase D).

WB:WBGene00013498	Y70G10A.2
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; Sirolimus; and antimycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Alagille syndrome and tetralogy of Fallot. Is predicted to encode a protein with the following domain: .

WB:WBGene00013499	Y70G10A.3
Is predicted to have sodium-independent organic anion transmembrane transporter activity. Is expressed in excretory cell and hypodermis. Is an ortholog of human SLCO4A1 (solute carrier organic anion transporter family member 4A1).

WB:WBGene00013500	Y71A12B.2
Is affected by several genes including daf-16; daf-2; and fer-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013501	Y71A12B.3
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00013502	clec-111
Is predicted to have carbohydrate binding activity.

WB:WBGene00013503	clec-112
Is affected by several genes including clk-1; unc-75; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by allantoin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00013504	Y71A12B.7
No description available

WB:WBGene00013505	Y71A12B.8
Is affected by several genes including eat-2; csr-1; and hpl-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00013506	usp-3
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity and zinc ion binding activity. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Y-linked spermatogenic failure 2; and non-syndromic X-linked intellectual disability. Is an ortholog of human USP3 (ubiquitin specific peptidase 3).

WB:WBGene00013507	Y71A12B.10
Is predicted to have identical protein binding activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2 and hereditary spastic paraplegia 57. Is an ortholog of human TFG (trafficking from ER to golgi regulator).

WB:WBGene00013508	Y71A12B.11
Is enriched in DA neuron; VA neuron; dopaminergic neurons; hypodermis; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; D-glucose; and indole based on microarray and RNA-seq studies.

WB:WBGene00013509	Y71A12B.12
Is enriched in GABAergic neurons; body wall muscle cell; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-type fold and Leucine-rich repeat domain superfamily.

WB:WBGene00013510	Y71A12B.13
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00013511	Y71A12B.15
Is affected by several genes including clk-1; sma-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00013512	nhr-276
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00013513	Y71A12C.2
Is enriched in I5 neuron; cholinergic neurons; germline precursor cell; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SNARE associated Golgi protein and SNARE associated Golgi protein. Is an ortholog of human TMEM41A (transmembrane protein 41A).

WB:WBGene00013514	Y73F4A.1
Is enriched in coelomocyte; head mesodermal cell; intestine; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; levamisole; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00013515	Y73F4A.2
Is enriched in body wall musculature; intestine; somatic nervous system; tail neurons; and vulval muscle based on microarray and Chronogram studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including hydrogen sulfide; tryptophan; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00013516	Y73F4A.3
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; methylmercuric chloride; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00013517	lgc-52
Is predicted to have chloride channel activity. Is an ortholog of human GLRA3 (glycine receptor alpha 3) and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00013518	Y73F8A.5
Is enriched in cephalic sheath cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Growth factor receptor cysteine-rich domain superfamily; Tyrosine-protein kinase ephrin type A/B receptor-like; and EIG121-like. Is an ortholog of human ELAPOR2 (endosome-lysosome associated apoptosis and autophagy regulator family member 2).

WB:WBGene00013519	Y73F8A.10
Is enriched in male based on RNA-seq studies. Is affected by cyc-1 and hpl-2 based on microarray and tiling array studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00013520	best-21
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1) and BEST2 (bestrophin 2).

WB:WBGene00013521	Y73F8A.12
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013522	Y73F8A.13
Is enriched in arcade cell; germ line; mechanosensory neurons; pharyngeal-intestinal valve cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; sir-2.1; and isp-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Hydrolyzable Tannins; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00013523	Y73F8A.14
Is enriched in amphid sheath cell; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013524	Y73F8A.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Tunicamycin; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00013525	irld-59
Is affected by several genes including clk-1; nhr-25; and mir-34 based on microarray studies. Is affected by four chemicals including fluoranthene; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00013526	Y73F8A.20
Is enriched in FLP; amphid sheath cell; and in male based on microarray and RNA-seq studies. Is affected by several genes including eat-2; npr-1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Serpin superfamily.

WB:WBGene00013527	Y73F8A.22
Is affected by several genes including eat-2; mex-3; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00013528	Y73F8A.23
Is affected by several genes including clk-1; zip-2; and adr-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00013529	Y73F8A.24
Is predicted to contribute to RNA polymerase II CTD heptapeptide repeat kinase activity. Is expressed in head and tail. Is an ortholog of human GTF2H4 (general transcription factor IIH subunit 4).

WB:WBGene00013530	ntl-11
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CCR4-NOT transcription complex subunit 11 and CCR4-NOT transcription complex subunit 11. Is an ortholog of human CNOT11 (CCR4-NOT transcription complex subunit 11).

WB:WBGene00013531	Y73F8A.26
Is enriched in germ line; head mesodermal cell; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-12; eat-2; and lin-35 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Mianserin; stavudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 7 and osteogenesis imperfecta type 8. Is predicted to encode a protein with the following domain: . Is an ortholog of human CRTAP (cartilage associated protein).

WB:WBGene00013532	Y73F8A.27
Is predicted to have 2 iron, 2 sulfur cluster binding activity and electron transfer activity. Human ortholog(s) of this gene are implicated in mitochondrial myopathy. Is an ortholog of human FDX2 (ferredoxin 2).

WB:WBGene00013533	Y73F8A.29
No description available

WB:WBGene00013534	acr-24
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00013535	gyg-3
Is affected by several genes including sek-1; isp-1; and smg-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00013536	Y73F8A.32
Is affected by several genes including cep-1; sod-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013537	Y73F8A.33
Is affected by several genes including alg-1; mex-1; and smg-2 based on RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013538	ari-1.4
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is an ortholog of human ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1).

WB:WBGene00013539	Y73F8A.35
Is predicted to have catalytic activity.

WB:WBGene00013540	cest-12
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00013541	lonp-2
Is predicted to have ATP binding activity; ATP-dependent peptidase activity; and serine-type endopeptidase activity. Is an ortholog of human LONP2 (lon peptidase 2, peroxisomal).

WB:WBGene00013542	lron-12
Is enriched in OLL; PVD; body wall muscle cell; and muscle cell based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome; high myopia-sensorineural deafness syndrome; and trichotillomania. Is predicted to encode a protein with the following domains: BspA type Leucine rich repeat region (6 copies); BspA type Leucine rich repeat region; and Leucine-rich repeat domain superfamily.

WB:WBGene00013543	Y75B8A.6
Is predicted to have DNA binding activity and zinc ion binding activity.

WB:WBGene00013544	Y75B8A.7
Is enriched in AFD; body wall muscle cell; and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by D-glucose; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Mpp10 protein and U3 small nucleolar ribonucleoprotein complex, subunit Mpp10. Is an ortholog of human MPHOSPH10 (M-phase phosphoprotein 10).

WB:WBGene00013545	Y75B8A.8
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and fbf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013547	Y75B8A.10
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; antimycin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00013548	lury-1
Exhibits neuropeptide receptor binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of feeding behavior; and positive regulation of oviposition. Is expressed in M1 neuron; M2 neuron; and coelomocyte.

WB:WBGene00013549	Y75B8A.13
Is enriched in NSM; arcade cell; germ line; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013550	Y75B8A.14
Is predicted to have GTPase activity. Is an ortholog of human GPN3 (GPN-loop GTPase 3).

WB:WBGene00013551	Y75B8A.16
Is predicted to have voltage-gated anion channel activity. Is an ortholog of human GPR89B (G protein-coupled receptor 89B).

WB:WBGene00013552	gmn-1
Is enriched in body wall muscle cell; germ line; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013553	Y75B8A.18
Is enriched in AFD; germ line; hypodermis; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including age-1; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00013554	Y75B8A.19
Is enriched in AVK and NSM based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by Rotenone and antimycin based on RNA-seq studies.

WB:WBGene00013555	fbxa-89
Is affected by several genes including pmk-1; npr-1; and dpy-7 based on tiling array and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013556	Y75B8A.23
Is enriched in several structures, including Z1.p; Z4.a; amphid sheath cell; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00013557	Y75B8A.24
Is predicted to have 1-phosphatidylinositol 4-kinase activity. Is used to study chromosome 22q11.2 deletion syndrome, distal. Is an ortholog of human PI4KA (phosphatidylinositol 4-kinase alpha).

WB:WBGene00013558	Y75B8A.25
Is enriched in NSM; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and sir-2.1 based on RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013559	Y75B8A.28
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Heme; D-glucose; and nanoparticle based on microarray and RNA-seq studies.

WB:WBGene00013560	zip-12
Is enriched in hypodermis; intestine; mechanosensory neurons; pharyngeal muscle cell; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; levamisole; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013561	Y75B8A.31
Is predicted to contribute to siRNA binding activity. Is an ortholog of human FAM172A (family with sequence similarity 172 member A).

WB:WBGene00013562	Y75B8A.32
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00013563	Y75B8A.33
Is enriched in Z1.p; Z4.a; ciliated neurons; male distal tip cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Sodium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00013564	Y75B8A.34
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013565	Y75B8A.37
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including alg-1; hpl-2; and his-24 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013566	Y75B12A.2
Is affected by several genes including daf-2; skn-1; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by nine chemicals including Tunicamycin; sodium arsenite; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013567	Y75B12B.1
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-12; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase and Mos1 transposase, HTH domain.

WB:WBGene00013568	Y75B12B.3
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013569	bath-36
Is enriched in several structures, including germ line; head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00013570	Y75B12B.8
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mianserin; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00013571	str-266
Is affected by sir-2.1 and rrf-3 based on microarray studies. Is affected by Atrazine; cadmium; and Sirolimus based on microarray studies.

WB:WBGene00013572	Y75B12B.10
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00013573	Y75B12B.11
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013574	lron-13
Is enriched in AVA; pharynx; and ventral nerve cord based on microarray and tiling array studies. Is affected by several genes including daf-2; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00013575	acs-5
Is predicted to have catalytic activity. Is expressed in hypodermis. Is an ortholog of human ACSL1 (acyl-CoA synthetase long chain family member 1).

WB:WBGene00013576	Y76A2B.4
Is enriched in germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013577	Y76A2B.5
Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in methylmalonic aciduria and homocystinuria type cblD. Is predicted to encode a protein with the following domains: Methylmalonic aciduria and homocystinuria type D protein and Methylmalonic aciduria and homocystinuria type D protein. Is an ortholog of human MMADHC (metabolism of cobalamin associated D).

WB:WBGene00013578	scav-2
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 10 and progressive myoclonus epilepsy 4. Is predicted to encode a protein with the following domains: CD36 family and CD36 family. Is an ortholog of human CD36 (CD36 molecule); SCARB1 (scavenger receptor class B member 1); and SCARB2 (scavenger receptor class B member 2).

WB:WBGene00013579	Y79H2A.2
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00013580	Y79H2A.3
Is enriched in germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013581	Y79H2A.4
Is predicted to have nucleic acid binding activity.

WB:WBGene00013583	ceh-51
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in mesodermal cell fate specification; muscle cell fate specification; and pharyngeal muscle development. Localizes to nucleus. Is expressed in several structures, including MSaa; MSap; MSp; MSpa; and MSpp. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta type 4; orofacial cleft 15; and split hand-foot malformation 1 with sensorineural hearing loss. Is an ortholog of human DLX4 (distal-less homeobox 4).

WB:WBGene00013584	nhr-243
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00013585	cyp-42A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00013586	Y80D3A.8
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00013587	Y80D3A.9
Is enriched in arcade cell; head mesodermal cell; intestine; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including D-glucopyranose; sodium arsenite; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transport and Golgi organisation 2 and Transport and Golgi organisation protein 2. Is an ortholog of human TANGO2 (transport and golgi organization 2 homolog).

WB:WBGene00013588	nlp-42
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00013589	Y80D3A.11
Is affected by several genes including daf-16; skn-1; and hpl-2 based on RNA-seq studies. Is affected by allantoin and Sirolimus based on RNA-seq studies.

WB:WBGene00013590	Y81G3A.1
Is enriched in germ line; intestine; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Cry5B; Acrylamide; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013591	gcn-2
Is predicted to have protein kinase activity. Is involved in several processes, including mitochondrial unfolded protein response; positive regulation of macromolecule metabolic process; and stress granule assembly. Is an ortholog of human EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4).

WB:WBGene00013592	Y81G3A.4
Is enriched in PLM; Z1; Z4; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013593	Y87G2A.1
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on RNA-seq; proteomic; and microarray studies. Is affected by seven chemicals including Mianserin; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013594	Y87G2A.2
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT8 (acyl-CoA thioesterase 8).

WB:WBGene00013595	atg-4.1
Exhibits cysteine-type endopeptidase activity. Is involved in autophagy and proteolysis. Localizes to cytoplasm. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P8.p hermaphrodite; head muscle; and somatic nervous system. Is an ortholog of human ATG4A (autophagy related 4A cysteine peptidase) and ATG4B (autophagy related 4B cysteine peptidase).

WB:WBGene00013596	nyn-2
Is involved in production of siRNA involved in RNA interference.

WB:WBGene00013597	gpi-1
Is predicted to have glucose-6-phosphate isomerase activity and monosaccharide binding activity. Is expressed in head. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in congenital nonspherocytic hemolytic anemia. Is an ortholog of human GPI (glucose-6-phosphate isomerase).

WB:WBGene00013598	vps-28
Is involved in receptor catabolic process. Localizes to ESCRT I complex. Is an ortholog of human VPS28 (VPS28 subunit of ESCRT-I).

WB:WBGene00013599	eipr-1
Is involved in positive regulation of dense core granule transport; positive regulation of locomotion involved in locomotory behavior; and positive regulation of oviposition. Is an ortholog of human EIPR1 (EARP complex and GARP complex interacting protein 1).

WB:WBGene00013600	Y87G2A.12
No description available

WB:WBGene00013601	Y87G2A.13
Is enriched in excretory cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Predicted transmembrane protein 161AB and Transmembrane protein 161A/B. Is an ortholog of human TMEM161A (transmembrane protein 161A) and TMEM161B (transmembrane protein 161B).

WB:WBGene00013602	Y87G2A.16
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00013603	soem-1
Is expressed in PQR. Is predicted to encode a protein with the following domains: SH2 domain; SH2 domain; and SH2 domain superfamily. Is an ortholog of human SHB (SH2 domain containing adaptor protein B) and SHD (Src homology 2 domain containing transforming protein D).

WB:WBGene00013604	Y87G2A.18
Is enriched in AFD; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human LITAF (lipopolysaccharide induced TNF factor).

WB:WBGene00013605	Y95D11A.1
Is predicted to be a structural constituent of ribosome.

WB:WBGene00013606	cand-1
Is involved in regulation of protein deneddylation. Localizes to nucleus. Is expressed widely. Is used to study cancer. Is an ortholog of human CAND1 (cullin associated and neddylation dissociated 1) and CAND2 (cullin associated and neddylation dissociated 2 (putative)).

WB:WBGene00013607	clec-27
Is predicted to have carbohydrate binding activity.

WB:WBGene00013608	clec-35
Is predicted to have carbohydrate binding activity.

WB:WBGene00013609	clec-37
Is predicted to have carbohydrate binding activity.

WB:WBGene00013610	fbxa-206
Is enriched in several structures, including I5 neuron; cholinergic neurons; germ line; germline precursor cell; and head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Sirolimus; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00013611	Y102A5C.2
Is enriched in several structures, including I5 neuron; cholinergic neurons; germ line; germline precursor cell; and head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00013612	fbxa-207
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by stavudine and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013613	Y102A5C.4
Is affected by several genes including clk-1; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Alovudine; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00013614	clec-237
Is affected by several genes including daf-2; let-60; and sir-2.1 based on microarray and RNA-seq studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00013615	fbxa-110
Is affected by several genes including mex-3; mex-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00013616	fbxa-148
Is affected by several genes including pgl-1; lin-15B; and fbf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box A protein FB155/FB224.

WB:WBGene00013617	fbxa-204
Is affected by clk-1 and dlc-1 based on microarray and RNA-seq studies. Is affected by fluoranthene and nitroguanidine based on microarray studies.

WB:WBGene00013618	fbxa-205
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00013619	fbxa-112
Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013620	fbxa-111
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by tryptophan; methylmercuric chloride; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013621	clec-239
Is predicted to have carbohydrate binding activity.

WB:WBGene00013622	clec-238
Is predicted to have carbohydrate binding activity.

WB:WBGene00013623	fbxa-90
Is enriched in intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including age-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; paraquat; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013624	srbc-80
Is affected by several genes including lin-4; lin-14; and eat-2 based on RNA-seq and microarray studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00013625	srz-53
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by resveratrol; cadmium; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00013626	srz-54
Is expressed in ASIL; ASIR; PVT; intestine; and pharynx. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00013627	srz-52
Is affected by sir-2.1 and ain-1 based on microarray studies.

WB:WBGene00013628	Y102A5C.27
Is enriched in DA neuron; NSM; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by cyc-1 and rsr-2 based on microarray and tiling array studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013629	srz-95
Is affected by clk-1 and gei-8 based on microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00013630	Y102A5D.1
No description available

WB:WBGene00013631	Y102F5A.1
Is affected by several genes including eat-2; mir-34; and tdp-1 based on microarray and RNA-seq studies. Is affected by cadmium based on microarray studies.

WB:WBGene00013632	Y105C5A.1
Is predicted to have DNA-binding transcription factor activity; transcription factor binding activity; and transcription regulatory region DNA binding activity.

WB:WBGene00013633	Y105C5A.8
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013634	Y105C5A.9
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including skn-1; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013635	Y105C5A.10
Is enriched in NSM based on tiling array studies. Is affected by age-1 and spn-4 based on microarray and RNA-seq studies.

WB:WBGene00013636	Y105C5A.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including copper sulfate; methylmercury hydroxide; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00013637	Y105C5A.13
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including copper sulfate; methylmercury hydroxide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00013638	Y105C5A.14
Is enriched in several structures, including body wall muscle cell; excretory cell; germ line; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013639	Y105C5A.15
Is expressed in pharynx. Is predicted to encode a protein with the following domain: Ribonuclease H-like superfamily.

WB:WBGene00013640	Y105C5A.17
Is enriched in AVA; AVE; dopaminergic neurons; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and hpl-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin; multi-walled carbon nanotube; and adsorbable organic bromine compound based on microarray and RNA-seq studies.

WB:WBGene00013642	daf-38
Exhibits protein heterodimerization activity. Is involved in G protein-coupled receptor signaling pathway involved in dauer larval development. Is expressed in chemosensory neurons and head neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 7 with or without anosmia.

WB:WBGene00013643	Y105C5A.24
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including LEOPARD syndrome (multiple); Noonan syndrome 1; and Noonan syndrome 5. Is an ortholog of human MAP3K7 (mitogen-activated protein kinase kinase kinase 7).

WB:WBGene00013644	Y105C5A.25
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including manganese chloride; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00013645	Y105C5B.1
Is affected by several genes including clk-1; rrf-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00013646	Y105C5B.3
Is predicted to have acid phosphatase activity and metal ion binding activity. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00013647	Y105C5B.5
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; proteomic; tiling array; and microarray studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00013648	Y105C5B.7
Is affected by several genes including hsf-1; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Heme; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00013649	Y105C5B.8
Is affected by several genes including age-1; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013650	Y105C5B.9
Is predicted to have dioxygenase activity and metal ion binding activity. Is an ortholog of human PHYHD1 (phytanoyl-CoA dioxygenase domain containing 1).

WB:WBGene00013651	Y105C5B.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00013652	sams-2
Is enriched in NSM; OLL; PVD; and germ line based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013653	Y105C5B.14
Is enriched in intestine and muscle cell based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Actin-crosslinking.

WB:WBGene00013654	Y105C5B.15
Is predicted to have acid phosphatase activity and metal ion binding activity. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00013655	lgc-19
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00013656	Y105C5B.17
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including D-glucose; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: CAP superfamily.

WB:WBGene00013657	Y105C5B.18
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013658	Y105C5B.19
Is expressed widely. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00013659	Y105C5B.20
Is enriched in several structures, including I5 neuron; cephalic sheath cell; cholinergic neurons; coelomocyte; and germ line based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013660	Y105C5B.22
No description available

WB:WBGene00013661	Y105C5B.23
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including bar-1; alg-1; and csr-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00013662	Y105C5B.25
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00013663	Y105C5B.26
No description available

WB:WBGene00013664	Y105C5B.27
No description available

WB:WBGene00013665	hlh-32
Is predicted to have protein dimerization activity. Human ortholog(s) of this gene are implicated in congenital malabsorptive diarrhea 4 and persistent hyperplastic primary vitreous. Is an ortholog of human BHLHE23 (basic helix-loop-helix family member e23).

WB:WBGene00013666	Y105E8A.1
Is expressed in head and intestine. Is predicted to encode a protein with the following domains: SH3-binding, glutamic acid-rich protein; SH3-binding, glutamic acid-rich protein; and Thioredoxin-like superfamily. Is an ortholog of human SH3BGRL (SH3 domain binding glutamate rich protein like) and SH3BGRL2 (SH3 domain binding glutamate rich protein like 2).

WB:WBGene00013667	Y105E8A.2
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-12; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glucosidase II beta subunit-like protein; Mannose-6-phosphate receptor binding domain superfamily; and Protein OS9-like. Is an ortholog of human ERLEC1 (endoplasmic reticulum lectin 1).

WB:WBGene00013668	slc-30A5
Is predicted to have cation transmembrane transporter activity. Localizes to endoplasmic reticulum. Is an ortholog of human SLC30A5 (solute carrier family 30 member 5).

WB:WBGene00013669	tcab-1
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive dyskeratosis congenita 3. Is an ortholog of human WRAP53 (WD repeat containing antisense to TP53).

WB:WBGene00013670	hpo-13
Is predicted to have beta-glucosidase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 46. Is an ortholog of human GBA2 (glucosylceramidase beta 2).

WB:WBGene00013671	Y105E8A.11
Is enriched in ASER; germ line; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in multiple mitochondrial dysfunctions syndrome 2. Is predicted to encode a protein with the following domains: BolA-like protein; BolA protein; and BolA-like superfamily. Is an ortholog of human BOLA3 (bolA family member 3).

WB:WBGene00013672	catp-1
Is predicted to have sodium:potassium-exchanging ATPase activity. Is involved in dauer larval development. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; Kufor-Rakeb syndrome; and keratosis (multiple).

WB:WBGene00013673	Y105E8A.13
Is enriched in OLL; PLM; PVD; hypodermis; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00013674	Y105E8A.14
Is predicted to have poly-ADP-D-ribose binding activity and ubiquitin-protein transferase activity. Is expressed in intestine; marginal cell; pharyngeal muscle cell; and rectal gland cell. Is an ortholog of human RNF146 (ring finger protein 146).

WB:WBGene00013676	ekl-4
Is predicted to have transcription corepressor activity. Is involved in negative regulation of cell fate specification. Is an ortholog of human DMAP1 (DNA methyltransferase 1 associated protein 1).

WB:WBGene00013677	yars-1
Is predicted to have tyrosine-tRNA ligase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease dominant intermediate C. Is an ortholog of human YARS1 (tyrosyl-tRNA synthetase 1).

WB:WBGene00013678	Y105E8A.20
Is predicted to have methionine-tRNA ligase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 20; combined oxidative phosphorylation deficiency 25; and spastic ataxia 3. Is an ortholog of human MARS2 (methionyl-tRNA synthetase 2, mitochondrial).

WB:WBGene00013679	Y105E8A.21
Is enriched in AFD; ASER; AVK; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including dpy-10; pmk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucose; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: WD40-repeat-containing domain superfamily.

WB:WBGene00013680	rpom-1
Is predicted to have DNA-directed 5'-3' RNA polymerase activity and mitochondrial promoter sequence-specific DNA binding activity. Is expressed in several structures, including intestine; muscle cell; nerve ring; oocyte; and vulva. Is an ortholog of human POLRMT (RNA polymerase mitochondrial).

WB:WBGene00013682	Y105E8A.25
Is predicted to have guanyl-nucleotide exchange factor activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4H.

WB:WBGene00013683	zoo-1
Is involved in actin filament organization; embryo development; and embryonic morphogenesis. Localizes to adherens junction and bicellular tight junction. Human ortholog(s) of this gene are implicated in progressive familial intrahepatic cholestasis 4. Is an ortholog of human TJP3 (tight junction protein 3).

WB:WBGene00013684	Y105E8A.27
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00013685	Y105E8A.28
Is enriched in AVE based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013687	exoc-8
Is expressed in PVDL and PVDR. Is predicted to encode a protein with the following domains: Vps51/Vps67; PH-like domain superfamily; and Exocyst complex component Exo84. Is an ortholog of human EXOC8 (exocyst complex component 8).

WB:WBGene00013688	riok-2
Is predicted to have protein kinase activity. Is involved in nematode larval development. Is an ortholog of human RIOK2 (RIO kinase 2).

WB:WBGene00013689	bath-40
Is predicted to have ubiquitin protein ligase binding activity. Is an ortholog of human SPOP (speckle type BTB/POZ protein).

WB:WBGene00013690	hprt-1
Exhibits identical protein binding activity. Human ortholog(s) of this gene are implicated in Lesch-Nyhan syndrome. Is an ortholog of human HPRT1 (hypoxanthine phosphoribosyltransferase 1).

WB:WBGene00013691	Y105E8B.6
Is enriched in several structures, including NSM; body wall muscle cell; germ line; germline precursor cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; elt-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including stavudine; Deoxyglucose; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00013692	Y105E8B.7
Is enriched in intestine; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and lin-35 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; antimycin; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; YEATS family; YEATS; and YEATS superfamily. Is an ortholog of human YEATS4 (YEATS domain containing 4).

WB:WBGene00013693	Y105E8B.9
Is predicted to have beta-glucuronidase activity and carbohydrate binding activity. Human ortholog(s) of this gene are implicated in Sly syndrome. Is an ortholog of human GUSB (glucuronidase beta).

WB:WBGene00013694	mekk-3
Is predicted to have ATP binding activity and protein kinase activity. Localizes to sarcoplasmic reticulum.

WB:WBGene00013695	epg-8
Is involved in macroautophagy; positive regulation of autophagy; and positive regulation of embryonic development. Localizes to cytoplasm. Is expressed in neurons and pharyngeal muscle cell.

WB:WBGene00013696	Y106G6A.4
Is enriched in several structures, including Z4.a; excretory cell; intestine; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00013697	dsbn-1
Is involved in endosomal transport. Is used to study Hermansky-Pudlak syndrome. Human ortholog(s) of this gene are implicated in Hermansky-Pudlak syndrome 7.

WB:WBGene00013698	Y106G6D.1
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; stavudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013699	Y106G6D.2
Is enriched in BAG; dopaminergic neurons; hypodermis; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; bisphenol A; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00013700	Y106G6D.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00013701	Y106G6D.4
Is predicted to have MAP kinase activity. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00013702	Y106G6D.6
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mianserin; procyanidin; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013703	rbm-12
Is predicted to have nucleic acid binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 109 and schizophrenia 19. Is an ortholog of human RBM12 (RNA binding motif protein 12).

WB:WBGene00013704	Y106G6D.8
Is enriched in hypodermis and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; levamisole; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013705	Y106G6E.1
Is predicted to have MAP kinase activity. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00013706	Y106G6E.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00013707	Y106G6E.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00013708	Y106G6E.4
Is predicted to have 5-formyltetrahydrofolate cyclo-ligase activity. Is an ortholog of human ST20-MTHFS (ST20-MTHFS readthrough).

WB:WBGene00013709	csnk-1
Is predicted to have protein serine/threonine kinase activity. Is involved in several processes, including first cell cycle pseudocleavage; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity; and regulation of mitotic spindle elongation. Localizes to aster; cell cortex; and plasma membrane. Is an ortholog of human CSNK1G3 (casein kinase 1 gamma 3).

WB:WBGene00013710	Y106G6G.1
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013711	Y106G6G.2
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Is an ortholog of human ARFGEF3 (ARFGEF family member 3).

WB:WBGene00013712	dlc-6
Is enriched in AVK; BAG; somatic gonad precursor; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Dynein light chain type 1; Dynein light chain, type 1/2; and Dynein light chain superfamily.

WB:WBGene00013713	Y106G6G.4
Is enriched in neurons; somatic gonad precursor; and in male based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00013714	Y106G6G.5
No description available

WB:WBGene00013716	Y106G6H.1
Is enriched in head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; bisphenol S; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00013717	madf-10
Is expressed in head muscle; head neurons; motor neurons; and ventral nerve cord. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00013718	pdpr-1
Is predicted to have oxidoreductase activity. Is an ortholog of human PDPR (pyruvate dehydrogenase phosphatase regulatory subunit).

WB:WBGene00013719	Y106G6H.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Aspirin; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily.

WB:WBGene00013720	Y106G6H.8
Is enriched in several structures, including NSM; germ line; germline precursor cell; intestine; and mechanosensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twelve chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF423) and Protein of unknown function DUF423. Is an ortholog of human TMEM256 (transmembrane protein 256).

WB:WBGene00013721	Y106G6H.9
Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00013722	Y106G6H.10
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013723	Y106G6H.13
Is enriched in NSM; neurons; pharynx; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00013724	Y106G6H.14
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Variant SH3 domain; SH3 domain; Ankyrin repeat; Ankyrin repeat-containing domain; SH3-like domain superfamily; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human OSTF1 (osteoclast stimulating factor 1).

WB:WBGene00013725	ska-1
Exhibits microtubule binding activity. Localizes to condensed chromosome kinetochore and mitotic spindle. Is an ortholog of human SKA1 (spindle and kinetochore associated complex subunit 1).

WB:WBGene00013726	Y106G6H.16
Is enriched in body wall muscle cell; germ line; neurons; pharyngeal muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; gld-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and Humic Substances based on microarray and RNA-seq studies.

WB:WBGene00013727	Y111B2A.1
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in abdominal obesity-metabolic syndrome 3 and autosomal dominant non-syndromic intellectual disability 7.

WB:WBGene00013728	Y111B2A.2
Is enriched in germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and let-7 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by nine chemicals including manganese chloride; bisphenol S; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytochrome c oxidase subunit VIc; Mitochondrial cytochrome c oxidase subunit VIc/VIIs; and Mitochondrial cytochrome c oxidase subunit VIc/VIIs superfamily.

WB:WBGene00013729	Y111B2A.3
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq; proteomic; and microarray studies. Is affected by fourteen chemicals including manganese chloride; bisphenol A; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00013730	sql-1
Localizes to Golgi apparatus. Human ortholog(s) of this gene are implicated in achondrogenesis type IA. Is an ortholog of human TRIP11 (thyroid hormone receptor interactor 11).

WB:WBGene00013732	aakg-1
Is predicted to have adenyl ribonucleotide binding activity and kinase activity. Human ortholog(s) of this gene are implicated in Wolff-Parkinson-White syndrome; hypertrophic cardiomyopathy 6; and lethal congenital glycogen storage disease of heart. Is an ortholog of human PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2).

WB:WBGene00013734	Y111B2A.10
Is enriched in NSM; OLL; PVD; germ line; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 21 and immunodeficiency-centromeric instability-facial anomalies syndrome 2. Is predicted to encode a protein with the following domains: C2H2-type zinc finger; Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human ZNF689 (zinc finger protein 689).

WB:WBGene00013735	Y111B2A.12
Is enriched in cholinergic neurons; germ line; pharyngeal neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human AAMP (angio associated migratory cell protein).

WB:WBGene00013736	gtf-2A2
Is predicted to have TBP-class protein binding activity and transcription coactivator activity. Is an ortholog of human GTF2A2 (general transcription factor IIA subunit 2).

WB:WBGene00013737	tpst-1
Exhibits protein-tyrosine sulfotransferase activity. Is involved in several processes, including collagen metabolic process; cuticle development involved in collagen and cuticulin-based cuticle molting cycle; and peptidyl-tyrosine sulfation. Localizes to trans-Golgi network. Is expressed in AIYL; AIYR; head neurons; and hypodermis. Is an ortholog of human TPST1 (tyrosylprotein sulfotransferase 1) and TPST2 (tyrosylprotein sulfotransferase 2).

WB:WBGene00013738	elpc-2
Is expressed in several structures, including body wall musculature; coelomocyte; excretory cell; intestine; and pharynx. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and Elongator complex protein 2. Is an ortholog of human ELP2 (elongator acetyltransferase complex subunit 2).

WB:WBGene00013739	spin-4
Is predicted to have transmembrane transporter activity. Is an ortholog of human SPNS1 (sphingolipid transporter 1 (putative)).

WB:WBGene00013740	hut-1
Is predicted to have UDP-galactose transmembrane transporter activity and UDP-glucose transmembrane transporter activity. Is involved in endoplasmic reticulum organization and nematode larval development. Localizes to Golgi apparatus and endoplasmic reticulum. Is expressed in coelomocyte; egg-laying apparatus; gonad; intestine; and pharyngeal cell. Is an ortholog of human SLC35B1 (solute carrier family 35 member B1).

WB:WBGene00013741	Y111B2A.21
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013742	sas-1
Localizes to centriole. Is expressed in sperm. Is used to study orofaciodigital syndrome.

WB:WBGene00013744	Y111B2A.27
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013746	lgc-55
Exhibits chloride channel activity. Is involved in chloride transport and mechanosensory behavior. Localizes to neuronal cell body and postsynaptic density. Is expressed in GLR; egg-laying apparatus; head muscle; nerve ring; and neurons.

WB:WBGene00013747	spe-19
Is involved in spermatid development.

WB:WBGene00013748	ssu-1
Exhibits 1-hydroxypyrene sulfotransferase activity and aryl sulfotransferase activity. Is involved in sulfur compound metabolic process. Localizes to cytosol. Is expressed in ASJL and ASJR. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 14. Is an ortholog of several human genes including SULT1B1 (sulfotransferase family 1B member 1); SULT2B1 (sulfotransferase family 2B member 1); and SULT6B1 (sulfotransferase family 6B member 1).

WB:WBGene00013749	Y113G7A.12
Is enriched in NSM; OLL; PVD; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013750	Y113G7A.13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including glp-1; elt-2; and pgl-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including stavudine; paraquat; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00013751	Y113G7A.14
Is enriched in BAG; body wall muscle cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-7; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013752	nlp-69
Is expressed in head neurons and mechanosensory neurons.

WB:WBGene00013753	Y113G7A.16
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013754	fbxa-116
Is involved in innate immune response.

WB:WBGene00013755	fbxa-115
Is enriched in several structures, including intestine; male distal tip cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013756	ftr-1
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; manganese chloride; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013757	fbxa-113
Is affected by several genes including daf-2; clk-1; and hsp-6 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013758	fbxa-114
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013759	fbxb-59
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; F-box associated; and F-box associated domain, type 2.

WB:WBGene00013760	srbc-34
Is enriched in intestine based on microarray studies. Is affected by several genes including eat-2; mex-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013761	Y113G7B.11
Is enriched in OLL; PVD; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00013762	Y113G7B.12
Is predicted to have extracellular matrix structural constituent.

WB:WBGene00013763	Y113G7B.14
Is enriched in head mesodermal cell; intestine; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; levamisole; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00013764	Y113G7B.15
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSC (cathepsin C); CTSK (cathepsin K); and CTSS (cathepsin S).

WB:WBGene00013765	cdkr-3
Is involved in IRE1-mediated unfolded protein response. Is expressed in neurons; pharynx; and spermatheca. Is an ortholog of human CDK5RAP3 (CDK5 regulatory subunit associated protein 3).

WB:WBGene00013766	prmt-1
Exhibits S-adenosyl-L-methionine binding activity and protein-arginine N-methyltransferase activity. Is involved in several processes, including cellular protein modification process; determination of adult lifespan; and heat acclimation. Localizes to cytoplasm. Is expressed in head; intestinal cell; pharyngeal cell; ventral nerve cord; and vulval cell. Is an ortholog of human PRMT1 (protein arginine methyltransferase 1) and PRMT8 (protein arginine methyltransferase 8).

WB:WBGene00013768	sld-5
Is predicted to contribute to 3'-5' DNA helicase activity. Localizes to nucleus. Is an ortholog of human GINS4 (GINS complex subunit 4).

WB:WBGene00013770	Y113G7B.26
Is affected by several genes including hpl-2; his-24; and hpl-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and tetrabromobisphenol A based on RNA-seq and microarray studies.

WB:WBGene00013771	Y113G7C.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00013772	clec-192
Is affected by clk-1 based on microarray studies. Is affected by resveratrol; adsorbable organic bromine compound; and Sirolimus based on microarray studies.

WB:WBGene00013773	Y116A8A.2
Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00013774	clec-193
Is predicted to have carbohydrate binding activity.

WB:WBGene00013775	Y116A8A.4
Is enriched in AVA; AVE; NSM; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00013776	Y116A8A.6
Is enriched in AVA; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00013777	Y116A8A.7
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00013778	clec-194
Is predicted to have carbohydrate binding activity.

WB:WBGene00013779	Y116A8B.1
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00013780	Y116A8B.2
No description available

WB:WBGene00013781	Y116A8B.4
Is enriched in dopaminergic neurons and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013782	npr-32
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 8 with or without anosmia.

WB:WBGene00013783	Y116A8C.1
Is affected by several genes including daf-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013784	Y116A8C.3
Is expressed in head.

WB:WBGene00013785	nep-23
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00013786	nep-24
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 5D and essential hypertension.

WB:WBGene00013788	Y116A8C.8
Is affected by several genes including drh-3; slr-2; and rsr-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine and paraquat based on microarray studies.

WB:WBGene00013789	Y116A8C.9
Is enriched in GABAergic neurons and germ line based on RNA-seq studies. Is affected by several genes including lin-28; sma-2; and sma-4 based on RNA-seq and microarray studies. Is affected by Rotenone; cadmium; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Transmembrane Fragile-X-F-associated protein. Is an ortholog of human TMEM185A (transmembrane protein 185A).

WB:WBGene00013790	Y116A8C.10
Is predicted to have GTPase activity. Is an ortholog of human RABL3 (RAB, member of RAS oncogene family like 3).

WB:WBGene00013791	Y116A8C.11
Is affected by several genes including eat-2; pmk-1; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013792	rad-54.B
Is predicted to have DNA translocase activity. Human ortholog(s) of this gene are implicated in non-Hodgkin lymphoma. Is an ortholog of human RAD54B (RAD54 homolog B).

WB:WBGene00013794	dct-13
Is predicted to have mRNA 3'-UTR binding activity. Is expressed in head muscle; head neurons; intestine; pharyngeal neurons; and somatic nervous system. Is an ortholog of human ZFP36L1 (ZFP36 ring finger protein like 1).

WB:WBGene00013795	nhr-229
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00013796	Y116A8C.19
Is predicted to have mRNA 3'-UTR binding activity. Is expressed in head muscle; intestine; and ventral nerve cord. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00013797	Y116A8C.20
Is predicted to have mRNA 3'-UTR binding activity. Is expressed in dorsal nerve cord and ventral nerve cord. Is an ortholog of human ZFP36 (ZFP36 ring finger protein) and ZFP36L2 (ZFP36 ring finger protein like 2).

WB:WBGene00013798	clec-195
Is predicted to have carbohydrate binding activity.

WB:WBGene00013799	athp-3
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00013800	Y116A8C.23
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00013801	Y116A8C.24
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00013802	Y116A8C.25
Is predicted to have kinase activity. Is an ortholog of human FN3KRP (fructosamine 3 kinase related protein).

WB:WBGene00013803	snx-13
Is predicted to have phosphatidylinositol binding activity. Is an ortholog of human SNX13 (sorting nexin 13).

WB:WBGene00013804	Y116A8C.27
Is enriched in germ line; intestine; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Cry5B; stavudine; and antimycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in mitochondrial complex V (ATP synthase) deficiency, nuclear type 1. Is predicted to encode a protein with the following domains: ATP12 chaperone protein; ATP12, ATP synthase F1-assembly protein; and ATP12 orthogonal Bundle domain superfamily. Is an ortholog of human ATPAF2 (ATP synthase mitochondrial F1 complex assembly factor 2).

WB:WBGene00013805	bca-2
Exhibits carbonate dehydratase activity. Is involved in cellular metabolic process.

WB:WBGene00013806	Y116A8C.29
Is enriched in AFD and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00013807	Y116A8C.30
Is predicted to have NADH dehydrogenase (ubiquinone) activity and electron transfer activity. Is an ortholog of human NDUFAF2 (NADH:ubiquinone oxidoreductase complex assembly factor 2).

WB:WBGene00013808	sfa-1
Is predicted to have RNA binding activity. Is involved in alternative mRNA splicing, via spliceosome. Is an ortholog of human SF1 (splicing factor 1).

WB:WBGene00013809	Y116A8C.33
Is expressed in intestine. Is predicted to encode a protein with the following domain: .

WB:WBGene00013810	Y116A8C.37
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00013811	Y116A8C.38
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00013812	Y116A8C.40
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00013814	Y116A8C.43
Is affected by several genes including daf-2; eat-2; and lin-15B based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00013815	Y116A8C.44
Is enriched in muscle cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq studies. Is affected by five chemicals including tryptophan; Psoralens; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00013816	Y116F11A.1
Is predicted to have ATP binding activity and DNA helicase activity.

WB:WBGene00013817	Y116F11A.3
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-12; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00013819	Y116F11A.6
Is enriched in intestine; muscle cell; neurons; and retrovesicular ganglion based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Death-like domain superfamily.

WB:WBGene00013820	Y116F11B.2
Is affected by several genes including rrf-3; clk-1; and bar-1 based on RNA-seq and microarray studies. Is affected by methylmercury hydroxide; manganese chloride; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00013821	srz-35
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00013822	Y116F11B.6
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00013823	Y116F11B.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013824	Y116F11B.8
Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; D-glucose; and metformin based on microarray and RNA-seq studies.

WB:WBGene00013825	Y116F11B.9
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00013826	Y116F11B.10
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by Zidovudine; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00013827	Y116F11B.11
Is affected by rsr-2 and hmg-3 based on tiling array and RNA-seq studies. Is affected by methylmercuric chloride and Colistin based on microarray studies.

WB:WBGene00013828	Y116F11B.13
Is affected by several genes including daf-16; daf-2; and mex-1 based on microarray and RNA-seq studies. Is affected by allantoin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013829	Y116F11B.14
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including tryptophan; methylmercuric chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00013830	ZC15.1
Is enriched in AVE; AVK; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol; Atrazine; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013831	clec-262
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; C-type lectin-like/link domain superfamily; and C-type lectin fold.

WB:WBGene00013832	ZC15.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00013833	ZC15.5
Is enriched in AVE and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; eat-2; and dpy-7 based on RNA-seq studies. Is affected by Zidovudine; Sodium Chloride; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00013834	clec-261
Is predicted to have carbohydrate binding activity.

WB:WBGene00013835	mlt-4
Is involved in ecdysis, collagen and cuticulin-based cuticle. Human ortholog(s) of this gene are implicated in nephronophthisis 2. Is an ortholog of human INVS (inversin).

WB:WBGene00013836	fbxa-29
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on RNA-seq; tiling array; and microarray studies. Is affected by five chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013837	fbxa-30
Is involved in innate immune response.

WB:WBGene00013838	fbxa-31
Is enriched in ASER; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; D-glucopyranose; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013839	fbxa-32
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by stavudine; paraquat; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013840	fbxa-151
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; sesamin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013841	fbxa-33
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Sodium Chloride; and allantoin based on RNA-seq studies.

WB:WBGene00013842	fbxa-34
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Sodium Chloride; and metformin based on RNA-seq studies.

WB:WBGene00013843	fbxa-49
Is enriched in muscle cell and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00013844	fbxa-50
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; procyanidin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00013845	fbxa-37
Is enriched in coelomocyte; germline precursor cell; hypodermis; muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Cadmium Chloride; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00013846	ZC84.1
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00013847	cls-3
Is involved in astral microtubule organization and establishment of mitotic spindle localization. Is expressed in neurons and pharyngeal gland cell. Is an ortholog of human CLASP1 (cytoplasmic linker associated protein 1) and CLASP2 (cytoplasmic linker associated protein 2).

WB:WBGene00013848	npr-29
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00013849	ZC84.6
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00013850	ZC84.7
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013852	hhat-1
Is predicted to have palmitoyltransferase activity. Is an ortholog of human HHAT (hedgehog acyltransferase).

WB:WBGene00013853	ZC116.1
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00013854	cyc-2.2
Is predicted to have electron transfer activity; heme binding activity; and metal ion binding activity. Human ortholog(s) of this gene are implicated in thrombocytopenia. Is an ortholog of human CYCS (cytochrome c, somatic).

WB:WBGene00013855	cubn-1
Is predicted to have calcium ion binding activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in Alagille syndrome and tetralogy of Fallot. Is an ortholog of human CUBN (cubilin).

WB:WBGene00013856	ZC168.2
Is involved in ATF6-mediated unfolded protein response and PERK-mediated unfolded protein response.

WB:WBGene00013857	orc-5
Is predicted to have DNA replication origin binding activity. Is an ortholog of human ORC5 (origin recognition complex subunit 5).

WB:WBGene00013858	ssp-34
Is enriched in GABAergic neurons and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00013859	ZC247.1
Is enriched in AFD; body wall musculature; dopaminergic neurons; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by twenty-one chemicals including hydrogen sulfide; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Autophagy protein Atg8 ubiquitin-like.

WB:WBGene00013860	ZC247.2
Is enriched in GABAergic neurons; OLL; PVD; body wall muscle cell; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by eleven chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00013861	ZC247.4
No description available

WB:WBGene00013862	wdr-5.3
Localizes to MLL3/4 complex. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 20; nephronophthisis 20; and primary autosomal recessive microcephaly 2 with or without cortical malformations. Is an ortholog of human WDR5 (WD repeat domain 5) and WDR5B (WD repeat domain 5B).

WB:WBGene00013863	ZC302.3
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00013865	ZC334.7
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity.

WB:WBGene00013866	cbs-1
Exhibits cystathionine beta-synthase activity; cysteine synthase activity; and pyridoxal phosphate binding activity. Is involved in sulfur compound biosynthetic process. Localizes to cytoplasm. Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in homocystinuria. Is an ortholog of human CBSL (cystathionine beta-synthase like).

WB:WBGene00013867	ZC373.2
Is enriched in AVK and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including Heme; Ethanol; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013868	ZC373.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00013869	mlck-1
Is predicted to have myosin light chain kinase activity. Is expressed in anal sphincter muscle; hermaphrodite gonad; pharynx; and vulval cell. Is an ortholog of human MYLK3 (myosin light chain kinase 3) and MYLK4 (myosin light chain kinase family member 4).

WB:WBGene00013870	ZC373.5
Is predicted to have methylthioribulose 1-phosphate dehydratase activity and zinc ion binding activity. Is expressed in tail. Is an ortholog of human APIP (APAF1 interacting protein).

WB:WBGene00013871	gnrr-3
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00013872	ZC374.2
Is enriched in body wall muscle cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and sesamin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Fibronectin type III domain; Fibronectin type III; Immunoglobulin-like fold; and Fibronectin type III superfamily.

WB:WBGene00013873	cest-2.3
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase) and CES2 (carboxylesterase 2).

WB:WBGene00013874	cest-2.2
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase) and CES2 (carboxylesterase 2).

WB:WBGene00013875	cest-2.1
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase) and CES2 (carboxylesterase 2).

WB:WBGene00013876	ceh-74
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord and ventral nerve cord.

WB:WBGene00013877	ints-2
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by six chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Integrator complex subunit 2 and Integrator complex subunit 2. Is an ortholog of human INTS2 (integrator complex subunit 2).

WB:WBGene00013878	atfs-1
Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and mitochondrial sequence-specific DNA-binding transcription factor activity. Is involved in several processes, including mitochondrial unfolded protein response; positive regulation of nematode larval development; and regulation of gene expression. Localizes to mitochondrial matrix. Colocalizes with nucleus.

WB:WBGene00013879	ZC376.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00013880	mppb-1
Contributes to metalloendopeptidase activity. Is involved in proteolysis. Localizes to mitochondrial processing peptidase complex. Human ortholog(s) of this gene are implicated in multiple mitochondrial dysfunctions syndrome 6. Is an ortholog of human PMPCB (peptidase, mitochondrial processing subunit beta).

WB:WBGene00013881	mans-4
Is predicted to have mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Human ortholog(s) of this gene are implicated in non-syndromic intellectual disability. Is an ortholog of human MAN1B1 (mannosidase alpha class 1B member 1).

WB:WBGene00013882	msa-1
Is enriched in several structures, including cephalic sheath cell; germ line; hypodermis; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; Rotenone; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterised conserved protein UCP207779.

WB:WBGene00013883	npr-13
Is predicted to have neuropeptide Y receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human PRLHR (prolactin releasing hormone receptor).

WB:WBGene00013884	ZC412.3
Is enriched in PLM; body wall muscle cell; body wall musculature; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including nicotinic acid; Rotenone; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Abnormal cell migration protein 18-like.

WB:WBGene00013886	ZC412.5
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5386) and Protein of unknown function DUF5386.

WB:WBGene00013887	nspa-5
Is enriched in amphid sheath cell; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; Ethanol; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013888	nspa-3
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013889	ZC412.8
Is affected by several genes including daf-2; eat-2; and pmk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013890	ZC412.9
Is enriched in arcade cell; neurons; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Acrylamide; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013891	ZC434.3
Is enriched in PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013892	ZC434.4
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by four chemicals including Rotenone; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosomal RNA-processing protein 7 (RRP7) C-terminal domain; Ribosomal RNA-processing protein 7, C-terminal domain; and Ribosomal RNA-processing protein 7. Is an ortholog of human RRP7A (ribosomal RNA processing 7 homolog A).

WB:WBGene00013893	coa-6
Is predicted to have ribonuclease P activity. Is an ortholog of human PRORP (protein only RNase P catalytic subunit).

WB:WBGene00013894	ZC434.8
Is predicted to have creatine kinase activity. Is an ortholog of human CKMT2 (creatine kinase, mitochondrial 2).

WB:WBGene00013895	ZC434.9
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of several human genes including CPA2 (carboxypeptidase A2); CPA5 (carboxypeptidase A5); and CPA6 (carboxypeptidase A6).

WB:WBGene00013896	ZC443.1
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00013897	ZC443.2
Is enriched in coelomocyte; neurons; pharynx; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00013898	ZC443.3
Is predicted to contribute to translation initiation factor activity. Is expressed in several structures, including pharynx.

WB:WBGene00013899	ZC443.4
Is predicted to contribute to translation initiation factor activity.

WB:WBGene00013900	ugt-18
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00013901	ugt-16
Is predicted to have UDP-glycosyltransferase activity. Is expressed in intestine and pharynx. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00013902	ZC455.1
Is enriched in coelomocyte based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; D-glucopyranose; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013903	ugt-3
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A4 (UDP glucuronosyltransferase family 1 member A4); UGT2B11 (UDP glucuronosyltransferase family 2 member B11); and UGT2B15 (UDP glucuronosyltransferase family 2 member B15).

WB:WBGene00013904	ugt-6
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A5 (UDP glucuronosyltransferase family 1 member A5); and UGT1A6 (UDP glucuronosyltransferase family 1 member A6).

WB:WBGene00013905	ugt-4
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A4 (UDP glucuronosyltransferase family 1 member A4); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2A3 (UDP glucuronosyltransferase family 2 member A3).

WB:WBGene00013906	ugt-5
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A3 (UDP glucuronosyltransferase family 1 member A3); UGT2A3 (UDP glucuronosyltransferase family 2 member A3); and UGT2B10 (UDP glucuronosyltransferase family 2 member B10).

WB:WBGene00013907	sre-20
Is affected by several genes including mex-3; dpy-21; and spn-4 based on RNA-seq studies. Is affected by Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00013908	srbc-43
Is affected by rsr-2; eat-2; and sftb-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Progesterone; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013909	srbc-44
Is affected by several genes including clk-1; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013910	srbc-45
Is affected by rsr-2; mir-34; and daf-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00013911	irld-60
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00013912	irld-19
Is affected by several genes including daf-2; sir-2.1; and set-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine; dibromoacetic acid; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00013913	irld-61
Is affected by cyc-1; alg-1; and thoc-5 based on microarray and RNA-seq studies. Is affected by Progesterone based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00013914	lgc-37
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in alcohol dependence and brain disease (multiple). Is an ortholog of several human genes including GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1); GABRA6 (gamma-aminobutyric acid type A receptor subunit alpha6); and GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2).

WB:WBGene00013915	irld-20
Is affected by cyc-1; rsr-2; and prg-1 based on microarray and tiling array studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00013916	ZC504.1
Is predicted to have serine-type endopeptidase inhibitor activity.

WB:WBGene00013917	cdk-11.2
Is predicted to have cyclin-dependent protein serine/threonine kinase activity. Is involved in positive regulation of embryonic development. Localizes to cytoplasm and nucleus. Is expressed in gonad; gonadal sheath cell; somatic cell; and somatic gonad. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 2 and primary autosomal recessive microcephaly 12. Is an ortholog of human CDK11A (cyclin dependent kinase 11A) and CDK11B (cyclin dependent kinase 11B).

WB:WBGene00013918	C12C8.t6
No description available

WB:WBGene00013919	ZC506.1
Is predicted to have calcium ion binding activity and mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Is expressed in tail. Is an ortholog of human EDEM3 (ER degradation enhancing alpha-mannosidase like protein 3).

WB:WBGene00013920	pssy-1
Is enriched in AFD; dopaminergic neurons; and pharynx based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Humic Substances based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Lenz-Majewski hyperostotic dwarfism. Is predicted to encode a protein with the following domains: Phosphorylation site; Phosphatidyl serine synthase; and Phosphatidyl serine synthase. Is an ortholog of human PTDSS1 (phosphatidylserine synthase 1).

WB:WBGene00013921	best-22
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00013923	ghi-1
Is predicted to have lipid binding activity.

WB:WBGene00013924	rad-23
Is predicted to have polyubiquitin modification-dependent protein binding activity; proteasome binding activity; and ubiquitin binding activity. Is expressed in dorsal nerve cord; head; neurons; ventral nerve cord; and vulva. Is an ortholog of human RAD23A (RAD23 homolog A, nucleotide excision repair protein) and RAD23B (RAD23 homolog B, nucleotide excision repair protein).

WB:WBGene00013925	coa-7
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including aldicarb; Rotenone; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease. Is predicted to encode a protein with the following domains: Sel1 repeat; Sel1-like repeat; Tetratricopeptide-like helical domain superfamily; and Beta-lactamase HcpB-like. Is an ortholog of human COA7 (cytochrome c oxidase assembly factor 7 (putative)).

WB:WBGene00013926	nep-1
Is predicted to have metal ion binding activity and metalloendopeptidase activity. Is expressed in RIH and pharynx. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension. Is an ortholog of human ECE1 (endothelin converting enzyme 1).

WB:WBGene00013927	clec-95
Is predicted to have carbohydrate binding activity.

WB:WBGene00013928	clec-94
Is predicted to have carbohydrate binding activity.

WB:WBGene00013929	clec-93
Is predicted to have carbohydrate binding activity.

WB:WBGene00013930	clec-96
Is predicted to have carbohydrate binding activity.

WB:WBGene00013931	clec-97
Is predicted to have carbohydrate binding activity.

WB:WBGene00013932	clec-98
Is predicted to have carbohydrate binding activity.

WB:WBGene00013933	clec-99
Is predicted to have carbohydrate binding activity.

WB:WBGene00013934	ZK131.11
Is enriched in head mesodermal cell; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Cry5B; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00013935	ZK218.1
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00013936	ZK218.2
No description available

WB:WBGene00013937	ZK218.3
Is affected by several genes including lin-15B; mex-3; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00013938	ZK218.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00013939	ZK218.5
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Zidovudine; Tunicamycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00013940	nhr-248
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00013941	ZK218.7
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00013942	ZK218.8
Is affected by several genes including eat-2; cyc-1; and klf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00013943	ZK218.11
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00013944	ZK228.1
Is affected by several genes including lin-4; lin-14; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013945	ZK228.2
No description available

WB:WBGene00013946	ZK228.3
Is enriched in intestine and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including diallyl trisulfide; Tunicamycin; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Acetyltransferase (GNAT) domain; Acyl-CoA N-acyltransferase; and YitH, acetyltransferase (GNAT) domain.

WB:WBGene00013947	ZK228.4
Is predicted to have N-acetyltransferase activity. Is involved in innate immune response.

WB:WBGene00013948	C13B4.t1
No description available

WB:WBGene00013949	ZK262.2
Is expressed in neuronal sheath cell and pharynx. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00013950	txt-8
Is predicted to have hydrolase activity.

WB:WBGene00013951	ZK262.4
Is enriched in DA neuron; GABAergic neurons; VA neuron; amphid sheath cell; and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and aak-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013952	ZK262.5
No description available

WB:WBGene00013953	ZK262.8
Is enriched in DA neuron; VA neuron; body wall muscle cell; germline precursor cell; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including skn-1; age-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Testosterone; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00013954	ZK262.9
Is enriched in NSM based on tiling array studies. Is affected by several genes including skn-1; pgl-1; and hsp-6 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; paraquat; and Testosterone based on RNA-seq and microarray studies.

WB:WBGene00013955	kri-1
Localizes to apical plasma membrane; apicolateral plasma membrane; and nucleus. Is expressed in intestine and pharynx. Human ortholog(s) of this gene are implicated in cerebral cavernous malformation 1. Is an ortholog of human KRIT1 (KRIT1 ankyrin repeat containing).

WB:WBGene00013956	ZK265.3
Is enriched in NSM; amphid sheath cell; somatic gonad precursor; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00013957	sre-23
Is involved in IRE1-mediated unfolded protein response. Is expressed in head and tail.

WB:WBGene00013958	nol-16
Localizes to nucleolus. Is an ortholog of human NOP16 (NOP16 nucleolar protein).

WB:WBGene00013959	ZK265.7
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00013960	cutl-8
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013961	ZK285.2
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00013962	ZK287.1
Is predicted to have hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines and zinc ion binding activity. Is expressed in tail.

WB:WBGene00013963	sulp-8
Is predicted to have transmembrane transporter activity. Localizes to basolateral plasma membrane. Is expressed in excretory cell and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human SLC26A4 (solute carrier family 26 member 4).

WB:WBGene00013964	nlp-73
Is enriched in intestine and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013965	ZK287.4
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00013966	ztf-9
Is enriched in germ line; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Sirolimus; Rifampin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00013967	ZK287.7
Is predicted to have RNA binding activity and pseudouridine synthase activity. Is an ortholog of human RPUSD3 (RNA pseudouridine synthase D3) and RPUSD4 (RNA pseudouridine synthase D4).

WB:WBGene00013968	ZK287.9
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00013969	tep-1
Is predicted to have endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1; age related macular degeneration 9; and complement deficiency (multiple). Is an ortholog of human CD109 (CD109 molecule).

WB:WBGene00013970	klu-1
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity.

WB:WBGene00013971	scl-19
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Hydrolyzable Tannins; Colistin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00013972	scl-20
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including tryptophan; methylmercuric chloride; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00013973	asp-18
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00013974	npr-9
Is predicted to have G protein-coupled receptor activity. Is involved in foraging behavior. Is expressed in AIBL and AIBR. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia; hypogonadotropic hypogonadism 8 with or without anosmia; and type 2 diabetes mellitus. Is an ortholog of human GALR1 (galanin receptor 1) and GALR2 (galanin receptor 2).

WB:WBGene00013975	ZK455.5
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00013976	hizr-1
Exhibits DNA-binding transcription factor activity; cis-regulatory region sequence-specific DNA binding activity; and zinc ion binding activity. Is involved in cellular response to zinc ion; positive regulation of gene expression; and regulation of growth. Localizes to cytoplasm and nucleus.

WB:WBGene00013978	ZK507.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00013979	ZK507.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00013980	dos-1
Is predicted to have Notch binding activity.

WB:WBGene00013982	ZK512.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00013983	ZK512.2
Is predicted to have RNA binding activity and RNA helicase activity. Is expressed in head; intestine; and tail. Is an ortholog of human DDX55 (DEAD-box helicase 55).

WB:WBGene00013984	ZK512.4
Is predicted to have 7S RNA binding activity. Is expressed widely. Is an ortholog of human SRP9 (signal recognition particle 9).

WB:WBGene00013985	sec-16A.1
Is involved in endoplasmic reticulum to Golgi vesicle-mediated transport and protein localization to endoplasmic reticulum exit site. Localizes to endoplasmic reticulum exit site. Is an ortholog of human SEC16A (SEC16 homolog A, endoplasmic reticulum export factor).

WB:WBGene00013986	ZK512.7
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty chemicals including Ethanol; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00013987	ZK512.8
Is enriched in NSM; arcade cell; germ line; pharyngeal-intestinal valve cell; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5386) and Protein of unknown function DUF5386.

WB:WBGene00013988	ZK512.10
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00013989	ZK512.11
Is enriched in AFD; ASER; head mesodermal cell; and muscle cell based on RNA-seq studies. Is affected by several genes including rrf-3; pgl-1; and glh-1 based on RNA-seq studies. Is affected by allantoin; Sirolimus; and paraquat based on RNA-seq studies.

WB:WBGene00013993	C15C6.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00013994	ZK524.4
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human SNRK (SNF related kinase).

WB:WBGene00013995	mboa-5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and npr-1 based on RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00013996	ZK550.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00013997	ZK550.3
Is predicted to have metalloendopeptidase activity. Is an ortholog of human THOP1 (thimet oligopeptidase 1).

WB:WBGene00013998	gtf-2E1
Is predicted to have RNA polymerase II complex binding activity. Is involved in transcription initiation from RNA polymerase II promoter. Localizes to transcription factor TFIIE complex. Is an ortholog of human GTF2E1 (general transcription factor IIE subunit 1).

WB:WBGene00013999	ZK550.5
Is predicted to have phytanoyl-CoA dioxygenase activity. Is expressed in nerve ring. Human ortholog(s) of this gene are implicated in Refsum disease. Is an ortholog of human PHYH (phytanoyl-CoA 2-hydroxylase).

WB:WBGene00014000	ZK550.6
Is predicted to have phytanoyl-CoA dioxygenase activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Refsum disease. Is an ortholog of human PHYH (phytanoyl-CoA 2-hydroxylase).

WB:WBGene00014001	pyk-2
Is predicted to have pyruvate kinase activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is expressed in intestine. Human ortholog(s) of this gene are implicated in pyruvate kinase deficiency of red cells. Is an ortholog of human PKLR (pyruvate kinase L/R) and PKM (pyruvate kinase M1/2).

WB:WBGene00014002	ZK593.2
Is enriched in body wall muscle cell; dopaminergic neurons; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00014003	ZK593.3
Is enriched in coelomocyte and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by nineteen chemicals including 1-methylnicotinamide; D-glucopyranose; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00014004	fic-1
Exhibits protein adenylyltransferase activity. Is involved in defense response to Gram-negative bacterium and protein adenylylation. Localizes to endoplasmic reticulum and nuclear envelope. Is expressed widely. Is an ortholog of human FICD (FIC domain protein adenylyltransferase).

WB:WBGene00014005	ZK593.9
Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00014006	ZK596.1
Is expressed in g1AL; g1AR; g1P; g2L; and g2R. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00014007	ZK596.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00014008	ZK596.3
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eleven chemicals including D-glucopyranose; D-glucose; and 4-bromodiphenyl ether based on RNA-seq and microarray studies.

WB:WBGene00014009	lips-6
Is predicted to have lipase activity. Is expressed in intestine.

WB:WBGene00014011	ZK632.2
Is predicted to have mRNA binding activity. Is an ortholog of human SLC4A1AP (solute carrier family 4 member 1 adaptor protein).

WB:WBGene00014012	riok-3
Is predicted to have protein serine/threonine kinase activity. Is expressed in intestine. Is an ortholog of human RIOK3 (RIO kinase 3).

WB:WBGene00014013	ZK632.4
Is predicted to have mannose-6-phosphate isomerase activity. Is expressed in amphid neurons; head neurons; hypodermis; intestine; and nervous system. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ib. Is an ortholog of human MPI (mannose phosphate isomerase).

WB:WBGene00014014	ZK632.5
Is enriched in OLL; PVD; germ line; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014015	panl-3
Is predicted to contribute to poly(A)-specific ribonuclease activity. Is involved in reproduction. Is an ortholog of human PAN3 (poly(A) specific ribonuclease subunit PAN3).

WB:WBGene00014016	ZK632.9
Is enriched in germline precursor cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; DNA-binding nuclear phosphoprotein p8; and Nuclear protein 1-like.

WB:WBGene00014017	ZK632.10
Is enriched in Z1; Z4; germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00014018	ZK632.11
Is enriched in AFD; body wall muscle cell; germ line; germline precursor cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PSP and PSP, proline-rich. Is an ortholog of human ZCCHC8 (zinc finger CCHC-type containing 8).

WB:WBGene00014019	ZK632.12
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Is expressed in intestine; pharynx; and reproductive system. Is an ortholog of human PLEKHF2 (pleckstrin homology and FYVE domain containing 2).

WB:WBGene00014020	ZK632.14
Is predicted to have nucleic acid binding activity. Is an ortholog of human RPP25L (ribonuclease P/MRP subunit p25 like).

WB:WBGene00014021	svop-1
Is predicted to have transmembrane transporter activity. Is an ortholog of human SVOP (SV2 related protein).

WB:WBGene00014022	ZK637.2
Localizes to striated muscle dense body. Is an ortholog of human FAM136A (family with sequence similarity 136 member A).

WB:WBGene00014023	lnkn-1
Localizes to apical plasma membrane and lateral plasma membrane. Is expressed in several structures, including excretory cell; germ cell; gonad; hypodermis; and nervous system. Is an ortholog of human ITFG1 (integrin alpha FG-GAP repeat containing 1).

WB:WBGene00014024	ZK637.4
Is enriched in intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00014025	asna-1
Exhibits ATPase activity. Is involved in detoxification of arsenic-containing substance and positive regulation of insulin secretion. Localizes to axon and neuronal cell body. Is expressed in several structures, including excretory cell; intestine; nervous system; pharynx; and reproductive system. Is an ortholog of human GET3 (guided entry of tail-anchored proteins factor 3, ATPase).

WB:WBGene00014026	C17D12.t1
No description available

WB:WBGene00014027	tpk-1
Is predicted to have thiamine diphosphokinase activity. Is expressed in body wall musculature and pharyngeal muscle cell. Is an ortholog of human TPK1 (thiamin pyrophosphokinase 1).

WB:WBGene00014028	trxr-2
Exhibits thioredoxin-disulfide reductase activity. Is involved in oxidation-reduction process. Localizes to mitochondrion. Is expressed in intestine; muscle cell; nervous system; and vulva. Is used to study chromosome 22q11.2 deletion syndrome, distal. Is an ortholog of human TXNRD2 (thioredoxin reductase 2).

WB:WBGene00014029	ZK637.12
Is enriched in germ line; intestine; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00014030	glb-1
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in VC neuron; germ line; head muscle; head neurons; and tail neurons.

WB:WBGene00014031	ZK637.14
Is predicted to have ubiquitin protein ligase activity.

WB:WBGene00014032	ZK637.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Rifampin; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00014033	arrd-15
Localizes to striated muscle dense body. Is expressed in ganglia and vulval muscle, type 1. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00014034	ZK643.2
Is predicted to have dCMP deaminase activity. Is expressed in hypodermis. Is an ortholog of human DCTD (dCMP deaminase).

WB:WBGene00014035	seb-2
Is predicted to have G protein-coupled receptor activity. Is expressed in head muscle; vm1; vm1; vm1; and vm1. Human ortholog(s) of this gene are implicated in bone development disease (multiple) and primary failure of tooth eruption. Is an ortholog of human CALCRL (calcitonin receptor like receptor).

WB:WBGene00014036	ZK643.5
Is expressed in head ganglion; lateral ganglion; tail neurons; ventral ganglion; and ventral nerve cord. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00014037	ZK643.6
Is affected by several genes including daf-2; hpl-2; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00014039	ZK662.2
Is enriched in DA neuron and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including 1-methylnicotinamide; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014040	ZK662.5
Is affected by several genes including daf-2; eat-2; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ribonuclease H-like superfamily and Protein lin-15B-like.

WB:WBGene00014041	ZK666.1
Is affected by several genes including daf-2; rrf-3; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00014042	ZK666.2
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; D-glucose; and resveratrol based on microarray and RNA-seq studies.

WB:WBGene00014043	clec-58
Is predicted to have carbohydrate binding activity.

WB:WBGene00014044	ZK666.4
Is affected by several genes including daf-2; let-60; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including hydrogen sulfide; Tunicamycin; and cadmium based on microarray studies.

WB:WBGene00014045	clec-59
Is predicted to have carbohydrate binding activity.

WB:WBGene00014046	clec-60
Is involved in defense response to Gram-positive bacterium. Is expressed in intestine.

WB:WBGene00014047	clec-61
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00014048	ZK666.8
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00014049	ZK666.11
Is affected by several genes including hpl-2; drh-3; and smn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014050	ZK666.12
Is affected by several genes including daf-12; prg-1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00014051	spv-1
Is predicted to have GTPase activator activity and metal ion binding activity. Is expressed in head neurons; hypodermis; spermatheca; spermathecal cell; and tail neurons. Is an ortholog of human ARHGAP29 (Rho GTPase activating protein 29) and GMIP (GEM interacting protein).

WB:WBGene00014052	ZK669.2
Is enriched in AFD; PLM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; bisphenol A; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00014053	ZK669.3
Is enriched in OLL; PVD; dopaminergic neurons; hypodermis; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; procyanidin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00014054	dbt-1
Is predicted to have acetyltransferase activity and lipoic acid binding activity. Is involved in several processes, including positive regulation of fatty acid biosynthetic process; positive regulation of nematode larval development; and positive regulation of oviposition. Localizes to cilium; cytosol; and neuron projection. Is expressed in several structures, including body wall musculature; head neurons; hypodermis; and intestine. Human ortholog(s) of this gene are implicated in maple syrup urine disease. Is an ortholog of human DBT (dihydrolipoamide branched chain transacylase E2).

WB:WBGene00014055	ZK669.5
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4.

WB:WBGene00014057	ZK673.1
Is enriched in OLL; PVD; amphid sheath cell; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; Tunicamycin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00014058	ZK673.2
Is predicted to have ATP binding activity and adenylate kinase activity. Is an ortholog of human AK3 (adenylate kinase 3) and AK4 (adenylate kinase 4).

WB:WBGene00014060	ZK673.4
Is predicted to have metal ion binding activity.

WB:WBGene00014061	ZK673.5
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including hydrogen sulfide; Rifampin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00014062	ZK673.6
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00014063	clec-143
Is predicted to have carbohydrate binding activity.

WB:WBGene00014064	sdz-37
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00014065	ZK673.11
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; sir-2.1; and lin-39 based on RNA-seq; tiling array; and microarray studies. Is affected by Chlorpyrifos; Diazinon; and Colistin based on microarray studies.

WB:WBGene00014066	rev-1
Is predicted to have DNA-directed DNA polymerase activity and deoxycytidyl transferase activity. Is expressed in intestine; neurons; and vulval muscle, type 1. Is an ortholog of human REV1 (REV1 DNA directed polymerase).

WB:WBGene00014067	ZK675.4
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including skn-1; age-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Mercuric Chloride; and sesamin based on microarray and RNA-seq studies.

WB:WBGene00014068	nhr-255
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00014069	ZK678.3
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is an ortholog of human CCNA1 (cyclin A1).

WB:WBGene00014070	srxa-9
Is affected by several genes including eat-2; pgl-1; and rrf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00014073	ZK757.1
Is expressed in AIYL and AIYR. Is predicted to encode a protein with the following domain: Protein of unknown function DUF1182.

WB:WBGene00014074	ZK757.2
Is predicted to have protein tyrosine/serine/threonine phosphatase activity. Human ortholog(s) of this gene are implicated in Lafora disease; hypogonadotropic hypogonadism 19 with or without anosmia; and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP14 (dual specificity phosphatase 14).

WB:WBGene00014075	dhhc-4
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is expressed in several structures, including enteric muscle; gonad; nervous system; pharyngeal-intestinal valve; and rectum. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ZDHHC15 (zinc finger DHHC-type palmitoyltransferase 15).

WB:WBGene00014076	ZK792.1
Is expressed in intestine; nervous system; and rectal epithelium. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human PXYLP1 (2-phosphoxylose phosphatase 1).

WB:WBGene00014077	ZK792.4
Is expressed in several structures, including amphid socket cell; head; intestine; pharynx; and rectal gland cell. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 36. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human ESPN (espin) and ESPNL (espin like).

WB:WBGene00014078	ZK792.5
Is predicted to have RNA binding activity. Is an ortholog of human NOP9 (NOP9 nucleolar protein).

WB:WBGene00014079	ZK792.7
Is expressed in body wall musculature; head neurons; pharyngeal muscle cell; and tail neurons. Is predicted to encode a protein with the following domain: PGAP5/Cdc1/Ted1.

WB:WBGene00014080	atg-4.2
Exhibits cysteine-type endopeptidase activity. Is involved in proteolysis. Is expressed in embryonic cell; gonad; and oocyte. Is an ortholog of human ATG4C (autophagy related 4C cysteine peptidase) and ATG4D (autophagy related 4D cysteine peptidase).

WB:WBGene00014081	ipmk-1
Is predicted to have kinase activity. Is an ortholog of human IPMK (inositol polyphosphate multikinase).

WB:WBGene00014082	ZK795.2
Is expressed in germ line.

WB:WBGene00014083	ZK795.3
Is predicted to have snoRNA binding activity. Is expressed in several structures, including P6.paa; P6.pap; enteric muscle; excretory cell; and reproductive system. Is an ortholog of human IMP4 (IMP U3 small nucleolar ribonucleoprotein 4).

WB:WBGene00014084	snb-7
Is predicted to have SNAP receptor activity and syntaxin binding activity. Human ortholog(s) of this gene are implicated in spastic ataxia 1.

WB:WBGene00014085	ZK809.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00014086	ZK809.3
Is enriched in NSM and germ line based on proteomic and RNA-seq studies. Is affected by several genes including let-60; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NADH:ubiquinone oxidoreductase, NDUFB6/B17 subunit and NADH dehydrogenase 1, beta subcomplex, subunit 6.

WB:WBGene00014087	ZK809.5
Is enriched in AVA; GABAergic neurons; germ line; germline precursor cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; sodium arsenite; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00014088	ZK809.8
Is enriched in PLM; body wall muscle cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00014089	ZK822.1
Is enriched in OLL; PVD; intestine; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00014090	ZK822.2
Is enriched in several structures, including PLM; RIS; germ line; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00014091	ZK822.4
Is enriched in AFD; PLM; and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including aldicarb; bisphenol A; and procyanidin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00014092	ZK822.5
Is predicted to have transmembrane transporter activity. Is expressed in several structures, including intestine; nervous system; non-striated muscle; pharynx; and rectal gland cell. Human ortholog(s) of this gene are implicated in renal glycosuria. Is an ortholog of human SLC5A12 (solute carrier family 5 member 12) and SLC5A8 (solute carrier family 5 member 8).

WB:WBGene00014093	ZK829.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Cry5B; Colistin; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00014094	ZK829.3
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00014095	gdh-1
Is predicted to have glutamate dehydrogenase (NAD+) activity. Is expressed in head; intestine; pharynx; rectal gland cell; and tail. Human ortholog(s) of this gene are implicated in familial hyperinsulinemic hypoglycemia 6 and late onset Parkinson's disease. Is an ortholog of human GLUD1 (glutamate dehydrogenase 1) and GLUD2 (glutamate dehydrogenase 2).

WB:WBGene00014096	ZK829.7
Is predicted to have alcohol dehydrogenase (NADP+) activity. Is expressed in several structures, including anal depressor muscle; egg-laying apparatus; intestine; nervous system; and rectal epithelium. Human ortholog(s) of this gene are implicated in alcohol dependence and late onset Parkinson's disease.

WB:WBGene00014097	ZK829.9
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00014098	ogdh-2
Is predicted to have oxoglutarate dehydrogenase (succinyl-transferring) activity. Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in 2-aminoadipic 2-oxoadipic aciduria and Charcot-Marie-Tooth disease axonal type 2Q. Is an ortholog of human DHTKD1 (dehydrogenase E1 and transketolase domain containing 1).

WB:WBGene00014099	ZK836.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; 1-methylnicotinamide; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00014100	ZK849.1
Is enriched in neurons; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain; and PDZ superfamily.

WB:WBGene00014101	gopc-1
Exhibits identical protein binding activity. Is an ortholog of human GOPC (golgi associated PDZ and coiled-coil motif containing).

WB:WBGene00014102	best-25
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of several human genes including BEST2 (bestrophin 2); BEST3 (bestrophin 3); and BEST4 (bestrophin 4).

WB:WBGene00014103	best-26
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00014104	ZK849.6
Is enriched in amphid sheath cell; cholinergic neurons; hypodermis; muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00014105	ZK856.4
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including fbf-1; hpl-2; and rsd-2 based on RNA-seq and microarray studies. Is affected by resveratrol and nitroguanidine based on microarray studies.

WB:WBGene00014106	ZK856.5
Is predicted to have phosphoric diester hydrolase activity. Is an ortholog of human SMPDL3B (sphingomyelin phosphodiesterase acid like 3B).

WB:WBGene00014107	ZK856.6
Is enriched in AFD; ASER; PLM; and neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00014108	ZK856.7
Is enriched in amphid sheath cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014109	chpf-1
Is predicted to have calcium ion binding activity. Is expressed in head; intestine; tail; and in male. Human ortholog(s) of this gene are implicated in Usher syndrome type 1J and autosomal recessive nonsyndromic deafness 48. Is an ortholog of human CHP1 (calcineurin like EF-hand protein 1).

WB:WBGene00014111	rpc-25
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and let-60 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SHS2 domain found in N terminus of Rpb7p/Rpc25p/MJ0397; RNA polymerase III subunit Rpc25; RNA polymerase Rpb7-like , N-terminal; Nucleic acid-binding, OB-fold; RNA polymerase III, subunit Rpc25; and RNA polymerase Rpb7-like, N-terminal domain superfamily. Is an ortholog of human POLR3H (RNA polymerase III subunit H).

WB:WBGene00014112	ZK856.11
Is predicted to have translation initiation factor activity. Localizes to nucleus. Is an ortholog of human EIF1AD (eukaryotic translation initiation factor 1A domain containing).

WB:WBGene00014113	hpo-40
Is enriched in PLM; germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fifteen chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00014114	tftc-3
Is enriched in germ line; germline precursor cell; intestine; and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including let-60; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and Transcription factor Tfc4/TFIIIC-102/Sfc4. Is an ortholog of human GTF3C3 (general transcription factor IIIC subunit 3).

WB:WBGene00014115	gld-4
Exhibits polynucleotide adenylyltransferase activity. Is involved in mRNA polyadenylation. Localizes to P granule and polysome. Is expressed in Z2; Z3; and germ line. Is an ortholog of human TENT4A (terminal nucleotidyltransferase 4A).

WB:WBGene00014116	ZK858.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00014117	clec-91
Is predicted to have carbohydrate binding activity. Is expressed in germ line. Is an ortholog of human KLRF2 (killer cell lectin like receptor F2).

WB:WBGene00014118	ZK858.5
Is enriched in germ line; germline precursor cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TM2 domain and TM2 domain. Is an ortholog of human DNAJC22 (DnaJ heat shock protein family (Hsp40) member C22).

WB:WBGene00014119	ZK858.6
Is expressed in intestine. Is predicted to encode a protein with the following domains: Endomembrane protein 70 and Nonaspanin (TM9SF). Is an ortholog of human TM9SF4 (transmembrane 9 superfamily member 4).

WB:WBGene00014120	ZK858.7
Is enriched in Psub2; germ line; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by five chemicals including Cry5B; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Gcd10p family and tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6. Is an ortholog of human TRMT6 (tRNA methyltransferase 6).

WB:WBGene00014121	ZK858.8
Is enriched in AVK; amphid sheath cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00014122	ZK863.1
Is enriched in AFD and neurons based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014123	elpc-3
Is predicted to have phosphorylase kinase regulator activity. Is involved in several processes, including gamete generation; olfactory learning; and translation. Is expressed in CAN; HSN; amphid neurons; pharynx; and vulva. Is an ortholog of human ELP3 (elongator acetyltransferase complex subunit 3).

WB:WBGene00014124	usip-1
Exhibits RNA uridylyltransferase activity. Is involved in U6 snRNA 3'-end processing. Localizes to nucleoplasm. Human ortholog(s) of this gene are implicated in spastic ataxia 4. Is an ortholog of human MTPAP (mitochondrial poly(A) polymerase) and TUT1 (terminal uridylyl transferase 1, U6 snRNA-specific).

WB:WBGene00014125	ZK863.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including Rotenone; Tunicamycin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014126	C17D12.t2
No description available

WB:WBGene00014127	ZK892.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00014128	ZK892.4
Is predicted to have CoA-transferase activity. Human ortholog(s) of this gene are implicated in alpha-methylacyl-CoA racemase deficiency and congenital bile acid synthesis defect 4. Is an ortholog of human AMACR (alpha-methylacyl-CoA racemase).

WB:WBGene00014129	ZK892.5
Is enriched in GABAergic neurons and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including manganese chloride; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014130	ZK892.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014131	sdz-38
Is expressed in several structures, including MSaa; MSap; MSp; MSpa; and MSpp. Is predicted to encode a protein with the following domain: .

WB:WBGene00014132	ZK896.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including methylmercury hydroxide; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00014134	ZK896.3
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00014135	ZK896.4
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; D-glucopyranose; and sodium arsenite based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain; CUB-like domain; and Spermadhesin, CUB domain superfamily.

WB:WBGene00014136	ZK896.5
Is enriched in AFD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; microarray; and proteomic studies. Is affected by seventeen chemicals including methylmercuric chloride; Tunicamycin; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00014137	clec-187
Is predicted to have carbohydrate binding activity. Is involved in innate immune response.

WB:WBGene00014138	clec-186
Is predicted to have carbohydrate binding activity. Is involved in innate immune response.

WB:WBGene00014139	nstp-5
Is predicted to have UDP-galactose transmembrane transporter activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIm. Is an ortholog of human SLC35A2 (solute carrier family 35 member A2).

WB:WBGene00014140	ZK899.1
Is enriched in hypodermis; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including stavudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00014141	ZK899.2
Is expressed in buccal cavity and rectum. Is predicted to encode a protein with the following domain: .

WB:WBGene00014142	ZK899.3
Is affected by several genes including age-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00014143	ZK899.5
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00014144	ZK899.6
Is enriched in BAG; NSM; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00014145	ZK899.7
Is enriched in neurons and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00014147	C17D12.t3
No description available

WB:WBGene00014148	ZK909.3
Is predicted to have guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity. Is an ortholog of human HDDC3 (HD domain containing 3).

WB:WBGene00014149	fbxb-70
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including aldicarb; 1-methylnicotinamide; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00014150	ZK909.6
Is enriched in head mesodermal cell; hypodermis; muscle cell; neurons; and ray based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00014151	vps-15
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4).

WB:WBGene00014152	ZK930.2
Is enriched in AVE and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Rifampin; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Miles-Carpenter syndrome. Is predicted to encode a protein with the following domains: Zinc finger-containing protein and Zinc finger, C4H2-type. Is an ortholog of human ZC4H2 (zinc finger C4H2-type containing).

WB:WBGene00014153	vab-23
Is involved in several processes, including embryonic body morphogenesis; epidermis morphogenesis; and vulval development. Localizes to nuclear speck. Is expressed in several structures, including hermaphrodite somatic gonadal cell; ventral uterine precursor; vulval cell; vulval muscle; and vulval precursor cell. Human ortholog(s) of this gene are implicated in Miles-Carpenter syndrome. Is an ortholog of human ZC4H2 (zinc finger C4H2-type containing).

WB:WBGene00014154	ZK930.4
Is enriched in several structures, including Z1.p; Z4.a; amphid sheath cell; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00014155	ZK930.5
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; pmk-1; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00014156	ZK930.6
Is predicted to have ATP-dependent peptidase activity and serine-type endopeptidase activity.

WB:WBGene00014157	ZK930.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including let-60; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Rifampin; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00014158	ZK938.1
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00014159	arrd-4
Is expressed in amphid neurons and sensory neurons. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00014160	ZK938.3
Is predicted to have gluconokinase activity.

WB:WBGene00014161	arrd-5
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and rde-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of several human genes including ARRDC1 (arrestin domain containing 1); ARRDC3 (arrestin domain containing 3); and TXNIP (thioredoxin interacting protein).

WB:WBGene00014162	chil-9
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00014163	rnh-1.2
Is predicted to have RNA-DNA hybrid ribonuclease activity and nucleic acid binding activity.

WB:WBGene00014164	lact-2
Is enriched in intestine and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Rifampin; and graphene oxide based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00014165	puf-12
Is predicted to have mRNA binding activity. Is an ortholog of human PUM3 (pumilio RNA binding family member 3).

WB:WBGene00014166	ZK945.4
Is predicted to have zinc ion binding activity.

WB:WBGene00014168	ZK945.6
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00014169	ZK945.7
Is enriched in DA neuron; VA neuron; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00014170	ZK945.8
Is predicted to have protein phosphatase 1 binding activity and protein serine/threonine phosphatase inhibitor activity. Is an ortholog of human PPP1R11 (protein phosphatase 1 regulatory inhibitor subunit 11).

WB:WBGene00014171	nep-26
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension. Is an ortholog of human KEL (Kell metallo-endopeptidase (Kell blood group)).

WB:WBGene00014172	clpp-1
Exhibits serine-type endopeptidase activity. Is involved in mitochondrial unfolded protein response and proteolysis. Localizes to mitochondrial matrix. Is expressed in intestine. Human ortholog(s) of this gene are implicated in Perrault syndrome. Is an ortholog of human CLPP (caseinolytic mitochondrial matrix peptidase proteolytic subunit).

WB:WBGene00014173	ZK970.7
Is involved in response to gamma radiation.

WB:WBGene00014174	ZK970.8
Is predicted to have guanyl-nucleotide exchange factor activity and zinc ion binding activity. Is an ortholog of human RABIF (RAB interacting factor).

WB:WBGene00014175	ZK971.1
Is enriched in coelomocyte; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and let-60 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Tunicamycin; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00014176	ZK1010.2
Is enriched in germ line; germline precursor cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 11. Is predicted to encode a protein with the following domains: Uncharacterised ACR, YagE family COG1723 and Domain of unknown function DUF155. Is an ortholog of human RMND1 (required for meiotic nuclear division 1 homolog).

WB:WBGene00014177	frg-1
Exhibits actin filament binding activity and protein homodimerization activity. Is involved in actin filament bundle assembly. Localizes to nucleolus and striated muscle dense body. Is used to study facioscapulohumeral muscular dystrophy. Human ortholog(s) of this gene are implicated in facioscapulohumeral muscular dystrophy 1. Is an ortholog of human FRG1 (FSHD region gene 1).

WB:WBGene00014178	ZK1010.4
Is enriched in Z1; Z4; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Tunicamycin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00014179	ZK1010.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including aldicarb; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies.

WB:WBGene00014180	ZK1010.6
Is enriched in NSM and RID based on tiling array and RNA-seq studies. Is affected by several genes including mex-1; csr-1; and spn-4 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00014181	ZK1010.8
Is enriched in NSM; coelomocyte; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including sesamin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014182	ZK1025.2
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00014183	ZK1025.3
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; Nitric Oxide; and tryptophan based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00014184	ZK1025.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00014185	ZK1025.5
Is affected by several genes including clk-1; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by Ethanol; methylmercury hydroxide; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00014186	nhr-244
Is affected by several genes including skn-1; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Mianserin; metformin; and resveratrol based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8. Is predicted to encode a protein with the following domains: Nuclear hormone receptor, ligand-binding domain and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00014188	ZK1025.8
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00014189	nhr-245
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00014190	irld-62
Is affected by several genes including sir-2.1; prg-1; and unc-75 based on tiling array; RNA-seq; and microarray studies. Is affected by Acrylamide; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00014191	srt-22
Is affected by several genes including elt-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00014192	nhr-246
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00014193	nhr-247
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity.

WB:WBGene00014194	ZK1037.6
Is enriched in DA neuron based on microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00014195	srz-10
Is affected by several genes including drh-3; rsr-2; and thoc-5 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00014196	ZK1053.1
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00014197	ZK1053.2
Is enriched in Z1.p; Z4.a; male distal tip cell; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00014198	ZK1053.3
Is affected by several genes including elt-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Mianserin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein sepa-1.

WB:WBGene00014199	ZK1053.4
Localizes to cytoplasm.

WB:WBGene00014200	scrm-2
Is predicted to have phospholipid scramblase activity. Is an ortholog of several human genes including PLSCR3 (phospholipid scramblase 3); PLSCR4 (phospholipid scramblase 4); and PLSCR5 (phospholipid scramblase family member 5).

WB:WBGene00014201	ZK1053.6
Is predicted to have cation transmembrane transporter activity.

WB:WBGene00014202	mmcm-1
Is predicted to have methylmalonyl-CoA mutase activity. Localizes to mitochondrion. Is used to study methylmalonic acidemia. Human ortholog(s) of this gene are implicated in methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency. Is an ortholog of human MMUT (methylmalonyl-CoA mutase).

WB:WBGene00014203	ZK1058.3
Is predicted to have UDP-glucose:hexose-1-phosphate uridylyltransferase activity. Human ortholog(s) of this gene are implicated in classic galactosemia. Is an ortholog of human GALT (galactose-1-phosphate uridylyltransferase).

WB:WBGene00014204	ccdc-47
Is predicted to have calcium ion binding activity. Is expressed in tail. Is an ortholog of human CCDC47 (coiled-coil domain containing 47).

WB:WBGene00014205	metl-6
Is predicted to have methyltransferase activity. Is an ortholog of human METTL6 (methyltransferase like 6).

WB:WBGene00014206	nit-1
Is predicted to have nitrilase activity and nitrile hydratase activity. Is expressed in several structures, including E; Ea; Ep; MSaa; and MSpa.

WB:WBGene00014207	ZK1058.9
Is enriched in body wall muscle cell; germ line; and muscle cell based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00014208	znfx-1
Is predicted to have RNA binding activity. Is expressed in germ cell. Is an ortholog of human ZNFX1 (zinc finger NFX1-type containing 1).

WB:WBGene00014209	ZK1067.3
Is enriched in AFD; germ line; hypodermis; mechanosensory neurons; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and lin-35 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00014210	ZK1067.4
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TMEM151 family and Transmembrane protein 151. Is an ortholog of human TMEM151A (transmembrane protein 151A) and TMEM151B (transmembrane protein 151B).

WB:WBGene00014213	ZK1073.1
Is enriched in germ line; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; D-glucose; and nicotine based on RNA-seq; proteomic; and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4D. Is predicted to encode a protein with the following domains: Phosphorylation site; Ndr family; NDRG; and Alpha/Beta hydrolase fold. Is an ortholog of human NDRG1 (N-myc downstream regulated 1); NDRG2 (NDRG family member 2); and NDRG3 (NDRG family member 3).

WB:WBGene00014214	ZK1073.2
Is enriched in PLM; RIS; head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including sek-1; pgl-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014215	obr-3
Is predicted to have cholesterol binding activity and sterol transporter activity. Is involved in regulation of growth and transforming growth factor beta receptor signaling pathway. Is expressed in hypodermis; neurons; and pharyngeal muscle cell. Is an ortholog of human OSBPL5 (oxysterol binding protein like 5).

WB:WBGene00014216	ZK1086.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014217	ZK1086.3
Is affected by several genes including sir-2.1; lin-15B; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00014218	ZK1098.1
Is predicted to have RNA binding activity. Localizes to nucleus. Is an ortholog of human PRPF40A (pre-mRNA processing factor 40 homolog A) and PRPF40B (pre-mRNA processing factor 40 homolog B).

WB:WBGene00014219	ZK1098.2
Is enriched in AVK; PLM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ribonuclease H-like superfamily.

WB:WBGene00014220	ZK1098.3
Is predicted to have 3'-5' exonuclease activity. Is an ortholog of human EXD3 (exonuclease 3'-5' domain containing 3).

WB:WBGene00014221	eif-2Balpha
Exhibits identical protein binding activity. Is predicted to contribute to guanyl-nucleotide exchange factor activity and translation initiation factor activity. Human ortholog(s) of this gene are implicated in leukoencephalopathy with vanishing white matter. Is an ortholog of human EIF2B1 (eukaryotic translation initiation factor 2B subunit alpha).

WB:WBGene00014222	trpp-3
Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle; growth; and protein secretion. Is an ortholog of human TRAPPC3 (trafficking protein particle complex 3).

WB:WBGene00014223	ZK1098.6
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014224	mrps-23
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS23 (mitochondrial ribosomal protein S23).

WB:WBGene00014225	ZK1098.9
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; bisphenol A; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00014226	ZK1098.11
Is predicted to have transferase activity. Is an ortholog of human NATD1 (N-acetyltransferase domain containing 1).

WB:WBGene00014227	ZK1128.1
Is predicted to have protein-arginine omega-N symmetric methyltransferase activity. Is an ortholog of human NDUFAF7 (NADH:ubiquinone oxidoreductase complex assembly factor 7).

WB:WBGene00014228	mett-10
Is predicted to have 23S rRNA (adenine(1618)-N(6))-methyltransferase activity. Is involved in centrosome cycle; embryo development; and vulval development. Localizes to nucleus. Is expressed in germ line; gonad; intestine; and vulva. Is an ortholog of human METTL16 (methyltransferase like 16).

WB:WBGene00014229	ZK1128.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00014230	gtf-2H3
Is predicted to contribute to DNA-dependent ATPase activity and RNA polymerase II CTD heptapeptide repeat kinase activity. Is an ortholog of human GTF2H3 (general transcription factor IIH subunit 3).

WB:WBGene00014232	ttll-4
Exhibits tubulin-glutamic acid ligase activity. Is involved in protein polyglutamylation and response to hermaphrodite contact. Is an ortholog of human TTLL4 (tubulin tyrosine ligase like 4).

WB:WBGene00014233	ZK1128.7
Is enriched in OLL; PVD; dopaminergic neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on RNA-seq; proteomic; and microarray studies. Is affected by ten chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 2 (multiple); cataract 9 multiple types; and distal hereditary motor neuronopathy type 2 (multiple). Is predicted to encode a protein with the following domains: Hsp20/alpha crystallin family; Alpha crystallin/Small heat shock protein, animal type; Alpha crystallin/Hsp20 domain; and HSP20-like chaperone.

WB:WBGene00014234	vps-29
Localizes to cytosol. Is an ortholog of human VPS29 (VPS29 retromer complex component).

WB:WBGene00014235	ZK1225.1
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00014236	ZK1225.2
Is affected by several genes including let-60; clk-1; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by antimycin and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00014237	ZK1225.3
No description available

WB:WBGene00014238	ZK1225.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00014239	ZK1225.5
Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00014240	htas-1
Is predicted to have DNA binding activity. Is expressed in sperm and spermatid. Is an ortholog of human H2AC20 (H2A clustered histone 20); H2AC21 (H2A clustered histone 21); and H2AJ (H2A.J histone).

WB:WBGene00014241	ZK1251.3
Is predicted to have 3-oxo-5-alpha-steroid 4-dehydrogenase activity. Is an ortholog of human SRD5A1 (steroid 5 alpha-reductase 1).

WB:WBGene00014242	sdz-36
Is expressed in several structures, including Caa; Cap; Cpa; Ea; and Psub4.

WB:WBGene00014243	dcaf-1
Is enriched in AVA; body wall muscle cell; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; LIS1 homology motif; Armadillo-like helical; WD40/YVTN repeat-like-containing domain superfamily; Armadillo-type fold; VPRBP/DCAF1 family; and WD40-repeat-containing domain superfamily. Is an ortholog of human DCAF1 (DDB1 and CUL4 associated factor 1).

WB:WBGene00014244	ZK1307.1
Is enriched in hypodermis and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Amidinotransferase. Is an ortholog of human DDAH1 (dimethylarginine dimethylaminohydrolase 1).

WB:WBGene00014245	ZK1307.2
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Tunicamycin; D-glucose; and indole based on RNA-seq and microarray studies.

WB:WBGene00014246	ZK1307.3
Is enriched in NSM; OLL; PVD; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00014247	ZK1307.4
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00014248	ZK1307.7
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00014249	ZK1307.8
Is predicted to have calcium ion binding activity. Is involved in IRE1-mediated unfolded protein response and PERK-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in polycystic liver disease. Is an ortholog of human PRKCSH (protein kinase C substrate 80K-H).

WB:WBGene00014250	ZK1307.9
Is enriched in several structures, including AFD; body wall muscle cell; coelomocyte; germ line; and germline precursor cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Lithium Chloride; Rotenone; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF572) and Saf4/Yju2 protein. Is an ortholog of human CCDC130 (coiled-coil domain containing 130).

WB:WBGene00014251	gstk-1
Is predicted to have glutathione peroxidase activity and glutathione transferase activity. Is involved in innate immune response. Localizes to peroxisome. Is expressed in body wall musculature; hypodermis; and rectal gland cell. Is an ortholog of human GSTK1 (glutathione S-transferase kappa 1).

WB:WBGene00014252	ZK1320.2
Is involved in innate immune response.

WB:WBGene00014253	ZK1320.3
Is expressed in intestine. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5352) and Protein of unknown function DUF5352.

WB:WBGene00014254	cyp-13A10
Is predicted to have monooxygenase activity. Human ortholog(s) of this gene are implicated in essential hypertension. Is an ortholog of several human genes including CYP3A4 (cytochrome P450 family 3 subfamily A member 4); CYP3A43 (cytochrome P450 family 3 subfamily A member 43); and CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough).

WB:WBGene00014255	ZK1320.5
Is enriched in AVK; RID; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00014256	ZK1320.7
Is predicted to have nucleic acid binding activity. Is an ortholog of human GPANK1 (G-patch domain and ankyrin repeats 1).

WB:WBGene00014257	ZK1320.8
No description available

WB:WBGene00014258	ZK1320.9
Is predicted to have acetate CoA-transferase activity and acetyl-CoA hydrolase activity.

WB:WBGene00014259	ZK1320.11
Is enriched in AVE; body wall muscle cell; carbon dioxide sensory neurons; dopaminergic neurons; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; microarray; and tiling array studies. Is affected by six chemicals including Rotenone; Mianserin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014260	ZK1321.1
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and csr-1 based on microarray and RNA-seq studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00014261	shk-1
Exhibits delayed rectifier potassium channel activity. Is involved in potassium ion transmembrane transport. Localizes to plasma membrane. Is expressed in body wall musculature; head ganglion; interneuron; muscle cell; and sensory neurons. Human ortholog(s) of this gene are implicated in several diseases, including heart conduction disease (multiple); hereditary ataxia (multiple); and long QT syndrome (multiple). Is an ortholog of several human genes including KCNA1 (potassium voltage-gated channel subfamily A member 1); KCNA10 (potassium voltage-gated channel subfamily A member 10); and KCNA2 (potassium voltage-gated channel subfamily A member 2).

WB:WBGene00014262	ZK1321.4
Is predicted to have actin binding activity and muscle alpha-actinin binding activity. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1C; myofibrillar myopathy 4; and osteoporosis.

WB:WBGene00014263	C18D4.t1
No description available

WB:WBGene00014264	C24H11.t1
No description available

WB:WBGene00014265	C26G2.t1
No description available

WB:WBGene00014266	C28A5.7
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00014267	C28A5.t1
No description available

WB:WBGene00014268	C28A5.t2
No description available

WB:WBGene00014269	C28A5.t3
Is affected by daf-2 based on microarray studies.

WB:WBGene00014270	C29F4.t1
No description available

WB:WBGene00014271	C29F7.t1
No description available

WB:WBGene00014272	C29F7.t2
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00014273	C29F7.t3
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014274	C31E10.t1
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00014275	C33G3.t2
No description available

WB:WBGene00014276	C34E11.t1
No description available

WB:WBGene00014277	C35D6.6
Is affected by hpl-2 based on tiling array studies.

WB:WBGene00014278	C35D6.7
No description available

WB:WBGene00014279	C36F7.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014280	C36F7.t2
No description available

WB:WBGene00014281	C36F7.t3
No description available

WB:WBGene00014282	C37A5.t1
No description available

WB:WBGene00014283	C38C6.t1
No description available

WB:WBGene00014284	C40C9.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014285	C40C9.t2
No description available

WB:WBGene00014286	C40H5.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014287	C47E8.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014288	C47F8.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00014289	C49F5.t1
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00014290	C51F7.3
Is affected by several genes including daf-2; clk-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00014291	C52E4.8
Is enriched in germ line based on RNA-seq studies. Is affected by clk-1; dlc-1; and sftb-1 based on microarray and RNA-seq studies.

WB:WBGene00014292	C52G5.t1
No description available

WB:WBGene00014293	C53B4.9
Is affected by several genes including clk-1; cep-1; and alg-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00014294	C53C7.5
Is enriched in Psub1; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014295	C53C7.t1
No description available

WB:WBGene00014296	C53C7.t2
No description available

WB:WBGene00014297	C53C7.t3
No description available

WB:WBGene00014298	C53D6.t1
No description available

WB:WBGene00014299	C56G7.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014300	D2023.1
Is predicted to have heme binding activity and metal ion binding activity.

WB:WBGene00014301	DY3.t2
Is affected by several genes including daf-12; pgl-1; and glh-1 based on tiling array and RNA-seq studies.

WB:WBGene00014302	rte-5
No description available

WB:WBGene00014303	F02D10.t2
No description available

WB:WBGene00014304	F02D10.t3
No description available

WB:WBGene00014305	F02H6.t1
No description available

WB:WBGene00014306	F07C6.5
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014307	F07H5.3
Is enriched in several structures, including body wall musculature; head mesodermal cell; intestine; muscle cell; and nerve ring neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014308	F07H5.4
Is enriched in several structures, including body wall musculature; head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Ethanol; Rotenone; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00014309	F07H5.5
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00014310	F08G2.9
Is expressed widely.

WB:WBGene00014311	F08G2.10
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014312	F08G2.11
Is affected by dlc-1 and sftb-1 based on RNA-seq studies.

WB:WBGene00014313	F08G5.t1
No description available

WB:WBGene00014314	F08G5.t2
No description available

WB:WBGene00014315	F08G5.t3
Is affected by daf-2 based on microarray studies.

WB:WBGene00014316	F08H9.10
Is affected by adr-2 and sftb-1 based on RNA-seq studies.

WB:WBGene00014317	F08H9.11
Is affected by daf-16 and sftb-1 based on RNA-seq studies.

WB:WBGene00014318	F09B9.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014319	F09B9.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014320	F11A1.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014321	F11A1.t2
No description available

WB:WBGene00014322	F11A5.14
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including cep-1; dlc-1; and adr-2 based on RNA-seq studies.

WB:WBGene00014323	F11A5.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014324	F13G11.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014325	F14B4.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014326	F14B4.t2
No description available

WB:WBGene00014327	F14B6.t1
No description available

WB:WBGene00014328	F14B6.t2
No description available

WB:WBGene00014329	F14F7.t1
No description available

WB:WBGene00014330	F14H8.t1
No description available

WB:WBGene00014331	F15B9.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014332	F15D3.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014333	F15G9.t1
No description available

WB:WBGene00014334	F15G9.t2
No description available

WB:WBGene00014335	F15H9.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00014336	F15H9.6
Is affected by sftb-1 based on RNA-seq studies.

WB:WBGene00014337	F15H9.t1
No description available

WB:WBGene00014338	F17A2.t1
No description available

WB:WBGene00014339	F17H10.t1
No description available

WB:WBGene00014340	F19H6.t1
No description available

WB:WBGene00014341	F21A3.t1
No description available

WB:WBGene00014342	F21A3.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014343	F21C3.t1
Is affected by emr-1; lem-2; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00014344	F22G12.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014345	F22G12.t2
No description available

WB:WBGene00014346	F23A7.t1
No description available

WB:WBGene00014347	F23D12.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014348	F23D12.t2
No description available

WB:WBGene00014349	F27D4.t1
No description available

WB:WBGene00014350	F28F8.t1
No description available

WB:WBGene00014351	F28F8.t2
No description available

WB:WBGene00014352	F28F8.t3
No description available

WB:WBGene00014353	F28F8.t4
No description available

WB:WBGene00014354	F28H6.t1
No description available

WB:WBGene00014355	F28H6.t2
No description available

WB:WBGene00014356	F28H6.t3
No description available

WB:WBGene00014357	F28H6.t4
No description available

WB:WBGene00014358	F28H6.t5
No description available

WB:WBGene00014359	F28H6.t6
No description available

WB:WBGene00014360	F28H6.t7
No description available

WB:WBGene00014361	F31B12.t1
No description available

WB:WBGene00014362	F31E9.t1
No description available

WB:WBGene00014363	F32B4.t1
No description available

WB:WBGene00014364	F34H10.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014365	F35H8.t1
No description available

WB:WBGene00014366	F38E11.10
Is affected by daf-12 and sftb-1 based on tiling array and RNA-seq studies.

WB:WBGene00014367	F38E11.11
Is affected by sftb-1 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014368	F39B1.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014369	F39B1.t2
No description available

WB:WBGene00014370	F40G12.13
Is affected by daf-16; dlc-1; and sftb-1 based on RNA-seq studies.

WB:WBGene00014371	F40G12.14
Is enriched in germ line based on RNA-seq studies. Is affected by daf-16; dlc-1; and sftb-1 based on RNA-seq studies.

WB:WBGene00014372	F42D1.t1
No description available

WB:WBGene00014373	F42F12.t1
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00014374	F42G10.t1
No description available

WB:WBGene00014375	F44D12.11
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014376	F45G2.t1
No description available

WB:WBGene00014377	F47A4.t1
No description available

WB:WBGene00014378	F49C5.t1
No description available

WB:WBGene00014379	F49C5.t2
No description available

WB:WBGene00014380	F49C5.t3
No description available

WB:WBGene00014381	F49C5.t4
No description available

WB:WBGene00014382	F49E2.t1
No description available

WB:WBGene00014384	F52E10.t1
Is affected by daf-12; clk-1; and daf-2 based on tiling array and microarray studies.

WB:WBGene00014385	F52E10.t2
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00014386	F52E10.t3
No description available

WB:WBGene00014387	F52E10.t4
Is affected by daf-2 based on microarray studies.

WB:WBGene00014388	F52E10.t5
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014389	F53B6.t1
No description available

WB:WBGene00014390	F53F8.t1
No description available

WB:WBGene00014391	mir-392
Is affected by several genes including daf-12; alg-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by graphene oxide and sanguinarine based on RNA-seq studies.

WB:WBGene00014392	F54C8.8
No description available

WB:WBGene00014393	F54C8.9
No description available

WB:WBGene00014394	F54C8.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014395	F54F7.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014396	F54F7.t2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014397	F55A11.10
Is affected by cep-1 and daf-2 based on RNA-seq studies.

WB:WBGene00014398	F55F3.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014399	F55F3.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014400	F55G7.t1
No description available

WB:WBGene00014401	F55G7.t2
No description available

WB:WBGene00014402	F56F3.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00014403	F56H6.14
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00014404	F56H6.15
Is affected by prg-1 and sftb-1 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00014405	F56H6.16
Is enriched in germ line based on RNA-seq studies. Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00014406	F57F5.t1
No description available

WB:WBGene00014407	F57G8.t1
No description available

WB:WBGene00014408	F57G8.t2
No description available

WB:WBGene00014409	F57G8.t3
No description available

WB:WBGene00014410	F57G8.t4
No description available

WB:WBGene00014411	F58D5.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014413	H06A10.t1
No description available

WB:WBGene00014414	K01A6.t1
No description available

WB:WBGene00014415	K01A11.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014416	K02A4.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014417	K02A4.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014418	K02B12.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014419	K02E2.t1
No description available

WB:WBGene00014420	K02E11.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014421	K03B8.10
Is affected by several genes including cep-1; hpl-2; and dlc-1 based on RNA-seq studies.

WB:WBGene00014422	K03B8.t1
No description available

WB:WBGene00014423	K06A4.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014424	K07A1.t1
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00014425	K07C10.2
Is affected by rsr-2 based on RNA-seq studies.

WB:WBGene00014426	K07C10.t1
No description available

WB:WBGene00014427	K08E7.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014428	K08H2.t1
No description available

WB:WBGene00014429	K09A11.t1
No description available

WB:WBGene00014430	K09B11.11
No description available

WB:WBGene00014431	K09B11.12
No description available

WB:WBGene00014432	K09B11.13
No description available

WB:WBGene00014433	K09B11.14
No description available

WB:WBGene00014434	K09B11.15
No description available

WB:WBGene00014435	K09B11.16
No description available

WB:WBGene00014436	K09C8.t1
No description available

WB:WBGene00014437	K10C8.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014438	K11E4.t1
No description available

WB:WBGene00014439	K11E4.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00014440	K11E4.t3
No description available

WB:WBGene00014441	K11E4.t4
Is affected by daf-12 and hmg-3 based on tiling array and RNA-seq studies.

WB:WBGene00014442	K11E4.t5
Is affected by daf-12 and hmg-3 based on tiling array and RNA-seq studies.

WB:WBGene00014443	K11E4.t6
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014444	K11H3.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014445	K11H3.t2
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014446	M01E5.t1
No description available

WB:WBGene00014447	M106.6
No description available

WB:WBGene00014448	M163.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00014449	M163.t2
No description available

WB:WBGene00014450	MTCE.1
No description available

WB:WBGene00014451	MTCE.2
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00014452	MTCE.5
Is affected by prg-1; rpl-33; and rpl-5 based on RNA-seq studies.

WB:WBGene00014453	MTCE.6
No description available

WB:WBGene00014454	MTCE.7
Is affected by several genes including hsf-1; eat-2; and bar-1 based on RNA-seq and microarray studies. Is affected by Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00014455	MTCE.8
No description available

WB:WBGene00014456	MTCE.9
Is affected by prg-1; rpl-33; and rpl-5 based on RNA-seq studies.

WB:WBGene00014457	MTCE.10
No description available

WB:WBGene00014458	MTCE.13
No description available

WB:WBGene00014459	MTCE.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00014460	MTCE.15
No description available

WB:WBGene00014461	MTCE.17
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00014462	MTCE.18
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00014463	MTCE.19
Is affected by prg-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00014464	MTCE.20
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00014465	MTCE.22
Is affected by aak-2; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00014466	MTCE.24
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00014467	MTCE.27
No description available

WB:WBGene00014468	MTCE.28
No description available

WB:WBGene00014469	MTCE.29
No description available

WB:WBGene00014470	MTCE.30
Is affected by prg-1; daf-2; and zip-3 based on RNA-seq and microarray studies.

WB:WBGene00014471	MTCE.32
Is affected by daf-2 based on microarray studies.

WB:WBGene00014472	MTCE.33
Is affected by several genes including hsf-1; npr-1; and sek-1 based on RNA-seq studies. Is affected by four chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00014473	MTCE.36
No description available

WB:WBGene00014474	R01H5.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014475	R03E1.t1
No description available

WB:WBGene00014476	R03E1.t2
No description available

WB:WBGene00014477	R04D3.t1
No description available

WB:WBGene00014478	R04D3.t2
No description available

WB:WBGene00014479	R04D3.t3
No description available

WB:WBGene00014480	R04D3.t4
Is affected by clk-1 based on microarray studies.

WB:WBGene00014481	R04D3.t5
No description available

WB:WBGene00014482	R04F11.t1
No description available

WB:WBGene00014483	R05D7.6
No description available

WB:WBGene00014484	R07E5.16
No description available

WB:WBGene00014485	R09E10.t1
Is affected by lem-2 based on RNA-seq studies.

WB:WBGene00014486	R11.t1
No description available

WB:WBGene00014487	R11.t2
No description available

WB:WBGene00014488	R11.t3
No description available

WB:WBGene00014489	R11.t4
No description available

WB:WBGene00014490	R11G10.t1
No description available

WB:WBGene00014491	R11G10.t2
No description available

WB:WBGene00014492	R166.6
Is enriched in AVK; NSM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; sek-1; and isp-1 based on RNA-seq and microarray studies. Is affected by Alovudine and antimycin based on RNA-seq studies.

WB:WBGene00014493	T01B4.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014494	T01B4.t2
No description available

WB:WBGene00014495	T01B4.t3
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00014496	T01B4.t4
No description available

WB:WBGene00014497	T01C1.t1
No description available

WB:WBGene00014498	T02G6.t1
No description available

WB:WBGene00014499	T03E6.t1
No description available

WB:WBGene00014500	T04D3.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014501	T04D3.t2
No description available

WB:WBGene00014502	T04D3.t3
No description available

WB:WBGene00014503	T04D3.t4
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014504	T04F8.t1
No description available

WB:WBGene00014505	T05E11.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercury hydroxide; 1-methylnicotinamide; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00014506	T06D8.11
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00014507	T06H11.t1
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014508	T06H11.t2
No description available

WB:WBGene00014509	T06H11.t3
No description available

WB:WBGene00014510	T07D10.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014511	T08G5.11
Is affected by several genes including daf-16; meg-3; and meg-4 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014512	T09F5.t1
No description available

WB:WBGene00014513	T10B9.t1
No description available

WB:WBGene00014514	T10B10.t1
No description available

WB:WBGene00014515	T10B10.t2
No description available

WB:WBGene00014516	hpo-42
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00014517	T11F9.15
Is affected by dlc-1 and sftb-1 based on RNA-seq studies.

WB:WBGene00014518	T11F9.16
Is affected by several genes including clk-1; cep-1; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00014519	T14G8.t1
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00014520	T18D3.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014521	T19C4.t1
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014522	T20D3.12
No description available

WB:WBGene00014523	T20D3.13
No description available

WB:WBGene00014524	T21B4.t1
No description available

WB:WBGene00014525	T22A3.t1
No description available

WB:WBGene00014526	T22A3.t2
No description available

WB:WBGene00014527	T22A3.t3
Is affected by clk-1 based on microarray studies.

WB:WBGene00014528	T22A3.t4
No description available

WB:WBGene00014529	T22C1.t1
No description available

WB:WBGene00014530	T22C8.t1
No description available

WB:WBGene00014531	T23F1.t1
No description available

WB:WBGene00014532	T23F1.t2
No description available

WB:WBGene00014533	T23H4.t1
No description available

WB:WBGene00014534	mir-355
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014535	T28D6.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00014536	T28D6.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014537	VK10D6R.t1
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00014538	W02H3.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00014539	W03C9.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014540	W03G11.t1
No description available

WB:WBGene00014541	W04D2.7
Is affected by several genes including daf-16; daf-2; and hpl-2 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00014542	W04G5.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including cep-1; hpl-2; and dlc-1 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014543	W05B2.8
Is affected by tdp-1; dpy-21; and hmg-3 based on RNA-seq studies.

WB:WBGene00014544	W05B2.t1
No description available

WB:WBGene00014545	W06D4.t1
No description available

WB:WBGene00014546	W06G6.t1
No description available

WB:WBGene00014547	W06G6.t2
No description available

WB:WBGene00014548	W06G6.t3
No description available

WB:WBGene00014549	W07G1.8
Is affected by dlc-1 and sftb-1 based on RNA-seq studies.

WB:WBGene00014550	W07G1.9
No description available

WB:WBGene00014551	W07G4.t1
No description available

WB:WBGene00014552	W09D6.t1
No description available

WB:WBGene00014553	W09D6.t2
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00014554	Y7A5A.t1
No description available

WB:WBGene00014555	Y7A5A.t2
No description available

WB:WBGene00014556	Y7A5A.t3
No description available

WB:WBGene00014557	Y7A5A.t4
No description available

WB:WBGene00014558	Y7A5A.t5
No description available

WB:WBGene00014559	Y7A9D.t1
No description available

WB:WBGene00014560	Y7A9D.t2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014561	Y7A9D.t3
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014562	Y17D7B.7
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014563	Y37A1B.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014564	Y38E10A.t1
Is affected by daf-12 and adr-1 based on tiling array and RNA-seq studies.

WB:WBGene00014565	Y38H6A.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014566	Y39A1A.t1
No description available

WB:WBGene00014567	Y39B6A.t9
No description available

WB:WBGene00014568	Y39B6A.t10
No description available

WB:WBGene00014569	bkip-1
Exhibits ion channel binding activity. Is involved in regulation of ion transmembrane transporter activity. Localizes to neuron projection and striated muscle dense body. Is expressed in body wall musculature; head mesodermal cell; muscle cell; neurons; and somatic nervous system.

WB:WBGene00014570	Y40H7A.t1
No description available

WB:WBGene00014571	Y40H7A.t2
No description available

WB:WBGene00014572	Y43D4A.t1
No description available

WB:WBGene00014573	Y43D4A.t2
No description available

WB:WBGene00014574	Y43F4A.t1
No description available

WB:WBGene00014575	Y43F4A.t2
No description available

WB:WBGene00014576	Y43F11A.6
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014577	Y47H9A.2
Is affected by hpl-2 and sftb-1 based on tiling array and RNA-seq studies.

WB:WBGene00014578	Y49E10.t1
No description available

WB:WBGene00014579	Y51A2B.t1
No description available

WB:WBGene00014580	Y51H4A.t2
Is affected by adr-1 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014581	Y51H4A.t3
No description available

WB:WBGene00014582	Y51H4A.t4
Is affected by daf-2 based on microarray studies.

WB:WBGene00014583	Y51H4A.t5
No description available

WB:WBGene00014584	Y51H4A.t6
No description available

WB:WBGene00014585	Y53C10A.t1
No description available

WB:WBGene00014586	rte-2
No description available

WB:WBGene00014587	Y53C10A.t3
No description available

WB:WBGene00014588	Y53C12A.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014589	Y54G9A.8
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq and microarray studies.

WB:WBGene00014590	Y57A10B.t1
No description available

WB:WBGene00014591	Y57A10C.t1
Is affected by elli-1 based on microarray studies.

WB:WBGene00014592	Y57G11B.t1
No description available

WB:WBGene00014593	Y57G11C.35
Is affected by daf-12; cep-1; and sftb-1 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014594	Y57G11C.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014595	Y59A8B.t3
No description available

WB:WBGene00014596	Y65A5A.t1
No description available

WB:WBGene00014597	Y65A5A.t2
No description available

WB:WBGene00014598	Y65A5A.t3
No description available

WB:WBGene00014599	Y65A5A.t4
No description available

WB:WBGene00014600	Y66D12A.t1
No description available

WB:WBGene00014601	Y70C5A.t1
No description available

WB:WBGene00014602	Y73F8A.t1
No description available

WB:WBGene00014603	Y73F8A.t3
No description available

WB:WBGene00014604	Y73F8A.t4
No description available

WB:WBGene00014605	Y95D11A.t1
No description available

WB:WBGene00014606	Y105C5A.t1
No description available

WB:WBGene00014607	Y105C5A.t2
No description available

WB:WBGene00014608	Y105C5B.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014609	Y105C5B.t2
No description available

WB:WBGene00014610	Y105C5B.t3
No description available

WB:WBGene00014611	Y105C5B.t4
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014612	mir-354
Is affected by several genes including daf-12; alg-1; and alg-2 based on tiling array and RNA-seq studies.

WB:WBGene00014613	Y111B2A.25
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including clk-1; dcr-1; and smg-2 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00014614	Y113G7B.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014615	Y116F11A.4
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014616	Y116F11A.t1
No description available

WB:WBGene00014617	ZC412.t1
No description available

WB:WBGene00014618	ZC412.t2
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00014619	ZC455.t1
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00014620	ZK39.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00014621	rrn-4.1
No description available

WB:WBGene00014622	sls-1.10
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00014623	ZK262.t1
No description available

WB:WBGene00014624	ZK507.t1
No description available

WB:WBGene00014625	ZK617.t1
No description available

WB:WBGene00014626	ZK678.t1
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00014627	ZK678.t2
No description available

WB:WBGene00014628	ZK678.t3
No description available

WB:WBGene00014629	ZK678.t5
Is affected by clk-1 based on microarray studies.

WB:WBGene00014630	ZK822.t1
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00014631	ZK897.2
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014632	ZK897.3
Is affected by cep-1; alg-1; and sftb-1 based on RNA-seq studies.

WB:WBGene00014633	ZK897.4
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00014634	ZK899.t1
No description available

WB:WBGene00014635	ZK970.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014636	ZK970.t2
No description available

WB:WBGene00014637	ZK970.t3
No description available

WB:WBGene00014638	ZK970.t4
No description available

WB:WBGene00014639	ZK1010.t1
No description available

WB:WBGene00014640	ZK1067.t1
No description available

WB:WBGene00014641	B0285.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014643	B0391.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014644	B0399.t1
No description available

WB:WBGene00014645	B0399.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00014646	B0399.t3
No description available

WB:WBGene00014647	B0399.t4
Is affected by clk-1 based on microarray studies.

WB:WBGene00014648	B0399.t5
No description available

WB:WBGene00014649	B0399.t6
No description available

WB:WBGene00014650	B0399.t7
No description available

WB:WBGene00014651	B0399.t8
No description available

WB:WBGene00014652	B0399.t9
Is affected by clk-1 based on microarray studies.

WB:WBGene00014653	B0399.t10
No description available

WB:WBGene00014654	B0399.t11
No description available

WB:WBGene00014655	B0399.t12
Is affected by clk-1 based on microarray studies.

WB:WBGene00014656	B0399.t13
No description available

WB:WBGene00014657	B0399.t14
Is affected by daf-2 based on microarray studies.

WB:WBGene00014658	B0399.t15
No description available

WB:WBGene00014659	B0399.t16
No description available

WB:WBGene00014660	B0457.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including paraquat; dibromoacetic acid; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00014663	C01G6.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00014664	C04F12.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00014665	C04G2.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Ethanol; methylmercury hydroxide; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00014666	C05D12.3
Is enriched in body wall muscle cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twenty-three chemicals including nicotinic acid; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in inclusion-cell disease and pseudo-Hurler polydystrophy. Is predicted to encode a protein with the following domain: von Willebrand factor A-like domain superfamily.

WB:WBGene00014667	C06A1.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00014668	C06C3.9
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; elt-2; and pmk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014669	zipt-2.1
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A1 (solute carrier family 39 member 1) and SLC39A2 (solute carrier family 39 member 2).

WB:WBGene00014670	C08E8.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014671	C08E8.t2
No description available

WB:WBGene00014672	C08F11.6
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Alovudine; and allantoin based on RNA-seq studies.

WB:WBGene00014673	C08H9.9
Is affected by several genes including daf-16; eat-2; and smg-2 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound and Sirolimus based on microarray studies.

WB:WBGene00014674	C12D8.2
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by Triclosan based on microarray studies.

WB:WBGene00014675	C12D8.3
Is affected by daf-2; eat-2; and flcn-1 based on microarray studies. Is affected by Colistin and Triclosan based on microarray studies.

WB:WBGene00014676	C12D8.7
Is affected by clk-1; daf-2; and eat-2 based on microarray studies.

WB:WBGene00014677	C14B4.t1
No description available

WB:WBGene00014678	C15H7.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00014679	srz-25
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00014681	C25D7.14
Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Acrylamide; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00014682	C25F9.t1
No description available

WB:WBGene00014683	C25F9.t2
No description available

WB:WBGene00014684	C25F9.t3
No description available

WB:WBGene00014685	C25F9.t4
No description available

WB:WBGene00014686	C25F9.t5
Is affected by clk-1 and eat-2 based on microarray and RNA-seq studies.

WB:WBGene00014689	C28D4.11
Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00014691	C33A11.t1
Is affected by daf-2 based on microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00014692	C33A12.17
Is affected by eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014693	C33A12.18
No description available

WB:WBGene00014694	C33D3.2
Is affected by alg-1 and eat-2 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00014695	C33G3.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00014696	C33G3.t3
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00014697	cyp-25A3
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 14. Is an ortholog of human TBXAS1 (thromboxane A synthase 1).

WB:WBGene00014698	C37A5.3
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including Rotenone; Sodium Chloride; and tert-Butylhydroperoxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014699	C37A5.5
Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014700	C37A5.6
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014701	C43D7.1
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00014702	C43D7.3
Is affected by several genes including skn-1; eat-2; and pgl-1 based on RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00014703	C47A4.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies.

WB:WBGene00014704	C47A10.t1
No description available

WB:WBGene00014705	C47A10.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00014706	C47A10.t3
No description available

WB:WBGene00014707	C47A10.t4
No description available

WB:WBGene00014708	C47A10.t5
Is affected by daf-2 based on microarray studies.

WB:WBGene00014709	C48D1.6
No description available

WB:WBGene00014710	C50B6.13
Is affected by several genes including eat-2; let-418; and adr-1 based on RNA-seq studies.

WB:WBGene00014711	C50F4.15
Is affected by clk-1 based on microarray studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00014712	C50H2.9
No description available

WB:WBGene00014714	C54C8.8
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00014715	C54E10.t1
No description available

WB:WBGene00014716	C54E10.t2
No description available

WB:WBGene00014717	C54E10.t3
No description available

WB:WBGene00014718	C54E10.t4
No description available

WB:WBGene00014719	C54E10.t5
No description available

WB:WBGene00014720	C54E10.t6
No description available

WB:WBGene00014721	C54E10.t7
No description available

WB:WBGene00014722	C55A1.13
No description available

WB:WBGene00014723	srz-49
No description available

WB:WBGene00014724	D1046.t1
No description available

WB:WBGene00014727	DY3.t1
No description available

WB:WBGene00014728	E03A3.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014729	E03H4.9
Is affected by hpl-2; hmg-3; and eat-2 based on RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00014730	F01D5.4
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014731	F02E9.8
Is affected by dlc-1 and eat-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00014732	F09F3.8
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014733	F10A3.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00014734	F11A3.3
Is affected by ham-3; hpl-2; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014735	cyp-35D2
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00014738	F19H8.t1
No description available

WB:WBGene00014739	F21D9.7
No description available

WB:WBGene00014740	F21H7.6
No description available

WB:WBGene00014741	F22B8.2
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014744	F25H9.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00014745	F26D2.8
Is affected by eat-2 based on RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014746	F27D4.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014748	F30F8.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00014751	F36G9.4
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00014752	F38E11.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014753	F40D4.14
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00014754	F40F9.11
Is enriched in intestine based on microarray studies. Is affected by hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00014755	F40F12.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including glp-1; eat-2; and npr-1 based on RNA-seq studies. Is affected by six chemicals including Sodium Chloride; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00014757	F44G3.4
No description available

WB:WBGene00014758	F45H7.t1
No description available

WB:WBGene00014759	F46A8.1
Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; paraquat; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00014760	F46A8.2
Is affected by several genes including rrf-3; lin-35; and pgl-1 based on microarray and RNA-seq studies. Is affected by stavudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014761	F46A8.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Cry5B; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00014763	F46F2.t1
Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00014764	srz-46
Is affected by eat-2 based on microarray studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00014766	F49E11.t1
No description available

WB:WBGene00014767	F49E11.t2
No description available

WB:WBGene00014768	F49H6.6
No description available

WB:WBGene00014769	F53B2.7
Is affected by several genes including daf-16; smg-2; and atfs-1 based on RNA-seq studies.

WB:WBGene00014770	F54F3.2
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; paraquat; and Heme based on RNA-seq and microarray studies.

WB:WBGene00014771	F55G11.3
Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00014772	F56D5.4
Is enriched in AVK; germ line; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014773	F56D5.8
Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray and RNA-seq studies.

WB:WBGene00014774	F57G4.7
No description available

WB:WBGene00014775	F57G12.t1
No description available

WB:WBGene00014776	F57G12.t2
No description available

WB:WBGene00014777	F58A4.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014778	F58D12.2
Is affected by dlc-1; eat-2; and daf-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00014779	F59A1.2
No description available

WB:WBGene00014781	F59A1.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014782	F59A1.t2
No description available

WB:WBGene00014783	F59A1.t3
Is affected by clk-1 based on microarray studies.

WB:WBGene00014784	F59A1.t4
No description available

WB:WBGene00014785	F59A1.t5
Is affected by clk-1 based on microarray studies.

WB:WBGene00014786	F59A1.t6
Is affected by daf-2 based on microarray studies.

WB:WBGene00014787	F59A1.t7
Is affected by clk-1 based on microarray studies.

WB:WBGene00014788	F59A1.t8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00014789	F59C6.10
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014790	H03G16.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and tetrabromobisphenol A based on RNA-seq and microarray studies.

WB:WBGene00014793	H40L08.2
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Heme; Rotenone; and procyanidin based on microarray and RNA-seq studies.

WB:WBGene00014794	K02E2.5
Is affected by dlc-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014795	K03D7.1
No description available

WB:WBGene00014796	K03D7.3
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00014798	K05D4.1
No description available

WB:WBGene00014799	K05D4.5
Is affected by hmg-3 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00014800	nhr-200
No description available

WB:WBGene00014801	K08E5.1
Is affected by several genes including daf-16; cep-1; and hpl-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; stavudine; and allantoin based on RNA-seq studies.

WB:WBGene00014803	K08G2.14
Is affected by resveratrol based on microarray studies.

WB:WBGene00014805	K08H10.5
Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by methylmercury hydroxide based on RNA-seq studies.

WB:WBGene00014806	M01G12.8
Is affected by several genes including daf-16; hsf-1; and eat-2 based on RNA-seq studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014807	M04D5.1
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Cole-Carpenter syndrome. Is predicted to encode a protein with the following domains: Thioredoxin-like domain and Thioredoxin-like superfamily. Is an ortholog of human ERP27 (endoplasmic reticulum protein 27).

WB:WBGene00014809	M142.3
Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies.

WB:WBGene00014811	M162.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and smg-1 based on RNA-seq studies. Is affected by stavudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014813	M176.9
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00014814	R03D7.3
Is affected by several genes including clk-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014817	R07B5.1
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00014818	R07B5.2
No description available

WB:WBGene00014819	R08A2.6
No description available

WB:WBGene00014820	R09B3.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; nuo-6; and unc-39 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014821	R10E8.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014822	R11H6.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by five chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014824	R12G8.t2
No description available

WB:WBGene00014825	R13.5
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00014826	R13H4.2
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on proteomic; microarray; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; nicotinic acid; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00014827	T01B7.1
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by allantoin based on microarray studies.

WB:WBGene00014828	T01G1.t1
No description available

WB:WBGene00014829	T01G1.t2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014831	T04A11.11
No description available

WB:WBGene00014832	srab-27
No description available

WB:WBGene00014833	T07C12.4
Is affected by clk-1 based on microarray studies.

WB:WBGene00014834	T08G5.4
Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00014835	T09F5.4
No description available

WB:WBGene00014836	T09F5.12
Is enriched in AFD; PLM; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercury hydroxide; Rotenone; and 4-bromodiphenyl ether based on RNA-seq and microarray studies.

WB:WBGene00014837	T09F5.13
Is affected by alg-1 and let-60 based on RNA-seq and microarray studies. Is affected by Cholestanol based on microarray studies.

WB:WBGene00014838	cyp-13A9
Is affected by several genes including daf-16; eat-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00014839	T10H4.1
Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00014841	T19C4.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00014842	clec-30
Is affected by clk-1 and smg-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014843	T21H8.t1
Is affected by hrde-1 and emb-4 based on RNA-seq studies.

WB:WBGene00014844	T23D5.5
Is affected by clk-1 based on microarray studies.

WB:WBGene00014845	T23F1.2
No description available

WB:WBGene00014846	T26H5.6
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00014847	T27F6.9
No description available

WB:WBGene00014848	VM106R.1
Is enriched in AVK and neurons based on RNA-seq studies. Is affected by several genes including daf-16; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 3 and scalp-ear-nipple syndrome. Human KCTD12 exhibits identical protein binding activity. Is predicted to encode a protein with the following domains: Phosphorylation site; BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD12 (potassium channel tetramerization domain containing 12); KCTD16 (potassium channel tetramerization domain containing 16); and KCTD8 (potassium channel tetramerization domain containing 8).

WB:WBGene00014849	VW02B12L.t1
No description available

WB:WBGene00014850	VW02B12L.t2
Is affected by prg-1 and eat-2 based on RNA-seq studies.

WB:WBGene00014851	W01G7.2
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Colistin; and Triclosan based on RNA-seq and microarray studies.

WB:WBGene00014852	W02A11.6
Is affected by several genes including eat-2; pgl-1; and sma-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00014853	W02A11.t1
No description available

WB:WBGene00014854	W05B2.3
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00014855	W06D12.t1
No description available

WB:WBGene00014856	W06D12.t2
No description available

WB:WBGene00014857	W08D2.9
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by nine chemicals including Ethanol; Quercetin; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00014858	W09C5.3
Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Psoralens based on RNA-seq studies.

WB:WBGene00014861	Y6B3B.2
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014862	Y7A9C.2
Is affected by clk-1 based on microarray studies.

WB:WBGene00014863	Y11D7A.16
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by prg-1; hmg-3; and eat-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00014864	Y18D10A.22
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; stavudine; and Rifampin based on microarray and RNA-seq studies. Is an ortholog of human HIP1 (huntingtin interacting protein 1) and HIP1R (huntingtin interacting protein 1 related).

WB:WBGene00014865	Y26G10.t1
No description available

WB:WBGene00014866	Y26G10.t2
No description available

WB:WBGene00014867	Y26G10.t3
Is affected by clk-1 based on microarray studies.

WB:WBGene00014868	Y32B12B.t1
No description available

WB:WBGene00014869	Y32B12B.t2
No description available

WB:WBGene00014870	Y37H9A.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Alovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00014871	Y37H9A.5
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00014872	Y38E10A.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00014873	Y38E10A.t3
No description available

WB:WBGene00014874	Y38H6A.4
Is affected by several genes including eat-2; hpl-2; and sin-3 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00014875	Y39B6A.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014876	Y39B6A.t2
No description available

WB:WBGene00014877	Y39B6A.t3
Is affected by clk-1 based on microarray studies.

WB:WBGene00014878	Y39B6A.t4
No description available

WB:WBGene00014879	Y39B6A.t5
No description available

WB:WBGene00014880	Y39B6A.t6
No description available

WB:WBGene00014881	Y39B6A.t7
No description available

WB:WBGene00014882	Y39B6A.t8
No description available

WB:WBGene00014883	Y39C12A.2
Is affected by several genes including daf-16; glp-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00014884	Y39E4B.14
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014885	Y39G8B.8
Is affected by vhl-1; ints-5; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00014886	Y41E3.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00014887	Y43F8A.t1
No description available

WB:WBGene00014888	Y43F8B.8
Is affected by several genes including rrf-3; eat-2; and alg-1 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00014889	Y43F8C.t1
No description available

WB:WBGene00014890	Y43F8C.t2
No description available

WB:WBGene00014891	Y43F8C.t3
No description available

WB:WBGene00014892	Y43F8C.t4
No description available

WB:WBGene00014893	Y43F8C.t5
No description available

WB:WBGene00014894	Y43F8C.t6
No description available

WB:WBGene00014895	Y43F8C.t7
Is affected by clk-1 based on microarray studies.

WB:WBGene00014896	Y43F8C.t8
No description available

WB:WBGene00014897	Y43F8C.t9
Is affected by clk-1 and dpy-21 based on microarray and RNA-seq studies.

WB:WBGene00014898	Y45F3A.6
Is affected by eat-2 based on RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00014902	Y49E10.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014903	Y49E10.8
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and Colistin based on RNA-seq and microarray studies.

WB:WBGene00014904	Y49E10.26
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00014905	Y51A2A.2
Is affected by several genes including daf-2; eat-2; and hsp-6 based on microarray and RNA-seq studies.

WB:WBGene00014906	fbxa-109
Is affected by wdr-5.1 based on RNA-seq studies. Is affected by Alovudine based on RNA-seq studies.

WB:WBGene00014907	fbxa-117
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; paraquat; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00014908	Y51A2B.t2
No description available

WB:WBGene00014909	Y51B9A.2
Is affected by adr-1; daf-2; and sin-3 based on RNA-seq and microarray studies.

WB:WBGene00014910	Y51B9A.t1
Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00014911	Y51H4A.t1
No description available

WB:WBGene00014912	Y51H4A.t7
No description available

WB:WBGene00014914	Y52B11A.11
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and atfs-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 45. Is predicted to encode a protein with the following domain: .

WB:WBGene00014915	Y53C10A.1
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014916	fbxa-124
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including clk-1; sir-2.1; and dcr-1 based on microarray and RNA-seq studies. Is affected by four chemicals including stavudine; resveratrol; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00014917	fbxa-122
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including sir-2.1; fog-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including manganese chloride; Quercetin; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00014918	fbxa-123
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00014920	Y53F4B.38
Is affected by several genes including hpl-2; smg-2; and let-418 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014921	Y54E5B.5
Is affected by clk-1 based on microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00014922	Y57G11B.4
Is affected by hmg-3 and ain-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00014923	Y57G11C.26
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00014924	Y57G11C.28
Is affected by several genes including pgl-1; glh-1; and smg-2 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00014925	Y57G11C.29
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00014926	Y57G11C.30
Is affected by alg-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00014927	Y59A8A.6
No description available

WB:WBGene00014928	Y59A8B.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014929	Y59A8B.t2
No description available

WB:WBGene00014930	Y59A8B.t4
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00014931	Y59A8B.t5
No description available

WB:WBGene00014932	Y59A8B.t6
No description available

WB:WBGene00014933	Y60A3A.11
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00014934	Y60A3A.17
Is affected by hmg-3 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00014935	Y60A3A.t1
No description available

WB:WBGene00014936	Y60A3A.t2
No description available

WB:WBGene00014937	Y61B8A.3
No description available

WB:WBGene00014938	mdt-9
Is predicted to have guanyl-nucleotide exchange factor activity. Is an ortholog of human RABIF (RAB interacting factor).

WB:WBGene00014939	Y66A7A.t1
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00014940	Y67H2A.3
No description available

WB:WBGene00014941	Y67H2A.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucopyranose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00014943	Y68A4A.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00014944	Y68A4A.12
Is affected by several genes including clk-1; eat-2; and dpy-21 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Colistin; and 2 based on RNA-seq and microarray studies.

WB:WBGene00014945	Y69H2.t1
No description available

WB:WBGene00014946	Y70G10A.1
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00014947	Y71A12B.14
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00014948	Y73F8A.4
Is affected by clk-1 based on microarray studies.

WB:WBGene00014949	Y75B12A.1
Is affected by several genes including daf-16; glp-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Cholestanol based on RNA-seq and microarray studies.

WB:WBGene00014950	Y76A2B.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00014951	Y76A2B.t2
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00014952	Y80D3A.t1
No description available

WB:WBGene00014953	Y81G3A.2
No description available

WB:WBGene00014954	Y102A5C.5
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; metformin; and allantoin based on RNA-seq studies.

WB:WBGene00014955	Y102A5C.6
Is enriched in germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; gld-1; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00014956	Y102A5C.11
Is affected by hpl-2 based on RNA-seq studies. Is affected by four chemicals including Alovudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014957	Y102A5C.30
Is affected by clk-1 based on microarray studies.

WB:WBGene00014958	Y105C5A.2
Is affected by several genes including glp-1; skn-1; and sek-1 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00014961	Y105C5A.19
Is affected by daf-16 and eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014962	Y105C5A.20
Is affected by daf-16 and eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014963	Y105C5A.21
Is affected by elli-1; eat-2; and ints-5 based on microarray and RNA-seq studies.

WB:WBGene00014964	Y105E8B.10
Is affected by daf-16 based on RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014965	Y106G6D.5
Is predicted to have ATP binding activity and helicase activity. Human ortholog(s) of this gene are implicated in Seckel syndrome 8; autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions  6; and neurodegenerative disease (multiple). Is an ortholog of human SETX (senataxin).

WB:WBGene00014966	Y106G6D.t1
No description available

WB:WBGene00014967	Y113G7A.2
Is affected by several genes including daf-16; eat-2; and let-418 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00014969	Y113G7A.t1
No description available

WB:WBGene00014970	Y113G7A.t2
No description available

WB:WBGene00014971	Y113G7A.t3
Is affected by daf-2 based on microarray studies.

WB:WBGene00014972	Y113G7A.t4
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00014973	Y113G7A.t5
No description available

WB:WBGene00014974	Y113G7B.t2
No description available

WB:WBGene00014975	Y116A8A.10
Is affected by several genes including daf-16; pgl-1; and sma-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014976	Y116A8C.7
Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00014977	ZC15.4
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq studies. Is affected by Alovudine and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00014978	ZC47.8
Is affected by several genes including hsf-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by Sodium Chloride; Cadmium Chloride; and paraquat based on RNA-seq studies.

WB:WBGene00014979	ZC47.11
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00014980	ZC84.5
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by Microcystin-LR based on microarray studies.

WB:WBGene00014981	ZK218.9
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00014983	ZK228.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00014984	ZK262.12
Is affected by chd-3; adr-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00014987	ZK637.6
Is expressed in hypodermis and pharynx.

WB:WBGene00014989	best-23
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00014990	ZK678.t4
No description available

WB:WBGene00014991	ZK829.12
No description available

WB:WBGene00014992	ZK1025.1
Is affected by several genes including daf-16; hsf-1; and eat-2 based on RNA-seq studies. Is affected by eight chemicals including manganese chloride; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014993	ZK1037.2
Is affected by resveratrol based on microarray studies.

WB:WBGene00014994	ZK1225.7
Is affected by several genes including daf-16; eat-2; and hpl-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00014996	ZK1251.5
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Ethanol; manganese chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00014997	AC7.3
Is enriched in AFD and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00014998	AH9.1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00014999	AH9.3
Is enriched in FLP; intestine; and somatic gonad precursor based on tiling array; microarray; proteomic; and RNA-seq studies. Is affected by several genes including daf-2; let-60; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; Zidovudine; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015000	AH9.4
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00015001	B0025.4
Is predicted to contribute to histone acetyltransferase activity (H3-K23 specific). Is an ortholog of human MEAF6 (MYST/Esa1 associated factor 6).

WB:WBGene00015002	B0034.1
Is expressed in hypodermis; tail; vulval cell; vulval cell; and vulval cell.

WB:WBGene00015003	B0034.2
Is enriched in ventral nerve cord based on tiling array studies. Is affected by several genes including aak-2; hpl-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00015004	B0034.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including antimycin; paraquat; and dafa#1 based on RNA-seq and microarray studies.

WB:WBGene00015005	B0034.5
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015006	B0041.1
Is enriched in coelomocyte and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00015007	ain-2
Is involved in negative regulation of gene expression; regulation of cell fate specification; and regulation of development, heterochronic. Is expressed widely.

WB:WBGene00015008	lmd-2
Is enriched in body wall musculature; intestine; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Quercetin; Hydrolyzable Tannins; and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domains: LysM domain; LysM domain; and LysM domain superfamily. Is an ortholog of human LYSMD1 (LysM domain containing 1) and LYSMD2 (LysM domain containing 2).

WB:WBGene00015009	B0041.5
Is involved in regulation of lipid storage and regulation of peptide transport. Is an ortholog of human SLC35F5 (solute carrier family 35 member F5).

WB:WBGene00015010	ptps-1
Exhibits 6-pyruvoyltetrahydropterin synthase activity and identical protein binding activity. Is involved in tetrahydrobiopterin biosynthetic process. Is expressed in hypodermis and neurons. Human ortholog(s) of this gene are implicated in Bh4-deficient hyperphenylalaninemia A. Is an ortholog of human PTS (6-pyruvoyltetrahydropterin synthase).

WB:WBGene00015011	B0041.8
Is enriched in AFD; body wall musculature; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and npr-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015012	bath-20
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015013	btb-3
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and dcr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015014	bath-24
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015015	math-1
Is enriched in NSM; amphid sheath cell; and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; lin-15B; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube and Alovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015016	bath-14
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including sir-2.1; isp-1; and sma-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015017	B0205.1
Is enriched in AFD; ASER; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00015018	srz-85
Is enriched in Z1.p; Z4.a; male distal tip cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00015019	B0205.4
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity. Is an ortholog of human FUT1 (fucosyltransferase 1 (H blood group)) and FUT2 (fucosyltransferase 2).

WB:WBGene00015020	B0205.5
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by several genes including mex-3; hpl-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015021	nfs-1
Is predicted to have cysteine desulfurase activity. Is an ortholog of human NFS1 (NFS1 cysteine desulfurase).

WB:WBGene00015022	B0205.8
Is predicted to have RNA binding activity.

WB:WBGene00015023	B0205.9
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; antimycin; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00015024	B0205.10
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015025	mrpl-9
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL9 (mitochondrial ribosomal protein L9).

WB:WBGene00015026	B0207.1
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human PTPN9 (protein tyrosine phosphatase non-receptor type 9).

WB:WBGene00015027	B0207.2
Is enriched in AFD; dopaminergic neurons; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and lin-35 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015028	B0207.5
Is expressed in vas deferens valve cell.

WB:WBGene00015029	B0207.6
Is predicted to have GTPase activity. Is an ortholog of human GPN2 (GPN-loop GTPase 2).

WB:WBGene00015030	B0207.7
Is predicted to have protein serine/threonine kinase activity. Is expressed in AIYL and AIYR.

WB:WBGene00015032	B0207.9
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015033	B0207.10
Is enriched in muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and elt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015034	B0207.11
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; D-glucose; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015035	otpl-1
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1) and OTOP2 (otopetrin 2).

WB:WBGene00015036	sre-5
Is affected by several genes including sir-2.1; mir-34; and spc-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00015037	B0212.3
Is enriched in several structures, including Z4.a; germ line; male distal tip cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00015038	nstp-6
Is predicted to have UDP-galactose transmembrane transporter activity. Is an ortholog of human SLC35A1 (solute carrier family 35 member A1).

WB:WBGene00015039	B0213.1
No description available

WB:WBGene00015040	cyp-34A5
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015041	cyp-34A6
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015042	cyp-34A7
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015043	cyp-34A8
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015044	cyp-34A9
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015045	cyp-34A10
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015046	nlp-34
Is enriched in several structures, including RID; carbon dioxide sensory neurons; germline precursor cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015047	faah-1
Is predicted to have amidase activity and fatty acid amide hydrolase activity. Is involved in positive regulation of axon regeneration. Is expressed in pharyngeal neurons and pharynx. Is an ortholog of human FAAH (fatty acid amide hydrolase).

WB:WBGene00015048	faah-2
Is predicted to have amidase activity and fatty acid amide hydrolase activity. Is an ortholog of human FAAH (fatty acid amide hydrolase).

WB:WBGene00015049	B0218.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00015050	clec-51
Is predicted to have signaling receptor activity. Is an ortholog of human MRC1 (mannose receptor C-type 1); MRC2 (mannose receptor C type 2); and PLA2R1 (phospholipase A2 receptor 1).

WB:WBGene00015051	B0218.7
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-two chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00015052	clec-52
Is predicted to have signaling receptor activity. Is involved in defense response to Gram-positive bacterium. Is an ortholog of human MRC1 (mannose receptor C-type 1).

WB:WBGene00015053	B0222.1
Is enriched in AFD and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00015054	pitr-2
Is predicted to have sodium:inorganic phosphate symporter activity. Human ortholog(s) of this gene are implicated in basal ganglia calcification. Is an ortholog of human SLC20A1 (solute carrier family 20 member 1) and SLC20A2 (solute carrier family 20 member 2).

WB:WBGene00015055	pitr-3
Is predicted to have sodium:inorganic phosphate symporter activity. Human ortholog(s) of this gene are implicated in basal ganglia calcification. Is an ortholog of human SLC20A1 (solute carrier family 20 member 1) and SLC20A2 (solute carrier family 20 member 2).

WB:WBGene00015056	B0222.5
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00015057	gad-3
Is predicted to have flavin adenine dinucleotide binding activity and xanthine dehydrogenase activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human AOX1 (aldehyde oxidase 1) and XDH (xanthine dehydrogenase).

WB:WBGene00015058	B0222.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015059	B0228.1
Is enriched in hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015061	cpna-2
Is expressed in body wall musculature; muscle cell; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: Phosphorylation site; Copine; von Willebrand factor, type A; Copine; and von Willebrand factor A-like domain superfamily.

WB:WBGene00015062	trx-1
Exhibits protein disulfide oxidoreductase activity. Is involved in determination of adult lifespan. Localizes to several cellular components, including dendrite; neuronal cell body; and non-motile cilium. Is expressed in ASJL; ASJR; and head neurons. Is an ortholog of human TXN (thioredoxin).

WB:WBGene00015063	B0228.6
Is enriched in germ line; intestine; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00015064	B0228.7
Is predicted to have S-methyl-5-thioadenosine phosphorylase activity. Is expressed in Ea and Ep. Is an ortholog of human MTAP (methylthioadenosine phosphorylase).

WB:WBGene00015065	B0228.8
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including let-60; drh-3; and adr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5382) and Protein of unknown function DUF5382.

WB:WBGene00015066	B0228.9
Is affected by several genes including clk-1; prg-1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5382) and Protein of unknown function DUF5382.

WB:WBGene00015067	cest-35.1
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00015068	srt-68
Is expressed in head neurons. Is predicted to encode a protein with the following domain: 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015069	srt-67
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Ag nanoparticles based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015070	srt-70
Is expressed in ADFL; ADFR; PHBL; and PHBR. Is predicted to encode a protein with the following domain: 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015071	cest-30
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00015072	srt-69
Is enriched in dopaminergic neurons and neurons based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by tryptophan; resveratrol; and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domain: 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015073	B0238.9
Is enriched in several structures, including Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Headcase protein family homologue and Headcase protein. Is an ortholog of human HECA (hdc homolog, cell cycle regulator).

WB:WBGene00015074	natc-2
Is predicted to have peptide alpha-N-acetyltransferase activity. Is involved in dauer larval development. Is an ortholog of human NAA30 (N-alpha-acetyltransferase 30, NatC catalytic subunit).

WB:WBGene00015075	B0238.11
Is enriched in body wall muscle cell; germ line; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: High mobility group box domain superfamily.

WB:WBGene00015076	B0238.12
Is enriched in FLP; OLL; PVD; dopaminergic neurons; and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00015077	B0238.13
Is affected by several genes including daf-16; daf-2; and lin-4 based on proteomic; microarray; and RNA-seq studies. Is affected by eleven chemicals including tryptophan; tert-Butylhydroperoxide; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015078	srt-66
Is affected by daf-12 based on microarray studies. Is affected by tetrabromobisphenol A based on microarray studies.

WB:WBGene00015079	B0244.4
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015080	B0244.5
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015081	B0244.6
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015082	B0244.7
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015083	egg-1
Is predicted to have signaling receptor activity. Is involved in eggshell formation; positive regulation of protein localization to cell periphery; and single fertilization. Localizes to plasma membrane. Is expressed in germ line.

WB:WBGene00015084	B0244.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00015085	B0244.10
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015087	B0252.1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00015088	B0252.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease.

WB:WBGene00015089	B0252.5
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including manganese chloride; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00015091	B0261.1
Is predicted to have TFIIIC-class transcription factor complex binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 112. Is an ortholog of human BDP1 (B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB).

WB:WBGene00015092	mrpl-47
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL47 (mitochondrial ribosomal protein L47).

WB:WBGene00015093	B0261.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015094	B0261.6
Is enriched in amphid sheath cell; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00015095	B0261.7
Is enriched in several structures, including germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including manganese chloride; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015096	B0261.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by Mianserin based on RNA-seq studies.

WB:WBGene00015097	B0273.1
Is enriched in body wall muscle cell; germ line; muscle cell; and in male based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00015098	snpc-3.1
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: snRNA-activating protein of 50kDa MW C terminal and snRNA-activating protein complex, subunit 3. Is an ortholog of human SNAPC3 (small nuclear RNA activating complex polypeptide 3).

WB:WBGene00015099	ggtb-1
Is predicted to contribute to Rab geranylgeranyltransferase activity. Is involved in PERK-mediated unfolded protein response. Is expressed in head; intestine; and tail. Is an ortholog of human RABGGTB (Rab geranylgeranyltransferase subunit beta).

WB:WBGene00015100	B0280.2
Is predicted to have actin filament binding activity. Human ortholog(s) of this gene are implicated in Wiskott-Aldrich syndrome and thrombocytopenia.

WB:WBGene00015101	rpia-1
Is predicted to have ribose-5-phosphate isomerase activity. Is expressed in head neurons; intestine; nerve ring; and tail neurons. Is an ortholog of human RPIA (ribose 5-phosphate isomerase A).

WB:WBGene00015102	cpg-2
Exhibits chitin binding activity. Is involved in several processes, including eggshell formation; mitotic cytokinesis; and regulation of cytokinesis. Localizes to external encapsulating structure and perivitelline space. Is expressed in eggshell.

WB:WBGene00015103	B0280.7
Is expressed in g1AL; g1AR; g1P; g2L; and g2R.

WB:WBGene00015104	B0280.9
Is enriched in body wall muscle cell; germ line; and intestine based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Zidovudine; Cry5B; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human UTP18 (UTP18 small subunit processome component).

WB:WBGene00015105	pot-1
Exhibits C-rich strand telomeric DNA binding activity. Is involved in negative regulation of telomere maintenance via telomere lengthening and telomere maintenance. Localizes to nuclear chromosome, telomeric region.

WB:WBGene00015106	B0280.11
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00015107	viro-2
Is predicted to have actin filament binding activity. Is expressed in intestinal cell and somatic cell. Human ortholog(s) of this gene are implicated in Wiskott-Aldrich syndrome and thrombocytopenia.

WB:WBGene00015108	B0281.1
Is affected by several genes including skn-1; clk-1; and nhl-2 based on microarray and RNA-seq studies. Is affected by paraquat and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00015109	B0281.2
No description available

WB:WBGene00015110	B0281.3
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human TRIM13 (tripartite motif containing 13) and TRIM59 (tripartite motif containing 59).

WB:WBGene00015111	B0281.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00015112	B0281.5
Is involved in ion transport and protein folding. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00015113	B0281.6
Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00015114	B0281.8
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human TRIM21 (tripartite motif containing 21).

WB:WBGene00015115	B0286.1
Is enriched in AVA; GABAergic neurons; head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; Rotenone; and Zidovudine based on RNA-seq studies.

WB:WBGene00015116	paic-1
Exhibits identical protein binding activity. Is an ortholog of human PAICS (phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase).

WB:WBGene00015117	B0294.1
Is enriched in ASER; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015118	B0294.3
Is enriched in DA neuron; VA neuron; body wall muscle cell; hypodermis; and ventral nerve cord based on tiling array studies. Is affected by several genes including clk-1; kri-1; and smg-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00015119	B0302.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including elt-2; pgl-1; and mex-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015120	B0302.3
No description available

WB:WBGene00015121	B0302.4
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Progesterone; resveratrol; and Chlorpyrifos based on microarray studies.

WB:WBGene00015122	B0302.5
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015123	B0302.6
No description available

WB:WBGene00015124	anmt-1
Is predicted to have N-methyltransferase activity. Localizes to striated muscle dense body and striated muscle myosin thick filament. Is an ortholog of human NNMT (nicotinamide N-methyltransferase) and PNMT (phenylethanolamine N-methyltransferase).

WB:WBGene00015125	B0303.3
Is predicted to have acetyl-CoA C-acyltransferase activity. Localizes to mitochondrion. Is expressed in tail. Human ortholog(s) of this gene are implicated in mitochondrial trifunctional protein deficiency. Is an ortholog of human HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta).

WB:WBGene00015126	B0303.4
Is enriched in AVK; coelomocyte; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; Ubiquitin-like domain superfamily; and Transmembrane and ubiquitin-like domain-containing protein 1/2. Is an ortholog of human TMUB1 (transmembrane and ubiquitin like domain containing 1) and TMUB2 (transmembrane and ubiquitin like domain containing 2).

WB:WBGene00015127	B0303.5
No description available

WB:WBGene00015128	B0303.7
Is enriched in hypodermis; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Chlorpyrifos; Diazinon; and paraquat based on microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive chronic granulomatous disease cytochrome b-positive type III. Is predicted to encode a protein with the following domains: SH3 domain; SH3 domain; and SH3-like domain superfamily. Is an ortholog of human SH3D19 (SH3 domain containing 19).

WB:WBGene00015129	sdz-1
Is involved in mesendoderm development. Is expressed in several structures, including E; Ea; Ep; MSpa; and somatic gonad precursor.

WB:WBGene00015130	vps-33.1
Is expressed in several structures, including body wall musculature; hypodermis; intestine; pharynx; and spermatheca. Is predicted to encode a protein with the following domains: Sec1 family; Sec1-like protein; Vacuolar protein sorting-associated protein 33; Sec1-like, domain 2; Sec1-like superfamily; Sec1-like, domain 3a; Sec1-like, domain 1; and Vacuolar protein sorting-associated protein 33, domain 3b. Is an ortholog of human VPS33A (VPS33A core subunit of CORVET and HOPS complexes).

WB:WBGene00015131	B0303.11
Is predicted to have transmembrane transporter activity. Is expressed in excretory duct cell. Human ortholog(s) of this gene are implicated in agenesis of the corpus callosum with peripheral neuropathy; epilepsy (multiple); and renal tubular transport disease (multiple). Is an ortholog of human SLC12A1 (solute carrier family 12 member 1); SLC12A2 (solute carrier family 12 member 2); and SLC12A3 (solute carrier family 12 member 3).

WB:WBGene00015132	B0303.14
Is enriched in several structures, including Z1.p; Z4.a; ciliated neurons; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; allantoin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015133	mrpl-11
Is predicted to have large ribosomal subunit rRNA binding activity. Is an ortholog of human MRPL11 (mitochondrial ribosomal protein L11).

WB:WBGene00015134	B0304.2
Is enriched in several structures, including BAG; cephalic sheath cell; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00015135	cyp-23A1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2) and CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015136	B0304.4
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Zidovudine; and metformin based on microarray and RNA-seq studies.

WB:WBGene00015137	B0310.1
Is predicted to have potassium ion leak channel activity.

WB:WBGene00015138	B0310.2
Is predicted to have DNA binding activity and metal ion binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is an ortholog of human MAZ (MYC associated zinc finger protein) and ZNF692 (zinc finger protein 692).

WB:WBGene00015139	B0310.3
Is enriched in AFD; ASER; body wall muscle cell; head mesodermal cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; levamisole; and tert-Butylhydroperoxide based on microarray and RNA-seq studies.

WB:WBGene00015141	ugt-46
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT2B28 (UDP glucuronosyltransferase family 2 member B28); UGT2B4 (UDP glucuronosyltransferase family 2 member B4); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00015142	B0310.6
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00015143	rbm-26
Is predicted to have mRNA binding activity. Is expressed in gonad; neurons; and tail. Is an ortholog of human RBM26 (RNA binding motif protein 26) and RBM27 (RNA binding motif protein 27).

WB:WBGene00015145	arle-14
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ARF7 effector protein C-terminus; ARL14 effector protein; and ARF7 effector protein, C-terminal. Is an ortholog of human ARL14EP (ADP ribosylation factor like GTPase 14 effector protein).

WB:WBGene00015146	abi-1
Exhibits SH3 domain binding activity; protein N-terminus binding activity; and protein kinase binding activity. Is involved in several processes, including positive regulation of endocytosis; presynaptic actin cytoskeleton organization; and synaptic vesicle clustering. Localizes to several cellular components, including axon; dendrite; and neuronal cell body. Is expressed in coelomocyte; head neurons; and ventral cord neurons. Is an ortholog of human ABI1 (abl interactor 1).

WB:WBGene00015147	B0336.7
Is predicted to have DNA binding activity. Is expressed in intestine and neurons.

WB:WBGene00015148	hpo-28
Is enriched in OLL; PLM; PVD; body wall muscle cell; and muscle cell based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including D-glucose; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold. Is an ortholog of human MOSPD2 (motile sperm domain containing 2).

WB:WBGene00015149	B0336.12
Is enriched in AVA based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015150	B0336.13
Is predicted to have TBP-class protein binding activity and transcription coactivator activity. Is an ortholog of human GTF2A2 (general transcription factor IIA subunit 2).

WB:WBGene00015151	B0348.1
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including npr-1; spn-4; and cyc-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Cry5B; and Triclosan based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein.

WB:WBGene00015152	B0348.2
Is enriched in intestine and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Tunicamycin; Cry5B; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein.

WB:WBGene00015153	B0348.5
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00015155	B0353.1
Is enriched in OLL; PVD; intestine; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015156	cwf-19L2
Is enriched in germ line; germline precursor cell; head mesodermal cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sir-2.1; and mab-5 based on RNA-seq; tiling array; and microarray studies. Is affected by seven chemicals including Zidovudine; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein similar to CwfJ C-terminus 2; Cwf19-like protein, C-terminal domain-2; and Cwf19-like protein. Is an ortholog of human CWF19L2 (CWF19 like cell cycle control factor 2).

WB:WBGene00015157	B0361.3
Is enriched in germ line; head mesodermal cell; and hypodermis based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Zidovudine; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015158	B0361.4
Is predicted to have heme binding activity and oxygen binding activity.

WB:WBGene00015159	psd-1
Is predicted to have phosphatidylserine decarboxylase activity. Is an ortholog of human PISD (phosphatidylserine decarboxylase).

WB:WBGene00015160	B0361.6
Is predicted to have methyltransferase activity. Is an ortholog of human SPOUT1 (SPOUT domain containing methyltransferase 1).

WB:WBGene00015161	pho-5
Is predicted to have acid phosphatase activity. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal) and ACP3 (acid phosphatase 3).

WB:WBGene00015162	algn-11
Is predicted to have GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ip. Is an ortholog of human ALG11 (ALG11 alpha-1,2-mannosyltransferase).

WB:WBGene00015163	B0361.9
Is enriched in PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00015164	ykt-6
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human YKT6 (YKT6 v-SNARE homolog).

WB:WBGene00015165	B0361.11
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease.

WB:WBGene00015166	B0403.1
No description available

WB:WBGene00015167	B0403.3
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015168	pdi-6
Is predicted to have protein disulfide isomerase activity. Is involved in negative regulation of IRE1-mediated unfolded protein response. Is expressed in head; intestinal muscle; and tail. Is an ortholog of human PDIA6 (protein disulfide isomerase family A member 6).

WB:WBGene00015169	B0403.5
Is enriched in Z1; Z4; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including D-glucose; 4-bromodiphenyl ether; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00015170	B0410.1
Is affected by several genes including pgl-1; mex-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015171	vang-1
Exhibits PDZ domain binding activity. Is involved in Wnt signaling pathway, planar cell polarity pathway and digestive tract morphogenesis. Localizes to apical plasma membrane and basolateral plasma membrane. Is expressed in several structures, including egg-laying apparatus; gonad; hyp7; hyp7; and neurons. Is an ortholog of human VANGL1 (VANGL planar cell polarity protein 1) and VANGL2 (VANGL planar cell polarity protein 2).

WB:WBGene00015172	B0410.3
Is enriched in PLM and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00015173	trpp-11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; pmk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2S. Is predicted to encode a protein with the following domains: Trafficking protein particle complex subunit 10, TRAPPC10 and TRAPP II complex, TRAPPC10. Is an ortholog of human TRAPPC11 (trafficking protein particle complex 11).

WB:WBGene00015175	srz-4
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00015176	vps-51
Exhibits syntaxin binding activity. Is involved in negative regulation of dense core granule transport; positive regulation of dense core granule transport; and positive regulation of locomotion involved in locomotory behavior. Localizes to GARP complex. Is expressed in body wall musculature; intestinal cell; and neurons. Is an ortholog of human VPS51 (VPS51 subunit of GARP complex).

WB:WBGene00015177	tmc-2
Is predicted to have mechanosensitive ion channel activity. Is expressed in body wall musculature and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 36 and autosomal recessive nonsyndromic deafness 7. Is an ortholog of human TMC3 (transmembrane channel like 3).

WB:WBGene00015178	B0416.2
Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including tryptophan; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00015179	B0416.3
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and dcr-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015180	B0416.4
Is predicted to have metal ion binding activity.

WB:WBGene00015181	B0416.5
Is predicted to have cofactor transmembrane transporter activity. Is expressed in gonad. Is an ortholog of human SLC49A3 (solute carrier family 49 member 3).

WB:WBGene00015182	B0416.7
Is enriched in PLM; body wall muscle cell; germ line; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00015183	B0432.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015184	djr-1.1
Is predicted to have protein deglycase activity. Is involved in several processes, including cellular response to aldehyde; glyoxal metabolic process; and monocarboxylic acid biosynthetic process. Localizes to cytoplasm and nucleus. Is expressed in intestine. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in Parkinson's disease 7. Is an ortholog of human PARK7 (Parkinsonism associated deglycase).

WB:WBGene00015185	mrpl-41
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL41 (mitochondrial ribosomal protein L41).

WB:WBGene00015186	misc-1
Is predicted to have oxoglutarate:malate antiporter activity. Localizes to mitochondrion. Is expressed in several structures, including intestine; neurons; and pharynx. Is an ortholog of human SLC25A11 (solute carrier family 25 member 11).

WB:WBGene00015188	B0432.7
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Armadillo-type fold and Protein CIP2A. Is an ortholog of human CIP2A (cellular inhibitor of PP2A).

WB:WBGene00015189	B0432.8
Is predicted to have hydrolase activity, acting on ester bonds. Is an ortholog of human TATDN3 (TatD DNase domain containing 3).

WB:WBGene00015190	B0432.9
Is enriched in NSM; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; antimycin; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Metallo-beta-lactamase superfamily; Metallo-beta-lactamase; Ribonuclease Z/Hydroxyacylglutathione hydrolase-like; and Metallo-beta-lactamase domain-containing protein 1. Is an ortholog of human MBLAC1 (metallo-beta-lactamase domain containing 1).

WB:WBGene00015191	B0432.10
Is enriched in several structures, including AFD; Z1.p; Z4.a; germ line; and male distal tip cell based on RNA-seq studies. Is affected by several genes including sir-2.1; lin-35; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015192	B0432.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015193	clec-117
Is predicted to have carbohydrate binding activity.

WB:WBGene00015194	trul-1
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Seckel syndrome 9. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human TRAIP (TRAF interacting protein).

WB:WBGene00015196	B0454.5
Is expressed in ventral cord blast cell. Is predicted to encode a protein with the following domain: Transmembrane protein 272.

WB:WBGene00015197	B0454.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68. Is an ortholog of human SLC7A4 (solute carrier family 7 member 4).

WB:WBGene00015198	clec-2
Is predicted to have carbohydrate binding activity.

WB:WBGene00015199	B0454.8
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercury hydroxide; Tunicamycin; and Acrylamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00015200	lido-13
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00015201	B0478.2
No description available

WB:WBGene00015202	B0478.3
Is predicted to have calcium ion binding activity and phospholipase A2 activity.

WB:WBGene00015203	cdk-11.1
Is predicted to have cyclin-dependent protein serine/threonine kinase activity. Is involved in gamete generation and positive regulation of embryonic development. Localizes to cytoplasm and nucleus. Is expressed in gonadal sheath cell; somatic cell; and somatic gonad. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 2 and primary autosomal recessive microcephaly 12. Is an ortholog of human CDK11A (cyclin dependent kinase 11A) and CDK11B (cyclin dependent kinase 11B).

WB:WBGene00015204	B0495.5
Is predicted to have catalytic activity. Is an ortholog of human SPATA20 (spermatogenesis associated 20).

WB:WBGene00015205	moa-2
Is enriched in germ line; muscle cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015206	B0495.7
Is predicted to have metal ion binding activity and metallopeptidase activity. Is expressed in several structures, including AB and Psub1. Is an ortholog of human ERMP1 (endoplasmic reticulum metallopeptidase 1).

WB:WBGene00015207	luc-7L
Is predicted to have mRNA binding activity. Is an ortholog of human LUC7L (LUC7 like) and LUC7L2 (LUC7 like 2, pre-mRNA splicing factor).

WB:WBGene00015208	B0495.9
Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in spastic ataxia 5 and spinocerebellar ataxia type 28. Is predicted to encode a protein with the following domain: .

WB:WBGene00015210	B0496.1
Is enriched in Z1 and Z4 based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015211	B0496.2
Is enriched in AFD; germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; pmk-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015214	srtx-1
Is involved in thermosensory behavior. Localizes to neuron projection membrane and neuron projection terminus. Is expressed in AFDL; AFDR; AWCL; and AWCR.

WB:WBGene00015215	B0496.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; antimycin; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00015216	valv-1
Is predicted to have zinc ion binding activity. Is involved in digestive system process and oviposition. Is an ortholog of human CRIP1 (cysteine rich protein 1).

WB:WBGene00015217	tes-1
Is predicted to have zinc ion binding activity. Is expressed in AB. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 1B. Is an ortholog of human LMCD1 (LIM and cysteine rich domains 1) and TES (testin LIM domain protein).

WB:WBGene00015218	B0507.1
Is involved in pharyngeal gland morphogenesis. Is expressed in hermaphrodite distal tip cell; pharyngeal gland cell; pharyngeal-intestinal valve; rectal gland cell; and spermatheca.

WB:WBGene00015219	B0507.2
Is enriched in coelomocyte; head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; RNA-seq; and tiling array studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BRO1-like domain; BRO1 domain; BRO1 domain superfamily; and BRO1 domain-containing protein BROX. Is an ortholog of human BROX (BRO1 domain and CAAX motif containing).

WB:WBGene00015220	B0507.3
Is enriched in head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; levamisole; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015221	B0507.4
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including clk-1; eat-2; and lin-15B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00015222	B0507.5
Is affected by several genes including sir-2.1; lin-15B; and prg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by aldicarb and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015223	B0507.6
Is enriched in body wall muscle cell; cephalic sheath cell; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00015224	B0507.7
Is enriched in body wall muscle cell; coelomocyte; germ line; intestine; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015225	B0507.8
Is enriched in body wall muscle cell; cephalic sheath cell; excretory cell; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Nitric Oxide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies.

WB:WBGene00015226	B0507.9
Is enriched in GABAergic neurons; OLL; PVD; dopaminergic neurons; and excretory cell based on microarray and tiling array studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mercuric Chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015227	ddn-1
Is expressed in AFD; M5 neuron; body wall musculature; and chemosensory neurons.

WB:WBGene00015228	B0511.2
Is enriched in OLL; PVD; germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00015229	fbxa-125
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00015230	tag-344
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human TSSK2 (testis specific serine kinase 2) and TSSK6 (testis specific serine kinase 6).

WB:WBGene00015231	cutl-14
Is enriched in several structures, including dopaminergic neurons; germline precursor cell; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Mercuric Chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00015232	B0511.6
Is predicted to have RNA binding activity and RNA helicase activity. Is expressed in head and tail. Is an ortholog of human DDX18 (DEAD-box helicase 18).

WB:WBGene00015233	B0511.7
Is predicted to have mRNA binding activity and protein serine/threonine phosphatase inhibitor activity. Is an ortholog of human PPP1R8 (protein phosphatase 1 regulatory subunit 8).

WB:WBGene00015235	cdc-26
Is expressed in germ line.

WB:WBGene00015236	B0511.11
Is enriched in AVA; germ line; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015237	B0511.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and alg-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Pecanex protein (C-terminus); Pecanex, C-terminal; and Protein Pecanex. Is an ortholog of human PCNX2 (pecanex 2) and PCNX3 (pecanex 3).

WB:WBGene00015238	mppe-1
Is predicted to have hydrolase activity and metal ion binding activity. Is an ortholog of human MPPE1 (metallophosphoesterase 1).

WB:WBGene00015241	B0524.2
Is predicted to have triglyceride lipase activity. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 10. Is an ortholog of human PNPLA4 (patatin like phospholipase domain containing 4).

WB:WBGene00015242	B0524.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00015243	B0524.4
Is enriched in germ line; intestine; and seam cell based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00015244	B0524.5
Is enriched in I5 neuron; cholinergic neurons; germ line; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Mianserin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00015245	B0524.6
Is enriched in body wall muscle cell; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015246	scl-23
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily.

WB:WBGene00015247	B0545.4
Is predicted to have protein dimerization activity.

WB:WBGene00015248	mai-2
Exhibits ATPase inhibitor activity. Is involved in negative regulation of ATPase activity. Localizes to mitochondrion. Is expressed in germ line and tail. Is an ortholog of human ATP5IF1 (ATP synthase inhibitory factor subunit 1).

WB:WBGene00015249	otub-4
Is predicted to have Lys63-specific deubiquitinase activity and thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human OTUD5 (OTU deubiquitinase 5).

WB:WBGene00015250	B0546.3
Is predicted to have metal ion binding activity. Is an ortholog of human YPEL5 (yippee like 5).

WB:WBGene00015251	B0546.4
Is predicted to have metal ion binding activity. Is an ortholog of human YPEL5 (yippee like 5).

WB:WBGene00015252	B0546.5
Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1182) and Protein of unknown function DUF1182.

WB:WBGene00015253	B0547.2
Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00015254	B0554.1
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including age-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015255	B0554.2
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; sir-2.1; and ain-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol; Atrazine; and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00015257	B0554.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00015258	B0554.5
Is expressed in excretory cell. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00015259	dod-20
Is enriched in DA neuron; VA neuron; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00015260	B0554.7
Is enriched in excretory cell and neurons based on tiling array and microarray studies. Is affected by several genes including sir-2.1; dpy-21; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including hydrogen sulfide; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00015261	B0563.1
Is enriched in GABAergic neurons; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; elt-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015262	B0563.5
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015263	B0563.6
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015264	B0563.7
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00015265	B0563.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Alovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015266	BE0003N10.1
Is predicted to have 3'-5'-exoribonuclease activity and polyribonucleotide nucleotidyltransferase activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 70 and combined oxidative phosphorylation deficiency 13. Is an ortholog of human PNPT1 (polyribonucleotide nucleotidyltransferase 1).

WB:WBGene00015267	chin-1
Is predicted to have GTPase activator activity. Is involved in protein localization and regulation of GTPase activity. Localizes to cell cortex. Human ortholog(s) of this gene are implicated in Duane retraction syndrome. Is an ortholog of human CHN1 (chimerin 1) and CHN2 (chimerin 2).

WB:WBGene00015268	BE0003N10.3
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human FBXO11 (F-box protein 11).

WB:WBGene00015269	C01B4.2
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00015270	C01B4.6
Is predicted to have carbohydrate binding activity and isomerase activity. Is an ortholog of human GALM (galactose mutarotase).

WB:WBGene00015271	C01B4.7
Is predicted to have transmembrane transporter activity.

WB:WBGene00015272	C01B4.8
Is predicted to have transmembrane transporter activity.

WB:WBGene00015273	mct-2
Is predicted to have monocarboxylic acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A14 (solute carrier family 16 member 14); SLC16A4 (solute carrier family 16 member 4); and SLC16A9 (solute carrier family 16 member 9).

WB:WBGene00015277	C01B7.7
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00015278	C01B10.3
Is predicted to have inositol-polyphosphate 5-phosphatase activity. Is expressed in pharyngeal muscle cell and rectal epithelium. Is an ortholog of human INPP5A (inositol polyphosphate-5-phosphatase A).

WB:WBGene00015279	cest-5.1
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; levamisole; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold.

WB:WBGene00015280	C01B10.6
Is enriched in head mesodermal cell; intestine; pharyngeal muscle cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-four chemicals including Ethanol; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015281	C01B10.7
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including aldicarb; Tunicamycin; and Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015282	C01B10.8
Is expressed in intestine. Is predicted to encode a protein with the following domains: Spermine/spermidine synthase domain; Methyltransferase domain; Methyltransferase domain; and S-adenosyl-L-methionine-dependent methyltransferase. Is an ortholog of human EEF1AKNMT (eEF1A lysine and N-terminal methyltransferase).

WB:WBGene00015283	C01B10.9
Is predicted to have bis(5'-adenosyl)-triphosphatase activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial calcification of infancy; autosomal recessive hypophosphatemic rickets; and obesity. Is an ortholog of human ENPP4 (ectonucleotide pyrophosphatase/phosphodiesterase 4).

WB:WBGene00015284	cest-5.2
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq; microarray; and proteomic studies. Is affected by twelve chemicals including levamisole; stavudine; and metformin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold.

WB:WBGene00015285	gmeb-1
Is predicted to have DNA binding activity and transcription coactivator activity. Is an ortholog of human GMEB1 (glucocorticoid modulatory element binding protein 1).

WB:WBGene00015286	best-3
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST3 (bestrophin 3).

WB:WBGene00015287	osta-1
Localizes to periciliary membrane compartment. Is expressed in amphid neurons; ciliated neurons; phasmid neurons; and sensory neurons. Is an ortholog of human SLC51A (solute carrier family 51 subunit alpha).

WB:WBGene00015288	best-4
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2); BEST3 (bestrophin 3); and BEST4 (bestrophin 4).

WB:WBGene00015289	C01B12.6
No description available

WB:WBGene00015291	C01B12.8
Is enriched in AFD; germ line; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; dpy-10; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015292	C01C4.2
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine and cadmium based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015293	C01C4.3
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis and lung cancer. Is an ortholog of human SBK1 (SH3 domain binding kinase 1) and SBK2 (SH3 domain binding kinase family member 2).

WB:WBGene00015294	C01C10.2
Is enriched in AFD; PLM; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; levamisole; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015295	acl-12
Is predicted to have transferase activity, transferring acyl groups. Is involved in IRE1-mediated unfolded protein response and PERK-mediated unfolded protein response.

WB:WBGene00015296	gtf-2F1
Is predicted to have DNA binding activity. Is an ortholog of human GTF2F1 (general transcription factor IIF subunit 1).

WB:WBGene00015297	sco-1
Is predicted to have copper ion binding activity. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease; fatal infantile cardioencephalomyopathy due to cytochrome c oxidase deficiency 1; and myopia. Is an ortholog of human SCO1 (synthesis of cytochrome C oxidase 1).

WB:WBGene00015298	C01F1.3
Is enriched in OLL; PVD; hypodermis; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1. Is predicted to encode a protein with the following domain: NAD(P)-binding domain superfamily. Is an ortholog of human TGDS (TDP-glucose 4,6-dehydratase).

WB:WBGene00015299	C01F1.4
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and let-60 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00015300	C01F1.5
Is predicted to have metallopeptidase activity.

WB:WBGene00015301	C01F1.6
Is predicted to have signaling receptor binding activity. Is expressed in head. Is an ortholog of human ANKRD13C (ankyrin repeat domain 13C).

WB:WBGene00015303	rga-6
Is involved in defense response to fungus. Is an ortholog of human ARHGAP36 (Rho GTPase activating protein 36) and ARHGAP6 (Rho GTPase activating protein 6).

WB:WBGene00015305	C01G5.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF851) and Protein of unknown function DUF851.

WB:WBGene00015306	C01G5.4
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00015307	C01G5.5
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00015308	ddi-1
Is predicted to have aspartic-type endopeptidase activity. Is involved in negative regulation of synapse assembly. Localizes to cytoplasm and nucleus. Is expressed widely. Is an ortholog of human DDI1 (DNA damage inducible 1 homolog 1) and DDI2 (DNA damage inducible 1 homolog 2).

WB:WBGene00015309	C01G5.7
Is predicted to have dynein light intermediate chain binding activity and small GTPase binding activity.

WB:WBGene00015310	fan-1
Is predicted to have 5'-3' exonuclease activity; 5'-flap endonuclease activity; and flap-structured DNA binding activity. Is involved in DNA repair. Localizes to nucleus. Is expressed in embryonic cell; germ cell; head neurons; intestine; and tail neurons. Human ortholog(s) of this gene are implicated in karyomegalic interstitial nephritis. Is an ortholog of human FAN1 (FANCD2 and FANCI associated nuclease 1).

WB:WBGene00015311	C01G5.9
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015312	C01G8.1
Is expressed in germ line.

WB:WBGene00015313	hpo-32
Is enriched in AVK; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by fifteen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015315	srbc-29
Is affected by clk-1; mir-34; and drh-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015316	srbc-30
Is enriched in NSM based on tiling array studies. Is affected by rsr-2; prg-1; and clk-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015317	srbc-32
Is affected by mir-34 and drh-3 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015318	srbc-36
Is affected by several genes including daf-2; clk-1; and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015319	C02A12.7
No description available

WB:WBGene00015320	C02B8.1
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including glp-1; clk-1; and hpl-2 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015321	fbxc-38
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by hydrogen sulfide; Tunicamycin; and indole based on microarray studies.

WB:WBGene00015322	C02B8.3
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5354) and Protein of unknown function DUF5354.

WB:WBGene00015323	frpr-1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015324	C02B8.6
Is predicted to have poly-ADP-D-ribose binding activity and ubiquitin-protein transferase activity. Is an ortholog of human RNF146 (ring finger protein 146).

WB:WBGene00015325	C02B8.7
Is enriched in NSM and dopaminergic neurons based on tiling array studies. Is affected by daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5354) and Protein of unknown function DUF5354.

WB:WBGene00015326	ivd-1
Is predicted to have isovaleryl-CoA dehydrogenase activity. Is involved in positive regulation of proteasomal ubiquitin-dependent protein catabolic process and regulation of response to oxidative stress. Is expressed in head. Human ortholog(s) of this gene are implicated in isovaleric acidemia. Is an ortholog of human IVD (isovaleryl-CoA dehydrogenase).

WB:WBGene00015327	snpn-1
Is predicted to have SNARE binding activity. Is involved in endosomal transport and positive regulation of intracellular protein transport. Is used to study Hermansky-Pudlak syndrome. Is an ortholog of human SNAPIN (SNAP associated protein).

WB:WBGene00015328	C02B10.3
Is enriched in excretory cell; intestine; neurons; pharynx; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including let-7; gld-1; and clk-1 based on proteomic; microarray; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domain: EGF-like domain.

WB:WBGene00015329	C02B10.4
Is predicted to have nucleic acid binding activity.

WB:WBGene00015330	C02B10.5
Is enriched in AVK; OLL; PVD; germ line; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pmk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Rifampin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is an ortholog of human PYGO1 (pygopus family PHD finger 1) and PYGO2 (pygopus family PHD finger 2).

WB:WBGene00015331	C02B10.6
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00015332	tyr-1
Is predicted to have metal ion binding activity and monooxygenase activity. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type III. Is an ortholog of human DCT (dopachrome tautomerase) and TYRP1 (tyrosinase related protein 1).

WB:WBGene00015333	slc-17.3
Is predicted to have transmembrane transporter activity.

WB:WBGene00015334	sup-18
Is predicted to have iodide peroxidase activity. Is expressed in anal depressor muscle; head neurons; and vulval muscle. Is an ortholog of human IYD (iodotyrosine deiodinase).

WB:WBGene00015335	acdh-6
Is predicted to have flavin adenine dinucleotide binding activity and isovaleryl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6.

WB:WBGene00015336	C02D5.2
Is enriched in body wall musculature; intestine; muscle cell; and neurons based on microarray studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gamma interferon inducible lysosomal thiol reductase (GILT) and Gamma interferon inducible lysosomal thiol reductase GILT. Is an ortholog of human IFI30 (IFI30 lysosomal thiol reductase).

WB:WBGene00015337	gsto-2
Is predicted to have glutathione dehydrogenase (ascorbate) activity. Is expressed in head; intestine; and tail. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTO1 (glutathione S-transferase omega 1) and GSTO2 (glutathione S-transferase omega 2).

WB:WBGene00015338	catp-2
Is predicted to have sodium:potassium-exchanging ATPase activity. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; Menkes disease; and neurodegenerative disease (multiple). Is an ortholog of human ATP4A (ATPase H+/K+ transporting subunit alpha).

WB:WBGene00015339	C02E7.6
Is expressed in neurons and ventral nerve cord. Is predicted to encode a protein with the following domain: .

WB:WBGene00015340	C02E7.7
Is enriched in DA neuron; carbon dioxide sensory neurons; germline precursor cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-two chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015341	C02E7.8
Is affected by sir-2.1 based on microarray studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00015342	C02E7.10
Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including 1-methylnicotinamide; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00015344	nra-4
Is involved in protein-containing complex assembly. Localizes to endoplasmic reticulum. Is expressed in germ line; motor neurons; and non-striated muscle. Is an ortholog of human NOMO1 (NODAL modulator 1); NOMO2 (NODAL modulator 2); and NOMO3 (NODAL modulator 3).

WB:WBGene00015345	C02F5.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5356) and Uncharacterised protein family C02F5.10.

WB:WBGene00015346	C02F5.3
Is predicted to have GTP binding activity. Is an ortholog of human DRG2 (developmentally regulated GTP binding protein 2).

WB:WBGene00015347	cids-1
Is predicted to have RNA polymerase II complex binding activity. Is involved in mRNA 3'-end processing. Is an ortholog of human RPRD1A (regulation of nuclear pre-mRNA domain containing 1A) and RPRD1B (regulation of nuclear pre-mRNA domain containing 1B).

WB:WBGene00015348	C02F5.5
Is enriched in germ line; hypodermis; interneuron; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00015349	henn-1
Exhibits small RNA 2'-O-methyltransferase. Is involved in RNA methylation; piRNA metabolic process; and regulation of production of siRNA involved in RNA interference. Localizes to nucleoplasm and perinuclear region of cytoplasm. Is expressed in germ line and somatic cell. Is an ortholog of human HENMT1 (HEN methyltransferase 1).

WB:WBGene00015350	fbxl-1
Is predicted to contribute to ubiquitin-protein transferase activity. Is involved in several processes, including dauer entry; defecation rhythm; and regulation of defecation rhythm. Localizes to several cellular components, including cilium; dendrite; and perikaryon. Is an ortholog of human FBXL2 (F-box and leucine rich repeat protein 2) and FBXL20 (F-box and leucine rich repeat protein 20).

WB:WBGene00015351	C02F5.10
Is enriched in several structures, including GABAergic neurons; NSM; Z4.a; germ line; and male distal tip cell based on RNA-seq and tiling array studies. Is affected by several genes including eat-2; isp-1; and hsp-6 based on RNA-seq and microarray studies. Is affected by ten chemicals including stavudine; Sodium Chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5356) and Uncharacterised protein family C02F5.10.

WB:WBGene00015352	C02F5.12
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00015353	C02F5.13
Is enriched in AFD; Psub3; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TM2 domain and TM2 domain. Is an ortholog of human TM2D2 (TM2 domain containing 2).

WB:WBGene00015354	snet-1
Is involved in regulation of chemotaxis; regulation of olfactory learning; and response to pheromone. Is expressed in coelomocyte and ganglia.

WB:WBGene00015355	C02F12.5
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00015356	tag-278
Is expressed in body wall musculature. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Family with sequence similarity 184, A and B; FAM184 family; and Protein FAM184A/B, N-terminal. Is an ortholog of human FAM184A (family with sequence similarity 184 member A).

WB:WBGene00015357	C02F12.8
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including bisphenol A; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015359	C02G6.1
Is enriched in AFD; OLL; PVD; dopaminergic neurons; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; methylmercuric chloride; and Psoralens based on microarray and RNA-seq studies. Is an ortholog of human IDE (insulin degrading enzyme).

WB:WBGene00015360	C02G6.2
Is predicted to have catalytic activity and metal ion binding activity. Is an ortholog of human IDE (insulin degrading enzyme).

WB:WBGene00015361	C02H6.1
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00015362	fbxa-105
Is involved in innate immune response.

WB:WBGene00015364	npr-19
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015365	C03A7.1
No description available

WB:WBGene00015366	C03A7.2
Is affected by several genes including rrf-3; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Tunicamycin; stavudine; and Progesterone based on microarray and RNA-seq studies.

WB:WBGene00015367	srt-64
Is affected by mir-34; lin-22; and eri-1 based on microarray and RNA-seq studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015368	srt-65
Is expressed in amphid neurons; head; and pharyngeal cell. Is predicted to encode a protein with the following domain: 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015369	ugt-51
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A5 (UDP glucuronosyltransferase family 1 member A5); and UGT2A3 (UDP glucuronosyltransferase family 2 member A3).

WB:WBGene00015371	C03A7.13
Is predicted to have UDP-glycosyltransferase activity.

WB:WBGene00015372	C03B1.1
Is affected by several genes including daf-12; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015373	C03B1.2
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including tryptophan; indole; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015374	C03B1.3
Is enriched in several structures, including Z4.a; male distal tip cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by rsr-2 based on tiling array studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00015375	C03B1.4
Is enriched in several structures, including Z1.p; Z4.a; male distal tip cell; somatic gonad precursor; and touch receptor neurons based on microarray and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including tryptophan; metformin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015376	C03B1.5
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in lung cancer.

WB:WBGene00015377	C03B1.6
Is enriched in neurons based on tiling array and microarray studies. Is affected by cyc-1; clk-1; and let-60 based on microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00015378	C03B1.7
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; pgl-1; and dcr-1 based on RNA-seq and microarray studies. Is affected by D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015379	C03B1.9
Is affected by rsr-2; aak-1; and aak-2 based on tiling array and RNA-seq studies. Is affected by resveratrol and Atrazine based on microarray studies.

WB:WBGene00015380	C03B1.10
Is enriched in AFD and PLM based on RNA-seq studies. Is affected by several genes including mex-1; spn-4; and drh-3 based on tiling array and RNA-seq studies. Is affected by Chlorpyrifos based on microarray studies.

WB:WBGene00015381	C03B1.13
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00015382	C03B1.14
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015385	C03B8.2
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015386	C03B8.3
Is enriched in body wall muscle cell; excretory cell; germ line; muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane protein 65 and Transmembrane protein 65.

WB:WBGene00015387	kcnl-3
Is predicted to have calmodulin binding activity and small conductance calcium-activated potassium channel activity. Human ortholog(s) of this gene are implicated in dehydrated hereditary stomatocytosis 2. Is an ortholog of several human genes including KCNN1 (potassium calcium-activated channel subfamily N member 1); KCNN2 (potassium calcium-activated channel subfamily N member 2); and KCNN4 (potassium calcium-activated channel subfamily N member 4).

WB:WBGene00015388	C03F11.2
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Metallo-beta-lactamase superfamily; Metallo-beta-lactamase; Ribonuclease Z/Hydroxyacylglutathione hydrolase-like; and Metallo-beta-lactamase domain-containing protein 1. Is an ortholog of human MBLAC1 (metallo-beta-lactamase domain containing 1).

WB:WBGene00015389	scav-1
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 10 and progressive myoclonus epilepsy 4. Is predicted to encode a protein with the following domains: CD36 family and CD36 family. Is an ortholog of human SCARB2 (scavenger receptor class B member 2).

WB:WBGene00015390	C03F11.4
Is enriched in several structures, including coelomocyte; germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015391	sdha-1
Is predicted to have electron transfer activity; flavin adenine dinucleotide binding activity; and succinate dehydrogenase (ubiquinone) activity. Localizes to mitochondrion. Is expressed in head. Human ortholog(s) of this gene are implicated in several diseases, including dilated cardiomyopathy 1GG; mitochondrial complex II deficiency; and paraganglioma. Is an ortholog of human SDHA (succinate dehydrogenase complex flavoprotein subunit A).

WB:WBGene00015392	nspc-7
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq; tiling array; and microarray studies. Is affected by fourteen chemicals including Ethanol; Rotenone; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015393	exc-13
Is enriched in GABAergic neurons; excretory cell; head mesodermal cell; mechanosensory neurons; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00015394	C03G6.6
Is affected by several genes including daf-16; daf-12; and prg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; antimycin; and single-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00015395	nhr-147
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00015396	nhr-148
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00015397	nhr-149
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00015398	tag-293
Is enriched in AFD and intestine based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; nicotinic acid; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00015399	cyp-35A1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in response to xenobiotic stimulus. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets.

WB:WBGene00015400	cyp-35A2
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in response to xenobiotic stimulus. Is expressed in intestine. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00015401	srsx-24
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015402	C03G6.17
Is enriched in GABAergic neurons; amphid sheath cell; excretory cell; hypodermis; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; D-glucose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00015403	clec-10
Is predicted to have carbohydrate binding activity.

WB:WBGene00015404	nstp-4
Is predicted to have UDP-galactose transmembrane transporter activity. Is expressed in head; intestinal muscle; and tail. Is an ortholog of human SLC35A3 (solute carrier family 35 member A3).

WB:WBGene00015405	C03H5.3
Is enriched in AFD; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00015406	C03H5.4
Is predicted to have calcium ion binding activity and carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in familial benign fleck retina. Is an ortholog of several human genes including PLA2G2A (phospholipase A2 group IIA); PLA2G2E (phospholipase A2 group IIE); and PLA2G5 (phospholipase A2 group V).

WB:WBGene00015407	C03H5.5
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF3L (eukaryotic translation initiation factor 3 subunit L).

WB:WBGene00015408	C03H5.6
Is enriched in neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including skn-1; sir-2.1; and lin-39 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015409	C03H5.7
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00015410	tbc-6
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human GRTP1 (growth hormone regulated TBC protein 1).

WB:WBGene00015411	srz-60
Is affected by several genes including eat-2; sek-1; and mex-3 based on tiling array and RNA-seq studies. Is affected by Psoralens; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00015412	lgc-9
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00015413	pdhb-1
Is predicted to have pyruvate dehydrogenase (acetyl-transferring) activity. Localizes to mitochondrion. Is expressed in head. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human PDHB (pyruvate dehydrogenase E1 subunit beta).

WB:WBGene00015414	C04C3.4
Is affected by several genes including eat-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015416	C04C3.6
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015417	C04C3.7
Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00015418	pac-1
Exhibits GTPase activator activity. Is involved in Rho protein signal transduction; protein localization; and regulation of gastrulation. Localizes to cell junction. Is expressed in anus; epithelial cell; hypodermis; pharynx; and pm7. Is an ortholog of human ARHGAP23 (Rho GTPase activating protein 23).

WB:WBGene00015419	srsx-18
Is predicted to have G protein-coupled receptor activity. Is expressed in linker cell.

WB:WBGene00015421	C04E6.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00015422	C04E6.5
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability.

WB:WBGene00015423	C04E6.7
Is predicted to have hydrolase activity.

WB:WBGene00015424	C04E6.8
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: NTF2-like domain superfamily.

WB:WBGene00015425	C04E6.11
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in French Canadian Leigh disease. Is predicted to encode a protein with the following domains: Tetratricopeptide-like helical domain superfamily and Leucine-rich PPR motif-containing protein. Is an ortholog of human LRPPRC (leucine rich pentatricopeptide repeat containing).

WB:WBGene00015426	C04E6.12
Is enriched in RIS and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: Serine protease inhibitor-like superfamily.

WB:WBGene00015427	C04E6.13
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; nanoparticle; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015428	C04E7.1
Is affected by several genes including eat-2; eri-1; and mut-2 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00015429	sor-3
Is involved in several processes, including negative regulation of transcription, DNA-templated; nematode larval development; and neuron differentiation. Localizes to cytoplasm and nucleus. Is expressed widely.

WB:WBGene00015430	C04E7.3
Is enriched in AVA; AVE; coelomocyte; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and mex-3 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; Cry5B; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00015432	srbc-4
Is affected by daf-2 based on microarray studies.

WB:WBGene00015433	C04E12.2
Is enriched in head mesodermal cell; hypodermis; and muscle cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00015434	C04E12.4
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00015435	C04E12.5
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00015436	C04E12.6
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin; resveratrol; and Sirolimus based on microarray studies.

WB:WBGene00015437	scrm-3
Is predicted to have phospholipid scramblase activity. Is expressed in body wall musculature and touch receptor neurons. Is an ortholog of human PLSCR3 (phospholipid scramblase 3); PLSCR4 (phospholipid scramblase 4); and PLSCR5 (phospholipid scramblase family member 5).

WB:WBGene00015438	srbc-2
Is affected by rsr-2; daf-16; and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015439	C04E12.10
Is affected by several genes including daf-16; daf-12; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015440	arrd-20
Is enriched in DA neuron; RIS; VA neuron; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015441	arrd-21
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015442	C04F1.1
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00015444	C04F5.2
Is enriched in GABAergic neurons; germ line; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by eat-2 and ints-4 based on RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015446	srab-1
Is expressed in AWBL and AWBR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00015447	srab-2
Is affected by drh-3 based on RNA-seq studies. Is affected by Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00015448	srab-3
Is expressed in ganglia. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00015449	ugt-63
Is predicted to have UDP-glycosyltransferase activity. Is expressed in hypodermis and muscle cell. Is an ortholog of several human genes including UGT1A10 (UDP glucuronosyltransferase family 1 member A10); UGT1A5 (UDP glucuronosyltransferase family 1 member A5); and UGT1A8 (UDP glucuronosyltransferase family 1 member A8).

WB:WBGene00015450	C04F5.8
Is predicted to have methyltransferase activity.

WB:WBGene00015451	C04F5.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including dpy-10; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including D-glucose; bisphenol S; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00015453	C04G6.2
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including Nitric Oxide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00015454	C04G6.4
Is predicted to have protein kinase A regulatory subunit binding activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human PRRC1 (proline rich coiled-coil 1).

WB:WBGene00015455	txt-9
Is involved in innate immune response.

WB:WBGene00015456	C04G6.6
Is enriched in body wall muscle cell; cholinergic neurons; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00015457	C04G6.7
Is enriched in body wall muscle cell; cholinergic neurons; hypodermis; and pharyngeal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; Zidovudine; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015458	C04G6.10
Is expressed in pm6. Is predicted to encode a protein with the following domain: .

WB:WBGene00015459	C04G6.11
Is affected by cyc-1; rsr-2; and csr-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00015460	C05C8.1
Is enriched in NSM; coelomocyte; dopaminergic neurons; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; Cry5B; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat, cysteine-containing subtype; ATP synthase subunit s, mitochondrial; and Leucine-rich repeat domain superfamily. Is an ortholog of human DMAC2L (distal membrane arm assembly complex 2 like).

WB:WBGene00015461	krr-1
Is predicted to have RNA binding activity. Is expressed in head and tail. Is an ortholog of human KRR1 (KRR1 small subunit processome component homolog).

WB:WBGene00015462	C05C8.5
Is predicted to have exonuclease activity. Is an ortholog of human REXO5 (RNA exonuclease 5).

WB:WBGene00015463	hpo-9
Is enriched in Psub1; body wall musculature; cephalic sheath cell; germ line; and germline precursor cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB And C-terminal Kelch; BTB/POZ domain; F5/8 type C domain; BTB/POZ domain; Coagulation factor 5/8 C-terminal domain; Galactose-binding-like domain superfamily; SKP1/BTB/POZ domain superfamily; and BTB/Kelch-associated. Is an ortholog of human BTBD9 (BTB domain containing 9).

WB:WBGene00015464	C05C8.7
Is predicted to have mannose-6-phosphate isomerase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ib. Is an ortholog of human MPI (mannose phosphate isomerase).

WB:WBGene00015465	C05C8.8
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015466	hyls-1
Is involved in cilium assembly and foraging behavior. Localizes to centriole and non-motile cilium. Is expressed in amphid neurons; inner labial neurons; and outer labial neurons. Is an ortholog of human HYLS1 (HYLS1 centriolar and ciliogenesis associated).

WB:WBGene00015467	basl-1
Is predicted to have carboxy-lyase activity and pyridoxal phosphate binding activity. Human ortholog(s) of this gene are implicated in aromatic L-amino acid decarboxylase deficiency. Is an ortholog of human DDC (dopa decarboxylase).

WB:WBGene00015468	madf-11
Is expressed in hermaphrodite distal tip cell; intestine; neurons; pharyngeal muscle cell; and ventral nerve cord. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like and MADF domain.

WB:WBGene00015469	C05D2.8
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on SAGE; microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015470	C05D2.10
Is enriched in AVE; NSM; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sir-2.1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR37 (WD repeat domain 37).

WB:WBGene00015471	lmp-2
Is enriched in head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including tryptophan; Mianserin; and bisphenol A based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Danon disease. Is predicted to encode a protein with the following domain: Lysosome-associated membrane glycoprotein. Is an ortholog of human LAMP1 (lysosomal associated membrane protein 1).

WB:WBGene00015472	C05D9.3
Localizes to plasma membrane. Human ortholog(s) of this gene are implicated in epidermolysis bullosa simplex localized type; junctional epidermolysis bullosa non-Herlitz type; and junctional epidermolysis bullosa with pyloric atresia.

WB:WBGene00015473	C05D9.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Zidovudine; Rifampin; and Sirolimus based on RNA-seq studies.

WB:WBGene00015474	C05D9.7
Is enriched in germ line; muscle cell; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including glp-1; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; Rotenone; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00015476	C05D9.9
Is enriched in OLL; PVD; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Rotenone; Tunicamycin; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold and Immunoglobulin-like domain superfamily.

WB:WBGene00015477	attf-4
Is predicted to have DNA binding activity. Is expressed in several structures, including head muscle; pharyngeal-intestinal valve; pharynx; tail neurons; and ventral nerve cord.

WB:WBGene00015478	mapk-15
Is predicted to have MAP kinase activity. Is involved in dopamine uptake; protein localization to ciliary transition zone; and regulation of cilium assembly. Localizes to axoneme; cell-cell junction; and ciliary basal body. Is expressed in neurons; oocyte; and in male. Is an ortholog of human MAPK15 (mitogen-activated protein kinase 15).

WB:WBGene00015479	wht-1
Is predicted to have ATP binding activity and ATPase activity. Is an ortholog of human ABCG1 (ATP binding cassette subfamily G member 1) and ABCG4 (ATP binding cassette subfamily G member 4).

WB:WBGene00015480	C05D10.4
Is enriched in GABAergic neurons; excretory cell; and intestine based on tiling array and microarray studies. Is affected by several genes including dpy-10; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; SAM domain (Sterile alpha motif); Sterile alpha motif domain; and Sterile alpha motif/pointed domain superfamily.

WB:WBGene00015481	C05D11.1
Is predicted to have metalloendopeptidase activity. Is an ortholog of human PITRM1 (pitrilysin metallopeptidase 1).

WB:WBGene00015483	C05D11.5
Is predicted to have hydroxypyruvate isomerase activity. Is an ortholog of human HYI (hydroxypyruvate isomerase (putative)).

WB:WBGene00015484	atgl-1
Is predicted to have triglyceride lipase activity. Localizes to lipid droplet. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 10. Is an ortholog of human PNPLA2 (patatin like phospholipase domain containing 2) and PNPLA3 (patatin like phospholipase domain containing 3).

WB:WBGene00015485	C05D11.8
Is enriched in coelomocyte and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including aldicarb; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Retinoic acid induced 16-like protein and Retinoic acid induced 16-like protein. Is an ortholog of human FAM160A1 (family with sequence similarity 160 member A1) and FAM160A2 (family with sequence similarity 160 member A2).

WB:WBGene00015486	popl-1
Is predicted to have ribonuclease MRP activity and ribonuclease P activity. Is an ortholog of human POP1 (POP1 homolog, ribonuclease P/MRP subunit).

WB:WBGene00015487	mrps-17
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS17 (mitochondrial ribosomal protein S17).

WB:WBGene00015488	C05D11.13
Is enriched in AVK; OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rotenone; Alovudine; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00015489	C05E4.7
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin and Sirolimus based on microarray studies.

WB:WBGene00015490	C05E4.8
No description available

WB:WBGene00015491	C05E4.12
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015492	lnp-1
Is predicted to have metal ion binding activity. Is involved in several processes, including regulation of oviposition; synapse assembly; and synaptic vesicle transport. Localizes to several cellular components, including neuron projection; neuronal cell body; and synaptic vesicle. Is expressed in hypodermis; muscle cell; and neurons. Is an ortholog of human LNPK (lunapark, ER junction formation factor).

WB:WBGene00015493	C05E11.2
Is affected by tatn-1 and sir-2.1 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00015494	C05E11.3
Is enriched in cephalic sheath cell; head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including skn-1; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015495	C05E11.6
Is enriched in neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including bisphenol S; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Crustacean CHH/MIH/GIH neurohormone family; Crustacean CHH/MIH/GIH neurohormone family; and Crustacean CHH/MIH/GIH neurohormone superfamily.

WB:WBGene00015496	C05E11.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015497	nhr-76
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in positive regulation of fatty acid beta-oxidation by octopamine signaling pathway; positive regulation of fatty acid beta-oxidation by serotonin receptor signaling pathway; and positive regulation of transcription by RNA polymerase II. Is expressed in several structures, including body wall musculature; excretory gland cell; intestine; pharynx; and vulval muscle.

WB:WBGene00015499	ints-1
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF3677); Domain of unknown function DUF3677; and Integrator complex subunit 1. Is an ortholog of human INTS1 (integrator complex subunit 1).

WB:WBGene00015500	C06A5.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00015501	C06A5.3
Is enriched in GABAergic neurons and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; PWWP domain; and PWWP domain. Is an ortholog of human HDGFL2 (HDGF like 2) and PSIP1 (PC4 and SFRS1 interacting protein 1).

WB:WBGene00015502	madf-7
No description available

WB:WBGene00015503	C06A5.5
No description available

WB:WBGene00015504	simr-1
Is enriched in several structures, including cephalic sheath cell; germ line; germline precursor cell; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and lin-4 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00015505	C06A5.8
Is predicted to have metal ion binding activity. Is expressed in germ line and oocyte.

WB:WBGene00015506	C06A5.10
No description available

WB:WBGene00015507	C06A6.2
Is enriched in OLL; PVD; and intestine based on microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by four chemicals including Atrazine; Quercetin; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015508	mvb-12
Is involved in endosome to lysosome transport via multivesicular body sorting pathway and receptor catabolic process. Localizes to ESCRT I complex and cytosol. Is expressed in amphid neurons; hypodermis; intestine; and pm7. Is an ortholog of human MVB12A (multivesicular body subunit 12A) and MVB12B (multivesicular body subunit 12B).

WB:WBGene00015509	C06A6.4
Is predicted to have aminoacylase activity. Is an ortholog of human ACY1 (aminoacylase 1).

WB:WBGene00015510	erp-44.2
Is enriched in OLL; PVD; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin-like domain; Thioredoxin domain; and Thioredoxin-like superfamily. Is an ortholog of human ERP44 (endoplasmic reticulum protein 44).

WB:WBGene00015511	C06A6.7
Is enriched in AFD; AVK; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by D-glucose; antimycin; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015512	mthf-1
Is predicted to have FAD binding activity and methylenetetrahydrofolate reductase (NAD(P)H) activity. Is expressed in tail. Is used to study lipid metabolism disorder. Human ortholog(s) of this gene are implicated in several diseases, including homocystinuria; neural tube defect; and thrombophilia. Is an ortholog of human MTHFR (methylenetetrahydrofolate reductase).

WB:WBGene00015513	snpc-1.1
Is predicted to have sequence-specific DNA binding activity. Is an ortholog of human SNAPC1 (small nuclear RNA activating complex polypeptide 1).

WB:WBGene00015514	nlp-77
Is enriched in body wall musculature; hypodermis; neurons; somatic nervous system; and vulval muscle based on Chronogram and proteomic studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on proteomic; microarray; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00015515	spdl-1
Is involved in several processes, including mitotic chromosome movement towards spindle pole; positive regulation of kinetochore assembly; and regulation of mitotic sister chromatid segregation. Localizes to kinetochore and microtubule.

WB:WBGene00015516	C06A8.6
Is predicted to have protein kinase binding activity. Is an ortholog of human PPP1R7 (protein phosphatase 1 regulatory subunit 7).

WB:WBGene00015517	C06A8.8
Is enriched in excretory cell; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including tryptophan; juglone; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Joubert syndrome 25. Is predicted to encode a protein with the following domain: . Is an ortholog of human CEP104 (centrosomal protein 104).

WB:WBGene00015518	C06E1.1
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia (multiple); and retinitis pigmentosa 77. Is predicted to encode a protein with the following domains: TB2/DP1, HVA22 family and TB2/DP1/HVA22-related protein.

WB:WBGene00015519	doxa-1
Is expressed in gonad; hypodermis; terminal bulb; and vulva. Is predicted to encode a protein with the following domains: Dual oxidase maturation factor and Dual oxidase maturation factor. Is an ortholog of human DUOXA2 (dual oxidase maturation factor 2).

WB:WBGene00015520	fip-3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; hpl-2; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00015521	fipr-16
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00015522	C06E1.7
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00015523	ztf-30
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00015524	C06E1.9
Is predicted to have RNA binding activity; histone-glutamine methyltransferase activity; and rRNA methyltransferase activity.

WB:WBGene00015525	rha-2
Is predicted to have RNA binding activity. Is an ortholog of human DHX37 (DEAH-box helicase 37).

WB:WBGene00015526	C06E1.11
Is enriched in germ line; germline precursor cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including nhr-49; hpl-2; and smg-2 based on RNA-seq studies. Is affected by nine chemicals including stavudine; tert-Butylhydroperoxide; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015527	C06E2.1
Is enriched in body wall muscle cell; germline precursor cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015528	C06E2.2
Is affected by pgrn-1; clk-1; and daf-16 based on RNA-seq and microarray studies.

WB:WBGene00015529	C06E2.5
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00015530	C06E4.1
Is affected by several genes including sir-2.1; pgl-1; and eri-1 based on tiling array; RNA-seq; and microarray studies. Is affected by dafa#1 and Triclosan based on microarray studies. Is predicted to encode a protein with the following domain: Protein-tyrosine phosphatase-like.

WB:WBGene00015531	C06E4.2
Is enriched in ASER; head mesodermal cell; neurons; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015532	C06E4.3
Is enriched in AFD; amphid sheath cell; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including tryptophan; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00015533	C06E4.4
Is affected by lin-15B; rsr-2; and eat-2 based on microarray and tiling array studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00015534	C06E4.5
Is predicted to have histone kinase activity (H3-T3 specific).

WB:WBGene00015535	C06E4.6
Is enriched in intestine and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and lin-4 based on microarray and RNA-seq studies. Is affected by ten chemicals including tryptophan; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00015536	glb-2
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons.

WB:WBGene00015537	C06E4.8
Is enriched in several structures, including amphid sheath cell; intestine; male distal tip cell; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; D-glucose; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015538	sams-3
Is predicted to have methionine adenosyltransferase activity. Is an ortholog of human MAT1A (methionine adenosyltransferase 1A) and MAT2A (methionine adenosyltransferase 2A).

WB:WBGene00015539	C06E7.2
Is enriched in cephalic sheath cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and fog-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015540	sams-4
Is predicted to have methionine adenosyltransferase activity. Is expressed in pharyngeal gland cell. Is an ortholog of human MAT1A (methionine adenosyltransferase 1A) and MAT2A (methionine adenosyltransferase 2A).

WB:WBGene00015541	C06E7.4
Is enriched in AFD and DA neuron based on RNA-seq and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; 1-methylnicotinamide; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00015543	C06E8.4
No description available

WB:WBGene00015544	C06E8.5
Is predicted to have lipid binding activity. Is an ortholog of human LBP (lipopolysaccharide binding protein).

WB:WBGene00015545	C06G1.1
Is predicted to have lipid binding activity. Is expressed in excretory system; seam cell; tail hypodermis; and vulval muscle.

WB:WBGene00015546	C06G1.2
Is enriched in DA neuron; head mesodermal cell; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00015547	ain-1
Is involved in several processes, including negative regulation of gene expression; regulation of development, heterochronic; and regulation of vulval development. Localizes to P-body. Is expressed widely.

WB:WBGene00015549	C06G3.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; Mianserin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015550	C06G3.4
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015551	adah-1
Is predicted to have adenosine deaminase activity. Human ortholog(s) of this gene are implicated in adenosine deaminase deficiency. Is an ortholog of human ADA (adenosine deaminase).

WB:WBGene00015552	C06G3.6
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and protein kinase C binding activity. Human ortholog(s) of this gene are implicated in FTDALS3 and Paget's disease of bone.

WB:WBGene00015553	trxr-1
Is predicted to have thioredoxin-disulfide reductase activity. Is involved in ecdysis, collagen and cuticulin-based cuticle. Is expressed in several structures, including hypodermis; interfacial epithelial cell; intestine; pharynx; and vulva. Is an ortholog of human TXNRD3 (thioredoxin reductase 3).

WB:WBGene00015554	C06G3.8
Is predicted to have DNA binding activity. Is an ortholog of human NABP1 (nucleic acid binding protein 1) and NABP2 (nucleic acid binding protein 2).

WB:WBGene00015555	ufl-1
Is predicted to have UFM1 transferase activity. Is expressed in intestine. Is an ortholog of human UFL1 (UFM1 specific ligase 1).

WB:WBGene00015556	C06G3.12
No description available

WB:WBGene00015557	hrpk-2
Is predicted to have RNA binding activity.

WB:WBGene00015558	C06G4.4
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and intestine based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Mianserin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015559	npr-17
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is expressed in ganglia and head neurons. Human ortholog(s) of this gene are implicated in essential hypertension.

WB:WBGene00015560	C07A12.2
Is enriched in AVE; neurons; ventral nerve cord; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Sodium Chloride; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015561	C07A12.7
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GAT domain; GAT domain; and GAT domain superfamily. Is an ortholog of human TOM1L2 (target of myb1 like 2 membrane trafficking protein).

WB:WBGene00015562	C07D8.2
Is affected by several genes including sir-2.1; npr-1; and met-2 based on microarray and RNA-seq studies. Is affected by Cadmium Chloride and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00015564	C07D8.5
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2. Is an ortholog of human AKR1C8P (aldo-keto reductase family 1 member C8, pseudogene).

WB:WBGene00015565	C07D8.6
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Is expressed in germ line. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2. Is an ortholog of human AKR1B1 (aldo-keto reductase family 1 member B); AKR1B10 (aldo-keto reductase family 1 member B10); and AKR1E2 (aldo-keto reductase family 1 member E2).

WB:WBGene00015566	C07D10.1
Is enriched in NSM; body wall muscle cell; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; F-box domain; F-box domain; Leucine-rich repeat domain superfamily; and F-box-like domain superfamily.

WB:WBGene00015567	bath-44
Is predicted to have ubiquitin protein ligase binding activity.

WB:WBGene00015568	sre-3
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00015569	C07D10.5
Is enriched in several structures, including body wall muscle cell; intestine; male distal tip cell; pharynx; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015570	C07F11.2
Is enriched in GABAergic neurons; dopaminergic neurons; and excretory cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including allantoin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015572	C07G1.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00015573	C07G1.7
Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including nicotinic acid; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015574	irg-1
Is predicted to have deaminase activity. Is involved in defense response to Gram-negative bacterium and innate immune response.

WB:WBGene00015575	srbc-35
Is affected by several genes including let-60; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00015576	C07G3.8
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin; Alovudine; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00015577	ugt-64
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT1A7 (UDP glucuronosyltransferase family 1 member A7).

WB:WBGene00015578	C07G3.10
Is predicted to have lipid binding activity.

WB:WBGene00015579	C07H6.2
Is predicted to have protein phosphatase 1 binding activity and protein serine/threonine phosphatase inhibitor activity. Is an ortholog of human PPP1R11 (protein phosphatase 1 regulatory inhibitor subunit 11).

WB:WBGene00015580	cls-1
Is involved in cytoskeleton organization and positive regulation of microtubule depolymerization. Is expressed in head and tail. Is an ortholog of human CLASP1 (cytoplasmic linker associated protein 1) and CLASP2 (cytoplasmic linker associated protein 2).

WB:WBGene00015581	C07H6.4
Is predicted to have RNA binding activity. Is an ortholog of human U2SURP (U2 snRNP associated SURP domain containing).

WB:WBGene00015582	C07H6.9
Is enriched in Z1.p; Z4.a; germ line; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00015583	C08A9.3
Is predicted to have double-stranded RNA binding activity. Is an ortholog of human SIDT1 (SID1 transmembrane family member 1) and SIDT2 (SID1 transmembrane family member 2).

WB:WBGene00015586	lido-1
Is enriched in body wall musculature; germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00015587	lido-2
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00015588	lido-3
Is affected by several genes including sir-2.1; csr-1; and smg-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015589	lido-4
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; pgl-1; and sma-4 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00015590	bath-15
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015591	cyk-7
Is involved in intercellular bridge organization. Localizes to Flemming body.

WB:WBGene00015592	C08D8.1
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00015593	C08E3.1
Is enriched in ciliated neurons; head mesodermal cell; and intestine based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; Mercuric Chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00015594	btb-15
Is affected by several genes including eat-2; hpl-2; and smn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00015595	bath-33
Is affected by several genes including daf-2; rrf-3; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; bisphenol A; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015596	fbxa-161
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including tryptophan; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00015597	fbxa-162
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including methylmercury hydroxide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00015598	fbxa-163
Is enriched in body wall muscle cell; intestine; and neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including methylmercuric chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00015599	fbxa-164
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including aldicarb; Tunicamycin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00015600	fbxa-165
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00015601	fbxa-166
Is enriched in intestine and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00015602	fbxa-158
Is enriched in ALM; PLM; and intestine based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00015603	fbxa-159
Is affected by several genes including eat-2; npr-1; and isp-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00015604	fbxa-160
Is affected by several genes including lin-35; lin-15B; and rsr-2 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol and copper sulfate based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00015605	C08E3.13
Is expressed in intestine and vulva.

WB:WBGene00015606	math-2
Is enriched in NSM based on tiling array studies. Is affected by several genes including mex-1; let-418; and chd-3 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00015607	fbxb-13
Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00015608	math-3
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015609	math-4
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015610	C08F1.6
Is enriched in DA neuron; VA neuron; hypodermis; and intestine based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015611	C08F1.8
Is enriched in AVK; NSM; RID; head mesodermal cell; and intestine based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including aldicarb; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015612	C08F1.9
No description available

WB:WBGene00015613	C08F1.10
Is enriched in cephalic sheath cell and intestine based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including aldicarb; hydrogen sulfide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015614	C08G5.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and smg-2 based on RNA-seq and microarray studies. Is affected by four chemicals including aldicarb; Tunicamycin; and Diazinon based on microarray studies.

WB:WBGene00015615	fbxc-48
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF3557.

WB:WBGene00015616	C08G5.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq; tiling array; and microarray studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies.

WB:WBGene00015618	C08G5.6
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00015619	C08G9.1
Is enriched in body wall musculature; germ line; head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015620	C08G9.2
Is predicted to have serine-type endopeptidase inhibitor activity. Is expressed in head neurons and pharynx. Is an ortholog of several human genes including WFDC10A (WAP four-disulfide core domain 10A); WFDC13 (WAP four-disulfide core domain 13); and WFDC5 (WAP four-disulfide core domain 5).

WB:WBGene00015621	C09B7.2
Is enriched in coelomocyte; excretory cell; head mesodermal cell; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00015622	C09B8.3
Is enriched in pharyngeal muscle cell based on proteomic studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Sodium Chloride; Rifampin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Modulator of levamisole receptor-1 and Modulator of levamisole receptor-1.

WB:WBGene00015623	C09B8.4
Is enriched in NSM; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Rotenone; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Eukaryotic protein of unknown function (DUF829); Protein of unknown function DUF829, TMEM53; and Alpha/Beta hydrolase fold. Is an ortholog of human TMEM53 (transmembrane protein 53).

WB:WBGene00015624	C09B8.5
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; methylmercury hydroxide; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF3557.

WB:WBGene00015625	C09B8.8
Is enriched in dopaminergic neurons and hypodermis based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00015626	C09B9.1
Is enriched in NSM and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including aldicarb; tryptophan; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00015627	C09B9.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and lin-4 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00015628	best-6
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1) and BEST2 (bestrophin 2).

WB:WBGene00015629	C09B9.4
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00015630	C09B9.7
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00015631	clec-89
Is predicted to have signaling receptor activity.

WB:WBGene00015632	C09D4.1
Is predicted to have heme binding activity and heme transporter activity. Human ortholog(s) of this gene are implicated in proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome. Is an ortholog of human FLVCR2 (FLVCR heme transporter 2).

WB:WBGene00015633	C09D4.2
Is enriched in body wall muscle cell; head mesodermal cell; male-specific anatomical entity; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Cry5B; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4773) and Domain of unknown function DUF4773.

WB:WBGene00015634	C09D4.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00015635	C09D4.4
Is enriched in germ line; germline precursor cell; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Putative serine esterase (DUF676); Domain of unknown function DUF676, lipase-like; and Alpha/Beta hydrolase fold. Is an ortholog of human FAM135A (family with sequence similarity 135 member A) and FAM135B (family with sequence similarity 135 member B).

WB:WBGene00015636	C09D4.6
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015637	srxa-5
Is expressed in head neurons; nervous system; and pharyngeal neurons. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00015638	C09E7.4
Is predicted to have protein dimerization activity.

WB:WBGene00015639	C09E7.5
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-12; eat-2; and rrf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Sirolimus based on RNA-seq studies.

WB:WBGene00015640	C09E7.6
Is enriched in AVA; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00015641	C09E7.7
Is enriched in germ line; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sek-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015642	C09E7.8
Is expressed in head. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00015644	C09E8.1
Is predicted to have neurotransmitter:sodium symporter activity.

WB:WBGene00015645	lips-7
Is predicted to have lipase activity. Is expressed in excretory system; head; rectum; and vulva.

WB:WBGene00015646	mlt-10
Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle and epidermis development. Localizes to extracellular space. Is expressed in hypodermal cell and pharyngeal epithelial cell.

WB:WBGene00015647	C09F5.1
Is expressed in hypodermal cell; intestine; and vulva. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015648	orai-1
Exhibits store-operated calcium channel activity. Is involved in ovulation and store-operated calcium entry. Localizes to apical plasma membrane; basolateral plasma membrane; and voltage-gated calcium channel complex. Is expressed in gonadal sheath cell; head; and tail. Human ortholog(s) of this gene are implicated in tubular aggregate myopathy. Is an ortholog of human ORAI3 (ORAI calcium release-activated calcium modulator 3).

WB:WBGene00015649	C09F5.3
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00015650	pkg-2
Is predicted to have ATP binding activity and cGMP-dependent protein kinase activity. Human ortholog(s) of this gene are implicated in platelet-type bleeding disorder 19 and thoracic aortic aneurysm. Is an ortholog of human PRKG1 (protein kinase cGMP-dependent 1).

WB:WBGene00015651	ceh-53
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of several human genes including ALX4 (ALX homeobox 4); RHOXF1 (Rhox homeobox family member 1); and RHOXF2B (Rhox homeobox family member 2B).

WB:WBGene00015652	srz-79
Is enriched in NSM based on tiling array studies. Is affected by rsr-2; adr-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by tryptophan and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00015653	srz-78
Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00015654	srz-77
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00015655	C09G12.5
Is expressed in vas deferens. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00015656	srz-70
Is affected by aak-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; resveratrol; and copper sulfate based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00015657	C09G12.7
No description available

WB:WBGene00015658	tsg-101
Is involved in endosome to lysosome transport via multivesicular body sorting pathway and receptor catabolic process. Localizes to ESCRT I complex. Is expressed in head and tail. Is an ortholog of human TSG101 (tumor susceptibility 101).

WB:WBGene00015660	catp-3
Is predicted to have sodium:potassium-exchanging ATPase activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; Menkes disease; and neurodegenerative disease (multiple). Is an ortholog of human ATP4A (ATPase H+/K+ transporting subunit alpha).

WB:WBGene00015661	C09H5.7
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00015662	C10A4.1
Is predicted to have protein dimerization activity. Is an ortholog of human ZBED1 (zinc finger BED-type containing 1).

WB:WBGene00015663	C10A4.2
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including let-60; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00015664	C10A4.3
Is enriched in several structures, including intestine; male distal tip cell; neurons; pharyngeal muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00015665	C10A4.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including age-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015666	gad-2
Is involved in gastrulation.

WB:WBGene00015667	C10A4.6
Is affected by several genes including elt-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Microcystin-LR based on RNA-seq and microarray studies.

WB:WBGene00015668	C10A4.7
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00015670	C10B5.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including aldicarb; allantoin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human GNB1L (G protein subunit beta 1 like).

WB:WBGene00015671	C10B5.3
Is enriched in head mesodermal cell and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015672	C10E2.1
Is enriched in neurons based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015673	C10E2.2
Is predicted to have ubiquitin protein ligase activity and zinc ion binding activity. Is an ortholog of human FBXO30 (F-box protein 30).

WB:WBGene00015675	C10E2.5
Is enriched in NSM; germ line; head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including aldicarb; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00015676	mct-6
Is predicted to have monocarboxylic acid transmembrane transporter activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A12 (solute carrier family 16 member 12) and SLC16A14 (solute carrier family 16 member 14).

WB:WBGene00015677	cpg-4
Is enriched in germ line; germline precursor cell; head mesodermal cell; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chondroitin proteoglycan 4 and Chondroitin proteoglycan 4.

WB:WBGene00015678	mcp-1
Exhibits GDP-D-glucose phosphorylase activity. Is involved in glucose metabolic process. Localizes to cytoplasm. Is expressed in anterior hypodermis; reproductive system; and spermatheca. Is an ortholog of human GDPGP1 (GDP-D-glucose phosphorylase 1).

WB:WBGene00015679	C10F3.7
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercuric chloride; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015680	egal-1
Is predicted to have 3'-5' exonuclease activity and nucleic acid binding activity. Is an ortholog of human EXD1 (exonuclease 3'-5' domain containing 1).

WB:WBGene00015681	C10G8.2
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00015682	C10G8.3
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00015683	C10G8.4
Is enriched in ASER and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Heme; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00015684	C10G8.8
Is expressed in tail. Is predicted to encode a protein with the following domains: Phosphorylation site and Protein of unknown function DUF4594. Is an ortholog of human CCDC9B (coiled-coil domain containing 9B).

WB:WBGene00015685	C10G11.1
Is enriched in neurons and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Cry5B; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein ZC21.8.

WB:WBGene00015686	C10G11.6
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including hsf-1; pgl-1; and lin-28 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Aspirin; and Alovudine based on RNA-seq studies.

WB:WBGene00015687	chdp-1
Is expressed in several structures, including neurons. Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Calponin homology domain; and CH domain superfamily.

WB:WBGene00015688	C10G11.8
Is predicted to have TBP-class protein binding activity and proteasome-activating ATPase activity. Is an ortholog of human PSMC1 (proteasome 26S subunit, ATPase 1).

WB:WBGene00015689	spch-2
Localizes to nuclear chromatin. Is expressed in sperm.

WB:WBGene00015690	C10G11.10
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; antimycin; and fluoranthene based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein ZC21.8.

WB:WBGene00015691	viln-1
Is predicted to have actin filament binding activity. Is expressed in head and tail. Is an ortholog of human SVIL (supervillin).

WB:WBGene00015692	ugt-25
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00015693	ugt-28
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A10 (UDP glucuronosyltransferase family 1 member A10); UGT1A6 (UDP glucuronosyltransferase family 1 member A6); and UGT1A8 (UDP glucuronosyltransferase family 1 member A8).

WB:WBGene00015694	ugt-27
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A5 (UDP glucuronosyltransferase family 1 member A5); and UGT2B10 (UDP glucuronosyltransferase family 2 member B10).

WB:WBGene00015695	ugt-26
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A4 (UDP glucuronosyltransferase family 1 member A4); UGT1A6 (UDP glucuronosyltransferase family 1 member A6); and UGT2B10 (UDP glucuronosyltransferase family 2 member B10).

WB:WBGene00015696	C10H11.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00015697	mlst-8
Is involved in mesendoderm development. Is an ortholog of human MLST8 (MTOR associated protein, LST8 homolog).

WB:WBGene00015698	kca-1
Exhibits kinesin binding activity. Is involved in embryo development; establishment of meiotic spindle localization; and polar body extrusion after meiotic divisions. Localizes to kinesin I complex. Is expressed in gonad and oocyte.

WB:WBGene00015700	asp-9
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy.

WB:WBGene00015701	C11D2.3
Is enriched in OLL; PLM; PVD; arcade cell; and pharyngeal-intestinal valve cell based on microarray and RNA-seq studies. Is affected by several genes including let-60; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; stavudine; and Sodium Chloride based on RNA-seq studies.

WB:WBGene00015702	C11D2.4
Is enriched in several structures, including cephalic sheath cell; germ line; germline precursor cell; muscle cell; and sensory neurons based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and let-7 based on proteomic; microarray; and RNA-seq studies. Is affected by six chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Potential Queuosine, Q, salvage protein family and Queuosine salvage protein family. Is an ortholog of human C9orf64 (chromosome 9 open reading frame 64).

WB:WBGene00015703	C11D2.7
Is predicted to have RNA binding activity. Is an ortholog of human MCTS1 (MCTS1 re-initiation and release factor).

WB:WBGene00015704	tiam-1
Exhibits Rac guanyl-nucleotide exchange factor activity. Is involved in positive regulation of GTPase activity. Localizes to cell periphery and growth cone. Is expressed in gonad and neurons. Is an ortholog of human TIAM2 (TIAM Rac1 associated GEF 2).

WB:WBGene00015705	nhr-152
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head neurons; intestine; and pharynx. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00015706	C12D5.3
Is enriched in dopaminergic neurons and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and aak-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015707	C12D5.4
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by tetrabromobisphenol A based on microarray studies.

WB:WBGene00015708	C12D5.5
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and aak-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Mercuric Chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015709	cyp-33A1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00015710	C12D5.9
Is enriched in amphid sheath cell; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00015711	C12D5.10
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including sir-2.1; isp-1; and hpl-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00015712	sre-11
Is affected by several genes including clk-1; mex-3; and adr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Sirolimus; and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00015713	C12D12.1
Is enriched in OLL; PVD; germ line; head mesodermal cell; and intestine based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty chemicals including methylmercuric chloride; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00015714	C12D12.3
Is enriched in Z1; Z4; body wall muscle cell; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including metformin; Psoralens; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00015716	sox-4
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in several diseases, including 46 XY gonadal dysgenesis; PCWH syndrome; and Waardenburg's syndrome (multiple). Is an ortholog of human SRY (sex determining region Y).

WB:WBGene00015717	C12D12.6
No description available

WB:WBGene00015718	C13A2.1
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015719	C13A2.2
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00015720	C13A2.3
Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including 1-methylnicotinamide; methylmercuric chloride; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00015721	C13A2.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-12; and lin-4 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00015722	C13A2.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015723	C13A2.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015724	C13A2.7
Is affected by several genes including daf-16; daf-12; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00015725	C13A2.9
Is affected by several genes including daf-16; daf-12; and sir-2.1 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00015726	C13A2.10
Is enriched in GABAergic neurons and NSM based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00015727	C13A2.11
Is enriched in DA neuron; NSM; VA neuron; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by rsr-2; mir-34; and sir-2.1 based on tiling array and microarray studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00015728	C13A10.1
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; bar-1; and csr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015729	C13A10.2
Is enriched in coelomocyte; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; 4-bromodiphenyl ether; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00015730	srt-1
Is affected by rsr-2 based on tiling array studies. Is affected by Atrazine; fluoranthene; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015731	C13B7.6
Is enriched in DD neuron; GABAergic neurons; germ line; germline precursor cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Sirolimus; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00015732	C13B9.1
No description available

WB:WBGene00015733	C13B9.2
Is predicted to have glycerate kinase activity. Human ortholog(s) of this gene are implicated in D-glyceric aciduria. Is an ortholog of human GLYCTK (glycerate kinase).

WB:WBGene00015734	copd-1
Is enriched in germ line; hypodermis; and neurons based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; nicotine; and multi-walled carbon nanotube based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Clathrin adaptor complex small chain; Adaptor complexes medium subunit family; Longin-like domain superfamily; AP complex, mu/sigma subunit; Coatomer delta subunit; Mu homology domain; and AP-2 complex subunit mu, C-terminal superfamily. Is an ortholog of human ARCN1 (archain 1).

WB:WBGene00015735	pdfr-1
Is predicted to have calcitonin receptor activity and peptide hormone binding activity. Is expressed in several structures, including I1 neuron; RMEV; ganglia; mechanosensory neurons; and vulD. Human ortholog(s) of this gene are implicated in bone disease (multiple); primary failure of tooth eruption; and type 2 diabetes mellitus. Is an ortholog of human CALCR (calcitonin receptor) and CALCRL (calcitonin receptor like receptor).

WB:WBGene00015736	srsx-11
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015737	srsx-12
Is predicted to have G protein-coupled receptor activity. Is expressed in AVG; PVT; head neurons; and vulval muscle.

WB:WBGene00015738	srsx-13
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015739	ugt-7
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A3 (UDP glucuronosyltransferase family 1 member A3); UGT2A3 (UDP glucuronosyltransferase family 2 member A3); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00015740	C13E3.1
Is enriched in head mesodermal cell; hypodermis; male-specific anatomical entity; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by four chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00015741	C13F10.1
Is enriched in body wall musculature; head mesodermal cell; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00015742	kxd-1
Is enriched in AFD; body wall muscle cell; germ line; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Cry5B; and Testosterone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterized conserved protein; Uncharacterised domain KxDL; and KxDL motif-containing protein 1-like. Is an ortholog of human KXD1 (KxDL motif containing 1).

WB:WBGene00015743	soap-1
Is involved in apical protein localization. Is an ortholog of human HEATR5B (HEAT repeat containing 5B).

WB:WBGene00015744	C13F10.5
Is enriched in germ line; head mesodermal cell; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterized conserved domain (SAYSvFN); Uncharacterised domain SAYSvFN; and SAYSvFN domain-containing protein 1. Is an ortholog of human SAYSD1 (SAYSVFN motif domain containing 1).

WB:WBGene00015745	C13F10.6
Is enriched in germ line; germline precursor cell; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00015746	C13F10.7
Exhibits identical protein binding activity. Is an ortholog of human SREK1IP1 (SREK1 interacting protein 1).

WB:WBGene00015747	C13G5.2
Is enriched in germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015748	C14A11.2
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00015750	C14A11.5
Is enriched in AVA; BAG; NSM; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015751	C14A11.6
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015752	C14B9.2
Is predicted to have protein disulfide isomerase activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human PDIA4 (protein disulfide isomerase family A member 4).

WB:WBGene00015753	C14B9.3
Is enriched in AFD; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including levamisole; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Post-GPI attachment to proteins factor 2.

WB:WBGene00015754	C14B9.8
Is predicted to contribute to phosphorylase kinase activity. Human ortholog(s) of this gene are implicated in glycogen storage disease IXa and glycogen storage disease IXd. Is an ortholog of human PHKA1 (phosphorylase kinase regulatory subunit alpha 1) and PHKA2 (phosphorylase kinase regulatory subunit alpha 2).

WB:WBGene00015755	C14B9.10
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by four chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Ubiquinol-cytochrome C reductase, UQCRX/QCR9 like; Cytochrome b-c1 complex subunit 9; and Cytochrome b-c1 complex subunit 9 superfamily.

WB:WBGene00015756	C14C6.2
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00015757	C14C6.3
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity. Is expressed in seam cell.

WB:WBGene00015758	nhr-155
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00015759	C14C6.5
Is involved in innate immune response.

WB:WBGene00015760	C14C6.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015761	C14C6.7
Is affected by several genes including daf-2; isp-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by cadmium based on microarray studies.

WB:WBGene00015762	C14C6.8
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015763	C14C6.12
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including copper sulfate; Zidovudine; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00015764	C14C6.13
Is affected by several genes including clk-1; drh-3; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00015765	C14C11.1
Is enriched in PLM; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015766	C14C11.2
Is enriched in several structures, including germ line; germline precursor cell; male distal tip cell; seam cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; bisphenol A; and bisphenol S based on RNA-seq studies.

WB:WBGene00015767	hex-2
Exhibits hexosaminidase activity. Is involved in carbohydrate metabolic process. Is expressed in head neurons; hypodermis; tail neurons; and vulva. Is an ortholog of human HEXD (hexosaminidase D).

WB:WBGene00015768	C14C11.4
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00015769	C14C11.7
Is enriched in AFD; PLM; germ line; pharyngeal muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; tryptophan; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00015770	C14E2.1
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including rde-1; rrf-1; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015771	got-1.3
Is enriched in AVE based on tiling array studies. Is affected by several genes including eat-2; mex-3; and let-418 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00015772	C14E2.3
Is affected by several genes including lin-4; lin-14; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00015773	C14E2.4
Is predicted to contribute to procollagen-proline 4-dioxygenase activity.

WB:WBGene00015774	C14E2.5
Is affected by ain-1 based on microarray studies.

WB:WBGene00015775	C14E2.6
Is affected by several genes including aak-2; mex-3; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00015776	dct-1
Exhibits protease binding activity and protein homodimerization activity. Is involved in several processes, including autophagy of mitochondrion; determination of adult lifespan; and positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis. Localizes to mitochondrial outer membrane and protein-containing complex. Is expressed in body wall musculature; intestine; pharynx; and vulval muscle. Is an ortholog of human BNIP3 (BCL2 interacting protein 3).

WB:WBGene00015777	sfxn-2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN2 (sideroflexin 2).

WB:WBGene00015778	got-2.2
Is predicted to have L-aspartate:2-oxoglutarate aminotransferase activity. Is an ortholog of human GOT2 (glutamic-oxaloacetic transaminase 2).

WB:WBGene00015779	lrch-1
Is enriched in AFD; ASER; head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including sek-1; pgl-1; and dcr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including 1-methylnicotinamide; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in agammaglobulinemia 5. Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Leucine rich repeat; Leucine-rich repeat; Calponin homology domain; Leucine-rich repeat, typical subtype; Leucine-rich repeat domain superfamily; and CH domain superfamily. Is an ortholog of human LRCH1 (leucine rich repeats and calponin homology domain containing 1); LRCH2 (leucine rich repeats and calponin homology domain containing 2); and LRCH3 (leucine rich repeats and calponin homology domain containing 3).

WB:WBGene00015780	C14F11.4
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015781	C14F11.6
Is predicted to have dTDP-4-dehydrorhamnose 3,5-epimerase activity.

WB:WBGene00015782	C14F11.7
Is enriched in germ line; neurons; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015783	C15B12.1
Is predicted to have L-pipecolate oxidase activity and sarcosine oxidase activity. Is an ortholog of human PIPOX (pipecolic acid and sarcosine oxidase).

WB:WBGene00015784	C15B12.2
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by paraquat; resveratrol; and tetrabromobisphenol A based on RNA-seq and microarray studies.

WB:WBGene00015785	C15B12.3
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including cyc-1; tatn-1; and rsr-2 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00015786	C15B12.4
Is enriched in amphid sheath cell; body wall muscle cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including bisphenol A; resveratrol; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00015787	actl-1
Is enriched in AVK and NSM based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015788	C15B12.8
Is predicted to have L-pipecolate oxidase activity and sarcosine oxidase activity. Is an ortholog of human PIPOX (pipecolic acid and sarcosine oxidase).

WB:WBGene00015789	syx-6
Is predicted to have SNAP receptor activity. Localizes to Golgi trans cisterna. Is expressed in head. Is an ortholog of human STX6 (syntaxin 6).

WB:WBGene00015790	C15C7.4
Is enriched in DA neuron; VA neuron; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including aldicarb; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00015791	C15C7.5
Is expressed in head neurons and pharyngeal muscle cell. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015792	C15C7.6
Is enriched in Z1; Z4; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015793	C15C7.7
Exhibits peptide-O-fucosyltransferase activity. Is involved in protein O-linked fucosylation. Human ortholog(s) of this gene are implicated in Dowling-Degos disease. Is an ortholog of human POFUT1 (protein O-fucosyltransferase 1).

WB:WBGene00015794	C15F1.1
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF1794); Calycin; and Domain of unknown function DUF1794. Is an ortholog of human THAP4 (THAP domain containing 4).

WB:WBGene00015795	C15F1.2
Is enriched in OLL; PVD; and male-specific anatomical entity based on microarray studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Lithium Chloride; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00015796	C15F1.5
Is predicted to have metal ion binding activity.

WB:WBGene00015797	C15F1.8
Is enriched in AVE; NSM; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00015798	C15H9.2
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; tert-Butylhydroperoxide; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015799	C15H9.3
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00015800	C15H9.4
Is enriched in AVK; coelomocyte; excretory cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and lin-35 based on microarray; RNA-seq; and tiling array studies. Is affected by Rotenone; stavudine; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Predicted transmembrane and coiled-coil 2 protein; and Testis-specific protein TEX28/transmembrane and coiled-coil domains protein. Is an ortholog of human TMCC1 (transmembrane and coiled-coil domain family 1); TMCC2 (transmembrane and coiled-coil domain family 2); and TMCC3 (transmembrane and coiled-coil domain family 3).

WB:WBGene00015801	C15H9.5
Is enriched in neurons and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-12; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Lung seven transmembrane receptor; and Transmembrane protein GPR107/GPR108-like. Is an ortholog of human GPR108 (G protein-coupled receptor 108).

WB:WBGene00015802	kynu-1
Is predicted to have kynureninase activity. Is expressed in E lineage cell and hypodermal cell. Is an ortholog of human KYNU (kynureninase).

WB:WBGene00015803	C15H9.9
Is expressed in marginal cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00015805	C15H9.11
Is enriched in GABAergic neurons; arcade cell; and pharyngeal-intestinal valve cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015806	smrc-1
Is predicted to have DNA helicase activity and annealing helicase activity. Is expressed in male. Human ortholog(s) of this gene are implicated in Schimke immuno-osseous dysplasia. Is an ortholog of human SMARCAL1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1).

WB:WBGene00015807	C16A3.2
Is predicted to have protein tyrosine/serine/threonine phosphatase activity. Human ortholog(s) of this gene are implicated in Lafora disease; hypogonadotropic hypogonadism 19 with or without anosmia; and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP22 (dual specificity phosphatase 22).

WB:WBGene00015809	C16A3.4
Is predicted to have nucleic acid binding activity and zinc ion binding activity. Is an ortholog of human ZNF622 (zinc finger protein 622).

WB:WBGene00015810	C16A3.5
Is enriched in NSM; germ line; hypodermis; intestine; and neurons based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by ten chemicals including biotin; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Complex 1 protein (LYR family); Complex 1 LYR protein; and NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9. Is an ortholog of human NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9).

WB:WBGene00015811	C16A3.6
Is enriched in several structures, including body wall muscle cell; coelomocyte; germ line; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mak16 protein C-terminal region; Ribosomal L28e protein family; Mak16 protein; and Ribosomal L28e/Mak16. Is an ortholog of human MAK16 (MAK16 homolog).

WB:WBGene00015813	thoc-2
Is predicted to have mRNA binding activity. Is an ortholog of human THOC2 (THO complex 2).

WB:WBGene00015814	oatr-1
Is predicted to have identical protein binding activity; ornithine-oxo-acid transaminase activity; and pyridoxal phosphate binding activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in gyrate atrophy. Is an ortholog of human OAT (ornithine aminotransferase).

WB:WBGene00015815	C16A11.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Tunicamycin; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Coiled-coil domain-containing protein 93. Is an ortholog of human CCDC93 (coiled-coil domain containing 93).

WB:WBGene00015816	C16A11.3
Is predicted to have metal ion binding activity.

WB:WBGene00015817	C16A11.4
Is predicted to have metal ion binding activity.

WB:WBGene00015818	C16A11.5
Is enriched in OLL; PVD; germ line; germline precursor cell; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015819	fbxc-44
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF3557.

WB:WBGene00015820	C16A11.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015821	clec-135
Is predicted to have carbohydrate binding activity.

WB:WBGene00015822	C16B8.2
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Growth factor receptor cysteine-rich domain superfamily.

WB:WBGene00015823	C16B8.3
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015824	C16B8.4
Is expressed in AIYL and AIYR. Is predicted to encode a protein with the following domain: Fibronectin type III superfamily.

WB:WBGene00015825	C16C4.1
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by rsr-2 and klf-1 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00015826	math-12
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00015827	math-13
Is affected by lin-14 and lin-4 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015828	math-14
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Heme; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015829	math-15
Is enriched in NSM; OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including aldicarb; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015830	fbxb-98
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00015832	math-16
Is affected by several genes including skn-1; clk-1; and smn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015833	math-17
Is affected by several genes including skn-1; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015834	math-5
Is affected by several genes including skn-1; lin-35; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015835	math-6
Is affected by several genes including skn-1; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015836	math-7
Is affected by several genes including eat-2; pgl-1; and prg-1 based on RNA-seq and tiling array studies. Is affected by five chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015837	math-8
Is affected by several genes including daf-2; eat-2; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Cadmium Chloride; Alovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015838	math-9
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015839	math-10
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including tryptophan; Tunicamycin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00015840	math-11
Is affected by several genes including lin-4; lin-14; and clk-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00015841	skpo-2
Is predicted to have peroxidase activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7. Is an ortholog of human EPX (eosinophil peroxidase).

WB:WBGene00015842	C16C8.4
Is predicted to have protein tag and ubiquitin protein ligase binding activity.

WB:WBGene00015843	C16C8.5
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ubiquitin-like domain and Ubiquitin-like domain superfamily.

WB:WBGene00015844	C16C8.6
No description available

WB:WBGene00015845	C16C8.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015846	C16C8.8
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; drh-3; and nhl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015847	C16C8.9
Is enriched in AVE; germ line; male-specific anatomical entity; and in male based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Alovudine; stavudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00015848	C16C8.10
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015849	C16C8.11
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and gld-1 based on microarray and RNA-seq studies. Is affected by six chemicals including manganese chloride; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00015850	C16C8.12
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00015851	C16C8.13
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and fog-2 based on proteomic; microarray; and RNA-seq studies. Is affected by seven chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015852	C16C8.14
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Mianserin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00015853	C16C8.16
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00015854	C16C8.17
Is enriched in germ line; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including allantoin; Psoralens; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015855	C16C8.18
Is enriched in AVK; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily. Is an ortholog of human RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00015856	C16C8.19
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Alovudine; stavudine; and allantoin based on RNA-seq studies.

WB:WBGene00015857	C16D9.1
Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00015858	C16D9.3
Is enriched in AVA and neurons based on tiling array studies. Is affected by several genes including sek-1; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Sodium Chloride; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015859	C16D9.4
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including aldicarb; diallyl trisulfide; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF1647); and Protein of unknown function DUF1647.

WB:WBGene00015860	C16D9.5
Is enriched in neurons and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00015861	C16D9.6
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00015862	srt-25
Is affected by several genes including clk-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00015863	C16D9.8
Is affected by cyc-1 and sir-2.1 based on microarray studies. Is affected by four chemicals including aldicarb; resveratrol; and Chlorpyrifos based on microarray studies.

WB:WBGene00015864	C16D9.9
Is enriched in neurons and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Cadmium Chloride; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00015865	C16E9.1
Is predicted to have extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is an ortholog of human MATN1 (matrilin 1).

WB:WBGene00015866	C16E9.2
Is expressed in hypodermal cell; muscle cell; and nervous system. Is predicted to encode a protein with the following domain: Protein of unknown function DUF2045. Is an ortholog of human KIAA0930 (KIAA0930).

WB:WBGene00015867	ncs-7
Is predicted to have calcium ion binding activity. Is expressed in neurons and vulval muscle. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14 and retinitis pigmentosa 48. Is an ortholog of human KCNIP1 (potassium voltage-gated channel interacting protein 1).

WB:WBGene00015868	C16H3.3
Is enriched in intestine; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Rotenone; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015869	nhr-257
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00015870	C17A2.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015871	C17A2.3
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00015872	C17A2.4
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity. Is an ortholog of human FUT1 (fucosyltransferase 1 (H blood group)) and FUT2 (fucosyltransferase 2).

WB:WBGene00015873	oac-4
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00015874	C17A2.6
Is affected by several genes including clk-1; eat-2; and dpy-21 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015875	C17A2.7
Is affected by several genes including clk-1; hpl-2; and smn-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00015876	C17B7.2
Is enriched in PLM and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015877	C17B7.3
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; indole; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00015878	C17B7.4
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Ethanol; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00015879	C17B7.5
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00015881	C17B7.7
No description available

WB:WBGene00015882	C17B7.8
Is affected by several genes including daf-16; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by Tunicamycin; multi-walled carbon nanotube; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015883	C17B7.9
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including resveratrol; Atrazine; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00015884	C17B7.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercuric chloride; Mercuric Chloride; and tert-Butylhydroperoxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015885	fbxa-65
Is enriched in several structures, including coelomocyte; intestine; mechanosensory neurons; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by nine chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00015886	C17B7.12
Is enriched in neurons based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; Ethanol; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015887	C17C3.1
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT8 (acyl-CoA thioesterase 8).

WB:WBGene00015888	C17C3.2
Is affected by rsr-2 and dlc-1 based on tiling array and RNA-seq studies. Is affected by aldicarb; fluoranthene; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Papain-like cysteine peptidase superfamily.

WB:WBGene00015889	C17C3.3
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT8 (acyl-CoA thioesterase 8).

WB:WBGene00015890	C17C3.5
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by sixteen chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00015891	C17C3.6
Is affected by several genes including hsp-6; let-418; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; antimycin; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box-like domain superfamily.

WB:WBGene00015892	C17C3.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including tryptophan; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00015893	C17C3.11
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride; Tunicamycin; and paraquat based on microarray studies. Is predicted to encode a protein with the following domain: Protein kinase-like domain superfamily.

WB:WBGene00015894	acdh-2
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Is expressed in body wall musculature and intestine. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADSB (acyl-CoA dehydrogenase short/branched chain).

WB:WBGene00015895	C17C3.13
Is affected by rsr-2; clk-1; and dlc-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domain: Papain-like cysteine peptidase superfamily.

WB:WBGene00015896	C17C3.15
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including 1-methylnicotinamide; sodium arsenite; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00015897	nhr-156
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in excretory system; intestine; neurons; pharynx; and ventral nerve cord.

WB:WBGene00015898	sre-9
Is affected by several genes including daf-2; clk-1; and alg-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00015899	C17E7.4
Is expressed in germ line. Is predicted to encode a protein with the following domain: .

WB:WBGene00015900	nhr-157
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00015901	nhr-158
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00015902	nhr-159
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00015903	C17E7.9
Is enriched in I5 neuron; cholinergic neurons; germ line; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Ethanol; Rotenone; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00015904	irld-22
Is affected by several genes including clk-1; sir-2.1; and isp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00015905	C17E7.12
Is enriched in DA neuron; VA neuron; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including hydrogen sulfide; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015906	C17E7.13
Is enriched in ASER and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; multi-walled carbon nanotube; and sesamin based on microarray and RNA-seq studies.

WB:WBGene00015907	C17F3.1
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; Ethanol; and nicotinic acid based on microarray and RNA-seq studies.

WB:WBGene00015908	C17F3.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00015909	clec-124
Is predicted to have carbohydrate binding activity.

WB:WBGene00015910	C17F4.2
Is enriched in germline precursor cell; hypodermis; intestine; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015911	C17F4.3
Is enriched in amphid sheath cell and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00015912	fbxc-50
Is expressed in germ line. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00015913	C17F4.7
Is enriched in cholinergic neurons; head mesodermal cell; intestine; pharyngeal cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including cholesterol; lathosterol; and Heme based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015914	C17F4.8
Is enriched in GABAergic neurons; intestine; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mex-1 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercury hydroxide; stavudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00015915	C17G10.1
Is predicted to have peptidyl-proline dioxygenase activity. Is expressed in hypodermis. Is an ortholog of human OGFOD1 (2-oxoglutarate and iron dependent oxygenase domain containing 1).

WB:WBGene00015916	ttc-4
Is expressed in head. Is predicted to encode a protein with the following domains: Tetratricopeptide-like helical domain superfamily and Tetratricopeptide repeat. Is an ortholog of human TTC4 (tetratricopeptide repeat domain 4).

WB:WBGene00015917	C17G10.3
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015918	C17G10.6
Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: ShKT domain.

WB:WBGene00015919	C17G10.7
Is enriched in dopaminergic neurons; germline precursor cell; hypodermis; sensory neurons; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Sodium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015920	eif-3.L
Is predicted to have translation initiation factor activity. Is expressed in head and tail. Is an ortholog of human EIF3L (eukaryotic translation initiation factor 3 subunit L).

WB:WBGene00015921	C17H11.1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00015922	C17H11.2
Is enriched in OLL; PVD; germline precursor cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; sir-2.1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by Zidovudine; paraquat; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015923	C17H11.3
No description available

WB:WBGene00015924	C17H11.4
Is enriched in AB and germ line based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by dafa#1 and Sirolimus based on microarray studies.

WB:WBGene00015925	C17H11.5
Is affected by several genes including clk-1; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; bisphenol A; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00015926	C17H11.6
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is expressed in tail. Is an ortholog of human RNF19B (ring finger protein 19B).

WB:WBGene00015927	dyci-1
Is predicted to have dynein heavy chain binding activity and dynein light chain binding activity. Is expressed in ciliated neurons. Is an ortholog of human DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1) and DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2).

WB:WBGene00015928	C17H12.2
Is expressed in gonad. Is predicted to encode a protein with the following domains: Uncharacterized conserved protein (DUF2152) and Protein of unknown function DUF2152. Is an ortholog of human KIAA2013 (KIAA2013).

WB:WBGene00015929	C17H12.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00015930	cest-4
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including tryptophan; bisphenol A; and bisphenol S based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold.

WB:WBGene00015931	C17H12.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00015932	C17H12.6
Is involved in innate immune response.

WB:WBGene00015933	C17H12.8
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-seven chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00015934	ceh-48
Is predicted to have DNA binding activity. Is expressed in head; spermathecal-uterine junction; ventral nerve cord; and vulva. Is an ortholog of human ONECUT1 (one cut homeobox 1) and ONECUT2 (one cut homeobox 2).

WB:WBGene00015935	C17H12.10
Is enriched in head mesodermal cell; muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00015936	C17H12.11
Is enriched in body wall muscle cell; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015937	C17H12.12
Is enriched in AVK; germ line; muscle cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00015938	anat-1
Is predicted to have N-acetyltransferase activity.

WB:WBGene00015939	damt-1
Exhibits site-specific DNA-methyltransferase (adenine-specific) activity. Is involved in DNA methylation on adenine. Is an ortholog of human METTL4 (methyltransferase like 4).

WB:WBGene00015940	zipt-3
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A3 (solute carrier family 39 member 3).

WB:WBGene00015941	C18A3.3
Is enriched in body wall muscle cell; germ line; intestine; mechanosensory neurons; and somatic gonad precursor based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Eukaryotic rRNA processing protein EBP2 and Eukaryotic rRNA processing. Is an ortholog of human EBNA1BP2 (EBNA1 binding protein 2).

WB:WBGene00015942	osta-2
Is expressed in ciliated neurons. Is predicted to encode a protein with the following domains: Organic solute transporter Ostalpha and Organic solute transporter subunit alpha/Transmembrane protein 184. Is an ortholog of human SLC51A (solute carrier family 51 subunit alpha).

WB:WBGene00015943	tiar-1
Is predicted to have mRNA binding activity. Is involved in several processes, including determination of adult lifespan; nematode larval development; and response to UV. Localizes to P granule; cytoplasmic stress granule; and nucleus. Is expressed in germ line; head; hypodermis; somatic cell; and tail. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human TIA1 (TIA1 cytotoxic granule associated RNA binding protein) and TIAL1 (TIA1 cytotoxic granule associated RNA binding protein like 1).

WB:WBGene00015944	C18A3.7
Is enriched in AFD; ventral nerve cord; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015945	C18A3.9
Is enriched in intestine based on microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol; cadmium; and Diazinon based on microarray studies.

WB:WBGene00015946	C18A3.10
Is affected by several genes including daf-2; kri-1; and emb-4 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015947	C18A11.1
Is enriched in several structures, including amphid sheath cell; coelomocyte; dopaminergic neurons; head mesodermal cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015948	C18A11.2
Is enriched in neurons and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; isp-1; and alg-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and metformin based on RNA-seq and microarray studies.

WB:WBGene00015949	C18A11.3
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00015950	C18A11.4
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including tryptophan; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: SH2 domain superfamily.

WB:WBGene00015952	C18B2.1
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00015953	C18B2.2
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00015954	C18B2.3
Is expressed in anal depressor muscle; body wall musculature; and vulval muscle. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00015955	C18B2.4
Is predicted to have chromatin DNA binding activity and transcription coactivator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 107. Is an ortholog of human WBP2 (WW domain binding protein 2).

WB:WBGene00015956	C18B2.5
Is predicted to have GTPase activity and molecular adaptor activity.

WB:WBGene00015957	del-9
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human ASIC5 (acid sensing ion channel subunit family member 5).

WB:WBGene00015958	srbc-11
Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by resveratrol; Acrylamide; and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015959	srbc-10
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015960	srbc-9
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and tetrabromobisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015961	srbc-7
Is expressed in ASJL and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015962	srbc-8
Is enriched in neurons based on microarray studies. Is affected by clk-1 and rsr-2 based on microarray and tiling array studies. Is affected by dafa#1 and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00015963	C18B10.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq studies. Is affected by seven chemicals including bisphenol S; metformin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00015964	glb-5
Exhibits oxygen sensor activity. Is involved in detection of oxygen. Is expressed in PQR; head neurons; intestine; pharynx; and somatic nervous system.

WB:WBGene00015965	ugt-48
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT2B10 (UDP glucuronosyltransferase family 2 member B10); UGT2B17 (UDP glucuronosyltransferase family 2 member B17); and UGT2B4 (UDP glucuronosyltransferase family 2 member B4).

WB:WBGene00015968	C18C4.7
Is predicted to have cytoskeletal protein binding activity. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple).

WB:WBGene00015969	glb-6
Exhibits heme binding activity; iron ion binding activity; and oxygen binding activity. Is expressed in neurons and somatic nervous system.

WB:WBGene00015970	C18E3.1
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00015971	swsn-2.2
Is predicted to have RNA polymerase II transcription factor binding activity. Localizes to condensed chromosome; nuclear envelope; and nucleoplasm. Is used to study alcohol use disorder. Is an ortholog of human SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1) and SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3).

WB:WBGene00015972	C18E3.3
Is enriched in several structures, including Z1.p; Z4.a; body wall muscle cell; germ line; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015974	snrp-40.2
Is enriched in Z1; Z4; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including manganese chloride; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; and WD40-repeat-containing domain superfamily. Is an ortholog of human SNRNP40 (small nuclear ribonucleoprotein U5 subunit 40).

WB:WBGene00015975	cas-2
Is predicted to have actin binding activity and adenylate cyclase binding activity. Is an ortholog of human CAP1 (cyclase associated actin cytoskeleton regulatory protein 1) and CAP2 (cyclase associated actin cytoskeleton regulatory protein 2).

WB:WBGene00015976	C18E3.9
Is enriched in AFD; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00015977	C18F10.2
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-12; pgl-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including tryptophan; Tunicamycin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015978	C18F10.7
Is enriched in ASER; excretory cell; germ line; and germline precursor cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; Ankyrin repeat domain-containing protein 13; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human ANKRD13A (ankyrin repeat domain 13A); ANKRD13B (ankyrin repeat domain 13B); and ANKRD13D (ankyrin repeat domain 13D).

WB:WBGene00015979	C18F10.9
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies.

WB:WBGene00015980	C18G1.1
Is enriched in body wall musculature; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; aak-2; and mex-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Sodium Chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015981	elt-7
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is involved in endodermal cell fate determination. Localizes to nucleus. Is expressed in E lineage cell.

WB:WBGene00015982	bgnt-1.4
Is predicted to have transferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00015984	C18G1.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015985	C18G1.7
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00015986	C18G1.8
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00015987	C18G1.9
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including aldicarb; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015988	lido-18
Is enriched in male based on RNA-seq studies. Is affected by several genes including skn-1; daf-12; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including manganese chloride; Alovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (many copies); Domain of unknown function; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00015989	C18H2.2
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; metformin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00015990	C18H2.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00015991	C18H2.4
Is enriched in germ line; neurons; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including methylmercuric chloride; metformin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00015992	C18H2.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BRCA1 C Terminus (BRCT) domain; Domain of unknown function; Ankyrin repeat; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00015993	C18H7.1
Is predicted to have extracellular matrix structural constituent. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple).

WB:WBGene00015994	C18H7.4
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00015996	C18H7.6
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by metformin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00015997	C18H7.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00015998	srt-59
Is enriched in germ line based on RNA-seq studies. Is affected by dpy-21; mir-34; and daf-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00015999	prmt-4
Is affected by several genes including daf-16; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase domain; S-adenosyl-L-methionine-dependent methyltransferase; and Methyltransferase domain 25.

WB:WBGene00016000	C18H9.1
Is affected by several genes including rrf-3; clk-1; and mex-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00016002	gyf-1
Is enriched in germ line and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GYF domain; GYF domain; and GYF-like domain superfamily. Is an ortholog of human GIGYF1 (GRB10 interacting GYF protein 1) and GIGYF2 (GRB10 interacting GYF protein 2).

WB:WBGene00016003	C18H9.5
Is predicted to have transmembrane transporter activity.

WB:WBGene00016004	C18H9.6
Is enriched in AVE; head mesodermal cell; intestine; mechanosensory neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by thirty-one chemicals including 1-methylnicotinamide; Mercuric Chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016005	ift-74
Is predicted to have beta-tubulin binding activity. Is involved in several processes, including detection of stimulus involved in sensory perception; growth; and intraciliary transport. Localizes to non-motile cilium. Is an ortholog of human IFT74 (intraflagellar transport 74).

WB:WBGene00016006	fln-2
Is expressed in several structures, including anal depressor muscle; distal tip cell; intestine; pharynx; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Carvajal syndrome; epidermolysis bullosa (multiple); and muscular dystrophy (multiple). Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Filamin/ABP280 repeat; Filamin/ABP280 repeat; Calponin homology domain; Immunoglobulin-like fold; Immunoglobulin E-set; Filamin/ABP280 repeat-like; and CH domain superfamily.

WB:WBGene00016008	C23F12.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by metformin; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00016009	C23F12.4
Is enriched in body wall muscle cell; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pmk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Cry5B; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016010	C23G10.1
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00016011	C23G10.2
Is predicted to have deaminase activity. Is an ortholog of human RIDA (reactive intermediate imine deaminase A homolog).

WB:WBGene00016012	C23G10.5
Is enriched in AFD; body wall muscle cell; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016013	ugt-66
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00016014	C23G10.7
Is predicted to have tRNA (uracil) methyltransferase activity. Is an ortholog of human TRMT44 (tRNA methyltransferase 44 homolog).

WB:WBGene00016015	C23G10.8
Is expressed in tail. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function (DUF1768); NADAR; and YbiA-like superfamily.

WB:WBGene00016016	C23G10.10
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including lin-35; daf-19; and unc-70 based on microarray and RNA-seq studies. Is affected by Tunicamycin and Colistin based on microarray studies.

WB:WBGene00016017	C23G10.11
Is expressed in hypodermal cell.

WB:WBGene00016018	C23H3.2
Is enriched in body wall musculature; hypodermis; intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016019	ascc-1
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in Barrett's esophagus. Is an ortholog of human ASCC1 (activating signal cointegrator 1 complex subunit 1).

WB:WBGene00016020	sptl-1
Is predicted to have pyridoxal phosphate binding activity and serine C-palmitoyltransferase activity. Is involved in establishment or maintenance of epithelial cell apical/basal polarity. Is expressed in head. Human ortholog(s) of this gene are implicated in hereditary sensory and autonomic neuropathy type 1A. Is an ortholog of human SPTLC1 (serine palmitoyltransferase long chain base subunit 1).

WB:WBGene00016021	C23H3.5
Is enriched in PLM; body wall muscle cell; germ line; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by five chemicals including resveratrol; Humic Substances; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4477) and Domain of unknown function DUF4477.

WB:WBGene00016022	C23H3.9
Is enriched in several structures, including head mesodermal cell; intestine; neurons; pharynx; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Metallo-beta-lactamase; Ribonuclease Z/Hydroxyacylglutathione hydrolase-like; and Metallo-beta-lactamase domain-containing protein 1. Is an ortholog of human MBLAC1 (metallo-beta-lactamase domain containing 1).

WB:WBGene00016023	prmt-6
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase domain; S-adenosyl-L-methionine-dependent methyltransferase; and Methyltransferase domain 25.

WB:WBGene00016024	glb-7
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons and tail neurons.

WB:WBGene00016025	xbx-4
Is expressed in amphid neurons; ciliated neurons; head neurons; and sensory neurons. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF3719) and Protein of unknown function DUF3719.

WB:WBGene00016027	C23H5.8
Is enriched in OLL; PVD; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including methylmercury hydroxide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00016028	flp-24
Is enriched in GABAergic neurons; OLL; PVD; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016029	elf-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in gonad development and regulation of cell division. Is expressed in head neurons and pharynx. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human ELF1 (E74 like ETS transcription factor 1); ELF2 (E74 like ETS transcription factor 2); and ELF4 (E74 like ETS transcription factor 4).

WB:WBGene00016030	sel-15
Is predicted to have protein kinase activity. Is an ortholog of human FPGT-TNNI3K (FPGT-TNNI3K readthrough).

WB:WBGene00016031	C24A1.4
No description available

WB:WBGene00016032	C24A3.1
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain-containing protein 154 and Coiled-coil domain-containing protein 154. Is an ortholog of human CCDC154 (coiled-coil domain containing 154).

WB:WBGene00016033	C24A3.2
Localizes to plasma membrane.

WB:WBGene00016034	C24A3.4
Is predicted to have CoA-transferase activity. Human ortholog(s) of this gene are implicated in alpha-methylacyl-CoA racemase deficiency and congenital bile acid synthesis defect 4. Is an ortholog of human AMACR (alpha-methylacyl-CoA racemase).

WB:WBGene00016035	C24A3.7
No description available

WB:WBGene00016037	dop-6
Is predicted to have G protein-coupled serotonin receptor activity. Is expressed in AVF; head neurons; and tail. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome. Is an ortholog of human DRD4 (dopamine receptor D4).

WB:WBGene00016038	cst-2
Is predicted to have protein serine/threonine kinase activity. Is expressed in AQR and PQR. Is an ortholog of human STK3 (serine/threonine kinase 3).

WB:WBGene00016039	C24A8.5
Is enriched in body wall muscle cell; germ line; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016040	C24A11.1
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016044	C24B5.1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00016045	spas-1
Exhibits several functions, including ATP binding activity; identical protein binding activity; and microtubule-severing ATPase activity. Is involved in several processes, including cytoskeleton organization; positive regulation of microtubule depolymerization; and vulval development. Localizes to perinuclear region of cytoplasm and protein-containing complex. Colocalizes with microtubule cytoskeleton. Is expressed in several structures, including intestine; mechanosensory neurons; somatic nervous system; tail ganglion; and vulva. Is used to study hereditary spastic paraplegia. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 4. Is an ortholog of human SPAST (spastin).

WB:WBGene00016046	C24B5.4
Is predicted to have hydrolase activity, acting on ester bonds and zinc ion binding activity. Is expressed in body wall musculature. Is an ortholog of human C11orf54 (chromosome 11 open reading frame 54).

WB:WBGene00016047	srt-26
Is expressed in AWC-ON.

WB:WBGene00016048	C24B9.3
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00016049	srt-28
Is expressed in AWC-ON. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016050	srt-29
Is expressed in AWC-ON. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016051	srt-27
Is expressed in ASGL; ASGR; ASIL; and ASIR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016052	dod-3
Is enriched in several structures, including coelomocyte; head mesodermal cell; pharyngeal muscle cell; sensory neurons; and ventral nerve cord based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-eight chemicals including Ethanol; tryptophan; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00016053	ptp-5.1
Is predicted to have protein tyrosine phosphatase activity. Localizes to nucleus. Is expressed in head.

WB:WBGene00016054	C24D10.2
Is enriched in DA neuron; VA neuron; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C27D6.3-like.

WB:WBGene00016055	C24D10.4
Is enriched in NSM; PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00016056	C24D10.5
Is enriched in germ line; neurons; pharyngeal muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Alovudine; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00016057	C24D10.6
Is enriched in germ line; intestine; and muscle cell based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CHCH domain; CHCH; and Coiled-coil-helix-coiled-coil-helix domain-containing protein 1. Is an ortholog of human CHCHD1 (coiled-coil-helix-coiled-coil-helix domain containing 1).

WB:WBGene00016058	nspd-3
Is enriched in several structures, including AVG; RIM; amphid sheath cell; command interneuron; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00016059	hir-1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is expressed in pharynx and seam cell. Human ortholog(s) of this gene are implicated in several diseases, including endocrine gland cancer (multiple); hematologic cancer (multiple); and synostosis (multiple).

WB:WBGene00016060	mms-19
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Dos2-interacting transcription regulator of RNA-Pol-II; Armadillo-type fold; MMS19, N-terminal; and DNA repair/transcription protein MET18/MMS19. Is an ortholog of human MMS19 (MMS19 homolog, cytosolic iron-sulfur assembly component).

WB:WBGene00016061	hpo-15
Is predicted to have polyamine oxidase activity. Human ortholog(s) of this gene are implicated in Brunner Syndrome. Is an ortholog of human PAOX (polyamine oxidase) and SMOX (spermine oxidase).

WB:WBGene00016062	C24G6.8
Is predicted to have aminoacyl-tRNA hydrolase activity. Is an ortholog of human PTRH2 (peptidyl-tRNA hydrolase 2).

WB:WBGene00016063	delm-2
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of several human genes including ASIC1 (acid sensing ion channel subunit 1); ASIC2 (acid sensing ion channel subunit 2); and ASIC3 (acid sensing ion channel subunit 3).

WB:WBGene00016064	acd-1
Is predicted to have sodium channel activity. Is involved in response to acidic pH and sodium ion transport. Is expressed in AMshL and AMshR. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of several human genes including ASIC1 (acid sensing ion channel subunit 1); ASIC2 (acid sensing ion channel subunit 2); and ASIC4 (acid sensing ion channel subunit family member 4).

WB:WBGene00016065	C24G7.3
No description available

WB:WBGene00016066	acd-2
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human ASIC1 (acid sensing ion channel subunit 1) and ASIC4 (acid sensing ion channel subunit family member 4).

WB:WBGene00016067	C24H10.1
Is enriched in AVG; RIM; command interneuron; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and npr-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Clc-like and Clc protein-like.

WB:WBGene00016068	C24H10.2
Is enriched in intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and lin-39 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016069	C24H10.3
Is enriched in several structures, including Z1.p; Z4.a; male distal tip cell; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016070	C24H10.4
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including clk-1; lin-35; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by hydrogen sulfide; dafa#1; and Sirolimus based on microarray studies.

WB:WBGene00016071	C24H12.1
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016072	C24H12.2
Is enriched in germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016073	C24H12.4
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX56 (DEAD-box helicase 56).

WB:WBGene00016074	dnsn-1
Is enriched in Z1.p; Z4.a; germ line; head mesodermal cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Donson. Is an ortholog of human DONSON (DNA replication fork stabilization factor DONSON).

WB:WBGene00016075	C24H12.6
Is enriched in DA neuron; VA neuron; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00016076	C24H12.7
Is enriched in NSM and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00016077	C24H12.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and let-418 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016078	C24H12.9
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Alovudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016080	C24H12.11
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Mianserin; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016081	C25A6.1
Is predicted to have protein serine/threonine phosphatase activity. Is an ortholog of human PPP1CA (protein phosphatase 1 catalytic subunit alpha).

WB:WBGene00016082	C25A8.1
Is affected by several genes including daf-12; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00016083	C25A8.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016084	cht-3
Is predicted to have chitin binding activity and chitinase activity. Is expressed in uterine toroidal epithelial cell and vulval cell. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00016085	C25A8.5
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00016087	C25A11.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain and BTB/POZ domain.

WB:WBGene00016088	clec-266
Is predicted to have carbohydrate binding activity. Is expressed in intestinal cell. Is an ortholog of human CLEC10A (C-type lectin domain containing 10A).

WB:WBGene00016089	aexr-1
Is predicted to have neuropeptide receptor activity.

WB:WBGene00016090	aexr-2
Is predicted to have neuropeptide receptor activity. Is involved in lysosome organization.

WB:WBGene00016091	nhr-30
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head.

WB:WBGene00016092	cyp-33B1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00016093	srsx-34
Is predicted to have G protein-coupled receptor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00016094	C25E10.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including sir-2.1; pmk-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is predicted to encode a protein with the following domain: MFS transporter superfamily. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00016095	C25E10.5
Is enriched in AFD; GABAergic neurons; PLM; amphid sheath cell; and excretory cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including bisphenol A; levamisole; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is predicted to encode a protein with the following domain: MFS transporter superfamily. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00016096	C25E10.7
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00016097	C25E10.8
Is expressed in intestine. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00016099	C25E10.10
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; Rotenone; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00016100	C25E10.11
Is enriched in amphid sheath cell; arcade cell; neurons; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and alg-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00016101	C25E10.12
Is predicted to have hydrolase activity. Is an ortholog of human MPPED1 (metallophosphoesterase domain containing 1) and MPPED2 (metallophosphoesterase domain containing 2).

WB:WBGene00016102	C25F6.1
Is enriched in AFD; body wall muscle cell; head mesodermal cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Zidovudine; cadmium; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00016103	dpyd-1
Is predicted to have several functions, including NADP binding activity; dihydropyrimidine dehydrogenase (NADP+) activity; and uracil binding activity. Human ortholog(s) of this gene are implicated in dihydropyrimidine dehydrogenase deficiency. Is an ortholog of human DPYD (dihydropyrimidine dehydrogenase).

WB:WBGene00016104	ddr-1
Is predicted to have collagen binding activity and protein tyrosine kinase collagen receptor activity. Is involved in motor neuron axon guidance and positive regulation of axon regeneration. Is expressed in hypodermis; intestinal muscle; nervous system; and pharynx. Is an ortholog of human DDR1 (discoidin domain receptor tyrosine kinase 1) and DDR2 (discoidin domain receptor tyrosine kinase 2).

WB:WBGene00016105	C25F6.6
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016106	C25F6.7
Is predicted to have amyloid-beta binding activity. Human ortholog(s) of this gene are implicated in ITM2B-related cerebral amyloid angiopathy 1 and ITM2B-related cerebral amyloid angiopathy 2. Is an ortholog of human ITM2A (integral membrane protein 2A) and ITM2B (integral membrane protein 2B).

WB:WBGene00016107	C25G6.1
Is enriched in neurons and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; isp-1; and alg-1 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00016108	C25G6.3
Is predicted to have catalytic activity.

WB:WBGene00016109	C25G6.4
Is enriched in intestine; neurons; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and sod-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00016110	npr-11
Is predicted to have neuropeptide Y receptor activity. Is expressed in AIAL; AIAR; AIYL; AIYR; and neurons.

WB:WBGene00016111	C25H3.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016112	C25H3.3
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT13 (acyl-CoA thioesterase 13).

WB:WBGene00016113	eif-2D
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF2D (eukaryotic translation initiation factor 2D).

WB:WBGene00016114	flp-27
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00016115	mdt-26
Is enriched in AVK; germ line; sensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and TFIIS/LEDGF domain superfamily.

WB:WBGene00016116	C25H3.7
Is enriched in several structures, including ASER; NSM; germ line; germline precursor cell; and intestine based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-12; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Mianserin; and Alovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase, C-terminal domain; Glutathione S-transferase N-terminal domain; Thioredoxin-like fold; Metaxin, glutathione S-transferase domain; Thioredoxin-like superfamily; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00016118	C25H3.9
Is expressed in hypodermis; intestine; and pharynx. Is predicted to encode a protein with the following domains: NADH:ubiquinone oxidoreductase, NDUFB5/SGDH subunit and NADH:ubiquinone oxidoreductase, NDUFB5/SGDH subunit. Is an ortholog of human NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5).

WB:WBGene00016119	C25H3.10
Is enriched in several structures, including coelomocyte; germ line; hypodermis; neurons; and ventral nerve cord based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Heme; D-glucose; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00016120	C25H3.11
Is predicted to have carbohydrate binding activity. Is an ortholog of human VPS13D (vacuolar protein sorting 13 homolog D).

WB:WBGene00016121	ift-43
Is expressed in ciliated neurons.

WB:WBGene00016123	C25H3.14
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT13 (acyl-CoA thioesterase 13).

WB:WBGene00016124	dnc-4
Localizes to dynactin complex. Is an ortholog of human DCTN4 (dynactin subunit 4).

WB:WBGene00016125	C26B2.2
Is enriched in several structures, including AVE; coelomocyte; germ line; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00016126	nhr-258
Is predicted to have chromatin binding activity; nuclear receptor activity; and transcription regulatory region sequence-specific DNA binding activity. Is expressed in neurons.

WB:WBGene00016128	elpc-4
Is predicted to have phosphorylase kinase regulator activity. Is an ortholog of human ELP4 (elongator acetyltransferase complex subunit 4).

WB:WBGene00016129	C26B2.7
Is enriched in germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including hydrogen sulfide; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00016130	C26B2.8
Is enriched in GABAergic neurons and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including methylmercuric chloride; D-glucose; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lustrin, cysteine-rich repeated domain; Lustrin, cysteine-rich repeated; and PEBP-like superfamily.

WB:WBGene00016131	C26B9.1
Is enriched in OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF4481. Is an ortholog of human TMEM268 (transmembrane protein 268).

WB:WBGene00016132	C26B9.2
Is enriched in hypodermis; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016133	C26B9.3
Is enriched in PLM; germ line; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercury hydroxide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: GM2-AP, lipid-recognition domain superfamily.

WB:WBGene00016134	C26B9.5
Is predicted to have dipeptidyl-peptidase activity. Localizes to membrane raft. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00016135	C26B9.6
Is predicted to have poly-ADP-D-ribose binding activity and ubiquitin-protein transferase activity. Is an ortholog of human RNF146 (ring finger protein 146).

WB:WBGene00016136	C26B9.7
Is enriched in germline precursor cell; hypodermis; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including tryptophan; methylmercury hydroxide; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00016137	C26E6.1
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00016138	flh-2
Exhibits sequence-specific DNA binding activity. Is involved in negative regulation of transcription, DNA-templated and nematode larval development. Localizes to nucleus. Is expressed in hypodermis and vulva.

WB:WBGene00016139	ntl-9
Is involved in hemidesmosome assembly. Is expressed in gonad. Is an ortholog of human CNOT9 (CCR4-NOT transcription complex subunit 9).

WB:WBGene00016140	rpb-2
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is expressed in head and tail. Is an ortholog of human POLR2B (RNA polymerase II subunit B).

WB:WBGene00016142	mrps-18C
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 9. Is an ortholog of human MRPL3 (mitochondrial ribosomal protein L3).

WB:WBGene00016143	eri-9
Is enriched in germ line; germline precursor cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including gld-1; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zc3h12a-like Ribonuclease NYN domain and Zc3h12a-like Ribonuclease NYN domain.

WB:WBGene00016144	mmab-1
Is predicted to have cob(I)yrinic acid a,c-diamide adenosyltransferase activity. Is used to study methylmalonic acidemia. Human ortholog(s) of this gene are implicated in methylmalonic acidemia cblB type. Is an ortholog of human MMAB (metabolism of cobalamin associated B).

WB:WBGene00016145	C26E6.12
Is predicted to have GTP binding activity. Is an ortholog of human GTPBP10 (GTP binding protein 10).

WB:WBGene00016146	C26F1.1
Is enriched in DA neuron; carbon dioxide sensory neurons; hypodermis; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016147	cyp-32A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00016148	C26F1.3
Is enriched in AFD; body wall muscle cell; germ line; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016149	frpr-3
Is predicted to have G protein-coupled receptor activity. Is expressed in head neurons and nerve ring.

WB:WBGene00016150	hint-3
Is enriched in germline precursor cell; head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Scavenger mRNA decapping enzyme C-term binding and HIT-like superfamily. Is an ortholog of human HINT3 (histidine triad nucleotide binding protein 3).

WB:WBGene00016151	smc-5
Is predicted to have ATP binding activity. Is involved in meiotic DNA double-strand break processing involved in reciprocal meiotic recombination. Localizes to condensed nuclear chromosome. Is expressed in germ line. Is an ortholog of human SMC5 (structural maintenance of chromosomes 5).

WB:WBGene00016152	pho-12
Is enriched in mechanosensory neurons and neuronal sheath cell based on microarray and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by Rotenone and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal); ACP3 (acid phosphatase 3); and ACP4 (acid phosphatase 4).

WB:WBGene00016153	C27A2.5
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including D-glucose; Zidovudine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016154	szy-5
Is enriched in AVA; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including age-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Linolenic Acids; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in nephronophthisis 14. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human ZNF791 (zinc finger protein 791).

WB:WBGene00016155	C27A12.4
Is enriched in NSM; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00016156	ari-1.3
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is an ortholog of human ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1).

WB:WBGene00016157	ari-1.2
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is an ortholog of human ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1).

WB:WBGene00016158	ari-1.1
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Localizes to cytoplasm and nucleus. Is expressed in several structures, including germ line; hermaphrodite distal tip cell; neurons; non-striated muscle; and somatic nervous system. Is an ortholog of human ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1).

WB:WBGene00016159	pigo-1
Is predicted to have mannose-ethanolamine phosphotransferase activity. Is an ortholog of human PIGO (phosphatidylinositol glycan anchor biosynthesis class O).

WB:WBGene00016160	C27D6.1
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by Progesterone; Acrylamide; and Colistin based on microarray studies. Is predicted to encode a protein with the following domain: Coiled-coil domain-containing protein 170-like. Is an ortholog of human CCDC170 (coiled-coil domain containing 170).

WB:WBGene00016161	C27D6.3
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Heme; Ethanol; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C27D6.3-like.

WB:WBGene00016162	crh-2
Is predicted to have cAMP response element binding activity. Is expressed in body wall musculature; seam cell; spermatheca; and tail. Human ortholog(s) of this gene are implicated in achromatopsia 7 and osteogenesis imperfecta type 16. Is an ortholog of human CREB3L1 (cAMP responsive element binding protein 3 like 1).

WB:WBGene00016163	C27D9.1
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00016164	C27D9.2
Is enriched in OLL; PVD; dopaminergic neurons; intestine; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00016165	wdr-60
Is predicted to have dynein heavy chain binding activity and dynein light chain binding activity. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 8 with or without polydactyly. Is an ortholog of human DYNC2I1 (dynein 2 intermediate chain 1).

WB:WBGene00016166	C27F2.4
Is predicted to have rRNA (guanine) methyltransferase activity. Is an ortholog of human BUD23 (BUD23 rRNA methyltransferase and ribosome maturation factor).

WB:WBGene00016167	vps-22
Is expressed in body wall musculature; pharyngeal muscle cell; and vulval muscle. Is predicted to encode a protein with the following domains: EAP30/Vps36 family; ESCRT-2 complex, Snf8; Winged helix-like DNA-binding domain superfamily; Winged helix DNA-binding domain superfamily; and Snf8/Vps36 family. Is an ortholog of human SNF8 (SNF8 subunit of ESCRT-II).

WB:WBGene00016168	C27F2.6
Is enriched in DA neuron; germ line; interneuron; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; paraquat; and dibromoacetic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016169	C27F2.7
Is expressed in head neurons; hypodermis; intestine; and tail neurons. Is predicted to encode a protein with the following domains: F-box-like; F-box domain; and F-box-like domain superfamily.

WB:WBGene00016170	tmem-131
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including gld-1; hsf-1; and sek-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and nicotine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Transmembrane protein 131-like; Transmembrane protein 131-like domain; and Transmembrane protein 131-like. Is an ortholog of human TMEM131 (transmembrane protein 131).

WB:WBGene00016171	C27F2.10
Is predicted to have RNA binding activity and double-stranded DNA binding activity. Is an ortholog of human PCID2 (PCI domain containing 2).

WB:WBGene00016172	C27H5.2
Is enriched in OLL; PVD; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including aldicarb; tryptophan; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transactive response DNA-binding protein N-terminal domain and TAR DNA-binding protein 43, N-terminal.

WB:WBGene00016173	fust-1
Is predicted to have RNA binding activity and transcription coregulator activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 6; bone sarcoma (multiple); and essential tremor 4. Is an ortholog of human TAF15 (TATA-box binding protein associated factor 15).

WB:WBGene00016174	mfsd-13.2
Is enriched in amphid sheath cell; hypodermis; and intestine based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty chemicals including methylmercuric chloride; indole; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Transmembrane protein 180. Is an ortholog of human MFSD13A (major facilitator superfamily domain containing 13A).

WB:WBGene00016175	C27H5.6
Is enriched in AVK; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including aldicarb; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016177	C28C12.1
Is enriched in several structures, including Z1.p; Z4.a; germ line; hypodermis; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00016178	mesp-1
Is expressed in germ line.

WB:WBGene00016179	C28C12.3
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00016180	C28C12.4
Is expressed in pharyngeal muscle cell and tail neurons. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00016181	C28C12.11
Is enriched in ASER; germ line; head mesodermal cell; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: EF-hand domain pair.

WB:WBGene00016182	C28C12.12
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016183	C28F5.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; tryptophan; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00016184	glb-9
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in neurons and somatic nervous system.

WB:WBGene00016185	C28F5.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by antimycin and resveratrol based on RNA-seq and microarray studies. Is an ortholog of human IDE (insulin degrading enzyme).

WB:WBGene00016186	C28F5.5
No description available

WB:WBGene00016187	C28G1.2
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; 4-bromodiphenyl ether; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpin (serine protease inhibitor); Serpin family; Serpin domain; Serpin superfamily; and Serpin superfamily, domain 2.

WB:WBGene00016188	sec-15
Is expressed in embryonic cell; excretory canal; and hypodermis. Is predicted to encode a protein with the following domains: Vps51/Vps67; Exocyst complex subunit Sec15-like; Exocyst complex component EXOC6/Sec15; Exocyst complex component EXOC6/Sec15, C-terminal, domain 2; and Exocyst complex component EXOC6/Sec15, C-terminal, domain 1. Is an ortholog of human EXOC6 (exocyst complex component 6) and EXOC6B (exocyst complex component 6B).

WB:WBGene00016189	sprp-4
Is expressed in dorsal nerve cord; nerve ring; and ventral nerve cord. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00016190	rcs-1
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of several human genes including TRIM17 (tripartite motif containing 17); TRIM6-TRIM34 (TRIM6-TRIM34 readthrough); and TRIM65 (tripartite motif containing 65).

WB:WBGene00016191	C28G1.6
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of several human genes including TRIM17 (tripartite motif containing 17); TRIM6-TRIM34 (TRIM6-TRIM34 readthrough); and TRIM65 (tripartite motif containing 65).

WB:WBGene00016192	bcl-7
Is expressed in distal tip cell; germ cell; and gonadal sheath cell. Is predicted to encode a protein with the following domains: BCL7, N-terminal conserver region and BCL7. Is an ortholog of human BCL7A (BAF chromatin remodeling complex subunit BCL7A); BCL7B (BAF chromatin remodeling complex subunit BCL7B); and BCL7C (BAF chromatin remodeling complex subunit BCL7C).

WB:WBGene00016193	C28H8.2
Is enriched in AFD; PLM; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5390) and Protein of unknown function DUF5390.

WB:WBGene00016194	C28H8.3
Is predicted to have ATP binding activity; helicase activity; and nucleic acid binding activity. Human ortholog(s) of this gene are implicated in premature ovarian failure. Is an ortholog of human DDX60 (DExD/H-box helicase 60).

WB:WBGene00016195	erd-2.2
Is predicted to have ER retention sequence binding activity. Is an ortholog of human KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1) and KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2).

WB:WBGene00016196	C28H8.5
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Ethanol; 1-methylnicotinamide; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like; Domain of unknown function (DUF1794); ShKT domain; Calycin; and Domain of unknown function DUF1794. Is an ortholog of human THAP4 (THAP domain containing 4).

WB:WBGene00016197	pxl-1
Exhibits vinculin binding activity. Is involved in muscle structure development; nematode larval development; and pharyngeal pumping. Localizes to adherens junction; contractile fiber; and podosome. Is expressed in pharyngeal muscle cell and pharynx. Is an ortholog of human LPXN (leupaxin); PXN (paxillin); and TGFB1I1 (transforming growth factor beta 1 induced transcript 1).

WB:WBGene00016198	C28H8.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies. Is affected by Alovudine; resveratrol; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016199	C28H8.8
Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00016200	dpff-1
Is predicted to have histone acetyltransferase activity and histone binding activity. Is expressed widely. Is used to study alcohol use disorder. Is an ortholog of human DPF3 (double PHD fingers 3).

WB:WBGene00016201	tdo-2
Is predicted to have heme binding activity and tryptophan 2,3-dioxygenase activity. Human ortholog(s) of this gene are implicated in familial hypertryptophanemia. Is an ortholog of human TDO2 (tryptophan 2,3-dioxygenase).

WB:WBGene00016202	kle-2
Is predicted to have chromatin binding activity. Is involved in mitotic sister chromatid segregation. Is an ortholog of human NCAPH2 (non-SMC condensin II complex subunit H2).

WB:WBGene00016203	tag-250
Is expressed in hypodermis; intestine; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in cataract 36. Is predicted to encode a protein with the following domains: Tudor domain; Tudor domain; and SNase-like, OB-fold superfamily.

WB:WBGene00016204	gsto-1
Exhibits glutathione dehydrogenase (ascorbate) activity and glutathione transferase activity. Is involved in several processes, including cellular response to extracellular stimulus; protein glutathionylation; and response to superoxide. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTO1 (glutathione S-transferase omega 1) and GSTO2 (glutathione S-transferase omega 2).

WB:WBGene00016206	C29E4.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Zidovudine and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016207	C29E4.10
Is predicted to have galactosylceramidase activity. Human ortholog(s) of this gene are implicated in Krabbe disease. Is an ortholog of human GALC (galactosylceramidase).

WB:WBGene00016208	C29E4.11
Is affected by several genes including let-60; sir-2.1; and isp-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Atrazine; Quercetin; and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00016209	C29E4.12
Is enriched in AFD; ASER; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq; microarray; and proteomic studies. Is affected by six chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein FMC1 homologue. Is an ortholog of human FMC1-LUC7L2 (FMC1-LUC7L2 readthrough).

WB:WBGene00016210	C29F5.1
Localizes to sarcoplasmic reticulum. Is expressed in anal depressor muscle; anal sphincter muscle; body wall musculature; and vulval muscle.

WB:WBGene00016211	sdz-3
Is enriched in body wall muscle cell; germ line; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Rifampin; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00016212	C29F5.3
Is enriched in ASER; coelomocyte; muscle cell; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zc3h12a-like Ribonuclease NYN domain and Ribonuclease Zc3h12a-like, NYN domain.

WB:WBGene00016213	C29F5.5
Is affected by several genes including eat-2; sir-2.1; and drh-3 based on microarray and RNA-seq studies. Is affected by resveratrol; dafa#1; and Sirolimus based on microarray studies.

WB:WBGene00016214	C29F5.6
No description available

WB:WBGene00016215	glb-10
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Localizes to plasma membrane. Is expressed in several structures, including excretory cell; gonad; neurons; non-striated muscle; and somatic nervous system.

WB:WBGene00016216	pals-22
Is enriched in hypodermis; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016217	C29F9.2
Is enriched in ASER; intestine; and male-specific anatomical entity based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercury hydroxide; and procyanidin based on microarray and RNA-seq studies.

WB:WBGene00016218	pals-23
Is involved in innate immune response.

WB:WBGene00016219	pals-24
Is enriched in head mesodermal cell; intestine; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eighteen chemicals including 1-methylnicotinamide; manganese chloride; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00016220	C29F9.5
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity.

WB:WBGene00016221	C29F9.6
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity.

WB:WBGene00016222	C29F9.8
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00016223	C29F9.9
Is affected by several genes including daf-12; lin-15B; and mut-2 based on microarray and tiling array studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00016224	fbxa-57
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00016225	fbxa-58
Is enriched in AVA and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by paraquat and allantoin based on microarray studies.

WB:WBGene00016226	C29F9.12
Is affected by several genes including glp-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Progesterone; Colistin; and Triclosan based on microarray studies.

WB:WBGene00016227	nhr-280
Is affected by several genes including sir-2.1; pmk-1; and aak-2 based on RNA-seq and microarray studies. Is affected by hydrogen sulfide; allantoin; and Triclosan based on microarray studies. Is predicted to encode a protein with the following domain: Nuclear hormone receptor-like domain superfamily.

WB:WBGene00016230	C29G2.2
Is expressed in head.

WB:WBGene00016231	C29G2.3
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00016232	srt-4
Is affected by several genes including clk-1; dpy-21; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016233	nhr-290
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016234	C29G2.6
Is enriched in dopaminergic neurons; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5332) and Protein of unknown function DUF5332.

WB:WBGene00016235	C29H12.2
Is enriched in several structures, including cephalic sheath cell; head mesodermal cell; neurons; pharynx; and retrovesicular ganglion based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; lin-4; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including Zidovudine; Cry5B; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Triose-phosphate Transporter family; Sugar phosphate transporter domain; and Nucleotide-sugar transporter-related. Is an ortholog of human SLC35F6 (solute carrier family 35 member F6).

WB:WBGene00016236	heri-1
Is predicted to have protein serine/threonine kinase activity. Is expressed in several structures, including Psub3; Psub4; Z2; Z3; and germ cell.

WB:WBGene00016237	C29H12.6
Is expressed in marginal cell.

WB:WBGene00016238	mob-4
Is predicted to have metal ion binding activity. Is an ortholog of human MOB4 (MOB family member 4, phocein).

WB:WBGene00016239	C30A5.4
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and nanoparticle based on microarray and RNA-seq studies.

WB:WBGene00016241	C30A5.9
No description available

WB:WBGene00016242	C30A5.10
Is predicted to have group II metabotropic glutamate receptor activity. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1B.

WB:WBGene00016244	C30B5.2
Is enriched in germ line; hypodermis; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including gld-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; stavudine; and Deoxyglucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vacuolar protein sorting 55 and Vps55/LEPROT. Is an ortholog of human LEPROT (leptin receptor overlapping transcript) and LEPROTL1 (leptin receptor overlapping transcript like 1).

WB:WBGene00016245	rbmx-2
Is predicted to have RNA binding activity. Is an ortholog of human RBMX2 (RNA binding motif protein X-linked 2).

WB:WBGene00016246	daf-37
Exhibits ascr#2 binding activity; protein heterodimerization activity; and protein homodimerization activity. Is involved in G protein-coupled receptor signaling pathway involved in dauer larval development and G protein-coupled receptor signaling pathway involved in social behavior. Localizes to non-motile cilium. Is expressed in head neurons.

WB:WBGene00016247	C30B5.6
Is enriched in GABAergic neurons; coelomocyte; excretory cell; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterised protein family, transmembrane-17.

WB:WBGene00016248	C30B5.7
Is enriched in hypodermis; neurons; somatic gonad precursor; ventral nerve cord; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srsx and Serpentine type 7TM GPCR chemoreceptor Srsx.

WB:WBGene00016249	mrpl-32
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL32 (mitochondrial ribosomal protein L32).

WB:WBGene00016250	hsp-110
Is predicted to have ATP binding activity. Is involved in determination of adult lifespan; protein folding; and response to topologically incorrect protein. Is an ortholog of human HSPA4 (heat shock protein family A (Hsp70) member 4); HSPA4L (heat shock protein family A (Hsp70) member 4 like); and HSPH1 (heat shock protein family H (Hsp110) member 1).

WB:WBGene00016253	C30E1.4
Is predicted to have double-stranded RNA binding activity.

WB:WBGene00016254	fbxb-114
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016255	C30E1.6
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00016257	C30E1.8
Is affected by hpl-2; npr-1; and smn-1 based on tiling array and RNA-seq studies. Is affected by Cry5B and Sirolimus based on microarray studies.

WB:WBGene00016258	vha-16
Is predicted to have proton-exporting ATPase activity, phosphorylative mechanism and proton-transporting ATPase activity, rotational mechanism. Is expressed in head and tail. Is an ortholog of human ATP6V0D1 (ATPase H+ transporting V0 subunit d1).

WB:WBGene00016259	C30F8.3
Is enriched in PLM; Z1; and Z4 based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00016260	rege-1
Is predicted to have RNA binding activity; endonuclease activity; and metal ion binding activity. Is expressed in tail. Is an ortholog of human ZC3H12C (zinc finger CCCH-type containing 12C).

WB:WBGene00016261	C30F12.2
Is predicted to have ATPase activity. Is expressed in head. Is an ortholog of human AFG1L (AFG1 like ATPase).

WB:WBGene00016262	C30F12.3
Is enriched in Psub1; cephalic sheath cell; hypodermis; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and Ag nanoparticles based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016263	C30F12.4
Is enriched in cholinergic neurons; germ line; germline precursor cell; hypodermis; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00016264	C30F12.5
Is enriched in germline precursor cell and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by nine chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016265	trhr-1
Is predicted to have thyrotropin-releasing hormone receptor activity. Is expressed in pm4 and pm5. Is an ortholog of human TRHR (thyrotropin releasing hormone receptor).

WB:WBGene00016266	idhg-2
Is predicted to have isocitrate dehydrogenase (NAD+) activity. Is an ortholog of human IDH3G (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma).

WB:WBGene00016267	C30G4.1
No description available

WB:WBGene00016268	C30G4.2
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hpl-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00016269	C30G4.4
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00016271	irld-23
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00016273	C30G12.1
Is enriched in GABAergic neurons and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq; microarray; and tiling array studies. Is affected by eight chemicals including multi-walled carbon nanotube; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016274	C30G12.2
Is enriched in intestine based on SAGE; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by thirty-one chemicals including Ethanol; tryptophan; and 1-methylnicotinamide based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily.

WB:WBGene00016276	C30G12.4
Is enriched in GABAergic neurons; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercury hydroxide; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00016277	C30G12.6
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including age-1; hsf-1; and elt-2 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-type fold.

WB:WBGene00016278	erp-44.1
Is enriched in several structures, including germ line; head mesodermal cell; mechanosensory neurons; somatic nervous system; and tail neurons based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by aldicarb; Tunicamycin; and paraquat based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin-like domain; Thioredoxin domain; and Thioredoxin-like superfamily. Is an ortholog of human ERP44 (endoplasmic reticulum protein 44).

WB:WBGene00016279	C31B8.1
Is affected by several genes including sir-2.1; aak-2; and nhr-25 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00016280	C31B8.2
Is affected by several genes including mut-2; mir-34; and adr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00016281	pals-32
Is enriched in several structures, including coelomocyte; dopaminergic neurons; excretory cell; pharyngeal muscle cell; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including tryptophan; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00016282	C31B8.7
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00016283	zmp-3
Exhibits metallopeptidase activity. Is expressed in anchor cell. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type. Is an ortholog of human MMP1 (matrix metallopeptidase 1) and MMP8 (matrix metallopeptidase 8).

WB:WBGene00016284	C31B8.9
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00016285	C31B8.12
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00016286	C31H1.1
Is enriched in AVK; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including dpy-10; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00016287	C31H1.2
Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; stavudine; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016288	C31H1.5
Is predicted to have calcium ion binding activity and phospholipase A2 activity. Is an ortholog of human PLA2G12A (phospholipase A2 group XIIA) and PLA2G12B (phospholipase A2 group XIIB).

WB:WBGene00016289	lntl-1
Is enriched in excretory cell; germ line; intestine; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016291	C31H1.8
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00016292	tbc-7
Is enriched in body wall musculature; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in DOORS syndrome; early infantile epileptic encephalopathy 16; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: TLD; Rab-GTPase-TBC domain; Rab-GTPase-TBC domain; TLDc domain; and Rab-GTPase-TBC domain superfamily. Is an ortholog of human TBC1D24 (TBC1 domain family member 24).

WB:WBGene00016293	C31H2.3
Is enriched in AFD; ASER; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016294	C31H2.4
Is predicted to have 4-hydroxyphenylpyruvate dioxygenase activity.

WB:WBGene00016295	fbxc-40
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016296	fbxc-16
Is affected by several genes including daf-16; daf-2; and mex-3 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00016297	fbxc-15
Is affected by several genes including daf-2; eat-2; and drh-3 based on microarray and RNA-seq studies. Is affected by four chemicals including 1-methylnicotinamide; methylmercuric chloride; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016298	fbxc-14
Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016299	C32B5.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016300	C32B5.7
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis.

WB:WBGene00016301	fbxc-6
Is enriched in intestine and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00016302	fbxc-7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016303	fbxc-32
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016304	fbxc-41
Is enriched in NSM; neurons; and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00016305	fbxc-57
Is enriched in AVE; NSM; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016306	C32B5.13
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis.

WB:WBGene00016307	fbxc-18
Is enriched in hypodermis and intestine based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016308	C32B5.15
Is enriched in NSM; Z1; and Z4 based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016309	sdz-4
Is expressed in several structures, including Caa; Cap; Cpa; Ea; and Psub4. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016310	txt-18
Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016311	efr-3
Is enriched in AVK; DD neuron; NSM; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-type fold. Is an ortholog of human EFR3A (EFR3 homolog A) and EFR3B (EFR3 homolog B).

WB:WBGene00016312	C32D5.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00016313	set-4
Is predicted to have methyltransferase activity. Is involved in determination of adult lifespan. Is expressed in several structures, including hypodermis and muscle cell. Is an ortholog of human KMT5C (lysine methyltransferase 5C).

WB:WBGene00016314	C32D5.6
Is enriched in GABAergic neurons; excretory cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Heme; D-glucose; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF3808); Tetratricopeptide-like helical domain superfamily; Inclusion body clearance protein Iml2/Tetratricopeptide repeat protein 39; and Tetratricopeptide repeat. Is an ortholog of human TTC39A (tetratricopeptide repeat domain 39A) and TTC39B (tetratricopeptide repeat domain 39B).

WB:WBGene00016315	C32D5.7
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016316	C32D5.8
Is enriched in PLM; carbon dioxide sensory neurons; dopaminergic neurons; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including aldicarb; Rotenone; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00016317	C32D5.10
Is predicted to have ubiquitin-protein transferase activity.

WB:WBGene00016318	C32D5.11
Is enriched in OLL; PVD; germ line; and germline precursor cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in peroxisome biogenesis disorder 6A. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human PEX10 (peroxisomal biogenesis factor 10).

WB:WBGene00016319	C32D5.12
Is predicted to have 3-beta-hydroxy-delta5-steroid dehydrogenase activity. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1. Is an ortholog of human HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1) and HSD3B2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2).

WB:WBGene00016320	C32E8.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00016321	tppp-1
Is predicted to have tubulin binding activity. Is an ortholog of human TPPP2 (tubulin polymerization promoting protein family member 2) and TPPP3 (tubulin polymerization promoting protein family member 3).

WB:WBGene00016322	C32E8.4
Is enriched in amphid sheath cell; germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00016323	pmlr-1
Is predicted to have mRNA binding activity. Is an ortholog of human SNIP1 (Smad nuclear interacting protein 1).

WB:WBGene00016324	C32E8.6
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability.

WB:WBGene00016325	C32E8.9
Is predicted to have enoyl-CoA hydratase activity. Is an ortholog of human ECHDC1 (ethylmalonyl-CoA decarboxylase 1).

WB:WBGene00016326	ubr-1
Exhibits ubiquitin conjugating enzyme binding activity. Is involved in negative regulation of glutamate metabolic process and regulation of backward locomotion. Is expressed in body wall musculature; lateral ganglion; pharynx; and seam cell. Human ortholog(s) of this gene are implicated in Johanson-Blizzard syndrome. Is an ortholog of human UBR2 (ubiquitin protein ligase E3 component n-recognin 2).

WB:WBGene00016327	C32E12.1
Is enriched in AFD; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00016328	pde-5
Is predicted to have 3',5'-cyclic-GMP phosphodiesterase activity and cGMP-stimulated cyclic-nucleotide phosphodiesterase activity. Is involved in several processes, including determination of adult lifespan; negative regulation of cGMP-mediated signaling; and response to alkaline pH. Is expressed in AFDL and AFDR. Is an ortholog of human PDE10A (phosphodiesterase 10A).

WB:WBGene00016329	osr-1
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00016330	C32E12.4
Is enriched in head mesodermal cell; muscle cell; and sensory neurons based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016331	obr-4
Exhibits calmodulin binding activity. Is expressed in tail. Is an ortholog of human OSBPL9 (oxysterol binding protein like 9).

WB:WBGene00016332	C32F10.4
Is enriched in OLL; PVD; head mesodermal cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-60 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00016333	C32F10.8
Is predicted to have L-alanine:2-oxoglutarate aminotransferase activity. Is an ortholog of human GPT (glutamic--pyruvic transaminase) and GPT2 (glutamic--pyruvic transaminase 2).

WB:WBGene00016334	C33C12.1
Is enriched in AVE and neurons based on tiling array studies. Is affected by several genes including daf-2; unc-70; and dlc-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00016335	gba-1
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in Gaucher's disease (multiple); Lewy body dementia; and late onset Parkinson's disease. Is an ortholog of human GBA (glucosylceramidase beta).

WB:WBGene00016336	C33C12.4
Is enriched in several structures, including I5 neuron; cholinergic neurons; germ line; intestine; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00016337	fbxb-38
Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016338	srb-14
Is affected by several genes including clk-1; pgl-1; and sod-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00016339	C33C12.7
Is enriched in coelomocyte; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00016340	gba-2
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in Gaucher's disease (multiple); Lewy body dementia; and late onset Parkinson's disease. Is an ortholog of human GBA (glucosylceramidase beta).

WB:WBGene00016341	mtq-2
Is predicted to have S-adenosylmethionine-dependent methyltransferase activity and protein methyltransferase activity. Is an ortholog of human N6AMT1 (N-6 adenine-specific DNA methyltransferase 1).

WB:WBGene00016342	C33C12.10
Is enriched in ASER; AVE; AVK; NSM; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016343	cnnm-3
Is predicted to have transmembrane transporter activity. Is involved in several processes, including determination of adult lifespan; magnesium ion homeostasis; and positive regulation of vulval development. Localizes to basolateral plasma membrane. Is expressed in hypodermis and rectum. Human ortholog(s) of this gene are implicated in Jalili syndrome and renal hypomagnesemia 6. Is an ortholog of human CNNM2 (cyclin and CBS domain divalent metal cation transport mediator 2) and CNNM4 (cyclin and CBS domain divalent metal cation transport mediator 4).

WB:WBGene00016344	rsef-1
Is predicted to have GTPase activity. Is expressed in g1; spermathecal-uterine junction; and uterus. Is an ortholog of human RASEF (RAS and EF-hand domain containing).

WB:WBGene00016345	C33E10.1
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00016346	fbxa-120
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including dpy-10; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00016347	C33E10.5
Is affected by several genes including eat-2; pgl-1; and eri-1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00016348	C33E10.6
No description available

WB:WBGene00016349	C33E10.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016350	C33E10.10
Is expressed in pharynx. Is predicted to encode a protein with the following domain: NAD(P)-binding domain superfamily. Is an ortholog of human DHRS7B (dehydrogenase/reductase 7B).

WB:WBGene00016351	C33F10.1
Is enriched in amphid sheath cell; body wall muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Heme; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00016352	tbck-1
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBCK (TBC1 domain containing kinase).

WB:WBGene00016353	C33F10.4
Is enriched in germ line; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00016354	rig-6
Is predicted to have cell-cell adhesion mediator activity. Is involved in several processes, including negative regulation of defecation rhythm; negative regulation of locomotion involved in locomotory behavior; and nervous system development. Localizes to axon; neuronal cell body; and synapse. Is expressed in several structures, including excretory cell; muscle cell; neurons; rectal epithelium; and spermatheca. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and nonsyndromic deafness (multiple). Is an ortholog of human CNTN4 (contactin 4) and CNTN6 (contactin 6).

WB:WBGene00016355	lact-5
Is enriched in ASER; PLM; and hypodermis based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; 4-bromodiphenyl ether; and D-glucose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9 and primary coenzyme Q10 deficiency 4. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00016356	C33F10.8
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016357	C33F10.11
Is enriched in NSM; amphid sheath cell; body wall muscle cell; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00016358	C33F10.12
Is predicted to have inorganic phosphate transmembrane transporter activity. Is an ortholog of human SLC25A3 (solute carrier family 25 member 3).

WB:WBGene00016359	fbxb-88
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016360	C33G8.2
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00016361	drd-10
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by twenty-one chemicals including Nitric Oxide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00016362	C33G8.4
Is enriched in AFD; PLM; amphid sheath cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00016363	srab-4
Is expressed in neurons and pm6. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016364	nhr-161
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016365	nhr-139
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016366	nhr-140
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016367	nhr-162
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016368	nhr-163
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016369	C33G8.13
Is affected by several genes including daf-16; daf-12; and alg-1 based on tiling array and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00016370	C33H5.1
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by tryptophan; Quercetin; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00016371	C33H5.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00016373	swd-2.1
Is predicted to contribute to histone methyltransferase activity (H3-K4 specific). Is an ortholog of human WDR82 (WD repeat domain 82).

WB:WBGene00016374	swd-2.2
Is predicted to contribute to histone methyltransferase activity (H3-K4 specific). Is expressed in linker cell. Is an ortholog of human WDR82 (WD repeat domain 82).

WB:WBGene00016375	rpap-3
Is predicted to have heat shock protein binding activity. Human ortholog(s) of this gene are implicated in cataract 43; primary ciliary dyskinesia (multiple); and spermatogenic failure 6. Is an ortholog of human RPAP3 (RNA polymerase II associated protein 3).

WB:WBGene00016376	sec-10
Is expressed in several structures, including body wall musculature; coelomocyte; excretory canal; head neurons; and reproductive system. Is predicted to encode a protein with the following domains: Exocyst complex component Sec10; Exocyst complex component Sec10-like; and Exocyst complex component EXOC5/Sec10. Is an ortholog of human EXOC5 (exocyst complex component 5).

WB:WBGene00016378	imp-3
Is predicted to have aspartic-type endopeptidase activity.

WB:WBGene00016379	C33H5.13
Is involved in innate immune response.

WB:WBGene00016380	ntp-1
Exhibits pyrophosphatase activity. Is involved in ATP metabolic process and ribonucleotide metabolic process. Localizes to Golgi apparatus and perinuclear region of cytoplasm. Is an ortholog of human ENTPD4 (ectonucleoside triphosphate diphosphohydrolase 4) and ENTPD7 (ectonucleoside triphosphate diphosphohydrolase 7).

WB:WBGene00016381	sgo-1
Is enriched in AFD; AVA; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Shugoshin N-terminal coiled-coil region and Shugoshin, N-terminal coiled-coil domain.

WB:WBGene00016382	C33H5.16
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016383	zgpa-1
Is predicted to have metal ion binding activity and nucleic acid binding activity. Is an ortholog of human ZGPAT (zinc finger CCCH-type and G-patch domain containing).

WB:WBGene00016384	cdgs-1
Is predicted to have phosphatidate cytidylyltransferase activity. Is expressed in head and tail. Is an ortholog of human CDS1 (CDP-diacylglycerol synthase 1) and CDS2 (CDP-diacylglycerol synthase 2).

WB:WBGene00016386	tag-272
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00016387	kbp-5
Localizes to condensed chromosome kinetochore.

WB:WBGene00016388	C34B2.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016389	C34B2.4
Is predicted to have metal ion binding activity.

WB:WBGene00016390	ttc-1
Is expressed in intestinal cell and neurons. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily. Is an ortholog of human TTC1 (tetratricopeptide repeat domain 1).

WB:WBGene00016391	lonp-1
Is predicted to have ATP-dependent peptidase activity and single-stranded DNA binding activity. Is involved in protein catabolic process. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in CODAS syndrome. Is an ortholog of human LONP1 (lon peptidase 1, mitochondrial).

WB:WBGene00016392	sdha-2
Is predicted to have electron transfer activity; flavin adenine dinucleotide binding activity; and succinate dehydrogenase (ubiquinone) activity. Human ortholog(s) of this gene are implicated in several diseases, including dilated cardiomyopathy 1GG; mitochondrial complex II deficiency; and paraganglioma. Is an ortholog of human SDHA (succinate dehydrogenase complex flavoprotein subunit A).

WB:WBGene00016393	C34B2.8
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Human ortholog(s) of this gene are implicated in thyroid gland Hurthle cell carcinoma. Is an ortholog of human NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13).

WB:WBGene00016394	C34B2.9
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and bar-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016395	spcs-1
Is predicted to have peptidase activity. Is involved in IRE1-mediated unfolded protein response. Localizes to endoplasmic reticulum. Is an ortholog of human SPCS1 (signal peptidase complex subunit 1).

WB:WBGene00016396	C34B2.11
Is enriched in several structures, including GABAergic neurons; PLM; carbon dioxide sensory neurons; excretory cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Lithium Chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00016397	maph-9
Is predicted to have microtubule binding activity. Localizes to axoneme and ciliary base. Is expressed in chemosensory neurons and ciliated neurons. Is an ortholog of human MAP9 (microtubule associated protein 9).

WB:WBGene00016398	C34D4.2
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00016399	C34D4.3
Is enriched in several structures, including NSM; amphid sheath cell; germ line; intestine; and seam cell based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-six chemicals including Heme; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00016400	C34D4.4
Is enriched in AFD; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Eukaryotic protein of unknown function (DUF846) and Golgi apparatus membrane protein TVP23-like. Is an ortholog of human TVP23A (trans-golgi network vesicle protein 23 homolog A) and TVP23B (trans-golgi network vesicle protein 23 homolog B).

WB:WBGene00016401	C34D4.5
No description available

WB:WBGene00016402	C34D4.10
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and elt-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00016403	grsp-3
Is enriched in cholinergic neurons; hypodermis; intestine; muscle cell; and somatic gonad precursor based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00016404	mutd-1
Is involved in endosomal transport.

WB:WBGene00016405	hecd-1
Is predicted to have metal ion binding activity and ubiquitin-protein transferase activity. Is involved in several processes, including determination of adult lifespan; hemidesmosome assembly; and regulation of Notch signaling pathway. Is an ortholog of human HECTD1 (HECT domain E3 ubiquitin protein ligase 1).

WB:WBGene00016406	C34D10.1
Is enriched in OLL; PVD; dopaminergic neurons; and hypodermis based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; Immunoglobulin-like fold; and Motile sperm domain-containing protein 1. Is an ortholog of human MOSPD1 (motile sperm domain containing 1).

WB:WBGene00016407	unk-1
Is predicted to have metal ion binding activity. Is an ortholog of human UNK (unk zinc finger) and UNKL (unk like zinc finger).

WB:WBGene00016408	prmt-5
Exhibits activating transcription factor binding activity; p53 binding activity; and protein-arginine N-methyltransferase activity. Is involved in several processes, including negative regulation of DNA damage response, signal transduction by p53 class mediator; peptidyl-arginine methylation; and response to odorant. Localizes to nucleus. Is an ortholog of human PRMT5 (protein arginine methyltransferase 5).

WB:WBGene00016409	sumv-1
Localizes to cytoplasm; neuron projection; and nucleus. Is expressed in hypodermis and neurons. Is an ortholog of human INO80D (INO80 complex subunit D).

WB:WBGene00016410	C34E10.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00016411	C34E10.10
Is predicted to have small ribosomal subunit rRNA binding activity. Is an ortholog of human UTP23 (UTP23 small subunit processome component).

WB:WBGene00016412	mrps-26
Is enriched in body wall muscle cell; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial ribosome subunit S26 and 28S ribosomal protein S26. Is an ortholog of human MRPS26 (mitochondrial ribosomal protein S26).

WB:WBGene00016413	C34F11.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00016414	C34F11.2
Is enriched in germ line; muscle cell; neurons; retrovesicular ganglion; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016415	ampd-1
Is predicted to have AMP deaminase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 63 and pontocerebellar hypoplasia type 9. Is an ortholog of human AMPD2 (adenosine monophosphate deaminase 2).

WB:WBGene00016416	C34F11.5
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity.

WB:WBGene00016417	C34F11.8
Is enriched in FLP; hypodermis; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; 4-bromodiphenyl ether; and Ag nanoparticles based on RNA-seq and microarray studies.

WB:WBGene00016418	hpo-27
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Phosphorylation site; Armadillo-like helical; and Armadillo-type fold. Is an ortholog of human MROH1 (maestro heat like repeat family member 1).

WB:WBGene00016419	tyr-4
Is predicted to have copper ion binding activity and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type III. Is an ortholog of human TYRP1 (tyrosinase related protein 1).

WB:WBGene00016420	C34G6.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016421	cdc-7
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human CDC7 (cell division cycle 7).

WB:WBGene00016422	noah-1
Is involved in molting cycle.

WB:WBGene00016423	tag-275
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 18; cone-rod dystrophy 9; and early infantile epileptic encephalopathy 61. Is an ortholog of human ADAMDEC1 (ADAM like decysin 1).

WB:WBGene00016424	C34H4.1
Is involved in innate immune response.

WB:WBGene00016425	C34H4.2
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-eight chemicals including Heme; hydrogen sulfide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00016427	C34H4.5
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00016428	dmsr-7
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00016429	C35A11.2
Is enriched in NSM; Z1; Z4; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00016430	C35A11.3
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by rsr-2; daf-2; and mut-2 based on tiling array and microarray studies. Is affected by four chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016431	C35A11.4
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A5 (solute carrier family 2 member 5).

WB:WBGene00016432	C35B1.2
Is enriched in OLL; PLM; PVD; germ line; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium; paraquat; and Sirolimus based on microarray studies.

WB:WBGene00016433	C35B1.3
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016434	C35B1.4
Is enriched in cephalic sheath cell; dopaminergic neurons; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00016435	C35B1.5
Is enriched in GABAergic neurons; excretory cell; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00016436	C35B1.7
Is enriched in AFD; AVA; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pmk-1; fbf-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00016437	C35B1.8
Is affected by several genes including daf-2; rrf-3; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Ethanol; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016438	C35B8.3
Is enriched in AVA; OLL; PVD; coelomocyte; and neurons based on microarray and tiling array studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; resveratrol; and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4460); Domain of unknown function (DUF4461); T-cell activation inhibitor, mitochondrial; Domain of unknown function DUF4461; and Domain of unknown function DUF4460. Is an ortholog of human TCAIM (T cell activation inhibitor, mitochondrial).

WB:WBGene00016439	C35D10.1
Is enriched in several structures, including cephalic sheath cell; excretory cell; germ line; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rotenone; bisphenol A; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2012); Domain of unknown function DUF2012; and ER membrane protein complex subunit 7. Is an ortholog of human EMC7 (ER membrane protein complex subunit 7).

WB:WBGene00016440	gipc-1
Is enriched in germ line and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by thirty-two chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 15. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain-containing protein GIPC1/2/3; and PDZ superfamily. Is an ortholog of human GIPC1 (GIPC PDZ domain containing family member 1); GIPC2 (GIPC PDZ domain containing family member 2); and GIPC3 (GIPC PDZ domain containing family member 3).

WB:WBGene00016441	C35D10.3
Is enriched in AVK; NSM; coelomocyte; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00016442	C35D10.5
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquinol-cytochrome C chaperone; Ubiquinol-cytochrome c chaperone, CBP3; and Ubiquinol-cytochrome c chaperone/UPF0174. Is an ortholog of human UQCC1 (ubiquinol-cytochrome c reductase complex assembly factor 1).

WB:WBGene00016443	C35D10.6
Is predicted to have oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00016444	C35D10.7
Is enriched in AFD; body wall muscle cell; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016445	C35D10.8
Is enriched in several structures, including arcade cell; germ line; intestine; male distal tip cell; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016446	C35D10.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Rotenone; resveratrol; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin domain; and Thioredoxin-like superfamily. Is an ortholog of human TMX2 (thioredoxin related transmembrane protein 2).

WB:WBGene00016447	msd-4
Localizes to cell body and pseudopodium.

WB:WBGene00016448	C35D10.12
Is predicted to have tRNA (uracil) methyltransferase activity. Is an ortholog of human TRMT9B (tRNA methyltransferase 9B (putative)).

WB:WBGene00016449	tost-1
Is enriched in germ line; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00016450	clec-5
Is predicted to have carbohydrate binding activity. Is expressed in head.

WB:WBGene00016451	clec-6
Is predicted to have carbohydrate binding activity.

WB:WBGene00016452	C35D10.17
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytochrome c oxidase biogenesis protein Cmc1 like and Cytochrome c oxidase biogenesis protein Cmc1-like. Is an ortholog of human CMC2 (C-X9-C motif containing 2).

WB:WBGene00016453	vet-2
Localizes to cytoplasm.

WB:WBGene00016454	C35E7.2
Is enriched in neurons and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including aldicarb; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein sepa-1.

WB:WBGene00016455	C35E7.3
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein sepa-1.

WB:WBGene00016456	C35E7.4
Is expressed in head neurons; intestine; tail neurons; and vulval muscle. Is predicted to encode a protein with the following domain: Protein sepa-1.

WB:WBGene00016457	C35E7.5
Is enriched in several structures, including GABAergic neurons; germ line; intestine; pharyngeal muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Protein sepa-1.

WB:WBGene00016458	C35E7.6
Localizes to cytoplasm.

WB:WBGene00016459	C35E7.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00016460	C35E7.8
Localizes to endoplasmic reticulum.

WB:WBGene00016461	C35E7.9
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00016462	C35E7.10
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00016463	C35E7.11
Is expressed in RMFL; RMFR; RMHL; RMHR; and intestine.

WB:WBGene00016464	C36B7.1
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 2 and primary autosomal recessive microcephaly 12.

WB:WBGene00016465	C36B7.2
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 2 and primary autosomal recessive microcephaly 12.

WB:WBGene00016466	C36B7.3
Is enriched in AFD; ASER; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016467	C36B7.4
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00016468	C36B7.5
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily. Is an ortholog of human CFP (complement factor properdin).

WB:WBGene00016469	C36B7.6
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human CLPTM1 (CLPTM1 regulator of GABA type A receptor forward trafficking).

WB:WBGene00016470	srab-5
Is affected by clk-1 and eat-2 based on microarray studies.

WB:WBGene00016471	srab-8
Is expressed in amphid socket cell; neurons; and ray. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016472	srbc-6
Is affected by clk-1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016473	C36C5.4
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00016474	C36C5.5
Is enriched in several structures, including cephalic sheath cell; coelomocyte; muscle cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00016475	srab-9
Is expressed in amphid neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016476	srab-10
Is expressed in hypodermis. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016477	srab-11
Is expressed in chemosensory neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016478	srt-72
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on tiling array and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00016479	srab-6
Is affected by hpl-2; rsr-2; and mir-34 based on tiling array and microarray studies. Is affected by four chemicals including resveratrol; Atrazine; and tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016480	srab-7
Is expressed in amphid neurons and anal depressor muscle. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00016481	C36C5.12
Is enriched in cephalic sheath cell; coelomocyte; hypodermis; neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by seventeen chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00016482	C36C5.13
No description available

WB:WBGene00016483	C36C5.14
Is expressed in body wall musculature; nerve ring; and neurons. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00016484	C36C5.15
Is enriched in several structures, including cephalic sheath cell; coelomocyte; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including npr-1; aak-2; and sma-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Tunicamycin; glycine; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00016485	meg-4
Is involved in P granule assembly; germ cell proliferation; and organelle localization. Localizes to P granule. Is expressed in pharynx.

WB:WBGene00016486	fbxa-170
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including bisphenol A; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00016487	C36C9.4
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by aldicarb and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1258) and Protein of unknown function DUF1258.

WB:WBGene00016488	C36C9.5
Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00016489	fubl-3
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human FUBP1 (far upstream element binding protein 1); FUBP3 (far upstream element binding protein 3); and KHSRP (KH-type splicing regulatory protein).

WB:WBGene00016490	C36E6.2
Is predicted to have ubiquitin binding activity. Is an ortholog of human ILRUN (inflammation and lipid regulator with UBA-like and NBR1-like domains).

WB:WBGene00016491	acdh-5
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6.

WB:WBGene00016492	C37A2.6
Is predicted to have methyltransferase activity. Is an ortholog of human ETFBKMT (electron transfer flavoprotein subunit beta lysine methyltransferase).

WB:WBGene00016493	C37A2.7
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; 60s Acidic ribosomal protein; and Ribosomal protein P1/P2, N-terminal domain. Is an ortholog of human RPLP2 (ribosomal protein lateral stalk subunit P2).

WB:WBGene00016494	C37A2.8
Is enriched in ASER; AVK; body wall muscle cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including manganese chloride; D-glucose; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4078) and Protein of unknown function DUF4078. Is an ortholog of human CCDC174 (coiled-coil domain containing 174).

WB:WBGene00016495	C37C3.1
Is enriched in AVK; body wall muscle cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF1768); NADAR; and YbiA-like superfamily.

WB:WBGene00016496	C37C3.2
Is predicted to have GDP-dissociation inhibitor activity; eukaryotic initiation factor eIF2 binding activity; and translation initiation factor activity. Is involved in negative regulation of transcription by RNA polymerase II and translation. Is an ortholog of human EIF5 (eukaryotic translation initiation factor 5).

WB:WBGene00016497	vps-32.2
Is enriched in PLM and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and let-7 based on tiling array; proteomic; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in cataract 31 multiple types. Human CHMP4B exhibits protein homodimerization activity. Is an ortholog of human CHMP4B (charged multivesicular body protein 4B).

WB:WBGene00016499	txt-5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domains: Laminin EGF domain and Laminin EGF domain.

WB:WBGene00016500	memo-1
Is expressed in several structures, including gonad; neurons; pharynx; vulva; and vulval precursor cell. Is predicted to encode a protein with the following domains: Memo-like protein and MEMO1 family. Is an ortholog of human MEMO1 (mediator of cell motility 1).

WB:WBGene00016501	C37C3.9
Is enriched in AB; AVK; BAG; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00016502	C37C3.10
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including tryptophan; Tunicamycin; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00016503	C37C3.11
Is enriched in AFD; BAG; NSM; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and mex-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00016504	C37C3.12
Is affected by several genes including clk-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Cry5B; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human PTTG1IP (PTTG1 interacting protein).

WB:WBGene00016505	ttr-33
Is expressed in head; hypodermis; pharynx; and posterior arcade cell. Is used to study Parkinson's disease. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00016506	abhd-5.1
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in neutral lipid storage disease. Is an ortholog of human ABHD4 (abhydrolase domain containing 4, N-acyl phospholipase B) and ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase).

WB:WBGene00016507	abhd-5.2
Is predicted to have carboxylic ester hydrolase activity. Is expressed in hypodermis. Is used to study neutral lipid storage disease. Human ortholog(s) of this gene are implicated in neutral lipid storage disease. Is an ortholog of human ABHD4 (abhydrolase domain containing 4, N-acyl phospholipase B) and ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase).

WB:WBGene00016508	C37H5.5
Is predicted to have chromatin binding activity. Is an ortholog of human NOC3L (NOC3 like DNA replication regulator).

WB:WBGene00016509	adss-1
Is predicted to have adenylosuccinate synthase activity. Is an ortholog of human ADSS1 (adenylosuccinate synthase 1) and ADSS2 (adenylosuccinate synthase 2).

WB:WBGene00016511	C37H5.13
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT8 (acyl-CoA thioesterase 8).

WB:WBGene00016512	C38C3.3
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00016513	C38C3.4
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016514	C38C3.6
Is enriched in ASER; head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including mex-3; mex-1; and prg-1 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00016516	C38C3.8
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00016517	nhr-260
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity. Is expressed in seam cell.

WB:WBGene00016518	C38C5.1
Is enriched in BAG; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00016519	srz-56
Is expressed in ADLL and ADLR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00016520	C39B5.2
Is enriched in Z1.p; Z4.a; male distal tip cell; pharynx; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016521	fbxa-62
Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00016522	fbxa-38
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00016523	C39B5.5
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in CST3-related cerebral amyloid angiopathy and age related macular degeneration 11. Is predicted to encode a protein with the following domain: .

WB:WBGene00016524	C39B5.6
Is predicted to have glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity. Is an ortholog of human GATB (glutamyl-tRNA amidotransferase subunit B).

WB:WBGene00016525	fbxa-12
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including clk-1; npr-1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Tunicamycin; antimycin; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00016526	fbxa-8
Is affected by several genes including eat-2; sir-2.1; and smg-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016527	fbxa-47
Is enriched in OLL and PVD based on microarray and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; metformin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00016528	C39B5.10
Is affected by several genes including daf-2; smg-1; and hpl-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016529	C39D10.1
Is affected by clk-1; rsr-2; and rrf-2 based on microarray and tiling array studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00016530	C39D10.2
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq studies.

WB:WBGene00016531	pcyt-2.2
Is predicted to have catalytic activity. Is expressed in body wall musculature. Is an ortholog of human PCYT2 (phosphate cytidylyltransferase 2, ethanolamine).

WB:WBGene00016532	C39D10.5
Is expressed in nervous system.

WB:WBGene00016533	C39D10.6
Is enriched in GABAergic neurons based on microarray studies. Is affected by several genes including elt-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including bisphenol A; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016534	C39D10.7
Is predicted to have chitin binding activity. Is expressed in germ line.

WB:WBGene00016535	C39D10.8
Is enriched in ASER; OLL; PVD; hypodermis; and intestine based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00016537	C39E6.2
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including eat-2; dpy-21; and let-418 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016538	C39F7.1
Is enriched in intestine; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00016539	madd-2
Exhibits protein homodimerization activity; signaling receptor binding activity; and ubiquitin-protein transferase activity. Is involved in several processes, including axon guidance; cell projection assembly; and protein ubiquitination. Localizes to several cellular components, including cell leading edge; neuronal cell body; and striated muscle dense body. Is expressed in several structures, including anchor cell; intestinal cell; neurons; ray precursor cell; and vulval muscle, type 2. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human TRIM67 (tripartite motif containing 67) and TRIM9 (tripartite motif containing 9).

WB:WBGene00016540	C39F7.5
Is enriched in DA neuron; I5 neuron; SAB; intestine; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB And C-terminal Kelch; BTB/Kelch-associated; and BTB/POZ domain-containing protein 7. Is an ortholog of human BTBD7 (BTB domain containing 7).

WB:WBGene00016541	C39H7.1
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 11. Is an ortholog of human TTBK1 (tau tubulin kinase 1) and TTBK2 (tau tubulin kinase 2).

WB:WBGene00016542	C39H7.4
Is involved in innate immune response.

WB:WBGene00016543	srsx-14
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00016544	math-18
Is enriched in AFD and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including bisphenol S; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016545	C40A11.2
Is enriched in DA neuron; VA neuron; hypodermis; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00016546	C40A11.3
Is enriched in CEPshDL; CEPshDR; CEPshVL; and CEPshVR based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD13 (potassium channel tetramerization domain containing 13) and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00016547	C40A11.4
Is enriched in cephalic sheath cell; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00016548	hpo-7
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016549	C40A11.6
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00016550	C40A11.7
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mercuric Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00016551	C40A11.8
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016552	C40A11.9
No description available

WB:WBGene00016553	mir-8199
Is enriched in GABAergic neurons; NSM; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016554	math-19
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016555	math-20
Is enriched in intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016556	math-21
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016557	ceh-84
Is predicted to have DNA binding activity.

WB:WBGene00016558	pks-1
Is predicted to have hydrolase activity, acting on ester bonds; phosphopantetheine binding activity; and transferase activity. Is expressed in CANL and CANR.

WB:WBGene00016559	C41A3.2
Is enriched in coelomocyte; germ line; head mesodermal cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016561	eri-6
Is expressed in ASIL; ASIR; ASKL; ASKR; and hypodermis. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1280) and Protein of unknown function DUF1280.

WB:WBGene00016562	C41D11.3
Is expressed in amphid neurons; body wall musculature; pharyngeal muscle cell; and uterine muscle. Is predicted to encode a protein with the following domains: Cysteine/serine-rich nuclear protein N-terminus; Cysteine/serine-rich nuclear protein family; and Cysteine/serine-rich nuclear protein, N-terminal domain. Is an ortholog of human CSRNP1 (cysteine and serine rich nuclear protein 1) and CSRNP2 (cysteine and serine rich nuclear protein 2).

WB:WBGene00016564	cmt-1
Is enriched in germ line; germline precursor cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016565	C41D11.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Seckel syndrome 8; autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions  6; and neurodegenerative disease (multiple). Is predicted to encode a protein with the following domain: P-loop containing nucleoside triphosphate hydrolase.

WB:WBGene00016566	eri-7
Is predicted to have RNA binding activity and transcription termination site sequence-specific DNA binding activity. Is expressed in amphid neurons; gonad; and hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease axonal type 2S; Seckel syndrome 8; and neurodegenerative disease (multiple). Is an ortholog of human IGHMBP2 (immunoglobulin mu DNA binding protein 2).

WB:WBGene00016567	C41D11.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TM2 domain and TM2 domain. Is an ortholog of human TM2D3 (TM2 domain containing 3).

WB:WBGene00016568	C41G11.1
Is predicted to have hydrolase activity.

WB:WBGene00016570	gnrr-4
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in hypotrichosis 8. Is an ortholog of several human genes including GPR20 (G protein-coupled receptor 20); LPAR6 (lysophosphatidic acid receptor 6); and P2RY8 (P2Y receptor family member 8).

WB:WBGene00016572	C41H7.2
Is enriched in AVG; RIM; command interneuron; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016573	lido-12
Is enriched in germ line; intestine; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00016574	lido-11
Is enriched in several structures, including coelomocyte; excretory cell; germ line; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including allantoin; Quercetin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ras-mediated vulval-induction antagonist; and Protein LIN-8.

WB:WBGene00016575	lido-10
Is enriched in several structures, including NSM; coelomocyte; excretory cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rifampin; allantoin; and Quercetin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00016576	lido-9
Is enriched in body wall muscle cell; coelomocyte; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Linolenic Acids; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00016577	clec-3
Is predicted to have carbohydrate binding activity.

WB:WBGene00016578	sdz-5
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016579	sre-14
Is enriched in ASER; DA neuron; VA neuron; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016580	ppm-1.H
Is predicted to have [pyruvate dehydrogenase (lipoamide)] phosphatase activity and magnesium-dependent protein serine/threonine phosphatase activity. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human PPM1H (protein phosphatase, Mg2+/Mn2+ dependent 1H).

WB:WBGene00016581	C42C1.3
Is enriched in NSM; Z1.p; Z4.a; germ line; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including resveratrol; paraquat; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00016582	vps-8
Is enriched in several structures, including coelomocyte; germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Golgi CORVET complex core vacuolar protein 8; Vacuolar protein sorting-associated protein 8, central domain; and WD40-repeat-containing domain superfamily. Is an ortholog of human VPS8 (VPS8 subunit of CORVET complex).

WB:WBGene00016583	tag-335
Is predicted to have GTP binding activity and mannose-1-phosphate guanylyltransferase activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2T and congenital muscular dystrophy-dystroglycanopathy A14. Is an ortholog of human GMPPB (GDP-mannose pyrophosphorylase B).

WB:WBGene00016585	oac-59
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Is expressed in amphid neurons and hypodermis.

WB:WBGene00016586	C42C1.8
Is predicted to have cofactor transmembrane transporter activity. Is an ortholog of human SLC49A3 (solute carrier family 49 member 3).

WB:WBGene00016587	C42C1.9
Is enriched in germ line; pharynx; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipopolysaccharide kinase (Kdo/WaaP) family and Protein kinase-like domain superfamily.

WB:WBGene00016588	hpo-12
Is predicted to have ATP transmembrane transporter activity. Human ortholog(s) of this gene are implicated in glycogen storage disease I. Is an ortholog of human SLC25A19 (solute carrier family 25 member 19) and SLC37A4 (solute carrier family 37 member 4).

WB:WBGene00016589	ltah-1.1
Exhibits aminopeptidase activity. Is involved in peptide catabolic process. Localizes to cytosol. Is an ortholog of human LTA4H (leukotriene A4 hydrolase).

WB:WBGene00016590	C42C1.12
Is enriched in germ line; hypodermis; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016591	C42C1.13
Is predicted to have methyltransferase activity. Is an ortholog of human VCPKMT (valosin containing protein lysine methyltransferase).

WB:WBGene00016592	erl-1
Is predicted to have cholesterol binding activity. Localizes to endoplasmic reticulum membrane and protein-containing complex. Is expressed in gonad. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 18 and hereditary spastic paraplegia 62. Is an ortholog of human ERLIN1 (ER lipid raft associated 1) and ERLIN2 (ER lipid raft associated 2).

WB:WBGene00016594	C42D4.1
Is enriched in head mesodermal cell; intestine; male-specific anatomical entity; neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including 1-methylnicotinamide; Rotenone; and juglone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function DUF148; and Domain of unknown function DUF148.

WB:WBGene00016595	cest-10
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold.

WB:WBGene00016596	C42D4.3
Is expressed in hypodermis; spermatheca; and vulva. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00016597	clec-179
Is predicted to have carbohydrate binding activity.

WB:WBGene00016598	C42D4.13
Is enriched in NSM; germline precursor cell; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016599	C42D8.1
Is involved in innate immune response.

WB:WBGene00016600	ets-5
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is expressed in nervous system. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human FEV (FEV transcription factor, ETS family member).

WB:WBGene00016601	acin-1
Is predicted to have RNA binding activity. Is involved in gonad morphogenesis and regulation of cell migration. Is an ortholog of human ACIN1 (apoptotic chromatin condensation inducer 1).

WB:WBGene00016602	mus-81
Exhibits enzyme binding activity. Is involved in several processes, including DNA metabolic process; larval development; and positive regulation of embryonic development. Is an ortholog of human MUS81 (MUS81 structure-specific endonuclease subunit).

WB:WBGene00016603	met-1
Is predicted to have histone methyltransferase activity (H3-K36 specific). Is involved in histone lysine methylation; negative regulation of transcription by RNA polymerase II; and negative regulation of vulval development. Is expressed in hypodermis; intestine; and muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including Kleefstra syndrome 2; Sotos syndrome; and autosomal dominant non-syndromic intellectual disability (multiple). Is an ortholog of human NSD1 (nuclear receptor binding SET domain protein 1); NSD2 (nuclear receptor binding SET domain protein 2); and NSD3 (nuclear receptor binding SET domain protein 3).

WB:WBGene00016605	C43E11.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016606	exoc-7
Is predicted to have phosphatidylinositol-4,5-bisphosphate binding activity. Is expressed in several structures, including intestine; pharynx; somatic nervous system; tail neurons; and vulva. Is an ortholog of human EXOC7 (exocyst complex component 7).

WB:WBGene00016607	C43E11.9
Is predicted to have RNA binding activity. Is an ortholog of human NIP7 (nucleolar pre-rRNA processing protein NIP7).

WB:WBGene00016608	cogc-5
Is expressed in gonad. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIi. Is predicted to encode a protein with the following domain: Conserved oligomeric Golgi complex subunit 5. Is an ortholog of human COG5 (component of oligomeric golgi complex 5).

WB:WBGene00016609	C43E11.12
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; gld-1; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; Cry5B; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TFIIIC subunit triple barrel domain and Transcription factor TFIIIC, triple barrel domain.

WB:WBGene00016610	paqr-1
Is predicted to have signaling receptor activity. Is involved in positive regulation of fatty acid oxidation. Is expressed in excretory canal; gonadal sheath cell; mechanosensory neurons; and pharyngeal gland cell. Is an ortholog of human ADIPOR1 (adiponectin receptor 1).

WB:WBGene00016611	bicd-1
Is predicted to have cytoskeletal adaptor activity and dynein complex binding activity. Is involved in regulation of dendrite morphogenesis. Localizes to dendrite and neuronal cell body. Is expressed in several structures, including hyp7 syncytium; intestine; neurons; non-striated muscle; and pharyngeal-intestinal valve. Human ortholog(s) of this gene are implicated in spinal muscular atrophy with lower extremity predominance 2A and spinal muscular atrophy with lower extremity predominante 2B. Is an ortholog of human BICD1 (BICD cargo adaptor 1) and BICD2 (BICD cargo adaptor 2).

WB:WBGene00016612	C43G2.3
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00016613	best-9
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1).

WB:WBGene00016614	trpp-12
Is predicted to have endopeptidase activity. Is an ortholog of human TRAPPC12 (trafficking protein particle complex 12).

WB:WBGene00016616	mtpn-1
Is enriched in muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human MTPN (myotrophin).

WB:WBGene00016617	C43H6.4
Is enriched in neurons; seam cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; Rotenone; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-type fold.

WB:WBGene00016619	C43H6.6
Is enriched in BAG; dopaminergic neurons; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lectin C-type domain; CUB domain; CUB domain; C-type lectin-like; C-type lectin-like/link domain superfamily; C-type lectin fold; and Spermadhesin, CUB domain superfamily.

WB:WBGene00016620	dhhc-9
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human ZDHHC16 (zinc finger DHHC-type palmitoyltransferase 16).

WB:WBGene00016621	arch-1
Is predicted to have metal ion binding activity. Is an ortholog of human ZBTB8OS (zinc finger and BTB domain containing 8 opposite strand).

WB:WBGene00016622	mafr-1
Is predicted to have DNA binding activity and RNA polymerase III core binding activity. Localizes to cytoplasm and nucleus. Is expressed in hypodermis and intestine. Is an ortholog of human MAF1 (MAF1 homolog, negative regulator of RNA polymerase III).

WB:WBGene00016623	psmd-9
Is enriched in ASER; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including cadmium; Chlorpyrifos; and Hydrolyzable Tannins based on microarray studies. Is predicted to encode a protein with the following domains: Nas2 N_terminal domain; PDZ domain; 26S Proteasome non-ATPase regulatory subunit 9; PDZ superfamily; Nas2, N-terminal; and PDZ domain 6. Is an ortholog of human PSMD9 (proteasome 26S subunit, non-ATPase 9).

WB:WBGene00016624	hrpl-1
Is predicted to have mRNA binding activity. Is an ortholog of human HNRNPL (heterogeneous nuclear ribonucleoprotein L).

WB:WBGene00016625	aff-1
Is involved in multicellular organism development; regulation of oviposition; and syncytium formation by plasma membrane fusion. Localizes to plasma membrane. Is expressed in anchor cell; egg-laying apparatus; epithelial cell; neurons; and pharyngeal muscle cell.

WB:WBGene00016626	clhm-1
Exhibits voltage-gated calcium channel activity. Is involved in calcium ion transmembrane transport and regulation of locomotion. Localizes to non-motile cilium and plasma membrane. Is expressed in body wall musculature; head; sensory neurons; and spermatheca. Is an ortholog of human CALHM5 (calcium homeostasis modulator family member 5) and CALHM6 (calcium homeostasis modulator family member 6).

WB:WBGene00016627	C44B7.5
Is enriched in cephalic sheath cell; dopaminergic neurons; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by sixteen chemicals including Heme; Ethanol; and Rotenone based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37.

WB:WBGene00016628	slc-36.5
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of several human genes including SLC36A1 (solute carrier family 36 member 1); SLC36A2 (solute carrier family 36 member 2); and SLC36A3 (solute carrier family 36 member 3).

WB:WBGene00016629	C44B7.7
Is predicted to have gamma-glutamylcyclotransferase activity. Is an ortholog of human GGCT (gamma-glutamylcyclotransferase).

WB:WBGene00016630	acer-1
Is predicted to have acetate CoA-transferase activity and acetyl-CoA hydrolase activity. Is expressed in several structures, including germ line.

WB:WBGene00016631	C44B7.11
Is predicted to have metal ion binding activity and metallopeptidase activity. Is an ortholog of human ERMP1 (endoplasmic reticulum metallopeptidase 1).

WB:WBGene00016632	adal-1
Is predicted to have adenosine deaminase activity. Is an ortholog of human ADAL (adenosine deaminase like).

WB:WBGene00016633	C44B11.1
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Fas apoptotic inhibitory molecule (FAIM1); Fas apoptotic inhibitory molecule 1; and FAIM1 domain superfamily. Is an ortholog of human FAIM (Fas apoptotic inhibitory molecule).

WB:WBGene00016634	C44B11.4
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016635	C44B11.6
Is enriched in body wall muscle cell; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00016636	perm-2
Is expressed in oocyte.

WB:WBGene00016637	C44B12.3
Is enriched in several structures, including cholinergic neurons; coelomocyte; germ line; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00016638	perm-4
Is expressed in oocyte. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016639	C44B12.6
Is predicted to have cytokine activity.

WB:WBGene00016640	C44B12.7
No description available

WB:WBGene00016641	C44C1.1
Is enriched in germ line; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including let-60; clk-1; and npr-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016642	chil-10
Is predicted to have oligosaccharide binding activity. Is expressed in head. Human ortholog(s) of this gene are implicated in schizophrenia. Is an ortholog of human CHID1 (chitinase domain containing 1).

WB:WBGene00016643	vps-45
Is involved in pinocytosis and receptor-mediated endocytosis. Is expressed in several structures, including coelomocyte; head; hypodermis; intestine; and muscle cell. Is an ortholog of human VPS45 (vacuolar protein sorting 45 homolog).

WB:WBGene00016644	abhd-3.2
Is predicted to have acylglycerol lipase activity and short-chain carboxylesterase activity. Is an ortholog of human ABHD1 (abhydrolase domain containing 1) and ABHD3 (abhydrolase domain containing 3, phospholipase).

WB:WBGene00016645	C44C1.6
Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00016646	fbxc-5
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016647	fbxc-4
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucopyranose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016648	fbxc-2
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucopyranose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016649	fbxc-1
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016650	ubr-4
Is predicted to have zinc ion binding activity. Is an ortholog of human UBR4 (ubiquitin protein ligase E3 component n-recognin 4).

WB:WBGene00016652	got-2.1
Is predicted to have L-aspartate:2-oxoglutarate aminotransferase activity. Is an ortholog of human GOT2 (glutamic-oxaloacetic transaminase 2).

WB:WBGene00016653	ssb-1
Is predicted to have RNA binding activity. Is expressed in head and tail. Is an ortholog of human SSB (small RNA binding exonuclease protection factor La).

WB:WBGene00016654	C44E4.5
Is enriched in GABAergic neurons; germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and clk-1 based on proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; HSP20-like chaperone; and NudC domain-containing protein 1. Is an ortholog of human NUDCD1 (NudC domain containing 1).

WB:WBGene00016655	acbp-1
Is predicted to have fatty-acyl-CoA binding activity and lipid binding activity. Is involved in determination of adult lifespan and lipid storage. Is an ortholog of human DBI (diazepam binding inhibitor, acyl-CoA binding protein).

WB:WBGene00016657	C44E12.1
Is predicted to have hydrolase activity.

WB:WBGene00016658	C45B2.1
Is enriched in several structures, including cephalic sheath cell; dopaminergic neurons; excretory cell; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-five chemicals including Ethanol; Rotenone; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016659	C45B2.2
Is enriched in several structures, including cholinergic neurons; germline precursor cell; intestine; pharyngeal cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-three chemicals including 1-methylnicotinamide; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016660	C45B2.3
Is enriched in excretory cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; indole; and Ag nanoparticles based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016661	C45B2.6
Is predicted to have hydrolase activity.

WB:WBGene00016662	C45B2.8
Is enriched in AFD; GABAergic neurons; excretory cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including methylmercury hydroxide; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00016663	C45E1.4
Is enriched in ASER; PLM; dopaminergic neurons; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Rotenone; Zidovudine; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00016664	C45E5.1
Is predicted to have phosphatase activity. Is an ortholog of human PDXP (pyridoxal phosphatase) and PGP (phosphoglycolate phosphatase).

WB:WBGene00016665	chil-11
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00016666	C45E5.3
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016667	C45E5.4
Is enriched in OLL; PVD; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Heme; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00016668	ilys-1
Is predicted to have lysozyme activity. Is expressed in intestine; mc1; mc2; pm3; and pm4.

WB:WBGene00016669	ilys-2
Is predicted to have lysozyme activity. Is involved in defense response to Gram-positive bacterium. Is expressed in nerve ring and pm3.

WB:WBGene00016670	ilys-3
Exhibits lysozyme activity. Is involved in defense response to Gram-positive bacterium and determination of adult lifespan. Localizes to endosome; extracellular space; and lysosomal lumen. Is expressed in coelomocyte; hypodermis; intestinal cell; and terminal bulb.

WB:WBGene00016671	C45G7.4
Is predicted to have metal ion binding activity.

WB:WBGene00016673	ttbk-6
Is predicted to have protein serine/threonine kinase activity. Is expressed in ASKL; ASKR; amphid neurons; and neurons.

WB:WBGene00016674	C45G9.2
Is predicted to have tRNA dihydrouridine synthase activity. Is an ortholog of human DUS4L (dihydrouridine synthase 4 like).

WB:WBGene00016675	C45G9.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00016676	C45G9.5
Is enriched in AFD; PLM; coelomocyte; germ line; and hypodermis based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including D-glucose; Cry5B; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016677	C45G9.6
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Mianserin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016678	txbp-3
Is enriched in AFD; body wall muscle cell; excretory cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; daf-12; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain; Tax1-binding protein 3; and PDZ superfamily. Is an ortholog of human TAX1BP3 (Tax1 binding protein 3).

WB:WBGene00016679	C45G9.8
Is enriched in DA neuron; VA neuron; and neurons based on tiling array studies. Is affected by several genes including eat-2; cyc-1; and nhl-2 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00016680	C45G9.9
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and lin-4 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00016681	C45G9.10
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sek-1; and alg-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016682	C45G9.11
Is expressed in intestine.

WB:WBGene00016683	C45G9.12
Is enriched in OLL; RIM; hypodermis; and interneuron based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00016684	nlp-43
Is enriched in CEM; HOB; IL2 neuron; neurons; and ray neuron type B based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by Rotenone; Rifampin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00016685	srbc-16
Is affected by several genes including clk-1; sir-2.1; and mir-34 based on RNA-seq and microarray studies. Is affected by four chemicals including Diazinon; dafa#1; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016686	cyp-33C1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00016687	srbc-17
Is affected by several genes including clk-1; eat-2; and ain-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016688	srbc-18
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including clk-1; drh-3; and rsr-2 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00016689	srbc-21
Is affected by several genes including clk-1; sir-2.1; and mir-34 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; allantoin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016690	srbc-22
Is affected by several genes including hpl-2; drh-3; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016691	srbc-23
Is affected by pgrn-1 and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016692	srbc-24
Is affected by several genes including eat-2; set-2; and mir-34 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016693	srbc-20
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016694	C45H4.13
Is affected by several genes including mex-1; smg-2; and spn-4 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00016695	C45H4.14
Is expressed in germ line.

WB:WBGene00016696	srbc-19
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including aldicarb; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00016697	cyp-33C2
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00016698	C46A5.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016699	del-7
Is predicted to have sodium channel activity. Is expressed in NSML and NSMR. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple).

WB:WBGene00016700	C46A5.4
Is predicted to have peroxidase activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7.

WB:WBGene00016701	dsb-3
Is enriched in NSM; germ line; germline precursor cell; and hypodermis based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00016702	C46A5.6
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016703	rdl-1
Is expressed in BAG and amphid neurons. Is predicted to encode a protein with the following domains: RD3 protein and Retinal degeneration protein 3.

WB:WBGene00016704	hosl-1
Is predicted to have lipase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in familial partial lipodystrophy type 6. Is an ortholog of human LIPE (lipase E, hormone sensitive type).

WB:WBGene00016705	slcr-46.1
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: MFS transporter superfamily. Is an ortholog of human SLC46A1 (solute carrier family 46 member 1); SLC46A2 (solute carrier family 46 member 2); and SLC46A3 (solute carrier family 46 member 3).

WB:WBGene00016706	C46C11.3
Is enriched in AFD; body wall muscle cell; head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PMP-22/EMP/MP20/Claudin tight junction and PMP-22/EMP/MP20/Claudin superfamily.

WB:WBGene00016707	C46E10.1
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00016708	C46E10.2
Is affected by cyc-1; rsr-2; and sir-2.1 based on microarray and tiling array studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00016709	C46E10.3
Is affected by rsr-2 based on tiling array studies. Is affected by dibromoacetic acid based on microarray studies.

WB:WBGene00016710	fbxc-52
Is enriched in several structures, including PLM; Z4.a; body wall muscle cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Cry5B; allantoin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function (DUF3557); and Protein of unknown function DUF3557.

WB:WBGene00016711	fbxc-53
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00016712	C46E10.8
Is expressed in dorsal nerve cord; head neurons; tail neurons; and ventral nerve cord. Is predicted to encode a protein with the following domains: Zinc-finger of C2H2 type; zinc-finger C2H2-type; Zinc finger C2H2-type; Zinc finger C2H2 superfamily; and Zinc-finger C2H2-type 11.

WB:WBGene00016713	C46E10.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00016714	C46F2.1
Is enriched in intestine and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; Mianserin; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00016716	acs-17
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ACSL3 (acyl-CoA synthetase long chain family member 3).

WB:WBGene00016717	math-22
Is enriched in ASER and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016718	math-23
Is affected by several genes including lin-15B; ain-2; and ubc-9 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016719	math-24
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016720	math-25
Is affected by several genes including lin-4; lin-14; and smn-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00016721	C46G7.1
Is predicted to have endoribonuclease activity. Is an ortholog of human RNASEK (ribonuclease K).

WB:WBGene00016722	C46G7.2
Localizes to A band and striated muscle dense body. Is expressed in body wall musculature and vulval muscle.

WB:WBGene00016723	C46G7.3
No description available

WB:WBGene00016724	C46H3.1
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016725	C46H3.2
Is enriched in AFD; NSM; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SAM domain (Sterile alpha motif); Sterile alpha motif domain; and Sterile alpha motif/pointed domain superfamily. Is an ortholog of human CASKIN2 (CASK interacting protein 2).

WB:WBGene00016727	C46H11.1
Is enriched in neurons based on tiling array studies. Is affected by rsr-2 and ubc-9 based on tiling array and microarray studies. Is affected by Atrazine; copper sulfate; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00016728	C46H11.2
Is predicted to have N,N-dimethylaniline monooxygenase activity; NADP binding activity; and flavin adenine dinucleotide binding activity. Human ortholog(s) of this gene are implicated in trimethylaminuria. Is an ortholog of human FMO2 (flavin containing dimethylaniline monoxygenase 2) and FMO5 (flavin containing dimethylaniline monoxygenase 5).

WB:WBGene00016729	C46H11.3
Is predicted to have actin filament binding activity. Is an ortholog of human ARPC5 (actin related protein 2/3 complex subunit 5) and ARPC5L (actin related protein 2/3 complex subunit 5 like).

WB:WBGene00016730	C46H11.6
Is expressed in anal depressor muscle; body wall musculature; intestine; and vulval muscle. Is predicted to encode a protein with the following domain: Uncharacterized protein T15H9.4-like.

WB:WBGene00016731	C46H11.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00016732	phat-1
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AR; g1P; and pharyngeal gland cell.

WB:WBGene00016733	phat-2
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AL; g1AR; g1P; g2L; and g2R.

WB:WBGene00016734	C46H11.10
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00016735	fhod-1
Is expressed in muscle cell; pharyngeal muscle cell; and seam cell. Is predicted to encode a protein with the following domains: Formin Homology 2 Domain; Armadillo-like helical; Formin, FH2 domain; Armadillo-type fold; and Formin, FH2 domain superfamily. Is an ortholog of human FHOD1 (formin homology 2 domain containing 1) and FHOD3 (formin homology 2 domain containing 3).

WB:WBGene00016737	miro-2
Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00016738	C47D2.1
Is enriched in head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and isp-1 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00016739	pitr-1
Is predicted to have sodium:inorganic phosphate symporter activity. Is expressed in several structures, including body wall musculature; hermaphrodite gonad; intestine; nerve ring; and pharynx. Human ortholog(s) of this gene are implicated in basal ganglia calcification. Is an ortholog of human SLC20A1 (solute carrier family 20 member 1) and SLC20A2 (solute carrier family 20 member 2).

WB:WBGene00016740	C48B6.2
Is predicted to have snoRNA binding activity. Is expressed in head neurons and pharyngeal muscle cell. Is an ortholog of human IMP3 (IMP U3 small nucleolar ribonucleoprotein 3).

WB:WBGene00016741	C48B6.3
Is expressed in germ line. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4588); Protein of unknown function DUF4588; and UPF0472 protein C16orf72-like. Is an ortholog of human C16orf72 (chromosome 16 open reading frame 72).

WB:WBGene00016742	C48B6.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016743	srb-15
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00016744	bbs-9
Localizes to ciliary basal body. Is used to study Bardet-Biedl syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 9. Is an ortholog of human BBS9 (Bardet-Biedl syndrome 9).

WB:WBGene00016745	C48B6.9
Is enriched in NSM; coelomocyte; germ line; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mianserin; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Jiraiya and Jiraiya.

WB:WBGene00016746	C48B6.10
Is enriched in C; cephalic sheath cell; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016747	nmur-1
Is predicted to have G protein-coupled receptor activity. Is an ortholog of human NMUR1 (neuromedin U receptor 1) and NMUR2 (neuromedin U receptor 2).

WB:WBGene00016748	aexr-3
Is predicted to have neuropeptide receptor activity.

WB:WBGene00016749	C48E7.1
Is enriched in hypodermis and neurons based on tiling array; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00016750	let-611
Is predicted to have DNA-directed 5'-3' RNA polymerase activity and single-stranded DNA binding activity. Is an ortholog of human POLR3C (RNA polymerase III subunit C).

WB:WBGene00016751	C48E7.6
Is enriched in GABAergic neurons; body wall muscle cell; and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including sesamin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Fraser syndrome 2. Is predicted to encode a protein with the following domain: Cadherin-like. Is an ortholog of human CSPG4 (chondroitin sulfate proteoglycan 4).

WB:WBGene00016752	C48E7.7
Is enriched in amphid sheath cell; germ line; intestine; and male-specific anatomical entity based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00016753	oac-9
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00016754	cebp-2
Is predicted to have DNA-binding transcription factor activity. Is involved in defense response to Gram-negative bacterium; regulation of lipid metabolic process; and regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in somatic cell. Is an ortholog of human CEBPG (CCAAT enhancer binding protein gamma).

WB:WBGene00016755	C49A9.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eri-1 based on microarray and RNA-seq studies. Is affected by nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00016756	C49A9.2
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; D-glucose; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF272); and Protein of unknown function DUF272.

WB:WBGene00016757	C49A9.3
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucopyranose; bisphenol A; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00016758	C49A9.4
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00016759	C49A9.5
Is enriched in FLP; head mesodermal cell; and intestine based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and lin-35 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including D-glucopyranose; bisphenol S; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00016760	C49A9.6
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including D-glucopyranose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00016761	tkr-2
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 11 with or without anosmia. Is an ortholog of human TACR1 (tachykinin receptor 1); TACR2 (tachykinin receptor 2); and TACR3 (tachykinin receptor 3).

WB:WBGene00016762	ugt-24
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00016763	C49A9.9
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF272); and Protein of unknown function DUF272.

WB:WBGene00016764	C49A9.10
Is enriched in AFD; GABAergic neurons; coelomocyte; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; npr-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; stavudine; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Oxidoreductase-like protein, N-terminal; Oxidoreductase-like, N-terminal; and Oxidoreductase-like domain-containing protein 1. Is an ortholog of human OXLD1 (oxidoreductase like domain containing 1).

WB:WBGene00016765	C49C8.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016766	C49C8.2
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including aldicarb; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00016767	C49C8.3
Is enriched in AVK; germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00016768	cyp-33E1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00016769	C49C8.5
Is involved in innate immune response.

WB:WBGene00016770	C49C8.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by sesamin; glycine; and adsorbable organic bromine compound based on microarray and RNA-seq studies.

WB:WBGene00016771	C49D10.1
No description available

WB:WBGene00016772	nhr-166
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons.

WB:WBGene00016773	oac-10
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00016775	C49D10.7
Is enriched in NSM and neurons based on tiling array and microarray studies. Is affected by several genes including clk-1; cyc-1; and ain-2 based on microarray and tiling array studies. Is affected by resveratrol; Atrazine; and Sirolimus based on microarray studies.

WB:WBGene00016776	oac-11
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00016777	nhr-261
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00016778	nep-3
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00016779	sdz-7
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including tryptophan; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00016781	C49G7.3
Is enriched in germ line; intestine; and mechanosensory neurons based on proteomic; tiling array; and microarray studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00016782	phat-3
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AR; g1P; and pharyngeal gland cell.

WB:WBGene00016783	irg-2
Is involved in defense response to Gram-negative bacterium and innate immune response.

WB:WBGene00016785	C49G7.7
Is enriched in CEPshDL; CEPshDR; CEPshVL; and CEPshVR based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00016786	cyp-35A4
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in response to xenobiotic stimulus. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00016788	C49G7.10
Is involved in innate immune response.

WB:WBGene00016789	djr-1.2
Is predicted to have protein deglycase activity. Is involved in several processes, including cellular response to aldehyde; glyoxal metabolic process; and monocarboxylic acid biosynthetic process. Localizes to cytoplasm. Is expressed in several structures, including excretory canal; inner labial neurons; phasmid neurons; rectal gland cell; and ventral nerve cord. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in Parkinson's disease 7. Is an ortholog of human PARK7 (Parkinsonism associated deglycase).

WB:WBGene00016790	C49H3.3
Is predicted to have basal RNA polymerase II transcription machinery binding activity. Is an ortholog of human LLPH (LLP homolog, long-term synaptic facilitation factor).

WB:WBGene00016791	C49H3.4
Is predicted to have U7 snRNA binding activity. Is an ortholog of human LSM11 (LSM11, U7 small nuclear RNA associated).

WB:WBGene00016792	C49H3.6
Localizes to cytoplasm. Is expressed in intestinal muscle and ventral nerve cord. Is an ortholog of human CTTNBP2NL (CTTNBP2 N-terminal like).

WB:WBGene00016793	arp-11
Is predicted to contribute to cytoskeletal protein-membrane adaptor activity. Localizes to dynactin complex. Is an ortholog of human ACTR10 (actin related protein 10).

WB:WBGene00016794	C49H3.9
Is predicted to have zinc ion binding activity. Is an ortholog of human ZC3HC1 (zinc finger C3HC-type containing 1).

WB:WBGene00016795	C49H3.12
Is enriched in AFD and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00016796	cec-2
Is enriched in several structures, including AFD; amphid sheath cell; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chromo/chromo shadow domain and Chromo-like domain superfamily.

WB:WBGene00016797	C50A2.3
Is enriched in GABAergic neurons; PLM; dopaminergic neurons; excretory cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016798	ets-8
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Human ortholog(s) of this gene are implicated in acute myeloid leukemia and craniosynostosis. Is an ortholog of human ETV1 (ETS variant transcription factor 1); ETV4 (ETS variant transcription factor 4); and ETV5 (ETS variant transcription factor 5).

WB:WBGene00016799	C50C3.1
Is predicted to have metal ion binding activity.

WB:WBGene00016800	C50C3.2
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including bone development disease (multiple); intrinsic cardiomyopathy (multiple); and myopathy (multiple).

WB:WBGene00016801	C50C3.5
Is predicted to have calcium ion binding activity.

WB:WBGene00016803	bath-42
Is predicted to have ubiquitin protein ligase binding activity. Is expressed in intestine; pharyngeal muscle cell; seam cell; and vulval muscle. Is an ortholog of human SPOP (speckle type BTB/POZ protein).

WB:WBGene00016804	C50C3.12
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies.

WB:WBGene00016805	C50D2.1
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016806	C50D2.2
Is predicted to have transmembrane transporter activity. Is expressed in head. Human ortholog(s) of this gene are implicated in cystinuria and lysinuric protein intolerance. Is an ortholog of human SLC7A4 (solute carrier family 7 member 4).

WB:WBGene00016807	txt-1
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ superfamily; and Uncharacterized protein T15H9.4-like.

WB:WBGene00016808	C50D2.5
Is predicted to have RNA binding activity. Is an ortholog of human SF3B6 (splicing factor 3b subunit 6).

WB:WBGene00016809	C50D2.6
Is enriched in body wall musculature; intestine; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray and RNA-seq studies. Is affected by ten chemicals including bisphenol S; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016810	C50D2.7
Is predicted to have ADP-specific glucokinase activity and metal ion binding activity. Is an ortholog of human ADPGK (ADP dependent glucokinase).

WB:WBGene00016811	luc-7L3
Is predicted to have mRNA binding activity. Is an ortholog of human LUC7L3 (LUC7 like 3 pre-mRNA splicing factor).

WB:WBGene00016812	C50D2.9
Is predicted to have [acyl-carrier-protein] S-malonyltransferase activity. Is an ortholog of human MCAT (malonyl-CoA-acyl carrier protein transacylase).

WB:WBGene00016813	clec-214
Is predicted to have carbohydrate binding activity.

WB:WBGene00016815	clec-213
Is predicted to have carbohydrate binding activity.

WB:WBGene00016816	C50E3.5
Is enriched in OLL; PVD; germ line; and germline precursor cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including aldicarb; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00016817	C50E3.6
Is enriched in ASER; GABAergic neurons; PLM; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including allantoin; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016818	C50E3.7
Is affected by several genes including eat-2; sir-2.1; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016820	C50E3.9
Is affected by several genes including clk-1; eat-2; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016821	scl-26
Is affected by rsr-2 based on tiling array studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00016822	C50E3.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Zidovudine; and tert-Butylhydroperoxide based on RNA-seq and microarray studies.

WB:WBGene00016823	C50E3.12
Is enriched in AB and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including D-glucose; bisphenol A; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016824	C50E3.13
Is enriched in AB and germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00016825	C50E10.1
Is enriched in DA neuron; I5 neuron; SAB; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-two chemicals including methylmercury hydroxide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00016826	C50E10.2
Is enriched in Z1; Z4; and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including tryptophan; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00016827	sre-53
Is expressed in head. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016828	sre-52
Is expressed in PVT. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016829	sre-54
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016830	sre-55
Is affected by several genes including clk-1; sir-2.1; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016831	sre-56
Is expressed in head. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016832	sre-49
Is affected by several genes including clk-1; eat-2; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016833	sre-51
Is expressed in head neurons. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016834	sre-50
Is enriched in body wall musculature and ray based on microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00016835	C50F2.1
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including indole; Alovudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00016836	C50F2.2
Is enriched in AVA; GABAergic neurons; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00016837	syf-1
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; HAT (Half-A-TPR) repeat; and Tetratricopeptide-like helical domain superfamily. Is an ortholog of human XAB2 (XPA binding protein 2).

WB:WBGene00016838	C50F2.4
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies.

WB:WBGene00016839	C50F2.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016840	C50F2.7
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; bisphenol S; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: CD164-related protein.

WB:WBGene00016841	magu-3
Is predicted to have kinase activity. Is expressed in tail. Is an ortholog of human MPP6 (membrane palmitoylated protein 6).

WB:WBGene00016842	npr-35
Is predicted to have G protein-coupled receptor activity. Is expressed in AIYL and AIYR.

WB:WBGene00016843	C50F7.3
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including aldicarb; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T15H9.4-like.

WB:WBGene00016844	sucg-1
Is predicted to have succinate-CoA ligase (GDP-forming) activity. Is an ortholog of human SUCLG2 (succinate-CoA ligase GDP-forming subunit beta).

WB:WBGene00016845	C50F7.5
Is enriched in head mesodermal cell; intestine; mechanosensory neurons; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirty-five chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00016846	C50F7.6
Is enriched in AFD; GABAergic neurons; body wall muscle cell; body wall musculature; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Zidovudine; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human PDZD4 (PDZ domain containing 4); PDZRN3 (PDZ domain containing ring finger 3); and PDZRN4 (PDZ domain containing ring finger 4).

WB:WBGene00016847	C50F7.9
Is enriched in NSM and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by glycine and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016848	klo-1
Is predicted to have beta-glucosidase activity. Is expressed in excretory canal; excretory cell; and intestine. Human ortholog(s) of this gene are implicated in congenital lactase deficiency. Is an ortholog of human LCTL (lactase like).

WB:WBGene00016849	acs-21
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in combined malonic and methylmalonic acidemia. Is an ortholog of human ACSF3 (acyl-CoA synthetase family member 3).

WB:WBGene00016850	srt-8
Is expressed in ASIL and ASIR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016851	srt-71
Is affected by mir-34; eri-1; and let-60 based on microarray studies.

WB:WBGene00016852	srt-7
Is expressed in AWAL; AWAR; AWC-ON; and in male. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016853	srt-9
Is affected by mir-34 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00016854	srt-10
Is affected by tatn-1 based on RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00016855	C50H11.8
Is enriched in AFD; ASER; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; rrf-1; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by allantoin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00016856	srt-15
Is affected by several genes including clk-1; hpl-2; and mir-34 based on tiling array and microarray studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016857	srt-16
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by estrogen; Progesterone; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016858	C50H11.13
Is enriched in AVE and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and mex-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016859	srt-5
Is affected by drh-3 based on RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00016860	cyp-33C9
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2A13 (cytochrome P450 family 2 subfamily A member 13) and CYP2A6 (cytochrome P450 family 2 subfamily A member 6).

WB:WBGene00016861	C50H11.17
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including lin-15B; hpl-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by tryptophan; multi-walled carbon nanotube; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00016862	cest-32
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00016863	cest-35.2
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES5A (carboxylesterase 5A).

WB:WBGene00016864	C52A10.3
Is enriched in AVE and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016865	ets-9
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Human ortholog(s) of this gene are implicated in acute myeloid leukemia and craniosynostosis. Is an ortholog of human GABPA (GA binding protein transcription factor subunit alpha).

WB:WBGene00016866	coel-1
Is predicted to have alpha-tubulin binding activity. Is expressed in head; tail neurons; and touch receptor neurons. Is an ortholog of human TBCEL (tubulin folding cofactor E like).

WB:WBGene00016867	C52B9.4
Is enriched in AFD and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; let-7; and gld-1 based on tiling array; proteomic; and RNA-seq studies. Is affected by six chemicals including Atrazine; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Lung seven transmembrane receptor; Tumour necrosis factor-like domain superfamily; and Transmembrane protein GPR107/GPR108-like. Is an ortholog of human TMEM87A (transmembrane protein 87A) and TMEM87B (transmembrane protein 87B).

WB:WBGene00016868	C52B9.8
Is enriched in several structures, including cephalic sheath cell; germline precursor cell; head mesodermal cell; hypodermis; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sek-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by D-glucose; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Spermine/spermidine synthase domain and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00016869	C52B9.10
Is enriched in AFD; ASER; PLM; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including alg-1; drh-3; and ubc-9 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00016870	ets-10
Is enriched in OLL; PVD; and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; elt-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including D-glucose; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Winged helix DNA-binding domain superfamily.

WB:WBGene00016871	inso-1
Is predicted to have cullin family protein binding activity. Localizes to cell junction and striated muscle dense body. Human ortholog(s) of this gene are implicated in myoclonic dystonia 26. Is an ortholog of human KCTD5 (potassium channel tetramerization domain containing 5).

WB:WBGene00016872	dop-4
Exhibits dopamine neurotransmitter receptor activity. Is involved in adenylate cyclase-activating dopamine receptor signaling pathway. Is expressed in intestine; neurons; rectum; and vulva. Is used to study alcohol use disorder.

WB:WBGene00016873	C52B11.4
Is affected by several genes including dpy-10; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00016874	C52B11.5
Is predicted to have GTPase activity.

WB:WBGene00016877	C52D10.3
Is enriched in NSM; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: N-terminal domain of unknown function (DUF4140); Domain of unknown function (DUF4139); Conserved hypothetical protein CHP02231; Domain of unknown function DUF4140; and Domain of unknown function DUF4139.

WB:WBGene00016878	C52D10.5
No description available

WB:WBGene00016879	cnnm-1
Is predicted to have transmembrane transporter activity. Is involved in several processes, including determination of adult lifespan; magnesium ion homeostasis; and positive regulation of vulval development. Localizes to basolateral plasma membrane. Is expressed in several structures, including body wall musculature; hypodermis; intestine; pharynx; and rectum. Human ortholog(s) of this gene are implicated in Jalili syndrome and renal hypomagnesemia 6. Is an ortholog of human CNNM2 (cyclin and CBS domain divalent metal cation transport mediator 2) and CNNM4 (cyclin and CBS domain divalent metal cation transport mediator 4).

WB:WBGene00016880	fbxb-95
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016881	C52E2.2
Is enriched in cephalic sheath cell and dopaminergic neurons based on tiling array studies. Is affected by several genes including rrf-3; sir-2.1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin; Diazinon; and Sirolimus based on microarray studies.

WB:WBGene00016882	C52E2.3
Is affected by several genes including sir-2.1; mut-2; and let-418 based on microarray and RNA-seq studies. Is affected by four chemicals including aldicarb; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00016883	C52E2.4
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00016884	C52E2.5
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00016885	fbxb-97
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercuric chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016886	fbxb-96
Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; indole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00016887	C52E2.8
No description available

WB:WBGene00016888	znf-598
Is enriched in AFD; AVA; germ line; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Human ZNF598 exhibits ribosome binding activity and ubiquitin protein ligase activity. Is predicted to encode a protein with the following domains: Zinc finger, C3HC4 type (RING finger); Zinc finger, RING/FYVE/PHD-type; and Zinc finger C2H2-type. Is an ortholog of human ZNF598 (zinc finger protein 598, E3 ubiquitin ligase).

WB:WBGene00016889	lst-6
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 49 and polycystic kidney disease 1. Human DENND5B exhibits Rab guanyl-nucleotide exchange factor activity. Is predicted to encode a protein with the following domains: dDENN domain; DENN (AEX-3) domain; RUN domain; PLAT/LH2 domain; uDENN domain; PLAT/LH2 domain; cDENN domain; RUN domain; dDENN domain; uDENN domain; PLAT/LH2 domain superfamily; RUN domain superfamily; and DENN domain, C-terminal lobe. Is an ortholog of human DENND5A (DENN domain containing 5A) and DENND5B (DENN domain containing 5B).

WB:WBGene00016890	lst-5
Is expressed in several structures, including P5.paa; P5.pap; P5.ppa; P5.ppp; and P7.paa. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00016891	C53A3.1
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016892	pgph-3
Is predicted to have phosphatase activity. Is an ortholog of human PDXP (pyridoxal phosphatase) and PGP (phosphoglycolate phosphatase).

WB:WBGene00016893	C53B7.2
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including Ethanol; manganese chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00016894	C53B7.3
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; Rotenone; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016895	C53B7.6
Is affected by several genes including daf-2; clk-1; and lem-2 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride and Tunicamycin based on microarray studies.

WB:WBGene00016896	nep-4
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00016898	clik-2
Is enriched in pharyngeal muscle cell and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by nineteen chemicals including 1-methylnicotinamide; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Calponin family repeat; and Calponin repeat.

WB:WBGene00016899	C53C11.1
Is enriched in FLP; NSM; and germ line based on microarray; RNA-seq; and tiling array studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by six chemicals including allantoin; metformin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Sterile alpha motif/pointed domain superfamily.

WB:WBGene00016900	C53C11.2
Is enriched in dopaminergic neurons; head mesodermal cell; hypodermis; intestine; and mechanosensory neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Mianserin; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00016901	C53C11.4
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including eat-2; mex-1; and dpy-21 based on RNA-seq studies. Is affected by aldicarb and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: GETHR pentapeptide repeat (5 copies) and GETHR pentapeptide repeat.

WB:WBGene00016902	C53D5.1
Is enriched in germ line; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and fog-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Cry5B; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Protein-kinase domain of FAM69 and FAM69, protein-kinase domain. Is an ortholog of human DIPK1C (divergent protein kinase domain 1C).

WB:WBGene00016903	marc-4
Is predicted to have MHC protein binding activity and ubiquitin protein ligase activity.

WB:WBGene00016905	ztf-3
Is expressed in ASEL; ASER; neurons; pharynx; and rectum. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00016906	C53D5.5
Is predicted to have glutathione hydrolase activity and peptidyltransferase activity. Human ortholog(s) of this gene are implicated in gamma-glutamyl transpeptidase deficiency. Is an ortholog of human GGT1 (gamma-glutamyltransferase 1).

WB:WBGene00016907	C53H9.2
Is predicted to have GTPase activity. Is an ortholog of human LSG1 (large 60S subunit nuclear export GTPase 1).

WB:WBGene00016909	frpr-4
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in PVM; muscle cell; and neurons. Is an ortholog of human GPR139 (G protein-coupled receptor 139).

WB:WBGene00016911	drn-1
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is expressed in AIYL; AIYR; dorsal nerve cord; interneuron; and tail ganglion. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4. Is an ortholog of human DIRAS1 (DIRAS family GTPase 1) and DIRAS2 (DIRAS family GTPase 2).

WB:WBGene00016912	clec-86
Is predicted to have carbohydrate binding activity. Is involved in innate immune response. Is an ortholog of human REG3A (regenerating family member 3 alpha).

WB:WBGene00016913	lam-2
Is involved in positive regulation of locomotion. Human ortholog(s) of this gene are implicated in several diseases, including Pierson syndrome; amelogenesis imperfecta type 1A; and junctional epidermolysis bullosa (multiple). Is an ortholog of human LAMC1 (laminin subunit gamma 1).

WB:WBGene00016914	C54D1.7
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00016915	C54D2.1
Is enriched in GABAergic neurons and hypodermis based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercury hydroxide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EB module and EB domain.

WB:WBGene00016916	C54D2.2
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by 1-methylnicotinamide and D-glucose based on RNA-seq studies.

WB:WBGene00016917	C54E4.1
Is enriched in neurons and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including pgl-1; prg-1; and nhr-25 based on RNA-seq and microarray studies. Is affected by Chlorpyrifos and Microcystin-LR based on microarray studies.

WB:WBGene00016918	test-1
Is predicted to have calcium ion binding activity. Is an ortholog of human SPOCK2 (SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2) and SPOCK3 (SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3).

WB:WBGene00016919	C54E4.4
Is enriched in NSM; OLL; PVD; RIS; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00016920	C54E4.5
Is predicted to have inositol oxygenase activity. Is an ortholog of human MIOX (myo-inositol oxygenase).

WB:WBGene00016921	C54F6.3
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00016922	swt-2
Is predicted to have sugar transmembrane transporter activity. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).

WB:WBGene00016923	C54F6.5
Is enriched in body wall musculature; dopaminergic neurons; germ line; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00016924	C54F6.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including tryptophan; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016925	srb-18
Is predicted to have olfactory receptor activity.

WB:WBGene00016926	nhr-171
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016927	nhr-172
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00016928	srb-19
Is predicted to have olfactory receptor activity.

WB:WBGene00016929	C54F6.12
Is enriched in amphid sheath cell; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00016930	madf-6
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: MADF domain.

WB:WBGene00016931	C54G6.2
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Tubulin binding cofactor C; Tubulin binding cofactor C-like domain; Cyclase-associated protein CAP/septum formation inhibitor MinC, C-terminal; and TBCC domain-containing protein 1.

WB:WBGene00016932	C54G6.3
Is enriched in DA neuron; NSM; VA neuron; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; dpy-7; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016933	C54G7.1
Is enriched in DA neuron; VA neuron; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including tryptophan; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00016934	mboa-3
Is predicted to have transferase activity, transferring acyl groups. Is an ortholog of human MBOAT1 (membrane bound O-acyltransferase domain containing 1) and MBOAT2 (membrane bound O-acyltransferase domain containing 2).

WB:WBGene00016935	ifta-1
Is involved in chemotaxis; intraciliary transport; and non-motile cilium assembly. Localizes to axoneme and ciliary basal body. Is expressed in amphid neurons; inner labial neurons; outer labial neurons; and phasmid neurons. Human ortholog(s) of this gene are implicated in Sensenbrenner syndrome and short-rib thoracic dysplasia 7 with or without polydactyly. Is an ortholog of human WDR35 (WD repeat domain 35).

WB:WBGene00016936	C54H2.2
No description available

WB:WBGene00016937	tag-294
Is predicted to have metal ion binding activity. Is an ortholog of human RYBP (RING1 and YY1 binding protein) and YAF2 (YY1 associated factor 2).

WB:WBGene00016938	C54H2.4
Is enriched in dopaminergic neurons and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00016939	C55B6.1
Is predicted to have glycerol kinase activity. Is an ortholog of human GK5 (glycerol kinase 5).

WB:WBGene00016940	C55B6.4
Is enriched in NSM; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; lin-4; and lin-14 based on microarray and tiling array studies.

WB:WBGene00016941	C55B6.5
Is affected by several genes including sir-2.1; hpl-2; and drh-3 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein kinase-like domain superfamily.

WB:WBGene00016942	C55B7.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00016943	acdh-1
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in E lineage cell. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADSB (acyl-CoA dehydrogenase short/branched chain).

WB:WBGene00016944	uri-1
Is predicted to have chromatin binding activity; phosphatase inhibitor activity; and transcription corepressor activity. Is involved in several processes, including germ-line stem cell division; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; and positive regulation of cell cycle. Is expressed in germ line. Is an ortholog of human URI1 (URI1 prefoldin like chaperone).

WB:WBGene00016945	sulp-1
Is predicted to have transmembrane transporter activity. Is expressed in body wall musculature; excretory cell; hypodermis; intestine; and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of several human genes including SLC26A1 (solute carrier family 26 member 1); SLC26A10 (solute carrier family 26 member 10); and SLC26A7 (solute carrier family 26 member 7).

WB:WBGene00016946	C55B7.10
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016947	C55B7.11
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00016948	scrt-1
Is affected by several genes including daf-2; eat-2; and pal-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; bisphenol S; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00016949	C55C2.3
Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Tunicamycin; paraquat; and Colistin based on microarray studies.

WB:WBGene00016950	C55C2.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Cry5B; and paraquat based on microarray studies.

WB:WBGene00016951	C55C3.1
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in hyperalphalipoproteinemia 1. Is an ortholog of human BPI (bactericidal permeability increasing protein) and LBP (lipopolysaccharide binding protein).

WB:WBGene00016953	C55C3.3
Is enriched in germ line; neurons; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including nicotinic acid; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00016954	C55C3.4
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00016955	perm-5
Is predicted to have lipid binding activity. Is expressed in several structures, including vulval cell; vulval cell; vulval cell; vulval cell; and vulval cell.

WB:WBGene00016956	C55C3.6
Is enriched in AVA; DA neuron; VA neuron; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00016957	atic-1
Is predicted to have IMP cyclohydrolase activity and phosphoribosylaminoimidazolecarboxamide formyltransferase activity. Is an ortholog of human ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase).

WB:WBGene00016958	ilys-4
Is predicted to have lysozyme activity. Is expressed in DD neuron and neurons.

WB:WBGene00016959	C55H1.1
Is affected by several genes including clk-1; hpl-2; and pry-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00016960	vps-33.2
Is involved in spermatocyte division. Is expressed in intestine; pharynx; and spermatheca. Is used to study ARC syndrome. Human ortholog(s) of this gene are implicated in arthrogryposis, renal dysfunction, and cholestasis 1. Is an ortholog of human VPS33B (VPS33B late endosome and lysosome associated).

WB:WBGene00016961	vps-32.1
Localizes to endosome membrane. Is expressed in gonad; neurons; and vulva. Human ortholog(s) of this gene are implicated in cataract 31 multiple types. Is an ortholog of human CHMP4B (charged multivesicular body protein 4B).

WB:WBGene00016962	C56C10.4
Is enriched in ASER; PLM; and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00016963	C56C10.6
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016964	C56C10.7
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-12; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF974) and Trafficking protein particle complex subunit 13. Is an ortholog of human TRAPPC13 (trafficking protein particle complex 13).

WB:WBGene00016965	C56C10.9
Is predicted to have calcium ion binding activity. Is an ortholog of human SDF4 (stromal cell derived factor 4).

WB:WBGene00016966	aipr-1
Is expressed in several structures, including amphid sheath cell; dorsal nerve cord; neurons; oocyte; and spermatheca. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Leber congenital amaurosis 4; and growth hormone secreting pituitary adenoma. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and AIP/AIPL1. Is an ortholog of human AIP (aryl hydrocarbon receptor interacting protein).

WB:WBGene00016968	epg-5
Is involved in macroautophagy and negative regulation of autophagosome assembly. Localizes to cytoplasm. Is expressed in several structures, including body wall musculature; head; intestine; pharyngeal muscle cell; and tail. Human ortholog(s) of this gene are implicated in Vici syndrome. Is an ortholog of human EPG5 (ectopic P-granules autophagy protein 5 homolog).

WB:WBGene00016970	C56E6.2
Is predicted to have GTPase activity.

WB:WBGene00016971	toe-2
Is predicted to have kinase activity. Is involved in positive regulation of apoptotic process and regulation of asymmetric cell division. Is expressed in several structures, including QL.aa; QL.pp; QR.aa; QR.pp; and oxygen sensory neurons.

WB:WBGene00016972	C56E6.4
Is enriched in CEM; HOB; IL2 neuron; NSM; and ray neuron type B based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; mex-3; and fbf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including aldicarb; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Doublecortin domain and Doublecortin domain superfamily.

WB:WBGene00016973	abch-1
Is predicted to have ATPase-coupled transmembrane transporter activity. Is expressed in head. Human ortholog(s) of this gene are implicated in sitosterolemia. Is an ortholog of human ABCG5 (ATP binding cassette subfamily G member 5).

WB:WBGene00016974	lron-15
Is enriched in GABAergic neurons; body wall muscle cell; dopaminergic neurons; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily.

WB:WBGene00016975	nhr-173
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00016976	C56E10.3
Is enriched in amphid sheath cell; excretory cell; intestine; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Zidovudine; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00016977	akap-1
Is predicted to have RNA binding activity and protein kinase A regulatory subunit binding activity. Is expressed in several structures, including gonad and neurons. Is an ortholog of human AKAP1 (A-kinase anchoring protein 1).

WB:WBGene00016978	C56G2.3
Is predicted to have tRNA (guanine-N1-)-methyltransferase activity and tRNA binding activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 30. Is an ortholog of human TRMT10C (tRNA methyltransferase 10C, mitochondrial RNase P subunit).

WB:WBGene00016979	C56G2.4
Is enriched in NSM; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphatidylethanolamine-binding protein; Phosphatidylethanolamine-binding protein; Phosphatidylethanolamine-binding protein, eukaryotic; and PEBP-like superfamily.

WB:WBGene00016980	C56G2.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00016981	rpn-13
Exhibits ubiquitin-specific protease binding activity. Is expressed in intestine; neurons; and seam cell. Is an ortholog of human ADRM1 (adhesion regulating molecule 1).

WB:WBGene00016982	C56G2.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and aak-2 based on tiling array and RNA-seq studies. Is affected by six chemicals including stavudine; Sodium Chloride; and Rifampin based on RNA-seq studies.

WB:WBGene00016983	C56G2.15
Is predicted to have N-acetyltransferase activity and acetyl-CoA binding activity. Is an ortholog of human NAA80 (N-alpha-acetyltransferase 80, NatH catalytic subunit).

WB:WBGene00016984	npr-8
Is predicted to have neuropeptide Y receptor activity.

WB:WBGene00016985	C56G3.2
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00016987	CC8.2
Is enriched in Psub1; germ line; intestine; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is predicted to encode a protein with the following domains: Carbohydrate/starch-binding module (family 21); CBM21 (carbohydrate binding type-21) domain; Protein phosphatase 1 regulatory subunit 3B/C/D, metazoa; and CBM21 domain superfamily. Is an ortholog of human PPP1R3E (protein phosphatase 1 regulatory subunit 3E).

WB:WBGene00016988	CD4.1
Is enriched in body wall muscle cell; head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; paraquat; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00016989	mrpl-48
Is enriched in several structures, including NSM; germ line; intestine; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosomal protein S10p/S20e; Ribosomal protein S10 domain; Mitochondrial ribosomal protein L48; and Ribosomal protein S10 domain superfamily. Is an ortholog of human MRPL48 (mitochondrial ribosomal protein L48).

WB:WBGene00016990	vps-37
Is involved in receptor catabolic process. Localizes to ESCRT I complex and cytosol. Is expressed in head and tail. Is an ortholog of human VPS37B (VPS37B subunit of ESCRT-I) and VPS37C (VPS37C subunit of ESCRT-I).

WB:WBGene00016992	zhit-1
Is predicted to have histone deacetylase binding activity and nucleosome binding activity. Is an ortholog of human ZNHIT1 (zinc finger HIT-type containing 1).

WB:WBGene00016993	CD4.8
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00016995	acly-1
Is predicted to have ATP citrate synthase activity. Is an ortholog of human ACLY (ATP citrate lyase).

WB:WBGene00016996	D1005.2
Is predicted to have UTP:glucose-1-phosphate uridylyltransferase activity. Is an ortholog of human UGP2 (UDP-glucose pyrophosphorylase 2).

WB:WBGene00016997	cebp-1
Is involved in activation of MAPK activity; axon regeneration; and regulation of nervous system development. Localizes to cytoplasm; nucleus; and synapse. Is expressed in hypodermis; intestine; muscle cell; neurons; and pharynx. Human ortholog(s) of this gene are implicated in acute myeloid leukemia.

WB:WBGene00016998	D1005.4
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including hydrogen sulfide; Mianserin; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00016999	D1005.5
Is affected by several genes including lin-15B; hpl-2; and ain-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies.

WB:WBGene00017000	D1005.6
Is enriched in AVE; neurons; and ventral nerve cord based on tiling array studies. Is affected by rsr-2; dpy-21; and daf-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00017001	D1007.3
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucopyranose; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017002	D1007.4
Localizes to striated muscle dense body. Is an ortholog of human GEMIN6 (gem nuclear organelle associated protein 6).

WB:WBGene00017003	D1007.5
Is enriched in AVG; RIM; command interneuron; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Putative transmembrane protein and Uncharacterised protein family TMEM39. Is an ortholog of human TMEM39A (transmembrane protein 39A) and TMEM39B (transmembrane protein 39B).

WB:WBGene00017004	nrd-1
Is predicted to have RNA polymerase II complex binding activity. Is an ortholog of human SCAF4 (SR-related CTD associated factor 4).

WB:WBGene00017005	D1007.8
Is enriched in AVK; germ line; germline precursor cell; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Nucleic acid-binding, OB-fold.

WB:WBGene00017007	D1007.10
Is enriched in AVE; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017009	D1007.13
Is enriched in GABAergic neurons and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017010	D1007.15
Is enriched in ASER; intestine; muscle cell; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: P-type ATPase, A domain superfamily and Transmembrane protein 94. Is an ortholog of human TMEM94 (transmembrane protein 94).

WB:WBGene00017011	eaf-1
Localizes to nucleus. Is expressed in hypodermis; pharynx; tail; and vulva. Is an ortholog of human EAF1 (ELL associated factor 1) and EAF2 (ELL associated factor 2).

WB:WBGene00017012	acs-22
Is predicted to have long-chain fatty acid transporter activity and long-chain fatty acid-CoA ligase activity. Localizes to endoplasmic reticulum. Is expressed in head neurons; hypodermis; and pharynx. Is an ortholog of human SLC27A1 (solute carrier family 27 member 1) and SLC27A4 (solute carrier family 27 member 4).

WB:WBGene00017013	ensh-1
Is enriched in several structures, including Z1.p; Z4.a; cholinergic neurons; coelomocyte; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-7; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 56; congenital afibrinogenemia; and familial hypobetalipoproteinemia 2. Is predicted to encode a protein with the following domains: Fibrinogen beta and gamma chains, C-terminal globular domain; Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain; Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2; Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1; and Fibrinogen-like, C-terminal. Is an ortholog of human ANGPTL3 (angiopoietin like 3).

WB:WBGene00017014	dylt-2
Localizes to axoneme. Is expressed in inner labial neurons and outer labial neurons. Is an ortholog of human TCTEX1D2 (Tctex1 domain containing 2).

WB:WBGene00017015	D1014.2
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00017016	snap-1
Is predicted to have soluble NSF attachment protein activity and syntaxin binding activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human NAPA (NSF attachment protein alpha) and NAPB (NSF attachment protein beta).

WB:WBGene00017017	D1014.4
Is enriched in OLL; PVD; germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by Rotenone; stavudine; and Sirolimus based on RNA-seq studies.

WB:WBGene00017018	D1014.5
Is enriched in OLL and PVD based on microarray and tiling array studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Glycosyltransferase family 92; and Glycosyltransferase family 92.

WB:WBGene00017019	D1014.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017020	D1014.7
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017021	D1022.2
Is enriched in PLM; body wall muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00017022	D1022.3
Is predicted to have hydrolase activity.

WB:WBGene00017023	D1022.4
Is predicted to have hydrolase activity.

WB:WBGene00017024	D1022.5
Is predicted to have hydrolase activity.

WB:WBGene00017025	D1037.1
Is predicted to have RNA binding activity. Is an ortholog of human SON (SON DNA and RNA binding protein).

WB:WBGene00017026	ipla-4
Is predicted to have hydrolase activity.

WB:WBGene00017027	D1044.1
Is predicted to have kinase activity.

WB:WBGene00017028	dex-1
Is predicted to have calcium ion binding activity. Is involved in amphid sensory organ dendrite retrograde extension. Localizes to dendrite membrane. Is expressed in several structures, including anterior deirid sensillum; excretory system; pharynx; rectum; and socket cell.

WB:WBGene00017029	D1044.4
Is affected by several genes including daf-2; clk-1; and eri-1 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00017031	D1044.6
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and npr-1 based on RNA-seq; microarray; and proteomic studies. Is affected by seventeen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human ZNF318 (zinc finger protein 318).

WB:WBGene00017032	D1044.7
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium; Colistin; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: EB module; Lustrin, cysteine-rich repeated domain; EB domain; Cysteine-rich repeat; and Lustrin, cysteine-rich repeated.

WB:WBGene00017033	nekl-4
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human NEK10 (NIMA related kinase 10).

WB:WBGene00017034	otpl-2
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity and proton channel activity. Is expressed in neurons and pharynx. Is an ortholog of human OTOP1 (otopetrin 1) and OTOP2 (otopetrin 2).

WB:WBGene00017035	D1065.3
Is enriched in muscle cell and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00017036	D1069.1
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and sek-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00017037	D1069.3
Is enriched in several structures, including AVK; PLM; body wall musculature; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including stavudine; Humic Substances; and paraquat based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hypomyelinating leukodystrophy 5. Is predicted to encode a protein with the following domains: Phosphorylation site; Hyccin; and Hyccin. Is an ortholog of human FAM126A (family with sequence similarity 126 member A) and FAM126B (family with sequence similarity 126 member B).

WB:WBGene00017038	dmsr-4
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00017039	trk-1
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity.

WB:WBGene00017040	D1079.1
Is enriched in DD neuron; GABAergic neurons; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017041	D2007.1
Is involved in innate immune response. Is expressed in body wall musculature; head neurons; pharyngeal muscle cell; and spermatheca.

WB:WBGene00017042	D2007.2
Is expressed in head. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00017044	mrpl-18
Is predicted to have 5S rRNA binding activity. Is expressed in body wall musculature; neurons; and vulval muscle. Is an ortholog of human MRPL18 (mitochondrial ribosomal protein L18).

WB:WBGene00017045	atg-13
Is predicted to have protein kinase binding activity and protein kinase regulator activity. Is expressed in body wall musculature; nerve ring; neurons; and pharyngeal muscle cell. Is an ortholog of human ATG13 (autophagy related 13).

WB:WBGene00017046	utx-1
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; chromatin DNA binding activity; and histone demethylase activity (H3-K27 specific). Is involved in cell fate specification and histone H3-K27 demethylation. Localizes to MLL3/4 complex. Is expressed in several structures, including germ line; gonad; intestine; pharynx; and tail. Human ortholog(s) of this gene are implicated in Kabuki syndrome. Is an ortholog of human KDM6A (lysine demethylase 6A) and UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked).

WB:WBGene00017048	D2021.4
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT8 (acyl-CoA thioesterase 8).

WB:WBGene00017050	D2024.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00017051	afmd-1
Is predicted to have arylformamidase activity. Is an ortholog of human AFMID (arylformamidase).

WB:WBGene00017052	D2024.4
Is enriched in neurons and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017053	D2024.5
Localizes to endoplasmic reticulum.

WB:WBGene00017054	gstk-2
Is predicted to have glutathione peroxidase activity and glutathione transferase activity. Localizes to mitochondrion. Is expressed in body wall musculature; intestine; and pharynx. Is an ortholog of human GSTK1 (glutathione S-transferase kappa 1).

WB:WBGene00017055	D2062.1
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR2 (GLI pathogenesis related 2).

WB:WBGene00017056	D2062.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00017057	D2062.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; fluoranthene; and paraquat based on microarray studies.

WB:WBGene00017058	msrp-6
Is enriched in GABAergic neurons; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00017059	msrp-5
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00017060	D2063.1
Is predicted to have alcohol dehydrogenase (NAD+) activity. Localizes to striated muscle dense body. Human ortholog(s) of this gene are implicated in alcohol dependence and late onset Parkinson's disease.

WB:WBGene00017061	oac-12
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00017062	glrx-3
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity. Localizes to striated muscle dense body. Is an ortholog of human GLRX3 (glutaredoxin 3).

WB:WBGene00017063	mctp-1
Is predicted to have calcium ion binding activity. Is an ortholog of human MCTP1 (multiple C2 and transmembrane domain containing 1).

WB:WBGene00017064	ppfr-2
Is predicted to have protein phosphatase regulator activity. Is an ortholog of human PPP4R2 (protein phosphatase 4 regulatory subunit 2).

WB:WBGene00017065	D2092.4
Localizes to myofibril.

WB:WBGene00017066	maco-1
Is predicted to have actin filament binding activity and microtubule binding activity. Is involved in chemotaxis; neuronal signal transduction; and thermotaxis. Localizes to neuronal cell body; nuclear envelope; and rough endoplasmic reticulum. Is expressed in GABAergic neurons; nervous system; and neurons. Is an ortholog of human MACO1 (macoilin 1).

WB:WBGene00017068	D2092.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017069	timm-17B.2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tim17/Tim22/Tim23/Pmp24 family. Is an ortholog of human TIMM17A (translocase of inner mitochondrial membrane 17A) and TIMM17B (translocase of inner mitochondrial membrane 17B).

WB:WBGene00017070	praf-3
Is enriched in germ line; intestine; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; Zidovudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PRA1 family protein and Prenylated rab acceptor PRA1. Is an ortholog of human ARL6IP5 (ADP ribosylation factor like GTPase 6 interacting protein 5) and PRAF2 (PRA1 domain family member 2).

WB:WBGene00017071	aagr-1
Exhibits alpha-1,4-glucosidase activity. Is involved in glycogen catabolic process. Human ortholog(s) of this gene are implicated in congenital sucrase-isomaltase deficiency; glycogen storage disease II; and polycystic kidney disease 3. Is an ortholog of human MGAM (maltase-glucoamylase).

WB:WBGene00017072	D2096.5
Is enriched in germ line; neurons; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00017073	D2096.6
Is involved in endoplasmic reticulum unfolded protein response. Is expressed in epithelial cell; marginal cell; pharyngeal muscle cell; and pharynx.

WB:WBGene00017074	D2096.7
Is enriched in several structures, including GABAergic neurons; body wall muscle cell; coelomocyte; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017075	nap-1
Exhibits cholesterol binding activity and transcription factor binding activity. Localizes to cytoplasm and nucleus. Is an ortholog of human NAP1L1 (nucleosome assembly protein 1 like 1) and NAP1L4 (nucleosome assembly protein 1 like 4).

WB:WBGene00017076	D2096.9
Is enriched in intestine; neurons; retrovesicular ganglion; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercury hydroxide; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00017077	D2096.10
Is enriched in germ line; head mesodermal cell; hypodermis; neurons; and in male based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq; microarray; and tiling array studies. Is affected by thirteen chemicals including Mianserin; sesamin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00017078	D2096.11
Is predicted to have microtubule binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Carvajal syndrome; epidermolysis bullosa (multiple); and muscular dystrophy (multiple). Is an ortholog of human GAS2L3 (growth arrest specific 2 like 3).

WB:WBGene00017079	D2096.12
Is enriched in several structures, including Z4.a; coelomocyte; germ line; germline precursor cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; bisphenol S; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00017080	lec-12
Is predicted to have galactoside binding activity. Is an ortholog of several human genes including LGALS8 (galectin 8); LGALS9 (galectin 9); and LGALS9C (galectin 9C).

WB:WBGene00017082	DC2.5
Is enriched in several structures, including AFD; intestine; muscle cell; pharynx; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including TPEN; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 12; early infantile epileptic encephalopathy 28; and esophageal cancer. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human WWOX (WW domain containing oxidoreductase).

WB:WBGene00017083	kin-33
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human CHEK1 (checkpoint kinase 1).

WB:WBGene00017084	E01A2.1
Is predicted to have enzyme regulator activity. Is an ortholog of human GCLM (glutamate-cysteine ligase modifier subunit).

WB:WBGene00017085	E01A2.2
Is enriched in AVK; NSM; germ line; and neurons based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including D-glucose; Zidovudine; and Chlorpyrifos based on RNA-seq and microarray studies. Human SRRT exhibits RNA binding activity. Is predicted to encode a protein with the following domains: Arsenite-resistance protein 2; SERRATE/Ars2 , C-terminal; and SERRATE/Ars2. Is an ortholog of human SRRT (serrate, RNA effector molecule).

WB:WBGene00017087	E01A2.5
Is predicted to have diphthine-ammonia ligase activity. Is an ortholog of human DPH6 (diphthamine biosynthesis 6).

WB:WBGene00017088	akir-1
Is predicted to have DNA binding activity. Is expressed in hyp7 syncytium and tail neurons. Is an ortholog of human AKIRIN2 (akirin 2).

WB:WBGene00017089	poml-2
Is predicted to have arylesterase activity. Is an ortholog of human PON3 (paraoxonase 3).

WB:WBGene00017090	E01A2.8
Is affected by several genes including clk-1; eat-2; and csr-1 based on microarray and RNA-seq studies.

WB:WBGene00017091	ttr-40
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00017092	E02C12.6
Is enriched in OLL; PVD; and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including tryptophan; bisphenol A; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00017093	E02C12.8
Is enriched in AFD and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Mianserin; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679) and Uncharacterised  oxidoreductase Dhs-27.

WB:WBGene00017094	E02C12.9
Is affected by several genes including pmk-1; lin-15B; and pry-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00017095	E02C12.10
Is enriched in ASER and intestine based on RNA-seq studies. Is affected by several genes including glp-1; pgl-1; and dpy-21 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including bisphenol A; bisphenol S; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00017096	E02C12.11
Is enriched in AVA and AVE based on tiling array studies. Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; and Uncharacterised  oxidoreductase Dhs-27.

WB:WBGene00017097	E02C12.12
Is enriched in AVA; NSM; and body wall musculature based on tiling array and microarray studies. Is affected by several genes including lin-4; lin-14; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679) and Uncharacterised  oxidoreductase Dhs-27.

WB:WBGene00017098	mek-5
Is predicted to have RNA binding activity. Is expressed in head and tail. Is an ortholog of human KHDRBS2 (KH RNA binding domain containing, signal transduction associated 2).

WB:WBGene00017099	E02H9.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Zidovudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017100	E02H9.2
Is enriched in BAG; OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00017101	E02H9.3
Is enriched in DA neuron; VA neuron; germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF272); and Protein of unknown function DUF272.

WB:WBGene00017102	E02H9.4
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00017103	klo-2
Is predicted to have beta-glucosidase activity. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in congenital lactase deficiency. Is an ortholog of human LCTL (lactase like).

WB:WBGene00017104	E02H9.6
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; dpy-7; and pgl-1 based on RNA-seq studies. Is affected by seven chemicals including aldicarb; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00017105	E02H9.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017106	E02H9.9
Is enriched in AVA; AVE; dopaminergic neurons; and male-specific anatomical entity based on tiling array and microarray studies. Is affected by several genes including rrf-3; daf-12; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Transthyretin-like superfamily.

WB:WBGene00017107	srt-12
Is expressed in AWAL; AWAR; and in male. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00017108	cyp-43A1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity.

WB:WBGene00017109	clec-177
Is affected by rsr-2; rsd-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00017110	clec-176
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 based on tiling array studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and fluoranthene based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00017111	E03H12.4
Is affected by sir-2.1 and eat-2 based on microarray studies. Is affected by resveratrol and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00017112	E03H12.5
Is enriched in AVE; germ line; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017113	srz-24
Is expressed in ADLL; ADLR; ASJL; and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00017114	E03H12.7
Is enriched in body wall muscle cell; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; nicotinic acid; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00017115	E03H12.9
Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00017116	fbxb-78
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017117	fbxb-80
Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; bisphenol S; and metformin based on RNA-seq and microarray studies.

WB:WBGene00017118	E04A4.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on tiling array and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017119	timm-17B.1
Is predicted to have P-P-bond-hydrolysis-driven protein transmembrane transporter activity. Is an ortholog of human TIMM17A (translocase of inner mitochondrial membrane 17A) and TIMM17B (translocase of inner mitochondrial membrane 17B).

WB:WBGene00017120	tctn-1
Is enriched in BAG; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Joubert syndrome (multiple); Meckel syndrome 8; and orofaciodigital syndrome IV. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1619); Domain of unknown function DUF1619; and Tectonic. Is an ortholog of human TCTN1 (tectonic family member 1).

WB:WBGene00017121	cyc-2.1
Exhibits electron transfer activity. Is involved in electron transport chain. Is expressed in body wall musculature; excretory cell; intestinal cell; nervous system; and pharynx. Human ortholog(s) of this gene are implicated in thrombocytopenia. Is an ortholog of human CYCS (cytochrome c, somatic).

WB:WBGene00017122	pcrg-1
Is predicted to have Hsp70 protein binding activity; Hsp90 protein binding activity; and chaperone binding activity. Is expressed in ASE and OLQ. Is an ortholog of human PACRG (parkin coregulated).

WB:WBGene00017123	maoc-1
Exhibits identical protein binding activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is used to study obesity. Human ortholog(s) of this gene are implicated in D-bifunctional protein deficiency and Perrault syndrome. Is an ortholog of human HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4).

WB:WBGene00017124	E04F6.4
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 46. Is an ortholog of human PLD5 (phospholipase D family member 5).

WB:WBGene00017125	acdh-12
Is predicted to have fatty-acyl-CoA binding activity and very-long-chain-acyl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in very long chain acyl-CoA dehydrogenase deficiency. Is an ortholog of human ACADVL (acyl-CoA dehydrogenase very long chain).

WB:WBGene00017126	E04F6.6
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; bisphenol A; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017127	E04F6.8
Is enriched in several structures, including coelomocyte; excretory cell; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017128	E04F6.9
Is enriched in several structures, including AFD; cephalic sheath cell; dopaminergic neurons; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; nicotine; and Zidovudine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017129	E04F6.10
Is enriched in GABAergic neurons; dopaminergic neurons; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; sir-2.1; and eri-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017131	E04F6.15
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 12; early infantile epileptic encephalopathy 28; and esophageal cancer. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human WWOX (WW domain containing oxidoreductase).

WB:WBGene00017132	tofu-6
Is predicted to have RNA binding activity. Is involved in several processes, including DNA replication; embryonic cleavage; and mitotic sister chromatid separation. Is expressed in germ line.

WB:WBGene00017133	EEED8.2
Is predicted to have lipid binding activity. Is expressed in hypodermis and intestine.

WB:WBGene00017134	EEED8.3
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by fifteen chemicals including Heme; methylmercury hydroxide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00017135	EEED8.4
Is predicted to have RNA binding activity.

WB:WBGene00017136	ccpp-6
Exhibits metallocarboxypeptidase activity. Is involved in oviposition; protein deglutamylation; and proteolysis. Is an ortholog of human AGBL4 (ATP/GTP binding protein like 4).

WB:WBGene00017137	pink-1
Is predicted to have protein serine/threonine kinase activity. Is involved in several processes, including autophagy of mitochondrion; axon extension involved in axon guidance; and positive regulation of protein ubiquitination. Localizes to mitochondrion. Is expressed in hermaphrodite distal tip cell; intestine; neurons; pharynx; and vulva. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in Parkinson's disease 6. Is an ortholog of human PINK1 (PTEN induced kinase 1).

WB:WBGene00017138	EEED8.10
Is predicted to contribute to ubiquitin-protein transferase activity. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 13.

WB:WBGene00017139	clec-141
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: C-type lectin fold.

WB:WBGene00017140	EEED8.12
Is predicted to have RNA binding activity.

WB:WBGene00017141	EEED8.13
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including manganese chloride; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017142	EEED8.14
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00017143	EEED8.15
Is enriched in Z1; Z4; germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00017144	brap-2
Is predicted to have zinc ion binding activity. Is an ortholog of human BRAP (BRCA1 associated protein).

WB:WBGene00017146	EGAP1.1
Is enriched in AVA; GABAergic neurons; and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Cadmium Chloride; Sodium Chloride; and Rifampin based on RNA-seq studies.

WB:WBGene00017147	EGAP2.1
Is affected by several genes including dpy-10; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; Zidovudine; and resveratrol based on microarray and RNA-seq studies.

WB:WBGene00017148	EGAP2.2
Is enriched in body wall muscle cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00017149	EGAP4.1
Is enriched in AFD; body wall muscle cell; body wall musculature; dopaminergic neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00017150	EGAP5.1
Is expressed in nervous system.

WB:WBGene00017151	EGAP9.3
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00017152	EGAP798.1
Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by Progesterone based on microarray studies.

WB:WBGene00017153	E_BE45912.2
Is enriched in AFD; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; isp-1; and csr-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Sirolimus; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00017154	ugt-57
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00017156	F01E11.3
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Cry5B; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00017157	tyra-2
Is predicted to have adrenergic receptor activity. Is expressed in neurons. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome.

WB:WBGene00017158	hpo-10
Is expressed widely. Is predicted to encode a protein with the following domains: Phosphorylation site; SAC3/GANP family; and SAC3/GANP/THP3. Is an ortholog of human LENG8 (leukocyte receptor cluster member 8).

WB:WBGene00017159	F01F1.2
Is expressed in body wall musculature; intestine; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: Cytochrome c oxidase biogenesis protein Cmc1 like and Cytochrome c oxidase biogenesis protein Cmc1-like. Is an ortholog of human CMC1 (C-X9-C motif containing 1).

WB:WBGene00017160	F01F1.3
Is enriched in GABAergic neurons; germ line; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MIF4G-like domain superfamily and Armadillo-type fold.

WB:WBGene00017161	rabn-5
Exhibits GTPase activating protein binding activity. Is involved in molting cycle. Is an ortholog of human RABEP1 (rabaptin, RAB GTPase binding effector protein 1).

WB:WBGene00017162	ddx-23
Is predicted to have RNA binding activity. Is involved in several processes, including embryonic body morphogenesis; hermaphrodite germ-line sex determination; and pre-miRNA processing. Localizes to nucleus. Is expressed in germ cell; gonad; hypodermal cell; neurons; and ventral nerve cord. Is an ortholog of human DDX23 (DEAD-box helicase 23).

WB:WBGene00017163	dnpp-1
Exhibits identical protein binding activity. Is expressed in body wall musculature; intestine; pharynx; and vulva. Is an ortholog of human DNPEP (aspartyl aminopeptidase).

WB:WBGene00017164	eng-1
Is predicted to have mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity. Is expressed in pharyngeal cell. Is an ortholog of human ENGASE (endo-beta-N-acetylglucosaminidase).

WB:WBGene00017165	F01F1.11
Is enriched in body wall muscle cell; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein canopy homolog.

WB:WBGene00017166	aldo-2
Is predicted to have fructose-bisphosphate aldolase activity. Is expressed in several structures, including hyp7 syncytium. Human ortholog(s) of this gene are implicated in hereditary fructose intolerance syndrome. Is an ortholog of human ALDOA (aldolase, fructose-bisphosphate A) and ALDOC (aldolase, fructose-bisphosphate C).

WB:WBGene00017168	F01F1.14
Is enriched in AFD; FLP; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; tryptophan; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00017169	F01F1.15
Is enriched in head mesodermal cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on proteomic; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; TLR4 regulator and MIR-interacting MSAP; Domain of unknown function DUF3456; and Protein canopy homolog. Is an ortholog of human CNPY2 (canopy FGF signaling regulator 2).

WB:WBGene00017170	F01G12.1
Is affected by several genes including daf-2; eat-2; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by allantoin; Sirolimus; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00017172	F02C9.1
Is enriched in body wall muscle cell; cholinergic neurons; germ line; germline precursor cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including tryptophan; methylmercuric chloride; and Chlorpyrifos based on microarray studies.

WB:WBGene00017173	F02C9.2
Is affected by mir-34; ints-5; and smn-1 based on microarray and RNA-seq studies. Is affected by five chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00017174	tat-6
Is predicted to have ATPase-coupled intramembrane lipid transporter activity. Human ortholog(s) of this gene are implicated in benign recurrent intrahepatic cholestasis 1; intrahepatic cholestasis of pregnancy 1; and progressive familial intrahepatic cholestasis 1. Is an ortholog of human ATP9A (ATPase phospholipid transporting 9A (putative)) and ATP9B (ATPase phospholipid transporting 9B (putative)).

WB:WBGene00017175	irld-3
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00017176	nmur-3
Is predicted to have G protein-coupled photoreceptor activity. Is an ortholog of human GHSR (growth hormone secretagogue receptor).

WB:WBGene00017177	F02E8.4
Is enriched in GABAergic neurons; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00017178	atg-16.1
Is involved in aggrephagy. Localizes to cytoplasm. Is expressed in embryonic cell; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in inflammatory bowel disease 10. Is an ortholog of human ATG16L1 (autophagy related 16 like 1).

WB:WBGene00017179	wht-4
Is predicted to have ATPase-coupled transmembrane transporter activity. Is an ortholog of human ABCG1 (ATP binding cassette subfamily G member 1) and ABCG4 (ATP binding cassette subfamily G member 4).

WB:WBGene00017180	F02E11.2
Is enriched in ciliated neurons based on RNA-seq studies. Is affected by several genes including glp-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00017181	F02E11.3
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Sterile alpha motif/pointed domain superfamily.

WB:WBGene00017182	F02E11.4
Is affected by several genes including rrf-3; hpl-2; and drh-3 based on tiling array and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Smr domain and Smr domain superfamily.

WB:WBGene00017183	scl-15
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP1 (cysteine rich secretory protein 1); CRISP2 (cysteine rich secretory protein 2); and GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00017184	ncam-1
Is predicted to have cell-cell adhesion mediator activity. Is expressed in several structures, including GLR; PVC; cholinergic neurons; lateral ganglion; and pharyngeal neurons. Human ortholog(s) of this gene are implicated in several diseases, including Compton-North congenital myopathy; MASA syndrome; and nonsyndromic deafness (multiple). Is an ortholog of human NCAM1 (neural cell adhesion molecule 1) and NCAM2 (neural cell adhesion molecule 2).

WB:WBGene00017185	F07B7.1
Is affected by several genes including clk-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including allantoin; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00017186	F07B7.2
Is enriched in germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; allantoin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00017187	F07B7.6
No description available

WB:WBGene00017188	F07B7.7
Is affected by several genes including hpl-2; his-24; and set-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Atrazine; tetrabromobisphenol A; and Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017189	F07B7.8
Is affected by several genes including daf-16; eat-2; and dpy-7 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; multi-walled carbon nanotube; and Ag nanoparticles based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00017190	F07B7.12
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Regulator of chromosome condensation (RCC1) repeat; Regulator of chromosome condensation (RCC1) repeat; PHR domain; Regulator of chromosome condensation, RCC1; Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II; PHR; and PHR domain superfamily. Is an ortholog of human MYCBP2 (MYC binding protein 2).

WB:WBGene00017191	F07B7.13
Is enriched in body wall musculature; pharynx; somatic nervous system; tail neurons; and vulval muscle based on Chronogram studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00017192	F07B7.14
Is affected by mir-34 and mex-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00017193	F07C3.2
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by nine chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017194	F07C3.3
Is predicted to have catalytic activity.

WB:WBGene00017195	glo-4
Is predicted to have guanyl-nucleotide exchange factor activity. Is involved in negative regulation of axon extension. Localizes to axon and synapse. Is expressed in body wall musculature; intestine; muscle cell; nervous system; and pharynx. Human ortholog(s) of this gene are implicated in X-linked cone-rod dystrophy 1 and retinitis pigmentosa 3. Is an ortholog of human RCBTB1 (RCC1 and BTB domain containing protein 1) and RCBTB2 (RCC1 and BTB domain containing protein 2).

WB:WBGene00017197	F07C3.9
Is enriched in ASER; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including Tunicamycin; D-glucose; and levamisole based on microarray and RNA-seq studies.

WB:WBGene00017198	nhr-36
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00017199	clec-45
Is predicted to have carbohydrate binding activity.

WB:WBGene00017200	F07C4.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; antimycin; and Ethanol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00017201	grsp-4
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including bisphenol S; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017202	clec-46
Is enriched in DA neuron; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Heme; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00017203	F07C4.10
Is affected by several genes including lin-4; lin-14; and clk-1 based on tiling array and microarray studies. Is affected by methylmercuric chloride; Mercuric Chloride; and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00017204	F07C4.11
Is enriched in ALM; PLM; and pharynx based on microarray studies. Is affected by several genes including skn-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Tunicamycin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00017205	cest-29
Is affected by several genes including daf-16; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; stavudine; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00017206	F07C7.1
No description available

WB:WBGene00017207	fbxb-6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017208	fbxb-35
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017209	F07E5.4
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00017210	F07E5.5
Is predicted to have nucleic acid binding activity and zinc ion binding activity. Is an ortholog of human ZCCHC9 (zinc finger CCHC-type containing 9).

WB:WBGene00017211	fbxb-36
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017212	F07E5.7
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by methylmercury hydroxide; multi-walled carbon nanotube; and glycine based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017213	F07E5.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00017214	F07E5.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00017215	F07F6.1
Is predicted to have nucleic acid binding activity.

WB:WBGene00017216	F07F6.2
Is enriched in AVA; AVK; and NSM based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00017217	F07F6.4
Is predicted to have GTPase activator activity and metal ion binding activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 14. Is an ortholog of human ARFGAP2 (ADP ribosylation factor GTPase activating protein 2).

WB:WBGene00017218	dct-5
Is enriched in hypodermis and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Heme; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5332) and Protein of unknown function DUF5332.

WB:WBGene00017219	F07F6.7
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in schizophrenia. Is an ortholog of human APOL3 (apolipoprotein L3).

WB:WBGene00017220	F07F6.8
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in schizophrenia. Is an ortholog of human APOL3 (apolipoprotein L3).

WB:WBGene00017221	dgn-3
Is enriched in DA neuron; I5 neuron; SAB; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Dystroglycan (Dystrophin-associated glycoprotein 1) and Dystroglycan, C-terminal.

WB:WBGene00017222	F07G6.2
Is enriched in DA neuron; NSM; VA neuron; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including age-1; prg-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00017223	F07G6.3
Is affected by several genes including eat-2; eri-1; and rrf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017224	F07G6.5
Is affected by several genes including hpl-2; spn-4; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin and Sirolimus based on microarray studies.

WB:WBGene00017225	fbxa-52
Is enriched in hypodermis and intestine based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00017226	fbxa-53
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00017227	F07G6.8
Is enriched in NSM; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; sir-2.1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00017228	F07G11.1
Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercuric chloride; multi-walled carbon nanotube; and single-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00017229	F07G11.2
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00017230	F07G11.3
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017231	F07G11.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017232	F07G11.7
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by single-walled carbon nanotube and Sirolimus based on microarray studies.

WB:WBGene00017233	lmd-4
Is predicted to have chitin binding activity and hydrolase activity, acting on glycosyl bonds. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00017235	F08B4.3
Is enriched in OLL; PVD; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017236	nlp-60
Is expressed in ASEL; ASER; and nervous system.

WB:WBGene00017237	pole-2
Is predicted to have DNA binding activity. Is an ortholog of human POLE2 (DNA polymerase epsilon 2, accessory subunit).

WB:WBGene00017238	F08B4.7
Is predicted to have pre-mRNA 5'-splice site binding activity. Is an ortholog of human SNRPC (small nuclear ribonucleoprotein polypeptide C).

WB:WBGene00017239	F08B6.1
Is enriched in germ line; intestine; and seam cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rotenone; paraquat; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017240	calu-2
Is predicted to have calcium ion binding activity. Is expressed in body wall musculature; neurons; and pharynx. Is an ortholog of human RCN2 (reticulocalbin 2).

WB:WBGene00017241	pcyt-1
Exhibits choline-phosphate cytidylyltransferase activity. Is involved in phosphatidylcholine biosynthetic process. Is expressed in head. Is an ortholog of human PCYT1A (phosphate cytidylyltransferase 1, choline, alpha) and PCYT1B (phosphate cytidylyltransferase 1, choline, beta).

WB:WBGene00017243	F08C6.5
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017244	apy-1
Exhibits guanosine-diphosphatase activity and uridine-diphosphatase activity. Is involved in several processes, including endoplasmic reticulum unfolded protein response; nucleobase-containing compound catabolic process; and pharynx development. Localizes to membrane. Is expressed in hypodermis and pharynx. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia and multiple epiphyseal dysplasia 7. Is an ortholog of human CANT1 (calcium activated nucleotidase 1).

WB:WBGene00017245	srpa-72
Is predicted to contribute to ribosome binding activity. Is an ortholog of human SRP72 (signal recognition particle 72).

WB:WBGene00017246	F08D12.2
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00017247	F08D12.3
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00017248	F08D12.4
Is affected by several genes including eat-2; csr-1; and set-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017249	fbxb-108
Is affected by several genes including daf-2; eat-2; and alg-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017250	F08D12.7
Is expressed in several structures, including enteric muscle; hermaphrodite distal tip cell; neurons; ventral nerve cord; and vulval muscle. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00017251	fbxb-105
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017252	sdz-10
Is enriched in AVA; AVK; and NSM based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017253	sdz-9
Is enriched in RID and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017254	fbxb-111
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; eat-2; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017255	F08D12.12
Is enriched in arcade cell; neurons; pharyngeal-intestinal valve cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Sodium Chloride; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017257	F08F1.3
Is enriched in dopaminergic neurons; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by Atrazine and Humic Substances based on microarray studies.

WB:WBGene00017258	F08F1.4
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017259	F08F1.9
Is predicted to contribute to protein kinase activity. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNP (cyclin P).

WB:WBGene00017260	F08F3.1
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017261	acl-6
Is predicted to have glycerol-3-phosphate O-acyltransferase activity. Localizes to mitochondrion. Is expressed in muscle cell. Is an ortholog of human GPAM (glycerol-3-phosphate acyltransferase, mitochondrial).

WB:WBGene00017262	F08F3.4
Is predicted to have L-threonine 3-dehydrogenase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia.

WB:WBGene00017263	F08F3.6
Is expressed in germ line. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017264	F08F3.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosomal protein S5 domain 2-type fold, subgroup and Ribosomal protein S5 domain 2-type fold.

WB:WBGene00017265	snpc-1.3
Is predicted to have sequence-specific DNA binding activity. Is expressed in gonad; metacorpus; nerve ring; and terminal bulb. Is an ortholog of human SNAPC1 (small nuclear RNA activating complex polypeptide 1).

WB:WBGene00017266	F08F3.10
Is enriched in GABAergic neurons; body wall muscle cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; sir-2.1; and aak-2 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Zidovudine; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017267	numr-2
Localizes to nucleus. Is expressed in intestine; sensory neurons; uterine muscle; and vulval muscle.

WB:WBGene00017268	hmgr-1
Is predicted to have hydroxymethylglutaryl-CoA reductase (NADPH) activity and hydroxymethylglutaryl-CoA reductase activity. Is expressed in excretory cell; intestine; non-striated muscle; spermatheca; and ventral nerve cord. Is an ortholog of human HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase).

WB:WBGene00017269	F08F8.4
Is predicted to have acetyltransferase activity. Human ortholog(s) of this gene are implicated in Roberts syndrome and SC phocomelia syndrome. Is an ortholog of human ESCO2 (establishment of sister chromatid cohesion N-acetyltransferase 2).

WB:WBGene00017270	numr-1
Is expressed in egg-laying apparatus; intestine; neurons; and pharynx. Is predicted to encode a protein with the following domains: Phosphorylation site; Uncharacterized Strongylid L4 protein; and Uncharacterized strongylid L4 protein.

WB:WBGene00017271	F08F8.6
Is enriched in AFD; AVK; germ line; and in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including tryptophan; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00017272	F08F8.7
Is predicted to have metal ion binding activity and ribulose-phosphate 3-epimerase activity. Is an ortholog of human RPE (ribulose-5-phosphate-3-epimerase).

WB:WBGene00017273	gos-28
Is predicted to have SNAP receptor activity. Is expressed in intestine; seam cell; and vulva. Is an ortholog of human GOSR1 (golgi SNAP receptor complex member 1).

WB:WBGene00017274	F08F8.9
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017275	F08F8.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017277	F09C12.2
Is predicted to have ATP binding activity and MAP kinase activity. Is an ortholog of human MAPK7 (mitogen-activated protein kinase 7).

WB:WBGene00017278	F09C12.6
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00017279	F09C12.8
Is enriched in NSM; body wall musculature; germ line; and in male based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 1); Histidine phosphatase superfamily, clade-1; and Histidine phosphatase superfamily. Is an ortholog of human UBASH3B (ubiquitin associated and SH3 domain containing B).

WB:WBGene00017280	usp-39
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity and zinc ion binding activity. Is expressed in tail. Is an ortholog of human USP39 (ubiquitin specific peptidase 39).

WB:WBGene00017281	F09D12.2
Is enriched in FLP based on microarray studies. Is affected by several genes including let-60; aak-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017282	algn-2
Is predicted to have alpha-1,3-mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ii and congenital myasthenic syndrome 14. Is an ortholog of human ALG2 (ALG2 alpha-1,3/1,6-mannosyltransferase).

WB:WBGene00017283	F09E5.3
Is predicted to have deoxyribose-phosphate aldolase activity. Is an ortholog of human DERA (deoxyribose-phosphate aldolase).

WB:WBGene00017284	sec-6
Is predicted to have SNARE binding activity. Is expressed in intestine; muscle cell; and nervous system. Is an ortholog of human EXOC3 (exocyst complex component 3).

WB:WBGene00017285	F09E5.7
Is predicted to have pyridoxal phosphate binding activity.

WB:WBGene00017286	F09E5.8
Is predicted to have pyridoxal phosphate binding activity. Is an ortholog of human PLPBP (pyridoxal phosphate binding protein).

WB:WBGene00017287	F09E5.9
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by Rifampin and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00017288	F09E5.10
Is enriched in AVK; germ line; intestine; and sensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Quercetin and Humic Substances based on microarray studies.

WB:WBGene00017289	F09E5.11
Is enriched in several structures, including dopaminergic neurons; excretory cell; germ line; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by four chemicals including Rotenone; antimycin; and Humic Substances based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIp. Is predicted to encode a protein with the following domains: Endoplasmic reticulum-based factor for assembly of V-ATPase and ATPase, vacuolar ER assembly factor, Vma12. Is an ortholog of human TMEM199 (transmembrane protein 199).

WB:WBGene00017290	F09E5.12
Is enriched in AFD; ASER; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; pgl-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017291	F09E5.14
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00017292	F09E5.16
Is enriched in ASER; AVK; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017293	bmy-1
Exhibits identical protein binding activity. Is an ortholog of human MESD (mesoderm development LRP chaperone).

WB:WBGene00017294	F09E10.1
Is enriched in dopaminergic neurons and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00017295	F09E10.5
Is enriched in intestine based on microarray studies. Is affected by several genes including sir-2.1; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by four chemicals including metformin; Sirolimus; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00017296	F09E10.6
Is expressed in head. Is predicted to encode a protein with the following domain: .

WB:WBGene00017297	F09E10.7
Is enriched in neurons; somatic gonad precursor; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00017298	toca-1
Is involved in several processes, including negative regulation of protein localization to adherens junction; positive regulation of clathrin-dependent endocytosis; and positive regulation of oviposition. Localizes to cell-cell junction; intracellular vesicle; and plasma membrane. Is expressed in anchor cell and vulF. Is an ortholog of human FNBP1 (formin binding protein 1); FNBP1L (formin binding protein 1 like); and TRIP10 (thyroid hormone receptor interactor 10).

WB:WBGene00017299	molo-1
Localizes to acetylcholine-gated channel complex and neuromuscular junction. Is expressed in motor neurons; ventral nerve cord; and vulval muscle.

WB:WBGene00017300	rpc-2
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 7 with or without anosmia; hypomyelinating leukodystrophy 7 with or without oligodontia and-or hypogonadotropic hypogonadism; and hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism. Is an ortholog of human POLR3B (RNA polymerase III subunit B).

WB:WBGene00017301	hach-1
Is predicted to have 3-hydroxyisobutyryl-CoA hydrolase activity. Is an ortholog of human HIBCH (3-hydroxyisobutyryl-CoA hydrolase).

WB:WBGene00017302	F09F7.5
Is predicted to have Rho GTPase binding activity. Is an ortholog of human CDC42SE1 (CDC42 small effector 1) and CDC42SE2 (CDC42 small effector 2).

WB:WBGene00017303	F09F7.6
Is enriched in ASER; dopaminergic neurons; hypodermis; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including aldicarb; hydrogen sulfide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00017304	nmad-1
Exhibits oxidative DNA demethylase activity. Is involved in several processes, including meiotic chromosome condensation; positive regulation of organelle organization; and positive regulation of oviposition. Is expressed in muscle cell. Is an ortholog of human ALKBH4 (alkB homolog 4, lysine demethylase).

WB:WBGene00017305	nspb-12
Is enriched in arcade cell; mechanosensory neurons; pharyngeal-intestinal valve cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; D-glucose; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00017306	F09F9.1
Is enriched in FLP; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; D-glucopyranose; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017307	F09F9.2
Is enriched in germline precursor cell; hypodermis; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017308	F09F9.3
Is enriched in AFD and intestine based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017309	F09F9.4
Is enriched in cephalic sheath cell; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in multiple epiphyseal dysplasia 1 and pseudoachondroplasia. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; Thrombospondin type-1 (TSP1) repeat superfamily; and Thrombospondin type-1 domain-containing protein 1.

WB:WBGene00017310	F09G2.1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00017311	F09G2.2
Is expressed in several structures, including body wall musculature; head; intestine; pharyngeal cell; and tail. Is predicted to encode a protein with the following domains: Cyclin, N-terminal domain; Cyclin, N-terminal; and Cyclin-like superfamily. Is an ortholog of human CNPPD1 (cyclin Pas1/PHO80 domain containing 1).

WB:WBGene00017312	pitr-5
Is predicted to have sodium:inorganic phosphate symporter activity. Human ortholog(s) of this gene are implicated in basal ganglia calcification. Is an ortholog of human SLC20A1 (solute carrier family 20 member 1) and SLC20A2 (solute carrier family 20 member 2).

WB:WBGene00017313	cpsf-2
Is predicted to have RNA binding activity. Is an ortholog of human CPSF2 (cleavage and polyadenylation specific factor 2).

WB:WBGene00017314	lgc-39
Is predicted to contribute to chloride channel activity.

WB:WBGene00017315	ugt-36
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A10 (UDP glucuronosyltransferase family 1 member A10); UGT1A6 (UDP glucuronosyltransferase family 1 member A6); and UGT1A7 (UDP glucuronosyltransferase family 1 member A7).

WB:WBGene00017316	F09G2.8
Is predicted to have N-acylphosphatidylethanolamine-specific phospholipase D activity and phospholipase D activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 46. Is an ortholog of human PLD3 (phospholipase D family member 3).

WB:WBGene00017317	attf-2
Is predicted to have DNA binding activity.

WB:WBGene00017319	mrps-9
Is predicted to have RNA binding activity. Is an ortholog of human MRPS9 (mitochondrial ribosomal protein S9).

WB:WBGene00017320	F09G8.5
Is enriched in neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; D-glucose; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat; U2A'/phosphoprotein 32 family A, C-terminal; Leucine-rich repeat domain superfamily; and Cilia- and flagella-associated protein 410. Is an ortholog of human CFAP410 (cilia and flagella associated protein 410).

WB:WBGene00017321	F09G8.7
Is enriched in germ line; head mesodermal cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00017322	clec-160
Is predicted to have carbohydrate binding activity.

WB:WBGene00017323	mps-4
Exhibits potassium channel regulator activity. Is involved in regulation of potassium ion transport. Is expressed in enteric muscle; ganglia; and pharyngeal segment.

WB:WBGene00017324	F10C1.1
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is affected by dafa#1 and Sirolimus based on microarray studies.

WB:WBGene00017325	F10C1.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00017326	dmd-5
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in AVG; ventral nerve cord; and in male. Is an ortholog of human DMRTA2 (DMRT like family A2).

WB:WBGene00017327	F10C1.8
Is enriched in body wall musculature and head mesodermal cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; nicotine; and Zidovudine based on RNA-seq; proteomic; and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); epidermolysis bullosa simplex (multiple); and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site and Lamin tail domain superfamily.

WB:WBGene00017328	nemp-1
Is expressed in several structures, including arcade cell; pharyngeal cell; pharyngeal-intestinal valve; rectal gland cell; and spermatheca. Is predicted to encode a protein with the following domains: Phosphorylation site; NEMP family; and NEMP family. Is an ortholog of human NEMP1 (nuclear envelope integral membrane protein 1) and NEMP2 (nuclear envelope integral membrane protein 2).

WB:WBGene00017329	ugt-39
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A5 (UDP glucuronosyltransferase family 1 member A5); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2B10 (UDP glucuronosyltransferase family 2 member B10).

WB:WBGene00017330	sre-10
Is affected by dpy-21 and eat-2 based on RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00017331	ugt-40
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT2B17 (UDP glucuronosyltransferase family 2 member B17); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00017332	ugt-37
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00017333	ugt-38
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A6 (UDP glucuronosyltransferase family 1 member A6); UGT2B10 (UDP glucuronosyltransferase family 2 member B10); and UGT2B11 (UDP glucuronosyltransferase family 2 member B11).

WB:WBGene00017334	F10D2.8
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A9 (UDP glucuronosyltransferase family 1 member A9); UGT2B10 (UDP glucuronosyltransferase family 2 member B10); and UGT2B4 (UDP glucuronosyltransferase family 2 member B4).

WB:WBGene00017335	F10D2.10
Is enriched in body wall muscle cell; coelomocyte; germ line; head mesodermal cell; and intestine based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Ethanol; 1-methylnicotinamide; and Tunicamycin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is predicted to encode a protein with the following domains: Alpha/beta hydrolase of unknown function (DUF1057); Protein of unknown function DUF1057; and Alpha/Beta hydrolase fold.

WB:WBGene00017336	ugt-41
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A8 (UDP glucuronosyltransferase family 1 member A8); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2B15 (UDP glucuronosyltransferase family 2 member B15).

WB:WBGene00017338	F10D7.1
Is enriched in ASER; AVK; PLM; and neurons based on RNA-seq studies. Is affected by several genes including skn-1; clk-1; and aak-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00017339	mfsd-10
Is predicted to have transmembrane transporter activity. Is expressed in head. Is an ortholog of human MFSD10 (major facilitator superfamily domain containing 10).

WB:WBGene00017340	F10D7.3
Is predicted to have glutathione-disulfide reductase activity.

WB:WBGene00017341	F10D7.4
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; age-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00017342	F10D7.5
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human NEURL1 (neuralized E3 ubiquitin protein ligase 1) and NEURL1B (neuralized E3 ubiquitin protein ligase 1B).

WB:WBGene00017343	F10E7.1
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00017344	F10E7.2
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including manganese chloride; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017345	F10E7.3
Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by dafa#1 and allantoin based on microarray studies.

WB:WBGene00017347	F10E7.5
Is enriched in body wall muscle cell; germ line; neurons; somatic gonad precursor; and somatic nervous system based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by ten chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Insertion domain in 60S ribosomal protein L10P; Ribosomal protein L10; Ribosomal protein L10P; 60S ribosomal protein L10P, insertion domain; Ribosomal protein L10-like domain superfamily; and 50S ribosomal protein L10, insertion domain superfamily. Is an ortholog of human MRTO4 (MRT4 homolog, ribosome maturation factor).

WB:WBGene00017348	F10E7.6
Is enriched in germ line; germline precursor cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CCSMST1 family and CCSMST1 family.

WB:WBGene00017349	farl-11
Is involved in endoplasmic reticulum organization; epithelial tube morphogenesis; and positive regulation of endocytic recycling. Localizes to endoplasmic reticulum. Is expressed in germ line. Is an ortholog of human STRIP1 (striatin interacting protein 1) and STRIP2 (striatin interacting protein 2).

WB:WBGene00017350	F10E7.9
Is predicted to have potassium:chloride symporter activity. Is expressed in nerve ring; retrovesicular ganglion neurons; and tail neurons. Is an ortholog of human SLC12A8 (solute carrier family 12 member 8).

WB:WBGene00017351	cutl-5
Is enriched in male-specific anatomical entity and muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00017352	F10E7.11
Is predicted to have RNA polymerase II repressing transcription factor binding activity; histone deacetylase binding activity; and transcription corepressor activity. Is an ortholog of human MIER1 (MIER1 transcriptional regulator) and MIER3 (MIER family member 3).

WB:WBGene00017353	F10E9.1
Is expressed in amphid neurons and phasmid neurons.

WB:WBGene00017354	F10E9.2
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017355	F10E9.3
Is enriched in OLL; PVD; body wall muscle cell; germ line; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Uncharacterized protein F10E9.3-like.

WB:WBGene00017356	F10E9.4
Is enriched in body wall muscle cell; germ line; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including D-glucose; levamisole; and Testosterone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017357	F10E9.5
Is enriched in AVA; body wall muscle cell; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gemini of Cajal bodies-associated protein 8 and Gemini of Cajal bodies-associated protein 8. Is an ortholog of human GEMIN8 (gem nuclear organelle associated protein 8).

WB:WBGene00017358	F10E9.7
Is predicted to have catalytic activity.

WB:WBGene00017359	F10E9.10
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; pgl-1; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017360	F10E9.11
Is expressed in intestine. Is predicted to encode a protein with the following domains: rRNA processing and Fyv7/TAP26. Is an ortholog of human CCDC59 (coiled-coil domain containing 59).

WB:WBGene00017361	F10E9.12
Is enriched in excretory cell; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017362	F10G2.1
Is expressed in coelomocyte. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00017363	F10G2.2
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on RNA-seq; microarray; and proteomic studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017364	clec-7
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00017365	F10G2.4
Is enriched in dopaminergic neurons; germ line; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Tunicamycin; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00017366	F10G2.7
Is enriched in germ line and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00017367	nhr-263
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and sensory neurons based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Nuclear hormone receptor-like domain superfamily.

WB:WBGene00017369	F10G7.5
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A10 (solute carrier family 16 member 10) and SLC16A2 (solute carrier family 16 member 2).

WB:WBGene00017370	F10G7.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; npr-1; and hsp-6 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00017371	sre-39
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00017372	F10G7.9
Is predicted to have metal ion binding activity.

WB:WBGene00017373	F10G7.10
Is predicted to have ubiquitin protein ligase activity and zinc ion binding activity. Is an ortholog of human UBR3 (ubiquitin protein ligase E3 component n-recognin 3).

WB:WBGene00017374	ttr-41
Is enriched in intestine and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00017375	pbo-6
Exhibits extracellular ligand-gated ion channel activity. Is expressed in body wall musculature. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00017376	F11C7.2
Is expressed in amphid sheath cell and phasmid sheath cell. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00017378	F11C7.6
Is enriched in amphid sheath cell; head mesodermal cell; intestine; and in male based on RNA-seq studies. Is affected by several genes including hsf-1; pmk-1; and lin-15B based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including Tunicamycin; Sodium Chloride; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017379	F11C7.7
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including aak-2; hsp-6; and dpy-21 based on microarray and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; Rotenone; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00017380	F11D5.1
Is enriched in AFD; amphid sheath cell; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017381	ddr-2
Exhibits protein tyrosine kinase activity. Is involved in generation of neurons and peptidyl-tyrosine phosphorylation. Localizes to axon and plasma membrane. Is expressed in DD neuron; SAB; hypodermis; rectal gland cell; and tail. Human ortholog(s) of this gene are implicated in several diseases, including brain disease (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human DDR2 (discoidin domain receptor tyrosine kinase 2).

WB:WBGene00017382	F11D5.5
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00017383	F11D5.6
Is enriched in DA neuron; VA neuron; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by rsr-2; smg-2; and daf-2 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00017384	F11G11.4
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C27D6.3-like.

WB:WBGene00017385	F11G11.5
Is enriched in germ line; intestine; sensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Uncharacterized conserved protein (DUF2367); and Brain protein I3. Is an ortholog of human BRI3 (brain protein I3).

WB:WBGene00017386	nspd-5
Is enriched in AVK; amphid sheath cell; germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00017387	mpst-4
Is predicted to have thiosulfate sulfurtransferase activity. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00017388	F11G11.13
Is predicted to have creatine kinase activity.

WB:WBGene00017389	lgc-38
Is predicted to have GABA-A receptor activity and extracellular ligand-gated ion channel activity. Is expressed in AIYL; AIYR; head; and tail.

WB:WBGene00017390	F12A10.1
Is enriched in OLL; PLM; PVD; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq; tiling array; and microarray studies. Is affected by twenty-three chemicals including tryptophan; 1-methylnicotinamide; and Mercuric Chloride based on microarray and RNA-seq studies.

WB:WBGene00017391	F12A10.2
Is enriched in OLL; PVD; intestine; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017392	basl-2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including methylmercuric chloride; manganese chloride; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00017393	nep-5
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 5D and essential hypertension. Is an ortholog of human KEL (Kell metallo-endopeptidase (Kell blood group)).

WB:WBGene00017394	cal-8
Is predicted to have calcium ion binding activity and enzyme regulator activity.

WB:WBGene00017395	F12A10.6
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and mex-1 based on RNA-seq and microarray studies.

WB:WBGene00017396	suex-1
Is enriched in GABAergic neurons; dopaminergic neurons; excretory cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00017397	F12A10.8
Is enriched in Psub1; germ line; germline precursor cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017398	slc-17.6
Is predicted to have transmembrane transporter activity.

WB:WBGene00017399	lgc-51
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in hyperekplexia 1. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00017400	stg-2
Is involved in adult locomotory behavior and positive regulation of glutamatergic synaptic transmission. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 10.

WB:WBGene00017401	F12D9.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including pgl-1; mex-3; and glh-1 based on microarray and RNA-seq studies. Is affected by Cholestanol; Atrazine; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017402	F12E12.1
Is enriched in AFD; BAG; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Ethanol; Rotenone; and sodium arsenite based on RNA-seq and microarray studies.

WB:WBGene00017403	F12E12.2
Is affected by several genes including sir-2.1; hpl-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by allantoin based on microarray studies.

WB:WBGene00017404	F12E12.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nanoparticle; adsorbable organic bromine compound; and allantoin based on microarray studies.

WB:WBGene00017405	bath-31
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00017406	sdz-12
Is predicted to have metal ion binding activity. Is expressed in several structures, including Z1.pa; Z4.ap; dorsal uterine precursor; head muscle; and ventral uterine precursor. Human ortholog(s) of this gene are implicated in nephronophthisis 14.

WB:WBGene00017407	F12E12.6
Is enriched in Z1.p; Z4.a; body wall muscle cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rotenone and stavudine based on RNA-seq studies.

WB:WBGene00017408	sdz-11
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017410	F13A2.1
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on tiling array and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00017411	F13A2.2
Is enriched in several structures, including I5 neuron; cholinergic neurons; male distal tip cell; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; metformin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00017412	F13A2.3
Is affected by several genes including eri-1; mex-3; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00017413	F13A2.4
Is expressed in intestine; pharynx; and tail neurons.

WB:WBGene00017414	F13A2.5
Is enriched in Z1.p; Z4.a; male distal tip cell; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including sir-2.1; mex-3; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Cholestanol; Atrazine; and dafa#1 based on microarray studies.

WB:WBGene00017415	F13A2.6
Is affected by several genes including clk-1; sir-2.1; and isp-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00017416	F13B6.1
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; D-glucose; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00017417	F13B6.2
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017418	F13B6.3
Is enriched in arcade cell; head mesodermal cell; pharyngeal muscle cell; pharyngeal-intestinal valve cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Alovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00017419	sec-16A.2
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sec23-binding domain of Sec16; Vesicle coat trafficking protein Sec16 mid-region; Ancestral coatomer element 1, Sec16/Sec31; and Sec16, central conserved domain. Is an ortholog of human SEC16A (SEC16 homolog A, endoplasmic reticulum export factor).

WB:WBGene00017420	F13B9.2
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; D-glucose; and sesamin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017421	cutl-29
Is enriched in ciliated neurons and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00017422	F13C5.1
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; 4-bromodiphenyl ether; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017423	F13C5.2
Is expressed widely. Is predicted to encode a protein with the following domains: Phosphorylation site; Bromodomain; Bromodomain; and Bromodomain-like superfamily.

WB:WBGene00017424	F13C5.3
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017426	F13C5.5
Is enriched in intestine and pharyngeal muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; skn-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017427	acp-5
Is enriched in AFD; head mesodermal cell; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including bisphenol A; 4-bromodiphenyl ether; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily.

WB:WBGene00017428	F13D11.3
Is predicted to have protein tyrosine/serine/threonine phosphatase activity. Human ortholog(s) of this gene are implicated in Lafora disease; hypogonadotropic hypogonadism 19 with or without anosmia; and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human DUSP14 (dual specificity phosphatase 14).

WB:WBGene00017429	F13D11.4
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1.

WB:WBGene00017430	bcl-11
Is expressed in head; hypodermis; muscle cell; neurons; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Duane-radial ray syndrome; IVIC syndrome; and Townes-Brocks syndrome. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human BCL11A (BAF chromatin remodeling complex subunit BCL11A) and BCL11B (BAF chromatin remodeling complex subunit BCL11B).

WB:WBGene00017431	cest-33
Is predicted to have methyl indole-3-acetate esterase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES3 (carboxylesterase 3).

WB:WBGene00017432	F13H6.4
Is affected by several genes including eat-2; npr-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and 4-bromodiphenyl ether based on microarray and RNA-seq studies.

WB:WBGene00017433	F13H6.5
Is enriched in ASER; AVK; PLM; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017434	F13H8.1
Is enriched in coelomocyte; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq; tiling array; and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017435	F13H8.2
Is predicted to have snoRNA binding activity. Is expressed widely. Is an ortholog of human WDR3 (WD repeat domain 3).

WB:WBGene00017436	F13H8.3
Is affected by several genes including daf-2; glp-1; and skn-1 based on quantitative PCR; microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Tunicamycin; D-glucose; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Inosine-uridine preferring nucleoside hydrolase; Inosine/uridine-preferring nucleoside hydrolase domain; and Ribonucleoside hydrolase-like.

WB:WBGene00017437	nmgp-1
Is enriched in cephalic sheath cell; intestine; pharynx; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 4-bromodiphenyl ether; Alovudine; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Pelizaeus-Merzbacher disease and hereditary spastic paraplegia 2. Is predicted to encode a protein with the following domains: Myelin proteolipid protein (PLP or lipophilin) and Myelin proteolipid protein PLP. Is an ortholog of human GPM6A (glycoprotein M6A).

WB:WBGene00017438	F13H8.5
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including hydrogen sulfide; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00017439	F13H8.6
Is enriched in CEM; HOB; IL2 neuron; muscle cell; and ray neuron type B based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and mex-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Protein-tyrosine phosphatase-like.

WB:WBGene00017440	upb-1
Exhibits beta-ureidopropionase activity. Is involved in beta-alanine biosynthetic process via 3-ureidopropionate; thymine catabolic process; and uracil catabolic process. Localizes to striated muscle dense body. Is expressed in body wall musculature. Is an ortholog of human UPB1 (beta-ureidopropionase 1).

WB:WBGene00017441	F13H8.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including manganese chloride; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017442	F13H8.9
Is predicted to have catalytic activity. Is an ortholog of human SCLY (selenocysteine lyase).

WB:WBGene00017443	F13H8.11
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00017444	F13H8.12
Is enriched in germ line; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by four chemicals including methylmercuric chloride; manganese chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PapD-like superfamily and Immunoglobulin-like fold.

WB:WBGene00017445	sid-5
Is involved in RNA interference and RNA transport. Localizes to late endosome. Is expressed in embryonic cell; somatic cell; somatic gonad; and spermatheca.

WB:WBGene00017446	F14B8.4
Is enriched in hypodermis and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00017447	F14B8.5
Is enriched in germ line; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Rotenone; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00017448	F14B8.6
Is enriched in several structures, including AFD; intestine; male distal tip cell; pharyngeal muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017449	otpl-3
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1) and OTOP2 (otopetrin 2).

WB:WBGene00017450	bath-27
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including metformin; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00017451	lido-14
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including manganese chloride; cadmium; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00017452	bath-29
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; manganese chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00017453	F14D2.5
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including fbf-1; mex-1; and sma-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00017454	irld-5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00017455	F14D2.7
Is enriched in germ line; neurons; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including nicotinic acid; Rotenone; and Zidovudine based on RNA-seq studies.

WB:WBGene00017456	F14D2.8
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00017457	F14D2.9
No description available

WB:WBGene00017459	F14D2.11
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00017460	bath-30
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00017461	bath-28
Is enriched in germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; Zidovudine; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00017462	F14D2.14
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including elt-2; aak-2; and hsp-6 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Tunicamycin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017463	F14D12.1
Is predicted to have protein kinase binding activity. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 10 and fetal akinesia deformation sequence syndrome 1. Is an ortholog of human DOK7 (docking protein 7).

WB:WBGene00017464	sulp-2
Exhibits sulfate transmembrane transporter activity. Localizes to basolateral plasma membrane and non-motile cilium. Is expressed in dopaminergic neurons and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human SLC26A1 (solute carrier family 26 member 1); SLC26A10 (solute carrier family 26 member 10); and SLC26A2 (solute carrier family 26 member 2).

WB:WBGene00017465	F14F9.2
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including sodium arsenite; nanoparticle; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00017466	F14F9.3
Is enriched in AVA; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; Nitric Oxide; and tryptophan based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017467	F14F9.4
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017468	F14F9.5
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mianserin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Endonuclease/Exonuclease/phosphatase family; Endonuclease/exonuclease/phosphatase; and Endonuclease/exonuclease/phosphatase superfamily.

WB:WBGene00017469	F14F9.6
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Tunicamycin; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017470	F14H12.2
Is affected by several genes including daf-2; let-60; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and Psoralens based on RNA-seq studies.

WB:WBGene00017471	F14H12.3
Is enriched in FLP based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00017472	cst-1
Exhibits protein serine/threonine kinase activity. Is involved in determination of adult lifespan and muscle fiber development. Is expressed in hypodermis; sensory neurons; terminal bulb; and vulva. Is an ortholog of human STK3 (serine/threonine kinase 3).

WB:WBGene00017473	F14H12.6
Is enriched in Z1; Z4; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00017474	F14H12.7
Is enriched in several structures, including NSM; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00017475	F14H12.8
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017476	F15A8.1
Is enriched in NSM based on tiling array studies. Is affected by mir-34 and hmg-3 based on microarray and RNA-seq studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00017478	cest-26
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES3 (carboxylesterase 3).

WB:WBGene00017480	nstp-2
Is predicted to have UDP-N-acetylglucosamine transmembrane transporter activity and UDP-xylose transmembrane transporter activity. Is an ortholog of human SLC35B4 (solute carrier family 35 member B4).

WB:WBGene00017481	F15B10.3
Is enriched in Z1; Z4; germ line; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including methylmercuric chloride; Alovudine; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017482	set-9
Is predicted to have chromatin binding activity. Is involved in determination of adult lifespan. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 23. Is an ortholog of human KMT2E (lysine methyltransferase 2E (inactive)) and SETD5 (SET domain containing 5).

WB:WBGene00017483	lgc-22
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00017484	F15E6.3
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00017485	F15E6.4
Is enriched in ASER; PLM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00017486	F15E6.5
Is affected by several genes including clk-1; lin-15B; and ubc-9 based on microarray and RNA-seq studies. Is affected by Tunicamycin and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017487	F15E6.6
Is predicted to have flavin adenine dinucleotide binding activity and xanthine dehydrogenase activity. Is an ortholog of human AOX1 (aldehyde oxidase 1) and XDH (xanthine dehydrogenase).

WB:WBGene00017488	dct-7
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00017489	F15E6.9
Is enriched in germline precursor cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: P-loop containing nucleoside triphosphate hydrolase.

WB:WBGene00017490	pud-2.1
Is expressed in hypodermis and intestine. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00017491	irld-28
Is enriched in body wall muscle cell based on tiling array studies. Is affected by rsr-2; pgrn-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by cadmium and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00017492	irld-29
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by allantoin and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00017493	irld-30
Is enriched in neurons based on microarray studies. Is affected by several genes including let-60; eat-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00017494	irld-31
Is affected by several genes including drh-3; adr-1; and pgrn-1 based on RNA-seq studies. Is affected by dibromoacetic acid and Sirolimus based on microarray studies.

WB:WBGene00017496	srbc-15
Is enriched in NSM based on tiling array studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00017497	irld-32
Is affected by several genes including let-60; clk-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Tunicamycin; resveratrol; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017498	pud-4
Is expressed in hyp7 syncytium. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00017499	pud-1.1
Is expressed in hypodermis and intestine. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00017500	pud-2.2
Is expressed in hypodermis. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00017501	pud-3
Is expressed in head; hyp7 syncytium; pm3; and rectal gland cell. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00017502	F16B3.2
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017503	nhr-177
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00017504	F16B4.2
Is enriched in ASER; dopaminergic neurons; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rifampin; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00017505	F16B4.3
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017506	F16B4.4
Is expressed in hypodermis.

WB:WBGene00017507	F16B4.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017508	F16B4.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including age-1; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017509	F16B4.7
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Ag nanoparticles; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00017510	nhr-178
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in several structures, including ciliated neurons; coelomocyte; intestine; pharynx; and spermatheca.

WB:WBGene00017511	srbc-41
Is affected by several genes including daf-12; mut-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00017512	nhr-179
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in intestine; pharynx; and rectal gland cell.

WB:WBGene00017513	F16F9.1
Is enriched in GABAergic neurons; NSM; coelomocyte; excretory cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including stavudine; Zidovudine; and Humic Substances based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1C. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human LITAF (lipopolysaccharide induced TNF factor).

WB:WBGene00017514	F16F9.3
Is expressed in amphid sheath cell and phasmid sheath cell. Is predicted to encode a protein with the following domain: EF-hand domain pair.

WB:WBGene00017515	F16F9.4
Is predicted to have hydrolase activity. Is an ortholog of human AADACL3 (arylacetamide deacetylase like 3) and AADACL4 (arylacetamide deacetylase like 4).

WB:WBGene00017516	F16G10.1
Is enriched in NSM and hypodermis based on tiling array studies. Is affected by drh-3; eat-2; and spn-4 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017517	F16G10.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including elt-2; hpl-2; and drh-3 based on tiling array and RNA-seq studies. Is affected by Chlorpyrifos and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017518	F16G10.3
Is affected by rsr-2; mir-34; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017519	hpo-25
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and mdt-15 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin; sodium arsenite; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017520	F16G10.5
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including methylmercury hydroxide; methylmercuric chloride; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ domain; PDZ superfamily; and Uncharacterized protein T15H9.4-like.

WB:WBGene00017521	F16G10.6
Is enriched in NSM; intestine; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017522	F16G10.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including let-60; clk-1; and elt-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017523	F16G10.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; elt-2; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017524	F16G10.9
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017525	F16G10.10
Is enriched in pharynx and in male based on RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and let-418 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017526	F16G10.11
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Alovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017527	F16G10.13
Is enriched in AVE based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017528	F16G10.14
Is affected by several genes including eat-2; sir-2.1; and mex-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00017529	F16G10.15
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; tert-Butylhydroperoxide; and Cadmium Chloride based on microarray and RNA-seq studies.

WB:WBGene00017530	mfsd-12
Is predicted to have symporter activity. Is an ortholog of human MFSD12 (major facilitator superfamily domain containing 12).

WB:WBGene00017532	ent-5
Is predicted to have nucleoside transmembrane transporter activity. Human ortholog(s) of this gene are implicated in histiocytosis-lymphadenopathy plus syndrome. Is an ortholog of human SLC29A3 (solute carrier family 29 member 3).

WB:WBGene00017533	fbxa-178
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and aak-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; paraquat; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00017534	cwf-19L1
Is predicted to have RNA lariat debranching enzyme activator activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 17. Is an ortholog of human CWF19L1 (CWF19 like cell cycle control factor 1).

WB:WBGene00017535	atf-8
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in vulva. Is an ortholog of human TEF (TEF transcription factor, PAR bZIP family member).

WB:WBGene00017536	F17A9.4
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00017537	F17A9.5
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00017538	ceh-49
Is predicted to have DNA binding activity. Is expressed in coelomocyte; head muscle; head neurons; intestine; and somatic nervous system.

WB:WBGene00017539	F17E9.2
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017540	F17E9.3
Is involved in defense response to Gram-negative bacterium. Is expressed in seminal vesicle.

WB:WBGene00017541	F17E9.4
Is enriched in dopaminergic neurons; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by sixteen chemicals including Heme; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870); Protein of unknown function DUF870, Caenorhabditis species; and Transthyretin-like superfamily.

WB:WBGene00017542	F17E9.5
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-nine chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017543	lgc-5
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00017544	lgc-6
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion) and HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00017545	F18A1.1
Is enriched in germ line; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00017546	rpa-1
Exhibits enzyme binding activity. Is involved in positive regulation of helicase activity and positive regulation of nematode male tail tip morphogenesis. Localizes to nucleoplasm. Is expressed in germ line. Is an ortholog of human RPA1 (replication protein A1).

WB:WBGene00017547	alfa-1
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed widely. Is used to study amyotrophic lateral sclerosis. Human ortholog(s) of this gene are implicated in FTDALS1. Is an ortholog of human C9orf72 (C9orf72-SMCR8 complex subunit).

WB:WBGene00017548	F18A1.7
Is expressed in germ line. Is predicted to encode a protein with the following domains: Chondroitin proteoglycan 4 and Chondroitin proteoglycan 4.

WB:WBGene00017549	pid-1
Localizes to cytoplasm and nucleus.

WB:WBGene00017550	nep-6
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00017551	F18A12.2
Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; antimycin; and Chlorpyrifos based on microarray and RNA-seq studies.

WB:WBGene00017552	nep-7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including hydrogen sulfide; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00017553	nep-8
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00017554	nep-9
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 5D and essential hypertension.

WB:WBGene00017555	nep-10
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00017556	F18A12.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; elt-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017557	nep-11
Is predicted to have metal ion binding activity and metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension. Is an ortholog of human ECE1 (endothelin converting enzyme 1).

WB:WBGene00017559	mpz-3
Is expressed in male gonad. Is predicted to encode a protein with the following domains: PDZ superfamily and Uncharacterized protein T15H9.4-like.

WB:WBGene00017560	F18C5.5
Is enriched in OLL; PVD; germline precursor cell; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including methylmercury hydroxide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017561	F18C5.7
No description available

WB:WBGene00017562	F18C5.9
Is affected by several genes including skn-1; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00017563	F18C5.10
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00017564	srxa-4
Is affected by several genes including daf-16; lin-4; and lin-14 based on microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00017565	ddo-2
Exhibits D-aspartate oxidase activity and D-glutamate oxidase activity. Is involved in oxidation-reduction process. Is expressed in body wall musculature; intestinal cell; and pharyngeal muscle cell. Is an ortholog of human DAO (D-amino acid oxidase).

WB:WBGene00017566	F18E3.10
Is affected by several genes including sir-2.1; hpl-2; and ain-1 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00017567	F18E3.11
Is enriched in AFD; ASER; PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including hydrogen sulfide; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017568	F18E9.1
Is enriched in neurons and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017569	F18E9.3
Is enriched in germ line; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017570	F18E9.4
Is affected by several genes including daf-2; let-60; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017571	jmjd-3.1
Exhibits histone demethylase activity (H3-K27 specific). Is involved in histone H3-K27 demethylation and transdifferentiation. Localizes to nucleus. Is expressed in PDA and Y cell. Human ortholog(s) of this gene are implicated in Kabuki syndrome. Is an ortholog of human KDM6A (lysine demethylase 6A); KDM6B (lysine demethylase 6B); and UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked).

WB:WBGene00017573	F18E9.7
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017574	pxmp-4
Is expressed in head. Is predicted to encode a protein with the following domains: Tim17/Tim22/Tim23/Pmp24 family and Peroxisomal membrane protein 4. Is an ortholog of human PXMP4 (peroxisomal membrane protein 4).

WB:WBGene00017576	cdh-8
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple).

WB:WBGene00017577	F18F11.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017578	drl-1
Is predicted to have protein serine/threonine kinase activity. Is expressed in body wall musculature; neurons; seam cell; and vulval muscle.

WB:WBGene00017579	F18G5.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; daf-19; and his-72 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00017580	lgc-4
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Is an ortholog of human CHRNA10 (cholinergic receptor nicotinic alpha 10 subunit) and CHRNA9 (cholinergic receptor nicotinic alpha 9 subunit).

WB:WBGene00017581	F18G5.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including sir-2.1; dpy-21; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine; Chlorpyrifos; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00017582	F18G5.6
Is involved in innate immune response.

WB:WBGene00017583	F19B10.1
Is enriched in several structures, including Z4.a; germ line; male distal tip cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including hydrogen sulfide; Rotenone; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00017584	F19B10.2
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00017585	F19B10.3
Is affected by rsr-2; sir-2.1; and eat-2 based on tiling array and microarray studies. Is affected by Atrazine and Sirolimus based on microarray studies.

WB:WBGene00017586	F19B10.4
Is enriched in several structures, including AVA; PLM; coelomocyte; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including methylmercuric chloride; metformin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00017587	F19B10.5
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017588	F19B10.6
Is affected by several genes including clk-1; hpl-2; and ain-2 based on tiling array and microarray studies.

WB:WBGene00017589	F19B10.10
Is enriched in several structures, including germ line; head mesodermal cell; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017590	F19B10.11
Is affected by several genes including daf-12; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017591	F19C7.1
Is involved in innate immune response.

WB:WBGene00017592	F19C7.2
Is predicted to have dipeptidyl-peptidase activity. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00017593	F19C7.3
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hpl-2; and cye-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017594	F19C7.4
Is predicted to have dipeptidyl-peptidase activity. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00017597	F19C7.8
Is enriched in head mesodermal cell; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and dpy-7 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: STAC1/2/3. Is an ortholog of human STAC (SH3 and cysteine rich domain); STAC2 (SH3 and cysteine rich domain 2); and STAC3 (SH3 and cysteine rich domain 3).

WB:WBGene00017598	F19F10.1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Human ortholog(s) of this gene are implicated in acute myeloid leukemia and craniosynostosis.

WB:WBGene00017599	F19F10.3
Is enriched in amphid sheath cell; body wall muscle cell; excretory cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00017600	ttr-10
Is enriched in body wall muscle cell; head mesodermal cell; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00017601	ets-7
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Human ortholog(s) of this gene are implicated in acute myeloid leukemia and craniosynostosis. Is an ortholog of human ETV6 (ETS variant transcription factor 6).

WB:WBGene00017602	clec-211
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; mut-2; and spn-4 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine; dafa#1; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00017603	clec-212
Is predicted to have carbohydrate binding activity.

WB:WBGene00017605	sart-1
Is enriched in AVA; GABAergic neurons; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including D-glucose; Zidovudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; SART-1 family; and SNU66/SART1 family. Is an ortholog of human SART1 (spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP).

WB:WBGene00017606	ets-6
Is enriched in germ line; hypodermis; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including antimycin; Hydrolyzable Tannins; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribonuclease H-like superfamily and Protein lin-15B-like.

WB:WBGene00017607	F19F10.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sek-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribonuclease H-like superfamily and Protein lin-15B-like.

WB:WBGene00017608	ints-9
Is enriched in body wall muscle cell; germ line; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; age-1; and sma-2 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including Zidovudine; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Beta-Casp domain; Metallo-beta-lactamase superfamily domain; Metallo-beta-lactamase; Beta-Casp domain; Integrator complex subunit 9; and Ribonuclease Z/Hydroxyacylglutathione hydrolase-like. Is an ortholog of human INTS9 (integrator complex subunit 9).

WB:WBGene00017609	F19G12.1
Is predicted to have metal ion binding activity.

WB:WBGene00017610	F19G12.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Microcystin-LR based on microarray studies. Is an ortholog of human RRM2 (ribonucleotide reductase regulatory subunit M2) and RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B).

WB:WBGene00017611	F19G12.3
Is enriched in coelomocyte; pharynx; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Lithium Chloride; allantoin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: PAZ domain superfamily.

WB:WBGene00017612	F19G12.4
Is enriched in Z1; Z4; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017613	F20A1.1
Is enriched in AFD; PLM; amphid sheath cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00017614	F20A1.2
Is enriched in neurons based on microarray studies. Is affected by several genes including alg-1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017615	srsx-32
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00017616	F20A1.4
Is enriched in AFD; ASER; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by antimycin and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017618	F20A1.6
Is enriched in body wall muscle cell; dopaminergic neurons; germ line; mechanosensory neurons; and neuronal sheath cell based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by Rotenone and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00017619	F20A1.8
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including eat-2; alg-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00017620	tofu-2
Is enriched in germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by five chemicals including manganese chloride; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SPRY domain; Putative DNA-binding domain; SPRY domain; Schlafen, AlbA_2 domain; Concanavalin A-like lectin/glucanase domain superfamily; Schlafen, AlbA_2 domain superfamily; and B30.2/SPRY domain superfamily.

WB:WBGene00017621	txt-17
Is enriched in PLM; dopaminergic neurons; intestine; neuronal sheath cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00017622	F20B4.2
No description available

WB:WBGene00017625	cgt-2
Is predicted to have ceramide glucosyltransferase activity. Is expressed in intestine and vulva. Is an ortholog of human UGCG (UDP-glucose ceramide glucosyltransferase).

WB:WBGene00017626	F20B4.7
No description available

WB:WBGene00017627	F20B6.1
Is affected by several genes including daf-16; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00017628	F20B6.4
Is enriched in FLP; head mesodermal cell; intestine; and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017629	F20B6.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017630	F20B6.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017631	F20B6.7
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including aldicarb; Alovudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00017632	F20B6.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00017633	F20D6.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Cry5B; and Hydrolyzable Tannins based on microarray studies. Is predicted to encode a protein with the following domains: PDZ superfamily and Uncharacterized protein T15H9.4-like.

WB:WBGene00017634	F20D6.2
Is enriched in AVA and body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; stavudine; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00017635	F20D6.5
Is enriched in body wall musculature; intestine; neurons; and pharynx based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including levamisole; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00017636	F20D6.6
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00017637	F20D6.8
Is predicted to have GTP binding activity and calcium channel regulator activity.

WB:WBGene00017638	F20D6.9
Is predicted to have DNA binding activity and protein heterodimerization activity.

WB:WBGene00017639	F20D6.10
Is enriched in body wall muscle cell; body wall musculature; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017640	F20D6.11
Is predicted to have 2 iron, 2 sulfur cluster binding activity; flavin adenine dinucleotide binding activity; and oxidoreductase activity. Is expressed in tail. Is an ortholog of human AIFM3 (apoptosis inducing factor mitochondria associated 3).

WB:WBGene00017641	csr-1
Exhibits endoribonuclease activity, cleaving siRNA-paired mRNA. Is involved in P granule assembly; mRNA cleavage involved in gene silencing by siRNA; and mitotic sister chromatid segregation. Localizes to P granule; condensed nuclear chromosome; and metaphase plate. Is expressed in several structures, including germ line and in male.

WB:WBGene00017642	F20D12.2
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Phosphorylation site; SAC3/GANP family; and SAC3/GANP/THP3. Is an ortholog of human MCM3AP (minichromosome maintenance complex component 3 associated protein).

WB:WBGene00017643	czw-1
Localizes to RZZ complex. Is an ortholog of human ZW10 (zw10 kinetochore protein).

WB:WBGene00017644	exc-9
Is predicted to have zinc ion binding activity. Is involved in several processes, including body morphogenesis; morphogenesis of a polarized epithelium; and nematode male tail tip morphogenesis. Localizes to cytoplasm. Is expressed in several structures, including PLN; distal tip cell; excretory canal; nerve ring; and touch receptor neurons. Is an ortholog of human CRIP1 (cysteine rich protein 1).

WB:WBGene00017645	F20D12.7
Is enriched in AFD; ASER; AVK; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including ain-1; unc-70; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Humic Substances and dibromoacetic acid based on microarray studies.

WB:WBGene00017646	F20H11.1
Is predicted to have metal ion binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive osteopetrosis 6 and autosomal recessive spinocerebellar ataxia 15. Is an ortholog of human DEF8 (differentially expressed in FDCP 8 homolog).

WB:WBGene00017647	F20H11.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00017648	ddo-3
Is predicted to have D-aspartate oxidase activity and FAD binding activity. Is expressed in several structures, including coelomocyte; eggshell; excretory socket cell; non-striated muscle; and seminal vesicle. Is an ortholog of human DDO (D-aspartate oxidase).

WB:WBGene00017650	F21A9.1
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00017651	F21A9.2
Is predicted to have RNA polymerase II transcription factor binding activity.

WB:WBGene00017652	F21C10.1
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00017653	F21C10.3
Is enriched in neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Cadmium Chloride; and Cry5B based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A11. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00017654	F21C10.4
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00017655	F21C10.5
Is affected by several genes including clk-1; hpl-2; and ain-1 based on tiling array and microarray studies. Is affected by Sirolimus and allantoin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017656	F21C10.6
Is affected by several genes including sir-2.1; isp-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00017657	F21C10.7
Is enriched in body wall musculature; germ line; head mesodermal cell; male-specific anatomical entity; and muscle cell based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1KK and myopathy (multiple). Is predicted to encode a protein with the following domains: Phosphorylation site; Immunoglobulin I-set domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin-like fold; and Immunoglobulin-like domain superfamily.

WB:WBGene00017658	F21C10.9
Is predicted to have transferase activity.

WB:WBGene00017659	F21C10.10
Localizes to mitochondrion.

WB:WBGene00017660	F21C10.11
Is enriched in amphid sheath cell; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including diallyl trisulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00017661	frpr-6
Is predicted to have G protein-coupled receptor activity. Is an ortholog of human GPR139 (G protein-coupled receptor 139).

WB:WBGene00017662	F21D12.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00017663	F21D12.3
Is predicted to have amino acid transmembrane transporter activity. Is expressed in body wall musculature and motor neurons.

WB:WBGene00017664	npax-1
Is predicted to have DNA binding activity. Is expressed in head neurons.

WB:WBGene00017665	F21E9.1
No description available

WB:WBGene00017666	F21E9.2
Is enriched in GABAergic neurons; NSM; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017667	ttr-37
Is enriched in several structures, including ASER; dopaminergic neurons; head mesodermal cell; mechanosensory neurons; and pharyngeal muscle cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including diallyl trisulfide; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00017668	ins-39
Is expressed in gonad; intestine; neurons; and pharynx.

WB:WBGene00017669	F21E9.5
No description available

WB:WBGene00017670	F21E9.6
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; eri-1; and rrf-1 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00017671	pgal-1
Is predicted to have metal ion binding activity and peptidylamidoglycolate lyase activity. Is expressed in head ganglion; nervous system; and tail ganglion. Is an ortholog of human PAM (peptidylglycine alpha-amidating monooxygenase).

WB:WBGene00017672	F21F3.2
Is predicted to have MAP kinase activity. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00017673	icmt-1
Is predicted to have protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity. Is an ortholog of human ICMT (isoprenylcysteine carboxyl methyltransferase).

WB:WBGene00017674	F21F3.4
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4708) and Domain of unknown function DUF4708. Is an ortholog of human C18orf63 (chromosome 18 open reading frame 63).

WB:WBGene00017675	F21F3.6
Is enriched in germ line; germline precursor cell; intestine; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Cry5B; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017676	F21F3.7
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; aak-2; and gld-2 based on tiling array and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Eukaryotic protein of unknown function (DUF872); Protein of unknown function DUF872, transmembrane; and Transmembrane protein 134. Is an ortholog of human TMEM134 (transmembrane protein 134).

WB:WBGene00017677	asp-11
Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00017678	asp-12
Is predicted to have aspartic-type endopeptidase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00017679	F21F8.5
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Zidovudine; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00017680	F21F8.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including let-60; elt-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Sodium Chloride based on RNA-seq studies.

WB:WBGene00017681	slc-17.5
Is predicted to have transmembrane transporter activity.

WB:WBGene00017683	rbbp-5
Is involved in several processes, including histone H3-K4 methylation; oviposition; and transdifferentiation. Localizes to MLL3/4 complex. Is an ortholog of human RBBP5 (RB binding protein 5, histone lysine methyltransferase complex subunit).

WB:WBGene00017684	F21H12.2
Is enriched in dopaminergic neurons and neurons based on tiling array studies. Is affected by several genes including daf-16; sir-2.1; and cyc-1 based on microarray and RNA-seq studies.

WB:WBGene00017685	F21H12.3
Is affected by jmjd-3.1 and mir-34 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Cry5B; and Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017686	tpp-2
Is predicted to have tripeptidyl-peptidase activity. Is involved in positive regulation of lipid storage. Is expressed in intestine and nerve ring. Is an ortholog of human TPP2 (tripeptidyl peptidase 2).

WB:WBGene00017687	ets-4
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Localizes to nucleus. Is expressed in several structures, including P1; germ line; head; socket cell; and sperm. Is an ortholog of human SPDEF (SAM pointed domain containing ETS transcription factor).

WB:WBGene00017688	ttr-35
Is enriched in intestine and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on proteomic; microarray; and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00017690	ceh-60
Is predicted to have DNA binding activity. Is expressed in amphid neurons and sensory neurons. Human ortholog(s) of this gene are implicated in ceft palate, cardiac defects, and intellectual disabillity and holoprosencephaly 4. Is an ortholog of human TGIF1 (TGFB induced factor homeobox 1); TGIF2LX (TGFB induced factor homeobox 2 like X-linked); and TGIF2LY (TGFB induced factor homeobox 2 like Y-linked).

WB:WBGene00017691	ilys-5
Is predicted to have lysozyme activity.

WB:WBGene00017692	F22B7.1
Is enriched in head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; skn-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Cry5B; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017693	flp-23
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017694	F22B7.3
Is expressed in nervous system. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5390) and Protein of unknown function DUF5390.

WB:WBGene00017695	fip-1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including tryptophan; Ag nanoparticles; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00017696	polk-1
Is predicted to have DNA-directed DNA polymerase activity. Is involved in embryo development; error-prone translesion synthesis; and reproduction. Is an ortholog of human POLK (DNA polymerase kappa).

WB:WBGene00017698	F22B7.9
Is expressed in several structures, including Eala; Ealp; Eara; Earp; and Epla. Is predicted to encode a protein with the following domain: S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00017699	flcn-1
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in excretory cell; nervous system; spermatheca; and vulva. Is used to study Birt-Hogg-Dube syndrome. Human ortholog(s) of this gene are implicated in several diseases, including Birt-Hogg-Dube syndrome; Potocki-Lupski syndrome; and nonpapillary renal cell carcinoma. Is an ortholog of human FLCN (folliculin).

WB:WBGene00017700	F22D3.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00017701	F22D3.5
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by hydrogen sulfide based on microarray studies.

WB:WBGene00017702	malt-1
Is enriched in body wall muscle cell; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including levamisole; Chlorpyrifos; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: Caspase domain; Immunoglobulin I-set domain; MALT1 Ig-like domain; Death-like domain superfamily; Immunoglobulin I-set; Immunoglobulin-like fold; Caspase-like domain superfamily; Immunoglobulin-like domain superfamily; and MALT1 immunoglobulin-like domain. Is an ortholog of human MALT1 (MALT1 paracaspase).

WB:WBGene00017703	F22E5.1
Is enriched in OLL; PVD; dopaminergic neurons; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Tunicamycin; sodium arsenite; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00017704	F22E5.2
Is enriched in DA neuron; VA neuron; hypodermis; and intestine based on tiling array studies. Is affected by several genes including eat-2; pmk-1; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017705	F22E5.6
Is involved in IRE1-mediated unfolded protein response and PERK-mediated unfolded protein response. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00017706	F22E5.7
Is enriched in amphid sheath cell; body wall muscle cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00017707	F22E5.8
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD13 (potassium channel tetramerization domain containing 13) and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00017708	F22E5.9
Is expressed in several structures, including intestine.

WB:WBGene00017709	F22E5.11
Is enriched in ASER and amphid sheath cell based on RNA-seq studies. Is affected by mir-34; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00017710	F22E5.12
Is enriched in amphid sheath cell and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00017711	F22E5.13
Is enriched in Z1.p; Z4.a; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00017712	F22E5.17
Is enriched in AFD; ASER; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017713	F22E5.20
Is enriched in GABAergic neurons; hypodermis; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including hydrogen sulfide; Mianserin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00017714	F22F1.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00017715	F22F1.3
Is predicted to have transcription coregulator activity.

WB:WBGene00017716	sups-1
Is enriched in OLL; PVD; germline precursor cell; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00017717	F22F4.4
Is enriched in OLL; PVD; head mesodermal cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017718	F22F4.5
Is enriched in RID based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including Tunicamycin; sodium arsenite; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00017719	ldp-1
Is predicted to have oxidoreductase activity. Is expressed in head and tail. Is an ortholog of human SCCPDH (saccharopine dehydrogenase (putative)).

WB:WBGene00017720	F22F7.2
Is predicted to have oxidoreductase activity. Is an ortholog of human SCCPDH (saccharopine dehydrogenase (putative)).

WB:WBGene00017721	F22F7.3
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017722	F22F7.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00017723	bgnt-1.2
Is predicted to have transferase activity. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A1; congenital muscular dystrophy-dystroglycanopathy type A6; and muscular dystrophy-dystroglycanopathy type B6. Is an ortholog of human B4GAT1 (beta-1,4-glucuronyltransferase 1).

WB:WBGene00017724	F22F7.7
Is predicted to have gamma-glutamylcyclotransferase activity. Localizes to striated muscle dense body. Is an ortholog of human CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1).

WB:WBGene00017725	F22H10.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00017726	F22H10.2
Is involved in innate immune response.

WB:WBGene00017727	F22H10.3
Is enriched in head mesodermal cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucopyranose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00017729	F22H10.5
Is enriched in NSM and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00017730	F22H10.6
Is enriched in PLM; carbon dioxide sensory neurons; head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00017731	F23C8.1
Is enriched in several structures, including AVA; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017732	F23C8.3
Is enriched in muscle cell; neurons; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including glp-1; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017733	ubxn-1
Exhibits K48-linked polyubiquitin modification-dependent protein binding activity. Is involved in masculinization of hermaphroditic germ-line; positive regulation of cellular protein catabolic process; and spermatogenesis. Localizes to perinuclear region of cytoplasm. Is expressed in several structures, including gonad and spermatocyte. Is an ortholog of human UBXN1 (UBX domain protein 1).

WB:WBGene00017734	F23C8.5
Is predicted to have electron transfer activity. Human ortholog(s) of this gene are implicated in multiple acyl-CoA dehydrogenase deficiency. Is an ortholog of human ETFB (electron transfer flavoprotein subunit beta).

WB:WBGene00017735	did-2
Localizes to endosome membrane. Is expressed in several structures, including anal depressor muscle; hypodermis; intestine; nervous system; and vulva. Is an ortholog of human CHMP1B (charged multivesicular body protein 1B).

WB:WBGene00017736	F23C8.7
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00017737	F23C8.8
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human TSSK4 (testis specific serine kinase 4).

WB:WBGene00017738	tipn-1
Is predicted to have DNA binding activity. Is an ortholog of human TIPIN (TIMELESS interacting protein).

WB:WBGene00017739	F23C8.11
Is enriched in AVE based on tiling array studies. Is affected by several genes including aak-2; alg-1; and mex-3 based on RNA-seq and microarray studies. Is affected by Mianserin based on RNA-seq studies.

WB:WBGene00017741	F23C8.13
Is enriched in intestine; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Lithium Chloride; Rotenone; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is predicted to encode a protein with the following domain: PDZ superfamily.

WB:WBGene00017742	nfyc-1
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including excretory cell; gonad; head neurons; and oocyte. Is an ortholog of human NFYC (nuclear transcription factor Y subunit gamma).

WB:WBGene00017743	F23F1.2
Is predicted to have calcium ion binding activity.

WB:WBGene00017744	fbxc-54
Is enriched in body wall muscle cell; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq; microarray; and tiling array studies. Is affected by eleven chemicals including methylmercuric chloride; Psoralens; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00017745	F23F1.4
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: GM2-AP, lipid-recognition domain superfamily.

WB:WBGene00017746	F23F1.5
Is predicted to have RNA binding activity. Is expressed in head. Is an ortholog of human SNUPN (snurportin 1).

WB:WBGene00017747	F23F1.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in cystinuria; lysinuric protein intolerance; and retinitis pigmentosa 68. Is an ortholog of human SLC7A4 (solute carrier family 7 member 4).

WB:WBGene00017748	F23F1.7
Is enriched in AVK; dopaminergic neurons; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Saposin-like.

WB:WBGene00017749	rpoa-49
Is predicted to have DNA binding activity. Is an ortholog of human POLR1E (RNA polymerase I subunit E).

WB:WBGene00017750	F23F1.10
Is enriched in AFD; AVK; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by four chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq studies.

WB:WBGene00017751	F23F12.3
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00017752	sdz-15
Is involved in embryo development.

WB:WBGene00017754	F23F12.8
Is predicted to have NEDD8-specific protease activity; thiol-dependent ubiquitin-specific protease activity; and ubiquitin binding activity.

WB:WBGene00017755	zip-8
Is predicted to have DNA-binding transcription factor activity. Is expressed in intestinal cell.

WB:WBGene00017756	F23F12.12
Is enriched in AFD; ASER; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including hydrogen sulfide; Rotenone; and Deoxyglucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017757	bra-2
Is enriched in germ line and neurons based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 30. Is predicted to encode a protein with the following domain: . Is an ortholog of human ZMYND11 (zinc finger MYND-type containing 11).

WB:WBGene00017758	F23H11.2
Is predicted to have RNA polymerase I core promoter sequence-specific DNA binding activity.

WB:WBGene00017759	sucl-2
Is predicted to have nucleoside diphosphate kinase activity and succinate-CoA ligase (ADP-forming) activity. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 9. Is an ortholog of human SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha).

WB:WBGene00017760	F23H11.4
Is expressed in body wall musculature; hypodermis; intestine; neurons; and pharynx. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 14. Is predicted to encode a protein with the following domain: . Is an ortholog of human ARAP1 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1) and ARAP3 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3).

WB:WBGene00017761	F23H11.6
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including skn-1; elt-2; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00017762	F23H11.7
Is enriched in neurons and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including aldicarb; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00017763	crls-1
Exhibits cardiolipin synthase activity. Is involved in cardiolipin biosynthetic process; regulation of cell population proliferation; and regulation of mitochondrial membrane potential. Is an ortholog of human CRLS1 (cardiolipin synthase 1).

WB:WBGene00017764	F25A2.1
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Heme; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00017765	gcst-1
Is predicted to have aminomethyltransferase activity. Human ortholog(s) of this gene are implicated in glycine encephalopathy. Is an ortholog of human AMT (aminomethyltransferase).

WB:WBGene00017766	peli-1
Is predicted to have ubiquitin protein ligase activity. Is expressed in chemosensory neurons; ciliated neurons; and head. Is an ortholog of human PELI1 (pellino E3 ubiquitin protein ligase 1); PELI2 (pellino E3 ubiquitin protein ligase family member 2); and PELI3 (pellino E3 ubiquitin protein ligase family member 3).

WB:WBGene00017767	F25B4.4
Is enriched in several structures, including germ line; germline precursor cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; antimycin; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00017768	F25B4.5
Is enriched in germ line and head mesodermal cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HAT (Half-A-TPR) repeat and Tetratricopeptide-like helical domain superfamily. Is an ortholog of human PRPF39 (pre-mRNA processing factor 39).

WB:WBGene00017769	hmgs-1
Is predicted to have hydroxymethylglutaryl-CoA synthase activity. Is an ortholog of human HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) and HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2).

WB:WBGene00017770	F25B4.7
Is predicted to have ATP:ADP antiporter activity. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2; mitochondrial DNA depletion syndrome 12a; and mitochondrial DNA depletion syndrome 12b. Is an ortholog of human SLC25A4 (solute carrier family 25 member 4); SLC25A5 (solute carrier family 25 member 5); and SLC25A6 (solute carrier family 25 member 6).

WB:WBGene00017771	F25B4.8
Is predicted to have carbon-sulfur lyase activity. Is an ortholog of human CENPV (centromere protein V).

WB:WBGene00017772	clec-1
Is predicted to have carbohydrate binding activity.

WB:WBGene00017773	dct-6
Is enriched in neurons; somatic nervous system; and vulval muscle based on Chronogram and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including diallyl trisulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily and WD40-repeat-containing domain superfamily.

WB:WBGene00017774	nop-1
Is involved in anterior/posterior axis specification, embryo and mitotic cytokinesis. Localizes to cell cortex; cleavage furrow; and nucleus. Is expressed in embryonic cell.

WB:WBGene00017775	F25B5.3
Is predicted to have 5'-nucleotidase activity. Human ortholog(s) of this gene are implicated in hemolytic anemia. Is an ortholog of human NT5C3A (5'-nucleotidase, cytosolic IIIA) and NT5C3B (5'-nucleotidase, cytosolic IIIB).

WB:WBGene00017776	F25B5.5
Is predicted to have N6-isopentenyladenosine methylthiotransferase activity. Is an ortholog of human CDK5RAP1 (CDK5 regulatory subunit associated protein 1).

WB:WBGene00017777	F25B5.6
Is predicted to have tetrahydrofolylpolyglutamate synthase activity. Is an ortholog of human FPGS (folylpolyglutamate synthase).

WB:WBGene00017778	nono-1
Is predicted to have transcription regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability 34. Is an ortholog of human NONO (non-POU domain containing octamer binding); PSPC1 (paraspeckle component 1); and SFPQ (splicing factor proline and glutamine rich).

WB:WBGene00017779	gtr-1
Is expressed in neurons and ventral nerve cord. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00017780	F25E2.2
Is enriched in GABAergic neurons and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00017781	F25E2.3
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT8 (acyl-CoA thioesterase 8).

WB:WBGene00017782	F25E5.1
Is enriched in DD neuron; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Humic Substances; paraquat; and Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in Angelman syndrome; Prader-Willi syndrome; and non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domain: Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II.

WB:WBGene00017783	F25E5.2
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00017784	F25E5.3
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; Peptidase S1, PA clan; and Peptidase S1, PA clan, chymotrypsin-like fold.

WB:WBGene00017785	F25E5.4
Is enriched in Z1.p; Z4.a; male distal tip cell; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; Peptidase S1, PA clan; and Peptidase S1, PA clan, chymotrypsin-like fold.

WB:WBGene00017786	F25E5.5
Is enriched in several structures, including AVA; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00017787	nhr-141
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00017788	F25E5.7
Is enriched in AVA; AVK; germ line; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; Peptidase S1, PA clan; and Peptidase S1, PA clan, chymotrypsin-like fold.

WB:WBGene00017789	F25E5.8
Is enriched in AVA; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including diallyl trisulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017790	F25E5.9
Is affected by several genes including age-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine; cadmium; and tetrabromobisphenol A based on microarray studies.

WB:WBGene00017791	try-8
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00017792	F25E5.16
Is enriched in head mesodermal cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRAF-like and SKP1/BTB/POZ domain superfamily.

WB:WBGene00017794	mltn-13
Is affected by several genes including daf-16; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by Rifampin; glycine; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00017795	F25F8.1
Is enriched in several structures, including AVE; carbon dioxide sensory neurons; excretory cell; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017796	F25G6.1
Is enriched in AFD; ASER; AVK; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including skn-1; let-60; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00017797	symk-1
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including clk-1; sir-2.1; and sek-1 based on RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3453); Symplekin tight junction protein C terminal; Armadillo-like helical; Symplekin/Pta1; Symplekin  C-terminal; and Symplekin/Pta1, N-terminal. Is an ortholog of human SYMPK (symplekin).

WB:WBGene00017798	slc-17.8
Is predicted to have transmembrane transporter activity.

WB:WBGene00017799	F25G6.8
Is predicted to have 7S RNA binding activity and endoplasmic reticulum signal peptide binding activity. Is an ortholog of human SRP14 (signal recognition particle 14).

WB:WBGene00017800	F25G6.9
Is enriched in AVK; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-type fold.

WB:WBGene00017801	F26A1.1
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017802	F26A1.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00017803	F26A1.4
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00017805	F26A1.7
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including let-60; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; Rifampin; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sulfite exporter TauE/SafE and Transmembrane protein TauE-like.

WB:WBGene00017806	F26A1.8
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Sulfite exporter TauE/SafE and Transmembrane protein TauE-like.

WB:WBGene00017807	F26A1.9
Is enriched in germline precursor cell; hypodermis; male-specific anatomical entity; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017808	nspd-9
Is expressed in head. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00017809	clec-156
Is predicted to have carbohydrate binding activity.

WB:WBGene00017810	clec-157
Is predicted to have carbohydrate binding activity.

WB:WBGene00017811	F26A1.13
Is enriched in several structures, including Z1.p; Z4.a; coelomocyte; germ line; and male distal tip cell based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by Zidovudine; antimycin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Smr domain; Smr domain; P-loop containing nucleoside triphosphate hydrolase; and Smr domain superfamily.

WB:WBGene00017813	nlp-61
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00017814	F26A10.2
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is an ortholog of human ZNF148 (zinc finger protein 148).

WB:WBGene00017815	F26B1.1
Is enriched in NSM; coelomocyte; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Heme; D-glucose; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cytadhesin P30/P32 and Cytadhesin P30/P32.

WB:WBGene00017816	hrpk-1
Is predicted to have RNA binding activity. Is involved in cellular response to DNA damage stimulus and embryo development. Is an ortholog of human HNRNPK (heterogeneous nuclear ribonucleoprotein K).

WB:WBGene00017817	F26B1.5
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00017818	F26D11.1
Is predicted to have gluconokinase activity. Is an ortholog of human IDNK (IDNK gluconokinase).

WB:WBGene00017819	F26D11.2
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00017821	F26D11.4
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including sir-2.1; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00017822	clec-216
Is predicted to have carbohydrate binding activity.

WB:WBGene00017823	pals-34
Is enriched in coelomocyte; germ line; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00017824	clec-217
Is predicted to have carbohydrate binding activity.

WB:WBGene00017825	cee-1
Is enriched in AFD; PLM; germ line; muscle cell; and neurons based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and clk-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF410); Golgi to ER traffic protein 4; and Tetratricopeptide-like helical domain superfamily. Is an ortholog of human GET4 (guided entry of tail-anchored proteins factor 4).

WB:WBGene00017826	tag-340
Is predicted to have lipid binding activity. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia. Is an ortholog of human STARD3 (StAR related lipid transfer domain containing 3).

WB:WBGene00017827	F26F4.5
Is enriched in several structures, including NSM; Z4.a; germ line; germline precursor cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Opitz-GBBB syndrome and oblique facial clefting 1. Is predicted to encode a protein with the following domains: Calponin homology (CH) domain; Calponin homology domain; and CH domain superfamily. Is an ortholog of human SPECC1 (sperm antigen with calponin homology and coiled-coil domains 1) and SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1 like).

WB:WBGene00017828	F26F4.6
Is expressed in head.

WB:WBGene00017829	F26F4.9
Is enriched in germ line; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including age-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Sirolimus; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Selenoprotein S (SelS); Selenoprotein S; and Thioredoxin-like superfamily. Is an ortholog of human SELENOS (selenoprotein S).

WB:WBGene00017830	rpb-8
Is predicted to have DNA binding activity and DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2H (RNA polymerase II, I and III subunit H).

WB:WBGene00017831	F26F4.12
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeat; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human ANKRD49 (ankyrin repeat domain 49).

WB:WBGene00017832	kbp-2
Is involved in kinetochore assembly. Localizes to condensed chromosome kinetochore.

WB:WBGene00017833	F26F12.2
Is enriched in AVK; NSM; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and paraquat based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017834	F26F12.3
Is enriched in intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017835	F26F12.4
Is enriched in ALM; PLM; intestine; pharyngeal muscle cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00017836	F26F12.5
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00017837	F26G1.1
Is enriched in germ line; germline precursor cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including D-glucose; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: VPS35 endosomal protein sorting factor-like. Is an ortholog of human VPS35L (VPS35 endosomal protein sorting factor like).

WB:WBGene00017838	F26G1.2
Is enriched in dopaminergic neurons; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017839	F26G1.3
Is affected by several genes including clk-1; elt-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like and Transthyretin-like superfamily.

WB:WBGene00017840	ttm-2
Is involved in response to nematicide.

WB:WBGene00017841	F26G1.5
Is enriched in germline precursor cell; hypodermis; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00017842	nep-12
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension. Is an ortholog of human KEL (Kell metallo-endopeptidase (Kell blood group)).

WB:WBGene00017843	F26G5.1
Is expressed in germ line.

WB:WBGene00017845	srsx-9
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00017846	F27B3.4
No description available

WB:WBGene00017848	F27B3.6
Is enriched in GABAergic neurons based on tiling array studies. Is affected by several genes including daf-2; clk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017849	F27B3.7
Is enriched in AVA and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00017850	F27B10.1
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq studies.

WB:WBGene00017851	F27C1.1
Is enriched in AFD; amphid sheath cell; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-seven chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00017852	F27C1.2
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00017853	F27C1.3
Is enriched in amphid sheath cell; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Ethanol; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00017854	F27C1.4
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including Rotenone; Mianserin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017855	F27C1.6
Is enriched in germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Utp14 protein; and Small-subunit processome, Utp14. Is an ortholog of human UTP14A (UTP14A small subunit processome component) and UTP14C (UTP14C small subunit processome component).

WB:WBGene00017858	F27C1.11
Is enriched in AFD; ASER; PLM; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including aldicarb; stavudine; and Psoralens based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in occult macular dystrophy. Is predicted to encode a protein with the following domains: Doublecortin; IQ calmodulin-binding motif; IQ motif, EF-hand binding site; PLAT/LH2 domain; Doublecortin domain; PLAT/LH2 domain superfamily; and Doublecortin domain superfamily. Is an ortholog of human LOXHD1 (lipoxygenase homology domains 1).

WB:WBGene00017860	F27C1.13
Is affected by several genes including sir-2.1; alg-1; and mut-2 based on RNA-seq and microarray studies. Is affected by Tunicamycin and Atrazine based on microarray studies. Human ortholog(s) of this gene are implicated in occult macular dystrophy and retinitis pigmentosa 1. Is predicted to encode a protein with the following domains: Doublecortin; Doublecortin domain; Doublecortin domain superfamily; and RP1/RP1L1/DCX. Is an ortholog of human RP1L1 (RP1 like 1).

WB:WBGene00017861	F27D9.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00017864	pcca-1
Is predicted to have propionyl-CoA carboxylase activity. Localizes to mitochondrion. Is expressed in head and neurons. Is used to study propionic acidemia. Human ortholog(s) of this gene are implicated in propionic acidemia. Is an ortholog of human PCCA (propionyl-CoA carboxylase subunit alpha).

WB:WBGene00017865	F27D9.7
Is predicted to have metalloendopeptidase activity.

WB:WBGene00017866	stn-2
Exhibits cell adhesion molecule binding activity. Localizes to several cellular components, including cell body; plasma membrane; and sarcomere. Is expressed in body wall musculature; enteric muscle; neurons; and vulva. Is used to study Duchenne muscular dystrophy. Is an ortholog of human SNTG1 (syntrophin gamma 1) and SNTG2 (syntrophin gamma 2).

WB:WBGene00017867	slc-28.1
Is predicted to have nucleoside:sodium symporter activity. Is an ortholog of human SLC28A3 (solute carrier family 28 member 3).

WB:WBGene00017868	slc-28.2
Is predicted to have nucleoside:sodium symporter activity. Is an ortholog of human SLC28A1 (solute carrier family 28 member 1) and SLC28A2 (solute carrier family 28 member 2).

WB:WBGene00017869	F28A10.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00017870	F28A10.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; aak-2; and aak-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017871	F28A10.3
Is affected by several genes including rrf-3; eat-2; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00017872	F28A10.4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00017873	F28A10.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and lin-15B based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; Methyltransferase-like protein 24; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00017874	acdh-9
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Is an ortholog of human ACAD8 (acyl-CoA dehydrogenase family member 8).

WB:WBGene00017875	F28A10.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; multi-walled carbon nanotube; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00017876	F28A10.8
Is affected by several genes including drh-3; ash-2; and wdr-5.1 based on microarray; tiling array; and RNA-seq studies. Is affected by tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00017877	F28A10.9
Is affected by several genes including lin-4; lin-14; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including glycine; resveratrol; and tetrabromobisphenol A based on RNA-seq and microarray studies. Is an ortholog of human FKTN (fukutin).

WB:WBGene00017878	F28A10.10
Is affected by several genes including clk-1; aak-2; and hpl-2 based on microarray and RNA-seq studies. Is affected by fluoranthene and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00017879	acd-4
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of several human genes including ASIC1 (acid sensing ion channel subunit 1); ASIC2 (acid sensing ion channel subunit 2); and ASIC4 (acid sensing ion channel subunit family member 4).

WB:WBGene00017880	F28A12.3
Is expressed in inner labial neurons and outer labial neurons. Is predicted to encode a protein with the following domain: .

WB:WBGene00017881	asp-13
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy.

WB:WBGene00017885	dip-2
Is predicted to have catalytic activity. Is expressed in hypodermal cell and neurons. Is an ortholog of human DIP2A (disco interacting protein 2 homolog A); DIP2B (disco interacting protein 2 homolog B); and DIP2C (disco interacting protein 2 homolog C).

WB:WBGene00017886	mfsd-13.1
Is enriched in EMS and germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: MFS/sugar transport protein; MFS transporter superfamily; and Transmembrane protein 180. Is an ortholog of human MFSD13A (major facilitator superfamily domain containing 13A).

WB:WBGene00017887	F28B3.6
Is enriched in several structures, including germ line; germline precursor cell; intestine; mechanosensory neurons; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including gld-1; sir-2.1; and fbf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; resveratrol; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1757) and Protein of unknown function DUF1757.

WB:WBGene00017888	acl-11
Is predicted to have transferase activity, transferring acyl groups. Is an ortholog of human AGPAT5 (1-acylglycerol-3-phosphate O-acyltransferase 5).

WB:WBGene00017889	F28B3.10
Is enriched in several structures, including germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and sir-2.1 based on proteomic; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1757) and Protein of unknown function DUF1757.

WB:WBGene00017890	F28B4.1
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including eat-2; mex-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including hydrogen sulfide; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00017891	rgl-1
Is predicted to have GTPase regulator activity. Is involved in epidermal growth factor receptor signaling pathway and positive regulation of vulval development. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 4; familial adult myoclonic epilepsy 7; and platelet-type bleeding disorder 18. Is an ortholog of human RGL1 (ral guanine nucleotide dissociation stimulator like 1).

WB:WBGene00017892	F28B4.3
Is enriched in intestine and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nineteen chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in essential tremor 5. Is predicted to encode a protein with the following domains: Phosphorylation site; Lectin C-type domain; von Willebrand factor type A domain; EGF-like domain; C-type lectin-like; von Willebrand factor, type A; MD domain; C-type lectin-like/link domain superfamily; C-type lectin fold; and von Willebrand factor A-like domain superfamily.

WB:WBGene00017893	F28B4.4
Is enriched in dopaminergic neurons and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00017894	F28B12.1
Is enriched in several structures, including RID; carbon dioxide sensory neurons; intestine; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by allantoin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017895	vrk-1
Exhibits protein kinase activity. Is involved in several processes, including cell fate specification; gonad development; and regulation of fibroblast growth factor receptor signaling pathway. Localizes to chromatin and nuclear envelope. Is expressed in several structures, including P3.p hermaphrodite; P4.p hermaphrodite; P8.p hermaphrodite; hermaphrodite gonad; and ventral nerve cord. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 1A. Is an ortholog of human VRK1 (VRK serine/threonine kinase 1) and VRK2 (VRK serine/threonine kinase 2).

WB:WBGene00017896	F28C10.1
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including eat-2; lin-15B; and adr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017897	F28C10.2
No description available

WB:WBGene00017898	F28C10.3
Is predicted to have ribosomal protein S6 kinase activity.

WB:WBGene00017899	F28C10.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Testosterone and Sirolimus based on microarray studies.

WB:WBGene00017900	F28E10.1
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017901	igeg-1
Is enriched in PLM; RID; and intestine based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including Lithium Chloride; Rotenone; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold and Immunoglobulin-like domain superfamily.

WB:WBGene00017902	F28E10.4
Is enriched in AVK; amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T15H9.4-like.

WB:WBGene00017904	lim-8
Exhibits protein domain specific binding activity. Localizes to M band. Is expressed in excretory canal; head neurons; non-striated muscle; spermatheca; and vulva. Is an ortholog of human LMO7 (LIM domain 7).

WB:WBGene00017905	F28F5.6
Is enriched in AFD; body wall musculature; head mesodermal cell; and pharynx based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017906	F28F9.2
Is enriched in AVK; body wall muscle cell; and ciliated neurons based on tiling array and RNA-seq studies. Is affected by several genes including alg-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00017907	F28F9.3
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; aak-2; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00017908	F28H1.1
Is enriched in ASER; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; Mercuric Chloride; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00017909	F28H1.4
Is enriched in PLM; body wall muscle cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Membrane-associating domain and Marvel domain. Is an ortholog of human CMTM4 (CKLF like MARVEL transmembrane domain containing 4).

WB:WBGene00017910	F28H1.5
Is enriched in AFD; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00017911	fbxb-106
Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00017912	fbxb-107
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Mianserin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00017913	F29A7.3
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and eat-2 based on tiling array and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00017914	F29A7.4
Is predicted to have type 1 cannabinoid receptor binding activity. Is an ortholog of human CNRIP1 (cannabinoid receptor interacting protein 1).

WB:WBGene00017916	F29A7.6
Is expressed widely. Is predicted to encode a protein with the following domains: M-phase phosphoprotein 6 and M-phase phosphoprotein 6. Is an ortholog of human MPHOSPH6 (M-phase phosphoprotein 6).

WB:WBGene00017917	clec-120
Is affected by several genes including daf-2; sir-2.1; and mex-3 based on RNA-seq and microarray studies. Is affected by Mercuric Chloride and allantoin based on microarray studies.

WB:WBGene00017918	F29A7.8
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C-type lectin-like/link domain superfamily and C-type lectin fold.

WB:WBGene00017919	F29B9.1
Is predicted to have protein-lysine N-methyltransferase activity. Is an ortholog of human EEF1AKMT2 (EEF1A lysine methyltransferase 2).

WB:WBGene00017920	jmjd-1.2
Exhibits histone binding activity; histone demethylase activity (H3-K27 specific); and histone demethylase activity (H3-K9 specific). Is involved in histone H3-K27 demethylation; histone H3-K9 demethylation; and mitochondrial unfolded protein response. Localizes to nucleus. Is expressed in several structures, including germ cell; hypodermis; muscle cell; and neurons. Is used to study syndromic X-linked intellectual disability. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Siderius type. Is an ortholog of human KDM7A (lysine demethylase 7A).

WB:WBGene00017921	F29B9.5
Is enriched in germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human UBE2I (ubiquitin conjugating enzyme E2 I).

WB:WBGene00017922	F29B9.7
Is enriched in hypodermis and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00017923	F29B9.8
Localizes to plasma membrane. Is expressed in several structures, including hypodermis.

WB:WBGene00017924	mrps-21
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS21 (mitochondrial ribosomal protein S21).

WB:WBGene00017925	F29B9.11
Is enriched in AFD; ASER; NSM; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including let-60; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00017926	cox-6C
Is expressed in several structures, including body wall musculature; coelomocyte; pharynx; spermatheca; and vulva. Is predicted to encode a protein with the following domains: Cytochrome c oxidase subunit VIc; Mitochondrial cytochrome c oxidase subunit VIc/VIIs; and Mitochondrial cytochrome c oxidase subunit VIc/VIIs superfamily.

WB:WBGene00017927	F29C4.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00017928	tut-1
Exhibits sulfurtransferase activity and tRNA binding activity. Is involved in several processes, including gamete generation; tRNA metabolic process; and translation. Is an ortholog of human CTU1 (cytosolic thiouridylase subunit 1).

WB:WBGene00017929	grld-1
Is predicted to have RNA binding activity. Localizes to nucleus. Is expressed in epithelial cell; lateral ganglion; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability 34. Is an ortholog of human RBM15B (RNA binding motif protein 15B).

WB:WBGene00017930	F29G9.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00017931	picc-1
Is enriched in germ line; hypodermis; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CCDC85 family and CCDC85 family. Is an ortholog of human CCDC85A (coiled-coil domain containing 85A); CCDC85B (coiled-coil domain containing 85B); and CCDC85C (coiled-coil domain containing 85C).

WB:WBGene00017933	F29G9.7
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00017934	F30B5.4
Is predicted to have oxidoreductase activity. Is an ortholog of human OSGIN1 (oxidative stress induced growth inhibitor 1) and OSGIN2 (oxidative stress induced growth inhibitor family member 2).

WB:WBGene00017935	srbc-70
Is affected by several genes including daf-2; eat-2; and ain-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00017936	zipt-2.2
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A1 (solute carrier family 39 member 1) and SLC39A2 (solute carrier family 39 member 2).

WB:WBGene00017937	F30H5.3
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00017938	F31A3.3
Is enriched in ALM; ASER; PLM; coelomocyte; and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including multi-walled carbon nanotube; D-glucose; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00017939	F31A3.5
Is enriched in RIS; germ line; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Cry5B; Quercetin; and paraquat based on microarray studies.

WB:WBGene00017941	F31A9.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and bar-1 based on microarray and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; Tunicamycin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00017942	fbxc-37
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; indole; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00017943	F31A9.6
No description available

WB:WBGene00017944	F31D5.1
Is affected by several genes including daf-2; skn-1; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00017945	F31D5.2
Is enriched in dopaminergic neurons; germline precursor cell; hypodermis; neuronal sheath cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00017947	mth-2
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in bone development disease (multiple); primary failure of tooth eruption; and type 2 diabetes mellitus. Is an ortholog of human ADGRG2 (adhesion G protein-coupled receptor G2) and ADGRG7 (adhesion G protein-coupled receptor G7).

WB:WBGene00017948	mth-1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00017949	F31D5.6
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00017950	F31E3.2
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Is an ortholog of human RSKR (ribosomal protein S6 kinase related).

WB:WBGene00017951	panl-2
Is predicted to have nucleic acid binding activity. Is involved in reproduction. Is an ortholog of human PAN2 (poly(A) specific ribonuclease subunit PAN2).

WB:WBGene00017952	F31E3.6
Is enriched in AFD; PLM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Mianserin; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00017954	F31E8.4
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A2 (solute carrier family 31 member 2).

WB:WBGene00017955	F31E8.5
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00017956	F31E8.6
Is affected by smg-2; sir-2.1; and slr-2 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00017957	F31F4.1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273; Protein of unknown function DUF273; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00017959	ugt-42
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A10 (UDP glucuronosyltransferase family 1 member A10); UGT1A5 (UDP glucuronosyltransferase family 1 member A5); and UGT1A6 (UDP glucuronosyltransferase family 1 member A6).

WB:WBGene00017960	F31F4.11
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00017961	nhr-180
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in intestine.

WB:WBGene00017962	fbxa-72
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Tunicamycin; sodium arsenite; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00017963	F31F4.17
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00017964	F31F7.1
Is predicted to have transferase activity. Is involved in innate immune response.

WB:WBGene00017965	F31F7.2
Is enriched in CEM; HOB; IL2 neuron; neurons; and ray neuron type B based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00017967	ada-2
Is predicted to have DNA binding activity. Is an ortholog of human TADA2B (transcriptional adaptor 2B).

WB:WBGene00017968	skpo-3
Is predicted to have peroxidase activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7.

WB:WBGene00017969	ctsa-3.1
Is predicted to have serine-type carboxypeptidase activity. Localizes to membrane raft. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00017970	F32A5.4
Is enriched in Psub1 and RID based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by twenty chemicals including methylmercury hydroxide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Pepsin inhibitor-3-like repeated domain; Pepsin inhibitor-3-like repeated domain; and Pepsin inhibitor-3 domain superfamily.

WB:WBGene00017971	F32A5.8
Is enriched in PLM; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 12; early infantile epileptic encephalopathy 28; and esophageal cancer. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human WWOX (WW domain containing oxidoreductase).

WB:WBGene00017973	ift-81
Is predicted to have tubulin binding activity. Is involved in several processes, including detection of stimulus involved in sensory perception; growth; and intraciliary transport. Localizes to non-motile cilium. Is expressed in amphid neurons; chemosensory neurons; and phasmid neurons. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 19 with or without polydactyly. Is an ortholog of human IFT81 (intraflagellar transport 81).

WB:WBGene00017974	vps-41
Is predicted to have metal ion binding activity. Is involved in negative regulation of apoptotic process; vacuolar protein processing; and vacuolar transport. Is an ortholog of human VPS41 (VPS41 subunit of HOPS complex).

WB:WBGene00017975	F32B5.1
Is predicted to have creatine kinase activity. Is an ortholog of human CKMT2 (creatine kinase, mitochondrial 2).

WB:WBGene00017976	F32B5.2
Is enriched in neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017977	F32B5.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00017978	msrp-1
Is enriched in germ line; seam cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00017979	F32B5.6
Is enriched in OLL; PVD; coelomocyte; intestine; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Lithium Chloride; Cry5B; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00017980	F32B5.7
Is enriched in head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glycine-rich domain-containing protein-like and Glycine-rich domain-containing protein-like.

WB:WBGene00017981	figl-1
Exhibits ATPase activity; magnesium ion binding activity; and microtubule binding activity. Is involved in ATP metabolic process and positive regulation of mitotic cell cycle. Localizes to nucleus. Is expressed in germ line. Is an ortholog of human FIGNL1 (fidgetin like 1).

WB:WBGene00017982	hpo-18
Is predicted to contribute to ATPase activity. Is an ortholog of human ATP5F1E (ATP synthase F1 subunit epsilon).

WB:WBGene00017983	F32D1.3
Is enriched in BAG; NSM; RIS; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily. Is an ortholog of human TMTC2 (transmembrane O-mannosyltransferase targeting cadherins 2).

WB:WBGene00017984	F32D1.5
Is predicted to have GMP reductase activity. Is an ortholog of human GMPR (guanosine monophosphate reductase).

WB:WBGene00017985	neg-1
Localizes to nucleus. Is expressed in AB lineage cell; ABa; ABp; and Psub1.

WB:WBGene00017986	F32D1.7
Is enriched in several structures, including germ line; germline precursor cell; male distal tip cell; neurons; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including manganese chloride; bisphenol A; and Linolenic Acids based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00017987	F32D1.8
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00017988	fipp-1
Is enriched in AVK; cephalic sheath cell; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including Alovudine; Zidovudine; and Testosterone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Fip1 motif and Pre-mRNA polyadenylation factor Fip1 domain. Is an ortholog of human FIP1L1 (factor interacting with PAPOLA and CPSF1).

WB:WBGene00017989	nol-10
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NUC153 domain; NUC153; WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and Nucleolar protein 10/Enp2. Is an ortholog of human NOL10 (nucleolar protein 10).

WB:WBGene00017990	cec-4
Exhibits methylated histone binding activity. Is involved in chromosome attachment to the nuclear envelope; regulation of cell differentiation; and regulation of gene expression. Localizes to nuclear inner membrane. Is expressed in germ cell and somatic cell.

WB:WBGene00017991	clec-180
Is predicted to have carbohydrate binding activity.

WB:WBGene00017992	F32E10.5
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cataract 36. Is predicted to encode a protein with the following domains: Tudor domain and Tudor domain.

WB:WBGene00017993	cec-5
Is predicted to have chromatin binding activity and methylated histone binding activity.

WB:WBGene00017995	F32E10.8
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and alg-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including Zidovudine; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; and LDL receptor-like superfamily.

WB:WBGene00017996	F33D4.4
Is predicted to have sphingolipid delta-4 desaturase activity. Is an ortholog of human DEGS1 (delta 4-desaturase, sphingolipid 1) and DEGS2 (delta 4-desaturase, sphingolipid 2).

WB:WBGene00017997	mrpl-1
Is predicted to have RNA binding activity. Is an ortholog of human MRPL1 (mitochondrial ribosomal protein L1).

WB:WBGene00017998	F33D4.6
Is enriched in germline precursor cell; hypodermis; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; Nitric Oxide; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00017999	emc-6
Is expressed widely. Is predicted to encode a protein with the following domains: Rab5-interacting protein (Rab5ip); ER membrane protein complex subunit 6; and Rab5-interacting protein family. Is an ortholog of human EMC6 (ER membrane protein complex subunit 6).

WB:WBGene00018000	F33D11.1
Is predicted to have metal ion binding activity.

WB:WBGene00018001	F33D11.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018002	twk-47
Is predicted to have potassium ion leak channel activity.

WB:WBGene00018003	F33D11.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by mir-34; thoc-5; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Atrazine; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5382) and Protein of unknown function DUF5382.

WB:WBGene00018004	F33D11.7
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018005	nlp-62
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00018006	gpaa-1
Is enriched in NSM; germ line; germline precursor cell; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; metformin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Gaa1-like, GPI transamidase component and GPI transamidase component Gaa1. Is an ortholog of human GPAA1 (glycosylphosphatidylinositol anchor attachment 1).

WB:WBGene00018007	F33D11.10
Is predicted to have RNA helicase activity and mRNA binding activity. Is an ortholog of human EIF4A3 (eukaryotic translation initiation factor 4A3).

WB:WBGene00018008	vpr-1
Exhibits ephrin receptor binding activity and protein domain specific binding activity. Is expressed in body wall musculature; gonad; hypodermis; muscle cell; and nervous system. Is used to study amyotrophic lateral sclerosis. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 8 and autosomal dominant adult-onset proximal spinal muscular atrophy. Is an ortholog of human VAPB (VAMP associated protein B and C).

WB:WBGene00018009	dhhc-3
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human ZDHHC3 (zinc finger DHHC-type palmitoyltransferase 3).

WB:WBGene00018010	F33E11.2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00018011	F33E11.3
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Predicted coiled-coil domain-containing protein; Predicted coiled-coil domain-containing protein; Uncharacterised domain KLRAQ/TTKRSYEDQ, N-terminal; Uncharacterised domain KLRAQ/TTKRSYEDQ, C-terminal; and Protein phosphatase 1 regulatory subunit 21. Is an ortholog of human PPP1R21 (protein phosphatase 1 regulatory subunit 21).

WB:WBGene00018013	phf-10
Is predicted to have histone acetyltransferase activity and histone binding activity. Is used to study alcohol use disorder. Is an ortholog of human PHF10 (PHD finger protein 10).

WB:WBGene00018014	wdr-83
Is enriched in OLL; PVD; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR83 (WD repeat domain 83).

WB:WBGene00018015	F33G12.3
Is enriched in DD neuron; germ line; germline precursor cell; intestine; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Zidovudine; metformin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1308); Family of unknown function (DUF5614); Domain of unknown function DUF1308; and Domain of unknown function DUF5614. Is an ortholog of human C7orf25 (chromosome 7 open reading frame 25).

WB:WBGene00018016	lrr-1
Is involved in mitotic DNA replication checkpoint. Localizes to nucleus. Is an ortholog of human LRR1 (leucine rich repeat protein 1).

WB:WBGene00018017	golg-2
Is expressed in head ganglion; motor neurons; pharyngeal neurons; and tail neurons. Is predicted to encode a protein with the following domains: Phosphorylation site; Putative golgin subfamily A member 2-like protein 5; and Golgin subfamily A. Is an ortholog of human GOLGA2 (golgin A2).

WB:WBGene00018018	F33G12.6
Is predicted to have catalytic activity.

WB:WBGene00018019	F33H12.1
Is affected by several genes including let-60; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Alovudine; resveratrol; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BRCA1 C Terminus (BRCT) domain; BRCT domain; and BRCT domain superfamily.

WB:WBGene00018020	F33H12.6
No description available

WB:WBGene00018021	F34D6.1
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00018022	ceh-87
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity. Is expressed in head neurons; rectal gland cell; and tail neurons.

WB:WBGene00018023	set-11
Is predicted to have histone-lysine N-methyltransferase activity and zinc ion binding activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in several diseases, including Kleefstra syndrome 1; Kleefstra syndrome 2; and autosomal dominant non-syndromic intellectual disability (multiple). Is an ortholog of human EHMT2 (euchromatic histone lysine methyltransferase 2) and SUV39H1 (suppressor of variegation 3-9 homolog 1).

WB:WBGene00018024	F35A5.1
Is enriched in GABAergic neurons; body wall muscle cell; head mesodermal cell; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2CC and amyotrophic lateral sclerosis type 1. Is predicted to encode a protein with the following domains: Phosphorylation site and Neurofilament heavy polypeptide. Is an ortholog of human NEFH (neurofilament heavy).

WB:WBGene00018025	F35A5.2
Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018026	F35A5.4
Is expressed in pharynx. Is predicted to encode a protein with the following domains: Cysteine rich repeat and Cysteine rich repeat, tripleX.

WB:WBGene00018027	F35A5.5
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; D-glucose; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00018029	F35B3.2
No description available

WB:WBGene00018030	F35B3.3
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity.

WB:WBGene00018031	F35B3.4
Is enriched in DA neuron; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Heme; hydrogen sulfide; and Nitric Oxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00018032	F35B3.6
No description available

WB:WBGene00018033	F35B3.7
Is enriched in PLM; body wall muscle cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in esophageal cancer. Is predicted to encode a protein with the following domain: . Is an ortholog of human LZTS2 (leucine zipper tumor suppressor 2).

WB:WBGene00018034	sek-5
Is predicted to have MAP kinase kinase activity and protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 6 with or without polydactyly. Is an ortholog of human MAP2K7 (mitogen-activated protein kinase kinase 7).

WB:WBGene00018035	sek-4
Is predicted to have MAP kinase kinase activity and protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 6 with or without polydactyly. Is an ortholog of human MAP2K7 (mitogen-activated protein kinase kinase 7).

WB:WBGene00018036	F35C8.5
Is predicted to have C-4 methylsterol oxidase activity. Is an ortholog of human CH25H (cholesterol 25-hydroxylase).

WB:WBGene00018037	chtl-1
Is predicted to have transmembrane transporter activity. Is expressed in germ line. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 72. Is an ortholog of human SLC44A2 (solute carrier family 44 member 2).

WB:WBGene00018038	F35C8.8
Is enriched in AVE; AVK; GABAergic neurons; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018039	F35D2.1
Is enriched in OLL; PVD; and hypodermis based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including Ethanol; methylmercury hydroxide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018040	F35D2.2
Is enriched in AVK; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018041	F35D2.3
Is enriched in AVK; DA neuron; VA neuron; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domains: Laminin EGF domain; EGF-like domain; and Laminin EGF domain.

WB:WBGene00018042	mks-3
Is involved in non-motile cilium assembly. Localizes to ciliary transition zone. Is expressed in neurons. Is used to study Meckel syndrome. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 14; COACH syndrome; and Joubert syndrome 6. Is an ortholog of human TMEM67 (transmembrane protein 67).

WB:WBGene00018043	F35D11.1
Is enriched in dopaminergic neurons; germ line; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018044	F35D11.3
Is enriched in body wall musculature; dopaminergic neurons; head mesodermal cell; somatic nervous system; and vulval muscle based on Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and rde-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including levamisole; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF726); Protein of unknown function DUF726; and Alpha/Beta hydrolase fold. Is an ortholog of human TMCO4 (transmembrane and coiled-coil domains 4).

WB:WBGene00018045	F35D11.4
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CYTH domain; Adenylyl cyclase CyaB; CYTH domain; and CYTH-like domain superfamily.

WB:WBGene00018046	coa-3
Is enriched in germ line; head mesodermal cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain-containing protein 56; Cytochrome c oxidase assembly factor 3, mitochondrial, coiled-coil domain; and Cytochrome c oxidase assembly factor 3, mitochondrial. Is an ortholog of human COA3 (cytochrome c oxidase assembly factor 3).

WB:WBGene00018047	clec-136
Is predicted to have carbohydrate binding activity.

WB:WBGene00018048	clec-137
Is predicted to have carbohydrate binding activity. Is expressed in vas deferens.

WB:WBGene00018049	clec-138
Is predicted to have carbohydrate binding activity.

WB:WBGene00018050	clec-139
Is predicted to have carbohydrate binding activity.

WB:WBGene00018051	che-10
Is involved in cilium assembly. Localizes to ciliary basal body and ciliary transition zone. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 8. Is an ortholog of human CROCC (ciliary rootlet coiled-coil, rootletin).

WB:WBGene00018052	F35F10.1
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00018053	srbc-3
Is affected by clk-1; mir-34; and ain-1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00018054	F35F10.4
Is enriched in OLL; PVD; body wall muscle cell; and head mesodermal cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018055	F35F10.5
Is enriched in ASER; body wall muscle cell; hypodermis; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Ethanol; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018056	F35F10.6
Is enriched in OLL; PVD; and body wall muscle cell based on microarray; tiling array; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including tryptophan; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I) and PGPEP1L (pyroglutamyl-peptidase I like).

WB:WBGene00018057	F35F10.7
Is enriched in OLL; PVD; cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Putative pyroglutamyl peptidase PgaPase_1; Putative pyroglutamyl peptidase 1; Peptidase C15, pyroglutamyl peptidase I-like; and Peptidase C15, pyroglutamyl peptidase I-like superfamily. Is an ortholog of human PGPEP1 (pyroglutamyl-peptidase I) and PGPEP1L (pyroglutamyl-peptidase I like).

WB:WBGene00018058	srbc-1
Is affected by several genes including eat-2; smn-1; and adr-1 based on tiling array and RNA-seq studies. Is affected by seven chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00018059	F35F10.10
Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00018060	arrd-18
Is enriched in several structures, including coelomocyte; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on RNA-seq; microarray; and tiling array studies. Is affected by eight chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00018061	arrd-19
Is enriched in ASER; NSM; PLM; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00018062	F35F10.13
Is enriched in muscle cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Tunicamycin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00018063	F35F10.14
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00018064	cdc-73
Is predicted to have RNA polymerase II complex binding activity. Human ortholog(s) of this gene are implicated in hyperparathyroidism and parathyroid carcinoma. Is an ortholog of human CDC73 (cell division cycle 73).

WB:WBGene00018065	F35F11.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018066	F35F11.3
Is affected by several genes including eat-2; pgl-1; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00018067	npr-7
Is predicted to have neuropeptide Y receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human NPY1R (neuropeptide Y receptor Y1); NPY4R (neuropeptide Y receptor Y4); and PRLHR (prolactin releasing hormone receptor).

WB:WBGene00018068	F35H10.2
Is enriched in AVE; neurons; ventral nerve cord; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; hsf-1; and eat-2 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018069	F35H10.3
Is enriched in OLL; PVD; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018070	F35H10.5
Is enriched in germ line; intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including glp-1; skn-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and Rifampin based on RNA-seq and microarray studies. Human CENPX exhibits DNA binding activity. Is predicted to encode a protein with the following domains: CENP-S associating Centromere protein X and Centromere protein X. Is an ortholog of human CENPX (centromere protein X).

WB:WBGene00018071	F35H10.6
Is enriched in several structures, including AFD; germ line; germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and aak-2 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; bisphenol S; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Prefoldin subunit; Prefoldin alpha-like; and Prefoldin. Is an ortholog of human UXT (ubiquitously expressed prefoldin like chaperone).

WB:WBGene00018072	nprl-3
Is enriched in germ line; germline precursor cell; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nitrogen Permease regulator of amino acid transport activity 3 and Nitrogen permease regulator 3. Is an ortholog of human NPRL3 (NPR3 like, GATOR1 complex subunit).

WB:WBGene00018073	F35H10.10
Is predicted to have group II metabotropic glutamate receptor activity. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1B.

WB:WBGene00018074	F35H12.1
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Schwannomin-interacting protein 1; Schwannomin interacting protein 1, C-terminal; and Schwannomin interacting protein 1. Is an ortholog of human IQCJ-SCHIP1 (IQCJ-SCHIP1 readthrough) and SCHIP1 (schwannomin interacting protein 1).

WB:WBGene00018075	tbc-11
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human RABGAP1 (RAB GTPase activating protein 1) and RABGAP1L (RAB GTPase activating protein 1 like).

WB:WBGene00018076	pifk-1
Is predicted to have 1-phosphatidylinositol 4-kinase activity. Is expressed in head and tail. Is an ortholog of human PI4KB (phosphatidylinositol 4-kinase beta).

WB:WBGene00018077	F35H12.5
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia and neutral lipid storage disease.

WB:WBGene00018078	F35H12.6
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00018080	F36A4.1
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by D-glucose; antimycin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018081	F36A4.2
Is enriched in NSM; coelomocyte; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Heme; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018082	F36A4.3
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018083	F36A4.4
Is enriched in dopaminergic neurons and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018084	F36A4.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018085	ttr-20
Is enriched in hypodermis; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Cry5B; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00018087	F36D4.1
Is enriched in AVA; AVE; germ line; ventral nerve cord; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; D-glucose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00018088	trpp-4
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Mianserin; stavudine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sybindin-like family; Trafficking protein particle complex subunit; and Longin-like domain superfamily. Is an ortholog of human TRAPPC4 (trafficking protein particle complex 4).

WB:WBGene00018089	F36D4.4
Is predicted to have G protein-coupled receptor activity and peptide binding activity.

WB:WBGene00018090	F36D4.5
Is predicted to have peptidase activity. Is an ortholog of human DESI2 (desumoylating isopeptidase 2).

WB:WBGene00018091	F36D4.6
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-12; drh-3; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including tryptophan; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00018092	F36F12.1
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00018093	F36F12.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00018094	F36F12.3
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00018096	clec-207
Is predicted to have carbohydrate binding activity. Is expressed in vas deferens.

WB:WBGene00018097	clec-208
Is predicted to have carbohydrate binding activity.

WB:WBGene00018098	F36F12.7
Is enriched in seam cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; D-glucose; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00018099	ztf-28
Is expressed in intestine. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00018100	math-26
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including D-glucose; levamisole; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00018101	math-27
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Cry5B; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00018102	math-28
Is enriched in OLL; PVD; and dopaminergic neurons based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; Sodium Chloride; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00018103	F36H5.4
Is enriched in dopaminergic neurons; germ line; germline precursor cell; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018104	fbxb-53
Is involved in ATF6-mediated unfolded protein response.

WB:WBGene00018105	clec-19
Is predicted to have carbohydrate binding activity.

WB:WBGene00018106	F36H5.8
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including metformin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018107	F36H5.9
Is affected by several genes including clk-1; eat-2; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00018108	F36H5.10
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Alovudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018109	fbxb-12
Is affected by several genes including daf-2; eat-2; and sek-1 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; indole; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00018110	F36H9.1
Is predicted to have transmembrane receptor protein serine/threonine kinase activity.

WB:WBGene00018111	F36H9.2
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018112	F36H9.4
Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00018113	F36H9.5
Is enriched in AFD; Z1; Z4; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Post-GPI attachment to proteins factor 2.

WB:WBGene00018114	srt-41
Is expressed in AWCL and AWCR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018115	F36H9.7
Is enriched in neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018117	nlp-47
Is enriched in intestine; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018118	F36H12.2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including manganese chloride; bisphenol S; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018119	F36H12.3
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00018120	F36H12.4
Is enriched in AVG; RIM; command interneuron; germline precursor cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018121	F36H12.5
Is enriched in body wall muscle cell; germ line; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018122	ttbk-2
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 11. Is an ortholog of human TTBK1 (tau tubulin kinase 1) and TTBK2 (tau tubulin kinase 2).

WB:WBGene00018123	F36H12.9
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018124	F36H12.10
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018125	rmd-4
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Ethanol; methylmercuric chloride; and nanoparticle based on RNA-seq and microarray studies. Is an ortholog of human RMDN2 (regulator of microtubule dynamics 2) and RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00018127	F36H12.14
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including tryptophan; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00018130	F36H12.17
Is enriched in NSM; germ line; male-specific anatomical entity; and in male based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including lin-4; lin-14; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00018131	F37A4.1
Is enriched in PLM and germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq; microarray; and proteomic studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in PHARC syndrome. Is predicted to encode a protein with the following domains: alpha/beta hydrolase fold; Alpha/beta hydrolase fold-1; and Alpha/Beta hydrolase fold. Is an ortholog of human ABHD16A (abhydrolase domain containing 16A, phospholipase).

WB:WBGene00018132	F37A4.2
Is predicted to have double-stranded RNA binding activity; protein kinase binding activity; and protein kinase inhibitor activity. Is an ortholog of human PRKRIP1 (PRKR interacting protein 1).

WB:WBGene00018133	F37A4.3
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity.

WB:WBGene00018134	F37A4.4
Is enriched in germ line; hypodermis; muscle cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-four chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BRCA1 C Terminus (BRCT) domain; Ankyrin repeat; Domain of unknown function; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00018135	F37A4.5
Is predicted to have metallopeptidase activity; proteasome binding activity; and thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human PSMD14 (proteasome 26S subunit, non-ATPase 14).

WB:WBGene00018136	F37A4.6
Is enriched in AFD; PLM; germ line; intestine; and neurons based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00018137	bath-41
Is predicted to have ubiquitin protein ligase binding activity.

WB:WBGene00018138	folt-2
Is predicted to have folic acid binding activity and vitamin transmembrane transporter activity. Human ortholog(s) of this gene are implicated in biotin-responsive basal ganglia disease and thiamine-responsive megaloblastic anemia syndrome. Is an ortholog of human SLC19A1 (solute carrier family 19 member 1) and SLC19A2 (solute carrier family 19 member 2).

WB:WBGene00018139	sre-24
Is affected by rsr-2 and mir-34 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00018140	F37B4.10
Is expressed in head muscle; head neurons; tail neurons; and ventral nerve cord. Is predicted to encode a protein with the following domain: .

WB:WBGene00018141	oac-21
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018142	oac-22
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018143	oac-23
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018144	F37C4.4
Is enriched in hypodermis and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018145	F37C4.5
Is enriched in head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; RNA-seq; tiling array; and microarray studies. Is affected by seventeen chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4139); Conserved hypothetical protein CHP02231; and Domain of unknown function DUF4139.

WB:WBGene00018146	F37C4.6
Is predicted to have oxidoreductase activity. Is an ortholog of human PYROXD2 (pyridine nucleotide-disulphide oxidoreductase domain 2).

WB:WBGene00018148	F37C4.8
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercury hydroxide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00018149	yju-2
Is expressed in tail. Is predicted to encode a protein with the following domains: Family of unknown function (DUF572) and Saf4/Yju2 protein. Is an ortholog of human YJU2 (YJU2 splicing factor homolog).

WB:WBGene00018150	epg-4
Is involved in macroautophagy and negative regulation of autophagosome assembly. Localizes to endoplasmic reticulum. Is expressed in several structures, including body wall musculature; head; hypodermis; pharyngeal muscle cell; and tail. Is an ortholog of human EI24 (EI24 autophagy associated transmembrane protein).

WB:WBGene00018151	F37C12.3
Is predicted to have acyl binding activity and acyl carrier activity. Is an ortholog of human NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1).

WB:WBGene00018152	acs-4
Is predicted to have catalytic activity. Localizes to lipid droplet. Is expressed in hypodermis; intestine; pharynx; and somatic nervous system. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ACSL3 (acyl-CoA synthetase long chain family member 3) and ACSL4 (acyl-CoA synthetase long chain family member 4).

WB:WBGene00018153	F37C12.10
Is enriched in intestine and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; methylmercuric chloride; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00018154	exos-9
Is predicted to have AU-rich element binding activity. Is an ortholog of human EXOSC9 (exosome component 9).

WB:WBGene00018155	F37C12.14
Is enriched in ASER; FLP; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00018156	ncbp-1
Is predicted to have RNA cap binding activity and mRNA binding activity. Is an ortholog of human NCBP1 (nuclear cap binding protein subunit 1).

WB:WBGene00018157	lron-6
Is expressed in nerve ring neurons; retrovesicular ganglion neurons; and ventral nerve cord. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily.

WB:WBGene00018158	comp-1
Is predicted to have kinase activity.

WB:WBGene00018159	F37F2.2
Is predicted to have 7S RNA binding activity. Is an ortholog of human SRP19 (signal recognition particle 19).

WB:WBGene00018160	odr-8
Is predicted to have cysteine-type peptidase activity. Is involved in positive regulation of chemotaxis; protein localization to non-motile cilium; and response to ethanol. Localizes to protein-containing complex. Is expressed in amphid neurons and phasmid neurons. Human ortholog(s) of this gene are implicated in Beukes hip dysplasia. Is an ortholog of human UFSP2 (UFM1 specific peptidase 2).

WB:WBGene00018161	F38A5.2
Is enriched in OLL; PVD; body wall musculature; germ line; and intestine based on Chronogram; microarray; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: TraB family and TraB family. Is an ortholog of human TRABD (TraB domain containing).

WB:WBGene00018162	nspb-3
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on quantitative PCR; microarray; and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; D-glucose; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00018163	F38A5.6
Is enriched in germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BAR domain; BAR domain; and AH/BAR domain superfamily.

WB:WBGene00018164	sup-36
Is involved in embryonic digestive tract development. Is expressed in pharynx.

WB:WBGene00018165	F38A5.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018166	nspb-5
Is affected by several genes including daf-2; clk-1; and eat-2 based on quantitative PCR; microarray; and RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00018167	nspb-4
Is enriched in germ line and pharynx based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; quantitative PCR; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; D-glucose; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00018168	irld-7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; paraquat; and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00018169	nspb-2
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on quantitative PCR; microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Ethanol; multi-walled carbon nanotube; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00018170	nspb-1
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on quantitative PCR; tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Tunicamycin; multi-walled carbon nanotube; and Vitamin B 12 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00018172	F38B6.2
Is enriched in ALM; FLP; PLM; and pharynx based on microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018173	F38B6.3
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SEA domain; SEA domain; and SEA domain superfamily.

WB:WBGene00018174	F38B6.4
Is predicted to have phosphoribosylglycinamide formyltransferase activity. Is expressed in intestinal cell. Is an ortholog of human GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase).

WB:WBGene00018175	F38B6.6
Is predicted to have mannosyltransferase activity. Is an ortholog of human TMTC4 (transmembrane O-mannosyltransferase targeting cadherins 4).

WB:WBGene00018176	F38B6.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018178	F38E1.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018179	F38E1.6
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00018180	srsx-22
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00018181	mpdu-1
Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation If. Is an ortholog of human MPDU1 (mannose-P-dolichol utilization defect 1).

WB:WBGene00018182	F38E1.10
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; lin-35; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00018184	F38E9.1
Is predicted to have phosphoric diester hydrolase activity. Is an ortholog of human PLCXD2 (phosphatidylinositol specific phospholipase C X domain containing 2) and PLCXD3 (phosphatidylinositol specific phospholipase C X domain containing 3).

WB:WBGene00018185	F38E9.3
No description available

WB:WBGene00018186	F38E9.4
Is enriched in muscle cell based on microarray studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by metformin; Sirolimus; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018187	twf-2
Is predicted to have actin filament binding activity and actin monomer binding activity. Is expressed in hypodermis and intestine. Is an ortholog of human TWF1 (twinfilin actin binding protein 1) and TWF2 (twinfilin actin binding protein 2).

WB:WBGene00018188	F38E9.6
Is enriched in AFD; head mesodermal cell; and neurons based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018189	nhr-181
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons; intestine; neurons; and tail neurons.

WB:WBGene00018190	F38H12.5
Is affected by several genes including eat-2; sir-2.1; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00018191	frpr-7
Is expressed in ADE and interneuron. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00018192	F39B3.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; bar-1; and cyc-1 based on microarray and RNA-seq studies. Is affected by hydrogen sulfide and cadmium based on microarray studies.

WB:WBGene00018193	F39C12.1
Is affected by several genes including sir-2.1; sek-1; and fog-2 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Zinc-ribbon like family; WD40/YVTN repeat-like-containing domain superfamily; WD repeat protein mio, zinc-ribbon like domain; WD40-repeat-containing domain superfamily; and MIOS/Sea4. Is an ortholog of human MIOS (meiosis regulator for oocyte development).

WB:WBGene00018194	F39E9.1
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Heme; D-glucopyranose; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00018195	btb-16
Is enriched in OLL; PVD; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; Mianserin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018196	nep-13
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00018197	F39E9.5
No description available

WB:WBGene00018198	F39E9.6
Is enriched in AVK; DA neuron; VA neuron; body wall muscle cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018199	F39E9.7
Is enriched in head mesodermal cell; intestine; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018200	btb-17
Is enriched in ASER and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018201	btb-18
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018202	F39F10.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018203	F39F10.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018204	F39F10.4
Is enriched in GABAergic neurons; coelomocyte; germ line; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00018205	F39F10.5
Is predicted to have RNA transmembrane transporter activity.

WB:WBGene00018206	ugt-61
Is predicted to have UDP-glycosyltransferase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A10 (UDP glucuronosyltransferase family 1 member A10); and UGT1A9 (UDP glucuronosyltransferase family 1 member A9).

WB:WBGene00018207	F39G3.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00018208	F39G3.3
Is predicted to have RNA binding activity.

WB:WBGene00018209	F39G3.4
Is predicted to have oxidoreductase activity. Is an ortholog of human CYB561 (cytochrome b561).

WB:WBGene00018210	F39G3.5
Is predicted to have oxidoreductase activity. Is involved in innate immune response. Is an ortholog of human CYB561 (cytochrome b561).

WB:WBGene00018211	oac-24
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018212	F39H12.1
Is affected by several genes including pgl-1; prg-1; and csr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including D-glucose; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018213	F39H12.2
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR54 (WD repeat domain 54).

WB:WBGene00018214	F39H12.3
Is predicted to have calmodulin binding activity. Is an ortholog of human SPA17 (sperm autoantigenic protein 17).

WB:WBGene00018215	igcm-1
Is expressed in several structures, including interfacial epithelial cell; intestine; labial sensillum; neurons; and pharynx. Is predicted to encode a protein with the following domains: Fibronectin type III domain; Immunoglobulin V-set domain; Immunoglobulin I-set domain; Immunoglobulin domain; CD80-like C2-set immunoglobulin domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Fibronectin type III; Immunoglobulin I-set; Immunoglobulin V-set domain; CD80-like, immunoglobulin C2-set; Immunoglobulin-like fold; Fibronectin type III superfamily; and Immunoglobulin-like domain superfamily.

WB:WBGene00018216	F40A3.1
Is involved in innate immune response.

WB:WBGene00018217	F40A3.2
Is enriched in several structures, including RID; cephalic sheath cell; dopaminergic neurons; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018218	F40A3.3
Is predicted to have lipid binding activity. Localizes to mitochondrion. Is an ortholog of human PEBP1 (phosphatidylethanolamine binding protein 1).

WB:WBGene00018219	F40A3.4
Is enriched in hypodermis; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00018221	F40A3.6
Is enriched in PLM; body wall muscle cell; head mesodermal cell; intestine; and muscle cell based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including glp-1; let-7; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including methylmercuric chloride; Rotenone; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018222	F40A3.7
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00018223	bath-13
Is enriched in coelomocyte; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018224	bath-18
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; fog-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Alovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00018225	nep-14
Is affected by several genes including daf-2; skn-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies.

WB:WBGene00018226	F40B5.2
Is predicted to have hydrolase activity and metal ion binding activity. Is an ortholog of human TMPPE (transmembrane protein with metallophosphoesterase domain).

WB:WBGene00018227	nep-15
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00018228	F40C5.1
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00018229	F40C5.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and prg-1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018230	mage-1
Is expressed in hypodermis. Is predicted to encode a protein with the following domain: MAGE homology domain, winged helix WH2 motif.

WB:WBGene00018231	F40E3.3
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by mir-34 and daf-2 based on microarray studies. Is affected by aldicarb based on microarray studies.

WB:WBGene00018232	F40E3.5
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00018233	F40E3.6
Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Tunicamycin; sodium arsenite; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018234	F40E12.1
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and dibromoacetic acid based on RNA-seq and microarray studies.

WB:WBGene00018235	F40E12.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00018236	fbxb-71
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00018237	irg-7
Is predicted to have carbohydrate binding activity. Human ortholog(s) of this gene are implicated in essential tremor 5.

WB:WBGene00018238	F40F4.7
Is predicted to have N-acetyltransferase activity. Is an ortholog of human NAA50 (N-alpha-acetyltransferase 50, NatE catalytic subunit).

WB:WBGene00018239	sec-20
Is predicted to have SNAP receptor activity. Is an ortholog of human BNIP1 (BCL2 interacting protein 1).

WB:WBGene00018240	cox-17
Is predicted to have copper chaperone activity. Is an ortholog of human COX17 (cytochrome c oxidase copper chaperone COX17).

WB:WBGene00018241	F40G9.5
Is enriched in germ line; intestine; male-specific anatomical entity; and pharynx based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including methylmercuric chloride; Mianserin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018242	F40G9.6
Is enriched in hypodermis; intestine; male-specific anatomical entity; and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00018243	F40G9.7
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018244	F40G9.8
Is enriched in NSM based on tiling array studies. Is affected by cyc-1; drh-3; and eri-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018245	F40G9.9
Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Mercuric Chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00018246	clec-148
Is predicted to have signaling receptor activity.

WB:WBGene00018247	F40G9.12
Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00018248	F40G9.14
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; mex-1; and nhr-25 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00018249	F40H3.1
Is enriched in germline precursor cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and fog-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018250	F40H3.2
Is enriched in Z1; Z4; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018251	F40H3.3
Is enriched in ASER; body wall muscle cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercury hydroxide; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018252	F40H3.6
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rotenone and Zidovudine based on RNA-seq studies.

WB:WBGene00018253	F40H6.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00018254	F40H6.2
Is enriched in RID and in male based on RNA-seq studies. Is affected by several genes including sir-2.1; alg-1; and mex-3 based on RNA-seq and microarray studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00018255	F40H6.5
Is predicted to have galactoside binding activity. Is an ortholog of human LGALS12 (galectin 12).

WB:WBGene00018256	cutl-28
Is enriched in PLM and RID based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain; Apple domain; and PAN/Apple domain.

WB:WBGene00018257	F41B4.1
Is enriched in body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018258	F41B4.2
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5354) and Protein of unknown function DUF5354.

WB:WBGene00018259	F41B4.3
Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00018260	cyp-33C7
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00018261	cyp-33C5
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00018262	cyp-33C3
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00018263	F41B5.6
No description available

WB:WBGene00018264	cyp-33C6
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00018265	nhr-182
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018266	nhr-183
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons; tail neurons; and ventral nerve cord.

WB:WBGene00018267	F41C3.1
Is enriched in Z1; Z4; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00018268	F41C3.2
Is predicted to have transmembrane transporter activity. Is expressed in body wall musculature and uterine muscle.

WB:WBGene00018269	acs-11
Is predicted to have catalytic activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in combined malonic and methylmalonic acidemia. Is an ortholog of human ACSF3 (acyl-CoA synthetase family member 3).

WB:WBGene00018270	eas-1
Is enriched in EMS; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Got1/Sft2-like family and Vesicle transport protein, Got1/SFT2-like. Is an ortholog of human GOLT1A (golgi transport 1A) and GOLT1B (golgi transport 1B).

WB:WBGene00018271	ctsa-1.1
Is predicted to have serine-type carboxypeptidase activity. Is expressed in gonad. Human ortholog(s) of this gene are implicated in galactosialidosis. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00018273	F41C3.7
Is enriched in dopaminergic neurons; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including tryptophan; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00018274	F41C3.8
Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in I3 neuron; I6 neuron; and pharyngeal muscle cell.

WB:WBGene00018275	F41C3.11
Is enriched in OLL; PVD; hypodermis; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00018278	F41C6.4
Is predicted to have metalloendopeptidase activity.

WB:WBGene00018279	F41C6.6
Is affected by several genes including daf-16; alg-1; and mex-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018280	F41C6.7
Is predicted to have cadmium ion transmembrane transporter activity; ferrous iron transmembrane transporter activity; and zinc efflux active transmembrane transporter activity.

WB:WBGene00018281	tbc-18
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human SGSM3 (small G protein signaling modulator 3).

WB:WBGene00018282	F41D9.2
Is predicted to have axon guidance receptor activity.

WB:WBGene00018283	sulp-3
Is predicted to have transmembrane transporter activity. Is expressed in pm3; pm4; pm5; pm6; and pm7. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of human SLC26A5 (solute carrier family 26 member 5).

WB:WBGene00018284	F41E6.1
Is enriched in neurons; ventral nerve cord; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00018285	smk-1
Is involved in several processes, including defense response to bacterium; negative regulation of mitotic DNA damage checkpoint; and response to X-ray. Localizes to nucleus. Is expressed in hypodermis; intestine; and tail. Is an ortholog of human PPP4R3A (protein phosphatase 4 regulatory subunit 3A) and PPP4R3B (protein phosphatase 4 regulatory subunit 3B).

WB:WBGene00018286	F41E6.5
Is predicted to have L-lactate dehydrogenase activity. Is an ortholog of human HAO1 (hydroxyacid oxidase 1).

WB:WBGene00018288	F41E6.7
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including aak-2; mex-3; and hsp-6 based on microarray and RNA-seq studies. Is affected by eight chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018289	F41E6.8
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; antimycin; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00018290	vps-60
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Atrazine; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Snf7 and Snf7 family. Is an ortholog of human CHMP5 (charged multivesicular body protein 5).

WB:WBGene00018291	fip-4
Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00018292	F41E6.11
Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00018293	F41E6.12
Is enriched in OLL; PVD; germline precursor cell; and hypodermis based on microarray and tiling array studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; Tunicamycin; and D-glucopyranose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018294	atg-18
Exhibits phosphatidylinositol phosphate binding activity. Is involved in several processes, including autophagy; gamete generation; and positive regulation of triglyceride lipase activity. Localizes to phagocytic vesicle. Is expressed in several structures, including head and tail. Is an ortholog of human WIPI2 (WD repeat domain, phosphoinositide interacting 2).

WB:WBGene00018295	oac-29
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018296	F41F3.1
Is enriched in germ line; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00018297	F41F3.3
Is enriched in AFD; DA neuron; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Nitric Oxide; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018298	nlp-50
Is enriched in head mesodermal cell and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018299	F41G3.2
Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00018300	F41G3.3
Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018301	F41G3.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018302	F41G3.6
Is enriched in germ line; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; metformin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018303	F41G3.10
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and touch receptor neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CC domain; ShK domain-like; ShKT domain; and CC domain.

WB:WBGene00018304	agr-1
Exhibits dystroglycan binding activity. Localizes to basement membrane. Is expressed in hermaphrodite distal tip cell; hyp7 syncytium; motor neurons; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including Pierson syndrome; bone development disease (multiple); and junctional epidermolysis bullosa (multiple). Is an ortholog of human AGRN (agrin).

WB:WBGene00018305	exos-8
Is predicted to have AU-rich element binding activity. Is an ortholog of human EXOSC8 (exosome component 8).

WB:WBGene00018307	dyla-1
Is predicted to have dynein heavy chain binding activity. Is expressed in OLQDL; OLQDR; OLQVL; OLQVR; and head neurons. Is an ortholog of human DNALI1 (dynein axonemal light intermediate chain 1).

WB:WBGene00018309	F41G4.5
Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018310	F41G4.7
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018311	F41G4.8
Is enriched in GABAergic neurons; body wall muscle cell; coelomocyte; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018312	F41H8.1
Is affected by lin-15B and dpy-21 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00018313	F41H8.2
Is affected by daf-16; hpl-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00018314	F41H10.1
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; elt-2; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018315	F41H10.2
Is enriched in muscle cell and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018316	F41H10.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and sir-2.1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018317	F41H10.4
Is enriched in coelomocyte; germ line; hypodermis; and neurons based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-12; lin-4; and let-7 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by seven chemicals including D-glucose; levamisole; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domain: GRIP1-associated protein 1. Is an ortholog of human GRIPAP1 (GRIP1 associated protein 1).

WB:WBGene00018318	F41H10.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TLC domain and TRAM/LAG1/CLN8 homology domain. Is an ortholog of human TLCD1 (TLC domain containing 1) and TLCD2 (TLC domain containing 2).

WB:WBGene00018319	hda-6
Is predicted to have protein deacetylase activity. Is used to study Parkinson's disease. Is an ortholog of human HDAC6 (histone deacetylase 6).

WB:WBGene00018321	sand-1
Is involved in several processes, including early endosome to late endosome transport; phagosome maturation involved in apoptotic cell clearance; and positive regulation of early endosome to late endosome transport. Localizes to early endosome and membrane. Is an ortholog of human MON1A (MON1 homolog A, secretory trafficking associated) and MON1B (MON1 homolog B, secretory trafficking associated).

WB:WBGene00018322	F41H10.12
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-2; aak-2; and aak-1 based on microarray and RNA-seq studies. Is affected by Cholestanol; resveratrol; and dafa#1 based on microarray studies.

WB:WBGene00018323	F42A6.1
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; pgl-1; and mes-2 based on microarray; tiling array; and RNA-seq studies. Is affected by allantoin; Sirolimus; and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018324	F42A6.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including let-60; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018325	F42A6.3
Is enriched in germ line based on proteomic studies. Is affected by several genes including daf-16; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00018326	cyp-25A5
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq; proteomic; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Sodium Chloride; and Rifampin based on RNA-seq studies. Is an ortholog of human TBXAS1 (thromboxane A synthase 1).

WB:WBGene00018327	F42A6.5
Is predicted to have ubiquitin-protein transferase activity. Human ortholog(s) of this gene are implicated in breast cancer.

WB:WBGene00018328	F42A6.6
Is predicted to have Hsp70 protein binding activity and nuclear import signal receptor activity. Human ortholog(s) of this gene are implicated in hypomyelinating leukodystrophy 13. Is an ortholog of human HIKESHI (heat shock protein nuclear import factor hikeshi).

WB:WBGene00018329	fbxa-130
Is affected by several genes including let-60; clk-1; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018330	elks-1
Exhibits PDZ domain binding activity. Is involved in protein localization and regulation of protein deneddylation. Localizes to basement membrane and presynaptic active zone. Is expressed in nervous system. Is an ortholog of human ERC2 (ELKS/RAB6-interacting/CAST family member 2).

WB:WBGene00018332	F42A9.3
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00018333	cyp-33E3
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets.

WB:WBGene00018334	cyp-33E2
Exhibits monooxygenase activity. Is involved in long-chain fatty acid metabolic process and regulation of pharyngeal pumping. Localizes to intracellular membrane-bounded organelle. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00018335	F42A9.6
Is enriched in NSM; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00018336	F42A9.7
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00018337	F42A9.8
Is enriched in coelomocyte; germ line; neurons; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and metformin based on microarray and RNA-seq studies.

WB:WBGene00018338	F42A9.9
Is enriched in AFD; ALM; FLP; PLM; and neurons based on microarray and RNA-seq studies. Is affected by several genes including mex-3; mex-1; and spn-4 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018339	abcf-3
Is predicted to have ATP binding activity. Is involved in positive regulation of peptidyl-serine phosphorylation; regulation of apoptotic process; and regulation of translation. Is expressed in several structures, including body wall musculature; head neurons; hermaphrodite gonad; intestinal cell; and pharyngeal neurons. Is an ortholog of human ABCF3 (ATP binding cassette subfamily F member 3).

WB:WBGene00018340	anmt-2
Is predicted to have N-methyltransferase activity. Is expressed in pharyngeal muscle cell. Is an ortholog of human PNMT (phenylethanolamine N-methyltransferase).

WB:WBGene00018341	F42A10.5
Is expressed in head neurons; intestine; nerve ring; spermatheca; and tail. Is predicted to encode a protein with the following domains: Carnitine deficiency-associated protein 3 and Protein CDV3.

WB:WBGene00018342	F42A10.6
Is enriched in OLL and PVD based on SAGE; Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018343	F42A10.7
Is enriched in ASER and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-nine chemicals including methylmercury hydroxide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018344	npr-27
Is predicted to have G protein-coupled peptide receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus.

WB:WBGene00018345	F42C5.3
Is enriched in several structures, including dopaminergic neurons; germ line; male distal tip cell; neuronal sheath cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Nitric Oxide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies.

WB:WBGene00018346	F42C5.4
Is enriched in several structures, including Z4.a; coelomocyte; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Zinc finger, RING-type and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00018347	F42C5.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018348	F42C5.6
Is enriched in AVE based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and isp-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00018349	F42C5.9
Localizes to plasma membrane and striated muscle dense body.

WB:WBGene00018350	ifo-1
Is enriched in head mesodermal cell; intestine; pharyngeal muscle cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018351	F42G2.2
Is enriched in Z1; Z4; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Heme; D-glucopyranose; and sesamin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00018352	fbxc-20
Is enriched in pharynx and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00018353	fbxa-182
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and D-glucopyranose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00018354	F42G2.5
Is predicted to have FFAT motif binding activity. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 8 and autosomal dominant adult-onset proximal spinal muscular atrophy. Is an ortholog of human VAPB (VAMP associated protein B and C).

WB:WBGene00018355	ceh-86
Is predicted to have DNA binding activity.

WB:WBGene00018356	islo-1
Is expressed in body wall musculature and non-striated muscle. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018357	moc-3
Is predicted to have URM1 activating enzyme activity; nucleotidyltransferase activity; and thiosulfate sulfurtransferase activity. Is an ortholog of human MOCS3 (molybdenum cofactor synthesis 3).

WB:WBGene00018358	erp-44.3
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq studies. Human ortholog(s) of this gene are implicated in Cole-Carpenter syndrome. Is predicted to encode a protein with the following domains: Thioredoxin-like domain; Thioredoxin; Thioredoxin domain; and Thioredoxin-like superfamily. Is an ortholog of human ERP44 (endoplasmic reticulum protein 44).

WB:WBGene00018359	F42G8.8
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00018360	irld-8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00018361	F42G8.10
Is enriched in germ line; muscle cell; and neurons based on proteomic and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in syndromic microphthalmia. Is predicted to encode a protein with the following domains: ESSS subunit of NADH:ubiquinone oxidoreductase (complex I) and NADH:ubiquinone oxidoreductase, ESSS subunit. Is an ortholog of human NDUFB11 (NADH:ubiquinone oxidoreductase subunit B11).

WB:WBGene00018362	ppm-1.G
Is predicted to have magnesium-dependent protein serine/threonine phosphatase activity. Is expressed in gonad and head. Is an ortholog of human PPM1G (protein phosphatase, Mg2+/Mn2+ dependent 1G).

WB:WBGene00018363	nlp-52
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; eat-2; and alg-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including aldicarb; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00018364	dagl-2
Is enriched in several structures, including DA neuron; germ line; interneuron; intestine; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold. Is an ortholog of human DAGLA (diacylglycerol lipase alpha).

WB:WBGene00018365	tpst-2
Is predicted to have protein-tyrosine sulfotransferase activity. Is an ortholog of human TPST1 (tyrosylprotein sulfotransferase 1) and TPST2 (tyrosylprotein sulfotransferase 2).

WB:WBGene00018366	F42H10.2
Is predicted to have protein disulfide oxidoreductase activity. Is an ortholog of human CHCHD4 (coiled-coil-helix-coiled-coil-helix domain containing 4).

WB:WBGene00018367	F42H10.3
Is predicted to have actin filament binding activity. Localizes to cell junction and striated muscle dense body. Is an ortholog of human LASP1 (LIM and SH3 protein 1).

WB:WBGene00018369	mig-39
Is predicted to have metal ion binding activity and protein dimerization activity. Is expressed in distal tip cell and germ line.

WB:WBGene00018370	F42H10.6
Exhibits identical protein binding activity. Is an ortholog of human ACOT13 (acyl-CoA thioesterase 13).

WB:WBGene00018371	ess-2
Localizes to nucleus. Is expressed widely. Is used to study DiGeorge syndrome and velocardiofacial syndrome. Human ortholog(s) of this gene are implicated in velocardiofacial syndrome. Is an ortholog of human ESS2 (ess-2 splicing factor homolog).

WB:WBGene00018373	F43B10.1
Is predicted to have protein phosphatase regulator activity. Is an ortholog of human PPP2R3B (protein phosphatase 2 regulatory subunit B''beta).

WB:WBGene00018374	tag-343
Is predicted to have RNA polymerase II complex binding activity and chromatin binding activity.

WB:WBGene00018375	F43C9.1
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; tryptophan; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box-like domain superfamily.

WB:WBGene00018376	F43C9.2
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00018377	hum-10
Is predicted to have ATP binding activity; actin binding activity; and motor activity.

WB:WBGene00018378	F43C11.1
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018379	F43C11.2
Is enriched in NSM; germ line; male-specific anatomical entity; and in male based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018380	decr-1.1
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on quantitative PCR; microarray; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00018381	F43C11.4
Is affected by several genes including clk-1; sir-2.1; and mex-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018382	F43C11.5
Is affected by several genes including daf-12; clk-1; and smg-2 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00018383	F43C11.6
Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Mianserin and nitroguanidine based on RNA-seq and microarray studies.

WB:WBGene00018384	F43C11.7
Is predicted to have zinc ion binding activity. Is involved in defense response to Gram-positive bacterium and determination of adult lifespan. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of several human genes including MEFV (MEFV innate immuity regulator, pyrin); TRIM58 (tripartite motif containing 58); and TRIML1 (tripartite motif family like 1).

WB:WBGene00018385	F43C11.8
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H.

WB:WBGene00018386	enri-1
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and fog-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018387	F43C11.10
Is affected by several genes including daf-2; eat-2; and mir-35 based on tiling array; microarray; and RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00018388	F43C11.11
Is affected by several genes including eat-2; pgl-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018389	F43C11.12
Is enriched in AVE; NSM; and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sma-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018390	F43E2.1
Is enriched in DA neuron; VA neuron; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and cyc-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; stavudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Nucleotidyltransferase superfamily.

WB:WBGene00018391	rpb-4
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2D (RNA polymerase II subunit D).

WB:WBGene00018392	insc-1
Is expressed in several structures, including body wall musculature; hypodermis; and pharynx. Is predicted to encode a protein with the following domains: Armadillo-like helical; Armadillo-type fold; and Inscuteable. Is an ortholog of human INSC (INSC spindle orientation adaptor protein).

WB:WBGene00018393	msra-1
Exhibits L-methionine:thioredoxin-disulfide S-oxidoreductase activity and peptide-methionine (S)-S-oxide reductase activity. Is involved in oxidation-reduction process. Is expressed in hypodermis and neurons. Is an ortholog of human MSRA (methionine sulfoxide reductase A).

WB:WBGene00018394	F43E2.6
Is enriched in germ line; muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Tunicamycin; manganese chloride; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00018395	mtch-1
Is enriched in germ line; head mesodermal cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including stavudine; Zidovudine; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Mitochondrial carrier domain superfamily. Is an ortholog of human MTCH2 (mitochondrial carrier 2).

WB:WBGene00018397	F43E2.11
Is enriched in DA neuron; VA neuron; and ventral nerve cord based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human MTCH2 (mitochondrial carrier 2).

WB:WBGene00018398	sptl-2
Is predicted to have pyridoxal phosphate binding activity and serine C-palmitoyltransferase activity. Human ortholog(s) of this gene are implicated in erythropoietic protoporphyria; hereditary sensory and autonomic neuropathy type 1C; and sideroblastic anemia 1. Is an ortholog of human SPTLC2 (serine palmitoyltransferase long chain base subunit 2) and SPTLC3 (serine palmitoyltransferase long chain base subunit 3).

WB:WBGene00018399	F43H9.3
Is predicted to have nucleotidyltransferase activity.

WB:WBGene00018400	F43H9.4
Is predicted to have glycine N-acyltransferase activity.

WB:WBGene00018402	kvs-3
Is predicted to have voltage-gated potassium channel activity. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNF1 (potassium voltage-gated channel modifier subfamily F member 1).

WB:WBGene00018403	F44A2.3
Is predicted to have lipid binding activity. Is expressed in amphid socket cell; excretory duct; head; hypodermis; and vulva. Is an ortholog of human BPIFC (BPI fold containing family C) and PLTP (phospholipid transfer protein).

WB:WBGene00018404	nhr-39
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018405	F44A2.5
Is predicted to have translation activator activity. Localizes to sarcoplasmic reticulum. Is expressed in metacorpus and procorpus. Is an ortholog of human MIF4GD (MIF4G domain containing).

WB:WBGene00018406	F44A2.7
Is enriched in ASER and AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Acetyltransferase (GNAT) domain; Domain of unknown function DUF1248; Acyl-CoA N-acyltransferase; and YitH, acetyltransferase (GNAT) domain.

WB:WBGene00018407	F44B9.2
Is expressed in body wall musculature and vulval muscle.

WB:WBGene00018408	F44B9.5
Is predicted to have ubiquitin binding activity and ubiquitin-protein transferase activator activity. Is expressed in vulA; vulB1; and vulB2. Is an ortholog of human AUP1 (AUP1 lipid droplet regulating VLDL assembly factor).

WB:WBGene00018409	F44B9.8
Is predicted to contribute to DNA clamp loader activity. Is an ortholog of human RFC5 (replication factor C subunit 5).

WB:WBGene00018410	F44B9.9
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00018411	F44B9.10
Is predicted to have calcium ion binding activity and phospholipase A2 activity. Is an ortholog of human PLA2G12A (phospholipase A2 group XIIA) and PLA2G12B (phospholipase A2 group XIIB).

WB:WBGene00018412	nhr-37
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in neurons and seam cell.

WB:WBGene00018413	cyp-33C4
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00018414	nstp-8
Is predicted to have UDP-galactose transmembrane transporter activity. Is an ortholog of human SLC35A1 (solute carrier family 35 member A1).

WB:WBGene00018415	nhr-184
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018416	retr-1
No description available

WB:WBGene00018417	F44E2.3
Is enriched in germ line and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; D-glucose; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arginine and glutamate-rich 1 and Arginine and glutamate-rich protein 1.

WB:WBGene00018418	F44E2.4
Is enriched in OLL; PLM; PVD; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-three chemicals including methylmercury hydroxide; Rotenone; and manganese chloride based on RNA-seq; microarray; and proteomic studies. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; and LDL receptor-like superfamily.

WB:WBGene00018419	F44E2.6
Is predicted to have peptide-methionine (R)-S-oxide reductase activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 74. Is an ortholog of human MSRB2 (methionine sulfoxide reductase B2).

WB:WBGene00018420	F44E2.7
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00018421	F44E2.8
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including bisphenol S; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF1768); NADAR; and YbiA-like superfamily.

WB:WBGene00018422	F44E2.9
Is enriched in several structures, including body wall muscle cell; germ line; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018423	F44E2.10
Is predicted to have carbohydrate binding activity. Is an ortholog of human MLEC (malectin).

WB:WBGene00018424	pgph-2
Is predicted to have phosphatase activity. Is an ortholog of human PDXP (pyridoxal phosphatase) and PGP (phosphoglycolate phosphatase).

WB:WBGene00018425	F44E7.3
Is enriched in intestine; somatic gonad precursor; and in male based on RNA-seq and microarray studies. Is affected by several genes including let-60; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018426	F44E7.4
Is predicted to have catalytic activity and metal ion binding activity. Is expressed in gonad. Is an ortholog of human IDE (insulin degrading enzyme).

WB:WBGene00018427	F44E7.5
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by nineteen chemicals including manganese chloride; sodium arsenite; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018428	fbxa-183
Is enriched in GABAergic neurons and excretory cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including methylmercuric chloride; Tunicamycin; and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00018429	F44E7.7
Is predicted to have transmembrane transporter activity.

WB:WBGene00018430	nhr-142
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018431	F44E7.9
Is enriched in germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including hydrogen sulfide; Rotenone; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Rab5-interacting protein (Rab5ip); Rab5-interacting protein; and Rab5-interacting protein family. Is an ortholog of human RAB5IF (RAB5 interacting factor).

WB:WBGene00018432	irld-33
Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00018433	ceh-82
Is predicted to have DNA binding activity. Is expressed in neurons.

WB:WBGene00018434	ceh-81
Is predicted to have DNA binding activity. Is expressed in dorsal nerve cord; head muscle; tail neurons; and ventral nerve cord.

WB:WBGene00018435	btb-9
Is enriched in AFD and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018436	fbxb-11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00018437	btb-8
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018438	btb-6
Is enriched in BAG; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018439	fbxa-184
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00018440	F45C12.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including mex-3; mex-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00018441	math-29
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00018442	sdz-18
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018443	btb-7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018444	fbxb-48
Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00018445	fbxb-5
Is affected by several genes including eat-2; let-418; and drh-3 based on tiling array and RNA-seq studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00018446	ceh-83
Is predicted to have DNA binding activity. Is expressed in hypodermis; intestine; and vulva.

WB:WBGene00018447	irld-9
Is affected by several genes including lin-4; lin-14; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00018448	F45D11.1
Is enriched in intestine; muscle cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; tryptophan; and 4-bromodiphenyl ether based on microarray studies.

WB:WBGene00018449	F45D11.2
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; skn-1; and pmk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including sesamin; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018450	F45D11.3
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by six chemicals including sesamin; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018451	F45D11.4
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including sesamin; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018452	F45D11.5
Is enriched in NSM and cephalic sheath cell based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018453	F45D11.6
No description available

WB:WBGene00018454	fbxb-28
Is affected by several genes including eat-2; mex-3; and spn-4 based on tiling array and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018455	fbxc-42
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including bisphenol A; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00018456	fbxc-39
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00018457	fbxb-29
Is affected by several genes including daf-2; eat-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00018458	fbxb-30
Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00018459	F45D11.14
Is expressed in hypodermis and intestine. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF684); and Protein of unknown function DUF684.

WB:WBGene00018460	F45D11.15
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including Ethanol; Tunicamycin; and sesamin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF684); and Protein of unknown function DUF684.

WB:WBGene00018461	F45D11.16
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on proteomic; RNA-seq; and microarray studies. Is affected by eighteen chemicals including Ethanol; sesamin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF684); and Protein of unknown function DUF684.

WB:WBGene00018462	F45E1.1
Is enriched in DA neuron; VA neuron; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; dpy-7; and sek-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00018463	F45E1.2
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including lin-39; mex-3; and mex-1 based on RNA-seq; tiling array; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018465	F45E1.4
Is predicted to have phosphoglycolate phosphatase activity.

WB:WBGene00018466	F45E1.5
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018467	sdpn-1
Is predicted to have cytoskeletal protein binding activity and phospholipid binding activity. Is involved in endocytic recycling. Localizes to early endosome and recycling endosome membrane. Is expressed in intestine; pharyngeal muscle cell; and pharynx. Is an ortholog of human PACSIN1 (protein kinase C and casein kinase substrate in neurons 1); PACSIN2 (protein kinase C and casein kinase substrate in neurons 2); and PACSIN3 (protein kinase C and casein kinase substrate in neurons 3).

WB:WBGene00018468	cla-1
Is predicted to have several functions, including SNARE binding activity; calcium ion binding activity; and phospholipid binding activity. Is involved in maintenance of presynaptic active zone structure; spontaneous synaptic transmission; and synaptic vesicle cycle. Localizes to presynaptic active zone. Is expressed in nervous system. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 3.

WB:WBGene00018470	F45E4.5
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00018471	F45E4.6
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018472	nep-16
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00018473	cima-1
Is predicted to have sialic acid transmembrane transporter activity. Is involved in regulation of protein catabolic process and regulation of synapse organization. Localizes to lysosome. Is expressed in hypodermis and intestine.

WB:WBGene00018474	cnep-1
Is predicted to have protein serine/threonine phosphatase activity. Is involved in regulation of nuclear division. Localizes to nuclear envelope. Is an ortholog of human CTDNEP1 (CTD nuclear envelope phosphatase 1).

WB:WBGene00018475	mrpl-14
Is predicted to be a structural constituent of ribosome. Is an ortholog of human C1orf53 (chromosome 1 open reading frame 53).

WB:WBGene00018476	F45E12.6
Is enriched in neurons and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00018477	otpl-4
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1); OTOP2 (otopetrin 2); and OTOP3 (otopetrin 3).

WB:WBGene00018478	otpl-5
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1); OTOP2 (otopetrin 2); and OTOP3 (otopetrin 3).

WB:WBGene00018479	otpl-6
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1) and OTOP2 (otopetrin 2).

WB:WBGene00018480	otpl-7
Is predicted to have proton channel activity. Is an ortholog of human OTOP1 (otopetrin 1) and OTOP2 (otopetrin 2).

WB:WBGene00018481	F45F2.9
Is predicted to have 5'-deoxynucleotidase activity. Is an ortholog of human HDDC2 (HD domain containing 2).

WB:WBGene00018482	F45F2.10
Is enriched in body wall muscle cell; germ line; germline precursor cell; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ankyrin repeat-containing domain superfamily.

WB:WBGene00018483	F45F2.11
Is enriched in body wall muscle cell; germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00018484	F46C8.1
Is enriched in cephalic sheath cell; excretory cell; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018485	F46C8.3
Is enriched in DA neuron; VA neuron; body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; D-glucose; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018486	glb-16
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons and tail neurons.

WB:WBGene00018487	F46C8.8
Is enriched in germline precursor cell; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00018488	acs-1
Is predicted to have catalytic activity. Is involved in establishment or maintenance of epithelial cell apical/basal polarity. Is expressed in intestine; neurons; and somatic gonad. Is an ortholog of human ACSF2 (acyl-CoA synthetase family member 2).

WB:WBGene00018489	F46E10.2
Is enriched in hypodermis; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00018490	F46E10.3
Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018491	mdh-1
Is predicted to have L-malate dehydrogenase activity. Is an ortholog of human MDH1 (malate dehydrogenase 1).

WB:WBGene00018492	hpo-26
Is enriched in AFD and PLM based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Heme; 1-methylnicotinamide; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018493	F46F5.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by methylmercuric chloride and resveratrol based on microarray studies.

WB:WBGene00018494	F46F5.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by glycine; Atrazine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018495	F46F5.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including sir-2.1; bar-1; and aak-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin and resveratrol based on microarray studies.

WB:WBGene00018496	F46F5.5
Is predicted to have ATP binding activity; ATP-dependent peptidase activity; and serine-type endopeptidase activity.

WB:WBGene00018497	msrp-3
Is enriched in amphid sheath cell and germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including aldicarb; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies.

WB:WBGene00018498	F46F5.7
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00018499	F46F5.8
Is affected by several genes including rrf-3; clk-1; and rrf-1 based on tiling array and microarray studies. Is affected by Tunicamycin and paraquat based on microarray studies.

WB:WBGene00018500	msrp-4
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including multi-walled carbon nanotube; D-glucose; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018501	F46F5.10
Is enriched in NSM based on tiling array studies. Is affected by fbf-1 and sir-2.1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; fluoranthene; and dafa#1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00018502	F46F5.11
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercury hydroxide; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00018503	F46F5.12
Is affected by hpl-2; rsr-2; and ain-1 based on tiling array and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00018504	F46F5.13
Is affected by rsr-2; wdr-5.1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by fluoranthene and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00018505	F46F5.14
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; D-glucose; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273 and Protein of unknown function DUF273.

WB:WBGene00018506	F46F5.15
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and Colistin based on microarray studies.

WB:WBGene00018507	F46F5.16
Is affected by several genes including daf-2; sir-2.1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube and D-glucose based on RNA-seq studies.

WB:WBGene00018508	F46F11.1
Is predicted to have ATP binding activity and kinase activity. Localizes to cytoplasm. Is an ortholog of human PPIP5K2 (diphosphoinositol pentakisphosphate kinase 2).

WB:WBGene00018509	xrep-4
Is expressed in intestine; muscle cell; neurons; and pharynx. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00018510	F46F11.7
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domain: .

WB:WBGene00018511	F46F11.8
Is enriched in OLL; body wall muscle cell; germ line; germline precursor cell; and interneuron based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018512	trpp-8
Is enriched in germ line; germline precursor cell; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Aspirin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ER-Golgi trafficking TRAPP I complex 85 kDa subunit and TRAPP III complex, Trs85. Is an ortholog of human TRAPPC8 (trafficking protein particle complex 8).

WB:WBGene00018513	F46F11.10
Is predicted to have tRNA (guanine-N1-)-methyltransferase activity and tRNA binding activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 30. Is an ortholog of human TRMT10C (tRNA methyltransferase 10C, mitochondrial RNase P subunit).

WB:WBGene00018514	twnk-1
Is predicted to have 5'-3' DNA helicase activity and single-stranded DNA binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3; mitochondrial DNA depletion syndrome 7; and sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. Is an ortholog of human TWNK (twinkle mtDNA helicase).

WB:WBGene00018515	F46G11.2
Is enriched in AFD; GABAergic neurons; excretory cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018516	gakh-1
Is predicted to have AP-2 adaptor complex binding activity and protein serine/threonine kinase activity. Is expressed in intestine; neurons; and pharynx. Is an ortholog of human GAK (cyclin G associated kinase).

WB:WBGene00018517	F46G11.4
Is enriched in coelomocyte; head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including D-glucose; sesamin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00018518	F46H5.2
Is enriched in OLL; PVD; and intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Hydrolyzable Tannins; Humic Substances; and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and FAM122. Is an ortholog of human FAM122A (family with sequence similarity 122A) and FAM122B (family with sequence similarity 122B).

WB:WBGene00018519	F46H5.3
Is predicted to have creatine kinase activity. Is an ortholog of human CKMT2 (creatine kinase, mitochondrial 2).

WB:WBGene00018520	F46H5.4
Is predicted to have guanyl-nucleotide exchange factor activity. Human ortholog(s) of this gene are implicated in Adams-Oliver syndrome; early infantile epileptic encephalopathy 23; and hyper IgE recurrent infection syndrome 2. Is an ortholog of human DOCK6 (dedicator of cytokinesis 6); DOCK7 (dedicator of cytokinesis 7); and DOCK8 (dedicator of cytokinesis 8).

WB:WBGene00018521	F46H5.5
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018522	F46H5.7
Is enriched in germ line; intestine; and muscle cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Cry5B; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transactive response DNA-binding protein N-terminal domain; Glycogen recognition site of AMP-activated protein kinase; Immunoglobulin-like fold; Immunoglobulin E-set; SNF1 protein kinase subunit beta-2/beta-3; AMP-activated protein kinase, glycogen-binding domain; and TAR DNA-binding protein 43, N-terminal.

WB:WBGene00018523	lact-1
Is enriched in several structures, including cephalic sheath cell; head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Tunicamycin; D-glucose; and juglone based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 9 and primary coenzyme Q10 deficiency 4. Is predicted to encode a protein with the following domains: Beta-lactamase; Beta-lactamase-related; and Beta-lactamase/transpeptidase-like.

WB:WBGene00018525	F47B3.1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018526	F47B3.2
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018527	F47B3.3
Is enriched in body wall musculature; head mesodermal cell; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by resveratrol; Atrazine; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Membrane-associating domain and Marvel domain. Is an ortholog of human CMTM4 (CKLF like MARVEL transmembrane domain containing 4) and PLLP (plasmolipin).

WB:WBGene00018528	F47B3.4
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00018529	F47B3.5
Is enriched in ALM; PLM; and germ line based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00018530	F47B3.6
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018531	F47B3.7
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018532	F47B7.1
Is expressed in several structures, including hypodermis; vulva; and vulval precursor cell. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00018533	F47B7.2
Is predicted to have flavin-linked sulfhydryl oxidase activity and protein disulfide isomerase activity. Is expressed in head. Is an ortholog of human QSOX1 (quiescin sulfhydryl oxidase 1) and QSOX2 (quiescin sulfhydryl oxidase 2).

WB:WBGene00018534	F47B7.3
Is affected by several genes including clk-1; pmk-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol; Atrazine; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018535	F47B7.4
Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by glycine and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018536	F47B7.5
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including age-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00018537	F47B7.6
Is enriched in NSM; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018538	marg-1
Is expressed in marginal cell. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018539	nhr-185
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018540	btb-21
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Heme; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00018541	nhr-186
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018542	nhr-187
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in dorsal nerve cord; head muscle; and head neurons.

WB:WBGene00018543	ugt-32
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00018544	nhr-188
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons and tail neurons.

WB:WBGene00018545	nhr-189
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018547	clec-78
Is predicted to have calcium ion binding activity and carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium. Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 8; pigmented paravenous chorioretinal atrophy; and retinitis pigmentosa 12.

WB:WBGene00018548	clec-79
Is predicted to have carbohydrate binding activity.

WB:WBGene00018549	F47C12.6
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by ubc-9; clk-1; and mex-1 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018550	F47C12.7
Is enriched in NSM; body wall muscle cell; germ line; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; cyc-1; and ubc-9 based on microarray and tiling array studies. Is affected by Tunicamycin and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018551	F47C12.8
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including clk-1; lin-15B; and aak-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; Tunicamycin; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00018552	srt-19
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018553	srt-60
Is affected by clk-1 and eat-2 based on microarray studies.

WB:WBGene00018554	srt-3
Is affected by several genes including lin-4; lin-14; and eat-2 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018555	srt-35
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; csr-1; and ain-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018556	srt-36
Is expressed in ASIL and ASIR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018557	srt-38
Is affected by several genes including dpy-21; hpl-2; and spn-4 based on tiling array and RNA-seq studies. Is affected by cadmium and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018558	srt-20
Is expressed in ASIL; ASIR; ASJL; and ASJR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018559	srt-37
Is affected by several genes including daf-2; sir-2.1; and hpl-2 based on tiling array and microarray studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018560	F47D12.3
Is enriched in cephalic sheath cell; intestine; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018561	gadr-3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Armadillo-type fold and Leucine-rich repeat domain superfamily.

WB:WBGene00018562	F47D12.6
Is expressed in nerve ring.

WB:WBGene00018563	F47D12.7
Is enriched in AVK; amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including Heme; Ethanol; and nicotinic acid based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in spermatogenic failure 11. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB And C-terminal Kelch; Kelch motif; BTB/POZ domain; Kelch repeat type 1; SKP1/BTB/POZ domain superfamily; BTB/Kelch-associated; Kelch-type beta propeller; and BTB-kelch protein. Is an ortholog of human KLHL10 (kelch like family member 10).

WB:WBGene00018564	F47D12.9
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily and WD40-repeat-containing domain superfamily. Is an ortholog of human DCAF4 (DDB1 and CUL4 associated factor 4).

WB:WBGene00018565	F47E1.1
Is enriched in AFD; ASER; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018566	F47E1.2
Is predicted to have sodium-independent organic anion transmembrane transporter activity. Is an ortholog of human SLCO3A1 (solute carrier organic anion transporter family member 3A1).

WB:WBGene00018567	F47E1.3
Is predicted to have DNA-binding transcription factor activity; RNA polymerase II regulatory region sequence-specific DNA binding activity; and chromatin DNA binding activity. Is an ortholog of human PRDM14 (PR/SET domain 14).

WB:WBGene00018568	F47E1.4
Is predicted to have sodium-independent organic anion transmembrane transporter activity. Is an ortholog of human SLCO3A1 (solute carrier organic anion transporter family member 3A1).

WB:WBGene00018569	F47F2.1
Is predicted to have cAMP-dependent protein kinase activity. Localizes to cytoplasm. Is an ortholog of human PRKX (protein kinase X-linked).

WB:WBGene00018571	F47F2.3
Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018572	lin-42
Exhibits RNA polymerase II transcription factor binding activity. Is involved in negative regulation of dauer larval development; negative regulation of pri-miRNA transcription by RNA polymerase II; and regulation of development, heterochronic. Localizes to cytoplasm and nucleus. Is expressed in head; hyp7 syncytium; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in advanced sleep phase syndrome 1 and advanced sleep phase syndrome 3. Is an ortholog of human PER2 (period circadian regulator 2).

WB:WBGene00018573	oac-30
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018575	clec-119
Is predicted to have carbohydrate binding activity.

WB:WBGene00018576	F47G3.1
Is predicted to have metal ion binding activity.

WB:WBGene00018577	asna-2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and dcr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; Zidovudine; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00018578	F47G3.3
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018579	acs-16
Is predicted to have catalytic activity.

WB:WBGene00018580	F47G6.3
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00018582	F48A9.2
Is enriched in head mesodermal cell; intestine; neurons; pharynx; and seam cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00018585	F48A11.4
Is enriched in several structures, including ASER; Z4.a; germ line; germline precursor cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00018586	ubxn-3
Exhibits K48-linked polyubiquitin modification-dependent protein binding activity. Is involved in several processes, including masculinization of hermaphroditic germ-line; positive regulation of cellular protein catabolic process; and positive regulation of mitotic cell cycle, embryonic. Localizes to chromatin; nucleus; and perinuclear region of cytoplasm. Is expressed in gonad; neurons; spermatheca; and spermatocyte. Is an ortholog of human FAF1 (Fas associated factor 1).

WB:WBGene00018587	F48B9.1
Is affected by several genes including skn-1; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including aldicarb; Rotenone; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018589	F48B9.3
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1 and Chymotrypsin family Peptidase-S1.

WB:WBGene00018590	pdf-2
Is expressed in arcade cell; neurons; and rectum.

WB:WBGene00018591	npax-2
Is predicted to have DNA binding activity. Is expressed in head neurons; hypodermis; and vulF. Human ortholog(s) of this gene are implicated in several diseases, including Waardenburg's syndrome (multiple); diabetes mellitus (multiple); and eye disease (multiple).

WB:WBGene00018592	F48B9.7
No description available

WB:WBGene00018593	F48B9.8
Is enriched in excretory cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sek-1; pgl-1; and fbf-1 based on microarray and RNA-seq studies. Is affected by Humic Substances and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: RDD family; RDD; and Protein FAM8A1. Is an ortholog of human FAM8A1 (family with sequence similarity 8 member A1).

WB:WBGene00018594	aman-3
Is predicted to have alpha-mannosidase activity.

WB:WBGene00018595	fbxa-145
Is enriched in AVK; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; elt-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; manganese chloride; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box protein she-1-like.

WB:WBGene00018596	F48C1.3
Is affected by daf-12; dlc-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00018598	F48C1.5
Is enriched in AFD; germ line; germline precursor cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018599	F48C1.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018600	F48C1.8
Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018601	F48C1.9
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by thirty chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00018602	F48D6.4
Is enriched in ASER; head mesodermal cell; intestine; muscle cell; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00018603	F48E3.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00018604	uggt-1
Exhibits UDP-glucose:glycoprotein glucosyltransferase activity. Is involved in IRE1-mediated unfolded protein response; protein N-linked glycosylation via asparagine; and regulation of nematode larval development. Is expressed in several structures, including amphid neurons; germ line; nerve ring neurons; and phasmid neurons. Is an ortholog of human UGGT1 (UDP-glucose glycoprotein glucosyltransferase 1) and UGGT2 (UDP-glucose glycoprotein glucosyltransferase 2).

WB:WBGene00018605	F48E3.4
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00018606	F48E3.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Rotenone; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00018607	F48E3.8
Is predicted to have catalytic activity. Localizes to endoplasmic reticulum. Is expressed in AIYL; AIYR; and somatic cell. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 8; pigmented paravenous chorioretinal atrophy; and retinitis pigmentosa 12.

WB:WBGene00018608	F48E3.9
Is enriched in BAG based on tiling array studies. Is affected by several genes including rrf-3; daf-12; and let-7 based on tiling array; proteomic; microarray; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018609	F48E8.2
Is enriched in AVK; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nine chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; E2F-associated phosphoprotein; and E2F-associated phosphoprotein. Is an ortholog of human EAPP (E2F associated phosphoprotein).

WB:WBGene00018610	F48E8.3
Is predicted to have succinate dehydrogenase activity.

WB:WBGene00018611	F48E8.4
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Alovudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Glucosidase II beta subunit-like protein; Mannose-6-phosphate receptor binding domain superfamily; and Protein OS9-like. Is an ortholog of human OS9 (OS9 endoplasmic reticulum lectin).

WB:WBGene00018612	disl-2
Is predicted to have 3'-5'-exoribonuclease activity. Is involved in regulation of cell fate specification and regulation of development, heterochronic. Human ortholog(s) of this gene are implicated in Perlman syndrome. Is an ortholog of human DIS3L2 (DIS3 like 3'-5' exoribonuclease 2).

WB:WBGene00018613	skpt-1
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP2 (S-phase kinase associated protein 2).

WB:WBGene00018614	pals-31
Is enriched in several structures, including intestine; male distal tip cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and lin-4 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00018615	F48G7.4
Is enriched in several structures, including coelomocyte; excretory cell; intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box A protein FB155/FB224.

WB:WBGene00018616	F48G7.5
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Heme; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00018617	srt-17
Is affected by mir-34 and eat-2 based on microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018618	F48G7.7
Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by single-walled carbon nanotube; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00018619	F48G7.8
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Heme; Tunicamycin; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00018620	F48G7.9
Is predicted to have ATP binding activity; metal ion binding activity; and protein serine/threonine kinase activity.

WB:WBGene00018621	F48G7.10
Is predicted to have ATP binding activity; metal ion binding activity; and protein serine/threonine kinase activity. Is expressed in tail.

WB:WBGene00018622	nhr-190
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00018623	F48G7.12
Is enriched in germ line based on proteomic and RNA-seq studies. Is affected by several genes including lin-15B; nhr-25; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; and Uncharacterised  oxidoreductase Dhs-27.

WB:WBGene00018624	F48G7.13
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box A protein FB155/FB224.

WB:WBGene00018625	prp-17
Is enriched in AVA; body wall muscle cell; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; Pre-mRNA-processing factor 17; and WD40-repeat-containing domain superfamily. Is an ortholog of human CDC40 (cell division cycle 40).

WB:WBGene00018626	F49D11.2
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; alg-1; and unc-70 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00018627	F49D11.3
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00018628	F49D11.4
Is affected by several genes including clk-1; sir-2.1; and dpy-7 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018629	F49D11.5
No description available

WB:WBGene00018630	F49D11.6
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00018631	F49D11.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; antimycin; and Hydrolyzable Tannins based on microarray and RNA-seq studies.

WB:WBGene00018632	tag-296
Is predicted to have ceramide 1-phosphate binding activity and ceramide 1-phosphate transfer activity. Is an ortholog of human CPTP (ceramide-1-phosphate transfer protein).

WB:WBGene00018634	pigx-1
Is enriched in intestine; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Mianserin; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018635	nprl-2
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including age-1; daf-12; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nitrogen permease regulator 2 and Nitrogen permease regulator 2. Is an ortholog of human NPRL2 (NPR2 like, GATOR1 complex subunit).

WB:WBGene00018636	oef-1
Is expressed in P lineage cell; germ cell; and oocyte.

WB:WBGene00018637	F49E8.6
Is enriched in germ line; intestine; muscle cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including aldicarb; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00018638	F49E8.7
Is enriched in body wall muscle cell; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018639	tbc-16
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBC1D16 (TBC1 domain family member 16).

WB:WBGene00018640	F49E10.2
Is predicted to have carotenoid dioxygenase activity.

WB:WBGene00018641	F49E10.4
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; skn-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondria-eating protein; Mitochondria-eating protein; and Mitochondria-eating protein, C-terminal domain.

WB:WBGene00018643	drd-50
Is involved in defense response to Gram-positive bacterium and innate immune response.

WB:WBGene00018644	F49F1.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and cyc-1 based on microarray and RNA-seq studies. Is affected by aldicarb and tetrabromobisphenol A based on microarray studies.

WB:WBGene00018645	F49F1.5
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including Heme; hydrogen sulfide; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00018646	mul-1
Is involved in response to gamma radiation.

WB:WBGene00018647	F49F1.7
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including methylmercuric chloride; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00018648	F49F1.8
Is affected by several genes including skn-1; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including tryptophan; Alovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00018649	F49F1.9
Is predicted to have galactoside binding activity. Is an ortholog of human LGALS12 (galectin 12).

WB:WBGene00018650	F49F1.10
Is predicted to have galactoside binding activity. Is an ortholog of human LGALSL (galectin like).

WB:WBGene00018651	F49F1.11
Is predicted to have galactoside binding activity. Is an ortholog of human LGALSL (galectin like).

WB:WBGene00018652	F49F1.12
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including methylmercuric chloride; antimycin; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00018653	F49H12.2
Is enriched in body wall muscle cell; coelomocyte; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including age-1; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018654	F49H12.3
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018655	F49H12.4
Is expressed in AQR; PVDL; PVDR; head neurons; and tail neurons.

WB:WBGene00018656	txdc-12.2
Is enriched in OLL; PVD; hypodermis; intestine; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by sixteen chemicals including aldicarb; methylmercury hydroxide; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thioredoxin-like and Thioredoxin-like superfamily. Is an ortholog of human TXNDC12 (thioredoxin domain containing 12).

WB:WBGene00018657	acl-4
Is predicted to have transferase activity, transferring acyl groups. Localizes to endoplasmic reticulum. Is an ortholog of human GPAT3 (glycerol-3-phosphate acyltransferase 3) and GPAT4 (glycerol-3-phosphate acyltransferase 4).

WB:WBGene00018658	bath-22
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including ced-3; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018659	F52C6.2
Is predicted to have protein tag and ubiquitin protein ligase binding activity.

WB:WBGene00018660	F52C6.3
Exhibits identical protein binding activity.

WB:WBGene00018661	F52C6.4
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00018662	math-30
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and drh-3 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride and Sirolimus based on microarray studies.

WB:WBGene00018663	math-31
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Atrazine and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00018664	bath-11
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including ced-3; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018665	bath-4
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018666	bath-6
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Rotenone; stavudine; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018667	bath-7
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including aldicarb; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018668	bath-2
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018669	F52C6.12
Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00018670	F52C6.13
Is affected by several genes including skn-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018671	F52C6.14
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and csr-1 based on RNA-seq studies. Is affected by eight chemicals including aldicarb; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00018672	sorf-2
Is predicted to have phosphatidylinositol 3-kinase regulator activity. Is involved in organelle fusion; positive regulation of early endosome to late endosome transport; and regulation of endosome size. Localizes to early endosome and late endosome. Human ortholog(s) of this gene are implicated in cerebellar ataxia, mental retardation and dysequlibrium syndrome. Is an ortholog of human WDR81 (WD repeat domain 81).

WB:WBGene00018674	F52C9.3
Is predicted to have NAD+ kinase activity. Human ortholog(s) of this gene are implicated in Sengers syndrome and cataract 38. Is an ortholog of human AGK (acylglycerol kinase).

WB:WBGene00018675	F52C9.5
Is enriched in amphid sheath cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00018676	F52C9.6
No description available

WB:WBGene00018678	tdpo-1
Is predicted to have 3'-tyrosyl-DNA phosphodiesterase activity; double-stranded DNA binding activity; and single-stranded DNA binding activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 1 with axonal neuropathy. Is an ortholog of human TDP1 (tyrosyl-DNA phosphodiesterase 1).

WB:WBGene00018679	F52C12.2
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribosome biogenesis protein, C-terminal; Possible Fer4-like domain in RNase L inhibitor, RLI; Ribosome biogenesis protein, C-terminal; RNase L inhibitor RLI, possible metal-binding domain; and Ribosome biogenesis protein. Is an ortholog of human TSR3 (TSR3 ribosome maturation factor).

WB:WBGene00018680	tsen-54
Is enriched in AFD; PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 2A; pontocerebellar hypoplasia type 4; and pontocerebellar hypoplasia type 5. Is predicted to encode a protein with the following domains: tRNA-splicing endonuclease subunit sen54 N-term; tRNA-splicing endonuclease, subunit Sen54, N-terminal; and tRNA-splicing endonuclease, subunit Sen54. Is an ortholog of human TSEN54 (tRNA splicing endonuclease subunit 54).

WB:WBGene00018681	denn-4
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including let-60; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DENN (AEX-3) domain; uDENN domain; dDENN domain; cDENN domain; Pentatricopeptide repeat; dDENN domain; uDENN domain; Tetratricopeptide-like helical domain superfamily; and DENN domain, C-terminal lobe. Is an ortholog of human DENND4C (DENN domain containing 4C).

WB:WBGene00018682	aagr-4
Is predicted to have carbohydrate binding activity and hydrolase activity, hydrolyzing O-glycosyl compounds. Human ortholog(s) of this gene are implicated in congenital sucrase-isomaltase deficiency; glycogen storage disease II; and polycystic kidney disease 3. Is an ortholog of human GANAB (glucosidase II alpha subunit).

WB:WBGene00018683	F52D1.2
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00018684	fbxa-41
Is affected by several genes including daf-16; clk-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00018686	F52D2.3
No description available

WB:WBGene00018687	F52D2.5
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including hpl-2; mir-34; and mir-243 based on tiling array; microarray; and RNA-seq studies. Is affected by Colistin and nitroguanidine based on microarray studies.

WB:WBGene00018688	F52D2.6
Is affected by several genes including daf-2; eat-2; and sma-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Chlorpyrifos; Diazinon; and tetrabromobisphenol A based on microarray studies.

WB:WBGene00018689	F52D2.7
Is expressed in Z1 and Z4.

WB:WBGene00018690	fbxa-46
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018691	fbxa-17
Is affected by spn-4 based on RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00018692	F52E1.2
Is predicted to have carbohydrate binding activity. Is expressed in amphid sheath cell and phasmid sheath cell. Is an ortholog of human CLEC4E (C-type lectin domain family 4 member E).

WB:WBGene00018693	F52E1.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by hpl-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including cadmium; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00018694	F52E1.5
Is involved in innate immune response.

WB:WBGene00018696	pho-6
Is enriched in amphid sheath cell; excretory cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; npr-1; and lin-35 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Mercuric Chloride; Rifampin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP4 (acid phosphatase 4).

WB:WBGene00018697	F52E1.9
Is predicted to have phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity.

WB:WBGene00018698	vha-18
Is predicted to have proton-transporting ATPase activity, rotational mechanism. Is an ortholog of human ATP6V1H (ATPase H+ transporting V1 subunit H).

WB:WBGene00018699	F52E1.12
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; let-60; and daf-12 based on RNA-seq and microarray studies. Is affected by four chemicals including aldicarb; Sodium Chloride; and resveratrol based on microarray and RNA-seq studies.

WB:WBGene00018700	lmd-3
Is involved in determination of adult lifespan; response to heat; and response to oxidative stress. Is expressed in head. Is an ortholog of human NCOA7 (nuclear receptor coactivator 7) and OXR1 (oxidation resistance 1).

WB:WBGene00018701	pccb-1
Is enriched in several structures, including germ line; head mesodermal cell; mechanosensory neurons; non-striated muscle; and somatic nervous system based on proteomic; Chronogram; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including 25-azacoprostane; nicotine; and stavudine based on proteomic; RNA-seq; and microarray studies. Human ortholog(s) of this gene are implicated in propionic acidemia. Is predicted to encode a protein with the following domains: Carboxyl transferase domain; ClpP/crotonase-like domain superfamily; and Acetyl-CoA carboxylase. Is an ortholog of human PCCB (propionyl-CoA carboxylase subunit beta).

WB:WBGene00018702	F52E4.5
Is enriched in NSM; PLM; dopaminergic neurons; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Galactose oxidase/kelch, beta-propeller.

WB:WBGene00018703	sec-3
Is predicted to have GTP-Rho binding activity and phosphatidylinositol-4,5-bisphosphate binding activity. Is an ortholog of human EXOC1 (exocyst complex component 1).

WB:WBGene00018704	ztf-13
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and elt-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; Cry5B; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00018706	F52F10.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00018707	oac-31
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018708	oac-32
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00018709	srsx-8
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00018710	F52G3.1
Is enriched in head mesodermal cell and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including 1-methylnicotinamide; Rotenone; and nicotine based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; BAT2 N-terminus; BAT2, N-terminal; and Protein PRRC2. Is an ortholog of human PRRC2A (proline rich coiled-coil 2A) and PRRC2B (proline rich coiled-coil 2B).

WB:WBGene00018711	F52G3.3
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by Chlorpyrifos and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00018712	F52G3.4
Is enriched in AVK; RID; and seam cell based on RNA-seq studies. Is affected by several genes including rrf-3; sek-1; and pgl-1 based on tiling array and RNA-seq studies. Is affected by allantoin based on microarray studies.

WB:WBGene00018713	F52G3.5
Is enriched in ALM; OLL; PLM; and PVD based on microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like; ShKT domain; and Cysteine-rich repeat.

WB:WBGene00018714	F52H2.1
Is enriched in coelomocyte and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; aak-2; and glh-1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018715	F52H2.3
Is enriched in GABAergic neurons; PLM; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Zidovudine; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00018716	F52H2.4
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in renal glycosuria. Is an ortholog of human SLC5A12 (solute carrier family 5 member 12) and SLC5A8 (solute carrier family 5 member 8).

WB:WBGene00018717	F52H2.5
Is enriched in several structures, including body wall musculature; germ line; germline precursor cell; intestine; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018718	dhcr-24
Is predicted to have delta24(24-1) sterol reductase activity. Is an ortholog of human DHCR24 (24-dehydrocholesterol reductase).

WB:WBGene00018719	F52H2.7
Is predicted to have calcium ion binding activity and calcium-dependent phospholipid binding activity. Is an ortholog of human C2CD5 (C2 calcium dependent domain containing 5).

WB:WBGene00018720	F53A3.1
Is enriched in GABAergic neurons; PLM; body wall musculature; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018721	polh-1
Is predicted to have DNA-directed DNA polymerase activity. Is involved in several processes, including embryo development; error-prone translesion synthesis; and negative regulation of mitotic DNA damage checkpoint. Localizes to nucleus. Human ortholog(s) of this gene are implicated in xeroderma pigmentosum variant type. Is an ortholog of human POLH (DNA polymerase eta).

WB:WBGene00018723	F53A3.7
Is predicted to have chaperone binding activity. Is an ortholog of human DNLZ (DNL-type zinc finger).

WB:WBGene00018724	F53A9.1
Is enriched in ASER; OLL; PVD; dopaminergic neurons; and head mesodermal cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including Rotenone; sodium arsenite; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein Kreg-1.

WB:WBGene00018725	kreg-1
Is involved in stress response to copper ion.

WB:WBGene00018726	F53A9.3
Is enriched in GABAergic neurons and pharynx based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Tunicamycin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00018727	jbts-14
Is involved in non-motile cilium assembly. Localizes to ciliary basal body and ciliary transition zone. Is expressed in ciliated neurons.

WB:WBGene00018728	frpr-8
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00018729	F53A9.6
Is involved in innate immune response.

WB:WBGene00018730	F53A9.7
Is enriched in ASER; head mesodermal cell; muscle cell; neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Rotenone; juglone; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein Kreg-1.

WB:WBGene00018731	F53A9.8
Is involved in defense response to Gram-positive bacterium.

WB:WBGene00018732	F53A9.9
Is enriched in GABAergic neurons based on microarray studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Mercuric Chloride; Rotenone; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00018734	F53A10.2
Is predicted to have GTPase activator activity. Is expressed in intestine; neurons; and seam cell. Human ortholog(s) of this gene are implicated in cataract 45. Is an ortholog of human RAP1GAP (RAP1 GTPase activating protein).

WB:WBGene00018735	F53B1.2
Is predicted to have ceramide cholinephosphotransferase activity and sphingomyelin synthase activity. Is an ortholog of human SAMD8 (sterile alpha motif domain containing 8).

WB:WBGene00018736	F53B1.3
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-7; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018737	F53B1.4
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human TGDS (TDP-glucose 4,6-dehydratase).

WB:WBGene00018738	swip-10
Is enriched in OLL; PVD; and hypodermis based on microarray and tiling array studies. Is affected by several genes including rrf-3; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercury hydroxide; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Metallo-beta-lactamase superfamily; Metallo-beta-lactamase; Ribonuclease Z/Hydroxyacylglutathione hydrolase-like; and Metallo-beta-lactamase domain-containing protein 1. Is an ortholog of human MBLAC1 (metallo-beta-lactamase domain containing 1).

WB:WBGene00018739	F53B1.8
Is predicted to have sodium-independent organic anion transmembrane transporter activity. Is an ortholog of human SLCO4C1 (solute carrier organic anion transporter family member 4C1).

WB:WBGene00018740	tra-4
Is expressed in several structures, including excretory cell and ventral nerve cord. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00018741	comt-1
Is predicted to have S-adenosylmethionine-dependent methyltransferase activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 63; panic disorder; and schizophrenia. Is an ortholog of human COMTD1 (catechol-O-methyltransferase domain containing 1).

WB:WBGene00018742	F53B3.3
Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Armadillo-like helical; and Armadillo-type fold.

WB:WBGene00018743	F53B3.5
Is enriched in OLL; PVD; germ line; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by twenty-five chemicals including 1-methylnicotinamide; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PMP-22/EMP/MP20/Claudin tight junction and PMP-22/EMP/MP20/Claudin superfamily.

WB:WBGene00018744	F53B3.6
Is enriched in OLL; PLM; PVD; germline precursor cell; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including 1-methylnicotinamide; nicotinic acid; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018745	F53C3.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018746	fbxb-103
Is expressed in embryonic cell. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00018747	F53C3.3
Is enriched in hypodermis; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and sesamin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; CX module; and Domain of unknown function CX.

WB:WBGene00018748	F53C3.4
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including stavudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00018749	F53C3.5
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; levamisole; and Cadmium Chloride based on RNA-seq and microarray studies.

WB:WBGene00018750	F53C3.6
Is enriched in hypodermis; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; levamisole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00018751	F53C3.7
Is enriched in AVK; Z1.p; Z4.a; male distal tip cell; and male-specific anatomical entity based on RNA-seq studies. Is affected by several genes including daf-12; elt-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018752	F53C3.8
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018753	F53C3.9
No description available

WB:WBGene00018754	F53C3.11
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00018755	bcmo-2
Is predicted to have beta-carotene 15,15'-monooxygenase activity; carotenoid dioxygenase activity; and retinal isomerase activity. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 2; carotenemia; and retinitis pigmentosa 20. Is an ortholog of human BCO2 (beta-carotene oxygenase 2) and RPE65 (retinoid isomerohydrolase RPE65).

WB:WBGene00018756	plpp-1.1
Is predicted to have lipid phosphatase activity and phosphatidate phosphatase activity. Is an ortholog of human PLPP1 (phospholipid phosphatase 1) and PLPP3 (phospholipid phosphatase 3).

WB:WBGene00018757	tag-304
Localizes to nucleus. Is an ortholog of human GID8 (GID complex subunit 8 homolog).

WB:WBGene00018758	F53E10.1
Is predicted to have catalytic activity; molybdenum ion binding activity; and pyridoxal phosphate binding activity. Is expressed in head. Is an ortholog of human MTARC1 (mitochondrial amidoxime reducing component 1) and MTARC2 (mitochondrial amidoxime reducing component 2).

WB:WBGene00018759	F53E10.3
No description available

WB:WBGene00018760	irg-3
Is involved in innate immune response.

WB:WBGene00018761	F53E10.5
Is enriched in NSM; Z1.p; Z4.a; germ line; and male distal tip cell based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018762	F53E10.6
Is expressed in several structures, including body wall musculature and gonad. Is predicted to encode a protein with the following domains: Rrp15p and Ribosomal RNA-processing protein 15. Is an ortholog of human RRP15 (ribosomal RNA processing 15 homolog).

WB:WBGene00018763	F53F10.1
Localizes to mitochondrion. Is an ortholog of human CCDC102A (coiled-coil domain containing 102A) and CCDC102B (coiled-coil domain containing 102B).

WB:WBGene00018764	F53F10.2
Is predicted to have catalytic activity.

WB:WBGene00018765	mpc-2
Is predicted to have pyruvate transmembrane transporter activity. Is an ortholog of human MPC2 (mitochondrial pyruvate carrier 2).

WB:WBGene00018766	F53G2.1
Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00018767	F53G2.2
Is enriched in germ line and pharynx based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00018768	F53G2.3
Is affected by several genes including eat-2; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00018769	mnat-1
Is predicted to have cyclin-dependent protein serine/threonine kinase activator activity and kinase activity. Is an ortholog of human MNAT1 (MNAT1 component of CDK activating kinase).

WB:WBGene00018771	duox-2
Is predicted to have superoxide-generating NADPH oxidase activity. Is involved in cuticle development involved in collagen and cuticulin-based cuticle molting cycle and post-embryonic body morphogenesis. Human ortholog(s) of this gene are implicated in X-linked chronic granulomatous disease. Is an ortholog of human DUOX1 (dual oxidase 1) and DUOX2 (dual oxidase 2).

WB:WBGene00018772	F53G12.4
Is enriched in BAG; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00018773	F53G12.8
Is expressed in sperm.

WB:WBGene00018774	F53G12.9
Is enriched in DA neuron; VA neuron; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Cisplatin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase, C-terminal domain; Metaxin, glutathione S-transferase domain; and Glutathione S-transferase, C-terminal domain superfamily. Is an ortholog of human FAXC (failed axon connections homolog, metaxin like GST domain containing).

WB:WBGene00018776	F53H1.1
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX46 (DEAD-box helicase 46).

WB:WBGene00018777	F53H1.3
Is predicted to have Rab guanyl-nucleotide exchange factor activity. Is an ortholog of human DENND6B (DENN domain containing 6B).

WB:WBGene00018778	F53H1.4
Is predicted to have metal ion binding activity. Is expressed in gonad.

WB:WBGene00018779	F53H8.3
Is predicted to have transmembrane transporter activity. Is expressed in several structures, including Ealaa; Ealp; Earaa; Earp; and intestinal cell. Human ortholog(s) of this gene are implicated in arterial tortuosity syndrome. Is an ortholog of several human genes including SLC2A14 (solute carrier family 2 member 14); SLC2A7 (solute carrier family 2 member 7); and SLC2A9 (solute carrier family 2 member 9).

WB:WBGene00018781	F54A3.2
Is predicted to have microtubule binding activity and microtubule plus end polymerase. Is an ortholog of human CKAP5 (cytoskeleton associated protein 5).

WB:WBGene00018782	cct-3
Is predicted to have ATP binding activity and unfolded protein binding activity. Is an ortholog of human CCT3 (chaperonin containing TCP1 subunit 3).

WB:WBGene00018783	cbs-2
Is predicted to have cysteine synthase activity and pyridoxal phosphate binding activity. Human ortholog(s) of this gene are implicated in homocystinuria. Is an ortholog of human CBSL (cystathionine beta-synthase like).

WB:WBGene00018784	F54A3.5
Is enriched in ASER; germ line; and intestine based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF543) and MICOS complex subunit Mic10. Is an ortholog of human MICOS10 (mitochondrial contact site and cristae organizing system subunit 10).

WB:WBGene00018785	F54A3.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018786	hmbx-1
Is predicted to have telomeric DNA binding activity. Localizes to nucleus. Is expressed in body wall musculature; enteric muscle; somatic nervous system; and vulval muscle. Is an ortholog of human HMBOX1 (homeobox containing 1).

WB:WBGene00018787	cutl-20
Is enriched in OLL; PVD; and intestine based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018788	shc-1
Exhibits insulin-like growth factor receptor binding activity; mitogen-activated protein kinase kinase binding activity; and mitogen-activated protein kinase kinase kinase binding activity. Is involved in several processes, including positive regulation of axon regeneration; positive regulation of kinase activity; and response to endoplasmic reticulum stress. Localizes to cytoplasm and nucleus. Is expressed in gonad; head; neurons; and tail. Is an ortholog of human SHC1 (SHC adaptor protein 1).

WB:WBGene00018789	F54C1.1
Is predicted to have UDP-glycosyltransferase activity.

WB:WBGene00018791	F54C1.6
Is enriched in BAG and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and dpy-7 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Nucleoside diphosphate kinase-like domain superfamily.

WB:WBGene00018792	F54C1.8
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Mianserin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018793	mrpl-40
Is expressed widely. Is used to study chromosome 22q11.2 deletion syndrome, distal. Is predicted to encode a protein with the following domains: Mitochondrial ribosomal protein L28; Ribosomal protein L28/L40, mitochondrial; and 39S ribosomal protein L40, mitochondrial. Is an ortholog of human MRPL40 (mitochondrial ribosomal protein L40).

WB:WBGene00018794	attf-3
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by five chemicals including Rotenone; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00018795	F54C4.4
Is enriched in germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including age-1; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00018796	F54D7.1
No description available

WB:WBGene00018797	ept-1
Is predicted to have ethanolaminephosphotransferase activity. Is an ortholog of human SELENOI (selenoprotein I).

WB:WBGene00018798	gnrr-1
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is expressed in neurons; oocyte; pharynx; and sperm. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human GNRHR (gonadotropin releasing hormone receptor).

WB:WBGene00018801	F54D8.5
No description available

WB:WBGene00018802	F54D8.6
Is expressed in head. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018803	fbxa-24
Is enriched in hypodermis; intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including nicotinic acid; Mercuric Chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00018804	lido-15
Is enriched in PLM; carbon dioxide sensory neurons; dopaminergic neurons; germ line; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ras-mediated vulval-induction antagonist; and Protein LIN-8.

WB:WBGene00018805	F54D10.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and rde-4 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018806	F54D10.5
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018807	fbxa-146
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including lin-35; pgl-1; and sma-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018808	F54D10.7
Exhibits identical protein binding activity.

WB:WBGene00018809	F54D10.8
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00018810	F54D10.9
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Atrazine; cadmium; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00018811	pmt-2
Exhibits phosphatidyl-N-dimethylethanolamine N-methyltransferase activity and phosphatidyl-N-methylethanolamine N-methyltransferase activity. Is involved in phosphatidylcholine biosynthetic process. Is an ortholog of human METTL7B (methyltransferase like 7B).

WB:WBGene00018812	sumv-2
Is predicted to contribute to histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); and histone acetyltransferase activity (H4-K8 specific). Is an ortholog of human KANSL3 (KAT8 regulatory NSL complex subunit 3).

WB:WBGene00018813	F54D11.3
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00018814	F54D11.4
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including lin-39; pgl-1; and aak-2 based on RNA-seq; microarray; and proteomic studies. Is affected by Zidovudine; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human KANSL3 (KAT8 regulatory NSL complex subunit 3).

WB:WBGene00018815	F54D12.1
Is affected by several genes including eat-2; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00018816	F54D12.2
Is affected by drh-3; eat-2; and mex-1 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00018819	rog-1
Is expressed in germ line. Is predicted to encode a protein with the following domains: PTB domain (IRS-1 type) and IRS-type PTB domain. Is an ortholog of human FRS2 (fibroblast growth factor receptor substrate 2) and FRS3 (fibroblast growth factor receptor substrate 3).

WB:WBGene00018820	F54D12.7
Is affected by cyc-1; rsr-2; and prg-1 based on microarray and tiling array studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00018821	F54D12.8
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00018822	F54D12.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018823	F54E2.1
Localizes to membrane raft.

WB:WBGene00018824	F54E2.2
Is enriched in pharynx based on microarray studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018825	F54E2.5
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00018826	srt-34
Is affected by several genes including clk-1; eat-2; and nhr-25 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00018827	pst-2
Exhibits 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity. Is involved in 3'-phosphoadenosine 5'-phosphosulfate transport. Localizes to integral component of Golgi membrane. Is expressed in hypodermis; intestine; pharyngeal gland cell; and vulva. Is an ortholog of human SLC35B3 (solute carrier family 35 member B3).

WB:WBGene00018828	sdz-21
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein C05B5.4-like.

WB:WBGene00018829	F54E7.6
Is enriched in AFD and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018830	ska-3
Is enriched in several structures, including GABAergic neurons; Z4.a; germ line; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00018831	F54E7.9
Is predicted to have N-acetyltransferase activity. Is an ortholog of human NAA50 (N-alpha-acetyltransferase 50, NatE catalytic subunit).

WB:WBGene00018833	ztf-1
Is predicted to have DNA binding activity and metal ion binding activity. Is expressed in intestine and pharyngeal neurons.

WB:WBGene00018834	F54F2.6
Is affected by several genes including daf-12; clk-1; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00018835	F54F2.7
Is predicted to have actin filament binding activity and actin monomer binding activity. Is an ortholog of human ABITRAM (actin binding transcription modulator).

WB:WBGene00018836	F54F2.9
Is predicted to have DNA binding activity. Is expressed in coelomocyte; head neurons; and intestine. Is an ortholog of human DNAJC1 (DnaJ heat shock protein family (Hsp40) member C1).

WB:WBGene00018837	F54G2.1
Is enriched in body wall musculature; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial hemophagocytic lymphohistiocytosis 3. Is predicted to encode a protein with the following domains: C2 domain; Munc13 (mammalian uncoordinated) homology domain; C2 domain; Mammalian uncoordinated homology 13, subgroup, domain 2; and C2 domain superfamily. Is an ortholog of human BAIAP3 (BAI1 associated protein 3).

WB:WBGene00018838	F54G2.2
Is enriched in AFD; AVK; and neurons based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00018839	F54H5.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00018840	F54H5.3
Is predicted to have FFAT motif binding activity.

WB:WBGene00018841	F54H5.5
Is enriched in OLL; PVD; amphid sheath cell; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq studies.

WB:WBGene00018842	F54H12.2
Is predicted to have ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor.

WB:WBGene00018843	F54H12.3
No description available

WB:WBGene00018844	F54H12.4
Is affected by several genes including eat-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by Rifampin and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00018845	F54H12.5
Is enriched in several structures, including Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018846	eef-1B.1
Is predicted to have guanyl-nucleotide exchange factor activity. Is an ortholog of human EEF1B2 (eukaryotic translation elongation factor 1 beta 2).

WB:WBGene00018847	marc-6
Is predicted to have ubiquitin-protein transferase activity. Is involved in growth. Is an ortholog of human MARCHF6 (membrane associated ring-CH-type finger 6).

WB:WBGene00018848	F55A3.2
Is enriched in NSM; germ line; and intestine based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including D-glucose; stavudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00018849	spt-16
Is predicted to have histone binding activity and nucleosome binding activity. Is involved in pharynx development; positive regulation of chromosome segregation; and regulation of embryonic development. Localizes to nucleus. Is expressed in several structures, including intestine. Is an ortholog of human SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit).

WB:WBGene00018850	gpx-8
Is predicted to have peroxidase activity. Is an ortholog of human GPX4 (glutathione peroxidase 4).

WB:WBGene00018851	F55A3.6
Is enriched in coelomocyte; germ line; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; let-60; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by Alovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018852	F55A3.7
Is enriched in germ line and head mesodermal cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is an ortholog of human SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit).

WB:WBGene00018853	sec-22
Is predicted to have SNAP receptor activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in somatic cell and tail. Is an ortholog of human SEC22B (SEC22 homolog B, vesicle trafficking protein).

WB:WBGene00018854	nlf-1
Is expressed in nervous system. Is predicted to encode a protein with the following domain: .

WB:WBGene00018855	F55A4.3
Is expressed in amphid neurons and phasmid neurons.

WB:WBGene00018856	F55A4.4
Is enriched in AVK; OLL; PVD; body wall musculature; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00018857	stau-1
Exhibits double-stranded RNA binding activity. Is involved in germ cell development and negative regulation of RNA interference. Human ortholog(s) of this gene are implicated in dystonia 16. Is an ortholog of human STAU1 (staufen double-stranded RNA binding protein 1).

WB:WBGene00018858	F55A4.6
No description available

WB:WBGene00018859	F55A4.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and lin-35 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Sodium Chloride; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Calponin family repeat and Calponin repeat.

WB:WBGene00018860	vpat-1
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC18B1 (solute carrier family 18 member B1).

WB:WBGene00018861	cutl-21
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; dpy-7; and sek-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018862	wago-2
Is enriched in several structures, including AVK; NSM; germ line; germline precursor cell; and head mesodermal cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq; proteomic; and microarray studies.

WB:WBGene00018863	F55A12.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00018864	F55A12.5
Is enriched in AVA; OLL; PVD; and germ line based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including D-glucose; bisphenol S; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018865	F55A12.6
Is affected by several genes including clk-1; dpy-7; and sek-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00018866	nath-10
Is predicted to have rRNA cytidine N-acetyltransferase activity and tRNA binding activity. Is expressed in head and tail. Is an ortholog of human NAT10 (N-acetyltransferase 10).

WB:WBGene00018867	zhp-1
Is predicted to have SUMO transferase activity. Is an ortholog of human RNF212B (ring finger protein 212B).

WB:WBGene00018868	F55C7.2
Is expressed in intestinal muscle.

WB:WBGene00018869	rfip-1
Is predicted to have ADP-ribosylation factor binding activity and Rab GTPase binding activity. Is expressed in several structures, including excretory canal; head neurons; intestine; pharynx; and tail neurons. Is an ortholog of human RAB11FIP3 (RAB11 family interacting protein 3) and RAB11FIP4 (RAB11 family interacting protein 4).

WB:WBGene00018870	F55C12.2
Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by paraquat; adsorbable organic bromine compound; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018871	F55C12.4
Is expressed in neurons.

WB:WBGene00018872	F55C12.5
Is predicted to have lipid binding activity. Is expressed in AIYL and AIYR. Is an ortholog of human TEX2 (testis expressed 2).

WB:WBGene00018873	F55C12.6
Is enriched in PLM and germ line based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00018874	tag-234
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and levamisole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018875	F55D1.1
Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00018877	aman-1
Is predicted to have alpha-mannosidase activity. Human ortholog(s) of this gene are implicated in alpha-mannosidosis. Is an ortholog of human MAN2B1 (mannosidase alpha class 2B member 1).

WB:WBGene00018878	glit-1
Is predicted to have neurexin family protein binding activity and signaling receptor activity. Is involved in cellular response to paraquat and negative regulation of oxidative stress-induced neuron death. Is expressed in dopaminergic neurons and head. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of several human genes including NLGN1 (neuroligin 1); NLGN4X (neuroligin 4 X-linked); and NLGN4Y (neuroligin 4 Y-linked).

WB:WBGene00018879	F55D10.4
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018880	acc-3
Is predicted to have chloride channel activity.

WB:WBGene00018881	F55E10.1
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and dibromoacetic acid based on RNA-seq and microarray studies.

WB:WBGene00018882	F55E10.2
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00018883	F55E10.4
Is affected by several genes including sir-2.1; drh-3; and adr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including resveratrol; cadmium; and dibromoacetic acid based on microarray studies.

WB:WBGene00018884	F55E10.5
Is affected by several genes including eat-2; rrf-1; and unc-70 based on RNA-seq and microarray studies. Is affected by dafa#1 and Sirolimus based on microarray studies.

WB:WBGene00018885	drd-5
Is enriched in intestine based on tiling array and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by sixteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B6 (hydroxysteroid 17-beta dehydrogenase 6) and SDR9C7 (short chain dehydrogenase/reductase family 9C member 7).

WB:WBGene00018886	npr-28
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is expressed in head neurons; tail neurons; and in male.

WB:WBGene00018888	F55F1.2
Is enriched in body wall muscle cell based on tiling array studies. Is affected by mex-1 and ain-2 based on RNA-seq and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00018890	F55F8.2
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX24 (DEAD-box helicase 24).

WB:WBGene00018891	F55F8.3
Is enriched in germ line and intestine based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including D-glucose; stavudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Dip2/Utp12 Family; WD domain, G-beta repeat; WD40 repeat; Small-subunit processome, Utp12; Quinoprotein amine dehydrogenase, beta chain-like; WD40/YVTN repeat-like-containing domain superfamily; Periodic tryptophan protein 2; and WD40-repeat-containing domain superfamily. Is an ortholog of human PWP2 (PWP2 small subunit processome component).

WB:WBGene00018892	cir-1
Exhibits protein self-association. Is involved in oogenesis. Localizes to nucleus. Is an ortholog of human CIR1 (corepressor interacting with RBPJ, CIR1).

WB:WBGene00018893	wdr-12
Is predicted to have ribonucleoprotein complex binding activity. Is an ortholog of human WDR12 (WD repeat domain 12).

WB:WBGene00018894	mff-2
Is enriched in AFD; ASER; germ line; and intestine based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial and peroxisomal fission factor Mff; Mff/Tango-11; and Mff-like domain. Is an ortholog of human MFF (mitochondrial fission factor).

WB:WBGene00018895	F55F8.7
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00018896	F55F8.8
Is affected by several genes including clk-1; pmk-1; and dpy-7 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018897	zipt-2.4
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A2 (solute carrier family 39 member 2).

WB:WBGene00018898	F55F10.1
Is predicted to have ATP binding activity and ATPase activity. Is an ortholog of human MDN1 (midasin AAA ATPase 1).

WB:WBGene00018899	F55G1.1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00018900	rod-1
Exhibits protein domain specific binding activity. Is involved in several processes, including chromosome organization; positive regulation of kinetochore assembly; and regulation of mitotic sister chromatid segregation. Localizes to RZZ complex. Is an ortholog of human KNTC1 (kinetochore associated 1).

WB:WBGene00018901	slc-25A18.2
Is predicted to have L-aspartate transmembrane transporter activity and L-glutamate transmembrane transporter activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 3. Is an ortholog of human SLC25A18 (solute carrier family 25 member 18) and SLC25A22 (solute carrier family 25 member 22).

WB:WBGene00018902	F55G1.6
Is expressed in virL and virR.

WB:WBGene00018903	F55G1.7
Is enriched in cephalic sheath cell; germ line; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Zidovudine; tert-Butylhydroperoxide; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00018904	F55G1.9
Is predicted to have pyrroline-5-carboxylate reductase activity. Is expressed in hypodermis and intestinal cell.

WB:WBGene00018906	egas-4
Is predicted to have calcium ion binding activity and sodium channel activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis.

WB:WBGene00018907	F55G1.15
Is enriched in GABAergic neurons; excretory cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Mercuric Chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018908	fncm-1
Is enriched in Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018909	slx-1
Exhibits enzyme binding activity. Contributes to 3'-flap endonuclease activity; 5'-flap endonuclease activity; and crossover junction endodeoxyribonuclease activity. Is involved in several processes, including DNA metabolic process; larval development; and negative regulation of nematode larval development. Localizes to Slx1-Slx4 complex. Is an ortholog of human SLX1A (SLX1 homolog A, structure-specific endonuclease subunit).

WB:WBGene00018910	F56A4.2
Is predicted to have carbohydrate binding activity.

WB:WBGene00018911	F56A4.3
Is predicted to have glutathione transferase activity. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00018912	F56A4.4
Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Glutathione S-transferase, N-terminal domain; Glutathione S-transferase, N-terminal; and Thioredoxin-like superfamily. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00018913	F56A4.5
Is affected by several genes including skn-1; clk-1; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00018914	F56A4.6
Is affected by several genes including pgl-1; bar-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by cadmium based on microarray studies.

WB:WBGene00018915	str-267
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00018916	F56A4.8
No description available

WB:WBGene00018917	irld-35
Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray; quantitative PCR; and RNA-seq studies. Is affected by R24 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00018918	F56A4.10
Is predicted to have transmembrane transporter activity.

WB:WBGene00018919	F56A4.11
Is affected by several genes including sir-2.1; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by Lithium Chloride based on microarray studies.

WB:WBGene00018920	F56A4.12
Is predicted to have transmembrane transporter activity.

WB:WBGene00018921	sago-2
Is predicted to have nucleic acid binding activity.

WB:WBGene00018922	F56A6.3
No description available

WB:WBGene00018923	eme-1
Exhibits enzyme binding activity.

WB:WBGene00018924	F56A11.4
Is enriched in neurons based on microarray and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and isp-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin; multi-walled carbon nanotube; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018925	F56A11.5
Is predicted to have catalytic activity; molybdenum ion binding activity; and pyridoxal phosphate binding activity. Is an ortholog of human MTARC1 (mitochondrial amidoxime reducing component 1) and MTARC2 (mitochondrial amidoxime reducing component 2).

WB:WBGene00018926	F56A11.6
Is enriched in amphid sheath cell; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00018928	F56B3.2
Is enriched in NSM; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EB module and EB domain.

WB:WBGene00018929	F56B3.3
Is affected by several genes including sir-2.1; ain-2; and mir-34 based on RNA-seq and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00018930	F56B3.6
Is enriched in germ line; pharynx; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia (multiple); and retinitis pigmentosa 77. Is predicted to encode a protein with the following domains: TB2/DP1, HVA22 family and TB2/DP1/HVA22-related protein. Is an ortholog of human REEP5 (receptor accessory protein 5) and REEP6 (receptor accessory protein 6).

WB:WBGene00018931	ugt-52
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00018932	mrpl-2
Is predicted to have RNA binding activity. Is an ortholog of human MRPL2 (mitochondrial ribosomal protein L2).

WB:WBGene00018933	F56B3.9
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and mex-3 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00018934	F56B3.11
Is enriched in ASER; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TIM21 and Mitochondrial import inner membrane translocase subunit Tim21. Is an ortholog of human TIMM21 (translocase of inner mitochondrial membrane 21).

WB:WBGene00018935	skr-18
Is predicted to contribute to ubiquitin protein ligase activity. Is an ortholog of human SKP1 (S-phase kinase associated protein 1).

WB:WBGene00018937	F56B6.6
Is expressed in pharyngeal gland cell and tail neurons. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00018938	F56C3.1
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray studies. Is affected by Diazinon; dibromoacetic acid; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00018939	fbxa-190
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00018940	F56C3.3
Is affected by several genes including clk-1; sir-2.1; and ain-1 based on microarray and tiling array studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018941	F56C3.4
Is affected by several genes including clk-1; sir-2.1; and nhr-25 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00018942	F56C3.5
Is affected by clk-1 and eat-2 based on microarray studies. Is affected by Atrazine and allantoin based on microarray studies.

WB:WBGene00018943	dgn-2
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array and RNA-seq studies. Is affected by five chemicals including allantoin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2P and congenital muscular dystrophy-dystroglycanopathy type A9. Is predicted to encode a protein with the following domains: Dystroglycan (Dystrophin-associated glycoprotein 1) and Dystroglycan, C-terminal. Is an ortholog of human DAG1 (dystroglycan 1).

WB:WBGene00018944	F56C3.7
Is enriched in NSM based on tiling array studies. Is affected by nhr-114 and rsr-2 based on microarray and tiling array studies. Is affected by estrogen; resveratrol; and Sirolimus based on microarray studies.

WB:WBGene00018945	F56C3.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and sma-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00018946	F56C3.9
Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by eighteen chemicals including hydrogen sulfide; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00018947	F56C9.2
No description available

WB:WBGene00018948	F56C9.3
Is predicted to have cadmium ion transmembrane transporter activity; ferrous iron transmembrane transporter activity; and zinc efflux active transmembrane transporter activity. Human ortholog(s) of this gene are implicated in hypermanganesemia with dystonia 1 and type 2 diabetes mellitus.

WB:WBGene00018949	acbp-4
Is predicted to have fatty-acyl-CoA binding activity. Is expressed in intestine. Is an ortholog of human ACBD4 (acyl-CoA binding domain containing 4).

WB:WBGene00018950	F56C9.6
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; bisphenol S; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018951	F56C9.7
Is involved in regulation of lipid storage and regulation of peptide transport.

WB:WBGene00018952	F56C9.8
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00018953	F56C9.10
Is enriched in AFD; PLM; germ line; and intestine based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Human BCAS3 exhibits several functions, including acetyltransferase activator activity; beta-tubulin binding activity; and histone binding activity. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily and WD40-repeat-containing domain superfamily. Is an ortholog of human BCAS3 (BCAS3 microtubule associated cell migration factor).

WB:WBGene00018954	lab-2
Is enriched in Z1; Z4; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00018955	F56C11.3
Is predicted to have flavin adenine dinucleotide binding activity; flavin-linked sulfhydryl oxidase activity; and protein disulfide oxidoreductase activity. Is an ortholog of human GFER (growth factor, augmenter of liver regeneration).

WB:WBGene00018957	F56C11.5
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including sir-2.1; fbf-1; and sma-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018958	cest-27
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00018959	F56D1.1
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00018960	ilcr-2
Is predicted to have interleukin-17 receptor activity. Is involved in positive regulation of locomotion. Localizes to plasma membrane and receptor complex. Is expressed in RMGL; RMGR; body wall musculature; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in chronic mucocutaneous candidiasis; hypogonadotropic hypogonadism 18 with or without anosmia; and hypogonadotropic hypogonadism 7 with or without anosmia. Is an ortholog of human IL17RA (interleukin 17 receptor A).

WB:WBGene00018961	mrps-16
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 2. Is an ortholog of human MRPS16 (mitochondrial ribosomal protein S16).

WB:WBGene00018963	ucr-1
Is predicted to contribute to endopeptidase activity. Localizes to mitochondrion. Is an ortholog of human UQCRC1 (ubiquinol-cytochrome c reductase core protein 1).

WB:WBGene00018964	F56D2.2
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is an ortholog of human RNF14 (ring finger protein 14).

WB:WBGene00018965	F56D2.3
Is enriched in OLL; PVD; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00018966	F56D2.5
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is involved in innate immune response. Is an ortholog of human RNF14 (ring finger protein 14).

WB:WBGene00018967	ddx-15
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DHX15 (DEAH-box helicase 15).

WB:WBGene00018968	F56D2.8
Is enriched in hypodermis; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: NTF2-like domain superfamily.

WB:WBGene00018969	F56D3.1
Is enriched in OLL; PVD; germ line; germline precursor cell; and hypodermis based on proteomic; microarray; and tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-one chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00018970	clec-68
Is predicted to have carbohydrate binding activity. Is involved in innate immune response.

WB:WBGene00018971	clec-67
Is predicted to have carbohydrate binding activity. Is involved in PERK-mediated unfolded protein response. Is expressed in intestine.

WB:WBGene00018972	srz-19
Is affected by several genes including clk-1; isp-1; and mex-3 based on microarray and RNA-seq studies. Is affected by Rifampin and dafa#1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00018973	srz-20
Is affected by several genes including daf-2; sir-2.1; and drh-3 based on RNA-seq and microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00018974	fcho-1
Is predicted to have cytoskeletal protein binding activity. Is involved in clathrin-dependent endocytosis. Localizes to plasma membrane. Is expressed in amphid neurons; hypodermis; intestine; pharyngeal cell; and rectal gland cell. Is an ortholog of human FCHO2 (FCH and mu domain containing endocytic adaptor 2).

WB:WBGene00018975	F56E10.1
Is enriched in AVA; AVE; germ line; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; npr-1; and lin-35 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Histone transcription regulator 3/CABIN1.

WB:WBGene00018976	daam-1
Is predicted to have Rho GTPase binding activity and actin binding activity. Is an ortholog of human DAAM1 (dishevelled associated activator of morphogenesis 1) and DAAM2 (dishevelled associated activator of morphogenesis 2).

WB:WBGene00018978	ttr-58
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; methylmercuric chloride; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00018979	ttr-55
Is affected by rsr-2; damt-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb and antimycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00018980	F56F4.3
Is predicted to have neurotransmitter:sodium symporter activity. Human ortholog(s) of this gene are implicated in Hartnup disease; anxiety disorder; and postural orthostatic tachycardia syndrome.

WB:WBGene00018981	F56F4.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00018982	abt-6
Is affected by several genes including sir-2.1; smg-2; and drh-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Lithium Chloride; and lithium carbonate based on microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Tangier disease; autosomal recessive congenital ichthyosis (multiple); and retinal degeneration (multiple).

WB:WBGene00018983	F56F4.7
No description available

WB:WBGene00018984	F56F10.1
Is predicted to have dipeptidyl-peptidase activity. Is involved in innate immune response. Localizes to membrane raft. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00018985	F56F10.2
Is enriched in several structures, including coelomocyte; head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; Leucine-rich repeat domain superfamily; and F-box-like domain superfamily.

WB:WBGene00018986	cdo-1
Is predicted to have cysteine dioxygenase activity and ferrous iron binding activity. Is expressed in tail. Is an ortholog of human CDO1 (cysteine dioxygenase type 1).

WB:WBGene00018987	lgl-1
Is predicted to have several functions, including GTPase activator activity; Rab GTPase binding activity; and syntaxin binding activity. Is involved in establishment of spindle orientation and protein localization. Localizes to basolateral plasma membrane and cell cortex. Is expressed in epithelial cell and intestine. Is an ortholog of human LLGL1 (LLGL scribble cell polarity complex component 1) and LLGL2 (LLGL scribble cell polarity complex component 2).

WB:WBGene00018988	F56F11.1
Is enriched in head mesodermal cell and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00018989	F56F11.2
Is enriched in AFD; GABAergic neurons; head mesodermal cell; muscle cell; and touch receptor neurons based on microarray and RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and hsp-6 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00018990	klf-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in apoptotic cell clearance; apoptotic process; and cellular lipid metabolic process. Is expressed in hypodermis; intestine; and neurons. Is an ortholog of human KLF6 (Kruppel like factor 6) and KLF7 (Kruppel like factor 7).

WB:WBGene00018991	F56F11.4
Is predicted to have TBP-class protein binding activity. Is an ortholog of human PSMC5 (proteasome 26S subunit, ATPase 5).

WB:WBGene00018992	trpl-1
Is affected by several genes including skn-1; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00018993	nhr-266
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00018994	F56H1.3
Is enriched in OLL; PVD; germ line; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00018995	ccpp-1
Is predicted to have metallocarboxypeptidase activity and zinc ion binding activity. Is involved in oviposition. Is expressed in ciliated neurons and gubernacular muscle. Human ortholog(s) of this gene are implicated in Fuchs' endothelial dystrophy. Is an ortholog of human AGBL1 (ATP/GTP binding protein like 1) and AGTPBP1 (ATP/GTP binding protein 1).

WB:WBGene00018996	F57B9.1
Is predicted to have pyridoxamine-phosphate oxidase activity. Human ortholog(s) of this gene are implicated in pyridoxamine 5'-phosphate oxidase deficiency. Is an ortholog of human PNPO (pyridoxamine 5'-phosphate oxidase).

WB:WBGene00018997	F57B9.3
Is predicted to have RNA helicase activity and translation initiation factor activity. Is involved in negative regulation of transcription by RNA polymerase II and translation. Is an ortholog of human EIF4A2 (eukaryotic translation initiation factor 4A2).

WB:WBGene00018998	flap-1
Is enriched in PLM; cephalic sheath cell; germ line; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: LRRFIP family and Leucine-rich repeat flightless-interacting protein 1/2. Is an ortholog of human LRRFIP2 (LRR binding FLII interacting protein 2).

WB:WBGene00018999	F57B9.8
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00019001	ipgm-1
Exhibits phosphoglycerate mutase activity. Is involved in cellular carbohydrate metabolic process. Is expressed in body wall musculature; intestine; and nerve ring.

WB:WBGene00019002	syp-6
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019003	tmed-3
Is enriched in germ line; head mesodermal cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: emp24/gp25L/p24 family/GOLD; GOLD domain; Transmembrane emp24 domain-containing protein 7; TMP21-related; and GOLD domain superfamily. Is an ortholog of human TMED7-TICAM2 (TMED7-TICAM2 readthrough).

WB:WBGene00019004	xpg-1
Is predicted to have 5'-flap endonuclease activity and crossover junction endodeoxyribonuclease activity. Is an ortholog of human ERCC5 (ERCC excision repair 5, endonuclease).

WB:WBGene00019005	F57B10.8
Is predicted to have RNA binding activity. Is an ortholog of human ABT1 (activator of basal transcription 1).

WB:WBGene00019006	spg-20
Is expressed in IL2DL; IL2DR; IL2VL; IL2VR; and body wall musculature. Human ortholog(s) of this gene are implicated in Troyer syndrome. Is predicted to encode a protein with the following domains: Inheritance of peroxisomes protein 1; Senescence-associated protein; MIT; Senescence/spartin-associated; and Inheritance of peroxisomes protein 1. Is an ortholog of human SPART (spartin).

WB:WBGene00019007	ucr-11
Is predicted to have ubiquinol-cytochrome-c reductase activity. Localizes to mitochondrion.

WB:WBGene00019008	pdxk-1
Is predicted to have pyridoxal kinase activity. Is an ortholog of human PDXK (pyridoxal kinase).

WB:WBGene00019009	clec-90
Is predicted to have carbohydrate binding activity.

WB:WBGene00019010	glo-2
Exhibits protein homodimerization activity. Is involved in endosomal transport and positive regulation of intracellular protein transport. Localizes to endosome. Is expressed in intestine and seam cell. Is used to study Hermansky-Pudlak syndrome.

WB:WBGene00019011	F57C9.4
Is expressed in gonad; hypodermis; and intestine. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00019012	F57C9.6
Is predicted to have G protein-coupled photoreceptor activity.

WB:WBGene00019013	tofu-4
Is expressed in germ cell.

WB:WBGene00019014	F57C12.2
Is predicted to have ribosomal large subunit binding activity and ubiquitin protein ligase activity.

WB:WBGene00019015	F57F4.1
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT9 (acyl-CoA thioesterase 9).

WB:WBGene00019016	F57F4.2
Is enriched in body wall muscle cell; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019017	F57F4.4
Localizes to membrane raft.

WB:WBGene00019018	abts-3
Is predicted to have inorganic anion exchanger activity. Is expressed in hypodermis and neurons. Human ortholog(s) of this gene are implicated in Fuchs' endothelial dystrophy; congenital hereditary endothelial dystrophy of cornea; and corneal dystrophy-perceptive deafness syndrome. Is an ortholog of human SLC4A11 (solute carrier family 4 member 11).

WB:WBGene00019019	frpr-10
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00019020	F57H12.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00019021	F57H12.6
Is enriched in OLL; PVD; hypodermis; intestine; and male-specific anatomical entity based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; and RNA-seq studies. Is affected by twenty-five chemicals including Nitric Oxide; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019022	F58A6.1
Is predicted to have delta3,5-delta2,4-dienoyl-CoA isomerase activity. Is an ortholog of human ECH1 (enoyl-CoA hydratase 1).

WB:WBGene00019023	F58A6.2
Is enriched in head mesodermal cell and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including tryptophan; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00019024	F58A6.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including nicotinic acid; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interactor of ZYG-11 and Protein of unknown function DUF856, Caenorhabditis species.

WB:WBGene00019025	srb-16
Is predicted to have G protein-coupled receptor activity. Is expressed in neurons; pharyngeal cell; tail; and in male.

WB:WBGene00019026	F58A6.9
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-three chemicals including aldicarb; Ethanol; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00019027	srb-12
Is predicted to have G protein-coupled receptor activity. Is expressed in head.

WB:WBGene00019028	srb-13
Is predicted to have G protein-coupled receptor activity. Is expressed in amphid neurons.

WB:WBGene00019029	F58B6.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Mianserin; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00019030	exc-6
Is predicted to have actin binding activity. Is involved in several processes, including epithelial cell development; positive regulation of actin filament binding activity; and regulation of microtubule polymerization. Localizes to filamentous actin. Is an ortholog of human FHDC1 (FH2 domain containing 1).

WB:WBGene00019032	srsx-17
Is predicted to have G protein-coupled receptor activity. Is expressed in nervous system.

WB:WBGene00019033	F58E1.1
No description available

WB:WBGene00019034	fbxb-25
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including nanoparticle; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019035	fbxb-26
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; multi-walled carbon nanotube; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019036	irld-36
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00019037	fbxb-17
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Mercuric Chloride; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019038	irld-37
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019039	fbxb-18
Is enriched in NSM and hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Mianserin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019040	fbxb-19
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; bisphenol S; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019041	fbxc-22
Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Mercuric Chloride; multi-walled carbon nanotube; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019042	fbxc-21
Is enriched in dopaminergic neurons and hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including nanoparticle; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019043	fbxc-26
Is affected by several genes including let-60; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019044	F58E1.13
Is enriched in NSM based on tiling array studies. Is affected by several genes including let-60; lin-4; and lin-14 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019045	fbxb-47
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019046	F58E2.2
Is enriched in several structures, including cephalic sheath cell; coelomocyte; dopaminergic neurons; mechanosensory neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including rrf-3; sir-2.1; and rrf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00019047	F58E2.3
Is enriched in several structures, including body wall muscle cell; coelomocyte; hypodermis; sensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00019048	F58E2.4
Is enriched in several structures, including PLM; Z4.a; body wall muscle cell; intestine; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00019049	F58E2.5
Is affected by several genes including mex-3; mex-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by resveratrol and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00019050	srz-88
Is affected by let-60 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00019051	srz-23
Is enriched in NSM based on tiling array studies. Is affected by several genes including sir-2.1; prg-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00019053	F58F6.5
Is affected by cyc-1; hpl-2; and rsr-2 based on microarray and tiling array studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00019054	F58F6.6
Is affected by several genes including lin-35; lin-15B; and drh-3 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00019055	F58F9.1
Is enriched in AFD; ASER; AVK; and neurons based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019057	F58F9.3
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; and mechanosensory neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; D-glucopyranose; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00019058	F58F9.4
Is enriched in CEM; HOB; IL2 neuron; intestine; and ray neuron type B based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 4-bromodiphenyl ether; Rifampin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF272) and Protein of unknown function DUF272.

WB:WBGene00019059	F58F9.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and mex-1 based on microarray and RNA-seq studies. Is affected by Zidovudine and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019060	acox-3
Is predicted to have fatty acid binding activity; flavin adenine dinucleotide binding activity; and pristanoyl-CoA oxidase activity. Is expressed in intestinal cell. Is an ortholog of human ACOX3 (acyl-CoA oxidase 3, pristanoyl).

WB:WBGene00019061	F58F12.1
Is predicted to contribute to proton-transporting ATP synthase activity, rotational mechanism. Localizes to mitochondrion. Is an ortholog of human ATP5F1D (ATP synthase F1 subunit delta).

WB:WBGene00019062	F58F12.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; D-glucose; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00019063	F58F12.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00019064	myo-5
Is predicted to have ATP binding activity; actin filament binding activity; and motor activity. Human ortholog(s) of this gene are implicated in several diseases, including intrinsic cardiomyopathy (multiple); muscle tissue disease (multiple); and nonsyndromic deafness (multiple). Is an ortholog of human MYH6 (myosin heavy chain 6) and MYH7 (myosin heavy chain 7).

WB:WBGene00019065	F58G4.3
Is affected by rsr-2 based on tiling array studies. Is affected by Atrazine; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00019066	sdz-23
Is expressed in E; Ea; and Ep. Is predicted to encode a protein with the following domain: .

WB:WBGene00019067	F58H7.1
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and lin-39 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and Testosterone based on microarray and RNA-seq studies.

WB:WBGene00019068	faah-3
Is predicted to have amidase activity and fatty acid amide hydrolase activity. Is an ortholog of human FAAH (fatty acid amide hydrolase).

WB:WBGene00019069	lgc-30
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00019070	F58H7.5
Is enriched in germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019071	F58H7.6
No description available

WB:WBGene00019072	fbxc-8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019073	fbxc-3
Is enriched in intestine and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucopyranose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019074	cpd-1
Is predicted to have metallocarboxypeptidase activity. Is an ortholog of human CPD (carboxypeptidase D).

WB:WBGene00019075	F59A3.2
Is enriched in germ line; germline precursor cell; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and let-60 based on microarray and RNA-seq studies. Is affected by seven chemicals including bisphenol S; Alovudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00019076	mrpl-24
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL24 (mitochondrial ribosomal protein L24).

WB:WBGene00019077	zipt-11
Is predicted to have zinc ion transmembrane transporter activity. Is an ortholog of human SLC39A11 (solute carrier family 39 member 11).

WB:WBGene00019079	rpa-4
Is predicted to have single-stranded DNA binding activity. Is an ortholog of human RPA2 (replication protein A2).

WB:WBGene00019080	F59A3.7
Is enriched in FLP and germ line based on microarray and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by antimycin; paraquat; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019081	F59A3.8
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00019082	pup-3
Is enriched in cephalic sheath cell; germ line; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and mpk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spastic ataxia 4. Is predicted to encode a protein with the following domains: Cid1 family poly A polymerase; PAP/25A-associated; and Nucleotidyltransferase superfamily.

WB:WBGene00019083	F59A3.10
Is enriched in neurons based on tiling array studies. Is affected by rsr-2 and ubc-9 based on tiling array and microarray studies. Is affected by four chemicals including resveratrol; Sirolimus; and 2 based on microarray studies.

WB:WBGene00019084	F59A6.2
Is enriched in several structures, including cholinergic neurons; command interneuron; germ line; germline precursor cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00019085	F59A6.3
Is enriched in ciliated neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and eri-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including aldicarb; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein F26C11.3-like.

WB:WBGene00019086	F59A6.4
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019087	F59A6.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019089	clec-206
Is predicted to have carbohydrate binding activity.

WB:WBGene00019090	F59A7.2
Is involved in defense response to Gram-negative bacterium.

WB:WBGene00019091	srab-13
Is expressed in amphid neurons; vulval cell; and in male. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00019092	F59A7.5
Is enriched in amphid sheath cell and neurons based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019094	F59A7.7
Is predicted to have cysteine synthase activity and pyridoxal phosphate binding activity.

WB:WBGene00019095	F59A7.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Alovudine; allantoin; and Sirolimus based on RNA-seq studies. Is an ortholog of human TTF2 (transcription termination factor 2).

WB:WBGene00019096	cysl-4
Is predicted to have cysteine synthase activity and pyridoxal phosphate binding activity. Is an ortholog of human CBSL (cystathionine beta-synthase like).

WB:WBGene00019097	F59B1.2
Is enriched in germ line; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on RNA-seq; microarray; and proteomic studies. Is affected by sixteen chemicals including Mianserin; D-glucose; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00019098	F59B1.4
Is affected by several genes including unc-70; cyc-1; and mir-34 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00019099	F59B1.6
Is affected by tatn-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00019100	F59B1.8
Is involved in innate immune response.

WB:WBGene00019101	F59B1.10
Is enriched in GABAergic neurons; body wall muscle cell; dopaminergic neurons; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; metformin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00019102	F59C12.3
Is enriched in several structures, including AFD; coelomocyte; excretory cell; head mesodermal cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; D-glucose; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Nucleotidyltransferase superfamily. Is an ortholog of human AMOT (angiomotin).

WB:WBGene00019103	F59D6.1
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019104	asp-7
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00019105	asp-8
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA4 (pepsinogen A4); and PGC (progastricsin).

WB:WBGene00019106	irld-38
Is affected by several genes including drh-3; mir-34; and ints-6 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00019107	irld-10
Is affected by several genes including clk-1; lin-15B; and cyc-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00019108	chpf-2
Is predicted to have calcium ion binding activity. Is expressed in ray and in male. Human ortholog(s) of this gene are implicated in Usher syndrome type 1J and autosomal recessive nonsyndromic deafness 48. Is an ortholog of human CHP2 (calcineurin like EF-hand protein 2).

WB:WBGene00019109	F59E11.2
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRS1 (dehydrogenase/reductase 1).

WB:WBGene00019111	F59E11.5
Is enriched in Z1; Z4; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function (DUF19); and Domain of unknown function DUF19.

WB:WBGene00019112	F59E11.6
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and glycine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00019113	F59E11.7
Is expressed in AVG. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00019114	nhr-194
Is expressed in amphid neurons; ciliated neurons; head neurons; and sensory neurons.

WB:WBGene00019115	nhr-195
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00019116	nhr-143
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00019117	nhr-144
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; levamisole; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019118	F59E12.1
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Bromodomain; Bromodomain; and Bromodomain-like superfamily. Is an ortholog of human BRD8 (bromodomain containing 8).

WB:WBGene00019119	F59E12.3
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019120	npl-4.1
Is predicted to have ubiquitin binding activity and ubiquitin protein ligase binding activity. Is involved in positive regulation of protein localization to nucleus. Localizes to VCP-NPL4-UFD1 AAA ATPase complex and nucleus. Is an ortholog of human NPLOC4 (NPL4 homolog, ubiquitin recognition factor).

WB:WBGene00019121	npl-4.2
Is predicted to have ubiquitin binding activity and ubiquitin protein ligase binding activity. Is involved in ER-associated misfolded protein catabolic process and embryo development. Localizes to VCP-NPL4-UFD1 AAA ATPase complex and nucleus. Is an ortholog of human NPLOC4 (NPL4 homolog, ubiquitin recognition factor).

WB:WBGene00019122	F59E12.6
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity.

WB:WBGene00019123	F59E12.8
Is enriched in muscle cell based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T25E4.2-like.

WB:WBGene00019124	F59E12.9
Is enriched in germ line; hypodermis; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019125	ddl-1
Is involved in cytoplasmic sequestering of protein; determination of adult lifespan; and regulation of transcription regulatory region DNA binding activity. Localizes to cytoplasm. Is expressed in body wall musculature; neurons; pharynx; spermatheca; and vulval muscle. Is an ortholog of human WASHC3 (WASH complex subunit 3).

WB:WBGene00019126	sam-4
Is involved in several processes, including locomotion; positive regulation of anterograde synaptic vesicle transport; and positive regulation of pharyngeal pumping. Localizes to synaptic vesicle membrane. Is expressed in nerve ring. Is an ortholog of human BORCS5 (BLOC-1 related complex subunit 5).

WB:WBGene00019127	cgt-3
Is predicted to have ceramide glucosyltransferase activity. Is involved in several processes, including glucosylceramide biosynthetic process; regulation of protein localization to basolateral plasma membrane; and transforming growth factor beta receptor signaling pathway involved in regulation of growth. Localizes to plasma membrane. Is expressed in several structures, including germ line; pharyngeal muscle cell; pharyngeal-intestinal valve; rectal gland cell; and rectal valve cell. Is an ortholog of human UGCG (UDP-glucose ceramide glucosyltransferase).

WB:WBGene00019128	F59G1.4
Is expressed in amphid neurons; head ganglion; inner labial neurons; and phasmid neurons. Human ortholog(s) of this gene are implicated in Joubert syndrome 30. Is predicted to encode a protein with the following domain: LisH domain-containing protein ARMC9. Is an ortholog of human ARMC9 (armadillo repeat containing 9).

WB:WBGene00019129	F59G1.8
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019130	gbas-1
Exhibits G-protein alpha-subunit binding activity and guanyl-nucleotide exchange factor activity. Is involved in small GTPase mediated signal transduction. Is expressed in several structures, including GLR; coelomocyte; distal tip cell; intestine; and neurons.

WB:WBGene00019131	bath-12
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019132	bath-19
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019133	F59H6.2
Is enriched in NSM and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019134	F59H6.3
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00019135	math-32
Is enriched in NSM; body wall muscle cell; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; methylmercuric chloride; and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00019136	F59H6.5
No description available

WB:WBGene00019137	ceh-85
Is expressed in several structures, including head muscle; intestine; neurons; somatic nervous system; and vulval muscle.

WB:WBGene00019138	bath-21
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; antimycin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019139	bath-1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019140	bath-3
Is enriched in germ line; germline precursor cell; head mesodermal cell; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019141	bath-5
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019142	btb-4
Is enriched in AFD; AVE; body wall muscle cell; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and ced-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019143	H01M10.1
Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; resveratrol; and paraquat based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019144	H01M10.2
Is enriched in Z1.p; Z4.a; amphid sheath cell; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00019145	H02F09.2
Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Cadmium Chloride; Cry5B; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019146	H02F09.3
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including hydrogen sulfide; manganese chloride; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00019147	H02F09.4
No description available

WB:WBGene00019148	H03E18.1
Is enriched in OLL; PLM; PVD; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-four chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; PAN domain; and PAN/Apple domain.

WB:WBGene00019149	H03E18.2
Is enriched in AVK; GABAergic neurons; NSM; coelomocyte; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and dcr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019150	H04J21.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including tryptophan; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00019151	pck-3
Is predicted to have manganese ion binding activity and phosphoenolpyruvate carboxykinase (GTP) activity. Is expressed in excretory cell. Is an ortholog of human PCK1 (phosphoenolpyruvate carboxykinase 1) and PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial).

WB:WBGene00019152	nspb-6
Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1459) and Protein of unknown function DUF1459.

WB:WBGene00019153	H04M03.3
Is enriched in amphid sheath cell; germ line; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily.

WB:WBGene00019154	glf-1
Exhibits UDP-galactopyranose mutase activity. Is involved in cellular polysaccharide biosynthetic process. Localizes to cytoplasm. Is expressed in hypodermis; muscle cell; and neurons. Human ortholog(s) of this gene are implicated in Brunner Syndrome.

WB:WBGene00019155	H04M03.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; fluoranthene; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019156	H04M03.12
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sek-1 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00019157	H05C05.1
Is predicted to have nucleic acid binding activity.

WB:WBGene00019158	H05C05.2
Is enriched in body wall muscle cell; coelomocyte; germ line; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Zidovudine; Hydrolyzable Tannins; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019159	H05C05.3
Is enriched in intestine based on microarray studies. Is affected by several genes including clk-1; pgl-1; and mex-1 based on microarray and RNA-seq studies.

WB:WBGene00019160	nlp-49
Is expressed in nerve ring neurons.

WB:WBGene00019162	eif-1.A
Is predicted to have translation initiation factor activity. Is expressed in head and tail. Is an ortholog of human EIF1AX (eukaryotic translation initiation factor 1A X-linked) and EIF1AY (eukaryotic translation initiation factor 1A Y-linked).

WB:WBGene00019163	ubxn-6
Is expressed in pharynx. Is predicted to encode a protein with the following domains: PUB domain; PUB domain; Ubiquitin-like domain superfamily; and PUB-like domain superfamily. Is an ortholog of human UBXN6 (UBX domain protein 6).

WB:WBGene00019164	H06H21.8
Is enriched in AFD; excretory cell; and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; D-glucose; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00019165	mpz-4
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PDZ domain; PDZ superfamily; and Uncharacterized protein T15H9.4-like.

WB:WBGene00019166	tat-2
Is predicted to have ATPase-coupled intramembrane lipid transporter activity. Is involved in sterol metabolic process. Is expressed in several structures, including excretory system; gonad; pharynx; rectal gland cell; and vulva. Human ortholog(s) of this gene are implicated in benign recurrent intrahepatic cholestasis 1; intrahepatic cholestasis of pregnancy 1; and progressive familial intrahepatic cholestasis 1. Is an ortholog of human ATP8B2 (ATPase phospholipid transporting 8B2).

WB:WBGene00019167	H06I04.1
Is enriched in body wall muscle cell; germ line; head mesodermal cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019168	H06I04.3
Is predicted to have rRNA (guanine) methyltransferase activity and rRNA (uridine-2'-O-)-methyltransferase activity. Is an ortholog of human FTSJ3 (FtsJ RNA 2'-O-methyltransferase 3).

WB:WBGene00019169	H06I04.5
Is enriched in NSM; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00019170	H06I04.6
Is enriched in ASER; FLP; muscle cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00019171	fipr-29
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; elt-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019174	H09G03.1
Is enriched in several structures, including PLM; amphid sheath cell; excretory cell; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00019176	H10D12.2
Is enriched in male-specific anatomical entity and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00019177	H10D18.1
Is enriched in AVK and neurons based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019178	scl-12
Is enriched in body wall muscle cell; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including cholesterol; lathosterol; and indole based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2) and CRISP3 (cysteine rich secretory protein 3).

WB:WBGene00019179	scl-13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including cholesterol; lathosterol; and indole based on microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; Venom allergen 5-like; CAP domain; and CAP superfamily. Is an ortholog of human GLIPR1 (GLI pathogenesis related 1).

WB:WBGene00019180	H10D18.5
Is enriched in body wall musculature; head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019181	H10D18.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including eat-2; mex-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019182	H10E21.1
Is expressed in intestine; rectal valve cell; tail hypodermis; and tail spike.

WB:WBGene00019183	npr-30
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in essential hypertension.

WB:WBGene00019184	H10E21.4
Is predicted to have actin filament binding activity; calcium ion binding activity; and calcium-dependent protein binding activity.

WB:WBGene00019185	H10E21.5
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human RNF150 (ring finger protein 150).

WB:WBGene00019186	fbxb-58
Is affected by several genes including eat-2; sir-2.1; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by dafa#1 and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019187	H11E01.2
Is predicted to have transmembrane transporter activity.

WB:WBGene00019188	H11E01.3
Is enriched in body wall musculature; intestine; nerve ring neurons; and neurons based on microarray; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF4590.

WB:WBGene00019189	H11L12.1
Is enriched in germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019190	H12I13.1
Is predicted to have ATP binding activity; protein kinase activity; and thiol-dependent ubiquitinyl hydrolase activity.

WB:WBGene00019192	H12I13.3
Is affected by rsr-2; prg-1; and drh-3 based on tiling array and RNA-seq studies. Is affected by Progesterone; Atrazine; and allantoin based on microarray studies.

WB:WBGene00019193	H12I13.5
Is affected by several genes including eat-2; mex-3; and ubc-9 based on microarray and RNA-seq studies. Is affected by Tunicamycin; allantoin; and Sirolimus based on microarray studies.

WB:WBGene00019194	H12I13.6
Is enriched in germ line and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Ethanol; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019195	H14A12.1
No description available

WB:WBGene00019196	H14A12.3
Is enriched in AVK; coelomocyte; germ line; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Kohlschutter-Tonz syndrome. Is predicted to encode a protein with the following domains: Rogdi leucine zipper containing protein and RAVE subunit 2/Rogdi. Is an ortholog of human ROGDI (rogdi atypical leucine zipper).

WB:WBGene00019197	H14A12.5
Is enriched in I5 neuron; cholinergic neurons; head mesodermal cell; intestine; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Lithium Chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00019198	strm-1
Exhibits S-adenosylmethionine-dependent methyltransferase activity. Is involved in macromolecule methylation and regulation of dauer larval development. Is expressed in hypodermis and pharynx.

WB:WBGene00019199	H14E04.2
Is enriched in AVK; DA neuron; VA neuron; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; sir-2.1; and npr-1 based on microarray; proteomic; and RNA-seq studies. Is affected by eight chemicals including nanoparticle; Alovudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019200	H14E04.3
Is enriched in intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Mercuric Chloride; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00019202	H14N18.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and cadmium based on RNA-seq and microarray studies.

WB:WBGene00019203	ttr-47
Is enriched in germline precursor cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00019204	H14N18.4
Is predicted to have glutathione hydrolase activity and peptidyltransferase activity. Human ortholog(s) of this gene are implicated in gamma-glutamyl transpeptidase deficiency. Is an ortholog of human GGT1 (gamma-glutamyltransferase 1).

WB:WBGene00019205	kcc-2
Exhibits potassium:chloride symporter activity. Is involved in chloride transport; potassium ion transport; and regulation of GABAergic synaptic transmission. Is expressed in body wall musculature; egg-laying apparatus; hermaphrodite distal tip cell; intestine; and neurons. Human ortholog(s) of this gene are implicated in Gitelman syndrome; agenesis of the corpus callosum with peripheral neuropathy; and epilepsy (multiple). Is an ortholog of human SLC12A5 (solute carrier family 12 member 5).

WB:WBGene00019207	fgt-1
Is predicted to have transmembrane transporter activity. Is involved in glucose transmembrane transport. Is expressed in hypodermis; intestinal cell; muscle cell; neurons; and pharynx. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A3 (solute carrier family 2 member 3).

WB:WBGene00019208	lips-14
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; D-glucose; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00019209	emc-1
Is enriched in EMS; germ line; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; let-7; and gld-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by Zidovudine and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Quinoprotein alcohol dehydrogenase-like superfamily; WD40/YVTN repeat-like-containing domain superfamily; and ER membrane protein complex subunit 1. Is an ortholog of human EMC1 (ER membrane protein complex subunit 1).

WB:WBGene00019210	H18N23.1
No description available

WB:WBGene00019211	H18N23.2
Is enriched in body wall musculature; dopaminergic neurons; head mesodermal cell; intestine; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is predicted to encode a protein with the following domains: Phosphorylation site; Carbohydrate/starch-binding module (family 21); CBM21 (carbohydrate binding type-21) domain; Protein phosphatase 1 regulatory subunit 3B/C/D, metazoa; and CBM21 domain superfamily. Is an ortholog of human PPP1R3B (protein phosphatase 1 regulatory subunit 3B).

WB:WBGene00019212	zmp-2
Exhibits metallopeptidase activity. Is involved in several processes, including ecdysis, collagen and cuticulin-based cuticle; negative regulation of cellular metabolic process; and negative regulation of protein import into nucleus. Is expressed in several structures, including anal region; body wall musculature; gonad; tail; and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type.

WB:WBGene00019213	H20E11.1
Is enriched in several structures, including body wall musculature; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Heme; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00019214	H20E11.2
Is enriched in body wall musculature; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-four chemicals including aldicarb; Nitric Oxide; and Mercuric Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00019215	H20E11.3
Is involved in innate immune response.

WB:WBGene00019216	H20J04.1
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00019217	athp-2
Is predicted to have DNA binding activity. Is an ortholog of human BAZ1A (bromodomain adjacent to zinc finger domain 1A).

WB:WBGene00019218	madf-3
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-16; sek-1; and alg-1 based on RNA-seq and microarray studies. Is affected by stavudine; Zidovudine; and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00019219	H20J04.4
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX49 (DEAD-box helicase 49).

WB:WBGene00019220	pfd-2
Is predicted to have protein folding chaperone. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human PFDN2 (prefoldin subunit 2).

WB:WBGene00019221	H20J04.6
Is enriched in GABAergic neurons and NSM based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Linolenic Acids; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF778) and TMEM222/RTE1. Is an ortholog of human TMEM222 (transmembrane protein 222).

WB:WBGene00019222	H20J04.7
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019224	gnrr-5
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00019225	bgal-2
Is predicted to have beta-galactosidase activity. Human ortholog(s) of this gene are implicated in GM1 gangliosidosis (multiple) and mucopolysaccharidosis type IVB. Is an ortholog of human GLB1 (galactosidase beta 1) and GLB1L (galactosidase beta 1 like).

WB:WBGene00019226	H22K11.3
Is enriched in ALM; AVA; and PLM based on tiling array and microarray studies. Is affected by several genes including eat-2; lem-2; and mir-34 based on RNA-seq; tiling array; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019227	sgca-1
Is predicted to have calcium ion binding activity. Localizes to striated muscle dense body. Is expressed in anal depressor muscle; anal sphincter muscle; body wall musculature; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2D and myoclonic dystonia 11. Is an ortholog of human SGCE (sarcoglycan epsilon).

WB:WBGene00019228	H23L24.1
Is enriched in neurons and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including eat-2; lin-15B; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019229	ipla-5
Is predicted to have hydrolase activity.

WB:WBGene00019230	ttll-11
Exhibits tubulin-glutamic acid ligase activity. Is involved in protein polyglutamylation and response to hermaphrodite contact. Is expressed in ciliated neurons and in male. Is an ortholog of human TTLL11 (tubulin tyrosine ligase like 11).

WB:WBGene00019231	H23L24.4
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00019232	ugt-13
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT2B28 (UDP glucuronosyltransferase family 2 member B28); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00019233	ugt-14
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A10 (UDP glucuronosyltransferase family 1 member A10); and UGT1A6 (UDP glucuronosyltransferase family 1 member A6).

WB:WBGene00019234	ugt-8
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A8 (UDP glucuronosyltransferase family 1 member A8); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00019235	H23N18.4
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A7 (UDP glucuronosyltransferase family 1 member A7); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00019236	H23N18.5
Is predicted to have phospholipase A2 activity.

WB:WBGene00019237	H24G06.1
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 20; nephronophthisis 20; and primary autosomal recessive microcephaly 2 with or without cortical malformations. Is predicted to encode a protein with the following domain: . Is an ortholog of human WDR62 (WD repeat domain 62).

WB:WBGene00019239	H24K24.2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019240	adh-5
Is predicted to have S-(hydroxymethyl)glutathione dehydrogenase activity; alcohol dehydrogenase activity, zinc-dependent; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in alcohol dependence and late onset Parkinson's disease. Is an ortholog of human ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide).

WB:WBGene00019241	trm-2A
Is predicted to have RNA binding activity and RNA methyltransferase activity. Is an ortholog of human TRMT2A (tRNA methyltransferase 2 homolog A).

WB:WBGene00019242	srbc-40
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-2; let-60; and hpl-2 based on microarray and RNA-seq studies. Is affected by aldicarb and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00019243	fbxb-72
Is enriched in AVK; intestine; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019244	H25P19.1
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Mianserin; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019245	sacy-1
Is predicted to have RNA binding activity and RNA helicase activity. Localizes to cytoplasm and nucleus. Is expressed in hypodermis; intestine; and somatic cell. Is an ortholog of human DDX41 (DEAD-box helicase 41).

WB:WBGene00019246	rpb-5
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2E (RNA polymerase II, I and III subunit E).

WB:WBGene00019247	syp-4
Localizes to central element.

WB:WBGene00019248	H27M09.5
Is enriched in several structures, including Z1.p; Z4.a; body wall muscle cell; germ line; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including nicotinic acid; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00019249	hrpa-2
Is predicted to have mRNA binding activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type.

WB:WBGene00019250	H28G03.2
Is enriched in germ line and neurons based on microarray; RNA-seq; and tiling array studies. Is affected by several genes including clk-1; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by Quercetin; single-walled carbon nanotube; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019251	H28G03.3
Is affected by several genes including daf-2; sir-2.1; and nhr-25 based on RNA-seq and microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00019252	H28G03.4
No description available

WB:WBGene00019253	H31G24.1
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including mex-3; crh-1; and nhr-114 based on microarray and RNA-seq studies. Is affected by manganese chloride; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00019254	H31G24.3
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019255	H32C10.1
Is enriched in AVK; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including nicotinic acid; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: HAD superfamily. Is an ortholog of human HDHD5 (haloacid dehalogenase like hydrolase domain containing 5).

WB:WBGene00019257	dhhc-13
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is an ortholog of human ZDHHC13 (zinc finger DHHC-type palmitoyltransferase 13) and ZDHHC17 (zinc finger DHHC-type palmitoyltransferase 17).

WB:WBGene00019259	H34C03.2
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human USP4 (ubiquitin specific peptidase 4).

WB:WBGene00019260	H34I24.1
Is enriched in AFD; GABAergic neurons; body wall muscle cell; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019261	H34I24.2
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seventeen chemicals including manganese chloride; Mianserin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019262	dmsr-12
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00019263	H35B03.1
Is enriched in excretory cell; head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019264	H35B03.2
Is predicted to contribute to ribonuclease P activity. Is an ortholog of human RPP30 (ribonuclease P/MRP subunit p30).

WB:WBGene00019265	H35N09.1
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00019266	H35N09.2
Is predicted to have nucleic acid binding activity.

WB:WBGene00019267	H39E20.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Diazinon; and paraquat based on microarray studies.

WB:WBGene00019268	H41C03.1
Is enriched in OLL; PVD; hypodermis; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including bisphenol A; TPEN; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; CRAL/TRIO, N-terminal domain superfamily; and CRAL-TRIO lipid binding domain superfamily. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00019269	H41C03.2
Is enriched in neurons based on microarray studies. Is affected by several genes including let-60; dpy-7; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00019270	H41C03.3
Is enriched in ASER and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and D-glucopyranose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00019272	H42K12.3
Is enriched in OLL; PVD; and hypodermis based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain; PAN/Apple domain; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00019273	H43E16.1
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including hydrogen sulfide; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019274	H43I07.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by stavudine; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in 3-methylglutaconic aciduria type 3 and optic atrophy 3. Is predicted to encode a protein with the following domains: Optic atrophy 3 protein (OPA3) and Optic atrophy 3-like. Is an ortholog of human OPA3 (outer mitochondrial membrane lipid metabolism regulator OPA3).

WB:WBGene00019275	rpac-40
Is predicted to contribute to RNA polymerase I activity and RNA polymerase III activity. Human ortholog(s) of this gene are implicated in Treacher Collins syndrome and hypomyelinating leukodystrophy 11. Is an ortholog of human POLR1C (RNA polymerase I and III subunit C).

WB:WBGene00019276	algn-5
Is enriched in NSM; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and npr-1 based on RNA-seq studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domain: Nucleotide-diphospho-sugar transferases. Is an ortholog of human ALG5 (ALG5 dolichyl-phosphate beta-glucosyltransferase).

WB:WBGene00019277	sgcb-1
Is expressed in body wall musculature; enteric muscle; neurons; seam cell; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal recessive limb-girdle muscular dystrophy type 2E. Is predicted to encode a protein with the following domains: Sarcoglycan complex subunit protein; Sarcoglycan complex subunit protein; and Beta-sarcoglycan. Is an ortholog of human SGCB (sarcoglycan beta).

WB:WBGene00019278	K01A2.3
Is expressed in intestine.

WB:WBGene00019279	K01A2.4
Is enriched in AFD; PLM; body wall musculature; and head mesodermal cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including Heme; 1-methylnicotinamide; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019280	K01A2.5
Is predicted to have hydrolase activity. Is expressed in hypodermis. Is an ortholog of human BPHL (biphenyl hydrolase like).

WB:WBGene00019281	K01A2.6
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Alovudine; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00019282	mps-2
Exhibits potassium channel regulator activity. Is involved in regulation of chemotaxis and regulation of potassium ion transport. Is expressed in ADFL; ADFR; anal depressor muscle; anal sphincter muscle; and intestinal muscle.

WB:WBGene00019283	K01A2.9
Is enriched in DA neuron; body wall musculature; head mesodermal cell; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Chlorpyrifos based on microarray and RNA-seq studies.

WB:WBGene00019284	K01A2.10
Is enriched in several structures, including coelomocyte; excretory cell; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; indole; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Coiled-coil domain-containing protein 74A/74B/92. Is an ortholog of human CCDC92 (coiled-coil domain containing 92).

WB:WBGene00019285	cbn-1
Is predicted to have actin filament binding activity; calcium ion binding activity; and calcium-dependent protein binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00019286	K01A12.2
Is enriched in AFD; GABAergic neurons; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and fog-2 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019287	K01A12.3
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00019288	K02A2.1
Is predicted to have hydrolase activity.

WB:WBGene00019289	kcc-3
Is predicted to have potassium:chloride symporter activity. Is involved in microvillus organization and negative regulation of guanylate cyclase activity. Localizes to apical plasma membrane. Is expressed in amphid sheath cell; head; phasmid sheath cell; and tail. Human ortholog(s) of this gene are implicated in epilepsy (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SLC12A4 (solute carrier family 12 member 4) and SLC12A5 (solute carrier family 12 member 5).

WB:WBGene00019290	K02A2.5
Is enriched in germline precursor cell; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Alovudine; glycine; and Cadmium Chloride based on RNA-seq and microarray studies.

WB:WBGene00019291	K02A2.6
No description available

WB:WBGene00019292	K02A6.1
Is enriched in FLP based on microarray studies. Is affected by clk-1; hrde-1; and drh-3 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00019293	K02A6.2
Is enriched in several structures, including PLM; arcade cell; carbon dioxide sensory neurons; pharyngeal-intestinal valve cell; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and mex-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019294	K02A6.3
Is enriched in OLL; PVD; dopaminergic neurons; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Ethanol; levamisole; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; Leucine-rich repeat domain superfamily; and F-box-like domain superfamily.

WB:WBGene00019295	pfkb-1.2
Is predicted to have 6-phosphofructo-2-kinase activity and fructose-2,6-bisphosphate 2-phosphatase activity. Is an ortholog of several human genes including PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1); PFKFB2 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2); and PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4).

WB:WBGene00019296	mcu-1
Exhibits identical protein binding activity. Is involved in several processes, including calcium import into the mitochondrion; mitochondrial calcium ion homeostasis; and protein homooligomerization. Is an ortholog of human MCU (mitochondrial calcium uniporter).

WB:WBGene00019297	K02B2.6
Is affected by several genes including daf-2; let-60; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; resveratrol; and fluoranthene based on microarray studies.

WB:WBGene00019298	pnp-1
Is predicted to have purine-nucleoside phosphorylase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in purine nucleoside phosphorylase deficiency. Is an ortholog of human PNP (purine nucleoside phosphorylase).

WB:WBGene00019299	snai-1
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in PHAL; PHAR; PHBL; PHBR; and amphid neurons. Is an ortholog of human SNAI1 (snail family transcriptional repressor 1).

WB:WBGene00019300	swt-1
Exhibits sugar transmembrane transporter activity. Localizes to Golgi apparatus and plasma membrane. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).

WB:WBGene00019301	K02D10.1
Is predicted to have phosphatase activity. Is an ortholog of human NIPSNAP1 (nipsnap homolog 1) and NIPSNAP2 (nipsnap homolog 2).

WB:WBGene00019302	K02D10.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00019303	K02D10.3
Is enriched in GABAergic neurons; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by eat-2; ints-1; and ints-4 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019304	K02D10.4
Is enriched in body wall muscle cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019305	snap-29
Is predicted to have SNAP receptor activity and syntaxin binding activity. Is involved in intracellular protein transmembrane transport; ovulation; and secretion. Localizes to apical plasma membrane and recycling endosome. Is expressed in several structures, including coelomocyte; excretory canal; gland cell; hermaphrodite somatic gonadal cell; and vulva. Is used to study chromosome 22q11.2 deletion syndrome, distal. Human ortholog(s) of this gene are implicated in CEDNIK syndrome. Is an ortholog of human SNAP29 (synaptosome associated protein 29).

WB:WBGene00019306	K02E7.1
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00019307	K02E7.2
No description available

WB:WBGene00019308	K02E7.3
No description available

WB:WBGene00019309	K02E7.4
Is affected by several genes including eat-2; aak-2; and cyc-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019310	K02E7.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00019311	K02E7.6
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00019312	K02E7.7
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00019313	btb-10
Is enriched in Z1.p; Z4.a; hypodermis; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019314	K02E7.10
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSK (cathepsin K).

WB:WBGene00019315	K02E7.11
Is enriched in coelomocyte and neurons based on tiling array studies. Is affected by several genes including daf-12; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00019316	K02E7.12
Is enriched in body wall muscle cell; body wall musculature; coelomocyte; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00019317	K02E10.1
Is predicted to have GTPase activity.

WB:WBGene00019318	K02E10.4
Is enriched in AFD; OLL; PVD; hypodermis; and male-specific anatomical entity based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lustrin, cysteine-rich repeated domain; Cysteine-rich repeat; and Lustrin, cysteine-rich repeated.

WB:WBGene00019319	K02E10.5
Is enriched in dopaminergic neurons and neurons based on tiling array and microarray studies. Is affected by several genes including age-1; sir-2.1; and egl-5 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00019320	K02E10.6
Is enriched in several structures, including NSM; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; sesamin; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00019321	K02E10.7
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human STK33 (serine/threonine kinase 33).

WB:WBGene00019322	ahcy-1
Is predicted to have adenosylhomocysteinase activity. Is expressed in head. Human ortholog(s) of this gene are implicated in hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase. Is an ortholog of human AHCY (adenosylhomocysteinase).

WB:WBGene00019323	teg-4
Is predicted to have nucleic acid binding activity. Is an ortholog of human SF3B3 (splicing factor 3b subunit 3).

WB:WBGene00019324	K02F2.5
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019326	K02F3.2
Is predicted to have acidic amino acid transmembrane transporter activity; calcium ion binding activity; and identical protein binding activity. Human ortholog(s) of this gene are implicated in adult-onset type II citrullinemia; early infantile epileptic encephalopathy 39; and neonatal-onset type II citrullinemia. Is an ortholog of human SLC25A12 (solute carrier family 25 member 12).

WB:WBGene00019327	zip-2
Is predicted to have DNA-binding transcription factor activity. Is involved in several processes, including defense response to Gram-negative bacterium; positive regulation of innate immune response; and transcription by RNA polymerase II. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in acute myeloid leukemia.

WB:WBGene00019328	clec-149
Is predicted to have carbohydrate binding activity. Is an ortholog of several human genes including ASGR1 (asialoglycoprotein receptor 1); CD209 (CD209 molecule); and CLEC4G (C-type lectin domain family 4 member G).

WB:WBGene00019329	ceeh-1
Exhibits epoxide hydrolase activity. Is involved in cellular lipid metabolic process. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is an ortholog of human EPHX3 (epoxide hydrolase 3) and EPHX4 (epoxide hydrolase 4).

WB:WBGene00019331	dos-3
Is predicted to have Notch binding activity.

WB:WBGene00019332	K02F3.9
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including glp-1; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019333	moma-1
Localizes to mitochondrial outer membrane. Is an ortholog of human APOOL (apolipoprotein O like).

WB:WBGene00019334	K02F3.12
Is predicted to have 3'-5' DNA helicase activity; annealing helicase activity; and four-way junction helicase activity. Is an ortholog of human RECQL (RecQ like helicase).

WB:WBGene00019335	K02F6.1
Is predicted to have nucleic acid binding activity and zinc ion binding activity.

WB:WBGene00019337	K02F6.3
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function; Ankyrin repeat; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00019338	K02F6.4
Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeat; Domain of unknown function; BRCT domain; Ankyrin repeat; Domain of unknown function WSN; BRCT domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00019339	K02F6.5
Is affected by several genes including daf-16; daf-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00019340	K02F6.6
Is affected by several genes including daf-2; pgl-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00019341	K02F6.7
Is enriched in NSM; germ line; and hypodermis based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019342	K02F6.8
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-19; and hcf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Microcystin-LR; and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00019343	nep-18
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension. Is an ortholog of human KEL (Kell metallo-endopeptidase (Kell blood group)).

WB:WBGene00019344	dhhc-10
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is involved in IRE1-mediated unfolded protein response. Is expressed in several structures, including enteric muscle; intestine; pharynx; spermatheca; and ventral nerve cord. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Raymond type.

WB:WBGene00019345	tmem-135
Is involved in several processes, including determination of adult lifespan; positive regulation of lipid storage; and positive regulation of mitochondrial membrane potential. Localizes to cytoplasm and lipid droplet. Is expressed in epithelial system and pharynx. Is an ortholog of human TMEM135 (transmembrane protein 135).

WB:WBGene00019346	K02G10.5
Is predicted to have sodium-independent organic anion transmembrane transporter activity.

WB:WBGene00019347	mbl-1
Is predicted to have RNA binding activity. Is expressed in excretory cell; neurons; and tail. Is an ortholog of human MBNL1 (muscleblind like splicing regulator 1) and MBNL2 (muscleblind like splicing regulator 2).

WB:WBGene00019348	K02H11.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00019349	trx-5
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including dpy-21; ubc-9; and tatn-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; Nucleoredoxin-like protein 2; and Thioredoxin-like superfamily. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00019350	K02H11.9
Is affected by several genes including hpl-2; his-24; and drh-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019351	lron-7
Is expressed in head. Is predicted to encode a protein with the following domains: Leucine rich repeat; Cysteine-rich flanking region, C-terminal; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily. Is an ortholog of human OPTC (opticin).

WB:WBGene00019352	K03A1.4
Is predicted to have calcium ion binding activity. Is expressed in head neurons and tail neurons. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93.

WB:WBGene00019353	K03B4.1
Is predicted to have ATP binding activity and serine-tRNA ligase activity.

WB:WBGene00019354	K03B4.2
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; let-60; and gld-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Cry5B; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019355	K03B4.4
Is enriched in neurons and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; D-glucose; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00019356	K03B4.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00019357	cpg-8
Is enriched in several structures, including AFD; body wall musculature; germ line; hypodermis; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-60; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019360	neto-1
Is enriched in intestine; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by Rotenone and paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: Low-density lipoprotein receptor domain class A; CUB domain; CUB domain; Low-density lipoprotein (LDL) receptor class A repeat; Spermadhesin, CUB domain superfamily; and LDL receptor-like superfamily. Is an ortholog of human NETO2 (neuropilin and tolloid like 2).

WB:WBGene00019361	clik-3
Is enriched in NSM and pharyngeal muscle cell based on RNA-seq; tiling array; and proteomic studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by twelve chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Calponin family repeat and Calponin repeat.

WB:WBGene00019362	cdk-2
Is predicted to have cyclin-dependent protein serine/threonine kinase activity. Is involved in several processes, including germline cell cycle switching, mitotic to meiotic cell cycle; hermaphrodite genitalia morphogenesis; and regulation of cellular protein localization. Localizes to chromatin. Is an ortholog of human CDK3 (cyclin dependent kinase 3).

WB:WBGene00019364	mksr-1
Is involved in several processes, including larval foraging behavior; non-motile cilium assembly; and protein localization to ciliary transition zone. Localizes to ciliary transition zone. Is expressed in amphid neurons; ciliated neurons; and sensory neurons. Is used to study ciliopathy and nephronophthisis. Human ortholog(s) of this gene are implicated in Joubert syndrome 27. Is an ortholog of human B9D1 (B9 domain containing 1).

WB:WBGene00019365	rei-2
Is predicted to have protein kinase inhibitor activity. Is an ortholog of human SH3BP5L (SH3 binding domain protein 5 like).

WB:WBGene00019366	K03F8.1
No description available

WB:WBGene00019367	K03H6.1
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00019368	txt-4
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00019369	K03H6.4
Is enriched in AFD; body wall muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019370	K03H6.5
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00019371	K03H9.1
Is affected by hpl-2 and rsr-2 based on tiling array studies.

WB:WBGene00019372	K03H9.3
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019373	K04A8.1
Is involved in innate immune response.

WB:WBGene00019374	K04A8.2
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including drh-3; cyc-1; and rpn-10 based on microarray and RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019376	lipl-4
Exhibits triglyceride lipase activity. Is involved in several processes, including determination of adult lifespan; long-chain fatty acid biosynthetic process; and triglyceride catabolic process. Localizes to lysosome. Is expressed in intestine and seam cell. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of human LIPN (lipase family member N).

WB:WBGene00019378	K04A8.7
No description available

WB:WBGene00019379	K04A8.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; methylmercuric chloride; and Sodium Chloride based on microarray and RNA-seq studies. Human UGT3A1 exhibits glucuronosyltransferase activity. Is an ortholog of human UGT3A1 (UDP glycosyltransferase family 3 member A1) and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00019380	K04C2.2
Is predicted to have sequence-specific DNA binding activity and transcription corepressor activity. Is an ortholog of human MYBBP1A (MYB binding protein 1a).

WB:WBGene00019381	K04C2.3
Is enriched in AFD; dopaminergic neurons; germ line; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019382	K04C2.5
Is enriched in AFD and hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; multi-walled carbon nanotube; and Neurotoxins based on microarray and RNA-seq studies.

WB:WBGene00019383	K04E7.1
Is affected by dpy-21; drh-3; and thoc-5 based on RNA-seq studies.

WB:WBGene00019384	K04F1.1
Is enriched in NSM; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; prg-1; and mut-2 based on proteomic; RNA-seq; and microarray studies. Is affected by Tunicamycin and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00019385	irld-41
Is affected by eat-2 based on microarray studies.

WB:WBGene00019386	irld-42
Is affected by several genes including clk-1; elt-2; and drh-3 based on microarray and RNA-seq studies. Is affected by cadmium and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00019387	K04F1.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; hpl-2; and his-24 based on tiling array; microarray; and RNA-seq studies. Is affected by dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019388	K04F1.9
Is enriched in cephalic sheath cell; dopaminergic neurons; germ line; hypodermis; and mechanosensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-seven chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019389	irld-40
Is affected by several genes including elt-2; sir-2.1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; resveratrol; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00019390	irld-43
Is affected by drh-3 and hpl-2 based on RNA-seq studies. Is affected by resveratrol and dibromoacetic acid based on microarray studies.

WB:WBGene00019391	irld-11
Is enriched in neurons based on microarray studies. Is affected by rsr-2; hpl-2; and let-60 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00019392	irld-44
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00019393	irld-45
Is affected by tatn-1; clk-1; and daf-2 based on RNA-seq and microarray studies. Is affected by cadmium and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00019394	K04F10.1
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 1. Is an ortholog of human ATXN1 (ataxin 1) and ATXN1L (ataxin 1 like).

WB:WBGene00019395	K04F10.2
Is involved in motile cilium assembly. Localizes to ciliary base. Is expressed in ciliated neurons and intestinal cell. Human ortholog(s) of this gene are implicated in Joubert syndrome 26. Is an ortholog of human KATNIP (katanin interacting protein).

WB:WBGene00019396	K04F10.3
Is enriched in AVA; body wall muscle cell; excretory cell; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; gld-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019397	K04F10.5
No description available

WB:WBGene00019399	K04F10.7
Is enriched in ASER and germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FAM76 protein and FAM76 protein. Is an ortholog of human FAM76A (family with sequence similarity 76 member A) and FAM76B (family with sequence similarity 76 member B).

WB:WBGene00019400	K04G7.1
Is expressed in body wall musculature and head neurons. Is predicted to encode a protein with the following domains: Phosphorylation site; Integrase zinc binding domain; and Integrase zinc-binding domain.

WB:WBGene00019401	nuo-4
Is enriched in NSM; OLL; PLM; and PVD based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on RNA-seq; tiling array; microarray; and proteomic studies. Is affected by seven chemicals including 25-azacoprostane; Rifampin; and allantoin based on proteomic; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Deoxynucleoside kinase; P-loop containing nucleoside triphosphate hydrolase; and Deoxynucleoside kinase domain. Is an ortholog of human NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10).

WB:WBGene00019402	syf-2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including resveratrol; cadmium; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: SYF2 splicing factor and mRNA splicing factor SYF2. Is an ortholog of human SYF2 (SYF2 pre-mRNA splicing factor).

WB:WBGene00019403	K05B2.2
Is expressed in several structures, including head muscle; interfacial epithelial cell; pharyngeal muscle cell; rectal gland cell; and vulva. Is predicted to encode a protein with the following domains: Ubiquitin-like domain superfamily and N-terminal RASSF family. Is an ortholog of human RASSF8 (Ras association domain family member 8).

WB:WBGene00019404	K05B2.4
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT1 (acyl-CoA thioesterase 1).

WB:WBGene00019405	K05F1.1
Is enriched in DA neuron; VA neuron; germ line; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DX module and Domain of unknown function DX.

WB:WBGene00019406	acdh-8
Is predicted to have medium-chain-acyl-CoA dehydrogenase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADM (acyl-CoA dehydrogenase medium chain).

WB:WBGene00019407	lect-2
Is involved in innervation; regulation of dendrite extension; and regulation of dendrite morphogenesis. Localizes to several cellular components, including cell surface; perikaryon; and sensory dendrite. Is expressed in body wall musculature; coelomocyte; head neurons; and ventral cord neurons. Is an ortholog of human LECT2 (leukocyte cell derived chemotaxin 2).

WB:WBGene00019408	K05F1.6
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease.

WB:WBGene00019409	K05F1.8
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Atrazine; and cadmium based on microarray studies.

WB:WBGene00019410	K05F1.9
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00019411	K05F1.10
Is involved in innate immune response.

WB:WBGene00019412	fbxb-49
Is affected by several genes including eat-2; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019413	fbxb-50
Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019414	fbxb-51
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Alovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019415	K05F6.4
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on proteomic; microarray; and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019416	fbxb-44
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019417	fbxb-52
Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019418	fbxb-54
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019419	K05F6.8
Is affected by several genes including daf-2; mex-1; and ain-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019420	fbxb-46
Is affected by several genes including daf-2; mex-3; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019421	K05F6.10
Is enriched in GABAergic neurons; coelomocyte; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including methylmercury hydroxide; Tunicamycin; and Ethanol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain and MATH/TRAF domain.

WB:WBGene00019422	K05G3.1
Is affected by several genes including eat-2; sir-2.1; and smg-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ribonuclease H-like superfamily.

WB:WBGene00019423	K05G3.2
Is affected by several genes including clk-1; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00019424	aptf-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is involved in positive regulation of transcription by RNA polymerase II and sleep. Is expressed in head neurons and pharyngeal neurons. Human ortholog(s) of this gene are implicated in Char syndrome and branchiooculofacial syndrome. Is an ortholog of several human genes including TFAP2A (transcription factor AP-2 alpha); TFAP2C (transcription factor AP-2 gamma); and TFAP2D (transcription factor AP-2 delta).

WB:WBGene00019425	K06A1.2
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019426	cutl-16
Is enriched in pharynx and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00019427	atg-16.2
Is involved in defense response to Gram-positive bacterium; gamete generation; and macroautophagy. Localizes to cytoplasm. Is expressed in body wall musculature; embryonic cell; intestine; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in inflammatory bowel disease 10. Is an ortholog of human ATG16L1 (autophagy related 16 like 1).

WB:WBGene00019428	dgk-5
Is predicted to have diacylglycerol kinase activity. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 7. Is an ortholog of human DGKI (diacylglycerol kinase iota) and DGKZ (diacylglycerol kinase zeta).

WB:WBGene00019429	K06A5.1
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including manganese chloride; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chromo/chromo shadow domain and Chromo-like domain superfamily.

WB:WBGene00019430	K06A5.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interactor of ZYG-11 and Protein of unknown function DUF856, Caenorhabditis species.

WB:WBGene00019431	K06A5.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00019432	knl-2
Localizes to condensed nuclear chromosome kinetochore. Is an ortholog of human MIS18BP1 (MIS18 binding protein 1).

WB:WBGene00019433	acdh-3
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6 and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADSB (acyl-CoA dehydrogenase short/branched chain).

WB:WBGene00019434	nmtn-1
Is enriched in arcade cell; germ line; neurons; pharyngeal-intestinal valve cell; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including rrf-3; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and WD repeat-containing protein 47. Is an ortholog of human WDR47 (WD repeat domain 47).

WB:WBGene00019435	K06A9.1
Is enriched in cephalic sheath cell; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019436	K06A9.2
Is enriched in GABAergic neurons; body wall musculature; head mesodermal cell; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including tert-Butylhydroperoxide; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box-like domain superfamily.

WB:WBGene00019437	K06A9.3
Is enriched in ASER and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sod-2; and mex-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: EGF-like domain; EGF-like domain; and Galactose-binding-like domain superfamily.

WB:WBGene00019438	cyp-25A6
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity.

WB:WBGene00019439	K06B9.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by allantoin; Sirolimus; and Rifampin based on RNA-seq studies. Is an ortholog of human UAP1 (UDP-N-acetylglucosamine pyrophosphorylase 1) and UAP1L1 (UDP-N-acetylglucosamine pyrophosphorylase 1 like 1).

WB:WBGene00019441	K06B9.4
Is enriched in Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including metformin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00019442	K06C4.1
Is affected by several genes including daf-16; sek-1; and pry-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Mianserin and multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00019444	frpr-11
Is predicted to have G protein-coupled receptor activity. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00019445	frpr-12
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00019446	K06C4.14
No description available

WB:WBGene00019447	K06C4.15
No description available

WB:WBGene00019448	frpr-13
Is enriched in BAG; DA neuron; VA neuron; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including bisphenol A; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00019449	K06H6.1
Is expressed in seam cell. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF268 and Protein of unknown function DUF268, Caenorhabditis species.

WB:WBGene00019450	K06H6.2
Is expressed in head neurons and nervous system. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; Methyltransferase-like protein 24; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00019451	nstp-7
Is predicted to have UDP-galactose transmembrane transporter activity. Is an ortholog of human SLC35A1 (solute carrier family 35 member A1).

WB:WBGene00019452	K06H6.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00019453	K06H6.5
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00019454	K06H6.6
Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray and tiling array studies. Is affected by Chlorpyrifos based on microarray studies.

WB:WBGene00019455	K06H7.1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00019456	K06H7.2
Is enriched in several structures, including AVA; excretory cell; mechanosensory neurons; muscle cell; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including levamisole; stavudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; F-box associated domain, type 2; and F-box protein she-1-like.

WB:WBGene00019457	vms-1
Is predicted to have metal ion binding activity. Localizes to cytoplasm and dendrite. Is expressed in amphid neurons; head neurons; intestine; tail neurons; and ventral nerve cord. Is an ortholog of human ANKZF1 (ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1).

WB:WBGene00019458	K06H7.7
Is enriched in AFD; AVA; germ line; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019459	K06H7.8
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019460	idi-1
Is predicted to have isopentenyl-diphosphate delta-isomerase activity. Is an ortholog of human IDI1 (isopentenyl-diphosphate delta isomerase 1) and IDI2 (isopentenyl-diphosphate delta isomerase 2).

WB:WBGene00019461	K07A3.3
Is predicted to have ATP binding activity and ATP-dependent peptidase activity. Is an ortholog of human CLPX (caseinolytic mitochondrial matrix peptidase chaperone subunit X).

WB:WBGene00019462	ccm-2
Is enriched in AVK; coelomocyte; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including tryptophan; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: PH-like domain superfamily.

WB:WBGene00019464	K07B1.4
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Is an ortholog of human MOGAT1 (monoacylglycerol O-acyltransferase 1).

WB:WBGene00019465	acl-14
Is predicted to have transferase activity, transferring acyl groups. Is expressed in head and tail. Is an ortholog of human LPGAT1 (lysophosphatidylglycerol acyltransferase 1).

WB:WBGene00019466	tos-1
Is enriched in body wall musculature; germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and rde-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including aldicarb; Rotenone; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00019467	K07B1.7
Is predicted to have nucleic acid binding activity. Is an ortholog of human GPATCH3 (G-patch domain containing 3).

WB:WBGene00019469	srz-89
Is affected by resveratrol; Diazinon; and Chlorpyrifos based on microarray studies.

WB:WBGene00019470	cyp-35B3
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00019471	cyp-35B2
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00019472	cyp-35B1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is expressed in hypodermal cell. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2R1 (cytochrome P450 family 2 subfamily R member 1) and CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00019473	cyp-35A5
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in response to xenobiotic stimulus. Is expressed in intestine. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00019476	timp-1
Is predicted to have metalloendopeptidase inhibitor activity and protease binding activity. Is expressed in several structures, including coelomocyte; gonad; head neurons; nerve ring; and vulval cell. Human ortholog(s) of this gene are implicated in Sorsby's fundus dystrophy. Is an ortholog of human TIMP2 (TIMP metallopeptidase inhibitor 2) and TIMP3 (TIMP metallopeptidase inhibitor 3).

WB:WBGene00019477	cest-17
Is predicted to have carboxylic ester hydrolase activity. Is expressed in gonad; intestine; pharynx; and somatic gonad. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase).

WB:WBGene00019478	cri-2
Is predicted to have metalloendopeptidase inhibitor activity and protease binding activity. Is expressed in several structures, including enteric muscle; gonad; hyp12; nerve ring; and tail hypodermis. Human ortholog(s) of this gene are implicated in Sorsby's fundus dystrophy. Is an ortholog of human TIMP2 (TIMP metallopeptidase inhibitor 2).

WB:WBGene00019479	K07C11.7
Is predicted to have hydrolase activity. Is an ortholog of human MPPED1 (metallophosphoesterase domain containing 1) and MPPED2 (metallophosphoesterase domain containing 2).

WB:WBGene00019480	K07C11.8
Is enriched in body wall muscle cell; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019481	cogc-6
Is involved in gonad morphogenesis and regulation of cell migration. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIl. Is an ortholog of human COG6 (component of oligomeric golgi complex 6).

WB:WBGene00019482	K07C11.10
Is expressed in amphid neurons and phasmid neurons. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 18. Is predicted to encode a protein with the following domains: Cilia BBSome complex subunit 10 and Cilia BBSome complex subunit 10. Is an ortholog of human BBIP1 (BBSome interacting protein 1).

WB:WBGene00019483	K07D4.2
Is predicted to have endonuclease activity.

WB:WBGene00019484	K07D4.4
Is enriched in ASER; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Lithium Chloride; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00019485	K07D4.5
Is enriched in GABAergic neurons; coelomocyte; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; mex-3; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by dibromoacetic acid and tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Plant self-incompatibility protein S1 and Plant self-incompatibility S1.

WB:WBGene00019486	K07D4.6
Is enriched in head mesodermal cell and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including tryptophan; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019487	ephx-1
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in anchor cell; anterior distal tip cell; head; posterior distal tip cell; and uterine toroidal epithelial cell. Is an ortholog of human ARHGEF15 (Rho guanine nucleotide exchange factor 15) and ARHGEF16 (Rho guanine nucleotide exchange factor 16).

WB:WBGene00019488	K07D4.9
Is enriched in Psub1; head mesodermal cell; hypodermis; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00019489	K07E1.1
Is predicted to have acireductone dioxygenase [iron(II)-requiring] activity. Is an ortholog of human ADI1 (acireductone dioxygenase 1).

WB:WBGene00019490	K07E3.1
Is enriched in AFD; OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including Heme; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019491	K07E3.2
Is enriched in AVA; dopaminergic neurons; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; D-glucose; and metformin based on microarray and RNA-seq studies.

WB:WBGene00019492	K07E3.4
Is predicted to have formate-tetrahydrofolate ligase activity; methenyltetrahydrofolate cyclohydrolase activity; and methylenetetrahydrofolate dehydrogenase (NADP+) activity. Human ortholog(s) of this gene are implicated in neural tube defect. Is an ortholog of human MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1).

WB:WBGene00019493	catp-5
Is predicted to have ATP binding activity; ATPase activity; and metal ion binding activity. Is expressed in amphid neurons; excretory cell; germ cell; gonad; and intestine. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; Kufor-Rakeb syndrome; and keratosis (multiple). Is an ortholog of human ATP13A3 (ATPase 13A3).

WB:WBGene00019494	K07E8.1
Is enriched in NSM; dopaminergic neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; mut-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00019495	sdz-24
Is predicted to have nucleic acid binding activity.

WB:WBGene00019496	frpr-14
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00019497	K07E8.6
Is predicted to have chaperone binding activity; heat shock protein binding activity; and unfolded protein binding activity. Is an ortholog of human CDC37 (cell division cycle 37, HSP90 cochaperone) and CDC37L1 (cell division cycle 37 like 1).

WB:WBGene00019498	K07E8.7
Is predicted to have pseudouridine synthase activity. Is an ortholog of human RPUSD2 (RNA pseudouridine synthase domain containing 2).

WB:WBGene00019499	K07E8.10
No description available

WB:WBGene00019501	K07E12.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00019502	K07G6.1
Is enriched in coelomocyte and intestine based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00019503	tbce-1
Is predicted to have alpha-tubulin binding activity. Localizes to cytoplasm. Human ortholog(s) of this gene are implicated in hypoparathyroidism-retardation-dysmorphism syndrome. Is an ortholog of human Tbce.

WB:WBGene00019504	K07H8.2
Is predicted to have cation transmembrane transporter activity. Is an ortholog of human SLC41A1 (solute carrier family 41 member 1).

WB:WBGene00019506	K07H8.5
Is enriched in AVG; RIM; command interneuron; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including Ethanol; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019507	K07H8.7
Is enriched in NSM; amphid sheath cell; germ line; and intestine based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; bisphenol A; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019508	K07H8.8
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00019509	K07H8.9
Is predicted to have mRNA binding activity. Is an ortholog of human QKI (QKI, KH domain containing RNA binding).

WB:WBGene00019510	K07H8.10
Is predicted to have RNA binding activity.

WB:WBGene00019511	lido-8
Is enriched in several structures, including body wall musculature; excretory cell; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including manganese chloride; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00019512	K08A2.2
Is enriched in AVA; germ line; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including tryptophan; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248) and Domain of unknown function DUF1248.

WB:WBGene00019513	lido-7
Is enriched in OLL; PVD; germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; antimycin; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00019514	K08B4.2
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including Alzheimer's disease 18; cone-rod dystrophy 9; and early infantile epileptic encephalopathy 61.

WB:WBGene00019515	ugt-19
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A3 (UDP glucuronosyltransferase family 1 member A3); and UGT2A3 (UDP glucuronosyltransferase family 2 member A3).

WB:WBGene00019516	ugt-20
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00019517	K08B4.5
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00019518	K08B5.1
Is enriched in Z1; Z4; germline precursor cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; 4-bromodiphenyl ether; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00019519	K08B5.2
Is enriched in intestine; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00019520	K08B12.1
Is expressed in hypodermis. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00019521	dmd-7
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in several structures, including excretory cell; intestine; pharynx; rectum; and vulval muscle.

WB:WBGene00019522	K08B12.3
Is predicted to have phosphatase activity. Is an ortholog of human HDHD2 (haloacid dehalogenase like hydrolase domain containing 2).

WB:WBGene00019524	K08D9.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00019525	K08D9.4
Is enriched in AVK; mechanosensory neurons; pharynx; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including skn-1; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including tryptophan; levamisole; and Sodium Chloride based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is predicted to encode a protein with the following domains: Alpha/beta hydrolase of unknown function (DUF1057) and Protein of unknown function DUF1057.

WB:WBGene00019526	K08D9.5
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by Sirolimus and allantoin based on microarray studies.

WB:WBGene00019527	K08D9.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00019528	K08D10.1
No description available

WB:WBGene00019529	K08D10.5
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00019530	scrm-8
Is predicted to have phospholipid scramblase activity. Is an ortholog of several human genes including PLSCR1 (phospholipid scramblase 1); PLSCR3 (phospholipid scramblase 3); and PLSCR5 (phospholipid scramblase family member 5).

WB:WBGene00019531	scrm-5
Is predicted to have phospholipid scramblase activity. Is an ortholog of several human genes including PLSCR1 (phospholipid scramblase 1); PLSCR3 (phospholipid scramblase 3); and PLSCR5 (phospholipid scramblase family member 5).

WB:WBGene00019532	K08D10.9
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019533	K08D10.10
Is enriched in DA neuron and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including aldicarb; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00019534	K08D10.11
Is affected by several genes including age-1; sir-2.1; and isp-1 based on microarray and RNA-seq studies.

WB:WBGene00019535	tsen-34
Is predicted to have tRNA-intron endonuclease activity. Human ortholog(s) of this gene are implicated in pontocerebellar hypoplasia type 2C. Is an ortholog of human TSEN34 (tRNA splicing endonuclease subunit 34).

WB:WBGene00019536	rpi-2
Is predicted to have GTPase activator activity. Localizes to cilium and periciliary membrane compartment. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 2. Is an ortholog of human RP2 (RP2 activator of ARL3 GTPase).

WB:WBGene00019537	K08D12.3
Is predicted to have mRNA binding activity; single-stranded RNA binding activity; and translation regulator activity. Is expressed in head muscle and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in myotonic dystrophy type 2. Is an ortholog of human CNBP (CCHC-type zinc finger nucleic acid binding protein).

WB:WBGene00019538	K08D12.4
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019540	K08D12.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019541	K08F11.1
Is enriched in I5 neuron; cholinergic neurons; germ line; germline precursor cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including age-1; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Alovudine; and metformin based on microarray and RNA-seq studies.

WB:WBGene00019542	K08F11.2
No description available

WB:WBGene00019543	cif-1
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF3M (eukaryotic translation initiation factor 3 subunit M).

WB:WBGene00019544	miro-1
Is predicted to have GTP binding activity and GTPase activity. Is involved in mitochondrion organization. Is expressed in body wall muscle cell; neurons; and pharyngeal muscle cell. Is an ortholog of human RHOT2 (ras homolog family member T2).

WB:WBGene00019545	K09B3.1
Is enriched in amphid sheath cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by Zidovudine; glycine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00019546	glct-6
Is predicted to have galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity and metal ion binding activity. Is an ortholog of human B3GAT2 (beta-1,3-glucuronyltransferase 2).

WB:WBGene00019547	K09C4.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00019548	K09C4.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00019549	K09C4.4
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00019550	K09C4.5
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00019552	K09C4.7
Is enriched in Z1.p; Z4.a; coelomocyte; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including let-60; clk-1; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including aldicarb; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00019553	K09C4.9
Is enriched in Z1; Z4; coelomocyte; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including eri-1; hpl-2; and mut-2 based on tiling array and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019554	K09C4.10
Is enriched in coelomocyte and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019556	K09C6.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019557	K09C6.3
Is enriched in AFD; NSM; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including let-60; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00019558	srbc-12
Is affected by several genes including daf-2; eat-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00019559	srbc-13
Is affected by several genes including eat-2; hpl-2; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by aldicarb; dafa#1; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00019560	K09C6.6
Is affected by drh-3 and klf-1 based on RNA-seq studies. Is affected by Cry5B and Sirolimus based on microarray studies.

WB:WBGene00019561	K09C6.7
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019562	K09C6.8
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019563	K09C6.9
Is enriched in amphid sheath cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including nicotinic acid; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019564	K09D9.1
Is involved in innate immune response.

WB:WBGene00019565	cyp-35A3
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Is involved in response to xenobiotic stimulus. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00019566	K09D9.3
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on tiling array and RNA-seq studies.

WB:WBGene00019567	K09D9.9
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019568	K09D9.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00019569	K09D9.12
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019570	K09E2.1
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sek-1 based on RNA-seq and microarray studies. Is affected by single-walled carbon nanotube and adsorbable organic bromine compound based on microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00019571	K09E2.2
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Tunicamycin; Sodium Chloride; and adsorbable organic bromine compound based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cancer susceptibility candidate protein 1. Is an ortholog of human CFAP94 (cilia and flagella associated protein 94).

WB:WBGene00019572	K09E2.3
Is enriched in head mesodermal cell; hypodermis; intestine; muscle cell; and sensory neurons based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; microarray; and RNA-seq studies. Is affected by nine chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019573	K09E3.1
No description available

WB:WBGene00019574	K09E3.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; sma-2; and sma-4 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine and allantoin based on microarray studies.

WB:WBGene00019575	K09E3.4
Is affected by several genes including clk-1; pgl-1; and csr-1 based on microarray and RNA-seq studies.

WB:WBGene00019576	lido-5
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including D-glucose; nanoparticle; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00019577	lido-6
Is enriched in Z1.p; Z4.a; coelomocyte; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00019578	K09E3.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including Lithium Chloride; D-glucose; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00019579	oac-57
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00019580	oac-58
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00019581	K09E10.3
No description available

WB:WBGene00019582	K09F5.1
Is affected by eat-2 based on RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019583	K09F5.4
Is enriched in DA neuron; NSM; and VA neuron based on tiling array studies. Is affected by mir-34 and daf-2 based on microarray studies.

WB:WBGene00019584	set-12
Is predicted to have histone methyltransferase activity (H3-K36 specific). Is expressed in germ line and hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Sotos syndrome; and Wolf-Hirschhorn syndrome. Is an ortholog of human NSD1 (nuclear receptor binding SET domain protein 1).

WB:WBGene00019585	K09F6.2
No description available

WB:WBGene00019586	K09F6.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00019587	K09F6.4
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019588	K09F6.5
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00019589	K09F6.6
Is enriched in ASER and intestine based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019590	K09F6.7
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including age-1; clk-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00019591	fbxc-25
Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019592	K09F6.9
Is enriched in ASER; coelomocyte; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; D-glucose; and 4-bromodiphenyl ether based on microarray and RNA-seq studies.

WB:WBGene00019593	K09F6.10
Is enriched in cephalic sheath cell; coelomocyte; hypodermis; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00019594	K09H9.1
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Regulator protein PHA-1 and Regulator protein, PHA-1.

WB:WBGene00019595	dscc-1
Is predicted to contribute to DNA clamp loader activity. Is an ortholog of human DSCC1 (DNA replication and sister chromatid cohesion 1).

WB:WBGene00019596	K09H9.4
No description available

WB:WBGene00019597	K09H9.5
Is enriched in OLL; PVD; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00019598	K09H9.7
Is expressed in intestine. Is predicted to encode a protein with the following domain: .

WB:WBGene00019599	acds-10
Is predicted to have flavin adenine dinucleotide binding activity; hydrolase activity; and oxidoreductase activity, acting on the CH-CH group of donors. Is expressed in P3.p hermaphrodite; P4.p hermaphrodite; and P8.p hermaphrodite. Is an ortholog of human ACAD10 (acyl-CoA dehydrogenase family member 10).

WB:WBGene00019600	rga-3
Exhibits GTPase activator activity. Is involved in asymmetric protein localization involved in cell fate determination; cortical actin cytoskeleton organization; and regulation of actin filament-based process. Localizes to cell cortex and centrosome. Is expressed in embryonic cell; germ line; and pharyngeal muscle cell. Is an ortholog of human ARHGAP11A (Rho GTPase activating protein 11A).

WB:WBGene00019601	K09H11.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00019603	K09H11.6
Is enriched in AVK and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; mex-3; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00019604	pgph-1
Is predicted to have phosphatase activity. Is an ortholog of human PDXP (pyridoxal phosphatase) and PGP (phosphoglycolate phosphatase).

WB:WBGene00019605	ctsa-4.1
Is predicted to have serine-type carboxypeptidase activity. Human ortholog(s) of this gene are implicated in galactosialidosis. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00019606	clec-88
Is predicted to have carbohydrate binding activity. Is an ortholog of human KLRF2 (killer cell lectin like receptor F2).

WB:WBGene00019607	K10B2.4
Is expressed in excretory cell; head neurons; tail neurons; and ventral nerve cord. Is predicted to encode a protein with the following domains: Uncharacterised protein family (UPF0139) and Uncharacterised protein family UPF0139. Is an ortholog of human WDR83OS (WD repeat domain 83 opposite strand).

WB:WBGene00019608	ani-2
Is predicted to have GTP-Rho binding activity. Is involved in several processes, including female gamete generation; gonad development; and syncytium formation. Localizes to cytoplasm. Is expressed in germ line. Human ortholog(s) of this gene are implicated in focal segmental glomerulosclerosis 8. Is an ortholog of human ANLN (anillin actin binding protein).

WB:WBGene00019609	K10B3.1
Is expressed in several structures, including head; hypodermal cell; and tail. Is predicted to encode a protein with the following domains: 4F5 protein family; Uncharacterised protein family SERF, N-terminal; and ZNF706/At2g23090 superfamily. Is an ortholog of human ZNF706 (zinc finger protein 706).

WB:WBGene00019610	K10B3.2
No description available

WB:WBGene00019611	K10B3.5
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00019612	gpcp-1
Is predicted to have glycerophosphocholine phosphodiesterase activity. Is an ortholog of human GPCPD1 (glycerophosphocholine phosphodiesterase 1).

WB:WBGene00019613	K10B4.1
Is predicted to have peroxidase activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7.

WB:WBGene00019614	srt-54
Is affected by several genes including clk-1; pgl-1; and mex-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00019615	K10B4.3
Is enriched in germ line and intestine based on proteomic and microarray studies. Is affected by several genes including hsf-1; lin-35; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Rotenone; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PH domain; Pleckstrin homology domain; PH-like domain superfamily; Armadillo-type fold; and Protein melted-like. Is an ortholog of human VEPH1 (ventricular zone expressed PH domain containing 1).

WB:WBGene00019616	nmur-2
Exhibits neuropeptide receptor activity. Is involved in neuropeptide signaling pathway. Is an ortholog of human NMUR1 (neuromedin U receptor 1) and NMUR2 (neuromedin U receptor 2).

WB:WBGene00019617	ctsa-2
Is predicted to have serine-type carboxypeptidase activity. Localizes to membrane raft. Human ortholog(s) of this gene are implicated in galactosialidosis. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00019618	K10C2.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by Cadmium Chloride based on RNA-seq studies.

WB:WBGene00019619	asp-14
Is predicted to have aspartic-type endopeptidase activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of several human genes including CTSE (cathepsin E); PGA3 (pepsinogen A3); and PGA4 (pepsinogen A4).

WB:WBGene00019620	fah-1
Is predicted to have fumarylacetoacetase activity. Is expressed in hypodermis. Is used to study tyrosinemia type I. Human ortholog(s) of this gene are implicated in tyrosinemia type I. Is an ortholog of human FAH (fumarylacetoacetate hydrolase).

WB:WBGene00019621	K10C2.6
Is enriched in NSM based on tiling array studies. Is affected by cyc-1; clk-1; and dpy-21 based on microarray and RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00019622	K10C2.7
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Tunicamycin; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00019623	K10C9.1
Is enriched in cephalic sheath cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including D-glucose; indole; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019624	rnst-2
Is predicted to have endoribonuclease activity. Is expressed in several structures, including intestine; neuronal sheath cell; pharynx; tail; and vulva. Is an ortholog of human RNASET2 (ribonuclease T2).

WB:WBGene00019625	K10C9.4
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00019626	K10C9.7
Is enriched in DA neuron; I5 neuron; SAB; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00019627	hira-1
Is predicted to have transcription corepressor activity. Is used to study chromosome 22q11.2 deletion syndrome, distal. Is an ortholog of human HIRA (histone cell cycle regulator).

WB:WBGene00019628	pup-2
Exhibits RNA uridylyltransferase activity. Is involved in pre-miRNA processing. Human ortholog(s) of this gene are implicated in spastic ataxia 4. Is an ortholog of human TUT4 (terminal uridylyl transferase 4) and TUT7 (terminal uridylyl transferase 7).

WB:WBGene00019629	cid-1
Exhibits RNA uridylyltransferase activity. Is involved in RNA 3' uridylation. Localizes to P granule; condensed nuclear chromosome; and perinuclear region of cytoplasm. Is expressed in germ line and intestine. Is an ortholog of human TUT7 (terminal uridylyl transferase 7).

WB:WBGene00019630	emb-1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00019631	K10D2.5
Is enriched in germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq; proteomic; and microarray studies. Is affected by four chemicals including manganese chloride; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Cytochrome b5-like heme/steroid binding domain superfamily.

WB:WBGene00019633	K10D2.7
Is predicted to have molybdopterin synthase activity and nucleotide binding activity.

WB:WBGene00019635	K10E9.2
No description available

WB:WBGene00019636	gsto-3
Is predicted to have glutathione dehydrogenase (ascorbate) activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTO1 (glutathione S-transferase omega 1) and GSTO2 (glutathione S-transferase omega 2).

WB:WBGene00019637	K10F12.5
No description available

WB:WBGene00019638	K10F12.6
Is affected by several genes including mex-3; csr-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019639	K10F12.7
Is affected by several genes including elt-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00019640	dos-2
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercury hydroxide; D-glucose; and glycine based on RNA-seq and microarray studies.

WB:WBGene00019641	cank-26
Is expressed in PHB; lateral ganglion; and ventral nerve cord.

WB:WBGene00019642	K11C4.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019643	K11C4.2
Is predicted to have signaling receptor activity. Is expressed in head. Is an ortholog of human PAQR8 (progestin and adipoQ receptor family member 8).

WB:WBGene00019644	cpt-4
Is predicted to have carnitine O-palmitoyltransferase activity. Is an ortholog of human CPT1A (carnitine palmitoyltransferase 1A); CPT1B (carnitine palmitoyltransferase 1B); and CPT1C (carnitine palmitoyltransferase 1C).

WB:WBGene00019645	swt-7
Is involved in defense response to Gram-negative bacterium and innate immune response. Is an ortholog of human SLC50A1 (solute carrier family 50 member 1).

WB:WBGene00019646	K11D12.6
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00019647	K11D12.7
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Guttmacher syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00019648	K11D12.8
Is enriched in NSM; dopaminergic neurons; and excretory cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019649	exc-14
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human MUL1 (mitochondrial E3 ubiquitin protein ligase 1).

WB:WBGene00019650	K11D12.11
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00019651	K11D12.12
Is enriched in GABAergic neurons; body wall muscle cell; carbon dioxide sensory neurons; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00019652	cest-34
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00019653	cest-31
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00019654	cest-28
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES2 (carboxylesterase 2).

WB:WBGene00019655	K11G9.5
Is predicted to have transmembrane transporter activity.

WB:WBGene00019656	slc-25A10
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC25A10 (solute carrier family 25 member 10).

WB:WBGene00019657	K11G12.6
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Quercetin; Hydrolyzable Tannins; and paraquat based on microarray studies. Human ortholog(s) of this gene are implicated in familial lipase maturation factor 1 deficiency. Is predicted to encode a protein with the following domains: Lipase maturation factor and Lipase maturation factor. Is an ortholog of human LMF2 (lipase maturation factor 2).

WB:WBGene00019658	K11H12.1
Is enriched in ASER; AVK; germ line; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; cadmium; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BolA-like protein; BolA protein; and BolA-like superfamily. Is an ortholog of human BOLA1 (bolA family member 1).

WB:WBGene00019659	K11H12.3
Is enriched in intestine and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; D-glucopyranose; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00019660	K11H12.4
Is enriched in head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by twenty-five chemicals including Heme; diallyl trisulfide; and hydrogen sulfide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00019661	K11H12.5
Is enriched in hypodermis; intestine; pharyngeal muscle cell; and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; bisphenol S; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00019662	K11H12.6
Is enriched in GABAergic neurons based on tiling array studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019663	K11H12.7
Is expressed in body wall musculature; head neurons; pharyngeal neurons; and pharynx. Is predicted to encode a protein with the following domain: .

WB:WBGene00019664	K11H12.8
Is enriched in NSM; OLL; PVD; germ line; and germline precursor cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eight chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Inhibitor of apoptosis-promoting Bax1 and Bax inhibitor 1-related. Is an ortholog of human GHITM (growth hormone inducible transmembrane protein).

WB:WBGene00019665	K11H12.9
Is predicted to have ATP binding activity and protein kinase activity. Human ortholog(s) of this gene are implicated in endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy 10.

WB:WBGene00019666	sago-1
Is predicted to have nucleic acid binding activity.

WB:WBGene00019667	spe-49
Is expressed in sperm. Is predicted to encode a protein with the following domains: DC-STAMP-like protein and Dendritic cell-specific transmembrane protein-like. Is an ortholog of human DCST1 (DC-STAMP domain containing 1).

WB:WBGene00019668	fil-2
Is predicted to have lipase activity. Is expressed in intestine.

WB:WBGene00019669	K12B6.4
Is affected by several genes including sir-2.1; sek-1; and alg-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019672	K12B6.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucose; bisphenol A; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019673	K12C11.1
Is predicted to have aminopeptidase activity and manganese ion binding activity. Human ortholog(s) of this gene are implicated in prolidase deficiency. Is an ortholog of human PEPD (peptidase D).

WB:WBGene00019674	K12C11.3
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00019675	K12D9.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase domain; Methyltransferase domain; S-adenosyl-L-methionine-dependent methyltransferase; and Winged helix-like DNA-binding domain superfamily.

WB:WBGene00019676	irld-46
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and his-3 based on microarray and RNA-seq studies.

WB:WBGene00019677	K12H4.2
Is predicted to have ribosomal large subunit binding activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human MALSU1 (mitochondrial assembly of ribosomal large subunit 1).

WB:WBGene00019678	K12H4.3
Is enriched in several structures, including AFD; body wall muscle cell; germ line; intestine; and somatic gonad precursor based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and let-60 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including Mianserin; Cry5B; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Brix domain; Brix domain; and Ribosome biogenesis protein BRX1. Is an ortholog of human BRIX1 (biogenesis of ribosomes BRX1).

WB:WBGene00019679	spcs-3
Is predicted to have peptidase activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human SPCS3 (signal peptidase complex subunit 3).

WB:WBGene00019680	K12H4.5
Is enriched in AFD; ASER; and PLM based on RNA-seq and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019681	K12H4.6
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019682	K12H4.7
Is predicted to have dipeptidyl-peptidase activity. Is involved in innate immune response. Is expressed in intestine. Is an ortholog of human PRSS16 (serine protease 16).

WB:WBGene00019683	K12H6.2
Is enriched in ASER; germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019684	K12H6.4
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019685	K12H6.5
Is enriched in muscle cell; neurons; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; daf-12; and drh-3 based on tiling array and RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019686	K12H6.6
Is enriched in GABAergic neurons; excretory cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including Alovudine; Cadmium Chloride; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TLC domain and TRAM/LAG1/CLN8 homology domain. Is an ortholog of human TLCD1 (TLC domain containing 1).

WB:WBGene00019687	K12H6.7
Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019688	K12H6.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019689	K12H6.9
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019690	set-13
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and fog-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Kleefstra syndrome 2; Sotos syndrome; and autosomal dominant non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domains: SET domain and SET domain.

WB:WBGene00019691	K12H6.12
Is expressed in ciliated neurons; head muscle; intestine; and smooth muscle. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00019692	fubl-4
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human FUBP1 (far upstream element binding protein 1) and FUBP3 (far upstream element binding protein 3).

WB:WBGene00019693	ostd-1
Is involved in endoplasmic reticulum organization and regulation of cell division. Is an ortholog of human RPN2 (ribophorin II).

WB:WBGene00019694	M01A10.4
No description available

WB:WBGene00019696	M01B12.1
No description available

WB:WBGene00019697	M01B12.4
Is enriched in germ line; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on proteomic; microarray; and RNA-seq studies. Is affected by five chemicals including bisphenol S; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019698	riok-1
Is predicted to have protein serine/threonine kinase activity. Is involved in several processes, including gamete generation; positive regulation of vulval development; and regulation of intracellular signal transduction. Is expressed in gonad; nervous system; and vulva. Is an ortholog of human RIOK1 (RIO kinase 1).

WB:WBGene00019699	math-34
Is enriched in coelomocyte and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including tryptophan; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00019700	btb-11
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00019701	M01D1.4
No description available

WB:WBGene00019702	fbxb-39
Is affected by several genes including clk-1; eat-2; and mex-3 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019703	fbxb-41
Is enriched in DA neuron; VA neuron; hypodermis; intestine; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019704	fbxb-40
Is enriched in NSM; cephalic sheath cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; bisphenol S; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019705	fbxb-45
Is enriched in several structures, including NSM; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019706	M01D7.1
Is affected by several genes including daf-2; let-60; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019709	M01E10.3
Is affected by several genes including age-1; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Atrazine and cadmium based on microarray studies.

WB:WBGene00019710	M01E11.1
Is predicted to have protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity. Is an ortholog of human ICMT (isoprenylcysteine carboxyl methyltransferase).

WB:WBGene00019711	ctnb-1
Is expressed in head muscle; intestine; nerve ring; pharynx; and ventral nerve cord. Is predicted to encode a protein with the following domains: Catenin-beta-like, Arm-motif containing nuclear; Armadillo; Armadillo-like helical; Beta-catenin-like protein 1, N-terminal; Armadillo-type fold; and Beta-catenin-like protein 1. Is an ortholog of human CTNNBL1 (catenin beta like 1).

WB:WBGene00019712	rmh-1
Is predicted to have nucleotide binding activity. Is an ortholog of human RMI1 (RecQ mediated genome instability 1).

WB:WBGene00019713	pqn-52
Is enriched in several structures, including cholinergic neurons; coelomocyte; germ line; germline precursor cell; and head mesodermal cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-7; gld-1; and elt-2 based on proteomic; RNA-seq; and microarray studies. Is affected by sixteen chemicals including aldicarb; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00019714	M01G4.1
Is affected by cyc-1 based on microarray studies.

WB:WBGene00019715	M01G5.1
Is enriched in germ line; germline precursor cell; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including glp-1; hsf-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rotenone; bisphenol S; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00019716	M01G5.3
Is affected by several genes including let-7; gld-1; and pgl-1 based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; stavudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TMPIT-like protein and TMPIT-like. Is an ortholog of human TMEM120B (transmembrane protein 120B).

WB:WBGene00019717	trx-3
Localizes to apical plasma membrane; cytoplasm; and nucleus. Is an ortholog of human NXNL1 (nucleoredoxin like 1) and NXNL2 (nucleoredoxin like 2).

WB:WBGene00019718	M01H9.2
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00019719	M01H9.3
Is enriched in several structures, including coelomocyte; dopaminergic neurons; germ line; head mesodermal cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019720	M01H9.4
Is enriched in AFD; ASER; FLP; head mesodermal cell; and intestine based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00019721	M01H9.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00019722	M02A10.1
Is enriched in AFD; ASER; PLM; and neurons based on RNA-seq and microarray studies. Is affected by several genes including hpl-2; let-418; and drh-3 based on tiling array and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00019723	fbxc-47
Is enriched in germ line; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Sirolimus; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF3557.

WB:WBGene00019724	M02B7.2
Is predicted to have 3'-5'-exoribonuclease activity. Is an ortholog of human ERI3 (ERI1 exoribonuclease family member 3).

WB:WBGene00019725	algn-14
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by Rotenone; resveratrol; and Atrazine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital myasthenic syndrome 15. Is predicted to encode a protein with the following domains: Oligosaccharide biosynthesis protein Alg14 like and Oligosaccharide biosynthesis protein Alg14-like. Is an ortholog of human ALG14 (ALG14 UDP-N-acetylglucosaminyltransferase subunit).

WB:WBGene00019726	bris-1
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human IQSEC1 (IQ motif and Sec7 domain ArfGEF 1) and IQSEC2 (IQ motif and Sec7 domain ArfGEF 2).

WB:WBGene00019727	zig-12
Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is expressed in body wall musculature and vulval muscle. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1KK and myopathy (multiple).

WB:WBGene00019728	M02D8.2
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019729	M02D8.3
Is enriched in several structures, including Z4.a; germ line; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including aldicarb; D-glucose; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00019730	asns-2
Is predicted to have asparagine synthase (glutamine-hydrolyzing) activity. Is an ortholog of human ASNS (asparagine synthetase (glutamine-hydrolyzing)).

WB:WBGene00019731	M02D8.5
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; levamisole; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Spermadhesin, CUB domain superfamily.

WB:WBGene00019732	M02D8.6
Is enriched in AFD; body wall muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019733	M02E1.1
Is enriched in coelomocyte; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019734	nlp-64
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including Rotenone; Mianserin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00019735	M02F4.1
Is enriched in intestine based on microarray studies. Is affected by several genes including csr-1; hpl-2; and smg-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019736	M02F4.2
Is enriched in intestine based on microarray studies. Is affected by several genes including mex-1; dpy-21; and spn-4 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019738	clec-265
Is predicted to have carbohydrate binding activity.

WB:WBGene00019739	M02F4.9
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00019740	srt-31
Is affected by several genes including sir-2.1; csr-1; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00019741	nhr-201
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00019742	nhr-202
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00019743	nhr-203
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00019744	M02H5.8
Is enriched in AFD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by twenty chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00019745	srbc-57
Is affected by several genes including rrf-3; eat-2; and mex-3 based on microarray and RNA-seq studies. Is affected by dibromoacetic acid and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00019746	M03A1.3
Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and D-glucopyranose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: Eukaryotic cytochrome b561 and Cytochrome b561/ferric reductase transmembrane. Is an ortholog of human FRRS1 (ferric chelate reductase 1).

WB:WBGene00019747	ipla-1
Exhibits phospholipase activity; phospholipid binding activity; and protein homodimerization activity. Is involved in several processes, including glycerophospholipid metabolic process; protein-containing complex assembly; and regulation of asymmetric cell division. Localizes to several cellular components, including cytosol; endoplasmic reticulum; and phosphatase complex. Is expressed in pharyngeal-intestinal valve; rectum; and spermatheca. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 28. Is an ortholog of human DDHD1 (DDHD domain containing 1).

WB:WBGene00019748	atg-2
Is involved in positive regulation of autophagy. Is expressed in AIYL and AIYR. Is an ortholog of human ATG2A (autophagy related 2A) and ATG2B (autophagy related 2B).

WB:WBGene00019749	M03A8.3
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including aldicarb; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: PH-like domain superfamily.

WB:WBGene00019750	M03D4.3
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; isp-1; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including aldicarb; D-glucose; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00019751	M03D4.4
Is expressed in pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Human ZNF653 exhibits several functions, including AF-2 domain binding activity; transcription corepressor activity; and transcription factor binding activity. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of human ZNF653 (zinc finger protein 653).

WB:WBGene00019753	M03E7.1
Is enriched in body wall musculature; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00019754	M03E7.2
Is enriched in GABAergic neurons; PLM; and excretory cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019755	M03E7.3
Is affected by several genes including daf-2; eat-2; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Diazinon based on microarray and RNA-seq studies.

WB:WBGene00019756	M03E7.4
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in Donnai-Barrow syndrome and familial hypercholesterolemia.

WB:WBGene00019757	memb-2
Is predicted to have SNAP receptor activity and SNARE binding activity. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 6. Is an ortholog of human GOSR2 (golgi SNAP receptor complex member 2).

WB:WBGene00019758	M03F4.4
Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00019759	M03F4.6
Is enriched in AFD and PLM based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Neurotoxins; sesamin; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domains: EB module; EB domain; Cysteine-rich repeat; and Growth factor receptor cysteine-rich domain superfamily.

WB:WBGene00019760	calu-1
Exhibits calcium ion binding activity. Is involved in cuticle development. Localizes to endoplasmic reticulum. Is expressed in tail. Is an ortholog of human CALU (calumenin).

WB:WBGene00019761	M03F8.1
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twenty chemicals including aldicarb; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00019762	M03F8.3
Is enriched in PLM and germ line based on Chronogram and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HAT (Half-A-TPR) repeat; HAT (Half-A-TPR) repeat; and Tetratricopeptide-like helical domain superfamily. Is an ortholog of human CRNKL1 (crooked neck pre-mRNA splicing factor 1).

WB:WBGene00019763	galt-1
Exhibits beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity. Is involved in N-glycan processing and protein galactosylation. Is expressed in coelomocyte and intestine.

WB:WBGene00019764	M03F8.5
Is enriched in amphid sheath cell and germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; alg-1; and unc-70 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF229) and Protein of unknown function DUF229.

WB:WBGene00019765	M03F8.6
Is predicted to have extracellular ligand-gated ion channel activity.

WB:WBGene00019766	M4.1
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FHA domain; Forkhead-associated (FHA) domain; and SMAD/FHA domain superfamily. Is an ortholog of human SLMAP (sarcolemma associated protein).

WB:WBGene00019767	rpa-2
Exhibits enzyme binding activity. Is involved in positive regulation of helicase activity. Is expressed in pharyngeal neurons and seam cell. Is an ortholog of human RPA2 (replication protein A2).

WB:WBGene00019768	M04F3.2
Is enriched in FLP; OLL; PVD; germ line; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq studies.

WB:WBGene00019769	kin-35
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00019770	M04F3.4
Is predicted to have calcium ion binding activity. Is an ortholog of human PDCD6 (programmed cell death 6).

WB:WBGene00019771	M04F3.5
Is predicted to have actin binding activity. Is involved in cell projection assembly and membrane organization. Localizes to filopodium and intrinsic component of the cytoplasmic side of the plasma membrane. Is an ortholog of human MTSS1 (MTSS I-BAR domain containing 1) and MTSS2 (MTSS I-BAR domain containing 2).

WB:WBGene00019772	M04G7.1
Is expressed in pharyngeal gland cell. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00019773	M04G7.2
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00019774	M04G7.3
Is enriched in muscle cell and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019776	M6.4
Is enriched in AFD; ASER; BAG; dopaminergic neurons; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on microarray and RNA-seq studies.

WB:WBGene00019777	M57.1
Is enriched in AFD; AVA; hypodermis; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00019778	M57.2
Is predicted to contribute to Rab geranylgeranyltransferase activity. Is an ortholog of human RABGGTA (Rab geranylgeranyltransferase subunit alpha).

WB:WBGene00019779	endu-2
Is predicted to have endoribonuclease activity. Is involved in defense response to Gram-negative bacterium and innate immune response. Is expressed in amphid neurons; head muscle; and muscle cell. Is an ortholog of human ENDOU (endonuclease, poly(U) specific).

WB:WBGene00019780	M60.4
Is enriched in several structures, including body wall musculature; dopaminergic neurons; head mesodermal cell; intestine; and mechanosensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including aldicarb; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019781	M60.6
Is expressed in gonadal sheath cell; pharynx; tail neurons; and vulval muscle, type 1. Is predicted to encode a protein with the following domains: CD20-like family; CD20-like family; and Membrane-spanning 4-domains subfamily A.

WB:WBGene00019782	M60.7
Is enriched in several structures, including GABAergic neurons; amphid sheath cell; coelomocyte; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SOCS box; Ankyrin repeats (3 copies); Ankyrin repeat; SOCS box domain; Ankyrin repeat; Ankyrin repeat-containing domain; SOCS box-like domain superfamily; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human ASB14 (ankyrin repeat and SOCS box containing 14) and ASB15 (ankyrin repeat and SOCS box containing 15).

WB:WBGene00019783	M70.1
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00019784	M70.2
Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; cadmium; and Chlorpyrifos based on microarray studies.

WB:WBGene00019785	M70.3
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by twenty-five chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00019786	M70.4
Is enriched in DA neuron; germ line; interneuron; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interleukin-like EMT inducer; Nucleotide-diphospho-sugar transferases; FAM3 family; and ILEI/PANDER domain. Is an ortholog of human FAM3A (FAM3 metabolism regulating signaling molecule A) and FAM3C (FAM3 metabolism regulating signaling molecule C).

WB:WBGene00019787	M70.5
Is expressed in pharynx. Is predicted to encode a protein with the following domain: Six-bladed beta-propeller, TolB-like.

WB:WBGene00019788	M116.1
Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019789	M116.2
Is enriched in germline precursor cell and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019790	M116.3
No description available

WB:WBGene00019791	sdz-25
Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019792	M116.5
Is predicted to have actin binding activity and microtubule binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Carvajal syndrome; epidermolysis bullosa (multiple); and muscular dystrophy (multiple). Is an ortholog of human CLMN (calmin).

WB:WBGene00019793	M151.1
Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Alovudine; allantoin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019794	M151.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Zidovudine; glycine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019795	M151.3
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00019796	M151.4
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; alg-1; and sma-4 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019797	fbxb-31
Is enriched in germ line based on proteomic studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019798	fbxb-32
Is affected by several genes including daf-2; eat-2; and mex-3 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00019799	M151.7
Is enriched in NSM; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019800	mtss-1
Is predicted to have single-stranded DNA binding activity. Is expressed in head; intestine; and tail. Is an ortholog of human SSBP1 (single stranded DNA binding protein 1).

WB:WBGene00019801	aak-1
Is predicted to have protein serine/threonine kinase activity. Is involved in negative regulation of cell population proliferation. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 30. Is an ortholog of human PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) and PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2).

WB:WBGene00019803	PDB1.1
Is predicted to have cadmium ion transmembrane transporter activity; ferrous iron transmembrane transporter activity; and zinc efflux active transmembrane transporter activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in hypermanganesemia with dystonia 1 and type 2 diabetes mellitus.

WB:WBGene00019804	R01B10.2
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019805	R01B10.3
Is enriched in ASER; PLM; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and age-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Mianserin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Solute carrier family 3 member 2 N-terminus and Solute carrier family 3 member 2, N-terminal domain.

WB:WBGene00019806	pgap-3
Is predicted to have hydrolase activity, acting on ester bonds. Is an ortholog of human PGAP3 (post-GPI attachment to proteins phospholipase 3).

WB:WBGene00019807	jamp-1
Is expressed in amphid neurons; intestine; pharyngeal neurons; and sensory neurons. Is predicted to encode a protein with the following domains: JNK1/MAPK8-associated membrane protein and JNK1/MAPK8-associated membrane protein. Is an ortholog of human JKAMP (JNK1/MAPK8 associated membrane protein).

WB:WBGene00019808	seip-1
Is enriched in AFD; AVK; and germ line based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Human ortholog(s) of this gene are implicated in congenital generalized lipodystrophy type 2; distal hereditary motor neuronopathy type 5A; and hereditary spastic paraplegia 17. Is predicted to encode a protein with the following domains: Putative adipose-regulatory protein (Seipin) and Seipin family. Is an ortholog of human BSCL2 (BSCL2 lipid droplet biogenesis associated, seipin).

WB:WBGene00019809	R01H2.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and dpy-21 based on RNA-seq and microarray studies. Is affected by fluoranthene; Chlorpyrifos; and tetrabromobisphenol A based on microarray studies.

WB:WBGene00019810	R01H2.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; and Peptidase S1, PA clan.

WB:WBGene00019811	egg-2
Is predicted to have signaling receptor activity. Is involved in eggshell formation; positive regulation of protein localization to cell periphery; and single fertilization. Localizes to plasma membrane. Is expressed in germ line.

WB:WBGene00019812	R01H2.4
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including aldicarb; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00019813	ger-1
Exhibits GDP-L-fucose synthase activity. Is involved in GDP-L-fucose biosynthetic process. Is expressed in pharynx; seam cell; and spermatheca. Is an ortholog of human GFUS (GDP-L-fucose synthase).

WB:WBGene00019814	R02C2.1
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 54; glycogen storage disease IXc; and hypertrophic cardiomyopathy 1.

WB:WBGene00019815	kin-34
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 54; glycogen storage disease IXc; and hypertrophic cardiomyopathy 1. Is an ortholog of human CHEK1 (checkpoint kinase 1).

WB:WBGene00019816	nhr-204
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00019817	txt-2
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 54; glycogen storage disease IXc; and hypertrophic cardiomyopathy 1. Is an ortholog of human CHEK1 (checkpoint kinase 1).

WB:WBGene00019818	R02C2.7
Is enriched in pharyngeal muscle cell based on tiling array and proteomic studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including tryptophan; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00019819	aass-1
Is predicted to have oxidoreductase activity. Is expressed in gonadal sheath cell and hypodermal cell. Human ortholog(s) of this gene are implicated in hyperlysinemia. Is an ortholog of human AASS (aminoadipate-semialdehyde synthase).

WB:WBGene00019820	cogc-8
Is involved in gonad morphogenesis and regulation of cell migration. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIh. Is an ortholog of human COG8 (component of oligomeric golgi complex 8).

WB:WBGene00019821	gtf-2H1
Is predicted to contribute to DNA-dependent ATPase activity and RNA polymerase II CTD heptapeptide repeat kinase activity. Is an ortholog of human GTF2H1 (general transcription factor IIH subunit 1).

WB:WBGene00019822	ints-13
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cell cycle and development regulator and Cell cycle regulator Mat89Bb. Is an ortholog of human INTS13 (integrator complex subunit 13).

WB:WBGene00019823	fnta-1
Is predicted to contribute to CAAX-protein geranylgeranyltransferase activity and protein farnesyltransferase activity. Is an ortholog of human FNTA (farnesyltransferase, CAAX box, alpha).

WB:WBGene00019824	R02D3.7
Is expressed in body wall musculature; excretory cell; head muscle; seam cell; and ventral nerve cord. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00019825	R02D3.8
Is predicted to have 3'-5'-exoribonuclease activity. Is involved in PERK-mediated unfolded protein response and innate immune response. Is an ortholog of human ERI3 (ERI1 exoribonuclease family member 3).

WB:WBGene00019826	R02E4.1
Is expressed in head mesodermal cell; hermaphrodite distal tip cell; non-striated muscle; and rectal epithelium.

WB:WBGene00019827	mop-25.1
Is predicted to contribute to protein serine/threonine kinase activity. Is an ortholog of human CAB39 (calcium binding protein 39) and CAB39L (calcium binding protein 39 like).

WB:WBGene00019828	R02E12.4
Is enriched in BAG; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sek-1; alg-1; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; metformin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tektin family and Tektin. Is an ortholog of human TEKT4 (tektin 4).

WB:WBGene00019829	R02E12.5
Is enriched in intestine and neurons based on RNA-seq studies. Is affected by several genes including eat-2; fog-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Domain of unknown function (DUF4612); and Protein of unknown function DUF4612. Is an ortholog of human C1orf21 (chromosome 1 open reading frame 21).

WB:WBGene00019830	hrg-1
Exhibits heme binding activity and heme transporter activity. Is involved in heme transport. Localizes to endosome membrane and lysosomal membrane. Is an ortholog of human SLC48A1 (solute carrier family 48 member 1).

WB:WBGene00019831	R02F2.1
Is predicted to contribute to protein kinase activity. Human ortholog(s) of this gene are implicated in multiple myeloma; primary ciliary dyskinesia 29; and von Hippel-Lindau disease. Is an ortholog of human CCNI (cyclin I).

WB:WBGene00019832	osg-1
Is predicted to have Rho guanyl-nucleotide exchange factor activity. Is involved in response to oxidative stress. Is expressed in body wall musculature and head neurons. Is an ortholog of human ARHGEF17 (Rho guanine nucleotide exchange factor 17).

WB:WBGene00019833	R02F2.4
Is predicted to have chitin binding activity.

WB:WBGene00019834	R02F2.5
Is enriched in amphid sheath cell; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00019835	R02F2.6
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019836	R02F2.7
Is enriched in NSM; body wall muscle cell; and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Mianserin; Cry5B; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00019837	R02F2.8
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC38A11 (solute carrier family 38 member 11); SLC38A7 (solute carrier family 38 member 7); and SLC38A8 (solute carrier family 38 member 8).

WB:WBGene00019838	R02F2.9
Is predicted to have translation release factor activity. Is an ortholog of human MRPL58 (mitochondrial ribosomal protein L58).

WB:WBGene00019839	R02F11.1
Is enriched in mechanosensory neurons; pharynx; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019840	R02F11.2
Is enriched in OLL; PVD; body wall musculature; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including skn-1; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00019841	R02F11.3
Is predicted to have cadmium ion transmembrane transporter activity; ferrous iron transmembrane transporter activity; and zinc efflux active transmembrane transporter activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus.

WB:WBGene00019842	R02F11.4
Is predicted to have alpha-tubulin binding activity; dynein heavy chain binding activity; and motor activity. Human ortholog(s) of this gene are implicated in primary ciliary dyskinesia 13 and primary ciliary dyskinesia 19. Is an ortholog of human CEP97 (centrosomal protein 97).

WB:WBGene00019843	R03E9.2
Is predicted to have mannosyl-oligosaccharide glucosidase activity.

WB:WBGene00019844	abts-4
Is predicted to have inorganic anion exchanger activity. Localizes to basolateral plasma membrane. Human ortholog(s) of this gene are implicated in hereditary spherocytosis type 4. Is an ortholog of human SLC4A2 (solute carrier family 4 member 2).

WB:WBGene00019845	irld-13
Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019846	gpx-7
Is predicted to have peroxidase activity. Is an ortholog of human GPX4 (glutathione peroxidase 4).

WB:WBGene00019847	R03G5.6
Is enriched in DA neuron; RIS; and dopaminergic neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including stavudine; Diazinon; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00019849	oac-40
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00019850	srt-18
Is affected by several genes including lin-4; lin-14; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Tunicamycin and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00019851	oac-41
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00019853	srsx-20
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; sek-1; and alg-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00019854	R03H10.1
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00019855	R03H10.2
Is enriched in OLL; PVD; and hypodermis based on microarray; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00019856	R03H10.4
Is expressed in seminal vesicle. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00019857	R03H10.5
Is enriched in coelomocyte and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by resveratrol; cadmium; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00019858	R03H10.6
Exhibits double-stranded DNA binding activity. Is an ortholog of human RPA1 (replication protein A1).

WB:WBGene00019859	R03H10.7
Is predicted to have damaged DNA binding activity and single-stranded telomeric DNA binding activity. Is an ortholog of human RPA1 (replication protein A1).

WB:WBGene00019860	R03H10.9
No description available

WB:WBGene00019861	R04A9.1
Is enriched in neurons and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by cadmium and Sirolimus based on microarray studies.

WB:WBGene00019862	nrde-3
Exhibits siRNA binding activity. Is involved in RNA import into nucleus; olfactory learning; and regulation of gene expression. Localizes to RNAi effector complex and nucleus. Is expressed in AWCL and AWCR.

WB:WBGene00019863	R04A9.3
Is enriched in AVA; OLL; PVD; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00019864	ceh-93
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in seam cell.

WB:WBGene00019865	R04A9.6
Is enriched in AVE and hypodermis based on tiling array studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; multi-walled carbon nanotube; and bisphenol S based on RNA-seq studies.

WB:WBGene00019866	R04B3.1
Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Ethanol; methylmercury hydroxide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00019867	R04B3.2
Is predicted to have N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity. Human ortholog(s) of this gene are implicated in aspartylglucosaminuria. Is an ortholog of human AGA (aspartylglucosaminidase).

WB:WBGene00019868	R04B3.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Ethanol; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019869	cnnm-2
Is predicted to have transmembrane transporter activity. Is involved in determination of adult lifespan and positive regulation of gonad development. Human ortholog(s) of this gene are implicated in Jalili syndrome and renal hypomagnesemia 6. Is an ortholog of human CNNM3 (cyclin and CBS domain divalent metal cation transport mediator 3).

WB:WBGene00019870	R04E5.7
Is enriched in neurons and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019871	R04E5.8
Is enriched in germ line and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq; tiling array; and microarray studies. Is affected by nine chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019872	R04E5.9
Is enriched in neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019873	arrd-26
Is enriched in cephalic sheath cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sek-1; pgl-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set.

WB:WBGene00019874	R05C11.2
Is enriched in AVA; AVK; and GABAergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on tiling array and RNA-seq studies. Is affected by seven chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00019875	mca-2
Is predicted to have calcium transmembrane transporter activity, phosphorylative mechanism. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in Kufor-Rakeb syndrome and autosomal recessive nonsyndromic deafness 12. Is an ortholog of several human genes including ATP2B2 (ATPase plasma membrane Ca2+ transporting 2); ATP2B3 (ATPase plasma membrane Ca2+ transporting 3); and ATP2B4 (ATPase plasma membrane Ca2+ transporting 4).

WB:WBGene00019877	R05D3.2
Is predicted to have transmembrane signaling receptor activity. Human ortholog(s) of this gene are implicated in bone development disease (multiple); hypoplastic or aplastic tibia with polydactyly; and polydactyly. Is an ortholog of human LMBR1 (limb development membrane protein 1) and LMBR1L (limb development membrane protein 1 like).

WB:WBGene00019878	R05D3.3
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00019879	R05D3.5
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Cry5B; and paraquat based on microarray studies.

WB:WBGene00019880	R05D3.6
Is predicted to have proton-transporting ATP synthase activity, rotational mechanism. Is an ortholog of human ATP5F1E (ATP synthase F1 subunit epsilon).

WB:WBGene00019881	R05D3.8
Is predicted to have mRNA binding activity.

WB:WBGene00019882	R05D3.9
Is enriched in germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like superfamily and Thioredoxin domain-containing protein 16.

WB:WBGene00019883	met-2
Is predicted to have histone methyltransferase activity (H3-K9 specific). Is involved in several processes, including histone lysine methylation; negative regulation of vulval development; and regulation of gene expression. Localizes to cytoplasm. Is expressed in hypodermis; intestine; muscle cell; neurons; and in male. Human ortholog(s) of this gene are implicated in Sotos syndrome; acute myeloid leukemia; and autosomal dominant non-syndromic intellectual disability 29. Is an ortholog of human SETDB1 (SET domain bifurcated histone lysine methyltransferase 1) and SETDB2 (SET domain bifurcated histone lysine methyltransferase 2).

WB:WBGene00019884	R05D3.12
Is predicted to have several functions, including ATP binding activity; DNA binding activity; and DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity. Is an ortholog of human TOP2A (DNA topoisomerase II alpha) and TOP2B (DNA topoisomerase II beta).

WB:WBGene00019885	R05D8.7
Is predicted to have nucleotide binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00019886	R05D8.9
Is enriched in GABAergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twenty-four chemicals including tryptophan; Tunicamycin; and Mianserin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00019887	R05D8.11
Is enriched in germline precursor cell; hypodermis; intestine; and ventral nerve cord based on tiling array studies. Is affected by several genes including clk-1; dpy-7; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00019888	btbd-10
Is expressed in hypodermal cell; intestine; pharyngeal neurons; and pharyngeal-intestinal valve. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; SKP1/BTB/POZ domain superfamily; BTBD10/KCTD20, BTB/POZ domain; and BTBD10/KCTD20. Is an ortholog of human BTBD10 (BTB domain containing 10) and KCTD20 (potassium channel tetramerization domain containing 20).

WB:WBGene00019889	R05F9.4
No description available

WB:WBGene00019890	R05F9.6
Is predicted to have phosphoglucomutase activity. Is expressed in head. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation It. Is an ortholog of human PGM1 (phosphoglucomutase 1).

WB:WBGene00019891	R05F9.7
Is affected by csr-1; clk-1; and alg-1 based on RNA-seq and microarray studies. Is affected by Atrazine and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00019892	R05F9.9
Is enriched in several structures, including body wall muscle cell; germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019893	sgt-1
Is predicted to have molecular adaptor activity. Human ortholog(s) of this gene are implicated in cataract 43; primary ciliary dyskinesia 28; and spermatogenic failure 6. Is an ortholog of human SGTB (small glutamine rich tetratricopeptide repeat containing beta).

WB:WBGene00019894	R05F9.11
Is predicted to have sequence-specific DNA binding activity. Is an ortholog of human SNAPC1 (small nuclear RNA activating complex polypeptide 1).

WB:WBGene00019895	aagr-2
Exhibits alpha-1,4-glucosidase activity. Is involved in glycogen catabolic process. Human ortholog(s) of this gene are implicated in congenital sucrase-isomaltase deficiency; glycogen storage disease II; and polycystic kidney disease 3. Is an ortholog of human MGAM (maltase-glucoamylase).

WB:WBGene00019896	R05G6.1
Is enriched in male-specific anatomical entity; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00019897	R05G6.2
No description available

WB:WBGene00019898	R05G6.4
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human NOSIP (nitric oxide synthase interacting protein).

WB:WBGene00019899	R05G6.5
Is enriched in BAG; germ line; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; lin-35; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Dpy-30 motif; Dpy-30 motif; Nucleoside diphosphate kinase-like domain superfamily; and Sdc1/DPY30. Is an ortholog of human NME5 (NME/NM23 family member 5).

WB:WBGene00019900	vdac-1
Is predicted to have voltage-gated anion channel activity. Is involved in mitochondrion organization. Is expressed in AWCL and AWCR. Is an ortholog of human VDAC1 (voltage dependent anion channel 1); VDAC2 (voltage dependent anion channel 2); and VDAC3 (voltage dependent anion channel 3).

WB:WBGene00019901	R05G6.9
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is an ortholog of human DLK2 (delta like non-canonical Notch ligand 2) and WIF1 (WNT inhibitory factor 1).

WB:WBGene00019902	R05G6.10
Is predicted to have guanyl-nucleotide exchange factor activity. Is expressed in neurons; pharynx; and rectal gland cell. Is an ortholog of human RASGEF1B (RasGEF domain family member 1B).

WB:WBGene00019903	R05G9.1
Is enriched in AVK and NSM based on tiling array and RNA-seq studies. Is affected by rsr-2; uaf-1; and daf-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and dafa#1 based on microarray studies.

WB:WBGene00019904	twk-49
Is predicted to have potassium ion leak channel activity.

WB:WBGene00019905	R05G9.3
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including bisphenol A; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00019906	R05G9R.1
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019907	R05H11.1
Is enriched in coelomocyte; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including D-glucose; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019908	R05H11.2
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including manganese chloride; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019909	R06A10.1
Is enriched in amphid sheath cell and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: MFS transporter superfamily.

WB:WBGene00019911	R06A10.4
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Is an ortholog of human PSKH2 (protein serine kinase H2).

WB:WBGene00019912	R06B10.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies.

WB:WBGene00019913	R06B10.2
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00019914	clec-150
Is predicted to have carbohydrate binding activity.

WB:WBGene00019915	tbc-10
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBC1D10A (TBC1 domain family member 10A).

WB:WBGene00019916	R06B10.7
Is affected by several genes including mex-1; ifg-1; and rsr-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00019917	clec-43
Is predicted to have carbohydrate binding activity.

WB:WBGene00019918	fbxc-36
Is enriched in several structures, including amphid sheath cell; excretory cell; germ line; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Cry5B; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019919	R07C3.3
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-12; mut-2; and sin-3 based on microarray; tiling array; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00019920	acs-15
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ACSL1 (acyl-CoA synthetase long chain family member 1).

WB:WBGene00019921	fbxc-34
Is enriched in head mesodermal cell; hypodermis; intestine; pharyngeal muscle cell; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019922	fbxc-28
Is enriched in BAG; germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019923	fbxc-29
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Mianserin; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019924	fbxc-33
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019925	fbxc-31
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Alovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019926	fbxc-27
Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019927	fbxc-24
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and dpy-7 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00019928	clec-44
Is affected by several genes including clk-1; elt-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00019929	R07C3.13
Is enriched in germ line; head mesodermal cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00019930	fbxc-35
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019931	R07C12.1
Is enriched in DA neuron and dopaminergic neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Tunicamycin; levamisole; and procyanidin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019932	R07C12.2
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00019933	R07C12.3
Is affected by several genes including daf-16; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Alovudine; Testosterone; and dafa#1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019934	R07C12.4
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Cadmium Chloride and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00019935	R07E4.1
Is enriched in DD neuron; PLM; RIS; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold; Fibronectin type III superfamily; and Ankyrin repeat and fibronectin type-III domain-containing protein 1. Is an ortholog of human ANKFN1 (ankyrin repeat and fibronectin type III domain containing 1).

WB:WBGene00019937	R07E4.3
Is predicted to contribute to ubiquinol-cytochrome-c reductase activity. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 4. Is an ortholog of human UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII).

WB:WBGene00019938	R07E4.5
Is enriched in germ line; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019939	lips-17
Is predicted to have lipase activity.

WB:WBGene00019940	npp-21
Is predicted to be a structural constituent of nuclear pore. Is an ortholog of human TPR (translocated promoter region, nuclear basket protein).

WB:WBGene00019941	pgam-5
Is predicted to have phosphoprotein phosphatase activity. Is expressed in neurons and pharynx. Is an ortholog of human PGAM5 (PGAM family member 5, mitochondrial serine/threonine protein phosphatase).

WB:WBGene00019943	R07G3.7
Is enriched in OLL; PLM; PVD; dopaminergic neurons; and germ line based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00019944	R07G3.8
Is predicted to have Rac GTPase binding activity. Is expressed in dorsal nerve cord; ventral nerve cord; and vulva. Is an ortholog of human CYRIA (CYFIP related Rac1 interactor A) and CYRIB (CYFIP related Rac1 interactor B).

WB:WBGene00019945	R08C7.1
Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00019946	chat-1
Is expressed in several structures, including intestine. Is predicted to encode a protein with the following domains: LEM3 (ligand-effect modulator 3) family / CDC50 family; CDC50/LEM3 family; and Cell cycle control protein 50B. Is an ortholog of human TMEM30A (transmembrane protein 30A) and TMEM30B (transmembrane protein 30B).

WB:WBGene00019947	htz-1
Is predicted to have DNA binding activity. Is involved in negative regulation of cell fate specification and negative regulation of transcription, DNA-templated. Localizes to chromatin; condensed chromosome; and nucleus. Is expressed in several structures, including distal tip cell and somatic gonad. Is an ortholog of human H2AZ1 (H2A.Z variant histone 1) and H2AZ2 (H2A.Z variant histone 2).

WB:WBGene00019948	R08C7.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00019949	R08C7.5
Is enriched in germ line; seam cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00019950	clec-175
Is predicted to have carbohydrate binding activity.

WB:WBGene00019951	R08C7.8
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00019952	fbxb-74
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00019953	wapl-1
Is involved in negative regulation of cohesin loading and positive regulation of double-strand break repair via homologous recombination. Localizes to germ cell nucleus. Is an ortholog of human WAPL (WAPL cohesin release factor).

WB:WBGene00019954	R08C7.11
Is enriched in germ line based on RNA-seq studies. Is affected by drh-3 and daf-2 based on RNA-seq and microarray studies. Is affected by cadmium and Sirolimus based on microarray studies.

WB:WBGene00019955	R08C7.12
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and pmk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: TDU repeat.

WB:WBGene00019956	fbxb-75
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00019957	R08E3.1
Is predicted to have Notch binding activity.

WB:WBGene00019959	R08E3.3
Is predicted to have cullin family protein binding activity. Is expressed in anterior gonad arm. Human ortholog(s) of this gene are implicated in Ritscher-Schinzel syndrome 2. Is an ortholog of human CCDC22 (coiled-coil domain containing 22).

WB:WBGene00019960	ztf-16
Is predicted to have metal ion binding activity. Is involved in gonad development and positive regulation of gene expression. Localizes to nucleus. Is expressed in accessory cell; gonad; hypodermis; and tail. Human ortholog(s) of this gene are implicated in nephronophthisis 14.

WB:WBGene00019961	R08E5.1
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including aldicarb; hydrogen sulfide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase domain; Methyltransferase domain; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00019962	cysl-3
Exhibits cysteine synthase activity. Is involved in cysteine biosynthetic process from serine. Is an ortholog of human CBSL (cystathionine beta-synthase like).

WB:WBGene00019963	R08E5.3
Is expressed in intestine. Is predicted to encode a protein with the following domains: Methyltransferase domain; Methyltransferase domain; S-adenosyl-L-methionine-dependent methyltransferase; and Winged helix-like DNA-binding domain superfamily.

WB:WBGene00019964	R08E5.4
Is enriched in amphid sheath cell; body wall muscle cell; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00019965	R08F11.1
Is predicted to have beta-glucosidase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 46. Is an ortholog of human GBA2 (glucosylceramidase beta 2).

WB:WBGene00019966	srt-30
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00019967	cyp-33C8
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00019968	R08F11.4
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase domain; Methyltransferase domain; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00019969	fpn-1.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; hpl-2; and ash-2 based on microarray and RNA-seq studies. Is affected by Colistin and dafa#1 based on microarray studies.

WB:WBGene00019970	R08F11.7
Is predicted to have peroxidase activity. Is involved in defense response to Gram-positive bacterium. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7.

WB:WBGene00019971	ergo-1
Exhibits DEAD/H-box RNA helicase binding activity and siRNA binding activity. Is involved in production of siRNA involved in RNA interference and regulation of production of siRNA involved in RNA interference. Localizes to cytoplasm.

WB:WBGene00019972	R09A1.2
Is enriched in head mesodermal cell; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019973	R09A1.3
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00019974	R09A1.4
No description available

WB:WBGene00019975	flp-34
Is enriched in head mesodermal cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00019976	fbxa-195
Is affected by several genes including pgl-1; glh-1; and smg-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Colistin; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00019977	fpn-1.2
Is predicted to have iron ion transmembrane transporter activity. Human ortholog(s) of this gene are implicated in hemochromatosis type 4. Is an ortholog of human SLC40A1 (solute carrier family 40 member 1).

WB:WBGene00019978	hacd-1
Is predicted to have 3-hydroxyacyl-CoA dehydrogenase activity and NAD+ binding activity.

WB:WBGene00019979	R09B5.11
Is predicted to have transmembrane transporter activity. Is expressed in seam cell. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12. Is an ortholog of human SLC2A1 (solute carrier family 2 member 1); SLC2A3 (solute carrier family 2 member 3); and SLC2A4 (solute carrier family 2 member 4).

WB:WBGene00019980	chil-14
Is predicted to have oligosaccharide binding activity. Is an ortholog of human CHID1 (chitinase domain containing 1).

WB:WBGene00019981	srbc-59
Is affected by rsr-2; unc-75; and drh-3 based on tiling array and RNA-seq studies. Is affected by resveratrol and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00019982	srbc-58
Is expressed in neurons. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00019983	sti-1
Exhibits ATPase inhibitor activity; Hsp70 protein binding activity; and Hsp90 protein binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of ATPase activity; and response to heat. Localizes to cytoplasm. Is expressed in gonad; male-specific anatomical entity; pharyngeal muscle cell; tail; and vulva. Human ortholog(s) of this gene are implicated in cataract 43 and spermatogenic failure 6. Is an ortholog of human STIP1 (stress induced phosphoprotein 1).

WB:WBGene00019984	R09E12.5
No description available

WB:WBGene00019985	R09E12.6
No description available

WB:WBGene00019986	R09F10.1
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis. Is an ortholog of human CTSF (cathepsin F).

WB:WBGene00019987	R09F10.3
Is enriched in germ line; head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including Alovudine; Zidovudine; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mediator complex subunit 27 and Mediator complex, subunit Med27.

WB:WBGene00019988	R09F10.5
Is expressed in gonadal sheath cell; head muscle; intestine; and neurons.

WB:WBGene00019989	R09F10.8
Is enriched in germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; nanoparticle; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00019990	R09H3.1
No description available

WB:WBGene00019991	R09H3.3
Is enriched in coelomocyte; germline precursor cell; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including rrf-3; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00019992	R10A10.1
Is affected by prg-1 based on tiling array studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00019993	rbx-2
Is predicted to have NEDD8 transferase activity; cullin family protein binding activity; and ubiquitin protein ligase activity. Is an ortholog of human RNF7 (ring finger protein 7).

WB:WBGene00019994	cdh-1
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Elsahy-Waters syndrome; Usher syndrome type 1D; and reproductive organ cancer (multiple). Is an ortholog of human DCHS1 (dachsous cadherin-related 1).

WB:WBGene00019995	R10F2.4
Is enriched in ASER and neurons based on RNA-seq studies. Is affected by several genes including sek-1; pgl-1; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; cadmium; and dafa#1 based on RNA-seq and microarray studies.

WB:WBGene00019996	R10F2.5
Is affected by several genes including pgl-1; alg-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; Sirolimus; and Cry5B based on RNA-seq and microarray studies. Human OSCP1 exhibits transmembrane transporter activity. Is predicted to encode a protein with the following domains: Organic solute transport protein 1 and Organic solute carrier protein 1. Is an ortholog of human OSCP1 (organic solute carrier partner 1).

WB:WBGene00019997	R10F2.6
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00019998	R10H1.1
Is enriched in body wall muscle cell; body wall musculature; intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 44. Is predicted to encode a protein with the following domains: Coiled-coil domain-containing protein 50  N-terminus; Coiled-coil domain-containing protein 50,  N-terminal; and Coiled-coil domain-containing protein 50. Is an ortholog of human CCDC50 (coiled-coil domain containing 50).

WB:WBGene00019999	srab-14
Is expressed in ASEL and ASER. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00020000	R10H1.3
No description available

WB:WBGene00020003	R11E3.1
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00020004	R11E3.2
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC23A1 (solute carrier family 23 member 1) and SLC23A2 (solute carrier family 23 member 2).

WB:WBGene00020005	R11E3.3
No description available

WB:WBGene00020006	set-15
Is involved in determination of adult lifespan. Is expressed in intestine and neurons. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 1; and autosomal dominant non-syndromic intellectual disability (multiple).

WB:WBGene00020007	R11F4.1
Is predicted to have glycerol kinase activity. Human ortholog(s) of this gene are implicated in glycerol kinase deficiency. Is an ortholog of human GK (glycerol kinase) and GK2 (glycerol kinase 2).

WB:WBGene00020008	R11F4.2
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00020010	R11G1.1
Is enriched in AVA; BAG; dopaminergic neurons; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; metformin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Low-density lipoprotein (LDL) receptor class A repeat and LDL receptor-like superfamily.

WB:WBGene00020011	R11G1.2
Is enriched in Z1; Z4; germ line; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00020012	R11G1.6
Is predicted to have metal ion binding activity. Localizes to plasma membrane. Is an ortholog of human C2CD2 (C2 calcium dependent domain containing 2) and C2CD2L (C2CD2 like).

WB:WBGene00020013	R11G11.3
Is affected by daf-12 and rsr-2 based on tiling array studies. Is affected by fluoranthene and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00020014	R11G11.6
Is enriched in OLL; PVD; and pharyngeal muscle cell based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00020015	nhr-210
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020016	lipl-3
Is predicted to have hydrolase activity, acting on ester bonds. Is involved in lipid catabolic process. Localizes to lysosome. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of human LIPN (lipase family member N).

WB:WBGene00020017	R12A1.3
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human WFDC8 (WAP four-disulfide core domain 8).

WB:WBGene00020018	R12B2.2
Is enriched in several structures, including GABAergic neurons; command interneuron; germ line; intestine; and mechanosensory neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by single-walled carbon nanotube; paraquat; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Golgin-45. Is an ortholog of human BLZF1 (basic leucine zipper nuclear factor 1).

WB:WBGene00020019	R12B2.3
Is enriched in RIM; germ line; interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and metformin based on microarray and RNA-seq studies.

WB:WBGene00020020	R12B2.6
Is enriched in coelomocyte; neurons; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and mex-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00020021	R12B2.7
Is enriched in DA neuron; VA neuron; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and mab-5 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00020022	gldc-1
Is predicted to have glycine binding activity; glycine dehydrogenase (decarboxylating) activity; and pyridoxal phosphate binding activity. Is expressed in head. Human ortholog(s) of this gene are implicated in glycine encephalopathy. Is an ortholog of human GLDC (glycine decarboxylase).

WB:WBGene00020023	frpr-16
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00020025	R12C12.5
Is expressed in germ line. Human CHMP4A exhibits ATPase binding activity and protein homodimerization activity. Is predicted to encode a protein with the following domains: Snf7 and Snf7 family. Is an ortholog of human CHMP4A (charged multivesicular body protein 4A) and CHMP4C (charged multivesicular body protein 4C).

WB:WBGene00020026	R12C12.6
Is expressed in excretory cell; hermaphrodite gonad; and rectal valve cell. Is predicted to encode a protein with the following domains: TMEM9 and TMEM9. Is an ortholog of human TMEM9 (transmembrane protein 9) and TMEM9B (TMEM9 domain family member B).

WB:WBGene00020027	R12C12.7
Is enriched in germ line; intestine; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including D-glucose; stavudine; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00020028	R12C12.8
Is enriched in AVA; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Alovudine; stavudine; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00020029	R12C12.9
Is enriched in excretory cell; intestine; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00020030	kel-20
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Cry5B; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB And C-terminal Kelch; Kelch motif; BTB/POZ domain; BTB/POZ domain; Kelch repeat type 1; SKP1/BTB/POZ domain superfamily; BTB/Kelch-associated; Kelch-type beta propeller; and BTB-kelch protein. Is an ortholog of human KLHL20 (kelch like family member 20).

WB:WBGene00020031	suco-1
Is expressed widely. Is predicted to encode a protein with the following domains: Sad1 / UNC-like C-terminal and SUN domain. Is an ortholog of human SUCO (SUN domain containing ossification factor).

WB:WBGene00020032	R12E2.6
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including aldicarb; sodium arsenite; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00020033	R12E2.7
Is expressed in several structures, including enteric muscle; vulC; vulval cell; vulval cell; and vulval cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00020034	R12E2.8
Is enriched in intestine based on tiling array studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020035	egg-5
Exhibits protein kinase binding activity. Is involved in several processes, including female gamete generation; negative regulation of protein kinase activity; and positive regulation of protein localization to cell cortex. Localizes to cell cortex and nucleus. Is expressed in oocyte. Is an ortholog of human PTPRJ (protein tyrosine phosphatase receptor type J).

WB:WBGene00020036	R12E2.11
Exhibits orotate phosphoribosyltransferase activity. Is involved in UMP biosynthetic process. Is expressed in body wall musculature; spermatheca; and vulval muscle. Human ortholog(s) of this gene are implicated in orotic aciduria. Is an ortholog of human UMPS (uridine monophosphate synthetase).

WB:WBGene00020037	mrps-6
Is predicted to have small ribosomal subunit rRNA binding activity. Is an ortholog of human MRPS6 (mitochondrial ribosomal protein S6).

WB:WBGene00020038	R12E2.13
Is involved in IRE1-mediated unfolded protein response and innate immune response. Is an ortholog of human SDF2 (stromal cell derived factor 2).

WB:WBGene00020039	R12E2.14
Is enriched in AFD; ASER; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020040	R12E2.15
Is enriched in DA neuron; carbon dioxide sensory neurons; germline precursor cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-seven chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020041	R13A1.1
Is enriched in AVE and in male based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00020042	R13A1.3
Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00020043	R13A1.5
Is enriched in AVE; NSM; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00020045	glb-23
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; ventral cord neurons; and ventral nerve cord.

WB:WBGene00020046	best-16
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00020047	ttr-32
Is enriched in dopaminergic neurons; germline precursor cell; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including levamisole; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00020048	lgc-12
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is expressed in mechanosensory neurons. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00020049	ttr-8
Is enriched in body wall musculature; dopaminergic neurons; intestine; mechanosensory neurons; and pharynx based on Chronogram and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Rotenone; D-glucose; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00020050	R13A5.7
Is enriched in head mesodermal cell; intestine; and male-specific anatomical entity based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020051	mfsd-6
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MFS_1 like family; Major facilitator superfamily associated domain; and MFS transporter superfamily. Is an ortholog of human MFSD6 (major facilitator superfamily domain containing 6).

WB:WBGene00020052	R13A5.10
Is predicted to have catalytic activity.

WB:WBGene00020053	R13A5.11
Is predicted to have phosphoprotein phosphatase activity.

WB:WBGene00020054	R13D7.2
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; bisphenol A; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00020055	srt-6
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including lin-4; lin-14; and let-418 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00020056	R13D11.1
Is affected by mir-34; daf-2; and eat-2 based on microarray studies. Is affected by Atrazine and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00020057	R13D11.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00020058	R13D11.4
Is predicted to have N-acetyltransferase activity.

WB:WBGene00020059	srab-15
Is affected by let-418 and hpl-2 based on RNA-seq studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00020060	srab-16
Localizes to non-motile cilium. Is expressed in AWBL; AWBR; AWCL; and AWCR.

WB:WBGene00020061	R13D11.7
No description available

WB:WBGene00020062	nhr-270
Is predicted to have several functions, including DNA-binding transcription factor activity; steroid hormone receptor activity; and zinc ion binding activity.

WB:WBGene00020063	R13D11.10
Is enriched in dopaminergic neurons; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; nhr-25; and pry-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00020064	kbp-1
Is involved in kinetochore assembly. Localizes to condensed chromosome kinetochore.

WB:WBGene00020065	clec-159
Is expressed in head and tail.

WB:WBGene00020066	dhhc-5
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is expressed in excretory cell and intestine. Is an ortholog of human ZDHHC21 (zinc finger DHHC-type palmitoyltransferase 21).

WB:WBGene00020067	clec-158
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C-type lectin-like/link domain superfamily and C-type lectin fold.

WB:WBGene00020068	cra-1
Is predicted to contribute to peptide alpha-N-acetyltransferase activity. Is an ortholog of human NAA25 (N-alpha-acetyltransferase 25, NatB auxiliary subunit).

WB:WBGene00020069	R13H7.2
Is predicted to have G protein-coupled receptor activity. Is expressed in neurons.

WB:WBGene00020070	rmd-6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including D-glucose; nanoparticle; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily. Is an ortholog of human RMDN3 (regulator of microtubule dynamics 3).

WB:WBGene00020071	R13H9.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020072	R13H9.6
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020073	sdz-28
Is involved in gastrulation.

WB:WBGene00020074	R52.2
No description available

WB:WBGene00020075	math-35
Is expressed in intestine.

WB:WBGene00020076	R52.4
Is enriched in NSM based on tiling array studies. Is affected by rsr-2; eat-2; and sir-2.1 based on tiling array and microarray studies. Is affected by Microcystin-LR based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020077	R52.5
Is affected by several genes including clk-1; mex-3; and mex-1 based on tiling array; microarray; and RNA-seq studies. Is affected by cadmium; tetrabromobisphenol A; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00020078	R52.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including mex-3; csr-1; and spn-4 based on tiling array and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00020080	math-37
Is enriched in AFD and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00020081	sdz-29
Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020082	gcp-2.1
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in hemochromatosis type 3. Is an ortholog of human FOLH1 (folate hydrolase 1) and NAALAD2 (N-acetylated alpha-linked acidic dipeptidase 2).

WB:WBGene00020083	R57.2
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00020084	R105.1
Is enriched in NSM; germ line; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00020086	npr-24
Is predicted to have G protein-coupled receptor activity and peptide binding activity. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 8 with or without anosmia. Is an ortholog of human SSTR5 (somatostatin receptor 5).

WB:WBGene00020087	R119.1
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00020088	R119.2
Is predicted to have aminopeptidase activity and manganese ion binding activity. Human ortholog(s) of this gene are implicated in nephronophthisis-like nephropathy 1. Is an ortholog of human XPNPEP3 (X-prolyl aminopeptidase 3).

WB:WBGene00020089	R119.3
Localizes to mitochondrion. Human ortholog(s) of this gene are implicated in primary hypertrophic osteoarthropathy.

WB:WBGene00020090	R119.5
Is predicted to have protein-L-isoaspartate (D-aspartate) O-methyltransferase activity. Is an ortholog of human PCMTD1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1) and PCMTD2 (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2).

WB:WBGene00020091	rnp-8
Exhibits enzyme binding activity; poly(G) binding activity; and polynucleotide adenylyltransferase activator activity. Is involved in positive regulation of polynucleotide adenylyltransferase activity. Localizes to protein-containing complex. Is expressed in germ line and oocyte.

WB:WBGene00020092	pcf-11
Is predicted to have RNA polymerase II complex binding activity and mRNA binding activity. Is an ortholog of human PCF11 (PCF11 cleavage and polyadenylation factor subunit).

WB:WBGene00020093	R144.3
Is predicted to have ubiquinone binding activity.

WB:WBGene00020094	wip-1
Exhibits cytoskeletal regulatory protein binding activity. Is involved in embryonic body morphogenesis; regulation of cell migration; and regulation of protein stability. Is expressed in hypodermis. Is an ortholog of human WIPF1 (WAS/WASL interacting protein family member 1) and WIPF2 (WAS/WASL interacting protein family member 2).

WB:WBGene00020095	smcr-8
Is predicted to contribute to Rab guanyl-nucleotide exchange factor activity. Is an ortholog of human SMCR8 (SMCR8-C9orf72 complex subunit).

WB:WBGene00020096	R144.6
Is predicted to have carbohydrate transmembrane transporter activity. Is an ortholog of human TMEM144 (transmembrane protein 144).

WB:WBGene00020097	larp-1
Exhibits poly(G) binding activity and poly(U) RNA binding activity. Localizes to P-body. Is expressed in germ line; head; and tail. Is an ortholog of human LARP1 (La ribonucleoprotein 1, translational regulator).

WB:WBGene00020098	R144.10
Is expressed in head and tail.

WB:WBGene00020099	R144.11
Is expressed in head. Is predicted to encode a protein with the following domain: Transmembrane protein 177. Is an ortholog of human TMEM177 (transmembrane protein 177).

WB:WBGene00020100	mks-1
Is expressed in neurons. Is used to study Meckel syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 13; Joubert syndrome 28; and Meckel syndrome 1. Is predicted to encode a protein with the following domains: Ciliary basal body-associated, B9 protein and B9 domain. Is an ortholog of human MKS1 (MKS transition zone complex subunit 1).

WB:WBGene00020101	lmtr-5
Is predicted to contribute to guanyl-nucleotide exchange factor activity. Is an ortholog of human LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5).

WB:WBGene00020102	R148.3
Is expressed in body wall musculature; neurons; and pharynx. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020103	R148.4
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00020104	R148.5
Is enriched in AVG; RIM; command interneuron; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and PTB/PI domain.

WB:WBGene00020105	R148.7
Is enriched in amphid sheath cell; germ line; intestine; muscle cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including 1-methylnicotinamide; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00020106	R151.1
Is predicted to have protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including brain disease (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00020107	R151.2
Is predicted to have ATP binding activity and ribose phosphate diphosphokinase activity. Is expressed in head; somatic gonad precursor; somatic nervous system; and tail. Human ortholog(s) of this gene are implicated in Arts syndrome; X-linked deafness 1; and X-linked recessive disease (multiple). Is an ortholog of human PRPS1 (phosphoribosyl pyrophosphate synthetase 1) and PRPS2 (phosphoribosyl pyrophosphate synthetase 2).

WB:WBGene00020109	der-2
Is predicted to have misfolded protein binding activity and ubiquitin-specific protease binding activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human DERL2 (derlin 2) and DERL3 (derlin 3).

WB:WBGene00020110	hsp-75
Is predicted to have protein kinase binding activity and unfolded protein binding activity. Is an ortholog of human TRAP1 (TNF receptor associated protein 1).

WB:WBGene00020111	R151.8
Is predicted to have chromatin binding activity. Is an ortholog of human CRAMP1 (cramped chromatin regulator homolog 1).

WB:WBGene00020112	pfd-5
Is predicted to have unfolded protein binding activity. Is expressed in body wall musculature; head muscle; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human PFDN5 (prefoldin subunit 5).

WB:WBGene00020113	R151.10
Is predicted to have magnesium ion binding activity and phosphatase activity. Localizes to sarcoplasmic reticulum. Is an ortholog of human PUDP (pseudouridine 5'-phosphatase).

WB:WBGene00020114	pde-4
Is predicted to have 3',5'-cyclic-AMP phosphodiesterase activity. Is involved in several processes, including adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; negative regulation of cAMP-mediated signaling; and sleep. Localizes to synapse. Is expressed in DD neuron and VD neuron. Human ortholog(s) of this gene are implicated in acrodysostosis. Is an ortholog of human PDE4B (phosphodiesterase 4B).

WB:WBGene00020115	mboa-6
Is predicted to have O-acyltransferase activity. Is involved in several processes, including glycerophospholipid biosynthetic process; positive regulation of growth rate; and post-embryonic body morphogenesis. Is expressed in pharyngeal muscle cell and tail. Is an ortholog of human LPCAT3 (lysophosphatidylcholine acyltransferase 3).

WB:WBGene00020116	moa-1
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00020117	R155.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00020118	R155.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; antimycin; and glycine based on microarray and RNA-seq studies.

WB:WBGene00020119	R160.2
Is enriched in NSM and hypodermis based on tiling array studies. Is affected by rsr-2 based on tiling array studies.

WB:WBGene00020120	R160.3
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and lin-4 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including aldicarb; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00020121	R160.4
Is affected by several genes including daf-2; pgl-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020122	R160.5
Is affected by rsr-2; drh-3; and adr-1 based on tiling array and RNA-seq studies. Is affected by dafa#1 and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00020123	R160.6
Is enriched in NSM based on tiling array studies. Is affected by hpl-2 and rsr-2 based on tiling array studies.

WB:WBGene00020124	R173.2
No description available

WB:WBGene00020125	cest-19
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CES5A (carboxylesterase 5A).

WB:WBGene00020126	flp-26
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00020127	R193.1
Is affected by several genes including eat-2; hrde-1; and smn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00020128	R193.2
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty-six chemicals including Heme; aldicarb; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00020129	R193.3
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00020130	igcm-2
Is expressed in several structures, including PVT; gonad; head neurons; intestine; and pharynx. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 73 and autosomal recessive nonsyndromic deafness 84A. Is predicted to encode a protein with the following domains: Immunoglobulin domain; Fibronectin type III domain; Immunoglobulin domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Fibronectin type III; Immunoglobulin; Immunoglobulin-like fold; Fibronectin type III superfamily; and Immunoglobulin-like domain superfamily. Is an ortholog of human IGSF9 (immunoglobulin superfamily member 9).

WB:WBGene00020131	gcy-28
Exhibits guanylate cyclase activity. Is involved in several processes, including olfactory behavior; sensory perception of chemical stimulus; and sensory processing. Localizes to cell body and neuron projection. Is expressed in body wall musculature; gonad; hypodermis; intestine; and neurons. Human ortholog(s) of this gene are implicated in Miura type epiphyseal chondrodysplasia and acromesomelic dysplasia, Maroteaux type. Is an ortholog of human NPR1 (natriuretic peptide receptor 1).

WB:WBGene00020134	T01B6.1
Is enriched in GABAergic neurons; OLL; PVD; head mesodermal cell; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Adenomatous polyposis coli tumour suppressor protein and Suppressor APC domain-containing protein 1/2. Is an ortholog of human SAPCD2 (suppressor APC domain containing 2).

WB:WBGene00020135	aakg-4
Is predicted to have kinase activity. Is expressed in several structures, including accessory cell; dorsal nerve cord; neurons; non-striated muscle; and preanal ganglion.

WB:WBGene00020136	nlp-45
Is enriched in AFD; OLL; PVD; hypodermis; and neurons based on microarray and RNA-seq studies. Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including antimycin; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00020137	T01B10.5
Is enriched in male-specific anatomical entity and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00020138	T01B11.1
Is enriched in neurons and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including elt-2; unc-70; and ain-2 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020139	eppl-1
Is predicted to have lyase activity; pyridoxal phosphate binding activity; and transaminase activity. Is expressed in PQR; amphid neurons; and hypodermis. Is an ortholog of human ETNPPL (ethanolamine-phosphate phospho-lyase).

WB:WBGene00020140	ant-1.4
Is predicted to have ATP:ADP antiporter activity. Localizes to mitochondrion. Is expressed in amphid sensillum; body wall musculature; rectal gland cell; somatic nervous system; and vulval muscle. Human ortholog(s) of this gene are implicated in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2; mitochondrial DNA depletion syndrome 12a; and mitochondrial DNA depletion syndrome 12b. Is an ortholog of human SLC25A4 (solute carrier family 25 member 4) and SLC25A5 (solute carrier family 25 member 5).

WB:WBGene00020141	lmd-5
Is predicted to have chitin binding activity and hydrolase activity, acting on glycosyl bonds. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00020142	aak-2
Exhibits AMP-activated protein kinase activity. Is involved in several processes, including determination of adult lifespan; positive regulation of dauer larval development; and regulation of protein secretion. Localizes to axon; cytoplasm; and neuronal cell body. Is expressed in several structures, including body wall musculature; excretory canal; interfacial epithelial cell; neurons; and reproductive system. Is an ortholog of human PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) and PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2).

WB:WBGene00020143	T01C8.2
Is enriched in PLM; cephalic sheath cell; hypodermis; and muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Neuropeptide-like peptide 36.

WB:WBGene00020144	T01C8.3
Is enriched in intestine and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and pmk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; multi-walled carbon nanotube; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020145	got-1.1
Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by dafa#1; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00020146	got-1.2
Exhibits L-aspartate:2-oxoglutarate aminotransferase activity. Is involved in positive regulation of glutamate metabolic process. Localizes to cytoplasm. Is expressed in head; neurons; and tail. Is an ortholog of human GOT1 (glutamic-oxaloacetic transaminase 1).

WB:WBGene00020148	T01D1.3
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; daf-12; and lin-4 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; Rotenone; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00020149	T01D1.4
Is predicted to have acireductone dioxygenase [iron(II)-requiring] activity. Is an ortholog of human ADI1 (acireductone dioxygenase 1).

WB:WBGene00020150	T01D1.5
Is affected by several genes including sir-2.1; mex-3; and mex-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00020151	T01G6.1
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00020152	nhr-211
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020153	nhr-212
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020154	T01G6.10
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; dpy-21; and smg-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; Psoralens; and nitroguanidine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00020155	T02B11.3
Is expressed in AMshL; AMshR; amphid sheath cell; and phasmid sheath cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00020156	T02B11.4
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including nicotinic acid; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020157	T02B11.6
Is predicted to have transmembrane transporter activity.

WB:WBGene00020158	T02C5.1
Is enriched in coelomocyte; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; glp-1; and lin-4 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Cry5B; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TNFR/NGFR cysteine-rich region and TNFR/NGFR cysteine-rich region.

WB:WBGene00020160	igcm-3
Is expressed in arcade cell; hypodermis; pharyngeal muscle cell; spermatheca; and vulva. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold and Immunoglobulin-like domain superfamily.

WB:WBGene00020163	T02G5.3
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93. Is predicted to encode a protein with the following domain: EF-hand domain pair. Is an ortholog of human EFCAB7 (EF-hand calcium binding domain 7).

WB:WBGene00020164	T02G5.4
Is enriched in germ line; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq; proteomic; and microarray studies. Is an ortholog of human ACAT1 (acetyl-CoA acetyltransferase 1).

WB:WBGene00020165	T02G5.5
No description available

WB:WBGene00020166	T02G5.7
Is predicted to have acetyl-CoA C-acetyltransferase activity. Human ortholog(s) of this gene are implicated in beta-ketothiolase deficiency. Is an ortholog of human ACAT1 (acetyl-CoA acetyltransferase 1).

WB:WBGene00020167	T02G5.11
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Heme; Rotenone; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00020168	mct-5
Is predicted to have monocarboxylic acid transmembrane transporter activity. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A11 (solute carrier family 16 member 11) and SLC16A6 (solute carrier family 16 member 6).

WB:WBGene00020169	mmaa-1
Is predicted to have ATP binding activity; GTP binding activity; and GTPase activity. Is used to study methylmalonic acidemia. Human ortholog(s) of this gene are implicated in methylmalonic acidemia cblA type. Is an ortholog of human MMAA (metabolism of cobalamin associated A).

WB:WBGene00020170	T02G5.14
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; Rotenone; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020171	T02H6.1
Is predicted to have snoRNA binding activity. Is an ortholog of human RRP9 (ribosomal RNA processing 9, U3 small nucleolar RNA binding protein).

WB:WBGene00020172	thoc-1
Is enriched in PLM and germ line based on RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and sir-2.1 based on RNA-seq; proteomic; and microarray studies. Is affected by four chemicals including Hydrolyzable Tannins; Humic Substances; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; THO complex subunit 1 transcription elongation factor; and THO complex, subunit THOC1. Is an ortholog of human THOC1 (THO complex 1).

WB:WBGene00020173	T02H6.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including aldicarb; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020174	T02H6.4
Is affected by several genes including pgl-1; aak-2; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including tryptophan; methylmercuric chloride; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00020175	T02H6.5
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including daf-2; mex-3; and csr-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Alovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00020176	T02H6.6
Is affected by several genes including mex-3; ain-1; and spn-4 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and dibromoacetic acid based on RNA-seq and microarray studies.

WB:WBGene00020177	T02H6.7
Is enriched in CEM; HOB; IL2 neuron; ray neuron type B; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including methylmercuric chloride; Cry5B; and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00020178	T02H6.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride and allantoin based on microarray studies.

WB:WBGene00020179	T02H6.9
Is enriched in Z1.p; Z4.a; male distal tip cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Mianserin; multi-walled carbon nanotube; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00020180	T02H6.10
Is affected by rsr-2; eat-2; and eri-1 based on tiling array; RNA-seq; and microarray studies. Is affected by tryptophan; Atrazine; and Sirolimus based on microarray studies.

WB:WBGene00020181	T02H6.11
Is enriched in intestine based on microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by Rotenone; Deoxyglucose; and Chlorpyrifos based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 3. Is predicted to encode a protein with the following domains: Ubiquinol-cytochrome C reductase complex 14kD subunit; Cytochrome b-c1 complex subunit 7; and Cytochrome b-c1 complex subunit 7 superfamily. Is an ortholog of human UQCRB (ubiquinol-cytochrome c reductase binding protein).

WB:WBGene00020182	ugt-53
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT1A7 (UDP glucuronosyltransferase family 1 member A7); UGT2B28 (UDP glucuronosyltransferase family 2 member B28); and UGT2B4 (UDP glucuronosyltransferase family 2 member B4).

WB:WBGene00020183	T03D3.5
Is enriched in body wall muscle cell; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020184	uba-5
Exhibits UFM1 activating enzyme activity and ubiquitin conjugating enzyme binding activity. Is involved in determination of adult lifespan; reproduction; and stress response to metal ion. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 24 and early infantile epileptic encephalopathy 44. Is an ortholog of human UBA5 (ubiquitin like modifier activating enzyme 5).

WB:WBGene00020185	pgk-1
Is predicted to have ADP binding activity; ATP binding activity; and phosphoglycerate kinase activity. Is an ortholog of human PGK1 (phosphoglycerate kinase 1).

WB:WBGene00020186	T03F1.4
No description available

WB:WBGene00020187	gsp-4
Is predicted to have protein serine/threonine phosphatase activity. Is involved in several processes, including amoeboid sperm motility; male meiosis chromosome segregation; and oviposition. Localizes to cytoplasm; nuclear chromatin; and pseudopodium. Is expressed in ILsoDL; ILsoVL; anal sphincter muscle; intestine; and sperm. Is an ortholog of human PPP1CA (protein phosphatase 1 catalytic subunit alpha).

WB:WBGene00020188	T03F1.6
Is enriched in Z1.p; Z4.a; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00020189	tfbm-1
Is predicted to have rRNA (adenine-N6,N6-)-dimethyltransferase activity. Is an ortholog of human TFB1M (transcription factor B1, mitochondrial).

WB:WBGene00020190	guk-1
Is predicted to have guanylate kinase activity. Is expressed in anchor cell. Is an ortholog of human GUK1 (guanylate kinase 1).

WB:WBGene00020191	clec-53
Is predicted to have signaling receptor activity. Is an ortholog of human MRC2 (mannose receptor C type 2).

WB:WBGene00020192	T03F1.11
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in Usher syndrome type 1J and autosomal recessive nonsyndromic deafness 48.

WB:WBGene00020193	T03F1.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Integral membrane protein S linking to the trans Golgi network; Integral membrane protein SYS1; and Integral membrane protein SYS1-related. Is an ortholog of human SYS1 (SYS1 golgi trafficking protein).

WB:WBGene00020194	T03G6.1
Is enriched in PLM; head mesodermal cell; hypodermis; and intestine based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Acetyltransferase (GNAT) domain and YitH, acetyltransferase (GNAT) domain.

WB:WBGene00020195	T03G6.3
Is predicted to have catalytic activity. Localizes to I band and striated muscle dense body. Is expressed in vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including arterial calcification of infancy; autosomal recessive hypophosphatemic rickets; and obesity. Is an ortholog of human ENPP6 (ectonucleotide pyrophosphatase/phosphodiesterase 6).

WB:WBGene00020196	T03G11.3
Is predicted to have metal ion binding activity. Is an ortholog of human ZC2HC1A (zinc finger C2HC-type containing 1A).

WB:WBGene00020197	mans-3
Is predicted to have mannosyl-oligosaccharide 1,2-alpha-mannosidase activity. Human ortholog(s) of this gene are implicated in non-syndromic intellectual disability. Is an ortholog of human MAN1B1 (mannosidase alpha class 1B member 1).

WB:WBGene00020199	metl-9
Is predicted to have methyltransferase activity. Is an ortholog of human METTL9 (methyltransferase like 9).

WB:WBGene00020200	T04A6.1
Is expressed in anal sphincter muscle. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00020201	T04A6.2
Is enriched in several structures, including Z4.a; germline precursor cell; male distal tip cell; somatic gonad precursor; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by four chemicals including aldicarb; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020202	T04A6.3
Is enriched in several structures, including PLM; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and isp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Tunicamycin; Cry5B; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Chymotrypsin family Peptidase-S1; Chymotrypsin family Peptidase-S1; and Cytosolic motility protein.

WB:WBGene00020203	T04B8.1
Is affected by several genes including sir-2.1; alg-1; and mex-3 based on RNA-seq and microarray studies. Is affected by four chemicals including resveratrol; tetrabromobisphenol A; and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domain: Vitelline membrane outer layer protein I (VOMI) superfamily.

WB:WBGene00020204	T04B8.2
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and metformin based on RNA-seq and microarray studies.

WB:WBGene00020205	arrd-1
Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC1 (arrestin domain containing 1).

WB:WBGene00020207	T04B8.5
Is predicted to have potassium:chloride symporter activity. Human ortholog(s) of this gene are implicated in Gitelman syndrome; early infantile epileptic encephalopathy 34; and idiopathic generalized epilepsy 14. Is an ortholog of human SLC12A9 (solute carrier family 12 member 9).

WB:WBGene00020208	fnip-2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Cry5B; and Psoralens based on RNA-seq and microarray studies. Human FNIP1 exhibits ATPase inhibitor activity; chaperone binding activity; and guanyl-nucleotide exchange factor activity. Is predicted to encode a protein with the following domains: Folliculin-interacting protein C-terminus; Folliculin-interacting protein middle domain; Folliculin-interacting protein, middle domain; and Folliculin-interacting protein, C-terminal domain. Is an ortholog of human FNIP1 (folliculin interacting protein 1) and FNIP2 (folliculin interacting protein 2).

WB:WBGene00020209	T04C9.1
Is predicted to have GTPase activator activity. Is expressed in head. Human ortholog(s) of this gene are implicated in X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance and juvenile myelomonocytic leukemia. Is an ortholog of human ARHGAP10 (Rho GTPase activating protein 10) and ARHGAP42 (Rho GTPase activating protein 42).

WB:WBGene00020210	T04C9.2
Is enriched in DA neuron; VA neuron; dopaminergic neurons; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and lin-39 based on RNA-seq; tiling array; and microarray studies. Is affected by four chemicals including Mercuric Chloride; indole; and cadmium based on microarray studies.

WB:WBGene00020211	T04C9.3
Is enriched in AFD and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; hpl-2; and ets-4 based on microarray and tiling array studies.

WB:WBGene00020212	T04D1.2
Is enriched in DA neuron; interneuron; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020214	attf-5
Is expressed widely.

WB:WBGene00020215	T04G9.4
Is predicted to have holo-[acyl-carrier-protein] synthase activity. Is an ortholog of human AASDHPPT (aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase).

WB:WBGene00020216	trap-2
Is expressed widely. Is predicted to encode a protein with the following domains: Translocon-associated protein beta (TRAPB) and Translocon-associated protein subunit beta. Is an ortholog of human SSR2 (signal sequence receptor subunit 2).

WB:WBGene00020217	T04G9.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including pgl-1; fbf-1; and glh-1 based on RNA-seq and microarray studies. Is affected by tryptophan; allantoin; and Sirolimus based on microarray studies.

WB:WBGene00020218	T04G9.7
Is enriched in AVK; cephalic sheath cell; dopaminergic neurons; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including Heme; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00020219	T05A7.1
Is enriched in several structures, including body wall musculature; dopaminergic neurons; germ line; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and gld-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00020220	clec-140
Is predicted to have carbohydrate binding activity.

WB:WBGene00020221	T05A7.3
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB domain; CUB domain; and Spermadhesin, CUB domain superfamily.

WB:WBGene00020222	fut-6
Exhibits alpha-(1->3)-fucosyltransferase activity. Is involved in fucosylation. Is an ortholog of human FUT4 (fucosyltransferase 4) and FUT7 (fucosyltransferase 7).

WB:WBGene00020223	T05A7.6
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020224	T05A7.7
Is enriched in GABAergic neurons; NSM; and cephalic sheath cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Growth factor receptor cysteine-rich domain superfamily.

WB:WBGene00020225	sre-40
Is enriched in neurons based on tiling array studies. Is affected by several genes including clk-1; mex-1; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by Psoralens; allantoin; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00020227	T05A8.1
Is enriched in DA neuron; VA neuron; and hypodermis based on tiling array studies. Is affected by several genes including skn-1; eat-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including aldicarb; methylmercuric chloride; and metformin based on microarray and RNA-seq studies.

WB:WBGene00020228	T05A8.2
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020229	T05A8.3
Is enriched in head mesodermal cell; muscle cell; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and fog-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00020230	nep-2
Is predicted to have metallopeptidase activity and zinc ion binding activity. Is involved in olfactory learning and regulation of chemotaxis. Localizes to cell surface. Is expressed in GLR and body wall musculature. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease axonal type 2T; X-linked dominant hypophosphatemic rickets; and distal arthrogryposis type 5D. Is an ortholog of human MMEL1 (membrane metalloendopeptidase like 1).

WB:WBGene00020231	T05A8.5
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; WD40-repeat-containing domain superfamily; and WD repeat-containing protein 31. Is an ortholog of human WDR31 (WD repeat domain 31).

WB:WBGene00020232	T05A8.6
Is enriched in male-specific anatomical entity based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including methylmercuric chloride; sodium arsenite; and single-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00020233	T05A8.7
Is enriched in several structures, including AVK; Z4.a; male distal tip cell; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00020234	T05A12.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; dlc-1; and iff-1 based on RNA-seq and microarray studies. Is affected by D-glucose; stavudine; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020235	T05A12.4
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human SHPRH (SNF2 histone linker PHD RING helicase).

WB:WBGene00020236	lgc-1
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00020237	phat-4
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AL; g1AR; g1P; g2L; and g2R.

WB:WBGene00020238	T05B4.4
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00020239	T05B4.8
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; skn-1; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and deoxynivalenol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00020240	T05B4.9
Is affected by several genes including clk-1; lin-15B; and dpy-21 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and fluoranthene based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00020241	T05B4.10
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin; resveratrol; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00020242	phat-5
Is involved in pharyngeal gland morphogenesis. Is expressed in g1AL and g1AR.

WB:WBGene00020243	T05B4.12
Is enriched in cephalic sheath cell; dopaminergic neurons; and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00020244	T05B4.13
Is expressed in g1AL; g1AR; g1P; g2L; and g2R. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00020245	T05B11.1
Is enriched in intestine; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00020246	clic-1
Is predicted to have clathrin heavy chain binding activity. Localizes to periciliary membrane compartment. Is expressed in head. Is an ortholog of human CLTA (clathrin light chain A) and CLTB (clathrin light chain B).

WB:WBGene00020247	T05B11.4
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00020248	T05C1.1
Is enriched in OLL; PVD; head mesodermal cell; and hypodermis based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including tryptophan; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00020249	T05C1.2
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-7; alg-1; and prg-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020250	T05C1.3
Is enriched in NSM; PLM; amphid sheath cell; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00020251	camt-1
Is predicted to have sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in nonprogressive cerebellar ataxia with mental retardation. Is an ortholog of human CAMTA2 (calmodulin binding transcription activator 2).

WB:WBGene00020252	T05C1.5
Is affected by several genes including daf-16; daf-2; and drh-3 based on microarray and RNA-seq studies. Is affected by four chemicals including indole; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like; CC domain; ShKT domain; and CC domain.

WB:WBGene00020254	T05C3.2
Is affected by several genes including daf-2; daf-12; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Tunicamycin; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; Domain of unknown function (DUF4062); NACHT domain; WD40 repeat; NACHT nucleoside triphosphatase; Quinoprotein alcohol dehydrogenase-like superfamily; WD40/YVTN repeat-like-containing domain superfamily; Domain of unknown function DUF4062; and P-loop containing nucleoside triphosphate hydrolase. Is an ortholog of human NWD2 (NACHT and WD repeat domain containing 2).

WB:WBGene00020255	T05C3.3
No description available

WB:WBGene00020256	T05C3.6
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia 46. Is an ortholog of human PLD3 (phospholipase D family member 3); PLD4 (phospholipase D family member 4); and PLD5 (phospholipase D family member 5).

WB:WBGene00020258	T05E7.1
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of several human genes including ACOT1 (acyl-CoA thioesterase 1); ACOT2 (acyl-CoA thioesterase 2); and BAAT (bile acid-CoA:amino acid N-acyltransferase).

WB:WBGene00020259	T05E7.3
Is enriched in germ line; germline precursor cell; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucose; levamisole; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Ritscher-Schinzel syndrome 1 and hereditary spastic paraplegia 8. Is predicted to encode a protein with the following domains: Hereditary spastic paraplegia protein strumpellin and WASH complex, subunit strumpellin. Is an ortholog of human WASHC5 (WASH complex subunit 5).

WB:WBGene00020260	T05E7.4
Is enriched in GABAergic neurons; RIS; body wall muscle cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and 4-bromodiphenyl ether based on microarray and RNA-seq studies.

WB:WBGene00020261	vet-1
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00020262	ferl-1
Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Miyoshi muscular dystrophy 1; autosomal recessive limb-girdle muscular dystrophy type 2B; and distal muscular dystrophy with anterior tibial onset. Is an ortholog of human DYSF (dysferlin); FER1L5 (fer-1 like family member 5); and MYOF (myoferlin).

WB:WBGene00020263	let-355
Is predicted to have RNA binding activity. Is an ortholog of human DHX33 (DEAH-box helicase 33).

WB:WBGene00020264	acl-8
Is predicted to have transferase activity, transferring acyl groups. Is an ortholog of human LCLAT1 (lysocardiolipin acyltransferase 1).

WB:WBGene00020265	fbxa-196
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00020266	T05H4.3
Is enriched in neurons based on microarray studies. Is affected by several genes including sir-2.1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat; Leucine-rich repeat, typical subtype; U2A'/phosphoprotein 32 family A, C-terminal; and Leucine-rich repeat domain superfamily. Is an ortholog of human LRRC9 (leucine rich repeat containing 9).

WB:WBGene00020267	T05H4.4
Is predicted to have FAD binding activity. Is an ortholog of human CYB5R3 (cytochrome b5 reductase 3).

WB:WBGene00020268	hpo-19
Is predicted to have FAD binding activity. Is an ortholog of human CYB5R3 (cytochrome b5 reductase 3).

WB:WBGene00020269	erfa-1
Is predicted to have sequence-specific mRNA binding activity and translation release factor activity, codon specific. Is an ortholog of human ETF1 (eukaryotic translation termination factor 1).

WB:WBGene00020270	T05H4.7
Is predicted to have chitinase activity.

WB:WBGene00020271	T05H4.8
Is affected by set-25; met-2; and eat-2 based on RNA-seq and microarray studies. Is affected by Ethanol and Microcystin-LR based on RNA-seq and microarray studies.

WB:WBGene00020272	T05H4.9
No description available

WB:WBGene00020273	T05H4.10
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nucleolar pre-ribosomal-associated protein 1; Armadillo-like helical; Armadillo-type fold; Nucleolar pre-ribosomal-associated protein 1, C-terminal domain; and Nucleolar pre-ribosomal-associated protein 1. Is an ortholog of human URB1 (URB1 ribosome biogenesis homolog).

WB:WBGene00020274	T05H4.11
Is enriched in AFD; germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; gld-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; Zidovudine; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00020275	atp-4
Is predicted to have proton transmembrane transporter activity. Is an ortholog of human ATP5PF (ATP synthase peripheral stalk subunit F6).

WB:WBGene00020276	T05H4.15
Is enriched in amphid sheath cell; coelomocyte; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box associated domain, type 2; and F-box protein she-1-like.

WB:WBGene00020277	T06A1.1
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00020279	glb-25
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00020280	T06A1.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00020281	T06A4.1
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of human CPA1 (carboxypeptidase A1); CPA2 (carboxypeptidase A2); and CPA4 (carboxypeptidase A4).

WB:WBGene00020282	mps-3
Exhibits potassium channel regulator activity. Is involved in regulation of chemotaxis and regulation of potassium ion transport. Is expressed in ADF; lumbar neurons; and pharyngeal neurons.

WB:WBGene00020283	T06A4.3
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of several human genes including CPA1 (carboxypeptidase A1); CPA4 (carboxypeptidase A4); and CPA5 (carboxypeptidase A5).

WB:WBGene00020284	mel-46
Is predicted to have RNA binding activity and RNA helicase activity. Is expressed in germ line. Is an ortholog of human DDX20 (DEAD-box helicase 20).

WB:WBGene00020285	T06A10.2
Is enriched in intestine and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; mut-2; and let-418 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; Tunicamycin; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00020286	gtsf-1
Localizes to cytoplasm. Is an ortholog of human GTSF1 (gametocyte specific factor 1) and GTSF1L (gametocyte specific factor 1 like).

WB:WBGene00020287	lsy-13
Is predicted to have methylated histone binding activity. Human ortholog(s) of this gene are implicated in head and neck squamous cell carcinoma. Is an ortholog of human ING2 (inhibitor of growth family member 2).

WB:WBGene00020288	srt-73
Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00020289	T06C10.3
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00020290	T06D4.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including methylmercury hydroxide; nanoparticle; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020291	T06D4.2
Is enriched in NSM and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020292	nep-19
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including methylmercuric chloride; antimycin; and resveratrol based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00020293	nep-20
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in distal arthrogryposis type 5D and essential hypertension.

WB:WBGene00020294	T06F4.1
Is enriched in body wall musculature; head mesodermal cell; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00020295	pqbp-1.2
Is expressed in intestine. Human ortholog(s) of this gene are implicated in Renpenning syndrome. Human PQBP1 exhibits double-stranded DNA binding activity and ribonucleoprotein complex binding activity. Is an ortholog of human PQBP1 (polyglutamine binding protein 1).

WB:WBGene00020296	rrp-8
Is predicted to have methylated histone binding activity. Is expressed widely. Is an ortholog of human RRP8 (ribosomal RNA processing 8).

WB:WBGene00020297	nog-1
Is predicted to have GTP binding activity. Is involved in several processes, including determination of adult lifespan; negative regulation of lipid storage; and regulation of insulin receptor signaling pathway involved in determination of adult lifespan. Localizes to nucleolus. Is expressed in several structures, including excretory cell; germ cell; intestine; pharynx; and vulva. Is an ortholog of human GTPBP4 (GTP binding protein 4).

WB:WBGene00020298	T07A9.10
Is enriched in several structures, including body wall muscle cell; excretory cell; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and sma-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Mianserin; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sec1 family; Sec1-like protein; Sec1-like, domain 2; Sec1-like superfamily; Sec1-like, domain 3a; and Sec1-like, domain 1. Is an ortholog of human STXBP3 (syntaxin binding protein 3).

WB:WBGene00020299	T07A9.12
Is enriched in AFD; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; fbf-1; and glh-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; Mianserin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Transmembrane Fragile-X-F-associated protein. Is an ortholog of human TMEM203 (transmembrane protein 203).

WB:WBGene00020300	ssna-1
Is enriched in germ line; male-specific anatomical entity; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: SSNA1 family. Is an ortholog of human SSNA1 (SS nuclear autoantigen 1).

WB:WBGene00020301	T07D1.2
Is expressed in E; Ea; and Ep. Is predicted to encode a protein with the following domains: RING-type zinc-finger; Zinc finger, RING/FYVE/PHD-type; RING-type zinc-finger, LisH dimerisation motif; and Rmd5. Is an ortholog of human RMND5A (required for meiotic nuclear division 5 homolog A) and RMND5B (required for meiotic nuclear division 5 homolog B).

WB:WBGene00020302	T07D1.3
Is expressed in mechanosensory neurons.

WB:WBGene00020304	fbxa-200
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including hydrogen sulfide; D-glucose; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00020305	T07D3.2
Is affected by several genes including age-1; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00020306	T07D3.3
Is affected by daf-12; rsr-2; and drh-3 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00020307	T07D3.4
Is enriched in several structures, including AVE; cephalic sheath cell; head mesodermal cell; mechanosensory neurons; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including diallyl trisulfide; Mianserin; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1X and muscular dystrophy (multiple). Is predicted to encode a protein with the following domain: Fukutin-related. Is an ortholog of human FKTN (fukutin).

WB:WBGene00020308	T07D3.5
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and dpy-7 based on tiling array; RNA-seq; and microarray studies. Is affected by stavudine; Rifampin; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00020309	T07D3.6
Is affected by several genes including eat-2; dpy-7; and aak-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq studies. Is an ortholog of human FKTN (fukutin).

WB:WBGene00020310	T07D3.8
No description available

WB:WBGene00020311	T07D3.9
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT9 (acyl-CoA thioesterase 9).

WB:WBGene00020312	T07E3.1
No description available

WB:WBGene00020313	T07E3.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including paraquat; Colistin; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020314	T07E3.3
Is predicted to have glutathione peroxidase activity and glutathione transferase activity. Is an ortholog of human GSTK1 (glutathione S-transferase kappa 1).

WB:WBGene00020315	T07E3.4
Is enriched in muscle cell; sensory neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including methylmercuric chloride; Tunicamycin; and levamisole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00020316	brc-2
Exhibits single-stranded DNA binding activity. Is involved in several processes, including DNA metabolic process; embryo development; and oviposition. Localizes to condensed nuclear chromosome.

WB:WBGene00020317	pdf-1
Is expressed in neurons and rectum.

WB:WBGene00020318	T07F8.1
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-12; eat-2; and nhr-25 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Sodium Chloride; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1280) and Protein of unknown function DUF1280.

WB:WBGene00020319	npr-31
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus.

WB:WBGene00020320	T07F8.4
Is predicted to have RNA polymerase II repressing transcription factor binding activity; histone deacetylase binding activity; and transcription corepressor activity. Is expressed in gonad; pharynx; and spermatheca. Is an ortholog of human MIER1 (MIER1 transcriptional regulator); MIER2 (MIER family member 2); and MIER3 (MIER family member 3).

WB:WBGene00020321	T07F12.1
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including dpy-10; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Zidovudine; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 1); Histidine phosphatase superfamily, clade-1; and Histidine phosphatase superfamily. Is an ortholog of human UBASH3B (ubiquitin associated and SH3 domain containing B).

WB:WBGene00020322	T07F12.2
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Zidovudine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protease-associated domain-containing protein 1. Is an ortholog of human PRADC1 (protease associated domain containing 1).

WB:WBGene00020323	arrd-23
Is enriched in dopaminergic neurons and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), C-terminal domain; Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC5 (arrestin domain containing 5).

WB:WBGene00020324	T07F12.4
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020325	bath-46
Is enriched in AFD and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-60; and lin-4 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including methylmercury hydroxide; bisphenol A; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00020326	math-38
Is involved in defense response to Gram-positive bacterium.

WB:WBGene00020327	clec-21
Is predicted to have carbohydrate binding activity.

WB:WBGene00020328	clec-20
Is predicted to have carbohydrate binding activity.

WB:WBGene00020329	bath-26
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including tryptophan; methylmercury hydroxide; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00020330	cest-16
Is predicted to have carboxylic ester hydrolase activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is an ortholog of human CEL (carboxyl ester lipase).

WB:WBGene00020333	sre-12
Is affected by mir-34; drh-3; and sir-2.1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00020334	epg-7
Exhibits molecular adaptor activity. Is involved in positive regulation of macroautophagy. Localizes to cytoplasm. Is expressed in neurons; pharyngeal muscle cell; and tail. Human ortholog(s) of this gene are implicated in breast cancer. Is an ortholog of human RB1CC1 (RB1 inducible coiled-coil 1).

WB:WBGene00020335	ttr-30
Is enriched in dopaminergic neurons; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including Rotenone; juglone; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00020338	T08A9.6
Is enriched in excretory cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Lithium Chloride; Zidovudine; and metformin based on microarray and RNA-seq studies.

WB:WBGene00020339	ttr-59
Is enriched in dopaminergic neurons; germline precursor cell; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00020340	T08B1.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00020341	T08B1.4
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00020342	fbxa-201
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; antimycin; and glycine based on microarray and RNA-seq studies.

WB:WBGene00020343	acs-3
Is predicted to have catalytic activity. Is expressed in several structures, including excretory cell; intestine; seam cell; tail; and vulva. Is an ortholog of human ACSL5 (acyl-CoA synthetase long chain family member 5).

WB:WBGene00020345	T08B2.4
Is enriched in germ line and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spastic ataxia 4. Is predicted to encode a protein with the following domain: .

WB:WBGene00020346	rbm-5
Is predicted to have RNA binding activity and metal ion binding activity. Is expressed in CAN; head neurons; intestinal cell; muscle cell; and ventral nerve cord. Is an ortholog of human RBM5 (RNA binding motif protein 5).

WB:WBGene00020347	ech-1.2
Is predicted to have enoyl-CoA hydratase activity and long-chain-3-hydroxyacyl-CoA dehydrogenase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in mitochondrial trifunctional protein deficiency. Is an ortholog of human HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha).

WB:WBGene00020348	mrpl-23
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL23 (mitochondrial ribosomal protein L23).

WB:WBGene00020349	T08B2.11
Is expressed in head neurons and intestine. Is predicted to encode a protein with the following domain: .

WB:WBGene00020350	T08B2.12
Is enriched in male-specific anatomical entity; muscle cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00020351	T08B6.1
Is enriched in AVE based on tiling array studies. Is affected by several genes including rrf-3; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube; cadmium; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020352	T08B6.2
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; resveratrol; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00020353	T08B6.4
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on proteomic; microarray; RNA-seq; and tiling array studies. Is affected by twenty-three chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020354	sgnh-1
Is predicted to have RNA binding activity. Is an ortholog of human PABPN1 (poly(A) binding protein nuclear 1) and PABPN1L (PABPN1 like, cytoplasmic).

WB:WBGene00020356	T08B6.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00020357	T08E11.1
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020358	math-39
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00020359	math-40
Is enriched in FLP; GABAergic neurons; OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including D-glucopyranose; antimycin; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00020360	math-41
Is enriched in OLL; PVD; dopaminergic neurons; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucopyranose; sesamin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00020361	fbxc-19
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00020362	fbxb-10
Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Mianserin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020363	fbxa-3
Is enriched in AFD; body wall muscle cell; coelomocyte; pharynx; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020364	T08E11.8
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020365	T08G2.2
Is enriched in FLP based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273 and Protein of unknown function DUF273.

WB:WBGene00020366	acdh-10
Is predicted to have medium-chain-acyl-CoA dehydrogenase activity. Localizes to mitochondrion. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADM (acyl-CoA dehydrogenase medium chain).

WB:WBGene00020368	ast-1
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in neuron differentiation; positive regulation of transcription by RNA polymerase II; and regulation of nematode male tail tip morphogenesis. Localizes to nucleus. Is expressed in intestine; neurons; and rectal gland cell. Human ortholog(s) of this gene are implicated in acute myeloid leukemia and craniosynostosis. Is an ortholog of human ERG (ETS transcription factor ERG) and FLI1 (Fli-1 proto-oncogene, ETS transcription factor).

WB:WBGene00020369	exc-15
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2. Is an ortholog of human AKR1A1 (aldo-keto reductase family 1 member A1).

WB:WBGene00020370	T08H10.3
Is enriched in NSM; amphid sheath cell; head mesodermal cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00020371	oac-60
Is affected by several genes including pgl-1; csr-1; and glh-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin and Atrazine based on microarray studies.

WB:WBGene00020372	T09A12.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020373	gpx-6
Is predicted to have peroxidase activity. Is an ortholog of human GPX4 (glutathione peroxidase 4).

WB:WBGene00020374	serp-1.2
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including hydrogen sulfide; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ribosome associated membrane protein RAMP4 and Stress-associated endoplasmic reticulum protein. Is an ortholog of human SERP1 (stress associated endoplasmic reticulum protein 1) and SERP2 (stress associated endoplasmic reticulum protein family member 2).

WB:WBGene00020375	pigv-1
Is predicted to have mannosyltransferase activity. Is expressed in excretory cell; hypodermis; intestine; pharynx; and rectal epithelium. Is an ortholog of human PIGV (phosphatidylinositol glycan anchor biosynthesis class V).

WB:WBGene00020376	T09B4.2
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including let-7; gld-1; and eat-2 based on proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including manganese chloride; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lamina-associated polypeptide 1C and LAP1C-like, C-terminal domain superfamily.

WB:WBGene00020377	T09B4.3
Is enriched in amphid sheath cell; body wall muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including manganese chloride; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020378	T09B4.4
Is predicted to have calcium ion binding activity and enzyme regulator activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 93. Is an ortholog of human CALML4 (calmodulin like 4).

WB:WBGene00020379	T09B4.5
Is enriched in cephalic sheath cell; germ line; head mesodermal cell; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020380	T09B4.6
Is enriched in intestine; pharynx; somatic gonad precursor; and in male based on microarray and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: BTG-like domain superfamily.

WB:WBGene00020381	T09B4.7
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including Mercuric Chloride; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00020382	T09B4.8
Is predicted to have pyridoxal phosphate binding activity and transaminase activity. Is an ortholog of human AGXT2 (alanine--glyoxylate aminotransferase 2).

WB:WBGene00020383	tin-44
Is predicted to have chaperone binding activity. Is expressed in tail. Is an ortholog of human TIMM44 (translocase of inner mitochondrial membrane 44).

WB:WBGene00020384	T09D3.3
Is enriched in NSM based on tiling array studies. Is affected by several genes including skn-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00020385	nhr-216
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020386	dach-1
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2U1 (cytochrome P450 family 2 subfamily U member 1).

WB:WBGene00020387	T10B5.1
No description available

WB:WBGene00020388	T10B5.2
Is enriched in Z1.p; Z4.a; male distal tip cell; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00020389	T10B5.3
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including aldicarb; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Dip2/Utp12 Family; and Small-subunit processome, Utp12. Is an ortholog of human WDR43 (WD repeat domain 43).

WB:WBGene00020390	T10B5.4
Is predicted to have N-acetyltransferase activity.

WB:WBGene00020391	cct-7
Is predicted to have ATP binding activity and unfolded protein binding activity. Is expressed in anchor cell; head; non-striated muscle; and tail. Is an ortholog of human CCT7 (chaperonin containing TCP1 subunit 7).

WB:WBGene00020392	knl-3
Is involved in chromosome organization; positive regulation of chromosome organization; and protein localization to kinetochore. Localizes to condensed chromosome kinetochore.

WB:WBGene00020393	T10B5.7
Is enriched in OLL; PVD; and intestine based on SAGE; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00020394	T10B5.8
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00020395	T10B5.9
No description available

WB:WBGene00020396	T10B5.10
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020397	pcbd-1
Is predicted to have 4-alpha-hydroxytetrahydrobiopterin dehydratase activity. Is expressed in head; hypodermis; neurons; and pharyngeal muscle cell. Is an ortholog of human PCBD1 (pterin-4 alpha-carbinolamine dehydratase 1).

WB:WBGene00020398	cerk-1
Is predicted to have ATP binding activity; dihydroceramide kinase activity; and kinase activity. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 26. Is an ortholog of human CERK (ceramide kinase).

WB:WBGene00020399	ztf-4
Is predicted to have RNA binding activity. Is expressed in body wall musculature; egg-laying apparatus; neurons; and pharynx. Is an ortholog of human HNRNPC (heterogeneous nuclear ribonucleoprotein C); HNRNPCL1 (heterogeneous nuclear ribonucleoprotein C like 1); and RALY (RALY heterogeneous nuclear ribonucleoprotein).

WB:WBGene00020400	T10B11.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020401	T10B11.5
Is enriched in intestine; pharyngeal muscle cell; sensory neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Rotenone; levamisole; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Eukaryotic protein of unknown function (DUF829); Protein of unknown function DUF829, TMEM53; and Alpha/Beta hydrolase fold. Is an ortholog of human TMEM53 (transmembrane protein 53).

WB:WBGene00020402	T10B11.6
Localizes to mitochondrion. Is expressed in distal tip cell; intestinal muscle; rectal epithelial cell; and ventral nerve cord. Is an ortholog of human TMEM53 (transmembrane protein 53).

WB:WBGene00020403	hrde-4
Is enriched in AVK; germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including D-glucose; Zidovudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00020404	T10B11.8
Is enriched in germ line; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020406	T10D4.1
Is affected by several genes including eat-2; alg-1; and drh-3 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00020407	chil-24
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00020408	T10D4.6
Is enriched in germ line; intestine; neurons; pharynx; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on quantitative PCR; microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including nicotinic acid; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020409	T10D4.7
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including D-glucose; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00020410	T10D4.11
Is affected by sir-2.1; tdp-1; and let-60 based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00020411	T10E9.1
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including manganese chloride; Zidovudine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box protein she-1-like.

WB:WBGene00020412	T10E9.2
Is enriched in germ line; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and lin-39 based on microarray and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and Linolenic Acids based on RNA-seq and microarray studies.

WB:WBGene00020413	T10E9.3
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eighteen chemicals including hydrogen sulfide; nicotinic acid; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00020414	T10E9.4
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-five chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DX module and Domain of unknown function DX.

WB:WBGene00020415	T10E9.5
Is enriched in AVK and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; mex-3; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020416	T10E9.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TB2/DP1, HVA22 family and TB2/DP1/HVA22-related protein.

WB:WBGene00020417	nuo-2
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is involved in determination of adult lifespan. Localizes to mitochondrion. Is an ortholog of human NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3).

WB:WBGene00020418	T10E9.8
Is enriched in several structures, including AFD; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by ten chemicals including Heme; hydrogen sulfide; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00020419	acdh-4
Is predicted to have flavin adenine dinucleotide binding activity and oxidoreductase activity, acting on the CH-CH group of donors. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6 and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADSB (acyl-CoA dehydrogenase short/branched chain).

WB:WBGene00020420	T10E10.3
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00020421	T10E10.4
Is predicted to have chitin binding activity.

WB:WBGene00020422	T10F2.2
Is predicted to have L-ornithine transmembrane transporter activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in ornithine translocase deficiency. Is an ortholog of human SLC25A15 (solute carrier family 25 member 15).

WB:WBGene00020423	prp-19
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human PRPF19 (pre-mRNA processing factor 19).

WB:WBGene00020424	T10H9.1
Is enriched in GABAergic neurons; body wall musculature; excretory cell; and neurons based on tiling array and microarray studies. Is affected by several genes including glp-1; daf-12; and lin-4 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00020425	syx-18
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human STX18 (syntaxin 18).

WB:WBGene00020426	T10H10.2
Is predicted to have flavin-linked sulfhydryl oxidase activity and protein disulfide isomerase activity. Is an ortholog of human QSOX1 (quiescin sulfhydryl oxidase 1) and QSOX2 (quiescin sulfhydryl oxidase 2).

WB:WBGene00020427	sav-1
Is enriched in OLL; PVD; and muscle cell based on microarray and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on RNA-seq and microarray studies. Is affected by Rotenone and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; WW domain; WW domain; and WW domain superfamily. Is an ortholog of human SAV1 (salvador family WW domain containing protein 1).

WB:WBGene00020428	irld-48
Is affected by several genes including sir-2.1; ain-1; and rsr-2 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00020430	irld-49
Is affected by several genes including elt-2; rrf-1; and dpy-21 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00020431	irld-50
Is affected by several genes including elt-2; sir-2.1; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00020432	hpa-2
Is affected by clk-1 based on microarray studies.

WB:WBGene00020433	T11F8.1
Is enriched in AFD; germ line; germline precursor cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and metformin based on microarray and RNA-seq studies.

WB:WBGene00020434	T11F8.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including hydrogen sulfide; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00020435	T11F8.4
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020436	T12A2.1
Is predicted to have imidazolonepropionase activity. Is an ortholog of human AMDHD1 (amidohydrolase domain containing 1).

WB:WBGene00020437	stt-3
Is predicted to have dolichyl-diphosphooligosaccharide-protein glycotransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ix. Is an ortholog of human STT3B (STT3 oligosaccharyltransferase complex catalytic subunit B).

WB:WBGene00020438	T12A2.3
Is enriched in body wall musculature; somatic nervous system; tail neurons; and vulval muscle based on Chronogram studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00020439	T12A2.5
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on tiling array and RNA-seq studies. Is affected by seven chemicals including tryptophan; 1-methylnicotinamide; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00020440	T12A2.6
Is enriched in RID based on RNA-seq studies. Is affected by hpl-2; drh-3; and let-60 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine and Chlorpyrifos based on microarray studies.

WB:WBGene00020441	bcas-2
Is enriched in germ line; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and isp-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Zidovudine; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Breast carcinoma amplified sequence 2 (BCAS2) and Pre-mRNA-splicing factor SPF27. Is an ortholog of human BCAS2 (BCAS2 pre-mRNA processing factor).

WB:WBGene00020442	gen-1
Exhibits crossover junction endodeoxyribonuclease activity. Is involved in double-strand break repair via homologous recombination; intracellular signal transduction; and negative regulation of nematode larval development.

WB:WBGene00020443	esyt-2
Is expressed in body wall musculature; gonad; nervous system; neurons; and pharynx. Is predicted to encode a protein with the following domains: C2 domain; Synaptotagmin-like mitochondrial-lipid-binding domain; C2 domain; C2 domain superfamily; and Synaptotagmin, SMP domain. Is an ortholog of human ESYT2 (extended synaptotagmin 2).

WB:WBGene00020444	T12B3.1
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human PTPDC1 (protein tyrosine phosphatase domain containing 1).

WB:WBGene00020445	T12B3.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00020446	T12B3.3
Is predicted to have phosphoric diester hydrolase activity. Is an ortholog of human GDE1 (glycerophosphodiester phosphodiesterase 1).

WB:WBGene00020447	mob-3
Is enriched in NSM; Psub1; and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by antimycin; multi-walled carbon nanotube; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mob1/phocein family; MOB kinase activator family; and MOB kinase activator superfamily. Is an ortholog of human MOB3A (MOB kinase activator 3A); MOB3B (MOB kinase activator 3B); and MOB3C (MOB kinase activator 3C).

WB:WBGene00020448	fbxa-51
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including levamisole; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020449	fbxa-54
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00020450	fbxa-10
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00020451	fbxa-11
Is enriched in AVE; Z1.p; Z4.a; body wall muscle cell; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020452	fbxa-22
Is affected by hpl-2 and rsr-2 based on tiling array studies. Is affected by tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020453	fbxa-55
Is enriched in AFD; ASER; and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020454	fbxa-56
Is affected by drh-3 and eat-2 based on RNA-seq and microarray studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020455	fbxa-59
Is involved in innate immune response.

WB:WBGene00020456	fbxa-60
Is involved in PERK-mediated unfolded protein response and innate immune response.

WB:WBGene00020457	fbxa-67
Is enriched in body wall muscle cell; hypodermis; intestine; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by ten chemicals including bisphenol A; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020458	fbxa-70
Is affected by several genes including daf-16; daf-12; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00020459	fbxa-23
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including age-1; lin-4; and lin-14 based on microarray and RNA-seq studies.

WB:WBGene00020460	nhr-273
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00020461	T12C9.7
Is predicted to contribute to protein kinase activity. Human ortholog(s) of this gene are implicated in multiple myeloma; primary ciliary dyskinesia 29; and von Hippel-Lindau disease.

WB:WBGene00020462	ari-2
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is an ortholog of human ARIH2 (ariadne RBR E3 ubiquitin protein ligase 2).

WB:WBGene00020463	cec-6
Is enriched in germ line; germline precursor cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis. Is predicted to encode a protein with the following domains: Phosphorylation site; Chromo (CHRromatin Organisation MOdifier) domain; Chromo/chromo shadow domain; Chromo-like domain superfamily; and Chromo domain.

WB:WBGene00020464	tebp-2
Is enriched in NSM; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and npr-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by fifteen chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020465	T12E12.6
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is involved in embryo development; regulation of meiotic cell cycle process involved in oocyte maturation; and regulation of oviposition.

WB:WBGene00020466	sld-2
Is expressed in germ line. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020467	T12F5.2
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Linolenic Acids; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020468	T13A10.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00020469	T13A10.2
Is predicted to have metal ion binding activity.

WB:WBGene00020471	pho-14
Is expressed in anal depressor muscle; body wall musculature; and intestinal muscle. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP3 (acid phosphatase 3) and ACP4 (acid phosphatase 4).

WB:WBGene00020472	lips-11
Is predicted to have lipase activity. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00020473	lips-12
Is predicted to have lipase activity.

WB:WBGene00020474	lips-13
Is predicted to have lipase activity.

WB:WBGene00020475	sut-1
Localizes to cytoplasm and nucleus. Is expressed in neurons. Is used to study tauopathy.

WB:WBGene00020476	T13B5.9
Is predicted to have peptidase activity.

WB:WBGene00020478	T13C2.2
Is enriched in AFD and DA neuron based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00020479	T13C2.3
Is enriched in GABAergic neurons; body wall muscle cell; head mesodermal cell; male-specific anatomical entity; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00020480	ssup-72
Is predicted to have RNA polymerase II CTD heptapeptide repeat phosphatase activity. Is expressed in hypodermis; intestine; and nervous system. Is an ortholog of human SSU72 (SSU72 homolog, RNA polymerase II CTD phosphatase).

WB:WBGene00020481	T13C2.6
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in Donnai-Barrow syndrome; cerebellar ataxia, mental retardation and dysequlibrium syndrome; and familial hypercholesterolemia. Is an ortholog of human LDLR (low density lipoprotein receptor) and VLDLR (very low density lipoprotein receptor).

WB:WBGene00020482	T13C2.7
Is enriched in AFD; ASER; BAG; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Zidovudine; and metformin based on RNA-seq studies.

WB:WBGene00020483	T13C5.2
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercuric chloride; multi-walled carbon nanotube; and glycine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00020484	T13C5.3
Is enriched in OLL; PLM; PVD; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; let-60; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00020485	ceh-54
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head neurons. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple).

WB:WBGene00020486	T13C5.6
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human PLPP7 (phospholipid phosphatase 7 (inactive)).

WB:WBGene00020487	T13C5.7
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Zidovudine; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00020488	T13G4.1
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GYF domain; GYF domain; and GYF-like domain superfamily.

WB:WBGene00020489	hot-8
Is enriched in body wall musculature and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00020490	tmc-1
Exhibits sodium channel activity. Is involved in detection of stimulus involved in sensory perception; ion transmembrane transport; and sensory perception of chemical stimulus. Localizes to integral component of plasma membrane; neuronal cell body; and non-motile cilium. Is expressed in body wall musculature and neurons. Human ortholog(s) of this gene are implicated in autosomal dominant nonsyndromic deafness 36 and autosomal recessive nonsyndromic deafness 7. Is an ortholog of human TMC3 (transmembrane channel like 3).

WB:WBGene00020491	T13G4.4
Is predicted to have S-adenosylmethionine-homocysteine S-methyltransferase activity.

WB:WBGene00020492	T13G4.5
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00020494	T13G4.7
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including age-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020496	spat-3
Is predicted to have chromatin binding activity and ubiquitin protein ligase activity. Is involved in several processes, including histone H2A ubiquitination; negative regulation of vulval development; and nematode male tail tip morphogenesis. Is used to study developmental disorder of mental health. Is an ortholog of human RING1 (ring finger protein 1) and RNF2 (ring finger protein 2).

WB:WBGene00020497	T14A8.2
Is enriched in BAG; dopaminergic neurons; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00020498	T14B4.1
Is predicted to have tRNA (guanine) methyltransferase activity. Is an ortholog of human TARBP1 (TAR (HIV-1) RNA binding protein 1).

WB:WBGene00020499	mrps-18.C
Is predicted to have small ribosomal subunit rRNA binding activity. Is an ortholog of human MRPS18C (mitochondrial ribosomal protein S18C).

WB:WBGene00020500	T14B4.3
Is predicted to have signaling receptor activity. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Hedera type. Is an ortholog of human ATP6AP2 (ATPase H+ transporting accessory protein 2).

WB:WBGene00020501	T14B4.5
Is enriched in germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020502	T14B4.8
Is enriched in several structures, including germ line; head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Alovudine; Cry5B; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00020503	T14B4.9
Is enriched in GABAergic neurons and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Colistin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia; cataract 13 with adult i phenotype; and pseudoxanthoma elasticum. Is predicted to encode a protein with the following domains: Core-2/I-Branching enzyme and Glycosyl transferase, family 14. Is an ortholog of several human genes including GCNT1 (glucosaminyl (N-acetyl) transferase 1); GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type); and GCNT7 (glucosaminyl (N-acetyl) transferase family member 7).

WB:WBGene00020504	svh-2
Exhibits mitogen-activated protein kinase kinase kinase binding activity and transmembrane receptor protein tyrosine kinase activity. Is involved in generation of neurons; peptidyl-tyrosine autophosphorylation; and positive regulation of MAPK cascade. Is expressed in distal tip cell; excretory canal; and muscle cell. Human ortholog(s) of this gene are implicated in several diseases, including brain disease (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of human MERTK (MER proto-oncogene, tyrosine kinase) and TYRO3 (TYRO3 protein tyrosine kinase).

WB:WBGene00020505	T14E8.2
Is predicted to have transmembrane receptor protein tyrosine kinase activator activity.

WB:WBGene00020506	dop-3
Exhibits dopamine neurotransmitter receptor activity, coupled via Gi/Go. Is involved in several processes, including adenylate cyclase-inhibiting dopamine receptor signaling pathway; male mating behavior; and response to odorant. Is expressed in neurons. Is an ortholog of human DRD2 (dopamine receptor D2).

WB:WBGene00020507	vha-15
Is predicted to have proton-transporting ATPase activity, rotational mechanism. Is an ortholog of human ATP6V1H (ATPase H+ transporting V1 subunit H).

WB:WBGene00020508	T14F9.2
Is enriched in several structures, including PLM; Z1.p; Z4.a; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; Zidovudine; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020509	hex-1
Exhibits beta-N-acetylhexosaminidase activity. Is involved in carbohydrate metabolic process. Is expressed in coelomocyte and pharyngeal neurons. Human ortholog(s) of this gene are implicated in Sandhoff disease and Tay-Sachs disease. Is an ortholog of human HEXA (hexosaminidase subunit alpha) and HEXB (hexosaminidase subunit beta).

WB:WBGene00020510	T14G11.1
Is enriched in body wall musculature; head mesodermal cell; intestine; and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00020511	immt-1
Is involved in cristae formation; mitochondrion morphogenesis; and response to reactive oxygen species. Localizes to mitochondrial proton-transporting ATP synthase complex. Is an ortholog of human IMMT (inner membrane mitochondrial protein).

WB:WBGene00020512	T14G12.1
No description available

WB:WBGene00020514	T14G12.5
No description available

WB:WBGene00020515	T14G12.6
Is enriched in AVE based on tiling array studies. Is affected by several genes including daf-12; sir-2.1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00020516	T15B7.1
Is enriched in AVA; AVE; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including autosomal dominant nonsyndromic deafness 56; congenital afibrinogenemia; and familial hypobetalipoproteinemia 2. Human FCN1 exhibits G-protein coupled receptor binding activity; pattern recognition receptor activity; and sialic acid binding activity. Is predicted to encode a protein with the following domains: Lectin C-type domain; Fibrinogen beta and gamma chains, C-terminal globular domain; C-type lectin-like; Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain; C-type lectin-like/link domain superfamily; C-type lectin fold; and Fibrinogen-like, C-terminal. Is an ortholog of human ANGPT1 (angiopoietin 1); FCN1 (ficolin 1); and FCN3 (ficolin 3).

WB:WBGene00020517	hpo-8
Is predicted to have 3-hydroxyacyl-CoA dehydratase activity. Is an ortholog of human HACD1 (3-hydroxyacyl-CoA dehydratase 1) and HACD2 (3-hydroxyacyl-CoA dehydratase 2).

WB:WBGene00020520	T15B7.8
Is affected by several genes including daf-16; age-1; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00020522	T15B7.10
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00020523	dmsr-14
Is predicted to have G protein-coupled peptide receptor activity. Is an ortholog of human GPR139 (G protein-coupled receptor 139).

WB:WBGene00020524	dmsr-13
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00020525	dmsr-15
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00020526	T15B7.14
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020527	T15B7.15
Is expressed in intestinal cell; neurons; somatic gonad; and spermatheca. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020528	lgc-54
Is predicted to have chloride channel activity.

WB:WBGene00020530	T15B12.1
Localizes to mitochondrion. Is an ortholog of human SMTNL2 (smoothelin like 2).

WB:WBGene00020531	T15B12.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020532	math-42
Is expressed in intestine. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00020533	T16A1.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00020534	fbxc-49
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF3557.

WB:WBGene00020535	T16A1.4
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020536	T16A1.5
Is affected by tdp-1; hmg-3; and daf-2 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00020537	fbxb-37
Is enriched in AVK and NSM based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020538	T16A1.9
No description available

WB:WBGene00020539	T16D1.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including age-1; sir-2.1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00020540	pals-25
Is enriched in several structures, including body wall musculature; intestine; mechanosensory neurons; muscle cell; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020541	fbxb-81
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020542	fbxb-82
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00020543	fbxb-83
Is enriched in BAG based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mercuric Chloride; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020544	fbxb-84
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00020545	adbp-2
Is affected by several genes including clk-1; mex-3; and nhr-25 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00020546	zig-13
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including let-60; clk-1; and dpy-7 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; tert-Butylhydroperoxide; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold and Immunoglobulin-like domain superfamily.

WB:WBGene00020547	srz-7
Is enriched in neurons based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by Acrylamide; Chlorpyrifos; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00020548	T17A3.12
Is enriched in cephalic sheath cell based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00020549	nmt-1
Is predicted to have glycylpeptide N-tetradecanoyltransferase activity. Is an ortholog of human NMT2 (N-myristoyltransferase 2).

WB:WBGene00020550	T17H7.1
Is expressed in OLLL and OLLR. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00020551	T17H7.7
Is enriched in several structures, including DA neuron; PLM; germline precursor cell; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by twenty-three chemicals including Ethanol; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00020553	ttc-17
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-12; gld-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetratricopeptide-like helical domain superfamily and Tetratricopeptide repeat. Is an ortholog of human TTC17 (tetratricopeptide repeat domain 17).

WB:WBGene00020554	T19A5.3
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020555	nhr-219
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in amphid neurons; ciliated neurons; head neurons; and sensory neurons.

WB:WBGene00020556	pamn-1
Is predicted to have copper ion binding activity; peptidylamidoglycolate lyase activity; and peptidylglycine monooxygenase activity. Is expressed in head ganglion and tail ganglion. Is an ortholog of human PAM (peptidylglycine alpha-amidating monooxygenase).

WB:WBGene00020557	T19B4.3
Is predicted to have AMP binding activity; adenine binding activity; and adenine phosphoribosyltransferase activity. Human ortholog(s) of this gene are implicated in adenine phosphoribosyltransferase deficiency. Is an ortholog of human APRT (adenine phosphoribosyltransferase).

WB:WBGene00020558	T19B4.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on RNA-seq; proteomic; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00020559	best-17
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00020560	T19C3.2
Is enriched in NSM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including hydrogen sulfide; Nitric Oxide; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T19C3.2-like.

WB:WBGene00020561	T19C3.3
Is enriched in hypodermis and neurons based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and sek-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020562	T19C3.4
Is enriched in cephalic sheath cell; muscle cell; and sensory neurons based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Cry5B; stavudine; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia 31; and hereditary spastic paraplegia 72. Is predicted to encode a protein with the following domains: Phosphorylation site; TB2/DP1, HVA22 family; and TB2/DP1/HVA22-related protein. Is an ortholog of human REEP1 (receptor accessory protein 1); REEP2 (receptor accessory protein 2); and REEP4 (receptor accessory protein 4).

WB:WBGene00020563	T19C3.5
Is predicted to have lipid binding activity. Is an ortholog of human BPI (bactericidal permeability increasing protein) and LBP (lipopolysaccharide binding protein).

WB:WBGene00020564	T19C3.6
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00020565	T19C3.7
Is affected by several genes including eat-2; mex-1; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including aldicarb; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020566	ttr-7
Is enriched in germline precursor cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00020567	adt-3
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is an ortholog of human ADAMTS10 (ADAM metallopeptidase with thrombospondin type 1 motif 10).

WB:WBGene00020568	T19D2.3
Is enriched in AFD; PLM; body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Rotenone; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00020569	lgc-32
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00020571	lpr-7
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020572	rund-1
Exhibits Rab GTPase binding activity. Is involved in several processes, including dense core granule maturation; positive regulation of locomotion involved in locomotory behavior; and positive regulation of oviposition. Localizes to several cellular components, including Golgi trans cisterna; neuronal cell body; and perinuclear region of cytoplasm. Is expressed in uterus. Is an ortholog of human RUNDC1 (RUN domain containing 1).

WB:WBGene00020573	T19D7.5
Is enriched in intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; alg-1; and lin-22 based on RNA-seq studies. Is affected by Colistin and Sirolimus based on microarray studies.

WB:WBGene00020574	T19D7.6
Is enriched in ASER; OLL; PVD; dopaminergic neurons; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including diallyl trisulfide; levamisole; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat domain superfamily and Leucine-rich melanocyte differentiation-associated protein. Is an ortholog of human LRMDA (leucine rich melanocyte differentiation associated).

WB:WBGene00020575	T19D7.7
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00020576	T19D12.1
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including hydrogen sulfide; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020577	T19D12.2
Is enriched in ASER; head mesodermal cell; intestine; and mechanosensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; levamisole; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: von Willebrand factor A-like domain superfamily.

WB:WBGene00020578	T19D12.3
Is enriched in GABAergic neurons; excretory cell; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fifteen chemicals including methylmercuric chloride; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00020579	T19D12.4
Is involved in defense response to Gram-negative bacterium and innate immune response. Localizes to membrane raft. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple).

WB:WBGene00020580	T19D12.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00020581	T19D12.6
Is enriched in several structures, including germ line; head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Carpenter syndrome; Pierson syndrome; and junctional epidermolysis bullosa (multiple). Is predicted to encode a protein with the following domains: Laminin G domain; Laminin G domain; and Concanavalin A-like lectin/glucanase domain superfamily. Is an ortholog of human EGFLAM (EGF like, fibronectin type III and laminin G domains).

WB:WBGene00020582	oig-8
Is expressed in sensory neurons. Is predicted to encode a protein with the following domains: Immunoglobulin-like fold and Immunoglobulin-like domain superfamily.

WB:WBGene00020583	T19D12.9
Is predicted to have transmembrane transporter activity.

WB:WBGene00020584	T19D12.10
Is predicted to have transmembrane transporter activity.

WB:WBGene00020585	clec-178
Is predicted to have signaling receptor activity. Is an ortholog of human REG4 (regenerating family member 4).

WB:WBGene00020586	frpr-18
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in enteric muscle and neurons.

WB:WBGene00020587	ugt-9
Is predicted to have UDP-glycosyltransferase activity. Is expressed in pharyngeal cell. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A10 (UDP glucuronosyltransferase family 1 member A10); UGT1A9 (UDP glucuronosyltransferase family 1 member A9); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00020588	T19H12.2
Is predicted to have histone binding activity. Is expressed in germ line. Is an ortholog of human ANP32A (acidic nuclear phosphoprotein 32 family member A); ANP32B (acidic nuclear phosphoprotein 32 family member B); and ANP32E (acidic nuclear phosphoprotein 32 family member E).

WB:WBGene00020589	T19H12.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020590	T19H12.6
Is predicted to have glutathione hydrolase activity and peptidyltransferase activity. Human ortholog(s) of this gene are implicated in gamma-glutamyl transpeptidase deficiency.

WB:WBGene00020591	nhr-220
Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020592	ugt-12
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A3 (UDP glucuronosyltransferase family 1 member A3); UGT1A8 (UDP glucuronosyltransferase family 1 member A8); and UGT2B11 (UDP glucuronosyltransferase family 2 member B11).

WB:WBGene00020593	ugt-11
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A1 (UDP glucuronosyltransferase family 1 member A1); UGT1A4 (UDP glucuronosyltransferase family 1 member A4); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00020594	ugt-10
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A9 (UDP glucuronosyltransferase family 1 member A9); UGT2B17 (UDP glucuronosyltransferase family 2 member B17); and UGT2B28 (UDP glucuronosyltransferase family 2 member B28).

WB:WBGene00020595	T20B5.2
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including glp-1; skn-1; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020596	oga-1
Exhibits hexosaminidase activity and protein serine/threonine phosphatase activity. Is involved in several processes, including glycogen metabolic process; lipid storage; and negative regulation of protein glycosylation. Is expressed in body wall musculature; coelomocyte; nerve ring; pharyngeal muscle cell; and rectal muscle. Is used to study type 2 diabetes mellitus. Is an ortholog of human OGA (O-GlcNAcase).

WB:WBGene00020598	T20B6.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00020599	T20B6.3
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020600	trd-1
Is expressed in gonad; gonadal primordium; seam cell; and vulval precursor cell. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; PPR repeat; Pentatricopeptide repeat; Tetratricopeptide-like helical domain superfamily; and Tetratricopeptide repeat. Is an ortholog of human TTC27 (tetratricopeptide repeat domain 27).

WB:WBGene00020601	T20B12.3
Is enriched in Psub1; body wall muscle cell; germ line; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CBF/Mak21 family; CCAAT-binding factor; and Nucleolar complex protein 4. Is an ortholog of human NOC4L (nucleolar complex associated 4 homolog).

WB:WBGene00020602	T20B12.4
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box associated domain, type 2; and F-box protein she-1-like.

WB:WBGene00020603	T20B12.5
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by rsr-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020604	T20B12.7
Is predicted to have electron transfer activity; iron-sulfur cluster binding activity; and metal ion binding activity. Is an ortholog of human CIAPIN1 (cytokine induced apoptosis inhibitor 1).

WB:WBGene00020605	lgc-50
Is predicted to have chloride channel activity.

WB:WBGene00020607	srab-20
Is expressed in PHAL; PHAR; PHBL; and PHBR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00020608	srab-22
Is affected by several genes including sir-2.1; csr-1; and ain-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00020609	T20D4.3
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00020611	txt-11
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00020612	arrd-22
Is enriched in germline precursor cell; intestine; muscle cell; neurons; and somatic gonad precursor based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin (or S-antigen), C-terminal domain; Arrestin-like, N-terminal; Arrestin C-terminal-like domain; Arrestin, C-terminal; and Immunoglobulin E-set. Is an ortholog of human ARRDC2 (arrestin domain containing 2).

WB:WBGene00020613	T20D4.7
Is involved in PERK-mediated unfolded protein response. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00020614	T20D4.8
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including sir-2.1; aak-2; and dpy-21 based on microarray and RNA-seq studies. Is affected by dibromoacetic acid; dafa#1; and Sirolimus based on microarray studies.

WB:WBGene00020615	T20D4.9
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and aak-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020616	T20D4.10
Is enriched in OLL; PVD; body wall muscle cell; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020617	T20D4.11
Is enriched in OLL; PVD; body wall muscle cell; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020618	T20D4.12
Is enriched in cephalic sheath cell; dopaminergic neurons; hypodermis; mechanosensory neurons; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; Ethanol; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020619	T20D4.13
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020620	T20D4.15
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; glycine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020622	T20D4.17
Is enriched in AFD and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; cadmium; and Chlorpyrifos based on RNA-seq and microarray studies.

WB:WBGene00020623	srab-21
Is affected by age-1 and sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00020624	T20D4.19
Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including bisphenol S; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00020625	mrrf-1
Is predicted to have ribosomal large subunit binding activity. Is an ortholog of human MRRF (mitochondrial ribosome recycling factor).

WB:WBGene00020626	T20F5.4
Is enriched in PLM; germline precursor cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00020627	T20F5.5
Is enriched in several structures, including Z1.p; Z4.a; germline precursor cell; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including dpy-10; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00020628	T20F5.6
Is enriched in NSM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including age-1; hsf-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including aldicarb; bisphenol S; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00020629	T20F5.7
Is enriched in NSM; germ line; germline precursor cell; and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including sir-2.1; aak-2; and fbf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00020630	T20F7.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00020631	T20F7.3
Is predicted to have kinase activity. Human ortholog(s) of this gene are implicated in Kawasaki disease. Is an ortholog of human IP6K1 (inositol hexakisphosphate kinase 1) and IP6K3 (inositol hexakisphosphate kinase 3).

WB:WBGene00020632	T20F7.5
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including glp-1; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020633	aakg-2
Is predicted to have kinase activity. Is an ortholog of human PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1).

WB:WBGene00020634	acs-9
Is predicted to have catalytic activity.

WB:WBGene00020635	T20H4.2
Is expressed in head neurons. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00020636	T20H4.5
Is predicted to contribute to NADH dehydrogenase activity. Is involved in mitochondrial electron transport, NADH to ubiquinone and response to drug. Localizes to mitochondrion. Is an ortholog of human NDUFS8 (NADH:ubiquinone oxidoreductase core subunit S8).

WB:WBGene00020637	fbxa-7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including skn-1; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Mercuric Chloride; allantoin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00020638	fbxa-43
Is enriched in AVA and AVE based on tiling array studies. Is affected by several genes including age-1; sir-2.1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020639	fbxa-71
Is affected by several genes including rrf-3; elt-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020640	fbxa-73
Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020641	fbxa-68
Is affected by several genes including clk-1; lin-35; and lin-15B based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00020642	T20H9.6
Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020644	T20H12.2
No description available

WB:WBGene00020645	T21D9.2
Is affected by rsr-2; drh-3; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by resveratrol and dafa#1 based on microarray studies.

WB:WBGene00020646	zmp-6
Is predicted to have metalloendopeptidase activity. Is expressed in anchor cell. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type. Is an ortholog of human MMP23B (matrix metallopeptidase 23B); MMP26 (matrix metallopeptidase 26); and MMP7 (matrix metallopeptidase 7).

WB:WBGene00020647	pqbp-1.1
Is involved in triglyceride metabolic process. Localizes to nuclear body. Is expressed in gonad. Is used to study Renpenning syndrome. Human ortholog(s) of this gene are implicated in Renpenning syndrome. Is an ortholog of human PQBP1 (polyglutamine binding protein 1).

WB:WBGene00020648	T21D12.7
Is predicted to have serine-type endopeptidase inhibitor activity.

WB:WBGene00020649	sma-10
Exhibits type I transforming growth factor beta receptor binding activity and type II transforming growth factor beta receptor binding activity. Is involved in several processes, including positive regulation of transforming growth factor beta receptor signaling pathway; regulation of mesodermal cell fate specification; and transforming growth factor beta receptor signaling pathway. Localizes to integral component of plasma membrane. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1F; familial temporal lobe epilepsy 1; and urofacial syndrome. Is an ortholog of human LRIG1 (leucine rich repeats and immunoglobulin like domains 1); LRIG2 (leucine rich repeats and immunoglobulin like domains 2); and LRIG3 (leucine rich repeats and immunoglobulin like domains 3).

WB:WBGene00020650	T21D12.11
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including mex-3; mex-1; and ain-1 based on RNA-seq and microarray studies. Is affected by six chemicals including tryptophan; methylmercuric chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020651	T21D12.12
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human TFPI2 (tissue factor pathway inhibitor 2).

WB:WBGene00020652	egg-4
Exhibits protein kinase binding activity and protein kinase inhibitor activity. Is involved in several processes, including female gamete generation; negative regulation of protein kinase activity; and positive regulation of protein localization to cell cortex. Localizes to cell cortex and nucleus. Is expressed in germ line and oocyte. Is an ortholog of human PTPRJ (protein tyrosine phosphatase receptor type J).

WB:WBGene00020653	T21E3.2
Is enriched in AVA; DA neuron; VA neuron; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00020655	T21E12.3
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00020656	T21E12.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercury hydroxide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00020657	lgc-53
Is predicted to have chloride channel activity. Is expressed in neurons.

WB:WBGene00020658	argn-1
Is predicted to have manganese ion binding activity. Is involved in innate immune response. Human ortholog(s) of this gene are implicated in hyperargininemia. Is an ortholog of human ARG1 (arginase 1) and ARG2 (arginase 2).

WB:WBGene00020659	T21G5.1
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00020660	T21G5.2
Is enriched in AFD; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00020661	smz-2
Is involved in male meiosis chromosome segregation. Localizes to nuclear chromatin. Is expressed in sperm.

WB:WBGene00020662	T21H3.1
Is enriched in OLL; PVD; Psub1; head mesodermal cell; and pharyngeal muscle cell based on SAGE; Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00020663	cutl-22
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020664	T21H3.5
Is enriched in AFD; OLL; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020665	T22B2.1
Is enriched in BAG based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00020666	T22B2.2
Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020667	T22B2.3
Is enriched in FLP; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020669	T22B2.5
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00020670	T22B2.6
Is enriched in DA neuron based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Mercuric Chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00020672	T22B7.3
Is enriched in AFD; ASER; germline precursor cell; and hypodermis based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including Heme; Ethanol; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Amidinotransferase. Is an ortholog of human DDAH1 (dimethylarginine dimethylaminohydrolase 1) and DDAH2 (dimethylarginine dimethylaminohydrolase 2).

WB:WBGene00020673	T22B7.4
Is predicted to have methylated histone binding activity and transcription coregulator activity. Is an ortholog of human SGF29 (SAGA complex associated factor 29).

WB:WBGene00020674	T22B7.7
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT9 (acyl-CoA thioesterase 9).

WB:WBGene00020675	T22B11.1
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020678	T22B11.4
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Is expressed in pharyngeal gland cell.

WB:WBGene00020679	ogdh-1
Is predicted to have oxoglutarate dehydrogenase (succinyl-transferring) activity. Is involved in protein folding. Localizes to mitochondrion. Is expressed in head and tail. Is an ortholog of human OGDH (oxoglutarate dehydrogenase) and OGDHL (oxoglutarate dehydrogenase L).

WB:WBGene00020680	T22D1.1
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00020682	T22D1.3
Is predicted to have IMP dehydrogenase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in Leber congenital amaurosis 11 and retinitis pigmentosa 10. Is an ortholog of human IMPDH1 (inosine monophosphate dehydrogenase 1).

WB:WBGene00020683	ribo-1
Is predicted to have dolichyl-diphosphooligosaccharide-protein glycotransferase activity. Is an ortholog of human RPN1 (ribophorin I).

WB:WBGene00020684	T22D1.5
Is predicted to have protein phosphatase regulator activity.

WB:WBGene00020686	T22D1.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020687	ruvb-2
Is predicted to have DNA helicase activity. Localizes to cytoplasm and nucleus. Is expressed in gonad. Is an ortholog of human RUVBL2 (RuvB like AAA ATPase 2).

WB:WBGene00020688	cest-6
Is enriched in FLP based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; nanoparticle; and Zidovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold.

WB:WBGene00020689	npr-12
Is predicted to have neuropeptide Y receptor activity. Is expressed in FLPL; FLPR; PVDL; and PVDR.

WB:WBGene00020690	T22E5.1
Is enriched in body wall musculature; intestine; neurons; retrovesicular ganglion; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and isp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00020691	igdb-3
Is enriched in Z1.p; Z4.a; male distal tip cell; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module; Fibronectin type III domain; Domain of unknown function DB; Fibronectin type III; Immunoglobulin-like fold; Fibronectin type III superfamily; and Immunoglobulin-like domain superfamily.

WB:WBGene00020692	T22E5.6
Is enriched in FLP based on microarray studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00020693	lron-8
Is expressed in body wall musculature; head muscle; pharynx; and rectal gland cell. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome; high myopia-sensorineural deafness syndrome; and trichotillomania. Is predicted to encode a protein with the following domains: Cysteine-rich flanking region, C-terminal; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily. Is an ortholog of human LRRC38 (leucine rich repeat containing 38).

WB:WBGene00020694	dhhc-11
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is expressed in head neurons and spermathecal-uterine junction. Is an ortholog of human ZDHHC11 (zinc finger DHHC-type containing 11).

WB:WBGene00020695	T22F3.2
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and non-syndromic X-linked intellectual disability. Is an ortholog of several human genes including USP17L1 (ubiquitin specific peptidase 17 like family member 1); USP17L4 (ubiquitin specific peptidase 17 like family member 4); and USP17L8 (ubiquitin specific peptidase 17 like family member 8).

WB:WBGene00020696	pygl-1
Is predicted to have glycogen phosphorylase activity and pyridoxal phosphate binding activity. Is expressed in germ line. Human ortholog(s) of this gene are implicated in glycogen storage disease V and glycogen storage disease VI. Is an ortholog of human PYGL (glycogen phosphorylase L) and PYGM (glycogen phosphorylase, muscle associated).

WB:WBGene00020697	T22F3.7
Is predicted to have transmembrane transporter activity.

WB:WBGene00020698	T22F3.8
Is predicted to have transmembrane transporter activity.

WB:WBGene00020699	T22F3.10
Is predicted to have transmembrane transporter activity.

WB:WBGene00020700	T22F3.11
Is predicted to have transmembrane transporter activity.

WB:WBGene00020701	T22F7.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A9 (solute carrier family 22 member 9).

WB:WBGene00020702	T22F7.3
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00020703	T22F7.4
Is enriched in coelomocyte; head mesodermal cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site and Uncharacterized protein F10E9.3-like.

WB:WBGene00020705	T22H9.1
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: rRNA biogenesis protein RRP36 and rRNA biogenesis protein RRP36. Is an ortholog of human RRP36 (ribosomal RNA processing 36).

WB:WBGene00020706	atg-9
Localizes to cytoplasm. Is expressed in AIYL; AIYR; and neurons. Is an ortholog of human ATG9A (autophagy related 9A).

WB:WBGene00020707	wago-10
Is predicted to have nucleic acid binding activity.

WB:WBGene00020708	dmd-8
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in amphid neurons.

WB:WBGene00020709	T23B3.1
Is enriched in germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including clk-1; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by Zidovudine; Humic Substances; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00020710	T23B3.2
Is enriched in several structures, including excretory cell; germ line; muscle cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including aldicarb; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00020711	rmd-5
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and metformin based on RNA-seq studies.

WB:WBGene00020712	ckr-1
Is predicted to have G protein-coupled receptor activity. Is involved in determination of adult lifespan. Is expressed in nerve ring. Is an ortholog of human CCKAR (cholecystokinin A receptor) and CCKBR (cholecystokinin B receptor).

WB:WBGene00020713	T23B3.5
Is enriched in germ line; intestine; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty-six chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020714	T23B3.6
Is enriched in amphid sheath cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020715	nspd-4
Is enriched in arcade cell; intestine; pharyngeal-intestinal valve cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and let-60 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00020716	phf-30
Is predicted to have metal ion binding activity. Is an ortholog of human INTS12 (integrator complex subunit 12).

WB:WBGene00020717	mrpl-4
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL4 (mitochondrial ribosomal protein L4).

WB:WBGene00020718	mrps-2
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 36. Is an ortholog of human MRPS2 (mitochondrial ribosomal protein S2).

WB:WBGene00020719	natc-1
Is predicted to have peptide alpha-N-acetyltransferase activity. Is involved in several processes, including determination of adult lifespan; response to paraquat; and stress response to metal ion. Localizes to cytoplasm. Is an ortholog of human NAA35 (N-alpha-acetyltransferase 35, NatC auxiliary subunit).

WB:WBGene00020720	T23B12.5
Is enriched in Z1; Z4; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; D-glucose; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family; Frag1/DRAM/Sfk1; and Post-GPI attachment to proteins factor 2. Is an ortholog of human PGAP2 (post-GPI attachment to proteins 2).

WB:WBGene00020721	T23B12.6
Is enriched in Psub1; germ line; germline precursor cell; head mesodermal cell; and neurons based on Chronogram; microarray; and RNA-seq studies. Is affected by several genes including daf-12; gld-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including levamisole; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; WD40 repeat; Potassium channel tetramerisation-type BTB domain; SKP1/BTB/POZ domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human KCTD3 (potassium channel tetramerization domain containing 3).

WB:WBGene00020722	T23B12.8
Is predicted to contribute to hormone activity.

WB:WBGene00020723	T23B12.9
No description available

WB:WBGene00020724	T23B12.10
No description available

WB:WBGene00020725	cnp-3
Is expressed in hypodermis; intestine; spermatheca; and uterus.

WB:WBGene00020726	T23C6.4
Is enriched in intestine; neurons; and somatic gonad precursor based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020727	npr-21
Is predicted to have G protein-coupled peptide receptor activity. Is expressed in head neurons; intestine; tail neurons; and ventral nerve cord.

WB:WBGene00020728	T23E1.1
Is predicted to have catalytic activity.

WB:WBGene00020729	T23E1.2
Is enriched in germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq studies.

WB:WBGene00020730	T23E1.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by D-glucose; paraquat; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RNA polymerase II transcription factor SIII (Elongin) subunit A and RNA polymerase II transcription factor SIII, subunit A.

WB:WBGene00020731	T23E7.1
No description available

WB:WBGene00020732	T23E7.2
Is enriched in body wall muscle cell; germ line; head mesodermal cell; and muscle cell based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-one chemicals including 1-methylnicotinamide; nicotinic acid; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human FAM186A (family with sequence similarity 186 member A).

WB:WBGene00020733	T23E7.3
No description available

WB:WBGene00020735	T23F2.2
Is predicted to have cytoskeletal protein binding activity.

WB:WBGene00020736	T23F2.3
Is enriched in intestine; muscle cell; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including aldicarb; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00020737	T23F2.4
Is enriched in carbon dioxide sensory neurons; cephalic sheath cell; dopaminergic neurons; hypodermis; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Sodium Chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00020738	T23F2.5
Is enriched in several structures, including carbon dioxide sensory neurons; germ line; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00020739	T23F4.1
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Humic Substances; and dafa#1 based on RNA-seq and microarray studies.

WB:WBGene00020740	T23F4.2
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Rifampin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020741	dlhd-1
Is predicted to have hydrolase activity.

WB:WBGene00020742	T23H2.3
Is predicted to have ATP binding activity. Is an ortholog of human TTF2 (transcription termination factor 2).

WB:WBGene00020743	mam-8
Is expressed in head neurons. Is predicted to encode a protein with the following domains: MAM domain, meprin/A5/mu; MAM domain; and Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00020744	T24A6.1
Is predicted to contribute to protein kinase activity.

WB:WBGene00020746	srbc-66
Exhibits G protein-coupled receptor activity. Is involved in G protein-coupled receptor signaling pathway and dauer larval development. Localizes to non-motile cilium and periciliary membrane compartment. Is expressed in ASKL and ASKR.

WB:WBGene00020747	T24A6.7
Is enriched in GABAergic neurons; amphid sheath cell; body wall muscle cell; and ciliated neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and npr-1 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; procyanidin; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF1768); NADAR; and YbiA-like superfamily.

WB:WBGene00020748	nhr-221
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human HNF4A (hepatocyte nuclear factor 4 alpha) and HNF4G (hepatocyte nuclear factor 4 gamma).

WB:WBGene00020749	srbc-67
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; clk-1; and mir-34 based on tiling array and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00020750	nhr-222
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020751	srbc-69
No description available

WB:WBGene00020752	srbc-68
Is affected by several genes including sir-2.1; prg-1; and hpl-2 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00020753	T24A6.16
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00020754	T24A6.17
Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00020755	grl-31
Is expressed in vulF. Is predicted to encode a protein with the following domains: Ground-like domain and Ground-like domain.

WB:WBGene00020756	T24A6.20
Is enriched in GABAergic neurons; amphid sheath cell; coelomocyte; excretory cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Acetyltransferase (GNAT) domain; Acyl-CoA N-acyltransferase; and YitH, acetyltransferase (GNAT) domain.

WB:WBGene00020757	ucr-2.3
Is predicted to have metalloendopeptidase activity. Is involved in protein folding. Is expressed in neurons and pharyngeal gland cell. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 5. Is an ortholog of human UQCRC2 (ubiquinol-cytochrome c reductase core protein 2).

WB:WBGene00020758	T24C4.2
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and bisphenol S based on microarray and RNA-seq studies.

WB:WBGene00020759	T24C4.3
Is enriched in AFD; ASER; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; alg-1; and mex-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; tryptophan; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020760	T24C4.4
Is involved in innate immune response.

WB:WBGene00020761	T24C4.5
Is predicted to have DNA primase activity and single-stranded DNA binding activity. Is an ortholog of human PRIM1 (DNA primase subunit 1).

WB:WBGene00020762	zer-1
Localizes to Cul2-RING ubiquitin ligase complex. Is an ortholog of human ZER1 (zyg-11 related cell cycle regulator).

WB:WBGene00020763	ztf-18
Is predicted to have nucleic acid binding activity. Is expressed in body wall musculature; head neurons; tail neurons; and ventral nerve cord.

WB:WBGene00020764	T24C12.1
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00020765	T24C12.3
Is predicted to have hydrolase activity, acting on glycosyl bonds.

WB:WBGene00020766	T24C12.4
Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020767	lgc-40
Is predicted to contribute to chloride channel activity. Is an ortholog of several human genes including GLRA1 (glycine receptor alpha 1); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00020769	T24D8.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-12; eri-1; and bar-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00020770	eat-17
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is expressed in intestine; pharyngeal muscle cell; and vulva. Is an ortholog of human EVI5 (ecotropic viral integration site 5).

WB:WBGene00020771	T24E12.1
Is enriched in AB and germ line based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00020772	T24E12.2
Is enriched in intestine and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00020773	T24E12.3
Is enriched in several structures, including Z1.p; Z4.a; male distal tip cell; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including elt-2; pgl-1; and glh-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00020774	T24E12.5
Is enriched in OLL; PVD; dopaminergic neurons; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including aldicarb; hydrogen sulfide; and tryptophan based on microarray and RNA-seq studies.

WB:WBGene00020775	T24E12.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; ubc-9; and acs-3 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00020777	T24E12.10
Is enriched in Z1.p; Z4.a; male distal tip cell; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; metformin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020778	T24E12.11
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020779	T24G10.2
Is predicted to have transcription factor binding activity.

WB:WBGene00020780	T24H5.1
No description available

WB:WBGene00020781	T24H7.2
Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human HYOU1 (hypoxia up-regulated 1).

WB:WBGene00020782	T24H7.3
Is enriched in germ line; germline precursor cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by Zidovudine; Atrazine; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Protein of unknown function (DUF727); GSKIP domain; GSKIP domain superfamily; and GSK3B-interacting protein. Is an ortholog of human GSKIP (GSK3B interacting protein).

WB:WBGene00020783	blos-4
Is involved in endosomal transport.

WB:WBGene00020784	tat-4
Is predicted to have ATPase-coupled intramembrane lipid transporter activity. Is involved in sterol metabolic process. Is expressed in hermaphrodite gonad; intestine; pharyngeal-intestinal valve; and rectal gland cell. Human ortholog(s) of this gene are implicated in benign recurrent intrahepatic cholestasis 1; intrahepatic cholestasis of pregnancy 1; and progressive familial intrahepatic cholestasis 1. Is an ortholog of human ATP10A (ATPase phospholipid transporting 10A (putative)); ATP10B (ATPase phospholipid transporting 10B (putative)); and ATP10D (ATPase phospholipid transporting 10D (putative)).

WB:WBGene00020785	T25B2.1
Is affected by several genes including rrf-3; clk-1; and bar-1 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00020786	T25B2.2
Is affected by several genes including daf-2; glp-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by sixteen chemicals including aldicarb; Ethanol; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020787	T25B6.1
Is affected by several genes including clk-1; eat-2; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Diazinon and Sirolimus based on microarray studies.

WB:WBGene00020788	nep-22
Is predicted to have metalloendopeptidase activity. Localizes to membrane raft. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2T; distal arthrogryposis type 5D; and essential hypertension.

WB:WBGene00020789	T25B6.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020790	T25B6.4
Is enriched in AFD; PLM; coelomocyte; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020791	T25B6.5
Is enriched in GABAergic neurons and body wall musculature based on tiling array and microarray studies. Is affected by several genes including elt-2; sir-2.1; and npr-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00020792	T25B6.6
Is enriched in OLL; PVD; intestine; and neurons based on microarray and RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and lem-2 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including Tunicamycin; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020793	T25D1.1
Is affected by several genes including eat-2; spr-5; and cyc-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020794	T25D1.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1258) and Protein of unknown function DUF1258.

WB:WBGene00020795	T25D1.3
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including eat-2; set-2; and lin-22 based on tiling array; microarray; and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020796	mrpl-28
Is predicted to be a structural constituent of ribosome. Is expressed in hypodermis and pharynx. Is an ortholog of human MRPL28 (mitochondrial ribosomal protein L28).

WB:WBGene00020797	T25D3.3
Is predicted to have cysteine synthase activity and pyridoxal phosphate binding activity.

WB:WBGene00020798	T25D3.4
Is predicted to have transmembrane transporter activity. Is an ortholog of human MFSD14A (major facilitator superfamily domain containing 14A) and MFSD14B (major facilitator superfamily domain containing 14B).

WB:WBGene00020799	T25D10.1
Is involved in innate immune response.

WB:WBGene00020800	zig-10
Is expressed in cholinergic neurons; head neurons; hypodermis; and seam cell. Is predicted to encode a protein with the following domains: Immunoglobulin domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin-like fold; Immunoglobulin-like domain superfamily; and Basigin-like.

WB:WBGene00020801	T25D10.4
Is enriched in AFD; ASER; PLM; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by sixteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00020802	btb-2
Is enriched in head mesodermal cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00020803	T25E4.1
Is enriched in DA neuron; GABAergic neurons; germ line; intestine; and pharynx based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5346) and Protein of unknown function DUF5346.

WB:WBGene00020804	T25E4.2
Is enriched in NSM based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including tryptophan; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T25E4.2-like.

WB:WBGene00020805	T25F10.1
Is affected by several genes including sir-2.1; sod-2; and mir-34 based on microarray and RNA-seq studies. Is affected by cadmium and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00020806	T25F10.3
Is enriched in DA neuron; GABAergic neurons; NSM; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fifteen chemicals including D-glucose; sesamin; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome. Is predicted to encode a protein with the following domain: EGF-like domain.

WB:WBGene00020807	T25F10.4
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; resveratrol; and Colistin based on microarray studies.

WB:WBGene00020808	clik-1
Is enriched in body wall muscle cell; body wall musculature; germ line; head mesodermal cell; and muscle cell based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; sir-2.1; and lin-35 based on RNA-seq; microarray; and proteomic studies. Is affected by fourteen chemicals including D-glucose; Aspirin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Calponin family repeat; and Calponin repeat.

WB:WBGene00020809	T25G12.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020811	T25G12.3
Is enriched in seam cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020812	acdh-7
Is predicted to have medium-chain-acyl-CoA dehydrogenase activity. Is expressed in anterior gonad arm. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 6; medium chain acyl-CoA dehydrogenase deficiency; and peroxisomal acyl-CoA oxidase deficiency. Is an ortholog of human ACADM (acyl-CoA dehydrogenase medium chain).

WB:WBGene00020813	T25G12.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; RNA-seq; and microarray studies. Is affected by ten chemicals including nicotine; stavudine; and Rifampin based on proteomic; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00020814	T25G12.8
No description available

WB:WBGene00020815	T25G12.9
No description available

WB:WBGene00020817	T25G12.11
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00020819	T26A5.2
Is enriched in germ line; germline precursor cell; head mesodermal cell; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00020820	algn-1
Is predicted to have mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ik. Is an ortholog of human ALG1 (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase).

WB:WBGene00020821	jhdm-1
Is predicted to have histone demethylase activity (H3-K36 specific) and metal ion binding activity. Human ortholog(s) of this gene are implicated in syndromic X-linked intellectual disability Siderius type. Is an ortholog of human KDM2B (lysine demethylase 2B).

WB:WBGene00020822	T26A5.6
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Zidovudine; antimycin; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transport protein Avl9 and AVL9/DENND6 domain. Is an ortholog of human AVL9 (AVL9 cell migration associated).

WB:WBGene00020823	T26A5.8
Is predicted to have chromatin DNA binding activity. Is expressed in body wall musculature; head neurons; intestine; tail neurons; and ventral nerve cord. Is an ortholog of human POLE3 (DNA polymerase epsilon 3, accessory subunit).

WB:WBGene00020824	T26A8.1
Is enriched in Psub3; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00020825	tmem-231
Is involved in non-motile cilium assembly. Localizes to ciliary transition zone. Is expressed in amphid neurons; ciliated neurons; inner labial neurons; outer labial neurons; and phasmid neurons. Is used to study Meckel syndrome and orofaciodigital syndrome. Human ortholog(s) of this gene are implicated in Joubert syndrome 20. Is an ortholog of human TMEM231 (transmembrane protein 231).

WB:WBGene00020826	T26A8.3
Is enriched in germ line; neurons; and in male based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020827	T26A8.4
Is predicted to have DNA-binding transcription factor activity. Is an ortholog of human ZC3H4 (zinc finger CCCH-type containing 4).

WB:WBGene00020828	T26C11.2
Is affected by several genes including rrf-3; aak-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00020829	T26C11.3
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies.

WB:WBGene00020830	T26C11.4
Is enriched in germ line; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and pmk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Cry5B; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00020831	T26C12.1
Is predicted to have lyase activity; magnesium ion binding activity; and thiamine pyrophosphate binding activity. Is an ortholog of human ILVBL (ilvB acetolactate synthase like).

WB:WBGene00020832	T26C12.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and cadmium based on microarray and RNA-seq studies.

WB:WBGene00020833	T26C12.3
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; Noonan syndrome 8; and autoimmune lymphoproliferative syndrome type 4.

WB:WBGene00020834	T27A1.2
Is enriched in AVK; germ line; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020835	T27A1.3
Is enriched in dopaminergic neurons; intestine; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00020836	lgc-34
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Localizes to plasma membrane. Is expressed in head and intestinal muscle.

WB:WBGene00020837	slc-36.2
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC36A4 (solute carrier family 36 member 4).

WB:WBGene00020838	trak-1
Is predicted to have myosin binding activity. Is expressed in several structures, including CAN; amphid neurons; hermaphrodite somatic gonadal cell; phasmid sensillum; and rectum. Is an ortholog of human TRAK1 (trafficking kinesin protein 1).

WB:WBGene00020839	usp-5
Is predicted to have cysteine-type endopeptidase activity and thiol-dependent ubiquitin-specific protease activity. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Y-linked spermatogenic failure 2; and non-syndromic X-linked intellectual disability. Is an ortholog of human USP13 (ubiquitin specific peptidase 13) and USP5 (ubiquitin specific peptidase 5).

WB:WBGene00020840	spch-3
Localizes to nuclear chromatin. Is expressed in sperm.

WB:WBGene00020841	T27A3.5
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human PTPN7 (protein tyrosine phosphatase non-receptor type 7).

WB:WBGene00020842	nmrk-1
Is predicted to have molybdopterin synthase activity. Human ortholog(s) of this gene are implicated in molybdenum cofactor deficiency type B. Is an ortholog of human MOCS2 (molybdenum cofactor synthesis 2).

WB:WBGene00020843	T27A3.7
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human NSMCE1 (NSE1 homolog, SMC5-SMC6 complex component).

WB:WBGene00020844	T27A10.2
Is enriched in AFD; GABAergic neurons; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; D-glucose; and metformin based on RNA-seq studies.

WB:WBGene00020845	T27A10.5
Is enriched in AVK based on RNA-seq studies. Is affected by rsr-2; mir-34; and sir-2.1 based on tiling array and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00020846	T27A10.6
Is expressed in seam cell. Is predicted to encode a protein with the following domain: .

WB:WBGene00020847	cgr-1
Localizes to cytoplasm. Is expressed in intestine. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is an ortholog of human SEC14L3 (SEC14 like lipid binding 3) and SEC14L4 (SEC14 like lipid binding 4).

WB:WBGene00020849	nhr-225
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020850	nhr-226
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in intestine.

WB:WBGene00020851	nhr-227
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00020852	nhr-228
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in head neurons; intestine; pharynx; and tail neurons.

WB:WBGene00020853	fbxa-137
Is enriched in AFD and BAG based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00020854	T27C4.1
Is enriched in Psub1; head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Rotenone; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Neurensin; and Neurensin.

WB:WBGene00020855	hpo-36
Is affected by several genes including age-1; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; manganese chloride; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00020856	srt-61
Is affected by several genes including daf-16; daf-12; and mex-3 based on RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00020857	srt-62
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-12; bar-1; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00020858	mop-25.3
Is enriched in AVK; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mo25-like; Armadillo-like helical; Mo25-like; and Armadillo-type fold.

WB:WBGene00020859	bath-25
Is affected by several genes including glp-1; skn-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00020860	nspd-10
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00020861	T27E4.1
Is predicted to have several functions, including SNARE binding activity; calcium ion binding activity; and phospholipid binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 11.

WB:WBGene00020862	fip-2
Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Ethanol; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00020863	T27E4.5
Is predicted to have peptidase inhibitor activity.

WB:WBGene00020864	oac-50
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including hydrogen sulfide; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Nose resistant-to-fluoxetine protein, N-terminal.

WB:WBGene00020865	T27E4.7
Is enriched in AFD; BAG; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00020866	vps-24
Is enriched in germ line; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies. Human RNF103-CHMP3 exhibits identical protein binding activity; phosphatidylcholine binding activity; and ubiquitin-specific protease binding activity. Is predicted to encode a protein with the following domains: Snf7 and Snf7 family. Is an ortholog of human RNF103-CHMP3 (RNF103-CHMP3 readthrough).

WB:WBGene00020867	shc-2
Is enriched in dopaminergic neurons; hypodermis; mechanosensory neurons; muscle cell; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SH2 domain; SH2 domain; and SH2 domain superfamily.

WB:WBGene00020868	eif-1
Is predicted to have ribosomal small subunit binding activity and translation initiation factor activity. Is expressed in head and tail. Is an ortholog of human EIF1B (eukaryotic translation initiation factor 1B).

WB:WBGene00020869	T28A11.2
Is enriched in PLM; body wall muscle cell; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including 1-methylnicotinamide; Rotenone; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020870	T28A11.3
Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020871	T28A11.4
Is enriched in dopaminergic neurons; muscle cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including copper sulfate; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020872	T28A11.5
Is enriched in GABAergic neurons; body wall muscle cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including npr-1; lin-35; and bar-1 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Mercuric Chloride; and paraquat based on microarray and RNA-seq studies.

WB:WBGene00020873	T28A11.6
Is enriched in DA neuron; VA neuron; body wall muscle cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00020874	srbc-5
Is affected by rrf-3 and let-60 based on microarray studies. Is affected by Chlorpyrifos and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00020875	T28A11.13
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including sir-2.1; lin-35; and lin-15B based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00020876	T28A11.14
No description available

WB:WBGene00020877	srt-63
Is expressed in neurons. Is predicted to encode a protein with the following domain: 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00020878	T28A11.16
Is enriched in body wall muscle cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Mercuric Chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020879	T28A11.17
Is enriched in NSM based on tiling array studies. Is affected by several genes including age-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020880	T28A11.18
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; paraquat; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020881	T28A11.19
Is enriched in coelomocyte; dopaminergic neurons; mechanosensory neurons; muscle cell; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Mercuric Chloride; Tunicamycin; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00020882	T28A11.20
Is affected by several genes including daf-16; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020883	fbxa-64
Is expressed in body wall musculature; ventral nerve cord; and vulval muscle. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00020884	T28B4.1
Is predicted to contribute to ubiquitin protein ligase activity. Is expressed in body wall musculature and vulval muscle.

WB:WBGene00020885	T28B4.2
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including eat-2; aak-2; and smg-2 based on tiling array and RNA-seq studies. Is affected by seven chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020886	ttr-6
Localizes to nucleus.

WB:WBGene00020887	hic-1
Is expressed in cholinergic neurons; head; tail; and ventral nerve cord. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00020888	T28C12.1
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00020889	T28C12.2
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00020890	fbxa-202
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; HTH domain in Mos1 transposase; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00020891	cest-24
Is predicted to have carboxylic ester hydrolase activity. Is expressed in hypodermis and seam cell. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8.

WB:WBGene00020892	T28C12.5
Is expressed in neurons.

WB:WBGene00020893	T28C12.6
Is predicted to have peptidase inhibitor activity.

WB:WBGene00020894	T28D9.1
Is enriched in cholinergic neurons; germ line; pharyngeal neurons; retrovesicular ganglion; and somatic gonad precursor based on Chronogram; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by six chemicals including Rotenone; Linolenic Acids; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020895	plpp-1.2
Is predicted to have lipid phosphatase activity and phosphatidate phosphatase activity. Is an ortholog of human PLPP3 (phospholipid phosphatase 3).

WB:WBGene00020896	T28D9.4
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; let-7; and dpy-10 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by nine chemicals including Rotenone; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00020897	del-10
Is predicted to have sodium channel activity.

WB:WBGene00020898	lido-16
Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including methylmercuric chloride; Mercuric Chloride; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ras-mediated vulval-induction antagonist and Protein LIN-8.

WB:WBGene00020899	T28D9.11
Is affected by several genes including daf-16; clk-1; and lin-39 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00020900	T28F2.1
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00020901	T28F2.2
Is enriched in intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; npr-1; and lin-35 based on quantitative PCR; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human COMMD4 (COMM domain containing 4).

WB:WBGene00020902	jmjc-1
Is predicted to have histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K4 specific); and iron ion binding activity. Is involved in several processes, including response to ethanol; response to heat; and response to osmotic stress. Is an ortholog of human RIOX1 (ribosomal oxygenase 1).

WB:WBGene00020903	acd-5
Is predicted to have sodium channel activity. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of several human genes including ASIC1 (acid sensing ion channel subunit 1); ASIC2 (acid sensing ion channel subunit 2); and ASIC3 (acid sensing ion channel subunit 3).

WB:WBGene00020904	T28F12.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including aak-2; isp-1; and sod-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Rotenone and paraquat based on RNA-seq and microarray studies.

WB:WBGene00020905	T28H11.7
Is enriched in excretory cell; intestine; muscle cell; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00020906	T28H11.8
Is predicted to have transmembrane transporter activity. Is expressed in excretory cell.

WB:WBGene00020908	VC5.2
Is enriched in GABAergic neurons; body wall musculature; male-specific anatomical entity; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Laminin EGF domain; Nematode polyprotein allergen ABA-1; EGF-like domain; Laminin EGF domain; Polyprotein allergen, nematode; and DVA-1 superfamily.

WB:WBGene00020909	W01A11.1
Is predicted to have cis-stilbene-oxide hydrolase activity. Is an ortholog of human EPHX1 (epoxide hydrolase 1).

WB:WBGene00020910	dgtr-1
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Localizes to sarcoplasmic reticulum. Is an ortholog of human MOGAT1 (monoacylglycerol O-acyltransferase 1).

WB:WBGene00020911	cpt-6
Is predicted to have carnitine O-palmitoyltransferase activity. Is expressed in hypodermis. Is an ortholog of human CPT1A (carnitine palmitoyltransferase 1A); CPT1B (carnitine palmitoyltransferase 1B); and CPT1C (carnitine palmitoyltransferase 1C).

WB:WBGene00020912	W01A11.7
Is enriched in AFD; dopaminergic neurons; excretory cell; intestine; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Lithium Chloride; aldicarb; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00020913	W01B11.1
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00020914	sulp-6
Is predicted to have transmembrane transporter activity. Is expressed in intestine. Human ortholog(s) of this gene are implicated in several diseases, including Pendred Syndrome; autosomal recessive nonsyndromic deafness (multiple); and osteochondrodysplasia (multiple). Is an ortholog of several human genes including SLC26A1 (solute carrier family 26 member 1); SLC26A2 (solute carrier family 26 member 2); and SLC26A4 (solute carrier family 26 member 4).

WB:WBGene00020915	nol-58
Is predicted to have snoRNA binding activity. Is an ortholog of human NOP58 (NOP58 ribonucleoprotein).

WB:WBGene00020917	W01B11.6
Is enriched in coelomocyte; germline precursor cell; head mesodermal cell; muscle cell; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-three chemicals including Rotenone; 4-bromodiphenyl ether; and levamisole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin domain; and Thioredoxin-like superfamily.

WB:WBGene00020918	W01C8.1
Is enriched in GABAergic neurons; excretory cell; and neurons based on tiling array studies. Is affected by several genes including daf-2; let-60; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00020919	set-19
Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Kleefstra syndrome 2; Sotos syndrome; and autosomal dominant non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domains: SET domain and SET domain.

WB:WBGene00020920	set-20
Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 2; and autosomal dominant non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domain: SET domain.

WB:WBGene00020921	W01C8.5
Is enriched in OLL; PVD; intestine; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in thrombophilia. Is predicted to encode a protein with the following domains: Electron transfer DM13 and DM13 domain.

WB:WBGene00020922	W01H2.2
Is enriched in DA neuron; GABAergic neurons; VA neuron; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and lin-39 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00020923	W02B3.3
Is enriched in NSM and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-12; clk-1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and allantoin based on microarray studies.

WB:WBGene00020924	W02B3.4
Is enriched in NSM; intestine; and somatic gonad precursor based on Chronogram; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1X and muscular dystrophy (multiple). Is predicted to encode a protein with the following domain: Fukutin-related. Is an ortholog of human FKTN (fukutin).

WB:WBGene00020927	W02B3.7
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including clk-1; sir-2.1; and rrf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Sirolimus; and fluoranthene based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1X and muscular dystrophy (multiple). Is predicted to encode a protein with the following domain: Fukutin-related. Is an ortholog of human FKTN (fukutin).

WB:WBGene00020929	W02C12.2
Is enriched in body wall musculature; intestine; neurons; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and mab-5 based on microarray and RNA-seq studies. Is affected by nine chemicals including diallyl trisulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00020930	hlh-30
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Is involved in several processes, including defense response to bacterium; determination of adult lifespan; and positive regulation of transcription by RNA polymerase II. Localizes to cytoplasm and nucleus. Is expressed in several structures, including nerve ring; rectal valve cell; somatic cell; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in Tietz syndrome; Waardenburg syndrome type 2A; and renal cell carcinoma. Is an ortholog of human MITF (melanocyte inducing transcription factor) and TFEB (transcription factor EB).

WB:WBGene00020931	cytb-5.2
Is predicted to have heme binding activity and metal ion binding activity. Is an ortholog of human CYB5A (cytochrome b5 type A).

WB:WBGene00020932	dhod-1
Is predicted to have dihydroorotate dehydrogenase activity. Human ortholog(s) of this gene are implicated in postaxial acrofacial dysostosis. Is an ortholog of human DHODH (dihydroorotate dehydrogenase (quinone)).

WB:WBGene00020933	W02D3.4
Is predicted to have carbohydrate transmembrane transporter activity. Is an ortholog of human TMEM144 (transmembrane protein 144).

WB:WBGene00020935	fnci-1
Is predicted to have DNA polymerase binding activity. Human ortholog(s) of this gene are implicated in Fanconi anemia complementation group I. Is an ortholog of human FANCI (FA complementation group I).

WB:WBGene00020936	hrpf-1
Is predicted to have RNA binding activity. Is expressed widely. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 109 and schizophrenia 19. Is an ortholog of human HNRNPF (heterogeneous nuclear ribonucleoprotein F); HNRNPH1 (heterogeneous nuclear ribonucleoprotein H1); and HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2).

WB:WBGene00020937	W02D3.12
Is enriched in OLL; PVD; body wall muscle cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1674) and Succinate dehydrogenase assembly factor 4. Is an ortholog of human SDHAF4 (succinate dehydrogenase complex assembly factor 4).

WB:WBGene00020938	clec-218
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00020939	W02D7.3
Is enriched in PLM; amphid sheath cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020940	W02D7.4
Is predicted to have N-acetyltransferase activity.

WB:WBGene00020941	W02D7.5
Is predicted to have N-acetyltransferase activity.

WB:WBGene00020942	W02D7.6
Is enriched in germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00020943	W02D7.8
Is enriched in FLP; intestine; and neurons based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including methylmercuric chloride; Cry5B; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00020944	W02D7.9
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by several genes including clk-1; aak-2; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020945	clec-219
Is predicted to have carbohydrate binding activity. Is expressed in vas deferens.

WB:WBGene00020946	W02D7.11
Is enriched in GABAergic neurons; OLL; PVD; dopaminergic neurons; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Zidovudine; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00020947	W02F12.2
Is predicted to have N-acylsphingosine amidohydrolase activity. Is an ortholog of human ACER1 (alkaline ceramidase 1) and ACER2 (alkaline ceramidase 2).

WB:WBGene00020948	era-1
Is expressed in several structures, including AB; AB lineage cell; ABa; ABp; and germ line.

WB:WBGene00020949	W02F12.4
Is predicted to have 3'-5'-exodeoxyribonuclease activity. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome; lupus erythematosus (multiple); and retinal vasculopathy with cerebral leukodystrophy. Is an ortholog of human TREX1 (three prime repair exonuclease 1) and TREX2 (three prime repair exonuclease 2).

WB:WBGene00020950	dlst-1
Is predicted to have dihydrolipoyllysine-residue succinyltransferase activity. Is an ortholog of human DLST (dihydrolipoamide S-succinyltransferase).

WB:WBGene00020951	sna-1
Is predicted to have transcription coregulator activity.

WB:WBGene00020952	kel-8
Is involved in protein ubiquitination and ubiquitin-dependent protein catabolic process. Localizes to several cellular components, including Cul3-RING ubiquitin ligase complex; neuronal cell body; and postsynaptic density. Is expressed in command interneuron and intestine. Is an ortholog of human KLHL8 (kelch like family member 8).

WB:WBGene00020953	W02G9.3
Is predicted to have RNA binding activity. Is an ortholog of human THUMPD1 (THUMP domain containing 1).

WB:WBGene00020954	W02G9.4
Is enriched in intestine; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Heme; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CUB domain; CUB domain; and Spermadhesin, CUB domain superfamily. Is an ortholog of human CDCP2 (CUB domain containing protein 2) and NRP2 (neuropilin 2).

WB:WBGene00020955	angl-1
Is predicted to have 3'-5'-exoribonuclease activity. Is expressed in PDB; body wall musculature; intestine; pharyngeal muscle cell; and ventral cord neurons. Is an ortholog of human ANGEL1 (angel homolog 1).

WB:WBGene00020957	W02H5.2
Is predicted to have actin filament binding activity.

WB:WBGene00020958	W02H5.3
No description available

WB:WBGene00020959	W02H5.4
No description available

WB:WBGene00020961	sknr-1
Is predicted to have DNA binding activity. Is an ortholog of human NFE2L1 (nuclear factor, erythroid 2 like 1) and NFE2L2 (nuclear factor, erythroid 2 like 2).

WB:WBGene00020962	W02H5.8
Is predicted to have glycerone kinase activity. Is an ortholog of human TKFC (triokinase and FMN cyclase).

WB:WBGene00020964	polq-1
Is predicted to have ATP binding activity; DNA binding activity; and DNA-directed DNA polymerase activity. Is involved in base-excision repair, gap-filling and cellular response to ionizing radiation. Is an ortholog of human POLQ (DNA polymerase theta).

WB:WBGene00020966	W03A5.1
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including bone development disease (multiple); gastrointestinal system cancer (multiple); and hematologic cancer (multiple).

WB:WBGene00020967	W03A5.2
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family and Frag1/DRAM/Sfk1. Is an ortholog of human TMEM150B (transmembrane protein 150B).

WB:WBGene00020970	W03A5.6
Is enriched in AVK; NSM; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and lin-28 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rotenone; Chlorpyrifos; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Guanylate-kinase-associated protein (GKAP) protein and SAPAP family.

WB:WBGene00020971	W03B1.1
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including methylmercuric chloride; Sodium Chloride; and metformin based on microarray and RNA-seq studies.

WB:WBGene00020972	trpl-2
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and intestine based on RNA-seq studies. Is affected by several genes including let-60; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00020973	W03B1.3
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00020974	W03B1.5
Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00020976	oac-51
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00020977	oac-52
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00020978	W03B1.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including methylmercuric chloride; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00020979	fbxb-55
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020981	W03D2.6
Is enriched in OLL; PVD; and intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Rotenone; manganese chloride; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00020982	ilys-6
Is predicted to have lysozyme activity. Is expressed in coelomocyte; intestine; and pharyngeal gland cell.

WB:WBGene00020983	W03D2.9
Is enriched in AFD and hypodermis based on RNA-seq studies. Is affected by several genes including rrf-3; let-7; and dpy-10 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020984	W03D8.1
Is enriched in muscle cell and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including D-glucose; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00020985	W03D8.2
Is predicted to have protein serine/threonine phosphatase activity. Is an ortholog of human PPP1CA (protein phosphatase 1 catalytic subunit alpha).

WB:WBGene00020986	W03D8.3
Is enriched in NSM; germ line; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00020987	W03D8.5
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00020988	W03D8.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Alovudine; Sodium Chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00020989	W03D8.8
Is predicted to have acyl-CoA hydrolase activity. Is an ortholog of human ACOT4 (acyl-CoA thioesterase 4).

WB:WBGene00020990	W03D8.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-four chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Interactor of ZYG-11 and Protein of unknown function DUF856, Caenorhabditis species.

WB:WBGene00020991	W03D8.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; D-glucose; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00020992	W03F8.2
Is enriched in neurons; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00020993	W03F8.3
Is predicted to have ribosome binding activity and translation release factor activity, codon specific. Is an ortholog of human MTRF1L (mitochondrial translational release factor 1 like).

WB:WBGene00020994	W03F8.4
Is enriched in germ line; germline precursor cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; bisphenol S; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Galloway-Mowat syndrome 5. Is predicted to encode a protein with the following domains: Kinase binding protein CGI-121; CGI121/TPRKB; and CGI121/TPRKB superfamily. Is an ortholog of human TPRKB (TP53RK binding protein).

WB:WBGene00020995	W03F8.6
Is enriched in ALM and PLM based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Ethanol; Rotenone; and Neurotoxins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00020997	gpa-18
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple).

WB:WBGene00020999	W03F9.1
Is predicted to have zinc ion binding activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is an ortholog of human ZPR1 (ZPR1 zinc finger).

WB:WBGene00021000	W03F9.2
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021001	W03F9.3
Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00021002	W03F9.4
Is predicted to have carnitine O-palmitoyltransferase activity.

WB:WBGene00021003	W03F9.9
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; lin-15B; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by resveratrol and cadmium based on microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00021004	sftb-2
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF382); PSP; PSP, proline-rich; and Domain of unknown function DUF382. Is an ortholog of human SF3B2 (splicing factor 3b subunit 2).

WB:WBGene00021005	ule-1
Is predicted to have chitin binding activity.

WB:WBGene00021006	dct-9
Is enriched in GABAergic neurons; germ line; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00021007	W03F11.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00021008	W03F11.5
Is enriched in body wall musculature and seam cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Heme; methylmercuric chloride; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00021009	afd-1
Is predicted to have cell adhesion molecule binding activity. Is an ortholog of human AFDN (afadin, adherens junction formation factor).

WB:WBGene00021010	W03G1.2
Is enriched in OLL; PVD; body wall muscle cell; and in male based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF851) and Protein of unknown function DUF851.

WB:WBGene00021011	W03G1.5
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Mercuric Chloride; Tunicamycin; and Cadmium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Uncharacterized Strongylid L4 protein and Uncharacterized strongylid L4 protein.

WB:WBGene00021012	pig-1
Is predicted to have non-membrane spanning protein tyrosine kinase activity and protein serine/threonine kinase activity. Is involved in several processes, including generation of neurons; hemidesmosome assembly; and regulation of apoptotic process. Localizes to centrosome and cytoplasm. Is expressed in several structures, including AVM; QL.aa; QL.pp; QR.aa; and nerve ring neurons. Is an ortholog of human MELK (maternal embryonic leucine zipper kinase).

WB:WBGene00021013	W03G1.8
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00021014	pid-4
Is enriched in several structures, including I5 neuron; cholinergic neurons; germ line; germline precursor cell; and head mesodermal cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021015	enu-3.3
Is enriched in germ line; germline precursor cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021016	W03G9.5
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00021017	cil-7
Localizes to several cellular components, including ciliary base; neuronal cell body; and non-motile cilium. Is expressed in ciliated neurons.

WB:WBGene00021018	W04B5.1
Is enriched in several structures, including ASER; excretory cell; head mesodermal cell; intestine; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021019	W04B5.2
Is enriched in head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including aldicarb; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00021020	W04B5.3
Is predicted to have carbohydrate binding activity.

WB:WBGene00021021	mrpl-30
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL30 (mitochondrial ribosomal protein L30).

WB:WBGene00021022	W04B5.5
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in autoimmune lymphoproliferative syndrome type 3 and type 2 diabetes mellitus. Is an ortholog of human PDPK1 (3-phosphoinositide dependent protein kinase 1).

WB:WBGene00021023	W04B5.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00021024	W04C9.2
Is enriched in several structures, including ASER; NSM; germ line; germline precursor cell; and intestine based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; Rifampin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MICOS complex subunit MIC13, QIL1 and MICOS complex subunit Mic13.

WB:WBGene00021025	cutl-13
Is enriched in intestine based on microarray studies. Is affected by several genes including skn-1; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00021026	W04C9.4
Localizes to nucleolus.

WB:WBGene00021027	W04C9.5
Is predicted to have GTP binding activity and calcium channel regulator activity.

WB:WBGene00021028	W04C9.6
Is predicted to have transmembrane transporter activity.

WB:WBGene00021029	W04D12.1
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-12; clk-1; and nhr-25 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00021030	W04H10.1
Is affected by several genes including daf-12; eat-2; and isp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021031	W04H10.2
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021032	clec-118
Is predicted to have carbohydrate binding activity.

WB:WBGene00021033	srz-32
Is expressed in ADLL; ADLR; ASHL; and ASHR. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00021034	enu-3.4
Is enriched in AVG; RIM; command interneuron; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00021035	W05F2.3
Is expressed in germ line.

WB:WBGene00021036	W05F2.4
Is expressed in body wall musculature and vulval muscle. Is predicted to encode a protein with the following domain: .

WB:WBGene00021037	fbxa-203
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including manganese chloride; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021038	W05F2.6
Is enriched in germ line; germline precursor cell; head mesodermal cell; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and elt-2 based on microarray; RNA-seq; and proteomic studies. Is affected by ten chemicals including manganese chloride; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021039	W05F2.7
Is enriched in interfacial epithelial cell; neurons; pharyngeal-intestinal valve cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including glp-1; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Rotenone; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00021040	W05G11.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; manganese chloride; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in multiple myeloma and von Hippel-Lindau disease. Is an ortholog of human CCNA1 (cyclin A1).

WB:WBGene00021041	clp-10
Is predicted to have calcium-dependent cysteine-type endopeptidase activity. Is an ortholog of human CAPN15 (calpain 15).

WB:WBGene00021042	btb-5
Is enriched in AVK and GABAergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00021043	pck-1
Is predicted to have manganese ion binding activity and phosphoenolpyruvate carboxykinase (GTP) activity. Localizes to cytosol and striated muscle dense body. Is an ortholog of human PCK1 (phosphoenolpyruvate carboxykinase 1) and PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial).

WB:WBGene00021044	W05H7.1
Is enriched in muscle cell and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00021045	W05H7.2
Is affected by several genes including daf-16; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Chlorpyrifos; Diazinon; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00021046	sedl-1
Is enriched in germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including allantoin; metformin; and Sirolimus based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondyloepiphyseal dysplasia tarda. Is predicted to encode a protein with the following domains: Sedlin, N-terminal conserved region; Trafficking protein particle complex subunit 2; and Longin-like domain superfamily. Is an ortholog of human TRAPPC2 (trafficking protein particle complex 2).

WB:WBGene00021047	zfp-3
Is predicted to have DNA-binding transcription factor activity. Localizes to nucleus.

WB:WBGene00021048	W05H9.1
Is enriched in germ line; head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on proteomic; Chronogram; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twenty-five chemicals including tryptophan; Tunicamycin; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00021049	W05H9.2
Is enriched in germ line; neurons; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; stavudine; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00021050	W05H9.3
Is enriched in several structures, including body wall muscle cell; coelomocyte; excretory cell; intestine; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021051	W05H9.4
Is enriched in EMS; Psub1; germ line; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; fog-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021052	W06A11.1
Is enriched in PLM; amphid sheath cell; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021053	gadr-4
Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; indole; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00021054	fbxb-118
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021055	W06A11.4
Is expressed in intestinal cell.

WB:WBGene00021056	W06B4.1
Is predicted to have N-acetylglucosamine kinase activity. Is an ortholog of human NAGK (N-acetylglucosamine kinase).

WB:WBGene00021057	W06B4.2
Is predicted to have N-acetylglucosamine kinase activity. Is an ortholog of human NAGK (N-acetylglucosamine kinase).

WB:WBGene00021058	vps-18
Is predicted to have protein-macromolecule adaptor activity. Is involved in endosome organization; phagosome-lysosome fusion involved in apoptotic cell clearance; and regulation of endosome size. Localizes to cytoplasm. Is expressed in body wall musculature; coelomocyte; hermaphrodite gonad; hypodermis; and intestine. Is an ortholog of human VPS18 (VPS18 core subunit of CORVET and HOPS complexes).

WB:WBGene00021059	atat-2
Exhibits tubulin N-acetyltransferase activity. Is involved in protein acetylation and thigmotaxis. Is expressed in ciliated neurons and touch receptor neurons. Is an ortholog of human ATAT1 (alpha tubulin acetyltransferase 1).

WB:WBGene00021060	dct-11
Is enriched in AFD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; Cry5B; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021061	W06E11.1
Is enriched in AVA; body wall muscle cell; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rotenone; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Sin-like protein conserved region; and DNA-directed RNA polymerase III subunit Rpc5. Is an ortholog of human POLR3E (RNA polymerase III subunit E).

WB:WBGene00021063	sbds-1
Is enriched in body wall muscle cell; coelomocyte; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by six chemicals including aldicarb; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in Shwachman-Diamond syndrome and aplastic anemia. Is predicted to encode a protein with the following domains: Shwachman-Bodian-Diamond syndrome (SBDS) protein; SBDS protein C-terminal domain; Ribosome maturation protein Sdo1/SBDS; Ribosome maturation protein SBDS, C-terminal; Ribosome maturation protein SBDS, N-terminal; Ribosome maturation protein SBDS, N-terminal domain superfamily; Ribosome maturation protein Sdo1/SBDS, central domain superfamily; and Ribosome maturation protein Sdo1/SBDS-like. Is an ortholog of human SBDS (SBDS ribosome maturation factor).

WB:WBGene00021066	W06H8.2
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00021067	W06H8.4
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00021068	W06H8.6
Is expressed in body wall musculature; pharyngeal muscle cell; and vulval muscle.

WB:WBGene00021070	cpr-8
Is predicted to have cysteine-type peptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00021072	W07B8.4
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis. Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00021073	nol-2
Is predicted to have rRNA (cytosine-C5-)-methyltransferase activity. Is expressed widely. Is an ortholog of human NOP2 (NOP2 nucleolar protein).

WB:WBGene00021074	W07E6.2
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including allantoin; Rifampin; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; G-protein, beta subunit; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; and WD40-repeat-containing domain superfamily. Is an ortholog of human NLE1 (notchless homolog 1).

WB:WBGene00021075	sms-5
Is predicted to have ceramide cholinephosphotransferase activity and sphingomyelin synthase activity. Is an ortholog of human SGMS1 (sphingomyelin synthase 1) and SGMS2 (sphingomyelin synthase 2).

WB:WBGene00021076	W07E6.5
Is enriched in germ line; germline precursor cell; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by seven chemicals including Mianserin; stavudine; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021077	W07E6.6
No description available

WB:WBGene00021078	unc-132
Is predicted to have GTP binding activity; phosphatidic acid binding activity; and phosphatidylinositol binding activity.

WB:WBGene00021079	W08A12.2
Is enriched in ALM; PLM; body wall muscle cell; body wall musculature; and muscle cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; D-glucose; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00021080	W08A12.3
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-16; age-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021081	pals-33
Is enriched in body wall muscle cell; excretory cell; intestine; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including tryptophan; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00021082	zip-11
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity.

WB:WBGene00021083	W08E12.2
Is enriched in DA neuron; NSM; and male-specific anatomical entity based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021084	W08E12.3
Is expressed in pm8. Is predicted to encode a protein with the following domain: .

WB:WBGene00021085	W08E12.4
Is expressed in pharynx and pm8. Is predicted to encode a protein with the following domain: .

WB:WBGene00021086	W08E12.5
Is enriched in DA neuron; intestine; male-specific anatomical entity; and pharynx based on microarray; Chronogram; and RNA-seq studies. Is affected by several genes including dpy-10; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Neurotoxins; Heme; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021087	W08E12.6
Is enriched in DA neuron based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021088	W08E12.7
Is predicted to have nucleic acid binding activity. Is expressed in gonad and pharynx. Is an ortholog of human PA2G4 (proliferation-associated 2G4).

WB:WBGene00021089	W08E12.8
Is enriched in Z1.p; Z4.a; male distal tip cell; sensory neurons; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including nicotinic acid; D-glucose; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00021090	W08E12.9
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including rrf-3; sir-2.1; and his-72 based on RNA-seq and microarray studies. Is affected by methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021091	W08F4.1
Is affected by cyc-1; ahr-1; and eat-2 based on microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021092	fbxb-34
Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00021093	W08F4.3
Is expressed in tail. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 16 and distal spinal muscular atrophy 2. Is predicted to encode a protein with the following domains: ERG2 and Sigma1 receptor like protein and ERG2/sigma1 receptor-like. Is an ortholog of human SIGMAR1 (sigma non-opioid intracellular receptor 1).

WB:WBGene00021094	W08F4.5
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00021095	mlt-8
Is predicted to have enzyme activator activity. Is expressed in hypodermal cell.

WB:WBGene00021096	W08F4.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and hsp-6 based on microarray and RNA-seq studies. Is affected by D-glucose and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00021097	cdc-37
Is predicted to have chaperone binding activity; heat shock protein binding activity; and unfolded protein binding activity. Localizes to condensed chromosome; cytoplasm; and mitotic spindle. Is expressed in anchor cell. Is an ortholog of human CDC37 (cell division cycle 37, HSP90 cochaperone).

WB:WBGene00021098	fbxb-14
Is enriched in DA neuron; I5 neuron; SAB; VA neuron; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021099	W08F4.10
Is affected by several genes including clk-1; hpl-2; and spn-4 based on tiling array; microarray; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021100	W08F4.11
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00021101	W08F4.12
Is enriched in body wall muscle cell; neurons; and retrovesicular ganglion based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and sodium arsenite based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021103	eri-3
Is involved in spermatogenesis.

WB:WBGene00021104	W09B6.4
Is enriched in intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including hydrogen sulfide; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00021106	W09B7.1
Is expressed in intestinal cell.

WB:WBGene00021107	W09B7.2
Is expressed in intestinal cell.

WB:WBGene00021108	W09B7.3
Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00021109	W09C3.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00021110	W09C3.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including aldicarb; hydrogen sulfide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00021111	W09C3.3
Is enriched in neurons; retrovesicular ganglion; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00021112	W09C3.4
Is predicted to have DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR3F (RNA polymerase III subunit F).

WB:WBGene00021113	gsp-3
Is predicted to have protein serine/threonine phosphatase activity. Is involved in several processes, including amoeboid sperm motility; male meiosis chromosome segregation; and oviposition. Localizes to cytoplasm; nuclear chromatin; and pseudopodium. Is expressed in sperm. Is an ortholog of human PPP1CA (protein phosphatase 1 catalytic subunit alpha).

WB:WBGene00021114	W09C3.7
Is enriched in germ line; head mesodermal cell; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021115	W09C3.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including manganese chloride; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021116	ncs-6
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 14 and retinitis pigmentosa 48.

WB:WBGene00021117	clec-126
Is predicted to have carbohydrate binding activity.

WB:WBGene00021118	clec-125
Is predicted to have carbohydrate binding activity.

WB:WBGene00021120	W09G12.6
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021121	W09G12.7
Is enriched in OLL; PVD; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including Nitric Oxide; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021122	W09G12.8
Is affected by several genes including clk-1; pgl-1; and hsp-6 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Peptide N glycanase, PAW domain and Galactose-binding-like domain superfamily.

WB:WBGene00021123	W09G12.9
Is enriched in germline precursor cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00021124	W10C4.1
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00021125	ccb-2
Is predicted to have high voltage-gated calcium channel activity. Is expressed in head neurons and ventral nerve cord. Human ortholog(s) of this gene are implicated in Brugada syndrome 4; episodic ataxia type 5; and idiopathic generalized epilepsy 9. Is an ortholog of several human genes including CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2); CACNB3 (calcium voltage-gated channel auxiliary subunit beta 3); and CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4).

WB:WBGene00021127	W10C8.4
Is predicted to have glutathione transferase activity.

WB:WBGene00021128	W10C8.5
Is predicted to have creatine kinase activity. Is an ortholog of human CKMT2 (creatine kinase, mitochondrial 2).

WB:WBGene00021129	W10D9.1
Is enriched in pharynx based on microarray studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00021130	W10D9.2
Is affected by several genes including daf-2; sir-2.1; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021131	W10D9.3
Is enriched in body wall muscle cell; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; isp-1; and hlh-30 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4796) and Protein of unknown function DUF4796. Is an ortholog of human MKRN2OS (MKRN2 opposite strand).

WB:WBGene00021132	nfyb-1
Is predicted to contribute to RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including excretory cell; gonad; head neurons; and oocyte. Is an ortholog of human NFYB (nuclear transcription factor Y subunit beta).

WB:WBGene00021133	tomm-22
Is enriched in AFD; PLM; and germ line based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial import receptor subunit Tom22 and Mitochondrial import receptor subunit Tom22. Is an ortholog of human TOMM22 (translocase of outer mitochondrial membrane 22).

WB:WBGene00021134	W10G11.1
Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00021135	W10G11.2
Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rifampin; Mianserin; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00021136	W10G11.3
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rifampin; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00021137	W10G11.4
Is affected by several genes including clk-1; alg-1; and mex-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including tryptophan; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00021138	clec-127
Is predicted to have carbohydrate binding activity.

WB:WBGene00021139	clec-128
Is predicted to have carbohydrate binding activity.

WB:WBGene00021140	clec-131
Is affected by cyc-1 and rsr-2 based on microarray and tiling array studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00021141	clec-134
Is affected by several genes including rrf-3; eat-2; and sma-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; C-type lectin-like/link domain superfamily; and C-type lectin fold.

WB:WBGene00021142	clec-133
Is predicted to have carbohydrate binding activity.

WB:WBGene00021143	clec-132
Is predicted to have carbohydrate binding activity.

WB:WBGene00021144	clec-130
Is predicted to have carbohydrate binding activity.

WB:WBGene00021145	clec-129
Is predicted to have carbohydrate binding activity.

WB:WBGene00021146	lgc-45
Is predicted to contribute to chloride channel activity.

WB:WBGene00021148	W10G11.19
Is enriched in AFD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by eight chemicals including Lithium Chloride; Zidovudine; and paraquat based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Thioredoxin-like superfamily and Thioredoxin domain-containing protein 16.

WB:WBGene00021149	dnc-3
Localizes to dynactin complex.

WB:WBGene00021150	Y1B5A.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00021151	Y4C6A.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; manganese chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00021152	mgl-3
Is predicted to have group III metabotropic glutamate receptor activity. Is involved in positive regulation of lipid storage. Is expressed in NSM; head neurons; and nerve ring. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1B. Is an ortholog of human GRM6 (glutamate metabotropic receptor 6); GRM7 (glutamate metabotropic receptor 7); and GRM8 (glutamate metabotropic receptor 8).

WB:WBGene00021153	Y4C6A.3
Is predicted to have metal ion binding activity.

WB:WBGene00021154	Y4C6A.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; let-60; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; manganese chloride; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021155	Y4C6B.1
Is enriched in several structures, including Z4.a; arcade cell; germ line; male distal tip cell; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021156	Y4C6B.2
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC38A8 (solute carrier family 38 member 8).

WB:WBGene00021157	Y4C6B.3
Is predicted to have transmembrane transporter activity.

WB:WBGene00021158	Y4C6B.4
Is predicted to have transmembrane transporter activity.

WB:WBGene00021159	slc-46A
Is predicted to have transmembrane transporter activity. Is expressed in intestine and pharyngeal neurons. Human ortholog(s) of this gene are implicated in hereditary folate malabsorption. Is an ortholog of human SLC46A1 (solute carrier family 46 member 1) and SLC46A3 (solute carrier family 46 member 3).

WB:WBGene00021160	gba-4
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in Gaucher's disease (multiple); Lewy body dementia; and late onset Parkinson's disease. Is an ortholog of human GBA (glucosylceramidase beta).

WB:WBGene00021161	Y4C6B.7
Is enriched in body wall muscle cell; dopaminergic neurons; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021162	Y5H2A.1
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Heme; methylmercuric chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00021163	nhr-275
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00021164	svh-11
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity. Is involved in positive regulation of axon regeneration.

WB:WBGene00021165	Y5H2B.3
Is enriched in hypodermis and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including diallyl trisulfide; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies.

WB:WBGene00021166	srbc-42
Is affected by rsr-2 and pgrn-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00021167	cyp-32B1
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00021168	cyp-33C12
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00021169	srt-40
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00021170	arx-4
Is predicted to have actin filament binding activity. Is involved in epithelial cell migration and morphogenesis of embryonic epithelium. Is expressed in head and tail. Is an ortholog of human ARPC2 (actin related protein 2/3 complex subunit 2).

WB:WBGene00021171	Y8A9A.2
Is expressed in g1P; g2L; and g2R. Human ortholog(s) of this gene are implicated in several diseases, including Weill-Marchesani syndrome; autosomal recessive isolated ectopia lentis 2; and ectopia lentis with ectopia of pupil. Is predicted to encode a protein with the following domains: Thrombospondin type 1 domain; Thrombospondin type-1 (TSP1) repeat; and Thrombospondin type-1 (TSP1) repeat superfamily.

WB:WBGene00021172	Y8A9A.3
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00021173	Y8A9A.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00021174	fbxb-99
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00021175	math-46
Is enriched in NSM based on tiling array studies. Is affected by several genes including age-1; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: DUF236 repeat and DUF236 repeat.

WB:WBGene00021176	txt-3
Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Mercuric Chloride; Tunicamycin; and indole based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00021177	Y9C9A.5
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00021178	Y9C9A.8
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00021179	fbxa-86
Is affected by several genes including skn-1; clk-1; and lin-35 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mercuric Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; Leucine-rich repeat domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021180	Y9C9A.13
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00021181	srz-27
Is expressed in ASHL; ASHR; ASIL; ASIR; and PVT.

WB:WBGene00021182	srz-28
Is affected by several genes including age-1; clk-1; and drh-3 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium based on microarray studies.

WB:WBGene00021183	Y9C9A.16
Is predicted to have FAD binding activity and sulfide:quinone oxidoreductase activity. Is an ortholog of human SQOR (sulfide quinone oxidoreductase).

WB:WBGene00021184	Y9C9A.17
Is affected by rsr-2; mir-34; and eat-2 based on tiling array and microarray studies. Is affected by tetrabromobisphenol A; allantoin; and Sirolimus based on microarray studies.

WB:WBGene00021185	Y9C12A.1
Is enriched in head mesodermal cell; neurons; retrovesicular ganglion; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including D-glucopyranose; D-glucose; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Tumour protein p53-inducible protein 11; and Tumor protein p53-inducible protein 11. Is an ortholog of human TP53I11 (tumor protein p53 inducible protein 11).

WB:WBGene00021186	Y9D1A.1
Is enriched in OLL; RIM; germ line; interneuron; and pharynx based on microarray and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and mpk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00021187	Y9D1A.2
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by D-glucose and metformin based on RNA-seq studies.

WB:WBGene00021188	Y13C8A.1
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021190	Y14H12A.1
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021191	Y14H12B.1
Is enriched in NSM; germ line; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021192	Y14H12B.2
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twelve chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00021193	math-44
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00021194	Y16E11A.2
No description available

WB:WBGene00021195	Y17G9A.2
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; let-60; and daf-12 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00021196	Y17G9A.3
Is affected by several genes including nhr-25; dpy-21; and smg-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF684.

WB:WBGene00021197	Y17G9A.4
Is affected by several genes including daf-2; skn-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00021198	npp-26
Is enriched in AVA and NSM based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021199	Y17G9B.2
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mianserin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00021200	cyp-31A3
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Is involved in several processes, including asymmetric cell division; embryonic morphogenesis; and female gamete generation. Is expressed in gonad and oocyte. Is used to study Bietti crystalline corneoretinal dystrophy. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00021201	Y17G9B.4
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity.

WB:WBGene00021202	Y17G9B.5
Is enriched in AFD; germ line; germline precursor cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including let-60; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Zidovudine; antimycin; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C-terminal domain of the ECSIT protein; Evolutionarily conserved signalling intermediate in Toll pathway; ECSIT; and ECSIT, C-terminal domain. Is an ortholog of human ECSIT (ECSIT signaling integrator).

WB:WBGene00021204	fbxb-77
Is enriched in NSM; neurons; and somatic gonad precursor based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021205	Y17G9B.8
Is predicted to have methylated histone binding activity and transcription coregulator activity. Is an ortholog of human SGF29 (SAGA complex associated factor 29).

WB:WBGene00021207	ptp-5.3
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00021208	Y18H1A.2
Is enriched in AFD; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leukocyte receptor cluster member 1-like. Is an ortholog of human LENG1 (leukocyte receptor cluster member 1).

WB:WBGene00021209	hgap-1
Is predicted to have GTPase activator activity. Is involved in determination of adult lifespan. Is an ortholog of human RALGAPA1 (Ral GTPase activating protein catalytic subunit alpha 1) and RALGAPA2 (Ral GTPase activating protein catalytic subunit alpha 2).

WB:WBGene00021210	Y18H1A.4
Is predicted to have intramolecular transferase activity, phosphotransferases.

WB:WBGene00021212	Y18H1A.8
Is enriched in germ line; hypodermis; and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021213	Y18H1A.9
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of human CPA1 (carboxypeptidase A1); CPA2 (carboxypeptidase A2); and CPA4 (carboxypeptidase A4).

WB:WBGene00021214	hasp-2
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00021215	Y18H1A.11
Is predicted to have choline-phosphate cytidylyltransferase activity and phosphatidylcholine binding activity. Is an ortholog of human PCYT1A (phosphate cytidylyltransferase 1, choline, alpha) and PCYT1B (phosphate cytidylyltransferase 1, choline, beta).

WB:WBGene00021216	Y19D10A.1
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00021217	Y19D10A.2
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00021218	srd-76
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies.

WB:WBGene00021219	Y19D10A.4
Is predicted to have transmembrane transporter activity.

WB:WBGene00021220	Y19D10A.5
Is predicted to have transmembrane transporter activity.

WB:WBGene00021221	Y19D10A.6
Is predicted to have metalloendopeptidase activity.

WB:WBGene00021222	irld-53
Is enriched in DD neuron; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; quantitative PCR; tiling array; and RNA-seq studies. Is affected by eight chemicals including Progesterone; Atrazine; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00021223	Y19D10A.8
Is predicted to have transmembrane transporter activity.

WB:WBGene00021224	clec-209
Is enriched in DA neuron; DD neuron; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including manganese chloride; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lectin C-type domain; C-type lectin-like; C-type lectin-like/link domain superfamily; and C-type lectin fold.

WB:WBGene00021225	Y19D10A.10
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including rrf-3; eat-2; and lin-35 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021226	Y19D10A.11
Is predicted to have transmembrane transporter activity.

WB:WBGene00021227	mct-1
Is predicted to have transmembrane transporter activity. Is expressed in pharynx. Human ortholog(s) of this gene are implicated in Allan-Herndon-Dudley syndrome and familial hyperinsulinemic hypoglycemia 7. Is an ortholog of human SLC16A14 (solute carrier family 16 member 14).

WB:WBGene00021228	str-265
Is affected by rsr-2 based on tiling array studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Serpentine type 7TM GPCR chemoreceptor Str; and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00021230	Y19D10B.1
Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00021232	irld-15
Is enriched in AFD and NSM based on tiling array and RNA-seq studies. Is affected by several genes including aak-2; mex-1; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00021233	Y19D10B.4
Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; Zidovudine; and graphene oxide based on RNA-seq studies.

WB:WBGene00021234	irld-16
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including unc-75; drh-3; and adr-1 based on RNA-seq and microarray studies. Is affected by dibromoacetic acid; dafa#1; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00021235	Y19D10B.6
Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and sesamin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021236	pud-1.2
Is expressed in hypodermis and intestine. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00021237	crtc-1
Exhibits cAMP response element binding protein binding activity. Is involved in determination of adult lifespan. Localizes to cytosol and nucleus. Is expressed in RICL; RICR; head neurons; intestine; and tail neurons. Is an ortholog of human CRTC1 (CREB regulated transcription coactivator 1).

WB:WBGene00021238	gap-3
Is involved in chemosensory behavior; learning or memory; and negative regulation of MAPK cascade. Is expressed in several structures, including body wall musculature; egg-laying apparatus; germ cell; head neurons; and spermatheca. Is an ortholog of human RASA1 (RAS p21 protein activator 1).

WB:WBGene00021239	Y20F4.4
Is enriched in germ line and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by paraquat and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021240	Y20F4.5
No description available

WB:WBGene00021241	Y22D7AL.1
Is affected by cyc-1; rsr-2; and ain-1 based on microarray and tiling array studies.

WB:WBGene00021243	Y22D7AL.3
Is enriched in intestine based on microarray studies. Is affected by several genes including ain-1; cyc-1; and ain-2 based on microarray and tiling array studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00021244	Y22D7AL.4
Is affected by several genes including pgl-1; mex-3; and csr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Sodium Chloride; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021245	Y22D7AL.6
Is enriched in OLL; PVD; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00021246	Y22D7AL.7
Is enriched in germ line; germline precursor cell; neurons; and retrovesicular ganglion based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including dpy-10; hsf-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Zidovudine; antimycin; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00021247	Y22D7AL.9
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; and Tetratricopeptide repeat. Is an ortholog of human TTC28 (tetratricopeptide repeat domain 28).

WB:WBGene00021248	Y22D7AL.10
Is predicted to have chaperone binding activity; metal ion binding activity; and unfolded protein binding activity. Is an ortholog of human HSPE1 (heat shock protein family E (Hsp10) member 1).

WB:WBGene00021249	Y22D7AL.11
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including sodium arsenite; Psoralens; and allantoin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in dilated cardiomyopathy 1X and muscular dystrophy (multiple). Is predicted to encode a protein with the following domain: Fukutin-related. Is an ortholog of human FKTN (fukutin).

WB:WBGene00021250	Y22D7AL.12
Is enriched in several structures, including body wall muscle cell; cholinergic neurons; coelomocyte; germline precursor cell; and ventral nerve cord based on tiling array studies. Is affected by drh-3 based on RNA-seq studies.

WB:WBGene00021251	Y22D7AL.13
Is affected by sir-2.1 based on microarray studies. Is affected by tetrabromobisphenol A based on microarray studies.

WB:WBGene00021252	cht-4
Is predicted to have chitin binding activity and chitinase activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00021253	Y22D7AL.15
Is enriched in dopaminergic neurons; head mesodermal cell; intestine; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Rotenone; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1C. Is predicted to encode a protein with the following domains: LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human LITAF (lipopolysaccharide induced TNF factor).

WB:WBGene00021254	Y22D7AL.16
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity.

WB:WBGene00021256	Y22D7AR.2
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on RNA-seq; proteomic; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; Domain of unknown function; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and Domain of unknown function WSN.

WB:WBGene00021257	Y22D7AR.3
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium and Sirolimus based on microarray studies.

WB:WBGene00021259	glb-30
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00021260	Y22D7AR.6
Is predicted to have kinase activity. Human ortholog(s) of this gene are implicated in Kawasaki disease. Is an ortholog of human IP6K2 (inositol hexakisphosphate kinase 2).

WB:WBGene00021261	Y22D7AR.7
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00021262	fbxa-74
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Mercuric Chloride; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021263	Y22D7AR.10
Is enriched in arcade cell; germ line; intestine; and pharyngeal-intestinal valve cell based on proteomic; Chronogram; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including aldicarb; hydrogen sulfide; and Ethanol based on microarray and RNA-seq studies.

WB:WBGene00021264	fbxa-13
Is enriched in NSM; OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and isp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Alovudine; and tert-Butylhydroperoxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021265	Y22D7AR.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; nicotinic acid; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00021266	Y22D7AR.14
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00021267	Y23B4A.1
Is affected by several genes including eri-1; drh-3; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including aldicarb; hydrogen sulfide; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00021268	capa-1
Exhibits G protein-coupled receptor binding activity. Is involved in neuropeptide signaling pathway.

WB:WBGene00021269	Y23H5A.2
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00021270	pid-3
Is enriched in germ line; germline precursor cell; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021271	spe-47
Is enriched in AVK; RIS; head mesodermal cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00021272	Y23H5B.1
Is enriched in AVK; RID; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00021273	Y23H5B.2
Is enriched in body wall muscle cell; hypodermis; neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00021274	Y23H5B.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-12; bar-1; and aak-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00021275	dmsr-2
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00021276	Y23H5B.5
Is enriched in AFD; body wall muscle cell; and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; UTP15 C terminal; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; U3 small nucleolar RNA-associated protein 15, C-terminal; and WD40-repeat-containing domain superfamily. Is an ortholog of human UTP15 (UTP15 small subunit processome component).

WB:WBGene00021277	Y23H5B.6
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX10 (DEAD-box helicase 10).

WB:WBGene00021278	Y23H5B.7
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; lin-35; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021279	Y23H5B.8
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00021280	nspd-8
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray studies. Is affected by five chemicals including Tunicamycin; resveratrol; and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00021281	ell-1
Localizes to nucleus. Is expressed in hypodermis; intestine; pharynx; tail; and vulva. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 49 and pseudo-TORCH syndrome 1. Is an ortholog of human ELL (elongation factor for RNA polymerase II) and ELL2 (elongation factor for RNA polymerase II 2).

WB:WBGene00021282	set-21
Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 1; and autosomal dominant non-syndromic intellectual disability (multiple). Is predicted to encode a protein with the following domain: SET domain.

WB:WBGene00021284	Y24D9A.6
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-12; aak-2; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by metformin; Sirolimus; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00021285	Y24D9A.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by cadmium and fluoranthene based on microarray studies.

WB:WBGene00021286	tald-1
Is predicted to have sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity. Is an ortholog of human TALDO1 (transaldolase 1).

WB:WBGene00021287	Y24D9B.1
Is enriched in ASER; AVK; cephalic sheath cell; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Zc3h12a-like Ribonuclease NYN domain and Ribonuclease Zc3h12a-like, NYN domain. Is an ortholog of human KHNYN (KH and NYN domain containing); N4BP1 (NEDD4 binding protein 1); and NYNRIN (NYN domain and retroviral integrase containing).

WB:WBGene00021288	clec-123
Is predicted to have carbohydrate binding activity.

WB:WBGene00021289	Y25C1A.2
Is enriched in NSM; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00021290	clec-122
Is predicted to have carbohydrate binding activity.

WB:WBGene00021291	clec-121
Is predicted to have carbohydrate binding activity. Is involved in IRE1-mediated unfolded protein response.

WB:WBGene00021292	copb-1
Is predicted to have structural molecule activity. Is expressed in head and tail. Is an ortholog of human COPB1 (COPI coat complex subunit beta 1).

WB:WBGene00021293	Y25C1A.6
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00021294	Y25C1A.7
Is predicted to have Rab GTPase binding activity. Is an ortholog of human YIPF1 (Yip1 domain family member 1) and YIPF2 (Yip1 domain family member 2).

WB:WBGene00021295	Y25C1A.8
Is predicted to have lipopolysaccharide binding activity. Is an ortholog of human ZRANB2 (zinc finger RANBP2-type containing 2).

WB:WBGene00021296	Y25C1A.13
Is predicted to have delta3,5-delta2,4-dienoyl-CoA isomerase activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2. Is an ortholog of human ECH1 (enoyl-CoA hydratase 1).

WB:WBGene00021297	fbxc-55
Is affected by several genes including elt-2; dpy-21; and hpl-2 based on tiling array and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00021298	Y27F2A.6
Is enriched in germline precursor cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00021299	Y27F2A.8
Is enriched in GABAergic neurons and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00021300	Y27F2A.9
Is affected by several genes including clk-1; bar-1; and aak-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021301	Y32G9A.2
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including skn-1; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00021302	Y32G9A.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercuric chloride and Colistin based on microarray studies.

WB:WBGene00021303	Y32G9A.5
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021304	nphp-2
Is involved in protein localization to ciliary inversin compartment. Localizes to ciliary inversin compartment. Is expressed in neurons. Human ortholog(s) of this gene are implicated in ankyrin-B-related cardiac arrhythmia; autosomal recessive non-syndromic intellectual disability; and hereditary spherocytosis type 1.

WB:WBGene00021305	zig-11
Is predicted to have cell-cell adhesion mediator activity. Is an ortholog of human NPTN (neuroplastin).

WB:WBGene00021306	Y32G9A.9
No description available

WB:WBGene00021309	Y32G9B.1
Is enriched in AVG; RIM; command interneuron; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00021310	Y32H12A.1
Is enriched in body wall musculature; pharynx; somatic nervous system; tail neurons; and vulval muscle based on Chronogram studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Tunicamycin; Alovudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00021311	thoc-5
Is predicted to have mRNA binding activity. Is an ortholog of human THOC5 (THO complex 5).

WB:WBGene00021312	szy-2
Is predicted to have protein phosphatase inhibitor activity. Is involved in several processes, including cell division; centrosome cycle; and regulation of centrosome duplication. Is an ortholog of human PPP1R2 (protein phosphatase 1 regulatory inhibitor subunit 2).

WB:WBGene00021313	paqr-2
Is predicted to have signaling receptor activity. Is involved in positive regulation of fatty acid oxidation; response to cold; and tail spike morphogenesis. Localizes to plasma membrane. Is expressed in gonadal sheath cell; head ganglion; head muscle; neurons; and seam cell. Is an ortholog of human ADIPOR2 (adiponectin receptor 2).

WB:WBGene00021314	Y32H12A.6
Is predicted to have FMN binding activity. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1; cerebral infarction; and hypertension (multiple). Is an ortholog of human TYW1 (tRNA-yW synthesizing protein 1 homolog).

WB:WBGene00021315	Y32H12A.7
Is enriched in AFD; GABAergic neurons; germ line; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ABC1 family; UbiB domain; and Protein kinase-like domain superfamily. Is an ortholog of human ADCK2 (aarF domain containing kinase 2).

WB:WBGene00021316	Y32H12A.8
Is expressed in head and tail. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; Zinc-ribbon, C4HC2 type; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR24 (WD repeat domain 24).

WB:WBGene00021317	Y32H12A.9
Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00021319	Y34B4A.2
Is predicted to have SNARE binding activity. Is involved in regulation of endosome size. Is an ortholog of human UVRAG (UV radiation resistance associated).

WB:WBGene00021320	Y34B4A.4
Is predicted to have guanyl-nucleotide exchange factor activity. Is an ortholog of human RAPGEF1 (Rap guanine nucleotide exchange factor 1).

WB:WBGene00021321	Y34B4A.5
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021322	Y34B4A.6
Is enriched in germ line; head mesodermal cell; intestine; mechanosensory neurons; and pharyngeal muscle cell based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021323	Y34B4A.7
Is enriched in several structures, including excretory cell; head mesodermal cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by Humic Substances and paraquat based on microarray studies. Is predicted to encode a protein with the following domain: S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00021324	rga-8
Is predicted to have GTPase activator activity and Rac GTPase binding activity. Is an ortholog of human ARHGAP44 (Rho GTPase activating protein 44).

WB:WBGene00021325	Y34B4A.9
Is enriched in head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021326	Y34B4A.10
Is enriched in germline precursor cell; hypodermis; and intestine based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021327	mrpl-38
Is expressed in tail. Is predicted to encode a protein with the following domains: Phosphatidylethanolamine-binding protein; Phosphatidylethanolamine-binding protein; Phosphatidylethanolamine-binding protein, eukaryotic; and PEBP-like superfamily. Is an ortholog of human MRPL38 (mitochondrial ribosomal protein L38).

WB:WBGene00021328	npr-23
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00021329	Y34D9A.3
Is enriched in germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and lin-39 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021331	glrx-10
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity. Is used to study Parkinson's disease. Is an ortholog of human GLRX (glutaredoxin).

WB:WBGene00021332	Y34D9A.7
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PSP and PSP, proline-rich. Is an ortholog of human ZCCHC8 (zinc finger CCHC-type containing 8).

WB:WBGene00021333	Y34D9A.8
Is enriched in head mesodermal cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by ten chemicals including Cadmium Chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Low-density lipoprotein receptor domain class A; Low-density lipoprotein (LDL) receptor class A repeat; LDL receptor-like superfamily; and Low-density lipoprotein receptor-related protein 11.

WB:WBGene00021334	vps-4
Is predicted to have ATPase activity. Is involved in mechanosensory behavior and protein localization to postsynaptic membrane. Is an ortholog of human VPS4A (vacuolar protein sorting 4 homolog A) and VPS4B (vacuolar protein sorting 4 homolog B).

WB:WBGene00021335	spp-23
Is enriched in DA neuron; VA neuron; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; tiling array; and microarray studies. Is affected by sixteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00021336	Y34F4.1
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00021337	Y34F4.2
Is enriched in ASER; OLL; PVD; dopaminergic neurons; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-one chemicals including 1-methylnicotinamide; Tunicamycin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00021338	Y34F4.3
Is enriched in AVA based on tiling array studies. Is affected by several genes including daf-2; fog-2; and dcr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Tunicamycin; paraquat; and Atrazine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in spastic ataxia 4. Is predicted to encode a protein with the following domains: Cid1 family poly A polymerase and PAP/25A-associated.

WB:WBGene00021339	Y34F4.4
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Heme; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00021340	Y34F4.5
Is enriched in OLL; PVD; germline precursor cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including stavudine; antimycin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00021342	Y35H6.3
Is enriched in coelomocyte; germ line; germline precursor cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00021343	cutl-23
Is enriched in hypodermis; nerve ring neurons; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Tunicamycin; and stavudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including congenital muscular dystrophy (multiple); dystonia 27; and nonsyndromic deafness (multiple). Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; Zona pellucida-like domain; Zona pellucida domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily. Is an ortholog of human COL6A6 (collagen type VI alpha 6 chain).

WB:WBGene00021344	rev-3
Is predicted to have DNA-directed DNA polymerase activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human REV3L (REV3 like, DNA directed polymerase zeta catalytic subunit).

WB:WBGene00021345	Y37B11A.3
Is enriched in AFD; ASER; AVK; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in combined D-2- and L-2-hydroxyglutaric aciduria. Is predicted to encode a protein with the following domains: Mitochondrial carrier protein; Mitochondrial substrate/solute carrier; and Mitochondrial carrier domain superfamily. Is an ortholog of human SLC25A1 (solute carrier family 25 member 1).

WB:WBGene00021346	Y37E3.1
Is enriched in arcade cell; germ line; neurons; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; hpl-2; and dpy-9 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Atrazine; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat protein 5 OB fold domain; Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; Tetratricopeptide repeat protein 5, OB fold domain; and TTC5, OB fold domain superfamily. Is an ortholog of human TTC5 (tetratricopeptide repeat domain 5).

WB:WBGene00021347	rpb-10
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2L (RNA polymerase II, I and III subunit L).

WB:WBGene00021348	moag-4
Is involved in protein destabilization. Localizes to cytosol and nucleus. Is an ortholog of human SERF2 (small EDRK-rich factor 2).

WB:WBGene00021349	arl-13
Is predicted to have GTP binding activity. Is involved in cilium organization; receptor localization to non-motile cilium; and sensory perception of chemical stimulus. Localizes to cell projection membrane; ciliary inversin compartment; and non-motile cilium. Is expressed in ciliated neurons and head. Is used to study Joubert syndrome. Human ortholog(s) of this gene are implicated in Joubert syndrome 8. Is an ortholog of human ARL13B (ADP ribosylation factor like GTPase 13B).

WB:WBGene00021350	Y37E3.8
Is predicted to be a structural constituent of ribosome. Is an ortholog of human RPL27A (ribosomal protein L27a).

WB:WBGene00021351	eif-2alpha
Is predicted to have ribosome binding activity and translation initiation factor activity. Is an ortholog of human EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha).

WB:WBGene00021352	pcyt-2.1
Is predicted to have catalytic activity. Is an ortholog of human PCYT2 (phosphate cytidylyltransferase 2, ethanolamine).

WB:WBGene00021353	iglr-3
Is enriched in germ line; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; eat-2; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Immunoglobulin I-set domain; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin-like fold; Leucine-rich repeat domain superfamily; and Immunoglobulin-like domain superfamily. Is an ortholog of human LRRC24 (leucine rich repeat containing 24).

WB:WBGene00021354	fpn-1.1
Is predicted to have iron ion transmembrane transporter activity. Is used to study Parkinson's disease. Human ortholog(s) of this gene are implicated in hemochromatosis type 4. Is an ortholog of human SLC40A1 (solute carrier family 40 member 1).

WB:WBGene00021355	Y37E3.17
Is predicted to have dimethylglycine dehydrogenase activity. Is an ortholog of human DMGDH (dimethylglycine dehydrogenase).

WB:WBGene00021356	Y37E3.18
No description available

WB:WBGene00021357	Y37E11AL.1
Is enriched in DD neuron; GABAergic neurons; body wall musculature; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; lin-39; and ain-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021358	Y37E11AL.2
Is predicted to have protein phosphatase inhibitor activity.

WB:WBGene00021359	Y37E11AL.3
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021360	Y37E11AL.4
Is enriched in AVE; BAG; and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; bar-1; and aak-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; paraquat; and Colistin based on microarray studies.

WB:WBGene00021362	fmil-1
Is predicted to have calcium ion binding activity.

WB:WBGene00021363	taf-6.2
Is predicted to have RNA polymerase II general transcription initiation factor activity. Is an ortholog of human TAF6 (TATA-box binding protein associated factor 6).

WB:WBGene00021364	Y37E11AL.9
Is affected by several genes including daf-2; mex-3; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021365	smgl-2
Is predicted to have RNA binding activity. Is involved in nuclear-transcribed mRNA catabolic process. Is an ortholog of human DHX34 (DExH-box helicase 34).

WB:WBGene00021366	Y37E11AM.2
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including age-1; hsf-1; and egl-5 based on microarray and RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00021367	Y37E11AM.3
Is predicted to have 3-dehydrosphinganine reductase activity. Human ortholog(s) of this gene are implicated in erythrokeratodermia variabilis et progressiva 4. Is an ortholog of human KDSR (3-ketodihydrosphingosine reductase).

WB:WBGene00021368	best-20
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST4 (bestrophin 4).

WB:WBGene00021369	siah-1
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is expressed in AIYL; AIYR; and tail. Is an ortholog of human SIAH1 (siah E3 ubiquitin protein ligase 1).

WB:WBGene00021370	nape-2
Exhibits N-acylphosphatidylethanolamine-specific phospholipase D activity. Is involved in N-acylethanolamine metabolic process. Localizes to neuron projection. Is expressed in pharynx; somatic nervous system; spermatheca; and vulval muscle. Is an ortholog of human NAPEPLD (N-acyl phosphatidylethanolamine phospholipase D).

WB:WBGene00021371	nape-1
Exhibits N-acylphosphatidylethanolamine-specific phospholipase D activity. Is involved in N-acylethanolamine metabolic process. Localizes to neuronal cell body. Is expressed in nervous system; pharynx; and vulval muscle. Is an ortholog of human NAPEPLD (N-acyl phosphatidylethanolamine phospholipase D).

WB:WBGene00021372	ugt-45
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of human UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00021373	Y37E11AR.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Immunoglobulin-like domain superfamily and FAM187A/B. Is an ortholog of human FAM187B (family with sequence similarity 187 member B).

WB:WBGene00021374	Y37E11B.1
Is enriched in intestine; neurons; and retrovesicular ganglion based on microarray and tiling array studies. Is affected by several genes including let-60; eat-2; and lin-39 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00021375	Y37E11B.2
Is enriched in AFD; body wall muscle cell; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by antimycin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021376	blos-7
Is enriched in germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BLOC-1-related complex sub-unit 6 and BLOC-1-related complex subunit 6. Is an ortholog of human BORCS6 (BLOC-1 related complex subunit 6).

WB:WBGene00021377	Y37E11B.5
Is predicted to have tRNA dihydrouridine synthase activity. Is an ortholog of human DUS3L (dihydrouridine synthase 3 like).

WB:WBGene00021378	Y37E11B.6
Is predicted to contribute to ribonuclease P activity.

WB:WBGene00021379	Y37E11B.7
Is enriched in AFD; ASER; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Nitric Oxide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021380	Y37E11B.9
Is affected by several genes including daf-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercury hydroxide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00021381	Y37E11B.10
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty chemicals including hydrogen sulfide; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies.

WB:WBGene00021382	Y37F4.1
Is enriched in neurons and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including D-glucose; Sodium Chloride; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00021383	Y37F4.2
Is enriched in BAG and neurons based on tiling array studies. Is affected by age-1; rsr-2; and clk-1 based on microarray and tiling array studies.

WB:WBGene00021384	Y37F4.3
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and nhl-2 based on tiling array and RNA-seq studies. Is affected by allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00021385	Y37F4.4
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by ain-1 based on microarray studies.

WB:WBGene00021386	Y37F4.5
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00021387	Y37F4.6
Is predicted to have DNA binding activity and DNA-binding transcription factor activity.

WB:WBGene00021388	Y37F4.7
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nicotinic acid and antimycin based on RNA-seq studies.

WB:WBGene00021389	Y38A10A.2
Is enriched in AFD; germline precursor cell; hypodermis; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; tryptophan; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF229) and Protein of unknown function DUF229.

WB:WBGene00021390	fbxa-214
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00021391	smut-1
Is predicted to have ATP binding activity and nucleic acid binding activity. Is expressed in embryonic cell and germ cell.

WB:WBGene00021392	Y38A10A.7
Is predicted to have H2A histone acetyltransferase activity; H4 histone acetyltransferase activity; and peptide-serine-N-acetyltransferase activity. Is an ortholog of human NAA40 (N-alpha-acetyltransferase 40, NatD catalytic subunit).

WB:WBGene00021394	Y38C1AA.1
Is predicted to have transferase activity, transferring acyl groups. Is an ortholog of human TMEM68 (transmembrane protein 68).

WB:WBGene00021395	pnc-1
Exhibits nicotinamidase activity. Is involved in nicotinamide metabolic process. Localizes to cytoplasm; extracellular space; and nucleus. Is expressed in several structures, including coelomocyte; epithelial cell; head ganglion; lumbar neurons; and pharyngeal cell.

WB:WBGene00021396	cutl-24
Is enriched in OLL; PVD; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; metformin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zona pellucida-like domain and Zona pellucida domain.

WB:WBGene00021397	Y38C1AA.6
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Sodium Chloride; antimycin; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00021398	Y38C1AA.7
Is affected by several genes including daf-2; age-1; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty-six chemicals including aldicarb; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021400	Y38C1AA.9
Is predicted to have Notch binding activity.

WB:WBGene00021401	prdx-6
Is predicted to have peroxiredoxin activity. Human ortholog(s) of this gene are implicated in methylmalonic aciduria and homocystinuria type cblC. Is an ortholog of human PRDX6 (peroxiredoxin 6).

WB:WBGene00021402	Y38C1AA.12
Is enriched in AVK; PLM; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; npr-1; and sma-4 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021403	Y38C1AB.1
Is predicted to have transferase activity, transferring glycosyl groups. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00021404	trpl-3
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; lin-22; and mir-34 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is predicted to encode a protein with the following domain: .

WB:WBGene00021405	Y38C1AB.3
Is affected by several genes including daf-16; rrf-1; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; resveratrol; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021406	frm-5.2
Is enriched in OLL; PVD; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; let-60; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Progesterone based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in hydrocephalus. Human FRMPD2 exhibits 1-phosphatidylinositol binding activity. Is predicted to encode a protein with the following domains: FERM central domain; FERM N-terminal domain; FERM C-terminal PH-like domain; PDZ domain; PDZ domain; PH-like domain superfamily; FERM/acyl-CoA-binding protein superfamily; FERM, N-terminal; FERM, C-terminal PH-like domain; FERM central domain; Band 4.1 domain; Ubiquitin-like domain superfamily; FERM superfamily, second domain; and PDZ superfamily. Is an ortholog of human FRMPD2 (FERM and PDZ domain containing 2).

WB:WBGene00021407	Y38C1AB.5
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00021408	trpl-4
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; sir-2.1; and isp-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including amyotrophic lateral sclerosis-parkinsonism/dementia complex 1; congenital stationary night blindness 1C; and intestinal hypomagnesemia 1. Is predicted to encode a protein with the following domain: .

WB:WBGene00021409	Y38C1AB.7
Is affected by sma-2; sma-4; and daf-16 based on microarray and RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00021410	Y38C1BA.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021412	cyp-29A3
Is predicted to have heme binding activity; iron ion binding activity; and oxidoreductase activity. Human ortholog(s) of this gene are implicated in Bietti crystalline corneoretinal dystrophy; aromatase excess syndrome; and autosomal recessive congenital ichthyosis 5. Is an ortholog of human CYP4V2 (cytochrome P450 family 4 subfamily V member 2).

WB:WBGene00021413	srt-52
Is affected by drh-3; adr-1; and mex-1 based on RNA-seq studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00021414	Y38C9B.3
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and tiling array studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021415	nsy-4
Exhibits calcium channel inhibitor activity and protein kinase inhibitor activity. Is involved in determination of left/right asymmetry in nervous system; inactivation of MAPKKK activity; and negative regulation of cation channel activity. Localizes to several cellular components, including axon; dendrite; and non-motile cilium. Is expressed in anterior hypodermis; blast cell; excretory cell; neurons; and tail hypodermis.

WB:WBGene00021416	mksr-2
Is involved in several processes, including larval foraging behavior; non-motile cilium assembly; and protein localization to ciliary transition zone. Localizes to ciliary basal body; ciliary transition zone; and dendrite terminus. Is expressed in neurons. Is used to study ciliopathy. Is an ortholog of human B9D2 (B9 domain containing 2).

WB:WBGene00021417	nhr-236
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00021418	Y38F2AL.6
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00021419	eri-5
Exhibits enzyme binding activity and protein-macromolecule adaptor activity. Is involved in production of small RNA involved in gene silencing by RNA.

WB:WBGene00021420	trap-3
Is enriched in C; hypodermis; intestine; mechanosensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; Zidovudine; and Deoxyglucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Translocon-associated protein, gamma subunit (TRAP-gamma) and Translocon-associated protein subunit gamma. Is an ortholog of human SSR3 (signal sequence receptor subunit 3).

WB:WBGene00021421	Y38F2AR.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including age-1; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human TIMMDC1 (translocase of inner mitochondrial membrane domain containing 1).

WB:WBGene00021422	Y38F2AR.4
No description available

WB:WBGene00021423	tftc-1
Is enriched in OLL; PVD; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human GTF3C1 (general transcription factor IIIC subunit 1).

WB:WBGene00021425	ppgn-1
Is predicted to have ATP binding activity and metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 7. Is an ortholog of human SPG7 (SPG7 matrix AAA peptidase subunit, paraplegin).

WB:WBGene00021427	sec-61.B
Is predicted to have ARF guanyl-nucleotide exchange factor activity. Is an ortholog of human SEC61B (SEC61 translocon subunit beta).

WB:WBGene00021428	Y38F2AR.10
Is predicted to have FFAT motif binding activity.

WB:WBGene00021430	Y38F2AR.12
Is predicted to have 5-oxoprolinase (ATP-hydrolyzing) activity. Is an ortholog of human OPLAH (5-oxoprolinase, ATP-hydrolysing).

WB:WBGene00021432	Y39A3A.1
No description available

WB:WBGene00021433	Y39A3A.2
Is affected by several genes including eat-2; alg-1; and smg-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00021434	Y39A3A.3
Is enriched in cephalic sheath cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Mercuric Chloride; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Vitelline membrane outer layer protein I (VOMI) superfamily.

WB:WBGene00021435	Y39A3A.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00021436	Y39A3B.1
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Peptidase family M28 and Peptidase M28.

WB:WBGene00021437	lgc-42
Is predicted to contribute to chloride channel activity. Human ortholog(s) of this gene are implicated in hyperekplexia 1. Is an ortholog of several human genes including GLRA2 (glycine receptor alpha 2); GLRA3 (glycine receptor alpha 3); and GLRA4 (glycine receptor alpha 4 (pseudogene)).

WB:WBGene00021438	Y39A3B.3
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including eat-2; smg-1; and csr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00021439	ckr-2
Exhibits neuropeptide binding activity. Is involved in determination of adult lifespan and neuropeptide signaling pathway. Is expressed in AIYL; AIYR; GABAergic neurons; and cholinergic neurons. Is an ortholog of human CCKBR (cholecystokinin B receptor).

WB:WBGene00021440	Y39A3CL.1
Is enriched in several structures, including germ line; germline precursor cell; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and sir-2.1 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021441	Y39A3CL.3
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; hsf-1; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021442	Y39A3CL.4
Is enriched in excretory cell; germ line; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and sek-1 based on RNA-seq; microarray; and proteomic studies. Is affected by eight chemicals including aldicarb; Zidovudine; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: TLD and TLDc domain.

WB:WBGene00021443	Y39A3CL.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and sma-2 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021444	ttc-7
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in multiple intestinal atresia. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; and Tetratricopeptide repeat. Is an ortholog of human TTC7B (tetratricopeptide repeat domain 7B).

WB:WBGene00021446	hlh-33
Is predicted to have protein dimerization activity.

WB:WBGene00021448	Y39D8A.1
Is enriched in OLL; PVD; excretory cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Mercuric Chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00021449	mltn-7
Is affected by several genes including daf-16; daf-12; and alg-1 based on RNA-seq and microarray studies. Is affected by Rotenone; multi-walled carbon nanotube; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00021450	mltn-6
Is affected by several genes including daf-16; daf-2; and let-60 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00021451	mltn-8
Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Sodium Chloride; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00021452	Y39F10A.1
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021453	Y39F10A.2
Is affected by several genes including age-1; rrf-3; and mut-2 based on microarray and tiling array studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00021454	Y39F10A.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain; Methyltransferase FkbM; Methyltransferase-like protein 24; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00021455	Y39F10A.4
No description available

WB:WBGene00021456	rfip-2
Is predicted to have Rab GTPase binding activity. Is an ortholog of human RAB11FIP2 (RAB11 family interacting protein 2) and RAB11FIP5 (RAB11 family interacting protein 5).

WB:WBGene00021457	Y39F10C.1
Is enriched in neurons and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00021458	Y39G10AL.1
Is enriched in AVK; Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00021460	zwl-1
Is involved in positive regulation of mitotic spindle pole body separation; positive regulation of protein localization to kinetochore; and protein localization to kinetochore involved in kinetochore assembly. Localizes to RZZ complex. Is an ortholog of human ZWILCH (zwilch kinetochore protein).

WB:WBGene00021461	nekl-1
Is predicted to have protein serine/threonine kinase activity. Is expressed in amphid neurons and lumbar neurons. Human ortholog(s) of this gene are implicated in nephronophthisis 9 and renal-hepatic-pancreatic dysplasia. Is an ortholog of human NEK9 (NIMA related kinase 9).

WB:WBGene00021463	zeel-1
Is expressed in embryonic cell. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00021464	ugt-31
Is predicted to have UDP-glycosyltransferase activity. Is an ortholog of several human genes including UGT2B28 (UDP glucuronosyltransferase family 2 member B28); UGT2B4 (UDP glucuronosyltransferase family 2 member B4); and UGT2B7 (UDP glucuronosyltransferase family 2 member B7).

WB:WBGene00021465	ekl-7
Is enriched in germ line; germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; dpy-10; and elt-2 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including methylmercuric chloride; Alovudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00021466	eif-2gamma
Is predicted to have translation initiation factor activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in MEHMO syndrome. Is an ortholog of human EIF2S3 (eukaryotic translation initiation factor 2 subunit gamma).

WB:WBGene00021467	Y39G10AR.9
Is enriched in AB; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including age-1; gld-1; and hsf-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human PAAF1 (proteasomal ATPase associated factor 1).

WB:WBGene00021468	epg-2
Is involved in macroautophagy and negative regulation of autophagosome assembly. Localizes to cytoplasm.

WB:WBGene00021469	Y39G10AR.11
Is enriched in ASER; AVK; NSM; and neurons based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; Rotenone; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021470	tpxl-1
Exhibits protein kinase binding activity. Is involved in astral microtubule organization and mitotic spindle assembly. Localizes to astral microtubule; meiotic spindle; and spindle pole centrosome.

WB:WBGene00021471	Y39G10AR.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021472	Y39G10AR.16
Is enriched in amphid sheath cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00021473	sydn-1
Localizes to nuclear speck. Is expressed in germ cell; hypodermis; neurons; and oocyte.

WB:WBGene00021474	dot-1.1
Is predicted to have histone methyltransferase activity (H3-K79 specific). Is expressed widely. Is an ortholog of human DOT1L (DOT1 like histone lysine methyltransferase).

WB:WBGene00021475	tbca-1
Is predicted to have tubulin binding activity. Is an ortholog of human TBCA (tubulin folding cofactor A).

WB:WBGene00021476	nsun-4
Is predicted to have methyltransferase activity. Is an ortholog of human NSUN4 (NOP2/Sun RNA methyltransferase 4).

WB:WBGene00021477	srbc-64
Exhibits G protein-coupled receptor activity. Is involved in G protein-coupled receptor signaling pathway and dauer larval development. Localizes to non-motile cilium and periciliary membrane compartment. Is expressed in ASKL and ASKR.

WB:WBGene00021478	Y39H10A.1
Is enriched in amphid sheath cell; arcade cell; dopaminergic neurons; neurons; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Mercuric Chloride; multi-walled carbon nanotube; and indole based on microarray and RNA-seq studies.

WB:WBGene00021479	oac-55
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00021482	Y39H10A.6
Is enriched in AVK; NSM; arcade cell; pharyngeal-intestinal valve cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Cry5B; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR26 (WD repeat domain 26).

WB:WBGene00021483	Y40A1A.1
Is enriched in Z1 and Z4 based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00021484	Y40A1A.2
Is affected by several genes including age-1; eat-2; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00021485	Y40A1A.3
Is enriched in muscle cell based on microarray studies. Is affected by several genes including clk-1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including tryptophan; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00021486	lbp-9
Is predicted to have lipid binding activity. Is an ortholog of human FABP4 (fatty acid binding protein 4).

WB:WBGene00021487	comt-3
Is predicted to have S-adenosylmethionine-dependent methyltransferase activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 63; panic disorder; and schizophrenia. Is an ortholog of human COMTD1 (catechol-O-methyltransferase domain containing 1).

WB:WBGene00021488	srab-23
Is affected by several genes including eat-2; mex-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00021489	Y40B10A.4
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00021490	Y40B10A.5
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srsx and Serpentine type 7TM GPCR chemoreceptor Srsx.

WB:WBGene00021491	comt-4
Is predicted to have S-adenosylmethionine-dependent methyltransferase activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 63; panic disorder; and schizophrenia. Is an ortholog of human COMTD1 (catechol-O-methyltransferase domain containing 1).

WB:WBGene00021492	comt-5
Is predicted to have S-adenosylmethionine-dependent methyltransferase activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 63; panic disorder; and schizophrenia. Is an ortholog of human COMTD1 (catechol-O-methyltransferase domain containing 1).

WB:WBGene00021493	Y40B10A.9
Is predicted to have phospholipase activity. Is expressed in body wall musculature. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00021494	Y40B10B.1
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including methylmercuric chloride; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human VMO1 (vitelline membrane outer layer 1 homolog).

WB:WBGene00021495	sqst-2
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and protein kinase C binding activity. Human ortholog(s) of this gene are implicated in FTDALS3 and Paget's disease of bone.

WB:WBGene00021496	daf-42
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by Zidovudine and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021497	Y40C5A.4
Is predicted to have phosphoric diester hydrolase activity. Is expressed in AIYL and AIYR.

WB:WBGene00021498	Y40C7B.1
No description available

WB:WBGene00021499	Y40C7B.3
No description available

WB:WBGene00021500	Y40C7B.4
Is enriched in coelomocyte; intestine; mechanosensory neurons; and pharyngeal muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; D-glucopyranose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00021501	Y40C7B.5
No description available

WB:WBGene00021502	Y40D12A.1
Is predicted to have mRNA (nucleoside-2'-O-)-methyltransferase activity. Is an ortholog of human CMTR2 (cap methyltransferase 2).

WB:WBGene00021503	ctsa-4.2
Is predicted to have serine-type carboxypeptidase activity. Localizes to membrane raft. Human ortholog(s) of this gene are implicated in galactosialidosis. Is an ortholog of human CTSA (cathepsin A).

WB:WBGene00021504	Y41D4A.1
Is enriched in male based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and pmk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; allantoin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00021505	Y41D4A.3
Is enriched in GABAergic neurons and hypodermis based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021506	Y41D4A.4
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Endomembrane protein 70 and Nonaspanin (TM9SF). Is an ortholog of human TM9SF3 (transmembrane 9 superfamily member 3).

WB:WBGene00021507	Y41D4A.5
Is predicted to have protein tyrosine phosphatase activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis; systemic lupus erythematosus; and type 1 diabetes mellitus. Is an ortholog of human PTPN22 (protein tyrosine phosphatase non-receptor type 22).

WB:WBGene00021508	Y41D4A.6
Is predicted to have glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity. Is an ortholog of human QRSL1 (glutaminyl-tRNA amidotransferase subunit QRSL1).

WB:WBGene00021509	Y41D4A.7
Is enriched in body wall muscle cell and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and sir-2.1 based on RNA-seq; tiling array; and microarray studies. Is affected by Rifampin and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021510	frpr-19
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00021511	Y41D4B.1
Is enriched in DA neuron; NSM; VA neuron; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; glh-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00021512	Y41D4B.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Tetratricopeptide-like helical domain superfamily.

WB:WBGene00021513	Y41D4B.6
Is enriched in Z1.p; Z4.a; hypodermis; male distal tip cell; and male-specific anatomical entity based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein Lag2.

WB:WBGene00021514	Y41D4B.11
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by four chemicals including D-glucose; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Coiled-coil domain-containing protein 137.

WB:WBGene00021515	set-23
Is predicted to have metal ion binding activity and methyltransferase activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including Kabuki syndrome; Kleefstra syndrome 2; and Sotos syndrome. Is an ortholog of human SETMAR (SET domain and mariner transposase fusion gene).

WB:WBGene00021516	Y41D4B.14
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021517	Y41D4B.15
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; gon_male_dtc posterior; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00021518	hpo-6
Localizes to membrane raft.

WB:WBGene00021519	Y41D4B.17
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and mechanosensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Mianserin; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00021520	Y41D4B.18
Is enriched in OLL; PVD; and intestine based on microarray and tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; tryptophan; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00021521	nhr-287
Is enriched in AFD and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021522	nhr-274
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00021524	Y41D4B.24
Is enriched in AVE; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: 7 transmembrane receptor (rhodopsin family) and GPCR, rhodopsin-like, 7TM.

WB:WBGene00021525	Y41D4B.26
Is enriched in several structures, including Z1.p; Z4.a; intestine; male distal tip cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein Lag2.

WB:WBGene00021526	Y41G9A.2
Is enriched in FLP and dopaminergic neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021527	aakg-3
Is predicted to have kinase activity. Is expressed in alimentary muscle; body wall musculature; head neurons; spermatheca; and ventral nerve cord. Human ortholog(s) of this gene are implicated in Wolff-Parkinson-White syndrome; hypertrophic cardiomyopathy 6; and lethal congenital glycogen storage disease of heart. Is an ortholog of human PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1).

WB:WBGene00021528	gbb-1
Exhibits G protein-coupled GABA receptor activity. Is involved in G protein-coupled receptor signaling pathway; negative regulation of cholinergic synaptic transmission; and response to drug. Is expressed in nervous system. Is an ortholog of human GABBR1 (gamma-aminobutyric acid type B receptor subunit 1).

WB:WBGene00021529	Y41G9A.5
Is enriched in OLL; PVD; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercury hydroxide; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021530	Y41G9A.6
Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00021531	Y42G9A.1
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Cry5B; paraquat; and Quercetin based on microarray and RNA-seq studies.

WB:WBGene00021532	Y42G9A.2
Is enriched in PLM; amphid sheath cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021533	Y42G9A.3
Is enriched in body wall musculature; muscle cell; and pharynx based on Chronogram and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including 1-methylnicotinamide; Mercuric Chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily. Is an ortholog of human LRRC58 (leucine rich repeat containing 58).

WB:WBGene00021534	mvk-1
Is predicted to have mevalonate kinase activity. Localizes to cytosol. Is expressed in head. Human ortholog(s) of this gene are implicated in mevalonic aciduria. Is an ortholog of human MVK (mevalonate kinase).

WB:WBGene00021535	wht-7
Is predicted to have ATPase-coupled transmembrane transporter activity. Is an ortholog of human ABCG1 (ATP binding cassette subfamily G member 1) and ABCG4 (ATP binding cassette subfamily G member 4).

WB:WBGene00021536	Y42H9AR.1
Is enriched in AVK; OLL; PVD; germ line; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Zidovudine; Humic Substances; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GRASP55/65 PDZ-like domain; GRASP55/65; GRASP55/65 PDZ-like domain; and PDZ superfamily. Is an ortholog of human GORASP2 (golgi reassembly stacking protein 2).

WB:WBGene00021537	Y42H9AR.2
Is enriched in several structures, including Z1.p; Z4.a; amphid sheath cell; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; D-glucose; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Inhibitor of apoptosis-promoting Bax1; Bax inhibitor 1-related; and MFS transporter superfamily. Is an ortholog of human FAIM2 (Fas apoptotic inhibitory molecule 2) and TMBIM1 (transmembrane BAX inhibitor motif containing 1).

WB:WBGene00021538	rabs-5
Is predicted to have phosphatidylinositol-3-phosphate binding activity. Is involved in pinocytosis and receptor-mediated endocytosis. Is expressed in PQR; amphid neurons; phasmid neurons; and ray neurons. Is an ortholog of human RBSN (rabenosyn, RAB effector).

WB:WBGene00021539	Y42H9AR.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-12; gld-1; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021540	Y42H9AR.5
Is enriched in several structures, including body wall musculature; germline precursor cell; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rotenone; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021541	Y42H9B.3
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00021542	Y43B11AL.1
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; bisphenol S; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00021543	Y43B11AR.1
Is enriched in excretory cell; neuronal sheath cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021544	Y43B11AR.3
Is predicted to have RNA binding activity and pseudouridine synthase activity. Is an ortholog of human TRUB2 (TruB pseudouridine synthase family member 2).

WB:WBGene00021545	Y43H11AL.1
Is predicted to contribute to histone acetyltransferase activity.

WB:WBGene00021546	laat-1
Exhibits L-lysine transmembrane transporter activity and arginine transmembrane transporter activity. Is involved in amino acid homeostasis; basic amino acid transport; and positive regulation of autophagy. Localizes to integral component of organelle membrane and lysosomal membrane. Is used to study lysosomal storage disease. Is an ortholog of human SLC66A1 (solute carrier family 66 member 1).

WB:WBGene00021547	Y44E3A.1
Is enriched in PLM; seam cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including levamisole; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00021548	trx-4
Is predicted to have oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; protein disulfide oxidoreductase activity; and protein-disulfide reductase activity. Is an ortholog of human TXN (thioredoxin).

WB:WBGene00021549	cdap-2
Is enriched in OLL; PVD; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including aldicarb; Rotenone; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Variant SH3 domain; SH3 domain; and SH3-like domain superfamily. Is an ortholog of human CD2AP (CD2 associated protein).

WB:WBGene00021551	edc-4
Is enriched in OLL; PVD; germ line; and somatic gonad precursor based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including age-1; gld-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; WD40 region of Ge1, enhancer of mRNA-decapping protein; and Enhancer of mRNA-decapping protein 4, WD40 repeat region. Is an ortholog of human EDC4 (enhancer of mRNA decapping 4).

WB:WBGene00021552	zip-4
Is predicted to have DNA-binding transcription factor activity. Is expressed in gonad; pharynx; spermatheca; and vulva. Human ortholog(s) of this gene are implicated in acute myeloid leukemia.

WB:WBGene00021553	tyr-5
Is predicted to have metal ion binding activity and oxidoreductase activity. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type III. Is an ortholog of human DCT (dopachrome tautomerase) and TYRP1 (tyrosinase related protein 1).

WB:WBGene00021554	Y45G5AL.1
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; hsf-1; and lin-35 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by seven chemicals including Rotenone; Cry5B; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021555	pid-5
Is predicted to have hydrolase activity and metal ion binding activity. Is an ortholog of human XPNPEP1 (X-prolyl aminopeptidase 1) and XPNPEP2 (X-prolyl aminopeptidase 2).

WB:WBGene00021556	Y45G5AM.3
Is enriched in AFD and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; stavudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00021557	Y45G5AM.5
Is enriched in hypodermis and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00021558	Y45G5AM.6
Localizes to striated muscle dense body.

WB:WBGene00021559	Y45G5AM.7
Is enriched in AVA; germ line; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021560	coh-4
Is involved in meiotic sister chromatid cohesion.

WB:WBGene00021561	Y45G5AM.9
Is predicted to have clathrin binding activity. Is an ortholog of human AFTPH (aftiphilin).

WB:WBGene00021562	nuo-5
Is predicted to have 4 iron, 4 sulfur cluster binding activity. Is an ortholog of human NDUFS1 (NADH:ubiquinone oxidoreductase core subunit S1).

WB:WBGene00021563	Y45G12B.2
Is predicted to have metal ion binding activity. Is an ortholog of human ZFPL1 (zinc finger protein like 1).

WB:WBGene00021564	Y45G12B.3
Is predicted to have (S)-2-hydroxy-acid oxidase activity and 2-hydroxyglutarate dehydrogenase activity. Human ortholog(s) of this gene are implicated in L-2-hydroxyglutaric aciduria. Is an ortholog of human L2HGDH (L-2-hydroxyglutarate dehydrogenase).

WB:WBGene00021565	Y45G12C.1
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including levamisole; Zidovudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1647) and Protein of unknown function DUF1647.

WB:WBGene00021566	Y45G12C.3
Is predicted to have glutathione transferase activity. Is an ortholog of human GSTP1 (glutathione S-transferase pi 1).

WB:WBGene00021567	Y45G12C.4
Is affected by several genes including bar-1; pry-1; and lin-22 based on tiling array; RNA-seq; and microarray studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00021568	srt-2
Is affected by rsr-2 and pgrn-1 based on tiling array and RNA-seq studies. Is affected by aldicarb based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00021569	Y45G12C.6
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00021570	srd-73
Is affected by several genes including lin-35; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00021571	srbc-81
Is affected by rsr-2; pgrn-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00021572	srd-72
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00021573	Y45G12C.10
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00021574	Y45G12C.11
Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00021575	Y45G12C.13
No description available

WB:WBGene00021576	fbxc-51
Is enriched in Z1.p; Z4.a; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00021577	Y46B2A.2
No description available

WB:WBGene00021578	Y46B2A.3
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; mex-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by aldicarb and estrogen based on microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily. Is an ortholog of human MUC1 (mucin 1, cell surface associated).

WB:WBGene00021579	clec-73
Is predicted to have carbohydrate binding activity. Is expressed in intestine.

WB:WBGene00021580	clec-174
Is predicted to have carbohydrate binding activity.

WB:WBGene00021581	clec-70
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00021582	clec-71
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00021583	clec-72
Is predicted to have carbohydrate binding activity.

WB:WBGene00021584	Y46C8AL.6
No description available

WB:WBGene00021585	clec-74
Is predicted to have carbohydrate binding activity.

WB:WBGene00021586	clec-75
Is predicted to have carbohydrate binding activity.

WB:WBGene00021587	clec-76
Is predicted to have carbohydrate binding activity.

WB:WBGene00021589	Y46D2A.1
Is enriched in muscle cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including D-glucose; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00021590	Y46D2A.2
Is enriched in AFD; OLL; PVD; head mesodermal cell; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Heme; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00021591	Y46D2A.3
Is affected by hpl-2; drh-3; and eat-2 based on tiling array and RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021592	Y46E12A.2
Is affected by several genes including daf-2; clk-1; and dpy-7 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00021593	Y46E12A.3
Is affected by several genes including eat-2; rde-1; and rde-4 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and Colistin based on microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 101 and autosomal recessive nonsyndromic deafness 25. Is predicted to encode a protein with the following domain: Thioredoxin-like superfamily. Is an ortholog of human GRXCR1 (glutaredoxin and cysteine rich domain containing 1).

WB:WBGene00021594	tig-3
Is predicted to have cytokine activity. Human ortholog(s) of this gene are implicated in several diseases, including Loeys-Dietz syndrome (multiple); bone disease (multiple); and microphthalmia (multiple).

WB:WBGene00021595	Y46E12BL.2
Is enriched in NSM; OLL; PVD; and germ line based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Cry5B; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NUC173 domain; Uncharacterised domain NUC173; and Armadillo-type fold. Is an ortholog of human RRP12 (ribosomal RNA processing 12 homolog).

WB:WBGene00021596	spsb-2
Is expressed in hypodermis and intestine. Is predicted to encode a protein with the following domains: SPRY domain; SOCS box; SOCS box domain; SPRY domain; Concanavalin A-like lectin/glucanase domain superfamily; and B30.2/SPRY domain superfamily. Is an ortholog of human SPSB1 (splA/ryanodine receptor domain and SOCS box containing 1) and SPSB4 (splA/ryanodine receptor domain and SOCS box containing 4).

WB:WBGene00021597	spsb-1
Is expressed in arcade cell; excretory system; hypodermis; intestine; and pharyngeal muscle cell. Is predicted to encode a protein with the following domains: SOCS box; SPRY domain; SOCS box domain; SPRY domain; Concanavalin A-like lectin/glucanase domain superfamily; and B30.2/SPRY domain superfamily. Is an ortholog of human SPSB1 (splA/ryanodine receptor domain and SOCS box containing 1) and SPSB4 (splA/ryanodine receptor domain and SOCS box containing 4).

WB:WBGene00021599	srt-42
Is enriched in AVK; NSM; neurons; and somatic gonad precursor based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on RNA-seq; tiling array; and microarray studies. Is affected by Tunicamycin; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00021600	Y46H3A.4
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021601	Y46H3A.5
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Tunicamycin; and procyanidin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00021602	clec-205
Is predicted to have carbohydrate binding activity.

WB:WBGene00021603	clec-204
Is predicted to have carbohydrate binding activity.

WB:WBGene00021604	Y46H3C.4
Is affected by several genes including daf-16; nhl-2; and emb-4 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00021605	Y46H3C.5
Is enriched in OLL; PVD; germ line; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00021606	Y46H3C.6
Is enriched in germline precursor cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and let-60 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Alovudine; and allantoin based on RNA-seq studies.

WB:WBGene00021607	Y46H3C.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021608	Y46H3D.1
Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00021609	irld-17
Is affected by several genes including daf-16; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00021610	nhr-237
Is predicted to have DNA-binding transcription factor activity. Is expressed in nerve ring; pharynx; tail neurons; and ventral nerve cord.

WB:WBGene00021611	nhr-238
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00021612	Y46H3D.8
Is affected by several genes including sir-2.1; mir-34; and rsr-2 based on tiling array and microarray studies. Is affected by four chemicals including aldicarb; procyanidin; and cadmium based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00021613	ttc-37
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Rotenone; bisphenol S; and Alovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 4 and multiple intestinal atresia. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and Ski3/TTC37. Is an ortholog of human TTC37 (tetratricopeptide repeat domain 37).

WB:WBGene00021614	Y47A7.2
Is enriched in head mesodermal cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00021615	Y47C4A.1
Is predicted to have ATP binding activity and metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 7.

WB:WBGene00021616	Y47D7A.2
Is enriched in DA neuron; VA neuron; body wall muscle cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by drh-3; nhl-2; and rrf-3 based on RNA-seq studies. Is affected by cadmium and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021617	Y47D7A.3
Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00021619	Y47D7A.6
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rotenone; D-glucose; and glycine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021620	Y47D7A.7
Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021621	Y47D7A.9
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including rrf-3; eat-2; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; D-glucose; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021622	hpo-37
Is affected by cyc-1; ubc-9; and ain-1 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00021623	Y47D7A.11
Is enriched in body wall muscle cell; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; pmk-1; and drh-3 based on RNA-seq and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; multi-walled carbon nanotube; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021624	Y47D7A.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by five chemicals including Tunicamycin; Rifampin; and Quercetin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021625	Y47D7A.13
Is enriched in DA neuron; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirty chemicals including hydrogen sulfide; Nitric Oxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021626	rft-2
Exhibits riboflavin transmembrane transporter activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. Is an ortholog of human SLC52A2 (solute carrier family 52 member 2) and SLC52A3 (solute carrier family 52 member 3).

WB:WBGene00021627	Y47D7A.15
Is enriched in coelomocyte and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by twenty chemicals including hydrogen sulfide; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021628	Y47D9A.1
Is predicted to have nucleotidyltransferase activity. Is an ortholog of human GMPPA (GDP-mannose pyrophosphorylase A).

WB:WBGene00021629	scpl-3
Is predicted to have phosphoprotein phosphatase activity. Is an ortholog of human CTDSPL2 (CTD small phosphatase like 2).

WB:WBGene00021630	Y47D9A.3
Is enriched in amphid sheath cell; head mesodermal cell; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00021631	Y47D9A.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00021632	Y47D9A.5
Is enriched in ALM; PLM; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00021633	Y47G6A.3
Is enriched in neurons; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Tunicamycin; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00021634	rde-10
Is enriched in AFD; RIM; germ line; and interneuron based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and gld-2 based on microarray and RNA-seq studies. Is affected by six chemicals including antimycin; Atrazine; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; piRNA pathway germ-plasm component; and Maelstrom domain.

WB:WBGene00021635	Y47G6A.5
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of several human genes including FGR (FGR proto-oncogene, Src family tyrosine kinase); HCK (HCK proto-oncogene, Src family tyrosine kinase); and LCK (LCK proto-oncogene, Src family tyrosine kinase).

WB:WBGene00021636	pcaf-1
Is predicted to have histone acetyltransferase activity. Is an ortholog of human KAT2A (lysine acetyltransferase 2A).

WB:WBGene00021637	Y47G6A.7
Is predicted to have antiporter activity. Is expressed in head. Is an ortholog of human SLC35C2 (solute carrier family 35 member C2).

WB:WBGene00021638	Y47G6A.9
Is enriched in germ line; germline precursor cell; head mesodermal cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DNA-directed RNA polymerase III subunit Rpc31 and DNA-directed RNA polymerase III, subunit Rpc31. Is an ortholog of human POLR3G (RNA polymerase III subunit G) and POLR3GL (RNA polymerase III subunit GL).

WB:WBGene00021639	Y47G6A.13
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00021640	Y47G6A.14
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including let-60; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human TRIM6 (tripartite motif containing 6).

WB:WBGene00021641	Y47G6A.15
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00021643	ccep-290
Is involved in non-motile cilium assembly and protein localization to ciliary transition zone. Localizes to central cylinder. Is expressed in amphid neurons and phasmid neurons.

WB:WBGene00021644	Y47G6A.18
Is predicted to have phosphatidylinositol-4-phosphate binding activity. Is an ortholog of human GOLPH3 (golgi phosphoprotein 3).

WB:WBGene00021645	Y47G6A.19
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5. Is an ortholog of human CPA1 (carboxypeptidase A1); CPA2 (carboxypeptidase A2); and CPA4 (carboxypeptidase A4).

WB:WBGene00021646	Y47G6A.21
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and lin-35 based on proteomic; RNA-seq; and microarray studies. Is affected by Cry5B and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00021647	Y47G6A.22
Is enriched in germline precursor cell; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; Psoralens; and estrogen based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00021648	mis-12
Is involved in kinetochore assembly. Localizes to condensed chromosome kinetochore.

WB:WBGene00021649	Y47G6A.25
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021650	Y47G6A.26
Is enriched in NSM; amphid sheath cell; and in male based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercuric chloride; Tunicamycin; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00021651	miro-3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by allantoin and Sirolimus based on RNA-seq studies. Is an ortholog of human RHOT1 (ras homolog family member T1) and RHOT2 (ras homolog family member T2).

WB:WBGene00021653	Y47G6A.30
Is enriched in AFD; ASER; and hypodermis based on RNA-seq studies. Is affected by several genes including dpy-10; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Cadmium Chloride; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00021654	Y47G7B.2
Is enriched in several structures, including amphid sheath cell; germ line; male distal tip cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including stavudine; Cisplatin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00021655	Y48A5A.1
Is predicted to have unfolded protein binding activity. Is an ortholog of human SHQ1 (SHQ1, H/ACA ribonucleoprotein assembly factor).

WB:WBGene00021656	Y48D7A.1
Is enriched in GABAergic neurons and muscle cell based on microarray studies. Is affected by several genes including daf-2; eat-2; and rrf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021657	Y48G1A.1
Is enriched in Z1.p; Z4.a; germ line; germline precursor cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and isp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including D-glucose; Alovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II.

WB:WBGene00021658	Y48G1A.2
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; methylmercury hydroxide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00021660	nol-14
Is enriched in body wall muscle cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by Rotenone and Atrazine based on RNA-seq and microarray studies. Human NOP14 exhibits enzyme binding activity. Is predicted to encode a protein with the following domains: Phosphorylation site; Nop14-like family; and Nucleolar protein 14. Is an ortholog of human NOP14 (NOP14 nucleolar protein).

WB:WBGene00021661	mbtr-1
Is enriched in several structures, including AVG; RIM; command interneuron; germ line; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 11. Is predicted to encode a protein with the following domains: mbt repeat and Mbt repeat. Is an ortholog of human L3MBTL1 (L3MBTL histone methyl-lysine binding protein 1) and SFMBT2 (Scm like with four mbt domains 2).

WB:WBGene00021662	snpc-3.3
Is enriched in AVA; AVE; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by metformin; Sirolimus; and antimycin based on RNA-seq studies. Is an ortholog of human SNAPC3 (small nuclear RNA activating complex polypeptide 3).

WB:WBGene00021663	Y48G1BL.4
No description available

WB:WBGene00021664	Y48G1BL.5
Is enriched in germline precursor cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021666	Y48G1BL.7
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00021667	snpc-3.2
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: snRNA-activating protein of 50kDa MW C terminal and snRNA-activating protein complex, subunit 3. Is an ortholog of human SNAPC3 (small nuclear RNA activating complex polypeptide 3).

WB:WBGene00021668	Y48G1BM.2
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00021669	Y48G1BM.4
No description available

WB:WBGene00021671	Y48G1BM.6
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; Alovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021672	Y48G1BM.7
Is affected by several genes including pgl-1; mex-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00021673	Y48G1BM.8
Is enriched in germline precursor cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by Rotenone; Alovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021675	Y48G1BR.1
Is enriched in hypodermis based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SEA domain; SEA domain; and SEA domain superfamily.

WB:WBGene00021676	pid-2
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021677	pgs-1
Is predicted to have CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity. Is involved in regulation of cell population proliferation and regulation of mitochondrial membrane potential. Is an ortholog of human PGS1 (phosphatidylglycerophosphate synthase 1).

WB:WBGene00021678	Y48G1C.5
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00021679	Y48G1C.6
Is predicted to have DNA binding activity. Is an ortholog of human POGK (pogo transposable element derived with KRAB domain).

WB:WBGene00021681	Y48G1C.8
Is enriched in NSM; OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by seven chemicals including Rotenone; Zidovudine; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021682	Y48G1C.9
Is enriched in germ line; hypodermis; intestine; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Mianserin; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: LSM domain; LSM domain, eukaryotic/archaea-type; LSM domain superfamily; and LSM domain containing 1. Is an ortholog of human NAA38 (N-alpha-acetyltransferase 38, NatC auxiliary subunit).

WB:WBGene00021683	Y48G1C.10
Is enriched in OLL; PVD; germ line; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and npr-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Alovudine; and Chlorpyrifos based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4B2; Charcot-Marie-Tooth disease type 4B3; and centronuclear myopathy X-linked. Is predicted to encode a protein with the following domains: Myotubularin-like phosphatase domain; Myotubularin-associated protein; Myotubularin-like phosphatase domain; Myotubularin-related 12-like C-terminal domain; Protein-tyrosine phosphatase-like; and Myotubularin family. Is an ortholog of human MTMR10 (myotubularin related protein 10) and MTMR12 (myotubularin related protein 12).

WB:WBGene00021685	herc-1
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human HERC4 (HECT and RLD domain containing E3 ubiquitin protein ligase 4).

WB:WBGene00021686	nsun-2
Is predicted to have tRNA (cytosine-5-)-methyltransferase activity and tRNA binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive non-syndromic intellectual disability. Is an ortholog of human NSUN2 (NOP2/Sun RNA methyltransferase 2).

WB:WBGene00021687	Y48G8AL.7
Is enriched in several structures, including germ line; germline precursor cell; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021689	Y48G8AL.10
Is predicted to have DNA binding activity and DNA-binding transcription factor activity. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 21 and immunodeficiency-centromeric instability-facial anomalies syndrome 2. Is an ortholog of several human genes including ZNF729 (zinc finger protein 729); ZNF845 (zinc finger protein 845); and ZNF99 (zinc finger protein 99).

WB:WBGene00021690	Y48G8AL.12
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including aldicarb; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021691	Y48G8AL.13
Is enriched in intestine and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including let-60; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; Rotenone; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TLC domain and TRAM/LAG1/CLN8 homology domain. Is an ortholog of human TLCD1 (TLC domain containing 1).

WB:WBGene00021692	Y48G8AL.15
Is predicted to have nucleoside diphosphate kinase activity. Is an ortholog of human NME6 (NME/NM23 nucleoside diphosphate kinase 6).

WB:WBGene00021693	Y48G8AR.2
Is predicted to have metal ion binding activity.

WB:WBGene00021694	Y48G8AR.3
Is enriched in neurons and in male based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; hpl-2; and ain-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Atrazine; cadmium; and fluoranthene based on microarray studies.

WB:WBGene00021697	gcn-1
Is predicted to have protein kinase binding activity; protein kinase regulator activity; and ribosome binding activity. Is involved in positive regulation of transcription from RNA polymerase II promoter in response to increased salt; regulation of apoptotic process; and regulation of cellular protein metabolic process. Is expressed in several structures, including body wall musculature; head neurons; hermaphrodite gonad; intestinal cell; and pharyngeal neurons. Is an ortholog of human GCN1 (GCN1 activator of EIF2AK4).

WB:WBGene00021698	frl-1
Is predicted to have actin filament binding activity. Is an ortholog of human FMNL1 (formin like 1); FMNL2 (formin like 2); and FMNL3 (formin like 3).

WB:WBGene00021699	Y48G9A.5
No description available

WB:WBGene00021700	Y48G9A.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Alovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021701	Y48G9A.7
Is enriched in OLL and PVD based on microarray and tiling array studies. Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00021702	Y48G9A.9
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00021703	cpt-3
Is predicted to have carnitine O-palmitoyltransferase activity. Is an ortholog of human CPT1A (carnitine palmitoyltransferase 1A); CPT1B (carnitine palmitoyltransferase 1B); and CPT1C (carnitine palmitoyltransferase 1C).

WB:WBGene00021704	Y48G9A.11
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00021706	srbc-39
Is affected by daf-16 and drh-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00021707	srbc-38
Is affected by several genes including eat-2; mex-3; and nhr-25 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00021708	srbc-37
Is affected by hpl-2 and rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00021709	ugt-29
Is predicted to have UDP-glycosyltransferase activity. Is expressed in pharynx; tail; and vulval muscle. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT2B11 (UDP glucuronosyltransferase family 2 member B11); UGT3A1 (UDP glycosyltransferase family 3 member A1); and UGT3A2 (UDP glycosyltransferase family 3 member A2).

WB:WBGene00021710	cyp-33C11
Is predicted to have heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 56; lung cancer; and rickets. Is an ortholog of human CYP2J2 (cytochrome P450 family 2 subfamily J member 2).

WB:WBGene00021711	wago-11
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and alg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021712	Y49F6A.4
No description available

WB:WBGene00021713	Y49F6A.5
Is enriched in germline precursor cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; npr-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Tunicamycin; tert-Butylhydroperoxide; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00021714	cyh-1
Is predicted to contribute to RNA polymerase II CTD heptapeptide repeat kinase activity. Is an ortholog of human CCNH (cyclin H).

WB:WBGene00021715	Y49F6B.2
Is enriched in several structures, including AVA; body wall muscle cell; germ line; intestine; and somatic gonad precursor based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by eight chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Fcf2 pre-rRNA processing; Fcf2 pre-rRNA processing, C-terminal; and Fcf2/DNTTIP2. Is an ortholog of human DNTTIP2 (deoxynucleotidyltransferase terminal interacting protein 2).

WB:WBGene00021716	fbxb-112
Is affected by several genes including daf-2; glp-1; and eat-2 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Tunicamycin; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00021717	sdz-32
Is enriched in DA neuron; VA neuron; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00021718	Y49F6B.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021719	fbxb-104
Is enriched in hypodermis; intestine; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021720	Y49F6B.8
Is enriched in AVG; RIM; amphid sheath cell; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265) and Protein of unknown function DUF1265.

WB:WBGene00021721	Y49F6B.9
Is predicted to have ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Is an ortholog of human RNF19A (ring finger protein 19A, RBR E3 ubiquitin protein ligase) and RNF19B (ring finger protein 19B).

WB:WBGene00021722	srz-5
Is affected by several genes including rrf-3; sir-2.1; and mut-2 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00021723	bath-8
Is affected by several genes including daf-2; sir-2.1; and hpl-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021724	Y49F6C.2
Is enriched in pharynx based on microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021725	bath-9
Is enriched in several structures, including cholinergic neurons; excretory cell; head mesodermal cell; pharynx; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00021726	bath-10
Is enriched in hypodermis; intestine; and neurons based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00021727	bath-23
Is enriched in NSM; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; hpl-2; and ain-2 based on RNA-seq and microarray studies. Is affected by aldicarb and Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: MATH domain; BTB/POZ domain; BTB/POZ domain; MATH/TRAF domain; TRAF-like; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00021728	Y49F6C.6
Is affected by several genes including clk-1; fog-2; and cyc-1 based on microarray and RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00021729	Y49F6C.7
Is enriched in muscle cell based on microarray studies. Is affected by several genes including hpl-2; spn-4; and drh-3 based on tiling array and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021730	Y49F6C.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including aldicarb; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00021731	Y49G5A.1
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00021732	Y49G5B.1
Is expressed in gonad.

WB:WBGene00021733	otub-2
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human OTUD7A (OTU deubiquitinase 7A) and OTUD7B (OTU deubiquitinase 7B).

WB:WBGene00021734	Y50C1A.2
Is enriched in arcade cell; neurons; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and dpy-7 based on microarray and RNA-seq studies. Is affected by Sodium Chloride and dibromoacetic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily and WD40-repeat-containing domain superfamily.

WB:WBGene00021735	Y50D4A.1
Is enriched in OLL; PVD; germ line; germline precursor cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00021736	wrb-1
Is enriched in germ line and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CHD5-like protein and Get1 family. Is an ortholog of human GET1 (guided entry of tail-anchored proteins factor 1).

WB:WBGene00021737	Y50D4A.3
Is affected by several genes including fbf-1; spn-4; and mir-34 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00021738	Y50D4A.4
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including pmk-1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Atrazine; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Colon cancer-associated protein Mic1-like; Regulator of MON1-CCZ1 complex, C-terminal; and Regulator of MON1-CCZ1 complex. Is an ortholog of human RMC1 (regulator of MON1-CCZ1).

WB:WBGene00021739	Y50D4A.5
Is enriched in dopaminergic neurons; germ line; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; fog-2; and smg-1 based on RNA-seq studies. Is affected by five chemicals including Rotenone; stavudine; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00021740	Y50D4B.1
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021741	Y50D4B.2
Is enriched in AFD; RID; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including aldicarb; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human SCCPDH (saccharopine dehydrogenase (putative)).

WB:WBGene00021743	Y50D4B.4
Is predicted to have peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity. Human ortholog(s) of this gene are implicated in NGLY1-deficiency.

WB:WBGene00021744	clec-203
Is predicted to have carbohydrate binding activity.

WB:WBGene00021745	Y50D4B.6
Is predicted to have transmembrane receptor protein tyrosine kinase activity. Human ortholog(s) of this gene are implicated in several diseases, including dysostosis (multiple); endocrine gland cancer (multiple); and hematologic cancer (multiple). Is an ortholog of several human genes including CSF1R (colony stimulating factor 1 receptor); KIT (KIT proto-oncogene, receptor tyrosine kinase); and PDGFRA (platelet derived growth factor receptor alpha).

WB:WBGene00021746	Y50D4B.7
Is affected by several genes including clk-1; elt-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00021747	Y50D4C.2
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including bisphenol S; nicotine; and Alovudine based on RNA-seq; proteomic; and microarray studies. Is an ortholog of human ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide).

WB:WBGene00021748	Y50D4C.3
Is predicted to have RNA binding activity. Is an ortholog of human TDRD3 (tudor domain containing 3).

WB:WBGene00021749	Y50D4C.5
Is enriched in OLL; PVD; and germ line based on microarray and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq studies.

WB:WBGene00021750	Y50D4C.6
Is predicted to have oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen. Is an ortholog of human ADO (2-aminoethanethiol dioxygenase).

WB:WBGene00021751	Y50D7A.1
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including sir-2.1; lin-28; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Kelch motif; Galactose oxidase, central domain; Kelch repeat type 2; and Kelch-type beta propeller. Is an ortholog of human FBXO42 (F-box protein 42).

WB:WBGene00021752	xpd-1
Is predicted to contribute to RNA polymerase II CTD heptapeptide repeat kinase activity. Human ortholog(s) of this gene are implicated in photosensitive trichothiodystrophy and xeroderma pigmentosum group D. Is an ortholog of human ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit).

WB:WBGene00021753	Y50D7A.3
Is predicted to have ATP binding activity; calmodulin binding activity; and phosphorylase kinase activity. Human ortholog(s) of this gene are implicated in glycogen storage disease IXc and hypertrophic cardiomyopathy 1. Is an ortholog of human PHKG1 (phosphorylase kinase catalytic subunit gamma 1) and PHKG2 (phosphorylase kinase catalytic subunit gamma 2).

WB:WBGene00021754	hpo-29
Is predicted to contribute to peptide alpha-N-acetyltransferase activity. Human ortholog(s) of this gene are implicated in autosomal dominant mental retardation 50. Is an ortholog of human NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit) and NAA16 (N-alpha-acetyltransferase 16, NatA auxiliary subunit).

WB:WBGene00021755	hpo-38
Is enriched in arcade cell; germ line; neurons; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Mianserin; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021756	Y50D7A.8
Is expressed in head. Is predicted to encode a protein with the following domain: .

WB:WBGene00021757	taco-1
Is enriched in ASER; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including antimycin; Atrazine; and Cry5B based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease. Is predicted to encode a protein with the following domains: Transcriptional regulator; Transcriptional regulator TACO1-like; Integrase-like, N-terminal; Transcriptional regulator TACO1-like, domain 3; and YebC-like. Is an ortholog of human TACO1 (translational activator of cytochrome c oxidase I).

WB:WBGene00021758	Y50D7A.10
Is predicted to have Arp2/3 complex binding activity and actin binding activity. Is an ortholog of human GMFB (glia maturation factor beta) and GMFG (glia maturation factor gamma).

WB:WBGene00021761	Y51B11A.1
No description available

WB:WBGene00021762	Y51F10.1
No description available

WB:WBGene00021763	Y51F10.2
Is enriched in Psub1; amphid sheath cell; germ line; and germline precursor cell based on RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021764	Y51F10.3
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including npr-1; fog-2; and aak-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021765	Y51F10.4
Is predicted to have amino acid transmembrane transporter activity. Is an ortholog of human SLC38A10 (solute carrier family 38 member 10).

WB:WBGene00021766	hex-4
Exhibits hexosaminidase activity. Is involved in carbohydrate metabolic process. Is expressed in seam cell. Is an ortholog of human HEXD (hexosaminidase D).

WB:WBGene00021768	Y51F10.7
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by twenty chemicals including cholesterol; lathosterol; and diallyl trisulfide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021769	Y51F10.8
No description available

WB:WBGene00021771	spe-48
Is predicted to have ubiquitin binding activity.

WB:WBGene00021772	math-45
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00021773	fbxb-42
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; methylmercuric chloride; and bisphenol A based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00021774	fbxb-43
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercuric chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00021776	Y51H7BR.4
Is enriched in coelomocyte; hypodermis; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by methylmercury hydroxide and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021778	Y51H7BR.7
Is affected by several genes including daf-2; aak-2; and dpy-21 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including aldicarb; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ectodermal ciliogenesis protein and SPEC3/Stum. Is an ortholog of human STUM (stum, mechanosensory transduction mediator homolog).

WB:WBGene00021779	Y51H7C.1
Is enriched in amphid sheath cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021780	scl-17
Is enriched in NSM and amphid sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and csr-1 based on proteomic; tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Rifampin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily. Is an ortholog of human CRISP2 (cysteine rich secretory protein 2).

WB:WBGene00021781	Y51H7C.3
Is enriched in several structures, including ciliated neurons; germ line; germline precursor cell; seam cell; and ventral nerve cord based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021783	alkb-1
Is predicted to have dioxygenase activity. Is an ortholog of human ALKBH1 (alkB homolog 1, histone H2A dioxygenase).

WB:WBGene00021784	cogc-4
Is involved in gonad morphogenesis and regulation of cell migration. Human ortholog(s) of this gene are implicated in Saul-Wilson syndrome and congenital disorder of glycosylation type IIj. Is an ortholog of human COG4 (component of oligomeric golgi complex 4).

WB:WBGene00021785	Y51H7C.7
Is enriched in NSM; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Exosome-associated factor Rrp47/DNA strand repair C1D. Is an ortholog of human C1D (C1D nuclear receptor corepressor).

WB:WBGene00021786	Y51H7C.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; antimycin; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00021787	Y51H7C.9
Is predicted to have L-serine ammonia-lyase activity and L-threonine ammonia-lyase activity.

WB:WBGene00021788	Y51H7C.10
Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00021789	nol-6
Is predicted to have RNA binding activity. Is involved in negative regulation of innate immune response. Is an ortholog of human NOL6 (nucleolar protein 6).

WB:WBGene00021790	Y51H7C.12
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00021791	Y51H7C.13
Is enriched in DA neuron; NSM; VA neuron; and amphid sheath cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twenty-five chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00021792	Y52D5A.1
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including methylmercuric chloride; Tunicamycin; and paraquat based on microarray studies.

WB:WBGene00021793	Y52D5A.2
Is predicted to have ATP binding activity and non-membrane spanning protein tyrosine kinase activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00021794	Y52E8A.1
Is affected by several genes including glp-1; clk-1; and mex-3 based on microarray; proteomic; and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: PDZ superfamily.

WB:WBGene00021795	Y52E8A.2
Is enriched in several structures, including AFD; arcade cell; germ line; head mesodermal cell; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including aldicarb; hydrogen sulfide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00021796	Y52E8A.3
Is enriched in OLL; PVD; intestine; and neurons based on tiling array studies. Is affected by several genes including glp-1; skn-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nineteen chemicals including 1-methylnicotinamide; Mercuric Chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thioredoxin-like; Thioredoxin-like fold; and Thioredoxin-like superfamily. Is an ortholog of human NXNL2 (nucleoredoxin like 2).

WB:WBGene00021797	plep-1
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Mercuric Chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00021798	Y52E8A.6
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00021799	Y53G8AL.1
Is enriched in neurons and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; metformin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Inner membrane component of T3SS, cytoplasmic domain; Forkhead-associated (FHA) domain; SMAD/FHA domain superfamily; and YscD, cytoplasmic domain.

WB:WBGene00021800	nduf-9
Is predicted to have NADH dehydrogenase activity. Is expressed in head and tail. Is an ortholog of human NDUFA9 (NADH:ubiquinone oxidoreductase subunit A9).

WB:WBGene00021801	Y53G8AL.3
Is enriched in CEM; HOB; IL2 neuron; NSM; and ray neuron type B based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Atrazine and Sirolimus based on microarray studies.

WB:WBGene00021802	Y53G8AM.1
No description available

WB:WBGene00021803	Y53G8AM.2
Is enriched in GABAergic neurons and NSM based on RNA-seq studies. Is affected by several genes including daf-2; mex-3; and ain-1 based on tiling array; microarray; and RNA-seq studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00021804	Y53G8AM.4
Is expressed in amphid neurons and phasmid neurons. Is predicted to encode a protein with the following domain: Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00021805	Y53G8AM.5
Is enriched in DD neuron; intestine; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including skn-1; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including tryptophan; Tunicamycin; and TPEN based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021806	Y53G8AM.6
Is affected by several genes including sir-2.1; aak-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by antimycin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021807	Y53G8AM.7
Is enriched in neurons based on tiling array studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00021808	Y53G8AM.8
Is predicted to have DNA binding activity.

WB:WBGene00021809	Y53G8AR.1
Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021810	phf-15
Is predicted to have metal ion binding activity. Is an ortholog of human JADE3 (jade family PHD finger 3).

WB:WBGene00021811	ral-1
Is predicted to have GDP binding activity; GTP binding activity; and GTPase activity. Is involved in several processes, including multivesicular body assembly; positive regulation of vulval development; and regulation of exocyst localization. Is expressed in several structures, including excretory canal; germ line; tail; vulva; and vulval precursor cell. Human ortholog(s) of this gene are implicated in several diseases, including Noonan syndrome 6; autoimmune lymphoproliferative syndrome type 4; and epidermal nevus. Is an ortholog of human RALA (RAS like proto-oncogene A).

WB:WBGene00021812	Y53G8AR.5
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human RNF25 (ring finger protein 25).

WB:WBGene00021813	Y53G8AR.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SAP domain; SAP domain; and SAP domain superfamily. Is an ortholog of human SARNP (SAP domain containing ribonucleoprotein).

WB:WBGene00021814	mfsd-8
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 7. Is an ortholog of human MFSD8 (major facilitator superfamily domain containing 8).

WB:WBGene00021815	Y53G8AR.8
Is predicted to contribute to ubiquitin-protein transferase activity. Localizes to mitochondrion. Is an ortholog of human DMAC2 (distal membrane arm assembly complex 2).

WB:WBGene00021816	Y53G8AR.9
Is predicted to have RNA binding activity. Is an ortholog of human ZC3H10 (zinc finger CCCH-type containing 10).

WB:WBGene00021817	Y53G8B.1
Is predicted to have glutathione transferase activity and maleylacetoacetate isomerase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTZ1 (glutathione S-transferase zeta 1).

WB:WBGene00021818	Y53G8B.2
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Is an ortholog of human MOGAT1 (monoacylglycerol O-acyltransferase 1).

WB:WBGene00021819	Y53G8B.3
Is affected by several genes including daf-2; npr-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00021820	nipa-1
Is predicted to have magnesium ion transmembrane transporter activity. Is involved in adult locomotory behavior. Localizes to neuronal cell body. Is used to study hereditary spastic paraplegia. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 6 and hereditary spastic paraplegia 6. Is an ortholog of human NIPA2 (NIPA magnesium transporter 2) and NIPAL1 (NIPA like domain containing 1).

WB:WBGene00021821	Y54B9A.1
Is enriched in OLL and PVD based on microarray studies. Is affected by mir-34; ints-5; and ints-6 based on microarray and RNA-seq studies. Is affected by six chemicals including sesamin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: GETHR pentapeptide repeat (5 copies) and GETHR pentapeptide repeat.

WB:WBGene00021822	Y54C5A.1
Is enriched in NSM and coelomocyte based on tiling array studies. Is affected by rsr-2; clk-1; and sir-2.1 based on tiling array and microarray studies. Is affected by resveratrol and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00021823	Y54C5B.1
No description available

WB:WBGene00021826	txl-1
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by Zidovudine; Sirolimus; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PITH domain; Thioredoxin; Galactose-binding-like domain superfamily; PITH domain; Thioredoxin domain; Thioredoxin-like superfamily; and PITH domain superfamily. Is an ortholog of human TXNL1 (thioredoxin like 1).

WB:WBGene00021827	dnc-6
Localizes to dynactin complex. Is an ortholog of human DCTN6 (dynactin subunit 6).

WB:WBGene00021828	Y54E10A.6
Is predicted to have RNA binding activity and phenylalanine-tRNA ligase activity. Is an ortholog of human LRRC47 (leucine rich repeat containing 47).

WB:WBGene00021829	mrpl-17
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL17 (mitochondrial ribosomal protein L17).

WB:WBGene00021830	Y54E10A.10
Is predicted to have rRNA binding activity. Is an ortholog of human RPF2 (ribosome production factor 2 homolog).

WB:WBGene00021831	Y54E10A.11
Is predicted to have ribosomal large subunit binding activity and ubiquitin protein ligase activity. Is an ortholog of human LTN1 (listerin E3 ubiquitin protein ligase 1).

WB:WBGene00021832	syp-5
Is enriched in several structures, including DA neuron; germ line; germline precursor cell; head mesodermal cell; and interneuron based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; D-glucose; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00021833	Y54E10A.13
Is enriched in NSM; body wall muscle cell; germline precursor cell; and hypodermis based on tiling array studies. Is affected by several genes including pgl-1; cep-1; and glh-1 based on microarray and RNA-seq studies. Is affected by Psoralens and allantoin based on RNA-seq studies.

WB:WBGene00021834	mab-31
Is involved in nematode male tail tip morphogenesis and transforming growth factor beta receptor signaling pathway. Localizes to nucleus. Is expressed in hyp7 syncytium; intestine; pharynx; ray; and socket cell.

WB:WBGene00021835	Y54E10A.17
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00021837	Y54E10BL.1
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride based on microarray studies.

WB:WBGene00021838	Y54E10BL.3
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; age-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021839	nduf-5
Is enriched in ASER; OLL; PVD; germ line; and hypodermis based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by four chemicals including biotin; Rotenone; and fluoranthene based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: NADH:ubiquinone oxidoreductase, NDUFS5-15kDa and NADH:ubiquinone oxidoreductase, iron-sulphur subunit 5. Is an ortholog of human NDUFS5 (NADH:ubiquinone oxidoreductase subunit S5).

WB:WBGene00021840	pign-1
Is predicted to have mannose-ethanolamine phosphotransferase activity. Localizes to integral component of endoplasmic reticulum membrane. Is expressed in body wall musculature; hypodermis; intestine; and pharynx. Human ortholog(s) of this gene are implicated in multiple congenital anomalies-hypotonia-seizures syndrome 1. Is an ortholog of human PIGN (phosphatidylinositol glycan anchor biosynthesis class N).

WB:WBGene00021841	Y54E10BR.2
Is predicted to have GTP binding activity. Is an ortholog of human ARFRP1 (ADP ribosylation factor related protein 1).

WB:WBGene00021842	Y54E10BR.3
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human RNF126 (ring finger protein 126).

WB:WBGene00021843	Y54E10BR.4
Is predicted to have endoribonuclease activity. Localizes to cytoplasm. Is expressed in neurons. Is an ortholog of human NOB1 (NIN1 (RPN12) binding protein 1 homolog).

WB:WBGene00021844	sec-11
Is predicted to have peptidase activity. Is involved in IRE1-mediated unfolded protein response. Is an ortholog of human SEC11A (SEC11 homolog A, signal peptidase complex subunit) and SEC11C (SEC11 homolog C, signal peptidase complex subunit).

WB:WBGene00021845	rpb-7
Is predicted to have single-stranded DNA binding activity; single-stranded RNA binding activity; and translation initiation factor binding activity. Is an ortholog of human POLR2G (RNA polymerase II subunit G).

WB:WBGene00021846	ztf-23
Is enriched in PLM; germ line; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00021847	Y54F10AL.1
Is predicted to have calcium ion transmembrane transporter activity and manganese ion transmembrane transporter activity. Is expressed in head. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIk. Is an ortholog of human TMEM165 (transmembrane protein 165).

WB:WBGene00021848	nhr-239
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in head neurons and pharyngeal neurons. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus.

WB:WBGene00021849	Y54F10AM.5
Is enriched in ASER; PLM; germ line; and germline precursor cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including biotin; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 8. Is an ortholog of human NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8).

WB:WBGene00021850	Y54F10AM.6
Is enriched in AFD; OLL; PVD; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including Heme; methylmercury hydroxide; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T19C3.2-like.

WB:WBGene00021852	Y54F10AM.8
Is predicted to have phospholipase activity. Is an ortholog of human PLBD2 (phospholipase B domain containing 2).

WB:WBGene00021853	Y54F10AM.11
Is enriched in AB; AVG; RIM; command interneuron; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; Rotenone; and nanoparticle based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00021854	Y54F10AR.1
Is predicted to have phospholipid binding activity and phospholipid transporter activity. Is an ortholog of human PITPNA (phosphatidylinositol transfer protein alpha).

WB:WBGene00021855	Y54F10AR.2
Is enriched in germ line; germline precursor cell; muscle cell; sensory neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; clk-1; and isp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021856	ppm-1.D
Is predicted to have magnesium-dependent protein serine/threonine phosphatase activity and mitogen-activated protein kinase binding activity. Human ortholog(s) of this gene are implicated in breast cancer. Is an ortholog of human PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D).

WB:WBGene00021857	iffb-1
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF5B (eukaryotic translation initiation factor 5B).

WB:WBGene00021858	Y54F10BM.3
Is predicted to have protein tyrosine phosphatase activity. Is expressed in anterior gonad arm.

WB:WBGene00021859	fbxa-39
Is affected by several genes including skn-1; eat-2; and lin-35 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00021860	fbxa-9
Is affected by several genes including elt-2; mex-3; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Tunicamycin; paraquat; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021861	Y54F10BM.6
Is enriched in OLL and PVD based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00021862	fbxa-48
Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including methylmercuric chloride; Tunicamycin; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021863	Y54F10BM.9
Is enriched in germ line; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by D-glucose; Cry5B; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00021864	fbxa-1
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including age-1; eat-2; and smg-1 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021865	fbxa-66
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; bisphenol A; and Cadmium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021866	Y54F10BM.12
Is enriched in body wall muscle cell; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including fog-2; pgl-1; and lin-15B based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021867	Y54F10BM.13
Is predicted to have JUN kinase phosphatase activity. Is an ortholog of human DUSP19 (dual specificity phosphatase 19).

WB:WBGene00021868	atln-1
Is predicted to have GTP binding activity and GTPase activity. Is involved in IRE1-mediated unfolded protein response. Human ortholog(s) of this gene are implicated in hereditary sensory neuropathy type 1D; hereditary sensory neuropathy type 1F; and hereditary spastic paraplegia 3A. Is an ortholog of human ATL3 (atlastin GTPase 3).

WB:WBGene00021869	vrp-1
Is expressed in intestinal cell. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021870	samt-1
Is predicted to have molybdate ion transmembrane transporter activity. Is an ortholog of human MFSD5 (major facilitator superfamily domain containing 5).

WB:WBGene00021871	dml-1
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; gld-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021872	clec-85
Is predicted to have carbohydrate binding activity. Is expressed in intestine.

WB:WBGene00021873	clec-82
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00021875	Y54G2A.10
Is enriched in amphid sheath cell; head mesodermal cell; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including Ethanol; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021876	Y54G2A.11
Is enriched in body wall musculature; hypodermis; intestine; and ventral nerve cord based on Chronogram; tiling array; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including Heme; 1-methylnicotinamide; and Rotenone based on microarray and RNA-seq studies.

WB:WBGene00021877	Y54G2A.12
Is enriched in AFD; germ line; germline precursor cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily; Pre-mRNA-processing factor 17; and WD40-repeat-containing domain superfamily. Is an ortholog of human CDC40 (cell division cycle 40).

WB:WBGene00021878	Y54G2A.13
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Ethanol; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00021879	clec-83
Is predicted to have carbohydrate binding activity.

WB:WBGene00021880	Y54G2A.15
Is enriched in amphid sheath cell; seam cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00021881	Y54G2A.16
Is enriched in body wall musculature; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and sma-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00021882	nprt-1
Is predicted to have nicotinate phosphoribosyltransferase activity. Is an ortholog of human NAPRT (nicotinate phosphoribosyltransferase).

WB:WBGene00021883	Y54G2A.18
Is involved in IRE1-mediated unfolded protein response. Localizes to membrane raft. Is an ortholog of human BCAP31 (B cell receptor associated protein 31).

WB:WBGene00021884	Y54G2A.19
Is enriched in germ line; intestine; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; gld-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Zidovudine; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00021885	Y54G2A.20
Is enriched in NSM based on tiling array studies. Is affected by several genes including skn-1; pgl-1; and sod-2 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00021886	Y54G2A.21
Is enriched in AVK; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Alovudine; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00021887	fbxc-45
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including manganese chloride; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF3557.

WB:WBGene00021888	manf-1
Exhibits sulfatide binding activity. Is involved in developmental growth; negative regulation of neuron death; and regulation of response to endoplasmic reticulum stress. Is expressed in several structures, including anus; excretory gland cell; pharynx; rectal valve cell; and vulval muscle. Is an ortholog of human MANF (mesencephalic astrocyte derived neurotrophic factor).

WB:WBGene00021889	Y54G2A.24
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00021890	Y54G2A.26
Is enriched in germ line; head mesodermal cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including hydrogen sulfide; Cry5B; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021892	Y54G2A.28
Is enriched in OLL; PVD; germline precursor cell; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00021893	ndnf-1
Is enriched in PLM; body wall muscle cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; elt-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including levamisole; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised conserved protein (DUF2369) and Protein NDNF. Is an ortholog of human NDNF (neuron derived neurotrophic factor).

WB:WBGene00021894	Y54G2A.32
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021895	clec-84
Is predicted to have carbohydrate binding activity.

WB:WBGene00021897	ser-6
Exhibits octopamine receptor activity. Is involved in positive regulation of fatty acid beta-oxidation by octopamine signaling pathway. Is expressed in intestine; neurons; and in male.

WB:WBGene00021898	Y54G2A.36
Is enriched in Z1.p; Z4.a; germ line; head mesodermal cell; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; Linolenic Acids; and tert-Butylhydroperoxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Chondroitin proteoglycan 3.

WB:WBGene00021899	Y54H5A.1
Is enriched in OLL; PVD; body wall muscle cell; germ line; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by bisphenol S; Diazinon; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histone-binding protein RBBP4 or subunit C of CAF1 complex; WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; Histone-binding protein RBBP4, N-terminal; and WD40-repeat-containing domain superfamily. Is an ortholog of human GRWD1 (glutamate rich WD repeat containing 1).

WB:WBGene00021900	Y54H5A.2
Is enriched in body wall muscle cell; germ line; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; gld-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including bisphenol S; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF383); Domain of unknown function (DUF384); Protein HGH1 N-terminal; Protein HGH1 C-terminal; Armadillo-like helical; Armadillo-type fold; and Protein Hgh1. Is an ortholog of human HGH1 (HGH1 homolog).

WB:WBGene00021901	rbm-42
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2 and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human RBM42 (RNA binding motif protein 42).

WB:WBGene00021902	oxy-4
Is predicted to have 4 iron, 4 sulfur cluster binding activity and metal ion binding activity. Is an ortholog of human CIAO3 (cytosolic iron-sulfur assembly component 3).

WB:WBGene00021904	gtf-2H5
Is enriched in germ line; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transcription factor TFIIH complex subunit Tfb5; TFIIH subunit TTDA/Tfb5; and TFB5-like superfamily. Is an ortholog of human GTF2H5 (general transcription factor IIH subunit 5).

WB:WBGene00021905	helq-1
Exhibits ATPase binding activity and single-stranded DNA helicase activity. Is involved in resolution of meiotic recombination intermediates. Is an ortholog of human HELQ (helicase, POLQ like).

WB:WBGene00021906	Y55B1AR.2
Is enriched in germ line; head mesodermal cell; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-12; let-7; and gld-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by eight chemicals including bisphenol S; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021907	Y55B1AR.3
Is enriched in NSM and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pmk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Sodium Chloride; and Atrazine based on microarray and RNA-seq studies.

WB:WBGene00021908	Y55B1AR.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00021909	Y55B1BL.1
Is enriched in excretory cell; hypodermis; and neurons based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rifampin; D-glucose; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00021910	stim-1
Exhibits calcium channel regulator activity and identical protein binding activity. Is involved in several processes, including ovulation; positive regulation of transport; and store-operated calcium entry. Localizes to several cellular components, including dendrite; neuronal cell body; and plasma membrane. Is expressed in gonadal sheath cell; intestine; spermatheca; and uterine toroidal epithelial cell. Human ortholog(s) of this gene are implicated in Stormorken syndrome and tubular aggregate myopathy. Is an ortholog of human STIM1 (stromal interaction molecule 1).

WB:WBGene00021911	affl-1
Is affected by several genes including pgl-1; glh-1; and met-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin; Sirolimus; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00021912	affl-2
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Cholestanol; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00021913	cec-8
Is predicted to have chromatin binding activity and methylated histone binding activity.

WB:WBGene00021914	magu-1
Is expressed in arcade cell; intestine; and marginal cell. Is predicted to encode a protein with the following domains: PDZ domain; Guanylate kinase; Variant SH3 domain; SH3 domain; PDZ domain; Guanylate kinase/L-type calcium channel beta subunit; P-loop containing nucleoside triphosphate hydrolase; SH3-like domain superfamily; and PDZ superfamily. Is an ortholog of human MPP7 (membrane palmitoylated protein 7).

WB:WBGene00021915	Y55D5A.1
Is expressed in amphid neurons; intestine; and sensory neurons.

WB:WBGene00021916	Y55D5A.2
Is affected by several genes including eat-2; lin-35; and lin-15B based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; Diazinon; and Sirolimus based on microarray studies.

WB:WBGene00021917	Y55D5A.3
Is predicted to have fatty acid amide hydrolase activity. Is an ortholog of human NAAA (N-acylethanolamine acid amidase).

WB:WBGene00021918	Y55D5A.4
Is enriched in head mesodermal cell and muscle cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021919	cutl-25
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Zona pellucida-like domain; and Zona pellucida domain.

WB:WBGene00021920	mrps-25
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS25 (mitochondrial ribosomal protein S25).

WB:WBGene00021921	rbm-39
Is predicted to have RNA binding activity. Is expressed in PVDL; PVDR; neurons; and tail. Human ortholog(s) of this gene are implicated in Y-linked spermatogenic failure 2; autosomal dominant limb-girdle muscular dystrophy type 3; and syndromic X-linked intellectual disability Shashi type. Is an ortholog of human RBM39 (RNA binding motif protein 39).

WB:WBGene00021922	atg-3
Is predicted to have Atg8 ligase activity. Is involved in macroautophagy. Is an ortholog of human ATG3 (autophagy related 3).

WB:WBGene00021923	Y55F3AM.5
Is enriched in germ line; germline precursor cell; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; isp-1; and alg-1 based on proteomic; RNA-seq; and microarray studies. Is affected by four chemicals including antimycin; multi-walled carbon nanotube; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2013); Armadillo-like helical; Armadillo-type fold; and Domain of unknown function DUF2013.

WB:WBGene00021925	immp-2
Is predicted to have serine-type peptidase activity. Is an ortholog of human IMMP2L (inner mitochondrial membrane peptidase subunit 2).

WB:WBGene00021926	Y55F3AM.9
Is predicted to have Lys48-specific deubiquitinase activity and cysteine-type carboxypeptidase activity. Is an ortholog of human MINDY1 (MINDY lysine 48 deubiquitinase 1) and MINDY2 (MINDY lysine 48 deubiquitinase 2).

WB:WBGene00021927	abhd-14
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is an ortholog of human ABHD14B (abhydrolase domain containing 14B).

WB:WBGene00021928	Y55F3AM.11
Is enriched in germ line and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Mianserin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Methyltransferase domain; Methyltransferase domain; Methyltransferase-like protein 24; and S-adenosyl-L-methionine-dependent methyltransferase.

WB:WBGene00021929	dcap-1
Is predicted to have enzyme regulator activity and mRNA binding activity. Is involved in several processes, including determination of adult lifespan; nematode larval development; and response to heat. Localizes to P granule and P-body. Is expressed in head and tail. Is an ortholog of human DCP1B (decapping mRNA 1B).

WB:WBGene00021930	Y55F3AM.13
Is enriched in germ line and somatic gonad precursor based on proteomic and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; proteomic; and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00021931	Y55F3AM.14
Is expressed in dorsal nerve cord; head muscle; intestine; and ventral nerve cord. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; C2H2-type zinc finger; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily. Is an ortholog of several human genes including ZNF155 (zinc finger protein 155); ZNF417 (zinc finger protein 417); and ZNF776 (zinc finger protein 776).

WB:WBGene00021932	cox-18
Is predicted to have membrane insertase activity. Is an ortholog of human COX18 (cytochrome c oxidase assembly factor COX18).

WB:WBGene00021933	Y55F3AR.2
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-16; daf-2; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by Rotenone and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Thioredoxin; Domain of unknown function (DUF4605); Thioredoxin domain; Domain of unknown function DUF4605; and Thioredoxin-like superfamily. Is an ortholog of human TXNL1 (thioredoxin like 1).

WB:WBGene00021934	cct-8
Is predicted to have ATP binding activity and unfolded protein binding activity. Is an ortholog of human CCT8 (chaperonin containing TCP1 subunit 8).

WB:WBGene00021935	mrpl-46
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL46 (mitochondrial ribosomal protein L46).

WB:WBGene00021936	zipt-15
Is predicted to have zinc ion transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including acrodermatitis enteropathica; congenital disorder of glycosylation type IIn; and hypermanganesemia with dystonia 2. Is an ortholog of human SLC39A14 (solute carrier family 39 member 14) and SLC39A8 (solute carrier family 39 member 8).

WB:WBGene00021938	Y55F3BR.1
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX1 (DEAD-box helicase 1).

WB:WBGene00021939	Y55F3BR.2
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3. Is an ortholog of human WFIKKN1 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1) and WFIKKN2 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2).

WB:WBGene00021941	lgc-33
Is predicted to have chloride channel activity.

WB:WBGene00021942	madf-1
Is enriched in germ line; germline precursor cell; head mesodermal cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by four chemicals including Rotenone; Mianserin; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: MADF domain.

WB:WBGene00021943	Y55F3BR.6
Is enriched in several structures, including excretory cell; germline precursor cell; head mesodermal cell; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and let-7 based on microarray; proteomic; and RNA-seq studies. Is affected by fourteen chemicals including aldicarb; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Hsp20/alpha crystallin family; Alpha crystallin/Small heat shock protein, animal type; Alpha crystallin/Hsp20 domain; and HSP20-like chaperone. Is an ortholog of human CRYAB (crystallin alpha B); HSPB1 (heat shock protein family B (small) member 1); and HSPB6 (heat shock protein family B (small) member 6).

WB:WBGene00021945	lem-4
Exhibits protein phosphatase 2A binding activity. Is involved in mitotic nuclear envelope reassembly; negative regulation of phosphorylation; and positive regulation of protein dephosphorylation. Localizes to nuclear envelope. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 16. Is an ortholog of human ANKLE2 (ankyrin repeat and LEM domain containing 2).

WB:WBGene00021947	srt-23
Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00021948	kvs-5
Is predicted to have voltage-gated potassium channel activity. Localizes to plasma membrane. Human ortholog(s) of this gene are implicated in several diseases, including electroclinical syndrome (multiple); heart conduction disease (multiple); and long QT syndrome (multiple). Is an ortholog of human KCNF1 (potassium voltage-gated channel modifier subfamily F member 1).

WB:WBGene00021949	clec-164
Is predicted to have carbohydrate binding activity.

WB:WBGene00021950	cutl-26
Is enriched in FLP; germ line; head mesodermal cell; hypodermis; and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including sesamin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Zona pellucida domain.

WB:WBGene00021951	srt-24
Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00021952	vha-19
Localizes to membrane raft. Is expressed in excretory canal; hypodermis; intestine; pharynx; and vulva. Is an ortholog of human ATP6AP1 (ATPase H+ transporting accessory protein 1).

WB:WBGene00021953	Y55H10A.2
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-12; clk-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021954	Y55H10B.1
No description available

WB:WBGene00021955	Y55H10B.2
No description available

WB:WBGene00021956	Y57E12AL.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Cry5B; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serine incorporator (Serinc) and Serine incorporator/TMS membrane protein. Is an ortholog of human SERINC1 (serine incorporator 1) and SERINC3 (serine incorporator 3).

WB:WBGene00021957	Y57E12AL.2
Is affected by jmjd-3.1 and drh-3 based on RNA-seq studies. Is affected by five chemicals including Atrazine; Chlorpyrifos; and Colistin based on microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF4473.

WB:WBGene00021958	Y57E12AL.4
Is affected by eat-2 based on RNA-seq studies. Is affected by four chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF4473.

WB:WBGene00021959	Y57E12AL.6
Is enriched in several structures, including germ line; germline precursor cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq; proteomic; and microarray studies. Is affected by six chemicals including stavudine; Atrazine; and Hydrolyzable Tannins based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteasome maturation factor UMP1 and Proteasome maturation factor Ump1.

WB:WBGene00021960	tmem-258
Is enriched in germ line; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including aak-2; pal-1; and fbf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; Cry5B; and fluoranthene based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Oligosaccharyltransferase subunit 5 and Oligosaccharyltransferase complex subunit. Is an ortholog of human TMEM258 (transmembrane protein 258).

WB:WBGene00021961	Y57E12B.1
Is affected by several genes including clk-1; lin-35; and lin-15B based on microarray and RNA-seq studies. Is affected by four chemicals including methylmercuric chloride; single-walled carbon nanotube; and dafa#1 based on microarray studies.

WB:WBGene00021963	lipl-6
Is enriched in CEPshDL; CEPshDR; CEPshVL; and CEPshVR based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is predicted to encode a protein with the following domains: Partial alpha/beta-hydrolase lipase region; Partial AB-hydrolase lipase domain; and Alpha/Beta hydrolase fold. Is an ortholog of human LIPF (lipase F, gastric type) and LIPN (lipase family member N).

WB:WBGene00021964	Y57E12B.4
Is enriched in dopaminergic neurons and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; multi-walled carbon nanotube; and nanoparticle based on microarray and RNA-seq studies.

WB:WBGene00021965	Y57G7A.1
Is enriched in GABAergic neurons; amphid sheath cell; excretory cell; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Mianserin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00021966	Y57G7A.2
Is affected by several genes including daf-2; age-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including Mercuric Chloride; Rotenone; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00021967	Y57G7A.3
Is enriched in body wall muscle cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including nanoparticle; Humic Substances; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00021968	Y57G7A.5
Is enriched in germ line; neurons; retrovesicular ganglion; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; Rotenone; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00021969	Y57G7A.6
Is expressed in hypodermis. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00021970	srz-64
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00021971	Y57G7A.8
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021972	glb-31
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in head neurons.

WB:WBGene00021973	emc-2
Localizes to sarcoplasmic reticulum. Is an ortholog of human EMC2 (ER membrane protein complex subunit 2).

WB:WBGene00021974	Y57G7A.11
Is enriched in body wall muscle cell and dopaminergic neurons based on tiling array studies. Is affected by several genes including elt-2; mex-3; and ain-1 based on microarray and RNA-seq studies. Is affected by five chemicals including aldicarb; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00021975	Y58A7A.1
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00021976	Y58A7A.2
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including methylmercury hydroxide; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00021977	Y58A7A.3
Is enriched in amphid sheath cell; carbon dioxide sensory neurons; hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; 1-methylnicotinamide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021978	Y58A7A.4
Is expressed in head neurons and intestine. Is predicted to encode a protein with the following domain: .

WB:WBGene00021979	Y58A7A.5
Is involved in PERK-mediated unfolded protein response.

WB:WBGene00021980	glb-32
Is predicted to have heme binding activity; oxygen binding activity; and oxygen carrier activity. Is expressed in head neurons; lateral nerve cord; tail neurons; ventral cord neurons; and ventral nerve cord.

WB:WBGene00021981	lgc-26
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is involved in determination of adult lifespan and endocytosis. Localizes to cytoplasm.

WB:WBGene00021982	Y58G8A.2
No description available

WB:WBGene00021983	npr-5
Is predicted to have G protein-coupled receptor activity. Is involved in regulation of muscle contraction. Is expressed in body wall musculature; chemosensory neurons; and head neurons. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human NPY4R (neuropeptide Y receptor Y4) and PRLHR (prolactin releasing hormone receptor).

WB:WBGene00021984	Y59C2A.1
Is predicted to have metallocarboxypeptidase activity. Human ortholog(s) of this gene are implicated in familial febrile seizures 11 and familial temporal lobe epilepsy 5.

WB:WBGene00021985	Y59C2A.2
Is expressed in head and tail. Is predicted to encode a protein with the following domains: Tumour-associated protein and Membralin. Is an ortholog of human TMEM259 (transmembrane protein 259).

WB:WBGene00021986	Y59C2A.3
Is enriched in OLL; germ line; and interneuron based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including aldicarb; 1-methylnicotinamide; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021987	fbxa-40
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on RNA-seq and microarray studies. Is affected by fluoranthene; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00021988	rgs-8.2
Is affected by several genes including daf-16; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Regulator of G protein signaling domain; RGS domain; RGS, subdomain 1/3; and RGS domain superfamily.

WB:WBGene00021989	Y59E1A.3
No description available

WB:WBGene00021990	Y59E1B.1
Is enriched in Z1.p; Z4.a; male distal tip cell; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00021992	thn-6
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including hpl-2; mut-2; and drh-3 based on RNA-seq; tiling array; and microarray studies. Is affected by multi-walled carbon nanotube and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thaumatin family; Thaumatin family; and Osmotin/thaumatin-like superfamily.

WB:WBGene00021993	Y59E9AL.3
Is enriched in amphid sheath cell; hypodermis; neurons; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-two chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00021994	Y59E9AL.4
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC23A1 (solute carrier family 23 member 1) and SLC23A2 (solute carrier family 23 member 2).

WB:WBGene00021995	Y59E9AL.5
Is affected by several genes including daf-2; dpy-10; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00021996	Y59E9AL.6
Is enriched in body wall muscle cell; cholinergic neurons; germ line; hypodermis; and in male based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty-six chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00021997	Y59E9AR.1
Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Ethanol; methylmercury hydroxide; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00021998	Y59E9AR.2
Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Cry5B; resveratrol; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: Zc3h12a-like Ribonuclease NYN domain and Ribonuclease Zc3h12a-like, NYN domain.

WB:WBGene00021999	thn-5
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Thaumatin family; Thaumatin family; and Osmotin/thaumatin-like superfamily.

WB:WBGene00022000	tbx-42
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00022001	thn-7
Is affected by cyc-1; ets-4; and eat-2 based on microarray studies. Is affected by methylmercuric chloride and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022002	Y59E9AR.7
Is expressed in germ line. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00022003	Y59E9AR.8
Is affected by several genes including daf-16; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Zc3h12a-like Ribonuclease NYN domain and Ribonuclease Zc3h12a-like, NYN domain.

WB:WBGene00022004	npr-22
Exhibits neuropeptide receptor activity. Is involved in several processes, including determination of adult lifespan; negative regulation of feeding behavior; and positive regulation of oviposition. Is expressed in body wall musculature; intestine; neurons; and pharyngeal muscle cell. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 3 with or without anosmia and type 2 diabetes mellitus. Is an ortholog of human NPFFR2 (neuropeptide FF receptor 2).

WB:WBGene00022005	Y59H11AM.1
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; proteomic; and RNA-seq studies. Is affected by six chemicals including aldicarb; Ethanol; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00022006	mpst-5
Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Ethanol; methylmercuric chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Rhodanese-like domain; Rhodanese-like domain; and Rhodanese-like domain superfamily. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00022007	mpst-6
Is predicted to have thiosulfate sulfurtransferase activity. Is an ortholog of human MPST (mercaptopyruvate sulfurtransferase) and TST (thiosulfate sulfurtransferase).

WB:WBGene00022008	Y59H11AM.4
Is enriched in amphid sheath cell; head mesodermal cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00022010	catp-7
Is predicted to have ATP binding activity; ATPase activity; and metal ion binding activity. Is expressed in several structures, including amphid neurons; excretory cell; gonad; spermatocyte; and vulva. Human ortholog(s) of this gene are implicated in several diseases, including Brody myopathy; keratosis (multiple); and neurodegenerative disease (multiple). Is an ortholog of human ATP13A3 (ATPase 13A3).

WB:WBGene00022011	Y59H11AR.3
Is affected by drh-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00022012	Y59H11AR.4
Is predicted to have amino acid transmembrane transporter activity.

WB:WBGene00022013	Y60C6A.1
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including multi-walled carbon nanotube; nanoparticle; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00022014	Y61A9LA.1
Is predicted to have transmembrane transporter activity. Is expressed in hypodermis. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00022015	Y61A9LA.3
Is enriched in AVK; NSM; germ line; hypodermis; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and fbf-1 based on RNA-seq and microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies.

WB:WBGene00022016	Y61A9LA.4
Is affected by several genes including daf-16; daf-2; and lin-15B based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022017	Y61A9LA.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00022018	Y61A9LA.7
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Mianserin; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022019	sut-2
Is predicted to have poly(A) binding activity. Localizes to nucleus and perinuclear region of cytoplasm. Is expressed in germ line; hypodermis; and intestine. Is an ortholog of human ZC3H14 (zinc finger CCCH-type containing 14).

WB:WBGene00022020	hpo-39
Is enriched in DA neuron; I5 neuron; SAB; muscle cell; and retrovesicular ganglion based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and mex-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022021	Y61A9LA.10
Is predicted to have GTP binding activity; GTPase activity; and U3 snoRNA binding activity. Is expressed in head. Is an ortholog of human BMS1 (BMS1 ribosome biogenesis factor).

WB:WBGene00022022	txt-6
Is enriched in AFD; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; bisphenol S; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1757) and Protein of unknown function DUF1757.

WB:WBGene00022023	Y64H9A.1
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; clk-1; and drh-3 based on microarray and RNA-seq studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00022024	Y64H9A.2
Is enriched in OLL; PLM; PVD; germline precursor cell; and hypodermis based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty chemicals including methylmercury hydroxide; 1-methylnicotinamide; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00022025	cus-2
Is predicted to have RNA binding activity. Is an ortholog of human HTATSF1 (HIV-1 Tat specific factor 1).

WB:WBGene00022026	Y65B4A.2
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13. Is an ortholog of human CTSB (cathepsin B).

WB:WBGene00022027	vps-20
Is enriched in AFD; ASER; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; sir-2.1; and lin-35 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; Cry5B; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Snf7 and Snf7 family. Is an ortholog of human CHMP6 (charged multivesicular body protein 6).

WB:WBGene00022028	Y65B4A.4
Is predicted to have actin binding activity and adenylate cyclase binding activity.

WB:WBGene00022029	Y65B4A.6
Is predicted to have RNA helicase activity and mRNA binding activity. Is an ortholog of human EIF4A3 (eukaryotic translation initiation factor 4A3).

WB:WBGene00022030	Y65B4A.7
Is predicted to have metal ion binding activity.

WB:WBGene00022031	Y65B4A.8
Is predicted to have dephospho-CoA kinase activity. Human ortholog(s) of this gene are implicated in neurodegeneration with brain iron accumulation 6. Is an ortholog of human COASY (Coenzyme A synthase).

WB:WBGene00022032	Y65B4A.9
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00022033	Y65B4BL.1
Is enriched in OLL; PVD; hypodermis; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022034	deps-1
Localizes to P granule. Is expressed in germ line and oocyte.

WB:WBGene00022035	Y65B4BL.3
Is enriched in body wall muscle cell; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00022036	Y65B4BL.4
Is enriched in AFD; body wall muscle cell; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00022037	acs-13
Is predicted to have catalytic activity. Is expressed in head. Is an ortholog of human ACSL5 (acyl-CoA synthetase long chain family member 5).

WB:WBGene00022038	Y65B4BL.6
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; tryptophan; and 1-methylnicotinamide based on RNA-seq and microarray studies.

WB:WBGene00022039	Y65B4BL.7
Is enriched in intestine based on tiling array and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022040	Y65B4BR.1
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00022042	icd-2
Is expressed in intestinal cell. Is predicted to encode a protein with the following domains: Phosphorylation site; NAC domain; Nascent polypeptide-associated complex NAC domain; Nascent polypeptide-associated complex subunit alpha; and NAC A/B domain superfamily. Is an ortholog of human NACA (nascent polypeptide associated complex subunit alpha).

WB:WBGene00022043	psf-3
Is enriched in several structures, including Z4.a; germ line; germline precursor cell; intestine; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GINS complex protein; GINS complex, subunit Psf3; GINS subunit, domain A; GINS, helical bundle-like domain superfamily; and GINS complex, subunit Psf3 superfamily. Is an ortholog of human GINS3 (GINS complex subunit 3).

WB:WBGene00022044	dpm-1
Is predicted to have dolichyl-phosphate beta-D-mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ie. Is an ortholog of human DPM1 (dolichyl-phosphate mannosyltransferase subunit 1, catalytic).

WB:WBGene00022045	mrpl-55
Is predicted to be a structural constituent of ribosome. Localizes to mitochondrion. Is an ortholog of human MRPL55 (mitochondrial ribosomal protein L55).

WB:WBGene00022046	Y66H1A.4
Is predicted to have box H/ACA snoRNA binding activity. Is an ortholog of human GAR1 (GAR1 ribonucleoprotein).

WB:WBGene00022047	Y66H1A.5
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Mianserin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022048	fln-1
Is involved in several processes, including axon development; semaphorin-plexin signaling pathway; and uterus morphogenesis. Localizes to actin filament. Is expressed in body wall musculature; gonad; hypodermis; intestine; and vulval muscle. Human ortholog(s) of this gene are implicated in several diseases, including bone development disease (multiple); epidermolysis bullosa (multiple); and myopathy (multiple). Is an ortholog of human FLNA (filamin A) and FLNC (filamin C).

WB:WBGene00022051	rep-1
Is predicted to have Rab GTPase binding activity. Is expressed in alimentary muscle; body wall musculature; hypodermis; and neurons. Human ortholog(s) of this gene are implicated in choroideremia. Is an ortholog of human CHM (CHM Rab escort protein) and CHML (CHM like Rab escort protein).

WB:WBGene00022052	Y67D2.2
Is predicted to have thiol-dependent ubiquitinyl hydrolase activity. Human ortholog(s) of this gene are implicated in ACTH-secreting pituitary adenoma; Y-linked spermatogenic failure 2; and non-syndromic X-linked intellectual disability. Is an ortholog of human USP30 (ubiquitin specific peptidase 30).

WB:WBGene00022053	cisd-3.2
Is predicted to have 2 iron, 2 sulfur cluster binding activity. Is an ortholog of human CISD3 (CDGSH iron sulfur domain 3).

WB:WBGene00022054	Y67D2.4
Is predicted to have GTPase activity. Is an ortholog of human MTG1 (mitochondrial ribosome associated GTPase 1).

WB:WBGene00022055	Y67D2.5
Is predicted to have N-acetyltransferase activity. Is an ortholog of human NAT9 (N-acetyltransferase 9 (putative)).

WB:WBGene00022056	ddx-35
Is predicted to have RNA binding activity. Is an ortholog of human DHX35 (DEAH-box helicase 35).

WB:WBGene00022057	Y67D2.7
Is enriched in germ line; hypodermis; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by six chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; HCNGP-like protein; and SAP30-binding protein. Is an ortholog of human SAP30BP (SAP30 binding protein).

WB:WBGene00022059	Y67D8A.2
Is predicted to contribute to phosphorylase kinase activity. Human ortholog(s) of this gene are implicated in glycogen storage disease IXb. Is an ortholog of human PHKB (phosphorylase kinase regulatory subunit beta).

WB:WBGene00022060	dmd-9
Is predicted to have DNA-binding transcription factor activity; metal ion binding activity; and sequence-specific DNA binding activity. Is expressed in several structures, including body wall musculature; coelomocyte; intestine; neurons; and somatic nervous system.

WB:WBGene00022061	Y67D8B.1
Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022062	Y67D8B.2
Is enriched in neurons and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including pgl-1; alg-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00022063	nlp-81
Is enriched in neurons and retrovesicular ganglion based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00022064	Y67D8B.5
Is enriched in DA neuron; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including aldicarb; methylmercuric chloride; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00022066	Y67D8C.2
Is affected by several genes including eat-2; pgl-1; and dpy-21 based on RNA-seq studies. Is affected by five chemicals including aldicarb; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022067	ivph-3
Is enriched in germ line; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribonuclease H-like superfamily and Protein lin-15B-like.

WB:WBGene00022069	eel-1
Is predicted to have ubiquitin protein ligase activity. Is involved in several processes, including asymmetric protein localization involved in cell fate determination; hemidesmosome assembly; and signal transduction in response to DNA damage. Is expressed in several structures, including hermaphrodite gonad; intestine; neurons; pharynx; and vulva. Is used to study syndromic X-linked intellectual disability. Is an ortholog of human HUWE1 (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1).

WB:WBGene00022070	Y67D8C.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00022071	Y67D8C.7
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including rrf-3; eat-2; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube; cadmium; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022072	cpg-9
Is enriched in body wall muscle cell and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including Rotenone; Tunicamycin; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00022073	Y67D8C.9
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Is involved in embryo development; regulation of meiotic cell cycle process involved in oocyte maturation; and regulation of oviposition.

WB:WBGene00022074	Y69A2AR.1
Is enriched in germ line and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Aspirin; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022075	Y69A2AR.3
Is enriched in AFD; ASER; Psub1; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial and NADH-ubiquinone oxidoreductase flavoprotein 3.

WB:WBGene00022076	daao-1
Exhibits D-amino-acid oxidase activity. Is involved in oxidation-reduction process. Is expressed in intestinal cell. Is an ortholog of human DDO (D-aspartate oxidase).

WB:WBGene00022077	vamp-7
Is predicted to have SNAP receptor activity and syntaxin binding activity. Is an ortholog of human VAMP8 (vesicle associated membrane protein 8).

WB:WBGene00022078	epg-9
Exhibits protein kinase binding activity. Is involved in aggrephagy. Is expressed in several structures, including body wall musculature; head; hypodermis; pharyngeal muscle cell; and tail. Is an ortholog of human ATG101 (autophagy related 101).

WB:WBGene00022079	Y69A2AR.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00022081	Y69A2AR.10
No description available

WB:WBGene00022082	Y69A2AR.11
Is affected by eat-2; rrf-3; and wdr-5.1 based on microarray and RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00022083	Y69A2AR.12
Is enriched in body wall muscle cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022085	Y69A2AR.14
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including hydrogen sulfide; Ethanol; and tryptophan based on microarray and RNA-seq studies.

WB:WBGene00022086	sprr-3
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00022087	Y69A2AR.16
Is predicted to have nuclear export signal receptor activity. Is an ortholog of human XPO4 (exportin 4).

WB:WBGene00022089	Y69A2AR.18
Is predicted to contribute to proton-transporting ATP synthase activity, rotational mechanism. Is expressed in tail. Is an ortholog of human ATP5F1C (ATP synthase F1 subunit gamma).

WB:WBGene00022090	Y69A2AR.19
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00022091	Y69A2AR.20
No description available

WB:WBGene00022092	Y69A2AR.21
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including hydrogen sulfide; Zidovudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: cwf18 pre-mRNA splicing factor. Is an ortholog of human CCDC12 (coiled-coil domain containing 12).

WB:WBGene00022093	Y69A2AR.22
Is enriched in AFD; PLM; and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022094	Y69A2AR.23
Is enriched in NSM; amphid sheath cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00022095	Y69A2AR.24
Is enriched in hypodermis and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; sir-2.1; and cyc-1 based on microarray and tiling array studies. Is affected by tryptophan; indole; and resveratrol based on microarray studies.

WB:WBGene00022096	Y69A2AR.25
Is enriched in ASER and intestine based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray; quantitative PCR; and RNA-seq studies. Is affected by fifteen chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00022097	nhr-242
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00022099	Y69A2AR.28
Is enriched in several structures, including AFD; germ line; head mesodermal cell; intestine; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including aldicarb; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Spo12 family and Spo12.

WB:WBGene00022100	Y69A2AR.31
Is predicted to have signaling receptor activity. Is an ortholog of human GFRAL (GDNF family receptor alpha like).

WB:WBGene00022101	Y69A2AR.32
Is predicted to have mRNA binding activity. Is an ortholog of human QKI (QKI, KH domain containing RNA binding).

WB:WBGene00022102	Y69F12A.1
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00022103	cdh-12
Is predicted to have calcium ion binding activity.

WB:WBGene00022104	acsd-1
Is predicted to have aminocarboxymuconate-semialdehyde decarboxylase activity. Is an ortholog of human ACMSD (aminocarboxymuconate semialdehyde decarboxylase).

WB:WBGene00022105	Y71D11A.4
No description available

WB:WBGene00022106	lgc-46
Is predicted to have chloride channel activity. Is expressed in body wall musculature; nervous system; and pharyngeal muscle cell.

WB:WBGene00022107	Y71F9AL.1
Is predicted to have tRNA (guanine-N2-)-methyltransferase activity. Is an ortholog of human TRMT11 (tRNA methyltransferase 11 homolog).

WB:WBGene00022108	Y71F9AL.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00022109	Y71F9AL.3
No description available

WB:WBGene00022110	Y71F9AL.4
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human PTPN9 (protein tyrosine phosphatase non-receptor type 9).

WB:WBGene00022111	Y71F9AL.6
Is affected by several genes including daf-2; eat-2; and eri-1 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00022112	Y71F9AL.7
Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00022113	Y71F9AL.8
Is enriched in NSM; germ line; germline precursor cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00022114	Y71F9AL.9
Is enriched in anal depressor muscle; germ line; and intestine based on proteomic and Chronogram studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; RNA-seq; proteomic; and tiling array studies. Is affected by six chemicals including Atrazine; Cry5B; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; UBA-like superfamily; and Protein of unknown function DUF1387. Is an ortholog of human SPATS2 (spermatogenesis associated serine rich 2).

WB:WBGene00022115	Y71F9AL.10
Is enriched in FLP; body wall musculature; dopaminergic neurons; germ line; and muscle cell based on tiling array; microarray; and RNA-seq studies. Is affected by several genes including daf-2; age-1; and fbf-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human ZNRF2 (zinc and ring finger 2).

WB:WBGene00022116	Y71F9AL.11
Is enriched in AFD and FLP based on microarray and RNA-seq studies. Is affected by several genes including daf-16; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022117	Y71F9AL.12
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including Rotenone; antimycin; and Progesterone based on RNA-seq and microarray studies.

WB:WBGene00022118	dnc-5
Localizes to dynactin complex. Is an ortholog of human DCTN5 (dynactin subunit 5).

WB:WBGene00022119	copa-1
Is predicted to have structural molecule activity. Is expressed in distal tip cell and head. Is an ortholog of human COPA (COPI coat complex subunit alpha).

WB:WBGene00022121	cogc-3
Is involved in gonad morphogenesis and regulation of cell migration. Localizes to Golgi apparatus and endoplasmic reticulum. Is expressed in intestine; pharynx; seam cell; and vulva. Is an ortholog of human COG3 (component of oligomeric golgi complex 3).

WB:WBGene00022122	trap-1
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Tunicamycin; Deoxyglucose; and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Translocon-associated protein (TRAP), alpha subunit; and Translocon-associated protein (TRAP), alpha subunit. Is an ortholog of human SSR1 (signal sequence receptor subunit 1).

WB:WBGene00022123	Y71F9AR.2
Is predicted to have GTPase activity. Is an ortholog of human RASL12 (RAS like family 12).

WB:WBGene00022124	supr-1
Localizes to axon; cytoplasm; and nucleus.

WB:WBGene00022125	Y71F9B.1
Is enriched in hypodermis; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including skn-1; age-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Mianserin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00022126	Y71F9B.2
Is predicted to have phosphatidate cytidylyltransferase activity. Is an ortholog of human TAMM41 (TAM41 mitochondrial translocator assembly and maintenance homolog).

WB:WBGene00022127	yop-1
Localizes to cortical endoplasmic reticulum. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia (multiple); and retinitis pigmentosa 77. Is an ortholog of human REEP5 (receptor accessory protein 5) and REEP6 (receptor accessory protein 6).

WB:WBGene00022128	Y71F9B.6
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: CDK5 and ABL1 enzyme substrate 1/2. Is an ortholog of human CABLES1 (Cdk5 and Abl enzyme substrate 1) and CABLES2 (Cdk5 and Abl enzyme substrate 2).

WB:WBGene00022129	lron-11
Is expressed in hypodermis; muscle cell; and pharynx. Human ortholog(s) of this gene are implicated in Gilles de la Tourette syndrome; high myopia-sensorineural deafness syndrome; and trichotillomania. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily. Is an ortholog of human CPN2 (carboxypeptidase N subunit 2).

WB:WBGene00022130	Y71F9B.9
Is predicted to have 3-hydroxyacyl-CoA dehydrogenase activity. Is an ortholog of human CRYL1 (crystallin lambda 1).

WB:WBGene00022131	Y71F9B.13
Is enriched in germ line; hypodermis; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; D-glucose; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00022133	Y71F9B.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including hydrogen sulfide; tryptophan; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00022134	hrpu-2
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; lin-28; and aak-2 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; stavudine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022138	trpp-10
Is enriched in coelomocyte; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Rifampin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human TRAPPC10 (trafficking protein particle complex 10).

WB:WBGene00022139	tub-2
Is enriched in head mesodermal cell and neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tub family; Tubby, C-terminal; and Tubby-like, C-terminal. Is an ortholog of human TULP4 (TUB like protein 4).

WB:WBGene00022140	Y71G12A.4
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in PHARC syndrome.

WB:WBGene00022141	chaf-2
Is predicted to have histone binding activity. Is an ortholog of human CHAF1B (chromatin assembly factor 1 subunit B).

WB:WBGene00022142	Y71G12B.2
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00022143	Y71G12B.3
Is enriched in amphid sheath cell; body wall muscle cell; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00022144	pghm-1
Is predicted to have copper ion binding activity and peptidylglycine monooxygenase activity. Is expressed in head ganglion; nervous system; and tail ganglion. Is an ortholog of human PAM (peptidylglycine alpha-amidating monooxygenase).

WB:WBGene00022145	Y71G12B.5
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: NTF2-like domain superfamily.

WB:WBGene00022146	Y71G12B.6
Is enriched in Z1.p; Z4.a; hypodermis; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Mianserin; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1. Is predicted to encode a protein with the following domains: GDP-mannose 4,6 dehydratase; NAD(P)-binding domain; and NAD(P)-binding domain superfamily.

WB:WBGene00022148	ddx-27
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX27 (DEAD-box helicase 27).

WB:WBGene00022149	lin-65
Is involved in chromatin remodeling and mitochondrial unfolded protein response. Localizes to cytosol and nucleus. Is expressed in head neurons and intestine.

WB:WBGene00022150	Y71G12B.10
Is predicted to have hydroxymethylglutaryl-CoA lyase activity. Is an ortholog of human HMGCLL1 (3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1).

WB:WBGene00022152	atg-5
Is involved in autophagosome assembly and regulation of autophagy. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 25. Is an ortholog of human ATG5 (autophagy related 5).

WB:WBGene00022153	Y71G12B.13
Is enriched in AVK; PLM; and intestine based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by four chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00022154	drag-1
Is predicted to have coreceptor activity. Is involved in several processes, including mesodermal cell fate specification; regulation of BMP signaling pathway; and transforming growth factor beta receptor signaling pathway involved in regulation of growth. Localizes to plasma membrane and receptor complex. Is expressed in hypodermis and intestine. Human ortholog(s) of this gene are implicated in hemochromatosis type 2A. Is an ortholog of human RGMB (repulsive guidance molecule BMP co-receptor b).

WB:WBGene00022155	Y71G12B.17
Is predicted to have phospholipid binding activity and phospholipid transporter activity. Human ortholog(s) of this gene are implicated in cone-rod dystrophy 5. Is an ortholog of human PITPNA (phosphatidylinositol transfer protein alpha) and PITPNB (phosphatidylinositol transfer protein beta).

WB:WBGene00022156	Y71G12B.18
Is enriched in hypodermis and intestine based on tiling array and microarray studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Heme; Ethanol; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00022157	Y71G12B.22
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00022158	Y71G12B.23
Is predicted to have heme-copper terminal oxidase activity. Is an ortholog of human MMD (monocyte to macrophage differentiation associated).

WB:WBGene00022159	mppa-1
Contributes to metalloendopeptidase activity. Is involved in proteolysis. Localizes to mitochondrial processing peptidase complex. Human ortholog(s) of this gene are implicated in autosomal recessive spinocerebellar ataxia 2. Is an ortholog of human PMPCA (peptidase, mitochondrial processing subunit alpha).

WB:WBGene00022160	Y71G12B.25
Is predicted to have transmembrane transporter activity.

WB:WBGene00022161	Y71G12B.26
Is affected by several genes including daf-2; skn-1; and isp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rifampin; allantoin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022162	Y71G12B.27
Is predicted to have several functions, including cyclin-dependent protein serine/threonine kinase activator activity; histone binding activity; and ubiquitin binding activity. Is an ortholog of human CKS2 (CDC28 protein kinase regulatory subunit 2).

WB:WBGene00022163	Y71G12B.28
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; metformin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00022165	Y71H2AL.2
Is enriched in body wall musculature; head mesodermal cell; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; alg-1; and sma-2 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; paraquat; and dibromoacetic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022166	Y71H2AM.1
Is predicted to have N(6)-L-threonylcarbamoyladenine synthase activity and metal ion binding activity. Human ortholog(s) of this gene are implicated in Galloway-Mowat syndrome 3. Is an ortholog of human OSGEP (O-sialoglycoprotein endopeptidase).

WB:WBGene00022167	Y71H2AM.2
Is predicted to have phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity. Is an ortholog of human PIP4P1 (phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1).

WB:WBGene00022168	Y71H2AM.3
Is predicted to have cyclin binding activity; ubiquitin conjugating enzyme binding activity; and ubiquitin protein ligase activity. Is an ortholog of human UBE3D (ubiquitin protein ligase E3D).

WB:WBGene00022169	Y71H2AM.4
Is predicted to have NADH dehydrogenase (ubiquinone) activity. Is an ortholog of human NDUFC2 (NADH:ubiquinone oxidoreductase subunit C2).

WB:WBGene00022170	cox-6B
Is enriched in NSM; intestine; male-specific anatomical entity; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on RNA-seq; tiling array; proteomic; and microarray studies. Is affected by four chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in cytochrome-c oxidase deficiency disease. Is predicted to encode a protein with the following domains: Cytochrome oxidase c subunit VIb; Cytochrome c oxidase, subunit VIb; and Cytochrome c oxidase, subunit VIb superfamily. Is an ortholog of human COX6B1 (cytochrome c oxidase subunit 6B1) and COX6B2 (cytochrome c oxidase subunit 6B2).

WB:WBGene00022171	Y71H2AM.6
Is enriched in cephalic sheath cell; germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-12; and pmk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DNA / pantothenate metabolism flavoprotein; DNA/pantothenate metabolism flavoprotein, C-terminal; and CoaB-like superfamily. Is an ortholog of human PPCS (phosphopantothenoylcysteine synthetase).

WB:WBGene00022172	cosa-1
Is involved in reciprocal meiotic recombination. Localizes to site of double-strand break. Is an ortholog of human CNTD1 (cyclin N-terminal domain containing 1).

WB:WBGene00022173	set-27
Is predicted to have histone methyltransferase activity (H3-K36 specific); histone methyltransferase activity (H3-K4 specific); and transcription coactivator activity. Is expressed in muscle cell. Is an ortholog of human SETD3 (SET domain containing 3, actin histidine methyltransferase).

WB:WBGene00022174	slc-30A9
Is predicted to have cation transmembrane transporter activity. Is an ortholog of human SLC30A9 (solute carrier family 30 member 9).

WB:WBGene00022175	Y71H2AM.10
Is enriched in neurons; somatic gonad precursor; and ventral nerve cord based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Lithium Chloride based on microarray studies. Is predicted to encode a protein with the following domains: Transmembrane protein family 132; Transmembrane protein 132; and Transmembrane protein family 132, middle domain. Is an ortholog of several human genes including TMEM132C (transmembrane protein 132C); TMEM132D (transmembrane protein 132D); and TMEM132E (transmembrane protein 132E).

WB:WBGene00022176	Y71H2AM.11
Is predicted to have dipeptidase activity and metal ion binding activity. Is an ortholog of human CNDP2 (carnosine dipeptidase 2).

WB:WBGene00022177	Y71H2AM.12
Is predicted to have GTP binding activity; GTPase activity; and protein kinase binding activity.

WB:WBGene00022178	cest-25
Is enriched in several structures, including dopaminergic neurons; excretory cell; mechanosensory neurons; pharyngeal muscle cell; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by ten chemicals including D-glucose; Sodium Chloride; and Rifampin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 8. Human CES2 exhibits carboxylic ester hydrolase activity. Is predicted to encode a protein with the following domains: Carboxylesterase family; Carboxylesterase, type B; and Alpha/Beta hydrolase fold. Is an ortholog of human CEL (carboxyl ester lipase) and CES2 (carboxylesterase 2).

WB:WBGene00022179	Y71H2AM.14
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00022180	Y71H2AM.15
Localizes to cell junction and striated muscle dense body. Is an ortholog of human KIAA1217 (KIAA1217).

WB:WBGene00022181	pho-9
Is enriched in body wall musculature; intestine; sensory neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-two chemicals including Heme; Ethanol; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP4 (acid phosphatase 4).

WB:WBGene00022182	swsn-3
Is predicted to have nuclear receptor binding activity. Is used to study alcohol use disorder. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 15. Is an ortholog of human SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1).

WB:WBGene00022185	Y71H2AM.20
Is predicted to have peptidyl-prolyl cis-trans isomerase activity and protein tyrosine phosphatase activator activity. Is an ortholog of human PTPA (protein phosphatase 2 phosphatase activator).

WB:WBGene00022188	Y71H2AR.1
Is predicted to have protein-disulfide reductase activity. Is an ortholog of human TXNDC17 (thioredoxin domain containing 17).

WB:WBGene00022189	Y71H2AR.2
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13 and pycnodysostosis.

WB:WBGene00022190	josd-1
Is predicted to have thiol-dependent ubiquitin-specific protease activity. Is an ortholog of human JOSD1 (Josephin domain containing 1) and JOSD2 (Josephin domain containing 2).

WB:WBGene00022191	Y71H2B.1
Is predicted to have fatty-acyl-CoA binding activity.

WB:WBGene00022192	Y71H2B.2
Is enriched in OLL; PVD; germ line; and germline precursor cell based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PHAX RNA-binding domain; Phosphorylated adapter RNA export protein, RNA-binding domain; Phosphorylated adapter RNA export protein, RNA-binding domain superfamily; and Phosphorylated adapter RNA export protein. Is an ortholog of human PHAX (phosphorylated adaptor for RNA export).

WB:WBGene00022193	ppfr-4
Is predicted to have protein phosphatase 2A binding activity and protein phosphatase regulator activity. Is involved in embryo development and protein localization to basolateral plasma membrane. Human ortholog(s) of this gene are implicated in corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome. Is an ortholog of human IGBP1 (immunoglobulin binding protein 1).

WB:WBGene00022194	Y71H2B.4
Is enriched in OLL; PVD; body wall muscle cell; dopaminergic neurons; and muscle cell based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022195	Y71H2B.5
Is predicted to have catalytic activity.

WB:WBGene00022196	gpa-17
Is predicted to have G protein-coupled receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Human ortholog(s) of this gene are implicated in several diseases, including ACTH-independent macronodular adrenal hyperplasia 1; congenital stationary night blindness (multiple); and pseudohypoparathyroidism (multiple).

WB:WBGene00022197	Y71H2B.8
Is enriched in AVA; coelomocyte; muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022198	Y71H2B.11
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Rotenone; stavudine; and allantoin based on RNA-seq studies.

WB:WBGene00022199	pfk-1.1
Is predicted to have several functions, including 6-phosphofructokinase activity; adenyl ribonucleotide binding activity; and fructose-6-phosphate binding activity. Is expressed in germ line; hypodermis; neurons; and pharynx. Human ortholog(s) of this gene are implicated in glycogen storage disease VII. Is an ortholog of human PFKL (phosphofructokinase, liver type); PFKM (phosphofructokinase, muscle); and PFKP (phosphofructokinase, platelet).

WB:WBGene00022200	fard-1
Is predicted to have fatty-acyl-CoA reductase (alcohol-forming) activity. Is an ortholog of human FAR1 (fatty acyl-CoA reductase 1) and FAR2 (fatty acyl-CoA reductase 2).

WB:WBGene00022201	Y71H10B.1
Is predicted to have 5'-nucleotidase activity. Is expressed in tail. Human ortholog(s) of this gene are implicated in hereditary spastic paraplegia 45. Is an ortholog of human NT5C2 (5'-nucleotidase, cytosolic II).

WB:WBGene00022202	Y72A10A.1
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat domain superfamily and F-box-like domain superfamily.

WB:WBGene00022203	Y73B3A.1
Is predicted to have chromatin binding activity.

WB:WBGene00022204	Y73B3A.2
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on RNA-seq studies.

WB:WBGene00022205	Y73B3A.3
Is enriched in cephalic sheath cell; germline precursor cell; and interneuron based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Mianserin and bisphenol A based on RNA-seq studies. Is an ortholog of human FAM3A (FAM3 metabolism regulating signaling molecule A); FAM3C (FAM3 metabolism regulating signaling molecule C); and FAM3D (FAM3 metabolism regulating signaling molecule D).

WB:WBGene00022206	Y73B3A.4
Is enriched in AVG; RIM; body wall muscle cell; and command interneuron based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Six-bladed beta-propeller, TolB-like.

WB:WBGene00022207	elk-2
Is enriched in OLL; PVD; and head mesodermal cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and pgl-1 based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is an ortholog of human ELK1 (ETS transcription factor ELK1).

WB:WBGene00022208	Y73B3A.6
No description available

WB:WBGene00022209	Y73B3A.7
Is enriched in arcade cell; neurons; pharyngeal-intestinal valve cell; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022210	Y73B3A.8
Is enriched in germline precursor cell based on tiling array studies. Is affected by rsr-2; ain-1; and ain-2 based on tiling array and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00022211	Y73B3A.9
Is enriched in AVK; OLL; PVD; germ line; and germline precursor cell based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00022213	Y73B3A.11
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies.

WB:WBGene00022214	cal-6
Is enriched in DA neuron; NSM; VA neuron; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and alg-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00022215	Y73B3A.13
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022216	fbxa-16
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including tryptophan; methylmercuric chloride; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00022217	fbxa-221
Is enriched in AVA; AVE; dopaminergic neurons; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00022218	Y73B3A.16
Is enriched in germline precursor cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including dpy-10; sek-1; and fbf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Diazinon; paraquat; and Colistin based on microarray studies.

WB:WBGene00022219	Y73B3A.18
Is enriched in germ line; sensory neurons; and somatic gonad precursor based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00022220	Y73B3A.19
No description available

WB:WBGene00022221	Y73B3A.20
Is enriched in NSM; OLL; PVD; germ line; and intestine based on microarray and RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and smg-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022222	Y73B3A.21
Is affected by several genes including hsf-1; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022223	Y73B3B.1
Is predicted to have actin filament binding activity. Is an ortholog of human LCP1 (lymphocyte cytosolic protein 1); PLS1 (plastin 1); and PLS3 (plastin 3).

WB:WBGene00022224	set-28
Is expressed in germ line. Is predicted to encode a protein with the following domain: SET domain.

WB:WBGene00022225	Y73B3B.3
Is affected by several genes including hsf-1; lin-35; and pgl-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022227	Y73B3B.5
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Zidovudine; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00022228	Y73B6A.1
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00022229	Y73B6A.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pmk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022230	Y73B6A.3
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022231	tyr-6
Is predicted to have metal ion binding activity and oxidoreductase activity. Human ortholog(s) of this gene are implicated in oculocutaneous albinism type III. Is an ortholog of human DCT (dopachrome tautomerase) and TYRP1 (tyrosinase related protein 1).

WB:WBGene00022232	exos-2
Is predicted to have RNA binding activity. Localizes to cytoplasm and nucleus. Is an ortholog of human EXOSC2 (exosome component 2).

WB:WBGene00022233	ipla-6
Is predicted to have hydrolase activity. Is an ortholog of human PNPLA8 (patatin like phospholipase domain containing 8).

WB:WBGene00022235	sqd-1
Is predicted to have mRNA binding activity. Human ortholog(s) of this gene are implicated in autosomal dominant limb-girdle muscular dystrophy type 3. Is an ortholog of human HNRNPAB (heterogeneous nuclear ribonucleoprotein A/B).

WB:WBGene00022236	Y73B6BL.12
Is enriched in AFD; GABAergic neurons; and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Thioredoxin; Thioredoxin domain; and Thioredoxin-like superfamily.

WB:WBGene00022237	Y73B6BL.14
Is predicted to have DNA ligase (ATP) activity.

WB:WBGene00022239	Y73B6BL.16
No description available

WB:WBGene00022240	shl-1
Is predicted to have A-type (transient outward) potassium channel activity. Is expressed in body wall musculature; muscle cell; neurons; pharynx; and tail. Human ortholog(s) of this gene are implicated in several diseases, including Brugada syndrome 9; autosomal dominant cerebellar ataxia (multiple); and electroclinical syndrome (multiple). Is an ortholog of human KCND2 (potassium voltage-gated channel subfamily D member 2) and KCND3 (potassium voltage-gated channel subfamily D member 3).

WB:WBGene00022242	sfrp-1
Is predicted to have Wnt-protein binding activity. Localizes to nucleus. Is expressed in head muscle and ventral cord neurons. Human ortholog(s) of this gene are implicated in omodysplasia. Is an ortholog of human SFRP1 (secreted frizzled related protein 1) and SFRP2 (secreted frizzled related protein 2).

WB:WBGene00022243	Y73B6BL.22
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022244	Y73B6BL.23
Is enriched in BAG; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00022245	acp-6
Is enriched in cephalic sheath cell; germ line; head mesodermal cell; hypodermis; and mechanosensory neurons based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; RNA-seq; and tiling array studies. Is affected by nineteen chemicals including methylmercuric chloride; Mercuric Chloride; and Rotenone based on microarray; RNA-seq; and proteomic studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily.

WB:WBGene00022246	acp-7
Is enriched in OLL; PVD; arcade cell; excretory cell; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and tiling array studies. Is affected by fourteen chemicals including Rotenone; bisphenol A; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily.

WB:WBGene00022247	lgc-10
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human HTR3E (5-hydroxytryptamine receptor 3E).

WB:WBGene00022248	Y73B6BL.27
Is enriched in germ line; hypodermis; muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022249	Y73B6BL.28
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; hpl-2; and ain-1 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022250	Y73B6BL.29
Is predicted to have pseudouridine synthase activity. Is an ortholog of human PUSL1 (pseudouridine synthase like 1).

WB:WBGene00022251	blos-2
Is predicted to have gamma-tubulin binding activity. Is involved in endosomal transport. Is expressed in head. Is an ortholog of human BLOC1S2 (biogenesis of lysosomal organelles complex 1 subunit 2).

WB:WBGene00022252	Y73B6BL.31
Is enriched in dopaminergic neurons; excretory cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including 1-methylnicotinamide; D-glucose; and Aspirin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Triose-phosphate Transporter family; Sugar phosphate transporter domain; and Solute carrier family 35 member F3/F4. Is an ortholog of human SLC35F3 (solute carrier family 35 member F3) and SLC35F4 (solute carrier family 35 member F4).

WB:WBGene00022253	hrpf-2
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 109 and schizophrenia 19. Is an ortholog of human HNRNPF (heterogeneous nuclear ribonucleoprotein F).

WB:WBGene00022254	nlp-71
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; aak-2; and alg-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00022255	tmed-13
Is enriched in cephalic sheath cell; head mesodermal cell; and seam cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: emp24/gp25L/p24 family/GOLD; GOLD domain; and TMP21-related.

WB:WBGene00022256	Y73B6BL.37
Is predicted to have phospholipase activity. Is an ortholog of human PLB1 (phospholipase B1).

WB:WBGene00022257	puf-11
Is predicted to have mRNA 3'-UTR binding activity.

WB:WBGene00022258	Y73C8B.1
Is enriched in germline precursor cell; mechanosensory neurons; somatic gonad precursor; and somatic nervous system based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Ethanol; tryptophan; and 1-methylnicotinamide based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is predicted to encode a protein with the following domains: Alpha/beta hydrolase of unknown function (DUF1057); Protein of unknown function DUF1057; and Alpha/Beta hydrolase fold.

WB:WBGene00022259	Y73C8B.2
Is enriched in OLL; PLM; PVD; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and eat-2 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Rifampin; allantoin; and Atrazine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is predicted to encode a protein with the following domains: Alpha/beta hydrolase of unknown function (DUF1057); Protein of unknown function DUF1057; and Alpha/Beta hydrolase fold.

WB:WBGene00022260	Y73C8B.3
Is enriched in PLM and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; dpy-10; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by thirteen chemicals including 1-methylnicotinamide; Rotenone; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial hypercholesterolemia. Is predicted to encode a protein with the following domains: Alpha/beta hydrolase of unknown function (DUF1057); Protein of unknown function DUF1057; and Alpha/Beta hydrolase fold.

WB:WBGene00022261	clec-210
Is predicted to have carbohydrate binding activity.

WB:WBGene00022262	Y73C8C.3
Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022263	Y73C8C.4
Is enriched in AVA; NSM; and amphid sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including aldicarb; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00022264	sdz-34
Is affected by rsr-2 and adr-1 based on tiling array and RNA-seq studies.

WB:WBGene00022265	Y73C8C.8
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00022266	srt-56
Is affected by mir-34 and drh-3 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00022267	Y73C8C.10
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00022268	Y73E7A.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; elt-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain-containing protein 124 /Oxs1; Coiled-coil domain-containing protein 124/Oxs1; and High mobility group box domain superfamily. Is an ortholog of human CCDC124 (coiled-coil domain containing 124).

WB:WBGene00022269	aatf-1
Is enriched in body wall muscle cell and germ line based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and sek-1 based on microarray; RNA-seq; and proteomic studies. Is affected by Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: Apoptosis antagonizing transcription factor; Apoptosis-antagonizing transcription factor, C-terminal; Apoptosis-antagonizing transcription factor, C-terminal; AATF leucine zipper-containing domain; and Protein AATF/Bfr2. Is an ortholog of human AATF (apoptosis antagonizing transcription factor).

WB:WBGene00022270	Y73E7A.3
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC35F1 (solute carrier family 35 member F1) and SLC35F2 (solute carrier family 35 member F2).

WB:WBGene00022271	cpx-1
Is predicted to have SNARE binding activity. Localizes to axon and synapse. Is expressed in head neurons; motor neurons; nervous system; tail neurons; and ventral cord neurons. Human ortholog(s) of this gene are implicated in Wolf-Hirschhorn syndrome and early infantile epileptic encephalopathy 63. Is an ortholog of human CPLX2 (complexin 2).

WB:WBGene00022272	Y73E7A.5
Is affected by clk-1; smg-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Sodium Chloride; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022273	Y73E7A.6
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Bladder cancer-related protein BC10 and Bladder cancer-related BC10. Is an ortholog of human BLCAP (BLCAP apoptosis inducing factor).

WB:WBGene00022274	Y73E7A.8
Is predicted to have wide pore channel activity.

WB:WBGene00022275	txt-7
Is affected by several genes including daf-2; clk-1; and elt-2 based on tiling array and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022276	nlp-40
Is predicted to have neuropeptide receptor binding activity. Is involved in neuropeptide signaling pathway and positive regulation of defecation. Localizes to extracellular space. Is expressed in coelomocyte and intestinal cell.

WB:WBGene00022277	homt-1
Is predicted to have N-terminal protein N-methyltransferase activity. Is expressed in PVT and uterus. Is an ortholog of human NTMT1 (N-terminal Xaa-Pro-Lys N-methyltransferase 1).

WB:WBGene00022278	rcor-1
Is predicted to have several functions, including DNA-binding transcription factor activity; transcription corepressor activity; and transcription factor binding activity. Is an ortholog of human RCOR2 (REST corepressor 2).

WB:WBGene00022279	sesn-1
Is predicted to have leucine binding activity and oxidoreductase activity, acting on peroxide as acceptor. Is an ortholog of human SESN1 (sestrin 1); SESN2 (sestrin 2); and SESN3 (sestrin 3).

WB:WBGene00022280	Y74C10AL.2
Is enriched in germ line; muscle cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including aak-2; isp-1; and fbf-1 based on microarray and RNA-seq studies. Is affected by Rotenone and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Uncharacterised protein family (UPF0220) and Uncharacterised protein family UPF0220. Is an ortholog of human TMEM50B (transmembrane protein 50B).

WB:WBGene00022281	abtm-1
Is predicted to have ATPase-coupled transmembrane transporter activity. Is involved in cellular iron ion homeostasis. Localizes to mitochondrion. Is expressed in coelomocyte; hypodermis; intestine; and spermatheca. Is used to study X-linked sideroblastic anemia with ataxia. Human ortholog(s) of this gene are implicated in X-linked sideroblastic anemia with ataxia. Is an ortholog of human ABCB7 (ATP binding cassette subfamily B member 7).

WB:WBGene00022282	Y74C10AR.2
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00022283	lgc-27
Is predicted to have chloride channel activity. Is expressed in AIYL and AIYR.

WB:WBGene00022284	glb-33
Is predicted to have heme binding activity and oxygen binding activity. Is expressed in neurons and somatic nervous system.

WB:WBGene00022285	Y75B7AL.2
Is enriched in coelomocyte; intestine; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Amnionless and Amnionless. Is an ortholog of human AMN (amnion associated transmembrane protein).

WB:WBGene00022286	rga-4
Exhibits GTPase activator activity. Is involved in asymmetric protein localization involved in cell fate determination; cortical actin cytoskeleton organization; and regulation of actin filament-based process. Is expressed in embryonic cell and germ line. Is an ortholog of human ARHGAP11A (Rho GTPase activating protein 11A).

WB:WBGene00022287	Y75B7AR.1
Is enriched in several structures, including head mesodermal cell; muscle cell; neurons; pharynx; and somatic nervous system based on Chronogram; microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; nicotinic acid; and Mercuric Chloride based on RNA-seq and microarray studies.

WB:WBGene00022288	Y75B7B.1
Is enriched in neurons; retrovesicular ganglion; somatic gonad precursor; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF851) and Protein of unknown function DUF851.

WB:WBGene00022289	Y75B7B.2
Is enriched in male based on RNA-seq studies. Is affected by daf-16 and ints-5 based on RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Ankyrin repeat-containing domain superfamily.

WB:WBGene00022290	Y75D11A.1
Is affected by several genes including ash-2; adr-1; and pmt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by fluoranthene and Sirolimus based on microarray studies.

WB:WBGene00022291	Y75D11A.2
Is enriched in muscle cell based on microarray studies. Is affected by several genes including dpy-10; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including paraquat; Colistin; and Sirolimus based on microarray studies.

WB:WBGene00022292	Y75D11A.3
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including hydrogen sulfide; 4-bromodiphenyl ether; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00022293	Y75D11A.4
No description available

WB:WBGene00022294	Y75D11A.5
No description available

WB:WBGene00022295	cng-2
Is predicted to have cGMP binding activity; intracellular cAMP-activated cation channel activity; and intracellular cGMP-activated cation channel activity. Localizes to neuronal cell body. Is expressed in amphid neurons. Human ortholog(s) of this gene are implicated in several diseases, including achromatopsia 3; heart conduction disease (multiple); and retinal degeneration (multiple).

WB:WBGene00022296	xpc-1
Is predicted to have damaged DNA binding activity and single-stranded DNA binding activity. Is involved in response to UV. Is used to study xeroderma pigmentosum. Human ortholog(s) of this gene are implicated in xeroderma pigmentosum group C. Is an ortholog of human XPC (XPC complex subunit, DNA damage recognition and repair factor).

WB:WBGene00022297	Y76B12C.3
Is predicted to have oxidoreductase activity. Is expressed in g1AL; g1AR; g1P; g2L; and g2R. Is an ortholog of human SELENOF (selenoprotein F).

WB:WBGene00022298	Y76B12C.4
Is enriched in DA neuron; VA neuron; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00022299	Y76B12C.5
No description available

WB:WBGene00022300	Y76B12C.6
Is enriched in arcade cell; germ line; germline precursor cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is an ortholog of human STAMBP (STAM binding protein) and STAMBPL1 (STAM binding protein like 1).

WB:WBGene00022301	cpsf-1
Is predicted to have RNA binding activity. Is an ortholog of human CPSF1 (cleavage and polyadenylation specific factor 1).

WB:WBGene00022302	Y76B12C.8
Is enriched in ASER; AVK; PLM; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including D-glucose; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00022303	Y76B12C.9
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00022304	Y76G2A.1
No description available

WB:WBGene00022305	Y76G2A.2
No description available

WB:WBGene00022306	hxk-3
Is predicted to have fructokinase activity; glucokinase activity; and mannokinase activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 4G; diabetes mellitus (multiple); and familial hyperinsulinemic hypoglycemia 3. Is an ortholog of human GCK (glucokinase).

WB:WBGene00022307	nadk-1
Is predicted to have NAD+ kinase activity. Is an ortholog of human NADK2 (NAD kinase 2, mitochondrial).

WB:WBGene00022308	Y77E11A.3
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00022309	rpc-11
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR3K (RNA polymerase III subunit K).

WB:WBGene00022310	Y77E11A.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including hydrogen sulfide; Zidovudine; and Chlorpyrifos based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022311	Y77E11A.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-12; eat-2; and pmk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00022312	clec-171
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; let-60; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00022313	Y77E11A.12
Is expressed in body wall musculature. Is predicted to encode a protein with the following domains: GRAM domain; GRAM domain; and GRAM domain-containing protein 4. Is an ortholog of human GRAMD4 (GRAM domain containing 4).

WB:WBGene00022314	Y77E11A.14
Is enriched in dopaminergic neurons; hypodermis; intestine; pharyngeal muscle cell; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Saposin-like.

WB:WBGene00022315	Y81B9A.1
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by copper sulfate and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022316	Y81B9A.2
Is enriched in Z1.p; Z4.a; male distal tip cell; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00022317	Y81B9A.3
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022318	Y82E9BL.1
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00022319	Y82E9BL.2
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00022320	Y82E9BL.3
Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including tryptophan; Mercuric Chloride; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022321	fbxa-25
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022322	Y82E9BL.5
Is affected by several genes including alg-1; cyc-1; and mir-34 based on microarray and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Mercuric Chloride; and Tunicamycin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022323	Y82E9BL.6
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including bisphenol A; Alovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022324	fbxa-26
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022325	fbxa-5
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022326	fbxa-14
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022327	fbxa-15
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022328	Y82E9BL.12
Is enriched in AVA and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and sek-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including tryptophan; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Methyltransferase FkbM domain and Methyltransferase FkbM.

WB:WBGene00022329	fbxa-79
Is enriched in AFD; ASER; intestine; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; D-glucopyranose; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022330	fbxa-80
Is enriched in NSM; body wall muscle cell; coelomocyte; command interneuron; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and npr-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; levamisole; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022331	fbxa-19
Is enriched in AVA; GABAergic neurons; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including npr-1; pgl-1; and lin-15B based on microarray and RNA-seq studies. Is affected by six chemicals including R24; paraquat; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022332	fbxa-20
Is enriched in AVE; GABAergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00022333	fbxa-27
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; methylmercury hydroxide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022334	Y82E9BR.1
Is enriched in PLM; Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including 1-methylnicotinamide; methylmercuric chloride; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00022335	Y82E9BR.2
Is enriched in germ line; germline precursor cell; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00022336	Y82E9BR.3
Is predicted to have proton-transporting ATP synthase activity, rotational mechanism. Is expressed in hypodermis and pharyngeal muscle cell. Is an ortholog of human ATP5MC1 (ATP synthase membrane subunit c locus 1) and ATP5MC3 (ATP synthase membrane subunit c locus 3).

WB:WBGene00022337	pals-16
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including age-1; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00022338	Y82E9BR.5
Is enriched in OLL; PVD; and intestine based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including sir-2.1; pmk-1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022339	Y82E9BR.6
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022340	Y82E9BR.7
Is enriched in male based on RNA-seq studies. Is affected by lin-15B and daf-2 based on microarray studies.

WB:WBGene00022341	Y82E9BR.8
Is affected by spn-4 and set-2 based on RNA-seq studies.

WB:WBGene00022342	Y82E9BR.9
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by rsr-2 based on tiling array studies.

WB:WBGene00022343	Y82E9BR.10
Is enriched in head mesodermal cell and hypodermis based on RNA-seq studies. Is affected by cyc-1; clk-1; and mir-34 based on microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00022344	pals-40
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00022345	fbxa-138
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Cadmium Chloride and paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022346	pals-17
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; stavudine; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00022347	Y82E9BR.14
Is predicted to have ceramide 1-phosphate binding activity and ceramide 1-phosphate transfer activity. Is an ortholog of human GLTP (glycolipid transfer protein).

WB:WBGene00022348	Y82E9BR.16
Is predicted to have transmembrane transporter activity. Is expressed in germ line. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A4 (solute carrier family 22 member 4) and SLC22A5 (solute carrier family 22 member 5).

WB:WBGene00022349	Y82E9BR.17
Is enriched in several structures, including Z4.a; intestine; male distal tip cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies.

WB:WBGene00022350	Y82E9BR.18
Is predicted to have ribosomal large subunit binding activity and tRNA binding activity. Is an ortholog of human NEMF (nuclear export mediator factor).

WB:WBGene00022351	Y82E9BR.19
Is enriched in germ line; germline precursor cell; and pharynx based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00022352	Y82E9BR.20
Is enriched in NSM and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00022353	pals-18
Is enriched in OLL; PVD; head mesodermal cell; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; Cry5B; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00022354	Y82E9BR.22
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq studies.

WB:WBGene00022356	eak-3
Is expressed in XXXL and XXXR.

WB:WBGene00022357	kbp-4
Localizes to Ndc80 complex and condensed chromosome kinetochore.

WB:WBGene00022358	Y92H12A.2
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human NEDD4 (NEDD4 E3 ubiquitin protein ligase).

WB:WBGene00022360	ints-3
Is enriched in AVK; germ line; and intestine based on RNA-seq and proteomic studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Integrator complex subunit 3 and Integrator complex subunit 3. Is an ortholog of human INTS3 (integrator complex subunit 3).

WB:WBGene00022361	Y92H12A.5
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; proteomic; and RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Putative death-receptor fusion protein (DUF2428); Armadillo-type fold; and Domain of unknown function DUF2428, death-receptor-like. Is an ortholog of human THADA (THADA armadillo repeat containing).

WB:WBGene00022363	Y92H12BL.1
Is predicted to have N6-threonylcarbomyladenosine methylthiotransferase activity. Is an ortholog of human CDKAL1 (CDK5 regulatory subunit associated protein 1 like 1).

WB:WBGene00022365	Y92H12BL.4
Is predicted to have GTPase activator activity. Is an ortholog of human ARHGAP39 (Rho GTPase activating protein 39).

WB:WBGene00022366	Y92H12BL.5
Is predicted to have pyrophosphatase activity. Human ortholog(s) of this gene are implicated in primary hypertrophic osteoarthropathy. Is an ortholog of several human genes including NUDT10 (nudix hydrolase 10); NUDT3 (nudix hydrolase 3); and NUDT4 (nudix hydrolase 4).

WB:WBGene00022367	Y92H12BM.1
Is predicted to have GTPase activator activity. Is an ortholog of human ARHGAP39 (Rho GTPase activating protein 39).

WB:WBGene00022368	Y92H12BR.2
Is enriched in ASER; germ line; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; npr-1; and pgl-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by five chemicals including Atrazine; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00022369	Y92H12BR.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00022370	Y92H12BR.4
Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00022371	set-29
Is predicted to have protein-lysine N-methyltransferase activity. Is expressed in intestine and muscle cell. Is an ortholog of human SETD4 (SET domain containing 4).

WB:WBGene00022372	Y92H12BR.7
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phytanoyl-CoA hydroxylase-interacting protein-like. Is an ortholog of human PHYHIP (phytanoyl-CoA 2-hydroxylase interacting protein) and PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like).

WB:WBGene00022373	mrpl-15
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL15 (mitochondrial ribosomal protein L15).

WB:WBGene00022374	nhr-277
Is predicted to have chromatin binding activity; nuclear receptor activity; and transcription regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in 46 XY gonadal dysgenesis; premature ovarian failure; and spermatogenic failure 8.

WB:WBGene00022375	Y94H6A.2
Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; 4-bromodiphenyl ether; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00022376	Y94H6A.3
Is enriched in OLL; PVD; germ line; and intestine based on microarray and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00022377	gpx-4
Is predicted to have glutathione peroxidase activity. Is an ortholog of human GPX3 (glutathione peroxidase 3) and GPX6 (glutathione peroxidase 6).

WB:WBGene00022378	Y94H6A.5
Is predicted to have RNA binding activity and RNA helicase activity. Is an ortholog of human DDX54 (DEAD-box helicase 54).

WB:WBGene00022379	Y94H6A.7
Is predicted to have protein tyrosine phosphatase activity. Is an ortholog of human ACP1 (acid phosphatase 1).

WB:WBGene00022380	Y94H6A.8
Is predicted to have NADH dehydrogenase (ubiquinone) activity and electron transfer activity. Localizes to mitochondrion. Is an ortholog of human NDUFA12 (NADH:ubiquinone oxidoreductase subunit A12).

WB:WBGene00022381	ubxn-2
Exhibits K48-linked polyubiquitin modification-dependent protein binding activity and protein kinase binding activity. Is involved in several processes, including establishment of mitotic spindle orientation; masculinization of hermaphroditic germ-line; and negative regulation of protein localization to centrosome. Localizes to nucleus; perinuclear region of cytoplasm; and spindle pole centrosome. Is expressed in several structures, including gonad and spermatocyte. Is an ortholog of human NSFL1C (NSFL1 cofactor).

WB:WBGene00022382	Y94H6A.10
Is enriched in AFD; PLM; intestine; muscle cell; and somatic gonad precursor based on RNA-seq; proteomic; and microarray studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by nineteen chemicals including 1-methylnicotinamide; Tunicamycin; and D-glucopyranose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022384	Y95B8A.3
No description available

WB:WBGene00022385	Y95B8A.4
Is enriched in AVK; amphid sheath cell; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by sixteen chemicals including methylmercuric chloride; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00022386	Y95B8A.6
Is enriched in hypodermis; muscle cell; and neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022388	Y95B8A.8
Is predicted to have double-stranded RNA binding activity and single-stranded RNA binding activity. Human ortholog(s) of this gene are implicated in dystonia 16. Is an ortholog of human ZFR (zinc finger RNA binding protein).

WB:WBGene00022389	pde-6
Is predicted to have 3',5'-cyclic-AMP phosphodiesterase activity. Is involved in negative regulation of oocyte maturation. Human ortholog(s) of this gene are implicated in primary pigmented nodular adrenocortical disease; retinal disease (multiple); and striatonigral degeneration. Is an ortholog of human PDE8A (phosphodiesterase 8A) and PDE8B (phosphodiesterase 8B).

WB:WBGene00022390	him-19
Is involved in meiotic DNA double-strand break formation and regulation of synaptonemal complex assembly.

WB:WBGene00022391	prhg-1
Is predicted to have guanyl-nucleotide exchange factor activity. Human ortholog(s) of this gene are implicated in neurodevelopmental disorder with midbrain and hindbrain malformations. Is an ortholog of human PLEKHG7 (pleckstrin homology and RhoGEF domain containing G7).

WB:WBGene00022392	Y97E10AL.1
Is enriched in several structures, including AFD; Z1.p; Z4.a; dopaminergic neurons; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including Tunicamycin; Sodium Chloride; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ectodermal ciliogenesis protein and SPEC3/Stum. Is an ortholog of human STUM (stum, mechanosensory transduction mediator homolog).

WB:WBGene00022393	abhd-12
Is predicted to have lysophospholipase activity. Human ortholog(s) of this gene are implicated in PHARC syndrome. Is an ortholog of human ABHD12 (abhydrolase domain containing 12, lysophospholipase) and ABHD12B (abhydrolase domain containing 12B).

WB:WBGene00022394	natb-1
Is predicted to have peptide alpha-N-acetyltransferase activity. Is an ortholog of human NAA20 (N-alpha-acetyltransferase 20, NatB catalytic subunit).

WB:WBGene00022395	ceh-76
Is predicted to have DNA binding activity.

WB:WBGene00022396	Y97E10AR.1
Is enriched in DA neuron; VA neuron; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including 1-methylnicotinamide; methylmercuric chloride; and sesamin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00022397	Y97E10AR.2
Is predicted to have glutathione hydrolase activity and peptidyltransferase activity. Is expressed in body wall musculature; head neurons; and intestine. Human ortholog(s) of this gene are implicated in gamma-glutamyl transpeptidase deficiency. Is an ortholog of human GGT1 (gamma-glutamyltransferase 1); GGT2 (gamma-glutamyltransferase 2); and GGT5 (gamma-glutamyltransferase 5).

WB:WBGene00022398	Y97E10AR.3
Is enriched in BAG; germ line; intestine; neurons; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00022399	Y97E10AR.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00022400	rpb-9
Is predicted to contribute to DNA-directed 5'-3' RNA polymerase activity. Is an ortholog of human POLR2I (RNA polymerase II subunit I).

WB:WBGene00022401	Y97E10AR.6
Is enriched in AVK; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; isp-1; and fbf-1 based on microarray; RNA-seq; and proteomic studies. Is affected by seven chemicals including Cry5B; levamisole; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; BSD domain; BSD domain; and BSD domain superfamily. Is an ortholog of human BSDC1 (BSD domain containing 1).

WB:WBGene00022402	lmtr-2
Is predicted to contribute to guanyl-nucleotide exchange factor activity and molecular adaptor activity. Is an ortholog of human LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2).

WB:WBGene00022403	Y97E10B.1
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00022404	srsx-5
Is predicted to have G protein-coupled receptor activity. Is expressed in ASIL; ASIR; ASKL; ASKR; and AWC-OFF.

WB:WBGene00022405	srsx-6
Is predicted to have G protein-coupled receptor activity. Is expressed in head neurons.

WB:WBGene00022406	srsx-7
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00022407	srsx-4
Is affected by lin-15B and adr-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00022408	srsx-3
Is predicted to have G protein-coupled receptor activity. Localizes to non-motile cilium. Is expressed in AWBL; AWBR; AWC-OFF; AWCL; and AWCR.

WB:WBGene00022409	srt-53
Is enriched in AFD; ASER; PLM; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including lin-15B; ain-1; and mir-34 based on microarray and tiling array studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00022410	Y97E10C.1
Is enriched in body wall musculature; head mesodermal cell; intestine; muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; D-glucose; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00022411	Y102A11A.1
Is enriched in OLL; PVD; intestine; and muscle cell based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Rotenone; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022412	Y102A11A.2
Is expressed in head and tail. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022413	Y102A11A.3
Is enriched in coelomocyte; head mesodermal cell; intestine; and sensory neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00022414	Y102A11A.4
No description available

WB:WBGene00022415	Y102A11A.5
Is enriched in PLM; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including aldicarb; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00022416	Y102A11A.6
Is enriched in CEM; HOB; IL2 neuron; intestine; and ray neuron type B based on Chronogram and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Zidovudine based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in neurogenic arthrogryposis multiplex congenita. Is predicted to encode a protein with the following domains: Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC); Endoplasmic reticulum vesicle transporter; Endoplasmic reticulum vesicle transporter, C-terminal; and Endoplasmic reticulum vesicle transporter, N-terminal. Is an ortholog of human ERGIC1 (endoplasmic reticulum-golgi intermediate compartment 1).

WB:WBGene00022417	Y102A11A.7
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00022418	igcm-4
Is enriched in several structures, including RIS; cephalic sheath cell; germ line; head mesodermal cell; and mechanosensory neurons based on microarray and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and metformin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Wolf-Hirschhorn syndrome. Is predicted to encode a protein with the following domains: Immunoglobulin domain; Immunoglobulin I-set domain; Immunoglobulin subtype 2; Immunoglobulin subtype; Immunoglobulin I-set; Immunoglobulin-like fold; and Immunoglobulin-like domain superfamily. Is an ortholog of human FGFRL1 (fibroblast growth factor receptor like 1).

WB:WBGene00022419	Y102A11A.9
Is enriched in coelomocyte; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and lin-35 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; D-glucopyranose; and Cadmium Chloride based on microarray and RNA-seq studies.

WB:WBGene00022420	wdr-4
Is predicted to contribute to tRNA (guanine-N7-)-methyltransferase activity. Is an ortholog of human WDR4 (WD repeat domain 4).

WB:WBGene00022421	Y102E9.3
Is enriched in NSM and coelomocyte based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00022423	nhr-41
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in several structures, including excretory cell; hypodermis; neurons; rectum; and vulva. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is an ortholog of human NR2C2 (nuclear receptor subfamily 2 group C member 2).

WB:WBGene00022425	plst-1
Is predicted to have actin filament binding activity. Is expressed in hypodermis; intestine; and pharynx. Is an ortholog of human LCP1 (lymphocyte cytosolic protein 1) and PLS3 (plastin 3).

WB:WBGene00022426	Y104H12D.2
Is enriched in OLL; PVD; body wall muscle cell; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and sir-2.1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by four chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00022427	spl-3
Is predicted to have sphinganine-1-phosphate aldolase activity. Human ortholog(s) of this gene are implicated in nephrotic syndrome type 14. Is an ortholog of human SGPL1 (sphingosine-1-phosphate lyase 1).

WB:WBGene00022428	Y104H12D.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; aak-2; and fbf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022429	Y108F1.1
Is affected by several genes including daf-16; sek-1; and isp-1 based on RNA-seq and microarray studies. Is affected by cadmium; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00022430	Y108F1.2
No description available

WB:WBGene00022431	set-33
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022432	math-43
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; sek-1; and hpl-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Mianserin; Alovudine; and Cisplatin based on RNA-seq studies.

WB:WBGene00022433	Y108F1.5
Is predicted to have RNA binding activity.

WB:WBGene00022434	Y108G3AL.2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; resveratrol; and cadmium based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; PRP38 family; and Pre-mRNA-splicing factor 38. Is an ortholog of human PRPF38B (pre-mRNA processing factor 38B).

WB:WBGene00022435	cfap-36
Localizes to axoneme and ciliary base. Is expressed in ciliated neurons. Is an ortholog of human CFAP36 (cilia and flagella associated protein 36).

WB:WBGene00022438	Y110A2AL.1
Is affected by several genes including daf-2; rrf-3; and mex-3 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Smr domain and Smr domain superfamily.

WB:WBGene00022439	Y110A2AL.2
Is expressed in g2L and g2R. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00022440	Y110A2AL.3
Is enriched in OLL and PVD based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00022441	Y110A2AL.4
Is enriched in excretory cell; head mesodermal cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twenty-two chemicals including 1-methylnicotinamide; methylmercuric chloride; and sesamin based on RNA-seq and microarray studies.

WB:WBGene00022442	Y110A2AL.5
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; drh-3; and rsr-2 based on tiling array; microarray; and RNA-seq studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00022443	Y110A2AL.6
Is enriched in body wall muscle cell; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including sodium arsenite; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022444	Y110A2AL.7
Is enriched in germ line; male-specific anatomical entity; and in male based on proteomic; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00022445	Y110A2AL.9
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00022446	Y110A2AL.10
Is enriched in FLP based on microarray studies. Is affected by several genes including mex-3; mex-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube; Tunicamycin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Smr domain superfamily.

WB:WBGene00022447	pigw-1
Is predicted to have glucosaminyl-phosphatidylinositol O-acyltransferase activity. Is an ortholog of human PIGW (phosphatidylinositol glycan anchor biosynthesis class W).

WB:WBGene00022448	pinn-1
Is predicted to have peptidyl-prolyl cis-trans isomerase activity. Is an ortholog of human PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1).

WB:WBGene00022450	ubc-26
Is predicted to have ubiquitin conjugating enzyme activity. Is an ortholog of human UBE2J2 (ubiquitin conjugating enzyme E2 J2).

WB:WBGene00022452	Y110A2AR.1
Is enriched in I5 neuron; cholinergic neurons; germ line; germline precursor cell; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including dpy-10; gld-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and Mianserin based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in distal hereditary motor neuronopathy type 5B; hereditary spastic paraplegia (multiple); and retinitis pigmentosa 77. Is predicted to encode a protein with the following domains: TB2/DP1, HVA22 family and TB2/DP1/HVA22-related protein. Is an ortholog of human REEP2 (receptor accessory protein 2).

WB:WBGene00022453	ncap-1
Is expressed in nerve ring. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 21. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1681); PH-like domain superfamily; and NECAP, PHear domain. Is an ortholog of human NECAP2 (NECAP endocytosis associated 2).

WB:WBGene00022454	trf-2
Is predicted to have ubiquitin-protein transferase activity. Is an ortholog of human TRAF1 (TNF receptor associated factor 1) and TRAF6 (TNF receptor associated factor 6).

WB:WBGene00022455	tyms-1
Exhibits thymidylate synthase activity. Is involved in dTMP biosynthetic process. Is an ortholog of human TYMS (thymidylate synthetase).

WB:WBGene00022456	pfkb-1.1
Is predicted to have 6-phosphofructo-2-kinase activity and fructose-2,6-bisphosphate 2-phosphatase activity. Is an ortholog of human PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1) and PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3).

WB:WBGene00022457	Y110A7A.7
Is enriched in germ line; muscle cell; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Tunicamycin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00022458	prp-31
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Zidovudine; Ethanol; and Chlorpyrifos based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in retinitis pigmentosa 11. Is predicted to encode a protein with the following domains: snoRNA binding domain, fibrillarin; Prp31 C terminal domain; Nop domain; NOSIC; Prp31 C-terminal; U4/U6 small nuclear ribonucleoprotein Prp31; Helix hairpin bin domain superfamily; Nop domain superfamily; and Nop, C-terminal domain. Is an ortholog of human PRPF31 (pre-mRNA processing factor 31).

WB:WBGene00022459	Y110A7A.9
Is expressed in head. Human ortholog(s) of this gene are implicated in hypogonadotropic hypogonadism 14 with or without anosmia and hypogonadotropic hypogonadism 7 with or without anosmia. Is predicted to encode a protein with the following domains: Quinoprotein amine dehydrogenase, beta chain-like; WD40/YVTN repeat-like-containing domain superfamily; WD40-repeat-containing domain superfamily; and WD repeat-containing protein 11. Is an ortholog of human WDR11 (WD repeat domain 11).

WB:WBGene00022460	use-1
Is enriched in PLM; cephalic sheath cell; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Membrane fusion protein Use1 and Vesicle transport protein, Use1. Is an ortholog of human USE1 (unconventional SNARE in the ER 1).

WB:WBGene00022462	Y110A7A.15
Is enriched in germ line and head mesodermal cell based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Six-bladed beta-propeller, TolB-like.

WB:WBGene00022463	elpc-1
Is predicted to have tRNA binding activity. Is involved in several processes, including gamete generation; olfactory learning; and translation. Localizes to cytoplasm; neuron projection; and neuronal cell body. Is expressed in CAN; HSN; pharynx; sensory neurons; and vulva. Is used to study Riley-Day syndrome. Human ortholog(s) of this gene are implicated in Riley-Day syndrome. Is an ortholog of human ELP1 (elongator complex protein 1).

WB:WBGene00022465	ift-20
Localizes to dendrite; neuronal cell body; and non-motile cilium. Is expressed in ciliated neurons; sensory neurons; and tail. Is an ortholog of human IFT20 (intraflagellar transport 20).

WB:WBGene00022466	Y119C1A.1
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022467	Y119C1B.1
Is enriched in several structures, including Z4.a; body wall muscle cell; intestine; male distal tip cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00022469	Y119C1B.3
Is enriched in cephalic sheath cell; intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; prg-1; and sma-2 based on RNA-seq studies. Is affected by eight chemicals including Mercuric Chloride; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane protein 26 and Transmembrane protein 26. Is an ortholog of human TMEM26 (transmembrane protein 26).

WB:WBGene00022470	mrpl-19
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL19 (mitochondrial ribosomal protein L19).

WB:WBGene00022471	rnf-145
Is predicted to have ubiquitin protein ligase activity. Is an ortholog of human RNF145 (ring finger protein 145).

WB:WBGene00022472	Y119C1B.6
Is enriched in head mesodermal cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; prg-1; and sma-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022473	bet-1
Exhibits SUMO binding activity and lysine-acetylated histone binding activity. Is involved in several processes, including multicellular organismal locomotion; muscle cell cellular homeostasis; and regulation of transcription, DNA-templated. Localizes to chromosome; metaphase plate; and nucleus. Is expressed in several structures, including hypodermal cell and seam cell. Is an ortholog of human BRD2 (bromodomain containing 2); BRD3 (bromodomain containing 3); and BRDT (bromodomain testis associated).

WB:WBGene00022474	zig-9
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by seven chemicals including diallyl trisulfide; Mianserin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Immunoglobulin-like domain superfamily.

WB:WBGene00022475	Y119C1B.10
Is enriched in ASER; AVA; OLL; PVD; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; D-glucose; and levamisole based on RNA-seq and microarray studies.

WB:WBGene00022476	fbxa-75
Is enriched in cephalic sheath cell and dopaminergic neurons based on tiling array studies. Is affected by several genes including skn-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; nanoparticle; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022477	fbxa-28
Is affected by rsr-2; eat-2; and sftb-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022478	fbxa-35
Is enriched in PLM and muscle cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022479	fbxa-36
Is enriched in AVA based on tiling array studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022480	Y119D3A.5
No description available

WB:WBGene00022481	srz-9
Is affected by rsr-2; tatn-1; and pry-1 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00022482	fbxa-208
Is affected by several genes including daf-16; dpy-10; and dcr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Cry5B; Hydrolyzable Tannins; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022483	srz-8
Is affected by rsr-2; tatn-1; and pry-1 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00022484	fbxa-77
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022485	fbxa-63
Is enriched in intestine; mechanosensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; Psoralens; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022486	fbxa-61
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including methylmercuric chloride; stavudine; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00022487	fbxa-21
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; let-60; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; Rotenone; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00022488	orc-3
Is enriched in several structures, including Z4.a; germ line; head mesodermal cell; male distal tip cell; and seam cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including stavudine; Zidovudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00022489	Y119D3B.12
Is predicted to have mRNA binding activity. Is an ortholog of human LUC7L3 (LUC7 like 3 pre-mRNA splicing factor).

WB:WBGene00022490	Y119D3B.13
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022491	Y119D3B.14
Is predicted to have GTP binding activity; GTPase activity; and translation elongation factor activity. Is an ortholog of human GFM2 (GTP dependent ribosome recycling factor mitochondrial 2).

WB:WBGene00022492	dss-1
Is involved in several processes, including intestinal absorption; positive regulation of protein ubiquitination; and vulval development. Localizes to cytoplasm and nucleus. Is expressed in head neurons. Is an ortholog of human SEM1 (SEM1 26S proteasome complex subunit).

WB:WBGene00022493	mrpl-45
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by four chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Tim44-like domain; Tim44-like domain; and NTF2-like domain superfamily. Is an ortholog of human MRPL45 (mitochondrial ribosomal protein L45).

WB:WBGene00022494	fbxa-91
Is enriched in AFD and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022495	fbxa-78
Is involved in innate immune response.

WB:WBGene00022496	fbxa-92
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including D-glucopyranose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022497	Y119D3B.21
Is enriched in several structures, including head mesodermal cell; intestine; neurons; pharyngeal muscle cell; and retrovesicular ganglion based on SAGE; tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including 1-methylnicotinamide; Tunicamycin; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00022498	hsd-2
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1. Is an ortholog of human SDR42E2 (short chain dehydrogenase/reductase family 42E, member 2).

WB:WBGene00022499	set-30
Exhibits histone methyltransferase activity (H3-K4 specific). Is involved in histone H3-K4 methylation. Human ortholog(s) of this gene are implicated in spermatogenic failure 14. Is an ortholog of human SMYD2 (SET and MYND domain containing 2).

WB:WBGene00022500	lfi-1
Localizes to kinetochore microtubule and nucleus. Is an ortholog of human CROCC (ciliary rootlet coiled-coil, rootletin).

WB:WBGene00022501	ZC8.6
Is predicted to have 1-phosphatidylinositol 4-kinase activity. Is an ortholog of human PI4K2A (phosphatidylinositol 4-kinase type 2 alpha) and PI4K2B (phosphatidylinositol 4-kinase type 2 beta).

WB:WBGene00022502	ZC13.1
Is enriched in NSM; body wall musculature; germ line; and somatic gonad precursor based on Chronogram and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Alovudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C3HC4 type (RING finger); Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human RNFT2 (ring finger protein, transmembrane 2).

WB:WBGene00022503	ZC13.2
Is enriched in ASER; BAG; dopaminergic neurons; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; elt-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including stavudine; Zidovudine; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00022504	mam-1
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including 1-methylnicotinamide; methylmercuric chloride; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MAM domain, meprin/A5/mu; MAM domain; and Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00022505	ZC21.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq; tiling array; and microarray studies. Is affected by fifteen chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022506	ZC21.6
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-16; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022507	ZC21.8
Is enriched in NSM; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Cry5B based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein ZC21.8.

WB:WBGene00022508	ZC53.1
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00022509	ZC53.2
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00022510	ZC53.3
No description available

WB:WBGene00022511	ZC53.4
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00022512	dot-1.5
Is predicted to have histone methyltransferase activity (H3-K79 specific). Is an ortholog of human DOT1L (DOT1 like histone lysine methyltransferase).

WB:WBGene00022514	ZC64.1
No description available

WB:WBGene00022515	ttr-48
Is enriched in OLL; PVD; head mesodermal cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by thirteen chemicals including Rotenone; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00022516	mtx-2
Localizes to mitochondrion. Is an ortholog of human MTX2 (metaxin 2).

WB:WBGene00022517	ZC123.1
Is expressed in hypodermis.

WB:WBGene00022518	zfh-2
Is predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in anal depressor muscle; anal sphincter muscle; body wall musculature; nerve ring; and vulval muscle. Human ortholog(s) of this gene are implicated in congenital ptosis and prostate cancer. Is an ortholog of human ZFHX3 (zinc finger homeobox 3).

WB:WBGene00022519	ZC123.4
Is predicted to have cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 12. Is an ortholog of human CDK14 (cyclin dependent kinase 14).

WB:WBGene00022520	ZC132.1
No description available

WB:WBGene00022521	ZC132.2
Is enriched in neurons based on tiling array studies. Is affected by several genes including clk-1; eat-2; and prg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022522	ZC132.3
Is enriched in AFD; ASER; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00022523	ZC132.4
No description available

WB:WBGene00022524	ZC132.5
No description available

WB:WBGene00022526	ZC132.8
Is enriched in neurons based on tiling array studies. Is affected by rsr-2; clk-1; and sir-2.1 based on tiling array and microarray studies. Is affected by four chemicals including resveratrol; Acrylamide; and dafa#1 based on microarray studies.

WB:WBGene00022527	ZC132.9
Is enriched in neurons based on tiling array and microarray studies. Is affected by rpn-10; sir-2.1; and daf-19 based on RNA-seq and microarray studies. Is affected by four chemicals including resveratrol; Acrylamide; and allantoin based on microarray studies.

WB:WBGene00022528	srt-13
Is affected by several genes including pgl-1; aak-2; and csr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including tryptophan; Rifampin; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00022529	srt-14
Is affected by clk-1; ins-11; and daf-16 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00022530	ZC155.2
Is predicted to have DNA binding activity and protein heterodimerization activity. Is expressed in cholinergic neurons; head neurons; and tail neurons.

WB:WBGene00022531	morc-1
Exhibits topological DNA entrapment activity. Is involved in DNA topological change. Localizes to nuclear body. Is expressed in somatic cell. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease axonal type 2Z. Is an ortholog of human MORC2 (MORC family CW-type zinc finger 2).

WB:WBGene00022532	ZC155.4
Is predicted to have phosphoric diester hydrolase activity. Is an ortholog of human GDE1 (glycerophosphodiester phosphodiesterase 1).

WB:WBGene00022533	cutl-19
Localizes to Golgi apparatus.

WB:WBGene00022534	syx-16
Is predicted to have SNAP receptor activity and SNARE binding activity. Human ortholog(s) of this gene are implicated in pseudohypoparathyroidism type IB. Is an ortholog of human STX16 (syntaxin 16).

WB:WBGene00022536	ZC178.2
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tandem-repeating region of mucin, epiglycanin-like; Tandem-repeating region of mucin, epiglycanin-like; and Mucin-21.

WB:WBGene00022537	ZC190.2
Is affected by several genes including daf-2; clk-1; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by resveratrol; Microcystin-LR; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00022538	ZC190.4
Is predicted to have mRNA binding activity and translation repressor activity. Is an ortholog of human SAMD4A (sterile alpha motif domain containing 4A) and SAMD4B (sterile alpha motif domain containing 4B).

WB:WBGene00022539	ZC190.5
Is affected by several genes including daf-12; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022540	ZC190.6
Is affected by mir-34; drh-3; and daf-19 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq studies.

WB:WBGene00022541	ZC190.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; allantoin; and Sirolimus based on microarray and RNA-seq studies.

WB:WBGene00022542	ZC190.8
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022544	ZC190.10
Is enriched in NSM and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including Alovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00022545	ZC196.1
Is enriched in OLL and PVD based on microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022546	ZC196.2
Is predicted to have FFAT motif binding activity. Human ortholog(s) of this gene are implicated in amyotrophic lateral sclerosis type 8 and autosomal dominant adult-onset proximal spinal muscular atrophy. Is an ortholog of human VAPB (VAMP associated protein B and C).

WB:WBGene00022547	ZC196.3
Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercuric chloride; Mercuric Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00022548	ZC196.4
Is enriched in coelomocyte; hypodermis; intestine; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Mercuric Chloride; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00022549	ZC196.5
Is enriched in AFD and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF713) and Protein of unknown function DUF713.

WB:WBGene00022550	droe-8
Is enriched in cephalic sheath cell; muscle cell; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; Mercuric Chloride; and procyanidin based on microarray and RNA-seq studies.

WB:WBGene00022551	ZC196.8
Is enriched in neurons based on tiling array studies. Is affected by several genes including lin-35; lin-15B; and drh-3 based on microarray and RNA-seq studies. Is affected by dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00022552	ZC196.9
Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray and RNA-seq studies. Is affected by Chlorpyrifos; Diazinon; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00022553	ZC204.1
Is affected by hpl-2; drh-3; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by Chlorpyrifos; Ag nanoparticles; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00022554	duxl-1
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity. Is expressed in coelomocyte; excretory cell; gonad; and spermatheca.

WB:WBGene00022555	btb-12
Is enriched in germ line and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and csr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00022556	ZC204.6
Is enriched in male based on RNA-seq studies. Is affected by drh-3 and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022557	fbxb-15
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00022558	fbxb-21
Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00022559	fbxb-20
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including hydrogen sulfide; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00022560	fbxb-16
Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00022561	btb-13
Is enriched in NSM and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022562	ZC204.12
Is expressed in head neurons and pharynx. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022563	ZC204.13
Is affected by several genes including daf-2; sir-2.1; and hpl-2 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022564	ZC204.14
Is enriched in NSM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022565	ZC239.2
Is enriched in neurons based on tiling array studies. Is affected by mir-34; sek-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and tetrabromobisphenol A based on RNA-seq and microarray studies. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022566	ZC239.3
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and dpy-21 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022567	ZC239.4
Is enriched in arcade cell; cephalic sheath cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and elt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; ENTH/VHS; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022568	ZC239.5
Is enriched in several structures, including ASER; Z4.a; amphid sheath cell; body wall musculature; and male distal tip cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022569	ZC239.6
Is enriched in male-specific anatomical entity; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Alovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022570	sdz-35
Is involved in IRE1-mediated unfolded protein response and PERK-mediated unfolded protein response. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022571	ZC239.13
Is enriched in AFD and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including hsf-1; elt-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by paraquat; tetrabromobisphenol A; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00022572	ZC239.14
Is enriched in AVA; dopaminergic neurons; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-three chemicals including tryptophan; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022573	ZC239.15
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by metformin; Sirolimus; and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD10 (potassium channel tetramerization domain containing 10); KCTD13 (potassium channel tetramerization domain containing 13); and TNFAIP1 (TNF alpha induced protein 1).

WB:WBGene00022574	ZC239.16
Is enriched in ASER; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; levamisole; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily. Is an ortholog of human KCTD13 (potassium channel tetramerization domain containing 13).

WB:WBGene00022575	ZC239.17
Is enriched in intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; Potassium channel tetramerisation-type BTB domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00022576	ZC250.2
Is predicted to have acetylglucosaminyltransferase activity. Human ortholog(s) of this gene are implicated in Peters plus syndrome. Is an ortholog of human B3GLCT (beta 3-glucosyltransferase).

WB:WBGene00022577	nstp-3
Is predicted to have UDP-galactose transmembrane transporter activity. Is an ortholog of human SLC35A1 (solute carrier family 35 member A1).

WB:WBGene00022578	ZC262.1
Is affected by several genes including rrf-3; aak-2; and isp-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including aldicarb; resveratrol; and Chlorpyrifos based on microarray studies.

WB:WBGene00022579	ZC262.2
Is enriched in OLL; PVD; germ line; and intestine based on microarray and RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including aldicarb; Rotenone; and Atrazine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site. Is an ortholog of human RSRC2 (arginine and serine rich coiled-coil 2).

WB:WBGene00022580	iglr-2
Is predicted to have small ribosomal subunit rRNA binding activity. Is expressed in gonadal sheath cell.

WB:WBGene00022581	ZC262.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; csr-1; and mdt-15 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022582	ZC262.5
Is predicted to contribute to ATPase activity. Localizes to mitochondrion. Is an ortholog of human ATP5F1E (ATP synthase F1 subunit epsilon).

WB:WBGene00022583	mrps-18A
Is predicted to have small ribosomal subunit rRNA binding activity. Is an ortholog of human MRPS18A (mitochondrial ribosomal protein S18A).

WB:WBGene00022584	ZC266.1
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00022586	ZC308.4
Is enriched in several structures, including BAG; germ line; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including methylmercury hydroxide; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00022587	ZC317.1
Is enriched in NSM and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Atrazine; cadmium; and fluoranthene based on microarray studies.

WB:WBGene00022588	ZC317.2
Is enriched in GABAergic neurons and dopaminergic neurons based on tiling array studies. Is affected by several genes including lin-15B; isp-1; and csr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by four chemicals including indole; Rifampin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022589	ZC317.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022590	ZC317.7
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and gld-1 based on RNA-seq; microarray; and tiling array studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00022591	cuti-1
Localizes to cytoplasm. Is expressed in anus; excretory pore; hypodermis; and vulva.

WB:WBGene00022592	klu-2
Is predicted to have DNA-binding transcription factor activity and transcription regulatory region DNA binding activity. Is an ortholog of human ZNF740 (zinc finger protein 740).

WB:WBGene00022593	ZC328.3
Is expressed in head. Is predicted to encode a protein with the following domains: VAD1 Analog of StAR-related lipid transfer domain; VASt domain; and Membrane-anchored lipid-binding protein Ysp2/Lam4-like. Is an ortholog of human GRAMD1C (GRAM domain containing 1C).

WB:WBGene00022594	ZC328.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022596	ZC395.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022597	ZC395.5
Is enriched in ASER; GABAergic neurons; PLM; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and let-60 based on microarray and RNA-seq studies. Is affected by twenty-three chemicals including methylmercuric chloride; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022598	ztf-8
Is involved in double-strand break repair. Localizes to condensed chromosome and nucleolus. Is expressed in dorsal nerve cord; embryonic cell; gonad; head muscle; and head neurons.

WB:WBGene00022599	daf-41
Is predicted to have Hsp90 protein binding activity and chaperone binding activity. Localizes to myofibril. Is expressed in amphid neurons; anal depressor muscle; phasmid neurons; seam cell; and vulva. Is an ortholog of human PTGES3 (prostaglandin E synthase 3).

WB:WBGene00022600	ZC395.11
Is enriched in NSM based on tiling array studies. Is affected by ifg-1 based on microarray studies. Is affected by Humic Substances based on microarray studies.

WB:WBGene00022601	ZC404.1
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and lin-39 based on tiling array; RNA-seq; and microarray studies. Is affected by Rifampin; allantoin; and cadmium based on RNA-seq and microarray studies.

WB:WBGene00022603	gck-2
Is predicted to have MAP kinase kinase kinase kinase activity. Is expressed in several structures, including embryonic cell and vulval precursor cell. Is used to study ciliopathy. Is an ortholog of human MAP4K3 (mitogen-activated protein kinase kinase kinase kinase 3) and MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5).

WB:WBGene00022604	dmsr-10
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00022605	dmsr-11
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00022606	dmsr-9
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00022608	madf-9
Is enriched in AVE and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; lin-39; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Alcohol dehydrogenase transcription factor Myb/SANT-like; MADF domain; and Transcription factor Adf-1.

WB:WBGene00022609	ZC416.2
Is enriched in hypodermis; muscle cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022610	ltah-1.2
Is predicted to have epoxide hydrolase activity. Is involved in negative regulation of fatty acid transport; regulation of lipid storage; and regulation of peptide transport. Is an ortholog of human LTA4H (leukotriene A4 hydrolase).

WB:WBGene00022611	ZC449.1
Is enriched in germline precursor cell; hypodermis; muscle cell; neurons; and retrovesicular ganglion based on microarray and tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00022612	ZC449.2
Is enriched in OLL; PVD; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercuric chloride; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00022613	sek-3
Is predicted to have JUN kinase kinase activity and protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in short-rib thoracic dysplasia 6 with or without polydactyly. Is an ortholog of human MAP2K4 (mitogen-activated protein kinase kinase 4).

WB:WBGene00022614	ZC449.4
Is enriched in body wall musculature; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022615	ZC449.5
Is enriched in head mesodermal cell; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022616	hsd-3
Is predicted to have oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Human ortholog(s) of this gene are implicated in congenital adrenal hyperplasia and congenital bile acid synthesis defect 1. Is an ortholog of human SDR42E2 (short chain dehydrogenase/reductase family 42E, member 2).

WB:WBGene00022617	ZC477.2
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00022618	ZC477.3
Is enriched in germ line; neurons; and retrovesicular ganglion based on microarray and RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including D-glucose; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Coiled-coil domain-containing protein 51. Is an ortholog of human CCDC51 (coiled-coil domain containing 51).

WB:WBGene00022619	ZC477.4
Is affected by rsr-2; clk-1; and spr-5 based on tiling array and microarray studies. Is affected by four chemicals including resveratrol; Colistin; and dafa#1 based on microarray studies.

WB:WBGene00022620	rde-8
Exhibits endoribonuclease activity and mRNA binding activity. Is involved in RNA phosphodiester bond hydrolysis, endonucleolytic; positive regulation of RNA-directed 5'-3' RNA polymerase activity; and production of siRNA involved in RNA interference. Localizes to mutator focus. Is expressed in germ line.

WB:WBGene00022621	ZC477.7
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00022622	ZC477.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022623	ZC487.1
Is predicted to have ATP binding activity.

WB:WBGene00022624	ZC487.2
Is affected by rsr-2; csr-1; and elt-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022627	ZC513.2
Is predicted to have lipid binding activity. Is an ortholog of human BPI (bactericidal permeability increasing protein) and PLTP (phospholipid transfer protein).

WB:WBGene00022628	ZC513.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by sixteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00022629	algn-12
Is predicted to have alpha-1,6-mannosyltransferase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Ig. Is an ortholog of human ALG12 (ALG12 alpha-1,6-mannosyltransferase).

WB:WBGene00022630	fbxa-223
Is enriched in head mesodermal cell and in male based on RNA-seq studies. Is affected by several genes including eat-2; pmk-1; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; methylmercuric chloride; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00022631	nekl-2
Is predicted to have ATP binding activity; metal ion binding activity; and protein serine/threonine kinase activity. Is involved in molting cycle and positive regulation of endocytosis. Is expressed in hyp7 syncytium. Human ortholog(s) of this gene are implicated in nephronophthisis 9 and renal-hepatic-pancreatic dysplasia. Is an ortholog of human NEK8 (NIMA related kinase 8).

WB:WBGene00022632	ZC581.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00022633	ZC581.3
Is enriched in body wall musculature; head mesodermal cell; male-specific anatomical entity; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Mercuric Chloride; 4-bromodiphenyl ether; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00022634	ZC581.7
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00022635	ZC581.9
Is predicted to have ATP binding activity and protein kinase activity. Is an ortholog of human SCYL2 (SCY1 like pseudokinase 2).

WB:WBGene00022636	nhr-278
Is affected by clk-1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00022637	nhr-252
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00022638	scl-27
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-12; elt-2; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including tryptophan; methylmercuric chloride; and Rotenone based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Cysteine-rich secretory protein family; Cysteine-rich  secretory protein-related; CAP domain; and CAP superfamily.

WB:WBGene00022639	nhr-253
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity. Is expressed in ASEL; ASER; and neurons.

WB:WBGene00022640	nhr-254
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00022641	ZK6.6
Is enriched in excretory cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including aldicarb; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00022642	lipl-5
Is predicted to have hydrolase activity, acting on ester bonds. Is involved in defense response to Gram-negative bacterium; lipid homeostasis; and triglyceride catabolic process. Localizes to lysosome. Is expressed in coelomocyte and intestine. Human ortholog(s) of this gene are implicated in autosomal recessive congenital ichthyosis 8 and lysosomal and lipase deficiency. Is an ortholog of several human genes including LIPF (lipase F, gastric type); LIPK (lipase family member K); and LIPN (lipase family member N).

WB:WBGene00022643	ZK6.8
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by nineteen chemicals including 1-methylnicotinamide; methylmercuric chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ion channel regulatory protein UNC-93; Ion channel regulatory protein, UNC-93; and MFS transporter superfamily. Is an ortholog of human MFSD11 (major facilitator superfamily domain containing 11).

WB:WBGene00022644	dod-19
Is involved in innate immune response. Localizes to membrane raft.

WB:WBGene00022645	ZK6.11
Is involved in innate immune response. Localizes to membrane raft.

WB:WBGene00022646	acl-9
Is predicted to have transferase activity, transferring acyl groups. Is an ortholog of human LCLAT1 (lysocardiolipin acyltransferase 1).

WB:WBGene00022647	slc-17.1
Is predicted to have transmembrane transporter activity. Localizes to sarcoplasmic reticulum. Is an ortholog of human SLC17A5 (solute carrier family 17 member 5).

WB:WBGene00022648	ZK54.3
Is enriched in AVK; GABAergic neurons; NSM; RID; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Sodium Chloride; and nitroguanidine based on RNA-seq and microarray studies.

WB:WBGene00022649	ZK84.1
Is enriched in germ line based on proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by twenty-one chemicals including hydrogen sulfide; Rotenone; and sodium arsenite based on microarray and RNA-seq studies.

WB:WBGene00022650	ZK84.2
Is enriched in AFD and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022651	ZK84.4
Is affected by mir-34 and hpl-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride; Mercuric Chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022652	ZK84.5
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; D-glucose; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00022653	ZK105.1
Is enriched in body wall musculature and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by eighteen chemicals including Heme; Ethanol; and 1-methylnicotinamide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00022654	ZK105.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: STELLO glycosyltransferases and STELLO-like.

WB:WBGene00022655	srsx-40
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srsx and Serpentine type 7TM GPCR chemoreceptor Srsx.

WB:WBGene00022656	ZK105.5
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by Cadmium Chloride and Ag nanoparticles based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00022657	ZK105.6
Is enriched in AFD and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00022658	srh-188
Is affected by tatn-1 and clk-1 based on RNA-seq and microarray studies.

WB:WBGene00022660	ZK112.4
Is affected by several genes including daf-16; daf-12; and ain-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00022661	ZK112.5
Is enriched in coelomocyte; male-specific anatomical entity; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and alg-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including aldicarb; methylmercury hydroxide; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022662	ZK112.6
Is affected by several genes including sir-2.1; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022663	glrx-21
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity. Is an ortholog of human GLRX2 (glutaredoxin 2).

WB:WBGene00022664	ZK121.2
Is predicted to have nucleic acid binding activity. Is an ortholog of human ARPP21 (cAMP regulated phosphoprotein 21) and R3HDM2 (R3H domain containing 2).

WB:WBGene00022665	ZK154.1
Is enriched in AFD and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq; microarray; and proteomic studies. Is affected by fifteen chemicals including Ethanol; methylmercury hydroxide; and methylmercuric chloride based on RNA-seq and microarray studies.

WB:WBGene00022666	ZK154.4
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and dcr-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including aldicarb; Rotenone; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Cancer-associated antigen RCAS1. Is an ortholog of human EBAG9 (estrogen receptor binding site associated antigen 9).

WB:WBGene00022667	ZK154.5
Is enriched in germ line; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including D-glucose; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00022668	ZK154.6
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Rifampin; allantoin; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00022669	ZK177.1
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022670	ZK177.2
Is predicted to have histone kinase activity (H3-T3 specific). Is an ortholog of human HASPIN (histone H3 associated protein kinase).

WB:WBGene00022671	ZK177.3
Is expressed in intestine. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00022672	npp-24
Is enriched in germ line; intestine; mechanosensory neurons; muscle cell; and somatic gonad precursor based on microarray and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and daf-12 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Zidovudine; Atrazine; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Nuclear pore component and Nucleoporin Nup88.

WB:WBGene00022673	ZK177.8
Is predicted to have dGTPase activity. Is expressed in head and tail. Human ortholog(s) of this gene are implicated in Aicardi-Goutieres syndrome and Chilblain lupus. Is an ortholog of human SAMHD1 (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1).

WB:WBGene00022674	ZK177.9
Is enriched in GABAergic neurons; body wall muscle cell; coelomocyte; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including methylmercuric chloride; D-glucose; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00022675	gbb-2
Exhibits G protein-coupled GABA receptor activity. Is involved in G protein-coupled receptor signaling pathway; negative regulation of cholinergic synaptic transmission; and response to drug. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 59. Is an ortholog of human GABBR2 (gamma-aminobutyric acid type B receptor subunit 2).

WB:WBGene00022677	rfth-1
Is predicted to have lipid transporter activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation In. Is an ortholog of human RFT1 (RFT1 homolog).

WB:WBGene00022678	sar-1
Is predicted to have GTPase activity. Is involved in embryo development. Human ortholog(s) of this gene are implicated in Joubert syndrome 8 and chylomicron retention disease. Is an ortholog of human SAR1A (secretion associated Ras related GTPase 1A).

WB:WBGene00022679	ZK180.5
Is enriched in DA neuron; hypodermis; intestine; pharyngeal muscle cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; quantitative PCR; tiling array; proteomic; and RNA-seq studies. Is affected by twenty-six chemicals including hydrogen sulfide; 1-methylnicotinamide; and nicotinic acid based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022680	ZK180.6
Is enriched in DA neuron; OLL; PLM; and PVD based on microarray and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; proteomic; and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; Nitric Oxide; and methylmercury hydroxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022681	ZK185.1
Is enriched in NSM and intestine based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and sma-2 based on microarray; RNA-seq; and tiling array studies. Is affected by Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022682	ZK185.2
Is predicted to have cation transmembrane transporter activity.

WB:WBGene00022683	ZK185.3
Is predicted to have glycine N-acyltransferase activity. Is an ortholog of human GLYAT (glycine-N-acyltransferase) and GLYATL3 (glycine-N-acyltransferase like 3).

WB:WBGene00022684	ZK250.1
No description available

WB:WBGene00022685	ZK250.2
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including daf-2; lin-35; and mex-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; dafa#1; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00022686	ZK250.3
No description available

WB:WBGene00022687	ZK250.4
No description available

WB:WBGene00022688	math-47
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00022689	math-48
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by methylmercuric chloride and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00022690	math-49
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; daf-12; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00022691	math-50
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by fluoranthene; Chlorpyrifos; and nitroguanidine based on microarray studies.

WB:WBGene00022692	ZK250.9
No description available

WB:WBGene00022693	ZK250.10
Is affected by several genes including daf-16; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022694	gcna-1
Is involved in meiotic chromosome segregation. Localizes to condensed chromosome. Is expressed in germ cell. Is an ortholog of human GCNA (germ cell nuclear acidic peptidase).

WB:WBGene00022695	ZK328.6
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00022696	ift-139
Is expressed in amphid neurons; ciliated neurons; head neurons; sensory neurons; and tail neurons. Is used to study nephronophthisis. Human ortholog(s) of this gene are implicated in asphyxiating thoracic dystrophy 4 and nephronophthisis 12. Is predicted to encode a protein with the following domains: Tetratricopeptide repeat; Tetratricopeptide-like helical domain superfamily; Tetratricopeptide repeat; and Tetratricopeptide repeat protein 21A/21B. Is an ortholog of human TTC21B (tetratricopeptide repeat domain 21B).

WB:WBGene00022697	cyy-1
Is predicted to have cyclin-dependent protein serine/threonine kinase regulator activity. Is involved in negative regulation of synapse assembly; regulation of neuron remodeling; and regulation of terminal button organization. Localizes to axon and dendrite. Is an ortholog of human CCNYL1 (cyclin Y like 1).

WB:WBGene00022698	ZK353.2
Is enriched in coelomocyte and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; elt-2; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00022699	ZK353.3
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including aldicarb; methylmercuric chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022700	ZK353.4
Is enriched in AVK; FLP; amphid sheath cell; and in male based on microarray and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00022702	cutc-1
Is predicted to have copper ion binding activity. Is involved in several processes, including oviposition; response to copper ion; and vulval development. Localizes to cell junction and striated muscle dense body. Is an ortholog of human CUTC (cutC copper transporter).

WB:WBGene00022703	ubxn-4
Is involved in positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress and ubiquitin-dependent ERAD pathway. Is an ortholog of human UBXN4 (UBX domain protein 4).

WB:WBGene00022704	ZK353.9
Is enriched in NSM; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PITH domain; Galactose-binding-like domain superfamily; PITH domain; and PITH domain superfamily. Is an ortholog of human PITHD1 (PITH domain containing 1).

WB:WBGene00022705	ZK354.2
Is predicted to have protein serine/threonine kinase activity.

WB:WBGene00022706	ZK354.3
Is enriched in DA neuron; VA neuron; body wall muscle cell; germ line; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00022707	ZK354.6
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in spinocerebellar ataxia type 11. Is an ortholog of human TTBK1 (tau tubulin kinase 1) and TTBK2 (tau tubulin kinase 2).

WB:WBGene00022708	ZK354.7
Is enriched in germ line and hypodermis based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including methylmercuric chloride; D-glucose; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00022709	ZK354.8
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00022710	ZK354.9
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00022711	irld-63
Is affected by several genes including let-60; sir-2.1; and alg-1 based on RNA-seq and microarray studies. Is affected by fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00022712	ZK355.2
Is enriched in Z1; Z4; body wall musculature; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; Cry5B; and resveratrol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022713	ZK355.3
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including cholesterol; lathosterol; and tryptophan based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022714	irld-64
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including let-60; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by fluoranthene and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00022715	irld-65
Is enriched in amphid sheath cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including skn-1; unc-75; and flcn-1 based on RNA-seq and microarray studies. Is affected by Sodium Chloride and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00022716	irld-66
Is affected by rrf-2 based on microarray studies. Is affected by tryptophan; resveratrol; and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00022717	hipr-1
Is predicted to have actin filament binding activity; clathrin binding activity; and phosphatidylinositol bisphosphate binding activity. Is involved in several processes, including defecation; neurotransmitter secretion; and ultradian rhythm. Is expressed in germ line; gonad; neurons; and pharynx. Is an ortholog of human HIP1 (huntingtin interacting protein 1) and HIP1R (huntingtin interacting protein 1 related).

WB:WBGene00022718	ZK370.4
Is predicted to have lysophospholipase activity. Human ortholog(s) of this gene are implicated in several diseases, including Boucher-Neuhauser syndrome; Laurence-Moon syndrome; and Oliver-McFarlane syndrome. Is an ortholog of human PNPLA7 (patatin like phospholipase domain containing 7).

WB:WBGene00022719	pdhk-2
Is predicted to have protein serine/threonine kinase activity. Localizes to perinuclear region of cytoplasm. Is expressed in head neurons; intestine; pharynx; and vulval muscle. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease X-linked dominant 6. Is an ortholog of several human genes including PDK1 (pyruvate dehydrogenase kinase 1); PDK3 (pyruvate dehydrogenase kinase 3); and PDK4 (pyruvate dehydrogenase kinase 4).

WB:WBGene00022720	ZK370.6
Is enriched in body wall musculature; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00022721	ugtp-1
Is predicted to have pyrimidine nucleotide-sugar transmembrane transporter activity. Localizes to Golgi medial cisterna and cortical granule. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation type IIf. Is an ortholog of human SLC35A1 (solute carrier family 35 member A1).

WB:WBGene00022722	tomm-70
Localizes to mitochondrion. Is expressed in muscle cell; pharyngeal muscle cell; and tail. Is an ortholog of human TOMM70 (translocase of outer mitochondrial membrane 70).

WB:WBGene00022723	ZK380.2
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including age-1; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00022724	ZK380.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including mex-1; dpy-21; and spn-4 based on tiling array and RNA-seq studies. Is affected by eight chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00022725	ZK381.2
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00022726	nhr-249
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including hydrogen sulfide; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00022727	prkl-1
Is predicted to have zinc ion binding activity. Is expressed in several structures, including QL; egg-laying apparatus; gonad; head; and somatic nervous system. Human ortholog(s) of this gene are implicated in progressive myoclonus epilepsy 1B. Is an ortholog of human PRICKLE2 (prickle planar cell polarity protein 2).

WB:WBGene00022728	ZK402.1
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by Testosterone based on microarray studies.

WB:WBGene00022729	ZK402.2
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00022730	ZK402.3
Is enriched in ASER; germ line; hypodermis; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by four chemicals including aldicarb; antimycin; and Humic Substances based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00022731	ZK402.5
Is enriched in germline precursor cell; neurons; retrovesicular ganglion; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and let-60 based on RNA-seq and microarray studies. Is affected by eight chemicals including resveratrol; Atrazine; and Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00022732	ZK418.2
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by twenty chemicals including methylmercury hydroxide; nicotinic acid; and methylmercuric chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022733	tmem-17
Localizes to ciliary transition zone. Is expressed in amphid neurons; ciliated neurons; inner labial neurons; outer labial neurons; and phasmid neurons. Is an ortholog of human TMEM17 (transmembrane protein 17).

WB:WBGene00022734	ZK418.5
Is enriched in Psub3; excretory cell; germ line; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Rotenone; Zidovudine; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Predicted membrane protein (DUF2053) and Transmembrane protein 147. Is an ortholog of human TMEM147 (transmembrane protein 147).

WB:WBGene00022735	ZK418.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by four chemicals including methylmercuric chloride; Rotenone; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Putative G-protein coupled receptor, Chromadorea.

WB:WBGene00022736	ZK418.7
Is enriched in ASER; amphid sheath cell; head mesodermal cell; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Putative G-protein coupled receptor, Chromadorea.

WB:WBGene00022737	tofu-7
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus.

WB:WBGene00022738	fubl-2
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus. Is an ortholog of human FUBP3 (far upstream element binding protein 3).

WB:WBGene00022739	toe-1
Is predicted to have snoRNA binding activity. Is an ortholog of human HEATR1 (HEAT repeat containing 1).

WB:WBGene00022741	ZK430.5
Is predicted to have cysteine-type endopeptidase activity. Is an ortholog of human ESPL1 (extra spindle pole bodies like 1, separase).

WB:WBGene00022742	ZK430.7
Is enriched in body wall muscle cell; germ line; and somatic gonad precursor based on proteomic; tiling array; and RNA-seq studies. Is affected by several genes including glp-1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sof1-like domain; WD domain, G-beta repeat; WD40 repeat; Sof1-like protein; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human DCAF13 (DDB1 and CUL4 associated factor 13).

WB:WBGene00022743	mlt-7
Exhibits peroxidase activity. Is involved in several processes, including cuticle development involved in collagen and cuticulin-based cuticle molting cycle; nematode larval development; and post-embryonic body morphogenesis. Is expressed in anterior hypodermis and hypodermal cell. Human ortholog(s) of this gene are implicated in Alzheimer's disease 1 and anterior segment dysgenesis 7. Is an ortholog of human EPX (eosinophil peroxidase).

WB:WBGene00022744	ZK470.1
Is enriched in AVK and neurons based on RNA-seq studies. Is affected by several genes including elt-2; alg-1; and mex-3 based on RNA-seq studies. Is affected by four chemicals including D-glucose; metformin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Mpv17 / PMP22 family and Mpv17/PMP22. Is an ortholog of human MPV17L2 (MPV17 mitochondrial inner membrane protein like 2).

WB:WBGene00022745	ZK470.2
Is enriched in body wall musculature; hypodermis; intestine; and neurons based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022746	ZK470.4
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Mercuric Chloride and Tunicamycin based on microarray studies.

WB:WBGene00022747	ZK470.6
Is enriched in arcade cell; muscle cell; and pharyngeal-intestinal valve cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including 1-methylnicotinamide; glycine; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022748	oaz-1
Is predicted to have ornithine decarboxylase inhibitor activity. Is expressed in spermathecal-uterine valve cell. Is an ortholog of human OAZ2 (ornithine decarboxylase antizyme 2) and OAZ3 (ornithine decarboxylase antizyme 3).

WB:WBGene00022749	ZK484.3
Is enriched in OLL; PVD; germ line; and somatic gonad precursor based on proteomic; microarray; and RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; proteomic; and RNA-seq studies. Is affected by five chemicals including Hydrolyzable Tannins; Humic Substances; and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00022750	tres-1
Is expressed in gonad. Is predicted to encode a protein with the following domains: Phosphorylation site and Treslin. Is an ortholog of human TICRR (TOPBP1 interacting checkpoint and replication regulator).

WB:WBGene00022751	msrp-2
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and age-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by twenty-nine chemicals including Ethanol; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00022752	ZK484.6
Is predicted to have intramolecular transferase activity, phosphotransferases.

WB:WBGene00022753	ZK484.7
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00022754	nspd-1
Is enriched in AVK; amphid sheath cell; coelomocyte; intestine; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by nineteen chemicals including Ethanol; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00022755	nhr-250
Is affected by several genes including ubc-9; pmt-2; and wdr-5.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022756	nhr-251
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00022757	ZK488.5
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00022758	ZK488.6
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00022759	ZK546.2
Is enriched in PLM; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Zidovudine; Hydrolyzable Tannins; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily. Is an ortholog of human LRRC57 (leucine rich repeat containing 57).

WB:WBGene00022760	ZK546.3
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on RNA-seq; microarray; and tiling array studies. Is affected by thirteen chemicals including Ethanol; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022761	ZK546.4
Is enriched in AVK; body wall muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including methylmercuric chloride; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00022762	ZK546.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and npr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal dominant non-syndromic intellectual disability 22. Is predicted to encode a protein with the following domains: Zinc finger C2H2-type and Zinc finger C2H2 superfamily.

WB:WBGene00022763	ZK546.7
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00022764	ZK546.8
No description available

WB:WBGene00022765	ZK546.14
Is predicted to have DNA binding activity and RNA binding activity. Is an ortholog of human SURF6 (surfeit 6).

WB:WBGene00022766	cblc-1
Is predicted to have anion binding activity; cyanocobalamin reductase (cyanide-eliminating) activity; and demethylase activity. Human ortholog(s) of this gene are implicated in methylmalonic aciduria and homocystinuria type cblC. Is an ortholog of human MMACHC (metabolism of cobalamin associated C).

WB:WBGene00022767	ZK563.2
Is predicted to have phosphate ion transmembrane transporter activity and sodium:phosphate symporter activity. Human ortholog(s) of this gene are implicated in several diseases, including Fanconi syndrome; hereditary hypophosphatemic rickets with hypercalciuria; and hypophosphatemic nephrolithiasis/osteoporosis 1. Is an ortholog of human SLC34A2 (solute carrier family 34 member 2).

WB:WBGene00022768	ZK563.3
No description available

WB:WBGene00022769	sorf-1
Is predicted to have phosphatidylinositol 3-kinase regulator activity. Is involved in organelle fusion; positive regulation of early endosome to late endosome transport; and regulation of endosome size. Localizes to early endosome and late endosome. Is an ortholog of human WDR91 (WD repeat domain 91).

WB:WBGene00022770	acp-1
Is predicted to have acid phosphatase activity.

WB:WBGene00022771	ZK616.1
Is predicted to have RNA binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Y-linked spermatogenic failure 2; amyotrophic lateral sclerosis type 20; and autosomal dominant limb-girdle muscular dystrophy type 3. Is an ortholog of human RBMY1D (RNA binding motif protein Y-linked family 1 member D).

WB:WBGene00022772	ZK616.2
Is predicted to have protein disulfide oxidoreductase activity. Is an ortholog of human CHCHD4 (coiled-coil-helix-coiled-coil-helix domain containing 4).

WB:WBGene00022773	ZK616.3
Is predicted to have protein disulfide oxidoreductase activity. Is an ortholog of human CHCHD4 (coiled-coil-helix-coiled-coil-helix domain containing 4).

WB:WBGene00022774	swsn-6
Is predicted to have chromatin binding activity. Is used to study alcohol use disorder. Is an ortholog of human ACTL6A (actin like 6A) and ACTL6B (actin like 6B).

WB:WBGene00022775	ZK616.5
Is enriched in germ line; germline precursor cell; head mesodermal cell; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00022776	perm-3
Is enriched in NSM and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1077) and TMEM85/ER membrane protein complex subunit 4. Is an ortholog of human EMC4 (ER membrane protein complex subunit 4).

WB:WBGene00022778	ZK616.8
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including hydrogen sulfide; Ethanol; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: PLAT/LH2 domain superfamily.

WB:WBGene00022780	ZK622.1
Is predicted to have non-membrane spanning protein tyrosine kinase activity and signaling receptor binding activity. Is an ortholog of human FER (FER tyrosine kinase) and FES (FES proto-oncogene, tyrosine kinase).

WB:WBGene00022781	pmt-1
Exhibits phosphoethanolamine N-methyltransferase activity. Is involved in multicellular organism reproduction; nematode larval development; and phosphatidylcholine biosynthesis from phosphoryl-ethanolamine via N-dimethylethanolamine phosphate and CDP-choline. Is expressed in seam cell.

WB:WBGene00022782	ZK622.4
Is predicted to have metal ion binding activity.

WB:WBGene00022783	tomm-7
Is involved in mitochondrion organization. Is expressed in intestine and pharynx. Is an ortholog of human TOMM7 (translocase of outer mitochondrial membrane 7).

WB:WBGene00022785	ZK652.6
Is predicted to have DNA binding activity; ubiquitin protein ligase activity; and zinc ion binding activity. Is an ortholog of human KCMF1 (potassium channel modulatory factor 1).

WB:WBGene00022786	ZK652.8
Is expressed in head neurons; intestine; nervous system; and tail neurons.

WB:WBGene00022787	tag-307
Is predicted to have DNA binding activity. Is an ortholog of human POLDIP2 (DNA polymerase delta interacting protein 2).

WB:WBGene00022788	slc-17.7
Is predicted to have transmembrane transporter activity.

WB:WBGene00022789	lron-2
Is expressed in tail. Human ortholog(s) of this gene are implicated in congenital stationary night blindness 1F and familial temporal lobe epilepsy 1. Is predicted to encode a protein with the following domains: Leucine rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; and Leucine-rich repeat domain superfamily. Is an ortholog of several human genes including LGI1 (leucine rich glioma inactivated 1); LGI2 (leucine rich repeat LGI family member 2); and LRRC52 (leucine rich repeat containing 52).

WB:WBGene00022790	ZK682.7
Is enriched in AFD; ASER; BAG; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; eat-2; and dpy-7 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00022791	ZK686.1
Is enriched in PLM; germ line; hypodermis; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq studies.

WB:WBGene00022792	ZK686.2
Is predicted to have RNA binding activity and RNA helicase activity. Is expressed in neurons. Is an ortholog of human DDX51 (DEAD-box helicase 51).

WB:WBGene00022793	ZK686.3
Is enriched in intestine based on microarray studies. Is affected by several genes including let-7; gld-1; and clk-1 based on microarray; proteomic; and RNA-seq studies. Is affected by four chemicals including Rotenone; estrogen; and cadmium based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia and autosomal recessive non-syndromic intellectual disability. Is predicted to encode a protein with the following domains: OST3 / OST6 family, transporter family; Oligosaccharyl transferase complex, subunit OST3/OST6; and Thioredoxin-like superfamily. Is an ortholog of human MAGT1 (magnesium transporter 1) and TUSC3 (tumor suppressor candidate 3).

WB:WBGene00022794	snu-23
Is predicted to have DNA binding activity and zinc ion binding activity. Is an ortholog of human ZMAT2 (zinc finger matrin-type 2).

WB:WBGene00022795	ZK686.5
Is predicted to have DNA binding activity and metal ion binding activity.

WB:WBGene00022796	ZK688.1
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00022797	best-24
Is predicted to have chloride channel activity. Is expressed in head neurons; hypodermis; intestine; and nervous system. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00022798	fahd-1
Is predicted to have acetylpyruvate hydrolase activity. Is expressed in body wall musculature; excretory canal; pharynx; and vulva. Is an ortholog of human FAHD1 (fumarylacetoacetate hydrolase domain containing 1).

WB:WBGene00022799	ZK688.4
Is affected by several genes including daf-12; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including metformin; Sirolimus; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00022800	ZK688.5
Is predicted to have misfolded protein binding activity and polyubiquitin modification-dependent protein binding activity. Is an ortholog of human BAG6 (BAG cochaperone 6).

WB:WBGene00022801	pcp-5
Is predicted to have dipeptidyl-peptidase activity. Is expressed in body wall musculature. Is an ortholog of human PRCP (prolylcarboxypeptidase).

WB:WBGene00022802	ZK688.7
Is enriched in several structures, including Z4.a; germ line; intestine; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022803	ZK688.9
Is enriched in body wall muscle cell; germ line; neurons; retrovesicular ganglion; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; glp-1; and gld-1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including manganese chloride; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TIP41-like family and TIP41-like protein. Is an ortholog of human TIPRL (TOR signaling pathway regulator).

WB:WBGene00022804	ZK697.1
Is affected by several genes including ain-1; mir-34; and adr-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00022805	nhr-256
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00022806	ZK697.3
Is affected by rsr-2 based on tiling array studies. Is affected by resveratrol; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00022807	srab-25
Is expressed in intestine. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00022808	ZK697.8
Is predicted to have hydroxyisourate hydrolase activity. Human ortholog(s) of this gene are implicated in carpal tunnel syndrome; dystransthyretinemic hyperthyroxinemia; and transthyretin amyloidosis. Is an ortholog of human TTR (transthyretin).

WB:WBGene00022809	ZK697.14
Is affected by several genes including let-60; eat-2; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; multi-walled carbon nanotube; and indole based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human CBR1 (carbonyl reductase 1) and CBR3 (carbonyl reductase 3).

WB:WBGene00022810	ZK721.3
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; D-glucopyranose; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022811	ZK721.4
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00022812	uvs-1
Is predicted to have RNA polymerase II complex binding activity. Is involved in response to UV and transcription-coupled nucleotide-excision repair. Is an ortholog of human UVSSA (UV stimulated scaffold protein A).

WB:WBGene00022813	ZK742.3
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00022814	ZK742.4
Is predicted to have FMN binding activity and oxidoreductase activity.

WB:WBGene00022815	asic-1
Is predicted to have acid-sensing ion channel activity. Is involved in positive regulation of dopamine secretion. Is expressed in neurons. Human ortholog(s) of this gene are implicated in bronchiectasis (multiple) and renal tubular transport disease (multiple). Is an ortholog of human SCNN1B (sodium channel epithelial 1 subunit beta) and SCNN1G (sodium channel epithelial 1 subunit gamma).

WB:WBGene00022816	fbn-1
Is predicted to have calcium ion binding activity. Is used to study connective tissue disease. Human ortholog(s) of this gene are implicated in several diseases, including Alagille syndrome; Marfan syndrome; and bone development disease (multiple). Is an ortholog of human FBN2 (fibrillin 2).

WB:WBGene00022817	upp-1
Exhibits thymidine phosphorylase activity and uridine phosphorylase activity. Is involved in thymidine metabolic process; uracil catabolic process; and uridine catabolic process. Is expressed in gonad; hypodermis; pharynx; and spermatheca. Is an ortholog of human UPP1 (uridine phosphorylase 1) and UPP2 (uridine phosphorylase 2).

WB:WBGene00022818	ZK783.3
Is enriched in NSM; seam cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including methylmercuric chloride; glycine; and resveratrol based on microarray and RNA-seq studies.

WB:WBGene00022820	ZK813.1
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Lithium Chloride; Heme; and Ethanol based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Chorion family 2 and Chorion 2.

WB:WBGene00022821	ZK813.2
Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including Ethanol; methylmercuric chloride; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00022822	ZK813.3
Is expressed in spermatheca. Is predicted to encode a protein with the following domains: Chorion family 2 and Chorion 2.

WB:WBGene00022823	ZK813.4
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022824	ZK813.5
Is predicted to have G protein-coupled photoreceptor activity.

WB:WBGene00022825	ZK816.1
Is enriched in AVK; RIS; dopaminergic neurons; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022826	ZK816.3
Is enriched in coelomocyte and pharynx based on microarray and tiling array studies. Is affected by hpl-2 and daf-2 based on tiling array and microarray studies.

WB:WBGene00022827	ZK816.4
Is expressed in pharynx. Is predicted to encode a protein with the following domain: .

WB:WBGene00022829	ZK867.2
Is predicted to have ionotropic glutamate receptor activity.

WB:WBGene00022830	ZK973.1
Is predicted to have mRNA binding activity. Is an ortholog of human SRBD1 (S1 RNA binding domain 1).

WB:WBGene00022831	cec-10
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on microarray; proteomic; and RNA-seq studies. Is affected by nine chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Chromo/chromo shadow domain; Chromo-like domain superfamily; and Ankyrin repeat-containing domain superfamily.

WB:WBGene00022832	pdp-1
Is predicted to have [pyruvate dehydrogenase (lipoamide)] phosphatase activity and magnesium-dependent protein serine/threonine phosphatase activity. Human ortholog(s) of this gene are implicated in pyruvate decarboxylase deficiency. Is an ortholog of human PDP1 (pyruvate dehyrogenase phosphatase catalytic subunit 1).

WB:WBGene00022833	ZK973.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including methylmercuric chloride; Cry5B; and Atrazine based on microarray studies.

WB:WBGene00022834	ZK973.8
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including manganese chloride; Mianserin; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1265); Protein of unknown function DUF1265; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00022835	ZK973.9
Is predicted to have transcription coactivator activity. Is an ortholog of human SS18 (SS18 subunit of BAF chromatin remodeling complex).

WB:WBGene00022836	ZK973.11
Is predicted to have thiol oxidase activity. Is expressed in head neurons; intestine; and nervous system. Is an ortholog of human TMX3 (thioredoxin related transmembrane protein 3).

WB:WBGene00022837	ceh-45
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity. Is expressed in pharynx and spermatheca. Human ortholog(s) of this gene are implicated in several diseases, including WAGR syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human GSC (goosecoid homeobox).

WB:WBGene00022838	ZK993.2
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022840	ZK994.1
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022842	ZK994.6
Is enriched in neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including let-60; eat-2; and lin-35 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022843	ZK1055.2
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including aldicarb; Alovudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273; Protein of unknown function DUF273; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00022845	ZK1055.4
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including methylmercury hydroxide; methylmercuric chloride; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273; Protein of unknown function DUF273; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00022846	ZK1055.5
Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00022847	ZK1055.6
Is enriched in AVA; coelomocyte; intestine; sensory neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including aldicarb; methylmercuric chloride; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Conserved hypothetical protein CHP02231.

WB:WBGene00022848	ZK1055.7
Is involved in innate immune response.

WB:WBGene00022849	acs-6
Is predicted to have catalytic activity. Human ortholog(s) of this gene are implicated in non-syndromic X-linked intellectual disability. Is an ortholog of human ACSBG1 (acyl-CoA synthetase bubblegum family member 1) and ACSBG2 (acyl-CoA synthetase bubblegum family member 2).

WB:WBGene00022850	ZK1127.3
Is enriched in body wall muscle cell; germ line; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; bisphenol A; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chromatin modification-related protein EAF7 and Chromatin modification-related protein Eaf7/MRGBP.

WB:WBGene00022851	ZK1127.4
Is predicted to have kinase regulator activity and tubulin binding activity. Is an ortholog of human BCCIP (BRCA2 and CDKN1A interacting protein).

WB:WBGene00022852	ZK1127.5
Is predicted to have endoribonuclease activity. Is an ortholog of human RCL1 (RNA terminal phosphate cyclase like 1).

WB:WBGene00022853	ZK1127.6
Is enriched in AB and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq; proteomic; and microarray studies. Is affected by seven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is an ortholog of human TCERG1 (transcription elongation regulator 1).

WB:WBGene00022854	cin-4
Is predicted to have ATP binding activity; DNA binding activity; and DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity. Is an ortholog of human TOP2A (DNA topoisomerase II alpha).

WB:WBGene00022855	tcer-1
Is predicted to have RNA polymerase binding activity and transcription coregulator activity. Localizes to nuclear periphery. Is expressed in several structures, including germ cell; gonad; hypodermal cell; intestinal cell; and somatic cell. Is an ortholog of human TCERG1 (transcription elongation regulator 1).

WB:WBGene00022856	cth-2
Is predicted to have cystathionine gamma-lyase activity and pyridoxal phosphate binding activity. Localizes to endoplasmic reticulum. Human ortholog(s) of this gene are implicated in cystathioninuria. Is an ortholog of human CTH (cystathionine gamma-lyase).

WB:WBGene00022857	ZK1127.12
Is enriched in PLM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and pmk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00022858	ZK1193.2
Is enriched in DA neuron; I5 neuron; SAB; intestine; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twenty-one chemicals including Ethanol; methylmercuric chloride; and Mercuric Chloride based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domains: von Willebrand factor type A domain; von Willebrand factor, type A; and von Willebrand factor A-like domain superfamily.

WB:WBGene00022861	dve-1
Exhibits chaperone binding activity. Is involved in embryo development and mitochondrial unfolded protein response. Localizes to nuclear transcription factor complex. Is expressed in several structures, including amphid neurons; rectum; somatic nervous system; tail; and vulva. Human ortholog(s) of this gene are implicated in chromosome 2q32-q33 deletion syndrome. Is an ortholog of human SATB2 (SATB homeobox 2).

WB:WBGene00022862	ZK1236.1
Is predicted to have GTP binding activity; GTPase activity; and ribosome binding activity. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 40. Is an ortholog of human GUF1 (GUF1 homolog, GTPase).

WB:WBGene00022863	ZK1236.4
No description available

WB:WBGene00022864	ZK1236.5
Is enriched in NSM; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00022865	ufbp-1
Localizes to nucleus. Is expressed in head neurons. Is an ortholog of human DDRGK1 (DDRGK domain containing 1).

WB:WBGene00022866	ZK1240.1
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H.

WB:WBGene00022867	ZK1240.2
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H.

WB:WBGene00022868	ZK1240.3
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of several human genes including TRIM17 (tripartite motif containing 17); TRIM6-TRIM34 (TRIM6-TRIM34 readthrough); and TRIM65 (tripartite motif containing 65).

WB:WBGene00022869	ZK1240.4
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; sir-2.1; and lin-15B based on microarray and RNA-seq studies. Is affected by Zidovudine; paraquat; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00022870	ZK1240.5
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of several human genes including TRIM17 (tripartite motif containing 17); TRIM6-TRIM34 (TRIM6-TRIM34 readthrough); and TRIM65 (tripartite motif containing 65).

WB:WBGene00022871	ZK1240.6
Is predicted to have zinc ion binding activity.

WB:WBGene00022872	ZK1240.8
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of several human genes including TRIM17 (tripartite motif containing 17); TRIM6-TRIM34 (TRIM6-TRIM34 readthrough); and TRIM65 (tripartite motif containing 65).

WB:WBGene00022873	ZK1240.9
Is predicted to have zinc ion binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Bardet-Biedl syndrome 11; Opitz-GBBB syndrome; and autosomal recessive limb-girdle muscular dystrophy type 2H. Is an ortholog of human TRIM74 (tripartite motif containing 74).

WB:WBGene00022874	nep-25
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in X-linked dominant hypophosphatemic rickets.

WB:WBGene00022875	ZK1248.4
Is affected by several genes including daf-2; age-1; and eat-2 based on microarray; RNA-seq; tiling array; and proteomic studies. Is affected by five chemicals including Tunicamycin; Cry5B; and resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00022876	ZK1248.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; RNA-seq; and tiling array studies. Is affected by seventeen chemicals including nicotinic acid; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248) and Domain of unknown function DUF1248.

WB:WBGene00022877	wago-5
Is predicted to have nucleic acid binding activity.

WB:WBGene00022880	tbc-2
Exhibits GTPase activator activity. Is involved in positive regulation of GTPase activity and positive regulation of early endosome to late endosome transport. Localizes to late endosome. Is expressed in gonadal sheath cell; hypodermis; intestine; and pharyngeal muscle cell. Is an ortholog of human TBC1D2 (TBC1 domain family member 2) and TBC1D2B (TBC1 domain family member 2B).

WB:WBGene00022881	ZK1248.11
Is predicted to have SUMO transferase activity and zinc ion binding activity. Is an ortholog of human NSMCE2 (NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase).

WB:WBGene00022882	ZK1248.13
Is enriched in body wall muscle cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including manganese chloride; Zidovudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00022883	ZK1248.15
Is enriched in AVA; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: PIN domain; WW domain; PIN domain; PIN-like domain superfamily; and WW domain superfamily. Is an ortholog of human SWT1 (SWT1 RNA endoribonuclease homolog).

WB:WBGene00022884	ZK1248.17
Is enriched in AVK; DD neuron; Z1.p; Z4.a; and male distal tip cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including multi-walled carbon nanotube; nicotine; and metformin based on RNA-seq; proteomic; and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00022885	ZK1248.19
Is predicted to have beta-catenin binding activity. Is an ortholog of human LZIC (leucine zipper and CTNNBIP1 domain containing).

WB:WBGene00022886	ZK1290.1
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00022887	ZK1290.5
Is predicted to have alditol:NADP+ 1-oxidoreductase activity. Human ortholog(s) of this gene are implicated in congenital bile acid synthesis defect 2.

WB:WBGene00022888	rnh-1.1
Exhibits RNA-DNA hybrid ribonuclease activity. Is involved in RNA phosphodiester bond hydrolysis, endonucleolytic.

WB:WBGene00022889	ZK1290.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00022890	fbxa-224
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including methylmercuric chloride; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00022891	ZK1290.10
Is enriched in AFD and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including tryptophan; bisphenol A; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: ShKT domain.

WB:WBGene00022892	ZK1290.11
Is enriched in body wall musculature; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; eat-2; and sma-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00022893	ZK1290.13
Is enriched in ASER; head mesodermal cell; and intestine based on Chronogram; tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including D-glucopyranose; Cry5B; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00022894	B0212.t1
No description available

WB:WBGene00022895	B0213.18
Is affected by ins-11 and hmg-3 based on RNA-seq studies.

WB:WBGene00022896	B0228.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00022897	B0244.t1
No description available

WB:WBGene00022898	B0244.t2
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00022899	B0244.t3
Is affected by daf-2 based on microarray studies.

WB:WBGene00022900	B0344.t1
No description available

WB:WBGene00022901	B0344.t2
No description available

WB:WBGene00022902	B0344.t3
No description available

WB:WBGene00022903	B0350.t1
No description available

WB:WBGene00022904	C01B12.9
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00022905	C02F12.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022906	C03F11.t1
No description available

WB:WBGene00022907	C04A2.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00022908	C04E7.t1
No description available

WB:WBGene00022909	C04F2.t1
No description available

WB:WBGene00022910	C05D2.11
Is enriched in body wall musculature; muscle cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rotenone and antimycin based on RNA-seq studies.

WB:WBGene00022911	C05G6.t1
No description available

WB:WBGene00022912	C06E4.t1
No description available

WB:WBGene00022913	C06G1.t1
No description available

WB:WBGene00022914	C06G1.t2
No description available

WB:WBGene00022915	C06G1.t3
No description available

WB:WBGene00022916	C06G1.t4
Is affected by daf-2 based on microarray studies.

WB:WBGene00022917	C06G4.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022918	C09B7.3
Is affected by daf-12 and hpl-2 based on tiling array studies.

WB:WBGene00022919	C09B7.4
Is affected by daf-12 and rsr-2 based on tiling array studies.

WB:WBGene00022920	C09B9.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00022921	C10G8.t1
No description available

WB:WBGene00022922	C12D12.7
Is affected by rsr-2 and sir-2.1 based on tiling array and microarray studies.

WB:WBGene00022923	C14B9.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022924	C14B9.t2
Is affected by daf-12 and hmg-3 based on tiling array and RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00022925	C14F11.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00022926	C16B8.5
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00022927	C16B8.t1
No description available

WB:WBGene00022928	C16B8.t2
No description available

WB:WBGene00022929	C16B8.t3
No description available

WB:WBGene00022930	C16C8.t1
No description available

WB:WBGene00022931	C16C8.t2
No description available

WB:WBGene00022932	C16D9.10
Is enriched in germ line based on RNA-seq studies.

WB:WBGene00022933	C16D9.t2
No description available

WB:WBGene00022934	C16D9.t3
No description available

WB:WBGene00022935	C16D9.t4
No description available

WB:WBGene00022936	C16H3.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00022937	C16H3.t2
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00022938	C18A11.t1
No description available

WB:WBGene00022939	C18A11.t2
No description available

WB:WBGene00022940	C23H5.10
Is affected by unc-39 based on RNA-seq studies.

WB:WBGene00022941	C25F6.t1
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00022942	C25F6.t2
No description available

WB:WBGene00022943	C25F6.t3
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00022944	C25F6.t4
No description available

WB:WBGene00022945	C27A2.t1
No description available

WB:WBGene00022946	C27A12.t1
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00022947	C28G1.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022948	C28G1.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00022949	C28G1.t3
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00022950	C28G1.t4
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022951	C30E1.9
Is enriched in neurons and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; Rotenone; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00022952	C30E1.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022953	C35E7.t1
No description available

WB:WBGene00022954	C36C9.t2
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00022955	C37A2.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022956	C39D10.t1
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00022957	C39D10.t2
No description available

WB:WBGene00022958	C42D8.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022959	C43G2.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022960	C43G2.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00022961	C44B7.t1
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00022962	C48C5.t1
No description available

WB:WBGene00022963	C48C5.t2
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00022964	C48C5.t3
No description available

WB:WBGene00022965	C48C5.t4
No description available

WB:WBGene00022966	C52E12.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00022967	C52E12.t3
No description available

WB:WBGene00022968	C55F2.3
No description available

WB:WBGene00022969	C56G3.t1
No description available

WB:WBGene00022970	CD4.10
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies.

WB:WBGene00022971	D1009.t1
Is affected by daf-2 based on RNA-seq and microarray studies.

WB:WBGene00022972	D1009.t2
No description available

WB:WBGene00022973	E01H11.t1
No description available

WB:WBGene00022974	E03E2.t1
No description available

WB:WBGene00022975	E03E2.t2
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00022976	E03E2.t3
No description available

WB:WBGene00022977	F01G12.t1
No description available

WB:WBGene00022978	F02E11.t1
No description available

WB:WBGene00022979	F08F1.t1
No description available

WB:WBGene00022980	F08F1.t2
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00022981	F08F1.t3
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022982	F09E10.10
Is affected by several genes including daf-16; daf-2; and lin-35 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube; Colistin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00022983	F10C1.t1
Is affected by daf-2 and pptr-1 based on microarray and RNA-seq studies.

WB:WBGene00022984	F10C1.t2
No description available

WB:WBGene00022985	F11H8.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00022986	F12D9.t1
No description available

WB:WBGene00022987	F12D9.t2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00022988	F12D9.t3
No description available

WB:WBGene00022989	F12D9.t4
No description available

WB:WBGene00022990	F12D9.t5
No description available

WB:WBGene00022991	F12D9.t6
No description available

WB:WBGene00022992	F14B8.t1
No description available

WB:WBGene00022993	F15A8.t1
No description available

WB:WBGene00022994	F15A8.t2
No description available

WB:WBGene00022995	F18C5.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00022996	F18G5.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00022997	F18G5.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00022998	F22B7.t1
Is affected by adr-1 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00022999	F22B7.t2
No description available

WB:WBGene00023000	F22B7.t3
No description available

WB:WBGene00023001	F22B7.t4
Is affected by clk-1 based on microarray studies.

WB:WBGene00023002	F22B7.t5
No description available

WB:WBGene00023003	F22F1.t1
No description available

WB:WBGene00023004	F22F1.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023005	F22F1.t3
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023006	F22F1.t4
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023007	F22F1.t5
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00023008	F22F1.t6
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023009	F22F1.t7
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023010	F22F1.t8
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023011	F22F1.t9
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023012	F22H10.t1
Is affected by tdp-1 and hmg-3 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00023013	F25F6.t1
No description available

WB:WBGene00023014	F25F6.t2
No description available

WB:WBGene00023015	F27B10.t1
No description available

WB:WBGene00023016	rte-3
No description available

WB:WBGene00023017	F27E11.t1
No description available

WB:WBGene00023018	F28F5.t1
No description available

WB:WBGene00023019	F29C4.t1
No description available

WB:WBGene00023020	F30H5.4
Is affected by several genes including sek-1; pgl-1; and cep-1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00023021	F32A5.9
Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Cry5B; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00023022	F32A6.t1
No description available

WB:WBGene00023023	F33D11.t1
No description available

WB:WBGene00023024	F33D11.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00023025	F33G12.t1
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00023026	F35A5.t1
No description available

WB:WBGene00023027	F35H10.12
Is affected by prg-1 and clk-1 based on RNA-seq and microarray studies.

WB:WBGene00023028	F36D4.t1
No description available

WB:WBGene00023029	F36D4.t2
No description available

WB:WBGene00023030	F36H12.18
Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00023031	F37A4.t1
No description available

WB:WBGene00023032	F38E9.t1
No description available

WB:WBGene00023033	F38E9.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00023034	F38G1.t1
No description available

WB:WBGene00023035	F38G1.t2
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00023036	F39E9.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00023037	F40H6.t1
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00023038	F41A4.t1
No description available

WB:WBGene00023039	F41B5.11
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00023040	F41D9.t1
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00023041	F41D9.t2
No description available

WB:WBGene00023042	F41D9.t3
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023043	F41D9.t4
No description available

WB:WBGene00023044	F42A10.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023045	F42A10.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023046	F42H10.t1
No description available

WB:WBGene00023047	F43C9.t1
No description available

WB:WBGene00023048	F43E12.t1
No description available

WB:WBGene00023049	F44A2.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023050	F46G11.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023051	F46G11.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023052	F47E1.t1
No description available

WB:WBGene00023053	F47E1.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00023054	F47E1.t3
Is affected by daf-2 based on RNA-seq and microarray studies.

WB:WBGene00023055	F47G6.t1
No description available

WB:WBGene00023056	F48E3.t1
No description available

WB:WBGene00023057	F49D11.t1
No description available

WB:WBGene00023058	F49D11.t2
No description available

WB:WBGene00023059	F49E7.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00023060	F49E7.t2
Is affected by daf-12 and clk-1 based on tiling array and microarray studies.

WB:WBGene00023061	F49E7.t3
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00023062	F52C9.t1
No description available

WB:WBGene00023063	F52H2.t1
Is affected by daf-12 and prg-1 based on tiling array and RNA-seq studies.

WB:WBGene00023064	F52H2.t2
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023065	F53F10.6
Is enriched in NSM and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-12; sir-2.1; and isp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Tunicamycin; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00023066	F53F10.7
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-12; cep-1; and dlc-1 based on tiling array and RNA-seq studies.

WB:WBGene00023067	rpl-41.1
Is predicted to be a structural constituent of ribosome.

WB:WBGene00023068	rpl-41.2
Is predicted to be a structural constituent of ribosome.

WB:WBGene00023069	rncs-1
Is expressed in hypodermal cell and vulva.

WB:WBGene00023070	F56C3.t1
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00023071	F56C9.12
Is affected by several genes including daf-12; clk-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00023072	F56F4.t1
No description available

WB:WBGene00023073	F56F4.t2
No description available

WB:WBGene00023074	F56F10.t1
No description available

WB:WBGene00023075	F59C12.t1
No description available

WB:WBGene00023076	F59C12.t2
No description available

WB:WBGene00023077	F59C12.t3
No description available

WB:WBGene00023078	H08J11.t1
No description available

WB:WBGene00023079	H08J11.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00023080	H08J11.t3
No description available

WB:WBGene00023081	H08J11.t4
No description available

WB:WBGene00023082	H08J11.t5
Is affected by daf-2 based on microarray studies.

WB:WBGene00023083	H09I01.2
Is affected by hpl-2; clk-1; and daf-2 based on tiling array and microarray studies.

WB:WBGene00023084	H19M22.4
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00023085	H35N09.t1
No description available

WB:WBGene00023086	H35N09.t2
No description available

WB:WBGene00023087	K01A12.t1
Is affected by clk-1 and hmg-3 based on microarray and RNA-seq studies.

WB:WBGene00023088	K01A12.t2
No description available

WB:WBGene00023089	K01A12.t3
Is affected by clk-1 and hmg-3 based on microarray and RNA-seq studies.

WB:WBGene00023090	K01A12.t4
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00023091	K01A12.t5
No description available

WB:WBGene00023092	K02D7.t1
No description available

WB:WBGene00023093	K03F8.t1
No description available

WB:WBGene00023094	K03H6.t1
No description available

WB:WBGene00023095	K04A8.t2
No description available

WB:WBGene00023096	K04A8.t3
No description available

WB:WBGene00023097	K04C2.t1
No description available

WB:WBGene00023098	K04C2.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00023099	K04C2.t3
No description available

WB:WBGene00023100	K05G3.t1
No description available

WB:WBGene00023101	K08B5.t1
No description available

WB:WBGene00023102	K08B5.t2
No description available

WB:WBGene00023103	K09C6.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023104	K10F12.8
Is affected by several genes including cyc-1; dlc-1; and pptr-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00023105	K11C4.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023106	K11H12.t1
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00023107	K12H4.t1
No description available

WB:WBGene00023108	M01E10.t1
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00023109	M01E10.t2
No description available

WB:WBGene00023110	M02F4.t1
No description available

WB:WBGene00023111	M02F4.t2
No description available

WB:WBGene00023112	M03A1.t1
No description available

WB:WBGene00023113	M03A1.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00023115	M57.t1
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023116	R02E12.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023117	R04A9.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00023118	R04E5.t1
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00023119	R04E5.t2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00023120	R04E5.t3
No description available

WB:WBGene00023121	R04E5.t4
No description available

WB:WBGene00023122	R04E5.t5
No description available

WB:WBGene00023123	R04E5.t6
Is affected by pgrn-1 and rrf-3 based on RNA-seq studies.

WB:WBGene00023124	R11B5.t1
No description available

WB:WBGene00023125	R11B5.t2
Is affected by clk-1; elli-1; and daf-2 based on microarray studies.

WB:WBGene00023126	R11B5.t3
No description available

WB:WBGene00023127	R148.t1
No description available

WB:WBGene00023128	T03G6.t1
No description available

WB:WBGene00023129	T05A8.t1
No description available

WB:WBGene00023130	T05A8.t2
No description available

WB:WBGene00023131	T05C7.t1
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00023132	T07H6.t1
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00023133	T07H6.t2
No description available

WB:WBGene00023134	T08A9.t1
No description available

WB:WBGene00023135	T09B4.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023136	T09B4.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00023137	T13B5.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00023138	T14B4.t1
Is affected by clk-1; adr-1; and daf-2 based on microarray and RNA-seq studies.

WB:WBGene00023139	T14F9.t1
No description available

WB:WBGene00023140	T15B12.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00023141	T16D1.t1
No description available

WB:WBGene00023142	T20F5.1
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00023143	T22F3.t1
No description available

WB:WBGene00023144	T22F3.t2
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00023145	T22F3.t3
Is affected by clk-1 based on microarray studies.

WB:WBGene00023146	T22F3.t4
No description available

WB:WBGene00023147	T22F7.t1
No description available

WB:WBGene00023148	T25B6.t1
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00023149	T25B6.t2
No description available

WB:WBGene00023150	T25D1.t2
No description available

WB:WBGene00023151	T25E4.t1
No description available

WB:WBGene00023152	T26C11.t1
No description available

WB:WBGene00023153	T27B1.t1
No description available

WB:WBGene00023154	T28B4.t1
No description available

WB:WBGene00023155	T28C12.t1
No description available

WB:WBGene00023156	T28F2.t1
Is affected by clk-1 and pptr-1 based on microarray and RNA-seq studies.

WB:WBGene00023157	W02G9.t1
No description available

WB:WBGene00023158	W02G9.t2
No description available

WB:WBGene00023159	W06H8.5
Is enriched in head mesodermal cell; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; sek-1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Humic Substances; single-walled carbon nanotube; and paraquat based on microarray studies.

WB:WBGene00023160	W09G10.t1
No description available

WB:WBGene00023161	W09G10.t2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00023162	W09G10.t3
Is affected by dlc-1; daf-2; and ints-7 based on RNA-seq and microarray studies.

WB:WBGene00023163	W09G12.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00023164	W10G11.t1
No description available

WB:WBGene00023165	W10G11.t2
No description available

WB:WBGene00023166	Y4C6B.t1
No description available

WB:WBGene00023167	Y4C6B.t2
No description available

WB:WBGene00023168	Y17G9A.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023169	Y18H1A.t1
Is affected by clk-1; meg-3; and meg-4 based on microarray and RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00023170	Y22D7AL.t3
No description available

WB:WBGene00023171	Y22D7AL.t4
No description available

WB:WBGene00023172	Y23H5A.8
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and age-1 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00023173	Y25C1A.t1
No description available

WB:WBGene00023174	Y25C1A.t2
No description available

WB:WBGene00023175	Y37B11A.t2
No description available

WB:WBGene00023176	Y39G10AL.t1
No description available

WB:WBGene00023177	Y51H7BR.t1
No description available

WB:WBGene00023178	Y54G2A.t1
Is affected by prg-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00023179	Y54G2A.t2
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00023180	Y54G2A.t3
Is affected by daf-2 based on microarray studies.

WB:WBGene00023181	Y54G2A.t4
Is affected by daf-2 based on microarray studies.

WB:WBGene00023182	Y54G2A.t5
Is affected by daf-2 based on microarray studies.

WB:WBGene00023183	Y55F3BR.9
Is affected by rsr-2; cep-1; and hmg-3 based on RNA-seq studies.

WB:WBGene00023184	Y55F3BR.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00023185	Y59E1B.t2
No description available

WB:WBGene00023186	Y67D8B.3
Is affected by several genes including daf-2; eat-2; and isp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube; paraquat; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00023187	Y67D8C.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including cep-1; let-418; and dlc-1 based on RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00023188	Y69A2AR.t2
No description available

WB:WBGene00023189	Y71D11A.7
Is affected by clk-1 and daf-2 based on microarray and RNA-seq studies.

WB:WBGene00023190	Y71H2AM.t1
No description available

WB:WBGene00023191	Y73B3A.17
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; egl-9; and ifg-1 based on RNA-seq and microarray studies.

WB:WBGene00023192	Y73B6BL.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023193	Y74C9A.6
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and cep-1 based on RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00023194	Y75D11A.t2
Is affected by ced-3 based on RNA-seq studies.

WB:WBGene00023195	Y82E9BR.t1
No description available

WB:WBGene00023196	Y92C3A.t2
No description available

WB:WBGene00023197	Y92C3A.t3
No description available

WB:WBGene00023198	Y92H12A.t1
No description available

WB:WBGene00023199	Y95B8A.t1
No description available

WB:WBGene00023200	Y97E10C.t1
Is affected by daf-12; daf-2; and eat-2 based on tiling array and microarray studies.

WB:WBGene00023201	Y102E9.t1
No description available

WB:WBGene00023202	Y104H12A.t1
No description available

WB:WBGene00023203	Y110A2AL.t1
No description available

WB:WBGene00023204	Y110A2AL.t2
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00023205	Y119D3B.10
Is affected by nitroguanidine based on microarray studies.

WB:WBGene00023206	Y119D3B.t1
No description available

WB:WBGene00023207	ZC132.t1
Is affected by prg-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00023208	ZC449.t1
No description available

WB:WBGene00023209	ZC513.7
Is enriched in germ line; head mesodermal cell; and intestine based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; daf-12; and gld-1 based on microarray; tiling array; and RNA-seq studies. Is affected by fifteen chemicals including 1-methylnicotinamide; Rotenone; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00023210	ZK154.t1
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00023211	ZK154.t2
No description available

WB:WBGene00023212	ZK154.t3
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023213	ZK154.t4
Is affected by daf-12 based on tiling array studies.

WB:WBGene00023214	ZK154.t5
No description available

WB:WBGene00023215	ZK380.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023216	ZK563.t1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00023217	ZK622.t1
No description available

WB:WBGene00023218	rte-4
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00023219	ZK783.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023220	ZK994.t1
No description available

WB:WBGene00023221	ZK994.t2
No description available

WB:WBGene00023222	ZK994.t3
No description available

WB:WBGene00023223	ZK1236.8
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00023224	B0280.6
Is affected by daf-16 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00023225	B0281.7
Is affected by several genes including skn-1; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00023226	B0344.1
Is affected by kri-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00023227	BE0003N10.t1
No description available

WB:WBGene00023228	BE0003N10.t2
No description available

WB:WBGene00023229	BE0003N10.t3
No description available

WB:WBGene00023230	BE0003N10.t4
No description available

WB:WBGene00023231	BE0003N10.t5
No description available

WB:WBGene00023232	BE0003N10.t6
Is affected by clk-1 based on microarray studies.

WB:WBGene00023233	C08A9.2
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00023234	C09G12.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023235	C13A2.8
No description available

WB:WBGene00023236	C14E2.t1
No description available

WB:WBGene00023237	C17C3.14
No description available

WB:WBGene00023238	C17H12.7
Is affected by dlc-1 and eat-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00023239	C18C4.4
Is affected by dlc-1 and eat-2 based on RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00023240	C23H5.4
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00023241	C23H5.5
Is affected by tatn-1; dlc-1; and adr-2 based on RNA-seq studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023242	C23H5.6
Is affected by eat-2 and adr-2 based on RNA-seq studies. Is affected by allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023243	C24D10.3
Is enriched in intestine based on microarray studies. Is affected by elli-1 based on microarray studies. Is affected by Acrylamide based on microarray studies.

WB:WBGene00023244	C24H12.3
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00023245	C33E10.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00023246	C33E10.4
Is affected by several genes including hsf-1; eat-2; and pgl-1 based on RNA-seq studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00023247	C33E10.7
Is affected by several genes including daf-2; eat-2; and let-418 based on RNA-seq and microarray studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023248	C33E10.9
Is affected by clk-1 and adr-1 based on microarray and RNA-seq studies.

WB:WBGene00023249	C35B1.t1
No description available

WB:WBGene00023250	C36C9.t1
No description available

WB:WBGene00023251	C36C9.t3
No description available

WB:WBGene00023252	C39H7.2
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and eat-2 based on RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and metformin based on RNA-seq studies.

WB:WBGene00023253	C44C11.t1
No description available

WB:WBGene00023254	C44C11.t2
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00023255	C45H4.t1
No description available

WB:WBGene00023256	C50A2.t1
No description available

WB:WBGene00023257	C50A2.t2
No description available

WB:WBGene00023259	C52D10.10
Is affected by several genes including daf-16; dpy-10; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Quercetin; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00023260	C52E12.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023262	C54F6.2
Is affected by daf-16 and eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023263	D1005.t1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and isp-1 based on RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023264	D1065.2
Is affected by clk-1; daf-2; and eat-2 based on microarray studies. Is affected by Alovudine and stavudine based on RNA-seq studies.

WB:WBGene00023265	E03H12.8
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00023266	F07E5.10
Is affected by several genes including skn-1; eat-2; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00023267	F07G11.6
Is affected by several genes including clk-1; eat-2; and prg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00023268	F15A8.3
No description available

WB:WBGene00023269	F16F9.t1
No description available

WB:WBGene00023270	F17E9.14
Is affected by smg-2 based on RNA-seq studies.

WB:WBGene00023271	F19G12.t1
Is affected by several genes including eat-2; hpl-2; and mir-71 based on RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00023272	F22E5.19
No description available

WB:WBGene00023273	F23C8.2
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00023274	F23C8.10
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023275	F23G4.t1
No description available

WB:WBGene00023276	F25B4.3
Is affected by prg-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00023277	F29C4.3
Is affected by clk-1; dpy-7; and smn-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023278	F30D4.1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023279	F36A4.9
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023281	F39E9.8
Is affected by clk-1 based on microarray studies.

WB:WBGene00023282	F39E9.9
No description available

WB:WBGene00023283	F40H7.6
No description available

WB:WBGene00023284	F41B5.1
Is predicted to have DNA binding activity.

WB:WBGene00023285	F42G2.t1
No description available

WB:WBGene00023286	F44C4.6
No description available

WB:WBGene00023287	F46F5.3
No description available

WB:WBGene00023288	F49F1.13
Is affected by eat-2; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00023289	F53A3.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00023290	F53B1.t1
No description available

WB:WBGene00023291	F53H1.2
Is affected by smg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00023292	F54D8.9
No description available

WB:WBGene00023293	F54D12.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023294	F54D12.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00023295	F56C11.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023296	F56D12.t1
No description available

WB:WBGene00023297	F56D12.t2
No description available

WB:WBGene00023298	F56D12.t3
No description available

WB:WBGene00023299	F56D12.t4
Is affected by clk-1 based on microarray studies.

WB:WBGene00023300	F56F11.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023301	F58E2.1
Is enriched in muscle cell and neurons based on microarray studies. Is affected by several genes including clk-1; sir-2.1; and fbf-1 based on microarray and RNA-seq studies. Is affected by Triclosan based on microarray studies.

WB:WBGene00023302	F58E2.6
Is enriched in neurons based on microarray studies. Is affected by clk-1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00023303	F58E2.8
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00023304	F58F6.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023305	F58F6.t2
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00023306	F59A7.10
Is affected by daf-2; eat-2; and flcn-1 based on microarray studies. Is affected by multi-walled carbon nanotube and Colistin based on RNA-seq and microarray studies.

WB:WBGene00023307	H06I04.t1
No description available

WB:WBGene00023308	H11E01.t1
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00023309	H17B01.t1
No description available

WB:WBGene00023310	H17B01.t2
No description available

WB:WBGene00023311	H17B01.t3
No description available

WB:WBGene00023312	H17B01.t4
No description available

WB:WBGene00023313	H28G03.5
Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00023314	H31G24.2
Is enriched in body wall musculature based on microarray studies. Is affected by several genes including daf-16; ain-1; and ain-2 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Psoralens based on RNA-seq studies.

WB:WBGene00023315	K02E7.8
Is affected by adr-1 and eat-2 based on RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00023316	K02E7.t1
No description available

WB:WBGene00023317	K02H11.8
No description available

WB:WBGene00023318	K07D4.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by stavudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00023319	K07E8.2
Is affected by clk-1 and sir-2.1 based on microarray studies.

WB:WBGene00023320	K07E8.4
Is enriched in intestine based on microarray studies. Is affected by set-25; met-2; and eat-2 based on RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Cholestanol based on RNA-seq and microarray studies.

WB:WBGene00023321	K07E8.8
Is affected by clk-1 and sir-2.1 based on microarray studies.

WB:WBGene00023322	K08B12.4
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; let-418; and chd-3 based on RNA-seq studies. Is affected by allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023323	K08F11.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Hydrolyzable Tannins and paraquat based on microarray studies.

WB:WBGene00023324	K10B2.t1
No description available

WB:WBGene00023325	K10F12.1
Is affected by hmg-3 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00023326	M03D4.5
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023327	R03H4.8
Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023328	R04B3.t1
No description available

WB:WBGene00023329	R04B3.t2
No description available

WB:WBGene00023330	R13D7.5
No description available

WB:WBGene00023331	R13H7.3
No description available

WB:WBGene00023332	R148.t2
No description available

WB:WBGene00023333	R148.t3
No description available

WB:WBGene00023334	R148.t4
No description available

WB:WBGene00023335	T03D3.7
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00023336	T03D3.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by clk-1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00023337	T03D3.9
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00023338	T03D3.10
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00023339	T03D3.13
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00023340	T05B11.5
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00023341	T05H4.t1
No description available

WB:WBGene00023342	T05H4.t2
No description available

WB:WBGene00023343	T06A1.6
Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00023344	T08B2.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023345	T12B5.9
Is affected by several genes including smg-2; mir-71; and ceh-60 based on RNA-seq studies. Is affected by Sodium Chloride based on RNA-seq studies.

WB:WBGene00023346	T13B5.t1
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00023347	T22F3.1
No description available

WB:WBGene00023348	T24E12.7
Is affected by eat-2 based on RNA-seq studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023349	T25D1.t1
Is affected by dpy-21 and eat-2 based on RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00023351	T27C4.5
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023352	T28B4.t2
No description available

WB:WBGene00023353	W01H2.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023354	W02D7.1
No description available

WB:WBGene00023355	W02F12.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and smg-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023356	W03F9.8
No description available

WB:WBGene00023357	W03H1.t1
No description available

WB:WBGene00023358	W10G11.8
Is affected by several genes including clk-1; eat-2; and rrf-1 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00023359	Y4C6B.t3
No description available

WB:WBGene00023360	Y22D7AL.t1
No description available

WB:WBGene00023361	Y22D7AL.t2
No description available

WB:WBGene00023362	Y22D7AL.t5
Is affected by clk-1 based on microarray studies.

WB:WBGene00023363	Y22D7AL.t6
Is affected by clk-1 based on microarray studies.

WB:WBGene00023364	Y22D7AR.t1
No description available

WB:WBGene00023365	Y34B4A.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023366	Y37E11B.t1
No description available

WB:WBGene00023367	Y37E11B.t2
No description available

WB:WBGene00023368	Y37F4.t1
No description available

WB:WBGene00023369	Y37F4.t2
No description available

WB:WBGene00023370	Y39A3B.t1
Is affected by daf-2 based on microarray studies.

WB:WBGene00023371	Y47C4A.t1
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023372	Y47C4A.t2
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00023373	Y53G8B.t1
No description available

WB:WBGene00023375	Y53G8B.t3
No description available

WB:WBGene00023376	Y53G8B.t4
Is affected by clk-1 based on microarray studies.

WB:WBGene00023377	Y53G8B.t5
No description available

WB:WBGene00023378	Y53G8B.t6
No description available

WB:WBGene00023379	Y53G8B.t7
No description available

WB:WBGene00023380	Y53G8B.t8
No description available

WB:WBGene00023381	Y53G8B.t9
No description available

WB:WBGene00023382	Y57E12AL.3
Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00023383	Y59E1B.t1
No description available

WB:WBGene00023384	Y60C6A.t1
No description available

WB:WBGene00023385	Y67D2.t1
Is affected by clk-1 based on microarray studies.

WB:WBGene00023386	Y67D2.t2
No description available

WB:WBGene00023387	Y67D2.t3
No description available

WB:WBGene00023388	Y67D2.t4
Is affected by clk-1 based on microarray studies.

WB:WBGene00023389	Y69A2AR.t1
No description available

WB:WBGene00023390	Y69A2AR.t3
No description available

WB:WBGene00023391	Y73B3A.t1
Is affected by smg-2 and ins-11 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00023392	Y77E11A.t1
Is affected by clk-1 and eat-2 based on microarray studies.

WB:WBGene00023393	Y77E11A.t2
Is affected by clk-1 based on microarray studies.

WB:WBGene00023394	Y77E11A.t3
No description available

WB:WBGene00023395	Y82E9BL.9
Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00023396	Y94H6A.t1
Is affected by dpy-21 and eat-2 based on RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00023397	Y104H12A.t2
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00023398	ZC123.t1
No description available

WB:WBGene00023399	ZC239.1
Is affected by several genes including clk-1; eat-2; and smg-2 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00023400	ZK380.3
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00023401	ZK380.t2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00023402	ZK488.3
Is affected by Colistin based on microarray studies.

WB:WBGene00023403	ZK682.1
No description available

WB:WBGene00023404	plr-1
Is predicted to have ubiquitin protein ligase activity. Is involved in negative regulation of Wnt signaling pathway. Localizes to Golgi apparatus; early endosome; and late endosome. Is expressed in several structures, including egg-laying apparatus; enteric muscle; neurons; pharynx; and tail. Is an ortholog of human ZNRF3 (zinc and ring finger 3).

WB:WBGene00023405	sor-1
Exhibits RNA binding activity. Is involved in multicellular organism development and regulation of gene expression, epigenetic. Localizes to nuclear speck.

WB:WBGene00023406	K01G12.1
No description available

WB:WBGene00023407	cex-1
Is predicted to have calcium ion binding activity. Is expressed in RIML and RIMR.

WB:WBGene00023408	cex-2
Is predicted to have calcium ion binding activity. Is expressed in head and tail.

WB:WBGene00023409	mbd-2
Is predicted to have methyl-CpG binding activity. Is an ortholog of human MBD2 (methyl-CpG binding domain protein 2) and MBD3 (methyl-CpG binding domain protein 3).

WB:WBGene00023410	clpr-2
Is predicted to have calcium-dependent cysteine-type endopeptidase activity.

WB:WBGene00023411	srz-3
Is enriched in dopaminergic neurons and intestine based on tiling array and RNA-seq studies. Is affected by rsr-2 based on tiling array studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023413	H31B20.2
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by rsr-2 based on tiling array studies.

WB:WBGene00023414	R01H2.7
Is enriched in excretory cell; head mesodermal cell; hypodermis; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00023415	F16C3.3
Is enriched in BAG and neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00023416	spi-1
Is predicted to have serine-type endopeptidase inhibitor activity.

WB:WBGene00023417	swm-1
Is predicted to have serine-type endopeptidase inhibitor activity. Is involved in spermatid development. Localizes to extracellular space and secretory vesicle. Is expressed in body wall musculature; coelomocyte; reproductive tract; and in male.

WB:WBGene00023418	R06F6.12
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including dpy-10; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00023419	F53F4.16
Is enriched in body wall muscle cell; germ line; hypodermis; intestine; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on RNA-seq; proteomic; and microarray studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00023420	C26D10.7
Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array and RNA-seq studies. Is affected by seven chemicals including methylmercuric chloride; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Type I membrane glycoproteins cell-cell fusogen; Cell-cell fusogen EFF/AFF; and Cell-cell fusogen EFF/AFF, domain 3.

WB:WBGene00023421	rde-11
Is predicted to have metal ion binding activity.

WB:WBGene00023422	mrpl-21
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPL21 (mitochondrial ribosomal protein L21).

WB:WBGene00023423	F43C1.7
Is enriched in AFD; AVK; coelomocyte; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including multi-walled carbon nanotube; procyanidin; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: NFACT protein RNA binding domain; NFACT, RNA-binding domain; and Jlp2/Ccd25. Is an ortholog of human CCDC25 (coiled-coil domain containing 25).

WB:WBGene00023424	C53D6.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; age-1; and dpy-10 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; methylmercuric chloride; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00023425	try-9
Is predicted to have serine-type endopeptidase activity.

WB:WBGene00023427	F14D2.15
Is enriched in AFD; germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Zidovudine; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00023428	K07C5.10
Is affected by several genes including clk-1; pgl-1; and cep-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00023429	W08G11.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hpl-2; elli-1; and ints-1 based on microarray and RNA-seq studies.

WB:WBGene00023430	D1054.17
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00023431	C25E10.13
Is enriched in OLL; PVD; and amphid sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including aak-2; unc-70; and aak-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00023432	K12B6.9
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Mianserin; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00023433	B0513.10
No description available

WB:WBGene00023434	C04F12.11
No description available

WB:WBGene00023435	C31A11.8
No description available

WB:WBGene00023436	F08G12.6
No description available

WB:WBGene00023437	F35E8.3
No description available

WB:WBGene00023438	F59C6.1
No description available

WB:WBGene00023439	R05A10.9
No description available

WB:WBGene00023440	T01C1.1
No description available

WB:WBGene00023441	T21B4.11
No description available

WB:WBGene00023442	Y37D8A.7
No description available

WB:WBGene00023443	Y51A2C.1
No description available

WB:WBGene00023444	Y51H4A.29
No description available

WB:WBGene00023445	Y73F8A.28
No description available

WB:WBGene00023446	Y94A7B.2
No description available

WB:WBGene00023447	ZC334.4
No description available

WB:WBGene00023448	ZK856.2
No description available

WB:WBGene00023449	ZK1251.4
No description available

WB:WBGene00023450	T12D8.10
Is enriched in AFD; ASER; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and pgl-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: BolA-like protein; BolA protein; and BolA-like superfamily. Is an ortholog of human BOLA2B (bolA family member 2B).

WB:WBGene00023451	mlc-7
Is predicted to have calcium ion binding activity. Human ortholog(s) of this gene are implicated in hypertrophic cardiomyopathy 8.

WB:WBGene00023452	mir-353
Is affected by several genes including daf-12; alg-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube and nicotine based on RNA-seq studies.

WB:WBGene00023453	mir-356.1
Is affected by several genes including pptr-1; tdp-1; and hmg-3 based on RNA-seq studies.

WB:WBGene00023454	mir-357
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00023455	mir-358
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00023456	mir-360
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00023457	mir-359
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00023458	M02E1.3
Is affected by several genes including daf-16; sek-1; and smg-1 based on RNA-seq studies. Is affected by Mianserin; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00023459	Y18D10A.26
Is affected by several genes including eat-2; prg-1; and dpy-21 based on tiling array and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00023460	F46H6.5
Is enriched in AFD; excretory cell; muscle cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023461	F53G12.12
Is affected by daf-12; cep-1; and dpy-21 based on tiling array and RNA-seq studies.

WB:WBGene00023462	srz-83
Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023463	srz-82
Is enriched in germ line based on RNA-seq studies. Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023464	srz-80
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00023465	srz-81
Is affected by alg-1 and adr-1 based on RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00023466	R151.11
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00023467	Y38F2AR.14
Is affected by prg-1; hpl-2; and dlc-1 based on RNA-seq studies.

WB:WBGene00023468	B0412.6
Is affected by several genes including clk-1; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00023469	C16A3.11
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00023470	srz-87
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00023471	srz-86
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00023472	F16A11.5
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including cep-1; alg-1; and let-418 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and metformin based on RNA-seq studies.

WB:WBGene00023473	F58A4.13
No description available

WB:WBGene00023474	srz-37
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by rsr-2; drh-3; and let-60 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023475	srz-69
Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023476	srz-55
Is enriched in neurons based on microarray studies. Is affected by ain-2 based on microarray studies.

WB:WBGene00023477	nspc-1
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Ethanol; Rotenone; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00023478	srz-62
Is affected by hpl-2 and rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023479	srz-67
Is affected by several genes including clk-1; mex-1; and drh-3 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023480	srz-68
No description available

WB:WBGene00023481	srz-22
No description available

WB:WBGene00023482	C05B5.9
Is affected by several genes including hsf-1; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00023483	Y75B8A.39
Is enriched in intestine; neurons; and retrovesicular ganglion based on microarray and tiling array studies. Is affected by several genes including skn-1; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including methylmercury hydroxide; multi-walled carbon nanotube; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00023484	Y54G2A.37
Is predicted to have carbohydrate binding activity.

WB:WBGene00023485	ttr-49
Is enriched in head mesodermal cell and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; levamisole; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00023486	K08B4.7
Is enriched in coelomocyte and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in CST3-related cerebral amyloid angiopathy and age related macular degeneration 11.

WB:WBGene00023487	mrps-24
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS24 (mitochondrial ribosomal protein S24).

WB:WBGene00023488	srz-84
No description available

WB:WBGene00023489	F42A10.9
Is predicted to have gamma-glutamylaminecyclotransferase activity. Is an ortholog of human GGACT (gamma-glutamylamine cyclotransferase).

WB:WBGene00023490	F36A2.14
Is enriched in arcade cell; germ line; pharyngeal-intestinal valve cell; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including nicotinic acid; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00023491	tsp-21
Exhibits identical protein binding activity. Is involved in positive regulation of signal transduction; regulation of mesodermal cell fate specification; and transforming growth factor beta receptor signaling pathway involved in regulation of growth. Localizes to basolateral plasma membrane. Is expressed in several structures, including M lineage cell; gonad; intestine; rectal epithelium; and vulva. Is used to study cancer. Human ortholog(s) of this gene are implicated in eye disease (multiple) and non-syndromic X-linked intellectual disability. Is an ortholog of several human genes including CD53 (CD53 molecule); TSPAN4 (tetraspanin 4); and TSPAN9 (tetraspanin 9).

WB:WBGene00023492	T24D3.2
Is enriched in PLM; dopaminergic neurons; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Ethanol; Alovudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00023493	nspc-12
Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by four chemicals including hydrogen sulfide; Mianserin; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00023494	osr-2
No description available

WB:WBGene00023495	osr-3
No description available

WB:WBGene00023496	osr-4
No description available

WB:WBGene00023497	lin-15B
Is predicted to have DNA binding activity and metal ion binding activity. Is involved in negative regulation of Ras protein signal transduction; negative regulation of vulval development; and regulation of cell fate specification. Is expressed in several structures, including anterior gonad arm; oocyte; and somatic cell.

WB:WBGene00023498	lin-15A
Is involved in several processes, including negative regulation of vulval development; protein stabilization; and vulval development. Localizes to nucleus. Is expressed in gonad.

WB:WBGene00023499	srz-63
Is affected by several genes including mex-3; mex-1; and spn-4 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023500	C11H1.9
Is enriched in PLM; hypodermis; muscle cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on proteomic; microarray; and RNA-seq studies. Is affected by eleven chemicals including D-glucopyranose; levamisole; and Psoralens based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in familial isolated deficiency of vitamin E. Is predicted to encode a protein with the following domains: CRAL/TRIO domain; CRAL-TRIO lipid binding domain; GOLD domain superfamily; and CRAL-TRIO lipid binding domain superfamily.

WB:WBGene00023501	F11E6.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq; tiling array; and microarray studies. Is affected by sixteen chemicals including Rotenone; Tunicamycin; and juglone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00023502	clec-184
Is predicted to have carbohydrate binding activity.

WB:WBGene00023503	F17C11.13
Is enriched in intestine; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; dpy-10; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and levamisole based on microarray and RNA-seq studies.

WB:WBGene00023504	F26F2.8
Is enriched in NSM and hypodermis based on RNA-seq and tiling array studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00023505	srz-102
Is expressed in ADLL; ADLR; PVT; and vulva. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023506	srz-11
Is affected by clk-1 and mir-34 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023507	srz-26
No description available

WB:WBGene00023508	srz-38
Is enriched in NSM and amphid sheath cell based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023509	srz-39
No description available

WB:WBGene00023510	srz-40
No description available

WB:WBGene00023511	srz-41
No description available

WB:WBGene00023512	srz-51
Is affected by clk-1 and daf-2 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00023513	srz-71
Is affected by several genes including daf-2; eat-2; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023514	srz-72
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is affected by nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023515	srz-97
Is enriched in AFD; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Psoralens; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023516	srz-98
No description available

WB:WBGene00023517	srz-75
Is affected by several genes including let-60; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00023518	srz-76
Is enriched in NSM based on tiling array studies. Is affected by several genes including let-60; clk-1; and drh-3 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00023519	Y60A3A.24
Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by Alovudine and stavudine based on RNA-seq studies.

WB:WBGene00023520	oig-5
Is enriched in DA neuron; RID; VA neuron; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including eat-2; aak-2; and ain-2 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Immunoglobulin I-set domain; Immunoglobulin I-set; Immunoglobulin-like fold; and Immunoglobulin-like domain superfamily.

WB:WBGene00043049	F32H2.11
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq and microarray studies. Is affected by Ethanol and methylmercury hydroxide based on RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function, DUF273; Protein of unknown function DUF273; and Nucleotide-diphospho-sugar transferases.

WB:WBGene00043050	oig-4
Localizes to extracellular space and neuromuscular junction. Is expressed in body wall musculature; neurons; pm6; and somatic nervous system.

WB:WBGene00043051	C29E4.13
Is enriched in AVA; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00043052	srz-104
Is expressed in ADLL; ADLR; and PVT. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00043053	F47H4.12
Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00043054	T21B4.15
Is enriched in head mesodermal cell; intestine; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00043055	F19B2.10
Is enriched in AVK based on RNA-seq studies. Is affected by clk-1; eat-2; and daf-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00043056	nfya-2
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Is expressed in excretory cell; gonad; head neurons; intestine; and oocyte. Is an ortholog of human NFYA (nuclear transcription factor Y subunit alpha).

WB:WBGene00043057	M142.8
Is predicted to have protein-lysine N-methyltransferase activity. Is an ortholog of human EEF1AKMT1 (EEF1A lysine methyltransferase 1).

WB:WBGene00043058	sre-34
Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00043059	srab-26
Is affected by several genes including eat-2; let-418; and ubc-9 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR receptor class ab chemoreceptor and 7TM GPCR, serpentine receptor class ab (Srab).

WB:WBGene00043060	R144.12
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; microarray; and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Transmembrane protein 177. Is an ortholog of human TMEM177 (transmembrane protein 177).

WB:WBGene00043061	Y54G2A.38
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00043062	clec-80
Is predicted to have carbohydrate binding activity.

WB:WBGene00043064	nbet-1
Is predicted to have SNAP receptor activity. Is an ortholog of human BET1 (Bet1 golgi vesicular membrane trafficking protein).

WB:WBGene00043065	C55C3.7
Is enriched in AVA and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by sodium arsenite and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00043066	acr-25
Is predicted to have acetylcholine-gated cation-selective channel activity and transmembrane signaling receptor activity. Human ortholog(s) of this gene are implicated in chromosome 15q13.3 microdeletion syndrome. Is an ortholog of human CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion).

WB:WBGene00043067	dlc-5
Is predicted to have dynein intermediate chain binding activity and dynein light intermediate chain binding activity. Is expressed in pharynx.

WB:WBGene00043068	F32E10.9
Is enriched in AVK; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-35 based on RNA-seq and microarray studies. Is affected by Rotenone; manganese chloride; and antimycin based on RNA-seq studies.

WB:WBGene00043069	F20D6.12
Is affected by mir-34 based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00043097	C02D5.4
Is predicted to have glutathione dehydrogenase (ascorbate) activity. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease (multiple); X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome; and autosomal recessive nonsyndromic deafness 103. Is an ortholog of human GSTO1 (glutathione S-transferase omega 1) and GSTO2 (glutathione S-transferase omega 2).

WB:WBGene00043120	C09H10.4
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by daf-2; sir-2.1; and lin-35 based on microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00043147	nspd-6
Is enriched in amphid sheath cell; germ line; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and dpy-10 based on microarray and RNA-seq studies. Is affected by twenty chemicals including Ethanol; methylmercury hydroxide; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF780) and Protein of unknown function DUF780, Caenorhabditis species.

WB:WBGene00043156	C27F2.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Cry5B; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cupin-like domain and Cupin-like domain 8. Is an ortholog of human JMJD8 (jumonji domain containing 8).

WB:WBGene00043187	nspa-9
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on quantitative PCR; microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including hydrogen sulfide; resveratrol; and Acrylamide based on microarray studies.

WB:WBGene00043239	F08D12.5
Is affected by sir-2.1 and eat-2 based on microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00043279	F22D6.8
Is enriched in body wall muscle cell; germ line; neurons; and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00043283	F23B2.9
Is enriched in AVK based on RNA-seq studies. Is affected by clk-1 based on microarray studies. Is affected by Progesterone and resveratrol based on microarray studies.

WB:WBGene00043297	F28F5.4
Is enriched in GABAergic neurons; NSM; coelomocyte; neurons; and pharyngeal muscle cell based on microarray and tiling array studies. Is affected by several genes including skn-1; sir-2.1; and aak-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Sodium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00043302	F32D8.11
Is enriched in intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including D-glucopyranose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00043308	tmem-107
Is involved in dendrite development; non-motile cilium assembly; and protein localization to ciliary transition zone. Localizes to ciliary transition zone. Is expressed in ciliated neurons.

WB:WBGene00043327	F45D11.7
Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; F-box associated domain, type 2; and Leucine-rich repeat domain superfamily.

WB:WBGene00043328	F45D11.11
Is affected by eri-1 and mut-2 based on microarray studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; F-box associated domain, type 2; and Leucine-rich repeat domain superfamily.

WB:WBGene00043408	K03H6.3
No description available

WB:WBGene00043419	K08A2.6
No description available

WB:WBGene00043466	R05G6.3
Is affected by eat-2 and mir-243 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00043469	R09H3.2
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by hrde-1; adr-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00043534	W02B12.13
Is enriched in neurons and retrovesicular ganglion based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Rotenone; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00043537	W03G1.3
No description available

WB:WBGene00043538	W03G1.4
No description available

WB:WBGene00043666	Y45G5AM.4
Is enriched in AFD; ASER; PLM; arcade cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00043702	Y54G2A.7
Is predicted to have carbohydrate binding activity.

WB:WBGene00043705	egrh-2
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific. Human ortholog(s) of this gene are implicated in several diseases, including Charcot-Marie-Tooth disease (multiple); Denys-Drash syndrome; and Frasier syndrome. Is an ortholog of human EGR1 (early growth response 1).

WB:WBGene00043707	Y55F3C.6
No description available

WB:WBGene00043743	Y59E9AL.2
Is enriched in DA neuron; I5 neuron; SAB; retrovesicular ganglion; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and dpy-10 based on proteomic; RNA-seq; and microarray studies. Is affected by twenty-four chemicals including Ethanol; methylmercury hydroxide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00043948	ZC262.7
Is affected by several genes including daf-16; hsf-1; and alg-1 based on RNA-seq and microarray studies. Is affected by six chemicals including nicotine; Sodium Chloride; and Psoralens based on proteomic and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including complex cortical dysplasia with other brain malformations (multiple); hereditary sensory and autonomic neuropathy type 2 (multiple); and non-syndromic intellectual disability (multiple).

WB:WBGene00043952	ZC404.2
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including manganese chloride; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00043980	F11D5.7
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in several diseases, including arterial tortuosity syndrome; dystonia (multiple); and idiopathic generalized epilepsy 12.

WB:WBGene00043981	T14E8.4
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and elt-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00043982	B0403.6
Is enriched in body wall muscle cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and alg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00043983	C39D10.11
Is enriched in head mesodermal cell; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Tunicamycin; D-glucopyranose; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00043984	C56E6.7
Is enriched in AFD and AVK based on RNA-seq studies. Is affected by clk-1 and mir-34 based on microarray studies.

WB:WBGene00043985	C44C10.11
Is enriched in AFD; head mesodermal cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-60 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00043986	fut-5
Exhibits 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity. Is involved in fucosylation. Is an ortholog of human FUT4 (fucosyltransferase 4) and FUT7 (fucosyltransferase 7).

WB:WBGene00043987	AC8.9
Is affected by several genes including daf-16; hsf-1; and sek-1 based on RNA-seq studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00043988	AC8.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00043989	AC8.11
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq and proteomic studies. Is affected by five chemicals including metformin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00043990	AC8.12
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00043991	mir-258.2
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00043992	bbs-4
Is predicted to have microtubule motor activity. Localizes to ciliary basal body. Is used to study Bardet-Biedl syndrome. Human ortholog(s) of this gene are implicated in Bardet-Biedl syndrome 4. Is an ortholog of human BBS4 (Bardet-Biedl syndrome 4).

WB:WBGene00043993	T26G10.6
Is affected by daf-16; dpy-21; and eat-2 based on RNA-seq studies.

WB:WBGene00043994	C07A9.12
Is enriched in excretory cell; germline precursor cell; hypodermis; neurons; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00043995	F40F12.9
Is predicted to have mRNA binding activity; single-stranded RNA binding activity; and translation regulator activity.

WB:WBGene00043996	fbxb-87
Is enriched in AVA based on tiling array studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00043997	Y79H2A.12
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including glp-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2700) and Protein of unknown function DUF2700.

WB:WBGene00043998	T21C12.8
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including glp-1; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044000	Y75B8A.41
Is affected by several genes including daf-16; eat-2; and hpl-2 based on RNA-seq studies.

WB:WBGene00044001	C09G4.4
Is enriched in ASER; germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044002	srt-74
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00044003	Y41E3.18
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in PHARC syndrome.

WB:WBGene00044004	C24A8.6
Is predicted to have G protein-coupled receptor activity. Human ortholog(s) of this gene are implicated in several diseases, including attention deficit hyperactivity disorder; essential tremor 1; and prune belly syndrome.

WB:WBGene00044005	F37C12.18
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by nine chemicals including nicotinic acid; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00044006	nlp-82
Is enriched in AVA; neurons; somatic gonad precursor; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00044007	ZK1320.13
Is predicted to have calmodulin binding activity.

WB:WBGene00044008	gip-2
Is expressed in nervous system. Is predicted to encode a protein with the following domains: Gamma tubulin complex component N-terminal and Gamma tubulin complex component protein, N-terminal.

WB:WBGene00044009	ZK822.6
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00044010	sup-45
No description available

WB:WBGene00044011	T06E4.12
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and proteomic studies. Is affected by ten chemicals including Ethanol; tryptophan; and methylmercury hydroxide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Pistil-specific extensin-like protein.

WB:WBGene00044012	srxa-19
Is affected by dpy-21; drh-3; and eat-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx; 7TM GPCR, serpentine receptor class xa (Srxa); and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00044013	F15H10.9
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including hpl-2; his-24; and mir-34 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044014	F15H10.10
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including eat-2; sir-2.1; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044015	K06A4.8
Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including manganese chloride; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044016	C35A5.10
Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including 1-methylnicotinamide; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cysteine-rich repeat.

WB:WBGene00044018	T04B2.8
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including hsp-6; csr-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; antimycin; and Chlorpyrifos based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044019	C55A6.12
Is enriched in germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by sixteen chemicals including Rotenone; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Calycin.

WB:WBGene00044020	ZK856.14
Is expressed in ASEL; ASER; and neurons.

WB:WBGene00044021	R02E4.2
Is enriched in body wall muscle cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044022	AC3.9
Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044024	C35A5.11
Is enriched in ASER; PLM; germline precursor cell; hypodermis; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044025	T01G1.4
Is predicted to have dehydrodolichyl diphosphate synthase activity and polyprenyltransferase activity. Human ortholog(s) of this gene are implicated in developmental delay and seizures with or without movement abnormalities and retinitis pigmentosa 59. Is an ortholog of human DHDDS (dehydrodolichyl diphosphate synthase subunit).

WB:WBGene00044026	cisd-1
Is predicted to have 2 iron, 2 sulfur cluster binding activity. Is expressed in embryonic cell and intestinal cell. Human ortholog(s) of this gene are implicated in Wolfram syndrome 2. Is an ortholog of human CISD2 (CDGSH iron sulfur domain 2).

WB:WBGene00044027	F27E5.8
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00044028	nlp-63
Is enriched in neurons based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044029	C05D12.7
Is enriched in neurons and somatic nervous system based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00044030	Y17G7B.23
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Mianserin; multi-walled carbon nanotube; and Zidovudine based on RNA-seq studies.

WB:WBGene00044031	F49C5.9
Is affected by several genes including daf-2; set-2; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00044032	ceh-99
Is predicted to have DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding activity.

WB:WBGene00044034	Y38E10A.28
Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044035	F27E5.7
Is enriched in AFD; NSM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044036	ZK673.12
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00044037	ZK892.8
Is affected by daf-16; elli-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00044038	C47G2.6
Is affected by several genes including hsf-1; eat-2; and hpl-2 based on RNA-seq studies.

WB:WBGene00044040	F54D5.16
Is affected by several genes including daf-16; hsf-1; and isp-1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044041	F57G9.6
Is affected by several genes including eat-2; hpl-2; and smg-2 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044042	Y46G5A.37
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Colistin based on RNA-seq and microarray studies.

WB:WBGene00044043	Y46G5A.38
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044044	C08B6.14
Is predicted to have acid phosphatase activity and metal ion binding activity. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00044045	R11G10.3
Is enriched in OLL; PVD; hypodermis; muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00044046	ZK666.13
Is affected by clk-1 and hsf-1 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00044047	Y57A10C.11
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044048	F57G9.7
Is affected by several genes including hpl-2; drh-3; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00044049	sfxn-5
Is predicted to have transmembrane transporter activity. Is an ortholog of human SFXN5 (sideroflexin 5).

WB:WBGene00044051	Y57A10A.37
Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044052	Y57A10C.12
No description available

WB:WBGene00044053	C01G12.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and smg-2 based on RNA-seq and microarray studies. Is affected by allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00044054	C04H5.9
Is affected by several genes including rrf-3; eat-2; and raga-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Sodium Chloride; Rifampin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044056	Y53F4B.40
Is affected by adr-1; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00044057	F18A11.7
Is affected by clk-1; daf-16; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044058	F17B5.6
Is predicted to have galactoside 2-alpha-L-fucosyltransferase activity.

WB:WBGene00044059	T27C5.12
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00044061	tbc-12
Is predicted to have GTPase activator activity and Rab GTPase binding activity. Is an ortholog of human TBC1D14 (TBC1 domain family member 14).

WB:WBGene00044062	snb-6
Is predicted to have SNAP receptor activity and syntaxin binding activity. Human ortholog(s) of this gene are implicated in spastic ataxia 1.

WB:WBGene00044063	bpnt-1
Is predicted to have 3'(2'),5'-bisphosphate nucleotidase activity. Is expressed in several structures, including tail. Is an ortholog of human BPNT1 (3'(2'), 5'-bisphosphate nucleotidase 1).

WB:WBGene00044065	tag-229
Is predicted to have DNA binding activity.

WB:WBGene00044066	fbxb-66
Is enriched in hypodermis and pharynx based on microarray and tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seventeen chemicals including hydrogen sulfide; 1-methylnicotinamide; and methylmercuric chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00044067	zipt-7.1
Exhibits zinc ion transmembrane transporter activity. Is involved in several processes, including cellular zinc ion homeostasis; positive regulation of brood size; and positive regulation of fertilization. Localizes to membrane. Is expressed in hypodermis; neurons; spermatocyte; ventral nerve cord; and vulva. Is an ortholog of human SLC39A7 (solute carrier family 39 member 7).

WB:WBGene00044068	syd-9
Is predicted to have RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nuclear speck. Is expressed in ASEL; ASER; muscle cell; nerve ring neurons; and neurons.

WB:WBGene00044069	hat-1
Is predicted to have H4 histone acetyltransferase activity and histone binding activity. Is expressed in germ line. Is an ortholog of human HAT1 (histone acetyltransferase 1).

WB:WBGene00044070	set-18
Is predicted to have histone-lysine N-methyltransferase activity. Localizes to endoplasmic reticulum; sarcomere; and striated muscle dense body. Is expressed in body wall musculature; non-striated muscle; pharynx; and vulva. Is an ortholog of human SMYD1 (SET and MYND domain containing 1) and SMYD3 (SET and MYND domain containing 3).

WB:WBGene00044071	dhhc-14
Is predicted to have protein-cysteine S-palmitoyltransferase activity. Is expressed in body wall musculature and neurons. Is an ortholog of human ZDHHC17 (zinc finger DHHC-type palmitoyltransferase 17).

WB:WBGene00044072	ham-3
Is predicted to have RNA polymerase II transcription factor binding activity. Localizes to nucleus. Is used to study alcohol use disorder. Is an ortholog of human SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1) and SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3).

WB:WBGene00044073	tag-244
Is involved in innate immune response.

WB:WBGene00044074	mltn-5
Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by methylmercury hydroxide based on RNA-seq studies. Is predicted to encode a protein with the following domains: Moulting cycle and Moulting cycle MLT-10-like protein.

WB:WBGene00044077	pacs-1
Is expressed in several structures, including excretory cell; intestine; neurons; pharynx; and vulva. Human ortholog(s) of this gene are implicated in Schuurs-Hoeijmakers Syndrome and early infantile epileptic encephalopathy 66. Is predicted to encode a protein with the following domains: Phosphorylation site; PACS-1 cytosolic sorting protein; and Phosphofurin acidic cluster sorting protein 1. Is an ortholog of human PACS1 (phosphofurin acidic cluster sorting protein 1) and PACS2 (phosphofurin acidic cluster sorting protein 2).

WB:WBGene00044078	tag-243
Is predicted to have actin binding activity. Is an ortholog of human ABRA (actin binding Rho activating protein).

WB:WBGene00044079	tag-241
Is enriched in head mesodermal cell; muscle cell; neurons; and pharynx based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray; RNA-seq; and proteomic studies. Is affected by fourteen chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: . Is an ortholog of human MTCL1 (microtubule crosslinking factor 1).

WB:WBGene00044080	D1086.10
Is enriched in cephalic sheath cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and let-7 based on proteomic; RNA-seq; and microarray studies. Is affected by twenty chemicals including Ethanol; manganese chloride; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00044081	D1086.11
Is enriched in dopaminergic neurons; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and let-7 based on RNA-seq; proteomic; and microarray studies. Is affected by eleven chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00044082	D1086.12
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044083	tin-9.2
Is predicted to have metal ion binding activity. Is involved in inductive cell migration; regulation of growth; and reproduction. Localizes to mitochondrion. Is an ortholog of human TIMM10B (translocase of inner mitochondrial membrane 10B).

WB:WBGene00044084	sre-46
Is affected by mir-34; drh-3; and ints-4 based on microarray and RNA-seq studies. Is affected by 2 and 4-dinitroanisole based on microarray studies. Is predicted to encode a protein with the following domains: C. elegans Sre G protein-coupled chemoreceptor and 7TM GPCR, serpentine receptor class e (Sre).

WB:WBGene00044085	Y105C5B.30
Is affected by several genes including skn-1; eat-2; and smn-1 based on RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Psoralens based on RNA-seq studies.

WB:WBGene00044086	clec-228
Is predicted to have carbohydrate binding activity.

WB:WBGene00044087	C45H4.18
Is affected by several genes including clk-1; eat-2; and mex-3 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sru and 7TM GPCR, serpentine receptor class u (Sru).

WB:WBGene00044088	oac-2
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups.

WB:WBGene00044089	srbc-31
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by mut-2 and acs-3 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044090	srbc-33
Is affected by tatn-1 and mir-34 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044091	srbc-60
Is affected by several genes including mex-3; mex-1; and dpy-21 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044092	srbc-71
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044093	srbc-72
Is affected by tatn-1 and clk-1 based on RNA-seq and microarray studies.

WB:WBGene00044094	fitm-2
Is involved in lipid droplet formation. Is an ortholog of human FITM2 (fat storage inducing transmembrane protein 2).

WB:WBGene00044095	srh-121
Is affected by clk-1 and mut-2 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00044096	srh-96
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00044097	srh-64
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044099	srd-75
Is enriched in muscle cell and neurons based on microarray studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00044100	srbc-27
Is enriched in NSM based on tiling array studies. Is affected by hpl-2; rsr-2; and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044101	srbc-28
No description available

WB:WBGene00044102	srbc-46
No description available

WB:WBGene00044103	srbc-47
No description available

WB:WBGene00044104	srbc-53
Is affected by clk-1 based on microarray studies.

WB:WBGene00044105	srbc-55
Is enriched in neurons based on microarray studies. Is affected by rsr-2 and rrf-3 based on tiling array and microarray studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044106	srbc-84
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including let-60; elt-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044107	F58G6.9
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1) and SLC31A2 (solute carrier family 31 member 2).

WB:WBGene00044109	K02E11.10
Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including hydrogen sulfide; Ethanol; and Nitric Oxide based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044112	srm-5
Is expressed in ASHL; ASHR; ASIL; ASIR; and RIH. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00044113	C54F6.15
Is enriched in dopaminergic neurons and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and sek-1 based on microarray and RNA-seq studies. Is affected by indole; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044114	srxa-11
Is affected by several genes including clk-1; mir-34; and jmjd-3.1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00044115	srxa-12
Is enriched in AVK and neurons based on RNA-seq and microarray studies. Is affected by several genes including drh-3; ain-2; and mir-34 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00044116	srxa-13
Is affected by mir-34 and eat-2 based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis serpentine receptor-like protein, class xa and 7TM GPCR, serpentine receptor class xa (Srxa).

WB:WBGene00044117	srsx-10
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00044119	srh-191
Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00044120	C36B1.13
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; stavudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044121	gcp-2.3
Is affected by several genes including daf-2; eat-2; and pmk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and Diazinon based on RNA-seq and microarray studies. Is an ortholog of human FOLH1 (folate hydrolase 1); NAALAD2 (N-acetylated alpha-linked acidic dipeptidase 2); and NAALADL1 (N-acetylated alpha-linked acidic dipeptidase like 1).

WB:WBGene00044122	T28B8.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by ten chemicals including manganese chloride; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044124	srsx-15
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00044125	srsx-16
Is predicted to have G protein-coupled receptor activity.

WB:WBGene00044126	srsx-23
Is affected by dpy-21; daf-2; and ints-8 based on RNA-seq and microarray studies.

WB:WBGene00044127	BE10.5
Is enriched in NSM; amphid sheath cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044128	BE10.6
Is affected by several genes including daf-16; aak-2; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044129	C01B9.3
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00044130	C05B5.10
Is enriched in muscle cell based on RNA-seq studies. Is affected by clk-1; adr-1; and eat-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044131	Y45G12C.16
Is affected by several genes including daf-16; daf-2; and let-7 based on RNA-seq; proteomic; and microarray studies.

WB:WBGene00044132	C23H4.8
Is enriched in germline precursor cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044133	C44C10.12
Is affected by hpl-2 and dpy-21 based on tiling array and RNA-seq studies.

WB:WBGene00044134	D1025.10
Is enriched in body wall muscle cell and neurons based on tiling array studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq; tiling array; and microarray studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00044135	F08G12.11
Is enriched in ASER and amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; unc-70; and lem-2 based on RNA-seq studies. Is affected by Tunicamycin; multi-walled carbon nanotube; and Colistin based on microarray and RNA-seq studies.

WB:WBGene00044136	F23D12.8
Is enriched in DA neuron; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by rsr-2; mir-34; and spn-4 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044137	F28H6.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; D-glucose; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00044138	sssh-1
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sleepless protein and Protein quiver.

WB:WBGene00044139	F42D1.4
Is enriched in AVE; coelomocyte; muscle cell; and in male based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; smn-1; and hmg-3 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00044140	F42F12.11
Is affected by several genes including eat-2; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044141	H03G16.6
Is affected by several genes including eat-2; hpl-2; and spn-4 based on tiling array and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044142	H13N06.7
Is predicted to have microtubule binding activity.

WB:WBGene00044143	K09E9.4
Is predicted to have cAMP-dependent protein kinase inhibitor activity. Is an ortholog of human PKIA (cAMP-dependent protein kinase inhibitor alpha); PKIB (cAMP-dependent protein kinase inhibitor beta); and PKIG (cAMP-dependent protein kinase inhibitor gamma).

WB:WBGene00044144	M153.4
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including stavudine; Zidovudine; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-finger of a C2HC-type and Zinc finger C2HC domain-containing protein. Is an ortholog of human ZNF474 (zinc finger protein 474).

WB:WBGene00044145	M163.9
Is affected by several genes including clk-1; eat-2; and drh-3 based on microarray and RNA-seq studies.

WB:WBGene00044146	M163.10
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by rsr-2 based on tiling array studies.

WB:WBGene00044147	M163.11
Is affected by several genes including elt-2; eat-2; and pgl-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00044148	T08D10.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including alg-1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by five chemicals including hydrogen sulfide; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00044149	T24D5.6
Is enriched in NSM; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by several genes including eat-2; dpy-21; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044150	VB0395L.1
Is predicted to have metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity.

WB:WBGene00044151	W04G3.12
Is enriched in PLM and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044152	W04G3.10
Is predicted to have phospholipase A2 activity.

WB:WBGene00044153	W04G3.11
Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044154	Y7A5A.10
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; mex-3; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00044155	Y7A5A.11
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044156	Y66C5A.1
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq studies.

WB:WBGene00044157	Y66C5A.2
Is enriched in NSM; Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on tiling array and RNA-seq studies. Is affected by rsr-2 and clk-1 based on tiling array and microarray studies.

WB:WBGene00044158	Y53C12A.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00044159	F26C11.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hpl-2; and nhl-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00044160	W10C6.2
Is affected by several genes including mex-3; hpl-2; and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Ribosomal protein S5 domain 2-type fold, subgroup and Ribosomal protein S5 domain 2-type fold.

WB:WBGene00044161	C47G2.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rifampin; Sirolimus; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00044162	F49C5.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including sir-2.1; aak-2; and aak-1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00044163	F49C5.11
Is enriched in AFD; ASER; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00044164	Y46G5A.39
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including tryptophan; Psoralens; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00044166	C54C6.7
Is enriched in intestine and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00044167	C36A4.11
Is enriched in Z1; Z4; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; Sodium Chloride; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00044168	M05D6.10
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq studies. Is affected by four chemicals including Rotenone; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00044169	C06C3.10
Is enriched in germline precursor cell; hypodermis; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044170	Y51B9A.10
Is affected by smg-2 and daf-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044171	Y54E2A.13
No description available

WB:WBGene00044174	fipr-5
Is enriched in arcade cell; germ line; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00044175	fipr-9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domain: Neuropeptide-like protein 28/29/30/31.

WB:WBGene00044176	C30G7.2
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; pgl-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044177	C30G7.3
Is enriched in germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00044178	C30G7.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including Ethanol; D-glucose; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00044179	C30G7.5
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and mir-34 based on tiling array and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044180	C47E8.11
Is enriched in coelomocyte; intestine; neurons; somatic gonad precursor; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00044181	F09C6.11
Is enriched in pharyngeal muscle cell based on tiling array studies. Is affected by several genes including aak-2; dpy-21; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including tryptophan; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00044182	F09C6.12
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044183	F09C6.13
Is enriched in excretory cell; germ line; muscle cell; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including tryptophan; Tunicamycin; and sodium arsenite based on microarray and RNA-seq studies.

WB:WBGene00044184	F11A5.16
Is enriched in germ line based on RNA-seq studies. Is affected by rsr-2 and smg-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044185	F14F8.14
Is enriched in Z1.p; Z4.a; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by daf-2 based on microarray studies. Is affected by Triclosan based on microarray studies.

WB:WBGene00044187	ttll-9
Is predicted to have ATP binding activity and ligase activity. Is an ortholog of human TTLL9 (tubulin tyrosine ligase like 9).

WB:WBGene00044188	F28F8.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and lin-35 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq studies.

WB:WBGene00044189	F36D3.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00044191	F43D2.6
Is enriched in hypodermis and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq studies. Is affected by nine chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044192	F46B6.13
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044193	F47B8.13
Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044194	F47B8.14
Is affected by several genes including daf-2; daf-12; and pgl-1 based on tiling array and RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044195	F49A5.10
Is enriched in NSM based on tiling array studies. Is affected by hpl-2 and klf-1 based on tiling array and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044196	F55C9.12
Is affected by several genes including clk-1; eat-2; and adr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044197	fbxb-63
Is enriched in NSM and muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; indole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00044198	F56H9.6
Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00044199	F57B1.8
Is affected by several genes including daf-2; dpy-21; and hpl-2 based on RNA-seq and microarray studies.

WB:WBGene00044200	H37A05.4
Is enriched in coelomocyte and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044201	H39E23.3
Is predicted to have microtubule binding activity.

WB:WBGene00044202	K10G4.10
Is enriched in NSM based on tiling array studies. Is affected by several genes including skn-1; clk-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00044203	T02E9.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; alg-1; and rsr-2 based on tiling array and RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044204	suds-3
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00044205	T13F3.8
Is enriched in AVG; RIM; command interneuron; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00044206	T26H5.9
Is enriched in head mesodermal cell; intestine; muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by twenty-three chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00044207	Y6G8.5
Is enriched in NSM and intestine based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; bisphenol A; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044208	Y6G8.6
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including dpy-21; hpl-2; and rsr-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044209	Y32F6A.6
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044210	Y51A2D.21
Is enriched in Z1; Z4; hypodermis; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044211	Y60A3A.25
Is affected by several genes including daf-12; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044212	Y68A4A.13
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by twelve chemicals including methylmercury hydroxide; Tunicamycin; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00044213	Y102A5C.36
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00044215	ZK228.10
Is affected by several genes including skn-1; hsf-1; and dpy-21 based on tiling array and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044216	C47E8.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including manganese chloride; metformin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044217	F23D12.9
Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq studies. Is affected by allantoin; metformin; and Rifampin based on RNA-seq studies.

WB:WBGene00044218	F23H12.10
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and prg-1 based on RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00044219	F28F8.10
Is affected by several genes including pgl-1; sma-2; and glh-1 based on RNA-seq studies. Is affected by Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044220	Y102A5C.35
Is affected by several genes including daf-2; hpl-2; and ain-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Alovudine; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00044221	F41G3.18
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and mex-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044222	T16G12.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sma-2 based on RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044224	F17C8.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00044225	C38D4.10
Is predicted to have chromatin binding activity and methylated histone binding activity.

WB:WBGene00044226	K08E5.4
Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00044227	C07A9.13
Is enriched in PLM; germ line; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00044228	T03F6.7
Is affected by rsr-2 and drh-3 based on tiling array and RNA-seq studies.

WB:WBGene00044229	T03F6.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Tunicamycin and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00044230	C36E8.6
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including drh-3; ubc-9; and adr-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044232	C18D11.7
Is affected by several genes including clk-1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00044233	dolk-1
Is predicted to have dolichol kinase activity. Human ortholog(s) of this gene are implicated in congenital disorder of glycosylation Im. Is an ortholog of human DOLK (dolichol kinase).

WB:WBGene00044234	Y111B2A.37
No description available

WB:WBGene00044235	C06A1.7
Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044236	C17E4.11
Is predicted to have methyltransferase activity. Is an ortholog of human EEF1AKMT4 (EEF1A lysine methyltransferase 4).

WB:WBGene00044237	pals-9
Is enriched in PLM and cephalic sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044238	C30H6.12
Is enriched in body wall muscle cell; dopaminergic neurons; and intestine based on tiling array and microarray studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Cadmium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044239	C33D9.10
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-12; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044240	C47E12.14
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by hpl-2; rsr-2; and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044241	C53D6.11
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00044242	C54C8.12
Is enriched in NSM and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including tryptophan; Rotenone; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00044243	F16C3.4
Is enriched in amphid sheath cell; germ line; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044244	F26D10.13
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00044245	F32A7.8
Is enriched in ventral nerve cord based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; multi-walled carbon nanotube; and nanoparticle based on microarray and RNA-seq studies.

WB:WBGene00044246	F36D1.10
Is affected by rsr-2 and dpy-21 based on tiling array and RNA-seq studies.

WB:WBGene00044247	F36H2.4
Is affected by several genes including daf-2; daf-12; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00044249	F55B11.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00044250	F56G4.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; manganese chloride; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00044251	F59C6.12
Is enriched in germ line and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and isp-1 based on microarray and RNA-seq studies. Is affected by five chemicals including hydrogen sulfide; Zidovudine; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4505) and Protein of unknown function DUF4505. Is an ortholog of human C8orf82 (chromosome 8 open reading frame 82).

WB:WBGene00044253	M117.6
Is enriched in GABAergic neurons and germ line based on RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and aak-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00044256	Y45F10C.6
Is enriched in DA neuron; VA neuron; and excretory cell based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00044257	Y45F10D.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; bar-1; and lem-2 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044258	Y57G11C.51
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00044259	Y73F8A.36
Is affected by several genes including daf-2; skn-1; and let-60 based on RNA-seq and microarray studies. Is affected by five chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044260	Y87G2A.19
Is enriched in arcade cell; pharyngeal muscle cell; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on proteomic; RNA-seq; and microarray studies. Is affected by ten chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Charcot-Marie-Tooth disease type 1C. Is predicted to encode a protein with the following domains: Phosphorylation site; LITAF-like zinc ribbon domain; LPS-induced tumour necrosis factor alpha factor; and LITAF domain containing protein. Is an ortholog of human LITAF (lipopolysaccharide induced TNF factor).

WB:WBGene00044261	Y87G2A.20
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including tryptophan; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00044262	Y95D11A.2
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044263	Y105C5A.26
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044264	Y105E8A.32
Is affected by clk-1; smg-2; and tdp-1 based on microarray and RNA-seq studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies.

WB:WBGene00044265	Y105E8B.11
Is enriched in AVK and NSM based on tiling array and RNA-seq studies. Is affected by aak-2 and clk-1 based on RNA-seq and microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00044266	ZK39.9
Is affected by hpl-2 and rsr-2 based on tiling array studies.

WB:WBGene00044267	F41D3.12
Is affected by clk-1 based on microarray studies.

WB:WBGene00044268	T27E7.10
Is affected by several genes including daf-2; clk-1; and sek-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and metformin based on RNA-seq studies.

WB:WBGene00044270	F35E2.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Hydrolyzable Tannins; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00044271	nspa-2
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by twelve chemicals including hydrogen sulfide; multi-walled carbon nanotube; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00044272	nspa-4
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by sixteen chemicals including hydrogen sulfide; Ethanol; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00044273	nspa-6
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including hydrogen sulfide; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00044274	nspa-7
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and gld-2 based on RNA-seq and microarray studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00044275	nspa-10
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by hydrogen sulfide based on microarray studies.

WB:WBGene00044276	nspa-11
Is affected by hpl-2 and daf-2 based on RNA-seq and microarray studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00044277	nspa-12
Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00044278	F09C6.14
Is affected by several genes including daf-2; clk-1; and unc-70 based on tiling array; microarray; and RNA-seq studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00044279	grl-32
Is affected by several genes including daf-2; sir-2.1; and pmk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044280	W02A2.9
Is enriched in intestine; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including Tunicamycin; D-glucose; and 4-bromodiphenyl ether based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00044281	R04A9.7
Is predicted to have ribosomal protein S6 kinase activity. Is an ortholog of human RPS6KB1 (ribosomal protein S6 kinase B1).

WB:WBGene00044282	T19H12.12
Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044283	spp-22
Is enriched in head mesodermal cell and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein T25E4.2-like.

WB:WBGene00044284	spp-21
Is affected by several genes including daf-16; daf-2; and elt-2 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including Tunicamycin; indole; and D-glucose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00044285	thn-8
Is affected by elli-1 and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044286	ugt-35
Is predicted to have UDP-glycosyltransferase activity. Human ortholog(s) of this gene are implicated in Crigler-Najjar syndrome and Gilbert syndrome. Is an ortholog of several human genes including UGT1A7 (UDP glucuronosyltransferase family 1 member A7); UGT2A3 (UDP glucuronosyltransferase family 2 member A3); and UGT2B4 (UDP glucuronosyltransferase family 2 member B4).

WB:WBGene00044287	F21H12.7
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-16; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044288	F30H5.5
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044289	Y37F4.8
Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; D-glucose; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00044290	B0035.18
Is enriched in AFD; germ line; germline precursor cell; head mesodermal cell; and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and aak-2 based on RNA-seq and tiling array studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Cytochrome c oxidase subunit VIc; Mitochondrial cytochrome c oxidase subunit VIc/VIIs; and Mitochondrial cytochrome c oxidase subunit VIc/VIIs superfamily.

WB:WBGene00044291	C25F9.10
Is enriched in OLL; PVD; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including dpy-10; elt-2; and rde-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044292	F56D6.8
Is enriched in body wall muscle cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; Tunicamycin; and Cadmium Chloride based on RNA-seq and microarray studies.

WB:WBGene00044293	K08D12.7
Is affected by several genes including let-60; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044294	C01B10.11
Is enriched in ASER; germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on proteomic; microarray; and RNA-seq studies. Is affected by eleven chemicals including Ethanol; methylmercury hydroxide; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00044295	C09E7.10
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; elt-2; and prg-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044296	F10C1.9
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; D-glucopyranose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Lamin tail domain superfamily.

WB:WBGene00044297	C25B8.8
Is enriched in AFD; ASER; PLM; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044298	T23B7.2
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and let-60 based on microarray and RNA-seq studies. Is affected by nine chemicals including Sodium Chloride; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein ZC21.8.

WB:WBGene00044299	C42D8.9
Is enriched in AFD and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including multi-walled carbon nanotube; Sodium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044300	D1022.9
Is enriched in GABAergic neurons and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including manganese chloride; D-glucose; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00044301	lgc-28
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00044302	F28E10.5
Is enriched in NSM; germ line; intestine; and in male based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including methylmercuric chloride; stavudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00044303	hst-3.2
Is predicted to have [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity. Is involved in heparan sulfate proteoglycan biosynthetic process. Is expressed in epithelial cell; hypodermis; neurons; and vulva. Is an ortholog of human HS3ST6 (heparan sulfate-glucosamine 3-sulfotransferase 6).

WB:WBGene00044304	F52B10.3
Is enriched in AVK; NSM; PLM; head mesodermal cell; and neurons based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00044305	rad-8
Is predicted to have oxidoreductase activity. Is involved in several processes, including defense response to other organism; positive regulation of growth rate; and response to superoxide. Localizes to mitochondrion. Is expressed in several structures, including intestine; muscle cell; neurons; and pharynx. Human ortholog(s) of this gene are implicated in optic atrophy 10. Is an ortholog of human RTN4IP1 (reticulon 4 interacting protein 1).

WB:WBGene00044306	F58F9.8
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044307	F58F9.9
Is enriched in male based on RNA-seq studies. Is affected by rsr-2 based on tiling array studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044308	F58F9.10
Is affected by clk-1; smg-2; and drh-3 based on microarray and RNA-seq studies.

WB:WBGene00044309	F58F9.11
Is affected by several genes including clk-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044310	H20J04.9
Is predicted to have methyltransferase activity.

WB:WBGene00044311	K04C2.7
Is enriched in AVE; dopaminergic neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044312	K04C2.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044313	M02D8.7
Is enriched in AFD; ASER; and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on microarray and RNA-seq studies. Is affected by Acrylamide and nitroguanidine based on microarray studies.

WB:WBGene00044314	fbxb-33
Is enriched in BAG and NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00044315	F41G3.20
Is affected by several genes including daf-2; isp-1; and tax-6 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including resveratrol; Hydrolyzable Tannins; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: CC domain; ShK domain-like; ShKT domain; and CC domain.

WB:WBGene00044316	F41G3.21
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including Zidovudine; Sodium Chloride; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00044317	F41G3.19
Is affected by rsr-2 and dpy-21 based on tiling array and RNA-seq studies. Is affected by nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00044318	tag-267
Is enriched in germ line; hypodermis; intestine; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by seven chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044319	tag-266
Is enriched in dopaminergic neurons and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; age-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by four chemicals including Alovudine; stavudine; and Chlorpyrifos based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in acute myeloid leukemia. Is predicted to encode a protein with the following domains: Golgin subfamily A member 7/ERF4 family; Golgin subfamily A member 7/ERF4; and Cysteine-rich hydrophobic domain-containing protein 1/2. Is an ortholog of human CHIC1 (cysteine rich hydrophobic domain 1) and CHIC2 (cysteine rich hydrophobic domain 2).

WB:WBGene00044321	mrps-30
Is predicted to be a structural constituent of ribosome. Is an ortholog of human MRPS30 (mitochondrial ribosomal protein S30).

WB:WBGene00044322	tag-280
Is enriched in germ line and muscle cell based on RNA-seq studies. Is affected by several genes including let-7; gld-1; and hsf-1 based on proteomic; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; Mianserin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised conserved protein (DUF2368) and Plasminogen receptor (KT). Is an ortholog of human PLGRKT (plasminogen receptor with a C-terminal lysine).

WB:WBGene00044323	tag-281
Is enriched in ASER; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Uncharacterised conserved protein (DUF2368) and Plasminogen receptor (KT). Is an ortholog of human PLGRKT (plasminogen receptor with a C-terminal lysine).

WB:WBGene00044324	ufm-1
Is expressed in egg-laying apparatus; hermaphrodite gonad; intestine; and seam cell. Human ortholog(s) of this gene are implicated in hypomyelinating leukodystrophy 14. Is predicted to encode a protein with the following domains: Ubiquitin fold modifier 1 protein; Ubiquitin-fold modifier 1; and Ubiquitin-like domain superfamily. Is an ortholog of human UFM1 (ubiquitin fold modifier 1).

WB:WBGene00044325	tag-321
Localizes to mitochondrion. Is an ortholog of human TMEM65 (transmembrane protein 65).

WB:WBGene00044326	tag-322
Is enriched in germ line; head mesodermal cell; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray; tiling array; RNA-seq; and proteomic studies. Is affected by nine chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Human FAM98B exhibits identical protein binding activity and protein methyltransferase activity. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2465) and FAM98. Is an ortholog of human FAM98A (family with sequence similarity 98 member A) and FAM98B (family with sequence similarity 98 member B).

WB:WBGene00044329	cpsf-4
Is predicted to have nucleic acid binding activity and zinc ion binding activity. Is an ortholog of human CPSF4 (cleavage and polyadenylation specific factor 4).

WB:WBGene00044330	alr-1
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in several structures, including anterior hypodermis; neurons; pseudocoelom; socket cell; and somatic nervous system. Human ortholog(s) of this gene are implicated in several diseases, including Partington syndrome; diabetes mellitus (multiple); and eye disease (multiple). Is an ortholog of human ALX1 (ALX homeobox 1) and ARX (aristaless related homeobox).

WB:WBGene00044331	clec-25
Is predicted to have carbohydrate binding activity.

WB:WBGene00044332	clec-36
Is predicted to have carbohydrate binding activity.

WB:WBGene00044333	C01G12.13
Is enriched in amphid sheath cell; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including manganese chloride; D-glucose; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00044334	W06G6.14
No description available

WB:WBGene00044335	Y51A2D.22
No description available

WB:WBGene00044336	Y7A5A.12
No description available

WB:WBGene00044337	nspc-2
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; prg-1; and egl-9 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Ethanol; Rifampin; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044338	nspc-3
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including Mianserin; D-glucose; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044339	nspc-4
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including Ethanol; Rotenone; and Mianserin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044340	nspc-5
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by Mianserin and Triclosan based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044341	ave-1
Is enriched in AFD; OLL; PLM; PVD; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; pgl-1; and mex-1 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Human ortholog(s) of this gene are implicated in familial adult myoclonic epilepsy 1. Is predicted to encode a protein with the following domains: SAM domain (Sterile alpha motif); Sterile alpha motif domain; and Sterile alpha motif/pointed domain superfamily. Is an ortholog of human SAMD10 (sterile alpha motif domain containing 10).

WB:WBGene00044342	T05B11.7
Is enriched in intestine and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; lin-4; and lin-14 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00044343	clec-77
Is affected by several genes including skn-1; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00044344	mrpl-39
Is predicted to have nucleotide binding activity. Is an ortholog of human MRPL39 (mitochondrial ribosomal protein L39).

WB:WBGene00044345	Y48G1C.12
Is enriched in cephalic sheath cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Anaphase-promoting complex, subunit 10 (APC10); APC10/DOC domain; Galactose-binding-like domain superfamily; and Anaphase-promoting complex subunit APC10/Doc1. Is an ortholog of human ANAPC10 (anaphase promoting complex subunit 10).

WB:WBGene00044346	Y59E9AL.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00044347	Y71G12B.30
Is predicted to have protein serine/threonine phosphatase activity.

WB:WBGene00044348	Y71G12B.31
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00044349	Y71G12B.32
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray; RNA-seq; and tiling array studies. Is affected by ten chemicals including bisphenol S; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: F-box protein she-1-like.

WB:WBGene00044350	Y73B6BL.44
Is affected by several genes including daf-2; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044352	ZK381.8
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00044353	ZK418.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including alg-1; dpy-21; and rsr-2 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00044354	ZK418.11
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including daf-16; alg-1; and dpy-21 based on RNA-seq studies. Is affected by five chemicals including tryptophan; Rifampin; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in maturity-onset diabetes of the young type 1 and type 2 diabetes mellitus. Is predicted to encode a protein with the following domains: Ligand-binding domain of nuclear hormone receptor; Nuclear hormone receptor, ligand-binding domain; and Nuclear hormone receptor-like domain superfamily.

WB:WBGene00044355	ZK563.7
Is predicted to have guanosine-diphosphatase activity and uridine-diphosphatase activity. Human ortholog(s) of this gene are implicated in Desbuquois dysplasia and multiple epiphyseal dysplasia 7. Is an ortholog of human CANT1 (calcium activated nucleotidase 1).

WB:WBGene00044356	W02D7.12
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; dpy-10; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044357	nspc-6
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Ethanol; Mianserin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044358	Y71G12B.33
Is affected by several genes including daf-2; eat-2; and hpl-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00044359	C16C4.17
Is enriched in germline precursor cell and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and prg-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Tunicamycin and Colistin based on microarray studies.

WB:WBGene00044360	C33C12.11
Is affected by several genes including daf-16; aak-2; and mex-3 based on tiling array and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00044361	K09F6.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and sek-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; multi-walled carbon nanotube; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044362	F42G2.7
Is predicted to have phytanoyl-CoA dioxygenase activity. Human ortholog(s) of this gene are implicated in Refsum disease. Is an ortholog of human PHYH (phytanoyl-CoA 2-hydroxylase).

WB:WBGene00044363	F22E5.21
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including hydrogen sulfide; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF684) and Protein of unknown function DUF684.

WB:WBGene00044364	nspf-1
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and lin-39 based on RNA-seq; tiling array; and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044365	nspf-2
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044366	nspf-3
Is enriched in AVK; DA neuron; VA neuron; dopaminergic neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044367	T05A8.8
Is enriched in ASER; AVE; Z1.p; Z4.a; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and prg-1 based on RNA-seq and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00044368	K12H6.10
Is enriched in amphid sheath cell; body wall muscle cell; germline precursor cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00044369	irld-67
Is enriched in AVA; GABAergic neurons; and NSM based on tiling array and RNA-seq studies. Is affected by clk-1 and daf-2 based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00044370	C41H7.9
Is enriched in AFD and intestine based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including hydrogen sulfide; Rifampin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044371	ZC239.20
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00044372	ZC239.21
Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Rotenone; multi-walled carbon nanotube; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00044373	C17F4.11
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00044374	C17F4.12
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pmk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00044375	F39E9.14
Is affected by eat-2 and mex-3 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044376	Y49F6B.12
Is enriched in amphid sheath cell; cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00044377	Y49F6B.13
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sma-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq studies.

WB:WBGene00044378	Y49F6B.14
Is affected by rsr-2 and clk-1 based on tiling array and microarray studies.

WB:WBGene00044379	F40H7.12
Is enriched in several structures, including PLM; Z1.p; Z4.a; carbon dioxide sensory neurons; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Actin-crosslinking.

WB:WBGene00044380	T24E12.12
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00044381	K10G6.5
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including hydrogen sulfide; tryptophan; and Tunicamycin based on microarray studies.

WB:WBGene00044382	Y14H12A.2
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Tunicamycin; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00044383	T05A7.11
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00044384	F11G11.14
Is enriched in amphid sheath cell; male-specific anatomical entity; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eight chemicals including Tunicamycin; metformin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Uncharacterized protein ZC21.8.

WB:WBGene00044385	F59A6.10
Is enriched in excretory cell and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and eat-2 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Tunicamycin; nanoparticle; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00044386	C27A2.7
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-2; aak-2; and fbf-1 based on microarray and RNA-seq studies. Is affected by glycine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00044387	C27A2.8
Is enriched in intestine and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by nine chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00044388	C27D6.11
Is predicted to have protein serine/threonine kinase activity. Is an ortholog of human TSSK1B (testis specific serine kinase 1B) and TSSK6 (testis specific serine kinase 6).

WB:WBGene00044389	C27D6.12
Is enriched in OLL; PLM; PVD; and amphid sheath cell based on microarray and RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and sod-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044390	ZK177.11
Is predicted to have protein dimerization activity.

WB:WBGene00044391	C25H3.15
Is enriched in germline precursor cell and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044392	C25H3.16
Is enriched in ASER; AVK; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044393	ZK1248.20
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; D-glucose; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044394	B0034.7
Is enriched in ASER; dopaminergic neurons; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044395	R12C12.10
Is enriched in germline precursor cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including methylmercury hydroxide; 1-methylnicotinamide; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00044396	ZK1290.14
Is enriched in PLM; intestine; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00044397	nspc-8
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Deoxyglucose; Humic Substances; and single-walled carbon nanotube based on microarray studies.

WB:WBGene00044398	nspc-11
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by Triclosan based on microarray studies.

WB:WBGene00044399	F11F1.8
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00044401	Y55B1BR.6
Is enriched in DA neuron; VA neuron; dopaminergic neurons; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; pmk-1; and lin-35 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00044402	Y82E9BL.18
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including tryptophan; D-glucopyranose; and Cadmium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00044403	fbxa-219
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by bisphenol A; Zidovudine; and paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00044405	C29F7.8
Is affected by four chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00044406	F02A9.7
Is enriched in muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044409	C45G9.14
Is enriched in dopaminergic neurons; somatic gonad precursor; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including drh-3; meg-3; and rsr-2 based on tiling array and RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00044410	F48E8.8
Is enriched in excretory cell; hypodermis; intestine; muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-39; and sek-1 based on RNA-seq and microarray studies.

WB:WBGene00044411	R12B2.8
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; alg-1; and mex-3 based on RNA-seq and microarray studies. Is affected by nanoparticle; Zidovudine; and Colistin based on microarray and RNA-seq studies.

WB:WBGene00044412	F40H6.6
Is enriched in AFD; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; fog-2; and sma-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044413	B0205.12
Is enriched in hypodermis and muscle cell based on RNA-seq studies. Is affected by several genes including hsf-1; aak-2; and alg-1 based on RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4535) and Short transmembrane mitochondrial protein 1.

WB:WBGene00044414	C06A5.12
Is enriched in germ line and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and hif-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; Mianserin; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044415	C08E3.14
Is affected by rsr-2; dpy-21; and smn-1 based on tiling array and RNA-seq studies.

WB:WBGene00044416	C08E3.15
Is affected by several genes including skn-1; clk-1; and hpl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044417	C08F1.11
Is enriched in Z1; Z4; and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Mianserin; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044418	C08G5.7
Is enriched in several structures, including coelomocyte; head mesodermal cell; intestine; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by twelve chemicals including Ethanol; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044419	fbxc-17
Is affected by several genes including daf-2; clk-1; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044420	C50D2.10
Is enriched in Z1.p; Z4.a; germ line; intestine; and male distal tip cell based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; D-glucose; and metformin based on RNA-seq studies.

WB:WBGene00044421	D1007.18
Is enriched in OLL; PVD; and neurons based on tiling array studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Sirolimus; antimycin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00044423	F53F10.8
Is enriched in NSM; germ line; germline precursor cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sir-2.1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including hydrogen sulfide; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Putative transmembrane family 234 and Putative transmembrane family 234. Is an ortholog of human TMEM234 (transmembrane protein 234).

WB:WBGene00044424	F54D12.10
Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00044425	F54D12.11
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00044427	F56A6.5
Is enriched in NSM and pharynx based on RNA-seq and tiling array studies. Is affected by several genes including skn-1; eat-2; and adr-1 based on RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00044428	T01D1.7
Is affected by several genes including elt-2; hpl-2; and drh-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044429	T07H3.7
Is enriched in DA neuron; NSM; VA neuron; and intestine based on tiling array studies. Is affected by several genes including clk-1; aak-2; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044430	T23F4.5
Is affected by several genes including dpy-21; hpl-2; and smg-2 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00044431	mzt-1
Is enriched in AFD; PLM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; Mitotic-spindle organizing gamma-tubulin ring associated; and Mitotic-spindle organizing protein 1.

WB:WBGene00044432	W03G9.9
Is enriched in NSM based on tiling array studies. Is affected by several genes including eat-2; drh-3; and mir-34 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044433	W10C8.6
Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including D-glucose; Rifampin; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00044434	Y18H1A.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including manganese chloride; D-glucose; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044435	Y20F4.8
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Family of unknown function (DUF5641) and Domain of unknown function DUF5641.

WB:WBGene00044436	Y47G6A.31
Is enriched in DA neuron; VA neuron; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; fog-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ring finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type. Is an ortholog of human RNF4 (ring finger protein 4).

WB:WBGene00044437	Y47G6A.32
Is enriched in AFD; BAG; NSM; and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by ten chemicals including 1-methylnicotinamide; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MANEC domain and Seven cysteines, N-terminal.

WB:WBGene00044438	Y51F10.11
Is enriched in coelomocyte based on tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq studies. Is affected by seven chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Phosphorylation site; NICE-3 protein; and C1orf43.

WB:WBGene00044439	Y51H7C.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by four chemicals including D-glucose; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044440	adpr-1
Is affected by several genes including fog-2; lem-2; and emr-1 based on RNA-seq studies. Is affected by six chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: WD40/YVTN repeat-like-containing domain superfamily and WD40-repeat-containing domain superfamily. Is an ortholog of human WDTC1 (WD and tetratricopeptide repeats 1).

WB:WBGene00044441	Y119C1B.11
Is affected by several genes including eat-2; hpl-2; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by Psoralens and Sirolimus based on RNA-seq studies.

WB:WBGene00044442	T08A9.13
Is enriched in intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044443	ZC21.10
Is enriched in AVK; GABAergic neurons; coelomocyte; sensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Alovudine; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044444	F09G8.10
Is affected by several genes including daf-16; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044445	C02F5.14
Is enriched in PLM; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including 1-methylnicotinamide; nicotinic acid; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044446	C06G4.6
Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Tunicamycin; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00044447	ZK688.10
Is enriched in GABAergic neurons; excretory cell; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including tryptophan; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00044448	ZK783.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including hydrogen sulfide; manganese chloride; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00044449	fipr-20
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00044450	fipr-18
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sma-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00044451	fipr-19
Is affected by several genes including rrf-3; eat-2; and drh-3 based on RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00044452	Y102E9.5
Is enriched in body wall muscle cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Zidovudine; and allantoin based on RNA-seq studies.

WB:WBGene00044453	Y102E9.6
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including clk-1; hpl-2; and his-72 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Secreted clade V proteins and Secreted clade V protein.

WB:WBGene00044454	F27B3.8
Is enriched in NSM and pharyngeal muscle cell based on tiling array studies. Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00044455	F23F12.13
Is predicted to have transmembrane transporter activity. Human ortholog(s) of this gene are implicated in rheumatoid arthritis and systemic primary carnitine deficiency disease. Is an ortholog of human SLC22A14 (solute carrier family 22 member 14).

WB:WBGene00044457	C18H7.11
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including hydrogen sulfide; tryptophan; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00044458	K11H12.10
Is enriched in dopaminergic neurons based on tiling array studies. Is affected by several genes including elt-2; npr-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00044459	Y55F3C.9
Is enriched in Z1; Z4; body wall muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00044460	Y55F3C.10
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; csr-1; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srt and 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00044461	Y18H1A.14
Is predicted to have transferase activity, transferring glycosyl groups.

WB:WBGene00044462	C44B12.9
Is enriched in body wall muscle cell; cholinergic neurons; coelomocyte; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by allantoin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00044463	W09G12.10
Is enriched in OLL; PLM; PVD; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; 1-methylnicotinamide; and nicotinic acid based on RNA-seq and microarray studies.

WB:WBGene00044464	Y77E11A.16
Is enriched in neurons and ventral nerve cord based on tiling array studies. Is affected by several genes including elt-2; alg-1; and csr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srd and 7TM GPCR, serpentine receptor class d (Srd).

WB:WBGene00044466	Y48A5A.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and let-7 based on proteomic and RNA-seq studies. Is affected by hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in mitochondrial complex III deficiency nuclear type 7. Is an ortholog of human UQCC2 (ubiquinol-cytochrome c reductase complex assembly factor 2).

WB:WBGene00044467	R05C11.4
Is enriched in muscle cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-12; sek-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00044468	Y69A2AL.2
Is predicted to have calcium ion binding activity and carboxylic ester hydrolase activity. Is an ortholog of human PLA2G1B (phospholipase A2 group IB).

WB:WBGene00044469	clec-173
Is predicted to have carbohydrate binding activity.

WB:WBGene00044470	C09G12.17
Is affected by several genes including mex-1; hpl-2; and ubc-9 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044471	F56D6.9
Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; Tunicamycin; and indole based on RNA-seq and microarray studies.

WB:WBGene00044472	dct-8
Is enriched in hypodermis and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00044473	F56D6.11
Is affected by hpl-2; rsr-2; and clk-1 based on tiling array and microarray studies.

WB:WBGene00044474	F56D6.12
Is affected by several genes including daf-2; dpy-10; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; Hydrolyzable Tannins; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00044475	F56D6.13
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eighteen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00044476	F56D6.14
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00044477	F49F1.14
Is enriched in DA neuron; VA neuron; body wall muscle cell; head mesodermal cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by manganese chloride; multi-walled carbon nanotube; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00044478	K06B9.6
Is enriched in Z1; Z4; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and pgl-1 based on RNA-seq and microarray studies. Is affected by hydrogen sulfide; 4-bromodiphenyl ether; and Cry5B based on microarray studies.

WB:WBGene00044479	F15E6.10
Is enriched in arcade cell; cephalic sheath cell; dopaminergic neurons; germline precursor cell; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eleven chemicals including Ethanol; Rotenone; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00044480	ZK185.4
Is affected by several genes including daf-16; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Frag1/DRAM/Sfk1 family; Frag1/DRAM/Sfk1; and Post-GPI attachment to proteins factor 2.

WB:WBGene00044481	ZK185.5
Is predicted to have cadmium ion transmembrane transporter activity; ferrous iron transmembrane transporter activity; and zinc efflux active transmembrane transporter activity. Human ortholog(s) of this gene are implicated in type 2 diabetes mellitus.

WB:WBGene00044482	F29B9.12
Is enriched in AVK; DA neuron; VA neuron; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including pgl-1; mex-3; and mex-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044483	H06H21.11
Is enriched in AFD; AVK; NSM; germ line; and germline precursor cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and npr-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00044484	hot-9
Is enriched in neurons and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; skn-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans ly-6-related protein and Caenorhabditis elegans ly-6-related.

WB:WBGene00044485	Y54G2A.41
Is enriched in ASER; AVE; RIS; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; proteomic; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044486	Y54G2A.42
Is affected by several genes including daf-12; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00044487	Y54G2A.44
Is enriched in DA neuron; VA neuron; amphid sheath cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; mex-3; and csr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044488	Y54G2A.45
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Alpha/Beta hydrolase fold.

WB:WBGene00044489	pudl-1
Is expressed in head neurons and hyp7 syncytium. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00044490	pudl-2
Is expressed in hyp7 syncytium and pm5. Is predicted to encode a protein with the following domains: Up-Regulated in long-lived daf-2 and Up-regulated in Daf-2.

WB:WBGene00044491	Y54G2A.48
Is enriched in DA neuron; VA neuron; and body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Cisplatin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00044492	Y54G2A.49
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044493	Y54G2A.50
Is predicted to have DNA helicase activity.

WB:WBGene00044495	Y54G2A.40
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and pmk-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044498	Y59E9AR.10
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray studies. Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00044499	T11F8.5
Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Triclosan based on RNA-seq and microarray studies.

WB:WBGene00044500	T19E7.6
Is enriched in GABAergic neurons; excretory cell; muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; D-glucose; and stavudine based on RNA-seq studies.

WB:WBGene00044501	C55C3.8
Is predicted to have histone kinase activity (H3-T3 specific).

WB:WBGene00044502	C46G7.5
Is enriched in GABAergic neurons; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044503	Y73B6A.6
Is affected by several genes including clk-1; eat-2; and csr-1 based on microarray and RNA-seq studies. Is affected by five chemicals including 1-methylnicotinamide; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044504	R13A1.10
Is enriched in body wall muscle cell and intestine based on tiling array and microarray studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; antimycin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; Leucine-rich repeat domain superfamily; and F-box protein she-1-like.

WB:WBGene00044505	D2024.10
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including hpl-2; drh-3; and mir-34 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044508	nsy-7
Exhibits sequence-specific DNA binding activity. Is involved in determination of left/right asymmetry in nervous system and negative regulation of transcription by RNA polymerase II. Localizes to nucleus. Is expressed in amphid sensillum and intestine.

WB:WBGene00044509	K07H8.12
Is enriched in body wall muscle cell; coelomocyte; head mesodermal cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; sek-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by indole; paraquat; and resveratrol based on microarray and RNA-seq studies.

WB:WBGene00044510	K07H8.11
Is enriched in neurons based on tiling array studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00044511	clec-181
Is predicted to have carbohydrate binding activity.

WB:WBGene00044512	W03F9.11
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044513	nlp-70
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and sma-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Rotenone; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00044514	R09E12.9
Is enriched in PLM and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twenty-five chemicals including hydrogen sulfide; Ethanol; and tryptophan based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4440); Domain of unknown function DUF4440; and NTF2-like domain superfamily.

WB:WBGene00044515	K10C9.9
Is enriched in ASER and muscle cell based on RNA-seq studies. Is affected by several genes including rrf-3; dpy-7; and isp-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including tryptophan; Tunicamycin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00044516	Y32G9A.12
Is affected by several genes including clk-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044517	Y32G9A.13
Is affected by several genes including eat-2; hpl-2; and smg-2 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including Rotenone; stavudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044518	fipr-25
Is enriched in cephalic sheath cell and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-2; hpl-2; and mir-34 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044519	F59A7.11
Is affected by several genes including daf-2; hpl-2; and rsks-1 based on tiling array and microarray studies. Is affected by Mianserin and indole based on RNA-seq and microarray studies.

WB:WBGene00044520	F59A7.12
Is affected by several genes including pgl-1; bar-1; and alg-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044521	Y5H2A.4
Is enriched in DA neuron; VA neuron; body wall muscle cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by hydrogen sulfide; dafa#1; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044523	F37B4.14
Is affected by several genes including hpl-2; dop-1; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044524	Y73C8C.12
Is affected by hpl-2 and rsr-2 based on tiling array studies.

WB:WBGene00044525	Y73C8B.5
Is predicted to have calcium ion binding activity.

WB:WBGene00044526	T28A11.22
Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including hydrogen sulfide; Mianserin; and bisphenol S based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00044527	Y39H10B.2
Is enriched in several structures, including body wall muscle cell; excretory cell; intestine; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including manganese chloride; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00044528	lgc-29
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity. Is an ortholog of human HTR3A (5-hydroxytryptamine receptor 3A).

WB:WBGene00044529	irld-1
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including nicotinic acid; Mianserin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00044530	F32D1.11
Is enriched in PLM and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00044531	F13A2.9
Is enriched in Z1.p; Z4.a; cholinergic neurons; male distal tip cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on tiling array and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044532	T20F10.6
No description available

WB:WBGene00044533	F41F3.8
Is enriched in body wall muscle cell; germline precursor cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by ten chemicals including methylmercury hydroxide; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044534	H23N18.6
Is enriched in OLL; PVD; excretory cell; and ventral nerve cord based on tiling array studies. Is affected by several genes including skn-1; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including D-glucose; stavudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00044535	K11D12.13
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00044536	F14F9.8
Is enriched in NSM and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by ten chemicals including Tunicamycin; manganese chloride; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044537	B0238.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and metformin based on microarray and RNA-seq studies.

WB:WBGene00044538	T09D3.8
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and bar-1 based on RNA-seq and microarray studies. Is affected by four chemicals including D-glucose; Cry5B; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00044539	K09H11.9
Is affected by several genes including aak-2; mex-3; and hsp-6 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00044541	K09H11.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Alovudine; and Sodium Chloride based on RNA-seq studies.

WB:WBGene00044542	CD4.11
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including glp-1; rrf-3; and daf-12 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Sodium Chloride; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Concanavalin A-like lectin/glucanase domain superfamily and Vacuolar protein sorting-associated protein 37.

WB:WBGene00044543	C53A3.3
Is affected by clk-1; drh-3; and pmt-2 based on microarray and RNA-seq studies.

WB:WBGene00044544	F26F12.8
Is enriched in neurons and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044545	EGAP9.4
Is enriched in NSM and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-12; and elt-2 based on RNA-seq studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044546	T01C4.8
Is enriched in NSM based on tiling array studies. Is affected by rsr-2 and let-60 based on tiling array and microarray studies. Is affected by resveratrol based on microarray studies. Human ortholog(s) of this gene are implicated in schizophrenia. Is predicted to encode a protein with the following domain: Glycoside hydrolase superfamily.

WB:WBGene00044547	C13A2.12
Is predicted to have microtubule binding activity.

WB:WBGene00044548	cnc-9
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by Colistin and nitroguanidine based on microarray studies.

WB:WBGene00044549	clec-215
Is affected by hpl-2; dpy-21; and mir-34 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; C-type lectin-like/link domain superfamily; and C-type lectin fold.

WB:WBGene00044550	C50E3.15
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray studies. Is affected by Progesterone based on microarray studies. Is predicted to encode a protein with the following domains: C-type lectin-like/link domain superfamily and C-type lectin fold.

WB:WBGene00044551	ZK105.8
Is affected by several genes including daf-12; clk-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Alovudine and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00044552	Y97E10AR.8
Is predicted to have DNA binding activity.

WB:WBGene00044553	T23B12.11
Is enriched in head mesodermal cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044554	F41E6.15
Is enriched in germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Rotenone; bisphenol A; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044556	F38G1.3
Is enriched in DA neuron; PLM; VA neuron; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; dpy-7; and sek-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including D-glucose; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00044557	ZC13.10
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044558	F56C3.10
Is affected by clk-1 and drh-3 based on microarray and RNA-seq studies.

WB:WBGene00044559	ZK380.5
Is enriched in ASER; arcade cell; head mesodermal cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Hydrolyzable Tannins; Humic Substances; and paraquat based on microarray studies.

WB:WBGene00044560	C36C9.6
Is affected by several genes including eat-2; dpy-21; and spn-4 based on RNA-seq and microarray studies. Is affected by four chemicals including sodium arsenite; Rifampin; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044561	Y75D11A.6
Is affected by rsr-2; dpy-21; and klf-1 based on tiling array and RNA-seq studies.

WB:WBGene00044562	C14E2.7
Is enriched in neurons based on tiling array studies. Is affected by several genes including mex-3; mex-1; and unc-70 based on RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044563	T26C11.8
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044564	ZK813.6
Is enriched in intestine based on tiling array studies. Is affected by several genes including skn-1; clk-1; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including Mianserin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Kazal-type serine protease inhibitor domain; Kazal-type serine protease inhibitor domain; Kazal domain; and Kazal domain superfamily.

WB:WBGene00044565	F53B1.9
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by hpl-2; rsr-2; and adr-1 based on tiling array and RNA-seq studies. Is affected by hydrogen sulfide based on microarray studies.

WB:WBGene00044567	C46C11.4
Is affected by several genes including daf-2; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by nine chemicals including hydrogen sulfide; 1-methylnicotinamide; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00044568	ntc-1
Is expressed in neurons and ventral nerve cord.

WB:WBGene00044569	C25F6.8
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including Sodium Chloride; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044570	T22B7.8
Is enriched in ASER; intestine; and male-specific anatomical entity based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; sir-2.1; and lin-35 based on RNA-seq and microarray studies. Is affected by Cry5B and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00044571	C46F4.3
Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00044573	C15B12.9
Is affected by alg-1; adr-1; and mex-3 based on RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044574	F23G4.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and aak-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin; antimycin; and Cadmium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044575	F38B6.8
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-2; alg-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00044577	F43E12.1
No description available

WB:WBGene00044578	K01A12.4
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including hydrogen sulfide; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044579	C06E2.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on microarray; RNA-seq; and proteomic studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044580	C24A3.9
Is enriched in intestine based on RNA-seq studies. Is affected by rsr-2 and clk-1 based on tiling array and microarray studies.

WB:WBGene00044581	Y81B9A.4
Is affected by prg-1 and drh-3 based on tiling array and RNA-seq studies.

WB:WBGene00044582	B0222.11
Is enriched in ASER and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including multi-walled carbon nanotube; antimycin; and Cholestanol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00044583	F07G6.9
Is affected by mir-34 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044584	T03G11.9
Is enriched in GABAergic neurons and body wall muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; egl-5; and mex-3 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Rifampin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044585	C40H5.8
Is affected by several genes including daf-16; sir-2.1; and hpl-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044586	Y61A9LA.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044587	srz-105
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on tiling array and RNA-seq studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00044588	ZK1236.9
Is enriched in AFD; AVK; and intestine based on RNA-seq and microarray studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by allantoin; Sirolimus; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00044589	C29F5.8
Is enriched in dopaminergic neurons and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-21; and drh-3 based on tiling array; RNA-seq; and microarray studies. Is affected by glycine based on RNA-seq studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: DOMON domain and DOMON domain.

WB:WBGene00044602	C31B8.16
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00044603	acbp-7
Is predicted to have fatty-acyl-CoA binding activity.

WB:WBGene00044604	T10F2.5
Is enriched in AFD; OLL; PVD; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; hpl-2; and mir-34 based on RNA-seq and microarray studies. Is affected by eight chemicals including hydrogen sulfide; Rotenone; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Sedlin, N-terminal conserved region; Trafficking protein particle complex subunit 2; and Longin-like domain superfamily. Is an ortholog of human TRAPPC2L (trafficking protein particle complex 2 like).

WB:WBGene00044605	ttr-36
Is enriched in body wall muscle cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; RNA-seq; and microarray studies. Is affected by fourteen chemicals including hydrogen sulfide; Rotenone; and D-glucopyranose based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00044606	T07G12.14
Is affected by several genes including eat-2; pgl-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00044607	K02A11.4
Is enriched in OLL; PVD; intestine; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Rotenone; procyanidin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Saposin-like.

WB:WBGene00044608	glrx-22
Is predicted to have electron transfer activity and protein disulfide oxidoreductase activity. Is an ortholog of human GLRX2 (glutaredoxin 2).

WB:WBGene00044609	tbcc-1
Is enriched in germ line; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and lin-28 based on tiling array and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies. Human TBCC exhibits GTPase activity. Is predicted to encode a protein with the following domains: Tubulin binding cofactor C; Tubulin binding cofactor C-like domain; Cyclase-associated protein CAP/septum formation inhibitor MinC, C-terminal; and Tubulin-specific chaperone C. Is an ortholog of human TBCC (tubulin folding cofactor C).

WB:WBGene00044610	D2092.10
Is enriched in neurons based on tiling array studies. Is affected by clk-1 based on microarray studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00044611	T27A3.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including tryptophan; D-glucose; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00044612	Y57E12AR.1
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00044614	C36B1.14
Is predicted to have PDZ domain binding activity and microtubule binding activity. Is an ortholog of human CRIPT (CXXC repeat containing interactor of PDZ3 domain).

WB:WBGene00044615	B0252.8
Is enriched in GABAergic neurons; OLL; PVD; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Rotenone; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00044616	M01A12.4
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00044617	bus-1
Is predicted to have transferase activity, transferring acyl groups other than amino-acyl groups. Is involved in morphogenesis of an epithelium. Localizes to membrane. Is expressed in F cell; K cell; and U cell.

WB:WBGene00044618	bus-2
Is predicted to have UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; acetylgalactosaminyltransferase activity; and acetylglucosaminyltransferase activity. Is expressed in head muscle; intestine; seam cell; and spermatheca. Human ortholog(s) of this gene are implicated in congenital muscular dystrophy-dystroglycanopathy type A11. Is an ortholog of human B3GNT3 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3); B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5); and B3GNT6 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6).

WB:WBGene00044619	bus-3
No description available

WB:WBGene00044620	bus-4
Is predicted to have glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity. Is expressed in intestine; pharynx; and seam cell. Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00044621	bus-5
No description available

WB:WBGene00044622	bus-6
No description available

WB:WBGene00044623	bus-8
Is predicted to have alpha-1,3-mannosyltransferase activity. Is expressed in seam cell.

WB:WBGene00044624	bus-10
No description available

WB:WBGene00044626	bus-13
No description available

WB:WBGene00044627	bus-14
No description available

WB:WBGene00044628	bus-15
No description available

WB:WBGene00044629	bus-16
No description available

WB:WBGene00044630	bus-17
Is predicted to have UDP-galactosyltransferase activity; acetylgalactosaminyltransferase activity; and acetylglucosaminyltransferase activity. Is an ortholog of human B3GNT6 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6).

WB:WBGene00044631	bus-18
Exhibits transferase activity, transferring acyl groups. Is involved in morphogenesis of an epithelium and phosphatidylinositol metabolic process. Localizes to endoplasmic reticulum. Is expressed in several structures, including AIY; excretory gland cell; hypodermis; interfacial epithelial cell; and vulva. Is an ortholog of human LCLAT1 (lysocardiolipin acyltransferase 1).

WB:WBGene00044632	Y73F8A.37
Is affected by clk-1; smg-2; and dlc-1 based on microarray and RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00044633	F54H12.7
Is enriched in germ line; intestine; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including Tunicamycin; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00044634	C29E4.14
Is predicted to have calcium ion binding activity. Is an ortholog of human MCFD2 (multiple coagulation factor deficiency 2, ER cargo receptor complex subunit).

WB:WBGene00044636	B0393.9
Is enriched in coelomocyte; germ line; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including tryptophan; manganese chloride; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00044637	rft-1
Exhibits riboflavin transmembrane transporter activity. Is involved in embryo development. Human ortholog(s) of this gene are implicated in Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. Is an ortholog of human SLC52A2 (solute carrier family 52 member 2) and SLC52A3 (solute carrier family 52 member 3).

WB:WBGene00044638	F23A7.8
Is enriched in Psub1; germ line; germline precursor cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including hydrogen sulfide; Rotenone; and manganese chloride based on microarray and RNA-seq studies.

WB:WBGene00044639	C24H12.12
Is affected by several genes including eat-2; pgl-1; and dpy-21 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including indole; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044640	B0432.14
Is enriched in head mesodermal cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq; tiling array; and microarray studies. Is affected by Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044641	T01D1.8
Is enriched in AFD and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and lin-4 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044642	clec-69
Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by seventeen chemicals including Rotenone; D-glucose; and sesamin based on RNA-seq and microarray studies.

WB:WBGene00044643	H17B01.5
Is enriched in ASER; RIS; dopaminergic neurons; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; aak-2; and mex-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044644	B0205.13
Is enriched in AFD; hypodermis; intestine; and mechanosensory neurons based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on proteomic; RNA-seq; microarray; and tiling array studies. Is affected by twenty-three chemicals including hydrogen sulfide; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00044645	Y51H7BR.8
Is affected by several genes including mex-3; dpy-21; and spn-4 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044646	B0205.14
Is enriched in coelomocyte; dopaminergic neurons; and ventral nerve cord based on tiling array studies. Is affected by several genes including glp-1; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including tryptophan; methylmercury hydroxide; and Tunicamycin based on microarray and RNA-seq studies.

WB:WBGene00044648	R144.13
Is predicted to have ubiquinone binding activity. Is an ortholog of human COQ10A (coenzyme Q10A).

WB:WBGene00044649	C23H5.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044650	Y71G10AR.4
Is enriched in germ line; hypodermis; and neurons based on proteomic; microarray; tiling array; and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and aak-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Sodium Bile acid symporter family; Bile acid:sodium symporter/arsenical resistance protein  Acr3; Bile acid:sodium symporter; and Sodium/solute  symporter  superfamily. Is an ortholog of human SLC10A3 (solute carrier family 10 member 3) and SLC10A5 (solute carrier family 10 member 5).

WB:WBGene00044651	egrh-3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sma-2 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00044652	apo-5
No description available

WB:WBGene00044653	T13F3.9
Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00044654	fbxa-85
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq; tiling array; and microarray studies. Is affected by Tunicamycin and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00044655	fbxa-194
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and pgl-1 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; HTH domain in Mos1 transposase; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00044657	K10G4.11
No description available

WB:WBGene00044658	C01G10.17
Is enriched in arcade cell; male-specific anatomical entity; neurons; pharyngeal muscle cell; and pharyngeal-intestinal valve cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including Tunicamycin; D-glucose; and bisphenol A based on microarray and RNA-seq studies.

WB:WBGene00044659	fbxa-142
Is enriched in AVA based on tiling array studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00044660	fbxa-87
Is affected by several genes including daf-2; glp-1; and eat-2 based on RNA-seq studies. Is affected by four chemicals including 1-methylnicotinamide; stavudine; and Sodium Chloride based on RNA-seq studies.

WB:WBGene00044661	fbxa-143
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Tunicamycin; and antimycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00044662	F26G1.9
Is enriched in PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including methylmercury hydroxide; D-glucose; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00044663	F26G1.10
Is enriched in PLM; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Transthyretin-like.

WB:WBGene00044664	F59A6.11
Is affected by several genes including eat-2; sir-2.1; and lin-39 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including Ethanol; tryptophan; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00044665	F59A6.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including hydrogen sulfide; Zidovudine; and metformin based on microarray and RNA-seq studies.

WB:WBGene00044666	F33G12.7
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; let-7; and gld-1 based on RNA-seq; proteomic; and microarray studies. Is affected by four chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00044667	ZK622.5
Is enriched in DA neuron; VA neuron; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and isp-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00044668	C18A3.11
Is affected by rsr-2 and spn-4 based on tiling array and RNA-seq studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00044670	rac-3
Is affected by several genes including let-60; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Alovudine and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044672	fbxa-4
Is enriched in intestine based on tiling array and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including antimycin; R24; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00044673	C07D10.6
Is enriched in AVA based on tiling array studies. Is affected by several genes including mex-3; mex-1; and hpl-2 based on microarray and RNA-seq studies. Is affected by Mianserin based on RNA-seq studies.

WB:WBGene00044674	B0280.17
Is predicted to have RNA binding activity.

WB:WBGene00044675	fbxa-76
Is enriched in OLL; PVD; Z1; Z4; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-12; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00044676	fbxa-42
Is enriched in AVE based on tiling array studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including multi-walled carbon nanotube; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00044677	ZK353.10
Is enriched in arcade cell; head mesodermal cell; neurons; and pharyngeal-intestinal valve cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; lin-39; and pgl-1 based on microarray; RNA-seq; and tiling array studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044678	B0303.16
Is affected by several genes including aak-2; drh-3; and aak-1 based on tiling array and RNA-seq studies.

WB:WBGene00044679	K02B12.9
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including rrf-3; alg-1; and atfs-1 based on RNA-seq and microarray studies.

WB:WBGene00044680	F30A10.13
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; rrf-3; and lin-4 based on RNA-seq and microarray studies. Is affected by eleven chemicals including manganese chloride; Mianserin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044681	T24C4.8
Is enriched in intestine and pharyngeal muscle cell based on tiling array and microarray studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00044683	C36E6.8
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Ethanol; nicotinic acid; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00044684	T08G11.2
Is enriched in germ line and in male based on proteomic and RNA-seq studies. Is affected by several genes including daf-2; age-1; and daf-12 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; methylmercuric chloride; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044685	gla-1
No description available

WB:WBGene00044686	flp-28
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044687	B0563.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including Tunicamycin; multi-walled carbon nanotube; and nanoparticle based on RNA-seq and microarray studies.

WB:WBGene00044689	arid-1
Is predicted to have DNA binding activity. Is an ortholog of human ARID4B (AT-rich interaction domain 4B).

WB:WBGene00044690	M02B7.7
Is enriched in body wall muscle cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and alg-1 based on RNA-seq; microarray; and proteomic studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Protein POLR1D, isoform 2-like.

WB:WBGene00044691	F47C12.11
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by hpl-2; ubc-9; and dlc-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044692	fbxb-91
Is enriched in NSM; hypodermis; intestine; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00044693	fbxb-92
Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including indole; Alovudine; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00044694	fbxb-90
Is affected by several genes including daf-2; eat-2; and sek-1 based on tiling array; microarray; and RNA-seq studies. Is affected by twelve chemicals including hydrogen sulfide; Rotenone; and Mianserin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00044695	fbxb-27
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044696	F52E1.14
Is enriched in OLL; PVD; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by twenty-one chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00044697	poml-4
Is predicted to have arylesterase activity. Is an ortholog of human PON2 (paraoxonase 2) and PON3 (paraoxonase 3).

WB:WBGene00044698	K09F5.6
Is enriched in body wall muscle cell; head mesodermal cell; neurons; and retrovesicular ganglion based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; Rotenone; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044699	nhr-286
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00044700	T08D2.9
Is affected by several genes including daf-2; pgl-1; and prg-1 based on RNA-seq studies.

WB:WBGene00044701	AH9.6
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Sodium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044702	F46C3.4
Is enriched in RID and germ line based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00044703	F46C3.5
Is affected by several genes including daf-2; let-418; and chd-3 based on RNA-seq and microarray studies. Is affected by 1-methylnicotinamide based on RNA-seq studies.

WB:WBGene00044704	C18A3.12
Is affected by daf-12 and prg-1 based on tiling array and RNA-seq studies.

WB:WBGene00044705	T22F3.12
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Is an ortholog of human PPIAL4A (peptidylprolyl isomerase A like 4A); PPIAL4D (peptidylprolyl isomerase A like 4D); and PPIL6 (peptidylprolyl isomerase like 6).

WB:WBGene00044706	Y26D4A.15
Is affected by dpy-21 and rrf-1 based on RNA-seq and microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00044707	pals-15
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044708	pals-11
Is affected by several genes including skn-1; rrf-3; and elt-2 based on microarray; tiling array; and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044709	pals-12
Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044710	Y26D4A.16
No description available

WB:WBGene00044711	pals-10
Is affected by several genes including skn-1; elt-2; and bar-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00044712	F22G12.8
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00044713	ZK1225.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00044714	ZK1225.10
Is affected by clk-1 and sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00044716	ZK1225.12
No description available

WB:WBGene00044718	T20D4.20
Is enriched in NSM and body wall muscle cell based on tiling array studies. Is affected by several genes including daf-16; rrf-3; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including Tunicamycin; resveratrol; and Atrazine based on microarray studies.

WB:WBGene00044719	clec-172
Is predicted to have carbohydrate binding activity. Is involved in defense response to Gram-positive bacterium.

WB:WBGene00044720	metl-2
Is predicted to have tRNA (cytosine-3-)-methyltransferase activity. Is an ortholog of human METTL2A (methyltransferase like 2A) and METTL2B (methyltransferase like 2B).

WB:WBGene00044722	C17H1.12
Is affected by daf-2 and ints-2 based on microarray and RNA-seq studies.

WB:WBGene00044723	K11H12.11
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including D-glucopyranose; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00044724	R02E4.3
Is enriched in several structures, including GABAergic neurons; PLM; carbon dioxide sensory neurons; excretory cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including Ethanol; 1-methylnicotinamide; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00044725	R11G1.7
Is enriched in Z1; Z4; dopaminergic neurons; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including hydrogen sulfide; 1-methylnicotinamide; and Mianserin based on microarray and RNA-seq studies.

WB:WBGene00044726	Y53F4B.43
Is predicted to have fucosyltransferase activity.

WB:WBGene00044727	Y53F4B.44
Is affected by eat-2 based on microarray studies.

WB:WBGene00044728	Y53F4B.45
Is enriched in head mesodermal cell; muscle cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray; tiling array; and RNA-seq studies. Is affected by thirteen chemicals including 4-bromodiphenyl ether; tert-Butylhydroperoxide; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00044729	Y53F4B.46
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00044731	eat-1
Is involved in regulation of growth.

WB:WBGene00044732	T03G11.10
Is enriched in AFD; ASER; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray; tiling array; and RNA-seq studies. Is affected by eleven chemicals including Mianserin; multi-walled carbon nanotube; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044733	W08F4.13
Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated; F-box domain; F-box domain; and F-box associated domain, type 2.

WB:WBGene00044734	Y19D10A.16
Is predicted to have aldose 1-epimerase activity. Is an ortholog of human GALM (galactose mutarotase).

WB:WBGene00044735	Y19D10A.17
Is enriched in muscle cell based on microarray studies. Is affected by tetrabromobisphenol A based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044736	gfrp-1
Is predicted to have GTP cyclohydrolase binding activity. Is expressed in head; hyp7 syncytium; hypodermis; and neurons. Is an ortholog of human GCHFR (GTP cyclohydrolase I feedback regulator).

WB:WBGene00044737	ttr-45
Is enriched in amphid sheath cell; head mesodermal cell; hypodermis; intestine; and muscle cell based on tiling array; RNA-seq; and proteomic studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq; proteomic; tiling array; and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00044738	folt-3
Is predicted to have folic acid binding activity and vitamin transmembrane transporter activity. Human ortholog(s) of this gene are implicated in biotin-responsive basal ganglia disease and thiamine-responsive megaloblastic anemia syndrome. Is an ortholog of human SLC19A1 (solute carrier family 19 member 1); SLC19A2 (solute carrier family 19 member 2); and SLC19A3 (solute carrier family 19 member 3).

WB:WBGene00044739	F54G8.6
Is affected by dpy-21 and adr-1 based on RNA-seq studies.

WB:WBGene00044741	Y57G11C.52
Is enriched in ventral nerve cord and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00044742	Y55F3BR.10
Is enriched in AVA; AVK; germ line; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq; microarray; and tiling array studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044743	crb-3
Is expressed in several structures, including excretory canal; intestinal cell; rectal epithelium; somatic nervous system; and uterus.

WB:WBGene00044744	F10G7.12
Is enriched in germ line; neurons; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00044745	Y62E10A.20
Is predicted to have ribosome binding activity. Is an ortholog of human MAIP1 (matrix AAA peptidase interacting protein 1).

WB:WBGene00044746	C53H9.3
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by four chemicals including hydrogen sulfide; D-glucose; and Rifampin based on microarray and RNA-seq studies.

WB:WBGene00044747	ZK1005.2
No description available

WB:WBGene00044748	ZK402.6
Is affected by Testosterone based on microarray studies.

WB:WBGene00044749	W01C8.8
Is affected by daf-12 and sir-2.1 based on tiling array and microarray studies.

WB:WBGene00044750	Y39D8C.2
No description available

WB:WBGene00044751	F14D2.16
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00044752	Y73B6BL.45
Is affected by mir-34 and drh-3 based on microarray and RNA-seq studies.

WB:WBGene00044753	F49H12.7
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including skn-1; hpl-2; and mir-71 based on RNA-seq; tiling array; and microarray studies. Is affected by six chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00044754	Y119C1B.12
Is affected by several genes including rrf-3; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044755	C32D5.14
Is affected by several genes including daf-12; mex-3; and rsr-2 based on tiling array and RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00044756	F58F12.4
Is enriched in PLM; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00044757	Y55F3BR.11
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; multi-walled carbon nanotube; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00044758	Y37H2A.12
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Rotenone; manganese chloride; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: HTH domain in Mos1 transposase; F-box domain; F-box domain; and Mos1 transposase, HTH domain.

WB:WBGene00044759	T06E6.15
Is enriched in neurons and seam cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00044760	Y71H2AM.25
Is predicted to have cysteine-type endopeptidase activity. Human ortholog(s) of this gene are implicated in neuronal ceroid lipofuscinosis 13; pycnodysostosis; and tooth disease (multiple). Is an ortholog of human CTSK (cathepsin K).

WB:WBGene00044761	pals-19
Is enriched in several structures, including dopaminergic neurons; head mesodermal cell; intestine; pharyngeal muscle cell; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies.

WB:WBGene00044762	ZK688.11
Is enriched in AFD; germ line; and neurons based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; hpl-2; and hlh-30 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044763	ZK688.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; D-glucose; and levamisole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MSP (Major sperm protein) domain; Major sperm protein (MSP) domain; PapD-like superfamily; and Immunoglobulin-like fold.

WB:WBGene00044764	W01A8.7
Is affected by several genes including alg-1; smg-2; and ubc-9 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044765	C17B7.13
No description available

WB:WBGene00044766	Y55F3C.11
No description available

WB:WBGene00044767	T23B7.3
Is enriched in intestine and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00044768	M117.7
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044769	C17E4.12
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Colistin and Triclosan based on microarray studies.

WB:WBGene00044770	C53C11.5
Is enriched in several structures, including AVK; GABAergic neurons; cephalic sheath cell; head mesodermal cell; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including 1-methylnicotinamide; bisphenol S; and Zidovudine based on RNA-seq studies.

WB:WBGene00044771	tmem-218
Is involved in non-motile cilium assembly. Localizes to ciliary transition zone. Is expressed in amphid neurons and phasmid neurons.

WB:WBGene00044772	T23E7.6
Is enriched in hypodermis and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq; tiling array; and microarray studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00044773	C08A9.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by eleven chemicals including Ethanol; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chromadorea ALT protein and Chromadorea ALT.

WB:WBGene00044774	F16B3.3
Is enriched in muscle cell and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including rrf-3; hsf-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044775	ZK1290.15
Is affected by daf-12; prg-1; and clk-1 based on tiling array and microarray studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00044776	T02B11.8
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Granulin; Granulin; Granulin superfamily; and Granulin family.

WB:WBGene00044777	T02B11.9
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and hsf-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including manganese chloride; D-glucose; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044778	K09C6.10
Is affected by rsr-2; pgrn-1; and drh-3 based on tiling array and RNA-seq studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00044779	T10H9.8
Is enriched in dopaminergic neurons; germline precursor cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: EF-hand domain pair.

WB:WBGene00044780	F18E9.8
Is enriched in neurons based on tiling array studies. Is affected by several genes including let-60; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044781	Y53H1A.6
Is affected by dpy-21 based on RNA-seq studies. Is affected by Sirolimus and allantoin based on microarray studies.

WB:WBGene00044782	F41D3.13
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00044783	T26H5.10
Is enriched in GABAergic neurons; OLL; PVD; intestine; and ventral nerve cord based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fifteen chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044784	F13H10.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domains: Small subunit of serine palmitoyltransferase-like and Small subunit of serine palmitoyltransferase-like. Is an ortholog of human SPTSSA (serine palmitoyltransferase small subunit A).

WB:WBGene00044786	ZK1053.7
Is affected by rsr-2; dpy-21; and adr-1 based on tiling array and RNA-seq studies.

WB:WBGene00044787	pals-36
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044788	ttr-38
Is enriched in excretory cell and hypodermis based on tiling array studies. Is affected by several genes including eat-2; npr-1; and dpy-7 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Tunicamycin; Zidovudine; and Sodium Chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00044789	T07A9.14
Is predicted to be a structural constituent of ribosome. Human ortholog(s) of this gene are implicated in Diamond-Blackfan anemia.

WB:WBGene00044790	clec-224
Is predicted to have carbohydrate binding activity.

WB:WBGene00044791	bnc-1
Is expressed in cholinergic neurons and in male. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; Zinc finger C2H2 superfamily; and Protein disconnected-like. Is an ortholog of human BNC1 (basonuclin 1) and BNC2 (basonuclin 2).

WB:WBGene00044792	F59C6.14
Is enriched in OLL; PVD; head mesodermal cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00044794	Y59A8B.25
Is predicted to have soluble NSF attachment protein activity and syntaxin binding activity. Is an ortholog of human NAPG (NSF attachment protein gamma).

WB:WBGene00044795	C06H5.8
Is predicted to have transcription coregulator activity.

WB:WBGene00044796	W03D8.11
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including methylmercury hydroxide; manganese chloride; and levamisole based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044797	F13E9.13
Is predicted to have catalytic activity.

WB:WBGene00044798	tbx-43
Is predicted to have DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II activating transcription factor binding activity; and RNA polymerase II regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in several diseases, including X-linked cleft palate with or without ankyloglossia; adrenocorticotropic hormone deficiency; and dysostosis (multiple). Is an ortholog of human EOMES (eomesodermin) and TBR1 (T-box brain transcription factor 1).

WB:WBGene00044799	ZK686.6
Is enriched in DA neuron; VA neuron; and intestine based on tiling array and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00044800	C56A3.9
Is affected by dpy-7 and eat-2 based on RNA-seq studies. Is affected by six chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044801	ZC262.9
Is affected by several genes including clk-1; bar-1; and lem-2 based on RNA-seq and microarray studies. Is affected by methylmercury hydroxide and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00044802	ZC262.10
Is affected by several genes including lem-2; nhl-2; and emr-1 based on RNA-seq and microarray studies. Is affected by methylmercury hydroxide based on RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00044803	C02G6.3
Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array and RNA-seq studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00044804	ZK938.8
Is affected by daf-16 and smn-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00044805	Y53C10A.15
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity.

WB:WBGene00044806	T19H5.5
No description available

WB:WBGene00044807	T19H5.6
Is predicted to have chitin binding activity. Human ortholog(s) of this gene are implicated in schizophrenia.

WB:WBGene00044808	Y39A1A.25
Is affected by daf-16 and dlc-1 based on RNA-seq studies.

WB:WBGene00044809	M04F3.6
Is affected by several genes including daf-2; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Humic Substances; paraquat; and Sirolimus based on microarray studies.

WB:WBGene00044810	Y37E3.19
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044811	F12E12.11
Is enriched in several structures, including amphid sheath cell; carbon dioxide sensory neurons; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including tryptophan; Rotenone; and Tunicamycin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13. Is predicted to encode a protein with the following domains: Enoyl-(Acyl carrier protein) reductase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human HSD17B14 (hydroxysteroid 17-beta dehydrogenase 14).

WB:WBGene00044889	T10D4.14
Is affected by rsr-2 and dpy-21 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00044891	T07C4.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including aak-2; smg-2; and aak-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Mianserin; stavudine; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: COMM domain and COMM domain.

WB:WBGene00044892	clec-257
Is predicted to have carbohydrate binding activity.

WB:WBGene00044893	mig-33
No description available

WB:WBGene00044894	Y71F9AR.4
Is enriched in several structures, including arcade cell; germ line; germline precursor cell; pharyngeal-intestinal valve cell; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on microarray; tiling array; and RNA-seq studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00044895	R06A10.5
Is enriched in DA neuron; VA neuron; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by Colistin based on microarray studies.

WB:WBGene00044896	K12C11.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; Sirolimus; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00044897	M01D7.9
Is predicted to have single-stranded RNA binding activity.

WB:WBGene00044898	let-383
Is enriched in germline precursor cell; hypodermis; intestine; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00044900	cnc-11
Is involved in defense response to fungus and innate immune response.

WB:WBGene00044901	Y41G9A.10
Is enriched in dopaminergic neurons; excretory cell; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Rotenone; Tunicamycin; and juglone based on RNA-seq and microarray studies.

WB:WBGene00044902	Y19D10A.18
Is affected by dpy-21 based on RNA-seq studies. Is affected by tetrabromobisphenol A and dafa#1 based on microarray studies.

WB:WBGene00044903	K03H1.13
Is predicted to have kinase activity. Is an ortholog of human FPGT (fucose-1-phosphate guanylyltransferase).

WB:WBGene00044905	T26E3.11
Is affected by several genes including daf-2; eat-2; and let-418 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00044906	Y67A10A.11
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by hpl-2 and adr-1 based on RNA-seq studies. Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044907	K08E7.10
Is affected by clk-1; daf-16; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00044908	F38A1.15
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and mex-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and Concanavalin A-like lectin/glucanase domain superfamily.

WB:WBGene00044909	C48D1.7
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00044911	H38K22.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and aak-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including D-glucose; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00044912	H38K22.7
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including sir-2.1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Sodium Chloride; Cry5B; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00044914	T11B7.6
No description available

WB:WBGene00044916	F40F8.11
Is predicted to have RNA binding activity.

WB:WBGene00044917	F40F8.12
Is enriched in GABAergic neurons; ciliated neurons; intestine; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Mianserin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00044918	mig-27
No description available

WB:WBGene00044920	F20G2.7
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00044921	F53C11.9
Is enriched in body wall muscle cell; cephalic sheath cell; and dopaminergic neurons based on tiling array studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00044922	Y43C5A.7
Is enriched in head mesodermal cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including manganese chloride; D-glucose; and bisphenol A based on RNA-seq studies.

WB:WBGene00044923	T27E4.10
Is affected by several genes including daf-12; dpy-21; and dlc-1 based on tiling array and RNA-seq studies.

WB:WBGene00044924	M106.7
Is predicted to have catalytic activity and nucleotide binding activity. Is an ortholog of human CRCP (CGRP receptor component).

WB:WBGene00044925	Y37E3.20
Is affected by several genes including ptl-1; dlc-1; and hda-6 based on RNA-seq studies.

WB:WBGene00044926	Y39G10AR.24
No description available

WB:WBGene00044927	F32B5.9
Is affected by several genes including pgl-1; cep-1; and glh-1 based on tiling array and RNA-seq studies.

WB:WBGene00044928	Y71F9AM.7
Is affected by hpl-2 and clk-1 based on tiling array and microarray studies.

WB:WBGene00044929	R12E2.17
Is affected by daf-12 based on tiling array studies.

WB:WBGene00044930	T19B4.8
Is affected by several genes including prg-1; meg-3; and rsr-2 based on RNA-seq studies.

WB:WBGene00044931	Y37E3.21
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00044932	Y37E3.22
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044933	ZK484.9
Is affected by daf-2 and mys-1 based on RNA-seq studies.

WB:WBGene00044934	T27A3.9
Is affected by several genes including daf-2; prg-1; and ptl-1 based on RNA-seq studies.

WB:WBGene00044935	T08B2.13
Is affected by daf-12; hpl-2; and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00044936	T24H7.6
Is affected by several genes including daf-12; hpl-2; and dlc-1 based on tiling array and RNA-seq studies.

WB:WBGene00044937	ZK546.18
Is affected by daf-12; cep-1; and nhr-86 based on tiling array and RNA-seq studies.

WB:WBGene00044938	C27H5.9
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00044939	B0412.7
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00044940	H06I04.8
Is affected by several genes including daf-12; pgl-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00044941	F54E7.10
Is affected by several genes including daf-12; clk-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00044942	F54E7.11
Is affected by several genes including daf-12; clk-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00044943	R151.12
Is affected by hpl-2 based on tiling array and RNA-seq studies.

WB:WBGene00044944	R151.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00044945	C07H6.10
Is affected by several genes including daf-12; clk-1; and pgl-1 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044946	C03B8.5
Is affected by daf-12 and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00044947	F32E10.10
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00044948	K11H12.12
Is affected by several genes including daf-12; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00044949	Y49A10A.2
Is enriched in germ line and neurons based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including 1-methylnicotinamide; bisphenol S; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00044951	2RSSE.3
Is affected by several genes including daf-16; sek-1; and pgl-1 based on RNA-seq studies.

WB:WBGene00044952	Y24D9A.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and prg-1 based on RNA-seq and microarray studies. Is affected by bisphenol A and glycine based on RNA-seq studies.

WB:WBGene00044953	D2096.13
Is affected by several genes including eat-2; hpl-2; and nhl-2 based on microarray; tiling array; and RNA-seq studies. Is affected by ten chemicals including Rotenone; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044954	D2096.14
Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00044955	K07C11.11
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00044956	K07C11.12
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00044957	C08D8.3
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00044958	ZK994.7
Is affected by hpl-2 based on tiling array studies.

WB:WBGene00044959	mig-34
No description available

WB:WBGene00044960	fbxa-173
Is affected by several genes including clk-1; dpy-21; and hpl-2 based on microarray and RNA-seq studies.

WB:WBGene00044961	F56A12.5
Is affected by several genes including daf-2; dpy-21; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00044962	F28D1.13
Is affected by several genes including daf-12; pgl-1; and glh-1 based on tiling array and RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00044963	K07C5.11
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00044964	F22D6.16
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00044965	smy-6
Is affected by daf-2 based on microarray studies.

WB:WBGene00044966	smy-12
No description available

WB:WBGene00044967	smy-9
Is affected by hpl-2; clk-1; and daf-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00044968	K10H10.11
Is affected by hda-6 and ptl-1 based on RNA-seq studies.

WB:WBGene00044969	T28D6.10
Is affected by ifo-1 based on microarray studies.

WB:WBGene00044970	F38E11.14
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00044971	C15H11.12
Is affected by several genes including daf-2; eat-2; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00044972	F35E12.11
Is affected by several genes including daf-2; alg-1; and hpl-2 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00044973	F08G2.12
Is affected by daf-2 and sir-2.1 based on microarray studies. Is affected by Ethanol and resveratrol based on microarray studies.

WB:WBGene00044974	C27H6.5
Is affected by rsr-2; daf-2; and ptrn-1 based on RNA-seq studies.

WB:WBGene00044975	F47G4.9
Is affected by hpl-2 based on tiling array studies.

WB:WBGene00044976	T26H2.10
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; stavudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00044977	F56C4.4
Is enriched in ASER; coelomocyte; dopaminergic neurons; germ line; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and dpy-10 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including bisphenol S; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044978	F58D2.3
Is affected by several genes including daf-2; eat-2; and lin-54 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Armadillo-type fold.

WB:WBGene00044979	Y41E3.19
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; D-glucose; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044980	B0399.3
No description available

WB:WBGene00044981	D2013.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00044982	C01A2.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00044983	T04B2.9
No description available

WB:WBGene00044984	C27C7.9
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00044985	F37B12.5
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00044986	C34E7.5
No description available

WB:WBGene00044987	K07A1.17
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00044988	W01A8.8
Is predicted to have hormone activity. Is an ortholog of human STC1 (stanniocalcin 1) and STC2 (stanniocalcin 2).

WB:WBGene00044989	Y37A1B.17
Is predicted to have Rho guanyl-nucleotide exchange factor activity. Is an ortholog of human DNMBP (dynamin binding protein).

WB:WBGene00044990	T25B9.11
Is enriched in amphid sheath cell and intestine based on RNA-seq studies. Is affected by several genes including glp-1; daf-12; and dpy-10 based on tiling array; microarray; and RNA-seq studies. Is affected by fourteen chemicals including tryptophan; Rotenone; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00044991	T25B9.12
Is enriched in amphid sheath cell and intestine based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and ifo-1 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00044992	rax-2
No description available

WB:WBGene00044994	rax-4
No description available

WB:WBGene00044995	Y105C5A.28
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and dpy-21 based on RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00044997	nspd-11
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00044998	M199.9
Is enriched in cephalic sheath cell based on tiling array studies. Is affected by several genes including daf-2; sek-1; and fog-2 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; bisphenol A; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045000	Y41E3.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00045002	F44D12.12
No description available

WB:WBGene00045003	F38A1.16
No description available

WB:WBGene00045006	R05A10.10
No description available

WB:WBGene00045007	K01G12.4
No description available

WB:WBGene00045009	M117.8
Is affected by clk-1 based on microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045011	T27E7.11
No description available

WB:WBGene00045012	K08F4.13
Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies.

WB:WBGene00045013	F08A7.1
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045016	Y105C5A.30
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00045017	F36H1.13
No description available

WB:WBGene00045018	Y40H7A.14
No description available

WB:WBGene00045019	Y37A1B.18
Is affected by several genes including daf-16; dpy-10; and clk-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including multi-walled carbon nanotube; Quercetin; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00045022	K04D7.7
No description available

WB:WBGene00045024	C43F9.11
Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00045025	Y73F8A.39
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00045026	Y7A9C.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00045027	Y105C5A.31
Is affected by chd-3; let-418; and eat-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00045028	C35D6.11
No description available

WB:WBGene00045029	Y57G11C.54
Is affected by clk-1 based on microarray studies.

WB:WBGene00045036	K08E4.7
Is enriched in NSM; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and lin-4 based on tiling array; microarray; and RNA-seq studies. Is affected by eleven chemicals including manganese chloride; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Phosphorylation site; BTB/POZ domain; MATH domain; BTB/POZ domain; MATH/TRAF domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00045037	F38A1.17
Is affected by clk-1; adr-1; and daf-2 based on microarray and RNA-seq studies.

WB:WBGene00045038	ule-2
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on RNA-seq; proteomic; and microarray studies. Is affected by fourteen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045040	C35D6.12
No description available

WB:WBGene00045043	Y116A8C.48
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including clk-1; hpl-2; and tatn-1 based on RNA-seq and microarray studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00045045	Y45F10B.17
Is affected by clk-1 based on microarray studies.

WB:WBGene00045046	Y64G10A.9
Is affected by clk-1 based on microarray studies.

WB:WBGene00045048	D1007.19
Is enriched in AFD; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including glp-1; daf-12; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including Alovudine; Sodium Chloride; and metformin based on RNA-seq studies.

WB:WBGene00045050	ZC15.10
Is enriched in AVE; DA neuron; VA neuron; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by eleven chemicals including Tunicamycin; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

WB:WBGene00045051	K11H12.13
Is affected by several genes including daf-12; pgl-1; and glh-1 based on tiling array and RNA-seq studies.

WB:WBGene00045052	K12C11.6
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00045053	K12C11.7
Is predicted to have copper ion transmembrane transporter activity. Is an ortholog of human SLC31A1 (solute carrier family 31 member 1).

WB:WBGene00045054	T20F10.7
No description available

WB:WBGene00045055	C16D9.11
Is affected by rsr-2; daf-2; and nhr-86 based on RNA-seq studies.

WB:WBGene00045056	F13H10.9
Is enriched in dopaminergic neurons; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045057	Y106G6G.7
Is affected by several genes including pgl-1; alg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00045058	gadr-5
Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00045059	Y45F10B.18
No description available

WB:WBGene00045060	F55B11.7
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including sodium arsenite; D-glucose; and Progesterone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00045061	Y57G11B.8
Is affected by several genes including daf-2; daf-12; and hpl-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045062	Y38H8A.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and hsp-6 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00045063	Y37A1A.4
Is enriched in several structures, including Z4.a; excretory cell; male distal tip cell; neurons; and somatic gonad precursor based on microarray; tiling array; and RNA-seq studies. Is affected by several genes including let-60; hsf-1; and lin-35 based on microarray and RNA-seq studies. Is affected by eighteen chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in autosomal recessive nonsyndromic deafness 104. Is predicted to encode a protein with the following domains: Filopodia upregulated, FAM65; RIPOR family member 3; and FAM65, N-terminal. Is an ortholog of human RIPOR2 (RHO family interacting cell polarization regulator 2) and RIPOR3 (RIPOR family member 3).

WB:WBGene00045065	Y40H7A.15
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045066	Y41E3.21
Is enriched in DA neuron and neurons based on microarray studies. Is affected by daf-16 and tdp-1 based on RNA-seq and microarray studies.

WB:WBGene00045067	F07C6.6
Is enriched in AVK; body wall muscle cell; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and dpy-7 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00045068	C08F11.16
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00045069	C08F11.17
Is affected by several genes including daf-2; clk-1; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1505) and Protein of unknown function DUF1505.

WB:WBGene00045071	T03F7.8
Is affected by rsr-2 and clk-1 based on RNA-seq and microarray studies.

WB:WBGene00045072	Y43F4B.11
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00045073	sli-3
No description available

WB:WBGene00045074	R166.7
Is affected by several genes including daf-2; daf-12; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045075	W04G5.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00045076	W04G5.13
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00045077	Y71A12B.18
Is enriched in AVK; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including 1-methylnicotinamide; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045078	C46C2.7
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including bisphenol A; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045079	rax-3
No description available

WB:WBGene00045080	rax-5
No description available

WB:WBGene00045081	rax-6
No description available

WB:WBGene00045082	F46F11.12
Is affected by several genes including daf-12; cep-1; and hpl-2 based on tiling array and RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00045083	C04G6.12
Is affected by clk-1 and daf-2 based on microarray and RNA-seq studies.

WB:WBGene00045084	K11C4.6
Is affected by daf-12 and clk-1 based on tiling array and microarray studies.

WB:WBGene00045085	Y24D9A.10
Is affected by hpl-2; daf-16; and hmg-3 based on tiling array and RNA-seq studies.

WB:WBGene00045086	Y43B11AR.7
Is affected by several genes including glp-1; skn-1; and pgl-1 based on RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00045087	B0041.9
Is affected by daf-12 based on tiling array studies.

WB:WBGene00045088	F48A11.7
Is affected by several genes including daf-2; daf-12; and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00045089	C05H8.3
No description available

WB:WBGene00045090	C27H5.10
Is affected by hpl-2 based on tiling array studies.

WB:WBGene00045091	C27H5.11
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00045092	H06I04.9
Is affected by several genes including daf-12; pgl-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045093	Y23H5B.10
Is enriched in NSM based on RNA-seq studies. Is affected by cep-1; nhr-86; and sftb-1 based on RNA-seq studies.

WB:WBGene00045094	D1007.20
Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00045095	mrpr-1
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including sir-2.1; npr-1; and cep-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; multi-walled carbon nanotube; and glycine based on RNA-seq and microarray studies.

WB:WBGene00045096	K01A6.7
Is enriched in amphid sheath cell and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Ethanol; Sodium Chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045097	VY10G11R.2
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00045098	VY10G11R.3
Is affected by clk-1 based on microarray studies.

WB:WBGene00045099	Y67A10A.13
Is affected by clk-1 based on microarray studies.

WB:WBGene00045100	K03D3.14
Is affected by rsr-2; csr-1; and clk-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00045101	C35D6.13
Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00045102	F52B11.8
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Cholestanol; and estrogen based on RNA-seq and microarray studies.

WB:WBGene00045103	T09E11.12
Human ortholog(s) of this gene are implicated in Tn polyagglutination syndrome. Is an ortholog of human C1GALT1C1 (C1GALT1 specific chaperone 1).

WB:WBGene00045104	C04G2.12
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00045105	Y7A9C.11
Is affected by several genes including daf-2; eat-2; and prg-1 based on RNA-seq and microarray studies. Is affected by Colistin and Triclosan based on microarray studies.

WB:WBGene00045106	Y7A9C.12
Is affected by clk-1 based on microarray studies.

WB:WBGene00045107	Y7A9C.13
No description available

WB:WBGene00045108	H01G02.4
Is enriched in NSM; germ line; and intestine based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; Rifampin; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00045109	smy-2
Is affected by daf-12 and unc-70 based on tiling array and RNA-seq studies.

WB:WBGene00045110	K12D12.6
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00045111	K12D12.7
Is affected by rpl-33 and rpl-5 based on RNA-seq studies.

WB:WBGene00045112	K12D12.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00045113	Y43F4B.12
Is affected by several genes including clk-1; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00045114	W01C9.6
Is affected by several genes including clk-1; pgl-1; and cep-1 based on tiling array; RNA-seq; and microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00045115	K02C4.7
Is affected by clk-1; ints-2; and ints-5 based on microarray and RNA-seq studies.

WB:WBGene00045116	C53D6.12
Is affected by cep-1 and sftb-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045117	M163.12
No description available

WB:WBGene00045118	T04A8.17
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00045119	F08G2.13
No description available

WB:WBGene00045120	Y43F8C.22
Is affected by several genes including cep-1; hpl-2; and dlc-1 based on RNA-seq studies.

WB:WBGene00045121	C46C2.8
Is affected by hpl-2; rsr-2; and daf-2 based on tiling array and RNA-seq studies.

WB:WBGene00045122	F22B3.10
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including lin-4; lin-14; and fbf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by copper sulfate and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00045123	W01D2.7
No description available

WB:WBGene00045124	C07A9.14
Is affected by several genes including daf-2; cep-1; and adr-1 based on RNA-seq studies.

WB:WBGene00045125	F54C9.12
Is affected by daf-12 and hpl-2 based on tiling array and RNA-seq studies.

WB:WBGene00045126	C14C10.8
Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00045127	W03C9.9
No description available

WB:WBGene00045128	Y116A8C.49
Is affected by several genes including daf-2; spn-4; and drh-3 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00045129	Y75B12B.12
Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00045130	F28C6.11
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00045131	T04A11.14
Is affected by several genes including daf-16; lin-4; and lin-14 based on RNA-seq and microarray studies.

WB:WBGene00045132	ZK643.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including skn-1; prg-1; and hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045133	M163.13
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00045134	K07C5.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00045136	D1046.6
Is affected by rsr-2 and cep-1 based on RNA-seq studies.

WB:WBGene00045137	F56A12.6
Is affected by daf-12 and ints-1 based on tiling array and RNA-seq studies.

WB:WBGene00045138	F25H2.14
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array; RNA-seq; and microarray studies.

WB:WBGene00045139	F01D5.12
Is affected by cep-1 and tdp-1 based on RNA-seq studies.

WB:WBGene00045140	T06C12.16
Is affected by several genes including daf-2; ptl-1; and efa-6 based on RNA-seq studies.

WB:WBGene00045141	Y53F4B.47
Is affected by several genes including daf-2; cep-1; and meg-3 based on RNA-seq studies.

WB:WBGene00045142	Y53F4B.48
Is affected by several genes including prg-1; kri-1; and atfs-1 based on RNA-seq studies.

WB:WBGene00045143	Y43D4A.8
Is affected by daf-16 and sir-2.1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045144	Y64G10A.10
Is enriched in DA neuron and VA neuron based on tiling array studies. Is affected by several genes including eat-2; mex-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by Rifampin; allantoin; and Psoralens based on RNA-seq studies.

WB:WBGene00045145	F10D2.13
Is affected by several genes including clk-1; cep-1; and vgln-1 based on RNA-seq and microarray studies. Is affected by Tunicamycin and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045146	Y41E3.22
Is enriched in AVE; hypodermis; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Tunicamycin; and Psoralens based on RNA-seq studies.

WB:WBGene00045147	T10B9.11
Is affected by several genes including clk-1; alg-1; and dpy-21 based on microarray and RNA-seq studies.

WB:WBGene00045148	C06A1.8
Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array and RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00045149	W05B2.9
Is affected by several genes including daf-2; cep-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00045150	ZK265.10
Is affected by daf-2 and adr-1 based on RNA-seq studies.

WB:WBGene00045151	F17C11.14
Is affected by several genes including daf-12; pgl-1; and prg-1 based on tiling array and RNA-seq studies.

WB:WBGene00045152	C06A1.9
Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array and RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00045153	F11A10.9
Is affected by cep-1; dlc-1; and sftb-1 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00045154	C10C6.8
Is affected by cep-1; daf-2; and sftb-1 based on RNA-seq and microarray studies.

WB:WBGene00045155	Y116A8C.50
Is affected by several genes including daf-2; daf-12; and clk-1 based on tiling array and microarray studies.

WB:WBGene00045156	T02E1.9
Is affected by several genes including clk-1; prg-1; and ptl-1 based on RNA-seq and microarray studies.

WB:WBGene00045157	K02C4.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; pgl-1; and cep-1 based on tiling array and RNA-seq studies.

WB:WBGene00045158	M163.14
Is affected by hpl-2 based on tiling array studies.

WB:WBGene00045159	smy-3
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00045160	C41C4.11
Is affected by hpl-2 and adr-1 based on tiling array and RNA-seq studies.

WB:WBGene00045161	lfor-2
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies. Is affected by Ethanol and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00045162	F25H2.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including cep-1; prg-1; and hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and bisphenol A based on RNA-seq studies.

WB:WBGene00045163	Y67A10A.14
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and clk-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045164	F59C6.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including pgl-1; prg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00045165	H38K22.8
Is enriched in intestine based on microarray studies. Is affected by prg-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00045166	Y54G2A.51
No description available

WB:WBGene00045167	F43A11.8
Is affected by several genes including cep-1; prg-1; and hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and glycine based on RNA-seq studies.

WB:WBGene00045168	srpr-1.2
Is affected by several genes including pgl-1; cep-1; and bar-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045169	T19C4.11
No description available

WB:WBGene00045170	T19C4.12
Is affected by meg-3; meg-4; and sftb-1 based on RNA-seq studies.

WB:WBGene00045171	K09E9.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-12; cep-1; and prg-1 based on tiling array and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045172	K08E3.11
Is affected by clk-1 based on microarray studies.

WB:WBGene00045174	Y64G10A.12
No description available

WB:WBGene00045175	C10C6.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq studies. Is affected by four chemicals including manganese chloride; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00045176	C53B7.8
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00045177	T21D12.14
Is enriched in OLL; PVD; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by eight chemicals including 1-methylnicotinamide; D-glucose; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00045178	fipr-27
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; bar-1; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045179	F01G10.11
Is affected by several genes including daf-16; dcr-1; and bar-1 based on microarray studies. Is affected by six chemicals including Heme; Humic Substances; and copper sulfate based on microarray studies.

WB:WBGene00045180	K07F5.17
Is enriched in amphid sheath cell; germ line; and male-specific anatomical entity based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including antimycin; resveratrol; and Acrylamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Uncharacterized protein ZC21.8.

WB:WBGene00045182	W01B6.10
Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray studies. Is affected by five chemicals including resveratrol; single-walled carbon nanotube; and paraquat based on microarray studies.

WB:WBGene00045183	T28C6.10
Is enriched in dopaminergic neurons; hypodermis; intestine; and pharyngeal muscle cell based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including multi-walled carbon nanotube; bisphenol S; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045184	T23F6.7
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies. Is affected by Colistin and Triclosan based on microarray studies.

WB:WBGene00045185	VY10G11R.4
No description available

WB:WBGene00045188	B0284.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045189	srpr-1.1
Is enriched in DD neuron based on microarray studies. Is affected by several genes including lin-4; lin-14; and cep-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; multi-walled carbon nanotube; and single-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00045190	R01H2.8
Is enriched in BAG and neurons based on tiling array and microarray studies. Is affected by several genes including dpy-7; sek-1; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by multi-walled carbon nanotube and Colistin based on RNA-seq and microarray studies.

WB:WBGene00045191	aho-1
No description available

WB:WBGene00045192	aho-3
Is predicted to have palmitoyl-(protein) hydrolase activity. Is involved in associative learning and behavioral response to starvation. Localizes to cytoplasmic vesicle and sensory dendrite. Is expressed in AIY; amphid neurons; and serotonergic neurons. Is an ortholog of human ABHD17A (abhydrolase domain containing 17A, depalmitoylase); ABHD17B (abhydrolase domain containing 17B, depalmitoylase); and ABHD17C (abhydrolase domain containing 17C, depalmitoylase).

WB:WBGene00045193	F53B2.10
Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045194	smy-1
Is affected by daf-12; daf-2; and ints-4 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00045195	F53F4.17
Is enriched in neurons and ventral nerve cord based on tiling array and microarray studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Mianserin; nanoparticle; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045197	C29F4.4
Is affected by clk-1 based on microarray studies.

WB:WBGene00045198	K10D11.7
Is enriched in NSM based on tiling array studies. Is affected by several genes including clk-1; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045199	smy-5
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00045200	smy-4
Is affected by clk-1 based on microarray studies.

WB:WBGene00045201	smy-10
No description available

WB:WBGene00045202	Y64G10A.13
Is affected by nitroguanidine based on microarray studies.

WB:WBGene00045203	smy-8
No description available

WB:WBGene00045204	smy-11
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00045205	smy-7
No description available

WB:WBGene00045207	F13E9.14
Is enriched in coelomocyte; neurons; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including bisphenol A; procyanidin; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00045208	F13E9.15
Is enriched in DA neuron; VA neuron; amphid sheath cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including Ethanol; multi-walled carbon nanotube; and bisphenol A based on RNA-seq and microarray studies.

WB:WBGene00045209	F13E9.16
Is enriched in GABAergic neurons; body wall muscle cell; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Cry5B; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00045210	C54D2.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mex-3 based on tiling array; microarray; and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00045211	C18D11.9
Is affected by several genes including dpy-21; drh-3; and mir-34 based on microarray; tiling array; and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045212	Y110A7A.21
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Mianserin; Sodium Chloride; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00045215	ceh-63
Exhibits RNA polymerase II regulatory region sequence-specific DNA binding activity. Localizes to nucleus. Is expressed in head; tail; uterus; and in male. Human ortholog(s) of this gene are implicated in several diseases, including Athabaskan brainstem dysgenesis syndrome; diabetes mellitus (multiple); and dysostosis (multiple).

WB:WBGene00045218	K08C9.8
Is affected by several genes including clk-1; eat-2; and dpy-21 based on microarray and RNA-seq studies. Is affected by four chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq studies.

WB:WBGene00045234	Y26D4A.17
Is affected by mir-34 based on microarray studies.

WB:WBGene00045235	Y26D4A.18
Is affected by clk-1 based on microarray studies.

WB:WBGene00045236	Y26D4A.19
Is affected by daf-2 and smn-1 based on microarray and RNA-seq studies.

WB:WBGene00045237	mrt-1
Exhibits 3'-5' exonuclease activity and single-stranded DNA binding activity. Is involved in nucleotide-excision repair; reproduction; and telomere maintenance via telomerase. Is an ortholog of human DCLRE1B (DNA cross-link repair 1B).

WB:WBGene00045238	rpr-1
Is affected by several genes including skn-1; hpl-2; and atfs-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin; paraquat; and nitroguanidine based on microarray and RNA-seq studies.

WB:WBGene00045239	Y49E10.29
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq studies. Is affected by thirteen chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00045240	seg-1
No description available

WB:WBGene00045241	seg-2
No description available

WB:WBGene00045242	C05B5.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including tryptophan; sodium arsenite; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045243	chep-1
No description available

WB:WBGene00045244	chep-2
No description available

WB:WBGene00045245	ttr-34
Is enriched in dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family; Transthyretin-like; and Transthyretin-like superfamily.

WB:WBGene00045246	C29E4.15
Is enriched in several structures, including AFD; NSM; Z4.a; germ line; and male distal tip cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Mianserin; and Alovudine based on RNA-seq studies.

WB:WBGene00045247	F54H12.8
Is enriched in coelomocyte; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including manganese chloride; multi-walled carbon nanotube; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00045248	ZK180.7
Is enriched in head mesodermal cell and neurons based on RNA-seq and microarray studies. Is affected by several genes including skn-1; unc-70; and ain-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Sodium Chloride; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00045249	T07A9.15
Is enriched in AVE and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq studies. Is affected by four chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00045250	Y73B6BL.47
Is enriched in AVE; GABAergic neurons; RIS; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; eat-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by Zidovudine and Colistin based on RNA-seq and microarray studies.

WB:WBGene00045251	F54F7.9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by nine chemicals including 1-methylnicotinamide; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00045252	Y62H9A.15
Is enriched in ASER; hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Tunicamycin; Mianserin; and Psoralens based on RNA-seq studies.

WB:WBGene00045253	F46C3.6
Is enriched in ASER and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045254	F33E2.8
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00045255	nhr-146
Is predicted to have DNA-binding transcription factor activity.

WB:WBGene00045261	H29C22.1
Is enriched in cephalic sheath cell; dopaminergic neurons; germ line; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by fourteen chemicals including 1-methylnicotinamide; Rotenone; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045265	K10C2.8
Is enriched in NSM and germ line based on RNA-seq and tiling array studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by ten chemicals including Ethanol; Tunicamycin; and D-glucose based on RNA-seq and microarray studies.

WB:WBGene00045268	ttr-42
Is enriched in cephalic sheath cell and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Transthyretin-like superfamily.

WB:WBGene00045269	F46G11.6
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including methylmercury hydroxide; D-glucose; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045270	C04E7.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00045271	F07G6.10
Is enriched in GABAergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; proteomic; and microarray studies. Is affected by fifteen chemicals including Ethanol; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00045272	F59C12.4
Is enriched in body wall muscle cell; germ line; head mesodermal cell; hypodermis; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and dpy-10 based on RNA-seq and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; Rotenone; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00045273	C08A9.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and fog-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00045274	nre-1
No description available

WB:WBGene00045275	F18E3.12
Is enriched in AFD; ASER; PLM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045276	F18E3.13
Is enriched in several structures, including PLM; carbon dioxide sensory neurons; germline precursor cell; intestine; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by sixteen chemicals including Rotenone; Tunicamycin; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045277	ZK742.6
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; sod-2; and mex-3 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and antimycin based on RNA-seq studies.

WB:WBGene00045278	B0513.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00045279	B0513.12
Is affected by ahr-1 and daf-16 based on RNA-seq studies.

WB:WBGene00045280	Y116A8C.51
No description available

WB:WBGene00045281	Y51H4A.33
No description available

WB:WBGene00045282	Y57G11C.56
Is affected by hpl-2 and adr-1 based on tiling array and RNA-seq studies.

WB:WBGene00045283	K08E4.8
Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00045285	C08F11.18
No description available

WB:WBGene00045286	C08F11.19
No description available

WB:WBGene00045287	C47A4.7
Is enriched in neurons based on microarray studies. Is affected by ain-2 based on microarray studies.

WB:WBGene00045289	fbxa-169
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and mex-3 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00045290	Y102A5C.37
Is affected by clk-1 based on microarray studies.

WB:WBGene00045291	F23D12.10
Is enriched in Z1.p; Z4.a; germ line; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and isp-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including methylmercury hydroxide; D-glucose; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00045292	fbxa-179
Is enriched in Z1.p; Z4.a; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and mex-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including tryptophan; Zidovudine; and metformin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00045293	fbxa-175
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and npr-1 based on microarray and RNA-seq studies.

WB:WBGene00045294	H12I19.9
Is affected by clk-1 and dpy-21 based on microarray and RNA-seq studies.

WB:WBGene00045295	fbxa-222
Is enriched in head mesodermal cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and Zidovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; HTH domain in Mos1 transposase; F-box domain; F-box A protein FB155/FB224; and Mos1 transposase, HTH domain.

WB:WBGene00045297	fbxc-43
Is enriched in germ line; germline precursor cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on microarray; RNA-seq; and tiling array studies. Is affected by nine chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00045298	fbxc-12
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00045299	fbxc-11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and eri-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00045300	fbxc-10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and eri-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00045301	fbxc-9
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eight chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00045302	fbxc-30
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF3557) and Protein of unknown function DUF3557.

WB:WBGene00045303	Y27F2A.10
Is affected by elt-2 and elt-7 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00045304	Y27F2A.11
Is affected by clk-1 and daf-2 based on microarray studies. Is affected by tryptophan and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00045305	ZC250.4
Is enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by twelve chemicals including Rotenone; bisphenol S; and 4-bromodiphenyl ether based on RNA-seq and microarray studies.

WB:WBGene00045306	ZC250.5
Is predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Human ortholog(s) of this gene are implicated in osteogenesis imperfecta type 9.

WB:WBGene00045308	C37H5.14
Is enriched in Z1.p; Z4.a; germ line; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including pmk-1; pgl-1; and bar-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: RAI1 like PD-(D/E)XK nuclease; RAI1-like; and RAI1-like family. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00045309	srg-52
Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00045311	Y57G11C.57
Is affected by wdr-5.1 and eat-2 based on microarray and RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00045313	T27E7.12
Is affected by clk-1 based on microarray studies.

WB:WBGene00045314	Y39C12A.10
No description available

WB:WBGene00045315	Y116A8C.52
Is affected by clk-1; daf-2; and eat-2 based on microarray studies.

WB:WBGene00045316	C49F5.9
Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00045319	M04B2.8
Is affected by several genes including daf-2; eat-2; and dpy-21 based on RNA-seq and microarray studies.

WB:WBGene00045321	Y43D4A.10
Is affected by several genes including met-2; set-2; and ash-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00045322	C09F9.7
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00045323	C09G9.9
Is affected by clk-1 based on microarray studies.

WB:WBGene00045324	mir-787
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00045325	mir-789.1
Is affected by hrpr-1; unc-70; and hrpk-1 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00045326	mir-789.2
Is affected by hrpk-1 based on RNA-seq studies. Is affected by nicotine and sanguinarine based on quantitative PCR and RNA-seq studies.

WB:WBGene00045327	mir-793
Is expressed in ASEL; ASER; and neurons.

WB:WBGene00045328	mir-794
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR and RNA-seq studies.

WB:WBGene00045329	mir-795
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00045330	mir-798
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00045331	F14D7.12
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including dpy-7; alg-1; and hpl-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including Rotenone; D-glucose; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00045332	F14D7.13
Is affected by dpy-21; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00045336	R11D1.12
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00045337	M01B2.12
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including clk-1; unc-70; and drh-3 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Phytanoyl-CoA hydroxylase-interacting protein-like. Is an ortholog of human PHYHIP (phytanoyl-CoA 2-hydroxylase interacting protein) and PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like).

WB:WBGene00045338	M01B2.13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by eight chemicals including bisphenol A; Alovudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phytanoyl-CoA hydroxylase-interacting protein-like. Is an ortholog of human PHYHIP (phytanoyl-CoA 2-hydroxylase interacting protein) and PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like).

WB:WBGene00045339	T10H4.13
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including dpy-21; smg-2; and unc-70 based on RNA-seq studies. Is predicted to encode a protein with the following domain: Phytanoyl-CoA hydroxylase-interacting protein-like. Is an ortholog of human PHYHIP (phytanoyl-CoA 2-hydroxylase interacting protein) and PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like).

WB:WBGene00045340	T10G3.8
Is enriched in head mesodermal cell; muscle cell; neurons; and ventral nerve cord based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; sir-2.1; and lin-35 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00045341	mir-784
Is affected by several genes including hsf-1; eat-2; and alg-1 based on RNA-seq studies.

WB:WBGene00045342	mir-785
Is affected by several genes including eat-2; alg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR and RNA-seq studies.

WB:WBGene00045343	mir-786
Is expressed in intestinal cell.

WB:WBGene00045344	Y43F8C.23
No description available

WB:WBGene00045345	Y43F8C.24
No description available

WB:WBGene00045346	C06H5.9
Is affected by clk-1 based on microarray studies.

WB:WBGene00045347	C14A6.9
Is affected by bar-1; wdr-5.1; and daf-16 based on microarray and RNA-seq studies. Is affected by allantoin based on microarray studies.

WB:WBGene00045348	C14A6.10
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by nine chemicals including metformin; Cry5B; and Quercetin based on RNA-seq and microarray studies.

WB:WBGene00045350	mir-788
Is affected by several genes including glp-4; alg-1; and prg-1 based on RNA-seq studies.

WB:WBGene00045351	mir-790
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and nicotine based on RNA-seq studies.

WB:WBGene00045352	mir-791
Is expressed in carbon dioxide sensory neurons.

WB:WBGene00045353	mir-792
Is expressed in head neurons.

WB:WBGene00045354	mir-796
Is affected by several genes including eat-2; prg-1; and alg-5 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and sanguinarine based on RNA-seq studies.

WB:WBGene00045355	D1086.17
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00045356	T03E6.9
Is enriched in Z1; Z4; male-specific anatomical entity; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and mex-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; multi-walled carbon nanotube; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00045357	F13A7.14
Is enriched in Z1.p; Z4.a; germ line; gon_male_dtc anterior; and gon_male_dtc posterior based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045358	mir-797
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00045359	mir-799
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00045360	mir-800
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine; multi-walled carbon nanotube; and graphene oxide based on quantitative PCR and RNA-seq studies.

WB:WBGene00045361	clec-253
Is affected by several genes including aak-2; drh-3; and aak-1 based on RNA-seq and microarray studies.

WB:WBGene00045362	F11D11.12
Is affected by several genes including daf-2; mex-3; and mex-1 based on RNA-seq and microarray studies.

WB:WBGene00045363	F11D11.13
Is affected by Testosterone and resveratrol based on microarray studies.

WB:WBGene00045364	clec-250
Is predicted to have carbohydrate binding activity.

WB:WBGene00045365	ZC449.7
Is enriched in PLM and intestine based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00045366	Y17D7C.3
Is enriched in AVK; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00045367	F17C11.15
Is affected by several genes including clk-1; pgl-1; and prg-1 based on RNA-seq and microarray studies.

WB:WBGene00045368	T23G5.7
No description available

WB:WBGene00045369	F26E4.14
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00045370	ZK265.11
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including prg-1; ptl-1; and ptrn-1 based on RNA-seq studies.

WB:WBGene00045371	M163.15
No description available

WB:WBGene00045372	W01D2.8
Is affected by rsr-2 and daf-2 based on RNA-seq studies.

WB:WBGene00045373	Y46G5A.40
Is affected by several genes including clk-1; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00045374	B0393.10
Is affected by several genes including clk-1; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00045375	C17D12.8
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00045376	F25H5.9
Is affected by rsr-2; cep-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00045377	F19H8.6
No description available

WB:WBGene00045378	H04D03.5
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00045379	C45B11.6
Is predicted to have cis-stilbene-oxide hydrolase activity. Is an ortholog of human EPHX1 (epoxide hydrolase 1).

WB:WBGene00045380	W06G6.15
Is affected by several genes including dpy-21; hpl-2; and drh-3 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00045381	F28B1.9
Is enriched in male based on RNA-seq studies. Is affected by adr-1 and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045382	T05E12.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and fog-2 based on tiling array; RNA-seq; and microarray studies. Is affected by six chemicals including stavudine; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00045383	sup-46
Is predicted to have mRNA binding activity. Is an ortholog of human HNRNPM (heterogeneous nuclear ribonucleoprotein M) and MYEF2 (myelin expression factor 2).

WB:WBGene00045385	lgc-24
Is predicted to have extracellular ligand-gated ion channel activity and transmembrane signaling receptor activity.

WB:WBGene00045386	nlp-76
Is enriched in AFD; neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including nanoparticle; Zidovudine; and Sodium Chloride based on microarray and RNA-seq studies.

WB:WBGene00045387	K09H9.8
Is enriched in hypodermis and somatic gonad precursor based on tiling array; proteomic; and RNA-seq studies. Is affected by several genes including daf-2; let-60; and rrf-3 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Rotenone; D-glucose; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00045388	lfor-1
Is affected by several genes including daf-16; pgl-1; and dpy-21 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00045389	Y38F1A.11
No description available

WB:WBGene00045390	C38C3.10
Is enriched in AFD; PLM; amphid sheath cell; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00045391	F52D4.1
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00045392	F26D11.12
Is enriched in PLM; body wall muscle cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00045393	F26D11.13
Is enriched in body wall muscle cell; coelomocyte; intestine; and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including skn-1; daf-12; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045394	ZK813.7
Is enriched in cephalic sheath cell; dopaminergic neurons; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; rrf-3; and dpy-10 based on RNA-seq; tiling array; microarray; and proteomic studies. Is affected by ten chemicals including Ethanol; Rotenone; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00045395	F09F9.5
Is enriched in AFD and neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045396	ZC334.12
Is enriched in AVE; AVK; DA neuron; and VA neuron based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00045397	Y54G2A.52
Is enriched in head mesodermal cell; intestine; pharyngeal muscle cell; and sensory neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00045398	Y71F9AM.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; alg-1; and drh-3 based on microarray and RNA-seq studies. Is affected by Ethanol; 2; and 4-dinitroanisole based on RNA-seq and microarray studies.

WB:WBGene00045399	Y47G6A.33
Is enriched in hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq studies.

WB:WBGene00045400	C54D10.13
Is enriched in intestine; mechanosensory neurons; pharyngeal muscle cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by four chemicals including stavudine; Sodium Chloride; and Cry5B based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045401	eol-1
Is predicted to have 5'-3' exonuclease activity; RNA pyrophosphohydrolase activity; and mRNA binding activity. Is involved in regulation of olfactory learning. Is expressed in AVF; oxygen sensory neurons; and reproductive system. Is an ortholog of human DXO (decapping exoribonuclease).

WB:WBGene00045402	Y75B12B.13
Is affected by hpl-2 and dpy-21 based on tiling array and RNA-seq studies.

WB:WBGene00045403	K10H10.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00045404	C06C3.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045405	D1086.18
Is affected by several genes including daf-2; glp-1; and daf-12 based on RNA-seq; tiling array; and microarray studies. Is affected by eleven chemicals including sodium arsenite; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00045406	D1086.19
Is enriched in germ line; hypodermis; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and sir-2.1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Mianserin; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045407	T07D4.5
Is enriched in AFD; dopaminergic neurons; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and npr-1 based on RNA-seq; microarray; and proteomic studies. Is affected by seven chemicals including Rotenone; stavudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: p53 and DNA damage-regulated protein 1. Is an ortholog of human PDRG1 (p53 and DNA damage regulated 1).

WB:WBGene00045408	F31E9.8
Is enriched in neurons based on microarray studies. Is affected by clk-1; mut-2; and rrf-2 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00045410	E01G4.7
Is enriched in body wall muscle cell; head mesodermal cell; hypodermis; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and sek-1 based on tiling array and RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00045411	C25F9.11
Is enriched in OLL; PVD; dopaminergic neurons; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including Ethanol; Nitric Oxide; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00045412	C25F9.12
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including hsf-1; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Sodium Chloride; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00045413	C25F9.13
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00045414	T19H5.7
Is enriched in AVK and dopaminergic neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by eight chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies.

WB:WBGene00045415	Y43F8B.15
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Tunicamycin; tert-Butylhydroperoxide; and Rifampin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: SNF2-like, N-terminal domain superfamily.

WB:WBGene00045416	Y37H2A.14
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on proteomic; RNA-seq; and microarray studies. Is affected by twenty-seven chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00045417	Y37H2A.13
Is enriched in AVA based on tiling array studies. Is affected by several genes including daf-16; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including 1-methylnicotinamide; Rotenone; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00045418	F15B9.10
Is enriched in coelomocyte; germ line; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by five chemicals including Zidovudine; Humic Substances; and single-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Modulator of levamisole receptor-1 and Modulator of levamisole receptor-1.

WB:WBGene00045419	lsy-12
Is predicted to have histone acetyltransferase activity and histone binding activity. Is an ortholog of human KAT7 (lysine acetyltransferase 7).

WB:WBGene00045427	lsy-21
No description available

WB:WBGene00045428	lsy-26
No description available

WB:WBGene00045429	lsy-25
No description available

WB:WBGene00045431	lsy-19
No description available

WB:WBGene00045432	lsy-20
No description available

WB:WBGene00045433	F49D11.10
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and clk-1 based on RNA-seq; microarray; and proteomic studies. Is affected by Rotenone; Humic Substances; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; and WD40-repeat-containing domain superfamily. Is an ortholog of human WDR75 (WD repeat domain 75).

WB:WBGene00045434	Y95D11A.3
Is enriched in body wall muscle cell; germ line; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including sir-2.1; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including manganese chloride; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00045455	F26G1.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by six chemicals including nicotinic acid; Rotenone; and D-glucopyranose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like and Transthyretin-like superfamily.

WB:WBGene00045456	C10A4.9
Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00045457	F33H12.7
Is enriched in dopaminergic neurons; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nineteen chemicals including tryptophan; methylmercury hydroxide; and 1-methylnicotinamide based on microarray and RNA-seq studies.

WB:WBGene00045458	F17B5.8
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on proteomic; tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including tryptophan; Tunicamycin; and sodium arsenite based on microarray and RNA-seq studies.

WB:WBGene00045459	Y59A8B.26
Is enriched in muscle cell based on microarray studies. Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies. Is affected by adsorbable organic bromine compound; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00045460	C15C8.8
Is enriched in germline precursor cell based on tiling array studies. Is affected by several genes including clk-1; dpy-7; and pry-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Tunicamycin; stavudine; and Zidovudine based on microarray and RNA-seq studies.

WB:WBGene00045461	C25F9.14
Is enriched in ASER; head mesodermal cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; bisphenol A; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045462	such-2
No description available

WB:WBGene00045463	such-3
No description available

WB:WBGene00045464	such-4
No description available

WB:WBGene00045465	such-5
No description available

WB:WBGene00045466	such-6
No description available

WB:WBGene00045467	such-7
No description available

WB:WBGene00045468	F08A8.8
Is enriched in DA neuron; VA neuron; germ line; and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00045473	F30A10.14
Is enriched in NSM; cephalic sheath cell; dopaminergic neurons; and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by twelve chemicals including Ethanol; Tunicamycin; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045474	C49G9.2
Is enriched in hypodermis based on tiling array studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00045475	T07A5.7
Is enriched in Z1; Z4; hypodermis; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Fukutin-related.

WB:WBGene00045479	C44E4.8
No description available

WB:WBGene00045480	F14F3.5
Is enriched in germ line; hypodermis; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including eat-2; mex-1; and spn-4 based on microarray and RNA-seq studies. Is affected by six chemicals including Tunicamycin; allantoin; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00045481	M153.5
Is affected by several genes including skn-1; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including stavudine; Zidovudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045482	T03F6.9
Is enriched in AFD; DA neuron; GABAergic neurons; VA neuron; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including mex-1; unc-70; and spn-4 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Mianserin; and Psoralens based on RNA-seq studies.

WB:WBGene00045483	oxy-5
Is expressed in chemosensory neurons; head neurons; intestine; pharynx; and tail neurons. Is predicted to encode a protein with the following domains: Ribosomal protein S36, mitochondrial and Ribosomal protein S36, mitochondrial.

WB:WBGene00045484	F34D10.9
Is enriched in several structures, including Z1.p; Z4.a; male distal tip cell; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including daf-2; lin-4; and lin-14 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including manganese chloride; Mianserin; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00045486	K05F6.12
Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including bisphenol A; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00045487	C08E8.7
Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00045488	F57B1.9
Is enriched in cephalic sheath cell and hypodermis based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; Tunicamycin; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00045490	F14D7.14
Is affected by daf-16; mir-34; and eat-2 based on RNA-seq and microarray studies. Is affected by tryptophan and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF4473) and Protein of unknown function DUF4473.

WB:WBGene00045491	F14D7.15
No description available

WB:WBGene00045492	ZK218.14
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00045493	F55G7.4
Is enriched in AFD; GABAergic neurons; and NSM based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; dpy-21; and hpl-2 based on tiling array; microarray; and RNA-seq studies.

WB:WBGene00045494	ZK662.6
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00045495	F11C1.7
Is enriched in cephalic sheath cell; germ line; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and prg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Mff/Tango-11.

WB:WBGene00045496	C08E8.8
Is affected by dpy-21 and adr-1 based on RNA-seq studies.

WB:WBGene00045497	K03A11.6
Is affected by several genes including daf-16; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by four chemicals including Zidovudine; glycine; and adsorbable organic bromine compound based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00045498	F56F4.8
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including 1-methylnicotinamide; Tunicamycin; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00045500	T05E12.9
Is affected by several genes including clk-1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00045501	Y6G8.8
Is affected by several genes including daf-2; eat-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00045502	F49H6.14
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00045503	mev-5
No description available

WB:WBGene00045504	mev-6
No description available

WB:WBGene00045505	mev-7
No description available

WB:WBGene00045506	F57G4.10
Is affected by adr-1; meg-3; and meg-4 based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00045507	F10A3.17
Is enriched in intestine and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucopyranose; stavudine; and Sodium Chloride based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00045508	D1081.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00045509	T07D10.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00045510	F11A5.17
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045511	F11A5.18
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00045512	Y60A3A.27
No description available

WB:WBGene00045513	F14H3.14
Is enriched in NSM based on tiling array studies. Is affected by clk-1; elt-2; and pry-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00045514	ZK1037.12
No description available

WB:WBGene00045515	nhr-291
Is predicted to have DNA-binding transcription factor activity; sequence-specific DNA binding activity; and zinc ion binding activity.

WB:WBGene00045516	F43D2.7
Is affected by several genes including daf-16; clk-1; and eat-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00045517	R11D1.13
Is enriched in amphid sheath cell; dopaminergic neurons; intestine; and sensory neurons based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including elt-2; eat-2; and prg-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00045518	21ur-5153
No description available

WB:WBGene00045519	21ur-4348
No description available

WB:WBGene00045520	21ur-3279
No description available

WB:WBGene00045521	21ur-4491
No description available

WB:WBGene00045522	21ur-1293
No description available

WB:WBGene00045523	21ur-4900
No description available

WB:WBGene00045524	21ur-2872
No description available

WB:WBGene00045525	21ur-4886
No description available

WB:WBGene00045526	21ur-3726
No description available

WB:WBGene00045527	21ur-3449
No description available

WB:WBGene00045528	21ur-4318
No description available

WB:WBGene00045529	21ur-3987
No description available

WB:WBGene00045530	21ur-770
No description available

WB:WBGene00045531	21ur-3262
No description available

WB:WBGene00045532	21ur-116
No description available

WB:WBGene00045533	21ur-338
No description available

WB:WBGene00045534	21ur-248
No description available

WB:WBGene00045535	21ur-2337
No description available

WB:WBGene00045536	21ur-2148
No description available

WB:WBGene00045537	21ur-3280
No description available

WB:WBGene00045538	21ur-783
No description available

WB:WBGene00045539	21ur-2502
No description available

WB:WBGene00045540	21ur-2533
No description available

WB:WBGene00045541	21ur-2515
No description available

WB:WBGene00045542	21ur-194
No description available

WB:WBGene00045543	21ur-1754
No description available

WB:WBGene00045544	21ur-3162
No description available

WB:WBGene00045545	21ur-4859
No description available

WB:WBGene00045546	21ur-3313
No description available

WB:WBGene00045547	21ur-2522
No description available

WB:WBGene00045548	21ur-2768
No description available

WB:WBGene00045549	21ur-4660
No description available

WB:WBGene00045550	21ur-380
No description available

WB:WBGene00045551	21ur-127
No description available

WB:WBGene00045552	21ur-3009
No description available

WB:WBGene00045553	21ur-4396
No description available

WB:WBGene00045554	21ur-3929
No description available

WB:WBGene00045555	21ur-4158
No description available

WB:WBGene00045556	21ur-972
No description available

WB:WBGene00045557	21ur-4509
No description available

WB:WBGene00045558	21ur-4358
No description available

WB:WBGene00045559	21ur-4032
No description available

WB:WBGene00045560	21ur-3396
No description available

WB:WBGene00045561	21ur-4184
No description available

WB:WBGene00045562	21ur-231
No description available

WB:WBGene00045563	21ur-4606
No description available

WB:WBGene00045564	21ur-4026
No description available

WB:WBGene00045565	21ur-1557
No description available

WB:WBGene00045566	21ur-4925
No description available

WB:WBGene00045567	21ur-4269
No description available

WB:WBGene00045568	21ur-3115
No description available

WB:WBGene00045569	21ur-4858
No description available

WB:WBGene00045570	21ur-422
No description available

WB:WBGene00045571	21ur-3283
No description available

WB:WBGene00045572	21ur-66
No description available

WB:WBGene00045573	21ur-3960
No description available

WB:WBGene00045574	21ur-3455
No description available

WB:WBGene00045575	21ur-3399
No description available

WB:WBGene00045576	21ur-1907
No description available

WB:WBGene00045577	21ur-341
No description available

WB:WBGene00045578	21ur-4400
No description available

WB:WBGene00045579	21ur-213
No description available

WB:WBGene00045580	21ur-3922
No description available

WB:WBGene00045581	21ur-3683
No description available

WB:WBGene00045582	21ur-3176
No description available

WB:WBGene00045583	21ur-4174
No description available

WB:WBGene00045584	21ur-4213
No description available

WB:WBGene00045585	21ur-687
No description available

WB:WBGene00045586	21ur-5133
No description available

WB:WBGene00045587	21ur-4538
No description available

WB:WBGene00045588	21ur-4731
No description available

WB:WBGene00045589	21ur-1571
No description available

WB:WBGene00045590	21ur-5440
No description available

WB:WBGene00045591	21ur-3641
No description available

WB:WBGene00045592	21ur-4673
No description available

WB:WBGene00045593	21ur-2000
No description available

WB:WBGene00045594	21ur-2563
No description available

WB:WBGene00045595	21ur-676
No description available

WB:WBGene00045596	21ur-5434
No description available

WB:WBGene00045597	21ur-2918
No description available

WB:WBGene00045598	21ur-3144
No description available

WB:WBGene00045599	21ur-3790
No description available

WB:WBGene00045600	21ur-3069
No description available

WB:WBGene00045601	21ur-1104
No description available

WB:WBGene00045602	21ur-4930
No description available

WB:WBGene00045603	21ur-5393
No description available

WB:WBGene00045604	21ur-4121
No description available

WB:WBGene00045605	21ur-1446
No description available

WB:WBGene00045606	21ur-4963
No description available

WB:WBGene00045607	21ur-3239
No description available

WB:WBGene00045608	21ur-4548
No description available

WB:WBGene00045609	21ur-2932
No description available

WB:WBGene00045610	21ur-1584
No description available

WB:WBGene00045611	21ur-620
No description available

WB:WBGene00045612	21ur-5367
No description available

WB:WBGene00045613	21ur-2568
Is affected by daf-2 based on microarray studies.

WB:WBGene00045614	21ur-2293
No description available

WB:WBGene00045615	21ur-310
No description available

WB:WBGene00045616	21ur-344
No description available

WB:WBGene00045617	21ur-5229
No description available

WB:WBGene00045618	21ur-3525
No description available

WB:WBGene00045619	21ur-5354
No description available

WB:WBGene00045620	21ur-2363
No description available

WB:WBGene00045621	21ur-5452
No description available

WB:WBGene00045622	21ur-2954
No description available

WB:WBGene00045623	21ur-3951
No description available

WB:WBGene00045624	21ur-3736
No description available

WB:WBGene00045625	21ur-419
No description available

WB:WBGene00045626	21ur-5135
No description available

WB:WBGene00045627	21ur-4966
No description available

WB:WBGene00045628	21ur-3440
No description available

WB:WBGene00045629	21ur-2914
No description available

WB:WBGene00045630	21ur-2195
No description available

WB:WBGene00045631	21ur-4580
No description available

WB:WBGene00045632	21ur-2136
No description available

WB:WBGene00045633	21ur-5345
No description available

WB:WBGene00045634	21ur-3163
No description available

WB:WBGene00045635	21ur-98
No description available

WB:WBGene00045636	21ur-629
No description available

WB:WBGene00045637	21ur-3513
No description available

WB:WBGene00045638	21ur-4117
No description available

WB:WBGene00045639	21ur-1324
No description available

WB:WBGene00045640	21ur-2876
No description available

WB:WBGene00045641	21ur-4617
No description available

WB:WBGene00045642	21ur-3810
No description available

WB:WBGene00045643	21ur-2772
No description available

WB:WBGene00045644	21ur-3853
No description available

WB:WBGene00045645	21ur-1572
No description available

WB:WBGene00045646	21ur-4784
No description available

WB:WBGene00045647	21ur-101
No description available

WB:WBGene00045648	21ur-4235
No description available

WB:WBGene00045649	21ur-198
No description available

WB:WBGene00045650	21ur-2547
No description available

WB:WBGene00045651	21ur-1325
No description available

WB:WBGene00045652	21ur-378
No description available

WB:WBGene00045653	21ur-1257
No description available

WB:WBGene00045654	21ur-3621
No description available

WB:WBGene00045655	21ur-2179
No description available

WB:WBGene00045656	21ur-2373
No description available

WB:WBGene00045657	21ur-4637
No description available

WB:WBGene00045658	21ur-5357
No description available

WB:WBGene00045659	21ur-1723
No description available

WB:WBGene00045660	21ur-5403
No description available

WB:WBGene00045661	21ur-780
No description available

WB:WBGene00045662	21ur-4553
No description available

WB:WBGene00045663	21ur-5087
No description available

WB:WBGene00045664	21ur-553
No description available

WB:WBGene00045665	21ur-3191
No description available

WB:WBGene00045666	21ur-3306
No description available

WB:WBGene00045667	21ur-22
No description available

WB:WBGene00045668	21ur-1242
No description available

WB:WBGene00045669	21ur-1303
No description available

WB:WBGene00045670	21ur-2441
No description available

WB:WBGene00045671	21ur-1935
No description available

WB:WBGene00045672	21ur-2786
No description available

WB:WBGene00045673	21ur-3453
No description available

WB:WBGene00045674	21ur-4693
No description available

WB:WBGene00045675	21ur-2281
No description available

WB:WBGene00045676	21ur-2712
No description available

WB:WBGene00045677	21ur-5214
No description available

WB:WBGene00045678	21ur-1078
No description available

WB:WBGene00045679	21ur-3510
No description available

WB:WBGene00045680	21ur-4163
No description available

WB:WBGene00045681	21ur-5291
No description available

WB:WBGene00045682	21ur-527
No description available

WB:WBGene00045683	21ur-5312
No description available

WB:WBGene00045684	21ur-5385
No description available

WB:WBGene00045685	21ur-1986
No description available

WB:WBGene00045686	21ur-3553
No description available

WB:WBGene00045687	21ur-1049
No description available

WB:WBGene00045688	21ur-4041
No description available

WB:WBGene00045689	21ur-3409
No description available

WB:WBGene00045690	21ur-5085
No description available

WB:WBGene00045691	21ur-4812
No description available

WB:WBGene00045692	21ur-946
No description available

WB:WBGene00045693	21ur-2392
No description available

WB:WBGene00045694	21ur-5223
No description available

WB:WBGene00045695	21ur-4519
No description available

WB:WBGene00045696	21ur-2704
No description available

WB:WBGene00045697	21ur-481
No description available

WB:WBGene00045698	21ur-5244
No description available

WB:WBGene00045699	21ur-5080
No description available

WB:WBGene00045700	21ur-1137
No description available

WB:WBGene00045701	21ur-1580
No description available

WB:WBGene00045702	21ur-1740
No description available

WB:WBGene00045703	21ur-457
No description available

WB:WBGene00045704	21ur-3053
No description available

WB:WBGene00045705	21ur-3074
No description available

WB:WBGene00045706	21ur-163
No description available

WB:WBGene00045707	21ur-1530
No description available

WB:WBGene00045708	21ur-3591
No description available

WB:WBGene00045709	21ur-5427
No description available

WB:WBGene00045710	21ur-2758
No description available

WB:WBGene00045711	21ur-2189
No description available

WB:WBGene00045712	21ur-877
No description available

WB:WBGene00045713	21ur-2188
No description available

WB:WBGene00045714	21ur-895
No description available

WB:WBGene00045715	21ur-764
No description available

WB:WBGene00045716	21ur-2080
No description available

WB:WBGene00045717	21ur-3347
No description available

WB:WBGene00045718	21ur-1995
No description available

WB:WBGene00045719	21ur-927
No description available

WB:WBGene00045720	21ur-1318
No description available

WB:WBGene00045721	21ur-1126
No description available

WB:WBGene00045722	21ur-4997
No description available

WB:WBGene00045723	21ur-368
No description available

WB:WBGene00045724	21ur-1377
No description available

WB:WBGene00045725	21ur-4839
No description available

WB:WBGene00045726	21ur-4151
No description available

WB:WBGene00045727	21ur-719
No description available

WB:WBGene00045728	21ur-2397
No description available

WB:WBGene00045729	21ur-4447
No description available

WB:WBGene00045730	21ur-1475
No description available

WB:WBGene00045731	21ur-2329
No description available

WB:WBGene00045732	21ur-4317
No description available

WB:WBGene00045733	21ur-4254
No description available

WB:WBGene00045734	21ur-3918
No description available

WB:WBGene00045735	21ur-3996
No description available

WB:WBGene00045736	21ur-1612
No description available

WB:WBGene00045737	21ur-3619
No description available

WB:WBGene00045738	21ur-4550
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00045739	21ur-5063
No description available

WB:WBGene00045740	21ur-4575
No description available

WB:WBGene00045741	21ur-157
No description available

WB:WBGene00045743	21ur-5073
No description available

WB:WBGene00045744	21ur-26
No description available

WB:WBGene00045745	21ur-805
No description available

WB:WBGene00045746	21ur-1219
No description available

WB:WBGene00045747	21ur-4706
No description available

WB:WBGene00045748	21ur-4832
No description available

WB:WBGene00045749	21ur-2613
No description available

WB:WBGene00045750	21ur-3704
No description available

WB:WBGene00045751	21ur-2649
No description available

WB:WBGene00045752	21ur-909
No description available

WB:WBGene00045753	21ur-2356
No description available

WB:WBGene00045754	21ur-3041
No description available

WB:WBGene00045755	21ur-506
No description available

WB:WBGene00045756	21ur-4821
No description available

WB:WBGene00045757	21ur-4437
No description available

WB:WBGene00045758	21ur-133
No description available

WB:WBGene00045759	21ur-5218
No description available

WB:WBGene00045760	21ur-4478
No description available

WB:WBGene00045761	21ur-3127
No description available

WB:WBGene00045762	21ur-1620
No description available

WB:WBGene00045763	21ur-3601
No description available

WB:WBGene00045764	21ur-2085
No description available

WB:WBGene00045765	21ur-4567
No description available

WB:WBGene00045766	21ur-279
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00045767	21ur-2961
No description available

WB:WBGene00045768	21ur-5176
No description available

WB:WBGene00045769	21ur-1922
No description available

WB:WBGene00045770	21ur-5265
No description available

WB:WBGene00045771	21ur-237
No description available

WB:WBGene00045772	21ur-4898
No description available

WB:WBGene00045773	21ur-5304
No description available

WB:WBGene00045774	21ur-4765
No description available

WB:WBGene00045775	21ur-710
No description available

WB:WBGene00045776	21ur-3475
No description available

WB:WBGene00045777	21ur-3137
No description available

WB:WBGene00045778	21ur-1912
No description available

WB:WBGene00045779	21ur-3112
No description available

WB:WBGene00045780	21ur-1878
No description available

WB:WBGene00045781	21ur-2913
No description available

WB:WBGene00045782	21ur-4300
No description available

WB:WBGene00045783	21ur-447
No description available

WB:WBGene00045784	21ur-1
No description available

WB:WBGene00045785	21ur-520
No description available

WB:WBGene00045786	21ur-1018
No description available

WB:WBGene00045787	21ur-3818
No description available

WB:WBGene00045788	21ur-3836
No description available

WB:WBGene00045789	21ur-5257
No description available

WB:WBGene00045790	21ur-4773
No description available

WB:WBGene00045791	21ur-1977
No description available

WB:WBGene00045792	21ur-1072
No description available

WB:WBGene00045793	21ur-3911
No description available

WB:WBGene00045794	21ur-1550
No description available

WB:WBGene00045795	21ur-289
No description available

WB:WBGene00045796	21ur-3106
No description available

WB:WBGene00045797	21ur-2624
Is affected by several genes including hsp-6; hpl-2; and numr-1 based on RNA-seq studies.

WB:WBGene00045798	21ur-5413
No description available

WB:WBGene00045799	21ur-2826
No description available

WB:WBGene00045800	21ur-986
No description available

WB:WBGene00045801	21ur-1539
No description available

WB:WBGene00045802	21ur-1687
No description available

WB:WBGene00045803	21ur-1769
No description available

WB:WBGene00045804	21ur-1354
No description available

WB:WBGene00045805	21ur-3767
No description available

WB:WBGene00045806	21ur-1413
No description available

WB:WBGene00045807	21ur-2250
No description available

WB:WBGene00045808	21ur-1627
No description available

WB:WBGene00045809	21ur-630
No description available

WB:WBGene00045810	21ur-3054
No description available

WB:WBGene00045811	21ur-1502
No description available

WB:WBGene00045812	21ur-3808
No description available

WB:WBGene00045813	21ur-3942
No description available

WB:WBGene00045814	21ur-5079
No description available

WB:WBGene00045815	21ur-1284
No description available

WB:WBGene00045816	21ur-73
No description available

WB:WBGene00045817	21ur-4793
No description available

WB:WBGene00045818	21ur-3584
No description available

WB:WBGene00045819	21ur-5261
No description available

WB:WBGene00045820	21ur-2113
No description available

WB:WBGene00045821	21ur-3060
No description available

WB:WBGene00045822	21ur-4192
No description available

WB:WBGene00045823	21ur-1895
No description available

WB:WBGene00045824	21ur-4351
No description available

WB:WBGene00045825	21ur-2587
No description available

WB:WBGene00045826	21ur-1680
No description available

WB:WBGene00045827	21ur-1481
No description available

WB:WBGene00045828	21ur-5116
No description available

WB:WBGene00045829	21ur-2034
No description available

WB:WBGene00045830	21ur-4950
No description available

WB:WBGene00045831	21ur-646
No description available

WB:WBGene00045832	21ur-1037
No description available

WB:WBGene00045833	21ur-4327
No description available

WB:WBGene00045834	21ur-552
No description available

WB:WBGene00045835	21ur-1249
No description available

WB:WBGene00045836	21ur-678
No description available

WB:WBGene00045837	21ur-155
No description available

WB:WBGene00045838	21ur-2719
No description available

WB:WBGene00045839	21ur-4954
No description available

WB:WBGene00045840	21ur-2725
No description available

WB:WBGene00045841	21ur-436
No description available

WB:WBGene00045842	21ur-1438
No description available

WB:WBGene00045843	21ur-4160
No description available

WB:WBGene00045844	21ur-1456
No description available

WB:WBGene00045845	21ur-1701
No description available

WB:WBGene00045846	21ur-4985
No description available

WB:WBGene00045847	21ur-4756
No description available

WB:WBGene00045848	21ur-2018
No description available

WB:WBGene00045849	21ur-5274
No description available

WB:WBGene00045850	21ur-2286
No description available

WB:WBGene00045851	21ur-3316
No description available

WB:WBGene00045852	21ur-4338
No description available

WB:WBGene00045853	21ur-1220
No description available

WB:WBGene00045854	21ur-2975
No description available

WB:WBGene00045855	21ur-4682
No description available

WB:WBGene00045856	21ur-3638
No description available

WB:WBGene00045857	21ur-2386
No description available

WB:WBGene00045858	21ur-5146
No description available

WB:WBGene00045859	21ur-5253
No description available

WB:WBGene00045860	21ur-31
No description available

WB:WBGene00045861	21ur-1147
No description available

WB:WBGene00045862	21ur-5013
No description available

WB:WBGene00045863	21ur-1894
No description available

WB:WBGene00045864	21ur-5172
No description available

WB:WBGene00045865	21ur-768
No description available

WB:WBGene00045866	21ur-3690
No description available

WB:WBGene00045867	21ur-880
No description available

WB:WBGene00045868	21ur-2141
No description available

WB:WBGene00045869	21ur-178
No description available

WB:WBGene00045870	21ur-2728
No description available

WB:WBGene00045871	21ur-4340
No description available

WB:WBGene00045872	21ur-906
No description available

WB:WBGene00045873	21ur-2345
No description available

WB:WBGene00045874	21ur-754
No description available

WB:WBGene00045875	21ur-58
No description available

WB:WBGene00045876	21ur-4409
No description available

WB:WBGene00045877	21ur-2707
No description available

WB:WBGene00045878	21ur-4669
No description available

WB:WBGene00045879	21ur-4724
No description available

WB:WBGene00045880	21ur-3842
No description available

WB:WBGene00045881	21ur-3422
No description available

WB:WBGene00045882	21ur-4299
No description available

WB:WBGene00045883	21ur-752
No description available

WB:WBGene00045884	21ur-250
No description available

WB:WBGene00045885	21ur-1674
No description available

WB:WBGene00045886	21ur-48
No description available

WB:WBGene00045887	21ur-5194
No description available

WB:WBGene00045888	21ur-3779
No description available

WB:WBGene00045889	21ur-4711
No description available

WB:WBGene00045890	21ur-5113
No description available

WB:WBGene00045891	21ur-4772
No description available

WB:WBGene00045892	21ur-1005
No description available

WB:WBGene00045893	21ur-1904
No description available

WB:WBGene00045894	21ur-3545
No description available

WB:WBGene00045895	21ur-3246
No description available

WB:WBGene00045896	21ur-2957
No description available

WB:WBGene00045897	21ur-3781
No description available

WB:WBGene00045898	21ur-1647
No description available

WB:WBGene00045899	21ur-3253
No description available

WB:WBGene00045900	21ur-3297
No description available

WB:WBGene00045901	21ur-3291
No description available

WB:WBGene00045902	21ur-793
No description available

WB:WBGene00045903	21ur-1351
No description available

WB:WBGene00045904	21ur-4662
No description available

WB:WBGene00045905	21ur-5412
No description available

WB:WBGene00045906	21ur-3674
No description available

WB:WBGene00045907	21ur-3257
No description available

WB:WBGene00045908	21ur-2819
No description available

WB:WBGene00045909	21ur-1395
No description available

WB:WBGene00045910	21ur-3768
No description available

WB:WBGene00045911	21ur-3032
No description available

WB:WBGene00045912	21ur-3577
No description available

WB:WBGene00045913	21ur-1092
No description available

WB:WBGene00045914	21ur-3731
Is affected by efa-6 based on RNA-seq studies.

WB:WBGene00045915	21ur-4477
No description available

WB:WBGene00045916	21ur-3434
No description available

WB:WBGene00045917	21ur-1067
No description available

WB:WBGene00045918	21ur-4420
No description available

WB:WBGene00045919	21ur-1495
No description available

WB:WBGene00045920	21ur-3670
No description available

WB:WBGene00045921	21ur-5228
No description available

WB:WBGene00045922	21ur-4214
No description available

WB:WBGene00045923	21ur-3896
No description available

WB:WBGene00045924	21ur-1345
No description available

WB:WBGene00045925	21ur-1172
No description available

WB:WBGene00045926	21ur-274
No description available

WB:WBGene00045927	21ur-2239
No description available

WB:WBGene00045928	21ur-5209
No description available

WB:WBGene00045929	21ur-257
No description available

WB:WBGene00045930	21ur-844
No description available

WB:WBGene00045931	21ur-4427
No description available

WB:WBGene00045932	21ur-1418
No description available

WB:WBGene00045933	21ur-1134
No description available

WB:WBGene00045934	21ur-500
No description available

WB:WBGene00045935	21ur-398
No description available

WB:WBGene00045936	21ur-5171
No description available

WB:WBGene00045937	21ur-1628
No description available

WB:WBGene00045938	21ur-4316
No description available

WB:WBGene00045939	21ur-488
No description available

WB:WBGene00045940	21ur-529
No description available

WB:WBGene00045941	21ur-4541
No description available

WB:WBGene00045942	21ur-188
No description available

WB:WBGene00045943	21ur-1799
No description available

WB:WBGene00045944	21ur-2825
No description available

WB:WBGene00045945	21ur-2812
No description available

WB:WBGene00045946	21ur-894
No description available

WB:WBGene00045947	21ur-3590
No description available

WB:WBGene00045948	21ur-4033
No description available

WB:WBGene00045949	21ur-1113
No description available

WB:WBGene00045950	21ur-3425
No description available

WB:WBGene00045951	21ur-2421
No description available

WB:WBGene00045952	21ur-2941
No description available

WB:WBGene00045953	21ur-2023
No description available

WB:WBGene00045954	21ur-2048
No description available

WB:WBGene00045955	21ur-5198
No description available

WB:WBGene00045956	21ur-5048
No description available

WB:WBGene00045957	21ur-938
No description available

WB:WBGene00045958	21ur-4106
No description available

WB:WBGene00045959	21ur-4442
No description available

WB:WBGene00045960	21ur-4804
No description available

WB:WBGene00045961	21ur-164
No description available

WB:WBGene00045962	21ur-4126
No description available

WB:WBGene00045963	21ur-3197
No description available

WB:WBGene00045964	21ur-2594
No description available

WB:WBGene00045965	21ur-4125
No description available

WB:WBGene00045966	21ur-1954
No description available

WB:WBGene00045967	21ur-4061
No description available

WB:WBGene00045968	21ur-1524
No description available

WB:WBGene00045969	21ur-1125
No description available

WB:WBGene00045970	21ur-1664
No description available

WB:WBGene00045971	21ur-3384
No description available

WB:WBGene00045972	21ur-514
No description available

WB:WBGene00045973	21ur-2657
No description available

WB:WBGene00045974	21ur-804
No description available

WB:WBGene00045975	21ur-2206
No description available

WB:WBGene00045976	21ur-4551
No description available

WB:WBGene00045977	21ur-2859
No description available

WB:WBGene00045978	21ur-463
No description available

WB:WBGene00045979	21ur-544
No description available

WB:WBGene00045980	21ur-2129
No description available

WB:WBGene00045981	21ur-992
No description available

WB:WBGene00045982	21ur-1199
No description available

WB:WBGene00045983	21ur-3771
No description available

WB:WBGene00045984	21ur-4067
No description available

WB:WBGene00045985	21ur-1790
No description available

WB:WBGene00045986	21ur-1165
No description available

WB:WBGene00045987	21ur-1441
No description available

WB:WBGene00045988	21ur-649
No description available

WB:WBGene00045989	21ur-584
No description available

WB:WBGene00045990	21ur-3373
No description available

WB:WBGene00045991	21ur-533
No description available

WB:WBGene00045992	21ur-2309
No description available

WB:WBGene00045993	21ur-1433
No description available

WB:WBGene00045994	21ur-5323
No description available

WB:WBGene00045995	21ur-13
No description available

WB:WBGene00045996	21ur-2495
No description available

WB:WBGene00045997	21ur-3903
No description available

WB:WBGene00045998	21ur-700
No description available

WB:WBGene00045999	21ur-4243
No description available

WB:WBGene00046000	21ur-4161
No description available

WB:WBGene00046001	21ur-2801
No description available

WB:WBGene00046002	21ur-3048
No description available

WB:WBGene00046003	21ur-2997
No description available

WB:WBGene00046004	21ur-1621
No description available

WB:WBGene00046005	21ur-3478
No description available

WB:WBGene00046006	21ur-2362
No description available

WB:WBGene00046007	21ur-4055
No description available

WB:WBGene00046008	21ur-3360
No description available

WB:WBGene00046009	21ur-2849
No description available

WB:WBGene00046010	21ur-2648
No description available

WB:WBGene00046011	21ur-5342
No description available

WB:WBGene00046012	21ur-2424
No description available

WB:WBGene00046013	21ur-5021
No description available

WB:WBGene00046014	21ur-2448
No description available

WB:WBGene00046015	21ur-963
No description available

WB:WBGene00046016	21ur-2994
No description available

WB:WBGene00046017	21ur-50
No description available

WB:WBGene00046018	21ur-4221
No description available

WB:WBGene00046019	21ur-1857
No description available

WB:WBGene00046020	21ur-3185
No description available

WB:WBGene00046021	21ur-76
No description available

WB:WBGene00046022	21ur-2945
No description available

WB:WBGene00046023	21ur-292
No description available

WB:WBGene00046024	21ur-2625
No description available

WB:WBGene00046025	21ur-5231
No description available

WB:WBGene00046026	21ur-2556
No description available

WB:WBGene00046027	21ur-2007
No description available

WB:WBGene00046028	21ur-1881
No description available

WB:WBGene00046029	21ur-505
No description available

WB:WBGene00046030	21ur-3209
No description available

WB:WBGene00046031	21ur-1747
No description available

WB:WBGene00046032	21ur-4085
No description available

WB:WBGene00046033	21ur-4741
No description available

WB:WBGene00046034	21ur-4381
No description available

WB:WBGene00046035	21ur-3101
No description available

WB:WBGene00046036	21ur-4419
No description available

WB:WBGene00046037	21ur-1690
No description available

WB:WBGene00046038	21ur-729
No description available

WB:WBGene00046039	21ur-1340
No description available

WB:WBGene00046040	21ur-1659
No description available

WB:WBGene00046041	21ur-2213
No description available

WB:WBGene00046042	21ur-2163
No description available

WB:WBGene00046043	21ur-2794
No description available

WB:WBGene00046044	21ur-3565
No description available

WB:WBGene00046045	21ur-3761
No description available

WB:WBGene00046046	21ur-1920
No description available

WB:WBGene00046047	21ur-2923
No description available

WB:WBGene00046048	21ur-869
No description available

WB:WBGene00046049	21ur-5303
No description available

WB:WBGene00046050	21ur-1865
No description available

WB:WBGene00046051	21ur-631
No description available

WB:WBGene00046052	21ur-825
No description available

WB:WBGene00046053	21ur-3599
Is affected by daf-2 based on microarray studies.

WB:WBGene00046054	21ur-5208
No description available

WB:WBGene00046055	21ur-1934
No description available

WB:WBGene00046056	21ur-3544
No description available

WB:WBGene00046057	21ur-1696
No description available

WB:WBGene00046058	21ur-1274
No description available

WB:WBGene00046059	21ur-1837
No description available

WB:WBGene00046060	21ur-2661
No description available

WB:WBGene00046061	21ur-919
No description available

WB:WBGene00046062	21ur-3336
No description available

WB:WBGene00046063	21ur-3570
No description available

WB:WBGene00046064	21ur-5051
No description available

WB:WBGene00046065	21ur-1383
No description available

WB:WBGene00046066	21ur-391
No description available

WB:WBGene00046067	21ur-4480
No description available

WB:WBGene00046068	21ur-1845
No description available

WB:WBGene00046069	21ur-3010
No description available

WB:WBGene00046070	21ur-3871
No description available

WB:WBGene00046071	21ur-2883
No description available

WB:WBGene00046072	21ur-727
No description available

WB:WBGene00046073	21ur-1591
No description available

WB:WBGene00046074	21ur-1918
No description available

WB:WBGene00046075	21ur-4616
No description available

WB:WBGene00046076	21ur-5404
No description available

WB:WBGene00046077	21ur-5213
No description available

WB:WBGene00046078	21ur-299
No description available

WB:WBGene00046079	21ur-1001
No description available

WB:WBGene00046080	21ur-1426
No description available

WB:WBGene00046081	21ur-4624
No description available

WB:WBGene00046082	21ur-912
No description available

WB:WBGene00046083	21ur-2734
No description available

WB:WBGene00046084	21ur-1042
No description available

WB:WBGene00046085	21ur-23
No description available

WB:WBGene00046086	21ur-325
No description available

WB:WBGene00046087	21ur-734
No description available

WB:WBGene00046088	21ur-409
No description available

WB:WBGene00046089	21ur-2171
No description available

WB:WBGene00046090	21ur-5053
No description available

WB:WBGene00046091	21ur-1566
No description available

WB:WBGene00046092	21ur-41
No description available

WB:WBGene00046093	21ur-2297
No description available

WB:WBGene00046094	21ur-265
No description available

WB:WBGene00046095	21ur-2391
No description available

WB:WBGene00046096	21ur-1686
No description available

WB:WBGene00046097	21ur-971
No description available

WB:WBGene00046098	21ur-4091
No description available

WB:WBGene00046099	21ur-2017
No description available

WB:WBGene00046100	21ur-2779
No description available

WB:WBGene00046101	21ur-146
No description available

WB:WBGene00046102	21ur-4653
No description available

WB:WBGene00046103	21ur-3464
No description available

WB:WBGene00046104	21ur-4454
No description available

WB:WBGene00046105	21ur-191
No description available

WB:WBGene00046106	21ur-480
No description available

WB:WBGene00046107	21ur-400
No description available

WB:WBGene00046108	21ur-4846
No description available

WB:WBGene00046109	21ur-2935
No description available

WB:WBGene00046110	21ur-1289
No description available

WB:WBGene00046111	21ur-4116
No description available

WB:WBGene00046112	21ur-2751
No description available

WB:WBGene00046113	21ur-1190
No description available

WB:WBGene00046114	21ur-2298
No description available

WB:WBGene00046115	21ur-2939
No description available

WB:WBGene00046116	21ur-2746
No description available

WB:WBGene00046117	21ur-2479
Is affected by lem-2 based on RNA-seq studies.

WB:WBGene00046118	21ur-3327
No description available

WB:WBGene00046119	21ur-2409
No description available

WB:WBGene00046120	21ur-3797
No description available

WB:WBGene00046121	21ur-3554
No description available

WB:WBGene00046122	21ur-4738
No description available

WB:WBGene00046123	21ur-4521
No description available

WB:WBGene00046124	21ur-2672
No description available

WB:WBGene00046125	21ur-1236
No description available

WB:WBGene00046126	21ur-2837
No description available

WB:WBGene00046127	21ur-3884
No description available

WB:WBGene00046128	21ur-305
No description available

WB:WBGene00046129	21ur-4457
No description available

WB:WBGene00046130	21ur-3376
No description available

WB:WBGene00046131	21ur-2193
No description available

WB:WBGene00046132	21ur-4375
No description available

WB:WBGene00046133	21ur-2638
No description available

WB:WBGene00046134	21ur-3999
No description available

WB:WBGene00046135	21ur-1264
No description available

WB:WBGene00046136	21ur-888
No description available

WB:WBGene00046137	21ur-1033
No description available

WB:WBGene00046138	21ur-2220
No description available

WB:WBGene00046139	21ur-86
No description available

WB:WBGene00046140	21ur-3206
No description available

WB:WBGene00046141	21ur-487
No description available

WB:WBGene00046142	21ur-983
No description available

WB:WBGene00046143	21ur-4973
No description available

WB:WBGene00046144	21ur-3756
No description available

WB:WBGene00046145	21ur-3658
No description available

WB:WBGene00046146	21ur-3158
No description available

WB:WBGene00046147	21ur-3223
No description available

WB:WBGene00046148	21ur-2402
No description available

WB:WBGene00046149	21ur-225
No description available

WB:WBGene00046150	21ur-4885
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046151	21ur-2319
No description available

WB:WBGene00046152	21ur-4143
No description available

WB:WBGene00046153	21ur-4749
No description available

WB:WBGene00046154	21ur-4599
No description available

WB:WBGene00046155	21ur-5377
No description available

WB:WBGene00046156	21ur-1546
No description available

WB:WBGene00046157	21ur-2076
No description available

WB:WBGene00046158	21ur-1153
No description available

WB:WBGene00046159	21ur-5181
No description available

WB:WBGene00046160	21ur-1718
No description available

WB:WBGene00046161	21ur-816
No description available

WB:WBGene00046162	21ur-1402
No description available

WB:WBGene00046163	21ur-361
No description available

WB:WBGene00046164	21ur-5001
No description available

WB:WBGene00046165	21ur-410
No description available

WB:WBGene00046166	21ur-2455
No description available

WB:WBGene00046167	21ur-2338
No description available

WB:WBGene00046168	21ur-2603
No description available

WB:WBGene00046169	21ur-4763
No description available

WB:WBGene00046170	21ur-1512
No description available

WB:WBGene00046171	21ur-51
No description available

WB:WBGene00046172	21ur-1279
No description available

WB:WBGene00046173	21ur-3233
No description available

WB:WBGene00046174	21ur-653
No description available

WB:WBGene00046175	21ur-745
No description available

WB:WBGene00046176	21ur-3971
No description available

WB:WBGene00046177	21ur-2344
No description available

WB:WBGene00046178	21ur-1872
No description available

WB:WBGene00046179	21ur-663
No description available

WB:WBGene00046180	21ur-498
No description available

WB:WBGene00046181	21ur-1650
No description available

WB:WBGene00046182	21ur-3294
No description available

WB:WBGene00046183	21ur-4540
No description available

WB:WBGene00046184	21ur-491
No description available

WB:WBGene00046185	21ur-546
No description available

WB:WBGene00046186	21ur-1420
No description available

WB:WBGene00046187	21ur-4
No description available

WB:WBGene00046188	21ur-2647
No description available

WB:WBGene00046189	21ur-2354
No description available

WB:WBGene00046190	21ur-3976
No description available

WB:WBGene00046191	21ur-3788
No description available

WB:WBGene00046192	21ur-3682
No description available

WB:WBGene00046193	21ur-3287
No description available

WB:WBGene00046194	21ur-2435
No description available

WB:WBGene00046195	21ur-3526
No description available

WB:WBGene00046196	21ur-1266
No description available

WB:WBGene00046197	21ur-1841
No description available

WB:WBGene00046198	21ur-1812
No description available

WB:WBGene00046199	21ur-3654
No description available

WB:WBGene00046200	21ur-2225
No description available

WB:WBGene00046201	21ur-5313
No description available

WB:WBGene00046202	21ur-4236
No description available

WB:WBGene00046203	21ur-1177
No description available

WB:WBGene00046204	21ur-1120
No description available

WB:WBGene00046205	21ur-5165
No description available

WB:WBGene00046206	21ur-2890
No description available

WB:WBGene00046207	21ur-3238
No description available

WB:WBGene00046208	21ur-1304
No description available

WB:WBGene00046209	21ur-333
No description available

WB:WBGene00046210	21ur-5266
No description available

WB:WBGene00046211	21ur-3035
No description available

WB:WBGene00046212	21ur-2987
No description available

WB:WBGene00046213	21ur-4622
No description available

WB:WBGene00046214	21ur-3184
No description available

WB:WBGene00046215	21ur-377
No description available

WB:WBGene00046216	21ur-3528
No description available

WB:WBGene00046217	21ur-3408
No description available

WB:WBGene00046218	21ur-2688
No description available

WB:WBGene00046219	21ur-38
No description available

WB:WBGene00046220	21ur-3131
No description available

WB:WBGene00046221	21ur-3061
No description available

WB:WBGene00046222	21ur-5453
No description available

WB:WBGene00046223	21ur-5217
No description available

WB:WBGene00046224	21ur-4164
No description available

WB:WBGene00046225	21ur-2035
No description available

WB:WBGene00046226	21ur-3271
No description available

WB:WBGene00046227	21ur-1936
No description available

WB:WBGene00046228	21ur-692
No description available

WB:WBGene00046229	21ur-4699
No description available

WB:WBGene00046230	21ur-1835
No description available

WB:WBGene00046231	21ur-102
No description available

WB:WBGene00046232	21ur-1053
No description available

WB:WBGene00046233	21ur-4845
No description available

WB:WBGene00046234	21ur-2303
No description available

WB:WBGene00046235	21ur-3441
No description available

WB:WBGene00046236	21ur-4426
No description available

WB:WBGene00046237	21ur-1968
No description available

WB:WBGene00046238	21ur-5086
No description available

WB:WBGene00046239	21ur-881
No description available

WB:WBGene00046240	21ur-4792
No description available

WB:WBGene00046241	21ur-3516
No description available

WB:WBGene00046242	21ur-4291
No description available

WB:WBGene00046243	21ur-4581
No description available

WB:WBGene00046244	21ur-4326
No description available

WB:WBGene00046245	21ur-4965
No description available

WB:WBGene00046246	21ur-4605
No description available

WB:WBGene00046247	21ur-572
No description available

WB:WBGene00046248	21ur-197
No description available

WB:WBGene00046249	21ur-1283
No description available

WB:WBGene00046250	21ur-2119
No description available

WB:WBGene00046251	21ur-579
No description available

WB:WBGene00046252	21ur-390
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046253	21ur-5384
No description available

WB:WBGene00046254	21ur-1273
No description available

WB:WBGene00046255	21ur-1038
No description available

WB:WBGene00046256	21ur-3196
No description available

WB:WBGene00046257	21ur-4577
No description available

WB:WBGene00046258	21ur-654
No description available

WB:WBGene00046259	21ur-4511
No description available

WB:WBGene00046260	21ur-2695
No description available

WB:WBGene00046261	21ur-4114
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046262	21ur-21
No description available

WB:WBGene00046263	21ur-3635
No description available

WB:WBGene00046264	21ur-1258
No description available

WB:WBGene00046265	21ur-2903
No description available

WB:WBGene00046266	21ur-4849
No description available

WB:WBGene00046267	21ur-297
No description available

WB:WBGene00046268	21ur-416
No description available

WB:WBGene00046269	21ur-4638
No description available

WB:WBGene00046270	21ur-2058
No description available

WB:WBGene00046271	21ur-1762
No description available

WB:WBGene00046272	21ur-4915
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00046273	21ur-4134
No description available

WB:WBGene00046274	21ur-597
No description available

WB:WBGene00046275	21ur-1241
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046276	21ur-3809
No description available

WB:WBGene00046277	21ur-2131
No description available

WB:WBGene00046278	21ur-610
No description available

WB:WBGene00046279	21ur-2442
No description available

WB:WBGene00046280	21ur-3189
No description available

WB:WBGene00046281	21ur-606
No description available

WB:WBGene00046282	21ur-1640
No description available

WB:WBGene00046283	21ur-499
No description available

WB:WBGene00046284	21ur-5242
No description available

WB:WBGene00046285	21ur-311
No description available

WB:WBGene00046286	21ur-5233
No description available

WB:WBGene00046287	21ur-4694
No description available

WB:WBGene00046288	21ur-2915
No description available

WB:WBGene00046289	21ur-5066
No description available

WB:WBGene00046290	21ur-5038
No description available

WB:WBGene00046291	21ur-337
No description available

WB:WBGene00046292	21ur-1079
No description available

WB:WBGene00046293	21ur-1702
No description available

WB:WBGene00046294	21ur-2380
No description available

WB:WBGene00046295	21ur-1206
No description available

WB:WBGene00046296	21ur-2530
No description available

WB:WBGene00046297	21ur-1234
No description available

WB:WBGene00046298	21ur-2468
No description available

WB:WBGene00046299	21ur-1867
No description available

WB:WBGene00046300	21ur-554
No description available

WB:WBGene00046301	21ur-4813
No description available

WB:WBGene00046302	21ur-2374
No description available

WB:WBGene00046303	21ur-4759
No description available

WB:WBGene00046304	21ur-5112
No description available

WB:WBGene00046305	21ur-3997
No description available

WB:WBGene00046306	21ur-1913
No description available

WB:WBGene00046307	21ur-648
No description available

WB:WBGene00046308	21ur-362
No description available

WB:WBGene00046309	21ur-2727
No description available

WB:WBGene00046310	21ur-4644
No description available

WB:WBGene00046311	21ur-245
No description available

WB:WBGene00046312	21ur-2870
No description available

WB:WBGene00046313	21ur-3912
No description available

WB:WBGene00046314	21ur-5435
No description available

WB:WBGene00046315	21ur-4869
No description available

WB:WBGene00046316	21ur-5262
No description available

WB:WBGene00046317	21ur-3509
No description available

WB:WBGene00046318	21ur-4870
No description available

WB:WBGene00046319	21ur-193
No description available

WB:WBGene00046320	21ur-2840
No description available

WB:WBGene00046321	21ur-3611
No description available

WB:WBGene00046322	21ur-3919
No description available

WB:WBGene00046323	21ur-3143
No description available

WB:WBGene00046324	21ur-2168
No description available

WB:WBGene00046325	21ur-2449
No description available

WB:WBGene00046326	21ur-585
No description available

WB:WBGene00046327	21ur-67
No description available

WB:WBGene00046328	21ur-456
No description available

WB:WBGene00046329	21ur-2278
No description available

WB:WBGene00046330	21ur-4031
No description available

WB:WBGene00046331	21ur-4971
No description available

WB:WBGene00046332	21ur-3261
No description available

WB:WBGene00046333	21ur-4319
No description available

WB:WBGene00046334	21ur-4629
No description available

WB:WBGene00046335	21ur-2814
No description available

WB:WBGene00046336	21ur-1248
No description available

WB:WBGene00046337	21ur-2162
No description available

WB:WBGene00046338	21ur-5002
No description available

WB:WBGene00046339	21ur-3454
No description available

WB:WBGene00046340	21ur-5029
No description available

WB:WBGene00046341	21ur-1154
No description available

WB:WBGene00046342	21ur-2871
No description available

WB:WBGene00046343	21ur-2955
No description available

WB:WBGene00046344	21ur-4309
No description available

WB:WBGene00046345	21ur-3647
No description available

WB:WBGene00046346	21ur-4399
No description available

WB:WBGene00046347	21ur-1187
No description available

WB:WBGene00046348	21ur-342
No description available

WB:WBGene00046349	21ur-1886
No description available

WB:WBGene00046350	21ur-3314
No description available

WB:WBGene00046351	21ur-3150
No description available

WB:WBGene00046352	21ur-3433
No description available

WB:WBGene00046353	21ur-2960
No description available

WB:WBGene00046354	21ur-4268
No description available

WB:WBGene00046355	21ur-4549
No description available

WB:WBGene00046356	21ur-4831
No description available

WB:WBGene00046357	21ur-2820
No description available

WB:WBGene00046358	21ur-4185
No description available

WB:WBGene00046359	21ur-1750
No description available

WB:WBGene00046360	21ur-4712
No description available

WB:WBGene00046361	21ur-5450
No description available

WB:WBGene00046362	21ur-3114
No description available

WB:WBGene00046363	21ur-4436
No description available

WB:WBGene00046364	21ur-4924
No description available

WB:WBGene00046365	21ur-532
No description available

WB:WBGene00046366	21ur-673
No description available

WB:WBGene00046367	21ur-3062
No description available

WB:WBGene00046368	21ur-920
No description available

WB:WBGene00046369	21ur-4717
No description available

WB:WBGene00046370	21ur-3175
No description available

WB:WBGene00046371	21ur-1570
No description available

WB:WBGene00046372	21ur-4897
No description available

WB:WBGene00046373	21ur-4857
No description available

WB:WBGene00046374	21ur-4539
No description available

WB:WBGene00046375	21ur-3397
No description available

WB:WBGene00046376	21ur-81
No description available

WB:WBGene00046377	21ur-3921
No description available

WB:WBGene00046378	21ur-1103
No description available

WB:WBGene00046379	21ur-147
No description available

WB:WBGene00046380	21ur-3107
No description available

WB:WBGene00046381	21ur-4508
No description available

WB:WBGene00046382	21ur-5258
No description available

WB:WBGene00046383	21ur-3174
No description available

WB:WBGene00046384	21ur-4931
No description available

WB:WBGene00046385	21ur-5441
No description available

WB:WBGene00046386	21ur-1119
No description available

WB:WBGene00046387	21ur-350
No description available

WB:WBGene00046388	21ur-5106
No description available

WB:WBGene00046389	21ur-492
No description available

WB:WBGene00046390	21ur-1602
No description available

WB:WBGene00046391	21ur-2720
No description available

WB:WBGene00046392	21ur-2453
No description available

WB:WBGene00046393	21ur-5287
No description available

WB:WBGene00046394	21ur-1503
No description available

WB:WBGene00046395	21ur-4681
No description available

WB:WBGene00046396	21ur-5414
No description available

WB:WBGene00046397	21ur-1460
No description available

WB:WBGene00046398	21ur-2584
No description available

WB:WBGene00046399	21ur-2750
No description available

WB:WBGene00046400	21ur-769
No description available

WB:WBGene00046401	21ur-2251
No description available

WB:WBGene00046402	21ur-954
No description available

WB:WBGene00046403	21ur-3642
No description available

WB:WBGene00046404	21ur-4955
Is affected by daf-2 based on microarray studies.

WB:WBGene00046405	21ur-1198
No description available

WB:WBGene00046406	21ur-5338
No description available

WB:WBGene00046407	21ur-1897
No description available

WB:WBGene00046408	21ur-1525
No description available

WB:WBGene00046409	21ur-241
No description available

WB:WBGene00046410	21ur-645
No description available

WB:WBGene00046411	21ur-4453
No description available

WB:WBGene00046412	21ur-3834
No description available

WB:WBGene00046413	21ur-4212
No description available

WB:WBGene00046414	21ur-4330
No description available

WB:WBGene00046415	21ur-1906
No description available

WB:WBGene00046416	21ur-3796
No description available

WB:WBGene00046417	21ur-1212
No description available

WB:WBGene00046418	21ur-1310
No description available

WB:WBGene00046419	21ur-1228
No description available

WB:WBGene00046420	21ur-403
No description available

WB:WBGene00046421	21ur-281
No description available

WB:WBGene00046422	21ur-5358
No description available

WB:WBGene00046423	21ur-4341
No description available

WB:WBGene00046424	21ur-1084
No description available

WB:WBGene00046425	21ur-3843
No description available

WB:WBGene00046426	21ur-3120
No description available

WB:WBGene00046427	21ur-5254
No description available

WB:WBGene00046428	21ur-2285
No description available

WB:WBGene00046429	21ur-5109
No description available

WB:WBGene00046430	21ur-4986
No description available

WB:WBGene00046431	21ur-3927
No description available

WB:WBGene00046432	21ur-2097
No description available

WB:WBGene00046433	21ur-3008
No description available

WB:WBGene00046434	21ur-755
No description available

WB:WBGene00046435	21ur-1626
No description available

WB:WBGene00046436	21ur-4588
No description available

WB:WBGene00046437	21ur-1146
No description available

WB:WBGene00046438	21ur-2159
No description available

WB:WBGene00046439	21ur-2711
No description available

WB:WBGene00046440	21ur-1703
No description available

WB:WBGene00046441	21ur-2888
No description available

WB:WBGene00046442	21ur-4458
No description available

WB:WBGene00046443	21ur-2030
No description available

WB:WBGene00046444	21ur-2920
No description available

WB:WBGene00046445	21ur-2974
No description available

WB:WBGene00046446	21ur-4004
No description available

WB:WBGene00046447	21ur-701
No description available

WB:WBGene00046448	21ur-1423
No description available

WB:WBGene00046449	21ur-4410
No description available

WB:WBGene00046450	21ur-2410
No description available

WB:WBGene00046451	21ur-3016
No description available

WB:WBGene00046452	21ur-5355
No description available

WB:WBGene00046453	21ur-5040
No description available

WB:WBGene00046454	21ur-1439
No description available

WB:WBGene00046455	21ur-156
No description available

WB:WBGene00046456	21ur-234
No description available

WB:WBGene00046457	21ur-4951
No description available

WB:WBGene00046458	21ur-753
No description available

WB:WBGene00046459	21ur-5280
No description available

WB:WBGene00046460	21ur-2847
No description available

WB:WBGene00046461	21ur-2142
No description available

WB:WBGene00046462	21ur-4554
No description available

WB:WBGene00046463	21ur-83
No description available

WB:WBGene00046464	21ur-1768
No description available

WB:WBGene00046465	21ur-871
No description available

WB:WBGene00046466	21ur-158
No description available

WB:WBGene00046467	21ur-1494
No description available

WB:WBGene00046468	21ur-2203
No description available

WB:WBGene00046469	21ur-1141
No description available

WB:WBGene00046470	21ur-4814
No description available

WB:WBGene00046471	21ur-115
No description available

WB:WBGene00046472	21ur-4852
No description available

WB:WBGene00046473	21ur-2731
No description available

WB:WBGene00046474	21ur-2169
No description available

WB:WBGene00046475	21ur-4430
No description available

WB:WBGene00046476	21ur-1163
No description available

WB:WBGene00046477	21ur-2396
No description available

WB:WBGene00046478	21ur-905
No description available

WB:WBGene00046479	21ur-5125
No description available

WB:WBGene00046480	21ur-5361
No description available

WB:WBGene00046481	21ur-3075
No description available

WB:WBGene00046482	21ur-97
No description available

WB:WBGene00046483	21ur-4349
No description available

WB:WBGene00046484	21ur-3812
No description available

WB:WBGene00046485	21ur-1976
Is affected by eat-2 based on microarray studies.

WB:WBGene00046486	21ur-561
No description available

WB:WBGene00046487	21ur-4518
No description available

WB:WBGene00046488	21ur-351
No description available

WB:WBGene00046489	21ur-2187
No description available

WB:WBGene00046490	21ur-4475
No description available

WB:WBGene00046491	21ur-1317
No description available

WB:WBGene00046492	21ur-876
No description available

WB:WBGene00046493	21ur-1996
No description available

WB:WBGene00046494	21ur-4824
No description available

WB:WBGene00046495	21ur-765
No description available

WB:WBGene00046496	21ur-4253
No description available

WB:WBGene00046497	21ur-3346
No description available

WB:WBGene00046498	21ur-3866
No description available

WB:WBGene00046499	21ur-3052
No description available

WB:WBGene00046500	21ur-396
No description available

WB:WBGene00046501	21ur-4401
No description available

WB:WBGene00046502	21ur-4310
No description available

WB:WBGene00046503	21ur-25
No description available

WB:WBGene00046504	21ur-2355
No description available

WB:WBGene00046505	21ur-1775
No description available

WB:WBGene00046506	21ur-1726
No description available

WB:WBGene00046507	21ur-204
No description available

WB:WBGene00046508	21ur-2708
No description available

WB:WBGene00046509	21ur-718
No description available

WB:WBGene00046510	21ur-5088
No description available

WB:WBGene00046511	21ur-5074
No description available

WB:WBGene00046512	21ur-4359
No description available

WB:WBGene00046513	21ur-9
No description available

WB:WBGene00046514	21ur-2087
No description available

WB:WBGene00046515	21ur-3136
No description available

WB:WBGene00046516	21ur-212
No description available

WB:WBGene00046517	21ur-5064
No description available

WB:WBGene00046518	21ur-1461
Is affected by daf-2 based on microarray studies.

WB:WBGene00046519	21ur-3531
No description available

WB:WBGene00046520	21ur-4566
No description available

WB:WBGene00046521	21ur-3755
No description available

WB:WBGene00046522	21ur-5324
No description available

WB:WBGene00046523	21ur-4766
No description available

WB:WBGene00046524	21ur-823
No description available

WB:WBGene00046525	21ur-3001
No description available

WB:WBGene00046526	21ur-1326
No description available

WB:WBGene00046527	21ur-4795
No description available

WB:WBGene00046528	21ur-1581
No description available

WB:WBGene00046529	21ur-1465
No description available

WB:WBGene00046530	21ur-5175
No description available

WB:WBGene00046531	21ur-699
No description available

WB:WBGene00046532	21ur-1585
No description available

WB:WBGene00046533	21ur-3089
No description available

WB:WBGene00046534	21ur-807
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00046535	21ur-1127
No description available

WB:WBGene00046536	21ur-2153
No description available

WB:WBGene00046537	21ur-4574
No description available

WB:WBGene00046538	21ur-1019
No description available

WB:WBGene00046539	21ur-3381
No description available

WB:WBGene00046540	21ur-3819
No description available

WB:WBGene00046541	21ur-2417
No description available

WB:WBGene00046542	21ur-4463
Is affected by eat-2 based on microarray studies.

WB:WBGene00046543	21ur-619
No description available

WB:WBGene00046544	21ur-1489
No description available

WB:WBGene00046545	21ur-10
No description available

WB:WBGene00046546	21ur-583
No description available

WB:WBGene00046547	21ur-1688
No description available

WB:WBGene00046548	21ur-2743
No description available

WB:WBGene00046549	21ur-2149
No description available

WB:WBGene00046550	21ur-4356
No description available

WB:WBGene00046551	21ur-2090
No description available

WB:WBGene00046552	21ur-3850
No description available

WB:WBGene00046553	21ur-1368
No description available

WB:WBGene00046554	21ur-1693
No description available

WB:WBGene00046555	21ur-14
No description available

WB:WBGene00046556	21ur-3338
No description available

WB:WBGene00046557	21ur-4736
No description available

WB:WBGene00046558	21ur-1746
No description available

WB:WBGene00046559	21ur-4068
No description available

WB:WBGene00046560	21ur-2143
Is affected by eat-2 based on microarray studies.

WB:WBGene00046561	21ur-3749
No description available

WB:WBGene00046562	21ur-462
No description available

WB:WBGene00046563	21ur-4142
No description available

WB:WBGene00046564	21ur-1600
No description available

WB:WBGene00046565	21ur-1195
No description available

WB:WBGene00046566	21ur-3772
No description available

WB:WBGene00046567	21ur-937
No description available

WB:WBGene00046568	21ur-4380
No description available

WB:WBGene00046569	21ur-4805
No description available

WB:WBGene00046570	21ur-1715
No description available

WB:WBGene00046571	21ur-4610
No description available

WB:WBGene00046572	21ur-4027
No description available

WB:WBGene00046573	21ur-4289
No description available

WB:WBGene00046574	21ur-266
No description available

WB:WBGene00046575	21ur-4086
No description available

WB:WBGene00046576	21ur-680
No description available

WB:WBGene00046577	21ur-4193
No description available

WB:WBGene00046578	21ur-4464
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00046579	21ur-4014
No description available

WB:WBGene00046580	21ur-4244
No description available

WB:WBGene00046581	21ur-1201
No description available

WB:WBGene00046582	21ur-973
No description available

WB:WBGene00046583	21ur-2809
No description available

WB:WBGene00046584	21ur-205
No description available

WB:WBGene00046585	21ur-1545
No description available

WB:WBGene00046586	21ur-4372
No description available

WB:WBGene00046587	21ur-2040
No description available

WB:WBGene00046588	21ur-3215
No description available

WB:WBGene00046589	21ur-2999
No description available

WB:WBGene00046590	21ur-1663
No description available

WB:WBGene00046591	21ur-3157
No description available

WB:WBGene00046592	21ur-2525
No description available

WB:WBGene00046593	21ur-4443
No description available

WB:WBGene00046594	21ur-3902
No description available

WB:WBGene00046595	21ur-4109
No description available

WB:WBGene00046596	21ur-1412
No description available

WB:WBGene00046597	21ur-1508
No description available

WB:WBGene00046598	21ur-2555
No description available

WB:WBGene00046599	21ur-4015
No description available

WB:WBGene00046600	21ur-4062
No description available

WB:WBGene00046601	21ur-397
No description available

WB:WBGene00046602	21ur-2860
No description available

WB:WBGene00046603	21ur-2595
No description available

WB:WBGene00046604	21ur-2996
No description available

WB:WBGene00046605	21ur-4823
No description available

WB:WBGene00046606	21ur-4329
No description available

WB:WBGene00046607	21ur-2944
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046608	21ur-2501
No description available

WB:WBGene00046609	21ur-5299
No description available

WB:WBGene00046610	21ur-2995
No description available

WB:WBGene00046611	21ur-2081
No description available

WB:WBGene00046612	21ur-3076
No description available

WB:WBGene00046613	21ur-1430
No description available

WB:WBGene00046614	21ur-4150
No description available

WB:WBGene00046615	21ur-5343
No description available

WB:WBGene00046616	21ur-2418
No description available

WB:WBGene00046617	21ur-3723
No description available

WB:WBGene00046618	21ur-3479
No description available

WB:WBGene00046619	21ur-3712
No description available

WB:WBGene00046620	21ur-1691
No description available

WB:WBGene00046621	21ur-3543
No description available

WB:WBGene00046622	21ur-726
No description available

WB:WBGene00046623	21ur-3854
No description available

WB:WBGene00046624	21ur-517
No description available

WB:WBGene00046625	21ur-728
No description available

WB:WBGene00046626	21ur-5397
No description available

WB:WBGene00046627	21ur-2802
No description available

WB:WBGene00046628	21ur-2353
No description available

WB:WBGene00046629	21ur-2084
No description available

WB:WBGene00046630	21ur-1825
No description available

WB:WBGene00046631	21ur-515
No description available

WB:WBGene00046632	21ur-3963
No description available

WB:WBGene00046633	21ur-2487
No description available

WB:WBGene00046634	21ur-1785
No description available

WB:WBGene00046635	21ur-5016
No description available

WB:WBGene00046636	21ur-4153
No description available

WB:WBGene00046637	21ur-3258
No description available

WB:WBGene00046638	21ur-833
No description available

WB:WBGene00046639	21ur-3332
No description available

WB:WBGene00046640	21ur-2811
No description available

WB:WBGene00046641	21ur-4906
No description available

WB:WBGene00046642	21ur-3382
No description available

WB:WBGene00046643	21ur-4222
No description available

WB:WBGene00046644	21ur-2216
No description available

WB:WBGene00046645	21ur-3208
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00046646	21ur-508
No description available

WB:WBGene00046647	21ur-1836
No description available

WB:WBGene00046648	21ur-3389
No description available

WB:WBGene00046649	21ur-2
No description available

WB:WBGene00046650	21ur-1925
No description available

WB:WBGene00046651	21ur-2245
No description available

WB:WBGene00046652	21ur-187
No description available

WB:WBGene00046653	21ur-3546
No description available

WB:WBGene00046654	21ur-3780
No description available

WB:WBGene00046655	21ur-182
No description available

WB:WBGene00046656	21ur-1556
No description available

WB:WBGene00046657	21ur-3481
No description available

WB:WBGene00046658	21ur-4771
No description available

WB:WBGene00046659	21ur-1987
No description available

WB:WBGene00046660	21ur-5424
No description available

WB:WBGene00046661	21ur-4494
No description available

WB:WBGene00046662	21ur-4261
No description available

WB:WBGene00046663	21ur-885
No description available

WB:WBGene00046664	21ur-1093
No description available

WB:WBGene00046665	21ur-4620
No description available

WB:WBGene00046666	21ur-4277
No description available

WB:WBGene00046667	21ur-3778
No description available

WB:WBGene00046668	21ur-4944
No description available

WB:WBGene00046669	21ur-3673
No description available

WB:WBGene00046670	21ur-5395
No description available

WB:WBGene00046671	21ur-3566
No description available

WB:WBGene00046672	21ur-1252
No description available

WB:WBGene00046673	21ur-4099
No description available

WB:WBGene00046674	21ur-3404
No description available

WB:WBGene00046675	21ur-3769
No description available

WB:WBGene00046676	21ur-4203
No description available

WB:WBGene00046677	21ur-2228
No description available

WB:WBGene00046678	21ur-4936
No description available

WB:WBGene00046679	21ur-1316
No description available

WB:WBGene00046680	21ur-57
No description available

WB:WBGene00046681	21ur-4860
No description available

WB:WBGene00046682	21ur-2109
No description available

WB:WBGene00046683	21ur-3369
No description available

WB:WBGene00046684	21ur-797
No description available

WB:WBGene00046685	21ur-2403
No description available

WB:WBGene00046686	21ur-1066
No description available

WB:WBGene00046687	21ur-3049
No description available

WB:WBGene00046688	21ur-5193
No description available

WB:WBGene00046689	21ur-4331
No description available

WB:WBGene00046690	21ur-256
No description available

WB:WBGene00046691	21ur-4654
No description available

WB:WBGene00046692	21ur-2123
No description available

WB:WBGene00046693	21ur-3249
No description available

WB:WBGene00046694	21ur-5138
No description available

WB:WBGene00046695	21ur-2096
No description available

WB:WBGene00046696	21ur-964
No description available

WB:WBGene00046697	21ur-3410
No description available

WB:WBGene00046698	21ur-328
Is affected by sod-2 and atfs-1 based on RNA-seq studies.

WB:WBGene00046699	21ur-1396
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00046700	21ur-1798
No description available

WB:WBGene00046701	21ur-1171
No description available

WB:WBGene00046702	21ur-3424
No description available

WB:WBGene00046703	21ur-897
No description available

WB:WBGene00046704	21ur-666
No description available

WB:WBGene00046705	21ur-5045
No description available

WB:WBGene00046706	21ur-2940
No description available

WB:WBGene00046707	21ur-1948
No description available

WB:WBGene00046708	21ur-4092
No description available

WB:WBGene00046709	21ur-2043
No description available

WB:WBGene00046710	21ur-1209
No description available

WB:WBGene00046711	21ur-3245
No description available

WB:WBGene00046712	21ur-1004
No description available

WB:WBGene00046713	21ur-5197
No description available

WB:WBGene00046714	21ur-3254
No description available

WB:WBGene00046715	21ur-843
No description available

WB:WBGene00046716	21ur-2016
No description available

WB:WBGene00046717	21ur-4785
No description available

WB:WBGene00046718	21ur-4667
No description available

WB:WBGene00046719	21ur-3472
No description available

WB:WBGene00046720	21ur-3217
No description available

WB:WBGene00046721	21ur-2513
No description available

WB:WBGene00046722	21ur-4914
No description available

WB:WBGene00046723	21ur-2531
No description available

WB:WBGene00046724	21ur-486
No description available

WB:WBGene00046725	21ur-4120
No description available

WB:WBGene00046726	21ur-2422
No description available

WB:WBGene00046727	21ur-3375
No description available

WB:WBGene00046728	21ur-3977
No description available

WB:WBGene00046729	21ur-3629
No description available

WB:WBGene00046730	21ur-224
No description available

WB:WBGene00046731	21ur-1030
No description available

WB:WBGene00046732	21ur-4591
No description available

WB:WBGene00046733	21ur-372
No description available

WB:WBGene00046734	21ur-298
No description available

WB:WBGene00046735	21ur-744
No description available

WB:WBGene00046736	21ur-3465
No description available

WB:WBGene00046737	21ur-4175
No description available

WB:WBGene00046738	21ur-2667
No description available

WB:WBGene00046739	21ur-2470
No description available

WB:WBGene00046740	21ur-1447
No description available

WB:WBGene00046741	21ur-1887
No description available

WB:WBGene00046742	21ur-4643
No description available

WB:WBGene00046743	21ur-5271
No description available

WB:WBGene00046744	21ur-2411
No description available

WB:WBGene00046745	21ur-4974
No description available

WB:WBGene00046746	21ur-3293
No description available

WB:WBGene00046747	21ur-1263
No description available

WB:WBGene00046748	21ur-5059
No description available

WB:WBGene00046749	21ur-3224
No description available

WB:WBGene00046750	21ur-3604
No description available

WB:WBGene00046751	21ur-3578
No description available

WB:WBGene00046752	21ur-4398
No description available

WB:WBGene00046753	21ur-1180
No description available

WB:WBGene00046754	21ur-3657
No description available

WB:WBGene00046755	21ur-4054
No description available

WB:WBGene00046756	21ur-114
No description available

WB:WBGene00046757	21ur-2882
No description available

WB:WBGene00046758	21ur-4748
No description available

WB:WBGene00046759	21ur-531
No description available

WB:WBGene00046760	21ur-2623
No description available

WB:WBGene00046761	21ur-5282
No description available

WB:WBGene00046762	21ur-1513
No description available

WB:WBGene00046763	21ur-140
No description available

WB:WBGene00046764	21ur-126
No description available

WB:WBGene00046765	21ur-3337
No description available

WB:WBGene00046766	21ur-1028
No description available

WB:WBGene00046767	21ur-444
No description available

WB:WBGene00046768	21ur-1840
No description available

WB:WBGene00046769	21ur-3272
No description available

WB:WBGene00046770	21ur-1651
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046771	21ur-2361
No description available

WB:WBGene00046772	21ur-1346
No description available

WB:WBGene00046773	21ur-453
No description available

WB:WBGene00046774	21ur-4722
No description available

WB:WBGene00046775	21ur-2066
No description available

WB:WBGene00046776	21ur-3653
No description available

WB:WBGene00046777	21ur-189
No description available

WB:WBGene00046778	21ur-411
No description available

WB:WBGene00046779	21ur-4069
No description available

WB:WBGene00046780	21ur-5224
No description available

WB:WBGene00046781	21ur-2614
No description available

WB:WBGene00046782	21ur-773
No description available

WB:WBGene00046783	21ur-47
No description available

WB:WBGene00046784	21ur-3681
No description available

WB:WBGene00046785	21ur-664
No description available

WB:WBGene00046786	21ur-2992
No description available

WB:WBGene00046787	21ur-611
No description available

WB:WBGene00046788	21ur-5448
No description available

WB:WBGene00046789	21ur-5127
No description available

WB:WBGene00046790	21ur-2639
No description available

WB:WBGene00046791	21ur-3288
No description available

WB:WBGene00046792	21ur-1265
No description available

WB:WBGene00046793	21ur-479
No description available

WB:WBGene00046794	21ur-4270
No description available

WB:WBGene00046795	21ur-428
No description available

WB:WBGene00046796	21ur-2343
No description available

WB:WBGene00046797	21ur-889
No description available

WB:WBGene00046798	21ur-3100
No description available

WB:WBGene00046799	21ur-4740
No description available

WB:WBGene00046800	21ur-2752
No description available

WB:WBGene00046801	21ur-5227
No description available

WB:WBGene00046802	21ur-4520
No description available

WB:WBGene00046803	21ur-5302
No description available

WB:WBGene00046804	21ur-3011
No description available

WB:WBGene00046805	21ur-2703
No description available

WB:WBGene00046806	21ur-526
No description available

WB:WBGene00046807	21ur-369
No description available

WB:WBGene00046808	21ur-4826
No description available

WB:WBGene00046809	21ur-306
No description available

WB:WBGene00046810	21ur-1048
No description available

WB:WBGene00046811	21ur-2687
No description available

WB:WBGene00046812	21ur-4994
No description available

WB:WBGene00046813	21ur-591
No description available

WB:WBGene00046814	21ur-2282
No description available

WB:WBGene00046815	21ur-2662
No description available

WB:WBGene00046816	21ur-3571
No description available

WB:WBGene00046817	21ur-2192
No description available

WB:WBGene00046818	21ur-1864
No description available

WB:WBGene00046819	21ur-2490
No description available

WB:WBGene00046820	21ur-5207
No description available

WB:WBGene00046821	21ur-2640
No description available

WB:WBGene00046822	21ur-4727
No description available

WB:WBGene00046823	21ur-3237
No description available

WB:WBGene00046824	21ur-2423
No description available

WB:WBGene00046825	21ur-1590
No description available

WB:WBGene00046826	21ur-3729
No description available

WB:WBGene00046827	21ur-3452
No description available

WB:WBGene00046828	21ur-578
No description available

WB:WBGene00046829	21ur-4186
No description available

WB:WBGene00046830	21ur-3732
No description available

WB:WBGene00046831	21ur-1873
No description available

WB:WBGene00046832	21ur-534
No description available

WB:WBGene00046833	21ur-3984
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00046834	21ur-2702
No description available

WB:WBGene00046835	21ur-3169
No description available

WB:WBGene00046836	21ur-794
No description available

WB:WBGene00046837	21ur-2132
No description available

WB:WBGene00046838	21ur-1000
No description available

WB:WBGene00046839	21ur-3284
No description available

WB:WBGene00046840	21ur-4542
No description available

WB:WBGene00046841	21ur-1860
No description available

WB:WBGene00046842	21ur-3354
No description available

WB:WBGene00046843	21ur-2968
No description available

WB:WBGene00046844	21ur-2024
No description available

WB:WBGene00046845	21ur-3897
No description available

WB:WBGene00046846	21ur-423
No description available

WB:WBGene00046847	21ur-3887
No description available

WB:WBGene00046848	21ur-68
No description available

WB:WBGene00046849	21ur-273
No description available

WB:WBGene00046850	21ur-3740
No description available

WB:WBGene00046851	21ur-1919
No description available

WB:WBGene00046852	21ur-4705
No description available

WB:WBGene00046853	21ur-2934
No description available

WB:WBGene00046854	21ur-1164
No description available

WB:WBGene00046855	21ur-2296
No description available

WB:WBGene00046856	21ur-4592
No description available

WB:WBGene00046857	21ur-2680
No description available

WB:WBGene00046858	21ur-628
No description available

WB:WBGene00046859	21ur-4615
No description available

WB:WBGene00046860	21ur-4388
No description available

WB:WBGene00046861	21ur-40
No description available

WB:WBGene00046862	21ur-2875
No description available

WB:WBGene00046863	21ur-1844
No description available

WB:WBGene00046864	21ur-5052
Is affected by eat-2 based on microarray studies.

WB:WBGene00046865	21ur-999
No description available

WB:WBGene00046866	21ur-1235
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00046867	21ur-408
No description available

WB:WBGene00046868	21ur-3027
No description available

WB:WBGene00046869	21ur-2938
No description available

WB:WBGene00046870	21ur-2236
No description available

WB:WBGene00046871	21ur-2658
No description available

WB:WBGene00046872	21ur-4739
No description available

WB:WBGene00046873	21ur-3952
No description available

WB:WBGene00046874	21ur-3492
No description available

WB:WBGene00046875	21ur-103
Is affected by daf-2 based on microarray studies.

WB:WBGene00046876	21ur-3941
No description available

WB:WBGene00046877	21ur-1673
No description available

WB:WBGene00046878	21ur-1225
No description available

WB:WBGene00046879	21ur-2172
No description available

WB:WBGene00046880	21ur-5054
No description available

WB:WBGene00046881	21ur-969
No description available

WB:WBGene00046882	21ur-5234
No description available

WB:WBGene00046883	21ur-1135
No description available

WB:WBGene00046884	21ur-1681
No description available

WB:WBGene00046885	21ur-2292
No description available

WB:WBGene00046886	21ur-2427
No description available

WB:WBGene00046887	21ur-2678
No description available

WB:WBGene00046888	21ur-1342
No description available

WB:WBGene00046889	21ur-215
No description available

WB:WBGene00046890	21ur-5250
No description available

WB:WBGene00046891	21ur-5089
No description available

WB:WBGene00046892	21ur-4249
No description available

WB:WBGene00046893	21ur-2160
No description available

WB:WBGene00046894	21ur-2831
No description available

WB:WBGene00046895	21ur-4302
No description available

WB:WBGene00046896	21ur-870
No description available

WB:WBGene00046897	21ur-2262
No description available

WB:WBGene00046898	21ur-4987
No description available

WB:WBGene00046899	21ur-1070
No description available

WB:WBGene00046900	21ur-235
No description available

WB:WBGene00046901	21ur-3612
No description available

WB:WBGene00046902	21ur-1689
No description available

WB:WBGene00046903	21ur-1292
No description available

WB:WBGene00046904	21ur-3828
No description available

WB:WBGene00046905	21ur-1397
No description available

WB:WBGene00046906	21ur-4851
No description available

WB:WBGene00046907	21ur-3868
No description available

WB:WBGene00046908	21ur-5174
No description available

WB:WBGene00046909	21ur-175
No description available

WB:WBGene00046910	21ur-557
No description available

WB:WBGene00046911	21ur-4274
No description available

WB:WBGene00046912	21ur-582
No description available

WB:WBGene00046913	21ur-725
No description available

WB:WBGene00046914	21ur-821
No description available

WB:WBGene00046915	21ur-2420
No description available

WB:WBGene00046916	21ur-1505
No description available

WB:WBGene00046917	21ur-4569
No description available

WB:WBGene00046918	21ur-1099
No description available

WB:WBGene00046919	21ur-2395
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046920	21ur-603
No description available

WB:WBGene00046921	21ur-2645
No description available

WB:WBGene00046922	21ur-1477
No description available

WB:WBGene00046923	21ur-4292
No description available

WB:WBGene00046924	21ur-358
No description available

WB:WBGene00046925	21ur-1462
No description available

WB:WBGene00046926	21ur-4407
No description available

WB:WBGene00046927	21ur-3260
No description available

WB:WBGene00046928	21ur-2154
No description available

WB:WBGene00046929	21ur-4576
No description available

WB:WBGene00046930	21ur-1751
No description available

WB:WBGene00046931	21ur-3195
No description available

WB:WBGene00046932	21ur-2928
No description available

WB:WBGene00046933	21ur-3607
No description available

WB:WBGene00046934	21ur-5178
No description available

WB:WBGene00046935	21ur-3088
No description available

WB:WBGene00046936	21ur-169
No description available

WB:WBGene00046937	21ur-4751
No description available

WB:WBGene00046938	21ur-2126
No description available

WB:WBGene00046939	21ur-4834
No description available

WB:WBGene00046940	21ur-2538
No description available

WB:WBGene00046941	21ur-3572
No description available

WB:WBGene00046942	21ur-1910
No description available

WB:WBGene00046943	21ur-750
No description available

WB:WBGene00046944	21ur-1483
No description available

WB:WBGene00046945	21ur-4452
No description available

WB:WBGene00046946	21ur-2756
No description available

WB:WBGene00046947	21ur-3940
No description available

WB:WBGene00046948	21ur-2252
No description available

WB:WBGene00046949	21ur-1102
No description available

WB:WBGene00046950	21ur-1993
No description available

WB:WBGene00046951	21ur-762
No description available

WB:WBGene00046952	21ur-3936
No description available

WB:WBGene00046953	21ur-1484
No description available

WB:WBGene00046954	21ur-4524
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00046955	21ur-5105
No description available

WB:WBGene00046956	21ur-260
No description available

WB:WBGene00046957	21ur-4680
No description available

WB:WBGene00046958	21ur-3108
No description available

WB:WBGene00046959	21ur-607
No description available

WB:WBGene00046960	21ur-3816
No description available

WB:WBGene00046961	21ur-1564
No description available

WB:WBGene00046962	21ur-2611
No description available

WB:WBGene00046963	21ur-1367
No description available

WB:WBGene00046964	21ur-2086
No description available

WB:WBGene00046965	21ur-3665
No description available

WB:WBGene00046966	21ur-4063
No description available

WB:WBGene00046967	21ur-1466
No description available

WB:WBGene00046968	21ur-201
No description available

WB:WBGene00046969	21ur-868
No description available

WB:WBGene00046970	21ur-1899
No description available

WB:WBGene00046971	21ur-452
No description available

WB:WBGene00046972	21ur-3094
No description available

WB:WBGene00046973	21ur-1682
No description available

WB:WBGene00046974	21ur-469
No description available

WB:WBGene00046975	21ur-4501
No description available

WB:WBGene00046976	21ur-1400
No description available

WB:WBGene00046977	21ur-698
No description available

WB:WBGene00046978	21ur-75
No description available

WB:WBGene00046979	21ur-1522
No description available

WB:WBGene00046980	21ur-1619
No description available

WB:WBGene00046981	21ur-3003
No description available

WB:WBGene00046982	21ur-5339
No description available

WB:WBGene00046983	21ur-4353
No description available

WB:WBGene00046984	21ur-3121
No description available

WB:WBGene00046985	21ur-1176
No description available

WB:WBGene00046986	21ur-2685
No description available

WB:WBGene00046987	21ur-1312
No description available

WB:WBGene00046988	21ur-4190
No description available

WB:WBGene00046989	21ur-3349
No description available

WB:WBGene00046990	21ur-5236
No description available

WB:WBGene00046991	21ur-2787
No description available

WB:WBGene00046992	21ur-3586
No description available

WB:WBGene00046993	21ur-5144
No description available

WB:WBGene00046994	21ur-2977
No description available

WB:WBGene00046995	21ur-3473
No description available

WB:WBGene00046996	21ur-52
No description available

WB:WBGene00046997	21ur-153
No description available

WB:WBGene00046998	21ur-4466
No description available

WB:WBGene00046999	21ur-2828
No description available

WB:WBGene00047000	21ur-5259
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047001	21ur-681
No description available

WB:WBGene00047002	21ur-1450
No description available

WB:WBGene00047003	21ur-988
No description available

WB:WBGene00047004	21ur-2567
No description available

WB:WBGene00047005	21ur-571
No description available

WB:WBGene00047006	21ur-3783
No description available

WB:WBGene00047007	21ur-284
No description available

WB:WBGene00047008	21ur-2358
No description available

WB:WBGene00047009	21ur-24
No description available

WB:WBGene00047010	21ur-3593
No description available

WB:WBGene00047011	21ur-4337
No description available

WB:WBGene00047012	21ur-5364
No description available

WB:WBGene00047013	21ur-4684
No description available

WB:WBGene00047014	21ur-4589
No description available

WB:WBGene00047015	21ur-438
No description available

WB:WBGene00047016	21ur-4664
No description available

WB:WBGene00047017	21ur-3636
No description available

WB:WBGene00047018	21ur-854
No description available

WB:WBGene00047019	21ur-2902
No description available

WB:WBGene00047020	21ur-4325
No description available

WB:WBGene00047021	21ur-108
No description available

WB:WBGene00047022	21ur-4342
No description available

WB:WBGene00047023	21ur-908
No description available

WB:WBGene00047024	21ur-3958
No description available

WB:WBGene00047025	21ur-4391
No description available

WB:WBGene00047026	21ur-2415
No description available

WB:WBGene00047027	21ur-3600
No description available

WB:WBGene00047028	21ur-4825
No description available

WB:WBGene00047029	21ur-1375
No description available

WB:WBGene00047030	21ur-2167
No description available

WB:WBGene00047031	21ur-1039
No description available

WB:WBGene00047032	21ur-3924
No description available

WB:WBGene00047033	21ur-5110
No description available

WB:WBGene00047034	21ur-5279
No description available

WB:WBGene00047035	21ur-2591
No description available

WB:WBGene00047036	21ur-2578
No description available

WB:WBGene00047037	21ur-5166
No description available

WB:WBGene00047038	21ur-2182
No description available

WB:WBGene00047039	21ur-1767
No description available

WB:WBGene00047040	21ur-5420
No description available

WB:WBGene00047041	21ur-4815
No description available

WB:WBGene00047042	21ur-3530
No description available

WB:WBGene00047043	21ur-1043
No description available

WB:WBGene00047044	21ur-4758
No description available

WB:WBGene00047045	21ur-196
No description available

WB:WBGene00047046	21ur-775
No description available

WB:WBGene00047047	21ur-3067
No description available

WB:WBGene00047048	21ur-1608
No description available

WB:WBGene00047049	21ur-4608
No description available

WB:WBGene00047050	21ur-1046
No description available

WB:WBGene00047051	21ur-1319
No description available

WB:WBGene00047052	21ur-2215
No description available

WB:WBGene00047053	21ur-594
No description available

WB:WBGene00047054	21ur-4030
No description available

WB:WBGene00047055	21ur-5432
No description available

WB:WBGene00047056	21ur-1732
No description available

WB:WBGene00047057	21ur-1244
No description available

WB:WBGene00047058	21ur-5111
No description available

WB:WBGene00047059	21ur-4945
No description available

WB:WBGene00047060	21ur-4182
No description available

WB:WBGene00047061	21ur-818
No description available

WB:WBGene00047062	21ur-2774
No description available

WB:WBGene00047063	21ur-3537
No description available

WB:WBGene00047064	21ur-5019
No description available

WB:WBGene00047065	21ur-503
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00047066	21ur-3146
No description available

WB:WBGene00047067	21ur-123
No description available

WB:WBGene00047068	21ur-808
No description available

WB:WBGene00047069	21ur-1131
No description available

WB:WBGene00047070	21ur-2012
No description available

WB:WBGene00047071	21ur-3973
No description available

WB:WBGene00047072	21ur-994
No description available

WB:WBGene00047073	21ur-5037
No description available

WB:WBGene00047074	21ur-2714
No description available

WB:WBGene00047075	21ur-1362
No description available

WB:WBGene00047076	21ur-596
No description available

WB:WBGene00047077	21ur-4670
No description available

WB:WBGene00047078	21ur-1497
No description available

WB:WBGene00047079	21ur-4902
No description available

WB:WBGene00047080	21ur-3981
No description available

WB:WBGene00047081	21ur-4209
No description available

WB:WBGene00047082	21ur-2161
No description available

WB:WBGene00047083	21ur-5196
No description available

WB:WBGene00047084	21ur-5028
No description available

WB:WBGene00047085	21ur-3311
No description available

WB:WBGene00047086	21ur-4536
No description available

WB:WBGene00047087	21ur-382
No description available

WB:WBGene00047088	21ur-5263
No description available

WB:WBGene00047089	21ur-1360
No description available

WB:WBGene00047090	21ur-3447
No description available

WB:WBGene00047091	21ur-1352
No description available

WB:WBGene00047092	21ur-2909
No description available

WB:WBGene00047093	21ur-4786
No description available

WB:WBGene00047094	21ur-3432
No description available

WB:WBGene00047095	21ur-2304
No description available

WB:WBGene00047096	21ur-2892
No description available

WB:WBGene00047097	21ur-836
No description available

WB:WBGene00047098	21ur-1937
No description available

WB:WBGene00047099	21ur-2541
No description available

WB:WBGene00047100	21ur-4513
No description available

WB:WBGene00047101	21ur-2874
No description available

WB:WBGene00047102	21ur-5094
No description available

WB:WBGene00047103	21ur-4888
No description available

WB:WBGene00047104	21ur-4043
No description available

WB:WBGene00047105	21ur-1118
No description available

WB:WBGene00047106	21ur-3073
No description available

WB:WBGene00047107	21ur-5446
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047108	21ur-2117
No description available

WB:WBGene00047109	21ur-564
No description available

WB:WBGene00047110	21ur-2598
No description available

WB:WBGene00047111	21ur-2984
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047112	21ur-5325
No description available

WB:WBGene00047113	21ur-1555
No description available

WB:WBGene00047114	21ur-1204
No description available

WB:WBGene00047115	21ur-4794
No description available

WB:WBGene00047116	21ur-3173
No description available

WB:WBGene00047117	21ur-20
No description available

WB:WBGene00047118	21ur-1210
No description available

WB:WBGene00047119	21ur-3457
No description available

WB:WBGene00047120	21ur-892
No description available

WB:WBGene00047121	21ur-2517
No description available

WB:WBGene00047122	21ur-4144
No description available

WB:WBGene00047123	21ur-1327
No description available

WB:WBGene00047124	21ur-5008
No description available

WB:WBGene00047125	21ur-1871
No description available

WB:WBGene00047126	21ur-4172
No description available

WB:WBGene00047127	21ur-3000
No description available

WB:WBGene00047128	21ur-365
No description available

WB:WBGene00047129	21ur-3282
No description available

WB:WBGene00047130	21ur-1301
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00047131	21ur-5401
No description available

WB:WBGene00047132	21ur-1601
No description available

WB:WBGene00047133	21ur-1054
No description available

WB:WBGene00047134	21ur-11
No description available

WB:WBGene00047135	21ur-3183
No description available

WB:WBGene00047136	21ur-3656
No description available

WB:WBGene00047137	21ur-2098
No description available

WB:WBGene00047138	21ur-1770
No description available

WB:WBGene00047139	21ur-647
No description available

WB:WBGene00047140	21ur-3860
No description available

WB:WBGene00047141	21ur-2369
No description available

WB:WBGene00047142	21ur-2005
No description available

WB:WBGene00047143	21ur-1905
No description available

WB:WBGene00047144	21ur-1109
No description available

WB:WBGene00047145	21ur-4215
No description available

WB:WBGene00047146	21ur-4133
No description available

WB:WBGene00047147	21ur-3371
No description available

WB:WBGene00047148	21ur-2930
No description available

WB:WBGene00047149	21ur-4546
No description available

WB:WBGene00047150	21ur-3833
No description available

WB:WBGene00047151	21ur-2390
No description available

WB:WBGene00047152	21ur-2956
No description available

WB:WBGene00047153	21ur-2744
No description available

WB:WBGene00047154	21ur-3648
No description available

WB:WBGene00047155	21ur-1984
No description available

WB:WBGene00047156	21ur-3081
No description available

WB:WBGene00047157	21ur-925
No description available

WB:WBGene00047158	21ur-3515
No description available

WB:WBGene00047159	21ur-4968
No description available

WB:WBGene00047160	21ur-5314
No description available

WB:WBGene00047161	21ur-3305
No description available

WB:WBGene00047162	21ur-5454
No description available

WB:WBGene00047163	21ur-2554
No description available

WB:WBGene00047164	21ur-5275
No description available

WB:WBGene00047165	21ur-1085
No description available

WB:WBGene00047166	21ur-376
No description available

WB:WBGene00047167	21ur-3130
No description available

WB:WBGene00047168	21ur-1598
No description available

WB:WBGene00047169	21ur-2158
Is affected by emr-1; lem-2; and damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00047170	21ur-1761
No description available

WB:WBGene00047171	21ur-1369
No description available

WB:WBGene00047172	21ur-3620
No description available

WB:WBGene00047173	21ur-623
No description available

WB:WBGene00047174	21ur-4801
No description available

WB:WBGene00047175	21ur-4927
No description available

WB:WBGene00047176	21ur-991
No description available

WB:WBGene00047177	21ur-1704
No description available

WB:WBGene00047178	21ur-702
No description available

WB:WBGene00047179	21ur-689
No description available

WB:WBGene00047180	21ur-2921
Is affected by eat-2 based on microarray studies.

WB:WBGene00047181	21ur-5156
No description available

WB:WBGene00047182	21ur-4003
No description available

WB:WBGene00047183	21ur-3855
No description available

WB:WBGene00047184	21ur-1259
No description available

WB:WBGene00047185	21ur-336
No description available

WB:WBGene00047186	21ur-312
No description available

WB:WBGene00047187	21ur-5430
No description available

WB:WBGene00047188	21ur-622
No description available

WB:WBGene00047189	21ur-2255
No description available

WB:WBGene00047190	21ur-2710
No description available

WB:WBGene00047191	21ur-615
No description available

WB:WBGene00047192	21ur-1276
No description available

WB:WBGene00047193	21ur-1076
No description available

WB:WBGene00047194	21ur-4307
No description available

WB:WBGene00047195	21ur-5293
No description available

WB:WBGene00047196	21ur-294
No description available

WB:WBGene00047197	21ur-5335
No description available

WB:WBGene00047198	21ur-1742
No description available

WB:WBGene00047199	21ur-3699
No description available

WB:WBGene00047200	21ur-5212
No description available

WB:WBGene00047201	21ur-2205
No description available

WB:WBGene00047202	21ur-4714
No description available

WB:WBGene00047203	21ur-228
No description available

WB:WBGene00047204	21ur-2371
No description available

WB:WBGene00047205	21ur-1749
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00047206	21ur-2698
No description available

WB:WBGene00047207	21ur-3512
No description available

WB:WBGene00047208	21ur-320
No description available

WB:WBGene00047209	21ur-267
No description available

WB:WBGene00047210	21ur-1431
No description available

WB:WBGene00047211	21ur-785
No description available

WB:WBGene00047212	21ur-655
No description available

WB:WBGene00047213	21ur-4233
No description available

WB:WBGene00047214	21ur-1309
No description available

WB:WBGene00047215	21ur-2360
No description available

WB:WBGene00047216	21ur-1692
No description available

WB:WBGene00047217	21ur-2060
No description available

WB:WBGene00047218	21ur-3330
No description available

WB:WBGene00047219	21ur-5383
No description available

WB:WBGene00047220	21ur-5187
No description available

WB:WBGene00047221	21ur-3216
No description available

WB:WBGene00047222	21ur-1975
No description available

WB:WBGene00047223	21ur-230
No description available

WB:WBGene00047224	21ur-496
No description available

WB:WBGene00047225	21ur-3043
No description available

WB:WBGene00047226	21ur-3322
No description available

WB:WBGene00047227	21ur-4482
No description available

WB:WBGene00047228	21ur-4700
No description available

WB:WBGene00047229	21ur-4421
No description available

WB:WBGene00047230	21ur-5071
No description available

WB:WBGene00047231	21ur-4228
No description available

WB:WBGene00047232	21ur-5184
No description available

WB:WBGene00047233	21ur-4118
No description available

WB:WBGene00047234	21ur-4874
No description available

WB:WBGene00047235	21ur-2295
No description available

WB:WBGene00047236	21ur-3882
No description available

WB:WBGene00047237	21ur-1040
No description available

WB:WBGene00047238	21ur-5206
No description available

WB:WBGene00047239	21ur-2261
No description available

WB:WBGene00047240	21ur-4523
No description available

WB:WBGene00047241	21ur-2284
No description available

WB:WBGene00047242	21ur-109
No description available

WB:WBGene00047243	21ur-3706
No description available

WB:WBGene00047244	21ur-2622
No description available

WB:WBGene00047245	21ur-2933
No description available

WB:WBGene00047246	21ur-4090
No description available

WB:WBGene00047247	21ur-2699
No description available

WB:WBGene00047248	21ur-5419
No description available

WB:WBGene00047249	21ur-2270
No description available

WB:WBGene00047250	21ur-33
No description available

WB:WBGene00047251	21ur-4284
No description available

WB:WBGene00047252	21ur-3353
No description available

WB:WBGene00047253	21ur-3232
No description available

WB:WBGene00047254	21ur-1230
Is affected by daf-2 based on microarray studies.

WB:WBGene00047255	21ur-216
No description available

WB:WBGene00047256	21ur-2691
No description available

WB:WBGene00047257	21ur-1965
No description available

WB:WBGene00047258	21ur-1075
No description available

WB:WBGene00047259	21ur-3329
No description available

WB:WBGene00047260	21ur-346
No description available

WB:WBGene00047261	21ur-4926
No description available

WB:WBGene00047262	21ur-2078
No description available

WB:WBGene00047263	21ur-1158
No description available

WB:WBGene00047264	21ur-406
No description available

WB:WBGene00047265	21ur-1694
No description available

WB:WBGene00047266	21ur-327
No description available

WB:WBGene00047267	21ur-2173
No description available

WB:WBGene00047268	21ur-1810
No description available

WB:WBGene00047269	21ur-2559
No description available

WB:WBGene00047270	21ur-2736
Is affected by hpl-2; hmg-4; and spt-16 based on RNA-seq studies.

WB:WBGene00047271	21ur-3225
No description available

WB:WBGene00047272	21ur-1217
No description available

WB:WBGene00047273	21ur-4848
No description available

WB:WBGene00047274	21ur-3493
No description available

WB:WBGene00047275	21ur-4093
No description available

WB:WBGene00047276	21ur-1448
No description available

WB:WBGene00047277	21ur-3218
No description available

WB:WBGene00047278	21ur-4260
No description available

WB:WBGene00047279	21ur-985
No description available

WB:WBGene00047280	21ur-5216
No description available

WB:WBGene00047281	21ur-5334
No description available

WB:WBGene00047282	21ur-1444
No description available

WB:WBGene00047283	21ur-2911
No description available

WB:WBGene00047284	21ur-4917
No description available

WB:WBGene00047285	21ur-143
No description available

WB:WBGene00047286	21ur-2967
No description available

WB:WBGene00047287	21ur-5374
No description available

WB:WBGene00047288	21ur-1243
No description available

WB:WBGene00047289	21ur-2636
No description available

WB:WBGene00047290	21ur-993
No description available

WB:WBGene00047291	21ur-1756
No description available

WB:WBGene00047292	21ur-1716
No description available

WB:WBGene00047293	21ur-4028
No description available

WB:WBGene00047294	21ur-1603
No description available

WB:WBGene00047295	21ur-4073
No description available

WB:WBGene00047296	21ur-4531
No description available

WB:WBGene00047297	21ur-3462
No description available

WB:WBGene00047298	21ur-2064
No description available

WB:WBGene00047299	21ur-3652
No description available

WB:WBGene00047300	21ur-1514
No description available

WB:WBGene00047301	21ur-3021
No description available

WB:WBGene00047302	21ur-3390
No description available

WB:WBGene00047303	21ur-2757
No description available

WB:WBGene00047304	21ur-3273
No description available

WB:WBGene00047305	21ur-4774
Is affected by daf-2 based on microarray studies.

WB:WBGene00047306	21ur-286
No description available

WB:WBGene00047307	21ur-1411
No description available

WB:WBGene00047308	21ur-1268
No description available

WB:WBGene00047309	21ur-1183
No description available

WB:WBGene00047310	21ur-2019
No description available

WB:WBGene00047311	21ur-743
No description available

WB:WBGene00047312	21ur-4445
No description available

WB:WBGene00047313	21ur-2601
No description available

WB:WBGene00047314	21ur-483
No description available

WB:WBGene00047315	21ur-835
No description available

WB:WBGene00047316	21ur-1237
No description available

WB:WBGene00047317	21ur-3056
No description available

WB:WBGene00047318	21ur-4723
No description available

WB:WBGene00047319	21ur-1474
No description available

WB:WBGene00047320	21ur-1536
No description available

WB:WBGene00047321	21ur-3418
No description available

WB:WBGene00047322	21ur-4373
No description available

WB:WBGene00047323	21ur-953
No description available

WB:WBGene00047324	21ur-2339
No description available

WB:WBGene00047325	21ur-2679
No description available

WB:WBGene00047326	21ur-4876
No description available

WB:WBGene00047327	21ur-53
No description available

WB:WBGene00047328	21ur-3017
No description available

WB:WBGene00047329	21ur-4601
No description available

WB:WBGene00047330	21ur-1112
No description available

WB:WBGene00047331	21ur-2998
No description available

WB:WBGene00047332	21ur-88
No description available

WB:WBGene00047333	21ur-974
No description available

WB:WBGene00047334	21ur-1870
No description available

WB:WBGene00047335	21ur-867
No description available

WB:WBGene00047336	21ur-2993
No description available

WB:WBGene00047337	21ur-3289
No description available

WB:WBGene00047338	21ur-2291
No description available

WB:WBGene00047339	21ur-3628
No description available

WB:WBGene00047340	21ur-429
No description available

WB:WBGene00047341	21ur-5283
No description available

WB:WBGene00047342	21ur-3754
No description available

WB:WBGene00047343	21ur-1181
No description available

WB:WBGene00047344	21ur-3285
No description available

WB:WBGene00047345	21ur-5309
No description available

WB:WBGene00047346	21ur-2264
No description available

WB:WBGene00047347	21ur-2246
No description available

WB:WBGene00047348	21ur-3320
No description available

WB:WBGene00047349	21ur-420
No description available

WB:WBGene00047350	21ur-3962
No description available

WB:WBGene00047351	21ur-2310
No description available

WB:WBGene00047352	21ur-3805
No description available

WB:WBGene00047353	21ur-1879
No description available

WB:WBGene00047354	21ur-478
No description available

WB:WBGene00047355	21ur-886
No description available

WB:WBGene00047356	21ur-4472
No description available

WB:WBGene00047357	21ur-665
No description available

WB:WBGene00047358	21ur-1739
No description available

WB:WBGene00047359	21ur-2635
No description available

WB:WBGene00047360	21ur-2332
No description available

WB:WBGene00047361	21ur-4145
No description available

WB:WBGene00047362	21ur-124
No description available

WB:WBGene00047363	21ur-1347
No description available

WB:WBGene00047364	21ur-4975
No description available

WB:WBGene00047365	21ur-3724
No description available

WB:WBGene00047366	21ur-3168
No description available

WB:WBGene00047367	21ur-928
No description available

WB:WBGene00047368	21ur-4726
No description available

WB:WBGene00047369	21ur-4191
No description available

WB:WBGene00047370	21ur-3368
No description available

WB:WBGene00047371	21ur-1927
No description available

WB:WBGene00047372	21ur-4650
No description available

WB:WBGene00047373	21ur-246
No description available

WB:WBGene00047374	21ur-1223
No description available

WB:WBGene00047375	21ur-4202
No description available

WB:WBGene00047376	21ur-1065
No description available

WB:WBGene00047377	21ur-3405
No description available

WB:WBGene00047378	21ur-2481
No description available

WB:WBGene00047379	21ur-465
No description available

WB:WBGene00047380	21ur-539
No description available

WB:WBGene00047381	21ur-2041
No description available

WB:WBGene00047382	21ur-254
No description available

WB:WBGene00047383	21ur-4493
No description available

WB:WBGene00047384	21ur-2790
No description available

WB:WBGene00047385	21ur-2111
No description available

WB:WBGene00047386	21ur-1855
No description available

WB:WBGene00047387	21ur-1943
No description available

WB:WBGene00047388	21ur-2404
No description available

WB:WBGene00047389	21ur-4324
No description available

WB:WBGene00047390	21ur-2959
No description available

WB:WBGene00047391	21ur-1902
No description available

WB:WBGene00047392	21ur-5402
No description available

WB:WBGene00047393	21ur-3318
No description available

WB:WBGene00047394	21ur-255
No description available

WB:WBGene00047395	21ur-3348
No description available

WB:WBGene00047396	21ur-525
No description available

WB:WBGene00047397	21ur-3733
No description available

WB:WBGene00047398	21ur-2766
No description available

WB:WBGene00047399	21ur-3672
No description available

WB:WBGene00047400	21ur-4952
No description available

WB:WBGene00047401	21ur-1911
No description available

WB:WBGene00047402	21ur-4242
No description available

WB:WBGene00047403	21ur-4111
No description available

WB:WBGene00047404	21ur-3579
No description available

WB:WBGene00047405	21ur-639
No description available

WB:WBGene00047406	21ur-4593
No description available

WB:WBGene00047407	21ur-2830
No description available

WB:WBGene00047408	21ur-4016
No description available

WB:WBGene00047409	21ur-2451
No description available

WB:WBGene00047410	21ur-3710
No description available

WB:WBGene00047411	21ur-1124
No description available

WB:WBGene00047412	21ur-695
No description available

WB:WBGene00047413	21ur-4267
No description available

WB:WBGene00047414	21ur-4479
No description available

WB:WBGene00047415	21ur-3204
No description available

WB:WBGene00047416	21ur-2042
No description available

WB:WBGene00047417	21ur-3356
No description available

WB:WBGene00047418	21ur-160
No description available

WB:WBGene00047419	21ur-4390
No description available

WB:WBGene00047420	21ur-3251
No description available

WB:WBGene00047421	21ur-3248
No description available

WB:WBGene00047422	21ur-5192
No description available

WB:WBGene00047423	21ur-3411
No description available

WB:WBGene00047424	21ur-2208
No description available

WB:WBGene00047425	21ur-3034
No description available

WB:WBGene00047426	21ur-2328
No description available

WB:WBGene00047427	21ur-3744
No description available

WB:WBGene00047428	21ur-5046
No description available

WB:WBGene00047429	21ur-1797
No description available

WB:WBGene00047430	21ur-181
No description available

WB:WBGene00047431	21ur-1170
No description available

WB:WBGene00047432	21ur-2655
No description available

WB:WBGene00047433	21ur-3567
No description available

WB:WBGene00047434	21ur-2807
No description available

WB:WBGene00047435	21ur-2976
No description available

WB:WBGene00047436	21ur-936
No description available

WB:WBGene00047437	21ur-1299
No description available

WB:WBGene00047438	21ur-2589
No description available

WB:WBGene00047439	21ur-387
No description available

WB:WBGene00047440	21ur-468
No description available

WB:WBGene00047441	21ur-2592
No description available

WB:WBGene00047442	21ur-3244
No description available

WB:WBGene00047443	21ur-3829
No description available

WB:WBGene00047444	21ur-3953
No description available

WB:WBGene00047445	21ur-1336
No description available

WB:WBGene00047446	21ur-2780
No description available

WB:WBGene00047447	21ur-471
No description available

WB:WBGene00047448	21ur-4646
No description available

WB:WBGene00047449	21ur-413
No description available

WB:WBGene00047450	21ur-3773
No description available

WB:WBGene00047451	21ur-4108
No description available

WB:WBGene00047452	21ur-3738
No description available

WB:WBGene00047453	21ur-802
No description available

WB:WBGene00047454	21ur-4671
No description available

WB:WBGene00047455	21ur-3386
No description available

WB:WBGene00047456	21ur-1721
No description available

WB:WBGene00047457	21ur-961
No description available

WB:WBGene00047458	21ur-3026
No description available

WB:WBGene00047459	21ur-2465
No description available

WB:WBGene00047460	21ur-4467
No description available

WB:WBGene00047461	21ur-1665
No description available

WB:WBGene00047462	21ur-2795
No description available

WB:WBGene00047463	21ur-4614
Is affected by eat-2 based on microarray studies.

WB:WBGene00047464	21ur-4383
No description available

WB:WBGene00047465	21ur-1956
No description available

WB:WBGene00047466	21ur-1676
No description available

WB:WBGene00047467	21ur-2426
No description available

WB:WBGene00047468	21ur-29
No description available

WB:WBGene00047469	21ur-5292
No description available

WB:WBGene00047470	21ur-4435
No description available

WB:WBGene00047471	21ur-990
No description available

WB:WBGene00047472	21ur-3129
No description available

WB:WBGene00047473	21ur-135
No description available

WB:WBGene00047474	21ur-4101
No description available

WB:WBGene00047475	21ur-4440
No description available

WB:WBGene00047476	21ur-1644
No description available

WB:WBGene00047477	21ur-4314
No description available

WB:WBGene00047478	21ur-69
No description available

WB:WBGene00047479	21ur-4123
No description available

WB:WBGene00047480	21ur-2514
No description available

WB:WBGene00047481	21ur-1924
No description available

WB:WBGene00047482	21ur-4152
No description available

WB:WBGene00047483	21ur-1370
No description available

WB:WBGene00047484	21ur-3711
No description available

WB:WBGene00047485	21ur-3445
No description available

WB:WBGene00047486	21ur-4802
No description available

WB:WBGene00047487	21ur-913
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00047488	21ur-5449
No description available

WB:WBGene00047489	21ur-2493
No description available

WB:WBGene00047490	21ur-3688
No description available

WB:WBGene00047491	21ur-5396
No description available

WB:WBGene00047492	21ur-772
No description available

WB:WBGene00047493	21ur-2146
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047494	21ur-433
No description available

WB:WBGene00047495	21ur-78
No description available

WB:WBGene00047496	21ur-3664
No description available

WB:WBGene00047497	21ur-4053
No description available

WB:WBGene00047498	21ur-1090
No description available

WB:WBGene00047499	21ur-3762
No description available

WB:WBGene00047500	21ur-4510
No description available

WB:WBGene00047501	21ur-751
No description available

WB:WBGene00047502	21ur-2650
No description available

WB:WBGene00047503	21ur-3906
No description available

WB:WBGene00047504	21ur-1824
No description available

WB:WBGene00047505	21ur-4000
No description available

WB:WBGene00047506	21ur-850
No description available

WB:WBGene00047507	21ur-125
No description available

WB:WBGene00047508	21ur-1253
No description available

WB:WBGene00047509	21ur-542
No description available

WB:WBGene00047510	21ur-2800
No description available

WB:WBGene00047511	21ur-518
No description available

WB:WBGene00047512	21ur-2253
No description available

WB:WBGene00047513	21ur-1884
No description available

WB:WBGene00047514	21ur-1589
No description available

WB:WBGene00047515	21ur-1786
No description available

WB:WBGene00047516	21ur-4743
No description available

WB:WBGene00047517	21ur-575
No description available

WB:WBGene00047518	21ur-617
No description available

WB:WBGene00047519	21ur-3523
No description available

WB:WBGene00047520	21ur-948
No description available

WB:WBGene00047521	21ur-3362
No description available

WB:WBGene00047522	21ur-1839
No description available

WB:WBGene00047523	21ur-799
No description available

WB:WBGene00047524	21ur-2059
No description available

WB:WBGene00047525	21ur-516
No description available

WB:WBGene00047526	21ur-1470
No description available

WB:WBGene00047527	21ur-85
No description available

WB:WBGene00047528	21ur-2566
No description available

WB:WBGene00047529	21ur-2861
No description available

WB:WBGene00047530	21ur-4500
No description available

WB:WBGene00047531	21ur-2889
No description available

WB:WBGene00047532	21ur-1523
No description available

WB:WBGene00047533	21ur-1169
No description available

WB:WBGene00047534	21ur-455
No description available

WB:WBGene00047535	21ur-3122
No description available

WB:WBGene00047536	21ur-2797
No description available

WB:WBGene00047537	21ur-5353
No description available

WB:WBGene00047538	21ur-2586
No description available

WB:WBGene00047539	21ur-490
No description available

WB:WBGene00047540	21ur-2459
No description available

WB:WBGene00047541	21ur-4020
No description available

WB:WBGene00047542	21ur-3095
No description available

WB:WBGene00047543	21ur-5107
No description available

WB:WBGene00047544	21ur-4147
No description available

WB:WBGene00047545	21ur-2741
No description available

WB:WBGene00047546	21ur-677
No description available

WB:WBGene00047547	21ur-5273
No description available

WB:WBGene00047548	21ur-3242
No description available

WB:WBGene00047549	21ur-349
No description available

WB:WBGene00047550	21ur-2969
No description available

WB:WBGene00047551	21ur-2135
No description available

WB:WBGene00047552	21ur-2099
No description available

WB:WBGene00047553	21ur-4350
No description available

WB:WBGene00047554	21ur-2416
No description available

WB:WBGene00047555	21ur-3585
No description available

WB:WBGene00047556	21ur-5281
No description available

WB:WBGene00047557	21ur-2669
No description available

WB:WBGene00047558	21ur-2822
No description available

WB:WBGene00047559	21ur-3806
No description available

WB:WBGene00047560	21ur-3219
No description available

WB:WBGene00047561	21ur-3080
No description available

WB:WBGene00047562	21ur-4953
No description available

WB:WBGene00047563	21ur-4594
No description available

WB:WBGene00047564	21ur-767
No description available

WB:WBGene00047565	21ur-4456
No description available

WB:WBGene00047566	21ur-1372
No description available

WB:WBGene00047567	21ur-987
No description available

WB:WBGene00047568	21ur-1403
No description available

WB:WBGene00047569	21ur-2929
No description available

WB:WBGene00047570	21ur-2467
No description available

WB:WBGene00047571	21ur-370
No description available

WB:WBGene00047572	21ur-2436
No description available

WB:WBGene00047573	21ur-4828
No description available

WB:WBGene00047574	21ur-4336
No description available

WB:WBGene00047575	21ur-1618
No description available

WB:WBGene00047576	21ur-2621
No description available

WB:WBGene00047577	21ur-49
No description available

WB:WBGene00047578	21ur-926
No description available

WB:WBGene00047579	21ur-5143
No description available

WB:WBGene00047580	21ur-283
No description available

WB:WBGene00047581	21ur-2546
No description available

WB:WBGene00047582	21ur-1013
No description available

WB:WBGene00047583	21ur-154
No description available

WB:WBGene00047584	21ur-2759
No description available

WB:WBGene00047585	21ur-5365
No description available

WB:WBGene00047586	21ur-1086
No description available

WB:WBGene00047587	21ur-1738
No description available

WB:WBGene00047588	21ur-1378
No description available

WB:WBGene00047589	21ur-2181
No description available

WB:WBGene00047590	21ur-980
No description available

WB:WBGene00047591	21ur-2180
No description available

WB:WBGene00047592	21ur-551
No description available

WB:WBGene00047593	21ur-176
No description available

WB:WBGene00047594	21ur-335
No description available

WB:WBGene00047595	21ur-5356
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00047596	21ur-4339
No description available

WB:WBGene00047597	21ur-162
No description available

WB:WBGene00047598	21ur-2140
No description available

WB:WBGene00047599	21ur-855
No description available

WB:WBGene00047600	21ur-4683
No description available

WB:WBGene00047601	21ur-3055
No description available

WB:WBGene00047602	21ur-268
No description available

WB:WBGene00047603	21ur-5421
No description available

WB:WBGene00047604	21ur-900
No description available

WB:WBGene00047605	21ur-1226
No description available

WB:WBGene00047606	21ur-956
No description available

WB:WBGene00047607	21ur-5211
No description available

WB:WBGene00047608	21ur-537
No description available

WB:WBGene00047609	21ur-3959
No description available

WB:WBGene00047610	21ur-697
No description available

WB:WBGene00047611	21ur-232
No description available

WB:WBGene00047612	21ur-5326
No description available

WB:WBGene00047613	21ur-560
No description available

WB:WBGene00047614	21ur-214
No description available

WB:WBGene00047615	21ur-4038
No description available

WB:WBGene00047616	21ur-3844
No description available

WB:WBGene00047617	21ur-558
No description available

WB:WBGene00047618	21ur-3317
No description available

WB:WBGene00047619	21ur-357
No description available

WB:WBGene00047620	21ur-4255
No description available

WB:WBGene00047621	21ur-763
No description available

WB:WBGene00047622	21ur-4049
No description available

WB:WBGene00047623	21ur-717
No description available

WB:WBGene00047624	21ur-4568
No description available

WB:WBGene00047625	21ur-739
No description available

WB:WBGene00047626	21ur-616
No description available

WB:WBGene00047627	21ur-5173
No description available

WB:WBGene00047628	21ur-3592
No description available

WB:WBGene00047629	21ur-95
No description available

WB:WBGene00047630	21ur-1741
No description available

WB:WBGene00047631	21ur-608
Is affected by eat-2 based on microarray studies.

WB:WBGene00047632	21ur-703
No description available

WB:WBGene00047633	21ur-5076
No description available

WB:WBGene00047634	21ur-4408
No description available

WB:WBGene00047635	21ur-2387
No description available

WB:WBGene00047636	21ur-5120
No description available

WB:WBGene00047637	21ur-1496
No description available

WB:WBGene00047638	21ur-643
No description available

WB:WBGene00047639	21ur-4052
No description available

WB:WBGene00047640	21ur-4750
No description available

WB:WBGene00047641	21ur-367
No description available

WB:WBGene00047642	21ur-439
No description available

WB:WBGene00047643	21ur-809
No description available

WB:WBGene00047644	21ur-581
No description available

WB:WBGene00047645	21ur-3986
No description available

WB:WBGene00047646	21ur-4275
No description available

WB:WBGene00047647	21ur-2884
No description available

WB:WBGene00047648	21ur-5426
No description available

WB:WBGene00047649	21ur-2089
No description available

WB:WBGene00047650	21ur-1994
No description available

WB:WBGene00047651	21ur-3615
No description available

WB:WBGene00047652	21ur-2503
No description available

WB:WBGene00047653	21ur-1436
No description available

WB:WBGene00047654	21ur-4707
No description available

WB:WBGene00047655	21ur-445
No description available

WB:WBGene00047656	21ur-477
No description available

WB:WBGene00047657	21ur-3666
No description available

WB:WBGene00047658	21ur-42
No description available

WB:WBGene00047659	21ur-4579
No description available

WB:WBGene00047660	21ur-1016
No description available

WB:WBGene00047661	21ur-5177
No description available

WB:WBGene00047662	21ur-100
No description available

WB:WBGene00047663	21ur-3935
No description available

WB:WBGene00047664	21ur-1291
No description available

WB:WBGene00047665	21ur-1713
No description available

WB:WBGene00047666	21ur-93
No description available

WB:WBGene00047667	21ur-1463
No description available

WB:WBGene00047668	21ur-3573
No description available

WB:WBGene00047669	21ur-220
No description available

WB:WBGene00047670	21ur-113
No description available

WB:WBGene00047671	21ur-3494
No description available

WB:WBGene00047672	21ur-820
No description available

WB:WBGene00047673	21ur-4949
No description available

WB:WBGene00047674	21ur-2733
No description available

WB:WBGene00047675	21ur-4764
No description available

WB:WBGene00047676	21ur-2539
No description available

WB:WBGene00047677	21ur-4887
No description available

WB:WBGene00047678	21ur-4017
No description available

WB:WBGene00047679	21ur-1468
No description available

WB:WBGene00047680	21ur-4370
No description available

WB:WBGene00047681	21ur-2210
No description available

WB:WBGene00047682	21ur-4465
No description available

WB:WBGene00047683	21ur-401
No description available

WB:WBGene00047684	21ur-1565
No description available

WB:WBGene00047685	21ur-563
No description available

WB:WBGene00047686	21ur-3734
No description available

WB:WBGene00047687	21ur-4368
Is affected by eat-2 based on microarray studies.

WB:WBGene00047688	21ur-967
No description available

WB:WBGene00047689	21ur-5104
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047690	21ur-3817
No description available

WB:WBGene00047691	21ur-1359
No description available

WB:WBGene00047692	21ur-2056
No description available

WB:WBGene00047693	21ur-2656
No description available

WB:WBGene00047694	21ur-12
No description available

WB:WBGene00047695	21ur-2855
No description available

WB:WBGene00047696	21ur-3109
No description available

WB:WBGene00047697	21ur-3827
No description available

WB:WBGene00047698	21ur-1467
No description available

WB:WBGene00047699	21ur-2569
No description available

WB:WBGene00047700	21ur-3138
No description available

WB:WBGene00047701	21ur-60
No description available

WB:WBGene00047702	21ur-1782
No description available

WB:WBGene00047703	21ur-4890
No description available

WB:WBGene00047704	21ur-530
No description available

WB:WBGene00047705	21ur-4967
No description available

WB:WBGene00047706	21ur-2827
No description available

WB:WBGene00047707	21ur-3581
No description available

WB:WBGene00047708	21ur-2562
Is affected by daf-2 based on microarray studies.

WB:WBGene00047709	21ur-1482
No description available

WB:WBGene00047710	21ur-4497
No description available

WB:WBGene00047711	21ur-1211
No description available

WB:WBGene00047712	21ur-1328
No description available

WB:WBGene00047713	21ur-621
No description available

WB:WBGene00047714	21ur-1538
No description available

WB:WBGene00047715	21ur-2347
No description available

WB:WBGene00047716	21ur-2877
No description available

WB:WBGene00047717	21ur-1077
No description available

WB:WBGene00047718	21ur-2919
No description available

WB:WBGene00047719	21ur-4201
No description available

WB:WBGene00047720	21ur-2256
No description available

WB:WBGene00047721	21ur-4470
No description available

WB:WBGene00047722	21ur-2686
No description available

WB:WBGene00047723	21ur-3714
No description available

WB:WBGene00047724	21ur-1542
No description available

WB:WBGene00047725	21ur-5163
No description available

WB:WBGene00047726	21ur-4428
No description available

WB:WBGene00047727	21ur-3861
No description available

WB:WBGene00047728	21ur-5136
No description available

WB:WBGene00047729	21ur-670
No description available

WB:WBGene00047730	21ur-682
No description available

WB:WBGene00047731	21ur-4059
No description available

WB:WBGene00047732	21ur-4132
No description available

WB:WBGene00047733	21ur-5276
No description available

WB:WBGene00047734	21ur-4891
No description available

WB:WBGene00047735	21ur-1311
No description available

WB:WBGene00047736	21ur-2865
No description available

WB:WBGene00047737	21ur-2033
No description available

WB:WBGene00047738	21ur-2494
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047739	21ur-3037
No description available

WB:WBGene00047740	21ur-5014
No description available

WB:WBGene00047741	21ur-4797
No description available

WB:WBGene00047742	21ur-330
No description available

WB:WBGene00047743	21ur-1302
No description available

WB:WBGene00047744	21ur-829
No description available

WB:WBGene00047745	21ur-2280
No description available

WB:WBGene00047746	21ur-360
No description available

WB:WBGene00047747	21ur-3540
No description available

WB:WBGene00047748	21ur-4298
No description available

WB:WBGene00047749	21ur-2440
No description available

WB:WBGene00047750	21ur-227
No description available

WB:WBGene00047751	21ur-2767
No description available

WB:WBGene00047752	21ur-1098
No description available

WB:WBGene00047753	21ur-375
No description available

WB:WBGene00047754	21ur-2785
No description available

WB:WBGene00047755	21ur-4042
No description available

WB:WBGene00047756	21ur-3500
No description available

WB:WBGene00047757	21ur-4234
No description available

WB:WBGene00047758	21ur-19
No description available

WB:WBGene00047759	21ur-3304
No description available

WB:WBGene00047760	21ur-2372
No description available

WB:WBGene00047761	21ur-2899
No description available

WB:WBGene00047762	21ur-4715
No description available

WB:WBGene00047763	21ur-5155
Is affected by daf-2 based on microarray studies.

WB:WBGene00047764	21ur-975
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047765	21ur-2775
No description available

WB:WBGene00047766	21ur-3735
No description available

WB:WBGene00047767	21ur-5382
No description available

WB:WBGene00047768	21ur-5431
No description available

WB:WBGene00047769	21ur-656
No description available

WB:WBGene00047770	21ur-2697
No description available

WB:WBGene00047771	21ur-5294
No description available

WB:WBGene00047772	21ur-1275
No description available

WB:WBGene00047773	21ur-1748
No description available

WB:WBGene00047774	21ur-5366
No description available

WB:WBGene00047775	21ur-1731
No description available

WB:WBGene00047776	21ur-1251
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00047777	21ur-1833
No description available

WB:WBGene00047778	21ur-782
No description available

WB:WBGene00047779	21ur-4737
No description available

WB:WBGene00047780	21ur-2022
No description available

WB:WBGene00047781	21ur-2346
No description available

WB:WBGene00047782	21ur-2873
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00047783	21ur-5093
No description available

WB:WBGene00047784	21ur-4710
Is affected by spt-16 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00047785	21ur-4607
Is affected by daf-2 based on microarray studies.

WB:WBGene00047786	21ur-195
No description available

WB:WBGene00047787	21ur-5433
No description available

WB:WBGene00047788	21ur-5027
No description available

WB:WBGene00047789	21ur-3068
No description available

WB:WBGene00047790	21ur-1579
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00047791	21ur-4696
No description available

WB:WBGene00047792	21ur-4229
No description available

WB:WBGene00047793	21ur-458
No description available

WB:WBGene00047794	21ur-1361
No description available

WB:WBGene00047795	21ur-3113
No description available

WB:WBGene00047796	21ur-4183
No description available

WB:WBGene00047797	21ur-3172
No description available

WB:WBGene00047798	21ur-366
No description available

WB:WBGene00047799	21ur-5447
No description available

WB:WBGene00047800	21ur-4901
No description available

WB:WBGene00047801	21ur-5000
No description available

WB:WBGene00047802	21ur-4631
No description available

WB:WBGene00047803	21ur-675
No description available

WB:WBGene00047804	21ur-3995
No description available

WB:WBGene00047805	21ur-2599
Is affected by bisphenol A based on RNA-seq studies.

WB:WBGene00047806	21ur-1260
No description available

WB:WBGene00047807	21ur-638
No description available

WB:WBGene00047808	21ur-5315
No description available

WB:WBGene00047809	21ur-5036
No description available

WB:WBGene00047810	21ur-3187
No description available

WB:WBGene00047811	21ur-3145
No description available

WB:WBGene00047812	21ur-2713
No description available

WB:WBGene00047813	21ur-3613
Is affected by eat-2 based on microarray studies.

WB:WBGene00047814	21ur-1320
No description available

WB:WBGene00047815	21ur-1752
No description available

WB:WBGene00047816	21ur-2612
No description available

WB:WBGene00047817	21ur-4537
No description available

WB:WBGene00047818	21ur-1963
No description available

WB:WBGene00047819	21ur-2447
No description available

WB:WBGene00047820	21ur-1101
No description available

WB:WBGene00047821	21ur-313
No description available

WB:WBGene00047822	21ur-1609
No description available

WB:WBGene00047823	21ur-5134
No description available

WB:WBGene00047824	21ur-1071
No description available

WB:WBGene00047825	21ur-5235
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047826	21ur-1175
No description available

WB:WBGene00047827	21ur-3520
No description available

WB:WBGene00047828	21ur-2985
No description available

WB:WBGene00047829	21ur-5264
No description available

WB:WBGene00047830	21ur-4173
No description available

WB:WBGene00047831	21ur-4787
No description available

WB:WBGene00047832	21ur-5268
No description available

WB:WBGene00047833	21ur-4343
No description available

WB:WBGene00047834	21ur-2878
No description available

WB:WBGene00047835	21ur-199
No description available

WB:WBGene00047836	21ur-122
No description available

WB:WBGene00047837	21ur-5057
No description available

WB:WBGene00047838	21ur-3602
No description available

WB:WBGene00047839	21ur-3456
No description available

WB:WBGene00047840	21ur-1778
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00047841	21ur-5394
No description available

WB:WBGene00047842	21ur-343
No description available

WB:WBGene00047843	21ur-2912
No description available

WB:WBGene00047844	21ur-4547
No description available

WB:WBGene00047845	21ur-5150
No description available

WB:WBGene00047846	21ur-5215
No description available

WB:WBGene00047847	21ur-1930
No description available

WB:WBGene00047848	21ur-3416
No description available

WB:WBGene00047849	21ur-2001
No description available

WB:WBGene00047850	21ur-2842
No description available

WB:WBGene00047851	21ur-4512
No description available

WB:WBGene00047852	21ur-2982
No description available

WB:WBGene00047853	21ur-1876
No description available

WB:WBGene00047854	21ur-4002
No description available

WB:WBGene00047855	21ur-1117
No description available

WB:WBGene00047856	21ur-3398
No description available

WB:WBGene00047857	21ur-2816
No description available

WB:WBGene00047858	21ur-3651
No description available

WB:WBGene00047859	21ur-2194
No description available

WB:WBGene00047860	21ur-2850
No description available

WB:WBGene00047861	21ur-887
No description available

WB:WBGene00047862	21ur-2602
No description available

WB:WBGene00047863	21ur-1152
No description available

WB:WBGene00047864	21ur-202
No description available

WB:WBGene00047865	21ur-5169
No description available

WB:WBGene00047866	21ur-144
No description available

WB:WBGene00047867	21ur-5375
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies.

WB:WBGene00047868	21ur-3463
No description available

WB:WBGene00047869	21ur-3559
No description available

WB:WBGene00047870	21ur-1184
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00047871	21ur-545
No description available

WB:WBGene00047872	21ur-4074
No description available

WB:WBGene00047873	21ur-2664
No description available

WB:WBGene00047874	21ur-2637
No description available

WB:WBGene00047875	21ur-3383
No description available

WB:WBGene00047876	21ur-562
No description available

WB:WBGene00047877	21ur-3970
No description available

WB:WBGene00047878	21ur-3096
No description available

WB:WBGene00047879	21ur-742
No description available

WB:WBGene00047880	21ur-1162
No description available

WB:WBGene00047881	21ur-1390
No description available

WB:WBGene00047882	21ur-4645
No description available

WB:WBGene00047883	21ur-3040
No description available

WB:WBGene00047884	21ur-834
No description available

WB:WBGene00047885	21ur-226
No description available

WB:WBGene00047886	21ur-4916
No description available

WB:WBGene00047887	21ur-5210
No description available

WB:WBGene00047888	21ur-4315
No description available

WB:WBGene00047889	21ur-569
No description available

WB:WBGene00047890	21ur-482
No description available

WB:WBGene00047891	21ur-2114
No description available

WB:WBGene00047892	21ur-2120
No description available

WB:WBGene00047893	21ur-134
No description available

WB:WBGene00047894	21ur-3152
No description available

WB:WBGene00047895	21ur-4094
No description available

WB:WBGene00047896	21ur-2891
No description available

WB:WBGene00047897	21ur-3532
No description available

WB:WBGene00047898	21ur-1515
No description available

WB:WBGene00047899	21ur-914
No description available

WB:WBGene00047900	21ur-822
No description available

WB:WBGene00047901	21ur-5284
No description available

WB:WBGene00047902	21ur-1182
No description available

WB:WBGene00047903	21ur-3167
No description available

WB:WBGene00047905	21ur-5444
No description available

WB:WBGene00047906	21ur-2290
No description available

WB:WBGene00047907	21ur-1885
No description available

WB:WBGene00047908	21ur-3609
No description available

WB:WBGene00047909	21ur-1348
No description available

WB:WBGene00047910	21ur-3994
No description available

WB:WBGene00047911	21ur-421
No description available

WB:WBGene00047912	21ur-4661
No description available

WB:WBGene00047913	21ur-3627
No description available

WB:WBGene00047914	21ur-3391
No description available

WB:WBGene00047915	21ur-1267
No description available

WB:WBGene00047916	21ur-2841
No description available

WB:WBGene00047917	21ur-3789
No description available

WB:WBGene00047918	21ur-3286
No description available

WB:WBGene00047919	21ur-4632
No description available

WB:WBGene00047920	21ur-61
No description available

WB:WBGene00047921	21ur-873
No description available

WB:WBGene00047922	21ur-3020
No description available

WB:WBGene00047923	21ur-1658
No description available

WB:WBGene00047924	21ur-3552
No description available

WB:WBGene00047925	21ur-3292
No description available

WB:WBGene00047926	21ur-4942
No description available

WB:WBGene00047927	21ur-426
No description available

WB:WBGene00047928	21ur-4976
No description available

WB:WBGene00047929	21ur-5129
No description available

WB:WBGene00047930	21ur-2966
No description available

WB:WBGene00047931	21ur-4498
No description available

WB:WBGene00047932	21ur-1032
No description available

WB:WBGene00047933	21ur-3321
No description available

WB:WBGene00047934	21ur-4481
No description available

WB:WBGene00047935	21ur-4840
No description available

WB:WBGene00047936	21ur-733
No description available

WB:WBGene00047937	21ur-2226
No description available

WB:WBGene00047938	21ur-4522
No description available

WB:WBGene00047939	21ur-5204
No description available

WB:WBGene00047940	21ur-3323
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00047941	21ur-3
No description available

WB:WBGene00047942	21ur-1064
No description available

WB:WBGene00047943	21ur-4208
No description available

WB:WBGene00047944	21ur-2471
No description available

WB:WBGene00047945	21ur-1449
No description available

WB:WBGene00047946	21ur-3934
No description available

WB:WBGene00047947	21ur-5195
No description available

WB:WBGene00047948	21ur-3298
No description available

WB:WBGene00047949	21ur-2260
No description available

WB:WBGene00047950	21ur-497
No description available

WB:WBGene00047951	21ur-940
No description available

WB:WBGene00047952	21ur-1957
No description available

WB:WBGene00047953	21ur-3087
No description available

WB:WBGene00047954	21ur-2231
No description available

WB:WBGene00047955	21ur-291
No description available

WB:WBGene00047956	21ur-238
No description available

WB:WBGene00047957	21ur-4816
No description available

WB:WBGene00047958	21ur-5301
No description available

WB:WBGene00047959	21ur-3539
No description available

WB:WBGene00047960	21ur-2061
No description available

WB:WBGene00047961	21ur-524
No description available

WB:WBGene00047962	21ur-1537
No description available

WB:WBGene00047963	21ur-3703
No description available

WB:WBGene00047964	21ur-4297
No description available

WB:WBGene00047965	21ur-1080
No description available

WB:WBGene00047966	21ur-3188
No description available

WB:WBGene00047967	21ur-4734
No description available

WB:WBGene00047968	21ur-4586
No description available

WB:WBGene00047969	21ur-1942
No description available

WB:WBGene00047970	21ur-5205
No description available

WB:WBGene00047971	21ur-4451
No description available

WB:WBGene00047972	21ur-2294
No description available

WB:WBGene00047973	21ur-1962
No description available

WB:WBGene00047974	21ur-304
No description available

WB:WBGene00047975	21ur-5050
No description available

WB:WBGene00047976	21ur-1683
No description available

WB:WBGene00047977	21ur-2700
No description available

WB:WBGene00047978	21ur-2238
No description available

WB:WBGene00047979	21ur-3331
No description available

WB:WBGene00047980	21ur-4847
No description available

WB:WBGene00047981	21ur-1445
No description available

WB:WBGene00047982	21ur-4122
No description available

WB:WBGene00047983	21ur-3029
No description available

WB:WBGene00047984	21ur-1159
No description available

WB:WBGene00047985	21ur-4446
No description available

WB:WBGene00047986	21ur-2067
No description available

WB:WBGene00047987	21ur-1010
No description available

WB:WBGene00047988	21ur-2174
No description available

WB:WBGene00047989	21ur-32
No description available

WB:WBGene00047990	21ur-4080
No description available

WB:WBGene00047991	21ur-3899
No description available

WB:WBGene00047992	21ur-559
No description available

WB:WBGene00047993	21ur-3014
No description available

WB:WBGene00047994	21ur-5240
No description available

WB:WBGene00047995	21ur-2558
No description available

WB:WBGene00047996	21ur-4301
No description available

WB:WBGene00047997	21ur-1800
No description available

WB:WBGene00047998	21ur-3885
No description available

WB:WBGene00047999	21ur-1427
No description available

WB:WBGene00048000	21ur-4854
No description available

WB:WBGene00048001	21ur-2199
No description available

WB:WBGene00048002	21ur-5183
No description available

WB:WBGene00048003	21ur-3655
No description available

WB:WBGene00048004	21ur-392
No description available

WB:WBGene00048005	21ur-2838
No description available

WB:WBGene00048006	21ur-2690
No description available

WB:WBGene00048007	21ur-4613
No description available

WB:WBGene00048008	21ur-3231
No description available

WB:WBGene00048009	21ur-1218
No description available

WB:WBGene00048010	21ur-2671
No description available

WB:WBGene00048011	21ur-2716
No description available

WB:WBGene00048012	21ur-1777
No description available

WB:WBGene00048013	21ur-3598
No description available

WB:WBGene00048014	21ur-4996
No description available

WB:WBGene00048015	21ur-609
No description available

WB:WBGene00048016	21ur-2796
No description available

WB:WBGene00048017	21ur-3361
No description available

WB:WBGene00048018	21ur-3663
No description available

WB:WBGene00048019	21ur-5043
No description available

WB:WBGene00048020	21ur-3954
No description available

WB:WBGene00048021	21ur-510
No description available

WB:WBGene00048022	21ur-1811
No description available

WB:WBGene00048023	21ur-1611
No description available

WB:WBGene00048024	21ur-845
No description available

WB:WBGene00048025	21ur-4155
No description available

WB:WBGene00048026	21ur-3845
No description available

WB:WBGene00048027	21ur-2147
No description available

WB:WBGene00048028	21ur-1807
No description available

WB:WBGene00048029	21ur-5022
No description available

WB:WBGene00048030	21ur-4609
No description available

WB:WBGene00048031	21ur-851
No description available

WB:WBGene00048032	21ur-4039
No description available

WB:WBGene00048033	21ur-2425
No description available

WB:WBGene00048034	21ur-3419
No description available

WB:WBGene00048035	21ur-2079
No description available

WB:WBGene00048036	21ur-1108
No description available

WB:WBGene00048037	21ur-5438
No description available

WB:WBGene00048038	21ur-3774
No description available

WB:WBGene00048039	21ur-3905
No description available

WB:WBGene00048040	21ur-77
No description available

WB:WBGene00048041	21ur-418
No description available

WB:WBGene00048042	21ur-145
No description available

WB:WBGene00048043	21ur-4803
No description available

WB:WBGene00048044	21ur-2771
No description available

WB:WBGene00048045	21ur-356
No description available

WB:WBGene00048046	21ur-3904
No description available

WB:WBGene00048047	21ur-4308
No description available

WB:WBGene00048048	21ur-519
No description available

WB:WBGene00048049	21ur-724
No description available

WB:WBGene00048050	21ur-4083
No description available

WB:WBGene00048051	21ur-4716
No description available

WB:WBGene00048052	21ur-1675
No description available

WB:WBGene00048053	21ur-470
No description available

WB:WBGene00048054	21ur-4276
No description available

WB:WBGene00048055	21ur-4382
No description available

WB:WBGene00048056	21ur-3374
No description available

WB:WBGene00048057	21ur-1189
No description available

WB:WBGene00048058	21ur-3763
No description available

WB:WBGene00048059	21ur-4103
No description available

WB:WBGene00048060	21ur-1838
No description available

WB:WBGene00048061	21ur-4873
No description available

WB:WBGene00048062	21ur-2670
No description available

WB:WBGene00048063	21ur-2247
No description available

WB:WBGene00048064	21ur-2646
No description available

WB:WBGene00048065	21ur-576
No description available

WB:WBGene00048066	21ur-4220
No description available

WB:WBGene00048067	21ur-817
No description available

WB:WBGene00048068	21ur-1834
No description available

WB:WBGene00048069	21ur-1724
No description available

WB:WBGene00048070	21ur-2368
No description available

WB:WBGene00048071	21ur-3303
No description available

WB:WBGene00048072	21ur-3274
No description available

WB:WBGene00048073	21ur-2100
No description available

WB:WBGene00048074	21ur-5239
No description available

WB:WBGene00048075	21ur-4552
No description available

WB:WBGene00048076	21ur-577
No description available

WB:WBGene00048077	21ur-1645
No description available

WB:WBGene00048078	21ur-3312
No description available

WB:WBGene00048079	21ur-2979
No description available

WB:WBGene00048080	21ur-1646
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00048081	21ur-4029
No description available

WB:WBGene00048082	21ur-4100
No description available

WB:WBGene00048083	21ur-5308
No description available

WB:WBGene00048084	21ur-708
No description available

WB:WBGene00048085	21ur-2331
No description available

WB:WBGene00048086	21ur-604
No description available

WB:WBGene00048087	21ur-618
No description available

WB:WBGene00048088	21ur-5348
No description available

WB:WBGene00048089	21ur-945
No description available

WB:WBGene00048090	21ur-2200
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00048091	21ur-543
No description available

WB:WBGene00048092	21ur-1398
No description available

WB:WBGene00048093	21ur-1335
No description available

WB:WBGene00048094	21ur-1091
No description available

WB:WBGene00048095	21ur-1783
No description available

WB:WBGene00048096	21ur-2006
No description available

WB:WBGene00048097	21ur-1385
No description available

WB:WBGene00048098	21ur-644
No description available

WB:WBGene00048099	21ur-1974
No description available

WB:WBGene00048100	21ur-4162
No description available

WB:WBGene00048101	21ur-2301
No description available

WB:WBGene00048102	21ur-4393
No description available

WB:WBGene00048103	21ur-3495
No description available

WB:WBGene00048104	21ur-4875
No description available

WB:WBGene00048105	21ur-1330
No description available

WB:WBGene00048106	21ur-3226
No description available

WB:WBGene00048107	21ur-3139
No description available

WB:WBGene00048108	21ur-4988
No description available

WB:WBGene00048109	21ur-2480
No description available

WB:WBGene00048110	21ur-3243
No description available

WB:WBGene00048111	21ur-3448
No description available

WB:WBGene00048112	21ur-4621
No description available

WB:WBGene00048113	21ur-866
No description available

WB:WBGene00048114	21ur-4119
No description available

WB:WBGene00048115	21ur-3869
No description available

WB:WBGene00048116	21ur-2862
No description available

WB:WBGene00048117	21ur-636
No description available

WB:WBGene00048118	21ur-1178
No description available

WB:WBGene00048119	21ur-4674
No description available

WB:WBGene00048120	21ur-3210
No description available

WB:WBGene00048121	21ur-3923
No description available

WB:WBGene00048122	21ur-1254
No description available

WB:WBGene00048123	21ur-388
No description available

WB:WBGene00048124	21ur-4980
No description available

WB:WBGene00048125	21ur-4515
No description available

WB:WBGene00048126	21ur-3470
No description available

WB:WBGene00048127	21ur-1543
No description available

WB:WBGene00048128	21ur-4729
No description available

WB:WBGene00048129	21ur-3719
No description available

WB:WBGene00048130	21ur-3671
No description available

WB:WBGene00048131	21ur-489
No description available

WB:WBGene00048132	21ur-1421
No description available

WB:WBGene00048133	21ur-3252
No description available

WB:WBGene00048134	21ur-911
No description available

WB:WBGene00048135	21ur-3159
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00048136	21ur-2452
No description available

WB:WBGene00048137	21ur-3782
No description available

WB:WBGene00048138	21ur-2813
No description available

WB:WBGene00048139	21ur-5191
No description available

WB:WBGene00048140	21ur-1357
No description available

WB:WBGene00048141	21ur-5009
No description available

WB:WBGene00048142	21ur-2808
No description available

WB:WBGene00048143	21ur-3721
No description available

WB:WBGene00048144	21ur-3247
No description available

WB:WBGene00048145	21ur-1410
No description available

WB:WBGene00048146	21ur-3205
No description available

WB:WBGene00048147	21ur-184
No description available

WB:WBGene00048148	21ur-935
No description available

WB:WBGene00048149	21ur-2593
No description available

WB:WBGene00048150	21ur-1419
No description available

WB:WBGene00048151	21ur-3568
No description available

WB:WBGene00048152	21ur-4652
No description available

WB:WBGene00048153	21ur-3355
No description available

WB:WBGene00048154	21ur-1634
No description available

WB:WBGene00048155	21ur-3645
No description available

WB:WBGene00048156	21ur-846
No description available

WB:WBGene00048157	21ur-1796
No description available

WB:WBGene00048158	21ur-2536
No description available

WB:WBGene00048159	21ur-3427
No description available

WB:WBGene00048160	21ur-2450
No description available

WB:WBGene00048161	21ur-1298
No description available

WB:WBGene00048162	21ur-3560
No description available

WB:WBGene00048163	21ur-4131
No description available

WB:WBGene00048164	21ur-2327
No description available

WB:WBGene00048165	21ur-4283
No description available

WB:WBGene00048166	21ur-96
No description available

WB:WBGene00048167	21ur-2839
No description available

WB:WBGene00048168	21ur-4064
No description available

WB:WBGene00048169	21ur-2021
No description available

WB:WBGene00048170	21ur-1207
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00048171	21ur-285
No description available

WB:WBGene00048172	21ur-930
No description available

WB:WBGene00048173	21ur-161
No description available

WB:WBGene00048174	21ur-5188
No description available

WB:WBGene00048175	21ur-3367
No description available

WB:WBGene00048176	21ur-3377
No description available

WB:WBGene00048177	21ur-1009
No description available

WB:WBGene00048178	21ur-549
No description available

WB:WBGene00048179	21ur-749
No description available

WB:WBGene00048180	21ur-890
No description available

WB:WBGene00048181	21ur-3594
No description available

WB:WBGene00048182	21ur-2488
No description available

WB:WBGene00048183	21ur-3123
No description available

WB:WBGene00048184	21ur-4912
No description available

WB:WBGene00048185	21ur-2248
No description available

WB:WBGene00048186	21ur-208
No description available

WB:WBGene00048187	21ur-4659
No description available

WB:WBGene00048188	21ur-1442
No description available

WB:WBGene00048189	21ur-4170
No description available

WB:WBGene00048190	21ur-4977
No description available

WB:WBGene00048191	21ur-2483
No description available

WB:WBGene00048192	21ur-5189
No description available

WB:WBGene00048193	21ur-3679
No description available

WB:WBGene00048194	21ur-3211
No description available

WB:WBGene00048195	21ur-484
No description available

WB:WBGene00048196	21ur-1832
No description available

WB:WBGene00048197	21ur-4433
No description available

WB:WBGene00048198	21ur-5350
No description available

WB:WBGene00048199	21ur-2949
No description available

WB:WBGene00048200	21ur-1972
No description available

WB:WBGene00048201	21ur-2045
No description available

WB:WBGene00048202	21ur-3975
No description available

WB:WBGene00048203	21ur-934
No description available

WB:WBGene00048204	21ur-2652
No description available

WB:WBGene00048205	21ur-2322
No description available

WB:WBGene00048206	21ur-138
No description available

WB:WBGene00048207	21ur-3295
No description available

WB:WBGene00048208	21ur-2896
No description available

WB:WBGene00048209	21ur-1063
No description available

WB:WBGene00048210	21ur-4776
No description available

WB:WBGene00048211	21ur-4240
No description available

WB:WBGene00048212	21ur-4878
No description available

WB:WBGene00048213	21ur-1129
No description available

WB:WBGene00048214	21ur-2165
No description available

WB:WBGene00048215	21ur-4018
No description available

WB:WBGene00048216	21ur-2257
No description available

WB:WBGene00048217	21ur-989
No description available

WB:WBGene00048218	21ur-4369
No description available

WB:WBGene00048219	21ur-4305
No description available

WB:WBGene00048220	21ur-3687
No description available

WB:WBGene00048221	21ur-501
No description available

WB:WBGene00048222	21ur-1667
No description available

WB:WBGene00048223	21ur-4225
No description available

WB:WBGene00048224	21ur-4720
No description available

WB:WBGene00048225	21ur-4628
No description available

WB:WBGene00048226	21ur-2764
No description available

WB:WBGene00048227	21ur-2815
No description available

WB:WBGene00048228	21ur-1050
No description available

WB:WBGene00048229	21ur-1391
No description available

WB:WBGene00048230	21ur-1596
No description available

WB:WBGene00048231	21ur-4019
No description available

WB:WBGene00048232	21ur-637
No description available

WB:WBGene00048233	21ur-4933
No description available

WB:WBGene00048234	21ur-684
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00048235	21ur-918
No description available

WB:WBGene00048236	21ur-4460
No description available

WB:WBGene00048237	21ur-1473
No description available

WB:WBGene00048238	21ur-5327
Is affected by emr-1; lem-2; and adr-1 based on RNA-seq studies.

WB:WBGene00048239	21ur-1931
No description available

WB:WBGene00048240	21ur-1711
No description available

WB:WBGene00048241	21ur-5
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00048242	21ur-5061
No description available

WB:WBGene00048243	21ur-3358
No description available

WB:WBGene00048244	21ur-2229
No description available

WB:WBGene00048245	21ur-574
No description available

WB:WBGene00048246	21ur-389
No description available

WB:WBGene00048247	21ur-288
No description available

WB:WBGene00048248	21ur-183
No description available

WB:WBGene00048249	21ur-253
No description available

WB:WBGene00048250	21ur-1858
No description available

WB:WBGene00048251	21ur-4836
No description available

WB:WBGene00048252	21ur-2990
No description available

WB:WBGene00048253	21ur-4001
No description available

WB:WBGene00048254	21ur-276
No description available

WB:WBGene00048255	21ur-1642
No description available

WB:WBGene00048256	21ur-1194
No description available

WB:WBGene00048257	21ur-4753
No description available

WB:WBGene00048258	21ur-800
No description available

WB:WBGene00048259	21ur-2798
No description available

WB:WBGene00048260	21ur-3443
No description available

WB:WBGene00048261	21ur-1553
No description available

WB:WBGene00048262	21ur-1926
No description available

WB:WBGene00048263	21ur-566
No description available

WB:WBGene00048264	21ur-3561
No description available

WB:WBGene00048265	21ur-4210
No description available

WB:WBGene00048266	21ur-3270
No description available

WB:WBGene00048267	21ur-3387
No description available

WB:WBGene00048268	21ur-977
No description available

WB:WBGene00048269	21ur-475
No description available

WB:WBGene00048270	21ur-2821
No description available

WB:WBGene00048271	21ur-3090
No description available

WB:WBGene00048272	21ur-4362
No description available

WB:WBGene00048273	21ur-2629
Is affected by eat-2 based on microarray studies.

WB:WBGene00048274	21ur-1789
No description available

WB:WBGene00048275	21ur-464
No description available

WB:WBGene00048276	21ur-2341
No description available

WB:WBGene00048277	21ur-4745
No description available

WB:WBGene00048278	21ur-4022
No description available

WB:WBGene00048279	21ur-4424
No description available

WB:WBGene00048280	21ur-3036
No description available

WB:WBGene00048281	21ur-4742
No description available

WB:WBGene00048282	21ur-5243
No description available

WB:WBGene00048283	21ur-1517
No description available

WB:WBGene00048284	21ur-2866
No description available

WB:WBGene00048285	21ur-1017
No description available

WB:WBGene00048286	21ur-3707
No description available

WB:WBGene00048287	21ur-848
No description available

WB:WBGene00048288	21ur-1087
No description available

WB:WBGene00048289	21ur-5148
No description available

WB:WBGene00048290	21ur-1107
No description available

WB:WBGene00048291	21ur-941
No description available

WB:WBGene00048292	21ur-3132
No description available

WB:WBGene00048293	21ur-4286
No description available

WB:WBGene00048294	21ur-3181
No description available

WB:WBGene00048295	21ur-4197
No description available

WB:WBGene00048296	21ur-2438
No description available

WB:WBGene00048297	21ur-5296
No description available

WB:WBGene00048298	21ur-3743
No description available

WB:WBGene00048299	21ur-2429
No description available

WB:WBGene00048300	21ur-4639
No description available

WB:WBGene00048301	21ur-1869
No description available

WB:WBGene00048302	21ur-3241
No description available

WB:WBGene00048303	21ur-4502
No description available

WB:WBGene00048304	21ur-1661
No description available

WB:WBGene00048305	21ur-1655
No description available

WB:WBGene00048306	21ur-2900
No description available

WB:WBGene00048307	21ur-1945
No description available

WB:WBGene00048308	21ur-3988
No description available

WB:WBGene00048309	21ur-1660
No description available

WB:WBGene00048310	21ur-4081
No description available

WB:WBGene00048311	21ur-2776
No description available

WB:WBGene00048312	21ur-1255
No description available

WB:WBGene00048313	21ur-3301
No description available

WB:WBGene00048314	21ur-5333
No description available

WB:WBGene00048315	21ur-1332
No description available

WB:WBGene00048316	21ur-830
No description available

WB:WBGene00048317	21ur-4051
No description available

WB:WBGene00048318	21ur-2289
No description available

WB:WBGene00048319	21ur-3364
No description available

WB:WBGene00048320	21ur-2749
No description available

WB:WBGene00048321	21ur-4808
No description available

WB:WBGene00048322	21ur-1784
No description available

WB:WBGene00048323	21ur-2805
No description available

WB:WBGene00048324	21ur-1338
No description available

WB:WBGene00048325	21ur-3662
No description available

WB:WBGene00048326	21ur-3485
No description available

WB:WBGene00048327	21ur-3044
No description available

WB:WBGene00048328	21ur-1678
No description available

WB:WBGene00048329	21ur-5012
No description available

WB:WBGene00048330	21ur-4102
No description available

WB:WBGene00048331	21ur-2003
No description available

WB:WBGene00048332	21ur-3086
No description available

WB:WBGene00048333	21ur-2302
No description available

WB:WBGene00048334	21ur-1150
No description available

WB:WBGene00048335	21ur-2202
No description available

WB:WBGene00048336	21ur-540
No description available

WB:WBGene00048337	21ur-852
No description available

WB:WBGene00048338	21ur-2359
No description available

WB:WBGene00048339	21ur-3742
No description available

WB:WBGene00048340	21ur-44
No description available

WB:WBGene00048341	21ur-1138
No description available

WB:WBGene00048342	21ur-635
No description available

WB:WBGene00048343	21ur-1958
No description available

WB:WBGene00048344	21ur-3785
No description available

WB:WBGene00048345	21ur-1191
No description available

WB:WBGene00048346	21ur-2737
No description available

WB:WBGene00048347	21ur-3908
No description available

WB:WBGene00048348	21ur-1950
No description available

WB:WBGene00048349	21ur-296
No description available

WB:WBGene00048350	21ur-4179
No description available

WB:WBGene00048351	21ur-2498
No description available

WB:WBGene00048352	21ur-309
No description available

WB:WBGene00048353	21ur-2676
No description available

WB:WBGene00048354	21ur-2218
No description available

WB:WBGene00048355	21ur-2152
No description available

WB:WBGene00048356	21ur-3875
No description available

WB:WBGene00048357	21ur-4853
No description available

WB:WBGene00048358	21ur-3227
No description available

WB:WBGene00048359	21ur-4378
No description available

WB:WBGene00048360	21ur-3230
No description available

WB:WBGene00048361	21ur-3880
No description available

WB:WBGene00048362	21ur-5388
No description available

WB:WBGene00048363	21ur-3324
No description available

WB:WBGene00048364	21ur-723
No description available

WB:WBGene00048365	21ur-1801
No description available

WB:WBGene00048366	21ur-1699
No description available

WB:WBGene00048367	21ur-1161
No description available

WB:WBGene00048368	21ur-4872
No description available

WB:WBGene00048369	21ur-1638
No description available

WB:WBGene00048370	21ur-861
No description available

WB:WBGene00048371	21ur-1100
No description available

WB:WBGene00048372	21ur-1186
No description available

WB:WBGene00048373	21ur-2833
No description available

WB:WBGene00048374	21ur-2666
No description available

WB:WBGene00048375	21ur-27
No description available

WB:WBGene00048376	21ur-1991
No description available

WB:WBGene00048377	21ur-2121
No description available

WB:WBGene00048378	21ur-4535
No description available

WB:WBGene00048379	21ur-872
No description available

WB:WBGene00048380	21ur-600
No description available

WB:WBGene00048381	21ur-5203
No description available

WB:WBGene00048382	21ur-694
No description available

WB:WBGene00048383	21ur-1424
No description available

WB:WBGene00048384	21ur-3015
No description available

WB:WBGene00048385	21ur-1437
No description available

WB:WBGene00048386	21ur-1595
No description available

WB:WBGene00048387	21ur-738
No description available

WB:WBGene00048388	21ur-1877
No description available

WB:WBGene00048389	21ur-94
No description available

WB:WBGene00048390	21ur-3753
No description available

WB:WBGene00048391	21ur-5399
No description available

WB:WBGene00048392	21ur-996
No description available

WB:WBGene00048393	21ur-3879
No description available

WB:WBGene00048394	21ur-302
No description available

WB:WBGene00048395	21ur-3702
No description available

WB:WBGene00048396	21ur-3201
No description available

WB:WBGene00048397	21ur-4321
No description available

WB:WBGene00048398	21ur-4484
No description available

WB:WBGene00048399	21ur-4071
No description available

WB:WBGene00048400	21ur-2388
No description available

WB:WBGene00048401	21ur-5186
No description available

WB:WBGene00048402	21ur-207
No description available

WB:WBGene00048403	21ur-4990
No description available

WB:WBGene00048404	21ur-660
No description available

WB:WBGene00048405	21ur-1939
No description available

WB:WBGene00048406	21ur-4760
No description available

WB:WBGene00048407	21ur-4948
No description available

WB:WBGene00048408	21ur-318
No description available

WB:WBGene00048409	21ur-5058
No description available

WB:WBGene00048410	21ur-5289
No description available

WB:WBGene00048411	21ur-3105
No description available

WB:WBGene00048412	21ur-811
No description available

WB:WBGene00048413	21ur-3678
No description available

WB:WBGene00048414	21ur-2057
No description available

WB:WBGene00048415	21ur-2128
No description available

WB:WBGene00048416	21ur-1714
No description available

WB:WBGene00048417	21ur-4657
No description available

WB:WBGene00048418	21ur-3521
No description available

WB:WBGene00048419	21ur-171
No description available

WB:WBGene00048420	21ur-2742
No description available

WB:WBGene00048421	21ur-1998
No description available

WB:WBGene00048422	21ur-3574
No description available

WB:WBGene00048423	21ur-939
No description available

WB:WBGene00048424	21ur-3154
No description available

WB:WBGene00048425	21ur-4095
No description available

WB:WBGene00048426	21ur-4735
No description available

WB:WBGene00048427	21ur-99
No description available

WB:WBGene00048428	21ur-3275
No description available

WB:WBGene00048429	21ur-4908
No description available

WB:WBGene00048430	21ur-1656
No description available

WB:WBGene00048431	21ur-4371
No description available

WB:WBGene00048432	21ur-4207
No description available

WB:WBGene00048433	21ur-1380
No description available

WB:WBGene00048434	21ur-716
No description available

WB:WBGene00048435	21ur-3965
No description available

WB:WBGene00048436	21ur-1232
No description available

WB:WBGene00048437	21ur-142
No description available

WB:WBGene00048438	21ur-4496
No description available

WB:WBGene00048439	21ur-89
No description available

WB:WBGene00048440	21ur-2334
No description available

WB:WBGene00048441	21ur-3380
No description available

WB:WBGene00048442	21ur-3826
No description available

WB:WBGene00048443	21ur-3468
No description available

WB:WBGene00048444	21ur-218
No description available

WB:WBGene00048445	21ur-915
No description available

WB:WBGene00048446	21ur-2405
No description available

WB:WBGene00048447	21ur-8
No description available

WB:WBGene00048448	21ur-1239
No description available

WB:WBGene00048449	21ur-4678
No description available

WB:WBGene00048450	21ur-3250
No description available

WB:WBGene00048451	21ur-4919
No description available

WB:WBGene00048452	21ur-244
No description available

WB:WBGene00048453	21ur-3892
No description available

WB:WBGene00048454	21ur-3370
No description available

WB:WBGene00048455	21ur-454
No description available

WB:WBGene00048456	21ur-1349
No description available

WB:WBGene00048457	21ur-1406
No description available

WB:WBGene00048458	21ur-5418
No description available

WB:WBGene00048459	21ur-4842
No description available

WB:WBGene00048460	21ur-1168
No description available

WB:WBGene00048461	21ur-1625
No description available

WB:WBGene00048462	21ur-4827
No description available

WB:WBGene00048463	21ur-5238
No description available

WB:WBGene00048464	21ur-3865
No description available

WB:WBGene00048465	21ur-2608
No description available

WB:WBGene00048466	21ur-2050
No description available

WB:WBGene00048467	21ur-5020
No description available

WB:WBGene00048468	21ur-5220
No description available

WB:WBGene00048469	21ur-2115
No description available

WB:WBGene00048470	21ur-3501
No description available

WB:WBGene00048471	21ur-3023
No description available

WB:WBGene00048472	21ur-5164
No description available

WB:WBGene00048473	21ur-261
No description available

WB:WBGene00048474	21ur-1816
No description available

WB:WBGene00048475	21ur-2233
No description available

WB:WBGene00048476	21ur-4070
No description available

WB:WBGene00048477	21ur-2028
No description available

WB:WBGene00048478	21ur-117
No description available

WB:WBGene00048479	21ur-2606
No description available

WB:WBGene00048480	21ur-2224
No description available

WB:WBGene00048481	21ur-3028
No description available

WB:WBGene00048482	21ur-1737
No description available

WB:WBGene00048483	21ur-4320
No description available

WB:WBGene00048484	21ur-1541
No description available

WB:WBGene00048485	21ur-4077
No description available

WB:WBGene00048486	21ur-2235
No description available

WB:WBGene00048487	21ur-1371
No description available

WB:WBGene00048488	21ur-3392
No description available

WB:WBGene00048489	21ur-106
No description available

WB:WBGene00048490	21ur-4595
No description available

WB:WBGene00048491	21ur-1631
No description available

WB:WBGene00048492	21ur-2553
No description available

WB:WBGene00048493	21ur-828
No description available

WB:WBGene00048494	21ur-2106
No description available

WB:WBGene00048495	21ur-131
No description available

WB:WBGene00048496	21ur-2683
No description available

WB:WBGene00048497	21ur-5307
No description available

WB:WBGene00048498	21ur-2618
No description available

WB:WBGene00048499	21ur-790
No description available

WB:WBGene00048500	21ur-2965
No description available

WB:WBGene00048501	21ur-290
No description available

WB:WBGene00048502	21ur-5316
No description available

WB:WBGene00048503	21ur-865
No description available

WB:WBGene00048504	21ur-3956
No description available

WB:WBGene00048505	21ur-2633
No description available

WB:WBGene00048506	21ur-3558
No description available

WB:WBGene00048507	21ur-3039
No description available

WB:WBGene00048508	21ur-414
No description available

WB:WBGene00048509	21ur-4910
No description available

WB:WBGene00048510	21ur-976
No description available

WB:WBGene00048511	21ur-3888
No description available

WB:WBGene00048512	21ur-955
No description available

WB:WBGene00048513	21ur-2458
No description available

WB:WBGene00048514	21ur-3716
No description available

WB:WBGene00048515	21ur-2311
No description available

WB:WBGene00048516	21ur-2326
No description available

WB:WBGene00048517	21ur-3807
No description available

WB:WBGene00048518	21ur-1221
No description available

WB:WBGene00048519	21ur-1632
No description available

WB:WBGene00048520	21ur-2692
No description available

WB:WBGene00048521	21ur-538
No description available

WB:WBGene00048522	21ur-1157
No description available

WB:WBGene00048523	21ur-4641
No description available

WB:WBGene00048524	21ur-4037
No description available

WB:WBGene00048525	21ur-2851
No description available

WB:WBGene00048526	21ur-4863
No description available

WB:WBGene00048527	21ur-4146
No description available

WB:WBGene00048528	21ur-2527
No description available

WB:WBGene00048529	21ur-5286
No description available

WB:WBGene00048530	21ur-3488
No description available

WB:WBGene00048531	21ur-3085
No description available

WB:WBGene00048532	21ur-3038
No description available

WB:WBGene00048533	21ur-3050
No description available

WB:WBGene00048534	21ur-5340
No description available

WB:WBGene00048535	21ur-1606
No description available

WB:WBGene00048536	21ur-2038
No description available

WB:WBGene00048537	21ur-667
No description available

WB:WBGene00048538	21ur-1133
No description available

WB:WBGene00048539	21ur-2880
No description available

WB:WBGene00048540	21ur-2978
No description available

WB:WBGene00048541	21ur-3417
No description available

WB:WBGene00048542	21ur-4332
No description available

WB:WBGene00048543	21ur-4495
No description available

WB:WBGene00048544	21ur-923
No description available

WB:WBGene00048545	21ur-3266
No description available

WB:WBGene00048546	21ur-45
No description available

WB:WBGene00048547	21ur-4198
No description available

WB:WBGene00048548	21ur-3302
No description available

WB:WBGene00048549	21ur-4514
No description available

WB:WBGene00048550	21ur-3925
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00048551	21ur-2983
No description available

WB:WBGene00048552	21ur-4817
No description available

WB:WBGene00048553	21ur-1321
No description available

WB:WBGene00048554	21ur-2072
No description available

WB:WBGene00048555	21ur-613
No description available

WB:WBGene00048556	21ur-1981
No description available

WB:WBGene00048557	21ur-5069
No description available

WB:WBGene00048558	21ur-3614
No description available

WB:WBGene00048559	21ur-786
No description available

WB:WBGene00048560	21ur-5035
No description available

WB:WBGene00048561	21ur-2157
No description available

WB:WBGene00048562	21ur-4217
No description available

WB:WBGene00048563	21ur-1081
No description available

WB:WBGene00048564	21ur-2799
No description available

WB:WBGene00048565	21ur-3471
No description available

WB:WBGene00048566	21ur-3694
No description available

WB:WBGene00048567	21ur-3776
No description available

WB:WBGene00048568	21ur-2472
No description available

WB:WBGene00048569	21ur-4113
No description available

WB:WBGene00048570	21ur-1705
No description available

WB:WBGene00048571	21ur-1849
No description available

WB:WBGene00048572	21ur-4677
No description available

WB:WBGene00048573	21ur-4587
No description available

WB:WBGene00048574	21ur-5090
No description available

WB:WBGene00048575	21ur-2330
No description available

WB:WBGene00048576	21ur-5096
No description available

WB:WBGene00048577	21ur-3426
No description available

WB:WBGene00048578	21ur-2560
No description available

WB:WBGene00048579	21ur-624
No description available

WB:WBGene00048580	21ur-1202
No description available

WB:WBGene00048581	21ur-4958
No description available

WB:WBGene00048582	21ur-2549
No description available

WB:WBGene00048583	21ur-4239
No description available

WB:WBGene00048584	21ur-5161
No description available

WB:WBGene00048585	21ur-4130
No description available

WB:WBGene00048586	21ur-4882
No description available

WB:WBGene00048587	21ur-3511
No description available

WB:WBGene00048588	21ur-4867
No description available

WB:WBGene00048589	21ur-672
No description available

WB:WBGene00048590	21ur-1045
No description available

WB:WBGene00048591	21ur-3575
No description available

WB:WBGene00048592	21ur-1569
No description available

WB:WBGene00048593	21ur-4780
No description available

WB:WBGene00048594	21ur-1174
No description available

WB:WBGene00048595	21ur-2349
No description available

WB:WBGene00048596	21ur-2519
No description available

WB:WBGene00048597	21ur-3722
No description available

WB:WBGene00048598	21ur-589
No description available

WB:WBGene00048599	21ur-2543
No description available

WB:WBGene00048600	21ur-3794
No description available

WB:WBGene00048601	21ur-3064
No description available

WB:WBGene00048602	21ur-1122
No description available

WB:WBGene00048603	21ur-2275
No description available

WB:WBGene00048604	21ur-1297
No description available

WB:WBGene00048605	21ur-2931
No description available

WB:WBGene00048606	21ur-1358
No description available

WB:WBGene00048607	21ur-3955
No description available

WB:WBGene00048608	21ur-2885
No description available

WB:WBGene00048609	21ur-709
No description available

WB:WBGene00048610	21ur-3151
No description available

WB:WBGene00048611	21ur-1760
No description available

WB:WBGene00048612	21ur-2484
No description available

WB:WBGene00048613	21ur-2907
No description available

WB:WBGene00048614	21ur-3147
No description available

WB:WBGene00048615	21ur-3401
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00048616	21ur-2894
No description available

WB:WBGene00048617	21ur-3909
No description available

WB:WBGene00048618	21ur-364
No description available

WB:WBGene00048619	21ur-2782
No description available

WB:WBGene00048620	21ur-3814
No description available

WB:WBGene00048621	21ur-4534
No description available

WB:WBGene00048622	21ur-151
No description available

WB:WBGene00048623	21ur-3518
No description available

WB:WBGene00048624	21ur-1056
No description available

WB:WBGene00048625	21ur-3667
No description available

WB:WBGene00048626	21ur-3140
No description available

WB:WBGene00048627	21ur-4232
Is affected by daf-2 based on microarray studies.

WB:WBGene00048628	21ur-760
No description available

WB:WBGene00048629	21ur-599
No description available

WB:WBGene00048630	21ur-4960
No description available

WB:WBGene00048631	21ur-1307
No description available

WB:WBGene00048632	21ur-5081
No description available

WB:WBGene00048633	21ur-4200
No description available

WB:WBGene00048634	21ur-4084
No description available

WB:WBGene00048635	21ur-2462
No description available

WB:WBGene00048636	21ur-4560
No description available

WB:WBGene00048637	21ur-2184
No description available

WB:WBGene00048638	21ur-3111
No description available

WB:WBGene00048639	21ur-523
No description available

WB:WBGene00048640	21ur-3059
No description available

WB:WBGene00048641	21ur-774
No description available

WB:WBGene00048642	21ur-5398
No description available

WB:WBGene00048643	21ur-1610
No description available

WB:WBGene00048644	21ur-1020
No description available

WB:WBGene00048645	21ur-4648
No description available

WB:WBGene00048646	21ur-4819
No description available

WB:WBGene00048647	21ur-2151
No description available

WB:WBGene00048648	21ur-4139
No description available

WB:WBGene00048649	21ur-2950
No description available

WB:WBGene00048650	21ur-3982
No description available

WB:WBGene00048651	21ur-5439
No description available

WB:WBGene00048652	21ur-5139
No description available

WB:WBGene00048653	21ur-2762
No description available

WB:WBGene00048654	21ur-593
No description available

WB:WBGene00048655	21ur-5248
No description available

WB:WBGene00048656	21ur-4708
No description available

WB:WBGene00048657	21ur-4934
No description available

WB:WBGene00048658	21ur-3335
No description available

WB:WBGene00048659	21ur-3856
No description available

WB:WBGene00048660	21ur-4698
No description available

WB:WBGene00048661	21ur-5349
No description available

WB:WBGene00048662	21ur-3458
No description available

WB:WBGene00048663	21ur-1110
No description available

WB:WBGene00048664	21ur-4178
No description available

WB:WBGene00048665	21ur-1286
No description available

WB:WBGene00048666	21ur-3713
No description available

WB:WBGene00048667	21ur-1730
No description available

WB:WBGene00048668	21ur-1024
No description available

WB:WBGene00048669	21ur-4893
No description available

WB:WBGene00048670	21ur-2241
No description available

WB:WBGene00048671	21ur-3969
No description available

WB:WBGene00048672	21ur-3730
No description available

WB:WBGene00048673	21ur-4970
No description available

WB:WBGene00048674	21ur-2381
No description available

WB:WBGene00048675	21ur-4939
No description available

WB:WBGene00048676	21ur-4385
No description available

WB:WBGene00048677	21ur-5445
No description available

WB:WBGene00048678	21ur-4469
No description available

WB:WBGene00048679	21ur-3551
No description available

WB:WBGene00048680	21ur-4044
No description available

WB:WBGene00048681	21ur-2185
No description available

WB:WBGene00048682	21ur-331
No description available

WB:WBGene00048683	21ur-2175
Is affected by hmg-4 and spt-16 based on RNA-seq studies.

WB:WBGene00048684	21ur-4943
No description available

WB:WBGene00048685	21ur-5121
No description available

WB:WBGene00048686	21ur-5278
No description available

WB:WBGene00048687	21ur-5410
No description available

WB:WBGene00048688	21ur-3469
No description available

WB:WBGene00048689	21ur-5097
No description available

WB:WBGene00048690	21ur-2577
No description available

WB:WBGene00048691	21ur-3133
No description available

WB:WBGene00048692	21ur-435
No description available

WB:WBGene00048693	21ur-4788
No description available

WB:WBGene00048694	21ur-1959
No description available

WB:WBGene00048695	21ur-1736
No description available

WB:WBGene00048696	21ur-314
No description available

WB:WBGene00048697	21ur-5300
No description available

WB:WBGene00048698	21ur-4168
No description available

WB:WBGene00048699	21ur-1486
No description available

WB:WBGene00048700	21ur-1893
No description available

WB:WBGene00048701	21ur-112
No description available

WB:WBGene00048702	21ur-1967
No description available

WB:WBGene00048703	21ur-907
No description available

WB:WBGene00048704	21ur-3728
No description available

WB:WBGene00048705	21ur-4450
No description available

WB:WBGene00048706	21ur-4558
No description available

WB:WBGene00048707	21ur-5380
No description available

WB:WBGene00048708	21ur-1806
No description available

WB:WBGene00048709	21ur-4503
No description available

WB:WBGene00048710	21ur-3406
No description available

WB:WBGene00048711	21ur-3431
No description available

WB:WBGene00048712	21ur-4584
No description available

WB:WBGene00048713	21ur-5018
No description available

WB:WBGene00048714	21ur-3708
No description available

WB:WBGene00048715	21ur-2908
No description available

WB:WBGene00048716	21ur-4989
No description available

WB:WBGene00048717	21ur-1469
No description available

WB:WBGene00048718	21ur-1014
No description available

WB:WBGene00048719	21ur-4413
No description available

WB:WBGene00048720	21ur-1407
No description available

WB:WBGene00048721	21ur-3992
No description available

WB:WBGene00048722	21ur-3583
No description available

WB:WBGene00048723	21ur-4474
No description available

WB:WBGene00048724	21ur-3002
No description available

WB:WBGene00048725	21ur-1534
No description available

WB:WBGene00048726	21ur-3045
No description available

WB:WBGene00048727	21ur-2971
No description available

WB:WBGene00048728	21ur-570
No description available

WB:WBGene00048729	21ur-2166
No description available

WB:WBGene00048730	21ur-2445
No description available

WB:WBGene00048731	21ur-3646
No description available

WB:WBGene00048732	21ur-1314
No description available

WB:WBGene00048733	21ur-4702
No description available

WB:WBGene00048734	21ur-902
No description available

WB:WBGene00048735	21ur-1145
No description available

WB:WBGene00048736	21ur-476
No description available

WB:WBGene00048737	21ur-259
No description available

WB:WBGene00048738	21ur-4021
No description available

WB:WBGene00048739	21ur-4928
No description available

WB:WBGene00048740	21ur-1562
No description available

WB:WBGene00048741	21ur-5102
No description available

WB:WBGene00048742	21ur-1853
No description available

WB:WBGene00048743	21ur-1290
No description available

WB:WBGene00048744	21ur-2901
No description available

WB:WBGene00048745	21ur-90
No description available

WB:WBGene00048746	21ur-4313
No description available

WB:WBGene00048747	21ur-1774
No description available

WB:WBGene00048748	21ur-2564
No description available

WB:WBGene00048749	21ur-3863
No description available

WB:WBGene00048750	21ur-3633
No description available

WB:WBGene00048751	21ur-2715
No description available

WB:WBGene00048752	21ur-1757
No description available

WB:WBGene00048753	21ur-3933
No description available

WB:WBGene00048754	21ur-4008
No description available

WB:WBGene00048755	21ur-732
No description available

WB:WBGene00048756	21ur-1521
No description available

WB:WBGene00048757	21ur-340
No description available

WB:WBGene00048758	21ur-3947
No description available

WB:WBGene00048759	21ur-5423
No description available

WB:WBGene00048760	21ur-5362
No description available

WB:WBGene00048761	21ur-80
No description available

WB:WBGene00048762	21ur-1097
No description available

WB:WBGene00048763	21ur-1479
No description available

WB:WBGene00048764	21ur-2917
No description available

WB:WBGene00048765	21ur-4258
No description available

WB:WBGene00048766	21ur-2431
No description available

WB:WBGene00048767	21ur-1088
No description available

WB:WBGene00048768	21ur-2379
No description available

WB:WBGene00048769	21ur-1011
No description available

WB:WBGene00048770	21ur-3343
No description available

WB:WBGene00048771	21ur-5103
No description available

WB:WBGene00048772	21ur-4266
No description available

WB:WBGene00048773	21ur-968
No description available

WB:WBGene00048774	21ur-2926
No description available

WB:WBGene00048775	21ur-642
No description available

WB:WBGene00048776	21ur-222
No description available

WB:WBGene00048777	21ur-2020
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00048778	21ur-2092
No description available

WB:WBGene00048779	21ur-1364
No description available

WB:WBGene00048780	21ur-4405
No description available

WB:WBGene00048781	21ur-3913
No description available

WB:WBGene00048782	21ur-3118
No description available

WB:WBGene00048783	21ur-2948
No description available

WB:WBGene00048784	21ur-899
No description available

WB:WBGene00048785	21ur-5336
No description available

WB:WBGene00048786	21ur-62
No description available

WB:WBGene00048787	21ur-2139
No description available

WB:WBGene00048788	21ur-4366
No description available

WB:WBGene00048789	21ur-2537
No description available

WB:WBGene00048790	21ur-5142
No description available

WB:WBGene00048791	21ur-4820
No description available

WB:WBGene00048792	21ur-2413
No description available

WB:WBGene00048793	21ur-2846
No description available

WB:WBGene00048794	21ur-1684
No description available

WB:WBGene00048795	21ur-168
No description available

WB:WBGene00048796	21ur-4251
No description available

WB:WBGene00048797	21ur-3182
No description available

WB:WBGene00048798	21ur-2272
No description available

WB:WBGene00048799	21ur-2014
No description available

WB:WBGene00048800	21ur-3395
No description available

WB:WBGene00048801	21ur-1901
No description available

WB:WBGene00048802	21ur-2573
No description available

WB:WBGene00048803	21ur-3097
No description available

WB:WBGene00048804	21ur-355
No description available

WB:WBGene00048805	21ur-1916
No description available

WB:WBGene00048806	21ur-856
No description available

WB:WBGene00048807	21ur-2722
No description available

WB:WBGene00048808	21ur-4335
No description available

WB:WBGene00048809	21ur-1808
No description available

WB:WBGene00048810	21ur-4355
No description available

WB:WBGene00048811	21ur-2617
No description available

WB:WBGene00048812	21ur-3759
No description available

WB:WBGene00048813	21ur-1506
No description available

WB:WBGene00048814	21ur-2729
No description available

WB:WBGene00048815	21ur-4434
No description available

WB:WBGene00048816	21ur-4728
No description available

WB:WBGene00048817	21ur-2580
Is affected by eat-2 based on microarray studies.

WB:WBGene00048819	21ur-4226
No description available

WB:WBGene00048820	21ur-1973
No description available

WB:WBGene00048821	21ur-958
No description available

WB:WBGene00048822	21ur-601
No description available

WB:WBGene00048823	21ur-4295
No description available

WB:WBGene00048824	21ur-1451
No description available

WB:WBGene00048825	21ur-2212
No description available

WB:WBGene00048826	21ur-5119
No description available

WB:WBGene00048827	21ur-1771
No description available

WB:WBGene00048828	21ur-2620
No description available

WB:WBGene00048829	21ur-3606
No description available

WB:WBGene00048830	21ur-4352
No description available

WB:WBGene00048831	21ur-1554
No description available

WB:WBGene00048832	21ur-4344
No description available

WB:WBGene00048833	21ur-2505
No description available

WB:WBGene00048834	21ur-4603
No description available

WB:WBGene00048835	21ur-3616
No description available

WB:WBGene00048836	21ur-3831
No description available

WB:WBGene00048837	21ur-3698
No description available

WB:WBGene00048838	21ur-1343
No description available

WB:WBGene00048839	21ur-1498
No description available

WB:WBGene00048840	21ur-3800
No description available

WB:WBGene00048841	21ur-1617
No description available

WB:WBGene00048842	21ur-4835
No description available

WB:WBGene00048843	21ur-683
No description available

WB:WBGene00048844	21ur-3587
No description available

WB:WBGene00048845	21ur-5147
No description available

WB:WBGene00048846	21ur-3839
No description available

WB:WBGene00048847	21ur-4247
No description available

WB:WBGene00048848	21ur-839
No description available

WB:WBGene00048849	21ur-2258
No description available

WB:WBGene00048850	21ur-2991
No description available

WB:WBGene00048851	21ur-1409
No description available

WB:WBGene00048852	21ur-173
No description available

WB:WBGene00048853	21ur-1245
No description available

WB:WBGene00048854	21ur-269
No description available

WB:WBGene00048855	21ur-4721
No description available

WB:WBGene00048856	21ur-4416
No description available

WB:WBGene00048857	21ur-3739
No description available

WB:WBGene00048858	21ur-884
No description available

WB:WBGene00048859	21ur-3536
No description available

WB:WBGene00048860	21ur-4392
No description available

WB:WBGene00048861	21ur-4685
No description available

WB:WBGene00048862	21ur-1528
No description available

WB:WBGene00048863	21ur-4285
No description available

WB:WBGene00048864	21ur-5346
No description available

WB:WBGene00048865	21ur-1388
No description available

WB:WBGene00048866	21ur-4011
No description available

WB:WBGene00048867	21ur-3385
No description available

WB:WBGene00048868	21ur-3388
No description available

WB:WBGene00048869	21ur-3858
No description available

WB:WBGene00048870	21ur-5044
No description available

WB:WBGene00048871	21ur-1256
No description available

WB:WBGene00048872	21ur-467
No description available

WB:WBGene00048873	21ur-3737
No description available

WB:WBGene00048874	21ur-1829
No description available

WB:WBGene00048875	21ur-1852
No description available

WB:WBGene00048876	21ur-252
No description available

WB:WBGene00048877	21ur-474
No description available

WB:WBGene00048878	21ur-1355
No description available

WB:WBGene00048879	21ur-4672
No description available

WB:WBGene00048880	21ur-2366
No description available

WB:WBGene00048881	21ur-1416
No description available

WB:WBGene00048882	21ur-847
No description available

WB:WBGene00048883	21ur-2437
No description available

WB:WBGene00048884	21ur-2867
No description available

WB:WBGene00048885	21ur-1055
No description available

WB:WBGene00048886	21ur-2122
No description available

WB:WBGene00048887	21ur-1868
No description available

WB:WBGene00048888	21ur-4627
No description available

WB:WBGene00048889	21ur-3556
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00048890	21ur-3661
No description available

WB:WBGene00048891	21ur-17
No description available

WB:WBGene00048892	21ur-3626
No description available

WB:WBGene00048893	21ur-2428
No description available

WB:WBGene00048894	21ur-120
No description available

WB:WBGene00048895	21ur-810
No description available

WB:WBGene00048896	21ur-2125
No description available

WB:WBGene00048897	21ur-270
No description available

WB:WBGene00048898	21ur-5049
No description available

WB:WBGene00048899	21ur-2430
No description available

WB:WBGene00048900	21ur-5295
No description available

WB:WBGene00048901	21ur-4909
No description available

WB:WBGene00048902	21ur-1313
No description available

WB:WBGene00048903	21ur-4744
No description available

WB:WBGene00048904	21ur-4288
No description available

WB:WBGene00048905	21ur-4651
No description available

WB:WBGene00048906	21ur-3668
No description available

WB:WBGene00048907	21ur-4630
No description available

WB:WBGene00048908	21ur-1337
No description available

WB:WBGene00048909	21ur-2628
No description available

WB:WBGene00048910	21ur-4423
No description available

WB:WBGene00048911	21ur-121
No description available

WB:WBGene00048912	21ur-3746
No description available

WB:WBGene00048913	21ur-2829
No description available

WB:WBGene00048914	21ur-758
No description available

WB:WBGene00048915	21ur-4809
No description available

WB:WBGene00048916	21ur-4527
No description available

WB:WBGene00048917	21ur-262
No description available

WB:WBGene00048918	21ur-541
No description available

WB:WBGene00048919	21ur-2044
No description available

WB:WBGene00048920	21ur-5190
No description available

WB:WBGene00048921	21ur-3878
No description available

WB:WBGene00048922	21ur-730
No description available

WB:WBGene00048923	21ur-275
No description available

WB:WBGene00048924	21ur-3689
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00048925	21ur-4363
No description available

WB:WBGene00048926	21ur-3300
No description available

WB:WBGene00048927	21ur-1192
No description available

WB:WBGene00048928	21ur-4468
No description available

WB:WBGene00048929	21ur-5328
No description available

WB:WBGene00048930	21ur-722
No description available

WB:WBGene00048931	21ur-4105
No description available

WB:WBGene00048932	21ur-580
No description available

WB:WBGene00048933	21ur-4982
No description available

WB:WBGene00048934	21ur-3507
No description available

WB:WBGene00048935	21ur-1130
No description available

WB:WBGene00048936	21ur-1677
No description available

WB:WBGene00048937	21ur-3907
No description available

WB:WBGene00048938	21ur-130
No description available

WB:WBGene00048939	21ur-3989
No description available

WB:WBGene00048940	21ur-3194
No description available

WB:WBGene00048941	21ur-2738
No description available

WB:WBGene00048942	21ur-4877
No description available

WB:WBGene00048943	21ur-3765
No description available

WB:WBGene00048944	21ur-1331
No description available

WB:WBGene00048945	21ur-2217
No description available

WB:WBGene00048946	21ur-5007
No description available

WB:WBGene00048947	21ur-2288
No description available

WB:WBGene00048948	21ur-1795
No description available

WB:WBGene00048949	21ur-2499
No description available

WB:WBGene00048950	21ur-2340
No description available

WB:WBGene00048951	21ur-1139
No description available

WB:WBGene00048952	21ur-3784
No description available

WB:WBGene00048953	21ur-1151
No description available

WB:WBGene00048954	21ur-4010
No description available

WB:WBGene00048955	21ur-4129
No description available

WB:WBGene00048956	21ur-1434
No description available

WB:WBGene00048957	21ur-1944
No description available

WB:WBGene00048958	21ur-853
No description available

WB:WBGene00048959	21ur-838
No description available

WB:WBGene00048960	21ur-229
No description available

WB:WBGene00048961	21ur-1047
No description available

WB:WBGene00048962	21ur-3379
No description available

WB:WBGene00048963	21ur-1971
No description available

WB:WBGene00048964	21ur-2677
No description available

WB:WBGene00048965	21ur-1008
No description available

WB:WBGene00048966	21ur-1062
No description available

WB:WBGene00048967	21ur-5152
No description available

WB:WBGene00048968	21ur-3325
No description available

WB:WBGene00048969	21ur-511
No description available

WB:WBGene00048970	21ur-2651
No description available

WB:WBGene00048971	21ur-209
No description available

WB:WBGene00048972	21ur-1341
No description available

WB:WBGene00048973	21ur-1932
No description available

WB:WBGene00048974	21ur-3281
No description available

WB:WBGene00048975	21ur-1408
No description available

WB:WBGene00048976	21ur-4633
No description available

WB:WBGene00048977	21ur-893
No description available

WB:WBGene00048978	21ur-4432
No description available

WB:WBGene00048979	21ur-1947
No description available

WB:WBGene00048980	21ur-2321
No description available

WB:WBGene00048981	21ur-661
No description available

WB:WBGene00048982	21ur-3429
No description available

WB:WBGene00048983	21ur-4563
No description available

WB:WBGene00048984	21ur-2105
No description available

WB:WBGene00048985	21ur-2773
No description available

WB:WBGene00048986	21ur-704
No description available

WB:WBGene00048987	21ur-2047
No description available

WB:WBGene00048988	21ur-2110
No description available

WB:WBGene00048989	21ur-137
No description available

WB:WBGene00048990	21ur-509
No description available

WB:WBGene00048991	21ur-3624
No description available

WB:WBGene00048992	21ur-3550
No description available

WB:WBGene00048993	21ur-4154
No description available

WB:WBGene00048994	21ur-3822
No description available

WB:WBGene00048995	21ur-942
No description available

WB:WBGene00048996	21ur-1262
No description available

WB:WBGene00048997	21ur-2133
No description available

WB:WBGene00048998	21ur-2895
No description available

WB:WBGene00048999	21ur-4663
No description available

WB:WBGene00049000	21ur-3830
No description available

WB:WBGene00049001	21ur-3341
No description available

WB:WBGene00049002	21ur-4775
No description available

WB:WBGene00049003	21ur-5055
No description available

WB:WBGene00049004	21ur-3357
No description available

WB:WBGene00049005	21ur-3446
No description available

WB:WBGene00049006	21ur-1643
No description available

WB:WBGene00049007	21ur-2572
No description available

WB:WBGene00049008	21ur-4257
No description available

WB:WBGene00049009	21ur-5132
No description available

WB:WBGene00049010	21ur-921
No description available

WB:WBGene00049011	21ur-324
No description available

WB:WBGene00049012	21ur-3569
No description available

WB:WBGene00049013	21ur-933
No description available

WB:WBGene00049014	21ur-1549
No description available

WB:WBGene00049015	21ur-4658
No description available

WB:WBGene00049016	21ur-1205
No description available

WB:WBGene00049017	21ur-3128
No description available

WB:WBGene00049018	21ur-3677
No description available

WB:WBGene00049019	21ur-287
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049020	21ur-1559
No description available

WB:WBGene00049021	21ur-1472
No description available

WB:WBGene00049022	21ur-3595
No description available

WB:WBGene00049023	21ur-1392
No description available

WB:WBGene00049024	21ur-3979
No description available

WB:WBGene00049025	21ur-4265
No description available

WB:WBGene00049026	21ur-3414
No description available

WB:WBGene00049027	21ur-2516
No description available

WB:WBGene00049028	21ur-1929
No description available

WB:WBGene00049029	21ur-6
No description available

WB:WBGene00049030	21ur-4799
No description available

WB:WBGene00049031	21ur-2610
No description available

WB:WBGene00049032	21ur-3686
No description available

WB:WBGene00049033	21ur-3212
No description available

WB:WBGene00049034	21ur-3072
No description available

WB:WBGene00049035	21ur-2336
No description available

WB:WBGene00049036	21ur-4490
No description available

WB:WBGene00049037	21ur-1874
No description available

WB:WBGene00049038	21ur-1269
No description available

WB:WBGene00049039	21ur-2863
No description available

WB:WBGene00049040	21ur-2600
No description available

WB:WBGene00049041	21ur-4078
No description available

WB:WBGene00049042	21ur-2312
No description available

WB:WBGene00049043	21ur-4072
No description available

WB:WBGene00049044	21ur-1780
No description available

WB:WBGene00049045	21ur-3848
No description available

WB:WBGene00049046	21ur-1983
No description available

WB:WBGene00049047	21ur-2051
No description available

WB:WBGene00049048	21ur-1540
No description available

WB:WBGene00049049	21ur-1633
No description available

WB:WBGene00049050	21ur-1270
No description available

WB:WBGene00049051	21ur-1624
No description available

WB:WBGene00049052	21ur-2627
No description available

WB:WBGene00049053	21ur-3893
No description available

WB:WBGene00049054	21ur-4880
No description available

WB:WBGene00049055	21ur-118
No description available

WB:WBGene00049056	21ur-5062
No description available

WB:WBGene00049057	21ur-404
No description available

WB:WBGene00049058	21ur-4800
No description available

WB:WBGene00049059	21ur-3240
No description available

WB:WBGene00049060	21ur-2463
No description available

WB:WBGene00049061	21ur-2609
No description available

WB:WBGene00049062	21ur-2029
No description available

WB:WBGene00049063	21ur-3148
No description available

WB:WBGene00049064	21ur-2230
No description available

WB:WBGene00049065	21ur-3715
No description available

WB:WBGene00049066	21ur-63
No description available

WB:WBGene00049067	21ur-3608
No description available

WB:WBGene00049068	21ur-3098
No description available

WB:WBGene00049069	21ur-3022
No description available

WB:WBGene00049070	21ur-1374
No description available

WB:WBGene00049071	21ur-5407
No description available

WB:WBGene00049072	21ur-186
No description available

WB:WBGene00049073	21ur-2223
No description available

WB:WBGene00049074	21ur-3685
No description available

WB:WBGene00049075	21ur-329
No description available

WB:WBGene00049076	21ur-1401
No description available

WB:WBGene00049077	21ur-2367
No description available

WB:WBGene00049078	21ur-3825
No description available

WB:WBGene00049079	21ur-4082
No description available

WB:WBGene00049080	21ur-2526
No description available

WB:WBGene00049081	21ur-2806
No description available

WB:WBGene00049082	21ur-2803
No description available

WB:WBGene00049083	21ur-2266
No description available

WB:WBGene00049084	21ur-1229
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049085	21ur-4918
No description available

WB:WBGene00049086	21ur-2964
No description available

WB:WBGene00049087	21ur-3057
No description available

WB:WBGene00049088	21ur-2619
No description available

WB:WBGene00049089	21ur-2073
No description available

WB:WBGene00049090	21ur-3476
No description available

WB:WBGene00049091	21ur-4384
No description available

WB:WBGene00049092	21ur-2634
No description available

WB:WBGene00049093	21ur-4250
No description available

WB:WBGene00049094	21ur-1476
No description available

WB:WBGene00049095	21ur-43
No description available

WB:WBGene00049096	21ur-3220
No description available

WB:WBGene00049097	21ur-1822
No description available

WB:WBGene00049098	21ur-3124
No description available

WB:WBGene00049099	21ur-679
No description available

WB:WBGene00049100	21ur-5011
No description available

WB:WBGene00049101	21ur-864
No description available

WB:WBGene00049102	21ur-5317
No description available

WB:WBGene00049103	21ur-3557
No description available

WB:WBGene00049104	21ur-741
No description available

WB:WBGene00049105	21ur-3720
No description available

WB:WBGene00049106	21ur-5072
No description available

WB:WBGene00049107	21ur-2607
No description available

WB:WBGene00049108	21ur-4612
No description available

WB:WBGene00049109	21ur-2325
No description available

WB:WBGene00049110	21ur-4036
No description available

WB:WBGene00049111	21ur-3792
No description available

WB:WBGene00049112	21ur-5378
No description available

WB:WBGene00049113	21ur-2590
No description available

WB:WBGene00049114	21ur-4864
No description available

WB:WBGene00049115	21ur-59
No description available

WB:WBGene00049116	21ur-236
No description available

WB:WBGene00049117	21ur-4649
No description available

WB:WBGene00049118	21ur-4439
No description available

WB:WBGene00049119	21ur-2644
No description available

WB:WBGene00049120	21ur-737
No description available

WB:WBGene00049121	21ur-303
No description available

WB:WBGene00049122	21ur-693
Is affected by daf-2 based on microarray studies.

WB:WBGene00049123	21ur-1382
No description available

WB:WBGene00049124	21ur-1160
No description available

WB:WBGene00049125	21ur-3964
No description available

WB:WBGene00049126	21ur-5185
No description available

WB:WBGene00049127	21ur-3846
No description available

WB:WBGene00049128	21ur-5202
No description available

WB:WBGene00049129	21ur-965
No description available

WB:WBGene00049130	21ur-2389
No description available

WB:WBGene00049131	21ur-5389
No description available

WB:WBGene00049132	21ur-2013
No description available

WB:WBGene00049133	21ur-129
No description available

WB:WBGene00049134	21ur-179
No description available

WB:WBGene00049135	21ur-860
No description available

WB:WBGene00049136	21ur-1231
No description available

WB:WBGene00049137	21ur-4303
No description available

WB:WBGene00049138	21ur-713
No description available

WB:WBGene00049139	21ur-4009
No description available

WB:WBGene00049140	21ur-3957
No description available

WB:WBGene00049141	21ur-3484
No description available

WB:WBGene00049142	21ur-3290
No description available

WB:WBGene00049143	21ur-1504
No description available

WB:WBGene00049144	21ur-4138
No description available

WB:WBGene00049145	21ur-3883
No description available

WB:WBGene00049146	21ur-3939
No description available

WB:WBGene00049147	21ur-4768
No description available

WB:WBGene00049148	21ur-4978
No description available

WB:WBGene00049149	21ur-4206
Is affected by spt-16 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00049150	21ur-4065
No description available

WB:WBGene00049151	21ur-3741
No description available

WB:WBGene00049152	21ur-3228
No description available

WB:WBGene00049153	21ur-3202
No description available

WB:WBGene00049154	21ur-2482
No description available

WB:WBGene00049155	21ur-1615
Is affected by ints-9 based on RNA-seq studies.

WB:WBGene00049156	21ur-4273
No description available

WB:WBGene00049157	21ur-3980
No description available

WB:WBGene00049158	21ur-3310
No description available

WB:WBGene00049159	21ur-3496
No description available

WB:WBGene00049160	21ur-995
No description available

WB:WBGene00049161	21ur-2857
No description available

WB:WBGene00049162	21ur-3752
No description available

WB:WBGene00049163	21ur-2263
No description available

WB:WBGene00049164	21ur-1443
No description available

WB:WBGene00049165	21ur-4379
No description available

WB:WBGene00049166	21ur-614
No description available

WB:WBGene00049167	21ur-1639
No description available

WB:WBGene00049168	21ur-172
No description available

WB:WBGene00049169	21ur-3945
No description available

WB:WBGene00049170	21ur-293
No description available

WB:WBGene00049171	21ur-381
No description available

WB:WBGene00049172	21ur-4525
No description available

WB:WBGene00049173	21ur-2054
No description available

WB:WBGene00049174	21ur-2118
No description available

WB:WBGene00049175	21ur-4881
No description available

WB:WBGene00049176	21ur-3012
No description available

WB:WBGene00049177	21ur-3104
No description available

WB:WBGene00049178	21ur-3153
No description available

WB:WBGene00049179	21ur-504
No description available

WB:WBGene00049180	21ur-443
No description available

WB:WBGene00049181	21ur-448
No description available

WB:WBGene00049182	21ur-1657
No description available

WB:WBGene00049183	21ur-4647
No description available

WB:WBGene00049184	21ur-4998
No description available

WB:WBGene00049185	21ur-91
No description available

WB:WBGene00049186	21ur-3276
No description available

WB:WBGene00049187	21ur-4096
No description available

WB:WBGene00049188	21ur-4483
No description available

WB:WBGene00049189	21ur-4991
No description available

WB:WBGene00049190	21ur-1802
No description available

WB:WBGene00049191	21ur-3350
No description available

WB:WBGene00049192	21ur-1898
No description available

WB:WBGene00049193	21ur-916
No description available

WB:WBGene00049194	21ur-837
No description available

WB:WBGene00049195	21ur-2755
No description available

WB:WBGene00049196	21ur-3972
No description available

WB:WBGene00049197	21ur-3650
No description available

WB:WBGene00049198	21ur-4487
No description available

WB:WBGene00049199	21ur-2062
No description available

WB:WBGene00049200	21ur-2521
No description available

WB:WBGene00049201	21ur-2879
No description available

WB:WBGene00049202	21ur-3538
No description available

WB:WBGene00049203	21ur-1563
No description available

WB:WBGene00049204	21ur-427
No description available

WB:WBGene00049205	21ur-3898
No description available

WB:WBGene00049206	21ur-4947
No description available

WB:WBGene00049207	21ur-3199
No description available

WB:WBGene00049208	21ur-595
No description available

WB:WBGene00049209	21ur-521
No description available

WB:WBGene00049210	21ur-2406
No description available

WB:WBGene00049211	21ur-2271
No description available

WB:WBGene00049212	21ur-5082
No description available

WB:WBGene00049213	21ur-5025
No description available

WB:WBGene00049214	21ur-2464
No description available

WB:WBGene00049215	21ur-5411
Is affected by daf-2 based on microarray studies.

WB:WBGene00049216	21ur-5006
No description available

WB:WBGene00049217	21ur-4562
No description available

WB:WBGene00049218	21ur-2765
No description available

WB:WBGene00049219	21ur-2156
No description available

WB:WBGene00049220	21ur-4530
No description available

WB:WBGene00049221	21ur-149
No description available

WB:WBGene00049222	21ur-1809
No description available

WB:WBGene00049223	21ur-70
No description available

WB:WBGene00049224	21ur-2791
No description available

WB:WBGene00049225	21ur-777
No description available

WB:WBGene00049226	21ur-1722
No description available

WB:WBGene00049227	21ur-3838
No description available

WB:WBGene00049228	21ur-3058
No description available

WB:WBGene00049229	21ur-3932
No description available

WB:WBGene00049230	21ur-2906
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00049231	21ur-3170
No description available

WB:WBGene00049232	21ur-1817
No description available

WB:WBGene00049233	21ur-4571
No description available

WB:WBGene00049234	21ur-3171
No description available

WB:WBGene00049235	21ur-4395
No description available

WB:WBGene00049236	21ur-2980
No description available

WB:WBGene00049237	21ur-1329
No description available

WB:WBGene00049238	21ur-598
No description available

WB:WBGene00049239	21ur-3502
No description available

WB:WBGene00049240	21ur-3372
Is expressed in germ line.

WB:WBGene00049241	21ur-3517
No description available

WB:WBGene00049242	21ur-5158
No description available

WB:WBGene00049243	21ur-1025
No description available

WB:WBGene00049244	21ur-3393
No description available

WB:WBGene00049245	21ur-1758
No description available

WB:WBGene00049246	21ur-221
No description available

WB:WBGene00049247	21ur-5372
No description available

WB:WBGene00049248	21ur-3110
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00049249	21ur-2333
No description available

WB:WBGene00049250	21ur-4528
No description available

WB:WBGene00049251	21ur-1285
No description available

WB:WBGene00049252	21ur-5230
No description available

WB:WBGene00049253	21ur-1882
No description available

WB:WBGene00049254	21ur-5030
No description available

WB:WBGene00049255	21ur-5237
No description available

WB:WBGene00049256	21ur-1021
No description available

WB:WBGene00049257	21ur-1578
No description available

WB:WBGene00049258	21ur-1707
No description available

WB:WBGene00049259	21ur-3983
No description available

WB:WBGene00049260	21ur-4110
No description available

WB:WBGene00049261	21ur-2684
No description available

WB:WBGene00049262	21ur-2378
No description available

WB:WBGene00049263	21ur-2492
No description available

WB:WBGene00049264	21ur-3489
No description available

WB:WBGene00049265	21ur-3166
No description available

WB:WBGene00049266	21ur-2476
No description available

WB:WBGene00049267	21ur-3524
No description available

WB:WBGene00049268	21ur-1106
No description available

WB:WBGene00049269	21ur-174
No description available

WB:WBGene00049270	21ur-4892
No description available

WB:WBGene00049271	21ur-5306
No description available

WB:WBGene00049272	21ur-3444
No description available

WB:WBGene00049273	21ur-2145
No description available

WB:WBGene00049274	21ur-4280
No description available

WB:WBGene00049275	21ur-332
No description available

WB:WBGene00049276	21ur-3617
No description available

WB:WBGene00049277	21ur-4415
No description available

WB:WBGene00049278	21ur-5267
No description available

WB:WBGene00049279	21ur-819
No description available

WB:WBGene00049280	21ur-4199
No description available

WB:WBGene00049281	21ur-1831
No description available

WB:WBGene00049282	21ur-1779
No description available

WB:WBGene00049283	21ur-650
No description available

WB:WBGene00049284	21ur-2399
No description available

WB:WBGene00049285	21ur-384
No description available

WB:WBGene00049286	21ur-4306
No description available

WB:WBGene00049287	21ur-3993
No description available

WB:WBGene00049288	21ur-4796
No description available

WB:WBGene00049289	21ur-4248
No description available

WB:WBGene00049290	21ur-3968
No description available

WB:WBGene00049291	21ur-412
No description available

WB:WBGene00049292	21ur-5298
No description available

WB:WBGene00049293	21ur-592
No description available

WB:WBGene00049294	21ur-1471
No description available

WB:WBGene00049295	21ur-2777
No description available

WB:WBGene00049296	21ur-4962
No description available

WB:WBGene00049297	21ur-2176
No description available

WB:WBGene00049298	21ur-4690
No description available

WB:WBGene00049299	21ur-602
No description available

WB:WBGene00049300	21ur-87
No description available

WB:WBGene00049301	21ur-4871
No description available

WB:WBGene00049302	21ur-4695
No description available

WB:WBGene00049303	21ur-3580
No description available

WB:WBGene00049304	21ur-4216
No description available

WB:WBGene00049305	21ur-3693
No description available

WB:WBGene00049306	21ur-2032
No description available

WB:WBGene00049307	21ur-787
Is affected by Y37A1B.5 based on RNA-seq studies.

WB:WBGene00049308	21ur-3066
No description available

WB:WBGene00049309	21ur-947
No description available

WB:WBGene00049310	21ur-522
No description available

WB:WBGene00049311	21ur-5341
No description available

WB:WBGene00049312	21ur-2316
No description available

WB:WBGene00049313	21ur-2039
No description available

WB:WBGene00049314	21ur-2789
No description available

WB:WBGene00049315	21ur-2004
No description available

WB:WBGene00049316	21ur-1892
No description available

WB:WBGene00049317	21ur-2898
No description available

WB:WBGene00049318	21ur-3874
No description available

WB:WBGene00049319	21ur-2561
No description available

WB:WBGene00049320	21ur-4296
No description available

WB:WBGene00049321	21ur-442
No description available

WB:WBGene00049322	21ur-784
No description available

WB:WBGene00049323	21ur-1992
No description available

WB:WBGene00049324	21ur-2534
No description available

WB:WBGene00049325	21ur-1982
No description available

WB:WBGene00049326	21ur-1588
No description available

WB:WBGene00049327	21ur-3437
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00049328	21ur-2818
No description available

WB:WBGene00049329	21ur-2198
No description available

WB:WBGene00049330	21ur-5247
No description available

WB:WBGene00049331	21ur-5095
No description available

WB:WBGene00049332	21ur-315
No description available

WB:WBGene00049333	21ur-2910
No description available

WB:WBGene00049334	21ur-4935
No description available

WB:WBGene00049335	21ur-3857
No description available

WB:WBGene00049336	21ur-2348
No description available

WB:WBGene00049337	21ur-3439
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049338	21ur-668
No description available

WB:WBGene00049339	21ur-1616
No description available

WB:WBGene00049340	21ur-3203
No description available

WB:WBGene00049341	21ur-2951
No description available

WB:WBGene00049342	21ur-924
No description available

WB:WBGene00049343	21ur-4585
No description available

WB:WBGene00049344	21ur-2540
No description available

WB:WBGene00049345	21ur-4701
No description available

WB:WBGene00049346	21ur-2055
No description available

WB:WBGene00049347	21ur-4903
No description available

WB:WBGene00049348	21ur-550
No description available

WB:WBGene00049349	21ur-1350
No description available

WB:WBGene00049350	21ur-5162
No description available

WB:WBGene00049351	21ur-1706
No description available

WB:WBGene00049352	21ur-4157
No description available

WB:WBGene00049353	21ur-3065
No description available

WB:WBGene00049354	21ur-345
No description available

WB:WBGene00049355	21ur-1044
No description available

WB:WBGene00049356	21ur-4079
No description available

WB:WBGene00049357	21ur-4868
No description available

WB:WBGene00049358	21ur-5034
No description available

WB:WBGene00049359	21ur-1116
No description available

WB:WBGene00049360	21ur-3265
No description available

WB:WBGene00049361	21ur-4781
No description available

WB:WBGene00049362	21ur-4241
No description available

WB:WBGene00049363	21ur-3400
No description available

WB:WBGene00049364	21ur-72
No description available

WB:WBGene00049365	21ur-165
No description available

WB:WBGene00049366	21ur-2843
No description available

WB:WBGene00049367	21ur-1903
No description available

WB:WBGene00049368	21ur-2958
No description available

WB:WBGene00049369	21ur-2207
No description available

WB:WBGene00049370	21ur-858
No description available

WB:WBGene00049371	21ur-4181
No description available

WB:WBGene00049372	21ur-1173
No description available

WB:WBGene00049373	21ur-1363
No description available

WB:WBGene00049374	21ur-2824
No description available

WB:WBGene00049375	21ur-1034
No description available

WB:WBGene00049376	21ur-3643
No description available

WB:WBGene00049377	21ur-3576
No description available

WB:WBGene00049378	21ur-1575
No description available

WB:WBGene00049379	21ur-696
No description available

WB:WBGene00049380	21ur-152
No description available

WB:WBGene00049381	21ur-565
No description available

WB:WBGene00049382	21ur-4367
No description available

WB:WBGene00049383	21ur-4969
No description available

WB:WBGene00049384	21ur-1507
No description available

WB:WBGene00049385	21ur-18
No description available

WB:WBGene00049386	21ur-3084
No description available

WB:WBGene00049387	21ur-641
No description available

WB:WBGene00049388	21ur-801
No description available

WB:WBGene00049389	21ur-4959
No description available

WB:WBGene00049390	21ur-1216
No description available

WB:WBGene00049391	21ur-200
No description available

WB:WBGene00049392	21ur-5141
No description available

WB:WBGene00049393	21ur-2893
Is affected by emr-1; lem-2; and Y37A1B.5 based on RNA-seq studies.

WB:WBGene00049394	21ur-4856
No description available

WB:WBGene00049395	21ur-2927
No description available

WB:WBGene00049396	21ur-3823
No description available

WB:WBGene00049397	21ur-3605
No description available

WB:WBGene00049398	21ur-3914
No description available

WB:WBGene00049399	21ur-1535
No description available

WB:WBGene00049400	21ur-3793
No description available

WB:WBGene00049401	21ur-5131
No description available

WB:WBGene00049402	21ur-5122
No description available

WB:WBGene00049403	21ur-280
No description available

WB:WBGene00049404	21ur-322
No description available

WB:WBGene00049405	21ur-4345
No description available

WB:WBGene00049406	21ur-4406
No description available

WB:WBGene00049407	21ur-5117
No description available

WB:WBGene00049408	21ur-4999
No description available

WB:WBGene00049409	21ur-4149
No description available

WB:WBGene00049410	21ur-4688
No description available

WB:WBGene00049411	21ur-3091
No description available

WB:WBGene00049412	21ur-1300
No description available

WB:WBGene00049413	21ur-167
No description available

WB:WBGene00049414	21ur-898
No description available

WB:WBGene00049415	21ur-2265
No description available

WB:WBGene00049416	21ur-1516
No description available

WB:WBGene00049417	21ur-3269
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049418	21ur-5167
No description available

WB:WBGene00049419	21ur-136
No description available

WB:WBGene00049420	21ur-2747
No description available

WB:WBGene00049421	21ur-217
No description available

WB:WBGene00049422	21ur-2414
No description available

WB:WBGene00049423	21ur-4444
No description available

WB:WBGene00049424	21ur-2446
Is affected by hmg-3 and spt-16 based on RNA-seq studies.

WB:WBGene00049425	21ur-5436
No description available

WB:WBGene00049426	21ur-4334
No description available

WB:WBGene00049427	21ur-4227
No description available

WB:WBGene00049428	21ur-875
No description available

WB:WBGene00049429	21ur-2101
No description available

WB:WBGene00049430	21ur-3775
No description available

WB:WBGene00049431	21ur-2382
No description available

WB:WBGene00049432	21ur-2457
No description available

WB:WBGene00049433	21ur-1425
No description available

WB:WBGene00049434	21ur-982
No description available

WB:WBGene00049435	21ur-1452
No description available

WB:WBGene00049436	21ur-4578
No description available

WB:WBGene00049437	21ur-107
No description available

WB:WBGene00049438	21ur-2240
No description available

WB:WBGene00049439	21ur-634
No description available

WB:WBGene00049440	21ur-4602
No description available

WB:WBGene00049441	21ur-2259
No description available

WB:WBGene00049443	21ur-1529
No description available

WB:WBGene00049444	21ur-2088
No description available

WB:WBGene00049445	21ur-2183
No description available

WB:WBGene00049446	21ur-857
No description available

WB:WBGene00049447	21ur-1772
No description available

WB:WBGene00049448	21ur-3697
No description available

WB:WBGene00049449	21ur-960
No description available

WB:WBGene00049450	21ur-1344
No description available

WB:WBGene00049451	21ur-3363
No description available

WB:WBGene00049452	21ur-1376
No description available

WB:WBGene00049453	21ur-2093
No description available

WB:WBGene00049454	21ur-3535
No description available

WB:WBGene00049455	21ur-1951
No description available

WB:WBGene00049456	21ur-950
No description available

WB:WBGene00049457	21ur-2211
No description available

WB:WBGene00049458	21ur-2581
No description available

WB:WBGene00049459	21ur-4290
No description available

WB:WBGene00049460	21ur-2065
No description available

WB:WBGene00049461	21ur-1322
No description available

WB:WBGene00049462	21ur-3319
No description available

WB:WBGene00049463	21ur-4429
No description available

WB:WBGene00049464	21ur-2473
No description available

WB:WBGene00049465	21ur-4679
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies.

WB:WBGene00049466	21ur-4789
No description available

WB:WBGene00049467	21ur-2579
No description available

WB:WBGene00049468	21ur-1280
No description available

WB:WBGene00049469	21ur-827
No description available

WB:WBGene00049470	21ur-1041
No description available

WB:WBGene00049471	21ur-4169
No description available

WB:WBGene00049472	21ur-4471
No description available

WB:WBGene00049473	21ur-4422
No description available

WB:WBGene00049474	21ur-1224
No description available

WB:WBGene00049475	21ur-5352
No description available

WB:WBGene00049476	21ur-705
No description available

WB:WBGene00049477	21ur-3309
No description available

WB:WBGene00049478	21ur-1999
No description available

WB:WBGene00049479	21ur-4752
No description available

WB:WBGene00049480	21ur-2576
No description available

WB:WBGene00049481	21ur-3639
No description available

WB:WBGene00049482	21ur-5017
No description available

WB:WBGene00049483	21ur-1964
No description available

WB:WBGene00049484	21ur-3042
No description available

WB:WBGene00049485	21ur-1490
No description available

WB:WBGene00049486	21ur-34
No description available

WB:WBGene00049487	21ur-432
No description available

WB:WBGene00049488	21ur-1764
No description available

WB:WBGene00049489	21ur-111
No description available

WB:WBGene00049490	21ur-759
No description available

WB:WBGene00049491	21ur-3705
No description available

WB:WBGene00049492	21ur-1082
No description available

WB:WBGene00049493	21ur-2740
No description available

WB:WBGene00049494	21ur-2832
No description available

WB:WBGene00049495	21ur-4559
No description available

WB:WBGene00049496	21ur-3340
No description available

WB:WBGene00049497	21ur-1144
No description available

WB:WBGene00049498	21ur-1123
No description available

WB:WBGene00049499	21ur-3430
No description available

WB:WBGene00049500	21ur-1670
No description available

WB:WBGene00049501	21ur-5351
No description available

WB:WBGene00049502	21ur-1417
No description available

WB:WBGene00049503	21ur-3978
No description available

WB:WBGene00049504	21ur-5329
No description available

WB:WBGene00049505	21ur-2718
No description available

WB:WBGene00049506	21ur-3229
No description available

WB:WBGene00049507	21ur-2970
No description available

WB:WBGene00049508	21ur-1917
No description available

WB:WBGene00049509	21ur-1074
No description available

WB:WBGene00049510	21ur-4414
No description available

WB:WBGene00049511	21ur-2735
No description available

WB:WBGene00049512	21ur-407
No description available

WB:WBGene00049513	21ur-190
No description available

WB:WBGene00049514	21ur-1805
No description available

WB:WBGene00049515	21ur-5337
No description available

WB:WBGene00049516	21ur-2394
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00049517	21ur-1238
No description available

WB:WBGene00049518	21ur-4323
No description available

WB:WBGene00049519	21ur-2588
No description available

WB:WBGene00049520	21ur-2721
No description available

WB:WBGene00049521	21ur-54
No description available

WB:WBGene00049522	21ur-1729
No description available

WB:WBGene00049523	21ur-731
No description available

WB:WBGene00049524	21ur-2724
No description available

WB:WBGene00049525	21ur-901
No description available

WB:WBGene00049526	21ur-1485
No description available

WB:WBGene00049527	21ur-4007
No description available

WB:WBGene00049528	21ur-1666
No description available

WB:WBGene00049529	21ur-3634
No description available

WB:WBGene00049530	21ur-3946
No description available

WB:WBGene00049531	21ur-1096
No description available

WB:WBGene00049532	21ur-5101
No description available

WB:WBGene00049533	21ur-1435
No description available

WB:WBGene00049534	21ur-761
No description available

WB:WBGene00049535	21ur-3815
No description available

WB:WBGene00049536	21ur-4810
No description available

WB:WBGene00049537	21ur-1089
No description available

WB:WBGene00049538	21ur-5363
No description available

WB:WBGene00049539	21ur-1167
No description available

WB:WBGene00049540	21ur-4732
No description available

WB:WBGene00049541	21ur-3342
No description available

WB:WBGene00049542	21ur-5201
No description available

WB:WBGene00049543	21ur-1821
No description available

WB:WBGene00049544	21ur-2616
No description available

WB:WBGene00049545	21ur-1012
No description available

WB:WBGene00049546	21ur-1697
No description available

WB:WBGene00049547	21ur-1813
No description available

WB:WBGene00049548	21ur-5179
No description available

WB:WBGene00049549	21ur-1278
No description available

WB:WBGene00049550	21ur-3847
No description available

WB:WBGene00049551	21ur-4137
Is affected by daf-2 based on microarray studies.

WB:WBGene00049552	21ur-1422
No description available

WB:WBGene00049553	21ur-1261
No description available

WB:WBGene00049554	21ur-3990
No description available

WB:WBGene00049555	21ur-2308
No description available

WB:WBGene00049556	21ur-5151
No description available

WB:WBGene00049557	21ur-3758
No description available

WB:WBGene00049558	21ur-3873
No description available

WB:WBGene00049559	21ur-4476
Is affected by daf-2 based on microarray studies.

WB:WBGene00049560	21ur-1003
No description available

WB:WBGene00049561	21ur-826
No description available

WB:WBGene00049562	21ur-3326
No description available

WB:WBGene00049563	21ur-588
No description available

WB:WBGene00049564	21ur-2694
No description available

WB:WBGene00049565	21ur-2853
No description available

WB:WBGene00049566	21ur-1233
No description available

WB:WBGene00049567	21ur-4048
No description available

WB:WBGene00049568	21ur-714
No description available

WB:WBGene00049569	21ur-4779
No description available

WB:WBGene00049570	21ur-5386
No description available

WB:WBGene00049571	21ur-2937
No description available

WB:WBGene00049572	21ur-5451
No description available

WB:WBGene00049573	21ur-2276
No description available

WB:WBGene00049574	21ur-998
No description available

WB:WBGene00049575	21ur-3103
No description available

WB:WBGene00049576	21ur-4635
Is affected by daf-2 based on microarray studies.

WB:WBGene00049577	21ur-1029
No description available

WB:WBGene00049578	21ur-1979
No description available

WB:WBGene00049579	21ur-2407
No description available

WB:WBGene00049580	21ur-4387
No description available

WB:WBGene00049581	21ur-966
No description available

WB:WBGene00049582	21ur-2352
No description available

WB:WBGene00049583	21ur-5180
No description available

WB:WBGene00049584	21ur-1818
No description available

WB:WBGene00049585	21ur-1776
No description available

WB:WBGene00049586	21ur-307
No description available

WB:WBGene00049587	21ur-4097
No description available

WB:WBGene00049588	21ur-4264
No description available

WB:WBGene00049589	21ur-4486
No description available

WB:WBGene00049590	21ur-4861
No description available

WB:WBGene00049591	21ur-1188
No description available

WB:WBGene00049592	21ur-1227
No description available

WB:WBGene00049593	21ur-3497
No description available

WB:WBGene00049594	21ur-300
No description available

WB:WBGene00049595	21ur-1499
No description available

WB:WBGene00049596	21ur-3938
No description available

WB:WBGene00049597	21ur-3821
No description available

WB:WBGene00049598	21ur-4762
No description available

WB:WBGene00049599	21ur-5010
No description available

WB:WBGene00049600	21ur-4230
No description available

WB:WBGene00049601	21ur-3359
No description available

WB:WBGene00049602	21ur-662
No description available

WB:WBGene00049603	21ur-2460
No description available

WB:WBGene00049604	21ur-3013
No description available

WB:WBGene00049605	21ur-449
No description available

WB:WBGene00049606	21ur-2717
No description available

WB:WBGene00049607	21ur-815
No description available

WB:WBGene00049608	21ur-3236
No description available

WB:WBGene00049609	21ur-1843
No description available

WB:WBGene00049610	21ur-2496
No description available

WB:WBGene00049611	21ur-1636
No description available

WB:WBGene00049612	21ur-590
No description available

WB:WBGene00049613	21ur-813
No description available

WB:WBGene00049614	21ur-4376
No description available

WB:WBGene00049615	21ur-1128
No description available

WB:WBGene00049616	21ur-2008
No description available

WB:WBGene00049617	21ur-1814
No description available

WB:WBGene00049618	21ur-4704
No description available

WB:WBGene00049619	21ur-4896
No description available

WB:WBGene00049620	21ur-1059
No description available

WB:WBGene00049621	21ur-2077
No description available

WB:WBGene00049622	21ur-3466
No description available

WB:WBGene00049623	21ur-1719
No description available

WB:WBGene00049624	21ur-3156
No description available

WB:WBGene00049625	21ur-82
No description available

WB:WBGene00049626	21ur-4156
No description available

WB:WBGene00049627	21ur-3527
No description available

WB:WBGene00049628	21ur-1015
No description available

WB:WBGene00049629	21ur-4992
No description available

WB:WBGene00049630	21ur-5320
No description available

WB:WBGene00049631	21ur-5091
No description available

WB:WBGene00049632	21ur-4844
No description available

WB:WBGene00049633	21ur-2732
No description available

WB:WBGene00049634	21ur-2070
No description available

WB:WBGene00049635	21ur-4205
No description available

WB:WBGene00049636	21ur-3141
No description available

WB:WBGene00049637	21ur-3967
No description available

WB:WBGene00049638	21ur-4676
No description available

WB:WBGene00049639	21ur-5056
No description available

WB:WBGene00049640	21ur-1166
No description available

WB:WBGene00049641	21ur-1213
No description available

WB:WBGene00049642	21ur-2626
No description available

WB:WBGene00049643	21ur-1356
No description available

WB:WBGene00049644	21ur-2864
No description available

WB:WBGene00049645	21ur-4148
No description available

WB:WBGene00049646	21ur-3718
No description available

WB:WBGene00049647	21ur-180
No description available

WB:WBGene00049648	21ur-5318
No description available

WB:WBGene00049649	21ur-3849
No description available

WB:WBGene00049650	21ur-1735
No description available

WB:WBGene00049651	21ur-242
No description available

WB:WBGene00049652	21ur-4141
No description available

WB:WBGene00049653	21ur-84
No description available

WB:WBGene00049654	21ur-2604
No description available

WB:WBGene00049655	21ur-1381
No description available

WB:WBGene00049656	21ur-2668
No description available

WB:WBGene00049657	21ur-1866
No description available

WB:WBGene00049658	21ur-789
No description available

WB:WBGene00049659	21ur-2237
No description available

WB:WBGene00049660	21ur-1896
No description available

WB:WBGene00049661	21ur-3894
No description available

WB:WBGene00049662	21ur-795
No description available

WB:WBGene00049663	21ur-5272
No description available

WB:WBGene00049664	21ur-740
No description available

WB:WBGene00049665	21ur-1415
No description available

WB:WBGene00049666	21ur-2456
No description available

WB:WBGene00049667	21ur-424
No description available

WB:WBGene00049668	21ur-1031
No description available

WB:WBGene00049669	21ur-957
No description available

WB:WBGene00049670	21ur-278
No description available

WB:WBGene00049671	21ur-3890
No description available

WB:WBGene00049672	21ur-3801
No description available

WB:WBGene00049673	21ur-3680
No description available

WB:WBGene00049674	21ur-5408
No description available

WB:WBGene00049675	21ur-4889
No description available

WB:WBGene00049676	21ur-3339
No description available

WB:WBGene00049677	21ur-2551
No description available

WB:WBGene00049678	21ur-1561
No description available

WB:WBGene00049679	21ur-5415
No description available

WB:WBGene00049680	21ur-863
No description available

WB:WBGene00049681	21ur-3870
No description available

WB:WBGene00049682	21ur-263
No description available

WB:WBGene00049683	21ur-233
No description available

WB:WBGene00049684	21ur-395
No description available

WB:WBGene00049685	21ur-2190
No description available

WB:WBGene00049686	21ur-4075
No description available

WB:WBGene00049687	21ur-5126
No description available

WB:WBGene00049688	21ur-1593
No description available

WB:WBGene00049689	21ur-2269
No description available

WB:WBGene00049690	21ur-5330
No description available

WB:WBGene00049691	21ur-2753
No description available

WB:WBGene00049692	21ur-2887
No description available

WB:WBGene00049693	21ur-4459
No description available

WB:WBGene00049694	21ur-1247
No description available

WB:WBGene00049695	21ur-30
No description available

WB:WBGene00049696	21ur-882
No description available

WB:WBGene00049697	21ur-2384
No description available

WB:WBGene00049698	21ur-2074
No description available

WB:WBGene00049699	21ur-3221
No description available

WB:WBGene00049700	21ur-3877
No description available

WB:WBGene00049701	21ur-2317
No description available

WB:WBGene00049702	21ur-2630
No description available

WB:WBGene00049703	21ur-4665
No description available

WB:WBGene00049704	21ur-3867
No description available

WB:WBGene00049705	21ur-2858
No description available

WB:WBGene00049706	21ur-2475
No description available

WB:WBGene00049707	21ur-1744
No description available

WB:WBGene00049708	21ur-2313
No description available

WB:WBGene00049709	21ur-4271
No description available

WB:WBGene00049710	21ur-223
No description available

WB:WBGene00049711	21ur-4293
No description available

WB:WBGene00049712	21ur-3506
No description available

WB:WBGene00049713	21ur-4544
No description available

WB:WBGene00049714	21ur-981
No description available

WB:WBGene00049715	21ur-56
No description available

WB:WBGene00049716	21ur-747
No description available

WB:WBGene00049717	21ur-5416
No description available

WB:WBGene00049718	21ur-2036
No description available

WB:WBGene00049719	21ur-2222
No description available

WB:WBGene00049720	21ur-2529
No description available

WB:WBGene00049721	21ur-5379
No description available

WB:WBGene00049722	21ur-2848
No description available

WB:WBGene00049723	21ur-3421
No description available

WB:WBGene00049724	21ur-2204
No description available

WB:WBGene00049725	21ur-1862
No description available

WB:WBGene00049726	21ur-3046
No description available

WB:WBGene00049727	21ur-4713
No description available

WB:WBGene00049728	21ur-1955
No description available

WB:WBGene00049729	21ur-2485
No description available

WB:WBGene00049730	21ur-4431
No description available

WB:WBGene00049731	21ur-3547
No description available

WB:WBGene00049732	21ur-547
No description available

WB:WBGene00049733	21ur-970
No description available

WB:WBGene00049734	21ur-1946
No description available

WB:WBGene00049735	21ur-4223
No description available

WB:WBGene00049736	21ur-2535
No description available

WB:WBGene00049737	21ur-2709
No description available

WB:WBGene00049738	21ur-4107
No description available

WB:WBGene00049739	21ur-4448
No description available

WB:WBGene00049740	21ur-1792
No description available

WB:WBGene00049741	21ur-2673
No description available

WB:WBGene00049742	21ur-2943
No description available

WB:WBGene00049743	21ur-4246
No description available

WB:WBGene00049744	21ur-5370
No description available

WB:WBGene00049745	21ur-1007
No description available

WB:WBGene00049746	21ur-4311
No description available

WB:WBGene00049747	21ur-1794
No description available

WB:WBGene00049748	21ur-943
No description available

WB:WBGene00049749	21ur-2320
No description available

WB:WBGene00049750	21ur-1583
No description available

WB:WBGene00049751	21ur-3213
No description available

WB:WBGene00049752	21ur-2227
No description available

WB:WBGene00049753	21ur-535
No description available

WB:WBGene00049754	21ur-932
No description available

WB:WBGene00049755	21ur-1960
No description available

WB:WBGene00049756	21ur-4104
No description available

WB:WBGene00049757	21ur-2642
No description available

WB:WBGene00049758	21ur-3751
No description available

WB:WBGene00049759	21ur-1672
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049760	21ur-3366
No description available

WB:WBGene00049761	21ur-2197
No description available

WB:WBGene00049762	21ur-1295
No description available

WB:WBGene00049763	21ur-2500
No description available

WB:WBGene00049764	21ur-4328
No description available

WB:WBGene00049765	21ur-4346
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00049766	21ur-3596
No description available

WB:WBGene00049767	21ur-2510
No description available

WB:WBGene00049768	21ur-1952
No description available

WB:WBGene00049769	21ur-3315
No description available

WB:WBGene00049770	21ur-1429
No description available

WB:WBGene00049771	21ur-2659
No description available

WB:WBGene00049772	21ur-2026
No description available

WB:WBGene00049773	21ur-691
No description available

WB:WBGene00049774	21ur-4747
No description available

WB:WBGene00049775	21ur-2520
No description available

WB:WBGene00049776	21ur-1725
No description available

WB:WBGene00049777	21ur-2654
No description available

WB:WBGene00049778	21ur-841
No description available

WB:WBGene00049779	21ur-4282
No description available

WB:WBGene00049780	21ur-3352
No description available

WB:WBGene00049781	21ur-1115
No description available

WB:WBGene00049782	21ur-2108
No description available

WB:WBGene00049783	21ur-4035
No description available

WB:WBGene00049784	21ur-2069
No description available

WB:WBGene00049785	21ur-3709
No description available

WB:WBGene00049786	21ur-4879
No description available

WB:WBGene00049787	21ur-2134
No description available

WB:WBGene00049788	21ur-842
No description available

WB:WBGene00049789	21ur-2761
No description available

WB:WBGene00049790	21ur-1856
No description available

WB:WBGene00049791	21ur-2375
No description available

WB:WBGene00049792	21ur-4402
No description available

WB:WBGene00049793	21ur-1052
No description available

WB:WBGene00049794	21ur-431
No description available

WB:WBGene00049795	21ur-4188
No description available

WB:WBGene00049796	21ur-323
No description available

WB:WBGene00049797	21ur-3092
No description available

WB:WBGene00049798	21ur-3625
No description available

WB:WBGene00049799	21ur-4357
No description available

WB:WBGene00049800	21ur-4425
No description available

WB:WBGene00049801	21ur-4066
No description available

WB:WBGene00049802	21ur-211
No description available

WB:WBGene00049803	21ur-2046
No description available

WB:WBGene00049804	21ur-2112
No description available

WB:WBGene00049805	21ur-2817
No description available

WB:WBGene00049806	21ur-1069
No description available

WB:WBGene00049807	21ur-3255
No description available

WB:WBGene00049808	21ur-1641
No description available

WB:WBGene00049809	21ur-4634
No description available

WB:WBGene00049810	21ur-3415
No description available

WB:WBGene00049811	21ur-2335
No description available

WB:WBGene00049812	21ur-1379
No description available

WB:WBGene00049813	21ur-2778
No description available

WB:WBGene00049814	21ur-461
No description available

WB:WBGene00049815	21ur-1393
No description available

WB:WBGene00049816	21ur-1989
No description available

WB:WBGene00049817	21ur-3031
No description available

WB:WBGene00049818	21ur-466
No description available

WB:WBGene00049819	21ur-4165
No description available

WB:WBGene00049820	21ur-185
No description available

WB:WBGene00049821	21ur-4596
No description available

WB:WBGene00049822	21ur-1197
No description available

WB:WBGene00049823	21ur-4012
No description available

WB:WBGene00049824	21ur-1969
No description available

WB:WBGene00049825	21ur-1827
No description available

WB:WBGene00049826	21ur-3018
No description available

WB:WBGene00049827	21ur-1387
No description available

WB:WBGene00049828	21ur-512
No description available

WB:WBGene00049829	21ur-1787
No description available

WB:WBGene00049830	21ur-1648
No description available

WB:WBGene00049831	21ur-3787
No description available

WB:WBGene00049832	21ur-493
No description available

WB:WBGene00049833	21ur-1851
No description available

WB:WBGene00049834	21ur-1941
No description available

WB:WBGene00049835	21ur-1928
No description available

WB:WBGene00049836	21ur-37
No description available

WB:WBGene00049837	21ur-417
No description available

WB:WBGene00049838	21ur-1828
No description available

WB:WBGene00049839	21ur-2792
No description available

WB:WBGene00049840	21ur-3748
No description available

WB:WBGene00049841	21ur-272
No description available

WB:WBGene00049842	21ur-4360
No description available

WB:WBGene00049843	21ur-1532
No description available

WB:WBGene00049844	21ur-3334
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00049845	21ur-2596
No description available

WB:WBGene00049846	21ur-640
No description available

WB:WBGene00049847	21ur-1830
No description available

WB:WBGene00049848	21ur-2836
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049849	21ur-3745
No description available

WB:WBGene00049850	21ur-2083
No description available

WB:WBGene00049851	21ur-1848
No description available

WB:WBGene00049852	21ur-2804
No description available

WB:WBGene00049853	21ur-657
No description available

WB:WBGene00049854	21ur-5137
No description available

WB:WBGene00049855	21ur-251
No description available

WB:WBGene00049856	21ur-5200
No description available

WB:WBGene00049857	21ur-3555
No description available

WB:WBGene00049858	21ur-1200
No description available

WB:WBGene00049859	21ur-4115
No description available

WB:WBGene00049860	21ur-5226
No description available

WB:WBGene00049861	21ur-2469
No description available

WB:WBGene00049862	21ur-402
No description available

WB:WBGene00049863	21ur-3125
No description available

WB:WBGene00049864	21ur-4128
No description available

WB:WBGene00049865	21ur-46
No description available

WB:WBGene00049866	21ur-1250
No description available

WB:WBGene00049867	21ur-4058
No description available

WB:WBGene00049868	21ur-1339
No description available

WB:WBGene00049869	21ur-2706
No description available

WB:WBGene00049870	21ur-3480
No description available

WB:WBGene00049871	21ur-3949
No description available

WB:WBGene00049872	21ur-3542
No description available

WB:WBGene00049873	21ur-4972
No description available

WB:WBGene00049874	21ur-3851
No description available

WB:WBGene00049875	21ur-1888
No description available

WB:WBGene00049876	21ur-791
No description available

WB:WBGene00049877	21ur-4287
No description available

WB:WBGene00049878	21ur-3207
No description available

WB:WBGene00049879	21ur-3563
No description available

WB:WBGene00049880	21ur-4087
No description available

WB:WBGene00049881	21ur-1440
No description available

WB:WBGene00049882	21ur-3160
No description available

WB:WBGene00049883	21ur-4555
No description available

WB:WBGene00049884	21ur-5369
No description available

WB:WBGene00049885	21ur-1196
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049886	21ur-3165
No description available

WB:WBGene00049887	21ur-4611
No description available

WB:WBGene00049888	21ur-1334
No description available

WB:WBGene00049889	21ur-1140
No description available

WB:WBGene00049890	21ur-4983
No description available

WB:WBGene00049891	21ur-4194
No description available

WB:WBGene00049892	21ur-2947
No description available

WB:WBGene00049893	21ur-3259
No description available

WB:WBGene00049894	21ur-4755
No description available

WB:WBGene00049895	21ur-5425
No description available

WB:WBGene00049896	21ur-3631
No description available

WB:WBGene00049897	21ur-2434
No description available

WB:WBGene00049898	21ur-4187
Is affected by eat-2 based on microarray studies.

WB:WBGene00049899	21ur-4573
No description available

WB:WBGene00049900	21ur-3660
No description available

WB:WBGene00049901	21ur-4995
No description available

WB:WBGene00049902	21ur-555
No description available

WB:WBGene00049903	21ur-4499
No description available

WB:WBGene00049904	21ur-1586
No description available

WB:WBGene00049905	21ur-736
No description available

WB:WBGene00049906	21ur-1272
No description available

WB:WBGene00049907	21ur-3840
No description available

WB:WBGene00049908	21ur-1394
No description available

WB:WBGene00049909	21ur-1143
No description available

WB:WBGene00049910	21ur-4830
No description available

WB:WBGene00049911	21ur-4837
No description available

WB:WBGene00049912	21ur-3345
No description available

WB:WBGene00049913	21ur-3864
No description available

WB:WBGene00049914	21ur-3824
No description available

WB:WBGene00049915	21ur-1804
No description available

WB:WBGene00049916	21ur-1480
No description available

WB:WBGene00049917	21ur-2068
No description available

WB:WBGene00049918	21ur-3900
No description available

WB:WBGene00049919	21ur-494
No description available

WB:WBGene00049920	21ur-712
No description available

WB:WBGene00049921	21ur-706
No description available

WB:WBGene00049922	21ur-4841
No description available

WB:WBGene00049923	21ur-2477
No description available

WB:WBGene00049924	21ur-239
No description available

WB:WBGene00049925	21ur-4767
No description available

WB:WBGene00049926	21ur-4364
No description available

WB:WBGene00049927	21ur-1552
No description available

WB:WBGene00049928	21ur-2835
No description available

WB:WBGene00049929	21ur-249
No description available

WB:WBGene00049930	21ur-2973
No description available

WB:WBGene00049931	21ur-2723
No description available

WB:WBGene00049932	21ur-3799
No description available

WB:WBGene00049933	21ur-3644
No description available

WB:WBGene00049934	21ur-354
No description available

WB:WBGene00049935	21ur-2094
No description available

WB:WBGene00049936	21ur-5359
No description available

WB:WBGene00049937	21ur-3597
No description available

WB:WBGene00049938	21ur-3004
No description available

WB:WBGene00049939	21ur-5100
No description available

WB:WBGene00049940	21ur-2575
No description available

WB:WBGene00049941	21ur-437
No description available

WB:WBGene00049942	21ur-1095
No description available

WB:WBGene00049943	21ur-4626
No description available

WB:WBGene00049944	21ur-1458
No description available

WB:WBGene00049945	21ur-1296
No description available

WB:WBGene00049946	21ur-4855
No description available

WB:WBGene00049947	21ur-5406
No description available

WB:WBGene00049948	21ur-4791
No description available

WB:WBGene00049949	21ur-879
No description available

WB:WBGene00049950	21ur-5170
No description available

WB:WBGene00049951	21ur-2769
No description available

WB:WBGene00049952	21ur-4006
No description available

WB:WBGene00049953	21ur-110
No description available

WB:WBGene00049954	21ur-321
No description available

WB:WBGene00049955	21ur-5145
No description available

WB:WBGene00049956	21ur-1574
No description available

WB:WBGene00049957	21ur-2674
No description available

WB:WBGene00049958	21ur-4655
No description available

WB:WBGene00049959	21ur-4946
No description available

WB:WBGene00049960	21ur-3931
No description available

WB:WBGene00049961	21ur-5368
No description available

WB:WBGene00049962	21ur-4556
No description available

WB:WBGene00049963	21ur-5128
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00049964	21ur-2412
No description available

WB:WBGene00049965	21ur-1373
No description available

WB:WBGene00049966	21ur-5251
No description available

WB:WBGene00049967	21ur-5041
No description available

WB:WBGene00049968	21ur-2869
No description available

WB:WBGene00049969	21ur-430
No description available

WB:WBGene00049970	21ur-2852
No description available

WB:WBGene00049971	21ur-2585
No description available

WB:WBGene00049972	21ur-1548
No description available

WB:WBGene00049973	21ur-5123
No description available

WB:WBGene00049974	21ur-1428
No description available

WB:WBGene00049975	21ur-1500
No description available

WB:WBGene00049976	21ur-1531
No description available

WB:WBGene00049977	21ur-651
No description available

WB:WBGene00049978	21ur-2398
No description available

WB:WBGene00049979	21ur-3603
No description available

WB:WBGene00049980	21ur-3268
No description available

WB:WBGene00049981	21ur-1035
No description available

WB:WBGene00049982	21ur-1861
No description available

WB:WBGene00049983	21ur-1759
No description available

WB:WBGene00049984	21ur-4245
No description available

WB:WBGene00049985	21ur-2924
No description available

WB:WBGene00049986	21ur-1149
No description available

WB:WBGene00049987	21ur-4403
No description available

WB:WBGene00049988	21ur-4505
No description available

WB:WBGene00049989	21ur-2963
No description available

WB:WBGene00049990	21ur-3083
No description available

WB:WBGene00049991	21ur-3589
Is affected by eat-2 based on microarray studies.

WB:WBGene00049992	21ur-4668
No description available

WB:WBGene00049993	21ur-4394
No description available

WB:WBGene00049994	21ur-4865
No description available

WB:WBGene00049995	21ur-4770
No description available

WB:WBGene00049996	21ur-166
No description available

WB:WBGene00049997	21ur-2641
No description available

WB:WBGene00049998	21ur-568
No description available

WB:WBGene00049999	21ur-1883
No description available

WB:WBGene00050000	21ur-548
No description available

WB:WBGene00050001	21ur-64
No description available

WB:WBGene00050002	21ur-5118
No description available

WB:WBGene00050003	21ur-2810
No description available

WB:WBGene00050004	21ur-3696
No description available

WB:WBGene00050005	21ur-1914
No description available

WB:WBGene00050006	21ur-3099
No description available

WB:WBGene00050007	21ur-4462
No description available

WB:WBGene00050008	21ur-5255
No description available

WB:WBGene00050009	21ur-5140
No description available

WB:WBGene00050010	21ur-1454
No description available

WB:WBGene00050011	21ur-4023
No description available

WB:WBGene00050012	21ur-2031
No description available

WB:WBGene00050013	21ur-3618
No description available

WB:WBGene00050014	21ur-904
No description available

WB:WBGene00050015	21ur-3077
No description available

WB:WBGene00050016	21ur-4687
No description available

WB:WBGene00050017	21ur-2507
No description available

WB:WBGene00050018	21ur-2582
No description available

WB:WBGene00050019	21ur-612
No description available

WB:WBGene00050020	21ur-4418
No description available

WB:WBGene00050021	21ur-3135
No description available

WB:WBGene00050022	21ur-5099
No description available

WB:WBGene00050023	21ur-5003
No description available

WB:WBGene00050024	21ur-1453
No description available

WB:WBGene00050025	21ur-1728
No description available

WB:WBGene00050026	21ur-2052
No description available

WB:WBGene00050027	21ur-3837
No description available

WB:WBGene00050028	21ur-3180
No description available

WB:WBGene00050029	21ur-385
No description available

WB:WBGene00050030	21ur-441
No description available

WB:WBGene00050031	21ur-2615
No description available

WB:WBGene00050032	21ur-4921
No description available

WB:WBGene00050033	21ur-3498
No description available

WB:WBGene00050034	21ur-3915
No description available

WB:WBGene00050035	21ur-3802
No description available

WB:WBGene00050036	21ur-1734
No description available

WB:WBGene00050037	21ur-2011
No description available

WB:WBGene00050038	21ur-2571
No description available

WB:WBGene00050039	21ur-685
No description available

WB:WBGene00050040	21ur-5149
No description available

WB:WBGene00050041	21ur-5077
No description available

WB:WBGene00050042	21ur-929
No description available

WB:WBGene00050043	21ur-2400
No description available

WB:WBGene00050044	21ur-1073
No description available

WB:WBGene00050045	21ur-3692
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00050046	21ur-1323
No description available

WB:WBGene00050047	21ur-3534
No description available

WB:WBGene00050048	21ur-1933
No description available

WB:WBGene00050049	21ur-626
No description available

WB:WBGene00050050	21ur-3277
No description available

WB:WBGene00050051	21ur-1875
No description available

WB:WBGene00050052	21ur-4940
No description available

WB:WBGene00050053	21ur-4219
No description available

WB:WBGene00050054	21ur-5442
No description available

WB:WBGene00050055	21ur-4937
No description available

WB:WBGene00050056	21ur-3436
No description available

WB:WBGene00050057	21ur-669
No description available

WB:WBGene00050058	21ur-3308
No description available

WB:WBGene00050059	21ur-5221
No description available

WB:WBGene00050060	21ur-1022
No description available

WB:WBGene00050061	21ur-5015
No description available

WB:WBGene00050062	21ur-1988
No description available

WB:WBGene00050063	21ur-3623
No description available

WB:WBGene00050064	21ur-3811
No description available

WB:WBGene00050065	21ur-5373
No description available

WB:WBGene00050066	21ur-3235
No description available

WB:WBGene00050067	21ur-2474
No description available

WB:WBGene00050068	21ur-3178
No description available

WB:WBGene00050069	21ur-3451
No description available

WB:WBGene00050070	21ur-2191
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00050071	21ur-3179
No description available

WB:WBGene00050072	21ur-1493
No description available

WB:WBGene00050073	21ur-1305
No description available

WB:WBGene00050074	21ur-1051
No description available

WB:WBGene00050075	21ur-688
No description available

WB:WBGene00050076	21ur-756
Is affected by daf-2 based on microarray studies.

WB:WBGene00050077	21ur-1405
No description available

WB:WBGene00050078	21ur-4811
No description available

WB:WBGene00050079	21ur-3438
No description available

WB:WBGene00050080	21ur-1083
No description available

WB:WBGene00050081	21ur-2324
No description available

WB:WBGene00050082	21ur-3985
No description available

WB:WBGene00050083	21ur-2681
No description available

WB:WBGene00050084	21ur-3007
No description available

WB:WBGene00050085	21ur-2383
No description available

WB:WBGene00050086	21ur-4932
No description available

WB:WBGene00050087	21ur-788
No description available

WB:WBGene00050088	21ur-1155
No description available

WB:WBGene00050089	21ur-798
No description available

WB:WBGene00050090	21ur-3562
No description available

WB:WBGene00050091	21ur-2952
No description available

WB:WBGene00050092	21ur-1567
No description available

WB:WBGene00050093	21ur-896
No description available

WB:WBGene00050094	21ur-1847
No description available

WB:WBGene00050095	21ur-5409
No description available

WB:WBGene00050096	21ur-2025
No description available

WB:WBGene00050097	21ur-5246
No description available

WB:WBGene00050098	21ur-2209
No description available

WB:WBGene00050099	21ur-3428
No description available

WB:WBGene00050100	21ur-4532
No description available

WB:WBGene00050101	21ur-1315
No description available

WB:WBGene00050102	21ur-1763
No description available

WB:WBGene00050103	21ur-4733
No description available

WB:WBGene00050104	21ur-264
No description available

WB:WBGene00050105	21ur-2137
No description available

WB:WBGene00050106	21ur-1909
No description available

WB:WBGene00050107	21ur-627
No description available

WB:WBGene00050108	21ur-15
No description available

WB:WBGene00050109	21ur-2219
No description available

WB:WBGene00050110	21ur-4517
No description available

WB:WBGene00050111	21ur-2981
No description available

WB:WBGene00050112	21ur-71
No description available

WB:WBGene00050113	21ur-4798
No description available

WB:WBGene00050114	21ur-3264
No description available

WB:WBGene00050115	21ur-1745
No description available

WB:WBGene00050116	21ur-674
No description available

WB:WBGene00050117	21ur-781
No description available

WB:WBGene00050118	21ur-1623
No description available

WB:WBGene00050119	21ur-1577
No description available

WB:WBGene00050120	21ur-5024
No description available

WB:WBGene00050121	21ur-3503
No description available

WB:WBGene00050122	21ur-2155
No description available

WB:WBGene00050123	21ur-3460
No description available

WB:WBGene00050124	21ur-1208
No description available

WB:WBGene00050125	21ur-4923
No description available

WB:WBGene00050126	21ur-4543
No description available

WB:WBGene00050127	21ur-3920
No description available

WB:WBGene00050128	21ur-3486
No description available

WB:WBGene00050129	21ur-3149
No description available

WB:WBGene00050130	21ur-779
No description available

WB:WBGene00050131	21ur-2905
No description available

WB:WBGene00050132	21ur-148
No description available

WB:WBGene00050133	21ur-2544
No description available

WB:WBGene00050134	21ur-5033
No description available

WB:WBGene00050135	21ur-1179
No description available

WB:WBGene00050136	21ur-3117
No description available

WB:WBGene00050137	21ur-859
No description available

WB:WBGene00050138	21ur-4570
No description available

WB:WBGene00050139	21ur-5391
No description available

WB:WBGene00050140	21ur-2144
No description available

WB:WBGene00050141	21ur-4884
No description available

WB:WBGene00050142	21ur-2760
No description available

WB:WBGene00050143	21ur-507
No description available

WB:WBGene00050144	21ur-1288
No description available

WB:WBGene00050145	21ur-4600
No description available

WB:WBGene00050146	21ur-4961
No description available

WB:WBGene00050147	21ur-4237
No description available

WB:WBGene00050148	21ur-5321
No description available

WB:WBGene00050149	21ur-451
No description available

WB:WBGene00050150	21ur-1519
No description available

WB:WBGene00050151	21ur-5347
No description available

WB:WBGene00050152	21ur-1560
No description available

WB:WBGene00050153	21ur-1526
No description available

WB:WBGene00050154	21ur-5387
No description available

WB:WBGene00050155	21ur-2393
No description available

WB:WBGene00050156	21ur-5168
No description available

WB:WBGene00050157	21ur-4565
No description available

WB:WBGene00050158	21ur-2823
No description available

WB:WBGene00050159	21ur-1026
No description available

WB:WBGene00050160	21ur-3659
No description available

WB:WBGene00050161	21ur-1509
No description available

WB:WBGene00050162	21ur-776
No description available

WB:WBGene00050163	21ur-3193
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00050164	21ur-2988
No description available

WB:WBGene00050165	21ur-1708
No description available

WB:WBGene00050166	21ur-3078
Is affected by eat-2 based on microarray studies.

WB:WBGene00050167	21ur-4718
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00050168	21ur-4411
No description available

WB:WBGene00050169	21ur-2277
No description available

WB:WBGene00050170	21ur-4691
No description available

WB:WBGene00050171	21ur-5157
No description available

WB:WBGene00050172	21ur-1105
No description available

WB:WBGene00050173	21ur-5310
No description available

WB:WBGene00050174	21ur-2300
No description available

WB:WBGene00050175	21ur-2283
No description available

WB:WBGene00050176	21ur-1240
No description available

WB:WBGene00050177	21ur-5241
No description available

WB:WBGene00050178	21ur-5437
No description available

WB:WBGene00050179	21ur-1819
No description available

WB:WBGene00050180	21ur-2881
No description available

WB:WBGene00050181	21ur-4176
No description available

WB:WBGene00050182	21ur-347
No description available

WB:WBGene00050183	21ur-5092
No description available

WB:WBGene00050184	21ur-1653
No description available

WB:WBGene00050185	21ur-2491
Is affected by eat-2 based on microarray studies.

WB:WBGene00050186	21ur-5083
No description available

WB:WBGene00050187	21ur-874
No description available

WB:WBGene00050188	21ur-5067
No description available

WB:WBGene00050189	21ur-3333
No description available

WB:WBGene00050190	21ur-832
No description available

WB:WBGene00050191	21ur-5031
No description available

WB:WBGene00050192	21ur-4196
No description available

WB:WBGene00050193	21ur-4046
No description available

WB:WBGene00050194	21ur-2177
No description available

WB:WBGene00050195	21ur-633
No description available

WB:WBGene00050196	21ur-3142
No description available

WB:WBGene00050197	21ur-39
No description available

WB:WBGene00050198	21ur-2486
No description available

WB:WBGene00050199	21ur-4782
No description available

WB:WBGene00050200	21ur-3798
No description available

WB:WBGene00050201	21ur-5199
No description available

WB:WBGene00050202	21ur-3895
No description available

WB:WBGene00050203	21ur-3564
No description available

WB:WBGene00050204	21ur-277
No description available

WB:WBGene00050205	21ur-3998
No description available

WB:WBGene00050206	21ur-4618
No description available

WB:WBGene00050207	21ur-4582
No description available

WB:WBGene00050208	21ur-5319
No description available

WB:WBGene00050209	21ur-4171
No description available

WB:WBGene00050210	21ur-2232
No description available

WB:WBGene00050211	21ur-2845
No description available

WB:WBGene00050212	21ur-849
No description available

WB:WBGene00050213	21ur-2015
No description available

WB:WBGene00050214	21ur-5249
No description available

WB:WBGene00050215	21ur-2528
No description available

WB:WBGene00050216	21ur-5376
No description available

WB:WBGene00050217	21ur-4076
No description available

WB:WBGene00050218	21ur-1891
No description available

WB:WBGene00050219	21ur-2234
No description available

WB:WBGene00050220	21ur-2385
No description available

WB:WBGene00050221	21ur-2632
No description available

WB:WBGene00050222	21ur-4489
No description available

WB:WBGene00050223	21ur-1533
No description available

WB:WBGene00050224	21ur-3093
No description available

WB:WBGene00050225	21ur-3717
No description available

WB:WBGene00050226	21ur-2314
No description available

WB:WBGene00050227	21ur-910
No description available

WB:WBGene00050228	21ur-1214
No description available

WB:WBGene00050229	21ur-4545
No description available

WB:WBGene00050230	21ur-399
No description available

WB:WBGene00050231	21ur-2550
No description available

WB:WBGene00050232	21ur-3474
No description available

WB:WBGene00050233	21ur-5305
No description available

WB:WBGene00050234	21ur-2009
No description available

WB:WBGene00050235	21ur-4386
No description available

WB:WBGene00050236	21ur-3079
No description available

WB:WBGene00050237	21ur-4604
No description available

WB:WBGene00050238	21ur-425
No description available

WB:WBGene00050239	21ur-3413
No description available

WB:WBGene00050240	21ur-1630
No description available

WB:WBGene00050241	21ur-2287
No description available

WB:WBGene00050242	21ur-1654
No description available

WB:WBGene00050243	21ur-5070
No description available

WB:WBGene00050244	21ur-105
No description available

WB:WBGene00050245	21ur-1592
No description available

WB:WBGene00050246	21ur-1491
No description available

WB:WBGene00050247	21ur-2027
No description available

WB:WBGene00050248	21ur-2075
No description available

WB:WBGene00050249	21ur-4899
No description available

WB:WBGene00050250	21ur-5245
No description available

WB:WBGene00050251	21ur-2323
No description available

WB:WBGene00050252	21ur-796
No description available

WB:WBGene00050253	21ur-2631
No description available

WB:WBGene00050254	21ur-2854
No description available

WB:WBGene00050255	21ur-2196
No description available

WB:WBGene00050256	21ur-2953
No description available

WB:WBGene00050257	21ur-2268
No description available

WB:WBGene00050258	21ur-2675
No description available

WB:WBGene00050259	21ur-316
No description available

WB:WBGene00050260	21ur-394
No description available

WB:WBGene00050261	21ur-5371
No description available

WB:WBGene00050262	21ur-3876
No description available

WB:WBGene00050263	21ur-4666
No description available

WB:WBGene00050264	21ur-862
No description available

WB:WBGene00050265	21ur-3222
No description available

WB:WBGene00050266	21ur-2443
No description available

WB:WBGene00050267	21ur-3889
No description available

WB:WBGene00050268	21ur-4272
No description available

WB:WBGene00050269	21ur-2318
No description available

WB:WBGene00050270	21ur-2221
No description available

WB:WBGene00050271	21ur-2705
No description available

WB:WBGene00050272	21ur-3403
No description available

WB:WBGene00050273	21ur-3872
No description available

WB:WBGene00050274	21ur-3047
No description available

WB:WBGene00050275	21ur-308
No description available

WB:WBGene00050276	21ur-5331
No description available

WB:WBGene00050277	21ur-1743
No description available

WB:WBGene00050278	21ur-746
No description available

WB:WBGene00050279	21ur-1978
No description available

WB:WBGene00050280	21ur-4047
No description available

WB:WBGene00050281	21ur-206
No description available

WB:WBGene00050282	21ur-3378
No description available

WB:WBGene00050283	21ur-1698
No description available

WB:WBGene00050284	21ur-997
No description available

WB:WBGene00050285	21ur-1966
No description available

WB:WBGene00050286	21ur-3881
No description available

WB:WBGene00050287	21ur-2748
No description available

WB:WBGene00050288	21ur-3966
No description available

WB:WBGene00050289	21ur-3640
No description available

WB:WBGene00050290	21ur-2665
No description available

WB:WBGene00050291	21ur-2532
No description available

WB:WBGene00050292	21ur-556
No description available

WB:WBGene00050293	21ur-1023
No description available

WB:WBGene00050294	21ur-4279
No description available

WB:WBGene00050295	21ur-2408
No description available

WB:WBGene00050296	21ur-2351
No description available

WB:WBGene00050297	21ur-4473
No description available

WB:WBGene00050298	21ur-3102
No description available

WB:WBGene00050299	21ur-3750
No description available

WB:WBGene00050300	21ur-170
No description available

WB:WBGene00050301	21ur-1277
No description available

WB:WBGene00050302	21ur-3490
No description available

WB:WBGene00050303	21ur-1002
No description available

WB:WBGene00050304	21ur-4322
No description available

WB:WBGene00050305	21ur-2307
No description available

WB:WBGene00050306	21ur-1384
No description available

WB:WBGene00050307	21ur-301
No description available

WB:WBGene00050308	21ur-1889
No description available

WB:WBGene00050309	21ur-2376
No description available

WB:WBGene00050310	21ur-4904
No description available

WB:WBGene00050311	21ur-4136
No description available

WB:WBGene00050312	21ur-3622
No description available

WB:WBGene00050313	21ur-4224
No description available

WB:WBGene00050314	21ur-3482
No description available

WB:WBGene00050315	21ur-3200
No description available

WB:WBGene00050316	21ur-3886
No description available

WB:WBGene00050317	21ur-4389
No description available

WB:WBGene00050318	21ur-4135
No description available

WB:WBGene00050319	21ur-4485
No description available

WB:WBGene00050320	21ur-4850
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00050321	21ur-4636
No description available

WB:WBGene00050322	21ur-1820
No description available

WB:WBGene00050323	21ur-1753
Is affected by daf-2 based on microarray studies.

WB:WBGene00050324	21ur-4377
No description available

WB:WBGene00050325	21ur-1710
No description available

WB:WBGene00050326	21ur-4993
No description available

WB:WBGene00050327	21ur-4231
No description available

WB:WBGene00050328	21ur-3891
No description available

WB:WBGene00050329	21ur-3862
No description available

WB:WBGene00050330	21ur-5060
No description available

WB:WBGene00050331	21ur-4050
No description available

WB:WBGene00050332	21ur-812
No description available

WB:WBGene00050333	21ur-1058
No description available

WB:WBGene00050334	21ur-814
No description available

WB:WBGene00050335	21ur-2763
No description available

WB:WBGene00050336	21ur-4312
No description available

WB:WBGene00050337	21ur-4675
No description available

WB:WBGene00050338	21ur-4822
No description available

WB:WBGene00050339	21ur-2605
No description available

WB:WBGene00050340	21ur-3937
No description available

WB:WBGene00050341	21ur-2299
No description available

WB:WBGene00050342	21ur-1511
No description available

WB:WBGene00050343	21ur-1478
No description available

WB:WBGene00050344	21ur-4843
No description available

WB:WBGene00050345	21ur-1938
No description available

WB:WBGene00050346	21ur-1366
No description available

WB:WBGene00050347	21ur-4204
No description available

WB:WBGene00050348	21ur-4619
No description available

WB:WBGene00050349	21ur-3024
No description available

WB:WBGene00050350	21ur-2461
No description available

WB:WBGene00050351	21ur-2071
No description available

WB:WBGene00050352	21ur-2936
No description available

WB:WBGene00050353	21ur-1773
No description available

WB:WBGene00050354	21ur-2904
No description available

WB:WBGene00050355	21ur-3974
No description available

WB:WBGene00050356	21ur-192
No description available

WB:WBGene00050357	21ur-1637
No description available

WB:WBGene00050358	21ur-4098
No description available

WB:WBGene00050359	21ur-711
No description available

WB:WBGene00050360	21ur-7
No description available

WB:WBGene00050361	21ur-2170
No description available

WB:WBGene00050362	21ur-4761
No description available

WB:WBGene00050363	21ur-1333
No description available

WB:WBGene00050364	21ur-4730
No description available

WB:WBGene00050365	21ur-4013
No description available

WB:WBGene00050366	21ur-4166
No description available

WB:WBGene00050367	21ur-4127
No description available

WB:WBGene00050368	21ur-3852
No description available

WB:WBGene00050369	21ur-5332
No description available

WB:WBGene00050370	21ur-3522
No description available

WB:WBGene00050371	21ur-4625
No description available

WB:WBGene00050372	21ur-949
No description available

WB:WBGene00050373	21ur-1826
No description available

WB:WBGene00050374	21ur-3164
No description available

WB:WBGene00050375	21ur-4361
No description available

WB:WBGene00050376	21ur-3766
No description available

WB:WBGene00050377	21ur-1353
No description available

WB:WBGene00050378	21ur-460
No description available

WB:WBGene00050379	21ur-1679
No description available

WB:WBGene00050380	21ur-3669
No description available

WB:WBGene00050381	21ur-1921
No description available

WB:WBGene00050382	21ur-1057
No description available

WB:WBGene00050383	21ur-3930
No description available

WB:WBGene00050384	21ur-3030
No description available

WB:WBGene00050385	21ur-3684
No description available

WB:WBGene00050386	21ur-1193
No description available

WB:WBGene00050387	21ur-1414
No description available

WB:WBGene00050388	21ur-36
No description available

WB:WBGene00050389	21ur-5225
No description available

WB:WBGene00050390	21ur-4907
No description available

WB:WBGene00050391	21ur-1036
No description available

WB:WBGene00050392	21ur-2834
No description available

WB:WBGene00050393	21ur-2082
No description available

WB:WBGene00050394	21ur-3747
Is affected by daf-2 based on microarray studies.

WB:WBGene00050395	21ur-74
No description available

WB:WBGene00050396	21ur-1915
No description available

WB:WBGene00050397	21ur-2124
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00050398	21ur-4778
No description available

WB:WBGene00050399	21ur-2364
No description available

WB:WBGene00050400	21ur-104
No description available

WB:WBGene00050401	21ur-3943
No description available

WB:WBGene00050402	21ur-573
No description available

WB:WBGene00050403	21ur-373
No description available

WB:WBGene00050404	21ur-4829
No description available

WB:WBGene00050405	21ur-2107
No description available

WB:WBGene00050406	21ur-4790
No description available

WB:WBGene00050407	21ur-1669
No description available

WB:WBGene00050408	21ur-4304
No description available

WB:WBGene00050409	21ur-2305
No description available

WB:WBGene00050410	21ur-4262
No description available

WB:WBGene00050411	21ur-1668
No description available

WB:WBGene00050412	21ur-3950
No description available

WB:WBGene00050413	21ur-3770
No description available

WB:WBGene00050414	21ur-1815
No description available

WB:WBGene00050415	21ur-2439
No description available

WB:WBGene00050416	21ur-658
No description available

WB:WBGene00050417	21ur-4263
No description available

WB:WBGene00050418	21ur-2597
No description available

WB:WBGene00050419	21ur-4195
No description available

WB:WBGene00050420	21ur-3649
No description available

WB:WBGene00050421	21ur-4757
No description available

WB:WBGene00050422	21ur-3541
No description available

WB:WBGene00050423	21ur-4040
No description available

WB:WBGene00050424	21ur-3901
No description available

WB:WBGene00050425	21ur-4956
No description available

WB:WBGene00050426	21ur-3948
No description available

WB:WBGene00050427	21ur-2049
No description available

WB:WBGene00050428	21ur-2497
No description available

WB:WBGene00050429	21ur-1793
No description available

WB:WBGene00050430	21ur-1060
No description available

WB:WBGene00050431	21ur-528
No description available

WB:WBGene00050432	21ur-4984
No description available

WB:WBGene00050433	21ur-792
No description available

WB:WBGene00050434	21ur-1389
No description available

WB:WBGene00050435	21ur-536
No description available

WB:WBGene00050436	21ur-1156
No description available

WB:WBGene00050437	21ur-1880
No description available

WB:WBGene00050438	21ur-4911
No description available

WB:WBGene00050439	21ur-295
No description available

WB:WBGene00050440	21ur-771
No description available

WB:WBGene00050441	21ur-4112
No description available

WB:WBGene00050442	21ur-3725
No description available

WB:WBGene00050443	21ur-1940
No description available

WB:WBGene00050444	21ur-4180
No description available

WB:WBGene00050445	21ur-3307
No description available

WB:WBGene00050446	21ur-513
No description available

WB:WBGene00050447	21ur-4938
No description available

WB:WBGene00050448	21ur-3192
No description available

WB:WBGene00050449	21ur-4597
No description available

WB:WBGene00050450	21ur-3161
No description available

WB:WBGene00050451	21ur-4913
No description available

WB:WBGene00050452	21ur-3299
No description available

WB:WBGene00050453	21ur-2660
No description available

WB:WBGene00050454	21ur-2693
No description available

WB:WBGene00050455	21ur-1788
No description available

WB:WBGene00050456	21ur-5114
No description available

WB:WBGene00050457	21ur-2946
No description available

WB:WBGene00050458	21ur-177
No description available

WB:WBGene00050459	21ur-3186
No description available

WB:WBGene00050460	21ur-4088
No description available

WB:WBGene00050461	21ur-3019
No description available

WB:WBGene00050462	21ur-5026
No description available

WB:WBGene00050463	21ur-4159
No description available

WB:WBGene00050464	21ur-92
No description available

WB:WBGene00050465	21ur-3505
No description available

WB:WBGene00050466	21ur-128
No description available

WB:WBGene00050467	21ur-1671
No description available

WB:WBGene00050468	21ur-1294
No description available

WB:WBGene00050469	21ur-2653
No description available

WB:WBGene00050470	21ur-3499
No description available

WB:WBGene00050471	21ur-55
No description available

WB:WBGene00050472	21ur-840
No description available

WB:WBGene00050473	21ur-1949
No description available

WB:WBGene00050474	21ur-4060
No description available

WB:WBGene00050475	21ur-65
No description available

WB:WBGene00050476	21ur-3214
No description available

WB:WBGene00050477	21ur-1662
No description available

WB:WBGene00050478	21ur-1399
Is affected by eat-2 based on microarray studies.

WB:WBGene00050479	21ur-2377
No description available

WB:WBGene00050480	21ur-3423
No description available

WB:WBGene00050481	21ur-485
No description available

WB:WBGene00050482	21ur-1863
No description available

WB:WBGene00050483	21ur-931
No description available

WB:WBGene00050484	21ur-3435
No description available

WB:WBGene00050485	21ur-1582
No description available

WB:WBGene00050486	21ur-944
No description available

WB:WBGene00050487	21ur-247
No description available

WB:WBGene00050488	21ur-1622
No description available

WB:WBGene00050489	21ur-1185
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00050490	21ur-4449
No description available

WB:WBGene00050491	21ur-1006
No description available

WB:WBGene00050492	21ur-4281
No description available

WB:WBGene00050493	21ur-3365
No description available

WB:WBGene00050494	21ur-1649
Is affected by emr-1; lem-2; and dpy-21 based on RNA-seq studies.

WB:WBGene00050495	21ur-2518
No description available

WB:WBGene00050496	21ur-1859
No description available

WB:WBGene00050497	21ur-2002
No description available

WB:WBGene00050498	21ur-5005
No description available

WB:WBGene00050499	21ur-1961
No description available

WB:WBGene00050500	21ur-1953
No description available

WB:WBGene00050501	21ur-4807
No description available

WB:WBGene00050502	21ur-720
No description available

WB:WBGene00050503	21ur-1203
No description available

WB:WBGene00050504	21ur-2739
No description available

WB:WBGene00050505	21ur-383
No description available

WB:WBGene00050506	21ur-3351
No description available

WB:WBGene00050507	21ur-4640
No description available

WB:WBGene00050508	21ur-3548
No description available

WB:WBGene00050509	21ur-4656
No description available

WB:WBGene00050510	21ur-4397
No description available

WB:WBGene00050511	21ur-4438
No description available

WB:WBGene00050512	21ur-5344
No description available

WB:WBGene00050513	21ur-2104
No description available

WB:WBGene00050514	21ur-472
No description available

WB:WBGene00050515	21ur-2127
No description available

WB:WBGene00050516	21ur-141
No description available

WB:WBGene00050517	21ur-1850
No description available

WB:WBGene00050518	21ur-4189
No description available

WB:WBGene00050519	21ur-5297
No description available

WB:WBGene00050520	21ur-3256
No description available

WB:WBGene00050521	21ur-2897
No description available

WB:WBGene00050522	21ur-3820
No description available

WB:WBGene00050523	21ur-5047
No description available

WB:WBGene00050524	21ur-2942
No description available

WB:WBGene00050525	21ur-917
No description available

WB:WBGene00050526	21ur-4025
No description available

WB:WBGene00050527	21ur-2886
No description available

WB:WBGene00050528	21ur-2244
No description available

WB:WBGene00050529	21ur-1547
No description available

WB:WBGene00050530	21ur-2243
No description available

WB:WBGene00050531	21ur-1842
No description available

WB:WBGene00050532	21ur-4642
No description available

WB:WBGene00050533	21ur-3467
No description available

WB:WBGene00050534	21ur-3675
No description available

WB:WBGene00050535	21ur-1558
No description available

WB:WBGene00050536	21ur-1923
No description available

WB:WBGene00050537	21ur-1068
No description available

WB:WBGene00050538	21ur-2643
No description available

WB:WBGene00050539	21ur-4818
No description available

WB:WBGene00050540	21ur-3296
No description available

WB:WBGene00050541	21ur-1900
No description available

WB:WBGene00050542	21ur-5115
No description available

WB:WBGene00050543	21ur-2508
No description available

WB:WBGene00050544	21ur-2506
No description available

WB:WBGene00050545	21ur-2063
No description available

WB:WBGene00050546	21ur-243
No description available

WB:WBGene00050547	21ur-4404
No description available

WB:WBGene00050548	21ur-210
No description available

WB:WBGene00050549	21ur-5256
No description available

WB:WBGene00050550	21ur-150
No description available

WB:WBGene00050551	21ur-3119
No description available

WB:WBGene00050552	21ur-1791
No description available

WB:WBGene00050553	21ur-1501
No description available

WB:WBGene00050554	21ur-1527
No description available

WB:WBGene00050555	21ur-2186
No description available

WB:WBGene00050556	21ur-2583
No description available

WB:WBGene00050557	21ur-984
No description available

WB:WBGene00050558	21ur-319
No description available

WB:WBGene00050559	21ur-5277
No description available

WB:WBGene00050560	21ur-721
No description available

WB:WBGene00050561	21ur-3267
No description available

WB:WBGene00050562	21ur-4920
No description available

WB:WBGene00050563	21ur-2962
No description available

WB:WBGene00050564	21ur-3695
No description available

WB:WBGene00050565	21ur-3813
No description available

WB:WBGene00050566	21ur-4259
No description available

WB:WBGene00050567	21ur-4354
No description available

WB:WBGene00050568	21ur-1604
No description available

WB:WBGene00050569	21ur-5124
No description available

WB:WBGene00050570	21ur-4417
No description available

WB:WBGene00050571	21ur-3588
No description available

WB:WBGene00050572	21ur-3082
No description available

WB:WBGene00050573	21ur-2784
No description available

WB:WBGene00050574	21ur-3944
No description available

WB:WBGene00050575	21ur-2267
No description available

WB:WBGene00050576	21ur-2103
No description available

WB:WBGene00050577	21ur-567
No description available

WB:WBGene00050578	21ur-4806
No description available

WB:WBGene00050579	21ur-5065
No description available

WB:WBGene00050580	21ur-4177
No description available

WB:WBGene00050581	21ur-2150
No description available

WB:WBGene00050582	21ur-1306
No description available

WB:WBGene00050583	21ur-2925
No description available

WB:WBGene00050584	21ur-3477
No description available

WB:WBGene00050585	21ur-282
No description available

WB:WBGene00050586	21ur-3407
No description available

WB:WBGene00050587	21ur-3916
No description available

WB:WBGene00050588	21ur-2511
No description available

WB:WBGene00050589	21ur-473
No description available

WB:WBGene00050590	21ur-5285
No description available

WB:WBGene00050591	21ur-3803
No description available

WB:WBGene00050592	21ur-132
No description available

WB:WBGene00050593	21ur-374
No description available

WB:WBGene00050594	21ur-1629
No description available

WB:WBGene00050595	21ur-1727
No description available

WB:WBGene00050596	21ur-4365
No description available

WB:WBGene00050597	21ur-1148
No description available

WB:WBGene00050598	21ur-1488
No description available

WB:WBGene00050599	21ur-35
No description available

WB:WBGene00050600	21ur-5222
No description available

WB:WBGene00050601	21ur-806
No description available

WB:WBGene00050602	21ur-3917
No description available

WB:WBGene00050603	21ur-1222
No description available

WB:WBGene00050604	21ur-5252
No description available

WB:WBGene00050605	21ur-3420
No description available

WB:WBGene00050606	21ur-363
No description available

WB:WBGene00050607	21ur-903
No description available

WB:WBGene00050608	21ur-258
No description available

WB:WBGene00050609	21ur-3134
No description available

WB:WBGene00050610	21ur-2726
No description available

WB:WBGene00050611	21ur-2091
No description available

WB:WBGene00050612	21ur-2570
No description available

WB:WBGene00050613	21ur-1487
No description available

WB:WBGene00050614	21ur-3676
No description available

WB:WBGene00050615	21ur-5042
No description available

WB:WBGene00050616	21ur-2164
No description available

WB:WBGene00050617	21ur-2242
No description available

WB:WBGene00050618	21ur-4783
No description available

WB:WBGene00050619	21ur-3529
No description available

WB:WBGene00050620	21ur-4056
No description available

WB:WBGene00050621	21ur-5078
No description available

WB:WBGene00050622	21ur-2922
No description available

WB:WBGene00050623	21ur-1455
No description available

WB:WBGene00050624	21ur-2433
No description available

WB:WBGene00050625	21ur-959
No description available

WB:WBGene00050626	21ur-353
No description available

WB:WBGene00050627	21ur-3632
No description available

WB:WBGene00050628	21ur-3926
No description available

WB:WBGene00050629	21ur-632
No description available

WB:WBGene00050630	21ur-3777
No description available

WB:WBGene00050631	21ur-3835
No description available

WB:WBGene00050632	21ur-2972
No description available

WB:WBGene00050633	21ur-3450
No description available

WB:WBGene00050634	21ur-4725
No description available

WB:WBGene00050635	21ur-1246
No description available

WB:WBGene00050636	21ur-4045
No description available

WB:WBGene00050637	21ur-28
No description available

WB:WBGene00050638	21ur-3533
No description available

WB:WBGene00050639	21ur-757
No description available

WB:WBGene00050640	21ur-219
No description available

WB:WBGene00050641	21ur-3344
No description available

WB:WBGene00050642	21ur-5260
No description available

WB:WBGene00050643	21ur-1132
No description available

WB:WBGene00050644	21ur-1464
No description available

WB:WBGene00050645	21ur-4754
No description available

WB:WBGene00050646	21ur-707
No description available

WB:WBGene00050647	21ur-878
No description available

WB:WBGene00050648	21ur-2370
No description available

WB:WBGene00050649	21ur-446
No description available

WB:WBGene00050650	21ur-1587
No description available

WB:WBGene00050651	21ur-4167
No description available

WB:WBGene00050652	21ur-4746
No description available

WB:WBGene00050653	21ur-4572
No description available

WB:WBGene00050654	21ur-434
No description available

WB:WBGene00050655	21ur-3637
No description available

WB:WBGene00050656	21ur-4347
No description available

WB:WBGene00050657	21ur-735
No description available

WB:WBGene00050658	21ur-5098
No description available

WB:WBGene00050659	21ur-1142
No description available

WB:WBGene00050660	21ur-4979
No description available

WB:WBGene00050661	21ur-2306
No description available

WB:WBGene00050662	21ur-495
No description available

WB:WBGene00050663	21ur-3701
No description available

WB:WBGene00050664	21ur-1492
No description available

WB:WBGene00050665	21ur-4689
No description available

WB:WBGene00050666	21ur-1803
No description available

WB:WBGene00050667	21ur-4598
No description available

WB:WBGene00050668	21ur-625
No description available

WB:WBGene00050669	21ur-4957
No description available

WB:WBGene00050670	21ur-1061
No description available

WB:WBGene00050671	21ur-4929
No description available

WB:WBGene00050672	21ur-2095
No description available

WB:WBGene00050673	21ur-3910
No description available

WB:WBGene00050674	21ur-3033
No description available

WB:WBGene00050675	21ur-3727
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00050676	21ur-1720
No description available

WB:WBGene00050677	21ur-1997
No description available

WB:WBGene00050678	21ur-2745
No description available

WB:WBGene00050679	21ur-3791
No description available

WB:WBGene00050680	21ur-271
No description available

WB:WBGene00050681	21ur-1614
No description available

WB:WBGene00050682	21ur-4461
No description available

WB:WBGene00050683	21ur-1709
No description available

WB:WBGene00050684	21ur-405
No description available

WB:WBGene00050685	21ur-1970
No description available

WB:WBGene00050686	21ur-2116
No description available

WB:WBGene00050687	21ur-1094
No description available

WB:WBGene00050688	21ur-379
No description available

WB:WBGene00050689	21ur-4564
No description available

WB:WBGene00050690	21ur-16
No description available

WB:WBGene00050691	21ur-1685
No description available

WB:WBGene00050692	21ur-4005
No description available

WB:WBGene00050693	21ur-4769
No description available

WB:WBGene00050694	21ur-4703
No description available

WB:WBGene00050695	21ur-4238
No description available

WB:WBGene00050696	21ur-2730
No description available

WB:WBGene00050697	21ur-4557
No description available

WB:WBGene00050698	21ur-1281
No description available

WB:WBGene00050699	21ur-1121
No description available

WB:WBGene00050700	21ur-2574
No description available

WB:WBGene00050701	21ur-1846
No description available

WB:WBGene00050702	21ur-2432
No description available

WB:WBGene00050703	21ur-1695
No description available

WB:WBGene00050704	21ur-3519
No description available

WB:WBGene00050705	21ur-4140
No description available

WB:WBGene00050706	21ur-2793
No description available

WB:WBGene00050707	21ur-5290
No description available

WB:WBGene00050708	21ur-2010
No description available

WB:WBGene00050709	21ur-3859
No description available

WB:WBGene00050710	21ur-5322
No description available

WB:WBGene00050711	21ur-5269
No description available

WB:WBGene00050712	21ur-2781
No description available

WB:WBGene00050713	21ur-4883
No description available

WB:WBGene00050714	21ur-359
No description available

WB:WBGene00050715	21ur-5084
No description available

WB:WBGene00050716	21ur-1287
No description available

WB:WBGene00050717	21ur-1432
No description available

WB:WBGene00050718	21ur-3155
No description available

WB:WBGene00050719	21ur-3198
No description available

WB:WBGene00050720	21ur-4412
No description available

WB:WBGene00050721	21ur-1459
No description available

WB:WBGene00050722	21ur-4905
No description available

WB:WBGene00050723	21ur-1518
No description available

WB:WBGene00050724	21ur-3610
No description available

WB:WBGene00050725	21ur-4866
No description available

WB:WBGene00050726	21ur-4895
No description available

WB:WBGene00050727	21ur-4894
No description available

WB:WBGene00050728	21ur-5182
No description available

WB:WBGene00050729	21ur-2478
No description available

WB:WBGene00050730	21ur-4692
No description available

WB:WBGene00050731	21ur-1573
No description available

WB:WBGene00050732	21ur-450
No description available

WB:WBGene00050733	21ur-5232
No description available

WB:WBGene00050734	21ur-1027
No description available

WB:WBGene00050735	21ur-2273
No description available

WB:WBGene00050736	21ur-4697
No description available

WB:WBGene00050737	21ur-3757
No description available

WB:WBGene00050738	21ur-502
No description available

WB:WBGene00050739	21ur-1717
No description available

WB:WBGene00050740	21ur-2053
No description available

WB:WBGene00050741	21ur-3459
No description available

WB:WBGene00050742	21ur-3025
No description available

WB:WBGene00050743	21ur-1510
No description available

WB:WBGene00050744	21ur-348
No description available

WB:WBGene00050745	21ur-831
No description available

WB:WBGene00050746	21ur-1990
No description available

WB:WBGene00050747	21ur-2523
No description available

WB:WBGene00050748	21ur-659
No description available

WB:WBGene00050749	21ur-2548
No description available

WB:WBGene00050750	21ur-3394
No description available

WB:WBGene00050751	21ur-5004
No description available

WB:WBGene00050752	21ur-2754
No description available

WB:WBGene00050753	21ur-652
No description available

WB:WBGene00050754	21ur-3582
No description available

WB:WBGene00050755	21ur-5390
No description available

WB:WBGene00050756	21ur-1404
No description available

WB:WBGene00050757	21ur-4294
No description available

WB:WBGene00050758	21ur-922
No description available

WB:WBGene00050759	21ur-2342
No description available

WB:WBGene00050760	21ur-2989
No description available

WB:WBGene00050761	21ur-1700
No description available

WB:WBGene00050762	21ur-3760
No description available

WB:WBGene00050763	21ur-5068
No description available

WB:WBGene00050764	21ur-686
No description available

WB:WBGene00050765	21ur-5311
No description available

WB:WBGene00050766	21ur-1365
No description available

WB:WBGene00050767	21ur-5130
No description available

WB:WBGene00050768	21ur-5032
No description available

WB:WBGene00050769	21ur-2689
No description available

WB:WBGene00050770	21ur-79
No description available

WB:WBGene00050771	21ur-2557
No description available

WB:WBGene00050772	21ur-883
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00050773	21ur-4507
No description available

WB:WBGene00050774	21ur-4838
No description available

WB:WBGene00050775	21ur-2214
No description available

WB:WBGene00050776	21ur-334
No description available

WB:WBGene00050777	21ur-5159
No description available

WB:WBGene00050778	21ur-4964
No description available

WB:WBGene00050779	21ur-4374
No description available

WB:WBGene00050780	21ur-3442
No description available

WB:WBGene00050781	21ur-5270
No description available

WB:WBGene00050782	21ur-2365
No description available

WB:WBGene00050783	21ur-2201
No description available

WB:WBGene00050784	21ur-587
No description available

WB:WBGene00050785	21ur-2178
No description available

WB:WBGene00050786	21ur-1271
No description available

WB:WBGene00050787	21ur-119
No description available

WB:WBGene00050788	21ur-4941
No description available

WB:WBGene00050789	21ur-4526
No description available

WB:WBGene00050790	21ur-4777
No description available

WB:WBGene00050791	21ur-2565
No description available

WB:WBGene00050792	21ur-440
No description available

WB:WBGene00050793	21ur-1980
No description available

WB:WBGene00050794	21ur-748
No description available

WB:WBGene00050795	21ur-2037
No description available

WB:WBGene00050796	21ur-386
No description available

WB:WBGene00050797	21ur-3504
No description available

WB:WBGene00050798	21ur-5154
No description available

WB:WBGene00050799	21ur-3691
No description available

WB:WBGene00050800	21ur-1114
No description available

WB:WBGene00050801	21ur-3051
No description available

WB:WBGene00050802	21ur-1605
No description available

WB:WBGene00050803	21ur-2542
No description available

WB:WBGene00050804	21ur-4504
No description available

WB:WBGene00050805	21ur-4333
No description available

WB:WBGene00050806	21ur-5443
No description available

WB:WBGene00050807	21ur-4516
No description available

WB:WBGene00050808	21ur-3070
No description available

WB:WBGene00050809	21ur-778
No description available

WB:WBGene00050810	21ur-3177
No description available

WB:WBGene00050811	21ur-4024
No description available

WB:WBGene00050812	21ur-4492
No description available

WB:WBGene00050813	21ur-891
No description available

WB:WBGene00050814	21ur-2986
No description available

WB:WBGene00050815	21ur-3991
No description available

WB:WBGene00050816	21ur-4709
No description available

WB:WBGene00050817	21ur-4583
No description available

WB:WBGene00050818	21ur-1551
No description available

WB:WBGene00050819	21ur-3841
No description available

WB:WBGene00050820	21ur-5160
No description available

WB:WBGene00050821	21ur-3234
No description available

WB:WBGene00050822	21ur-2682
No description available

WB:WBGene00050823	21ur-5039
No description available

WB:WBGene00050824	21ur-1908
No description available

WB:WBGene00050825	21ur-2545
No description available

WB:WBGene00050826	21ur-4455
No description available

WB:WBGene00050827	21ur-3483
No description available

WB:WBGene00050828	21ur-3487
No description available

WB:WBGene00050829	21ur-5405
No description available

WB:WBGene00050830	21ur-2444
No description available

WB:WBGene00050831	21ur-4533
No description available

WB:WBGene00050832	21ur-3006
No description available

WB:WBGene00050833	21ur-3278
No description available

WB:WBGene00050834	21ur-4719
No description available

WB:WBGene00050835	21ur-3461
No description available

WB:WBGene00050836	21ur-1568
No description available

WB:WBGene00050837	21ur-1890
No description available

WB:WBGene00050838	21ur-4252
No description available

WB:WBGene00050839	21ur-339
No description available

WB:WBGene00050840	21ur-1597
No description available

WB:WBGene00050841	21ur-317
No description available

WB:WBGene00050842	21ur-4034
No description available

WB:WBGene00050843	21ur-5219
No description available

WB:WBGene00050844	21ur-3402
No description available

WB:WBGene00050845	21ur-3514
No description available

WB:WBGene00050846	21ur-1733
No description available

WB:WBGene00050847	21ur-952
No description available

WB:WBGene00050848	21ur-5381
No description available

WB:WBGene00050849	21ur-5422
No description available

WB:WBGene00050850	21ur-3961
No description available

WB:WBGene00050851	21ur-2770
No description available

WB:WBGene00050852	21ur-2138
No description available

WB:WBGene00050853	21ur-4218
No description available

WB:WBGene00050854	21ur-1520
No description available

WB:WBGene00050855	21ur-671
No description available

WB:WBGene00050856	21ur-1215
No description available

WB:WBGene00050857	21ur-3116
No description available

WB:WBGene00050858	21ur-3063
No description available

WB:WBGene00050859	21ur-3263
No description available

WB:WBGene00050860	21ur-4211
No description available

WB:WBGene00050861	21ur-3412
No description available

WB:WBGene00050862	21ur-5288
No description available

WB:WBGene00050863	21ur-1576
No description available

WB:WBGene00050864	21ur-3508
No description available

WB:WBGene00050865	21ur-4862
No description available

WB:WBGene00050866	21ur-326
No description available

WB:WBGene00050867	21ur-979
No description available

WB:WBGene00050868	21ur-5023
No description available

WB:WBGene00050869	21ur-2916
No description available

WB:WBGene00050870	21ur-4922
No description available

WB:WBGene00050871	21ur-5108
No description available

WB:WBGene00050873	21ur-1607
No description available

WB:WBGene00050874	21ur-1635
No description available

WB:WBGene00050875	bah-1
Is predicted to have transferase activity, transferring glycosyl groups. Is expressed in seam cell.

WB:WBGene00050876	bah-2
No description available

WB:WBGene00050877	bah-3
No description available

WB:WBGene00050878	Y71A12C.3
Is affected by adr-1; mex-1; and spn-4 based on RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00050879	D1081.11
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; D-glucose; and antimycin based on microarray and RNA-seq studies.

WB:WBGene00050880	F32H2.12
Is affected by several genes including daf-2; eat-2; and bar-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Mianserin; multi-walled carbon nanotube; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00050881	ZK39.10
Is enriched in NSM and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by D-glucose; Colistin; and Triclosan based on RNA-seq and microarray studies.

WB:WBGene00050883	Y102A5C.38
Is affected by several genes including daf-16; eat-2; and sek-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00050884	Y69H2.15
Is enriched in AFD; body wall muscle cell; head mesodermal cell; and muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00050885	Y94H6A.12
Is predicted to have aminoacyl-tRNA hydrolase activity. Is an ortholog of human PTRHD1 (peptidyl-tRNA hydrolase domain containing 1).

WB:WBGene00050889	T04C12.9
Is enriched in BAG; GABAergic neurons; excretory cell; and neurons based on tiling array studies. Is affected by several genes including clk-1; alg-1; and drh-3 based on microarray and RNA-seq studies.

WB:WBGene00050890	F17C11.16
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00050891	C08E8.9
Is enriched in ASER and PLM based on RNA-seq studies. Is affected by hpl-2 based on tiling array studies.

WB:WBGene00050892	ttr-57
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; eat-2; and eri-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Transthyretin-like.

WB:WBGene00050893	Y94A7B.11
Is enriched in intestine based on RNA-seq studies. Is affected by clk-1 and mir-34 based on microarray studies. Is predicted to encode a protein with the following domains: Reactive mitochondrial oxygen species modulator 1 and Romo1/Mgr2. Is an ortholog of human ROMO1 (reactive oxygen species modulator 1).

WB:WBGene00050894	F49H6.15
Is affected by clk-1; daf-2; and eat-2 based on microarray studies. Is affected by tryptophan and Microcystin-LR based on microarray studies.

WB:WBGene00050896	ttr-56
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including antimycin; Cry5B; and Atrazine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Transthyretin-like family and Transthyretin-like.

WB:WBGene00050897	C47A10.13
No description available

WB:WBGene00050898	T19B10.12
Is affected by several genes including daf-2; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00050899	T10C6.15
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including sodium arsenite; Cadmium Chloride; and Sodium Chloride based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; F-box-like domain superfamily; and F-box A protein FB155/FB224.

WB:WBGene00050900	ZK228.11
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00050902	T26F2.4
No description available

WB:WBGene00050903	Y17D7C.4
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; Alovudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00050904	Y70C5A.3
Is enriched in head mesodermal cell and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including Tunicamycin; levamisole; and stavudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00050906	F20E11.17
Is enriched in dopaminergic neurons; excretory cell; and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray and RNA-seq studies. Is affected by ten chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00050907	Y51A2B.9
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including hpl-2; ain-1; and ain-2 based on tiling array; microarray; and RNA-seq studies. Is affected by tryptophan; antimycin; and Colistin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function and Domain of unknown function WSN.

WB:WBGene00050910	Y43F8B.17
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00050911	Y43F8B.18
Is affected by several genes including rrf-3; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00050912	F43E2.12
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including manganese chloride; Sodium Chloride; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00050913	T12B5.14
Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including Rotenone; Tunicamycin; and Mianserin based on RNA-seq and microarray studies.

WB:WBGene00050914	T12B5.15
Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by eleven chemicals including Ethanol; Rotenone; and Tunicamycin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00050915	Y6E2A.10
Is enriched in coelomocyte and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on tiling array; microarray; and RNA-seq studies. Is affected by thirteen chemicals including Ethanol; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00050916	F55F10.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including D-glucose; antimycin; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00050917	Y53G8AL.4
Is enriched in OLL; PVD; and neurons based on tiling array studies. Is affected by several genes including hsf-1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Crustacean CHH/MIH/GIH neurohormone family; Crustacean CHH/MIH/GIH neurohormone family; and Crustacean CHH/MIH/GIH neurohormone superfamily.

WB:WBGene00050918	mig-35
No description available

WB:WBGene00050919	C45G9.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on microarray and RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF851) and Protein of unknown function DUF851.

WB:WBGene00050920	Y54H5A.5
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including eat-2; hpl-2; and met-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00050921	mir-1019
Is affected by alg-5 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00050922	mir-1020
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00050923	mir-1021
No description available

WB:WBGene00050924	mir-1018
Is affected by several genes including eat-2; prg-1; and meg-3 based on RNA-seq studies. Is affected by nicotine and multi-walled carbon nanotube based on quantitative PCR and RNA-seq studies.

WB:WBGene00050926	B0250.11
Is affected by several genes including pgl-1; dpy-21; and glh-1 based on RNA-seq studies. Is affected by Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00050927	B0250.12
Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00050928	F49H6.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00050929	F58D12.5
Is enriched in ASER based on RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00050930	T08G5.13
No description available

WB:WBGene00050931	F59B2.14
Is enriched in NSM based on RNA-seq studies. Is predicted to encode a protein with the following domain: Zinc finger C2H2-type.

WB:WBGene00050932	F46B3.19
Is enriched in NSM and hypodermis based on tiling array studies. Is affected by several genes including clk-1; bar-1; and hsp-6 based on microarray and RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00050933	T19C9.9
Is affected by smn-1 based on RNA-seq studies. Is affected by Triclosan based on microarray studies.

WB:WBGene00050934	T19C9.10
Is predicted to have ATP binding activity and DNA helicase activity.

WB:WBGene00050935	Y37H2A.16
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00050936	ZK856.16
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including fog-2; pgl-1; and aak-2 based on tiling array; RNA-seq; microarray; and proteomic studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00050937	R02D5.8
Is enriched in germ line; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; pgl-1; and isp-1 based on tiling array; microarray; and RNA-seq studies. Is affected by seven chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ATP synthase subunit s, mitochondrial and Leucine-rich repeat domain superfamily. Is an ortholog of human DMAC2L (distal membrane arm assembly complex 2 like).

WB:WBGene00050938	F23H12.11
Is affected by clk-1 based on microarray studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00050939	C05G5.7
Is enriched in body wall muscle cell; hypodermis; and pharyngeal muscle cell based on tiling array studies. Is affected by several genes including daf-2; rrf-3; and sek-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including 1-methylnicotinamide; nicotinic acid; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00050940	C25D7.16
Is enriched in muscle cell and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00050941	C33F10.14
Is predicted to have NAD binding activity and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of human HTATIP2 (HIV-1 Tat interactive protein 2).

WB:WBGene00050943	ZC412.10
Is enriched in OLL; PVD; dopaminergic neurons; hypodermis; and in male based on tiling array and RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including 1-methylnicotinamide; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00050944	C14A11.9
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including pgl-1; isp-1; and fbf-1 based on RNA-seq; tiling array; and microarray studies. Is affected by five chemicals including Rotenone; Diazinon; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00050945	C45B11.7
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00050946	M162.12
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Ethanol; D-glucopyranose; and Rifampin based on RNA-seq studies.

WB:WBGene00050947	K07C5.13
Is affected by several genes including clk-1; eat-2; and prg-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00050948	Y48B6A.16
Is affected by several genes including pgl-1; dpy-21; and glh-1 based on RNA-seq studies. Is affected by four chemicals including Rotenone; stavudine; and metformin based on RNA-seq studies.

WB:WBGene00050949	K08G2.16
Is affected by clk-1 based on microarray studies.

WB:WBGene00050950	Y60A3A.28
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00050951	T26H2.11
Is affected by clk-1; daf-2; and eat-2 based on microarray studies.

WB:WBGene00050954	K06B4.14
Is affected by several genes including daf-2; eat-2; and isp-1 based on microarray studies. Is affected by Hydrolyzable Tannins; paraquat; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00050955	C14A6.12
Is enriched in NSM based on tiling array studies. Is affected by drh-3; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by nanoparticle; resveratrol; and Colistin based on microarray studies.

WB:WBGene00050956	C14A6.13
Is enriched in body wall muscle cell and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Tunicamycin; manganese chloride; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00050957	C10A4.10
Is enriched in Z1; Z4; hypodermis; intestine; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by eight chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00050958	F28B1.10
No description available

WB:WBGene00050959	F26F2.9
Is affected by bar-1; mir-34; and mir-35 based on microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00050960	T03E6.10
No description available

WB:WBGene00050961	T03E6.11
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by tetrabromobisphenol A and Microcystin-LR based on microarray studies.

WB:WBGene00050962	F49A5.11
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00050963	ZK218.15
No description available

WB:WBGene00050964	Y50E8A.18
Is affected by hpl-2; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00050965	F49H6.17
No description available

WB:WBGene00050967	C25F9.15
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by antimycin and nitroguanidine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00050968	R11G10.4
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including rrf-3; hpl-2; and drh-3 based on tiling array and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00050970	D2023.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; sek-1; and hpl-2 based on RNA-seq studies. Is affected by metformin based on RNA-seq studies.

WB:WBGene00050971	F11D11.15
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00050972	T23D5.13
Is affected by daf-2 and sir-2.1 based on microarray studies.

WB:WBGene00050973	Y26G10.3
Is enriched in male based on RNA-seq studies. Is affected by dpy-21 and let-60 based on RNA-seq and microarray studies.

WB:WBGene00050974	Y6G8.9
Is enriched in ASER; PLM; and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00050976	F28B1.11
Is affected by clk-1 based on microarray studies.

WB:WBGene00050977	F56H9.7
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00050978	som-1
No description available

WB:WBGene00050980	som-3
No description available

WB:WBGene00050981	som-4
No description available

WB:WBGene00077434	F46B3.20
Is enriched in AVK based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00077436	F46B3.22
Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Atrazine; and Colistin based on RNA-seq and microarray studies.

WB:WBGene00077437	Y59H11AR.6
Is affected by several genes including daf-16; glp-1; and rrf-3 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077438	C18D4.10
Is affected by clk-1; hmg-3; and smn-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00077439	F55B12.10
Is enriched in several structures, including germ line; interfacial epithelial cell; male distal tip cell; mechanosensory neurons; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077440	Y75B12B.14
Is affected by clk-1 and hmg-3 based on microarray and RNA-seq studies.

WB:WBGene00077441	C43D7.10
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077442	F11D11.16
No description available

WB:WBGene00077443	Y71A12B.19
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077444	F54B8.17
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00077445	Y51A2A.12
Is enriched in body wall muscle cell; dopaminergic neurons; and hypodermis based on tiling array studies. Is affected by several genes including daf-2; eat-2; and tax-6 based on RNA-seq and microarray studies.

WB:WBGene00077446	F49A5.12
Is affected by pmk-1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00077447	C14A6.14
Is affected by clk-1 and his-3 based on microarray and RNA-seq studies.

WB:WBGene00077448	D1086.20
Is affected by several genes including hsf-1; sma-2; and sma-4 based on RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077449	C08B6.15
Is affected by tatn-1 and daf-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077450	K06B4.15
Is enriched in amphid sheath cell; germ line; hypodermis; and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by nine chemicals including manganese chloride; D-glucose; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00077451	Y69H2.16
Is affected by adr-1; eat-2; and daf-2 based on RNA-seq and microarray studies. Is affected by nitroguanidine based on microarray studies.

WB:WBGene00077452	Y62F5A.11
Is affected by clk-1 based on microarray studies.

WB:WBGene00077453	Y62F5A.12
Is enriched in AFD; ASER; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq studies.

WB:WBGene00077454	Y17D7C.5
No description available

WB:WBGene00077455	Y69H2.17
Is enriched in AVK and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-12; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CUB domain; CUB domain; and Spermadhesin, CUB domain superfamily.

WB:WBGene00077456	T23D5.14
No description available

WB:WBGene00077457	Y39B6A.49
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and hsp-6 based on RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077459	Y6G8.10
No description available

WB:WBGene00077460	Y6G8.11
Is affected by Colistin based on microarray studies.

WB:WBGene00077461	F12F6.11
Is affected by several genes including daf-2; prg-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00077462	JC8.15
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00077463	T03E6.12
Is affected by clk-1 based on microarray studies.

WB:WBGene00077464	Y70C5B.2
Is affected by pmt-2 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00077465	rrn-4.2
Is affected by ham-3; swsn-2.2; and hpl-2 based on RNA-seq studies.

WB:WBGene00077466	rrn-4.3
Is affected by clk-1 and pptr-1 based on microarray and RNA-seq studies.

WB:WBGene00077467	rrn-4.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00077468	rrn-4.5
No description available

WB:WBGene00077469	rrn-4.6
No description available

WB:WBGene00077470	rrn-4.7
No description available

WB:WBGene00077471	rrn-4.8
No description available

WB:WBGene00077472	rrn-4.9
No description available

WB:WBGene00077473	rrn-4.10
No description available

WB:WBGene00077474	rrn-4.11
No description available

WB:WBGene00077475	rrn-4.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00077476	rrn-4.13
No description available

WB:WBGene00077477	rrn-4.14
No description available

WB:WBGene00077478	sls-1.1
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00077479	sls-1.2
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00077480	sls-1.3
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00077481	sls-1.4
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00077482	sls-1.5
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00077483	sls-1.6
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00077484	sls-1.7
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00077485	sls-1.8
Is affected by several genes including daf-16; sek-1; and pgl-1 based on RNA-seq studies.

WB:WBGene00077486	sls-1.9
Is affected by several genes including daf-16; daf-2; and sek-1 based on RNA-seq and microarray studies.

WB:WBGene00077487	sls-1.11
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00077488	sls-1.12
Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077489	C04G6.13
Is enriched in body wall muscle cell based on tiling array studies. Is affected by several genes including clk-1; pmk-1; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including sodium arsenite; D-glucose; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00077490	M03A1.8
Is enriched in amphid sheath cell and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twenty-nine chemicals including Rotenone; Tunicamycin; and manganese chloride based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in early infantile epileptic encephalopathy 37. Is predicted to encode a protein with the following domains: Eukaryotic cytochrome b561 and Cytochrome b561/ferric reductase transmembrane. Is an ortholog of human FRRS1 (ferric chelate reductase 1).

WB:WBGene00077491	K08H10.10
Is enriched in PLM; dopaminergic neurons; intestine; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucose; Alovudine; and allantoin based on RNA-seq studies.

WB:WBGene00077492	F09C6.15
Is affected by ubc-9 based on microarray studies. Is affected by Tunicamycin based on microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00077493	F09C6.16
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00077494	F28B1.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077495	Y20C6A.4
Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00077496	F11A3.4
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by daf-2 and sir-2.1 based on microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077497	K06A4.10
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00077498	R07B5.10
Is affected by clk-1; dlc-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00077499	T11A5.8
No description available

WB:WBGene00077500	C27H6.9
Is predicted to have single-stranded DNA exodeoxyribonuclease activity. Human ortholog(s) of this gene are implicated in mitochondrial DNA depletion syndrome 11. Is an ortholog of human MGME1 (mitochondrial genome maintenance exonuclease 1).

WB:WBGene00077501	K08H10.11
Is affected by several genes including hpl-2; hmg-4; and spt-16 based on RNA-seq studies.

WB:WBGene00077502	AC3.11
No description available

WB:WBGene00077503	AC3.12
Is predicted to have transmembrane receptor protein serine/threonine kinase activity.

WB:WBGene00077504	AC3.13
Is affected by several genes including daf-16; clk-1; and hsp-6 based on microarray and RNA-seq studies.

WB:WBGene00077506	F25D1.7
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00077508	T27F6.10
Is enriched in AVA and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077510	Y42A5A.6
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00077514	F07B10.7
Is affected by clk-1; drh-3; and hpl-2 based on microarray and RNA-seq studies. Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00077515	E01A2.9
Is affected by several genes including clk-1; pgl-1; and dpy-21 based on microarray and RNA-seq studies.

WB:WBGene00077516	C50C3.13
Is affected by several genes including clk-1; prg-1; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00077517	C50C3.14
Is affected by cep-1 and sftb-1 based on RNA-seq studies.

WB:WBGene00077519	T27C10.8
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including Rotenone; Sodium Chloride; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077520	C37A5.11
Is enriched in muscle cell; neurons; pharynx; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and prg-1 based on RNA-seq and microarray studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00077521	maf-1
Is predicted to have DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Human ortholog(s) of this gene are implicated in several diseases, including Ayme-Gripp syndrome; cataract 21 multiple types; and multicentric carpotarsal osteolysis syndrome. Is an ortholog of human MAFF (MAF bZIP transcription factor F) and MAFK (MAF bZIP transcription factor K).

WB:WBGene00077522	T10D4.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00077523	C23H5.12
Is affected by several genes including hsf-1; hpl-2; and met-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00077524	F36D1.11
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00077525	C41G7.8
Is enriched in head mesodermal cell; intestine; neurons; and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077526	C25A1.16
Is enriched in ASER; germ line; intestine; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077527	C25A1.17
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077528	Y26D4A.20
No description available

WB:WBGene00077529	jud-1
No description available

WB:WBGene00077530	jud-2
No description available

WB:WBGene00077531	F40G9.15
Is enriched in hypodermis; male-specific anatomical entity; and in male based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by thirteen chemicals including 1-methylnicotinamide; Mianserin; and multi-walled carbon nanotube based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077532	jud-3
No description available

WB:WBGene00077534	F41D3.14
Is affected by ahr-1 based on RNA-seq studies.

WB:WBGene00077535	F15H9.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00077536	F38B7.10
Is affected by several genes including dpy-7; alg-1; and mex-3 based on RNA-seq and microarray studies. Is affected by Tunicamycin and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00077537	Y47H10A.6
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and sma-4 based on RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00077538	T04F3.5
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including sek-1; hpl-2; and ubc-9 based on tiling array; microarray; and RNA-seq studies. Is affected by tryptophan; Tunicamycin; and allantoin based on microarray studies.

WB:WBGene00077539	Y52B11A.12
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and sek-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Mianserin; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00077540	lsy-23
No description available

WB:WBGene00077541	lsy-24
No description available

WB:WBGene00077543	F27D4.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including pgl-1; aak-2; and mex-3 based on tiling array and RNA-seq studies. Is affected by seven chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies.

WB:WBGene00077546	C01A2.9
Is affected by several genes including elt-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077548	F21C3.7
Is enriched in intestine; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on tiling array; microarray; and RNA-seq studies. Is affected by six chemicals including D-glucose; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077549	F11A6.3
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077550	Y106G6G.8
No description available

WB:WBGene00077551	H15N14.3
Is affected by eat-2 based on microarray studies.

WB:WBGene00077552	H15N14.4
Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00077553	C26C6.10
Is enriched in OLL; PVD; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including elt-2; sir-2.1; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Tunicamycin; Zidovudine; and Colistin based on microarray and RNA-seq studies.

WB:WBGene00077555	F28C12.8
Is affected by clk-1 based on microarray studies.

WB:WBGene00077556	Y18D10A.27
Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00077557	F15D3.9
Is enriched in amphid sheath cell and germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Tunicamycin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077558	T06D10.3
Is affected by several genes including daf-2; mex-1; and smg-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and stavudine based on RNA-seq studies.

WB:WBGene00077559	R05D7.7
Is enriched in AFD; excretory cell; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including aak-2; dpy-21; and alg-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00077561	W05H12.3
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies. Is affected by Psoralens and allantoin based on RNA-seq studies.

WB:WBGene00077562	ZC443.7
Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srbc and 7TM GPCR, serpentine receptor class bc (Srbc).

WB:WBGene00077563	peel-1
Is expressed in spermatocyte.

WB:WBGene00077564	C44H9.9
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00077565	W07G4.7
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies. Is affected by tryptophan and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077566	C34B4.6
Is affected by clk-1 based on microarray studies.

WB:WBGene00077567	Y2H9A.5
No description available

WB:WBGene00077568	C56A3.10
Is affected by several genes including daf-16; smg-2; and met-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077569	F53F4.18
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077570	F55B12.11
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00077571	T26F2.5
No description available

WB:WBGene00077572	T08G5.14
Is affected by several genes including lin-35; alg-1; and lagr-1 based on RNA-seq and microarray studies.

WB:WBGene00077573	T08G5.15
Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00077574	T08G5.16
Is affected by eat-2; ints-8; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077575	F14D7.16
Is affected by eat-2 based on microarray studies.

WB:WBGene00077576	C15H11.13
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including rrf-3; npr-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including tryptophan; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00077577	R02D5.9
Is enriched in muscle cell and neurons based on microarray studies. Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00077579	R11H6.7
Is enriched in male based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077580	R08A2.8
No description available

WB:WBGene00077581	H12D21.16
Is affected by adr-1 and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Hydrolyzable Tannins based on RNA-seq and microarray studies.

WB:WBGene00077582	F14H8.8
Is enriched in germ line and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00077583	C01G10.18
Is enriched in NSM; body wall musculature; and germline precursor cell based on tiling array and microarray studies. Is affected by several genes including drh-3; ain-2; and crh-1 based on RNA-seq and microarray studies. Is affected by resveratrol; adsorbable organic bromine compound; and Sirolimus based on microarray studies.

WB:WBGene00077584	C01G10.19
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00077585	T01G5.8
Is enriched in germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00077586	T09F5.17
No description available

WB:WBGene00077588	T26H8.5
Is affected by drh-3; thoc-5; and daf-2 based on RNA-seq and microarray studies. Is affected by Triclosan based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077589	R08H2.15
No description available

WB:WBGene00077590	R08H2.16
Is affected by clk-1 based on microarray studies.

WB:WBGene00077592	T25B2.3
Is affected by several genes including clk-1; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by stavudine; Zidovudine; and Colistin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00077593	C49G7.12
Is enriched in several structures, including GABAergic neurons; cephalic sheath cell; ciliated neurons; coelomocyte; and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by twenty-one chemicals including Nitric Oxide; 1-methylnicotinamide; and D-glucopyranose based on RNA-seq and microarray studies.

WB:WBGene00077594	nhr-151
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077595	K06B4.16
Is affected by clk-1 based on microarray studies.

WB:WBGene00077596	K06B4.17
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077597	T23D5.15
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00077598	T23D5.16
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077599	T20F5.8
Is enriched in male based on RNA-seq studies. Is affected by hpl-2; daf-2; and daf-16 based on tiling array and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; D-glucose; and Psoralens based on RNA-seq studies.

WB:WBGene00077600	F54B8.18
Is affected by clk-1 based on microarray studies.

WB:WBGene00077601	T06C12.17
Is affected by daf-19 based on microarray studies. Is affected by Ag nanoparticles based on microarray studies.

WB:WBGene00077602	F35E8.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00077603	T05G11.9
No description available

WB:WBGene00077604	H24D24.3
No description available

WB:WBGene00077605	F36G9.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00077606	C06C6.10
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00077607	T10C6.16
Is enriched in NSM and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and mex-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077608	F22B8.9
Is affected by clk-1 based on microarray studies.

WB:WBGene00077609	F44G3.15
Is affected by clk-1 based on microarray studies.

WB:WBGene00077610	F44G3.16
No description available

WB:WBGene00077611	F11A5.19
Is affected by ints-5 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00077612	F21H7.15
No description available

WB:WBGene00077613	F21H7.16
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00077614	C31A11.12
Is affected by clk-1 based on microarray studies.

WB:WBGene00077615	T08G3.14
No description available

WB:WBGene00077616	F57E7.4
Is enriched in AVE and amphid sheath cell based on tiling array and RNA-seq studies. Is affected by several genes including clk-1; mex-3; and mex-1 based on tiling array; RNA-seq; and microarray studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077617	F57E7.5
No description available

WB:WBGene00077618	F57E7.6
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077619	F36D3.15
Is affected by hrpr-1 and hpl-2 based on RNA-seq studies.

WB:WBGene00077620	W06G6.16
Is affected by several genes including daf-16; daf-12; and clk-1 based on microarray and RNA-seq studies.

WB:WBGene00077621	Y70C5C.8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077622	T25E12.14
Is affected by alg-1; hmg-3; and adr-1 based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077624	Y102A5C.40
Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077625	Y102A5C.41
No description available

WB:WBGene00077626	Y102A5C.42
No description available

WB:WBGene00077627	T19C9.11
Is affected by clk-1 and smn-1 based on microarray and RNA-seq studies.

WB:WBGene00077629	K10G4.13
Is affected by several genes including glp-1; skn-1; and hsf-1 based on RNA-seq studies. Is affected by seven chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00077630	F31E9.10
No description available

WB:WBGene00077631	T27C5.15
Is affected by resveratrol based on microarray studies.

WB:WBGene00077632	T27C5.16
Is affected by clk-1 based on microarray studies. Is affected by Progesterone based on microarray studies.

WB:WBGene00077633	T27C5.17
No description available

WB:WBGene00077634	Y46G5A.41
Is affected by dpy-21; ain-1; and ain-2 based on RNA-seq and microarray studies.

WB:WBGene00077635	Y46G5A.42
Is affected by clk-1 and eat-2 based on microarray and RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00077636	Y46G5A.43
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077637	Y6G8.12
No description available

WB:WBGene00077638	Y6G8.13
Is affected by clk-1; hrpr-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077640	Y26G10.4
Is affected by drh-3 based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077641	Y94A7B.12
Is affected by several genes including clk-1; pgl-1; and glh-1 based on microarray and RNA-seq studies.

WB:WBGene00077642	C14A6.15
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077643	trpp-1
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including hsf-1; lin-28; and jmjd-3.1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Sybindin-like family; Trafficking protein particle complex subunit; and Longin-like domain superfamily. Is an ortholog of human TRAPPC1 (trafficking protein particle complex 1).

WB:WBGene00077644	Y37H2C.5
No description available

WB:WBGene00077646	Y51A2A.14
Is affected by Sirolimus based on microarray studies.

WB:WBGene00077647	Y51A2A.15
No description available

WB:WBGene00077648	Y51A2B.10
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00077649	Y51A2B.11
Is affected by adr-1; eat-2; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00077650	ZK262.14
No description available

WB:WBGene00077651	ZK262.15
Is affected by clk-1 and smn-1 based on microarray and RNA-seq studies.

WB:WBGene00077652	ZK228.12
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Alovudine; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00077653	Y51A2D.23
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00077654	Y69H2.18
Is affected by clk-1 based on microarray studies.

WB:WBGene00077655	asp-19
Is predicted to have aspartic-type endopeptidase activity. Human ortholog(s) of this gene are implicated in familial juvenile hyperuricemic nephropathy. Is an ortholog of human BACE1 (beta-secretase 1).

WB:WBGene00077656	F11D11.17
No description available

WB:WBGene00077657	F11D11.18
Is affected by several genes including clk-1; sir-2.1; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00077658	M106.8
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by several genes including dpy-10; gld-1; and pgl-1 based on RNA-seq; microarray; and proteomic studies. Is affected by five chemicals including stavudine; Zidovudine; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00077659	F11D11.19
Is affected by several genes including daf-2; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by dafa#1 and Sirolimus based on microarray studies.

WB:WBGene00077660	Y17D7B.9
Is affected by daf-16; sir-2.1; and spg-7 based on RNA-seq and microarray studies. Is affected by Cry5B and Sirolimus based on microarray studies.

WB:WBGene00077662	T26H2.12
Is affected by chd-3 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00077663	F55C9.14
Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00077664	C43D7.11
Is affected by several genes including daf-2; eat-2; and let-418 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077666	M162.13
No description available

WB:WBGene00077667	M162.14
No description available

WB:WBGene00077669	Y38H6A.5
Is enriched in AFD; amphid sheath cell; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by stavudine; Zidovudine; and adsorbable organic bromine compound based on RNA-seq and microarray studies.

WB:WBGene00077670	K02E2.9
Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077671	K02E2.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00077672	B0250.13
No description available

WB:WBGene00077673	B0563.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and elt-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin; Alovudine; and tert-Butylhydroperoxide based on microarray and RNA-seq studies.

WB:WBGene00077674	K02A6.4
Is enriched in AFD and amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies.

WB:WBGene00077675	cin-1
No description available

WB:WBGene00077676	cin-2
No description available

WB:WBGene00077677	cin-3
No description available

WB:WBGene00077678	cin-5
No description available

WB:WBGene00077679	K11E4.6
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00077680	F54F7.10
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and alg-1 based on microarray and RNA-seq studies. Is affected by five chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Skp1 family, tetramerisation domain; S-phase kinase-associated protein 1-like; SKP1/BTB/POZ domain superfamily; SKP1 component, POZ domain; and Elongin-C. Is an ortholog of human ELOC (elongin C).

WB:WBGene00077681	Y44A6D.7
Is enriched in neurons and ventral nerve cord based on tiling array studies. Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00077682	F58B4.7
Is affected by several genes including hsf-1; pgl-1; and aak-2 based on RNA-seq studies. Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00077684	Y26D4A.21
Is enriched in intestine and pharyngeal muscle cell based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on microarray and RNA-seq studies. Is affected by thirteen chemicals including Tunicamycin; multi-walled carbon nanotube; and D-glucose based on microarray and RNA-seq studies.

WB:WBGene00077685	C04F12.12
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on tiling array; RNA-seq; and microarray studies. Is affected by four chemicals including D-glucose; Zidovudine; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00077686	T26E3.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077687	Y52B11A.14
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on RNA-seq studies. Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00077688	Y43F8B.19
Is predicted to contribute to procollagen-proline 4-dioxygenase activity.

WB:WBGene00077689	Y105E8A.34
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including let-60; rrf-3; and sek-1 based on microarray and RNA-seq studies. Is affected by four chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and Rifampin based on RNA-seq studies.

WB:WBGene00077690	mtp-18
Is enriched in ASER; body wall muscle cell; intestine; and muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including D-glucose; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial 18 KDa protein (MTP18) and Mitochondrial 18kDa protein. Is an ortholog of human MTFP1 (mitochondrial fission process 1).

WB:WBGene00077691	T06E4.14
Is enriched in hypodermis; intestine; and pharyngeal muscle cell based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-16; skn-1; and rrf-3 based on tiling array; RNA-seq; and microarray studies. Is affected by seventeen chemicals including Ethanol; methylmercury hydroxide; and 1-methylnicotinamide based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077692	C08E8.10
Is enriched in several structures, including PLM; cephalic sheath cell; dopaminergic neurons; germline precursor cell; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; sodium arsenite; and multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077693	T04C12.11
Is enriched in AFD; ASER; PLM; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077694	C43D7.12
Is affected by dpy-21 based on RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00077695	F14D7.17
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00077696	marc-1
Is predicted to have ubiquitin-protein transferase activity.

WB:WBGene00077697	F58E6.13
Is enriched in PLM; RIS; head mesodermal cell; hypodermis; and somatic gonad precursor based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on microarray; proteomic; tiling array; and RNA-seq studies. Is affected by twenty-five chemicals including Nitric Oxide; methylmercury hydroxide; and nicotinic acid based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in spondylocostal dysostosis. Is predicted to encode a protein with the following domains: Putative ephrin-receptor like; EGF domain; EGF-like domain; EGF-like domain; Growth factor receptor cysteine-rich domain superfamily; Tyrosine-protein kinase ephrin type A/B receptor-like; and EGF domain.

WB:WBGene00077698	lurp-4
Is enriched in head mesodermal cell and neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and elt-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including 1-methylnicotinamide; multi-walled carbon nanotube; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ly-6 antigen/uPA receptor-like.

WB:WBGene00077699	C45B11.8
Is enriched in AVK; germ line; and pharynx based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including D-glucose; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077700	sex-2
Is involved in negative regulation of transcription by RNA polymerase II and primary sex determination.

WB:WBGene00077701	poml-3
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by seventeen chemicals including manganese chloride; D-glucose; and 4-bromodiphenyl ether based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: SMP-30/Gluconolactonase/LRE-like region; Six-bladed beta-propeller, TolB-like; and SMP-30/Gluconolactonase/LRE-like region. Is an ortholog of human PON3 (paraoxonase 3).

WB:WBGene00077703	K08E5.5
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-12; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00077704	F12A10.9
Is affected by several genes including rrf-3; eat-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by six chemicals including Sirolimus; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077705	mir-1829.1
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00077706	mir-1829.2
Is affected by several genes including eat-2; alg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR and RNA-seq studies.

WB:WBGene00077707	mir-1829.3
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00077708	mir-1817
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00077709	mir-1822
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00077712	nipi-4
Is predicted to have ATP binding activity and protein kinase activity. Is involved in defense response to fungus; positive regulation of gene expression; and response to wounding. Is expressed in hypodermis.

WB:WBGene00077713	nipi-5
No description available

WB:WBGene00077714	R102.11
Is enriched in AFD; PLM; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; skn-1; and rrf-3 based on RNA-seq and microarray studies. Is affected by nine chemicals including Mianserin; D-glucose; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077715	mir-1818
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00077716	mir-1819
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077717	mir-1823
Is affected by alg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077718	mir-1824
Is affected by several genes including alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00077719	mir-1828
Is affected by alg-5 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00077720	mir-1833
Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00077721	mir-1022
Is expressed in sensory neurons; uterus; and vulva.

WB:WBGene00077722	mir-58.2
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq studies. Is affected by nicotine and graphene oxide based on quantitative PCR and RNA-seq studies.

WB:WBGene00077723	mir-1830
Is affected by several genes including eat-2; glp-4; and alg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00077724	mir-1831
No description available

WB:WBGene00077725	mir-1832.1
Is affected by several genes including eat-2; glp-4; and prg-1 based on RNA-seq studies.

WB:WBGene00077726	mir-1820
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine and graphene oxide based on quantitative PCR and RNA-seq studies.

WB:WBGene00077727	mir-1821
Is expressed in ASEL; ASER; and head neurons.

WB:WBGene00077728	T23G11.11
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-16; pgl-1; and glh-1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; D-glucose; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00077729	szy-1
Is involved in several processes, including cell division; centrosome cycle; and regulation of centrosome duplication.

WB:WBGene00077731	szy-3
Is involved in regulation of centrosome duplication.

WB:WBGene00077732	szy-4
Is involved in regulation of centrosome duplication.

WB:WBGene00077735	szy-7
Is involved in regulation of centrosome duplication.

WB:WBGene00077736	szy-8
Is involved in embryo development and regulation of centrosome duplication.

WB:WBGene00077737	szy-9
Is involved in regulation of centrosome duplication.

WB:WBGene00077739	szy-11
Is involved in meiotic chromosome segregation and regulation of centrosome duplication.

WB:WBGene00077740	szy-12
Is involved in regulation of centrosome duplication.

WB:WBGene00077742	szy-14
Is involved in regulation of centrosome duplication.

WB:WBGene00077743	szy-15
Is involved in embryo development and regulation of centrosome duplication.

WB:WBGene00077744	szy-16
Is involved in regulation of centrosome duplication.

WB:WBGene00077745	szy-17
Is involved in meiotic chromosome segregation and regulation of centrosome duplication.

WB:WBGene00077746	szy-18
Is involved in cell division; centrosome cycle; and regulation of centrosome duplication.

WB:WBGene00077747	szy-19
Is involved in regulation of centrosome duplication.

WB:WBGene00077750	W01B6.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077751	irld-27
Is affected by several genes including daf-16; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00077752	Y105C5A.508
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including allantoin; metformin; and Psoralens based on RNA-seq studies.

WB:WBGene00077753	R13.6
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies.

WB:WBGene00077754	Y116A8C.199
No description available

WB:WBGene00077755	Y40H7A.147
Is enriched in intestine based on RNA-seq studies. Is affected by clk-1; hsf-1; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00077756	Y11D7A.19
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including 1-methylnicotinamide; Mianserin; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00077757	E02H4.7
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including Rotenone; manganese chloride; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077758	irld-12
Is affected by Chlorpyrifos based on microarray studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00077759	irld-51
Is affected by hpl-2 based on tiling array studies. Is predicted to encode a protein with the following domains: Receptor L domain; Receptor L-domain; and Receptor L-domain superfamily.

WB:WBGene00077761	zip-9
Is predicted to have DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II regulatory region sequence-specific DNA binding activity.

WB:WBGene00077762	Y57G11C.499
Is enriched in germline precursor cell; head mesodermal cell; and intestine based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including clk-1; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00077763	glb-34
Is predicted to have several functions, including heme binding activity; oxygen binding activity; and oxygen carrier activity. Human ortholog(s) of this gene are implicated in hemolytic anemia (multiple); primary polycythemia (multiple); and sickle cell anemia. Is an ortholog of human CYGB (cytoglobin).

WB:WBGene00077764	F59C6.16
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by seventeen chemicals including 1-methylnicotinamide; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00077765	T20F10.8
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077766	rgba-1
Is expressed in cephalic sheath cell; ray; ray structural cell; and socket cell.

WB:WBGene00077767	F22D6.17
Is affected by clk-1; daf-16; and daf-2 based on microarray and RNA-seq studies.

WB:WBGene00077768	K04G2.12
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00077769	F33E2.10
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00077770	M04D5.3
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; glp-1; and dpy-10 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00077771	C41G7.9
Is enriched in NSM and germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray; RNA-seq; and proteomic studies. Is affected by five chemicals including Rotenone; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: TspO/MBR family; TspO/MBR-related protein; and TspO/MBR-related superfamily. Is an ortholog of human TSPO (translocator protein) and TSPO2 (translocator protein 2).

WB:WBGene00077772	T02G6.10
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; multi-walled carbon nanotube; and metformin based on RNA-seq studies.

WB:WBGene00077773	F25H5.10
Is enriched in intestine based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and dpy-21 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00077775	nlp-58
Is enriched in BAG; head mesodermal cell; neurons; and ventral nerve cord based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00077778	dopy-3
No description available

WB:WBGene00077779	dopy-5
No description available

WB:WBGene00077780	dopy-6
No description available

WB:WBGene00077781	F40E3.7
Is affected by several genes including daf-16; hpl-2; and smg-2 based on tiling array and RNA-seq studies. Is affected by Sodium Chloride and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00077782	T26H10.2
Is enriched in neurons and in male based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00077783	D1054.18
Is enriched in intestine based on tiling array studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on tiling array; RNA-seq; and microarray studies. Is affected by ten chemicals including Rotenone; multi-walled carbon nanotube; and Alovudine based on RNA-seq and microarray studies.

WB:WBGene00077784	F35C8.9
Is enriched in AVK based on RNA-seq studies. Is affected by hpl-2; hmg-3; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00077785	F35E2.11
Is enriched in male based on RNA-seq studies. Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00077786	F53F8.7
Is enriched in NSM; dopaminergic neurons; muscle cell; and neurons based on tiling array and RNA-seq studies. Is affected by several genes including pgl-1; csr-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Psoralens; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00077787	T05E12.10
Is enriched in NSM and germ line based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and pgl-1 based on tiling array; RNA-seq; and microarray studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00077788	W07G4.8
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; alg-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by Cry5B; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00077789	Y26D4A.22
Is affected by daf-2 and smn-1 based on microarray and RNA-seq studies.

WB:WBGene00086546	cil-1
Is predicted to have phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity. Is involved in positive regulation of flagellated sperm motility and regulation of brood size. Localizes to several cellular components, including dendrite; neuronal cell body; and non-motile cilium. Is expressed in PVDL and PVDR. Human ortholog(s) of this gene are implicated in several diseases, including Parkinson's disease 20; X-linked recessive disease (multiple); and congenital muscular dystrophy with cataracts and intellectual disability. Is an ortholog of human INPP5K (inositol polyphosphate-5-phosphatase K).

WB:WBGene00086547	cil-2
No description available

WB:WBGene00086548	cil-3
No description available

WB:WBGene00086550	cil-5
No description available

WB:WBGene00086551	D2005.7
Is enriched in germ line; germline precursor cell; head mesodermal cell; and pharynx based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00086552	C17D12.9
Is affected by hpl-2 and dpy-21 based on tiling array and RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00086553	ZC334.13
Is enriched in neurons based on tiling array studies. Is affected by several genes including prg-1; unc-70; and spc-1 based on microarray and RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00086554	D1081.12
Is predicted to have GTP binding activity.

WB:WBGene00086555	F49B2.7
Is enriched in neurons based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00086556	F36D1.12
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by daf-16 and ints-4 based on RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00086557	K07A12.8
Is enriched in AFD; ASER; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; pgl-1; and aak-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00086558	F12E12.12
Is enriched in Z1.p; Z4.a; carbon dioxide sensory neurons; male distal tip cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including skn-1; clk-1; and eat-2 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including tryptophan; Sodium Chloride; and Rifampin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including Leber congenital amaurosis 13; apparent mineralocorticoid excess syndrome; and autosomal recessive congenital ichthyosis 13.

WB:WBGene00086559	Y43F8B.20
Is enriched in DA neuron; VA neuron; neurons; and pharynx based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including daf-2; eat-2; and mir-34 based on RNA-seq and microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00086560	ZK355.8
Is enriched in dopaminergic neurons and intestine based on tiling array studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00086561	K01A2.12
Is enriched in DA neuron; GABAergic neurons; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-16; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Cry5B; Quercetin; and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00086562	T02G6.11
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00086563	K08C9.9
Is enriched in NSM based on tiling array studies. Is affected by clk-1; dpy-21; and sir-2.1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00086564	K08C9.10
Is affected by let-7; gld-1; and pmt-2 based on proteomic and microarray studies.

WB:WBGene00086565	W06G6.17
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00086566	C08H9.16
Is enriched in germ line and germline precursor cell based on RNA-seq studies. Is affected by several genes including daf-2; sek-1; and alg-1 based on RNA-seq and proteomic studies. Is affected by Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Folate-sensitive fragile site protein Fra10Ac1 and Folate-sensitive fragile site protein Fra10Ac1. Is an ortholog of human FRA10AC1 (FRA10A associated CGG repeat 1).

WB:WBGene00086567	C05C10.8
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and nhl-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00086568	Y2H9A.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on tiling array; microarray; and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00086569	F38A6.5
Is enriched in OLL; PVD; body wall muscle cell; and head mesodermal cell based on tiling array and RNA-seq studies. Is affected by several genes including glp-1; daf-12; and sek-1 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00119201	C08E8.11
Is affected by several genes including eat-2; ain-1; and nhl-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00119202	epa-18
No description available

WB:WBGene00119203	T04A8.18
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; rrf-3; and lin-35 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00119204	ZC116.5
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Sodium Chloride; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00138711	R07B1.13
Is enriched in AFD; PLM; coelomocyte; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by fourteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and D-glucose based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: C6 domain and C6 domain.

WB:WBGene00138714	T02D1.9
Is enriched in neurons based on microarray studies. Is affected by dibromoacetic acid based on microarray studies.

WB:WBGene00138715	Y6G8.14
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00138716	F17B5.10
Is predicted to have carbohydrate binding activity.

WB:WBGene00138717	F52C12.6
Is predicted to have protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in Galloway-Mowat syndrome 4. Is an ortholog of human TP53RK (TP53 regulating kinase).

WB:WBGene00138719	F26F2.10
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; Cry5B; and glycine based on RNA-seq and microarray studies.

WB:WBGene00138720	F58H1.8
Is enriched in AFD; germ line; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Sirolimus; and multi-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00138721	pals-37
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Ethanol; stavudine; and Sodium Chloride based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Centrosome and spindle pole associated protein 1.

WB:WBGene00138724	F15B9.11
Is affected by several genes including daf-2; clk-1; and elt-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Tunicamycin; multi-walled carbon nanotube; and Psoralens based on RNA-seq studies.

WB:WBGene00164968	K08H2.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including manganese chloride; Alovudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00164969	K09C8.9
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by 1-methylnicotinamide based on RNA-seq studies.

WB:WBGene00164971	T21E8.6
Is affected by hpl-2; daf-2; and sin-3 based on RNA-seq and microarray studies. Is affected by four chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00164972	T21E8.7
Is affected by smg-2 based on RNA-seq studies. Is affected by eight chemicals including stavudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00164973	C39B10.7
Is enriched in AFD and intestine based on tiling array and RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and unc-70 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00164974	F46C3.7
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00164983	C36A4.12
Is affected by tatn-1; daf-16; and smg-2 based on RNA-seq studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00164985	ZK1010.10
Is predicted to have histone acetyltransferase activity; transcription coregulator activity; and zinc ion binding activity.

WB:WBGene00164986	Y48A6C.6
Is affected by several genes including eat-2; alg-1; and dlc-1 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00164989	dopy-4
No description available

WB:WBGene00164991	21ur-13442
No description available

WB:WBGene00164992	21ur-9698
No description available

WB:WBGene00164993	21ur-13666
No description available

WB:WBGene00164994	21ur-9733
No description available

WB:WBGene00164995	21ur-15156
No description available

WB:WBGene00164996	21ur-13838
No description available

WB:WBGene00164997	21ur-10879
No description available

WB:WBGene00164998	21ur-10162
No description available

WB:WBGene00164999	21ur-8062
No description available

WB:WBGene00165000	21ur-10875
No description available

WB:WBGene00165001	21ur-8807
No description available

WB:WBGene00165002	21ur-13275
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165003	21ur-10772
No description available

WB:WBGene00165004	21ur-12132
No description available

WB:WBGene00165005	21ur-12650
No description available

WB:WBGene00165006	21ur-10780
No description available

WB:WBGene00165007	21ur-5517
No description available

WB:WBGene00165009	21ur-11798
No description available

WB:WBGene00165010	21ur-6438
No description available

WB:WBGene00165011	21ur-14214
No description available

WB:WBGene00165012	21ur-13773
No description available

WB:WBGene00165013	21ur-14731
No description available

WB:WBGene00165014	21ur-13331
No description available

WB:WBGene00165015	21ur-12098
No description available

WB:WBGene00165016	21ur-14343
No description available

WB:WBGene00165017	21ur-5533
No description available

WB:WBGene00165018	21ur-8237
No description available

WB:WBGene00165019	21ur-11415
No description available

WB:WBGene00165020	21ur-10381
No description available

WB:WBGene00165021	21ur-8417
No description available

WB:WBGene00165022	21ur-7663
No description available

WB:WBGene00165023	21ur-13460
No description available

WB:WBGene00165024	21ur-13551
No description available

WB:WBGene00165025	21ur-6855
No description available

WB:WBGene00165026	21ur-9589
No description available

WB:WBGene00165027	21ur-11151
No description available

WB:WBGene00165028	21ur-6431
No description available

WB:WBGene00165029	21ur-9824
No description available

WB:WBGene00165030	21ur-5719
No description available

WB:WBGene00165031	21ur-9354
No description available

WB:WBGene00165032	21ur-7930
No description available

WB:WBGene00165033	21ur-14211
No description available

WB:WBGene00165034	21ur-10350
No description available

WB:WBGene00165035	21ur-12577
No description available

WB:WBGene00165036	21ur-8400
No description available

WB:WBGene00165037	21ur-8299
No description available

WB:WBGene00165038	21ur-9842
No description available

WB:WBGene00165039	21ur-5880
No description available

WB:WBGene00165040	21ur-13486
No description available

WB:WBGene00165041	21ur-5951
No description available

WB:WBGene00165042	21ur-10453
No description available

WB:WBGene00165043	21ur-7485
No description available

WB:WBGene00165044	21ur-12258
No description available

WB:WBGene00165045	21ur-8436
No description available

WB:WBGene00165046	21ur-10091
No description available

WB:WBGene00165047	21ur-12645
No description available

WB:WBGene00165048	21ur-7066
No description available

WB:WBGene00165049	21ur-15672
No description available

WB:WBGene00165050	21ur-14049
No description available

WB:WBGene00165051	21ur-14338
No description available

WB:WBGene00165052	21ur-12499
No description available

WB:WBGene00165053	21ur-8229
No description available

WB:WBGene00165054	21ur-13726
No description available

WB:WBGene00165055	21ur-12136
No description available

WB:WBGene00165056	21ur-13558
No description available

WB:WBGene00165057	21ur-10440
No description available

WB:WBGene00165058	21ur-13038
No description available

WB:WBGene00165059	21ur-11728
No description available

WB:WBGene00165060	21ur-14285
No description available

WB:WBGene00165061	21ur-8284
No description available

WB:WBGene00165062	21ur-8433
No description available

WB:WBGene00165063	21ur-14301
No description available

WB:WBGene00165064	21ur-12835
No description available

WB:WBGene00165065	21ur-10741
No description available

WB:WBGene00165066	21ur-7502
No description available

WB:WBGene00165067	21ur-10237
No description available

WB:WBGene00165068	21ur-9218
No description available

WB:WBGene00165069	21ur-8833
No description available

WB:WBGene00165070	21ur-12888
No description available

WB:WBGene00165071	21ur-6770
No description available

WB:WBGene00165072	21ur-7604
No description available

WB:WBGene00165073	21ur-8215
No description available

WB:WBGene00165074	21ur-7800
No description available

WB:WBGene00165075	21ur-13468
No description available

WB:WBGene00165076	21ur-12485
No description available

WB:WBGene00165077	21ur-11811
No description available

WB:WBGene00165078	21ur-10445
No description available

WB:WBGene00165079	21ur-10064
No description available

WB:WBGene00165080	21ur-14832
No description available

WB:WBGene00165081	21ur-8247
No description available

WB:WBGene00165082	21ur-15040
No description available

WB:WBGene00165083	21ur-12052
No description available

WB:WBGene00165084	21ur-12165
No description available

WB:WBGene00165085	21ur-5762
No description available

WB:WBGene00165086	21ur-9405
No description available

WB:WBGene00165087	21ur-11486
No description available

WB:WBGene00165088	21ur-7598
No description available

WB:WBGene00165089	21ur-6929
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00165090	21ur-6337
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165091	21ur-13449
No description available

WB:WBGene00165092	21ur-15148
No description available

WB:WBGene00165093	21ur-13001
No description available

WB:WBGene00165094	21ur-7868
No description available

WB:WBGene00165095	21ur-12977
No description available

WB:WBGene00165096	21ur-10593
No description available

WB:WBGene00165097	21ur-14473
No description available

WB:WBGene00165098	21ur-12443
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165099	21ur-12966
No description available

WB:WBGene00165100	21ur-7671
No description available

WB:WBGene00165101	21ur-5834
No description available

WB:WBGene00165102	21ur-14042
No description available

WB:WBGene00165103	21ur-6785
No description available

WB:WBGene00165104	21ur-14476
No description available

WB:WBGene00165105	21ur-6752
No description available

WB:WBGene00165106	21ur-12329
No description available

WB:WBGene00165107	21ur-9451
No description available

WB:WBGene00165108	21ur-7545
No description available

WB:WBGene00165109	21ur-14626
No description available

WB:WBGene00165110	21ur-9149
No description available

WB:WBGene00165111	21ur-8793
No description available

WB:WBGene00165112	21ur-14003
No description available

WB:WBGene00165113	21ur-7398
No description available

WB:WBGene00165114	21ur-6548
No description available

WB:WBGene00165115	21ur-9100
No description available

WB:WBGene00165116	21ur-10948
No description available

WB:WBGene00165117	21ur-12069
No description available

WB:WBGene00165118	21ur-6403
No description available

WB:WBGene00165119	21ur-15553
No description available

WB:WBGene00165120	21ur-8717
No description available

WB:WBGene00165121	21ur-9420
No description available

WB:WBGene00165122	21ur-7774
No description available

WB:WBGene00165123	21ur-10345
No description available

WB:WBGene00165124	21ur-9891
No description available

WB:WBGene00165125	21ur-14703
No description available

WB:WBGene00165126	21ur-12382
No description available

WB:WBGene00165127	21ur-5618
No description available

WB:WBGene00165128	21ur-7333
No description available

WB:WBGene00165129	21ur-8730
No description available

WB:WBGene00165130	21ur-14035
No description available

WB:WBGene00165131	21ur-14406
No description available

WB:WBGene00165132	21ur-6107
No description available

WB:WBGene00165133	21ur-12538
No description available

WB:WBGene00165134	21ur-11762
No description available

WB:WBGene00165135	21ur-10836
No description available

WB:WBGene00165136	21ur-8989
No description available

WB:WBGene00165137	21ur-15419
No description available

WB:WBGene00165138	21ur-15309
No description available

WB:WBGene00165139	21ur-14007
No description available

WB:WBGene00165140	21ur-13810
No description available

WB:WBGene00165141	21ur-15469
No description available

WB:WBGene00165142	21ur-12723
No description available

WB:WBGene00165143	21ur-10734
No description available

WB:WBGene00165144	21ur-6139
No description available

WB:WBGene00165146	21ur-7805
No description available

WB:WBGene00165147	21ur-7541
No description available

WB:WBGene00165148	21ur-14066
No description available

WB:WBGene00165149	21ur-7918
No description available

WB:WBGene00165150	21ur-11855
No description available

WB:WBGene00165151	21ur-11959
No description available

WB:WBGene00165152	21ur-11831
No description available

WB:WBGene00165153	21ur-7474
No description available

WB:WBGene00165154	21ur-10467
No description available

WB:WBGene00165155	21ur-7853
No description available

WB:WBGene00165156	21ur-10787
No description available

WB:WBGene00165157	21ur-8479
No description available

WB:WBGene00165158	21ur-13225
No description available

WB:WBGene00165159	21ur-10840
No description available

WB:WBGene00165160	21ur-12458
No description available

WB:WBGene00165161	21ur-6421
No description available

WB:WBGene00165162	21ur-5944
No description available

WB:WBGene00165163	21ur-7229
No description available

WB:WBGene00165164	21ur-7751
No description available

WB:WBGene00165165	21ur-5959
No description available

WB:WBGene00165166	21ur-15701
No description available

WB:WBGene00165167	21ur-11339
No description available

WB:WBGene00165168	21ur-7910
No description available

WB:WBGene00165169	21ur-10193
No description available

WB:WBGene00165170	21ur-13231
No description available

WB:WBGene00165171	21ur-14370
No description available

WB:WBGene00165172	21ur-11737
No description available

WB:WBGene00165173	21ur-5899
No description available

WB:WBGene00165174	21ur-5829
No description available

WB:WBGene00165175	21ur-5669
No description available

WB:WBGene00165176	21ur-15245
No description available

WB:WBGene00165177	21ur-13152
No description available

WB:WBGene00165178	21ur-12260
No description available

WB:WBGene00165179	21ur-11789
No description available

WB:WBGene00165180	21ur-12855
No description available

WB:WBGene00165181	21ur-6028
No description available

WB:WBGene00165182	21ur-12768
No description available

WB:WBGene00165183	21ur-8122
No description available

WB:WBGene00165184	21ur-14880
No description available

WB:WBGene00165185	21ur-6706
No description available

WB:WBGene00165186	21ur-14530
No description available

WB:WBGene00165187	21ur-13308
No description available

WB:WBGene00165188	21ur-13392
No description available

WB:WBGene00165189	21ur-10414
No description available

WB:WBGene00165190	21ur-12332
No description available

WB:WBGene00165191	21ur-14892
No description available

WB:WBGene00165192	21ur-12224
No description available

WB:WBGene00165193	21ur-12007
No description available

WB:WBGene00165194	21ur-15624
No description available

WB:WBGene00165195	21ur-13923
No description available

WB:WBGene00165196	21ur-12876
No description available

WB:WBGene00165197	21ur-8558
No description available

WB:WBGene00165198	21ur-10728
No description available

WB:WBGene00165199	21ur-6698
No description available

WB:WBGene00165200	21ur-12716
No description available

WB:WBGene00165201	21ur-7232
No description available

WB:WBGene00165202	21ur-12013
No description available

WB:WBGene00165203	21ur-7204
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00165204	21ur-8509
No description available

WB:WBGene00165205	21ur-15215
No description available

WB:WBGene00165206	21ur-9430
No description available

WB:WBGene00165207	21ur-10846
No description available

WB:WBGene00165208	21ur-13738
No description available

WB:WBGene00165209	21ur-6522
No description available

WB:WBGene00165210	21ur-13044
No description available

WB:WBGene00165211	21ur-10657
Is affected by daf-2 based on microarray studies.

WB:WBGene00165212	21ur-13281
No description available

WB:WBGene00165213	21ur-15590
No description available

WB:WBGene00165214	21ur-10718
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165215	21ur-14925
No description available

WB:WBGene00165217	21ur-6205
No description available

WB:WBGene00165218	21ur-15086
No description available

WB:WBGene00165219	21ur-8129
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165220	21ur-14461
No description available

WB:WBGene00165221	21ur-7480
No description available

WB:WBGene00165222	21ur-14927
No description available

WB:WBGene00165223	21ur-8652
No description available

WB:WBGene00165224	21ur-6912
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165225	21ur-12619
No description available

WB:WBGene00165226	21ur-8489
No description available

WB:WBGene00165227	21ur-5892
No description available

WB:WBGene00165228	21ur-6794
No description available

WB:WBGene00165229	21ur-11607
No description available

WB:WBGene00165230	21ur-6866
No description available

WB:WBGene00165231	21ur-5488
No description available

WB:WBGene00165232	21ur-7987
No description available

WB:WBGene00165233	21ur-12981
No description available

WB:WBGene00165234	21ur-11923
No description available

WB:WBGene00165235	21ur-7717
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00165236	21ur-5496
No description available

WB:WBGene00165237	21ur-11584
No description available

WB:WBGene00165238	21ur-7886
No description available

WB:WBGene00165239	21ur-6114
No description available

WB:WBGene00165240	21ur-10729
No description available

WB:WBGene00165241	21ur-14394
No description available

WB:WBGene00165242	21ur-7166
No description available

WB:WBGene00165243	21ur-12155
No description available

WB:WBGene00165244	21ur-10391
No description available

WB:WBGene00165245	21ur-12583
No description available

WB:WBGene00165246	21ur-10921
No description available

WB:WBGene00165247	21ur-13435
No description available

WB:WBGene00165248	21ur-5925
No description available

WB:WBGene00165249	21ur-9503
No description available

WB:WBGene00165250	21ur-13051
No description available

WB:WBGene00165251	21ur-11648
No description available

WB:WBGene00165252	21ur-6922
No description available

WB:WBGene00165253	21ur-13086
No description available

WB:WBGene00165254	21ur-6919
No description available

WB:WBGene00165255	21ur-13765
No description available

WB:WBGene00165256	21ur-6570
No description available

WB:WBGene00165257	21ur-13292
No description available

WB:WBGene00165258	21ur-7249
No description available

WB:WBGene00165259	21ur-13328
No description available

WB:WBGene00165260	21ur-5814
No description available

WB:WBGene00165261	21ur-14963
No description available

WB:WBGene00165262	21ur-14204
No description available

WB:WBGene00165263	21ur-5525
No description available

WB:WBGene00165264	21ur-6811
No description available

WB:WBGene00165265	21ur-10823
No description available

WB:WBGene00165266	21ur-9163
No description available

WB:WBGene00165267	21ur-8461
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00165268	21ur-6686
No description available

WB:WBGene00165269	21ur-7927
No description available

WB:WBGene00165270	21ur-10419
No description available

WB:WBGene00165271	21ur-12087
No description available

WB:WBGene00165272	21ur-14728
No description available

WB:WBGene00165273	21ur-14428
No description available

WB:WBGene00165274	21ur-14769
No description available

WB:WBGene00165275	21ur-6720
No description available

WB:WBGene00165276	21ur-13324
No description available

WB:WBGene00165277	21ur-8198
No description available

WB:WBGene00165278	21ur-5818
No description available

WB:WBGene00165279	21ur-15533
No description available

WB:WBGene00165280	21ur-8625
No description available

WB:WBGene00165281	21ur-14014
No description available

WB:WBGene00165282	21ur-12938
No description available

WB:WBGene00165283	21ur-8001
No description available

WB:WBGene00165284	21ur-11829
No description available

WB:WBGene00165285	21ur-11310
No description available

WB:WBGene00165286	21ur-10280
No description available

WB:WBGene00165287	21ur-10694
No description available

WB:WBGene00165288	21ur-14889
No description available

WB:WBGene00165289	21ur-6768
No description available

WB:WBGene00165290	21ur-6328
No description available

WB:WBGene00165291	21ur-5749
No description available

WB:WBGene00165292	21ur-5858
No description available

WB:WBGene00165293	21ur-8510
No description available

WB:WBGene00165294	21ur-12659
No description available

WB:WBGene00165295	21ur-6843
No description available

WB:WBGene00165296	21ur-6378
No description available

WB:WBGene00165297	21ur-8407
No description available

WB:WBGene00165298	21ur-8323
No description available

WB:WBGene00165299	21ur-11421
No description available

WB:WBGene00165300	21ur-11950
No description available

WB:WBGene00165301	21ur-14327
No description available

WB:WBGene00165302	21ur-13790
No description available

WB:WBGene00165303	21ur-13651
No description available

WB:WBGene00165304	21ur-7566
No description available

WB:WBGene00165305	21ur-15424
No description available

WB:WBGene00165306	21ur-15026
No description available

WB:WBGene00165307	21ur-10188
No description available

WB:WBGene00165308	21ur-9080
No description available

WB:WBGene00165309	21ur-15274
No description available

WB:WBGene00165310	21ur-9910
No description available

WB:WBGene00165311	21ur-10537
No description available

WB:WBGene00165312	21ur-11233
No description available

WB:WBGene00165313	21ur-13998
No description available

WB:WBGene00165314	21ur-5878
No description available

WB:WBGene00165315	21ur-10769
No description available

WB:WBGene00165316	21ur-9492
No description available

WB:WBGene00165317	21ur-10127
No description available

WB:WBGene00165318	21ur-13193
No description available

WB:WBGene00165319	21ur-8046
No description available

WB:WBGene00165320	21ur-6495
No description available

WB:WBGene00165321	21ur-7456
No description available

WB:WBGene00165322	21ur-15621
No description available

WB:WBGene00165323	21ur-9672
No description available

WB:WBGene00165324	21ur-11084
No description available

WB:WBGene00165325	21ur-9730
No description available

WB:WBGene00165326	21ur-15166
No description available

WB:WBGene00165327	21ur-13304
No description available

WB:WBGene00165328	21ur-13126
No description available

WB:WBGene00165329	21ur-9701
No description available

WB:WBGene00165330	21ur-7348
No description available

WB:WBGene00165331	21ur-12117
Is affected by eat-2 based on microarray studies.

WB:WBGene00165332	21ur-9836
Is enriched in RID based on RNA-seq studies. Is affected by unc-39 based on RNA-seq studies.

WB:WBGene00165333	21ur-12958
No description available

WB:WBGene00165334	21ur-12480
No description available

WB:WBGene00165335	21ur-13713
No description available

WB:WBGene00165336	21ur-10554
No description available

WB:WBGene00165337	21ur-13970
No description available

WB:WBGene00165338	21ur-14680
No description available

WB:WBGene00165339	21ur-12918
No description available

WB:WBGene00165340	21ur-12953
No description available

WB:WBGene00165341	21ur-5773
No description available

WB:WBGene00165342	21ur-12113
No description available

WB:WBGene00165343	21ur-10795
No description available

WB:WBGene00165344	21ur-10433
No description available

WB:WBGene00165345	21ur-10576
No description available

WB:WBGene00165346	21ur-14363
No description available

WB:WBGene00165347	21ur-6287
No description available

WB:WBGene00165348	21ur-6952
No description available

WB:WBGene00165349	21ur-6541
No description available

WB:WBGene00165350	21ur-8660
No description available

WB:WBGene00165351	21ur-7185
No description available

WB:WBGene00165352	21ur-12711
No description available

WB:WBGene00165353	21ur-11697
No description available

WB:WBGene00165354	21ur-11144
No description available

WB:WBGene00165355	21ur-6124
No description available

WB:WBGene00165356	21ur-15630
Is affected by hpl-2; meg-3; and meg-4 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00165357	21ur-14095
No description available

WB:WBGene00165358	21ur-8314
No description available

WB:WBGene00165359	21ur-6321
No description available

WB:WBGene00165360	21ur-12413
No description available

WB:WBGene00165361	21ur-7124
No description available

WB:WBGene00165362	21ur-12343
No description available

WB:WBGene00165363	21ur-6501
No description available

WB:WBGene00165364	21ur-8113
No description available

WB:WBGene00165365	21ur-10756
No description available

WB:WBGene00165366	21ur-13039
No description available

WB:WBGene00165367	21ur-12513
No description available

WB:WBGene00165368	21ur-6931
No description available

WB:WBGene00165369	21ur-13340
No description available

WB:WBGene00165370	21ur-8727
No description available

WB:WBGene00165371	21ur-11471
No description available

WB:WBGene00165372	21ur-10256
No description available

WB:WBGene00165373	21ur-9312
No description available

WB:WBGene00165374	21ur-14970
No description available

WB:WBGene00165375	21ur-5648
No description available

WB:WBGene00165376	21ur-11903
No description available

WB:WBGene00165377	21ur-6178
No description available

WB:WBGene00165378	21ur-11769
No description available

WB:WBGene00165379	21ur-6198
No description available

WB:WBGene00165380	21ur-10022
No description available

WB:WBGene00165381	21ur-9649
No description available

WB:WBGene00165382	21ur-14856
No description available

WB:WBGene00165383	21ur-11991
No description available

WB:WBGene00165384	21ur-6454
No description available

WB:WBGene00165385	21ur-12515
No description available

WB:WBGene00165386	21ur-8505
No description available

WB:WBGene00165387	21ur-6663
No description available

WB:WBGene00165388	21ur-11177
No description available

WB:WBGene00165389	21ur-10293
No description available

WB:WBGene00165390	21ur-9383
No description available

WB:WBGene00165391	21ur-15402
No description available

WB:WBGene00165392	21ur-9930
No description available

WB:WBGene00165393	21ur-6732
No description available

WB:WBGene00165394	21ur-6606
No description available

WB:WBGene00165395	21ur-10038
No description available

WB:WBGene00165396	21ur-7188
No description available

WB:WBGene00165397	21ur-10631
No description available

WB:WBGene00165398	21ur-8979
No description available

WB:WBGene00165399	21ur-9565
No description available

WB:WBGene00165400	21ur-13927
No description available

WB:WBGene00165401	21ur-12891
No description available

WB:WBGene00165402	21ur-12460
No description available

WB:WBGene00165403	21ur-11507
No description available

WB:WBGene00165404	21ur-8963
No description available

WB:WBGene00165405	21ur-10634
No description available

WB:WBGene00165406	21ur-10862
No description available

WB:WBGene00165407	21ur-9346
No description available

WB:WBGene00165408	21ur-13150
No description available

WB:WBGene00165409	21ur-14236
No description available

WB:WBGene00165410	21ur-6371
No description available

WB:WBGene00165411	21ur-13957
No description available

WB:WBGene00165412	21ur-6100
No description available

WB:WBGene00165413	21ur-9784
No description available

WB:WBGene00165414	21ur-5885
No description available

WB:WBGene00165415	21ur-13012
No description available

WB:WBGene00165416	21ur-9940
No description available

WB:WBGene00165417	21ur-12472
No description available

WB:WBGene00165418	21ur-8278
No description available

WB:WBGene00165419	21ur-13968
No description available

WB:WBGene00165420	21ur-11300
No description available

WB:WBGene00165421	21ur-9371
No description available

WB:WBGene00165422	21ur-6991
No description available

WB:WBGene00165423	21ur-14154
No description available

WB:WBGene00165424	21ur-12148
No description available

WB:WBGene00165425	21ur-6992
No description available

WB:WBGene00165426	21ur-8529
No description available

WB:WBGene00165427	21ur-7519
No description available

WB:WBGene00165428	21ur-15149
No description available

WB:WBGene00165429	21ur-14434
No description available

WB:WBGene00165430	21ur-10119
No description available

WB:WBGene00165431	21ur-9902
No description available

WB:WBGene00165432	21ur-14368
No description available

WB:WBGene00165433	21ur-5523
No description available

WB:WBGene00165434	21ur-13984
No description available

WB:WBGene00165435	21ur-11701
No description available

WB:WBGene00165436	21ur-9617
No description available

WB:WBGene00165438	21ur-7562
No description available

WB:WBGene00165439	21ur-14742
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165440	21ur-14638
No description available

WB:WBGene00165441	21ur-11468
No description available

WB:WBGene00165442	21ur-11196
No description available

WB:WBGene00165443	21ur-15495
No description available

WB:WBGene00165444	21ur-14554
No description available

WB:WBGene00165445	21ur-15647
No description available

WB:WBGene00165446	21ur-6576
No description available

WB:WBGene00165447	21ur-15293
No description available

WB:WBGene00165448	21ur-12709
No description available

WB:WBGene00165449	21ur-6483
No description available

WB:WBGene00165450	21ur-6008
No description available

WB:WBGene00165451	21ur-12529
No description available

WB:WBGene00165452	21ur-11374
No description available

WB:WBGene00165453	21ur-7539
No description available

WB:WBGene00165454	21ur-7099
No description available

WB:WBGene00165455	21ur-8683
No description available

WB:WBGene00165456	21ur-8258
No description available

WB:WBGene00165457	21ur-13793
No description available

WB:WBGene00165458	21ur-11409
No description available

WB:WBGene00165459	21ur-14260
No description available

WB:WBGene00165460	21ur-7220
No description available

WB:WBGene00165461	21ur-13676
No description available

WB:WBGene00165462	21ur-10595
No description available

WB:WBGene00165463	21ur-7961
No description available

WB:WBGene00165464	21ur-6200
No description available

WB:WBGene00165465	21ur-9917
No description available

WB:WBGene00165466	21ur-14420
No description available

WB:WBGene00165467	21ur-12490
No description available

WB:WBGene00165468	21ur-9547
No description available

WB:WBGene00165469	21ur-7224
No description available

WB:WBGene00165470	21ur-8410
No description available

WB:WBGene00165471	21ur-7243
No description available

WB:WBGene00165472	21ur-9580
No description available

WB:WBGene00165473	21ur-14436
No description available

WB:WBGene00165474	21ur-10171
No description available

WB:WBGene00165475	21ur-8022
No description available

WB:WBGene00165476	21ur-7268
No description available

WB:WBGene00165477	21ur-9079
No description available

WB:WBGene00165478	21ur-14751
No description available

WB:WBGene00165479	21ur-5998
No description available

WB:WBGene00165480	21ur-15151
No description available

WB:WBGene00165481	21ur-9937
No description available

WB:WBGene00165482	21ur-5906
No description available

WB:WBGene00165483	21ur-15102
No description available

WB:WBGene00165484	21ur-8205
No description available

WB:WBGene00165485	21ur-13617
No description available

WB:WBGene00165486	21ur-9052
No description available

WB:WBGene00165487	21ur-7847
No description available

WB:WBGene00165488	21ur-9986
No description available

WB:WBGene00165489	21ur-7813
No description available

WB:WBGene00165490	21ur-12551
No description available

WB:WBGene00165491	21ur-9110
No description available

WB:WBGene00165492	21ur-10995
No description available

WB:WBGene00165493	21ur-8134
No description available

WB:WBGene00165494	21ur-14083
No description available

WB:WBGene00165495	21ur-14641
No description available

WB:WBGene00165496	21ur-15349
No description available

WB:WBGene00165497	21ur-7295
No description available

WB:WBGene00165498	21ur-12812
No description available

WB:WBGene00165499	21ur-14985
No description available

WB:WBGene00165500	21ur-12341
No description available

WB:WBGene00165501	21ur-7694
No description available

WB:WBGene00165502	21ur-7609
No description available

WB:WBGene00165503	21ur-15679
No description available

WB:WBGene00165504	21ur-13179
No description available

WB:WBGene00165505	21ur-8909
No description available

WB:WBGene00165506	21ur-6225
No description available

WB:WBGene00165507	21ur-13094
No description available

WB:WBGene00165508	21ur-10220
No description available

WB:WBGene00165509	21ur-10108
No description available

WB:WBGene00165510	21ur-8047
No description available

WB:WBGene00165511	21ur-15613
No description available

WB:WBGene00165512	21ur-13930
No description available

WB:WBGene00165513	21ur-6535
No description available

WB:WBGene00165514	21ur-13843
No description available

WB:WBGene00165515	21ur-11062
No description available

WB:WBGene00165516	21ur-9888
No description available

WB:WBGene00165517	21ur-9748
No description available

WB:WBGene00165518	21ur-8050
No description available

WB:WBGene00165519	21ur-12328
No description available

WB:WBGene00165520	21ur-6820
No description available

WB:WBGene00165521	21ur-11110
No description available

WB:WBGene00165522	21ur-12931
No description available

WB:WBGene00165523	21ur-7686
No description available

WB:WBGene00165524	21ur-5475
No description available

WB:WBGene00165525	21ur-8772
No description available

WB:WBGene00165526	21ur-10960
No description available

WB:WBGene00165527	21ur-8169
No description available

WB:WBGene00165528	21ur-10993
No description available

WB:WBGene00165529	21ur-10336
No description available

WB:WBGene00165530	21ur-15376
No description available

WB:WBGene00165531	21ur-7156
No description available

WB:WBGene00165532	21ur-12754
No description available

WB:WBGene00165533	21ur-8477
No description available

WB:WBGene00165534	21ur-9814
No description available

WB:WBGene00165535	21ur-7933
No description available

WB:WBGene00165536	21ur-12864
No description available

WB:WBGene00165537	21ur-11575
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00165538	21ur-15382
No description available

WB:WBGene00165539	21ur-14243
No description available

WB:WBGene00165540	21ur-8098
No description available

WB:WBGene00165541	21ur-15354
No description available

WB:WBGene00165542	21ur-7094
No description available

WB:WBGene00165543	21ur-14612
No description available

WB:WBGene00165544	21ur-6716
No description available

WB:WBGene00165545	21ur-6087
No description available

WB:WBGene00165546	21ur-8852
No description available

WB:WBGene00165547	21ur-9177
No description available

WB:WBGene00165548	21ur-6309
No description available

WB:WBGene00165549	21ur-10033
No description available

WB:WBGene00165550	21ur-6243
No description available

WB:WBGene00165551	21ur-8577
No description available

WB:WBGene00165552	21ur-8773
No description available

WB:WBGene00165553	21ur-13788
No description available

WB:WBGene00165554	21ur-10353
No description available

WB:WBGene00165555	21ur-7957
No description available

WB:WBGene00165556	21ur-13760
No description available

WB:WBGene00165557	21ur-10667
No description available

WB:WBGene00165558	21ur-12468
No description available

WB:WBGene00165559	21ur-5728
No description available

WB:WBGene00165560	21ur-12685
No description available

WB:WBGene00165561	21ur-7341
No description available

WB:WBGene00165562	21ur-11075
No description available

WB:WBGene00165563	21ur-9741
No description available

WB:WBGene00165564	21ur-15688
No description available

WB:WBGene00165565	21ur-13202
No description available

WB:WBGene00165566	21ur-6171
No description available

WB:WBGene00165567	21ur-14839
No description available

WB:WBGene00165568	21ur-12522
No description available

WB:WBGene00165569	21ur-10815
No description available

WB:WBGene00165570	21ur-12080
No description available

WB:WBGene00165571	21ur-10200
No description available

WB:WBGene00165572	21ur-11768
No description available

WB:WBGene00165573	21ur-8029
No description available

WB:WBGene00165574	21ur-11844
No description available

WB:WBGene00165575	21ur-7394
No description available

WB:WBGene00165576	21ur-14683
No description available

WB:WBGene00165577	21ur-13691
No description available

WB:WBGene00165578	21ur-9849
No description available

WB:WBGene00165579	21ur-8273
No description available

WB:WBGene00165580	21ur-7045
No description available

WB:WBGene00165581	21ur-8352
No description available

WB:WBGene00165582	21ur-8080
No description available

WB:WBGene00165583	21ur-11820
No description available

WB:WBGene00165584	21ur-11937
No description available

WB:WBGene00165585	21ur-8443
No description available

WB:WBGene00165586	21ur-15526
No description available

WB:WBGene00165587	21ur-11246
No description available

WB:WBGene00165588	21ur-6972
Is affected by daf-2 based on microarray studies.

WB:WBGene00165589	21ur-11746
No description available

WB:WBGene00165590	21ur-11989
No description available

WB:WBGene00165591	21ur-10584
No description available

WB:WBGene00165592	21ur-13527
No description available

WB:WBGene00165593	21ur-9243
No description available

WB:WBGene00165594	21ur-8054
No description available

WB:WBGene00165595	21ur-8934
No description available

WB:WBGene00165596	21ur-14818
No description available

WB:WBGene00165597	21ur-10055
No description available

WB:WBGene00165598	21ur-14548
No description available

WB:WBGene00165599	21ur-9367
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165600	21ur-10120
No description available

WB:WBGene00165601	21ur-14793
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00165602	21ur-13185
No description available

WB:WBGene00165603	21ur-6947
No description available

WB:WBGene00165604	21ur-14174
No description available

WB:WBGene00165605	21ur-8302
No description available

WB:WBGene00165606	21ur-14605
No description available

WB:WBGene00165607	21ur-10935
No description available

WB:WBGene00165608	21ur-15584
No description available

WB:WBGene00165609	21ur-9489
No description available

WB:WBGene00165610	21ur-6080
No description available

WB:WBGene00165611	21ur-15473
No description available

WB:WBGene00165612	21ur-8613
No description available

WB:WBGene00165613	21ur-14173
No description available

WB:WBGene00165614	21ur-12704
No description available

WB:WBGene00165615	21ur-14142
No description available

WB:WBGene00165616	21ur-12046
No description available

WB:WBGene00165617	21ur-10701
No description available

WB:WBGene00165618	21ur-8639
No description available

WB:WBGene00165619	21ur-11569
No description available

WB:WBGene00165620	21ur-12244
No description available

WB:WBGene00165621	21ur-11224
No description available

WB:WBGene00165622	21ur-14192
No description available

WB:WBGene00165623	21ur-9632
No description available

WB:WBGene00165624	21ur-8591
No description available

WB:WBGene00165625	21ur-15303
No description available

WB:WBGene00165626	21ur-13402
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165627	21ur-13519
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165628	21ur-15568
No description available

WB:WBGene00165629	21ur-9871
No description available

WB:WBGene00165630	21ur-6417
No description available

WB:WBGene00165631	21ur-8869
No description available

WB:WBGene00165632	21ur-8032
No description available

WB:WBGene00165633	21ur-13615
No description available

WB:WBGene00165634	21ur-10989
No description available

WB:WBGene00165635	21ur-10626
No description available

WB:WBGene00165636	21ur-9004
No description available

WB:WBGene00165637	21ur-8223
No description available

WB:WBGene00165638	21ur-7697
No description available

WB:WBGene00165639	21ur-13826
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00165640	21ur-6474
No description available

WB:WBGene00165641	21ur-15014
No description available

WB:WBGene00165642	21ur-11037
No description available

WB:WBGene00165643	21ur-8347
No description available

WB:WBGene00165644	21ur-10081
No description available

WB:WBGene00165645	21ur-13712
No description available

WB:WBGene00165646	21ur-9702
No description available

WB:WBGene00165647	21ur-14517
No description available

WB:WBGene00165648	21ur-8020
No description available

WB:WBGene00165649	21ur-13576
No description available

WB:WBGene00165650	21ur-8840
No description available

WB:WBGene00165651	21ur-5733
No description available

WB:WBGene00165652	21ur-6899
No description available

WB:WBGene00165653	21ur-10687
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00165654	21ur-8764
No description available

WB:WBGene00165655	21ur-7998
No description available

WB:WBGene00165656	21ur-7618
No description available

WB:WBGene00165657	21ur-11175
No description available

WB:WBGene00165658	21ur-14840
No description available

WB:WBGene00165659	21ur-9270
No description available

WB:WBGene00165660	21ur-11316
No description available

WB:WBGene00165661	21ur-13474
No description available

WB:WBGene00165662	21ur-12661
No description available

WB:WBGene00165663	21ur-11014
No description available

WB:WBGene00165664	21ur-8570
No description available

WB:WBGene00165665	21ur-13707
No description available

WB:WBGene00165666	21ur-6281
No description available

WB:WBGene00165667	21ur-13454
No description available

WB:WBGene00165668	21ur-13136
No description available

WB:WBGene00165669	21ur-9132
No description available

WB:WBGene00165670	21ur-9182
No description available

WB:WBGene00165671	21ur-14520
No description available

WB:WBGene00165672	21ur-9679
No description available

WB:WBGene00165673	21ur-13900
No description available

WB:WBGene00165674	21ur-13868
No description available

WB:WBGene00165675	21ur-15199
No description available

WB:WBGene00165676	21ur-13266
No description available

WB:WBGene00165677	21ur-11291
No description available

WB:WBGene00165678	21ur-14266
No description available

WB:WBGene00165679	21ur-9408
No description available

WB:WBGene00165680	21ur-10782
No description available

WB:WBGene00165681	21ur-8914
Is affected by glycine based on RNA-seq studies.

WB:WBGene00165682	21ur-11901
No description available

WB:WBGene00165683	21ur-6056
No description available

WB:WBGene00165684	21ur-14676
No description available

WB:WBGene00165685	21ur-9479
No description available

WB:WBGene00165686	21ur-6156
No description available

WB:WBGene00165687	21ur-13121
No description available

WB:WBGene00165688	21ur-12964
No description available

WB:WBGene00165689	21ur-10868
No description available

WB:WBGene00165690	21ur-8056
No description available

WB:WBGene00165691	21ur-15466
No description available

WB:WBGene00165692	21ur-12894
No description available

WB:WBGene00165693	21ur-12524
No description available

WB:WBGene00165694	21ur-12392
No description available

WB:WBGene00165695	21ur-6980
No description available

WB:WBGene00165696	21ur-6301
No description available

WB:WBGene00165697	21ur-13643
No description available

WB:WBGene00165698	21ur-9721
No description available

WB:WBGene00165699	21ur-13495
No description available

WB:WBGene00165700	21ur-10275
No description available

WB:WBGene00165701	21ur-8755
No description available

WB:WBGene00165702	21ur-14869
No description available

WB:WBGene00165703	21ur-10561
No description available

WB:WBGene00165704	21ur-9652
No description available

WB:WBGene00165705	21ur-7351
No description available

WB:WBGene00165706	21ur-8695
No description available

WB:WBGene00165707	21ur-8066
No description available

WB:WBGene00165708	21ur-15056
No description available

WB:WBGene00165709	21ur-10789
No description available

WB:WBGene00165710	21ur-10931
No description available

WB:WBGene00165711	21ur-10009
No description available

WB:WBGene00165712	21ur-14103
No description available

WB:WBGene00165713	21ur-6026
No description available

WB:WBGene00165714	21ur-15364
No description available

WB:WBGene00165715	21ur-10813
No description available

WB:WBGene00165716	21ur-8309
No description available

WB:WBGene00165717	21ur-14486
No description available

WB:WBGene00165718	21ur-9329
No description available

WB:WBGene00165719	21ur-6241
No description available

WB:WBGene00165720	21ur-8932
No description available

WB:WBGene00165721	21ur-7126
No description available

WB:WBGene00165722	21ur-7439
No description available

WB:WBGene00165723	21ur-11736
No description available

WB:WBGene00165724	21ur-9394
No description available

WB:WBGene00165725	21ur-13062
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165726	21ur-8027
No description available

WB:WBGene00165727	21ur-7572
No description available

WB:WBGene00165728	21ur-5581
No description available

WB:WBGene00165729	21ur-9490
No description available

WB:WBGene00165730	21ur-8787
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00165731	21ur-14253
No description available

WB:WBGene00165732	21ur-11759
No description available

WB:WBGene00165733	21ur-9436
No description available

WB:WBGene00165734	21ur-9336
No description available

WB:WBGene00165735	21ur-6285
No description available

WB:WBGene00165736	21ur-12182
No description available

WB:WBGene00165737	21ur-12421
No description available

WB:WBGene00165738	21ur-7199
No description available

WB:WBGene00165739	21ur-5915
No description available

WB:WBGene00165740	21ur-15294
No description available

WB:WBGene00165741	21ur-14328
No description available

WB:WBGene00165742	21ur-9764
No description available

WB:WBGene00165743	21ur-6102
No description available

WB:WBGene00165744	21ur-11349
No description available

WB:WBGene00165745	21ur-6650
No description available

WB:WBGene00165746	21ur-14283
No description available

WB:WBGene00165747	21ur-11774
No description available

WB:WBGene00165748	21ur-10380
No description available

WB:WBGene00165749	21ur-8569
No description available

WB:WBGene00165750	21ur-15543
No description available

WB:WBGene00165751	21ur-6031
No description available

WB:WBGene00165752	21ur-11026
No description available

WB:WBGene00165753	21ur-10523
No description available

WB:WBGene00165754	21ur-10844
No description available

WB:WBGene00165755	21ur-8688
No description available

WB:WBGene00165756	21ur-15514
No description available

WB:WBGene00165757	21ur-11592
No description available

WB:WBGene00165758	21ur-12025
No description available

WB:WBGene00165759	21ur-6341
No description available

WB:WBGene00165760	21ur-14077
No description available

WB:WBGene00165761	21ur-14722
No description available

WB:WBGene00165762	21ur-12642
No description available

WB:WBGene00165763	21ur-9105
No description available

WB:WBGene00165764	21ur-7799
No description available

WB:WBGene00165765	21ur-9298
No description available

WB:WBGene00165766	21ur-13408
No description available

WB:WBGene00165767	21ur-6352
No description available

WB:WBGene00165768	21ur-7173
No description available

WB:WBGene00165769	21ur-7311
No description available

WB:WBGene00165770	21ur-9033
No description available

WB:WBGene00165771	21ur-11255
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00165772	21ur-8243
No description available

WB:WBGene00165773	21ur-8942
No description available

WB:WBGene00165774	21ur-6640
No description available

WB:WBGene00165775	21ur-6111
No description available

WB:WBGene00165776	21ur-11536
No description available

WB:WBGene00165777	21ur-9240
No description available

WB:WBGene00165778	21ur-12702
No description available

WB:WBGene00165779	21ur-8768
No description available

WB:WBGene00165780	21ur-9976
No description available

WB:WBGene00165781	21ur-10825
No description available

WB:WBGene00165782	21ur-12242
No description available

WB:WBGene00165783	21ur-12037
No description available

WB:WBGene00165784	21ur-7700
No description available

WB:WBGene00165785	21ur-14711
No description available

WB:WBGene00165786	21ur-9906
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00165787	21ur-11244
No description available

WB:WBGene00165788	21ur-9411
No description available

WB:WBGene00165789	21ur-13128
No description available

WB:WBGene00165790	21ur-7329
No description available

WB:WBGene00165791	21ur-13369
No description available

WB:WBGene00165792	21ur-15184
No description available

WB:WBGene00165793	21ur-11285
No description available

WB:WBGene00165794	21ur-9460
No description available

WB:WBGene00165795	21ur-5546
No description available

WB:WBGene00165796	21ur-9301
No description available

WB:WBGene00165797	21ur-11260
No description available

WB:WBGene00165798	21ur-8560
No description available

WB:WBGene00165799	21ur-7584
No description available

WB:WBGene00165800	21ur-5787
No description available

WB:WBGene00165801	21ur-8076
No description available

WB:WBGene00165802	21ur-9919
No description available

WB:WBGene00165803	21ur-9264
No description available

WB:WBGene00165804	21ur-10000
No description available

WB:WBGene00165805	21ur-9066
No description available

WB:WBGene00165806	21ur-10287
No description available

WB:WBGene00165807	21ur-10322
No description available

WB:WBGene00165808	21ur-10264
No description available

WB:WBGene00165809	21ur-6122
No description available

WB:WBGene00165810	21ur-11805
No description available

WB:WBGene00165811	21ur-10011
No description available

WB:WBGene00165812	21ur-14911
No description available

WB:WBGene00165813	21ur-11121
No description available

WB:WBGene00165814	21ur-8602
No description available

WB:WBGene00165815	21ur-8867
Is affected by daf-2 based on microarray studies.

WB:WBGene00165816	21ur-14228
No description available

WB:WBGene00165817	21ur-15643
No description available

WB:WBGene00165818	21ur-11542
No description available

WB:WBGene00165819	21ur-10101
No description available

WB:WBGene00165820	21ur-15595
No description available

WB:WBGene00165821	21ur-9537
No description available

WB:WBGene00165822	21ur-12023
No description available

WB:WBGene00165823	21ur-8890
No description available

WB:WBGene00165824	21ur-11279
No description available

WB:WBGene00165825	21ur-7013
No description available

WB:WBGene00165826	21ur-15384
Is enriched in intestine based on RNA-seq studies.

WB:WBGene00165827	21ur-11441
No description available

WB:WBGene00165828	21ur-7579
No description available

WB:WBGene00165829	21ur-6728
No description available

WB:WBGene00165830	21ur-10649
No description available

WB:WBGene00165831	21ur-6825
No description available

WB:WBGene00165832	21ur-7591
No description available

WB:WBGene00165833	21ur-6359
No description available

WB:WBGene00165834	21ur-10612
No description available

WB:WBGene00165835	21ur-8004
No description available

WB:WBGene00165836	21ur-13253
No description available

WB:WBGene00165837	21ur-10903
No description available

WB:WBGene00165838	21ur-5865
No description available

WB:WBGene00165839	21ur-13273
No description available

WB:WBGene00165840	21ur-13967
No description available

WB:WBGene00165841	21ur-13661
No description available

WB:WBGene00165842	21ur-5470
No description available

WB:WBGene00165843	21ur-6989
No description available

WB:WBGene00165844	21ur-12290
No description available

WB:WBGene00165845	21ur-10627
No description available

WB:WBGene00165846	21ur-8956
No description available

WB:WBGene00165847	21ur-13057
No description available

WB:WBGene00165848	21ur-6647
No description available

WB:WBGene00165849	21ur-13593
No description available

WB:WBGene00165850	21ur-6176
No description available

WB:WBGene00165851	21ur-11505
No description available

WB:WBGene00165852	21ur-14669
No description available

WB:WBGene00165853	21ur-10409
No description available

WB:WBGene00165854	21ur-9143
No description available

WB:WBGene00165855	21ur-9235
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00165856	21ur-13580
No description available

WB:WBGene00165857	21ur-13633
No description available

WB:WBGene00165858	21ur-6901
No description available

WB:WBGene00165859	21ur-15371
No description available

WB:WBGene00165860	21ur-11306
No description available

WB:WBGene00165861	21ur-15209
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165862	21ur-14044
No description available

WB:WBGene00165863	21ur-8232
No description available

WB:WBGene00165864	21ur-6293
No description available

WB:WBGene00165865	21ur-15045
No description available

WB:WBGene00165866	21ur-5965
No description available

WB:WBGene00165867	21ur-14883
No description available

WB:WBGene00165868	21ur-13682
No description available

WB:WBGene00165869	21ur-7974
No description available

WB:WBGene00165870	21ur-13986
No description available

WB:WBGene00165871	21ur-7158
No description available

WB:WBGene00165872	21ur-6624
No description available

WB:WBGene00165873	21ur-12787
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165874	21ur-14597
No description available

WB:WBGene00165875	21ur-10195
No description available

WB:WBGene00165876	21ur-8619
No description available

WB:WBGene00165877	21ur-8579
No description available

WB:WBGene00165878	21ur-7833
No description available

WB:WBGene00165879	21ur-5795
No description available

WB:WBGene00165880	21ur-9356
No description available

WB:WBGene00165881	21ur-15068
No description available

WB:WBGene00165882	21ur-12563
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165883	21ur-15210
No description available

WB:WBGene00165884	21ur-11498
No description available

WB:WBGene00165885	21ur-11795
No description available

WB:WBGene00165886	21ur-12282
No description available

WB:WBGene00165887	21ur-11045
No description available

WB:WBGene00165888	21ur-14447
No description available

WB:WBGene00165889	21ur-10710
No description available

WB:WBGene00165890	21ur-9769
No description available

WB:WBGene00165891	21ur-7722
No description available

WB:WBGene00165892	21ur-11718
No description available

WB:WBGene00165893	21ur-11466
No description available

WB:WBGene00165894	21ur-6001
No description available

WB:WBGene00165895	21ur-11896
No description available

WB:WBGene00165896	21ur-10329
No description available

WB:WBGene00165897	21ur-9691
No description available

WB:WBGene00165898	21ur-9594
No description available

WB:WBGene00165899	21ur-14903
No description available

WB:WBGene00165900	21ur-10219
No description available

WB:WBGene00165901	21ur-12431
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00165902	21ur-12213
No description available

WB:WBGene00165903	21ur-6442
No description available

WB:WBGene00165904	21ur-15217
No description available

WB:WBGene00165905	21ur-11877
No description available

WB:WBGene00165906	21ur-14092
No description available

WB:WBGene00165907	21ur-14894
No description available

WB:WBGene00165908	21ur-6078
No description available

WB:WBGene00165909	21ur-6636
No description available

WB:WBGene00165910	21ur-9540
No description available

WB:WBGene00165911	21ur-11021
No description available

WB:WBGene00165912	21ur-10975
No description available

WB:WBGene00165913	21ur-8170
No description available

WB:WBGene00165914	21ur-12608
No description available

WB:WBGene00165915	21ur-6383
No description available

WB:WBGene00165916	21ur-9201
No description available

WB:WBGene00165917	21ur-6217
No description available

WB:WBGene00165918	21ur-12740
No description available

WB:WBGene00165919	21ur-10838
No description available

WB:WBGene00165920	21ur-5957
No description available

WB:WBGene00165921	21ur-5502
No description available

WB:WBGene00165922	21ur-5934
No description available

WB:WBGene00165923	21ur-8641
No description available

WB:WBGene00165924	21ur-14585
No description available

WB:WBGene00165925	21ur-7880
No description available

WB:WBGene00165926	21ur-7434
No description available

WB:WBGene00165927	21ur-13892
No description available

WB:WBGene00165928	21ur-11873
No description available

WB:WBGene00165929	21ur-8580
No description available

WB:WBGene00165930	21ur-14452
No description available

WB:WBGene00165931	21ur-8750
No description available

WB:WBGene00165932	21ur-7784
No description available

WB:WBGene00165933	21ur-15136
No description available

WB:WBGene00165934	21ur-12351
No description available

WB:WBGene00165935	21ur-10129
No description available

WB:WBGene00165936	21ur-15003
No description available

WB:WBGene00165937	21ur-14828
No description available

WB:WBGene00165938	21ur-11660
No description available

WB:WBGene00165939	21ur-11266
No description available

WB:WBGene00165940	21ur-6638
No description available

WB:WBGene00165941	21ur-11204
No description available

WB:WBGene00165942	21ur-8865
No description available

WB:WBGene00165943	21ur-8831
No description available

WB:WBGene00165944	21ur-10926
No description available

WB:WBGene00165945	21ur-13375
No description available

WB:WBGene00165946	21ur-8376
No description available

WB:WBGene00165947	21ur-6659
No description available

WB:WBGene00165948	21ur-11267
No description available

WB:WBGene00165949	21ur-11069
No description available

WB:WBGene00165950	21ur-6098
No description available

WB:WBGene00165951	21ur-14671
No description available

WB:WBGene00165952	21ur-11005
No description available

WB:WBGene00165953	21ur-11700
No description available

WB:WBGene00165954	21ur-12675
No description available

WB:WBGene00165955	21ur-11407
Is affected by skn-1 based on RNA-seq studies.

WB:WBGene00165956	21ur-5598
No description available

WB:WBGene00165957	21ur-12152
No description available

WB:WBGene00165958	21ur-5554
No description available

WB:WBGene00165959	21ur-6041
No description available

WB:WBGene00165960	21ur-15648
No description available

WB:WBGene00165961	21ur-14182
No description available

WB:WBGene00165962	21ur-13422
No description available

WB:WBGene00165963	21ur-10955
No description available

WB:WBGene00165964	21ur-10048
No description available

WB:WBGene00165965	21ur-14842
No description available

WB:WBGene00165966	21ur-13003
No description available

WB:WBGene00165967	21ur-7364
No description available

WB:WBGene00165968	21ur-11754
No description available

WB:WBGene00165969	21ur-7646
No description available

WB:WBGene00165970	21ur-12853
No description available

WB:WBGene00165971	21ur-6366
No description available

WB:WBGene00165972	21ur-13942
No description available

WB:WBGene00165973	21ur-12387
No description available

WB:WBGene00165974	21ur-8690
No description available

WB:WBGene00165975	21ur-15117
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00165976	21ur-9519
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00165977	21ur-14240
No description available

WB:WBGene00165978	21ur-9095
No description available

WB:WBGene00165979	21ur-11632
No description available

WB:WBGene00165980	21ur-7130
No description available

WB:WBGene00165981	21ur-5942
No description available

WB:WBGene00165982	21ur-10113
No description available

WB:WBGene00165983	21ur-8589
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00165984	21ur-5819
No description available

WB:WBGene00165985	21ur-11030
No description available

WB:WBGene00165986	21ur-9778
No description available

WB:WBGene00165987	21ur-7003
No description available

WB:WBGene00165988	21ur-15494
No description available

WB:WBGene00165989	21ur-12621
No description available

WB:WBGene00165990	21ur-7936
No description available

WB:WBGene00165991	21ur-11634
No description available

WB:WBGene00165992	21ur-9129
No description available

WB:WBGene00165993	21ur-10402
No description available

WB:WBGene00165994	21ur-13429
No description available

WB:WBGene00165995	21ur-10972
No description available

WB:WBGene00165996	21ur-14022
No description available

WB:WBGene00165997	21ur-12785
No description available

WB:WBGene00165998	21ur-9759
No description available

WB:WBGene00165999	21ur-13107
No description available

WB:WBGene00166000	21ur-12766
No description available

WB:WBGene00166001	21ur-14414
No description available

WB:WBGene00166002	21ur-10600
No description available

WB:WBGene00166003	21ur-5839
No description available

WB:WBGene00166004	21ur-10803
No description available

WB:WBGene00166005	21ur-10489
No description available

WB:WBGene00166006	21ur-9344
No description available

WB:WBGene00166007	21ur-7498
No description available

WB:WBGene00166008	21ur-5469
No description available

WB:WBGene00166009	21ur-12742
No description available

WB:WBGene00166010	21ur-11707
No description available

WB:WBGene00166011	21ur-14758
Is affected by skn-1 based on RNA-seq studies.

WB:WBGene00166012	21ur-8153
No description available

WB:WBGene00166013	21ur-12833
No description available

WB:WBGene00166014	21ur-6577
No description available

WB:WBGene00166015	21ur-6888
No description available

WB:WBGene00166016	21ur-14657
No description available

WB:WBGene00166017	21ur-9320
No description available

WB:WBGene00166018	21ur-12733
No description available

WB:WBGene00166019	21ur-9912
No description available

WB:WBGene00166020	21ur-6017
No description available

WB:WBGene00166021	21ur-10675
No description available

WB:WBGene00166022	21ur-9087
No description available

WB:WBGene00166023	21ur-5708
No description available

WB:WBGene00166024	21ur-7849
No description available

WB:WBGene00166025	21ur-9306
No description available

WB:WBGene00166026	21ur-8769
No description available

WB:WBGene00166027	21ur-13995
No description available

WB:WBGene00166028	21ur-12998
Is affected by rsr-2 based on tiling array studies.

WB:WBGene00166029	21ur-9860
No description available

WB:WBGene00166030	21ur-9693
No description available

WB:WBGene00166031	21ur-12363
No description available

WB:WBGene00166032	21ur-8487
No description available

WB:WBGene00166033	21ur-7822
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166034	21ur-7461
No description available

WB:WBGene00166035	21ur-9763
No description available

WB:WBGene00166036	21ur-13502
No description available

WB:WBGene00166037	21ur-15244
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00166038	21ur-14416
No description available

WB:WBGene00166039	21ur-11216
No description available

WB:WBGene00166040	21ur-10778
No description available

WB:WBGene00166041	21ur-10581
No description available

WB:WBGene00166042	21ur-8498
No description available

WB:WBGene00166043	21ur-13888
No description available

WB:WBGene00166044	21ur-7621
No description available

WB:WBGene00166045	21ur-5670
No description available

WB:WBGene00166046	21ur-12071
No description available

WB:WBGene00166047	21ur-5970
No description available

WB:WBGene00166048	21ur-15444
No description available

WB:WBGene00166049	21ur-5656
No description available

WB:WBGene00166050	21ur-7524
No description available

WB:WBGene00166051	21ur-6086
No description available

WB:WBGene00166052	21ur-12085
No description available

WB:WBGene00166053	21ur-5979
No description available

WB:WBGene00166054	21ur-8136
No description available

WB:WBGene00166055	21ur-10520
No description available

WB:WBGene00166057	21ur-12941
No description available

WB:WBGene00166058	21ur-9514
No description available

WB:WBGene00166059	21ur-13638
No description available

WB:WBGene00166060	21ur-7104
No description available

WB:WBGene00166062	21ur-9524
No description available

WB:WBGene00166063	21ur-9570
No description available

WB:WBGene00166064	21ur-9948
No description available

WB:WBGene00166065	21ur-6613
No description available

WB:WBGene00166066	21ur-8512
No description available

WB:WBGene00166067	21ur-10515
No description available

WB:WBGene00166068	21ur-6256
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166069	21ur-6833
No description available

WB:WBGene00166070	21ur-15467
No description available

WB:WBGene00166071	21ur-14498
No description available

WB:WBGene00166072	21ur-10340
No description available

WB:WBGene00166073	21ur-12821
No description available

WB:WBGene00166074	21ur-8452
No description available

WB:WBGene00166075	21ur-7076
No description available

WB:WBGene00166076	21ur-9122
No description available

WB:WBGene00166077	21ur-7035
No description available

WB:WBGene00166078	21ur-12924
No description available

WB:WBGene00166079	21ur-10181
No description available

WB:WBGene00166080	21ur-8949
No description available

WB:WBGene00166081	21ur-7526
No description available

WB:WBGene00166082	21ur-10458
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00166083	21ur-14019
No description available

WB:WBGene00166084	21ur-8596
No description available

WB:WBGene00166085	21ur-13907
No description available

WB:WBGene00166086	21ur-15096
No description available

WB:WBGene00166087	21ur-14650
No description available

WB:WBGene00166088	21ur-7466
No description available

WB:WBGene00166089	21ur-6168
No description available

WB:WBGene00166090	21ur-12692
No description available

WB:WBGene00166091	21ur-10018
No description available

WB:WBGene00166092	21ur-8016
No description available

WB:WBGene00166093	21ur-6969
No description available

WB:WBGene00166094	21ur-5614
No description available

WB:WBGene00166095	21ur-15318
No description available

WB:WBGene00166096	21ur-13540
No description available

WB:WBGene00166097	21ur-6964
No description available

WB:WBGene00166098	21ur-14556
No description available

WB:WBGene00166099	21ur-9607
No description available

WB:WBGene00166100	21ur-6496
No description available

WB:WBGene00166101	21ur-14162
No description available

WB:WBGene00166102	21ur-11962
No description available

WB:WBGene00166103	21ur-11710
No description available

WB:WBGene00166104	21ur-9239
No description available

WB:WBGene00166105	21ur-15674
No description available

WB:WBGene00166106	21ur-5758
No description available

WB:WBGene00166107	21ur-7763
No description available

WB:WBGene00166108	21ur-11808
No description available

WB:WBGene00166109	21ur-8534
No description available

WB:WBGene00166110	21ur-6312
No description available

WB:WBGene00166111	21ur-13025
No description available

WB:WBGene00166112	21ur-12289
No description available

WB:WBGene00166113	21ur-11599
No description available

WB:WBGene00166114	21ur-14500
No description available

WB:WBGene00166115	21ur-12303
No description available

WB:WBGene00166116	21ur-15694
No description available

WB:WBGene00166117	21ur-12251
No description available

WB:WBGene00166118	21ur-10244
No description available

WB:WBGene00166119	21ur-6895
No description available

WB:WBGene00166120	21ur-10967
No description available

WB:WBGene00166121	21ur-11166
No description available

WB:WBGene00166122	21ur-10130
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166123	21ur-7211
No description available

WB:WBGene00166124	21ur-15655
No description available

WB:WBGene00166125	21ur-6593
No description available

WB:WBGene00166126	21ur-7057
No description available

WB:WBGene00166127	21ur-14129
No description available

WB:WBGene00166128	21ur-11969
No description available

WB:WBGene00166129	21ur-9381
No description available

WB:WBGene00166130	21ur-8523
No description available

WB:WBGene00166131	21ur-8446
No description available

WB:WBGene00166132	21ur-7890
No description available

WB:WBGene00166133	21ur-11920
No description available

WB:WBGene00166134	21ur-12657
No description available

WB:WBGene00166135	21ur-9020
No description available

WB:WBGene00166136	21ur-7448
No description available

WB:WBGene00166137	21ur-13723
No description available

WB:WBGene00166138	21ur-15053
No description available

WB:WBGene00166139	21ur-12142
No description available

WB:WBGene00166140	21ur-12574
No description available

WB:WBGene00166141	21ur-13817
No description available

WB:WBGene00166142	21ur-11669
No description available

WB:WBGene00166143	21ur-6827
No description available

WB:WBGene00166144	21ur-10591
No description available

WB:WBGene00166145	21ur-15192
No description available

WB:WBGene00166146	21ur-11434
No description available

WB:WBGene00166147	21ur-10239
No description available

WB:WBGene00166148	21ur-12373
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166149	21ur-5668
No description available

WB:WBGene00166150	21ur-7191
No description available

WB:WBGene00166151	21ur-14878
No description available

WB:WBGene00166152	21ur-12445
No description available

WB:WBGene00166153	21ur-7764
No description available

WB:WBGene00166154	21ur-9834
No description available

WB:WBGene00166155	21ur-9803
No description available

WB:WBGene00166156	21ur-5535
No description available

WB:WBGene00166157	21ur-11391
No description available

WB:WBGene00166158	21ur-15070
No description available

WB:WBGene00166159	21ur-6600
No description available

WB:WBGene00166160	21ur-14161
No description available

WB:WBGene00166161	21ur-10145
No description available

WB:WBGene00166162	21ur-5464
No description available

WB:WBGene00166163	21ur-14122
No description available

WB:WBGene00166164	21ur-9021
No description available

WB:WBGene00166165	21ur-5635
No description available

WB:WBGene00166166	21ur-7236
No description available

WB:WBGene00166167	21ur-6161
No description available

WB:WBGene00166168	21ur-6746
No description available

WB:WBGene00166169	21ur-14344
No description available

WB:WBGene00166170	21ur-10798
No description available

WB:WBGene00166171	21ur-14787
No description available

WB:WBGene00166172	21ur-12603
No description available

WB:WBGene00166173	21ur-5927
No description available

WB:WBGene00166174	21ur-13741
No description available

WB:WBGene00166175	21ur-9388
No description available

WB:WBGene00166176	21ur-9216
No description available

WB:WBGene00166177	21ur-6804
No description available

WB:WBGene00166178	21ur-10430
No description available

WB:WBGene00166179	21ur-14513
No description available

WB:WBGene00166180	21ur-8186
No description available

WB:WBGene00166181	21ur-12775
No description available

WB:WBGene00166182	21ur-5694
No description available

WB:WBGene00166183	21ur-14764
No description available

WB:WBGene00166184	21ur-12389
No description available

WB:WBGene00166185	21ur-6527
No description available

WB:WBGene00166186	21ur-12946
No description available

WB:WBGene00166187	21ur-11771
No description available

WB:WBGene00166188	21ur-15223
No description available

WB:WBGene00166189	21ur-13417
No description available

WB:WBGene00166190	21ur-12797
No description available

WB:WBGene00166191	21ur-14072
No description available

WB:WBGene00166192	21ur-13534
No description available

WB:WBGene00166193	21ur-13754
No description available

WB:WBGene00166194	21ur-14939
No description available

WB:WBGene00166195	21ur-12276
No description available

WB:WBGene00166196	21ur-10206
No description available

WB:WBGene00166197	21ur-13571
No description available

WB:WBGene00166198	21ur-14276
No description available

WB:WBGene00166199	21ur-13249
No description available

WB:WBGene00166200	21ur-9665
No description available

WB:WBGene00166201	21ur-5714
No description available

WB:WBGene00166202	21ur-13239
No description available

WB:WBGene00166203	21ur-14148
No description available

WB:WBGene00166204	21ur-13606
No description available

WB:WBGene00166205	21ur-8777
No description available

WB:WBGene00166206	21ur-15010
No description available

WB:WBGene00166207	21ur-9729
No description available

WB:WBGene00166208	21ur-7815
No description available

WB:WBGene00166209	21ur-7884
No description available

WB:WBGene00166210	21ur-6349
No description available

WB:WBGene00166211	21ur-10510
No description available

WB:WBGene00166212	21ur-7370
No description available

WB:WBGene00166213	21ur-12300
No description available

WB:WBGene00166214	21ur-5742
No description available

WB:WBGene00166215	21ur-10548
No description available

WB:WBGene00166216	21ur-8703
No description available

WB:WBGene00166217	21ur-12201
No description available

WB:WBGene00166218	21ur-15470
No description available

WB:WBGene00166219	21ur-12193
No description available

WB:WBGene00166220	21ur-13144
No description available

WB:WBGene00166221	21ur-15328
No description available

WB:WBGene00166222	21ur-14808
No description available

WB:WBGene00166223	21ur-13696
No description available

WB:WBGene00166224	21ur-13244
No description available

WB:WBGene00166225	21ur-10398
Is affected by daf-2 based on microarray studies.

WB:WBGene00166226	21ur-7737
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166227	21ur-7029
No description available

WB:WBGene00166228	21ur-9444
No description available

WB:WBGene00166229	21ur-6874
No description available

WB:WBGene00166230	21ur-11613
No description available

WB:WBGene00166231	21ur-14698
No description available

WB:WBGene00166232	21ur-11235
No description available

WB:WBGene00166233	21ur-10736
No description available

WB:WBGene00166234	21ur-12307
No description available

WB:WBGene00166235	21ur-10387
Is affected by paraquat based on RNA-seq studies.

WB:WBGene00166236	21ur-8267
No description available

WB:WBGene00166237	21ur-6265
No description available

WB:WBGene00166238	21ur-15666
No description available

WB:WBGene00166239	21ur-13113
No description available

WB:WBGene00166240	21ur-15077
No description available

WB:WBGene00166241	21ur-8573
No description available

WB:WBGene00166242	21ur-7904
No description available

WB:WBGene00166243	21ur-12556
No description available

WB:WBGene00166244	21ur-9587
No description available

WB:WBGene00166245	21ur-8649
No description available

WB:WBGene00166246	21ur-6513
No description available

WB:WBGene00166247	21ur-11779
No description available

WB:WBGene00166248	21ur-9206
No description available

WB:WBGene00166249	21ur-7897
No description available

WB:WBGene00166250	21ur-10853
No description available

WB:WBGene00166251	21ur-7139
No description available

WB:WBGene00166252	21ur-11352
No description available

WB:WBGene00166253	21ur-14426
No description available

WB:WBGene00166254	21ur-14544
No description available

WB:WBGene00166255	21ur-14617
No description available

WB:WBGene00166256	21ur-5822
No description available

WB:WBGene00166257	21ur-14774
No description available

WB:WBGene00166258	21ur-6704
No description available

WB:WBGene00166259	21ur-14064
No description available

WB:WBGene00166260	21ur-12354
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166261	21ur-8127
No description available

WB:WBGene00166262	21ur-6551
No description available

WB:WBGene00166263	21ur-10490
No description available

WB:WBGene00166264	21ur-12067
No description available

WB:WBGene00166265	21ur-13847
No description available

WB:WBGene00166266	21ur-7554
No description available

WB:WBGene00166267	21ur-7970
No description available

WB:WBGene00166268	21ur-12322
No description available

WB:WBGene00166269	21ur-14438
No description available

WB:WBGene00166270	21ur-14994
No description available

WB:WBGene00166271	21ur-11057
No description available

WB:WBGene00166272	21ur-7378
No description available

WB:WBGene00166273	21ur-8507
No description available

WB:WBGene00166274	21ur-11916
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166275	21ur-9819
No description available

WB:WBGene00166276	21ur-14030
No description available

WB:WBGene00166277	21ur-13539
No description available

WB:WBGene00166278	21ur-6864
No description available

WB:WBGene00166279	21ur-8275
No description available

WB:WBGene00166280	21ur-5805
No description available

WB:WBGene00166281	21ur-8503
No description available

WB:WBGene00166282	21ur-11680
No description available

WB:WBGene00166283	21ur-6520
No description available

WB:WBGene00166284	21ur-14392
No description available

WB:WBGene00166285	21ur-11942
No description available

WB:WBGene00166286	21ur-5642
No description available

WB:WBGene00166287	21ur-7016
No description available

WB:WBGene00166288	21ur-15508
No description available

WB:WBGene00166289	21ur-13014
No description available

WB:WBGene00166290	21ur-14744
No description available

WB:WBGene00166291	21ur-11642
No description available

WB:WBGene00166292	21ur-7725
No description available

WB:WBGene00166293	21ur-11322
No description available

WB:WBGene00166294	21ur-10480
No description available

WB:WBGene00166295	21ur-6327
No description available

WB:WBGene00166296	21ur-9942
No description available

WB:WBGene00166297	21ur-12721
No description available

WB:WBGene00166298	21ur-6132
No description available

WB:WBGene00166299	21ur-10230
No description available

WB:WBGene00166300	21ur-13314
No description available

WB:WBGene00166301	21ur-11521
No description available

WB:WBGene00166302	21ur-8650
Is affected by wdr-5.1 based on RNA-seq studies.

WB:WBGene00166303	21ur-13233
No description available

WB:WBGene00166304	21ur-11583
No description available

WB:WBGene00166305	21ur-8835
No description available

WB:WBGene00166306	21ur-8138
No description available

WB:WBGene00166307	21ur-10671
No description available

WB:WBGene00166308	21ur-9091
No description available

WB:WBGene00166309	21ur-5472
No description available

WB:WBGene00166310	21ur-11739
No description available

WB:WBGene00166311	21ur-12330
No description available

WB:WBGene00166312	21ur-12019
No description available

WB:WBGene00166313	21ur-14196
No description available

WB:WBGene00166314	21ur-13317
No description available

WB:WBGene00166315	21ur-11678
No description available

WB:WBGene00166316	21ur-9085
No description available

WB:WBGene00166317	21ur-6910
No description available

WB:WBGene00166318	21ur-12209
No description available

WB:WBGene00166319	21ur-10191
No description available

WB:WBGene00166320	21ur-6840
No description available

WB:WBGene00166321	21ur-6861
No description available

WB:WBGene00166322	21ur-13840
No description available

WB:WBGene00166323	21ur-6917
No description available

WB:WBGene00166324	21ur-8621
No description available

WB:WBGene00166325	21ur-15413
No description available

WB:WBGene00166326	21ur-13322
No description available

WB:WBGene00166327	21ur-9190
No description available

WB:WBGene00166328	21ur-7979
No description available

WB:WBGene00166329	21ur-11402
No description available

WB:WBGene00166330	21ur-8249
No description available

WB:WBGene00166331	21ur-9108
No description available

WB:WBGene00166332	21ur-13866
No description available

WB:WBGene00166333	21ur-6234
No description available

WB:WBGene00166334	21ur-14186
No description available

WB:WBGene00166335	21ur-10229
No description available

WB:WBGene00166336	21ur-10088
No description available

WB:WBGene00166337	21ur-8627
No description available

WB:WBGene00166338	21ur-13211
No description available

WB:WBGene00166339	21ur-5498
No description available

WB:WBGene00166340	21ur-14779
Is affected by emr-1 and lem-2 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00166341	21ur-12761
No description available

WB:WBGene00166342	21ur-9297
No description available

WB:WBGene00166343	21ur-10261
No description available

WB:WBGene00166344	21ur-8659
No description available

WB:WBGene00166345	21ur-12771
No description available

WB:WBGene00166346	21ur-15000
No description available

WB:WBGene00166347	21ur-13088
No description available

WB:WBGene00166348	21ur-15520
No description available

WB:WBGene00166349	21ur-12874
No description available

WB:WBGene00166350	21ur-6908
No description available

WB:WBGene00166351	21ur-8286
No description available

WB:WBGene00166352	21ur-14272
No description available

WB:WBGene00166353	21ur-14020
No description available

WB:WBGene00166354	21ur-5812
No description available

WB:WBGene00166355	21ur-8997
No description available

WB:WBGene00166356	21ur-13671
No description available

WB:WBGene00166357	21ur-8482
No description available

WB:WBGene00166358	21ur-9865
No description available

WB:WBGene00166359	21ur-8463
No description available

WB:WBGene00166360	21ur-12575
No description available

WB:WBGene00166361	21ur-9951
No description available

WB:WBGene00166362	21ur-15434
No description available

WB:WBGene00166363	21ur-9595
No description available

WB:WBGene00166364	21ur-5816
No description available

WB:WBGene00166365	21ur-6034
No description available

WB:WBGene00166366	21ur-5827
No description available

WB:WBGene00166367	21ur-14114
No description available

WB:WBGene00166368	21ur-10098
No description available

WB:WBGene00166369	21ur-6558
No description available

WB:WBGene00166370	21ur-9573
No description available

WB:WBGene00166371	21ur-14202
No description available

WB:WBGene00166372	21ur-14887
No description available

WB:WBGene00166373	21ur-11952
No description available

WB:WBGene00166374	21ur-13227
No description available

WB:WBGene00166375	21ur-15579
No description available

WB:WBGene00166376	21ur-7216
No description available

WB:WBGene00166377	21ur-10793
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00166378	21ur-12318
No description available

WB:WBGene00166379	21ur-6426
No description available

WB:WBGene00166380	21ur-13326
No description available

WB:WBGene00166381	21ur-14176
No description available

WB:WBGene00166382	21ur-12419
No description available

WB:WBGene00166383	21ur-11588
No description available

WB:WBGene00166384	21ur-5769
No description available

WB:WBGene00166385	21ur-10722
No description available

WB:WBGene00166386	21ur-13397
No description available

WB:WBGene00166387	21ur-9203
No description available

WB:WBGene00166388	21ur-7753
No description available

WB:WBGene00166389	21ur-14918
No description available

WB:WBGene00166390	21ur-13053
No description available

WB:WBGene00166391	21ur-9191
No description available

WB:WBGene00166392	21ur-6762
No description available

WB:WBGene00166393	21ur-11766
No description available

WB:WBGene00166394	21ur-11490
No description available

WB:WBGene00166395	21ur-14603
No description available

WB:WBGene00166396	21ur-15597
No description available

WB:WBGene00166397	21ur-14312
No description available

WB:WBGene00166398	21ur-9187
No description available

WB:WBGene00166399	21ur-11473
No description available

WB:WBGene00166400	21ur-7168
No description available

WB:WBGene00166401	21ur-8809
No description available

WB:WBGene00166402	21ur-13918
No description available

WB:WBGene00166403	21ur-7476
No description available

WB:WBGene00166404	21ur-6845
No description available

WB:WBGene00166405	21ur-15484
No description available

WB:WBGene00166406	21ur-13443
No description available

WB:WBGene00166407	21ur-8087
No description available

WB:WBGene00166408	21ur-8060
No description available

WB:WBGene00166409	21ur-13875
No description available

WB:WBGene00166410	21ur-11153
No description available

WB:WBGene00166411	21ur-7487
No description available

WB:WBGene00166412	21ur-14959
Is affected by eat-2 based on microarray studies.

WB:WBGene00166413	21ur-12186
No description available

WB:WBGene00166414	21ur-12664
No description available

WB:WBGene00166415	21ur-15236
No description available

WB:WBGene00166416	21ur-12138
No description available

WB:WBGene00166417	21ur-14264
No description available

WB:WBGene00166418	21ur-15146
No description available

WB:WBGene00166419	21ur-14303
No description available

WB:WBGene00166420	21ur-10347
No description available

WB:WBGene00166421	21ur-9531
No description available

WB:WBGene00166422	21ur-5481
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00166423	21ur-9276
No description available

WB:WBGene00166424	21ur-14700
No description available

WB:WBGene00166425	21ur-11941
No description available

WB:WBGene00166426	21ur-9422
No description available

WB:WBGene00166427	21ur-8120
No description available

WB:WBGene00166428	21ur-8227
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00166429	21ur-9254
No description available

WB:WBGene00166430	21ur-8748
No description available

WB:WBGene00166431	21ur-9505
No description available

WB:WBGene00166432	21ur-13164
No description available

WB:WBGene00166433	21ur-13668
No description available

WB:WBGene00166434	21ur-12043
No description available

WB:WBGene00166435	21ur-8405
No description available

WB:WBGene00166436	21ur-10877
No description available

WB:WBGene00166437	21ur-12441
No description available

WB:WBGene00166438	21ur-8719
No description available

WB:WBGene00166439	21ur-12134
No description available

WB:WBGene00166440	21ur-6207
No description available

WB:WBGene00166441	21ur-15237
No description available

WB:WBGene00166442	21ur-9735
No description available

WB:WBGene00166443	21ur-8924
No description available

WB:WBGene00166444	21ur-13767
No description available

WB:WBGene00166445	21ur-10770
No description available

WB:WBGene00166446	21ur-9013
No description available

WB:WBGene00166447	21ur-10455
No description available

WB:WBGene00166448	21ur-13405
No description available

WB:WBGene00166449	21ur-5844
No description available

WB:WBGene00166450	21ur-14718
No description available

WB:WBGene00166451	21ur-11862
No description available

WB:WBGene00166452	21ur-5953
No description available

WB:WBGene00166453	21ur-6780
No description available

WB:WBGene00166454	21ur-15404
No description available

WB:WBGene00166455	21ur-6786
No description available

WB:WBGene00166456	21ur-13042
No description available

WB:WBGene00166457	21ur-10352
No description available

WB:WBGene00166458	21ur-13497
No description available

WB:WBGene00166459	21ur-13756
No description available

WB:WBGene00166460	21ur-9838
No description available

WB:WBGene00166461	21ur-14834
No description available

WB:WBGene00166462	21ur-10160
No description available

WB:WBGene00166463	21ur-11508
No description available

WB:WBGene00166464	21ur-13728
No description available

WB:WBGene00166465	21ur-8675
No description available

WB:WBGene00166466	21ur-7665
No description available

WB:WBGene00166467	21ur-10556
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166468	21ur-13311
No description available

WB:WBGene00166469	21ur-8884
No description available

WB:WBGene00166470	21ur-8282
No description available

WB:WBGene00166471	21ur-9403
No description available

WB:WBGene00166472	21ur-9303
No description available

WB:WBGene00166473	21ur-12898
No description available

WB:WBGene00166474	21ur-13911
No description available

WB:WBGene00166475	21ur-10997
No description available

WB:WBGene00166476	21ur-6588
No description available

WB:WBGene00166477	21ur-7206
No description available

WB:WBGene00166478	21ur-8017
No description available

WB:WBGene00166479	21ur-9846
No description available

WB:WBGene00166480	21ur-8990
No description available

WB:WBGene00166481	21ur-14450
No description available

WB:WBGene00166482	21ur-7916
No description available

WB:WBGene00166483	21ur-12287
No description available

WB:WBGene00166484	21ur-7543
No description available

WB:WBGene00166485	21ur-11925
No description available

WB:WBGene00166486	21ur-8746
No description available

WB:WBGene00166487	21ur-14471
No description available

WB:WBGene00166488	21ur-9039
No description available

WB:WBGene00166489	21ur-9644
No description available

WB:WBGene00166490	21ur-13578
No description available

WB:WBGene00166491	21ur-8448
No description available

WB:WBGene00166492	21ur-6772
No description available

WB:WBGene00166493	21ur-10442
No description available

WB:WBGene00166494	21ur-13731
No description available

WB:WBGene00166495	21ur-8987
No description available

WB:WBGene00166496	21ur-14701
No description available

WB:WBGene00166497	21ur-9958
No description available

WB:WBGene00166498	21ur-5832
No description available

WB:WBGene00166499	21ur-6672
No description available

WB:WBGene00166500	21ur-12280
No description available

WB:WBGene00166501	21ur-10435
No description available

WB:WBGene00166502	21ur-9844
No description available

WB:WBGene00166503	21ur-9554
No description available

WB:WBGene00166504	21ur-5996
No description available

WB:WBGene00166505	21ur-12296
No description available

WB:WBGene00166506	21ur-14005
No description available

WB:WBGene00166507	21ur-5560
No description available

WB:WBGene00166508	21ur-8564
No description available

WB:WBGene00166509	21ur-10447
No description available

WB:WBGene00166510	21ur-11528
No description available

WB:WBGene00166511	21ur-9221
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166512	21ur-13484
No description available

WB:WBGene00166513	21ur-9018
No description available

WB:WBGene00166514	21ur-8220
No description available

WB:WBGene00166515	21ur-14404
No description available

WB:WBGene00166516	21ur-13218
No description available

WB:WBGene00166517	21ur-6227
No description available

WB:WBGene00166518	21ur-13364
No description available

WB:WBGene00166519	21ur-13015
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00166520	21ur-14531
No description available

WB:WBGene00166521	21ur-6338
No description available

WB:WBGene00166522	21ur-12838
No description available

WB:WBGene00166523	21ur-14738
No description available

WB:WBGene00166524	21ur-11838
No description available

WB:WBGene00166525	21ur-14979
No description available

WB:WBGene00166526	21ur-7301
No description available

WB:WBGene00166527	21ur-6983
Is affected by eat-2 based on microarray studies.

WB:WBGene00166528	21ur-7807
No description available

WB:WBGene00166529	21ur-14009
No description available

WB:WBGene00166530	21ur-12943
No description available

WB:WBGene00166531	21ur-13333
No description available

WB:WBGene00166532	21ur-8297
No description available

WB:WBGene00166533	21ur-11319
No description available

WB:WBGene00166534	21ur-15497
No description available

WB:WBGene00166535	21ur-13561
No description available

WB:WBGene00166536	21ur-8492
No description available

WB:WBGene00166537	21ur-8669
No description available

WB:WBGene00166538	21ur-9984
No description available

WB:WBGene00166539	21ur-14792
No description available

WB:WBGene00166540	21ur-14509
No description available

WB:WBGene00166541	21ur-9054
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166542	21ur-8520
No description available

WB:WBGene00166543	21ur-6154
No description available

WB:WBGene00166544	21ur-11608
No description available

WB:WBGene00166545	21ur-8907
No description available

WB:WBGene00166546	21ur-8795
No description available

WB:WBGene00166547	21ur-11842
No description available

WB:WBGene00166548	21ur-5949
No description available

WB:WBGene00166549	21ur-14150
No description available

WB:WBGene00166550	21ur-11388
No description available

WB:WBGene00166551	21ur-11198
No description available

WB:WBGene00166552	21ur-12466
No description available

WB:WBGene00166553	21ur-10811
No description available

WB:WBGene00166554	21ur-9390
No description available

WB:WBGene00166555	21ur-6742
No description available

WB:WBGene00166556	21ur-13101
No description available

WB:WBGene00166557	21ur-12397
No description available

WB:WBGene00166558	21ur-8475
No description available

WB:WBGene00166559	21ur-13686
No description available

WB:WBGene00166560	21ur-7315
No description available

WB:WBGene00166561	21ur-14983
No description available

WB:WBGene00166562	21ur-14381
No description available

WB:WBGene00166563	21ur-9979
No description available

WB:WBGene00166564	21ur-10979
No description available

WB:WBGene00166565	21ur-7863
No description available

WB:WBGene00166566	21ur-15347
No description available

WB:WBGene00166567	21ur-13845
No description available

WB:WBGene00166568	21ur-6460
No description available

WB:WBGene00166569	21ur-12246
No description available

WB:WBGene00166570	21ur-8519
No description available

WB:WBGene00166571	21ur-12553
No description available

WB:WBGene00166572	21ur-7811
No description available

WB:WBGene00166573	21ur-5856
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166574	21ur-12814
No description available

WB:WBGene00166575	21ur-11964
No description available

WB:WBGene00166576	21ur-6245
No description available

WB:WBGene00166577	21ur-15079
No description available

WB:WBGene00166578	21ur-8470
No description available

WB:WBGene00166579	21ur-15692
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00166580	21ur-11573
No description available

WB:WBGene00166581	21ur-11272
No description available

WB:WBGene00166582	21ur-9586
No description available

WB:WBGene00166583	21ur-8541
No description available

WB:WBGene00166584	21ur-10254
No description available

WB:WBGene00166585	21ur-7692
No description available

WB:WBGene00166586	21ur-5682
No description available

WB:WBGene00166587	21ur-8428
No description available

WB:WBGene00166588	21ur-5722
No description available

WB:WBGene00166589	21ur-7293
No description available

WB:WBGene00166590	21ur-15351
No description available

WB:WBGene00166591	21ur-12339
No description available

WB:WBGene00166592	21ur-15683
No description available

WB:WBGene00166593	21ur-7896
No description available

WB:WBGene00166594	21ur-12866
No description available

WB:WBGene00166595	21ur-8912
No description available

WB:WBGene00166596	21ur-6539
No description available

WB:WBGene00166597	21ur-13096
No description available

WB:WBGene00166598	21ur-14241
No description available

WB:WBGene00166599	21ur-7150
No description available

WB:WBGene00166600	21ur-11560
No description available

WB:WBGene00166601	21ur-14248
No description available

WB:WBGene00166602	21ur-9974
No description available

WB:WBGene00166603	21ur-9319
No description available

WB:WBGene00166604	21ur-14445
No description available

WB:WBGene00166605	21ur-8741
No description available

WB:WBGene00166606	21ur-14577
No description available

WB:WBGene00166607	21ur-13390
No description available

WB:WBGene00166608	21ur-8383
No description available

WB:WBGene00166609	21ur-6193
No description available

WB:WBGene00166610	21ur-9812
No description available

WB:WBGene00166611	21ur-11732
No description available

WB:WBGene00166612	21ur-12867
No description available

WB:WBGene00166613	21ur-15072
Is affected by daf-2 based on microarray studies.

WB:WBGene00166614	21ur-9660
No description available

WB:WBGene00166615	21ur-7258
No description available

WB:WBGene00166616	21ur-6959
No description available

WB:WBGene00166617	21ur-9175
No description available

WB:WBGene00166618	21ur-9851
No description available

WB:WBGene00166619	21ur-10355
No description available

WB:WBGene00166620	21ur-6069
No description available

WB:WBGene00166621	21ur-7266
No description available

WB:WBGene00166622	21ur-15603
No description available

WB:WBGene00166623	21ur-11073
No description available

WB:WBGene00166624	21ur-10306
No description available

WB:WBGene00166625	21ur-12048
No description available

WB:WBGene00166626	21ur-14565
No description available

WB:WBGene00166627	21ur-9658
No description available

WB:WBGene00166628	21ur-9098
No description available

WB:WBGene00166629	21ur-13074
No description available

WB:WBGene00166630	21ur-12520
No description available

WB:WBGene00166631	21ur-13698
No description available

WB:WBGene00166632	21ur-8411
No description available

WB:WBGene00166633	21ur-15187
No description available

WB:WBGene00166634	21ur-12801
No description available

WB:WBGene00166635	21ur-8844
No description available

WB:WBGene00166636	21ur-7935
No description available

WB:WBGene00166637	21ur-7744
No description available

WB:WBGene00166638	21ur-8919
No description available

WB:WBGene00166639	21ur-12885
No description available

WB:WBGene00166640	21ur-11132
No description available

WB:WBGene00166641	21ur-7959
No description available

WB:WBGene00166642	21ur-12688
No description available

WB:WBGene00166643	21ur-8692
No description available

WB:WBGene00166644	21ur-9569
No description available

WB:WBGene00166645	21ur-7608
No description available

WB:WBGene00166646	21ur-8141
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166647	21ur-5615
No description available

WB:WBGene00166648	21ur-12425
No description available

WB:WBGene00166649	21ur-9805
No description available

WB:WBGene00166650	21ur-6871
No description available

WB:WBGene00166651	21ur-15394
No description available

WB:WBGene00166652	21ur-10122
No description available

WB:WBGene00166653	21ur-15337
No description available

WB:WBGene00166654	21ur-13951
No description available

WB:WBGene00166655	21ur-14468
No description available

WB:WBGene00166656	21ur-10222
No description available

WB:WBGene00166657	21ur-8082
No description available

WB:WBGene00166658	21ur-8548
No description available

WB:WBGene00166659	21ur-11662
No description available

WB:WBGene00166660	21ur-6945
No description available

WB:WBGene00166661	21ur-14159
No description available

WB:WBGene00166662	21ur-7242
No description available

WB:WBGene00166663	21ur-7044
No description available

WB:WBGene00166664	21ur-14949
No description available

WB:WBGene00166665	21ur-6920
No description available

WB:WBGene00166666	21ur-13410
No description available

WB:WBGene00166667	21ur-11035
No description available

WB:WBGene00166668	21ur-13611
No description available

WB:WBGene00166669	21ur-8902
No description available

WB:WBGene00166670	21ur-14388
No description available

WB:WBGene00166671	21ur-10888
No description available

WB:WBGene00166672	21ur-13761
No description available

WB:WBGene00166673	21ur-5650
No description available

WB:WBGene00166674	21ur-14082
No description available

WB:WBGene00166675	21ur-14012
No description available

WB:WBGene00166676	21ur-10141
No description available

WB:WBGene00166677	21ur-15623
No description available

WB:WBGene00166678	21ur-10159
No description available

WB:WBGene00166679	21ur-13191
No description available

WB:WBGene00166680	21ur-11827
No description available

WB:WBGene00166681	21ur-8637
No description available

WB:WBGene00166682	21ur-13553
No description available

WB:WBGene00166683	21ur-10170
No description available

WB:WBGene00166684	21ur-11139
No description available

WB:WBGene00166685	21ur-10173
No description available

WB:WBGene00166686	21ur-15247
No description available

WB:WBGene00166687	21ur-13493
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00166688	21ur-8040
No description available

WB:WBGene00166689	21ur-10754
No description available

WB:WBGene00166690	21ur-11501
No description available

WB:WBGene00166691	21ur-11379
No description available

WB:WBGene00166692	21ur-12400
No description available

WB:WBGene00166693	21ur-8977
No description available

WB:WBGene00166694	21ur-8212
No description available

WB:WBGene00166695	21ur-15618
No description available

WB:WBGene00166696	21ur-15088
No description available

WB:WBGene00166697	21ur-10004
No description available

WB:WBGene00166698	21ur-6581
No description available

WB:WBGene00166699	21ur-15150
No description available

WB:WBGene00166700	21ur-12706
No description available

WB:WBGene00166701	21ur-12589
No description available

WB:WBGene00166702	21ur-12075
No description available

WB:WBGene00166703	21ur-11117
No description available

WB:WBGene00166704	21ur-11687
No description available

WB:WBGene00166705	21ur-8030
No description available

WB:WBGene00166706	21ur-14568
No description available

WB:WBGene00166707	21ur-11008
No description available

WB:WBGene00166708	21ur-6800
No description available

WB:WBGene00166709	21ur-5861
No description available

WB:WBGene00166710	21ur-6493
No description available

WB:WBGene00166711	21ur-8250
No description available

WB:WBGene00166712	21ur-10762
No description available

WB:WBGene00166713	21ur-11417
No description available

WB:WBGene00166714	21ur-8643
No description available

WB:WBGene00166715	21ur-12962
No description available

WB:WBGene00166716	21ur-6118
No description available

WB:WBGene00166717	21ur-14037
No description available

WB:WBGene00166718	21ur-10470
No description available

WB:WBGene00166719	21ur-12935
No description available

WB:WBGene00166720	21ur-9185
No description available

WB:WBGene00166721	21ur-6272
No description available

WB:WBGene00166722	21ur-15025
No description available

WB:WBGene00166723	21ur-7114
No description available

WB:WBGene00166724	21ur-12115
No description available

WB:WBGene00166725	21ur-15345
No description available

WB:WBGene00166726	21ur-13079
No description available

WB:WBGene00166727	21ur-12670
No description available

WB:WBGene00166728	21ur-9369
No description available

WB:WBGene00166729	21ur-8615
No description available

WB:WBGene00166730	21ur-9915
No description available

WB:WBGene00166731	21ur-11752
No description available

WB:WBGene00166732	21ur-10291
No description available

WB:WBGene00166733	21ur-11801
No description available

WB:WBGene00166734	21ur-13783
No description available

WB:WBGene00166735	21ur-10861
No description available

WB:WBGene00166736	21ur-7252
No description available

WB:WBGene00166737	21ur-7906
No description available

WB:WBGene00166738	21ur-7658
No description available

WB:WBGene00166739	21ur-7457
No description available

WB:WBGene00166740	21ur-6369
No description available

WB:WBGene00166741	21ur-7450
No description available

WB:WBGene00166742	21ur-8106
No description available

WB:WBGene00166743	21ur-13958
No description available

WB:WBGene00166744	21ur-10881
No description available

WB:WBGene00166745	21ur-12315
No description available

WB:WBGene00166746	21ur-9361
No description available

WB:WBGene00166747	21ur-13302
No description available

WB:WBGene00166748	21ur-5579
No description available

WB:WBGene00166749	21ur-15441
No description available

WB:WBGene00166750	21ur-6608
No description available

WB:WBGene00166751	21ur-6076
No description available

WB:WBGene00166752	21ur-11975
No description available

WB:WBGene00166753	21ur-15126
No description available

WB:WBGene00166754	21ur-9563
No description available

WB:WBGene00166755	21ur-5760
No description available

WB:WBGene00166756	21ur-11695
No description available

WB:WBGene00166757	21ur-12127
No description available

WB:WBGene00166758	21ur-12808
No description available

WB:WBGene00166759	21ur-10045
No description available

WB:WBGene00166760	21ur-13828
No description available

WB:WBGene00166761	21ur-12955
No description available

WB:WBGene00166762	21ur-12506
No description available

WB:WBGene00166763	21ur-7602
No description available

WB:WBGene00166764	21ur-6467
No description available

WB:WBGene00166765	21ur-11194
No description available

WB:WBGene00166766	21ur-7510
No description available

WB:WBGene00166767	21ur-9454
No description available

WB:WBGene00166768	21ur-14484
No description available

WB:WBGene00166769	21ur-7610
No description available

WB:WBGene00166770	21ur-7568
No description available

WB:WBGene00166771	21ur-5771
No description available

WB:WBGene00166772	21ur-15592
Is affected by daf-2 based on microarray studies.

WB:WBGene00166773	21ur-15298
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00166774	21ur-9399
No description available

WB:WBGene00166775	21ur-14870
Is affected by eat-2 based on microarray studies.

WB:WBGene00166776	21ur-13306
No description available

WB:WBGene00166777	21ur-9123
No description available

WB:WBGene00166778	21ur-12011
No description available

WB:WBGene00166779	21ur-5611
No description available

WB:WBGene00166780	21ur-6105
No description available

WB:WBGene00166781	21ur-5883
No description available

WB:WBGene00166782	21ur-5456
No description available

WB:WBGene00166783	21ur-9070
No description available

WB:WBGene00166784	21ur-15659
No description available

WB:WBGene00166785	21ur-8681
No description available

WB:WBGene00166786	21ur-8039
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00166787	21ur-7564
No description available

WB:WBGene00166788	21ur-5521
No description available

WB:WBGene00166789	21ur-9376
No description available

WB:WBGene00166790	21ur-13929
No description available

WB:WBGene00166791	21ur-9542
No description available

WB:WBGene00166792	21ur-8897
No description available

WB:WBGene00166793	21ur-8725
No description available

WB:WBGene00166794	21ur-10828
No description available

WB:WBGene00166795	21ur-9900
No description available

WB:WBGene00166796	21ur-12747
No description available

WB:WBGene00166797	21ur-5649
No description available

WB:WBGene00166798	21ur-6831
No description available

WB:WBGene00166799	21ur-10152
No description available

WB:WBGene00166800	21ur-5748
No description available

WB:WBGene00166801	21ur-9782
No description available

WB:WBGene00166802	21ur-9754
No description available

WB:WBGene00166803	21ur-13805
No description available

WB:WBGene00166804	21ur-6566
No description available

WB:WBGene00166805	21ur-13795
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166806	21ur-14799
No description available

WB:WBGene00166807	21ur-7950
No description available

WB:WBGene00166808	21ur-8466
No description available

WB:WBGene00166809	21ur-10278
No description available

WB:WBGene00166810	21ur-13750
No description available

WB:WBGene00166811	21ur-8662
No description available

WB:WBGene00166812	21ur-7537
No description available

WB:WBGene00166813	21ur-15356
Is affected by eat-2 based on microarray studies.

WB:WBGene00166814	21ur-10678
No description available

WB:WBGene00166815	21ur-7534
No description available

WB:WBGene00166816	21ur-14849
No description available

WB:WBGene00166817	21ur-9615
No description available

WB:WBGene00166819	21ur-6202
No description available

WB:WBGene00166820	21ur-13123
No description available

WB:WBGene00166821	21ur-14610
No description available

WB:WBGene00166822	21ur-7836
No description available

WB:WBGene00166823	21ur-10535
No description available

WB:WBGene00166824	21ur-14402
No description available

WB:WBGene00166825	21ur-11185
No description available

WB:WBGene00166826	21ur-7681
No description available

WB:WBGene00166827	21ur-6452
No description available

WB:WBGene00166828	21ur-13423
No description available

WB:WBGene00166829	21ur-14075
No description available

WB:WBGene00166830	21ur-11605
No description available

WB:WBGene00166831	21ur-8630
No description available

WB:WBGene00166832	21ur-13719
No description available

WB:WBGene00166833	21ur-7222
No description available

WB:WBGene00166834	21ur-15527
No description available

WB:WBGene00166835	21ur-9072
No description available

WB:WBGene00166836	21ur-5594
No description available

WB:WBGene00166837	21ur-12111
No description available

WB:WBGene00166838	21ur-5993
No description available

WB:WBGene00166839	21ur-6691
No description available

WB:WBGene00166840	21ur-11476
No description available

WB:WBGene00166841	21ur-7855
No description available

WB:WBGene00166842	21ur-6974
No description available

WB:WBGene00166843	21ur-7835
No description available

WB:WBGene00166844	21ur-6940
No description available

WB:WBGene00166845	21ur-14156
No description available

WB:WBGene00166846	21ur-14058
No description available

WB:WBGene00166847	21ur-14636
No description available

WB:WBGene00166848	21ur-8179
No description available

WB:WBGene00166849	21ur-6485
No description available

WB:WBGene00166850	21ur-12718
No description available

WB:WBGene00166851	21ur-7942
No description available

WB:WBGene00166852	21ur-12491
No description available

WB:WBGene00166853	21ur-15652
No description available

WB:WBGene00166854	21ur-14923
No description available

WB:WBGene00166855	21ur-8939
No description available

WB:WBGene00166856	21ur-5528
No description available

WB:WBGene00166857	21ur-14238
No description available

WB:WBGene00166858	21ur-7226
No description available

WB:WBGene00166859	21ur-8732
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166860	21ur-6796
No description available

WB:WBGene00166861	21ur-9170
No description available

WB:WBGene00166862	21ur-7559
No description available

WB:WBGene00166863	21ur-12895
No description available

WB:WBGene00166864	21ur-6314
No description available

WB:WBGene00166865	21ur-13618
No description available

WB:WBGene00166866	21ur-11336
No description available

WB:WBGene00166867	21ur-10428
No description available

WB:WBGene00166868	21ur-15645
No description available

WB:WBGene00166869	21ur-11457
No description available

WB:WBGene00166870	21ur-14099
No description available

WB:WBGene00166871	21ur-11875
No description available

WB:WBGene00166872	21ur-9280
No description available

WB:WBGene00166873	21ur-9262
No description available

WB:WBGene00166874	21ur-9921
No description available

WB:WBGene00166875	21ur-9711
No description available

WB:WBGene00166876	21ur-12154
No description available

WB:WBGene00166877	21ur-11879
No description available

WB:WBGene00166878	21ur-9237
No description available

WB:WBGene00166879	21ur-7735
No description available

WB:WBGene00166880	21ur-13621
No description available

WB:WBGene00166881	21ur-8871
No description available

WB:WBGene00166882	21ur-14961
No description available

WB:WBGene00166883	21ur-12347
No description available

WB:WBGene00166884	21ur-7408
No description available

WB:WBGene00166885	21ur-11857
No description available

WB:WBGene00166886	21ur-6310
No description available

WB:WBGene00166887	21ur-6927
No description available

WB:WBGene00166888	21ur-15641
No description available

WB:WBGene00166889	21ur-8875
No description available

WB:WBGene00166890	21ur-5550
No description available

WB:WBGene00166891	21ur-7702
No description available

WB:WBGene00166892	21ur-7719
No description available

WB:WBGene00166893	21ur-8012
No description available

WB:WBGene00166894	21ur-15251
No description available

WB:WBGene00166895	21ur-7055
No description available

WB:WBGene00166896	21ur-5500
No description available

WB:WBGene00166897	21ur-12640
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00166898	21ur-11549
No description available

WB:WBGene00166899	21ur-10684
No description available

WB:WBGene00166900	21ur-6377
No description available

WB:WBGene00166901	21ur-8104
No description available

WB:WBGene00166902	21ur-11202
No description available

WB:WBGene00166903	21ur-9620
No description available

WB:WBGene00166904	21ur-10660
No description available

WB:WBGene00166905	21ur-10324
No description available

WB:WBGene00166906	21ur-11006
No description available

WB:WBGene00166907	21ur-10640
No description available

WB:WBGene00166908	21ur-12624
No description available

WB:WBGene00166909	21ur-12214
No description available

WB:WBGene00166910	21ur-6236
No description available

WB:WBGene00166911	21ur-15532
No description available

WB:WBGene00166912	21ur-11540
No description available

WB:WBGene00166913	21ur-8199
No description available

WB:WBGene00166914	21ur-6572
No description available

WB:WBGene00166915	21ur-13587
No description available

WB:WBGene00166916	21ur-9183
No description available

WB:WBGene00166917	21ur-15407
No description available

WB:WBGene00166918	21ur-8723
No description available

WB:WBGene00166919	21ur-11378
No description available

WB:WBGene00166920	21ur-12902
No description available

WB:WBGene00166921	21ur-6508
No description available

WB:WBGene00166922	21ur-6631
No description available

WB:WBGene00166923	21ur-14506
No description available

WB:WBGene00166924	21ur-12180
No description available

WB:WBGene00166925	21ur-13477
No description available

WB:WBGene00166926	21ur-9293
No description available

WB:WBGene00166927	21ur-13663
No description available

WB:WBGene00166928	21ur-8362
No description available

WB:WBGene00166929	21ur-5583
No description available

WB:WBGene00166930	21ur-9892
No description available

WB:WBGene00166931	21ur-6067
No description available

WB:WBGene00166932	21ur-6645
No description available

WB:WBGene00166933	21ur-14678
No description available

WB:WBGene00166934	21ur-11064
No description available

WB:WBGene00166935	21ur-8892
No description available

WB:WBGene00166936	21ur-5841
No description available

WB:WBGene00166937	21ur-13591
No description available

WB:WBGene00166938	21ur-6459
No description available

WB:WBGene00166939	21ur-15373
No description available

WB:WBGene00166940	21ur-9862
No description available

WB:WBGene00166941	21ur-6392
No description available

WB:WBGene00166942	21ur-13009
No description available

WB:WBGene00166943	21ur-7521
No description available

WB:WBGene00166944	21ur-15185
No description available

WB:WBGene00166945	21ur-13367
No description available

WB:WBGene00166946	21ur-8899
No description available

WB:WBGene00166947	21ur-11869
No description available

WB:WBGene00166948	21ur-14304
No description available

WB:WBGene00166949	21ur-13073
No description available

WB:WBGene00166950	21ur-14226
No description available

WB:WBGene00166951	21ur-11803
No description available

WB:WBGene00166952	21ur-14821
No description available

WB:WBGene00166953	21ur-10377
No description available

WB:WBGene00166954	21ur-6425
No description available

WB:WBGene00166955	21ur-6019
No description available

WB:WBGene00166956	21ur-8958
No description available

WB:WBGene00166957	21ur-10954
No description available

WB:WBGene00166958	21ur-11304
No description available

WB:WBGene00166959	21ur-8559
No description available

WB:WBGene00166960	21ur-12433
No description available

WB:WBGene00166961	21ur-8850
No description available

WB:WBGene00166962	21ur-15559
No description available

WB:WBGene00166963	21ur-14729
No description available

WB:WBGene00166964	21ur-15664
No description available

WB:WBGene00166965	21ur-8239
No description available

WB:WBGene00166966	21ur-11636
No description available

WB:WBGene00166967	21ur-6295
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00166968	21ur-12517
No description available

WB:WBGene00166969	21ur-12615
No description available

WB:WBGene00166970	21ur-10516
No description available

WB:WBGene00166971	21ur-11496
No description available

WB:WBGene00166972	21ur-11578
No description available

WB:WBGene00166973	21ur-10982
No description available

WB:WBGene00166974	21ur-15212
No description available

WB:WBGene00166975	21ur-11603
No description available

WB:WBGene00166976	21ur-6683
No description available

WB:WBGene00166977	21ur-10647
No description available

WB:WBGene00166978	21ur-11119
No description available

WB:WBGene00166979	21ur-15043
No description available

WB:WBGene00166980	21ur-10691
No description available

WB:WBGene00166981	21ur-6655
No description available

WB:WBGene00166982	21ur-10669
No description available

WB:WBGene00166983	21ur-8823
No description available

WB:WBGene00166984	21ur-9228
No description available

WB:WBGene00166985	21ur-6954
No description available

WB:WBGene00166986	21ur-15138
No description available

WB:WBGene00166987	21ur-11338
No description available

WB:WBGene00166988	21ur-9283
No description available

WB:WBGene00166989	21ur-6003
No description available

WB:WBGene00166990	21ur-10905
No description available

WB:WBGene00166991	21ur-8849
No description available

WB:WBGene00166992	21ur-9963
No description available

WB:WBGene00166993	21ur-15168
No description available

WB:WBGene00166994	21ur-13634
No description available

WB:WBGene00166995	21ur-12638
No description available

WB:WBGene00166996	21ur-13155
No description available

WB:WBGene00166997	21ur-6450
No description available

WB:WBGene00166998	21ur-11788
No description available

WB:WBGene00166999	21ur-10082
No description available

WB:WBGene00167000	21ur-8766
No description available

WB:WBGene00167001	21ur-7972
No description available

WB:WBGene00167002	21ur-10924
No description available

WB:WBGene00167003	21ur-7944
No description available

WB:WBGene00167004	21ur-11381
No description available

WB:WBGene00167005	21ur-6560
No description available

WB:WBGene00167006	21ur-15539
No description available

WB:WBGene00167007	21ur-14872
No description available

WB:WBGene00167008	21ur-13693
No description available

WB:WBGene00167009	21ur-15005
No description available

WB:WBGene00167010	21ur-9530
No description available

WB:WBGene00167011	21ur-7786
No description available

WB:WBGene00167012	21ur-9627
No description available

WB:WBGene00167013	21ur-5785
No description available

WB:WBGene00167014	21ur-12399
No description available

WB:WBGene00167015	21ur-7146
No description available

WB:WBGene00167016	21ur-10851
No description available

WB:WBGene00167017	21ur-7112
No description available

WB:WBGene00167018	21ur-14108
No description available

WB:WBGene00167019	21ur-8753
No description available

WB:WBGene00167020	21ur-10655
No description available

WB:WBGene00167021	21ur-7593
No description available

WB:WBGene00167022	21ur-14905
No description available

WB:WBGene00167023	21ur-8600
No description available

WB:WBGene00167024	21ur-14199
No description available

WB:WBGene00167025	21ur-14854
No description available

WB:WBGene00167026	21ur-7030
No description available

WB:WBGene00167027	21ur-6510
No description available

WB:WBGene00167028	21ur-13939
No description available

WB:WBGene00167029	21ur-11526
No description available

WB:WBGene00167030	21ur-12278
No description available

WB:WBGene00167031	21ur-10747
No description available

WB:WBGene00167032	21ur-6415
No description available

WB:WBGene00167033	21ur-10285
No description available

WB:WBGene00167034	21ur-6657
No description available

WB:WBGene00167035	21ur-9904
No description available

WB:WBGene00167036	21ur-12560
No description available

WB:WBGene00167037	21ur-14806
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167038	21ur-9249
No description available

WB:WBGene00167039	21ur-6620
No description available

WB:WBGene00167040	21ur-6296
No description available

WB:WBGene00167041	21ur-10393
No description available

WB:WBGene00167042	21ur-10818
No description available

WB:WBGene00167043	21ur-5936
No description available

WB:WBGene00167044	21ur-6381
No description available

WB:WBGene00167045	21ur-14190
No description available

WB:WBGene00167046	21ur-11128
No description available

WB:WBGene00167047	21ur-8333
No description available

WB:WBGene00167048	21ur-10892
No description available

WB:WBGene00167049	21ur-7690
No description available

WB:WBGene00167050	21ur-15267
No description available

WB:WBGene00167051	21ur-10740
No description available

WB:WBGene00167052	21ur-13146
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167053	21ur-13298
No description available

WB:WBGene00167054	21ur-10400
No description available

WB:WBGene00167055	21ur-10866
No description available

WB:WBGene00167056	21ur-9157
No description available

WB:WBGene00167057	21ur-13700
No description available

WB:WBGene00167058	21ur-6730
No description available

WB:WBGene00167059	21ur-15282
No description available

WB:WBGene00167060	21ur-15639
No description available

WB:WBGene00167061	21ur-8359
No description available

WB:WBGene00167062	21ur-8335
No description available

WB:WBGene00167063	21ur-15516
No description available

WB:WBGene00167064	21ur-12035
No description available

WB:WBGene00167065	21ur-9686
No description available

WB:WBGene00167066	21ur-12844
No description available

WB:WBGene00167067	21ur-11652
No description available

WB:WBGene00167068	21ur-8245
No description available

WB:WBGene00167069	21ur-6181
No description available

WB:WBGene00167070	21ur-6719
No description available

WB:WBGene00167071	21ur-15552
No description available

WB:WBGene00167072	21ur-14164
No description available

WB:WBGene00167073	21ur-8842
No description available

WB:WBGene00167074	21ur-11621
Is affected by glycine based on RNA-seq studies.

WB:WBGene00167075	21ur-10210
No description available

WB:WBGene00167076	21ur-10620
No description available

WB:WBGene00167077	21ur-6407
No description available

WB:WBGene00167078	21ur-7313
No description available

WB:WBGene00167079	21ur-9472
No description available

WB:WBGene00167080	21ur-13858
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167081	21ur-12948
No description available

WB:WBGene00167082	21ur-15305
No description available

WB:WBGene00167083	21ur-11440
No description available

WB:WBGene00167084	21ur-9789
No description available

WB:WBGene00167085	21ur-15090
No description available

WB:WBGene00167086	21ur-15016
No description available

WB:WBGene00167087	21ur-14386
No description available

WB:WBGene00167088	21ur-11730
No description available

WB:WBGene00167089	21ur-11269
No description available

WB:WBGene00167090	21ur-14595
No description available

WB:WBGene00167091	21ur-9134
No description available

WB:WBGene00167092	21ur-9139
No description available

WB:WBGene00167093	21ur-14511
No description available

WB:WBGene00167094	21ur-14318
Is enriched in muscle cell based on RNA-seq studies.

WB:WBGene00167095	21ur-14101
Is affected by daf-2 based on microarray studies.

WB:WBGene00167096	21ur-6343
No description available

WB:WBGene00167097	21ur-8398
No description available

WB:WBGene00167098	21ur-13890
No description available

WB:WBGene00167099	21ur-12423
No description available

WB:WBGene00167100	21ur-11898
No description available

WB:WBGene00167101	21ur-10469
No description available

WB:WBGene00167102	21ur-13457
No description available

WB:WBGene00167103	21ur-8785
No description available

WB:WBGene00167104	21ur-14867
Is affected by eat-2 based on microarray studies.

WB:WBGene00167105	21ur-14515
No description available

WB:WBGene00167106	21ur-13898
No description available

WB:WBGene00167107	21ur-13419
No description available

WB:WBGene00167108	21ur-13574
No description available

WB:WBGene00167109	21ur-7092
No description available

WB:WBGene00167110	21ur-9797
No description available

WB:WBGene00167111	21ur-14667
No description available

WB:WBGene00167112	21ur-13064
No description available

WB:WBGene00167113	21ur-14847
No description available

WB:WBGene00167114	21ur-9334
No description available

WB:WBGene00167115	21ur-6316
No description available

WB:WBGene00167116	21ur-9208
No description available

WB:WBGene00167117	21ur-8948
No description available

WB:WBGene00167118	21ur-6882
No description available

WB:WBGene00167119	21ur-11047
No description available

WB:WBGene00167120	21ur-14859
No description available

WB:WBGene00167121	21ur-14624
No description available

WB:WBGene00167122	21ur-5515
No description available

WB:WBGene00167123	21ur-15362
No description available

WB:WBGene00167124	21ur-9877
No description available

WB:WBGene00167125	21ur-11757
No description available

WB:WBGene00167126	21ur-10007
No description available

WB:WBGene00167127	21ur-11253
No description available

WB:WBGene00167128	21ur-6303
No description available

WB:WBGene00167129	21ur-15194
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167130	21ur-15204
No description available

WB:WBGene00167131	21ur-12598
No description available

WB:WBGene00167132	21ur-7656
No description available

WB:WBGene00167133	21ur-11173
No description available

WB:WBGene00167134	21ur-5477
No description available

WB:WBGene00167135	21ur-7063
No description available

WB:WBGene00167136	21ur-12548
No description available

WB:WBGene00167137	21ur-10104
No description available

WB:WBGene00167138	21ur-10204
No description available

WB:WBGene00167139	21ur-8049
No description available

WB:WBGene00167140	21ur-8697
No description available

WB:WBGene00167141	21ur-10123
No description available

WB:WBGene00167142	21ur-9639
No description available

WB:WBGene00167143	21ur-6283
No description available

WB:WBGene00167144	21ur-10370
No description available

WB:WBGene00167145	21ur-13710
No description available

WB:WBGene00167146	21ur-9792
No description available

WB:WBGene00167147	21ur-8192
No description available

WB:WBGene00167148	21ur-5684
No description available

WB:WBGene00167149	21ur-10273
No description available

WB:WBGene00167150	21ur-9041
No description available

WB:WBGene00167151	21ur-7797
No description available

WB:WBGene00167152	21ur-7616
No description available

WB:WBGene00167153	21ur-7193
No description available

WB:WBGene00167154	21ur-13645
No description available

WB:WBGene00167155	21ur-15464
No description available

WB:WBGene00167156	21ur-9498
No description available

WB:WBGene00167157	21ur-7428
No description available

WB:WBGene00167158	21ur-14281
No description available

WB:WBGene00167159	21ur-8552
No description available

WB:WBGene00167160	21ur-10438
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00167161	21ur-5917
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167162	21ur-14966
No description available

WB:WBGene00167163	21ur-7250
No description available

WB:WBGene00167164	21ur-9308
No description available

WB:WBGene00167165	21ur-7708
No description available

WB:WBGene00167166	21ur-8064
No description available

WB:WBGene00167167	21ur-15123
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167168	21ur-8386
No description available

WB:WBGene00167169	21ur-7037
No description available

WB:WBGene00167170	21ur-8454
No description available

WB:WBGene00167171	21ur-8260
No description available

WB:WBGene00167172	21ur-13981
No description available

WB:WBGene00167173	21ur-9392
No description available

WB:WBGene00167174	21ur-13542
No description available

WB:WBGene00167175	21ur-8269
No description available

WB:WBGene00167176	21ur-14665
No description available

WB:WBGene00167177	21ur-9994
No description available

WB:WBGene00167178	21ur-10477
No description available

WB:WBGene00167179	21ur-9487
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167180	21ur-14559
No description available

WB:WBGene00167181	21ur-13781
No description available

WB:WBGene00167182	21ur-13770
No description available

WB:WBGene00167183	21ur-7871
No description available

WB:WBGene00167184	21ur-7078
No description available

WB:WBGene00167185	21ur-14132
No description available

WB:WBGene00167186	21ur-8880
No description available

WB:WBGene00167187	21ur-11483
No description available

WB:WBGene00167188	21ur-11626
No description available

WB:WBGene00167189	21ur-11093
No description available

WB:WBGene00167190	21ur-8922
No description available

WB:WBGene00167191	21ur-13027
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00167192	21ur-14341
No description available

WB:WBGene00167193	21ur-15108
No description available

WB:WBGene00167194	21ur-8961
No description available

WB:WBGene00167195	21ur-13521
No description available

WB:WBGene00167196	21ur-6405
No description available

WB:WBGene00167197	21ur-10563
No description available

WB:WBGene00167198	21ur-5756
No description available

WB:WBGene00167199	21ur-7286
No description available

WB:WBGene00167200	21ur-14588
No description available

WB:WBGene00167201	21ur-15316
No description available

WB:WBGene00167202	21ur-7761
No description available

WB:WBGene00167203	21ur-14536
No description available

WB:WBGene00167204	21ur-7990
No description available

WB:WBGene00167205	21ur-11615
No description available

WB:WBGene00167206	21ur-10242
No description available

WB:WBGene00167207	21ur-9103
No description available

WB:WBGene00167208	21ur-6395
No description available

WB:WBGene00167209	21ur-12654
No description available

WB:WBGene00167210	21ur-11354
No description available

WB:WBGene00167211	21ur-12827
No description available

WB:WBGene00167212	21ur-12375
No description available

WB:WBGene00167213	21ur-10143
No description available

WB:WBGene00167214	21ur-15326
No description available

WB:WBGene00167215	21ur-6533
No description available

WB:WBGene00167216	21ur-9031
No description available

WB:WBGene00167217	21ur-8536
No description available

WB:WBGene00167218	21ur-5569
No description available

WB:WBGene00167219	21ur-6750
No description available

WB:WBGene00167220	21ur-14907
No description available

WB:WBGene00167221	21ur-12191
No description available

WB:WBGene00167222	21ur-6622
No description available

WB:WBGene00167223	21ur-6679
No description available

WB:WBGene00167224	21ur-13555
No description available

WB:WBGene00167225	21ur-14836
No description available

WB:WBGene00167226	21ur-13936
No description available

WB:WBGene00167227	21ur-11164
No description available

WB:WBGene00167228	21ur-10158
No description available

WB:WBGene00167229	21ur-6876
No description available

WB:WBGene00167230	21ur-13745
No description available

WB:WBGene00167231	21ur-11777
No description available

WB:WBGene00167232	21ur-13532
No description available

WB:WBGene00167233	21ur-13886
No description available

WB:WBGene00167234	21ur-8701
No description available

WB:WBGene00167235	21ur-6145
No description available

WB:WBGene00167236	21ur-14188
No description available

WB:WBGene00167237	21ur-15676
No description available

WB:WBGene00167238	21ur-13819
No description available

WB:WBGene00167239	21ur-5466
No description available

WB:WBGene00167240	21ur-10013
No description available

WB:WBGene00167241	21ur-9418
No description available

WB:WBGene00167242	21ur-13483
No description available

WB:WBGene00167243	21ur-14816
No description available

WB:WBGene00167244	21ur-14785
No description available

WB:WBGene00167245	21ur-7441
No description available

WB:WBGene00167246	21ur-6893
No description available

WB:WBGene00167247	21ur-6529
No description available

WB:WBGene00167248	21ur-8929
No description available

WB:WBGene00167249	21ur-7829
No description available

WB:WBGene00167250	21ur-12572
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00167251	21ur-7238
No description available

WB:WBGene00167252	21ur-9327
No description available

WB:WBGene00167253	21ur-9896
No description available

WB:WBGene00167254	21ur-8818
No description available

WB:WBGene00167255	21ur-15162
No description available

WB:WBGene00167256	21ur-8070
No description available

WB:WBGene00167257	21ur-5692
No description available

WB:WBGene00167258	21ur-10969
No description available

WB:WBGene00167259	21ur-8673
No description available

WB:WBGene00167260	21ur-9145
Is enriched in muscle cell based on RNA-seq studies.

WB:WBGene00167261	21ur-13510
No description available

WB:WBGene00167262	21ur-6523
No description available

WB:WBGene00167263	21ur-8019
No description available

WB:WBGene00167264	21ur-5706
No description available

WB:WBGene00167265	21ur-15378
No description available

WB:WBGene00167266	21ur-14120
No description available

WB:WBGene00167267	21ur-9447
No description available

WB:WBGene00167268	21ur-11400
No description available

WB:WBGene00167269	21ur-12264
No description available

WB:WBGene00167270	21ur-11365
No description available

WB:WBGene00167271	21ur-10135
No description available

WB:WBGene00167272	21ur-12157
No description available

WB:WBGene00167273	21ur-14046
No description available

WB:WBGene00167274	21ur-7673
No description available

WB:WBGene00167275	21ur-7857
No description available

WB:WBGene00167276	21ur-14069
No description available

WB:WBGene00167277	21ur-9027
Is affected by daf-2 based on microarray studies.

WB:WBGene00167278	21ur-11538
No description available

WB:WBGene00167279	21ur-14762
No description available

WB:WBGene00167280	21ur-7929
No description available

WB:WBGene00167281	21ur-6601
No description available

WB:WBGene00167282	21ur-15510
No description available

WB:WBGene00167283	21ur-8184
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00167284	21ur-6744
No description available

WB:WBGene00167285	21ur-12694
No description available

WB:WBGene00167286	21ur-12451
No description available

WB:WBGene00167287	21ur-6511
No description available

WB:WBGene00167288	21ur-12207
No description available

WB:WBGene00167289	21ur-6219
No description available

WB:WBGene00167290	21ur-10712
No description available

WB:WBGene00167291	21ur-9446
No description available

WB:WBGene00167292	21ur-14944
No description available

WB:WBGene00167293	21ur-7695
No description available

WB:WBGene00167294	21ur-15321
No description available

WB:WBGene00167295	21ur-13341
No description available

WB:WBGene00167296	21ur-9261
No description available

WB:WBGene00167297	21ur-15032
No description available

WB:WBGene00167298	21ur-13204
No description available

WB:WBGene00167299	21ur-7850
No description available

WB:WBGene00167300	21ur-14379
No description available

WB:WBGene00167301	21ur-12773
No description available

WB:WBGene00167302	21ur-6897
No description available

WB:WBGene00167303	21ur-11886
No description available

WB:WBGene00167304	21ur-15173
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167305	21ur-9600
No description available

WB:WBGene00167306	21ur-6444
No description available

WB:WBGene00167307	21ur-5625
No description available

WB:WBGene00167308	21ur-11553
No description available

WB:WBGene00167309	21ur-7413
No description available

WB:WBGene00167310	21ur-10930
No description available

WB:WBGene00167311	21ur-7980
No description available

WB:WBGene00167312	21ur-13430
No description available

WB:WBGene00167313	21ur-10546
No description available

WB:WBGene00167314	21ur-14619
No description available

WB:WBGene00167315	21ur-11298
No description available

WB:WBGene00167316	21ur-13684
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00167317	21ur-6937
No description available

WB:WBGene00167318	21ur-9667
No description available

WB:WBGene00167319	21ur-14141
No description available

WB:WBGene00167320	21ur-9773
No description available

WB:WBGene00167321	21ur-10957
No description available

WB:WBGene00167322	21ur-10545
No description available

WB:WBGene00167323	21ur-8803
No description available

WB:WBGene00167324	21ur-5696
No description available

WB:WBGene00167325	21ur-12253
No description available

WB:WBGene00167326	21ur-6091
No description available

WB:WBGene00167327	21ur-9268
No description available

WB:WBGene00167328	21ur-12199
No description available

WB:WBGene00167329	21ur-8374
No description available

WB:WBGene00167330	21ur-8312
No description available

WB:WBGene00167331	21ur-10338
No description available

WB:WBGene00167332	21ur-6665
No description available

WB:WBGene00167333	21ur-13626
No description available

WB:WBGene00167334	21ur-15051
No description available

WB:WBGene00167335	21ur-14274
No description available

WB:WBGene00167336	21ur-12859
No description available

WB:WBGene00167337	21ur-14696
No description available

WB:WBGene00167338	21ur-12795
No description available

WB:WBGene00167339	21ur-11423
No description available

WB:WBGene00167340	21ur-12558
No description available

WB:WBGene00167341	21ur-8828
No description available

WB:WBGene00167342	21ur-12143
No description available

WB:WBGene00167343	21ur-14546
No description available

WB:WBGene00167344	21ur-9932
No description available

WB:WBGene00167345	21ur-6278
No description available

WB:WBGene00167346	21ur-10385
No description available

WB:WBGene00167347	21ur-9999
No description available

WB:WBGene00167348	21ur-5967
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00167349	21ur-11983
No description available

WB:WBGene00167350	21ur-6258
No description available

WB:WBGene00167351	21ur-6128
No description available

WB:WBGene00167352	21ur-5737
No description available

WB:WBGene00167353	21ur-6615
No description available

WB:WBGene00167354	21ur-13348
No description available

WB:WBGene00167355	21ur-15446
No description available

WB:WBGene00167356	21ur-6012
No description available

WB:WBGene00167357	21ur-11914
No description available

WB:WBGene00167358	21ur-9939
No description available

WB:WBGene00167359	21ur-10074
No description available

WB:WBGene00167360	21ur-7479
No description available

WB:WBGene00167361	21ur-10232
No description available

WB:WBGene00167362	21ur-7001
No description available

WB:WBGene00167363	21ur-15039
No description available

WB:WBGene00167364	21ur-12623
No description available

WB:WBGene00167365	21ur-12735
No description available

WB:WBGene00167366	21ur-11262
No description available

WB:WBGene00167367	21ur-9210
No description available

WB:WBGene00167368	21ur-5872
No description available

WB:WBGene00167369	21ur-13462
No description available

WB:WBGene00167370	21ur-7175
No description available

WB:WBGene00167371	21ur-10519
No description available

WB:WBGene00167372	21ur-10482
No description available

WB:WBGene00167373	21ur-10497
No description available

WB:WBGene00167374	21ur-8583
No description available

WB:WBGene00167375	21ur-10046
No description available

WB:WBGene00167376	21ur-13380
No description available

WB:WBGene00167377	21ur-6579
No description available

WB:WBGene00167378	21ur-10673
No description available

WB:WBGene00167379	21ur-10217
No description available

WB:WBGene00167380	21ur-13740
No description available

WB:WBGene00167381	21ur-11222
No description available

WB:WBGene00167382	21ur-7362
No description available

WB:WBGene00167383	21ur-5596
No description available

WB:WBGene00167384	21ur-11531
No description available

WB:WBGene00167385	21ur-7122
No description available

WB:WBGene00167386	21ur-13437
No description available

WB:WBGene00167387	21ur-9516
No description available

WB:WBGene00167388	21ur-12361
No description available

WB:WBGene00167389	21ur-12677
No description available

WB:WBGene00167390	21ur-10318
No description available

WB:WBGene00167391	21ur-10805
No description available

WB:WBGene00167392	21ur-7358
No description available

WB:WBGene00167393	21ur-13500
No description available

WB:WBGene00167394	21ur-11673
No description available

WB:WBGene00167395	21ur-9571
No description available

WB:WBGene00167396	21ur-9757
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00167397	21ur-9093
No description available

WB:WBGene00167398	21ur-14336
No description available

WB:WBGene00167399	21ur-10698
No description available

WB:WBGene00167400	21ur-14459
No description available

WB:WBGene00167401	21ur-6567
No description available

WB:WBGene00167402	21ur-10364
No description available

WB:WBGene00167403	21ur-15392
No description available

WB:WBGene00167404	21ur-11393
No description available

WB:WBGene00167405	21ur-10917
No description available

WB:WBGene00167406	21ur-6886
No description available

WB:WBGene00167407	21ur-14655
No description available

WB:WBGene00167408	21ur-11712
No description available

WB:WBGene00167409	21ur-12126
No description available

WB:WBGene00167410	21ur-8151
No description available

WB:WBGene00167411	21ur-15501
No description available

WB:WBGene00167412	21ur-10111
No description available

WB:WBGene00167413	21ur-5731
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167414	21ur-10249
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167415	21ur-8353
No description available

WB:WBGene00167416	21ur-6853
No description available

WB:WBGene00167417	21ur-7353
No description available

WB:WBGene00167418	21ur-13549
No description available

WB:WBGene00167419	21ur-12005
No description available

WB:WBGene00167420	21ur-11780
No description available

WB:WBGene00167421	21ur-11324
No description available

WB:WBGene00167422	21ur-9706
No description available

WB:WBGene00167423	21ur-8109
No description available

WB:WBGene00167424	21ur-12908
No description available

WB:WBGene00167425	21ur-5662
No description available

WB:WBGene00167426	21ur-5559
No description available

WB:WBGene00167427	21ur-15098
No description available

WB:WBGene00167428	21ur-13264
No description available

WB:WBGene00167429	21ur-10407
No description available

WB:WBGene00167430	21ur-15258
No description available

WB:WBGene00167431	21ur-10303
No description available

WB:WBGene00167432	21ur-7492
No description available

WB:WBGene00167433	21ur-15432
No description available

WB:WBGene00167434	21ur-14418
No description available

WB:WBGene00167435	21ur-12059
No description available

WB:WBGene00167436	21ur-6799
No description available

WB:WBGene00167437	21ur-7840
No description available

WB:WBGene00167438	21ur-13988
No description available

WB:WBGene00167439	21ur-15573
No description available

WB:WBGene00167440	21ur-15545
No description available

WB:WBGene00167441	21ur-12477
No description available

WB:WBGene00167442	21ur-11439
No description available

WB:WBGene00167443	21ur-13997
No description available

WB:WBGene00167444	21ur-15458
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00167445	21ur-10266
No description available

WB:WBGene00167446	21ur-15626
No description available

WB:WBGene00167447	21ur-7271
No description available

WB:WBGene00167448	21ur-9695
No description available

WB:WBGene00167449	21ur-14295
No description available

WB:WBGene00167450	21ur-8708
No description available

WB:WBGene00167451	21ur-15273
No description available

WB:WBGene00167452	21ur-12301
No description available

WB:WBGene00167453	21ur-7218
No description available

WB:WBGene00167454	21ur-15110
No description available

WB:WBGene00167455	21ur-9526
No description available

WB:WBGene00167456	21ur-9150
No description available

WB:WBGene00167457	21ur-8968
No description available

WB:WBGene00167458	21ur-8999
No description available

WB:WBGene00167459	21ur-7528
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167460	21ur-5552
No description available

WB:WBGene00167461	21ur-12083
No description available

WB:WBGene00167462	21ur-7106
No description available

WB:WBGene00167463	21ur-11432
No description available

WB:WBGene00167464	21ur-5846
No description available

WB:WBGene00167465	21ur-13657
No description available

WB:WBGene00167466	21ur-6036
No description available

WB:WBGene00167467	21ur-7634
No description available

WB:WBGene00167468	21ur-13812
No description available

WB:WBGene00167469	21ur-5985
No description available

WB:WBGene00167470	21ur-12073
No description available

WB:WBGene00167471	21ur-5777
No description available

WB:WBGene00167472	21ur-11211
No description available

WB:WBGene00167473	21ur-12534
No description available

WB:WBGene00167474	21ur-8010
No description available

WB:WBGene00167475	21ur-10768
No description available

WB:WBGene00167476	21ur-13905
No description available

WB:WBGene00167477	21ur-15066
No description available

WB:WBGene00167478	21ur-13673
No description available

WB:WBGene00167479	21ur-8598
No description available

WB:WBGene00167480	21ur-8567
No description available

WB:WBGene00167481	21ur-6166
No description available

WB:WBGene00167482	21ur-13589
No description available

WB:WBGene00167483	21ur-5879
No description available

WB:WBGene00167484	21ur-7132
No description available

WB:WBGene00167485	21ur-7082
No description available

WB:WBGene00167487	21ur-14258
No description available

WB:WBGene00167488	21ur-11108
No description available

WB:WBGene00167489	21ur-10602
No description available

WB:WBGene00167490	21ur-7389
No description available

WB:WBGene00167491	21ur-12270
No description available

WB:WBGene00167492	21ur-9040
No description available

WB:WBGene00167493	21ur-7022
No description available

WB:WBGene00167494	21ur-6024
No description available

WB:WBGene00167495	21ur-7321
No description available

WB:WBGene00167496	21ur-9386
No description available

WB:WBGene00167497	21ur-7820
No description available

WB:WBGene00167498	21ur-6210
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167499	21ur-6186
No description available

WB:WBGene00167500	21ur-11443
No description available

WB:WBGene00167501	21ur-5590
No description available

WB:WBGene00167502	21ur-7530
No description available

WB:WBGene00167503	21ur-14558
No description available

WB:WBGene00167504	21ur-6212
No description available

WB:WBGene00167505	21ur-14481
No description available

WB:WBGene00167506	21ur-12752
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00167507	21ur-13220
No description available

WB:WBGene00167508	21ur-7648
No description available

WB:WBGene00167509	21ur-8975
No description available

WB:WBGene00167510	21ur-12161
No description available

WB:WBGene00167511	21ur-14579
No description available

WB:WBGene00167512	21ur-5898
No description available

WB:WBGene00167513	21ur-12653
No description available

WB:WBGene00167514	21ur-12129
No description available

WB:WBGene00167515	21ur-10558
No description available

WB:WBGene00167516	21ur-10277
No description available

WB:WBGene00167517	21ur-9899
No description available

WB:WBGene00167518	21ur-6422
No description available

WB:WBGene00167519	21ur-11143
No description available

WB:WBGene00167520	21ur-7473
Is affected by daf-2 based on microarray studies.

WB:WBGene00167521	21ur-12525
No description available

WB:WBGene00167522	21ur-6609
No description available

WB:WBGene00167523	21ur-15342
No description available

WB:WBGene00167524	21ur-13963
No description available

WB:WBGene00167525	21ur-12667
No description available

WB:WBGene00167526	21ur-9780
No description available

WB:WBGene00167527	21ur-11241
No description available

WB:WBGene00167528	21ur-6935
No description available

WB:WBGene00167529	21ur-8693
No description available

WB:WBGene00167530	21ur-10760
No description available

WB:WBGene00167531	21ur-5540
No description available

WB:WBGene00167532	21ur-13796
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167533	21ur-9832
No description available

WB:WBGene00167534	21ur-8191
No description available

WB:WBGene00167535	21ur-6209
No description available

WB:WBGene00167536	21ur-11931
No description available

WB:WBGene00167537	21ur-10704
No description available

WB:WBGene00167538	21ur-15193
No description available

WB:WBGene00167539	21ur-15022
No description available

WB:WBGene00167540	21ur-11907
No description available

WB:WBGene00167541	21ur-6838
No description available

WB:WBGene00167542	21ur-14015
No description available

WB:WBGene00167543	21ur-15605
No description available

WB:WBGene00167544	21ur-12587
No description available

WB:WBGene00167545	21ur-14400
No description available

WB:WBGene00167546	21ur-12805
No description available

WB:WBGene00167547	21ur-13599
No description available

WB:WBGene00167548	21ur-12957
No description available

WB:WBGene00167549	21ur-14441
No description available

WB:WBGene00167550	21ur-14508
No description available

WB:WBGene00167551	21ur-10580
No description available

WB:WBGene00167552	21ur-9676
No description available

WB:WBGene00167553	21ur-9801
No description available

WB:WBGene00167554	21ur-13354
No description available

WB:WBGene00167555	21ur-6463
No description available

WB:WBGene00167556	21ur-8107
No description available

WB:WBGene00167557	21ur-12116
No description available

WB:WBGene00167558	21ur-6197
No description available

WB:WBGene00167559	21ur-9250
No description available

WB:WBGene00167560	21ur-12817
No description available

WB:WBGene00167561	21ur-12313
No description available

WB:WBGene00167562	21ur-15634
No description available

WB:WBGene00167563	21ur-11985
No description available

WB:WBGene00167564	21ur-6693
No description available

WB:WBGene00167565	21ur-5912
No description available

WB:WBGene00167566	21ur-15270
No description available

WB:WBGene00167567	21ur-13821
No description available

WB:WBGene00167568	21ur-8967
No description available

WB:WBGene00167569	21ur-10298
No description available

WB:WBGene00167570	21ur-8900
No description available

WB:WBGene00167571	21ur-14026
No description available

WB:WBGene00167572	21ur-8608
No description available

WB:WBGene00167573	21ur-6159
No description available

WB:WBGene00167574	21ur-5652
No description available

WB:WBGene00167575	21ur-7810
No description available

WB:WBGene00167576	21ur-15297
No description available

WB:WBGene00167577	21ur-8378
No description available

WB:WBGene00167578	21ur-10021
No description available

WB:WBGene00167579	21ur-12921
No description available

WB:WBGene00167580	21ur-7953
No description available

WB:WBGene00167581	21ur-6195
No description available

WB:WBGene00167582	21ur-6675
No description available

WB:WBGene00167583	21ur-14165
No description available

WB:WBGene00167584	21ur-9713
No description available

WB:WBGene00167585	21ur-15456
No description available

WB:WBGene00167586	21ur-6120
No description available

WB:WBGene00167587	21ur-14231
No description available

WB:WBGene00167588	21ur-11970
No description available

WB:WBGene00167589	21ur-8072
No description available

WB:WBGene00167590	21ur-9745
No description available

WB:WBGene00167591	21ur-6387
No description available

WB:WBGene00167592	21ur-6125
No description available

WB:WBGene00167593	21ur-11562
No description available

WB:WBGene00167594	21ur-8905
No description available

WB:WBGene00167595	21ur-7095
No description available

WB:WBGene00167596	21ur-12167
No description available

WB:WBGene00167597	21ur-14846
No description available

WB:WBGene00167598	21ur-6643
No description available

WB:WBGene00167599	21ur-8601
No description available

WB:WBGene00167600	21ur-12124
No description available

WB:WBGene00167601	21ur-9375
No description available

WB:WBGene00167602	21ur-14233
No description available

WB:WBGene00167603	21ur-5458
No description available

WB:WBGene00167604	21ur-7513
No description available

WB:WBGene00167605	21ur-14933
No description available

WB:WBGene00167606	21ur-14074
No description available

WB:WBGene00167607	21ur-6071
No description available

WB:WBGene00167608	21ur-7152
No description available

WB:WBGene00167609	21ur-14056
No description available

WB:WBGene00167610	21ur-7557
No description available

WB:WBGene00167611	21ur-7683
No description available

WB:WBGene00167612	21ur-14633
No description available

WB:WBGene00167613	21ur-9641
No description available

WB:WBGene00167614	21ur-7838
No description available

WB:WBGene00167615	21ur-14648
No description available

WB:WBGene00167616	21ur-11564
No description available

WB:WBGene00167617	21ur-11749
No description available

WB:WBGene00167618	21ur-6456
No description available

WB:WBGene00167619	21ur-12750
No description available

WB:WBGene00167620	21ur-6995
No description available

WB:WBGene00167621	21ur-5491
No description available

WB:WBGene00167622	21ur-9363
No description available

WB:WBGene00167623	21ur-8474
No description available

WB:WBGene00167624	21ur-11148
No description available

WB:WBGene00167625	21ur-13823
No description available

WB:WBGene00167626	21ur-12285
No description available

WB:WBGene00167627	21ur-11172
No description available

WB:WBGene00167628	21ur-7509
No description available

WB:WBGene00167629	21ur-14754
No description available

WB:WBGene00167630	21ur-13601
No description available

WB:WBGene00167631	21ur-12759
No description available

WB:WBGene00167632	21ur-8722
No description available

WB:WBGene00167633	21ur-7535
No description available

WB:WBGene00167634	21ur-12045
No description available

WB:WBGene00167635	21ur-14399
No description available

WB:WBGene00167636	21ur-5663
No description available

WB:WBGene00167637	21ur-13977
No description available

WB:WBGene00167638	21ur-6977
No description available

WB:WBGene00167639	21ur-8938
No description available

WB:WBGene00167640	21ur-10765
No description available

WB:WBGene00167641	21ur-9561
No description available

WB:WBGene00167642	21ur-6270
No description available

WB:WBGene00167643	21ur-14988
No description available

WB:WBGene00167644	21ur-7347
No description available

WB:WBGene00167645	21ur-14921
No description available

WB:WBGene00167646	21ur-15179
No description available

WB:WBGene00167647	21ur-14899
No description available

WB:WBGene00167648	21ur-13425
Is affected by daf-16 and hmg-3 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00167649	21ur-7181
No description available

WB:WBGene00167650	21ur-5947
No description available

WB:WBGene00167651	21ur-6440
No description available

WB:WBGene00167652	21ur-14981
No description available

WB:WBGene00167653	21ur-12448
No description available

WB:WBGene00167654	21ur-11463
No description available

WB:WBGene00167655	21ur-9316
No description available

WB:WBGene00167656	21ur-14746
No description available

WB:WBGene00167657	21ur-11289
No description available

WB:WBGene00167658	21ur-10748
No description available

WB:WBGene00167659	21ur-8776
No description available

WB:WBGene00167660	21ur-12606
No description available

WB:WBGene00167661	21ur-6930
No description available

WB:WBGene00167662	21ur-8995
No description available

WB:WBGene00167663	21ur-14562
No description available

WB:WBGene00167664	21ur-7024
No description available

WB:WBGene00167665	21ur-6004
No description available

WB:WBGene00167666	21ur-14246
No description available

WB:WBGene00167667	21ur-11558
No description available

WB:WBGene00167668	21ur-7637
No description available

WB:WBGene00167669	21ur-6538
No description available

WB:WBGene00167670	21ur-7376
No description available

WB:WBGene00167671	21ur-12337
No description available

WB:WBGene00167672	21ur-10103
No description available

WB:WBGene00167673	21ur-6806
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167674	21ur-7493
No description available

WB:WBGene00167675	21ur-13091
No description available

WB:WBGene00167676	21ur-7159
No description available

WB:WBGene00167677	21ur-5792
No description available

WB:WBGene00167678	21ur-12710
No description available

WB:WBGene00167679	21ur-9922
No description available

WB:WBGene00167680	21ur-8804
No description available

WB:WBGene00167681	21ur-14431
No description available

WB:WBGene00167682	21ur-13287
No description available

WB:WBGene00167683	21ur-12744
No description available

WB:WBGene00167684	21ur-11072
No description available

WB:WBGene00167685	21ur-9174
No description available

WB:WBGene00167686	21ur-8667
No description available

WB:WBGene00167687	21ur-7843
No description available

WB:WBGene00167688	21ur-7817
No description available

WB:WBGene00167689	21ur-14772
No description available

WB:WBGene00167690	21ur-6332
No description available

WB:WBGene00167691	21ur-6943
No description available

WB:WBGene00167692	21ur-8164
No description available

WB:WBGene00167693	21ur-5479
No description available

WB:WBGene00167694	21ur-12277
No description available

WB:WBGene00167695	21ur-6506
No description available

WB:WBGene00167696	21ur-8084
No description available

WB:WBGene00167697	21ur-9774
No description available

WB:WBGene00167698	21ur-12496
No description available

WB:WBGene00167699	21ur-5779
No description available

WB:WBGene00167700	21ur-14596
No description available

WB:WBGene00167701	21ur-13081
No description available

WB:WBGene00167702	21ur-7111
No description available

WB:WBGene00167703	21ur-11012
No description available

WB:WBGene00167704	21ur-12749
No description available

WB:WBGene00167705	21ur-13530
No description available

WB:WBGene00167706	21ur-7435
No description available

WB:WBGene00167707	21ur-13980
No description available

WB:WBGene00167708	21ur-6134
No description available

WB:WBGene00167709	21ur-11275
No description available

WB:WBGene00167710	21ur-9568
No description available

WB:WBGene00167711	21ur-7500
No description available

WB:WBGene00167712	21ur-13131
No description available

WB:WBGene00167713	21ur-7304
No description available

WB:WBGene00167714	21ur-15004
No description available

WB:WBGene00167715	21ur-8634
No description available

WB:WBGene00167716	21ur-12681
No description available

WB:WBGene00167717	21ur-10751
No description available

WB:WBGene00167718	21ur-8365
No description available

WB:WBGene00167719	21ur-6727
No description available

WB:WBGene00167720	21ur-13953
No description available

WB:WBGene00167721	21ur-13749
No description available

WB:WBGene00167722	21ur-6064
No description available

WB:WBGene00167723	21ur-5873
No description available

WB:WBGene00167724	21ur-13235
No description available

WB:WBGene00167725	21ur-12434
No description available

WB:WBGene00167726	21ur-11363
No description available

WB:WBGene00167727	21ur-8094
No description available

WB:WBGene00167728	21ur-15013
No description available

WB:WBGene00167729	21ur-12504
No description available

WB:WBGene00167730	21ur-7291
No description available

WB:WBGene00167731	21ur-11370
No description available

WB:WBGene00167732	21ur-15181
No description available

WB:WBGene00167733	21ur-14616
No description available

WB:WBGene00167734	21ur-9069
No description available

WB:WBGene00167735	21ur-14993
No description available

WB:WBGene00167736	21ur-8356
No description available

WB:WBGene00167737	21ur-12915
No description available

WB:WBGene00167738	21ur-13147
No description available

WB:WBGene00167739	21ur-11405
No description available

WB:WBGene00167740	21ur-10571
No description available

WB:WBGene00167741	21ur-9982
No description available

WB:WBGene00167742	21ur-9455
No description available

WB:WBGene00167743	21ur-9884
No description available

WB:WBGene00167744	21ur-6759
No description available

WB:WBGene00167745	21ur-7264
No description available

WB:WBGene00167746	21ur-7283
No description available

WB:WBGene00167747	21ur-10224
No description available

WB:WBGene00167748	21ur-7269
No description available

WB:WBGene00167749	21ur-5784
No description available

WB:WBGene00167750	21ur-11122
No description available

WB:WBGene00167751	21ur-11137
No description available

WB:WBGene00167752	21ur-14943
No description available

WB:WBGene00167753	21ur-14288
No description available

WB:WBGene00167754	21ur-11954
No description available

WB:WBGene00167755	21ur-9880
No description available

WB:WBGene00167756	21ur-14000
No description available

WB:WBGene00167757	21ur-11192
No description available

WB:WBGene00167758	21ur-14686
No description available

WB:WBGene00167759	21ur-11977
No description available

WB:WBGene00167760	21ur-14571
No description available

WB:WBGene00167761	21ur-10262
No description available

WB:WBGene00167762	21ur-7908
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167763	21ur-12101
No description available

WB:WBGene00167764	21ur-5889
No description available

WB:WBGene00167765	21ur-6498
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00167766	21ur-7893
No description available

WB:WBGene00167767	21ur-12484
No description available

WB:WBGene00167768	21ur-5802
No description available

WB:WBGene00167769	21ur-8910
No description available

WB:WBGene00167770	21ur-9727
No description available

WB:WBGene00167771	21ur-6824
No description available

WB:WBGene00167772	21ur-9311
No description available

WB:WBGene00167773	21ur-10705
No description available

WB:WBGene00167774	21ur-10358
No description available

WB:WBGene00167775	21ur-6554
No description available

WB:WBGene00167776	21ur-11377
No description available

WB:WBGene00167777	21ur-8686
No description available

WB:WBGene00167778	21ur-7746
No description available

WB:WBGene00167779	21ur-12464
No description available

WB:WBGene00167780	21ur-10175
No description available

WB:WBGene00167781	21ur-15684
No description available

WB:WBGene00167782	21ur-7083
No description available

WB:WBGene00167783	21ur-14377
No description available

WB:WBGene00167784	21ur-14170
No description available

WB:WBGene00167785	21ur-10155
No description available

WB:WBGene00167786	21ur-9657
No description available

WB:WBGene00167787	21ur-15353
No description available

WB:WBGene00167788	21ur-11412
No description available

WB:WBGene00167789	21ur-11995
No description available

WB:WBGene00167790	21ur-8161
No description available

WB:WBGene00167791	21ur-6084
No description available

WB:WBGene00167792	21ur-8324
No description available

WB:WBGene00167793	21ur-13346
No description available

WB:WBGene00167794	21ur-9878
No description available

WB:WBGene00167795	21ur-6914
No description available

WB:WBGene00167796	21ur-7184
No description available

WB:WBGene00167797	21ur-7754
No description available

WB:WBGene00167799	21ur-6174
No description available

WB:WBGene00167800	21ur-7605
No description available

WB:WBGene00167801	21ur-8277
No description available

WB:WBGene00167802	21ur-10894
No description available

WB:WBGene00167803	21ur-9474
No description available

WB:WBGene00167804	21ur-10420
No description available

WB:WBGene00167805	21ur-6269
No description available

WB:WBGene00167806	21ur-8118
No description available

WB:WBGene00167807	21ur-15069
No description available

WB:WBGene00167808	21ur-12793
No description available

WB:WBGene00167809	21ur-7262
No description available

WB:WBGene00167810	21ur-14865
No description available

WB:WBGene00167811	21ur-13758
No description available

WB:WBGene00167812	21ur-7914
No description available

WB:WBGene00167813	21ur-13815
No description available

WB:WBGene00167814	21ur-10446
No description available

WB:WBGene00167815	21ur-8729
No description available

WB:WBGene00167816	21ur-8225
No description available

WB:WBGene00167817	21ur-12104
No description available

WB:WBGene00167818	21ur-9256
No description available

WB:WBGene00167819	21ur-13491
No description available

WB:WBGene00167820	21ur-10882
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167821	21ur-14735
No description available

WB:WBGene00167822	21ur-12937
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00167823	21ur-12092
No description available

WB:WBGene00167824	21ur-9839
No description available

WB:WBGene00167825	21ur-6602
No description available

WB:WBGene00167826	21ur-14039
No description available

WB:WBGene00167827	21ur-11972
No description available

WB:WBGene00167828	21ur-10449
No description available

WB:WBGene00167829	21ur-9608
No description available

WB:WBGene00167830	21ur-10871
No description available

WB:WBGene00167831	21ur-7040
No description available

WB:WBGene00167832	21ur-12017
No description available

WB:WBGene00167833	21ur-12541
No description available

WB:WBGene00167834	21ur-13464
No description available

WB:WBGene00167835	21ur-14045
No description available

WB:WBGene00167836	21ur-12177
No description available

WB:WBGene00167837	21ur-9133
No description available

WB:WBGene00167838	21ur-5845
No description available

WB:WBGene00167839	21ur-9816
No description available

WB:WBGene00167840	21ur-9895
No description available

WB:WBGene00167841	21ur-8432
No description available

WB:WBGene00167842	21ur-14976
No description available

WB:WBGene00167843	21ur-11347
No description available

WB:WBGene00167845	21ur-9737
No description available

WB:WBGene00167846	21ur-13861
No description available

WB:WBGene00167847	21ur-9684
No description available

WB:WBGene00167848	21ur-13470
No description available

WB:WBGene00167849	21ur-6847
No description available

WB:WBGene00167850	21ur-9929
No description available

WB:WBGene00167851	21ur-11115
No description available

WB:WBGene00167852	21ur-10526
No description available

WB:WBGene00167853	21ur-7667
No description available

WB:WBGene00167854	21ur-9855
No description available

WB:WBGene00167855	21ur-14707
No description available

WB:WBGene00167856	21ur-14602
No description available

WB:WBGene00167857	21ur-12414
No description available

WB:WBGene00167858	21ur-12228
No description available

WB:WBGene00167859	21ur-8403
No description available

WB:WBGene00167860	21ur-7749
No description available

WB:WBGene00167861	21ur-9226
No description available

WB:WBGene00167862	21ur-6788
No description available

WB:WBGene00167863	21ur-12666
No description available

WB:WBGene00167864	21ur-9853
No description available

WB:WBGene00167865	21ur-12649
No description available

WB:WBGene00167866	21ur-12094
No description available

WB:WBGene00167867	21ur-14218
No description available

WB:WBGene00167868	21ur-6345
No description available

WB:WBGene00167869	21ur-7025
No description available

WB:WBGene00167870	21ur-13543
No description available

WB:WBGene00167871	21ur-9610
No description available

WB:WBGene00167872	21ur-8563
No description available

WB:WBGene00167873	21ur-13047
No description available

WB:WBGene00167874	21ur-7248
No description available

WB:WBGene00167875	21ur-14053
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00167876	21ur-15668
No description available

WB:WBGene00167877	21ur-13167
No description available

WB:WBGene00167878	21ur-15415
No description available

WB:WBGene00167879	21ur-13271
No description available

WB:WBGene00167880	21ur-14957
No description available

WB:WBGene00167881	21ur-13834
No description available

WB:WBGene00167882	21ur-7768
No description available

WB:WBGene00167883	21ur-12323
No description available

WB:WBGene00167884	21ur-8798
No description available

WB:WBGene00167885	21ur-10413
No description available

WB:WBGene00167886	21ur-10990
No description available

WB:WBGene00167887	21ur-10168
No description available

WB:WBGene00167888	21ur-8280
No description available

WB:WBGene00167889	21ur-5484
No description available

WB:WBGene00167890	21ur-13809
No description available

WB:WBGene00167891	21ur-12493
No description available

WB:WBGene00167892	21ur-12985
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167893	21ur-8210
No description available

WB:WBGene00167894	21ur-9576
No description available

WB:WBGene00167895	21ur-5603
No description available

WB:WBGene00167896	21ur-10349
No description available

WB:WBGene00167897	21ur-13198
No description available

WB:WBGene00167898	21ur-15264
No description available

WB:WBGene00167899	21ur-6531
No description available

WB:WBGene00167900	21ur-12386
No description available

WB:WBGene00167901	21ur-11481
No description available

WB:WBGene00167902	21ur-9992
No description available

WB:WBGene00167903	21ur-7298
No description available

WB:WBGene00167904	21ur-8595
No description available

WB:WBGene00167905	21ur-10776
No description available

WB:WBGene00167906	21ur-11948
No description available

WB:WBGene00167907	21ur-8305
No description available

WB:WBGene00167908	21ur-10233
No description available

WB:WBGene00167909	21ur-15144
Is affected by daf-2 based on microarray studies.

WB:WBGene00167910	21ur-13161
No description available

WB:WBGene00167911	21ur-14409
No description available

WB:WBGene00167912	21ur-15477
No description available

WB:WBGene00167913	21ur-14876
No description available

WB:WBGene00167914	21ur-14470
No description available

WB:WBGene00167915	21ur-15454
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00167916	21ur-14280
No description available

WB:WBGene00167917	21ur-8672
No description available

WB:WBGene00167918	21ur-9195
No description available

WB:WBGene00167919	21ur-11328
No description available

WB:WBGene00167920	21ur-7200
No description available

WB:WBGene00167921	21ur-9546
No description available

WB:WBGene00167922	21ur-5571
No description available

WB:WBGene00167923	21ur-7207
No description available

WB:WBGene00167924	21ur-10479
No description available

WB:WBGene00167925	21ur-11158
No description available

WB:WBGene00167926	21ur-14207
No description available

WB:WBGene00167927	21ur-7462
No description available

WB:WBGene00167928	21ur-7336
No description available

WB:WBGene00167929	21ur-11334
No description available

WB:WBGene00167930	21ur-9074
No description available

WB:WBGene00167931	21ur-12502
No description available

WB:WBGene00167932	21ur-11321
No description available

WB:WBGene00167933	21ur-10078
No description available

WB:WBGene00167934	21ur-9424
No description available

WB:WBGene00167935	21ur-7801
No description available

WB:WBGene00167936	21ur-15561
No description available

WB:WBGene00167937	21ur-11478
No description available

WB:WBGene00167938	21ur-6798
No description available

WB:WBGene00167939	21ur-11154
No description available

WB:WBGene00167940	21ur-10060
No description available

WB:WBGene00167941	21ur-8008
No description available

WB:WBGene00167942	21ur-14250
No description available

WB:WBGene00167943	21ur-5864
No description available

WB:WBGene00167944	21ur-14477
No description available

WB:WBGene00167945	21ur-8711
No description available

WB:WBGene00167946	21ur-14466
No description available

WB:WBGene00167947	21ur-12728
No description available

WB:WBGene00167948	21ur-7416
No description available

WB:WBGene00167949	21ur-13428
No description available

WB:WBGene00167950	21ur-11180
No description available

WB:WBGene00167951	21ur-14262
No description available

WB:WBGene00167952	21ur-5803
No description available

WB:WBGene00167953	21ur-12626
No description available

WB:WBGene00167954	21ur-11689
No description available

WB:WBGene00167955	21ur-15661
No description available

WB:WBGene00167956	21ur-15574
No description available

WB:WBGene00167957	21ur-12237
No description available

WB:WBGene00167958	21ur-14387
No description available

WB:WBGene00167959	21ur-14784
No description available

WB:WBGene00167960	21ur-14456
No description available

WB:WBGene00167961	21ur-6305
No description available

WB:WBGene00167962	21ur-15530
No description available

WB:WBGene00167963	21ur-8176
No description available

WB:WBGene00167964	21ur-15358
No description available

WB:WBGene00167965	21ur-13729
No description available

WB:WBGene00167966	21ur-8207
No description available

WB:WBGene00167967	21ur-6702
No description available

WB:WBGene00167968	21ur-6052
No description available

WB:WBGene00167969	21ur-9358
No description available

WB:WBGene00167970	21ur-13008
No description available

WB:WBGene00167971	21ur-11859
No description available

WB:WBGene00167972	21ur-6039
No description available

WB:WBGene00167973	21ur-9189
No description available

WB:WBGene00167974	21ur-6842
No description available

WB:WBGene00167975	21ur-6049
No description available

WB:WBGene00167976	21ur-11581
No description available

WB:WBGene00167977	21ur-6435
No description available

WB:WBGene00167978	21ur-7318
No description available

WB:WBGene00167979	21ur-12336
No description available

WB:WBGene00167980	21ur-6670
No description available

WB:WBGene00167981	21ur-14424
No description available

WB:WBGene00167982	21ur-15699
No description available

WB:WBGene00167983	21ur-10737
No description available

WB:WBGene00167984	21ur-10502
No description available

WB:WBGene00167985	21ur-10126
No description available

WB:WBGene00167986	21ur-5955
No description available

WB:WBGene00167987	21ur-6451
No description available

WB:WBGene00167988	21ur-14716
No description available

WB:WBGene00167989	21ur-14032
No description available

WB:WBGene00167990	21ur-10662
No description available

WB:WBGene00167991	21ur-5921
No description available

WB:WBGene00167992	21ur-6035
No description available

WB:WBGene00167993	21ur-7549
No description available

WB:WBGene00167994	21ur-14917
No description available

WB:WBGene00167995	21ur-8514
No description available

WB:WBGene00167996	21ur-9527
No description available

WB:WBGene00167997	21ur-12533
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00167998	21ur-10410
No description available

WB:WBGene00167999	21ur-10035
No description available

WB:WBGene00168000	21ur-10198
No description available

WB:WBGene00168001	21ur-8420
No description available

WB:WBGene00168002	21ur-8091
No description available

WB:WBGene00168003	21ur-6247
No description available

WB:WBGene00168004	21ur-7864
No description available

WB:WBGene00168005	21ur-14937
No description available

WB:WBGene00168006	21ur-13849
No description available

WB:WBGene00168007	21ur-5474
No description available

WB:WBGene00168008	21ur-12791
No description available

WB:WBGene00168009	21ur-10952
No description available

WB:WBGene00168010	21ur-13228
No description available

WB:WBGene00168011	21ur-12810
No description available

WB:WBGene00168012	21ur-11079
No description available

WB:WBGene00168013	21ur-6883
No description available

WB:WBGene00168014	21ur-14563
No description available

WB:WBGene00168015	21ur-13842
No description available

WB:WBGene00168016	21ur-5688
No description available

WB:WBGene00168017	21ur-13099
No description available

WB:WBGene00168018	21ur-12944
No description available

WB:WBGene00168019	21ur-11682
No description available

WB:WBGene00168020	21ur-9646
No description available

WB:WBGene00168021	21ur-6682
No description available

WB:WBGene00168022	21ur-13054
No description available

WB:WBGene00168023	21ur-6023
No description available

WB:WBGene00168024	21ur-13564
No description available

WB:WBGene00168025	21ur-15421
No description available

WB:WBGene00168026	21ur-11525
No description available

WB:WBGene00168027	21ur-9062
No description available

WB:WBGene00168028	21ur-12294
No description available

WB:WBGene00168029	21ur-10723
No description available

WB:WBGene00168030	21ur-7109
No description available

WB:WBGene00168031	21ur-8743
No description available

WB:WBGene00168032	21ur-14749
No description available

WB:WBGene00168033	21ur-6816
No description available

WB:WBGene00168034	21ur-8985
No description available

WB:WBGene00168035	21ur-9115
No description available

WB:WBGene00168036	21ur-10792
No description available

WB:WBGene00168037	21ur-14364
No description available

WB:WBGene00168038	21ur-12065
No description available

WB:WBGene00168039	21ur-12309
No description available

WB:WBGene00168040	21ur-15416
No description available

WB:WBGene00168041	21ur-13209
No description available

WB:WBGene00168042	21ur-13082
No description available

WB:WBGene00168043	21ur-5631
No description available

WB:WBGene00168044	21ur-13924
No description available

WB:WBGene00168045	21ur-9192
No description available

WB:WBGene00168046	21ur-6791
Is affected by daf-2 based on microarray studies.

WB:WBGene00168047	21ur-14443
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168048	21ur-14321
No description available

WB:WBGene00168049	21ur-8422
No description available

WB:WBGene00168050	21ur-15219
No description available

WB:WBGene00168051	21ur-12409
No description available

WB:WBGene00168052	21ur-6262
No description available

WB:WBGene00168053	21ur-6096
No description available

WB:WBGene00168054	21ur-9972
No description available

WB:WBGene00168055	21ur-8622
No description available

WB:WBGene00168056	21ur-15409
No description available

WB:WBGene00168057	21ur-13479
No description available

WB:WBGene00168058	21ur-12312
No description available

WB:WBGene00168059	21ur-10492
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00168060	21ur-5835
No description available

WB:WBGene00168061	21ur-5810
No description available

WB:WBGene00168062	21ur-6491
No description available

WB:WBGene00168063	21ur-13170
No description available

WB:WBGene00168064	21ur-11187
No description available

WB:WBGene00168065	21ur-10215
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00168066	21ur-6237
No description available

WB:WBGene00168067	21ur-13664
No description available

WB:WBGene00168068	21ur-9599
Is affected by eat-2; emr-1; and lem-2 based on RNA-seq studies.

WB:WBGene00168069	21ur-14185
No description available

WB:WBGene00168070	21ur-5638
No description available

WB:WBGene00168071	21ur-14119
No description available

WB:WBGene00168072	21ur-12580
No description available

WB:WBGene00168073	21ur-10067
No description available

WB:WBGene00168074	21ur-10832
No description available

WB:WBGene00168075	21ur-15537
No description available

WB:WBGene00168076	21ur-14600
No description available

WB:WBGene00168077	21ur-9825
No description available

WB:WBGene00168078	21ur-15239
No description available

WB:WBGene00168079	21ur-12737
No description available

WB:WBGene00168080	21ur-15249
No description available

WB:WBGene00168081	21ur-13320
No description available

WB:WBGene00168082	21ur-7876
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168083	21ur-10053
No description available

WB:WBGene00168084	21ur-7483
No description available

WB:WBGene00168085	21ur-15581
No description available

WB:WBGene00168086	21ur-15609
No description available

WB:WBGene00168087	21ur-5940
No description available

WB:WBGene00168088	21ur-8128
No description available

WB:WBGene00168089	21ur-5767
No description available

WB:WBGene00168090	21ur-9535
No description available

WB:WBGene00168091	21ur-11926
No description available

WB:WBGene00168092	21ur-8837
No description available

WB:WBGene00168093	21ur-14777
No description available

WB:WBGene00168094	21ur-12440
No description available

WB:WBGene00168095	21ur-5607
Is affected by eat-2 based on microarray studies.

WB:WBGene00168096	21ur-9215
No description available

WB:WBGene00168097	21ur-14307
No description available

WB:WBGene00168098	21ur-7652
No description available

WB:WBGene00168099	21ur-10095
No description available

WB:WBGene00168100	21ur-6571
No description available

WB:WBGene00168101	21ur-9304
No description available

WB:WBGene00168102	21ur-6324
No description available

WB:WBGene00168103	21ur-8174
No description available

WB:WBGene00168104	21ur-14215
No description available

WB:WBGene00168105	21ur-12108
No description available

WB:WBGene00168106	21ur-15391
No description available

WB:WBGene00168107	21ur-6469
No description available

WB:WBGene00168108	21ur-12600
No description available

WB:WBGene00168109	21ur-15230
No description available

WB:WBGene00168110	21ur-9341
No description available

WB:WBGene00168111	21ur-7713
No description available

WB:WBGene00168112	21ur-13366
No description available

WB:WBGene00168113	21ur-7069
No description available

WB:WBGene00168114	21ur-14656
No description available

WB:WBGene00168115	21ur-11664
No description available

WB:WBGene00168116	21ur-9868
No description available

WB:WBGene00168117	21ur-5815
No description available

WB:WBGene00168118	21ur-13734
No description available

WB:WBGene00168119	21ur-13197
No description available

WB:WBGene00168120	21ur-11825
No description available

WB:WBGene00168121	21ur-9953
Is affected by eat-2 based on microarray studies.

WB:WBGene00168122	21ur-11248
No description available

WB:WBGene00168123	21ur-10783
No description available

WB:WBGene00168124	21ur-13412
No description available

WB:WBGene00168125	21ur-13213
No description available

WB:WBGene00168126	21ur-14179
No description available

WB:WBGene00168127	21ur-8830
No description available

WB:WBGene00168128	21ur-15426
No description available

WB:WBGene00168129	21ur-13234
No description available

WB:WBGene00168130	21ur-12348
No description available

WB:WBGene00168131	21ur-6146
No description available

WB:WBGene00168132	21ur-14884
No description available

WB:WBGene00168133	21ur-5980
No description available

WB:WBGene00168134	21ur-12850
No description available

WB:WBGene00168135	21ur-15256
No description available

WB:WBGene00168136	21ur-13717
No description available

WB:WBGene00168137	21ur-7288
No description available

WB:WBGene00168138	21ur-13628
No description available

WB:WBGene00168139	21ur-12746
No description available

WB:WBGene00168140	21ur-5509
No description available

WB:WBGene00168141	21ur-8791
No description available

WB:WBGene00168142	21ur-14458
No description available

WB:WBGene00168143	21ur-14252
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00168144	21ur-10807
No description available

WB:WBGene00168145	21ur-10485
No description available

WB:WBGene00168146	21ur-15178
No description available

WB:WBGene00168147	21ur-12772
No description available

WB:WBGene00168148	21ur-11714
No description available

WB:WBGene00168149	21ur-9125
No description available

WB:WBGene00168150	21ur-15289
No description available

WB:WBGene00168151	21ur-8952
No description available

WB:WBGene00168152	21ur-14627
No description available

WB:WBGene00168153	21ur-10362
No description available

WB:WBGene00168154	21ur-5745
No description available

WB:WBGene00168155	21ur-11431
No description available

WB:WBGene00168156	21ur-11703
No description available

WB:WBGene00168157	21ur-13114
No description available

WB:WBGene00168158	21ur-10959
No description available

WB:WBGene00168159	21ur-11296
No description available

WB:WBGene00168160	21ur-9753
No description available

WB:WBGene00168161	21ur-10913
No description available

WB:WBGene00168162	21ur-11912
No description available

WB:WBGene00168163	21ur-9159
No description available

WB:WBGene00168164	21ur-6996
No description available

WB:WBGene00168165	21ur-13675
No description available

WB:WBGene00168166	21ur-9518
No description available

WB:WBGene00168167	21ur-14915
No description available

WB:WBGene00168168	21ur-6476
No description available

WB:WBGene00168169	21ur-10509
No description available

WB:WBGene00168170	21ur-7412
No description available

WB:WBGene00168171	21ur-10672
No description available

WB:WBGene00168172	21ur-7866
No description available

WB:WBGene00168173	21ur-13655
No description available

WB:WBGene00168174	21ur-10511
No description available

WB:WBGene00168175	21ur-11237
No description available

WB:WBGene00168176	21ur-9168
No description available

WB:WBGene00168177	21ur-10908
No description available

WB:WBGene00168178	21ur-12846
No description available

WB:WBGene00168179	21ur-11395
No description available

WB:WBGene00168180	21ur-11837
No description available

WB:WBGene00168181	21ur-6968
No description available

WB:WBGene00168182	21ur-13804
No description available

WB:WBGene00168183	21ur-8585
No description available

WB:WBGene00168184	21ur-15111
No description available

WB:WBGene00168185	21ur-6545
No description available

WB:WBGene00168186	21ur-14635
No description available

WB:WBGene00168187	21ur-13357
No description available

WB:WBGene00168188	21ur-5987
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00168189	21ur-5969
No description available

WB:WBGene00168190	21ur-12904
No description available

WB:WBGene00168191	21ur-9746
No description available

WB:WBGene00168192	21ur-7354
No description available

WB:WBGene00168193	21ur-7547
No description available

WB:WBGene00168194	21ur-15092
No description available

WB:WBGene00168195	21ur-7401
No description available

WB:WBGene00168196	21ur-9396
No description available

WB:WBGene00168197	21ur-14675
No description available

WB:WBGene00168198	21ur-12942
No description available

WB:WBGene00168199	21ur-14360
No description available

WB:WBGene00168200	21ur-6822
No description available

WB:WBGene00168201	21ur-11394
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00168202	21ur-12367
No description available

WB:WBGene00168203	21ur-10713
No description available

WB:WBGene00168204	21ur-8042
No description available

WB:WBGene00168205	21ur-8946
No description available

WB:WBGene00168206	21ur-12679
No description available

WB:WBGene00168207	21ur-5623
No description available

WB:WBGene00168208	21ur-11850
No description available

WB:WBGene00168209	21ur-13021
No description available

WB:WBGene00168210	21ur-10945
No description available

WB:WBGene00168211	21ur-8629
No description available

WB:WBGene00168212	21ur-15240
No description available

WB:WBGene00168213	21ur-8656
No description available

WB:WBGene00168214	21ur-14714
No description available

WB:WBGene00168215	21ur-8983
No description available

WB:WBGene00168216	21ur-9663
No description available

WB:WBGene00168217	21ur-15037
No description available

WB:WBGene00168218	21ur-10368
No description available

WB:WBGene00168219	21ur-5999
No description available

WB:WBGene00168220	21ur-7845
No description available

WB:WBGene00168221	21ur-8057
No description available

WB:WBGene00168222	21ur-13945
No description available

WB:WBGene00168223	21ur-15280
No description available

WB:WBGene00168224	21ur-13343
No description available

WB:WBGene00168225	21ur-11797
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00168226	21ur-11533
No description available

WB:WBGene00168227	21ur-5538
No description available

WB:WBGene00168228	21ur-14532
No description available

WB:WBGene00168229	21ur-13382
No description available

WB:WBGene00168230	21ur-12837
No description available

WB:WBGene00168231	21ur-11509
No description available

WB:WBGene00168232	21ur-9651
No description available

WB:WBGene00168233	21ur-7120
No description available

WB:WBGene00168234	21ur-15145
No description available

WB:WBGene00168235	21ur-9161
No description available

WB:WBGene00168236	21ur-7363
No description available

WB:WBGene00168237	21ur-6761
No description available

WB:WBGene00168238	21ur-10344
No description available

WB:WBGene00168239	21ur-9046
No description available

WB:WBGene00168240	21ur-12393
No description available

WB:WBGene00168241	21ur-15063
No description available

WB:WBGene00168242	21ur-6447
No description available

WB:WBGene00168243	21ur-15663
No description available

WB:WBGene00168244	21ur-8037
No description available

WB:WBGene00168245	21ur-13876
No description available

WB:WBGene00168246	21ur-13991
No description available

WB:WBGene00168247	21ur-14271
No description available

WB:WBGene00168248	21ur-5960
No description available

WB:WBGene00168249	21ur-11161
No description available

WB:WBGene00168250	21ur-14974
No description available

WB:WBGene00168251	21ur-12596
No description available

WB:WBGene00168252	21ur-6275
No description available

WB:WBGene00168253	21ur-7767
No description available

WB:WBGene00168254	21ur-6878
No description available

WB:WBGene00168255	21ur-8350
No description available

WB:WBGene00168256	21ur-15312
No description available

WB:WBGene00168257	21ur-13431
No description available

WB:WBGene00168258	21ur-10461
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168259	21ur-12789
No description available

WB:WBGene00168260	21ur-11518
No description available

WB:WBGene00168261	21ur-8157
No description available

WB:WBGene00168262	21ur-8679
No description available

WB:WBGene00168263	21ur-12159
No description available

WB:WBGene00168264	21ur-5848
No description available

WB:WBGene00168265	21ur-11168
No description available

WB:WBGene00168266	21ur-8310
No description available

WB:WBGene00168267	21ur-12531
No description available

WB:WBGene00168268	21ur-11080
No description available

WB:WBGene00168269	21ur-7985
No description available

WB:WBGene00168270	21ur-11676
No description available

WB:WBGene00168271	21ur-15226
No description available

WB:WBGene00168272	21ur-9506
No description available

WB:WBGene00168273	21ur-9944
No description available

WB:WBGene00168274	21ur-9603
No description available

WB:WBGene00168275	21ur-14663
No description available

WB:WBGene00168276	21ur-11106
No description available

WB:WBGene00168277	21ur-10915
No description available

WB:WBGene00168278	21ur-9090
No description available

WB:WBGene00168279	21ur-6360
No description available

WB:WBGene00168280	21ur-6739
No description available

WB:WBGene00168281	21ur-11823
No description available

WB:WBGene00168282	21ur-5975
No description available

WB:WBGene00168283	21ur-11430
No description available

WB:WBGene00168284	21ur-10577
No description available

WB:WBGene00168285	21ur-7968
No description available

WB:WBGene00168286	21ur-11087
No description available

WB:WBGene00168287	21ur-6802
No description available

WB:WBGene00168288	21ur-6252
No description available

WB:WBGene00168289	21ur-6858
No description available

WB:WBGene00168290	21ur-5561
No description available

WB:WBGene00168291	21ur-10014
No description available

WB:WBGene00168292	21ur-13513
No description available

WB:WBGene00168293	21ur-12190
No description available

WB:WBGene00168294	21ur-8882
No description available

WB:WBGene00168295	21ur-6891
No description available

WB:WBGene00168296	21ur-13103
No description available

WB:WBGene00168297	21ur-12205
No description available

WB:WBGene00168298	21ur-7100
No description available

WB:WBGene00168299	21ur-14359
No description available

WB:WBGene00168300	21ur-10682
No description available

WB:WBGene00168301	21ur-9674
No description available

WB:WBGene00168302	21ur-7215
No description available

WB:WBGene00168303	21ur-13612
No description available

WB:WBGene00168304	21ur-10305
No description available

WB:WBGene00168305	21ur-6677
No description available

WB:WBGene00168306	21ur-8384
No description available

WB:WBGene00168307	21ur-15690
No description available

WB:WBGene00168308	21ur-5703
No description available

WB:WBGene00168309	21ur-7278
No description available

WB:WBGene00168310	21ur-9009
No description available

WB:WBGene00168311	21ur-15438
No description available

WB:WBGene00168312	21ur-14946
No description available

WB:WBGene00168313	21ur-8102
No description available

WB:WBGene00168314	21ur-13256
No description available

WB:WBGene00168315	21ur-6081
No description available

WB:WBGene00168316	21ur-8460
No description available

WB:WBGene00168317	21ur-10331
No description available

WB:WBGene00168318	21ur-5460
No description available

WB:WBGene00168319	21ur-7383
No description available

WB:WBGene00168320	21ur-8364
No description available

WB:WBGene00168321	21ur-8287
No description available

WB:WBGene00168322	21ur-12780
No description available

WB:WBGene00168323	21ur-12360
No description available

WB:WBGene00168324	21ur-7133
No description available

WB:WBGene00168325	21ur-10247
No description available

WB:WBGene00168326	21ur-15052
No description available

WB:WBGene00168327	21ur-12993
No description available

WB:WBGene00168328	21ur-6925
No description available

WB:WBGene00168329	21ur-13338
No description available

WB:WBGene00168330	21ur-12426
No description available

WB:WBGene00168331	21ur-12057
No description available

WB:WBGene00168332	21ur-6471
No description available

WB:WBGene00168333	21ur-9449
No description available

WB:WBGene00168334	21ur-14200
No description available

WB:WBGene00168335	21ur-6229
No description available

WB:WBGene00168336	21ur-8565
Is affected by daf-2 based on microarray studies.

WB:WBGene00168337	21ur-7275
No description available

WB:WBGene00168338	21ur-11232
No description available

WB:WBGene00168339	21ur-10240
No description available

WB:WBGene00168340	21ur-12802
No description available

WB:WBGene00168341	21ur-10058
No description available

WB:WBGene00168342	21ur-15325
No description available

WB:WBGene00168343	21ur-9520
No description available

WB:WBGene00168344	21ur-14909
No description available

WB:WBGene00168345	21ur-9332
No description available

WB:WBGene00168346	21ur-12249
No description available

WB:WBGene00168347	21ur-13108
No description available

WB:WBGene00168348	21ur-12782
No description available

WB:WBGene00168349	21ur-10599
No description available

WB:WBGene00168350	21ur-7812
No description available

WB:WBGene00168351	21ur-9275
No description available

WB:WBGene00168352	21ur-14292
No description available

WB:WBGene00168353	21ur-13813
No description available

WB:WBGene00168354	21ur-11659
No description available

WB:WBGene00168355	21ur-13386
No description available

WB:WBGene00168356	21ur-7256
No description available

WB:WBGene00168357	21ur-7632
No description available

WB:WBGene00168358	21ur-12453
No description available

WB:WBGene00168359	21ur-9202
No description available

WB:WBGene00168360	21ur-15314
No description available

WB:WBGene00168361	21ur-5531
No description available

WB:WBGene00168362	21ur-6525
No description available

WB:WBGene00168363	21ur-8395
No description available

WB:WBGene00168364	21ur-11571
No description available

WB:WBGene00168365	21ur-12021
No description available

WB:WBGene00168366	21ur-7007
No description available

WB:WBGene00168367	21ur-10051
No description available

WB:WBGene00168368	21ur-7523
No description available

WB:WBGene00168369	21ur-15506
No description available

WB:WBGene00168370	21ur-8707
No description available

WB:WBGene00168371	21ur-10425
No description available

WB:WBGene00168372	21ur-11993
No description available

WB:WBGene00168373	21ur-9026
No description available

WB:WBGene00168374	21ur-11884
No description available

WB:WBGene00168375	21ur-11860
No description available

WB:WBGene00168376	21ur-6851
No description available

WB:WBGene00168377	21ur-13241
No description available

WB:WBGene00168378	21ur-11721
No description available

WB:WBGene00168379	21ur-9348
No description available

WB:WBGene00168380	21ur-6774
No description available

WB:WBGene00168381	21ur-7135
No description available

WB:WBGene00168382	21ur-15081
No description available

WB:WBGene00168383	21ur-5715
No description available

WB:WBGene00168384	21ur-8476
No description available

WB:WBGene00168385	21ur-8886
No description available

WB:WBGene00168386	21ur-6868
No description available

WB:WBGene00168387	21ur-14491
No description available

WB:WBGene00168388	21ur-8263
No description available

WB:WBGene00168389	21ur-14126
No description available

WB:WBGene00168390	21ur-5557
No description available

WB:WBGene00168391	21ur-8917
No description available

WB:WBGene00168392	21ur-7080
No description available

WB:WBGene00168393	21ur-11888
No description available

WB:WBGene00168394	21ur-8413
No description available

WB:WBGene00168395	21ur-13246
No description available

WB:WBGene00168396	21ur-8456
No description available

WB:WBGene00168397	21ur-14348
No description available

WB:WBGene00168398	21ur-12185
No description available

WB:WBGene00168399	21ur-15588
Is affected by spc-1 and unc-70 based on RNA-seq studies.

WB:WBGene00168400	21ur-8088
No description available

WB:WBGene00168401	21ur-10300
No description available

WB:WBGene00168402	21ur-9837
No description available

WB:WBGene00168403	21ur-15360
No description available

WB:WBGene00168404	21ur-7041
No description available

WB:WBGene00168405	21ur-15651
No description available

WB:WBGene00168406	21ur-5690
No description available

WB:WBGene00168407	21ur-15448
No description available

WB:WBGene00168408	21ur-15291
No description available

WB:WBGene00168409	21ur-8530
No description available

WB:WBGene00168410	21ur-8996
No description available

WB:WBGene00168411	21ur-14134
No description available

WB:WBGene00168412	21ur-8182
No description available

WB:WBGene00168413	21ur-13075
No description available

WB:WBGene00168414	21ur-13165
No description available

WB:WBGene00168415	21ur-10963
No description available

WB:WBGene00168416	21ur-9440
No description available

WB:WBGene00168417	21ur-14411
No description available

WB:WBGene00168418	21ur-10084
No description available

WB:WBGene00168419	21ur-11601
No description available

WB:WBGene00168420	21ur-8861
No description available

WB:WBGene00168421	21ur-13523
No description available

WB:WBGene00168422	21ur-11130
No description available

WB:WBGene00168423	21ur-8527
No description available

WB:WBGene00168424	21ur-14592
No description available

WB:WBGene00168425	21ur-13181
No description available

WB:WBGene00168426	21ur-9266
No description available

WB:WBGene00168427	21ur-11965
No description available

WB:WBGene00168428	21ur-12696
No description available

WB:WBGene00168429	21ur-6094
No description available

WB:WBGene00168430	21ur-14144
No description available

WB:WBGene00168431	21ur-6743
No description available

WB:WBGene00168432	21ur-10568
No description available

WB:WBGene00168433	21ur-14814
No description available

WB:WBGene00168434	21ur-5723
No description available

WB:WBGene00168435	21ur-7861
No description available

WB:WBGene00168436	21ur-5710
No description available

WB:WBGene00168437	21ur-10491
No description available

WB:WBGene00168438	21ur-15565
No description available

WB:WBGene00168439	21ur-13058
No description available

WB:WBGene00168440	21ur-7118
No description available

WB:WBGene00168441	21ur-9324
No description available

WB:WBGene00168442	21ur-14294
No description available

WB:WBGene00168443	21ur-15018
No description available

WB:WBGene00168444	21ur-14768
No description available

WB:WBGene00168445	21ur-7946
No description available

WB:WBGene00168446	21ur-15335
No description available

WB:WBGene00168447	21ur-10503
No description available

WB:WBGene00168448	21ur-9247
No description available

WB:WBGene00168449	21ur-15517
No description available

WB:WBGene00168450	21ur-11638
No description available

WB:WBGene00168451	21ur-11616
No description available

WB:WBGene00168452	21ur-11840
No description available

WB:WBGene00168453	21ur-13763
No description available

WB:WBGene00168454	21ur-10149
No description available

WB:WBGene00168455	21ur-13396
No description available

WB:WBGene00168456	21ur-12527
No description available

WB:WBGene00168457	21ur-11631
No description available

WB:WBGene00168458	21ur-11979
No description available

WB:WBGene00168459	21ur-9056
No description available

WB:WBGene00168460	21ur-14552
No description available

WB:WBGene00168461	21ur-15307
No description available

WB:WBGene00168462	21ur-10282
No description available

WB:WBGene00168463	21ur-7660
No description available

WB:WBGene00168464	21ur-10606
No description available

WB:WBGene00168465	21ur-5799
No description available

WB:WBGene00168466	21ur-6163
No description available

WB:WBGene00168467	21ur-9997
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168468	21ur-13647
No description available

WB:WBGene00168469	21ur-7793
No description available

WB:WBGene00168470	21ur-12972
No description available

WB:WBGene00168472	21ur-14540
No description available

WB:WBGene00168473	21ur-11650
Is affected by hmg-4 based on RNA-seq studies.

WB:WBGene00168474	21ur-10816
No description available

WB:WBGene00168475	21ur-9551
No description available

WB:WBGene00168476	21ur-15658
No description available

WB:WBGene00168477	21ur-10436
No description available

WB:WBGene00168478	21ur-14334
No description available

WB:WBGene00168479	21ur-13776
No description available

WB:WBGene00168480	21ur-7576
No description available

WB:WBGene00168481	21ur-9289
No description available

WB:WBGene00168482	21ur-6412
No description available

WB:WBGene00168483	21ur-10929
No description available

WB:WBGene00168484	21ur-14195
No description available

WB:WBGene00168485	21ur-11263
No description available

WB:WBGene00168486	21ur-7641
No description available

WB:WBGene00168487	21ur-7144
No description available

WB:WBGene00168488	21ur-15099
No description available

WB:WBGene00168489	21ur-9541
No description available

WB:WBGene00168490	21ur-7657
No description available

WB:WBGene00168491	21ur-9787
No description available

WB:WBGene00168492	21ur-6633
No description available

WB:WBGene00168493	21ur-7426
No description available

WB:WBGene00168494	21ur-10073
No description available

WB:WBGene00168495	21ur-12482
No description available

WB:WBGene00168496	21ur-6880
No description available

WB:WBGene00168497	21ur-12219
No description available

WB:WBGene00168498	21ur-11744
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00168499	21ur-15547
No description available

WB:WBGene00168500	21ur-9636
No description available

WB:WBGene00168501	21ur-12032
No description available

WB:WBGene00168502	21ur-9962
No description available

WB:WBGene00168503	21ur-11782
No description available

WB:WBGene00168504	21ur-9716
No description available

WB:WBGene00168505	21ur-12279
No description available

WB:WBGene00168506	21ur-12028
No description available

WB:WBGene00168507	21ur-8221
No description available

WB:WBGene00168508	21ur-13912
No description available

WB:WBGene00168509	21ur-7920
No description available

WB:WBGene00168510	21ur-11623
No description available

WB:WBGene00168511	21ur-8493
No description available

WB:WBGene00168512	21ur-7588
No description available

WB:WBGene00168513	21ur-7770
No description available

WB:WBGene00168514	21ur-7391
No description available

WB:WBGene00168515	21ur-7017
No description available

WB:WBGene00168516	21ur-10613
No description available

WB:WBGene00168517	21ur-7901
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168518	21ur-5529
No description available

WB:WBGene00168519	21ur-13262
No description available

WB:WBGene00168520	21ur-9011
No description available

WB:WBGene00168521	21ur-11220
No description available

WB:WBGene00168522	21ur-10746
No description available

WB:WBGene00168523	21ur-8036
No description available

WB:WBGene00168524	21ur-11513
No description available

WB:WBGene00168525	21ur-7826
No description available

WB:WBGene00168526	21ur-8023
No description available

WB:WBGene00168527	21ur-12034
No description available

WB:WBGene00168528	21ur-14516
No description available

WB:WBGene00168529	21ur-14525
No description available

WB:WBGene00168530	21ur-7795
No description available

WB:WBGene00168531	21ur-13619
No description available

WB:WBGene00168532	21ur-13361
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168533	21ur-15636
No description available

WB:WBGene00168534	21ur-13458
No description available

WB:WBGene00168535	21ur-9432
No description available

WB:WBGene00168536	21ur-11800
No description available

WB:WBGene00168537	21ur-13278
No description available

WB:WBGene00168538	21ur-11656
No description available

WB:WBGene00168539	21ur-12546
No description available

WB:WBGene00168540	21ur-9465
No description available

WB:WBGene00168541	21ur-9135
No description available

WB:WBGene00168542	21ur-13020
No description available

WB:WBGene00168543	21ur-10005
No description available

WB:WBGene00168544	21ur-14952
No description available

WB:WBGene00168545	21ur-13652
No description available

WB:WBGene00168546	21ur-7614
No description available

WB:WBGene00168547	21ur-11301
No description available

WB:WBGene00168548	21ur-9924
No description available

WB:WBGene00168549	21ur-9391
No description available

WB:WBGene00168550	21ur-8894
No description available

WB:WBGene00168551	21ur-13856
No description available

WB:WBGene00168552	21ur-10785
No description available

WB:WBGene00168553	21ur-8371
No description available

WB:WBGene00168554	21ur-11517
No description available

WB:WBGene00168555	21ur-13033
No description available

WB:WBGene00168556	21ur-14529
No description available

WB:WBGene00168557	21ur-11956
No description available

WB:WBGene00168558	21ur-9532
No description available

WB:WBGene00168559	21ur-13141
No description available

WB:WBGene00168560	21ur-11891
No description available

WB:WBGene00168561	21ur-10848
No description available

WB:WBGene00168562	21ur-14900
No description available

WB:WBGene00168563	21ur-13702
No description available

WB:WBGene00168564	21ur-11259
No description available

WB:WBGene00168565	21ur-14629
No description available

WB:WBGene00168566	21ur-10856
No description available

WB:WBGene00168567	21ur-14805
No description available

WB:WBGene00168568	21ur-12926
No description available

WB:WBGene00168569	21ur-12832
No description available

WB:WBGene00168570	21ur-9708
No description available

WB:WBGene00168571	21ur-8816
No description available

WB:WBGene00168572	21ur-10617
No description available

WB:WBGene00168573	21ur-15462
No description available

WB:WBGene00168574	21ur-6021
No description available

WB:WBGene00168575	21ur-5683
No description available

WB:WBGene00168576	21ur-12610
No description available

WB:WBGene00168577	21ur-15195
No description available

WB:WBGene00168578	21ur-8338
No description available

WB:WBGene00168579	21ur-14107
No description available

WB:WBGene00168580	21ur-14726
No description available

WB:WBGene00168581	21ur-8927
No description available

WB:WBGene00168582	21ur-10260
No description available

WB:WBGene00168583	21ur-11620
No description available

WB:WBGene00168584	21ur-6288
No description available

WB:WBGene00168585	21ur-12230
No description available

WB:WBGene00168586	21ur-15439
No description available

WB:WBGene00168587	21ur-10532
No description available

WB:WBGene00168588	21ur-5657
Is affected by eat-2 based on microarray studies.

WB:WBGene00168589	21ur-13782
Is affected by zip-3 and smn-1 based on RNA-seq studies.

WB:WBGene00168590	21ur-13964
No description available

WB:WBGene00168591	21ur-9811
No description available

WB:WBGene00168592	21ur-7951
No description available

WB:WBGene00168593	21ur-7323
No description available

WB:WBGene00168594	21ur-10279
No description available

WB:WBGene00168595	21ur-7129
No description available

WB:WBGene00168596	21ur-6713
No description available

WB:WBGene00168597	21ur-6355
No description available

WB:WBGene00168598	21ur-11312
No description available

WB:WBGene00168599	21ur-9000
No description available

WB:WBGene00168600	21ur-9404
No description available

WB:WBGene00168601	21ur-13896
No description available

WB:WBGene00168602	21ur-8856
No description available

WB:WBGene00168603	21ur-9043
No description available

WB:WBGene00168604	21ur-5567
No description available

WB:WBGene00168605	21ur-5893
No description available

WB:WBGene00168606	21ur-8295
No description available

WB:WBGene00168607	21ur-13260
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168608	21ur-11698
No description available

WB:WBGene00168609	21ur-7387
No description available

WB:WBGene00168610	21ur-9097
No description available

WB:WBGene00168611	21ur-10829
No description available

WB:WBGene00168612	21ur-6183
No description available

WB:WBGene00168613	21ur-8783
No description available

WB:WBGene00168614	21ur-14130
No description available

WB:WBGene00168615	21ur-7994
No description available

WB:WBGene00168616	21ur-14324
No description available

WB:WBGene00168617	21ur-9625
No description available

WB:WBGene00168618	21ur-7895
No description available

WB:WBGene00168619	21ur-7732
No description available

WB:WBGene00168620	21ur-8077
No description available

WB:WBGene00168621	21ur-8483
No description available

WB:WBGene00168622	21ur-9485
No description available

WB:WBGene00168623	21ur-7628
No description available

WB:WBGene00168624	21ur-7149
No description available

WB:WBGene00168625	21ur-10985
No description available

WB:WBGene00168626	21ur-13585
No description available

WB:WBGene00168627	21ur-15030
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168628	21ur-5753
No description available

WB:WBGene00168629	21ur-10652
No description available

WB:WBGene00168630	21ur-5783
No description available

WB:WBGene00168631	21ur-14695
No description available

WB:WBGene00168632	21ur-8843
No description available

WB:WBGene00168633	21ur-12356
No description available

WB:WBGene00168634	21ur-11041
No description available

WB:WBGene00168635	21ur-7073
No description available

WB:WBGene00168636	21ur-9037
No description available

WB:WBGene00168637	21ur-9294
No description available

WB:WBGene00168638	21ur-14047
No description available

WB:WBGene00168639	21ur-7727
No description available

WB:WBGene00168640	21ur-8920
No description available

WB:WBGene00168641	21ur-5820
No description available

WB:WBGene00168642	21ur-5938
No description available

WB:WBGene00168643	21ur-8465
No description available

WB:WBGene00168644	21ur-7873
No description available

WB:WBGene00168645	21ur-6764
No description available

WB:WBGene00168646	21ur-8343
No description available

WB:WBGene00168647	21ur-7705
No description available

WB:WBGene00168648	21ur-8877
No description available

WB:WBGene00168649	21ur-8248
No description available

WB:WBGene00168650	21ur-12216
No description available

WB:WBGene00168651	21ur-12384
No description available

WB:WBGene00168652	21ur-7581
No description available

WB:WBGene00168653	21ur-11209
No description available

WB:WBGene00168654	21ur-12145
No description available

WB:WBGene00168655	21ur-11455
No description available

WB:WBGene00168656	21ur-14098
No description available

WB:WBGene00168657	21ur-13637
No description available

WB:WBGene00168658	21ur-11280
No description available

WB:WBGene00168659	21ur-15387
Is affected by emr-1; lem-2; and spt-16 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00168660	21ur-7430
No description available

WB:WBGene00168661	21ur-8691
No description available

WB:WBGene00168662	21ur-10901
No description available

WB:WBGene00168663	21ur-11229
No description available

WB:WBGene00168664	21ur-13569
No description available

WB:WBGene00168665	21ur-9659
No description available

WB:WBGene00168666	21ur-5896
No description available

WB:WBGene00168667	21ur-14229
No description available

WB:WBGene00168668	21ur-12273
No description available

WB:WBGene00168669	21ur-11095
No description available

WB:WBGene00168670	21ur-11252
No description available

WB:WBGene00168671	21ur-9152
No description available

WB:WBGene00168672	21ur-6143
No description available

WB:WBGene00168673	21ur-6629
No description available

WB:WBGene00168674	21ur-12630
No description available

WB:WBGene00168675	21ur-9598
No description available

WB:WBGene00168676	21ur-10270
No description available

WB:WBGene00168677	21ur-11200
No description available

WB:WBGene00168678	21ur-9291
No description available

WB:WBGene00168679	21ur-9415
No description available

WB:WBGene00168680	21ur-11335
No description available

WB:WBGene00168681	21ur-13176
No description available

WB:WBGene00168682	21ur-6115
No description available

WB:WBGene00168683	21ur-13934
No description available

WB:WBGene00168684	21ur-11502
No description available

WB:WBGene00168685	21ur-8821
No description available

WB:WBGene00168686	21ur-14040
No description available

WB:WBGene00168687	21ur-6654
No description available

WB:WBGene00168688	21ur-8800
No description available

WB:WBGene00168689	21ur-15205
No description available

WB:WBGene00168690	21ur-10646
No description available

WB:WBGene00168691	21ur-15132
No description available

WB:WBGene00168692	21ur-14871
No description available

WB:WBGene00168693	21ur-13509
No description available

WB:WBGene00168694	21ur-14824
No description available

WB:WBGene00168695	21ur-10369
No description available

WB:WBGene00168696	21ur-5730
No description available

WB:WBGene00168697	21ur-7303
No description available

WB:WBGene00168698	21ur-5506
No description available

WB:WBGene00168699	21ur-8943
No description available

WB:WBGene00168700	21ur-12762
No description available

WB:WBGene00168701	21ur-10375
No description available

WB:WBGene00168702	21ur-14113
No description available

WB:WBGene00168703	21ur-11403
No description available

WB:WBGene00168704	21ur-14011
No description available

WB:WBGene00168705	21ur-5905
No description available

WB:WBGene00168706	21ur-6390
No description available

WB:WBGene00168707	21ur-15380
No description available

WB:WBGene00168708	21ur-12705
No description available

WB:WBGene00168709	21ur-13941
No description available

WB:WBGene00168710	21ur-14313
No description available

WB:WBGene00168711	21ur-14224
No description available

WB:WBGene00168712	21ur-7331
No description available

WB:WBGene00168713	21ur-10328
No description available

WB:WBGene00168714	21ur-9799
No description available

WB:WBGene00168715	21ur-12633
No description available

WB:WBGene00168716	21ur-7552
No description available

WB:WBGene00168717	21ur-13125
No description available

WB:WBGene00168718	21ur-6375
No description available

WB:WBGene00168719	21ur-9794
No description available

WB:WBGene00168720	21ur-5930
No description available

WB:WBGene00168721	21ur-8331
No description available

WB:WBGene00168722	21ur-5919
No description available

WB:WBGene00168723	21ur-11343
No description available

WB:WBGene00168724	21ur-8193
No description available

WB:WBGene00168725	21ur-8607
No description available

WB:WBGene00168726	21ur-11025
No description available

WB:WBGene00168727	21ur-15512
No description available

WB:WBGene00168728	21ur-6013
No description available

WB:WBGene00168729	21ur-6906
No description available

WB:WBGene00168730	21ur-7338
No description available

WB:WBGene00168731	21ur-15159
No description available

WB:WBGene00168732	21ur-14151
No description available

WB:WBGene00168733	21ur-5584
No description available

WB:WBGene00168734	21ur-14088
No description available

WB:WBGene00168735	21ur-13881
No description available

WB:WBGene00168736	21ur-11551
No description available

WB:WBGene00168737	21ur-11546
No description available

WB:WBGene00168738	21ur-9112
No description available

WB:WBGene00168739	21ur-9494
No description available

WB:WBGene00168740	21ur-10269
No description available

WB:WBGene00168741	21ur-15049
No description available

WB:WBGene00168742	21ur-14890
No description available

WB:WBGene00168743	21ur-13377
No description available

WB:WBGene00168744	21ur-10184
No description available

WB:WBGene00168745	21ur-14181
No description available

WB:WBGene00168746	21ur-13158
No description available

WB:WBGene00168747	21ur-13597
No description available

WB:WBGene00168748	21ur-6297
No description available

WB:WBGene00168749	21ur-15369
No description available

WB:WBGene00168750	21ur-12825
No description available

WB:WBGene00168751	21ur-12604
No description available

WB:WBGene00168752	21ur-12171
No description available

WB:WBGene00168753	21ur-7161
No description available

WB:WBGene00168754	21ur-9765
No description available

WB:WBGene00168755	21ur-11491
No description available

WB:WBGene00168756	21ur-7595
No description available

WB:WBGene00168757	21ur-7032
No description available

WB:WBGene00168758	21ur-11446
No description available

WB:WBGene00168759	21ur-7314
No description available

WB:WBGene00168760	21ur-12960
No description available

WB:WBGene00168761	21ur-15127
No description available

WB:WBGene00168762	21ur-6507
No description available

WB:WBGene00168763	21ur-13603
No description available

WB:WBGene00168764	21ur-9231
No description available

WB:WBGene00168765	21ur-15612
No description available

WB:WBGene00168766	21ur-14622
No description available

WB:WBGene00168767	21ur-13622
No description available

WB:WBGene00168768	21ur-8143
No description available

WB:WBGene00168769	21ur-6436
No description available

WB:WBGene00168770	21ur-11791
No description available

WB:WBGene00168771	21ur-8760
No description available

WB:WBGene00168772	21ur-15486
No description available

WB:WBGene00168773	21ur-12672
No description available

WB:WBGene00168774	21ur-10834
No description available

WB:WBGene00168775	21ur-10472
No description available

WB:WBGene00168776	21ur-6073
No description available

WB:WBGene00168777	21ur-14139
No description available

WB:WBGene00168778	21ur-14581
No description available

WB:WBGene00168779	21ur-6517
No description available

WB:WBGene00168780	21ur-9468
No description available

WB:WBGene00168781	21ur-14852
No description available

WB:WBGene00168782	21ur-10395
No description available

WB:WBGene00168783	21ur-7978
No description available

WB:WBGene00168784	21ur-15686
No description available

WB:WBGene00168785	21ur-15355
No description available

WB:WBGene00168786	21ur-7245
No description available

WB:WBGene00168787	21ur-9419
No description available

WB:WBGene00168788	21ur-15153
No description available

WB:WBGene00168789	21ur-5866
No description available

WB:WBGene00168790	21ur-10105
No description available

WB:WBGene00168791	21ur-11671
No description available

WB:WBGene00168792	21ur-8756
No description available

WB:WBGene00168793	21ur-14244
No description available

WB:WBGene00168794	21ur-12861
No description available

WB:WBGene00168795	21ur-5712
No description available

WB:WBGene00168796	21ur-8472
No description available

WB:WBGene00168797	21ur-12881
No description available

WB:WBGene00168798	21ur-15067
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00168799	21ur-7154
No description available

WB:WBGene00168800	21ur-11058
No description available

WB:WBGene00168801	21ur-6955
No description available

WB:WBGene00168802	21ur-7468
No description available

WB:WBGene00168803	21ur-5800
No description available

WB:WBGene00168804	21ur-8132
No description available

WB:WBGene00168805	21ur-13040
No description available

WB:WBGene00168806	21ur-7306
No description available

WB:WBGene00168807	21ur-11461
No description available

WB:WBGene00168808	21ur-9682
No description available

WB:WBGene00168809	21ur-5666
No description available

WB:WBGene00168810	21ur-9259
No description available

WB:WBGene00168811	21ur-15075
No description available

WB:WBGene00168812	21ur-12684
No description available

WB:WBGene00168813	21ur-7689
No description available

WB:WBGene00168814	21ur-14646
No description available

WB:WBGene00168815	21ur-6101
No description available

WB:WBGene00168816	21ur-8887
No description available

WB:WBGene00168817	21ur-10539
No description available

WB:WBGene00168818	21ur-11089
No description available

WB:WBGene00168819	21ur-14941
No description available

WB:WBGene00168820	21ur-10636
No description available

WB:WBGene00168821	21ur-14385
No description available

WB:WBGene00168822	21ur-9491
No description available

WB:WBGene00168823	21ur-8307
No description available

WB:WBGene00168824	21ur-12544
No description available

WB:WBGene00168825	21ur-6725
No description available

WB:WBGene00168826	21ur-14573
No description available

WB:WBGene00168827	21ur-14147
No description available

WB:WBGene00168828	21ur-12326
No description available

WB:WBGene00168829	21ur-8770
No description available

WB:WBGene00168830	21ur-6249
No description available

WB:WBGene00168831	21ur-5686
No description available

WB:WBGene00168832	21ur-6941
No description available

WB:WBGene00168833	21ur-9172
No description available

WB:WBGene00168834	21ur-8341
No description available

WB:WBGene00168835	21ur-13954
No description available

WB:WBGene00168836	21ur-13916
No description available

WB:WBGene00168837	21ur-11654
No description available

WB:WBGene00168838	21ur-7147
No description available

WB:WBGene00168839	21ur-12498
No description available

WB:WBGene00168840	21ur-9935
No description available

WB:WBGene00168841	21ur-8392
No description available

WB:WBGene00168842	21ur-13133
No description available

WB:WBGene00168843	21ur-6006
No description available

WB:WBGene00168844	21ur-8375
No description available

WB:WBGene00168845	21ur-15572
No description available

WB:WBGene00168846	21ur-15007
No description available

WB:WBGene00168847	21ur-7903
No description available

WB:WBGene00168848	21ur-10664
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00168849	21ur-8086
No description available

WB:WBGene00168850	21ur-12436
No description available

WB:WBGene00168851	21ur-10137
No description available

WB:WBGene00168852	21ur-7328
No description available

WB:WBGene00168853	21ur-14874
No description available

WB:WBGene00168854	21ur-8632
No description available

WB:WBGene00168855	21ur-9829
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168856	21ur-14798
No description available

WB:WBGene00168857	21ur-13537
No description available

WB:WBGene00168858	21ur-11990
No description available

WB:WBGene00168859	21ur-14350
No description available

WB:WBGene00168860	21ur-10031
No description available

WB:WBGene00168861	21ur-9671
No description available

WB:WBGene00168862	21ur-11010
No description available

WB:WBGene00168863	21ur-9314
No description available

WB:WBGene00168864	21ur-12807
No description available

WB:WBGene00168865	21ur-14166
No description available

WB:WBGene00168866	21ur-7058
No description available

WB:WBGene00168867	21ur-8611
No description available

WB:WBGene00168868	21ur-13285
No description available

WB:WBGene00168869	21ur-10896
No description available

WB:WBGene00168870	21ur-8166
No description available

WB:WBGene00168871	21ur-9975
No description available

WB:WBGene00168872	21ur-10887
No description available

WB:WBGene00168873	21ur-7227
No description available

WB:WBGene00168874	21ur-6061
No description available

WB:WBGene00168875	21ur-7396
No description available

WB:WBGene00168876	21ur-10457
No description available

WB:WBGene00168877	21ur-10301
No description available

WB:WBGene00168878	21ur-12462
No description available

WB:WBGene00168879	21ur-8480
No description available

WB:WBGene00168880	21ur-11135
No description available

WB:WBGene00168881	21ur-11997
No description available

WB:WBGene00168882	21ur-8819
No description available

WB:WBGene00168883	21ur-5928
No description available

WB:WBGene00168884	21ur-11141
No description available

WB:WBGene00168885	21ur-10573
No description available

WB:WBGene00168886	21ur-9980
No description available

WB:WBGene00168887	21ur-12000
No description available

WB:WBGene00168888	21ur-10226
No description available

WB:WBGene00168889	21ur-10422
No description available

WB:WBGene00168890	21ur-13116
No description available

WB:WBGene00168891	21ur-14812
No description available

WB:WBGene00168892	21ur-12599
No description available

WB:WBGene00168893	21ur-8003
No description available

WB:WBGene00168894	21ur-11414
No description available

WB:WBGene00168895	21ur-7791
No description available

WB:WBGene00168896	21ur-8812
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168897	21ur-12988
No description available

WB:WBGene00168898	21ur-12916
No description available

WB:WBGene00168899	21ur-14685
No description available

WB:WBGene00168900	21ur-9882
No description available

WB:WBGene00168901	21ur-6556
No description available

WB:WBGene00168902	21ur-15375
No description available

WB:WBGene00168903	21ur-9988
No description available

WB:WBGene00168904	21ur-6150
No description available

WB:WBGene00168905	21ur-5573
No description available

WB:WBGene00168906	21ur-11362
No description available

WB:WBGene00168907	21ur-6970
No description available

WB:WBGene00168908	21ur-7756
No description available

WB:WBGene00168909	21ur-13722
No description available

WB:WBGene00168910	21ur-5887
No description available

WB:WBGene00168911	21ur-11641
No description available

WB:WBGene00168912	21ur-8326
No description available

WB:WBGene00168913	21ur-10177
No description available

WB:WBGene00168914	21ur-10781
No description available

WB:WBGene00168915	21ur-12346
No description available

WB:WBGene00168916	21ur-15286
No description available

WB:WBGene00168917	21ur-6066
No description available

WB:WBGene00168918	21ur-9886
No description available

WB:WBGene00168919	21ur-8096
No description available

WB:WBGene00168920	21ur-9767
No description available

WB:WBGene00168921	21ur-5519
No description available

WB:WBGene00168922	21ur-8545
No description available

WB:WBGene00168923	21ur-6699
No description available

WB:WBGene00168924	21ur-11742
No description available

WB:WBGene00168925	21ur-10934
No description available

WB:WBGene00168926	21ur-10884
No description available

WB:WBGene00168927	21ur-10026
No description available

WB:WBGene00168928	21ur-15183
No description available

WB:WBGene00168929	21ur-11868
No description available

WB:WBGene00168930	21ur-10937
No description available

WB:WBGene00168931	21ur-6267
No description available

WB:WBGene00168932	21ur-9217
No description available

WB:WBGene00168933	21ur-10700
No description available

WB:WBGene00168934	21ur-8233
No description available

WB:WBGene00168935	21ur-8739
No description available

WB:WBGene00168936	21ur-6148
No description available

WB:WBGene00168937	21ur-12911
No description available

WB:WBGene00168938	21ur-8973
No description available

WB:WBGene00168939	21ur-15340
No description available

WB:WBGene00168940	21ur-11935
No description available

WB:WBGene00168941	21ur-15028
No description available

WB:WBGene00168942	21ur-9365
No description available

WB:WBGene00168943	21ur-14347
No description available

WB:WBGene00168944	21ur-10608
No description available

WB:WBGene00168945	21ur-9181
No description available

WB:WBGene00168946	21ur-7195
No description available

WB:WBGene00168947	21ur-15549
No description available

WB:WBGene00168948	21ur-11816
No description available

WB:WBGene00168949	21ur-13798
No description available

WB:WBGene00168950	21ur-12070
No description available

WB:WBGene00168951	21ur-11179
No description available

WB:WBGene00168952	21ur-11082
No description available

WB:WBGene00168953	21ur-10582
No description available

WB:WBGene00168954	21ur-9466
No description available

WB:WBGene00168955	21ur-15607
No description available

WB:WBGene00168956	21ur-12669
No description available

WB:WBGene00168957	21ur-6276
No description available

WB:WBGene00168958	21ur-11113
No description available

WB:WBGene00168959	21ur-5775
No description available

WB:WBGene00168960	21ur-13557
No description available

WB:WBGene00168961	21ur-6604
No description available

WB:WBGene00168962	21ur-12990
No description available

WB:WBGene00168963	21ur-8618
No description available

WB:WBGene00168964	21ur-6433
No description available

WB:WBGene00168965	21ur-12511
No description available

WB:WBGene00168966	21ur-13414
No description available

WB:WBGene00168967	21ur-11905
No description available

WB:WBGene00168968	21ur-15602
No description available

WB:WBGene00168969	21ur-9861
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00168970	21ur-13854
No description available

WB:WBGene00168971	21ur-12040
No description available

WB:WBGene00168972	21ur-9252
No description available

WB:WBGene00168973	21ur-12173
No description available

WB:WBGene00168974	21ur-7496
No description available

WB:WBGene00168975	21ur-11190
No description available

WB:WBGene00168976	21ur-7831
No description available

WB:WBGene00168977	21ur-12388
No description available

WB:WBGene00168978	21ur-10235
No description available

WB:WBGene00168979	21ur-6695
No description available

WB:WBGene00168980	21ur-13356
No description available

WB:WBGene00168981	21ur-6240
No description available

WB:WBGene00168982	21ur-9750
No description available

WB:WBGene00168983	21ur-5600
No description available

WB:WBGene00168984	21ur-14631
No description available

WB:WBGene00168985	21ur-9076
No description available

WB:WBGene00168986	21ur-15600
No description available

WB:WBGene00168987	21ur-10019
No description available

WB:WBGene00168988	21ur-13786
No description available

WB:WBGene00168989	21ur-11706
Is affected by paraquat based on RNA-seq studies.

WB:WBGene00168990	21ur-13195
No description available

WB:WBGene00168991	21ur-14356
No description available

WB:WBGene00168992	21ur-7345
No description available

WB:WBGene00168993	21ur-5744
No description available

WB:WBGene00168994	21ur-15452
No description available

WB:WBGene00168995	21ur-8254
No description available

WB:WBGene00168996	21ur-9776
No description available

WB:WBGene00168997	21ur-11385
No description available

WB:WBGene00168998	21ur-5851
No description available

WB:WBGene00168999	21ur-10758
No description available

WB:WBGene00169000	21ur-12310
No description available

WB:WBGene00169001	21ur-12079
No description available

WB:WBGene00169002	21ur-11332
No description available

WB:WBGene00169003	21ur-10587
No description available

WB:WBGene00169004	21ur-7481
No description available

WB:WBGene00169005	21ur-7772
No description available

WB:WBGene00169006	21ur-6372
No description available

WB:WBGene00169007	21ur-11967
No description available

WB:WBGene00169008	21ur-15610
No description available

WB:WBGene00169009	21ur-7654
No description available

WB:WBGene00169010	21ur-8524
No description available

WB:WBGene00169011	21ur-12829
No description available

WB:WBGene00169012	21ur-7859
No description available

WB:WBGene00169013	21ur-12050
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00169014	21ur-7334
No description available

WB:WBGene00169015	21ur-13791
No description available

WB:WBGene00169016	21ur-7507
No description available

WB:WBGene00169017	21ur-8336
No description available

WB:WBGene00169018	21ur-10258
No description available

WB:WBGene00169019	21ur-9643
No description available

WB:WBGene00169020	21ur-10299
No description available

WB:WBGene00169021	21ur-14897
No description available

WB:WBGene00169022	21ur-9128
No description available

WB:WBGene00169023	21ur-7107
No description available

WB:WBGene00169024	21ur-5599
No description available

WB:WBGene00169025	21ur-8279
No description available

WB:WBGene00169026	21ur-12923
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00169027	21ur-7454
No description available

WB:WBGene00169028	21ur-15422
No description available

WB:WBGene00169029	21ur-14269
Is affected by damt-1 based on RNA-seq studies. Is affected by antimycin and paraquat based on RNA-seq studies.

WB:WBGene00169030	21ur-11225
No description available

WB:WBGene00169031	21ur-6465
No description available

WB:WBGene00169032	21ur-14935
No description available

WB:WBGene00169033	21ur-7515
No description available

WB:WBGene00169034	21ur-9743
No description available

WB:WBGene00169035	21ur-7635
No description available

WB:WBGene00169036	21ur-13607
No description available

WB:WBGene00169037	21ur-12122
No description available

WB:WBGene00169038	21ur-14235
No description available

WB:WBGene00169039	21ur-13975
No description available

WB:WBGene00169040	21ur-9458
No description available

WB:WBGene00169041	21ur-9913
No description available

WB:WBGene00169042	21ur-14205
No description available

WB:WBGene00169043	21ur-6318
No description available

WB:WBGene00169044	21ur-10319
No description available

WB:WBGene00169045	21ur-12474
No description available

WB:WBGene00169046	21ur-14795
No description available

WB:WBGene00169047	21ur-7955
No description available

WB:WBGene00169048	21ur-10465
No description available

WB:WBGene00169049	21ur-9584
No description available

WB:WBGene00169050	21ur-11566
No description available

WB:WBGene00169051	21ur-6481
No description available

WB:WBGene00169052	21ur-9471
No description available

WB:WBGene00169053	21ur-14913
No description available

WB:WBGene00169054	21ur-13600
No description available

WB:WBGene00169055	21ur-9555
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00169056	21ur-10057
No description available

WB:WBGene00169057	21ur-6010
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00169058	21ur-6993
No description available

WB:WBGene00169059	21ur-6561
No description available

WB:WBGene00169060	21ur-7517
No description available

WB:WBGene00169061	21ur-7533
No description available

WB:WBGene00169062	21ur-13926
No description available

WB:WBGene00169063	21ur-7451
No description available

WB:WBGene00169064	21ur-13515
No description available

WB:WBGene00169065	21ur-6595
No description available

WB:WBGene00169066	21ur-8203
No description available

WB:WBGene00169067	21ur-10973
No description available

WB:WBGene00169068	21ur-6979
No description available

WB:WBGene00169069	21ur-10739
No description available

WB:WBGene00169070	21ur-6300
No description available

WB:WBGene00169071	21ur-11933
No description available

WB:WBGene00169072	21ur-15576
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169073	21ur-9689
No description available

WB:WBGene00169074	21ur-8052
No description available

WB:WBGene00169075	21ur-14560
No description available

WB:WBGene00169076	21ur-8485
No description available

WB:WBGene00169077	21ur-6199
No description available

WB:WBGene00169078	21ur-8270
No description available

WB:WBGene00169079	21ur-12757
No description available

WB:WBGene00169080	21ur-8720
No description available

WB:WBGene00169081	21ur-14931
No description available

WB:WBGene00169082	21ur-7560
No description available

WB:WBGene00169083	21ur-9373
No description available

WB:WBGene00169084	21ur-6673
No description available

WB:WBGene00169085	21ur-13019
No description available

WB:WBGene00169086	21ur-14882
No description available

WB:WBGene00169087	21ur-10040
No description available

WB:WBGene00169088	21ur-8993
No description available

WB:WBGene00169089	21ur-12235
No description available

WB:WBGene00169090	21ur-12009
No description available

WB:WBGene00169091	21ur-9955
No description available

WB:WBGene00169092	21ur-11124
No description available

WB:WBGene00169093	21ur-5534
No description available

WB:WBGene00169094	21ur-8189
No description available

WB:WBGene00169095	21ur-8839
No description available

WB:WBGene00169096	21ur-10384
No description available

WB:WBGene00169097	21ur-6814
No description available

WB:WBGene00169098	21ur-14323
No description available

WB:WBGene00169099	21ur-13006
No description available

WB:WBGene00169100	21ur-6204
No description available

WB:WBGene00169101	21ur-12306
No description available

WB:WBGene00169102	21ur-9847
No description available

WB:WBGene00169103	21ur-7102
No description available

WB:WBGene00169104	21ur-13283
No description available

WB:WBGene00169105	21ur-8196
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00169106	21ur-7759
No description available

WB:WBGene00169107	21ur-14085
No description available

WB:WBGene00169108	21ur-12334
No description available

WB:WBGene00169109	21ur-14757
No description available

WB:WBGene00169110	21ur-14034
No description available

WB:WBGene00169111	21ur-12566
No description available

WB:WBGene00169112	21ur-7325
No description available

WB:WBGene00169113	21ur-6826
No description available

WB:WBGene00169114	21ur-8806
No description available

WB:WBGene00169115	21ur-12063
No description available

WB:WBGene00169116	21ur-12602
No description available

WB:WBGene00169117	21ur-12350
No description available

WB:WBGene00169118	21ur-14928
No description available

WB:WBGene00169119	21ur-13018
No description available

WB:WBGene00169120	21ur-7171
No description available

WB:WBGene00169121	21ur-13029
No description available

WB:WBGene00169122	21ur-10790
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00169123	21ur-10037
No description available

WB:WBGene00169124	21ur-14391
No description available

WB:WBGene00169125	21ur-14366
No description available

WB:WBGene00169126	21ur-6385
No description available

WB:WBGene00169127	21ur-15176
No description available

WB:WBGene00169128	21ur-14397
No description available

WB:WBGene00169129	21ur-14028
No description available

WB:WBGene00169130	21ur-15142
No description available

WB:WBGene00169131	21ur-9330
No description available

WB:WBGene00169132	21ur-14316
No description available

WB:WBGene00169133	21ur-6714
No description available

WB:WBGene00169134	21ur-5493
No description available

WB:WBGene00169135	21ur-10494
No description available

WB:WBGene00169136	21ur-6793
No description available

WB:WBGene00169137	21ur-12586
No description available

WB:WBGene00169138	21ur-6818
No description available

WB:WBGene00169139	21ur-14429
No description available

WB:WBGene00169140	21ur-6313
No description available

WB:WBGene00169141	21ur-12979
No description available

WB:WBGene00169142	21ur-9064
No description available

WB:WBGene00169143	21ur-5765
No description available

WB:WBGene00169144	21ur-10732
No description available

WB:WBGene00169145	21ur-7404
No description available

WB:WBGene00169146	21ur-13157
No description available

WB:WBGene00169147	21ur-8665
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169148	21ur-6708
No description available

WB:WBGene00169149	21ur-7721
No description available

WB:WBGene00169150	21ur-15615
No description available

WB:WBGene00169151	21ur-12852
No description available

WB:WBGene00169152	21ur-10978
No description available

WB:WBGene00169153	21ur-9197
No description available

WB:WBGene00169154	21ur-11342
No description available

WB:WBGene00169155	21ur-14068
No description available

WB:WBGene00169156	21ur-12268
No description available

WB:WBGene00169157	21ur-10839
No description available

WB:WBGene00169158	21ur-11077
No description available

WB:WBGene00169159	21ur-8981
No description available

WB:WBGene00169160	21ur-8847
No description available

WB:WBGene00169161	21ur-6514
No description available

WB:WBGene00169162	21ur-10726
No description available

WB:WBGene00169163	21ur-15667
No description available

WB:WBGene00169164	21ur-12256
No description available

WB:WBGene00169165	21ur-11556
No description available

WB:WBGene00169166	21ur-13566
No description available

WB:WBGene00169167	21ur-13223
No description available

WB:WBGene00169168	21ur-13056
No description available

WB:WBGene00169169	21ur-12479
No description available

WB:WBGene00169170	21ur-6504
No description available

WB:WBGene00169171	21ur-7676
No description available

WB:WBGene00169172	21ur-8145
No description available

WB:WBGene00169173	21ur-11684
No description available

WB:WBGene00169174	21ur-7878
No description available

WB:WBGene00169175	21ur-13919
No description available

WB:WBGene00169176	21ur-12579
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00169177	21ur-9739
No description available

WB:WBGene00169178	21ur-11847
No description available

WB:WBGene00169179	21ur-12713
No description available

WB:WBGene00169180	21ur-13736
No description available

WB:WBGene00169181	21ur-7701
No description available

WB:WBGene00169182	21ur-15232
No description available

WB:WBGene00169183	21ur-6478
No description available

WB:WBGene00169184	21ur-11921
No description available

WB:WBGene00169185	21ur-9101
No description available

WB:WBGene00169186	21ur-13084
No description available

WB:WBGene00169187	21ur-14117
No description available

WB:WBGene00169188	21ur-8126
No description available

WB:WBGene00169189	21ur-9155
No description available

WB:WBGene00169190	21ur-14607
No description available

WB:WBGene00169191	21ur-14609
No description available

WB:WBGene00169192	21ur-13775
No description available

WB:WBGene00169193	21ur-7343
No description available

WB:WBGene00169194	21ur-12221
No description available

WB:WBGene00169195	21ur-10372
No description available

WB:WBGene00169196	21ur-8832
No description available

WB:WBGene00169197	21ur-10296
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169198	21ur-11763
No description available

WB:WBGene00169199	21ur-6365
No description available

WB:WBGene00169200	21ur-12357
No description available

WB:WBGene00169201	21ur-11852
No description available

WB:WBGene00169202	21ur-8328
No description available

WB:WBGene00169203	21ur-15629
No description available

WB:WBGene00169204	21ur-10366
No description available

WB:WBGene00169205	21ur-10312
No description available

WB:WBGene00169206	21ur-9592
No description available

WB:WBGene00169207	21ur-7881
No description available

WB:WBGene00169208	21ur-11693
No description available

WB:WBGene00169209	21ur-8648
No description available

WB:WBGene00169210	21ur-15593
No description available

WB:WBGene00169211	21ur-5605
No description available

WB:WBGene00169212	21ur-12292
No description available

WB:WBGene00169213	21ur-11928
No description available

WB:WBGene00169214	21ur-12476
No description available

WB:WBGene00169215	21ur-9165
No description available

WB:WBGene00169216	21ur-5826
No description available

WB:WBGene00169217	21ur-8500
No description available

WB:WBGene00169218	21ur-8516
No description available

WB:WBGene00169219	21ur-8441
No description available

WB:WBGene00169220	21ur-9529
No description available

WB:WBGene00169221	21ur-10873
No description available

WB:WBGene00169222	21ur-15400
No description available

WB:WBGene00169223	21ur-15021
No description available

WB:WBGene00169224	21ur-15524
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00169225	21ur-14024
No description available

WB:WBGene00169226	21ur-8684
No description available

WB:WBGene00169227	21ur-15121
No description available

WB:WBGene00169228	21ur-14968
No description available

WB:WBGene00169229	21ur-12878
No description available

WB:WBGene00169230	21ur-9058
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169231	21ur-15202
No description available

WB:WBGene00169232	21ur-14710
No description available

WB:WBGene00169233	21ur-12024
No description available

WB:WBGene00169234	21ur-11587
No description available

WB:WBGene00169235	21ur-7988
No description available

WB:WBGene00169236	21ur-15398
No description available

WB:WBGene00169237	21ur-11189
No description available

WB:WBGene00169238	21ur-6757
No description available

WB:WBGene00169239	21ur-14690
No description available

WB:WBGene00169240	21ur-10063
No description available

WB:WBGene00169242	21ur-11375
No description available

WB:WBGene00169243	21ur-13329
No description available

WB:WBGene00169244	21ur-11450
No description available

WB:WBGene00169245	21ur-13800
No description available

WB:WBGene00169246	21ur-6230
No description available

WB:WBGene00169247	21ur-10196
No description available

WB:WBGene00169248	21ur-9433
No description available

WB:WBGene00169249	21ur-8936
No description available

WB:WBGene00169250	21ur-13440
No description available

WB:WBGene00169251	21ur-12983
No description available

WB:WBGene00169252	21ur-10942
No description available

WB:WBGene00169253	21ur-12106
No description available

WB:WBGene00169254	21ur-12015
No description available

WB:WBGene00169255	21ur-15158
No description available

WB:WBGene00169256	21ur-7912
No description available

WB:WBGene00169257	21ur-9148
No description available

WB:WBGene00169258	21ur-12500
No description available

WB:WBGene00169259	21ur-10313
No description available

WB:WBGene00169260	21ur-10431
No description available

WB:WBGene00169261	21ur-7381
No description available

WB:WBGene00169262	21ur-8200
No description available

WB:WBGene00169263	21ur-8429
No description available

WB:WBGene00169264	21ur-13294
No description available

WB:WBGene00169265	21ur-5675
No description available

WB:WBGene00169266	21ur-9857
No description available

WB:WBGene00169267	21ur-13036
No description available

WB:WBGene00169268	21ur-6172
No description available

WB:WBGene00169269	21ur-14723
No description available

WB:WBGene00169270	21ur-11833
No description available

WB:WBGene00169271	21ur-14709
No description available

WB:WBGene00169272	21ur-13409
No description available

WB:WBGene00169273	21ur-6904
No description available

WB:WBGene00169274	21ur-9927
No description available

WB:WBGene00169275	21ur-7669
No description available

WB:WBGene00169276	21ur-8597
No description available

WB:WBGene00169277	21ur-12613
No description available

WB:WBGene00169278	21ur-9840
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00169279	21ur-11919
No description available

WB:WBGene00169280	21ur-11219
No description available

WB:WBGene00169281	21ur-6849
No description available

WB:WBGene00169282	21ur-14051
No description available

WB:WBGene00169283	21ur-7418
No description available

WB:WBGene00169284	21ur-10802
No description available

WB:WBGene00169285	21ur-13045
No description available

WB:WBGene00169286	21ur-11016
No description available

WB:WBGene00169287	21ur-8111
Is affected by eat-2 based on microarray studies.

WB:WBGene00169288	21ur-6350
No description available

WB:WBGene00169289	21ur-10774
No description available

WB:WBGene00169290	21ur-13705
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169291	21ur-9850
No description available

WB:WBGene00169292	21ur-14704
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169293	21ur-7027
No description available

WB:WBGene00169294	21ur-12819
No description available

WB:WBGene00169295	21ur-15295
No description available

WB:WBGene00169296	21ur-6782
No description available

WB:WBGene00169297	21ur-10743
No description available

WB:WBGene00169298	21ur-12194
No description available

WB:WBGene00169299	21ur-12726
No description available

WB:WBGene00169300	21ur-14002
No description available

WB:WBGene00169301	21ur-13447
No description available

WB:WBGene00169302	21ur-15260
No description available

WB:WBGene00169303	21ur-14705
No description available

WB:WBGene00169304	21ur-8139
No description available

WB:WBGene00169305	21ur-7550
No description available

WB:WBGene00169306	21ur-10843
No description available

WB:WBGene00169307	21ur-14955
No description available

WB:WBGene00169308	21ur-9678
No description available

WB:WBGene00169309	21ur-12893
No description available

WB:WBGene00169310	21ur-7659
No description available

WB:WBGene00169311	21ur-8388
No description available

WB:WBGene00169312	21ur-8401
No description available

WB:WBGene00169313	21ur-13134
No description available

WB:WBGene00169314	21ur-14555
No description available

WB:WBGene00169315	21ur-14183
No description available

WB:WBGene00169316	21ur-6779
No description available

WB:WBGene00169317	21ur-13836
No description available

WB:WBGene00169318	21ur-9655
No description available

WB:WBGene00169319	21ur-13902
No description available

WB:WBGene00169320	21ur-12090
No description available

WB:WBGene00169321	21ur-11974
No description available

WB:WBGene00169322	21ur-11674
No description available

WB:WBGene00169323	21ur-14654
No description available

WB:WBGene00169324	21ur-7202
No description available

WB:WBGene00169325	21ur-13401
No description available

WB:WBGene00169326	21ur-13071
No description available

WB:WBGene00169327	21ur-6776
No description available

WB:WBGene00169328	21ur-13920
No description available

WB:WBGene00169329	21ur-11946
No description available

WB:WBGene00169330	21ur-12487
No description available

WB:WBGene00169331	21ur-7736
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169332	21ur-7209
No description available

WB:WBGene00169333	21ur-11358
No description available

WB:WBGene00169334	21ur-11070
No description available

WB:WBGene00169335	21ur-5882
No description available

WB:WBGene00169336	21ur-13372
No description available

WB:WBGene00169337	21ur-13466
No description available

WB:WBGene00169338	21ur-13093
No description available

WB:WBGene00169339	21ur-14775
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169340	21ur-12169
No description available

WB:WBGene00169341	21ur-13315
No description available

WB:WBGene00169342	21ur-11315
No description available

WB:WBGene00169343	21ur-7281
No description available

WB:WBGene00169344	21ur-14991
No description available

WB:WBGene00169345	21ur-8300
No description available

WB:WBGene00169346	21ur-11156
No description available

WB:WBGene00169347	21ur-15411
No description available

WB:WBGene00169348	21ur-14475
No description available

WB:WBGene00169349	21ur-10416
No description available

WB:WBGene00169350	21ur-9501
No description available

WB:WBGene00169351	21ur-14407
No description available

WB:WBGene00169352	21ur-13982
No description available

WB:WBGene00169353	21ur-13163
No description available

WB:WBGene00169354	21ur-10379
No description available

WB:WBGene00169355	21ur-11733
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169356	21ur-12416
No description available

WB:WBGene00169357	21ur-9578
No description available

WB:WBGene00169358	21ur-9017
No description available

WB:WBGene00169359	21ur-12407
No description available

WB:WBGene00169360	21ur-8713
No description available

WB:WBGene00169361	21ur-14733
No description available

WB:WBGene00169362	21ur-12769
No description available

WB:WBGene00169363	21ur-12455
No description available

WB:WBGene00169364	21ur-14986
No description available

WB:WBGene00169365	21ur-11182
No description available

WB:WBGene00169366	21ur-8219
No description available

WB:WBGene00169367	21ur-12446
No description available

WB:WBGene00169368	21ur-14782
No description available

WB:WBGene00169369	21ur-11326
No description available

WB:WBGene00169370	21ur-8715
No description available

WB:WBGene00169371	21ur-13807
No description available

WB:WBGene00169372	21ur-8438
No description available

WB:WBGene00169373	21ur-13023
No description available

WB:WBGene00169374	21ur-6700
No description available

WB:WBGene00169375	21ur-13221
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169376	21ur-9059
No description available

WB:WBGene00169377	21ur-14770
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169378	21ur-7964
No description available

WB:WBGene00169379	21ur-15493
No description available

WB:WBGene00169380	21ur-8357
No description available

WB:WBGene00169381	21ur-9194
No description available

WB:WBGene00169382	21ur-12970
No description available

WB:WBGene00169383	21ur-9225
No description available

WB:WBGene00169384	21ur-7803
No description available

WB:WBGene00169385	21ur-12858
No description available

WB:WBGene00169386	21ur-10821
No description available

WB:WBGene00169387	21ur-14464
No description available

WB:WBGene00169388	21ur-12523
No description available

WB:WBGene00169389	21ur-11369
No description available

WB:WBGene00169390	21ur-9426
No description available

WB:WBGene00169391	21ur-10962
No description available

WB:WBGene00169392	21ur-8209
No description available

WB:WBGene00169393	21ur-6401
No description available

WB:WBGene00169394	21ur-9722
No description available

WB:WBGene00169395	21ur-14998
No description available

WB:WBGene00169396	21ur-13480
No description available

WB:WBGene00169397	21ur-10069
No description available

WB:WBGene00169398	21ur-5673
No description available

WB:WBGene00169399	21ur-8014
No description available

WB:WBGene00169401	21ur-5701
No description available

WB:WBGene00169402	21ur-10077
No description available

WB:WBGene00169403	21ur-8925
No description available

WB:WBGene00169404	21ur-14255
No description available

WB:WBGene00169405	21ur-11459
No description available

WB:WBGene00169406	21ur-7432
No description available

WB:WBGene00169407	21ur-6047
No description available

WB:WBGene00169408	21ur-13258
No description available

WB:WBGene00169409	21ur-11747
No description available

WB:WBGene00169410	21ur-6610
No description available

WB:WBGene00169411	21ur-7626
No description available

WB:WBGene00169412	21ur-12371
No description available

WB:WBGene00169413	21ur-5751
No description available

WB:WBGene00169414	21ur-13489
No description available

WB:WBGene00169415	21ur-7922
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00169416	21ur-10118
No description available

WB:WBGene00169417	21ur-11426
No description available

WB:WBGene00169418	21ur-9522
No description available

WB:WBGene00169419	21ur-10827
No description available

WB:WBGene00169420	21ur-5891
No description available

WB:WBGene00169421	21ur-13187
No description available

WB:WBGene00169422	21ur-15323
No description available

WB:WBGene00169423	21ur-9605
No description available

WB:WBGene00169424	21ur-8467
No description available

WB:WBGene00169425	21ur-6215
No description available

WB:WBGene00169426	21ur-15109
No description available

WB:WBGene00169427	21ur-13248
No description available

WB:WBGene00169428	21ur-8424
No description available

WB:WBGene00169429	21ur-7699
No description available

WB:WBGene00169430	21ur-11866
No description available

WB:WBGene00169431	21ur-10597
No description available

WB:WBGene00169432	21ur-14375
No description available

WB:WBGene00169433	21ur-5462
No description available

WB:WBGene00169434	21ur-8265
No description available

WB:WBGene00169435	21ur-7823
No description available

WB:WBGene00169436	21ur-12055
No description available

WB:WBGene00169437	21ur-10043
No description available

WB:WBGene00169438	21ur-10890
No description available

WB:WBGene00169439	21ur-13388
No description available

WB:WBGene00169440	21ur-13550
No description available

WB:WBGene00169441	21ur-10307
No description available

WB:WBGene00169442	21ur-8745
No description available

WB:WBGene00169443	21ur-15436
No description available

WB:WBGene00169444	21ur-11611
Is affected by eat-2 based on microarray studies.

WB:WBGene00169445	21ur-7197
No description available

WB:WBGene00169446	21ur-14527
No description available

WB:WBGene00169447	21ur-9023
No description available

WB:WBGene00169448	21ur-15262
No description available

WB:WBGene00169449	21ur-15678
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169450	21ur-9496
No description available

WB:WBGene00169451	21ur-15058
No description available

WB:WBGene00169452	21ur-10389
No description available

WB:WBGene00169453	21ur-8705
No description available

WB:WBGene00169454	21ur-10965
No description available

WB:WBGene00169455	21ur-7273
No description available

WB:WBGene00169456	21ur-10427
No description available

WB:WBGene00169457	21ur-8794
No description available

WB:WBGene00169458	21ur-10245
No description available

WB:WBGene00169459	21ur-13276
No description available

WB:WBGene00169460	21ur-15333
No description available

WB:WBGene00169461	21ur-10139
No description available

WB:WBGene00169462	21ur-12039
No description available

WB:WBGene00169463	21ur-7316
No description available

WB:WBGene00169464	21ur-11723
Is affected by eat-2 based on microarray studies.

WB:WBGene00169465	21ur-13243
No description available

WB:WBGene00169466	21ur-6449
No description available

WB:WBGene00169467	21ur-9204
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00169468	21ur-15681
No description available

WB:WBGene00169469	21ur-12995
No description available

WB:WBGene00169470	21ur-7308
No description available

WB:WBGene00169471	21ur-8172
No description available

WB:WBGene00169472	21ur-6399
No description available

WB:WBGene00169473	21ur-12096
No description available

WB:WBGene00169474	21ur-5510
No description available

WB:WBGene00169475	21ur-6050
No description available

WB:WBGene00169476	21ur-7233
No description available

WB:WBGene00169477	21ur-7047
No description available

WB:WBGene00169478	21ur-11784
No description available

WB:WBGene00169479	21ur-12739
No description available

WB:WBGene00169480	21ur-11003
No description available

WB:WBGene00169481	21ur-9442
No description available

WB:WBGene00169482	21ur-8367
No description available

WB:WBGene00169483	21ur-6807
No description available

WB:WBGene00169484	21ur-8458
Is affected by daf-2 based on microarray studies.

WB:WBGene00169485	21ur-14659
No description available

WB:WBGene00169486	21ur-13200
No description available

WB:WBGene00169487	21ur-10213
No description available

WB:WBGene00169488	21ur-8779
No description available

WB:WBGene00169489	21ur-14136
No description available

WB:WBGene00169490	21ur-10541
No description available

WB:WBGene00169491	21ur-5592
No description available

WB:WBGene00169492	21ur-13507
No description available

WB:WBGene00169493	21ur-8180
No description available

WB:WBGene00169494	21ur-11945
No description available

WB:WBGene00169495	21ur-10644
No description available

WB:WBGene00169496	21ur-5726
No description available

WB:WBGene00169497	21ur-12698
No description available

WB:WBGene00169498	21ur-14620
Is affected by daf-2 based on microarray studies.

WB:WBGene00169499	21ur-7892
No description available

WB:WBGene00169500	21ur-6347
No description available

WB:WBGene00169501	21ur-10071
No description available

WB:WBGene00169502	21ur-9353
No description available

WB:WBGene00169503	21ur-14278
No description available

WB:WBGene00169504	21ur-13547
No description available

WB:WBGene00169505	21ur-8532
No description available

WB:WBGene00169506	21ur-10899
No description available

WB:WBGene00169507	21ur-14383
No description available

WB:WBGene00169508	21ur-10403
No description available

WB:WBGene00169509	21ur-12777
No description available

WB:WBGene00169510	21ur-6741
No description available

WB:WBGene00169511	21ur-10147
No description available

WB:WBGene00169512	21ur-11576
No description available

WB:WBGene00169513	21ur-9995
No description available

WB:WBGene00169514	21ur-15671
No description available

WB:WBGene00169515	21ur-14332
No description available

WB:WBGene00169516	21ur-14766
No description available

WB:WBGene00169517	21ur-15491
No description available

WB:WBGene00169518	21ur-15104
No description available

WB:WBGene00169519	21ur-15269
No description available

WB:WBGene00169520	21ur-7011
No description available

WB:WBGene00169521	21ur-15563
No description available

WB:WBGene00169522	21ur-6515
No description available

WB:WBGene00169523	21ur-5588
No description available

WB:WBGene00169524	21ur-8539
No description available

WB:WBGene00169525	21ur-10154
No description available

WB:WBGene00169526	21ur-9808
No description available

WB:WBGene00169527	21ur-15428
No description available

WB:WBGene00169528	21ur-15541
No description available

WB:WBGene00169529	21ur-8845
No description available

WB:WBGene00169530	21ur-8781
No description available

WB:WBGene00169531	21ur-7899
No description available

WB:WBGene00169532	21ur-13172
No description available

WB:WBGene00169533	21ur-15471
No description available

WB:WBGene00169534	21ur-14493
No description available

WB:WBGene00169535	21ur-5621
No description available

WB:WBGene00169536	21ur-5977
No description available

WB:WBGene00169537	21ur-11910
No description available

WB:WBGene00169538	21ur-10927
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00169539	21ur-8988
No description available

WB:WBGene00169540	21ur-13909
No description available

WB:WBGene00169541	21ur-14763
No description available

WB:WBGene00169542	21ur-9946
No description available

WB:WBGene00169543	21ur-6585
No description available

WB:WBGene00169544	21ur-5876
No description available

WB:WBGene00169545	21ur-10487
No description available

WB:WBGene00169546	21ur-5989
No description available

WB:WBGene00169547	21ur-12198
No description available

WB:WBGene00169548	21ur-7824
No description available

WB:WBGene00169549	21ur-11776
No description available

WB:WBGene00169550	21ur-11067
No description available

WB:WBGene00169551	21ur-8408
No description available

WB:WBGene00169552	21ur-12405
No description available

WB:WBGene00169553	21ur-13744
No description available

WB:WBGene00169554	21ur-6661
Is affected by chd-3 based on RNA-seq studies.

WB:WBGene00169555	21ur-9114
No description available

WB:WBGene00169556	21ur-6254
No description available

WB:WBGene00169557	21ur-14542
No description available

WB:WBGene00169558	21ur-12907
No description available

WB:WBGene00169559	21ur-11390
No description available

WB:WBGene00169560	21ur-5536
No description available

WB:WBGene00169561	21ur-13694
No description available

WB:WBGene00169562	21ur-7624
No description available

WB:WBGene00169563	21ur-10474
No description available

WB:WBGene00169564	21ur-6998
No description available

WB:WBGene00169565	21ur-10180
No description available

WB:WBGene00169566	21ur-6152
No description available

WB:WBGene00169567	21ur-15276
No description available

WB:WBGene00169568	21ur-11340
No description available

WB:WBGene00169569	21ur-10910
No description available

WB:WBGene00169570	21ur-9428
No description available

WB:WBGene00169571	21ur-8155
No description available

WB:WBGene00169572	21ur-14844
No description available

WB:WBGene00169573	21ur-10731
No description available

WB:WBGene00169574	21ur-10542
No description available

WB:WBGene00169575	21ur-8349
No description available

WB:WBGene00169576	21ur-11239
No description available

WB:WBGene00169577	21ur-11126
No description available

WB:WBGene00169578	21ur-7740
No description available

WB:WBGene00169579	21ur-15035
No description available

WB:WBGene00169580	21ur-14299
No description available

WB:WBGene00169581	21ur-11454
No description available

WB:WBGene00169582	21ur-10186
No description available

WB:WBGene00169583	21ur-14673
No description available

WB:WBGene00169584	21ur-9339
No description available

WB:WBGene00169585	21ur-15113
No description available

WB:WBGene00169586	21ur-10513
No description available

WB:WBGene00169587	21ur-11419
No description available

WB:WBGene00169588	21ur-5601
No description available

WB:WBGene00169589	21ur-14652
No description available

WB:WBGene00169590	21ur-6598
Is affected by damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00169591	21ur-8954
No description available

WB:WBGene00169592	21ur-9006
No description available

WB:WBGene00169593	21ur-15094
No description available

WB:WBGene00169594	21ur-13215
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169595	21ur-14036
No description available

WB:WBGene00169596	21ur-12509
No description available

WB:WBGene00169597	21ur-11146
No description available

WB:WBGene00169598	21ur-13677
No description available

WB:WBGene00169599	21ur-8025
No description available

WB:WBGene00169600	21ur-10911
No description available

WB:WBGene00169601	21ur-10865
No description available

WB:WBGene00169602	21ur-9272
No description available

WB:WBGene00169603	21ur-10505
No description available

WB:WBGene00169604	21ur-11988
No description available

WB:WBGene00169605	21ur-9634
No description available

WB:WBGene00169606	21ur-11397
No description available

WB:WBGene00169607	21ur-9141
No description available

WB:WBGene00169608	21ur-11835
No description available

WB:WBGene00169609	21ur-5717
No description available

WB:WBGene00169610	21ur-6564
No description available

WB:WBGene00169611	21ur-13359
No description available

WB:WBGene00169612	21ur-12823
No description available

WB:WBGene00169613	21ur-12365
No description available

WB:WBGene00169614	21ur-14575
No description available

WB:WBGene00169615	21ur-14625
No description available

WB:WBGene00169617	21ur-13384
No description available

WB:WBGene00169618	21ur-9761
No description available

WB:WBGene00169619	21ur-12635
No description available

WB:WBGene00169620	21ur-15061
No description available

WB:WBGene00169621	21ur-14973
No description available

WB:WBGene00169622	21ur-11618
No description available

WB:WBGene00169623	21ur-6748
No description available

WB:WBGene00169624	21ur-13943
No description available

WB:WBGene00169625	21ur-15310
No description available

WB:WBGene00169626	21ur-14326
No description available

WB:WBGene00169627	21ur-9827
No description available

WB:WBGene00169628	21ur-10342
No description available

WB:WBGene00169629	21ur-9619
No description available

WB:WBGene00169630	21ur-8965
No description available

WB:WBGene00169631	21ur-14353
No description available

WB:WBGene00169632	21ur-12061
No description available

WB:WBGene00169633	21ur-15396
No description available

WB:WBGene00169634	21ur-13874
No description available

WB:WBGene00169635	21ur-5774
No description available

WB:WBGene00169636	21ur-10800
No description available

WB:WBGene00169637	21ur-5945
No description available

WB:WBGene00169638	21ur-9384
No description available

WB:WBGene00169639	21ur-15242
No description available

WB:WBGene00169640	21ur-11294
No description available

WB:WBGene00169641	21ur-10715
No description available

WB:WBGene00169642	21ur-9378
No description available

WB:WBGene00169643	21ur-10382
No description available

WB:WBGene00169644	21ur-7163
No description available

WB:WBGene00169645	21ur-15490
No description available

WB:WBGene00169646	21ur-11214
No description available

WB:WBGene00169647	21ur-11028
No description available

WB:WBGene00169648	21ur-13748
No description available

WB:WBGene00169649	21ur-14079
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies.

WB:WBGene00169650	21ur-7385
No description available

WB:WBGene00169651	21ur-15254
No description available

WB:WBGene00169652	21ur-10463
No description available

WB:WBGene00169653	21ur-9154
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169654	21ur-14070
No description available

WB:WBGene00169655	21ur-12395
No description available

WB:WBGene00169656	21ur-10016
No description available

WB:WBGene00169657	21ur-14789
No description available

WB:WBGene00169658	21ur-6141
No description available

WB:WBGene00169659	21ur-15228
No description available

WB:WBGene00169660	21ur-10670
No description available

WB:WBGene00169661	21ur-8168
No description available

WB:WBGene00169662	21ur-13993
No description available

WB:WBGene00169663	21ur-5467
No description available

WB:WBGene00169664	21ur-7086
No description available

WB:WBGene00169665	21ur-7366
No description available

WB:WBGene00169666	21ur-8061
No description available

WB:WBGene00169667	21ur-7446
No description available

WB:WBGene00169668	21ur-9511
No description available

WB:WBGene00169669	21ur-5982
No description available

WB:WBGene00169670	21ur-8079
No description available

WB:WBGene00169671	21ur-11597
No description available

WB:WBGene00169672	21ur-10809
No description available

WB:WBGene00169673	21ur-12077
No description available

WB:WBGene00169674	21ur-15033
Is affected by emr-1; hmg-3; and spt-16 based on RNA-seq studies.

WB:WBGene00169675	21ur-9908
No description available

WB:WBGene00169676	21ur-7368
No description available

WB:WBGene00169677	21ur-8677
No description available

WB:WBGene00169678	21ur-13433
No description available

WB:WBGene00169679	21ur-10755
No description available

WB:WBGene00169680	21ur-5677
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00169681	21ur-6015
Is affected by daf-2 based on microarray studies.

WB:WBGene00169682	21ur-15633
No description available

WB:WBGene00169683	21ur-15059
No description available

WB:WBGene00169684	21ur-11716
No description available

WB:WBGene00169685	21ur-11590
No description available

WB:WBGene00169686	21ur-11435
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00169687	21ur-10161
No description available

WB:WBGene00169688	21ur-11104
No description available

WB:WBGene00169689	21ur-11756
No description available

WB:WBGene00169690	21ur-10131
No description available

WB:WBGene00169691	21ur-6239
No description available

WB:WBGene00169692	21ur-10764
No description available

WB:WBGene00169693	21ur-14693
No description available

WB:WBGene00169694	21ur-7361
No description available

WB:WBGene00169695	21ur-13802
No description available

WB:WBGene00169696	21ur-9083
No description available

WB:WBGene00169697	21ur-5563
No description available

WB:WBGene00169698	21ur-6362
No description available

WB:WBGene00169699	21ur-9463
No description available

WB:WBGene00169700	21ur-9690
No description available

WB:WBGene00169701	21ur-14661
No description available

WB:WBGene00169702	21ur-13379
No description available

WB:WBGene00169703	21ur-6370
No description available

WB:WBGene00169704	21ur-7976
No description available

WB:WBGene00169705	21ur-15338
No description available

WB:WBGene00169706	21ur-15120
No description available

WB:WBGene00169707	21ur-10650
No description available

WB:WBGene00169708	21ur-9718
No description available

WB:WBGene00169709	21ur-5781
No description available

WB:WBGene00169710	21ur-10629
No description available

WB:WBGene00169711	21ur-11871
No description available

WB:WBGene00169712	21ur-13659
No description available

WB:WBGene00169713	21ur-11467
No description available

WB:WBGene00169714	21ur-13583
No description available

WB:WBGene00169715	21ur-8864
No description available

WB:WBGene00169716	21ur-12081
No description available

WB:WBGene00169717	21ur-7190
No description available

WB:WBGene00169718	21ur-15577
No description available

WB:WBGene00169719	21ur-8100
No description available

WB:WBGene00169720	21ur-12842
No description available

WB:WBGene00169721	21ur-14826
No description available

WB:WBGene00169722	21ur-11032
No description available

WB:WBGene00169723	21ur-10680
No description available

WB:WBGene00169724	21ur-8751
No description available

WB:WBGene00169725	21ur-14965
No description available

WB:WBGene00169726	21ur-6428
No description available

WB:WBGene00169727	21ur-11448
No description available

WB:WBGene00169728	21ur-10201
No description available

WB:WBGene00169729	21ur-8654
No description available

WB:WBGene00169730	21ur-6767
No description available

WB:WBGene00169731	21ur-11283
No description available

WB:WBGene00169732	21ur-14748
No description available

WB:WBGene00169733	21ur-11227
No description available

WB:WBGene00169734	21ur-13267
No description available

WB:WBGene00169735	21ur-12674
No description available

WB:WBGene00169736	21ur-6170
No description available

WB:WBGene00169737	21ur-13680
No description available

WB:WBGene00169738	21ur-13631
No description available

WB:WBGene00169739	21ur-12646
No description available

WB:WBGene00169740	21ur-14838
No description available

WB:WBGene00169741	21ur-7597
No description available

WB:WBGene00169742	21ur-7739
No description available

WB:WBGene00169743	21ur-11282
No description available

WB:WBGene00169744	21ur-6652
No description available

WB:WBGene00169745	21ur-14110
No description available

WB:WBGene00169746	21ur-15389
No description available

WB:WBGene00169747	21ur-8231
No description available

WB:WBGene00169748	21ur-13398
No description available

WB:WBGene00169749	21ur-14290
No description available

WB:WBGene00169750	21ur-11097
No description available

WB:WBGene00169751	21ur-8289
No description available

WB:WBGene00169752	21ur-14502
No description available

WB:WBGene00169753	21ur-10025
No description available

WB:WBGene00169754	21ur-12240
No description available

WB:WBGene00169755	21ur-6641
No description available

WB:WBGene00169756	21ur-10641
No description available

WB:WBGene00169757	21ur-15116
No description available

WB:WBGene00169758	21ur-8616
No description available

WB:WBGene00169759	21ur-7000
No description available

WB:WBGene00169760	21ur-14547
No description available

WB:WBGene00169761	21ur-6863
No description available

WB:WBGene00169762	21ur-13127
No description available

WB:WBGene00169763	21ur-9279
No description available

WB:WBGene00169764	21ur-7374
No description available

WB:WBGene00169765	21ur-5504
No description available

WB:WBGene00169766	21ur-15207
No description available

WB:WBGene00169767	21ur-9715
No description available

WB:WBGene00169768	21ur-6396
No description available

WB:WBGene00169769	21ur-12707
No description available

WB:WBGene00169770	21ur-11043
No description available

WB:WBGene00169771	21ur-6113
No description available

WB:WBGene00169772	21ur-9413
No description available

WB:WBGene00169773	21ur-11039
No description available

WB:WBGene00169774	21ur-8393
No description available

WB:WBGene00169775	21ur-13573
Is affected by daf-2 based on microarray studies.

WB:WBGene00169776	21ur-8586
No description available

WB:WBGene00169777	21ur-12378
No description available

WB:WBGene00169778	21ur-5809
No description available

WB:WBGene00169779	21ur-8259
No description available

WB:WBGene00169780	21ur-8757
No description available

WB:WBGene00169781	21ur-15504
No description available

WB:WBGene00169782	21ur-6625
No description available

WB:WBGene00169783	21ur-14153
No description available

WB:WBGene00169784	21ur-10373
No description available

WB:WBGene00169785	21ur-7213
No description available

WB:WBGene00169786	21ur-6232
No description available

WB:WBGene00169787	21ur-15190
No description available

WB:WBGene00169788	21ur-11207
No description available

WB:WBGene00169789	21ur-8933
No description available

WB:WBGene00169790	21ur-15367
No description available

WB:WBGene00169791	21ur-5903
No description available

WB:WBGene00169792	21ur-10983
No description available

WB:WBGene00169793	21ur-9581
No description available

WB:WBGene00169794	21ur-5788
No description available

WB:WBGene00169795	21ur-7643
No description available

WB:WBGene00169796	21ur-9233
No description available

WB:WBGene00169797	21ur-5857
No description available

WB:WBGene00169798	21ur-15221
No description available

WB:WBGene00169799	21ur-13237
No description available

WB:WBGene00169800	21ur-13118
No description available

WB:WBGene00169801	21ur-10621
No description available

WB:WBGene00169802	21ur-13844
No description available

WB:WBGene00169803	21ur-13077
No description available

WB:WBGene00169804	21ur-7137
No description available

WB:WBGene00169805	21ur-11523
No description available

WB:WBGene00169806	21ur-12298
No description available

WB:WBGene00169807	21ur-7788
No description available

WB:WBGene00169808	21ur-11308
No description available

WB:WBGene00169809	21ur-14315
No description available

WB:WBGene00169810	21ur-7005
No description available

WB:WBGene00169811	21ur-13595
No description available

WB:WBGene00169812	21ur-6299
No description available

WB:WBGene00169813	21ur-13370
No description available

WB:WBGene00169814	21ur-13269
No description available

WB:WBGene00169815	21ur-9700
No description available

WB:WBGene00169816	21ur-6044
No description available

WB:WBGene00169817	21ur-13168
No description available

WB:WBGene00169818	21ur-6688
No description available

WB:WBGene00169819	21ur-7505
No description available

WB:WBGene00169820	21ur-8581
No description available

WB:WBGene00169821	21ur-5586
No description available

WB:WBGene00169822	21ur-14227
No description available

WB:WBGene00169823	21ur-15047
No description available

WB:WBGene00169824	21ur-13188
No description available

WB:WBGene00169825	21ur-8915
No description available

WB:WBGene00169826	21ur-15519
No description available

WB:WBGene00169827	21ur-10659
No description available

WB:WBGene00169828	21ur-9796
No description available

WB:WBGene00169829	21ur-10093
No description available

WB:WBGene00169830	21ur-5932
No description available

WB:WBGene00169831	21ur-14362
No description available

WB:WBGene00169832	21ur-6290
No description available

WB:WBGene00169833	21ur-14614
No description available

WB:WBGene00169834	21ur-6962
No description available

WB:WBGene00169835	21ur-8043
No description available

WB:WBGene00169836	21ur-11544
No description available

WB:WBGene00169837	21ur-8605
No description available

WB:WBGene00169838	21ur-11646
No description available

WB:WBGene00169839	21ur-11023
No description available

WB:WBGene00169840	21ur-15214
No description available

WB:WBGene00169841	21ur-15134
No description available

WB:WBGene00169842	21ur-7571
No description available

WB:WBGene00169843	21ur-13624
No description available

WB:WBGene00169844	21ur-7034
No description available

WB:WBGene00169845	21ur-9967
No description available

WB:WBGene00169846	21ur-10165
No description available

WB:WBGene00169847	21ur-5544
No description available

WB:WBGene00169848	21ur-7888
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169849	21ur-10814
No description available

WB:WBGene00169850	21ur-14096
No description available

WB:WBGene00169851	21ur-14454
No description available

WB:WBGene00169852	21ur-7116
No description available

WB:WBGene00169853	21ur-7590
No description available

WB:WBGene00169854	21ur-7687
No description available

WB:WBGene00169855	21ur-14222
No description available

WB:WBGene00169856	21ur-6950
No description available

WB:WBGene00169857	21ur-7948
No description available

WB:WBGene00169858	21ur-8575
No description available

WB:WBGene00169859	21ur-8879
No description available

WB:WBGene00169860	21ur-15570
No description available

WB:WBGene00169861	21ur-15279
No description available

WB:WBGene00169862	21ur-10289
No description available

WB:WBGene00169863	21ur-14863
No description available

WB:WBGene00169864	21ur-12232
No description available

WB:WBGene00169865	21ur-14488
No description available

WB:WBGene00169866	21ur-13517
No description available

WB:WBGene00169867	21ur-11480
No description available

WB:WBGene00169868	21ur-10619
No description available

WB:WBGene00169869	21ur-7142
No description available

WB:WBGene00169870	21ur-12030
No description available

WB:WBGene00169871	21ur-5576
No description available

WB:WBGene00169872	21ur-6136
No description available

WB:WBGene00169873	21ur-13528
No description available

WB:WBGene00169874	21ur-12764
No description available

WB:WBGene00169875	21ur-7983
No description available

WB:WBGene00169876	21ur-7783
No description available

WB:WBGene00169877	21ur-8005
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169878	21ur-11000
No description available

WB:WBGene00169879	21ur-9550
Is affected by eat-2 based on microarray studies.

WB:WBGene00169880	21ur-11359
No description available

WB:WBGene00169881	21ur-13111
No description available

WB:WBGene00169882	21ur-15009
No description available

WB:WBGene00169883	21ur-13451
No description available

WB:WBGene00169884	21ur-13649
No description available

WB:WBGene00169885	21ur-12147
No description available

WB:WBGene00169886	21ur-6419
No description available

WB:WBGene00169887	21ur-12438
No description available

WB:WBGene00169888	21ur-12561
No description available

WB:WBGene00169889	21ur-5659
No description available

WB:WBGene00169890	21ur-8670
No description available

WB:WBGene00169891	21ur-15536
No description available

WB:WBGene00169892	21ur-14522
No description available

WB:WBGene00169893	21ur-13978
No description available

WB:WBGene00169894	21ur-6335
No description available

WB:WBGene00169895	21ur-11511
No description available

WB:WBGene00169896	21ur-14831
No description available

WB:WBGene00169897	21ur-15480
No description available

WB:WBGene00169898	21ur-13452
No description available

WB:WBGene00169899	21ur-7941
No description available

WB:WBGene00169900	21ur-14850
No description available

WB:WBGene00169901	21ur-9785
No description available

WB:WBGene00169902	21ur-14485
No description available

WB:WBGene00169903	21ur-11625
No description available

WB:WBGene00169904	21ur-9557
No description available

WB:WBGene00169905	21ur-7869
No description available

WB:WBGene00169906	21ur-15657
No description available

WB:WBGene00169907	21ur-6410
No description available

WB:WBGene00169908	21ur-14105
No description available

WB:WBGene00169909	21ur-10685
No description available

WB:WBGene00169910	21ur-13961
No description available

WB:WBGene00169911	21ur-12223
No description available

WB:WBGene00169912	21ur-10615
No description available

WB:WBGene00169913	21ur-9244
No description available

WB:WBGene00169914	21ur-13914
No description available

WB:WBGene00169915	21ur-14523
No description available

WB:WBGene00169916	21ur-13947
No description available

WB:WBGene00169917	21ur-9322
No description available

WB:WBGene00169918	21ur-15197
No description available

WB:WBGene00169919	21ur-14124
No description available

WB:WBGene00169920	21ur-6617
No description available

WB:WBGene00169921	21ur-8034
No description available

WB:WBGene00169922	21ur-8216
No description available

WB:WBGene00169923	21ur-9287
No description available

WB:WBGene00169924	21ur-11726
No description available

WB:WBGene00169925	21ur-11487
No description available

WB:WBGene00169926	21ur-6058
No description available

WB:WBGene00169927	21ur-7424
No description available

WB:WBGene00169928	21ur-10624
No description available

WB:WBGene00169929	21ur-7586
No description available

WB:WBGene00169930	21ur-15042
No description available

WB:WBGene00169931	21ur-7052
No description available

WB:WBGene00169932	21ur-13403
No description available

WB:WBGene00169933	21ur-12026
No description available

WB:WBGene00169934	21ur-6987
No description available

WB:WBGene00169935	21ur-11515
No description available

WB:WBGene00169936	21ur-8241
No description available

WB:WBGene00169937	21ur-9628
No description available

WB:WBGene00169938	21ur-7068
No description available

WB:WBGene00169939	21ur-9872
No description available

WB:WBGene00169940	21ur-13251
No description available

WB:WBGene00169941	21ur-8556
No description available

WB:WBGene00169942	21ur-9483
No description available

WB:WBGene00169943	21ur-14496
No description available

WB:WBGene00169944	21ur-12617
No description available

WB:WBGene00169946	21ur-7707
No description available

WB:WBGene00169947	21ur-8644
No description available

WB:WBGene00169948	21ur-8496
No description available

WB:WBGene00169949	21ur-8896
No description available

WB:WBGene00169950	21ur-9437
No description available

WB:WBGene00169951	21ur-7715
No description available

WB:WBGene00169952	21ur-11257
No description available

WB:WBGene00169953	21ur-13650
No description available

WB:WBGene00169954	21ur-13784
No description available

WB:WBGene00169955	21ur-12210
No description available

WB:WBGene00169956	21ur-10530
No description available

WB:WBGene00169957	21ur-15015
No description available

WB:WBGene00169958	21ur-15555
No description available

WB:WBGene00169959	21ur-12390
No description available

WB:WBGene00169960	21ur-10610
No description available

WB:WBGene00169961	21ur-11019
No description available

WB:WBGene00169962	21ur-7612
No description available

WB:WBGene00169963	21ur-10003
No description available

WB:WBGene00169964	21ur-13067
No description available

WB:WBGene00169965	21ur-14311
No description available

WB:WBGene00169966	21ur-15301
No description available

WB:WBGene00169967	21ur-8854
No description available

WB:WBGene00169968	21ur-12699
No description available

WB:WBGene00169969	21ur-8319
No description available

WB:WBGene00169970	21ur-12839
No description available

WB:WBGene00169971	21ur-9867
No description available

WB:WBGene00169972	21ur-11799
No description available

WB:WBGene00169973	21ur-9960
No description available

WB:WBGene00169974	21ur-14803
No description available

WB:WBGene00169975	21ur-9534
No description available

WB:WBGene00169976	21ur-10858
No description available

WB:WBGene00169977	21ur-7437
No description available

WB:WBGene00169978	21ur-10525
No description available

WB:WBGene00169979	21ur-14010
No description available

WB:WBGene00169980	21ur-15200
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00169981	21ur-13871
No description available

WB:WBGene00169982	21ur-14331
No description available

WB:WBGene00169983	21ur-14308
No description available

WB:WBGene00169984	21ur-15460
No description available

WB:WBGene00169985	21ur-6737
No description available

WB:WBGene00169986	21ur-9137
No description available

WB:WBGene00169987	21ur-15487
No description available

WB:WBGene00169988	21ur-14950
No description available

WB:WBGene00169989	21ur-14801
No description available

WB:WBGene00169990	21ur-12928
No description available

WB:WBGene00169991	21ur-12986
No description available

WB:WBGene00169992	21ur-12428
No description available

WB:WBGene00169993	21ur-7254
No description available

WB:WBGene00169994	21ur-14286
No description available

WB:WBGene00169995	21ur-9977
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00169996	21ur-6486
No description available

WB:WBGene00169997	21ur-8814
No description available

WB:WBGene00169998	21ur-11250
No description available

WB:WBGene00169999	21ur-15377
No description available

WB:WBGene00170000	21ur-14168
No description available

WB:WBGene00170001	21ur-11696
No description available

WB:WBGene00170002	21ur-6185
No description available

WB:WBGene00170003	21ur-9481
No description available

WB:WBGene00170004	21ur-7875
No description available

WB:WBGene00170005	21ur-11960
No description available

WB:WBGene00170006	21ur-11090
No description available

WB:WBGene00170007	21ur-8382
No description available

WB:WBGene00170008	21ur-6472
No description available

WB:WBGene00170009	21ur-13143
No description available

WB:WBGene00170010	21ur-13704
No description available

WB:WBGene00170011	21ur-8068
Is affected by daf-2 based on microarray studies.

WB:WBGene00170012	21ur-9697
No description available

WB:WBGene00170013	21ur-11818
No description available

WB:WBGene00170014	21ur-9874
No description available

WB:WBGene00170015	21ur-11060
No description available

WB:WBGene00170016	21ur-10854
No description available

WB:WBGene00170017	21ur-14534
No description available

WB:WBGene00170018	21ur-7127
No description available

WB:WBGene00170019	21ur-5790
No description available

WB:WBGene00170020	21ur-13894
No description available

WB:WBGene00170021	21ur-12770
No description available

WB:WBGene00170022	21ur-9926
No description available

WB:WBGene00170023	21ur-7992
No description available

WB:WBGene00170024	21ur-8293
No description available

WB:WBGene00170025	21ur-13641
No description available

WB:WBGene00170026	21ur-11902
No description available

WB:WBGene00170027	21ur-5565
No description available

WB:WBGene00170028	21ur-7064
No description available

WB:WBGene00170029	21ur-7429
No description available

WB:WBGene00170030	21ur-8851
No description available

WB:WBGene00170031	21ur-12788
No description available

WB:WBGene00170032	21ur-14123
No description available

WB:WBGene00170033	21ur-15465
No description available

WB:WBGene00170034	21ur-6981
No description available

WB:WBGene00170035	21ur-11383
No description available

WB:WBGene00170036	21ur-6488
No description available

WB:WBGene00170037	21ur-7809
No description available

WB:WBGene00170038	21ur-14093
No description available

WB:WBGene00170039	21ur-13063
No description available

WB:WBGene00170040	21ur-6242
No description available

WB:WBGene00170041	21ur-14759
No description available

WB:WBGene00170042	21ur-8351
No description available

WB:WBGene00170043	21ur-9740
No description available

WB:WBGene00170044	21ur-8320
No description available

WB:WBGene00170045	21ur-9355
No description available

WB:WBGene00170046	21ur-9499
No description available

WB:WBGene00170047	21ur-8048
No description available

WB:WBGene00170048	21ur-7125
No description available

WB:WBGene00170049	21ur-12637
No description available

WB:WBGene00170050	21ur-12597
No description available

WB:WBGene00170051	21ur-10812
No description available

WB:WBGene00170052	21ur-5582
No description available

WB:WBGene00170053	21ur-13407
No description available

WB:WBGene00170054	21ur-14514
No description available

WB:WBGene00170055	21ur-8551
No description available

WB:WBGene00170056	21ur-13870
No description available

WB:WBGene00170057	21ur-9284
No description available

WB:WBGene00170058	21ur-11350
No description available

WB:WBGene00170059	21ur-5725
No description available

WB:WBGene00170060	21ur-15689
No description available

WB:WBGene00170061	21ur-12181
No description available

WB:WBGene00170062	21ur-7038
No description available

WB:WBGene00170063	21ur-10267
No description available

WB:WBGene00170064	21ur-8065
No description available

WB:WBGene00170065	21ur-11330
No description available

WB:WBGene00170066	21ur-11020
No description available

WB:WBGene00170067	21ur-9395
No description available

WB:WBGene00170068	21ur-8676
No description available

WB:WBGene00170069	21ur-12643
No description available

WB:WBGene00170070	21ur-8566
No description available

WB:WBGene00170071	21ur-10845
No description available

WB:WBGene00170072	21ur-6340
No description available

WB:WBGene00170073	21ur-6973
No description available

WB:WBGene00170074	21ur-9034
No description available

WB:WBGene00170075	21ur-14861
No description available

WB:WBGene00170076	21ur-14284
No description available

WB:WBGene00170077	21ur-8858
No description available

WB:WBGene00170078	21ur-13933
No description available

WB:WBGene00170079	21ur-7320
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170080	21ur-9299
No description available

WB:WBGene00170081	21ur-5620
No description available

WB:WBGene00170082	21ur-9626
No description available

WB:WBGene00170083	21ur-6351
No description available

WB:WBGene00170084	21ur-5849
No description available

WB:WBGene00170085	21ur-9905
No description available

WB:WBGene00170086	21ur-14721
No description available

WB:WBGene00170087	21ur-9078
No description available

WB:WBGene00170088	21ur-9435
No description available

WB:WBGene00170089	21ur-9035
No description available

WB:WBGene00170090	21ur-11627
No description available

WB:WBGene00170091	21ur-11661
No description available

WB:WBGene00170092	21ur-15135
No description available

WB:WBGene00170093	21ur-8874
No description available

WB:WBGene00170094	21ur-9488
No description available

WB:WBGene00170095	21ur-11256
No description available

WB:WBGene00170096	21ur-13899
No description available

WB:WBGene00170097	21ur-9653
No description available

WB:WBGene00170098	21ur-13860
No description available

WB:WBGene00170099	21ur-12153
No description available

WB:WBGene00170100	21ur-6284
No description available

WB:WBGene00170101	21ur-8015
No description available

WB:WBGene00170102	21ur-15544
No description available

WB:WBGene00170103	21ur-7310
No description available

WB:WBGene00170104	21ur-10522
No description available

WB:WBGene00170105	21ur-11543
No description available

WB:WBGene00170106	21ur-9400
No description available

WB:WBGene00170107	21ur-11899
No description available

WB:WBGene00170108	21ur-15569
No description available

WB:WBGene00170109	21ur-10506
No description available

WB:WBGene00170110	21ur-12250
No description available

WB:WBGene00170111	21ur-14102
No description available

WB:WBGene00170112	21ur-14819
No description available

WB:WBGene00170113	21ur-13867
No description available

WB:WBGene00170114	21ur-8549
No description available

WB:WBGene00170115	21ur-7703
No description available

WB:WBGene00170116	21ur-11236
No description available

WB:WBGene00170117	21ur-14084
No description available

WB:WBGene00170118	21ur-7846
No description available

WB:WBGene00170119	21ur-9211
No description available

WB:WBGene00170120	21ur-9241
No description available

WB:WBGene00170121	21ur-13956
No description available

WB:WBGene00170122	21ur-8590
No description available

WB:WBGene00170123	21ur-14521
No description available

WB:WBGene00170124	21ur-13879
No description available

WB:WBGene00170125	21ur-11036
No description available

WB:WBGene00170126	21ur-13577
No description available

WB:WBGene00170127	21ur-14841
No description available

WB:WBGene00170128	21ur-9007
No description available

WB:WBGene00170129	21ur-7422
No description available

WB:WBGene00170130	21ur-12189
No description available

WB:WBGene00170131	21ur-7585
No description available

WB:WBGene00170132	21ur-9604
No description available

WB:WBGene00170133	21ur-13178
No description available

WB:WBGene00170134	21ur-6187
No description available

WB:WBGene00170135	21ur-11029
No description available

WB:WBGene00170136	21ur-11874
No description available

WB:WBGene00170137	21ur-13711
No description available

WB:WBGene00170138	21ur-8021
No description available

WB:WBGene00170139	21ur-11223
No description available

WB:WBGene00170140	21ur-9281
No description available

WB:WBGene00170141	21ur-13514
No description available

WB:WBGene00170142	21ur-10001
No description available

WB:WBGene00170143	21ur-8571
No description available

WB:WBGene00170144	21ur-10388
No description available

WB:WBGene00170145	21ur-12592
No description available

WB:WBGene00170146	21ur-10625
No description available

WB:WBGene00170147	21ur-5909
No description available

WB:WBGene00170148	21ur-7251
No description available

WB:WBGene00170149	21ur-11890
No description available

WB:WBGene00170150	21ur-11317
No description available

WB:WBGene00170151	21ur-15513
No description available

WB:WBGene00170152	21ur-13274
Is affected by lem-2 based on RNA-seq studies.

WB:WBGene00170153	21ur-13104
No description available

WB:WBGene00170154	21ur-7192
No description available

WB:WBGene00170155	21ur-13456
No description available

WB:WBGene00170156	21ur-8576
No description available

WB:WBGene00170157	21ur-9760
No description available

WB:WBGene00170158	21ur-12149
No description available

WB:WBGene00170159	21ur-11063
No description available

WB:WBGene00170160	21ur-10860
No description available

WB:WBGene00170161	21ur-14265
No description available

WB:WBGene00170162	21ur-5653
No description available

WB:WBGene00170163	21ur-11002
No description available

WB:WBGene00170164	21ur-15017
No description available

WB:WBGene00170165	21ur-11909
No description available

WB:WBGene00170166	21ur-12038
No description available

WB:WBGene00170167	21ur-6055
No description available

WB:WBGene00170168	21ur-13455
Is affected by daf-2 based on microarray studies.

WB:WBGene00170169	21ur-6607
No description available

WB:WBGene00170170	21ur-8763
No description available

WB:WBGene00170171	21ur-13859
No description available

WB:WBGene00170172	21ur-8334
No description available

WB:WBGene00170173	21ur-11895
No description available

WB:WBGene00170174	21ur-7999
No description available

WB:WBGene00170175	21ur-13137
No description available

WB:WBGene00170176	21ur-9234
No description available

WB:WBGene00170177	21ur-11900
No description available

WB:WBGene00170178	21ur-9015
No description available

WB:WBGene00170179	21ur-10333
No description available

WB:WBGene00170180	21ur-11882
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00170181	21ur-5830
No description available

WB:WBGene00170182	21ur-10551
No description available

WB:WBGene00170183	21ur-12614
No description available

WB:WBGene00170184	21ur-6018
No description available

WB:WBGene00170185	21ur-11118
No description available

WB:WBGene00170186	21ur-6414
No description available

WB:WBGene00170187	21ur-7723
No description available

WB:WBGene00170188	21ur-5962
No description available

WB:WBGene00170189	21ur-8332
No description available

WB:WBGene00170190	21ur-7973
No description available

WB:WBGene00170191	21ur-9680
No description available

WB:WBGene00170192	21ur-15365
No description available

WB:WBGene00170193	21ur-7138
No description available

WB:WBGene00170194	21ur-8373
No description available

WB:WBGene00170195	21ur-9248
No description available

WB:WBGene00170196	21ur-14967
No description available

WB:WBGene00170197	21ur-5860
No description available

WB:WBGene00170198	21ur-8028
No description available

WB:WBGene00170199	21ur-11465
No description available

WB:WBGene00170200	21ur-8317
No description available

WB:WBGene00170201	21ur-12266
No description available

WB:WBGene00170202	21ur-13699
No description available

WB:WBGene00170203	21ur-11735
No description available

WB:WBGene00170204	21ur-10981
No description available

WB:WBGene00170205	21ur-13592
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00170206	21ur-11429
No description available

WB:WBGene00170207	21ur-15203
No description available

WB:WBGene00170208	21ur-13891
No description available

WB:WBGene00170209	21ur-6635
No description available

WB:WBGene00170210	21ur-12997
No description available

WB:WBGene00170211	21ur-14666
No description available

WB:WBGene00170212	21ur-5807
No description available

WB:WBGene00170213	21ur-14902
No description available

WB:WBGene00170214	21ur-6382
No description available

WB:WBGene00170215	21ur-10656
No description available

WB:WBGene00170216	21ur-13994
No description available

WB:WBGene00170217	21ur-5990
No description available

WB:WBGene00170218	21ur-11367
No description available

WB:WBGene00170219	21ur-9964
No description available

WB:WBGene00170220	21ur-12291
No description available

WB:WBGene00170221	21ur-11044
No description available

WB:WBGene00170222	21ur-13205
No description available

WB:WBGene00170223	21ur-11428
No description available

WB:WBGene00170224	21ur-10976
No description available

WB:WBGene00170225	21ur-7592
No description available

WB:WBGene00170226	21ur-5824
No description available

WB:WBGene00170227	21ur-6637
No description available

WB:WBGene00170228	21ur-8754
No description available

WB:WBGene00170229	21ur-10476
No description available

WB:WBGene00170230	21ur-14569
No description available

WB:WBGene00170231	21ur-8640
No description available

WB:WBGene00170232	21ur-14518
No description available

WB:WBGene00170233	21ur-7145
No description available

WB:WBGene00170234	21ur-7617
No description available

WB:WBGene00170235	21ur-8889
No description available

WB:WBGene00170236	21ur-11265
No description available

WB:WBGene00170237	21ur-15122
No description available

WB:WBGene00170238	21ur-9265
No description available

WB:WBGene00170239	21ur-9200
No description available

WB:WBGene00170240	21ur-10310
No description available

WB:WBGene00170241	21ur-11717
No description available

WB:WBGene00170242	21ur-11092
No description available

WB:WBGene00170243	21ur-6032
No description available

WB:WBGene00170244	21ur-9623
No description available

WB:WBGene00170245	21ur-10666
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170246	21ur-6957
No description available

WB:WBGene00170247	21ur-7077
No description available

WB:WBGene00170248	21ur-8409
No description available

WB:WBGene00170249	21ur-12352
No description available

WB:WBGene00170250	21ur-9993
No description available

WB:WBGene00170251	21ur-14590
No description available

WB:WBGene00170252	21ur-14807
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00170253	21ur-15161
No description available

WB:WBGene00170254	21ur-12609
No description available

WB:WBGene00170255	21ur-8926
No description available

WB:WBGene00170256	21ur-12359
No description available

WB:WBGene00170257	21ur-12701
No description available

WB:WBGene00170258	21ur-6092
No description available

WB:WBGene00170259	21ur-13846
No description available

WB:WBGene00170260	21ur-5935
No description available

WB:WBGene00170261	21ur-6043
No description available

WB:WBGene00170262	21ur-9345
No description available

WB:WBGene00170263	21ur-11497
No description available

WB:WBGene00170264	21ur-14116
No description available

WB:WBGene00170265	21ur-10049
No description available

WB:WBGene00170266	21ur-6294
No description available

WB:WBGene00170267	21ur-9300
No description available

WB:WBGene00170268	21ur-13524
No description available

WB:WBGene00170269	21ur-10187
No description available

WB:WBGene00170270	21ur-10683
No description available

WB:WBGene00170271	21ur-8073
No description available

WB:WBGene00170272	21ur-8031
No description available

WB:WBGene00170273	21ur-13852
No description available

WB:WBGene00170274	21ur-9067
No description available

WB:WBGene00170275	21ur-15642
No description available

WB:WBGene00170276	21ur-14078
No description available

WB:WBGene00170277	21ur-13186
No description available

WB:WBGene00170278	21ur-13632
No description available

WB:WBGene00170279	21ur-5575
No description available

WB:WBGene00170280	21ur-14451
No description available

WB:WBGene00170281	21ur-5914
No description available

WB:WBGene00170282	21ur-7734
No description available

WB:WBGene00170283	21ur-7056
No description available

WB:WBGene00170284	21ur-12398
No description available

WB:WBGene00170285	21ur-8346
No description available

WB:WBGene00170286	21ur-13374
No description available

WB:WBGene00170287	21ur-5634
No description available

WB:WBGene00170288	21ur-10850
No description available

WB:WBGene00170289	21ur-14960
No description available

WB:WBGene00170290	21ur-15646
No description available

WB:WBGene00170291	21ur-5900
No description available

WB:WBGene00170292	21ur-9863
No description available

WB:WBGene00170293	21ur-12439
No description available

WB:WBGene00170294	21ur-8385
No description available

WB:WBGene00170295	21ur-14109
No description available

WB:WBGene00170296	21ur-11099
Is affected by meg-3; meg-4; and pptr-1 based on RNA-seq studies.

WB:WBGene00170297	21ur-9461
No description available

WB:WBGene00170298	21ur-9158
No description available

WB:WBGene00170299	21ur-13683
No description available

WB:WBGene00170300	21ur-12192
No description available

WB:WBGene00170301	21ur-13678
No description available

WB:WBGene00170302	21ur-12690
No description available

WB:WBGene00170303	21ur-11778
No description available

WB:WBGene00170304	21ur-15596
No description available

WB:WBGene00170305	21ur-8561
Is affected by eat-2 based on microarray studies.

WB:WBGene00170306	21ur-9719
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00170307	21ur-14910
No description available

WB:WBGene00170308	21ur-10286
No description available

WB:WBGene00170309	21ur-11691
No description available

WB:WBGene00170310	21ur-14857
No description available

WB:WBGene00170311	21ur-12022
No description available

WB:WBGene00170312	21ur-9412
No description available

WB:WBGene00170313	21ur-6648
No description available

WB:WBGene00170314	21ur-13635
No description available

WB:WBGene00170315	21ur-13072
No description available

WB:WBGene00170316	21ur-9538
No description available

WB:WBGene00170317	21ur-10102
No description available

WB:WBGene00170318	21ur-12940
No description available

WB:WBGene00170319	21ur-14317
No description available

WB:WBGene00170320	21ur-15241
No description available

WB:WBGene00170321	21ur-6729
No description available

WB:WBGene00170322	21ur-9209
No description available

WB:WBGene00170323	21ur-13642
No description available

WB:WBGene00170324	21ur-13948
No description available

WB:WBGene00170325	21ur-11783
No description available

WB:WBGene00170326	21ur-11278
No description available

WB:WBGene00170327	21ur-10163
No description available

WB:WBGene00170328	21ur-10211
No description available

WB:WBGene00170329	21ur-12965
No description available

WB:WBGene00170330	21ur-7885
No description available

WB:WBGene00170331	21ur-8817
No description available

WB:WBGene00170332	21ur-10628
No description available

WB:WBGene00170333	21ur-15385
No description available

WB:WBGene00170334	21ur-11305
No description available

WB:WBGene00170335	21ur-13885
No description available

WB:WBGene00170336	21ur-8506
No description available

WB:WBGene00170337	21ur-7373
No description available

WB:WBGene00170338	21ur-9798
No description available

WB:WBGene00170339	21ur-14677
No description available

WB:WBGene00170340	21ur-14712
No description available

WB:WBGene00170341	21ur-6902
No description available

WB:WBGene00170342	21ur-8369
No description available

WB:WBGene00170343	21ur-11535
No description available

WB:WBGene00170344	21ur-12344
No description available

WB:WBGene00170345	21ur-14817
No description available

WB:WBGene00170346	21ur-8810
No description available

WB:WBGene00170347	21ur-13129
No description available

WB:WBGene00170348	21ur-14535
No description available

WB:WBGene00170349	21ur-6733
No description available

WB:WBGene00170350	21ur-6928
No description available

WB:WBGene00170351	21ur-10940
No description available

WB:WBGene00170352	21ur-6445
No description available

WB:WBGene00170353	21ur-12925
No description available

WB:WBGene00170354	21ur-14926
No description available

WB:WBGene00170355	21ur-9337
No description available

WB:WBGene00170356	21ur-10777
No description available

WB:WBGene00170357	21ur-6697
No description available

WB:WBGene00170358	21ur-14415
No description available

WB:WBGene00170359	21ur-5695
No description available

WB:WBGene00170360	21ur-14071
No description available

WB:WBGene00170361	21ur-7527
No description available

WB:WBGene00170362	21ur-14354
No description available

WB:WBGene00170363	21ur-5976
No description available

WB:WBGene00170364	21ur-9028
No description available

WB:WBGene00170365	21ur-13473
No description available

WB:WBGene00170366	21ur-12156
No description available

WB:WBGene00170367	21ur-8698
No description available

WB:WBGene00170368	21ur-9309
No description available

WB:WBGene00170369	21ur-11290
No description available

WB:WBGene00170370	21ur-9086
No description available

WB:WBGene00170371	21ur-5971
No description available

WB:WBGene00170372	21ur-12691
No description available

WB:WBGene00170373	21ur-5613
No description available

WB:WBGene00170374	21ur-15443
No description available

WB:WBGene00170375	21ur-5463
No description available

WB:WBGene00170376	21ur-13818
No description available

WB:WBGene00170377	21ur-8261
No description available

WB:WBGene00170378	21ur-7622
No description available

WB:WBGene00170379	21ur-12507
No description available

WB:WBGene00170380	21ur-14378
No description available

WB:WBGene00170381	21ur-12072
No description available

WB:WBGene00170382	21ur-7680
No description available

WB:WBGene00170383	21ur-8488
No description available

WB:WBGene00170384	21ur-11635
No description available

WB:WBGene00170385	21ur-10450
No description available

WB:WBGene00170386	21ur-7103
No description available

WB:WBGene00170387	21ur-9751
No description available

WB:WBGene00170388	21ur-13503
No description available

WB:WBGene00170389	21ur-9029
No description available

WB:WBGene00170390	21ur-15046
No description available

WB:WBGene00170391	21ur-12798
No description available

WB:WBGene00170392	21ur-8495
No description available

WB:WBGene00170393	21ur-5700
No description available

WB:WBGene00170394	21ur-7467
No description available

WB:WBGene00170395	21ur-6834
No description available

WB:WBGene00170396	21ur-11217
No description available

WB:WBGene00170397	21ur-15259
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00170398	21ur-6027
No description available

WB:WBGene00170399	21ur-7981
No description available

WB:WBGene00170400	21ur-13355
No description available

WB:WBGene00170401	21ur-15060
No description available

WB:WBGene00170402	21ur-12319
No description available

WB:WBGene00170403	21ur-5597
No description available

WB:WBGene00170404	21ur-7176
No description available

WB:WBGene00170405	21ur-7525
No description available

WB:WBGene00170406	21ur-9049
No description available

WB:WBGene00170407	21ur-11210
No description available

WB:WBGene00170408	21ur-12822
No description available

WB:WBGene00170409	21ur-11814
No description available

WB:WBGene00170410	21ur-14259
No description available

WB:WBGene00170411	21ur-5545
No description available

WB:WBGene00170412	21ur-6614
No description available

WB:WBGene00170413	21ur-7477
No description available

WB:WBGene00170414	21ur-6070
No description available

WB:WBGene00170415	21ur-6583
No description available

WB:WBGene00170416	21ur-15319
No description available

WB:WBGene00170417	21ur-6497
No description available

WB:WBGene00170418	21ur-10958
No description available

WB:WBGene00170419	21ur-6982
No description available

WB:WBGene00170420	21ur-5591
No description available

WB:WBGene00170421	21ur-6042
No description available

WB:WBGene00170422	21ur-12403
No description available

WB:WBGene00170423	21ur-13906
No description available

WB:WBGene00170424	21ur-15065
No description available

WB:WBGene00170425	21ur-6651
No description available

WB:WBGene00170426	21ur-12969
No description available

WB:WBGene00170427	21ur-13737
No description available

WB:WBGene00170428	21ur-7645
No description available

WB:WBGene00170429	21ur-5943
No description available

WB:WBGene00170430	21ur-7497
No description available

WB:WBGene00170431	21ur-13516
No description available

WB:WBGene00170432	21ur-15031
No description available

WB:WBGene00170433	21ur-12730
No description available

WB:WBGene00170434	21ur-13110
No description available

WB:WBGene00170435	21ur-12741
No description available

WB:WBGene00170436	21ur-14298
No description available

WB:WBGene00170437	21ur-10010
No description available

WB:WBGene00170438	21ur-7356
No description available

WB:WBGene00170439	21ur-7629
No description available

WB:WBGene00170440	21ur-10281
No description available

WB:WBGene00170441	21ur-10949
No description available

WB:WBGene00170442	21ur-10968
No description available

WB:WBGene00170443	21ur-7742
No description available

WB:WBGene00170444	21ur-9223
No description available

WB:WBGene00170445	21ur-7937
No description available

WB:WBGene00170446	21ur-12120
No description available

WB:WBGene00170447	21ur-10218
No description available

WB:WBGene00170448	21ur-8535
No description available

WB:WBGene00170449	21ur-13421
No description available

WB:WBGene00170450	21ur-6279
No description available

WB:WBGene00170451	21ur-9758
No description available

WB:WBGene00170452	21ur-10676
No description available

WB:WBGene00170453	21ur-5555
No description available

WB:WBGene00170454	21ur-14371
No description available

WB:WBGene00170455	21ur-15509
No description available

WB:WBGene00170456	21ur-6011
No description available

WB:WBGene00170457	21ur-9094
No description available

WB:WBGene00170458	21ur-12676
No description available

WB:WBGene00170459	21ur-14827
No description available

WB:WBGene00170460	21ur-10114
No description available

WB:WBGene00170461	21ur-7926
No description available

WB:WBGene00170462	21ur-11614
No description available

WB:WBGene00170463	21ur-10317
No description available

WB:WBGene00170464	21ur-5984
No description available

WB:WBGene00170465	21ur-14639
No description available

WB:WBGene00170466	21ur-9144
No description available

WB:WBGene00170467	21ur-12949
No description available

WB:WBGene00170468	21ur-11398
No description available

WB:WBGene00170469	21ur-12734
No description available

WB:WBGene00170470	21ur-12909
No description available

WB:WBGene00170471	21ur-15118
No description available

WB:WBGene00170472	21ur-13605
No description available

WB:WBGene00170473	21ur-5750
No description available

WB:WBGene00170474	21ur-9873
No description available

WB:WBGene00170475	21ur-5489
No description available

WB:WBGene00170476	21ur-11633
No description available

WB:WBGene00170477	21ur-14413
No description available

WB:WBGene00170478	21ur-11051
No description available

WB:WBGene00170479	21ur-7004
No description available

WB:WBGene00170480	21ur-10919
No description available

WB:WBGene00170481	21ur-10075
No description available

WB:WBGene00170482	21ur-9417
No description available

WB:WBGene00170483	21ur-14843
No description available

WB:WBGene00170484	21ur-8923
No description available

WB:WBGene00170485	21ur-10918
No description available

WB:WBGene00170486	21ur-11708
No description available

WB:WBGene00170487	21ur-15283
No description available

WB:WBGene00170488	21ur-6302
No description available

WB:WBGene00170489	21ur-13746
No description available

WB:WBGene00170490	21ur-5705
No description available

WB:WBGene00170491	21ur-9911
No description available

WB:WBGene00170492	21ur-6578
No description available

WB:WBGene00170493	21ur-10348
No description available

WB:WBGene00170494	21ur-12847
No description available

WB:WBGene00170495	21ur-12903
No description available

WB:WBGene00170496	21ur-10488
No description available

WB:WBGene00170497	21ur-12564
No description available

WB:WBGene00170498	21ur-12875
No description available

WB:WBGene00170499	21ur-10971
No description available

WB:WBGene00170500	21ur-12634
No description available

WB:WBGene00170501	21ur-7090
No description available

WB:WBGene00170502	21ur-8266
No description available

WB:WBGene00170503	21ur-9664
No description available

WB:WBGene00170504	21ur-10146
No description available

WB:WBGene00170505	21ur-12058
No description available

WB:WBGene00170506	21ur-15222
No description available

WB:WBGene00170507	21ur-12584
No description available

WB:WBGene00170508	21ur-13416
No description available

WB:WBGene00170509	21ur-9328
No description available

WB:WBGene00170510	21ur-12283
No description available

WB:WBGene00170511	21ur-12620
No description available

WB:WBGene00170512	21ur-7115
No description available

WB:WBGene00170513	21ur-12444
No description available

WB:WBGene00170514	21ur-14275
No description available

WB:WBGene00170515	21ur-13252
No description available

WB:WBGene00170516	21ur-9770
No description available

WB:WBGene00170517	21ur-7816
No description available

WB:WBGene00170518	21ur-6218
No description available

WB:WBGene00170519	21ur-6280
No description available

WB:WBGene00170520	21ur-12836
No description available

WB:WBGene00170521	21ur-9523
No description available

WB:WBGene00170522	21ur-11772
No description available

WB:WBGene00170523	21ur-15665
No description available

WB:WBGene00170524	21ur-10207
No description available

WB:WBGene00170525	21ur-11299
No description available

WB:WBGene00170526	21ur-14149
No description available

WB:WBGene00170527	21ur-8709
No description available

WB:WBGene00170528	21ur-13535
No description available

WB:WBGene00170529	21ur-6394
No description available

WB:WBGene00170530	21ur-9728
No description available

WB:WBGene00170531	21ur-15174
No description available

WB:WBGene00170532	21ur-11554
No description available

WB:WBGene00170533	21ur-8778
No description available

WB:WBGene00170534	21ur-12776
No description available

WB:WBGene00170535	21ur-6348
No description available

WB:WBGene00170536	21ur-10390
No description available

WB:WBGene00170537	21ur-7633
No description available

WB:WBGene00170538	21ur-15011
No description available

WB:WBGene00170539	21ur-14699
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00170540	21ur-10547
No description available

WB:WBGene00170541	21ur-6873
No description available

WB:WBGene00170542	21ur-10429
No description available

WB:WBGene00170543	21ur-10309
No description available

WB:WBGene00170544	21ur-11792
No description available

WB:WBGene00170545	21ur-6475
No description available

WB:WBGene00170546	21ur-6169
No description available

WB:WBGene00170547	21ur-7020
No description available

WB:WBGene00170548	21ur-7905
No description available

WB:WBGene00170549	21ur-12555
No description available

WB:WBGene00170550	21ur-14339
No description available

WB:WBGene00170551	21ur-12629
No description available

WB:WBGene00170552	21ur-14169
No description available

WB:WBGene00170553	21ur-7431
No description available

WB:WBGene00170554	21ur-12200
No description available

WB:WBGene00170555	21ur-14895
No description available

WB:WBGene00170556	21ur-6264
No description available

WB:WBGene00170557	21ur-9443
No description available

WB:WBGene00170558	21ur-14063
No description available

WB:WBGene00170559	21ur-9478
No description available

WB:WBGene00170560	21ur-12308
No description available

WB:WBGene00170561	21ur-14543
No description available

WB:WBGene00170562	21ur-14739
No description available

WB:WBGene00170563	21ur-6666
No description available

WB:WBGene00170564	21ur-9588
No description available

WB:WBGene00170565	21ur-8960
No description available

WB:WBGene00170566	21ur-6763
No description available

WB:WBGene00170567	21ur-5617
No description available

WB:WBGene00170568	21ur-11351
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170569	21ur-14584
No description available

WB:WBGene00170570	21ur-14670
Is affected by ins-11 based on RNA-seq studies. Is affected by bisphenol A based on RNA-seq studies.

WB:WBGene00170571	21ur-11999
No description available

WB:WBGene00170572	21ur-6097
No description available

WB:WBGene00170573	21ur-10397
No description available

WB:WBGene00170574	21ur-8789
Is affected by ints-2 based on RNA-seq studies.

WB:WBGene00170575	21ur-10564
No description available

WB:WBGene00170576	21ur-11670
No description available

WB:WBGene00170577	21ur-6856
No description available

WB:WBGene00170578	21ur-11917
No description available

WB:WBGene00170579	21ur-11984
No description available

WB:WBGene00170580	21ur-6311
No description available

WB:WBGene00170581	21ur-15697
No description available

WB:WBGene00170582	21ur-8451
No description available

WB:WBGene00170583	21ur-13349
No description available

WB:WBGene00170584	21ur-8121
No description available

WB:WBGene00170585	21ur-7365
No description available

WB:WBGene00170586	21ur-13461
No description available

WB:WBGene00170587	21ur-13837
No description available

WB:WBGene00170588	21ur-10695
No description available

WB:WBGene00170589	21ur-14004
No description available

WB:WBGene00170590	21ur-5780
No description available

WB:WBGene00170591	21ur-9833
No description available

WB:WBGene00170592	21ur-6896
No description available

WB:WBGene00170593	21ur-11598
No description available

WB:WBGene00170594	21ur-6747
No description available

WB:WBGene00170595	21ur-11167
No description available

WB:WBGene00170596	21ur-10080
No description available

WB:WBGene00170597	21ur-7442
No description available

WB:WBGene00170598	21ur-7765
No description available

WB:WBGene00170599	21ur-14140
No description available

WB:WBGene00170600	21ur-11360
No description available

WB:WBGene00170601	21ur-8187
No description available

WB:WBGene00170602	21ur-12141
No description available

WB:WBGene00170603	21ur-7447
No description available

WB:WBGene00170604	21ur-10243
No description available

WB:WBGene00170605	21ur-10589
No description available

WB:WBGene00170606	21ur-8808
No description available

WB:WBGene00170607	21ur-5757
No description available

WB:WBGene00170608	21ur-8522
No description available

WB:WBGene00170609	21ur-8543
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170610	21ur-10304
No description available

WB:WBGene00170611	21ur-10459
No description available

WB:WBGene00170612	21ur-13724
No description available

WB:WBGene00170613	21ur-14574
No description available

WB:WBGene00170614	21ur-9804
No description available

WB:WBGene00170615	21ur-15001
No description available

WB:WBGene00170616	21ur-14495
No description available

WB:WBGene00170617	21ur-14345
No description available

WB:WBGene00170618	21ur-15502
No description available

WB:WBGene00170619	21ur-9389
No description available

WB:WBGene00170620	21ur-15433
No description available

WB:WBGene00170621	21ur-6222
No description available

WB:WBGene00170622	21ur-11666
No description available

WB:WBGene00170623	21ur-6144
No description available

WB:WBGene00170624	21ur-8149
No description available

WB:WBGene00170625	21ur-15107
No description available

WB:WBGene00170626	21ur-8285
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00170627	21ur-6085
No description available

WB:WBGene00170628	21ur-12364
Is affected by hmg-4 and spt-16 based on RNA-seq studies.

WB:WBGene00170629	21ur-7279
No description available

WB:WBGene00170630	21ur-13026
No description available

WB:WBGene00170631	21ur-13742
No description available

WB:WBGene00170632	21ur-6918
No description available

WB:WBGene00170633	21ur-10208
No description available

WB:WBGene00170634	21ur-5926
No description available

WB:WBGene00170635	21ur-5699
No description available

WB:WBGene00170636	21ur-7698
No description available

WB:WBGene00170637	21ur-9635
No description available

WB:WBGene00170638	21ur-15008
No description available

WB:WBGene00170639	21ur-7640
No description available

WB:WBGene00170640	21ur-15054
No description available

WB:WBGene00170641	21ur-6367
No description available

WB:WBGene00170642	21ur-6755
No description available

WB:WBGene00170643	21ur-8361
No description available

WB:WBGene00170644	21ur-9321
No description available

WB:WBGene00170645	21ur-14160
No description available

WB:WBGene00170646	21ur-10932
No description available

WB:WBGene00170647	21ur-12208
No description available

WB:WBGene00170648	21ur-10138
No description available

WB:WBGene00170649	21ur-14868
No description available

WB:WBGene00170650	21ur-8185
No description available

WB:WBGene00170651	21ur-5761
No description available

WB:WBGene00170652	21ur-15140
No description available

WB:WBGene00170653	21ur-7210
No description available

WB:WBGene00170654	21ur-14997
No description available

WB:WBGene00170655	21ur-7544
No description available

WB:WBGene00170656	21ur-9219
No description available

WB:WBGene00170657	21ur-5833
No description available

WB:WBGene00170658	21ur-10998
No description available

WB:WBGene00170659	21ur-12980
No description available

WB:WBGene00170660	21ur-8646
No description available

WB:WBGene00170661	21ur-8425
No description available

WB:WBGene00170662	21ur-8747
No description available

WB:WBGene00170663	21ur-10592
No description available

WB:WBGene00170664	21ur-12288
No description available

WB:WBGene00170665	21ur-12486
No description available

WB:WBGene00170666	21ur-6771
No description available

WB:WBGene00170667	21ur-11976
No description available

WB:WBGene00170668	21ur-7246
No description available

WB:WBGene00170669	21ur-9012
No description available

WB:WBGene00170670	21ur-12135
No description available

WB:WBGene00170671	21ur-12887
No description available

WB:WBGene00170672	21ur-6781
No description available

WB:WBGene00170673	21ur-15418
No description available

WB:WBGene00170674	21ur-14557
No description available

WB:WBGene00170675	21ur-11184
No description available

WB:WBGene00170676	21ur-12374
No description available

WB:WBGene00170677	21ur-11452
No description available

WB:WBGene00170678	21ur-12976
No description available

WB:WBGene00170679	21ur-13469
No description available

WB:WBGene00170680	21ur-13753
No description available

WB:WBGene00170681	21ur-6889
No description available

WB:WBGene00170682	21ur-8097
No description available

WB:WBGene00170683	21ur-8599
No description available

WB:WBGene00170684	21ur-9452
No description available

WB:WBGene00170685	21ur-6528
No description available

WB:WBGene00170686	21ur-7203
No description available

WB:WBGene00170687	21ur-6547
No description available

WB:WBGene00170688	21ur-8214
No description available

WB:WBGene00170689	21ur-10238
No description available

WB:WBGene00170690	21ur-12259
Is affected by eat-2 based on microarray studies.

WB:WBGene00170691	21ur-7540
No description available

WB:WBGene00170692	21ur-12125
No description available

WB:WBGene00170693	21ur-6589
No description available

WB:WBGene00170694	21ur-13217
No description available

WB:WBGene00170695	21ur-12856
No description available

WB:WBGene00170697	21ur-13013
No description available

WB:WBGene00170698	21ur-13226
No description available

WB:WBGene00170699	21ur-14405
No description available

WB:WBGene00170700	21ur-14008
No description available

WB:WBGene00170701	21ur-6224
No description available

WB:WBGene00170702	21ur-12342
No description available

WB:WBGene00170703	21ur-7750
No description available

WB:WBGene00170704	21ur-14919
No description available

WB:WBGene00170705	21ur-14041
No description available

WB:WBGene00170706	21ur-10717
No description available

WB:WBGene00170707	21ur-6619
No description available

WB:WBGene00170708	21ur-10496
No description available

WB:WBGene00170709	21ur-7821
No description available

WB:WBGene00170710	21ur-11529
No description available

WB:WBGene00170711	21ur-6753
No description available

WB:WBGene00170712	21ur-7180
No description available

WB:WBGene00170713	21ur-7300
No description available

WB:WBGene00170714	21ur-10721
No description available

WB:WBGene00170715	21ur-12369
No description available

WB:WBGene00170716	21ur-6167
No description available

WB:WBGene00170717	21ur-6138
No description available

WB:WBGene00170718	21ur-6797
No description available

WB:WBGene00170719	21ur-12478
No description available

WB:WBGene00170720	21ur-15554
No description available

WB:WBGene00170721	21ur-9579
No description available

WB:WBGene00170722	21ur-13444
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170723	21ur-7475
No description available

WB:WBGene00170724	21ur-9439
No description available

WB:WBGene00170725	21ur-8702
No description available

WB:WBGene00170726	21ur-14057
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00170727	21ur-6784
No description available

WB:WBGene00170728	21ur-12410
No description available

WB:WBGene00170729	21ur-7503
No description available

WB:WBGene00170730	21ur-10742
No description available

WB:WBGene00170731	21ur-9875
No description available

WB:WBGene00170732	21ur-12537
No description available

WB:WBGene00170733	21ur-12899
No description available

WB:WBGene00170734	21ur-8440
No description available

WB:WBGene00170735	21ur-10794
No description available

WB:WBGene00170736	21ur-5821
No description available

WB:WBGene00170737	21ur-6540
No description available

WB:WBGene00170738	21ur-9732
No description available

WB:WBGene00170739	21ur-9699
No description available

WB:WBGene00170740	21ur-13092
No description available

WB:WBGene00170741	21ur-15155
No description available

WB:WBGene00170742	21ur-12099
No description available

WB:WBGene00170743	21ur-13772
No description available

WB:WBGene00170744	21ur-12100
No description available

WB:WBGene00170745	21ur-8511
No description available

WB:WBGene00170746	21ur-12086
No description available

WB:WBGene00170747	21ur-13441
No description available

WB:WBGene00170748	21ur-6402
No description available

WB:WBGene00170749	21ur-15654
No description available

WB:WBGene00170750	21ur-14720
No description available

WB:WBGene00170751	21ur-14219
No description available

WB:WBGene00170752	21ur-10771
No description available

WB:WBGene00170753	21ur-14773
No description available

WB:WBGene00170754	21ur-6948
No description available

WB:WBGene00170755	21ur-7636
No description available

WB:WBGene00170756	21ur-9050
No description available

WB:WBGene00170757	21ur-6769
No description available

WB:WBGene00170758	21ur-8416
No description available

WB:WBGene00170759	21ur-7662
No description available

WB:WBGene00170760	21ur-9556
No description available

WB:WBGene00170761	21ur-12450
No description available

WB:WBGene00170762	21ur-8749
No description available

WB:WBGene00170763	21ur-7395
No description available

WB:WBGene00170764	21ur-7486
No description available

WB:WBGene00170765	21ur-5806
No description available

WB:WBGene00170766	21ur-6326
No description available

WB:WBGene00170767	21ur-14732
No description available

WB:WBGene00170768	21ur-8716
No description available

WB:WBGene00170769	21ur-12164
No description available

WB:WBGene00170770	21ur-14342
No description available

WB:WBGene00170771	21ur-6836
No description available

WB:WBGene00170772	21ur-10250
No description available

WB:WBGene00170773	21ur-15489
No description available

WB:WBGene00170774	21ur-12196
No description available

WB:WBGene00170775	21ur-5532
No description available

WB:WBGene00170776	21ur-8445
No description available

WB:WBGene00170777	21ur-11325
No description available

WB:WBGene00170778	21ur-14300
No description available

WB:WBGene00170779	21ur-12131
No description available

WB:WBGene00170780	21ur-9830
No description available

WB:WBGene00170781	21ur-11485
No description available

WB:WBGene00170782	21ur-12578
No description available

WB:WBGene00170783	21ur-13037
No description available

WB:WBGene00170784	21ur-9614
No description available

WB:WBGene00170785	21ur-8291
No description available

WB:WBGene00170786	21ur-11694
No description available

WB:WBGene00170787	21ur-10804
No description available

WB:WBGene00170788	21ur-12225
No description available

WB:WBGene00170789	21ur-13232
No description available

WB:WBGene00170790	21ur-9242
No description available

WB:WBGene00170791	21ur-6787
No description available

WB:WBGene00170792	21ur-13865
No description available

WB:WBGene00170793	21ur-13069
No description available

WB:WBGene00170794	21ur-7714
No description available

WB:WBGene00170795	21ur-6717
No description available

WB:WBGene00170796	21ur-14788
Is affected by daf-2 based on microarray studies.

WB:WBGene00170797	21ur-8228
No description available

WB:WBGene00170798	21ur-11331
No description available

WB:WBGene00170799	21ur-13725
No description available

WB:WBGene00170800	21ur-10878
No description available

WB:WBGene00170801	21ur-8738
No description available

WB:WBGene00170802	21ur-7067
No description available

WB:WBGene00170803	21ur-13060
No description available

WB:WBGene00170804	21ur-10443
No description available

WB:WBGene00170805	21ur-10116
No description available

WB:WBGene00170806	21ur-13327
No description available

WB:WBGene00170807	21ur-6612
No description available

WB:WBGene00170808	21ur-12658
No description available

WB:WBGene00170809	21ur-14330
No description available

WB:WBGene00170810	21ur-11366
No description available

WB:WBGene00170811	21ur-8147
No description available

WB:WBGene00170812	21ur-13307
No description available

WB:WBGene00170813	21ur-6233
No description available

WB:WBGene00170814	21ur-6512
No description available

WB:WBGene00170815	21ur-12939
No description available

WB:WBGene00170816	21ur-8430
No description available

WB:WBGene00170817	21ur-10295
No description available

WB:WBGene00170818	21ur-7919
No description available

WB:WBGene00170819	21ur-12297
No description available

WB:WBGene00170820	21ur-13436
No description available

WB:WBGene00170821	21ur-6065
No description available

WB:WBGene00170822	21ur-15534
No description available

WB:WBGene00170823	21ur-7165
No description available

WB:WBGene00170824	21ur-10444
No description available

WB:WBGene00170825	21ur-10822
Is affected by emr-1; lem-2; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00170826	21ur-15598
No description available

WB:WBGene00170827	21ur-8135
No description available

WB:WBGene00170828	21ur-14566
No description available

WB:WBGene00170829	21ur-5813
No description available

WB:WBGene00170830	21ur-14549
No description available

WB:WBGene00170831	21ur-7745
No description available

WB:WBGene00170832	21ur-9957
No description available

WB:WBGene00170833	21ur-5817
No description available

WB:WBGene00170834	21ur-6482
No description available

WB:WBGene00170835	21ur-11585
No description available

WB:WBGene00170836	21ur-14888
No description available

WB:WBGene00170837	21ur-6379
No description available

WB:WBGene00170838	21ur-8497
No description available

WB:WBGene00170839	21ur-13323
No description available

WB:WBGene00170840	21ur-13332
No description available

WB:WBGene00170841	21ur-14604
No description available

WB:WBGene00170842	21ur-15229
No description available

WB:WBGene00170843	21ur-12581
No description available

WB:WBGene00170844	21ur-8624
No description available

WB:WBGene00170845	21ur-10733
No description available

WB:WBGene00170846	21ur-12729
No description available

WB:WBGene00170847	21ur-13050
No description available

WB:WBGene00170848	21ur-12179
No description available

WB:WBGene00170849	21ur-14962
No description available

WB:WBGene00170850	21ur-9931
No description available

WB:WBGene00170851	21ur-6844
No description available

WB:WBGene00170852	21ur-7327
No description available

WB:WBGene00170853	21ur-5495
No description available

WB:WBGene00170854	21ur-8731
No description available

WB:WBGene00170855	21ur-13917
No description available

WB:WBGene00170856	21ur-9164
No description available

WB:WBGene00170857	21ur-6329
No description available

WB:WBGene00170858	21ur-14395
No description available

WB:WBGene00170859	21ur-7679
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00170860	21ur-10466
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170861	21ur-13560
No description available

WB:WBGene00170862	21ur-15095
Is affected by daf-2 and ints-5 based on microarray and RNA-seq studies.

WB:WBGene00170863	21ur-11828
No description available

WB:WBGene00170864	21ur-10708
No description available

WB:WBGene00170865	21ur-6900
No description available

WB:WBGene00170866	21ur-5490
No description available

WB:WBGene00170867	21ur-15341
No description available

WB:WBGene00170868	21ur-6429
No description available

WB:WBGene00170869	21ur-15233
No description available

WB:WBGene00170870	21ur-13282
No description available

WB:WBGene00170871	21ur-14978
No description available

WB:WBGene00170872	21ur-10399
No description available

WB:WBGene00170873	21ur-15616
No description available

WB:WBGene00170874	21ur-13771
No description available

WB:WBGene00170875	21ur-5480
No description available

WB:WBGene00170876	21ur-13153
No description available

WB:WBGene00170877	21ur-7469
No description available

WB:WBGene00170878	21ur-6266
No description available

WB:WBGene00170879	21ur-6131
No description available

WB:WBGene00170880	21ur-15585
No description available

WB:WBGene00170881	21ur-7653
No description available

WB:WBGene00170882	21ur-10841
No description available

WB:WBGene00170883	21ur-12321
No description available

WB:WBGene00170884	21ur-14833
No description available

WB:WBGene00170885	21ur-11943
No description available

WB:WBGene00170886	21ur-6149
No description available

WB:WBGene00170887	21ur-15482
No description available

WB:WBGene00170888	21ur-14373
No description available

WB:WBGene00170889	21ur-12068
No description available

WB:WBGene00170890	21ur-13830
No description available

WB:WBGene00170891	21ur-7495
No description available

WB:WBGene00170892	21ur-14587
No description available

WB:WBGene00170893	21ur-7911
No description available

WB:WBGene00170894	21ur-10837
No description available

WB:WBGene00170895	21ur-7986
No description available

WB:WBGene00170896	21ur-12840
No description available

WB:WBGene00170897	21ur-9821
No description available

WB:WBGene00170898	21ur-6430
No description available

WB:WBGene00170899	21ur-10984
No description available

WB:WBGene00170900	21ur-11408
No description available

WB:WBGene00170901	21ur-11056
No description available

WB:WBGene00170902	21ur-8588
No description available

WB:WBGene00170903	21ur-5665
No description available

WB:WBGene00170904	21ur-8796
No description available

WB:WBGene00170905	21ur-12900
No description available

WB:WBGene00170906	21ur-13395
No description available

WB:WBGene00170907	21ur-14133
No description available

WB:WBGene00170908	21ur-10194
No description available

WB:WBGene00170909	21ur-14203
No description available

WB:WBGene00170910	21ur-12571
No description available

WB:WBGene00170911	21ur-6707
No description available

WB:WBGene00170912	21ur-10415
No description available

WB:WBGene00170913	21ur-6244
No description available

WB:WBGene00170914	21ur-10346
No description available

WB:WBGene00170915	21ur-14875
No description available

WB:WBGene00170916	21ur-5958
No description available

WB:WBGene00170917	21ur-9199
No description available

WB:WBGene00170918	21ur-8557
No description available

WB:WBGene00170919	21ur-11582
No description available

WB:WBGene00170920	21ur-15403
No description available

WB:WBGene00170921	21ur-8518
No description available

WB:WBGene00170922	21ur-7231
No description available

WB:WBGene00170923	21ur-15625
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00170924	21ur-11522
No description available

WB:WBGene00170925	21ur-12724
No description available

WB:WBGene00170926	21ur-15238
No description available

WB:WBGene00170927	21ur-14242
No description available

WB:WBGene00170928	21ur-13312
No description available

WB:WBGene00170929	21ur-14021
No description available

WB:WBGene00170930	21ur-6503
No description available

WB:WBGene00170931	21ur-8834
No description available

WB:WBGene00170932	21ur-13485
No description available

WB:WBGene00170933	21ur-15083
No description available

WB:WBGene00170934	21ur-12012
No description available

WB:WBGene00170935	21ur-5499
No description available

WB:WBGene00170936	21ur-15216
No description available

WB:WBGene00170937	21ur-12767
No description available

WB:WBGene00170938	21ur-14212
No description available

WB:WBGene00170939	21ur-5687
No description available

WB:WBGene00170940	21ur-9941
No description available

WB:WBGene00170941	21ur-10087
No description available

WB:WBGene00170942	21ur-12618
No description available

WB:WBGene00170943	21ur-10720
No description available

WB:WBGene00170944	21ur-11738
No description available

WB:WBGene00170945	21ur-14189
No description available

WB:WBGene00170946	21ur-9783
No description available

WB:WBGene00170947	21ur-10023
No description available

WB:WBGene00170948	21ur-14462
No description available

WB:WBGene00170949	21ur-14611
No description available

WB:WBGene00170950	21ur-8123
No description available

WB:WBGene00170951	21ur-8256
No description available

WB:WBGene00170952	21ur-6690
No description available

WB:WBGene00170953	21ur-15479
No description available

WB:WBGene00170954	21ur-14924
No description available

WB:WBGene00170955	21ur-8962
No description available

WB:WBGene00170956	21ur-10904
No description available

WB:WBGene00170957	21ur-13290
No description available

WB:WBGene00170958	21ur-9502
No description available

WB:WBGene00170959	21ur-9901
No description available

WB:WBGene00170960	21ur-11076
No description available

WB:WBGene00170961	21ur-11506
No description available

WB:WBGene00170962	21ur-7518
No description available

WB:WBGene00170963	21ur-6939
No description available

WB:WBGene00170964	21ur-11854
No description available

WB:WBGene00170965	21ur-8234
No description available

WB:WBGene00170966	21ur-9548
No description available

WB:WBGene00170967	21ur-15604
Is affected by eat-2 based on microarray studies.

WB:WBGene00170968	21ur-12114
No description available

WB:WBGene00170969	21ur-9366
No description available

WB:WBGene00170970	21ur-14448
No description available

WB:WBGene00170971	21ur-8682
No description available

WB:WBGene00170972	21ur-7607
No description available

WB:WBGene00170973	21ur-15395
No description available

WB:WBGene00170974	21ur-13969
No description available

WB:WBGene00170975	21ur-14741
No description available

WB:WBGene00170976	21ur-14369
No description available

WB:WBGene00170977	21ur-15284
No description available

WB:WBGene00170978	21ur-6455
No description available

WB:WBGene00170979	21ur-7960
No description available

WB:WBGene00170980	21ur-7956
No description available

WB:WBGene00170981	21ur-8140
No description available

WB:WBGene00170982	21ur-10863
No description available

WB:WBGene00170983	21ur-10679
No description available

WB:WBGene00170984	21ur-10632
No description available

WB:WBGene00170985	21ur-10151
No description available

WB:WBGene00170986	21ur-6990
No description available

WB:WBGene00170987	21ur-9370
No description available

WB:WBGene00170988	21ur-14206
No description available

WB:WBGene00170989	21ur-9073
No description available

WB:WBGene00170990	21ur-14155
No description available

WB:WBGene00170991	21ur-10753
No description available

WB:WBGene00170992	21ur-15248
No description available

WB:WBGene00170993	21ur-5522
No description available

WB:WBGene00170994	21ur-11197
No description available

WB:WBGene00170995	21ur-13714
No description available

WB:WBGene00170996	21ur-5867
No description available

WB:WBGene00170997	21ur-11479
No description available

WB:WBGene00170998	21ur-12471
No description available

WB:WBGene00170999	21ur-8251
No description available

WB:WBGene00171000	21ur-11878
No description available

WB:WBGene00171001	21ur-8661
No description available

WB:WBGene00171002	21ur-9918
No description available

WB:WBGene00171003	21ur-9071
No description available

WB:WBGene00171004	21ur-10761
No description available

WB:WBGene00171005	21ur-12971
No description available

WB:WBGene00171006	21ur-13151
No description available

WB:WBGene00171007	21ur-10936
No description available

WB:WBGene00171008	21ur-13350
No description available

WB:WBGene00171009	21ur-5997
No description available

WB:WBGene00171010	21ur-15619
No description available

WB:WBGene00171011	21ur-9124
No description available

WB:WBGene00171012	21ur-11373
No description available

WB:WBGene00171013	21ur-14237
No description available

WB:WBGene00171014	21ur-11152
No description available

WB:WBGene00171015	21ur-5855
No description available

WB:WBGene00171016	21ur-12118
No description available

WB:WBGene00171017	21ur-7862
No description available

WB:WBGene00171018	21ur-9088
No description available

WB:WBGene00171019	21ur-12521
No description available

WB:WBGene00171020	21ur-7728
No description available

WB:WBGene00171021	21ur-5875
No description available

WB:WBGene00171022	21ur-6009
No description available

WB:WBGene00171023	21ur-13987
No description available

WB:WBGene00171024	21ur-14630
No description available

WB:WBGene00171025	21ur-7538
No description available

WB:WBGene00171026	21ur-6575
No description available

WB:WBGene00171027	21ur-7832
No description available

WB:WBGene00171028	21ur-13192
No description available

WB:WBGene00171029	21ur-15620
No description available

WB:WBGene00171030	21ur-15631
No description available

WB:WBGene00171031	21ur-8870
No description available

WB:WBGene00171032	21ur-12886
No description available

WB:WBGene00171033	21ur-11951
No description available

WB:WBGene00171034	21ur-5850
No description available

WB:WBGene00171035	21ur-11176
No description available

WB:WBGene00171036	21ur-11537
Is affected by eat-2 based on microarray studies.

WB:WBGene00171037	21ur-14435
No description available

WB:WBGene00171038	21ur-9985
No description available

WB:WBGene00171039	21ur-15029
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00171040	21ur-15425
No description available

WB:WBGene00171041	21ur-12950
No description available

WB:WBGene00171042	21ur-9065
No description available

WB:WBGene00171043	21ur-11116
No description available

WB:WBGene00171044	21ur-12959
No description available

WB:WBGene00171045	21ur-13505
No description available

WB:WBGene00171046	21ur-15261
Is affected by emr-1; lem-2; and unc-70 based on RNA-seq studies.

WB:WBGene00171047	21ur-6119
No description available

WB:WBGene00171048	21ur-7085
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00171049	21ur-8197
No description available

WB:WBGene00171050	21ur-6671
No description available

WB:WBGene00171051	21ur-7924
No description available

WB:WBGene00171052	21ur-6494
No description available

WB:WBGene00171053	21ur-7223
No description available

WB:WBGene00171054	21ur-7409
No description available

WB:WBGene00171055	21ur-13687
No description available

WB:WBGene00171056	21ur-15275
No description available

WB:WBGene00171057	21ur-15100
No description available

WB:WBGene00171058	21ur-15141
No description available

WB:WBGene00171059	21ur-11981
No description available

WB:WBGene00171060	21ur-5524
No description available

WB:WBGene00171061	21ur-14971
No description available

WB:WBGene00171062	21ur-14433
No description available

WB:WBGene00171063	21ur-10639
No description available

WB:WBGene00171064	21ur-14576
No description available

WB:WBGene00171065	21ur-7014
No description available

WB:WBGene00171066	21ur-7685
No description available

WB:WBGene00171067	21ur-8390
No description available

WB:WBGene00171068	21ur-10668
No description available

WB:WBGene00171069	21ur-7907
No description available

WB:WBGene00171070	21ur-9566
No description available

WB:WBGene00171071	21ur-8190
No description available

WB:WBGene00171072	21ur-13973
Is affected by emr-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00171073	21ur-13095
No description available

WB:WBGene00171074	21ur-6121
No description available

WB:WBGene00171075	21ur-7567
No description available

WB:WBGene00171076	21ur-12755
No description available

WB:WBGene00171077	21ur-12492
No description available

WB:WBGene00171078	21ur-12514
No description available

WB:WBGene00171079	21ur-7453
No description available

WB:WBGene00171080	21ur-6190
No description available

WB:WBGene00171081	21ur-6563
No description available

WB:WBGene00171082	21ur-8986
No description available

WB:WBGene00171083	21ur-10922
No description available

WB:WBGene00171084	21ur-5772
No description available

WB:WBGene00171085	21ur-15440
No description available

WB:WBGene00171086	21ur-15170
No description available

WB:WBGene00171087	21ur-7340
No description available

WB:WBGene00171088	21ur-7482
No description available

WB:WBGene00171089	21ur-8045
No description available

WB:WBGene00171090	21ur-12316
No description available

WB:WBGene00171091	21ur-12331
No description available

WB:WBGene00171092	21ur-7601
No description available

WB:WBGene00171093	21ur-13078
No description available

WB:WBGene00171094	21ur-6502
No description available

WB:WBGene00171095	21ur-9453
No description available

WB:WBGene00171096	21ur-12516
No description available

WB:WBGene00171097	21ur-12910
No description available

WB:WBGene00171098	21ur-11606
No description available

WB:WBGene00171099	21ur-13303
No description available

WB:WBGene00171100	21ur-11083
No description available

WB:WBGene00171101	21ur-9648
No description available

WB:WBGene00171102	21ur-9377
No description available

WB:WBGene00171103	21ur-10294
No description available

WB:WBGene00171104	21ur-9382
No description available

WB:WBGene00171105	21ur-12051
No description available

WB:WBGene00171106	21ur-12712
No description available

WB:WBGene00171107	21ur-7563
No description available

WB:WBGene00171108	21ur-8315
No description available

WB:WBGene00171109	21ur-9198
Is affected by eat-2 based on microarray studies.

WB:WBGene00171110	21ur-6317
No description available

WB:WBGene00171111	21ur-10054
No description available

WB:WBGene00171112	21ur-9315
No description available

WB:WBGene00171113	21ur-10562
No description available

WB:WBGene00171114	21ur-15673
No description available

WB:WBGene00171115	21ur-8726
No description available

WB:WBGene00171116	21ur-7259
No description available

WB:WBGene00171117	21ur-11864
No description available

WB:WBGene00171118	21ur-8931
No description available

WB:WBGene00171119	21ur-7187
No description available

WB:WBGene00171120	21ur-6735
No description available

WB:WBGene00171121	21ur-9889
No description available

WB:WBGene00171122	21ur-10569
No description available

WB:WBGene00171123	21ur-7260
No description available

WB:WBGene00171124	21ur-12686
No description available

WB:WBGene00171125	21ur-8380
No description available

WB:WBGene00171126	21ur-8053
No description available

WB:WBGene00171127	21ur-12467
No description available

WB:WBGene00171128	21ur-7267
No description available

WB:WBGene00171129	21ur-5727
No description available

WB:WBGene00171130	21ur-12047
No description available

WB:WBGene00171131	21ur-14682
No description available

WB:WBGene00171132	21ur-11880
No description available

WB:WBGene00171133	21ur-6870
No description available

WB:WBGene00171134	21ur-8542
No description available

WB:WBGene00171135	21ur-9493
No description available

WB:WBGene00171136	21ur-12687
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171137	21ur-13184
No description available

WB:WBGene00171138	21ur-13041
No description available

WB:WBGene00171139	21ur-14172
No description available

WB:WBGene00171140	21ur-11271
No description available

WB:WBGene00171141	21ur-11845
No description available

WB:WBGene00171142	21ur-12245
No description available

WB:WBGene00171143	21ur-10107
No description available

WB:WBGene00171144	21ur-14380
No description available

WB:WBGene00171145	21ur-11133
No description available

WB:WBGene00171146	21ur-8360
No description available

WB:WBGene00171147	21ur-9970
No description available

WB:WBGene00171148	21ur-7399
No description available

WB:WBGene00171149	21ur-13552
No description available

WB:WBGene00171150	21ur-15357
No description available

WB:WBGene00171151	21ur-10749
No description available

WB:WBGene00171152	21ur-11745
No description available

WB:WBGene00171153	21ur-7852
No description available

WB:WBGene00171154	21ur-9263
No description available

WB:WBGene00171155	21ur-6923
No description available

WB:WBGene00171156	21ur-12422
No description available

WB:WBGene00171157	21ur-15071
No description available

WB:WBGene00171158	21ur-14794
No description available

WB:WBGene00171159	21ur-13999
No description available

WB:WBGene00171160	21ur-8689
No description available

WB:WBGene00171161	21ur-7798
No description available

WB:WBGene00171162	21ur-14987
No description available

WB:WBGene00171163	21ur-14791
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171164	21ur-11245
No description available

WB:WBGene00171165	21ur-14469
No description available

WB:WBGene00171166	21ur-8612
No description available

WB:WBGene00171167	21ur-8308
No description available

WB:WBGene00171168	21ur-13526
No description available

WB:WBGene00171169	21ur-9870
No description available

WB:WBGene00171170	21ur-15331
No description available

WB:WBGene00171171	21ur-8242
No description available

WB:WBGene00171172	21ur-7093
No description available

WB:WBGene00171173	21ur-7939
No description available

WB:WBGene00171174	21ur-11007
No description available

WB:WBGene00171175	21ur-15152
No description available

WB:WBGene00171176	21ur-8204
No description available

WB:WBGene00171177	21ur-13616
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171178	21ur-5641
No description available

WB:WBGene00171179	21ur-13931
No description available

WB:WBGene00171180	21ur-8971
No description available

WB:WBGene00171181	21ur-12813
No description available

WB:WBGene00171182	21ur-11832
No description available

WB:WBGene00171183	21ur-14752
Is affected by daf-2 based on microarray studies.

WB:WBGene00171184	21ur-9005
No description available

WB:WBGene00171185	21ur-11548
No description available

WB:WBGene00171186	21ur-7758
No description available

WB:WBGene00171187	21ur-6582
No description available

WB:WBGene00171188	21ur-10891
No description available

WB:WBGene00171189	21ur-12660
No description available

WB:WBGene00171190	21ur-6723
No description available

WB:WBGene00171191	21ur-9841
No description available

WB:WBGene00171192	21ur-7296
No description available

WB:WBGene00171193	21ur-9938
No description available

WB:WBGene00171194	21ur-13559
No description available

WB:WBGene00171195	21ur-6179
No description available

WB:WBGene00171196	21ur-11389
No description available

WB:WBGene00171197	21ur-8992
No description available

WB:WBGene00171198	21ur-15348
No description available

WB:WBGene00171199	21ur-12919
No description available

WB:WBGene00171200	21ur-7140
No description available

WB:WBGene00171201	21ur-14267
No description available

WB:WBGene00171202	21ur-7806
No description available

WB:WBGene00171203	21ur-10688
No description available

WB:WBGene00171204	21ur-8903
No description available

WB:WBGene00171205	21ur-9051
No description available

WB:WBGene00171206	21ur-12552
No description available

WB:WBGene00171207	21ur-6088
No description available

WB:WBGene00171208	21ur-13135
No description available

WB:WBGene00171209	21ur-14061
No description available

WB:WBGene00171210	21ur-11643
Is affected by several genes including lem-2; emr-1; and Y37A1B.5 based on RNA-seq studies.

WB:WBGene00171211	21ur-14191
No description available

WB:WBGene00171212	21ur-11740
No description available

WB:WBGene00171213	21ur-14984
No description available

WB:WBGene00171214	21ur-11027
No description available

WB:WBGene00171215	21ur-15165
No description available

WB:WBGene00171216	21ur-14038
No description available

WB:WBGene00171217	21ur-10889
No description available

WB:WBGene00171218	21ur-11574
No description available

WB:WBGene00171219	21ur-11992
No description available

WB:WBGene00171220	21ur-5476
No description available

WB:WBGene00171221	21ur-8114
No description available

WB:WBGene00171222	21ur-14810
No description available

WB:WBGene00171223	21ur-13789
No description available

WB:WBGene00171224	21ur-7155
No description available

WB:WBGene00171225	21ur-8150
No description available

WB:WBGene00171226	21ur-11804
No description available

WB:WBGene00171227	21ur-14050
No description available

WB:WBGene00171228	21ur-14001
No description available

WB:WBGene00171229	21ur-15682
No description available

WB:WBGene00171230	21ur-7511
No description available

WB:WBGene00171231	21ur-10495
No description available

WB:WBGene00171232	21ur-13959
No description available

WB:WBGene00171233	21ur-7775
No description available

WB:WBGene00171234	21ur-13848
No description available

WB:WBGene00171235	21ur-6536
No description available

WB:WBGene00171236	21ur-8133
No description available

WB:WBGene00171237	21ur-8399
No description available

WB:WBGene00171238	21ur-6068
No description available

WB:WBGene00171239	21ur-10032
No description available

WB:WBGene00171240	21ur-10257
No description available

WB:WBGene00171241	21ur-6809
No description available

WB:WBGene00171242	21ur-5578
No description available

WB:WBGene00171243	21ur-8913
No description available

WB:WBGene00171244	21ur-14644
No description available

WB:WBGene00171245	21ur-5907
No description available

WB:WBGene00171246	21ur-11111
No description available

WB:WBGene00171247	21ur-11609
Is affected by eat-2 based on microarray studies.

WB:WBGene00171248	21ur-12865
No description available

WB:WBGene00171249	21ur-6000
No description available

WB:WBGene00171250	21ur-7693
No description available

WB:WBGene00171251	21ur-12549
No description available

WB:WBGene00171252	21ur-8090
No description available

WB:WBGene00171253	21ur-8771
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies.

WB:WBGene00171254	21ur-11460
No description available

WB:WBGene00171255	21ur-6778
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171256	21ur-10335
No description available

WB:WBGene00171257	21ur-13825
No description available

WB:WBGene00171258	21ur-7059
No description available

WB:WBGene00171259	21ur-12809
No description available

WB:WBGene00171260	21ur-11337
No description available

WB:WBGene00171261	21ur-6282
No description available

WB:WBGene00171262	21ur-11719
No description available

WB:WBGene00171263	21ur-11579
No description available

WB:WBGene00171264	21ur-8765
No description available

WB:WBGene00171265	21ur-10517
No description available

WB:WBGene00171266	21ur-8330
No description available

WB:WBGene00171267	21ur-6689
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171268	21ur-12569
No description available

WB:WBGene00171269	21ur-6684
No description available

WB:WBGene00171270	21ur-12275
No description available

WB:WBGene00171271	21ur-11570
No description available

WB:WBGene00171272	21ur-14904
No description available

WB:WBGene00171273	21ur-8344
No description available

WB:WBGene00171274	21ur-5530
No description available

WB:WBGene00171275	21ur-9791
No description available

WB:WBGene00171276	21ur-11129
No description available

WB:WBGene00171277	21ur-9544
No description available

WB:WBGene00171278	21ur-8238
No description available

WB:WBGene00171279	21ur-10692
No description available

WB:WBGene00171280	21ur-14822
No description available

WB:WBGene00171281	21ur-5794
No description available

WB:WBGene00171282	21ur-15368
No description available

WB:WBGene00171283	21ur-15224
Is affected by daf-2 based on microarray studies.

WB:WBGene00171284	21ur-13883
No description available

WB:WBGene00171285	21ur-13154
No description available

WB:WBGene00171286	21ur-15082
No description available

WB:WBGene00171287	21ur-12170
No description available

WB:WBGene00171288	21ur-8724
No description available

WB:WBGene00171289	21ur-15218
No description available

WB:WBGene00171290	21ur-7796
No description available

WB:WBGene00171291	21ur-15538
No description available

WB:WBGene00171292	21ur-7594
No description available

WB:WBGene00171293	21ur-6658
No description available

WB:WBGene00171294	21ur-11495
No description available

WB:WBGene00171295	21ur-12212
No description available

WB:WBGene00171296	21ur-10923
No description available

WB:WBGene00171297	21ur-14829
No description available

WB:WBGene00171298	21ur-15172
No description available

WB:WBGene00171299	21ur-14855
No description available

WB:WBGene00171300	21ur-15124
No description available

WB:WBGene00171301	21ur-11382
No description available

WB:WBGene00171302	21ur-11794
No description available

WB:WBGene00171303	21ur-11709
No description available

WB:WBGene00171304	21ur-6668
No description available

WB:WBGene00171305	21ur-14076
No description available

WB:WBGene00171306	21ur-6180
No description available

WB:WBGene00171307	21ur-6025
No description available

WB:WBGene00171308	21ur-5937
No description available

WB:WBGene00171309	21ur-6380
No description available

WB:WBGene00171310	21ur-6656
No description available

WB:WBGene00171311	21ur-11261
No description available

WB:WBGene00171312	21ur-6142
No description available

WB:WBGene00171313	21ur-7870
No description available

WB:WBGene00171314	21ur-6518
No description available

WB:WBGene00171315	21ur-14586
No description available

WB:WBGene00171316	21ur-10916
No description available

WB:WBGene00171317	21ur-10654
No description available

WB:WBGene00171318	21ur-15211
No description available

WB:WBGene00171319	21ur-8680
No description available

WB:WBGene00171320	21ur-11889
No description available

WB:WBGene00171321	21ur-6885
No description available

WB:WBGene00171322	21ur-15515
No description available

WB:WBGene00171323	21ur-8868
Is affected by daf-2 based on microarray studies.

WB:WBGene00171324	21ur-14873
No description available

WB:WBGene00171325	21ur-14664
No description available

WB:WBGene00171326	21ur-11449
No description available

WB:WBGene00171327	21ur-14198
No description available

WB:WBGene00171328	21ur-10124
No description available

WB:WBGene00171329	21ur-10189
No description available

WB:WBGene00171330	21ur-6112
No description available

WB:WBGene00171331	21ur-13586
No description available

WB:WBGene00171332	21ur-6731
No description available

WB:WBGene00171333	21ur-5508
No description available

WB:WBGene00171334	21ur-10172
No description available

WB:WBGene00171335	21ur-14694
No description available

WB:WBGene00171336	21ur-9710
No description available

WB:WBGene00171337	21ur-13685
No description available

WB:WBGene00171338	21ur-11458
No description available

WB:WBGene00171339	21ur-9106
No description available

WB:WBGene00171340	21ur-11120
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171341	21ur-15119
No description available

WB:WBGene00171342	21ur-6909
No description available

WB:WBGene00171343	21ur-13031
No description available

WB:WBGene00171344	21ur-11094
No description available

WB:WBGene00171345	21ur-11371
No description available

WB:WBGene00171346	21ur-15531
No description available

WB:WBGene00171347	21ur-12215
No description available

WB:WBGene00171348	21ur-13662
No description available

WB:WBGene00171349	21ur-9621
No description available

WB:WBGene00171350	21ur-7718
No description available

WB:WBGene00171351	21ur-12703
No description available

WB:WBGene00171352	21ur-15406
No description available

WB:WBGene00171353	21ur-6160
No description available

WB:WBGene00171354	21ur-5992
No description available

WB:WBGene00171355	21ur-10471
Is affected by eat-2 based on microarray studies.

WB:WBGene00171356	21ur-13145
No description available

WB:WBGene00171357	21ur-13938
No description available

WB:WBGene00171358	21ur-8011
No description available

WB:WBGene00171359	21ur-8363
No description available

WB:WBGene00171360	21ur-15644
No description available

WB:WBGene00171361	21ur-11286
No description available

WB:WBGene00171362	21ur-14679
No description available

WB:WBGene00171363	21ur-6646
No description available

WB:WBGene00171364	21ur-6358
No description available

WB:WBGene00171365	21ur-5547
No description available

WB:WBGene00171366	21ur-8872
No description available

WB:WBGene00171367	21ur-8642
No description available

WB:WBGene00171368	21ur-11015
No description available

WB:WBGene00171369	21ur-11475
No description available

WB:WBGene00171370	21ur-9184
No description available

WB:WBGene00171371	21ur-14567
No description available

WB:WBGene00171372	21ur-12963
No description available

WB:WBGene00171373	21ur-8790
No description available

WB:WBGene00171374	21ur-12547
No description available

WB:WBGene00171375	21ur-13897
No description available

WB:WBGene00171376	21ur-8824
No description available

WB:WBGene00171377	21ur-8947
No description available

WB:WBGene00171378	21ur-10097
No description available

WB:WBGene00171379	21ur-15445
No description available

WB:WBGene00171380	21ur-10248
No description available

WB:WBGene00171381	21ur-12641
No description available

WB:WBGene00171382	21ur-14319
No description available

WB:WBGene00171383	21ur-15186
No description available

WB:WBGene00171384	21ur-10378
No description available

WB:WBGene00171385	21ur-9131
No description available

WB:WBGene00171386	21ur-15344
No description available

WB:WBGene00171387	21ur-5739
No description available

WB:WBGene00171388	21ur-13476
No description available

WB:WBGene00171389	21ur-7039
No description available

WB:WBGene00171390	21ur-13966
No description available

WB:WBGene00171391	21ur-14820
No description available

WB:WBGene00171392	21ur-10321
No description available

WB:WBGene00171393	21ur-11668
No description available

WB:WBGene00171394	21ur-9292
No description available

WB:WBGene00171395	21ur-9916
No description available

WB:WBGene00171396	21ur-14320
No description available

WB:WBGene00171397	21ur-14815
No description available

WB:WBGene00171398	21ur-10900
No description available

WB:WBGene00171399	21ur-7371
No description available

WB:WBGene00171400	21ur-7932
No description available

WB:WBGene00171401	21ur-9030
No description available

WB:WBGene00171402	21ur-12362
Is affected by eat-2 based on microarray studies.

WB:WBGene00171403	21ur-10906
No description available

WB:WBGene00171404	21ur-15695
No description available

WB:WBGene00171405	21ur-13368
No description available

WB:WBGene00171406	21ur-13475
No description available

WB:WBGene00171407	21ur-15546
No description available

WB:WBGene00171408	21ur-15383
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171409	21ur-10179
No description available

WB:WBGene00171410	21ur-7819
No description available

WB:WBGene00171411	21ur-6393
No description available

WB:WBGene00171412	21ur-8397
No description available

WB:WBGene00171413	21ur-6630
No description available

WB:WBGene00171414	21ur-8898
No description available

WB:WBGene00171415	21ur-9876
No description available

WB:WBGene00171416	21ur-9410
No description available

WB:WBGene00171417	21ur-13581
No description available

WB:WBGene00171418	21ur-5551
No description available

WB:WBGene00171419	21ur-10699
No description available

WB:WBGene00171420	21ur-10953
No description available

WB:WBGene00171421	21ur-15640
No description available

WB:WBGene00171422	21ur-5842
No description available

WB:WBGene00171423	21ur-6509
No description available

WB:WBGene00171424	21ur-8940
No description available

WB:WBGene00171425	21ur-14503
No description available

WB:WBGene00171426	21ur-14483
No description available

WB:WBGene00171427	21ur-11254
No description available

WB:WBGene00171428	21ur-7709
No description available

WB:WBGene00171429	21ur-11758
No description available

WB:WBGene00171430	21ur-13120
No description available

WB:WBGene00171431	21ur-9692
No description available

WB:WBGene00171432	21ur-11442
No description available

WB:WBGene00171433	21ur-7097
No description available

WB:WBGene00171434	21ur-7062
No description available

WB:WBGene00171435	21ur-7958
No description available

WB:WBGene00171436	21ur-5514
No description available

WB:WBGene00171437	21ur-8063
No description available

WB:WBGene00171438	21ur-7393
No description available

WB:WBGene00171439	21ur-5916
No description available

WB:WBGene00171440	21ur-8786
No description available

WB:WBGene00171441	21ur-12029
No description available

WB:WBGene00171442	21ur-12786
No description available

WB:WBGene00171443	21ur-5886
No description available

WB:WBGene00171444	21ur-8911
No description available

WB:WBGene00171445	21ur-9897
No description available

WB:WBGene00171446	21ur-13160
No description available

WB:WBGene00171447	21ur-5671
No description available

WB:WBGene00171448	21ur-9042
No description available

WB:WBGene00171449	21ur-10648
No description available

WB:WBGene00171450	21ur-14512
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00171451	21ur-13778
No description available

WB:WBGene00171452	21ur-13265
No description available

WB:WBGene00171453	21ur-7194
No description available

WB:WBGene00171454	21ur-6623
No description available

WB:WBGene00171455	21ur-14091
No description available

WB:WBGene00171456	21ur-7655
No description available

WB:WBGene00171457	21ur-9638
No description available

WB:WBGene00171458	21ur-13708
No description available

WB:WBGene00171459	21ur-15044
No description available

WB:WBGene00171460	21ur-5568
No description available

WB:WBGene00171461	21ur-12815
No description available

WB:WBGene00171462	21ur-14497
No description available

WB:WBGene00171463	21ur-5501
No description available

WB:WBGene00171464	21ur-6353
No description available

WB:WBGene00171465	21ur-7427
No description available

WB:WBGene00171466	21ur-11663
No description available

WB:WBGene00171467	21ur-12227
No description available

WB:WBGene00171468	21ur-13280
No description available

WB:WBGene00171469	21ur-14282
No description available

WB:WBGene00171470	21ur-10255
No description available

WB:WBGene00171471	21ur-13138
No description available

WB:WBGene00171472	21ur-9486
No description available

WB:WBGene00171473	21ur-11034
No description available

WB:WBGene00171474	21ur-7070
Is affected by eat-2 based on microarray studies.

WB:WBGene00171475	21ur-13494
Is affected by eat-2 based on microarray studies.

WB:WBGene00171476	21ur-15463
No description available

WB:WBGene00171477	21ur-11268
No description available

WB:WBGene00171478	21ur-7969
No description available

WB:WBGene00171479	21ur-9213
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00171480	21ur-15019
No description available

WB:WBGene00171481	21ur-14329
No description available

WB:WBGene00171482	21ur-6738
No description available

WB:WBGene00171483	21ur-5680
No description available

WB:WBGene00171484	21ur-7984
No description available

WB:WBGene00171485	21ur-15266
No description available

WB:WBGene00171486	21ur-14490
No description available

WB:WBGene00171487	21ur-9624
No description available

WB:WBGene00171488	21ur-8866
No description available

WB:WBGene00171489	21ur-11205
No description available

WB:WBGene00171490	21ur-9357
No description available

WB:WBGene00171491	21ur-15334
No description available

WB:WBGene00171492	21ur-8322
No description available

WB:WBGene00171493	21ur-9032
No description available

WB:WBGene00171494	21ur-6155
No description available

WB:WBGene00171495	21ur-8950
No description available

WB:WBGene00171496	21ur-10893
No description available

WB:WBGene00171497	21ur-14713
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00171498	21ur-6881
No description available

WB:WBGene00171499	21ur-10605
No description available

WB:WBGene00171500	21ur-13297
No description available

WB:WBGene00171501	21ur-7433
No description available

WB:WBGene00171502	21ur-7802
No description available

WB:WBGene00171503	21ur-11046
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00171504	21ur-13780
No description available

WB:WBGene00171505	21ur-11653
No description available

WB:WBGene00171506	21ur-10806
No description available

WB:WBGene00171507	21ur-15304
No description available

WB:WBGene00171508	21ur-10566
No description available

WB:WBGene00171509	21ur-13000
No description available

WB:WBGene00171510	21ur-8213
No description available

WB:WBGene00171511	21ur-13575
No description available

WB:WBGene00171512	21ur-15567
No description available

WB:WBGene00171513	21ur-9393
No description available

WB:WBGene00171514	21ur-11353
No description available

WB:WBGene00171515	21ur-12974
No description available

WB:WBGene00171516	21ur-11348
No description available

WB:WBGene00171517	21ur-6718
No description available

WB:WBGene00171518	21ur-8244
No description available

WB:WBGene00171519	21ur-12590
No description available

WB:WBGene00171520	21ur-5734
No description available

WB:WBGene00171521	21ur-15281
No description available

WB:WBGene00171522	21ur-13718
No description available

WB:WBGene00171523	21ur-7299
No description available

WB:WBGene00171524	21ur-14756
No description available

WB:WBGene00171525	21ur-11893
No description available

WB:WBGene00171526	21ur-7583
No description available

WB:WBGene00171527	21ur-9687
No description available

WB:WBGene00171528	21ur-7414
No description available

WB:WBGene00171529	21ur-13692
No description available

WB:WBGene00171530	21ur-9282
No description available

WB:WBGene00171531	21ur-8891
No description available

WB:WBGene00171532	21ur-9893
No description available

WB:WBGene00171533	21ur-8038
No description available

WB:WBGene00171534	21ur-11004
No description available

WB:WBGene00171535	21ur-6189
No description available

WB:WBGene00171536	21ur-6408
No description available

WB:WBGene00171537	21ur-8178
No description available

WB:WBGene00171538	21ur-14866
No description available

WB:WBGene00171539	21ur-14100
No description available

WB:WBGene00171540	21ur-13097
No description available

WB:WBGene00171541	21ur-5655
Is affected by Y37A1B.5 based on RNA-seq studies.

WB:WBGene00171542	21ur-11065
No description available

WB:WBGene00171543	21ur-14225
No description available

WB:WBGene00171544	21ur-12424
No description available

WB:WBGene00171545	21ur-6867
No description available

WB:WBGene00171546	21ur-8761
No description available

WB:WBGene00171547	21ur-13272
No description available

WB:WBGene00171548	21ur-12281
No description available

WB:WBGene00171549	21ur-10611
No description available

WB:WBGene00171550	21ur-7827
No description available

WB:WBGene00171551	21ur-7997
No description available

WB:WBGene00171552	21ur-9060
No description available

WB:WBGene00171553	21ur-8041
No description available

WB:WBGene00171554	21ur-13857
No description available

WB:WBGene00171555	21ur-7123
No description available

WB:WBGene00171556	21ur-10946
No description available

WB:WBGene00171557	21ur-12849
No description available

WB:WBGene00171558	21ur-6524
No description available

WB:WBGene00171559	21ur-6898
No description available

WB:WBGene00171560	21ur-12036
No description available

WB:WBGene00171561	21ur-8593
No description available

WB:WBGene00171562	21ur-11897
Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00171563	21ur-6286
No description available

WB:WBGene00171564	21ur-6711
No description available

WB:WBGene00171565	21ur-14043
No description available

WB:WBGene00171566	21ur-12452
No description available

WB:WBGene00171567	21ur-8396
No description available

WB:WBGene00171568	21ur-9650
No description available

WB:WBGene00171569	21ur-10988
No description available

WB:WBGene00171570	21ur-5741
No description available

WB:WBGene00171571	21ur-9762
No description available

WB:WBGene00171572	21ur-8183
No description available

WB:WBGene00171573	21ur-14623
No description available

WB:WBGene00171574	21ur-8354
No description available

WB:WBGene00171575	21ur-10136
No description available

WB:WBGene00171576	21ur-10392
Is affected by rrf-3 based on RNA-seq studies.

WB:WBGene00171577	21ur-15370
No description available

WB:WBGene00171578	21ur-14761
No description available

WB:WBGene00171579	21ur-15431
No description available

WB:WBGene00171580	21ur-7292
No description available

WB:WBGene00171581	21ur-14945
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00171582	21ur-13240
No description available

WB:WBGene00171583	21ur-14598
No description available

WB:WBGene00171584	21ur-9495
No description available

WB:WBGene00171585	21ur-15002
No description available

WB:WBGene00171586	21ur-13245
No description available

WB:WBGene00171587	21ur-7615
No description available

WB:WBGene00171588	21ur-7696
No description available

WB:WBGene00171589	21ur-13996
No description available

WB:WBGene00171590	21ur-9326
No description available

WB:WBGene00171591	21ur-10544
No description available

WB:WBGene00171592	21ur-6250
No description available

WB:WBGene00171593	21ur-12206
No description available

WB:WBGene00171594	21ur-13533
No description available

WB:WBGene00171595	21ur-12760
No description available

WB:WBGene00171596	21ur-15518
No description available

WB:WBGene00171597	21ur-8268
No description available

WB:WBGene00171598	21ur-8018
No description available

WB:WBGene00171599	21ur-6745
No description available

WB:WBGene00171600	21ur-7449
No description available

WB:WBGene00171601	21ur-7785
No description available

WB:WBGene00171602	21ur-7841
No description available

WB:WBGene00171603	21ur-10386
No description available

WB:WBGene00171604	21ur-14273
No description available

WB:WBGene00171605	21ur-6594
No description available

WB:WBGene00171606	21ur-12784
No description available

WB:WBGene00171607	21ur-12432
No description available

WB:WBGene00171608	21ur-15558
No description available

WB:WBGene00171609	21ur-14697
No description available

WB:WBGene00171610	21ur-15551
No description available

WB:WBGene00171611	21ur-12796
No description available

WB:WBGene00171612	21ur-14545
No description available

WB:WBGene00171613	21ur-5697
No description available

WB:WBGene00171614	21ur-6963
No description available

WB:WBGene00171615	21ur-9969
No description available

WB:WBGene00171616	21ur-8603
No description available

WB:WBGene00171617	21ur-13850
No description available

WB:WBGene00171618	21ur-11770
No description available

WB:WBGene00171619	21ur-11297
No description available

WB:WBGene00171620	21ur-13511
No description available

WB:WBGene00171621	21ur-15078
No description available

WB:WBGene00171622	21ur-12252
No description available

WB:WBGene00171623	21ur-6519
No description available

WB:WBGene00171624	21ur-6803
No description available

WB:WBGene00171625	21ur-13207
No description available

WB:WBGene00171626	21ur-15379
No description available

WB:WBGene00171627	21ur-13334
No description available

WB:WBGene00171628	21ur-9666
No description available

WB:WBGene00171629	21ur-14163
No description available

WB:WBGene00171630	21ur-7420
No description available

WB:WBGene00171631	21ur-14131
No description available

WB:WBGene00171632	21ur-6938
No description available

WB:WBGene00171633	21ur-12557
No description available

WB:WBGene00171634	21ur-7388
No description available

WB:WBGene00171635	21ur-6330
No description available

WB:WBGene00171636	21ur-8453
No description available

WB:WBGene00171637	21ur-11318
No description available

WB:WBGene00171638	21ur-15097
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00171639	21ur-7921
No description available

WB:WBGene00171640	21ur-5837
No description available

WB:WBGene00171641	21ur-10012
No description available

WB:WBGene00171642	21ur-13463
No description available

WB:WBGene00171643	21ur-5755
No description available

WB:WBGene00171644	21ur-8469
No description available

WB:WBGene00171645	21ur-5626
No description available

WB:WBGene00171646	21ur-7305
No description available

WB:WBGene00171647	21ur-5482
No description available

WB:WBGene00171648	21ur-15485
No description available

WB:WBGene00171649	21ur-5636
No description available

WB:WBGene00171650	21ur-5786
No description available

WB:WBGene00171651	21ur-9513
No description available

WB:WBGene00171652	21ur-10693
No description available

WB:WBGene00171653	21ur-7762
No description available

WB:WBGene00171654	21ur-7642
No description available

WB:WBGene00171655	21ur-6894
No description available

WB:WBGene00171656	21ur-11939
No description available

WB:WBGene00171657	21ur-14537
No description available

WB:WBGene00171658	21ur-6307
No description available

WB:WBGene00171659	21ur-7143
No description available

WB:WBGene00171660	21ur-6406
No description available

WB:WBGene00171661	21ur-8159
No description available

WB:WBGene00171662	21ur-11595
No description available

WB:WBGene00171663	21ur-15317
No description available

WB:WBGene00171664	21ur-13347
No description available

WB:WBGene00171665	21ur-7711
No description available

WB:WBGene00171666	21ur-10590
No description available

WB:WBGene00171667	21ur-15675
No description available

WB:WBGene00171668	21ur-14337
No description available

WB:WBGene00171669	21ur-15105
No description available

WB:WBGene00171670	21ur-9387
No description available

WB:WBGene00171671	21ur-12655
No description available

WB:WBGene00171672	21ur-7277
No description available

WB:WBGene00171673	21ur-6376
No description available

WB:WBGene00171674	21ur-15475
No description available

WB:WBGene00171675	21ur-13336
No description available

WB:WBGene00171676	21ur-12056
No description available

WB:WBGene00171677	21ur-9343
No description available

WB:WBGene00171678	21ur-11100
No description available

WB:WBGene00171679	21ur-13548
No description available

WB:WBGene00171680	21ur-6916
No description available

WB:WBGene00171681	21ur-6424
No description available

WB:WBGene00171682	21ur-5465
No description available

WB:WBGene00171683	21ur-10241
No description available

WB:WBGene00171684	21ur-13766
No description available

WB:WBGene00171685	21ur-7444
No description available

WB:WBGene00171686	21ur-7285
No description available

WB:WBGene00171687	21ur-13811
No description available

WB:WBGene00171688	21ur-14835
No description available

WB:WBGene00171689	21ur-9920
No description available

WB:WBGene00171690	21ur-5924
No description available

WB:WBGene00171691	21ur-8075
No description available

WB:WBGene00171692	21ur-14906
No description available

WB:WBGene00171693	21ur-10555
No description available

WB:WBGene00171694	21ur-6875
No description available

WB:WBGene00171695	21ur-11720
No description available

WB:WBGene00171696	21ur-12175
No description available

WB:WBGene00171697	21ur-13254
No description available

WB:WBGene00171698	21ur-13418
No description available

WB:WBGene00171699	21ur-7962
No description available

WB:WBGene00171700	21ur-10199
No description available

WB:WBGene00171701	21ur-14658
No description available

WB:WBGene00171702	21ur-14128
No description available

WB:WBGene00171703	21ur-14719
No description available

WB:WBGene00171704	21ur-13087
No description available

WB:WBGene00171705	21ur-8700
No description available

WB:WBGene00171706	21ur-9220
No description available

WB:WBGene00171707	21ur-8991
No description available

WB:WBGene00171708	21ur-14121
No description available

WB:WBGene00171709	21ur-6854
No description available

WB:WBGene00171710	21ur-11672
No description available

WB:WBGene00171712	21ur-13554
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171713	21ur-7631
Is affected by eat-2 based on microarray studies.

WB:WBGene00171714	21ur-10157
No description available

WB:WBGene00171715	21ur-5693
No description available

WB:WBGene00171716	21ur-10205
No description available

WB:WBGene00171717	21ur-7272
No description available

WB:WBGene00171718	21ur-11165
No description available

WB:WBGene00171719	21ur-11658
No description available

WB:WBGene00171720	21ur-11915
No description available

WB:WBGene00171721	21ur-15320
No description available

WB:WBGene00171722	21ur-10681
No description available

WB:WBGene00171723	21ur-7828
No description available

WB:WBGene00171724	21ur-14073
No description available

WB:WBGene00171725	21ur-7491
No description available

WB:WBGene00171726	21ur-7529
No description available

WB:WBGene00171727	21ur-14305
No description available

WB:WBGene00171728	21ur-5553
No description available

WB:WBGene00171729	21ur-6213
No description available

WB:WBGene00171730	21ur-8553
No description available

WB:WBGene00171731	21ur-9818
No description available

WB:WBGene00171732	21ur-8379
No description available

WB:WBGene00171733	21ur-15457
No description available

WB:WBGene00171734	21ur-7620
No description available

WB:WBGene00171735	21ur-9694
No description available

WB:WBGene00171736	21ur-7350
No description available

WB:WBGene00171737	21ur-12391
No description available

WB:WBGene00171738	21ur-12820
No description available

WB:WBGene00171739	21ur-11885
No description available

WB:WBGene00171740	21ur-6458
No description available

WB:WBGene00171741	21ur-10408
No description available

WB:WBGene00171742	21ur-13989
No description available

WB:WBGene00171743	21ur-9464
No description available

WB:WBGene00171744	21ur-10452
No description available

WB:WBGene00171745	21ur-11637
No description available

WB:WBGene00171746	21ur-12693
No description available

WB:WBGene00171747	21ur-6828
No description available

WB:WBGene00171748	21ur-11519
No description available

WB:WBGene00171749	21ur-11424
No description available

WB:WBGene00171750	21ur-13656
No description available

WB:WBGene00171751	21ur-7105
No description available

WB:WBGene00171752	21ur-15329
No description available

WB:WBGene00171753	21ur-15272
No description available

WB:WBGene00171754	21ur-7848
No description available

WB:WBGene00171755	21ur-8735
No description available

WB:WBGene00171756	21ur-7021
No description available

WB:WBGene00171757	21ur-9146
No description available

WB:WBGene00171758	21ur-10779
No description available

WB:WBGene00171759	21ur-12828
No description available

WB:WBGene00171760	21ur-7471
No description available

WB:WBGene00171761	21ur-11303
No description available

WB:WBGene00171762	21ur-14417
No description available

WB:WBGene00171763	21ur-5978
No description available

WB:WBGene00171764	21ur-8998
No description available

WB:WBGene00171765	21ur-10759
No description available

WB:WBGene00171766	21ur-10767
No description available

WB:WBGene00171767	21ur-14257
No description available

WB:WBGene00171768	21ur-5661
No description available

WB:WBGene00171769	21ur-11711
No description available

WB:WBGene00171770	21ur-9335
No description available

WB:WBGene00171771	21ur-6984
No description available

WB:WBGene00171772	21ur-6211
No description available

WB:WBGene00171773	21ur-6543
No description available

WB:WBGene00171774	21ur-13541
No description available

WB:WBGene00171775	21ur-13588
No description available

WB:WBGene00171776	21ur-9445
No description available

WB:WBGene00171777	21ur-5778
No description available

WB:WBGene00171778	21ur-11527
No description available

WB:WBGene00171779	21ur-8969
No description available

WB:WBGene00171780	21ur-9703
No description available

WB:WBGene00171781	21ur-12595
No description available

WB:WBGene00171782	21ur-7322
Is affected by daf-2 based on microarray studies.

WB:WBGene00171783	21ur-11212
No description available

WB:WBGene00171784	21ur-7081
No description available

WB:WBGene00171785	21ur-11109
No description available

WB:WBGene00171786	21ur-15243
No description available

WB:WBGene00171787	21ur-8876
No description available

WB:WBGene00171788	21ur-10284
No description available

WB:WBGene00171789	21ur-12066
No description available

WB:WBGene00171790	21ur-14647
No description available

WB:WBGene00171791	21ur-9362
No description available

WB:WBGene00171792	21ur-11961
No description available

WB:WBGene00171793	21ur-7531
No description available

WB:WBGene00171794	21ur-6099
No description available

WB:WBGene00171795	21ur-13904
No description available

WB:WBGene00171796	21ur-6259
No description available

WB:WBGene00171797	21ur-12751
No description available

WB:WBGene00171798	21ur-13604
No description available

WB:WBGene00171799	21ur-6616
No description available

WB:WBGene00171800	21ur-9048
No description available

WB:WBGene00171801	21ur-7752
No description available

WB:WBGene00171802	21ur-13112
No description available

WB:WBGene00171803	21ur-9633
No description available

WB:WBGene00171804	21ur-10047
No description available

WB:WBGene00171805	21ur-7928
Is affected by daf-2 based on microarray studies.

WB:WBGene00171806	21ur-9606
No description available

WB:WBGene00171807	21ur-6127
No description available

WB:WBGene00171809	21ur-12004
No description available

WB:WBGene00171810	21ur-6765
No description available

WB:WBGene00171811	21ur-7464
Is affected by chd-3 based on RNA-seq studies.

WB:WBGene00171812	21ur-5871
No description available

WB:WBGene00171813	21ur-10216
No description available

WB:WBGene00171814	21ur-15507
Is affected by eat-2 based on microarray studies.

WB:WBGene00171815	21ur-12261
No description available

WB:WBGene00171816	21ur-9572
No description available

WB:WBGene00171817	21ur-11812
No description available

WB:WBGene00171818	21ur-13877
No description available

WB:WBGene00171819	21ur-11221
No description available

WB:WBGene00171820	21ur-14879
Is affected by daf-2 based on microarray studies.

WB:WBGene00171821	21ur-12376
No description available

WB:WBGene00171822	21ur-13627
No description available

WB:WBGene00171823	21ur-9380
No description available

WB:WBGene00171824	21ur-9269
No description available

WB:WBGene00171825	21ur-11399
No description available

WB:WBGene00171826	21ur-10914
No description available

WB:WBGene00171827	21ur-13518
No description available

WB:WBGene00171828	21ur-7478
No description available

WB:WBGene00171829	21ur-9121
No description available

WB:WBGene00171830	21ur-12905
No description available

WB:WBGene00171831	21ur-8921
No description available

WB:WBGene00171832	21ur-8582
No description available

WB:WBGene00171833	21ur-10947
No description available

WB:WBGene00171834	21ur-11876
No description available

WB:WBGene00171835	21ur-7178
No description available

WB:WBGene00171836	21ur-14886
No description available

WB:WBGene00171837	21ur-10231
No description available

WB:WBGene00171838	21ur-12622
No description available

WB:WBGene00171839	21ur-6568
No description available

WB:WBGene00171840	21ur-6639
No description available

WB:WBGene00171841	21ur-5973
Is affected by daf-2 based on microarray studies.

WB:WBGene00171842	21ur-7573
No description available

WB:WBGene00171843	21ur-10401
No description available

WB:WBGene00171844	21ur-9092
No description available

WB:WBGene00171845	21ur-15191
No description available

WB:WBGene00171846	21ur-15637
No description available

WB:WBGene00171847	21ur-7121
No description available

WB:WBGene00171848	21ur-9756
No description available

WB:WBGene00171849	21ur-10645
No description available

WB:WBGene00171850	21ur-9084
No description available

WB:WBGene00171851	21ur-7235
No description available

WB:WBGene00171852	21ur-6289
No description available

WB:WBGene00171853	21ur-5986
No description available

WB:WBGene00171854	21ur-11433
No description available

WB:WBGene00171855	21ur-14017
No description available

WB:WBGene00171856	21ur-5713
No description available

WB:WBGene00171857	21ur-11392
No description available

WB:WBGene00171858	21ur-12158
No description available

WB:WBGene00171859	21ur-8836
No description available

WB:WBGene00171860	21ur-15163
No description available

WB:WBGene00171861	21ur-10150
No description available

WB:WBGene00171862	21ur-12678
No description available

WB:WBGene00171863	21ur-6860
No description available

WB:WBGene00171864	21ur-10674
No description available

WB:WBGene00171865	21ur-8152
No description available

WB:WBGene00171866	21ur-10907
No description available

WB:WBGene00171867	21ur-14786
No description available

WB:WBGene00171868	21ur-12187
No description available

WB:WBGene00171869	21ur-15257
No description available

WB:WBGene00171870	21ur-10363
No description available

WB:WBGene00171871	21ur-8959
No description available

WB:WBGene00171872	21ur-11085
No description available

WB:WBGene00171873	21ur-13106
No description available

WB:WBGene00171875	21ur-10112
No description available

WB:WBGene00171876	21ur-10483
No description available

WB:WBGene00171877	21ur-11530
No description available

WB:WBGene00171878	21ur-7160
No description available

WB:WBGene00171879	21ur-6033
No description available

WB:WBGene00171880	21ur-12010
No description available

WB:WBGene00171881	21ur-7599
No description available

WB:WBGene00171882	21ur-8481
No description available

WB:WBGene00171883	21ur-5768
No description available

WB:WBGene00171884	21ur-6235
No description available

WB:WBGene00171885	21ur-15455
No description available

WB:WBGene00171886	21ur-9296
No description available

WB:WBGene00171887	21ur-11401
No description available

WB:WBGene00171888	21ur-9813
No description available

WB:WBGene00171889	21ur-10920
No description available

WB:WBGene00171890	21ur-9852
No description available

WB:WBGene00171891	21ur-6108
No description available

WB:WBGene00171892	21ur-7716
No description available

WB:WBGene00171893	21ur-6921
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00171894	21ur-12967
No description available

WB:WBGene00171895	21ur-11311
No description available

WB:WBGene00171896	21ur-12302
No description available

WB:WBGene00171897	21ur-13030
No description available

WB:WBGene00171898	21ur-13212
No description available

WB:WBGene00171899	21ur-6907
No description available

WB:WBGene00171900	21ur-11364
No description available

WB:WBGene00171901	21ur-5740
No description available

WB:WBGene00171902	21ur-15521
No description available

WB:WBGene00171903	21ur-11102
No description available

WB:WBGene00171904	21ur-14393
No description available

WB:WBGene00171905	21ur-7339
No description available

WB:WBGene00171906	21ur-12442
No description available

WB:WBGene00171907	21ur-6037
No description available

WB:WBGene00171908	21ur-10089
No description available

WB:WBGene00171909	21ur-15405
No description available

WB:WBGene00171910	21ur-13089
No description available

WB:WBGene00171911	21ur-5890
No description available

WB:WBGene00171912	21ur-11856
No description available

WB:WBGene00171913	21ur-9539
No description available

WB:WBGene00171914	21ur-10228
No description available

WB:WBGene00171915	21ur-7071
No description available

WB:WBGene00171916	21ur-7217
Is affected by emr-1 and lem-2 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00171917	21ur-14115
No description available

WB:WBGene00171918	21ur-13922
Is affected by emr-1; lem-2; and spt-16 based on RNA-seq studies.

WB:WBGene00171919	21ur-8620
No description available

WB:WBGene00171920	21ur-6557
No description available

WB:WBGene00171921	21ur-12656
No description available

WB:WBGene00171922	21ur-11249
No description available

WB:WBGene00171923	21ur-8162
No description available

WB:WBGene00171924	21ur-14702
No description available

WB:WBGene00171925	21ur-13689
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00171926	21ur-12295
Is affected by eat-2 based on microarray studies.

WB:WBGene00171927	21ur-8130
No description available

WB:WBGene00171928	21ur-9952
No description available

WB:WBGene00171929	21ur-13321
No description available

WB:WBGene00171930	21ur-5497
No description available

WB:WBGene00171931	21ur-11230
No description available

WB:WBGene00171932	21ur-13670
No description available

WB:WBGene00171933	21ur-6591
No description available

WB:WBGene00171934	21ur-6427
Is affected by daf-2 based on microarray studies.

WB:WBGene00171935	21ur-14201
No description available

WB:WBGene00171936	21ur-5828
No description available

WB:WBGene00171937	21ur-8658
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00171938	21ur-11843
No description available

WB:WBGene00171939	21ur-7023
No description available

WB:WBGene00171940	21ur-11474
No description available

WB:WBGene00171941	21ur-8163
No description available

WB:WBGene00171942	21ur-10468
No description available

WB:WBGene00171943	21ur-12700
No description available

WB:WBGene00171944	21ur-5811
No description available

WB:WBGene00171945	21ur-8631
No description available

WB:WBGene00171946	21ur-7131
No description available

WB:WBGene00171947	21ur-12418
No description available

WB:WBGene00171948	21ur-6976
No description available

WB:WBGene00171949	21ur-12457
No description available

WB:WBGene00171950	21ur-8464
No description available

WB:WBGene00171951	21ur-10354
No description available

WB:WBGene00171952	21ur-14737
No description available

WB:WBGene00171953	21ur-7332
No description available

WB:WBGene00171954	21ur-7647
No description available

WB:WBGene00171955	21ur-8626
No description available

WB:WBGene00171956	21ur-13562
No description available

WB:WBGene00171957	21ur-7747
No description available

WB:WBGene00171958	21ur-9178
No description available

WB:WBGene00171959	21ur-11760
No description available

WB:WBGene00171960	21ur-15125
No description available

WB:WBGene00171961	21ur-8638
No description available

WB:WBGene00171962	21ur-10418
No description available

WB:WBGene00171963	21ur-9959
No description available

WB:WBGene00171964	21ur-10735
No description available

WB:WBGene00171965	21ur-7002
No description available

WB:WBGene00171966	21ur-10835
No description available

WB:WBGene00171967	21ur-8009
No description available

WB:WBGene00171968	21ur-7167
No description available

WB:WBGene00171969	21ur-10099
No description available

WB:WBGene00171970	21ur-5897
No description available

WB:WBGene00171971	21ur-10326
No description available

WB:WBGene00171972	21ur-13839
No description available

WB:WBGene00171973	21ur-10788
No description available

WB:WBGene00171974	21ur-14618
No description available

WB:WBGene00171975	21ur-12271
No description available

WB:WBGene00171976	21ur-8508
No description available

WB:WBGene00171977	21ur-13210
No description available

WB:WBGene00171978	21ur-13531
No description available

WB:WBGene00171979	21ur-14642
No description available

WB:WBGene00171980	21ur-6040
No description available

WB:WBGene00171981	21ur-9823
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00171982	21ur-11936
No description available

WB:WBGene00171983	21ur-9843
No description available

WB:WBGene00171984	21ur-15583
Is affected by emr-1; lem-2; and spt-16 based on RNA-seq studies.

WB:WBGene00171985	21ur-13313
No description available

WB:WBGene00171986	21ur-13325
No description available

WB:WBGene00171987	21ur-6846
No description available

WB:WBGene00171988	21ur-5667
No description available

WB:WBGene00171989	21ur-8687
No description available

WB:WBGene00171990	21ur-9943
No description available

WB:WBGene00171991	21ur-6580
No description available

WB:WBGene00171992	21ur-6206
No description available

WB:WBGene00171993	21ur-14727
No description available

WB:WBGene00171994	21ur-13381
No description available

WB:WBGene00171995	21ur-6521
No description available

WB:WBGene00171996	21ur-11195
No description available

WB:WBGene00171997	21ur-9820
No description available

WB:WBGene00171998	21ur-14213
No description available

WB:WBGene00171999	21ur-5643
No description available

WB:WBGene00172000	21ur-15235
No description available

WB:WBGene00172001	21ur-9596
No description available

WB:WBGene00172002	21ur-12722
No description available

WB:WBGene00172003	21ur-10847
No description available

WB:WBGene00172004	21ur-6865
No description available

WB:WBGene00172006	21ur-14427
No description available

WB:WBGene00172007	21ur-10500
No description available

WB:WBGene00172008	21ur-8733
No description available

WB:WBGene00172009	21ur-14460
No description available

WB:WBGene00172010	21ur-11520
No description available

WB:WBGene00172011	21ur-12732
No description available

WB:WBGene00172012	21ur-9360
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172013	21ur-11580
No description available

WB:WBGene00172014	21ur-14589
No description available

WB:WBGene00172015	21ur-11681
No description available

WB:WBGene00172016	21ur-14881
No description available

WB:WBGene00172017	21ur-14187
No description available

WB:WBGene00172018	21ur-10719
No description available

WB:WBGene00172019	21ur-11679
No description available

WB:WBGene00172020	21ur-14296
No description available

WB:WBGene00172021	21ur-13318
No description available

WB:WBGene00172022	21ur-14893
No description available

WB:WBGene00172023	21ur-8137
No description available

WB:WBGene00172024	21ur-11493
No description available

WB:WBGene00172025	21ur-8283
No description available

WB:WBGene00172026	21ur-13438
No description available

WB:WBGene00172027	21ur-12002
No description available

WB:WBGene00172028	21ur-11727
No description available

WB:WBGene00172029	21ur-15591
No description available

WB:WBGene00172030	21ur-12053
No description available

WB:WBGene00172031	21ur-12123
No description available

WB:WBGene00172032	21ur-9612
No description available

WB:WBGene00172033	21ur-15468
No description available

WB:WBGene00172034	21ur-9075
No description available

WB:WBGene00172035	21ur-7542
No description available

WB:WBGene00172036	21ur-6887
No description available

WB:WBGene00172037	21ur-12102
No description available

WB:WBGene00172038	21ur-10528
No description available

WB:WBGene00172039	21ur-13910
No description available

WB:WBGene00172040	21ur-6165
No description available

WB:WBGene00172041	21ur-9973
No description available

WB:WBGene00172042	21ur-7508
No description available

WB:WBGene00172043	21ur-8740
No description available

WB:WBGene00172044	21ur-12727
No description available

WB:WBGene00172045	21ur-6339
No description available

WB:WBGene00172046	21ur-13363
No description available

WB:WBGene00172047	21ur-13406
No description available

WB:WBGene00172048	21ur-14055
No description available

WB:WBGene00172049	21ur-12897
No description available

WB:WBGene00172050	21ur-13855
No description available

WB:WBGene00172051	21ur-9553
No description available

WB:WBGene00172052	21ur-12317
No description available

WB:WBGene00172053	21ur-11949
No description available

WB:WBGene00172054	21ur-13016
No description available

WB:WBGene00172055	21ur-5995
No description available

WB:WBGene00172056	21ur-11978
No description available

WB:WBGene00172057	21ur-7674
No description available

WB:WBGene00172058	21ur-13730
No description available

WB:WBGene00172059	21ur-9668
No description available

WB:WBGene00172060	21ur-10020
No description available

WB:WBGene00172061	21ur-6812
No description available

WB:WBGene00172062	21ur-13579
No description available

WB:WBGene00172063	21ur-6075
No description available

WB:WBGene00172064	21ur-6587
No description available

WB:WBGene00172065	21ur-10507
No description available

WB:WBGene00172066	21ur-12576
No description available

WB:WBGene00172067	21ur-12774
No description available

WB:WBGene00172068	21ur-15412
No description available

WB:WBGene00172069	21ur-7851
No description available

WB:WBGene00172070	21ur-8447
No description available

WB:WBGene00172071	21ur-9504
No description available

WB:WBGene00172072	21ur-13538
No description available

WB:WBGene00172073	21ur-6751
No description available

WB:WBGene00172074	21ur-8937
No description available

WB:WBGene00172075	21ur-11242
No description available

WB:WBGene00172076	21ur-12932
No description available

WB:WBGene00172077	21ur-13149
No description available

WB:WBGene00172078	21ur-12379
No description available

WB:WBGene00172079	21ur-12133
No description available

WB:WBGene00172080	21ur-14403
No description available

WB:WBGene00172081	21ur-7808
No description available

WB:WBGene00172082	21ur-12381
No description available

WB:WBGene00172083	21ur-9019
No description available

WB:WBGene00172084	21ur-11830
No description available

WB:WBGene00172085	21ur-8513
No description available

WB:WBGene00172086	21ur-12535
No description available

WB:WBGene00172087	21ur-5609
No description available

WB:WBGene00172088	21ur-14580
No description available

WB:WBGene00172089	21ur-5831
No description available

WB:WBGene00172090	21ur-10498
No description available

WB:WBGene00172091	21ur-13446
No description available

WB:WBGene00172092	21ur-12794
No description available

WB:WBGene00172093	21ur-15496
No description available

WB:WBGene00172094	21ur-15180
No description available

WB:WBGene00172095	21ur-5660
No description available

WB:WBGene00172096	21ur-14474
No description available

WB:WBGene00172097	21ur-9845
No description available

WB:WBGene00172098	21ur-14006
No description available

WB:WBGene00172099	21ur-8930
No description available

WB:WBGene00172100	21ur-6773
No description available

WB:WBGene00172101	21ur-6404
No description available

WB:WBGene00172102	21ur-11552
No description available

WB:WBGene00172103	21ur-7664
No description available

WB:WBGene00172104	21ur-11761
No description available

WB:WBGene00172105	21ur-11940
No description available

WB:WBGene00172106	21ur-6534
No description available

WB:WBGene00172107	21ur-6439
No description available

WB:WBGene00172108	21ur-8236
No description available

WB:WBGene00172109	21ur-8439
No description available

WB:WBGene00172110	21ur-14340
No description available

WB:WBGene00172111	21ur-9983
No description available

WB:WBGene00172112	21ur-7065
No description available

WB:WBGene00172113	21ur-13739
No description available

WB:WBGene00172114	21ur-7555
No description available

WB:WBGene00172115	21ur-9255
No description available

WB:WBGene00172116	21ur-14730
No description available

WB:WBGene00172117	21ur-8226
No description available

WB:WBGene00172118	21ur-14220
No description available

WB:WBGene00172119	21ur-12137
No description available

WB:WBGene00172120	21ur-13289
No description available

WB:WBGene00172121	21ur-11810
No description available

WB:WBGene00172122	21ur-12715
No description available

WB:WBGene00172123	21ur-8081
No description available

WB:WBGene00172124	21ur-8718
No description available

WB:WBGene00172125	21ur-9179
No description available

WB:WBGene00172126	21ur-11906
No description available

WB:WBGene00172127	21ur-6257
No description available

WB:WBGene00172128	21ur-13863
No description available

WB:WBGene00172129	21ur-15483
No description available

WB:WBGene00172130	21ur-12663
No description available

WB:WBGene00172131	21ur-7488
No description available

WB:WBGene00172132	21ur-6549
No description available

WB:WBGene00172133	21ur-14570
No description available

WB:WBGene00172134	21ur-13049
No description available

WB:WBGene00172135	21ur-6542
No description available

WB:WBGene00172136	21ur-6357
No description available

WB:WBGene00172137	21ur-9277
No description available

WB:WBGene00172138	21ur-12854
No description available

WB:WBGene00172139	21ur-10999
No description available

WB:WBGene00172140	21ur-14302
No description available

WB:WBGene00172141	21ur-7015
No description available

WB:WBGene00172142	21ur-7205
No description available

WB:WBGene00172143	21ur-13755
No description available

WB:WBGene00172144	21ur-12018
No description available

WB:WBGene00172145	21ur-12830
No description available

WB:WBGene00172146	21ur-13080
No description available

WB:WBGene00172147	21ur-5952
No description available

WB:WBGene00172148	21ur-10521
No description available

WB:WBGene00172149	21ur-8427
No description available

WB:WBGene00172150	21ur-10454
No description available

WB:WBGene00172151	21ur-13727
No description available

WB:WBGene00172152	21ur-9933
No description available

WB:WBGene00172153	21ur-14771
No description available

WB:WBGene00172154	21ur-9601
No description available

WB:WBGene00172155	21ur-11861
No description available

WB:WBGene00172156	21ur-13709
No description available

WB:WBGene00172157	21ur-6789
No description available

WB:WBGene00172158	21ur-8674
No description available

WB:WBGene00172159	21ur-11323
No description available

WB:WBGene00172160	21ur-9734
No description available

WB:WBGene00172161	21ur-12084
No description available

WB:WBGene00172162	21ur-14995
No description available

WB:WBGene00172163	21ur-14958
No description available

WB:WBGene00172164	21ur-14717
Is affected by daf-2 based on microarray studies.

WB:WBGene00172165	21ur-12816
No description available

WB:WBGene00172166	21ur-5843
No description available

WB:WBGene00172167	21ur-8434
No description available

WB:WBGene00172168	21ur-10876
No description available

WB:WBGene00172169	21ur-13751
No description available

WB:WBGene00172170	21ur-9859
No description available

WB:WBGene00172171	21ur-12412
No description available

WB:WBGene00172172	21ur-14992
No description available

WB:WBGene00172173	21ur-13669
No description available

WB:WBGene00172174	21ur-8491
No description available

WB:WBGene00172175	21ur-10065
No description available

WB:WBGene00172176	21ur-7010
No description available

WB:WBGene00172177	21ur-12494
No description available

WB:WBGene00172178	21ur-8246
No description available

WB:WBGene00172179	21ur-10351
No description available

WB:WBGene00172180	21ur-5884
No description available

WB:WBGene00172181	21ur-11568
No description available

WB:WBGene00172182	21ur-15073
No description available

WB:WBGene00172183	21ur-13478
No description available

WB:WBGene00172184	21ur-13199
No description available

WB:WBGene00172185	21ur-7157
No description available

WB:WBGene00172186	21ur-10121
No description available

WB:WBGene00172187	21ur-8841
No description available

WB:WBGene00172188	21ur-13183
No description available

WB:WBGene00172189	21ur-8883
No description available

WB:WBGene00172190	21ur-12800
No description available

WB:WBGene00172191	21ur-15085
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172192	21ur-13498
No description available

WB:WBGene00172193	21ur-7241
No description available

WB:WBGene00172194	21ur-11645
No description available

WB:WBGene00172195	21ur-12689
No description available

WB:WBGene00172196	21ur-15453
No description available

WB:WBGene00172197	21ur-13660
No description available

WB:WBGene00172198	21ur-8826
No description available

WB:WBGene00172199	21ur-6002
No description available

WB:WBGene00172200	21ur-8774
No description available

WB:WBGene00172201	21ur-14948
No description available

WB:WBGene00172202	21ur-5941
No description available

WB:WBGene00172203	21ur-8002
No description available

WB:WBGene00172204	21ur-14127
No description available

WB:WBGene00172205	21ur-5570
No description available

WB:WBGene00172206	21ur-6053
No description available

WB:WBGene00172207	21ur-15363
No description available

WB:WBGene00172208	21ur-9099
No description available

WB:WBGene00172209	21ur-12884
No description available

WB:WBGene00172210	21ur-10221
No description available

WB:WBGene00172211	21ur-13950
No description available

WB:WBGene00172212	21ur-10109
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172213	21ur-8099
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172214	21ur-7854
No description available

WB:WBGene00172215	21ur-8614
No description available

WB:WBGene00172216	21ur-7186
No description available

WB:WBGene00172217	21ur-12913
No description available

WB:WBGene00172218	21ur-14358
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172219	21ur-5503
No description available

WB:WBGene00172220	21ur-8802
No description available

WB:WBGene00172221	21ur-6872
No description available

WB:WBGene00172222	21ur-13690
No description available

WB:WBGene00172223	21ur-11665
No description available

WB:WBGene00172224	21ur-14389
No description available

WB:WBGene00172225	21ur-8547
No description available

WB:WBGene00172226	21ur-10738
No description available

WB:WBGene00172227	21ur-7043
Is affected by daf-2 based on microarray studies.

WB:WBGene00172228	21ur-12239
No description available

WB:WBGene00172229	21ur-14158
No description available

WB:WBGene00172230	21ur-14349
No description available

WB:WBGene00172231	21ur-14081
No description available

WB:WBGene00172232	21ur-6946
No description available

WB:WBGene00172233	21ur-14013
No description available

WB:WBGene00172234	21ur-7410
No description available

WB:WBGene00172235	21ur-11826
No description available

WB:WBGene00172236	21ur-14467
No description available

WB:WBGene00172237	21ur-6484
No description available

WB:WBGene00172238	21ur-9661
No description available

WB:WBGene00172239	21ur-14143
No description available

WB:WBGene00172240	21ur-5512
No description available

WB:WBGene00172241	21ur-10810
No description available

WB:WBGene00172242	21ur-9130
No description available

WB:WBGene00172243	21ur-11074
No description available

WB:WBGene00172244	21ur-10174
No description available

WB:WBGene00172245	21ur-11922
No description available

WB:WBGene00172246	21ur-7265
No description available

WB:WBGene00172247	21ur-15359
No description available

WB:WBGene00172248	21ur-11009
No description available

WB:WBGene00172249	21ur-11243
No description available

WB:WBGene00172250	21ur-7639
No description available

WB:WBGene00172251	21ur-12049
No description available

WB:WBGene00172252	21ur-7257
No description available

WB:WBGene00172253	21ur-14578
No description available

WB:WBGene00172254	21ur-9726
No description available

WB:WBGene00172255	21ur-5685
No description available

WB:WBGene00172256	21ur-8272
No description available

WB:WBGene00172257	21ur-15336
No description available

WB:WBGene00172258	21ur-9119
No description available

WB:WBGene00172259	21ur-13174
No description available

WB:WBGene00172260	21ur-8521
No description available

WB:WBGene00172261	21ur-12559
No description available

WB:WBGene00172262	21ur-11785
No description available

WB:WBGene00172263	21ur-10883
No description available

WB:WBGene00172264	21ur-10961
No description available

WB:WBGene00172265	21ur-10553
No description available

WB:WBGene00172266	21ur-14688
No description available

WB:WBGene00172267	21ur-14594
No description available

WB:WBGene00172268	21ur-14750
No description available

WB:WBGene00172269	21ur-9673
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172270	21ur-9473
No description available

WB:WBGene00172271	21ur-7600
No description available

WB:WBGene00172272	21ur-11387
No description available

WB:WBGene00172273	21ur-8908
No description available

WB:WBGene00172274	21ur-5948
No description available

WB:WBGene00172275	21ur-12792
No description available

WB:WBGene00172276	21ur-7312
No description available

WB:WBGene00172277	21ur-14982
No description available

WB:WBGene00172278	21ur-12680
No description available

WB:WBGene00172279	21ur-10880
No description available

WB:WBGene00172280	21ur-9835
No description available

WB:WBGene00172281	21ur-6721
No description available

WB:WBGene00172282	21ur-11767
No description available

WB:WBGene00172283	21ur-15653
No description available

WB:WBGene00172284	21ur-15698
No description available

WB:WBGene00172285	21ur-15638
No description available

WB:WBGene00172286	21ur-6246
No description available

WB:WBGene00172287	21ur-12247
No description available

WB:WBGene00172288	21ur-9053
No description available

WB:WBGene00172289	21ur-12554
No description available

WB:WBGene00172290	21ur-13393
No description available

WB:WBGene00172291	21ur-14401
No description available

WB:WBGene00172292	21ur-7814
No description available

WB:WBGene00172293	21ur-8668
No description available

WB:WBGene00172294	21ur-10432
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00172295	21ur-13492
No description available

WB:WBGene00172296	21ur-8767
No description available

WB:WBGene00172297	21ur-11994
No description available

WB:WBGene00172298	21ur-12489
No description available

WB:WBGene00172299	21ur-7091
No description available

WB:WBGene00172300	21ur-8116
No description available

WB:WBGene00172301	21ur-11145
No description available

WB:WBGene00172302	21ur-6342
No description available

WB:WBGene00172303	21ur-11963
No description available

WB:WBGene00172304	21ur-13295
No description available

WB:WBGene00172305	21ur-15350
No description available

WB:WBGene00172306	21ur-14247
No description available

WB:WBGene00172307	21ur-11802
No description available

WB:WBGene00172308	21ur-13827
No description available

WB:WBGene00172309	21ur-6911
No description available

WB:WBGene00172310	21ur-7294
No description available

WB:WBGene00172311	21ur-5721
No description available

WB:WBGene00172312	21ur-11199
No description available

WB:WBGene00172313	21ur-6550
No description available

WB:WBGene00172314	21ur-13644
No description available

WB:WBGene00172315	21ur-13832
No description available

WB:WBGene00172316	21ur-11572
No description available

WB:WBGene00172317	21ur-7691
No description available

WB:WBGene00172318	21ur-8092
No description available

WB:WBGene00172319	21ur-13928
No description available

WB:WBGene00172320	21ur-9318
No description available

WB:WBGene00172321	21ur-9476
No description available

WB:WBGene00172322	21ur-12868
No description available

WB:WBGene00172323	21ur-13100
No description available

WB:WBGene00172324	21ur-7778
No description available

WB:WBGene00172325	21ur-10169
No description available

WB:WBGene00172326	21ur-9313
No description available

WB:WBGene00172327	21ur-12930
No description available

WB:WBGene00172328	21ur-6177
No description available

WB:WBGene00172329	21ur-9781
No description available

WB:WBGene00172330	21ur-12269
No description available

WB:WBGene00172331	21ur-15614
No description available

WB:WBGene00172332	21ur-14249
No description available

WB:WBGene00172333	21ur-5478
No description available

WB:WBGene00172334	21ur-11274
No description available

WB:WBGene00172335	21ur-15346
No description available

WB:WBGene00172336	21ur-7777
No description available

WB:WBGene00172337	21ur-6315
No description available

WB:WBGene00172338	21ur-8528
No description available

WB:WBGene00172339	21ur-7943
No description available

WB:WBGene00172340	21ur-12748
No description available

WB:WBGene00172341	21ur-15024
No description available

WB:WBGene00172342	21ur-10630
No description available

WB:WBGene00172343	21ur-5549
No description available

WB:WBGene00172344	21ur-14197
No description available

WB:WBGene00172345	21ur-15137
No description available

WB:WBGene00172346	21ur-6966
No description available

WB:WBGene00172347	21ur-9720
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00172348	21ur-12166
No description available

WB:WBGene00172349	21ur-7225
No description available

WB:WBGene00172350	21ur-5747
No description available

WB:WBGene00172351	21ur-14848
No description available

WB:WBGene00172352	21ur-12401
No description available

WB:WBGene00172353	21ur-14505
No description available

WB:WBGene00172354	21ur-7565
No description available

WB:WBGene00172355	21ur-9755
No description available

WB:WBGene00172356	21ur-15393
No description available

WB:WBGene00172357	21ur-12639
No description available

WB:WBGene00172358	21ur-6692
No description available

WB:WBGene00172359	21ur-13806
No description available

WB:WBGene00172360	21ur-5612
No description available

WB:WBGene00172361	21ur-7650
No description available

WB:WBGene00172362	21ur-9398
No description available

WB:WBGene00172363	21ur-11186
No description available

WB:WBGene00172364	21ur-13792
No description available

WB:WBGene00172365	21ur-5595
No description available

WB:WBGene00172366	21ur-15299
No description available

WB:WBGene00172367	21ur-15147
No description available

WB:WBGene00172368	21ur-15080
No description available

WB:WBGene00172369	21ur-7536
No description available

WB:WBGene00172370	21ur-15528
No description available

WB:WBGene00172371	21ur-15292
No description available

WB:WBGene00172372	21ur-8504
No description available

WB:WBGene00172373	21ur-6201
No description available

WB:WBGene00172374	21ur-11930
No description available

WB:WBGene00172375	21ur-10534
No description available

WB:WBGene00172376	21ur-7558
No description available

WB:WBGene00172377	21ur-9685
No description available

WB:WBGene00172378	21ur-14398
No description available

WB:WBGene00172379	21ur-14743
No description available

WB:WBGene00172380	21ur-5520
No description available

WB:WBGene00172381	21ur-5877
No description available

WB:WBGene00172382	21ur-7834
No description available

WB:WBGene00172383	21ur-14421
No description available

WB:WBGene00172384	21ur-14637
No description available

WB:WBGene00172385	21ur-8663
No description available

WB:WBGene00172386	21ur-6453
No description available

WB:WBGene00172387	21ur-8253
No description available

WB:WBGene00172388	21ur-15167
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies.

WB:WBGene00172389	21ur-13610
No description available

WB:WBGene00172390	21ur-14922
No description available

WB:WBGene00172391	21ur-7682
No description available

WB:WBGene00172392	21ur-12408
No description available

WB:WBGene00172393	21ur-11953
No description available

WB:WBGene00172394	21ur-6975
No description available

WB:WBGene00172395	21ur-5869
No description available

WB:WBGene00172396	21ur-8303
No description available

WB:WBGene00172397	21ur-10709
No description available

WB:WBGene00172398	21ur-11500
No description available

WB:WBGene00172399	21ur-10677
No description available

WB:WBGene00172400	21ur-11839
No description available

WB:WBGene00172401	21ur-12112
No description available

WB:WBGene00172402	21ur-14157
No description available

WB:WBGene00172403	21ur-9368
No description available

WB:WBGene00172404	21ur-5492
No description available

WB:WBGene00172405	21ur-14239
No description available

WB:WBGene00172406	21ur-15622
No description available

WB:WBGene00172407	21ur-5455
No description available

WB:WBGene00172408	21ur-6388
No description available

WB:WBGene00172409	21ur-15474
No description available

WB:WBGene00172410	21ur-15617
No description available

WB:WBGene00172411	21ur-10583
No description available

WB:WBGene00172412	21ur-13424
No description available

WB:WBGene00172413	21ur-10702
No description available

WB:WBGene00172414	21ur-7221
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172415	21ur-13411
No description available

WB:WBGene00172416	21ur-14175
No description available

WB:WBGene00172417	21ur-11604
No description available

WB:WBGene00172418	21ur-11702
No description available

WB:WBGene00172419	21ur-12465
No description available

WB:WBGene00172420	21ur-11751
No description available

WB:WBGene00172421	21ur-7379
No description available

WB:WBGene00172422	21ur-6117
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172423	21ur-8976
No description available

WB:WBGene00172424	21ur-10015
No description available

WB:WBGene00172425	21ur-10575
No description available

WB:WBGene00172426	21ur-13190
No description available

WB:WBGene00172427	21ur-10570
No description available

WB:WBGene00172428	21ur-12872
No description available

WB:WBGene00172429	21ur-15442
No description available

WB:WBGene00172430	21ur-14437
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172431	21ur-5804
No description available

WB:WBGene00172432	21ur-8478
No description available

WB:WBGene00172433	21ur-7087
No description available

WB:WBGene00172434	21ur-7569
No description available

WB:WBGene00172435	21ur-8059
No description available

WB:WBGene00172436	21ur-14681
No description available

WB:WBGene00172437	21ur-7244
No description available

WB:WBGene00172438	21ur-9002
No description available

WB:WBGene00172439	21ur-12074
No description available

WB:WBGene00172440	21ur-11416
No description available

WB:WBGene00172441	21ur-13352
No description available

WB:WBGene00172442	21ur-6273
No description available

WB:WBGene00172443	21ur-8105
No description available

WB:WBGene00172444	21ur-6492
No description available

WB:WBGene00172445	21ur-15606
No description available

WB:WBGene00172446	21ur-11589
No description available

WB:WBGene00172447	21ur-12349
No description available

WB:WBGene00172448	21ur-14553
Is affected by eat-2 based on microarray studies.

WB:WBGene00172449	21ur-12952
No description available

WB:WBGene00172450	21ur-10292
No description available

WB:WBGene00172451	21ur-7113
No description available

WB:WBGene00172452	21ur-12314
No description available

WB:WBGene00172453	21ur-6565
No description available

WB:WBGene00172454	21ur-11174
No description available

WB:WBGene00172455	21ur-7865
No description available

WB:WBGene00172456	21ur-13971
No description available

WB:WBGene00172457	21ur-5910
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00172458	21ur-5840
No description available

WB:WBGene00172459	21ur-6953
No description available

WB:WBGene00172460	21ur-12753
No description available

WB:WBGene00172462	21ur-5616
No description available

WB:WBGene00172463	21ur-5870
No description available

WB:WBGene00172464	21ur-7455
No description available

WB:WBGene00172465	21ur-8404
No description available

WB:WBGene00172466	21ur-12662
No description available

WB:WBGene00172467	21ur-13301
No description available

WB:WBGene00172468	21ur-6466
No description available

WB:WBGene00172469	21ur-5862
No description available

WB:WBGene00172470	21ur-10637
No description available

WB:WBGene00172471	21ur-7407
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00172472	21ur-9749
No description available

WB:WBGene00172473	21ur-7349
No description available

WB:WBGene00172474	21ur-6308
No description available

WB:WBGene00172475	21ur-12671
No description available

WB:WBGene00172476	21ur-10044
No description available

WB:WBGene00172477	21ur-9564
No description available

WB:WBGene00172478	21ur-10661
No description available

WB:WBGene00172479	21ur-12505
No description available

WB:WBGene00172480	21ur-9647
No description available

WB:WBGene00172481	21ur-14649
No description available

WB:WBGene00172482	21ur-11541
No description available

WB:WBGene00172483	21ur-11561
No description available

WB:WBGene00172484	21ur-7458
No description available

WB:WBGene00172485	21ur-14564
No description available

WB:WBGene00172486	21ur-12128
No description available

WB:WBGene00172487	21ur-6932
No description available

WB:WBGene00172488	21ur-7934
No description available

WB:WBGene00172489	21ur-11287
No description available

WB:WBGene00172490	21ur-10869
No description available

WB:WBGene00172491	21ur-8298
No description available

WB:WBGene00172492	21ur-13305
No description available

WB:WBGene00172493	21ur-14938
No description available

WB:WBGene00172494	21ur-14446
No description available

WB:WBGene00172495	21ur-14230
No description available

WB:WBGene00172496	21ur-6839
No description available

WB:WBGene00172497	21ur-8984
No description available

WB:WBGene00172498	21ur-12518
No description available

WB:WBGene00172499	21ur-6500
No description available

WB:WBGene00172500	21ur-13590
No description available

WB:WBGene00172501	21ur-5770
No description available

WB:WBGene00172502	21ur-6368
No description available

WB:WBGene00172503	21ur-15027
No description available

WB:WBGene00172504	21ur-6192
No description available

WB:WBGene00172505	21ur-15064
No description available

WB:WBGene00172506	21ur-11344
No description available

WB:WBGene00172507	21ur-9045
No description available

WB:WBGene00172508	21ur-9752
No description available

WB:WBGene00172509	21ur-7042
No description available

WB:WBGene00172510	21ur-11980
No description available

WB:WBGene00172511	21ur-13122
No description available

WB:WBGene00172512	21ur-6374
No description available

WB:WBGene00172513	21ur-8173
No description available

WB:WBGene00172514	21ur-9140
No description available

WB:WBGene00172515	21ur-10560
No description available

WB:WBGene00172516	21ur-11602
No description available

WB:WBGene00172517	21ur-10367
No description available

WB:WBGene00172518	21ur-10214
No description available

WB:WBGene00172519	21ur-13351
No description available

WB:WBGene00172520	21ur-14419
No description available

WB:WBGene00172521	21ur-5961
No description available

WB:WBGene00172522	21ur-15505
No description available

WB:WBGene00172523	21ur-15188
No description available

WB:WBGene00172524	21ur-5468
No description available

WB:WBGene00172525	21ur-13263
Is affected by daf-2 based on microarray studies.

WB:WBGene00172526	21ur-9470
No description available

WB:WBGene00172527	21ur-10773
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172528	21ur-13620
No description available

WB:WBGene00172529	21ur-7945
No description available

WB:WBGene00172530	21ur-14410
No description available

WB:WBGene00172531	21ur-12417
No description available

WB:WBGene00172532	21ur-15225
No description available

WB:WBGene00172533	21ur-12826
No description available

WB:WBGene00172534	21ur-10585
No description available

WB:WBGene00172535	21ur-12394
No description available

WB:WBGene00172536	21ur-7008
No description available

WB:WBGene00172537	21ur-13629
No description available

WB:WBGene00172538	21ur-7575
No description available

WB:WBGene00172539	21ur-5704
No description available

WB:WBGene00172540	21ur-13432
No description available

WB:WBGene00172541	21ur-6736
No description available

WB:WBGene00172542	21ur-15662
No description available

WB:WBGene00172543	21ur-14858
No description available

WB:WBGene00172544	21ur-13383
No description available

WB:WBGene00172545	21ur-11927
No description available

WB:WBGene00172546	21ur-5691
No description available

WB:WBGene00172547	21ur-14653
No description available

WB:WBGene00172548	21ur-8964
No description available

WB:WBGene00172549	21ur-6153
No description available

WB:WBGene00172550	21ur-14492
No description available

WB:WBGene00172551	21ur-5972
No description available

WB:WBGene00172552	21ur-15277
No description available

WB:WBGene00172553	21ur-7982
No description available

WB:WBGene00172554	21ur-14734
No description available

WB:WBGene00172555	21ur-9507
No description available

WB:WBGene00172556	21ur-13506
No description available

WB:WBGene00172557	21ur-11088
No description available

WB:WBGene00172558	21ur-9934
No description available

WB:WBGene00172559	21ur-12843
No description available

WB:WBGene00172560	21ur-11639
No description available

WB:WBGene00172561	21ur-10406
No description available

WB:WBGene00172562	21ur-7965
No description available

WB:WBGene00172563	21ur-9909
No description available

WB:WBGene00172564	21ur-13743
No description available

WB:WBGene00172565	21ur-5754
No description available

WB:WBGene00172566	21ur-11444
No description available

WB:WBGene00172567	21ur-12076
No description available

WB:WBGene00172568	21ur-10002
No description available

WB:WBGene00172569	21ur-6669
No description available

WB:WBGene00172570	21ur-14767
No description available

WB:WBGene00172571	21ur-10808
No description available

WB:WBGene00172572	21ur-11169
No description available

WB:WBGene00172573	21ur-11213
No description available

WB:WBGene00172574	21ur-6361
No description available

WB:WBGene00172575	21ur-12003
No description available

WB:WBGene00172576	21ur-7787
No description available

WB:WBGene00172577	21ur-7128
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00172578	21ur-11107
No description available

WB:WBGene00172579	21ur-6516
No description available

WB:WBGene00172580	21ur-10567
No description available

WB:WBGene00172581	21ur-14457
No description available

WB:WBGene00172582	21ur-12204
No description available

WB:WBGene00172583	21ur-5709
No description available

WB:WBGene00172584	21ur-11704
No description available

WB:WBGene00172585	21ur-11824
No description available

WB:WBGene00172586	21ur-15177
No description available

WB:WBGene00172587	21ur-7282
No description available

WB:WBGene00172588	21ur-14251
No description available

WB:WBGene00172589	21ur-10730
No description available

WB:WBGene00172590	21ur-15089
No description available

WB:WBGene00172591	21ur-7625
No description available

WB:WBGene00172592	21ur-7352
No description available

WB:WBGene00172593	21ur-7649
No description available

WB:WBGene00172594	21ur-5644
No description available

WB:WBGene00172595	21ur-9705
No description available

WB:WBGene00172596	21ur-7417
No description available

WB:WBGene00172597	21ur-10017
No description available

WB:WBGene00172598	21ur-14715
No description available

WB:WBGene00172599	21ur-5674
No description available

WB:WBGene00172600	21ur-15420
No description available

WB:WBGene00172601	21ur-9928
No description available

WB:WBGene00172602	21ur-10867
No description available

WB:WBGene00172603	21ur-5738
No description available

WB:WBGene00172604	21ur-13344
No description available

WB:WBGene00172605	21ur-7319
No description available

WB:WBGene00172606	21ur-6074
No description available

WB:WBGene00172607	21ur-6997
No description available

WB:WBGene00172608	21ur-15255
No description available

WB:WBGene00172609	21ur-9397
No description available

WB:WBGene00172610	21ur-6965
No description available

WB:WBGene00172611	21ur-10117
Is affected by daf-2 based on microarray studies.

WB:WBGene00172612	21ur-12254
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00172613	21ur-5988
No description available

WB:WBGene00172614	21ur-9528
No description available

WB:WBGene00172615	21ur-13115
No description available

WB:WBGene00172616	21ur-9305
No description available

WB:WBGene00172617	21ur-9126
No description available

WB:WBGene00172618	21ur-8982
No description available

WB:WBGene00172619	21ur-6599
No description available

WB:WBGene00172620	21ur-5630
No description available

WB:WBGene00172621	21ur-7825
No description available

WB:WBGene00172622	21ur-10826
No description available

WB:WBGene00172623	21ur-14194
No description available

WB:WBGene00172624	21ur-5724
No description available

WB:WBGene00172625	21ur-8468
No description available

WB:WBGene00172626	21ur-9273
No description available

WB:WBGene00172627	21ur-10042
No description available

WB:WBGene00172628	21ur-9429
No description available

WB:WBGene00172629	21ur-11238
No description available

WB:WBGene00172630	21ur-10332
No description available

WB:WBGene00172631	21ur-14499
No description available

WB:WBGene00172632	21ur-7402
No description available

WB:WBGene00172633	21ur-5994
No description available

WB:WBGene00172634	21ur-11355
No description available

WB:WBGene00172635	21ur-9747
No description available

WB:WBGene00172636	21ur-12745
No description available

WB:WBGene00172637	21ur-7355
No description available

WB:WBGene00172638	21ur-15499
No description available

WB:WBGene00172639	21ur-15130
No description available

WB:WBGene00172640	21ur-8885
No description available

WB:WBGene00172641	21ur-6546
No description available

WB:WBGene00172642	21ur-10964
No description available

WB:WBGene00172643	21ur-6477
No description available

WB:WBGene00172644	21ur-10508
No description available

WB:WBGene00172645	21ur-10512
No description available

WB:WBGene00172646	21ur-12454
No description available

WB:WBGene00172647	21ur-15447
No description available

WB:WBGene00172648	21ur-15112
No description available

WB:WBGene00172649	21ur-8645
No description available

WB:WBGene00172650	21ur-12738
No description available

WB:WBGene00172651	21ur-15529
No description available

WB:WBGene00172652	21ur-13358
No description available

WB:WBGene00172653	21ur-13563
No description available

WB:WBGene00172654	21ur-15386
No description available

WB:WBGene00172655	21ur-14760
Is affected by ins-11 and damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00172656	21ur-10361
No description available

WB:WBGene00172657	21ur-10912
No description available

WB:WBGene00172658	21ur-11438
No description available

WB:WBGene00172659	21ur-12091
No description available

WB:WBGene00172660	21ur-8103
No description available

WB:WBGene00172661	21ur-7520
No description available

WB:WBGene00172662	21ur-5746
No description available

WB:WBGene00172663	21ur-12248
No description available

WB:WBGene00172664	21ur-15038
No description available

WB:WBGene00172665	21ur-14533
No description available

WB:WBGene00172666	21ur-5624
No description available

WB:WBGene00172667	21ur-5539
No description available

WB:WBGene00172668	21ur-10499
No description available

WB:WBGene00172669	21ur-15091
No description available

WB:WBGene00172670	21ur-6274
No description available

WB:WBGene00172671	21ur-10484
No description available

WB:WBGene00172672	21ur-6821
No description available

WB:WBGene00172673	21ur-13208
No description available

WB:WBGene00172674	21ur-6164
No description available

WB:WBGene00172675	21ur-5732
No description available

WB:WBGene00172676	21ur-14674
No description available

WB:WBGene00172677	21ur-5637
No description available

WB:WBGene00172678	21ur-5507
No description available

WB:WBGene00172679	21ur-9707
No description available

WB:WBGene00172680	21ur-8953
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172681	21ur-7411
No description available

WB:WBGene00172682	21ur-13814
No description available

WB:WBGene00172683	21ur-5610
No description available

WB:WBGene00172684	21ur-12945
No description available

WB:WBGene00172685	21ur-10550
No description available

WB:WBGene00172686	21ur-7179
No description available

WB:WBGene00172687	21ur-11532
No description available

WB:WBGene00172688	21ur-8584
No description available

WB:WBGene00172689	21ur-9515
No description available

WB:WBGene00172690	21ur-9229
No description available

WB:WBGene00172691	21ur-13803
No description available

WB:WBGene00172692	21ur-9340
No description available

WB:WBGene00172693	21ur-15635
No description available

WB:WBGene00172694	21ur-11380
No description available

WB:WBGene00172695	21ur-5716
No description available

WB:WBGene00172696	21ur-6398
No description available

WB:WBGene00172697	21ur-8181
No description available

WB:WBGene00172698	21ur-12648
No description available

WB:WBGene00172699	21ur-10819
No description available

WB:WBGene00172700	21ur-13242
No description available

WB:WBGene00172701	21ur-9613
No description available

WB:WBGene00172702	21ur-9662
No description available

WB:WBGene00172703	21ur-15587
No description available

WB:WBGene00172704	21ur-15057
No description available

WB:WBGene00172705	21ur-13940
No description available

WB:WBGene00172706	21ur-10439
No description available

WB:WBGene00172707	21ur-12324
No description available

WB:WBGene00172708	21ur-12890
No description available

WB:WBGene00172709	21ur-13544
No description available

WB:WBGene00172710	21ur-11617
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172711	21ur-13831
No description available

WB:WBGene00172712	21ur-15669
No description available

WB:WBGene00172713	21ur-5511
No description available

WB:WBGene00172714	21ur-13201
No description available

WB:WBGene00172715	21ur-10799
No description available

WB:WBGene00172716	21ur-6740
No description available

WB:WBGene00172717	21ur-10083
No description available

WB:WBGene00172718	21ur-10394
No description available

WB:WBGene00172719	21ur-8414
No description available

WB:WBGene00172720	21ur-8531
No description available

WB:WBGene00172721	21ur-9350
No description available

WB:WBGene00172722	21ur-6869
No description available

WB:WBGene00172723	21ur-8893
No description available

WB:WBGene00172724	21ur-7270
No description available

WB:WBGene00172725	21ur-13109
No description available

WB:WBGene00172726	21ur-8262
No description available

WB:WBGene00172727	21ur-12695
No description available

WB:WBGene00172728	21ur-10643
No description available

WB:WBGene00172729	21ur-15566
Is affected by several genes including pgl-1; glh-1; and hpl-2 based on RNA-seq studies.

WB:WBGene00172730	21ur-8736
No description available

WB:WBGene00172731	21ur-7382
No description available

WB:WBGene00172732	21ur-6093
No description available

WB:WBGene00172733	21ur-11131
No description available

WB:WBGene00172734	21ur-14135
No description available

WB:WBGene00172735	21ur-15361
Is affected by daf-2 based on microarray studies.

WB:WBGene00172736	21ur-15522
No description available

WB:WBGene00172737	21ur-6214
No description available

WB:WBGene00172738	21ur-8860
No description available

WB:WBGene00172739	21ur-10072
No description available

WB:WBGene00172740	21ur-11966
No description available

WB:WBGene00172741	21ur-7386
No description available

WB:WBGene00172742	21ur-11138
No description available

WB:WBGene00172743	21ur-8089
No description available

WB:WBGene00172744	21ur-11591
No description available

WB:WBGene00172745	21ur-15288
No description available

WB:WBGene00172746	21ur-13895
No description available

WB:WBGene00172747	21ur-14489
Is affected by daf-2 based on microarray studies.

WB:WBGene00172748	21ur-7443
No description available

WB:WBGene00172749	21ur-6051
No description available

WB:WBGene00172750	21ur-13247
No description available

WB:WBGene00172751	21ur-13148
No description available

WB:WBGene00172752	21ur-7860
No description available

WB:WBGene00172753	21ur-12625
No description available

WB:WBGene00172754	21ur-5678
No description available

WB:WBGene00172755	21ur-14279
No description available

WB:WBGene00172756	21ur-6140
No description available

WB:WBGene00172757	21ur-8069
No description available

WB:WBGene00172758	21ur-9807
No description available

WB:WBGene00172759	21ur-11887
No description available

WB:WBGene00172760	21ur-10343
No description available

WB:WBGene00172761	21ur-8455
No description available

WB:WBGene00172762	21ur-12528
No description available

WB:WBGene00172763	21ur-13345
No description available

WB:WBGene00172764	21ur-14692
No description available

WB:WBGene00172765	21ur-9267
No description available

WB:WBGene00172766	21ur-9325
No description available

WB:WBGene00172767	21ur-12763
No description available

WB:WBGene00172768	21ur-13613
No description available

WB:WBGene00172769	21ur-8201
No description available

WB:WBGene00172770	21ur-10360
No description available

WB:WBGene00172771	21ur-7991
No description available

WB:WBGene00172772	21ur-8801
No description available

WB:WBGene00172773	21ur-10529
No description available

WB:WBGene00172774	21ur-9025
No description available

WB:WBGene00172775	21ur-11125
No description available

WB:WBGene00172776	21ur-10308
No description available

WB:WBGene00172777	21ur-13255
No description available

WB:WBGene00172778	21ur-7887
No description available

WB:WBGene00172779	21ur-9510
Is affected by bisphenol A based on RNA-seq studies.

WB:WBGene00172780	21ur-11913
No description available

WB:WBGene00172781	21ur-14335
No description available

WB:WBGene00172782	21ur-6960
No description available

WB:WBGene00172783	21ur-12238
No description available

WB:WBGene00172784	21ur-7760
No description available

WB:WBGene00172785	21ur-9800
Is affected by daf-2 based on microarray studies.

WB:WBGene00172786	21ur-7644
No description available

WB:WBGene00172787	21ur-6662
No description available

WB:WBGene00172788	21ur-13654
No description available

WB:WBGene00172789	21ur-6852
No description available

WB:WBGene00172790	21ur-15324
No description available

WB:WBGene00172791	21ur-9675
No description available

WB:WBGene00172792	21ur-15437
No description available

WB:WBGene00172793	21ur-13387
No description available

WB:WBGene00172794	21ur-8538
No description available

WB:WBGene00172795	21ur-7360
No description available

WB:WBGene00172796	21ur-15103
No description available

WB:WBGene00172797	21ur-8288
No description available

WB:WBGene00172798	21ur-7623
No description available

WB:WBGene00172799	21ur-11066
No description available

WB:WBGene00172800	21ur-14145
No description available

WB:WBGene00172801	21ur-14080
No description available

WB:WBGene00172802	21ur-15327
No description available

WB:WBGene00172803	21ur-6892
No description available

WB:WBGene00172804	21ur-11755
No description available

WB:WBGene00172805	21ur-12241
No description available

WB:WBGene00172806	21ur-12783
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172807	21ur-14357
No description available

WB:WBGene00172808	21ur-6678
No description available

WB:WBGene00172809	21ur-6356
No description available

WB:WBGene00172810	21ur-10543
No description available

WB:WBGene00172811	21ur-10142
No description available

WB:WBGene00172812	21ur-14947
No description available

WB:WBGene00172813	21ur-11610
No description available

WB:WBGene00172814	21ur-12992
No description available

WB:WBGene00172815	21ur-9448
No description available

WB:WBGene00172816	21ur-13701
No description available

WB:WBGene00172817	21ur-8211
No description available

WB:WBGene00172818	21ur-15313
No description available

WB:WBGene00172819	21ur-6344
No description available

WB:WBGene00172820	21ur-8499
No description available

WB:WBGene00172821	21ur-14601
No description available

WB:WBGene00172822	21ur-8710
No description available

WB:WBGene00172823	21ur-6526
No description available

WB:WBGene00172824	21ur-11883
No description available

WB:WBGene00172825	21ur-14089
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00172826	21ur-9669
No description available

WB:WBGene00172827	21ur-6877
No description available

WB:WBGene00172828	21ur-13399
No description available

WB:WBGene00172829	21ur-6038
No description available

WB:WBGene00172830	21ur-10246
No description available

WB:WBGene00172831	21ur-12054
No description available

WB:WBGene00172832	21ur-15372
No description available

WB:WBGene00172833	21ur-12708
No description available

WB:WBGene00172834	21ur-15074
No description available

WB:WBGene00172835	21ur-8758
No description available

WB:WBGene00172836	21ur-14908
No description available

WB:WBGene00172837	21ur-8540
No description available

WB:WBGene00172838	21ur-13572
No description available

WB:WBGene00172839	21ur-7276
No description available

WB:WBGene00172840	21ur-9008
No description available

WB:WBGene00172841	21ur-10134
No description available

WB:WBGene00172842	21ur-12368
No description available

WB:WBGene00172843	21ur-9024
No description available

WB:WBGene00172844	21ur-9333
No description available

WB:WBGene00172845	21ur-14501
No description available

WB:WBGene00172846	21ur-7630
No description available

WB:WBGene00172847	21ur-14668
No description available

WB:WBGene00172848	21ur-11162
No description available

WB:WBGene00172849	21ur-15315
No description available

WB:WBGene00172850	21ur-7214
No description available

WB:WBGene00172851	21ur-12545
No description available

WB:WBGene00172852	21ur-12803
No description available

WB:WBGene00172853	21ur-15693
No description available

WB:WBGene00172854	21ur-12020
No description available

WB:WBGene00172855	21ur-7436
No description available

WB:WBGene00172856	21ur-7506
No description available

WB:WBGene00172857	21ur-10572
No description available

WB:WBGene00172858	21ur-11722
No description available

WB:WBGene00172859	21ur-5562
No description available

WB:WBGene00172860	21ur-12616
No description available

WB:WBGene00172861	21ur-10786
No description available

WB:WBGene00172862	21ur-14152
No description available

WB:WBGene00172863	21ur-8555
No description available

WB:WBGene00172864	21ur-9274
No description available

WB:WBGene00172865	21ur-13864
No description available

WB:WBGene00172866	21ur-9136
No description available

WB:WBGene00172867	21ur-10622
No description available

WB:WBGene00172868	21ur-14310
No description available

WB:WBGene00172869	21ur-13752
No description available

WB:WBGene00172870	21ur-12197
No description available

WB:WBGene00172871	21ur-8784
No description available

WB:WBGene00172872	21ur-8706
No description available

WB:WBGene00172873	21ur-7582
No description available

WB:WBGene00172874	21ur-14804
No description available

WB:WBGene00172875	21ur-9533
No description available

WB:WBGene00172876	21ur-9044
No description available

WB:WBGene00172877	21ur-8859
No description available

WB:WBGene00172878	21ur-12927
No description available

WB:WBGene00172879	21ur-14180
No description available

WB:WBGene00172880	21ur-13720
No description available

WB:WBGene00172881	21ur-7738
No description available

WB:WBGene00172882	21ur-6758
No description available

WB:WBGene00172883	21ur-8372
No description available

WB:WBGene00172884	21ur-13646
No description available

WB:WBGene00172885	21ur-7917
No description available

WB:WBGene00172886	21ur-15511
No description available

WB:WBGene00172887	21ur-5911
No description available

WB:WBGene00172888	21ur-15461
No description available

WB:WBGene00172889	21ur-12831
No description available

WB:WBGene00172890	21ur-14048
No description available

WB:WBGene00172891	21ur-13404
No description available

WB:WBGene00172892	21ur-13236
No description available

WB:WBGene00172893	21ur-11628
No description available

WB:WBGene00172894	21ur-12611
No description available

WB:WBGene00172895	21ur-14864
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00172896	21ur-9456
No description available

WB:WBGene00172897	21ur-5566
No description available

WB:WBGene00172898	21ur-13965
No description available

WB:WBGene00172899	21ur-11819
No description available

WB:WBGene00172900	21ur-10263
No description available

WB:WBGene00172901	21ur-10533
No description available

WB:WBGene00172902	21ur-13296
No description available

WB:WBGene00172903	21ur-11123
No description available

WB:WBGene00172904	21ur-5658
No description available

WB:WBGene00172905	21ur-14953
No description available

WB:WBGene00172906	21ur-12427
No description available

WB:WBGene00172907	21ur-14725
No description available

WB:WBGene00172908	21ur-8699
No description available

WB:WBGene00172909	21ur-11559
No description available

WB:WBGene00172910	21ur-11228
No description available

WB:WBGene00172911	21ur-8574
No description available

WB:WBGene00172912	21ur-11539
No description available

WB:WBGene00172913	21ur-12593
No description available

WB:WBGene00172914	21ur-15128
No description available

WB:WBGene00172915	21ur-9096
No description available

WB:WBGene00172916	21ur-15306
No description available

WB:WBGene00172917	21ur-6409
No description available

WB:WBGene00172918	21ur-9462
No description available

WB:WBGene00172919	21ur-10614
No description available

WB:WBGene00172920	21ur-11054
No description available

WB:WBGene00172921	21ur-9923
No description available

WB:WBGene00172922	21ur-10909
No description available

WB:WBGene00172923	21ur-9038
No description available

WB:WBGene00172924	21ur-13066
No description available

WB:WBGene00172925	21ur-9484
No description available

WB:WBGene00172926	21ur-11644
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00172927	21ur-7606
No description available

WB:WBGene00172928	21ur-5939
No description available

WB:WBGene00172929	21ur-14482
No description available

WB:WBGene00172930	21ur-9560
No description available

WB:WBGene00172931	21ur-6712
No description available

WB:WBGene00172932	21ur-14510
No description available

WB:WBGene00172933	21ur-8855
No description available

WB:WBGene00172934	21ur-11775
No description available

WB:WBGene00172935	21ur-13270
No description available

WB:WBGene00172936	21ur-7196
No description available

WB:WBGene00172937	21ur-15540
No description available

WB:WBGene00172938	21ur-11870
No description available

WB:WBGene00172939	21ur-14740
No description available

WB:WBGene00172940	21ur-9788
Is affected by eat-2 based on microarray studies.

WB:WBGene00172941	21ur-7977
No description available

WB:WBGene00172942	21ur-12973
No description available

WB:WBGene00172943	21ur-8035
Is affected by daf-2 based on microarray studies.

WB:WBGene00172944	21ur-10986
No description available

WB:WBGene00172945	21ur-13182
No description available

WB:WBGene00172946	21ur-7169
No description available

WB:WBGene00172947	21ur-13450
No description available

WB:WBGene00172948	21ur-11445
No description available

WB:WBGene00172949	21ur-10928
No description available

WB:WBGene00172950	21ur-12860
No description available

WB:WBGene00172951	21ur-7589
No description available

WB:WBGene00172952	21ur-13140
No description available

WB:WBGene00172953	21ur-9552
No description available

WB:WBGene00172954	21ur-9998
No description available

WB:WBGene00172955	21ur-12370
No description available

WB:WBGene00172956	21ur-9288
No description available

WB:WBGene00172957	21ur-11651
No description available

WB:WBGene00172958	21ur-8752
No description available

WB:WBGene00172959	21ur-6859
No description available

WB:WBGene00172960	21ur-15139
No description available

WB:WBGene00172961	21ur-10944
No description available

WB:WBGene00172962	21ur-13499
No description available

WB:WBGene00172963	21ur-7967
No description available

WB:WBGene00172964	21ur-6418
No description available

WB:WBGene00172965	21ur-13695
No description available

WB:WBGene00172966	21ur-5793
No description available

WB:WBGene00172967	21ur-7792
No description available

WB:WBGene00172968	21ur-8878
No description available

WB:WBGene00172969	21ur-12082
No description available

WB:WBGene00172970	21ur-10271
No description available

WB:WBGene00172971	21ur-7110
No description available

WB:WBGene00172972	21ur-11622
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00172973	21ur-11894
No description available

WB:WBGene00172974	21ur-14090
No description available

WB:WBGene00172975	21ur-15650
No description available

WB:WBGene00172976	21ur-15366
No description available

WB:WBGene00172977	21ur-7018
No description available

WB:WBGene00172978	21ur-11547
No description available

WB:WBGene00172979	21ur-13913
No description available

WB:WBGene00172980	21ur-7794
No description available

WB:WBGene00172981	21ur-10268
No description available

WB:WBGene00172982	21ur-5513
No description available

WB:WBGene00172983	21ur-11512
No description available

WB:WBGene00172984	21ur-13459
No description available

WB:WBGene00172985	21ur-5904
No description available

WB:WBGene00172986	21ur-8342
No description available

WB:WBGene00172987	21ur-11657
No description available

WB:WBGene00172988	21ur-12263
No description available

WB:WBGene00172989	21ur-9359
No description available

WB:WBGene00172990	21ur-12033
No description available

WB:WBGene00172991	21ur-8366
No description available

WB:WBGene00172992	21ur-7237
No description available

WB:WBGene00172993	21ur-15012
No description available

WB:WBGene00172994	21ur-8587
No description available

WB:WBGene00172995	21ur-14526
No description available

WB:WBGene00172996	21ur-9010
No description available

WB:WBGene00172997	21ur-10618
No description available

WB:WBGene00172998	21ur-8494
No description available

WB:WBGene00172999	21ur-7255
No description available

WB:WBGene00173000	21ur-13175
No description available

WB:WBGene00173001	21ur-7330
No description available

WB:WBGene00173002	21ur-13376
Is affected by hmg-3; hmg-4; and spt-16 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

WB:WBGene00173003	21ur-8394
No description available

WB:WBGene00173004	21ur-7317
No description available

WB:WBGene00173005	21ur-12510
No description available

WB:WBGene00173006	21ur-8313
No description available

WB:WBGene00173007	21ur-14223
No description available

WB:WBGene00173008	21ur-5585
No description available

WB:WBGene00173009	21ur-6446
No description available

WB:WBGene00173010	21ur-6298
No description available

WB:WBGene00173011	21ur-9793
No description available

WB:WBGene00173012	21ur-10970
No description available

WB:WBGene00173013	21ur-10473
No description available

WB:WBGene00173014	21ur-14853
No description available

WB:WBGene00173015	21ur-11786
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00173016	21ur-14314
No description available

WB:WBGene00173017	21ur-8024
No description available

WB:WBGene00173018	21ur-8165
No description available

WB:WBGene00173019	21ur-14891
No description available

WB:WBGene00173020	21ur-11024
No description available

WB:WBGene00173021	21ur-14593
No description available

WB:WBGene00173022	21ur-6621
No description available

WB:WBGene00173023	21ur-6014
No description available

WB:WBGene00173024	21ur-8606
No description available

WB:WBGene00173025	21ur-12961
No description available

WB:WBGene00173026	21ur-13362
No description available

WB:WBGene00173027	21ur-10325
No description available

WB:WBGene00173028	21ur-10711
No description available

WB:WBGene00173029	21ur-8780
No description available

WB:WBGene00173030	21ur-8339
No description available

WB:WBGene00173031	21ur-8160
No description available

WB:WBGene00173032	21ur-9777
No description available

WB:WBGene00173033	21ur-10183
No description available

WB:WBGene00173034	21ur-13688
No description available

WB:WBGene00173035	21ur-6687
No description available

WB:WBGene00173036	21ur-14940
No description available

WB:WBGene00173037	21ur-9111
No description available

WB:WBGene00173038	21ur-9260
No description available

WB:WBGene00173039	21ur-9864
No description available

WB:WBGene00173040	21ur-7302
No description available

WB:WBGene00173041	21ur-13596
No description available

WB:WBGene00173042	21ur-6022
No description available

WB:WBGene00173043	21ur-15556
No description available

WB:WBGene00173044	21ur-12286
No description available

WB:WBGene00173045	21ur-6437
No description available

WB:WBGene00173046	21ur-13882
No description available

WB:WBGene00173047	21ur-9230
No description available

WB:WBGene00173048	21ur-14138
No description available

WB:WBGene00173049	21ur-10690
No description available

WB:WBGene00173050	21ur-9003
No description available

WB:WBGene00173051	21ur-11425
No description available

WB:WBGene00173052	21ur-5966
No description available

WB:WBGene00173053	21ur-12272
No description available

WB:WBGene00173054	21ur-8381
No description available

WB:WBGene00173055	21ur-14823
No description available

WB:WBGene00173056	21ur-5854
No description available

WB:WBGene00173057	21ur-14621
No description available

WB:WBGene00173058	21ur-8846
No description available

WB:WBGene00173059	21ur-11309
No description available

WB:WBGene00173060	21ur-13962
No description available

WB:WBGene00173061	21ur-12144
No description available

WB:WBGene00173062	21ur-15287
No description available

WB:WBGene00173063	21ur-7995
No description available

WB:WBGene00173064	21ur-9968
No description available

WB:WBGene00173065	21ur-6253
No description available

WB:WBGene00173066	21ur-10337
No description available

WB:WBGene00173067	21ur-8345
No description available

WB:WBGene00173068	21ur-7780
No description available

WB:WBGene00173069	21ur-11494
No description available

WB:WBGene00173070	21ur-9559
No description available

WB:WBGene00173071	21ur-7141
No description available

WB:WBGene00173072	21ur-8484
No description available

WB:WBGene00173073	21ur-13623
No description available

WB:WBGene00173074	21ur-10697
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00173075	21ur-14374
No description available

WB:WBGene00173076	21ur-6062
No description available

WB:WBGene00173077	21ur-7162
No description available

WB:WBGene00173078	21ur-9104
No description available

WB:WBGene00173079	21ur-9295
No description available

WB:WBGene00173080	21ur-13636
No description available

WB:WBGene00173081	21ur-13584
No description available

WB:WBGene00173082	21ur-6694
No description available

WB:WBGene00173083	21ur-15599
No description available

WB:WBGene00173084	21ur-13520
No description available

WB:WBGene00173085	21ur-8327
No description available

WB:WBGene00173086	21ur-13371
No description available

WB:WBGene00173087	21ur-15332
No description available

WB:WBGene00173088	21ur-7923
No description available

WB:WBGene00173089	21ur-6129
No description available

WB:WBGene00173090	21ur-10376
No description available

WB:WBGene00173091	21ur-10902
No description available

WB:WBGene00173092	21ur-15381
No description available

WB:WBGene00173093	21ur-11040
No description available

WB:WBGene00173094	21ur-11033
No description available

WB:WBGene00173095	21ur-7072
No description available

WB:WBGene00173096	21ur-10518
No description available

WB:WBGene00173097	21ur-6628
No description available

WB:WBGene00173098	21ur-7704
No description available

WB:WBGene00173099	21ur-11208
No description available

WB:WBGene00173100	21ur-7596
No description available

WB:WBGene00173101	21ur-12383
No description available

WB:WBGene00173102	21ur-13568
No description available

WB:WBGene00173103	21ur-7872
No description available

WB:WBGene00173104	21ur-11713
No description available

WB:WBGene00173105	21ur-10689
No description available

WB:WBGene00173106	21ur-14662
No description available

WB:WBGene00173107	21ur-14256
No description available

WB:WBGene00173108	21ur-11203
No description available

WB:WBGene00173109	21ur-10651
No description available

WB:WBGene00173110	21ur-8881
No description available

WB:WBGene00173111	21ur-14964
No description available

WB:WBGene00173112	21ur-12605
No description available

WB:WBGene00173113	21ur-12989
No description available

WB:WBGene00173114	21ur-13944
No description available

WB:WBGene00173115	21ur-13937
No description available

WB:WBGene00173116	21ur-5895
No description available

WB:WBGene00173117	21ur-11865
No description available

WB:WBGene00173118	21ur-14837
No description available

WB:WBGene00173119	21ur-8158
No description available

WB:WBGene00173120	21ur-9497
No description available

WB:WBGene00173121	21ur-15206
No description available

WB:WBGene00173122	21ur-7724
No description available

WB:WBGene00173123	21ur-9151
No description available

WB:WBGene00173124	21ur-12883
No description available

WB:WBGene00173125	21ur-15548
No description available

WB:WBGene00173126	21ur-11096
No description available

WB:WBGene00173127	21ur-9987
No description available

WB:WBGene00173128	21ur-6986
No description available

WB:WBGene00173129	21ur-7425
No description available

WB:WBGene00173130	21ur-6644
No description available

WB:WBGene00173131	21ur-9597
No description available

WB:WBGene00173132	21ur-8945
No description available

WB:WBGene00173133	21ur-6592
No description available

WB:WBGene00173134	21ur-9712
No description available

WB:WBGene00173135	21ur-7060
No description available

WB:WBGene00173136	21ur-11499
No description available

WB:WBGene00173137	21ur-11503
No description available

WB:WBGene00173138	21ur-8657
No description available

WB:WBGene00173139	21ur-13076
No description available

WB:WBGene00173140	21ur-12027
No description available

WB:WBGene00173141	21ur-6391
No description available

WB:WBGene00173142	21ur-14112
No description available

WB:WBGene00173143	21ur-8822
No description available

WB:WBGene00173144	21ur-5918
No description available

WB:WBGene00173145	21ur-5729
Is affected by daf-2 based on microarray studies.

WB:WBGene00173146	21ur-12631
No description available

WB:WBGene00173147	21ur-15252
No description available

WB:WBGene00173148	21ur-12184
No description available

WB:WBGene00173149	21ur-12435
No description available

WB:WBGene00173150	21ur-6632
No description available

WB:WBGene00173151	21ur-6386
No description available

WB:WBGene00173152	21ur-15131
No description available

WB:WBGene00173153	21ur-8058
No description available

WB:WBGene00173154	21ur-11404
No description available

WB:WBGene00173155	21ur-12353
No description available

WB:WBGene00173156	21ur-9416
No description available

WB:WBGene00173157	21ur-9290
No description available

WB:WBGene00173158	21ur-5558
No description available

WB:WBGene00173159	21ur-6194
No description available

WB:WBGene00173160	21ur-9061
No description available

WB:WBGene00173161	21ur-14234
No description available

WB:WBGene00173162	21ur-15041
No description available

WB:WBGene00173163	21ur-14444
No description available

WB:WBGene00173164	21ur-13983
No description available

WB:WBGene00173165	21ur-7837
No description available

WB:WBGene00173166	21ur-13794
No description available

WB:WBGene00173167	21ur-9775
No description available

WB:WBGene00173168	21ur-12110
No description available

WB:WBGene00173169	21ur-9077
No description available

WB:WBGene00173170	21ur-14615
No description available

WB:WBGene00173171	21ur-6389
No description available

WB:WBGene00173172	21ur-13976
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00173173	21ur-14932
No description available

WB:WBGene00173174	21ur-14232
No description available

WB:WBGene00173175	21ur-7177
No description available

WB:WBGene00173176	21ur-6203
No description available

WB:WBGene00173177	21ur-13732
No description available

WB:WBGene00173178	21ur-9525
No description available

WB:WBGene00173179	21ur-7684
No description available

WB:WBGene00173180	21ur-10635
No description available

WB:WBGene00173181	21ur-14942
No description available

WB:WBGene00173182	21ur-14898
No description available

WB:WBGene00173183	21ur-14177
No description available

WB:WBGene00173184	21ur-7405
No description available

WB:WBGene00173185	21ur-7009
No description available

WB:WBGene00173186	21ur-5874
No description available

WB:WBGene00173187	21ur-9744
No description available

WB:WBGene00173188	21ur-7501
No description available

WB:WBGene00173189	21ur-14422
No description available

WB:WBGene00173190	21ur-13878
No description available

WB:WBGene00173191	21ur-8071
No description available

WB:WBGene00173192	21ur-15627
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173193	21ur-14936
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00173194	21ur-9374
No description available

WB:WBGene00173195	21ur-12717
No description available

WB:WBGene00173196	21ur-14634
No description available

WB:WBGene00173197	21ur-5457
No description available

WB:WBGene00173198	21ur-9574
No description available

WB:WBGene00173199	21ur-10638
No description available

WB:WBGene00173200	21ur-7556
No description available

WB:WBGene00173201	21ur-13139
No description available

WB:WBGene00173202	21ur-6810
No description available

WB:WBGene00173203	21ur-12975
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173204	21ur-7031
No description available

WB:WBGene00173205	21ur-5664
No description available

WB:WBGene00173206	21ur-9640
No description available

WB:WBGene00173207	21ur-6994
No description available

WB:WBGene00173208	21ur-11955
No description available

WB:WBGene00173209	21ur-6603
No description available

WB:WBGene00173210	21ur-11765
No description available

WB:WBGene00173211	21ur-12934
No description available

WB:WBGene00173212	21ur-12857
No description available

WB:WBGene00173213	21ur-8177
No description available

WB:WBGene00173214	21ur-7512
No description available

WB:WBGene00173215	21ur-6126
No description available

WB:WBGene00173216	21ur-14408
No description available

WB:WBGene00173217	21ur-13602
No description available

WB:WBGene00173218	21ur-9224
No description available

WB:WBGene00173219	21ur-8274
No description available

WB:WBGene00173220	21ur-11750
No description available

WB:WBGene00173221	21ur-9766
No description available

WB:WBGene00173222	21ur-5776
No description available

WB:WBGene00173223	21ur-11563
No description available

WB:WBGene00173224	21ur-11410
No description available

WB:WBGene00173225	21ur-8813
No description available

WB:WBGene00173226	21ur-7952
No description available

WB:WBGene00173227	21ur-13196
No description available

WB:WBGene00173228	21ur-10434
No description available

WB:WBGene00173229	21ur-14060
No description available

WB:WBGene00173230	21ur-6569
No description available

WB:WBGene00173231	21ur-11565
No description available

WB:WBGene00173232	21ur-8592
No description available

WB:WBGene00173233	21ur-6562
No description available

WB:WBGene00173234	21ur-5859
No description available

WB:WBGene00173235	21ur-12042
No description available

WB:WBGene00173236	21ur-12870
No description available

WB:WBGene00173237	21ur-13609
No description available

WB:WBGene00173238	21ur-14920
No description available

WB:WBGene00173239	21ur-8935
No description available

WB:WBGene00173240	21ur-12160
No description available

WB:WBGene00173241	21ur-13413
No description available

WB:WBGene00173242	21ur-6710
No description available

WB:WBGene00173243	21ur-9469
No description available

WB:WBGene00173244	21ur-8108
No description available

WB:WBGene00173245	21ur-13884
No description available

WB:WBGene00173246	21ur-8554
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00173247	21ur-15498
No description available

WB:WBGene00173248	21ur-14745
No description available

WB:WBGene00173249	21ur-15611
No description available

WB:WBGene00173250	21ur-7494
No description available

WB:WBGene00173251	21ur-10980
No description available

WB:WBGene00173252	21ur-8296
No description available

WB:WBGene00173253	21ur-11240
No description available

WB:WBGene00173254	21ur-9349
No description available

WB:WBGene00173255	21ur-12683
No description available

WB:WBGene00173256	21ur-15271
No description available

WB:WBGene00173257	21ur-11112
No description available

WB:WBGene00173258	21ur-7392
No description available

WB:WBGene00173259	21ur-8694
No description available

WB:WBGene00173260	21ur-11822
No description available

WB:WBGene00173261	21ur-8402
No description available

WB:WBGene00173262	21ur-12406
No description available

WB:WBGene00173263	21ur-15608
No description available

WB:WBGene00173264	21ur-10276
No description available

WB:WBGene00173265	21ur-14263
No description available

WB:WBGene00173266	21ur-8083
No description available

WB:WBGene00173267	21ur-10703
No description available

WB:WBGene00173268	21ur-6837
No description available

WB:WBGene00173269	21ur-6423
No description available

WB:WBGene00173270	21ur-7377
No description available

WB:WBGene00173271	21ur-14439
No description available

WB:WBGene00173272	21ur-6188
No description available

WB:WBGene00173273	21ur-8377
No description available

WB:WBGene00173274	21ur-14572
No description available

WB:WBGene00173275	21ur-6271
No description available

WB:WBGene00173276	21ur-6060
No description available

WB:WBGene00173277	21ur-15189
No description available

WB:WBGene00173278	21ur-13353
No description available

WB:WBGene00173279	21ur-13083
No description available

WB:WBGene00173280	21ur-10604
No description available

WB:WBGene00173281	21ur-11193
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173282	21ur-14507
No description available

WB:WBGene00173283	21ur-7228
No description available

WB:WBGene00173284	21ur-9251
No description available

WB:WBGene00173285	21ur-13598
No description available

WB:WBGene00173286	21ur-6487
No description available

WB:WBGene00173287	21ur-6462
No description available

WB:WBGene00173288	21ur-15451
No description available

WB:WBGene00173289	21ur-6468
No description available

WB:WBGene00173290	21ur-13508
No description available

WB:WBGene00173291	21ur-12325
No description available

WB:WBGene00173292	21ur-7346
No description available

WB:WBGene00173293	21ur-6196
No description available

WB:WBGene00173294	21ur-10653
Is affected by wdr-5.1 based on RNA-seq studies.

WB:WBGene00173295	21ur-12503
No description available

WB:WBGene00173296	21ur-13299
No description available

WB:WBGene00173297	21ur-13779
No description available

WB:WBGene00173298	21ur-13032
No description available

WB:WBGene00173299	21ur-14442
No description available

WB:WBGene00173300	21ur-9457
No description available

WB:WBGene00173301	21ur-5541
No description available

WB:WBGene00173302	21ur-11686
No description available

WB:WBGene00173303	21ur-14797
No description available

WB:WBGene00173304	21ur-8966
No description available

WB:WBGene00173305	21ur-9543
No description available

WB:WBGene00173306	21ur-12954
No description available

WB:WBGene00173307	21ur-15500
No description available

WB:WBGene00173308	21ur-8666
No description available

WB:WBGene00173309	21ur-13501
No description available

WB:WBGene00173310	21ur-5881
No description available

WB:WBGene00173311	21ur-7084
No description available

WB:WBGene00173312	21ur-10757
No description available

WB:WBGene00173313	21ur-7119
No description available

WB:WBGene00173314	21ur-11968
No description available

WB:WBGene00173315	21ur-7423
No description available

WB:WBGene00173316	21ur-12929
No description available

WB:WBGene00173317	21ur-8951
No description available

WB:WBGene00173318	21ur-11986
No description available

WB:WBGene00173319	21ur-6726
No description available

WB:WBGene00173320	21ur-12818
No description available

WB:WBGene00173321	21ur-7089
No description available

WB:WBGene00173322	21ur-5471
No description available

WB:WBGene00173323	21ur-10481
No description available

WB:WBGene00173324	21ur-9885
No description available

WB:WBGene00173325	21ur-7733
No description available

WB:WBGene00173326	21ur-12345
No description available

WB:WBGene00173327	21ur-14689
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00173328	21ur-5485
No description available

WB:WBGene00173329	21ur-7856
No description available

WB:WBGene00173330	21ur-11731
No description available

WB:WBGene00173331	21ur-9656
No description available

WB:WBGene00173332	21ur-8901
No description available

WB:WBGene00173333	21ur-14790
No description available

WB:WBGene00173334	21ur-11136
No description available

WB:WBGene00173335	21ur-10421
No description available

WB:WBGene00173336	21ur-10895
No description available

WB:WBGene00173337	21ur-14376
No description available

WB:WBGene00173338	21ur-14287
No description available

WB:WBGene00173339	21ur-9981
No description available

WB:WBGene00173340	21ur-10565
No description available

WB:WBGene00173341	21ur-13829
No description available

WB:WBGene00173342	21ur-7053
No description available

WB:WBGene00173343	21ur-11013
No description available

WB:WBGene00173344	21ur-11932
No description available

WB:WBGene00173345	21ur-12912
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173346	21ur-15196
No description available

WB:WBGene00173347	21ur-14755
No description available

WB:WBGene00173348	21ur-11924
No description available

WB:WBGene00173349	21ur-11692
No description available

WB:WBGene00173350	21ur-9854
No description available

WB:WBGene00173351	21ur-5681
No description available

WB:WBGene00173352	21ur-8325
No description available

WB:WBGene00173353	21ur-10885
No description available

WB:WBGene00173354	21ur-14708
No description available

WB:WBGene00173355	21ur-8685
No description available

WB:WBGene00173356	21ur-7261
No description available

WB:WBGene00173357	21ur-13117
No description available

WB:WBGene00173358	21ur-7894
No description available

WB:WBGene00173359	21ur-7755
No description available

WB:WBGene00173360	21ur-12231
No description available

WB:WBGene00173361	21ur-6457
No description available

WB:WBGene00173362	21ur-6175
No description available

WB:WBGene00173363	21ur-10156
No description available

WB:WBGene00173364	21ur-9475
No description available

WB:WBGene00173365	21ur-6660
No description available

WB:WBGene00173366	21ur-12481
No description available

WB:WBGene00173367	21ur-15169
No description available

WB:WBGene00173368	21ur-7183
No description available

WB:WBGene00173369	21ur-15390
No description available

WB:WBGene00173370	21ur-9989
No description available

WB:WBGene00173371	21ur-12804
No description available

WB:WBGene00173372	21ur-9894
No description available

WB:WBGene00173373	21ur-10176
No description available

WB:WBGene00173374	21ur-9881
No description available

WB:WBGene00173375	21ur-9310
No description available

WB:WBGene00173376	21ur-11313
No description available

WB:WBGene00173377	21ur-7284
No description available

WB:WBGene00173378	21ur-13952
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00173379	21ur-6805
No description available

WB:WBGene00173380	21ur-10357
No description available

WB:WBGene00173381	21ur-11376
No description available

WB:WBGene00173382	21ur-15352
No description available

WB:WBGene00173383	21ur-7779
No description available

WB:WBGene00173384	21ur-14106
No description available

WB:WBGene00173385	21ur-12869
No description available

WB:WBGene00173386	21ur-8721
No description available

WB:WBGene00173387	21ur-9810
No description available

WB:WBGene00173388	21ur-10766
No description available

WB:WBGene00173389	21ur-12463
No description available

WB:WBGene00173390	21ur-7263
No description available

WB:WBGene00173391	21ur-8442
No description available

WB:WBGene00173392	21ur-6553
No description available

WB:WBGene00173393	21ur-11647
No description available

WB:WBGene00173394	21ur-8115
No description available

WB:WBGene00173395	21ur-12588
No description available

WB:WBGene00173396	21ur-14504
No description available

WB:WBGene00173397	21ur-11996
No description available

WB:WBGene00173398	21ur-10752
No description available

WB:WBGene00173399	21ur-10607
No description available

WB:WBGene00173400	21ur-8473
No description available

WB:WBGene00173401	21ur-6441
No description available

WB:WBGene00173402	21ur-6413
No description available

WB:WBGene00173403	21ur-14245
No description available

WB:WBGene00173404	21ur-14980
No description available

WB:WBGene00173405	21ur-10029
No description available

WB:WBGene00173406	21ur-8775
No description available

WB:WBGene00173407	21ur-10144
No description available

WB:WBGene00173408	21ur-5946
No description available

WB:WBGene00173409	21ur-8974
No description available

WB:WBGene00173410	21ur-13490
No description available

WB:WBGene00173411	21ur-13426
No description available

WB:WBGene00173412	21ur-14640
No description available

WB:WBGene00173413	21ur-8609
No description available

WB:WBGene00173414	21ur-13288
No description available

WB:WBGene00173415	21ur-15702
No description available

WB:WBGene00173416	21ur-13797
No description available

WB:WBGene00173417	21ur-11729
Is affected by hmg-3 and spt-16 based on RNA-seq studies.

WB:WBGene00173418	21ur-12449
No description available

WB:WBGene00173419	21ur-6956
No description available

WB:WBGene00173420	21ur-9898
No description available

WB:WBGene00173421	21ur-5922
No description available

WB:WBGene00173422	21ur-12459
No description available

WB:WBGene00173423	21ur-9961
No description available

WB:WBGene00173424	21ur-8537
No description available

WB:WBGene00173425	21ur-12519
No description available

WB:WBGene00173426	21ur-13556
No description available

WB:WBGene00173427	21ur-11743
No description available

WB:WBGene00173428	21ur-14067
No description available

WB:WBGene00173429	21ur-12267
No description available

WB:WBGene00173430	21ur-14561
No description available

WB:WBGene00173431	21ur-8304
No description available

WB:WBGene00173432	21ur-13768
No description available

WB:WBGene00173433	21ur-9173
No description available

WB:WBGene00173434	21ur-10857
No description available

WB:WBGene00173435	21ur-11464
No description available

WB:WBGene00173436	21ur-10663
No description available

WB:WBGene00173437	21ur-8255
No description available

WB:WBGene00173438	21ur-7151
No description available

WB:WBGene00173439	21ur-7098
No description available

WB:WBGene00173440	21ur-15106
No description available

WB:WBGene00173441	21ur-6949
No description available

WB:WBGene00173442	21ur-8906
No description available

WB:WBGene00173443	21ur-9212
No description available

WB:WBGene00173444	21ur-9068
No description available

WB:WBGene00173445	21ur-8281
No description available

WB:WBGene00173446	21ur-9431
No description available

WB:WBGene00173447	21ur-12495
No description available

WB:WBGene00173448	21ur-12682
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173449	21ur-13955
No description available

WB:WBGene00173450	21ur-8635
No description available

WB:WBGene00173451	21ur-10745
No description available

WB:WBGene00173452	21ur-11872
No description available

WB:WBGene00173453	21ur-13785
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173454	21ur-15677
No description available

WB:WBGene00173455	21ur-14384
No description available

WB:WBGene00173456	21ur-10234
No description available

WB:WBGene00173457	21ur-7771
No description available

WB:WBGene00173458	21ur-13130
No description available

WB:WBGene00173459	21ur-7307
No description available

WB:WBGene00173460	21ur-6133
No description available

WB:WBGene00173461	21ur-8742
No description available

WB:WBGene00173462	21ur-9016
No description available

WB:WBGene00173463	21ur-6106
No description available

WB:WBGene00173464	21ur-6306
No description available

WB:WBGene00173465	21ur-13162
No description available

WB:WBGene00173466	21ur-9991
No description available

WB:WBGene00173467	21ur-12121
No description available

WB:WBGene00173468	21ur-13445
No description available

WB:WBGene00173469	21ur-6532
No description available

WB:WBGene00173470	21ur-14472
No description available

WB:WBGene00173471	21ur-12627
No description available

WB:WBGene00173472	21ur-11947
No description available

WB:WBGene00173473	21ur-13171
No description available

WB:WBGene00173474	21ur-15582
No description available

WB:WBGene00173475	21ur-6832
No description available

WB:WBGene00173476	21ur-11484
No description available

WB:WBGene00173477	21ur-9725
No description available

WB:WBGene00173478	21ur-10478
No description available

WB:WBGene00173480	21ur-7465
No description available

WB:WBGene00173481	21ur-5645
No description available

WB:WBGene00173482	21ur-9618
No description available

WB:WBGene00173483	21ur-7026
No description available

WB:WBGene00173484	21ur-10167
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00173485	21ur-13166
No description available

WB:WBGene00173486	21ur-11101
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173487	21ur-7710
No description available

WB:WBGene00173488	21ur-6884
No description available

WB:WBGene00173489	21ur-9227
No description available

WB:WBGene00173490	21ur-10085
No description available

WB:WBGene00173491	21ur-6926
No description available

WB:WBGene00173492	21ur-9575
No description available

WB:WBGene00173493	21ur-7548
No description available

WB:WBGene00173494	21ur-9409
No description available

WB:WBGene00173495	21ur-15290
No description available

WB:WBGene00173496	21ur-8206
No description available

WB:WBGene00173497	21ur-15685
No description available

WB:WBGene00173498	21ur-11188
No description available

WB:WBGene00173499	21ur-9736
No description available

WB:WBGene00173500	21ur-8526
No description available

WB:WBGene00173501	21ur-11329
No description available

WB:WBGene00173502	21ur-11586
No description available

WB:WBGene00173503	21ur-11155
No description available

WB:WBGene00173504	21ur-7019
No description available

WB:WBGene00173505	21ur-15575
Is affected by chd-3; let-418; and smn-1 based on RNA-seq studies.

WB:WBGene00173506	21ur-9879
No description available

WB:WBGene00173507	21ur-9246
No description available

WB:WBGene00173508	21ur-14916
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00173509	21ur-15476
No description available

WB:WBGene00173510	21ur-15087
No description available

WB:WBGene00173511	21ur-9423
No description available

WB:WBGene00173512	21ur-12188
No description available

WB:WBGene00173513	21ur-7470
No description available

WB:WBGene00173514	21ur-13862
No description available

WB:WBGene00173515	21ur-11346
No description available

WB:WBGene00173516	21ur-14736
No description available

WB:WBGene00173517	21ur-9055
No description available

WB:WBGene00173518	21ur-8734
No description available

WB:WBGene00173519	21ur-11171
No description available

WB:WBGene00173520	21ur-10870
No description available

WB:WBGene00173521	21ur-12542
No description available

WB:WBGene00173522	21ur-14977
No description available

WB:WBGene00173523	21ur-7061
No description available

WB:WBGene00173524	21ur-11841
No description available

WB:WBGene00173525	21ur-6228
No description available

WB:WBGene00173526	21ur-13279
No description available

WB:WBGene00173527	21ur-6978
No description available

WB:WBGene00173528	21ur-8224
No description available

WB:WBGene00173529	21ur-7079
No description available

WB:WBGene00173530	21ur-12896
No description available

WB:WBGene00173531	21ur-13481
No description available

WB:WBGene00173532	21ur-12016
No description available

WB:WBGene00173533	21ur-11971
No description available

WB:WBGene00173534	21ur-14956
No description available

WB:WBGene00173535	21ur-8007
No description available

WB:WBGene00173536	21ur-6559
No description available

WB:WBGene00173537	21ur-14396
No description available

WB:WBGene00173538	21ur-13820
No description available

WB:WBGene00173539	21ur-5459
No description available

WB:WBGene00173540	21ur-9331
No description available

WB:WBGene00173541	21ur-6251
No description available

WB:WBGene00173542	21ur-7915
No description available

WB:WBGene00173543	21ur-15220
No description available

WB:WBGene00173544	21ur-8862
No description available

WB:WBGene00173545	21ur-13017
No description available

WB:WBGene00173546	21ur-11411
No description available

WB:WBGene00173547	21ur-10527
No description available

WB:WBGene00173548	21ur-9848
No description available

WB:WBGene00173550	21ur-10059
No description available

WB:WBGene00173551	21ur-12984
No description available

WB:WBGene00173552	21ur-15557
No description available

WB:WBGene00173553	21ur-14929
No description available

WB:WBGene00173554	21ur-11904
No description available

WB:WBGene00173555	21ur-12501
No description available

WB:WBGene00173556	21ur-9047
No description available

WB:WBGene00173557	21ur-12229
No description available

WB:WBGene00173558	21ur-13065
No description available

WB:WBGene00173559	21ur-7842
No description available

WB:WBGene00173560	21ur-15550
No description available

WB:WBGene00173561	21ur-14479
No description available

WB:WBGene00173562	21ur-6848
No description available

WB:WBGene00173563	21ur-9169
No description available

WB:WBGene00173564	21ur-12095
No description available

WB:WBGene00173565	21ur-9186
No description available

WB:WBGene00173566	21ur-7748
No description available

WB:WBGene00173567	21ur-6985
No description available

WB:WBGene00173568	21ur-11815
No description available

WB:WBGene00173569	21ur-13439
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173570	21ur-7666
No description available

WB:WBGene00173571	21ur-9257
No description available

WB:WBGene00173572	21ur-12665
No description available

WB:WBGene00173573	21ur-13471
No description available

WB:WBGene00173574	21ur-9856
No description available

WB:WBGene00173575	21ur-11386
No description available

WB:WBGene00173576	21ur-11836
No description available

WB:WBGene00173577	21ur-8421
No description available

WB:WBGene00173578	21ur-15414
No description available

WB:WBGene00173579	21ur-6331
No description available

WB:WBGene00173580	21ur-8728
No description available

WB:WBGene00173581	21ur-8562
No description available

WB:WBGene00173582	21ur-9971
No description available

WB:WBGene00173583	21ur-10775
No description available

WB:WBGene00173584	21ur-14990
No description available

WB:WBGene00173585	21ur-14551
No description available

WB:WBGene00173586	21ur-14365
Is affected by eat-2 based on microarray studies.

WB:WBGene00173587	21ur-13833
No description available

WB:WBGene00173588	21ur-13757
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00173589	21ur-5494
No description available

WB:WBGene00173590	21ur-13873
No description available

WB:WBGene00173591	21ur-12404
No description available

WB:WBGene00173592	21ur-13448
No description available

WB:WBGene00173593	21ur-6775
No description available

WB:WBGene00173594	21ur-12103
No description available

WB:WBGene00173595	21ur-6470
No description available

WB:WBGene00173596	21ur-7247
No description available

WB:WBGene00173597	21ur-8797
No description available

WB:WBGene00173598	21ur-11159
No description available

WB:WBGene00173599	21ur-13048
No description available

WB:WBGene00173600	21ur-6490
No description available

WB:WBGene00173601	21ur-11938
No description available

WB:WBGene00173602	21ur-14538
No description available

WB:WBGene00173603	21ur-6238
No description available

WB:WBGene00173604	21ur-12470
No description available

WB:WBGene00173605	21ur-12879
No description available

WB:WBGene00173606	21ur-14178
No description available

WB:WBGene00173607	21ur-13391
No description available

WB:WBGene00173608	21ur-5766
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173609	21ur-12358
No description available

WB:WBGene00173610	21ur-5518
No description available

WB:WBGene00173611	21ur-13365
No description available

WB:WBGene00173612	21ur-9176
No description available

WB:WBGene00173613	21ur-7048
No description available

WB:WBGene00173614	21ur-7499
No description available

WB:WBGene00173615	21ur-12311
No description available

WB:WBGene00173616	21ur-10356
No description available

WB:WBGene00173617	21ur-14494
No description available

WB:WBGene00173618	21ur-12994
No description available

WB:WBGene00173619	21ur-6760
No description available

WB:WBGene00173620	21ur-10992
No description available

WB:WBGene00173621	21ur-7769
No description available

WB:WBGene00173622	21ur-11295
No description available

WB:WBGene00173623	21ur-15628
No description available

WB:WBGene00173624	21ur-13156
No description available

WB:WBGene00173625	21ur-14270
No description available

WB:WBGene00173626	21ur-7675
No description available

WB:WBGene00173627	21ur-5838
No description available

WB:WBGene00173628	21ur-13319
No description available

WB:WBGene00173629	21ur-14306
No description available

WB:WBGene00173630	21ur-7877
No description available

WB:WBGene00173631	21ur-8000
No description available

WB:WBGene00173632	21ur-15265
No description available

WB:WBGene00173633	21ur-9162
No description available

WB:WBGene00173634	21ur-8144
No description available

WB:WBGene00173635	21ur-13316
No description available

WB:WBGene00173636	21ur-14025
No description available

WB:WBGene00173637	21ur-10052
No description available

WB:WBGene00173638	21ur-12415
No description available

WB:WBGene00173639	21ur-14216
No description available

WB:WBGene00173640	21ur-12220
No description available

WB:WBGene00173641	21ur-9683
No description available

WB:WBGene00173642	21ur-10096
No description available

WB:WBGene00173643	21ur-6756
No description available

WB:WBGene00173644	21ur-12882
No description available

WB:WBGene00173645	21ur-12532
No description available

WB:WBGene00173646	21ur-12567
No description available

WB:WBGene00173647	21ur-5572
No description available

WB:WBGene00173648	21ur-15164
No description available

WB:WBGene00173649	21ur-14465
No description available

WB:WBGene00173650	21ur-10106
No description available

WB:WBGene00173651	21ur-12139
No description available

WB:WBGene00173652	21ur-8450
No description available

WB:WBGene00173653	21ur-11677
No description available

WB:WBGene00173654	21ur-14018
No description available

WB:WBGene00173655	21ur-12845
No description available

WB:WBGene00173656	21ur-13335
No description available

WB:WBGene00173657	21ur-11247
Is affected by daf-2 based on microarray studies.

WB:WBGene00173658	21ur-6325
No description available

WB:WBGene00173659	21ur-13665
No description available

WB:WBGene00173660	21ur-14608
No description available

WB:WBGene00173661	21ur-9826
No description available

WB:WBGene00173662	21ur-11086
No description available

WB:WBGene00173663	21ur-9869
No description available

WB:WBGene00173664	21ur-14289
No description available

WB:WBGene00173665	21ur-12335
No description available

WB:WBGene00173666	21ur-13214
No description available

WB:WBGene00173667	21ur-15594
No description available

WB:WBGene00173668	21ur-9954
No description available

WB:WBGene00173669	21ur-13762
No description available

WB:WBGene00173670	21ur-13733
No description available

WB:WBGene00173671	21ur-10223
No description available

WB:WBGene00173672	21ur-13257
No description available

WB:WBGene00173673	21ur-8838
No description available

WB:WBGene00173674	21ur-15399
No description available

WB:WBGene00173675	21ur-6110
No description available

WB:WBGene00173676	21ur-5954
No description available

WB:WBGene00173677	21ur-14778
No description available

WB:WBGene00173678	21ur-9817
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173679	21ur-8636
No description available

WB:WBGene00173680	21ur-5825
No description available

WB:WBGene00173681	21ur-15427
No description available

WB:WBGene00173682	21ur-12107
No description available

WB:WBGene00173683	21ur-14029
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00173684	21ur-11524
No description available

WB:WBGene00173685	21ur-9236
No description available

WB:WBGene00173686	21ur-5632
No description available

WB:WBGene00173687	21ur-7867
No description available

WB:WBGene00173688	21ur-12008
No description available

WB:WBGene00173689	21ur-14430
No description available

WB:WBGene00173690	21ur-12340
No description available

WB:WBGene00173691	21ur-7415
No description available

WB:WBGene00173692	21ur-6434
No description available

WB:WBGene00173693	21ur-14783
No description available

WB:WBGene00173694	21ur-8515
No description available

WB:WBGene00173695	21ur-11557
No description available

WB:WBGene00173696	21ur-7963
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00173697	21ur-10316
No description available

WB:WBGene00173698	21ur-15589
No description available

WB:WBGene00173699	21ur-14425
No description available

WB:WBGene00173700	21ur-6915
No description available

WB:WBGene00173701	21ur-12176
No description available

WB:WBGene00173702	21ur-6079
No description available

WB:WBGene00173703	21ur-13007
No description available

WB:WBGene00173704	21ur-9188
No description available

WB:WBGene00173705	21ur-6667
No description available

WB:WBGene00173706	21ur-11858
No description available

WB:WBGene00173707	21ur-13222
No description available

WB:WBGene00173708	21ur-6790
No description available

WB:WBGene00173709	21ur-6552
No description available

WB:WBGene00173710	21ur-15562
No description available

WB:WBGene00173711	21ur-6208
No description available

WB:WBGene00173712	21ur-12064
No description available

WB:WBGene00173713	21ur-11142
No description available

WB:WBGene00173714	21ur-14086
No description available

WB:WBGene00173715	21ur-14031
No description available

WB:WBGene00173716	21ur-11469
No description available

WB:WBGene00173717	21ur-7287
No description available

WB:WBGene00173718	21ur-6783
No description available

WB:WBGene00173719	21ur-10411
No description available

WB:WBGene00173720	21ur-11052
No description available

WB:WBGene00173721	21ur-12236
No description available

WB:WBGene00173722	21ur-6263
No description available

WB:WBGene00173723	21ur-14137
No description available

WB:WBGene00173724	21ur-12255
No description available

WB:WBGene00173725	21ur-12811
No description available

WB:WBGene00173726	21ur-10066
No description available

WB:WBGene00173727	21ur-6322
No description available

WB:WBGene00173728	21ur-7337
No description available

WB:WBGene00173729	21ur-7170
No description available

WB:WBGene00173730	21ur-10714
No description available

WB:WBGene00173731	21ur-10833
No description available

WB:WBGene00173732	21ur-13098
No description available

WB:WBGene00173733	21ur-6681
No description available

WB:WBGene00173734	21ur-12725
No description available

WB:WBGene00173735	21ur-12790
No description available

WB:WBGene00173736	21ur-13206
No description available

WB:WBGene00173737	21ur-13465
No description available

WB:WBGene00173738	21ur-15171
No description available

WB:WBGene00173739	21ur-6819
No description available

WB:WBGene00173740	21ur-12202
No description available

WB:WBGene00173741	21ur-5604
No description available

WB:WBGene00173742	21ur-11787
No description available

WB:WBGene00173743	21ur-14322
No description available

WB:WBGene00173744	21ur-6005
No description available

WB:WBGene00173745	21ur-9116
No description available

WB:WBGene00173746	21ur-6815
No description available

WB:WBGene00173747	21ur-8628
No description available

WB:WBGene00173748	21ur-9107
No description available

WB:WBGene00173749	21ur-10034
No description available

WB:WBGene00173750	21ur-12093
No description available

WB:WBGene00173751	21ur-13565
No description available

WB:WBGene00173752	21ur-8792
No description available

WB:WBGene00173753	21ur-10125
No description available

WB:WBGene00173754	21ur-10724
No description available

WB:WBGene00173755	21ur-12293
No description available

WB:WBGene00173756	21ur-13300
No description available

WB:WBGene00173757	21ur-13219
No description available

WB:WBGene00173758	21ur-6703
No description available

WB:WBGene00173759	21ur-10791
No description available

WB:WBGene00173760	21ur-8805
No description available

WB:WBGene00173761	21ur-11683
No description available

WB:WBGene00173762	21ur-13841
No description available

WB:WBGene00173763	21ur-5608
Is affected by daf-2 based on microarray studies.

WB:WBGene00173764	21ur-14209
No description available

WB:WBGene00173765	21ur-6461
No description available

WB:WBGene00173766	21ur-10725
No description available

WB:WBGene00173767	21ur-8419
No description available

WB:WBGene00173768	21ur-10460
No description available

WB:WBGene00173769	21ur-9205
No description available

WB:WBGene00173770	21ur-13869
No description available

WB:WBGene00173771	21ur-6544
No description available

WB:WBGene00173772	21ur-6988
No description available

WB:WBGene00173773	21ur-15472
No description available

WB:WBGene00173774	21ur-8301
No description available

WB:WBGene00173775	21ur-7234
No description available

WB:WBGene00173776	21ur-6808
No description available

WB:WBGene00173777	21ur-9438
No description available

WB:WBGene00173778	21ur-9441
No description available

WB:WBGene00173779	21ur-5589
Is affected by daf-2 based on microarray studies.

WB:WBGene00173780	21ur-5759
No description available

WB:WBGene00173781	21ur-12697
No description available

WB:WBGene00173782	21ur-7136
No description available

WB:WBGene00173783	21ur-10559
No description available

WB:WBGene00173784	21ur-15680
No description available

WB:WBGene00173785	21ur-6130
No description available

WB:WBGene00173786	21ur-10493
No description available

WB:WBGene00173787	21ur-9347
No description available

WB:WBGene00173788	21ur-10110
No description available

WB:WBGene00173789	21ur-13394
No description available

WB:WBGene00173790	21ur-15055
No description available

WB:WBGene00173791	21ur-14372
No description available

WB:WBGene00173792	21ur-7891
No description available

WB:WBGene00173793	21ur-7309
No description available

WB:WBGene00173794	21ur-13203
No description available

WB:WBGene00173795	21ur-11293
No description available

WB:WBGene00173796	21ur-13992
No description available

WB:WBGene00173797	21ur-6346
No description available

WB:WBGene00173798	21ur-10540
No description available

WB:WBGene00173799	21ur-10966
No description available

WB:WBGene00173800	21ur-9323
No description available

WB:WBGene00173801	21ur-7766
No description available

WB:WBGene00173802	21ur-10148
No description available

WB:WBGene00173803	21ur-11160
No description available

WB:WBGene00173804	21ur-10549
No description available

WB:WBGene00173805	21ur-7239
No description available

WB:WBGene00173806	21ur-15410
No description available

WB:WBGene00173807	21ur-14382
No description available

WB:WBGene00173808	21ur-12222
No description available

WB:WBGene00173809	21ur-15084
No description available

WB:WBGene00173810	21ur-15050
No description available

WB:WBGene00173811	21ur-8533
No description available

WB:WBGene00173812	21ur-8368
No description available

WB:WBGene00173813	21ur-7012
No description available

WB:WBGene00173814	21ur-12778
No description available

WB:WBGene00173815	21ur-10396
No description available

WB:WBGene00173816	21ur-13546
No description available

WB:WBGene00173817	21ur-14541
No description available

WB:WBGene00173818	21ur-10209
No description available

WB:WBGene00173819	21ur-10070
No description available

WB:WBGene00173820	21ur-7445
No description available

WB:WBGene00173821	21ur-12372
No description available

WB:WBGene00173822	21ur-14809
No description available

WB:WBGene00173823	21ur-11593
No description available

WB:WBGene00173824	21ur-13024
No description available

WB:WBGene00173825	21ur-15564
No description available

WB:WBGene00173826	21ur-14333
No description available

WB:WBGene00173827	21ur-13921
No description available

WB:WBGene00173828	21ur-9945
No description available

WB:WBGene00173829	21ur-10852
No description available

WB:WBGene00173830	21ur-11577
No description available

WB:WBGene00173831	21ur-14765
No description available

WB:WBGene00173832	21ur-11596
No description available

WB:WBGene00173833	21ur-13979
No description available

WB:WBGene00173834	21ur-6924
No description available

WB:WBGene00173835	21ur-10076
No description available

WB:WBGene00173836	21ur-11773
No description available

WB:WBGene00173837	21ur-9521
No description available

WB:WBGene00173838	21ur-14193
No description available

WB:WBGene00173839	21ur-13908
No description available

WB:WBGene00173840	21ur-12243
No description available

WB:WBGene00173841	21ur-14254
No description available

WB:WBGene00173842	21ur-11918
No description available

WB:WBGene00173843	21ur-14293
No description available

WB:WBGene00173844	21ur-6082
No description available

WB:WBGene00173845	21ur-10797
No description available

WB:WBGene00173846	21ur-8148
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00173847	21ur-9966
No description available

WB:WBGene00173848	21ur-15101
No description available

WB:WBGene00173849	21ur-7274
No description available

WB:WBGene00173850	21ur-11748
No description available

WB:WBGene00173851	21ur-13935
No description available

WB:WBGene00173852	21ur-15322
No description available

WB:WBGene00173853	21ur-10898
No description available

WB:WBGene00173854	21ur-6573
No description available

WB:WBGene00173855	21ur-10941
No description available

WB:WBGene00173856	21ur-11127
No description available

WB:WBGene00173857	21ur-5698
No description available

WB:WBGene00173858	21ur-11427
No description available

WB:WBGene00173859	21ur-7384
No description available

WB:WBGene00173860	21ur-11806
No description available

WB:WBGene00173861	21ur-7380
No description available

WB:WBGene00173862	21ur-14097
No description available

WB:WBGene00173863	21ur-14277
No description available

WB:WBGene00173864	21ur-12274
No description available

WB:WBGene00173865	21ur-11612
No description available

WB:WBGene00173866	21ur-15435
No description available

WB:WBGene00173867	21ur-10598
No description available

WB:WBGene00173868	21ur-6045
No description available

WB:WBGene00173869	21ur-13488
No description available

WB:WBGene00173870	21ur-7925
No description available

WB:WBGene00173871	21ur-14352
No description available

WB:WBGene00173872	21ur-6850
No description available

WB:WBGene00173873	21ur-12539
No description available

WB:WBGene00173874	21ur-8156
No description available

WB:WBGene00173875	21ur-10140
No description available

WB:WBGene00173876	21ur-5968
No description available

WB:WBGene00173877	21ur-7440
No description available

WB:WBGene00173878	21ur-12781
No description available

WB:WBGene00173879	21ur-8387
No description available

WB:WBGene00173880	21ur-7198
No description available

WB:WBGene00173881	21ur-9022
No description available

WB:WBGene00173882	21ur-6095
No description available

WB:WBGene00173883	21ur-11357
No description available

WB:WBGene00173884	21ur-15586
No description available

WB:WBGene00173885	21ur-5718
No description available

WB:WBGene00173886	21ur-11231
No description available

WB:WBGene00173887	21ur-6749
No description available

WB:WBGene00173888	21ur-6879
No description available

WB:WBGene00173889	21ur-7134
No description available

WB:WBGene00173890	21ur-7490
No description available

WB:WBGene00173891	21ur-10426
No description available

WB:WBGene00173892	21ur-12411
No description available

WB:WBGene00173893	21ur-14291
No description available

WB:WBGene00173894	21ur-6590
No description available

WB:WBGene00173895	21ur-11292
No description available

WB:WBGene00173896	21ur-5461
No description available

WB:WBGene00173897	21ur-5556
No description available

WB:WBGene00173898	21ur-9512
No description available

WB:WBGene00173899	21ur-15660
No description available

WB:WBGene00173900	21ur-8704
No description available

WB:WBGene00173901	21ur-15503
No description available

WB:WBGene00173902	21ur-6089
No description available

WB:WBGene00173903	21ur-14480
No description available

WB:WBGene00173904	21ur-7400
Is affected by eat-2 based on microarray studies.

WB:WBGene00173905	21ur-13434
No description available

WB:WBGene00173906	21ur-8970
No description available

WB:WBGene00173907	21ur-8415
No description available

WB:WBGene00173908	21ur-8055
No description available

WB:WBGene00173909	21ur-13427
No description available

WB:WBGene00173910	21ur-7369
No description available

WB:WBGene00173911	21ur-10008
No description available

WB:WBGene00173912	21ur-15632
No description available

WB:WBGene00173913	21ur-14901
No description available

WB:WBGene00173914	21ur-9582
No description available

WB:WBGene00173915	21ur-5974
No description available

WB:WBGene00173916	21ur-12150
No description available

WB:WBGene00173917	21ur-6397
No description available

WB:WBGene00173918	21ur-13901
No description available

WB:WBGene00173919	21ur-6363
No description available

WB:WBGene00173920	21ur-8696
Is affected by damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00173921	21ur-11724
No description available

WB:WBGene00173922	21ur-15311
No description available

WB:WBGene00173923	21ur-6479
No description available

WB:WBGene00173924	21ur-12163
No description available

WB:WBGene00173925	21ur-9082
No description available

WB:WBGene00173926	21ur-6835
No description available

WB:WBGene00173927	21ur-11504
No description available

WB:WBGene00173928	21ur-11685
No description available

WB:WBGene00173929	21ur-12396
No description available

WB:WBGene00173930	21ur-12195
No description available

WB:WBGene00173931	21ur-10801
No description available

WB:WBGene00173932	21ur-9385
No description available

WB:WBGene00173933	21ur-11022
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00173934	21ur-14412
No description available

WB:WBGene00173935	21ur-10716
No description available

WB:WBGene00173936	21ur-13339
No description available

WB:WBGene00173937	21ur-7357
No description available

WB:WBGene00173938	21ur-10274
No description available

WB:WBGene00173939	21ur-11215
No description available

WB:WBGene00173940	21ur-7879
No description available

WB:WBGene00173941	21ur-5629
No description available

WB:WBGene00173942	21ur-9153
No description available

WB:WBGene00173943	21ur-9089
No description available

WB:WBGene00173944	21ur-11105
No description available

WB:WBGene00173945	21ur-15133
No description available

WB:WBGene00173946	21ur-15227
No description available

WB:WBGene00173947	21ur-7174
No description available

WB:WBGene00173948	21ur-11181
No description available

WB:WBGene00173949	21ur-10404
No description available

WB:WBGene00173950	21ur-11982
No description available

WB:WBGene00173951	21ur-7280
No description available

WB:WBGene00173952	21ur-9379
No description available

WB:WBGene00173953	21ur-15034
No description available

WB:WBGene00173954	21ur-13522
No description available

WB:WBGene00173955	21ur-8928
No description available

WB:WBGene00173956	21ur-12901
No description available

WB:WBGene00173957	21ur-15523
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00173958	21ur-15160
No description available

WB:WBGene00173959	21ur-10462
No description available

WB:WBGene00173960	21ur-7036
No description available

WB:WBGene00173961	21ur-14691
No description available

WB:WBGene00173962	21ur-14033
No description available

WB:WBGene00173963	21ur-13059
No description available

WB:WBGene00173964	21ur-15250
No description available

WB:WBGene00173965	21ur-15449
No description available

WB:WBGene00173966	21ur-11630
No description available

WB:WBGene00173967	21ur-15268
No description available

WB:WBGene00173968	21ur-13614
No description available

WB:WBGene00173969	21ur-10763
No description available

WB:WBGene00173970	21ur-13972
No description available

WB:WBGene00173971	21ur-8044
No description available

WB:WBGene00173972	21ur-5983
No description available

WB:WBGene00173973	21ur-6801
No description available

WB:WBGene00173974	21ur-6951
No description available

WB:WBGene00173975	21ur-15481
No description available

WB:WBGene00173976	21ur-13747
No description available

WB:WBGene00173977	21ur-11715
No description available

WB:WBGene00173978	21ur-8171
No description available

WB:WBGene00173979	21ur-6857
No description available

WB:WBGene00173980	21ur-15062
No description available

WB:WBGene00173981	21ur-14972
No description available

WB:WBGene00173982	21ur-9602
No description available

WB:WBGene00173983	21ur-11436
No description available

WB:WBGene00173984	21ur-13504
No description available

WB:WBGene00173985	21ur-14455
No description available

WB:WBGene00173986	21ur-6586
No description available

WB:WBGene00173987	21ur-11911
No description available

WB:WBGene00173988	21ur-12968
No description available

WB:WBGene00173989	21ur-5672
No description available

WB:WBGene00173990	21ur-7326
No description available

WB:WBGene00173991	21ur-10062
No description available

WB:WBGene00173992	21ur-6255
No description available

WB:WBGene00173993	21ur-7101
No description available

WB:WBGene00173994	21ur-5622
No description available

WB:WBGene00173995	21ur-15143
No description available

WB:WBGene00173996	21ur-5537
No description available

WB:WBGene00173997	21ur-11545
No description available

WB:WBGene00173998	21ur-14672
No description available

WB:WBGene00173999	21ur-11451
No description available

WB:WBGene00174000	21ur-14367
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174001	21ur-11147
No description available

WB:WBGene00174002	21ur-6611
No description available

WB:WBGene00174003	21ur-6999
No description available

WB:WBGene00174004	21ur-13816
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00174005	21ur-14845
No description available

WB:WBGene00174006	21ur-10824
No description available

WB:WBGene00174007	21ur-9001
No description available

WB:WBGene00174008	21ur-12906
No description available

WB:WBGene00174009	21ur-10265
No description available

WB:WBGene00174010	21ur-9517
No description available

WB:WBGene00174011	21ur-6221
No description available

WB:WBGene00174012	21ur-13420
No description available

WB:WBGene00174013	21ur-7522
No description available

WB:WBGene00174014	21ur-14054
No description available

WB:WBGene00174015	21ur-7741
No description available

WB:WBGene00174016	21ur-7844
No description available

WB:WBGene00174017	21ur-15175
No description available

WB:WBGene00174018	21ur-13674
No description available

WB:WBGene00174019	21ur-9427
No description available

WB:WBGene00174020	21ur-10486
No description available

WB:WBGene00174021	21ur-5639
No description available

WB:WBGene00174022	21ur-6967
No description available

WB:WBGene00174023	21ur-15670
No description available

WB:WBGene00174024	21ur-9142
No description available

WB:WBGene00174025	21ur-10864
No description available

WB:WBGene00174026	21ur-15093
No description available

WB:WBGene00174027	21ur-14651
No description available

WB:WBGene00174028	21ur-6048
No description available

WB:WBGene00174029	21ur-8955
No description available

WB:WBGene00174030	21ur-11853
No description available

WB:WBGene00174031	21ur-10212
No description available

WB:WBGene00174032	21ur-15691
No description available

WB:WBGene00174033	21ur-11420
No description available

WB:WBGene00174034	21ur-5902
No description available

WB:WBGene00174035	21ur-5580
No description available

WB:WBGene00174036	21ur-13512
No description available

WB:WBGene00174037	21ur-10514
No description available

WB:WBGene00174038	21ur-8647
No description available

WB:WBGene00174039	21ur-6597
No description available

WB:WBGene00174040	21ur-6448
No description available

WB:WBGene00174041	21ur-9611
No description available

WB:WBGene00174042	21ur-13715
No description available

WB:WBGene00174043	21ur-15036
No description available

WB:WBGene00174044	21ur-11396
No description available

WB:WBGene00174045	21ur-10365
No description available

WB:WBGene00174046	21ur-9232
No description available

WB:WBGene00174047	21ur-7729
No description available

WB:WBGene00174048	21ur-12824
No description available

WB:WBGene00174049	21ur-15114
No description available

WB:WBGene00174050	21ur-6162
No description available

WB:WBGene00174051	21ur-12585
No description available

WB:WBGene00174052	21ur-7419
No description available

WB:WBGene00174053	21ur-13102
No description available

WB:WBGene00174054	21ur-14780
No description available

WB:WBGene00174055	21ur-5764
No description available

WB:WBGene00174056	21ur-8944
No description available

WB:WBGene00174057	21ur-8578
No description available

WB:WBGene00174058	21ur-7706
No description available

WB:WBGene00174059	21ur-11302
No description available

WB:WBGene00174060	21ur-10950
No description available

WB:WBGene00174061	21ur-8550
No description available

WB:WBGene00174062	21ur-8918
No description available

WB:WBGene00174063	21ur-10185
No description available

WB:WBGene00174064	21ur-10339
No description available

WB:WBGene00174065	21ur-12377
No description available

WB:WBGene00174066	21ur-13594
No description available

WB:WBGene00174067	21ur-6059
No description available

WB:WBGene00174068	21ur-13119
No description available

WB:WBGene00174069	21ur-14632
No description available

WB:WBGene00174070	21ur-8895
No description available

WB:WBGene00174071	21ur-8026
No description available

WB:WBGene00174072	21ur-6090
No description available

WB:WBGene00174073	21ur-12632
No description available

WB:WBGene00174074	21ur-8829
No description available

WB:WBGene00174075	21ur-11790
No description available

WB:WBGene00174076	21ur-15285
No description available

WB:WBGene00174077	21ur-12420
No description available

WB:WBGene00174078	21ur-13880
No description available

WB:WBGene00174079	21ur-13639
No description available

WB:WBGene00174080	21ur-13159
No description available

WB:WBGene00174081	21ur-13949
No description available

WB:WBGene00174082	21ur-6464
No description available

WB:WBGene00174083	21ur-10320
No description available

WB:WBGene00174084	21ur-13378
No description available

WB:WBGene00174085	21ur-7553
No description available

WB:WBGene00174086	21ur-8337
No description available

WB:WBGene00174087	21ur-10658
No description available

WB:WBGene00174088	21ur-14524
No description available

WB:WBGene00174089	21ur-11492
No description available

WB:WBGene00174090	21ur-9590
No description available

WB:WBGene00174091	21ur-11550
No description available

WB:WBGene00174092	21ur-14599
No description available

WB:WBGene00174093	21ur-6680
Is affected by daf-2 based on microarray studies.

WB:WBGene00174094	21ur-14851
No description available

WB:WBGene00174095	21ur-10092
No description available

WB:WBGene00174096	21ur-10327
No description available

WB:WBGene00174097	21ur-13625
No description available

WB:WBGene00174098	21ur-11201
No description available

WB:WBGene00174099	21ur-6216
No description available

WB:WBGene00174100	21ur-5801
No description available

WB:WBGene00174101	21ur-12607
No description available

WB:WBGene00174102	21ur-6277
No description available

WB:WBGene00174103	21ur-10475
No description available

WB:WBGene00174104	21ur-5894
No description available

WB:WBGene00174105	21ur-15430
No description available

WB:WBGene00174106	21ur-12146
No description available

WB:WBGene00174107	21ur-6292
No description available

WB:WBGene00174108	21ur-9795
No description available

WB:WBGene00174109	21ur-5933
No description available

WB:WBGene00174110	21ur-8167
No description available

WB:WBGene00174111	21ur-13189
No description available

WB:WBGene00174112	21ur-5676
No description available

WB:WBGene00174113	21ur-7117
No description available

WB:WBGene00174114	21ur-12756
No description available

WB:WBGene00174115	21ur-8459
No description available

WB:WBGene00174116	21ur-7874
No description available

WB:WBGene00174117	21ur-7947
No description available

WB:WBGene00174118	21ur-6020
No description available

WB:WBGene00174119	21ur-7075
No description available

WB:WBGene00174120	21ur-6030
No description available

WB:WBGene00174121	21ur-12841
No description available

WB:WBGene00174122	21ur-7731
No description available

WB:WBGene00174123	21ur-11447
No description available

WB:WBGene00174124	21ur-14221
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174125	21ur-6473
No description available

WB:WBGene00174126	21ur-10504
No description available

WB:WBGene00174127	21ur-13259
No description available

WB:WBGene00174128	21ur-8604
No description available

WB:WBGene00174129	21ur-10166
No description available

WB:WBGene00174130	21ur-14643
No description available

WB:WBGene00174131	21ur-7782
No description available

WB:WBGene00174132	21ur-6184
No description available

WB:WBGene00174133	21ur-14453
No description available

WB:WBGene00174134	21ur-8093
No description available

WB:WBGene00174135	21ur-7688
No description available

WB:WBGene00174136	21ur-12562
Is affected by daf-2 based on microarray studies.

WB:WBGene00174137	21ur-10115
No description available

WB:WBGene00174138	21ur-11807
No description available

WB:WBGene00174139	21ur-8348
No description available

WB:WBGene00174140	21ur-14582
No description available

WB:WBGene00174141	21ur-11934
No description available

WB:WBGene00174142	21ur-8486
No description available

WB:WBGene00174143	21ur-6685
No description available

WB:WBGene00174144	21ur-7212
No description available

WB:WBGene00174145	21ur-6626
No description available

WB:WBGene00174146	21ur-13180
No description available

WB:WBGene00174147	21ur-15388
No description available

WB:WBGene00174148	21ur-9717
No description available

WB:WBGene00174149	21ur-10601
No description available

WB:WBGene00174150	21ur-12987
No description available

WB:WBGene00174151	21ur-7367
No description available

WB:WBGene00174152	21ur-10132
No description available

WB:WBGene00174153	21ur-12304
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00174154	21ur-15339
No description available

WB:WBGene00174155	21ur-13268
No description available

WB:WBGene00174156	21ur-9113
No description available

WB:WBGene00174157	21ur-7726
No description available

WB:WBGene00174158	21ur-6411
No description available

WB:WBGene00174159	21ur-15649
No description available

WB:WBGene00174160	21ur-10817
No description available

WB:WBGene00174161	21ur-11567
No description available

WB:WBGene00174162	21ur-13630
No description available

WB:WBGene00174163	21ur-11031
No description available

WB:WBGene00174164	21ur-11863
No description available

WB:WBGene00174165	21ur-13582
No description available

WB:WBGene00174166	21ur-7889
No description available

WB:WBGene00174167	21ur-8568
No description available

WB:WBGene00174168	21ur-13960
No description available

WB:WBGene00174169	21ur-8271
No description available

WB:WBGene00174170	21ur-15208
No description available

WB:WBGene00174171	21ur-13681
No description available

WB:WBGene00174172	21ur-12437
No description available

WB:WBGene00174173	21ur-10024
No description available

WB:WBGene00174174	21ur-14591
No description available

WB:WBGene00174175	21ur-6766
No description available

WB:WBGene00174176	21ur-7164
No description available

WB:WBGene00174177	21ur-11753
No description available

WB:WBGene00174178	21ur-11281
No description available

WB:WBGene00174179	21ur-13853
No description available

WB:WBGene00174180	21ur-8820
No description available

WB:WBGene00174181	21ur-7898
No description available

WB:WBGene00174182	21ur-14111
No description available

WB:WBGene00174183	21ur-10202
No description available

WB:WBGene00174184	21ur-11264
No description available

WB:WBGene00174185	21ur-6116
No description available

WB:WBGene00174186	21ur-8292
No description available

WB:WBGene00174187	21ur-9245
No description available

WB:WBGene00174188	21ur-9790
No description available

WB:WBGene00174189	21ur-10225
No description available

WB:WBGene00174190	21ur-13946
No description available

WB:WBGene00174191	21ur-11781
No description available

WB:WBGene00174192	21ur-14087
No description available

WB:WBGene00174193	21ur-11600
No description available

WB:WBGene00174194	21ur-10642
No description available

WB:WBGene00174195	21ur-5505
No description available

WB:WBGene00174196	21ur-8617
No description available

WB:WBGene00174197	21ur-9714
No description available

WB:WBGene00174198	21ur-11987
No description available

WB:WBGene00174199	21ur-12355
No description available

WB:WBGene00174200	21ur-15535
No description available

WB:WBGene00174201	21ur-12765
No description available

WB:WBGene00174202	21ur-15330
No description available

WB:WBGene00174203	21ur-13887
No description available

WB:WBGene00174204	21ur-14930
No description available

WB:WBGene00174205	21ur-13799
No description available

WB:WBGene00174206	21ur-5789
No description available

WB:WBGene00174207	21ur-6634
No description available

WB:WBGene00174208	21ur-8655
No description available

WB:WBGene00174209	21ur-8230
No description available

WB:WBGene00174210	21ur-7074
No description available

WB:WBGene00174211	21ur-15115
No description available

WB:WBGene00174212	21ur-7049
No description available

WB:WBGene00174213	21ur-13385
No description available

WB:WBGene00174214	21ur-14912
No description available

WB:WBGene00174215	21ur-6642
No description available

WB:WBGene00174216	21ur-11098
No description available

WB:WBGene00174217	21ur-11038
No description available

WB:WBGene00174218	21ur-14660
No description available

WB:WBGene00174219	21ur-9207
Is affected by hmg-3; hmg-4; and spt-16 based on RNA-seq studies.

WB:WBGene00174220	21ur-6862
No description available

WB:WBGene00174221	21ur-9631
No description available

WB:WBGene00174222	21ur-9278
No description available

WB:WBGene00174223	21ur-5798
No description available

WB:WBGene00174224	21ur-6944
No description available

WB:WBGene00174225	21ur-10374
No description available

WB:WBGene00174226	21ur-9866
No description available

WB:WBGene00174227	21ur-11206
No description available

WB:WBGene00174228	21ur-9637
No description available

WB:WBGene00174229	21ur-14125
No description available

WB:WBGene00174230	21ur-6291
No description available

WB:WBGene00174231	21ur-10524
No description available

WB:WBGene00174232	21ur-8782
No description available

WB:WBGene00174233	21ur-7789
No description available

WB:WBGene00174234	21ur-8235
No description available

WB:WBGene00174235	21ur-5913
No description available

WB:WBGene00174236	21ur-10531
No description available

WB:WBGene00174237	21ur-6722
No description available

WB:WBGene00174238	21ur-11655
No description available

WB:WBGene00174239	21ur-13277
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174240	21ur-9482
No description available

WB:WBGene00174241	21ur-11018
No description available

WB:WBGene00174242	21ur-9709
No description available

WB:WBGene00174243	21ur-8853
No description available

WB:WBGene00174244	21ur-11258
No description available

WB:WBGene00174245	21ur-14309
No description available

WB:WBGene00174246	21ur-9138
No description available

WB:WBGene00174247	21ur-10302
No description available

WB:WBGene00174248	21ur-8857
No description available

WB:WBGene00174249	21ur-12089
No description available

WB:WBGene00174250	21ur-13124
No description available

WB:WBGene00174251	21ur-15048
No description available

WB:WBGene00174252	21ur-13570
No description available

WB:WBGene00174253	21ur-9622
No description available

WB:WBGene00174254	21ur-6905
No description available

WB:WBGene00174255	21ur-8370
No description available

WB:WBGene00174256	21ur-9286
No description available

WB:WBGene00174257	21ur-5950
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies.

WB:WBGene00174258	21ur-14802
No description available

WB:WBGene00174259	21ur-7900
No description available

WB:WBGene00174260	21ur-10855
No description available

WB:WBGene00174261	21ur-13238
No description available

WB:WBGene00174262	21ur-11091
No description available

WB:WBGene00174263	21ur-13142
No description available

WB:WBGene00174264	21ur-15488
No description available

WB:WBGene00174265	21ur-5651
No description available

WB:WBGene00174266	21ur-13697
No description available

WB:WBGene00174267	21ur-7570
No description available

WB:WBGene00174268	21ur-9258
No description available

WB:WBGene00174269	21ur-5543
No description available

WB:WBGene00174270	21ur-6354
Is affected by emr-1; lem-2; and hpl-2 based on RNA-seq studies.

WB:WBGene00174271	21ur-12673
No description available

WB:WBGene00174272	21ur-7253
No description available

WB:WBGene00174273	21ur-13703
No description available

WB:WBGene00174274	21ur-7580
No description available

WB:WBGene00174275	21ur-14800
No description available

WB:WBGene00174276	21ur-8572
No description available

WB:WBGene00174277	21ur-6104
No description available

WB:WBGene00174278	21ur-13640
No description available

WB:WBGene00174279	21ur-10027
No description available

WB:WBGene00174280	21ur-12920
No description available

WB:WBGene00174281	21ur-14811
No description available

WB:WBGene00174282	21ur-6029
No description available

WB:WBGene00174283	21ur-9996
No description available

WB:WBGene00174284	21ur-14268
No description available

WB:WBGene00174285	21ur-13872
No description available

WB:WBGene00174286	21ur-8318
No description available

WB:WBGene00174287	21ur-7033
No description available

WB:WBGene00174288	21ur-6933
No description available

WB:WBGene00174289	21ur-11345
No description available

WB:WBGene00174290	21ur-15300
No description available

WB:WBGene00174291	21ur-7611
No description available

WB:WBGene00174292	21ur-9480
No description available

WB:WBGene00174293	21ur-12668
No description available

WB:WBGene00174294	21ur-5791
No description available

WB:WBGene00174295	21ur-12647
No description available

WB:WBGene00174296	21ur-8013
No description available

WB:WBGene00174297	21ur-6649
No description available

WB:WBGene00174298	21ur-9890
No description available

WB:WBGene00174299	21ur-11061
No description available

WB:WBGene00174300	21ur-5702
No description available

WB:WBGene00174301	21ur-9696
No description available

WB:WBGene00174302	21ur-11817
No description available

WB:WBGene00174303	21ur-10859
No description available

WB:WBGene00174304	21ur-13658
No description available

WB:WBGene00174305	21ur-12151
No description available

WB:WBGene00174306	21ur-13893
No description available

WB:WBGene00174307	21ur-9925
No description available

WB:WBGene00174308	21ur-8078
No description available

WB:WBGene00174309	21ur-14325
No description available

WB:WBGene00174310	21ur-9352
No description available

WB:WBGene00174311	21ur-14951
Is affected by chd-3 and wdr-5.1 based on RNA-seq studies.

WB:WBGene00174312	21ur-6137
No description available

WB:WBGene00174313	21ur-6734
No description available

WB:WBGene00174314	21ur-9036
No description available

WB:WBGene00174315	21ur-10686
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00174316	21ur-12233
No description available

WB:WBGene00174317	21ur-11234
No description available

WB:WBGene00174318	21ur-9786
No description available

WB:WBGene00174319	21ur-6618
No description available

WB:WBGene00174320	21ur-10283
No description available

WB:WBGene00174321	21ur-14825
No description available

WB:WBGene00174322	21ur-14519
No description available

WB:WBGene00174323	21ur-6334
No description available

WB:WBGene00174324	21ur-11624
No description available

WB:WBGene00174325	21ur-7940
No description available

WB:WBGene00174326	21ur-7790
No description available

WB:WBGene00174327	21ur-7587
No description available

WB:WBGene00174328	21ur-13068
No description available

WB:WBGene00174329	21ur-7148
No description available

WB:WBGene00174330	21ur-10623
No description available

WB:WBGene00174331	21ur-14830
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00174332	21ur-15542
No description available

WB:WBGene00174333	21ur-14862
No description available

WB:WBGene00174334	21ur-9978
No description available

WB:WBGene00174335	21ur-5868
No description available

WB:WBGene00174336	21ur-9779
No description available

WB:WBGene00174337	21ur-8067
No description available

WB:WBGene00174338	21ur-10437
No description available

WB:WBGene00174339	21ur-13453
Is affected by daf-16 based on RNA-seq studies. Is affected by juglone based on RNA-seq studies.

WB:WBGene00174340	21ur-5847
No description available

WB:WBGene00174341	21ur-9271
No description available

WB:WBGene00174342	21ur-11846
No description available

WB:WBGene00174343	21ur-13529
No description available

WB:WBGene00174344	21ur-11510
No description available

WB:WBGene00174345	21ur-8678
No description available

WB:WBGene00174346	21ur-11001
No description available

WB:WBGene00174347	21ur-14487
No description available

WB:WBGene00174348	21ur-8311
No description available

WB:WBGene00174349	21ur-8006
No description available

WB:WBGene00174350	21ur-12031
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174351	21ur-11068
No description available

WB:WBGene00174352	21ur-8671
No description available

WB:WBGene00174353	21ur-13648
No description available

WB:WBGene00174354	21ur-15213
No description available

WB:WBGene00174355	21ur-8888
No description available

WB:WBGene00174356	21ur-12172
No description available

WB:WBGene00174357	21ur-15308
No description available

WB:WBGene00174358	21ur-14104
No description available

WB:WBGene00174359	21ur-11049
No description available

WB:WBGene00174360	21ur-13915
No description available

WB:WBGene00174361	21ur-8033
No description available

WB:WBGene00174362	21ur-8240
No description available

WB:WBGene00174363	21ur-6676
No description available

WB:WBGene00174364	21ur-10616
No description available

WB:WBGene00174365	21ur-9629
No description available

WB:WBGene00174366	21ur-12218
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00174367	21ur-11619
No description available

WB:WBGene00174368	21ur-11725
No description available

WB:WBGene00174369	21ur-12834
No description available

WB:WBGene00174370	21ur-7619
No description available

WB:WBGene00174371	21ur-6248
No description available

WB:WBGene00174372	21ur-6057
No description available

WB:WBGene00174373	21ur-15198
No description available

WB:WBGene00174374	21ur-12947
No description available

WB:WBGene00174375	21ur-8085
No description available

WB:WBGene00174376	21ur-9285
No description available

WB:WBGene00174377	21ur-14361
No description available

WB:WBGene00174378	21ur-5736
No description available

WB:WBGene00174379	21ur-11042
No description available

WB:WBGene00174380	21ur-9307
No description available

WB:WBGene00174381	21ur-7504
No description available

WB:WBGene00174382	21ur-11892
No description available

WB:WBGene00174383	21ur-7051
No description available

WB:WBGene00174384	21ur-13177
No description available

WB:WBGene00174385	21ur-7438
No description available

WB:WBGene00174386	21ur-8340
No description available

WB:WBGene00174387	21ur-10552
No description available

WB:WBGene00174388	21ur-11488
No description available

WB:WBGene00174389	21ur-8217
No description available

WB:WBGene00174390	21ur-14528
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174391	21ur-13261
No description available

WB:WBGene00174392	21ur-6416
No description available

WB:WBGene00174393	21ur-11514
No description available

WB:WBGene00174394	21ur-10441
No description available

WB:WBGene00174395	21ur-10886
No description available

WB:WBGene00174396	21ur-14167
No description available

WB:WBGene00174397	21ur-7603
No description available

WB:WBGene00174398	21ur-7189
No description available

WB:WBGene00174399	21ur-12914
No description available

WB:WBGene00174400	21ur-10423
No description available

WB:WBGene00174401	21ur-5852
No description available

WB:WBGene00174402	21ur-9109
No description available

WB:WBGene00174403	21ur-5487
No description available

WB:WBGene00174404	21ur-13043
No description available

WB:WBGene00174405	21ur-5836
No description available

WB:WBGene00174406	21ur-12530
No description available

WB:WBGene00174407	21ur-7858
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174408	21ur-11011
No description available

WB:WBGene00174409	21ur-5929
No description available

WB:WBGene00174410	21ur-10456
No description available

WB:WBGene00174411	21ur-8544
No description available

WB:WBGene00174412	21ur-7397
No description available

WB:WBGene00174413	21ur-8610
No description available

WB:WBGene00174414	21ur-14687
No description available

WB:WBGene00174415	21ur-14684
No description available

WB:WBGene00174416	21ur-7818
No description available

WB:WBGene00174417	21ur-13974
No description available

WB:WBGene00174418	21ur-8074
No description available

WB:WBGene00174419	21ur-6971
No description available

WB:WBGene00174420	21ur-10897
No description available

WB:WBGene00174421	21ur-13787
No description available

WB:WBGene00174422	21ur-8904
No description available

WB:WBGene00174423	21ur-10056
No description available

WB:WBGene00174424	21ur-14440
No description available

WB:WBGene00174425	21ur-13360
No description available

WB:WBGene00174426	21ur-7730
No description available

WB:WBGene00174427	21ur-11690
No description available

WB:WBGene00174428	21ur-12168
No description available

WB:WBGene00174429	21ur-8306
No description available

WB:WBGene00174430	21ur-7459
No description available

WB:WBGene00174431	21ur-11413
No description available

WB:WBGene00174432	21ur-13286
No description available

WB:WBGene00174433	21ur-15423
No description available

WB:WBGene00174434	21ur-12461
Is affected by emr-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00174435	21ur-7452
No description available

WB:WBGene00174436	21ur-11957
No description available

WB:WBGene00174437	21ur-7372
No description available

WB:WBGene00174438	21ur-14813
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174439	21ur-7677
No description available

WB:WBGene00174440	21ur-11649
No description available

WB:WBGene00174441	21ur-8112
No description available

WB:WBGene00174442	21ur-11140
No description available

WB:WBGene00174443	21ur-13291
No description available

WB:WBGene00174444	21ur-9883
No description available

WB:WBGene00174445	21ur-7883
No description available

WB:WBGene00174446	21ur-6754
No description available

WB:WBGene00174447	21ur-6829
No description available

WB:WBGene00174448	21ur-15343
No description available

WB:WBGene00174449	21ur-10334
No description available

WB:WBGene00174450	21ur-11640
No description available

WB:WBGene00174451	21ur-11361
No description available

WB:WBGene00174452	21ur-12140
No description available

WB:WBGene00174453	21ur-6480
No description available

WB:WBGene00174454	21ur-15006
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174455	21ur-5654
No description available

WB:WBGene00174456	21ur-12469
No description available

WB:WBGene00174457	21ur-12917
No description available

WB:WBGene00174458	21ur-8117
No description available

WB:WBGene00174459	21ur-11741
No description available

WB:WBGene00174460	21ur-9364
No description available

WB:WBGene00174461	21ur-6823
No description available

WB:WBGene00174462	21ur-11998
No description available

WB:WBGene00174463	21ur-5908
No description available

WB:WBGene00174464	21ur-12601
No description available

WB:WBGene00174465	21ur-14550
No description available

WB:WBGene00174466	21ur-5574
No description available

WB:WBGene00174467	21ur-10359
No description available

WB:WBGene00174468	21ur-14753
No description available

WB:WBGene00174469	21ur-13721
No description available

WB:WBGene00174470	21ur-5888
No description available

WB:WBGene00174471	21ur-9887
No description available

WB:WBGene00174472	21ur-13330
No description available

WB:WBGene00174473	21ur-6724
No description available

WB:WBGene00174474	21ur-8471
No description available

WB:WBGene00174475	21ur-14645
No description available

WB:WBGene00174476	21ur-11534
No description available

WB:WBGene00174477	21ur-5963
No description available

WB:WBGene00174478	21ur-14989
No description available

WB:WBGene00174479	21ur-7913
No description available

WB:WBGene00174480	21ur-8051
No description available

WB:WBGene00174481	21ur-10068
No description available

WB:WBGene00174482	21ur-7993
No description available

WB:WBGene00174483	21ur-5931
No description available

WB:WBGene00174484	21ur-5782
No description available

WB:WBGene00174485	21ur-6151
No description available

WB:WBGene00174486	21ur-10750
No description available

WB:WBGene00174487	21ur-14606
No description available

WB:WBGene00174488	21ur-14351
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00174489	21ur-8490
No description available

WB:WBGene00174490	21ur-12806
No description available

WB:WBGene00174491	21ur-8391
No description available

WB:WBGene00174492	21ur-14463
No description available

WB:WBGene00174493	21ur-13769
No description available

WB:WBGene00174494	21ur-6555
No description available

WB:WBGene00174495	21ur-11251
No description available

WB:WBGene00174496	21ur-15374
No description available

WB:WBGene00174497	21ur-14796
No description available

WB:WBGene00174498	21ur-5711
No description available

WB:WBGene00174499	21ur-8131
No description available

WB:WBGene00174500	21ur-6173
No description available

WB:WBGene00174501	21ur-12211
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174502	21ur-12651
No description available

WB:WBGene00174503	21ur-8276
No description available

WB:WBGene00174504	21ur-15154
No description available

WB:WBGene00174505	21ur-8119
No description available

WB:WBGene00174506	21ur-10164
No description available

WB:WBGene00174507	21ur-12430
No description available

WB:WBGene00174508	21ur-9238
No description available

WB:WBGene00174509	21ur-6537
No description available

WB:WBGene00174510	21ur-6830
No description available

WB:WBGene00174511	21ur-15076
No description available

WB:WBGene00174512	21ur-14346
No description available

WB:WBGene00174513	21ur-12799
No description available

WB:WBGene00174514	21ur-10236
No description available

WB:WBGene00174515	21ur-11050
No description available

WB:WBGene00174516	21ur-11406
No description available

WB:WBGene00174517	21ur-8202
No description available

WB:WBGene00174518	21ur-9558
No description available

WB:WBGene00174519	21ur-10820
No description available

WB:WBGene00174520	21ur-15571
No description available

WB:WBGene00174521	21ur-14065
No description available

WB:WBGene00174522	21ur-14449
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00174523	21ur-11462
No description available

WB:WBGene00174524	21ur-7651
No description available

WB:WBGene00174525	21ur-15246
No description available

WB:WBGene00174526	21ur-6505
No description available

WB:WBGene00174527	21ur-11555
No description available

WB:WBGene00174528	21ur-14171
No description available

WB:WBGene00174529	21ur-7290
No description available

WB:WBGene00174530	21ur-11270
No description available

WB:WBGene00174531	21ur-10538
No description available

WB:WBGene00174532	21ur-10996
No description available

WB:WBGene00174533	21ur-5689
No description available

WB:WBGene00174534	21ur-7463
No description available

WB:WBGene00174535	21ur-9681
No description available

WB:WBGene00174536	21ur-9317
No description available

WB:WBGene00174537	21ur-7153
No description available

WB:WBGene00174538	21ur-9831
No description available

WB:WBGene00174539	21ur-7773
No description available

WB:WBGene00174540	21ur-9809
No description available

WB:WBGene00174541	21ur-13011
No description available

WB:WBGene00174542	21ur-12174
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00174543	21ur-15450
No description available

WB:WBGene00174544	21ur-13536
No description available

WB:WBGene00174545	21ur-9171
No description available

WB:WBGene00174546	21ur-10030
No description available

WB:WBGene00174547	21ur-13889
No description available

WB:WBGene00174548	21ur-11277
No description available

WB:WBGene00174549	21ur-11150
No description available

WB:WBGene00174550	21ur-14146
No description available

WB:WBGene00174551	21ur-6420
No description available

WB:WBGene00174552	21ur-12265
No description available

WB:WBGene00174553	21ur-10297
No description available

WB:WBGene00174554	21ur-10994
No description available

WB:WBGene00174555	21ur-13132
No description available

WB:WBGene00174556	21ur-6696
No description available

WB:WBGene00174557	21ur-13373
No description available

WB:WBGene00174558	21ur-14583
No description available

WB:WBGene00174559	21ur-12497
No description available

WB:WBGene00174560	21ur-9936
No description available

WB:WBGene00174561	21ur-7712
No description available

WB:WBGene00174562	21ur-8110
No description available

WB:WBGene00174563	21ur-8633
No description available

WB:WBGene00174564	21ur-13487
No description available

WB:WBGene00174565	21ur-13525
No description available

WB:WBGene00174566	21ur-14432
No description available

WB:WBGene00174567	21ur-8525
No description available

WB:WBGene00174568	21ur-10609
No description available

WB:WBGene00174569	21ur-11793
No description available

WB:WBGene00174570	21ur-6674
No description available

WB:WBGene00174571	21ur-12257
No description available

WB:WBGene00174572	21ur-10259
No description available

WB:WBGene00174573	21ur-9414
No description available

WB:WBGene00174574	21ur-13679
No description available

WB:WBGene00174575	21ur-12758
No description available

WB:WBGene00174576	21ur-10574
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174577	21ur-10594
No description available

WB:WBGene00174578	21ur-12543
No description available

WB:WBGene00174579	21ur-11516
No description available

WB:WBGene00174580	21ur-8594
No description available

WB:WBGene00174581	21ur-9642
No description available

WB:WBGene00174582	21ur-9907
No description available

WB:WBGene00174583	21ur-10579
No description available

WB:WBGene00174584	21ur-11191
No description available

WB:WBGene00174585	21ur-6499
No description available

WB:WBGene00174586	21ur-6961
No description available

WB:WBGene00174587	21ur-9802
No description available

WB:WBGene00174588	21ur-12550
No description available

WB:WBGene00174589	21ur-6182
No description available

WB:WBGene00174590	21ur-10633
No description available

WB:WBGene00174591	21ur-12001
Is affected by daf-2 based on microarray studies.

WB:WBGene00174592	21ur-6364
No description available

WB:WBGene00174593	21ur-6795
No description available

WB:WBGene00174594	21ur-5707
No description available

WB:WBGene00174595	21ur-6158
No description available

WB:WBGene00174596	21ur-10939
No description available

WB:WBGene00174597	21ur-9742
No description available

WB:WBGene00174598	21ur-13824
No description available

WB:WBGene00174599	21ur-9545
No description available

WB:WBGene00174600	21ur-9372
No description available

WB:WBGene00174601	21ur-11226
No description available

WB:WBGene00174602	21ur-6304
No description available

WB:WBGene00174603	21ur-10706
No description available

WB:WBGene00174604	21ur-5763
No description available

WB:WBGene00174605	21ur-14613
No description available

WB:WBGene00174606	21ur-7839
No description available

WB:WBGene00174607	21ur-6936
No description available

WB:WBGene00174608	21ur-7514
No description available

WB:WBGene00174609	21ur-6336
No description available

WB:WBGene00174610	21ur-6596
No description available

WB:WBGene00174611	21ur-9127
No description available

WB:WBGene00174612	21ur-9914
No description available

WB:WBGene00174613	21ur-6072
No description available

WB:WBGene00174614	21ur-9688
No description available

WB:WBGene00174615	21ur-8175
No description available

WB:WBGene00174616	21ur-11908
No description available

WB:WBGene00174617	21ur-6191
No description available

WB:WBGene00174618	21ur-12473
No description available

WB:WBGene00174619	21ur-8449
No description available

WB:WBGene00174620	21ur-10796
No description available

WB:WBGene00174621	21ur-6443
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00174622	21ur-15278
No description available

WB:WBGene00174623	21ur-10252
No description available

WB:WBGene00174624	21ur-12305
No description available

WB:WBGene00174625	21ur-13653
No description available

WB:WBGene00174626	21ur-11881
No description available

WB:WBGene00174627	21ur-11699
No description available

WB:WBGene00174628	21ur-9583
No description available

WB:WBGene00174629	21ur-10974
No description available

WB:WBGene00174630	21ur-15478
No description available

WB:WBGene00174631	21ur-8095
No description available

WB:WBGene00174632	21ur-8811
No description available

WB:WBGene00174633	21ur-6319
No description available

WB:WBGene00174634	21ur-12951
No description available

WB:WBGene00174635	21ur-7516
No description available

WB:WBGene00174636	21ur-7532
No description available

WB:WBGene00174637	21ur-7561
No description available

WB:WBGene00174638	21ur-5863
No description available

WB:WBGene00174639	21ur-11149
No description available

WB:WBGene00174640	21ur-12862
No description available

WB:WBGene00174641	21ur-7182
No description available

WB:WBGene00174642	21ur-15687
No description available

WB:WBGene00174643	21ur-5808
No description available

WB:WBGene00174644	21ur-13090
No description available

WB:WBGene00174645	21ur-9768
No description available

WB:WBGene00174646	21ur-14094
Is affected by eat-2 based on microarray studies.

WB:WBGene00174647	21ur-12880
No description available

WB:WBGene00174648	21ur-15601
No description available

WB:WBGene00174649	21ur-14261
No description available

WB:WBGene00174650	21ur-12162
No description available

WB:WBGene00174651	21ur-11081
No description available

WB:WBGene00174652	21ur-9567
No description available

WB:WBGene00174653	21ur-11384
No description available

WB:WBGene00174654	21ur-15656
No description available

WB:WBGene00174655	21ur-8972
No description available

WB:WBGene00174656	21ur-11059
No description available

WB:WBGene00174657	21ur-10956
No description available

WB:WBGene00174658	21ur-7375
No description available

WB:WBGene00174659	21ur-5516
No description available

WB:WBGene00174660	21ur-10290
No description available

WB:WBGene00174661	21ur-8294
No description available

WB:WBGene00174662	21ur-7638
Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00174663	21ur-13309
No description available

WB:WBGene00174664	21ur-15023
No description available

WB:WBGene00174665	21ur-15397
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00174666	21ur-14747
No description available

WB:WBGene00174667	21ur-6489
No description available

WB:WBGene00174668	21ur-7489
No description available

WB:WBGene00174669	21ur-6384
No description available

WB:WBGene00174670	21ur-11809
No description available

WB:WBGene00174671	21ur-15020
No description available

WB:WBGene00174672	21ur-10933
No description available

WB:WBGene00174673	21ur-11368
No description available

WB:WBGene00174674	21ur-7240
No description available

WB:WBGene00174675	21ur-7931
No description available

WB:WBGene00174676	21ur-13230
No description available

WB:WBGene00174677	21ur-11705
No description available

WB:WBGene00174678	21ur-12512
No description available

WB:WBGene00174679	21ur-9467
No description available

WB:WBGene00174680	21ur-8257
No description available

WB:WBGene00174681	21ur-5587
No description available

WB:WBGene00174682	21ur-12991
No description available

WB:WBGene00174683	21ur-13932
No description available

WB:WBGene00174684	21ur-14934
No description available

WB:WBGene00174685	21ur-12041
No description available

WB:WBGene00174686	21ur-13415
No description available

WB:WBGene00174687	21ur-7342
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00174688	21ur-12743
No description available

WB:WBGene00174689	21ur-7344
No description available

WB:WBGene00174690	21ur-9670
No description available

WB:WBGene00174691	21ur-13777
No description available

WB:WBGene00174692	21ur-6942
No description available

WB:WBGene00174693	21ur-12956
No description available

WB:WBGene00174694	21ur-7757
No description available

WB:WBGene00174695	21ur-11071
No description available

WB:WBGene00174696	21ur-11320
No description available

WB:WBGene00174697	21ur-12526
No description available

WB:WBGene00174698	21ur-14896
No description available

WB:WBGene00174699	21ur-13822
No description available

WB:WBGene00174700	21ur-8154
No description available

WB:WBGene00174701	21ur-11333
No description available

WB:WBGene00174702	21ur-12922
No description available

WB:WBGene00174703	21ur-9253
No description available

WB:WBGene00174704	21ur-7830
No description available

WB:WBGene00174705	21ur-10588
No description available

WB:WBGene00174706	21ur-7421
No description available

WB:WBGene00174707	21ur-13851
No description available

WB:WBGene00174708	21ur-11178
No description available

WB:WBGene00174709	21ur-13034
No description available

WB:WBGene00174710	21ur-7403
No description available

WB:WBGene00174711	21ur-10557
No description available

WB:WBGene00174712	21ur-8653
Is affected by hrpr-1 based on RNA-seq studies.

WB:WBGene00174713	21ur-8664
No description available

WB:WBGene00174714	21ur-6373
No description available

WB:WBGene00174715	21ur-10831
No description available

WB:WBGene00174716	21ur-12078
No description available

WB:WBGene00174717	21ur-10039
No description available

WB:WBGene00174718	21ur-7390
No description available

WB:WBGene00174719	21ur-9120
No description available

WB:WBGene00174720	21ur-5743
No description available

WB:WBGene00174721	21ur-5823
No description available

WB:WBGene00174722	21ur-5628
No description available

WB:WBGene00174723	21ur-15231
No description available

WB:WBGene00174724	21ur-14118
No description available

WB:WBGene00174725	21ur-9156
No description available

WB:WBGene00174726	21ur-10371
No description available

WB:WBGene00174727	21ur-6063
No description available

WB:WBGene00174728	21ur-11675
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174729	21ur-5633
No description available

WB:WBGene00174730	21ur-10696
No description available

WB:WBGene00174731	21ur-7335
Is affected by eat-2 based on microarray studies.

WB:WBGene00174732	21ur-13010
No description available

WB:WBGene00174733	21ur-15234
No description available

WB:WBGene00174734	21ur-13194
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174735	21ur-7975
No description available

WB:WBGene00174736	21ur-7230
No description available

WB:WBGene00174737	21ur-12714
No description available

WB:WBGene00174738	21ur-5602
No description available

WB:WBGene00174739	21ur-9593
No description available

WB:WBGene00174740	21ur-13337
No description available

WB:WBGene00174741	21ur-13310
No description available

WB:WBGene00174742	21ur-15696
No description available

WB:WBGene00174743	21ur-11667
No description available

WB:WBGene00174744	21ur-13216
No description available

WB:WBGene00174745	21ur-7046
No description available

WB:WBGene00174746	21ur-9828
No description available

WB:WBGene00174747	21ur-9536
No description available

WB:WBGene00174748	21ur-15459
No description available

WB:WBGene00174749	21ur-9214
No description available

WB:WBGene00174750	21ur-11764
No description available

WB:WBGene00174751	21ur-12628
No description available

WB:WBGene00174752	21ur-6841
No description available

WB:WBGene00174753	21ur-14969
No description available

WB:WBGene00174754	21ur-9193
No description available

WB:WBGene00174755	21ur-8437
No description available

WB:WBGene00174756	21ur-8444
No description available

WB:WBGene00174757	21ur-10341
No description available

WB:WBGene00174758	21ur-12565
No description available

WB:WBGene00174759	21ur-5901
No description available

WB:WBGene00174760	21ur-15525
No description available

WB:WBGene00174761	21ur-10190
No description available

WB:WBGene00174762	21ur-5920
No description available

WB:WBGene00174763	21ur-14877
No description available

WB:WBGene00174764	21ur-15560
No description available

WB:WBGene00174765	21ur-6007
No description available

WB:WBGene00174766	21ur-5606
No description available

WB:WBGene00174767	21ur-10424
No description available

WB:WBGene00174768	21ur-6333
No description available

WB:WBGene00174769	21ur-6077
No description available

WB:WBGene00174770	21ur-12380
No description available

WB:WBGene00174771	21ur-6903
No description available

WB:WBGene00174772	21ur-15182
No description available

WB:WBGene00174773	21ur-14023
No description available

WB:WBGene00174774	21ur-6223
No description available

WB:WBGene00174775	21ur-6913
No description available

WB:WBGene00174776	21ur-7289
No description available

WB:WBGene00174777	21ur-12006
No description available

WB:WBGene00174778	21ur-12447
No description available

WB:WBGene00174779	21ur-13764
No description available

WB:WBGene00174780	21ur-8517
No description available

WB:WBGene00174781	21ur-15201
No description available

WB:WBGene00174782	21ur-6016
No description available

WB:WBGene00174783	21ur-13801
No description available

WB:WBGene00174784	21ur-13735
No description available

WB:WBGene00174785	21ur-15401
No description available

WB:WBGene00174786	21ur-8146
No description available

WB:WBGene00174787	21ur-12877
No description available

WB:WBGene00174788	21ur-8329
No description available

WB:WBGene00174789	21ur-15253
No description available

WB:WBGene00174790	21ur-11688
No description available

WB:WBGene00174791	21ur-6231
No description available

WB:WBGene00174792	21ur-12119
No description available

WB:WBGene00174793	21ur-8195
No description available

WB:WBGene00174794	21ur-15429
No description available

WB:WBGene00174795	21ur-13472
No description available

WB:WBGene00174796	21ur-11078
No description available

WB:WBGene00174797	21ur-9509
No description available

WB:WBGene00174798	21ur-12234
No description available

WB:WBGene00174799	21ur-9180
No description available

WB:WBGene00174800	21ur-8994
No description available

WB:WBGene00174801	21ur-10036
No description available

WB:WBGene00174802	21ur-10464
No description available

WB:WBGene00174803	21ur-12996
No description available

WB:WBGene00174804	21ur-12338
No description available

WB:WBGene00174805	21ur-6268
No description available

WB:WBGene00174806	21ur-7172
Is affected by eat-2 based on microarray studies.

WB:WBGene00174807	21ur-15417
No description available

WB:WBGene00174808	21ur-10784
No description available

WB:WBGene00174809	21ur-12062
No description available

WB:WBGene00174810	21ur-10086
No description available

WB:WBGene00174811	21ur-7050
No description available

WB:WBGene00174812	21ur-12366
No description available

WB:WBGene00174813	21ur-8188
No description available

WB:WBGene00174814	21ur-14478
No description available

WB:WBGene00174815	21ur-9118
No description available

WB:WBGene00174816	21ur-14390
No description available

WB:WBGene00174817	21ur-8218
No description available

WB:WBGene00174818	21ur-14052
No description available

WB:WBGene00174819	21ur-9956
No description available

WB:WBGene00174820	21ur-10977
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174821	21ur-5956
No description available

WB:WBGene00174822	21ur-12178
No description available

WB:WBGene00174823	21ur-10665
No description available

WB:WBGene00174824	21ur-6792
No description available

WB:WBGene00174825	21ur-10050
No description available

WB:WBGene00174826	21ur-15700
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00174827	21ur-6432
No description available

WB:WBGene00174828	21ur-10094
No description available

WB:WBGene00174829	21ur-13229
No description available

WB:WBGene00174830	21ur-14027
No description available

WB:WBGene00174831	21ur-14423
No description available

WB:WBGene00174832	21ur-6147
No description available

WB:WBGene00174833	21ur-11453
No description available

WB:WBGene00174834	21ur-12936
No description available

WB:WBGene00174835	21ur-8848
No description available

WB:WBGene00174836	21ur-9166
No description available

WB:WBGene00174837	21ur-13608
No description available

WB:WBGene00174838	21ur-7720
No description available

WB:WBGene00174839	21ur-7324
No description available

WB:WBGene00174840	21ur-6320
No description available

WB:WBGene00174841	21ur-10383
No description available

WB:WBGene00174842	21ur-5720
No description available

WB:WBGene00174843	21ur-11341
No description available

WB:WBGene00174844	21ur-12109
No description available

WB:WBGene00174845	21ur-10951
No description available

WB:WBGene00174846	21ur-6709
No description available

WB:WBGene00174847	21ur-11489
No description available

WB:WBGene00174848	21ur-14210
No description available

WB:WBGene00174849	21ur-6817
No description available

WB:WBGene00174850	21ur-13925
No description available

WB:WBGene00174851	21ur-8863
No description available

WB:WBGene00174852	21ur-15129
No description available

WB:WBGene00174853	21ur-12429
No description available

WB:WBGene00174854	21ur-7108
No description available

WB:WBGene00174855	21ur-12851
No description available

WB:WBGene00174856	21ur-11851
No description available

WB:WBGene00174857	21ur-10727
No description available

WB:WBGene00174858	21ur-6958
No description available

WB:WBGene00174859	21ur-13567
No description available

WB:WBGene00174860	21ur-6261
No description available

WB:WBGene00174861	21ur-13250
No description available

WB:WBGene00174862	21ur-8980
No description available

WB:WBGene00174863	21ur-13005
No description available

WB:WBGene00174864	21ur-13224
No description available

WB:WBGene00174865	21ur-6813
No description available

WB:WBGene00174866	21ur-6584
No description available

WB:WBGene00174867	21ur-11470
No description available

WB:WBGene00174868	21ur-9160
No description available

WB:WBGene00174869	21ur-12385
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174870	21ur-9450
No description available

WB:WBGene00174871	21ur-7297
No description available

WB:WBGene00174872	21ur-15492
No description available

WB:WBGene00174873	21ur-7096
No description available

WB:WBGene00174874	21ur-7208
No description available

WB:WBGene00174875	21ur-9167
No description available

WB:WBGene00174876	21ur-5647
No description available

WB:WBGene00174877	21ur-8744
No description available

WB:WBGene00174878	21ur-8125
No description available

WB:WBGene00174879	21ur-12299
No description available

WB:WBGene00174880	21ur-14208
No description available

WB:WBGene00174881	21ur-12488
No description available

WB:WBGene00174882	21ur-13400
No description available

WB:WBGene00174883	21ur-14184
No description available

WB:WBGene00174884	21ur-10311
No description available

WB:WBGene00174885	21ur-13070
No description available

WB:WBGene00174886	21ur-13808
No description available

WB:WBGene00174887	21ur-15296
No description available

WB:WBGene00174888	21ur-11958
No description available

WB:WBGene00174889	21ur-6123
No description available

WB:WBGene00174890	21ur-11834
No description available

WB:WBGene00174891	21ur-9063
No description available

WB:WBGene00174892	21ur-9577
No description available

WB:WBGene00174893	21ur-10153
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00174894	21ur-11157
No description available

WB:WBGene00174895	21ur-14776
No description available

WB:WBGene00174896	21ur-11848
No description available

WB:WBGene00174897	21ur-11314
No description available

WB:WBGene00174898	21ur-7670
No description available

WB:WBGene00174899	21ur-14996
No description available

WB:WBGene00174900	21ur-9425
No description available

WB:WBGene00174901	21ur-7219
No description available

WB:WBGene00174902	21ur-7546
No description available

WB:WBGene00174903	21ur-8623
No description available

WB:WBGene00174904	21ur-6701
No description available

WB:WBGene00174905	21ur-14539
No description available

WB:WBGene00174906	21ur-7882
No description available

WB:WBGene00174907	21ur-12097
No description available

WB:WBGene00174908	21ur-7668
No description available

WB:WBGene00174909	21ur-14059
No description available

WB:WBGene00174910	21ur-9222
No description available

WB:WBGene00174911	21ur-10417
No description available

WB:WBGene00174912	21ur-6777
No description available

WB:WBGene00174913	21ur-14781
No description available

WB:WBGene00174914	21ur-11482
No description available

WB:WBGene00174915	21ur-10596
No description available

WB:WBGene00174916	21ur-13284
No description available

WB:WBGene00174917	21ur-12863
No description available

WB:WBGene00174918	21ur-8712
No description available

WB:WBGene00174919	21ur-12982
No description available

WB:WBGene00174920	21ur-7661
No description available

WB:WBGene00174921	21ur-11327
No description available

WB:WBGene00174922	21ur-7484
No description available

WB:WBGene00174923	21ur-6400
No description available

WB:WBGene00174924	21ur-9434
No description available

WB:WBGene00174925	21ur-14999
No description available

WB:WBGene00174926	21ur-9500
No description available

WB:WBGene00174927	21ur-15580
No description available

WB:WBGene00174928	21ur-10197
No description available

WB:WBGene00174929	21ur-11929
No description available

WB:WBGene00174930	21ur-11944
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00174931	21ur-12889
Is affected by daf-2 based on microarray studies.

WB:WBGene00174932	21ur-5797
No description available

WB:WBGene00174933	21ur-9616
No description available

WB:WBGene00174934	21ur-8358
No description available

WB:WBGene00174935	21ur-10100
No description available

WB:WBGene00174936	21ur-8714
No description available

WB:WBGene00174937	21ur-12044
No description available

WB:WBGene00174938	21ur-7804
No description available

WB:WBGene00174939	21ur-13990
No description available

WB:WBGene00174940	21ur-13985
No description available

WB:WBGene00174941	21ur-13105
No description available

WB:WBGene00174942	21ur-10451
No description available

WB:WBGene00174943	21ur-14885
No description available

WB:WBGene00174944	21ur-10061
No description available

WB:WBGene00174945	21ur-11183
No description available

WB:WBGene00174946	21ur-9014
No description available

WB:WBGene00174947	21ur-11734
No description available

WB:WBGene00174948	21ur-12848
No description available

WB:WBGene00174949	21ur-8208
No description available

WB:WBGene00174950	21ur-10938
No description available

WB:WBGene00174951	21ur-10079
No description available

WB:WBGene00174952	21ur-9723
No description available

WB:WBGene00174953	21ur-13173
No description available

WB:WBGene00174954	21ur-12719
No description available

WB:WBGene00174955	21ur-12284
No description available

WB:WBGene00174956	21ur-9057
No description available

WB:WBGene00174957	21ur-13467
No description available

WB:WBGene00174958	21ur-9338
No description available

WB:WBGene00174959	21ur-15157
No description available

WB:WBGene00174960	21ur-9738
No description available

WB:WBGene00174961	21ur-14628
No description available

WB:WBGene00174962	21ur-10128
Is affected by several genes including emr-1; hmg-4; and hmg-3 based on RNA-seq studies.

WB:WBGene00174963	21ur-11017
No description available

WB:WBGene00174964	21ur-7551
Is affected by daf-2 based on microarray studies.

WB:WBGene00174965	21ur-11218
No description available

WB:WBGene00174966	21ur-14724
No description available

WB:WBGene00174967	21ur-9815
No description available

WB:WBGene00174968	21ur-13022
No description available

WB:WBGene00174969	21ur-11477
No description available

WB:WBGene00174970	21ur-8222
No description available

WB:WBGene00174971	21ur-15302
No description available

WB:WBGene00174972	21ur-14914
No description available

WB:WBGene00174973	21ur-8501
No description available

WB:WBGene00174974	21ur-9858
No description available

WB:WBGene00174975	21ur-14217
No description available

WB:WBGene00174976	21ur-14860
No description available

WB:WBGene00174977	21ur-12612
No description available

WB:WBGene00174978	21ur-7472
No description available

WB:WBGene00174979	21ur-8423
No description available

WB:WBGene00174980	21ur-9407
No description available

WB:WBGene00174981	21ur-14016
No description available

WB:WBGene00174982	21ur-14975
Is affected by glycine based on RNA-seq studies.

WB:WBGene00174983	21ur-12333
No description available

WB:WBGene00174984	21ur-15263
No description available

WB:WBGene00174985	21ur-12130
No description available

WB:WBGene00174986	21ur-14706
No description available

WB:WBGene00174987	21ur-9102
No description available

WB:WBGene00174988	21ur-12327
No description available

WB:WBGene00174989	21ur-8457
No description available

WB:WBGene00174990	21ur-12402
No description available

WB:WBGene00174991	21ur-9654
No description available

WB:WBGene00174992	21ur-7201
No description available

WB:WBGene00174993	21ur-13903
No description available

WB:WBGene00174994	21ur-13046
No description available

WB:WBGene00174995	21ur-13759
No description available

WB:WBGene00174996	21ur-11813
No description available

WB:WBGene00174997	21ur-10744
No description available

WB:WBGene00174998	21ur-6715
No description available

WB:WBGene00174999	21ur-13055
No description available

WB:WBGene00175000	21ur-9196
No description available

WB:WBGene00175001	21ur-11973
No description available

WB:WBGene00175002	21ur-13835
No description available

WB:WBGene00175003	21ur-7028
No description available

WB:WBGene00175004	21ur-10412
No description available

WB:WBGene00175005	21ur-9402
No description available

WB:WBGene00175006	21ur-12105
No description available

WB:WBGene00175007	21ur-5640
No description available

WB:WBGene00175008	21ur-10842
No description available

WB:WBGene00175009	21ur-12508
No description available

WB:WBGene00175010	21ur-15408
No description available

WB:WBGene00175011	21ur-9147
No description available

WB:WBGene00175012	21ur-9459
No description available

WB:WBGene00175013	21ur-13774
No description available

WB:WBGene00175014	21ur-6530
No description available

WB:WBGene00175015	21ur-14954
No description available

WB:WBGene00175016	21ur-6605
No description available

WB:WBGene00175017	21ur-5473
No description available

WB:WBGene00175018	21ur-8264
No description available

WB:WBGene00175019	21ur-12978
No description available

WB:WBGene00175020	21ur-12320
No description available

WB:WBGene00175021	21ur-12014
No description available

WB:WBGene00175022	21ur-7743
No description available

WB:WBGene00175023	21ur-13085
No description available

WB:WBGene00175024	21ur-12540
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00175025	F14E5.7
Is affected by several genes including daf-16; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by Humic Substances and paraquat based on microarray studies.

WB:WBGene00175027	W02F12.8
Is enriched in AFD; ASER; PLM; germline precursor cell; and hypodermis based on tiling array and RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00175028	nspe-8
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by procyanidin and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1412) and Protein of unknown function DUF1412.

WB:WBGene00175029	AH9.7
Is affected by clk-1 based on microarray studies. Is affected by resveratrol and nitroguanidine based on microarray studies.

WB:WBGene00175030	Y53C12A.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Zidovudine; Hydrolyzable Tannins; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: DTW domain and DTW. Is an ortholog of human DTWD1 (DTW domain containing 1).

WB:WBGene00175031	C06C3.12
Is affected by several genes including elt-2; sma-4; and smg-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00175034	F54B3.4
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by jmjd-3.1; jmjd-1.2; and spc-1 based on RNA-seq studies.

WB:WBGene00175035	F54C9.14
Is enriched in AVK and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and clk-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00175036	Y71A12B.21
Is affected by several genes including daf-16; clk-1; and prg-1 based on RNA-seq and microarray studies.

WB:WBGene00175055	dyf-15
No description available

WB:WBGene00175056	dyf-16
No description available

WB:WBGene00175057	lite-2
No description available

WB:WBGene00175058	lite-3
No description available

WB:WBGene00184956	F49C5.12
Is expressed in CEMDL; CEMDR; CEMVL; CEMVR; and tail.

WB:WBGene00184990	C14B1.12
Is enriched in DA neuron; I5 neuron; SAB; germ line; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including elt-2; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; manganese chloride; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00185001	F56A8.9
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including clk-1; npr-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: ERK and JNK pathways, inhibitor and Coiled-coil domain-containing protein 134. Is an ortholog of human CCDC134 (coiled-coil domain containing 134).

WB:WBGene00185002	K11H3.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including dpy-10; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including manganese chloride; bisphenol S; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: GYF domain; GYF domain; and GYF-like domain superfamily.

WB:WBGene00185005	T03F6.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including manganese chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00185006	F59B2.15
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including manganese chloride; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00185014	F17C8.9
Is predicted to have NADP binding activity and aspartate dehydrogenase activity. Is an ortholog of human ASPDH (aspartate dehydrogenase domain containing).

WB:WBGene00185048	urm-1
Is enriched in AFD; PLM; germ line; and hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; Mianserin; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Urm1 (Ubiquitin related modifier); Beta-grasp domain superfamily; Ubiquitin-related modifier 1; and Molybdopterin synthase/thiamin biosynthesis sulphur carrier, beta-grasp. Is an ortholog of human URM1 (ubiquitin related modifier 1).

WB:WBGene00185055	Y47D3B.12
Is affected by several genes including rrf-3; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00185067	Y54G11A.17
Is predicted to be a structural constituent of ribosome.

WB:WBGene00185076	Y7A9A.79
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq studies.

WB:WBGene00185077	F58D2.4
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00185078	F40G9.17
Is enriched in neurons and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including daf-2; let-7; and gld-1 based on proteomic; RNA-seq; and microarray studies. Is affected by eleven chemicals including stavudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ankyrin repeats (3 copies); Ankyrin repeats (many copies); Ankyrin repeat; Ankyrin repeat-containing domain; and Ankyrin repeat-containing domain superfamily. Is an ortholog of human PSMD10 (proteasome 26S subunit, non-ATPase 10).

WB:WBGene00185079	W10D9.6
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; clk-1; and lin-35 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Protein of unknown function DUF4796.

WB:WBGene00185086	F59A3.12
Is enriched in DD neuron and germ line based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on RNA-seq; microarray; and proteomic studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00185088	Y55F3BL.4
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including lin-35; fbf-1; and sin-3 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: SRR1 and SRR1-like domain.

WB:WBGene00185089	C16A11.10
Is predicted to have ATP binding activity and protein serine/threonine kinase activity. Human ortholog(s) of this gene are implicated in abdominal obesity-metabolic syndrome 3 and autosomal dominant non-syndromic intellectual disability 7.

WB:WBGene00185092	K08D8.7
Is enriched in ASER and intestine based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and elt-2 based on RNA-seq and microarray studies. Is affected by Zidovudine and paraquat based on RNA-seq studies.

WB:WBGene00185093	K08D8.8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00185095	W09C2.7
Is affected by several genes including daf-2; rrf-3; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Tunicamycin; antimycin; and Cry5B based on microarray and RNA-seq studies.

WB:WBGene00185096	W09C2.9
Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies.

WB:WBGene00185097	C49C3.20
Is affected by several genes including pgl-1; hsp-6; and fbf-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00185098	Y71G12B.35
Is enriched in AFD and head mesodermal cell based on RNA-seq studies. Is affected by several genes including sir-2.1; sin-3; and klf-1 based on RNA-seq and microarray studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00185100	T12A7.9
Is affected by several genes including eri-1; dpy-21; and mut-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: AH/BAR domain superfamily.

WB:WBGene00185101	Y65A5A.24
Is affected by clk-1 and daf-2 based on microarray studies.

WB:WBGene00185102	Y105C5A.1268
Is enriched in AVK; germ line; neurons; seam cell; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including clk-1; eat-2; and sek-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00185116	W09C2.8
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00185117	C45B11.9
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Sirolimus; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00185118	K02E2.11
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00185119	F16H6.11
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00189930	Y26G10.5
Is affected by let-60 based on microarray studies. Is affected by resveratrol and Acrylamide based on microarray studies.

WB:WBGene00189931	Y26G10.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including hrde-1; nhl-2; and adr-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00189932	Y26G10.7
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: Saposin-like.

WB:WBGene00189933	F38B7.11
Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00189937	Y6G8.15
Is affected by several genes including rrf-3; eat-2; and nhl-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00189943	Y116F11B.17
Is affected by several genes including eat-2; aak-2; and aak-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00189944	E03A3.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; clk-1; and dpy-7 based on microarray and RNA-seq studies. Is affected by six chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00189946	W04E12.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00189947	C06B3.16
Is affected by several genes including eat-2; lem-2; and emr-1 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00189948	F56H9.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00189949	Y48G1C.13
Is predicted to have chitin binding activity.

WB:WBGene00189950	C39B5.14
Is affected by several genes including daf-2; skn-1; and clk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Cadmium Chloride; Alovudine; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Lipase (class 3); Fungal lipase-like domain; and Alpha/Beta hydrolase fold.

WB:WBGene00189951	linc-29
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by Alovudine and paraquat based on RNA-seq studies.

WB:WBGene00189952	K10D2.8
Is enriched in head mesodermal cell and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including manganese chloride; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Leucine-rich repeat; Leucine Rich repeats (2 copies); Leucine Rich repeat; Leucine-rich repeat; Leucine-rich repeat, typical subtype; Leucine rich repeat 4; and Leucine-rich repeat domain superfamily. Is an ortholog of human PPP1R7 (protein phosphatase 1 regulatory subunit 7).

WB:WBGene00189953	R155.5
Is enriched in male based on RNA-seq studies. Is affected by several genes including pgl-1; hsp-6; and csr-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00189954	F40G9.18
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00189955	F40G9.19
Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00189956	Y34F4.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including tryptophan; 1-methylnicotinamide; and Alovudine based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00189957	M03F8.7
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00189958	F45H11.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00189961	Y54G2A.57
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00189962	mig-36
No description available

WB:WBGene00189963	mig-37
No description available

WB:WBGene00189964	F35C11.9
No description available

WB:WBGene00189966	rrn-4.15
Is affected by hpl-2 and adr-1 based on RNA-seq studies.

WB:WBGene00189967	Y46G5A.t1
No description available

WB:WBGene00189968	ZK1251.14
No description available

WB:WBGene00189969	F39B1.3
No description available

WB:WBGene00189970	mir-4812
Is affected by alg-5 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00189971	C41G6.17
No description available

WB:WBGene00189972	T10H4.16
No description available

WB:WBGene00189973	T10H4.17
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00189974	F31C3.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00189975	K02E2.12
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00189976	Y39E4B.16
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00189977	C47G2.9
No description available

WB:WBGene00189978	B0250.14
No description available

WB:WBGene00189979	W04A8.8
No description available

WB:WBGene00189980	F02C12.7
Is affected by smg-2 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00189981	Y60A3A.29
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00189982	C06C3.13
No description available

WB:WBGene00189983	Y71A12B.22
No description available

WB:WBGene00189984	K02E2.13
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00189985	F02D8.8
No description available

WB:WBGene00189986	C53D6.16
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00189987	C18H7.12
Is enriched in germ line based on RNA-seq studies. Is affected by clk-1; mir-34; and sir-2.1 based on microarray studies.

WB:WBGene00189993	C49C3.21
Is affected by several genes including elt-2; hpl-2; and elt-7 based on RNA-seq and microarray studies. Is affected by Rifampin and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00189995	C06E7.88
Is enriched in intestine and male-specific anatomical entity based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and stavudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194641	F47G3.4
Is enriched in head mesodermal cell; hypodermis; and muscle cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: Trypsin Inhibitor like cysteine rich domain; Trypsin Inhibitor-like, cysteine rich domain; and Serine protease inhibitor-like superfamily.

WB:WBGene00194642	C25H3.17
Is enriched in AFD; ASER; germ line; and intestine based on RNA-seq studies. Is affected by several genes including hsf-1; lem-2; and emr-1 based on RNA-seq studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00194643	C48D1.9
Is enriched in head mesodermal cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00194644	ZK795.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00194645	Y105C5A.1269
Is affected by several genes including skn-1; npr-1; and pgl-1 based on RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00194646	Y105C5A.1270
Is affected by several genes including daf-16; skn-1; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00194647	Y51H4A.935
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by four chemicals including Zidovudine; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00194649	Y57G11C.1130
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and fbf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Ethanol; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1179) and Protein of unknown function DUF1179.

WB:WBGene00194650	C36A4.14
Is enriched in AVK and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00194651	C33D9.13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by seventeen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and bisphenol S based on RNA-seq and microarray studies.

WB:WBGene00194652	F15H9.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and dpy-21 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194653	F36H2.6
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194654	M05B5.7
Is enriched in AVG; RIM; command interneuron; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies.

WB:WBGene00194656	T05F1.15
Is affected by dpy-21; alg-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00194657	T07D10.10
Is affected by several genes including daf-16; eat-2; and dpy-7 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00194658	R09E10.13
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including tryptophan; Sodium Chloride; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00194659	linc-1
Is affected by several genes including rrf-3; cep-1; and alg-1 based on RNA-seq studies. Is affected by Alovudine and stavudine based on RNA-seq studies.

WB:WBGene00194660	W09C5.12
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and met-2 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: Leucine-rich repeat domain superfamily.

WB:WBGene00194661	Y57G11C.1131
Is affected by several genes including daf-2; dpy-21; and sin-3 based on RNA-seq and microarray studies.

WB:WBGene00194663	F38B2.6
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Rotenone; manganese chloride; and sodium arsenite based on RNA-seq studies.

WB:WBGene00194664	K09E9.7
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by damt-1; nhl-2; and hsp-6 based on RNA-seq studies. Is affected by Rifampin and antimycin based on RNA-seq studies.

WB:WBGene00194665	ZK822.8
Is affected by several genes including daf-2; hsf-1; and sod-2 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00194666	Y57G11C.1132
Is enriched in male based on RNA-seq studies. Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00194667	Y105C5A.1271
Is enriched in RID based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including methylmercury hydroxide; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00194668	C08F11.116
Is affected by several genes including daf-16; cep-1; and hmg-3 based on RNA-seq studies.

WB:WBGene00194669	ZK1251.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00194670	K07E3.9
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Rotenone; multi-walled carbon nanotube; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00194672	Y116A8C.463
Is affected by hpl-2 and hmg-3 based on RNA-seq studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00194673	ZK593.11
Is affected by kri-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00194674	F23D12.11
Is affected by several genes including daf-16; daf-2; and skn-1 based on proteomic; RNA-seq; and microarray studies. Is affected by seventeen chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00194675	Y60A9A.3
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including clk-1; dpy-21; and hpl-2 based on RNA-seq and microarray studies.

WB:WBGene00194676	Y43F8B.21
Is affected by rrf-3 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00194677	D1054.19
Is enriched in hypodermis and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and eat-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194678	R10D12.18
Is affected by several genes including cep-1; hpl-2; and pptr-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194679	T26C11.9
Is enriched in AFD and neurons based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by ten chemicals including bisphenol A; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00194680	Y17D7C.6
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including rrf-3; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00194681	F40D4.16
Is affected by several genes including rrf-3; pgl-1; and cep-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00194682	F40D4.17
Is enriched in GABAergic neurons and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; ced-3; and pgl-1 based on RNA-seq studies. Is affected by four chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq studies.

WB:WBGene00194683	T20G5.15
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00194684	Y48A6B.14
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by Rifampin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00194686	Y49A3A.6
Is affected by emr-1; lem-2; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00194687	F57C12.6
Is affected by several genes including skn-1; hsf-1; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Mianserin; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00194689	Y38H6C.24
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by several genes including eat-2; npr-1; and sek-1 based on RNA-seq studies.

WB:WBGene00194690	T05D4.6
No description available

WB:WBGene00194691	ZK1098.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including manganese chloride; Cry5B; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00194692	T02C12.5
Is enriched in intestine and neurons based on RNA-seq studies. Is affected by several genes including clk-1; sir-2.1; and hsp-6 based on microarray and RNA-seq studies. Is affected by five chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194695	B0462.5
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including methylmercury hydroxide; bisphenol A; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00194696	EEED8.18
Is affected by several genes including daf-2; dpy-10; and elt-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; Rifampin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00194697	F59A3.13
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including tryptophan; Mianserin; and multi-walled carbon nanotube based on microarray and RNA-seq studies.

WB:WBGene00194698	F49D11.11
Is affected by dpy-21 based on RNA-seq studies. Is predicted to encode a protein with the following domain: 7TM GPCR, serpentine receptor class t (Srt).

WB:WBGene00194699	Y43F8B.22
Is enriched in ASER and PLM based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00194700	B0025.5
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Ethanol; nicotinic acid; and Rotenone based on RNA-seq and microarray studies.

WB:WBGene00194701	Y23H5B.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00194702	C32E8.12
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies.

WB:WBGene00194703	F26B1.8
Is enriched in intestine; seam cell; and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by twenty chemicals including Ethanol; Rotenone; and manganese chloride based on RNA-seq and microarray studies.

WB:WBGene00194704	T07H3.8
Is affected by several genes including clk-1; aak-2; and dpy-21 based on microarray and RNA-seq studies.

WB:WBGene00194706	C53A5.16
Is enriched in germ line; head mesodermal cell; and intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies. Is predicted to encode a protein with the following domain: Nucleotidyltransferase superfamily.

WB:WBGene00194707	C53A5.17
Is predicted to have tRNA (guanine-N1-)-methyltransferase activity. Human ortholog(s) of this gene are implicated in combined oxidative phosphorylation deficiency 26. Is an ortholog of human TRMT5 (tRNA methyltransferase 5).

WB:WBGene00194708	Y36E3A.2
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by seven chemicals including Tunicamycin; stavudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00194710	mks-2
Is involved in non-motile cilium assembly and protein localization to ciliary transition zone. Localizes to ciliary transition zone. Human ortholog(s) of this gene are implicated in Joubert syndrome 2 and Meckel syndrome 2. Is an ortholog of human TMEM216 (transmembrane protein 216).

WB:WBGene00194711	D2062.13
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194712	T11F9.21
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including rrf-3; pgl-1; and glh-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00194713	F19B10.13
Is enriched in AFD; ASER; AVK; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on microarray and RNA-seq studies. Is affected by seventeen chemicals including multi-walled carbon nanotube; Cadmium Chloride; and procyanidin based on RNA-seq and microarray studies.

WB:WBGene00194714	ZC204.17
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194715	T25E12.16
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and hsp-6 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and antimycin based on RNA-seq studies.

WB:WBGene00194716	ZK637.18
Is affected by several genes including daf-16; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194717	ZC239.22
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and glp-1 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including methylmercury hydroxide; 1-methylnicotinamide; and Alovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00194725	T16H12.13
Is affected by several genes including daf-16; daf-2; and clk-1 based on microarray and RNA-seq studies.

WB:WBGene00194726	R13A5.15
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00194727	C18D11.10
Is enriched in hypodermis based on RNA-seq studies. Is affected by hpl-2; hmg-3; and adr-1 based on RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00194729	ZK783.7
Is affected by several genes including daf-16; daf-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00194730	C29E4.17
Is affected by several genes including daf-2; eat-2; and dpy-21 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194731	Y39A1A.27
Is enriched in muscle cell and in male based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00194733	Y41C4A.21
Is affected by several genes including daf-2; aak-2; and csr-1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00194734	T04A6.4
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by daf-2; eat-2; and sir-2.1 based on microarray studies. Is affected by resveratrol and Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: Cytosolic motility protein and Cytosolic motility protein.

WB:WBGene00194735	Y82E9BL.19
Is affected by several genes including eat-2; dpy-21; and smn-1 based on RNA-seq studies. Is affected by six chemicals including tryptophan; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00194737	Y50D7A.13
Is predicted to have metalloendopeptidase activity. Human ortholog(s) of this gene are implicated in several diseases, including amelogenesis imperfecta hypomaturation type 2A2; recessive dystrophic epidermolysis bullosa; and spondyloepimetaphyseal dysplasia, Missouri type.

WB:WBGene00194738	Y46E12A.5
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00194742	F37C12.21
Is enriched in AFD; ASER; PLM; and intestine based on RNA-seq studies. Is affected by several genes including clk-1; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Psoralens; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00194744	Y38H6C.25
Is affected by several genes including clk-1; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00194746	pals-20
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and elt-2 based on microarray and RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00194747	H05C05.4
Is enriched in GABAergic neurons and PLM based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and aak-2 based on RNA-seq studies. Is affected by six chemicals including nanoparticle; Psoralens; and allantoin based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF2650) and Protein SUP-1-like.

WB:WBGene00194748	F56F3.7
Is affected by several genes including eat-2; cep-1; and alg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; Alovudine; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00194759	Y113G7A.17
Is affected by kri-1 and mpk-2 based on RNA-seq studies.

WB:WBGene00194768	Y50E8A.19
Is affected by several genes including daf-16; daf-12; and hsf-1 based on RNA-seq studies.

WB:WBGene00194769	Y32B12C.5
Is affected by several genes including daf-2; glp-1; and rrf-3 based on RNA-seq studies. Is affected by five chemicals including D-glucopyranose; Cadmium Chloride; and metformin based on RNA-seq and microarray studies.

WB:WBGene00194771	F32F2.3
Is affected by several genes including daf-2; dpy-21; and klf-1 based on RNA-seq and microarray studies.

WB:WBGene00194780	C12D8.20
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00194783	K03B8.14
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00194784	T11F9.22
Is affected by several genes including hpl-2; nhl-2; and cfp-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194785	C52E4.12
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; dpy-21; and nhl-2 based on RNA-seq and microarray studies.

WB:WBGene00194786	ZC455.13
No description available

WB:WBGene00194787	T16G1.13
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Ethanol; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00194788	R02D5.10
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including rrf-3; pgl-1; and alg-1 based on RNA-seq studies. Is affected by antimycin and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00194792	F32F2.2
Is affected by daf-16; adr-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00194793	W04G3.13
Is affected by several genes including clk-1; eat-2; and fog-2 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194794	F45B8.5
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; pgl-1; and isp-1 based on RNA-seq studies. Is affected by eight chemicals including Rotenone; manganese chloride; and stavudine based on RNA-seq studies.

WB:WBGene00194795	F42F12.14
Is enriched in hypodermis based on RNA-seq studies. Is affected by npr-1; eat-2; and unc-70 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194799	Y70C5A.4
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00194800	linc-83
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including cep-1; hsp-6; and met-2 based on RNA-seq studies. Is affected by graphene oxide and antimycin based on RNA-seq studies.

WB:WBGene00194801	Y6G8.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and clk-1 based on microarray and RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN domain and PAN/Apple domain.

WB:WBGene00194802	mir-1832.2
No description available

WB:WBGene00194803	C25F9.16
Is enriched in head mesodermal cell and muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00194804	mir-2207
Is affected by hrpk-1 based on RNA-seq studies.

WB:WBGene00194805	mir-2210
Is affected by several genes including alg-1; alg-2; and alg-5 based on RNA-seq studies. Is affected by nicotine; multi-walled carbon nanotube; and graphene oxide based on quantitative PCR and RNA-seq studies.

WB:WBGene00194806	mir-2211
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00194807	mir-2215
Is affected by alg-5 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00194808	mir-2216
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies. Is affected by nicotine and multi-walled carbon nanotube based on quantitative PCR and RNA-seq studies.

WB:WBGene00194809	mir-2218.1
Is affected by alg-5 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR and RNA-seq studies.

WB:WBGene00194810	mir-2218.2
Is affected by nicotine and glycine based on quantitative PCR and RNA-seq studies.

WB:WBGene00194811	F22E10.6
Is affected by chd-3; let-418; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00194812	F19B2.12
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including clk-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; manganese chloride; and allantoin based on RNA-seq studies.

WB:WBGene00194814	linc-34
Is affected by several genes including daf-16; pgl-1; and cep-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194815	Y43F8B.23
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Sodium Chloride; tert-Butylhydroperoxide; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00194816	ZK616.61
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including tryptophan; Rotenone; and manganese chloride based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194821	dmsr-16
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00194822	mir-2208.1
Is affected by alg-5 and pry-1 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00194823	mir-2208.2
Is affected by several genes including alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00194824	mir-2209.1
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on quantitative PCR studies.

WB:WBGene00194825	mir-2209.2
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194826	mir-2209.3
Is affected by alg-2 and alg-5 based on RNA-seq studies.

WB:WBGene00194827	mir-2213
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00194828	mir-2214
Is affected by several genes including glp-4; alg-1; and prg-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00194829	mir-2217.1
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00194830	mir-2219
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00194831	mir-2220
Is affected by alg-5 based on RNA-seq studies. Is affected by nicotine; multi-walled carbon nanotube; and sanguinarine based on quantitative PCR and RNA-seq studies.

WB:WBGene00194832	Y73B6BL.270
Is affected by dpy-21; ins-11; and damt-1 based on RNA-seq studies. Is affected by antimycin and Colistin based on RNA-seq and microarray studies.

WB:WBGene00194833	F17E9.15
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by hpl-2 and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00194834	H06H21.36
No description available

WB:WBGene00194835	Y17G9B.11
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and alg-1 based on RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00194836	C25H3.18
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; eat-2; and kri-1 based on RNA-seq studies. Is affected by four chemicals including Rotenone; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00194839	C01B10.44
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00194840	mir-2212
Is affected by several genes including glp-4; alg-1; and alg-2 based on RNA-seq studies. Is affected by nicotine based on RNA-seq studies.

WB:WBGene00194841	C44C10.13
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00194842	W10G6.5
Is affected by rpn-10 and hpl-2 based on RNA-seq studies.

WB:WBGene00194843	F58E2.11
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194844	Y55F3C.13
Is affected by smg-2 based on RNA-seq studies.

WB:WBGene00194847	F19C6.8
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-2; alg-1; and lem-2 based on RNA-seq and microarray studies.

WB:WBGene00194848	T27D12.6
Is enriched in ASER and pharynx based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq studies. Is affected by seven chemicals including stavudine; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00194849	K09A9.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on microarray and RNA-seq studies. Is affected by six chemicals including Rotenone; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00194850	F44F4.15
Is affected by clk-1; daf-2; and sir-2.1 based on microarray and RNA-seq studies.

WB:WBGene00194851	K07C10.3
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including cep-1; atfs-1; and mir-71 based on RNA-seq studies. Is affected by Zidovudine and paraquat based on RNA-seq studies.

WB:WBGene00194852	T28A8.8
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including lin-35; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; manganese chloride; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF545) and SPK domain.

WB:WBGene00194853	Y111B2A.29
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00194854	Y111B2A.30
Is affected by ins-11; adr-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00194855	Y75B8A.44
Is affected by several genes including clk-1; sma-2; and sma-4 based on microarray and RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00194856	K11D9.5
Is affected by cep-1 and daf-2 based on RNA-seq studies.

WB:WBGene00194861	H04D03.6
Is predicted to have chromatin binding activity and methylated histone binding activity.

WB:WBGene00194864	Y66A7A.9
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Ethanol; manganese chloride; and antimycin based on RNA-seq and microarray studies.

WB:WBGene00194865	F53A2.10
Is affected by cep-1; tdp-1; and adr-1 based on RNA-seq studies.

WB:WBGene00194866	Y41C4A.22
Is affected by hpl-2; alg-1; and thoc-5 based on RNA-seq studies.

WB:WBGene00194867	W09C2.10
Is affected by clk-1 based on microarray studies.

WB:WBGene00194868	M03C11.9
No description available

WB:WBGene00194869	K01A6.8
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and aak-2 based on RNA-seq and microarray studies. Is affected by procyanidin and Cadmium Chloride based on microarray and RNA-seq studies.

WB:WBGene00194870	F53A2.11
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00194871	R107.9
No description available

WB:WBGene00194876	flr-6
No description available

WB:WBGene00194877	flr-7
No description available

WB:WBGene00194883	B0496.11
Is enriched in amphid sheath cell and sensory neurons based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00194884	Y48B6A.17
Is affected by several genes including cep-1; puf-8; and ins-11 based on RNA-seq studies.

WB:WBGene00194885	Y57G11C.1133
No description available

WB:WBGene00194886	C05B5.12
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00194888	K10H10.13
Is affected by several genes including daf-2; csr-1; and hmg-3 based on RNA-seq and microarray studies.

WB:WBGene00194890	C01B9.4
Is affected by jmjd-3.1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00194891	Y6D1A.3
Is enriched in male gonad based on microarray studies. Is affected by several genes including daf-16; fbf-1; and prg-1 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; cadmium; and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00194892	dsb-2
Localizes to condensed chromosome. Is expressed in germ cell and gonad.

WB:WBGene00194894	T05B4.14
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by Ethanol and multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00194895	ZK105.11
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-12; sir-2.1; and dpy-21 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00194896	W02H5.11
Is affected by several genes including daf-16; eat-2; and spn-4 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00194898	C17B7.14
Is affected by several genes including sir-2.1; aak-2; and aak-1 based on RNA-seq and microarray studies.

WB:WBGene00194902	Y39H10B.3
Is affected by several genes including skn-1; hsf-1; and elt-2 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00194905	Y53F4B.51
Is enriched in neurons based on RNA-seq studies. Is affected by several genes including atfs-1; unc-70; and pmt-2 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194906	Y53C12A.11
Is enriched in germ line and intestine based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including manganese chloride; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00194907	E02H4.8
Is affected by sek-1; sir-2.1; and let-60 based on RNA-seq and microarray studies. Is affected by Rotenone based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194908	F22F7.8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including hsf-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including 1-methylnicotinamide; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00194909	F41E6.17
Is enriched in AVK; DA neuron; head mesodermal cell; and neurons based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; lin-35; and ain-1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00194910	ZC404.15
Is enriched in AVK and neurons based on RNA-seq studies. Is affected by several genes including pgl-1; csr-1; and glh-1 based on RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194912	ZK856.18
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; daf-12; and hsf-1 based on microarray and RNA-seq studies. Is affected by eight chemicals including allantoin; Sirolimus; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00194913	Y105C5A.1272
Is enriched in AFD based on RNA-seq studies. Is affected by cebp-1; alg-1; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00194914	F44D12.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including let-60; sir-2.1; and dpy-21 based on RNA-seq and microarray studies. Is affected by four chemicals including resveratrol; Acrylamide; and Colistin based on microarray studies.

WB:WBGene00194915	JC8.16
Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by stavudine and Zidovudine based on RNA-seq studies.

WB:WBGene00194916	F35D2.6
Is affected by several genes including rrf-3; eat-2; and pmk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including methylmercury hydroxide; stavudine; and Zidovudine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194917	Y45F10B.59
Is affected by several genes including eat-2; pgl-1; and csr-1 based on RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00194918	K08D8.9
Is affected by Psoralens and allantoin based on RNA-seq studies.

WB:WBGene00194919	K08D8.10
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00194920	H12I19.115
No description available

WB:WBGene00194921	ZK742.7
Is enriched in RIS based on RNA-seq studies. Is affected by several genes including skn-1; aak-2; and sma-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00194922	F13E9.19
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; dpy-21; and nhl-2 based on RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00194923	linc-121
Is affected by chd-3; let-418; and sin-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00194924	Y51H4A.936
Is affected by Sirolimus based on microarray studies.

WB:WBGene00194925	K08D8.11
Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00194926	K08D8.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; eat-2; and hif-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00194927	Y51H4A.937
No description available

WB:WBGene00194928	ZC513.14
Is affected by several genes including daf-16; dpy-7; and aak-2 based on RNA-seq studies. Is affected by tryptophan; nanoparticle; and Cry5B based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00194929	Y105C5B.1413
Is affected by dpy-21; daf-2; and sin-3 based on RNA-seq and microarray studies. Is affected by tryptophan and stavudine based on microarray and RNA-seq studies.

WB:WBGene00194930	Y73F8A.1159
No description available

WB:WBGene00194931	Y105C5A.1273
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00194932	F54F7.11
Is affected by several genes including hsp-6; mdt-15; and adr-1 based on RNA-seq studies.

WB:WBGene00194933	T12A7.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including tax-6; crh-1; and nhl-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194934	ZK809.9
Is enriched in NSM; somatic gonad precursor; and in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including sodium arsenite; Rifampin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Histidine phosphatase superfamily. Is an ortholog of human PXYLP1 (2-phosphoxylose phosphatase 1).

WB:WBGene00194935	M02G9.4
Is enriched in ASER and in male based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and hsp-6 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00194939	C01B9.5
Is affected by smg-2; ins-11; and daf-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194940	C34C6.9
Is affected by eat-2; cfp-1; and sin-3 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00194945	C32H11.16
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00194951	Y105C5A.1274
Is enriched in intestine based on microarray studies. Is affected by several genes including sir-2.1; lin-35; and nhr-25 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00194952	ZK666.14
Is enriched in hypodermis and in male based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and daf-12 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00194955	F37H8.6
Is affected by several genes including eat-2; sek-1; and alg-1 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00194957	Y116A8C.465
Is affected by several genes including daf-2; aak-2; and aak-1 based on microarray and RNA-seq studies.

WB:WBGene00194981	Y49E10.30
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by Alovudine and Humic Substances based on RNA-seq and microarray studies.

WB:WBGene00194982	Y17D7B.10
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by several genes including daf-2; aak-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by stavudine and antimycin based on RNA-seq studies.

WB:WBGene00194983	T25B2.4
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00194984	R102.15
Is affected by lem-2 and hsf-1 based on RNA-seq studies.

WB:WBGene00194985	Y25C1A.14
Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by six chemicals including 1-methylnicotinamide; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00194986	pigb-1
Is predicted to have mannosyltransferase activity. Is an ortholog of human PIGB (phosphatidylinositol glycan anchor biosynthesis class B).

WB:WBGene00194987	T14B4.10
No description available

WB:WBGene00194988	B0213.21
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00194989	B0213.22
No description available

WB:WBGene00194990	B0213.23
Is affected by dpy-21 and hmg-3 based on RNA-seq studies.

WB:WBGene00194991	B0213.24
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00194992	H27M09.6
Is affected by sftb-1 based on RNA-seq studies.

WB:WBGene00194993	T27E4.11
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including dlc-1; ints-2; and ints-1 based on RNA-seq studies.

WB:WBGene00194994	T27E4.12
Is affected by alg-1 and sftb-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00194995	C05G6.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00194996	Y69A2AR.36
Is affected by cep-1 and sftb-1 based on RNA-seq studies.

WB:WBGene00194997	F42C5.12
Is affected by several genes including pgl-1; glh-1; and hpl-2 based on RNA-seq studies.

WB:WBGene00194998	C16C4.18
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including eat-2; sir-2.1; and hpl-2 based on RNA-seq and microarray studies. Is affected by Rotenone and stavudine based on RNA-seq studies.

WB:WBGene00194999	B0205.15
No description available

WB:WBGene00195000	F54D8.7
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195001	Y17G9A.85
No description available

WB:WBGene00195002	T08B6.62
No description available

WB:WBGene00195003	Y46C8AL.11
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195004	K08D12.8
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00195005	ZK809.10
Is affected by cep-1; daf-2; and pmt-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195006	C35B1.9
Is affected by his-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00195007	mir-5595
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00195008	mir-4813
Is expressed in pharynx.

WB:WBGene00195009	F17E9.16
Is enriched in male based on RNA-seq studies. Is affected by adr-1 and eat-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00195010	Y37E11AL.12
Is affected by several genes including daf-2; eat-2; and aak-2 based on microarray and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00195011	ZK180.8
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by adr-1 and eat-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and paraquat based on RNA-seq studies.

WB:WBGene00195012	Y38C1BA.4
No description available

WB:WBGene00195014	H05L03.5
No description available

WB:WBGene00195015	H05L03.6
No description available

WB:WBGene00195016	srpr-2.1
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by manganese chloride based on RNA-seq studies.

WB:WBGene00195017	srpr-2.2
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by Ethanol and Tunicamycin based on RNA-seq studies.

WB:WBGene00195018	srpr-3
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including pgl-1; alg-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00195019	Y59H11AR.8
No description available

WB:WBGene00195020	Y59H11AR.9
Is affected by several genes including lem-2; emr-1; and tdp-1 based on RNA-seq studies.

WB:WBGene00195021	K08F11.7
No description available

WB:WBGene00195022	F39E9.15
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195023	F39E9.16
No description available

WB:WBGene00195024	F39E9.17
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00195025	F39E9.18
Is affected by several genes including sir-2.1; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and paraquat based on RNA-seq studies.

WB:WBGene00195026	F39E9.19
Is enriched in intestine based on microarray studies. Is affected by lin-14 and lin-4 based on microarray studies.

WB:WBGene00195027	F39E9.20
Is enriched in intestine based on microarray studies. Is affected by lin-14 and lin-4 based on microarray studies.

WB:WBGene00195028	F39E9.21
Is enriched in intestine based on microarray studies. Is affected by lin-14 and lin-4 based on microarray studies.

WB:WBGene00195029	Y37E11B.11
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00195030	F10E7.12
No description available

WB:WBGene00195031	Y37E3.23
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195032	Y37E3.24
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195033	Y37E3.25
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195034	F40G9.20
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by Cadmium Chloride based on RNA-seq studies.

WB:WBGene00195035	Y46H3C.9
No description available

WB:WBGene00195036	T08D2.10
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195037	F59H5.4
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195038	F59H6.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195039	K08A2.9
No description available

WB:WBGene00195040	K08A2.10
Is affected by several genes including sek-1; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195043	Y57G11C.1135
Is enriched in muscle cell based on RNA-seq studies. Is affected by several genes including cep-1; alg-1; and dpy-21 based on RNA-seq and microarray studies.

WB:WBGene00195045	W05F2.8
Is predicted to have chromatin binding activity and methylated histone binding activity.

WB:WBGene00195046	F42A9.11
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195048	K08D10.13
Is affected by several genes including let-418; chd-3; and nhr-114 based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domains: ShK domain-like and ShKT domain.

WB:WBGene00195049	CC8.3
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies. Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195050	T22D1.17
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and elt-2 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195051	T22D1.18
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by methylmercury hydroxide; multi-walled carbon nanotube; and glycine based on RNA-seq studies.

WB:WBGene00195056	C45E1.5
Is affected by sftb-1 and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00195057	B0261.9
Is affected by hpl-2; eat-2; and pfd-6 based on RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195058	C54E10.7
Is enriched in ASER based on RNA-seq studies. Is affected by fbf-1 based on microarray studies. Is affected by Chlorpyrifos; Diazinon; and Sirolimus based on microarray studies.

WB:WBGene00195060	linc-14
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and daf-12 based on RNA-seq studies. Is affected by graphene oxide and paraquat based on RNA-seq studies.

WB:WBGene00195061	ZK228.13
No description available

WB:WBGene00195063	coa-1
Is enriched in AVK; NSM; and germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and smn-1 based on RNA-seq and microarray studies. Is affected by Rotenone; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Cytochrome oxidase complex assembly protein 1 and Cytochrome c oxidase assembly factor 1. Is an ortholog of human COA1 (cytochrome c oxidase assembly factor 1 homolog).

WB:WBGene00195064	F17C11.20
Is affected by several genes including daf-16; daf-12; and cep-1 based on RNA-seq studies. Is affected by bisphenol A and bisphenol S based on RNA-seq studies.

WB:WBGene00195065	F20G2.9
Is affected by spt-16 and pmt-2 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00195067	C04C3.9
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including elt-2; nhl-2; and emb-4 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195068	Y48G8AL.16
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and aak-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00195069	W03G9.10
Is affected by tryptophan based on microarray studies. Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00195070	C16C8.20
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00195071	C16C8.21
Is affected by several genes including daf-2; rrf-1; and pptr-1 based on RNA-seq and microarray studies. Is affected by Ethanol and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Ubiquitin-like domain superfamily.

WB:WBGene00195072	C16C8.22
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Progesterone based on microarray studies.

WB:WBGene00195073	F02E11.7
Is enriched in neurons based on RNA-seq and microarray studies. Is affected by several genes including eat-2; pgl-1; and aak-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00195077	T24E12.13
Is affected by several genes including daf-2; let-60; and elt-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00195081	C04F6.7
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679); Protein kinase-like domain superfamily; Uncharacterised  oxidoreductase Dhs-27; and CHK kinase-like.

WB:WBGene00195084	C43C3.4
Is enriched in ASER and muscle cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00195086	F21C10.13
Is enriched in PLM; amphid sheath cell; and intestine based on RNA-seq studies. Is affected by elli-1 and nhl-2 based on microarray and RNA-seq studies. Is affected by Psoralens and allantoin based on RNA-seq studies.

WB:WBGene00195093	Y59E9AL.36
Is predicted to have RNA binding activity.

WB:WBGene00195117	T13F3.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00195142	M110.10
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; dpy-21; and hpl-2 based on RNA-seq studies. Is affected by five chemicals including Rotenone; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00195143	nlp-78
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by several genes including alg-1; atfs-1; and emb-4 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195144	C16D2.3
Is affected by spt-16 and rrf-3 based on RNA-seq studies.

WB:WBGene00195145	ZK666.15
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including daf-16; elt-2; and sma-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195146	F54D5.17
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq studies. Is affected by five chemicals including tryptophan; Zidovudine; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00195147	F14E5.8
Is enriched in ASER and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including manganese chloride; multi-walled carbon nanotube; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00195148	W02B12.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; nhl-2; and adr-1 based on RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq studies.

WB:WBGene00195149	F26H11.8
Is affected by hpl-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195150	Y81G3A.6
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00195151	F53H2.4
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including prg-1; sma-2; and sma-4 based on RNA-seq studies.

WB:WBGene00195154	F13A2.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq studies. Is affected by five chemicals including metformin; Psoralens; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00195155	W04A8.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by five chemicals including Rotenone; Alovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00195157	C12D8.21
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by alg-1; zip-2; and nuo-6 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00195158	F26F2.11
Is affected by ifo-1 based on microarray studies.

WB:WBGene00195159	T04C12.14
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by dpy-21; his-3; and sek-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195160	Y47D7A.17
Is affected by several genes including dpy-21; hpl-2; and nhl-2 based on RNA-seq and microarray studies.

WB:WBGene00195164	K12B6.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; multi-walled carbon nanotube; and Zidovudine based on RNA-seq studies.

WB:WBGene00195165	F57G4.11
Is affected by several genes including daf-16; glp-1; and skn-1 based on microarray and RNA-seq studies. Is affected by nine chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain and Domain of unknown function DUF38, Caenorhabditis species.

WB:WBGene00195166	W05B10.6
Is affected by emb-4 and spc-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195168	T13C5.9
Is affected by several genes including rrf-3; aak-2; and isp-1 based on RNA-seq studies. Is affected by Rifampin; allantoin; and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00195169	Y50D4A.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and eat-2 based on RNA-seq studies. Is affected by six chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq studies.

WB:WBGene00195170	linc-61
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and hsf-1 based on RNA-seq studies.

WB:WBGene00195171	T09D3.9
Is enriched in CEM; HOB; IL2 neuron; and ray neuron type B based on RNA-seq studies.

WB:WBGene00195172	K10G4.14
Is affected by cep-1; adr-1; and smn-1 based on RNA-seq studies.

WB:WBGene00195174	K08E5.6
Is affected by elt-2; elt-7; and smn-1 based on RNA-seq studies.

WB:WBGene00195175	Y105E8A.36
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sma-2 based on RNA-seq and microarray studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00195176	Y43F8B.24
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-12; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including tryptophan; Zidovudine; and Psoralens based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00195177	Y43F8B.25
Is affected by several genes including hsf-1; eat-2; and lin-35 based on RNA-seq and microarray studies. Is affected by five chemicals including multi-walled carbon nanotube; Cry5B; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00195178	ZC581.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on microarray and RNA-seq studies. Is affected by five chemicals including manganese chloride; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00195179	F48C1.11
Is affected by several genes including daf-16; skn-1; and dpy-10 based on microarray and RNA-seq studies. Is affected by eleven chemicals including tryptophan; multi-walled carbon nanotube; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00195180	C41D11.10
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; dop-1; and adr-1 based on microarray and RNA-seq studies. Is affected by six chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00195181	F15H10.12
Is affected by several genes including dpy-21; smn-1; and emb-4 based on microarray and RNA-seq studies. Is affected by four chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195182	C17G10.10
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; dpy-21; and hpl-2 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195183	R04A9.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rotenone; manganese chloride; and Alovudine based on RNA-seq studies.

WB:WBGene00195184	F19G12.8
Is enriched in intestine; pharynx; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including stavudine; Atrazine; and dibromoacetic acid based on RNA-seq and microarray studies.

WB:WBGene00195185	F19G12.9
Is enriched in AFD and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and eat-2 based on RNA-seq studies. Is affected by eight chemicals including Rotenone; metformin; and Psoralens based on RNA-seq studies.

WB:WBGene00195186	F19G12.10
Is enriched in PLM and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pgl-1 based on RNA-seq studies. Is affected by eight chemicals including Cadmium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00195188	F19G12.11
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00195189	ZC449.8
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and npr-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00195192	C54F6.16
Is affected by dpy-21 and smg-2 based on RNA-seq studies.

WB:WBGene00195208	W02H3.3
Is affected by sir-2.1 based on microarray studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00195209	C07B5.8
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00195210	Y7A5A.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00195211	C34F6.12
No description available

WB:WBGene00195212	F09B12.7
Is affected by several genes including aak-2; alg-1; and alg-2 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00195213	F11C1.9
Is affected by several genes including daf-2; dpy-21; and adr-2 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195214	F11C1.10
Is affected by several genes including rrf-3; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: Lipid droplet-associated hydrolase.

WB:WBGene00195215	F55G7.5
Is enriched in male based on RNA-seq studies. Is affected by dpy-21 and eat-2 based on RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00195226	ZC404.16
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; unc-70; and let-418 based on RNA-seq studies.

WB:WBGene00195227	Y71A12B.23
Is enriched in male based on RNA-seq studies. Is affected by several genes including eat-2; pgl-1; and hsp-6 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and antimycin based on RNA-seq studies.

WB:WBGene00195228	Y71A12B.24
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00195229	Y71A12B.25
No description available

WB:WBGene00195230	F36D1.13
No description available

WB:WBGene00195231	F36D1.14
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195232	F36D1.15
Is affected by pmt-2 and daf-2 based on microarray and RNA-seq studies.

WB:WBGene00195233	F31E9.11
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and clk-1 based on RNA-seq studies. Is affected by Rotenone; antimycin; and paraquat based on RNA-seq studies.

WB:WBGene00195234	C14C10.9
Is affected by dpy-21 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195235	C47E8.12
Is affected by dpy-21 and alg-1 based on RNA-seq studies.

WB:WBGene00195236	mir-356.2
Is affected by several genes including alg-1; prg-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00195237	Y116F11B.18
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195238	mir-4805
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00195239	ZK1127.13
Is enriched in AFD; germ line; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Ribonuclease H2 non-catalytic subunit (Ylr154p-like) and Ribonuclease H2, subunit C. Is an ortholog of human RNASEH2C (ribonuclease H2 subunit C).

WB:WBGene00195240	Y39B6A.69
Is affected by several genes including eat-2; hpl-2; and his-3 based on RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00195241	Y113G7B.27
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; bisphenol A; and Psoralens based on RNA-seq studies.

WB:WBGene00195242	Y113G7B.28
Is affected by eat-2 based on RNA-seq studies.

WB:WBGene00195243	F46B3.23
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00195244	F30A10.15
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rotenone; stavudine; and Psoralens based on RNA-seq studies.

WB:WBGene00195245	T26A8.6
Is affected by several genes including daf-2; prg-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00195246	ZK546.19
Is enriched in intestine based on microarray studies. Is affected by several genes including sir-2.1; nhl-2; and dlc-1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00195247	F41D3.15
No description available

WB:WBGene00195248	emc-5
Is predicted to have inorganic cation transmembrane transporter activity. Is an ortholog of human MMGT1 (membrane magnesium transporter 1).

WB:WBGene00195250	C13C4.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsp-6; lem-2; and emr-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195252	K10D6.6
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195253	H16D19.5
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on RNA-seq studies. Is affected by five chemicals including Rotenone; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00195254	H16D19.6
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including rrf-3; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00195255	H16D19.7
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by Rifampin and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00195256	F25D1.8
No description available

WB:WBGene00195257	W01A8.10
Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; metformin; and Psoralens based on RNA-seq studies.

WB:WBGene00195258	F11D5.8
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00195259	C16E9.7
No description available

WB:WBGene00195260	T27F7.5
No description available

WB:WBGene00195261	F26A10.4
No description available

WB:WBGene00195262	T22B7.9
No description available

WB:WBGene00195263	F02E8.7
No description available

WB:WBGene00195264	F14B8.8
No description available

WB:WBGene00195265	F47B7.9
No description available

WB:WBGene00195266	ZC132.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by elli-1 and adr-1 based on microarray and RNA-seq studies.

WB:WBGene00195267	C45E5.53
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00195268	C39F7.6
No description available

WB:WBGene00195269	F49E10.8
No description available

WB:WBGene00195270	T23F11.7
No description available

WB:WBGene00195271	F45H7.8
No description available

WB:WBGene00195272	C33F10.15
No description available

WB:WBGene00195273	K11E4.7
No description available

WB:WBGene00195274	ZK617.7
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195275	ZK867.4
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195276	T27E4.13
No description available

WB:WBGene00195277	Y38H6C.26
No description available

WB:WBGene00195278	F46G11.7
No description available

WB:WBGene00195279	C05D2.12
No description available

WB:WBGene00195280	Y67A10A.342
Is affected by tatn-1 based on RNA-seq studies.

WB:WBGene00195281	M79.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195282	Y43F8A.6
No description available

WB:WBGene00195283	F27C8.11
No description available

WB:WBGene00195284	Y55H10A.3
No description available

WB:WBGene00195285	T02E9.8
No description available

WB:WBGene00195286	C03E10.8
No description available

WB:WBGene00195287	B0495.11
No description available

WB:WBGene00195288	C11D2.98
No description available

WB:WBGene00195289	Y39G10AR.26
No description available

WB:WBGene00195290	F14D12.7
No description available

WB:WBGene00195291	T06F4.4
No description available

WB:WBGene00195292	Y47D3B.13
No description available

WB:WBGene00195293	F56A4.13
Is affected by daf-2 and ifo-1 based on microarray studies.

WB:WBGene00195294	C32A3.4
No description available

WB:WBGene00195295	F11D5.9
Is affected by cep-1; dlc-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195296	C08E8.12
No description available

WB:WBGene00195297	T19D2.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00195298	F14F3.6
No description available

WB:WBGene00195299	F11C1.11
No description available

WB:WBGene00195300	ZC190.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195301	F12F6.12
No description available

WB:WBGene00195302	ZK1131.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195303	Y22D7AR.16
No description available

WB:WBGene00195304	ZC53.8
No description available

WB:WBGene00195305	W05E10.7
No description available

WB:WBGene00195306	K07C11.13
No description available

WB:WBGene00195307	C31G12.5
No description available

WB:WBGene00195308	ZK617.8
No description available

WB:WBGene00195309	F59B8.5
Is affected by several genes including prg-1; lem-2; and emr-1 based on RNA-seq and microarray studies.

WB:WBGene00195310	ZK1086.5
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195311	M110.11
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00195312	C34H3.3
No description available

WB:WBGene00195313	F47E1.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00195314	F40F12.10
Is affected by wdr-23 based on RNA-seq studies.

WB:WBGene00195315	Y47H9C.16
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195316	T03G11.12
No description available

WB:WBGene00195317	T23G5.9
No description available

WB:WBGene00195318	C18C4.11
No description available

WB:WBGene00195319	R12A1.5
No description available

WB:WBGene00195320	Y53H1C.4
No description available

WB:WBGene00195321	C46F11.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195322	T06E4.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195323	B0432.16
No description available

WB:WBGene00195324	F56E3.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195325	K04H4.8
Is affected by Cry5B based on microarray studies.

WB:WBGene00195326	T06H11.6
No description available

WB:WBGene00195327	F11D5.10
No description available

WB:WBGene00195328	C01B7.8
No description available

WB:WBGene00195329	ZK512.12
No description available

WB:WBGene00195330	K08A8.4
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00195331	R10E12.3
No description available

WB:WBGene00195332	C40C9.6
No description available

WB:WBGene00195333	F54F12.3
No description available

WB:WBGene00195334	F52E4.9
No description available

WB:WBGene00195335	B0454.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195336	ZC581.11
No description available

WB:WBGene00195337	C31H2.5
No description available

WB:WBGene00195338	T02E9.9
No description available

WB:WBGene00195339	H32C10.94
No description available

WB:WBGene00195340	M88.9
No description available

WB:WBGene00195341	F54D5.18
No description available

WB:WBGene00195342	T19C4.15
No description available

WB:WBGene00195343	Y53C12A.12
No description available

WB:WBGene00195344	ZK525.4
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00195345	F25F6.2
Is affected by daf-2 based on microarray studies.

WB:WBGene00195346	W02H5.13
No description available

WB:WBGene00195347	K03H9.5
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00195348	F25H8.8
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00195349	ZK622.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00195350	ZK973.12
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195351	ZK40.3
No description available

WB:WBGene00195352	C10G11.12
No description available

WB:WBGene00195353	Y73F8A.1160
No description available

WB:WBGene00195354	ZK593.13
No description available

WB:WBGene00195355	Y92H12A.8
No description available

WB:WBGene00195356	F57H12.10
No description available

WB:WBGene00195357	F52E10.6
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195358	B0507.13
No description available

WB:WBGene00195359	R07G3.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195360	K05B2.6
No description available

WB:WBGene00195361	C24E9.1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195362	Y82E9BR.26
No description available

WB:WBGene00195363	M01H9.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195364	M01G4.3
No description available

WB:WBGene00195365	F45E4.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195366	C50F4.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195367	B0524.7
Is affected by several genes including daf-12; dpy-21; and lin-22 based on tiling array and RNA-seq studies.

WB:WBGene00195368	F28F5.8
Is affected by cep-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00195369	Y65B4BL.8
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00195370	F29B9.13
No description available

WB:WBGene00195371	C30C11.5
No description available

WB:WBGene00195372	C05E11.9
No description available

WB:WBGene00195373	F56F10.7
No description available

WB:WBGene00195374	R10E8.10
Is enriched in AFD; ASER; and intestine based on RNA-seq studies. Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00195375	C34E7.6
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195376	F16F9.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195377	F45B8.6
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00195378	T19E7.22
No description available

WB:WBGene00195379	ZK945.10
No description available

WB:WBGene00195380	C52G5.4
No description available

WB:WBGene00195381	C53D6.17
No description available

WB:WBGene00195382	F29F11.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195383	C09B8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195384	T13H10.4
No description available

WB:WBGene00195385	ZK867.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195386	T09E8.6
Is affected by let-418 and dlc-1 based on RNA-seq studies.

WB:WBGene00195387	F02D10.10
Is affected by lin-28; hmg-3; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195388	F12D9.3
No description available

WB:WBGene00195389	F54E4.5
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195390	ZC518.6
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195391	F46H6.7
No description available

WB:WBGene00195392	C07E3.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00195393	F28E10.6
No description available

WB:WBGene00195394	F32H2.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195395	C41A3.3
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195396	ZK40.4
No description available

WB:WBGene00195397	C54G7.5
No description available

WB:WBGene00195398	F55B12.12
No description available

WB:WBGene00195399	F35G2.7
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195400	B0379.8
No description available

WB:WBGene00195401	C06G1.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00195402	F44A6.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00195403	F28C1.10
No description available

WB:WBGene00195404	C10E2.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195405	F59C6.17
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00195406	B0350.67
No description available

WB:WBGene00195407	F08G5.9
No description available

WB:WBGene00195408	F10C1.11
No description available

WB:WBGene00195409	T10A3.2
No description available

WB:WBGene00195410	C39B5.15
No description available

WB:WBGene00195411	Y17G7A.2
No description available

WB:WBGene00195412	K03H1.16
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195413	D1022.11
No description available

WB:WBGene00195414	C33F10.16
Is affected by eat-2 based on microarray studies.

WB:WBGene00195415	C15F1.12
No description available

WB:WBGene00195416	C25F6.9
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195417	C16C2.5
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00195418	F48C5.3
No description available

WB:WBGene00195419	R173.5
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00195420	T10B5.12
No description available

WB:WBGene00195421	T25F10.7
No description available

WB:WBGene00195422	Y111B2A.31
No description available

WB:WBGene00195423	F55C10.7
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00195424	Y48G8AL.17
No description available

WB:WBGene00195425	ZC8.7
Is affected by cep-1; dlc-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195426	C10H11.11
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00195427	F02A9.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195428	F55E10.8
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00195429	C45B2.9
No description available

WB:WBGene00195430	C25F6.10
Is affected by several genes including cep-1; alg-1; and adr-1 based on RNA-seq studies.

WB:WBGene00195431	W02F12.9
No description available

WB:WBGene00195432	C56E6.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00195433	F41D9.6
No description available

WB:WBGene00195434	K07E8.13
No description available

WB:WBGene00195435	K01A6.9
No description available

WB:WBGene00195436	Y69A2AR.37
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195437	T07D3.10
No description available

WB:WBGene00195438	K08H10.13
No description available

WB:WBGene00195439	T27A8.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00195440	F59B2.16
No description available

WB:WBGene00195441	F07A11.9
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq and microarray studies.

WB:WBGene00195442	C54D10.15
No description available

WB:WBGene00195443	Y71F9B.17
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195444	T15B7.18
No description available

WB:WBGene00195445	Y23H5A.9
No description available

WB:WBGene00195446	T01B4.4
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00195447	F59D12.7
No description available

WB:WBGene00195448	T19B4.9
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00195449	F10D7.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195450	F35G12.14
Is affected by cep-1 and klf-1 based on RNA-seq studies.

WB:WBGene00195451	C09B7.5
No description available

WB:WBGene00195452	D2021.5
No description available

WB:WBGene00195453	T04C12.15
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00195454	ZK742.8
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00195455	C48E7.12
No description available

WB:WBGene00195456	T06F4.5
No description available

WB:WBGene00195457	K05D4.11
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00195458	K04A8.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195459	F27D4.9
No description available

WB:WBGene00195460	M70.6
No description available

WB:WBGene00195461	F28E10.7
No description available

WB:WBGene00195462	C52B11.6
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195463	ZK863.10
Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00195464	B0454.13
No description available

WB:WBGene00195465	Y37F4.10
No description available

WB:WBGene00195466	C33D12.9
No description available

WB:WBGene00195467	F12D9.4
No description available

WB:WBGene00195468	F53H10.4
No description available

WB:WBGene00195469	F46G11.8
No description available

WB:WBGene00195470	M03F8.8
No description available

WB:WBGene00195471	C40C9.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00195472	T21B6.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195473	F41E7.10
No description available

WB:WBGene00195474	K03H6.8
No description available

WB:WBGene00195475	K03H6.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00195476	F33D11.13
No description available

WB:WBGene00195477	Y57G11C.1136
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195478	F58A3.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195479	R09F10.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195480	F42D1.5
No description available

WB:WBGene00195481	ZK867.6
No description available

WB:WBGene00195482	B0350.68
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195483	F22A3.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195484	K03C7.4
No description available

WB:WBGene00195485	F55A12.11
No description available

WB:WBGene00195486	ZC308.5
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195487	C24A8.7
No description available

WB:WBGene00195488	F20B10.5
No description available

WB:WBGene00195489	Y55D5A.8
No description available

WB:WBGene00195490	C09D8.2
No description available

WB:WBGene00195491	H03A11.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195492	F36G3.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195493	M03D4.74
No description available

WB:WBGene00195494	F48C11.5
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195495	K02B9.6
No description available

WB:WBGene00195496	C40C9.8
No description available

WB:WBGene00195497	C48C5.4
No description available

WB:WBGene00195498	F56D12.8
No description available

WB:WBGene00195499	H22K11.5
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00195500	F32G8.8
No description available

WB:WBGene00195501	T10B5.13
No description available

WB:WBGene00195502	Y38C1AB.9
No description available

WB:WBGene00195503	Y110A2AL.16
No description available

WB:WBGene00195504	F11A6.4
No description available

WB:WBGene00195505	R03D7.9
Is affected by several genes including daf-16; daf-12; and cep-1 based on RNA-seq studies.

WB:WBGene00195506	C08C3.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00195507	T03G11.13
No description available

WB:WBGene00195508	C11E4.9
Is affected by dlc-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00195509	C15H7.6
No description available

WB:WBGene00195510	F55A8.3
No description available

WB:WBGene00195511	C03C10.10
No description available

WB:WBGene00195512	C04C11.5
No description available

WB:WBGene00195513	F38B6.9
No description available

WB:WBGene00195514	Y73A3A.1
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195515	ZK381.34
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195516	M01G5.7
No description available

WB:WBGene00195517	C05E11.10
Is affected by several genes including prg-1; hmg-4; and hmg-3 based on RNA-seq studies.

WB:WBGene00195518	ZK652.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195519	Y73B3A.23
Is affected by several genes including pgl-1; prg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195520	C18F3.6
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195521	C06A8.13
No description available

WB:WBGene00195522	F01G12.9
No description available

WB:WBGene00195523	C43C3.5
No description available

WB:WBGene00195524	F33C8.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00195525	C09F9.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195526	R07B1.15
No description available

WB:WBGene00195527	C09D8.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195528	K08B5.3
No description available

WB:WBGene00195529	F11A6.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195530	T04G9.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195531	C02B10.71
No description available

WB:WBGene00195532	C03F11.5
No description available

WB:WBGene00195533	Y55F3BR.12
No description available

WB:WBGene00195534	C29E6.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195535	B0432.17
No description available

WB:WBGene00195536	C55A6.14
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00195537	F10C2.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195538	M79.6
Is affected by nanoparticle based on microarray studies.

WB:WBGene00195539	C12D8.22
No description available

WB:WBGene00195540	T10E10.8
No description available

WB:WBGene00195541	F56C3.11
No description available

WB:WBGene00195542	C24A3.10
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00195543	W06H8.9
No description available

WB:WBGene00195544	Y95B8A.13
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00195545	F45B8.7
No description available

WB:WBGene00195546	ZK1025.11
No description available

WB:WBGene00195547	T28B11.2
Is enriched in AVK based on RNA-seq studies. Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195548	C16E9.8
No description available

WB:WBGene00195549	K02E11.13
No description available

WB:WBGene00195550	C10C5.9
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195551	C26E1.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195552	C05D12.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195553	F15D3.10
No description available

WB:WBGene00195554	T22E5.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195555	C27D11.2
No description available

WB:WBGene00195556	K11G9.7
No description available

WB:WBGene00195557	Y37E11B.12
No description available

WB:WBGene00195558	C18A3.13
No description available

WB:WBGene00195559	K07H8.14
No description available

WB:WBGene00195560	T06G6.13
No description available

WB:WBGene00195561	Y38A10A.8
No description available

WB:WBGene00195562	F28F5.9
No description available

WB:WBGene00195563	F19H6.8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00195564	ZC64.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195565	C48A7.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00195566	ZC64.6
No description available

WB:WBGene00195567	C23F12.6
No description available

WB:WBGene00195568	F12D9.5
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195569	M117.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195570	W06F12.5
No description available

WB:WBGene00195571	T24D8.10
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00195572	T21B6.7
No description available

WB:WBGene00195573	K08B5.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00195574	ZC13.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195575	B0563.12
No description available

WB:WBGene00195576	Y67D8C.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195577	C06E1.12
No description available

WB:WBGene00195578	W10C8.7
No description available

WB:WBGene00195579	C47G2.10
No description available

WB:WBGene00195580	R07D5.3
No description available

WB:WBGene00195581	F26C11.5
No description available

WB:WBGene00195582	C06E8.6
Is affected by cep-1; daf-2; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195583	R11B5.2
Is affected by eat-2 based on microarray studies.

WB:WBGene00195584	C34F6.13
No description available

WB:WBGene00195585	T28D6.11
No description available

WB:WBGene00195586	C34F11.10
No description available

WB:WBGene00195587	R04F11.7
No description available

WB:WBGene00195588	K08E5.7
No description available

WB:WBGene00195589	Y116F11B.19
No description available

WB:WBGene00195590	F43G9.14
No description available

WB:WBGene00195591	R53.9
No description available

WB:WBGene00195592	T02E1.10
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00195593	C34E11.8
No description available

WB:WBGene00195594	F31E8.7
No description available

WB:WBGene00195595	C56E6.11
No description available

WB:WBGene00195596	C15C6.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195597	Y73F8A.1161
No description available

WB:WBGene00195598	T21D9.3
No description available

WB:WBGene00195599	K08E5.8
No description available

WB:WBGene00195600	K08H10.14
Is affected by dlc-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00195601	M176.13
No description available

WB:WBGene00195602	T14B4.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195603	T04F8.10
No description available

WB:WBGene00195604	T14B4.12
No description available

WB:WBGene00195605	Y53C10A.16
No description available

WB:WBGene00195606	T26E3.13
No description available

WB:WBGene00195607	Y73F8A.1162
No description available

WB:WBGene00195608	F56G4.8
No description available

WB:WBGene00195609	Y41C4A.23
No description available

WB:WBGene00195610	ZC123.5
No description available

WB:WBGene00195611	K08D9.7
No description available

WB:WBGene00195612	Y51H7C.16
No description available

WB:WBGene00195613	T06D10.5
No description available

WB:WBGene00195614	F48C5.4
Is affected by eat-2 based on microarray studies.

WB:WBGene00195615	Y106G6A.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195616	C49F8.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195617	C52B9.13
No description available

WB:WBGene00195618	F37D6.7
No description available

WB:WBGene00195619	C17C3.21
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195620	F59C12.6
No description available

WB:WBGene00195621	F43H9.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195622	C50D2.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195623	Y54G2A.58
No description available

WB:WBGene00195624	R31.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195625	Y58A7A.7
Is affected by tdp-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195626	F13B12.12
No description available

WB:WBGene00195627	R13A1.13
No description available

WB:WBGene00195628	C48D1.10
Is affected by nanoparticle based on microarray studies.

WB:WBGene00195629	C05G5.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195630	F26D11.14
No description available

WB:WBGene00195631	F46F2.9
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00195632	Y80E2A.1
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195633	F44C4.9
No description available

WB:WBGene00195634	AC3.14
No description available

WB:WBGene00195635	T27D12.7
No description available

WB:WBGene00195636	ZK813.8
No description available

WB:WBGene00195637	C10F3.9
No description available

WB:WBGene00195638	W03G11.6
Is affected by pgrn-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195639	T03F7.10
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00195640	Y59A8B.27
No description available

WB:WBGene00195641	F58F12.5
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195642	R08B4.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195643	C01F1.7
No description available

WB:WBGene00195644	Y57A10B.8
No description available

WB:WBGene00195645	F25F8.5
No description available

WB:WBGene00195646	T01C1.5
No description available

WB:WBGene00195647	ZC487.6
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195648	W09B12.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195649	F10E9.13
No description available

WB:WBGene00195650	F58F12.6
No description available

WB:WBGene00195651	F07C3.11
Is affected by chd-3 and let-418 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195652	K11H3.9
No description available

WB:WBGene00195653	W10D9.7
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195654	Y73B6BL.271
No description available

WB:WBGene00195655	F43D9.7
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195656	T01H3.6
No description available

WB:WBGene00195657	D1009.7
No description available

WB:WBGene00195658	C34D1.6
No description available

WB:WBGene00195659	Y69E1A.9
No description available

WB:WBGene00195660	R07E3.9
No description available

WB:WBGene00195661	C08G9.4
No description available

WB:WBGene00195662	T19F4.2
Is affected by adr-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00195663	T24D11.2
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195664	C09B8.11
No description available

WB:WBGene00195665	C48A7.6
No description available

WB:WBGene00195666	C34E11.9
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00195667	F46C8.9
Is affected by chd-3 and let-418 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00195668	R11B5.3
No description available

WB:WBGene00195669	F47E1.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195670	F52B10.4
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195671	R186.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195672	Y37E3.26
No description available

WB:WBGene00195673	K08A8.5
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00195674	B0280.19
No description available

WB:WBGene00195675	F49C5.13
Is affected by dpy-21 and pmt-2 based on RNA-seq and microarray studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00195676	Y49E10.31
No description available

WB:WBGene00195677	F31E8.8
No description available

WB:WBGene00195678	W03G11.7
Is affected by pgrn-1 and dpy-21 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00195679	Y51H7C.17
No description available

WB:WBGene00195680	T22B11.6
No description available

WB:WBGene00195681	C14E2.9
No description available

WB:WBGene00195682	F57G4.12
No description available

WB:WBGene00195683	C15C6.6
No description available

WB:WBGene00195684	F08F3.12
Is affected by hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195685	Y42A5A.8
No description available

WB:WBGene00195686	Y70D2A.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195687	K03A1.8
No description available

WB:WBGene00195688	ZK180.9
No description available

WB:WBGene00195689	K10D6.7
No description available

WB:WBGene00195690	ZK381.35
Is affected by cep-1; daf-2; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195691	C35D10.18
No description available

WB:WBGene00195692	C14F11.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195693	T26H10.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195694	C43G2.25
No description available

WB:WBGene00195695	F54D12.12
No description available

WB:WBGene00195696	C54G7.6
No description available

WB:WBGene00195697	F28C1.11
No description available

WB:WBGene00195698	T22E5.9
No description available

WB:WBGene00195699	K04G11.7
No description available

WB:WBGene00195700	F13D12.11
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195701	F09B9.6
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00195702	F49C5.14
No description available

WB:WBGene00195703	F26A10.5
No description available

WB:WBGene00195704	C13C12.4
Is affected by Cry5B based on microarray studies.

WB:WBGene00195705	Y37A1B.330
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195706	K07C10.4
No description available

WB:WBGene00195707	C11G10.3
No description available

WB:WBGene00195708	F37B12.6
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195709	K04D7.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195710	B0416.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00195711	F56E3.6
No description available

WB:WBGene00195712	F41D9.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195713	F45D3.7
No description available

WB:WBGene00195714	C10F3.10
No description available

WB:WBGene00195715	F10F2.10
No description available

WB:WBGene00195716	R09A1.6
No description available

WB:WBGene00195717	T04C10.6
No description available

WB:WBGene00195718	W06B11.5
No description available

WB:WBGene00195719	C36F7.8
No description available

WB:WBGene00195720	F09E5.18
No description available

WB:WBGene00195721	ZC506.5
No description available

WB:WBGene00195722	C31H2.6
No description available

WB:WBGene00195723	C35A5.12
No description available

WB:WBGene00195724	C04C3.10
No description available

WB:WBGene00195725	F48B9.9
Is affected by ifo-1 based on microarray studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00195726	Y116F11B.20
No description available

WB:WBGene00195727	ZK377.4
Is affected by several genes including daf-16; daf-12; and cep-1 based on RNA-seq studies.

WB:WBGene00195728	T28D9.13
Is affected by pmt-2 and ints-4 based on microarray and RNA-seq studies.

WB:WBGene00195729	Y7A5A.14
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00195730	F54C9.15
No description available

WB:WBGene00195731	C49F8.6
No description available

WB:WBGene00195732	F14H12.9
Is affected by several genes including eat-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00195733	T28B11.3
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195734	F09C12.11
No description available

WB:WBGene00195735	ZK185.6
No description available

WB:WBGene00195736	F35E8.17
No description available

WB:WBGene00195737	Y82E9BR.27
Is affected by cep-1 and nhr-86 based on RNA-seq studies.

WB:WBGene00195738	T27F2.5
No description available

WB:WBGene00195739	Y66A7AL.1
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195740	F54E4.6
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195741	W05B2.10
No description available

WB:WBGene00195742	F54A3.7
No description available

WB:WBGene00195743	F55D10.6
No description available

WB:WBGene00195744	C14B9.11
Is affected by several genes including skn-1; cep-1; and unc-70 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00195745	ZK836.4
Is affected by cep-1; dlc-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00195746	F25B5.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195747	F17C8.10
No description available

WB:WBGene00195748	T28B11.4
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195749	K02F2.7
No description available

WB:WBGene00195750	F18E2.7
No description available

WB:WBGene00195751	C12C8.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00195752	Y106G6A.7
Is affected by cep-1; dlc-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00195753	B0350.69
No description available

WB:WBGene00195754	W09H1.7
Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00195755	B0207.13
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00195756	H05G16.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195757	T06A10.105
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00195758	F18E2.8
No description available

WB:WBGene00195759	T02E9.10
No description available

WB:WBGene00195760	K01A6.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00195761	C18B12.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195762	ZC64.7
No description available

WB:WBGene00195763	F40H6.7
No description available

WB:WBGene00195764	C04C11.6
No description available

WB:WBGene00195765	T08G2.4
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195766	F10C1.12
No description available

WB:WBGene00195767	T08A9.15
No description available

WB:WBGene00195768	T28B4.5
No description available

WB:WBGene00195769	Y39B6A.70
No description available

WB:WBGene00195770	H21P03.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00195771	W05F2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195772	C03H12.2
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00195773	Y66D12A.26
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195774	F20D1.12
No description available

WB:WBGene00195775	T05A6.8
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00195776	F37D6.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195777	D2023.10
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00195778	PAR2.5
No description available

WB:WBGene00195779	Y71H2AM.27
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00195780	T03G11.14
No description available

WB:WBGene00195781	T01B10.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195782	T13H2.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195783	D2007.6
No description available

WB:WBGene00195784	F31E8.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195785	C18B12.10
Is affected by pmt-2 based on microarray studies.

WB:WBGene00195786	C34H3.4
No description available

WB:WBGene00195787	F40E10.7
No description available

WB:WBGene00195788	F25D1.9
No description available

WB:WBGene00195789	K08A8.6
No description available

WB:WBGene00195790	F58H1.10
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195791	F42H10.9
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00195792	F58A4.16
Is affected by cep-1; hpl-2; and nhr-86 based on RNA-seq studies.

WB:WBGene00195793	B0496.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195794	B0393.11
Is affected by tdp-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00195795	R07E4.7
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195796	Y92C3A.4
No description available

WB:WBGene00195797	T14F9.6
No description available

WB:WBGene00195798	C33A11.5
No description available

WB:WBGene00195799	K07E12.3
No description available

WB:WBGene00195800	T19D12.11
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00195801	F35B12.11
Is affected by cep-1 and fog-2 based on RNA-seq studies.

WB:WBGene00195802	H14N18.5
No description available

WB:WBGene00195803	F46E10.13
Is affected by cep-1; tdp-1; and adr-1 based on RNA-seq studies.

WB:WBGene00195804	F11E6.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00195805	F35G2.8
Is affected by cep-1 based on RNA-seq studies. Is affected by 4-bromodiphenyl ether based on microarray studies.

WB:WBGene00195806	EGAP3.1
No description available

WB:WBGene00195807	F56H11.8
No description available

WB:WBGene00195808	F55C12.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195809	ZC455.14
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00195810	Y97E10AM.2
No description available

WB:WBGene00195811	H09I01.4
No description available

WB:WBGene00195812	C25B8.9
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00195813	F31C3.13
Is affected by tdp-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00195814	F59D12.8
No description available

WB:WBGene00195815	H08J11.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195816	C34B4.9
No description available

WB:WBGene00195817	K10C3.7
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00195818	F48C5.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195819	C13G3.4
Is affected by fog-2 based on RNA-seq studies.

WB:WBGene00195820	T22E5.10
No description available

WB:WBGene00195821	T03G6.4
No description available

WB:WBGene00195822	F28F9.7
No description available

WB:WBGene00195823	F53A9.11
No description available

WB:WBGene00195824	F27D9.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00195825	F27E11.6
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00195826	B0496.13
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00195827	Y34B4A.12
No description available

WB:WBGene00195828	Y105C5B.1414
No description available

WB:WBGene00195829	T26H2.13
No description available

WB:WBGene00195830	H03A11.5
No description available

WB:WBGene00195831	K03B8.15
No description available

WB:WBGene00195832	T28B11.5
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00195833	mir-8209
No description available

WB:WBGene00195834	H13N06.8
No description available

WB:WBGene00195835	C34B2.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00195836	F13E6.8
No description available

WB:WBGene00195837	F49E10.9
No description available

WB:WBGene00195838	F52B10.5
No description available

WB:WBGene00195839	T23F1.8
No description available

WB:WBGene00195840	F35B12.12
No description available

WB:WBGene00195841	C18A3.14
No description available

WB:WBGene00195842	F56E3.7
No description available

WB:WBGene00195843	F57G12.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195844	T04F3.6
No description available

WB:WBGene00195845	F15A2.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195846	F02H6.72
No description available

WB:WBGene00195847	Y52E8A.7
No description available

WB:WBGene00195848	F54H5.7
Is affected by ifo-1 based on microarray studies.

WB:WBGene00195849	ZC250.6
Is affected by emr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195850	F57C7.7
No description available

WB:WBGene00195851	F09C8.3
No description available

WB:WBGene00195852	T13H10.5
No description available

WB:WBGene00195853	Y73B6BL.272
No description available

WB:WBGene00195854	F32D8.16
No description available

WB:WBGene00195855	W06A7.6
Is affected by cep-1; spt-16; and adr-1 based on RNA-seq studies.

WB:WBGene00195856	C55A6.15
No description available

WB:WBGene00195857	C16E9.9
No description available

WB:WBGene00195858	F48C11.6
No description available

WB:WBGene00195859	W09D12.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195860	ZK897.8
No description available

WB:WBGene00195861	C48B6.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195862	T01B7.10
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195863	F35H10.14
Is affected by emr-1 and ins-11 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195864	F41A4.3
Is affected by prg-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195865	2RSSE.4
No description available

WB:WBGene00195866	F14F3.7
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195867	W06G6.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00195868	F26A10.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195869	D2023.11
No description available

WB:WBGene00195870	F22E10.7
No description available

WB:WBGene00195871	K04B12.5
No description available

WB:WBGene00195872	cTel17.1
No description available

WB:WBGene00195873	H11E01.4
No description available

WB:WBGene00195874	R04F11.8
No description available

WB:WBGene00195875	F11C7.8
No description available

WB:WBGene00195876	H03E18.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195877	R07E4.8
Is affected by cep-1 and hpl-2 based on RNA-seq studies.

WB:WBGene00195878	F46F3.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195879	F49E10.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00195880	F23H12.12
No description available

WB:WBGene00195881	T28B11.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195882	F59B10.7
Is affected by several genes including sek-1; pgl-1; and cep-1 based on RNA-seq studies.

WB:WBGene00195883	K02B12.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00195884	C17E4.14
No description available

WB:WBGene00195885	F38B7.12
No description available

WB:WBGene00195886	F08C6.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00195887	Y47D3A.33
No description available

WB:WBGene00195888	K07A12.9
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195889	T01B6.5
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00195890	F13D11.7
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195891	C09H10.11
No description available

WB:WBGene00195892	F35D2.7
No description available

WB:WBGene00195893	F43D2.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195894	ZK262.16
No description available

WB:WBGene00195895	T14G11.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195896	F31E3.8
Is affected by several genes including cep-1; lem-2; and emr-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00195897	Y41G9A.13
No description available

WB:WBGene00195898	W01H2.4
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00195899	F11D5.11
No description available

WB:WBGene00195900	K04D7.9
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00195901	H06I04.10
No description available

WB:WBGene00195902	T21B4.18
No description available

WB:WBGene00195903	K02E2.14
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00195904	T24F1.8
No description available

WB:WBGene00195905	ZK381.36
Is affected by alg-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00195906	C13G5.3
No description available

WB:WBGene00195907	T14F9.7
No description available

WB:WBGene00195908	Y46E12BL.5
No description available

WB:WBGene00195909	Y106G6A.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on microarray and RNA-seq studies.

WB:WBGene00195910	F29F11.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195911	C01B10.45
Is affected by daf-2 and ifo-1 based on microarray studies.

WB:WBGene00195912	H22K11.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195913	F54F12.4
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00195914	F14H12.10
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00195915	C07H6.11
No description available

WB:WBGene00195916	Y71A12B.26
No description available

WB:WBGene00195917	K09B11.19
No description available

WB:WBGene00195918	C35A11.5
No description available

WB:WBGene00195919	T24B8.9
No description available

WB:WBGene00195920	C54D10.16
Is affected by pmt-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00195921	F12F6.13
No description available

WB:WBGene00195922	C24H11.10
No description available

WB:WBGene00195923	Y54E10A.19
No description available

WB:WBGene00195924	Y47H9A.3
No description available

WB:WBGene00195925	W01C8.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195926	T09B4.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195927	F54D1.17
Is affected by glycine based on RNA-seq studies.

WB:WBGene00195928	F46G11.9
No description available

WB:WBGene00195929	Y51H7BR.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00195930	F42A10.11
No description available

WB:WBGene00195931	Y57A10A.38
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195932	F33D4.11
No description available

WB:WBGene00195933	C43D7.13
No description available

WB:WBGene00195934	T09D3.10
No description available

WB:WBGene00195935	F42G8.16
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00195936	C02D5.5
No description available

WB:WBGene00195937	C33G3.8
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00195938	R09A8.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195939	K11G12.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00195940	ZK470.7
No description available

WB:WBGene00195941	F55B12.13
No description available

WB:WBGene00195942	C15C8.9
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00195943	W08F4.14
No description available

WB:WBGene00195944	F22A3.10
No description available

WB:WBGene00195945	R03D7.10
No description available

WB:WBGene00195946	BE0003N10.4
No description available

WB:WBGene00195947	C02F4.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195948	Y7A9D.62
No description available

WB:WBGene00195949	Y53F4B.52
No description available

WB:WBGene00195950	F08C6.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195951	C23F12.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195952	K04H4.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195953	C42D8.10
No description available

WB:WBGene00195954	F44A6.8
No description available

WB:WBGene00195955	Y71A12C.4
No description available

WB:WBGene00195956	C54E4.6
No description available

WB:WBGene00195957	C14F11.9
No description available

WB:WBGene00195958	ZK867.7
No description available

WB:WBGene00195959	H03A11.6
No description available

WB:WBGene00195960	ZK381.37
No description available

WB:WBGene00195961	T28B4.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00195962	ZK973.13
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195963	Y44A6B.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195964	F56A11.8
No description available

WB:WBGene00195965	F26A10.7
No description available

WB:WBGene00195966	C16E9.10
Is affected by cep-1 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00195967	K08C7.9
No description available

WB:WBGene00195968	R11G1.8
No description available

WB:WBGene00195969	ZK563.8
No description available

WB:WBGene00195970	F52B10.6
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00195971	F55C5.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00195972	C38C6.9
No description available

WB:WBGene00195973	B0495.12
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00195974	C33B4.7
No description available

WB:WBGene00195975	K09A9.9
No description available

WB:WBGene00195976	W07G1.11
No description available

WB:WBGene00195977	C56E6.12
No description available

WB:WBGene00195978	VB0395L.2
No description available

WB:WBGene00195979	F31F7.4
No description available

WB:WBGene00195980	Y53F4B.53
Is affected by tatn-1 based on RNA-seq studies.

WB:WBGene00195981	W01C8.10
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00195982	ZK836.5
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00195983	K08B12.6
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00195984	C07H4.3
No description available

WB:WBGene00195985	Y6B3B.12
No description available

WB:WBGene00195986	F39C12.5
No description available

WB:WBGene00195987	C04C11.7
No description available

WB:WBGene00195988	Y54G2A.59
No description available

WB:WBGene00195989	K02A11.5
No description available

WB:WBGene00195990	Y69A2AR.38
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00195991	F02E11.8
No description available

WB:WBGene00195992	F09F9.7
No description available

WB:WBGene00195993	C24G6.10
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00195994	F39B3.4
No description available

WB:WBGene00195995	C42D8.11
No description available

WB:WBGene00195996	Y54G9A.11
No description available

WB:WBGene00195997	F42H10.10
No description available

WB:WBGene00195998	Y53H1C.5
No description available

WB:WBGene00195999	Y105E8A.37
No description available

WB:WBGene00196000	Y50D7A.14
No description available

WB:WBGene00196001	F52B10.7
No description available

WB:WBGene00196002	K03C7.5
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196003	F22D3.7
No description available

WB:WBGene00196004	F13D11.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00196005	ZK867.8
No description available

WB:WBGene00196006	C01F4.4
No description available

WB:WBGene00196007	B0334.16
No description available

WB:WBGene00196008	C25D7.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196009	F19C6.9
No description available

WB:WBGene00196010	C04H4.2
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196011	T06A4.4
No description available

WB:WBGene00196012	F32A6.7
No description available

WB:WBGene00196013	R08E3.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196014	F47B7.10
Is affected by ifo-1 based on microarray studies.

WB:WBGene00196015	Y67D8A.6
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00196016	W03A3.4
Is affected by daf-2 based on microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00196017	C17D12.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00196018	F28F8.11
No description available

WB:WBGene00196019	F12D9.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00196020	F35G2.9
Is affected by daf-2 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196021	F09G2.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by daf-2 based on microarray studies.

WB:WBGene00196022	B0495.13
No description available

WB:WBGene00196023	T03G11.15
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196024	C32C4.9
No description available

WB:WBGene00196025	C52E4.13
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196026	Y39A1B.5
No description available

WB:WBGene00196027	C30B5.10
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00196028	C32D5.15
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00196029	T06F4.6
No description available

WB:WBGene00196030	Y39B6A.71
No description available

WB:WBGene00196031	Y79H2A.13
No description available

WB:WBGene00196032	T18D3.10
No description available

WB:WBGene00196033	Y17D7C.7
No description available

WB:WBGene00196034	T04C12.16
No description available

WB:WBGene00196035	T27A1.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00196036	F49H12.8
No description available

WB:WBGene00196037	Y17D7B.11
No description available

WB:WBGene00196038	Y51H7C.18
No description available

WB:WBGene00196039	C04E7.7
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00196040	Y75B8A.45
No description available

WB:WBGene00196041	R02D5.11
No description available

WB:WBGene00196042	K11C4.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196043	ZK973.14
No description available

WB:WBGene00196044	ZK381.38
No description available

WB:WBGene00196045	F58F12.7
No description available

WB:WBGene00196046	F33G12.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196047	C02C6.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196048	T11F1.10
No description available

WB:WBGene00196049	ZK381.39
No description available

WB:WBGene00196050	C41G11.6
No description available

WB:WBGene00196051	Y22F5A.8
No description available

WB:WBGene00196052	T27E4.14
No description available

WB:WBGene00196053	F11H8.5
No description available

WB:WBGene00196054	F53B3.8
No description available

WB:WBGene00196055	T07D1.8
No description available

WB:WBGene00196056	T19C4.16
No description available

WB:WBGene00196057	ZK84.9
No description available

WB:WBGene00196058	Y55F3BR.13
No description available

WB:WBGene00196059	D2023.12
Is affected by spc-1 and unc-70 based on RNA-seq studies.

WB:WBGene00196060	VB0365.1
Is enriched in AVK based on RNA-seq studies. Is affected by daf-2 based on microarray studies.

WB:WBGene00196061	F07B10.8
No description available

WB:WBGene00196062	C49A1.11
No description available

WB:WBGene00196063	F25G6.12
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies.

WB:WBGene00196064	ZC477.15
No description available

WB:WBGene00196065	C34F6.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00196066	T19C4.17
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00196067	Y39G8C.5
No description available

WB:WBGene00196068	F40F9.13
No description available

WB:WBGene00196069	Y39A3CL.8
No description available

WB:WBGene00196070	C16A3.14
No description available

WB:WBGene00196071	F56F3.8
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196072	Y39A3B.6
No description available

WB:WBGene00196073	F54D12.13
No description available

WB:WBGene00196074	K12H6.13
No description available

WB:WBGene00196075	Y105E8A.38
Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00196076	Y71F9AR.5
No description available

WB:WBGene00196077	C06A1.10
No description available

WB:WBGene00196078	T02E9.11
No description available

WB:WBGene00196079	C29E6.9
No description available

WB:WBGene00196080	Y54G9A.12
No description available

WB:WBGene00196081	K06C4.18
No description available

WB:WBGene00196082	F54C4.5
No description available

WB:WBGene00196083	C53B7.9
No description available

WB:WBGene00196084	B0454.14
No description available

WB:WBGene00196085	R173.6
No description available

WB:WBGene00196086	F16H9.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196087	F08G5.10
No description available

WB:WBGene00196088	F58H1.11
Is affected by dlc-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196089	C15F1.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196090	F02G3.2
No description available

WB:WBGene00196091	C50F4.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00196092	ZK632.15
No description available

WB:WBGene00196093	K03H9.6
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196094	H19M22.5
Is affected by Cry5B based on microarray studies.

WB:WBGene00196095	F22B3.12
No description available

WB:WBGene00196096	ZK616.62
Is affected by emr-1; cep-1; and adr-1 based on RNA-seq studies.

WB:WBGene00196097	Y105E8B.12
No description available

WB:WBGene00196098	Y55F3AR.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196099	T09B4.14
Is affected by meg-3; meg-4; and pptr-1 based on RNA-seq studies.

WB:WBGene00196100	K10C3.8
Is affected by dlc-1 and ints-4 based on RNA-seq studies.

WB:WBGene00196101	T20F10.9
No description available

WB:WBGene00196102	C29H12.7
No description available

WB:WBGene00196103	Y51A2D.24
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00196104	C48D1.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196105	C18D1.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196106	ZC504.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196107	F41C6.8
No description available

WB:WBGene00196108	H02I12.10
No description available

WB:WBGene00196109	K02H8.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196110	T01C2.3
No description available

WB:WBGene00196111	C33B4.8
No description available

WB:WBGene00196112	K10D6.8
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00196113	F13H6.6
No description available

WB:WBGene00196114	Y51H7C.19
No description available

WB:WBGene00196115	F45B8.8
No description available

WB:WBGene00196116	T10E9.11
No description available

WB:WBGene00196117	F49E10.11
No description available

WB:WBGene00196118	Y32F6B.5
No description available

WB:WBGene00196119	F44E5.6
No description available

WB:WBGene00196120	T06H11.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196121	C40H5.10
No description available

WB:WBGene00196122	C24B5.7
No description available

WB:WBGene00196123	F55C5.13
Is affected by procyanidin based on microarray studies.

WB:WBGene00196124	F57B10.16
No description available

WB:WBGene00196125	R01E6.9
No description available

WB:WBGene00196126	T07H8.10
No description available

WB:WBGene00196127	K02E11.14
No description available

WB:WBGene00196128	Y51A2D.25
Is affected by hmg-3 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00196129	F11A6.6
Is affected by ifo-1 based on microarray studies.

WB:WBGene00196130	C54D1.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196131	C56G2.16
No description available

WB:WBGene00196132	C34H3.5
No description available

WB:WBGene00196133	C43D7.14
No description available

WB:WBGene00196134	C53B4.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196135	Y50D7A.15
No description available

WB:WBGene00196136	C16C8.23
No description available

WB:WBGene00196137	T18H9.8
No description available

WB:WBGene00196138	C05B10.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196139	T01C1.6
No description available

WB:WBGene00196140	T07F12.6
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00196141	R10E12.4
No description available

WB:WBGene00196142	B0403.7
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00196143	K07A1.18
No description available

WB:WBGene00196144	Y40H4A.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196145	T14F9.8
No description available

WB:WBGene00196146	F10G8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196147	W02A2.10
No description available

WB:WBGene00196148	B0457.8
No description available

WB:WBGene00196149	T28C12.7
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00196150	C30A5.11
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00196151	Y48G9A.17
No description available

WB:WBGene00196152	F54E4.7
No description available

WB:WBGene00196153	T14G12.8
No description available

WB:WBGene00196154	F28F9.8
No description available

WB:WBGene00196155	F40B5.4
No description available

WB:WBGene00196156	T19D7.8
No description available

WB:WBGene00196157	C07A4.4
No description available

WB:WBGene00196158	C52E12.8
No description available

WB:WBGene00196159	K04B12.6
No description available

WB:WBGene00196160	T14G8.5
No description available

WB:WBGene00196161	T13H10.6
No description available

WB:WBGene00196162	C05E11.11
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196163	F23H12.13
Is affected by hmg-4 based on RNA-seq studies.

WB:WBGene00196164	C29E6.10
No description available

WB:WBGene00196165	C53D6.18
Is affected by cep-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00196166	F45E4.16
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00196167	W06A7.7
No description available

WB:WBGene00196168	F39D8.5
No description available

WB:WBGene00196169	Y46E12A.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00196170	C04C11.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00196171	F12D9.7
No description available

WB:WBGene00196172	Y50D4B.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00196173	C07E3.14
No description available

WB:WBGene00196174	F28F5.10
Is affected by ifo-1 based on microarray studies.

WB:WBGene00196175	W03G11.8
Is affected by several genes including pgl-1; alg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196176	T28B11.7
Is affected by cep-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00196177	F54C4.6
No description available

WB:WBGene00196178	D1022.12
No description available

WB:WBGene00196179	Y51H7C.20
No description available

WB:WBGene00196180	T19D2.6
No description available

WB:WBGene00196181	C26F1.13
No description available

WB:WBGene00196182	F26G1.12
No description available

WB:WBGene00196183	T06F4.7
No description available

WB:WBGene00196184	C10E2.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00196185	F28F9.9
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196186	T09A5.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196187	Y53H1C.6
No description available

WB:WBGene00196188	F15C11.4
No description available

WB:WBGene00196189	ZK40.5
No description available

WB:WBGene00196190	F12D9.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196191	C18C4.12
No description available

WB:WBGene00196192	R01B10.7
No description available

WB:WBGene00196193	K01B6.5
No description available

WB:WBGene00196194	C05C9.5
No description available

WB:WBGene00196195	F28E10.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196196	T21E12.6
No description available

WB:WBGene00196197	F09F3.14
Is enriched in AFD; ASER; and PLM based on RNA-seq studies.

WB:WBGene00196198	C16E9.11
No description available

WB:WBGene00196199	T18D3.11
No description available

WB:WBGene00196200	Y58A7A.8
Is affected by several genes including daf-2; lem-2; and emr-1 based on RNA-seq and microarray studies.

WB:WBGene00196201	T19C4.18
No description available

WB:WBGene00196202	W04D2.8
Is affected by chd-3; let-418; and eat-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00196203	K03H1.17
No description available

WB:WBGene00196204	B0379.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196205	Y111B2A.32
No description available

WB:WBGene00196206	F28D1.19
No description available

WB:WBGene00196207	F41D9.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196208	C39D10.13
No description available

WB:WBGene00196209	C41A3.4
No description available

WB:WBGene00196210	F02D10.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00196211	F37D6.9
No description available

WB:WBGene00196212	F07B7.15
Is affected by daf-2 based on microarray studies. Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00196213	K12G11.7
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00196214	C56E6.13
No description available

WB:WBGene00196215	D2092.12
No description available

WB:WBGene00196216	C05A9.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196217	C48D1.12
No description available

WB:WBGene00196218	M70.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00196219	C10H11.12
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196220	C24H12.13
No description available

WB:WBGene00196221	B0350.70
No description available

WB:WBGene00196222	H19M22.6
Is affected by eat-2 based on microarray studies.

WB:WBGene00196223	ZK470.8
No description available

WB:WBGene00196224	Y54E10A.20
No description available

WB:WBGene00196225	T21H3.6
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196226	K01A6.11
No description available

WB:WBGene00196227	C25F6.11
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196228	F26A10.8
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196229	C14E2.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196230	Y73B6BL.273
No description available

WB:WBGene00196231	F57B7.6
No description available

WB:WBGene00196232	K07E8.14
No description available

WB:WBGene00196233	C54D2.8
No description available

WB:WBGene00196234	T10B11.9
Is enriched in GABAergic neurons based on microarray studies.

WB:WBGene00196235	W10C8.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196236	M03F4.9
No description available

WB:WBGene00196237	F55C10.8
No description available

WB:WBGene00196238	C40C9.9
No description available

WB:WBGene00196239	F55E10.9
No description available

WB:WBGene00196240	C25F6.12
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196241	ZK1193.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196242	K07C6.16
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00196243	F26A3.11
No description available

WB:WBGene00196244	B0524.8
No description available

WB:WBGene00196245	R08C7.16
Is affected by zip-3 based on RNA-seq studies.

WB:WBGene00196246	C05D9.10
No description available

WB:WBGene00196247	R07D5.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196248	R09F10.14
No description available

WB:WBGene00196249	C54D10.17
No description available

WB:WBGene00196250	ZC13.12
No description available

WB:WBGene00196251	C27A7.10
No description available

WB:WBGene00196252	T19E7.23
No description available

WB:WBGene00196253	T21B6.8
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00196254	F11D5.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196255	C43F9.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196256	B0454.15
No description available

WB:WBGene00196257	T04C12.17
No description available

WB:WBGene00196258	F25G6.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196259	F28E10.9
No description available

WB:WBGene00196260	F32B5.10
No description available

WB:WBGene00196261	E02A10.6
No description available

WB:WBGene00196262	T01B4.5
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196263	R08E3.6
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00196264	F09A5.10
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196265	C08C3.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196266	C47G2.11
No description available

WB:WBGene00196267	H32C10.95
No description available

WB:WBGene00196268	F52E10.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00196269	Y57A10A.39
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196270	F48E3.11
No description available

WB:WBGene00196271	F08C6.10
No description available

WB:WBGene00196272	C31G12.6
No description available

WB:WBGene00196273	H13N06.9
No description available

WB:WBGene00196274	C09D8.4
Is enriched in NSM based on RNA-seq studies.

WB:WBGene00196275	K08A8.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196276	C30F8.5
Is affected by nanoparticle based on microarray studies.

WB:WBGene00196277	T19D2.7
No description available

WB:WBGene00196278	Y50D4C.7
No description available

WB:WBGene00196279	Y67A10A.343
Is affected by daf-2 based on microarray studies.

WB:WBGene00196280	M01H9.7
Is affected by cox-5B; kri-1; and mpk-2 based on RNA-seq studies.

WB:WBGene00196281	C16E9.12
No description available

WB:WBGene00196282	F46G11.10
No description available

WB:WBGene00196283	B0391.13
No description available

WB:WBGene00196284	F26A10.9
No description available

WB:WBGene00196285	F40H3.7
Is enriched in NSM based on RNA-seq studies. Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196286	F11D5.13
No description available

WB:WBGene00196287	C05D2.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00196288	R153.3
No description available

WB:WBGene00196289	T14E8.5
No description available

WB:WBGene00196290	ZK593.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196291	C15H7.7
No description available

WB:WBGene00196292	F21D9.9
No description available

WB:WBGene00196293	F35G2.10
No description available

WB:WBGene00196294	Y41G9A.14
No description available

WB:WBGene00196295	F45H7.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196296	Y39G10AR.27
No description available

WB:WBGene00196297	T04D3.9
No description available

WB:WBGene00196298	C52A11.5
No description available

WB:WBGene00196299	Y51H7C.21
No description available

WB:WBGene00196300	T04C10.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196301	C11E4.10
No description available

WB:WBGene00196302	K08A8.8
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00196303	F10C2.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196304	F09A5.11
No description available

WB:WBGene00196305	F56E3.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196306	C54H2.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196307	C26G2.3
No description available

WB:WBGene00196308	F49E10.12
No description available

WB:WBGene00196309	F53B7.8
No description available

WB:WBGene00196310	C07G3.13
No description available

WB:WBGene00196311	Y38H6C.27
Is affected by daf-2 based on microarray studies.

WB:WBGene00196312	W05E10.8
No description available

WB:WBGene00196313	C33F10.17
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00196314	F15A2.9
No description available

WB:WBGene00196315	Y24D9A.11
Is affected by sod-2 and rrf-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196316	C43C3.6
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00196317	F55F1.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196318	T01C8.8
No description available

WB:WBGene00196319	Y45G5AM.10
No description available

WB:WBGene00196320	F42A6.11
No description available

WB:WBGene00196321	M79.7
No description available

WB:WBGene00196322	R05F9.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196323	F02G3.3
No description available

WB:WBGene00196324	Y5H2A.5
Is affected by several genes including emr-1; adr-1; and tdp-1 based on RNA-seq studies.

WB:WBGene00196325	ZK617.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196326	Y51A2D.26
No description available

WB:WBGene00196327	T05C12.12
No description available

WB:WBGene00196328	Y39G8C.6
No description available

WB:WBGene00196329	C48D5.4
No description available

WB:WBGene00196330	ZC190.12
Is affected by let-418 and dlc-1 based on RNA-seq studies.

WB:WBGene00196331	B0198.4
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00196332	T27B2.2
No description available

WB:WBGene00196333	VB0395L.3
No description available

WB:WBGene00196334	F40F12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196335	R03A10.8
No description available

WB:WBGene00196336	F13B12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196337	ZK836.6
No description available

WB:WBGene00196338	T02E9.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196339	Y37E11AL.13
No description available

WB:WBGene00196340	ZK40.6
No description available

WB:WBGene00196341	T27D12.8
No description available

WB:WBGene00196342	Y47H9C.17
No description available

WB:WBGene00196343	M04D5.4
No description available

WB:WBGene00196344	T03F7.11
No description available

WB:WBGene00196345	Y73F8A.1163
No description available

WB:WBGene00196346	T02E9.13
Is enriched in AVK based on RNA-seq studies. Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196347	C54D2.9
Is affected by hpl-2 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196348	R10E12.5
No description available

WB:WBGene00196349	F42D1.6
Is affected by pmt-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00196350	F01G12.10
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00196351	Y34B4A.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196352	Y22D7AR.17
No description available

WB:WBGene00196353	F39B3.5
No description available

WB:WBGene00196354	M79.8
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00196355	F22A3.11
No description available

WB:WBGene00196356	F43C11.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00196357	W02H5.14
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00196358	Y39D8B.4
No description available

WB:WBGene00196359	B0244.13
No description available

WB:WBGene00196360	R06C1.7
No description available

WB:WBGene00196361	C11G10.4
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196362	C17F4.13
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00196363	C34H3.6
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196364	C32C4.10
No description available

WB:WBGene00196365	C41A3.5
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196366	W02B3.8
No description available

WB:WBGene00196367	C10G11.13
No description available

WB:WBGene00196368	Y76A2B.7
Is affected by pmt-2 based on microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00196369	F14B8.9
No description available

WB:WBGene00196370	F52B10.8
No description available

WB:WBGene00196371	B0454.16
No description available

WB:WBGene00196372	Y82E9BR.28
No description available

WB:WBGene00196373	C30C11.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196374	T21B10.8
No description available

WB:WBGene00196375	C29E6.11
Is affected by cep-1 and klf-1 based on RNA-seq studies.

WB:WBGene00196376	K02D10.7
Is affected by cep-1 and F01D4.5 based on RNA-seq studies.

WB:WBGene00196377	C23H4.9
No description available

WB:WBGene00196378	F47E1.10
Is affected by eat-2 based on microarray studies.

WB:WBGene00196379	F28F9.10
No description available

WB:WBGene00196380	F11H8.6
No description available

WB:WBGene00196381	C32A3.5
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196382	T05B4.15
No description available

WB:WBGene00196383	F48C5.6
No description available

WB:WBGene00196384	ZK792.9
No description available

WB:WBGene00196385	K11E4.8
No description available

WB:WBGene00196386	K02B9.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196387	R04F11.9
No description available

WB:WBGene00196388	T23G5.10
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00196389	Y65B4BL.9
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196390	D1009.8
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00196391	ZK757.5
No description available

WB:WBGene00196392	ZC487.7
No description available

WB:WBGene00196393	T04F8.11
No description available

WB:WBGene00196394	T06A4.5
No description available

WB:WBGene00196395	Y111B2A.33
Is enriched in AFD and ASER based on RNA-seq studies.

WB:WBGene00196396	F31C3.14
Is affected by several genes including prg-1; ins-11; and tdp-1 based on RNA-seq and microarray studies.

WB:WBGene00196397	F48C1.12
Is affected by alg-1; dlc-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196398	W10D5.4
Is affected by pmt-2 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196399	T14F9.9
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies.

WB:WBGene00196400	Y73F8A.1164
No description available

WB:WBGene00196401	F27B10.2
No description available

WB:WBGene00196402	F10C1.13
No description available

WB:WBGene00196403	F33C8.6
No description available

WB:WBGene00196404	F58H7.9
No description available

WB:WBGene00196405	K08E5.9
No description available

WB:WBGene00196406	C16C2.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196407	T13H2.7
Is enriched in AFD and PLM based on RNA-seq studies.

WB:WBGene00196408	F15G9.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00196409	K03H9.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq and microarray studies.

WB:WBGene00196410	R02E12.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196411	T10H10.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00196412	Y66D12A.27
No description available

WB:WBGene00196413	C06B8.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196414	B0034.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196415	C54G7.7
No description available

WB:WBGene00196416	D1079.2
No description available

WB:WBGene00196417	K02F2.8
No description available

WB:WBGene00196418	Y53C10A.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00196419	ZK381.40
No description available

WB:WBGene00196420	ZK652.15
No description available

WB:WBGene00196421	F09C3.7
No description available

WB:WBGene00196422	ZC64.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196423	F56H11.9
Is affected by ifo-1 based on microarray studies.

WB:WBGene00196424	F54E4.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00196425	F42D1.7
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196426	R02E12.10
No description available

WB:WBGene00196427	K10B4.8
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00196428	Y37E3.27
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196429	F18G5.8
No description available

WB:WBGene00196430	Y75B8A.46
No description available

WB:WBGene00196431	F53F8.8
No description available

WB:WBGene00196432	T14G11.5
No description available

WB:WBGene00196433	C40H5.11
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00196434	K06C4.19
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00196435	C41G11.7
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00196436	C01B7.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196437	F37B12.7
Is affected by eat-2 based on microarray studies.

WB:WBGene00196438	Y39B6A.72
No description available

WB:WBGene00196439	Y57A10B.9
No description available

WB:WBGene00196440	K04A8.12
No description available

WB:WBGene00196441	K01A6.12
No description available

WB:WBGene00196442	T21B10.9
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00196443	C04H4.3
No description available

WB:WBGene00196444	F47E1.11
No description available

WB:WBGene00196445	F15A8.18
No description available

WB:WBGene00196446	F52B10.9
No description available

WB:WBGene00196447	F46C8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196448	Y59A8B.28
No description available

WB:WBGene00196449	Y75B7AL.5
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00196450	F20B10.6
No description available

WB:WBGene00196451	K04A8.13
No description available

WB:WBGene00196452	Y66D12A.28
No description available

WB:WBGene00196453	F27D9.10
No description available

WB:WBGene00196454	M01H9.8
No description available

WB:WBGene00196455	C34F6.15
No description available

WB:WBGene00196456	F18E9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196457	C46C11.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196458	Y45G5AM.11
No description available

WB:WBGene00196459	R151.14
No description available

WB:WBGene00196460	F45E1.8
No description available

WB:WBGene00196461	C10G6.51
No description available

WB:WBGene00196462	C11G10.5
No description available

WB:WBGene00196463	F08F1.11
No description available

WB:WBGene00196464	F35D2.8
Is affected by cep-1 and let-418 based on RNA-seq studies.

WB:WBGene00196465	Y51F10.12
No description available

WB:WBGene00196466	H21P03.5
No description available

WB:WBGene00196467	F43C9.5
No description available

WB:WBGene00196468	W09G3.12
No description available

WB:WBGene00196469	F08F3.13
Is affected by tdp-1 based on RNA-seq studies. Is affected by stavudine and Zidovudine based on RNA-seq studies.

WB:WBGene00196470	R05D3.13
No description available

WB:WBGene00196471	F57B1.10
No description available

WB:WBGene00196472	H08J11.4
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196473	Y70D2A.4
No description available

WB:WBGene00196474	K01A12.5
Is affected by hmg-3 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196475	F07C3.12
No description available

WB:WBGene00196476	C34H3.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196477	F57B1.11
No description available

WB:WBGene00196478	T09D3.11
No description available

WB:WBGene00196479	Y39G10AR.28
No description available

WB:WBGene00196480	C27A12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196481	F56D12.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196482	T25D1.4
No description available

WB:WBGene00196483	W05E10.9
No description available

WB:WBGene00196484	ZK994.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00196485	C16D9.12
Is affected by daf-2 and nhr-86 based on microarray and RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00196486	C48D5.5
No description available

WB:WBGene00196487	C18A3.15
No description available

WB:WBGene00196488	K06G5.5
No description available

WB:WBGene00196489	C15B12.10
No description available

WB:WBGene00196490	C03C10.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196491	M03F8.9
No description available

WB:WBGene00196492	C34C12.10
No description available

WB:WBGene00196493	ZK973.15
Is affected by several genes including eat-2; cep-1; and dpy-21 based on RNA-seq and microarray studies.

WB:WBGene00196494	C07A12.9
No description available

WB:WBGene00196495	T22B7.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196496	C09D8.5
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196497	ZK525.5
No description available

WB:WBGene00196498	B0350.71
No description available

WB:WBGene00196499	F38B6.10
No description available

WB:WBGene00196500	T11F9.23
Is affected by cep-1; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00196501	T28B11.8
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00196502	R05D7.8
No description available

WB:WBGene00196503	F14H12.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00196504	C05C9.6
No description available

WB:WBGene00196505	F42H10.11
No description available

WB:WBGene00196506	C35C5.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196507	F31F6.9
No description available

WB:WBGene00196508	T06G6.14
No description available

WB:WBGene00196509	F25B4.11
Is affected by cep-1; adr-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196510	F52H2.9
No description available

WB:WBGene00196511	C48C5.5
No description available

WB:WBGene00196512	C03F11.6
No description available

WB:WBGene00196513	Y57G11C.1137
No description available

WB:WBGene00196514	F44G3.18
No description available

WB:WBGene00196515	B0457.9
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196516	F35D2.9
No description available

WB:WBGene00196517	Y71F9B.18
No description available

WB:WBGene00196518	H01G02.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196519	C08F8.10
No description available

WB:WBGene00196520	Y105C5A.1275
No description available

WB:WBGene00196521	C18A3.16
No description available

WB:WBGene00196522	Y32F6A.7
No description available

WB:WBGene00196523	C04H4.4
No description available

WB:WBGene00196524	C10C5.10
No description available

WB:WBGene00196525	C47G2.12
No description available

WB:WBGene00196526	R07B1.16
No description available

WB:WBGene00196527	F55A8.4
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196528	C34B4.10
No description available

WB:WBGene00196529	K11G9.8
No description available

WB:WBGene00196530	Y60A3A.32
No description available

WB:WBGene00196531	C49F8.7
No description available

WB:WBGene00196532	R07B1.17
No description available

WB:WBGene00196533	F33D11.14
No description available

WB:WBGene00196534	Y113G7A.18
No description available

WB:WBGene00196535	C02B10.72
No description available

WB:WBGene00196536	H24G06.2
No description available

WB:WBGene00196537	F58B4.9
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00196538	C09F12.6
Is affected by hmg-3; spt-16; and adr-1 based on RNA-seq studies.

WB:WBGene00196539	M03D4.75
No description available

WB:WBGene00196540	Y37E11B.13
No description available

WB:WBGene00196541	R10F2.7
No description available

WB:WBGene00196542	C44B7.15
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00196543	C52B9.14
No description available

WB:WBGene00196544	F40G12.16
No description available

WB:WBGene00196545	C26B2.11
No description available

WB:WBGene00196546	F38A3.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196547	R04F11.10
No description available

WB:WBGene00196548	Y60A3A.33
No description available

WB:WBGene00196549	F55C12.9
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00196550	C24A8.8
No description available

WB:WBGene00196551	F15D3.11
No description available

WB:WBGene00196552	F09G2.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00196553	T05C1.7
No description available

WB:WBGene00196554	B0563.13
No description available

WB:WBGene00196555	R11B5.4
No description available

WB:WBGene00196556	F31B12.5
No description available

WB:WBGene00196557	B0432.18
No description available

WB:WBGene00196558	C33G3.9
No description available

WB:WBGene00196559	F35G2.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196560	C35C5.14
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196561	Y38A10A.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00196562	C56E6.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00196563	ZK675.6
No description available

WB:WBGene00196564	F36H1.14
No description available

WB:WBGene00196565	F56F3.9
No description available

WB:WBGene00196566	F47G6.6
No description available

WB:WBGene00196567	H22K11.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196568	M79.9
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196569	C54H2.7
No description available

WB:WBGene00196570	M195.5
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00196571	T06E4.17
No description available

WB:WBGene00196572	Y75B8A.47
No description available

WB:WBGene00196573	M163.16
Is affected by cep-1; ins-11; and eat-2 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00196574	F12D9.9
No description available

WB:WBGene00196575	F29G9.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196576	C46A5.13
Is affected by Cry5B based on microarray studies.

WB:WBGene00196577	T28D6.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196578	F55C12.10
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196579	C06G1.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196580	F26C11.6
No description available

WB:WBGene00196581	M117.10
No description available

WB:WBGene00196582	F08B12.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196583	R13A1.14
No description available

WB:WBGene00196584	C14F11.10
No description available

WB:WBGene00196585	C40C9.10
No description available

WB:WBGene00196586	C04A2.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196587	Y76F7A.1
No description available

WB:WBGene00196588	W06H8.10
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00196589	B0495.14
No description available

WB:WBGene00196590	B0035.19
No description available

WB:WBGene00196591	F47B7.11
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00196592	T24D8.11
No description available

WB:WBGene00196593	C03F11.7
No description available

WB:WBGene00196594	F28F9.11
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies.

WB:WBGene00196595	R03A10.9
Is affected by Cry5B based on microarray studies.

WB:WBGene00196596	T03G11.16
No description available

WB:WBGene00196597	F12D9.10
No description available

WB:WBGene00196598	R186.10
No description available

WB:WBGene00196599	M01H9.9
No description available

WB:WBGene00196600	E04D5.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196601	Y110A2AL.17
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00196602	W05E10.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196603	C13G3.5
Is affected by eat-2 based on microarray studies.

WB:WBGene00196604	T03G6.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00196605	W06B3.3
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00196606	Y15E3A.7
Is affected by cep-1; daf-2; and ints-4 based on RNA-seq and microarray studies.

WB:WBGene00196607	F40F8.13
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196608	F58A4.17
No description available

WB:WBGene00196609	F25G6.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00196610	W09C5.13
No description available

WB:WBGene00196611	F40F9.14
No description available

WB:WBGene00196612	F42E8.3
No description available

WB:WBGene00196613	T28B4.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00196614	C41G11.8
No description available

WB:WBGene00196615	F53F4.21
No description available

WB:WBGene00196616	F01E11.8
Is affected by hmg-4 based on RNA-seq studies.

WB:WBGene00196617	C50H2.15
No description available

WB:WBGene00196618	F59D12.9
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00196619	C04A11.6
No description available

WB:WBGene00196620	T11F9.24
No description available

WB:WBGene00196621	Y92C3A.5
No description available

WB:WBGene00196622	F29D11.3
No description available

WB:WBGene00196623	F09C8.4
No description available

WB:WBGene00196624	Y47C4A.2
No description available

WB:WBGene00196625	T28C12.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196626	F22E10.8
No description available

WB:WBGene00196627	H08J11.5
No description available

WB:WBGene00196628	C34C12.11
No description available

WB:WBGene00196629	T12B3.7
No description available

WB:WBGene00196630	F09D5.1
No description available

WB:WBGene00196631	F26D11.15
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196632	F22F4.8
No description available

WB:WBGene00196633	M01G4.4
No description available

WB:WBGene00196634	K03C7.6
No description available

WB:WBGene00196635	F31F7.5
Is affected by nanoparticle based on microarray studies.

WB:WBGene00196636	C27C7.10
No description available

WB:WBGene00196637	F52H2.10
No description available

WB:WBGene00196638	F14B4.4
No description available

WB:WBGene00196639	T22C1.14
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196640	T25D3.5
Is affected by cep-1; let-418; and klf-1 based on RNA-seq studies.

WB:WBGene00196641	F45E1.9
No description available

WB:WBGene00196642	F52B10.10
No description available

WB:WBGene00196643	F45B8.9
No description available

WB:WBGene00196644	K08H10.15
Is affected by hmg-3 and daf-2 based on RNA-seq and microarray studies. Is affected by 4-bromodiphenyl ether and Tunicamycin based on microarray studies.

WB:WBGene00196645	C34D10.3
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196646	C33D12.10
No description available

WB:WBGene00196647	T19D12.12
Is affected by dpy-21 and adr-2 based on RNA-seq studies.

WB:WBGene00196648	K03B8.16
No description available

WB:WBGene00196649	F42H10.12
No description available

WB:WBGene00196650	H01G02.7
No description available

WB:WBGene00196651	T01C1.7
No description available

WB:WBGene00196652	W01H2.5
No description available

WB:WBGene00196653	R04F11.11
No description available

WB:WBGene00196654	ZC53.9
No description available

WB:WBGene00196655	ZC250.7
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00196656	M02D8.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196657	T19D7.9
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00196658	C48B6.12
No description available

WB:WBGene00196659	F23H12.14
No description available

WB:WBGene00196660	T28B11.9
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196661	W03G11.9
Is affected by pgrn-1 and cep-1 based on RNA-seq studies.

WB:WBGene00196662	Y76F7A.2
No description available

WB:WBGene00196663	W03G11.10
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196664	ZC53.10
No description available

WB:WBGene00196665	R173.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00196666	T22C8.9
No description available

WB:WBGene00196667	cTel7X.2
No description available

WB:WBGene00196668	K11H12.14
No description available

WB:WBGene00196669	Y47D3B.14
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196670	ZK507.7
No description available

WB:WBGene00196671	ZK973.16
No description available

WB:WBGene00196672	F57G12.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196673	ZK897.9
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00196674	C15A7.5
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00196675	B0403.8
Is affected by ints-9 based on RNA-seq studies.

WB:WBGene00196676	T14F9.10
No description available

WB:WBGene00196677	C34D1.7
No description available

WB:WBGene00196678	D2023.13
No description available

WB:WBGene00196679	F10G8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00196680	F13D11.9
No description available

WB:WBGene00196681	M03F4.10
No description available

WB:WBGene00196682	F15A2.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196683	F41D9.9
No description available

WB:WBGene00196684	F59D8.3
Is affected by several genes including daf-2; cep-1; and lem-2 based on RNA-seq and microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00196685	T14F9.11
No description available

WB:WBGene00196686	F42E11.5
No description available

WB:WBGene00196687	C09B8.12
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00196688	B0250.15
Is affected by elli-1 based on microarray studies.

WB:WBGene00196689	C26B2.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196690	F20A1.12
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196691	M02D8.10
Is affected by pgrn-1 and cep-1 based on RNA-seq studies.

WB:WBGene00196692	Y73B3A.24
Is affected by damt-1 based on RNA-seq studies. Is affected by Ethanol and antimycin based on RNA-seq studies.

WB:WBGene00196693	F11C1.12
No description available

WB:WBGene00196694	C29H12.8
No description available

WB:WBGene00196695	T14G10.9
No description available

WB:WBGene00196696	H06I04.11
No description available

WB:WBGene00196697	C02B4.5
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00196698	F42D1.8
No description available

WB:WBGene00196699	C52G5.5
No description available

WB:WBGene00196700	F54E4.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00196701	ZC455.15
Is affected by daf-16 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00196702	T12A7.11
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00196703	F32B4.9
No description available

WB:WBGene00196704	C52B9.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196705	ZC328.6
No description available

WB:WBGene00196706	F35A5.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196707	B0393.12
No description available

WB:WBGene00196708	K08A8.9
No description available

WB:WBGene00196709	T04C12.18
Is affected by alg-1 and adr-1 based on RNA-seq studies.

WB:WBGene00196710	T21C9.14
No description available

WB:WBGene00196711	ZK892.9
No description available

WB:WBGene00196712	F22B5.11
No description available

WB:WBGene00196713	F18A12.9
No description available

WB:WBGene00196714	M153.6
No description available

WB:WBGene00196715	F46F3.7
No description available

WB:WBGene00196716	ZK899.9
No description available

WB:WBGene00196717	Y105E8A.39
No description available

WB:WBGene00196718	F49D11.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00196719	K09F5.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196720	ZC247.5
No description available

WB:WBGene00196721	F57B10.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196722	Y60A9A.4
No description available

WB:WBGene00196723	F53B3.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196724	T27F2.6
No description available

WB:WBGene00196725	Y66A7AL.2
No description available

WB:WBGene00196726	T08H4.6
No description available

WB:WBGene00196727	T05A6.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00196728	C27C12.8
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00196729	K04D7.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196730	F14D1.1
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00196731	C09G1.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196732	H12I19.116
No description available

WB:WBGene00196733	ZK381.41
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196734	C07A4.5
No description available

WB:WBGene00196735	T28B11.10
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196736	R74.9
No description available

WB:WBGene00196737	T28B4.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196738	F18E2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196739	C13C12.5
No description available

WB:WBGene00196740	H35B03.23
No description available

WB:WBGene00196741	C18B2.7
No description available

WB:WBGene00196742	T01B6.6
No description available

WB:WBGene00196743	K10C3.9
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00196744	Y73B6BL.274
No description available

WB:WBGene00196745	H05G16.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196746	C02H7.4
No description available

WB:WBGene00196747	Y53G8AR.10
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00196748	F13H8.13
No description available

WB:WBGene00196749	F54D12.14
No description available

WB:WBGene00196750	Y51H7BR.10
No description available

WB:WBGene00196751	K08B12.7
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00196752	T06D8.12
No description available

WB:WBGene00196753	W06B11.6
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00196754	F35E2.12
No description available

WB:WBGene00196755	F29G6.4
No description available

WB:WBGene00196756	C36F7.9
No description available

WB:WBGene00196757	F54D12.15
No description available

WB:WBGene00196758	Y69E1A.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196759	F58H1.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00196760	T23G4.126
No description available

WB:WBGene00196761	C54A12.5
No description available

WB:WBGene00196762	K08A2.11
No description available

WB:WBGene00196763	T20B5.4
No description available

WB:WBGene00196764	C45B2.10
No description available

WB:WBGene00196765	K08A8.10
Is affected by cep-1 and let-418 based on RNA-seq studies.

WB:WBGene00196766	W05E10.11
No description available

WB:WBGene00196767	K01A6.13
No description available

WB:WBGene00196768	ZK909.7
Is affected by emr-1; lem-2; and dpy-21 based on RNA-seq studies.

WB:WBGene00196769	B0457.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196770	F09B12.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196771	F54A3.8
No description available

WB:WBGene00196772	ZK813.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196773	ZC84.9
No description available

WB:WBGene00196774	Y40C5A.15
No description available

WB:WBGene00196775	F58G11.7
No description available

WB:WBGene00196776	F55G11.13
No description available

WB:WBGene00196777	T19A5.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196778	F26D12.99
No description available

WB:WBGene00196779	C15C7.10
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196780	C17E4.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196781	Y65B4BL.10
No description available

WB:WBGene00196782	T26C12.7
No description available

WB:WBGene00196783	F25F2.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196784	T22E5.11
No description available

WB:WBGene00196785	ZK328.10
No description available

WB:WBGene00196786	R12C12.11
No description available

WB:WBGene00196787	C14B9.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196788	C25A11.5
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00196789	ZC64.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196790	F38B7.13
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196791	W01B11.7
No description available

WB:WBGene00196792	C11D2.99
No description available

WB:WBGene00196793	C04C11.9
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196794	Y39B6A.73
No description available

WB:WBGene00196795	C06E7.89
No description available

WB:WBGene00196796	W10C8.9
No description available

WB:WBGene00196797	C02D4.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196798	F59C12.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00196799	R13H4.9
No description available

WB:WBGene00196800	C43G2.26
No description available

WB:WBGene00196801	W02B8.7
No description available

WB:WBGene00196802	C36F7.10
No description available

WB:WBGene00196803	C18E9.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196804	C45B2.11
No description available

WB:WBGene00196805	F45D3.8
No description available

WB:WBGene00196806	F39C12.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00196807	T01B6.7
No description available

WB:WBGene00196808	ZK678.10
No description available

WB:WBGene00196809	T10B10.10
No description available

WB:WBGene00196810	W06B11.7
Is affected by dpy-21 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00196811	F58H1.13
Is affected by Cry5B based on microarray studies.

WB:WBGene00196812	Y39B6A.74
No description available

WB:WBGene00196813	Y37A1B.331
No description available

WB:WBGene00196814	F14F3.8
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00196815	F40E10.8
No description available

WB:WBGene00196816	T27E4.15
Is affected by pmt-2 based on microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00196817	Y54G2A.60
No description available

WB:WBGene00196818	F25B5.9
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196819	F31E8.10
Is affected by cep-1; adr-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196820	F46C8.11
No description available

WB:WBGene00196821	F29C4.9
No description available

WB:WBGene00196822	T19C4.19
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196823	Y54G9A.13
No description available

WB:WBGene00196824	F11A6.7
Is affected by ifo-1 based on microarray studies.

WB:WBGene00196825	C53A5.18
No description available

WB:WBGene00196826	B0350.72
No description available

WB:WBGene00196827	C17C3.22
Is affected by daf-2 based on microarray studies.

WB:WBGene00196828	C40C9.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00196829	T23B12.12
No description available

WB:WBGene00196830	F40H3.8
No description available

WB:WBGene00196831	H35N03.2
No description available

WB:WBGene00196832	F08H9.13
No description available

WB:WBGene00196833	C27A2.10
No description available

WB:WBGene00196834	C24B5.8
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00196835	T11F9.25
No description available

WB:WBGene00196836	C26E1.5
No description available

WB:WBGene00196837	C17D12.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196838	F55C5.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196839	F19H6.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196840	K10D6.9
No description available

WB:WBGene00196841	F25H10.2
No description available

WB:WBGene00196842	DH11.7
No description available

WB:WBGene00196843	C41G11.9
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00196844	Y22F5A.9
No description available

WB:WBGene00196845	W02F12.10
Is affected by adr-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00196846	T22D1.19
No description available

WB:WBGene00196847	Y39A3CL.9
No description available

WB:WBGene00196848	ZK353.11
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00196849	T10E10.9
No description available

WB:WBGene00196850	F09F9.8
No description available

WB:WBGene00196851	Y38C1AA.15
No description available

WB:WBGene00196852	C02F4.10
Is enriched in AVK based on RNA-seq studies. Is affected by adr-1; dlc-1; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00196853	T07F10.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196854	CD4.13
No description available

WB:WBGene00196855	ZK381.42
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00196856	R10E11.10
No description available

WB:WBGene00196857	VB0365.2
No description available

WB:WBGene00196858	C30C11.7
No description available

WB:WBGene00196859	C47D12.9
No description available

WB:WBGene00196860	T02E9.14
No description available

WB:WBGene00196861	F41H10.36
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196862	K02A4.3
No description available

WB:WBGene00196863	F52E10.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00196864	F45H7.10
No description available

WB:WBGene00196865	F58B6.6
No description available

WB:WBGene00196866	C31G12.7
No description available

WB:WBGene00196867	ZC477.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00196868	C35A11.6
No description available

WB:WBGene00196869	R01E6.10
No description available

WB:WBGene00196870	D1044.10
No description available

WB:WBGene00196871	K11C4.8
Is affected by ahr-1; lem-2; and cep-1 based on RNA-seq studies.

WB:WBGene00196872	F40F9.15
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1; daf-2; and nhr-86 based on RNA-seq and microarray studies.

WB:WBGene00196873	C41G11.10
No description available

WB:WBGene00196874	C18A3.17
No description available

WB:WBGene00196875	Y104H12D.5
No description available

WB:WBGene00196876	C14F11.11
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00196877	W01A11.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196878	Y55F3C.14
No description available

WB:WBGene00196879	C30F8.6
No description available

WB:WBGene00196880	Y71A12B.27
No description available

WB:WBGene00196881	Y71F9AR.6
No description available

WB:WBGene00196882	C55A6.16
No description available

WB:WBGene00196883	F43E12.2
No description available

WB:WBGene00196884	C54D1.9
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00196885	ZC513.15
No description available

WB:WBGene00196886	K02A2.8
No description available

WB:WBGene00196887	R04F11.12
No description available

WB:WBGene00196888	T07D1.9
Is affected by chd-3 based on RNA-seq studies.

WB:WBGene00196889	C35A5.13
No description available

WB:WBGene00196890	Y105E8B.13
No description available

WB:WBGene00196891	R90.6
No description available

WB:WBGene00196892	C18D1.12
No description available

WB:WBGene00196893	F13H6.7
No description available

WB:WBGene00196894	F47F2.4
No description available

WB:WBGene00196895	T06H11.8
No description available

WB:WBGene00196896	Y39G8C.7
No description available

WB:WBGene00196897	C49A1.12
No description available

WB:WBGene00196898	C14C11.9
No description available

WB:WBGene00196899	Y43F8A.7
No description available

WB:WBGene00196900	C02B10.73
No description available

WB:WBGene00196901	Y51A2D.27
No description available

WB:WBGene00196902	C10F3.11
No description available

WB:WBGene00196903	M01E11.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196904	Y43E12A.4
No description available

WB:WBGene00196905	C30A5.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00196906	F08G5.11
No description available

WB:WBGene00196907	F22G12.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00196908	F09E5.19
No description available

WB:WBGene00196909	Y34B4A.14
No description available

WB:WBGene00196910	H14A12.8
No description available

WB:WBGene00196911	C53B7.10
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00196912	W02A2.11
No description available

WB:WBGene00196913	F56D1.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196914	R07E4.9
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196915	F56H11.10
No description available

WB:WBGene00196916	C56G2.17
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00196917	B0379.10
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00196918	F49E10.13
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00196919	R07B1.18
No description available

WB:WBGene00196920	C34H3.8
No description available

WB:WBGene00196921	Y75B8A.48
No description available

WB:WBGene00196922	R02D5.12
No description available

WB:WBGene00196923	F57F4.5
No description available

WB:WBGene00196924	D1053.5
No description available

WB:WBGene00196925	ZC504.8
No description available

WB:WBGene00196926	Y39G8B.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196927	C41A3.6
No description available

WB:WBGene00196928	F26F12.9
No description available

WB:WBGene00196929	C35C5.15
No description available

WB:WBGene00196930	F44E5.7
No description available

WB:WBGene00196931	B0001.10
No description available

WB:WBGene00196932	Y17D7B.12
No description available

WB:WBGene00196933	F43D9.8
Is affected by several genes including cep-1; tdp-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00196934	C54G6.6
No description available

WB:WBGene00196935	F13H6.8
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00196936	F25H8.9
No description available

WB:WBGene00196937	T01C1.8
No description available

WB:WBGene00196938	F49H12.9
No description available

WB:WBGene00196939	C18D1.13
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00196940	Y38H8A.10
No description available

WB:WBGene00196941	EGAP7.2
No description available

WB:WBGene00196942	C15C8.10
No description available

WB:WBGene00196943	T13H10.7
No description available

WB:WBGene00196944	T01C3.12
No description available

WB:WBGene00196945	F52D10.7
No description available

WB:WBGene00196946	F57C7.8
Is affected by cep-1; adr-1; and ints-4 based on RNA-seq studies.

WB:WBGene00196947	K02G10.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00196948	F08C6.11
No description available

WB:WBGene00196949	C47G2.13
No description available

WB:WBGene00196950	T28D9.14
No description available

WB:WBGene00196951	C54G7.8
Is affected by nanoparticle based on microarray studies.

WB:WBGene00196952	R07B1.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196953	F59D12.10
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00196954	R106.4
No description available

WB:WBGene00196955	F20A1.13
No description available

WB:WBGene00196956	C52E4.14
No description available

WB:WBGene00196957	ZK682.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00196958	F58A4.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196959	C49F8.8
No description available

WB:WBGene00196960	R13F6.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00196961	F20D1.13
No description available

WB:WBGene00196962	H34C03.18
No description available

WB:WBGene00196963	Y47H9A.4
Is affected by pmt-2 based on microarray studies. Is affected by 4-bromodiphenyl ether based on microarray studies.

WB:WBGene00196964	F55F3.5
No description available

WB:WBGene00196965	F16F9.7
No description available

WB:WBGene00196966	C47C12.7
No description available

WB:WBGene00196967	F14B8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196968	R06F6.13
No description available

WB:WBGene00196969	R03E9.6
No description available

WB:WBGene00196970	B0304.10
No description available

WB:WBGene00196971	F52B10.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196972	F22B3.13
No description available

WB:WBGene00196973	F42A10.12
Is affected by daf-2; dpy-21; and elli-1 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00196974	F41C6.9
No description available

WB:WBGene00196975	Y94H6A.13
No description available

WB:WBGene00196976	Y104H12D.6
No description available

WB:WBGene00196977	C42D8.12
No description available

WB:WBGene00196978	Y53H1C.7
No description available

WB:WBGene00196979	F09F9.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00196980	H16O14.76
No description available

WB:WBGene00196981	C06E1.13
No description available

WB:WBGene00196982	Y41C4A.24
No description available

WB:WBGene00196983	C07H6.12
No description available

WB:WBGene00196984	F09F3.15
No description available

WB:WBGene00196985	F35G2.12
Is affected by hpl-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00196986	H01A20.2
Is affected by sma-2 and cep-1 based on microarray and RNA-seq studies.

WB:WBGene00196987	C25E10.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196988	F32A11.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196989	F12F6.14
No description available

WB:WBGene00196990	K04A8.14
No description available

WB:WBGene00196991	F26A10.10
No description available

WB:WBGene00196992	F54H5.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00196993	F15C11.5
No description available

WB:WBGene00196994	T01H3.7
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00196995	Y55F3BR.14
No description available

WB:WBGene00196996	F46E10.14
Is affected by cep-1; dlc-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00196997	F55C5.15
No description available

WB:WBGene00196998	F21A3.9
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00196999	F07B7.16
No description available

WB:WBGene00197000	C34H3.9
No description available

WB:WBGene00197001	C13C4.9
No description available

WB:WBGene00197002	F33D4.12
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197003	K07C10.5
No description available

WB:WBGene00197004	F53B2.13
No description available

WB:WBGene00197005	K02A11.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197006	W05B2.11
No description available

WB:WBGene00197007	C33B4.9
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00197008	C05C9.7
Is affected by hmg-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197009	F18E2.10
No description available

WB:WBGene00197010	C32C4.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197011	F09C12.12
No description available

WB:WBGene00197012	Y40C5A.16
No description available

WB:WBGene00197013	F58H1.14
Is affected by several genes including daf-2; daf-12; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00197014	C34B2.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197015	AH10.7
No description available

WB:WBGene00197016	K10D6.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197017	F25G6.15
No description available

WB:WBGene00197018	H30A04.2
No description available

WB:WBGene00197019	Y38H6A.6
No description available

WB:WBGene00197020	F08G5.12
No description available

WB:WBGene00197021	M01G5.8
No description available

WB:WBGene00197022	Y53F4B.54
No description available

WB:WBGene00197023	Y67D8A.7
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197024	F56E3.9
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00197025	C14F5.7
No description available

WB:WBGene00197026	Y71A12B.28
No description available

WB:WBGene00197027	C52B9.16
No description available

WB:WBGene00197028	ZC64.10
No description available

WB:WBGene00197029	Y39B6A.75
No description available

WB:WBGene00197030	T01B10.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197031	F35H8.9
No description available

WB:WBGene00197032	F47G4.10
No description available

WB:WBGene00197033	T24B8.10
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 and elli-1 based on RNA-seq and microarray studies.

WB:WBGene00197034	C01F4.5
No description available

WB:WBGene00197035	F47G4.11
No description available

WB:WBGene00197036	E02A10.7
No description available

WB:WBGene00197037	K01G5.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197038	F09D5.2
No description available

WB:WBGene00197039	Y55B1BR.7
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00197040	ZC477.17
No description available

WB:WBGene00197041	F56B3.13
No description available

WB:WBGene00197042	R13F6.12
No description available

WB:WBGene00197043	C30G4.8
No description available

WB:WBGene00197044	C36F7.11
No description available

WB:WBGene00197045	C29A12.9
No description available

WB:WBGene00197046	T24B8.11
No description available

WB:WBGene00197047	B0334.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197048	C04D8.2
Is affected by several genes including daf-2; let-418; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00197049	Y53F4A.4
No description available

WB:WBGene00197050	K08E5.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197051	2RSSE.5
No description available

WB:WBGene00197052	F13D11.10
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00197053	F22E12.6
No description available

WB:WBGene00197054	ZK512.13
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00197055	T14G11.6
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00197056	VT21B10L.1
No description available

WB:WBGene00197057	C06A6.9
No description available

WB:WBGene00197058	ZK617.10
No description available

WB:WBGene00197059	T23H2.6
No description available

WB:WBGene00197060	T03E6.13
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197061	C14F11.12
No description available

WB:WBGene00197062	Y54E10A.21
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197063	F55A12.12
No description available

WB:WBGene00197064	C02C6.5
No description available

WB:WBGene00197065	M28.13
No description available

WB:WBGene00197066	F13H6.9
No description available

WB:WBGene00197067	T27B1.3
No description available

WB:WBGene00197068	F40H3.9
No description available

WB:WBGene00197069	Y38F2AR.16
No description available

WB:WBGene00197070	C35B8.6
No description available

WB:WBGene00197071	K12H6.14
No description available

WB:WBGene00197072	ZK867.9
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00197073	ZK836.7
No description available

WB:WBGene00197074	C30B5.11
No description available

WB:WBGene00197075	C01F6.12
No description available

WB:WBGene00197076	C03C11.5
No description available

WB:WBGene00197077	F14H12.12
No description available

WB:WBGene00197078	F44E7.13
No description available

WB:WBGene00197079	C16B8.6
No description available

WB:WBGene00197080	ZC15.11
Is affected by several genes including daf-2; eat-2; and sma-2 based on RNA-seq and microarray studies.

WB:WBGene00197081	C29A12.10
No description available

WB:WBGene00197082	R03D7.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197083	C16D9.13
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00197084	Y39G10AR.29
No description available

WB:WBGene00197085	C04H4.5
No description available

WB:WBGene00197086	T21B6.9
No description available

WB:WBGene00197087	F25H10.3
No description available

WB:WBGene00197088	Y113G7C.2
No description available

WB:WBGene00197089	Y60A3A.34
No description available

WB:WBGene00197090	T14D7.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00197091	F55A4.11
No description available

WB:WBGene00197092	C09D8.6
No description available

WB:WBGene00197093	C08F8.11
No description available

WB:WBGene00197094	K04D7.11
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197095	C56E6.15
No description available

WB:WBGene00197096	C34E11.10
No description available

WB:WBGene00197097	F13B9.9
Is affected by cep-1; pmt-2; and sek-1 based on RNA-seq and microarray studies.

WB:WBGene00197098	R04E5.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00197099	ZC416.9
No description available

WB:WBGene00197100	F28F5.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197101	F46G11.11
No description available

WB:WBGene00197102	C18A3.18
No description available

WB:WBGene00197103	C06G1.9
No description available

WB:WBGene00197104	C35A5.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197105	C18H9.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197106	F28F5.12
No description available

WB:WBGene00197107	F59A1.17
No description available

WB:WBGene00197108	F26F12.10
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00197109	Y66A7AL.3
No description available

WB:WBGene00197110	M03F8.10
No description available

WB:WBGene00197111	Y41D4B.28
No description available

WB:WBGene00197112	Y105E8A.40
No description available

WB:WBGene00197113	F22E12.7
No description available

WB:WBGene00197114	C02C6.6
No description available

WB:WBGene00197115	T14B1.4
No description available

WB:WBGene00197116	Y57G11C.1138
No description available

WB:WBGene00197117	F45B8.10
No description available

WB:WBGene00197118	C34H3.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197119	F36D4.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197120	F47G3.5
No description available

WB:WBGene00197121	F14B6.8
No description available

WB:WBGene00197122	K11D5.1
No description available

WB:WBGene00197123	F59G1.10
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00197124	T06H11.9
No description available

WB:WBGene00197125	T28F12.4
No description available

WB:WBGene00197126	C26E1.6
No description available

WB:WBGene00197127	T05B11.9
No description available

WB:WBGene00197128	T05A12.6
No description available

WB:WBGene00197129	T01G1.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197130	F11A1.11
No description available

WB:WBGene00197131	C54D10.18
No description available

WB:WBGene00197132	T21D9.4
No description available

WB:WBGene00197133	F14D1.2
No description available

WB:WBGene00197134	K08B5.5
No description available

WB:WBGene00197135	F40E10.9
No description available

WB:WBGene00197136	C47G2.14
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197137	R08B4.7
Is affected by prg-1 and cep-1 based on RNA-seq studies.

WB:WBGene00197138	F45H11.9
No description available

WB:WBGene00197139	C08C3.8
No description available

WB:WBGene00197140	F29D10.6
No description available

WB:WBGene00197141	F07C3.13
No description available

WB:WBGene00197142	C36B1.15
No description available

WB:WBGene00197143	F21D9.10
No description available

WB:WBGene00197144	F38H4.12
No description available

WB:WBGene00197145	W08F4.15
No description available

WB:WBGene00197146	F41D9.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197147	C09D8.7
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197148	C48A7.7
No description available

WB:WBGene00197149	C43F9.15
No description available

WB:WBGene00197150	ZK265.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197151	K02B9.8
No description available

WB:WBGene00197152	Y7A9D.63
No description available

WB:WBGene00197153	T18D3.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197154	C17G1.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197155	F23H12.15
No description available

WB:WBGene00197156	ZK1025.12
No description available

WB:WBGene00197157	ZC64.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197158	T04F8.12
No description available

WB:WBGene00197159	C34D1.8
No description available

WB:WBGene00197160	K07A9.5
No description available

WB:WBGene00197161	C24A8.9
No description available

WB:WBGene00197162	Y18H1A.16
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00197163	B0495.15
Is affected by cep-1; alg-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197164	T19D12.13
No description available

WB:WBGene00197165	F47B8.16
No description available

WB:WBGene00197166	C36F7.12
No description available

WB:WBGene00197167	F48C1.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197168	ZC504.9
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00197169	E01H11.4
No description available

WB:WBGene00197170	D1073.2
No description available

WB:WBGene00197171	F56D12.10
Is affected by ahr-1; cep-1; and egl-9 based on RNA-seq studies.

WB:WBGene00197172	C03C10.12
No description available

WB:WBGene00197173	F46G11.12
No description available

WB:WBGene00197174	F47B7.12
No description available

WB:WBGene00197175	C48A7.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00197176	Y39B6A.76
No description available

WB:WBGene00197177	Y53C10A.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00197178	T08A9.16
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00197179	Y47D3B.15
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00197180	C31H1.96
No description available

WB:WBGene00197181	R02E12.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197182	W10C8.10
No description available

WB:WBGene00197183	F55C10.9
No description available

WB:WBGene00197184	C30C11.8
No description available

WB:WBGene00197185	Y70D2A.5
No description available

WB:WBGene00197186	C05G5.9
No description available

WB:WBGene00197187	Y56A3A.37
No description available

WB:WBGene00197188	F18A11.8
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00197189	C06G1.10
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00197190	C14F11.13
No description available

WB:WBGene00197191	T04A6.6
No description available

WB:WBGene00197192	F10E9.14
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197193	C45E1.6
No description available

WB:WBGene00197194	F41E7.11
No description available

WB:WBGene00197195	ZK185.7
No description available

WB:WBGene00197196	C04C11.10
No description available

WB:WBGene00197197	Y73F8A.1165
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00197198	D1044.11
No description available

WB:WBGene00197199	F31E8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197200	F59F3.9
No description available

WB:WBGene00197201	M03F4.11
No description available

WB:WBGene00197202	F39D8.6
No description available

WB:WBGene00197203	F52E4.10
No description available

WB:WBGene00197204	B0034.9
No description available

WB:WBGene00197205	C23H4.10
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197206	C15B12.11
No description available

WB:WBGene00197207	K10D6.11
No description available

WB:WBGene00197208	ZK1128.9
No description available

WB:WBGene00197209	C34B4.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00197210	F56D1.9
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00197211	C06E2.11
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197212	F14F9.9
No description available

WB:WBGene00197213	T09A5.17
Is affected by adr-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197214	F38A3.4
No description available

WB:WBGene00197215	F57A8.9
Is affected by several genes including skn-1; eat-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00197216	ZC53.11
No description available

WB:WBGene00197217	F59D12.11
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00197218	T04C12.19
No description available

WB:WBGene00197219	F41E7.12
No description available

WB:WBGene00197220	C54G7.9
No description available

WB:WBGene00197221	F09F9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197222	F29G9.10
No description available

WB:WBGene00197223	F53B3.10
No description available

WB:WBGene00197224	C54D1.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197225	T19C4.20
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197226	F29G9.11
No description available

WB:WBGene00197227	F31E8.12
Is affected by cep-1; dlc-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00197228	T06E8.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197229	F52F12.11
No description available

WB:WBGene00197230	F58G1.11
No description available

WB:WBGene00197231	Y48B6A.18
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00197232	Y54E10A.22
No description available

WB:WBGene00197233	T05A6.10
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00197234	F55A12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197235	C41G11.11
No description available

WB:WBGene00197236	K03H9.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197237	F54D5.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197238	T19E7.24
No description available

WB:WBGene00197239	R04F11.13
No description available

WB:WBGene00197240	F22B3.14
No description available

WB:WBGene00197241	Y37E11C.3
No description available

WB:WBGene00197242	K12G11.8
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197243	C06G1.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197244	C06E2.12
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197245	EGAP1.4
No description available

WB:WBGene00197246	ZK809.11
No description available

WB:WBGene00197247	B0495.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00197248	K06C4.20
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197249	C24G6.11
No description available

WB:WBGene00197250	T02E9.15
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197251	T04C12.20
No description available

WB:WBGene00197252	F41C6.10
No description available

WB:WBGene00197253	Y13C8A.3
Is affected by uaf-1 based on RNA-seq studies.

WB:WBGene00197254	R153.4
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197255	F57B7.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197256	F35C8.10
No description available

WB:WBGene00197257	H21P03.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00197258	C54G4.11
No description available

WB:WBGene00197259	F11A6.8
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00197260	F57B1.12
No description available

WB:WBGene00197261	F10C1.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00197262	F19D8.9
No description available

WB:WBGene00197263	K02A11.7
No description available

WB:WBGene00197264	ZC123.6
No description available

WB:WBGene00197265	M195.6
No description available

WB:WBGene00197266	K11G9.9
No description available

WB:WBGene00197267	F25H8.10
No description available

WB:WBGene00197268	F08F1.12
No description available

WB:WBGene00197269	F59C12.8
No description available

WB:WBGene00197270	K02A4.4
No description available

WB:WBGene00197271	W09G3.13
No description available

WB:WBGene00197272	C18F3.7
No description available

WB:WBGene00197273	C23H3.10
No description available

WB:WBGene00197274	F20B10.7
No description available

WB:WBGene00197275	K04D7.12
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00197276	Y54G2A.61
No description available

WB:WBGene00197277	Y37E3.28
Is affected by prg-1 and cep-1 based on RNA-seq studies.

WB:WBGene00197278	K03H4.3
Is affected by cep-1; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00197279	C01B7.10
Is affected by cep-1; dlc-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197280	ZC513.16
Is affected by several genes including daf-16; daf-12; and cep-1 based on RNA-seq studies.

WB:WBGene00197281	Y41C4A.25
No description available

WB:WBGene00197282	C44C11.3
No description available

WB:WBGene00197283	R07G3.11
No description available

WB:WBGene00197284	T24A11.5
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197285	F48E3.12
No description available

WB:WBGene00197286	C42D8.13
Is affected by several genes including pgl-1; cep-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00197287	Y104H12D.7
No description available

WB:WBGene00197288	F13H6.10
No description available

WB:WBGene00197289	T19B10.13
No description available

WB:WBGene00197290	F21H7.17
No description available

WB:WBGene00197291	F29C4.10
No description available

WB:WBGene00197292	Y5H2B.8
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197293	ZK1290.18
No description available

WB:WBGene00197294	F53B7.9
No description available

WB:WBGene00197295	K12H6.15
No description available

WB:WBGene00197296	C09B7.6
Is affected by cep-1 and ints-4 based on RNA-seq studies.

WB:WBGene00197297	R08C7.17
No description available

WB:WBGene00197298	T23F11.8
No description available

WB:WBGene00197299	C39E6.9
No description available

WB:WBGene00197300	R08B4.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197301	Y58A7A.9
No description available

WB:WBGene00197302	C33F10.18
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197303	F26E4.16
Is affected by cep-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197304	F43G6.12
No description available

WB:WBGene00197305	C36F7.13
No description available

WB:WBGene00197306	Y39A3CL.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197307	Y66A7AL.4
No description available

WB:WBGene00197308	F55G1.18
No description available

WB:WBGene00197309	K04H4.10
No description available

WB:WBGene00197310	F26A10.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197311	C31G12.8
No description available

WB:WBGene00197312	C47G2.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197313	F25B4.12
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197314	F11D5.14
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197315	T13H10.8
No description available

WB:WBGene00197316	D1022.13
No description available

WB:WBGene00197317	T22F3.14
No description available

WB:WBGene00197318	Y50D4C.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00197319	C32C4.12
No description available

WB:WBGene00197320	F53B1.10
No description available

WB:WBGene00197321	ZC504.10
No description available

WB:WBGene00197322	T05G5.13
No description available

WB:WBGene00197323	C04C3.11
No description available

WB:WBGene00197324	F16A11.6
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00197325	T24A6.23
Is affected by daf-2 based on microarray studies.

WB:WBGene00197326	F25G6.16
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197327	F48C5.7
No description available

WB:WBGene00197328	F55C12.11
No description available

WB:WBGene00197329	K06G5.6
No description available

WB:WBGene00197330	W02H5.15
No description available

WB:WBGene00197331	M01G4.5
No description available

WB:WBGene00197332	F45B8.11
No description available

WB:WBGene00197333	cTel3X.2
No description available

WB:WBGene00197334	T25F10.8
No description available

WB:WBGene00197335	C05D2.14
No description available

WB:WBGene00197336	H20J04.10
No description available

WB:WBGene00197337	Y67D11A.2
No description available

WB:WBGene00197338	F39H12.5
No description available

WB:WBGene00197339	Y51A2D.28
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197340	ZK867.10
No description available

WB:WBGene00197341	R06C1.8
No description available

WB:WBGene00197342	F37H8.8
No description available

WB:WBGene00197343	W02B8.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197344	F11D5.15
No description available

WB:WBGene00197345	Y50D4A.7
No description available

WB:WBGene00197346	F02D10.12
No description available

WB:WBGene00197347	F11E6.20
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197348	T25B9.13
No description available

WB:WBGene00197349	C05E11.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197350	C18E9.13
No description available

WB:WBGene00197351	F54F2.10
No description available

WB:WBGene00197352	F07C4.16
No description available

WB:WBGene00197353	T26E3.14
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00197354	T07C12.17
No description available

WB:WBGene00197355	F52F10.7
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00197356	F01G12.11
No description available

WB:WBGene00197357	Y69H2.19
No description available

WB:WBGene00197358	K10C9.11
No description available

WB:WBGene00197359	C16E9.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197360	F46H6.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197361	K12C11.8
No description available

WB:WBGene00197362	C23H4.11
No description available

WB:WBGene00197363	W02F12.11
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00197364	C36F7.14
No description available

WB:WBGene00197365	T05C12.13
No description available

WB:WBGene00197366	F22A3.12
No description available

WB:WBGene00197367	W05E10.12
No description available

WB:WBGene00197368	T05B4.16
No description available

WB:WBGene00197369	F48G7.14
No description available

WB:WBGene00197370	Y37E11AL.14
No description available

WB:WBGene00197371	Y76A2B.8
No description available

WB:WBGene00197372	K08A8.11
No description available

WB:WBGene00197373	K03A1.9
No description available

WB:WBGene00197374	K04H4.11
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00197375	F13H6.11
No description available

WB:WBGene00197376	F28E10.10
No description available

WB:WBGene00197377	C05E11.13
No description available

WB:WBGene00197378	T22A3.11
No description available

WB:WBGene00197379	F16F9.8
No description available

WB:WBGene00197380	F08F1.13
No description available

WB:WBGene00197381	C07A12.10
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00197382	K08B12.8
No description available

WB:WBGene00197383	F55F1.7
No description available

WB:WBGene00197384	C18C4.13
No description available

WB:WBGene00197385	F18C5.13
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00197386	Y105C5A.1276
No description available

WB:WBGene00197387	F35E8.18
Is affected by daf-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197388	F54E4.10
No description available

WB:WBGene00197389	F38B6.11
No description available

WB:WBGene00197390	T21F2.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197391	K12H4.10
No description available

WB:WBGene00197392	K01A2.13
No description available

WB:WBGene00197393	C06B8.14
No description available

WB:WBGene00197394	H14E04.6
No description available

WB:WBGene00197395	Y57A10A.40
No description available

WB:WBGene00197396	F38B2.7
No description available

WB:WBGene00197397	Y67D8C.14
No description available

WB:WBGene00197398	F29F11.9
No description available

WB:WBGene00197399	C49H3.14
No description available

WB:WBGene00197400	B0336.14
No description available

WB:WBGene00197401	K08E3.13
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00197402	T07F12.7
No description available

WB:WBGene00197403	T14F9.12
No description available

WB:WBGene00197404	K03H1.18
No description available

WB:WBGene00197405	K02F6.10
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00197406	K02A4.5
No description available

WB:WBGene00197407	F40B5.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197408	F38E11.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197409	K01B6.6
No description available

WB:WBGene00197410	F10C1.15
No description available

WB:WBGene00197411	W03G9.11
No description available

WB:WBGene00197412	T24F1.9
No description available

WB:WBGene00197413	C02B4.6
No description available

WB:WBGene00197414	C43C3.7
No description available

WB:WBGene00197415	F35A5.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197416	F16F9.9
No description available

WB:WBGene00197417	H28G03.7
No description available

WB:WBGene00197418	F01E11.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197419	C54G7.10
No description available

WB:WBGene00197420	T22B11.7
No description available

WB:WBGene00197421	C54D2.10
Is affected by cep-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00197422	F08B12.7
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197423	F40F8.14
Is affected by daf-2 based on microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00197424	K11D9.6
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00197425	R11F4.5
No description available

WB:WBGene00197426	K08F8.8
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197427	Y42H9B.5
No description available

WB:WBGene00197428	K01B6.7
No description available

WB:WBGene00197429	W03G11.11
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197430	T09A5.18
No description available

WB:WBGene00197431	Y67D8C.15
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197432	T21G5.7
No description available

WB:WBGene00197433	F26H11.9
Is affected by daf-2; eat-2; and pmt-2 based on microarray studies.

WB:WBGene00197434	F26A10.12
No description available

WB:WBGene00197435	C11G6.5
No description available

WB:WBGene00197436	Y49G5B.2
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00197437	K09E2.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197438	T05A8.9
No description available

WB:WBGene00197439	C33D12.11
No description available

WB:WBGene00197440	F14F7.6
No description available

WB:WBGene00197441	T08B2.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197442	B0491.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00197443	F20D1.14
No description available

WB:WBGene00197444	K05G3.6
No description available

WB:WBGene00197445	Y17G9A.86
No description available

WB:WBGene00197446	C48D5.6
No description available

WB:WBGene00197447	T21E12.7
No description available

WB:WBGene00197448	ZK622.7
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197449	F13D11.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197450	ZK84.10
No description available

WB:WBGene00197451	C26G2.4
No description available

WB:WBGene00197452	C25F6.13
No description available

WB:WBGene00197453	H35N09.3
No description available

WB:WBGene00197454	T04H1.11
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00197455	F45B8.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00197456	C39E9.16
No description available

WB:WBGene00197457	T10B11.10
No description available

WB:WBGene00197458	C16E9.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197459	F28B4.5
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197460	C31E10.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197461	T04C10.8
No description available

WB:WBGene00197462	C02B4.7
No description available

WB:WBGene00197463	F32A6.8
Is affected by ifo-1 based on microarray studies.

WB:WBGene00197464	F15A8.8
No description available

WB:WBGene00197465	C25F6.14
Is affected by daf-12; daf-16; and dpy-21 based on RNA-seq studies.

WB:WBGene00197466	F52B10.12
No description available

WB:WBGene00197467	ZK836.8
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00197468	T02E9.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197469	H16O14.77
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197470	F29B9.14
No description available

WB:WBGene00197471	F56E3.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197472	F28E10.11
No description available

WB:WBGene00197473	C05A9.4
Is affected by ifo-1 based on microarray studies.

WB:WBGene00197474	C41A3.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197475	W01C8.11
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00197476	C41A3.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00197477	H05O09.3
No description available

WB:WBGene00197478	T13B5.10
No description available

WB:WBGene00197479	F18G5.9
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00197480	ZK1193.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197481	F38A6.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197482	C07A12.11
No description available

WB:WBGene00197483	F27B10.3
No description available

WB:WBGene00197484	C03A3.4
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00197485	C55C3.72
Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00197486	R151.15
Is affected by eat-2 based on microarray studies.

WB:WBGene00197487	F13C5.8
No description available

WB:WBGene00197488	F41C6.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197489	C30B5.12
No description available

WB:WBGene00197490	M02G9.5
No description available

WB:WBGene00197491	R04F11.14
No description available

WB:WBGene00197492	T06H11.10
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00197493	T28B11.11
Is affected by cep-1; dlc-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197494	R09D1.16
No description available

WB:WBGene00197495	R11B5.5
No description available

WB:WBGene00197496	F35D2.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197497	T24D5.8
No description available

WB:WBGene00197498	R11B5.6
No description available

WB:WBGene00197499	F08C6.12
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00197500	F08G2.14
No description available

WB:WBGene00197501	T21C9.15
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00197502	T14B4.13
No description available

WB:WBGene00197503	C45E1.7
No description available

WB:WBGene00197504	F23F12.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00197505	C01F4.6
No description available

WB:WBGene00197506	F23F12.16
No description available

WB:WBGene00197507	R08E3.7
No description available

WB:WBGene00197508	ZC334.14
No description available

WB:WBGene00197509	R02E4.4
No description available

WB:WBGene00197510	C18B12.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197511	ZK470.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197512	Y116F11A.7
No description available

WB:WBGene00197513	F22F1.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00197514	B0285.14
No description available

WB:WBGene00197515	C49F8.9
No description available

WB:WBGene00197516	T04C12.21
No description available

WB:WBGene00197517	R03G5.8
Is affected by sek-1 based on RNA-seq studies.

WB:WBGene00197518	F57G12.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00197519	Y105E8A.41
No description available

WB:WBGene00197520	C05C8.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by hmg-3 and dlc-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197521	ZC404.17
No description available

WB:WBGene00197522	T21B6.10
Is affected by Cry5B based on microarray studies.

WB:WBGene00197523	F58H1.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197524	D2023.14
No description available

WB:WBGene00197525	T10H9.9
No description available

WB:WBGene00197526	F32B5.11
No description available

WB:WBGene00197527	F44D12.17
No description available

WB:WBGene00197528	F44C4.10
No description available

WB:WBGene00197529	C29E6.12
No description available

WB:WBGene00197530	T12B5.16
No description available

WB:WBGene00197531	B0198.5
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197532	F09D5.3
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197533	F42G2.9
No description available

WB:WBGene00197534	F38H4.13
Is affected by daf-2; eat-2; and ints-4 based on microarray and RNA-seq studies.

WB:WBGene00197535	R13.7
No description available

WB:WBGene00197536	M01G5.9
No description available

WB:WBGene00197537	T08B1.8
No description available

WB:WBGene00197538	Y26D4A.23
No description available

WB:WBGene00197539	C07H6.13
No description available

WB:WBGene00197540	T08H4.7
No description available

WB:WBGene00197541	C07G1.10
No description available

WB:WBGene00197542	W01A11.11
No description available

WB:WBGene00197543	F57C7.9
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197544	Y7A5A.15
No description available

WB:WBGene00197545	Y53F4B.55
No description available

WB:WBGene00197546	F39B3.6
No description available

WB:WBGene00197547	Y39B6A.77
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197548	T10B10.11
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00197549	T09B4.15
No description available

WB:WBGene00197550	T24B8.12
Is affected by adr-1 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00197551	T22D1.20
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197552	Y49F6B.15
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies.

WB:WBGene00197553	F45E1.10
Is affected by eat-2 based on microarray studies.

WB:WBGene00197554	T14G12.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197555	Y67D8A.8
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by dlc-1 and pgrn-1 based on RNA-seq studies.

WB:WBGene00197556	C42D8.14
No description available

WB:WBGene00197557	F25H10.4
No description available

WB:WBGene00197558	Y38H6A.7
No description available

WB:WBGene00197559	C17D12.12
No description available

WB:WBGene00197560	K08A2.12
No description available

WB:WBGene00197561	C33F10.19
No description available

WB:WBGene00197562	T10D4.16
No description available

WB:WBGene00197563	B0403.9
No description available

WB:WBGene00197564	F52D10.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197565	F39B2.12
No description available

WB:WBGene00197566	E03E2.2
No description available

WB:WBGene00197567	C32C4.13
No description available

WB:WBGene00197568	F49E11.12
No description available

WB:WBGene00197569	F46G11.13
No description available

WB:WBGene00197570	F33D11.15
No description available

WB:WBGene00197571	C41G11.12
No description available

WB:WBGene00197572	F52B10.13
Is affected by ifo-1 based on microarray studies.

WB:WBGene00197573	F14B8.11
No description available

WB:WBGene00197574	C04C11.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197575	C30C11.9
No description available

WB:WBGene00197576	C01C10.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00197577	W08F4.16
No description available

WB:WBGene00197578	F13D11.12
No description available

WB:WBGene00197579	F44A2.9
No description available

WB:WBGene00197580	F19B6.6
No description available

WB:WBGene00197581	T28B4.9
No description available

WB:WBGene00197582	T03G11.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197583	T26H10.4
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197584	Y40C5A.17
No description available

WB:WBGene00197585	T08G11.8
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00197586	ZC64.12
No description available

WB:WBGene00197587	F38B7.14
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197588	T08G2.5
No description available

WB:WBGene00197589	C39D10.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00197590	F30H5.6
No description available

WB:WBGene00197591	K08B12.9
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197592	F52D10.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197593	F18F11.6
No description available

WB:WBGene00197594	T24B8.13
No description available

WB:WBGene00197595	R12E2.18
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197596	C25A11.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197597	M163.17
Is affected by cep-1 and ints-4 based on RNA-seq studies.

WB:WBGene00197598	F56A11.9
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00197599	F52B10.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00197600	C14F5.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197601	T26H10.5
No description available

WB:WBGene00197602	F28F8.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00197603	T19C4.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197604	K01G5.12
No description available

WB:WBGene00197605	H13J03.1
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197606	F35B3.8
No description available

WB:WBGene00197607	F47F2.5
No description available

WB:WBGene00197608	T02E9.17
No description available

WB:WBGene00197609	ZC21.11
No description available

WB:WBGene00197610	Y38H8A.11
No description available

WB:WBGene00197611	C39E9.17
No description available

WB:WBGene00197612	Y53F4B.56
No description available

WB:WBGene00197613	F49D11.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00197614	ZC506.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00197615	C25F6.15
Is affected by alg-1 and adr-1 based on RNA-seq studies.

WB:WBGene00197616	C29A12.11
No description available

WB:WBGene00197617	C06E7.90
Is affected by daf-2 based on microarray studies.

WB:WBGene00197618	F47G4.12
No description available

WB:WBGene00197619	Y110A2AL.18
No description available

WB:WBGene00197620	Y75B8A.49
Is affected by emr-1; lem-2; and hmg-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197621	F45F2.14
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197622	CD4.14
Is affected by alg-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197623	B0240.5
No description available

WB:WBGene00197624	Y55F3C.15
No description available

WB:WBGene00197625	T27E4.16
Is affected by cep-1 and ints-2 based on RNA-seq studies.

WB:WBGene00197626	ZK381.43
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197627	Y37F4.11
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00197628	K08E5.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00197629	F58F12.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197630	AH10.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197631	F43G6.13
No description available

WB:WBGene00197632	T23E7.8
No description available

WB:WBGene00197633	C56G2.18
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197634	C40C9.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197635	C31H2.7
No description available

WB:WBGene00197636	Y67D8C.16
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197637	R13F6.13
Is affected by dlc-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00197638	F43D2.9
No description available

WB:WBGene00197639	Y39A1B.6
No description available

WB:WBGene00197640	F57B1.13
No description available

WB:WBGene00197641	T03F7.12
No description available

WB:WBGene00197642	C16E9.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197643	F13H6.12
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197644	H30A04.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197645	C39E6.10
No description available

WB:WBGene00197646	ZK795.7
No description available

WB:WBGene00197647	K03C7.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197648	ZK20.8
No description available

WB:WBGene00197649	K03C7.8
No description available

WB:WBGene00197650	Y54F10AM.12
No description available

WB:WBGene00197651	R03A10.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197652	C05B5.13
No description available

WB:WBGene00197653	R186.11
No description available

WB:WBGene00197654	T16G1.14
Is affected by eat-2 based on microarray studies.

WB:WBGene00197655	F45E1.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197656	F09D5.4
No description available

WB:WBGene00197657	F11A5.20
No description available

WB:WBGene00197658	T01C1.9
Is affected by elli-1 based on microarray studies.

WB:WBGene00197659	F43C11.14
No description available

WB:WBGene00197660	C27A2.11
Is affected by hmg-3 and adr-1 based on RNA-seq studies.

WB:WBGene00197661	R12B2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197662	B0403.10
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197663	F13H6.13
Is affected by cep-1; daf-2; and adr-1 based on RNA-seq and microarray studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00197664	Y51A2D.29
No description available

WB:WBGene00197665	C48G7.4
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197666	C05D2.15
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00197667	R160.8
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00197668	F46H5.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197669	F56F3.10
No description available

WB:WBGene00197670	C54C6.8
No description available

WB:WBGene00197671	F46C8.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00197672	C48A7.9
No description available

WB:WBGene00197673	ZK973.17
No description available

WB:WBGene00197674	F58H1.16
Is affected by cep-1; adr-1; and daf-12 based on RNA-seq studies. Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00197675	ZK84.11
No description available

WB:WBGene00197676	Y59A8B.29
No description available

WB:WBGene00197677	F14F3.9
No description available

WB:WBGene00197678	R01E6.11
No description available

WB:WBGene00197679	F13H6.14
No description available

WB:WBGene00197680	Y76F7A.3
Is affected by nanoparticle based on microarray studies.

WB:WBGene00197681	Y51A2B.12
No description available

WB:WBGene00197682	R52.11
No description available

WB:WBGene00197683	ZK816.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197684	F59B2.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197685	Y53C12B.8
No description available

WB:WBGene00197686	B0034.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197687	C54H2.8
No description available

WB:WBGene00197688	ZK836.9
Is affected by ifo-1 based on microarray studies.

WB:WBGene00197689	F08G5.13
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00197690	C08G9.5
No description available

WB:WBGene00197691	K08F8.9
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00197692	Y22D7AR.18
No description available

WB:WBGene00197693	F36D1.16
No description available

WB:WBGene00197694	D2089.6
No description available

WB:WBGene00197695	C18F3.8
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00197696	C49A1.13
No description available

WB:WBGene00197697	B0432.19
No description available

WB:WBGene00197698	C05D12.9
No description available

WB:WBGene00197699	F53B7.10
No description available

WB:WBGene00197700	K09B11.20
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197701	F44E5.8
No description available

WB:WBGene00197702	C27F2.11
No description available

WB:WBGene00197703	F53B2.14
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00197704	B0379.11
No description available

WB:WBGene00197705	R01E6.12
No description available

WB:WBGene00197706	ZK470.10
No description available

WB:WBGene00197707	F20D1.15
Is affected by nanoparticle based on microarray studies.

WB:WBGene00197708	K12H4.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00197709	W09B12.3
No description available

WB:WBGene00197710	C14F11.14
Is affected by several genes including cep-1; adr-1; and ints-2 based on RNA-seq studies.

WB:WBGene00197711	Y32F6B.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00197712	F48A9.4
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00197713	Y48G8AR.4
No description available

WB:WBGene00197714	Y54E10BL.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00197715	B0024.17
No description available

WB:WBGene00197716	H15M21.1
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00197717	T01B6.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197718	F25G6.17
No description available

WB:WBGene00197719	Y42G9A.8
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197720	ZC504.11
No description available

WB:WBGene00197721	C45G7.8
No description available

WB:WBGene00197722	F43D9.9
No description available

WB:WBGene00197723	Y69A2AR.39
No description available

WB:WBGene00197724	F36H1.15
Is affected by emr-1 and lem-2 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197725	ZK1025.13
No description available

WB:WBGene00197726	C44B7.16
No description available

WB:WBGene00197727	F49H12.10
No description available

WB:WBGene00197728	C52B11.7
No description available

WB:WBGene00197729	R08B4.9
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00197730	C13G3.6
No description available

WB:WBGene00197731	F46F3.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197732	T02E9.18
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197733	T25C12.5
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00197734	W07G1.12
No description available

WB:WBGene00197735	F36D4.10
No description available

WB:WBGene00197736	B0207.14
No description available

WB:WBGene00197737	F38E9.7
No description available

WB:WBGene00197738	F43G9.15
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197739	F29F11.10
No description available

WB:WBGene00197740	T21H3.7
No description available

WB:WBGene00197741	C54A12.6
No description available

WB:WBGene00197742	F41D9.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197743	F11C1.13
Is affected by eat-2 based on microarray studies.

WB:WBGene00197744	F46C8.13
No description available

WB:WBGene00197745	C47E12.16
No description available

WB:WBGene00197746	ZK84.12
No description available

WB:WBGene00197747	Y39H10A.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197748	T05A1.16
Is affected by daf-2 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197749	F35H10.15
No description available

WB:WBGene00197750	ZK377.5
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00197751	ZK945.11
No description available

WB:WBGene00197752	F46F3.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197753	F58H1.17
No description available

WB:WBGene00197754	Y92C3A.6
No description available

WB:WBGene00197755	ZK899.10
No description available

WB:WBGene00197756	ZC250.8
No description available

WB:WBGene00197757	H36N01.1
No description available

WB:WBGene00197758	C36F7.15
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00197759	F56E3.11
No description available

WB:WBGene00197760	M163.18
No description available

WB:WBGene00197761	C18A11.10
Is affected by rbr-2 based on RNA-seq studies.

WB:WBGene00197762	K09F5.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197763	F44E8.43
Is affected by daf-2; eat-2; and pmt-2 based on microarray studies.

WB:WBGene00197764	F49E2.7
No description available

WB:WBGene00197765	C01B7.11
No description available

WB:WBGene00197766	C24A3.11
No description available

WB:WBGene00197767	B0285.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197768	W03G11.12
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197769	T28B11.12
Is affected by several genes including cep-1; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00197770	F27C8.12
No description available

WB:WBGene00197771	F09A5.12
No description available

WB:WBGene00197772	F22D6.18
No description available

WB:WBGene00197773	T27A10.8
Is affected by several genes including lem-2; ahr-1; and emr-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Ethanol; sodium arsenite; and bisphenol A based on RNA-seq studies.

WB:WBGene00197774	T10H4.18
No description available

WB:WBGene00197775	F26F12.11
Is affected by pgrn-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197776	F52F12.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197777	F13C5.9
No description available

WB:WBGene00197778	K06A1.7
No description available

WB:WBGene00197779	T27E4.17
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00197780	F48B9.10
No description available

WB:WBGene00197781	T04D3.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197782	K09E9.8
No description available

WB:WBGene00197783	R07B1.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00197784	K08A8.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197785	ZK1151.4
No description available

WB:WBGene00197786	K02G10.10
No description available

WB:WBGene00197787	ZC53.12
No description available

WB:WBGene00197788	ZC581.12
No description available

WB:WBGene00197789	Y6B3B.13
No description available

WB:WBGene00197790	C07A4.6
No description available

WB:WBGene00197791	F54C9.16
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00197792	H03A11.7
No description available

WB:WBGene00197793	T22B7.11
No description available

WB:WBGene00197794	M04D5.5
No description available

WB:WBGene00197795	F43D2.10
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197796	B0001.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197797	K08H10.16
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00197798	T05A6.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197799	B0454.17
No description available

WB:WBGene00197800	H01A20.3
No description available

WB:WBGene00197801	F58H1.18
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00197802	T19F4.3
No description available

WB:WBGene00197803	K07C10.6
Is affected by rsr-2 and ints-5 based on RNA-seq studies.

WB:WBGene00197804	F27D9.11
No description available

WB:WBGene00197805	C43G2.27
No description available

WB:WBGene00197806	T22E5.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197807	F52E4.11
No description available

WB:WBGene00197808	K12G11.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197809	B0334.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00197810	Y17G9A.87
No description available

WB:WBGene00197811	ZK180.10
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00197812	C06E8.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197813	T13H10.9
No description available

WB:WBGene00197814	F54A3.9
No description available

WB:WBGene00197815	F56A11.10
No description available

WB:WBGene00197816	T22E5.13
No description available

WB:WBGene00197817	C07B5.9
No description available

WB:WBGene00197818	ZK381.44
Is affected by nanoparticle based on microarray studies.

WB:WBGene00197819	T01B7.11
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197820	C15A7.6
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197821	T01B10.10
No description available

WB:WBGene00197822	H22K11.8
No description available

WB:WBGene00197823	Y52B11B.2
No description available

WB:WBGene00197824	Y73F8A.1166
No description available

WB:WBGene00197825	C54G4.12
No description available

WB:WBGene00197826	C53C9.4
Is affected by eat-2 based on microarray studies.

WB:WBGene00197827	R04F11.15
No description available

WB:WBGene00197828	C02B4.8
Is affected by daf-2; eat-2; and pmt-2 based on microarray studies. Is affected by Ethanol and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197829	C05C9.8
No description available

WB:WBGene00197830	C13G3.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00197831	M01G5.10
No description available

WB:WBGene00197832	F26A10.13
No description available

WB:WBGene00197833	C38C5.2
No description available

WB:WBGene00197834	T16G1.15
Is affected by ifo-1 based on microarray studies.

WB:WBGene00197835	F25B5.10
No description available

WB:WBGene00197836	C29A12.12
No description available

WB:WBGene00197837	K11C4.9
Is affected by Cry5B based on microarray studies.

WB:WBGene00197838	C02D4.6
No description available

WB:WBGene00197839	F14D12.8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197840	F58G11.8
Is affected by dpy-21 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00197841	K03B8.17
No description available

WB:WBGene00197842	Y54G2A.62
No description available

WB:WBGene00197843	ZK1010.11
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00197844	F54E4.11
No description available

WB:WBGene00197845	F55C12.12
No description available

WB:WBGene00197846	W03G11.13
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197847	K12G11.10
No description available

WB:WBGene00197848	F52B10.15
Is affected by ifo-1 based on microarray studies.

WB:WBGene00197849	F18E2.11
No description available

WB:WBGene00197850	W06B3.4
Is affected by pgrn-1 and cep-1 based on RNA-seq studies.

WB:WBGene00197851	F49E7.3
No description available

WB:WBGene00197852	Y64G10A.354
No description available

WB:WBGene00197853	C53C11.7
No description available

WB:WBGene00197854	W01H2.6
No description available

WB:WBGene00197855	Y50E8A.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197856	F53F4.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197857	C53D6.19
No description available

WB:WBGene00197858	F47G3.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197859	C09B8.13
No description available

WB:WBGene00197860	Y38F2AR.17
No description available

WB:WBGene00197861	F10D7.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00197862	T10E10.10
No description available

WB:WBGene00197863	F54G2.3
No description available

WB:WBGene00197864	C17E4.16
No description available

WB:WBGene00197865	D1046.10
No description available

WB:WBGene00197866	F26H11.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197867	Y48B6A.19
Is affected by daf-2 and klf-1 based on microarray and RNA-seq studies.

WB:WBGene00197868	T19A5.7
No description available

WB:WBGene00197869	D1054.20
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00197870	Y43F4A.5
Is affected by daf-2 and dpy-21 based on RNA-seq studies.

WB:WBGene00197871	D1081.14
No description available

WB:WBGene00197872	Y54E10A.23
No description available

WB:WBGene00197873	F55A4.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00197874	C27F2.12
No description available

WB:WBGene00197875	T19F4.4
No description available

WB:WBGene00197876	F31F6.10
No description available

WB:WBGene00197877	Y66A7AL.5
No description available

WB:WBGene00197878	F22E10.9
No description available

WB:WBGene00197879	ZK287.11
No description available

WB:WBGene00197880	C54G7.11
Is affected by hmg-3 and hmg-4 based on RNA-seq studies.

WB:WBGene00197881	C31G12.9
No description available

WB:WBGene00197882	F12F3.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197883	F31E8.13
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197884	F01F1.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197885	F43D2.11
No description available

WB:WBGene00197886	C13B4.5
No description available

WB:WBGene00197887	C30F2.6
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00197888	F16D3.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197889	R02D5.13
No description available

WB:WBGene00197890	F47C8.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197891	C29F3.9
Is affected by cep-1; daf-2; and nhr-86 based on RNA-seq and microarray studies.

WB:WBGene00197892	Y39B6A.78
No description available

WB:WBGene00197893	F25C8.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197894	F52E10.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00197895	C14B9.13
Is affected by hmg-3 and daf-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00197896	Y15E3A.8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197897	F58A4.19
No description available

WB:WBGene00197898	W09D6.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197899	ZK682.9
Is affected by Cry5B based on microarray studies.

WB:WBGene00197900	M01A10.7
No description available

WB:WBGene00197901	H01G02.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197902	R53.10
No description available

WB:WBGene00197903	T28B4.10
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00197904	T21H8.7
No description available

WB:WBGene00197905	F26F12.12
No description available

WB:WBGene00197906	T04C9.7
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1; adr-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197907	Y75B7AL.6
No description available

WB:WBGene00197908	B0303.17
No description available

WB:WBGene00197909	F18A11.9
No description available

WB:WBGene00197910	F01D5.13
No description available

WB:WBGene00197911	F40E10.10
No description available

WB:WBGene00197912	C25F6.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197913	R90.7
No description available

WB:WBGene00197914	C14C11.10
No description available

WB:WBGene00197915	C17H12.30
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00197916	K01A11.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00197917	C06E1.14
No description available

WB:WBGene00197918	B0344.3
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00197919	C24E9.2
No description available

WB:WBGene00197920	K03H6.10
No description available

WB:WBGene00197921	C14F11.15
No description available

WB:WBGene00197922	F43E12.3
No description available

WB:WBGene00197923	F57G12.6
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00197924	E04D5.8
No description available

WB:WBGene00197925	F31E3.9
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00197926	K03B8.18
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00197927	C04D8.3
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197928	F29F11.11
No description available

WB:WBGene00197929	Y9C9A.109
No description available

WB:WBGene00197930	T06H11.11
Is affected by several genes including hpl-2; let-418; and dlc-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and procyanidin based on RNA-seq and microarray studies.

WB:WBGene00197931	K10B4.9
No description available

WB:WBGene00197932	K08A2.13
No description available

WB:WBGene00197933	F08F1.14
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00197934	ZK867.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197935	T04C10.9
No description available

WB:WBGene00197936	Y73B6BL.275
Is affected by several genes including tdp-1; rpl-5; and hmg-4 based on RNA-seq studies.

WB:WBGene00197937	B0250.16
No description available

WB:WBGene00197938	C35A11.7
No description available

WB:WBGene00197939	C06E4.15
No description available

WB:WBGene00197940	F40E3.8
No description available

WB:WBGene00197941	ZC328.7
No description available

WB:WBGene00197942	T25D3.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197943	C34D1.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197944	F26D11.16
No description available

WB:WBGene00197945	C53C7.6
No description available

WB:WBGene00197946	ZK622.8
No description available

WB:WBGene00197947	Y51H7C.22
No description available

WB:WBGene00197948	T03G11.18
No description available

WB:WBGene00197949	T25B6.8
No description available

WB:WBGene00197950	K02B12.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00197951	Y43E12A.5
No description available

WB:WBGene00197952	C18D1.14
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197953	T06F4.8
No description available

WB:WBGene00197954	B0393.13
No description available

WB:WBGene00197955	VT23B5.1
Is affected by several genes including daf-2; set-2; and lin-22 based on microarray and RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197956	C35C5.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00197957	Y106G6A.9
No description available

WB:WBGene00197958	B0034.11
No description available

WB:WBGene00197959	C46G7.107
No description available

WB:WBGene00197960	C06E2.13
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00197961	Y65B4BL.11
No description available

WB:WBGene00197962	Y43F4A.6
Is affected by daf-2 and pmt-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00197963	F41E7.13
Is affected by eat-2 based on microarray studies.

WB:WBGene00197964	F10E9.15
No description available

WB:WBGene00197965	C30F12.8
No description available

WB:WBGene00197966	B0393.14
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00197967	C07A4.7
No description available

WB:WBGene00197968	ZK1290.19
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197969	Y70D2A.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00197970	C11G10.6
No description available

WB:WBGene00197971	T06D10.6
No description available

WB:WBGene00197972	F35C11.10
No description available

WB:WBGene00197973	C05G5.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197974	C44C11.4
No description available

WB:WBGene00197975	C06G1.12
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00197976	F56D1.10
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00197977	F47G3.7
Is affected by pmt-2 based on microarray studies.

WB:WBGene00197978	ZC123.7
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00197979	K05F1.12
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00197980	K01A2.14
No description available

WB:WBGene00197981	ZC64.13
No description available

WB:WBGene00197982	B0410.4
No description available

WB:WBGene00197983	F18A11.10
Is affected by dlc-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00197984	F43D9.10
No description available

WB:WBGene00197985	K04A8.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00197986	F46H6.9
No description available

WB:WBGene00197987	F45E4.17
No description available

WB:WBGene00197988	Y73F8A.1167
No description available

WB:WBGene00197989	R07D5.5
No description available

WB:WBGene00197990	T06F4.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00197991	T04C12.22
No description available

WB:WBGene00197992	C14F11.16
No description available

WB:WBGene00197993	F54A5.4
No description available

WB:WBGene00197994	C34E11.11
No description available

WB:WBGene00197995	F11D5.16
Is affected by cep-1; let-418; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00197996	C45E1.8
No description available

WB:WBGene00197997	H01G02.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00197998	T07D1.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00197999	T01C2.4
No description available

WB:WBGene00198000	K08B5.6
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198001	Y54E10A.24
Is affected by cep-1; dlc-1; and ints-4 based on RNA-seq studies.

WB:WBGene00198002	F14F11.3
No description available

WB:WBGene00198003	C54G7.12
No description available

WB:WBGene00198004	K02A4.6
No description available

WB:WBGene00198005	C26G2.5
No description available

WB:WBGene00198006	R160.9
No description available

WB:WBGene00198007	C34B4.12
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00198008	M60.9
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00198009	C50D2.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198010	Y17G7A.3
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198011	T20F10.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198012	Y54G2A.63
No description available

WB:WBGene00198013	B0457.11
No description available

WB:WBGene00198014	K09E9.9
No description available

WB:WBGene00198015	T01B6.9
No description available

WB:WBGene00198016	H21P03.7
No description available

WB:WBGene00198017	R107.10
No description available

WB:WBGene00198018	Y55D5A.9
No description available

WB:WBGene00198019	F57B1.14
No description available

WB:WBGene00198020	C16E9.16
Is affected by cep-1 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00198021	ZK1248.21
No description available

WB:WBGene00198022	F15A8.9
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00198023	T14F9.13
No description available

WB:WBGene00198024	H08J11.6
No description available

WB:WBGene00198025	F16F9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198026	Y71F9B.19
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198027	K04E7.4
No description available

WB:WBGene00198028	K10D6.12
No description available

WB:WBGene00198029	F54D5.20
Is affected by chd-3 based on RNA-seq studies.

WB:WBGene00198030	F25G6.18
No description available

WB:WBGene00198031	Y47D3B.16
No description available

WB:WBGene00198032	H35N09.4
No description available

WB:WBGene00198033	F09F9.11
No description available

WB:WBGene00198034	F36G3.7
No description available

WB:WBGene00198035	Y41C4A.26
No description available

WB:WBGene00198036	ZK622.9
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00198037	K03H4.4
No description available

WB:WBGene00198038	H03E18.4
No description available

WB:WBGene00198039	T19B10.14
No description available

WB:WBGene00198040	C18A3.19
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198041	Y59E9AL.37
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00198042	T28F4.7
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00198043	ZK616.63
No description available

WB:WBGene00198044	F48A11.8
No description available

WB:WBGene00198045	C09H10.12
No description available

WB:WBGene00198046	F19D8.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198047	K02A11.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198048	Y51A2D.30
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00198049	F57G8.12
No description available

WB:WBGene00198050	F29G9.12
No description available

WB:WBGene00198051	F52E4.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198052	Y105E8A.42
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00198053	T05A6.12
No description available

WB:WBGene00198054	B0495.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00198055	Y75B8A.50
No description available

WB:WBGene00198056	C01B7.12
No description available

WB:WBGene00198057	C06E2.14
Is affected by pgrn-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198058	F20B10.8
No description available

WB:WBGene00198059	Y39G10AL.4
No description available

WB:WBGene00198060	Y51H7C.23
No description available

WB:WBGene00198061	T06D10.7
Is affected by cep-1 and spc-1 based on RNA-seq studies.

WB:WBGene00198062	K08A8.13
No description available

WB:WBGene00198063	H05L03.7
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198064	C31H2.8
No description available

WB:WBGene00198065	C54D10.19
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198066	F47G4.13
No description available

WB:WBGene00198067	ZK617.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00198068	C25A11.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00198069	C23F12.8
No description available

WB:WBGene00198070	F07G11.10
No description available

WB:WBGene00198071	C12C8.6
No description available

WB:WBGene00198072	F18G5.10
No description available

WB:WBGene00198073	K08A8.14
No description available

WB:WBGene00198074	F47B8.17
No description available

WB:WBGene00198075	F57B7.8
No description available

WB:WBGene00198076	R13H7.19
No description available

WB:WBGene00198077	F59C12.9
No description available

WB:WBGene00198078	F53B1.11
No description available

WB:WBGene00198079	F35G2.13
No description available

WB:WBGene00198080	Y38F2AL.8
No description available

WB:WBGene00198081	C09D8.8
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00198082	W06D12.8
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00198083	C40H5.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198084	K11G9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198085	F47G3.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198086	F55A8.5
No description available

WB:WBGene00198087	C08F8.12
No description available

WB:WBGene00198088	C09D8.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198089	C24A11.11
No description available

WB:WBGene00198090	C47E8.13
No description available

WB:WBGene00198091	W09B12.4
No description available

WB:WBGene00198092	ZC190.13
No description available

WB:WBGene00198093	F55A12.14
No description available

WB:WBGene00198094	Y38C1BA.5
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00198095	F09A5.13
No description available

WB:WBGene00198096	F58A3.7
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198097	ZK1025.14
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00198098	T02C5.6
No description available

WB:WBGene00198099	K02H8.3
No description available

WB:WBGene00198100	F22E12.8
No description available

WB:WBGene00198101	F52B5.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198102	C24A11.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00198103	C56E10.5
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198104	Y58A7A.10
No description available

WB:WBGene00198105	C24D10.47
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198106	R09F10.15
No description available

WB:WBGene00198107	R03D7.12
No description available

WB:WBGene00198108	ZK1128.10
No description available

WB:WBGene00198109	C30A5.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198110	C10F3.12
Is affected by nanoparticle based on microarray studies.

WB:WBGene00198111	ZK662.7
No description available

WB:WBGene00198112	C35A11.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00198113	T06A1.8
No description available

WB:WBGene00198114	K02G10.11
No description available

WB:WBGene00198115	C06A1.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198116	C24A8.10
No description available

WB:WBGene00198117	C09B7.7
No description available

WB:WBGene00198118	C08C3.9
No description available

WB:WBGene00198119	T02C12.6
No description available

WB:WBGene00198120	K03E5.6
No description available

WB:WBGene00198121	R04F11.16
No description available

WB:WBGene00198122	F58F12.9
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00198123	Y41E3.458
No description available

WB:WBGene00198124	D2024.14
No description available

WB:WBGene00198125	H28G03.8
No description available

WB:WBGene00198126	F32G8.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198127	M03C11.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00198128	F59G1.11
No description available

WB:WBGene00198129	F32A6.9
No description available

WB:WBGene00198130	F25H8.11
No description available

WB:WBGene00198131	F36F2.11
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00198132	F56H11.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00198133	F07C3.14
No description available

WB:WBGene00198134	H01G02.10
No description available

WB:WBGene00198135	ZK525.6
No description available

WB:WBGene00198136	C43F9.16
No description available

WB:WBGene00198137	C43G2.28
No description available

WB:WBGene00198138	K11H3.10
No description available

WB:WBGene00198139	W04D2.9
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00198140	T05B4.17
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00198141	C16B8.7
No description available

WB:WBGene00198142	F26F12.13
No description available

WB:WBGene00198143	F12F3.6
No description available

WB:WBGene00198144	C36F7.16
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00198145	E03A3.11
No description available

WB:WBGene00198146	F56H6.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198147	C50A2.5
No description available

WB:WBGene00198148	K06G5.7
No description available

WB:WBGene00198149	F58B6.7
Is affected by eat-2 based on microarray studies.

WB:WBGene00198150	M79.10
No description available

WB:WBGene00198151	C04F12.15
No description available

WB:WBGene00198152	C48A7.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00198153	C34F11.11
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198154	C04C11.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00198155	F35A5.11
No description available

WB:WBGene00198156	T06H11.12
No description available

WB:WBGene00198157	R11B5.7
No description available

WB:WBGene00198158	Y60A3A.35
No description available

WB:WBGene00198159	C47G2.16
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00198160	T06H11.13
No description available

WB:WBGene00198161	C46A5.14
No description available

WB:WBGene00198162	W06H8.11
No description available

WB:WBGene00198163	T21D9.5
No description available

WB:WBGene00198164	F14D1.3
No description available

WB:WBGene00198165	M03A1.10
No description available

WB:WBGene00198166	VC5.8
No description available

WB:WBGene00198167	F38B6.12
No description available

WB:WBGene00198168	T22B7.12
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00198169	T10H9.10
No description available

WB:WBGene00198170	Y53C10A.19
No description available

WB:WBGene00198171	T04F8.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00198172	F16F9.11
No description available

WB:WBGene00198173	C14A11.10
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00198174	F31F7.6
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00198175	ZK381.45
No description available

WB:WBGene00198176	E02C12.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198177	C24A8.11
No description available

WB:WBGene00198178	ZK287.12
No description available

WB:WBGene00198179	W02B12.17
No description available

WB:WBGene00198180	F16F9.12
No description available

WB:WBGene00198181	Y73F8A.1168
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00198182	F56F3.11
No description available

WB:WBGene00198183	F46C5.11
No description available

WB:WBGene00198184	ZK381.46
No description available

WB:WBGene00198185	F56D12.11
No description available

WB:WBGene00198186	F12D9.11
No description available

WB:WBGene00198187	T26E3.15
No description available

WB:WBGene00198188	C11G6.6
No description available

WB:WBGene00198189	W05B2.12
No description available

WB:WBGene00198190	F25H2.16
No description available

WB:WBGene00198191	C34H3.11
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00198192	F19D8.5
No description available

WB:WBGene00198193	C17H12.31
Is affected by cep-1 and klf-1 based on RNA-seq studies.

WB:WBGene00198194	F52H2.11
No description available

WB:WBGene00198195	T27D12.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00198196	C48A7.11
No description available

WB:WBGene00198197	F41G3.22
No description available

WB:WBGene00198198	T07H6.7
No description available

WB:WBGene00198199	C12D12.9
No description available

WB:WBGene00198200	C53D6.20
No description available

WB:WBGene00198201	F59H5.5
No description available

WB:WBGene00198202	Y18D10A.28
No description available

WB:WBGene00198203	F35A5.12
No description available

WB:WBGene00198204	K07A9.6
No description available

WB:WBGene00198205	ZK973.18
No description available

WB:WBGene00198206	Y57A10A.41
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00198207	Y48G8AL.18
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198208	Y53H1C.8
No description available

WB:WBGene00198209	K08F8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198210	D1022.14
No description available

WB:WBGene00198211	K03H4.5
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198212	Y54F10BM.19
No description available

WB:WBGene00198213	M03F4.12
Is enriched in RID based on RNA-seq studies. Is affected by unc-39 and dlc-1 based on RNA-seq studies.

WB:WBGene00198214	C17E4.17
No description available

WB:WBGene00198215	C52E4.15
No description available

WB:WBGene00198216	M88.10
Is affected by cep-1 and mafr-1 based on RNA-seq and microarray studies.

WB:WBGene00198217	T25E4.3
No description available

WB:WBGene00198218	F59F3.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00198219	F13E6.9
No description available

WB:WBGene00198220	C34D1.10
No description available

WB:WBGene00198221	B0414.10
No description available

WB:WBGene00198222	C06A6.10
No description available

WB:WBGene00198223	C54D2.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198224	Y38C1AA.16
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00198225	K03H1.19
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198226	B0495.18
No description available

WB:WBGene00198227	C02D4.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198228	F21C10.14
No description available

WB:WBGene00198229	C43C3.8
No description available

WB:WBGene00198230	F40B5.6
No description available

WB:WBGene00198231	T01D3.9
No description available

WB:WBGene00198232	F18C5.14
Is affected by daf-2 and klf-1 based on microarray and RNA-seq studies.

WB:WBGene00198233	F55F3.6
No description available

WB:WBGene00198234	B0336.15
No description available

WB:WBGene00198235	K01B6.8
No description available

WB:WBGene00198236	C18A3.20
No description available

WB:WBGene00198237	T07F12.8
No description available

WB:WBGene00198238	B0207.15
No description available

WB:WBGene00198239	F22H10.9
Is affected by several genes including tdp-1; hmg-3; and damt-1 based on RNA-seq and microarray studies. Is affected by Ethanol and antimycin based on RNA-seq studies.

WB:WBGene00198240	F56E3.12
No description available

WB:WBGene00198241	K02A4.7
No description available

WB:WBGene00198242	F29F11.12
No description available

WB:WBGene00198243	C07A12.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198244	ZK1193.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198245	C46H11.12
Is affected by hmg-3 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198246	C03E10.9
No description available

WB:WBGene00198247	Y67D8C.17
No description available

WB:WBGene00198248	C18C4.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198249	C18D1.15
No description available

WB:WBGene00198250	T24D11.3
No description available

WB:WBGene00198251	F46H5.10
No description available

WB:WBGene00198252	T25D1.5
No description available

WB:WBGene00198253	T11A5.9
No description available

WB:WBGene00198254	C02B4.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00198255	T13B5.11
No description available

WB:WBGene00198256	Y47D3B.17
No description available

WB:WBGene00198257	T02E9.19
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198258	ZK617.12
No description available

WB:WBGene00198259	C34F11.12
No description available

WB:WBGene00198260	C34E11.12
No description available

WB:WBGene00198261	C29H12.9
No description available

WB:WBGene00198262	D2024.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198263	T06F4.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198264	K12F2.3
No description available

WB:WBGene00198265	Y39H10A.9
No description available

WB:WBGene00198266	R173.8
No description available

WB:WBGene00198267	C48E7.13
No description available

WB:WBGene00198268	F31E8.14
No description available

WB:WBGene00198269	F59D12.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198270	C54A12.7
No description available

WB:WBGene00198271	F58G1.12
No description available

WB:WBGene00198272	C16E9.17
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00198273	C41A3.9
No description available

WB:WBGene00198274	F40H3.10
No description available

WB:WBGene00198275	K09A9.10
No description available

WB:WBGene00198276	T19A5.8
Is affected by let-418 and dlc-1 based on RNA-seq studies.

WB:WBGene00198277	B0041.10
No description available

WB:WBGene00198278	K03C7.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198279	F53B2.15
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00198280	F25D7.6
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00198281	Y59E1B.5
No description available

WB:WBGene00198282	M02G9.6
No description available

WB:WBGene00198283	F55F1.8
No description available

WB:WBGene00198284	F44C4.11
No description available

WB:WBGene00198285	ZK617.13
No description available

WB:WBGene00198286	R151.16
No description available

WB:WBGene00198287	F13H6.15
No description available

WB:WBGene00198288	M70.8
No description available

WB:WBGene00198289	C24A3.12
No description available

WB:WBGene00198290	F56E3.13
No description available

WB:WBGene00198291	Y51A2D.31
No description available

WB:WBGene00198292	T14F9.14
No description available

WB:WBGene00198293	C12D8.23
Is affected by hmg-4 and spt-16 based on RNA-seq studies.

WB:WBGene00198294	T07D3.11
No description available

WB:WBGene00198295	F25H10.5
No description available

WB:WBGene00198296	H34C03.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198297	W03G11.14
Is affected by several genes including pgl-1; alg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00198298	F47B10.10
No description available

WB:WBGene00198299	F44E8.44
No description available

WB:WBGene00198300	T19E7.25
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198301	W06B3.5
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00198302	Y102A11A.10
No description available

WB:WBGene00198303	F53F4.23
Is affected by unc-39 based on RNA-seq studies.

WB:WBGene00198304	C25F6.17
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198305	R134.4
No description available

WB:WBGene00198306	F12D9.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198307	F12F6.15
Is enriched in NSM based on RNA-seq studies. Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198308	C04A11.7
No description available

WB:WBGene00198309	F35D2.11
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00198310	T08A9.17
No description available

WB:WBGene00198311	Y69E1A.11
No description available

WB:WBGene00198312	T21B10.10
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00198313	C29E6.13
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198314	ZK867.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198315	K02A11.9
Is affected by cep-1; dlc-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198316	K08E5.12
Is affected by dpy-21 and adr-1 based on RNA-seq studies.

WB:WBGene00198317	F57B10.18
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198318	C36C9.7
No description available

WB:WBGene00198319	F22A3.13
No description available

WB:WBGene00198320	Y37E11AL.15
Is affected by eat-2 based on microarray studies.

WB:WBGene00198321	C09D8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198322	M153.7
No description available

WB:WBGene00198323	F26A10.14
No description available

WB:WBGene00198324	F11A6.9
No description available

WB:WBGene00198325	C33F10.20
No description available

WB:WBGene00198326	R07G3.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198327	F37B12.8
No description available

WB:WBGene00198328	Y18H1A.17
No description available

WB:WBGene00198329	F42D1.9
No description available

WB:WBGene00198330	F14B8.12
No description available

WB:WBGene00198331	F52F10.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00198332	T03F7.13
No description available

WB:WBGene00198333	ZK617.14
No description available

WB:WBGene00198334	C16D9.14
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00198335	M04C9.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198336	F53B7.11
No description available

WB:WBGene00198337	T05G5.14
No description available

WB:WBGene00198338	T25E4.4
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198339	K01A12.6
No description available

WB:WBGene00198340	F23H12.16
No description available

WB:WBGene00198341	F42C5.13
Is affected by ints-8 based on RNA-seq studies.

WB:WBGene00198342	F41E7.14
Is affected by dpy-21 and hmg-3 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00198343	F57A10.7
Is affected by ifo-1 based on microarray studies.

WB:WBGene00198344	F54G8.7
No description available

WB:WBGene00198345	Y73B3A.25
No description available

WB:WBGene00198346	F34D6.10
No description available

WB:WBGene00198347	T01B10.11
No description available

WB:WBGene00198348	T06E8.4
No description available

WB:WBGene00198349	C45B2.12
No description available

WB:WBGene00198350	T25F10.9
No description available

WB:WBGene00198351	F28A12.5
Is affected by glycine based on RNA-seq studies.

WB:WBGene00198352	ZK867.13
No description available

WB:WBGene00198353	W03B1.16
No description available

WB:WBGene00198354	F11D5.17
No description available

WB:WBGene00198355	F28C1.12
No description available

WB:WBGene00198356	F45B8.13
No description available

WB:WBGene00198357	F55G1.19
No description available

WB:WBGene00198358	F02E8.8
No description available

WB:WBGene00198359	T13H10.10
No description available

WB:WBGene00198360	F58H1.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198361	Y66A7AL.6
No description available

WB:WBGene00198362	Y119D3B.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198363	H40L08.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198364	C09B8.14
No description available

WB:WBGene00198365	W02B8.9
No description available

WB:WBGene00198366	F11D5.18
No description available

WB:WBGene00198367	C04C3.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00198368	C05D2.16
No description available

WB:WBGene00198369	R06C1.9
No description available

WB:WBGene00198370	T25F10.10
No description available

WB:WBGene00198371	C16E9.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198372	R155.6
No description available

WB:WBGene00198373	F46C8.14
No description available

WB:WBGene00198374	F14D12.9
No description available

WB:WBGene00198375	C36F7.17
No description available

WB:WBGene00198376	K08A8.15
No description available

WB:WBGene00198377	C36B1.16
No description available

WB:WBGene00198378	C34H3.12
No description available

WB:WBGene00198379	C15H7.8
Is affected by ifo-1 based on microarray studies.

WB:WBGene00198380	T22B7.13
No description available

WB:WBGene00198381	T03G11.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198382	F26A10.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198383	C06G1.13
No description available

WB:WBGene00198384	C05E11.14
No description available

WB:WBGene00198385	T19D2.8
No description available

WB:WBGene00198386	cTel3X.3
No description available

WB:WBGene00198387	ZK512.14
No description available

WB:WBGene00198388	Y51H7C.24
No description available

WB:WBGene00198389	W10C8.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198390	ZK809.12
No description available

WB:WBGene00198391	D2030.14
No description available

WB:WBGene00198392	K09F5.9
No description available

WB:WBGene00198393	K03A1.10
No description available

WB:WBGene00198394	K04H4.12
No description available

WB:WBGene00198395	ZC53.13
No description available

WB:WBGene00198396	C27D11.3
No description available

WB:WBGene00198397	C14F11.17
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198398	B0250.17
No description available

WB:WBGene00198399	F01G12.12
Is affected by nanoparticle based on microarray studies.

WB:WBGene00198400	F08B12.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00198401	F47E1.12
No description available

WB:WBGene00198402	ZC487.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00198403	F15B9.12
No description available

WB:WBGene00198404	M88.11
No description available

WB:WBGene00198405	ZK185.8
No description available

WB:WBGene00198406	T05C12.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198407	Y50E8A.21
Is affected by daf-2 based on microarray studies.

WB:WBGene00198408	Y59A8B.30
No description available

WB:WBGene00198409	Y48A6C.7
No description available

WB:WBGene00198410	F26F12.14
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198411	C49A1.14
No description available

WB:WBGene00198412	ZK381.47
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00198413	C18A3.21
No description available

WB:WBGene00198414	T22B2.8
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00198415	K11E4.9
Is affected by hmg-3; daf-2; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198416	F49E10.14
No description available

WB:WBGene00198417	T24C2.7
No description available

WB:WBGene00198418	B0344.4
No description available

WB:WBGene00198419	F17E5.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198420	Y75B8A.51
No description available

WB:WBGene00198421	F45F2.15
No description available

WB:WBGene00198422	R11H6.8
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00198423	F26E4.17
No description available

WB:WBGene00198424	C31G12.10
No description available

WB:WBGene00198425	F08B12.9
No description available

WB:WBGene00198426	C25D7.18
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00198427	Y46H3D.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198428	C06E1.15
No description available

WB:WBGene00198429	F57B7.9
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00198430	F08G5.14
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00198431	F07A11.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and hpl-2 based on RNA-seq studies.

WB:WBGene00198432	F43C11.15
No description available

WB:WBGene00198433	C34H3.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198434	C56G2.19
No description available

WB:WBGene00198435	T19D12.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198436	C04H4.6
No description available

WB:WBGene00198437	H03A11.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198438	ZK836.10
Is affected by ifo-1 based on microarray studies.

WB:WBGene00198439	ZK262.17
No description available

WB:WBGene00198440	C05C9.9
No description available

WB:WBGene00198441	F56D2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198442	F37H8.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198443	Y54F10AM.13
No description available

WB:WBGene00198444	T10D4.17
No description available

WB:WBGene00198445	F43G6.14
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198446	T25D10.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198447	Y105C5B.1415
Is affected by daf-2 based on microarray studies.

WB:WBGene00198448	D1046.11
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00198449	C14A11.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198450	ZK377.6
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00198451	Y51A2D.32
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00198452	F57B1.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198453	T23F1.9
No description available

WB:WBGene00198454	F28C1.13
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00198455	Y54G9A.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198456	C30C11.10
No description available

WB:WBGene00198457	F58A6.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198458	H03E18.5
No description available

WB:WBGene00198459	R10E11.11
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00198460	B0416.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198461	C26E1.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198462	F01D5.14
Is affected by cep-1; tdp-1; and adr-1 based on RNA-seq studies.

WB:WBGene00198463	C27F2.13
No description available

WB:WBGene00198464	F52E10.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00198465	C02C6.7
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198466	F13H6.16
No description available

WB:WBGene00198467	F58A4.20
No description available

WB:WBGene00198468	C53D6.21
No description available

WB:WBGene00198469	H12D21.17
No description available

WB:WBGene00198470	F08G2.15
No description available

WB:WBGene00198471	C43D7.15
No description available

WB:WBGene00198472	F57F10.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198473	K09B11.21
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00198474	T10E10.11
No description available

WB:WBGene00198475	K08E4.10
No description available

WB:WBGene00198476	T18H9.9
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00198477	F49H12.11
No description available

WB:WBGene00198478	Y58A7A.11
Is affected by ifo-1 based on microarray studies.

WB:WBGene00198479	Y22D7AR.19
Is affected by elli-1 based on microarray studies.

WB:WBGene00198480	F54D5.21
No description available

WB:WBGene00198481	Y43F8C.26
No description available

WB:WBGene00198482	Y106G6D.9
No description available

WB:WBGene00198483	ZK389.1
No description available

WB:WBGene00198484	C55A6.17
No description available

WB:WBGene00198485	ZK816.7
No description available

WB:WBGene00198486	F31E3.10
No description available

WB:WBGene00198487	F48C11.7
No description available

WB:WBGene00198488	ZC513.17
No description available

WB:WBGene00198489	F53F8.9
No description available

WB:WBGene00198490	ZC250.9
Is affected by nanoparticle based on microarray studies.

WB:WBGene00198491	B0024.18
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198492	C47D2.3
No description available

WB:WBGene00198493	T01C1.10
No description available

WB:WBGene00198494	C14F11.18
No description available

WB:WBGene00198495	R08B4.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198496	ZC504.12
No description available

WB:WBGene00198497	F10G8.12
Is affected by cep-1; dlc-1; and ints-4 based on RNA-seq studies.

WB:WBGene00198498	R09F10.16
Is affected by several genes including lem-2; emr-1; and adr-1 based on RNA-seq studies.

WB:WBGene00198499	Y37F4.12
No description available

WB:WBGene00198500	R01E6.13
No description available

WB:WBGene00198501	C48C5.6
No description available

WB:WBGene00198502	T23F2.8
No description available

WB:WBGene00198503	Y77E11A.17
No description available

WB:WBGene00198504	F33D4.13
No description available

WB:WBGene00198505	T08H4.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00198506	F55B12.14
No description available

WB:WBGene00198507	C01F4.7
No description available

WB:WBGene00198508	C29E6.14
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00198509	M04B2.10
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198510	Y49F6B.16
No description available

WB:WBGene00198511	C09C7.2
No description available

WB:WBGene00198512	H22K11.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198513	F30H5.7
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198514	T12B5.17
No description available

WB:WBGene00198515	F01G12.13
No description available

WB:WBGene00198516	F08F1.15
No description available

WB:WBGene00198517	ZC53.14
No description available

WB:WBGene00198518	Y45F10B.60
No description available

WB:WBGene00198519	C18D1.16
No description available

WB:WBGene00198520	F25B4.13
No description available

WB:WBGene00198521	C07H6.14
No description available

WB:WBGene00198522	F28H6.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00198523	C14F5.9
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198524	C34H3.14
No description available

WB:WBGene00198525	F18A1.9
No description available

WB:WBGene00198526	C10G8.9
No description available

WB:WBGene00198527	Y69A2AR.40
No description available

WB:WBGene00198528	C44E12.4
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198529	F46F3.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198530	T26A5.10
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00198531	F36G9.18
Is affected by hmg-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198532	B0478.23
No description available

WB:WBGene00198533	Y104H12D.8
No description available

WB:WBGene00198534	T25D3.7
Is affected by eat-2 based on microarray studies.

WB:WBGene00198535	C44H4.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198536	C16D9.15
No description available

WB:WBGene00198537	Y49G5B.3
No description available

WB:WBGene00198538	H14E04.7
No description available

WB:WBGene00198539	T27E4.18
No description available

WB:WBGene00198540	C17D12.13
No description available

WB:WBGene00198541	T01H3.8
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00198542	C18B12.12
No description available

WB:WBGene00198543	ZC504.13
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198544	F22F1.6
No description available

WB:WBGene00198545	Y53F4B.57
No description available

WB:WBGene00198546	F44E5.9
No description available

WB:WBGene00198547	C44H4.10
Is affected by several genes including adr-1; tdp-1; and set-9 based on RNA-seq studies. Is affected by methylmercury hydroxide based on RNA-seq studies.

WB:WBGene00198548	T01G1.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198549	C34B4.13
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00198550	F08G2.16
No description available

WB:WBGene00198551	Y38C1AA.17
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198552	R04F11.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198553	C48D1.13
No description available

WB:WBGene00198554	T09B4.16
No description available

WB:WBGene00198555	R07B1.21
No description available

WB:WBGene00198556	K01A12.7
No description available

WB:WBGene00198557	C41G11.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198558	ZK682.10
No description available

WB:WBGene00198559	Y41E3.459
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198560	K04H4.13
No description available

WB:WBGene00198561	Y39A3CL.11
No description available

WB:WBGene00198562	Y67D11A.3
No description available

WB:WBGene00198563	T27B1.4
Is affected by prg-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198564	F49H12.12
Is affected by several genes including daf-16; daf-12; and prg-1 based on RNA-seq studies.

WB:WBGene00198565	T26C12.8
No description available

WB:WBGene00198566	C07H6.15
No description available

WB:WBGene00198567	F02D10.13
No description available

WB:WBGene00198568	F53B1.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00198569	T19B10.15
No description available

WB:WBGene00198570	W04A4.7
No description available

WB:WBGene00198571	ZK867.14
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198572	K11G12.9
No description available

WB:WBGene00198573	Y17G9A.88
Is affected by emr-1; lem-2; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00198574	ZK180.11
No description available

WB:WBGene00198575	F26F4.14
Is affected by cep-1; elli-1; and nhr-86 based on RNA-seq and microarray studies.

WB:WBGene00198576	F21H12.8
Is affected by ahr-1; daf-2; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198577	F40H3.11
No description available

WB:WBGene00198578	F52B10.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00198579	Y38H6A.8
Is affected by ifo-1 based on microarray studies.

WB:WBGene00198580	Y64G10A.355
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198581	Y94H6A.14
No description available

WB:WBGene00198582	F31E8.15
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00198583	F49E10.15
No description available

WB:WBGene00198584	T02E9.20
No description available

WB:WBGene00198585	F59A3.14
No description available

WB:WBGene00198586	W01A8.11
No description available

WB:WBGene00198587	W05B10.7
No description available

WB:WBGene00198588	Y63D3A.12
No description available

WB:WBGene00198589	F56A11.11
No description available

WB:WBGene00198590	H30A04.4
No description available

WB:WBGene00198591	F20D1.16
No description available

WB:WBGene00198592	Y71H9A.4
No description available

WB:WBGene00198593	K08A8.16
No description available

WB:WBGene00198594	T24B8.14
Is affected by nanoparticle based on microarray studies.

WB:WBGene00198595	ZK617.15
No description available

WB:WBGene00198596	F42C5.14
Is affected by ints-2 and ints-4 based on RNA-seq studies.

WB:WBGene00198597	Y73B6BL.276
No description available

WB:WBGene00198598	W01C8.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198599	F12F6.16
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198600	T08G2.6
No description available

WB:WBGene00198601	F19B6.7
No description available

WB:WBGene00198602	C14F11.19
No description available

WB:WBGene00198603	Y48A6B.15
No description available

WB:WBGene00198604	C17G1.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198605	F22D3.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00198606	F41C6.12
No description available

WB:WBGene00198607	C32D5.16
No description available

WB:WBGene00198608	T04G9.9
No description available

WB:WBGene00198609	F39B2.13
No description available

WB:WBGene00198610	EGAP3.2
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198611	Y40C5A.18
No description available

WB:WBGene00198612	ZC334.15
No description available

WB:WBGene00198613	F31F6.11
No description available

WB:WBGene00198614	T24B8.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198615	F46F3.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198616	F14B8.13
No description available

WB:WBGene00198617	ZK616.64
No description available

WB:WBGene00198618	T28B4.11
No description available

WB:WBGene00198619	T27A1.9
No description available

WB:WBGene00198620	F11C7.9
No description available

WB:WBGene00198621	F54D12.16
No description available

WB:WBGene00198622	M01G4.6
No description available

WB:WBGene00198623	C09B8.15
No description available

WB:WBGene00198624	F58G11.9
No description available

WB:WBGene00198625	K03B8.19
No description available

WB:WBGene00198626	Y92C3A.7
No description available

WB:WBGene00198627	F46C8.15
No description available

WB:WBGene00198628	C33D12.12
No description available

WB:WBGene00198629	W05E10.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198630	H06A10.3
No description available

WB:WBGene00198631	T10B10.12
No description available

WB:WBGene00198632	T28B4.12
No description available

WB:WBGene00198633	ZC21.12
No description available

WB:WBGene00198634	T09F3.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198635	F09D5.5
No description available

WB:WBGene00198636	F53A9.12
No description available

WB:WBGene00198637	R90.8
No description available

WB:WBGene00198638	ZK525.7
No description available

WB:WBGene00198639	F55C12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198640	Y73B6BL.277
No description available

WB:WBGene00198641	T19A5.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198642	Y39A1A.28
No description available

WB:WBGene00198643	W06B3.6
Is affected by pgrn-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198644	F57G8.13
No description available

WB:WBGene00198645	C04C11.13
No description available

WB:WBGene00198646	C25B8.10
No description available

WB:WBGene00198647	Y34B4A.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00198648	F38B7.15
No description available

WB:WBGene00198649	Y105E8A.43
No description available

WB:WBGene00198650	Y97E10AL.4
No description available

WB:WBGene00198651	C30F12.9
Is affected by ins-11 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198652	F25H8.12
No description available

WB:WBGene00198653	ZC455.16
No description available

WB:WBGene00198654	F26A10.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198655	Y64G10A.356
Is affected by daf-2 based on microarray studies.

WB:WBGene00198656	Y37D8A.27
No description available

WB:WBGene00198657	cTel29B.1
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198658	Y71H10A.3
No description available

WB:WBGene00198659	C05B5.14
No description available

WB:WBGene00198660	F14F3.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198661	D2023.15
Is affected by hmg-3; hmg-4; and spt-16 based on RNA-seq studies.

WB:WBGene00198662	W01H2.7
No description available

WB:WBGene00198663	F36D4.11
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00198664	T01B7.12
No description available

WB:WBGene00198665	T14G12.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198666	cTel17.2
No description available

WB:WBGene00198667	ZK287.13
No description available

WB:WBGene00198668	B0496.14
No description available

WB:WBGene00198669	T20B12.11
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00198670	F14F3.11
No description available

WB:WBGene00198671	F02G3.4
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198672	F58A4.21
No description available

WB:WBGene00198673	Y39B6A.79
No description available

WB:WBGene00198674	F25H8.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198675	C10F3.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00198676	Y17D7C.8
No description available

WB:WBGene00198677	F43D2.12
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00198678	F22E10.10
No description available

WB:WBGene00198679	C44B7.17
No description available

WB:WBGene00198680	F45E1.12
No description available

WB:WBGene00198681	W06A7.8
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198682	B0563.14
No description available

WB:WBGene00198683	C31H2.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00198684	H13J03.2
No description available

WB:WBGene00198685	F53F4.24
Is affected by adr-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00198686	F18E2.12
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00198687	T23B5.5
No description available

WB:WBGene00198688	F28E10.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198689	F13H6.17
No description available

WB:WBGene00198690	F42H10.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00198691	F37E3.4
No description available

WB:WBGene00198692	C09H10.13
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00198693	F13H10.10
No description available

WB:WBGene00198694	C25A11.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198695	C01C4.4
No description available

WB:WBGene00198696	Y53C12B.9
No description available

WB:WBGene00198697	ZK867.15
No description available

WB:WBGene00198698	H01G02.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198699	C06E4.16
No description available

WB:WBGene00198700	C05A9.5
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00198701	F08F1.16
No description available

WB:WBGene00198702	B0240.6
No description available

WB:WBGene00198703	R193.4
No description available

WB:WBGene00198704	C31H2.10
No description available

WB:WBGene00198705	C34D1.11
No description available

WB:WBGene00198706	M79.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198707	K02D7.7
No description available

WB:WBGene00198708	C01A2.10
No description available

WB:WBGene00198709	F35G2.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198710	K08A2.14
No description available

WB:WBGene00198711	C54C6.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198712	K09A11.8
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00198713	C17H12.32
No description available

WB:WBGene00198714	F10D7.8
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00198715	Y46E12A.7
No description available

WB:WBGene00198716	C18D1.17
No description available

WB:WBGene00198717	C34H3.15
No description available

WB:WBGene00198718	F31F7.7
No description available

WB:WBGene00198719	F48A11.9
No description available

WB:WBGene00198720	W01B6.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198721	Y57E12B.5
No description available

WB:WBGene00198722	C35C5.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00198723	B0393.15
No description available

WB:WBGene00198724	K10D6.13
No description available

WB:WBGene00198725	F55A11.13
Is affected by several genes including lem-2; emr-1; and meg-3 based on RNA-seq studies.

WB:WBGene00198726	K03B8.20
No description available

WB:WBGene00198727	Y23H5A.10
No description available

WB:WBGene00198728	W04D2.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198729	Y46E12BL.6
No description available

WB:WBGene00198730	F43D9.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198731	R04F11.18
No description available

WB:WBGene00198732	C13G3.8
No description available

WB:WBGene00198733	F43C9.6
No description available

WB:WBGene00198734	ZK470.11
No description available

WB:WBGene00198735	Y39B6A.80
No description available

WB:WBGene00198736	ZC581.13
Is affected by several genes including lem-2; emr-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00198737	T04C9.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198738	C47E12.17
No description available

WB:WBGene00198739	C26B2.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198740	F56D1.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00198741	T09A5.19
No description available

WB:WBGene00198742	T22B11.8
No description available

WB:WBGene00198743	B0198.6
Is affected by pgrn-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00198744	T26E3.16
No description available

WB:WBGene00198745	H30A04.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198746	F08C6.13
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198747	VC5.9
No description available

WB:WBGene00198748	M163.19
No description available

WB:WBGene00198749	F52D10.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198750	F11H8.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198751	K04D7.13
No description available

WB:WBGene00198752	F54D12.17
No description available

WB:WBGene00198753	F11E6.21
No description available

WB:WBGene00198754	K04G11.8
No description available

WB:WBGene00198755	T19C11.1
Is affected by daf-2 based on microarray studies.

WB:WBGene00198756	F13D11.13
No description available

WB:WBGene00198757	Y105E8A.44
Is affected by eat-2 based on microarray studies.

WB:WBGene00198758	Y119D3B.24
No description available

WB:WBGene00198759	F21C10.15
No description available

WB:WBGene00198760	Y7A5A.16
No description available

WB:WBGene00198761	ZK377.7
Is affected by adr-1; dlc-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198762	Y116F11B.21
No description available

WB:WBGene00198763	Y39B6A.81
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198764	C07G1.11
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00198765	F54A3.10
No description available

WB:WBGene00198766	F12F3.7
No description available

WB:WBGene00198767	F26F12.15
Is affected by pgrn-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198768	T24D5.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198769	T05A1.17
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198770	C14C11.11
No description available

WB:WBGene00198771	C06H2.9
No description available

WB:WBGene00198772	T25C12.6
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00198773	K02B12.12
Is affected by cep-1; hmg-3; and hmg-4 based on RNA-seq studies.

WB:WBGene00198774	ZK84.13
No description available

WB:WBGene00198775	F23F1.11
No description available

WB:WBGene00198776	F26A10.17
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00198777	F54C9.17
Is affected by pmt-2 based on microarray studies.

WB:WBGene00198778	C35A11.9
No description available

WB:WBGene00198779	C54H2.9
No description available

WB:WBGene00198780	Y7A9D.64
No description available

WB:WBGene00198781	C42D8.15
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00198782	C39F7.7
Is affected by hrpr-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00198783	F31A3.6
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00198784	M02B7.8
No description available

WB:WBGene00198785	C43C3.9
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198786	F55D10.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00198787	K09F5.10
No description available

WB:WBGene00198788	Y6B3B.14
No description available

WB:WBGene00198789	W03G11.15
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00198790	K02G10.12
No description available

WB:WBGene00198791	T16G1.16
No description available

WB:WBGene00198792	R04E5.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00198793	T28B11.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198794	C29A12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198795	B0285.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00198796	K08A8.17
Is affected by klf-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198797	Y73F8A.1169
Is affected by tdp-1; daf-2; and adr-1 based on RNA-seq and microarray studies.

WB:WBGene00198798	Y37A1B.332
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198799	T04C10.10
No description available

WB:WBGene00198800	F39E9.23
No description available

WB:WBGene00198801	T05A6.13
No description available

WB:WBGene00198802	ZK836.11
Is affected by ifo-1 based on microarray studies.

WB:WBGene00198803	C54D1.11
No description available

WB:WBGene00198804	T28B11.14
No description available

WB:WBGene00198805	Y37B11A.4
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and Zidovudine based on RNA-seq studies.

WB:WBGene00198806	Y76F7A.4
No description available

WB:WBGene00198807	T07F10.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198808	ZK381.48
No description available

WB:WBGene00198809	T06E8.5
Is affected by Cry5B based on microarray studies.

WB:WBGene00198810	F46C8.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198811	C13G3.9
No description available

WB:WBGene00198812	Y43D4A.162
No description available

WB:WBGene00198813	Y116F11A.8
No description available

WB:WBGene00198814	F31C3.15
Is affected by several genes including vit-2; tdp-1; and hmg-4 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00198815	ZK180.12
Is affected by emr-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198816	C12C8.7
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00198817	Y82E9BR.29
No description available

WB:WBGene00198818	T21C12.9
No description available

WB:WBGene00198819	T22E5.14
No description available

WB:WBGene00198820	F35H10.16
No description available

WB:WBGene00198821	T26H2.14
No description available

WB:WBGene00198822	F58H1.20
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198823	Y52B11A.16
No description available

WB:WBGene00198824	C09D1.4
No description available

WB:WBGene00198825	C54E4.7
No description available

WB:WBGene00198826	F43G9.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198827	T16G1.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00198828	F25H8.14
No description available

WB:WBGene00198829	C32C4.14
No description available

WB:WBGene00198830	C30A5.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00198831	F13H6.18
No description available

WB:WBGene00198832	T13H10.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00198833	K03H9.9
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00198834	C43G2.29
No description available

WB:WBGene00198835	C18B12.13
No description available

WB:WBGene00198836	H19M22.7
No description available

WB:WBGene00198837	T22E5.15
No description available

WB:WBGene00198838	K10C3.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198839	B0414.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198840	F08F3.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198841	T03G11.20
No description available

WB:WBGene00198842	K07E3.10
No description available

WB:WBGene00198843	T25F10.11
No description available

WB:WBGene00198844	F25B5.11
No description available

WB:WBGene00198845	R04F11.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198846	Y75B8A.52
No description available

WB:WBGene00198847	F49E2.8
No description available

WB:WBGene00198848	B0205.16
No description available

WB:WBGene00198849	F56E3.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198850	Y62F5A.13
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198851	C07A4.8
No description available

WB:WBGene00198852	F26F12.16
No description available

WB:WBGene00198853	C30B5.13
No description available

WB:WBGene00198854	W03G11.16
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00198855	F59G1.12
No description available

WB:WBGene00198856	T25C12.7
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00198857	Y116F11A.9
No description available

WB:WBGene00198858	C31H2.11
No description available

WB:WBGene00198859	F37B12.9
No description available

WB:WBGene00198860	C14B9.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00198861	C02D4.8
No description available

WB:WBGene00198862	R04F11.20
No description available

WB:WBGene00198863	K09F5.11
No description available

WB:WBGene00198864	Y43E12A.6
Is affected by cep-1; adr-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198865	B0198.7
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00198866	Y51H7C.25
No description available

WB:WBGene00198867	T13H10.12
No description available

WB:WBGene00198868	T09B9.7
No description available

WB:WBGene00198869	K08A8.18
No description available

WB:WBGene00198870	F25H10.6
No description available

WB:WBGene00198871	C02E7.16
No description available

WB:WBGene00198872	F20D1.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198873	F10C2.11
Is enriched in AVK based on RNA-seq studies. Is affected by dlc-1; ifo-1; and pptr-1 based on RNA-seq and microarray studies.

WB:WBGene00198874	T04F3.7
Is affected by daf-2; ifo-1; and klf-1 based on microarray and RNA-seq studies.

WB:WBGene00198875	H30A04.6
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00198876	Y105E8A.45
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00198877	F57A10.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198878	T28B11.15
No description available

WB:WBGene00198879	C04C11.14
No description available

WB:WBGene00198880	VC5.10
No description available

WB:WBGene00198881	C40C9.13
No description available

WB:WBGene00198882	C32A9.2
No description available

WB:WBGene00198883	F32B5.12
No description available

WB:WBGene00198884	T19A6.5
No description available

WB:WBGene00198885	F40H3.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198886	C47C12.8
No description available

WB:WBGene00198887	F58B4.10
No description available

WB:WBGene00198888	C54H2.10
No description available

WB:WBGene00198889	F10F2.11
No description available

WB:WBGene00198890	F55D1.3
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00198891	T06D8.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198892	C26B9.8
No description available

WB:WBGene00198893	T01H8.6
Is affected by daf-2 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198894	K09A11.9
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00198895	B0284.7
Is affected by glycine based on RNA-seq studies.

WB:WBGene00198896	C07A4.9
No description available

WB:WBGene00198897	C47E8.14
No description available

WB:WBGene00198898	Y42A5A.9
No description available

WB:WBGene00198899	K08A8.19
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00198900	F33E2.11
No description available

WB:WBGene00198901	Y73B6BL.278
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00198902	T07F12.9
Is affected by dpy-21 and alg-1 based on RNA-seq studies.

WB:WBGene00198903	W07G9.3
No description available

WB:WBGene00198904	T21H3.8
No description available

WB:WBGene00198905	T07D4.6
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00198906	R166.8
Is affected by Cry5B and glycine based on microarray and RNA-seq studies.

WB:WBGene00198907	M79.12
No description available

WB:WBGene00198908	R13H4.10
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00198909	T24D3.3
No description available

WB:WBGene00198910	F46C8.17
No description available

WB:WBGene00198911	Y39G8C.8
No description available

WB:WBGene00198912	ZK377.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198913	Y40B10A.10
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00198914	F25H8.15
No description available

WB:WBGene00198915	C26D10.8
No description available

WB:WBGene00198916	B0457.12
Is affected by several genes including pgl-1; cep-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00198917	K02G10.13
Is affected by Cry5B based on microarray studies.

WB:WBGene00198918	Y69E1A.12
No description available

WB:WBGene00198919	Y119D3B.25
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198920	C13G3.10
No description available

WB:WBGene00198921	F40E10.11
No description available

WB:WBGene00198922	F35C12.4
No description available

WB:WBGene00198923	Y37E11AL.16
No description available

WB:WBGene00198924	C15F1.14
Is affected by cep-1; adr-1; and sftb-1 based on RNA-seq studies.

WB:WBGene00198925	T07A5.8
No description available

WB:WBGene00198926	Y77E11A.18
No description available

WB:WBGene00198927	W06B11.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198928	T04C9.9
No description available

WB:WBGene00198929	T12B3.8
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00198930	Y22F5A.10
No description available

WB:WBGene00198931	ZK678.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00198932	F29C4.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00198933	Y37A1B.333
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00198934	W02B8.10
No description available

WB:WBGene00198935	B0198.8
Is affected by pgrn-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00198936	C15H9.12
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00198937	ZK287.14
No description available

WB:WBGene00198938	C11G10.7
No description available

WB:WBGene00198939	K04C2.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00198940	F31F7.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00198941	F43G9.17
No description available

WB:WBGene00198942	B0353.2
Is affected by eat-2 and klf-1 based on microarray and RNA-seq studies.

WB:WBGene00198943	F58B6.8
No description available

WB:WBGene00198944	Y65A5A.25
Is affected by cep-1 and let-418 based on RNA-seq studies.

WB:WBGene00198945	T08G5.18
Is affected by cep-1 and ints-5 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00198946	C34G6.9
Is affected by cep-1; set-26; and dlc-1 based on RNA-seq studies.

WB:WBGene00198947	F26A10.18
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00198948	Y60A9A.5
No description available

WB:WBGene00198949	C50A2.6
No description available

WB:WBGene00198950	T12D8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00198951	F26F12.17
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00198952	F35B3.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00198953	F54D12.18
No description available

WB:WBGene00198954	C50H2.16
No description available

WB:WBGene00198955	F57G12.7
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00198956	R10H1.6
No description available

WB:WBGene00198957	Y47H9C.18
No description available

WB:WBGene00198958	C28A5.8
No description available

WB:WBGene00198959	C40H5.13
No description available

WB:WBGene00198960	T19C11.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198961	C54G7.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00198962	C14F11.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198963	T21D9.6
No description available

WB:WBGene00198964	K01F9.6
Is affected by cep-1 and hpl-2 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00198965	Y7A9D.65
No description available

WB:WBGene00198966	Y39E4B.17
No description available

WB:WBGene00198967	Y17D7A.5
No description available

WB:WBGene00198968	Y39A3CL.12
No description available

WB:WBGene00198969	cTel79B.1
No description available

WB:WBGene00198970	T06H11.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00198971	F07F6.10
Is affected by several genes including lem-2; emr-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00198972	C52G5.6
No description available

WB:WBGene00198973	T14F9.15
No description available

WB:WBGene00198974	C13B4.6
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00198975	C17H12.33
No description available

WB:WBGene00198976	C35C5.18
No description available

WB:WBGene00198977	T28C12.9
No description available

WB:WBGene00198978	F52H2.12
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00198979	T19A5.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198980	C46G7.108
Is affected by cep-1; adr-1; and ifo-1 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00198981	F44C4.12
No description available

WB:WBGene00198982	C18A11.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198983	D1054.21
No description available

WB:WBGene00198984	F46A9.8
No description available

WB:WBGene00198985	T05A12.7
No description available

WB:WBGene00198986	B0496.15
No description available

WB:WBGene00198987	Y46E12BL.7
No description available

WB:WBGene00198988	F38E11.22
No description available

WB:WBGene00198989	C26E6.13
No description available

WB:WBGene00198990	K09F5.12
No description available

WB:WBGene00198991	T05G5.15
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00198992	C18B2.8
No description available

WB:WBGene00198993	T13H10.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00198994	B0478.24
No description available

WB:WBGene00198995	W07G1.13
No description available

WB:WBGene00198996	F13D11.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00198997	C11G10.8
No description available

WB:WBGene00198998	F20H11.6
Is affected by daf-12 and daf-2 based on tiling array and microarray studies.

WB:WBGene00198999	F28B4.6
No description available

WB:WBGene00199000	T24D8.12
No description available

WB:WBGene00199001	F54F11.4
No description available

WB:WBGene00199002	Y51A2D.33
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00199003	F42G9.10
Is affected by spc-1 and unc-70 based on RNA-seq studies.

WB:WBGene00199004	F39C12.7
No description available

WB:WBGene00199005	Y106G6H.17
No description available

WB:WBGene00199006	R186.12
No description available

WB:WBGene00199007	C25A11.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199008	T27A3.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199009	C01C4.5
Is affected by daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199010	C04F1.4
No description available

WB:WBGene00199011	T01B10.12
No description available

WB:WBGene00199012	F08F1.17
No description available

WB:WBGene00199013	Y87G2A.22
No description available

WB:WBGene00199014	F37H8.10
No description available

WB:WBGene00199015	R02D5.14
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00199016	W06H8.12
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199017	Y71G12B.36
Is affected by several genes including lem-2; emr-1; and pptr-1 based on RNA-seq studies.

WB:WBGene00199018	F57C7.10
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199019	W04D2.11
No description available

WB:WBGene00199020	Y48A6B.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00199021	T10H4.19
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199022	M60.10
No description available

WB:WBGene00199023	K10D6.14
No description available

WB:WBGene00199024	C34F11.13
No description available

WB:WBGene00199025	C09G12.18
No description available

WB:WBGene00199026	T28C12.10
Is affected by 4-bromodiphenyl ether and Tunicamycin based on microarray studies.

WB:WBGene00199027	E01G4.8
No description available

WB:WBGene00199028	Y46E12A.8
No description available

WB:WBGene00199029	F08G5.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00199030	Y77E11A.19
No description available

WB:WBGene00199031	F57G12.8
No description available

WB:WBGene00199032	C09H10.14
No description available

WB:WBGene00199033	H30A04.7
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199034	F56E3.15
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00199035	F54F3.5
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00199036	T03A1.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199037	C06E4.17
No description available

WB:WBGene00199038	C02D4.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00199039	F52F12.13
No description available

WB:WBGene00199040	R07G3.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199041	F37H8.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199042	H34C03.20
No description available

WB:WBGene00199043	C49F8.10
No description available

WB:WBGene00199044	K03E5.7
No description available

WB:WBGene00199045	Y53F4B.58
Is affected by adr-1; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00199046	T21B6.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00199047	Y7A5A.17
Is affected by eat-2 based on microarray studies.

WB:WBGene00199048	T06H11.15
No description available

WB:WBGene00199049	Y75B7AL.7
Is affected by dpy-21 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00199050	C23H5.13
No description available

WB:WBGene00199051	R03E9.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199052	F32A6.10
No description available

WB:WBGene00199053	T24B8.16
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199054	F49E10.16
No description available

WB:WBGene00199055	F46F3.12
No description available

WB:WBGene00199056	C05A9.6
No description available

WB:WBGene00199057	C06A8.14
No description available

WB:WBGene00199058	K07C10.7
No description available

WB:WBGene00199059	Y22D7AL.17
No description available

WB:WBGene00199060	F56E3.16
No description available

WB:WBGene00199061	W09G3.14
No description available

WB:WBGene00199062	C03C11.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199063	T14B4.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199064	ZK849.7
No description available

WB:WBGene00199065	C29A12.14
No description available

WB:WBGene00199066	M03E7.6
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00199067	Y39B6A.82
No description available

WB:WBGene00199068	F31A3.7
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00199069	F35B12.13
No description available

WB:WBGene00199070	C34G6.10
No description available

WB:WBGene00199071	F52H3.9
No description available

WB:WBGene00199072	C18H7.14
Is affected by daf-2 and klf-1 based on microarray and RNA-seq studies.

WB:WBGene00199073	F13H6.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199074	F15A2.11
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00199075	H37A05.5
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00199076	K10D6.15
No description available

WB:WBGene00199077	K10C3.11
No description available

WB:WBGene00199078	B0523.6
No description available

WB:WBGene00199079	R01E6.14
Is affected by tdp-1; hmg-3; and spt-16 based on RNA-seq studies.

WB:WBGene00199080	W05E10.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199081	W10C8.12
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199082	B0454.18
Is affected by lem-2 and hpl-2 based on RNA-seq studies.

WB:WBGene00199083	B0496.16
No description available

WB:WBGene00199084	C11G10.9
No description available

WB:WBGene00199085	F57G12.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199086	K08A8.20
No description available

WB:WBGene00199087	D1005.8
No description available

WB:WBGene00199088	Y39G10AR.30
Is affected by cep-1; spc-1; and unc-70 based on RNA-seq studies.

WB:WBGene00199089	B0395.7
No description available

WB:WBGene00199090	Y40C7B.7
No description available

WB:WBGene00199091	F32G8.10
Is affected by nanoparticle based on microarray studies.

WB:WBGene00199092	T23E7.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199093	F13H6.20
No description available

WB:WBGene00199094	T24D11.4
No description available

WB:WBGene00199095	T21B10.11
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00199096	F19C6.10
No description available

WB:WBGene00199097	B0403.11
No description available

WB:WBGene00199098	F45E1.13
No description available

WB:WBGene00199099	ZC412.11
No description available

WB:WBGene00199100	Y38F2AL.9
No description available

WB:WBGene00199101	C44E12.5
No description available

WB:WBGene00199102	Y53F4B.59
No description available

WB:WBGene00199103	Y71F9B.20
No description available

WB:WBGene00199104	T24B8.17
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199105	F35G2.15
No description available

WB:WBGene00199106	F54D7.8
No description available

WB:WBGene00199107	K01A6.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00199108	F22F1.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00199109	Y49F6B.17
No description available

WB:WBGene00199110	C32D5.17
No description available

WB:WBGene00199111	D2023.16
No description available

WB:WBGene00199112	C08B11.11
No description available

WB:WBGene00199113	C17D12.14
No description available

WB:WBGene00199114	R166.9
No description available

WB:WBGene00199115	T23E1.5
Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00199116	C09D4.8
No description available

WB:WBGene00199117	C30A5.15
No description available

WB:WBGene00199118	ZC506.7
No description available

WB:WBGene00199119	T19B10.16
No description available

WB:WBGene00199120	ZK418.12
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00199121	F22E12.9
No description available

WB:WBGene00199122	B0495.19
No description available

WB:WBGene00199123	F45B8.14
No description available

WB:WBGene00199124	C09B9.80
No description available

WB:WBGene00199125	C56A3.12
No description available

WB:WBGene00199126	M03D4.76
No description available

WB:WBGene00199127	R03C1.5
Is affected by chd-3 based on RNA-seq studies.

WB:WBGene00199128	C52E4.16
No description available

WB:WBGene00199129	T04F3.8
No description available

WB:WBGene00199130	C17H11.7
No description available

WB:WBGene00199131	W09G10.7
No description available

WB:WBGene00199132	C37H5.15
No description available

WB:WBGene00199133	ZC250.10
No description available

WB:WBGene00199134	R09F10.17
Is affected by several genes including daf-2; lem-2; and emr-1 based on RNA-seq and microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199135	E01G6.4
No description available

WB:WBGene00199136	W07G1.14
No description available

WB:WBGene00199137	B0547.34
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00199138	K06A4.11
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199139	W08F4.17
No description available

WB:WBGene00199140	Y39A3A.8
No description available

WB:WBGene00199141	R90.9
No description available

WB:WBGene00199142	C09B7.8
No description available

WB:WBGene00199143	F25G6.19
No description available

WB:WBGene00199144	R04E5.15
No description available

WB:WBGene00199145	ZK1067.10
Is affected by daf-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199146	Y71H9A.5
No description available

WB:WBGene00199147	F44E7.14
No description available

WB:WBGene00199148	C17F3.4
No description available

WB:WBGene00199149	Y22F5B.1
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199150	K11G9.11
No description available

WB:WBGene00199151	ZK994.10
No description available

WB:WBGene00199152	T06F4.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199153	C39E6.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199154	ZK512.15
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199155	Y71H9A.6
No description available

WB:WBGene00199156	H22K11.10
No description available

WB:WBGene00199157	ZK945.12
No description available

WB:WBGene00199158	C33D3.6
Is affected by eat-2 based on microarray studies.

WB:WBGene00199159	W06A7.9
No description available

WB:WBGene00199160	C32E12.7
No description available

WB:WBGene00199161	F46C5.12
No description available

WB:WBGene00199162	ZK131.12
Is affected by nanoparticle based on microarray studies.

WB:WBGene00199163	ZK617.16
No description available

WB:WBGene00199164	Y75B8A.53
Is affected by eat-2 based on microarray studies.

WB:WBGene00199165	T02E9.21
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199166	K08F8.11
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00199167	Y45F10B.61
Is affected by eat-2 based on microarray studies.

WB:WBGene00199168	T19F4.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199169	F09D5.6
No description available

WB:WBGene00199170	C02D4.10
No description available

WB:WBGene00199171	C30H6.19
No description available

WB:WBGene00199172	Y71D11A.8
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199173	D1046.12
No description available

WB:WBGene00199174	F13H8.14
No description available

WB:WBGene00199175	C53C7.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199176	F46G11.14
No description available

WB:WBGene00199177	T26H10.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199178	K04H4.14
No description available

WB:WBGene00199179	C44H4.11
No description available

WB:WBGene00199180	C08D8.4
No description available

WB:WBGene00199181	F28B4.7
No description available

WB:WBGene00199182	ZK1025.15
No description available

WB:WBGene00199183	T10D4.18
No description available

WB:WBGene00199184	E02A10.8
No description available

WB:WBGene00199185	VC5.11
No description available

WB:WBGene00199186	K06A4.12
No description available

WB:WBGene00199187	T24C2.8
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00199188	Y39A1A.29
No description available

WB:WBGene00199189	F11D5.19
No description available

WB:WBGene00199190	C05B5.15
No description available

WB:WBGene00199191	F25D7.7
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199192	K06A5.9
No description available

WB:WBGene00199193	F09C11.2
No description available

WB:WBGene00199194	C14F11.21
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199195	F11D5.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199196	T01B4.6
No description available

WB:WBGene00199197	W01A11.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199198	F54B11.13
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00199199	C05C9.10
No description available

WB:WBGene00199200	C37A5.12
No description available

WB:WBGene00199201	Y71F9AL.19
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199202	DL2.1
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199203	C18E9.14
No description available

WB:WBGene00199204	T11F9.26
No description available

WB:WBGene00199205	C04G6.14
No description available

WB:WBGene00199206	F18A1.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00199207	F42A9.13
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00199208	F15B9.13
No description available

WB:WBGene00199209	F31D4.10
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00199210	Y51A2B.13
No description available

WB:WBGene00199211	D1081.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199212	T05A10.8
Is affected by alg-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199213	F45H7.11
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00199214	W07E11.5
No description available

WB:WBGene00199215	C45E1.9
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199216	K03B8.21
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00199217	ZK973.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199218	R10E12.6
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199219	T08G2.7
No description available

WB:WBGene00199220	C43C3.10
No description available

WB:WBGene00199221	B0393.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00199222	T07H6.8
No description available

WB:WBGene00199223	C14F11.22
No description available

WB:WBGene00199224	F52B10.17
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199225	ZK1321.5
No description available

WB:WBGene00199226	F53A3.8
No description available

WB:WBGene00199227	F43E12.4
No description available

WB:WBGene00199228	H19M22.8
No description available

WB:WBGene00199229	K08B12.10
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199230	R173.9
No description available

WB:WBGene00199231	C34H3.16
No description available

WB:WBGene00199232	Y51H7C.26
No description available

WB:WBGene00199233	C44E12.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199234	ZC504.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00199235	F17C8.11
No description available

WB:WBGene00199236	T05A6.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199237	T25B6.9
No description available

WB:WBGene00199238	W05B10.8
No description available

WB:WBGene00199239	Y55D5A.10
No description available

WB:WBGene00199240	ZK381.49
No description available

WB:WBGene00199241	F31F6.12
No description available

WB:WBGene00199242	K02B2.35
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199243	F54E4.12
No description available

WB:WBGene00199244	ZK973.20
No description available

WB:WBGene00199245	H30A04.8
No description available

WB:WBGene00199246	F47B7.13
No description available

WB:WBGene00199247	T27E4.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199248	F57B7.10
No description available

WB:WBGene00199249	F49E7.4
No description available

WB:WBGene00199250	C36F7.18
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199251	F46F2.10
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199252	F16F9.13
No description available

WB:WBGene00199253	D1046.13
No description available

WB:WBGene00199254	R07D5.6
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00199255	T10H10.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199256	H36N01.2
No description available

WB:WBGene00199257	Y52B11A.17
No description available

WB:WBGene00199258	W06B11.9
Is affected by several genes including daf-2; cep-1; and dpy-21 based on RNA-seq and microarray studies.

WB:WBGene00199259	H01G02.12
No description available

WB:WBGene00199260	H36L18.3
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00199261	C24A3.13
No description available

WB:WBGene00199262	F53A9.13
No description available

WB:WBGene00199263	W10C4.2
No description available

WB:WBGene00199264	C56C10.14
No description available

WB:WBGene00199265	C05B10.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199266	Y102A11A.11
No description available

WB:WBGene00199267	F43G6.15
No description available

WB:WBGene00199268	C42D8.16
No description available

WB:WBGene00199269	F13H6.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199270	K03H9.10
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00199271	F41G4.10
No description available

WB:WBGene00199272	C25A8.9
No description available

WB:WBGene00199273	R12B2.10
No description available

WB:WBGene00199274	Y54G2A.64
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00199275	AC3.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199276	C45B11.10
Is affected by several genes including his-72; his-71; and hmg-4 based on RNA-seq studies.

WB:WBGene00199277	R13.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199278	F54D8.8
No description available

WB:WBGene00199279	Y73B3A.26
No description available

WB:WBGene00199280	K07A1.19
No description available

WB:WBGene00199281	C45G7.9
No description available

WB:WBGene00199282	Y56A3A.38
No description available

WB:WBGene00199283	F32A11.9
Is affected by tdp-1 and spt-16 based on RNA-seq studies.

WB:WBGene00199284	H32C10.96
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199285	K09E9.10
No description available

WB:WBGene00199286	W05H5.9
No description available

WB:WBGene00199287	Y73B6BL.279
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199288	C47E12.18
No description available

WB:WBGene00199289	Y57E12B.6
No description available

WB:WBGene00199290	ZK377.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199291	R02D5.15
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199292	Y48A6B.17
No description available

WB:WBGene00199293	C41G11.14
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199294	F02G3.5
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00199295	T19C4.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199296	F45D3.9
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00199297	T10E9.12
Is affected by lem-2 and hmg-3 based on RNA-seq studies.

WB:WBGene00199298	Y40C5A.19
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199299	Y38H6A.9
Is affected by Cry5B based on microarray studies.

WB:WBGene00199300	T21G5.8
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199301	K02A4.8
No description available

WB:WBGene00199302	R11.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00199303	F54F7.12
No description available

WB:WBGene00199304	C07G1.12
No description available

WB:WBGene00199305	C39E9.18
Is affected by spt-16; sir-2.1; and let-60 based on RNA-seq and microarray studies.

WB:WBGene00199306	R01E6.15
No description available

WB:WBGene00199307	F58H1.21
No description available

WB:WBGene00199308	C05D12.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00199309	C09G5.10
No description available

WB:WBGene00199310	K05B2.7
No description available

WB:WBGene00199311	ZK816.8
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00199312	B0457.13
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00199313	C04F6.8
No description available

WB:WBGene00199314	R02D5.16
No description available

WB:WBGene00199315	T04C12.23
Is affected by daf-2 based on microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00199316	PDB1.2
No description available

WB:WBGene00199317	Y23B4A.5
No description available

WB:WBGene00199318	R13H8.3
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199319	F47D12.10
Is affected by hpl-2 based on tiling array studies.

WB:WBGene00199320	R02D5.17
No description available

WB:WBGene00199321	B0034.12
No description available

WB:WBGene00199322	ZK550.42
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199323	C08D8.5
No description available

WB:WBGene00199324	M153.8
No description available

WB:WBGene00199325	F45H7.12
Is affected by several genes including daf-2; cep-1; and prg-1 based on RNA-seq and microarray studies.

WB:WBGene00199326	T01C8.9
No description available

WB:WBGene00199327	T13H2.8
No description available

WB:WBGene00199328	R10E12.7
Is affected by cep-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00199329	F11D5.21
No description available

WB:WBGene00199330	F31B9.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00199331	K12D12.9
No description available

WB:WBGene00199332	T23F2.9
No description available

WB:WBGene00199333	F45H11.10
No description available

WB:WBGene00199334	T27E4.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00199335	F33C8.7
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00199336	C41C4.14
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199337	F42D1.10
No description available

WB:WBGene00199338	F26A10.19
Is affected by adr-1 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00199339	C41G7.13
Is affected by emr-1; cep-1; and ins-11 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199340	Y43F8C.27
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199341	C50E10.12
No description available

WB:WBGene00199342	F22B3.15
No description available

WB:WBGene00199343	F42E11.6
No description available

WB:WBGene00199344	E02C12.16
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199345	F45B8.15
No description available

WB:WBGene00199346	F16A11.7
No description available

WB:WBGene00199347	F47B7.14
No description available

WB:WBGene00199348	C02B4.10
No description available

WB:WBGene00199349	C40H5.14
No description available

WB:WBGene00199350	F13D11.15
No description available

WB:WBGene00199351	EGAP3.3
No description available

WB:WBGene00199352	C26G2.6
No description available

WB:WBGene00199353	C05B10.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199354	C31H1.97
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199355	F56E3.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199356	R04F11.21
No description available

WB:WBGene00199357	Y39G8C.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00199358	F46H6.10
No description available

WB:WBGene00199359	F35E8.19
No description available

WB:WBGene00199360	F44E5.10
No description available

WB:WBGene00199361	B0310.7
No description available

WB:WBGene00199362	F29D10.7
No description available

WB:WBGene00199363	ZK945.13
No description available

WB:WBGene00199364	F17H10.7
No description available

WB:WBGene00199365	C17G1.11
No description available

WB:WBGene00199366	T06F4.12
No description available

WB:WBGene00199367	Y69H2.20
No description available

WB:WBGene00199368	Y38F1A.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199369	H14E04.8
No description available

WB:WBGene00199370	F25B4.14
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00199371	T03F7.14
Is affected by several genes including daf-2; cep-1; and meg-3 based on RNA-seq and microarray studies.

WB:WBGene00199372	C23H3.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199373	F14F3.12
No description available

WB:WBGene00199374	C07A12.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199375	C56A3.13
No description available

WB:WBGene00199376	Y66A7AL.7
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00199377	F09E5.20
No description available

WB:WBGene00199378	Y51A2D.34
No description available

WB:WBGene00199379	B0454.19
No description available

WB:WBGene00199380	F35D2.12
No description available

WB:WBGene00199381	F45G2.11
No description available

WB:WBGene00199382	F11D5.22
No description available

WB:WBGene00199383	K01A6.15
No description available

WB:WBGene00199384	F41E7.15
Is affected by several genes including his-72; his-71; and his-74 based on RNA-seq studies.

WB:WBGene00199385	F52E4.13
No description available

WB:WBGene00199386	C14F11.23
No description available

WB:WBGene00199387	R13A1.15
No description available

WB:WBGene00199388	F47F6.11
No description available

WB:WBGene00199389	B0563.15
No description available

WB:WBGene00199390	B0273.111
Is affected by elli-1 and daf-2 based on microarray studies.

WB:WBGene00199391	C32C4.15
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199392	B0310.8
No description available

WB:WBGene00199393	F56F10.8
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00199394	K11D2.6
No description available

WB:WBGene00199395	R90.10
Is affected by eat-2 based on microarray studies.

WB:WBGene00199396	T27B1.5
No description available

WB:WBGene00199397	M110.12
No description available

WB:WBGene00199398	ZC190.14
No description available

WB:WBGene00199399	F26A10.20
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199400	C48E7.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199401	F25F2.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00199402	B0336.16
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00199403	F14H12.13
No description available

WB:WBGene00199404	ZK1098.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199405	T06H11.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199406	C24B9.17
No description available

WB:WBGene00199407	T21E12.8
No description available

WB:WBGene00199408	T06G6.15
No description available

WB:WBGene00199409	C33F10.21
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199410	C14F11.24
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00199411	Y95B8A.14
No description available

WB:WBGene00199412	Y4C6B.98
Is affected by daf-2 based on microarray studies.

WB:WBGene00199413	F02D10.14
No description available

WB:WBGene00199414	F48E3.13
No description available

WB:WBGene00199415	C07H6.16
No description available

WB:WBGene00199416	Y40B1A.5
Is affected by daf-12 and zip-3 based on tiling array and RNA-seq studies.

WB:WBGene00199417	W10C8.13
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199418	T05B4.18
No description available

WB:WBGene00199419	C48D5.7
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00199420	F21C10.16
No description available

WB:WBGene00199421	F13H6.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199422	Y73A3A.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199423	ZK617.17
No description available

WB:WBGene00199424	R11B5.8
No description available

WB:WBGene00199425	C34H3.17
No description available

WB:WBGene00199426	D1022.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199427	Y38F2AR.18
No description available

WB:WBGene00199428	K01A6.16
No description available

WB:WBGene00199429	F38B6.13
No description available

WB:WBGene00199430	F52F10.9
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00199431	C31G12.11
No description available

WB:WBGene00199432	R06C1.10
No description available

WB:WBGene00199433	K11E4.10
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00199434	C17H12.34
No description available

WB:WBGene00199435	ZK669.8
No description available

WB:WBGene00199436	F46A8.12
No description available

WB:WBGene00199437	C08G9.6
No description available

WB:WBGene00199438	W04G3.14
No description available

WB:WBGene00199439	B0286.8
No description available

WB:WBGene00199440	F38E9.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199441	B0350.73
No description available

WB:WBGene00199442	Y69H2.21
No description available

WB:WBGene00199443	K06C4.21
No description available

WB:WBGene00199444	Y48B6A.20
No description available

WB:WBGene00199445	F57G12.10
Is affected by several genes including daf-16; daf-12; and cep-1 based on RNA-seq studies.

WB:WBGene00199446	F28E10.13
No description available

WB:WBGene00199447	F08B12.10
Is expressed in amphid neurons; head neurons; and tail neurons.

WB:WBGene00199448	C04A11.8
No description available

WB:WBGene00199449	F01E11.10
No description available

WB:WBGene00199450	C34F11.14
No description available

WB:WBGene00199451	T19F4.6
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199452	Y105C5A.1277
No description available

WB:WBGene00199453	C01B7.13
No description available

WB:WBGene00199454	F26F12.18
No description available

WB:WBGene00199455	C03A7.15
Is affected by several genes including daf-2; lem-2; and emr-1 based on RNA-seq and microarray studies.

WB:WBGene00199456	F13H6.23
No description available

WB:WBGene00199457	R13F6.14
No description available

WB:WBGene00199458	F29F11.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199459	C31G12.12
No description available

WB:WBGene00199460	C13B9.5
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199461	ZK1290.20
No description available

WB:WBGene00199462	B0495.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199463	F48A9.5
No description available

WB:WBGene00199464	T22B7.14
Is affected by tdp-1 and hmg-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199465	T23F2.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199466	F42D1.11
No description available

WB:WBGene00199467	F58D5.10
No description available

WB:WBGene00199468	T01B4.7
No description available

WB:WBGene00199469	M05B5.8
No description available

WB:WBGene00199470	ZK970.10
No description available

WB:WBGene00199471	C17G10.11
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199472	C18C4.15
No description available

WB:WBGene00199473	F45E6.7
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199474	ZK836.12
No description available

WB:WBGene00199475	ZK112.14
Is affected by cep-1; chd-3; and dlc-1 based on RNA-seq studies.

WB:WBGene00199476	C34B4.14
No description available

WB:WBGene00199477	T26H10.7
Is affected by alg-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00199478	C01F6.13
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00199479	H01G02.13
No description available

WB:WBGene00199480	T19F4.7
No description available

WB:WBGene00199481	F57B7.11
No description available

WB:WBGene00199482	C54D2.12
No description available

WB:WBGene00199483	Y41C4A.27
Is affected by daf-2 based on microarray studies.

WB:WBGene00199484	C05D9.11
No description available

WB:WBGene00199485	M117.11
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199486	Y48G8AR.5
No description available

WB:WBGene00199487	K08E4.11
No description available

WB:WBGene00199488	W06H8.13
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199489	C06G1.14
No description available

WB:WBGene00199490	M70.9
No description available

WB:WBGene00199491	F35C11.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00199492	Y69A2AR.41
No description available

WB:WBGene00199493	C07A9.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199494	ZK836.13
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199495	C25A1.18
No description available

WB:WBGene00199496	C06A6.11
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199497	R155.7
No description available

WB:WBGene00199498	K07E12.4
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199499	F58G11.10
No description available

WB:WBGene00199500	F09F9.12
Is affected by hmg-3; hmg-4; and spt-16 based on RNA-seq studies.

WB:WBGene00199501	Y102A11A.12
No description available

WB:WBGene00199502	K10D6.16
No description available

WB:WBGene00199503	C09B9.81
No description available

WB:WBGene00199504	Y49G5B.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199505	Y106G6C.1
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199506	F36D1.17
No description available

WB:WBGene00199507	R173.10
No description available

WB:WBGene00199508	F09C3.8
No description available

WB:WBGene00199509	ZK381.50
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199510	K01A11.7
No description available

WB:WBGene00199511	Y54E5B.6
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00199512	T24H7.7
No description available

WB:WBGene00199513	R08D7.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199514	C07H6.17
No description available

WB:WBGene00199515	F56B6.7
No description available

WB:WBGene00199516	F28D1.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199517	C02C6.8
No description available

WB:WBGene00199518	F22A3.14
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00199519	F01G12.14
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00199520	K08E7.11
No description available

WB:WBGene00199521	F55F1.9
No description available

WB:WBGene00199522	T24A11.6
No description available

WB:WBGene00199523	F25D7.8
Is affected by cep-1 and adr-1 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00199524	C55B6.6
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199525	C03A3.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199526	F55E10.10
No description available

WB:WBGene00199527	C31G12.13
No description available

WB:WBGene00199528	F35H8.10
No description available

WB:WBGene00199529	Y24D9A.12
No description available

WB:WBGene00199530	B0511.15
No description available

WB:WBGene00199531	C36F7.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199532	W03C9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199533	D1007.22
No description available

WB:WBGene00199534	F47C8.3
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00199535	F53F8.10
No description available

WB:WBGene00199536	F28F5.13
No description available

WB:WBGene00199537	F31F6.13
No description available

WB:WBGene00199538	C34E11.13
No description available

WB:WBGene00199539	ZK381.51
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199540	F45E4.18
No description available

WB:WBGene00199541	Y41E3.460
Is enriched in AVK based on RNA-seq studies. Is affected by kri-1 and mpk-2 based on RNA-seq studies.

WB:WBGene00199542	Y113G7A.19
No description available

WB:WBGene00199543	H08J11.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00199544	F46F2.11
No description available

WB:WBGene00199545	F12D9.13
No description available

WB:WBGene00199546	F35D2.13
No description available

WB:WBGene00199547	C24A1.5
No description available

WB:WBGene00199548	Y38E10A.30
No description available

WB:WBGene00199549	ZK809.13
No description available

WB:WBGene00199550	K02E10.9
No description available

WB:WBGene00199551	F57G4.13
No description available

WB:WBGene00199552	F54F2.11
No description available

WB:WBGene00199553	C34E7.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199554	F49E10.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199555	F57C7.11
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00199556	Y49F6A.7
No description available

WB:WBGene00199557	K01F9.7
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00199558	F22E12.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199559	K03H9.11
No description available

WB:WBGene00199560	C39B10.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199561	Y47D3B.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199562	T27B1.6
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00199563	C33G3.10
No description available

WB:WBGene00199564	Y43H11AL.5
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00199565	F47B10.11
No description available

WB:WBGene00199566	C54G4.13
No description available

WB:WBGene00199567	C34E11.14
No description available

WB:WBGene00199568	R03A10.11
No description available

WB:WBGene00199569	F25F6.3
No description available

WB:WBGene00199570	C43F9.17
No description available

WB:WBGene00199571	T21H8.8
No description available

WB:WBGene00199572	F41C6.13
No description available

WB:WBGene00199573	C06A6.12
No description available

WB:WBGene00199574	Y41D4B.29
No description available

WB:WBGene00199575	H03A11.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199576	C03H5.8
No description available

WB:WBGene00199577	F22F7.9
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199578	T28D6.13
No description available

WB:WBGene00199579	C17H11.8
No description available

WB:WBGene00199580	R03D7.13
No description available

WB:WBGene00199581	Y80D3A.12
No description available

WB:WBGene00199582	ZK1025.16
No description available

WB:WBGene00199583	T05B11.10
Is affected by chd-3 based on RNA-seq studies.

WB:WBGene00199584	F31E8.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199585	ZK1193.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199586	K04G2.13
Is enriched in ASER based on RNA-seq studies. Is affected by daf-2 based on microarray studies.

WB:WBGene00199587	E01G6.5
No description available

WB:WBGene00199588	F25H8.16
Is expressed in diagonal muscle; spicule protractor muscle; spicule retractor muscle; vulval muscle; and in male.

WB:WBGene00199589	C16E9.19
No description available

WB:WBGene00199590	F58H7.10
No description available

WB:WBGene00199591	Y54G2A.65
Is affected by daf-2 and unc-70 based on microarray and RNA-seq studies.

WB:WBGene00199592	ZK180.13
No description available

WB:WBGene00199593	ZK867.16
No description available

WB:WBGene00199594	M60.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199595	F49E2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199596	C49F8.11
No description available

WB:WBGene00199597	F53G12.15
No description available

WB:WBGene00199598	F38B6.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199599	K08A8.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199600	D1005.9
Is affected by bisphenol A based on RNA-seq studies.

WB:WBGene00199601	Y55F3BR.15
No description available

WB:WBGene00199602	W09C5.14
No description available

WB:WBGene00199603	F13G11.144
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00199604	Y39A1B.7
Is affected by Cry5B based on microarray studies.

WB:WBGene00199605	K09C8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00199606	T05A6.15
Is affected by cep-1 and let-418 based on RNA-seq studies.

WB:WBGene00199607	ZK973.21
No description available

WB:WBGene00199608	T21B6.12
No description available

WB:WBGene00199609	B0414.12
No description available

WB:WBGene00199610	T22B7.15
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199611	Y51H7C.27
No description available

WB:WBGene00199612	C06G1.15
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199613	F10E9.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00199614	C45B2.13
No description available

WB:WBGene00199615	T04F3.9
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00199616	C08C3.10
No description available

WB:WBGene00199617	F46F3.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199618	K10G6.6
No description available

WB:WBGene00199619	F54E7.13
No description available

WB:WBGene00199620	W05B2.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199621	B0034.13
No description available

WB:WBGene00199622	T08G11.9
No description available

WB:WBGene00199623	C01F4.8
No description available

WB:WBGene00199624	C02D4.11
No description available

WB:WBGene00199625	F34D10.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199626	ZC317.8
No description available

WB:WBGene00199627	K03C7.10
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199628	Y7A9D.66
No description available

WB:WBGene00199629	F52F12.14
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00199630	C09H10.15
No description available

WB:WBGene00199631	F59G1.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00199632	C15B12.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199633	F57F10.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199634	T10A3.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199635	Y39G10AR.31
No description available

WB:WBGene00199636	F29G9.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199637	C56G3.3
No description available

WB:WBGene00199638	R04B3.6
Is affected by unc-39 based on RNA-seq studies.

WB:WBGene00199639	F56A12.8
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199640	C31H5.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199641	K09G1.5
No description available

WB:WBGene00199642	T19E7.26
No description available

WB:WBGene00199643	F11A1.12
Is affected by eat-2 based on microarray studies.

WB:WBGene00199644	F23H12.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199645	C44B7.18
No description available

WB:WBGene00199646	Y51B9A.12
No description available

WB:WBGene00199647	ZK40.7
No description available

WB:WBGene00199648	DY3.9
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199649	F46G11.15
No description available

WB:WBGene00199650	C54G6.7
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199651	F09D5.7
No description available

WB:WBGene00199652	C41G11.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199653	B0350.74
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199654	F56E10.6
No description available

WB:WBGene00199655	C30D11.2
No description available

WB:WBGene00199656	F47A4.6
No description available

WB:WBGene00199657	C35D10.19
No description available

WB:WBGene00199658	C09D8.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00199659	D1044.12
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00199660	E02H4.9
No description available

WB:WBGene00199661	C16B8.8
Is affected by hmg-3 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00199662	W04G5.14
No description available

WB:WBGene00199663	B0507.14
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00199664	C44B12.10
No description available

WB:WBGene00199665	K04D7.14
No description available

WB:WBGene00199666	Y73B6BL.280
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00199667	T04F8.14
No description available

WB:WBGene00199668	R12G8.3
No description available

WB:WBGene00199669	Y54E10A.25
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199670	C10G11.14
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199671	Y75B8A.54
No description available

WB:WBGene00199672	F46G11.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00199673	C18H9.10
No description available

WB:WBGene00199674	K10H10.14
Is affected by prg-1; cep-1; and sftb-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199675	F54F7.13
No description available

WB:WBGene00199676	F42H10.14
No description available

WB:WBGene00199677	C10F3.14
No description available

WB:WBGene00199678	T10E10.12
No description available

WB:WBGene00199679	F38G1.4
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199680	C11G10.10
No description available

WB:WBGene00199681	Y54G9A.15
No description available

WB:WBGene00199682	C04C11.15
No description available

WB:WBGene00199683	Y53C10A.20
No description available

WB:WBGene00199684	Y42A5A.10
No description available

WB:WBGene00199685	ZK757.6
No description available

WB:WBGene00199686	T25D10.7
No description available

WB:WBGene00199687	C50E10.13
No description available

WB:WBGene00199688	C54C6.10
No description available

WB:WBGene00199689	W01C8.13
No description available

WB:WBGene00199690	F14D12.10
No description available

WB:WBGene00199691	F56B3.14
No description available

WB:WBGene00199692	R07H5.12
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00199693	F31E8.17
No description available

WB:WBGene00199694	2RSSE.6
Is affected by several genes including pgl-1; prg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199695	F08G2.17
No description available

WB:WBGene00199696	H21P03.8
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00199697	F11A6.10
No description available

WB:WBGene00199698	K11H3.11
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00199699	F07A11.11
No description available

WB:WBGene00199700	M60.12
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00199701	R151.17
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00199702	C11E4.11
Is affected by daf-2 based on microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00199703	F16F9.14
No description available

WB:WBGene00199704	C08B6.16
No description available

WB:WBGene00199705	T02E9.22
No description available

WB:WBGene00199706	T02C12.7
No description available

WB:WBGene00199707	C48C5.7
No description available

WB:WBGene00199708	C25F6.18
No description available

WB:WBGene00199709	T06F4.13
No description available

WB:WBGene00199710	F55A12.15
No description available

WB:WBGene00199711	ZK867.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199712	K02C4.9
No description available

WB:WBGene00199713	C43G2.30
No description available

WB:WBGene00199714	R02F11.6
Is affected by nanoparticle based on microarray studies.

WB:WBGene00199715	D1053.6
No description available

WB:WBGene00199716	C05C9.11
No description available

WB:WBGene00199717	T19B10.17
No description available

WB:WBGene00199718	F13G3.13
No description available

WB:WBGene00199719	C47F8.10
Is affected by pmt-2 and nmad-1 based on microarray and RNA-seq studies.

WB:WBGene00199720	C13A10.4
No description available

WB:WBGene00199721	H08J11.8
No description available

WB:WBGene00199722	F47E1.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00199723	W07E6.7
No description available

WB:WBGene00199724	F10C1.16
No description available

WB:WBGene00199725	Y47D3B.19
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00199726	F38E11.23
No description available

WB:WBGene00199727	F35A5.13
No description available

WB:WBGene00199728	F13H6.24
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199729	ZC513.18
No description available

WB:WBGene00199730	W08D2.11
Is affected by cep-1 and hsf-1 based on RNA-seq studies.

WB:WBGene00199731	C06G4.7
No description available

WB:WBGene00199732	F34H10.6
No description available

WB:WBGene00199733	C08E8.13
No description available

WB:WBGene00199734	C16C2.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00199735	F14F11.4
No description available

WB:WBGene00199736	W03G11.17
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00199737	F37D6.10
No description available

WB:WBGene00199738	C11G10.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199739	C32A9.3
No description available

WB:WBGene00199740	F07A11.12
Is affected by several genes including pgl-1; glh-1; and hpl-2 based on RNA-seq studies.

WB:WBGene00199741	F22B3.16
No description available

WB:WBGene00199742	T06E8.6
No description available

WB:WBGene00199743	F31D4.11
Is affected by daf-16 and elli-1 based on RNA-seq and microarray studies.

WB:WBGene00199744	R07B5.11
Is affected by daf-2 based on microarray studies. Is affected by 4-bromodiphenyl ether based on microarray studies.

WB:WBGene00199745	F10F2.12
No description available

WB:WBGene00199746	F58G11.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199747	F54F11.5
No description available

WB:WBGene00199748	R05H11.3
No description available

WB:WBGene00199749	T08G2.8
No description available

WB:WBGene00199750	F26D11.17
No description available

WB:WBGene00199751	T05E11.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199752	K12G11.11
No description available

WB:WBGene00199753	Y97E10B.12
No description available

WB:WBGene00199754	C27F2.14
No description available

WB:WBGene00199755	Y48C3A.22
No description available

WB:WBGene00199756	F31F6.14
No description available

WB:WBGene00199757	ZK973.22
No description available

WB:WBGene00199758	F43E12.5
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199759	F49E10.18
Is affected by daf-12; daf-16; and dpy-21 based on RNA-seq studies.

WB:WBGene00199760	Y40B1B.9
No description available

WB:WBGene00199761	C23H4.12
Is affected by cep-1 and chd-3 based on RNA-seq studies.

WB:WBGene00199762	T14F9.16
No description available

WB:WBGene00199763	C56G3.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00199764	K06A1.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199765	C44E12.7
No description available

WB:WBGene00199766	F56F4.10
Is affected by daf-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199767	Y14H12A.3
No description available

WB:WBGene00199768	F52F12.15
No description available

WB:WBGene00199769	H13J03.3
No description available

WB:WBGene00199770	F28B4.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199771	F52B10.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199772	T14F9.17
No description available

WB:WBGene00199773	Y46E12BL.8
No description available

WB:WBGene00199774	F14F3.13
No description available

WB:WBGene00199775	W09C5.15
No description available

WB:WBGene00199776	T28C12.11
No description available

WB:WBGene00199777	C50C3.15
No description available

WB:WBGene00199778	F32B6.13
No description available

WB:WBGene00199779	K08F8.12
No description available

WB:WBGene00199780	R12C12.12
No description available

WB:WBGene00199781	F46A9.9
Is affected by ifo-1 based on microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00199782	T09A5.20
No description available

WB:WBGene00199783	K11D9.7
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199784	F08G5.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199785	C48A7.12
Is affected by emr-1 and cep-1 based on RNA-seq studies.

WB:WBGene00199786	C25F6.19
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00199787	B0496.17
No description available

WB:WBGene00199788	B0395.8
No description available

WB:WBGene00199789	T10B10.13
Is affected by daf-2 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199790	F08A8.9
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199791	F26A1.17
No description available

WB:WBGene00199792	ZK381.52
No description available

WB:WBGene00199793	T24B8.18
No description available

WB:WBGene00199794	ZK617.18
No description available

WB:WBGene00199795	T28B11.16
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00199796	F40H3.13
No description available

WB:WBGene00199797	C54G7.14
No description available

WB:WBGene00199798	Y37A1B.334
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00199799	C49A1.15
No description available

WB:WBGene00199800	C33D12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199801	F42G10.4
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00199802	M03E7.7
No description available

WB:WBGene00199803	C50C3.16
No description available

WB:WBGene00199804	R03E1.5
No description available

WB:WBGene00199805	F01E11.11
No description available

WB:WBGene00199806	W05E10.15
Is affected by cep-1; adr-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199807	F28B4.9
No description available

WB:WBGene00199808	F21A3.10
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00199809	R08E3.8
No description available

WB:WBGene00199810	F19G12.12
Is affected by several genes including daf-2; cep-1; and tdp-1 based on RNA-seq and microarray studies.

WB:WBGene00199811	F55B12.15
No description available

WB:WBGene00199812	C06E4.18
No description available

WB:WBGene00199813	W09G10.8
No description available

WB:WBGene00199814	Y47H9A.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199815	ZK377.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199816	C34G6.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199817	C10B5.4
No description available

WB:WBGene00199818	Y38H6A.10
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199819	K08F8.13
No description available

WB:WBGene00199820	C34E11.15
No description available

WB:WBGene00199821	F52H3.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00199822	F20D1.18
No description available

WB:WBGene00199823	C45B2.14
No description available

WB:WBGene00199824	Y57E12B.7
No description available

WB:WBGene00199825	C18E3.10
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00199826	W07G1.15
No description available

WB:WBGene00199827	B0238.18
Is affected by klf-1 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199828	K10C2.10
No description available

WB:WBGene00199829	C52E4.17
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199830	T27A10.9
No description available

WB:WBGene00199831	F01E11.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199832	C44B7.19
No description available

WB:WBGene00199833	K02H8.4
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199834	Y22D7AL.18
No description available

WB:WBGene00199835	F18H3.6
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00199836	C18H7.15
No description available

WB:WBGene00199837	F14D12.11
No description available

WB:WBGene00199838	T08G2.9
No description available

WB:WBGene00199839	T21B6.13
No description available

WB:WBGene00199840	K10C3.12
Is affected by several genes including daf-2; cep-1; and let-418 based on RNA-seq and microarray studies.

WB:WBGene00199841	T12A2.19
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00199842	F38E9.9
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199843	T22B11.9
No description available

WB:WBGene00199844	D1054.22
No description available

WB:WBGene00199845	F23C11.2
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199846	F08G5.17
No description available

WB:WBGene00199847	W03G11.18
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00199848	T08B6.63
No description available

WB:WBGene00199849	B0496.18
No description available

WB:WBGene00199850	C02D4.12
No description available

WB:WBGene00199851	C35C5.19
No description available

WB:WBGene00199852	Y75B7AL.8
No description available

WB:WBGene00199853	T19C11.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199854	ZC21.13
No description available

WB:WBGene00199855	H14N18.6
No description available

WB:WBGene00199856	F08F1.18
No description available

WB:WBGene00199857	C54H2.11
No description available

WB:WBGene00199858	C40H5.15
No description available

WB:WBGene00199859	F58H1.22
No description available

WB:WBGene00199860	K06H6.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00199861	T19H12.13
No description available

WB:WBGene00199862	F59B10.8
No description available

WB:WBGene00199863	Y38C1AA.18
No description available

WB:WBGene00199864	F37B12.10
No description available

WB:WBGene00199865	C31H2.12
No description available

WB:WBGene00199866	H37A05.6
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199867	Y43E12A.7
No description available

WB:WBGene00199868	C28A5.9
No description available

WB:WBGene00199869	W05E10.16
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00199870	C28A5.10
No description available

WB:WBGene00199871	F46F3.14
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including let-418; dlc-1; and mys-1 based on RNA-seq studies.

WB:WBGene00199872	T01H8.7
No description available

WB:WBGene00199873	F26E4.18
No description available

WB:WBGene00199874	R10H1.7
No description available

WB:WBGene00199875	C40C9.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199876	F10F2.13
No description available

WB:WBGene00199877	F25H8.17
No description available

WB:WBGene00199878	B0491.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199879	R04F11.22
No description available

WB:WBGene00199880	C16E9.20
No description available

WB:WBGene00199881	K01D12.17
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199882	F47C8.4
Is affected by nanoparticle based on microarray studies.

WB:WBGene00199883	F10C2.12
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00199884	F43G9.18
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199885	B0457.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00199886	Y65A5A.26
No description available

WB:WBGene00199887	R04E5.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00199888	T24E12.14
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00199889	F58F6.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199890	F58H1.23
Is affected by Cry5B based on microarray studies.

WB:WBGene00199891	C29A12.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00199892	F37E3.5
No description available

WB:WBGene00199893	C29A12.16
No description available

WB:WBGene00199894	Y71H10A.4
No description available

WB:WBGene00199895	F35B12.14
No description available

WB:WBGene00199896	ZK287.15
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00199897	R13H4.11
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199898	Y57E12B.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00199899	F53G12.16
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199900	F32B5.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199901	Y39G8C.10
No description available

WB:WBGene00199902	C26B9.9
No description available

WB:WBGene00199903	W07E11.6
Is affected by klf-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199904	K04H4.15
No description available

WB:WBGene00199905	B0198.9
Is affected by pgrn-1 and cep-1 based on RNA-seq studies.

WB:WBGene00199906	T24D3.4
No description available

WB:WBGene00199907	Y40H7A.308
No description available

WB:WBGene00199908	T25C12.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199909	T28H10.5
No description available

WB:WBGene00199910	C56G7.4
No description available

WB:WBGene00199911	K09F5.13
No description available

WB:WBGene00199912	F57B9.12
No description available

WB:WBGene00199913	C39F7.8
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199914	T22B7.16
Is affected by tdp-1; hmg-3; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00199915	T19A6.6
No description available

WB:WBGene00199916	R04E5.17
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00199917	F15A8.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199918	mir-8192
No description available

WB:WBGene00199919	Y37A1B.335
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199920	F46C3.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00199921	F45B8.16
No description available

WB:WBGene00199922	ZC64.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199923	K04G2.14
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00199924	C38H2.4
No description available

WB:WBGene00199925	F55E10.11
No description available

WB:WBGene00199926	W07G4.10
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199927	Y77E11A.20
No description available

WB:WBGene00199928	F52F12.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00199929	F33E2.12
No description available

WB:WBGene00199930	T22H2.7
Is affected by ifo-1 based on microarray studies.

WB:WBGene00199931	W02B8.11
No description available

WB:WBGene00199932	B0273.112
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199933	F58B6.9
No description available

WB:WBGene00199934	M163.20
No description available

WB:WBGene00199935	F13E6.10
Is affected by hpl-2 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199936	Y62F5A.14
No description available

WB:WBGene00199937	T04C9.10
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199938	Y15E3A.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199939	T06H11.17
No description available

WB:WBGene00199940	2RSSE.7
No description available

WB:WBGene00199941	Y51A2B.14
No description available

WB:WBGene00199942	B0365.8
No description available

WB:WBGene00199943	C28A5.11
No description available

WB:WBGene00199944	C18B12.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199945	F14F3.14
No description available

WB:WBGene00199946	F52B5.10
No description available

WB:WBGene00199947	C18A11.12
No description available

WB:WBGene00199948	W01H2.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00199949	C06E7.91
No description available

WB:WBGene00199950	F46C8.18
No description available

WB:WBGene00199951	D1046.14
No description available

WB:WBGene00199952	F47C8.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199953	F38H4.14
No description available

WB:WBGene00199954	F25H10.7
No description available

WB:WBGene00199955	F45D3.10
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199956	ZK180.14
No description available

WB:WBGene00199957	H02I12.11
No description available

WB:WBGene00199958	F09E5.21
No description available

WB:WBGene00199959	R08B4.11
No description available

WB:WBGene00199960	C11G10.12
No description available

WB:WBGene00199961	C09B8.16
No description available

WB:WBGene00199962	Y51H7C.28
No description available

WB:WBGene00199963	T26H2.15
No description available

WB:WBGene00199964	T05A6.16
No description available

WB:WBGene00199965	W04E12.11
No description available

WB:WBGene00199966	H30A04.9
No description available

WB:WBGene00199967	H21P03.9
No description available

WB:WBGene00199968	K12F2.4
No description available

WB:WBGene00199969	T04A6.7
No description available

WB:WBGene00199970	F08F3.15
No description available

WB:WBGene00199971	T08G11.10
No description available

WB:WBGene00199972	Y102A11A.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199973	Y73B6BL.281
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199974	C14F11.25
Is affected by eat-2 based on microarray studies.

WB:WBGene00199975	F09F9.13
No description available

WB:WBGene00199976	T04C12.24
Is affected by pmt-2 based on microarray studies.

WB:WBGene00199977	R07A4.5
No description available

WB:WBGene00199978	H36N01.3
Is affected by pmt-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00199979	Y116F11B.22
No description available

WB:WBGene00199980	Y59A8B.31
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00199981	F26A1.18
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00199982	C34F11.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00199983	T04C12.25
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00199984	F14D2.18
No description available

WB:WBGene00199985	T02E9.23
No description available

WB:WBGene00199986	K09E9.11
No description available

WB:WBGene00199987	Y37F4.13
No description available

WB:WBGene00199988	T25B6.10
No description available

WB:WBGene00199989	D2024.16
No description available

WB:WBGene00199990	ZC504.15
No description available

WB:WBGene00199991	Y61A9LA.13
No description available

WB:WBGene00199992	M05B5.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00199993	F45H7.13
Is affected by eat-2 based on microarray studies.

WB:WBGene00199994	H36L18.4
No description available

WB:WBGene00199995	C34D1.12
No description available

WB:WBGene00199996	C45G7.10
No description available

WB:WBGene00199997	H32C10.97
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00199998	D1081.16
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00199999	Y80D3A.13
No description available

WB:WBGene00200000	C02D4.13
Is affected by cep-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00200001	T06D8.14
No description available

WB:WBGene00200002	C25F6.20
No description available

WB:WBGene00200003	K08B12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200004	ZK131.13
Is affected by nanoparticle based on microarray studies.

WB:WBGene00200005	C07G1.13
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200006	F49E10.19
No description available

WB:WBGene00200007	F40G9.21
No description available

WB:WBGene00200008	Y54G2A.66
No description available

WB:WBGene00200009	C29H12.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200010	C30B5.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00200011	ZK836.14
No description available

WB:WBGene00200012	Y95D11A.4
No description available

WB:WBGene00200013	F40E10.12
No description available

WB:WBGene00200014	F07C3.15
No description available

WB:WBGene00200015	Y71H2AL.3
No description available

WB:WBGene00200016	AC3.16
Is affected by several genes including daf-2; lem-2; and emr-1 based on RNA-seq and microarray studies.

WB:WBGene00200017	F44E5.11
No description available

WB:WBGene00200018	T12G3.9
No description available

WB:WBGene00200019	F43D2.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00200020	F46F2.12
Is enriched in AFD; ASER; and PLM based on RNA-seq studies.

WB:WBGene00200021	Y73B3A.27
No description available

WB:WBGene00200022	C55B7.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200023	C34E11.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00200024	Y71A12B.29
No description available

WB:WBGene00200025	T04C12.26
No description available

WB:WBGene00200026	R07D5.7
No description available

WB:WBGene00200027	Y42H9B.6
No description available

WB:WBGene00200028	F41G4.11
Is affected by eat-2 and pmt-2 based on microarray studies.

WB:WBGene00200029	C40H1.10
Is affected by tdp-1; hmg-3; and spt-16 based on RNA-seq studies.

WB:WBGene00200030	F54E4.13
No description available

WB:WBGene00200031	C08G9.7
No description available

WB:WBGene00200032	F55C10.10
Is affected by nanoparticle based on microarray studies.

WB:WBGene00200033	Y47D3B.20
No description available

WB:WBGene00200034	C03C11.7
No description available

WB:WBGene00200035	Y59C2A.4
No description available

WB:WBGene00200036	R02D5.18
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00200037	T21G5.9
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00200038	F59B2.18
No description available

WB:WBGene00200039	Y40C5A.20
No description available

WB:WBGene00200040	F02G3.6
No description available

WB:WBGene00200041	R03E9.8
No description available

WB:WBGene00200042	C12D12.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200043	C23H5.14
No description available

WB:WBGene00200044	ZK682.11
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00200045	C02B4.11
No description available

WB:WBGene00200046	Y47G6A.34
No description available

WB:WBGene00200047	F35B12.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200048	Y47H9C.19
No description available

WB:WBGene00200049	R11F4.6
No description available

WB:WBGene00200050	C47D2.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200051	ZK836.15
Is affected by ifo-1 and spc-1 based on microarray and RNA-seq studies.

WB:WBGene00200052	Y51H7C.29
No description available

WB:WBGene00200053	C01B7.14
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200054	C05G6.5
No description available

WB:WBGene00200055	R01E6.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200056	F58E6.15
No description available

WB:WBGene00200057	K04G7.13
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00200058	K02A4.9
Is affected by daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200059	K02B2.36
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00200060	F20A1.14
No description available

WB:WBGene00200061	Y48B6A.21
No description available

WB:WBGene00200062	C25F6.21
Is affected by daf-2 based on microarray studies.

WB:WBGene00200063	C43C3.11
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00200064	F13A7.15
No description available

WB:WBGene00200065	F12D9.14
No description available

WB:WBGene00200066	C34H3.18
No description available

WB:WBGene00200067	Y54E5B.7
No description available

WB:WBGene00200068	C54G7.15
No description available

WB:WBGene00200069	Y50D7A.16
No description available

WB:WBGene00200070	K06C4.22
No description available

WB:WBGene00200071	T19C4.23
No description available

WB:WBGene00200072	F56D1.12
No description available

WB:WBGene00200073	T06A1.9
No description available

WB:WBGene00200074	K09H11.12
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200075	F13G11.145
No description available

WB:WBGene00200076	T24D11.5
No description available

WB:WBGene00200077	F01G12.15
Is affected by tdp-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200078	K03F8.3
Is affected by daf-2 based on microarray studies.

WB:WBGene00200079	C30B5.15
No description available

WB:WBGene00200080	C32D5.18
Is affected by cep-1; kri-1; and mpk-2 based on RNA-seq studies.

WB:WBGene00200081	T14B4.15
No description available

WB:WBGene00200082	F22F1.8
Is affected by elli-1; daf-2; and pmt-2 based on microarray studies.

WB:WBGene00200083	Y110A2AL.19
Is affected by prg-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00200084	ZK39.11
No description available

WB:WBGene00200085	Y39A3CL.13
No description available

WB:WBGene00200086	F11D5.23
No description available

WB:WBGene00200087	H08J11.9
No description available

WB:WBGene00200088	F13H6.25
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200089	F44A2.10
No description available

WB:WBGene00200090	K06A4.13
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00200091	Y48A6B.18
No description available

WB:WBGene00200092	Y43F8A.8
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200093	Y105E8A.46
No description available

WB:WBGene00200094	Y80D3A.14
No description available

WB:WBGene00200095	F28F9.12
No description available

WB:WBGene00200096	M01E5.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00200097	C26G2.7
No description available

WB:WBGene00200098	Y71F9AL.20
No description available

WB:WBGene00200099	ZK632.16
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200100	K03C7.11
No description available

WB:WBGene00200101	R06C1.11
No description available

WB:WBGene00200102	M70.10
No description available

WB:WBGene00200103	M03D4.77
No description available

WB:WBGene00200104	F54D7.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200105	W08F4.18
No description available

WB:WBGene00200106	M03A1.11
No description available

WB:WBGene00200107	K02C4.10
No description available

WB:WBGene00200108	B0454.20
No description available

WB:WBGene00200109	F25H8.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200110	F52D10.11
No description available

WB:WBGene00200111	R09F10.18
Is affected by tdp-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200112	F14H8.10
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00200113	H06I04.12
No description available

WB:WBGene00200114	Y48G9A.18
No description available

WB:WBGene00200115	Y53F4B.60
No description available

WB:WBGene00200116	R90.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200117	F27C1.16
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200118	F38B6.15
No description available

WB:WBGene00200119	ZC506.8
No description available

WB:WBGene00200120	K02D7.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00200121	F40H3.14
No description available

WB:WBGene00200122	T04F3.10
No description available

WB:WBGene00200123	C29A12.17
No description available

WB:WBGene00200124	F36D1.18
No description available

WB:WBGene00200125	C24H11.11
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200126	T24B8.19
No description available

WB:WBGene00200127	E01G6.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200128	F37H8.12
No description available

WB:WBGene00200129	F49E10.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00200130	F25H8.19
No description available

WB:WBGene00200131	K07C5.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200132	ZC412.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200133	R12B2.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200134	T24A11.7
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200135	F32G8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00200136	C04A2.9
No description available

WB:WBGene00200137	W07G1.16
No description available

WB:WBGene00200138	F15A8.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00200139	K08A2.15
No description available

WB:WBGene00200140	C04C3.13
No description available

WB:WBGene00200141	F09F9.14
No description available

WB:WBGene00200142	C54D10.20
No description available

WB:WBGene00200143	F25H8.20
No description available

WB:WBGene00200144	F07E5.11
No description available

WB:WBGene00200145	K04D7.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200146	Y75B8A.55
No description available

WB:WBGene00200147	F59F5.8
Is affected by cyc-1 based on microarray studies.

WB:WBGene00200148	T24D8.13
No description available

WB:WBGene00200149	F28F5.14
No description available

WB:WBGene00200150	C07A9.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200151	C39E6.12
No description available

WB:WBGene00200152	C45B2.15
No description available

WB:WBGene00200153	F46C5.13
No description available

WB:WBGene00200154	F37B12.11
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00200155	R13.9
No description available

WB:WBGene00200156	C06A12.17
No description available

WB:WBGene00200157	C27D6.13
No description available

WB:WBGene00200158	Y106G6G.9
No description available

WB:WBGene00200159	T23B3.7
No description available

WB:WBGene00200160	T28B11.17
No description available

WB:WBGene00200161	K01A6.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200162	K02F3.13
Is affected by glycine based on RNA-seq studies.

WB:WBGene00200163	C05C9.12
No description available

WB:WBGene00200164	T14G10.10
No description available

WB:WBGene00200165	C37A5.13
No description available

WB:WBGene00200166	K11G9.12
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200167	F45D3.11
Is affected by sodium arsenite and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00200168	VC5.12
No description available

WB:WBGene00200169	K07H8.15
No description available

WB:WBGene00200170	DL2.2
No description available

WB:WBGene00200171	ZK1025.17
No description available

WB:WBGene00200172	K01A6.18
No description available

WB:WBGene00200173	T27F7.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200174	F17E9.17
No description available

WB:WBGene00200175	R01E6.17
No description available

WB:WBGene00200176	T19A5.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200177	C52G5.7
No description available

WB:WBGene00200178	H22K11.11
No description available

WB:WBGene00200179	H30A04.10
No description available

WB:WBGene00200180	F11D5.24
Is affected by cep-1; alg-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200181	ZK637.19
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200182	T24C2.9
No description available

WB:WBGene00200183	F11D5.25
No description available

WB:WBGene00200184	B0403.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00200185	Y4C6B.99
No description available

WB:WBGene00200186	T19D2.9
No description available

WB:WBGene00200187	C48A7.13
No description available

WB:WBGene00200188	F11C1.14
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00200189	K02D3.5
No description available

WB:WBGene00200190	F16F9.15
No description available

WB:WBGene00200191	C44H4.12
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00200192	ZC443.8
No description available

WB:WBGene00200193	F37B12.12
No description available

WB:WBGene00200194	T27A10.10
No description available

WB:WBGene00200195	Y71H9A.7
No description available

WB:WBGene00200196	C17G1.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00200197	W07G1.17
No description available

WB:WBGene00200198	T21C12.10
No description available

WB:WBGene00200199	C54D2.13
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00200200	F09F3.16
No description available

WB:WBGene00200201	T19E7.27
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200202	Y49G5B.5
No description available

WB:WBGene00200203	D2092.13
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200204	F57F5.7
No description available

WB:WBGene00200205	C05D2.17
No description available

WB:WBGene00200206	C03B8.6
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00200207	F28E10.14
No description available

WB:WBGene00200208	C47D2.5
No description available

WB:WBGene00200209	F32A6.11
No description available

WB:WBGene00200210	F23H12.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200211	B0034.14
No description available

WB:WBGene00200212	F17C8.12
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00200213	B0286.9
Is affected by eat-2 based on microarray studies.

WB:WBGene00200214	C17H12.35
No description available

WB:WBGene00200215	T19F4.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200216	F58G4.8
No description available

WB:WBGene00200217	C17G10.12
No description available

WB:WBGene00200218	F25F1.3
No description available

WB:WBGene00200219	T06A1.10
No description available

WB:WBGene00200220	Y48B6A.22
No description available

WB:WBGene00200221	F36D4.12
No description available

WB:WBGene00200222	Y39A1B.8
No description available

WB:WBGene00200223	ZC518.7
No description available

WB:WBGene00200224	F01E11.13
No description available

WB:WBGene00200225	T24A11.8
No description available

WB:WBGene00200226	C15B12.13
No description available

WB:WBGene00200227	F56E10.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00200228	F57F4.6
No description available

WB:WBGene00200229	F38E9.10
No description available

WB:WBGene00200230	Y69H2.22
No description available

WB:WBGene00200231	T10B9.12
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200232	R06C1.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00200233	Y42H9B.7
Is affected by several genes including daf-2; eat-2; and let-418 based on RNA-seq and microarray studies.

WB:WBGene00200234	ZK512.16
No description available

WB:WBGene00200235	C08G9.8
No description available

WB:WBGene00200236	ZK795.8
No description available

WB:WBGene00200237	Y57G11A.225
No description available

WB:WBGene00200238	W02G9.6
No description available

WB:WBGene00200239	F38B6.16
No description available

WB:WBGene00200240	B0344.5
No description available

WB:WBGene00200241	K06G5.8
No description available

WB:WBGene00200242	F15A8.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200243	Y106G6E.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200244	K06C4.23
Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00200245	ZK1290.21
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200246	M70.11
No description available

WB:WBGene00200247	VF15C11L.1
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200248	ZK617.19
No description available

WB:WBGene00200249	F12F3.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200250	ZK867.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00200251	R12B2.12
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200252	F31B12.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200253	C01G8.10
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200254	Y106G6D.10
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200255	F35H8.11
No description available

WB:WBGene00200256	R10E12.8
No description available

WB:WBGene00200257	B0350.75
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200258	Y54G11A.18
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200259	R02D5.19
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00200260	W06F12.6
No description available

WB:WBGene00200261	F26F12.19
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00200262	C44E4.10
No description available

WB:WBGene00200263	K03C7.12
No description available

WB:WBGene00200264	W10C8.14
No description available

WB:WBGene00200265	C17E4.18
No description available

WB:WBGene00200266	K02A4.10
No description available

WB:WBGene00200267	Y69A2AR.42
No description available

WB:WBGene00200268	F01G12.16
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by pgrn-1 and tdp-1 based on RNA-seq studies.

WB:WBGene00200269	Y15E3A.10
No description available

WB:WBGene00200270	F43B10.3
No description available

WB:WBGene00200271	ZK370.10
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00200272	C09B9.82
No description available

WB:WBGene00200273	C07E3.15
No description available

WB:WBGene00200274	M03A1.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00200275	F16F9.16
No description available

WB:WBGene00200276	F15H9.9
No description available

WB:WBGene00200277	F36D1.19
No description available

WB:WBGene00200278	R05H11.4
No description available

WB:WBGene00200279	K01B6.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200280	F53B7.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200281	ZK836.16
Is affected by spc-1 based on RNA-seq studies.

WB:WBGene00200282	D2024.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200283	C06A6.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200284	T18D3.13
No description available

WB:WBGene00200285	F55F1.10
No description available

WB:WBGene00200286	C49A1.16
No description available

WB:WBGene00200287	K03E6.8
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00200288	ZK381.53
Is affected by Cry5B based on microarray studies.

WB:WBGene00200289	F47B10.12
No description available

WB:WBGene00200290	B0511.16
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200291	C05E7.5
No description available

WB:WBGene00200292	F57F10.4
No description available

WB:WBGene00200293	C24A3.14
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00200294	Y71F9AL.21
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00200295	T27F7.7
No description available

WB:WBGene00200296	M79.13
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200297	C48C5.8
No description available

WB:WBGene00200298	T02C12.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200299	C25F6.22
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200300	F55A12.16
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200301	F49B2.8
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200302	F18A11.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200303	F29F11.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200304	R155.8
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200305	H28G03.9
No description available

WB:WBGene00200306	F10D7.9
No description available

WB:WBGene00200307	Y48G8AR.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200308	C56C10.15
No description available

WB:WBGene00200309	C46F4.4
No description available

WB:WBGene00200310	Y71F9B.21
No description available

WB:WBGene00200311	Y17G7A.4
No description available

WB:WBGene00200312	F42C5.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200313	F09F9.15
No description available

WB:WBGene00200314	K03A11.7
No description available

WB:WBGene00200315	C52G5.8
No description available

WB:WBGene00200316	C30D11.3
Is affected by hydrogen sulfide based on microarray studies.

WB:WBGene00200317	C36F7.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00200318	T22B2.9
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200319	T13H2.9
No description available

WB:WBGene00200320	Y59A8B.32
No description available

WB:WBGene00200321	C02B4.12
No description available

WB:WBGene00200322	Y119D3B.26
No description available

WB:WBGene00200323	K02E10.10
No description available

WB:WBGene00200324	F45B8.17
No description available

WB:WBGene00200325	C54A12.8
No description available

WB:WBGene00200326	F42D1.12
No description available

WB:WBGene00200327	C26G2.8
No description available

WB:WBGene00200328	T10A3.4
No description available

WB:WBGene00200329	F43E12.6
No description available

WB:WBGene00200330	F42G4.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200331	C08D8.6
Is affected by cep-1 and klf-1 based on RNA-seq studies.

WB:WBGene00200332	Y50D4A.8
No description available

WB:WBGene00200333	F26A10.21
No description available

WB:WBGene00200334	T06H11.18
No description available

WB:WBGene00200335	T02E9.24
No description available

WB:WBGene00200336	ZK945.14
No description available

WB:WBGene00200337	C41C4.15
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00200338	F41D9.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200339	F31B12.7
No description available

WB:WBGene00200340	F28F9.13
No description available

WB:WBGene00200341	W01A11.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200342	C42D8.17
No description available

WB:WBGene00200343	F53G2.10
No description available

WB:WBGene00200344	F13D11.16
No description available

WB:WBGene00200345	ZK270.3
No description available

WB:WBGene00200346	F43D2.14
No description available

WB:WBGene00200347	T28B11.18
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200348	F26A10.22
No description available

WB:WBGene00200349	T27D12.10
No description available

WB:WBGene00200350	Y51A2D.35
No description available

WB:WBGene00200351	Y50D4C.9
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00200352	F49C5.15
No description available

WB:WBGene00200353	T09E11.13
No description available

WB:WBGene00200354	T13H10.14
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00200355	F22A3.15
Is affected by cep-1; dlc-1; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200356	R11E3.15
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00200357	R03A10.12
No description available

WB:WBGene00200358	C17G1.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200359	F18E2.13
No description available

WB:WBGene00200360	R11B5.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200361	C34H3.19
No description available

WB:WBGene00200362	F14F3.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200363	Y69H2.23
No description available

WB:WBGene00200364	ZC581.14
No description available

WB:WBGene00200365	F16A11.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200366	K08A8.22
No description available

WB:WBGene00200367	Y42A5A.11
No description available

WB:WBGene00200368	T06F4.14
No description available

WB:WBGene00200369	Y73F8A.1170
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200370	T04C12.27
No description available

WB:WBGene00200371	Y67D11A.4
No description available

WB:WBGene00200372	E01G6.7
No description available

WB:WBGene00200373	VC5.13
No description available

WB:WBGene00200374	Y66A7AL.8
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00200375	T24H10.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200376	Y51H7C.30
No description available

WB:WBGene00200377	F46H6.11
No description available

WB:WBGene00200378	F22B3.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200379	F13H6.26
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200380	F14H12.14
No description available

WB:WBGene00200381	F02E8.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200382	T24D5.10
No description available

WB:WBGene00200383	Y38F2AR.19
No description available

WB:WBGene00200384	C31H2.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200385	C06A12.18
No description available

WB:WBGene00200386	T27F7.8
No description available

WB:WBGene00200387	F36D1.20
No description available

WB:WBGene00200388	R05G6.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200389	T02E9.25
No description available

WB:WBGene00200390	R08B4.12
Is affected by cep-1 and elli-1 based on RNA-seq and microarray studies.

WB:WBGene00200391	C40H1.11
No description available

WB:WBGene00200392	K01A6.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200393	C04C11.16
No description available

WB:WBGene00200394	C38C5.3
No description available

WB:WBGene00200395	F11D5.26
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200396	ZK84.14
No description available

WB:WBGene00200397	ZK632.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200398	C33F10.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200399	F26A10.23
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200400	C16E9.21
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200401	C02B4.13
No description available

WB:WBGene00200402	2L52.2
No description available

WB:WBGene00200403	K07E12.5
No description available

WB:WBGene00200404	F16H6.12
No description available

WB:WBGene00200405	ZK617.20
No description available

WB:WBGene00200406	C04H5.10
No description available

WB:WBGene00200407	C14F11.26
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200408	ZC123.8
No description available

WB:WBGene00200409	C55H1.4
No description available

WB:WBGene00200410	C14F11.27
No description available

WB:WBGene00200411	F08F1.19
No description available

WB:WBGene00200412	W01C8.14
No description available

WB:WBGene00200413	C48D5.8
Is affected by ifo-1 based on microarray studies.

WB:WBGene00200414	C43D7.16
No description available

WB:WBGene00200415	B0244.14
No description available

WB:WBGene00200416	C33D12.14
No description available

WB:WBGene00200417	F56A6.6
No description available

WB:WBGene00200418	C05H8.4
No description available

WB:WBGene00200419	K08F8.14
No description available

WB:WBGene00200420	Y15E3A.11
No description available

WB:WBGene00200421	T06F4.15
No description available

WB:WBGene00200422	Y95B8A.15
No description available

WB:WBGene00200423	T11F9.27
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200424	H19M22.9
No description available

WB:WBGene00200425	T27F7.9
No description available

WB:WBGene00200426	C43H6.10
No description available

WB:WBGene00200427	W06D4.9
No description available

WB:WBGene00200428	C16C2.8
No description available

WB:WBGene00200429	C42D4.17
No description available

WB:WBGene00200430	W08D2.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200431	K09G1.6
No description available

WB:WBGene00200432	C13A10.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200433	K03H4.6
Is affected by dlc-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200434	Y56A3A.39
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200435	R10H1.8
No description available

WB:WBGene00200436	C34B4.15
No description available

WB:WBGene00200437	K05B2.8
No description available

WB:WBGene00200438	F10E9.17
No description available

WB:WBGene00200439	C09H10.16
No description available

WB:WBGene00200440	F55F3.7
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00200441	DY3.10
No description available

WB:WBGene00200442	Y54E10A.26
Is affected by cep-1; daf-2; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200443	C11H1.10
No description available

WB:WBGene00200444	C15B12.14
No description available

WB:WBGene00200445	Y105C5A.1278
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00200446	Y51H7C.31
No description available

WB:WBGene00200447	C05E11.15
Is affected by several genes including fbf-1; ins-11; and klf-1 based on RNA-seq studies.

WB:WBGene00200448	Y38F2AR.20
No description available

WB:WBGene00200449	H32C10.98
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00200450	C04C11.17
No description available

WB:WBGene00200451	H08J11.10
No description available

WB:WBGene00200452	F46G11.17
No description available

WB:WBGene00200453	C16E9.22
No description available

WB:WBGene00200454	F47A4.7
No description available

WB:WBGene00200455	R151.18
No description available

WB:WBGene00200456	T12B3.9
Is affected by cep-1; ins-11; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200457	Y105C5A.1279
Is affected by daf-2 and adr-1 based on microarray and RNA-seq studies.

WB:WBGene00200458	F11A1.13
No description available

WB:WBGene00200459	F38H4.15
Is affected by cep-1; dlc-1; and ints-4 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00200460	B0212.7
No description available

WB:WBGene00200461	C18F3.9
No description available

WB:WBGene00200462	B0310.9
No description available

WB:WBGene00200463	T13H10.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200464	T22B7.17
No description available

WB:WBGene00200465	C44B12.11
No description available

WB:WBGene00200466	Y59A8B.33
No description available

WB:WBGene00200467	W09D6.10
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00200468	F20B10.9
No description available

WB:WBGene00200469	F13A2.12
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00200470	Y54G9A.16
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200471	K04D7.16
No description available

WB:WBGene00200472	H03A11.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200473	R12G8.4
No description available

WB:WBGene00200474	W01A11.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200475	F29A7.9
Is affected by eat-2 based on microarray studies.

WB:WBGene00200476	C48D5.9
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00200477	Y47D3B.21
No description available

WB:WBGene00200478	Y73B6BL.282
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200479	F15A8.13
Is affected by pmt-2 based on microarray studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00200480	B0310.10
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00200481	T14B1.5
No description available

WB:WBGene00200482	F11A6.11
No description available

WB:WBGene00200483	Y32F6B.7
No description available

WB:WBGene00200484	T09E11.14
No description available

WB:WBGene00200485	ZK757.7
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00200486	C02C6.9
No description available

WB:WBGene00200487	K08A8.23
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00200488	C16B8.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200489	K08B5.7
No description available

WB:WBGene00200490	C08B6.17
Is affected by hmg-3; hmg-4; and spt-16 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200491	T06F4.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200492	ZK563.9
No description available

WB:WBGene00200493	K03H9.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00200494	D2089.7
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00200495	T05A6.17
No description available

WB:WBGene00200496	Y53C10A.21
No description available

WB:WBGene00200497	F22E12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200498	F46C8.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00200499	F10C1.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00200500	T21B10.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200501	R08B4.13
No description available

WB:WBGene00200502	C54D2.14
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00200503	F29G9.14
Is affected by several genes including sek-1; pgl-1; and alg-1 based on RNA-seq and microarray studies. Is affected by 4-bromodiphenyl ether; Cry5B; and glycine based on microarray and RNA-seq studies.

WB:WBGene00200504	T21H8.9
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00200505	C35A11.10
No description available

WB:WBGene00200506	ZC123.9
Is affected by cep-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00200507	C03C11.8
No description available

WB:WBGene00200508	F14F11.5
No description available

WB:WBGene00200509	Y16B4A.3
Is affected by daf-2 based on microarray studies.

WB:WBGene00200510	F40E3.9
No description available

WB:WBGene00200511	R04B3.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200512	Y51A2B.15
No description available

WB:WBGene00200513	C11E4.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200514	R07G3.14
No description available

WB:WBGene00200515	R02F11.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200516	C47G2.17
No description available

WB:WBGene00200517	W04G5.15
Is affected by eat-2 based on microarray studies.

WB:WBGene00200518	F38B6.17
No description available

WB:WBGene00200519	F13G3.14
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00200520	C13D9.13
No description available

WB:WBGene00200521	T09B4.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200522	R04F11.23
No description available

WB:WBGene00200523	Y75B8A.56
No description available

WB:WBGene00200524	F22B7.14
Is affected by emr-1 based on RNA-seq studies.

WB:WBGene00200525	R07H5.13
No description available

WB:WBGene00200526	C05B10.17
No description available

WB:WBGene00200527	T10C6.19
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00200528	R09G11.3
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200529	ZC53.15
No description available

WB:WBGene00200530	C16B8.10
Is affected by cep-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00200531	C43F9.18
No description available

WB:WBGene00200532	K08E7.12
No description available

WB:WBGene00200533	T11A5.10
No description available

WB:WBGene00200534	H13N06.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200535	F56F10.9
No description available

WB:WBGene00200536	C04C11.18
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200537	R11B5.10
No description available

WB:WBGene00200538	C08F8.13
No description available

WB:WBGene00200539	ZK638.1
Is affected by daf-2 based on microarray studies.

WB:WBGene00200540	F46F3.15
No description available

WB:WBGene00200541	ZK180.15
No description available

WB:WBGene00200542	T06E8.7
No description available

WB:WBGene00200543	C34E7.8
No description available

WB:WBGene00200544	F28F5.15
No description available

WB:WBGene00200545	K01A12.8
No description available

WB:WBGene00200546	C09B7.9
No description available

WB:WBGene00200547	F49E10.21
No description available

WB:WBGene00200548	F47C8.6
No description available

WB:WBGene00200549	H03E18.6
No description available

WB:WBGene00200550	B0207.16
No description available

WB:WBGene00200551	C04C11.19
No description available

WB:WBGene00200552	C03A3.6
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200553	C02B10.74
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200554	H08J11.11
No description available

WB:WBGene00200555	R153.5
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00200556	C54G4.14
No description available

WB:WBGene00200557	F35D2.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00200558	W02B8.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00200559	ZK180.16
No description available

WB:WBGene00200560	Y43H11AL.6
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00200561	C10C6.11
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200562	F13B9.10
Is affected by alg-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200563	F56E3.18
No description available

WB:WBGene00200564	W01G7.6
No description available

WB:WBGene00200565	F26D10.22
No description available

WB:WBGene00200566	F10E9.18
No description available

WB:WBGene00200567	K11G9.13
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200568	C29F7.9
No description available

WB:WBGene00200569	Y49G5B.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200570	F25B4.15
No description available

WB:WBGene00200571	ZK1025.18
No description available

WB:WBGene00200572	T21H3.9
No description available

WB:WBGene00200573	W06H8.14
Is affected by eat-2 based on microarray studies.

WB:WBGene00200574	F20B10.10
Is affected by Cry5B based on microarray studies.

WB:WBGene00200575	F44E7.15
Is affected by adr-1; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00200576	F53B1.13
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200577	Y65B4BL.12
Is affected by cep-1 and ints-4 based on RNA-seq studies.

WB:WBGene00200578	T21B6.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00200579	B0034.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200580	C28G1.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00200581	F58H1.24
No description available

WB:WBGene00200582	K12G11.12
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200583	F17H10.8
No description available

WB:WBGene00200584	B0334.19
No description available

WB:WBGene00200585	T26H10.8
No description available

WB:WBGene00200586	C09D8.12
No description available

WB:WBGene00200587	C18A3.22
No description available

WB:WBGene00200588	M60.13
Is affected by cep-1; hmg-3; and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200589	ZC504.16
No description available

WB:WBGene00200590	T05B11.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200591	F47F2.6
No description available

WB:WBGene00200592	Y40B10B.3
No description available

WB:WBGene00200593	F41E7.16
No description available

WB:WBGene00200594	B0350.76
Is enriched in NSM based on RNA-seq studies. Is affected by several genes including pgl-1; glh-1; and hpl-2 based on RNA-seq studies.

WB:WBGene00200595	C37E2.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00200596	C01B7.15
No description available

WB:WBGene00200597	F38B6.18
No description available

WB:WBGene00200598	C07G2.4
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200599	F45G2.12
No description available

WB:WBGene00200600	C08G9.9
No description available

WB:WBGene00200601	M117.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200602	C24A1.6
No description available

WB:WBGene00200603	ZK970.11
No description available

WB:WBGene00200604	F32A6.12
No description available

WB:WBGene00200605	F35G2.16
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00200606	Y37E3.29
No description available

WB:WBGene00200607	Y54G2A.67
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200608	Y39G10AL.5
No description available

WB:WBGene00200609	Y97E10B.13
No description available

WB:WBGene00200610	C44C11.5
No description available

WB:WBGene00200611	C33G3.11
No description available

WB:WBGene00200612	Y46G5A.45
Is affected by eat-2 based on microarray studies.

WB:WBGene00200613	C08C3.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200614	Y57G11C.1139
No description available

WB:WBGene00200615	M01E10.4
No description available

WB:WBGene00200616	F56B3.15
No description available

WB:WBGene00200617	B0495.21
No description available

WB:WBGene00200618	ZK809.14
No description available

WB:WBGene00200619	F01E11.14
No description available

WB:WBGene00200620	T22B2.10
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200621	F22B3.18
No description available

WB:WBGene00200622	F46F3.16
No description available

WB:WBGene00200623	T24A11.9
No description available

WB:WBGene00200624	F10F2.14
No description available

WB:WBGene00200625	F54E4.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00200626	C45B2.16
No description available

WB:WBGene00200627	K08B12.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200628	T22B7.18
No description available

WB:WBGene00200629	F49E12.14
No description available

WB:WBGene00200630	C06A6.14
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00200631	C02B8.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200632	F37B12.13
No description available

WB:WBGene00200633	C46G7.109
No description available

WB:WBGene00200634	T09B4.18
No description available

WB:WBGene00200635	ZK381.54
No description available

WB:WBGene00200636	ZC53.16
Is affected by eat-2 based on microarray studies.

WB:WBGene00200637	K01A2.15
No description available

WB:WBGene00200638	H39E23.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200639	ZK381.55
No description available

WB:WBGene00200640	Y41D4B.30
No description available

WB:WBGene00200641	T24F3.1
No description available

WB:WBGene00200642	T21B6.15
No description available

WB:WBGene00200643	F29G9.15
No description available

WB:WBGene00200644	ZK973.23
No description available

WB:WBGene00200645	R03E9.9
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00200646	C35C5.20
No description available

WB:WBGene00200647	E02A10.9
No description available

WB:WBGene00200648	T21G5.10
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00200649	ZK180.17
No description available

WB:WBGene00200650	T12A7.12
No description available

WB:WBGene00200651	ZC477.18
No description available

WB:WBGene00200652	C16H3.6
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200653	Y51H7BR.11
No description available

WB:WBGene00200654	F27C1.17
No description available

WB:WBGene00200655	K09H11.13
No description available

WB:WBGene00200656	C17D12.15
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200657	C29E6.15
No description available

WB:WBGene00200658	C14F5.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200659	F10D2.15
Is affected by Ethanol and multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00200660	W10G11.23
No description available

WB:WBGene00200661	C17D12.16
No description available

WB:WBGene00200662	F12F6.17
Is affected by several genes including emr-1; adr-1; and tdp-1 based on RNA-seq studies.

WB:WBGene00200663	R08E3.9
No description available

WB:WBGene00200664	F25B4.16
No description available

WB:WBGene00200665	Y34B4A.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200666	T01C3.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00200667	F56A12.9
Is affected by cep-1 and spt-16 based on RNA-seq studies.

WB:WBGene00200668	ZK39.12
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00200669	B0025.6
No description available

WB:WBGene00200670	F08C6.14
No description available

WB:WBGene00200671	F58E6.16
No description available

WB:WBGene00200672	R06C7.12
No description available

WB:WBGene00200673	ZK994.11
No description available

WB:WBGene00200674	T24D11.6
No description available

WB:WBGene00200675	E01G6.8
No description available

WB:WBGene00200676	Y59A8B.34
No description available

WB:WBGene00200677	C55A6.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200678	K07H8.16
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00200679	R07D5.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200680	F55D10.8
No description available

WB:WBGene00200681	Y38F2AL.10
No description available

WB:WBGene00200682	W07G1.18
No description available

WB:WBGene00200683	C09G5.11
No description available

WB:WBGene00200684	F25H8.21
Is expressed in amphid sheath cell; excretory duct; and phasmid socket cell.

WB:WBGene00200685	D2023.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200686	R11D1.14
No description available

WB:WBGene00200687	C31G12.14
No description available

WB:WBGene00200688	C36F7.21
Is affected by daf-2 based on microarray studies.

WB:WBGene00200689	F35G2.17
No description available

WB:WBGene00200690	C34E11.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200691	F46C8.20
No description available

WB:WBGene00200692	H03A11.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200693	ZK1025.19
No description available

WB:WBGene00200694	F18E9.11
No description available

WB:WBGene00200695	H14N18.7
No description available

WB:WBGene00200696	C17H11.9
No description available

WB:WBGene00200697	C41H7.10
No description available

WB:WBGene00200698	F11D5.27
Is affected by daf-2 based on microarray studies.

WB:WBGene00200699	K10D6.17
Is affected by chd-3 and let-418 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200700	F08B6.6
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200701	C05B10.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200702	C16A3.15
Is affected by ifo-1 based on microarray studies.

WB:WBGene00200703	Y51H7C.32
No description available

WB:WBGene00200704	ZC21.14
No description available

WB:WBGene00200705	Y71A12B.30
No description available

WB:WBGene00200706	K08E4.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200707	Y71G12B.37
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00200708	K11H3.12
No description available

WB:WBGene00200709	Y49E10.32
No description available

WB:WBGene00200710	CD4.15
No description available

WB:WBGene00200711	C54D2.15
Is affected by several genes including hpl-2; lem-2; and emr-1 based on RNA-seq studies.

WB:WBGene00200712	H24G06.3
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200713	T07F10.11
No description available

WB:WBGene00200714	ZK836.17
Is affected by daf-2 and ifo-1 based on microarray studies.

WB:WBGene00200715	K04F10.8
Is affected by several genes including pgl-1; cep-1; and sod-2 based on RNA-seq studies. Is affected by Rotenone based on RNA-seq studies.

WB:WBGene00200716	C18F3.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200717	F11C1.15
No description available

WB:WBGene00200718	F55G7.6
No description available

WB:WBGene00200719	K11C4.10
No description available

WB:WBGene00200720	C37A5.14
No description available

WB:WBGene00200721	C16E9.23
No description available

WB:WBGene00200722	F47B7.15
No description available

WB:WBGene00200723	T23E1.6
Is affected by dlc-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200724	F32G8.12
No description available

WB:WBGene00200725	Y39A3CL.14
No description available

WB:WBGene00200726	Y71F9AR.7
No description available

WB:WBGene00200727	F25H8.22
Is affected by daf-2 based on microarray studies.

WB:WBGene00200728	F45B8.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200729	C02H7.5
No description available

WB:WBGene00200730	C08G9.10
No description available

WB:WBGene00200731	F48C11.8
No description available

WB:WBGene00200732	BE0003N10.5
No description available

WB:WBGene00200733	C34F11.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200734	C29A12.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200735	C26G2.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200736	C18A3.23
No description available

WB:WBGene00200737	Y40C5A.21
No description available

WB:WBGene00200738	F45B8.19
No description available

WB:WBGene00200739	K02D3.4
Is affected by daf-2 and ifo-1 based on microarray studies.

WB:WBGene00200740	Y47C4A.3
No description available

WB:WBGene00200741	B0403.13
No description available

WB:WBGene00200742	K02A11.10
No description available

WB:WBGene00200743	C05A2.2
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200744	T22B2.11
No description available

WB:WBGene00200745	F15B9.14
No description available

WB:WBGene00200746	C27H6.10
No description available

WB:WBGene00200747	F52B10.19
Is affected by cep-1; adr-1; and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00200748	E02C12.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200749	F38A3.5
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200750	F20D1.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200751	B0478.25
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200752	ZK697.16
No description available

WB:WBGene00200753	F48D6.5
No description available

WB:WBGene00200754	F45D3.12
No description available

WB:WBGene00200755	F08G5.18
No description available

WB:WBGene00200756	H01A20.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200757	D1046.15
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200758	F35B12.16
No description available

WB:WBGene00200759	F11D11.20
No description available

WB:WBGene00200760	Y26D4A.24
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00200761	C02D4.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00200762	T28B11.19
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200763	Y37B11A.5
No description available

WB:WBGene00200764	W07G1.19
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200765	C25H3.19
No description available

WB:WBGene00200766	F09C3.9
No description available

WB:WBGene00200767	Y71H9A.8
No description available

WB:WBGene00200768	Y23H5A.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00200769	T28D6.14
No description available

WB:WBGene00200770	W06A7.10
No description available

WB:WBGene00200771	C18D1.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00200772	K07C5.16
No description available

WB:WBGene00200773	T10E9.13
No description available

WB:WBGene00200774	W02B12.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00200775	F57C7.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200776	F40G9.22
No description available

WB:WBGene00200777	C39D10.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00200778	T10H10.6
No description available

WB:WBGene00200779	F56A11.12
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00200780	C05E11.16
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200781	C53B7.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00200782	C39B10.11
No description available

WB:WBGene00200783	T14F9.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200784	K06A1.9
Is affected by ifo-1 based on microarray studies.

WB:WBGene00200785	C49A9.39
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00200786	H36N01.4
No description available

WB:WBGene00200787	T12A2.20
No description available

WB:WBGene00200788	ZK643.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00200789	C44E12.8
No description available

WB:WBGene00200790	C45G7.11
No description available

WB:WBGene00200791	M7.14
No description available

WB:WBGene00200792	C34H3.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00200793	F46F3.17
No description available

WB:WBGene00200794	F15G9.8
No description available

WB:WBGene00200795	C08B11.12
Is affected by adr-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200796	H22K11.12
No description available

WB:WBGene00200797	Y7A5A.18
No description available

WB:WBGene00200798	F26D11.18
No description available

WB:WBGene00200799	F44D12.18
No description available

WB:WBGene00200800	K02B2.37
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00200801	F09D5.8
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200802	F40H3.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200803	K03H9.13
No description available

WB:WBGene00200804	T27F7.10
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00200805	F57F4.7
No description available

WB:WBGene00200806	E01G6.9
Is affected by Cry5B based on microarray studies.

WB:WBGene00200807	F40B5.7
No description available

WB:WBGene00200808	B0034.16
No description available

WB:WBGene00200809	T04C12.28
Is affected by several genes including daf-2; cep-1; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00200810	Y53H1C.9
No description available

WB:WBGene00200811	C06B8.15
No description available

WB:WBGene00200812	C17C3.23
Is affected by daf-2 based on microarray studies.

WB:WBGene00200813	C01B9.6
No description available

WB:WBGene00200814	F28F9.14
No description available

WB:WBGene00200815	D1044.13
No description available

WB:WBGene00200816	Y42H9B.8
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200817	F44E5.12
No description available

WB:WBGene00200818	F31E8.18
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00200819	ZK381.56
Is affected by daf-2 based on microarray studies.

WB:WBGene00200820	Y50D7A.17
No description available

WB:WBGene00200821	T12C9.8
No description available

WB:WBGene00200822	F09F3.17
No description available

WB:WBGene00200823	Y54G2A.68
Is affected by daf-2 based on microarray studies.

WB:WBGene00200824	F08C6.15
No description available

WB:WBGene00200825	C25F6.23
No description available

WB:WBGene00200826	W06B11.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200827	F08H9.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200828	F13D11.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200829	F43D9.12
No description available

WB:WBGene00200830	T28B11.20
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq and microarray studies.

WB:WBGene00200831	C41G11.16
No description available

WB:WBGene00200832	T13A10.62
No description available

WB:WBGene00200833	D2092.14
No description available

WB:WBGene00200834	K02E2.15
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200835	H32C10.99
No description available

WB:WBGene00200836	C25F9.17
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200837	R04F11.24
No description available

WB:WBGene00200838	ZK596.4
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00200839	F53B3.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200840	R13H8.4
No description available

WB:WBGene00200841	C24H11.12
No description available

WB:WBGene00200842	C50C3.17
No description available

WB:WBGene00200843	C07H4.4
No description available

WB:WBGene00200844	F09G8.11
No description available

WB:WBGene00200845	ZC373.8
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00200846	F19C6.11
No description available

WB:WBGene00200847	T16A9.6
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies. Is affected by Ethanol; Tunicamycin; and Cry5B based on RNA-seq and microarray studies.

WB:WBGene00200848	Y51H7C.33
No description available

WB:WBGene00200849	R53.11
No description available

WB:WBGene00200850	C18H7.16
No description available

WB:WBGene00200851	D2045.10
No description available

WB:WBGene00200852	E01G6.10
No description available

WB:WBGene00200853	C29H12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200854	C01H6.10
No description available

WB:WBGene00200855	cTel52S.1
No description available

WB:WBGene00200856	Y75B8A.57
No description available

WB:WBGene00200857	ZK470.12
No description available

WB:WBGene00200858	F28C1.14
No description available

WB:WBGene00200859	K10D6.18
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200860	F54A5.5
No description available

WB:WBGene00200861	F28A12.6
No description available

WB:WBGene00200862	R02D5.20
Is affected by cep-1 and pgrn-1 based on RNA-seq studies.

WB:WBGene00200863	Y69E1A.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200864	Y59A8B.35
No description available

WB:WBGene00200865	F28F9.15
No description available

WB:WBGene00200866	F47E1.14
No description available

WB:WBGene00200867	C04A2.10
No description available

WB:WBGene00200868	F26D12.100
No description available

WB:WBGene00200869	F09E8.11
No description available

WB:WBGene00200870	F42G4.10
Is affected by emr-1; lem-2; and cep-1 based on RNA-seq studies.

WB:WBGene00200871	C09B9.83
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200872	W03G11.19
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00200873	Y53F4B.61
No description available

WB:WBGene00200874	C04A2.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00200875	C13C4.10
No description available

WB:WBGene00200876	C16C8.24
No description available

WB:WBGene00200877	F39B1.4
Is affected by pmt-2 based on microarray studies.

WB:WBGene00200878	Y47G6A.35
Is enriched in AFD; ASER; and PLM based on RNA-seq studies.

WB:WBGene00200879	C52E4.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00200880	ZK377.11
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200881	Y73B6BL.283
No description available

WB:WBGene00200882	R09A8.7
No description available

WB:WBGene00200883	F45D3.13
No description available

WB:WBGene00200884	F25D1.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200885	T21B4.19
No description available

WB:WBGene00200886	F22F7.10
No description available

WB:WBGene00200887	Y51H7C.34
No description available

WB:WBGene00200888	R05D7.9
No description available

WB:WBGene00200889	K03C7.13
No description available

WB:WBGene00200890	C50B8.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200891	F25H10.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00200892	Y43F8B.26
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00200893	F52D10.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200894	C28A5.12
No description available

WB:WBGene00200895	C29H12.12
No description available

WB:WBGene00200896	F42H10.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00200897	B0491.11
No description available

WB:WBGene00200898	B0350.77
No description available

WB:WBGene00200899	F14D12.12
No description available

WB:WBGene00200900	F10D11.7
No description available

WB:WBGene00200901	ZK899.11
No description available

WB:WBGene00200902	Y119D3B.27
No description available

WB:WBGene00200903	K04C2.10
Is affected by eat-2 based on microarray studies.

WB:WBGene00200904	F54G8.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00200905	F59F5.9
No description available

WB:WBGene00200906	F15A8.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200907	W09C2.11
No description available

WB:WBGene00200908	K07F5.20
Is affected by pmt-2 based on microarray studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00200909	H08J11.12
Is affected by ifo-1 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200910	F11A6.12
No description available

WB:WBGene00200911	Y37A1B.336
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200912	T04F3.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00200913	F56F3.12
No description available

WB:WBGene00200914	F22B7.15
No description available

WB:WBGene00200915	ZK525.8
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200916	F46F3.18
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00200917	Y70C5A.5
No description available

WB:WBGene00200918	T09A12.6
No description available

WB:WBGene00200919	T04C9.11
Is affected by smg-2 based on RNA-seq studies.

WB:WBGene00200920	F29F11.15
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00200921	F45D3.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200922	T07F10.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200923	W05E10.17
No description available

WB:WBGene00200924	F35C12.5
Is enriched in AFD and ASER based on RNA-seq studies.

WB:WBGene00200925	H13N06.11
No description available

WB:WBGene00200926	K11C4.11
No description available

WB:WBGene00200927	Y116A8C.466
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200928	K10C2.11
No description available

WB:WBGene00200929	T06E4.18
Is affected by zip-3 based on RNA-seq studies.

WB:WBGene00200930	F17E5.5
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200931	W07G4.11
No description available

WB:WBGene00200932	F53B7.13
No description available

WB:WBGene00200933	C42D8.18
No description available

WB:WBGene00200934	C48A7.14
No description available

WB:WBGene00200935	F56E3.19
No description available

WB:WBGene00200936	T07D10.11
No description available

WB:WBGene00200937	F57C7.13
No description available

WB:WBGene00200938	K07E12.6
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200939	F10F2.15
No description available

WB:WBGene00200940	K08F4.14
No description available

WB:WBGene00200941	T25C12.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200942	R10E12.9
No description available

WB:WBGene00200943	F58F6.10
No description available

WB:WBGene00200944	ZK836.18
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00200945	Y48C3A.23
No description available

WB:WBGene00200946	T05B9.3
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00200947	F57F10.5
No description available

WB:WBGene00200948	Y42H9B.9
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00200949	C40C9.15
No description available

WB:WBGene00200950	T06H11.19
No description available

WB:WBGene00200951	R13H4.12
No description available

WB:WBGene00200952	C27C12.9
No description available

WB:WBGene00200953	T22C1.15
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00200954	C37E2.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00200955	B0454.21
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00200956	C15C7.11
No description available

WB:WBGene00200957	T02G6.12
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00200958	C11G10.13
No description available

WB:WBGene00200959	C14F11.28
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00200960	R10E11.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00200961	F26A10.24
No description available

WB:WBGene00200962	C01B10.46
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200963	C01B12.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00200964	Y97E10B.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200965	C45B2.17
No description available

WB:WBGene00200966	R13A1.16
No description available

WB:WBGene00200967	C13C4.11
No description available

WB:WBGene00200968	B0001.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200969	B0273.113
No description available

WB:WBGene00200970	F17B5.11
No description available

WB:WBGene00200971	T01B10.13
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00200972	T22B7.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200973	F25F2.5
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00200974	W04E12.12
No description available

WB:WBGene00200975	T13H10.16
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00200976	K10D6.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200977	T28B4.13
No description available

WB:WBGene00200978	M6.10
No description available

WB:WBGene00200979	K10D6.20
No description available

WB:WBGene00200980	K03B8.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200981	F35E12.12
Is affected by cep-1 and spt-16 based on RNA-seq studies.

WB:WBGene00200982	C06E7.92
No description available

WB:WBGene00200983	W01H2.9
No description available

WB:WBGene00200984	F07A11.13
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00200985	W04A4.8
No description available

WB:WBGene00200986	C15C8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00200987	F46A9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200988	C40H5.16
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00200989	ZK682.12
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00200990	F12D9.15
No description available

WB:WBGene00200991	C26E6.14
No description available

WB:WBGene00200992	C09D1.5
No description available

WB:WBGene00200993	C32A9.4
No description available

WB:WBGene00200994	F32B5.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00200995	F57G12.11
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00200996	ZK675.7
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00200997	C52E12.9
No description available

WB:WBGene00200998	ZK662.8
Is affected by several genes including daf-2; cep-1; and smg-2 based on RNA-seq and microarray studies.

WB:WBGene00200999	Y34B4A.17
No description available

WB:WBGene00201000	ZC53.17
No description available

WB:WBGene00201001	F11H8.8
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00201002	T28B11.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201003	C25B8.11
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00201004	R193.5
No description available

WB:WBGene00201005	M04B2.11
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00201006	C56E10.6
No description available

WB:WBGene00201007	Y80E2A.2
No description available

WB:WBGene00201008	R173.11
No description available

WB:WBGene00201009	W03G11.20
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00201010	T27A10.11
No description available

WB:WBGene00201011	F35E8.20
No description available

WB:WBGene00201012	T04C12.29
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201013	Y87G2A.23
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201014	T19A5.12
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00201015	T12G3.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201016	T09F5.18
No description available

WB:WBGene00201017	F08A8.10
No description available

WB:WBGene00201018	F56C11.7
No description available

WB:WBGene00201019	Y71F9B.22
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201020	K04A8.16
No description available

WB:WBGene00201021	Y47D3B.22
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201022	Y69A2AR.43
No description available

WB:WBGene00201023	F07C6.7
No description available

WB:WBGene00201024	C53C9.5
No description available

WB:WBGene00201025	R186.13
No description available

WB:WBGene00201026	T24B8.20
No description available

WB:WBGene00201027	K12F2.5
No description available

WB:WBGene00201028	T03G6.6
No description available

WB:WBGene00201029	Y39G8C.11
No description available

WB:WBGene00201030	C06E7.93
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201031	ZK792.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201032	Y39D8B.5
No description available

WB:WBGene00201033	B0395.9
No description available

WB:WBGene00201034	F57B7.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00201035	C52G5.9
Is affected by pmt-2 based on microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00201036	M03E7.8
No description available

WB:WBGene00201037	R08E3.10
No description available

WB:WBGene00201038	Y41G9A.15
No description available

WB:WBGene00201039	F40E10.13
No description available

WB:WBGene00201040	C30D11.4
No description available

WB:WBGene00201041	T28C12.12
No description available

WB:WBGene00201042	T02C5.7
No description available

WB:WBGene00201043	F16H11.6
No description available

WB:WBGene00201044	R12H7.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201045	ZK867.19
No description available

WB:WBGene00201046	Y67D2.8
Is enriched in AFD and ASER based on RNA-seq studies. Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00201047	F43C9.7
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201048	F09G8.12
No description available

WB:WBGene00201049	T05B4.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00201050	F41D9.13
No description available

WB:WBGene00201051	Y47D3B.23
No description available

WB:WBGene00201052	R09E10.14
No description available

WB:WBGene00201053	B0454.22
No description available

WB:WBGene00201054	C29A12.19
No description available

WB:WBGene00201055	C29A12.20
No description available

WB:WBGene00201056	C34D1.13
No description available

WB:WBGene00201057	F08G5.19
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201058	C06H2.10
No description available

WB:WBGene00201059	cTel7X.3
No description available

WB:WBGene00201060	K10G6.7
No description available

WB:WBGene00201061	F54D12.19
No description available

WB:WBGene00201062	C54G10.5
No description available

WB:WBGene00201063	T06D8.15
No description available

WB:WBGene00201064	B0302.7
Is affected by adr-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00201065	C34D10.4
No description available

WB:WBGene00201066	F29F11.16
No description available

WB:WBGene00201067	W07G1.20
No description available

WB:WBGene00201068	C49A1.17
No description available

WB:WBGene00201069	F22A3.16
No description available

WB:WBGene00201070	F25H10.9
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00201071	C28F5.6
No description available

WB:WBGene00201072	F32B6.14
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00201073	F54H5.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201074	F54H5.10
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00201075	F25D7.9
No description available

WB:WBGene00201076	F35G2.18
No description available

WB:WBGene00201077	T10B10.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00201078	C49F8.12
No description available

WB:WBGene00201079	K04B12.7
No description available

WB:WBGene00201080	F57G12.12
No description available

WB:WBGene00201081	K02H8.5
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201082	F47C8.7
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by procyanidin based on microarray studies.

WB:WBGene00201083	F59D12.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00201084	T23D8.10
No description available

WB:WBGene00201085	R04F11.25
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00201086	Y102A11A.14
Is affected by Cry5B based on microarray studies.

WB:WBGene00201087	T07F12.10
No description available

WB:WBGene00201088	R11G1.9
No description available

WB:WBGene00201089	Y40C7B.8
No description available

WB:WBGene00201090	ZC21.15
No description available

WB:WBGene00201091	Y40C5A.22
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201092	F48B9.11
No description available

WB:WBGene00201093	Y46E12BL.9
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00201094	W04D2.12
No description available

WB:WBGene00201095	F15A2.12
No description available

WB:WBGene00201096	F56F4.11
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201097	F19G12.13
Is affected by hmg-3 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201098	T21C9.16
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00201099	K02E10.11
No description available

WB:WBGene00201100	C32D5.19
No description available

WB:WBGene00201101	Y105E8A.47
No description available

WB:WBGene00201102	C40H1.12
Is affected by nanoparticle and Tunicamycin based on microarray studies.

WB:WBGene00201103	C01C4.6
Is affected by daf-2 based on microarray studies.

WB:WBGene00201104	ZC247.6
No description available

WB:WBGene00201105	C24H12.14
No description available

WB:WBGene00201106	F48C1.14
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00201107	C36F7.22
No description available

WB:WBGene00201108	B0350.78
Is enriched in AVK based on RNA-seq studies. Is affected by pmt-2 based on microarray studies.

WB:WBGene00201109	C46G7.110
No description available

WB:WBGene00201110	T21B6.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201111	C36E8.10
Is affected by several genes including eat-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00201112	W01C8.15
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00201113	T06F4.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201114	C01B10.47
Is affected by emr-1; lem-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00201115	C05C9.13
No description available

WB:WBGene00201116	C16E9.24
No description available

WB:WBGene00201117	C06A8.15
No description available

WB:WBGene00201118	R09H10.11
No description available

WB:WBGene00201119	W01A11.15
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201120	R07B1.22
No description available

WB:WBGene00201121	T01H3.9
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00201122	B0454.23
No description available

WB:WBGene00201123	Y42A5A.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201124	F40E10.14
No description available

WB:WBGene00201125	F17A9.7
Is affected by smg-2; spt-16; and adr-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00201126	C15C7.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201127	K02A6.5
No description available

WB:WBGene00201128	C34G6.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201129	M02F4.11
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201130	K10D6.21
No description available

WB:WBGene00201131	R153.6
No description available

WB:WBGene00201132	C45B2.18
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00201133	F35G2.19
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201134	H32K16.3
No description available

WB:WBGene00201135	E01G6.11
No description available

WB:WBGene00201136	C24A8.12
No description available

WB:WBGene00201137	C02G6.5
Is affected by cep-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00201138	T21B10.13
No description available

WB:WBGene00201139	F20B10.11
No description available

WB:WBGene00201140	C50E10.14
No description available

WB:WBGene00201141	Y76B12C.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201142	C11D2.100
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201143	F43C9.8
No description available

WB:WBGene00201145	F47F6.12
No description available

WB:WBGene00201146	K08A8.24
No description available

WB:WBGene00201147	Y53H1C.10
No description available

WB:WBGene00201148	R04F11.26
No description available

WB:WBGene00201149	B0457.15
Is affected by eat-2 based on microarray studies.

WB:WBGene00201150	ZK757.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201151	Y57G11C.1140
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00201152	C10A4.11
No description available

WB:WBGene00201153	C44B7.20
Is affected by several genes including daf-2; eat-2; and adr-1 based on RNA-seq and microarray studies.

WB:WBGene00201154	B0212.8
No description available

WB:WBGene00201155	VF23B12L.1
No description available

WB:WBGene00201156	C25F6.24
No description available

WB:WBGene00201157	Y49E10.33
No description available

WB:WBGene00201158	F38B6.19
No description available

WB:WBGene00201159	W05E10.18
No description available

WB:WBGene00201160	T05A8.10
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201161	K03H6.11
No description available

WB:WBGene00201162	F43G9.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00201163	ZC53.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201164	T28B8.9
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201165	Y110A7A.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201166	B0350.79
Is affected by several genes including pgl-1; alg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201167	C02D4.15
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201168	B0457.16
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201169	F31B12.8
Is affected by ifo-1 based on microarray studies.

WB:WBGene00201170	Y53C10A.22
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00201171	C46F11.8
No description available

WB:WBGene00201172	C27C7.11
No description available

WB:WBGene00201173	C33G3.12
No description available

WB:WBGene00201174	F22F1.9
No description available

WB:WBGene00201175	C18A11.13
No description available

WB:WBGene00201176	B0310.11
No description available

WB:WBGene00201177	ZC53.19
No description available

WB:WBGene00201178	F38B6.20
No description available

WB:WBGene00201179	F19B6.8
No description available

WB:WBGene00201180	B0563.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00201181	C16C2.9
No description available

WB:WBGene00201182	T14B4.16
No description available

WB:WBGene00201183	F12F6.18
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201184	C43D7.17
No description available

WB:WBGene00201185	F58E6.17
No description available

WB:WBGene00201186	R03D7.14
No description available

WB:WBGene00201187	C54G4.15
No description available

WB:WBGene00201188	DY3.11
No description available

WB:WBGene00201189	Y57A10B.10
No description available

WB:WBGene00201190	W03D8.12
Is affected by eat-2 based on microarray studies.

WB:WBGene00201191	F57G4.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00201192	F16A11.9
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201193	F25F1.4
No description available

WB:WBGene00201194	C09D8.13
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201195	Y113G7A.20
No description available

WB:WBGene00201196	F46E10.15
Is affected by cep-1; hpl-2; and dlc-1 based on RNA-seq studies.

WB:WBGene00201197	F17A2.15
No description available

WB:WBGene00201198	C36E6.11
No description available

WB:WBGene00201199	Y55F3BR.16
No description available

WB:WBGene00201200	C10C5.11
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00201201	C01G12.14
No description available

WB:WBGene00201202	T24D1.6
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201203	C06G1.16
No description available

WB:WBGene00201204	F15A2.13
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201205	K05B2.9
No description available

WB:WBGene00201206	K09E9.12
Is enriched in AFD; ASER; and PLM based on RNA-seq studies. Is affected by daf-16 based on RNA-seq studies.

WB:WBGene00201207	Y71H9A.9
No description available

WB:WBGene00201208	F08F3.16
No description available

WB:WBGene00201209	F32B4.10
No description available

WB:WBGene00201210	F26F12.20
No description available

WB:WBGene00201211	T23E1.7
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201212	K02A4.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201213	F41E7.17
No description available

WB:WBGene00201214	F55C10.11
No description available

WB:WBGene00201215	C11E4.13
No description available

WB:WBGene00201216	F54D12.20
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00201217	R02F11.8
No description available

WB:WBGene00201218	C16B8.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00201219	W08D2.13
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00201220	F15A8.15
Is affected by hmg-3 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201221	T25D10.8
No description available

WB:WBGene00201222	C27C7.12
No description available

WB:WBGene00201223	F10E9.19
No description available

WB:WBGene00201224	F46G11.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201225	T02E1.11
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00201226	F26G1.13
No description available

WB:WBGene00201227	C11H1.11
No description available

WB:WBGene00201228	M79.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201229	C18D1.19
No description available

WB:WBGene00201230	F59D6.10
No description available

WB:WBGene00201231	F14D12.13
No description available

WB:WBGene00201232	H24G06.4
No description available

WB:WBGene00201233	T01G5.10
No description available

WB:WBGene00201234	D1014.11
No description available

WB:WBGene00201235	K06G5.9
No description available

WB:WBGene00201236	F59C12.10
No description available

WB:WBGene00201237	C38D4.11
No description available

WB:WBGene00201238	ZK180.18
No description available

WB:WBGene00201239	F57G12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201240	Y51H7C.35
No description available

WB:WBGene00201241	F11A1.14
No description available

WB:WBGene00201242	F29G9.16
No description available

WB:WBGene00201243	F46F3.19
No description available

WB:WBGene00201244	T25D10.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201245	F56D1.13
No description available

WB:WBGene00201246	T18H9.10
Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00201247	F31E8.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201248	T23F2.11
No description available

WB:WBGene00201249	F35C11.12
No description available

WB:WBGene00201250	C09H10.17
No description available

WB:WBGene00201251	T07D1.11
No description available

WB:WBGene00201252	F37C12.22
Is affected by daf-2 based on microarray studies.

WB:WBGene00201253	K08A8.25
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201254	C16E9.25
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201255	W10C8.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201256	K03H9.14
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00201257	F58H1.25
No description available

WB:WBGene00201258	Y66D12A.29
Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00201259	F01E11.15
No description available

WB:WBGene00201260	Y76F7A.5
No description available

WB:WBGene00201261	R144.16
Is affected by daf-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201262	T10H10.7
No description available

WB:WBGene00201263	T05A6.18
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00201264	C12D8.24
Is affected by Tunicamycin and Cry5B based on microarray studies.

WB:WBGene00201265	C41G11.17
No description available

WB:WBGene00201266	Y73B6BL.284
No description available

WB:WBGene00201267	T05A6.19
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00201268	F09C8.5
No description available

WB:WBGene00201269	R01H5.1
No description available

WB:WBGene00201270	F15C11.6
Is affected by Cry5B based on microarray studies.

WB:WBGene00201271	Y75B8A.58
No description available

WB:WBGene00201272	T13H10.17
No description available

WB:WBGene00201273	F46B6.15
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00201274	Y95B8A.16
Is affected by cep-1 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201275	C52G5.10
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201276	C47G2.18
No description available

WB:WBGene00201277	C30C11.11
No description available

WB:WBGene00201278	R04D3.13
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00201279	C44C10.14
No description available

WB:WBGene00201280	F56D1.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201281	F26A10.25
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201282	F38E11.24
No description available

WB:WBGene00201283	C47E8.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00201284	F55C12.14
No description available

WB:WBGene00201285	T20G5.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00201286	F32D8.17
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00201287	H06I04.13
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00201288	T05H4.16
No description available

WB:WBGene00201289	C11E4.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00201290	Y43F8A.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201291	K08B4.41
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201292	C35A11.11
No description available

WB:WBGene00201293	F57B1.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201294	F55C12.15
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201295	F46F6.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00201296	F47E1.15
No description available

WB:WBGene00201297	F53B1.14
No description available

WB:WBGene00201298	ZK1193.10
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00201299	F10C1.18
No description available

WB:WBGene00201300	Y54E10A.27
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201301	C10F3.15
Is affected by cep-1 and alg-1 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00201302	F19D8.6
No description available

WB:WBGene00201303	F33A8.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201304	K08A8.26
No description available

WB:WBGene00201305	F56F3.13
Is affected by mafr-1 based on microarray studies.

WB:WBGene00201306	F57F10.6
No description available

WB:WBGene00201307	C48C5.9
No description available

WB:WBGene00201308	F47F2.7
No description available

WB:WBGene00201309	K10D6.22
Is affected by daf-2 based on microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201310	C39H7.70
No description available

WB:WBGene00201311	F34H10.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201312	T01B4.8
No description available

WB:WBGene00201313	F09F9.16
No description available

WB:WBGene00201314	F31F6.15
Is affected by prg-1 and spt-16 based on RNA-seq studies.

WB:WBGene00201315	C16B8.12
No description available

WB:WBGene00201316	C47C12.9
No description available

WB:WBGene00201317	F11A6.13
No description available

WB:WBGene00201318	F52F12.17
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201319	ZK858.9
No description available

WB:WBGene00201320	R07E4.10
No description available

WB:WBGene00201321	F53B1.15
No description available

WB:WBGene00201322	ZK353.12
No description available

WB:WBGene00201323	C10G6.52
No description available

WB:WBGene00201324	H09G03.3
No description available

WB:WBGene00201325	T01C2.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201326	ZC53.20
No description available

WB:WBGene00201327	T14B4.17
No description available

WB:WBGene00201328	Y105C5B.1416
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00201329	F02C12.9
No description available

WB:WBGene00201330	T14E8.6
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00201331	K07A3.4
No description available

WB:WBGene00201332	F16B3.4
No description available

WB:WBGene00201333	H40L08.5
No description available

WB:WBGene00201334	T10A3.5
No description available

WB:WBGene00201335	Y73B6BL.285
Is affected by cep-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00201336	F53B6.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00201337	T10C6.20
No description available

WB:WBGene00201338	C54D2.16
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201339	R03H10.10
No description available

WB:WBGene00201340	C52B9.17
No description available

WB:WBGene00201341	C49C3.22
No description available

WB:WBGene00201342	R07H5.14
Is affected by ifo-1 based on microarray studies.

WB:WBGene00201343	C15H9.13
No description available

WB:WBGene00201344	Y51A2D.36
No description available

WB:WBGene00201345	F09F3.18
No description available

WB:WBGene00201346	R11B5.11
No description available

WB:WBGene00201347	ZK938.9
No description available

WB:WBGene00201348	F28B12.5
No description available

WB:WBGene00201349	R10E12.10
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00201350	C28G1.8
No description available

WB:WBGene00201351	Y51F10.13
No description available

WB:WBGene00201352	C02B4.14
No description available

WB:WBGene00201353	T20B5.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201354	Y51A2D.37
No description available

WB:WBGene00201355	Y7A5A.19
No description available

WB:WBGene00201356	ZK617.21
No description available

WB:WBGene00201357	F58A4.22
No description available

WB:WBGene00201358	F46F3.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201359	F52B10.20
No description available

WB:WBGene00201360	C04C11.20
No description available

WB:WBGene00201361	F54E4.15
No description available

WB:WBGene00201362	C36C9.8
No description available

WB:WBGene00201363	Y73F8A.1171
No description available

WB:WBGene00201364	F11D5.28
No description available

WB:WBGene00201365	ZK930.12
No description available

WB:WBGene00201366	T01C8.10
Is affected by cep-1; adr-1; and pmt-2 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201367	R03C1.6
No description available

WB:WBGene00201368	ZK643.12
No description available

WB:WBGene00201369	F55F3.8
No description available

WB:WBGene00201370	C07A12.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00201371	T19H12.14
No description available

WB:WBGene00201372	W06H8.15
Is affected by several genes including cep-1; hpl-2; and let-418 based on RNA-seq studies.

WB:WBGene00201373	Y38E10A.31
Is affected by elli-1 based on microarray studies.

WB:WBGene00201374	C10C6.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201375	C05A9.7
No description available

WB:WBGene00201376	Y67D8C.18
No description available

WB:WBGene00201377	T19D2.10
No description available

WB:WBGene00201378	F13D11.18
No description available

WB:WBGene00201379	F14H12.15
No description available

WB:WBGene00201380	F10C1.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00201381	C08G5.9
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00201382	C07A12.15
No description available

WB:WBGene00201383	F25D7.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201384	B0222.14
No description available

WB:WBGene00201385	F10E9.20
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201386	Y4C6B.100
No description available

WB:WBGene00201387	H19M22.10
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201388	ZC64.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201389	ZK637.20
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00201390	T28D9.15
No description available

WB:WBGene00201391	C54E4.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00201392	K03A11.8
No description available

WB:WBGene00201393	C36F7.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201394	F55A8.6
No description available

WB:WBGene00201395	Y62F5A.15
No description available

WB:WBGene00201396	R08C7.18
No description available

WB:WBGene00201397	F46B6.16
No description available

WB:WBGene00201398	F31C3.16
Is affected by several genes including atfs-1; adr-1; and tdp-1 based on RNA-seq studies.

WB:WBGene00201399	F09C12.13
No description available

WB:WBGene00201400	R09E10.15
Is affected by lem-2 based on RNA-seq studies.

WB:WBGene00201401	T28B11.22
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201402	C06E4.19
No description available

WB:WBGene00201403	LLC1.120
No description available

WB:WBGene00201404	T24D8.14
No description available

WB:WBGene00201405	Y51H7D.1
No description available

WB:WBGene00201406	AH10.9
No description available

WB:WBGene00201407	T26C12.9
No description available

WB:WBGene00201408	T09B9.8
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00201409	C56A3.14
No description available

WB:WBGene00201410	ZC190.15
No description available

WB:WBGene00201411	F56E3.20
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201412	Y67D8C.19
No description available

WB:WBGene00201413	T01B6.10
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00201414	C52A10.4
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201415	Y15E3A.12
No description available

WB:WBGene00201416	C39D10.16
No description available

WB:WBGene00201417	F11D5.29
No description available

WB:WBGene00201418	C24H11.13
No description available

WB:WBGene00201419	K08B12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201420	T27B1.7
No description available

WB:WBGene00201421	C18B12.15
No description available

WB:WBGene00201422	W04D2.13
No description available

WB:WBGene00201423	ZK546.20
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00201424	VC5.14
No description available

WB:WBGene00201425	F14F3.16
No description available

WB:WBGene00201426	C14F11.29
Is affected by Cry5B based on microarray studies.

WB:WBGene00201427	F55G1.20
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq and microarray studies.

WB:WBGene00201428	F33H1.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201429	F45H7.14
Is affected by ifo-1 based on microarray studies.

WB:WBGene00201430	Y50D4C.10
No description available

WB:WBGene00201431	F02E8.10
No description available

WB:WBGene00201432	F42D1.13
No description available

WB:WBGene00201433	R153.7
No description available

WB:WBGene00201434	C47A10.14
No description available

WB:WBGene00201435	C10G11.15
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201436	ZC123.10
No description available

WB:WBGene00201437	F31B12.9
No description available

WB:WBGene00201438	F44E5.13
No description available

WB:WBGene00201439	C33F10.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201440	K02F2.9
No description available

WB:WBGene00201441	F22B3.19
No description available

WB:WBGene00201442	T22B7.20
No description available

WB:WBGene00201443	ZK617.22
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201444	B0213.25
No description available

WB:WBGene00201445	F02E8.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00201446	F56F10.10
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201447	T05C7.3
No description available

WB:WBGene00201448	R06C1.13
Is affected by several genes including pgl-1; alg-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201449	F56A6.7
No description available

WB:WBGene00201450	F46C3.9
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201451	ZK863.11
No description available

WB:WBGene00201452	F21H12.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201453	W02G9.7
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00201454	C31G12.15
No description available

WB:WBGene00201455	ZK39.13
No description available

WB:WBGene00201456	Y65B4BR.10
Is affected by nhr-86 based on RNA-seq studies.

WB:WBGene00201457	W01A11.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201458	VF15C11L.2
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00201459	F12A10.11
No description available

WB:WBGene00201460	Y43H11AL.7
No description available

WB:WBGene00201461	W06F12.7
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies. Is affected by nanoparticle based on microarray studies.

WB:WBGene00201462	H32C10.100
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201463	Y69H2.24
No description available

WB:WBGene00201464	T24A11.10
No description available

WB:WBGene00201465	C26F1.14
No description available

WB:WBGene00201466	C32A3.6
Is affected by several genes including pgl-1; cep-1; and prg-1 based on RNA-seq studies.

WB:WBGene00201467	F36H12.65
No description available

WB:WBGene00201468	C09B8.17
No description available

WB:WBGene00201469	Y59A8B.36
No description available

WB:WBGene00201470	T01A4.5
No description available

WB:WBGene00201471	Y97E10AL.5
No description available

WB:WBGene00201472	F49E10.22
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00201473	R02D5.21
Is affected by cep-1; dpy-21; and alg-1 based on RNA-seq studies.

WB:WBGene00201474	K07E12.7
No description available

WB:WBGene00201475	C52G5.11
No description available

WB:WBGene00201476	B0524.9
No description available

WB:WBGene00201477	F08G5.20
No description available

WB:WBGene00201478	D2005.9
No description available

WB:WBGene00201479	ZC449.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201480	C32A9.5
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201481	C15B12.15
No description available

WB:WBGene00201482	T11F9.28
No description available

WB:WBGene00201483	T12C9.9
No description available

WB:WBGene00201484	F36D1.21
No description available

WB:WBGene00201485	F40F4.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201486	C14F11.30
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201487	B0350.80
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201488	K09A11.10
Is affected by several genes including daf-2; pmt-2; and ifo-1 based on RNA-seq and microarray studies. Is affected by 4-bromodiphenyl ether based on microarray studies.

WB:WBGene00201489	C16E9.26
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201490	F13B12.14
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00201491	F47F6.13
No description available

WB:WBGene00201492	C25F6.25
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201493	C09B7.10
No description available

WB:WBGene00201494	H27M09.7
Is affected by rsr-2 based on RNA-seq studies.

WB:WBGene00201495	T27F7.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00201496	F56H11.12
No description available

WB:WBGene00201497	Y17G7B.24
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00201498	T22D1.21
No description available

WB:WBGene00201499	K07A3.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00201500	C15C7.13
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201501	F38A6.7
No description available

WB:WBGene00201502	F57B7.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201503	C25F6.26
Is affected by cep-1 and alg-1 based on RNA-seq studies.

WB:WBGene00201504	K01A12.9
No description available

WB:WBGene00201505	C34F11.17
No description available

WB:WBGene00201506	C25F6.27
No description available

WB:WBGene00201507	K03H4.7
Is affected by cep-1; dlc-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201508	F37D6.11
No description available

WB:WBGene00201509	F09D5.9
No description available

WB:WBGene00201510	C05E7.6
No description available

WB:WBGene00201511	Y46E12A.9
No description available

WB:WBGene00201512	K06C4.24
Is affected by daf-2 based on microarray studies.

WB:WBGene00201513	ZK1290.22
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201514	R107.11
No description available

WB:WBGene00201515	K01A6.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201516	F45B8.20
No description available

WB:WBGene00201517	ZC247.7
No description available

WB:WBGene00201518	C26G2.10
No description available

WB:WBGene00201519	C18H2.7
No description available

WB:WBGene00201520	Y17G9A.89
No description available

WB:WBGene00201521	K02A4.12
No description available

WB:WBGene00201522	F16F9.17
No description available

WB:WBGene00201523	M01A8.3
No description available

WB:WBGene00201524	T01C1.11
No description available

WB:WBGene00201525	K08A8.27
No description available

WB:WBGene00201526	T14F9.19
No description available

WB:WBGene00201527	C07E3.16
No description available

WB:WBGene00201528	F35D2.15
No description available

WB:WBGene00201529	M70.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00201530	F29F11.17
No description available

WB:WBGene00201531	T06F4.18
No description available

WB:WBGene00201532	C06E4.20
No description available

WB:WBGene00201533	T01H10.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201534	Y48G8AR.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201535	ZK381.57
No description available

WB:WBGene00201536	F13A2.13
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00201537	K01D12.18
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00201538	C55A6.19
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201539	M01A8.4
No description available

WB:WBGene00201540	C54D2.17
No description available

WB:WBGene00201541	H14A12.9
No description available

WB:WBGene00201542	Y51B9A.13
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00201543	F43B10.4
No description available

WB:WBGene00201544	F12D9.16
No description available

WB:WBGene00201545	K02A2.9
No description available

WB:WBGene00201546	C35B1.10
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201547	F54H12.9
Is affected by daf-2 based on microarray studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201548	Y37D8A.28
No description available

WB:WBGene00201549	F35D2.16
Is affected by several genes including daf-2; pgl-1; and glh-1 based on RNA-seq and microarray studies.

WB:WBGene00201550	C05B10.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00201551	C02C6.10
No description available

WB:WBGene00201552	F28D1.21
No description available

WB:WBGene00201553	F45B8.21
No description available

WB:WBGene00201554	Y46E12A.10
No description available

WB:WBGene00201555	C29E6.16
No description available

WB:WBGene00201556	D1022.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00201557	C03A3.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201558	F02A9.9
No description available

WB:WBGene00201559	F11D5.30
No description available

WB:WBGene00201560	F23H12.19
No description available

WB:WBGene00201561	C15H7.9
No description available

WB:WBGene00201562	T19D7.10
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201563	F46F3.21
Is affected by several genes including eat-2; cep-1; and let-418 based on RNA-seq and microarray studies.

WB:WBGene00201564	F13D11.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201565	C27H6.11
No description available

WB:WBGene00201566	C04D8.4
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201567	ZK40.8
No description available

WB:WBGene00201568	Y73B6BL.286
Is affected by daf-2 based on microarray studies.

WB:WBGene00201569	F32B5.15
No description available

WB:WBGene00201570	F09E5.22
No description available

WB:WBGene00201571	C34F11.18
No description available

WB:WBGene00201572	R04D3.14
Is affected by daf-2; eat-2; and pmt-2 based on microarray studies.

WB:WBGene00201573	T06A4.6
No description available

WB:WBGene00201574	Y67D8C.20
No description available

WB:WBGene00201575	F46E10.16
No description available

WB:WBGene00201576	C49H3.15
No description available

WB:WBGene00201577	T14F9.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201578	M04B2.12
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00201579	C55H1.5
No description available

WB:WBGene00201580	F08F1.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201581	F33G12.9
No description available

WB:WBGene00201582	F47F2.8
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201583	C24B5.9
No description available

WB:WBGene00201584	F16F9.18
No description available

WB:WBGene00201585	T05G5.16
No description available

WB:WBGene00201586	T04C12.30
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00201587	ZK867.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00201588	Y71F9AR.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201589	D1081.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201590	F38B6.21
No description available

WB:WBGene00201591	F18A11.12
No description available

WB:WBGene00201592	B0350.81
No description available

WB:WBGene00201593	C42D8.19
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201594	C07H6.18
No description available

WB:WBGene00201595	F22F1.10
No description available

WB:WBGene00201596	C29H12.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201597	Y102A11A.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201598	H30A04.11
No description available

WB:WBGene00201599	ZK836.19
Is affected by ifo-1 based on microarray studies.

WB:WBGene00201600	K02B2.38
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00201601	Y97E10AM.3
No description available

WB:WBGene00201602	F42C5.16
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 and ints-5 based on RNA-seq studies.

WB:WBGene00201603	ZK563.10
No description available

WB:WBGene00201604	C05A9.8
No description available

WB:WBGene00201605	F15G9.9
No description available

WB:WBGene00201606	C30C11.12
No description available

WB:WBGene00201607	C45G7.12
No description available

WB:WBGene00201608	Y50D7A.18
No description available

WB:WBGene00201609	F59F5.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00201610	T24D8.15
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201611	F25F8.6
No description available

WB:WBGene00201612	F09G2.12
No description available

WB:WBGene00201613	E01G6.12
No description available

WB:WBGene00201614	C34H3.21
No description available

WB:WBGene00201615	R52.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201616	Y17D7B.13
No description available

WB:WBGene00201617	F52C9.10
No description available

WB:WBGene00201618	R09A8.8
No description available

WB:WBGene00201619	C50B6.15
No description available

WB:WBGene00201620	C53B7.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201621	F58F12.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201622	T13A10.63
No description available

WB:WBGene00201623	ZK131.14
Is affected by elli-1 and adr-1 based on microarray and RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201624	C47G2.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00201625	F45D3.15
Is affected by daf-2 and eat-2 based on microarray studies. Is affected by Tunicamycin and Cadmium Chloride based on microarray and RNA-seq studies.

WB:WBGene00201626	F17C11.21
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201627	Y71F9AR.9
No description available

WB:WBGene00201628	C33G3.13
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201629	C41H7.11
No description available

WB:WBGene00201630	C28F5.7
No description available

WB:WBGene00201631	F22B7.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201632	F48C5.8
No description available

WB:WBGene00201633	F13D11.20
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00201634	C18F3.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201636	F10E9.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201637	C54E4.9
No description available

WB:WBGene00201638	F53H4.7
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00201639	Y54F10AM.14
No description available

WB:WBGene00201640	C09G12.19
Is affected by hpl-2 based on RNA-seq studies.

WB:WBGene00201641	F46F6.6
No description available

WB:WBGene00201642	C08B11.13
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201643	K06C4.25
No description available

WB:WBGene00201644	F31E8.20
No description available

WB:WBGene00201645	F16F9.19
No description available

WB:WBGene00201646	ZC412.13
Is affected by several genes including daf-2; hpl-2; and pmt-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and nanoparticle based on RNA-seq and microarray studies.

WB:WBGene00201647	F54D12.21
No description available

WB:WBGene00201648	C18F3.12
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201649	H30A04.12
No description available

WB:WBGene00201650	Y54G2A.69
No description available

WB:WBGene00201651	W07E11.7
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00201652	T14B4.18
No description available

WB:WBGene00201653	F25H8.23
No description available

WB:WBGene00201654	K11C4.12
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00201655	C39D10.17
Is affected by daf-2 based on microarray studies.

WB:WBGene00201656	CE7X_3.3
Is affected by mafr-1 based on microarray studies.

WB:WBGene00201657	C55A6.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201658	F42H10.16
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201659	Y116A8B.97
No description available

WB:WBGene00201660	R03E9.10
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201661	W02G9.8
No description available

WB:WBGene00201662	ZC308.6
Is affected by chd-3; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00201663	Y39A3A.9
No description available

WB:WBGene00201664	C27H6.12
No description available

WB:WBGene00201665	W09G3.15
No description available

WB:WBGene00201666	VK10D6R.2
No description available

WB:WBGene00201667	T06A4.7
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201668	T07H3.9
No description available

WB:WBGene00201669	cTel29B.2
No description available

WB:WBGene00201670	Y48B6A.23
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201671	Y55F3BR.17
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00201672	C49F8.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201673	F49E10.23
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00201674	C06A8.16
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00201675	R153.8
No description available

WB:WBGene00201676	M05B5.10
No description available

WB:WBGene00201677	F55C5.16
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201678	R13H8.5
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201679	R02D5.22
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00201680	K06A1.10
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00201681	Y53F4A.5
No description available

WB:WBGene00201682	ZK973.24
Is affected by daf-2 based on microarray studies.

WB:WBGene00201683	F09G8.13
No description available

WB:WBGene00201684	Y69A2AR.44
Is affected by adr-1 based on RNA-seq studies. Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201685	C53C9.6
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201686	F54C4.7
No description available

WB:WBGene00201687	C03A3.8
No description available

WB:WBGene00201688	Y71A12B.31
No description available

WB:WBGene00201689	C04D8.5
No description available

WB:WBGene00201690	F25H8.24
No description available

WB:WBGene00201691	Y43F8B.27
No description available

WB:WBGene00201692	R01E6.18
No description available

WB:WBGene00201693	Y38F2AL.11
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201694	C24A11.13
No description available

WB:WBGene00201695	CD4.16
No description available

WB:WBGene00201696	Y39G8B.12
No description available

WB:WBGene00201697	B0212.9
No description available

WB:WBGene00201698	ZK867.21
No description available

WB:WBGene00201699	ZC477.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00201700	F38B6.22
No description available

WB:WBGene00201701	Y49F6A.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00201702	C15H7.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00201703	R08B4.14
No description available

WB:WBGene00201704	ZK945.15
No description available

WB:WBGene00201705	F08C6.16
No description available

WB:WBGene00201706	F55D10.9
No description available

WB:WBGene00201707	M01G4.7
No description available

WB:WBGene00201708	Y51H7C.36
No description available

WB:WBGene00201709	Y43F8A.10
No description available

WB:WBGene00201710	C01H6.11
No description available

WB:WBGene00201711	M04B2.13
No description available

WB:WBGene00201712	B0403.14
No description available

WB:WBGene00201713	Y49E10.34
No description available

WB:WBGene00201714	C02C6.11
No description available

WB:WBGene00201715	W09C2.12
No description available

WB:WBGene00201716	C05C12.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201717	C41G11.18
Is enriched in NSM based on RNA-seq studies. Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00201718	F14H12.16
No description available

WB:WBGene00201719	K11H3.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00201720	F46C8.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201721	F52H2.13
No description available

WB:WBGene00201722	E02A10.10
No description available

WB:WBGene00201723	C37A5.15
No description available

WB:WBGene00201724	Y108G3AL.8
No description available

WB:WBGene00201725	R90.12
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201726	ZK381.58
No description available

WB:WBGene00201727	T07F12.11
No description available

WB:WBGene00201728	Y51H7C.37
No description available

WB:WBGene00201729	C16E9.27
Is affected by tdp-1; hpl-2; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201730	F38A6.8
No description available

WB:WBGene00201731	Y67D8A.9
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201732	F28F5.16
No description available

WB:WBGene00201733	R12H7.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201734	ZK154.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00201735	C04A2.12
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00201736	F11D5.31
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201737	F32B4.11
No description available

WB:WBGene00201738	W07G1.21
No description available

WB:WBGene00201739	F58B4.11
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00201740	C41G11.19
No description available

WB:WBGene00201741	R08E3.11
No description available

WB:WBGene00201742	ZC21.16
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00201743	K09H11.14
Is affected by hmg-3; hmg-4; and spt-16 based on RNA-seq studies.

WB:WBGene00201744	B0495.22
No description available

WB:WBGene00201745	C14F5.11
No description available

WB:WBGene00201746	F15A8.16
Is affected by tdp-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00201747	ZC477.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201748	F40H3.16
No description available

WB:WBGene00201749	T12E12.44
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201750	W01A11.17
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201751	W08F4.19
No description available

WB:WBGene00201752	F44E5.14
Is affected by dlc-1; pmt-2; and nhr-86 based on RNA-seq and microarray studies.

WB:WBGene00201753	H36N01.5
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201754	ZK484.10
Is affected by pmt-2 and ifo-1 based on microarray studies.

WB:WBGene00201755	C37A2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201756	C34H3.22
No description available

WB:WBGene00201757	C25H3.20
No description available

WB:WBGene00201758	Y59A8B.37
No description available

WB:WBGene00201759	M176.14
No description available

WB:WBGene00201760	F56A11.13
No description available

WB:WBGene00201761	F42A9.14
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201762	ZK377.12
No description available

WB:WBGene00201763	W03G1.10
No description available

WB:WBGene00201764	ZC412.14
No description available

WB:WBGene00201765	C10H11.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201766	K08B4.42
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00201767	Y39A3CL.15
No description available

WB:WBGene00201768	K02A11.11
No description available

WB:WBGene00201769	F09C12.14
No description available

WB:WBGene00201770	C12D8.25
No description available

WB:WBGene00201771	F48D6.6
No description available

WB:WBGene00201772	Y73B3A.28
Is affected by Ethanol based on RNA-seq studies.

WB:WBGene00201773	F42G2.10
No description available

WB:WBGene00201774	K10C8.5
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201775	F08G5.21
No description available

WB:WBGene00201776	C54E10.9
No description available

WB:WBGene00201777	Y48G8AL.19
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201778	H01A20.5
No description available

WB:WBGene00201779	Y34B4A.18
No description available

WB:WBGene00201780	Y73B3A.29
No description available

WB:WBGene00201781	Y37H2A.17
No description available

WB:WBGene00201782	Y26D4A.25
No description available

WB:WBGene00201783	R10D12.19
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201784	C09B7.11
No description available

WB:WBGene00201785	Y116F11B.23
No description available

WB:WBGene00201786	F20D1.20
No description available

WB:WBGene00201787	K07C5.17
No description available

WB:WBGene00201788	T28D6.15
Is affected by cep-1 and spt-16 based on RNA-seq studies.

WB:WBGene00201789	F11C1.16
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201790	T24D11.7
No description available

WB:WBGene00201791	R07D5.9
No description available

WB:WBGene00201792	T06H11.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00201793	E01H11.5
No description available

WB:WBGene00201794	Y105E8A.48
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00201795	C25E10.15
No description available

WB:WBGene00201796	F02G3.7
No description available

WB:WBGene00201797	T02E9.26
No description available

WB:WBGene00201798	F25G6.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00201799	T01C1.12
No description available

WB:WBGene00201800	C24A8.13
No description available

WB:WBGene00201801	F55D12.8
No description available

WB:WBGene00201802	Y80D3A.15
No description available

WB:WBGene00201803	C55A6.21
No description available

WB:WBGene00201804	C05A2.3
No description available

WB:WBGene00201805	F52E1.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00201806	W01A11.18
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00201807	F28A12.7
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00201808	C34F6.16
No description available

WB:WBGene00201809	W05E10.19
No description available

WB:WBGene00201810	C43D7.18
No description available

WB:WBGene00201811	Y15E3A.13
No description available

WB:WBGene00201812	T14F9.21
No description available

WB:WBGene00201813	B0310.12
Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00201814	F30H5.8
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201815	B0457.17
No description available

WB:WBGene00201816	M04D5.6
No description available

WB:WBGene00201817	ZK669.9
No description available

WB:WBGene00201818	R186.14
Is affected by eat-2 based on microarray studies.

WB:WBGene00201819	C30D11.5
No description available

WB:WBGene00201820	F54H5.11
No description available

WB:WBGene00201821	W06F12.8
No description available

WB:WBGene00201822	M03E7.9
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201823	C01C4.7
No description available

WB:WBGene00201824	F46A9.11
No description available

WB:WBGene00201825	F57G12.14
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201826	F13H10.11
No description available

WB:WBGene00201827	F26D11.19
No description available

WB:WBGene00201828	Y15E3A.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201829	Y8G1A.3
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201830	Y54G2A.70
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00201831	Y60A9A.6
No description available

WB:WBGene00201832	ZC449.10
No description available

WB:WBGene00201833	F54E4.16
Is affected by Cry5B based on microarray studies.

WB:WBGene00201834	T09F5.19
No description available

WB:WBGene00201835	F49E10.24
No description available

WB:WBGene00201836	F13D11.21
No description available

WB:WBGene00201837	F47B7.16
No description available

WB:WBGene00201838	C26E6.15
No description available

WB:WBGene00201839	F22B5.12
No description available

WB:WBGene00201840	F57C7.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201841	F57A10.9
No description available

WB:WBGene00201842	Y40C5A.23
No description available

WB:WBGene00201843	C34D1.14
No description available

WB:WBGene00201844	R31.5
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201845	ZK813.10
No description available

WB:WBGene00201846	Y46E12A.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201847	T28C12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201848	R11E3.16
No description available

WB:WBGene00201849	ZK617.23
No description available

WB:WBGene00201850	F32A6.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201851	B0496.19
No description available

WB:WBGene00201852	ZK662.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00201853	ZK867.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201854	F57F4.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00201855	C01B7.16
No description available

WB:WBGene00201856	Y76A2B.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201857	T28C12.14
No description available

WB:WBGene00201858	W04D2.14
Is affected by cep-1 and hmg-3 based on RNA-seq studies.

WB:WBGene00201859	F52H2.14
No description available

WB:WBGene00201860	F18E2.14
No description available

WB:WBGene00201861	B0395.10
No description available

WB:WBGene00201862	K03F8.4
No description available

WB:WBGene00201863	T28B4.14
No description available

WB:WBGene00201864	F54H5.12
Is affected by cep-1 and ifo-1 based on RNA-seq and microarray studies.

WB:WBGene00201865	F31E8.21
No description available

WB:WBGene00201866	F09D5.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201867	C15A7.7
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00201868	W01A11.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201869	ZC247.8
No description available

WB:WBGene00201870	F12D9.17
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201871	T24B8.21
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201872	C06E7.94
Is affected by emr-1 and lem-2 based on RNA-seq studies.

WB:WBGene00201873	H14N18.8
No description available

WB:WBGene00201874	T28B11.23
Is affected by daf-2 based on microarray studies.

WB:WBGene00201875	F28H7.12
No description available

WB:WBGene00201876	F39C12.8
No description available

WB:WBGene00201877	R11G1.10
No description available

WB:WBGene00201878	C39E9.19
No description available

WB:WBGene00201879	W07G4.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201880	T10B10.15
No description available

WB:WBGene00201881	R01E6.19
No description available

WB:WBGene00201882	T21C12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201883	R04F11.27
No description available

WB:WBGene00201884	W06B11.11
No description available

WB:WBGene00201885	Y46E12BR.2
No description available

WB:WBGene00201886	Y40C7B.9
No description available

WB:WBGene00201887	C53C7.8
No description available

WB:WBGene00201888	Y39G8C.12
No description available

WB:WBGene00201889	C26E6.16
No description available

WB:WBGene00201890	Y39G10AL.6
No description available

WB:WBGene00201891	W03G11.21
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00201892	K02H8.6
Is affected by several genes including daf-2; eat-2; and pgl-1 based on RNA-seq and microarray studies.

WB:WBGene00201893	F15A2.14
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00201894	F41D9.14
No description available

WB:WBGene00201895	R08E3.12
No description available

WB:WBGene00201896	Y67D2.9
No description available

WB:WBGene00201897	F01G10.20
No description available

WB:WBGene00201898	VC5.15
No description available

WB:WBGene00201899	C30B5.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201900	T21C9.17
No description available

WB:WBGene00201901	T09B4.19
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201902	F29F11.18
No description available

WB:WBGene00201903	F22A3.17
No description available

WB:WBGene00201904	C29A12.21
No description available

WB:WBGene00201905	C25B8.12
No description available

WB:WBGene00201906	W01H2.10
No description available

WB:WBGene00201907	F58H1.26
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201908	F09C8.6
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201909	C04C11.21
No description available

WB:WBGene00201910	B0280.20
No description available

WB:WBGene00201911	F43E12.7
No description available

WB:WBGene00201912	T06F4.19
No description available

WB:WBGene00201913	2RSSE.8
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201914	Y69E1A.14
No description available

WB:WBGene00201915	F35G2.20
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00201916	C48B6.13
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00201917	Y57E12B.9
No description available

WB:WBGene00201918	T06D8.16
No description available

WB:WBGene00201919	T28B11.24
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201920	C33D12.15
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00201921	C05A9.9
No description available

WB:WBGene00201922	ZC21.17
No description available

WB:WBGene00201923	K10D6.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201924	F45H7.15
No description available

WB:WBGene00201925	C04F1.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00201926	F52F12.18
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00201927	Y87G2A.24
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00201928	F59B10.9
No description available

WB:WBGene00201929	F25H8.25
No description available

WB:WBGene00201930	C18D1.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201931	W06G6.19
No description available

WB:WBGene00201932	C16H3.7
No description available

WB:WBGene00201933	F22E12.12
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201934	C52D10.130
No description available

WB:WBGene00201935	mir-8210
No description available

WB:WBGene00201936	K10D6.24
Is affected by cep-1 and dlc-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00201937	C29H12.14
No description available

WB:WBGene00201938	K09C6.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00201939	W05E10.20
No description available

WB:WBGene00201940	F46F3.22
No description available

WB:WBGene00201941	C37E2.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201942	F12F6.19
No description available

WB:WBGene00201943	F13D11.22
Is affected by daf-2 based on microarray studies.

WB:WBGene00201944	F54D5.22
No description available

WB:WBGene00201945	C09B9.84
No description available

WB:WBGene00201946	F26A10.26
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201947	F41H8.5
No description available

WB:WBGene00201948	ZC250.11
No description available

WB:WBGene00201949	F45D3.16
No description available

WB:WBGene00201950	F09E5.23
No description available

WB:WBGene00201951	F25H10.10
No description available

WB:WBGene00201952	F46F3.23
No description available

WB:WBGene00201953	K06A5.10
Is affected by nanoparticle based on microarray studies.

WB:WBGene00201954	ZC506.9
No description available

WB:WBGene00201955	ZK470.13
No description available

WB:WBGene00201956	T04C9.12
No description available

WB:WBGene00201957	K10C9.12
No description available

WB:WBGene00201958	F56C3.12
No description available

WB:WBGene00201959	C14F11.31
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201960	C05E11.17
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00201961	C08A9.12
No description available

WB:WBGene00201962	T23F11.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201963	Y37A1B.337
No description available

WB:WBGene00201964	F25D1.11
Is affected by cep-1; tdp-1; and ints-4 based on RNA-seq studies.

WB:WBGene00201965	F10D11.8
No description available

WB:WBGene00201966	C37H5.16
No description available

WB:WBGene00201967	F17E5.6
No description available

WB:WBGene00201968	VC5.16
No description available

WB:WBGene00201969	H03A11.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00201970	ZK899.12
No description available

WB:WBGene00201971	T06D8.17
No description available

WB:WBGene00201972	T26H2.16
No description available

WB:WBGene00201973	Y105E8A.49
No description available

WB:WBGene00201974	T07D10.12
No description available

WB:WBGene00201975	K02E10.12
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00201976	Y47H9C.20
No description available

WB:WBGene00201977	C01G12.15
No description available

WB:WBGene00201978	R03A10.13
No description available

WB:WBGene00201979	K04C2.11
No description available

WB:WBGene00201980	K08A8.28
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201981	F10F2.16
Is affected by tdp-1 based on RNA-seq studies.

WB:WBGene00201982	C04A2.13
No description available

WB:WBGene00201983	F11H8.9
No description available

WB:WBGene00201984	Y42H9B.10
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00201985	Y65A5A.27
No description available

WB:WBGene00201986	ZK370.11
No description available

WB:WBGene00201987	F35B12.17
No description available

WB:WBGene00201988	C44B7.21
Is affected by pmt-2 based on microarray studies.

WB:WBGene00201989	F43G9.20
No description available

WB:WBGene00201990	Y92C3A.8
No description available

WB:WBGene00201991	C07G1.14
Is affected by several genes including eat-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00201992	C13C12.6
Is affected by hpl-2 and hmg-3 based on RNA-seq studies.

WB:WBGene00201993	C27C12.10
No description available

WB:WBGene00201994	T25C12.10
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00201995	K12G11.13
No description available

WB:WBGene00201996	F47F2.9
No description available

WB:WBGene00201997	T27F2.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00201998	K11C4.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00201999	F54C8.11
No description available

WB:WBGene00202000	Y38F1A.13
Is affected by chd-3 and let-418 based on RNA-seq studies.

WB:WBGene00202001	ZK721.6
No description available

WB:WBGene00202002	C34E11.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202003	W04E12.13
No description available

WB:WBGene00202004	C47G2.20
No description available

WB:WBGene00202005	W06A7.11
No description available

WB:WBGene00202006	C13C4.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202007	Y67A6A.3
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00202008	B0478.26
No description available

WB:WBGene00202009	K08D9.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202010	C09B8.18
No description available

WB:WBGene00202011	R13H4.13
Is affected by pmt-2 based on microarray studies.

WB:WBGene00202012	F09B9.7
No description available

WB:WBGene00202013	Y73F8A.1172
Is affected by pmt-2 based on microarray studies.

WB:WBGene00202014	Y38F2AR.21
No description available

WB:WBGene00202015	C50C3.18
No description available

WB:WBGene00202016	C48A7.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202017	F36H1.16
No description available

WB:WBGene00202018	B0454.24
No description available

WB:WBGene00202019	Y104H12D.9
No description available

WB:WBGene00202020	F52B10.21
No description available

WB:WBGene00202021	C14F11.32
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202022	F40F9.16
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00202023	F44A2.11
No description available

WB:WBGene00202024	VK04G11.2
No description available

WB:WBGene00202025	T28B8.10
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00202026	C04A2.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202027	F32A7.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202028	F46G11.19
No description available

WB:WBGene00202029	K03C7.14
Is affected by several genes including daf-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00202030	C24F3.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00202031	C11E4.15
No description available

WB:WBGene00202032	T26H10.9
No description available

WB:WBGene00202033	K01C8.11
No description available

WB:WBGene00202034	T23F2.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202035	K02A4.13
No description available

WB:WBGene00202036	F46F6.7
No description available

WB:WBGene00202037	W09C2.13
No description available

WB:WBGene00202038	C34F6.17
No description available

WB:WBGene00202039	F52F12.19
No description available

WB:WBGene00202040	C27C7.13
No description available

WB:WBGene00202041	Y69A2AR.45
No description available

WB:WBGene00202042	F19D8.7
No description available

WB:WBGene00202043	ZK180.19
No description available

WB:WBGene00202044	F46G11.20
No description available

WB:WBGene00202045	ZK757.9
No description available

WB:WBGene00202046	F43D9.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00202047	F59D6.11
No description available

WB:WBGene00202048	M117.13
No description available

WB:WBGene00202049	F33C8.8
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00202050	M79.15
No description available

WB:WBGene00202051	C14H10.5
No description available

WB:WBGene00202052	C41G11.20
Is affected by cep-1; daf-2; and unc-70 based on RNA-seq and microarray studies.

WB:WBGene00202053	T04C12.31
No description available

WB:WBGene00202054	F57B7.14
No description available

WB:WBGene00202055	ZK993.4
No description available

WB:WBGene00202056	R03A10.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202057	C10G11.16
No description available

WB:WBGene00202058	F13H6.27
No description available

WB:WBGene00202059	C06G1.17
No description available

WB:WBGene00202060	F45B8.22
No description available

WB:WBGene00202061	F56D1.15
Is affected by dlc-1 and klf-1 based on RNA-seq studies.

WB:WBGene00202062	F15A8.17
No description available

WB:WBGene00202063	W10C8.16
No description available

WB:WBGene00202064	C44B12.12
No description available

WB:WBGene00202065	K02B9.9
No description available

WB:WBGene00202066	F56F3.14
Is affected by cep-1; alg-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00202067	T05B11.12
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00202068	F01E11.16
No description available

WB:WBGene00202069	T20G5.17
Is enriched in muscle cell based on RNA-seq studies. Is affected by alg-1 and daf-12 based on RNA-seq studies.

WB:WBGene00202070	R01H5.2
No description available

WB:WBGene00202071	T09D3.12
No description available

WB:WBGene00202072	ZK381.59
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202073	Y105C5A.1280
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00202074	T28B11.25
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00202075	D1073.3
No description available

WB:WBGene00202076	K04A8.17
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00202077	F46B6.17
No description available

WB:WBGene00202078	F38G1.5
No description available

WB:WBGene00202079	F38E11.25
No description available

WB:WBGene00202080	C10F3.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202081	F08C6.17
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00202082	F55C12.16
Is affected by ifo-1 based on microarray studies.

WB:WBGene00202083	F54F3.6
Is affected by ifo-1 based on microarray studies.

WB:WBGene00202084	C51E3.11
No description available

WB:WBGene00202085	F15C11.7
No description available

WB:WBGene00202086	F45E10.3
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00202087	K04G2.15
No description available

WB:WBGene00202088	C05D12.11
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00202089	T01G1.7
No description available

WB:WBGene00202090	F59C12.11
No description available

WB:WBGene00202091	K08A8.29
No description available

WB:WBGene00202092	F53B1.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00202093	ZC123.11
No description available

WB:WBGene00202094	Y75B8A.59
No description available

WB:WBGene00202095	K02A4.14
No description available

WB:WBGene00202096	Y66A7AL.9
No description available

WB:WBGene00202097	C05B10.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202098	C29F4.7
No description available

WB:WBGene00202099	C02E7.17
No description available

WB:WBGene00202100	K02A4.15
No description available

WB:WBGene00202101	Y39A3CR.10
No description available

WB:WBGene00202102	D1053.7
No description available

WB:WBGene00202103	F22B3.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202104	ZK563.11
No description available

WB:WBGene00202105	F55C12.17
No description available

WB:WBGene00202106	C09B7.12
No description available

WB:WBGene00202107	F44B9.11
No description available

WB:WBGene00202108	F23B12.10
Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00202109	F59B10.10
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00202110	M01D7.10
No description available

WB:WBGene00202111	C31G12.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00202112	T27B1.8
No description available

WB:WBGene00202113	B0457.18
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00202114	R07G3.15
No description available

WB:WBGene00202115	F34H10.8
No description available

WB:WBGene00202116	C50E10.15
No description available

WB:WBGene00202117	Y92C3A.9
No description available

WB:WBGene00202118	K02A2.10
No description available

WB:WBGene00202119	K06G5.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00202120	C43H6.11
No description available

WB:WBGene00202121	C10G6.53
No description available

WB:WBGene00202122	F29G9.17
No description available

WB:WBGene00202123	K08E7.13
No description available

WB:WBGene00202124	F22E12.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202125	T09A5.21
No description available

WB:WBGene00202126	Y51H7C.38
No description available

WB:WBGene00202127	C47G2.21
No description available

WB:WBGene00202128	F32H5.8
Is affected by cyc-1 based on microarray studies.

WB:WBGene00202129	C09G5.12
No description available

WB:WBGene00202130	C31H5.9
No description available

WB:WBGene00202131	T06E4.19
No description available

WB:WBGene00202132	C16B8.13
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00202133	C51E3.12
Is affected by cep-1 and pmt-2 based on RNA-seq and microarray studies.

WB:WBGene00202134	C11E4.16
No description available

WB:WBGene00202135	B0563.17
No description available

WB:WBGene00202136	F25D7.11
No description available

WB:WBGene00202137	Y54E10A.28
No description available

WB:WBGene00202138	C50E10.16
No description available

WB:WBGene00202139	C24H12.15
No description available

WB:WBGene00202140	F47C8.8
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00202141	R06B10.8
No description available

WB:WBGene00202142	C36F7.24
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202143	Y38A10A.10
No description available

WB:WBGene00202144	C24A1.7
No description available

WB:WBGene00202145	W02B8.13
No description available

WB:WBGene00202146	F48B9.12
No description available

WB:WBGene00202147	F41C6.14
No description available

WB:WBGene00202148	F32B5.16
Is affected by lem-2 based on RNA-seq studies.

WB:WBGene00202149	F10E9.22
No description available

WB:WBGene00202150	F33C8.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00202151	W05E10.21
No description available

WB:WBGene00202152	C31H5.10
No description available

WB:WBGene00202153	F39B1.5
No description available

WB:WBGene00202154	K07C6.17
No description available

WB:WBGene00202155	C36F7.25
Is affected by daf-2 based on microarray studies.

WB:WBGene00202156	C34G6.13
No description available

WB:WBGene00202157	EGAP3.4
No description available

WB:WBGene00202158	R10E12.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202159	K03H9.15
No description available

WB:WBGene00202160	K08A8.30
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00202161	C04E6.14
No description available

WB:WBGene00202162	Y53H1C.11
No description available

WB:WBGene00202163	F44A2.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202164	F47F6.14
No description available

WB:WBGene00202165	R05G9.4
No description available

WB:WBGene00202166	B0350.82
No description available

WB:WBGene00202167	T21B6.17
No description available

WB:WBGene00202168	F43C9.9
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00202169	F28F5.17
Is affected by pmt-2 based on microarray studies.

WB:WBGene00202170	C31H5.11
No description available

WB:WBGene00202171	F20B10.12
Is affected by Cry5B based on microarray studies.

WB:WBGene00202172	T06F4.20
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00202173	F53B6.11
No description available

WB:WBGene00202174	C10A4.12
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00202175	F11A6.14
No description available

WB:WBGene00202176	H08J11.13
No description available

WB:WBGene00202177	VC5.17
No description available

WB:WBGene00202178	F38A6.9
Is affected by let-418 based on RNA-seq studies.

WB:WBGene00202179	Y57G11C.1141
No description available

WB:WBGene00202180	B0350.83
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202181	C17H11.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202182	F40F11.5
No description available

WB:WBGene00202183	C34E11.19
No description available

WB:WBGene00202184	C11D2.101
No description available

WB:WBGene00202185	F41E7.18
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00202186	C10F3.17
No description available

WB:WBGene00202187	M01E10.5
Is affected by daf-2 based on microarray studies.

WB:WBGene00202188	F45F2.16
No description available

WB:WBGene00202189	Y67D2.10
No description available

WB:WBGene00202190	C33D12.16
No description available

WB:WBGene00202191	C28G1.9
No description available

WB:WBGene00202192	C23H4.13
No description available

WB:WBGene00202193	Y51H7C.39
No description available

WB:WBGene00202194	R13A5.16
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00202195	T27D1.4
No description available

WB:WBGene00202196	C09D8.14
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00202197	F43E12.8
No description available

WB:WBGene00202198	C04C11.22
No description available

WB:WBGene00202199	F38B6.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202200	F47F2.10
No description available

WB:WBGene00202201	K03B8.23
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00202202	Y48C3A.24
No description available

WB:WBGene00202203	C54E4.10
No description available

WB:WBGene00202204	K06A4.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00202205	W04G3.15
Is affected by Tunicamycin based on microarray studies.

WB:WBGene00202206	C03B1.16
No description available

WB:WBGene00202207	F26F2.12
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00202208	Y113G7A.21
No description available

WB:WBGene00202209	Y41D4B.31
No description available

WB:WBGene00202210	Y39G8C.13
No description available

WB:WBGene00202211	T22B7.21
No description available

WB:WBGene00202212	C09D8.15
Is affected by several genes including pgl-1; cep-1; and glh-1 based on RNA-seq studies.

WB:WBGene00202213	K08A2.16
Is affected by eat-2 based on microarray studies.

WB:WBGene00202214	R07B1.23
No description available

WB:WBGene00202215	F35D2.17
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00202216	Y55F3BR.18
No description available

WB:WBGene00202217	F38B6.24
No description available

WB:WBGene00202218	M60.14
No description available

WB:WBGene00202219	Y39A1B.9
No description available

WB:WBGene00202220	F45G2.13
No description available

WB:WBGene00202221	T01B10.14
No description available

WB:WBGene00202222	F58F12.11
No description available

WB:WBGene00202223	K10G6.8
No description available

WB:WBGene00202224	R05C11.5
No description available

WB:WBGene00202225	C40C9.16
No description available

WB:WBGene00202226	C05A9.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202227	C03H12.3
No description available

WB:WBGene00202228	B0454.25
No description available

WB:WBGene00202229	F57G4.15
No description available

WB:WBGene00202230	K02F2.10
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00202231	B0457.19
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00202232	C46C2.11
No description available

WB:WBGene00202233	F55D12.9
Is affected by ifo-1 based on microarray studies.

WB:WBGene00202234	F36H12.66
No description available

WB:WBGene00202235	T25D10.10
No description available

WB:WBGene00202236	W04G3.16
No description available

WB:WBGene00202237	C16C2.10
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00202238	C45G3.6
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00202239	Y37E11B.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00202240	F09G2.13
Is affected by eat-2 based on microarray studies.

WB:WBGene00202241	F54B11.14
Is enriched in AFD; ASER; and PLM based on RNA-seq studies.

WB:WBGene00202242	T23C6.6
No description available

WB:WBGene00202243	C14H10.6
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00202244	ZC64.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202245	K10D6.25
No description available

WB:WBGene00202246	T24D8.16
No description available

WB:WBGene00202247	F46E10.17
Is affected by ifo-1 based on microarray studies.

WB:WBGene00202248	C47A10.15
No description available

WB:WBGene00202249	F23B12.11
No description available

WB:WBGene00202250	R13A1.17
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00202251	C52G5.12
No description available

WB:WBGene00202252	Y69H2.25
No description available

WB:WBGene00202253	Y43H11AL.8
Is affected by eat-2 based on microarray studies.

WB:WBGene00202254	ZK381.60
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00202255	F36D1.22
No description available

WB:WBGene00202256	ZK863.12
No description available

WB:WBGene00202257	C02C6.12
No description available

WB:WBGene00202258	F19D8.8
No description available

WB:WBGene00202259	ZK973.25
No description available

WB:WBGene00202260	H01G02.14
No description available

WB:WBGene00202261	F52E1.16
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202262	T12C9.10
No description available

WB:WBGene00202263	C01F4.9
No description available

WB:WBGene00202264	ZK617.24
No description available

WB:WBGene00202265	F49E10.25
Is affected by klf-1 based on RNA-seq studies.

WB:WBGene00202266	C29E6.17
No description available

WB:WBGene00202267	C16E9.28
No description available

WB:WBGene00202268	F11D5.32
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202269	F23H12.20
No description available

WB:WBGene00202270	T03F7.15
No description available

WB:WBGene00202271	W02G9.9
Is affected by pmt-2 and pptr-1 based on microarray and RNA-seq studies.

WB:WBGene00202272	F28E10.15
No description available

WB:WBGene00202273	C46C2.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202274	T11F9.29
No description available

WB:WBGene00202275	K07E12.8
No description available

WB:WBGene00202276	F40F4.10
No description available

WB:WBGene00202277	Y37F4.14
No description available

WB:WBGene00202278	T18D3.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202279	T02E9.27
No description available

WB:WBGene00202280	Y108G3AL.9
No description available

WB:WBGene00202281	ZK792.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202282	K09A9.11
No description available

WB:WBGene00202283	T06H11.21
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202284	T28A11.24
No description available

WB:WBGene00202285	T04C4.2
No description available

WB:WBGene00202286	F12A10.12
No description available

WB:WBGene00202287	F49E10.26
No description available

WB:WBGene00202288	W03C9.11
No description available

WB:WBGene00202289	F52B10.22
No description available

WB:WBGene00202290	ZC53.21
No description available

WB:WBGene00202291	C32A9.6
No description available

WB:WBGene00202292	C25F6.28
No description available

WB:WBGene00202293	R02D5.23
Is affected by daf-2 based on microarray studies.

WB:WBGene00202294	C54G7.16
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202295	F37D6.12
No description available

WB:WBGene00202296	F47F6.15
No description available

WB:WBGene00202297	C50B8.8
No description available

WB:WBGene00202298	Y49E10.35
No description available

WB:WBGene00202299	F37A4.10
No description available

WB:WBGene00202300	C01G6.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00202301	F35G2.21
Is affected by daf-2 and pmt-2 based on microarray studies.

WB:WBGene00202302	C25F6.29
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00202303	W07G1.22
No description available

WB:WBGene00202304	F31F6.16
Is affected by elli-1 based on microarray studies.

WB:WBGene00202305	C40H1.13
No description available

WB:WBGene00202306	K04B12.8
No description available

WB:WBGene00202307	ZK643.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00202308	M70.13
No description available

WB:WBGene00202309	Y40H7A.309
No description available

WB:WBGene00202310	T02E9.28
No description available

WB:WBGene00202311	R10E12.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202312	F59E12.14
No description available

WB:WBGene00202313	BE10.7
Is affected by daf-2 based on microarray studies.

WB:WBGene00202314	C06E4.21
No description available

WB:WBGene00202315	F29F11.19
No description available

WB:WBGene00202316	K02G10.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00202317	B0350.84
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202318	ZK381.61
No description available

WB:WBGene00202319	C36F7.26
No description available

WB:WBGene00202320	K01A6.21
No description available

WB:WBGene00202321	K01A11.8
No description available

WB:WBGene00202322	T23G5.11
No description available

WB:WBGene00202323	Y82E9BR.30
No description available

WB:WBGene00202324	Y57G7A.13
No description available

WB:WBGene00202325	C18C4.16
No description available

WB:WBGene00202326	F43B10.5
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00202327	R03H4.11
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00202328	T04F8.15
No description available

WB:WBGene00202329	C05C9.14
No description available

WB:WBGene00202330	C26B9.10
No description available

WB:WBGene00202331	C27A12.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00202332	C05B10.21
No description available

WB:WBGene00202333	Y15E3A.15
No description available

WB:WBGene00202334	C29E4.18
No description available

WB:WBGene00202335	K11G9.14
No description available

WB:WBGene00202336	F55C12.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202337	F35A5.14
No description available

WB:WBGene00202338	F22B3.21
No description available

WB:WBGene00202339	T05B11.13
Is affected by Cry5B based on microarray studies.

WB:WBGene00202340	C54D2.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202341	ZK783.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00202342	ZK617.25
No description available

WB:WBGene00202343	F39D8.7
Is affected by several genes including pgl-1; glh-1; and pgl-3 based on RNA-seq studies.

WB:WBGene00202344	Y59A8B.38
No description available

WB:WBGene00202345	F11D5.33
No description available

WB:WBGene00202346	Y105E8B.14
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00202347	T01H10.10
No description available

WB:WBGene00202348	K02E2.16
No description available

WB:WBGene00202349	T01A4.6
Is affected by several genes including cep-1; let-418; and dlc-1 based on RNA-seq studies.

WB:WBGene00202350	F01G12.17
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00202351	K06C4.26
Is affected by daf-2 based on microarray studies.

WB:WBGene00202352	T19D7.11
No description available

WB:WBGene00202353	C18H9.11
No description available

WB:WBGene00202354	Y46E12A.12
No description available

WB:WBGene00202355	M176.15
No description available

WB:WBGene00202356	F07A11.14
Is affected by adr-1 and adr-2 based on RNA-seq studies.

WB:WBGene00202357	F12D9.18
No description available

WB:WBGene00202358	C09H10.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202359	Y95B8A.17
No description available

WB:WBGene00202360	C28F5.8
No description available

WB:WBGene00202361	ZK596.5
Is affected by several genes including daf-2; eat-2; and lem-2 based on RNA-seq and microarray studies.

WB:WBGene00202362	Y51H7C.40
No description available

WB:WBGene00202363	ZK262.18
No description available

WB:WBGene00202364	T24A11.11
No description available

WB:WBGene00202365	F21C3.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00202366	K01D12.19
No description available

WB:WBGene00202367	R11E3.17
No description available

WB:WBGene00202368	D1081.18
No description available

WB:WBGene00202369	F28D9.5
No description available

WB:WBGene00202370	ZK377.13
No description available

WB:WBGene00202371	F28D1.22
No description available

WB:WBGene00202372	Y105C5B.1417
No description available

WB:WBGene00202373	C01F1.8
No description available

WB:WBGene00202374	T01C8.11
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00202375	R05G6.19
No description available

WB:WBGene00202376	F28F9.16
No description available

WB:WBGene00202377	C14F11.33
No description available

WB:WBGene00202378	F37B12.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202379	C54G7.17
No description available

WB:WBGene00202380	F13C5.10
No description available

WB:WBGene00202381	C08E8.14
No description available

WB:WBGene00202382	F02C12.10
No description available

WB:WBGene00202383	R153.9
Is affected by cep-1; dpy-21; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00202384	Y53C10A.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202385	Y73B6BL.287
No description available

WB:WBGene00202386	C52B9.18
No description available

WB:WBGene00202387	T02E9.29
No description available

WB:WBGene00202388	C05A9.11
No description available

WB:WBGene00202389	Y47D3B.24
Is affected by nhr-86 based on RNA-seq studies. Is affected by sodium arsenite based on RNA-seq studies.

WB:WBGene00202390	C31H1.98
No description available

WB:WBGene00202391	C34H3.23
No description available

WB:WBGene00202392	cTel79B.2
No description available

WB:WBGene00202393	R11B5.12
No description available

WB:WBGene00202394	T10B9.13
Is affected by cep-1 and hmg-4 based on RNA-seq studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00202395	B0034.17
No description available

WB:WBGene00202396	Y22D7AL.19
No description available

WB:WBGene00202397	ZK377.14
No description available

WB:WBGene00202398	R09E10.16
Is affected by daf-2 based on RNA-seq studies.

WB:WBGene00202399	T22E6.1
No description available

WB:WBGene00202400	C27D6.14
Is affected by several genes including cep-1; hpl-2; and spc-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00202401	F53B3.12
No description available

WB:WBGene00202402	Y69H2.26
No description available

WB:WBGene00202403	Y67D8C.21
No description available

WB:WBGene00202404	T19D2.11
Is affected by Cry5B based on microarray studies.

WB:WBGene00202405	C10G11.17
Is affected by pmt-2 based on microarray studies.

WB:WBGene00202406	C07A12.16
No description available

WB:WBGene00202407	M02F4.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00202408	Y23H5B.13
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00202409	B0273.114
No description available

WB:WBGene00202410	F54F12.5
No description available

WB:WBGene00202411	F11D5.34
No description available

WB:WBGene00202412	Y54G2A.71
No description available

WB:WBGene00202413	R05H11.5
No description available

WB:WBGene00202414	F10C1.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00202415	F42A9.15
No description available

WB:WBGene00202416	Y16B4A.4
No description available

WB:WBGene00202417	E01H11.6
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on microarray studies.

WB:WBGene00202418	F41D9.15
No description available

WB:WBGene00202419	C02F4.11
Is affected by several genes including eat-2; pgl-1; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00202420	F53B6.12
No description available

WB:WBGene00202421	C14F11.34
Is affected by eat-2 based on microarray studies.

WB:WBGene00202422	K08B4.43
No description available

WB:WBGene00202423	ZK867.23
No description available

WB:WBGene00202424	T14E8.7
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00202425	T24D8.17
No description available

WB:WBGene00202426	C36C9.9
No description available

WB:WBGene00202427	T11F9.30
No description available

WB:WBGene00202428	E01F3.3
Is affected by daf-2 based on microarray studies.

WB:WBGene00202429	C16E9.29
Is affected by daf-2 based on microarray studies.

WB:WBGene00202430	C47G2.22
No description available

WB:WBGene00202431	F29C4.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00202432	Y41C4A.28
No description available

WB:WBGene00202433	K11E4.11
No description available

WB:WBGene00202434	K03C7.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202435	Y51A2D.38
No description available

WB:WBGene00202436	T21H3.10
No description available

WB:WBGene00202437	Y15E3A.16
No description available

WB:WBGene00202438	Y51H7D.2
No description available

WB:WBGene00202439	F46B6.18
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00202440	C32A3.7
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00202441	F35C12.6
No description available

WB:WBGene00202442	R05G6.20
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00202443	C13G3.11
No description available

WB:WBGene00202444	Y65B4BR.11
No description available

WB:WBGene00202445	K11D9.8
Is affected by cep-1; chd-3; and let-418 based on RNA-seq studies.

WB:WBGene00202446	F25F2.6
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00202447	T27B1.9
No description available

WB:WBGene00202448	C02D4.16
Is enriched in AFD based on RNA-seq studies.

WB:WBGene00202449	C10H11.14
No description available

WB:WBGene00202450	F42D1.14
No description available

WB:WBGene00202451	ZC64.17
No description available

WB:WBGene00202452	C32E12.8
No description available

WB:WBGene00202453	C30C11.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00202454	Y40C7B.10
No description available

WB:WBGene00202455	Y25C1A.15
No description available

WB:WBGene00202456	C11E4.17
No description available

WB:WBGene00202457	F02E8.12
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00202458	C33D12.17
No description available

WB:WBGene00202459	T09B9.9
No description available

WB:WBGene00202460	K08A8.31
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00202461	F47E1.16
Is affected by daf-2 based on microarray studies.

WB:WBGene00202462	F56F11.7
Is affected by ifo-1 based on microarray studies.

WB:WBGene00202463	F28A12.8
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00202464	C07A12.17
No description available

WB:WBGene00202465	W01A11.20
No description available

WB:WBGene00202466	C08E8.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00202467	C06A8.17
No description available

WB:WBGene00202468	F26A10.27
No description available

WB:WBGene00202469	DY3.12
No description available

WB:WBGene00202470	R08B4.15
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00202471	B0198.10
Is affected by pgrn-1 based on RNA-seq studies.

WB:WBGene00202472	F57G12.15
No description available

WB:WBGene00202473	F25F6.4
No description available

WB:WBGene00202474	C43D7.19
No description available

WB:WBGene00202475	C33F10.24
No description available

WB:WBGene00202476	C08F8.14
No description available

WB:WBGene00202477	F35C11.13
No description available

WB:WBGene00202478	ZK930.13
No description available

WB:WBGene00202479	R05F9.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202480	ZK829.13
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202481	C05E11.18
No description available

WB:WBGene00202482	F11D5.35
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00202483	F26G1.14
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00202484	C45B2.19
No description available

WB:WBGene00202485	F31B9.6
No description available

WB:WBGene00202486	K03A11.9
No description available

WB:WBGene00202487	T23F11.10
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00202488	ZC190.16
Is affected by alg-1 based on RNA-seq studies.

WB:WBGene00202489	R06C1.14
No description available

WB:WBGene00202490	F28A12.9
Is affected by cep-1 and elli-1 based on RNA-seq and microarray studies.

WB:WBGene00202491	F55B11.132
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00202492	T15B7.19
No description available

WB:WBGene00202493	T06F4.21
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202494	F53G12.17
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00202495	T26H5.11
Is enriched in intestine based on RNA-seq studies. Is affected by spt-16 and hpx-2 based on RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00202496	R02F11.9
Is affected by sir-2.1 based on microarray studies. Is affected by multi-walled carbon nanotube and resveratrol based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00202497	R02F11.10
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00202498	Y60C6A.2
Is affected by several genes including daf-2; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including tryptophan; allantoin; and Sirolimus based on microarray and RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00202499	B0507.15
Is affected by several genes including lin-35; isp-1; and nuo-6 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00202500	K09H11.15
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00202501	Y57E12B.10
Is affected by spt-16; pmt-2; and ints-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00202502	F41B5.12
Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00202503	let-75
Is affected by mir-34; hpl-2; and pry-1 based on microarray and RNA-seq studies.

WB:WBGene00202504	Y32B12B.8
Is affected by hmg-3 and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00202505	clk-4
No description available

WB:WBGene00202506	clk-5
No description available

WB:WBGene00202507	clk-6
No description available

WB:WBGene00202508	clk-7
No description available

WB:WBGene00202509	clk-9
No description available

WB:WBGene00202510	clk-10
No description available

WB:WBGene00202511	F07C3.16
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; elt-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00202512	C25E10.16
Is enriched in amphid sheath cell and neurons based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; aak-2; and ain-2 based on RNA-seq and microarray studies.

WB:WBGene00202513	ZK938.10
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by ints-5; ints-6; and smn-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00202514	T09F5.20
Is affected by several genes including sek-1; sin-3; and ints-5 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00206353	lol-1
No description available

WB:WBGene00206354	F27E5.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; skn-1; and hsf-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including D-glucopyranose; Zidovudine; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00206355	C34C6.10
Is enriched in ASER based on RNA-seq studies. Is affected by several genes including eat-2; aak-2; and smg-2 based on RNA-seq studies. Is affected by tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00206356	T08B2.15
Is enriched in male based on RNA-seq studies. Is affected by ints-4 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00206357	C09D4.9
Is enriched in somatic gonad precursor and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hsp-6 based on microarray and RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206358	F46E10.18
Is enriched in intestine and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00206359	C05E4.15
Is predicted to have alpha-(1->3)-fucosyltransferase activity.

WB:WBGene00206360	T13C5.10
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; eri-1; and rrf-1 based on microarray studies. Is affected by single-walled carbon nanotube and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis protein of unknown function, DUF282 and Protein of unknown function DUF282, Caenorhabditis species.

WB:WBGene00206361	K02G10.15
Is enriched in PLM; intestine; muscle cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; rrf-3; and hsf-1 based on RNA-seq studies. Is affected by seven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00206362	B0041.11
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq studies. Is affected by Zidovudine; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206363	F56H1.10
Is enriched in male based on RNA-seq studies. Is affected by jmjd-3.1; eat-2; and nhl-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00206364	C07A12.18
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00206365	B0563.18
No description available

WB:WBGene00206366	C03H5.9
Is predicted to have G protein-coupled olfactory receptor activity.

WB:WBGene00206368	Y39F10C.3
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including tryptophan; nanoparticle; and metformin based on microarray and RNA-seq studies.

WB:WBGene00206369	C06C6.12
No description available

WB:WBGene00206370	F02D8.9
No description available

WB:WBGene00206371	F28B12.6
Is enriched in muscle cell; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including skn-1; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including multi-walled carbon nanotube; stavudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00206372	B0454.26
Is enriched in AFD and in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00206373	C27A2.12
Is enriched in amphid sheath cell; hypodermis; and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; let-60; and rrf-3 based on RNA-seq and microarray studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Histidine phosphatase superfamily (branch 2); Histidine phosphatase superfamily, clade-2; and Histidine phosphatase superfamily. Is an ortholog of human ACP2 (acid phosphatase 2, lysosomal); ACP3 (acid phosphatase 3); and ACP4 (acid phosphatase 4).

WB:WBGene00206374	K10G6.9
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dpy-21 based on microarray and RNA-seq studies. Is affected by five chemicals including Mianserin; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00206375	T08B6.64
Is affected by several genes including cep-1; dlc-1; and adr-2 based on RNA-seq studies.

WB:WBGene00206377	F44E5.15
Is predicted to have endonuclease activity.

WB:WBGene00206378	C14E2.11
Is affected by hmg-3; eat-2; and set-2 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00206379	C55B6.7
No description available

WB:WBGene00206380	C42D4.18
Is enriched in germ line and intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-2; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00206381	F52H2.15
Is affected by several genes including daf-2; daf-12; and elt-2 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and antimycin based on RNA-seq studies.

WB:WBGene00206382	F01G12.18
Is affected by unc-70 and ints-4 based on RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206383	C32C4.16
Is enriched in neurons based on microarray studies. Is affected by alg-1 based on microarray studies. Is affected by Alovudine; Chlorpyrifos; and single-walled carbon nanotube based on RNA-seq and microarray studies.

WB:WBGene00206384	D1005.10
Is enriched in intestine based on microarray studies. Is affected by several genes including sir-2.1; daf-19; and kri-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Zidovudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00206385	T06D4.6
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00206386	K10C2.12
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and clk-1 based on RNA-seq studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: Ubiquitin family; Ubiquitin-like domain; and Ubiquitin-like domain superfamily.

WB:WBGene00206388	K10C2.14
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00206389	C29F7.10
Is enriched in germ line and hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00206390	F14F7.7
Is affected by several genes including let-60; eat-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00206391	C01B9.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00206392	F47D2.11
Is affected by thoc-5 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00206393	W04G5.16
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by skn-1 and wdr-5.1 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00206394	W05H5.10
No description available

WB:WBGene00206395	C08H9.18
Is affected by adr-1 and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00206411	R13D11.11
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by six chemicals including tryptophan; 4-bromodiphenyl ether; and Psoralens based on microarray and RNA-seq studies.

WB:WBGene00206412	T24H7.8
Is enriched in PLM and germ line based on RNA-seq studies. Is affected by several genes including eat-2; lem-2; and his-72 based on RNA-seq studies. Is affected by five chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00206413	ZK1240.11
Is enriched in intestine and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including elt-2; eat-2; and smg-2 based on RNA-seq and microarray studies. Is affected by Cadmium Chloride and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00206414	F31D5.7
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box protein she-1-like.

WB:WBGene00206415	F59H6.14
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and lin-35 based on microarray and RNA-seq studies. Is affected by Alovudine based on RNA-seq studies.

WB:WBGene00206416	W04H10.5
Is enriched in head mesodermal cell and pharynx based on RNA-seq studies. Is affected by several genes including eat-2; dpy-7; and cye-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including multi-walled carbon nanotube; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00206417	W04H10.6
Is affected by several genes including daf-2; eat-2; and aak-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including bisphenol S; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00206418	M04C3.5
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including stavudine; metformin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00206420	T26G10.7
Is enriched in germ line and muscle cell based on RNA-seq studies. Is affected by several genes including eat-2; pmk-1; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206421	T26G10.8
Is affected by several genes including eat-2; pptr-1; and meg-3 based on RNA-seq studies.

WB:WBGene00206422	T26G10.9
Is affected by dpy-21 and pptr-1 based on RNA-seq studies.

WB:WBGene00206423	Y41C4A.29
Is affected by prg-1 and sma-2 based on RNA-seq studies.

WB:WBGene00206459	Y80D4G.1
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; sek-1; and aak-2 based on RNA-seq studies. Is affected by five chemicals including Rotenone; metformin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206460	F56H9.9
Is affected by several genes including daf-2; unc-70; and spc-1 based on RNA-seq and microarray studies.

WB:WBGene00206461	Y47D3A.34
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies.

WB:WBGene00206462	B0391.14
Is affected by several genes including eat-2; dpy-7; and sin-3 based on RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00206464	F59C6.18
Is enriched in AFD; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Zidovudine; allantoin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00206466	T08D10.5
Is affected by eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00206468	ZC262.11
Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00206469	F58D2.5
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on RNA-seq and microarray studies. Is affected by Rifampin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00206470	F13E9.20
Is affected by eat-2 based on RNA-seq studies. Is affected by five chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00206471	Y22F5A.11
No description available

WB:WBGene00206472	bus-24
No description available

WB:WBGene00206473	B0273.115
Is predicted to have chondroitin 4-sulfotransferase activity.

WB:WBGene00206474	T22A3.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00206475	F27D9.12
Is enriched in seam cell based on RNA-seq studies. Is affected by eat-2; atf-7; and pmk-1 based on RNA-seq studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00206476	Y20F4.9
No description available

WB:WBGene00206477	ZC262.12
Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00206478	M6.11
Is predicted to have galactoside binding activity.

WB:WBGene00206479	C44C11.6
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-2; eat-2; and mir-71 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube; antimycin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00206481	Y51B9A.14
Is affected by daf-2; sir-2.1; and daf-16 based on RNA-seq and microarray studies.

WB:WBGene00206482	B0416.10
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including hsf-1; sma-2; and sma-4 based on RNA-seq studies. Is affected by stavudine based on RNA-seq studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain; Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00206483	B0416.11
Is affected by several genes including hsf-1; eat-2; and mir-71 based on RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Sodium Chloride; and Psoralens based on RNA-seq studies.

WB:WBGene00206484	C31H2.14
Is enriched in neurons based on microarray studies. Is affected by several genes including hsf-1; isp-1; and sod-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00206485	C10A4.13
Is enriched in AFD and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; daf-12; and eat-2 based on RNA-seq studies. Is affected by seven chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies.

WB:WBGene00206486	Y54F10BM.20
Is affected by cfp-1 and sin-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00206487	best-19
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST2 (bestrophin 2) and BEST4 (bestrophin 4).

WB:WBGene00206488	ZK757.10
Is affected by elt-2; elt-7; and adr-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Snake toxin and toxin-like protein and Snake toxin/toxin-like.

WB:WBGene00206489	F53F1.14
Is affected by several genes including daf-2; rrf-3; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00206490	Y57G11C.1142
No description available

WB:WBGene00206491	Y73F8A.1173
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including smg-1; prg-1; and sma-2 based on RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00206492	F11D11.21
Is enriched in seam cell based on RNA-seq studies. Is affected by meg-3; meg-4; and tdp-1 based on RNA-seq and microarray studies.

WB:WBGene00206493	Y38H8A.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; aak-2; and met-2 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00206494	C15H11.16
Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by Cry5B and glycine based on microarray and RNA-seq studies.

WB:WBGene00206495	F20E11.18
No description available

WB:WBGene00206496	Y51A2B.16
Is affected by daf-2 and ifo-1 based on microarray studies.

WB:WBGene00206497	Y52B11A.18
Is affected by several genes including daf-2; eat-2; and hrde-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00206498	C29A12.22
Is affected by eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206499	C06H5.11
Is affected by daf-2 based on microarray studies.

WB:WBGene00206500	F55C9.15
Is enriched in hypodermis based on RNA-seq studies. Is affected by daf-2 and nhl-2 based on microarray and RNA-seq studies. Is affected by paraquat based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00206501	F14D7.18
Is enriched in intestine and in male based on RNA-seq and microarray studies. Is affected by several genes including daf-2; sir-2.1; and isp-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Cry5B; Atrazine; and cadmium based on microarray studies.

WB:WBGene00206502	T01B7.13
Is enriched in intestine based on microarray studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by Tunicamycin; Cry5B; and glycine based on RNA-seq and microarray studies.

WB:WBGene00206503	T26E4.18
No description available

WB:WBGene00206504	K10G4.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00206505	B0250.18
Is affected by eat-2; sin-3; and wdr-5.1 based on RNA-seq and microarray studies. Is affected by Cry5B and Sirolimus based on microarray studies.

WB:WBGene00206506	F59A1.18
Is enriched in male based on RNA-seq studies. Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00206507	Y51A2A.16
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00206508	ZK262.19
Is affected by several genes including daf-2; rrf-3; and hsp-6 based on RNA-seq and microarray studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00206509	Y102A5C.43
Is affected by several genes including hsp-6; hpl-2; and hmg-3 based on RNA-seq studies. Is affected by Colistin based on microarray studies.

WB:WBGene00206510	Y113G7A.22
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00206511	W02H5.16
Is affected by several genes including daf-16; eat-2; and pgl-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srh and 7TM GPCR, serpentine receptor class h (Srh).

WB:WBGene00206512	Y39A3B.7
Is affected by several genes including skn-1; dpy-7; and smg-1 based on RNA-seq studies. Is affected by six chemicals including deoxynivalenol; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00206513	B0244.15
Is enriched in CEPshDL; CEPshDR; CEPshVL; CEPshVR; and intestine based on RNA-seq studies. Is affected by elt-2; ints-4; and ztf-11 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Rifampin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Putative G-protein coupled receptor, Chromadorea.

WB:WBGene00206514	R05G9.5
Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00206515	T28C6.11
Is enriched in intestine based on microarray studies. Is affected by several genes including sir-2.1; pmk-1; and lem-2 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00206516	F53E4.2
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by pfd-6 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00206517	T27F7.12
Is affected by several genes including daf-12; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by seven chemicals including metformin; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00206518	F36H5.12
Is affected by eat-2 and pmt-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00206519	F36H5.13
Is enriched in neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Mianserin; multi-walled carbon nanotube; and bisphenol A based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00206520	ZK897.10
Is affected by adr-1 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00206521	T02G5.15
Is enriched in GABAergic neurons and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and dpy-7 based on RNA-seq and microarray studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq and microarray studies.

WB:WBGene00206522	F14D2.19
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Papain-like cysteine peptidase superfamily.

WB:WBGene00206523	C54E10.10
Is affected by allantoin and Sirolimus based on RNA-seq studies.

WB:WBGene00206524	C54E10.11
Is enriched in male based on RNA-seq studies. Is affected by several genes including rrf-3; nhr-114; and hmg-3 based on microarray and RNA-seq studies. Is affected by multi-walled carbon nanotube; nanoparticle; and stavudine based on RNA-seq and microarray studies.

WB:WBGene00206525	R74.10
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00206526	C06C3.14
Is affected by several genes including eat-2; lem-2; and emr-1 based on RNA-seq and microarray studies.

WB:WBGene00206527	T27A8.7
Is enriched in male based on RNA-seq studies.

WB:WBGene00206528	Y53H1A.7
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by adr-1; eat-2; and sftb-1 based on RNA-seq studies. Is affected by multi-walled carbon nanotube; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00206529	C04A2.15
Is enriched in intestine based on RNA-seq studies. Is affected by cox-5B and pptr-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00206530	Y52B11A.19
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including met-2; unc-70; and set-25 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00206531	C29F7.11
Is affected by hmg-3 and damt-1 based on RNA-seq studies. Is affected by five chemicals including multi-walled carbon nanotube; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00206532	F11A6.15
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and eat-2 based on RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00206533	C30A5.16
Is affected by several genes including daf-12; eat-2; and adr-1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00206534	C31A11.13
Is affected by adr-1 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00206535	M162.15
Is affected by several genes including daf-2; eat-2; and nhr-114 based on microarray and RNA-seq studies. Is affected by tryptophan based on microarray studies.

WB:WBGene00206536	C14A6.16
Is enriched in NSM based on tiling array studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on microarray and RNA-seq studies. Is affected by sixteen chemicals including Lithium Chloride; methylmercuric chloride; and Mercuric Chloride based on microarray and RNA-seq studies.

WB:WBGene00206537	Y71H9A.10
Is affected by daf-12; daf-16; and dpy-21 based on RNA-seq studies. Is predicted to encode a protein with the following domain: Saposin-like.

WB:WBGene00206538	C09G5.13
Is enriched in AFD based on RNA-seq studies. Is affected by several genes including skn-1; dpy-7; and smg-2 based on RNA-seq studies. Is affected by six chemicals including tryptophan; Psoralens; and allantoin based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in several diseases, including COACH syndrome; Joubert syndrome 7; and retinal disease (multiple).

WB:WBGene00215616	W04G3.17
Is affected by smg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00219205	R03D7.15
No description available

WB:WBGene00219206	W05H12.4
Is enriched in intestine based on microarray studies. Is affected by sin-3; cfp-1; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00219207	C01F6.14
Is affected by several genes including clk-1; eat-2; and sek-1 based on RNA-seq studies. Is affected by six chemicals including stavudine; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00219208	B0365.9
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and pmk-1 based on RNA-seq and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Chondroitin proteoglycan 4 and Chondroitin proteoglycan 4.

WB:WBGene00219209	F29F11.20
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by daf-2 based on microarray studies.

WB:WBGene00219210	Y37H2A.18
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and elt-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box domain; F-box domain; and F-box A protein FB155/FB224.

WB:WBGene00219212	K10G4.16
No description available

WB:WBGene00219214	T10B9.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219215	F13B12.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219216	K08D10.14
Is enriched in intestine based on RNA-seq and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Alovudine; stavudine; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219217	C08F8.15
Is affected by several genes including daf-16; daf-2; and lin-4 based on microarray and RNA-seq studies. Is affected by fourteen chemicals including multi-walled carbon nanotube; bisphenol A; and bisphenol S based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00219218	Y73B6BL.288
Is enriched in germ line and neurons based on RNA-seq studies. Is affected by several genes including skn-1; hsf-1; and eat-2 based on RNA-seq studies. Is affected by allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00219219	mir-5546
Is affected by alg-5 based on RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219220	mir-5549
Is affected by alg-5 and hrpk-1 based on RNA-seq studies.

WB:WBGene00219221	mir-5551
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00219222	mir-4806
Is affected by several genes including alg-1; alg-2; and mir-71 based on RNA-seq studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00219223	mir-4814
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00219224	mir-4924
No description available

WB:WBGene00219225	mir-4927
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00219226	mir-4929
Is affected by alg-2; alg-5; and mir-71 based on RNA-seq studies.

WB:WBGene00219227	mir-4932
Is affected by alg-2 based on RNA-seq studies.

WB:WBGene00219228	mir-4933
No description available

WB:WBGene00219229	mir-4934
No description available

WB:WBGene00219230	mir-4935
No description available

WB:WBGene00219231	mir-5545
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00219232	mir-5547
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00219233	mir-5552
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00219234	B0511.17
Is affected by several genes including eat-2; smn-1; and wdr-5.1 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219235	K03B4.8
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by spc-1 and unc-70 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00219236	K03B4.9
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and sir-2.1 based on microarray and RNA-seq studies. Is affected by bisphenol A and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00219238	M151.9
Is affected by several genes including daf-2; dpy-10; and pmk-1 based on RNA-seq and microarray studies. Is affected by five chemicals including paraquat; tetrabromobisphenol A; and Microcystin-LR based on microarray studies.

WB:WBGene00219239	K05F6.14
Is affected by several genes including daf-2; let-418; and mir-35 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00219241	Y116A8A.150
Is affected by dlc-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00219242	F56A12.10
Is affected by several genes including daf-16; dpy-21; and his-3 based on RNA-seq studies.

WB:WBGene00219243	T23G4.127
Is enriched in muscle cell based on RNA-seq studies. Is affected by smg-2 based on RNA-seq studies.

WB:WBGene00219244	Y51H4A.938
Is affected by several genes including daf-2; eat-2; and nhl-2 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00219245	mir-2221
Is affected by alg-1; alg-5; and hrpk-1 based on RNA-seq studies.

WB:WBGene00219246	mir-2953
Is affected by several genes including alg-1; alg-2; and mir-71 based on RNA-seq studies.

WB:WBGene00219247	mir-4807
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219248	mir-4808
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00219249	mir-4809
Is affected by prg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00219250	mir-4810.1
Is affected by prg-1 and alg-5 based on RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219251	mir-4811
Is affected by several genes including eat-2; alg-1; and prg-1 based on RNA-seq and microarray studies.

WB:WBGene00219252	mir-4815
Is affected by hrpk-1 based on RNA-seq studies.

WB:WBGene00219253	mir-4916
Is affected by glp-4 based on RNA-seq studies.

WB:WBGene00219254	mir-4920
Is affected by prg-1 and alg-5 based on RNA-seq studies.

WB:WBGene00219255	mir-4921
No description available

WB:WBGene00219256	mir-4922.1
Is affected by hrpk-1 based on RNA-seq studies.

WB:WBGene00219257	mir-4922.2
Is affected by hrpk-1 based on RNA-seq studies.

WB:WBGene00219258	mir-4923.1
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00219259	mir-4923.2
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00219260	mir-4925
Is affected by alg-1; alg-2; and alg-5 based on RNA-seq studies.

WB:WBGene00219261	mir-4926
Is affected by mir-71 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00219262	mir-4930
No description available

WB:WBGene00219263	mir-4931
Is affected by glp-4 based on RNA-seq studies.

WB:WBGene00219264	mir-4936
Is affected by several genes including alg-1; prg-1; and alg-2 based on RNA-seq studies.

WB:WBGene00219265	mir-4937
Is affected by several genes including eat-2; prg-1; and alg-5 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube and graphene oxide based on RNA-seq studies.

WB:WBGene00219266	mir-4938
Is affected by several genes including alg-1; smg-1; and alg-2 based on RNA-seq studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.

WB:WBGene00219267	mir-5548
Is affected by several genes including sek-1; hmg-3; and alg-5 based on microarray and RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00219269	mir-5553
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00219270	mir-5550
Is affected by several genes including daf-2; alg-1; and prg-1 based on RNA-seq and microarray studies.

WB:WBGene00219271	F36H5.14
Is enriched in head mesodermal cell and intestine based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and elt-2 based on RNA-seq and microarray studies. Is affected by twelve chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00219272	C17C3.24
Is enriched in muscle cell based on RNA-seq studies. Is affected by daf-2 based on microarray studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219274	T25G12.13
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and alg-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including 4-bromodiphenyl ether; Psoralens; and Sirolimus based on microarray and RNA-seq studies. Human ortholog(s) of this gene are implicated in cortisone reductase deficiency 2. Is predicted to encode a protein with the following domains: short chain dehydrogenase; Short-chain dehydrogenase/reductase SDR; and NAD(P)-binding domain superfamily. Is an ortholog of human DHRS7B (dehydrogenase/reductase 7B).

WB:WBGene00219275	Y39G10AR.32
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219276	suls-1
No description available

WB:WBGene00219277	suls-2
No description available

WB:WBGene00219278	R09A8.9
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219279	T24D5.11
Is affected by hmg-3; adr-1; and eat-2 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00219280	C05B5.16
Is affected by spt-16 based on RNA-seq studies. Is affected by five chemicals including Sodium Chloride; Rifampin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219281	K10D3.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00219282	F43G9.21
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00219283	F55H12.7
Is affected by several genes including elt-2; eat-2; and elt-7 based on RNA-seq studies. Is affected by seven chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00219284	C41G7.15
Is enriched in male based on RNA-seq studies. Is affected by spt-16 based on RNA-seq studies.

WB:WBGene00219285	K07A1.20
Is affected by hrpr-1; daf-2; and adr-1 based on RNA-seq and microarray studies.

WB:WBGene00219286	C04F12.16
Is enriched in amphid sheath cell and in male based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and hsf-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219287	F36D1.23
Is affected by several genes including daf-2; aak-2; and aak-1 based on microarray and RNA-seq studies. Is affected by Acrylamide based on microarray studies.

WB:WBGene00219288	Y87G2A.25
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sma-2; and sma-4 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00219289	T05C12.15
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219290	AH6.17
No description available

WB:WBGene00219291	F35H8.12
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00219292	ZK1320.14
Is affected by several genes including eat-2; smg-2; and his-72 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00219293	B0334.20
Is enriched in intestine based on microarray studies. Is affected by adr-1 and sir-2.1 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00219294	F43G6.16
Is affected by several genes including daf-2; rrf-3; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; allantoin; and Psoralens based on RNA-seq studies.

WB:WBGene00219295	C34C12.12
Is affected by several genes including eat-2; smg-2; and adr-1 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00219296	C54C6.11
Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00219297	T23F11.11
Is affected by daf-2; ifo-1; and ints-6 based on microarray and RNA-seq studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219298	F55H2.8
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and Tunicamycin based on RNA-seq and microarray studies.

WB:WBGene00219299	C01G12.16
Is enriched in AFD based on RNA-seq studies. Is affected by eat-2 and nhl-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00219300	W10G6.6
Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219301	C44C10.15
Is enriched in male based on RNA-seq studies.

WB:WBGene00219302	Y43F8B.28
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and dlc-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219303	Y13C8A.4
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and smg-2 based on RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00219304	F56D6.16
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00219306	linc-4
Is affected by several genes including daf-2; hsf-1; and isp-1 based on RNA-seq and microarray studies. Is affected by Mianserin and stavudine based on RNA-seq studies.

WB:WBGene00219307	F56D6.17
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including rrf-3; hsf-1; and eat-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00219308	W06G6.20
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by ten chemicals including D-glucopyranose; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00219309	F26F2.13
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including skn-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rifampin; allantoin; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00219310	C17E4.19
Is affected by dpy-7; rrf-3; and sin-3 based on RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq and microarray studies.

WB:WBGene00219311	Y51A2A.17
No description available

WB:WBGene00219312	Y51A2A.18
Is affected by lin-14 and lin-4 based on microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00219313	C17E4.20
Is enriched in AFD and germ line based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Alovudine; metformin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00219314	C05B5.17
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies. Is affected by nine chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00219315	F07E5.12
Is affected by several genes including daf-2; eat-2; and lin-54 based on RNA-seq and microarray studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219316	F21A3.11
Is predicted to have acid phosphatase activity and metal ion binding activity. Is an ortholog of human ACP7 (acid phosphatase 7, tartrate resistant (putative)).

WB:WBGene00219317	F31E3.12
Is affected by several genes including skn-1; rrf-3; and eat-2 based on RNA-seq studies. Is affected by seven chemicals including stavudine; Zidovudine; and Sodium Chloride based on RNA-seq studies.

WB:WBGene00219318	R08A2.9
Is affected by hmg-3 based on RNA-seq studies.

WB:WBGene00219319	H25P06.5
Is affected by several genes including aak-2; aak-1; and hrde-1 based on RNA-seq studies. Is affected by eight chemicals including multi-walled carbon nanotube; Alovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00219321	T07H3.10
Is enriched in hypodermis based on RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00219322	C33C12.12
Is affected by several genes including glp-1; eat-2; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00219323	nspd-12
Is affected by flr-4; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219324	F47B8.18
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including skn-1; eat-2; and ain-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Sodium Chloride; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219325	F17C11.22
Is affected by several genes including daf-16; rrf-3; and daf-12 based on RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00219326	F36D3.16
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1248); Domain of unknown function DUF1248; and Acyl-CoA N-acyltransferase.

WB:WBGene00219327	ZK822.9
No description available

WB:WBGene00219329	K02D10.8
Is enriched in ASER; amphid sheath cell; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; unc-70; and ins-11 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219330	F18E2.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00219331	H25K10.141
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219332	Y116A8C.467
Is affected by several genes including daf-2; eat-2; and aak-2 based on microarray and RNA-seq studies.

WB:WBGene00219337	T16G1.18
Is affected by Sirolimus; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00219342	Y57G11C.1143
Is affected by cox-5B; aak-1; and aak-2 based on RNA-seq studies. Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00219343	Y17D7C.9
Is enriched in AVK and RID based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and adr-1 based on RNA-seq and microarray studies. Is affected by Cry5B based on microarray studies.

WB:WBGene00219351	Y7A5A.20
No description available

WB:WBGene00219352	Y7A5A.21
Is affected by skn-1 based on RNA-seq studies.

WB:WBGene00219362	ZK470.14
Is enriched in amphid sheath cell and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Zidovudine and Rifampin based on RNA-seq studies.

WB:WBGene00219368	F14H12.17
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by daf-2; sir-2.1; and eat-2 based on microarray studies. Is affected by nine chemicals including Rifampin; resveratrol; and Atrazine based on RNA-seq and microarray studies.

WB:WBGene00219369	R160.10
Is affected by eat-2; skn-1; and wdr-5.1 based on RNA-seq studies. Is affected by eight chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00219370	ZK262.20
Is enriched in intestine based on RNA-seq studies.

WB:WBGene00219371	C03G5.14
No description available

WB:WBGene00219373	F01E11.18
Is enriched in ASER; RIM; and interneuron based on RNA-seq studies. Is affected by several genes including daf-2; aak-2; and unc-70 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219374	C25A11.10
Is enriched in cholinergic neurons; germ line; pharyngeal neurons; and retrovesicular ganglion based on RNA-seq; tiling array; and microarray studies. Is affected by several genes including daf-16; daf-2; and skn-1 based on microarray; RNA-seq; and tiling array studies. Is affected by twelve chemicals including D-glucose; stavudine; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00219375	C02B8.12
Is affected by several genes including daf-16; daf-12; and aak-2 based on RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Cystine-knot cytokine.

WB:WBGene00219376	C28G1.10
Is predicted to have ubiquitin conjugating enzyme activity and ubiquitin protein ligase binding activity.

WB:WBGene00219377	F47C12.12
Is enriched in male-specific anatomical entity and in male based on RNA-seq and microarray studies. Is affected by several genes including rrf-3; nhr-25; and his-72 based on RNA-seq and microarray studies.

WB:WBGene00219378	F43G6.17
Is predicted to have hydrolase activity. Human ortholog(s) of this gene are implicated in Cornelia de Lange syndrome 5.

WB:WBGene00219381	C47A10.16
No description available

WB:WBGene00219383	Y61B8A.6
Is affected by ints-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Sri and 7TM GPCR, serpentine chemoreceptor class i (Sri).

WB:WBGene00219394	Y48A6C.8
Is affected by fog-2; aak-1; and aak-2 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00219395	M199.134
Is affected by eat-2 based on microarray studies.

WB:WBGene00219399	Y55F3AM.21
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; elt-2; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Alovudine; Rifampin; and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00219410	C04C3.14
Is affected by several genes including daf-2; rrf-3; and elt-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219411	T14G12.11
Is enriched in male based on RNA-seq studies. Is affected by hrpr-1; eat-2; and rrf-3 based on RNA-seq studies. Is affected by four chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00219412	ZK381.62
Is affected by several genes including daf-16; daf-12; and aak-2 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00219413	Y38F2AL.12
Is affected by several genes including daf-2; fog-2; and smg-2 based on RNA-seq and microarray studies. Is affected by Alovudine and Zidovudine based on RNA-seq studies.

WB:WBGene00219414	F14H3.15
Is enriched in arcade cell; neurons; pharyngeal-intestinal valve cell; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including elt-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00219415	linc-38
Is affected by cep-1; npr-1; and adr-1 based on RNA-seq studies.

WB:WBGene00219416	F23H12.21
Is affected by cox-5B based on RNA-seq studies.

WB:WBGene00219417	F34H10.9
Is affected by eat-2 and ints-5 based on RNA-seq studies.

WB:WBGene00219418	F44D12.19
Is enriched in intestine based on RNA-seq studies. Is affected by sir-2.1 based on microarray studies. Is affected by six chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00219420	T19C4.24
Is affected by several genes including aak-2; unc-70; and aak-1 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00219421	Y66D12A.30
No description available

WB:WBGene00219422	Y52B11A.20
Is affected by several genes including daf-2; eat-2; and met-2 based on RNA-seq and microarray studies. Is affected by four chemicals including multi-walled carbon nanotube; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00219423	C23H5.15
Is affected by several genes including daf-16; daf-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00219424	Y54G2A.72
Is affected by daf-2; meg-3; and meg-4 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00219425	Y54G2A.73
Is enriched in GABAergic neurons; germ line; and head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; clk-1; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; Zidovudine; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00219434	F54D5.23
Is enriched in AFD based on RNA-seq studies. Is affected by eat-2 and pfd-6 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00219436	C49H3.16
Is predicted to have serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene are implicated in congenital secretory sodium diarrhea 3.

WB:WBGene00219437	C50A2.7
Is affected by smn-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: PAN-like domain and PAN-3 domain.

WB:WBGene00219442	C08F8.16
Is affected by eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219443	Y57G11C.1144
Is affected by daf-2; eat-2; and sin-3 based on microarray and RNA-seq studies.

WB:WBGene00219444	Y41E3.461
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219445	C06H5.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00219446	C06H5.13
Is affected by daf-2 based on microarray and RNA-seq studies.

WB:WBGene00219447	C06H5.14
Is affected by several genes including daf-2; eat-2; and wdr-5.1 based on RNA-seq and microarray studies. Is affected by Mianserin and Zidovudine based on RNA-seq studies.

WB:WBGene00219448	K12G11.14
No description available

WB:WBGene00219449	Y38A10A.11
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Secreted clade V proteins and Secreted clade V protein.

WB:WBGene00219450	F53B6.13
Is enriched in AVK based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00219451	F52D2.12
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Zidovudine; bisphenol A; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00219452	F21D9.11
Is affected by eat-2; daf-2; and sek-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Mianserin; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00219453	linc-97
Is affected by hrpr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219454	C26H9A.3
No description available

WB:WBGene00219455	Y43F8B.29
Is affected by rrf-3; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00219456	ZK822.10
Is enriched in intestine based on RNA-seq studies. Is affected by his-3 based on RNA-seq studies.

WB:WBGene00219458	H21P03.10
No description available

WB:WBGene00219460	K09H9.9
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and prg-1 based on RNA-seq and microarray studies. Is affected by antimycin; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00219476	D1046.16
Is affected by dlc-1 based on RNA-seq studies. Is affected by Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219477	F57G8.14
Is affected by daf-2 and sir-2.1 based on microarray studies. Is affected by adsorbable organic bromine compound and allantoin based on microarray studies.

WB:WBGene00219478	Y105C5B.1418
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219483	Y116F11B.24
Is affected by daf-2 based on microarray studies.

WB:WBGene00219489	C10C6.13
Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219490	Y116A8B.98
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219491	Y53F4B.62
Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Alovudine; Zidovudine; and Psoralens based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00219492	Y53F4B.63
Is affected by nuo-6 based on microarray studies. Is affected by six chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00219493	C18D4.12
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by metformin; Sirolimus; and cadmium based on RNA-seq and microarray studies.

WB:WBGene00219497	linc-114
No description available

WB:WBGene00219498	Y106G6E.8
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00219505	Y52E8A.8
No description available

WB:WBGene00219541	eri-11
No description available

WB:WBGene00219542	eri-10
No description available

WB:WBGene00219543	eri-8
No description available

WB:WBGene00219544	C17G1.14
Is enriched in AVK based on RNA-seq studies. Is affected by allantoin and Sirolimus based on RNA-seq studies.

WB:WBGene00219545	F41E7.19
No description available

WB:WBGene00219546	F41E7.20
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00219547	T06A10.106
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including eat-2; set-2; and sin-3 based on RNA-seq studies. Is affected by six chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00219548	JC8.17
Is affected by several genes including cep-1; pptr-1; and meg-3 based on RNA-seq studies.

WB:WBGene00219549	F59A1.19
Is affected by daf-2 based on microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00219550	B0035.20
No description available

WB:WBGene00219551	K07F5.21
Is affected by cep-1; dlc-1; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219552	F53F4.25
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00219553	T08G5.19
No description available

WB:WBGene00219554	W03D2.11
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin and Sirolimus based on RNA-seq studies.

WB:WBGene00219555	Y46G5A.46
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219556	C04C11.23
Is enriched in muscle cell based on RNA-seq studies. Is affected by cep-1 and mdt-15 based on RNA-seq studies. Is affected by D-glucopyranose based on RNA-seq studies.

WB:WBGene00219557	anr-14
Is affected by meg-3; meg-4; and pptr-1 based on RNA-seq studies.

WB:WBGene00219558	anr-12
Is affected by daf-2 based on microarray studies.

WB:WBGene00219559	linc-5
Is expressed in muscle cell.

WB:WBGene00219560	linc-98
Is affected by daf-2 based on microarray studies.

WB:WBGene00219561	linc-142
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219562	linc-28
No description available

WB:WBGene00219563	linc-95
Is affected by adr-1; dlc-1; and sek-1 based on RNA-seq studies.

WB:WBGene00219564	linc-102
No description available

WB:WBGene00219565	linc-120
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219566	linc-33
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219567	linc-164
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219568	anr-9
No description available

WB:WBGene00219569	linc-147
Is enriched in AVK based on RNA-seq studies. Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219570	linc-82
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00219571	linc-15
Is affected by several genes including daf-2; hsf-1; and cep-1 based on RNA-seq studies. Is affected by four chemicals including bisphenol A; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00219572	linc-146
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00219573	anr-30
Is affected by hsf-1 based on RNA-seq studies.

WB:WBGene00219574	linc-54
Is affected by adr-1 and ints-4 based on RNA-seq studies.

WB:WBGene00219575	anr-8
Is affected by several genes including daf-16; pgl-1; and glh-1 based on RNA-seq studies.

WB:WBGene00219576	anr-13
Is affected by adr-1 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00219577	linc-119
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00219578	linc-141
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219579	linc-43
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by cep-1 and unc-70 based on RNA-seq studies.

WB:WBGene00219580	linc-18
Is affected by cep-1; daf-2; and rrf-3 based on RNA-seq and microarray studies.

WB:WBGene00219581	anr-20
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including smn-1; pptr-1; and ints-5 based on RNA-seq studies.

WB:WBGene00219582	anr-25
No description available

WB:WBGene00219583	anr-43
No description available

WB:WBGene00219584	linc-162
Is affected by npr-1 based on RNA-seq studies.

WB:WBGene00219585	linc-170
Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00219586	linc-108
No description available

WB:WBGene00219587	anr-16
Is affected by daf-2; sod-2; and atfs-1 based on RNA-seq studies.

WB:WBGene00219588	linc-80
No description available

WB:WBGene00219589	anr-35
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and pgl-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Rotenone; metformin; and Rifampin based on RNA-seq studies.

WB:WBGene00219590	linc-72
Is affected by several genes including hsf-1; cep-1; and hsp-6 based on RNA-seq studies. Is affected by D-glucopyranose; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00219591	linc-149
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00219592	linc-84
Is affected by several genes including daf-2; hsf-1; and nhr-49 based on RNA-seq and microarray studies. Is affected by tert-Butylhydroperoxide; antimycin; and paraquat based on RNA-seq studies.

WB:WBGene00219593	anr-15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219594	linc-59
No description available

WB:WBGene00219596	linc-140
No description available

WB:WBGene00219597	anr-11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219598	linc-113
Is affected by several genes including daf-16; daf-12; and dpy-21 based on RNA-seq studies.

WB:WBGene00219599	linc-99
No description available

WB:WBGene00219600	linc-118
No description available

WB:WBGene00219601	linc-129
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219602	linc-151
Is affected by daf-2 based on microarray studies.

WB:WBGene00219603	anr-57
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219604	linc-93
No description available

WB:WBGene00219605	linc-110
No description available

WB:WBGene00219606	linc-133
Is enriched in AVK based on RNA-seq studies. Is affected by daf-2 based on microarray studies.

WB:WBGene00219607	anr-7
Is affected by ins-11 based on RNA-seq studies.

WB:WBGene00219608	linc-58
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00219609	linc-7
Is enriched in AFD; AVK; RIS; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and npr-1 based on RNA-seq studies.

WB:WBGene00219610	anr-51
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00219611	linc-123
Is affected by hsf-1 based on RNA-seq studies.

WB:WBGene00219612	linc-153
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00219613	linc-148
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00219614	linc-105
Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00219615	linc-109
Is affected by several genes including daf-2; sek-1; and sma-2 based on RNA-seq and microarray studies.

WB:WBGene00219616	linc-111
Is affected by daf-2 based on microarray studies.

WB:WBGene00219617	linc-25
Is enriched in AVK based on RNA-seq studies. Is affected by dpy-21 and thoc-5 based on RNA-seq studies.

WB:WBGene00219618	linc-60
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00219619	linc-76
Is affected by several genes including daf-2; cep-1; and sod-2 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00219620	linc-74
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00219621	anr-46
Is affected by daf-2 based on microarray studies.

WB:WBGene00219622	anr-40
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219623	anr-2
Is affected by cox-5B based on RNA-seq studies.

WB:WBGene00219624	linc-62
No description available

WB:WBGene00219625	linc-168
No description available

WB:WBGene00219626	linc-157
Is affected by adr-1 and ints-5 based on RNA-seq studies.

WB:WBGene00219627	anr-3
No description available

WB:WBGene00219628	linc-161
No description available

WB:WBGene00219629	linc-87
No description available

WB:WBGene00219630	linc-70
Is affected by npr-1; kri-1; and mpk-2 based on RNA-seq studies.

WB:WBGene00219631	anr-37
No description available

WB:WBGene00219632	linc-163
No description available

WB:WBGene00219633	anr-55
No description available

WB:WBGene00219634	linc-86
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00219635	linc-51
No description available

WB:WBGene00219636	linc-81
Is affected by several genes including sek-1; cep-1; and dpy-21 based on RNA-seq studies. Is affected by bisphenol S based on RNA-seq studies.

WB:WBGene00219637	linc-124
Is enriched in AVK and head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219638	anr-29
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219639	linc-115
Is affected by smn-1 based on RNA-seq studies.

WB:WBGene00219640	anr-56
No description available

WB:WBGene00219641	linc-47
Is affected by several genes including daf-2; sek-1; and adr-1 based on RNA-seq and microarray studies. Is affected by Alovudine based on RNA-seq studies.

WB:WBGene00219642	anr-52
No description available

WB:WBGene00219643	linc-78
No description available

WB:WBGene00219644	linc-69
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00219645	linc-166
No description available

WB:WBGene00219646	linc-89
Is enriched in male based on RNA-seq studies. Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00219647	anr-27
Is affected by daf-2; spc-1; and unc-70 based on microarray and RNA-seq studies.

WB:WBGene00219648	linc-67
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00219649	linc-55
Is expressed in muscle cell.

WB:WBGene00219650	linc-56
Is affected by sma-2 and sma-4 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00219651	linc-130
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219652	linc-65
No description available

WB:WBGene00219653	linc-145
No description available

WB:WBGene00219654	linc-156
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219655	linc-107
Is affected by several genes including daf-16; skn-1; and daf-12 based on RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00219656	anr-48
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219657	linc-139
Is affected by cox-5B; dlc-1; and ints-4 based on RNA-seq studies.

WB:WBGene00219658	anr-21
Is affected by cep-1; cox-5B; and his-3 based on RNA-seq studies.

WB:WBGene00219659	anr-36
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including sek-1; cep-1; and spc-1 based on RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219660	linc-19
Is affected by several genes including rrf-3; hsf-1; and cep-1 based on RNA-seq studies.

WB:WBGene00219661	linc-45
Is affected by several genes including rrf-3; cep-1; and pptr-1 based on RNA-seq studies.

WB:WBGene00219662	linc-134
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00219663	anr-10
No description available

WB:WBGene00219664	linc-73
Is enriched in AVK based on RNA-seq studies. Is affected by adr-1 and unc-70 based on RNA-seq studies.

WB:WBGene00219665	linc-101
Is affected by several genes including daf-2; eat-2; and smg-2 based on RNA-seq and microarray studies.

WB:WBGene00219666	linc-31
Is enriched in AVK based on RNA-seq studies. Is affected by elli-1; thoc-5; and ints-6 based on microarray and RNA-seq studies.

WB:WBGene00219667	linc-66
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and mir-71 based on RNA-seq and microarray studies.

WB:WBGene00219668	anr-33
Is affected by hsf-1 based on RNA-seq studies.

WB:WBGene00219669	anr-28
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219670	anr-26
Is affected by daf-2 and sin-3 based on microarray and RNA-seq studies.

WB:WBGene00219671	anr-4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219672	anr-54
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219673	linc-96
Is affected by several genes including atfs-1; unc-70; and spc-1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00219674	linc-122
No description available

WB:WBGene00219675	linc-44
Is affected by several genes including sek-1; mir-71; and adr-2 based on microarray and RNA-seq studies.

WB:WBGene00219676	linc-48
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00219677	anr-17
No description available

WB:WBGene00219678	linc-9
Is affected by several genes including smg-2; ins-11; and sin-3 based on RNA-seq studies.

WB:WBGene00219679	anr-22
No description available

WB:WBGene00219680	linc-35
Is affected by cep-1 and damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00219681	anr-6
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219682	linc-50
Is affected by cep-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219683	anr-32
Is affected by several genes including cep-1; nhr-49; and atfs-1 based on RNA-seq studies. Is affected by tert-Butylhydroperoxide based on RNA-seq studies.

WB:WBGene00219684	linc-26
No description available

WB:WBGene00219685	linc-75
Is affected by daf-2 based on microarray studies.

WB:WBGene00219686	linc-125
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00219687	linc-12
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00219688	linc-21
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and rrf-3 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00219689	linc-41
Is affected by several genes including daf-2; rrf-3; and cep-1 based on RNA-seq studies.

WB:WBGene00219690	linc-10
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including rrf-3; cep-1; and adr-1 based on RNA-seq studies.

WB:WBGene00219691	linc-106
No description available

WB:WBGene00219692	linc-23
Is affected by daf-2 based on microarray studies.

WB:WBGene00219693	linc-144
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219694	linc-36
Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219695	linc-126
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219696	anr-39
Is affected by zip-3 and unc-70 based on RNA-seq studies.

WB:WBGene00219697	linc-169
Is affected by fog-3 and daf-2 based on microarray studies.

WB:WBGene00219698	linc-92
Is affected by skn-1 based on RNA-seq studies. Is affected by juglone based on RNA-seq studies.

WB:WBGene00219699	linc-22
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including sek-1; vit-2; and sma-2 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00219700	linc-6
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by stavudine and Zidovudine based on RNA-seq studies.

WB:WBGene00219701	anr-34
Is affected by hsf-1 and sek-1 based on RNA-seq studies.

WB:WBGene00219702	linc-138
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00219703	anr-38
Is enriched in AVK based on RNA-seq studies.

WB:WBGene00219704	linc-127
No description available

WB:WBGene00219705	anr-5
Is affected by numr-1 and numr-2 based on RNA-seq studies.

WB:WBGene00219706	linc-158
Is affected by daf-2 based on microarray studies.

WB:WBGene00219707	linc-8
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and sma-2 based on RNA-seq studies. Is affected by Zidovudine and paraquat based on RNA-seq studies.

WB:WBGene00219708	linc-13
Is affected by sin-3 based on RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00219709	linc-37
Is affected by several genes including daf-2; eat-2; and npr-1 based on RNA-seq and microarray studies. Is affected by four chemicals including graphene oxide; stavudine; and tert-Butylhydroperoxide based on RNA-seq studies.

WB:WBGene00219710	anr-45
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by adr-2 based on RNA-seq studies.

WB:WBGene00219711	anr-49
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219712	linc-167
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219713	linc-27
No description available

WB:WBGene00219714	linc-3
Is affected by daf-2 based on microarray studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219715	anr-18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219716	linc-88
No description available

WB:WBGene00219717	anr-23
No description available

WB:WBGene00219718	linc-42
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by damt-1; meg-3; and meg-4 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00219719	linc-57
Is expressed in muscle cell.

WB:WBGene00219720	linc-2
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 and sin-3 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00219721	linc-104
Is enriched in RID based on RNA-seq studies. Is affected by unc-39; thoc-5; and dlc-1 based on RNA-seq studies.

WB:WBGene00219722	linc-154
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219723	linc-135
Is affected by cox-5B and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219724	linc-100
Is affected by eat-2 based on microarray studies.

WB:WBGene00219725	linc-63
Is enriched in germ line based on RNA-seq studies. Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219726	linc-116
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by hrpr-1 and adr-1 based on RNA-seq studies.

WB:WBGene00219727	linc-39
Is affected by rrf-3 based on RNA-seq studies.

WB:WBGene00219728	linc-16
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219729	anr-44
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219730	linc-137
No description available

WB:WBGene00219731	linc-49
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219732	linc-112
No description available

WB:WBGene00219733	linc-53
Is affected by cep-1 and hrpr-1 based on RNA-seq studies. Is affected by stavudine and Zidovudine based on RNA-seq studies.

WB:WBGene00219734	linc-128
Is affected by dlc-1 and efa-6 based on RNA-seq studies.

WB:WBGene00219735	linc-150
No description available

WB:WBGene00219736	linc-20
Is affected by several genes including cep-1; sma-2; and smg-2 based on RNA-seq studies.

WB:WBGene00219737	linc-155
No description available

WB:WBGene00219738	anr-1
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219739	linc-136
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00219740	linc-117
No description available

WB:WBGene00219741	linc-77
Is affected by daf-2; eat-2; and ints-4 based on microarray and RNA-seq studies.

WB:WBGene00219742	linc-52
No description available

WB:WBGene00219743	linc-103
Is affected by several genes including skn-1; cep-1; and unc-70 based on RNA-seq studies. Is affected by graphene oxide and paraquat based on RNA-seq studies.

WB:WBGene00219744	anr-41
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219745	linc-90
Is enriched in AFD based on RNA-seq studies. Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219746	linc-91
Is affected by several genes including sek-1; cep-1; and smg-2 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00219747	linc-79
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219748	linc-46
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq studies. Is affected by five chemicals including Tunicamycin; Alovudine; and stavudine based on RNA-seq studies.

WB:WBGene00219749	linc-30
Is enriched in muscle cell based on RNA-seq studies. Is affected by set-25; met-2; and sftb-1 based on RNA-seq studies.

WB:WBGene00219750	Y38C1AA.19
Is enriched in intestine based on RNA-seq studies. Is affected by eat-2 and ints-7 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: zinc-RING finger domain and Zinc finger, RING-type.

WB:WBGene00219751	anr-24
Is affected by smg-2 based on RNA-seq studies. Is affected by graphene oxide and stavudine based on RNA-seq studies.

WB:WBGene00219752	anr-50
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219753	linc-152
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219754	linc-85
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by cep-1; smg-2; and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219755	linc-17
Is affected by several genes including rrf-3; hsf-1; and kri-1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00219756	linc-68
Is affected by several genes including daf-16; daf-2; and rrf-3 based on microarray and RNA-seq studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219757	linc-71
Is affected by kri-1 and mpk-2 based on RNA-seq studies. Is affected by Tunicamycin and Cadmium Chloride based on RNA-seq studies.

WB:WBGene00219758	linc-11
Is enriched in RID and head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; sek-1; and cep-1 based on RNA-seq studies.

WB:WBGene00219759	anr-58
Is affected by daf-2 based on microarray studies.

WB:WBGene00219760	anr-19
Is affected by cox-5B based on RNA-seq studies.

WB:WBGene00219761	linc-143
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00219762	linc-159
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00219763	linc-94
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219764	anr-47
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00219765	linc-165
No description available

WB:WBGene00219766	anr-42
Is affected by cox-5B and adr-1 based on RNA-seq studies.

WB:WBGene00219767	linc-131
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219768	linc-160
No description available

WB:WBGene00219769	linc-64
Is affected by several genes including daf-2; cep-1; and smg-1 based on RNA-seq and microarray studies.

WB:WBGene00219770	linc-40
Is affected by several genes including daf-2; skn-1; and npr-1 based on RNA-seq and microarray studies. Is affected by D-glucopyranose; Zidovudine; and paraquat based on RNA-seq studies.

WB:WBGene00219771	linc-24
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; cep-1; and sod-2 based on RNA-seq studies. Is affected by graphene oxide and stavudine based on RNA-seq studies.

WB:WBGene00219772	anr-53
No description available

WB:WBGene00219773	linc-32
Is affected by daf-2; meg-3; and meg-4 based on microarray and RNA-seq studies.

WB:WBGene00219774	F33A8.12
No description available

WB:WBGene00219775	F33A8.13
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00219776	AH9.9
No description available

WB:WBGene00219777	AH10.10
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219778	B0025.7
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and atfs-1 based on RNA-seq studies.

WB:WBGene00219779	B0025.8
Is affected by dpy-21; daf-2; and eat-2 based on RNA-seq and microarray studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00219780	B0228.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including daf-2; cep-1; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00219781	B0240.7
No description available

WB:WBGene00219782	B0250.19
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219783	B0285.17
Is affected by dpy-21; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00219784	B0348.8
No description available

WB:WBGene00219785	B0350.85
No description available

WB:WBGene00219786	B0365.10
Is affected by cep-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219787	B0379.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219788	B0379.13
No description available

WB:WBGene00219789	B0511.18
Is affected by cep-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00219790	B0524.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219791	C01B10.48
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219792	C01B10.49
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219793	C01F6.15
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00219794	C02C6.13
No description available

WB:WBGene00219795	C02F5.15
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00219796	C03D6.9
Is affected by several genes including daf-2; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00219797	C04A2.16
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219798	C04F12.17
No description available

WB:WBGene00219799	C05A9.12
No description available

WB:WBGene00219800	C05D9.12
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsf-1; prg-1; and sma-2 based on RNA-seq studies. Is affected by metformin based on RNA-seq studies.

WB:WBGene00219801	C05E4.16
No description available

WB:WBGene00219803	C06A1.12
Is enriched in body wall musculature and germ line based on RNA-seq and microarray studies. Is affected by several genes including dpy-10; hsf-1; and cep-1 based on RNA-seq and microarray studies. Is affected by eight chemicals including Zidovudine; antimycin; and Deoxyglucose based on RNA-seq and microarray studies.

WB:WBGene00219804	C06E7.95
No description available

WB:WBGene00219805	C07A12.19
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00219806	C07E3.17
Is affected by daf-16; skn-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00219807	C07H6.19
No description available

WB:WBGene00219808	C09H10.19
No description available

WB:WBGene00219809	C09H10.20
No description available

WB:WBGene00219810	mir-8196.2
Is affected by several genes including meg-3; meg-4; and ints-8 based on RNA-seq studies.

WB:WBGene00219811	C12C8.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219812	C13C12.7
No description available

WB:WBGene00219813	C14A11.13
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219814	C14A11.14
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219815	C14B9.15
No description available

WB:WBGene00219816	C14E2.12
Is affected by several genes including daf-2; hsf-1; and cep-1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00219817	C15A11.10
No description available

WB:WBGene00219818	C15F1.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219819	C16D2.4
No description available

WB:WBGene00219820	C17D12.17
No description available

WB:WBGene00219821	C17D12.18
Is affected by dlc-1 and sek-1 based on RNA-seq studies. Is affected by Tunicamycin; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00219822	C17H12.36
Is affected by several genes including cep-1; dlc-1; and smn-1 based on RNA-seq and microarray studies.

WB:WBGene00219823	C18A3.24
Is enriched in RID based on RNA-seq studies. Is affected by unc-39 based on RNA-seq studies.

WB:WBGene00219824	C18C4.17
Is affected by several genes including cep-1; dpy-21; and ptl-1 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00219825	C18D1.21
No description available

WB:WBGene00219826	C18H9.12
Is affected by several genes including daf-2; cep-1; and nuo-6 based on RNA-seq studies.

WB:WBGene00219827	C23G10.12
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219828	C24A1.8
No description available

WB:WBGene00219829	C24G6.12
No description available

WB:WBGene00219830	C24G7.6
Is affected by spc-1 based on RNA-seq studies.

WB:WBGene00219831	C25F6.30
Is affected by cep-1 and sek-1 based on RNA-seq studies. Is affected by stavudine and Zidovudine based on RNA-seq studies.

WB:WBGene00219832	C26B2.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219833	C26C6.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219834	C26C6.13
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219835	C26C6.14
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219836	C26G2.11
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219837	C28D4.17
No description available

WB:WBGene00219838	C28H8.14
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-16; hsf-1; and cep-1 based on RNA-seq studies. Is affected by Zidovudine and paraquat based on RNA-seq studies.

WB:WBGene00219839	C29F5.11
No description available

WB:WBGene00219840	C29F9.15
Is enriched in somatic gonad precursor based on RNA-seq studies.

WB:WBGene00219841	C30C11.14
Is affected by daf-2 based on microarray studies.

WB:WBGene00219842	C30C11.15
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00219843	C30D11.6
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219844	C30G12.9
No description available

WB:WBGene00219845	C32F10.9
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219846	C33E10.11
No description available

WB:WBGene00219847	C34E11.20
Is affected by several genes including daf-12; smn-1; and adr-1 based on RNA-seq studies.

WB:WBGene00219848	C34F6.18
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219849	C36C9.10
Is enriched in RIS; germ line; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; hsf-1; and clk-1 based on RNA-seq and microarray studies. Is affected by graphene oxide based on RNA-seq studies.

WB:WBGene00219850	C36E8.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219851	C37C3.16
No description available

WB:WBGene00219852	C41C4.16
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219853	C41C4.17
No description available

WB:WBGene00219854	C41C4.18
Is affected by prg-1 and hsf-1 based on RNA-seq studies.

WB:WBGene00219855	C41C4.19
No description available

WB:WBGene00219856	C41C4.20
Is affected by daf-2 based on microarray studies.

WB:WBGene00219857	C45E1.10
No description available

WB:WBGene00219858	C46A5.15
No description available

WB:WBGene00219859	C49F5.11
Is affected by several genes including daf-2; nuo-6; and pptr-1 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00219860	C51F7.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219861	C52D10.131
No description available

WB:WBGene00219862	C52G5.13
No description available

WB:WBGene00219863	C54G4.16
No description available

WB:WBGene00219864	C56G2.20
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219865	C56G2.21
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219866	D1054.23
Is affected by several genes including daf-2; cep-1; and prg-1 based on RNA-seq and microarray studies.

WB:WBGene00219867	D2013.13
No description available

WB:WBGene00219868	D2021.6
No description available

WB:WBGene00219869	D2023.18
No description available

WB:WBGene00219870	D2092.15
No description available

WB:WBGene00219871	E01A2.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219872	E04F6.17
No description available

WB:WBGene00219873	EEED8.19
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219874	F01D4.12
No description available

WB:WBGene00219875	F01E11.19
No description available

WB:WBGene00219876	F01G12.19
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00219877	F02D10.15
No description available

WB:WBGene00219878	F02G3.8
No description available

WB:WBGene00219879	F07A11.15
No description available

WB:WBGene00219880	F07C4.17
No description available

WB:WBGene00219881	F08B1.8
Is affected by dpy-21 and dlc-1 based on RNA-seq studies.

WB:WBGene00219882	F08B6.7
No description available

WB:WBGene00219883	F09B9.8
No description available

WB:WBGene00219884	F09E10.13
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219885	F09E10.14
Is affected by kri-1 and mpk-2 based on RNA-seq studies.

WB:WBGene00219886	F09E10.15
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including sek-1; isp-1; and prg-1 based on RNA-seq studies.

WB:WBGene00219887	F09E10.16
Is affected by adr-2; daf-2; and ints-2 based on RNA-seq and microarray studies.

WB:WBGene00219888	F09G2.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219889	F10E9.23
No description available

WB:WBGene00219890	F12A10.13
No description available

WB:WBGene00219891	F12F6.20
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219892	F14F3.17
No description available

WB:WBGene00219893	F15A8.19
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00219894	F16A11.12
No description available

WB:WBGene00219895	F16A11.13
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219896	F16H9.5
No description available

WB:WBGene00219897	F16H9.6
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00219898	F17C8.13
Is affected by eat-2 based on microarray studies.

WB:WBGene00219899	F17C11.24
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00219900	F17C11.25
No description available

WB:WBGene00219901	F18A1.11
No description available

WB:WBGene00219902	F18C5.15
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219903	F18H3.7
No description available

WB:WBGene00219904	F19C6.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by ins-11 and dlc-1 based on RNA-seq studies.

WB:WBGene00219905	F19F10.13
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including skn-1; prg-1; and kri-1 based on RNA-seq studies.

WB:WBGene00219906	F19G12.14
No description available

WB:WBGene00219907	F19H8.7
Is affected by smn-1 and ints-4 based on RNA-seq studies.

WB:WBGene00219908	F20C5.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including hsp-6; dlc-1; and iff-1 based on microarray and RNA-seq studies. Is affected by stavudine; Zidovudine; and antimycin based on RNA-seq studies.

WB:WBGene00219909	F20D12.10
Is affected by dpy-21 and adr-1 based on RNA-seq studies.

WB:WBGene00219910	F21F12.2
Is affected by several genes including daf-2; pgl-1; and mex-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Rotenone; multi-walled carbon nanotube; and Psoralens based on RNA-seq studies.

WB:WBGene00219911	F21F12.3
No description available

WB:WBGene00219912	F22H10.10
Is affected by several genes including sek-1; cep-1; and unc-70 based on RNA-seq studies. Is affected by metformin based on RNA-seq studies.

WB:WBGene00219913	F23B12.12
No description available

WB:WBGene00219914	F25G6.21
No description available

WB:WBGene00219915	F26A10.28
Is affected by several genes including daf-2; hsp-6; and atfs-1 based on microarray and RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00219916	F26D10.23
No description available

WB:WBGene00219917	F26D10.24
Is affected by several genes including cep-1; prg-1; and his-72 based on RNA-seq studies.

WB:WBGene00219918	F27C1.18
Is affected by several genes including daf-2; clk-1; and isp-1 based on RNA-seq studies. Is affected by antimycin and paraquat based on RNA-seq studies.

WB:WBGene00219919	F27D4.10
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219920	F27D4.11
No description available

WB:WBGene00219921	F28B1.13
No description available

WB:WBGene00219922	F28C10.5
Is affected by dpy-21 based on RNA-seq studies. Is affected by Testosterone based on microarray studies.

WB:WBGene00219923	F28D9.6
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00219924	F29F11.21
No description available

WB:WBGene00219925	F29G9.19
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219926	F30A10.16
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219927	F31C3.17
No description available

WB:WBGene00219928	F32A5.11
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219929	F32B4.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219930	F32B5.17
No description available

WB:WBGene00219931	F33C8.10
No description available

WB:WBGene00219932	F33E11.7
Is affected by adr-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219933	F35D11.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219934	F35F11.4
No description available

WB:WBGene00219935	F36H1.17
No description available

WB:WBGene00219936	F37A8.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219937	F37F2.4
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219938	F38B7.16
No description available

WB:WBGene00219939	F38H4.16
Is affected by lin-14 and lin-4 based on microarray studies.

WB:WBGene00219940	F39B2.14
Is enriched in AVK based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219941	F40F11.6
Is affected by ints-5 based on RNA-seq studies.

WB:WBGene00219942	F40H6.8
Is affected by cep-1; dpy-21; and adr-1 based on RNA-seq studies.

WB:WBGene00219943	F41D3.16
No description available

WB:WBGene00219944	F41E6.18
Is affected by prg-1 and cep-1 based on RNA-seq studies.

WB:WBGene00219945	F42A8.4
No description available

WB:WBGene00219946	F42H10.17
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00219947	F44A2.13
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00219948	F44E2.12
Is affected by prg-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00219949	F44E5.16
Is affected by several genes including daf-2; rrf-3; and ptl-1 based on RNA-seq and microarray studies.

WB:WBGene00219950	F46A8.13
Is enriched in neurons based on microarray studies. Is affected by several genes including rrf-3; hsf-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by ten chemicals including Tunicamycin; bisphenol S; and glycine based on RNA-seq and microarray studies.

WB:WBGene00219951	F46A9.12
Is affected by spc-1 based on RNA-seq studies.

WB:WBGene00219952	F46H6.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219953	F47B3.9
No description available

WB:WBGene00219954	F47E1.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00219955	F48A9.6
No description available

WB:WBGene00219956	F48A11.10
Is affected by cox-5B and sir-2.1 based on RNA-seq and microarray studies. Is affected by tetrabromobisphenol A based on microarray studies.

WB:WBGene00219957	F48F5.7
No description available

WB:WBGene00219958	F49E7.5
No description available

WB:WBGene00219959	F52D2.14
Is affected by several genes including daf-2; kri-1; and mpk-2 based on microarray and RNA-seq studies.

WB:WBGene00219960	F52D10.13
No description available

WB:WBGene00219961	F52E1.17
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219962	F52E10.11
Is affected by dpy-21 and adr-1 based on RNA-seq studies.

WB:WBGene00219963	F52E10.12
No description available

WB:WBGene00219964	F52G3.6
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies.

WB:WBGene00219965	F54A3.11
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00219966	F54E2.7
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219967	F54E4.17
No description available

WB:WBGene00219968	F54F2.13
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00219969	F54F11.6
Is enriched in germ line based on RNA-seq studies. Is affected by meg-3; meg-4; and sftb-1 based on RNA-seq studies.

WB:WBGene00219970	F54F12.6
No description available

WB:WBGene00219971	F54G2.4
Is enriched in AVK and RID based on RNA-seq studies. Is affected by unc-39 and smg-2 based on RNA-seq studies.

WB:WBGene00219972	F55A3.8
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219973	F55C7.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00219974	F55F1.11
No description available

WB:WBGene00219975	F55F3.9
No description available

WB:WBGene00219976	F55H12.9
Is affected by several genes including daf-2; sma-4; and met-2 based on RNA-seq and microarray studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00219977	F56A8.10
No description available

WB:WBGene00219978	F56A11.14
No description available

WB:WBGene00219979	F56A12.11
Is affected by several genes including cep-1; smn-1; and cox-5B based on RNA-seq studies. Is affected by glycine and Cadmium Chloride based on RNA-seq studies.

WB:WBGene00219980	F56D1.17
No description available

WB:WBGene00219981	F57G12.16
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219982	F58B4.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219983	F58D5.11
Is affected by several genes including cep-1; prg-1; and dpy-21 based on RNA-seq studies. Is affected by Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00219984	F58D5.12
Is affected by prg-1; sma-4; and damt-1 based on RNA-seq studies. Is affected by Zidovudine and antimycin based on RNA-seq studies.

WB:WBGene00219985	F58D5.13
Is affected by nuo-6 and sek-1 based on RNA-seq studies.

WB:WBGene00219986	F59A2.7
No description available

WB:WBGene00219987	F59C6.19
Is enriched in germ line and muscle cell based on RNA-seq studies. Is affected by sir-2.1 based on microarray studies. Is affected by Ethanol based on microarray studies.

WB:WBGene00219988	F59G1.14
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219989	H06I04.14
Is enriched in muscle cell based on microarray studies. Is affected by resveratrol; Cry5B; and Sirolimus based on microarray studies.

WB:WBGene00219990	H20J18.2
No description available

WB:WBGene00219991	H21P03.11
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00219992	H24G06.5
No description available

WB:WBGene00219994	H34C03.21
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219995	H36L18.5
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00219996	H40L08.6
Is affected by dpy-21 and thoc-5 based on RNA-seq studies.

WB:WBGene00219997	K02A6.6
Is affected by unc-70 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00219998	K02A11.12
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00219999	K02B9.10
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00220000	K02F2.11
Is enriched in AVK; intestine; and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including eat-2; hsp-6; and dlc-1 based on RNA-seq and microarray studies.

WB:WBGene00220001	K02F3.15
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00220002	K02F6.11
Is affected by daf-2 and sftb-1 based on microarray and RNA-seq studies.

WB:WBGene00220003	K02G10.16
Is affected by prg-1 and cep-1 based on RNA-seq studies.

WB:WBGene00220004	K03E5.9
Is affected by several genes including daf-2; sma-4; and dlc-1 based on RNA-seq and microarray studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00220005	K04D7.17
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220006	K04F10.9
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including cep-1; sma-2; and sma-4 based on RNA-seq studies.

WB:WBGene00220007	K06A4.15
Is enriched in intestine based on RNA-seq studies. Is affected by cep-1; dlc-1; and wdr-5.1 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00220008	K07C5.18
Is affected by ints-9 based on RNA-seq studies.

WB:WBGene00220009	K07E1.2
Is affected by cep-1; dpy-21; and smn-1 based on RNA-seq studies.

WB:WBGene00220010	K07G5.7
Is affected by several genes including cep-1; sma-4; and dpy-21 based on RNA-seq studies.

WB:WBGene00220011	K08B5.8
Is enriched in germ line based on RNA-seq studies. Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00220012	K08F11.8
No description available

WB:WBGene00220013	K09E10.5
No description available

WB:WBGene00220014	K09F5.14
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220015	K09H9.11
Is affected by damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00220016	K10C3.13
Is affected by prg-1 and damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00220017	K10D2.10
No description available

WB:WBGene00220018	K10D3.9
Is enriched in somatic gonad precursor based on RNA-seq studies.

WB:WBGene00220019	K10D3.10
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including hsf-1; cep-1; and smg-2 based on RNA-seq studies.

WB:WBGene00220020	K10F12.9
No description available

WB:WBGene00220021	K10G6.10
No description available

WB:WBGene00220022	K10G6.11
No description available

WB:WBGene00220023	K11C4.14
Is enriched in neurons based on microarray studies. Is affected by prg-1 and dcr-1 based on RNA-seq and microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00220024	K11D9.10
Is affected by dpy-21; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00220025	K11E8.7
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220026	M01D1.11
No description available

WB:WBGene00220027	M01D7.11
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00220028	M03A8.6
No description available

WB:WBGene00220029	M03D4.78
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00220030	M03F4.13
Is affected by spc-1 and unc-70 based on RNA-seq studies.

WB:WBGene00220031	M04G7.4
No description available

WB:WBGene00220032	M7.15
No description available

WB:WBGene00220033	M18.11
No description available

WB:WBGene00220034	M57.3
Is affected by eat-2 based on microarray studies.

WB:WBGene00220035	M60.15
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220036	R07B7.20
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00220037	R07G3.16
No description available

WB:WBGene00220038	R08C7.19
No description available

WB:WBGene00220039	R10A10.3
No description available

WB:WBGene00220040	R10E11.13
Is enriched in germ line based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00220041	R11A5.8
Is affected by cep-1; dpy-21; and dlc-1 based on RNA-seq studies.

WB:WBGene00220042	R11E3.18
Is affected by dlc-1; smn-1; and wdr-5.1 based on RNA-seq studies.

WB:WBGene00220043	R12C12.13
No description available

WB:WBGene00220044	R13G10.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220045	R31.6
No description available

WB:WBGene00220046	R31.7
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220047	R74.11
Is affected by adr-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220048	R106.6
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including cep-1; prg-1; and ins-11 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00220049	R106.7
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including sek-1; cep-1; and sma-4 based on RNA-seq studies. Is affected by stavudine based on RNA-seq studies.

WB:WBGene00220050	R144.18
Is affected by prg-1; cep-1; and mdt-15 based on RNA-seq studies. Is affected by D-glucopyranose based on RNA-seq studies.

WB:WBGene00220051	R160.11
Is affected by several genes including daf-2; dlc-1; and adr-1 based on microarray and RNA-seq studies.

WB:WBGene00220052	R166.10
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220053	R166.11
No description available

WB:WBGene00220054	T01A4.8
No description available

WB:WBGene00220055	mir-8196.1
Is expressed in head neurons and tail neurons.

WB:WBGene00220056	T01C2.6
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220057	T04C9.13
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220058	T05A6.20
No description available

WB:WBGene00220059	T06E4.20
No description available

WB:WBGene00220060	T07D3.12
No description available

WB:WBGene00220061	T07D4.7
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00220062	T08D2.11
Is affected by cep-1 and wdr-5.1 based on RNA-seq studies.

WB:WBGene00220063	T08H4.9
No description available

WB:WBGene00220064	T09B4.21
Is affected by adr-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220065	T09B4.22
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220066	T09B9.10
Is affected by several genes including cep-1; prg-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00220067	T12B3.10
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00220068	T12D8.12
No description available

WB:WBGene00220069	T13E5.1
Is affected by cep-1 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00220070	T14F9.22
No description available

WB:WBGene00220071	T15H9.8
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220072	T19C3.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220073	T19E7.29
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220074	T20B12.12
No description available

WB:WBGene00220075	T21B4.20
No description available

WB:WBGene00220076	T21B4.21
Is affected by several genes including rrf-3; sek-1; and sma-2 based on RNA-seq studies. Is affected by Zidovudine and glycine based on RNA-seq studies.

WB:WBGene00220077	T21C12.12
Is affected by several genes including cep-1; sma-2; and sma-4 based on RNA-seq studies.

WB:WBGene00220078	T21F2.3
Is affected by ints-9 based on RNA-seq studies.

WB:WBGene00220079	T21H8.10
No description available

WB:WBGene00220080	T21H8.11
No description available

WB:WBGene00220081	T22C1.17
Is affected by adr-1 and daf-12 based on RNA-seq studies.

WB:WBGene00220082	T22C8.10
No description available

WB:WBGene00220083	T23B12.13
No description available

WB:WBGene00220084	T23B12.14
Is affected by several genes including skn-1; sir-2.1; and isp-1 based on RNA-seq and microarray studies. Is affected by Alovudine based on RNA-seq studies.

WB:WBGene00220085	T23D8.11
No description available

WB:WBGene00220086	T23D8.12
Is affected by several genes including gld-1; aak-2; and isp-1 based on microarray studies. Is affected by five chemicals including Hydrolyzable Tannins; Humic Substances; and dafa#1 based on microarray studies.

WB:WBGene00220087	T23D8.13
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; sek-1; and prg-1 based on RNA-seq studies. Is affected by stavudine and Zidovudine based on RNA-seq studies.

WB:WBGene00220088	T23F11.12
No description available

WB:WBGene00220089	T23G11.12
Is affected by meg-3 and meg-4 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00220090	T24B8.22
Is affected by daf-2 and unc-70 based on microarray and RNA-seq studies.

WB:WBGene00220091	T24B8.23
Is affected by dlc-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00220092	T24H10.12
Is affected by cep-1; dlc-1; and ints-4 based on RNA-seq studies.

WB:WBGene00220093	T25C12.11
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including skn-1; sek-1; and cep-1 based on RNA-seq studies. Is affected by stavudine; Zidovudine; and paraquat based on RNA-seq studies.

WB:WBGene00220094	T25C12.12
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including sek-1; prg-1; and sma-4 based on RNA-seq studies. Is affected by stavudine; Zidovudine; and paraquat based on RNA-seq studies.

WB:WBGene00220095	T25D3.8
No description available

WB:WBGene00220096	T25D10.11
No description available

WB:WBGene00220097	T25G12.15
No description available

WB:WBGene00220098	T26C11.10
Is affected by daf-2 based on microarray studies.

WB:WBGene00220099	T26H10.10
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220100	T27A3.12
No description available

WB:WBGene00220101	T27A8.8
Is affected by daf-2 based on microarray studies.

WB:WBGene00220102	T27C4.7
No description available

WB:WBGene00220104	T27E4.22
Is affected by several genes including daf-16; cep-1; and dpy-21 based on RNA-seq studies.

WB:WBGene00220105	T27E9.11
No description available

WB:WBGene00220106	T28B8.11
No description available

WB:WBGene00220107	W01A11.21
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220108	W01D2.9
Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00220109	W01F3.4
Is affected by prg-1; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00220110	W01F3.5
Is affected by prg-1; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00220111	W01H2.11
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220112	W02B9.3
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00220113	W02C12.4
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00220114	W02H5.17
Is affected by dpy-21; ins-11; and dlc-1 based on RNA-seq studies.

WB:WBGene00220115	W02H5.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220116	W03A5.8
Is enriched in intestine based on RNA-seq studies. Is affected by unc-70 and ints-4 based on RNA-seq studies.

WB:WBGene00220117	W03B1.17
Is affected by several genes including cep-1; dlc-1; and ptrn-1 based on RNA-seq studies.

WB:WBGene00220118	W03D8.13
Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq and microarray studies.

WB:WBGene00220119	W04D12.2
Is affected by several genes including daf-2; eat-2; and cep-1 based on RNA-seq and microarray studies.

WB:WBGene00220120	W05G11.7
No description available

WB:WBGene00220121	W06A7.12
Is affected by dlc-1 and ints-4 based on RNA-seq studies.

WB:WBGene00220122	W06D12.9
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00220123	W06H8.16
Is affected by cox-5B and dlc-1 based on RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00220124	W06H8.17
No description available

WB:WBGene00220125	W07G1.23
Is affected by ints-5; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00220126	W10C8.17
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220127	W10D5.5
No description available

WB:WBGene00220128	Y6B3B.15
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220129	Y10G11A.91
No description available

WB:WBGene00220130	Y10G11A.92
No description available

WB:WBGene00220131	Y11D7A.21
Is affected by several genes including sir-2.1; cep-1; and damt-1 based on RNA-seq and microarray studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00220132	Y11D7A.22
No description available

WB:WBGene00220133	Y14H12A.4
Is affected by prg-1 and ceh-60 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00220134	Y17G7B.25
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00220135	Y18D10A.29
No description available

WB:WBGene00220136	Y20F4.11
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220137	Y24D9A.13
Is affected by single-walled carbon nanotube and allantoin based on microarray studies.

WB:WBGene00220138	Y32F6B.8
Is affected by dpy-21 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00220139	Y32G9A.15
No description available

WB:WBGene00220140	Y34F4.7
Is affected by several genes including rrf-3; smg-2; and mir-60 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00220141	Y37E11AR.9
Is enriched in neurons based on microarray studies. Is affected by fbf-1; ash-2; and tdp-1 based on microarray studies. Is affected by Humic Substances; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00220142	Y37F4.15
Is enriched in head mesodermal cell based on RNA-seq studies.

WB:WBGene00220143	Y38E10A.32
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220144	Y39A1A.30
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00220145	Y39A3CR.11
No description available

WB:WBGene00220146	Y40A1A.5
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00220147	Y40B1A.6
Is affected by cep-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220148	Y40B1B.10
No description available

WB:WBGene00220149	Y40H7A.310
No description available

WB:WBGene00220150	Y41C4A.30
No description available

WB:WBGene00220151	Y41C4A.31
No description available

WB:WBGene00220152	Y41D4B.33
Is affected by cep-1 and dpy-21 based on RNA-seq studies.

WB:WBGene00220153	Y41D4B.34
Is affected by several genes including dpy-10; fbf-1; and dpy-21 based on RNA-seq and microarray studies. Is affected by paraquat and Sirolimus based on microarray studies.

WB:WBGene00220154	Y41D4B.35
No description available

WB:WBGene00220155	Y41D4B.36
No description available

WB:WBGene00220156	Y41E3.463
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220157	Y41E3.464
No description available

WB:WBGene00220158	Y41G9A.16
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220159	Y44A6C.3
Is affected by cep-1; dpy-21; and adr-1 based on RNA-seq studies.

WB:WBGene00220160	Y44A6C.4
Is affected by dpy-21 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00220161	Y46E12BL.11
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00220162	Y46E12BM.1
Is affected by four chemicals including Microcystin-LR; adsorbable organic bromine compound; and allantoin based on microarray studies.

WB:WBGene00220163	Y47D3A.35
Is affected by prg-1; adr-2; and damt-1 based on RNA-seq studies. Is affected by antimycin and graphene oxide based on RNA-seq studies.

WB:WBGene00220164	Y47D3B.25
No description available

WB:WBGene00220165	Y47G6A.36
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; cep-1; and sma-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Tunicamycin; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies.

WB:WBGene00220166	Y47G6A.37
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00220167	Y47G6A.38
Is affected by ints-4 based on RNA-seq studies.

WB:WBGene00220168	Y48A6C.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including dpy-21; adr-2; and meg-3 based on RNA-seq studies.

WB:WBGene00220169	Y48B6A.25
Is affected by cep-1 based on RNA-seq studies. Is affected by Tunicamycin based on RNA-seq studies.

WB:WBGene00220170	Y48C3A.25
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220171	Y48G10A.9
Is affected by several genes including cep-1; prg-1; and sma-2 based on RNA-seq studies.

WB:WBGene00220172	Y49E10.36
Is affected by several genes including sek-1; dpy-21; and his-72 based on RNA-seq studies.

WB:WBGene00220173	Y50D4C.11
No description available

WB:WBGene00220174	Y51A2D.40
No description available

WB:WBGene00220175	Y51H4A.939
Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

WB:WBGene00220176	Y51H4A.940
No description available

WB:WBGene00220177	Y51H7BM.2
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220178	Y52D3.2
Is affected by dpy-21 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00220179	Y54E10A.29
Is affected by zip-3 based on RNA-seq studies.

WB:WBGene00220180	Y54G2A.74
Is affected by cep-1 based on RNA-seq studies. Is affected by metformin based on RNA-seq studies.

WB:WBGene00220181	Y55F3AM.23
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220182	Y55F3BL.5
Is affected by unc-70 based on RNA-seq studies.

WB:WBGene00220183	Y55F3BR.19
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220184	Y57A10A.44
No description available

WB:WBGene00220185	Y57G11C.1145
No description available

WB:WBGene00220186	Y57G11C.1146
No description available

WB:WBGene00220187	Y62F5A.16
Is affected by cep-1 and adr-1 based on RNA-seq studies.

WB:WBGene00220188	Y65B4A.10
Is affected by several genes including daf-2; fbf-1; and sma-2 based on RNA-seq and microarray studies.

WB:WBGene00220189	Y65B4A.11
Is affected by several genes including daf-2; prg-1; and atfs-1 based on RNA-seq and microarray studies.

WB:WBGene00220190	Y65B4BM.2
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by several genes including glp-1; skn-1; and sek-1 based on RNA-seq studies. Is affected by Alovudine; Zidovudine; and antimycin based on RNA-seq studies.

WB:WBGene00220191	Y65B4BR.12
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220192	Y66H1B.6
No description available

WB:WBGene00220193	Y67D2.11
No description available

WB:WBGene00220194	Y69E1A.15
Is affected by dpy-21 and zip-3 based on RNA-seq studies.

WB:WBGene00220195	Y71F9AL.24
No description available

WB:WBGene00220196	Y71G10AR.5
No description available

WB:WBGene00220197	Y71G12B.41
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220198	Y71G12B.42
Is affected by prg-1; his-3; and unc-70 based on RNA-seq studies. Is affected by Tunicamycin and stavudine based on RNA-seq studies.

WB:WBGene00220199	Y71H2AM.28
Is affected by prg-1; smn-1; and unc-70 based on RNA-seq studies.

WB:WBGene00220200	Y71H2B.12
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00220201	Y73B3A.30
No description available

WB:WBGene00220202	Y73B3A.31
No description available

WB:WBGene00220203	Y73B6A.14
No description available

WB:WBGene00220204	Y73B6A.15
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220205	Y73F8A.1175
No description available

WB:WBGene00220206	Y75B7AL.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220207	Y75B8A.62
Is affected by sek-1; unc-70; and sin-3 based on RNA-seq studies.

WB:WBGene00220208	Y75B12B.16
Is enriched in germ line based on RNA-seq studies. Is affected by cep-1 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

WB:WBGene00220209	Y75D11A.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220210	Y76A2B.10
No description available

WB:WBGene00220211	Y76B12C.11
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00220212	Y76G2B.1
Is affected by daf-2 based on microarray studies.

WB:WBGene00220213	Y77E11A.21
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220214	Y79H2A.14
No description available

WB:WBGene00220215	Y92C3B.4
Is affected by uaf-1 and sin-3 based on RNA-seq studies.

WB:WBGene00220216	Y94H6A.15
No description available

WB:WBGene00220217	Y95B8A.18
Is affected by daf-2 based on microarray studies.

WB:WBGene00220218	Y102A5D.22
No description available

WB:WBGene00220219	Y102A11A.16
No description available

WB:WBGene00220220	Y102A11A.17
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220221	Y105C5A.1282
No description available

WB:WBGene00220222	Y105C5A.1283
No description available

WB:WBGene00220223	Y105C5A.1284
Is enriched in germ line based on RNA-seq studies.

WB:WBGene00220224	Y105C5B.1419
Is affected by daf-2 based on microarray studies.

WB:WBGene00220225	Y105E8A.50
Is affected by several genes including daf-2; hsp-6; and atfs-1 based on microarray and RNA-seq studies. Is affected by Zidovudine and antimycin based on RNA-seq studies.

WB:WBGene00220226	Y105E8B.15
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220227	Y110A2AL.20
No description available

WB:WBGene00220228	Y111B2A.34
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00220229	Y111B2A.35
Is affected by daf-2 based on microarray studies.

WB:WBGene00220230	Y111B2A.36
Is affected by prg-1 based on RNA-seq studies.

WB:WBGene00220231	Y119C1B.13
No description available

WB:WBGene00220232	ZC334.17
No description available

WB:WBGene00220233	ZC395.12
Is affected by cep-1 and ins-11 based on RNA-seq studies.

WB:WBGene00220234	ZC410.9
No description available

WB:WBGene00220235	ZC412.15
No description available

WB:WBGene00220236	ZK20.9
Is affected by adr-2; dlc-1; and ints-4 based on RNA-seq studies.

WB:WBGene00220237	ZK20.10
No description available

WB:WBGene00220238	ZK185.9
Is affected by several genes including mir-71; dlc-1; and efa-6 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00220239	ZK218.23
No description available

WB:WBGene00220240	ZK270.4
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00220241	ZK270.5
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00220242	ZK328.11
No description available

WB:WBGene00220243	ZK484.11
Is affected by dpy-21 and ints-4 based on RNA-seq studies.

WB:WBGene00220244	ZK632.18
Is affected by cep-1 based on RNA-seq studies.

WB:WBGene00220245	ZK816.9
No description available

WB:WBGene00220246	ZK858.10
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq studies. Is affected by Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00220247	ZK892.10
No description available

WB:WBGene00220248	ZK930.15
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00220249	R144.19
No description available

WB:WBGene00220250	C09B9.85
Is predicted to have chloride channel activity. Human ortholog(s) of this gene are implicated in autosomal dominant vitreoretinochoroidopathy and retinal degeneration (multiple). Is an ortholog of human BEST1 (bestrophin 1); BEST2 (bestrophin 2); and BEST3 (bestrophin 3).

WB:WBGene00220251	F07C6.8
Is affected by ints-9 and spc-1 based on RNA-seq studies.

WB:WBGene00220252	C02F4.12
Is enriched in AVK based on RNA-seq studies. Is affected by adr-1 and dlc-1 based on RNA-seq studies.

WB:WBGene00220253	C05A2.4
Is enriched in pharynx based on RNA-seq studies. Is affected by dpy-21; hrpr-1; and eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00220254	Y105C5A.1285
No description available

WB:WBGene00220255	Y39B6A.83
No description available

WB:WBGene00220256	Y39B6A.84
No description available

WB:WBGene00220257	C02H6.3
Is affected by thoc-5 based on RNA-seq studies.

WB:WBGene00220258	C50C3.19
Is enriched in male based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on microarray and RNA-seq studies.

WB:WBGene00220259	ZK418.13
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; hsf-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00220260	Y105C5B.1420
Is affected by several genes including daf-2; rrf-3; and hsp-6 based on microarray and RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00220261	ZC434.10
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; antimycin; and glycine based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235003	F26F2.15
Is affected by smg-2 based on RNA-seq studies. Is affected by Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235080	mir-5592.1
Is affected by eat-2 and hrpk-1 based on RNA-seq studies.

WB:WBGene00235081	W06G6.21
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by ain-1 and eat-2 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00235084	mir-5594
Is affected by alg-5 based on RNA-seq studies.

WB:WBGene00235085	mir-5592.2
Is affected by eat-2 and hrpk-1 based on RNA-seq studies.

WB:WBGene00235086	T04C12.32
Is affected by cep-1 and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00235087	mir-5593.1
No description available

WB:WBGene00235088	mir-5593.2
No description available

WB:WBGene00235089	F46B3.24
Is affected by resveratrol based on microarray studies.

WB:WBGene00235090	C38D9.13
Is affected by several genes including daf-2; clk-1; and eat-2 based on RNA-seq studies. Is affected by four chemicals including Alovudine; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00235091	T08G3.15
Is affected by daf-2 and eat-2 based on microarray studies.

WB:WBGene00235092	C54F6.17
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including daf-2; let-60; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235093	C54F6.18
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and eat-2 based on RNA-seq and microarray studies. Is affected by nine chemicals including stavudine; Sodium Chloride; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235094	K08D9.9
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including bisphenol S; metformin; and Psoralens based on RNA-seq studies.

WB:WBGene00235095	B0035.21
Is enriched in intestine based on RNA-seq studies. Is affected by ins-11 and rrf-3 based on RNA-seq studies. Is affected by metformin and Sirolimus based on RNA-seq studies.

WB:WBGene00235096	thrm-2
No description available

WB:WBGene00235097	thrm-3
No description available

WB:WBGene00235098	thrm-4
No description available

WB:WBGene00235099	thrm-5
No description available

WB:WBGene00235100	disp-1
No description available

WB:WBGene00235101	thrm-1
No description available

WB:WBGene00235102	dib-1
Is enriched in AFD; PLM; germ line; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including daf-2; gld-1; and aak-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; paraquat; and dibromoacetic acid based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Mitosis protein DIM1; Dim1 family; and Thioredoxin-like superfamily. Is an ortholog of human TXNL4A (thioredoxin like 4A).

WB:WBGene00235106	F08H9.15
Is affected by several genes including daf-2; dpy-10; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including antimycin; Humic Substances; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00235107	Y41E3.465
No description available

WB:WBGene00235108	Y69H2.28
Is affected by resveratrol based on microarray studies.

WB:WBGene00235109	Y57G11A.226
Is affected by cox-5B; adr-1; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00235110	T14G12.12
Is affected by several genes including rrf-3; sir-2.1; and pmk-1 based on RNA-seq and microarray studies. Is affected by glycine and multi-walled carbon nanotube based on RNA-seq studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00235111	C25G4.16
No description available

WB:WBGene00235112	T23B5.6
No description available

WB:WBGene00235113	ZK105.12
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and sir-2.1 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235114	ZK105.13
Is enriched in amphid sheath cell; arcade cell; and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00235115	F47C12.13
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by dlc-1 and eat-2 based on RNA-seq and microarray studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Caenorhabditis elegans protein of unknown function (DUF870) and Protein of unknown function DUF870, Caenorhabditis species.

WB:WBGene00235116	C03G6.21
Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srx and 7TM GPCR, serpentine receptor class x  (Srx).

WB:WBGene00235117	Y19D10B.8
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Receptor L domain and Receptor L-domain.

WB:WBGene00235118	K04A8.18
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by daf-2 based on microarray studies. Is affected by adsorbable organic bromine compound and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00235119	R105.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00235120	R105.5
Is affected by daf-2 and eat-2 based on microarray studies. Is predicted to encode a protein with the following domains: Vitelline membrane outer layer protein I (VOMI); Vitelline membrane outer layer protein I (VOMI); and Vitelline membrane outer layer protein I (VOMI) superfamily.

WB:WBGene00235121	LLC1.121
Is affected by several genes including eat-2; sma-2; and sma-4 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00235122	mnm-6
No description available

WB:WBGene00235123	mnm-7
No description available

WB:WBGene00235124	mnm-8
No description available

WB:WBGene00235128	F09E8.12
Is affected by daf-2 based on microarray studies.

WB:WBGene00235129	ZC518.8
Is affected by adr-1 and adr-2 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00235132	ZK792.12
Is affected by adr-1 and eat-2 based on RNA-seq studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00235133	T26H5.14
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and clk-1 based on RNA-seq studies. Is affected by ten chemicals including Alovudine; stavudine; and Zidovudine based on RNA-seq studies.

WB:WBGene00235134	R07H5.16
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00235138	C05C12.9
No description available

WB:WBGene00235139	C06H5.10
No description available

WB:WBGene00235143	R07H5.15
No description available

WB:WBGene00235146	Y48G10A.10
No description available

WB:WBGene00235147	Y60A3A.36
No description available

WB:WBGene00235148	Y60A3A.30
No description available

WB:WBGene00235150	Y71A12B.32
No description available

WB:WBGene00235151	Y116F11B.27
No description available

WB:WBGene00235152	Y7A5A.22
Is affected by dpy-21 based on RNA-seq studies. Is affected by paraquat and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00235153	Y7A5A.23
Is affected by unc-39 based on RNA-seq studies.

WB:WBGene00235157	T03D8.8
Is affected by adr-2; rpl-33; and rpl-5 based on RNA-seq studies.

WB:WBGene00235158	Y37E3.30
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by Rifampin and Psoralens based on RNA-seq studies.

WB:WBGene00235159	CD4.17
No description available

WB:WBGene00235160	CD4.18
Is affected by skn-1 and sftb-1 based on RNA-seq studies.

WB:WBGene00235161	CD4.19
Is affected by sftb-1 based on RNA-seq studies.

WB:WBGene00235162	B0361.13
Is affected by daf-2 based on microarray studies.

WB:WBGene00235163	Y108G3AL.10
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by dpy-21; sek-1; and sin-3 based on RNA-seq studies.

WB:WBGene00235164	K09F6.13
Is enriched in ASER; AVK; PLM; and RID based on RNA-seq studies. Is affected by several genes including rrf-3; daf-12; and eat-2 based on RNA-seq studies. Is affected by seven chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00235165	Y47D7A.18
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by allantoin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235166	K08F4.15
No description available

WB:WBGene00235167	F19B6.9
No description available

WB:WBGene00235175	F20D1.21
No description available

WB:WBGene00235179	F32D1.12
No description available

WB:WBGene00235180	F35B3.10
Is enriched in germ line based on RNA-seq studies.

WB:WBGene00235181	F35E12.13
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00235183	F36A4.23
No description available

WB:WBGene00235188	K09C6.12
No description available

WB:WBGene00235190	K10F12.10
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00235197	rrn-4.16
No description available

WB:WBGene00235198	T09H2.2
No description available

WB:WBGene00235200	T27A8.9
Is affected by daf-2 based on microarray studies.

WB:WBGene00235201	T27C5.19
No description available

WB:WBGene00235206	W07G1.24
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00235209	Y17G9A.90
No description available

WB:WBGene00235235	Y59E1B.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00235237	Y71A12B.33
No description available

WB:WBGene00235247	Y9C9A.111
No description available

WB:WBGene00235250	C28G1.t5
No description available

WB:WBGene00235251	K02D3.t1
No description available

WB:WBGene00235252	Y73B6BL.t2
Is affected by daf-2 based on microarray studies.

WB:WBGene00235254	F49D11.14
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by Rifampin and Psoralens based on RNA-seq studies.

WB:WBGene00235255	K10H10.15
Is affected by daf-2 based on microarray studies.

WB:WBGene00235256	Y54G11A.19
Is enriched in PLM based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and elt-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Alovudine; Zidovudine; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00235257	T05C7.4
Is affected by daf-2 based on microarray studies.

WB:WBGene00235258	T05C7.5
Is affected by elli-1 based on microarray studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00235259	T05C7.6
Is affected by elli-1; daf-12; and wdr-5.1 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00235260	T05C7.7
Is affected by adr-1 and eat-2 based on RNA-seq studies.

WB:WBGene00235261	T05C7.8
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00235262	T05C7.9
No description available

WB:WBGene00235263	Y66H1A.8
Is enriched in GABAergic neurons based on RNA-seq studies. Is affected by smg-1; eat-2; and sir-2.1 based on RNA-seq and microarray studies. Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00235264	M04G7.5
Is affected by eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235265	W03G1.11
Is affected by eat-2 and pptr-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00235266	Y77E11A.22
Is affected by several genes including eat-2; dpy-21; and adr-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235267	Y77E11A.23
Is enriched in hypodermis based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and dcr-1 based on RNA-seq and microarray studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00235268	Y54G2A.76
Is affected by several genes including daf-16; daf-2; and skn-1 based on RNA-seq and microarray studies. Is affected by six chemicals including stavudine; Zidovudine; and Psoralens based on RNA-seq studies.

WB:WBGene00235269	F59E12.15
Is predicted to have histone kinase activity (H3-T3 specific).

WB:WBGene00235270	F59E12.16
Is enriched in intestine; muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including daf-2; sir-2.1; and alg-1 based on RNA-seq and microarray studies. Is affected by Humic Substances; allantoin; and nitroguanidine based on microarray studies.

WB:WBGene00235271	C49C8.8
Is enriched in head mesodermal cell; intestine; neurons; and retrovesicular ganglion based on RNA-seq and microarray studies. Is affected by several genes including skn-1; elt-2; and eat-2 based on RNA-seq and microarray studies. Is affected by eight chemicals including Sodium Chloride; metformin; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00235272	Y43B11AL.5
Is affected by ins-11; eat-2; and daf-2 based on RNA-seq and microarray studies. Is affected by five chemicals including stavudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00235273	T11F8.12
Is enriched in ASER and PLM based on RNA-seq studies. Is affected by elli-1 and daf-12 based on microarray and RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235274	C54E4.12
Is affected by eat-2 and sin-3 based on RNA-seq studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235275	T09A12.8
Is affected by paraquat based on RNA-seq studies.

WB:WBGene00235276	D2096.16
Is enriched in germ line and head mesodermal cell based on RNA-seq studies. Is affected by several genes including eat-2; dpy-21; and dlc-1 based on RNA-seq studies. Is affected by five chemicals including metformin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00235277	T04C4.3
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by elli-1 based on microarray studies. Is affected by Alovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00235278	ZK185.10
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00235279	Y67D8C.22
Is enriched in pharynx based on RNA-seq studies. Is affected by several genes including daf-2; aak-2; and atfs-1 based on RNA-seq and microarray studies. Is affected by glycine and resveratrol based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in Usher syndrome type 3A and retinitis pigmentosa 61. Is predicted to encode a protein with the following domain: Clarin. Is an ortholog of human CLRN1 (clarin 1); CLRN2 (clarin 2); and CLRN3 (clarin 3).

WB:WBGene00235280	F42A9.17
Is enriched in intestine based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and hsp-6 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00235281	Y4C6A.68
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including daf-2; eat-2; and isp-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Sodium Chloride; Rifampin; and Psoralens based on RNA-seq studies.

WB:WBGene00235282	F17E9.18
Is affected by dpy-21; adr-1; and daf-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235283	Y55F3BL.6
Is predicted to encode a protein with the following domains: Proteolipid membrane potential modulator and Proteolipid membrane potential modulator.

WB:WBGene00235284	T12G3.11
Is affected by several genes including sir-2.1; dpl-1; and efl-1 based on RNA-seq and microarray studies.

WB:WBGene00235285	F56D6.18
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00235286	C01F6.16
Is affected by dlc-1 and sek-1 based on RNA-seq studies.

WB:WBGene00235287	Y55F3C.17
Is predicted to have microtubule binding activity.

WB:WBGene00235288	Y69A2AR.46
Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies.

WB:WBGene00235289	Y73B6BL.289
Is predicted to have gamma-tubulin binding activity. Is an ortholog of human BLOC1S2 (biogenesis of lysosomal organelles complex 1 subunit 2).

WB:WBGene00235290	Y59H11AR.10
Is affected by several genes including daf-2; rrf-3; and eat-2 based on microarray and RNA-seq studies. Is affected by four chemicals including antimycin; Diazinon; and paraquat based on RNA-seq and microarray studies.

WB:WBGene00235291	C01G5.25
Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq and microarray studies. Is affected by Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00235292	F28E10.16
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-2; smg-2; and mir-35 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq and microarray studies.

WB:WBGene00235293	F56D6.19
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by five chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00235294	Y69A2AR.47
Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by Humic Substances; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00235295	C42D4.19
Is affected by several genes including eat-2; mdt-15; and atfs-1 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235296	C07G1.15
Is affected by several genes including daf-2; skn-1; and elt-2 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00235297	F56D6.20
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and aak-2 based on RNA-seq and microarray studies. Is affected by Zidovudine; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00235298	F19B6.10
Is affected by several genes including elt-2; elt-7; and ints-9 based on RNA-seq studies.

WB:WBGene00235299	Y69A2AR.48
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00235300	T06A10.107
Is affected by several genes including daf-2; eat-2; and isp-1 based on RNA-seq and microarray studies. Is affected by Rifampin; allantoin; and antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235301	B0513.90
Is affected by hrpr-1 and adr-1 based on RNA-seq studies. Is affected by six chemicals including Zidovudine; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235302	C07C7.3
Is affected by dpy-21 and adr-1 based on RNA-seq studies.

WB:WBGene00235303	T13A10.64
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00235304	Y116A8C.468
Is affected by damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00235305	Y116A8C.469
Is affected by daf-2; hsp-6; and daf-12 based on microarray and RNA-seq studies.

WB:WBGene00235307	B0507.17
Is affected by several genes including sir-2.1; sek-1; and smn-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00235308	C37C3.17
Is affected by several genes including skn-1; eat-2; and dpy-7 based on RNA-seq studies. Is affected by five chemicals including Zidovudine; Rifampin; and allantoin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235309	F21C10.17
Is enriched in AFD and intestine based on RNA-seq studies. Is affected by several genes including daf-2; eat-2; and sek-1 based on RNA-seq studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00235310	R02D1.2
Is predicted to have catalytic activity. Is an ortholog of human PBLD (phenazine biosynthesis like protein domain containing).

WB:WBGene00235311	Y57E12B.11
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including eat-2; sek-1; and kri-1 based on RNA-seq studies. Is affected by five chemicals including allantoin; Sirolimus; and metformin based on RNA-seq studies.

WB:WBGene00235312	F28A12.10
Is enriched in seam cell based on RNA-seq studies. Is affected by spc-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00235313	C25E10.17
Is enriched in ASER and pharynx based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00235314	B0348.9
Is affected by several genes including daf-2; dpy-21; and unc-70 based on RNA-seq and microarray studies.

WB:WBGene00235315	Y50D4A.10
Is enriched in head mesodermal cell and intestine based on RNA-seq studies. Is affected by elt-2; daf-2; and nuo-6 based on RNA-seq studies. Is affected by six chemicals including Sodium Chloride; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00235316	B0222.15
Is predicted to encode a protein with the following domain: .

WB:WBGene00235317	K04A8.19
Is enriched in PLM based on RNA-seq studies. Is affected by adr-1 and daf-2 based on RNA-seq and microarray studies.

WB:WBGene00235318	K11D5.2
Is affected by several genes including daf-2; eat-2; and dpy-21 based on RNA-seq and microarray studies.

WB:WBGene00235319	F44E7.17
Is enriched in germ line based on RNA-seq studies. Is affected by iff-1 based on RNA-seq studies.

WB:WBGene00235320	R02F11.11
No description available

WB:WBGene00235321	Y73C8B.9
Is enriched in PLM based on RNA-seq studies. Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00235322	F32F2.4
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00235323	F15B9.15
No description available

WB:WBGene00235324	F10G2.10
Is affected by sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00235325	C08D8.7
Is enriched in AFD; ASER; AVK; intestine; and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including ain-2; nuo-6; and ins-11 based on RNA-seq and microarray studies. Is affected by paraquat; Colistin; and allantoin based on microarray studies.

WB:WBGene00235326	F22F7.11
Is affected by Rifampin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00235327	T02B11.10
Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00235328	T06E4.21
Is affected by ints-4 and sftb-1 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00235329	F37B4.15
Is affected by smn-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235330	F21C10.18
Is affected by several genes including daf-16; daf-2; and rrf-3 based on RNA-seq and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00235331	K07C11.14
No description available

WB:WBGene00235332	K04A8.20
Is enriched in intestine based on RNA-seq studies. Is affected by several genes including rrf-3; mdt-15; and spc-1 based on RNA-seq studies. Is affected by six chemicals including D-glucopyranose; Alovudine; and metformin based on RNA-seq studies.

WB:WBGene00235333	C24H12.18
Is affected by eat-2; daf-2; and pfd-6 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00235334	F31F7.9
Is affected by dpy-21 based on RNA-seq studies.

WB:WBGene00235335	R02D5.24
Is affected by metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00235336	C54F6.19
Is affected by daf-2 based on microarray studies.

WB:WBGene00235337	btr-2
No description available

WB:WBGene00235338	C24H12.19
Is affected by daf-2; eat-2; and rrf-2 based on microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies.

WB:WBGene00235339	F14F8.15
Is enriched in somatic gonad precursor based on RNA-seq studies. Is affected by Rifampin based on RNA-seq studies.

WB:WBGene00235340	C45G7.13
Is enriched in arcade cell and pharyngeal-intestinal valve cell based on RNA-seq studies. Is affected by several genes including daf-2; skn-1; and let-60 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and metformin based on RNA-seq and microarray studies.

WB:WBGene00235341	Y69A2AR.49
Is affected by rrf-3 based on RNA-seq studies.

WB:WBGene00235342	Y69A2AR.50
Is affected by adr-1 and rrf-3 based on RNA-seq studies.

WB:WBGene00235343	Y69A2AR.51
Is affected by several genes including aak-2; aak-1; and adr-1 based on RNA-seq studies.

WB:WBGene00235346	Y94H6A.16
Is affected by sod-2 and nmad-1 based on RNA-seq studies.

WB:WBGene00235348	Y94H6A.17
Is affected by several genes including daf-16; daf-2; and daf-12 based on RNA-seq and microarray studies.

WB:WBGene00235350	Y54G2A.77
Is predicted to have transmembrane signaling receptor activity.

WB:WBGene00235351	C32B5.18
Is affected by daf-2; eat-2; and sin-3 based on microarray and RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.

WB:WBGene00235352	ZK250.13
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and pmk-1 based on RNA-seq and microarray studies. Is affected by seven chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: FTH domain; F-box domain; F-box domain; Domain of unknown function DUF38, Caenorhabditis species; and F-box A protein FB155/FB224.

WB:WBGene00235353	Y67D8C.23
Is affected by several genes including daf-2; glp-1; and skn-1 based on RNA-seq studies. Is affected by six chemicals including Alovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00235354	ZK250.14
Is affected by several genes including daf-2; eat-2; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Chlorpyrifos; Diazinon; and paraquat based on microarray studies. Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00235355	ZK250.15
Is affected by several genes including daf-2; pptr-1; and adr-2 based on RNA-seq and microarray studies. Is affected by four chemicals including Psoralens; allantoin; and Rifampin based on RNA-seq studies.

WB:WBGene00235356	Y67D8A.10
Is enriched in germ line and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-16; daf-12; and dlc-1 based on RNA-seq studies. Is affected by Zidovudine based on RNA-seq studies.

WB:WBGene00235357	Y37E11B.16
No description available

WB:WBGene00235358	F56D6.21
Is affected by fluoranthene and allantoin based on microarray studies.

WB:WBGene00235359	F56D6.22
Is enriched in amphid sheath cell based on RNA-seq studies. Is affected by several genes including daf-2; rrf-3; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq studies.

WB:WBGene00235361	F56D6.23
Is affected by adr-1; daf-2; and eat-2 based on RNA-seq and microarray studies.

WB:WBGene00235362	Y46C8AL.12
Is affected by daf-2 and daf-16 based on microarray studies.

WB:WBGene00235363	F49F1.2
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by eat-2 and rrf-3 based on RNA-seq and microarray studies. Is affected by seven chemicals including Zidovudine; Psoralens; and allantoin based on RNA-seq and microarray studies.

WB:WBGene00235364	F49F1.4
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by rrf-3 based on RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and Rifampin based on RNA-seq studies.

WB:WBGene00235365	F49F1.15
Is affected by eat-2; rrf-3; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Alovudine; stavudine; and Rifampin based on RNA-seq studies.

WB:WBGene00235366	F49F1.16
No description available

WB:WBGene00235367	F49F1.17
Is affected by eat-2 and daf-2 based on RNA-seq and microarray studies. Is affected by four chemicals including allantoin; Sirolimus; and Psoralens based on RNA-seq studies.

WB:WBGene00235368	F49F1.18
Is predicted to have galactoside binding activity. Is an ortholog of human LGALSL (galectin like).

WB:WBGene00235369	K08D10.18
Is affected by several genes including daf-2; eat-2; and hsp-6 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is an ortholog of several human genes including PLSCR2 (phospholipid scramblase 2); PLSCR3 (phospholipid scramblase 3); and PLSCR5 (phospholipid scramblase family member 5).

WB:WBGene00235370	K08D10.15
Is affected by eat-2; pptr-1; and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00235371	F30B5.11
Is affected by eat-2 and cfp-1 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00235372	F15E6.12
Is affected by meg-3 and meg-4 based on RNA-seq studies.

WB:WBGene00235373	Y24D9A.14
Is affected by dlc-1 and hsp-6 based on RNA-seq studies.

WB:WBGene00235374	R11E3.19
Is affected by eat-2; aak-1; and aak-2 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00235375	Y17G9A.91
Is affected by several genes including daf-2; pmk-1; and smg-2 based on RNA-seq and microarray studies. Is affected by dibromoacetic acid based on microarray studies.

WB:WBGene00235376	Y9C9A.112
No description available

WB:WBGene00235377	CE7X_3.4
Is affected by four chemicals including Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00235378	E03H12.27
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00235379	T28H11.31
No description available

WB:WBGene00235380	C24D10.49
Is affected by several genes including eat-2; kri-1; and adr-1 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00235381	Y74C9A.9
Is enriched in AVK and germ line based on RNA-seq studies. Is affected by ins-11; atfs-1; and sin-3 based on RNA-seq studies. Is affected by Sirolimus based on RNA-seq studies.

WB:WBGene00235382	ZK354.18
No description available

WB:WBGene00235383	ZK616.65
Is predicted to have protein tyrosine phosphatase activity.

WB:WBGene00235385	Y48G1A.7
Is affected by sma-2; sma-4; and atfs-1 based on RNA-seq studies. Is affected by Rifampin and allantoin based on RNA-seq studies.

WB:WBGene00235386	H32C10.101
No description available

WB:WBGene00235387	W04C9.8
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including rrf-3; pptr-1; and sin-3 based on RNA-seq studies.

WB:WBGene00235388	W04C9.9
Is affected by eat-2 based on RNA-seq studies. Is affected by Rifampin and Psoralens based on RNA-seq studies.

WB:WBGene00235389	C46G7.111
Is affected by iff-1 based on RNA-seq studies.

WB:WBGene00235390	F56A6.8
No description available

WB:WBGene00235391	F38A5.22
Is affected by several genes including eat-2; sir-2.1; and sma-2 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies. Is predicted to encode a protein with the following domains: Transthyretin-like family and Transthyretin-like.

WB:WBGene00236785	Y73B6A.16
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00236786	C17H12.37
Is enriched in PLM and muscle cell based on RNA-seq and microarray studies. Is affected by several genes including sir-2.1; eri-1; and rrf-1 based on microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00236787	T22D1.22
No description available

WB:WBGene00236788	ZK381.63
No description available

WB:WBGene00236789	Y18H1A.18
Is affected by adr-1 and spc-1 based on RNA-seq studies.

WB:WBGene00236797	Y71G12B.44
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00236798	F48C1.15
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00236799	F54E2.8
No description available

WB:WBGene00236800	linc-171
Is affected by dlc-1 based on RNA-seq studies.

WB:WBGene00236806	D2024.18
Is affected by dlc-1; eat-2; and pptr-1 based on RNA-seq studies.

WB:WBGene00236807	C06E4.22
No description available

WB:WBGene00236808	C54G6.8
No description available

WB:WBGene00236809	ZK993.5
Is affected by several genes including daf-16; elt-2; and unc-70 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00249808	Y48G8AL.20
Is affected by several genes including sod-2; sma-2; and sma-4 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00249812	F39E9.25
Is enriched in intestine based on microarray studies. Is affected by lin-14 and lin-4 based on microarray studies.

WB:WBGene00249813	F39E9.26
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00249814	K08A2.17
No description available

WB:WBGene00249815	F20D12.12
Is enriched in germ line based on RNA-seq studies. Is affected by atfs-1 and unc-70 based on RNA-seq studies. Is affected by Rifampin; Sirolimus; and allantoin based on RNA-seq studies.

WB:WBGene00249816	F42G8.18
Is affected by several genes including dpy-10; sir-2.1; and aak-2 based on microarray studies. Is affected by paraquat; adsorbable organic bromine compound; and nitrotriazolone based on microarray studies.

WB:WBGene00249817	F42G8.19
Is enriched in AFD; ASER; neurons; and somatic gonad precursor based on RNA-seq and microarray studies. Is affected by several genes including lin-4; lin-14; and sir-2.1 based on RNA-seq and microarray studies. Is affected by four chemicals including Atrazine; Colistin; and adsorbable organic bromine compound based on microarray studies. Is predicted to encode a protein with the following domains: Rhodanese-like domain and Rhodanese-like domain superfamily.

WB:WBGene00249825	F17E9.19
Is affected by resveratrol based on microarray studies.

WB:WBGene00249826	F42A9.18
Is affected by several genes including isp-1; nuo-6; and spc-1 based on RNA-seq studies.

WB:WBGene00255375	F08B4.8
Is enriched in AVG; RIM; and command interneuron based on RNA-seq studies. Is affected by several genes including daf-2; dpy-10; and gld-1 based on RNA-seq and microarray studies. Is affected by fifteen chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00255420	Y51F10.15
Is affected by several genes including smn-1; adr-1; and ints-5 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00255426	C04G2.14
Is enriched in germ line based on RNA-seq studies. Is affected by several genes including rrf-3; sma-4; and spc-1 based on RNA-seq studies.

WB:WBGene00255435	K08C7.10
No description available

WB:WBGene00255441	T11G6.11
No description available

WB:WBGene00255457	F23C8.14
Is enriched in intestine and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including elt-2; eat-2; and elt-7 based on RNA-seq studies. Is affected by Sirolimus; Rifampin; and allantoin based on RNA-seq studies.

WB:WBGene00255469	C25G4.17
Is predicted to have carbohydrate binding activity.

WB:WBGene00255522	Y57G11B.223
No description available

WB:WBGene00255543	Y41E3.466
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00255545	M199.135
No description available

WB:WBGene00255546	M199.136
Is predicted to encode a protein with the following domains: PAN-like domain; PAN-3 domain; and C-type lectin fold.

WB:WBGene00255549	Y71F9B.24
No description available

WB:WBGene00255550	W03D8.14
Is enriched in muscle cell based on microarray studies.

WB:WBGene00255553	Y51H4A.941
Is affected by Rifampin; Psoralens; and Sirolimus based on RNA-seq studies.

WB:WBGene00255560	mir-8186.1
No description available

WB:WBGene00255561	mir-8186.2
No description available

WB:WBGene00255562	mir-8191
No description available

WB:WBGene00255563	mir-2217.2
No description available

WB:WBGene00255564	mir-8206
No description available

WB:WBGene00255565	mir-8203
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00255566	mir-8200
No description available

WB:WBGene00255567	mir-8212
No description available

WB:WBGene00255568	mir-8204
No description available

WB:WBGene00255569	mir-8195
No description available

WB:WBGene00255570	mir-8207
No description available

WB:WBGene00255571	mir-2217.4
No description available

WB:WBGene00255572	mir-8189
No description available

WB:WBGene00255573	mir-8197
Is affected by daf-12 based on RNA-seq studies.

WB:WBGene00255574	mir-8208
No description available

WB:WBGene00255575	mir-8188
No description available

WB:WBGene00255576	mir-8190
No description available

WB:WBGene00255577	mir-8205
No description available

WB:WBGene00255578	mir-8193
No description available

WB:WBGene00255579	mir-8194
No description available

WB:WBGene00255580	mir-8211
No description available

WB:WBGene00255581	mir-4810.2
No description available

WB:WBGene00255582	mir-8201
No description available

WB:WBGene00255583	mir-2217.5
No description available

WB:WBGene00255584	mir-8187
No description available

WB:WBGene00255586	mir-8202
No description available

WB:WBGene00255587	mir-2217.3
No description available

WB:WBGene00255588	mir-8198
No description available

WB:WBGene00255594	Y48G1BL.8
Is affected by eat-2; cfp-1; and sir-2.1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies. Is predicted to encode a protein with the following domains: snRNA-activating protein of 50kDa MW C terminal and snRNA-activating protein complex, subunit 3.

WB:WBGene00255595	D1046.18
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by four chemicals including Rifampin; Sirolimus; and allantoin based on RNA-seq studies.

WB:WBGene00255596	Y37B11A.8
Is enriched in AVK based on RNA-seq studies. Is affected by several genes including isp-1; sin-3; and nmad-1 based on RNA-seq studies. Is affected by five chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00255597	pals-21
Is affected by eat-2 and ints-4 based on RNA-seq studies. Is affected by Rifampin; allantoin; and fluoranthene based on RNA-seq and microarray studies.

WB:WBGene00255598	BE0003N10.6
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by several genes including daf-2; clk-1; and isp-1 based on RNA-seq studies. Is affected by Sodium Chloride and glycine based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00255600	F54H5.14
Is predicted to have lipid binding activity.

WB:WBGene00255605	T23B3.8
Is enriched in neurons based on microarray studies. Is affected by eat-2; sir-2.1; and rde-1 based on RNA-seq and microarray studies. Is affected by fluoranthene based on microarray studies.

WB:WBGene00255606	T23B3.9
Is affected by spc-1 and unc-70 based on RNA-seq studies.

WB:WBGene00255607	F22H10.11
No description available

WB:WBGene00255611	Y116A8C.470
No description available

WB:WBGene00255702	C06A12.19
No description available

WB:WBGene00255703	C06A12.20
No description available

WB:WBGene00255704	B0348.10
Is enriched in AVK and somatic gonad precursor based on RNA-seq studies. Is affected by adr-1 based on RNA-seq studies. Is affected by four chemicals including metformin; Sirolimus; and Rifampin based on RNA-seq studies.

WB:WBGene00255709	Y116A8C.471
No description available

WB:WBGene00255714	B0511.19
Is enriched in head mesodermal cell based on RNA-seq studies. Is affected by several genes including rrf-3; gld-1; and eat-2 based on RNA-seq and microarray studies. Is affected by six chemicals including allantoin; Sirolimus; and Rifampin based on RNA-seq and microarray studies.

WB:WBGene00255715	sacy-2
No description available

WB:WBGene00255716	sacy-3
No description available

WB:WBGene00255717	sacy-4
No description available

WB:WBGene00255728	R02C2.8
Is affected by isp-1 based on RNA-seq studies.

WB:WBGene00255729	R11G11.16
No description available

WB:WBGene00255730	F48G7.15
Is affected by ints-2 based on RNA-seq studies.

WB:WBGene00255731	T02B11.11
Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00255732	T02B11.12
Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00255733	T02B11.13
Is predicted to encode a protein with the following domains: Domain of unknown function DUF148 and Domain of unknown function DUF148.

WB:WBGene00255734	gin-1
No description available

WB:WBGene00255735	gin-2
No description available

WB:WBGene00255736	C03H5.10
Is enriched in somatic gonad precursor based on RNA-seq studies.

WB:WBGene00268189	Y50D4B.9
Is affected by cox-5B; his-3; and ints-5 based on RNA-seq studies. Is affected by Rifampin; Psoralens; and resveratrol based on RNA-seq and microarray studies.

WB:WBGene00268190	Y50D4B.10
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00268191	Y50D4A.12
Is affected by fbf-1 based on microarray studies. Is affected by adsorbable organic bromine compound; Sirolimus; and allantoin based on microarray studies.

WB:WBGene00268192	ZK697.17
Is affected by eat-2 based on RNA-seq studies. Is affected by four chemicals including Psoralens; allantoin; and Sirolimus based on RNA-seq studies.

WB:WBGene00268193	ZK697.18
No description available

WB:WBGene00268194	F36H9.10
Is predicted to encode a protein with the following domain: .

WB:WBGene00268195	susm-1
No description available

WB:WBGene00268196	F59A7.14
Is affected by let-60 based on microarray studies. Is affected by five chemicals including Rifampin; allantoin; and Sirolimus based on RNA-seq and microarray studies.

WB:WBGene00268197	Y40B10A.11
Is predicted to encode a protein with the following domain: .

WB:WBGene00268198	F22F7.12
Is affected by sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Str and 7TM GPCR, serpentine receptor class r (Str).

WB:WBGene00268199	C45H4.21
Is affected by several genes including skn-1; dpy-7; and prg-1 based on RNA-seq; proteomic; and microarray studies.

WB:WBGene00268202	T27B7.9
Is affected by rrf-3 and sin-3 based on RNA-seq studies.

WB:WBGene00268203	C29G2.7
Is enriched in DA neuron; I5 neuron; SAB; muscle cell; and retrovesicular ganglion based on microarray studies.

WB:WBGene00268204	F53E10.8
Is affected by several genes including dpy-10; lin-35; and rde-4 based on microarray studies. Is affected by five chemicals including Humic Substances; R24; and paraquat based on microarray studies.

WB:WBGene00268205	C24B9.18
Is affected by resveratrol based on microarray studies.

WB:WBGene00268206	F54E2.9
Is enriched in neurons based on microarray studies. Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Protein of unknown function (DUF621) and Protein of unknown function DUF621.

WB:WBGene00268207	W08F4.20
Is affected by mut-2; lin-54; and tdp-1 based on microarray studies.

WB:WBGene00268208	W08F4.21
Is affected by meg-3; meg-4; and pptr-1 based on RNA-seq studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00268209	T04B8.6
Is affected by isp-1 and nuo-6 based on microarray studies. Is affected by paraquat based on microarray studies.

WB:WBGene00268210	K07E8.15
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00268211	T02H6.12
No description available

WB:WBGene00268212	D1065.6
No description available

WB:WBGene00268213	C17B7.15
Is affected by several genes including rrf-3; sir-2.1; and nhr-25 based on RNA-seq and microarray studies. Is affected by four chemicals including resveratrol; Chlorpyrifos; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00268214	C49F5.12
No description available

WB:WBGene00268215	C49F5.13
No description available

WB:WBGene00268216	F49B2.9
Is affected by sir-2.1 and isp-1 based on microarray studies. Is affected by Diazinon and Colistin based on microarray studies.

WB:WBGene00269331	Y39F10A.5
Is affected by mut-2 and rrf-3 based on microarray studies. Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00269332	Y39F10A.6
No description available

WB:WBGene00269333	F46F5.19
Is affected by rrf-3 and smn-1 based on RNA-seq studies.

WB:WBGene00269336	F28A10.11
Is affected by glycine based on RNA-seq studies.

WB:WBGene00269337	F28A10.12
Is affected by adr-1 and damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00269338	R07C3.16
Is affected by hpl-1; hpl-2; and his-24 based on microarray studies.

WB:WBGene00269346	R07C3.17
No description available

WB:WBGene00269352	K08D9.10
No description available

WB:WBGene00269355	T28A11.25
Is enriched in muscle cell based on microarray studies. Is affected by several genes including daf-16; sir-2.1; and aak-2 based on RNA-seq and microarray studies. Is affected by four chemicals including resveratrol; Cry5B; and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00269373	M01D1.12
Is affected by sin-3 based on RNA-seq studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00269376	C04G6.15
Is affected by several genes including adr-1; meg-3; and pgrn-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies.

WB:WBGene00269378	C07G3.15
Is affected by adr-1; sftb-1; and tdp-1 based on RNA-seq and microarray studies. Is affected by Atrazine and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00269379	C30B5.17
Is affected by several genes including sir-2.1; isp-1; and tax-6 based on RNA-seq and microarray studies. Is affected by Diazinon; paraquat; and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Kringle-like fold and Kringle superfamily.

WB:WBGene00269380	sow-2
No description available

WB:WBGene00269381	F08F8.11
Is affected by sir-2.1 and nuo-6 based on microarray studies. Is affected by Diazinon; paraquat; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00269382	F33D11.16
No description available

WB:WBGene00269383	ZK384.7
Is enriched in intestine based on microarray studies. Is affected by rrf-3; ceh-60; and pptr-1 based on RNA-seq studies.

WB:WBGene00269384	K09H11.16
Is affected by pptr-1 based on RNA-seq studies.

WB:WBGene00269385	F41F3.9
Is affected by isp-1 and nuo-6 based on microarray studies. Is affected by Hydrolyzable Tannins; paraquat; and dafa#1 based on microarray studies.

WB:WBGene00269386	F41F3.10
No description available

WB:WBGene00269387	btb-22
Is affected by spc-1 and unc-70 based on RNA-seq studies. Is affected by dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: BTB/POZ domain; BTB/POZ domain; and SKP1/BTB/POZ domain superfamily.

WB:WBGene00269388	F45C12.17
Is affected by several genes including mut-2; lin-54; and hsb-1 based on RNA-seq and microarray studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00269389	C08F1.12
Is enriched in muscle cell based on microarray studies. Is affected by mut-2 and lin-54 based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00269390	C08F1.13
Is enriched in muscle cell based on microarray studies. Is affected by mut-2 and lin-54 based on microarray studies.

WB:WBGene00269391	F54F2.14
Is enriched in intestine based on microarray studies. Is affected by several genes including gld-1; sir-2.1; and isp-1 based on RNA-seq and microarray studies. Is affected by six chemicals including Quercetin; Hydrolyzable Tannins; and Humic Substances based on microarray studies.

WB:WBGene00269392	F54F7.14
Is affected by several genes including daf-16; sir-2.1; and tax-6 based on RNA-seq and microarray studies.

WB:WBGene00269393	F56H1.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00269394	F59H6.15
Is affected by several genes including isp-1; alg-1; and dpy-9 based on microarray studies. Is affected by five chemicals including Atrazine; Hydrolyzable Tannins; and paraquat based on microarray studies.

WB:WBGene00269419	K05F6.15
Is affected by several genes including mir-35; lin-54; and mir-243 based on microarray studies. Is affected by five chemicals including resveratrol; Atrazine; and Quercetin based on microarray studies.

WB:WBGene00269420	K05F6.16
Is enriched in muscle cell based on microarray studies. Is affected by adr-1 based on RNA-seq studies. Is affected by copper sulfate and Sirolimus based on microarray studies.

WB:WBGene00269421	R06F6.14
Is affected by several genes including dcr-1; unc-70; and nuo-6 based on RNA-seq and microarray studies. Is affected by Colistin; Sirolimus; and Triclosan based on microarray studies.

WB:WBGene00269422	T01H10.11
No description available

WB:WBGene00269423	W08A12.5
No description available

WB:WBGene00269424	K09D9.14
No description available

WB:WBGene00269425	C49G7.13
Is affected by sir-2.1; lin-14; and lin-4 based on microarray studies. Is predicted to encode a protein with the following domains: CUB-like domain and CUB-like domain.

WB:WBGene00269426	C49G7.14
No description available

WB:WBGene00269427	D1065.7
No description available

WB:WBGene00269428	D1065.8
No description available

WB:WBGene00269429	H43I07.4
No description available

WB:WBGene00269430	F47D2.12
No description available

WB:WBGene00269431	T16A1.10
Is affected by several genes including rrf-3; ain-1; and set-2 based on RNA-seq and microarray studies.

WB:WBGene00269432	ZC132.11
Is enriched in neurons based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and lin-35 based on RNA-seq and microarray studies. Is affected by Colistin and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Serpentine type 7TM GPCR chemoreceptor Srz and 7TM GPCR, serpentine receptor class z (Srz).

WB:WBGene00269433	T16G12.12
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including sir-2.1; fbf-1; and unc-70 based on RNA-seq and microarray studies. Is affected by Humic Substances and single-walled carbon nanotube based on microarray studies.

WB:WBGene00269434	sqst-5
Is predicted to have K63-linked polyubiquitin modification-dependent protein binding activity and protein kinase C binding activity.

WB:WBGene00269435	T27C10.9
Is predicted to have calcium ion binding activity and enzyme regulator activity.

WB:WBGene00269436	F13A2.14
No description available

WB:WBGene00269437	Y47D7A.19
Is affected by rrf-3 based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00269438	Y56A3A.41
Is predicted to have nucleic acid binding activity.

WB:WBGene00270290	ZK938.11
Is enriched in intestine based on microarray studies. Is affected by several genes including eat-2; sir-2.1; and mir-35 based on RNA-seq and microarray studies. Is affected by five chemicals including Atrazine; fluoranthene; and copper sulfate based on microarray studies. Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin, C-terminal; and Immunoglobulin E-set.

WB:WBGene00270291	F36H5.15
No description available

WB:WBGene00270292	F36H5.16
No description available

WB:WBGene00270293	F36H5.17
Is affected by rrf-2 based on microarray studies. Is affected by Chlorpyrifos; Diazinon; and dafa#1 based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain and F-box domain.

WB:WBGene00270296	drop-2
No description available

WB:WBGene00270297	drop-3
No description available

WB:WBGene00270298	drop-5
No description available

WB:WBGene00270299	drop-6
No description available

WB:WBGene00270300	drop-7
No description available

WB:WBGene00270302	drop-9
No description available

WB:WBGene00270303	T28D9.16
Is affected by let-60 based on microarray studies.

WB:WBGene00270309	K05F1.13
Is affected by adr-1 and daf-19 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Leukocyte cell-derived chemotaxin 2.

WB:WBGene00270310	nde-5
No description available

WB:WBGene00270318	F26G1.15
No description available

WB:WBGene00270319	F26A1.19
Is affected by pgrn-1 and sftb-1 based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00270320	F27D9.13
Is affected by damt-1; ain-1; and ain-2 based on RNA-seq and microarray studies. Is affected by four chemicals including antimycin; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: von Willebrand factor A-like domain superfamily.

WB:WBGene00270321	Y41C4A.32
Is affected by several genes including daf-2; rrf-3; and dpy-10 based on RNA-seq and microarray studies. Is affected by nine chemicals including glycine; Chlorpyrifos; and Diazinon based on RNA-seq and microarray studies. Human ortholog(s) of this gene are implicated in primary autosomal recessive microcephaly 19. Is predicted to encode a protein with the following domains: WD domain, G-beta repeat; WD40 repeat; WD40/YVTN repeat-like-containing domain superfamily; G-protein beta WD-40 repeat; and WD40-repeat-containing domain superfamily.

WB:WBGene00270322	C17G10.13
Is predicted to have DNA binding activity.

WB:WBGene00271414	T05A7.12
Is predicted to encode a protein with the following domain: Protein-tyrosine phosphatase-like.

WB:WBGene00271415	T05A7.13
Is predicted to have fucosyltransferase activity.

WB:WBGene00271437	F10D2.16
Is enriched in neurons based on microarray studies. Is affected by resveratrol based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271444	T04C12.33
Is affected by Colistin based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271567	T28F4.8
Is affected by raga-1 based on RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00271577	B0244.16
Is predicted to encode a protein with the following domain: Putative G-protein coupled receptor, Chromadorea.

WB:WBGene00271598	Y18D10A.30
No description available

WB:WBGene00271605	H05L14.3
Is affected by sftb-1 based on RNA-seq studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271606	F22F4.9
Is affected by rrf-3 and sin-3 based on RNA-seq studies.

WB:WBGene00271632	Y110A7A.24
Is affected by adr-1 and sir-2.1 based on RNA-seq and microarray studies.

WB:WBGene00271633	F27B3.9
Is affected by lin-35; dpl-1; and efl-1 based on microarray studies.

WB:WBGene00271634	M18.12
No description available

WB:WBGene00271635	T01H3.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271636	W05G11.8
Is affected by ceh-60 based on RNA-seq studies.

WB:WBGene00271637	B0280.21
No description available

WB:WBGene00271638	B0280.22
No description available

WB:WBGene00271639	C50F2.12
No description available

WB:WBGene00271640	Y66H1A.9
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00271641	K04G7.14
No description available

WB:WBGene00271642	R106.8
Is enriched in DD neuron and neurons based on microarray studies. Is affected by several genes including dpy-10; eat-2; and lin-35 based on microarray studies. Is affected by four chemicals including Quercetin; Hydrolyzable Tannins; and Sirolimus based on microarray studies.

WB:WBGene00271643	W07G1.25
Is affected by ceh-60 and sftb-1 based on RNA-seq studies. Is affected by glycine based on RNA-seq studies.

WB:WBGene00271644	K09F6.14
No description available

WB:WBGene00271645	ZK1236.12
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00271646	C26B2.15
No description available

WB:WBGene00271647	C23G10.14
Is affected by rrf-3; meg-3; and meg-4 based on RNA-seq studies.

WB:WBGene00271648	H06O01.5
Is affected by resveratrol based on microarray studies.

WB:WBGene00271649	T22A3.13
No description available

WB:WBGene00271650	C17G10.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271651	F19B10.14
No description available

WB:WBGene00271652	C28G1.11
No description available

WB:WBGene00271653	Y47G6A.39
No description available

WB:WBGene00271654	Y54G9A.17
No description available

WB:WBGene00271655	M110.13
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00271656	T05G5.17
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00271657	Y38E10A.33
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271694	T10E9.14
Is predicted to have RNA binding activity.

WB:WBGene00271701	F10D7.10
No description available

WB:WBGene00271703	ZK1010.12
Is affected by hpl-1; hpl-2; and his-24 based on microarray studies. Is affected by resveratrol and dibromoacetic acid based on microarray studies.

WB:WBGene00271706	D2089.8
Is affected by several genes including fbf-1; tdp-1; and slr-2 based on RNA-seq and microarray studies. Is affected by antimycin; Hydrolyzable Tannins; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: Cysteine-rich domain; Cysteine-rich domain, DPF-motif; and Cysteine-rich DPF motif domain-containing protein 1.

WB:WBGene00271707	ZK105.14
Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19) and Domain of unknown function DUF19.

WB:WBGene00271715	B0244.17
Is affected by several genes including rrf-3; isp-1; and ash-2 based on RNA-seq and microarray studies. Is affected by seven chemicals including antimycin; Cry5B; and Humic Substances based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: Putative G-protein coupled receptor, Chromadorea.

WB:WBGene00271716	F39E9.28
No description available

WB:WBGene00271744	K09F6.15
Is affected by several genes including daf-2; eat-2; and hpl-2 based on RNA-seq and microarray studies. Is affected by antimycin and Sirolimus based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271774	R02F2.10
Is affected by aak-2 and let-60 based on microarray studies. Is affected by paraquat; Colistin; and Sirolimus based on microarray studies.

WB:WBGene00271775	EGAP1.5
No description available

WB:WBGene00271776	F53G12.18
Is affected by resveratrol based on microarray studies.

WB:WBGene00271777	Y48G8AR.8
No description available

WB:WBGene00271778	T01A4.9
No description available

WB:WBGene00271779	C35E7.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271780	F11A6.16
Is affected by adr-1 based on RNA-seq studies. Is predicted to encode a protein with the following domains: Fungus-induced protein and Fungus-induced protein.

WB:WBGene00271781	Y71F9AM.9
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271786	F58H7.11
Is affected by adr-1 based on RNA-seq studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00271788	M01H9.10
Is affected by dcr-1; tdp-1; and nuo-6 based on microarray studies. Is affected by paraquat based on microarray studies.

WB:WBGene00271789	K01G12.22
Is affected by adr-1; mut-2; and rrf-3 based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271790	W03D2.14
No description available

WB:WBGene00271791	W03D2.15
No description available

WB:WBGene00271792	Y45F10C.21
No description available

WB:WBGene00271795	Y46C8AM.1
Is predicted to have carbohydrate binding activity.

WB:WBGene00271796	C54F6.20
Is affected by several genes including dcr-1; isp-1; and alg-1 based on microarray studies. Is affected by four chemicals including Diazinon; Quercetin; and Humic Substances based on microarray studies.

WB:WBGene00271797	E02C12.19
Is predicted to encode a protein with the following domains: Protein of unknown function (DUF1679) and Uncharacterised  oxidoreductase Dhs-27.

WB:WBGene00271798	F54D5.24
Is affected by several genes including isp-1; pal-1; and nuo-6 based on microarray studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00271799	F07B7.17
Is affected by osm-8 and daf-19 based on microarray studies. Is affected by allantoin based on microarray studies.

WB:WBGene00271800	K06C4.27
No description available

WB:WBGene00271801	F07B7.18
No description available

WB:WBGene00271802	F10G2.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271803	C09G5.14
No description available

WB:WBGene00271804	F11D11.22
Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Transmembrane glycoprotein and Transmembrane glycoprotein.

WB:WBGene00271805	T01E8.10
No description available

WB:WBGene00271806	ZK938.12
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271807	F19F10.14
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271808	F21C10.19
Is affected by sir-2.1 based on microarray studies. Is affected by Quercetin based on microarray studies. Is predicted to encode a protein with the following domains: CX module and Domain of unknown function CX.

WB:WBGene00271809	D1022.17
No description available

WB:WBGene00271810	C27H5.12
No description available

WB:WBGene00271811	C18H9.13
No description available

WB:WBGene00271812	F58F12.12
No description available

WB:WBGene00271813	K03D7.12
No description available

WB:WBGene00271815	K04A8.21
Is affected by several genes including let-60; lin-35; and ash-2 based on RNA-seq and microarray studies. Is affected by eleven chemicals including Cry5B; Quercetin; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domains: Saposin B type domain and Saposin-like.

WB:WBGene00271816	R02F11.12
Is predicted to have carbohydrate binding activity.

WB:WBGene00271817	F55C12.19
Is affected by several genes including dpy-10; isp-1; and mut-2 based on microarray studies. Is affected by six chemicals including Cry5B; Chlorpyrifos; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271818	K05F1.14
Is affected by resveratrol based on microarray studies.

WB:WBGene00271819	F10C1.23
Is affected by resveratrol based on microarray studies.

WB:WBGene00271820	T18H9.11
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271821	T28C12.15
Is affected by adr-1 based on RNA-seq studies.

WB:WBGene00271822	F11G11.15
Is affected by adr-1 based on RNA-seq studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00271823	C33F10.26
No description available

WB:WBGene00271824	R03H10.11
Is affected by several genes including daf-16; eri-1; and rrf-1 based on microarray studies. Is affected by paraquat; dafa#1; and Sirolimus based on microarray studies.

WB:WBGene00271825	nipi-6
No description available

WB:WBGene00271826	nipi-7
No description available

WB:WBGene00271827	T19H12.15
Is affected by damt-1 based on RNA-seq studies. Is affected by antimycin based on RNA-seq studies. Is predicted to encode a protein with the following domains: CC domain and CC domain.

WB:WBGene00271828	nipi-8
No description available

WB:WBGene00271829	nipi-9
No description available

WB:WBGene00271830	W09G10.9
No description available

WB:WBGene00271831	Y46D2A.6
No description available

WB:WBGene00271832	Y60C6A.3
Is affected by several genes including sir-2.1; lin-35; and tbx-2 based on microarray studies. Is affected by eleven chemicals including Cry5B; Quercetin; and copper sulfate based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00271837	Y65D7A.1
No description available

WB:WBGene00271851	lov-3
No description available

WB:WBGene00284844	H38K22.9
No description available

WB:WBGene00284845	Y71F9AR.10
No description available

WB:WBGene00284846	ZC262.13
No description available

WB:WBGene00284847	F54D8.10
Is predicted to encode a protein with the following domain: .

WB:WBGene00284848	M02E1.4
No description available

WB:WBGene00284849	C03A3.9
No description available

WB:WBGene00284850	Y46B2A.4
No description available

WB:WBGene00284851	F28A10.13
No description available

WB:WBGene00284852	M04F3.7
No description available

WB:WBGene00284853	C32E8.13
No description available

WB:WBGene00284854	Y95D11A.5
No description available

WB:WBGene00284855	C04C11.25
No description available

WB:WBGene00284856	C09G1.7
No description available

WB:WBGene00284857	W08E3.5
No description available

WB:WBGene00284858	F32H2.15
No description available

WB:WBGene00284859	C30G12.10
No description available

WB:WBGene00284861	C30G12.11
No description available

WB:WBGene00284867	T22B7.22
No description available

WB:WBGene00302964	Y62E10A.23
Is enriched in muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including sir-2.1; dcr-1; and fbf-1 based on microarray studies. Is affected by four chemicals including Quercetin; paraquat; and Sirolimus based on microarray studies.

WB:WBGene00302968	Y62E10A.24
Is predicted to have nucleic acid binding activity and ribonuclease P activity.

WB:WBGene00302971	F59E12.17
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including sir-2.1; fbf-1; and ain-2 based on microarray studies. Is affected by Diazinon and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00302974	Y65B4BM.3
Is affected by tbx-2 based on microarray studies. Is affected by Colistin and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: DB module and Domain of unknown function DB.

WB:WBGene00302976	F49E8.8
Is enriched in intestine based on microarray studies. Is affected by sir-2.1; dcr-1; and fbf-1 based on microarray studies. Is affected by Humic Substances; paraquat; and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: GPI biosynthesis protein family Pig-F and GPI biosynthesis protein Pig-F.

WB:WBGene00302978	C42C1.19
Is predicted to have transmembrane transporter activity. Is an ortholog of human SLC37A4 (solute carrier family 37 member 4).

WB:WBGene00302980	F53E2.2
Exhibits actin filament binding activity. Is involved in several processes, including actin filament severing; cytoskeleton organization; and positive regulation of actin filament polymerization. Localizes to ribonucleoprotein complex and striated muscle thin filament. Human ortholog(s) of this gene are implicated in nemaline myopathy 7.

WB:WBGene00302982	W02H5.19
Is affected by sir-2.1; ain-2; and nhr-25 based on microarray studies. Is affected by Diazinon based on microarray studies. Is predicted to encode a protein with the following domains: Coiled-coil domain containing 32 and Coiled-coil domain containing protein 32.

WB:WBGene00302984	Y51H7C.41
Is affected by several genes including sir-2.1; eri-1; and fbf-1 based on microarray studies. Is affected by six chemicals including Atrazine; Cry5B; and Diazinon based on microarray studies. Is predicted to encode a protein with the following domain: Small integral membrane protein 7.

WB:WBGene00302986	Y37E11AM.4
Is affected by several genes including fbf-1; gld-2; and cyd-1 based on microarray studies. Is affected by six chemicals including cadmium; Quercetin; and Hydrolyzable Tannins based on microarray studies. Is an ortholog of human KDSR (3-ketodihydrosphingosine reductase).

WB:WBGene00302988	F26D11.20
Is enriched in intestine based on microarray studies. Is an ortholog of human IDNK (IDNK gluconokinase).

WB:WBGene00302991	cox-16
Is involved in mitochondrial cytochrome c oxidase assembly.

WB:WBGene00302993	T14B4.19
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including lin-4; lin-14; and sir-2.1 based on microarray studies. Is affected by thirteen chemicals including Atrazine; cadmium; and Quercetin based on microarray studies.

WB:WBGene00302995	H06H21.37
Is enriched in intestine; muscle cell; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including sir-2.1; isp-1; and fbf-1 based on microarray studies. Is affected by five chemicals including Diazinon; Hydrolyzable Tannins; and Humic Substances based on microarray studies.

WB:WBGene00302998	F53G2.12
Is affected by sir-2.1; slr-2; and lin-54 based on microarray studies. Is affected by Humic Substances and allantoin based on microarray studies. Is predicted to encode a protein with the following domains: Complex 1 protein (LYR family) and Complex 1 LYR protein.

WB:WBGene00303000	C37C3.18
Is predicted to have translation initiation factor activity. Is an ortholog of human EIF5 (eukaryotic translation initiation factor 5).

WB:WBGene00303002	Y48E1B.17
Is affected by several genes including daf-2; sir-2.1; and isp-1 based on microarray studies. Is affected by Diazinon and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: PIG-P and PIG-P.

WB:WBGene00303005	C34E10.12
Is predicted to encode a protein with the following domain: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8.

WB:WBGene00303007	Y57G11C.1147
Is enriched in intestine; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including sir-2.1; lin-35; and fbf-1 based on microarray studies. Is predicted to encode a protein with the following domain: Protein BRICK1. Is an ortholog of human NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6).

WB:WBGene00303009	mrpl-42
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including daf-16; daf-2; and gld-1 based on microarray studies. Is affected by Cry5B and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domains: Mitochondrial 28S ribosomal protein S32 and 39S ribosomal protein L42, mitochondrial.

WB:WBGene00303011	F17C11.26
Is enriched in intestine based on microarray studies. Is affected by sir-2.1; ain-1; and lin-35 based on microarray studies. Is affected by six chemicals including Cholestanol; Quercetin; and single-walled carbon nanotube based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00303013	T04H1.12
Is affected by resveratrol based on microarray studies.

WB:WBGene00303015	F20C5.11
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including dcr-1; isp-1; and alg-1 based on microarray studies. Is affected by nine chemicals including resveratrol; Cry5B; and Diazinon based on microarray studies.

WB:WBGene00303019	Y70G10A.4
No description available

WB:WBGene00303021	F02A9.10
Is predicted to have ATP binding activity and methylcrotonoyl-CoA carboxylase activity. Localizes to cytoplasm. Human ortholog(s) of this gene are implicated in 3-Methylcrotonyl-CoA carboxylase 2 deficiency. Is an ortholog of human MCCC2 (methylcrotonoyl-CoA carboxylase 2).

WB:WBGene00303023	K07F5.22
Localizes to sarcoplasmic reticulum. Is an ortholog of human TMEM167B (transmembrane protein 167B).

WB:WBGene00303024	H40L08.7
Is affected by several genes including dcr-1; mir-35; and nuo-6 based on microarray studies. Is affected by six chemicals including Heme; Quercetin; and Humic Substances based on microarray studies.

WB:WBGene00303026	T20D3.14
Is affected by several genes including let-60; sir-2.1; and ain-1 based on microarray studies. Is affected by Cry5B based on microarray studies. Is predicted to encode a protein with the following domain: Cytochrome oxidase assembly factor 4-like.

WB:WBGene00303028	F45H11.11
No description available

WB:WBGene00303030	C25A1.20
Is enriched in intestine and muscle cell based on microarray studies. Is affected by several genes including rrf-3; sir-2.1; and rrf-1 based on microarray studies. Is affected by five chemicals including estrogen; Humic Substances; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00303031	B0035.22
No description available

WB:WBGene00303032	B0041.12
No description available

WB:WBGene00303033	B0361.14
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00303034	C02C6.14
No description available

WB:WBGene00303035	C07G2.5
No description available

WB:WBGene00303036	C08B6.18
No description available

WB:WBGene00303037	C09E8.6
No description available

WB:WBGene00303038	C09E10.3
No description available

WB:WBGene00303039	C13F10.8
No description available

WB:WBGene00303040	C13G3.12
Is affected by sir-2.1 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00303041	C14C10.10
No description available

WB:WBGene00303042	C26H9A.4
No description available

WB:WBGene00303043	C28D4.18
No description available

WB:WBGene00303044	C34D10.5
No description available

WB:WBGene00303045	C43H6.12
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00303046	C48A7.16
No description available

WB:WBGene00303047	C49F8.14
No description available

WB:WBGene00303048	F55C5.17
No description available

WB:WBGene00303049	C55C3.73
No description available

WB:WBGene00303050	C56G2.22
No description available

WB:WBGene00303051	F01E11.20
No description available

WB:WBGene00303052	F08B12.11
No description available

WB:WBGene00303053	F08C6.18
No description available

WB:WBGene00303054	F44E5.17
No description available

WB:WBGene00303055	F13G3.15
No description available

WB:WBGene00303056	F27D4.12
No description available

WB:WBGene00303057	F33D11.17
No description available

WB:WBGene00303058	F47G4.14
Is enriched in intestine based on microarray studies. Is affected by sir-2.1; lin-14; and lin-4 based on microarray studies. Is affected by Cholestanol based on microarray studies.

WB:WBGene00303059	F48F5.8
No description available

WB:WBGene00303060	F52G3.7
No description available

WB:WBGene00303061	F52H3.11
No description available

WB:WBGene00303062	F55A4.13
No description available

WB:WBGene00303063	T06E8.8
No description available

WB:WBGene00303064	F59A6.13
No description available

WB:WBGene00303065	H03A11.13
No description available

WB:WBGene00303066	H40L08.8
No description available

WB:WBGene00303067	K01D12.20
No description available

WB:WBGene00303068	K08F8.15
No description available

WB:WBGene00303069	K11D12.14
No description available

WB:WBGene00303070	C53H9.4
No description available

WB:WBGene00303071	M176.16
No description available

WB:WBGene00303072	R10E9.4
No description available

WB:WBGene00303073	R12B2.13
No description available

WB:WBGene00303074	T03G6.7
Is affected by ain-1 and ain-2 based on microarray studies.

WB:WBGene00303075	T04C10.11
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies.

WB:WBGene00303076	T04H1.13
No description available

WB:WBGene00303077	T05A8.11
No description available

WB:WBGene00303078	T06D10.8
No description available

WB:WBGene00303079	T09F3.7
No description available

WB:WBGene00303080	T14B4.20
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00303081	T23F2.13
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by several genes including lin-4; lin-14; and dpy-10 based on microarray studies. Is affected by nine chemicals including Acrylamide; Quercetin; and Benzene based on microarray studies.

WB:WBGene00303082	T24D1.7
No description available

WB:WBGene00303083	T28F3.11
No description available

WB:WBGene00303085	Y32F6B.9
No description available

WB:WBGene00303086	Y37D8A.29
No description available

WB:WBGene00303087	Y39G8B.13
No description available

WB:WBGene00303088	Y44E3A.7
No description available

WB:WBGene00303089	Y46G5A.47
No description available

WB:WBGene00303090	Y47D9A.7
No description available

WB:WBGene00303091	Y50D4C.12
No description available

WB:WBGene00303092	Y54F10AM.15
No description available

WB:WBGene00303093	Y55B1BL.2
No description available

WB:WBGene00303094	Y71G12A.5
No description available

WB:WBGene00303095	Y71H2AL.4
No description available

WB:WBGene00303096	Y75B8A.63
No description available

WB:WBGene00303097	Y92H12BL.6
No description available

WB:WBGene00303098	ZK377.15
No description available

WB:WBGene00303099	ZK617.26
No description available

WB:WBGene00303100	ZK856.19
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00303101	F20B6.10
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00303102	T19D2.13
No description available

WB:WBGene00303103	W02D3.13
No description available

WB:WBGene00303104	ZC328.8
No description available

WB:WBGene00303105	R07E5.19
Is enriched in intestine and neurons based on microarray studies. Is affected by several genes including daf-2; glp-1; and sir-2.1 based on microarray studies. Is affected by six chemicals including cadmium; Diazinon; and Quercetin based on microarray studies. Human ortholog(s) of this gene are implicated in X-linked myopathy with excessive autophagy. Is predicted to encode a protein with the following domains: VMA21-like domain and Vacuolar ATPase assembly integral membrane protein Vma21.

WB:WBGene00303113	F09A5.15
No description available

WB:WBGene00303114	Y73B6A.17
No description available

WB:WBGene00303115	B0462.6
No description available

WB:WBGene00303139	bus-20
No description available

WB:WBGene00303140	srf-10
No description available

WB:WBGene00303141	bus-22
No description available

WB:WBGene00303142	bus-25
No description available

WB:WBGene00303143	bus-28
No description available

WB:WBGene00303201	Y40C7B.11
No description available

WB:WBGene00303208	Y71H2AM.29
Is affected by several genes including sir-2.1; isp-1; and fbf-1 based on microarray studies. Is affected by five chemicals including Cry5B; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00303231	C53A3.4
Is affected by mut-2; lin-54; and mir-35 based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00303233	D1014.13
Is affected by spr-5 based on microarray studies. Is affected by Chlorpyrifos; Diazinon; and nitroguanidine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00303359	ZK177.12
No description available

WB:WBGene00303360	ZK177.13
No description available

WB:WBGene00303362	C27D6.15
No description available

WB:WBGene00303363	R03H10.12
Is affected by alg-1 and lin-35 based on microarray studies. Is affected by Sirolimus and allantoin based on microarray studies.

WB:WBGene00303364	Y14H12A.5
Is predicted to encode a protein with the following domains: Tight junction protein, Claudin-like and Tight junction protein, claudin-like.

WB:WBGene00303365	M151.10
Is predicted to encode a protein with the following domain: .

WB:WBGene00303366	Y49F6A.11
Is affected by mir-243 and mir-35 based on microarray studies. Is affected by dibromoacetic acid and Colistin based on microarray studies.

WB:WBGene00303367	Y49F6A.12
No description available

WB:WBGene00303368	Y49F6B.19
No description available

WB:WBGene00303369	Y49F6B.20
No description available

WB:WBGene00303370	Y59A8A.8
No description available

WB:WBGene00303371	F59F4.6
No description available

WB:WBGene00303378	Y61B8B.3
No description available

WB:WBGene00303398	F46H5.11
Is predicted to encode a protein with the following domains: Nucleotide-diphospho-sugar transferase and Nucleotide-diphospho-sugar transferase.

WB:WBGene00303421	F20D6.15
Is predicted to encode a protein with the following domain: .

WB:WBGene00303423	F10D7.11
Is affected by slr-2; tdp-1; and tbx-2 based on microarray studies. Is affected by Diazinon and Hydrolyzable Tannins based on microarray studies.

WB:WBGene00303425	R02E12.12
Is predicted to encode a protein with the following domains: Zinc finger, C3HC4 type (RING finger); Zinc finger, RING-type; and Zinc finger, RING/FYVE/PHD-type.

WB:WBGene00304173	F07E5.13
Is affected by nuo-6 and pmk-1 based on microarray studies. Is affected by paraquat based on microarray studies. Is predicted to encode a protein with the following domains: F-box domain; F-box associated; F-box domain; and F-box associated domain, type 2.

WB:WBGene00304175	C37E2.10
Is predicted to encode a protein with the following domains: FAR-17a/AIG1-like protein and FAR-17a/AIG1-like protein.

WB:WBGene00304181	F38B7.17
No description available

WB:WBGene00304182	K02E11.15
No description available

WB:WBGene00304183	C15H11.17
No description available

WB:WBGene00304189	C52E12.11
No description available

WB:WBGene00304194	M163.21
No description available

WB:WBGene00304195	M163.22
No description available

WB:WBGene00304201	T07H8.11
Is affected by eat-2 based on microarray studies.

WB:WBGene00304202	F07C3.17
No description available

WB:WBGene00304203	D1086.21
No description available

WB:WBGene00304215	F17A2.16
Is affected by sir-2.1 based on microarray studies. Is affected by cadmium and Sirolimus based on microarray studies.

WB:WBGene00304219	Y49E10.37
No description available

WB:WBGene00304220	F53G2.13
Is affected by Chlorpyrifos and Sirolimus based on microarray studies.

WB:WBGene00304237	F39B3.7
No description available

WB:WBGene00304238	C33E10.12
No description available

WB:WBGene00304775	Y38E10A.34
Is predicted to encode a protein with the following domain: .

WB:WBGene00304776	K09A9.12
No description available

WB:WBGene00304782	C23F12.9
Is affected by tbx-2 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00304783	C31E10.11
No description available

WB:WBGene00304785	C36C9.11
No description available

WB:WBGene00304786	C36C9.12
Is affected by eat-2 based on microarray studies.

WB:WBGene00304787	C49F8.15
Is affected by several genes including pmk-1; aak-2; and nhr-25 based on microarray studies. Is affected by four chemicals including Selenium; Colistin; and Sirolimus based on microarray studies.

WB:WBGene00304788	C52B9.19
Is predicted to have DNA-binding transcription factor activity and sequence-specific DNA binding activity.

WB:WBGene00304789	F08F1.21
No description available

WB:WBGene00304790	ZC53.22
No description available

WB:WBGene00304791	Y62H9A.16
Is affected by sir-2.1 and rrf-1 based on microarray studies. Is affected by Diazinon based on microarray studies.

WB:WBGene00304792	Y71F9AL.25
Is affected by sir-2.1; tdp-1; and dnj-14 based on microarray studies. Is affected by Chlorpyrifos; Diazinon; and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00304793	H03G16.7
Is affected by several genes including crh-1; mir-35; and lin-54 based on microarray studies. Is affected by resveratrol based on microarray studies.

WB:WBGene00304794	H40L08.9
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00304797	F31B9.7
Is affected by ain-1; acs-3; and nhr-25 based on microarray studies.

WB:WBGene00304798	F31B9.8
No description available

WB:WBGene00304806	F41G4.13
Is affected by several genes including eat-2; mut-2; and deps-1 based on microarray studies. Is affected by dafa#1 based on microarray studies.

WB:WBGene00304808	F47E1.20
Is enriched in neurons based on microarray studies. Is affected by tetrabromobisphenol A and dibromoacetic acid based on microarray studies. Is predicted to encode a protein with the following domains: Zinc finger, C2H2 type; Zinc finger C2H2-type; and Zinc finger C2H2 superfamily.

WB:WBGene00304811	E02D9.3
Is predicted to have ATP binding activity and protein serine/threonine kinase activity.

WB:WBGene00304812	ZK380.6
No description available

WB:WBGene00304813	F07G6.11
No description available

WB:WBGene00304814	F07G6.12
No description available

WB:WBGene00304815	Y40A1A.6
No description available

WB:WBGene00304816	R11G1.11
Is affected by tdp-1 and hlh-25 based on microarray studies. Is affected by five chemicals including resveratrol; Atrazine; and Humic Substances based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00304817	R160.12
No description available

WB:WBGene00304818	R160.14
No description available

WB:WBGene00304819	R160.13
No description available

WB:WBGene00304820	R193.6
No description available

WB:WBGene00304822	T14G8.6
Is affected by daf-19; tbx-2; and eat-2 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00304823	Y7A5A.24
Is enriched in DA neuron; I5 neuron; SAB; and retrovesicular ganglion based on microarray studies. Is affected by eat-2 based on microarray studies. Is affected by Atrazine; cadmium; and fluoranthene based on microarray studies.

WB:WBGene00304824	Y7A5A.25
No description available

WB:WBGene00304825	Y41G9A.17
Is affected by adsorbable organic bromine compound based on microarray studies.

WB:WBGene00304826	Y59E1A.4
Is enriched in muscle cell based on microarray studies. Is affected by sir-2.1 based on microarray studies. Is affected by fluoranthene and Sirolimus based on microarray studies.

WB:WBGene00304827	Y73B3A.32
No description available

WB:WBGene00304828	Y108F1.6
Is affected by nitroguanidine based on microarray studies.

WB:WBGene00304895	F52G3.8
No description available

WB:WBGene00304901	C04F6.9
No description available

WB:WBGene00304906	Y81B9A.5
No description available

WB:WBGene00304907	C03B1.17
Is affected by cadmium and fluoranthene based on microarray studies.

WB:WBGene00304908	F20D1.22
No description available

WB:WBGene00304930	Y50E8A.22
No description available

WB:WBGene00304981	D1081.19
Is affected by isp-1 and nuo-6 based on microarray studies. Is affected by six chemicals including Atrazine; cadmium; and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00304985	D1081.20
Is predicted to encode a protein with the following domains: Snake toxin and toxin-like protein and Snake toxin/toxin-like.

WB:WBGene00304992	F35C12.7
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by several genes including let-60; sir-2.1; and nhr-25 based on microarray studies. Is affected by Humic Substances and Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: Phosphorylation site.

WB:WBGene00304996	F55A12.18
Is affected by daf-2 and tdp-1 based on microarray studies.

WB:WBGene00305018	K07A1.21
Is enriched in intestine based on microarray studies. Is affected by several genes including dpy-10; isp-1; and alg-1 based on microarray studies. Is affected by six chemicals including resveratrol; Acrylamide; and Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00305047	M01G12.15
Is affected by Atrazine based on microarray studies.

WB:WBGene00305048	M01G12.16
Is predicted to have G protein-coupled peptide receptor activity.

WB:WBGene00305049	Y53C10A.24
No description available

WB:WBGene00305050	Y92H12BL.7
Is affected by tdp-1 based on microarray studies. Is predicted to encode a protein with the following domains: RhoGAP domain; Rho GTPase-activating protein domain; and Rho GTPase activation protein.

WB:WBGene00305065	F14D2.20
No description available

WB:WBGene00305066	Y55B1BR.8
Is affected by fluoranthene based on microarray studies.

WB:WBGene00305067	F10C5.3
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00305069	Y80D4G.2
Is predicted to encode a protein with the following domain: .

WB:WBGene00305086	B0252.11
Is affected by several genes including dpy-10; sir-2.1; and aak-2 based on microarray studies. Is affected by four chemicals including resveratrol; Quercetin; and Humic Substances based on microarray studies.

WB:WBGene00305090	C07D10.7
No description available

WB:WBGene00305091	C16C8.26
Is affected by crh-1 based on microarray studies. Is affected by Sirolimus based on microarray studies.

WB:WBGene00305092	C16C8.25
No description available

WB:WBGene00305093	C16C8.27
Is enriched in male-specific anatomical entity based on microarray studies. Is affected by sir-2.1 based on microarray studies. Is affected by Progesterone based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00305095	C31C9.9
Is affected by isp-1 and nuo-6 based on microarray studies. Is affected by Sirolimus based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00305102	C46F9.5
No description available

WB:WBGene00305103	C16C4.19
No description available

WB:WBGene00305104	C46F9.6
Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00305109	C54A12.9
No description available

WB:WBGene00305110	F08D12.15
Is affected by Atrazine and fluoranthene based on microarray studies. Is predicted to encode a protein with the following domains: F-box associated and F-box associated domain, type 2.

WB:WBGene00305111	F22E5.22
Is affected by several genes including pmk-1; tax-6; and ogt-1 based on microarray studies. Is affected by four chemicals including Testosterone; Colistin; and dafa#1 based on microarray studies.

WB:WBGene00305112	F22E5.23
Is enriched in intestine based on microarray studies. Is affected by sir-2.1 and rrf-1 based on microarray studies. Is affected by five chemicals including Cry5B; Chlorpyrifos; and Diazinon based on microarray studies.

WB:WBGene00305113	F36H5.18
Is predicted to encode a protein with the following domain: .

WB:WBGene00305114	F43C11.16
Is affected by alg-1 and daf-19 based on microarray studies. Is affected by Acrylamide based on microarray studies. Is predicted to encode a protein with the following domains: TRA-1 regulated protein R03H10.4 and TRA-1 regulated.

WB:WBGene00305130	F49C5.16
Is predicted to encode a protein with the following domains: Domain of unknown function (DUF281) and Domain of unknown function DUF281.

WB:WBGene00305131	F54H12.10
Is affected by several genes including sir-2.1; ain-1; and spr-5 based on microarray studies. Is affected by Chlorpyrifos and Diazinon based on microarray studies.

WB:WBGene00305132	T10D4.19
Is affected by mut-2 based on microarray studies. Is affected by cadmium and Colistin based on microarray studies. Is predicted to encode a protein with the following domains: Domain of unknown function (DUF19); Domain of unknown function DUF19; and Uncharacterised protein family UPF0376.

WB:WBGene00305157	T24H7.9
Is involved in sterol metabolic process.

WB:WBGene00305158	Y16E11A.4
Is predicted to encode a protein with the following domains: MATH domain; MATH/TRAF domain; and TRAF-like.

WB:WBGene00305159	Y38E10A.35
Is affected by sir-2.1 based on microarray studies. Is affected by Atrazine based on microarray studies.

WB:WBGene00305173	H12C20.7
Is affected by several genes including daf-16; daf-2; and alg-1 based on microarray studies. Is affected by four chemicals including Atrazine; Hydrolyzable Tannins; and Humic Substances based on microarray studies.

WB:WBGene00305233	3R5.3
No description available

WB:WBGene00305234	AC3.17
No description available

WB:WBGene00305235	AH10.11
No description available

WB:WBGene00305236	B0019.5
No description available

WB:WBGene00305237	B0019.6
No description available

WB:WBGene00305238	B0303.18
No description available

WB:WBGene00305239	B0399.4
No description available

WB:WBGene00305240	B0412.9
No description available

WB:WBGene00305241	B0412.10
No description available

WB:WBGene00305242	B0412.11
No description available

WB:WBGene00305243	B0457.20
No description available

WB:WBGene00305244	B0511.20
No description available

WB:WBGene00305245	B0513.91
No description available

WB:WBGene00305246	BE0003N10.7
No description available

WB:WBGene00305247	C01G10.20
No description available

WB:WBGene00305248	C01G10.21
No description available

WB:WBGene00305249	C01G5.26
No description available

WB:WBGene00305250	C01G6.14
No description available

WB:WBGene00305251	C02C6.15
No description available

WB:WBGene00305252	C02C6.16
No description available

WB:WBGene00305253	C04E7.8
No description available

WB:WBGene00305254	C05D10.8
No description available

WB:WBGene00305255	C06A5.13
No description available

WB:WBGene00305256	C06G3.19
No description available

WB:WBGene00305257	C07B5.10
No description available

WB:WBGene00305258	C08B11.14
No description available

WB:WBGene00305259	C09D4.10
No description available

WB:WBGene00305260	C09D8.16
No description available

WB:WBGene00305261	C09E8.7
No description available

WB:WBGene00305262	C10C6.14
No description available

WB:WBGene00305263	C11G6.7
No description available

WB:WBGene00305264	C13B9.6
No description available

WB:WBGene00305265	C14A6.18
No description available

WB:WBGene00305266	C14A6.19
No description available

WB:WBGene00305267	C14A6.20
No description available

WB:WBGene00305268	C15F1.16
No description available

WB:WBGene00305269	C15H9.14
No description available

WB:WBGene00305270	C15H9.15
No description available

WB:WBGene00305271	C16A11.11
No description available

WB:WBGene00305272	C16B8.14
No description available

WB:WBGene00305273	C16C8.28
No description available

WB:WBGene00305274	C16C8.29
No description available

WB:WBGene00305275	C17D12.19
No description available

WB:WBGene00305276	C17D12.20
No description available

WB:WBGene00305277	C18A11.14
No description available

WB:WBGene00305278	C18D11.12
No description available

WB:WBGene00305279	C18E3.11
No description available

WB:WBGene00305280	C18F3.13
No description available

WB:WBGene00305281	C24A1.9
No description available

WB:WBGene00305282	C24A8.14
No description available

WB:WBGene00305283	C24G6.14
No description available

WB:WBGene00305284	C24H12.20
No description available

WB:WBGene00305285	C25D7.19
No description available

WB:WBGene00305286	C25D7.20
No description available

WB:WBGene00305287	C26H9A.5
No description available

WB:WBGene00305288	C27A12.14
No description available

WB:WBGene00305289	C28A5.13
No description available

WB:WBGene00305290	C28D4.19
No description available

WB:WBGene00305291	C28D4.20
No description available

WB:WBGene00305292	C28D4.21
No description available

WB:WBGene00305293	C29F7.12
No description available

WB:WBGene00305294	C30B5.18
No description available

WB:WBGene00305295	C31G12.17
No description available

WB:WBGene00305296	C33F10.27
No description available

WB:WBGene00305297	C33F10.28
No description available

WB:WBGene00305298	C33G8.18
No description available

WB:WBGene00305299	C33H5.22
No description available

WB:WBGene00305300	C34E10.13
No description available

WB:WBGene00305301	C34E7.9
No description available

WB:WBGene00305302	C34F11.19
No description available

WB:WBGene00305303	C35D10.20
No description available

WB:WBGene00305304	C35E7.13
No description available

WB:WBGene00305305	C36A4.15
No description available

WB:WBGene00305306	C36F7.27
No description available

WB:WBGene00305307	C37F5.2
No description available

WB:WBGene00305308	C39B5.18
No description available

WB:WBGene00305309	C39B5.17
No description available

WB:WBGene00305310	C40A11.11
No description available

WB:WBGene00305311	C40A11.12
No description available

WB:WBGene00305312	C40H1.14
No description available

WB:WBGene00305313	C41H7.12
No description available

WB:WBGene00305314	C43D7.20
No description available

WB:WBGene00305315	C43E11.14
No description available

WB:WBGene00305316	C44E4.11
No description available

WB:WBGene00305317	C44E4.12
No description available

WB:WBGene00305318	C46A5.16
No description available

WB:WBGene00305319	C46C2.13
No description available

WB:WBGene00305320	C47B2.10
No description available

WB:WBGene00305321	C47B2.11
No description available

WB:WBGene00305322	C47B2.12
No description available

WB:WBGene00305323	C48G7.5
No description available

WB:WBGene00305324	C52E12.12
No description available

WB:WBGene00305325	C52E4.19
No description available

WB:WBGene00305326	C54C6.12
No description available

WB:WBGene00305327	C54C6.13
No description available

WB:WBGene00305328	C54C6.14
No description available

WB:WBGene00305329	C55B7.14
No description available

WB:WBGene00305330	C55B7.15
No description available

WB:WBGene00305331	C56G2.23
No description available

WB:WBGene00305332	CC4.4
No description available

WB:WBGene00305333	CD4.20
No description available

WB:WBGene00305334	D2013.14
No description available

WB:WBGene00305335	DY3.13
No description available

WB:WBGene00305336	E01A2.12
No description available

WB:WBGene00305337	E03A3.12
No description available

WB:WBGene00305338	F02A9.11
No description available

WB:WBGene00305339	F02A9.12
No description available

WB:WBGene00305340	F02A9.13
No description available

WB:WBGene00305341	F02H6.73
No description available

WB:WBGene00305342	F07A5.9
No description available

WB:WBGene00305343	F07C6.9
No description available

WB:WBGene00305344	F09E5.24
No description available

WB:WBGene00305345	F09G2.15
No description available

WB:WBGene00305346	F10D2.17
No description available

WB:WBGene00305347	F10F2.17
No description available

WB:WBGene00305348	F10F2.18
No description available

WB:WBGene00305349	F11A10.10
No description available

WB:WBGene00305350	F12A10.14
No description available

WB:WBGene00305351	F13A7.16
No description available

WB:WBGene00305352	F13A7.17
No description available

WB:WBGene00305353	F13B9.11
No description available

WB:WBGene00305354	F14E5.9
No description available

WB:WBGene00305355	F15B10.5
No description available

WB:WBGene00305356	F15B10.6
No description available

WB:WBGene00305357	F15B9.16
No description available

WB:WBGene00305358	F15D3.12
No description available

WB:WBGene00305359	F18A12.10
No description available

WB:WBGene00305360	F18A12.11
No description available

WB:WBGene00305361	F19C7.9
No description available

WB:WBGene00305362	F20H11.7
No description available

WB:WBGene00305363	F21H12.11
No description available

WB:WBGene00305364	F22B8.10
No description available

WB:WBGene00305365	F22D6.19
No description available

WB:WBGene00305366	F22G12.10
No description available

WB:WBGene00305367	F25B5.12
No description available

WB:WBGene00305368	F25H5.12
No description available

WB:WBGene00305369	F25H8.26
No description available

WB:WBGene00305370	F26D2.19
No description available

WB:WBGene00305371	F26E4.19
No description available

WB:WBGene00305372	F26E4.20
No description available

WB:WBGene00305373	F26F12.21
No description available

WB:WBGene00305374	F27C1.19
No description available

WB:WBGene00305375	F27D4.13
No description available

WB:WBGene00305376	F28B3.11
No description available

WB:WBGene00305377	F28B3.12
No description available

WB:WBGene00305378	F28F5.18
No description available

WB:WBGene00305379	F31E3.14
No description available

WB:WBGene00305380	F32F2.5
No description available

WB:WBGene00305381	F32H2.16
No description available

WB:WBGene00305382	F32H2.17
No description available

WB:WBGene00305383	F33C8.11
No description available

WB:WBGene00305384	F33E11.8
No description available

WB:WBGene00305385	F33E11.9
No description available

WB:WBGene00305386	F34D10.11
No description available

WB:WBGene00305387	F35C5.14
No description available

WB:WBGene00305388	F35E2.13
No description available

WB:WBGene00305389	F35F11.5
No description available

WB:WBGene00305390	F35F11.6
No description available

WB:WBGene00305391	F35F11.7
No description available

WB:WBGene00305392	F35G12.15
No description available

WB:WBGene00305393	F36D3.17
No description available

WB:WBGene00305394	F36D3.18
No description available

WB:WBGene00305395	F36F2.12
No description available

WB:WBGene00305396	F36G9.19
No description available

WB:WBGene00305397	F36H5.19
No description available

WB:WBGene00305398	F36H5.20
No description available

WB:WBGene00305399	F37C4.9
No description available

WB:WBGene00305400	F37D6.13
No description available

WB:WBGene00305401	F37E3.6
No description available

WB:WBGene00305402	F37H8.14
No description available

WB:WBGene00305403	F38B7.18
No description available

WB:WBGene00305404	F39B2.15
No description available

WB:WBGene00305405	F39E9.29
No description available

WB:WBGene00305406	F39H2.6
No description available

WB:WBGene00305407	F40E10.15
No description available

WB:WBGene00305408	F40E3.11
No description available

WB:WBGene00305409	F40F12.12
No description available

WB:WBGene00305410	F40F12.13
No description available

WB:WBGene00305411	F40F12.14
No description available

WB:WBGene00305412	F40F8.15
No description available

WB:WBGene00305413	F40G9.23
No description available

WB:WBGene00305414	F44B9.12
No description available

WB:WBGene00305415	F44G4.9
No description available

WB:WBGene00305416	F46A9.14
No description available

WB:WBGene00305417	F46A9.15
No description available

WB:WBGene00305418	F46B6.19
No description available

WB:WBGene00305419	F46C5.15
No description available

WB:WBGene00305420	F46H5.12
No description available

WB:WBGene00305421	F47F6.16
No description available

WB:WBGene00305422	F48F5.9
No description available

WB:WBGene00305423	F49E8.9
No description available

WB:WBGene00305424	F49H12.13
No description available

WB:WBGene00305425	F52C12.7
No description available

WB:WBGene00305426	F52E1.18
No description available

WB:WBGene00305427	F52E1.19
No description available

WB:WBGene00305428	F52G2.10
No description available

WB:WBGene00305429	F52G2.11
No description available

WB:WBGene00305430	F53A3.9
No description available

WB:WBGene00305431	F53A3.10
No description available

WB:WBGene00305432	F53A3.11
No description available

WB:WBGene00305433	F53A3.12
No description available

WB:WBGene00305434	F53A3.13
No description available

WB:WBGene00305435	F53A3.14
No description available

WB:WBGene00305436	F53F10.9
No description available

WB:WBGene00305437	F53G12.19
No description available

WB:WBGene00305438	F53H2.5
No description available

WB:WBGene00305439	F53H2.6
No description available

WB:WBGene00305440	F53H2.7
No description available

WB:WBGene00305441	F54A3.12
No description available

WB:WBGene00305442	F54A3.13
No description available

WB:WBGene00305443	F54A3.14
No description available

WB:WBGene00305444	F54A5.6
No description available

WB:WBGene00305445	F54A5.7
No description available

WB:WBGene00305446	F54C4.8
No description available

WB:WBGene00305447	F54C4.9
No description available

WB:WBGene00305448	F54D12.22
No description available

WB:WBGene00305449	F54D12.23
No description available

WB:WBGene00305450	F54F2.15
No description available

WB:WBGene00305451	F54H12.11
No description available

WB:WBGene00305452	F55A8.7
No description available

WB:WBGene00305453	F55C9.16
No description available

WB:WBGene00305454	F56A3.6
No description available

WB:WBGene00305455	F56B3.16
No description available

WB:WBGene00305456	F56D12.12
No description available

WB:WBGene00305457	F56G4.9
No description available

WB:WBGene00305458	F56G4.10
No description available

WB:WBGene00305459	F56G4.11
No description available

WB:WBGene00305460	F57B9.13
No description available

WB:WBGene00305461	F57C2.7
No description available

WB:WBGene00305462	F57C7.15
No description available

WB:WBGene00305463	F57H12.11
No description available

WB:WBGene00305464	F58B6.10
No description available

WB:WBGene00305465	F58E10.8
No description available

WB:WBGene00305466	F58G1.14
No description available

WB:WBGene00305467	F59A7.15
No description available

WB:WBGene00305468	F59E12.18
No description available

WB:WBGene00305469	F59H5.7
No description available

WB:WBGene00305470	F59H5.8
No description available

WB:WBGene00305471	F59H5.9
No description available

WB:WBGene00305472	H04J21.6
No description available

WB:WBGene00305473	H04J21.5
No description available

WB:WBGene00305474	H05C05.5
No description available

WB:WBGene00305475	H06H21.38
No description available

WB:WBGene00305476	H06I04.15
No description available

WB:WBGene00305477	H06I04.16
No description available

WB:WBGene00305478	H10D18.7
No description available

WB:WBGene00305479	H12I13.7
No description available

WB:WBGene00305480	H14A12.10
No description available

WB:WBGene00305481	H17B01.6
No description available

WB:WBGene00305482	H22D07.2
No description available

WB:WBGene00305483	H27M09.9
No description available

WB:WBGene00305484	H28O16.4
No description available

WB:WBGene00305485	H37A05.7
No description available

WB:WBGene00305486	H37N21.2
No description available

WB:WBGene00305487	H38K22.10
No description available

WB:WBGene00305488	H43I07.5
No description available

WB:WBGene00305489	K01A11.9
No description available

WB:WBGene00305490	K01A2.16
No description available

WB:WBGene00305491	K01A2.17
No description available

WB:WBGene00305492	K01A2.18
No description available

WB:WBGene00305493	K01A2.19
No description available

WB:WBGene00305494	K01A6.23
No description available

WB:WBGene00305495	K01G5.13
No description available

WB:WBGene00305496	K02B2.39
No description available

WB:WBGene00305497	K02D10.9
No description available

WB:WBGene00305498	K02E7.15
No description available

WB:WBGene00305499	K02F3.16
No description available

WB:WBGene00305500	K02F6.12
No description available

WB:WBGene00305501	K03H4.8
No description available

WB:WBGene00305502	K03H4.9
No description available

WB:WBGene00305503	K03H4.10
No description available

WB:WBGene00305504	K03H4.11
No description available

WB:WBGene00305505	K04D7.18
No description available

WB:WBGene00305506	K04G2.16
No description available

WB:WBGene00305507	K05C4.12
No description available

WB:WBGene00305508	K06B4.18
No description available

WB:WBGene00305509	K07C11.15
No description available

WB:WBGene00305510	K07E12.9
No description available

WB:WBGene00305511	K07E12.10
No description available

WB:WBGene00305512	K07E12.11
No description available

WB:WBGene00305513	K07E8.16
No description available

WB:WBGene00305514	K07F5.23
No description available

WB:WBGene00305515	K08B4.44
No description available

WB:WBGene00305516	K08D10.19
No description available

WB:WBGene00305517	K08D10.20
No description available

WB:WBGene00305518	K08D10.21
No description available

WB:WBGene00305519	K08D10.22
No description available

WB:WBGene00305520	K08H10.17
No description available

WB:WBGene00305521	K09C6.13
No description available

WB:WBGene00305522	K09E4.7
No description available

WB:WBGene00305523	K09E4.8
No description available

WB:WBGene00305524	K09H9.12
No description available

WB:WBGene00305525	K10B3.12
No description available

WB:WBGene00305526	K10B3.13
No description available

WB:WBGene00305527	K10F12.11
No description available

WB:WBGene00305528	K11H12.15
No description available

WB:WBGene00305529	K12C11.9
No description available

WB:WBGene00305530	M01E11.10
No description available

WB:WBGene00305531	M01F1.12
No description available

WB:WBGene00305532	M01G5.11
No description available

WB:WBGene00305533	M01G5.12
No description available

WB:WBGene00305534	M02D8.12
No description available

WB:WBGene00305535	M03A1.13
No description available

WB:WBGene00305536	M03F8.12
No description available

WB:WBGene00305537	M04C9.10
No description available

WB:WBGene00305538	M04D5.7
No description available

WB:WBGene00305539	M04D5.8
No description available

WB:WBGene00305540	M151.11
No description available

WB:WBGene00305541	M151.12
No description available

WB:WBGene00305542	M57.4
No description available

WB:WBGene00305543	M70.14
No description available

WB:WBGene00305544	M70.15
No description available

WB:WBGene00305545	PAR2.6
No description available

WB:WBGene00305546	R02C2.9
No description available

WB:WBGene00305547	R02C2.10
No description available

WB:WBGene00305548	R05H10.8
No description available

WB:WBGene00305549	R06B10.9
No description available

WB:WBGene00305550	R06B10.10
No description available

WB:WBGene00305551	R06B10.11
No description available

WB:WBGene00305552	R06B9.7
No description available

WB:WBGene00305553	R06C1.15
No description available

WB:WBGene00305554	R07C12.5
No description available

WB:WBGene00305555	R07C3.18
No description available

WB:WBGene00305556	R07C3.19
No description available

WB:WBGene00305557	R07E5.20
No description available

WB:WBGene00305558	R08A2.10
No description available

WB:WBGene00305559	R107.12
No description available

WB:WBGene00305560	R10E4.13
No description available

WB:WBGene00305561	R10E9.5
No description available

WB:WBGene00305562	R119.8
No description available

WB:WBGene00305563	R119.9
No description available

WB:WBGene00305564	R11E3.20
No description available

WB:WBGene00305565	R12B2.14
No description available

WB:WBGene00305566	R12E2.19
No description available

WB:WBGene00305567	R13A5.18
No description available

WB:WBGene00305568	R13H8.6
No description available

WB:WBGene00305569	R155.9
No description available

WB:WBGene00305570	R155.10
No description available

WB:WBGene00305571	R52.13
No description available

WB:WBGene00305572	T01A4.10
No description available

WB:WBGene00305573	T01D1.9
No description available

WB:WBGene00305574	T01D1.10
No description available

WB:WBGene00305575	T02B11.14
No description available

WB:WBGene00305576	T02G5.16
No description available

WB:WBGene00305577	T02G5.17
No description available

WB:WBGene00305578	T02H6.13
No description available

WB:WBGene00305579	T02H6.14
No description available

WB:WBGene00305580	T04C4.4
No description available

WB:WBGene00305581	T04C4.5
No description available

WB:WBGene00305582	T04D3.11
No description available

WB:WBGene00305583	T05H4.17
No description available

WB:WBGene00305584	T06A10.108
No description available

WB:WBGene00305585	T06C12.18
No description available

WB:WBGene00305586	T06E6.16
No description available

WB:WBGene00305587	T07A5.9
No description available

WB:WBGene00305588	T07A5.10
No description available

WB:WBGene00305589	T07A9.18
No description available

WB:WBGene00305590	T07C4.14
No description available

WB:WBGene00305591	T07G12.20
No description available

WB:WBGene00305592	T07G12.21
No description available

WB:WBGene00305593	T08A11.3
No description available

WB:WBGene00305594	T08B2.16
No description available

WB:WBGene00305595	T08B2.17
No description available

WB:WBGene00305596	T09B4.24
No description available

WB:WBGene00305597	T10B11.11
No description available

WB:WBGene00305598	T10D4.20
No description available

WB:WBGene00305599	T13C2.8
No description available

WB:WBGene00305600	T13E8.4
No description available

WB:WBGene00305601	T13F2.16
No description available

WB:WBGene00305602	T13H5.9
No description available

WB:WBGene00305603	T16G12.15
No description available

WB:WBGene00305604	T16G12.14
No description available

WB:WBGene00305605	T17A3.14
No description available

WB:WBGene00305606	T17H7.9
No description available

WB:WBGene00305607	T19C11.4
No description available

WB:WBGene00305608	T19D12.15
No description available

WB:WBGene00305609	T20D3.15
No description available

WB:WBGene00305610	T21B6.18
No description available

WB:WBGene00305611	T22A3.14
No description available

WB:WBGene00305612	T22A3.15
No description available

WB:WBGene00305613	T22D1.23
No description available

WB:WBGene00305614	T23B5.7
No description available

WB:WBGene00305615	T23D8.14
No description available

WB:WBGene00305616	T23G4.128
No description available

WB:WBGene00305617	T23G5.12
No description available

WB:WBGene00305618	T24B8.24
No description available

WB:WBGene00305619	T24E12.15
No description available

WB:WBGene00305620	T24F1.10
No description available

WB:WBGene00305621	T24H5.2
No description available

WB:WBGene00305622	T25D1.7
No description available

WB:WBGene00305623	T25G12.16
No description available

WB:WBGene00305624	T26A5.12
No description available

WB:WBGene00305625	T26A5.13
No description available

WB:WBGene00305626	T26E3.17
No description available

WB:WBGene00305627	T27A8.10
No description available

WB:WBGene00305628	T27E7.77
No description available

WB:WBGene00305629	T27E7.78
No description available

WB:WBGene00305630	T27F6.11
No description available

WB:WBGene00305631	T28A8.9
No description available

WB:WBGene00305632	T28F12.5
No description available

WB:WBGene00305633	T28H11.32
No description available

WB:WBGene00305634	W01F3.6
No description available

WB:WBGene00305635	W02A11.9
No description available

WB:WBGene00305636	W02B12.19
No description available

WB:WBGene00305637	W02B9.5
No description available

WB:WBGene00305638	W03D2.16
No description available

WB:WBGene00305639	W03F11.8
No description available

WB:WBGene00305640	W04A8.10
No description available

WB:WBGene00305641	W05H9.6
No description available

WB:WBGene00305642	W06D4.10
No description available

WB:WBGene00305643	W06E11.8
No description available

WB:WBGene00305644	W06E11.9
No description available

WB:WBGene00305645	W08A12.6
No description available

WB:WBGene00305646	W09D6.11
No description available

WB:WBGene00305647	W09G3.17
No description available

WB:WBGene00305648	W09G3.18
No description available

WB:WBGene00305649	W09G3.19
No description available

WB:WBGene00305650	W09H1.9
No description available

WB:WBGene00305651	W10C4.3
No description available

WB:WBGene00305652	W10C6.3
No description available

WB:WBGene00305653	W10D9.8
No description available

WB:WBGene00305654	Y104H12BR.2
No description available

WB:WBGene00305655	Y104H12D.10
No description available

WB:WBGene00305656	Y105E8A.52
No description available

WB:WBGene00305657	Y105E8A.53
No description available

WB:WBGene00305658	Y105E8A.54
No description available

WB:WBGene00305659	Y105E8A.55
No description available

WB:WBGene00305660	Y105E8B.16
No description available

WB:WBGene00305661	Y105E8B.17
No description available

WB:WBGene00305662	Y10G11A.93
No description available

WB:WBGene00305663	Y110A7A.25
No description available

WB:WBGene00305664	Y111B2A.38
No description available

WB:WBGene00305665	Y111B2A.39
No description available

WB:WBGene00305666	Y111B2A.40
No description available

WB:WBGene00305667	Y111B2A.41
No description available

WB:WBGene00305668	Y111B2A.42
No description available

WB:WBGene00305669	Y111B2A.43
No description available

WB:WBGene00305670	Y111B2A.44
No description available

WB:WBGene00305671	Y113G7A.24
No description available

WB:WBGene00305672	Y113G7A.25
No description available

WB:WBGene00305673	Y113G7B.31
No description available

WB:WBGene00305674	Y113G7B.32
No description available

WB:WBGene00305675	Y116A8C.472
No description available

WB:WBGene00305676	Y116A8C.473
No description available

WB:WBGene00305677	Y116A8C.474
No description available

WB:WBGene00305678	Y119D3B.28
No description available

WB:WBGene00305679	Y119D3B.29
No description available

WB:WBGene00305680	Y119D3B.30
No description available

WB:WBGene00305681	Y119D3B.31
No description available

WB:WBGene00305682	Y119D3B.32
No description available

WB:WBGene00305683	Y11D7A.23
No description available

WB:WBGene00305684	Y18D10A.31
No description available

WB:WBGene00305685	Y18D10A.32
No description available

WB:WBGene00305686	Y18D10A.33
No description available

WB:WBGene00305687	Y18H1A.19
No description available

WB:WBGene00305688	Y20F4.12
No description available

WB:WBGene00305689	Y22D7AL.20
No description available

WB:WBGene00305690	Y22D7AL.21
No description available

WB:WBGene00305691	Y22D7AL.22
No description available

WB:WBGene00305692	Y22D7AR.20
No description available

WB:WBGene00305693	Y23H5A.12
No description available

WB:WBGene00305694	Y25C1A.16
No description available

WB:WBGene00305695	Y37D8A.30
No description available

WB:WBGene00305696	Y37E11AR.10
No description available

WB:WBGene00305697	Y37E3.31
No description available

WB:WBGene00305698	Y37H2A.20
No description available

WB:WBGene00305699	Y37H9A.9
No description available

WB:WBGene00305700	Y37H9A.10
No description available

WB:WBGene00305701	Y37H9A.11
No description available

WB:WBGene00305702	Y38A8.4
No description available

WB:WBGene00305703	Y38E10A.36
No description available

WB:WBGene00305704	Y38F1A.14
No description available

WB:WBGene00305705	Y38F2AR.23
No description available

WB:WBGene00305706	Y38F2AR.24
No description available

WB:WBGene00305707	Y38F2AR.25
No description available

WB:WBGene00305708	Y38F2AR.26
No description available

WB:WBGene00305709	Y38F2AR.27
No description available

WB:WBGene00305710	Y38F2AR.28
No description available

WB:WBGene00305711	Y38H8A.13
No description available

WB:WBGene00305712	Y39A1A.32
No description available

WB:WBGene00305713	Y39A3CL.16
No description available

WB:WBGene00305714	Y39A3CR.12
No description available

WB:WBGene00305715	Y39A3CR.13
No description available

WB:WBGene00305716	Y39B6A.86
No description available

WB:WBGene00305717	Y39B6A.87
No description available

WB:WBGene00305718	Y39B6A.88
No description available

WB:WBGene00305719	Y39B6A.89
No description available

WB:WBGene00305720	Y39B6A.90
No description available

WB:WBGene00305721	Y39E4B.18
No description available

WB:WBGene00305722	Y39E4B.19
No description available

WB:WBGene00305723	Y39F10B.2
No description available

WB:WBGene00305724	Y39G10AR.33
No description available

WB:WBGene00305725	Y39H10A.10
No description available

WB:WBGene00305726	Y40B1A.7
No description available

WB:WBGene00305727	Y40B1B.11
No description available

WB:WBGene00305728	Y41C4A.33
No description available

WB:WBGene00305729	Y41C4A.34
No description available

WB:WBGene00305730	Y41D4B.37
No description available

WB:WBGene00305731	Y41D4B.38
No description available

WB:WBGene00305732	Y41D4B.39
No description available

WB:WBGene00305733	Y42H9B.11
No description available

WB:WBGene00305734	Y42H9B.12
No description available

WB:WBGene00305735	Y42H9B.13
No description available

WB:WBGene00305736	Y43F4B.15
No description available

WB:WBGene00305737	Y43F8C.28
No description available

WB:WBGene00305738	Y43F8C.29
No description available

WB:WBGene00305739	Y43H11AL.9
No description available

WB:WBGene00305740	Y43H11AL.10
No description available

WB:WBGene00305741	Y43H11AL.11
No description available

WB:WBGene00305742	Y45F10A.9
No description available

WB:WBGene00305743	Y45F10A.10
No description available

WB:WBGene00305744	Y45F10B.62
No description available

WB:WBGene00305745	Y45F10D.140
No description available

WB:WBGene00305746	Y46E12BL.12
No description available

WB:WBGene00305747	Y46E12BL.13
No description available

WB:WBGene00305748	Y46E12BM.2
No description available

WB:WBGene00305749	Y46H3A.8
No description available

WB:WBGene00305750	Y47D3A.36
No description available

WB:WBGene00305751	Y47D3A.37
No description available

WB:WBGene00305752	Y47G6A.40
No description available

WB:WBGene00305753	Y47G6A.41
No description available

WB:WBGene00305754	Y47H10A.9
No description available

WB:WBGene00305755	Y47H9C.22
No description available

WB:WBGene00305756	Y47H9C.23
No description available

WB:WBGene00305757	Y48A5A.4
No description available

WB:WBGene00305758	Y48A6B.19
No description available

WB:WBGene00305759	Y48A6C.11
No description available

WB:WBGene00305760	Y48A6C.12
No description available

WB:WBGene00305761	Y48A6C.13
No description available

WB:WBGene00305762	Y48A6C.14
No description available

WB:WBGene00305763	Y48A6C.15
No description available

WB:WBGene00305764	Y48C3A.26
No description available

WB:WBGene00305765	Y48E1B.18
No description available

WB:WBGene00305766	Y48G1A.8
No description available

WB:WBGene00305767	Y48G1C.14
No description available

WB:WBGene00305768	Y48G1C.15
No description available

WB:WBGene00305769	Y48G8AL.21
No description available

WB:WBGene00305770	Y48G8AL.22
No description available

WB:WBGene00305771	Y48G9A.19
No description available

WB:WBGene00305772	Y48G9A.20
No description available

WB:WBGene00305773	Y48G9A.21
No description available

WB:WBGene00305774	Y48G9A.22
No description available

WB:WBGene00305775	Y49E10.38
No description available

WB:WBGene00305776	Y49F6B.21
No description available

WB:WBGene00305777	Y49F6B.22
No description available

WB:WBGene00305778	Y50C1A.3
No description available

WB:WBGene00305779	Y50D4A.13
No description available

WB:WBGene00305780	Y50D4C.13
No description available

WB:WBGene00305781	Y50D4C.14
No description available

WB:WBGene00305782	Y50D7A.19
No description available

WB:WBGene00305783	Y50D7A.20
No description available

WB:WBGene00305784	Y50D7A.21
No description available

WB:WBGene00305785	Y50D7A.22
No description available

WB:WBGene00305786	Y51A2D.42
No description available

WB:WBGene00305787	Y51A2D.43
No description available

WB:WBGene00305788	Y51A2D.44
No description available

WB:WBGene00305789	Y51F10.16
No description available

WB:WBGene00305790	Y51H4A.942
No description available

WB:WBGene00305791	Y51H4A.943
No description available

WB:WBGene00305792	Y52B11A.22
No description available

WB:WBGene00305793	Y53C12B.10
No description available

WB:WBGene00305794	Y53F4A.6
No description available

WB:WBGene00305795	Y53F4A.7
No description available

WB:WBGene00305796	Y53F4B.64
No description available

WB:WBGene00305797	Y53F4B.65
No description available

WB:WBGene00305798	Y53G8AR.11
No description available

WB:WBGene00305799	Y53G8AR.12
No description available

WB:WBGene00305800	Y53G8B.6
No description available

WB:WBGene00305801	Y53G8B.7
No description available

WB:WBGene00305802	Y53G8B.8
No description available

WB:WBGene00305803	Y53G8B.9
No description available

WB:WBGene00305804	Y53G8B.10
No description available

WB:WBGene00305805	Y53G8B.11
No description available

WB:WBGene00305806	Y53G8B.12
No description available

WB:WBGene00305807	Y53H1A.11
No description available

WB:WBGene00305808	Y53H1C.12
No description available

WB:WBGene00305809	Y53H1C.13
No description available

WB:WBGene00305810	Y54E10A.30
No description available

WB:WBGene00305811	Y54E10A.31
No description available

WB:WBGene00305812	Y54E2A.15
No description available

WB:WBGene00305813	Y54E5A.9
No description available

WB:WBGene00305814	Y54E5B.8
No description available

WB:WBGene00305815	Y54F10AL.4
No description available

WB:WBGene00305816	Y54F10AL.5
No description available

WB:WBGene00305817	Y54F10AL.6
No description available

WB:WBGene00305818	Y54F10AL.7
No description available

WB:WBGene00305819	Y54F10BM.24
No description available

WB:WBGene00305820	Y54G11A.24
No description available

WB:WBGene00305821	Y54G11A.21
No description available

WB:WBGene00305822	Y54G11A.22
No description available

WB:WBGene00305823	Y54G11A.23
No description available

WB:WBGene00305824	Y54G2A.78
No description available

WB:WBGene00305825	Y54G2A.79
No description available

WB:WBGene00305826	Y54G2A.80
No description available

WB:WBGene00305827	Y54H5A.7
No description available

WB:WBGene00305828	Y55B1BM.2
No description available

WB:WBGene00305829	Y55B1BR.9
No description available

WB:WBGene00305830	Y55B1BR.10
No description available

WB:WBGene00305831	Y55F3AM.24
No description available

WB:WBGene00305832	Y55F3AR.5
No description available

WB:WBGene00305833	Y55F3BL.7
No description available

WB:WBGene00305834	Y55F3BR.20
No description available

WB:WBGene00305835	Y56A3A.42
No description available

WB:WBGene00305836	Y56A3A.43
No description available

WB:WBGene00305837	Y56A3A.44
No description available

WB:WBGene00305838	Y57A10A.45
No description available

WB:WBGene00305839	Y57A10A.46
No description available

WB:WBGene00305840	Y57A10A.47
No description available

WB:WBGene00305841	Y57A10B.11
No description available

WB:WBGene00305842	Y59A8B.41
No description available

WB:WBGene00305843	Y59A8B.42
No description available

WB:WBGene00305844	Y59A8B.43
No description available

WB:WBGene00305845	Y59A8B.44
No description available

WB:WBGene00305846	Y59A8B.45
No description available

WB:WBGene00305847	Y59A8B.46
No description available

WB:WBGene00305848	Y60A3A.37
No description available

WB:WBGene00305849	Y60A3A.38
No description available

WB:WBGene00305850	Y60A3A.39
No description available

WB:WBGene00305851	Y60A3A.40
No description available

WB:WBGene00305852	Y60A3A.41
No description available

WB:WBGene00305853	Y61A9LA.14
No description available

WB:WBGene00305854	Y61A9LA.15
No description available

WB:WBGene00305855	Y61A9LA.16
No description available

WB:WBGene00305856	Y63D3A.13
No description available

WB:WBGene00305857	Y63D3A.14
No description available

WB:WBGene00305858	Y65B4BL.13
No description available

WB:WBGene00305859	Y67D8A.11
No description available

WB:WBGene00305860	Y67D8C.24
No description available

WB:WBGene00305861	Y67D8C.25
No description available

WB:WBGene00305862	Y67D8C.26
No description available

WB:WBGene00305863	Y69A2AR.52
No description available

WB:WBGene00305864	Y69A2AR.53
No description available

WB:WBGene00305865	Y69A2AR.54
No description available

WB:WBGene00305866	Y69A2AR.55
No description available

WB:WBGene00305867	Y69A2AR.56
No description available

WB:WBGene00305868	Y69E1A.16
No description available

WB:WBGene00305869	Y69H2.29
No description available

WB:WBGene00305870	Y69H2.30
No description available

WB:WBGene00305871	Y69H2.31
No description available

WB:WBGene00305872	Y69H2.32
No description available

WB:WBGene00305873	Y69H2.33
No description available

WB:WBGene00305874	Y6B3A.2
No description available

WB:WBGene00305875	Y6B3B.16
No description available

WB:WBGene00305876	Y6D1A.4
No description available

WB:WBGene00305877	Y71A12B.34
No description available

WB:WBGene00305878	Y71A12B.35
No description available

WB:WBGene00305879	Y71F9AM.10
No description available

WB:WBGene00305880	Y71G10AR.6
No description available

WB:WBGene00305881	Y71G12A.6
No description available

WB:WBGene00305882	Y71G12A.7
No description available

WB:WBGene00305883	Y71G12B.45
No description available

WB:WBGene00305884	Y71G12B.46
No description available

WB:WBGene00305885	Y71G12B.47
No description available

WB:WBGene00305886	Y73B3A.33
No description available

WB:WBGene00305887	Y73B6BL.291
No description available

WB:WBGene00305888	Y73B6BL.292
No description available

WB:WBGene00305889	Y73F8A.1177
No description available

WB:WBGene00305890	Y74C10AM.2
No description available

WB:WBGene00305891	Y75B8A.64
No description available

WB:WBGene00305892	Y75B8A.65
No description available

WB:WBGene00305893	Y76B12C.12
No description available

WB:WBGene00305894	Y76B12C.13
No description available

WB:WBGene00305895	Y76B12C.14
No description available

WB:WBGene00305896	Y76B12C.15
No description available

WB:WBGene00305897	Y76B12C.16
No description available

WB:WBGene00305898	Y77E11A.24
No description available

WB:WBGene00305899	Y77E11A.25
No description available

WB:WBGene00305900	Y77E11A.26
No description available

WB:WBGene00305901	Y79H2A.15
No description available

WB:WBGene00305902	Y80D3A.17
No description available

WB:WBGene00305903	Y80D3A.18
No description available

WB:WBGene00305904	Y80D3A.19
No description available

WB:WBGene00305905	Y80D3A.20
No description available

WB:WBGene00305906	Y80D3A.21
No description available

WB:WBGene00305907	Y80D3A.22
No description available

WB:WBGene00305908	Y82E9BR.33
No description available

WB:WBGene00305909	Y82E9BR.34
No description available

WB:WBGene00305910	Y82E9BR.35
No description available

WB:WBGene00305911	Y82E9BR.36
No description available

WB:WBGene00305912	Y87G2A.27
No description available

WB:WBGene00305913	Y87G2A.28
No description available

WB:WBGene00305914	Y87G2A.29
No description available

WB:WBGene00305915	Y87G2A.30
No description available

WB:WBGene00305916	Y92C3B.5
No description available

WB:WBGene00305917	Y92H12A.9
No description available

WB:WBGene00305918	Y92H12A.10
No description available

WB:WBGene00305919	Y92H12A.11
No description available

WB:WBGene00305920	Y92H12A.12
No description available

WB:WBGene00305921	Y92H12A.13
No description available

WB:WBGene00305922	Y92H12BL.8
No description available

WB:WBGene00305923	Y92H12BL.9
No description available

WB:WBGene00305924	Y92H12BL.10
No description available

WB:WBGene00305925	Y92H12BR.9
No description available

WB:WBGene00305926	Y92H12BR.10
No description available

WB:WBGene00305927	Y92H12BR.11
No description available

WB:WBGene00305928	Y95B8A.19
No description available

WB:WBGene00305929	Y95B8A.20
No description available

WB:WBGene00305930	Y95B8A.21
No description available

WB:WBGene00305931	Y95B8A.22
No description available

WB:WBGene00305932	ZC308.7
No description available

WB:WBGene00305933	ZC308.8
No description available

WB:WBGene00305934	ZC518.9
No description available

WB:WBGene00305935	ZK1010.13
No description available

WB:WBGene00305936	ZK1010.14
No description available

WB:WBGene00305937	ZK1098.14
No description available

WB:WBGene00305938	ZK1128.11
No description available

WB:WBGene00305939	ZK1307.10
No description available

WB:WBGene00305940	ZK1307.11
No description available

WB:WBGene00305941	ZK177.14
No description available

WB:WBGene00305942	ZK250.16
No description available

WB:WBGene00305943	ZK355.9
No description available

WB:WBGene00305944	ZK370.12
No description available

WB:WBGene00305945	ZK418.14
No description available

WB:WBGene00305946	ZK484.13
No description available

WB:WBGene00305947	ZK484.14
No description available

WB:WBGene00305948	ZK484.15
No description available

WB:WBGene00305949	ZK484.16
No description available

WB:WBGene00305950	ZK484.17
No description available

WB:WBGene00305951	ZK593.15
No description available

WB:WBGene00305952	ZK643.14
No description available

WB:WBGene00305953	ZK742.9
No description available

WB:WBGene00305954	ZK795.10
No description available

WB:WBGene00305955	ZK858.11
No description available

WB:WBGene00305956	ZK892.11
No description available

WB:WBGene00305957	ZK938.13
No description available

WB:WBGene00305970	C09E7.11
Is affected by dibromoacetic acid and adsorbable organic bromine compound based on microarray studies.

WB:WBGene00305979	C18H2.8
No description available

WB:WBGene00305980	C18H2.9
Is affected by isp-1 based on microarray studies. Is affected by Diazinon and allantoin based on microarray studies.

WB:WBGene00305981	C39B5.16
No description available

WB:WBGene00305991	E02H9.12
Is affected by tdp-1; nhr-25; and nuo-6 based on microarray studies. Is affected by Atrazine; fluoranthene; and Microcystin-LR based on microarray studies.

WB:WBGene00305992	E02H9.13
No description available

WB:WBGene00305993	H04D03.7
Is predicted to encode a protein with the following domain: .

WB:WBGene00305994	H04J21.4
Is affected by sir-2.1 and slr-2 based on microarray studies. Is affected by Atrazine based on microarray studies. Is predicted to encode a protein with the following domain: Ubiquitin-like domain superfamily.

WB:WBGene00305995	H09G03.4
No description available

WB:WBGene00305996	H09G03.5
No description available

WB:WBGene00305997	cTel54X.2
Is affected by ain-1 and eat-2 based on microarray studies. Is affected by Colistin and Sirolimus based on microarray studies.

WB:WBGene00305998	R148.8
Is affected by sir-2.1 based on microarray studies.

WB:WBGene00305999	T12A2.21
Is predicted to encode a protein with the following domain: Pre-mRNA-splicing factor SPF27.

WB:WBGene00306000	T12B5.18
Is affected by sir-2.1; lin-14; and lin-4 based on microarray studies.

WB:WBGene00306001	T16G12.13
Is affected by several genes including dpy-10; pmk-1; and isp-1 based on microarray studies. Is affected by five chemicals including Quercetin; Hydrolyzable Tannins; and paraquat based on microarray studies.

WB:WBGene00306002	T24C4.10
No description available

WB:WBGene00306003	W04B5.8
Is enriched in DA neuron; I5 neuron; SAB; neurons; and retrovesicular ganglion based on microarray studies. Is affected by several genes including rde-4; hpl-2; and his-24 based on microarray studies. Is affected by seven chemicals including Acrylamide; Atrazine; and Humic Substances based on microarray studies.

WB:WBGene00306004	Y39A1A.31
Is affected by sir-2.1 based on microarray studies. Is predicted to encode a protein with the following domain: .

WB:WBGene00306005	Y39A3B.8
No description available

WB:WBGene00306012	Y54F10BM.21
No description available

WB:WBGene00306013	Y54F10BM.22
No description available

WB:WBGene00306014	Y54F10BM.23
No description available

WB:WBGene00306062	K07C10.8
No description available

WB:WBGene00306066	Y54G11A.20
No description available

WB:WBGene00306069	F23F12.17
Is affected by several genes including sir-2.1; lin-35; and isp-1 based on microarray studies. Is affected by Humic Substances and Sirolimus based on microarray studies.

WB:WBGene00306070	W02A2.12
No description available

WB:WBGene00306071	mha-1
No description available

WB:WBGene00306072	mha-2
No description available

WB:WBGene00306073	mha-3
No description available

WB:WBGene00306076	Y53C10A.25
No description available

WB:WBGene00306078	Y51H7C.42
Is affected by Triclosan and nitroguanidine based on microarray studies.